data_2oii_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2oii _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo . . . . . 0 N--CA 1.488 1.156 0 N-CA-C 109.492 -1.003 . . . . 3.8300000000000001 109.492 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 847' ' ' VAL . . . . . . . . . . . . . 60.0 t -128.04 105.5 20.2 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 121.638 -0.664 . . . . 1.8300000000000001 109.986 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 848' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.37 -21.41 35.35 Favored 'Trans proline' 0 N--CA 1.486 1.076 0 O-C-N 123.196 1.103 . . . . 0.65000000000000002 110.985 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 849' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 26.47 67.43 0.06 Allowed 'General case' 0 N--CA 1.518 2.93 0 N-CA-C 113.111 0.782 . . . . 2.5800000000000001 113.111 179.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 850' ' ' VAL . . . . . . . . . . . . . 97.4 t -119.43 134.79 61.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.12 -0.987 . . . . 1.0900000000000001 111.042 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 851' ' ' ALA . . . . . . . . . . . . . . . -132.05 153.65 50.2 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 105.922 -1.881 . . . . 0.040000000000000001 105.922 177.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 852' ' ' PHE . . . . . 0.538 ' HA ' ' HB3' ' A' ' 874' ' ' ASN . 28.4 p90 -155.89 136.75 13.52 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-N 121.109 1.777 . . . . 0.050000000000000003 109.303 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 16.1 t -172.63 133.11 0.59 Allowed 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.168 -1.049 . . . . 0.040000000000000001 108.168 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -135.97 154.22 51.16 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.111 -0.993 . . . . 0.67000000000000004 109.325 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 855' ' ' ALA . . . . . . . . . . . . . . . -123.04 141.3 52.11 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.876 0.846 . . . . 0.51000000000000001 111.976 -178.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 856' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -110.09 138.27 46.7 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.656 -0.652 . . . . 0.050000000000000003 109.427 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 857' ' ' SER . . . . . 0.425 ' O ' ' O ' ' A' ' 858' ' ' LEU . 78.8 p -156.1 19.99 0.37 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.477 -0.765 . . . . 1.3300000000000001 111.325 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 858' ' ' LEU . . . . . 0.425 ' O ' ' O ' ' A' ' 857' ' ' SER . 4.2 pp -34.3 158.95 0.04 OUTLIER Pre-proline 0 N--CA 1.519 3.017 0 N-CA-C 112.816 0.672 . . . . 2.3300000000000001 112.816 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -60.95 -89.62 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 120.968 1.112 . . . . 2.3199999999999998 113.922 -177.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 54.9 ptt85 -127.98 -142.26 0.27 Allowed 'General case' 0 N--CA 1.502 2.127 0 O-C-N 120.809 -1.182 . . . . 0.040000000000000001 111.609 -177.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 27.9 m -36.14 121.15 0.67 Allowed 'General case' 0 N--CA 1.511 2.602 0 O-C-N 121.644 -0.66 . . . . 1.3100000000000001 112.291 -178.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.01 158.91 30.82 Favored Pre-proline 0 N--CA 1.488 1.466 0 N-CA-C 108.313 -0.995 . . . . 4.5099999999999998 108.313 177.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -70.23 -15.19 35.26 Favored 'Trans proline' 0 C--N 1.313 -1.337 0 O-C-N 123.206 1.108 . . . . 2.2400000000000002 111.231 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -176.91 -135.56 2.21 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.786 -1.326 . . . . 0.040000000000000001 109.786 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 23.3 m -69.47 155.88 39.75 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.344 -1.092 . . . . 1.51 111.01 -178.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 866' ' ' VAL . . . . . 0.4 ' CG1' ' CD2' ' A' ' 858' ' ' LEU . 33.7 m -91.35 136.73 26.63 Favored Pre-proline 0 N--CA 1.498 1.954 0 N-CA-C 113.549 0.944 . . . . 0.78000000000000003 113.549 -175.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 867' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -88.62 -150.39 0.04 OUTLIER 'Trans proline' 0 CA--C 1.539 0.767 0 N-CA-C 108.183 -1.507 . . . . 0.92000000000000004 108.183 177.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 868' ' ' PHE . . . . . 0.459 ' CD1' ' HG2' ' A' ' 881' ' ' PRO . 9.9 p90 -148.24 121.2 8.79 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.413 -1.43 . . . . 0.050000000000000003 110.312 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 50.1 p-10 -111.79 -3.52 14.92 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 119.374 -0.93 . . . . 1.7 111.919 -179.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 870' ' ' ARG . . . . . . . . . . . . . 26.1 mmm180 -90.4 88.43 7.18 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.999 -1.063 . . . . 2.5899999999999999 111.109 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 60.1 t -76.42 96.41 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 120.932 -1.105 . . . . 1.9399999999999999 109.173 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 872' ' ' LEU . . . . . . . . . . . . . 87.7 mt -86.97 -44.16 11.83 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.605 -0.684 . . . . 1.0600000000000001 110.921 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 873' ' ' LEU . . . . . . . . . . . . . 48.2 tp -172.3 107.69 0.2 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.159 -0.963 . . . . 4.1799999999999997 108.624 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 874' ' ' ASN . . . . . 0.538 ' HB3' ' HA ' ' A' ' 852' ' ' PHE . 12.0 p-10 174.36 81.36 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.483 0 O-C-N 121.592 -0.692 . . . . 0.040000000000000001 109.378 -178.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -69.69 -49.18 55.91 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.725 -1.234 . . . . 3.3799999999999999 111.37 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 876' ' ' GLY . . . . . 0.415 ' HA3' ' CE2' ' A' ' 878' ' ' TYR . . . -72.8 -26.8 70.4 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 110.642 -0.983 . . . . 0.040000000000000001 110.642 -179.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 78.96 -63.6 3.81 Favored Glycine 0 N--CA 1.497 2.741 0 N-CA-C 108.196 -1.961 . . . . 0.040000000000000001 108.196 -178.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 878' ' ' TYR . . . . . 0.415 ' CE2' ' HA3' ' A' ' 876' ' ' GLY . 92.6 m-85 61.7 -60.11 0.1 Allowed 'General case' 0 N--CA 1.504 2.265 0 N-CA-C 113.532 0.938 . . . . 3.46 113.532 178.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 879' ' ' TYR . . . . . 0.504 ' O ' ' CG ' ' A' ' 879' ' ' TYR . 9.8 p90 -111.24 104.69 13.21 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.919 -1.113 . . . . 0.040000000000000001 113.58 -177.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 880' ' ' ASP . . . . . 0.418 ' O ' ' N ' ' A' ' 884' ' ' GLY . 0.8 OUTLIER -69.77 112.86 13.63 Favored Pre-proline 0 N--CA 1.497 1.895 0 O-C-N 121.19 -0.944 . . . . 0.02 110.662 -178.807 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 881' ' ' PRO . . . . . 0.459 ' HG2' ' CD1' ' A' ' 868' ' ' PHE . 51.9 Cg_endo -78.33 -3.27 13.24 Favored 'Trans proline' 0 N--CA 1.489 1.221 0 O-C-N 123.489 1.257 . . . . 0.39000000000000001 111.102 179.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -77.62 -34.51 53.31 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 107.897 -1.149 . . . . 0.81000000000000005 107.897 178.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 71.0 p -112.07 -19.08 12.44 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.423 -0.808 . . . . 0.040000000000000001 109.072 176.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 884' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 880' ' ' ASP . . . 79.6 4.12 89.16 Favored Glycine 0 N--CA 1.495 2.603 0 N-CA-C 110.161 -1.176 . . . . 0.029999999999999999 110.161 -178.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 885' ' ' VAL . . . . . . . . . . . . . 66.5 t -73.3 95.08 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 C-N-CA 118.737 -1.185 . . . . 1.01 108.408 -178.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 886' ' ' PHE . . . . . 0.468 ' CD2' ' HB2' ' A' ' 879' ' ' TYR . 2.2 t80 -88.86 105.54 17.81 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 115.307 -0.86 . . . . 0.050000000000000003 111.746 -177.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 887' ' ' THR . . . . . 0.4 ' O ' ' HD3' ' A' ' 889' ' ' PRO . 35.3 m -98.03 100.31 11.64 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 107.588 -1.264 . . . . 0.68000000000000005 107.588 177.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 888' ' ' ALA . . . . . . . . . . . . . . . -99.28 106.63 40.14 Favored Pre-proline 0 N--CA 1.501 2.085 0 N-CA-C 114.049 1.129 . . . . 0.25 114.049 -176.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 889' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' A' ' 887' ' ' THR . 55.2 Cg_endo -90.18 -12.61 2.69 Favored 'Trans proline' 0 CA--C 1.546 1.093 0 C-N-CA 121.086 1.191 . . . . 1.6399999999999999 109.157 176.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 890' ' ' LEU . . . . . . . . . . . . . 72.4 mt -36.38 -50.13 0.75 Allowed 'General case' 0 N--CA 1.508 2.44 0 N-CA-C 113.855 1.057 . . . . 2.29 113.855 -177.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 51.8 96.17 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.117 -0.989 . . . . 0.63 110.321 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 156.21 -148.86 19.45 Favored Glycine 0 N--CA 1.48 1.624 0 N-CA-C 107.296 -2.322 . . . . 0.040000000000000001 107.296 -179.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 71.6 ttt-85 -111.44 127.6 55.73 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 107.753 -1.202 . . . . 3.0 107.753 177.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 894' ' ' TYR . . . . . 0.429 ' CD1' ' N ' ' A' ' 895' ' ' LEU . 0.0 OUTLIER -130.2 153.88 48.12 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.0 -1.063 . . . . 0.040000000000000001 110.876 -178.681 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 895' ' ' LEU . . . . . 0.429 ' N ' ' CD1' ' A' ' 894' ' ' TYR . 39.7 tp -96.58 114.11 25.74 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.405 -0.809 . . . . 1.27 109.961 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 896' ' ' LEU . . . . . 0.428 ' HB2' ' CZ ' ' A' ' 894' ' ' TYR . 10.3 tt -109.35 142.47 40.23 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.684 -0.635 . . . . 0.93999999999999995 111.18 -179.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 897' ' ' SER . . . . . . . . . . . . . 49.8 m -147.91 115.43 6.31 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.578 -0.701 . . . . 0.040000000000000001 110.838 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.7 147.22 31.04 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.633 -0.667 . . . . 0.47999999999999998 109.254 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 899' ' ' VAL . . . . . . . . . . . . . 99.1 t -92.69 120.1 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 C-N-CA 119.68 -0.808 . . . . 0.55000000000000004 111.237 -179.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 900' ' ' LEU . . . . . 0.406 ' N ' ' CD2' ' A' ' 900' ' ' LEU . 4.6 mm? -91.33 112.18 23.98 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 114.349 1.241 . . . . 1.5900000000000001 114.349 -175.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 23.3 m -67.52 141.72 56.79 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 107.077 -1.453 . . . . 0.050000000000000003 107.077 176.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -67.71 -66.45 2.33 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.506 -1.037 . . . . 0.029999999999999999 110.506 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 5.0 m170 46.08 65.88 1.07 Allowed 'General case' 0 N--CA 1.508 2.467 0 O-C-N 121.448 -1.03 . . . . 3.2000000000000002 111.253 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 43.2 ptt85 -69.23 -5.85 25.39 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.621 -0.675 . . . . 2.9199999999999999 112.152 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 905' ' ' HIS . . . . . 0.491 ' O ' ' CB ' ' A' ' 906' ' ' GLU . 76.2 t60 -61.86 4.37 0.12 Allowed 'General case' 0 N--CA 1.507 2.386 0 O-C-N 120.857 -1.152 . . . . 2.8700000000000001 113.141 -179.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 906' ' ' GLU . . . . . 0.491 ' CB ' ' O ' ' A' ' 905' ' ' HIS . 0.9 OUTLIER 94.7 -164.54 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.425 0 CA-C-N 120.593 1.542 . . . . 0.98999999999999999 112.076 178.984 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 907' ' ' LYS . . . . . 0.474 ' CB ' ' O ' ' A' ' 906' ' ' GLU . 29.5 ttmt 88.87 160.84 0.06 Allowed 'General case' 0 N--CA 1.522 3.137 0 N-CA-C 108.353 -0.98 . . . . 5.25 108.353 -177.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 61.4 t -122.4 116.74 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 120.818 -1.177 . . . . 0.39000000000000001 110.862 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 39.9 tp10 -105.12 131.78 52.18 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 107.629 -1.248 . . . . 1.72 107.629 177.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -156.54 120.78 4.43 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 106.819 -1.548 . . . . 0.67000000000000004 106.819 178.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 911' ' ' VAL . . . . . 0.437 ' HA ' ' HA ' ' A' ' 964' ' ' VAL . 14.4 p -77.3 132.96 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.713 -0.617 . . . . 0.54000000000000004 111.417 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 86.4 mt -65.47 156.26 32.98 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 108.193 -1.039 . . . . 1.5 108.193 178.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 913' ' ' SER . . . . . 0.43 ' CB ' ' HB ' ' A' ' 919' ' ' VAL . 1.4 t -125.66 136.27 53.05 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.462 -0.94 . . . . 1.3700000000000001 108.462 177.038 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 914' ' ' ARG . . . . . 0.427 ' O ' ' CB ' ' A' ' 915' ' ' SER . 0.0 OUTLIER -62.37 152.58 33.64 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.011 -1.056 . . . . 4.2999999999999998 111.827 -178.97 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 915' ' ' SER . . . . . 0.427 ' CB ' ' O ' ' A' ' 914' ' ' ARG . 3.5 t 83.41 -30.38 0.09 Allowed 'General case' 0 N--CA 1.52 3.056 0 C-N-CA 124.004 0.922 . . . . 2.0499999999999998 112.315 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 916' ' ' ASN . . . . . 0.422 ' O ' ' HB2' ' A' ' 917' ' ' GLN . 72.9 m-20 -126.46 -21.87 4.09 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 120.849 -1.157 . . . . 2.71 111.471 -179.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 917' ' ' GLN . . . . . 0.422 ' HB2' ' O ' ' A' ' 916' ' ' ASN . 58.6 mt-30 66.97 168.93 0.24 Allowed 'General case' 0 N--CA 1.518 2.955 0 N-CA-C 105.903 -1.888 . . . . 2.6800000000000002 105.903 -173.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 55.25 -128.87 45.1 Favored Glycine 1 N--CA 1.52 4.28 0 CA-C-N 123.64 2.927 . . . . 0.029999999999999999 106.388 -177.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 919' ' ' VAL . . . . . 0.43 ' HB ' ' CB ' ' A' ' 913' ' ' SER . 85.7 t 50.25 94.59 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.299 0 CA-C-N 118.573 1.187 . . . . 1.3899999999999999 109.249 -178.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 920' ' ' ALA . . . . . . . . . . . . . . . -92.64 94.08 8.84 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.266 -0.974 . . . . 0.029999999999999999 111.154 -179.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 921' ' ' ARG . . . . . 0.439 ' HB3' ' CZ ' ' A' ' 950' ' ' PHE . 35.1 ptt85 -80.3 -43.14 21.77 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 105.602 -1.999 . . . . 4.4199999999999999 105.602 176.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 922' ' ' VAL . . . . . . . . . . . . . 94.9 t -101.75 77.07 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 N-CA-C 105.041 -2.207 . . . . 0.84999999999999998 105.041 174.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -87.14 135.61 33.23 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 122.068 0.937 . . . . 2.46 112.39 -176.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 10.4 t -145.54 103.15 3.78 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.471 -1.307 . . . . 0.69999999999999996 107.471 178.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -103.39 81.75 0.37 Allowed Glycine 0 N--CA 1.486 2.023 0 N-CA-C 109.04 -1.624 . . . . 0.040000000000000001 109.04 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.967 0 N-CA-C 108.743 -1.743 . . . . 0.040000000000000001 108.743 179.877 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 21.7 m . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 120.963 0.411 . . . . 13.779999999999999 110.299 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 95.9 mt -109.88 129.28 55.67 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.506 -0.746 . . . . 13.76 110.325 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -152.08 169.83 31.4 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.347 -1.501 . . . . 9.1300000000000008 109.347 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 949' ' ' VAL . . . . . . . . . . . . . 34.3 m -118.4 132.4 68.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.465 -1.021 . . . . 7.0800000000000001 111.05 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 950' ' ' PHE . . . . . 0.439 ' CZ ' ' HB3' ' A' ' 921' ' ' ARG . 40.0 p90 -134.82 153.24 52.12 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.549 -0.719 . . . . 7.5899999999999999 109.124 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 69.3 m -121.59 -53.16 2.0 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.245 -0.91 . . . . 5.0300000000000002 112.356 -178.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 952' ' ' LEU . . . . . 0.425 ' O ' ' O ' ' A' ' 953' ' ' ILE . 56.6 tp -61.72 -76.33 0.06 Allowed 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.356 -0.84 . . . . 1.01 112.328 -177.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 953' ' ' ILE . . . . . 0.469 ' O ' ' HB3' ' A' ' 954' ' ' LEU . 44.6 pt -52.32 -145.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.753 0 N-CA-C 114.016 1.117 . . . . 2.6000000000000001 114.016 -176.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 954' ' ' LEU . . . . . 0.562 ' N ' ' CD1' ' A' ' 954' ' ' LEU . 0.0 OUTLIER 170.73 83.74 0.04 OUTLIER Pre-proline 0 N--CA 1.509 2.514 0 O-C-N 120.812 -1.18 . . . . 0.050000000000000003 111.66 179.441 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 955' ' ' PRO . . . . . 0.425 ' HD2' ' CE1' ' A' ' 950' ' ' PHE . 48.6 Cg_endo -76.24 95.45 1.04 Allowed 'Trans proline' 0 C--N 1.314 -1.271 0 N-CA-C 108.689 -1.312 . . . . 0.83999999999999997 108.689 177.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 956' ' ' LEU . . . . . 0.411 ' CD2' ' NH1' ' A' ' 914' ' ' ARG . 10.3 mp -122.47 143.73 49.51 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.133 -0.979 . . . . 0.040000000000000001 110.19 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -85.65 151.76 23.64 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 117.82 -1.086 . . . . 1.28 111.613 -179.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -68.95 119.75 13.75 Favored 'General case' 0 N--CA 1.509 2.48 0 CA-C-N 122.86 2.573 . . . . 0.17000000000000001 111.799 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 93.23 -21.75 38.57 Favored Glycine 0 N--CA 1.501 3.006 0 N-CA-C 111.127 -0.789 . . . . 0.040000000000000001 111.127 178.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 960' ' ' ASP . . . . . 0.403 ' HB3' ' NE ' ' A' ' 914' ' ' ARG . 0.5 OUTLIER -55.17 169.47 0.25 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.473 -1.016 . . . . 0.040000000000000001 110.201 -179.411 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 961' ' ' THR . . . . . 0.457 ' HA ' ' O ' ' A' ' 886' ' ' PHE . 44.0 m -136.52 139.55 42.34 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.903 -1.123 . . . . 1.78 112.432 -177.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 962' ' ' VAL . . . . . 0.403 ' CG2' ' CB ' ' A' ' 886' ' ' PHE . 31.9 m -100.08 144.82 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.649 -0.657 . . . . 0.040000000000000001 111.131 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 5.4 t -137.58 145.04 42.36 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.917 -0.49 . . . . 0.71999999999999997 109.991 -179.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 964' ' ' VAL . . . . . 0.437 ' HA ' ' HA ' ' A' ' 911' ' ' VAL . 61.9 t -92.17 136.3 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.028 -1.045 . . . . 1.05 111.297 -178.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -95.51 126.35 40.74 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 103.5 -2.778 . . . . 3.02 103.5 172.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 966' ' ' LEU . . . . . 0.406 ' O ' ' CG2' ' A' ' 967' ' ' VAL . 0.2 OUTLIER -133.42 61.3 1.68 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.453 -0.943 . . . . 1.46 108.453 177.362 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 967' ' ' VAL . . . . . 0.406 ' CG2' ' O ' ' A' ' 966' ' ' LEU . 97.8 t -157.65 96.26 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 108.366 -0.975 . . . . 1.9399999999999999 108.366 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 92.9 mmm -142.96 58.65 1.42 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.734 -1.229 . . . . 0.0 108.277 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 133.72 119.48 2.0 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 107.139 -2.385 . . . . 2.1099999999999999 107.139 -178.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -82.19 -57.03 3.57 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.028 -1.277 . . . . 5.8899999999999997 110.597 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 48.4 tp -58.76 89.7 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.429 -0.794 . . . . 4.3600000000000003 110.342 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -142.67 -152.57 0.42 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.561 -0.712 . . . . 1.8300000000000001 110.049 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -118.07 167.57 11.35 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.393 -0.817 . . . . 4.3499999999999996 110.211 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 30.3 t -101.98 130.29 48.47 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.578 -0.701 . . . . 1.27 110.067 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -156.05 159.01 38.76 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.485 -0.759 . . . . 5.0199999999999996 110.65 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.78 85.12 20.63 Favored Pre-proline 0 N--CA 1.5 2.042 0 O-C-N 121.701 -0.624 . . . . 2.4100000000000001 109.712 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -73.58 -172.11 0.99 Allowed 'Trans proline' 0 C--N 1.317 -1.1 0 O-C-N 123.253 1.133 . . . . 0.95999999999999996 111.3 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 5.2 mp -126.43 156.09 41.17 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 107.557 -1.275 . . . . 0.62 107.557 177.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 979' ' ' THR . . . . . . . . . . . . . 46.5 p -149.57 141.37 23.67 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.763 -1.211 . . . . 3.5699999999999998 111.155 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 980' ' ' ILE . . . . . 0.414 HG22 HD11 ' A' ' 980' ' ' ILE . 50.7 mm -107.31 128.92 61.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 N-CA-C 109.088 -0.708 . . . . 1.3300000000000001 109.088 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 981' ' ' PHE . . . . . 0.502 ' CD1' ' CE2' ' A' ' 879' ' ' TYR . 10.6 t80 -119.93 97.46 5.62 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 119.572 -0.851 . . . . 0.050000000000000003 111.899 -178.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 15.5 p -108.64 158.59 17.45 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.592 -0.693 . . . . 0.87 109.199 178.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 983' ' ' GLY . . . . . 0.429 ' HA3' ' CE1' ' A' ' 852' ' ' PHE . . . -174.29 110.78 0.34 Allowed Glycine 0 N--CA 1.498 2.783 0 N-CA-C 106.81 -2.516 . . . . 0.029999999999999999 106.81 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -107.85 149.41 28.29 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 114.245 1.202 . . . . 0.69999999999999996 114.245 -175.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 66.8 tp -72.04 136.51 46.69 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.75 -1.219 . . . . 0.040000000000000001 110.088 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 49.3 tp -106.66 -58.03 1.98 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.689 -0.632 . . . . 0.040000000000000001 110.02 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -143.9 145.87 32.6 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 107.739 -1.208 . . . . 0.040000000000000001 107.739 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.33 162.54 12.37 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 108.078 -2.009 . . . . 0.040000000000000001 108.078 179.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -76.9 111.79 18.54 Favored Pre-proline 0 N--CA 1.498 1.951 0 CA-C-N 118.536 1.168 . . . . 0.040000000000000001 109.536 179.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 990' ' ' PRO . . . . . 0.409 ' O ' ' HB2' ' A' ' 991' ' ' GLU . 49.2 Cg_endo -92.34 71.79 0.64 Allowed 'Trans proline' 0 C--N 1.318 -1.038 0 O-C-N 123.057 1.03 . . . . 0.45000000000000001 111.338 -179.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 991' ' ' GLU . . . . . 0.409 ' HB2' ' O ' ' A' ' 990' ' ' PRO . 72.3 mt-10 67.82 -73.33 0.08 Allowed 'General case' 0 N--CA 1.503 2.182 0 N-CA-C 108.345 -0.983 . . . . 1.97 108.345 -177.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 992' ' ' LEU . . . . . . . . . . . . . 4.1 mt 50.51 20.38 0.69 Allowed 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.577 -0.702 . . . . 2.3799999999999999 111.754 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -95.69 156.87 16.15 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.914 -1.116 . . . . 3.79 110.089 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 67.9 m80 -144.19 94.4 2.57 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.526 -0.734 . . . . 3.5099999999999998 110.269 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 995' ' ' ALA . . . . . . . . . . . . 2.517 . . . . . . . 0 N--CA 1.503 2.201 0 O-C-N 120.928 -1.108 . . . . 2.73 110.588 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo . . . . . 0 N--CA 1.488 1.172 0 N-CA-C 109.471 -1.011 . . . . 3.8300000000000001 109.471 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 847' ' ' VAL . . . . . . . . . . . . . 61.1 t -128.26 105.57 19.73 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.629 -0.669 . . . . 1.8300000000000001 109.93 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 848' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.29 -21.41 35.7 Favored 'Trans proline' 0 N--CA 1.486 1.087 0 O-C-N 123.253 1.133 . . . . 0.65000000000000002 111.042 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 849' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 26.48 66.9 0.06 Allowed 'General case' 0 N--CA 1.518 2.939 0 N-CA-C 113.151 0.797 . . . . 2.5800000000000001 113.151 179.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 850' ' ' VAL . . . . . . . . . . . . . 97.1 t -118.98 134.93 61.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.193 -0.942 . . . . 1.0900000000000001 111.06 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 851' ' ' ALA . . . . . . . . . . . . . . . -131.93 154.02 49.69 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 105.911 -1.885 . . . . 0.040000000000000001 105.911 177.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 852' ' ' PHE . . . . . 0.519 ' HA ' ' HB3' ' B' ' 874' ' ' ASN . 28.3 p90 -156.26 136.8 13.19 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-N 121.02 1.736 . . . . 0.050000000000000003 109.431 179.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 18.6 t -172.71 133.37 0.58 Allowed 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.046 -1.094 . . . . 0.040000000000000001 108.046 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -136.14 154.34 51.01 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.118 -0.989 . . . . 0.67000000000000004 109.339 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 855' ' ' ALA . . . . . . . . . . . . . . . -123.18 140.96 52.48 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.853 0.835 . . . . 0.51000000000000001 111.996 -178.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 856' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -109.79 138.74 45.73 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.729 -0.607 . . . . 0.050000000000000003 109.366 179.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 857' ' ' SER . . . . . 0.427 ' O ' ' O ' ' B' ' 858' ' ' LEU . 78.7 p -156.58 19.58 0.34 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.457 -0.777 . . . . 1.3300000000000001 111.345 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 858' ' ' LEU . . . . . 0.427 ' O ' ' O ' ' B' ' 857' ' ' SER . 4.2 pp -33.95 158.83 0.04 OUTLIER Pre-proline 0 N--CA 1.519 2.984 0 N-CA-C 112.888 0.699 . . . . 2.3300000000000001 112.888 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -60.77 -89.66 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 120.948 1.099 . . . . 2.3199999999999998 113.971 -177.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 55.0 ptt85 -127.91 -142.25 0.27 Allowed 'General case' 0 N--CA 1.501 2.1 0 O-C-N 120.753 -1.217 . . . . 0.040000000000000001 111.676 -177.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 28.4 m -36.24 121.4 0.69 Allowed 'General case' 0 N--CA 1.512 2.629 0 O-C-N 121.682 -0.637 . . . . 1.3100000000000001 112.354 -178.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 862' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.25 159.09 30.38 Favored Pre-proline 0 N--CA 1.488 1.461 0 N-CA-C 108.414 -0.958 . . . . 4.5099999999999998 108.414 177.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -70.28 -15.15 35.08 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 O-C-N 123.255 1.134 . . . . 2.2400000000000002 111.163 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -176.86 -135.55 2.21 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.901 -1.279 . . . . 0.040000000000000001 109.901 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 23.6 m -69.65 156.0 39.63 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.43 -1.041 . . . . 1.51 110.964 -178.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 866' ' ' VAL . . . . . 0.402 ' CG1' ' CD2' ' B' ' 858' ' ' LEU . 33.7 m -91.4 136.75 26.54 Favored Pre-proline 0 N--CA 1.498 1.935 0 N-CA-C 113.59 0.959 . . . . 0.78000000000000003 113.59 -175.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 867' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -88.52 -150.07 0.04 OUTLIER 'Trans proline' 0 CA--C 1.539 0.759 0 N-CA-C 108.134 -1.525 . . . . 0.92000000000000004 108.134 177.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 868' ' ' PHE . . . . . 0.461 ' CD1' ' N ' ' B' ' 868' ' ' PHE . 9.8 p90 -148.5 121.26 8.67 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.388 -1.445 . . . . 0.050000000000000003 110.246 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 50.0 p-10 -111.82 -3.81 14.81 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 119.373 -0.931 . . . . 1.7 111.991 -179.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 870' ' ' ARG . . . . . . . . . . . . . 26.3 mmm180 -90.08 88.92 7.46 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.074 -1.016 . . . . 2.5899999999999999 111.028 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 61.6 t -76.87 96.09 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 120.918 -1.113 . . . . 1.9399999999999999 109.159 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 872' ' ' LEU . . . . . . . . . . . . . 86.3 mt -86.63 -44.31 11.96 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.658 -0.651 . . . . 1.0600000000000001 110.988 -179.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 873' ' ' LEU . . . . . . . . . . . . . 48.3 tp -172.16 107.44 0.21 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.219 -0.926 . . . . 4.1799999999999997 108.528 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 874' ' ' ASN . . . . . 0.519 ' HB3' ' HA ' ' B' ' 852' ' ' PHE . 12.1 p-10 174.6 81.2 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.473 0 O-C-N 121.551 -0.718 . . . . 0.040000000000000001 109.429 -178.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -69.5 -49.2 56.9 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.826 -1.171 . . . . 3.3799999999999999 111.352 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 876' ' ' GLY . . . . . 0.413 ' HA3' ' CE2' ' B' ' 878' ' ' TYR . . . -73.03 -26.38 71.13 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 110.642 -0.983 . . . . 0.040000000000000001 110.642 -179.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 78.65 -63.58 3.72 Favored Glycine 0 N--CA 1.498 2.77 0 N-CA-C 108.258 -1.937 . . . . 0.040000000000000001 108.258 -178.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 878' ' ' TYR . . . . . 0.413 ' CE2' ' HA3' ' B' ' 876' ' ' GLY . 92.3 m-85 61.74 -60.12 0.11 Allowed 'General case' 0 N--CA 1.504 2.256 0 N-CA-C 113.545 0.942 . . . . 3.46 113.545 178.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 879' ' ' TYR . . . . . 0.516 ' CG ' ' O ' ' B' ' 879' ' ' TYR . 10.0 p90 -111.31 104.06 12.5 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.94 -1.1 . . . . 0.040000000000000001 113.601 -177.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 880' ' ' ASP . . . . . 0.421 ' O ' ' N ' ' B' ' 884' ' ' GLY . 0.8 OUTLIER -69.14 112.91 13.19 Favored Pre-proline 0 N--CA 1.497 1.914 0 O-C-N 121.165 -0.96 . . . . 0.02 110.645 -178.805 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 881' ' ' PRO . . . . . 0.461 ' HG2' ' CD1' ' B' ' 868' ' ' PHE . 51.6 Cg_endo -78.33 -3.32 13.28 Favored 'Trans proline' 0 N--CA 1.49 1.27 0 O-C-N 123.442 1.232 . . . . 0.39000000000000001 111.061 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -77.66 -34.68 52.95 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 107.935 -1.135 . . . . 0.81000000000000005 107.935 178.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 74.2 p -111.59 -19.72 12.41 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.3 -0.863 . . . . 0.040000000000000001 108.975 176.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 884' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' B' ' 880' ' ' ASP . . . 79.88 4.17 89.46 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 110.087 -1.205 . . . . 0.029999999999999999 110.087 -178.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 885' ' ' VAL . . . . . . . . . . . . . 69.0 t -73.3 95.2 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 C-N-CA 118.671 -1.212 . . . . 1.01 108.447 -178.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 886' ' ' PHE . . . . . 0.463 ' CD2' ' HB2' ' B' ' 879' ' ' TYR . 2.2 t80 -88.76 105.18 17.54 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 115.318 -0.856 . . . . 0.050000000000000003 111.86 -177.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 887' ' ' THR . . . . . 0.404 ' O ' ' HD3' ' B' ' 889' ' ' PRO . 35.3 m -97.72 100.05 11.42 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 107.655 -1.239 . . . . 0.68000000000000005 107.655 177.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 888' ' ' ALA . . . . . . . . . . . . . . . -99.14 106.64 39.73 Favored Pre-proline 0 N--CA 1.502 2.132 0 N-CA-C 114.1 1.148 . . . . 0.25 114.1 -176.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 889' ' ' PRO . . . . . 0.404 ' HD3' ' O ' ' B' ' 887' ' ' THR . 54.6 Cg_endo -90.25 -12.49 2.69 Favored 'Trans proline' 0 CA--C 1.546 1.121 0 C-N-CA 121.084 1.19 . . . . 1.6399999999999999 109.181 176.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 890' ' ' LEU . . . . . . . . . . . . . 71.9 mt -36.44 -49.99 0.75 Allowed 'General case' 0 N--CA 1.508 2.469 0 N-CA-C 113.851 1.056 . . . . 2.29 113.851 -177.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 51.75 96.27 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.41 0 O-C-N 121.159 -0.963 . . . . 0.63 110.346 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . 156.08 -148.77 19.27 Favored Glycine 0 N--CA 1.481 1.638 0 N-CA-C 107.26 -2.336 . . . . 0.040000000000000001 107.26 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 71.6 ttt-85 -111.49 127.73 55.79 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.762 -1.199 . . . . 3.0 107.762 177.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 894' ' ' TYR . . . . . 0.444 ' CZ ' ' HB2' ' B' ' 896' ' ' LEU . 0.0 OUTLIER -130.41 154.1 48.06 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.032 -1.043 . . . . 0.040000000000000001 110.903 -178.663 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 895' ' ' LEU . . . . . 0.44 ' N ' ' CD1' ' B' ' 894' ' ' TYR . 38.9 tp -96.82 114.08 25.68 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.464 -0.773 . . . . 1.27 110.033 -179.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 896' ' ' LEU . . . . . 0.444 ' HB2' ' CZ ' ' B' ' 894' ' ' TYR . 10.4 tt -109.19 143.91 37.99 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.634 -0.666 . . . . 0.93999999999999995 110.994 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 897' ' ' SER . . . . . . . . . . . . . 50.5 m -149.29 115.05 5.64 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.584 -0.697 . . . . 0.040000000000000001 110.748 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.39 147.55 30.22 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.173 -0.677 . . . . 0.47999999999999998 109.173 179.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 899' ' ' VAL . . . . . . . . . . . . . 97.5 t -93.0 120.53 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 C-N-CA 119.672 -0.811 . . . . 0.55000000000000004 111.123 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 900' ' ' LEU . . . . . 0.402 ' N ' ' CD2' ' B' ' 900' ' ' LEU . 4.6 mm? -91.64 112.17 23.98 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 114.326 1.232 . . . . 1.5900000000000001 114.326 -175.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 23.0 m -67.43 141.64 56.94 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 107.109 -1.441 . . . . 0.050000000000000003 107.109 176.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -67.63 -66.53 2.3 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 110.469 -1.052 . . . . 0.029999999999999999 110.469 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 5.0 m170 46.22 66.09 1.03 Allowed 'General case' 0 N--CA 1.508 2.439 0 O-C-N 121.456 -1.026 . . . . 3.2000000000000002 111.215 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 43.3 ptt85 -69.5 -5.7 25.78 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.634 -0.666 . . . . 2.9199999999999999 112.052 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 905' ' ' HIS . . . . . 0.492 ' O ' ' CB ' ' B' ' 906' ' ' GLU . 76.4 t60 -62.17 4.71 0.12 Allowed 'General case' 0 N--CA 1.506 2.359 0 O-C-N 120.811 -1.18 . . . . 2.8700000000000001 113.065 -179.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 906' ' ' GLU . . . . . 0.492 ' CB ' ' O ' ' B' ' 905' ' ' HIS . 0.8 OUTLIER 94.51 -164.57 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.388 0 CA-C-N 120.589 1.541 . . . . 0.98999999999999999 112.094 178.82 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 907' ' ' LYS . . . . . 0.475 ' CB ' ' O ' ' B' ' 906' ' ' GLU . 29.4 ttmt 88.88 160.84 0.06 Allowed 'General case' 0 N--CA 1.521 3.123 0 N-CA-C 108.321 -0.992 . . . . 5.25 108.321 -177.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 61.1 t -122.29 116.7 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 120.848 -1.158 . . . . 0.39000000000000001 110.864 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 39.9 tp10 -104.78 131.97 51.6 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 107.565 -1.272 . . . . 1.72 107.565 177.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -156.67 120.73 4.36 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 106.778 -1.564 . . . . 0.67000000000000004 106.778 178.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 911' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' B' ' 964' ' ' VAL . 14.4 p -77.31 132.97 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.75 -0.594 . . . . 0.54000000000000004 111.406 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 86.7 mt -65.6 156.04 33.95 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.18 -1.044 . . . . 1.5 108.18 178.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 913' ' ' SER . . . . . 0.426 ' CB ' ' HB ' ' B' ' 919' ' ' VAL . 1.4 t -125.1 137.37 54.18 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.329 -0.989 . . . . 1.3700000000000001 108.329 177.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 914' ' ' ARG . . . . . 0.426 ' O ' ' CB ' ' B' ' 915' ' ' SER . 0.0 OUTLIER -63.47 153.01 36.78 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.917 -1.114 . . . . 4.2999999999999998 111.757 -179.059 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 915' ' ' SER . . . . . 0.426 ' CB ' ' O ' ' B' ' 914' ' ' ARG . 3.5 t 83.24 -30.21 0.09 Allowed 'General case' 0 N--CA 1.521 3.1 0 C-N-CA 123.977 0.911 . . . . 2.0499999999999998 112.359 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 916' ' ' ASN . . . . . 0.436 ' O ' ' HB2' ' B' ' 917' ' ' GLN . 72.9 m-20 -126.8 -21.41 4.06 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 120.892 -1.13 . . . . 2.71 111.394 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 917' ' ' GLN . . . . . 0.436 ' HB2' ' O ' ' B' ' 916' ' ' ASN . 58.7 mt-30 66.99 168.97 0.24 Allowed 'General case' 0 N--CA 1.519 2.977 0 N-CA-C 105.892 -1.892 . . . . 2.6800000000000002 105.892 -173.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.9 -128.79 44.13 Favored Glycine 1 N--CA 1.521 4.302 0 CA-C-N 123.455 2.843 . . . . 0.029999999999999999 106.442 -177.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 919' ' ' VAL . . . . . 0.426 ' HB ' ' CB ' ' B' ' 913' ' ' SER . 84.1 t 50.55 94.57 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.3 0 CA-C-N 118.608 1.204 . . . . 1.3899999999999999 109.191 -178.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 920' ' ' ALA . . . . . . . . . . . . . . . -92.5 94.47 9.09 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.274 -0.97 . . . . 0.029999999999999999 111.116 -179.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 921' ' ' ARG . . . . . 0.438 ' HB3' ' CZ ' ' B' ' 950' ' ' PHE . 34.9 ptt85 -80.73 -43.29 20.48 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 105.553 -2.017 . . . . 4.4199999999999999 105.553 176.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 922' ' ' VAL . . . . . . . . . . . . . 94.0 t -101.68 77.59 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 N-CA-C 104.935 -2.246 . . . . 0.84999999999999998 104.935 174.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -87.56 135.78 33.21 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 122.105 0.955 . . . . 2.46 112.427 -176.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 924' ' ' SER . . . . . . . . . . . . . 10.2 t -145.6 103.4 3.79 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.461 -1.311 . . . . 0.69999999999999996 107.461 178.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -103.77 81.81 0.36 Allowed Glycine 0 N--CA 1.486 2.023 0 N-CA-C 108.965 -1.654 . . . . 0.040000000000000001 108.965 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.958 0 N-CA-C 108.74 -1.744 . . . . 0.040000000000000001 108.74 179.849 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 21.9 m . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 120.923 0.392 . . . . 13.779999999999999 110.412 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 95.5 mt -110.43 129.72 55.71 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.5 -0.75 . . . . 13.76 110.324 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -152.36 169.85 31.58 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.381 -1.487 . . . . 9.1300000000000008 109.381 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 949' ' ' VAL . . . . . . . . . . . . . 34.4 m -118.46 132.36 68.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.548 -0.972 . . . . 7.0800000000000001 111.077 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 950' ' ' PHE . . . . . 0.438 ' CZ ' ' HB3' ' B' ' 921' ' ' ARG . 39.8 p90 -134.98 152.6 51.88 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 109.127 -0.694 . . . . 7.5899999999999999 109.127 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 67.9 m -120.97 -53.03 2.07 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.318 -0.864 . . . . 5.0300000000000002 112.362 -178.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 952' ' ' LEU . . . . . 0.431 ' O ' ' O ' ' B' ' 953' ' ' ILE . 56.3 tp -61.91 -76.44 0.06 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.32 -0.862 . . . . 1.01 112.357 -177.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 953' ' ' ILE . . . . . 0.473 ' O ' ' HB3' ' B' ' 954' ' ' LEU . 43.9 pt -52.22 -145.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.749 0 N-CA-C 114.038 1.125 . . . . 2.6000000000000001 114.038 -176.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 954' ' ' LEU . . . . . 0.554 ' N ' ' CD1' ' B' ' 954' ' ' LEU . 0.0 OUTLIER 170.96 83.74 0.04 OUTLIER Pre-proline 0 N--CA 1.508 2.475 0 O-C-N 120.852 -1.155 . . . . 0.050000000000000003 111.609 179.494 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 955' ' ' PRO . . . . . 0.431 ' HD2' ' CE1' ' B' ' 950' ' ' PHE . 48.7 Cg_endo -76.34 95.23 1.03 Allowed 'Trans proline' 0 C--N 1.313 -1.292 0 N-CA-C 108.759 -1.285 . . . . 0.83999999999999997 108.759 177.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 956' ' ' LEU . . . . . 0.414 ' CD2' ' NH1' ' B' ' 914' ' ' ARG . 10.3 mp -122.3 143.9 49.33 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.151 -0.968 . . . . 0.040000000000000001 110.183 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -86.01 151.18 23.93 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 117.81 -1.09 . . . . 1.28 111.639 -179.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -68.61 119.72 13.49 Favored 'General case' 0 N--CA 1.51 2.54 0 CA-C-N 122.862 2.574 . . . . 0.17000000000000001 111.843 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 93.36 -21.5 40.24 Favored Glycine 0 N--CA 1.5 2.962 0 N-CA-C 111.15 -0.78 . . . . 0.040000000000000001 111.15 178.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 960' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.68 169.77 0.31 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.457 -1.025 . . . . 0.040000000000000001 110.203 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 961' ' ' THR . . . . . 0.452 ' HA ' ' O ' ' B' ' 886' ' ' PHE . 46.0 m -136.86 139.49 41.7 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 120.835 -1.165 . . . . 1.78 112.408 -177.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 962' ' ' VAL . . . . . 0.409 ' CG2' ' CB ' ' B' ' 886' ' ' PHE . 31.8 m -99.87 145.15 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 C-N-CA 120.023 -0.671 . . . . 0.040000000000000001 111.116 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 5.4 t -137.96 145.42 41.98 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.907 -0.496 . . . . 0.71999999999999997 109.981 -179.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 964' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' B' ' 911' ' ' VAL . 61.7 t -92.23 136.71 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.052 -1.03 . . . . 1.05 111.279 -178.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -95.69 126.42 40.96 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 103.464 -2.791 . . . . 3.02 103.464 172.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 966' ' ' LEU . . . . . 0.406 ' O ' ' CG2' ' B' ' 967' ' ' VAL . 0.2 OUTLIER -133.6 61.39 1.68 Allowed 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.408 -0.96 . . . . 1.46 108.408 177.365 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 967' ' ' VAL . . . . . 0.406 ' CG2' ' O ' ' B' ' 966' ' ' LEU . 97.6 t -157.73 96.64 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 108.283 -1.006 . . . . 1.9399999999999999 108.283 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 92.8 mmm -143.4 58.68 1.39 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.752 -1.217 . . . . 0.0 108.251 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 133.87 119.75 2.02 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 107.05 -2.42 . . . . 2.1099999999999999 107.05 -178.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -82.46 -57.1 3.5 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.971 -1.311 . . . . 5.8899999999999997 110.499 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 47.8 tp -58.68 90.03 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.402 -0.811 . . . . 4.3600000000000003 110.318 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -143.03 -152.92 0.43 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.637 -0.665 . . . . 1.8300000000000001 110.079 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -117.83 167.41 11.42 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.473 -0.767 . . . . 4.3499999999999996 110.278 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 30.2 t -101.79 130.26 48.18 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.554 -0.716 . . . . 1.27 110.082 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -156.07 158.99 38.71 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.535 -0.728 . . . . 5.0199999999999996 110.643 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.71 85.08 20.94 Favored Pre-proline 0 N--CA 1.5 2.056 0 O-C-N 121.62 -0.675 . . . . 2.4100000000000001 109.72 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -73.41 -171.89 0.92 Allowed 'Trans proline' 0 C--N 1.317 -1.129 0 O-C-N 123.3 1.158 . . . . 0.95999999999999996 111.283 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 978' ' ' LEU . . . . . . . . . . . . . 5.2 mp -126.82 155.93 42.1 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 107.546 -1.279 . . . . 0.62 107.546 177.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 979' ' ' THR . . . . . . . . . . . . . 47.6 p -149.47 141.59 23.98 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.837 -1.165 . . . . 3.5699999999999998 111.184 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 980' ' ' ILE . . . . . 0.411 HG22 HD11 ' B' ' 980' ' ' ILE . 50.6 mm -107.47 129.09 61.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 109.062 -0.718 . . . . 1.3300000000000001 109.062 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 981' ' ' PHE . . . . . 0.496 ' CD1' ' CE2' ' B' ' 879' ' ' TYR . 10.5 t80 -119.99 97.38 5.58 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 119.594 -0.843 . . . . 0.050000000000000003 111.926 -178.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 16.0 p -108.78 158.25 17.82 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 109.163 -0.68 . . . . 0.87 109.163 178.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 983' ' ' GLY . . . . . 0.425 ' HA3' ' CE1' ' B' ' 852' ' ' PHE . . . -173.98 111.09 0.35 Allowed Glycine 0 N--CA 1.498 2.812 0 N-CA-C 106.655 -2.578 . . . . 0.029999999999999999 106.655 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -108.28 149.27 28.86 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 114.32 1.23 . . . . 0.69999999999999996 114.32 -175.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 985' ' ' LEU . . . . . . . . . . . . . 66.4 tp -71.75 136.28 47.09 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.728 -1.233 . . . . 0.040000000000000001 110.201 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 986' ' ' LEU . . . . . . . . . . . . . 49.3 tp -106.53 -58.07 1.97 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.671 -0.643 . . . . 0.040000000000000001 109.946 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -143.87 146.07 32.76 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.71 -1.218 . . . . 0.040000000000000001 107.71 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.46 162.96 12.22 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 108.088 -2.005 . . . . 0.040000000000000001 108.088 179.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -77.38 111.88 20.08 Favored Pre-proline 0 N--CA 1.499 1.988 0 O-C-N 121.226 -1.161 . . . . 0.040000000000000001 109.524 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 990' ' ' PRO . . . . . 0.415 ' O ' ' HB2' ' B' ' 991' ' ' GLU . 48.7 Cg_endo -92.55 72.01 0.57 Allowed 'Trans proline' 0 C--N 1.318 -1.031 0 O-C-N 123.063 1.033 . . . . 0.45000000000000001 111.328 -178.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 991' ' ' GLU . . . . . 0.415 ' HB2' ' O ' ' B' ' 990' ' ' PRO . 72.4 mt-10 67.67 -73.43 0.08 Allowed 'General case' 0 N--CA 1.503 2.179 0 N-CA-C 108.251 -1.018 . . . . 1.97 108.251 -177.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 992' ' ' LEU . . . . . . . . . . . . . 4.1 mt 50.47 20.48 0.7 Allowed 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.58 -0.7 . . . . 2.3799999999999999 111.731 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 76.4 mt-10 -95.87 156.88 16.14 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.893 -1.13 . . . . 3.79 110.082 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 68.0 m80 -144.16 94.76 2.62 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.515 -0.741 . . . . 3.5099999999999998 110.2 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 995' ' ' ALA . . . . . . . . . . . . 2.517 . . . . . . . 0 N--CA 1.503 2.207 0 O-C-N 120.873 -1.142 . . . . 2.73 110.591 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo . . . . . 0 N--CA 1.488 1.152 0 N-CA-C 109.559 -0.977 . . . . 3.8300000000000001 109.559 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 847' ' ' VAL . . . . . . . . . . . . . 68.8 t -131.34 104.66 14.8 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.592 -0.692 . . . . 1.8300000000000001 109.819 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 848' ' ' PRO . . . . . 0.411 ' O ' ' C ' ' C' ' 849' ' ' GLN . 43.7 Cg_endo -69.7 -19.56 36.26 Favored 'Trans proline' 0 N--CA 1.487 1.118 0 O-C-N 123.295 1.155 . . . . 0.65000000000000002 111.264 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 849' ' ' GLN . . . . . 0.411 ' C ' ' O ' ' C' ' 848' ' ' PRO . 56.2 tt0 26.24 68.49 0.05 Allowed 'General case' 0 N--CA 1.52 3.037 0 N-CA-C 112.893 0.701 . . . . 2.5800000000000001 112.893 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 850' ' ' VAL . . . . . 0.436 ' CG1' ' CE2' ' C' ' 878' ' ' TYR . 93.5 t -117.21 135.24 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.245 -0.909 . . . . 1.0900000000000001 111.201 -178.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 851' ' ' ALA . . . . . . . . . . . . . . . -133.41 151.2 51.79 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 105.74 -1.948 . . . . 0.040000000000000001 105.74 177.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 852' ' ' PHE . . . . . 0.409 ' O ' ' CD1' ' C' ' 852' ' ' PHE . 11.2 p90 -158.89 133.27 7.89 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 120.865 1.666 . . . . 0.050000000000000003 108.914 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 7.4 t -174.09 134.04 0.43 Allowed 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 107.954 -1.128 . . . . 0.040000000000000001 107.954 -179.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -136.44 159.25 42.33 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.167 -0.958 . . . . 0.67000000000000004 109.671 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 855' ' ' ALA . . . . . . . . . . . . . . . -122.86 140.64 52.74 Favored 'General case' 0 N--CA 1.499 1.994 0 CA-C-O 121.939 0.876 . . . . 0.51000000000000001 112.254 -178.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 856' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -106.6 138.52 42.63 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.645 -0.659 . . . . 0.050000000000000003 109.578 179.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 857' ' ' SER . . . . . 0.43 ' O ' ' O ' ' C' ' 858' ' ' LEU . 1.3 m -159.23 18.65 0.18 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.443 -0.786 . . . . 1.3300000000000001 111.836 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 858' ' ' LEU . . . . . 0.43 ' O ' ' O ' ' C' ' 857' ' ' SER . 2.7 pp -34.57 160.0 0.04 OUTLIER Pre-proline 0 N--CA 1.519 3.02 0 CA-C-N 118.603 0.638 . . . . 2.3300000000000001 112.689 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -60.19 -88.52 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 120.734 0.956 . . . . 2.3199999999999998 113.348 -178.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 55.4 ptt85 -130.47 -143.35 0.25 Allowed 'General case' 0 N--CA 1.5 2.052 0 O-C-N 120.883 -1.135 . . . . 0.040000000000000001 111.978 -177.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 41.2 m -33.31 120.55 0.38 Allowed 'General case' 0 N--CA 1.511 2.617 0 N-CA-C 113.241 0.83 . . . . 1.3100000000000001 113.241 -178.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.79 159.49 29.16 Favored Pre-proline 0 N--CA 1.486 1.342 0 N-CA-C 107.626 -1.25 . . . . 4.5099999999999998 107.626 176.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -69.78 -13.66 34.93 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 O-C-N 123.104 1.055 . . . . 2.2400000000000002 111.524 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -176.65 -135.26 2.13 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.911 -1.275 . . . . 0.040000000000000001 109.911 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 30.1 m -70.41 157.76 37.22 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.332 -1.099 . . . . 1.51 110.416 -179.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 866' ' ' VAL . . . . . . . . . . . . . 30.7 m -95.23 142.67 24.92 Favored Pre-proline 0 N--CA 1.498 1.964 0 N-CA-C 114.233 1.197 . . . . 0.78000000000000003 114.233 -174.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 867' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -89.91 -150.69 0.04 OUTLIER 'Trans proline' 0 CA--C 1.541 0.871 0 N-CA-C 108.339 -1.446 . . . . 0.92000000000000004 108.339 177.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 868' ' ' PHE . . . . . 0.453 ' N ' ' CD1' ' C' ' 868' ' ' PHE . 14.1 p90 -148.32 121.05 8.64 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.48 -1.387 . . . . 0.050000000000000003 109.865 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 50.0 p-10 -112.03 -3.97 14.62 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.15 -0.969 . . . . 1.7 112.471 -178.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 870' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 -90.93 89.19 7.34 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.96 -1.087 . . . . 2.5899999999999999 111.031 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 61.2 t -76.51 96.52 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 120.979 -1.075 . . . . 1.9399999999999999 109.238 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 872' ' ' LEU . . . . . . . . . . . . . 66.8 mt -85.78 -44.61 12.35 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.546 -0.721 . . . . 1.0600000000000001 110.559 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 873' ' ' LEU . . . . . 0.41 ' O ' ' HB2' ' C' ' 874' ' ' ASN . 47.5 tp -172.21 104.33 0.17 Allowed 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.209 -0.932 . . . . 4.1799999999999997 108.71 178.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 874' ' ' ASN . . . . . 0.41 ' HB2' ' O ' ' C' ' 873' ' ' LEU . 49.5 t-20 178.25 82.65 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.33 0 O-C-N 121.733 -0.604 . . . . 0.040000000000000001 109.588 -178.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 33.0 p-10 -72.07 -49.44 36.48 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.092 -1.005 . . . . 3.3799999999999999 111.705 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 876' ' ' GLY . . . . . . . . . . . . . . . -73.24 -26.43 70.53 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 110.617 -0.993 . . . . 0.040000000000000001 110.617 -179.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 81.34 -61.46 4.6 Favored Glycine 0 N--CA 1.497 2.742 0 N-CA-C 108.27 -1.932 . . . . 0.040000000000000001 108.27 -178.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 878' ' ' TYR . . . . . 0.436 ' CE2' ' CG1' ' C' ' 850' ' ' VAL . 85.6 m-85 61.62 -61.95 0.09 Allowed 'General case' 0 N--CA 1.504 2.25 0 N-CA-C 113.426 0.899 . . . . 3.46 113.426 178.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 879' ' ' TYR . . . . . 0.494 ' O ' ' CG ' ' C' ' 879' ' ' TYR . 12.2 p90 -110.97 105.33 14.07 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.991 -1.068 . . . . 0.040000000000000001 113.259 -177.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 880' ' ' ASP . . . . . 0.419 ' O ' ' N ' ' C' ' 884' ' ' GLY . 1.2 m-20 -66.69 112.68 10.17 Favored Pre-proline 0 N--CA 1.497 1.883 0 O-C-N 121.161 -0.962 . . . . 0.02 110.526 -178.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 881' ' ' PRO . . . . . 0.448 ' HG2' ' CD1' ' C' ' 868' ' ' PHE . 52.2 Cg_endo -79.05 -3.33 13.1 Favored 'Trans proline' 0 N--CA 1.489 1.238 0 O-C-N 123.531 1.279 . . . . 0.39000000000000001 111.213 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -80.31 -34.57 36.65 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 108.033 -1.099 . . . . 0.81000000000000005 108.033 178.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 69.6 p -110.36 -20.31 12.66 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 115.462 -0.79 . . . . 0.040000000000000001 108.984 176.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 884' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' C' ' 880' ' ' ASP . . . 80.07 4.88 89.78 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 110.232 -1.147 . . . . 0.029999999999999999 110.232 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 71.0 t -74.39 94.61 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 C-N-CA 118.695 -1.202 . . . . 1.01 108.532 -178.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 886' ' ' PHE . . . . . 0.464 ' CD2' ' CB ' ' C' ' 879' ' ' TYR . 2.1 t80 -88.74 105.8 17.94 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 115.513 -0.767 . . . . 0.050000000000000003 111.785 -177.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 887' ' ' THR . . . . . . . . . . . . . 28.0 m -98.53 99.99 11.2 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.787 -1.19 . . . . 0.68000000000000005 107.787 177.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 888' ' ' ALA . . . . . . . . . . . . . . . -97.87 108.3 45.31 Favored Pre-proline 0 N--CA 1.5 2.062 0 N-CA-C 113.606 0.965 . . . . 0.25 113.606 -176.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 889' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -89.87 -12.77 2.81 Favored 'Trans proline' 0 CA--C 1.544 1.02 0 C-N-CA 120.999 1.133 . . . . 1.6399999999999999 109.246 176.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 890' ' ' LEU . . . . . 0.41 ' CD1' ' N ' ' C' ' 891' ' ' ALA . 3.0 pp -36.87 -48.34 0.74 Allowed 'General case' 0 N--CA 1.508 2.47 0 N-CA-C 113.819 1.044 . . . . 2.29 113.819 -177.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 891' ' ' ALA . . . . . 0.41 ' N ' ' CD1' ' C' ' 890' ' ' LEU . . . 51.17 95.49 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.34 0 O-C-N 120.998 -1.064 . . . . 0.63 110.472 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . 155.43 -146.9 15.1 Favored Glycine 0 N--CA 1.479 1.566 0 N-CA-C 107.274 -2.33 . . . . 0.040000000000000001 107.274 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 76.5 ttt-85 -108.52 127.06 53.6 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 107.223 -1.399 . . . . 3.0 107.223 176.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 894' ' ' TYR . . . . . 0.428 ' CE1' ' O ' ' C' ' 895' ' ' LEU . 0.5 OUTLIER -130.75 155.09 47.24 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.099 -1.001 . . . . 0.040000000000000001 110.841 -178.547 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 895' ' ' LEU . . . . . 0.428 ' O ' ' CE1' ' C' ' 894' ' ' TYR . 41.5 tp -99.79 117.3 33.82 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.652 -0.655 . . . . 1.27 110.539 -179.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 896' ' ' LEU . . . . . . . . . . . . . 4.5 tt -115.59 140.56 49.06 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.509 -0.745 . . . . 0.93999999999999995 110.35 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 897' ' ' SER . . . . . . . . . . . . . 50.3 m -147.07 118.44 7.87 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.376 -0.828 . . . . 0.040000000000000001 111.286 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -108.64 147.41 31.91 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 109.401 -0.592 . . . . 0.47999999999999998 109.401 178.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 899' ' ' VAL . . . . . . . . . . . . . 97.9 t -93.19 121.53 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 C-N-CA 119.68 -0.808 . . . . 0.55000000000000004 111.29 -179.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -90.52 111.59 22.93 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 114.564 1.32 . . . . 1.5900000000000001 114.564 -175.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 21.6 m -67.09 142.09 57.23 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 106.974 -1.491 . . . . 0.050000000000000003 106.974 176.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -69.14 -67.71 1.86 Allowed Glycine 0 N--CA 1.494 2.549 0 N-CA-C 110.435 -1.066 . . . . 0.029999999999999999 110.435 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 5.2 t-80 46.24 66.46 0.95 Allowed 'General case' 0 N--CA 1.509 2.483 0 O-C-N 121.442 -1.034 . . . . 3.2000000000000002 111.122 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 46.4 ptt85 -69.12 -6.9 31.42 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.611 -0.681 . . . . 2.9199999999999999 112.043 -179.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 905' ' ' HIS . . . . . 0.488 ' O ' ' CB ' ' C' ' 906' ' ' GLU . 78.1 t60 -58.24 4.58 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.516 0 CA-C-O 117.653 -1.165 . . . . 2.8700000000000001 113.953 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 906' ' ' GLU . . . . . 0.488 ' CB ' ' O ' ' C' ' 905' ' ' HIS . 0.0 OUTLIER 94.02 -167.1 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.413 0 CA-C-N 121.264 1.847 . . . . 0.98999999999999999 112.011 179.096 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 907' ' ' LYS . . . . . 0.476 ' CB ' ' O ' ' C' ' 906' ' ' GLU . 30.3 ttmt 87.89 160.42 0.07 Allowed 'General case' 0 N--CA 1.518 2.969 0 N-CA-C 108.026 -1.102 . . . . 5.25 108.026 -177.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 59.2 t -120.9 116.38 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 120.947 -1.095 . . . . 0.39000000000000001 110.652 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 75.7 tt0 -103.66 131.65 50.62 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 107.298 -1.371 . . . . 1.72 107.298 176.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -155.34 122.36 5.45 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 106.445 -1.687 . . . . 0.67000000000000004 106.445 178.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 911' ' ' VAL . . . . . 0.47 ' HA ' ' HA ' ' C' ' 964' ' ' VAL . 70.1 t -77.41 131.95 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.826 -0.546 . . . . 0.54000000000000004 110.679 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 84.0 mt -65.67 157.07 31.0 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.279 -0.888 . . . . 1.5 108.718 178.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 913' ' ' SER . . . . . 0.403 ' CB ' ' CG1' ' C' ' 919' ' ' VAL . 1.3 p -127.17 132.65 50.46 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.174 -1.047 . . . . 1.3700000000000001 108.174 176.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 914' ' ' ARG . . . . . 0.428 ' O ' ' CB ' ' C' ' 915' ' ' SER . 0.0 OUTLIER -58.81 154.45 14.92 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 120.764 -1.21 . . . . 4.2999999999999998 112.097 -178.848 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 915' ' ' SER . . . . . 0.428 ' CB ' ' O ' ' C' ' 914' ' ' ARG . 1.8 t 83.13 -30.29 0.09 Allowed 'General case' 0 N--CA 1.519 3.022 0 C-N-CA 123.869 0.868 . . . . 2.0499999999999998 112.476 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 916' ' ' ASN . . . . . 0.413 ' O ' ' HB2' ' C' ' 917' ' ' GLN . 97.2 m-20 -126.8 -23.5 3.67 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 120.891 -1.13 . . . . 2.71 111.173 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 917' ' ' GLN . . . . . 0.413 ' HB2' ' O ' ' C' ' 916' ' ' ASN . 41.8 mt-30 68.49 168.23 0.27 Allowed 'General case' 0 N--CA 1.517 2.917 0 N-CA-C 105.776 -1.935 . . . . 2.6800000000000002 105.776 -174.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 56.45 -127.72 44.56 Favored Glycine 1 N--CA 1.519 4.19 0 CA-C-N 123.397 2.817 . . . . 0.029999999999999999 106.467 -177.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 919' ' ' VAL . . . . . 0.403 ' CG1' ' CB ' ' C' ' 913' ' ' SER . 95.0 t 50.45 94.83 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.336 0 CA-C-N 118.534 1.167 . . . . 1.3899999999999999 109.426 -178.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 920' ' ' ALA . . . . . . . . . . . . . . . -93.93 93.7 8.05 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.336 -0.946 . . . . 0.029999999999999999 111.049 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 921' ' ' ARG . . . . . 0.432 ' HB3' ' CZ ' ' C' ' 950' ' ' PHE . 45.4 ptt85 -83.19 -42.96 16.67 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 105.582 -2.007 . . . . 4.4199999999999999 105.582 176.154 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 922' ' ' VAL . . . . . . . . . . . . . 77.3 t -101.05 74.65 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 104.71 -2.33 . . . . 0.84999999999999998 104.71 174.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -86.74 136.87 32.85 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 122.074 0.94 . . . . 2.46 112.614 -176.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 6.4 t -145.8 103.17 3.75 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 107.719 -1.215 . . . . 0.69999999999999996 107.719 178.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -107.48 85.75 0.43 Allowed Glycine 0 N--CA 1.488 2.123 0 N-CA-C 108.905 -1.678 . . . . 0.040000000000000001 108.905 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.278 0 N-CA-C 109.151 -1.58 . . . . 0.040000000000000001 109.151 -179.707 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 31.1 m . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 120.971 0.415 . . . . 13.779999999999999 110.335 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 92.5 mt -110.37 129.56 55.73 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.487 -0.758 . . . . 13.76 110.312 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -152.25 169.71 31.51 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.348 -1.501 . . . . 9.1300000000000008 109.348 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 949' ' ' VAL . . . . . . . . . . . . . 33.5 m -118.69 131.74 70.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.551 -0.97 . . . . 7.0800000000000001 110.843 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 950' ' ' PHE . . . . . 0.432 ' CZ ' ' HB3' ' C' ' 921' ' ' ARG . 48.2 p90 -133.36 151.14 51.82 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.579 -0.7 . . . . 7.5899999999999999 109.113 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 7.3 m -119.64 -53.19 2.21 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.401 -0.812 . . . . 5.0300000000000002 112.096 -178.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 952' ' ' LEU . . . . . 0.425 ' O ' ' O ' ' C' ' 953' ' ' ILE . 15.4 tp -62.99 -74.78 0.09 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.354 -0.841 . . . . 1.01 112.018 -177.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 953' ' ' ILE . . . . . 0.476 ' O ' ' HB3' ' C' ' 954' ' ' LEU . 41.8 pt -52.42 -146.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.77 0 N-CA-C 114.145 1.165 . . . . 2.6000000000000001 114.145 -176.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 954' ' ' LEU . . . . . 0.558 ' N ' ' CD1' ' C' ' 954' ' ' LEU . 0.0 OUTLIER 169.0 80.38 0.03 OUTLIER Pre-proline 0 N--CA 1.512 2.674 0 O-C-N 120.957 -1.089 . . . . 0.050000000000000003 111.695 179.563 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 955' ' ' PRO . . . . . 0.414 ' HD2' ' CE1' ' C' ' 950' ' ' PHE . 44.4 Cg_endo -72.66 98.84 1.0 Allowed 'Trans proline' 0 C--N 1.313 -1.325 0 N-CA-C 109.193 -1.118 . . . . 0.83999999999999997 109.193 178.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 956' ' ' LEU . . . . . . . . . . . . . 92.0 mt -125.26 142.29 51.59 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.052 -1.03 . . . . 0.040000000000000001 110.492 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 957' ' ' GLN . . . . . 0.407 ' HB2' ' HB3' ' C' ' 960' ' ' ASP . 87.2 mt-30 -84.98 149.49 25.57 Favored 'General case' 0 N--CA 1.501 2.124 0 CA-C-O 117.997 -1.001 . . . . 1.28 111.919 -178.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -62.11 122.29 15.19 Favored 'General case' 0 N--CA 1.512 2.635 0 CA-C-N 122.751 2.523 . . . . 0.17000000000000001 110.799 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 91.48 -10.31 75.09 Favored Glycine 0 N--CA 1.501 3.011 0 N-CA-C 110.167 -1.173 . . . . 0.040000000000000001 110.167 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 960' ' ' ASP . . . . . 0.407 ' HB3' ' HB2' ' C' ' 957' ' ' GLN . 16.3 p-10 -47.96 167.92 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.546 -0.973 . . . . 0.040000000000000001 111.98 -179.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 961' ' ' THR . . . . . 0.427 ' HA ' ' O ' ' C' ' 886' ' ' PHE . 91.1 m -137.96 127.15 24.42 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.403 -0.811 . . . . 1.78 110.087 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 962' ' ' VAL . . . . . 0.441 ' CG2' ' CB ' ' C' ' 886' ' ' PHE . 12.0 m -100.96 142.95 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 C-N-CA 119.392 -0.923 . . . . 0.040000000000000001 110.45 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 5.5 t -140.41 145.77 37.47 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.968 -0.457 . . . . 0.71999999999999997 109.875 -178.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 964' ' ' VAL . . . . . 0.47 ' HA ' ' HA ' ' C' ' 911' ' ' VAL . 60.1 t -100.71 136.96 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.041 -1.037 . . . . 1.05 111.296 -178.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -96.42 128.11 43.04 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 103.967 -2.605 . . . . 3.02 103.967 173.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 966' ' ' LEU . . . . . 0.4 ' O ' ' CG2' ' C' ' 967' ' ' VAL . 11.7 tp -132.38 64.33 1.61 Allowed 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.254 -1.017 . . . . 1.46 108.254 177.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 967' ' ' VAL . . . . . 0.4 ' CG2' ' O ' ' C' ' 966' ' ' LEU . 96.9 t -157.81 97.19 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 108.041 -1.096 . . . . 1.9399999999999999 108.041 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 91.1 mmm -143.17 59.13 1.41 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.713 -1.242 . . . . 0.0 108.359 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.35 119.93 1.97 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 107.124 -2.39 . . . . 2.1099999999999999 107.124 -178.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -81.56 -57.94 3.24 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.01 -1.288 . . . . 5.8899999999999997 110.574 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 45.4 tp -58.64 90.24 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.433 -0.792 . . . . 4.3600000000000003 110.395 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -142.97 -153.47 0.47 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.573 -0.704 . . . . 1.8300000000000001 110.188 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -118.69 166.86 12.24 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.501 -0.75 . . . . 4.3499999999999996 110.323 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 31.1 t -102.14 130.18 48.7 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.522 -0.736 . . . . 1.27 109.944 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 66.8 tt0 -156.25 159.53 38.98 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.466 -0.771 . . . . 5.0199999999999996 110.628 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.1 85.82 21.59 Favored Pre-proline 0 N--CA 1.5 2.067 0 O-C-N 121.646 -0.659 . . . . 2.4100000000000001 109.755 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -72.97 -170.74 0.66 Allowed 'Trans proline' 0 C--N 1.316 -1.138 0 O-C-N 123.323 1.17 . . . . 0.95999999999999996 111.159 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 978' ' ' LEU . . . . . . . . . . . . . 5.8 mp -126.17 155.88 41.03 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 107.703 -1.221 . . . . 0.62 107.703 178.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 979' ' ' THR . . . . . . . . . . . . . 63.7 p -148.83 141.17 24.15 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.853 -1.154 . . . . 3.5699999999999998 111.09 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 980' ' ' ILE . . . . . 0.43 HG22 HD11 ' C' ' 980' ' ' ILE . 49.2 mm -107.06 129.24 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 108.982 -0.747 . . . . 1.3300000000000001 108.982 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 981' ' ' PHE . . . . . 0.454 ' CD1' ' CE2' ' C' ' 879' ' ' TYR . 5.3 t80 -119.92 96.44 5.18 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 119.606 -0.837 . . . . 0.050000000000000003 111.796 -178.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 982' ' ' SER . . . . . . . . . . . . . 94.8 p -108.55 157.19 18.7 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.831 -0.803 . . . . 0.87 108.831 178.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 983' ' ' GLY . . . . . . . . . . . . . . . -172.86 112.86 0.45 Allowed Glycine 0 N--CA 1.496 2.671 0 N-CA-C 106.841 -2.503 . . . . 0.029999999999999999 106.841 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 984' ' ' ALA . . . . . . . . . . . . . . . -109.83 146.98 34.13 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 114.142 1.164 . . . . 0.69999999999999996 114.142 -176.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 985' ' ' LEU . . . . . . . . . . . . . 56.6 tp -71.24 136.88 48.21 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 120.788 -1.195 . . . . 0.040000000000000001 110.2 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 986' ' ' LEU . . . . . . . . . . . . . 51.7 tp -106.21 -60.65 1.62 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.597 -0.689 . . . . 0.040000000000000001 110.285 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -143.82 146.46 33.09 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.896 -1.15 . . . . 0.040000000000000001 107.896 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.79 162.62 12.31 Favored Glycine 0 N--CA 1.496 2.695 0 N-CA-C 108.132 -1.987 . . . . 0.040000000000000001 108.132 179.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.72 111.86 22.62 Favored Pre-proline 0 N--CA 1.499 1.999 0 CA-C-N 118.571 1.186 . . . . 0.040000000000000001 109.539 178.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 990' ' ' PRO . . . . . 0.413 ' O ' ' HB2' ' C' ' 991' ' ' GLU . 48.8 Cg_endo -92.59 74.0 0.48 Allowed 'Trans proline' 0 C--N 1.318 -1.059 0 O-C-N 123.117 1.062 . . . . 0.45000000000000001 111.527 -179.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 991' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' C' ' 990' ' ' PRO . 77.1 mt-10 67.26 -73.67 0.08 Allowed 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 108.48 -0.933 . . . . 1.97 108.48 -177.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 992' ' ' LEU . . . . . . . . . . . . . 6.9 mt 51.65 20.38 1.08 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.521 -0.737 . . . . 2.3799999999999999 111.591 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -95.39 156.88 16.13 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.855 -1.153 . . . . 3.79 110.066 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 67.3 m80 -146.44 94.55 2.47 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.534 -0.729 . . . . 3.5099999999999998 110.345 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 995' ' ' ALA . . . . . . . . . . . . 2.518 . . . . . . . 0 N--CA 1.504 2.225 0 O-C-N 120.955 -1.09 . . . . 2.73 110.616 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo . . . . . 0 N--CA 1.488 1.177 0 N-CA-C 109.482 -1.007 . . . . 3.8300000000000001 109.482 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 847' ' ' VAL . . . . . . . . . . . . . 60.1 t -132.04 103.58 14.16 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.583 -0.698 . . . . 1.8300000000000001 110.073 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 848' ' ' PRO . . . . . 0.403 ' O ' ' C ' ' A' ' 849' ' ' GLN . 43.9 Cg_endo -69.8 -19.89 35.34 Favored 'Trans proline' 0 N--CA 1.487 1.106 0 O-C-N 123.302 1.159 . . . . 0.65000000000000002 111.125 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 849' ' ' GLN . . . . . 0.403 ' C ' ' O ' ' A' ' 848' ' ' PRO . 56.4 tt0 26.42 69.24 0.05 Allowed 'General case' 0 N--CA 1.519 2.989 0 N-CA-C 112.948 0.721 . . . . 2.5800000000000001 112.948 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 850' ' ' VAL . . . . . . . . . . . . . 59.7 t -117.46 137.86 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.292 -0.88 . . . . 1.0900000000000001 111.63 -178.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 851' ' ' ALA . . . . . . . . . . . . . . . -127.69 155.41 44.0 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 105.723 -1.954 . . . . 0.040000000000000001 105.723 176.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 852' ' ' PHE . . . . . 0.413 ' HA ' ' CB ' ' A' ' 874' ' ' ASN . 21.4 p90 -160.4 128.87 4.73 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-N 121.016 1.735 . . . . 0.050000000000000003 108.864 179.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 33.1 t -175.57 134.57 0.3 Allowed 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.071 -1.085 . . . . 0.040000000000000001 108.071 -179.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -134.85 158.42 44.26 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.053 -1.029 . . . . 0.67000000000000004 109.501 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 855' ' ' ALA . . . . . . . . . . . . . . . -122.58 141.02 52.14 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 121.894 0.854 . . . . 0.51000000000000001 111.852 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 856' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -107.64 135.53 48.93 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 109.247 -0.649 . . . . 0.050000000000000003 109.247 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 857' ' ' SER . . . . . 0.428 ' O ' ' O ' ' A' ' 858' ' ' LEU . 16.9 p -153.05 17.82 0.57 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.419 -0.8 . . . . 1.3300000000000001 111.223 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 858' ' ' LEU . . . . . 0.428 ' O ' ' O ' ' A' ' 857' ' ' SER . 3.1 pp -29.66 154.08 0.03 OUTLIER Pre-proline 0 N--CA 1.52 3.046 0 N-CA-C 113.421 0.897 . . . . 2.3300000000000001 113.421 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -61.73 -88.8 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 120.934 1.09 . . . . 2.3199999999999998 113.683 -177.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 53.4 ptt85 -127.16 -142.12 0.27 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.895 -1.128 . . . . 0.040000000000000001 111.429 -177.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 36.8 m -39.11 119.02 0.85 Allowed 'General case' 0 N--CA 1.51 2.543 0 O-C-N 121.549 -0.719 . . . . 1.3100000000000001 111.919 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 862' ' ' GLU . . . . . 0.434 ' CG ' ' HD2' ' A' ' 863' ' ' PRO . 24.6 tt0 -97.35 149.57 35.86 Favored Pre-proline 0 N--CA 1.488 1.453 0 N-CA-C 108.17 -1.048 . . . . 4.5099999999999998 108.17 178.048 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 863' ' ' PRO . . . . . 0.434 ' HD2' ' CG ' ' A' ' 862' ' ' GLU . 41.6 Cg_endo -67.65 -13.31 38.47 Favored 'Trans proline' 0 C--N 1.316 -1.161 0 O-C-N 122.984 0.991 . . . . 2.2400000000000002 111.334 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -174.21 -137.36 2.43 Favored Glycine 0 N--CA 1.493 2.474 0 C-N-CA 119.76 -1.21 . . . . 0.040000000000000001 110.623 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 37.1 m -69.2 159.65 32.63 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.332 -1.099 . . . . 1.51 111.719 -177.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 27.0 m -89.93 132.73 35.48 Favored Pre-proline 0 N--CA 1.495 1.808 0 N-CA-C 113.422 0.897 . . . . 0.78000000000000003 113.422 -175.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 867' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -88.77 -153.82 0.05 OUTLIER 'Trans proline' 0 C--N 1.323 -0.794 0 N-CA-C 107.709 -1.689 . . . . 0.92000000000000004 107.709 177.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 868' ' ' PHE . . . . . 0.449 ' CD1' ' HG2' ' A' ' 881' ' ' PRO . 31.9 p90 -148.55 119.25 7.5 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.51 -1.369 . . . . 0.050000000000000003 109.944 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 50.1 p-10 -112.72 -3.24 14.29 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 119.322 -0.951 . . . . 1.7 112.207 -178.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 870' ' ' ARG . . . . . . . . . . . . . 26.5 mmm180 -89.98 88.69 7.4 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.908 -1.12 . . . . 2.5899999999999999 110.676 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 57.3 t -75.12 96.88 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.028 -1.045 . . . . 1.9399999999999999 109.787 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 872' ' ' LEU . . . . . . . . . . . . . 95.8 mt -83.92 -46.89 11.62 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.553 -0.717 . . . . 1.0600000000000001 110.231 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 873' ' ' LEU . . . . . . . . . . . . . 48.8 tp -174.82 104.48 0.09 Allowed 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.293 -0.879 . . . . 4.1799999999999997 108.676 178.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 874' ' ' ASN . . . . . 0.413 ' CB ' ' HA ' ' A' ' 852' ' ' PHE . 36.5 t-20 178.68 82.1 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.316 0 O-C-N 121.588 -0.695 . . . . 0.040000000000000001 109.675 -178.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -66.91 -47.06 72.93 Favored 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 119.289 -0.965 . . . . 3.3799999999999999 111.283 -179.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 876' ' ' GLY . . . . . 0.414 ' HA3' ' CE2' ' A' ' 878' ' ' TYR . . . -74.62 -25.29 70.35 Favored Glycine 0 N--CA 1.494 2.553 0 O-C-N 121.239 -0.913 . . . . 0.040000000000000001 111.836 -178.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 84.32 -59.8 4.9 Favored Glycine 0 N--CA 1.502 3.084 0 N-CA-C 108.154 -1.979 . . . . 0.040000000000000001 108.154 -178.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 878' ' ' TYR . . . . . 0.414 ' CE2' ' HA3' ' A' ' 876' ' ' GLY . 97.7 m-85 60.67 -66.13 0.05 Allowed 'General case' 0 N--CA 1.503 2.215 0 N-CA-C 114.327 1.232 . . . . 3.46 114.327 177.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 879' ' ' TYR . . . . . 0.469 ' CB ' ' CD2' ' A' ' 886' ' ' PHE . 23.7 p90 -112.37 109.17 18.64 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 114.796 1.406 . . . . 0.040000000000000001 114.796 -176.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -65.18 118.53 50.65 Favored Pre-proline 0 N--CA 1.495 1.816 0 O-C-N 121.369 -0.832 . . . . 0.02 110.026 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 881' ' ' PRO . . . . . 0.449 ' HG2' ' CD1' ' A' ' 868' ' ' PHE . 55.2 Cg_endo -76.87 0.24 9.85 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 O-C-N 123.469 1.247 . . . . 0.39000000000000001 112.094 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 -76.79 -64.81 1.04 Allowed 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 106.98 -1.489 . . . . 0.81000000000000005 106.98 178.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 30.4 p -94.1 -17.7 22.55 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.776 -0.824 . . . . 0.040000000000000001 108.776 177.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.08 22.11 55.65 Favored Glycine 0 N--CA 1.495 2.63 0 O-C-N 121.057 -1.027 . . . . 0.029999999999999999 110.749 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 885' ' ' VAL . . . . . . . . . . . . . 77.6 t -73.15 90.42 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 C-N-CA 118.353 -1.339 . . . . 1.01 108.23 -179.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 886' ' ' PHE . . . . . 0.469 ' CD2' ' CB ' ' A' ' 879' ' ' TYR . 0.7 OUTLIER -90.39 104.34 16.92 Favored 'General case' 0 N--CA 1.495 1.825 0 CA-C-N 115.291 -0.868 . . . . 0.050000000000000003 112.291 -177.298 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 887' ' ' THR . . . . . 0.4 ' O ' ' HD3' ' A' ' 889' ' ' PRO . 89.8 m -95.04 100.77 12.54 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 107.831 -1.174 . . . . 0.68000000000000005 107.831 177.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 888' ' ' ALA . . . . . . . . . . . . . . . -99.17 106.37 38.15 Favored Pre-proline 0 N--CA 1.5 2.047 0 N-CA-C 114.045 1.128 . . . . 0.25 114.045 -176.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 889' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' A' ' 887' ' ' THR . 54.6 Cg_endo -89.2 -11.94 3.45 Favored 'Trans proline' 0 CA--C 1.546 1.109 0 N-CA-C 108.975 -1.202 . . . . 1.6399999999999999 108.975 176.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 890' ' ' LEU . . . . . . . . . . . . . 4.9 tt -35.29 -51.23 0.58 Allowed 'General case' 0 N--CA 1.507 2.397 0 N-CA-C 113.92 1.082 . . . . 2.29 113.92 -177.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 51.79 95.03 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.374 0 O-C-N 121.188 -0.945 . . . . 0.63 110.175 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 156.05 -147.28 15.72 Favored Glycine 0 N--CA 1.478 1.487 0 N-CA-C 107.372 -2.291 . . . . 0.040000000000000001 107.372 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 72.4 ttt-85 -109.0 127.91 54.5 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.86 -1.163 . . . . 3.0 107.86 177.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 894' ' ' TYR . . . . . 0.45 ' CD1' ' N ' ' A' ' 895' ' ' LEU . 0.1 OUTLIER -130.98 144.46 51.49 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.05 -1.032 . . . . 0.040000000000000001 110.085 -179.305 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 895' ' ' LEU . . . . . 0.45 ' N ' ' CD1' ' A' ' 894' ' ' TYR . 34.3 tp -99.37 115.22 28.72 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.625 -0.672 . . . . 1.27 109.807 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 896' ' ' LEU . . . . . 0.426 ' HB2' ' CZ ' ' A' ' 894' ' ' TYR . 9.9 tt -112.16 145.87 39.06 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.579 -0.7 . . . . 0.93999999999999995 110.461 -179.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 897' ' ' SER . . . . . . . . . . . . . 71.2 m -144.74 119.11 9.6 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.379 -0.825 . . . . 0.040000000000000001 110.741 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.97 147.69 30.72 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.708 -0.62 . . . . 0.47999999999999998 109.448 179.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 899' ' ' VAL . . . . . . . . . . . . . 88.0 t -91.95 121.15 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.457 -0.777 . . . . 0.55000000000000004 110.98 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 900' ' ' LEU . . . . . 0.432 ' CD2' ' N ' ' A' ' 900' ' ' LEU . 4.4 mm? -95.02 111.75 23.52 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 114.423 1.268 . . . . 1.5900000000000001 114.423 -174.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 17.3 m -67.8 141.64 56.45 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 107.274 -1.38 . . . . 0.050000000000000003 107.274 176.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -67.92 -65.02 2.87 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 110.718 -0.953 . . . . 0.029999999999999999 110.718 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 5.8 m170 46.83 66.31 1.02 Allowed 'General case' 0 N--CA 1.508 2.437 0 O-C-N 121.464 -1.021 . . . . 3.2000000000000002 111.082 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 54.1 ptt85 -69.26 -5.91 25.94 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.578 -0.701 . . . . 2.9199999999999999 112.178 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 905' ' ' HIS . . . . . 0.489 ' O ' ' CB ' ' A' ' 906' ' ' GLU . 73.9 t60 -62.69 5.06 0.13 Allowed 'General case' 0 N--CA 1.507 2.393 0 O-C-N 120.888 -1.132 . . . . 2.8700000000000001 113.086 -179.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 906' ' ' GLU . . . . . 0.489 ' CB ' ' O ' ' A' ' 905' ' ' HIS . 0.6 OUTLIER 95.07 -164.97 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.452 0 CA-C-N 120.609 1.549 . . . . 0.98999999999999999 111.993 178.903 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 907' ' ' LYS . . . . . 0.463 ' CB ' ' O ' ' A' ' 906' ' ' GLU . 62.0 tttt 86.09 156.78 0.08 Allowed 'General case' 0 N--CA 1.52 3.03 0 N-CA-C 107.961 -1.126 . . . . 5.25 107.961 -176.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 60.7 t -122.1 117.45 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 120.791 -1.193 . . . . 0.39000000000000001 111.224 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 54.0 tp10 -101.56 133.24 46.54 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 107.291 -1.374 . . . . 1.72 107.291 176.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -155.74 123.0 5.45 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 106.811 -1.551 . . . . 0.67000000000000004 106.811 178.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 911' ' ' VAL . . . . . 0.475 ' HA ' ' HA ' ' A' ' 964' ' ' VAL . 93.8 t -84.28 131.83 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.902 -0.499 . . . . 0.54000000000000004 110.984 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 60.6 mt -66.92 157.56 32.92 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.46 -0.775 . . . . 1.5 109.351 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 1.4 p -124.65 137.6 54.36 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.003 -1.11 . . . . 1.3700000000000001 108.003 176.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 914' ' ' ARG . . . . . 0.424 ' O ' ' CB ' ' A' ' 915' ' ' SER . 0.1 OUTLIER -65.32 155.28 35.75 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.638 -1.289 . . . . 4.2999999999999998 111.359 -179.164 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 915' ' ' SER . . . . . 0.424 ' CB ' ' O ' ' A' ' 914' ' ' ARG . 1.7 p 83.42 -31.56 0.08 Allowed 'General case' 0 N--CA 1.521 3.118 0 C-N-CA 123.925 0.89 . . . . 2.0499999999999998 112.068 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -122.78 -21.91 5.47 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 120.953 -1.092 . . . . 2.71 111.192 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 917' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 67.04 166.53 0.22 Allowed 'General case' 0 N--CA 1.52 3.027 0 N-CA-C 105.742 -1.948 . . . . 2.6800000000000002 105.742 -174.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.33 -125.23 33.43 Favored Glycine 1 N--CA 1.521 4.324 0 CA-C-N 123.368 2.804 . . . . 0.029999999999999999 107.07 -177.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 919' ' ' VAL . . . . . . . . . . . . . 88.2 t 52.39 94.98 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 O-C-N 121.382 -1.069 . . . . 1.3899999999999999 109.068 -178.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 920' ' ' ALA . . . . . . . . . . . . . . . -90.87 91.07 8.19 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.246 -0.982 . . . . 0.029999999999999999 110.788 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 921' ' ' ARG . . . . . 0.435 ' HB3' ' CZ ' ' A' ' 950' ' ' PHE . 27.5 ptt85 -84.99 -42.2 15.11 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 106.013 -1.847 . . . . 4.4199999999999999 106.013 176.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 922' ' ' VAL . . . . . . . . . . . . . 74.6 t -101.96 74.29 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 105.76 -1.941 . . . . 0.84999999999999998 105.76 175.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -85.79 134.91 33.91 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.758 0.789 . . . . 2.46 111.545 -177.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 7.0 t -147.09 105.67 3.81 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 108.772 -0.825 . . . . 0.69999999999999996 108.772 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -103.46 83.49 0.42 Allowed Glycine 0 N--CA 1.487 2.035 0 N-CA-C 108.243 -1.943 . . . . 0.040000000000000001 108.243 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.226 0 N-CA-C 108.82 -1.712 . . . . 0.040000000000000001 108.82 -179.543 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 24.8 m . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.054 0.455 . . . . 13.779999999999999 110.29 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 95.7 mt -112.17 130.01 56.05 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.519 -0.738 . . . . 13.76 110.362 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -151.77 168.71 31.16 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.229 -1.548 . . . . 9.1300000000000008 109.229 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 949' ' ' VAL . . . . . . . . . . . . . 32.7 m -118.28 130.1 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.573 -0.957 . . . . 7.0800000000000001 110.691 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 950' ' ' PHE . . . . . 0.441 ' CZ ' ' HD2' ' A' ' 955' ' ' PRO . 50.0 p90 -135.18 152.46 51.61 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.57 -0.706 . . . . 7.5899999999999999 109.508 179.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 23.1 m -118.45 -54.52 2.27 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.44 -0.787 . . . . 5.0300000000000002 112.007 -178.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 952' ' ' LEU . . . . . 0.437 ' O ' ' O ' ' A' ' 953' ' ' ILE . 12.3 tp -62.05 -74.26 0.09 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.432 -0.793 . . . . 1.01 112.081 -177.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 953' ' ' ILE . . . . . 0.505 ' O ' ' HB3' ' A' ' 954' ' ' LEU . 1.5 pp -51.56 -149.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.713 0 N-CA-C 114.18 1.178 . . . . 2.6000000000000001 114.18 -176.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 954' ' ' LEU . . . . . 0.529 ' N ' ' CD1' ' A' ' 954' ' ' LEU . 0.0 OUTLIER 166.32 90.69 0.02 OUTLIER Pre-proline 0 N--CA 1.519 2.982 0 O-C-N 121.179 -0.951 . . . . 0.050000000000000003 111.755 179.174 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 955' ' ' PRO . . . . . 0.441 ' HD2' ' CZ ' ' A' ' 950' ' ' PHE . 51.7 Cg_endo -78.92 98.28 1.18 Allowed 'Trans proline' 0 C--N 1.315 -1.198 0 N-CA-C 109.037 -1.178 . . . . 0.83999999999999997 109.037 178.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 956' ' ' LEU . . . . . 0.408 ' CD2' ' NH1' ' A' ' 914' ' ' ARG . 11.1 mp -121.27 141.93 50.42 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.994 -1.066 . . . . 0.040000000000000001 109.954 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -84.5 150.86 24.98 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 117.782 -1.104 . . . . 1.28 111.842 -178.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -68.43 118.9 12.09 Favored 'General case' 0 N--CA 1.509 2.525 0 CA-C-N 123.034 2.652 . . . . 0.17000000000000001 111.431 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 93.03 -21.25 40.92 Favored Glycine 0 N--CA 1.5 2.959 0 N-CA-C 111.034 -0.826 . . . . 0.040000000000000001 111.034 178.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 960' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -56.57 170.46 0.38 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.426 -1.044 . . . . 0.040000000000000001 110.112 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 961' ' ' THR . . . . . 0.463 ' HA ' ' O ' ' A' ' 886' ' ' PHE . 42.1 m -135.94 137.76 41.65 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.906 -1.121 . . . . 1.78 112.282 -178.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 962' ' ' VAL . . . . . 0.42 ' CG2' ' CB ' ' A' ' 886' ' ' PHE . 33.6 m -98.14 145.37 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 C-N-CA 120.142 -0.623 . . . . 0.040000000000000001 110.352 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 5.2 t -137.4 145.02 42.73 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.792 -0.568 . . . . 0.71999999999999997 110.041 -178.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 964' ' ' VAL . . . . . 0.475 ' HA ' ' HA ' ' A' ' 911' ' ' VAL . 61.2 t -93.21 136.72 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.16 -0.963 . . . . 1.05 110.495 -179.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -93.73 127.42 39.43 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 103.613 -2.736 . . . . 3.02 103.613 173.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 966' ' ' LEU . . . . . 0.401 ' O ' ' CG2' ' A' ' 967' ' ' VAL . 4.1 tt -132.51 61.11 1.67 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.21 -1.033 . . . . 1.46 108.21 177.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 967' ' ' VAL . . . . . 0.401 ' CG2' ' O ' ' A' ' 966' ' ' LEU . 97.2 t -157.87 96.74 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 108.12 -1.067 . . . . 1.9399999999999999 108.12 179.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 88.1 mmm -143.66 59.16 1.38 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.747 -1.22 . . . . 0.0 108.34 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.13 119.64 1.95 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 107.107 -2.397 . . . . 2.1099999999999999 107.107 -178.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -82.17 -58.35 2.99 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.023 -1.281 . . . . 5.8899999999999997 110.378 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 46.7 tp -58.89 90.84 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.434 -0.791 . . . . 4.3600000000000003 110.244 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -142.0 -154.37 0.52 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.595 -0.691 . . . . 1.8300000000000001 110.208 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -119.53 170.7 8.93 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.479 -0.763 . . . . 4.3499999999999996 110.252 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 9.5 t -101.63 130.4 47.96 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.548 -0.72 . . . . 1.27 110.12 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -155.89 158.77 38.54 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.482 -0.761 . . . . 5.0199999999999996 110.41 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.5 85.72 17.32 Favored Pre-proline 0 N--CA 1.501 2.078 0 O-C-N 121.618 -0.676 . . . . 2.4100000000000001 109.87 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -73.61 -172.65 1.12 Allowed 'Trans proline' 0 C--N 1.318 -1.059 0 O-C-N 123.303 1.159 . . . . 0.95999999999999996 111.277 -179.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 5.4 mp -127.47 155.39 43.79 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.728 -1.212 . . . . 0.62 107.728 178.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 979' ' ' THR . . . . . . . . . . . . . 37.1 p -150.23 141.11 22.83 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.762 -1.212 . . . . 3.5699999999999998 111.186 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 980' ' ' ILE . . . . . . . . . . . . . 51.4 mm -107.38 128.76 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 109.099 -0.704 . . . . 1.3300000000000001 109.099 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 981' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -119.39 99.29 6.59 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 119.821 -0.752 . . . . 0.050000000000000003 111.8 -178.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 42.6 p -106.78 158.25 17.13 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.814 -0.81 . . . . 0.87 108.814 178.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . -172.78 110.13 0.33 Allowed Glycine 0 N--CA 1.498 2.803 0 N-CA-C 106.649 -2.58 . . . . 0.029999999999999999 106.649 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -110.67 149.67 30.13 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 114.551 1.315 . . . . 0.69999999999999996 114.551 -175.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 54.4 tp -70.73 133.9 47.0 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.816 -1.177 . . . . 0.040000000000000001 109.808 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 51.0 tp -107.37 -59.04 1.88 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.499 -0.751 . . . . 0.040000000000000001 109.989 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -144.47 145.06 31.67 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.565 -1.272 . . . . 0.040000000000000001 107.565 179.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.97 163.12 12.17 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 108.139 -1.984 . . . . 0.040000000000000001 108.139 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -75.3 112.5 18.97 Favored Pre-proline 0 N--CA 1.498 1.973 0 CA-C-N 118.52 1.16 . . . . 0.040000000000000001 109.482 179.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 990' ' ' PRO . . . . . 0.414 ' O ' ' HB2' ' A' ' 991' ' ' GLU . 50.2 Cg_endo -90.07 71.24 1.59 Allowed 'Trans proline' 0 C--N 1.319 -0.998 0 O-C-N 123.124 1.065 . . . . 0.45000000000000001 111.39 -178.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 991' ' ' GLU . . . . . 0.414 ' HB2' ' O ' ' A' ' 990' ' ' PRO . 69.8 mt-10 67.36 -73.94 0.07 Allowed 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 108.494 -0.928 . . . . 1.97 108.494 -177.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 992' ' ' LEU . . . . . . . . . . . . . 10.4 mt 50.92 20.64 0.82 Allowed 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.579 -0.701 . . . . 2.3799999999999999 111.647 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -94.2 156.85 16.34 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.888 -1.132 . . . . 3.79 109.959 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 72.2 m80 -146.24 93.44 2.32 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.571 -0.706 . . . . 3.5099999999999998 110.23 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 995' ' ' ALA . . . . . . . . . . . . 2.519 . . . . . . . 0 N--CA 1.503 2.219 0 O-C-N 120.821 -1.174 . . . . 2.73 110.574 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo . . . . . 0 N--CA 1.488 1.203 0 N-CA-C 109.502 -0.999 . . . . 3.8300000000000001 109.502 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 847' ' ' VAL . . . . . . . . . . . . . 59.8 t -132.05 103.57 14.15 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.638 -0.664 . . . . 1.8300000000000001 110.074 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 848' ' ' PRO . . . . . 0.41 ' O ' ' C ' ' B' ' 849' ' ' GLN . 44.0 Cg_endo -69.7 -20.23 35.41 Favored 'Trans proline' 0 N--CA 1.487 1.097 0 O-C-N 123.236 1.124 . . . . 0.65000000000000002 111.123 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 849' ' ' GLN . . . . . 0.41 ' C ' ' O ' ' B' ' 848' ' ' PRO . 56.3 tt0 26.67 69.7 0.05 Allowed 'General case' 0 N--CA 1.519 2.979 0 N-CA-C 112.84 0.682 . . . . 2.5800000000000001 112.84 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 850' ' ' VAL . . . . . . . . . . . . . 59.6 t -117.91 137.81 50.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.237 -0.915 . . . . 1.0900000000000001 111.616 -178.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 851' ' ' ALA . . . . . . . . . . . . . . . -128.06 154.76 45.32 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 105.707 -1.96 . . . . 0.040000000000000001 105.707 176.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 852' ' ' PHE . . . . . 0.415 ' HA ' ' CB ' ' B' ' 874' ' ' ASN . 20.8 p90 -159.64 129.35 5.42 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 121.006 1.73 . . . . 0.050000000000000003 108.742 179.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 32.7 t -175.75 134.25 0.28 Allowed 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.137 -1.061 . . . . 0.040000000000000001 108.137 -179.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -134.56 158.63 43.5 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.123 -0.985 . . . . 0.67000000000000004 109.526 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 855' ' ' ALA . . . . . . . . . . . . . . . -122.84 141.17 52.15 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.919 0.866 . . . . 0.51000000000000001 111.843 -178.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 856' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -107.8 135.18 49.65 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.276 -0.638 . . . . 0.050000000000000003 109.276 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 857' ' ' SER . . . . . 0.434 ' O ' ' O ' ' B' ' 858' ' ' LEU . 17.0 p -152.78 17.98 0.6 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.474 -0.766 . . . . 1.3300000000000001 111.144 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 858' ' ' LEU . . . . . 0.434 ' O ' ' O ' ' B' ' 857' ' ' SER . 3.1 pp -29.82 154.14 0.03 OUTLIER Pre-proline 0 N--CA 1.521 3.087 0 N-CA-C 113.337 0.866 . . . . 2.3300000000000001 113.337 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -61.82 -88.75 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.541 0 O-C-N 123.149 1.078 . . . . 2.3199999999999998 113.681 -177.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 53.4 ptt85 -127.2 -142.19 0.27 Allowed 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.86 -1.15 . . . . 0.040000000000000001 111.403 -177.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 37.0 m -39.12 118.63 0.81 Allowed 'General case' 0 N--CA 1.51 2.531 0 O-C-N 121.479 -0.763 . . . . 1.3100000000000001 111.9 -178.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 862' ' ' GLU . . . . . 0.433 ' CG ' ' HD2' ' B' ' 863' ' ' PRO . 24.6 tt0 -96.89 149.68 36.01 Favored Pre-proline 0 N--CA 1.489 1.484 0 N-CA-C 108.162 -1.051 . . . . 4.5099999999999998 108.162 177.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 863' ' ' PRO . . . . . 0.433 ' HD2' ' CG ' ' B' ' 862' ' ' GLU . 41.5 Cg_endo -67.69 -13.38 38.61 Favored 'Trans proline' 0 C--N 1.316 -1.181 0 O-C-N 123.015 1.008 . . . . 2.2400000000000002 111.385 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -174.0 -136.88 2.3 Favored Glycine 0 N--CA 1.494 2.501 0 C-N-CA 119.836 -1.174 . . . . 0.040000000000000001 110.665 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 37.2 m -69.55 160.19 31.95 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.276 -1.132 . . . . 1.51 111.75 -178.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 866' ' ' VAL . . . . . . . . . . . . . 26.9 m -90.31 132.75 34.74 Favored Pre-proline 0 N--CA 1.495 1.782 0 N-CA-C 113.419 0.896 . . . . 0.78000000000000003 113.419 -175.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 867' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -88.83 -154.05 0.05 OUTLIER 'Trans proline' 0 C--N 1.322 -0.817 0 N-CA-C 107.679 -1.7 . . . . 0.92000000000000004 107.679 177.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 868' ' ' PHE . . . . . 0.442 ' CD1' ' HG2' ' B' ' 881' ' ' PRO . 31.6 p90 -148.39 119.13 7.52 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.446 -1.409 . . . . 0.050000000000000003 109.874 179.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 50.1 p-10 -112.57 -2.84 14.49 Favored 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 119.284 -0.967 . . . . 1.7 112.153 -178.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 870' ' ' ARG . . . . . . . . . . . . . 26.0 mmm180 -90.32 88.62 7.28 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.977 -1.077 . . . . 2.5899999999999999 110.682 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 57.5 t -75.23 97.03 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.004 -1.06 . . . . 1.9399999999999999 109.661 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 872' ' ' LEU . . . . . . . . . . . . . 95.4 mt -84.29 -46.75 11.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.541 -0.724 . . . . 1.0600000000000001 110.273 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 873' ' ' LEU . . . . . . . . . . . . . 48.8 tp -174.66 104.43 0.1 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.265 -0.897 . . . . 4.1799999999999997 108.605 178.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 874' ' ' ASN . . . . . 0.415 ' CB ' ' HA ' ' B' ' 852' ' ' PHE . 36.5 t-20 178.67 82.27 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.654 -0.653 . . . . 0.040000000000000001 109.647 -178.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -67.09 -47.1 72.23 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 119.29 -0.964 . . . . 3.3799999999999999 111.244 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 876' ' ' GLY . . . . . 0.419 ' HA3' ' CE2' ' B' ' 878' ' ' TYR . . . -74.49 -25.58 69.93 Favored Glycine 0 N--CA 1.494 2.566 0 O-C-N 121.217 -0.927 . . . . 0.040000000000000001 111.813 -178.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 84.48 -59.74 4.89 Favored Glycine 0 N--CA 1.502 3.038 0 N-CA-C 108.11 -1.996 . . . . 0.040000000000000001 108.11 -178.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 878' ' ' TYR . . . . . 0.419 ' CE2' ' HA3' ' B' ' 876' ' ' GLY . 97.7 m-85 60.74 -66.13 0.05 Allowed 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 114.348 1.24 . . . . 3.46 114.348 177.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 879' ' ' TYR . . . . . 0.46 ' CB ' ' CD2' ' B' ' 886' ' ' PHE . 23.5 p90 -112.39 109.15 18.6 Favored 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 114.773 1.398 . . . . 0.040000000000000001 114.773 -176.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -65.17 118.47 50.03 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.396 -0.815 . . . . 0.02 109.999 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 881' ' ' PRO . . . . . 0.442 ' HG2' ' CD1' ' B' ' 868' ' ' PHE . 55.4 Cg_endo -76.84 0.17 9.91 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 O-C-N 123.432 1.227 . . . . 0.39000000000000001 112.143 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -76.66 -64.95 1.0 Allowed 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 106.963 -1.495 . . . . 0.81000000000000005 106.963 178.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 31.0 p -94.13 -17.25 22.97 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.784 -0.821 . . . . 0.040000000000000001 108.784 177.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.49 22.49 56.27 Favored Glycine 0 N--CA 1.494 2.541 0 O-C-N 121.091 -1.006 . . . . 0.029999999999999999 110.793 178.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 885' ' ' VAL . . . . . . . . . . . . . 79.4 t -73.41 90.74 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 C-N-CA 118.274 -1.371 . . . . 1.01 108.151 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 886' ' ' PHE . . . . . 0.46 ' CD2' ' CB ' ' B' ' 879' ' ' TYR . 0.6 OUTLIER -90.63 104.42 17.01 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 115.281 -0.872 . . . . 0.050000000000000003 112.244 -177.264 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 887' ' ' THR . . . . . 0.401 ' O ' ' HD3' ' B' ' 889' ' ' PRO . 90.3 m -95.06 101.03 12.76 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 107.774 -1.195 . . . . 0.68000000000000005 107.774 177.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 888' ' ' ALA . . . . . . . . . . . . . . . -99.4 106.28 38.32 Favored Pre-proline 0 N--CA 1.499 2.022 0 N-CA-C 114.042 1.127 . . . . 0.25 114.042 -176.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 889' ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' B' ' 887' ' ' THR . 54.4 Cg_endo -89.08 -12.08 3.47 Favored 'Trans proline' 0 CA--C 1.546 1.094 0 N-CA-C 108.981 -1.199 . . . . 1.6399999999999999 108.981 176.094 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 890' ' ' LEU . . . . . . . . . . . . . 4.9 tt -35.2 -51.21 0.56 Allowed 'General case' 0 N--CA 1.507 2.414 0 N-CA-C 113.903 1.075 . . . . 2.29 113.903 -177.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 51.7 95.04 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.347 0 O-C-N 121.192 -0.942 . . . . 0.63 110.193 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . 156.02 -147.36 15.91 Favored Glycine 0 N--CA 1.479 1.548 0 N-CA-C 107.335 -2.306 . . . . 0.040000000000000001 107.335 -178.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 72.5 ttt-85 -108.97 127.94 54.51 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 107.845 -1.168 . . . . 3.0 107.845 177.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 894' ' ' TYR . . . . . 0.456 ' CD1' ' N ' ' B' ' 895' ' ' LEU . 0.2 OUTLIER -130.86 144.63 51.6 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.023 -1.048 . . . . 0.040000000000000001 110.082 -179.258 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 895' ' ' LEU . . . . . 0.456 ' N ' ' CD1' ' B' ' 894' ' ' TYR . 34.4 tp -99.69 115.03 28.52 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.523 -0.736 . . . . 1.27 109.825 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 896' ' ' LEU . . . . . 0.413 ' HB2' ' CZ ' ' B' ' 894' ' ' TYR . 9.9 tt -111.93 145.63 39.23 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.576 -0.703 . . . . 0.93999999999999995 110.537 -179.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 897' ' ' SER . . . . . . . . . . . . . 71.2 m -144.52 118.86 9.58 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.389 -0.819 . . . . 0.040000000000000001 110.812 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.71 147.66 30.45 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.733 -0.604 . . . . 0.47999999999999998 109.489 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 899' ' ' VAL . . . . . . . . . . . . . 88.3 t -91.89 120.92 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.469 -0.769 . . . . 0.55000000000000004 111.006 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 900' ' ' LEU . . . . . 0.434 ' N ' ' CD2' ' B' ' 900' ' ' LEU . 4.4 mm? -94.85 111.3 23.1 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 114.498 1.296 . . . . 1.5900000000000001 114.498 -174.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 17.1 m -67.45 141.47 56.98 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 107.277 -1.379 . . . . 0.050000000000000003 107.277 176.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -68.02 -65.05 2.84 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 110.724 -0.951 . . . . 0.029999999999999999 110.724 -179.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 5.9 m170 46.81 66.43 0.99 Allowed 'General case' 0 N--CA 1.508 2.454 0 O-C-N 121.454 -1.027 . . . . 3.2000000000000002 111.093 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 54.0 ptt85 -69.33 -6.19 28.08 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.645 -0.66 . . . . 2.9199999999999999 112.106 -179.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 905' ' ' HIS . . . . . 0.484 ' O ' ' CB ' ' B' ' 906' ' ' GLU . 73.8 t60 -62.03 4.53 0.12 Allowed 'General case' 0 N--CA 1.506 2.352 0 O-C-N 120.906 -1.122 . . . . 2.8700000000000001 113.131 -179.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 906' ' ' GLU . . . . . 0.484 ' CB ' ' O ' ' B' ' 905' ' ' HIS . 0.7 OUTLIER 95.25 -165.11 0.0 OUTLIER 'General case' 0 N--CA 1.529 3.478 0 CA-C-N 120.605 1.548 . . . . 0.98999999999999999 111.914 179.089 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 907' ' ' LYS . . . . . 0.465 ' CB ' ' O ' ' B' ' 906' ' ' GLU . 61.9 tttt 86.3 156.4 0.08 Allowed 'General case' 0 N--CA 1.519 3.01 0 N-CA-C 107.982 -1.118 . . . . 5.25 107.982 -176.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 60.9 t -121.86 117.21 51.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 120.757 -1.214 . . . . 0.39000000000000001 111.351 -179.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 54.2 tp10 -101.26 133.43 45.84 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 107.295 -1.372 . . . . 1.72 107.295 176.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -156.05 123.32 5.41 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 106.759 -1.571 . . . . 0.67000000000000004 106.759 178.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 911' ' ' VAL . . . . . 0.467 ' HA ' ' HA ' ' B' ' 964' ' ' VAL . 92.5 t -84.65 132.23 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.89 -0.506 . . . . 0.54000000000000004 110.972 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 60.2 mt -67.06 157.78 32.69 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.417 -0.802 . . . . 1.5 109.303 178.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 913' ' ' SER . . . . . 0.405 ' CB ' ' CG1' ' B' ' 919' ' ' VAL . 1.4 p -125.11 136.78 53.98 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.105 -1.072 . . . . 1.3700000000000001 108.105 176.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 914' ' ' ARG . . . . . 0.416 ' O ' ' CB ' ' B' ' 915' ' ' SER . 0.1 OUTLIER -64.53 155.21 33.66 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 120.628 -1.295 . . . . 4.2999999999999998 111.428 -179.034 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 915' ' ' SER . . . . . 0.416 ' CB ' ' O ' ' B' ' 914' ' ' ARG . 1.7 p 83.53 -31.93 0.08 Allowed 'General case' 0 N--CA 1.521 3.119 0 C-N-CA 123.915 0.886 . . . . 2.0499999999999998 112.077 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 916' ' ' ASN . . . . . 0.403 ' O ' ' HB2' ' B' ' 917' ' ' GLN . 99.4 m-20 -122.34 -22.19 5.6 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.895 -1.128 . . . . 2.71 111.2 -179.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 917' ' ' GLN . . . . . 0.403 ' HB2' ' O ' ' B' ' 916' ' ' ASN . 43.8 mt-30 67.08 165.98 0.22 Allowed 'General case' 0 N--CA 1.519 3.021 0 N-CA-C 105.762 -1.94 . . . . 2.6800000000000002 105.762 -174.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.99 -125.29 35.19 Favored Glycine 1 N--CA 1.521 4.322 0 CA-C-N 123.492 2.86 . . . . 0.029999999999999999 106.905 -177.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 919' ' ' VAL . . . . . 0.405 ' CG1' ' CB ' ' B' ' 913' ' ' SER . 91.5 t 52.24 95.1 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 O-C-N 121.393 -1.063 . . . . 1.3899999999999999 109.119 -178.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.06 90.95 8.07 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.249 -0.981 . . . . 0.029999999999999999 110.723 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 921' ' ' ARG . . . . . 0.434 ' HB3' ' CZ ' ' B' ' 950' ' ' PHE . 27.6 ptt85 -84.96 -42.18 15.19 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 106.02 -1.844 . . . . 4.4199999999999999 106.02 176.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 922' ' ' VAL . . . . . . . . . . . . . 75.0 t -101.9 74.02 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 105.833 -1.914 . . . . 0.84999999999999998 105.833 175.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -85.55 135.01 33.99 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.74 0.781 . . . . 2.46 111.553 -177.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 924' ' ' SER . . . . . . . . . . . . . 6.8 t -147.12 105.51 3.78 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 108.77 -0.826 . . . . 0.69999999999999996 108.77 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -103.2 83.42 0.43 Allowed Glycine 0 N--CA 1.487 2.052 0 N-CA-C 108.307 -1.917 . . . . 0.040000000000000001 108.307 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.223 0 N-CA-C 108.865 -1.694 . . . . 0.040000000000000001 108.865 -179.6 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 25.3 m . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.042 0.449 . . . . 13.779999999999999 110.296 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 95.8 mt -111.64 129.96 55.92 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.508 -0.745 . . . . 13.76 110.389 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -151.67 168.33 31.06 Favored Glycine 0 N--CA 1.493 2.5 0 N-CA-C 109.243 -1.543 . . . . 9.1300000000000008 109.243 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 949' ' ' VAL . . . . . . . . . . . . . 31.6 m -118.09 130.17 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.515 -0.991 . . . . 7.0800000000000001 110.666 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 950' ' ' PHE . . . . . 0.434 ' CZ ' ' HB3' ' B' ' 921' ' ' ARG . 49.0 p90 -135.16 152.51 51.67 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.582 -0.699 . . . . 7.5899999999999999 109.466 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 23.3 m -118.52 -54.09 2.29 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.424 -0.797 . . . . 5.0300000000000002 111.922 -178.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 952' ' ' LEU . . . . . 0.434 ' O ' ' O ' ' B' ' 953' ' ' ILE . 12.5 tp -62.3 -74.43 0.09 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.352 -0.842 . . . . 1.01 112.056 -177.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 953' ' ' ILE . . . . . 0.503 ' O ' ' HB3' ' B' ' 954' ' ' LEU . 1.4 pp -51.48 -149.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.782 0 N-CA-C 114.22 1.193 . . . . 2.6000000000000001 114.22 -176.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 954' ' ' LEU . . . . . 0.529 ' N ' ' CD1' ' B' ' 954' ' ' LEU . 0.0 OUTLIER 166.07 90.59 0.02 OUTLIER Pre-proline 0 N--CA 1.518 2.944 0 O-C-N 121.107 -0.996 . . . . 0.050000000000000003 111.67 179.156 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 955' ' ' PRO . . . . . 0.432 ' HD2' ' CZ ' ' B' ' 950' ' ' PHE . 51.6 Cg_endo -78.96 98.48 1.19 Allowed 'Trans proline' 0 C--N 1.315 -1.205 0 N-CA-C 109.014 -1.187 . . . . 0.83999999999999997 109.014 178.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 956' ' ' LEU . . . . . 0.413 ' CD2' ' NH1' ' B' ' 914' ' ' ARG . 11.1 mp -121.47 141.97 50.5 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.973 -1.079 . . . . 0.040000000000000001 109.943 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -84.46 151.11 24.83 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 117.844 -1.074 . . . . 1.28 111.777 -178.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -68.6 118.66 11.91 Favored 'General case' 0 N--CA 1.508 2.466 0 CA-C-N 122.96 2.618 . . . . 0.17000000000000001 111.368 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 93.2 -21.48 40.03 Favored Glycine 0 N--CA 1.5 2.925 0 N-CA-C 111.056 -0.817 . . . . 0.040000000000000001 111.056 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 960' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -56.31 170.55 0.34 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.488 -1.007 . . . . 0.040000000000000001 110.149 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 961' ' ' THR . . . . . 0.457 ' HA ' ' O ' ' B' ' 886' ' ' PHE . 42.1 m -135.96 137.81 41.68 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.945 -1.097 . . . . 1.78 112.291 -178.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 962' ' ' VAL . . . . . 0.426 ' CG2' ' CB ' ' B' ' 886' ' ' PHE . 33.7 m -98.29 145.19 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.712 -0.618 . . . . 0.040000000000000001 110.404 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 5.2 t -137.1 145.13 43.54 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.885 -0.509 . . . . 0.71999999999999997 110.084 -178.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 964' ' ' VAL . . . . . 0.467 ' HA ' ' HA ' ' B' ' 911' ' ' VAL . 61.1 t -93.4 136.39 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.133 -0.98 . . . . 1.05 110.499 -179.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -93.68 127.05 39.19 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 103.651 -2.722 . . . . 3.02 103.651 173.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 966' ' ' LEU . . . . . 0.406 ' O ' ' CG2' ' B' ' 967' ' ' VAL . 4.1 tt -132.14 61.24 1.66 Allowed 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.288 -1.004 . . . . 1.46 108.288 177.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 967' ' ' VAL . . . . . 0.406 ' CG2' ' O ' ' B' ' 966' ' ' LEU . 97.9 t -158.0 96.53 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 108.143 -1.058 . . . . 1.9399999999999999 108.143 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 88.1 mmm -143.39 58.85 1.39 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.733 -1.229 . . . . 0.0 108.375 178.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.24 119.51 1.93 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 107.222 -2.351 . . . . 2.1099999999999999 107.222 -178.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -81.9 -58.31 3.04 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.036 -1.273 . . . . 5.8899999999999997 110.415 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 46.9 tp -58.99 90.62 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.437 -0.789 . . . . 4.3600000000000003 110.249 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -141.78 -154.33 0.51 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.536 -0.728 . . . . 1.8300000000000001 110.24 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -119.51 170.89 8.76 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.498 -0.751 . . . . 4.3499999999999996 110.276 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 9.5 t -101.76 130.44 48.17 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.528 -0.733 . . . . 1.27 110.086 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -155.91 158.81 38.59 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.49 -0.756 . . . . 5.0199999999999996 110.443 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.47 85.67 17.49 Favored Pre-proline 0 N--CA 1.501 2.077 0 O-C-N 121.588 -0.695 . . . . 2.4100000000000001 109.906 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -73.63 -172.73 1.14 Allowed 'Trans proline' 0 C--N 1.317 -1.13 0 O-C-N 123.326 1.172 . . . . 0.95999999999999996 111.248 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 978' ' ' LEU . . . . . . . . . . . . . 5.4 mp -127.34 155.55 43.4 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 107.762 -1.199 . . . . 0.62 107.762 178.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 979' ' ' THR . . . . . . . . . . . . . 37.0 p -150.32 141.12 22.76 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.811 -1.181 . . . . 3.5699999999999998 111.157 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 980' ' ' ILE . . . . . 0.442 HG22 HD11 ' B' ' 980' ' ' ILE . 51.4 mm -107.44 128.59 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 109.135 -0.691 . . . . 1.3300000000000001 109.135 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -119.2 99.29 6.62 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.461 -0.774 . . . . 0.050000000000000003 111.802 -178.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 43.2 p -106.79 158.24 17.14 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.834 -0.802 . . . . 0.87 108.834 178.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 983' ' ' GLY . . . . . . . . . . . . . . . -172.77 110.16 0.33 Allowed Glycine 0 N--CA 1.499 2.87 0 N-CA-C 106.685 -2.566 . . . . 0.029999999999999999 106.685 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -110.75 149.61 30.27 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 114.539 1.311 . . . . 0.69999999999999996 114.539 -175.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 985' ' ' LEU . . . . . . . . . . . . . 54.2 tp -70.71 133.84 46.95 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.874 -1.142 . . . . 0.040000000000000001 109.808 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 986' ' ' LEU . . . . . . . . . . . . . 50.6 tp -107.39 -59.01 1.88 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.547 -0.721 . . . . 0.040000000000000001 110.009 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -144.46 144.87 31.59 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.592 -1.262 . . . . 0.040000000000000001 107.592 179.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.84 162.95 12.2 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 108.117 -1.993 . . . . 0.040000000000000001 108.117 179.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -75.15 112.59 19.02 Favored Pre-proline 0 N--CA 1.498 1.938 0 O-C-N 121.226 -1.161 . . . . 0.040000000000000001 109.439 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 990' ' ' PRO . . . . . 0.412 ' O ' ' HB2' ' B' ' 991' ' ' GLU . 49.9 Cg_endo -90.05 71.27 1.6 Allowed 'Trans proline' 0 C--N 1.319 -0.976 0 O-C-N 123.119 1.062 . . . . 0.45000000000000001 111.339 -178.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 991' ' ' GLU . . . . . 0.412 ' HB2' ' O ' ' B' ' 990' ' ' PRO . 70.0 mt-10 67.29 -73.93 0.07 Allowed 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 108.463 -0.94 . . . . 1.97 108.463 -177.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 992' ' ' LEU . . . . . . . . . . . . . 10.4 mt 51.11 20.4 0.85 Allowed 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.587 -0.696 . . . . 2.3799999999999999 111.679 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -93.94 156.95 16.35 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.914 -1.116 . . . . 3.79 109.974 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 71.9 m80 -146.33 92.8 2.22 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.561 -0.712 . . . . 3.5099999999999998 110.382 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 995' ' ' ALA . . . . . . . . . . . . 2.518 . . . . . . . 0 N--CA 1.503 2.223 0 O-C-N 120.924 -1.11 . . . . 2.73 110.581 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo . . . . . 0 N--CA 1.487 1.142 0 N-CA-C 109.526 -0.99 . . . . 3.8300000000000001 109.526 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 847' ' ' VAL . . . . . . . . . . . . . 59.5 t -126.81 106.2 22.84 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 121.68 -0.638 . . . . 1.8300000000000001 109.989 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 848' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -69.52 -22.17 33.57 Favored 'Trans proline' 0 N--CA 1.488 1.152 0 O-C-N 123.238 1.125 . . . . 0.65000000000000002 111.09 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 849' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 24.93 64.6 0.05 Allowed 'General case' 0 N--CA 1.518 2.945 0 N-CA-C 113.605 0.965 . . . . 2.5800000000000001 113.605 179.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 850' ' ' VAL . . . . . . . . . . . . . 78.9 t -120.23 134.91 62.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.105 -0.997 . . . . 1.0900000000000001 110.948 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 851' ' ' ALA . . . . . . . . . . . . . . . -127.78 155.28 44.29 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 105.745 -1.946 . . . . 0.040000000000000001 105.745 176.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 852' ' ' PHE . . . . . 0.413 ' HA ' ' CB ' ' C' ' 874' ' ' ASN . 13.5 p90 -161.56 126.96 3.6 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 121.011 1.732 . . . . 0.050000000000000003 108.683 179.017 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 24.2 t -177.06 135.32 0.2 Allowed 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.039 -1.096 . . . . 0.040000000000000001 108.039 -179.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -132.5 158.32 42.39 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.042 -1.036 . . . . 0.67000000000000004 109.96 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 855' ' ' ALA . . . . . . . . . . . . . . . -122.27 139.75 53.43 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.773 0.797 . . . . 0.51000000000000001 111.051 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 856' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -112.61 139.41 48.23 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.692 -0.63 . . . . 0.050000000000000003 110.252 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 857' ' ' SER . . . . . 0.426 ' O ' ' O ' ' C' ' 858' ' ' LEU . 1.4 m -155.96 19.92 0.38 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.585 -0.697 . . . . 1.3300000000000001 111.07 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 858' ' ' LEU . . . . . 0.426 ' O ' ' O ' ' C' ' 857' ' ' SER . 2.3 pp -34.83 161.44 0.04 OUTLIER Pre-proline 0 N--CA 1.517 2.898 0 N-CA-C 113.171 0.804 . . . . 2.3300000000000001 113.171 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -61.68 -87.72 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 120.894 1.062 . . . . 2.3199999999999998 113.495 -178.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 55.3 ptt85 -130.6 -143.26 0.24 Allowed 'General case' 0 N--CA 1.501 2.122 0 O-C-N 120.811 -1.18 . . . . 0.040000000000000001 111.923 -177.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 14.6 m -37.54 129.17 1.07 Allowed 'General case' 0 N--CA 1.51 2.548 0 O-C-N 121.592 -0.693 . . . . 1.3100000000000001 112.537 -178.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.41 160.51 25.8 Favored Pre-proline 0 N--CA 1.489 1.523 0 N-CA-C 108.263 -1.014 . . . . 4.5099999999999998 108.263 177.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -71.62 -13.82 30.08 Favored 'Trans proline' 0 C--N 1.314 -1.282 0 O-C-N 123.184 1.097 . . . . 2.2400000000000002 111.507 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -177.33 -136.18 2.39 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.658 -1.377 . . . . 0.040000000000000001 109.658 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 22.8 m -68.2 154.5 41.59 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.388 -1.066 . . . . 1.51 110.249 -179.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 866' ' ' VAL . . . . . 0.401 ' CG1' ' CD2' ' C' ' 858' ' ' LEU . 46.0 t -98.68 139.19 20.93 Favored Pre-proline 0 N--CA 1.496 1.845 0 N-CA-C 113.366 0.876 . . . . 0.78000000000000003 113.366 -174.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 867' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -91.35 -147.64 0.03 OUTLIER 'Trans proline' 0 CA--C 1.545 1.065 0 O-C-N 123.583 1.307 . . . . 0.92000000000000004 108.847 177.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 868' ' ' PHE . . . . . 0.456 ' CD1' ' HG2' ' C' ' 881' ' ' PRO . 23.7 p90 -150.01 125.56 10.28 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.584 -1.323 . . . . 0.050000000000000003 110.101 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 42.4 p-10 -112.64 -3.08 14.37 Favored 'General case' 0 N--CA 1.499 2.001 0 C-N-CA 119.281 -0.967 . . . . 1.7 112.467 -178.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 870' ' ' ARG . . . . . . . . . . . . . 23.8 mmm180 -91.72 89.11 6.96 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.905 -1.122 . . . . 2.5899999999999999 110.991 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 57.9 t -70.71 97.47 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.039 -1.038 . . . . 1.9399999999999999 109.951 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 872' ' ' LEU . . . . . . . . . . . . . 82.8 mt -83.44 -47.39 11.45 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.485 -0.759 . . . . 1.0600000000000001 110.272 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 873' ' ' LEU . . . . . 0.4 ' O ' ' HB2' ' C' ' 874' ' ' ASN . 42.7 tp -174.45 103.53 0.1 Allowed 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.507 -0.923 . . . . 4.1799999999999997 108.507 178.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 874' ' ' ASN . . . . . 0.413 ' CB ' ' HA ' ' C' ' 852' ' ' PHE . 35.9 t-20 178.55 82.22 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.612 -0.68 . . . . 0.040000000000000001 109.45 -178.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 22.9 p-10 -67.11 -46.24 74.76 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 119.245 -0.982 . . . . 3.3799999999999999 111.279 -179.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 876' ' ' GLY . . . . . 0.413 ' HA3' ' CE2' ' C' ' 878' ' ' TYR . . . -74.55 -26.09 68.53 Favored Glycine 0 N--CA 1.494 2.551 0 O-C-N 121.28 -0.888 . . . . 0.040000000000000001 111.614 -178.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 82.54 -61.06 4.79 Favored Glycine 0 N--CA 1.502 3.072 0 N-CA-C 108.118 -1.993 . . . . 0.040000000000000001 108.118 -178.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 878' ' ' TYR . . . . . 0.413 ' CE2' ' HA3' ' C' ' 876' ' ' GLY . 97.7 m-85 60.95 -65.39 0.06 Allowed 'General case' 0 N--CA 1.502 2.161 0 N-CA-C 114.384 1.253 . . . . 3.46 114.384 177.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 879' ' ' TYR . . . . . 0.473 ' CB ' ' CG ' ' C' ' 886' ' ' PHE . 22.8 p90 -112.58 109.38 18.9 Favored 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 114.823 1.416 . . . . 0.040000000000000001 114.823 -176.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.63 117.82 51.27 Favored Pre-proline 0 N--CA 1.497 1.894 0 O-C-N 121.377 -0.827 . . . . 0.02 109.89 179.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 881' ' ' PRO . . . . . 0.456 ' HG2' ' CD1' ' C' ' 868' ' ' PHE . 55.2 Cg_endo -77.03 0.45 9.69 Favored 'Trans proline' 0 N--CA 1.494 1.551 0 O-C-N 123.435 1.229 . . . . 0.39000000000000001 112.116 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -73.84 -64.33 1.03 Allowed 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 106.459 -1.682 . . . . 0.81000000000000005 106.459 178.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 9.2 p -94.82 -18.16 21.45 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.502 -0.925 . . . . 0.040000000000000001 108.502 177.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.56 21.16 57.0 Favored Glycine 0 N--CA 1.493 2.499 0 O-C-N 121.167 -0.958 . . . . 0.029999999999999999 111.046 178.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 96.8 t -72.33 89.89 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 C-N-CA 118.256 -1.377 . . . . 1.01 108.25 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 886' ' ' PHE . . . . . 0.473 ' CG ' ' CB ' ' C' ' 879' ' ' TYR . 0.7 OUTLIER -90.48 104.0 16.63 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 115.199 -0.909 . . . . 0.050000000000000003 112.038 -177.468 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 887' ' ' THR . . . . . . . . . . . . . 91.2 m -96.48 101.46 13.09 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 107.888 -1.153 . . . . 0.68000000000000005 107.888 177.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 888' ' ' ALA . . . . . . . . . . . . . . . -99.87 102.59 17.88 Favored Pre-proline 0 N--CA 1.502 2.152 0 N-CA-C 114.297 1.221 . . . . 0.25 114.297 -176.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 889' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -83.04 -13.11 9.26 Favored 'Trans proline' 0 CA--C 1.545 1.07 0 N-CA-C 109.01 -1.188 . . . . 1.6399999999999999 109.01 175.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 890' ' ' LEU . . . . . . . . . . . . . 71.7 mt -37.37 -49.87 1.01 Allowed 'General case' 0 N--CA 1.507 2.422 0 N-CA-C 113.679 0.992 . . . . 2.29 113.679 -177.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 52.63 96.73 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.358 0 O-C-N 121.117 -0.989 . . . . 0.63 110.211 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . 156.26 -147.64 16.51 Favored Glycine 0 N--CA 1.479 1.514 0 N-CA-C 107.252 -2.339 . . . . 0.040000000000000001 107.252 -179.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 74.2 ttt-85 -107.8 129.0 55.09 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 107.934 -1.136 . . . . 3.0 107.934 177.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 894' ' ' TYR . . . . . 0.449 ' CD1' ' N ' ' C' ' 895' ' ' LEU . 0.1 OUTLIER -131.16 144.05 51.07 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.058 -1.026 . . . . 0.040000000000000001 110.151 -179.246 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 895' ' ' LEU . . . . . 0.449 ' N ' ' CD1' ' C' ' 894' ' ' TYR . 37.4 tp -97.83 112.85 24.6 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.735 -0.603 . . . . 1.27 109.531 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 896' ' ' LEU . . . . . 0.432 ' HB2' ' CZ ' ' C' ' 894' ' ' TYR . 10.3 tt -110.27 143.78 39.95 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.583 -0.698 . . . . 0.93999999999999995 110.448 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 897' ' ' SER . . . . . . . . . . . . . 5.2 m -145.23 119.26 9.39 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.471 -0.768 . . . . 0.040000000000000001 111.062 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.87 146.62 32.06 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.965 -0.754 . . . . 0.47999999999999998 108.965 178.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 899' ' ' VAL . . . . . . . . . . . . . 89.6 t -92.1 119.94 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.414 -0.803 . . . . 0.55000000000000004 111.054 -179.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 90.9 mt -92.98 111.21 22.75 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 114.096 1.146 . . . . 1.5900000000000001 114.096 -175.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 22.2 m -64.53 139.68 58.79 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 107.331 -1.359 . . . . 0.050000000000000003 107.331 177.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -61.54 -65.02 3.5 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 110.32 -1.112 . . . . 0.029999999999999999 110.32 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 45.48 64.74 1.32 Allowed 'General case' 0 N--CA 1.508 2.45 0 O-C-N 121.485 -1.009 . . . . 3.2000000000000002 111.298 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 42.4 ptt85 -67.82 -7.14 25.32 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.585 -0.697 . . . . 2.9199999999999999 111.988 -179.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 905' ' ' HIS . . . . . 0.485 ' O ' ' CB ' ' C' ' 906' ' ' GLU . 72.0 t60 -60.37 5.27 0.05 OUTLIER 'General case' 0 N--CA 1.507 2.381 0 O-C-N 120.9 -1.125 . . . . 2.8700000000000001 113.714 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 906' ' ' GLU . . . . . 0.485 ' CB ' ' O ' ' C' ' 905' ' ' HIS . 0.6 OUTLIER 92.11 -164.08 0.01 OUTLIER 'General case' 0 N--CA 1.527 3.38 0 CA-C-N 121.259 1.845 . . . . 0.98999999999999999 112.254 179.053 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 907' ' ' LYS . . . . . 0.485 ' CB ' ' O ' ' C' ' 906' ' ' GLU . 73.5 tttt 89.43 162.03 0.05 Allowed 'General case' 0 N--CA 1.52 3.069 0 N-CA-C 108.146 -1.057 . . . . 5.25 108.146 -177.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 59.0 t -122.31 115.28 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 120.934 -1.104 . . . . 0.39000000000000001 110.883 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 53.0 tp10 -104.07 131.3 51.48 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 107.549 -1.278 . . . . 1.72 107.549 177.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -155.68 120.86 4.83 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 106.882 -1.525 . . . . 0.67000000000000004 106.882 178.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 911' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' C' ' 964' ' ' VAL . 11.0 p -77.82 131.14 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.879 -0.513 . . . . 0.54000000000000004 111.222 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 73.0 mt -67.52 158.29 32.3 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.218 -0.926 . . . . 1.5 108.88 178.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 913' ' ' SER . . . . . 0.403 ' CB ' ' CG1' ' C' ' 919' ' ' VAL . 1.4 p -128.33 135.73 49.99 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.468 -0.938 . . . . 1.3700000000000001 108.468 176.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 914' ' ' ARG . . . . . 0.424 ' O ' ' CB ' ' C' ' 915' ' ' SER . 0.0 OUTLIER -63.29 154.28 32.15 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 120.585 -1.322 . . . . 4.2999999999999998 111.287 -179.223 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 915' ' ' SER . . . . . 0.424 ' CB ' ' O ' ' C' ' 914' ' ' ARG . 0.2 OUTLIER 83.24 -30.45 0.09 Allowed 'General case' 0 N--CA 1.521 3.104 0 C-N-CA 123.724 0.81 . . . . 2.0499999999999998 112.079 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 916' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -123.48 -22.72 4.96 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 120.83 -1.169 . . . . 2.71 111.103 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 67.32 166.25 0.23 Allowed 'General case' 0 N--CA 1.519 3.011 0 N-CA-C 105.745 -1.946 . . . . 2.6800000000000002 105.745 -174.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.9 -125.37 35.19 Favored Glycine 1 N--CA 1.522 4.368 0 CA-C-N 123.619 2.918 . . . . 0.029999999999999999 107.069 -177.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 919' ' ' VAL . . . . . 0.403 ' CG1' ' CB ' ' C' ' 913' ' ' SER . 93.0 t 50.75 93.86 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.229 0 O-C-N 121.401 -1.058 . . . . 1.3899999999999999 109.433 -178.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 920' ' ' ALA . . . . . . . . . . . . . . . -96.1 94.96 7.85 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 119.478 -0.889 . . . . 0.029999999999999999 110.953 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 921' ' ' ARG . . . . . 0.44 ' HB3' ' CZ ' ' C' ' 950' ' ' PHE . 45.0 ptt85 -83.83 -41.54 17.4 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 105.626 -1.991 . . . . 4.4199999999999999 105.626 175.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 922' ' ' VAL . . . . . . . . . . . . . 57.6 t -97.11 74.36 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 105.393 -2.077 . . . . 0.84999999999999998 105.393 174.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -90.04 135.79 33.44 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.93 0.871 . . . . 2.46 112.41 -176.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 6.7 t -146.5 102.85 3.62 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.853 -1.166 . . . . 0.69999999999999996 107.853 178.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -111.03 91.86 0.63 Allowed Glycine 0 N--CA 1.488 2.119 0 N-CA-C 108.908 -1.677 . . . . 0.040000000000000001 108.908 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.342 0 N-CA-C 109.372 -1.491 . . . . 0.040000000000000001 109.372 -179.75 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 25.6 m . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 120.982 0.42 . . . . 13.779999999999999 110.366 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 94.4 mt -114.15 131.62 56.37 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.441 -0.787 . . . . 13.76 110.393 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -151.67 170.71 31.17 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.252 -1.539 . . . . 9.1300000000000008 109.252 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 949' ' ' VAL . . . . . . . . . . . . . 34.8 m -118.43 133.34 65.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.571 -0.958 . . . . 7.0800000000000001 111.252 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 950' ' ' PHE . . . . . 0.44 ' CZ ' ' HB3' ' C' ' 921' ' ' ARG . 20.3 p90 -131.88 147.36 52.47 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.969 -0.752 . . . . 7.5899999999999999 108.969 178.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 13.2 m -122.09 -52.82 1.96 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.281 -0.887 . . . . 5.0300000000000002 112.277 -178.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 952' ' ' LEU . . . . . 0.406 ' O ' ' O ' ' C' ' 953' ' ' ILE . 45.2 tp -60.07 -77.84 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.421 -0.8 . . . . 1.01 112.421 -177.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 953' ' ' ILE . . . . . 0.436 ' O ' ' HB3' ' C' ' 954' ' ' LEU . 44.1 pt -54.01 -140.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.734 0 N-CA-C 113.851 1.056 . . . . 2.6000000000000001 113.851 -176.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 954' ' ' LEU . . . . . 0.529 ' N ' ' CD1' ' C' ' 954' ' ' LEU . 0.0 OUTLIER 176.27 76.58 0.09 OUTLIER Pre-proline 0 N--CA 1.507 2.38 0 O-C-N 120.663 -1.273 . . . . 0.050000000000000003 111.192 179.725 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 955' ' ' PRO . . . . . 0.424 ' HD2' ' CE1' ' C' ' 950' ' ' PHE . 44.6 Cg_endo -71.51 86.2 0.85 Allowed 'Trans proline' 0 C--N 1.312 -1.364 0 N-CA-C 109.349 -1.058 . . . . 0.83999999999999997 109.349 178.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 956' ' ' LEU . . . . . . . . . . . . . 7.5 mp -126.06 153.09 44.95 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.293 -0.88 . . . . 0.040000000000000001 110.64 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -81.49 151.01 28.01 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-O 117.737 -1.125 . . . . 1.28 111.574 -179.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -68.88 119.21 12.86 Favored 'General case' 0 N--CA 1.51 2.549 0 CA-C-N 123.083 2.674 . . . . 0.17000000000000001 111.223 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 91.8 -22.65 30.04 Favored Glycine 0 N--CA 1.501 3.019 0 N-CA-C 110.789 -0.924 . . . . 0.040000000000000001 110.789 178.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 960' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -51.82 172.45 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.519 -0.989 . . . . 0.040000000000000001 110.332 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 961' ' ' THR . . . . . 0.472 ' HA ' ' O ' ' C' ' 886' ' ' PHE . 53.5 p -133.18 138.81 46.72 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.087 -1.008 . . . . 1.78 112.307 -177.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 962' ' ' VAL . . . . . 0.417 ' CG2' ' CB ' ' C' ' 886' ' ' PHE . 18.5 m -96.19 144.9 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 C-N-CA 120.208 -0.597 . . . . 0.040000000000000001 109.696 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 6.6 t -137.81 145.64 42.57 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.823 -0.548 . . . . 0.71999999999999997 110.213 -178.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 964' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' C' ' 911' ' ' VAL . 57.5 t -100.17 135.91 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.067 -1.021 . . . . 1.05 110.899 -179.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -96.71 125.62 41.29 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 103.788 -2.671 . . . . 3.02 103.788 173.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 966' ' ' LEU . . . . . 0.401 ' O ' ' CG2' ' C' ' 967' ' ' VAL . 5.1 tt -131.87 62.79 1.63 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.067 -1.086 . . . . 1.46 108.067 177.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 967' ' ' VAL . . . . . 0.401 ' CG2' ' O ' ' C' ' 966' ' ' LEU . 97.6 t -157.79 96.77 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.065 -1.087 . . . . 1.9399999999999999 108.065 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 94.4 mmm -142.26 58.62 1.46 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.769 -1.207 . . . . 0.0 108.375 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 134.58 119.54 1.96 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 107.222 -2.351 . . . . 2.1099999999999999 107.222 -178.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -82.4 -58.12 3.07 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.031 -1.276 . . . . 5.8899999999999997 110.607 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 9.1 tt -58.94 89.84 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.427 -0.796 . . . . 4.3600000000000003 110.378 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -142.33 -152.59 0.42 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.584 -0.698 . . . . 1.8300000000000001 110.144 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -117.17 167.81 10.85 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.415 -0.803 . . . . 4.3499999999999996 110.045 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 29.3 t -101.54 130.19 47.77 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.547 -0.72 . . . . 1.27 110.152 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -156.22 153.68 29.56 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.526 -0.734 . . . . 5.0199999999999996 110.405 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.27 86.08 17.56 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.604 -0.685 . . . . 2.4100000000000001 109.853 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -75.39 -171.44 1.02 Allowed 'Trans proline' 0 C--N 1.318 -1.065 0 O-C-N 123.326 1.172 . . . . 0.95999999999999996 111.309 -179.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 978' ' ' LEU . . . . . . . . . . . . . 5.4 mp -123.36 156.68 34.9 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 107.512 -1.292 . . . . 0.62 107.512 177.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 979' ' ' THR . . . . . . . . . . . . . 45.0 p -149.72 141.65 23.81 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.777 -1.202 . . . . 3.5699999999999998 111.186 -179.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 980' ' ' ILE . . . . . 0.429 HG22 HD11 ' C' ' 980' ' ' ILE . 50.6 mm -105.64 128.47 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 N-CA-C 109.174 -0.676 . . . . 1.3300000000000001 109.174 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 981' ' ' PHE . . . . . 0.439 ' CD1' ' CE2' ' C' ' 879' ' ' TYR . 2.1 t80 -118.99 99.36 6.69 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 119.808 -0.757 . . . . 0.050000000000000003 111.486 -178.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 982' ' ' SER . . . . . . . . . . . . . 10.6 p -109.93 159.71 17.02 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.578 -0.701 . . . . 0.87 109.194 178.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 983' ' ' GLY . . . . . 0.41 ' O ' ' CE2' ' C' ' 852' ' ' PHE . . . -170.8 111.42 0.41 Allowed Glycine 0 N--CA 1.498 2.818 0 N-CA-C 106.594 -2.602 . . . . 0.029999999999999999 106.594 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 984' ' ' ALA . . . . . . . . . . . . . . . -109.01 147.19 32.7 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.199 -1.177 . . . . 0.69999999999999996 114.025 -176.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 985' ' ' LEU . . . . . . . . . . . . . 56.6 tp -72.36 135.72 45.95 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.722 -1.236 . . . . 0.040000000000000001 110.066 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 986' ' ' LEU . . . . . . . . . . . . . 49.1 tp -107.08 -61.58 1.53 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.524 -0.735 . . . . 0.040000000000000001 110.341 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -145.0 146.33 31.87 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.847 -1.168 . . . . 0.040000000000000001 107.847 179.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.35 162.79 12.29 Favored Glycine 0 N--CA 1.495 2.593 0 N-CA-C 108.146 -1.981 . . . . 0.040000000000000001 108.146 179.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -75.44 112.65 20.05 Favored Pre-proline 0 N--CA 1.498 1.965 0 O-C-N 121.19 -1.183 . . . . 0.040000000000000001 109.485 179.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 990' ' ' PRO . . . . . 0.414 ' O ' ' HB2' ' C' ' 991' ' ' GLU . 50.2 Cg_endo -89.82 71.26 1.72 Allowed 'Trans proline' 0 C--N 1.319 -0.985 0 O-C-N 123.132 1.07 . . . . 0.45000000000000001 111.466 -178.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 991' ' ' GLU . . . . . 0.414 ' HB2' ' O ' ' C' ' 990' ' ' PRO . 69.5 mt-10 67.41 -73.31 0.08 Allowed 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 108.662 -0.866 . . . . 1.97 108.662 -177.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 992' ' ' LEU . . . . . . . . . . . . . 11.7 mt 50.62 21.06 0.81 Allowed 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.584 -0.697 . . . . 2.3799999999999999 111.645 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 79.7 mt-10 -93.27 156.94 16.51 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.887 -1.133 . . . . 3.79 110.02 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 68.6 m80 -146.62 92.59 2.17 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.525 -0.734 . . . . 3.5099999999999998 110.21 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 995' ' ' ALA . . . . . . . . . . . . 2.518 . . . . . . . 0 N--CA 1.503 2.197 0 O-C-N 120.94 -1.1 . . . . 2.73 110.569 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo . . . . . 0 N--CA 1.488 1.157 0 N-CA-C 109.503 -0.999 . . . . 3.8300000000000001 109.503 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 847' ' ' VAL . . . . . . . . . . . . . 61.3 t -132.16 102.84 14.24 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.584 -0.697 . . . . 1.8300000000000001 110.06 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 848' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.84 -20.84 33.95 Favored 'Trans proline' 0 N--CA 1.487 1.124 0 O-C-N 123.276 1.145 . . . . 0.65000000000000002 110.973 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 849' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 28.04 68.1 0.07 Allowed 'General case' 0 N--CA 1.518 2.937 0 N-CA-C 112.911 0.708 . . . . 2.5800000000000001 112.911 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 850' ' ' VAL . . . . . . . . . . . . . 72.9 t -119.74 136.13 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.152 -0.968 . . . . 1.0900000000000001 111.413 -178.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 851' ' ' ALA . . . . . . . . . . . . . . . -126.62 159.41 33.65 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 106.043 -1.836 . . . . 0.040000000000000001 106.043 177.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 852' ' ' PHE . . . . . 0.43 ' CE1' ' HA3' ' A' ' 983' ' ' GLY . 46.7 p90 -157.56 131.79 8.3 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 121.019 1.736 . . . . 0.050000000000000003 108.728 178.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 32.5 t -175.67 133.02 0.28 Allowed 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.076 -1.083 . . . . 0.040000000000000001 108.076 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -133.45 156.08 48.37 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.071 -1.018 . . . . 0.67000000000000004 109.472 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 855' ' ' ALA . . . . . . . . . . . . . . . -124.4 140.17 53.21 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.808 0.813 . . . . 0.51000000000000001 111.305 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 856' ' ' LEU . . . . . 0.403 HD21 ' CG1' ' A' ' 866' ' ' VAL . 3.4 tm? -111.96 140.01 46.98 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.607 -0.683 . . . . 0.050000000000000003 110.156 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 857' ' ' SER . . . . . 0.409 ' O ' ' O ' ' A' ' 858' ' ' LEU . 37.0 p -157.59 17.05 0.26 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.543 -0.723 . . . . 1.3300000000000001 111.467 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 858' ' ' LEU . . . . . 0.409 ' O ' ' O ' ' A' ' 857' ' ' SER . 3.1 pp -35.67 161.57 0.04 OUTLIER Pre-proline 0 N--CA 1.518 2.935 0 N-CA-C 112.851 0.686 . . . . 2.3300000000000001 112.851 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -59.87 -89.17 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.453 0 O-C-N 122.938 0.968 . . . . 2.3199999999999998 113.294 -178.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 55.3 ptt85 -134.9 -141.61 0.18 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.839 -1.163 . . . . 0.040000000000000001 111.646 -177.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 73.8 m -32.89 122.09 0.36 Allowed 'General case' 0 N--CA 1.513 2.694 0 N-CA-C 112.996 0.739 . . . . 1.3100000000000001 112.996 -178.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.76 160.13 27.08 Favored Pre-proline 0 N--CA 1.489 1.483 0 N-CA-C 107.93 -1.137 . . . . 4.5099999999999998 107.93 177.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.05 -13.86 34.45 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.134 1.07 . . . . 2.2400000000000002 111.479 -179.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -177.3 -135.45 2.22 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.97 -1.252 . . . . 0.040000000000000001 109.97 179.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 37.2 m -67.56 157.34 34.6 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.35 -1.088 . . . . 1.51 110.53 -178.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 866' ' ' VAL . . . . . 0.404 ' CG1' ' CD2' ' A' ' 858' ' ' LEU . 50.8 t -100.55 139.34 20.54 Favored Pre-proline 0 N--CA 1.495 1.8 0 N-CA-C 113.459 0.911 . . . . 0.78000000000000003 113.459 -174.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 867' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -91.67 -148.19 0.03 OUTLIER 'Trans proline' 0 CA--C 1.548 1.177 0 O-C-N 123.621 1.327 . . . . 0.92000000000000004 109.481 177.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 868' ' ' PHE . . . . . 0.45 ' CD1' ' CG ' ' A' ' 881' ' ' PRO . 26.3 p90 -150.35 124.22 9.26 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.696 -1.253 . . . . 0.050000000000000003 109.539 179.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 50.4 p-10 -113.82 -2.16 13.73 Favored 'General case' 0 N--CA 1.5 2.066 0 C-N-CA 119.265 -0.974 . . . . 1.7 112.852 -178.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 870' ' ' ARG . . . . . . . . . . . . . 28.7 mmm180 -91.27 90.11 7.6 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.865 -1.147 . . . . 2.5899999999999999 110.999 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 57.4 t -71.81 96.72 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 120.971 -1.081 . . . . 1.9399999999999999 110.047 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 872' ' ' LEU . . . . . . . . . . . . . 96.8 mt -83.06 -47.46 11.65 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.456 -0.778 . . . . 1.0600000000000001 110.04 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 873' ' ' LEU . . . . . . . . . . . . . 41.2 tp -175.15 103.19 0.08 Allowed 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 108.381 -0.97 . . . . 4.1799999999999997 108.381 178.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 874' ' ' ASN . . . . . 0.404 ' CB ' ' HA ' ' A' ' 852' ' ' PHE . 36.7 t-20 178.29 81.68 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.324 0 O-C-N 121.681 -0.637 . . . . 0.040000000000000001 109.421 -178.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -66.26 -46.77 75.93 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 119.324 -0.95 . . . . 3.3799999999999999 111.22 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 876' ' ' GLY . . . . . 0.412 ' HA3' ' CE2' ' A' ' 878' ' ' TYR . . . -74.87 -24.56 71.74 Favored Glycine 0 N--CA 1.494 2.555 0 O-C-N 121.318 -0.864 . . . . 0.040000000000000001 111.916 -178.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 82.11 -62.48 4.54 Favored Glycine 0 N--CA 1.501 3.021 0 N-CA-C 107.896 -2.082 . . . . 0.040000000000000001 107.896 -178.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 878' ' ' TYR . . . . . 0.412 ' CE2' ' HA3' ' A' ' 876' ' ' GLY . 93.2 m-85 61.41 -61.99 0.09 Allowed 'General case' 0 N--CA 1.504 2.262 0 N-CA-C 114.596 1.332 . . . . 3.46 114.596 177.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 879' ' ' TYR . . . . . 0.467 ' CB ' ' CD2' ' A' ' 886' ' ' PHE . 20.4 p90 -110.58 109.03 19.17 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 114.849 1.425 . . . . 0.040000000000000001 114.849 -176.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -67.19 118.21 53.77 Favored Pre-proline 0 N--CA 1.495 1.813 0 O-C-N 121.385 -0.822 . . . . 0.02 109.899 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 881' ' ' PRO . . . . . 0.45 ' CG ' ' CD1' ' A' ' 868' ' ' PHE . 51.2 Cg_endo -76.84 1.2 8.84 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 O-C-N 123.443 1.233 . . . . 0.39000000000000001 112.165 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -76.19 -64.75 1.03 Allowed 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 106.78 -1.563 . . . . 0.81000000000000005 106.78 178.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 7.5 p -95.43 -17.91 21.13 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.702 -0.851 . . . . 0.040000000000000001 108.702 177.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 85.17 23.33 48.97 Favored Glycine 0 N--CA 1.495 2.577 0 C-N-CA 120.11 -1.043 . . . . 0.029999999999999999 110.679 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 885' ' ' VAL . . . . . . . . . . . . . 75.4 t -73.39 88.42 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 C-N-CA 118.351 -1.339 . . . . 1.01 108.085 -179.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 886' ' ' PHE . . . . . 0.467 ' CD2' ' CB ' ' A' ' 879' ' ' TYR . 0.6 OUTLIER -89.64 106.55 18.53 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 115.239 -0.891 . . . . 0.050000000000000003 112.135 -177.232 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 887' ' ' THR . . . . . . . . . . . . . 95.4 m -98.48 99.29 10.45 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 107.581 -1.266 . . . . 0.68000000000000005 107.581 177.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 888' ' ' ALA . . . . . . . . . . . . . . . -97.1 107.88 40.59 Favored Pre-proline 0 N--CA 1.502 2.132 0 N-CA-C 113.983 1.105 . . . . 0.25 113.983 -176.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 889' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -89.11 -13.5 2.99 Favored 'Trans proline' 0 CA--C 1.546 1.094 0 N-CA-C 109.093 -1.157 . . . . 1.6399999999999999 109.093 176.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 890' ' ' LEU . . . . . . . . . . . . . 51.8 mt -35.91 -51.08 0.7 Allowed 'General case' 0 N--CA 1.508 2.447 0 N-CA-C 113.735 1.013 . . . . 2.29 113.735 -177.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 51.83 95.76 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.321 0 O-C-N 121.211 -0.93 . . . . 0.63 110.294 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 157.71 -152.99 24.24 Favored Glycine 0 N--CA 1.479 1.531 0 N-CA-C 107.181 -2.368 . . . . 0.040000000000000001 107.181 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 893' ' ' ARG . . . . . 0.405 ' CZ ' ' CB ' ' C' ' 984' ' ' ALA . 71.9 ttt-85 -114.46 126.23 54.73 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 108.286 -1.005 . . . . 3.0 108.286 177.306 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 894' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -132.47 160.06 37.54 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.105 -0.997 . . . . 0.040000000000000001 111.342 -179.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 895' ' ' LEU . . . . . . . . . . . . . 36.4 tp -92.16 119.67 32.03 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.735 -0.603 . . . . 1.27 110.056 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 9.7 tt -109.64 143.67 39.05 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.717 -0.614 . . . . 0.93999999999999995 110.191 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 897' ' ' SER . . . . . . . . . . . . . 64.7 m -149.86 114.07 5.17 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.443 -0.786 . . . . 0.040000000000000001 111.159 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.71 146.53 31.97 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.942 -0.762 . . . . 0.47999999999999998 108.942 178.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 899' ' ' VAL . . . . . . . . . . . . . 90.1 t -95.02 120.06 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 C-N-CA 119.588 -0.845 . . . . 0.55000000000000004 111.183 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 900' ' ' LEU . . . . . 0.424 ' CD2' ' N ' ' A' ' 900' ' ' LEU . 4.5 mm? -95.52 112.04 23.83 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 114.331 1.234 . . . . 1.5900000000000001 114.331 -175.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 15.7 m -65.91 141.28 58.29 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 107.506 -1.294 . . . . 0.050000000000000003 107.506 177.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -67.11 -66.71 2.25 Favored Glycine 0 N--CA 1.495 2.597 0 N-CA-C 110.505 -1.038 . . . . 0.029999999999999999 110.505 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 12.0 m170 47.52 67.3 0.83 Allowed 'General case' 0 N--CA 1.507 2.378 0 O-C-N 121.533 -0.981 . . . . 3.2000000000000002 111.017 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 46.5 ptt85 -69.48 -6.82 33.01 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.58 -0.7 . . . . 2.9199999999999999 111.9 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 905' ' ' HIS . . . . . 0.485 ' O ' ' CB ' ' A' ' 906' ' ' GLU . 70.7 t60 -62.86 5.68 0.12 Allowed 'General case' 0 N--CA 1.506 2.35 0 O-C-N 120.943 -1.098 . . . . 2.8700000000000001 113.116 -179.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 906' ' ' GLU . . . . . 0.485 ' CB ' ' O ' ' A' ' 905' ' ' HIS . 0.6 OUTLIER 94.44 -164.29 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.407 0 CA-C-N 120.486 1.494 . . . . 0.98999999999999999 111.906 178.924 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 907' ' ' LYS . . . . . 0.458 ' CB ' ' O ' ' A' ' 906' ' ' GLU . 69.2 tttt 85.34 155.57 0.09 Allowed 'General case' 0 N--CA 1.519 3.01 0 N-CA-C 107.87 -1.159 . . . . 5.25 107.87 -176.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 59.5 t -123.44 115.55 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 120.733 -1.229 . . . . 0.39000000000000001 111.239 -179.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -97.3 135.48 39.16 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 107.077 -1.453 . . . . 1.72 107.077 176.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -154.72 123.66 6.25 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 106.985 -1.487 . . . . 0.67000000000000004 106.985 178.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 911' ' ' VAL . . . . . 0.504 ' HA ' ' HA ' ' A' ' 964' ' ' VAL . 86.1 t -80.43 130.55 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 CA-C-N 116.186 -0.461 . . . . 0.54000000000000004 110.933 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 86.0 mt -63.54 156.74 25.54 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.33 -0.856 . . . . 1.5 108.703 178.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 913' ' ' SER . . . . . 0.409 ' CB ' ' CG1' ' A' ' 919' ' ' VAL . 0.4 OUTLIER -128.38 131.27 48.53 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.17 -1.048 . . . . 1.3700000000000001 108.17 176.653 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 914' ' ' ARG . . . . . 0.432 ' O ' ' CB ' ' A' ' 915' ' ' SER . 0.0 OUTLIER -66.18 156.35 34.36 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 120.651 -1.28 . . . . 4.2999999999999998 111.706 -179.068 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 915' ' ' SER . . . . . 0.432 ' CB ' ' O ' ' A' ' 914' ' ' ARG . 4.2 t 83.19 -32.05 0.08 Allowed 'General case' 0 N--CA 1.522 3.163 0 C-N-CA 123.99 0.916 . . . . 2.0499999999999998 112.003 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 916' ' ' ASN . . . . . 0.403 ' O ' ' HB2' ' A' ' 917' ' ' GLN . 82.6 m-20 -122.73 -20.86 5.78 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.918 -1.114 . . . . 2.71 111.249 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 917' ' ' GLN . . . . . 0.403 ' HB2' ' O ' ' A' ' 916' ' ' ASN . 45.4 mt-30 66.64 164.8 0.2 Allowed 'General case' 0 N--CA 1.521 3.106 0 N-CA-C 105.744 -1.947 . . . . 2.6800000000000002 105.744 -174.2 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 53.94 -124.26 29.47 Favored Glycine 1 N--CA 1.521 4.345 0 CA-C-N 123.455 2.843 . . . . 0.029999999999999999 107.05 -177.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 919' ' ' VAL . . . . . 0.409 ' CG1' ' CB ' ' A' ' 913' ' ' SER . 73.5 t 51.56 94.18 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 O-C-N 121.425 -1.044 . . . . 1.3899999999999999 109.165 -178.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 920' ' ' ALA . . . . . . . . . . . . . . . -92.95 92.19 7.75 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.347 -0.941 . . . . 0.029999999999999999 110.67 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 921' ' ' ARG . . . . . 0.407 ' HB3' ' CZ ' ' A' ' 950' ' ' PHE . 29.2 ptt180 -85.11 -41.75 15.42 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 105.931 -1.877 . . . . 4.4199999999999999 105.931 176.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 922' ' ' VAL . . . . . . . . . . . . . 93.1 t -101.19 73.02 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 N-CA-C 106.021 -1.844 . . . . 0.84999999999999998 106.021 175.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -87.29 133.29 33.71 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.689 0.757 . . . . 2.46 111.381 -177.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 8.7 t -147.99 105.61 3.68 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.59 -0.893 . . . . 0.69999999999999996 108.59 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -102.82 84.41 0.47 Allowed Glycine 0 N--CA 1.487 2.054 0 N-CA-C 108.568 -1.813 . . . . 0.040000000000000001 108.568 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 108.786 -1.725 . . . . 0.040000000000000001 108.786 -179.69 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 67.1 m . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.007 0.432 . . . . 13.779999999999999 110.366 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 95.5 mt -109.52 130.55 55.5 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.509 -0.744 . . . . 13.76 110.276 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -152.79 169.21 31.82 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.388 -1.485 . . . . 9.1300000000000008 109.388 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 949' ' ' VAL . . . . . . . . . . . . . 34.3 m -118.56 130.49 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.577 -0.955 . . . . 7.0800000000000001 110.687 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 950' ' ' PHE . . . . . 0.407 ' CZ ' ' HB3' ' A' ' 921' ' ' ARG . 52.0 p90 -130.22 143.98 51.1 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.454 -0.779 . . . . 7.5899999999999999 109.415 179.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 31.3 m -121.61 -52.3 2.03 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.46 -0.775 . . . . 5.0300000000000002 111.97 -178.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 952' ' ' LEU . . . . . 0.404 ' O ' ' O ' ' A' ' 953' ' ' ILE . 45.7 tp -61.47 -75.88 0.06 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.44 -0.787 . . . . 1.01 112.439 -177.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 953' ' ' ILE . . . . . 0.441 ' O ' ' HB3' ' A' ' 954' ' ' LEU . 47.0 pt -53.65 -141.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.736 0 N-CA-C 113.981 1.104 . . . . 2.6000000000000001 113.981 -176.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 954' ' ' LEU . . . . . 0.539 ' N ' ' CD1' ' A' ' 954' ' ' LEU . 0.0 OUTLIER 174.32 75.09 0.05 OUTLIER Pre-proline 0 N--CA 1.507 2.378 0 O-C-N 120.755 -1.215 . . . . 0.050000000000000003 110.959 179.813 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 955' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -73.04 93.79 0.81 Allowed 'Trans proline' 0 C--N 1.315 -1.215 0 N-CA-C 109.227 -1.105 . . . . 0.83999999999999997 109.227 178.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 956' ' ' LEU . . . . . 0.403 ' CD2' ' NH1' ' A' ' 914' ' ' ARG . 5.0 mp -126.19 140.39 52.59 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.251 -0.906 . . . . 0.040000000000000001 110.624 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -79.77 152.52 29.75 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 117.864 -1.065 . . . . 1.28 111.201 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -67.14 121.2 15.1 Favored 'General case' 0 N--CA 1.511 2.58 0 CA-C-N 122.743 2.52 . . . . 0.17000000000000001 111.925 -179.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 94.31 -18.75 56.29 Favored Glycine 0 N--CA 1.501 3.004 0 N-CA-C 111.135 -0.786 . . . . 0.040000000000000001 111.135 178.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 960' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -52.42 167.56 0.13 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.445 -1.032 . . . . 0.040000000000000001 111.029 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 961' ' ' THR . . . . . 0.456 ' HA ' ' O ' ' A' ' 886' ' ' PHE . 57.3 m -135.66 135.84 40.45 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.936 -1.103 . . . . 1.78 111.623 -178.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 962' ' ' VAL . . . . . 0.404 ' CG2' ' CB ' ' A' ' 886' ' ' PHE . 33.8 m -100.43 145.24 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 O-C-N 121.57 -0.706 . . . . 0.040000000000000001 111.173 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 1.7 m -138.51 148.15 43.96 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.789 -0.569 . . . . 0.71999999999999997 109.964 -178.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 964' ' ' VAL . . . . . 0.504 ' HA ' ' HA ' ' A' ' 911' ' ' VAL . 61.4 t -99.66 137.92 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.128 -0.983 . . . . 1.05 110.584 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -91.68 128.88 37.69 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 104.121 -2.548 . . . . 3.02 104.121 173.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 966' ' ' LEU . . . . . 0.413 ' O ' ' CG2' ' A' ' 967' ' ' VAL . 0.4 OUTLIER -131.54 59.8 1.69 Allowed 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.22 -1.03 . . . . 1.46 108.22 177.078 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 967' ' ' VAL . . . . . 0.413 ' CG2' ' O ' ' A' ' 966' ' ' LEU . 90.6 t -158.64 97.25 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 108.041 -1.096 . . . . 1.9399999999999999 108.041 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 80.2 mmm -143.99 59.47 1.36 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.711 -1.243 . . . . 0.0 108.396 178.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.3 119.77 1.95 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 107.195 -2.362 . . . . 2.1099999999999999 107.195 -178.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -82.18 -59.05 2.69 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.082 -1.246 . . . . 5.8899999999999997 110.333 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 47.3 tp -59.08 90.76 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.437 -0.789 . . . . 4.3600000000000003 110.205 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -141.91 -154.51 0.52 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.56 -0.712 . . . . 1.8300000000000001 110.24 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -120.5 172.53 7.77 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.45 -0.781 . . . . 4.3499999999999996 110.349 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 30.6 t -101.25 130.3 47.35 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.534 -0.729 . . . . 1.27 110.016 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -155.66 159.0 39.22 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.553 -0.717 . . . . 5.0199999999999996 110.52 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.01 85.99 18.47 Favored Pre-proline 0 N--CA 1.5 2.053 0 O-C-N 121.648 -0.658 . . . . 2.4100000000000001 109.632 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -73.15 -173.06 1.15 Allowed 'Trans proline' 0 C--N 1.317 -1.098 0 O-C-N 123.309 1.163 . . . . 0.95999999999999996 111.359 -179.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 4.9 mp -128.52 153.94 46.66 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 107.547 -1.279 . . . . 0.62 107.547 177.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 979' ' ' THR . . . . . . . . . . . . . 41.8 p -149.99 141.57 23.49 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.8 -1.187 . . . . 3.5699999999999998 111.189 -179.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 980' ' ' ILE . . . . . . . . . . . . . 49.4 mm -106.86 128.72 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.893 -0.78 . . . . 1.3300000000000001 108.893 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 981' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -119.0 95.96 5.04 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 119.806 -0.758 . . . . 0.050000000000000003 111.891 -178.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 82.8 p -108.18 157.83 17.97 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.55 -0.719 . . . . 0.87 109.098 178.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 983' ' ' GLY . . . . . 0.43 ' HA3' ' CE1' ' A' ' 852' ' ' PHE . . . -176.84 108.17 0.25 Allowed Glycine 0 N--CA 1.499 2.875 0 N-CA-C 106.411 -2.676 . . . . 0.029999999999999999 106.411 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -108.53 152.33 24.89 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 114.658 1.355 . . . . 0.69999999999999996 114.658 -175.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 36.4 tp -72.15 135.33 46.15 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.829 -1.17 . . . . 0.040000000000000001 109.991 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 51.4 tp -106.09 -59.78 1.73 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.535 -0.728 . . . . 0.040000000000000001 109.879 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -143.15 146.52 33.8 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 107.57 -1.27 . . . . 0.040000000000000001 107.57 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.13 163.66 12.17 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 108.23 -1.948 . . . . 0.040000000000000001 108.23 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -74.56 112.61 18.11 Favored Pre-proline 0 N--CA 1.498 1.951 0 O-C-N 121.227 -1.161 . . . . 0.040000000000000001 109.439 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 990' ' ' PRO . . . . . 0.416 ' O ' ' HB2' ' A' ' 991' ' ' GLU . 50.6 Cg_endo -89.25 71.0 2.07 Favored 'Trans proline' 0 C--N 1.318 -1.036 0 O-C-N 123.132 1.07 . . . . 0.45000000000000001 111.494 -178.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 991' ' ' GLU . . . . . 0.416 ' HB2' ' O ' ' A' ' 990' ' ' PRO . 70.5 mt-10 67.23 -73.97 0.07 Allowed 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 108.562 -0.903 . . . . 1.97 108.562 -177.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 992' ' ' LEU . . . . . . . . . . . . . 11.4 mt 51.19 20.66 0.93 Allowed 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.572 -0.705 . . . . 2.3799999999999999 111.593 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -92.81 156.9 16.69 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.86 -1.15 . . . . 3.79 109.955 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 71.0 m80 -147.1 92.22 2.09 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.525 -0.734 . . . . 3.5099999999999998 110.314 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 995' ' ' ALA . . . . . . . . . . . . 2.516 . . . . . . . 0 N--CA 1.503 2.214 0 O-C-N 120.933 -1.105 . . . . 2.73 110.551 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo . . . . . 0 N--CA 1.488 1.16 0 N-CA-C 109.479 -1.008 . . . . 3.8300000000000001 109.479 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 847' ' ' VAL . . . . . . . . . . . . . 60.4 t -132.1 102.86 14.31 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.632 -0.667 . . . . 1.8300000000000001 110.122 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 848' ' ' PRO . . . . . 0.401 ' O ' ' C ' ' B' ' 849' ' ' GLN . 43.9 Cg_endo -69.76 -21.17 33.85 Favored 'Trans proline' 0 N--CA 1.487 1.1 0 O-C-N 123.328 1.173 . . . . 0.65000000000000002 110.941 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 849' ' ' GLN . . . . . 0.401 ' C ' ' O ' ' B' ' 848' ' ' PRO . 56.1 tt0 28.35 68.34 0.08 Allowed 'General case' 0 N--CA 1.517 2.901 0 N-CA-C 112.856 0.687 . . . . 2.5800000000000001 112.856 179.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 850' ' ' VAL . . . . . . . . . . . . . 74.4 t -120.07 136.11 58.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.213 -0.93 . . . . 1.0900000000000001 111.421 -178.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 851' ' ' ALA . . . . . . . . . . . . . . . -126.93 158.72 36.06 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 106.008 -1.849 . . . . 0.040000000000000001 106.008 177.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 852' ' ' PHE . . . . . 0.421 ' CE1' ' HA3' ' B' ' 983' ' ' GLY . 46.6 p90 -156.87 132.07 9.12 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 121.034 1.743 . . . . 0.050000000000000003 108.713 179.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 33.0 t -175.74 132.71 0.27 Allowed 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.118 -1.067 . . . . 0.040000000000000001 108.118 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -133.13 156.23 47.82 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.118 -0.989 . . . . 0.67000000000000004 109.487 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 855' ' ' ALA . . . . . 0.405 ' O ' ' HB2' ' B' ' 870' ' ' ARG . . . -124.47 140.38 53.01 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.784 0.802 . . . . 0.51000000000000001 111.306 -179.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 856' ' ' LEU . . . . . 0.403 HD21 ' CG1' ' B' ' 866' ' ' VAL . 3.4 tm? -112.24 139.5 47.72 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.622 -0.673 . . . . 0.050000000000000003 110.179 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 857' ' ' SER . . . . . 0.412 ' O ' ' O ' ' B' ' 858' ' ' LEU . 37.4 p -157.27 17.42 0.28 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.544 -0.723 . . . . 1.3300000000000001 111.42 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 858' ' ' LEU . . . . . 0.412 ' O ' ' O ' ' B' ' 857' ' ' SER . 3.2 pp -35.92 161.57 0.04 OUTLIER Pre-proline 0 N--CA 1.518 2.953 0 CA-C-N 118.656 0.662 . . . . 2.3300000000000001 112.784 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -59.86 -89.24 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.49 0 O-C-N 122.901 0.948 . . . . 2.3199999999999998 113.277 -178.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 55.3 ptt85 -134.92 -141.58 0.18 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.836 -1.165 . . . . 0.040000000000000001 111.675 -177.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 73.8 m -32.81 121.68 0.35 Allowed 'General case' 0 N--CA 1.512 2.646 0 N-CA-C 113.042 0.756 . . . . 1.3100000000000001 113.042 -178.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 862' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.47 160.16 27.01 Favored Pre-proline 0 N--CA 1.489 1.524 0 N-CA-C 107.953 -1.129 . . . . 4.5099999999999998 107.953 177.178 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -69.95 -14.01 34.92 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 O-C-N 123.157 1.083 . . . . 2.2400000000000002 111.576 -179.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -177.03 -134.54 2.01 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 110.027 -1.229 . . . . 0.040000000000000001 110.027 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 38.9 m -68.43 157.72 35.21 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.308 -1.113 . . . . 1.51 110.437 -179.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 866' ' ' VAL . . . . . 0.406 ' CG1' ' CD2' ' B' ' 858' ' ' LEU . 50.7 t -100.7 139.34 20.5 Favored Pre-proline 0 N--CA 1.495 1.778 0 N-CA-C 113.509 0.929 . . . . 0.78000000000000003 113.509 -174.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 867' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -91.72 -148.48 0.03 OUTLIER 'Trans proline' 0 CA--C 1.548 1.18 0 O-C-N 123.641 1.337 . . . . 0.92000000000000004 109.446 177.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 868' ' ' PHE . . . . . 0.455 ' CD1' ' CG ' ' B' ' 881' ' ' PRO . 26.1 p90 -150.17 124.1 9.31 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.622 -1.299 . . . . 0.050000000000000003 109.576 179.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 50.4 p-10 -113.68 -1.84 13.91 Favored 'General case' 0 N--CA 1.501 2.089 0 C-N-CA 119.222 -0.991 . . . . 1.7 112.875 -178.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 870' ' ' ARG . . . . . 0.405 ' HB2' ' O ' ' B' ' 855' ' ' ALA . 28.4 mmm180 -91.52 89.88 7.39 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.837 -1.164 . . . . 2.5899999999999999 111.011 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 57.6 t -71.8 96.83 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.009 -1.057 . . . . 1.9399999999999999 110.019 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 872' ' ' LEU . . . . . . . . . . . . . 96.7 mt -83.22 -47.34 11.66 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.535 -0.728 . . . . 1.0600000000000001 110.021 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 873' ' ' LEU . . . . . . . . . . . . . 41.0 tp -175.1 103.22 0.08 Allowed 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.416 -0.957 . . . . 4.1799999999999997 108.416 178.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 874' ' ' ASN . . . . . 0.401 ' CB ' ' HA ' ' B' ' 852' ' ' PHE . 36.5 t-20 178.33 81.78 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.663 -0.648 . . . . 0.040000000000000001 109.443 -178.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -66.44 -46.87 75.01 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 119.32 -0.952 . . . . 3.3799999999999999 111.208 -179.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 876' ' ' GLY . . . . . 0.414 ' HA3' ' CE2' ' B' ' 878' ' ' TYR . . . -74.71 -24.85 71.26 Favored Glycine 0 N--CA 1.494 2.551 0 O-C-N 121.242 -0.912 . . . . 0.040000000000000001 111.888 -178.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 82.27 -62.32 4.58 Favored Glycine 0 N--CA 1.502 3.042 0 N-CA-C 107.877 -2.089 . . . . 0.040000000000000001 107.877 -178.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 878' ' ' TYR . . . . . 0.414 ' CE2' ' HA3' ' B' ' 876' ' ' GLY . 93.2 m-85 61.41 -62.02 0.09 Allowed 'General case' 0 N--CA 1.504 2.252 0 N-CA-C 114.595 1.332 . . . . 3.46 114.595 177.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 879' ' ' TYR . . . . . 0.468 ' CG ' ' O ' ' B' ' 879' ' ' TYR . 20.3 p90 -110.55 109.12 19.32 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 114.826 1.417 . . . . 0.040000000000000001 114.826 -176.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -67.18 118.04 52.08 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.448 -0.783 . . . . 0.02 109.894 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 881' ' ' PRO . . . . . 0.455 ' CG ' ' CD1' ' B' ' 868' ' ' PHE . 53.0 Cg_endo -76.75 1.25 8.75 Favored 'Trans proline' 0 N--CA 1.492 1.431 0 O-C-N 123.426 1.224 . . . . 0.39000000000000001 112.194 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -76.2 -64.79 1.02 Allowed 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 106.8 -1.556 . . . . 0.81000000000000005 106.8 178.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 7.6 p -95.65 -17.3 21.42 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.759 -0.83 . . . . 0.040000000000000001 108.759 177.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.57 23.79 49.09 Favored Glycine 0 N--CA 1.494 2.55 0 C-N-CA 120.091 -1.052 . . . . 0.029999999999999999 110.721 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 885' ' ' VAL . . . . . . . . . . . . . 76.6 t -73.64 88.57 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 C-N-CA 118.315 -1.354 . . . . 1.01 108.022 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 886' ' ' PHE . . . . . 0.468 ' CD2' ' CB ' ' B' ' 879' ' ' TYR . 0.6 OUTLIER -89.82 106.7 18.64 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 115.324 -0.853 . . . . 0.050000000000000003 112.105 -177.293 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 887' ' ' THR . . . . . . . . . . . . . 95.5 m -98.53 99.52 10.68 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 107.539 -1.282 . . . . 0.68000000000000005 107.539 177.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 888' ' ' ALA . . . . . . . . . . . . . . . -97.3 107.73 40.24 Favored Pre-proline 0 N--CA 1.502 2.138 0 N-CA-C 113.992 1.108 . . . . 0.25 113.992 -176.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 889' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -88.92 -13.66 3.06 Favored 'Trans proline' 0 CA--C 1.545 1.056 0 O-C-N 123.29 1.153 . . . . 1.6399999999999999 109.164 176.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 890' ' ' LEU . . . . . . . . . . . . . 51.9 mt -35.68 -51.31 0.66 Allowed 'General case' 0 N--CA 1.508 2.46 0 N-CA-C 113.688 0.995 . . . . 2.29 113.688 -177.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 51.9 95.71 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.275 0 O-C-N 121.192 -0.943 . . . . 0.63 110.358 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . 157.76 -153.17 24.4 Favored Glycine 0 N--CA 1.479 1.515 0 N-CA-C 107.21 -2.356 . . . . 0.040000000000000001 107.21 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 72.1 ttt-85 -114.3 126.17 54.71 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.283 -1.006 . . . . 3.0 108.283 177.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 894' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -132.41 160.28 36.83 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.134 -0.979 . . . . 0.040000000000000001 111.286 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 895' ' ' LEU . . . . . . . . . . . . . 36.6 tp -92.32 119.49 31.94 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.742 -0.599 . . . . 1.27 110.178 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 896' ' ' LEU . . . . . . . . . . . . . 9.7 tt -109.55 142.9 39.97 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.68 -0.637 . . . . 0.93999999999999995 110.279 -179.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 897' ' ' SER . . . . . . . . . . . . . 64.4 m -149.1 113.96 5.4 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.464 -0.773 . . . . 0.040000000000000001 111.187 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.55 146.25 32.11 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.085 -0.709 . . . . 0.47999999999999998 109.085 178.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 899' ' ' VAL . . . . . . . . . . . . . 89.5 t -94.74 119.8 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 C-N-CA 119.602 -0.839 . . . . 0.55000000000000004 111.252 -179.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 900' ' ' LEU . . . . . 0.416 ' N ' ' CD2' ' B' ' 900' ' ' LEU . 4.5 mm? -95.27 111.69 23.5 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 114.416 1.265 . . . . 1.5900000000000001 114.416 -175.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 15.7 m -65.67 141.13 58.48 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 107.468 -1.308 . . . . 0.050000000000000003 107.468 177.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -67.22 -66.7 2.25 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 110.541 -1.024 . . . . 0.029999999999999999 110.541 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 11.9 m170 47.6 67.33 0.83 Allowed 'General case' 0 N--CA 1.507 2.388 0 O-C-N 121.47 -1.017 . . . . 3.2000000000000002 110.977 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 46.6 ptt85 -69.47 -6.99 34.09 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.638 -0.664 . . . . 2.9199999999999999 111.906 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 905' ' ' HIS . . . . . 0.484 ' O ' ' CB ' ' B' ' 906' ' ' GLU . 70.6 t60 -62.34 5.13 0.11 Allowed 'General case' 0 N--CA 1.507 2.382 0 O-C-N 120.915 -1.116 . . . . 2.8700000000000001 113.111 -179.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 906' ' ' GLU . . . . . 0.484 ' CB ' ' O ' ' B' ' 905' ' ' HIS . 0.6 OUTLIER 94.74 -164.31 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.432 0 CA-C-N 120.565 1.53 . . . . 0.98999999999999999 111.796 179.095 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 907' ' ' LYS . . . . . 0.467 ' CB ' ' O ' ' B' ' 906' ' ' GLU . 69.2 tttt 85.4 155.38 0.09 Allowed 'General case' 0 N--CA 1.519 2.985 0 N-CA-C 107.921 -1.14 . . . . 5.25 107.921 -176.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 60.1 t -123.27 115.34 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 120.716 -1.24 . . . . 0.39000000000000001 111.371 -179.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 43.4 tp10 -97.16 135.59 38.89 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 107.014 -1.476 . . . . 1.72 107.014 176.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -154.95 123.85 6.2 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 106.966 -1.494 . . . . 0.67000000000000004 106.966 179.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 911' ' ' VAL . . . . . 0.495 ' HA ' ' HA ' ' B' ' 964' ' ' VAL . 87.2 t -80.71 130.91 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 C-N-CA 120.522 -0.471 . . . . 0.54000000000000004 110.934 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 86.2 mt -63.72 156.92 25.59 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.27 -0.894 . . . . 1.5 108.671 178.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 913' ' ' SER . . . . . 0.4 ' CB ' ' CG1' ' B' ' 919' ' ' VAL . 0.4 OUTLIER -128.77 130.58 47.23 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.251 -1.018 . . . . 1.3700000000000001 108.251 176.647 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 914' ' ' ARG . . . . . 0.425 ' O ' ' CB ' ' B' ' 915' ' ' SER . 0.0 OUTLIER -65.45 156.2 33.14 Favored 'General case' 0 N--CA 1.507 2.387 0 O-C-N 120.674 -1.266 . . . . 4.2999999999999998 111.796 -178.963 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 915' ' ' SER . . . . . 0.425 ' CB ' ' O ' ' B' ' 914' ' ' ARG . 4.2 t 83.3 -32.39 0.08 Allowed 'General case' 0 N--CA 1.522 3.148 0 C-N-CA 123.991 0.917 . . . . 2.0499999999999998 112.019 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 916' ' ' ASN . . . . . 0.403 ' O ' ' HB2' ' B' ' 917' ' ' GLN . 82.5 m-20 -122.24 -21.23 5.93 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 120.87 -1.144 . . . . 2.71 111.328 -179.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 917' ' ' GLN . . . . . 0.403 ' HB2' ' O ' ' B' ' 916' ' ' ASN . 45.3 mt-30 66.77 164.34 0.19 Allowed 'General case' 0 N--CA 1.52 3.065 0 N-CA-C 105.76 -1.941 . . . . 2.6800000000000002 105.76 -174.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.52 -124.38 31.27 Favored Glycine 1 N--CA 1.522 4.368 0 CA-C-N 123.521 2.873 . . . . 0.029999999999999999 106.928 -177.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 919' ' ' VAL . . . . . 0.4 ' CG1' ' CB ' ' B' ' 913' ' ' SER . 75.8 t 51.42 94.25 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 O-C-N 121.413 -1.051 . . . . 1.3899999999999999 109.15 -178.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 920' ' ' ALA . . . . . . . . . . . . . . . -93.02 92.07 7.66 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 119.327 -0.949 . . . . 0.029999999999999999 110.643 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 921' ' ' ARG . . . . . 0.42 ' HB3' ' CZ ' ' B' ' 950' ' ' PHE . 29.3 ptt180 -85.03 -41.64 15.6 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 105.924 -1.88 . . . . 4.4199999999999999 105.924 176.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 922' ' ' VAL . . . . . . . . . . . . . 92.8 t -101.29 72.77 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 N-CA-C 106.052 -1.833 . . . . 0.84999999999999998 106.052 175.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -87.09 133.49 33.61 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.678 0.752 . . . . 2.46 111.376 -177.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 924' ' ' SER . . . . . . . . . . . . . 8.7 t -148.11 105.4 3.64 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.638 -0.875 . . . . 0.69999999999999996 108.638 179.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -102.55 84.36 0.48 Allowed Glycine 0 N--CA 1.487 2.091 0 N-CA-C 108.589 -1.804 . . . . 0.040000000000000001 108.589 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.205 0 N-CA-C 108.805 -1.718 . . . . 0.040000000000000001 108.805 -179.739 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 69.8 m . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.05 0.453 . . . . 13.779999999999999 110.296 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 95.3 mt -108.24 130.19 55.17 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.494 -0.754 . . . . 13.76 110.295 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -152.01 168.53 31.28 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.429 -1.468 . . . . 9.1300000000000008 109.429 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 949' ' ' VAL . . . . . . . . . . . . . 34.2 m -118.27 130.41 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.606 -0.938 . . . . 7.0800000000000001 110.547 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 950' ' ' PHE . . . . . 0.42 ' CZ ' ' HB3' ' B' ' 921' ' ' ARG . 52.0 p90 -130.37 144.11 51.18 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.492 -0.755 . . . . 7.5899999999999999 109.447 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 31.9 m -121.77 -51.91 2.02 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.451 -0.781 . . . . 5.0300000000000002 111.92 -178.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 952' ' ' LEU . . . . . 0.405 ' O ' ' O ' ' B' ' 953' ' ' ILE . 45.3 tp -61.81 -76.06 0.06 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.512 -0.742 . . . . 1.01 112.385 -177.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 953' ' ' ILE . . . . . 0.45 ' O ' ' HB3' ' B' ' 954' ' ' LEU . 47.0 pt -53.53 -141.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.724 0 N-CA-C 113.992 1.108 . . . . 2.6000000000000001 113.992 -176.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 954' ' ' LEU . . . . . 0.545 ' N ' ' CD1' ' B' ' 954' ' ' LEU . 0.0 OUTLIER 174.08 75.05 0.05 OUTLIER Pre-proline 0 N--CA 1.507 2.391 0 O-C-N 120.786 -1.196 . . . . 0.050000000000000003 110.906 179.754 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 955' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -73.07 93.93 0.81 Allowed 'Trans proline' 0 C--N 1.315 -1.212 0 N-CA-C 109.185 -1.121 . . . . 0.83999999999999997 109.185 178.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 956' ' ' LEU . . . . . . . . . . . . . 5.0 mp -126.32 140.39 52.55 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.242 -0.911 . . . . 0.040000000000000001 110.602 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -79.68 153.02 29.61 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 117.964 -1.017 . . . . 1.28 111.097 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -67.54 121.1 15.11 Favored 'General case' 0 N--CA 1.51 2.564 0 CA-C-N 122.563 2.438 . . . . 0.17000000000000001 111.838 -179.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 94.38 -19.01 55.79 Favored Glycine 0 N--CA 1.501 3.017 0 N-CA-C 111.132 -0.787 . . . . 0.040000000000000001 111.132 178.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 960' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -52.21 167.67 0.12 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.412 -1.052 . . . . 0.040000000000000001 111.027 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 961' ' ' THR . . . . . 0.456 ' HA ' ' O ' ' B' ' 886' ' ' PHE . 57.3 m -135.73 135.93 40.41 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 120.966 -1.084 . . . . 1.78 111.614 -178.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 962' ' ' VAL . . . . . 0.416 ' CG2' ' CB ' ' B' ' 886' ' ' PHE . 33.9 m -100.64 145.15 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 121.606 -0.684 . . . . 0.040000000000000001 111.13 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 1.8 m -138.39 148.01 44.03 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.816 -0.553 . . . . 0.71999999999999997 109.938 -178.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 964' ' ' VAL . . . . . 0.495 ' HA ' ' HA ' ' B' ' 911' ' ' VAL . 61.8 t -99.66 137.69 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.118 -0.989 . . . . 1.05 110.623 -179.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -91.58 128.57 37.46 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 104.202 -2.518 . . . . 3.02 104.202 173.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 966' ' ' LEU . . . . . 0.418 ' O ' ' CG2' ' B' ' 967' ' ' VAL . 0.4 OUTLIER -131.2 59.84 1.67 Allowed 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.305 -0.998 . . . . 1.46 108.305 177.162 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 967' ' ' VAL . . . . . 0.418 ' CG2' ' O ' ' B' ' 966' ' ' LEU . 90.1 t -158.76 96.97 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 108.104 -1.072 . . . . 1.9399999999999999 108.104 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 80.2 mmm -143.64 59.24 1.38 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.733 -1.229 . . . . 0.0 108.519 178.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.4 119.63 1.93 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 107.318 -2.313 . . . . 2.1099999999999999 107.318 -178.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -81.96 -59.05 2.71 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.095 -1.239 . . . . 5.8899999999999997 110.376 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 47.6 tp -59.14 90.49 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.423 -0.798 . . . . 4.3600000000000003 110.224 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -141.67 -154.51 0.52 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.536 -0.727 . . . . 1.8300000000000001 110.296 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -120.36 172.73 7.6 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.428 -0.795 . . . . 4.3499999999999996 110.315 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 30.3 t -101.47 130.32 47.69 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.517 -0.739 . . . . 1.27 109.983 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -155.68 158.99 39.17 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.457 -0.777 . . . . 5.0199999999999996 110.486 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.99 85.96 18.57 Favored Pre-proline 0 N--CA 1.5 2.048 0 O-C-N 121.607 -0.683 . . . . 2.4100000000000001 109.673 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -73.17 -173.15 1.18 Allowed 'Trans proline' 0 C--N 1.318 -1.078 0 O-C-N 123.286 1.151 . . . . 0.95999999999999996 111.319 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 978' ' ' LEU . . . . . . . . . . . . . 4.9 mp -128.34 154.15 46.27 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 107.565 -1.272 . . . . 0.62 107.565 177.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 979' ' ' THR . . . . . . . . . . . . . 41.6 p -150.17 141.46 23.22 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.788 -1.195 . . . . 3.5699999999999998 111.214 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 980' ' ' ILE . . . . . . . . . . . . . 49.4 mm -106.78 128.41 61.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 108.951 -0.759 . . . . 1.3300000000000001 108.951 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -118.82 96.2 5.16 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.488 -0.758 . . . . 0.050000000000000003 111.852 -178.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 78.7 p -108.6 158.01 17.97 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.557 -0.714 . . . . 0.87 109.159 178.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 983' ' ' GLY . . . . . 0.421 ' HA3' ' CE1' ' B' ' 852' ' ' PHE . . . -176.78 108.16 0.25 Allowed Glycine 0 N--CA 1.498 2.783 0 N-CA-C 106.529 -2.628 . . . . 0.029999999999999999 106.529 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -108.37 152.37 24.76 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 114.627 1.343 . . . . 0.69999999999999996 114.627 -175.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 985' ' ' LEU . . . . . . . . . . . . . 36.4 tp -72.25 135.36 46.01 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.926 -1.109 . . . . 0.040000000000000001 109.94 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 986' ' ' LEU . . . . . . . . . . . . . 51.4 tp -106.21 -59.67 1.75 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.655 -0.653 . . . . 0.040000000000000001 109.914 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -143.13 146.52 33.82 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 107.597 -1.26 . . . . 0.040000000000000001 107.597 178.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.03 163.26 12.21 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 108.278 -1.929 . . . . 0.040000000000000001 108.278 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -74.21 112.65 17.86 Favored Pre-proline 0 N--CA 1.498 1.944 0 O-C-N 121.173 -1.193 . . . . 0.040000000000000001 109.415 179.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 990' ' ' PRO . . . . . 0.414 ' O ' ' HB2' ' B' ' 991' ' ' GLU . 50.3 Cg_endo -89.32 71.06 2.02 Favored 'Trans proline' 0 C--N 1.319 -1.015 0 O-C-N 123.067 1.035 . . . . 0.45000000000000001 111.461 -178.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 991' ' ' GLU . . . . . 0.414 ' HB2' ' O ' ' B' ' 990' ' ' PRO . 70.8 mt-10 67.14 -73.94 0.07 Allowed 'General case' 0 N--CA 1.502 2.164 0 N-CA-C 108.581 -0.896 . . . . 1.97 108.581 -177.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 992' ' ' LEU . . . . . . . . . . . . . 11.5 mt 51.27 20.48 0.94 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.586 -0.697 . . . . 2.3799999999999999 111.621 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -92.53 156.91 16.83 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.912 -1.118 . . . . 3.79 110.019 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 70.7 m80 -147.15 91.73 2.03 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.549 -0.719 . . . . 3.5099999999999998 110.359 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 995' ' ' ALA . . . . . . . . . . . . 2.518 . . . . . . . 0 N--CA 1.503 2.19 0 O-C-N 120.899 -1.125 . . . . 2.73 110.622 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo . . . . . 0 N--CA 1.488 1.158 0 N-CA-C 109.516 -0.994 . . . . 3.8300000000000001 109.516 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 847' ' ' VAL . . . . . . . . . . . . . 60.3 t -126.11 105.48 25.41 Favored Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 121.639 -0.663 . . . . 1.8300000000000001 110.103 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 848' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -69.61 -23.56 31.36 Favored 'Trans proline' 0 N--CA 1.487 1.113 0 O-C-N 123.219 1.115 . . . . 0.65000000000000002 110.949 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 849' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 25.4 66.38 0.05 Allowed 'General case' 0 N--CA 1.518 2.944 0 N-CA-C 113.419 0.896 . . . . 2.5800000000000001 113.419 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 850' ' ' VAL . . . . . . . . . . . . . 77.7 t -120.0 135.74 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 121.113 -0.992 . . . . 1.0900000000000001 111.183 -179.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 851' ' ' ALA . . . . . . . . . . . . . . . -128.17 155.45 44.46 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 105.914 -1.884 . . . . 0.040000000000000001 105.914 176.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 852' ' ' PHE . . . . . 0.456 ' CD1' ' N ' ' C' ' 852' ' ' PHE . 15.2 p90 -160.42 127.03 4.22 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 120.973 1.715 . . . . 0.050000000000000003 108.631 179.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 6.3 t -177.28 134.28 0.18 Allowed 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.162 -1.051 . . . . 0.040000000000000001 108.162 -179.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -130.39 158.14 40.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.087 -1.008 . . . . 0.67000000000000004 109.685 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 855' ' ' ALA . . . . . 0.412 ' O ' ' HB2' ' C' ' 870' ' ' ARG . . . -121.39 140.71 51.77 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.818 0.818 . . . . 0.51000000000000001 111.061 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 856' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -113.23 135.74 53.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.612 -0.68 . . . . 0.050000000000000003 110.084 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 857' ' ' SER . . . . . 0.412 ' O ' ' O ' ' C' ' 858' ' ' LEU . 0.6 OUTLIER -153.35 18.64 0.55 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.502 -0.749 . . . . 1.3300000000000001 110.919 179.581 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 858' ' ' LEU . . . . . 0.412 ' O ' ' O ' ' C' ' 857' ' ' SER . 2.7 pp -34.7 159.65 0.04 OUTLIER Pre-proline 0 N--CA 1.516 2.856 0 N-CA-C 113.008 0.744 . . . . 2.3300000000000001 113.008 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -63.04 -88.39 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.399 0 O-C-N 123.078 1.041 . . . . 2.3199999999999998 113.257 -178.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 54.7 ptt85 -133.18 -142.0 0.2 Allowed 'General case' 0 N--CA 1.499 2.01 0 O-C-N 120.854 -1.154 . . . . 0.040000000000000001 111.422 -177.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 58.2 m -36.68 123.92 0.83 Allowed 'General case' 0 N--CA 1.511 2.586 0 O-C-N 121.609 -0.682 . . . . 1.3100000000000001 112.538 -178.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -104.04 160.24 26.71 Favored Pre-proline 0 N--CA 1.489 1.496 0 N-CA-C 108.052 -1.092 . . . . 4.5099999999999998 108.052 177.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -69.12 -14.41 38.06 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 123.185 1.097 . . . . 2.2400000000000002 111.404 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -177.25 -136.58 2.48 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 110.107 -1.197 . . . . 0.040000000000000001 110.107 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 32.7 m -65.23 156.89 30.43 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.366 -1.079 . . . . 1.51 110.746 -178.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 866' ' ' VAL . . . . . . . . . . . . . 64.5 t -96.58 134.61 23.09 Favored Pre-proline 0 N--CA 1.494 1.73 0 N-CA-C 113.136 0.791 . . . . 0.78000000000000003 113.136 -175.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 867' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -90.36 -149.13 0.03 OUTLIER 'Trans proline' 0 CA--C 1.544 1.022 0 O-C-N 123.577 1.304 . . . . 0.92000000000000004 108.837 177.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 868' ' ' PHE . . . . . 0.472 ' N ' ' CD1' ' C' ' 868' ' ' PHE . 13.8 p90 -150.0 123.65 9.17 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.53 -1.356 . . . . 0.050000000000000003 109.861 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 46.5 p-10 -113.82 -2.48 13.65 Favored 'General case' 0 N--CA 1.499 2.003 0 C-N-CA 119.185 -1.006 . . . . 1.7 112.892 -178.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 870' ' ' ARG . . . . . 0.412 ' HB2' ' O ' ' C' ' 855' ' ' ALA . 29.9 mmm180 -91.22 88.66 7.0 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.912 -1.117 . . . . 2.5899999999999999 110.998 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 57.3 t -72.21 97.48 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 120.94 -1.1 . . . . 1.9399999999999999 109.695 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 872' ' ' LEU . . . . . . . . . . . . . 96.3 mt -86.22 -46.04 10.74 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.611 -0.681 . . . . 1.0600000000000001 110.648 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 873' ' ' LEU . . . . . 0.41 ' O ' ' HB2' ' C' ' 874' ' ' ASN . 35.8 tp -173.61 102.27 0.12 Allowed 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.262 -0.899 . . . . 4.1799999999999997 108.702 178.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 874' ' ' ASN . . . . . 0.41 ' HB2' ' O ' ' C' ' 873' ' ' LEU . 36.3 t-20 177.7 82.68 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.26 0 N-CA-C 109.035 -0.728 . . . . 0.040000000000000001 109.035 -178.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -64.39 -46.15 84.54 Favored 'General case' 0 N--CA 1.497 1.916 0 C-N-CA 119.265 -0.974 . . . . 3.3799999999999999 111.171 -179.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 876' ' ' GLY . . . . . 0.426 ' HA3' ' CE2' ' C' ' 878' ' ' TYR . . . -73.8 -26.47 69.2 Favored Glycine 0 N--CA 1.494 2.519 0 C-N-CA 120.461 -0.876 . . . . 0.040000000000000001 111.977 -178.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 79.49 -63.94 3.89 Favored Glycine 0 N--CA 1.502 3.098 0 N-CA-C 107.868 -2.093 . . . . 0.040000000000000001 107.868 -178.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 878' ' ' TYR . . . . . 0.426 ' CE2' ' HA3' ' C' ' 876' ' ' GLY . 76.5 m-85 60.39 -63.92 0.06 Allowed 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 114.825 1.417 . . . . 3.46 114.825 177.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 879' ' ' TYR . . . . . 0.494 ' CE2' ' CD1' ' C' ' 981' ' ' PHE . 28.8 p90 -108.53 108.29 19.15 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 115.342 1.608 . . . . 0.040000000000000001 115.342 -175.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -70.69 117.55 56.63 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 121.758 -0.589 . . . . 0.02 110.191 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 881' ' ' PRO . . . . . 0.453 ' CG ' ' CD1' ' C' ' 868' ' ' PHE . 55.3 Cg_endo -76.83 1.97 8.01 Favored 'Trans proline' 0 N--CA 1.492 1.402 0 O-C-N 123.452 1.238 . . . . 0.39000000000000001 112.298 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -74.66 -65.02 0.91 Allowed 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 106.359 -1.719 . . . . 0.81000000000000005 106.359 178.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 6.0 p -96.45 -16.3 21.26 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.804 -0.813 . . . . 0.040000000000000001 108.804 177.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.54 23.02 52.25 Favored Glycine 0 N--CA 1.493 2.499 0 O-C-N 120.991 -1.068 . . . . 0.029999999999999999 110.692 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 95.2 t -73.38 87.5 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 C-N-CA 118.299 -1.36 . . . . 1.01 107.775 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 886' ' ' PHE . . . . . 0.497 ' O ' ' HA ' ' C' ' 961' ' ' THR . 0.7 OUTLIER -87.95 108.83 19.39 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-N 115.132 -0.94 . . . . 0.050000000000000003 111.569 -177.587 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 887' ' ' THR . . . . . . . . . . . . . 97.3 m -105.75 99.62 9.21 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 107.596 -1.261 . . . . 0.68000000000000005 107.596 177.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 888' ' ' ALA . . . . . . . . . . . . . . . -98.89 101.56 12.54 Favored Pre-proline 0 N--CA 1.501 2.089 0 N-CA-C 114.523 1.305 . . . . 0.25 114.523 -176.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 889' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -79.83 -15.03 12.2 Favored 'Trans proline' 0 N--CA 1.486 1.048 0 N-CA-C 108.786 -1.275 . . . . 1.6399999999999999 108.786 175.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 890' ' ' LEU . . . . . . . . . . . . . 66.1 mt -37.77 -49.15 1.15 Allowed 'General case' 0 N--CA 1.508 2.438 0 N-CA-C 113.463 0.912 . . . . 2.29 113.463 -177.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 52.66 97.73 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.193 -0.942 . . . . 0.63 110.451 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . 158.86 -154.5 25.59 Favored Glycine 0 N--CA 1.477 1.407 0 N-CA-C 107.29 -2.324 . . . . 0.040000000000000001 107.29 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 77.7 ttt-85 -116.28 123.94 48.94 Favored 'General case' 0 C--N 1.294 -1.825 0 O-C-N 121.671 -0.9 . . . . 3.0 108.589 177.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 894' ' ' TYR . . . . . 0.438 ' CE2' ' CD2' ' C' ' 954' ' ' LEU . 12.9 p90 -132.07 154.04 49.82 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.079 -1.013 . . . . 0.040000000000000001 110.954 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 895' ' ' LEU . . . . . . . . . . . . . 45.0 tp -99.65 113.78 26.44 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.706 -0.621 . . . . 1.27 109.796 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 896' ' ' LEU . . . . . . . . . . . . . 8.4 tt -118.01 145.08 45.02 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.678 -0.639 . . . . 0.93999999999999995 109.985 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 897' ' ' SER . . . . . . . . . . . . . 62.4 m -141.24 124.15 16.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.445 -0.784 . . . . 0.040000000000000001 111.184 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -100.78 148.42 24.94 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.73 -0.841 . . . . 0.47999999999999998 108.73 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 899' ' ' VAL . . . . . . . . . . . . . 96.7 t -92.33 120.53 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.369 -0.832 . . . . 0.55000000000000004 111.079 -179.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 91.4 mt -92.65 113.08 25.26 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 113.99 1.107 . . . . 1.5900000000000001 113.99 -175.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 901' ' ' THR . . . . . 0.41 HG22 ' CE1' ' C' ' 903' ' ' HIS . 16.7 m -62.54 141.28 58.51 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 107.545 -1.28 . . . . 0.050000000000000003 107.545 177.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -60.68 -65.23 3.47 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 110.362 -1.095 . . . . 0.029999999999999999 110.362 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 903' ' ' HIS . . . . . 0.41 ' CE1' HG22 ' C' ' 901' ' ' THR . 1.6 m80 46.23 65.11 1.26 Allowed 'General case' 0 N--CA 1.507 2.4 0 O-C-N 121.485 -1.009 . . . . 3.2000000000000002 111.095 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 42.4 ptt85 -66.72 -8.19 26.24 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.639 -0.663 . . . . 2.9199999999999999 111.971 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 905' ' ' HIS . . . . . 0.473 ' O ' ' CB ' ' C' ' 906' ' ' GLU . 61.0 t60 -63.67 5.32 0.21 Allowed 'General case' 0 N--CA 1.504 2.229 0 O-C-N 120.946 -1.096 . . . . 2.8700000000000001 112.624 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 906' ' ' GLU . . . . . 0.5 ' O ' ' CB ' ' C' ' 907' ' ' LYS . 2.8 mt-10 89.21 -152.96 0.01 OUTLIER 'General case' 0 N--CA 1.526 3.362 0 CA-C-N 121.215 1.825 . . . . 0.98999999999999999 111.59 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 907' ' ' LYS . . . . . 0.5 ' CB ' ' O ' ' C' ' 906' ' ' GLU . 62.2 tttt 90.19 163.85 0.05 OUTLIER 'General case' 0 N--CA 1.523 3.179 0 N-CA-C 107.925 -1.139 . . . . 5.25 107.925 -176.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 58.4 t -123.33 114.34 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 120.84 -1.162 . . . . 0.39000000000000001 110.843 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 44.3 tp10 -108.68 130.71 55.34 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 107.559 -1.275 . . . . 1.72 107.559 177.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -157.54 121.16 4.1 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 107.098 -1.445 . . . . 0.67000000000000004 107.098 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 911' ' ' VAL . . . . . 0.459 ' HA ' ' HA ' ' C' ' 964' ' ' VAL . 14.0 p -80.94 131.02 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 C-N-CA 120.35 -0.54 . . . . 0.54000000000000004 111.654 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 62.4 mt -67.43 157.94 32.97 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.359 -0.838 . . . . 1.5 109.036 178.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 913' ' ' SER . . . . . 0.4 ' CB ' ' CG1' ' C' ' 919' ' ' VAL . 1.5 p -126.07 138.87 53.74 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.568 -0.901 . . . . 1.3700000000000001 108.568 176.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 914' ' ' ARG . . . . . 0.424 ' O ' ' CB ' ' C' ' 915' ' ' SER . 0.0 OUTLIER -64.16 153.46 37.74 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 120.638 -1.289 . . . . 4.2999999999999998 111.607 -179.152 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 915' ' ' SER . . . . . 0.424 ' CB ' ' O ' ' C' ' 914' ' ' ARG . 0.2 OUTLIER 82.83 -30.37 0.09 Allowed 'General case' 0 N--CA 1.522 3.147 0 C-N-CA 123.766 0.826 . . . . 2.0499999999999998 112.457 179.575 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 916' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -122.17 -22.1 5.71 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.804 -1.185 . . . . 2.71 111.268 -179.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 67.09 166.52 0.22 Allowed 'General case' 0 N--CA 1.52 3.042 0 N-CA-C 105.792 -1.929 . . . . 2.6800000000000002 105.792 -174.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.58 -125.67 35.26 Favored Glycine 1 N--CA 1.522 4.384 0 CA-C-N 123.539 2.882 . . . . 0.029999999999999999 107.087 -177.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 919' ' ' VAL . . . . . 0.4 ' CG1' ' CB ' ' C' ' 913' ' ' SER . 92.4 t 51.01 94.02 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.238 0 O-C-N 121.452 -1.028 . . . . 1.3899999999999999 109.234 -178.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 920' ' ' ALA . . . . . . . . . . . . . . . -94.06 94.32 8.34 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.395 -0.922 . . . . 0.029999999999999999 110.735 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 921' ' ' ARG . . . . . 0.426 ' HB3' ' CZ ' ' C' ' 950' ' ' PHE . 45.2 ptt85 -79.14 -42.1 27.0 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 105.591 -2.003 . . . . 4.4199999999999999 105.591 176.049 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 922' ' ' VAL . . . . . . . . . . . . . 73.9 t -99.7 78.68 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 N-CA-C 105.441 -2.059 . . . . 0.84999999999999998 105.441 174.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -89.92 136.28 33.13 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 122.047 0.927 . . . . 2.46 112.775 -176.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 6.3 t -147.21 103.05 3.55 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 107.576 -1.268 . . . . 0.69999999999999996 107.576 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -107.71 82.27 0.31 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.656 -1.378 . . . . 0.040000000000000001 109.656 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 109.187 -1.565 . . . . 0.040000000000000001 109.187 179.747 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 17.7 m . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 120.937 0.398 . . . . 13.779999999999999 110.377 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 95.3 mt -114.66 131.36 56.75 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.472 -0.767 . . . . 13.76 110.321 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -151.7 170.13 31.17 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.433 -1.467 . . . . 9.1300000000000008 109.433 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 949' ' ' VAL . . . . . . . . . . . . . 26.9 m -117.44 136.26 55.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.488 -1.007 . . . . 7.0800000000000001 111.043 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 950' ' ' PHE . . . . . 0.426 ' CZ ' ' HB3' ' C' ' 921' ' ' ARG . 40.4 p90 -133.36 150.22 51.84 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.561 -0.712 . . . . 7.5899999999999999 109.336 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 68.4 m -118.07 -57.64 2.07 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.399 -0.813 . . . . 5.0300000000000002 111.81 -178.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 952' ' ' LEU . . . . . 0.454 ' O ' ' O ' ' C' ' 953' ' ' ILE . 46.4 tp -62.34 -75.69 0.07 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.423 -0.798 . . . . 1.01 111.505 -178.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 953' ' ' ILE . . . . . 0.47 ' O ' ' HB3' ' C' ' 954' ' ' LEU . 2.8 pp -49.41 -151.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.694 0 N-CA-C 114.563 1.32 . . . . 2.6000000000000001 114.563 -176.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 954' ' ' LEU . . . . . 0.569 ' N ' ' CD1' ' C' ' 954' ' ' LEU . 0.0 OUTLIER 171.22 90.39 0.04 OUTLIER Pre-proline 0 N--CA 1.515 2.807 0 O-C-N 120.659 -1.276 . . . . 0.050000000000000003 111.941 -179.289 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 955' ' ' PRO . . . . . 0.429 ' HD3' ' CD1' ' C' ' 953' ' ' ILE . 52.8 Cg_endo -83.0 92.37 0.9 Allowed 'Trans proline' 0 C--N 1.317 -1.113 0 N-CA-C 109.502 -0.999 . . . . 0.83999999999999997 109.502 178.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 956' ' ' LEU . . . . . . . . . . . . . 6.2 mp -125.11 147.86 48.82 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.066 -1.021 . . . . 0.040000000000000001 110.521 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -82.71 150.93 26.44 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 117.661 -1.162 . . . . 1.28 111.341 -178.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -64.65 118.11 8.41 Favored 'General case' 0 N--CA 1.506 2.365 0 CA-C-N 123.221 2.737 . . . . 0.17000000000000001 110.662 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.25 -18.56 53.89 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 110.903 -0.879 . . . . 0.040000000000000001 110.903 179.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 960' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.41 171.18 0.12 Allowed 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.265 -1.138 . . . . 0.040000000000000001 110.253 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 961' ' ' THR . . . . . 0.497 ' HA ' ' O ' ' C' ' 886' ' ' PHE . 40.7 m -137.71 141.07 41.05 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.95 -1.094 . . . . 1.78 112.844 -177.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 962' ' ' VAL . . . . . 0.409 ' CG2' ' CB ' ' C' ' 886' ' ' PHE . 27.3 m -100.44 145.45 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.88 -0.512 . . . . 0.040000000000000001 110.666 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 5.3 t -138.01 144.14 40.94 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.715 -0.616 . . . . 0.71999999999999997 110.153 -178.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 964' ' ' VAL . . . . . 0.459 ' HA ' ' HA ' ' C' ' 911' ' ' VAL . 58.9 t -91.45 137.29 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.185 -0.947 . . . . 1.05 110.803 -179.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -92.83 125.64 37.53 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 103.441 -2.8 . . . . 3.02 103.441 173.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 966' ' ' LEU . . . . . 0.411 ' O ' ' CG2' ' C' ' 967' ' ' VAL . 0.2 OUTLIER -134.53 56.81 1.83 Allowed 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.578 -0.897 . . . . 1.46 108.578 177.503 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 967' ' ' VAL . . . . . 0.411 ' CG2' ' O ' ' C' ' 966' ' ' LEU . 97.9 t -158.22 95.93 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.248 -1.019 . . . . 1.9399999999999999 108.248 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 92.8 mmm -142.87 59.28 1.43 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.724 -1.235 . . . . 0.0 108.462 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 134.35 119.62 1.98 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 107.282 -2.327 . . . . 2.1099999999999999 107.282 -178.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -82.56 -58.26 2.99 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.004 -1.291 . . . . 5.8899999999999997 110.531 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 48.1 tp -59.14 89.69 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.397 -0.814 . . . . 4.3600000000000003 110.313 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -142.71 -152.08 0.39 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.559 -0.713 . . . . 1.8300000000000001 109.97 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -115.93 166.99 11.35 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.391 -0.818 . . . . 4.3499999999999996 109.842 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 9.8 t -101.61 129.83 47.81 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.52 -0.738 . . . . 1.27 110.079 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -156.45 157.5 35.62 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.528 -0.732 . . . . 5.0199999999999996 110.553 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -143.22 85.91 9.4 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.658 -0.651 . . . . 2.4100000000000001 109.796 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -74.77 -169.86 0.68 Allowed 'Trans proline' 0 C--N 1.318 -1.045 0 O-C-N 123.189 1.099 . . . . 0.95999999999999996 111.325 -179.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 978' ' ' LEU . . . . . . . . . . . . . 5.1 mp -125.86 155.9 40.46 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.474 -1.306 . . . . 0.62 107.474 177.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 979' ' ' THR . . . . . . . . . . . . . 42.8 p -149.88 142.96 24.98 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.759 -1.213 . . . . 3.5699999999999998 111.334 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 980' ' ' ILE . . . . . . . . . . . . . 50.0 mm -105.41 127.88 59.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 108.837 -0.801 . . . . 1.3300000000000001 108.837 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 981' ' ' PHE . . . . . 0.494 ' CD1' ' CE2' ' C' ' 879' ' ' TYR . 5.2 t80 -117.9 96.05 5.18 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.311 -0.868 . . . . 0.050000000000000003 111.579 -178.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 982' ' ' SER . . . . . . . . . . . . . 51.3 p -106.3 158.78 16.61 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 109.066 -0.716 . . . . 0.87 109.066 178.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 983' ' ' GLY . . . . . 0.431 ' HA3' ' CE2' ' C' ' 852' ' ' PHE . . . -171.81 113.18 0.48 Allowed Glycine 0 N--CA 1.496 2.662 0 N-CA-C 106.624 -2.59 . . . . 0.029999999999999999 106.624 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 984' ' ' ALA . . . . . 0.405 ' CB ' ' CZ ' ' A' ' 893' ' ' ARG . . . -108.75 152.01 25.43 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 114.323 1.231 . . . . 0.69999999999999996 114.323 -175.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 985' ' ' LEU . . . . . . . . . . . . . 55.6 tp -75.89 136.14 40.13 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.848 -1.157 . . . . 0.040000000000000001 109.832 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 986' ' ' LEU . . . . . . . . . . . . . 51.4 tp -106.35 -62.82 1.34 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.573 -0.704 . . . . 0.040000000000000001 110.302 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -144.92 147.15 32.41 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 107.816 -1.179 . . . . 0.040000000000000001 107.816 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -111.86 162.74 12.33 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 108.071 -2.011 . . . . 0.040000000000000001 108.071 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -72.46 112.96 16.91 Favored Pre-proline 0 N--CA 1.498 1.935 0 O-C-N 121.207 -1.173 . . . . 0.040000000000000001 109.531 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 990' ' ' PRO . . . . . 0.407 ' O ' ' HB2' ' C' ' 991' ' ' GLU . 50.6 Cg_endo -87.66 70.13 3.31 Favored 'Trans proline' 0 C--N 1.319 -0.975 0 O-C-N 123.127 1.067 . . . . 0.45000000000000001 111.356 -178.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 991' ' ' GLU . . . . . 0.407 ' HB2' ' O ' ' C' ' 990' ' ' PRO . 71.4 mt-10 67.12 -74.11 0.07 Allowed 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 108.617 -0.883 . . . . 1.97 108.617 -177.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 992' ' ' LEU . . . . . . . . . . . . . 11.5 mt 50.55 21.03 0.79 Allowed 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.606 -0.684 . . . . 2.3799999999999999 111.646 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -92.54 156.77 16.91 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.89 -1.131 . . . . 3.79 110.038 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 68.6 m80 -146.56 91.84 2.09 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.52 -0.738 . . . . 3.5099999999999998 110.281 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 995' ' ' ALA . . . . . . . . . . . . 2.518 . . . . . . . 0 N--CA 1.504 2.248 0 O-C-N 120.95 -1.094 . . . . 2.73 110.589 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo . . . . . 0 N--CA 1.488 1.153 0 N-CA-C 109.581 -0.969 . . . . 3.8300000000000001 109.581 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 847' ' ' VAL . . . . . . . . . . . . . 61.4 t -132.03 103.56 14.19 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.636 -0.665 . . . . 1.8300000000000001 110.0 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 848' ' ' PRO . . . . . 0.4 ' O ' ' C ' ' A' ' 849' ' ' GLN . 44.1 Cg_endo -69.5 -20.08 36.52 Favored 'Trans proline' 0 N--CA 1.487 1.117 0 O-C-N 123.271 1.142 . . . . 0.65000000000000002 111.139 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 849' ' ' GLN . . . . . 0.4 ' C ' ' O ' ' A' ' 848' ' ' PRO . 55.7 tt0 27.03 68.2 0.06 Allowed 'General case' 0 N--CA 1.518 2.957 0 N-CA-C 112.919 0.711 . . . . 2.5800000000000001 112.919 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 850' ' ' VAL . . . . . . . . . . . . . 59.6 t -117.76 136.72 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.184 -0.948 . . . . 1.0900000000000001 111.459 -178.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 851' ' ' ALA . . . . . . . . . . . . . . . -125.83 156.65 39.22 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 105.783 -1.932 . . . . 0.040000000000000001 105.783 176.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 852' ' ' PHE . . . . . 0.409 ' HA ' ' CB ' ' A' ' 874' ' ' ASN . 24.2 p90 -160.34 128.61 4.7 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 121.014 1.734 . . . . 0.050000000000000003 108.732 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 29.7 t -174.96 134.98 0.35 Allowed 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.053 -1.091 . . . . 0.040000000000000001 108.053 -178.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -132.83 156.48 47.07 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.99 -1.069 . . . . 0.67000000000000004 109.497 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 855' ' ' ALA . . . . . . . . . . . . . . . -122.73 144.61 49.05 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.787 0.803 . . . . 0.51000000000000001 111.65 -178.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 856' ' ' LEU . . . . . 0.406 ' CD2' ' CG1' ' A' ' 866' ' ' VAL . 3.4 tm? -112.05 134.33 53.66 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.787 -0.571 . . . . 0.050000000000000003 110.112 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 857' ' ' SER . . . . . 0.414 ' O ' ' O ' ' A' ' 858' ' ' LEU . 55.8 p -150.63 16.7 0.79 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.531 -0.731 . . . . 1.3300000000000001 110.502 178.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 858' ' ' LEU . . . . . 0.414 ' O ' ' O ' ' A' ' 857' ' ' SER . 4.4 pp -32.94 158.26 0.03 OUTLIER Pre-proline 0 N--CA 1.517 2.924 0 N-CA-C 113.432 0.901 . . . . 2.3300000000000001 113.432 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -64.41 -88.48 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.451 0 O-C-N 123.171 1.09 . . . . 2.3199999999999998 113.075 -178.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 55.8 ptt85 -128.7 -143.37 0.27 Allowed 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.817 -1.177 . . . . 0.040000000000000001 111.691 -177.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 19.4 m -40.4 128.16 2.38 Favored 'General case' 0 N--CA 1.508 2.468 0 O-C-N 121.43 -0.794 . . . . 1.3100000000000001 112.38 -178.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -102.69 156.74 34.9 Favored Pre-proline 0 N--CA 1.489 1.496 0 N-CA-C 107.8 -1.185 . . . . 4.5099999999999998 107.8 177.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -70.03 -12.71 32.9 Favored 'Trans proline' 0 C--N 1.314 -1.288 0 O-C-N 123.032 1.017 . . . . 2.2400000000000002 111.363 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -175.74 -136.38 2.32 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.972 -1.251 . . . . 0.040000000000000001 109.972 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 27.8 m -66.43 156.88 33.43 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.32 -1.106 . . . . 1.51 110.944 -178.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 866' ' ' VAL . . . . . 0.406 ' CG1' ' CD2' ' A' ' 856' ' ' LEU . 48.4 t -93.15 134.61 26.85 Favored Pre-proline 0 N--CA 1.495 1.8 0 N-CA-C 113.273 0.842 . . . . 0.78000000000000003 113.273 -174.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 867' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -90.36 -152.74 0.04 OUTLIER 'Trans proline' 0 CA--C 1.541 0.869 0 N-CA-C 108.761 -1.284 . . . . 0.92000000000000004 108.761 177.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 868' ' ' PHE . . . . . 0.452 ' CD1' ' N ' ' A' ' 868' ' ' PHE . 24.1 p90 -149.76 122.21 8.5 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.573 -1.329 . . . . 0.050000000000000003 109.901 179.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 49.0 p-10 -113.39 -2.33 13.99 Favored 'General case' 0 N--CA 1.498 1.972 0 C-N-CA 119.287 -0.965 . . . . 1.7 112.299 -179.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 870' ' ' ARG . . . . . . . . . . . . . 30.3 mmm180 -90.59 88.91 7.31 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.962 -1.086 . . . . 2.5899999999999999 110.67 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 58.3 t -74.54 97.31 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 120.95 -1.094 . . . . 1.9399999999999999 109.919 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 872' ' ' LEU . . . . . . . . . . . . . 92.8 mt -82.97 -47.24 11.96 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.526 -0.734 . . . . 1.0600000000000001 110.24 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 873' ' ' LEU . . . . . . . . . . . . . 46.9 tp -174.66 103.95 0.1 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.243 -0.911 . . . . 4.1799999999999997 108.689 178.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 874' ' ' ASN . . . . . 0.409 ' CB ' ' HA ' ' A' ' 852' ' ' PHE . 35.7 t-20 178.9 81.71 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.3 0 O-C-N 121.55 -0.719 . . . . 0.040000000000000001 109.751 -178.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -66.91 -47.25 72.35 Favored 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 119.241 -0.984 . . . . 3.3799999999999999 111.128 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 876' ' ' GLY . . . . . 0.413 ' HA3' ' CE2' ' A' ' 878' ' ' TYR . . . -73.95 -25.01 72.62 Favored Glycine 0 N--CA 1.495 2.573 0 O-C-N 121.275 -0.89 . . . . 0.040000000000000001 111.668 -178.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 82.86 -61.38 4.78 Favored Glycine 0 N--CA 1.501 3.023 0 N-CA-C 108.085 -2.006 . . . . 0.040000000000000001 108.085 -178.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 878' ' ' TYR . . . . . 0.413 ' CE2' ' HA3' ' A' ' 876' ' ' GLY . 88.1 m-85 60.41 -64.96 0.05 Allowed 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 114.28 1.215 . . . . 3.46 114.28 177.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 879' ' ' TYR . . . . . 0.479 ' CB ' ' CD2' ' A' ' 886' ' ' PHE . 19.6 p90 -111.53 107.15 16.23 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 114.5 1.296 . . . . 0.040000000000000001 114.5 -176.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -66.03 117.39 42.11 Favored Pre-proline 0 N--CA 1.497 1.903 0 O-C-N 121.402 -0.811 . . . . 0.02 110.1 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 881' ' ' PRO . . . . . 0.408 ' HG2' ' CD1' ' A' ' 868' ' ' PHE . 55.6 Cg_endo -75.92 0.05 9.7 Favored 'Trans proline' 0 N--CA 1.496 1.637 0 O-C-N 123.547 1.288 . . . . 0.39000000000000001 112.195 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -77.77 -63.87 1.28 Allowed 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 106.803 -1.554 . . . . 0.81000000000000005 106.803 178.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 44.9 p -93.03 -19.55 21.44 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.543 -0.91 . . . . 0.040000000000000001 108.543 177.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.7 20.16 60.35 Favored Glycine 0 N--CA 1.497 2.758 0 O-C-N 121.089 -1.007 . . . . 0.029999999999999999 111.545 178.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 885' ' ' VAL . . . . . . . . . . . . . 88.1 t -74.19 91.96 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 C-N-CA 118.16 -1.416 . . . . 1.01 108.197 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 886' ' ' PHE . . . . . 0.479 ' CD2' ' CB ' ' A' ' 879' ' ' TYR . 0.7 OUTLIER -90.27 105.75 18.02 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 115.158 -0.928 . . . . 0.050000000000000003 112.118 -177.248 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 887' ' ' THR . . . . . 0.406 ' O ' ' HD3' ' A' ' 889' ' ' PRO . 70.6 m -96.44 100.96 12.52 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 107.911 -1.144 . . . . 0.68000000000000005 107.911 177.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 888' ' ' ALA . . . . . . . . . . . . . . . -98.61 106.65 38.01 Favored Pre-proline 0 N--CA 1.503 2.201 0 N-CA-C 114.146 1.165 . . . . 0.25 114.146 -176.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 889' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' A' ' 887' ' ' THR . 55.2 Cg_endo -89.08 -12.94 3.17 Favored 'Trans proline' 0 CA--C 1.546 1.098 0 N-CA-C 109.121 -1.146 . . . . 1.6399999999999999 109.121 176.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 890' ' ' LEU . . . . . . . . . . . . . 56.0 mt -34.25 -51.07 0.43 Allowed 'General case' 0 N--CA 1.509 2.482 0 N-CA-C 113.972 1.101 . . . . 2.29 113.972 -177.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 51.51 94.89 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.363 0 O-C-N 121.186 -0.946 . . . . 0.63 110.331 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 156.09 -147.3 15.75 Favored Glycine 0 N--CA 1.48 1.601 0 N-CA-C 107.536 -2.226 . . . . 0.040000000000000001 107.536 -179.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 893' ' ' ARG . . . . . 0.401 ' NH1' ' CD2' ' A' ' 986' ' ' LEU . 71.4 ttt-85 -109.13 127.76 54.44 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 107.576 -1.268 . . . . 3.0 107.576 177.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 894' ' ' TYR . . . . . 0.449 ' CD1' ' N ' ' A' ' 895' ' ' LEU . 0.1 OUTLIER -130.28 144.54 51.43 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.987 -1.071 . . . . 0.040000000000000001 110.041 -179.075 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 895' ' ' LEU . . . . . 0.449 ' N ' ' CD1' ' A' ' 894' ' ' TYR . 39.9 tp -97.25 114.24 25.96 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.59 -0.694 . . . . 1.27 109.616 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 896' ' ' LEU . . . . . 0.431 ' HB2' ' CZ ' ' A' ' 894' ' ' TYR . 9.7 tt -111.24 146.01 37.72 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.625 -0.672 . . . . 0.93999999999999995 110.812 -179.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 897' ' ' SER . . . . . . . . . . . . . 66.9 m -143.86 116.81 8.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.573 -0.705 . . . . 0.040000000000000001 110.503 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -106.57 146.77 30.25 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.258 -0.645 . . . . 0.47999999999999998 109.258 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 899' ' ' VAL . . . . . . . . . . . . . 88.3 t -97.47 119.18 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 C-N-CA 119.716 -0.794 . . . . 0.55000000000000004 111.277 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 900' ' ' LEU . . . . . 0.402 ' CD2' ' N ' ' A' ' 900' ' ' LEU . 4.5 mm? -95.16 112.18 23.92 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 114.175 1.176 . . . . 1.5900000000000001 114.175 -175.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 901' ' ' THR . . . . . 0.407 HG22 ' CE1' ' A' ' 903' ' ' HIS . 17.6 m -64.54 140.99 58.93 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 107.398 -1.334 . . . . 0.050000000000000003 107.398 177.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -63.26 -66.27 2.64 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 110.479 -1.048 . . . . 0.029999999999999999 110.479 -179.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 903' ' ' HIS . . . . . 0.407 ' CE1' HG22 ' A' ' 901' ' ' THR . 2.2 m80 46.52 66.06 1.06 Allowed 'General case' 0 N--CA 1.507 2.42 0 O-C-N 121.474 -1.015 . . . . 3.2000000000000002 111.118 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 54.1 ptt85 -68.72 -6.44 26.32 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.585 -0.697 . . . . 2.9199999999999999 111.916 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 905' ' ' HIS . . . . . 0.483 ' O ' ' CB ' ' A' ' 906' ' ' GLU . 75.9 t60 -60.79 3.4 0.08 Allowed 'General case' 0 N--CA 1.505 2.314 0 O-C-N 120.936 -1.103 . . . . 2.8700000000000001 113.034 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 906' ' ' GLU . . . . . 0.483 ' CB ' ' O ' ' A' ' 905' ' ' HIS . 0.8 OUTLIER 93.4 -163.58 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.377 0 CA-C-N 120.552 1.523 . . . . 0.98999999999999999 112.192 178.789 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 907' ' ' LYS . . . . . 0.481 ' CB ' ' O ' ' A' ' 906' ' ' GLU . 42.6 tttt 88.64 161.73 0.06 Allowed 'General case' 0 N--CA 1.519 2.991 0 N-CA-C 107.675 -1.231 . . . . 5.25 107.675 -176.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 61.0 t -121.97 115.77 47.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 120.876 -1.14 . . . . 0.39000000000000001 110.815 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 52.1 tp10 -100.71 132.62 46.01 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 107.19 -1.411 . . . . 1.72 107.19 176.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -156.82 120.64 4.28 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 106.731 -1.581 . . . . 0.67000000000000004 106.731 178.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 911' ' ' VAL . . . . . 0.467 ' HA ' ' HA ' ' A' ' 964' ' ' VAL . 95.6 t -83.18 131.99 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 C-N-CA 120.34 -0.544 . . . . 0.54000000000000004 110.756 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 72.8 mt -64.63 155.21 34.02 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.316 -0.865 . . . . 1.5 108.709 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 913' ' ' SER . . . . . 0.41 ' CB ' ' HB ' ' A' ' 919' ' ' VAL . 1.5 t -122.95 137.62 54.9 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.101 -1.074 . . . . 1.3700000000000001 108.101 177.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 914' ' ' ARG . . . . . 0.423 ' O ' ' CB ' ' A' ' 915' ' ' SER . 0.0 OUTLIER -64.1 153.73 36.71 Favored 'General case' 0 N--CA 1.505 2.308 0 O-C-N 120.834 -1.166 . . . . 4.2999999999999998 111.895 -178.884 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 915' ' ' SER . . . . . 0.423 ' CB ' ' O ' ' A' ' 914' ' ' ARG . 2.2 t 82.85 -31.91 0.09 Allowed 'General case' 0 N--CA 1.52 3.075 0 C-N-CA 123.977 0.911 . . . . 2.0499999999999998 112.452 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 916' ' ' ASN . . . . . 0.412 ' O ' ' HB2' ' A' ' 917' ' ' GLN . 98.2 m-20 -121.64 -20.59 6.46 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 120.838 -1.164 . . . . 2.71 111.509 -179.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 917' ' ' GLN . . . . . 0.412 ' HB2' ' O ' ' A' ' 916' ' ' ASN . 51.1 mt-30 66.74 165.93 0.21 Allowed 'General case' 0 N--CA 1.52 3.045 0 N-CA-C 105.653 -1.98 . . . . 2.6800000000000002 105.653 -173.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.15 -125.04 32.46 Favored Glycine 1 N--CA 1.521 4.342 0 CA-C-N 123.423 2.828 . . . . 0.029999999999999999 107.1 -177.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 919' ' ' VAL . . . . . 0.41 ' HB ' ' CB ' ' A' ' 913' ' ' SER . 76.7 t 51.71 94.9 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.229 0 O-C-N 121.466 -1.02 . . . . 1.3899999999999999 108.934 -178.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.17 91.93 8.45 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.237 -0.985 . . . . 0.029999999999999999 110.986 -178.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 921' ' ' ARG . . . . . 0.437 ' HB3' ' CZ ' ' A' ' 950' ' ' PHE . 42.4 ptt85 -84.2 -42.04 16.36 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 105.594 -2.002 . . . . 4.4199999999999999 105.594 175.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 922' ' ' VAL . . . . . . . . . . . . . 72.0 t -103.19 69.27 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 N-CA-C 105.446 -2.057 . . . . 0.84999999999999998 105.446 175.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -91.0 135.94 33.41 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.783 0.801 . . . . 2.46 112.139 -176.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 13.8 t -147.6 104.31 3.6 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 108.096 -1.075 . . . . 0.69999999999999996 108.096 178.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -110.93 90.28 0.57 Allowed Glycine 0 N--CA 1.487 2.08 0 N-CA-C 108.988 -1.645 . . . . 0.040000000000000001 108.988 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.403 0 N-CA-C 109.4 -1.48 . . . . 0.040000000000000001 109.4 -179.625 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 31.0 m . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.007 0.432 . . . . 13.779999999999999 110.307 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 97.5 mt -113.55 129.68 56.51 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.519 -0.738 . . . . 13.76 110.46 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -152.28 168.51 31.44 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.103 -1.599 . . . . 9.1300000000000008 109.103 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 949' ' ' VAL . . . . . . . . . . . . . 34.9 m -118.81 130.35 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.48 -1.012 . . . . 7.0800000000000001 110.928 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 950' ' ' PHE . . . . . 0.437 ' CZ ' ' HB3' ' A' ' 921' ' ' ARG . 32.2 p90 -133.42 149.28 51.81 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.563 -0.711 . . . . 7.5899999999999999 109.31 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 19.6 m -119.42 -53.87 2.21 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.446 -0.784 . . . . 5.0300000000000002 112.144 -178.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 952' ' ' LEU . . . . . 0.414 ' O ' ' O ' ' A' ' 953' ' ' ILE . 57.0 tp -59.98 -75.81 0.05 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.342 -0.849 . . . . 1.01 111.974 -177.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 953' ' ' ILE . . . . . 0.481 ' O ' ' HB3' ' A' ' 954' ' ' LEU . 49.3 pt -53.1 -144.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.663 0 N-CA-C 113.718 1.007 . . . . 2.6000000000000001 113.718 -176.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 954' ' ' LEU . . . . . 0.529 ' N ' ' CD1' ' A' ' 954' ' ' LEU . 0.0 OUTLIER 167.5 83.83 0.02 OUTLIER Pre-proline 0 N--CA 1.512 2.66 0 O-C-N 120.998 -1.064 . . . . 0.050000000000000003 111.535 178.976 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 955' ' ' PRO . . . . . 0.427 ' HD2' ' CE1' ' A' ' 950' ' ' PHE . 46.9 Cg_endo -74.02 98.14 1.06 Allowed 'Trans proline' 0 C--N 1.314 -1.285 0 N-CA-C 108.938 -1.216 . . . . 0.83999999999999997 108.938 177.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 956' ' ' LEU . . . . . 0.406 ' CD2' ' NH1' ' A' ' 914' ' ' ARG . 10.0 mp -122.59 144.13 49.31 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.053 -1.029 . . . . 0.040000000000000001 110.276 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -83.61 150.7 25.74 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 117.719 -1.134 . . . . 1.28 111.456 -179.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -69.58 120.08 14.82 Favored 'General case' 0 N--CA 1.509 2.482 0 CA-C-N 122.99 2.632 . . . . 0.17000000000000001 111.373 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 93.34 -21.74 38.83 Favored Glycine 0 N--CA 1.5 2.959 0 N-CA-C 110.94 -0.864 . . . . 0.040000000000000001 110.94 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 960' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -51.88 171.3 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.476 -1.014 . . . . 0.040000000000000001 110.538 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 961' ' ' THR . . . . . 0.441 ' HA ' ' O ' ' A' ' 886' ' ' PHE . 43.7 m -134.81 134.93 41.37 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.953 -1.092 . . . . 1.78 111.641 -178.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 962' ' ' VAL . . . . . 0.422 ' CG2' ' CB ' ' A' ' 886' ' ' PHE . 33.0 m -100.48 145.34 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 C-N-CA 119.851 -0.739 . . . . 0.040000000000000001 110.628 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 5.3 t -138.36 146.52 42.39 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.935 -0.478 . . . . 0.71999999999999997 109.979 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 964' ' ' VAL . . . . . 0.467 ' HA ' ' HA ' ' A' ' 911' ' ' VAL . 60.3 t -94.14 136.63 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.102 -0.999 . . . . 1.05 110.416 -179.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -93.52 126.55 38.73 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 103.547 -2.76 . . . . 3.02 103.547 173.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 966' ' ' LEU . . . . . 0.406 ' O ' ' CG2' ' A' ' 967' ' ' VAL . 0.5 OUTLIER -132.34 60.06 1.7 Allowed 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.251 -1.018 . . . . 1.46 108.251 177.466 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 967' ' ' VAL . . . . . 0.406 ' CG2' ' O ' ' A' ' 966' ' ' LEU . 95.9 t -158.2 96.65 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 N-CA-C 108.143 -1.058 . . . . 1.9399999999999999 108.143 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 90.4 mmm -143.26 59.53 1.4 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.716 -1.24 . . . . 0.0 108.272 178.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.33 119.81 1.96 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 106.994 -2.442 . . . . 2.1099999999999999 106.994 -178.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -82.2 -58.25 3.03 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 118.716 1.258 . . . . 5.8899999999999997 110.308 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 40.8 tp -59.12 90.53 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.493 -0.754 . . . . 4.3600000000000003 110.115 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -141.82 -154.33 0.51 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.588 -0.695 . . . . 1.8300000000000001 110.174 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -119.46 170.98 8.67 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.502 -0.749 . . . . 4.3499999999999996 110.338 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 10.7 t -101.47 130.22 47.67 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.535 -0.728 . . . . 1.27 109.962 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -156.3 158.73 37.96 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.481 -0.762 . . . . 5.0199999999999996 110.608 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.93 85.94 18.77 Favored Pre-proline 0 N--CA 1.5 2.048 0 O-C-N 121.611 -0.681 . . . . 2.4100000000000001 109.516 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -72.75 -171.83 0.83 Allowed 'Trans proline' 0 C--N 1.317 -1.109 0 O-C-N 123.31 1.163 . . . . 0.95999999999999996 111.389 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 4.9 mp -127.89 154.32 45.64 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 107.608 -1.256 . . . . 0.62 107.608 178.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 979' ' ' THR . . . . . . . . . . . . . 42.1 p -149.93 141.32 23.29 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.768 -1.208 . . . . 3.5699999999999998 111.181 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 980' ' ' ILE . . . . . 0.434 HG22 HD11 ' A' ' 980' ' ' ILE . 51.2 mm -107.06 128.06 62.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 109.006 -0.739 . . . . 1.3300000000000001 109.006 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 981' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -121.73 98.22 5.86 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.417 -0.802 . . . . 0.050000000000000003 111.783 -178.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 86.0 p -108.69 158.22 17.81 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.974 -0.75 . . . . 0.87 108.974 178.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . -171.82 108.58 0.28 Allowed Glycine 0 N--CA 1.498 2.78 0 N-CA-C 106.557 -2.617 . . . . 0.029999999999999999 106.557 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -109.4 148.21 31.49 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 114.337 1.236 . . . . 0.69999999999999996 114.337 -175.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 44.7 tp -69.79 135.1 49.3 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 120.796 -1.19 . . . . 0.040000000000000001 110.115 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 986' ' ' LEU . . . . . 0.401 ' CD2' ' NH1' ' A' ' 893' ' ' ARG . 41.8 tp -105.96 -60.29 1.66 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.621 -0.674 . . . . 0.040000000000000001 109.914 179.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -143.88 146.26 32.89 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 107.627 -1.249 . . . . 0.040000000000000001 107.627 179.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.33 163.28 12.19 Favored Glycine 0 N--CA 1.495 2.628 0 N-CA-C 108.094 -2.002 . . . . 0.040000000000000001 108.094 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -76.0 112.52 20.8 Favored Pre-proline 0 N--CA 1.499 2.005 0 O-C-N 121.229 -1.159 . . . . 0.040000000000000001 109.402 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 990' ' ' PRO . . . . . 0.409 ' O ' ' HB2' ' A' ' 991' ' ' GLU . 49.7 Cg_endo -90.27 71.85 1.41 Allowed 'Trans proline' 0 C--N 1.319 -1.006 0 O-C-N 123.164 1.086 . . . . 0.45000000000000001 111.386 -178.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 991' ' ' GLU . . . . . 0.409 ' HB2' ' O ' ' A' ' 990' ' ' PRO . 67.0 mt-10 67.32 -73.69 0.08 Allowed 'General case' 0 N--CA 1.503 2.178 0 N-CA-C 108.483 -0.932 . . . . 1.97 108.483 -177.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 992' ' ' LEU . . . . . . . . . . . . . 10.6 mt 50.91 20.73 0.83 Allowed 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.583 -0.698 . . . . 2.3799999999999999 111.599 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -93.58 156.71 16.57 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.912 -1.117 . . . . 3.79 109.989 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -145.91 92.97 2.27 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.54 -0.725 . . . . 3.5099999999999998 110.312 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 995' ' ' ALA . . . . . . . . . . . . 2.517 . . . . . . . 0 N--CA 1.504 2.254 0 O-C-N 120.85 -1.157 . . . . 2.73 110.575 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo . . . . . 0 N--CA 1.488 1.188 0 N-CA-C 109.523 -0.991 . . . . 3.8300000000000001 109.523 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 847' ' ' VAL . . . . . . . . . . . . . 61.3 t -132.14 103.48 14.07 Favored Pre-proline 0 N--CA 1.494 1.775 0 O-C-N 121.621 -0.674 . . . . 1.8300000000000001 109.989 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 848' ' ' PRO . . . . . 0.408 ' O ' ' C ' ' B' ' 849' ' ' GLN . 43.7 Cg_endo -69.45 -20.16 36.67 Favored 'Trans proline' 0 N--CA 1.487 1.133 0 O-C-N 123.245 1.129 . . . . 0.65000000000000002 111.064 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 849' ' ' GLN . . . . . 0.408 ' C ' ' O ' ' B' ' 848' ' ' PRO . 55.6 tt0 27.06 68.69 0.06 Allowed 'General case' 0 N--CA 1.518 2.96 0 N-CA-C 112.867 0.691 . . . . 2.5800000000000001 112.867 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 850' ' ' VAL . . . . . . . . . . . . . 59.7 t -118.2 136.68 54.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.218 -0.926 . . . . 1.0900000000000001 111.382 -178.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 851' ' ' ALA . . . . . . . . . . . . . . . -126.09 156.11 40.53 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 105.774 -1.936 . . . . 0.040000000000000001 105.774 176.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 852' ' ' PHE . . . . . 0.41 ' HA ' ' CB ' ' B' ' 874' ' ' ASN . 23.8 p90 -159.73 129.1 5.26 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 121.022 1.737 . . . . 0.050000000000000003 108.631 179.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 30.0 t -175.24 134.72 0.33 Allowed 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.176 -1.046 . . . . 0.040000000000000001 108.176 -178.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -132.56 156.75 46.29 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.099 -1.001 . . . . 0.67000000000000004 109.576 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 855' ' ' ALA . . . . . . . . . . . . . . . -122.9 145.13 48.73 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.774 0.797 . . . . 0.51000000000000001 111.697 -178.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 856' ' ' LEU . . . . . 0.407 HD21 ' CG1' ' B' ' 866' ' ' VAL . 3.4 tm? -112.51 134.01 54.27 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.743 -0.598 . . . . 0.050000000000000003 110.105 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 857' ' ' SER . . . . . 0.41 ' O ' ' O ' ' B' ' 858' ' ' LEU . 56.3 p -150.37 16.99 0.83 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.561 -0.712 . . . . 1.3300000000000001 110.513 178.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 858' ' ' LEU . . . . . 0.41 ' O ' ' O ' ' B' ' 857' ' ' SER . 4.4 pp -33.31 158.26 0.04 OUTLIER Pre-proline 0 N--CA 1.517 2.924 0 N-CA-C 113.33 0.863 . . . . 2.3300000000000001 113.33 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -64.5 -88.43 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.421 0 O-C-N 123.207 1.109 . . . . 2.3199999999999998 113.103 -178.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 55.8 ptt85 -128.71 -143.45 0.27 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.87 -1.144 . . . . 0.040000000000000001 111.729 -177.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 19.3 m -40.23 127.53 2.27 Favored 'General case' 0 N--CA 1.509 2.491 0 O-C-N 121.455 -0.778 . . . . 1.3100000000000001 112.359 -178.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 862' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -102.09 156.77 34.82 Favored Pre-proline 0 N--CA 1.488 1.465 0 N-CA-C 107.86 -1.163 . . . . 4.5099999999999998 107.86 177.138 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -69.81 -13.06 34.03 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 O-C-N 123.082 1.043 . . . . 2.2400000000000002 111.419 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -175.61 -135.91 2.21 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.993 -1.243 . . . . 0.040000000000000001 109.993 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 28.0 m -66.71 157.68 32.08 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.253 -1.145 . . . . 1.51 110.925 -178.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 866' ' ' VAL . . . . . 0.407 ' CG1' HD21 ' B' ' 856' ' ' LEU . 48.5 t -93.78 134.53 26.17 Favored Pre-proline 0 N--CA 1.495 1.784 0 N-CA-C 113.302 0.853 . . . . 0.78000000000000003 113.302 -174.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 867' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -90.38 -152.94 0.04 OUTLIER 'Trans proline' 0 CA--C 1.541 0.867 0 O-C-N 123.517 1.272 . . . . 0.92000000000000004 108.831 177.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 868' ' ' PHE . . . . . 0.45 ' CD1' ' N ' ' B' ' 868' ' ' PHE . 23.6 p90 -149.55 122.16 8.59 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 120.633 -1.292 . . . . 0.050000000000000003 109.956 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 49.2 p-10 -113.29 -1.94 14.15 Favored 'General case' 0 N--CA 1.498 1.971 0 C-N-CA 119.27 -0.972 . . . . 1.7 112.289 -179.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 870' ' ' ARG . . . . . . . . . . . . . 30.3 mmm180 -90.96 88.68 7.12 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.899 -1.126 . . . . 2.5899999999999999 110.784 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 58.5 t -74.56 97.32 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.005 -1.059 . . . . 1.9399999999999999 109.884 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 872' ' ' LEU . . . . . . . . . . . . . 94.7 mt -83.16 -46.99 12.07 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.488 -0.757 . . . . 1.0600000000000001 110.14 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 873' ' ' LEU . . . . . . . . . . . . . 46.5 tp -174.65 104.01 0.1 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.305 -0.872 . . . . 4.1799999999999997 108.703 178.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 874' ' ' ASN . . . . . 0.41 ' CB ' ' HA ' ' B' ' 852' ' ' PHE . 35.6 t-20 178.86 81.96 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.304 0 O-C-N 121.643 -0.66 . . . . 0.040000000000000001 109.76 -178.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -67.16 -47.31 71.4 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 119.268 -0.973 . . . . 3.3799999999999999 111.076 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 876' ' ' GLY . . . . . 0.409 ' HA3' ' CE2' ' B' ' 878' ' ' TYR . . . -73.87 -25.27 72.16 Favored Glycine 0 N--CA 1.494 2.562 0 O-C-N 121.336 -0.852 . . . . 0.040000000000000001 111.584 -178.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 83.01 -61.29 4.8 Favored Glycine 0 N--CA 1.501 3.003 0 N-CA-C 108.091 -2.003 . . . . 0.040000000000000001 108.091 -178.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 878' ' ' TYR . . . . . 0.409 ' CE2' ' HA3' ' B' ' 876' ' ' GLY . 88.4 m-85 60.47 -64.93 0.06 Allowed 'General case' 0 N--CA 1.504 2.248 0 N-CA-C 114.303 1.223 . . . . 3.46 114.303 177.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 879' ' ' TYR . . . . . 0.467 ' CB ' ' CD2' ' B' ' 886' ' ' PHE . 19.6 p90 -111.47 107.45 16.66 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 114.457 1.28 . . . . 0.040000000000000001 114.457 -176.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -66.21 117.17 40.6 Favored Pre-proline 0 N--CA 1.497 1.924 0 O-C-N 121.422 -0.798 . . . . 0.02 110.145 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 881' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -75.81 -0.12 9.85 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 O-C-N 123.57 1.3 . . . . 0.39000000000000001 112.15 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 88.4 mt-10 -77.45 -63.65 1.33 Allowed 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 106.801 -1.555 . . . . 0.81000000000000005 106.801 178.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 45.7 p -93.79 -18.82 21.64 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.678 -0.86 . . . . 0.040000000000000001 108.678 177.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.24 20.27 60.95 Favored Glycine 0 N--CA 1.497 2.711 0 O-C-N 121.11 -0.994 . . . . 0.029999999999999999 111.554 178.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 885' ' ' VAL . . . . . . . . . . . . . 87.8 t -74.14 91.9 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 C-N-CA 118.14 -1.424 . . . . 1.01 108.097 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 886' ' ' PHE . . . . . 0.467 ' CD2' ' CB ' ' B' ' 879' ' ' TYR . 0.7 OUTLIER -90.32 105.82 18.07 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-N 115.182 -0.917 . . . . 0.050000000000000003 111.999 -177.259 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 887' ' ' THR . . . . . 0.405 ' O ' ' HD3' ' B' ' 889' ' ' PRO . 69.7 m -96.47 101.15 12.73 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 107.868 -1.16 . . . . 0.68000000000000005 107.868 177.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 888' ' ' ALA . . . . . . . . . . . . . . . -98.78 106.51 37.73 Favored Pre-proline 0 N--CA 1.502 2.146 0 N-CA-C 114.153 1.168 . . . . 0.25 114.153 -176.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 889' ' ' PRO . . . . . 0.405 ' HD3' ' O ' ' B' ' 887' ' ' THR . 55.3 Cg_endo -89.02 -13.07 3.16 Favored 'Trans proline' 0 CA--C 1.546 1.105 0 C-N-CA 121.01 1.14 . . . . 1.6399999999999999 109.183 176.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 890' ' ' LEU . . . . . . . . . . . . . 56.5 mt -34.04 -51.29 0.42 Allowed 'General case' 0 N--CA 1.51 2.535 0 N-CA-C 113.997 1.11 . . . . 2.29 113.997 -177.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 51.54 94.84 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.336 0 O-C-N 121.13 -0.981 . . . . 0.63 110.379 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . 156.13 -147.54 16.32 Favored Glycine 0 N--CA 1.48 1.577 0 N-CA-C 107.451 -2.26 . . . . 0.040000000000000001 107.451 -179.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 72.0 ttt-85 -108.86 127.72 54.28 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 107.609 -1.256 . . . . 3.0 107.609 177.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 894' ' ' TYR . . . . . 0.45 ' CD1' ' N ' ' B' ' 895' ' ' LEU . 0.1 OUTLIER -130.22 144.67 51.5 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.048 -1.032 . . . . 0.040000000000000001 110.056 -179.064 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 895' ' ' LEU . . . . . 0.45 ' N ' ' CD1' ' B' ' 894' ' ' TYR . 39.7 tp -97.58 114.33 26.22 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.628 -0.67 . . . . 1.27 109.621 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 896' ' ' LEU . . . . . 0.428 ' HB2' ' CZ ' ' B' ' 894' ' ' TYR . 9.6 tt -111.34 145.62 38.54 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.574 -0.704 . . . . 0.93999999999999995 110.884 -179.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 897' ' ' SER . . . . . . . . . . . . . 65.9 m -143.53 116.56 8.88 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.636 -0.665 . . . . 0.040000000000000001 110.467 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -106.23 146.68 30.01 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 109.297 -0.631 . . . . 0.47999999999999998 109.297 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 899' ' ' VAL . . . . . . . . . . . . . 87.7 t -97.35 118.76 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 C-N-CA 119.757 -0.777 . . . . 0.55000000000000004 111.403 -179.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 900' ' ' LEU . . . . . 0.401 ' CD2' ' N ' ' B' ' 900' ' ' LEU . 4.5 mm? -94.81 111.9 23.66 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 114.283 1.216 . . . . 1.5900000000000001 114.283 -175.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 17.4 m -64.4 141.06 58.91 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 107.316 -1.365 . . . . 0.050000000000000003 107.316 177.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -63.58 -66.14 2.69 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 110.476 -1.05 . . . . 0.029999999999999999 110.476 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 2.1 m80 46.44 65.99 1.07 Allowed 'General case' 0 N--CA 1.507 2.383 0 O-C-N 121.447 -1.031 . . . . 3.2000000000000002 111.099 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 54.1 ptt85 -68.54 -6.75 27.11 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.64 -0.662 . . . . 2.9199999999999999 111.942 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 905' ' ' HIS . . . . . 0.482 ' O ' ' CB ' ' B' ' 906' ' ' GLU . 75.9 t60 -60.19 2.82 0.08 Allowed 'General case' 0 N--CA 1.506 2.33 0 O-C-N 120.914 -1.116 . . . . 2.8700000000000001 113.073 -179.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 906' ' ' GLU . . . . . 0.482 ' CB ' ' O ' ' B' ' 905' ' ' HIS . 0.8 OUTLIER 93.75 -163.76 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.387 0 CA-C-N 120.6 1.545 . . . . 0.98999999999999999 112.072 178.939 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 907' ' ' LYS . . . . . 0.472 ' CB ' ' O ' ' B' ' 906' ' ' GLU . 42.9 tttt 88.84 161.52 0.06 Allowed 'General case' 0 N--CA 1.519 2.979 0 N-CA-C 107.717 -1.216 . . . . 5.25 107.717 -176.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 61.7 t -121.7 115.65 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 120.901 -1.125 . . . . 0.39000000000000001 110.926 -179.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 52.2 tp10 -100.75 132.64 46.05 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 107.222 -1.399 . . . . 1.72 107.222 176.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -156.99 120.95 4.27 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 106.703 -1.592 . . . . 0.67000000000000004 106.703 178.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 911' ' ' VAL . . . . . 0.456 ' HA ' ' HA ' ' B' ' 964' ' ' VAL . 93.9 t -83.48 132.1 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.835 -0.54 . . . . 0.54000000000000004 110.71 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 72.3 mt -64.58 155.44 33.14 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.326 -0.859 . . . . 1.5 108.694 178.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 913' ' ' SER . . . . . 0.412 ' CB ' ' CG1' ' B' ' 919' ' ' VAL . 1.6 t -123.47 136.69 54.72 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.122 -1.066 . . . . 1.3700000000000001 108.122 177.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 914' ' ' ARG . . . . . 0.416 ' O ' ' CB ' ' B' ' 915' ' ' SER . 0.0 OUTLIER -63.08 153.57 33.71 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 120.839 -1.163 . . . . 4.2999999999999998 111.981 -178.784 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 915' ' ' SER . . . . . 0.416 ' CB ' ' O ' ' B' ' 914' ' ' ARG . 2.2 t 83.02 -32.2 0.08 Allowed 'General case' 0 N--CA 1.521 3.095 0 C-N-CA 124.03 0.932 . . . . 2.0499999999999998 112.404 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 916' ' ' ASN . . . . . 0.415 ' O ' ' HB2' ' B' ' 917' ' ' GLN . 98.1 m-20 -121.26 -20.85 6.57 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.867 -1.146 . . . . 2.71 111.607 -179.094 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 917' ' ' GLN . . . . . 0.415 ' HB2' ' O ' ' B' ' 916' ' ' ASN . 50.8 mt-30 66.75 165.51 0.21 Allowed 'General case' 0 N--CA 1.521 3.103 0 N-CA-C 105.661 -1.977 . . . . 2.6800000000000002 105.661 -173.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.8 -125.23 34.58 Favored Glycine 1 N--CA 1.521 4.304 0 CA-C-N 123.532 2.878 . . . . 0.029999999999999999 106.958 -177.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 919' ' ' VAL . . . . . 0.412 ' CG1' ' CB ' ' B' ' 913' ' ' SER . 79.9 t 51.5 95.08 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 O-C-N 121.456 -1.026 . . . . 1.3899999999999999 108.959 -178.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.26 91.75 8.33 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.207 -0.997 . . . . 0.029999999999999999 110.904 -179.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 921' ' ' ARG . . . . . 0.431 ' HB3' ' CZ ' ' B' ' 950' ' ' PHE . 42.4 ptt85 -84.17 -41.9 16.54 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 105.58 -2.007 . . . . 4.4199999999999999 105.58 175.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 922' ' ' VAL . . . . . . . . . . . . . 71.0 t -103.26 68.96 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 N-CA-C 105.53 -2.026 . . . . 0.84999999999999998 105.53 175.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -90.7 136.04 33.32 Favored 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 121.779 0.8 . . . . 2.46 112.147 -176.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 924' ' ' SER . . . . . . . . . . . . . 14.1 t -147.62 104.04 3.58 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.184 -1.043 . . . . 0.69999999999999996 108.184 178.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -110.63 90.24 0.57 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 108.979 -1.649 . . . . 0.040000000000000001 108.979 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.425 0 N-CA-C 109.386 -1.486 . . . . 0.040000000000000001 109.386 -179.709 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 32.3 m . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.031 0.444 . . . . 13.779999999999999 110.254 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 97.6 mt -112.81 129.64 56.37 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.509 -0.744 . . . . 13.76 110.434 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -151.82 167.89 31.1 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.127 -1.589 . . . . 9.1300000000000008 109.127 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 949' ' ' VAL . . . . . . . . . . . . . 35.3 m -118.62 130.12 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.499 -1.001 . . . . 7.0800000000000001 110.852 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 950' ' ' PHE . . . . . 0.431 ' CZ ' ' HB3' ' B' ' 921' ' ' ARG . 32.6 p90 -133.19 149.44 52.03 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.584 -0.697 . . . . 7.5899999999999999 109.248 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 19.4 m -119.5 -53.7 2.21 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.406 -0.809 . . . . 5.0300000000000002 112.022 -178.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 952' ' ' LEU . . . . . 0.429 ' O ' ' O ' ' B' ' 953' ' ' ILE . 56.5 tp -60.32 -75.67 0.06 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.442 -0.786 . . . . 1.01 111.966 -177.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 953' ' ' ILE . . . . . 0.484 ' O ' ' HB3' ' B' ' 954' ' ' LEU . 49.2 pt -53.02 -144.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.637 0 N-CA-C 113.749 1.018 . . . . 2.6000000000000001 113.749 -176.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 954' ' ' LEU . . . . . 0.538 ' N ' ' CD1' ' B' ' 954' ' ' LEU . 0.0 OUTLIER 167.48 83.58 0.02 OUTLIER Pre-proline 0 N--CA 1.512 2.67 0 O-C-N 120.977 -1.077 . . . . 0.050000000000000003 111.429 178.915 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 955' ' ' PRO . . . . . 0.427 ' HD2' ' CE1' ' B' ' 950' ' ' PHE . 46.2 Cg_endo -74.07 98.4 1.08 Allowed 'Trans proline' 0 C--N 1.313 -1.315 0 N-CA-C 108.863 -1.245 . . . . 0.83999999999999997 108.863 177.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 956' ' ' LEU . . . . . 0.403 ' CD2' ' NH1' ' B' ' 914' ' ' ARG . 10.0 mp -122.85 144.02 49.48 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.056 -1.027 . . . . 0.040000000000000001 110.22 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -83.43 151.1 25.65 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 117.829 -1.082 . . . . 1.28 111.39 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -69.75 119.91 14.7 Favored 'General case' 0 N--CA 1.509 2.479 0 CA-C-N 122.857 2.571 . . . . 0.17000000000000001 111.368 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 93.35 -21.91 37.92 Favored Glycine 0 N--CA 1.501 2.989 0 N-CA-C 110.949 -0.86 . . . . 0.040000000000000001 110.949 178.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 960' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -51.65 171.23 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.46 -1.023 . . . . 0.040000000000000001 110.514 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 961' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' B' ' 886' ' ' PHE . 42.0 m -134.67 135.08 41.8 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.025 -1.047 . . . . 1.78 111.655 -178.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 962' ' ' VAL . . . . . 0.425 ' CG2' ' CB ' ' B' ' 886' ' ' PHE . 33.0 m -100.66 145.22 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 C-N-CA 119.938 -0.705 . . . . 0.040000000000000001 110.661 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 5.2 t -138.27 146.22 42.23 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.943 -0.473 . . . . 0.71999999999999997 110.042 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 964' ' ' VAL . . . . . 0.456 ' HA ' ' HA ' ' B' ' 911' ' ' VAL . 59.9 t -94.01 136.27 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.04 -1.037 . . . . 1.05 110.433 -179.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -93.29 126.32 38.34 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 103.571 -2.752 . . . . 3.02 103.571 173.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 966' ' ' LEU . . . . . 0.409 ' O ' ' CG2' ' B' ' 967' ' ' VAL . 0.5 OUTLIER -132.08 59.98 1.69 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.324 -0.991 . . . . 1.46 108.324 177.512 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 967' ' ' VAL . . . . . 0.409 ' CG2' ' O ' ' B' ' 966' ' ' LEU . 95.7 t -158.23 96.32 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 108.222 -1.029 . . . . 1.9399999999999999 108.222 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 90.5 mmm -142.85 59.54 1.43 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.8 -1.187 . . . . 0.0 108.312 178.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.23 119.67 1.95 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 107.06 -2.416 . . . . 2.1099999999999999 107.06 -178.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -81.92 -58.24 3.07 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.106 -1.232 . . . . 5.8899999999999997 110.353 -179.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 40.9 tp -59.14 90.22 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.423 -0.798 . . . . 4.3600000000000003 110.103 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -141.56 -154.05 0.5 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.574 -0.704 . . . . 1.8300000000000001 110.156 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -119.64 171.2 8.54 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.509 -0.745 . . . . 4.3499999999999996 110.336 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 10.7 t -101.61 130.2 47.88 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.53 -0.731 . . . . 1.27 109.942 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -156.26 158.79 38.12 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.443 -0.786 . . . . 5.0199999999999996 110.598 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.01 85.94 18.55 Favored Pre-proline 0 N--CA 1.5 2.031 0 O-C-N 121.647 -0.658 . . . . 2.4100000000000001 109.541 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -72.76 -171.88 0.84 Allowed 'Trans proline' 0 C--N 1.317 -1.087 0 O-C-N 123.342 1.18 . . . . 0.95999999999999996 111.408 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 978' ' ' LEU . . . . . . . . . . . . . 4.9 mp -127.74 154.56 45.21 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 107.649 -1.241 . . . . 0.62 107.649 178.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 979' ' ' THR . . . . . . . . . . . . . 41.8 p -150.17 141.34 23.11 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.808 -1.183 . . . . 3.5699999999999998 111.17 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 980' ' ' ILE . . . . . 0.412 HG22 HD11 ' B' ' 980' ' ' ILE . 51.3 mm -107.09 127.74 62.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 108.985 -0.746 . . . . 1.3300000000000001 108.985 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -121.56 98.57 6.03 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.395 -0.816 . . . . 0.050000000000000003 111.817 -178.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 98.8 p -109.34 158.73 17.6 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.467 -0.771 . . . . 0.87 109.013 178.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 983' ' ' GLY . . . . . . . . . . . . . . . -171.86 108.84 0.29 Allowed Glycine 0 N--CA 1.497 2.716 0 N-CA-C 106.609 -2.596 . . . . 0.029999999999999999 106.609 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -109.34 147.88 31.99 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 114.177 1.177 . . . . 0.69999999999999996 114.177 -175.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 985' ' ' LEU . . . . . . . . . . . . . 44.2 tp -69.67 135.22 49.6 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.851 -1.155 . . . . 0.040000000000000001 110.057 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 986' ' ' LEU . . . . . . . . . . . . . 42.2 tp -106.12 -60.45 1.64 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.635 -0.665 . . . . 0.040000000000000001 109.895 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -143.83 146.05 32.78 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.581 -1.266 . . . . 0.040000000000000001 107.581 179.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.27 162.91 12.25 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 108.091 -2.003 . . . . 0.040000000000000001 108.091 179.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -75.55 112.5 19.59 Favored Pre-proline 0 N--CA 1.499 1.991 0 CA-C-N 118.503 1.152 . . . . 0.040000000000000001 109.414 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 990' ' ' PRO . . . . . 0.413 ' O ' ' HB2' ' B' ' 991' ' ' GLU . 49.8 Cg_endo -90.16 71.68 1.49 Allowed 'Trans proline' 0 C--N 1.319 -1.006 0 O-C-N 123.151 1.079 . . . . 0.45000000000000001 111.399 -178.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 991' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' B' ' 990' ' ' PRO . 66.9 mt-10 67.39 -73.65 0.08 Allowed 'General case' 0 N--CA 1.503 2.203 0 N-CA-C 108.516 -0.92 . . . . 1.97 108.516 -177.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 992' ' ' LEU . . . . . . . . . . . . . 10.8 mt 51.03 20.45 0.82 Allowed 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.639 -0.663 . . . . 2.3799999999999999 111.738 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -93.22 156.79 16.62 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.897 -1.127 . . . . 3.79 109.987 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 67.3 m80 -146.05 92.32 2.18 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.538 -0.726 . . . . 3.5099999999999998 110.386 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 995' ' ' ALA . . . . . . . . . . . . 2.516 . . . . . . . 0 N--CA 1.503 2.204 0 O-C-N 120.946 -1.096 . . . . 2.73 110.625 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo . . . . . 0 N--CA 1.487 1.147 0 N-CA-C 109.469 -1.012 . . . . 3.8300000000000001 109.469 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 847' ' ' VAL . . . . . . . . . . . . . 59.1 t -131.62 102.8 15.0 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.621 -0.675 . . . . 1.8300000000000001 110.311 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 848' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -70.49 -21.37 30.17 Favored 'Trans proline' 0 N--CA 1.487 1.1 0 O-C-N 123.331 1.174 . . . . 0.65000000000000002 111.186 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 849' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 27.94 69.25 0.07 Allowed 'General case' 0 N--CA 1.519 2.999 0 N-CA-C 112.703 0.631 . . . . 2.5800000000000001 112.703 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 850' ' ' VAL . . . . . . . . . . . . . 49.5 t -119.62 135.0 61.39 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.152 -0.968 . . . . 1.0900000000000001 111.764 -178.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 851' ' ' ALA . . . . . . . . . . . . . . . -127.17 154.88 44.23 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 105.517 -2.031 . . . . 0.040000000000000001 105.517 176.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 852' ' ' PHE . . . . . 0.449 ' CD1' ' N ' ' C' ' 852' ' ' PHE . 16.8 p90 -160.51 126.68 4.08 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 121.107 1.776 . . . . 0.050000000000000003 108.633 178.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 7.8 t -176.31 134.36 0.24 Allowed 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.012 -1.107 . . . . 0.040000000000000001 108.012 -179.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -130.57 156.37 44.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.141 -0.974 . . . . 0.67000000000000004 109.505 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 855' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' C' ' 870' ' ' ARG . . . -122.09 142.87 49.93 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 121.881 0.848 . . . . 0.51000000000000001 111.266 -179.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 856' ' ' LEU . . . . . 0.418 HD21 ' CG1' ' C' ' 866' ' ' VAL . 3.3 tm? -111.85 136.46 51.1 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.626 -0.672 . . . . 0.050000000000000003 109.923 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 857' ' ' SER . . . . . 0.418 ' O ' ' O ' ' C' ' 858' ' ' LEU . 1.1 m -153.54 15.67 0.51 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.462 -0.774 . . . . 1.3300000000000001 111.661 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 858' ' ' LEU . . . . . 0.418 ' O ' ' O ' ' C' ' 857' ' ' SER . 4.0 pp -34.91 160.8 0.04 OUTLIER Pre-proline 0 N--CA 1.518 2.944 0 N-CA-C 113.172 0.804 . . . . 2.3300000000000001 113.172 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -62.13 -87.12 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 120.992 1.128 . . . . 2.3199999999999998 113.779 -177.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 54.0 ptt85 -129.74 -142.79 0.25 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 120.883 -1.135 . . . . 0.040000000000000001 111.77 -177.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 67.4 m -38.82 130.83 1.41 Allowed 'General case' 0 N--CA 1.51 2.572 0 O-C-N 121.598 -0.689 . . . . 1.3100000000000001 112.17 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.47 158.55 31.59 Favored Pre-proline 0 N--CA 1.487 1.416 0 N-CA-C 108.633 -0.877 . . . . 4.5099999999999998 108.633 177.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -71.47 -14.52 30.81 Favored 'Trans proline' 0 C--N 1.313 -1.314 0 O-C-N 123.185 1.097 . . . . 2.2400000000000002 111.693 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -177.95 -134.28 2.03 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.681 -1.367 . . . . 0.040000000000000001 109.681 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 7.1 m -67.84 151.18 47.6 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.251 -1.146 . . . . 1.51 110.477 -179.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 866' ' ' VAL . . . . . 0.418 ' CG1' HD21 ' C' ' 856' ' ' LEU . 53.7 t -94.87 134.28 25.17 Favored Pre-proline 0 N--CA 1.497 1.888 0 N-CA-C 113.401 0.889 . . . . 0.78000000000000003 113.401 -174.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 867' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -89.07 -150.14 0.04 OUTLIER 'Trans proline' 0 CA--C 1.543 0.936 0 O-C-N 123.526 1.277 . . . . 0.92000000000000004 109.345 178.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 868' ' ' PHE . . . . . 0.433 ' N ' ' CD1' ' C' ' 868' ' ' PHE . 14.9 p90 -148.9 123.76 9.95 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.68 -1.262 . . . . 0.050000000000000003 109.653 179.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 49.5 p-10 -112.61 -3.1 14.39 Favored 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 119.273 -0.971 . . . . 1.7 112.492 -178.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 870' ' ' ARG . . . . . 0.401 ' HB2' ' O ' ' C' ' 855' ' ' ALA . 26.7 mmm180 -91.68 87.65 6.4 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.925 -1.109 . . . . 2.5899999999999999 111.03 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 57.9 t -73.68 97.56 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 120.919 -1.113 . . . . 1.9399999999999999 109.269 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 872' ' ' LEU . . . . . . . . . . . . . 96.3 mt -87.17 -45.04 11.04 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.564 -0.71 . . . . 1.0600000000000001 110.736 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 873' ' ' LEU . . . . . 0.412 ' O ' ' HB2' ' C' ' 874' ' ' ASN . 31.1 tp -171.99 102.3 0.17 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.144 -0.972 . . . . 4.1799999999999997 108.975 178.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 874' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' C' ' 873' ' ' LEU . 35.0 t-20 176.97 82.72 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.265 0 N-CA-C 108.782 -0.821 . . . . 0.040000000000000001 108.782 -179.073 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -65.47 -47.02 77.54 Favored 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 119.282 -0.967 . . . . 3.3799999999999999 111.359 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 876' ' ' GLY . . . . . 0.422 ' HA3' ' CE2' ' C' ' 878' ' ' TYR . . . -72.11 -26.92 71.22 Favored Glycine 0 N--CA 1.492 2.429 0 C-N-CA 120.361 -0.924 . . . . 0.040000000000000001 111.447 -178.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 81.34 -61.93 4.54 Favored Glycine 0 N--CA 1.5 2.905 0 N-CA-C 108.016 -2.034 . . . . 0.040000000000000001 108.016 -178.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 878' ' ' TYR . . . . . 0.422 ' CE2' ' HA3' ' C' ' 876' ' ' GLY . 96.3 m-85 60.39 -66.3 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 114.366 1.247 . . . . 3.46 114.366 177.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 879' ' ' TYR . . . . . 0.47 ' CB ' ' CD2' ' C' ' 886' ' ' PHE . 25.0 p90 -110.55 107.52 17.17 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 115.092 1.516 . . . . 0.040000000000000001 115.092 -175.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -71.82 120.76 81.92 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.437 -0.789 . . . . 0.02 109.939 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 881' ' ' PRO . . . . . 0.422 ' HG2' ' CD1' ' C' ' 868' ' ' PHE . 52.3 Cg_endo -78.25 0.24 10.08 Favored 'Trans proline' 0 N--CA 1.49 1.28 0 O-C-N 123.434 1.228 . . . . 0.39000000000000001 111.786 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -74.92 -63.62 1.22 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 106.083 -1.821 . . . . 0.81000000000000005 106.083 178.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 70.3 p -90.54 -21.73 21.65 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 108.513 -0.921 . . . . 0.040000000000000001 108.513 177.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 82.28 18.45 66.77 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 110.59 -1.004 . . . . 0.029999999999999999 110.59 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 96.6 t -75.54 92.2 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 C-N-CA 118.41 -1.316 . . . . 1.01 108.655 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 886' ' ' PHE . . . . . 0.47 ' CD2' ' CB ' ' C' ' 879' ' ' TYR . 0.8 OUTLIER -87.81 104.34 16.49 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 115.065 -0.97 . . . . 0.050000000000000003 111.541 -177.761 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 887' ' ' THR . . . . . 0.421 ' O ' ' HD3' ' C' ' 889' ' ' PRO . 96.8 m -98.97 99.42 10.46 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 107.38 -1.341 . . . . 0.68000000000000005 107.38 177.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 888' ' ' ALA . . . . . . . . . . . . . . . -97.4 106.64 33.77 Favored Pre-proline 0 N--CA 1.501 2.109 0 N-CA-C 114.413 1.264 . . . . 0.25 114.413 -176.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 889' ' ' PRO . . . . . 0.421 ' HD3' ' O ' ' C' ' 887' ' ' THR . 53.5 Cg_endo -88.06 -15.38 3.11 Favored 'Trans proline' 0 CA--C 1.546 1.078 0 N-CA-C 108.662 -1.322 . . . . 1.6399999999999999 108.662 175.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 890' ' ' LEU . . . . . . . . . . . . . 46.0 mt -38.33 -49.17 1.39 Allowed 'General case' 0 N--CA 1.506 2.346 0 N-CA-C 113.347 0.869 . . . . 2.29 113.347 -177.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 52.69 97.35 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.241 -0.912 . . . . 0.63 110.316 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . 159.41 -155.52 26.61 Favored Glycine 0 N--CA 1.477 1.425 0 N-CA-C 107.151 -2.38 . . . . 0.040000000000000001 107.151 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 73.4 ttt-85 -117.99 123.98 47.05 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.618 -0.93 . . . . 3.0 109.049 177.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 894' ' ' TYR . . . . . 0.43 ' CD1' HD22 ' C' ' 954' ' ' LEU . 49.5 p90 -134.08 156.69 47.81 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.057 -1.027 . . . . 0.040000000000000001 110.922 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 895' ' ' LEU . . . . . . . . . . . . . 40.3 tp -96.47 118.22 32.53 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.691 -0.631 . . . . 1.27 110.379 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 896' ' ' LEU . . . . . . . . . . . . . 9.5 tt -116.1 145.17 43.25 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.645 -0.66 . . . . 0.93999999999999995 109.92 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 897' ' ' SER . . . . . . . . . . . . . 47.4 m -140.0 124.2 17.79 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.431 -0.793 . . . . 0.040000000000000001 111.285 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -105.49 146.8 29.07 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.903 -0.777 . . . . 0.47999999999999998 108.903 178.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 899' ' ' VAL . . . . . . . . . . . . . 93.7 t -90.83 122.24 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 C-N-CA 119.727 -0.789 . . . . 0.55000000000000004 111.255 -178.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 93.8 mt -92.06 111.12 22.55 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 114.375 1.25 . . . . 1.5900000000000001 114.375 -175.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 20.3 m -67.29 140.35 57.31 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 106.98 -1.489 . . . . 0.050000000000000003 106.98 176.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -64.37 -64.73 3.41 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 110.497 -1.041 . . . . 0.029999999999999999 110.497 -179.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 45.1 62.6 2.06 Favored 'General case' 0 N--CA 1.508 2.447 0 O-C-N 121.508 -0.995 . . . . 3.2000000000000002 111.346 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -68.22 -7.5 30.92 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.588 -0.695 . . . . 2.9199999999999999 111.899 -179.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 905' ' ' HIS . . . . . 0.494 ' O ' ' CB ' ' C' ' 906' ' ' GLU . 74.5 t60 -63.34 7.86 0.09 Allowed 'General case' 0 N--CA 1.505 2.323 0 CA-C-O 117.604 -1.188 . . . . 2.8700000000000001 113.567 -179.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 906' ' ' GLU . . . . . 0.494 ' CB ' ' O ' ' C' ' 905' ' ' HIS . 0.8 OUTLIER 94.12 -164.29 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.474 0 CA-C-N 121.292 1.86 . . . . 0.98999999999999999 111.727 179.202 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 907' ' ' LYS . . . . . 0.477 ' CB ' ' O ' ' C' ' 906' ' ' GLU . 34.8 tttp 86.92 156.14 0.07 Allowed 'General case' 0 N--CA 1.519 3.002 0 N-CA-C 108.014 -1.106 . . . . 5.25 108.014 -176.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 60.1 t -122.58 116.11 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 120.835 -1.165 . . . . 0.39000000000000001 110.991 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -104.69 131.47 52.08 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 107.503 -1.295 . . . . 1.72 107.503 177.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -154.73 122.34 5.75 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 106.675 -1.602 . . . . 0.67000000000000004 106.675 178.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 911' ' ' VAL . . . . . 0.467 ' HA ' ' HA ' ' C' ' 964' ' ' VAL . 87.6 t -81.7 131.86 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.871 -0.518 . . . . 0.54000000000000004 110.975 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 52.8 mt -66.83 156.85 34.5 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.354 -0.841 . . . . 1.5 109.091 178.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 913' ' ' SER . . . . . 0.404 ' CB ' ' CG1' ' C' ' 919' ' ' VAL . 1.7 p -124.0 138.24 54.48 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.242 -1.021 . . . . 1.3700000000000001 108.242 177.025 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 914' ' ' ARG . . . . . 0.426 ' O ' ' CB ' ' C' ' 915' ' ' SER . 0.0 OUTLIER -64.79 153.2 40.66 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 120.624 -1.298 . . . . 4.2999999999999998 111.401 -179.112 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 915' ' ' SER . . . . . 0.426 ' CB ' ' O ' ' C' ' 914' ' ' ARG . 1.4 t 83.59 -30.55 0.08 Allowed 'General case' 0 N--CA 1.522 3.144 0 C-N-CA 123.853 0.861 . . . . 2.0499999999999998 112.199 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 916' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -122.18 -21.8 5.79 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 120.834 -1.166 . . . . 2.71 111.422 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 67.04 167.22 0.23 Allowed 'General case' 0 N--CA 1.52 3.045 0 N-CA-C 105.845 -1.909 . . . . 2.6800000000000002 105.845 -174.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 53.83 -126.37 35.23 Favored Glycine 1 N--CA 1.523 4.437 0 CA-C-N 123.481 2.855 . . . . 0.029999999999999999 107.132 -177.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 919' ' ' VAL . . . . . 0.404 ' CG1' ' CB ' ' C' ' 913' ' ' SER . 95.4 t 50.94 95.26 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 O-C-N 121.467 -1.019 . . . . 1.3899999999999999 109.425 -178.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 920' ' ' ALA . . . . . . . . . . . . . . . -93.05 93.03 8.1 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.27 -0.972 . . . . 0.029999999999999999 110.486 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 921' ' ' ARG . . . . . 0.436 ' HB3' ' CZ ' ' C' ' 950' ' ' PHE . 44.5 ptt85 -83.19 -41.7 18.13 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 105.956 -1.868 . . . . 4.4199999999999999 105.956 176.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 922' ' ' VAL . . . . . . . . . . . . . 84.8 t -98.84 77.54 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 105.712 -1.959 . . . . 0.84999999999999998 105.712 175.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -87.95 133.47 33.93 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.834 0.826 . . . . 2.46 111.755 -177.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 5.6 t -147.23 104.92 3.7 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.383 -0.969 . . . . 0.69999999999999996 108.383 178.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -103.14 89.72 0.72 Allowed Glycine 0 N--CA 1.486 1.978 0 N-CA-C 108.434 -1.866 . . . . 0.040000000000000001 108.434 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.219 0 N-CA-C 108.972 -1.651 . . . . 0.040000000000000001 108.972 -179.657 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 17.5 m . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 120.936 0.398 . . . . 13.779999999999999 110.348 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 92.3 mt -114.32 129.96 56.65 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.479 -0.763 . . . . 13.76 110.238 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -152.41 170.82 31.65 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.495 -1.442 . . . . 9.1300000000000008 109.495 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 949' ' ' VAL . . . . . . . . . . . . . 35.7 m -117.28 135.1 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.644 -0.915 . . . . 7.0800000000000001 110.947 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 950' ' ' PHE . . . . . 0.436 ' CZ ' ' HB3' ' C' ' 921' ' ' ARG . 42.6 p90 -133.61 150.62 51.6 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.603 -0.686 . . . . 7.5899999999999999 109.323 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 67.7 m -118.43 -55.77 2.19 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.385 -0.822 . . . . 5.0300000000000002 111.936 -178.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 952' ' ' LEU . . . . . 0.467 ' O ' ' O ' ' C' ' 953' ' ' ILE . 44.9 tp -64.83 -76.34 0.07 Allowed 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.39 -0.819 . . . . 1.01 111.512 -178.191 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 953' ' ' ILE . . . . . 0.467 ' O ' ' O ' ' C' ' 952' ' ' LEU . 2.1 pp -48.31 -151.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.78 0 N-CA-C 114.687 1.366 . . . . 2.6000000000000001 114.687 -176.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 954' ' ' LEU . . . . . 0.583 ' N ' ' CD1' ' C' ' 954' ' ' LEU . 0.0 OUTLIER 173.57 90.43 0.06 OUTLIER Pre-proline 0 N--CA 1.516 2.864 0 O-C-N 120.567 -1.333 . . . . 0.050000000000000003 112.42 -179.385 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 955' ' ' PRO . . . . . 0.427 ' HD2' ' CZ ' ' C' ' 950' ' ' PHE . 53.8 Cg_endo -82.93 89.68 1.1 Allowed 'Trans proline' 0 C--N 1.316 -1.14 0 N-CA-C 109.182 -1.122 . . . . 0.83999999999999997 109.182 178.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 956' ' ' LEU . . . . . . . . . . . . . 9.9 mp -124.42 146.76 48.71 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.984 -1.073 . . . . 0.040000000000000001 110.406 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -83.44 152.08 25.16 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 117.691 -1.147 . . . . 1.28 111.569 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -66.97 118.5 10.52 Favored 'General case' 0 N--CA 1.507 2.41 0 CA-C-N 122.985 2.63 . . . . 0.17000000000000001 110.896 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.43 -19.82 47.98 Favored Glycine 0 N--CA 1.5 2.923 0 N-CA-C 111.032 -0.827 . . . . 0.040000000000000001 111.032 178.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 960' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.69 170.62 0.16 Allowed 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.283 -1.128 . . . . 0.040000000000000001 110.073 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 961' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' C' ' 886' ' ' PHE . 31.2 m -136.67 140.1 42.48 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.877 -1.14 . . . . 1.78 112.836 -177.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 962' ' ' VAL . . . . . 0.43 ' CG2' ' CB ' ' C' ' 886' ' ' PHE . 33.1 m -98.96 145.84 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.681 -0.637 . . . . 0.040000000000000001 110.934 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 4.8 t -138.63 144.33 39.66 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.811 -0.556 . . . . 0.71999999999999997 109.996 -179.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 964' ' ' VAL . . . . . 0.467 ' HA ' ' HA ' ' C' ' 911' ' ' VAL . 59.7 t -94.95 135.81 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.024 -1.047 . . . . 1.05 110.77 -179.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -96.51 126.48 41.73 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 103.705 -2.702 . . . . 3.02 103.705 173.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 966' ' ' LEU . . . . . . . . . . . . . 2.8 tt -132.21 63.32 1.62 Allowed 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.256 -1.016 . . . . 1.46 108.256 177.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 967' ' ' VAL . . . . . . . . . . . . . 96.8 t -157.53 96.92 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.21 -1.033 . . . . 1.9399999999999999 108.21 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 93.2 mmm -142.37 59.45 1.45 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.742 -1.224 . . . . 0.0 108.316 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 134.73 119.47 1.95 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 107.173 -2.371 . . . . 2.1099999999999999 107.173 -178.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -82.4 -57.7 3.25 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.02 -1.283 . . . . 5.8899999999999997 110.607 -179.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 40.4 tp -58.66 90.12 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.471 -0.768 . . . . 4.3600000000000003 110.312 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -142.29 -153.18 0.45 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.578 -0.701 . . . . 1.8300000000000001 110.122 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 17.5 m80 -118.8 168.68 10.52 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.399 -0.813 . . . . 4.3499999999999996 110.075 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 28.9 t -101.42 130.94 47.73 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.534 -0.728 . . . . 1.27 109.918 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -156.31 157.91 36.54 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.452 -0.78 . . . . 5.0199999999999996 110.717 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.62 86.01 23.68 Favored Pre-proline 0 N--CA 1.5 2.071 0 O-C-N 121.667 -0.646 . . . . 2.4100000000000001 109.277 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.91 -170.15 0.66 Allowed 'Trans proline' 0 C--N 1.318 -1.046 0 O-C-N 123.416 1.219 . . . . 0.95999999999999996 111.49 -179.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 978' ' ' LEU . . . . . . . . . . . . . 6.2 tt -126.43 152.12 46.81 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 107.889 -1.152 . . . . 0.62 107.889 178.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 979' ' ' THR . . . . . . . . . . . . . 47.6 p -150.87 139.42 20.57 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.73 -1.231 . . . . 3.5699999999999998 111.084 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 980' ' ' ILE . . . . . . . . . . . . . 51.2 mm -106.39 129.48 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 109.213 -0.662 . . . . 1.3300000000000001 109.213 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 981' ' ' PHE . . . . . 0.451 ' CD1' ' CE2' ' C' ' 879' ' ' TYR . 4.7 t80 -118.35 95.25 4.79 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 119.703 -0.799 . . . . 0.050000000000000003 111.635 -178.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 982' ' ' SER . . . . . . . . . . . . . 23.1 p -107.85 158.88 16.96 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 109.164 -0.68 . . . . 0.87 109.164 178.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 983' ' ' GLY . . . . . 0.424 ' HA3' ' CE2' ' C' ' 852' ' ' PHE . . . -170.85 115.23 0.57 Allowed Glycine 0 N--CA 1.497 2.745 0 N-CA-C 106.701 -2.56 . . . . 0.029999999999999999 106.701 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 984' ' ' ALA . . . . . . . . . . . . . . . -108.31 150.34 27.46 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 114.352 1.241 . . . . 0.69999999999999996 114.352 -175.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 985' ' ' LEU . . . . . . . . . . . . . 53.5 tp -76.42 135.5 39.44 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.833 -1.167 . . . . 0.040000000000000001 109.637 179.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 986' ' ' LEU . . . . . . . . . . . . . 42.1 tp -106.98 -60.44 1.67 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.402 -0.811 . . . . 0.040000000000000001 110.304 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -142.81 146.73 34.47 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 107.698 -1.223 . . . . 0.040000000000000001 107.698 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.3 163.22 12.2 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 108.395 -1.882 . . . . 0.040000000000000001 108.395 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -75.65 112.85 21.63 Favored Pre-proline 0 N--CA 1.498 1.943 0 O-C-N 121.246 -1.15 . . . . 0.040000000000000001 109.59 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 990' ' ' PRO . . . . . 0.412 ' O ' ' HB2' ' C' ' 991' ' ' GLU . 50.6 Cg_endo -89.58 71.47 1.82 Allowed 'Trans proline' 0 C--N 1.32 -0.961 0 O-C-N 123.106 1.056 . . . . 0.45000000000000001 111.537 -179.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 991' ' ' GLU . . . . . 0.412 ' HB2' ' O ' ' C' ' 990' ' ' PRO . 66.0 mt-10 67.49 -73.29 0.08 Allowed 'General case' 0 N--CA 1.503 2.209 0 N-CA-C 108.593 -0.891 . . . . 1.97 108.593 -177.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 992' ' ' LEU . . . . . . . . . . . . . 11.1 mt 50.65 20.82 0.78 Allowed 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.592 -0.693 . . . . 2.3799999999999999 111.709 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -92.99 156.92 16.59 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.899 -1.126 . . . . 3.79 110.07 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 67.0 m80 -145.93 92.2 2.18 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.537 -0.727 . . . . 3.5099999999999998 110.265 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 995' ' ' ALA . . . . . . . . . . . . 2.517 . . . . . . . 0 N--CA 1.503 2.221 0 O-C-N 120.931 -1.106 . . . . 2.73 110.586 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo . . . . . 0 N--CA 1.488 1.162 0 N-CA-C 109.506 -0.998 . . . . 3.8300000000000001 109.506 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 847' ' ' VAL . . . . . . . . . . . . . 59.9 t -133.0 102.92 13.09 Favored Pre-proline 0 N--CA 1.496 1.835 0 O-C-N 121.603 -0.686 . . . . 1.8300000000000001 110.079 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 848' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -69.82 -19.87 35.27 Favored 'Trans proline' 0 N--CA 1.487 1.125 0 O-C-N 123.274 1.144 . . . . 0.65000000000000002 111.028 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 849' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 27.83 68.85 0.07 Allowed 'General case' 0 N--CA 1.518 2.968 0 N-CA-C 112.861 0.689 . . . . 2.5800000000000001 112.861 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 850' ' ' VAL . . . . . . . . . . . . . 83.9 t -119.66 137.26 54.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.151 -0.968 . . . . 1.0900000000000001 111.603 -178.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 851' ' ' ALA . . . . . . . . . . . . . . . -126.99 158.52 36.68 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 105.876 -1.898 . . . . 0.040000000000000001 105.876 176.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 852' ' ' PHE . . . . . 0.425 ' CE1' ' HA3' ' A' ' 983' ' ' GLY . 46.6 p90 -157.59 131.97 8.38 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 120.989 1.722 . . . . 0.050000000000000003 108.613 178.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 19.5 t -175.03 132.84 0.32 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.07 -1.085 . . . . 0.040000000000000001 108.07 -178.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -135.41 153.1 51.91 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.173 -0.955 . . . . 0.67000000000000004 109.182 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 855' ' ' ALA . . . . . . . . . . . . . . . -124.24 140.11 53.27 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.942 0.877 . . . . 0.51000000000000001 111.689 -178.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 856' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -106.8 137.46 44.8 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 109.366 -0.605 . . . . 0.050000000000000003 109.366 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 857' ' ' SER . . . . . 0.419 ' O ' ' O ' ' A' ' 858' ' ' LEU . 1.3 m -155.02 15.43 0.41 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.323 -0.861 . . . . 1.3300000000000001 111.697 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 858' ' ' LEU . . . . . 0.419 ' O ' ' O ' ' A' ' 857' ' ' SER . 3.0 pp -34.29 159.91 0.04 OUTLIER Pre-proline 0 N--CA 1.518 2.942 0 N-CA-C 113.088 0.773 . . . . 2.3300000000000001 113.088 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -60.87 -88.59 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 120.898 1.066 . . . . 2.3199999999999998 113.686 -177.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 54.3 ptt85 -126.19 -142.77 0.29 Allowed 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.902 -1.124 . . . . 0.040000000000000001 111.575 -177.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 75.1 m -38.53 126.22 1.42 Allowed 'General case' 0 N--CA 1.509 2.507 0 O-C-N 121.63 -0.668 . . . . 1.3100000000000001 112.148 -178.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -101.3 161.15 24.51 Favored Pre-proline 0 N--CA 1.489 1.512 0 N-CA-C 108.579 -0.897 . . . . 4.5099999999999998 108.579 178.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -71.09 -15.34 32.18 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 O-C-N 123.251 1.132 . . . . 2.2400000000000002 111.65 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -177.4 -136.5 2.48 Favored Glycine 0 N--CA 1.495 2.577 0 C-N-CA 119.541 -1.314 . . . . 0.040000000000000001 110.838 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 41.1 m -61.69 162.84 7.97 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.479 -1.012 . . . . 1.51 111.362 -178.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -97.12 127.01 40.09 Favored Pre-proline 0 N--CA 1.504 2.237 0 N-CA-C 113.042 0.756 . . . . 0.78000000000000003 113.042 -174.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 867' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -90.64 -153.18 0.04 OUTLIER 'Trans proline' 0 CA--C 1.54 0.787 0 N-CA-C 108.63 -1.335 . . . . 0.92000000000000004 108.63 177.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 868' ' ' PHE . . . . . 0.459 ' CD1' ' CG ' ' A' ' 881' ' ' PRO . 24.3 p90 -149.93 122.77 8.71 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 120.523 -1.361 . . . . 0.050000000000000003 110.247 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 49.6 p-10 -112.91 -3.19 14.14 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 119.442 -0.903 . . . . 1.7 112.083 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 870' ' ' ARG . . . . . . . . . . . . . 29.4 mmm180 -90.58 89.29 7.48 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.947 -1.096 . . . . 2.5899999999999999 110.675 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 58.1 t -73.13 97.16 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 120.975 -1.078 . . . . 1.9399999999999999 110.091 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 872' ' ' LEU . . . . . . . . . . . . . 96.1 mt -83.13 -47.28 11.8 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.498 -0.751 . . . . 1.0600000000000001 110.099 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 873' ' ' LEU . . . . . . . . . . . . . 43.0 tp -175.06 104.47 0.09 Allowed 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.308 -0.87 . . . . 4.1799999999999997 108.706 178.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 874' ' ' ASN . . . . . 0.402 ' CB ' ' HA ' ' A' ' 852' ' ' PHE . 35.0 t-20 178.33 81.9 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.336 0 O-C-N 121.6 -0.687 . . . . 0.040000000000000001 109.521 -178.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -66.85 -47.33 72.27 Favored 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 119.291 -0.964 . . . . 3.3799999999999999 111.334 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 876' ' ' GLY . . . . . 0.423 ' HA3' ' CE2' ' A' ' 878' ' ' TYR . . . -74.51 -25.19 70.87 Favored Glycine 0 N--CA 1.495 2.568 0 O-C-N 121.22 -0.925 . . . . 0.040000000000000001 111.777 -178.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 81.88 -62.09 4.58 Favored Glycine 0 N--CA 1.502 3.09 0 N-CA-C 107.974 -2.05 . . . . 0.040000000000000001 107.974 -178.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 878' ' ' TYR . . . . . 0.423 ' CE2' ' HA3' ' A' ' 876' ' ' GLY . 95.6 m-85 61.5 -60.27 0.1 Allowed 'General case' 0 N--CA 1.504 2.236 0 N-CA-C 114.498 1.296 . . . . 3.46 114.498 177.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 879' ' ' TYR . . . . . 0.475 ' CB ' ' CD2' ' A' ' 886' ' ' PHE . 21.3 p90 -111.73 108.96 18.57 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 114.66 1.356 . . . . 0.040000000000000001 114.66 -176.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -66.55 117.85 48.33 Favored Pre-proline 0 N--CA 1.497 1.899 0 O-C-N 121.403 -0.811 . . . . 0.02 109.911 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 881' ' ' PRO . . . . . 0.459 ' CG ' ' CD1' ' A' ' 868' ' ' PHE . 52.8 Cg_endo -77.15 -0.33 10.48 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 O-C-N 123.42 1.221 . . . . 0.39000000000000001 112.275 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -75.92 -62.91 1.43 Allowed 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 106.62 -1.622 . . . . 0.81000000000000005 106.62 178.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 19.5 p -94.44 -19.53 20.5 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.659 -0.867 . . . . 0.040000000000000001 108.659 177.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.43 20.83 57.93 Favored Glycine 0 N--CA 1.497 2.731 0 O-C-N 121.154 -0.966 . . . . 0.029999999999999999 111.035 178.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 885' ' ' VAL . . . . . . . . . . . . . 97.7 t -73.0 90.0 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 C-N-CA 118.261 -1.376 . . . . 1.01 108.132 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 886' ' ' PHE . . . . . 0.475 ' CD2' ' CB ' ' A' ' 879' ' ' TYR . 0.8 OUTLIER -89.31 104.04 16.62 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-N 115.298 -0.864 . . . . 0.050000000000000003 111.825 -177.555 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 887' ' ' THR . . . . . 0.406 ' O ' ' HD3' ' A' ' 889' ' ' PRO . 93.1 m -95.26 100.69 12.44 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 107.826 -1.175 . . . . 0.68000000000000005 107.826 177.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 888' ' ' ALA . . . . . . . . . . . . . . . -98.4 106.99 39.49 Favored Pre-proline 0 N--CA 1.502 2.153 0 N-CA-C 114.009 1.114 . . . . 0.25 114.009 -176.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 889' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' A' ' 887' ' ' THR . 53.6 Cg_endo -89.84 -12.67 2.86 Favored 'Trans proline' 0 CA--C 1.546 1.122 0 C-N-CA 121.055 1.17 . . . . 1.6399999999999999 109.111 176.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 890' ' ' LEU . . . . . . . . . . . . . 72.9 mt -36.59 -50.31 0.8 Allowed 'General case' 0 N--CA 1.509 2.479 0 N-CA-C 113.636 0.976 . . . . 2.29 113.636 -177.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 52.19 95.85 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.295 0 O-C-N 121.156 -0.965 . . . . 0.63 110.238 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 157.85 -153.33 24.54 Favored Glycine 0 N--CA 1.478 1.456 0 N-CA-C 107.234 -2.347 . . . . 0.040000000000000001 107.234 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 893' ' ' ARG . . . . . 0.403 ' CZ ' ' CB ' ' C' ' 984' ' ' ALA . 73.2 ttt-85 -115.53 126.3 54.09 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 121.533 -0.981 . . . . 3.0 108.552 177.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 894' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -132.87 160.09 37.97 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.083 -1.011 . . . . 0.040000000000000001 111.083 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 895' ' ' LEU . . . . . . . . . . . . . 36.0 tp -91.73 119.45 31.59 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.728 -0.607 . . . . 1.27 110.1 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 9.2 tt -109.69 144.31 38.25 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.7 -0.625 . . . . 0.93999999999999995 110.155 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 897' ' ' SER . . . . . . . . . . . . . 69.5 m -149.95 114.8 5.33 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.49 -0.756 . . . . 0.040000000000000001 111.007 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -106.96 146.84 30.57 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.912 -0.773 . . . . 0.47999999999999998 108.912 178.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 899' ' ' VAL . . . . . . . . . . . . . 88.2 t -96.45 119.13 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 C-N-CA 119.59 -0.844 . . . . 0.55000000000000004 111.255 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 900' ' ' LEU . . . . . 0.407 ' N ' ' CD2' ' A' ' 900' ' ' LEU . 4.5 mm? -95.75 111.18 23.2 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 114.036 1.124 . . . . 1.5900000000000001 114.036 -175.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 18.3 m -64.52 140.19 58.84 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 107.458 -1.312 . . . . 0.050000000000000003 107.458 177.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -63.09 -66.62 2.46 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 110.429 -1.068 . . . . 0.029999999999999999 110.429 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 4.1 m170 46.93 66.9 0.88 Allowed 'General case' 0 N--CA 1.507 2.398 0 O-C-N 121.495 -1.003 . . . . 3.2000000000000002 110.991 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -68.5 -7.17 29.84 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.581 -0.699 . . . . 2.9199999999999999 111.937 -179.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 905' ' ' HIS . . . . . 0.489 ' O ' ' CB ' ' A' ' 906' ' ' GLU . 67.0 t60 -63.55 4.54 0.24 Allowed 'General case' 0 N--CA 1.504 2.272 0 O-C-N 120.942 -1.099 . . . . 2.8700000000000001 112.843 -179.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 906' ' ' GLU . . . . . 0.489 ' CB ' ' O ' ' A' ' 905' ' ' HIS . 0.8 OUTLIER 94.7 -162.95 0.0 OUTLIER 'General case' 0 N--CA 1.53 3.552 0 CA-C-N 120.729 1.604 . . . . 0.98999999999999999 112.218 178.752 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 907' ' ' LYS . . . . . 0.447 ' HB2' ' O ' ' A' ' 906' ' ' GLU . 94.1 mttt 89.27 159.71 0.05 Allowed 'General case' 0 N--CA 1.522 3.162 0 N-CA-C 107.862 -1.162 . . . . 5.25 107.862 -176.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 58.6 t -122.29 116.37 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 120.882 -1.137 . . . . 0.39000000000000001 110.91 -179.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -100.78 132.89 45.96 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.513 -1.292 . . . . 1.72 107.513 176.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -156.99 121.95 4.54 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 106.988 -1.486 . . . . 0.67000000000000004 106.988 178.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 911' ' ' VAL . . . . . 0.489 ' HA ' ' HA ' ' A' ' 964' ' ' VAL . 95.3 t -85.08 131.85 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.85 -0.532 . . . . 0.54000000000000004 111.076 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 73.0 mt -65.76 157.66 29.69 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.432 -0.792 . . . . 1.5 109.011 178.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 913' ' ' SER . . . . . 0.4 ' CB ' ' HB ' ' A' ' 919' ' ' VAL . 2.6 t -124.1 136.61 54.35 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.266 -1.013 . . . . 1.3700000000000001 108.266 177.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 914' ' ' ARG . . . . . 0.427 ' O ' ' CB ' ' A' ' 915' ' ' SER . 0.0 OUTLIER -65.07 154.53 37.58 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 120.612 -1.305 . . . . 4.2999999999999998 111.357 -179.186 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 915' ' ' SER . . . . . 0.427 ' CB ' ' O ' ' A' ' 914' ' ' ARG . 4.3 t 83.14 -31.61 0.08 Allowed 'General case' 0 N--CA 1.521 3.124 0 C-N-CA 123.853 0.861 . . . . 2.0499999999999998 112.089 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 916' ' ' ASN . . . . . 0.435 ' O ' ' HB2' ' A' ' 917' ' ' GLN . 91.0 m-20 -123.61 -21.48 5.23 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 120.85 -1.157 . . . . 2.71 111.274 -179.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 917' ' ' GLN . . . . . 0.435 ' HB2' ' O ' ' A' ' 916' ' ' ASN . 44.4 mt-30 65.84 166.45 0.19 Allowed 'General case' 0 N--CA 1.519 2.984 0 N-CA-C 105.957 -1.868 . . . . 2.6800000000000002 105.957 -173.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.54 -125.62 35.0 Favored Glycine 1 N--CA 1.521 4.356 0 CA-C-N 123.382 2.81 . . . . 0.029999999999999999 106.78 -177.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 919' ' ' VAL . . . . . 0.4 ' HB ' ' CB ' ' A' ' 913' ' ' SER . 71.8 t 52.47 93.58 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.241 0 O-C-N 121.31 -1.112 . . . . 1.3899999999999999 108.74 -178.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.14 90.96 8.03 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.219 -0.993 . . . . 0.029999999999999999 110.956 -178.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 921' ' ' ARG . . . . . 0.435 ' HB3' ' CZ ' ' A' ' 950' ' ' PHE . 30.2 ptt180 -86.17 -41.88 14.32 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 105.831 -1.914 . . . . 4.4199999999999999 105.831 175.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 922' ' ' VAL . . . . . . . . . . . . . 85.0 t -103.97 67.45 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 105.979 -1.86 . . . . 0.84999999999999998 105.979 175.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -89.83 134.64 34.08 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.709 0.766 . . . . 2.46 111.655 -177.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 8.5 t -147.18 103.27 3.57 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.477 -0.935 . . . . 0.69999999999999996 108.477 178.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -109.59 90.28 0.59 Allowed Glycine 0 N--CA 1.487 2.063 0 N-CA-C 108.411 -1.875 . . . . 0.040000000000000001 108.411 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.352 0 N-CA-C 109.435 -1.466 . . . . 0.040000000000000001 109.435 -179.186 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 29.5 m . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 120.995 0.426 . . . . 13.779999999999999 110.341 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 95.2 mt -113.03 129.99 56.31 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.492 -0.755 . . . . 13.76 110.455 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -151.91 168.11 31.18 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.197 -1.561 . . . . 9.1300000000000008 109.197 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 949' ' ' VAL . . . . . . . . . . . . . 27.2 m -119.02 128.87 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.532 -0.981 . . . . 7.0800000000000001 110.78 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 950' ' ' PHE . . . . . 0.443 ' CE1' ' HD2' ' A' ' 955' ' ' PRO . 26.2 p90 -131.76 148.13 52.55 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.559 -0.713 . . . . 7.5899999999999999 109.487 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 19.8 m -121.26 -52.06 2.07 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.358 -0.838 . . . . 5.0300000000000002 112.169 -178.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 952' ' ' LEU . . . . . 0.426 ' O ' ' O ' ' A' ' 953' ' ' ILE . 53.8 tp -59.75 -75.1 0.06 Allowed 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.41 -0.806 . . . . 1.01 112.557 -177.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 953' ' ' ILE . . . . . 0.458 ' O ' ' HB3' ' A' ' 954' ' ' LEU . 43.3 pt -52.34 -143.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.784 0 N-CA-C 114.177 1.177 . . . . 2.6000000000000001 114.177 -176.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 954' ' ' LEU . . . . . 0.546 ' N ' ' CD1' ' A' ' 954' ' ' LEU . 0.0 OUTLIER 174.07 77.2 0.05 OUTLIER Pre-proline 0 N--CA 1.506 2.367 0 O-C-N 120.671 -1.268 . . . . 0.050000000000000003 111.291 179.929 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 955' ' ' PRO . . . . . 0.443 ' HD2' ' CE1' ' A' ' 950' ' ' PHE . 48.9 Cg_endo -76.66 91.73 1.13 Allowed 'Trans proline' 0 C--N 1.314 -1.238 0 N-CA-C 109.614 -0.956 . . . . 0.83999999999999997 109.614 178.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 956' ' ' LEU . . . . . 0.411 ' CD2' ' NH1' ' A' ' 914' ' ' ARG . 11.1 mp -121.98 146.14 47.44 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.225 -0.922 . . . . 0.040000000000000001 109.818 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -84.44 150.74 25.1 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 117.831 -1.081 . . . . 1.28 111.876 -178.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -70.2 120.24 15.58 Favored 'General case' 0 N--CA 1.51 2.525 0 CA-C-N 122.788 2.54 . . . . 0.17000000000000001 111.74 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.51 -22.63 31.99 Favored Glycine 0 N--CA 1.5 2.907 0 N-CA-C 111.122 -0.791 . . . . 0.040000000000000001 111.122 178.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 960' ' ' ASP . . . . . 0.414 ' HB3' ' NE ' ' A' ' 914' ' ' ARG . 0.4 OUTLIER -55.38 171.9 0.16 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.451 -1.029 . . . . 0.040000000000000001 110.006 -179.567 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 961' ' ' THR . . . . . 0.452 ' HA ' ' O ' ' A' ' 886' ' ' PHE . 41.5 m -135.06 135.43 41.26 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.879 -1.138 . . . . 1.78 111.884 -178.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 962' ' ' VAL . . . . . 0.401 ' CG2' ' CB ' ' A' ' 886' ' ' PHE . 32.7 m -97.79 145.92 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 C-N-CA 120.094 -0.642 . . . . 0.040000000000000001 110.138 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 5.6 t -138.5 145.98 41.43 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.852 -0.53 . . . . 0.71999999999999997 110.329 -178.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 964' ' ' VAL . . . . . 0.489 ' HA ' ' HA ' ' A' ' 911' ' ' VAL . 59.2 t -94.37 137.37 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.258 -0.901 . . . . 1.05 110.459 -179.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -93.28 127.54 38.91 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 103.791 -2.67 . . . . 3.02 103.791 173.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 966' ' ' LEU . . . . . 0.402 ' O ' ' CG2' ' A' ' 967' ' ' VAL . 0.2 OUTLIER -132.81 60.0 1.71 Allowed 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.35 -0.981 . . . . 1.46 108.35 177.309 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 967' ' ' VAL . . . . . 0.402 ' CG2' ' O ' ' A' ' 966' ' ' LEU . 98.5 t -157.96 96.88 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 108.049 -1.093 . . . . 1.9399999999999999 108.049 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 92.2 mmm -142.65 60.44 1.43 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.725 -1.234 . . . . 0.0 108.434 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.59 120.48 2.01 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 107.203 -2.359 . . . . 2.1099999999999999 107.203 -178.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -82.06 -59.88 2.41 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 118.76 1.28 . . . . 5.8899999999999997 110.189 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 50.9 tp -59.81 90.95 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.44 -0.787 . . . . 4.3600000000000003 109.894 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -141.41 -154.62 0.53 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.571 -0.706 . . . . 1.8300000000000001 110.39 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -118.8 171.27 8.33 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.471 -0.768 . . . . 4.3499999999999996 110.221 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 34.3 t -101.6 130.23 47.88 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.588 -0.695 . . . . 1.27 110.039 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -156.11 157.05 35.36 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.549 -0.719 . . . . 5.0199999999999996 110.485 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.07 85.74 18.67 Favored Pre-proline 0 N--CA 1.5 2.068 0 O-C-N 121.6 -0.688 . . . . 2.4100000000000001 109.721 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.37 -172.33 1.02 Allowed 'Trans proline' 0 C--N 1.318 -1.068 0 O-C-N 123.313 1.165 . . . . 0.95999999999999996 111.345 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 4.9 mp -127.7 154.44 45.31 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 107.691 -1.226 . . . . 0.62 107.691 178.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 979' ' ' THR . . . . . . . . . . . . . 41.4 p -150.18 140.94 22.7 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.696 -1.253 . . . . 3.5699999999999998 111.14 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 980' ' ' ILE . . . . . . . . . . . . . 46.3 mm -107.32 128.98 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 109.022 -0.733 . . . . 1.3300000000000001 109.022 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 981' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -118.95 95.16 4.71 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 119.804 -0.759 . . . . 0.050000000000000003 111.797 -178.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 82.9 p -107.93 157.96 17.76 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.545 -0.722 . . . . 0.87 109.192 178.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 983' ' ' GLY . . . . . 0.425 ' HA3' ' CE1' ' A' ' 852' ' ' PHE . . . -174.75 110.46 0.32 Allowed Glycine 0 N--CA 1.499 2.888 0 N-CA-C 106.356 -2.698 . . . . 0.029999999999999999 106.356 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -108.22 150.87 26.7 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 114.526 1.306 . . . . 0.69999999999999996 114.526 -175.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 33.1 tp -72.29 135.06 45.87 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.822 -1.174 . . . . 0.040000000000000001 110.07 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 51.8 tp -107.47 -55.8 2.3 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.595 -0.691 . . . . 0.040000000000000001 110.06 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -144.57 145.76 31.98 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 107.668 -1.234 . . . . 0.040000000000000001 107.668 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.6 163.32 12.17 Favored Glycine 0 N--CA 1.495 2.633 0 N-CA-C 108.232 -1.947 . . . . 0.040000000000000001 108.232 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -75.26 112.46 18.66 Favored Pre-proline 0 N--CA 1.499 1.989 0 O-C-N 121.195 -1.179 . . . . 0.040000000000000001 109.463 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 990' ' ' PRO . . . . . 0.414 ' O ' ' HB2' ' A' ' 991' ' ' GLU . 50.2 Cg_endo -90.53 70.79 1.39 Allowed 'Trans proline' 0 C--N 1.319 -1.023 0 O-C-N 123.151 1.079 . . . . 0.45000000000000001 111.565 -178.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 991' ' ' GLU . . . . . 0.414 ' HB2' ' O ' ' A' ' 990' ' ' PRO . 69.2 mt-10 67.28 -73.86 0.07 Allowed 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 108.586 -0.894 . . . . 1.97 108.586 -177.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 992' ' ' LEU . . . . . . . . . . . . . 11.0 mt 51.01 20.79 0.86 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.541 -0.724 . . . . 2.3799999999999999 111.641 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -94.11 156.89 16.34 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.818 -1.176 . . . . 3.79 109.993 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 72.2 m80 -146.63 93.49 2.3 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.588 -0.695 . . . . 3.5099999999999998 110.309 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 995' ' ' ALA . . . . . . . . . . . . 2.518 . . . . . . . 0 N--CA 1.503 2.224 0 O-C-N 120.868 -1.145 . . . . 2.73 110.572 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo . . . . . 0 N--CA 1.488 1.156 0 N-CA-C 109.5 -1.0 . . . . 3.8300000000000001 109.5 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 847' ' ' VAL . . . . . . . . . . . . . 60.0 t -133.07 102.87 13.03 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.567 -0.708 . . . . 1.8300000000000001 110.139 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 848' ' ' PRO . . . . . 0.405 ' O ' ' C ' ' B' ' 849' ' ' GLN . 43.6 Cg_endo -69.7 -20.16 35.48 Favored 'Trans proline' 0 N--CA 1.487 1.092 0 O-C-N 123.235 1.124 . . . . 0.65000000000000002 111.033 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 849' ' ' GLN . . . . . 0.405 ' C ' ' O ' ' B' ' 848' ' ' PRO . 56.1 tt0 28.0 69.1 0.07 Allowed 'General case' 0 N--CA 1.519 2.989 0 N-CA-C 112.768 0.655 . . . . 2.5800000000000001 112.768 179.295 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 850' ' ' VAL . . . . . . . . . . . . . 83.1 t -119.85 137.34 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.213 -0.93 . . . . 1.0900000000000001 111.623 -178.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 851' ' ' ALA . . . . . . . . . . . . . . . -127.52 157.67 39.5 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 105.907 -1.886 . . . . 0.040000000000000001 105.907 176.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 852' ' ' PHE . . . . . 0.413 ' CE1' ' HA3' ' B' ' 983' ' ' GLY . 46.4 p90 -156.63 132.43 9.58 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-N 121.04 1.745 . . . . 0.050000000000000003 108.541 179.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 20.8 t -175.11 132.59 0.31 Allowed 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.14 -1.059 . . . . 0.040000000000000001 108.14 -179.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -135.1 153.46 52.01 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.125 -0.985 . . . . 0.67000000000000004 109.211 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 855' ' ' ALA . . . . . . . . . . . . . . . -124.75 140.23 53.12 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.994 0.902 . . . . 0.51000000000000001 111.685 -178.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 856' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -107.04 137.05 45.84 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.391 -0.596 . . . . 0.050000000000000003 109.391 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 857' ' ' SER . . . . . 0.427 ' O ' ' O ' ' B' ' 858' ' ' LEU . 1.3 m -154.63 15.5 0.44 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.442 -0.786 . . . . 1.3300000000000001 111.712 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 858' ' ' LEU . . . . . 0.427 ' O ' ' O ' ' B' ' 857' ' ' SER . 3.1 pp -34.32 159.98 0.04 OUTLIER Pre-proline 0 N--CA 1.518 2.956 0 N-CA-C 113.064 0.765 . . . . 2.3300000000000001 113.064 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -61.04 -88.58 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 120.9 1.067 . . . . 2.3199999999999998 113.661 -177.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 54.2 ptt85 -126.28 -142.8 0.29 Allowed 'General case' 0 N--CA 1.5 2.052 0 O-C-N 120.893 -1.129 . . . . 0.040000000000000001 111.551 -177.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 75.3 m -38.41 125.51 1.35 Allowed 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.597 -0.69 . . . . 1.3100000000000001 112.178 -178.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 862' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.59 161.18 24.78 Favored Pre-proline 0 N--CA 1.488 1.451 0 N-CA-C 108.557 -0.905 . . . . 4.5099999999999998 108.557 178.026 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -71.1 -15.29 32.15 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 O-C-N 123.248 1.13 . . . . 2.2400000000000002 111.73 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -177.15 -135.8 2.29 Favored Glycine 0 N--CA 1.495 2.599 0 C-N-CA 119.549 -1.31 . . . . 0.040000000000000001 110.807 179.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 42.0 m -62.31 163.94 7.78 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.415 -1.05 . . . . 1.51 111.288 -178.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 866' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -98.09 127.03 38.07 Favored Pre-proline 0 N--CA 1.504 2.271 0 C-N-CA 119.796 -0.762 . . . . 0.78000000000000003 112.965 -174.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 867' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -90.6 -153.25 0.04 OUTLIER 'Trans proline' 0 CA--C 1.54 0.789 0 N-CA-C 108.614 -1.341 . . . . 0.92000000000000004 108.614 177.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 868' ' ' PHE . . . . . 0.459 ' CD1' ' CG ' ' B' ' 881' ' ' PRO . 24.4 p90 -149.95 122.56 8.58 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.529 -1.357 . . . . 0.050000000000000003 110.199 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 50.0 p-10 -112.64 -2.76 14.46 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 119.476 -0.89 . . . . 1.7 112.133 -179.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 870' ' ' ARG . . . . . . . . . . . . . 28.8 mmm180 -91.07 89.15 7.27 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.925 -1.109 . . . . 2.5899999999999999 110.694 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 57.3 t -73.05 97.31 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.012 -1.055 . . . . 1.9399999999999999 110.063 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 872' ' ' LEU . . . . . . . . . . . . . 96.0 mt -83.27 -47.11 11.87 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.496 -0.752 . . . . 1.0600000000000001 110.067 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 873' ' ' LEU . . . . . 0.401 ' O ' ' HB2' ' B' ' 874' ' ' ASN . 43.0 tp -175.15 104.43 0.09 Allowed 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 108.709 -0.849 . . . . 4.1799999999999997 108.709 178.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 874' ' ' ASN . . . . . 0.401 ' HB2' ' O ' ' B' ' 873' ' ' LEU . 34.8 t-20 178.37 81.99 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.626 -0.671 . . . . 0.040000000000000001 109.581 -178.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -66.96 -47.34 71.88 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 119.325 -0.95 . . . . 3.3799999999999999 111.327 -179.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 876' ' ' GLY . . . . . 0.42 ' HA3' ' CE2' ' B' ' 878' ' ' TYR . . . -74.59 -25.26 70.52 Favored Glycine 0 N--CA 1.495 2.602 0 O-C-N 121.269 -0.894 . . . . 0.040000000000000001 111.725 -178.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 81.96 -62.08 4.58 Favored Glycine 0 N--CA 1.502 3.05 0 N-CA-C 107.966 -2.054 . . . . 0.040000000000000001 107.966 -178.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 878' ' ' TYR . . . . . 0.42 ' CE2' ' HA3' ' B' ' 876' ' ' GLY . 95.7 m-85 61.52 -60.25 0.1 Allowed 'General case' 0 N--CA 1.504 2.24 0 N-CA-C 114.473 1.286 . . . . 3.46 114.473 177.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 879' ' ' TYR . . . . . 0.477 ' CB ' ' CD2' ' B' ' 886' ' ' PHE . 21.2 p90 -111.68 108.78 18.35 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 114.68 1.363 . . . . 0.040000000000000001 114.68 -176.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -66.41 117.77 47.04 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.354 -0.841 . . . . 0.02 109.925 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 881' ' ' PRO . . . . . 0.459 ' CG ' ' CD1' ' B' ' 868' ' ' PHE . 51.8 Cg_endo -77.09 -0.52 10.67 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 O-C-N 123.409 1.215 . . . . 0.39000000000000001 112.261 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -75.73 -63.1 1.37 Allowed 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 106.639 -1.615 . . . . 0.81000000000000005 106.639 178.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 19.7 p -94.38 -19.06 20.96 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.76 -0.83 . . . . 0.040000000000000001 108.76 177.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.88 21.28 57.9 Favored Glycine 0 N--CA 1.496 2.648 0 O-C-N 121.099 -1.0 . . . . 0.029999999999999999 111.03 178.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 885' ' ' VAL . . . . . . . . . . . . . 96.3 t -73.32 90.28 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 C-N-CA 118.242 -1.383 . . . . 1.01 108.123 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 886' ' ' PHE . . . . . 0.477 ' CD2' ' CB ' ' B' ' 879' ' ' TYR . 0.8 OUTLIER -89.52 104.17 16.75 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 115.323 -0.853 . . . . 0.050000000000000003 111.808 -177.542 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 887' ' ' THR . . . . . 0.404 ' O ' ' HD3' ' B' ' 889' ' ' PRO . 93.4 m -95.34 101.0 12.69 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 107.722 -1.214 . . . . 0.68000000000000005 107.722 177.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 888' ' ' ALA . . . . . . . . . . . . . . . -98.69 106.86 39.61 Favored Pre-proline 0 N--CA 1.503 2.179 0 N-CA-C 114.026 1.121 . . . . 0.25 114.026 -176.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 889' ' ' PRO . . . . . 0.404 ' HD3' ' O ' ' B' ' 887' ' ' THR . 53.2 Cg_endo -89.71 -12.71 2.92 Favored 'Trans proline' 0 CA--C 1.547 1.133 0 C-N-CA 121.028 1.152 . . . . 1.6399999999999999 109.107 176.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 890' ' ' LEU . . . . . . . . . . . . . 73.1 mt -36.51 -50.31 0.78 Allowed 'General case' 0 N--CA 1.508 2.465 0 N-CA-C 113.7 1.0 . . . . 2.29 113.7 -177.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 52.01 95.99 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.162 -0.961 . . . . 0.63 110.258 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . 157.86 -153.29 24.5 Favored Glycine 0 N--CA 1.478 1.478 0 N-CA-C 107.209 -2.357 . . . . 0.040000000000000001 107.209 -179.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 73.4 ttt-85 -115.58 126.12 53.82 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 108.448 -0.945 . . . . 3.0 108.448 177.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 894' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -132.53 160.23 37.13 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.113 -0.992 . . . . 0.040000000000000001 111.155 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 895' ' ' LEU . . . . . . . . . . . . . 36.2 tp -92.1 119.47 31.81 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.709 -0.62 . . . . 1.27 110.025 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 896' ' ' LEU . . . . . . . . . . . . . 9.2 tt -109.85 143.68 39.39 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.671 -0.643 . . . . 0.93999999999999995 110.147 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 897' ' ' SER . . . . . . . . . . . . . 69.6 m -149.3 114.61 5.51 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.49 -0.756 . . . . 0.040000000000000001 110.992 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -106.75 146.76 30.46 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.944 -0.761 . . . . 0.47999999999999998 108.944 178.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 899' ' ' VAL . . . . . . . . . . . . . 88.0 t -96.25 118.94 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 C-N-CA 119.646 -0.822 . . . . 0.55000000000000004 111.302 -179.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 900' ' ' LEU . . . . . 0.4 ' N ' ' CD2' ' B' ' 900' ' ' LEU . 4.5 mm? -95.71 110.65 22.75 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 114.102 1.149 . . . . 1.5900000000000001 114.102 -175.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 18.2 m -64.01 140.21 58.85 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 107.414 -1.328 . . . . 0.050000000000000003 107.414 177.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -63.3 -66.75 2.38 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 110.387 -1.085 . . . . 0.029999999999999999 110.387 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 4.1 m170 46.89 67.11 0.84 Allowed 'General case' 0 N--CA 1.507 2.383 0 O-C-N 121.505 -0.997 . . . . 3.2000000000000002 110.977 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 35.1 ptt180 -68.5 -7.54 33.16 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.642 -0.662 . . . . 2.9199999999999999 111.898 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 905' ' ' HIS . . . . . 0.487 ' O ' ' CB ' ' B' ' 906' ' ' GLU . 66.6 t60 -62.96 4.09 0.2 Allowed 'General case' 0 N--CA 1.505 2.278 0 CA-C-O 117.775 -1.107 . . . . 2.8700000000000001 112.851 -179.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 906' ' ' GLU . . . . . 0.487 ' CB ' ' O ' ' B' ' 905' ' ' HIS . 0.9 OUTLIER 94.89 -163.04 0.0 OUTLIER 'General case' 0 N--CA 1.53 3.533 0 CA-C-N 120.761 1.618 . . . . 0.98999999999999999 112.142 178.908 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 907' ' ' LYS . . . . . 0.46 ' HB2' ' O ' ' B' ' 906' ' ' GLU . 94.2 mttt 89.5 159.51 0.05 Allowed 'General case' 0 N--CA 1.522 3.164 0 N-CA-C 107.817 -1.179 . . . . 5.25 107.817 -177.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 58.4 t -122.25 116.01 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 120.933 -1.104 . . . . 0.39000000000000001 110.956 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 49.2 tp10 -100.2 133.21 44.94 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 107.542 -1.281 . . . . 1.72 107.542 176.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -157.42 122.11 4.4 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 106.98 -1.489 . . . . 0.67000000000000004 106.98 178.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 911' ' ' VAL . . . . . 0.478 ' HA ' ' HA ' ' B' ' 964' ' ' VAL . 94.7 t -85.34 132.14 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 C-N-CA 120.386 -0.526 . . . . 0.54000000000000004 111.11 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 72.3 mt -65.83 157.87 29.29 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.442 -0.787 . . . . 1.5 109.023 178.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 913' ' ' SER . . . . . 0.4 ' CB ' ' CG1' ' B' ' 919' ' ' VAL . 2.6 t -124.56 135.86 53.49 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.365 -0.976 . . . . 1.3700000000000001 108.365 177.052 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 914' ' ' ARG . . . . . 0.419 ' O ' ' CB ' ' B' ' 915' ' ' SER . 0.0 OUTLIER -64.28 154.57 34.77 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 120.596 -1.315 . . . . 4.2999999999999998 111.447 -179.054 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 915' ' ' SER . . . . . 0.419 ' CB ' ' O ' ' B' ' 914' ' ' ARG . 4.3 t 83.19 -31.86 0.08 Allowed 'General case' 0 N--CA 1.522 3.138 0 C-N-CA 123.867 0.867 . . . . 2.0499999999999998 112.131 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 916' ' ' ASN . . . . . 0.434 ' O ' ' HB2' ' B' ' 917' ' ' GLN . 90.8 m-20 -123.3 -21.89 5.25 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.856 -1.152 . . . . 2.71 111.353 -179.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 917' ' ' GLN . . . . . 0.434 ' HB2' ' O ' ' B' ' 916' ' ' ASN . 44.2 mt-30 65.87 165.72 0.19 Allowed 'General case' 0 N--CA 1.518 2.949 0 N-CA-C 106.024 -1.843 . . . . 2.6800000000000002 106.024 -173.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 55.38 -125.66 36.94 Favored Glycine 1 N--CA 1.52 4.267 0 CA-C-N 123.439 2.836 . . . . 0.029999999999999999 106.621 -177.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 919' ' ' VAL . . . . . 0.4 ' CG1' ' CB ' ' B' ' 913' ' ' SER . 68.9 t 52.34 93.72 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.302 0 O-C-N 121.356 -1.085 . . . . 1.3899999999999999 108.752 -178.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.3 90.84 7.91 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.205 -0.998 . . . . 0.029999999999999999 110.881 -178.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 921' ' ' ARG . . . . . 0.437 ' HB3' ' CZ ' ' B' ' 950' ' ' PHE . 30.1 ptt180 -86.15 -41.83 14.38 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 105.907 -1.886 . . . . 4.4199999999999999 105.907 175.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 922' ' ' VAL . . . . . . . . . . . . . 84.8 t -104.04 67.4 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 105.978 -1.86 . . . . 0.84999999999999998 105.978 175.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -89.72 134.68 34.04 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.705 0.764 . . . . 2.46 111.658 -177.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 924' ' ' SER . . . . . . . . . . . . . 8.5 t -147.13 103.33 3.58 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.503 -0.925 . . . . 0.69999999999999996 108.503 178.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -109.62 90.22 0.59 Allowed Glycine 0 N--CA 1.487 2.052 0 N-CA-C 108.349 -1.9 . . . . 0.040000000000000001 108.349 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.318 0 N-CA-C 109.459 -1.456 . . . . 0.040000000000000001 109.459 -179.267 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 29.9 m . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.009 0.433 . . . . 13.779999999999999 110.307 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 95.3 mt -111.87 129.94 55.99 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.543 -0.723 . . . . 13.76 110.379 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -151.39 167.56 30.82 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.256 -1.538 . . . . 9.1300000000000008 109.256 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 949' ' ' VAL . . . . . . . . . . . . . 30.7 m -118.7 129.13 75.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.514 -0.992 . . . . 7.0800000000000001 110.698 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 950' ' ' PHE . . . . . 0.437 ' CZ ' ' HB3' ' B' ' 921' ' ' ARG . 26.6 p90 -132.35 147.87 52.4 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.563 -0.71 . . . . 7.5899999999999999 109.518 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 19.7 m -121.22 -51.46 2.1 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.48 -0.762 . . . . 5.0300000000000002 112.063 -178.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 952' ' ' LEU . . . . . 0.416 ' O ' ' O ' ' B' ' 953' ' ' ILE . 52.5 tp -60.24 -75.28 0.06 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.389 -0.819 . . . . 1.01 112.549 -177.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 953' ' ' ILE . . . . . 0.46 ' O ' ' HB3' ' B' ' 954' ' ' LEU . 45.0 pt -52.1 -143.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.8 0 N-CA-C 114.237 1.199 . . . . 2.6000000000000001 114.237 -176.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 954' ' ' LEU . . . . . 0.551 ' N ' ' CD1' ' B' ' 954' ' ' LEU . 0.0 OUTLIER 173.79 77.01 0.05 OUTLIER Pre-proline 0 N--CA 1.507 2.387 0 O-C-N 120.629 -1.294 . . . . 0.050000000000000003 111.209 179.883 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 955' ' ' PRO . . . . . 0.431 ' HD2' ' CE1' ' B' ' 950' ' ' PHE . 49.4 Cg_endo -76.62 91.76 1.13 Allowed 'Trans proline' 0 C--N 1.314 -1.242 0 N-CA-C 109.606 -0.959 . . . . 0.83999999999999997 109.606 178.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 956' ' ' LEU . . . . . 0.409 ' CD2' ' NH1' ' B' ' 914' ' ' ARG . 11.1 mp -122.13 146.13 47.52 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.198 -0.939 . . . . 0.040000000000000001 109.738 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -84.33 150.86 25.1 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 117.964 -1.017 . . . . 1.28 111.84 -178.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -70.3 120.02 15.34 Favored 'General case' 0 N--CA 1.509 2.497 0 CA-C-N 122.658 2.481 . . . . 0.17000000000000001 111.664 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.65 -22.74 31.8 Favored Glycine 0 N--CA 1.5 2.922 0 N-CA-C 111.07 -0.812 . . . . 0.040000000000000001 111.07 178.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 960' ' ' ASP . . . . . 0.413 ' HB3' ' NE ' ' B' ' 914' ' ' ARG . 0.4 OUTLIER -55.27 171.99 0.15 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.455 -1.026 . . . . 0.040000000000000001 110.014 -179.528 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 961' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' B' ' 886' ' ' PHE . 40.7 m -135.02 135.65 41.5 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.993 -1.067 . . . . 1.78 111.845 -178.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 962' ' ' VAL . . . . . 0.403 ' CG2' ' CB ' ' B' ' 886' ' ' PHE . 32.7 m -98.07 145.77 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 C-N-CA 120.102 -0.639 . . . . 0.040000000000000001 110.122 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 5.6 t -138.24 146.01 42.06 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.905 -0.497 . . . . 0.71999999999999997 110.294 -178.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 964' ' ' VAL . . . . . 0.478 ' HA ' ' HA ' ' B' ' 911' ' ' VAL . 59.0 t -94.46 137.17 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.19 -0.943 . . . . 1.05 110.474 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -93.24 127.06 38.67 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 103.869 -2.641 . . . . 3.02 103.869 173.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 966' ' ' LEU . . . . . 0.406 ' O ' ' CG2' ' B' ' 967' ' ' VAL . 0.2 OUTLIER -132.32 60.23 1.69 Allowed 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.392 -0.966 . . . . 1.46 108.392 177.334 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 967' ' ' VAL . . . . . 0.406 ' CG2' ' O ' ' B' ' 966' ' ' LEU . 98.3 t -158.18 96.86 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 108.051 -1.092 . . . . 1.9399999999999999 108.051 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 92.3 mmm -142.52 60.09 1.44 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.735 -1.228 . . . . 0.0 108.571 179.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.62 120.36 2.0 Allowed Glycine 0 N--CA 1.492 2.417 0 N-CA-C 107.259 -2.337 . . . . 2.1099999999999999 107.259 -178.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -81.83 -59.8 2.46 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.073 -1.251 . . . . 5.8899999999999997 110.222 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 50.9 tp -59.83 90.6 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.45 -0.781 . . . . 4.3600000000000003 109.912 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -141.06 -154.69 0.53 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.592 -0.693 . . . . 1.8300000000000001 110.408 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -118.72 171.3 8.3 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.526 -0.734 . . . . 4.3499999999999996 110.245 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 34.5 t -101.58 130.23 47.85 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.572 -0.705 . . . . 1.27 110.065 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -156.12 157.17 35.55 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.48 -0.762 . . . . 5.0199999999999996 110.473 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.17 85.67 18.45 Favored Pre-proline 0 N--CA 1.501 2.082 0 O-C-N 121.623 -0.673 . . . . 2.4100000000000001 109.745 179.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -73.37 -172.44 1.04 Allowed 'Trans proline' 0 C--N 1.318 -1.065 0 O-C-N 123.303 1.16 . . . . 0.95999999999999996 111.386 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 978' ' ' LEU . . . . . . . . . . . . . 4.9 mp -127.52 154.66 44.86 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 107.71 -1.218 . . . . 0.62 107.71 178.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 979' ' ' THR . . . . . . . . . . . . . 41.0 p -150.41 140.89 22.46 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.814 -1.179 . . . . 3.5699999999999998 111.088 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 980' ' ' ILE . . . . . . . . . . . . . 46.2 mm -107.31 128.73 62.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 109.064 -0.717 . . . . 1.3300000000000001 109.064 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -118.84 95.36 4.8 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 119.787 -0.765 . . . . 0.050000000000000003 111.86 -178.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 80.5 p -108.28 158.13 17.74 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.546 -0.721 . . . . 0.87 109.294 178.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 983' ' ' GLY . . . . . 0.413 ' HA3' ' CE1' ' B' ' 852' ' ' PHE . . . -174.76 110.57 0.33 Allowed Glycine 0 N--CA 1.498 2.782 0 N-CA-C 106.514 -2.634 . . . . 0.029999999999999999 106.514 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -108.22 150.58 27.08 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 114.43 1.27 . . . . 0.69999999999999996 114.43 -175.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 985' ' ' LEU . . . . . . . . . . . . . 33.5 tp -72.05 135.01 46.18 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.856 -1.153 . . . . 0.040000000000000001 110.052 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 986' ' ' LEU . . . . . . . . . . . . . 51.6 tp -107.46 -55.77 2.3 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.59 -0.694 . . . . 0.040000000000000001 110.101 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -144.62 145.65 31.89 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.719 -1.215 . . . . 0.040000000000000001 107.719 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.45 163.07 12.2 Favored Glycine 0 N--CA 1.495 2.628 0 N-CA-C 108.289 -1.924 . . . . 0.040000000000000001 108.289 179.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -75.04 112.47 18.18 Favored Pre-proline 0 N--CA 1.498 1.955 0 O-C-N 121.174 -1.192 . . . . 0.040000000000000001 109.475 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 990' ' ' PRO . . . . . 0.413 ' O ' ' HB2' ' B' ' 991' ' ' GLU . 49.8 Cg_endo -90.58 70.89 1.35 Allowed 'Trans proline' 0 C--N 1.318 -1.042 0 O-C-N 123.113 1.06 . . . . 0.45000000000000001 111.517 -178.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 991' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' B' ' 990' ' ' PRO . 69.4 mt-10 67.12 -73.68 0.08 Allowed 'General case' 0 N--CA 1.503 2.183 0 N-CA-C 108.633 -0.877 . . . . 1.97 108.633 -177.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 992' ' ' LEU . . . . . . . . . . . . . 11.1 mt 51.13 20.39 0.86 Allowed 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.552 -0.717 . . . . 2.3799999999999999 111.656 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -93.69 156.97 16.39 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.869 -1.145 . . . . 3.79 110.057 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 71.9 m80 -146.7 92.91 2.21 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.519 -0.738 . . . . 3.5099999999999998 110.415 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 995' ' ' ALA . . . . . . . . . . . . 2.517 . . . . . . . 0 N--CA 1.503 2.22 0 O-C-N 120.886 -1.134 . . . . 2.73 110.603 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo . . . . . 0 N--CA 1.489 1.221 0 N-CA-C 109.521 -0.992 . . . . 3.8300000000000001 109.521 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 847' ' ' VAL . . . . . . . . . . . . . 88.1 t -131.42 102.7 15.31 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.606 -0.684 . . . . 1.8300000000000001 110.131 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 848' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -70.2 -20.41 32.8 Favored 'Trans proline' 0 N--CA 1.487 1.138 0 O-C-N 123.278 1.146 . . . . 0.65000000000000002 111.016 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 849' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 27.29 69.17 0.06 Allowed 'General case' 0 N--CA 1.519 2.979 0 N-CA-C 112.884 0.698 . . . . 2.5800000000000001 112.884 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 850' ' ' VAL . . . . . . . . . . . . . 67.7 t -119.41 133.91 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.258 -0.901 . . . . 1.0900000000000001 111.64 -178.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 851' ' ' ALA . . . . . . . . . . . . . . . -129.88 152.97 48.77 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 105.627 -1.99 . . . . 0.040000000000000001 105.627 176.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 852' ' ' PHE . . . . . 0.413 ' HA ' ' CB ' ' C' ' 874' ' ' ASN . 6.0 p90 -160.31 128.76 4.76 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 120.921 1.691 . . . . 0.050000000000000003 108.589 179.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 29.8 t -175.67 134.32 0.29 Allowed 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.065 -1.087 . . . . 0.040000000000000001 108.065 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -134.64 156.91 47.92 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.136 -0.978 . . . . 0.67000000000000004 109.596 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 855' ' ' ALA . . . . . . . . . . . . . . . -121.83 139.71 53.28 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.864 0.84 . . . . 0.51000000000000001 111.667 -179.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 856' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -103.04 135.85 43.95 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.69 -0.631 . . . . 0.050000000000000003 109.422 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 857' ' ' SER . . . . . 0.413 ' O ' ' O ' ' C' ' 858' ' ' LEU . 37.3 p -151.38 15.85 0.71 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.487 -0.758 . . . . 1.3300000000000001 111.206 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 858' ' ' LEU . . . . . 0.413 ' O ' ' O ' ' C' ' 857' ' ' SER . 4.4 pp -33.56 157.47 0.04 OUTLIER Pre-proline 0 N--CA 1.518 2.97 0 N-CA-C 112.899 0.703 . . . . 2.3300000000000001 112.899 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -61.57 -89.27 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 120.897 1.064 . . . . 2.3199999999999998 113.575 -177.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 54.7 ptt85 -127.82 -141.86 0.26 Allowed 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.953 -1.092 . . . . 0.040000000000000001 111.289 -177.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 71.5 m -37.9 123.04 1.04 Allowed 'General case' 0 N--CA 1.51 2.567 0 O-C-N 121.575 -0.703 . . . . 1.3100000000000001 112.064 -179.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.55 158.41 31.95 Favored Pre-proline 0 N--CA 1.488 1.429 0 N-CA-C 108.192 -1.04 . . . . 4.5099999999999998 108.192 177.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.07 -14.58 32.03 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 123.187 1.099 . . . . 2.2400000000000002 111.034 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -176.98 -135.51 2.21 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.725 -1.35 . . . . 0.040000000000000001 109.725 179.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 25.8 m -69.05 154.22 42.44 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.331 -1.1 . . . . 1.51 110.47 -179.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 866' ' ' VAL . . . . . . . . . . . . . 32.7 m -90.68 139.39 26.33 Favored Pre-proline 0 N--CA 1.497 1.881 0 N-CA-C 113.66 0.985 . . . . 0.78000000000000003 113.66 -175.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 867' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -88.92 -152.69 0.04 OUTLIER 'Trans proline' 0 C--N 1.325 -0.662 0 N-CA-C 108.286 -1.467 . . . . 0.92000000000000004 108.286 177.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 868' ' ' PHE . . . . . 0.449 ' CD1' ' N ' ' C' ' 868' ' ' PHE . 23.0 p90 -148.15 120.18 8.25 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.513 -1.367 . . . . 0.050000000000000003 109.625 179.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 50.2 p-10 -113.02 -2.97 14.1 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 119.38 -0.928 . . . . 1.7 112.029 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 870' ' ' ARG . . . . . . . . . . . . . 24.8 mmm180 -90.51 86.88 6.55 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.03 -1.044 . . . . 2.5899999999999999 110.825 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 61.6 t -73.12 96.73 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.074 -1.016 . . . . 1.9399999999999999 109.566 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 872' ' ' LEU . . . . . 0.4 ' HB3' ' CD1' ' A' ' 953' ' ' ILE . 51.9 mt -86.17 -45.18 11.58 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.554 -0.716 . . . . 1.0600000000000001 110.338 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 873' ' ' LEU . . . . . 0.406 ' O ' ' HB2' ' C' ' 874' ' ' ASN . 49.3 tp -173.3 102.8 0.12 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.238 -0.914 . . . . 4.1799999999999997 108.791 178.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 874' ' ' ASN . . . . . 0.413 ' CB ' ' HA ' ' C' ' 852' ' ' PHE . 37.4 t-20 177.98 82.65 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.319 0 O-C-N 121.721 -0.612 . . . . 0.040000000000000001 109.374 -178.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -67.19 -47.41 71.0 Favored 'General case' 0 N--CA 1.497 1.92 0 C-N-CA 119.203 -0.999 . . . . 3.3799999999999999 111.434 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 876' ' ' GLY . . . . . . . . . . . . . . . -73.53 -26.97 68.51 Favored Glycine 0 N--CA 1.494 2.548 0 O-C-N 121.271 -0.893 . . . . 0.040000000000000001 111.66 -178.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 83.13 -60.18 4.91 Favored Glycine 0 N--CA 1.503 3.109 0 N-CA-C 108.061 -2.015 . . . . 0.040000000000000001 108.061 -178.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 878' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 61.41 -66.19 0.06 Allowed 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 114.239 1.2 . . . . 3.46 114.239 177.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 879' ' ' TYR . . . . . 0.471 ' CB ' ' CD2' ' C' ' 886' ' ' PHE . 23.9 p90 -113.92 110.02 19.43 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 114.859 1.429 . . . . 0.040000000000000001 114.859 -176.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -66.83 117.98 50.43 Favored Pre-proline 0 N--CA 1.499 2.018 0 O-C-N 121.434 -0.791 . . . . 0.02 109.897 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 881' ' ' PRO . . . . . 0.447 ' HG2' ' CD1' ' C' ' 868' ' ' PHE . 55.3 Cg_endo -77.43 -0.26 10.44 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 O-C-N 123.386 1.203 . . . . 0.39000000000000001 112.141 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -74.58 -63.31 1.27 Allowed 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 106.538 -1.652 . . . . 0.81000000000000005 106.538 178.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 8.9 p -95.61 -17.62 21.21 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.704 -0.85 . . . . 0.040000000000000001 108.704 177.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.78 20.58 59.43 Favored Glycine 0 N--CA 1.495 2.631 0 O-C-N 121.024 -1.047 . . . . 0.029999999999999999 111.165 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 92.4 t -72.02 90.26 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 C-N-CA 118.135 -1.426 . . . . 1.01 108.019 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 886' ' ' PHE . . . . . 0.471 ' CD2' ' CB ' ' C' ' 879' ' ' TYR . 0.8 OUTLIER -90.93 104.77 17.32 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-N 115.268 -0.878 . . . . 0.050000000000000003 112.037 -177.259 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 887' ' ' THR . . . . . 0.409 ' O ' ' HD3' ' C' ' 889' ' ' PRO . 86.5 m -95.97 101.49 13.16 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 107.697 -1.223 . . . . 0.68000000000000005 107.697 177.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 888' ' ' ALA . . . . . . . . . . . . . . . -98.38 107.01 39.56 Favored Pre-proline 0 N--CA 1.502 2.155 0 N-CA-C 113.998 1.11 . . . . 0.25 113.998 -176.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 889' ' ' PRO . . . . . 0.409 ' HD3' ' O ' ' C' ' 887' ' ' THR . 53.6 Cg_endo -90.03 -13.26 2.59 Favored 'Trans proline' 0 CA--C 1.546 1.095 0 C-N-CA 120.975 1.117 . . . . 1.6399999999999999 109.228 176.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 890' ' ' LEU . . . . . . . . . . . . . 75.6 mt -38.7 -49.33 1.57 Allowed 'General case' 0 N--CA 1.507 2.382 0 N-CA-C 113.719 1.007 . . . . 2.29 113.719 -177.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 52.85 96.78 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.351 0 O-C-N 121.081 -1.012 . . . . 0.63 110.044 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . 155.79 -146.87 14.91 Favored Glycine 0 N--CA 1.48 1.568 0 N-CA-C 107.096 -2.402 . . . . 0.040000000000000001 107.096 -178.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 74.4 ttt-85 -107.17 129.32 54.87 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 107.947 -1.131 . . . . 3.0 107.947 177.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 894' ' ' TYR . . . . . 0.451 ' CD1' ' N ' ' C' ' 895' ' ' LEU . 0.4 OUTLIER -129.53 142.94 50.65 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.064 -1.022 . . . . 0.040000000000000001 110.086 -179.254 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 895' ' ' LEU . . . . . 0.451 ' N ' ' CD1' ' C' ' 894' ' ' TYR . 34.6 tp -102.08 115.39 30.44 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.632 -0.667 . . . . 1.27 109.597 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 896' ' ' LEU . . . . . 0.422 ' HB2' ' CZ ' ' C' ' 894' ' ' TYR . 10.3 tt -112.69 146.76 38.13 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.549 -0.719 . . . . 0.93999999999999995 110.594 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 897' ' ' SER . . . . . . . . . . . . . 8.3 m -141.4 117.26 10.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.523 -0.736 . . . . 0.040000000000000001 110.494 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -106.61 147.19 29.79 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.126 -0.694 . . . . 0.47999999999999998 109.126 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 899' ' ' VAL . . . . . . . . . . . . . 88.9 t -93.56 119.42 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 C-N-CA 119.729 -0.788 . . . . 0.55000000000000004 111.133 -179.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 96.7 mt -93.66 111.53 23.23 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 114.1 1.148 . . . . 1.5900000000000001 114.1 -175.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 16.7 m -64.12 140.12 58.84 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 107.32 -1.363 . . . . 0.050000000000000003 107.32 177.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -61.18 -64.48 4.01 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.29 -1.124 . . . . 0.029999999999999999 110.29 -179.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 45.18 63.77 1.63 Allowed 'General case' 0 N--CA 1.507 2.409 0 O-C-N 121.57 -0.959 . . . . 3.2000000000000002 111.323 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 41.9 ptt85 -67.26 -7.9 27.77 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.573 -0.704 . . . . 2.9199999999999999 111.895 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 905' ' ' HIS . . . . . 0.49 ' O ' ' CB ' ' C' ' 906' ' ' GLU . 74.0 t60 -61.3 5.15 0.07 Allowed 'General case' 0 N--CA 1.505 2.302 0 CA-C-O 117.601 -1.19 . . . . 2.8700000000000001 113.488 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 906' ' ' GLU . . . . . 0.49 ' CB ' ' O ' ' C' ' 905' ' ' HIS . 0.7 OUTLIER 92.58 -163.43 0.01 OUTLIER 'General case' 0 N--CA 1.528 3.447 0 CA-C-N 121.294 1.861 . . . . 0.98999999999999999 112.239 178.919 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 907' ' ' LYS . . . . . 0.488 ' CB ' ' O ' ' C' ' 906' ' ' GLU . 72.4 tttt 89.82 161.96 0.05 OUTLIER 'General case' 0 N--CA 1.52 3.065 0 N-CA-C 108.171 -1.048 . . . . 5.25 108.171 -177.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 59.4 t -122.69 115.39 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 120.927 -1.108 . . . . 0.39000000000000001 110.857 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 47.1 tt0 -108.07 129.99 55.11 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 107.644 -1.243 . . . . 1.72 107.644 177.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -155.93 120.83 4.71 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 106.8 -1.556 . . . . 0.67000000000000004 106.8 178.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 911' ' ' VAL . . . . . 0.453 ' HA ' ' HA ' ' C' ' 964' ' ' VAL . 13.3 p -77.3 131.09 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.79 -0.569 . . . . 0.54000000000000004 111.346 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 46.4 mt -67.81 157.62 34.37 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.284 -0.885 . . . . 1.5 108.717 178.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 913' ' ' SER . . . . . . . . . . . . . 1.6 p -123.72 139.56 53.87 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.67 -0.863 . . . . 1.3700000000000001 108.67 177.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 914' ' ' ARG . . . . . 0.425 ' O ' ' CB ' ' C' ' 915' ' ' SER . 0.0 OUTLIER -65.02 154.1 38.75 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 120.643 -1.286 . . . . 4.2999999999999998 111.568 -179.104 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 915' ' ' SER . . . . . 0.425 ' CB ' ' O ' ' C' ' 914' ' ' ARG . 4.4 t 83.28 -31.25 0.08 Allowed 'General case' 0 N--CA 1.522 3.164 0 C-N-CA 123.916 0.886 . . . . 2.0499999999999998 112.23 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 916' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -121.85 -22.01 5.89 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.889 -1.132 . . . . 2.71 111.226 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 66.99 166.93 0.23 Allowed 'General case' 0 N--CA 1.52 3.04 0 N-CA-C 105.802 -1.925 . . . . 2.6800000000000002 105.802 -174.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.64 -126.38 37.43 Favored Glycine 1 N--CA 1.521 4.344 0 CA-C-N 123.598 2.908 . . . . 0.029999999999999999 107.051 -177.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 919' ' ' VAL . . . . . . . . . . . . . 92.1 t 51.57 93.53 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.238 0 O-C-N 121.307 -1.114 . . . . 1.3899999999999999 109.129 -178.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 920' ' ' ALA . . . . . . . . . . . . . . . -93.42 93.82 8.36 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.332 -0.947 . . . . 0.029999999999999999 110.714 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 921' ' ' ARG . . . . . 0.427 ' HB3' ' CZ ' ' C' ' 950' ' ' PHE . 20.1 ptt85 -80.39 -41.83 23.9 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 105.938 -1.875 . . . . 4.4199999999999999 105.938 176.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 922' ' ' VAL . . . . . . . . . . . . . 90.5 t -101.86 75.11 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 106.088 -1.819 . . . . 0.84999999999999998 106.088 175.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -89.79 135.89 33.36 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.872 0.844 . . . . 2.46 112.355 -176.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 7.9 t -147.16 102.76 3.53 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.063 -1.088 . . . . 0.69999999999999996 108.063 178.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -110.83 88.95 0.53 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.967 -1.653 . . . . 0.040000000000000001 108.967 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.4 0 N-CA-C 109.353 -1.499 . . . . 0.040000000000000001 109.353 -179.713 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 11.2 m . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 120.962 0.411 . . . . 13.779999999999999 110.318 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 95.3 mt -114.22 129.77 56.63 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.505 -0.747 . . . . 13.76 110.319 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -152.16 170.34 31.47 Favored Glycine 0 N--CA 1.493 2.5 0 N-CA-C 109.398 -1.481 . . . . 9.1300000000000008 109.398 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 949' ' ' VAL . . . . . . . . . . . . . 33.7 m -117.17 136.39 54.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.538 -0.977 . . . . 7.0800000000000001 110.832 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 950' ' ' PHE . . . . . 0.427 ' CZ ' ' HB3' ' C' ' 921' ' ' ARG . 36.0 p90 -135.57 152.25 51.09 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.607 -0.683 . . . . 7.5899999999999999 109.622 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 69.4 m -118.32 -54.44 2.29 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.386 -0.821 . . . . 5.0300000000000002 111.514 -179.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 952' ' ' LEU . . . . . 0.448 ' O ' ' O ' ' C' ' 953' ' ' ILE . 46.6 tp -63.78 -77.03 0.06 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.46 -0.775 . . . . 1.01 111.421 -178.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 953' ' ' ILE . . . . . 0.48 ' O ' ' HB3' ' C' ' 954' ' ' LEU . 2.3 pp -49.45 -152.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.735 0 N-CA-C 114.324 1.231 . . . . 2.6000000000000001 114.324 -176.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 954' ' ' LEU . . . . . 0.549 ' N ' ' CD1' ' C' ' 954' ' ' LEU . 0.0 OUTLIER 169.11 92.09 0.03 OUTLIER Pre-proline 0 N--CA 1.516 2.869 0 O-C-N 120.949 -1.094 . . . . 0.050000000000000003 111.651 179.491 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 955' ' ' PRO . . . . . 0.421 ' HD2' ' CZ ' ' C' ' 950' ' ' PHE . 52.1 Cg_endo -80.4 93.0 1.05 Allowed 'Trans proline' 0 C--N 1.317 -1.117 0 N-CA-C 109.138 -1.139 . . . . 0.83999999999999997 109.138 178.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 956' ' ' LEU . . . . . . . . . . . . . 10.9 mp -122.85 144.01 49.49 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.014 -1.054 . . . . 0.040000000000000001 110.144 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -82.11 151.33 27.05 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 117.708 -1.139 . . . . 1.28 111.287 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -67.15 118.63 10.83 Favored 'General case' 0 N--CA 1.508 2.45 0 CA-C-N 123.078 2.672 . . . . 0.17000000000000001 111.082 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.42 -20.43 44.1 Favored Glycine 0 N--CA 1.499 2.888 0 N-CA-C 110.872 -0.891 . . . . 0.040000000000000001 110.872 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 960' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.63 169.69 0.13 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.381 -1.07 . . . . 0.040000000000000001 110.125 -179.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 961' ' ' THR . . . . . 0.462 ' HA ' ' O ' ' C' ' 886' ' ' PHE . 71.1 p -133.41 137.66 45.9 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.056 -1.027 . . . . 1.78 112.167 -177.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 962' ' ' VAL . . . . . 0.436 ' CG2' ' CB ' ' C' ' 886' ' ' PHE . 25.4 m -97.31 146.46 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 C-N-CA 120.13 -0.628 . . . . 0.040000000000000001 110.184 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 5.5 t -138.59 145.23 40.32 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.952 -0.468 . . . . 0.71999999999999997 109.989 -178.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 964' ' ' VAL . . . . . 0.453 ' HA ' ' HA ' ' C' ' 911' ' ' VAL . 65.1 t -97.27 136.0 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.034 -1.041 . . . . 1.05 110.578 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -97.37 125.61 42.09 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 103.906 -2.627 . . . . 3.02 103.906 173.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 966' ' ' LEU . . . . . 0.401 ' O ' ' CG2' ' C' ' 967' ' ' VAL . 1.1 tp -133.11 62.95 1.65 Allowed 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.296 -1.002 . . . . 1.46 108.296 177.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 967' ' ' VAL . . . . . 0.401 ' CG2' ' O ' ' C' ' 966' ' ' LEU . 97.3 t -157.64 97.44 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 108.224 -1.028 . . . . 1.9399999999999999 108.224 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 95.7 mmm -141.9 59.98 1.48 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.741 -1.224 . . . . 0.0 108.541 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.07 119.99 1.99 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 107.235 -2.346 . . . . 2.1099999999999999 107.235 -178.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -82.23 -58.55 2.9 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.053 -1.263 . . . . 5.8899999999999997 110.507 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 49.0 tp -59.43 89.94 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.448 -0.782 . . . . 4.3600000000000003 110.261 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -142.16 -152.66 0.42 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.622 -0.673 . . . . 1.8300000000000001 110.09 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -117.36 167.62 11.09 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.462 -0.774 . . . . 4.3499999999999996 110.022 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 10.3 t -101.7 130.56 48.11 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.557 -0.714 . . . . 1.27 110.2 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -155.96 153.85 30.22 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.532 -0.73 . . . . 5.0199999999999996 110.384 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.27 86.23 14.76 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.588 -0.695 . . . . 2.4100000000000001 109.897 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -75.76 -170.55 0.85 Allowed 'Trans proline' 0 C--N 1.318 -1.07 0 O-C-N 123.324 1.17 . . . . 0.95999999999999996 111.223 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 978' ' ' LEU . . . . . . . . . . . . . 5.0 mp -123.56 156.23 36.11 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 107.497 -1.297 . . . . 0.62 107.497 177.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 979' ' ' THR . . . . . . . . . . . . . 40.6 p -150.54 141.66 23.09 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.779 -1.2 . . . . 3.5699999999999998 111.251 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 980' ' ' ILE . . . . . . . . . . . . . 50.1 mm -106.08 128.55 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 109.216 -0.661 . . . . 1.3300000000000001 109.216 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 981' ' ' PHE . . . . . 0.436 ' CD1' ' CE2' ' C' ' 879' ' ' TYR . 2.3 t80 -118.15 97.29 5.72 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.499 -0.751 . . . . 0.050000000000000003 111.256 -178.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 982' ' ' SER . . . . . . . . . . . . . 18.2 p -108.41 159.85 16.35 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.081 -0.711 . . . . 0.87 109.081 178.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 983' ' ' GLY . . . . . 0.411 ' O ' ' CE2' ' C' ' 852' ' ' PHE . . . -169.04 115.01 0.58 Allowed Glycine 0 N--CA 1.497 2.764 0 N-CA-C 106.526 -2.629 . . . . 0.029999999999999999 106.526 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 984' ' ' ALA . . . . . 0.403 ' CB ' ' CZ ' ' A' ' 893' ' ' ARG . . . -109.26 147.95 31.78 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.156 -1.203 . . . . 0.69999999999999996 114.169 -175.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 985' ' ' LEU . . . . . . . . . . . . . 51.4 tp -75.38 135.06 40.82 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.809 -1.182 . . . . 0.040000000000000001 109.425 179.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 986' ' ' LEU . . . . . . . . . . . . . 48.4 tp -107.1 -61.71 1.51 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.477 -0.764 . . . . 0.040000000000000001 110.495 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -144.92 146.31 31.94 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 107.841 -1.17 . . . . 0.040000000000000001 107.841 179.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.25 162.82 12.28 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 108.097 -2.001 . . . . 0.040000000000000001 108.097 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -74.6 112.81 19.07 Favored Pre-proline 0 N--CA 1.498 1.967 0 O-C-N 121.206 -1.173 . . . . 0.040000000000000001 109.455 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 990' ' ' PRO . . . . . 0.41 ' O ' ' HB2' ' C' ' 991' ' ' GLU . 50.5 Cg_endo -88.76 70.98 2.38 Favored 'Trans proline' 0 C--N 1.32 -0.937 0 O-C-N 123.115 1.061 . . . . 0.45000000000000001 111.303 -178.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 991' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' C' ' 990' ' ' PRO . 67.7 mt-10 67.51 -73.31 0.08 Allowed 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 108.582 -0.895 . . . . 1.97 108.582 -177.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 992' ' ' LEU . . . . . . . . . . . . . 11.4 mt 50.45 20.83 0.74 Allowed 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.567 -0.708 . . . . 2.3799999999999999 111.69 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -92.91 157.01 16.58 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.936 -1.103 . . . . 3.79 110.055 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -146.32 92.0 2.12 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.579 -0.701 . . . . 3.5099999999999998 110.254 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 995' ' ' ALA . . . . . . . . . . . . 2.518 . . . . . . . 0 N--CA 1.504 2.23 0 O-C-N 120.913 -1.117 . . . . 2.73 110.564 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo . . . . . 0 N--CA 1.488 1.199 0 N-CA-C 109.451 -1.019 . . . . 3.8300000000000001 109.451 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 847' ' ' VAL . . . . . . . . . . . . . 66.6 t -134.93 102.82 10.98 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.617 -0.677 . . . . 1.8300000000000001 110.004 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 848' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.83 -18.66 36.56 Favored 'Trans proline' 0 N--CA 1.488 1.155 0 O-C-N 123.344 1.181 . . . . 0.65000000000000002 111.168 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 849' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 27.39 67.97 0.07 Allowed 'General case' 0 N--CA 1.518 2.927 0 N-CA-C 113.025 0.75 . . . . 2.5800000000000001 113.025 179.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 850' ' ' VAL . . . . . . . . . . . . . 69.9 t -119.39 137.02 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 121.202 -0.936 . . . . 1.0900000000000001 111.442 -178.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 851' ' ' ALA . . . . . . . . . . . . . . . -124.13 159.0 30.99 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 105.827 -1.916 . . . . 0.040000000000000001 105.827 176.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 852' ' ' PHE . . . . . 0.411 ' CE1' ' HA3' ' A' ' 983' ' ' GLY . 32.7 p90 -159.6 127.96 4.99 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 120.948 1.704 . . . . 0.050000000000000003 108.492 178.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 7.8 t -175.71 134.42 0.29 Allowed 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.152 -1.055 . . . . 0.040000000000000001 108.152 -178.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -131.98 157.41 44.15 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.083 -1.011 . . . . 0.67000000000000004 109.626 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 855' ' ' ALA . . . . . 0.405 ' O ' ' HB2' ' A' ' 870' ' ' ARG . . . -120.78 146.1 46.86 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-O 122.018 0.914 . . . . 0.51000000000000001 111.291 -178.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 856' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -113.01 133.36 54.99 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.738 -0.601 . . . . 0.050000000000000003 109.872 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 857' ' ' SER . . . . . 0.423 ' O ' ' O ' ' A' ' 858' ' ' LEU . 30.3 p -154.37 14.6 0.44 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.526 -0.734 . . . . 1.3300000000000001 111.683 179.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 858' ' ' LEU . . . . . 0.423 ' O ' ' O ' ' A' ' 857' ' ' SER . 4.5 pp -33.22 159.64 0.03 OUTLIER Pre-proline 0 N--CA 1.52 3.028 0 N-CA-C 113.427 0.899 . . . . 2.3300000000000001 113.427 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -61.85 -88.29 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 120.965 1.11 . . . . 2.3199999999999998 113.316 -178.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 53.6 ptt85 -128.01 -142.47 0.27 Allowed 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.887 -1.133 . . . . 0.040000000000000001 111.397 -177.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 8.8 m -41.28 129.04 2.99 Favored 'General case' 0 N--CA 1.509 2.498 0 O-C-N 121.459 -0.776 . . . . 1.3100000000000001 111.902 -179.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -94.81 152.77 39.96 Favored Pre-proline 0 N--CA 1.492 1.626 0 N-CA-C 108.107 -1.071 . . . . 4.5099999999999998 108.107 177.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -70.27 -12.22 31.55 Favored 'Trans proline' 0 C--N 1.314 -1.271 0 O-C-N 123.059 1.031 . . . . 2.2400000000000002 111.161 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -175.74 -136.07 2.25 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 110.107 -1.197 . . . . 0.040000000000000001 110.107 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 39.9 m -64.38 155.77 31.37 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.382 -1.07 . . . . 1.51 111.331 -178.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 2.7 t -91.12 128.07 48.97 Favored Pre-proline 0 N--CA 1.5 2.059 0 N-CA-C 113.399 0.889 . . . . 0.78000000000000003 113.399 -174.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 867' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -92.05 -155.62 0.05 OUTLIER 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 121.174 1.25 . . . . 0.92000000000000004 109.516 177.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 868' ' ' PHE . . . . . 0.445 ' N ' ' CD1' ' A' ' 868' ' ' PHE . 21.1 p90 -151.73 123.64 8.06 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.654 -1.279 . . . . 0.050000000000000003 109.994 179.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 44.0 p30 -114.62 -0.72 13.55 Favored 'General case' 0 N--CA 1.501 2.109 0 C-N-CA 119.345 -0.942 . . . . 1.7 112.762 -178.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 870' ' ' ARG . . . . . 0.405 ' HB2' ' O ' ' A' ' 855' ' ' ALA . 26.9 mmm180 -90.97 90.47 7.9 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 120.845 -1.16 . . . . 2.5899999999999999 111.099 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 60.4 t -74.7 97.13 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 120.978 -1.076 . . . . 1.9399999999999999 109.911 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 872' ' ' LEU . . . . . . . . . . . . . 96.3 mt -83.2 -46.81 12.27 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.468 -0.77 . . . . 1.0600000000000001 110.131 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 873' ' ' LEU . . . . . . . . . . . . . 36.9 tp -174.52 102.98 0.1 Allowed 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.521 -0.918 . . . . 4.1799999999999997 108.521 178.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 35.4 t-20 178.73 80.86 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.3 0 O-C-N 121.622 -0.674 . . . . 0.040000000000000001 109.555 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -66.7 -47.27 72.92 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.211 -0.931 . . . . 3.3799999999999999 111.204 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 876' ' ' GLY . . . . . . . . . . . . . . . -73.56 -24.86 73.86 Favored Glycine 0 N--CA 1.494 2.555 0 O-C-N 121.306 -0.871 . . . . 0.040000000000000001 111.509 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 84.0 -59.93 4.9 Favored Glycine 0 N--CA 1.502 3.041 0 N-CA-C 108.088 -2.005 . . . . 0.040000000000000001 108.088 -178.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 878' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 60.78 -65.79 0.06 Allowed 'General case' 0 N--CA 1.503 2.22 0 N-CA-C 114.206 1.188 . . . . 3.46 114.206 177.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 879' ' ' TYR . . . . . 0.478 ' CB ' ' CD2' ' A' ' 886' ' ' PHE . 21.0 p90 -112.73 109.35 18.79 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 114.833 1.42 . . . . 0.040000000000000001 114.833 -176.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.42 116.77 37.28 Favored Pre-proline 0 N--CA 1.496 1.825 0 O-C-N 121.381 -0.825 . . . . 0.02 109.647 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 881' ' ' PRO . . . . . 0.425 ' HG2' ' CD1' ' A' ' 868' ' ' PHE . 53.6 Cg_endo -75.59 -0.02 9.67 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 O-C-N 123.492 1.259 . . . . 0.39000000000000001 112.493 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -75.99 -63.15 1.38 Allowed 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 106.723 -1.584 . . . . 0.81000000000000005 106.723 178.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 41.1 p -94.1 -20.23 20.1 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.482 -0.933 . . . . 0.040000000000000001 108.482 177.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.21 20.94 58.08 Favored Glycine 0 N--CA 1.495 2.573 0 O-C-N 121.034 -1.041 . . . . 0.029999999999999999 111.385 178.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 885' ' ' VAL . . . . . . . . . . . . . 99.3 t -73.67 91.81 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 C-N-CA 118.103 -1.439 . . . . 1.01 108.196 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 886' ' ' PHE . . . . . 0.478 ' CD2' ' CB ' ' A' ' 879' ' ' TYR . 0.7 OUTLIER -89.87 104.75 17.29 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-N 115.118 -0.946 . . . . 0.050000000000000003 112.092 -177.143 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 887' ' ' THR . . . . . 0.423 ' O ' ' HD3' ' A' ' 889' ' ' PRO . 93.7 m -96.29 100.42 12.05 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 107.685 -1.228 . . . . 0.68000000000000005 107.685 177.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 888' ' ' ALA . . . . . . . . . . . . . . . -98.62 105.95 33.61 Favored Pre-proline 0 N--CA 1.502 2.132 0 N-CA-C 114.279 1.215 . . . . 0.25 114.279 -176.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 889' ' ' PRO . . . . . 0.423 ' HD3' ' O ' ' A' ' 887' ' ' THR . 54.1 Cg_endo -89.0 -13.37 3.09 Favored 'Trans proline' 0 CA--C 1.546 1.105 0 N-CA-C 108.935 -1.217 . . . . 1.6399999999999999 108.935 175.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 890' ' ' LEU . . . . . . . . . . . . . 69.3 mt -36.54 -49.97 0.77 Allowed 'General case' 0 N--CA 1.508 2.47 0 N-CA-C 113.612 0.967 . . . . 2.29 113.612 -177.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 52.09 96.03 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.189 -0.944 . . . . 0.63 110.289 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 158.0 -153.61 24.78 Favored Glycine 0 N--CA 1.478 1.468 0 N-CA-C 107.227 -2.349 . . . . 0.040000000000000001 107.227 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 893' ' ' ARG . . . . . 0.4 ' CZ ' ' CB ' ' C' ' 984' ' ' ALA . 72.9 ttt-85 -115.7 126.39 54.05 Favored 'General case' 0 C--N 1.294 -1.82 0 O-C-N 121.601 -0.94 . . . . 3.0 108.512 177.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 894' ' ' TYR . . . . . 0.42 ' CZ ' ' HB2' ' A' ' 896' ' ' LEU . 0.1 OUTLIER -132.26 159.99 37.49 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.177 -0.952 . . . . 0.040000000000000001 111.038 -179.74 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 895' ' ' LEU . . . . . . . . . . . . . 37.8 tp -91.77 118.49 30.74 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.69 -0.631 . . . . 1.27 110.168 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 896' ' ' LEU . . . . . 0.42 ' HB2' ' CZ ' ' A' ' 894' ' ' TYR . 9.2 tt -110.05 142.16 41.88 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.707 -0.621 . . . . 0.93999999999999995 110.047 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 897' ' ' SER . . . . . . . . . . . . . 64.1 m -148.9 115.51 5.92 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.452 -0.78 . . . . 0.040000000000000001 110.982 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.61 146.18 32.3 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.892 -0.781 . . . . 0.47999999999999998 108.892 178.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 899' ' ' VAL . . . . . 0.4 ' CG2' ' HB ' ' A' ' 980' ' ' ILE . 87.5 t -94.73 120.39 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.373 -0.829 . . . . 0.55000000000000004 111.033 -179.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 900' ' ' LEU . . . . . 0.442 ' CD2' ' N ' ' A' ' 900' ' ' LEU . 4.3 mm? -95.23 112.8 24.46 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 114.382 1.252 . . . . 1.5900000000000001 114.382 -174.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 15.6 m -66.85 141.53 57.65 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 107.334 -1.358 . . . . 0.050000000000000003 107.334 176.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -67.02 -65.83 2.62 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 110.583 -1.007 . . . . 0.029999999999999999 110.583 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 8.8 m170 46.72 66.7 0.92 Allowed 'General case' 0 N--CA 1.508 2.437 0 O-C-N 121.493 -1.004 . . . . 3.2000000000000002 111.155 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 43.2 ptt85 -69.38 -5.88 26.38 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.624 -0.672 . . . . 2.9199999999999999 112.108 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 905' ' ' HIS . . . . . 0.487 ' O ' ' CB ' ' A' ' 906' ' ' GLU . 72.7 t60 -62.32 5.03 0.12 Allowed 'General case' 0 N--CA 1.506 2.335 0 O-C-N 120.918 -1.114 . . . . 2.8700000000000001 113.155 -179.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 906' ' ' GLU . . . . . 0.487 ' CB ' ' O ' ' A' ' 905' ' ' HIS . 0.5 OUTLIER 94.63 -164.29 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.449 0 CA-C-N 120.562 1.528 . . . . 0.98999999999999999 111.824 179.007 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 907' ' ' LYS . . . . . 0.465 ' CB ' ' O ' ' A' ' 906' ' ' GLU . 63.1 tttt 85.59 156.59 0.09 Allowed 'General case' 0 N--CA 1.52 3.031 0 N-CA-C 108.024 -1.102 . . . . 5.25 108.024 -176.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 58.9 t -122.02 116.38 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 120.787 -1.196 . . . . 0.39000000000000001 111.099 -179.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -99.82 133.21 44.52 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 107.319 -1.363 . . . . 1.72 107.319 176.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -155.92 121.94 5.04 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 106.842 -1.54 . . . . 0.67000000000000004 106.842 178.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 911' ' ' VAL . . . . . 0.467 ' HA ' ' HA ' ' A' ' 964' ' ' VAL . 87.3 t -84.06 132.15 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.86 -0.525 . . . . 0.54000000000000004 110.783 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 62.2 mt -65.63 156.42 32.84 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.404 -0.81 . . . . 1.5 109.025 178.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 913' ' ' SER . . . . . 0.413 ' CB ' ' CG1' ' A' ' 919' ' ' VAL . 1.3 t -123.02 138.4 54.7 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.316 -0.994 . . . . 1.3700000000000001 108.316 177.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 914' ' ' ARG . . . . . 0.426 ' O ' ' CB ' ' A' ' 915' ' ' SER . 0.0 OUTLIER -65.15 154.79 36.94 Favored 'General case' 0 N--CA 1.505 2.284 0 O-C-N 120.762 -1.211 . . . . 4.2999999999999998 111.751 -179.049 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 915' ' ' SER . . . . . 0.426 ' CB ' ' O ' ' A' ' 914' ' ' ARG . 4.7 t 83.07 -32.71 0.08 Allowed 'General case' 0 N--CA 1.522 3.136 0 C-N-CA 123.979 0.911 . . . . 2.0499999999999998 112.254 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -121.1 -20.46 6.79 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.947 -1.095 . . . . 2.71 111.469 -179.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 917' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 66.82 165.04 0.21 Allowed 'General case' 0 N--CA 1.521 3.111 0 N-CA-C 105.452 -2.055 . . . . 2.6800000000000002 105.452 -173.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.33 -125.38 33.82 Favored Glycine 1 N--CA 1.521 4.357 0 CA-C-N 123.545 2.884 . . . . 0.029999999999999999 106.987 -177.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 919' ' ' VAL . . . . . 0.413 ' CG1' ' CB ' ' A' ' 913' ' ' SER . 78.6 t 51.58 94.9 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 O-C-N 121.513 -0.992 . . . . 1.3899999999999999 108.996 -178.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.38 92.29 8.51 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.246 -0.982 . . . . 0.029999999999999999 110.902 -179.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 921' ' ' ARG . . . . . 0.426 ' HB2' ' CE1' ' A' ' 950' ' ' PHE . 27.5 ptt180 -83.9 -41.76 17.07 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 105.756 -1.942 . . . . 4.4199999999999999 105.756 175.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 922' ' ' VAL . . . . . . . . . . . . . 78.7 t -102.19 73.44 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 106.308 -1.738 . . . . 0.84999999999999998 106.308 175.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -86.82 133.75 33.61 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.643 0.735 . . . . 2.46 111.231 -177.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 28.0 t -147.83 105.9 3.74 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.907 -0.775 . . . . 0.69999999999999996 108.907 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -102.91 83.65 0.44 Allowed Glycine 0 N--CA 1.487 2.043 0 N-CA-C 108.277 -1.929 . . . . 0.040000000000000001 108.277 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.126 0 N-CA-C 108.67 -1.772 . . . . 0.040000000000000001 108.67 -179.709 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 33.0 m . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.012 0.434 . . . . 13.779999999999999 110.21 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 96.2 mt -112.44 129.44 56.32 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.666 -0.646 . . . . 13.76 110.365 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -152.34 168.03 31.41 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 108.967 -1.653 . . . . 9.1300000000000008 108.967 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 949' ' ' VAL . . . . . . . . . . . . . 34.9 m -119.38 130.77 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.502 -0.999 . . . . 7.0800000000000001 110.998 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 950' ' ' PHE . . . . . 0.432 ' CE1' ' HD2' ' A' ' 955' ' ' PRO . 25.5 p90 -133.24 150.51 51.94 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.565 -0.709 . . . . 7.5899999999999999 109.149 179.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 19.5 m -120.66 -53.19 2.1 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.341 -0.85 . . . . 5.0300000000000002 112.314 -178.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 952' ' ' LEU . . . . . 0.427 ' O ' ' O ' ' A' ' 953' ' ' ILE . 13.6 tp -60.39 -73.01 0.1 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.411 -0.805 . . . . 1.01 112.576 -177.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 953' ' ' ILE . . . . . 0.473 ' O ' ' HB3' ' A' ' 954' ' ' LEU . 46.1 pt -52.6 -145.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.768 0 N-CA-C 114.06 1.133 . . . . 2.6000000000000001 114.06 -176.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 954' ' ' LEU . . . . . 0.548 ' N ' ' CD1' ' A' ' 954' ' ' LEU . 0.0 OUTLIER 171.84 77.45 0.04 OUTLIER Pre-proline 0 N--CA 1.51 2.554 0 O-C-N 120.768 -1.208 . . . . 0.050000000000000003 111.461 179.555 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 955' ' ' PRO . . . . . 0.432 ' HD2' ' CE1' ' A' ' 950' ' ' PHE . 48.4 Cg_endo -74.88 96.41 1.01 Allowed 'Trans proline' 0 C--N 1.315 -1.227 0 N-CA-C 109.521 -0.992 . . . . 0.83999999999999997 109.521 178.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 956' ' ' LEU . . . . . . . . . . . . . 10.4 mp -123.03 145.68 48.31 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.197 -0.939 . . . . 0.040000000000000001 110.214 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -83.71 150.41 25.86 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 117.773 -1.108 . . . . 1.28 111.675 -179.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -70.4 119.87 15.22 Favored 'General case' 0 N--CA 1.51 2.526 0 CA-C-N 122.967 2.621 . . . . 0.17000000000000001 111.558 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.6 -22.77 31.5 Favored Glycine 0 N--CA 1.501 3.008 0 N-CA-C 111.16 -0.776 . . . . 0.040000000000000001 111.16 178.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 960' ' ' ASP . . . . . 0.404 ' HB3' ' NE ' ' A' ' 914' ' ' ARG . 0.6 OUTLIER -52.14 172.14 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.49 -1.006 . . . . 0.040000000000000001 110.403 -179.409 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 961' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 886' ' ' PHE . 7.2 t -134.77 134.6 41.11 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.008 -1.058 . . . . 1.78 111.849 -178.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 962' ' ' VAL . . . . . 0.429 ' CG2' ' CB ' ' A' ' 886' ' ' PHE . 31.7 m -99.01 145.91 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 C-N-CA 120.074 -0.65 . . . . 0.040000000000000001 110.44 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 5.3 t -139.0 145.24 39.43 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.853 -0.529 . . . . 0.71999999999999997 110.115 -178.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 964' ' ' VAL . . . . . 0.467 ' HA ' ' HA ' ' A' ' 911' ' ' VAL . 55.5 t -94.12 136.57 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.105 -0.997 . . . . 1.05 110.714 -179.16 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -95.81 126.79 41.31 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 103.665 -2.717 . . . . 3.02 103.665 173.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 966' ' ' LEU . . . . . 0.408 ' O ' ' CG2' ' A' ' 967' ' ' VAL . 20.8 tp -132.6 62.35 1.65 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.304 -0.999 . . . . 1.46 108.304 177.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 967' ' ' VAL . . . . . 0.408 ' CG2' ' O ' ' A' ' 966' ' ' LEU . 89.9 t -158.21 97.19 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 108.049 -1.093 . . . . 1.9399999999999999 108.049 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 88.8 mmm -142.99 59.37 1.42 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.737 -1.227 . . . . 0.0 108.184 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.44 119.91 1.96 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 106.957 -2.457 . . . . 2.1099999999999999 106.957 -178.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -81.55 -57.9 3.26 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 118.696 1.248 . . . . 5.8899999999999997 110.368 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 44.2 tp -58.82 90.58 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.501 -0.75 . . . . 4.3600000000000003 110.203 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -141.43 -155.02 0.55 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.562 -0.711 . . . . 1.8300000000000001 110.344 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -119.79 172.03 7.99 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.476 -0.765 . . . . 4.3499999999999996 110.38 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 29.2 t -101.51 130.32 47.76 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.537 -0.727 . . . . 1.27 110.102 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -156.44 158.35 37.14 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.511 -0.743 . . . . 5.0199999999999996 110.548 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.72 86.36 15.91 Favored Pre-proline 0 N--CA 1.501 2.094 0 O-C-N 121.602 -0.686 . . . . 2.4100000000000001 109.713 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.07 -172.8 1.07 Allowed 'Trans proline' 0 C--N 1.317 -1.093 0 O-C-N 123.271 1.143 . . . . 0.95999999999999996 111.547 -179.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 5.2 mp -127.93 154.73 45.22 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 107.577 -1.268 . . . . 0.62 107.577 178.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 979' ' ' THR . . . . . . . . . . . . . 33.7 p -150.34 142.15 23.75 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.809 -1.182 . . . . 3.5699999999999998 111.368 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 980' ' ' ILE . . . . . 0.409 HG22 HD11 ' A' ' 980' ' ' ILE . 46.8 mm -106.5 127.44 61.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 108.798 -0.815 . . . . 1.3300000000000001 108.798 179.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 981' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -119.49 97.48 5.67 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 119.762 -0.775 . . . . 0.050000000000000003 111.726 -178.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 77.8 p -108.55 158.48 17.52 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.485 -0.759 . . . . 0.87 109.331 178.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 983' ' ' GLY . . . . . 0.411 ' HA3' ' CE1' ' A' ' 852' ' ' PHE . . . -174.98 107.55 0.24 Allowed Glycine 0 N--CA 1.499 2.859 0 N-CA-C 106.452 -2.659 . . . . 0.029999999999999999 106.452 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -108.75 152.5 24.77 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 114.507 1.299 . . . . 0.69999999999999996 114.507 -175.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 53.1 tp -71.29 134.03 46.49 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.793 -1.192 . . . . 0.040000000000000001 110.141 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 45.9 tp -107.61 -56.13 2.26 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.552 -0.718 . . . . 0.040000000000000001 109.804 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -145.26 145.2 31.18 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 107.701 -1.222 . . . . 0.040000000000000001 107.701 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -113.02 163.32 12.15 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 108.293 -1.923 . . . . 0.040000000000000001 108.293 179.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -75.44 112.69 20.27 Favored Pre-proline 0 N--CA 1.5 2.026 0 O-C-N 121.256 -1.144 . . . . 0.040000000000000001 109.485 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 990' ' ' PRO . . . . . 0.408 ' O ' ' HB2' ' A' ' 991' ' ' GLU . 50.7 Cg_endo -90.19 70.92 1.56 Allowed 'Trans proline' 0 C--N 1.319 -1.004 0 O-C-N 123.134 1.07 . . . . 0.45000000000000001 111.514 -179.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 991' ' ' GLU . . . . . 0.408 ' HB2' ' O ' ' A' ' 990' ' ' PRO . 70.6 mt-10 67.37 -73.61 0.08 Allowed 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 108.584 -0.895 . . . . 1.97 108.584 -177.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 992' ' ' LEU . . . . . . . . . . . . . 10.9 mt 51.05 20.58 0.85 Allowed 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.502 -0.749 . . . . 2.3799999999999999 111.638 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 83.6 mt-10 -94.09 156.87 16.36 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.879 -1.138 . . . . 3.79 110.085 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 72.4 m80 -146.63 93.33 2.27 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.526 -0.734 . . . . 3.5099999999999998 110.311 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 995' ' ' ALA . . . . . . . . . . . . 2.518 . . . . . . . 0 N--CA 1.503 2.198 0 O-C-N 120.831 -1.168 . . . . 2.73 110.614 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo . . . . . 0 N--CA 1.488 1.18 0 N-CA-C 109.429 -1.027 . . . . 3.8300000000000001 109.429 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 847' ' ' VAL . . . . . . . . . . . . . 66.4 t -134.93 102.91 10.94 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.557 -0.715 . . . . 1.8300000000000001 110.041 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 848' ' ' PRO . . . . . 0.405 ' O ' ' C ' ' B' ' 849' ' ' GLN . 44.2 Cg_endo -69.81 -18.93 36.51 Favored 'Trans proline' 0 N--CA 1.488 1.167 0 O-C-N 123.319 1.168 . . . . 0.65000000000000002 111.136 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 849' ' ' GLN . . . . . 0.405 ' C ' ' O ' ' B' ' 848' ' ' PRO . 55.9 tt0 27.59 68.22 0.07 Allowed 'General case' 0 N--CA 1.518 2.953 0 N-CA-C 112.951 0.723 . . . . 2.5800000000000001 112.951 179.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 850' ' ' VAL . . . . . . . . . . . . . 68.0 t -119.62 137.13 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.193 -0.942 . . . . 1.0900000000000001 111.427 -179.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 851' ' ' ALA . . . . . . . . . . . . . . . -124.71 158.21 33.77 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 105.828 -1.916 . . . . 0.040000000000000001 105.828 176.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 852' ' ' PHE . . . . . 0.418 ' CE1' ' HA3' ' B' ' 983' ' ' GLY . 32.1 p90 -158.82 128.27 5.61 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 121.056 1.753 . . . . 0.050000000000000003 108.493 179.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 7.6 t -175.79 134.09 0.28 Allowed 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.245 -1.021 . . . . 0.040000000000000001 108.245 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -131.49 157.76 42.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.106 -0.996 . . . . 0.67000000000000004 109.668 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 855' ' ' ALA . . . . . 0.404 ' O ' ' HB2' ' B' ' 870' ' ' ARG . . . -121.1 146.15 47.04 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.997 0.903 . . . . 0.51000000000000001 111.287 -178.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 856' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -113.17 132.83 55.32 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.712 -0.617 . . . . 0.050000000000000003 109.971 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 857' ' ' SER . . . . . 0.428 ' O ' ' O ' ' B' ' 858' ' ' LEU . 30.1 p -153.97 14.92 0.48 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.521 -0.737 . . . . 1.3300000000000001 111.711 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 858' ' ' LEU . . . . . 0.428 ' O ' ' O ' ' B' ' 857' ' ' SER . 4.5 pp -33.46 159.69 0.03 OUTLIER Pre-proline 0 N--CA 1.52 3.052 0 N-CA-C 113.401 0.889 . . . . 2.3300000000000001 113.401 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -61.96 -88.39 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 121.013 1.142 . . . . 2.3199999999999998 113.235 -178.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 53.6 ptt85 -127.94 -142.53 0.27 Allowed 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.893 -1.13 . . . . 0.040000000000000001 111.405 -177.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 8.8 m -41.21 128.29 2.88 Favored 'General case' 0 N--CA 1.509 2.482 0 O-C-N 121.383 -0.823 . . . . 1.3100000000000001 111.909 -179.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 862' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -94.09 152.81 40.67 Favored Pre-proline 0 N--CA 1.491 1.592 0 N-CA-C 108.085 -1.08 . . . . 4.5099999999999998 108.085 177.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -70.14 -12.36 32.03 Favored 'Trans proline' 0 C--N 1.314 -1.248 0 O-C-N 123.086 1.045 . . . . 2.2400000000000002 111.25 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -175.42 -134.92 1.99 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.063 -1.215 . . . . 0.040000000000000001 110.063 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 41.5 m -65.49 156.76 31.49 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.294 -1.121 . . . . 1.51 111.247 -178.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 866' ' ' VAL . . . . . . . . . . . . . 2.7 t -91.96 127.99 47.44 Favored Pre-proline 0 N--CA 1.499 1.995 0 N-CA-C 113.424 0.898 . . . . 0.78000000000000003 113.424 -174.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 867' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -92.01 -155.81 0.05 OUTLIER 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 121.149 1.233 . . . . 0.92000000000000004 109.547 177.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 868' ' ' PHE . . . . . 0.447 ' CD1' ' N ' ' B' ' 868' ' ' PHE . 21.7 p90 -151.56 123.43 8.06 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.636 -1.29 . . . . 0.050000000000000003 110.019 179.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 44.2 p30 -114.46 -0.32 13.79 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.2 -0.938 . . . . 1.7 112.815 -178.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 870' ' ' ARG . . . . . 0.404 ' HB2' ' O ' ' B' ' 855' ' ' ALA . 26.7 mmm180 -91.45 90.16 7.54 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.86 -1.15 . . . . 2.5899999999999999 111.145 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 59.6 t -74.42 97.2 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 120.951 -1.093 . . . . 1.9399999999999999 109.959 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 872' ' ' LEU . . . . . . . . . . . . . 96.2 mt -83.34 -46.67 12.32 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.492 -0.755 . . . . 1.0600000000000001 110.14 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 873' ' ' LEU . . . . . . . . . . . . . 36.9 tp -174.54 102.99 0.1 Allowed 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 108.507 -0.923 . . . . 4.1799999999999997 108.507 178.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 874' ' ' ASN . . . . . . . . . . . . . 35.4 t-20 178.73 81.12 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.337 0 O-C-N 121.63 -0.668 . . . . 0.040000000000000001 109.552 -178.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -66.94 -47.28 72.15 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.127 -0.983 . . . . 3.3799999999999999 111.198 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 876' ' ' GLY . . . . . . . . . . . . . . . -73.56 -24.98 73.6 Favored Glycine 0 N--CA 1.494 2.521 0 O-C-N 121.305 -0.872 . . . . 0.040000000000000001 111.454 -178.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 84.14 -59.78 4.91 Favored Glycine 0 N--CA 1.501 3.001 0 N-CA-C 108.075 -2.01 . . . . 0.040000000000000001 108.075 -178.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 878' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 60.82 -65.73 0.06 Allowed 'General case' 0 N--CA 1.503 2.189 0 N-CA-C 114.226 1.195 . . . . 3.46 114.226 177.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 879' ' ' TYR . . . . . 0.476 ' CB ' ' CD2' ' B' ' 886' ' ' PHE . 21.1 p90 -112.8 109.31 18.7 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 114.769 1.396 . . . . 0.040000000000000001 114.769 -176.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 880' ' ' ASP . . . . . 0.403 ' O ' ' N ' ' B' ' 884' ' ' GLY . 0.7 OUTLIER -66.25 116.72 36.28 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.343 -0.848 . . . . 0.02 109.698 179.799 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 881' ' ' PRO . . . . . 0.43 ' HG2' ' CD1' ' B' ' 868' ' ' PHE . 53.9 Cg_endo -75.53 -0.22 9.88 Favored 'Trans proline' 0 N--CA 1.497 1.709 0 O-C-N 123.47 1.247 . . . . 0.39000000000000001 112.534 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -75.7 -63.55 1.27 Allowed 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 106.716 -1.587 . . . . 0.81000000000000005 106.716 178.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 41.4 p -93.91 -19.9 20.52 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.482 -0.933 . . . . 0.040000000000000001 108.482 177.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 884' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' B' ' 880' ' ' ASP . . . 83.76 21.4 57.85 Favored Glycine 0 N--CA 1.494 2.556 0 O-C-N 121.05 -1.031 . . . . 0.029999999999999999 111.369 178.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 885' ' ' VAL . . . . . . . . . . . . . 98.8 t -73.91 92.14 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 C-N-CA 118.084 -1.446 . . . . 1.01 108.06 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 886' ' ' PHE . . . . . 0.476 ' CD2' ' CB ' ' B' ' 879' ' ' TYR . 0.7 OUTLIER -90.1 104.87 17.4 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 115.119 -0.946 . . . . 0.050000000000000003 112.085 -177.192 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 887' ' ' THR . . . . . 0.421 ' O ' ' HD3' ' B' ' 889' ' ' PRO . 93.9 m -96.41 100.67 12.26 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 107.63 -1.248 . . . . 0.68000000000000005 107.63 177.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 888' ' ' ALA . . . . . . . . . . . . . . . -98.87 105.86 33.91 Favored Pre-proline 0 N--CA 1.502 2.125 0 N-CA-C 114.267 1.21 . . . . 0.25 114.267 -176.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 889' ' ' PRO . . . . . 0.421 ' HD3' ' O ' ' B' ' 887' ' ' THR . 54.1 Cg_endo -88.9 -13.44 3.14 Favored 'Trans proline' 0 CA--C 1.546 1.118 0 N-CA-C 108.982 -1.199 . . . . 1.6399999999999999 108.982 175.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 890' ' ' LEU . . . . . . . . . . . . . 69.7 mt -36.39 -50.09 0.75 Allowed 'General case' 0 N--CA 1.508 2.457 0 N-CA-C 113.612 0.967 . . . . 2.29 113.612 -177.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 52.1 95.95 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.259 0 O-C-N 121.135 -0.978 . . . . 0.63 110.25 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . 158.05 -153.72 24.88 Favored Glycine 0 N--CA 1.478 1.496 0 N-CA-C 107.18 -2.368 . . . . 0.040000000000000001 107.18 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 72.8 ttt-85 -115.61 126.41 54.15 Favored 'General case' 0 C--N 1.295 -1.778 0 O-C-N 121.581 -0.952 . . . . 3.0 108.529 177.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 894' ' ' TYR . . . . . 0.415 ' CD2' HD22 ' B' ' 954' ' ' LEU . 0.1 OUTLIER -132.17 160.19 36.78 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.182 -0.949 . . . . 0.040000000000000001 111.041 -179.754 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 895' ' ' LEU . . . . . . . . . . . . . 37.9 tp -92.1 118.49 30.86 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.654 -0.654 . . . . 1.27 110.141 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 896' ' ' LEU . . . . . 0.414 ' HB2' ' CZ ' ' B' ' 894' ' ' TYR . 9.2 tt -110.0 141.59 42.58 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.761 -0.587 . . . . 0.93999999999999995 110.106 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 897' ' ' SER . . . . . . . . . . . . . 64.4 m -148.35 115.26 6.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.478 -0.764 . . . . 0.040000000000000001 111.032 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.26 146.07 31.93 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.989 -0.745 . . . . 0.47999999999999998 108.989 178.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 899' ' ' VAL . . . . . 0.402 ' CG2' ' HB ' ' B' ' 980' ' ' ILE . 88.0 t -94.64 120.15 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 C-N-CA 119.653 -0.819 . . . . 0.55000000000000004 111.138 -179.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 900' ' ' LEU . . . . . 0.443 ' N ' ' CD2' ' B' ' 900' ' ' LEU . 4.3 mm? -95.02 112.45 24.16 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 114.457 1.281 . . . . 1.5900000000000001 114.457 -174.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 15.3 m -66.58 141.44 57.84 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 107.319 -1.363 . . . . 0.050000000000000003 107.319 176.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -67.24 -65.84 2.6 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 110.608 -0.997 . . . . 0.029999999999999999 110.608 -179.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 8.8 m170 46.73 66.76 0.9 Allowed 'General case' 0 N--CA 1.508 2.453 0 O-C-N 121.492 -1.005 . . . . 3.2000000000000002 111.155 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 43.1 ptt85 -69.32 -6.28 28.58 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.62 -0.675 . . . . 2.9199999999999999 112.084 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 905' ' ' HIS . . . . . 0.485 ' O ' ' CB ' ' B' ' 906' ' ' GLU . 72.6 t60 -61.66 4.47 0.11 Allowed 'General case' 0 N--CA 1.505 2.324 0 O-C-N 120.929 -1.107 . . . . 2.8700000000000001 113.198 -179.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 906' ' ' GLU . . . . . 0.485 ' CB ' ' O ' ' B' ' 905' ' ' HIS . 0.5 OUTLIER 94.96 -164.44 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.439 0 CA-C-N 120.561 1.528 . . . . 0.98999999999999999 111.668 179.063 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 907' ' ' LYS . . . . . 0.472 ' CB ' ' O ' ' B' ' 906' ' ' GLU . 63.2 tttt 85.75 156.3 0.08 Allowed 'General case' 0 N--CA 1.52 3.035 0 N-CA-C 108.095 -1.076 . . . . 5.25 108.095 -176.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 59.2 t -121.81 116.18 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 120.814 -1.179 . . . . 0.39000000000000001 111.152 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -99.57 133.42 43.93 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 107.274 -1.38 . . . . 1.72 107.274 176.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -156.21 122.08 4.95 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 106.879 -1.526 . . . . 0.67000000000000004 106.879 178.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 911' ' ' VAL . . . . . 0.459 ' HA ' ' HA ' ' B' ' 964' ' ' VAL . 87.0 t -84.27 132.38 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.842 -0.536 . . . . 0.54000000000000004 110.813 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 63.0 mt -65.72 156.75 32.07 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.333 -0.854 . . . . 1.5 108.946 178.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 913' ' ' SER . . . . . 0.408 ' CB ' ' CG1' ' B' ' 919' ' ' VAL . 1.4 t -123.57 137.48 54.74 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.393 -0.965 . . . . 1.3700000000000001 108.393 177.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 914' ' ' ARG . . . . . 0.419 ' O ' ' CB ' ' B' ' 915' ' ' SER . 0.0 OUTLIER -64.12 154.64 33.99 Favored 'General case' 0 N--CA 1.505 2.311 0 O-C-N 120.77 -1.206 . . . . 4.2999999999999998 111.888 -178.988 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 915' ' ' SER . . . . . 0.419 ' CB ' ' O ' ' B' ' 914' ' ' ARG . 4.7 t 83.2 -33.0 0.08 Allowed 'General case' 0 N--CA 1.521 3.114 0 C-N-CA 124.017 0.927 . . . . 2.0499999999999998 112.272 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 916' ' ' ASN . . . . . 0.402 ' O ' ' HB2' ' B' ' 917' ' ' GLN . 92.4 m-20 -120.74 -20.76 6.89 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 120.909 -1.119 . . . . 2.71 111.46 -179.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 917' ' ' GLN . . . . . 0.402 ' HB2' ' O ' ' B' ' 916' ' ' ASN . 41.8 mt-30 66.83 164.46 0.2 Allowed 'General case' 0 N--CA 1.521 3.116 0 N-CA-C 105.472 -2.047 . . . . 2.6800000000000002 105.472 -173.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 55.09 -125.5 35.99 Favored Glycine 1 N--CA 1.521 4.349 0 CA-C-N 123.567 2.894 . . . . 0.029999999999999999 106.8 -177.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 919' ' ' VAL . . . . . 0.408 ' CG1' ' CB ' ' B' ' 913' ' ' SER . 82.3 t 51.39 95.05 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.253 0 O-C-N 121.476 -1.014 . . . . 1.3899999999999999 109.062 -178.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.51 92.16 8.39 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.31 -0.956 . . . . 0.029999999999999999 110.844 -179.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 921' ' ' ARG . . . . . 0.423 ' HB2' ' CE1' ' B' ' 950' ' ' PHE . 27.5 ptt180 -83.96 -41.73 17.01 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 105.738 -1.949 . . . . 4.4199999999999999 105.738 175.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 922' ' ' VAL . . . . . . . . . . . . . 77.9 t -102.16 73.14 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 N-CA-C 106.375 -1.713 . . . . 0.84999999999999998 106.375 175.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -86.49 133.76 33.72 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.637 0.732 . . . . 2.46 111.241 -177.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 924' ' ' SER . . . . . . . . . . . . . 27.8 t -147.83 105.77 3.72 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 108.974 -0.75 . . . . 0.69999999999999996 108.974 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -102.69 83.57 0.45 Allowed Glycine 0 N--CA 1.486 1.968 0 N-CA-C 108.37 -1.892 . . . . 0.040000000000000001 108.37 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.156 0 N-CA-C 108.661 -1.776 . . . . 0.040000000000000001 108.661 -179.72 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 32.7 m . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.078 0.466 . . . . 13.779999999999999 110.162 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 96.2 mt -111.03 129.4 55.92 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.581 -0.699 . . . . 13.76 110.325 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -151.73 166.76 30.89 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.114 -1.594 . . . . 9.1300000000000008 109.114 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 949' ' ' VAL . . . . . . . . . . . . . 35.5 m -118.81 130.24 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.519 -0.989 . . . . 7.0800000000000001 110.967 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 950' ' ' PHE . . . . . 0.428 ' CE1' ' HD2' ' B' ' 955' ' ' PRO . 25.5 p90 -133.03 150.41 52.13 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.546 -0.721 . . . . 7.5899999999999999 109.162 179.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 19.5 m -120.67 -52.76 2.11 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.367 -0.833 . . . . 5.0300000000000002 112.252 -178.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 952' ' ' LEU . . . . . 0.418 ' O ' ' O ' ' B' ' 953' ' ' ILE . 13.6 tp -60.62 -73.22 0.09 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.365 -0.835 . . . . 1.01 112.382 -177.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 953' ' ' ILE . . . . . 0.478 ' O ' ' HB3' ' B' ' 954' ' ' LEU . 46.0 pt -52.26 -144.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.779 0 N-CA-C 114.177 1.177 . . . . 2.6000000000000001 114.177 -176.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 954' ' ' LEU . . . . . 0.538 ' N ' ' CD1' ' B' ' 954' ' ' LEU . 0.0 OUTLIER 171.64 77.23 0.04 OUTLIER Pre-proline 0 N--CA 1.51 2.526 0 O-C-N 120.808 -1.183 . . . . 0.050000000000000003 111.39 179.478 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 955' ' ' PRO . . . . . 0.428 ' HD2' ' CE1' ' B' ' 950' ' ' PHE . 48.2 Cg_endo -74.89 96.54 1.02 Allowed 'Trans proline' 0 C--N 1.313 -1.295 0 N-CA-C 109.481 -1.007 . . . . 0.83999999999999997 109.481 178.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 956' ' ' LEU . . . . . 0.41 ' CD2' ' NH1' ' B' ' 914' ' ' ARG . 10.4 mp -123.11 145.62 48.42 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.125 -0.984 . . . . 0.040000000000000001 110.166 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 16.1 mt-30 -83.58 150.66 25.8 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 117.866 -1.064 . . . . 1.28 111.645 -179.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -70.5 119.62 14.93 Favored 'General case' 0 N--CA 1.51 2.545 0 CA-C-N 122.845 2.566 . . . . 0.17000000000000001 111.579 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.74 -22.98 30.72 Favored Glycine 0 N--CA 1.501 3.021 0 N-CA-C 111.111 -0.796 . . . . 0.040000000000000001 111.111 178.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 960' ' ' ASP . . . . . 0.405 ' HB3' ' NE ' ' B' ' 914' ' ' ARG . 0.6 OUTLIER -51.86 172.15 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.53 -0.982 . . . . 0.040000000000000001 110.358 -179.403 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 961' ' ' THR . . . . . 0.456 ' HA ' ' O ' ' B' ' 886' ' ' PHE . 7.1 t -134.73 134.71 41.3 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.986 -1.071 . . . . 1.78 111.855 -178.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 962' ' ' VAL . . . . . 0.436 ' CG2' ' CB ' ' B' ' 886' ' ' PHE . 31.1 m -99.17 145.8 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 C-N-CA 120.072 -0.651 . . . . 0.040000000000000001 110.453 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 5.3 t -138.79 145.23 39.88 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.861 -0.524 . . . . 0.71999999999999997 110.191 -178.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 964' ' ' VAL . . . . . 0.459 ' HA ' ' HA ' ' B' ' 911' ' ' VAL . 55.2 t -94.24 136.32 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.11 -0.994 . . . . 1.05 110.717 -179.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -95.72 126.37 40.94 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 103.755 -2.683 . . . . 3.02 103.755 173.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 966' ' ' LEU . . . . . 0.412 ' O ' ' CG2' ' B' ' 967' ' ' VAL . 20.8 tp -132.23 62.52 1.64 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.35 -0.981 . . . . 1.46 108.35 177.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 967' ' ' VAL . . . . . 0.412 ' CG2' ' O ' ' B' ' 966' ' ' LEU . 89.8 t -158.42 97.01 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 N-CA-C 108.095 -1.076 . . . . 1.9399999999999999 108.095 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 88.7 mmm -142.77 59.19 1.43 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.765 -1.21 . . . . 0.0 108.281 178.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.53 119.69 1.93 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 107.0 -2.44 . . . . 2.1099999999999999 107.0 -178.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -81.22 -57.86 3.32 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.063 -1.257 . . . . 5.8899999999999997 110.435 -179.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 44.2 tp -58.91 90.37 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.465 -0.772 . . . . 4.3600000000000003 110.223 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -141.27 -154.91 0.54 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.575 -0.703 . . . . 1.8300000000000001 110.304 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -119.86 172.1 7.95 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.464 -0.773 . . . . 4.3499999999999996 110.38 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 29.5 t -101.52 130.29 47.77 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.565 -0.709 . . . . 1.27 110.145 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -156.41 158.35 37.18 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.504 -0.747 . . . . 5.0199999999999996 110.553 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.7 86.32 16.0 Favored Pre-proline 0 N--CA 1.5 2.06 0 O-C-N 121.614 -0.679 . . . . 2.4100000000000001 109.7 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -73.12 -172.83 1.09 Allowed 'Trans proline' 0 C--N 1.317 -1.123 0 O-C-N 123.344 1.181 . . . . 0.95999999999999996 111.514 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 978' ' ' LEU . . . . . . . . . . . . . 5.2 mp -127.81 154.91 44.88 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.644 -1.243 . . . . 0.62 107.644 178.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 979' ' ' THR . . . . . . . . . . . . . 33.7 p -150.51 142.16 23.62 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.81 -1.181 . . . . 3.5699999999999998 111.384 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 980' ' ' ILE . . . . . 0.402 ' HB ' ' CG2' ' B' ' 899' ' ' VAL . 47.0 mm -106.49 127.06 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 108.765 -0.828 . . . . 1.3300000000000001 108.765 179.226 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -119.27 97.64 5.76 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.458 -0.776 . . . . 0.050000000000000003 111.767 -178.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 77.8 p -109.02 159.0 17.19 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.544 -0.722 . . . . 0.87 109.428 178.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 983' ' ' GLY . . . . . 0.418 ' HA3' ' CE1' ' B' ' 852' ' ' PHE . . . -175.01 107.77 0.25 Allowed Glycine 0 N--CA 1.499 2.869 0 N-CA-C 106.53 -2.628 . . . . 0.029999999999999999 106.53 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -108.62 152.33 24.93 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 114.44 1.274 . . . . 0.69999999999999996 114.44 -175.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 985' ' ' LEU . . . . . . . . . . . . . 53.3 tp -71.26 134.03 46.52 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.9 -1.125 . . . . 0.040000000000000001 110.108 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 986' ' ' LEU . . . . . . . . . . . . . 45.8 tp -107.62 -56.17 2.26 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.591 -0.693 . . . . 0.040000000000000001 109.923 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -145.34 145.05 31.05 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 107.737 -1.208 . . . . 0.040000000000000001 107.737 178.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.92 163.02 12.18 Favored Glycine 0 N--CA 1.496 2.653 0 N-CA-C 108.21 -1.956 . . . . 0.040000000000000001 108.21 179.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -75.13 112.76 19.73 Favored Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 121.165 -1.197 . . . . 0.040000000000000001 109.535 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 990' ' ' PRO . . . . . 0.407 ' O ' ' HB2' ' B' ' 991' ' ' GLU . 50.9 Cg_endo -90.18 70.95 1.56 Allowed 'Trans proline' 0 C--N 1.319 -0.985 0 O-C-N 123.13 1.068 . . . . 0.45000000000000001 111.423 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 991' ' ' GLU . . . . . 0.407 ' HB2' ' O ' ' B' ' 990' ' ' PRO . 70.6 mt-10 67.25 -73.57 0.08 Allowed 'General case' 0 N--CA 1.503 2.207 0 N-CA-C 108.6 -0.889 . . . . 1.97 108.6 -177.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 992' ' ' LEU . . . . . . . . . . . . . 10.9 mt 51.22 20.31 0.88 Allowed 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.551 -0.718 . . . . 2.3799999999999999 111.621 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 83.6 mt-10 -93.73 156.95 16.4 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.86 -1.15 . . . . 3.79 110.104 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 72.1 m80 -146.67 92.73 2.19 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.534 -0.729 . . . . 3.5099999999999998 110.395 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 995' ' ' ALA . . . . . . . . . . . . 2.517 . . . . . . . 0 N--CA 1.503 2.222 0 O-C-N 120.953 -1.092 . . . . 2.73 110.639 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo . . . . . 0 N--CA 1.488 1.174 0 N-CA-C 109.488 -1.005 . . . . 3.8300000000000001 109.488 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 847' ' ' VAL . . . . . . . . . . . . . 57.7 t -130.31 103.28 16.67 Favored Pre-proline 0 N--CA 1.496 1.869 0 O-C-N 121.604 -0.685 . . . . 1.8300000000000001 110.133 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 848' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.49 -21.29 30.32 Favored 'Trans proline' 0 N--CA 1.488 1.182 0 O-C-N 123.277 1.146 . . . . 0.65000000000000002 111.269 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 849' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 27.5 69.97 0.06 Allowed 'General case' 0 N--CA 1.519 3.024 0 N-CA-C 112.826 0.676 . . . . 2.5800000000000001 112.826 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 850' ' ' VAL . . . . . . . . . . . . . 61.2 t -119.93 134.57 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.234 -0.916 . . . . 1.0900000000000001 111.648 -178.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 851' ' ' ALA . . . . . . . . . . . . . . . -127.46 155.32 43.88 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 105.772 -1.936 . . . . 0.040000000000000001 105.772 176.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 852' ' ' PHE . . . . . 0.455 ' CD1' ' N ' ' C' ' 852' ' ' PHE . 13.2 p90 -159.96 127.56 4.65 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 121.049 1.75 . . . . 0.050000000000000003 108.557 178.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 29.4 t -176.72 134.13 0.21 Allowed 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.105 -1.072 . . . . 0.040000000000000001 108.105 -179.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -131.13 156.32 45.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.169 -0.957 . . . . 0.67000000000000004 109.642 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 855' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' C' ' 870' ' ' ARG . . . -121.54 141.54 50.96 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.891 0.853 . . . . 0.51000000000000001 111.107 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 856' ' ' LEU . . . . . 0.418 HD21 ' CG1' ' C' ' 866' ' ' VAL . 3.5 tm? -114.53 137.59 51.67 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.402 -0.811 . . . . 0.050000000000000003 110.171 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 857' ' ' SER . . . . . 0.431 ' O ' ' O ' ' C' ' 858' ' ' LEU . 1.9 m -153.8 19.38 0.52 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.52 -0.737 . . . . 1.3300000000000001 110.866 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 858' ' ' LEU . . . . . 0.431 ' O ' ' O ' ' C' ' 857' ' ' SER . 1.4 pp -34.06 160.9 0.04 OUTLIER Pre-proline 0 N--CA 1.516 2.853 0 N-CA-C 113.189 0.811 . . . . 2.3300000000000001 113.189 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -61.6 -88.2 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 120.816 1.011 . . . . 2.3199999999999998 113.306 -178.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 54.6 ptt85 -131.04 -142.33 0.23 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 120.873 -1.142 . . . . 0.040000000000000001 111.435 -177.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 74.5 m -38.42 130.23 1.32 Allowed 'General case' 0 N--CA 1.511 2.589 0 O-C-N 121.563 -0.71 . . . . 1.3100000000000001 112.172 -178.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -102.99 158.79 31.06 Favored Pre-proline 0 N--CA 1.488 1.436 0 N-CA-C 108.237 -1.023 . . . . 4.5099999999999998 108.237 177.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.18 -13.75 33.97 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 O-C-N 123.203 1.107 . . . . 2.2400000000000002 110.829 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -176.7 -136.03 2.31 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.08 -1.608 . . . . 0.040000000000000001 109.08 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 24.7 m -68.83 155.59 39.93 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.27 -1.135 . . . . 1.51 110.164 -179.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 866' ' ' VAL . . . . . 0.418 ' CG1' HD21 ' C' ' 856' ' ' LEU . 60.2 t -99.88 138.05 20.27 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.466 -0.771 . . . . 0.78000000000000003 113.048 -175.003 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 867' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -90.4 -147.05 0.03 OUTLIER 'Trans proline' 0 CA--C 1.546 1.086 0 O-C-N 123.533 1.28 . . . . 0.92000000000000004 109.234 178.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 868' ' ' PHE . . . . . 0.415 ' CE1' ' HD2' ' C' ' 881' ' ' PRO . 24.5 p90 -149.29 125.37 10.68 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.487 -1.383 . . . . 0.050000000000000003 110.032 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 50.9 p-10 -112.46 -2.82 14.59 Favored 'General case' 0 N--CA 1.499 2.013 0 C-N-CA 119.295 -0.962 . . . . 1.7 112.744 -178.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 870' ' ' ARG . . . . . 0.446 ' HB2' ' O ' ' C' ' 855' ' ' ALA . 25.8 mmm180 -91.41 88.84 6.99 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 120.849 -1.157 . . . . 2.5899999999999999 111.112 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 63.1 t -72.86 97.34 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 120.902 -1.123 . . . . 1.9399999999999999 109.288 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 872' ' ' LEU . . . . . . . . . . . . . 72.9 mt -86.48 -45.94 10.66 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.537 -0.727 . . . . 1.0600000000000001 110.561 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 873' ' ' LEU . . . . . 0.407 ' O ' ' HB2' ' C' ' 874' ' ' ASN . 36.8 tp -173.09 102.5 0.13 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.208 -0.932 . . . . 4.1799999999999997 108.715 178.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 874' ' ' ASN . . . . . 0.407 ' HB2' ' O ' ' C' ' 873' ' ' LEU . 35.5 t-20 177.49 82.46 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.231 0 N-CA-C 108.827 -0.805 . . . . 0.040000000000000001 108.827 -178.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -65.05 -46.68 80.23 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.194 -0.941 . . . . 3.3799999999999999 111.521 -178.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 876' ' ' GLY . . . . . 0.42 ' HA3' ' CE2' ' C' ' 878' ' ' TYR . . . -73.01 -26.56 70.7 Favored Glycine 0 N--CA 1.493 2.474 0 O-C-N 121.243 -0.91 . . . . 0.040000000000000001 111.748 -178.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 80.34 -62.38 4.3 Favored Glycine 0 N--CA 1.501 3.007 0 N-CA-C 107.911 -2.075 . . . . 0.040000000000000001 107.911 -178.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 878' ' ' TYR . . . . . 0.42 ' CE2' ' HA3' ' C' ' 876' ' ' GLY . 93.2 m-85 60.61 -65.73 0.05 Allowed 'General case' 0 N--CA 1.503 2.22 0 N-CA-C 114.404 1.261 . . . . 3.46 114.404 177.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 879' ' ' TYR . . . . . 0.505 ' CE2' ' CD1' ' C' ' 981' ' ' PHE . 28.8 p90 -110.27 106.83 16.38 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 114.826 1.417 . . . . 0.040000000000000001 114.826 -176.131 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 880' ' ' ASP . . . . . 0.422 ' O ' ' N ' ' C' ' 884' ' ' GLY . 1.2 t0 -73.75 117.19 58.99 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.489 -0.757 . . . . 0.02 109.806 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 881' ' ' PRO . . . . . 0.415 ' HD2' ' CE1' ' C' ' 868' ' ' PHE . 54.2 Cg_endo -77.07 1.07 9.07 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 O-C-N 123.34 1.179 . . . . 0.39000000000000001 112.351 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 71.5 mt-10 -73.55 -53.61 10.13 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 105.733 -1.951 . . . . 0.81000000000000005 105.733 177.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 14.7 p -99.7 -21.0 16.0 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 115.068 -0.969 . . . . 0.040000000000000001 108.841 177.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 884' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' C' ' 880' ' ' ASP . . . 81.93 15.76 74.25 Favored Glycine 0 N--CA 1.496 2.672 0 N-CA-C 110.434 -1.066 . . . . 0.029999999999999999 110.434 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 58.5 t -74.87 91.94 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 C-N-CA 118.422 -1.311 . . . . 1.01 108.584 -178.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 886' ' ' PHE . . . . . 0.488 ' O ' ' HA ' ' C' ' 961' ' ' THR . 1.0 OUTLIER -88.04 106.18 17.97 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 115.173 -0.921 . . . . 0.050000000000000003 111.531 -177.696 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 887' ' ' THR . . . . . 0.41 ' O ' ' HD3' ' C' ' 889' ' ' PRO . 88.3 m -101.46 99.79 10.16 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.669 -1.234 . . . . 0.68000000000000005 107.669 177.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 888' ' ' ALA . . . . . . . . . . . . . . . -98.45 102.0 13.21 Favored Pre-proline 0 N--CA 1.5 2.061 0 N-CA-C 114.375 1.25 . . . . 0.25 114.375 -176.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 889' ' ' PRO . . . . . 0.41 ' HD3' ' O ' ' C' ' 887' ' ' THR . 55.6 Cg_endo -81.45 -15.27 10.01 Favored 'Trans proline' 0 CA--C 1.544 1.014 0 N-CA-C 108.632 -1.334 . . . . 1.6399999999999999 108.632 175.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 890' ' ' LEU . . . . . . . . . . . . . 67.6 mt -37.27 -49.36 0.94 Allowed 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 113.394 0.887 . . . . 2.29 113.394 -177.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 52.4 96.99 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.241 0 O-C-N 121.268 -0.895 . . . . 0.63 110.196 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . 159.28 -153.64 24.72 Favored Glycine 0 N--CA 1.477 1.411 0 N-CA-C 107.45 -2.26 . . . . 0.040000000000000001 107.45 -179.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 76.0 ttt-85 -117.62 123.1 45.34 Favored 'General case' 0 C--N 1.293 -1.877 0 O-C-N 121.715 -0.874 . . . . 3.0 108.872 178.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 894' ' ' TYR . . . . . 0.447 ' CD2' HD22 ' C' ' 954' ' ' LEU . 13.6 p90 -132.89 155.91 48.17 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.024 -1.047 . . . . 0.040000000000000001 111.193 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 895' ' ' LEU . . . . . . . . . . . . . 46.0 tp -98.58 111.65 23.94 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.694 -0.629 . . . . 1.27 109.87 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 896' ' ' LEU . . . . . . . . . . . . . 10.1 tt -115.66 144.91 43.25 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.618 -0.676 . . . . 0.93999999999999995 109.926 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 897' ' ' SER . . . . . . . . . . . . . 43.3 m -142.03 124.87 16.05 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.393 -0.817 . . . . 0.040000000000000001 111.477 -179.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -101.22 148.13 25.46 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.759 -0.83 . . . . 0.47999999999999998 108.759 178.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 899' ' ' VAL . . . . . . . . . . . . . 84.7 t -92.42 120.79 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.321 -0.862 . . . . 0.55000000000000004 111.23 -179.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 91.6 mt -92.15 113.45 25.73 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 114.006 1.113 . . . . 1.5900000000000001 114.006 -175.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 21.7 m -62.7 140.9 58.74 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 107.527 -1.286 . . . . 0.050000000000000003 107.527 177.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -60.91 -65.37 3.36 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.238 -1.145 . . . . 0.029999999999999999 110.238 -179.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 6.5 m170 46.1 65.62 1.13 Allowed 'General case' 0 N--CA 1.506 2.363 0 O-C-N 121.518 -0.989 . . . . 3.2000000000000002 111.235 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -66.86 -8.28 27.86 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.623 -0.673 . . . . 2.9199999999999999 111.819 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 905' ' ' HIS . . . . . 0.474 ' O ' ' CB ' ' C' ' 906' ' ' GLU . 72.6 t60 -62.94 4.87 0.15 Allowed 'General case' 0 N--CA 1.503 2.215 0 O-C-N 120.915 -1.116 . . . . 2.8700000000000001 112.679 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 906' ' ' GLU . . . . . 0.498 ' O ' ' CB ' ' C' ' 907' ' ' LYS . 2.0 mt-10 89.73 -153.99 0.01 OUTLIER 'General case' 0 N--CA 1.526 3.329 0 CA-C-N 121.136 1.789 . . . . 0.98999999999999999 111.567 179.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 907' ' ' LYS . . . . . 0.498 ' CB ' ' O ' ' C' ' 906' ' ' GLU . 56.5 tttt 88.84 162.85 0.06 Allowed 'General case' 0 N--CA 1.52 3.066 0 N-CA-C 107.759 -1.2 . . . . 5.25 107.759 -176.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 59.7 t -122.7 114.59 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 120.778 -1.202 . . . . 0.39000000000000001 110.781 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -105.79 131.19 53.43 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 107.557 -1.275 . . . . 1.72 107.557 177.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -156.73 120.44 4.27 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 106.943 -1.503 . . . . 0.67000000000000004 106.943 178.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 911' ' ' VAL . . . . . 0.466 ' HA ' ' HA ' ' C' ' 964' ' ' VAL . 12.8 p -80.08 131.57 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 C-N-CA 120.306 -0.558 . . . . 0.54000000000000004 111.321 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 62.4 mt -66.23 156.72 33.4 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.258 -0.901 . . . . 1.5 108.885 178.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 913' ' ' SER . . . . . 0.418 ' CB ' ' CG1' ' C' ' 919' ' ' VAL . 1.7 t -126.19 136.93 53.44 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.377 -0.971 . . . . 1.3700000000000001 108.377 177.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 914' ' ' ARG . . . . . 0.425 ' O ' ' CB ' ' C' ' 915' ' ' SER . 0.0 OUTLIER -63.67 154.0 34.38 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 120.707 -1.246 . . . . 4.2999999999999998 111.708 -178.783 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 915' ' ' SER . . . . . 0.425 ' CB ' ' O ' ' C' ' 914' ' ' ARG . 2.4 t 83.28 -30.61 0.09 Allowed 'General case' 0 N--CA 1.521 3.119 0 C-N-CA 123.808 0.843 . . . . 2.0499999999999998 112.384 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 916' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -122.19 -21.74 5.8 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.868 -1.145 . . . . 2.71 111.362 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 67.36 166.11 0.23 Allowed 'General case' 0 N--CA 1.521 3.082 0 N-CA-C 105.491 -2.04 . . . . 2.6800000000000002 105.491 -173.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.27 -125.18 33.13 Favored Glycine 1 N--CA 1.521 4.362 0 CA-C-N 123.773 2.988 . . . . 0.029999999999999999 107.08 -177.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 919' ' ' VAL . . . . . 0.418 ' CG1' ' CB ' ' C' ' 913' ' ' SER . 96.7 t 49.83 94.06 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.266 0 O-C-N 121.543 -0.975 . . . . 1.3899999999999999 109.334 -178.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 920' ' ' ALA . . . . . . . . . . . . . . . -94.74 95.48 8.75 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.469 -0.892 . . . . 0.029999999999999999 110.886 -179.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 921' ' ' ARG . . . . . 0.434 ' HB3' ' CZ ' ' C' ' 950' ' ' PHE . 42.8 ptt85 -79.9 -42.05 24.92 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 105.538 -2.023 . . . . 4.4199999999999999 105.538 176.015 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 922' ' ' VAL . . . . . . . . . . . . . 84.6 t -99.89 76.8 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 N-CA-C 105.545 -2.02 . . . . 0.84999999999999998 105.545 175.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -90.61 136.7 32.9 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 122.005 0.907 . . . . 2.46 112.794 -176.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 5.1 t -146.99 103.36 3.6 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.619 -1.252 . . . . 0.69999999999999996 107.619 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -109.21 83.83 0.34 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.485 -1.446 . . . . 0.040000000000000001 109.485 -179.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.361 0 N-CA-C 109.172 -1.571 . . . . 0.040000000000000001 109.172 -179.997 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 22.7 m . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 120.997 0.427 . . . . 13.779999999999999 110.303 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 95.2 mt -112.87 129.89 56.3 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.518 -0.739 . . . . 13.76 110.453 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -151.77 169.89 31.21 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.212 -1.555 . . . . 9.1300000000000008 109.212 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 949' ' ' VAL . . . . . . . . . . . . . 34.1 m -118.04 135.73 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.519 -0.989 . . . . 7.0800000000000001 111.034 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 950' ' ' PHE . . . . . 0.434 ' CZ ' ' HB3' ' C' ' 921' ' ' ARG . 51.7 p90 -135.06 152.47 51.71 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.555 -0.716 . . . . 7.5899999999999999 109.379 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 7.6 t -119.05 -55.09 2.19 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.386 -0.822 . . . . 5.0300000000000002 111.852 -179.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 952' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' C' ' 953' ' ' ILE . 58.9 tp -62.71 -77.07 0.05 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.433 -0.792 . . . . 1.01 111.472 -178.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 953' ' ' ILE . . . . . 0.473 ' O ' ' HB3' ' C' ' 954' ' ' LEU . 2.1 pp -49.12 -151.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.688 0 N-CA-C 114.615 1.339 . . . . 2.6000000000000001 114.615 -176.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 954' ' ' LEU . . . . . 0.566 ' N ' ' CD1' ' C' ' 954' ' ' LEU . 0.0 OUTLIER 170.02 89.45 0.04 OUTLIER Pre-proline 0 N--CA 1.516 2.85 0 O-C-N 120.78 -1.2 . . . . 0.050000000000000003 112.068 -179.497 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 955' ' ' PRO . . . . . 0.419 ' HD2' ' CZ ' ' C' ' 950' ' ' PHE . 50.0 Cg_endo -83.66 94.65 0.78 Allowed 'Trans proline' 0 C--N 1.315 -1.196 0 N-CA-C 109.506 -0.998 . . . . 0.83999999999999997 109.506 178.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 956' ' ' LEU . . . . . 0.405 ' CD2' ' CZ ' ' C' ' 914' ' ' ARG . 6.6 mp -125.64 150.84 47.24 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.024 -1.047 . . . . 0.040000000000000001 110.622 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -81.89 151.5 27.25 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-O 117.66 -1.162 . . . . 1.28 111.323 -178.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -66.41 118.43 10.04 Favored 'General case' 0 N--CA 1.507 2.393 0 CA-C-N 123.202 2.728 . . . . 0.17000000000000001 110.874 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.54 -19.75 48.72 Favored Glycine 0 N--CA 1.499 2.897 0 N-CA-C 111.067 -0.813 . . . . 0.040000000000000001 111.067 178.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 960' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -52.32 171.91 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.344 -1.092 . . . . 0.040000000000000001 110.505 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 961' ' ' THR . . . . . 0.488 ' HA ' ' O ' ' C' ' 886' ' ' PHE . 26.3 m -136.93 140.38 42.23 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.043 -1.035 . . . . 1.78 112.614 -177.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 962' ' ' VAL . . . . . 0.406 ' CG2' ' CB ' ' C' ' 886' ' ' PHE . 26.8 m -101.07 145.47 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 C-N-CA 120.302 -0.559 . . . . 0.040000000000000001 110.809 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 6.2 t -137.99 144.44 41.13 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.815 -0.553 . . . . 0.71999999999999997 109.858 -179.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 964' ' ' VAL . . . . . 0.466 ' HA ' ' HA ' ' C' ' 911' ' ' VAL . 61.8 t -90.79 137.67 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.043 -1.036 . . . . 1.05 110.713 -178.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -92.67 125.17 37.17 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 103.289 -2.856 . . . . 3.02 103.289 173.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 966' ' ' LEU . . . . . 0.414 ' O ' ' CG2' ' C' ' 967' ' ' VAL . 0.2 OUTLIER -133.68 57.46 1.81 Allowed 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.635 -0.876 . . . . 1.46 108.635 177.76 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 967' ' ' VAL . . . . . 0.414 ' CG2' ' O ' ' C' ' 966' ' ' LEU . 98.1 t -158.48 96.41 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 N-CA-C 108.277 -1.009 . . . . 1.9399999999999999 108.277 179.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 90.2 mmm -142.74 59.22 1.43 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.759 -1.213 . . . . 0.0 108.459 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 134.44 119.53 1.97 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 107.205 -2.358 . . . . 2.1099999999999999 107.205 -178.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 95.4 mm-40 -82.34 -57.71 3.25 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.082 -1.246 . . . . 5.8899999999999997 110.684 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 41.4 tp -58.87 89.74 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.46 -0.775 . . . . 4.3600000000000003 110.401 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -142.63 -152.69 0.42 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.572 -0.705 . . . . 1.8300000000000001 110.129 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 7.7 t60 -116.74 167.43 11.1 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.384 -0.823 . . . . 4.3499999999999996 110.076 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 41.1 t -102.8 130.69 49.86 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.624 -0.673 . . . . 1.27 110.197 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -156.35 158.55 37.6 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.498 -0.751 . . . . 5.0199999999999996 110.753 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.82 86.1 15.9 Favored Pre-proline 0 N--CA 1.501 2.116 0 O-C-N 121.616 -0.677 . . . . 2.4100000000000001 109.716 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -75.71 -170.17 0.79 Allowed 'Trans proline' 0 C--N 1.318 -1.061 0 O-C-N 123.303 1.159 . . . . 0.95999999999999996 111.453 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 978' ' ' LEU . . . . . . . . . . . . . 5.2 mp -124.97 156.39 38.12 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 107.511 -1.292 . . . . 0.62 107.511 177.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 979' ' ' THR . . . . . . . . . . . . . 39.5 p -149.92 141.47 23.45 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.728 -1.232 . . . . 3.5699999999999998 111.325 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 980' ' ' ILE . . . . . 0.401 HG22 HD11 ' C' ' 980' ' ' ILE . 47.5 mm -106.96 128.48 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 109.122 -0.696 . . . . 1.3300000000000001 109.122 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 981' ' ' PHE . . . . . 0.505 ' CD1' ' CE2' ' C' ' 879' ' ' TYR . 3.2 t80 -117.89 95.44 4.92 Favored 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 119.69 -0.804 . . . . 0.050000000000000003 111.568 -178.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 982' ' ' SER . . . . . . . . . . . . . 12.5 p -107.63 158.27 17.39 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.6 -0.688 . . . . 0.87 109.255 178.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 983' ' ' GLY . . . . . 0.432 ' HA3' ' CE2' ' C' ' 852' ' ' PHE . . . -172.18 114.48 0.53 Allowed Glycine 0 N--CA 1.497 2.704 0 N-CA-C 106.601 -2.6 . . . . 0.029999999999999999 106.601 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 984' ' ' ALA . . . . . 0.4 ' CB ' ' CZ ' ' A' ' 893' ' ' ARG . . . -108.4 150.76 26.94 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 114.259 1.207 . . . . 0.69999999999999996 114.259 -175.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 985' ' ' LEU . . . . . . . . . . . . . 47.9 tp -75.32 135.71 40.88 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.814 -1.179 . . . . 0.040000000000000001 109.609 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 986' ' ' LEU . . . . . . . . . . . . . 45.5 tp -106.23 -63.16 1.29 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.461 -0.774 . . . . 0.040000000000000001 110.329 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -144.28 146.94 32.92 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 107.806 -1.183 . . . . 0.040000000000000001 107.806 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -111.96 162.71 12.33 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 107.99 -2.044 . . . . 0.040000000000000001 107.99 179.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.81 112.73 19.0 Favored Pre-proline 0 N--CA 1.497 1.895 0 O-C-N 121.135 -1.215 . . . . 0.040000000000000001 109.452 179.117 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 990' ' ' PRO . . . . . 0.413 ' O ' ' HB2' ' C' ' 991' ' ' GLU . 50.9 Cg_endo -89.29 71.24 2.01 Favored 'Trans proline' 0 C--N 1.319 -1.017 0 O-C-N 123.109 1.057 . . . . 0.45000000000000001 111.301 -178.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 991' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' C' ' 990' ' ' PRO . 85.7 mt-10 67.11 -73.77 0.07 Allowed 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 108.687 -0.857 . . . . 1.97 108.687 -177.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 992' ' ' LEU . . . . . . . . . . . . . 11.3 mt 50.5 21.3 0.83 Allowed 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.594 -0.691 . . . . 2.3799999999999999 111.553 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -93.35 156.97 16.47 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.936 -1.102 . . . . 3.79 110.144 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 68.6 m80 -146.31 92.48 2.18 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.597 -0.689 . . . . 3.5099999999999998 110.202 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 995' ' ' ALA . . . . . . . . . . . . 2.519 . . . . . . . 0 N--CA 1.503 2.224 0 O-C-N 120.917 -1.115 . . . . 2.73 110.614 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo . . . . . 0 N--CA 1.488 1.157 0 N-CA-C 109.525 -0.991 . . . . 3.8300000000000001 109.525 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 847' ' ' VAL . . . . . . . . . . . . . 62.0 t -134.49 103.26 11.34 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.574 -0.704 . . . . 1.8300000000000001 110.014 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 848' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -69.99 -18.64 35.83 Favored 'Trans proline' 0 N--CA 1.488 1.182 0 O-C-N 123.315 1.166 . . . . 0.65000000000000002 111.303 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 849' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 27.58 68.72 0.07 Allowed 'General case' 0 N--CA 1.518 2.975 0 N-CA-C 112.941 0.719 . . . . 2.5800000000000001 112.941 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 850' ' ' VAL . . . . . 0.418 ' CG1' ' CE2' ' A' ' 878' ' ' TYR . 62.1 t -118.92 135.81 58.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.221 -0.924 . . . . 1.0900000000000001 111.429 -178.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 851' ' ' ALA . . . . . . . . . . . . . . . -126.76 156.95 40.38 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 105.868 -1.901 . . . . 0.040000000000000001 105.868 176.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 852' ' ' PHE . . . . . 0.411 ' CE1' ' HA3' ' A' ' 983' ' ' GLY . 33.7 p90 -158.79 130.18 6.38 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 121.022 1.737 . . . . 0.050000000000000003 108.79 179.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 44.1 t -174.93 134.1 0.34 Allowed 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.125 -1.065 . . . . 0.040000000000000001 108.125 -179.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -134.01 155.92 49.12 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.07 -1.019 . . . . 0.67000000000000004 109.423 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 855' ' ' ALA . . . . . 0.412 ' O ' ' HB2' ' A' ' 870' ' ' ARG . . . -122.15 141.6 51.27 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.758 0.79 . . . . 0.51000000000000001 111.362 -179.032 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 856' ' ' LEU . . . . . 0.426 HD21 ' CG1' ' A' ' 866' ' ' VAL . 3.4 tm? -111.27 137.94 48.36 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.649 -0.657 . . . . 0.050000000000000003 109.939 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 857' ' ' SER . . . . . 0.416 ' O ' ' O ' ' A' ' 858' ' ' LEU . 1.5 m -156.77 16.86 0.31 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.579 -0.701 . . . . 1.3300000000000001 111.587 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 858' ' ' LEU . . . . . 0.416 ' O ' ' O ' ' A' ' 857' ' ' SER . 3.8 pp -35.02 160.35 0.04 OUTLIER Pre-proline 0 N--CA 1.519 2.991 0 N-CA-C 113.006 0.743 . . . . 2.3300000000000001 113.006 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -60.69 -88.64 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 120.87 1.046 . . . . 2.3199999999999998 113.796 -177.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 53.6 ptt85 -128.54 -142.72 0.26 Allowed 'General case' 0 N--CA 1.5 2.075 0 O-C-N 120.859 -1.151 . . . . 0.040000000000000001 111.756 -177.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 15.0 m -38.03 126.76 1.28 Allowed 'General case' 0 N--CA 1.51 2.569 0 O-C-N 121.643 -0.661 . . . . 1.3100000000000001 112.26 -178.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.59 158.99 31.17 Favored Pre-proline 0 N--CA 1.489 1.51 0 N-CA-C 108.423 -0.954 . . . . 4.5099999999999998 108.423 177.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -70.99 -14.55 32.25 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 O-C-N 123.245 1.129 . . . . 2.2400000000000002 111.379 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -177.7 -135.89 2.36 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.515 -1.434 . . . . 0.040000000000000001 109.515 179.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 26.8 m -65.97 156.05 34.75 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.33 -1.1 . . . . 1.51 110.134 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 866' ' ' VAL . . . . . 0.426 ' CG1' HD21 ' A' ' 856' ' ' LEU . 61.5 t -98.85 137.33 20.52 Favored Pre-proline 0 N--CA 1.494 1.736 0 N-CA-C 113.547 0.943 . . . . 0.78000000000000003 113.547 -174.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 867' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -92.41 -149.66 0.03 OUTLIER 'Trans proline' 0 CA--C 1.546 1.124 0 C-N-CA 121.335 1.356 . . . . 0.92000000000000004 109.634 178.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 868' ' ' PHE . . . . . 0.445 ' N ' ' CD1' ' A' ' 868' ' ' PHE . 19.3 p90 -150.7 124.0 8.91 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.679 -1.263 . . . . 0.050000000000000003 109.776 179.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 46.6 p30 -113.48 -2.23 13.95 Favored 'General case' 0 N--CA 1.5 2.062 0 C-N-CA 119.285 -0.966 . . . . 1.7 112.483 -178.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 870' ' ' ARG . . . . . 0.412 ' HB2' ' O ' ' A' ' 855' ' ' ALA . 26.7 mmm180 -90.11 89.29 7.61 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 120.889 -1.132 . . . . 2.5899999999999999 110.598 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 58.5 t -72.82 96.95 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 120.971 -1.081 . . . . 1.9399999999999999 109.91 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 872' ' ' LEU . . . . . . . . . . . . . 97.6 mt -82.84 -47.44 11.87 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.514 -0.741 . . . . 1.0600000000000001 110.177 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 873' ' ' LEU . . . . . . . . . . . . . 46.5 tp -174.99 104.26 0.09 Allowed 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 108.637 -0.875 . . . . 4.1799999999999997 108.637 178.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 874' ' ' ASN . . . . . 0.411 ' CB ' ' HA ' ' A' ' 852' ' ' PHE . 35.5 t-20 178.71 81.6 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.571 -0.706 . . . . 0.040000000000000001 109.802 -179.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -67.28 -48.05 68.81 Favored 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 119.321 -0.951 . . . . 3.3799999999999999 111.118 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 876' ' ' GLY . . . . . . . . . . . . . . . -73.58 -25.29 72.74 Favored Glycine 0 N--CA 1.494 2.529 0 O-C-N 121.284 -0.885 . . . . 0.040000000000000001 111.632 -178.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 82.39 -61.37 4.73 Favored Glycine 0 N--CA 1.502 3.044 0 N-CA-C 108.097 -2.001 . . . . 0.040000000000000001 108.097 -178.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 878' ' ' TYR . . . . . 0.418 ' CE2' ' CG1' ' A' ' 850' ' ' VAL . 95.8 m-85 61.15 -62.97 0.08 Allowed 'General case' 0 N--CA 1.503 2.201 0 N-CA-C 114.35 1.241 . . . . 3.46 114.35 177.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 879' ' ' TYR . . . . . 0.47 ' CB ' ' CD2' ' A' ' 886' ' ' PHE . 18.8 p90 -111.33 108.66 18.33 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 114.489 1.292 . . . . 0.040000000000000001 114.489 -176.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -65.0 114.7 15.94 Favored Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 121.402 -0.811 . . . . 0.02 110.094 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 881' ' ' PRO . . . . . 0.444 ' HG2' ' CD1' ' A' ' 868' ' ' PHE . 53.3 Cg_endo -75.15 -0.94 10.61 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 O-C-N 123.525 1.276 . . . . 0.39000000000000001 112.312 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -76.87 -65.4 0.95 Allowed 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.12 -1.437 . . . . 0.81000000000000005 107.12 178.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 31.6 p -92.25 -18.17 23.78 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.62 -0.882 . . . . 0.040000000000000001 108.62 177.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.22 19.79 60.12 Favored Glycine 0 N--CA 1.497 2.729 0 O-C-N 121.093 -1.005 . . . . 0.029999999999999999 111.554 178.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 885' ' ' VAL . . . . . . . . . . . . . 92.2 t -73.43 91.1 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 C-N-CA 118.089 -1.445 . . . . 1.01 108.137 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 886' ' ' PHE . . . . . 0.47 ' CD2' ' CB ' ' A' ' 879' ' ' TYR . 0.6 OUTLIER -89.73 105.11 17.58 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 115.207 -0.906 . . . . 0.050000000000000003 112.081 -177.443 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 887' ' ' THR . . . . . . . . . . . . . 85.0 m -95.96 100.36 12.04 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 107.711 -1.218 . . . . 0.68000000000000005 107.711 177.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 888' ' ' ALA . . . . . . . . . . . . . . . -98.42 107.43 42.01 Favored Pre-proline 0 N--CA 1.501 2.124 0 N-CA-C 114.094 1.146 . . . . 0.25 114.094 -176.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 889' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -90.19 -12.53 2.71 Favored 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 121.066 1.177 . . . . 1.6399999999999999 109.243 176.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 890' ' ' LEU . . . . . . . . . . . . . 63.6 mt -36.11 -50.52 0.71 Allowed 'General case' 0 N--CA 1.508 2.466 0 N-CA-C 113.856 1.058 . . . . 2.29 113.856 -177.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 51.68 95.84 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.342 0 O-C-N 121.158 -0.964 . . . . 0.63 110.314 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 156.58 -149.66 20.59 Favored Glycine 0 N--CA 1.479 1.562 0 N-CA-C 107.301 -2.32 . . . . 0.040000000000000001 107.301 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 70.7 ttt-85 -112.65 126.64 55.6 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 107.945 -1.131 . . . . 3.0 107.945 177.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 894' ' ' TYR . . . . . 0.424 ' CZ ' ' HB2' ' A' ' 896' ' ' LEU . 0.0 OUTLIER -131.21 155.09 47.67 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.045 -1.035 . . . . 0.040000000000000001 110.69 -179.178 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 895' ' ' LEU . . . . . 0.423 ' N ' ' CD1' ' A' ' 894' ' ' TYR . 34.9 tp -95.29 114.16 25.91 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.665 -0.647 . . . . 1.27 110.067 -179.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 896' ' ' LEU . . . . . 0.424 ' HB2' ' CZ ' ' A' ' 894' ' ' TYR . 9.8 tt -108.62 142.67 38.75 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.718 -0.614 . . . . 0.93999999999999995 110.628 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 897' ' ' SER . . . . . . . . . . . . . 69.9 m -147.41 115.4 6.5 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.516 -0.74 . . . . 0.040000000000000001 110.895 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.26 146.76 31.06 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.07 -0.715 . . . . 0.47999999999999998 109.07 179.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 899' ' ' VAL . . . . . . . . . . . . . 87.8 t -96.36 119.7 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 C-N-CA 119.627 -0.829 . . . . 0.55000000000000004 111.377 -179.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 900' ' ' LEU . . . . . 0.407 ' N ' ' CD2' ' A' ' 900' ' ' LEU . 4.5 mm? -94.39 111.53 23.28 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 114.057 1.132 . . . . 1.5900000000000001 114.057 -175.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 21.6 m -65.43 140.8 58.65 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 107.322 -1.362 . . . . 0.050000000000000003 107.322 177.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -64.66 -66.75 2.32 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 110.427 -1.069 . . . . 0.029999999999999999 110.427 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 5.9 m170 46.59 66.81 0.89 Allowed 'General case' 0 N--CA 1.507 2.403 0 O-C-N 121.522 -0.987 . . . . 3.2000000000000002 111.093 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 43.3 ptt85 -69.13 -5.76 24.33 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.542 -0.723 . . . . 2.9199999999999999 112.003 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 905' ' ' HIS . . . . . 0.485 ' O ' ' CB ' ' A' ' 906' ' ' GLU . 74.4 t60 -61.06 3.22 0.1 Allowed 'General case' 0 N--CA 1.506 2.328 0 O-C-N 120.834 -1.166 . . . . 2.8700000000000001 112.891 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 906' ' ' GLU . . . . . 0.485 ' CB ' ' O ' ' A' ' 905' ' ' HIS . 0.8 OUTLIER 93.69 -163.62 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.437 0 CA-C-N 120.513 1.506 . . . . 0.98999999999999999 112.425 178.549 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 907' ' ' LYS . . . . . 0.483 ' CB ' ' O ' ' A' ' 906' ' ' GLU . 51.2 tttt 88.95 161.18 0.06 Allowed 'General case' 0 N--CA 1.519 3.018 0 N-CA-C 107.72 -1.215 . . . . 5.25 107.72 -177.014 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 60.0 t -121.7 116.18 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 120.864 -1.148 . . . . 0.39000000000000001 110.787 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 54.1 tp10 -104.49 132.13 51.09 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 107.523 -1.288 . . . . 1.72 107.523 176.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -156.09 121.63 4.87 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 106.536 -1.653 . . . . 0.67000000000000004 106.536 178.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 911' ' ' VAL . . . . . 0.462 ' HA ' ' HA ' ' A' ' 964' ' ' VAL . 92.9 t -81.65 132.44 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.819 -0.551 . . . . 0.54000000000000004 110.753 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 71.6 mt -65.68 155.91 34.52 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.376 -0.828 . . . . 1.5 108.838 178.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 913' ' ' SER . . . . . 0.407 ' CB ' ' HB ' ' A' ' 919' ' ' VAL . 2.4 t -123.39 137.43 54.82 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.076 -1.083 . . . . 1.3700000000000001 108.076 176.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 914' ' ' ARG . . . . . 0.427 ' O ' ' CB ' ' A' ' 915' ' ' SER . 0.0 OUTLIER -64.28 154.14 36.06 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 120.791 -1.193 . . . . 4.2999999999999998 111.58 -179.001 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 915' ' ' SER . . . . . 0.427 ' CB ' ' O ' ' A' ' 914' ' ' ARG . 4.9 t 83.31 -32.27 0.08 Allowed 'General case' 0 N--CA 1.522 3.126 0 C-N-CA 124.016 0.927 . . . . 2.0499999999999998 112.294 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -122.37 -21.02 5.92 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 120.908 -1.12 . . . . 2.71 111.429 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 917' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 67.1 166.44 0.22 Allowed 'General case' 0 N--CA 1.521 3.102 0 N-CA-C 105.58 -2.007 . . . . 2.6800000000000002 105.58 -174.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.44 -125.79 35.25 Favored Glycine 1 N--CA 1.521 4.349 0 CA-C-N 123.405 2.82 . . . . 0.029999999999999999 107.001 -177.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 919' ' ' VAL . . . . . 0.407 ' HB ' ' CB ' ' A' ' 913' ' ' SER . 82.0 t 51.95 94.52 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.273 0 O-C-N 121.447 -1.031 . . . . 1.3899999999999999 108.915 -178.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.6 92.37 8.45 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.311 -0.955 . . . . 0.029999999999999999 111.12 -178.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 921' ' ' ARG . . . . . 0.434 ' HB3' ' CZ ' ' A' ' 950' ' ' PHE . 16.7 ptt180 -84.31 -42.25 16.0 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 105.752 -1.944 . . . . 4.4199999999999999 105.752 175.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 922' ' ' VAL . . . . . . . . . . . . . 75.1 t -103.75 69.63 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 N-CA-C 105.608 -1.997 . . . . 0.84999999999999998 105.608 175.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -89.68 136.26 33.14 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.887 0.851 . . . . 2.46 112.238 -176.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 13.2 t -146.48 103.4 3.68 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.922 -1.14 . . . . 0.69999999999999996 107.922 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -110.79 89.57 0.55 Allowed Glycine 0 N--CA 1.488 2.106 0 N-CA-C 108.941 -1.664 . . . . 0.040000000000000001 108.941 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.311 0 N-CA-C 109.324 -1.51 . . . . 0.040000000000000001 109.324 -179.604 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 22.8 m . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.063 0.458 . . . . 13.779999999999999 110.272 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 96.2 mt -112.88 129.88 56.3 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.54 -0.725 . . . . 13.76 110.403 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -151.57 167.86 30.95 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.056 -1.618 . . . . 9.1300000000000008 109.056 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 949' ' ' VAL . . . . . . . . . . . . . 32.9 m -118.95 130.34 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.501 -0.999 . . . . 7.0800000000000001 110.947 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 950' ' ' PHE . . . . . 0.434 ' CZ ' ' HB3' ' A' ' 921' ' ' ARG . 27.6 p90 -132.52 149.22 52.36 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.572 -0.705 . . . . 7.5899999999999999 109.283 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 19.5 m -120.19 -53.11 2.15 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.396 -0.815 . . . . 5.0300000000000002 112.04 -178.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 952' ' ' LEU . . . . . 0.417 ' O ' ' O ' ' A' ' 953' ' ' ILE . 16.8 tp -61.25 -74.3 0.08 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.388 -0.82 . . . . 1.01 112.309 -177.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 953' ' ' ILE . . . . . 0.463 ' O ' ' HB3' ' A' ' 954' ' ' LEU . 43.9 pt -53.27 -144.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.755 0 N-CA-C 114.034 1.124 . . . . 2.6000000000000001 114.034 -176.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 954' ' ' LEU . . . . . 0.559 ' N ' ' CD1' ' A' ' 954' ' ' LEU . 0.0 OUTLIER 171.46 78.8 0.04 OUTLIER Pre-proline 0 N--CA 1.51 2.572 0 O-C-N 120.762 -1.211 . . . . 0.050000000000000003 111.54 179.697 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 955' ' ' PRO . . . . . 0.432 ' HD2' ' CE1' ' A' ' 950' ' ' PHE . 47.1 Cg_endo -74.35 95.64 0.94 Allowed 'Trans proline' 0 C--N 1.313 -1.311 0 N-CA-C 109.343 -1.06 . . . . 0.83999999999999997 109.343 178.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 956' ' ' LEU . . . . . 0.403 ' CD2' ' NH1' ' A' ' 914' ' ' ARG . 10.2 mp -123.12 145.25 48.74 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.174 -0.954 . . . . 0.040000000000000001 110.236 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -84.66 151.17 24.64 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 117.814 -1.088 . . . . 1.28 111.856 -178.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -70.24 119.88 15.09 Favored 'General case' 0 N--CA 1.51 2.569 0 CA-C-N 122.926 2.603 . . . . 0.17000000000000001 111.943 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.81 -22.82 31.78 Favored Glycine 0 N--CA 1.502 3.065 0 N-CA-C 111.197 -0.761 . . . . 0.040000000000000001 111.197 178.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 960' ' ' ASP . . . . . 0.4 ' HB3' ' NE ' ' A' ' 914' ' ' ARG . 0.3 OUTLIER -53.3 171.74 0.07 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.505 -0.997 . . . . 0.040000000000000001 110.313 -179.341 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 961' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 886' ' ' PHE . 39.2 m -134.56 135.42 42.26 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.931 -1.106 . . . . 1.78 111.785 -178.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 962' ' ' VAL . . . . . 0.42 ' CG2' ' CB ' ' A' ' 886' ' ' PHE . 31.6 m -98.76 145.23 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 C-N-CA 120.045 -0.662 . . . . 0.040000000000000001 110.389 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 5.0 t -137.86 146.25 43.19 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.906 -0.496 . . . . 0.71999999999999997 110.131 -178.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 964' ' ' VAL . . . . . 0.462 ' HA ' ' HA ' ' A' ' 911' ' ' VAL . 58.3 t -95.06 136.37 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.091 -1.006 . . . . 1.05 110.503 -179.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -95.4 126.48 40.73 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 103.682 -2.71 . . . . 3.02 103.682 173.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 966' ' ' LEU . . . . . 0.4 ' O ' ' CG2' ' A' ' 967' ' ' VAL . 1.4 tt -133.46 61.29 1.68 Allowed 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.271 -1.011 . . . . 1.46 108.271 177.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 967' ' ' VAL . . . . . 0.4 ' CG2' ' O ' ' A' ' 966' ' ' LEU . 98.9 t -157.92 96.44 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 108.138 -1.06 . . . . 1.9399999999999999 108.138 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 93.1 mmm -143.04 58.45 1.41 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.708 -1.245 . . . . 0.0 108.198 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 133.09 119.21 2.0 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 106.538 -2.625 . . . . 2.1099999999999999 106.538 -177.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -84.83 -44.49 13.21 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 119.0 1.4 . . . . 5.8899999999999997 111.364 -179.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 43.0 tp -61.39 89.12 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.921 -1.112 . . . . 4.3600000000000003 110.081 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -141.89 -156.46 0.68 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.525 -0.734 . . . . 1.8300000000000001 110.272 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -121.61 176.05 5.91 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.535 -0.728 . . . . 4.3499999999999996 110.273 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 9.1 t -99.98 129.87 46.09 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.534 -0.728 . . . . 1.27 109.909 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -156.1 157.92 36.85 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.497 -0.752 . . . . 5.0199999999999996 110.671 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.33 86.8 16.41 Favored Pre-proline 0 N--CA 1.499 2.021 0 O-C-N 121.605 -0.684 . . . . 2.4100000000000001 109.506 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -72.91 -172.46 0.98 Allowed 'Trans proline' 0 C--N 1.318 -1.056 0 O-C-N 123.312 1.164 . . . . 0.95999999999999996 111.442 -179.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 5.0 mp -128.05 154.78 45.29 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 107.631 -1.248 . . . . 0.62 107.631 178.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 979' ' ' THR . . . . . . . . . . . . . 44.9 p -149.73 141.17 23.32 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.738 -1.226 . . . . 3.5699999999999998 111.279 -179.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 980' ' ' ILE . . . . . . . . . . . . . 50.3 mm -107.82 128.2 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 108.885 -0.783 . . . . 1.3300000000000001 108.885 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 981' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -121.88 97.33 5.44 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.428 -0.795 . . . . 0.050000000000000003 111.912 -178.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 92.6 p -108.84 158.44 17.66 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 109.041 -0.726 . . . . 0.87 109.041 178.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 983' ' ' GLY . . . . . 0.411 ' HA3' ' CE1' ' A' ' 852' ' ' PHE . . . -173.73 108.91 0.28 Allowed Glycine 0 N--CA 1.498 2.775 0 N-CA-C 106.635 -2.586 . . . . 0.029999999999999999 106.635 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -109.07 148.67 30.45 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 114.409 1.263 . . . . 0.69999999999999996 114.409 -175.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 35.1 tp -68.93 135.24 50.68 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 120.777 -1.202 . . . . 0.040000000000000001 110.275 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 50.8 tp -106.88 -58.8 1.89 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.648 -0.658 . . . . 0.040000000000000001 109.918 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -144.11 145.51 32.19 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 107.553 -1.277 . . . . 0.040000000000000001 107.553 179.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.69 163.29 12.17 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 108.23 -1.948 . . . . 0.040000000000000001 108.23 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -76.11 112.51 21.08 Favored Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.184 -1.186 . . . . 0.040000000000000001 109.41 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 990' ' ' PRO . . . . . 0.41 ' O ' ' HB2' ' A' ' 991' ' ' GLU . 49.8 Cg_endo -90.44 71.79 1.33 Allowed 'Trans proline' 0 C--N 1.318 -1.031 0 O-C-N 123.044 1.023 . . . . 0.45000000000000001 111.435 -178.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 991' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 990' ' ' PRO . 75.1 mt-10 67.44 -73.67 0.08 Allowed 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 108.476 -0.935 . . . . 1.97 108.476 -177.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 992' ' ' LEU . . . . . . . . . . . . . 11.0 mt 51.1 20.51 0.86 Allowed 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.504 -0.748 . . . . 2.3799999999999999 111.652 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 80.3 mt-10 -94.1 156.84 16.37 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.918 -1.114 . . . . 3.79 109.947 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -146.21 93.29 2.3 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.529 -0.732 . . . . 3.5099999999999998 110.333 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 995' ' ' ALA . . . . . . . . . . . . 2.518 . . . . . . . 0 N--CA 1.504 2.24 0 O-C-N 120.935 -1.103 . . . . 2.73 110.57 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo . . . . . 0 N--CA 1.488 1.171 0 N-CA-C 109.537 -0.986 . . . . 3.8300000000000001 109.537 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 847' ' ' VAL . . . . . . . . . . . . . 61.9 t -134.52 103.27 11.31 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.586 -0.696 . . . . 1.8300000000000001 110.054 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 848' ' ' PRO . . . . . 0.407 ' O ' ' C ' ' B' ' 849' ' ' GLN . 44.2 Cg_endo -69.91 -18.84 36.08 Favored 'Trans proline' 0 N--CA 1.488 1.182 0 O-C-N 123.321 1.169 . . . . 0.65000000000000002 111.314 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 849' ' ' GLN . . . . . 0.407 ' C ' ' O ' ' B' ' 848' ' ' PRO . 56.4 tt0 27.64 69.17 0.06 Allowed 'General case' 0 N--CA 1.518 2.957 0 N-CA-C 112.827 0.677 . . . . 2.5800000000000001 112.827 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 850' ' ' VAL . . . . . 0.418 ' CG1' ' CE2' ' B' ' 878' ' ' TYR . 61.9 t -119.27 135.89 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.202 -0.936 . . . . 1.0900000000000001 111.394 -178.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 851' ' ' ALA . . . . . . . . . . . . . . . -127.22 156.22 42.21 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 105.884 -1.895 . . . . 0.040000000000000001 105.884 176.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 852' ' ' PHE . . . . . 0.41 ' HA ' ' CB ' ' B' ' 874' ' ' ASN . 33.2 p90 -157.98 130.59 7.25 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 121.086 1.766 . . . . 0.050000000000000003 108.729 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 44.5 t -174.97 133.7 0.33 Allowed 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.214 -1.032 . . . . 0.040000000000000001 108.214 -179.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -133.65 155.98 48.72 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.096 -1.002 . . . . 0.67000000000000004 109.448 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 855' ' ' ALA . . . . . 0.408 ' O ' ' HB2' ' B' ' 870' ' ' ARG . . . -122.3 141.82 51.13 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.802 0.811 . . . . 0.51000000000000001 111.293 -179.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 856' ' ' LEU . . . . . 0.418 HD21 ' CG1' ' B' ' 866' ' ' VAL . 3.4 tm? -111.4 137.55 49.03 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.602 -0.686 . . . . 0.050000000000000003 110.016 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 857' ' ' SER . . . . . 0.419 ' O ' ' O ' ' B' ' 858' ' ' LEU . 1.5 m -156.43 17.05 0.33 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.543 -0.723 . . . . 1.3300000000000001 111.538 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 858' ' ' LEU . . . . . 0.419 ' O ' ' O ' ' B' ' 857' ' ' SER . 3.8 pp -35.2 160.45 0.04 OUTLIER Pre-proline 0 N--CA 1.52 3.028 0 N-CA-C 112.954 0.724 . . . . 2.3300000000000001 112.954 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -60.82 -88.6 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 120.877 1.051 . . . . 2.3199999999999998 113.803 -177.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 53.6 ptt85 -128.54 -142.74 0.26 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 120.897 -1.127 . . . . 0.040000000000000001 111.801 -177.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 15.2 m -37.96 126.12 1.23 Allowed 'General case' 0 N--CA 1.509 2.516 0 O-C-N 121.619 -0.676 . . . . 1.3100000000000001 112.3 -178.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 862' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.96 159.02 31.28 Favored Pre-proline 0 N--CA 1.489 1.511 0 N-CA-C 108.425 -0.954 . . . . 4.5099999999999998 108.425 177.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -70.9 -14.71 32.67 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 O-C-N 123.193 1.101 . . . . 2.2400000000000002 111.411 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -177.52 -134.97 2.12 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.508 -1.437 . . . . 0.040000000000000001 109.508 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 27.1 m -66.71 156.82 34.27 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.285 -1.126 . . . . 1.51 110.053 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 866' ' ' VAL . . . . . 0.418 ' CG1' HD21 ' B' ' 856' ' ' LEU . 61.1 t -99.44 137.34 20.3 Favored Pre-proline 0 N--CA 1.494 1.742 0 N-CA-C 113.485 0.92 . . . . 0.78000000000000003 113.485 -174.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 867' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -92.52 -149.82 0.03 OUTLIER 'Trans proline' 0 CA--C 1.546 1.121 0 C-N-CA 121.314 1.343 . . . . 0.92000000000000004 109.626 178.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 868' ' ' PHE . . . . . 0.451 ' CD1' ' N ' ' B' ' 868' ' ' PHE . 19.4 p90 -150.55 123.88 8.93 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.645 -1.284 . . . . 0.050000000000000003 109.765 179.158 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 46.5 p30 -113.34 -1.94 14.12 Favored 'General case' 0 N--CA 1.5 2.051 0 C-N-CA 119.287 -0.965 . . . . 1.7 112.56 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 870' ' ' ARG . . . . . 0.408 ' HB2' ' O ' ' B' ' 855' ' ' ALA . 26.4 mmm180 -90.47 89.05 7.41 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.848 -1.157 . . . . 2.5899999999999999 110.634 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 58.7 t -72.71 97.19 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.013 -1.054 . . . . 1.9399999999999999 109.864 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 872' ' ' LEU . . . . . . . . . . . . . 98.6 mt -83.14 -47.5 11.55 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.594 -0.691 . . . . 1.0600000000000001 110.155 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 873' ' ' LEU . . . . . . . . . . . . . 46.6 tp -175.0 104.14 0.09 Allowed 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.625 -0.88 . . . . 4.1799999999999997 108.625 178.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 874' ' ' ASN . . . . . 0.41 ' CB ' ' HA ' ' B' ' 852' ' ' PHE . 35.5 t-20 178.73 81.78 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.303 0 O-C-N 121.681 -0.637 . . . . 0.040000000000000001 109.74 -179.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -67.4 -48.12 68.3 Favored 'General case' 0 N--CA 1.499 1.998 0 C-N-CA 119.281 -0.967 . . . . 3.3799999999999999 111.164 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 876' ' ' GLY . . . . . . . . . . . . . . . -73.52 -25.57 72.17 Favored Glycine 0 N--CA 1.494 2.536 0 O-C-N 121.242 -0.911 . . . . 0.040000000000000001 111.599 -178.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 82.61 -61.15 4.78 Favored Glycine 0 N--CA 1.501 3.02 0 N-CA-C 108.105 -1.998 . . . . 0.040000000000000001 108.105 -178.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 878' ' ' TYR . . . . . 0.418 ' CE2' ' CG1' ' B' ' 850' ' ' VAL . 95.7 m-85 61.11 -62.94 0.08 Allowed 'General case' 0 N--CA 1.503 2.178 0 N-CA-C 114.361 1.245 . . . . 3.46 114.361 177.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 879' ' ' TYR . . . . . 0.477 ' CG ' ' O ' ' B' ' 879' ' ' TYR . 18.8 p90 -111.28 108.77 18.5 Favored 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 114.477 1.288 . . . . 0.040000000000000001 114.477 -176.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -65.09 114.67 16.0 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.37 -0.832 . . . . 0.02 110.085 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 881' ' ' PRO . . . . . 0.444 ' HG2' ' CD1' ' B' ' 868' ' ' PHE . 53.6 Cg_endo -75.14 -0.98 10.66 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 O-C-N 123.557 1.293 . . . . 0.39000000000000001 112.257 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -76.8 -65.48 0.94 Allowed 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 107.071 -1.455 . . . . 0.81000000000000005 107.071 178.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 32.4 p -92.39 -17.71 24.26 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.713 -0.847 . . . . 0.040000000000000001 108.713 177.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.78 20.09 60.33 Favored Glycine 0 N--CA 1.495 2.63 0 O-C-N 121.092 -1.005 . . . . 0.029999999999999999 111.538 178.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 885' ' ' VAL . . . . . . . . . . . . . 93.1 t -73.61 91.24 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 C-N-CA 118.13 -1.428 . . . . 1.01 108.058 -179.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 886' ' ' PHE . . . . . 0.463 ' CD2' ' CB ' ' B' ' 879' ' ' TYR . 0.6 OUTLIER -89.85 105.16 17.62 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 115.211 -0.904 . . . . 0.050000000000000003 112.056 -177.448 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 887' ' ' THR . . . . . . . . . . . . . 84.7 m -96.09 100.71 12.34 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 107.626 -1.25 . . . . 0.68000000000000005 107.626 177.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 888' ' ' ALA . . . . . . . . . . . . . . . -98.67 107.25 41.79 Favored Pre-proline 0 N--CA 1.502 2.148 0 N-CA-C 114.029 1.122 . . . . 0.25 114.029 -176.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 889' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -90.09 -12.6 2.75 Favored 'Trans proline' 0 CA--C 1.546 1.099 0 C-N-CA 121.043 1.162 . . . . 1.6399999999999999 109.274 176.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 890' ' ' LEU . . . . . . . . . . . . . 63.7 mt -36.02 -50.65 0.7 Allowed 'General case' 0 N--CA 1.509 2.481 0 N-CA-C 113.819 1.044 . . . . 2.29 113.819 -177.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 51.68 95.82 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.314 0 O-C-N 121.137 -0.977 . . . . 0.63 110.322 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . 156.6 -149.78 20.75 Favored Glycine 0 N--CA 1.479 1.564 0 N-CA-C 107.26 -2.336 . . . . 0.040000000000000001 107.26 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 71.1 ttt-85 -112.51 126.61 55.51 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 107.979 -1.119 . . . . 3.0 107.979 177.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 894' ' ' TYR . . . . . 0.435 ' CZ ' ' HB2' ' B' ' 896' ' ' LEU . 0.0 OUTLIER -131.1 155.29 47.2 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.122 -0.986 . . . . 0.040000000000000001 110.68 -179.133 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 895' ' ' LEU . . . . . 0.429 ' N ' ' CD1' ' B' ' 894' ' ' TYR . 34.8 tp -95.57 114.04 25.76 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.575 -0.703 . . . . 1.27 110.089 -179.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 896' ' ' LEU . . . . . 0.435 ' HB2' ' CZ ' ' B' ' 894' ' ' TYR . 9.7 tt -108.64 142.03 39.72 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.696 -0.628 . . . . 0.93999999999999995 110.695 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 897' ' ' SER . . . . . . . . . . . . . 69.6 m -146.75 115.27 6.74 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.565 -0.71 . . . . 0.040000000000000001 110.864 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.1 146.6 31.05 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.112 -0.699 . . . . 0.47999999999999998 109.112 179.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 899' ' ' VAL . . . . . . . . . . . . . 87.7 t -96.2 119.39 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 C-N-CA 119.6 -0.84 . . . . 0.55000000000000004 111.466 -179.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 900' ' ' LEU . . . . . 0.4 ' N ' ' CD2' ' B' ' 900' ' ' LEU . 4.5 mm? -94.11 111.11 22.8 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 114.2 1.185 . . . . 1.5900000000000001 114.2 -175.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 21.2 m -65.1 140.74 58.84 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 107.333 -1.358 . . . . 0.050000000000000003 107.333 177.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -64.88 -66.7 2.34 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.445 -1.062 . . . . 0.029999999999999999 110.445 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 5.8 m170 46.54 66.84 0.88 Allowed 'General case' 0 N--CA 1.508 2.428 0 O-C-N 121.439 -1.036 . . . . 3.2000000000000002 111.016 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 43.3 ptt85 -69.02 -6.05 25.56 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.591 -0.693 . . . . 2.9199999999999999 112.043 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 905' ' ' HIS . . . . . 0.48 ' O ' ' CB ' ' B' ' 906' ' ' GLU . 74.1 t60 -60.39 2.61 0.09 Allowed 'General case' 0 N--CA 1.506 2.332 0 O-C-N 120.857 -1.152 . . . . 2.8700000000000001 112.897 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 906' ' ' GLU . . . . . 0.48 ' CB ' ' O ' ' B' ' 905' ' ' HIS . 0.8 OUTLIER 93.95 -163.73 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.44 0 CA-C-N 120.584 1.538 . . . . 0.98999999999999999 112.36 178.741 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 907' ' ' LYS . . . . . 0.471 ' CB ' ' O ' ' B' ' 906' ' ' GLU . 51.5 tttt 89.13 161.01 0.06 Allowed 'General case' 0 N--CA 1.52 3.045 0 N-CA-C 107.755 -1.202 . . . . 5.25 107.755 -177.011 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 58.9 t -121.52 115.93 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 120.86 -1.15 . . . . 0.39000000000000001 110.93 -179.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 54.1 tp10 -104.35 132.21 50.85 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 107.546 -1.279 . . . . 1.72 107.546 177.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -156.25 121.82 4.85 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 106.56 -1.644 . . . . 0.67000000000000004 106.56 178.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 911' ' ' VAL . . . . . 0.454 ' HA ' ' HA ' ' B' ' 964' ' ' VAL . 92.4 t -81.86 132.67 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.791 -0.568 . . . . 0.54000000000000004 110.788 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 71.8 mt -65.76 156.08 34.19 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 108.763 -0.828 . . . . 1.5 108.763 178.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 913' ' ' SER . . . . . 0.41 ' CB ' ' CG1' ' B' ' 919' ' ' VAL . 2.4 t -123.81 136.56 54.47 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.157 -1.053 . . . . 1.3700000000000001 108.157 176.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 914' ' ' ARG . . . . . 0.419 ' O ' ' CB ' ' B' ' 915' ' ' SER . 0.0 OUTLIER -63.36 153.95 33.44 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 120.772 -1.205 . . . . 4.2999999999999998 111.701 -178.909 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 915' ' ' SER . . . . . 0.419 ' CB ' ' O ' ' B' ' 914' ' ' ARG . 4.9 t 83.49 -32.53 0.08 Allowed 'General case' 0 N--CA 1.52 3.06 0 C-N-CA 124.11 0.964 . . . . 2.0499999999999998 112.36 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 916' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -121.98 -21.4 6.01 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 120.797 -1.189 . . . . 2.71 111.461 -179.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 917' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 67.15 165.93 0.22 Allowed 'General case' 0 N--CA 1.52 3.026 0 N-CA-C 105.62 -1.993 . . . . 2.6800000000000002 105.62 -174.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 55.09 -125.86 37.06 Favored Glycine 1 N--CA 1.521 4.301 0 CA-C-N 123.575 2.898 . . . . 0.029999999999999999 106.882 -177.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 919' ' ' VAL . . . . . 0.41 ' CG1' ' CB ' ' B' ' 913' ' ' SER . 85.6 t 51.72 94.57 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.249 0 O-C-N 121.427 -1.043 . . . . 1.3899999999999999 108.96 -178.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.67 92.14 8.31 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 119.298 -0.961 . . . . 0.029999999999999999 111.114 -178.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 921' ' ' ARG . . . . . 0.438 ' HB3' ' CZ ' ' B' ' 950' ' ' PHE . 16.7 ptt180 -84.14 -42.25 16.22 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 105.749 -1.945 . . . . 4.4199999999999999 105.749 175.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 922' ' ' VAL . . . . . . . . . . . . . 75.0 t -103.78 69.42 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 105.563 -2.014 . . . . 0.84999999999999998 105.563 175.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -89.44 136.3 33.1 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.895 0.855 . . . . 2.46 112.22 -176.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 924' ' ' SER . . . . . . . . . . . . . 13.3 t -146.41 103.32 3.68 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 107.957 -1.127 . . . . 0.69999999999999996 107.957 178.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -110.62 89.39 0.54 Allowed Glycine 0 N--CA 1.488 2.154 0 N-CA-C 108.929 -1.668 . . . . 0.040000000000000001 108.929 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.385 0 N-CA-C 109.334 -1.506 . . . . 0.040000000000000001 109.334 -179.658 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 23.3 m . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.044 0.45 . . . . 13.779999999999999 110.218 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 96.2 mt -112.28 129.8 56.16 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.566 -0.709 . . . . 13.76 110.395 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -151.25 167.08 30.69 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.07 -1.612 . . . . 9.1300000000000008 109.07 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 949' ' ' VAL . . . . . . . . . . . . . 32.5 m -118.68 130.21 73.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.469 -1.018 . . . . 7.0800000000000001 110.85 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 950' ' ' PHE . . . . . 0.438 ' CZ ' ' HB3' ' B' ' 921' ' ' ARG . 27.8 p90 -132.41 149.44 52.34 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.591 -0.693 . . . . 7.5899999999999999 109.303 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 19.6 m -120.22 -52.72 2.16 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.413 -0.804 . . . . 5.0300000000000002 112.037 -178.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 952' ' ' LEU . . . . . 0.413 ' O ' ' O ' ' B' ' 953' ' ' ILE . 16.8 tp -61.59 -74.4 0.08 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.378 -0.827 . . . . 1.01 112.324 -177.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 953' ' ' ILE . . . . . 0.476 ' O ' ' HB3' ' B' ' 954' ' ' LEU . 44.8 pt -53.12 -143.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.723 0 N-CA-C 114.122 1.156 . . . . 2.6000000000000001 114.122 -176.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 954' ' ' LEU . . . . . 0.548 ' N ' ' CD1' ' B' ' 954' ' ' LEU . 0.0 OUTLIER 171.25 78.53 0.04 OUTLIER Pre-proline 0 N--CA 1.511 2.606 0 O-C-N 120.772 -1.205 . . . . 0.050000000000000003 111.507 179.609 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 955' ' ' PRO . . . . . 0.431 ' HD2' ' CE1' ' B' ' 950' ' ' PHE . 46.9 Cg_endo -74.28 95.86 0.94 Allowed 'Trans proline' 0 C--N 1.313 -1.306 0 N-CA-C 109.307 -1.074 . . . . 0.83999999999999997 109.307 178.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 956' ' ' LEU . . . . . 0.411 ' CD2' ' NH1' ' B' ' 914' ' ' ARG . 10.2 mp -123.28 145.19 48.89 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.15 -0.969 . . . . 0.040000000000000001 110.212 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -84.51 151.51 24.54 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 117.983 -1.008 . . . . 1.28 111.821 -179.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -70.47 119.66 14.96 Favored 'General case' 0 N--CA 1.51 2.566 0 CA-C-N 122.725 2.511 . . . . 0.17000000000000001 111.919 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.96 -23.1 30.72 Favored Glycine 0 N--CA 1.502 3.046 0 N-CA-C 111.154 -0.779 . . . . 0.040000000000000001 111.154 178.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 960' ' ' ASP . . . . . 0.401 ' HB3' ' NE ' ' B' ' 914' ' ' ARG . 0.4 OUTLIER -52.96 171.86 0.06 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.467 -1.02 . . . . 0.040000000000000001 110.376 -179.312 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 961' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' B' ' 886' ' ' PHE . 38.3 m -134.59 135.55 42.31 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.074 -1.016 . . . . 1.78 111.714 -178.094 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 962' ' ' VAL . . . . . 0.428 ' CG2' ' CB ' ' B' ' 886' ' ' PHE . 31.9 m -99.05 145.13 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 C-N-CA 119.989 -0.684 . . . . 0.040000000000000001 110.343 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 5.0 t -137.64 146.15 43.56 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.936 -0.478 . . . . 0.71999999999999997 110.166 -178.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 964' ' ' VAL . . . . . 0.454 ' HA ' ' HA ' ' B' ' 911' ' ' VAL . 58.3 t -95.13 136.07 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.073 -1.017 . . . . 1.05 110.529 -179.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -95.25 126.11 40.34 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 103.761 -2.681 . . . . 3.02 103.761 173.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 966' ' ' LEU . . . . . 0.402 ' O ' ' CG2' ' B' ' 967' ' ' VAL . 1.4 tt -133.13 61.39 1.68 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.309 -0.997 . . . . 1.46 108.309 177.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 967' ' ' VAL . . . . . 0.402 ' CG2' ' O ' ' B' ' 966' ' ' LEU . 98.5 t -158.04 96.25 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 108.148 -1.056 . . . . 1.9399999999999999 108.148 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 93.3 mmm -142.81 58.32 1.43 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.767 -1.208 . . . . 0.0 108.227 178.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 133.1 119.1 1.99 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 106.654 -2.578 . . . . 2.1099999999999999 106.654 -178.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -84.53 -44.53 13.49 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 118.912 1.356 . . . . 5.8899999999999997 111.404 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 43.3 tp -61.48 88.85 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.882 -1.136 . . . . 4.3600000000000003 110.048 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -141.59 -156.26 0.66 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.575 -0.703 . . . . 1.8300000000000001 110.249 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -121.68 176.28 5.8 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.599 -0.688 . . . . 4.3499999999999996 110.195 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 9.2 t -100.22 129.87 46.28 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.52 -0.738 . . . . 1.27 109.956 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -156.11 157.89 36.79 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.53 -0.731 . . . . 5.0199999999999996 110.629 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.31 86.75 16.51 Favored Pre-proline 0 N--CA 1.5 2.056 0 O-C-N 121.678 -0.639 . . . . 2.4100000000000001 109.521 179.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -72.92 -172.49 0.99 Allowed 'Trans proline' 0 N--CA 1.487 1.089 0 O-C-N 123.32 1.168 . . . . 0.95999999999999996 111.443 -179.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 978' ' ' LEU . . . . . . . . . . . . . 5.0 mp -127.93 154.99 44.92 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 107.619 -1.252 . . . . 0.62 107.619 178.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 979' ' ' THR . . . . . . . . . . . . . 44.3 p -149.9 141.07 23.08 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.746 -1.221 . . . . 3.5699999999999998 111.294 -179.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 980' ' ' ILE . . . . . 0.426 HG22 HD11 ' B' ' 980' ' ' ILE . 50.2 mm -107.84 127.8 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 108.892 -0.781 . . . . 1.3300000000000001 108.892 179.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -121.61 97.53 5.54 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 119.717 -0.793 . . . . 0.050000000000000003 111.906 -178.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 94.1 p -109.22 158.65 17.63 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.552 -0.717 . . . . 0.87 109.104 178.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 983' ' ' GLY . . . . . 0.409 ' HA3' ' CE1' ' B' ' 852' ' ' PHE . . . -173.66 109.07 0.29 Allowed Glycine 0 N--CA 1.499 2.872 0 N-CA-C 106.705 -2.558 . . . . 0.029999999999999999 106.705 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -109.07 148.71 30.4 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 114.361 1.245 . . . . 0.69999999999999996 114.361 -175.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 985' ' ' LEU . . . . . . . . . . . . . 35.0 tp -69.03 135.17 50.43 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.796 -1.19 . . . . 0.040000000000000001 110.255 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 986' ' ' LEU . . . . . . . . . . . . . 50.5 tp -106.88 -58.82 1.89 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.639 -0.663 . . . . 0.040000000000000001 109.932 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -144.07 145.34 32.1 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.591 -1.263 . . . . 0.040000000000000001 107.591 179.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.61 163.03 12.2 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 108.163 -1.975 . . . . 0.040000000000000001 108.163 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -75.76 112.48 20.02 Favored Pre-proline 0 N--CA 1.499 1.984 0 O-C-N 121.243 -1.151 . . . . 0.040000000000000001 109.406 179.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 990' ' ' PRO . . . . . 0.413 ' O ' ' HB2' ' B' ' 991' ' ' GLU . 49.6 Cg_endo -90.38 71.86 1.35 Allowed 'Trans proline' 0 C--N 1.319 -1.005 0 O-C-N 123.133 1.07 . . . . 0.45000000000000001 111.373 -179.012 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 991' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' B' ' 990' ' ' PRO . 74.9 mt-10 67.34 -73.56 0.08 Allowed 'General case' 0 N--CA 1.502 2.149 0 N-CA-C 108.552 -0.907 . . . . 1.97 108.552 -177.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 992' ' ' LEU . . . . . . . . . . . . . 10.9 mt 51.18 20.28 0.86 Allowed 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.536 -0.727 . . . . 2.3799999999999999 111.677 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 80.3 mt-10 -93.75 156.79 16.48 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.895 -1.128 . . . . 3.79 109.976 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 70.6 m80 -146.24 92.79 2.22 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.444 -0.785 . . . . 3.5099999999999998 110.388 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 995' ' ' ALA . . . . . . . . . . . . 2.517 . . . . . . . 0 N--CA 1.504 2.255 0 O-C-N 120.935 -1.103 . . . . 2.73 110.612 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo . . . . . 0 N--CA 1.488 1.158 0 N-CA-C 109.539 -0.985 . . . . 3.8300000000000001 109.539 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 847' ' ' VAL . . . . . . . . . . . . . 58.2 t -126.48 106.41 23.87 Favored Pre-proline 0 N--CA 1.496 1.835 0 O-C-N 121.597 -0.689 . . . . 1.8300000000000001 110.012 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 848' ' ' PRO . . . . . 0.403 ' O ' ' C ' ' C' ' 849' ' ' GLN . 44.4 Cg_endo -69.7 -22.68 32.01 Favored 'Trans proline' 0 N--CA 1.488 1.177 0 O-C-N 123.278 1.146 . . . . 0.65000000000000002 111.034 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 849' ' ' GLN . . . . . 0.403 ' C ' ' O ' ' C' ' 848' ' ' PRO . 54.5 tt0 25.17 64.9 0.06 Allowed 'General case' 0 N--CA 1.519 2.991 0 N-CA-C 113.379 0.881 . . . . 2.5800000000000001 113.379 179.138 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 850' ' ' VAL . . . . . . . . . . . . . 72.1 t -119.06 135.5 59.27 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.117 -0.989 . . . . 1.0900000000000001 111.028 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 851' ' ' ALA . . . . . . . . . . . . . . . -126.96 155.93 42.34 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 105.758 -1.942 . . . . 0.040000000000000001 105.758 176.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 852' ' ' PHE . . . . . 0.451 ' CD1' ' N ' ' C' ' 852' ' ' PHE . 16.0 p90 -160.26 127.38 4.41 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 121.016 1.734 . . . . 0.050000000000000003 108.625 178.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 38.8 t -176.65 134.88 0.22 Allowed 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.18 -1.044 . . . . 0.040000000000000001 108.18 -179.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -132.21 156.96 45.53 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.164 -0.96 . . . . 0.67000000000000004 109.779 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 855' ' ' ALA . . . . . . . . . . . . . . . -122.41 140.53 52.6 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.759 0.79 . . . . 0.51000000000000001 111.179 -179.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 856' ' ' LEU . . . . . 0.423 HD21 ' CG1' ' C' ' 866' ' ' VAL . 3.5 tm? -111.74 138.14 48.71 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.641 -0.662 . . . . 0.050000000000000003 110.036 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 857' ' ' SER . . . . . 0.427 ' O ' ' O ' ' C' ' 858' ' ' LEU . 21.1 m -155.27 18.66 0.42 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.395 -0.815 . . . . 1.3300000000000001 111.347 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 858' ' ' LEU . . . . . 0.427 ' O ' ' O ' ' C' ' 857' ' ' SER . 3.2 pp -34.81 160.87 0.04 OUTLIER Pre-proline 0 N--CA 1.52 3.067 0 N-CA-C 113.066 0.765 . . . . 2.3300000000000001 113.066 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -60.34 -88.22 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.462 0 O-C-N 122.99 0.995 . . . . 2.3199999999999998 113.455 -178.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 55.2 ptt85 -128.31 -143.34 0.27 Allowed 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.823 -1.173 . . . . 0.040000000000000001 111.808 -177.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 69.4 m -37.84 130.32 1.11 Allowed 'General case' 0 N--CA 1.511 2.581 0 O-C-N 121.622 -0.673 . . . . 1.3100000000000001 112.356 -178.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.14 160.45 26.03 Favored Pre-proline 0 N--CA 1.489 1.476 0 N-CA-C 108.326 -0.99 . . . . 4.5099999999999998 108.326 177.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.78 -13.57 26.83 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 O-C-N 123.152 1.08 . . . . 2.2400000000000002 111.453 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -177.78 -136.2 2.44 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.664 -1.374 . . . . 0.040000000000000001 109.664 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 17.0 m -68.23 153.86 42.89 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.329 -1.1 . . . . 1.51 109.92 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 866' ' ' VAL . . . . . 0.423 ' CG1' HD21 ' C' ' 856' ' ' LEU . 39.4 t -97.72 139.78 21.56 Favored Pre-proline 0 N--CA 1.493 1.691 0 N-CA-C 113.507 0.928 . . . . 0.78000000000000003 113.507 -174.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 867' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -91.4 -147.86 0.03 OUTLIER 'Trans proline' 0 CA--C 1.544 0.998 0 O-C-N 123.688 1.362 . . . . 0.92000000000000004 108.95 177.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 868' ' ' PHE . . . . . 0.458 ' CD1' ' HG2' ' C' ' 881' ' ' PRO . 14.0 p90 -149.88 124.12 9.52 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.51 -1.368 . . . . 0.050000000000000003 110.109 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 47.6 p-10 -112.45 -3.08 14.53 Favored 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 119.131 -1.027 . . . . 1.7 112.508 -178.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 870' ' ' ARG . . . . . . . . . . . . . 28.0 mmm180 -91.85 87.86 6.41 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.925 -1.109 . . . . 2.5899999999999999 111.112 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 60.7 t -71.55 96.94 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 120.927 -1.108 . . . . 1.9399999999999999 109.337 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 872' ' ' LEU . . . . . . . . . . . . . 95.3 mt -87.29 -44.73 11.2 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.592 -0.692 . . . . 1.0600000000000001 110.678 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 873' ' ' LEU . . . . . 0.414 ' O ' ' HB2' ' C' ' 874' ' ' ASN . 33.0 tp -172.91 102.02 0.13 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.101 -0.999 . . . . 4.1799999999999997 108.947 178.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 874' ' ' ASN . . . . . 0.414 ' HB2' ' O ' ' C' ' 873' ' ' LEU . 34.0 t-20 176.99 82.09 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.284 0 N-CA-C 108.987 -0.746 . . . . 0.040000000000000001 108.987 -179.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -65.34 -47.27 77.07 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.107 -0.995 . . . . 3.3799999999999999 111.308 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 876' ' ' GLY . . . . . 0.422 ' HA3' ' CE2' ' C' ' 878' ' ' TYR . . . -72.58 -26.47 71.59 Favored Glycine 0 N--CA 1.493 2.483 0 C-N-CA 120.423 -0.894 . . . . 0.040000000000000001 111.436 -178.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 79.61 -63.13 4.03 Favored Glycine 0 N--CA 1.5 2.956 0 N-CA-C 108.102 -1.999 . . . . 0.040000000000000001 108.102 -178.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 878' ' ' TYR . . . . . 0.422 ' CE2' ' HA3' ' C' ' 876' ' ' GLY . 89.4 m-85 60.76 -64.79 0.06 Allowed 'General case' 0 N--CA 1.502 2.146 0 N-CA-C 114.276 1.213 . . . . 3.46 114.276 177.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 879' ' ' TYR . . . . . 0.483 ' CE2' ' CD1' ' C' ' 981' ' ' PHE . 22.3 p90 -109.93 106.93 16.67 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 114.976 1.473 . . . . 0.040000000000000001 114.976 -176.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -69.64 119.22 69.58 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.401 -0.812 . . . . 0.02 109.759 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 881' ' ' PRO . . . . . 0.458 ' HG2' ' CD1' ' C' ' 868' ' ' PHE . 55.3 Cg_endo -79.26 -0.16 10.51 Favored 'Trans proline' 0 N--CA 1.487 1.132 0 O-C-N 123.363 1.191 . . . . 0.39000000000000001 111.563 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -76.31 -62.84 1.48 Allowed 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 106.433 -1.691 . . . . 0.81000000000000005 106.433 178.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 24.3 p -88.46 -21.87 23.98 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.136 -1.061 . . . . 0.040000000000000001 108.136 176.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 81.77 16.35 73.13 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 110.401 -1.079 . . . . 0.029999999999999999 110.401 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 84.4 t -73.93 91.91 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 C-N-CA 118.397 -1.321 . . . . 1.01 108.111 -179.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 886' ' ' PHE . . . . . 0.512 ' O ' ' HA ' ' C' ' 961' ' ' THR . 1.1 t80 -87.46 105.7 17.47 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 115.17 -0.923 . . . . 0.050000000000000003 111.628 -177.436 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 887' ' ' THR . . . . . 0.406 ' O ' ' HD3' ' C' ' 889' ' ' PRO . 86.7 m -102.45 99.72 9.79 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 107.806 -1.183 . . . . 0.68000000000000005 107.806 177.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 888' ' ' ALA . . . . . . . . . . . . . . . -98.66 101.19 11.14 Favored Pre-proline 0 N--CA 1.501 2.084 0 N-CA-C 114.388 1.255 . . . . 0.25 114.388 -176.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 889' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' C' ' 887' ' ' THR . 55.7 Cg_endo -80.06 -15.3 11.76 Favored 'Trans proline' 0 N--CA 1.486 1.042 0 N-CA-C 108.73 -1.296 . . . . 1.6399999999999999 108.73 175.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 890' ' ' LEU . . . . . . . . . . . . . 60.7 mt -37.35 -49.5 0.99 Allowed 'General case' 0 N--CA 1.508 2.425 0 N-CA-C 113.452 0.908 . . . . 2.29 113.452 -177.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 52.36 97.19 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.267 0 O-C-N 121.19 -0.944 . . . . 0.63 110.285 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . 158.94 -154.21 25.3 Favored Glycine 0 N--CA 1.477 1.422 0 N-CA-C 107.272 -2.331 . . . . 0.040000000000000001 107.272 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 74.5 ttt-85 -117.36 123.23 45.96 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.612 -0.934 . . . . 3.0 108.761 177.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 894' ' ' TYR . . . . . 0.43 ' CE2' HD22 ' C' ' 954' ' ' LEU . 20.3 p90 -133.78 155.54 49.62 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.117 -0.989 . . . . 0.040000000000000001 110.956 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 895' ' ' LEU . . . . . . . . . . . . . 49.0 tp -97.82 115.41 28.0 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.719 -0.613 . . . . 1.27 110.268 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 896' ' ' LEU . . . . . . . . . . . . . 9.3 tt -118.36 144.6 45.77 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.654 -0.654 . . . . 0.93999999999999995 109.945 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 897' ' ' SER . . . . . . . . . . . . . 55.4 m -141.82 124.57 16.01 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.429 -0.795 . . . . 0.040000000000000001 111.284 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -101.89 148.17 25.64 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.789 -0.819 . . . . 0.47999999999999998 108.789 178.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 899' ' ' VAL . . . . . . . . . . . . . 87.4 t -92.49 120.31 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.35 -0.844 . . . . 0.55000000000000004 111.256 -179.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 94.6 mt -92.78 112.23 24.11 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 114.036 1.125 . . . . 1.5900000000000001 114.036 -175.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 20.7 m -63.48 140.4 58.87 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 107.472 -1.307 . . . . 0.050000000000000003 107.472 177.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -61.12 -65.23 3.42 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 110.344 -1.103 . . . . 0.029999999999999999 110.344 -179.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 5.9 m170 45.86 64.39 1.48 Allowed 'General case' 0 N--CA 1.507 2.397 0 O-C-N 121.556 -0.967 . . . . 3.2000000000000002 111.239 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 42.7 ptt85 -67.68 -7.96 31.12 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.614 -0.679 . . . . 2.9199999999999999 111.83 -179.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 905' ' ' HIS . . . . . 0.493 ' O ' ' CB ' ' C' ' 906' ' ' GLU . 75.8 t60 -61.97 6.12 0.08 Allowed 'General case' 0 N--CA 1.506 2.342 0 CA-C-O 117.649 -1.167 . . . . 2.8700000000000001 113.468 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 906' ' ' GLU . . . . . 0.493 ' CB ' ' O ' ' C' ' 905' ' ' HIS . 0.8 OUTLIER 93.07 -163.45 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.441 0 CA-C-N 121.252 1.842 . . . . 0.98999999999999999 112.012 178.983 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 907' ' ' LYS . . . . . 0.493 ' CB ' ' O ' ' C' ' 906' ' ' GLU . 25.8 ttmt 89.9 161.91 0.05 OUTLIER 'General case' 0 N--CA 1.522 3.136 0 N-CA-C 108.061 -1.088 . . . . 5.25 108.061 -177.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 59.6 t -121.67 117.34 52.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 120.841 -1.162 . . . . 0.39000000000000001 110.915 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 43.1 tp10 -104.5 130.91 52.4 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 107.486 -1.302 . . . . 1.72 107.486 177.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -157.18 121.13 4.24 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 106.887 -1.523 . . . . 0.67000000000000004 106.887 178.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 911' ' ' VAL . . . . . 0.47 ' HA ' ' HA ' ' C' ' 964' ' ' VAL . 97.8 t -83.42 132.06 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.784 -0.573 . . . . 0.54000000000000004 110.863 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 64.4 mt -66.18 157.41 31.4 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.478 -0.764 . . . . 1.5 109.243 178.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 913' ' ' SER . . . . . 0.417 ' CB ' ' CG1' ' C' ' 919' ' ' VAL . 2.2 t -125.4 137.96 54.02 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.212 -1.033 . . . . 1.3700000000000001 108.212 176.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 914' ' ' ARG . . . . . 0.425 ' O ' ' CB ' ' C' ' 915' ' ' SER . 0.0 OUTLIER -63.94 154.06 35.11 Favored 'General case' 0 N--CA 1.504 2.275 0 O-C-N 120.681 -1.262 . . . . 4.2999999999999998 111.88 -178.714 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 915' ' ' SER . . . . . 0.425 ' CB ' ' O ' ' C' ' 914' ' ' ARG . 4.0 t 83.06 -31.41 0.09 Allowed 'General case' 0 N--CA 1.521 3.124 0 C-N-CA 123.865 0.866 . . . . 2.0499999999999998 112.382 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 916' ' ' ASN . . . . . 0.409 ' O ' ' HB2' ' C' ' 917' ' ' GLN . 94.5 m-20 -122.37 -21.72 5.72 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.785 -1.197 . . . . 2.71 111.252 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 917' ' ' GLN . . . . . 0.409 ' HB2' ' O ' ' C' ' 916' ' ' ASN . 46.5 mt-30 67.36 167.81 0.24 Allowed 'General case' 0 N--CA 1.52 3.044 0 N-CA-C 105.608 -1.997 . . . . 2.6800000000000002 105.608 -174.013 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.91 -127.47 41.08 Favored Glycine 1 N--CA 1.52 4.289 0 CA-C-N 123.589 2.904 . . . . 0.029999999999999999 107.022 -177.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 919' ' ' VAL . . . . . 0.417 ' CG1' ' CB ' ' C' ' 913' ' ' SER . 92.6 t 50.54 94.53 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.233 0 O-C-N 121.466 -1.02 . . . . 1.3899999999999999 109.206 -178.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 920' ' ' ALA . . . . . . . . . . . . . . . -93.21 94.37 8.76 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.395 -0.922 . . . . 0.029999999999999999 110.943 -179.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 921' ' ' ARG . . . . . 0.433 ' HB3' ' CZ ' ' C' ' 950' ' ' PHE . 40.7 ptt85 -81.36 -42.29 20.71 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 105.766 -1.938 . . . . 4.4199999999999999 105.766 176.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 922' ' ' VAL . . . . . . . . . . . . . 73.6 t -100.82 74.92 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 N-CA-C 105.523 -2.029 . . . . 0.84999999999999998 105.523 175.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -89.95 135.08 33.86 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.87 0.843 . . . . 2.46 112.315 -176.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 4.4 t -147.33 102.94 3.52 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.973 -1.121 . . . . 0.69999999999999996 107.973 178.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -110.08 89.84 0.56 Allowed Glycine 0 N--CA 1.488 2.105 0 N-CA-C 108.952 -1.659 . . . . 0.040000000000000001 108.952 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.33 0 N-CA-C 109.3 -1.52 . . . . 0.040000000000000001 109.3 -179.685 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 24.9 m . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 120.928 0.394 . . . . 13.779999999999999 110.355 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 95.6 mt -114.47 129.78 56.68 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.572 -0.705 . . . . 13.76 110.347 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -152.03 169.85 31.37 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.316 -1.514 . . . . 9.1300000000000008 109.316 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 949' ' ' VAL . . . . . . . . . . . . . 34.0 m -118.24 135.65 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.513 -0.993 . . . . 7.0800000000000001 110.985 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 950' ' ' PHE . . . . . 0.433 ' CZ ' ' HB3' ' C' ' 921' ' ' ARG . 49.4 p90 -134.76 151.92 51.35 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.524 -0.735 . . . . 7.5899999999999999 109.348 179.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 26.6 m -119.01 -55.26 2.18 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.375 -0.828 . . . . 5.0300000000000002 111.956 -178.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 952' ' ' LEU . . . . . 0.452 ' O ' ' O ' ' C' ' 953' ' ' ILE . 52.8 tp -63.15 -76.37 0.07 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.359 -0.838 . . . . 1.01 111.688 -178.039 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 953' ' ' ILE . . . . . 0.466 ' O ' ' HB3' ' C' ' 954' ' ' LEU . 2.0 pp -49.12 -150.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.784 0 N-CA-C 114.699 1.37 . . . . 2.6000000000000001 114.699 -176.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 954' ' ' LEU . . . . . 0.576 ' N ' ' CD1' ' C' ' 954' ' ' LEU . 0.0 OUTLIER 170.99 89.14 0.04 OUTLIER Pre-proline 0 N--CA 1.516 2.836 0 O-C-N 120.74 -1.225 . . . . 0.050000000000000003 111.88 -179.477 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 955' ' ' PRO . . . . . 0.422 ' HD3' ' CD1' ' C' ' 953' ' ' ILE . 50.9 Cg_endo -83.41 93.7 0.82 Allowed 'Trans proline' 0 C--N 1.317 -1.1 0 N-CA-C 109.419 -1.031 . . . . 0.83999999999999997 109.419 178.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 956' ' ' LEU . . . . . . . . . . . . . 7.9 mp -126.28 150.13 48.66 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.07 -1.019 . . . . 0.040000000000000001 110.772 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -83.16 151.81 25.54 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 117.743 -1.122 . . . . 1.28 111.518 -178.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -66.88 119.32 11.7 Favored 'General case' 0 N--CA 1.509 2.515 0 CA-C-N 123.022 2.647 . . . . 0.17000000000000001 111.213 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.72 -19.98 47.85 Favored Glycine 0 N--CA 1.499 2.882 0 N-CA-C 110.907 -0.877 . . . . 0.040000000000000001 110.907 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 960' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.44 170.58 0.15 Allowed 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.409 -1.054 . . . . 0.040000000000000001 110.353 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 961' ' ' THR . . . . . 0.512 ' HA ' ' O ' ' C' ' 886' ' ' PHE . 39.3 m -136.93 141.0 42.66 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.989 -1.069 . . . . 1.78 112.614 -177.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 962' ' ' VAL . . . . . 0.41 ' CG2' ' CB ' ' C' ' 886' ' ' PHE . 27.3 m -99.88 145.18 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 C-N-CA 120.395 -0.522 . . . . 0.040000000000000001 110.696 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 5.2 t -137.53 143.85 41.84 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.828 -0.545 . . . . 0.71999999999999997 109.861 -178.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 964' ' ' VAL . . . . . 0.47 ' HA ' ' HA ' ' C' ' 911' ' ' VAL . 61.6 t -91.94 136.94 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.103 -0.998 . . . . 1.05 110.733 -178.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -93.68 126.37 38.81 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 103.566 -2.753 . . . . 3.02 103.566 173.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 966' ' ' LEU . . . . . 0.404 ' O ' ' CG2' ' C' ' 967' ' ' VAL . 0.2 OUTLIER -133.63 59.23 1.74 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.662 -0.866 . . . . 1.46 108.662 177.503 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 967' ' ' VAL . . . . . 0.404 ' CG2' ' O ' ' C' ' 966' ' ' LEU . 99.5 t -157.8 96.31 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 108.327 -0.99 . . . . 1.9399999999999999 108.327 179.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 91.8 mmm -143.04 58.65 1.41 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.736 -1.227 . . . . 0.0 108.562 179.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 134.19 119.46 1.97 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 107.372 -2.291 . . . . 2.1099999999999999 107.372 -178.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 -82.76 -58.12 3.02 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.048 -1.266 . . . . 5.8899999999999997 110.662 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 46.3 tp -58.78 89.74 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.455 -0.778 . . . . 4.3600000000000003 110.449 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -143.33 -151.72 0.38 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.536 -0.727 . . . . 1.8300000000000001 110.011 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -117.0 167.03 11.5 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.352 -0.843 . . . . 4.3499999999999996 110.082 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 30.2 t -101.49 130.3 47.73 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.523 -0.736 . . . . 1.27 110.075 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -155.62 156.55 35.23 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.504 -0.747 . . . . 5.0199999999999996 110.525 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.76 84.82 17.53 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.679 -0.638 . . . . 2.4100000000000001 109.779 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -74.49 -172.19 1.13 Allowed 'Trans proline' 0 C--N 1.316 -1.16 0 O-C-N 123.359 1.189 . . . . 0.95999999999999996 111.074 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 978' ' ' LEU . . . . . . . . . . . . . 6.3 mp -123.32 156.42 35.36 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.456 -1.312 . . . . 0.62 107.456 177.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 979' ' ' THR . . . . . . . . . . . . . 47.6 p -149.33 141.49 23.99 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.733 -1.229 . . . . 3.5699999999999998 111.19 -179.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 980' ' ' ILE . . . . . . . . . . . . . 51.2 mm -105.8 128.22 60.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 108.974 -0.75 . . . . 1.3300000000000001 108.974 179.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 981' ' ' PHE . . . . . 0.483 ' CD1' ' CE2' ' C' ' 879' ' ' TYR . 3.3 t80 -117.95 95.76 5.05 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.394 -0.816 . . . . 0.050000000000000003 111.324 -178.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 982' ' ' SER . . . . . . . . . . . . . 11.6 p -108.18 158.43 17.45 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.599 -0.688 . . . . 0.87 109.213 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 983' ' ' GLY . . . . . 0.427 ' HA3' ' CE2' ' C' ' 852' ' ' PHE . . . -171.65 114.61 0.54 Allowed Glycine 0 N--CA 1.496 2.69 0 N-CA-C 106.648 -2.581 . . . . 0.029999999999999999 106.648 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 984' ' ' ALA . . . . . . . . . . . . . . . -108.92 151.57 26.11 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 114.213 1.19 . . . . 0.69999999999999996 114.213 -175.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 985' ' ' LEU . . . . . . . . . . . . . 55.4 tp -76.43 135.88 39.43 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.819 -1.176 . . . . 0.040000000000000001 109.701 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 986' ' ' LEU . . . . . . . . . . . . . 47.2 tp -106.75 -61.8 1.48 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.491 -0.756 . . . . 0.040000000000000001 110.36 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -144.13 146.67 32.92 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 107.786 -1.191 . . . . 0.040000000000000001 107.786 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.25 162.91 12.25 Favored Glycine 0 N--CA 1.495 2.616 0 N-CA-C 108.071 -2.012 . . . . 0.040000000000000001 108.071 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -74.95 112.76 19.31 Favored Pre-proline 0 N--CA 1.498 1.946 0 O-C-N 121.15 -1.206 . . . . 0.040000000000000001 109.48 179.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 990' ' ' PRO . . . . . 0.416 ' O ' ' HB2' ' C' ' 991' ' ' GLU . 50.2 Cg_endo -89.13 71.26 2.09 Favored 'Trans proline' 0 C--N 1.32 -0.967 0 O-C-N 123.108 1.057 . . . . 0.45000000000000001 111.291 -179.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 991' ' ' GLU . . . . . 0.416 ' HB2' ' O ' ' C' ' 990' ' ' PRO . 73.6 mt-10 67.52 -73.46 0.08 Allowed 'General case' 0 N--CA 1.503 2.182 0 N-CA-C 108.518 -0.919 . . . . 1.97 108.518 -177.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 992' ' ' LEU . . . . . . . . . . . . . 10.8 mt 50.48 20.73 0.73 Allowed 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.568 -0.707 . . . . 2.3799999999999999 111.748 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -93.47 156.75 16.57 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.878 -1.139 . . . . 3.79 110.044 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 68.7 m80 -145.64 92.65 2.25 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.509 -0.745 . . . . 3.5099999999999998 110.254 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 995' ' ' ALA . . . . . . . . . . . . 2.519 . . . . . . . 0 N--CA 1.504 2.249 0 O-C-N 120.968 -1.082 . . . . 2.73 110.637 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo . . . . . 0 N--CA 1.488 1.151 0 N-CA-C 109.491 -1.004 . . . . 3.8300000000000001 109.491 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 847' ' ' VAL . . . . . . . . . . . . . 59.0 t -133.78 102.68 12.32 Favored Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 121.546 -0.721 . . . . 1.8300000000000001 109.993 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 848' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.79 -19.25 36.22 Favored 'Trans proline' 0 N--CA 1.487 1.114 0 O-C-N 123.316 1.166 . . . . 0.65000000000000002 111.272 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 849' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 27.91 68.09 0.07 Allowed 'General case' 0 N--CA 1.518 2.953 0 N-CA-C 112.901 0.704 . . . . 2.5800000000000001 112.901 179.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 850' ' ' VAL . . . . . . . . . . . . . 65.3 t -119.65 137.01 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.148 -0.97 . . . . 1.0900000000000001 111.51 -178.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 851' ' ' ALA . . . . . . . . . . . . . . . -123.79 159.92 28.47 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 105.921 -1.881 . . . . 0.040000000000000001 105.921 176.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 852' ' ' PHE . . . . . 0.416 ' CE1' ' HA3' ' A' ' 983' ' ' GLY . 34.2 p90 -159.29 127.82 5.15 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 120.88 1.673 . . . . 0.050000000000000003 108.465 178.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 8.8 t -175.4 134.49 0.31 Allowed 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.185 -1.042 . . . . 0.040000000000000001 108.185 -178.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -130.24 156.92 43.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.03 -1.044 . . . . 0.67000000000000004 109.739 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 855' ' ' ALA . . . . . 0.422 ' O ' ' HB2' ' A' ' 870' ' ' ARG . . . -119.76 144.11 47.45 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.806 0.813 . . . . 0.51000000000000001 110.809 -179.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 856' ' ' LEU . . . . . 0.412 HD21 ' CG1' ' A' ' 866' ' ' VAL . 2.1 tm? -115.21 134.23 55.33 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.508 -0.745 . . . . 0.050000000000000003 110.45 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 857' ' ' SER . . . . . 0.411 ' N ' HD13 ' A' ' 856' ' ' LEU . 1.7 m -156.74 14.41 0.28 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.486 -0.759 . . . . 1.3300000000000001 111.866 179.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 858' ' ' LEU . . . . . 0.409 ' O ' ' O ' ' A' ' 857' ' ' SER . 0.3 OUTLIER -36.56 162.28 0.04 OUTLIER Pre-proline 0 N--CA 1.524 3.231 0 CA-C-N 119.053 0.842 . . . . 2.3300000000000001 113.07 -179.58 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -61.26 -89.31 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.534 0 O-C-N 123.103 1.054 . . . . 2.3199999999999998 113.841 -177.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 53.9 ptt85 -134.21 -142.42 0.2 Allowed 'General case' 0 N--CA 1.502 2.144 0 O-C-N 120.761 -1.212 . . . . 0.040000000000000001 111.787 -177.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 5.2 m -36.65 126.89 0.86 Allowed 'General case' 0 N--CA 1.511 2.612 0 O-C-N 121.659 -0.651 . . . . 1.3100000000000001 112.366 -178.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -104.73 165.55 13.08 Favored Pre-proline 0 N--CA 1.489 1.496 0 N-CA-C 108.652 -0.87 . . . . 4.5099999999999998 108.652 177.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -73.54 -14.42 24.87 Favored 'Trans proline' 0 C--N 1.313 -1.311 0 O-C-N 123.284 1.149 . . . . 2.2400000000000002 111.388 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -177.93 -135.29 2.23 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 110.162 -1.175 . . . . 0.040000000000000001 110.162 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 26.4 m -64.71 156.65 29.69 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.41 -1.053 . . . . 1.51 110.912 -178.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 866' ' ' VAL . . . . . 0.412 ' CG1' HD21 ' A' ' 856' ' ' LEU . 56.2 t -96.95 132.79 25.22 Favored Pre-proline 0 N--CA 1.496 1.838 0 N-CA-C 113.453 0.908 . . . . 0.78000000000000003 113.453 -174.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 867' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -90.68 -149.51 0.03 OUTLIER 'Trans proline' 0 CA--C 1.545 1.066 0 O-C-N 123.571 1.3 . . . . 0.92000000000000004 109.332 177.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 868' ' ' PHE . . . . . 0.466 ' N ' ' CD1' ' A' ' 868' ' ' PHE . 19.4 p90 -150.34 123.49 8.86 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.584 -1.322 . . . . 0.050000000000000003 109.837 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 49.9 p-10 -113.62 -2.68 13.74 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.129 -0.982 . . . . 1.7 112.841 -178.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 870' ' ' ARG . . . . . 0.422 ' HB2' ' O ' ' A' ' 855' ' ' ALA . 28.2 mmm180 -91.58 89.9 7.37 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 120.819 -1.176 . . . . 2.5899999999999999 111.131 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 57.9 t -72.77 96.66 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 120.984 -1.072 . . . . 1.9399999999999999 109.694 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 872' ' ' LEU . . . . . . . . . . . . . 86.6 mt -83.32 -46.81 12.18 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.505 -0.747 . . . . 1.0600000000000001 110.164 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 873' ' ' LEU . . . . . . . . . . . . . 32.7 tp -174.33 102.35 0.1 Allowed 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 108.595 -0.891 . . . . 4.1799999999999997 108.595 178.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 33.9 t-20 178.33 80.98 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.256 0 N-CA-C 109.264 -0.643 . . . . 0.040000000000000001 109.264 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -65.41 -47.03 77.68 Favored 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 119.344 -0.942 . . . . 3.3799999999999999 111.129 -179.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 876' ' ' GLY . . . . . . . . . . . . . . . -73.97 -24.26 74.36 Favored Glycine 0 N--CA 1.494 2.55 0 O-C-N 121.316 -0.865 . . . . 0.040000000000000001 111.672 -178.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 84.41 -60.04 4.87 Favored Glycine 0 N--CA 1.502 3.099 0 N-CA-C 107.949 -2.06 . . . . 0.040000000000000001 107.949 -178.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 878' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 60.32 -66.63 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.14 0 N-CA-C 114.424 1.268 . . . . 3.46 114.424 177.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 879' ' ' TYR . . . . . 0.469 ' CB ' ' CD2' ' A' ' 886' ' ' PHE . 21.3 p90 -110.77 109.69 20.02 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 114.831 1.419 . . . . 0.040000000000000001 114.831 -176.235 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -66.0 117.08 38.97 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 121.534 -0.729 . . . . 0.02 110.191 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 881' ' ' PRO . . . . . 0.433 ' HG2' ' CD1' ' A' ' 868' ' ' PHE . 54.4 Cg_endo -75.88 0.39 9.31 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 O-C-N 123.413 1.217 . . . . 0.39000000000000001 112.222 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -75.35 -65.19 0.92 Allowed 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 106.952 -1.499 . . . . 0.81000000000000005 106.952 178.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 2.2 p -95.74 -17.0 21.57 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.802 -0.814 . . . . 0.040000000000000001 108.802 177.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.68 22.98 52.0 Favored Glycine 0 N--CA 1.494 2.533 0 C-N-CA 120.127 -1.035 . . . . 0.029999999999999999 110.664 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 885' ' ' VAL . . . . . . . . . . . . . 92.0 t -73.2 88.46 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 C-N-CA 118.357 -1.337 . . . . 1.01 107.917 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 886' ' ' PHE . . . . . 0.489 ' O ' ' HA ' ' A' ' 961' ' ' THR . 0.6 OUTLIER -89.13 106.38 18.4 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 115.04 -0.982 . . . . 0.050000000000000003 112.175 -177.053 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 887' ' ' THR . . . . . . . . . . . . . 97.0 m -98.85 99.16 10.2 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 107.495 -1.298 . . . . 0.68000000000000005 107.495 177.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 888' ' ' ALA . . . . . . . . . . . . . . . -97.25 108.11 42.39 Favored Pre-proline 0 N--CA 1.501 2.08 0 N-CA-C 114.207 1.188 . . . . 0.25 114.207 -176.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 889' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -89.39 -13.7 2.8 Favored 'Trans proline' 0 CA--C 1.546 1.076 0 O-C-N 123.288 1.152 . . . . 1.6399999999999999 109.137 176.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 890' ' ' LEU . . . . . . . . . . . . . 63.1 mt -35.93 -50.64 0.68 Allowed 'General case' 0 N--CA 1.509 2.508 0 N-CA-C 113.694 0.998 . . . . 2.29 113.694 -177.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 52.18 95.52 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.189 -0.945 . . . . 0.63 110.269 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 157.59 -154.09 25.23 Favored Glycine 0 N--CA 1.478 1.436 0 N-CA-C 107.055 -2.418 . . . . 0.040000000000000001 107.055 -179.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 893' ' ' ARG . . . . . 0.4 ' CZ ' ' CB ' ' C' ' 984' ' ' ALA . 71.0 ttt-85 -116.4 125.31 51.87 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.529 -0.983 . . . . 3.0 108.567 177.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 894' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -132.05 161.38 33.37 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.134 -0.979 . . . . 0.040000000000000001 111.084 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 895' ' ' LEU . . . . . . . . . . . . . 43.6 tp -91.86 119.48 31.68 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.723 -0.611 . . . . 1.27 110.274 -179.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 9.2 tt -110.18 144.42 38.85 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.742 -0.599 . . . . 0.93999999999999995 109.98 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 897' ' ' SER . . . . . . . . . . . . . 69.2 m -149.45 114.66 5.47 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.51 -0.744 . . . . 0.040000000000000001 111.032 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.41 146.27 31.88 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.915 -0.772 . . . . 0.47999999999999998 108.915 178.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 899' ' ' VAL . . . . . . . . . . . . . 87.3 t -96.52 119.18 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 C-N-CA 119.566 -0.854 . . . . 0.55000000000000004 111.16 -179.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 900' ' ' LEU . . . . . 0.42 ' CD2' ' N ' ' A' ' 900' ' ' LEU . 4.5 mm? -95.95 113.22 24.82 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 114.223 1.194 . . . . 1.5900000000000001 114.223 -175.107 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 18.3 m -65.38 140.92 58.69 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 107.551 -1.277 . . . . 0.050000000000000003 107.551 177.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -64.68 -65.31 3.03 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 110.573 -1.011 . . . . 0.029999999999999999 110.573 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 46.95 66.44 0.99 Allowed 'General case' 0 N--CA 1.507 2.42 0 O-C-N 121.515 -0.991 . . . . 3.2000000000000002 111.01 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 54.3 ptt85 -68.8 -6.49 27.04 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.618 -0.676 . . . . 2.9199999999999999 112.059 -179.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 905' ' ' HIS . . . . . 0.491 ' O ' ' CB ' ' A' ' 906' ' ' GLU . 73.0 t60 -62.64 5.16 0.13 Allowed 'General case' 0 N--CA 1.505 2.293 0 O-C-N 120.91 -1.119 . . . . 2.8700000000000001 113.11 -179.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 906' ' ' GLU . . . . . 0.491 ' CB ' ' O ' ' A' ' 905' ' ' HIS . 0.9 OUTLIER 95.35 -164.82 0.0 OUTLIER 'General case' 0 N--CA 1.529 3.478 0 CA-C-N 120.561 1.528 . . . . 0.98999999999999999 111.947 179.004 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 907' ' ' LYS . . . . . 0.468 ' CB ' ' O ' ' A' ' 906' ' ' GLU . 52.9 tttt 87.21 157.58 0.07 Allowed 'General case' 0 N--CA 1.52 3.039 0 N-CA-C 108.143 -1.058 . . . . 5.25 108.143 -176.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 60.9 t -122.28 117.85 53.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 120.857 -1.152 . . . . 0.39000000000000001 111.179 -179.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -98.82 134.09 42.2 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 107.35 -1.352 . . . . 1.72 107.35 176.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -156.46 122.69 5.0 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 107.028 -1.471 . . . . 0.67000000000000004 107.028 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 911' ' ' VAL . . . . . 0.505 ' HA ' ' HA ' ' A' ' 964' ' ' VAL . 93.8 t -85.15 131.17 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 C-N-CA 120.442 -0.503 . . . . 0.54000000000000004 111.108 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 88.3 mt -65.22 157.97 27.44 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.397 -0.814 . . . . 1.5 109.361 178.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 913' ' ' SER . . . . . 0.404 ' CB ' ' CG1' ' A' ' 919' ' ' VAL . 1.7 t -127.64 134.94 49.64 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.239 -1.023 . . . . 1.3700000000000001 108.239 176.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 914' ' ' ARG . . . . . 0.42 ' O ' ' CB ' ' A' ' 915' ' ' SER . 0.0 OUTLIER -65.12 155.11 35.92 Favored 'General case' 0 N--CA 1.506 2.358 0 O-C-N 120.577 -1.327 . . . . 4.2999999999999998 111.628 -179.128 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 915' ' ' SER . . . . . 0.42 ' CB ' ' O ' ' A' ' 914' ' ' ARG . 1.6 p 82.93 -31.14 0.09 Allowed 'General case' 0 N--CA 1.52 3.046 0 C-N-CA 123.852 0.861 . . . . 2.0499999999999998 112.222 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 916' ' ' ASN . . . . . 0.428 ' O ' ' HB2' ' A' ' 917' ' ' GLN . 89.4 m-20 -122.63 -21.55 5.64 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.903 -1.123 . . . . 2.71 111.267 -179.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 917' ' ' GLN . . . . . 0.428 ' HB2' ' O ' ' A' ' 916' ' ' ASN . 58.9 mt-30 66.37 166.07 0.2 Allowed 'General case' 0 N--CA 1.519 3.018 0 N-CA-C 105.816 -1.92 . . . . 2.6800000000000002 105.816 -173.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.32 -125.32 33.65 Favored Glycine 1 N--CA 1.521 4.348 0 CA-C-N 123.472 2.851 . . . . 0.029999999999999999 106.98 -177.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 919' ' ' VAL . . . . . 0.404 ' CG1' ' CB ' ' A' ' 913' ' ' SER . 77.0 t 51.51 94.9 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 O-C-N 121.39 -1.065 . . . . 1.3899999999999999 109.15 -178.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 920' ' ' ALA . . . . . . . . . . . . . . . -92.34 93.0 8.4 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.318 -0.953 . . . . 0.029999999999999999 110.818 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 921' ' ' ARG . . . . . 0.426 ' HB2' ' CE1' ' A' ' 950' ' ' PHE . 23.1 ptt180 -84.15 -42.15 16.31 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 105.873 -1.899 . . . . 4.4199999999999999 105.873 176.119 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 922' ' ' VAL . . . . . . . . . . . . . 95.7 t -101.53 72.73 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 N-CA-C 105.94 -1.874 . . . . 0.84999999999999998 105.94 175.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -88.32 133.42 34.08 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.663 0.744 . . . . 2.46 111.502 -177.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 9.9 t -148.67 105.68 3.6 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.787 -0.82 . . . . 0.69999999999999996 108.787 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -101.56 82.67 0.47 Allowed Glycine 0 N--CA 1.487 2.037 0 N-CA-C 108.201 -1.96 . . . . 0.040000000000000001 108.201 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.211 0 N-CA-C 108.989 -1.644 . . . . 0.040000000000000001 108.989 -179.523 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 73.8 m . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 120.968 0.413 . . . . 13.779999999999999 110.31 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 96.7 mt -113.4 129.82 56.45 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.504 -0.747 . . . . 13.76 110.393 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -151.97 168.06 31.2 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.098 -1.601 . . . . 9.1300000000000008 109.098 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 949' ' ' VAL . . . . . . . . . . . . . 33.0 m -118.93 129.93 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.5 -1.0 . . . . 7.0800000000000001 110.916 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 950' ' ' PHE . . . . . 0.431 ' CE1' ' HD2' ' A' ' 955' ' ' PRO . 27.7 p90 -132.69 148.15 52.34 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.547 -0.721 . . . . 7.5899999999999999 109.212 179.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 58.5 m -121.15 -52.27 2.08 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.414 -0.804 . . . . 5.0300000000000002 112.103 -178.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 952' ' ' LEU . . . . . 0.414 ' O ' ' O ' ' A' ' 953' ' ' ILE . 20.5 tp -60.31 -73.67 0.09 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.446 -0.784 . . . . 1.01 112.403 -177.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 953' ' ' ILE . . . . . 0.457 ' O ' ' HB3' ' A' ' 954' ' ' LEU . 47.9 pt -53.44 -143.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.738 0 N-CA-C 114.008 1.114 . . . . 2.6000000000000001 114.008 -176.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 954' ' ' LEU . . . . . 0.548 ' N ' ' CD1' ' A' ' 954' ' ' LEU . 0.0 OUTLIER 172.57 75.0 0.04 OUTLIER Pre-proline 0 N--CA 1.508 2.47 0 O-C-N 120.825 -1.172 . . . . 0.050000000000000003 111.01 179.635 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 955' ' ' PRO . . . . . 0.431 ' HD2' ' CE1' ' A' ' 950' ' ' PHE . 47.9 Cg_endo -74.74 95.85 0.98 Allowed 'Trans proline' 0 C--N 1.315 -1.232 0 N-CA-C 109.702 -0.922 . . . . 0.83999999999999997 109.702 179.198 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 956' ' ' LEU . . . . . . . . . . . . . 7.1 mp -125.1 149.88 47.4 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.179 -0.95 . . . . 0.040000000000000001 110.27 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -82.75 150.78 26.48 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 117.701 -1.142 . . . . 1.28 111.468 -179.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -68.36 119.48 12.94 Favored 'General case' 0 N--CA 1.51 2.553 0 CA-C-N 123.098 2.681 . . . . 0.17000000000000001 111.316 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.87 -21.87 37.1 Favored Glycine 0 N--CA 1.5 2.924 0 N-CA-C 110.829 -0.908 . . . . 0.040000000000000001 110.829 178.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 960' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.13 172.27 0.09 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.504 -0.998 . . . . 0.040000000000000001 110.138 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 961' ' ' THR . . . . . 0.489 ' HA ' ' O ' ' A' ' 886' ' ' PHE . 39.3 m -135.87 138.81 42.86 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.963 -1.085 . . . . 1.78 112.377 -178.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 962' ' ' VAL . . . . . 0.416 ' CG2' ' CB ' ' A' ' 886' ' ' PHE . 32.4 m -98.72 144.22 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 C-N-CA 120.149 -0.62 . . . . 0.040000000000000001 110.03 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 5.5 t -139.69 143.88 37.29 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.671 -0.643 . . . . 0.71999999999999997 109.914 -178.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 964' ' ' VAL . . . . . 0.505 ' HA ' ' HA ' ' A' ' 911' ' ' VAL . 59.1 t -95.0 137.19 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.097 -1.002 . . . . 1.05 110.699 -179.108 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -91.5 128.91 37.51 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 103.819 -2.66 . . . . 3.02 103.819 173.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 966' ' ' LEU . . . . . 0.404 ' O ' ' CG2' ' A' ' 967' ' ' VAL . 1.5 tp -131.33 59.71 1.68 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.162 -1.051 . . . . 1.46 108.162 177.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 967' ' ' VAL . . . . . 0.404 ' CG2' ' O ' ' A' ' 966' ' ' LEU . 97.8 t -158.16 96.54 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 108.096 -1.075 . . . . 1.9399999999999999 108.096 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 87.1 mmm -143.58 59.13 1.38 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.761 -1.212 . . . . 0.0 108.262 178.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 134.96 119.52 1.95 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 106.91 -2.476 . . . . 2.1099999999999999 106.91 -178.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -82.34 -58.24 3.02 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.039 -1.271 . . . . 5.8899999999999997 110.327 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 44.0 tp -58.86 90.81 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.406 -0.809 . . . . 4.3600000000000003 110.171 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -141.65 -154.56 0.53 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.614 -0.679 . . . . 1.8300000000000001 110.236 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -120.05 172.42 7.76 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.522 -0.736 . . . . 4.3499999999999996 110.268 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 38.6 t -101.37 130.05 47.48 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.576 -0.703 . . . . 1.27 109.946 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -156.03 157.74 36.64 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.527 -0.733 . . . . 5.0199999999999996 110.515 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.14 85.34 19.04 Favored Pre-proline 0 N--CA 1.5 2.035 0 O-C-N 121.652 -0.655 . . . . 2.4100000000000001 109.662 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -72.81 -172.52 0.98 Allowed 'Trans proline' 0 C--N 1.317 -1.123 0 O-C-N 123.304 1.16 . . . . 0.95999999999999996 111.192 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 5.9 mp -128.04 154.24 45.88 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 107.575 -1.268 . . . . 0.62 107.575 177.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 979' ' ' THR . . . . . . . . . . . . . 43.2 p -149.79 142.07 24.17 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.851 -1.156 . . . . 3.5699999999999998 111.185 -179.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 980' ' ' ILE . . . . . . . . . . . . . 46.9 mm -105.87 127.76 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 108.708 -0.849 . . . . 1.3300000000000001 108.708 179.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 981' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -120.26 97.73 5.72 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 119.641 -0.823 . . . . 0.050000000000000003 111.828 -178.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 59.2 p -107.86 158.66 17.15 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 109.114 -0.699 . . . . 0.87 109.114 178.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 983' ' ' GLY . . . . . 0.416 ' HA3' ' CE1' ' A' ' 852' ' ' PHE . . . -175.36 107.26 0.24 Allowed Glycine 0 N--CA 1.499 2.836 0 N-CA-C 106.354 -2.699 . . . . 0.029999999999999999 106.354 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -109.21 152.64 24.9 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 114.583 1.327 . . . . 0.69999999999999996 114.583 -175.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 30.5 tp -72.23 134.2 45.49 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.887 -1.133 . . . . 0.040000000000000001 109.895 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 48.6 tp -107.9 -57.8 2.06 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.564 -0.71 . . . . 0.040000000000000001 110.208 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -144.28 145.35 31.97 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 107.592 -1.262 . . . . 0.040000000000000001 107.592 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.68 163.22 12.18 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 108.218 -1.953 . . . . 0.040000000000000001 108.218 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -74.43 112.7 18.36 Favored Pre-proline 0 N--CA 1.498 1.932 0 O-C-N 121.259 -1.142 . . . . 0.040000000000000001 109.468 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 990' ' ' PRO . . . . . 0.422 ' O ' ' HB2' ' A' ' 991' ' ' GLU . 50.6 Cg_endo -89.2 70.89 2.11 Favored 'Trans proline' 0 C--N 1.319 -1.022 0 O-C-N 123.199 1.105 . . . . 0.45000000000000001 111.482 -178.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 991' ' ' GLU . . . . . 0.422 ' HB2' ' O ' ' A' ' 990' ' ' PRO . 77.2 mt-10 67.18 -73.91 0.07 Allowed 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 108.524 -0.917 . . . . 1.97 108.524 -177.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 992' ' ' LEU . . . . . . . . . . . . . 10.5 mt 51.19 20.7 0.93 Allowed 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.562 -0.711 . . . . 2.3799999999999999 111.532 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -93.3 157.11 16.41 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.933 -1.105 . . . . 3.79 110.044 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 71.5 m80 -146.85 92.64 2.16 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.515 -0.74 . . . . 3.5099999999999998 110.195 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 995' ' ' ALA . . . . . . . . . . . . 2.519 . . . . . . . 0 N--CA 1.503 2.2 0 O-C-N 120.904 -1.122 . . . . 2.73 110.599 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo . . . . . 0 N--CA 1.487 1.147 0 N-CA-C 109.506 -0.998 . . . . 3.8300000000000001 109.506 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 847' ' ' VAL . . . . . . . . . . . . . 58.9 t -133.85 102.69 12.24 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.619 -0.676 . . . . 1.8300000000000001 109.994 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 848' ' ' PRO . . . . . 0.404 ' O ' ' C ' ' B' ' 849' ' ' GLN . 44.0 Cg_endo -69.68 -19.62 36.25 Favored 'Trans proline' 0 N--CA 1.488 1.152 0 O-C-N 123.279 1.147 . . . . 0.65000000000000002 111.245 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 849' ' ' GLN . . . . . 0.404 ' C ' ' O ' ' B' ' 848' ' ' PRO . 56.0 tt0 28.22 68.33 0.08 Allowed 'General case' 0 N--CA 1.518 2.931 0 N-CA-C 112.831 0.678 . . . . 2.5800000000000001 112.831 179.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 850' ' ' VAL . . . . . . . . . . . . . 66.2 t -119.95 137.07 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.141 -0.974 . . . . 1.0900000000000001 111.445 -178.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 851' ' ' ALA . . . . . . . . . . . . . . . -124.15 159.15 30.68 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 105.945 -1.872 . . . . 0.040000000000000001 105.945 176.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 852' ' ' PHE . . . . . 0.424 ' CE1' ' HA3' ' B' ' 983' ' ' GLY . 33.5 p90 -158.56 128.09 5.73 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 120.943 1.702 . . . . 0.050000000000000003 108.344 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 7.9 t -175.48 134.18 0.3 Allowed 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.281 -1.007 . . . . 0.040000000000000001 108.281 -178.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -129.83 157.22 42.84 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.011 -1.056 . . . . 0.67000000000000004 109.824 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 855' ' ' ALA . . . . . 0.433 ' O ' ' HB2' ' B' ' 870' ' ' ARG . . . -119.92 144.7 47.3 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.843 0.83 . . . . 0.51000000000000001 110.776 -179.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 856' ' ' LEU . . . . . 0.416 HD21 ' CG1' ' B' ' 866' ' ' VAL . 2.1 tm? -115.83 133.72 55.74 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.493 -0.754 . . . . 0.050000000000000003 110.542 -179.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 857' ' ' SER . . . . . 0.409 ' O ' ' O ' ' B' ' 858' ' ' LEU . 1.8 m -156.4 14.45 0.31 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.459 -0.775 . . . . 1.3300000000000001 111.804 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 858' ' ' LEU . . . . . 0.409 ' O ' ' O ' ' B' ' 857' ' ' SER . 0.3 OUTLIER -36.53 162.19 0.04 OUTLIER Pre-proline 0 N--CA 1.524 3.254 0 CA-C-N 119.052 0.842 . . . . 2.3300000000000001 113.074 -179.693 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -61.26 -89.38 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 120.947 1.098 . . . . 2.3199999999999998 113.804 -177.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 53.9 ptt85 -134.19 -142.46 0.2 Allowed 'General case' 0 N--CA 1.501 2.114 0 O-C-N 120.802 -1.186 . . . . 0.040000000000000001 111.815 -177.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 5.2 m -36.56 126.46 0.84 Allowed 'General case' 0 N--CA 1.512 2.645 0 O-C-N 121.671 -0.643 . . . . 1.3100000000000001 112.373 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 862' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -104.34 165.67 12.95 Favored Pre-proline 0 N--CA 1.488 1.451 0 N-CA-C 108.637 -0.875 . . . . 4.5099999999999998 108.637 177.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -73.45 -14.57 25.11 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 O-C-N 123.294 1.155 . . . . 2.2400000000000002 111.396 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -177.68 -133.75 1.91 Allowed Glycine 0 N--CA 1.495 2.592 0 N-CA-C 110.184 -1.167 . . . . 0.040000000000000001 110.184 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 27.1 m -66.07 157.64 30.54 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.351 -1.088 . . . . 1.51 110.733 -178.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 866' ' ' VAL . . . . . 0.416 ' CG1' HD21 ' B' ' 856' ' ' LEU . 56.9 t -97.73 132.71 24.49 Favored Pre-proline 0 N--CA 1.496 1.833 0 N-CA-C 113.402 0.89 . . . . 0.78000000000000003 113.402 -174.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 867' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -90.71 -149.73 0.03 OUTLIER 'Trans proline' 0 CA--C 1.544 1.02 0 C-N-CA 121.219 1.279 . . . . 0.92000000000000004 109.356 177.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 868' ' ' PHE . . . . . 0.462 ' CD1' ' N ' ' B' ' 868' ' ' PHE . 19.4 p90 -150.19 123.25 8.82 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.493 -1.379 . . . . 0.050000000000000003 109.858 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 50.2 p-10 -113.35 -2.32 14.02 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.101 -1.0 . . . . 1.7 112.786 -178.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 870' ' ' ARG . . . . . 0.433 ' HB2' ' O ' ' B' ' 855' ' ' ALA . 28.0 mmm180 -91.74 89.79 7.24 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.861 -1.149 . . . . 2.5899999999999999 111.167 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 57.5 t -72.9 96.75 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 120.978 -1.077 . . . . 1.9399999999999999 109.669 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 872' ' ' LEU . . . . . . . . . . . . . 87.1 mt -83.56 -46.66 12.15 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.508 -0.745 . . . . 1.0600000000000001 110.117 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 873' ' ' LEU . . . . . . . . . . . . . 32.6 tp -174.31 102.25 0.1 Allowed 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.583 -0.895 . . . . 4.1799999999999997 108.583 178.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 874' ' ' ASN . . . . . . . . . . . . . 33.8 t-20 178.36 81.08 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.664 -0.647 . . . . 0.040000000000000001 109.371 -179.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -65.5 -47.1 77.17 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 119.349 -0.941 . . . . 3.3799999999999999 111.102 -179.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 876' ' ' GLY . . . . . . . . . . . . . . . -73.98 -24.27 74.3 Favored Glycine 0 N--CA 1.493 2.477 0 O-C-N 121.285 -0.884 . . . . 0.040000000000000001 111.687 -178.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 84.41 -59.95 4.88 Favored Glycine 0 N--CA 1.502 3.069 0 N-CA-C 107.948 -2.061 . . . . 0.040000000000000001 107.948 -178.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 878' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 60.41 -66.68 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 114.474 1.287 . . . . 3.46 114.474 177.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 879' ' ' TYR . . . . . 0.471 ' CB ' ' CD2' ' B' ' 886' ' ' PHE . 21.3 p90 -110.78 109.62 19.91 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 114.785 1.402 . . . . 0.040000000000000001 114.785 -176.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -65.94 117.06 38.54 Favored Pre-proline 0 N--CA 1.496 1.847 0 O-C-N 121.557 -0.715 . . . . 0.02 110.117 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 881' ' ' PRO . . . . . 0.438 ' HG2' ' CD1' ' B' ' 868' ' ' PHE . 53.8 Cg_endo -75.78 0.23 9.45 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 O-C-N 123.477 1.251 . . . . 0.39000000000000001 112.252 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -75.26 -65.23 0.91 Allowed 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 106.953 -1.499 . . . . 0.81000000000000005 106.953 178.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 2.2 p -95.87 -16.53 21.74 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.88 -0.785 . . . . 0.040000000000000001 108.88 177.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.2 23.34 52.02 Favored Glycine 0 N--CA 1.493 2.489 0 C-N-CA 120.069 -1.063 . . . . 0.029999999999999999 110.719 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 885' ' ' VAL . . . . . . . . . . . . . 92.6 t -73.56 88.7 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 C-N-CA 118.392 -1.323 . . . . 1.01 107.806 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 886' ' ' PHE . . . . . 0.492 ' O ' ' HA ' ' B' ' 961' ' ' THR . 0.6 OUTLIER -89.36 106.28 18.34 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 115.121 -0.945 . . . . 0.050000000000000003 112.234 -177.12 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 887' ' ' THR . . . . . . . . . . . . . 96.9 m -98.67 99.44 10.56 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 107.493 -1.299 . . . . 0.68000000000000005 107.493 176.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 888' ' ' ALA . . . . . . . . . . . . . . . -97.52 108.13 43.31 Favored Pre-proline 0 N--CA 1.502 2.134 0 N-CA-C 114.119 1.155 . . . . 0.25 114.119 -176.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 889' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -89.37 -13.85 2.77 Favored 'Trans proline' 0 CA--C 1.546 1.091 0 N-CA-C 109.135 -1.14 . . . . 1.6399999999999999 109.135 176.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 890' ' ' LEU . . . . . . . . . . . . . 62.9 mt -35.73 -50.64 0.64 Allowed 'General case' 0 N--CA 1.509 2.497 0 N-CA-C 113.68 0.992 . . . . 2.29 113.68 -177.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 52.1 95.44 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.154 -0.966 . . . . 0.63 110.338 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . 157.65 -154.16 25.28 Favored Glycine 0 N--CA 1.478 1.491 0 N-CA-C 107.085 -2.406 . . . . 0.040000000000000001 107.085 -179.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 71.7 ttt-85 -116.34 125.26 51.85 Favored 'General case' 0 C--N 1.294 -1.807 0 O-C-N 121.564 -0.963 . . . . 3.0 108.511 177.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 894' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -131.9 161.63 32.56 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.082 -1.011 . . . . 0.040000000000000001 111.113 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 895' ' ' LEU . . . . . . . . . . . . . 43.3 tp -92.27 119.32 31.75 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.681 -0.637 . . . . 1.27 110.355 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 896' ' ' LEU . . . . . . . . . . . . . 9.1 tt -110.11 143.87 39.55 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.725 -0.609 . . . . 0.93999999999999995 110.053 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 897' ' ' SER . . . . . . . . . . . . . 68.7 m -148.81 114.5 5.66 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.426 -0.796 . . . . 0.040000000000000001 111.098 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.23 145.99 31.97 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.011 -0.737 . . . . 0.47999999999999998 109.011 178.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 899' ' ' VAL . . . . . . . . . . . . . 88.4 t -96.22 119.07 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.356 -0.84 . . . . 0.55000000000000004 111.245 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 900' ' ' LEU . . . . . 0.421 ' N ' ' CD2' ' B' ' 900' ' ' LEU . 4.5 mm? -95.97 112.7 24.36 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 114.288 1.218 . . . . 1.5900000000000001 114.288 -175.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 18.1 m -64.94 140.79 58.9 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 107.531 -1.285 . . . . 0.050000000000000003 107.531 177.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -64.83 -65.26 3.04 Favored Glycine 0 N--CA 1.494 2.515 0 N-CA-C 110.639 -0.985 . . . . 0.029999999999999999 110.639 -179.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 46.89 66.64 0.94 Allowed 'General case' 0 N--CA 1.507 2.411 0 O-C-N 121.472 -1.017 . . . . 3.2000000000000002 110.964 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 54.3 ptt85 -68.85 -6.78 29.05 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.639 -0.663 . . . . 2.9199999999999999 112.073 -179.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 905' ' ' HIS . . . . . 0.488 ' O ' ' CB ' ' B' ' 906' ' ' GLU . 72.8 t60 -62.08 4.74 0.12 Allowed 'General case' 0 N--CA 1.505 2.323 0 O-C-N 120.876 -1.14 . . . . 2.8700000000000001 113.111 -179.132 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 906' ' ' GLU . . . . . 0.488 ' CB ' ' O ' ' B' ' 905' ' ' HIS . 0.9 OUTLIER 95.62 -164.94 0.0 OUTLIER 'General case' 0 N--CA 1.53 3.549 0 CA-C-N 120.612 1.551 . . . . 0.98999999999999999 111.781 179.1 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 907' ' ' LYS . . . . . 0.47 ' CB ' ' O ' ' B' ' 906' ' ' GLU . 53.3 tttt 87.31 157.28 0.07 Allowed 'General case' 0 N--CA 1.52 3.073 0 N-CA-C 108.132 -1.062 . . . . 5.25 108.132 -177.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 60.9 t -122.08 117.5 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 120.894 -1.129 . . . . 0.39000000000000001 111.243 -179.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -98.33 134.37 41.43 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 107.333 -1.358 . . . . 1.72 107.333 176.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -156.83 122.8 4.85 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 106.992 -1.484 . . . . 0.67000000000000004 106.992 178.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 911' ' ' VAL . . . . . 0.503 ' HA ' ' HA ' ' B' ' 964' ' ' VAL . 94.9 t -85.34 131.54 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.906 -0.496 . . . . 0.54000000000000004 111.061 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 88.2 mt -65.44 158.13 27.6 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.362 -0.836 . . . . 1.5 109.359 178.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 913' ' ' SER . . . . . 0.411 ' CB ' ' CG1' ' B' ' 919' ' ' VAL . 1.8 t -127.97 134.39 49.28 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.274 -1.01 . . . . 1.3700000000000001 108.274 176.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 914' ' ' ARG . . . . . 0.411 ' O ' ' CB ' ' B' ' 915' ' ' SER . 0.0 OUTLIER -64.51 155.05 34.11 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 120.577 -1.327 . . . . 4.2999999999999998 111.685 -179.067 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 915' ' ' SER . . . . . 0.411 ' CB ' ' O ' ' B' ' 914' ' ' ARG . 1.6 p 83.05 -31.44 0.09 Allowed 'General case' 0 N--CA 1.521 3.093 0 C-N-CA 123.84 0.856 . . . . 2.0499999999999998 112.224 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 916' ' ' ASN . . . . . 0.428 ' O ' ' HB2' ' B' ' 917' ' ' GLN . 89.2 m-20 -122.25 -21.91 5.73 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.92 -1.112 . . . . 2.71 111.288 -179.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 917' ' ' GLN . . . . . 0.428 ' HB2' ' O ' ' B' ' 916' ' ' ASN . 58.5 mt-30 66.5 165.43 0.2 Allowed 'General case' 0 N--CA 1.52 3.029 0 N-CA-C 105.782 -1.933 . . . . 2.6800000000000002 105.782 -174.012 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 55.05 -125.38 35.58 Favored Glycine 1 N--CA 1.52 4.268 0 CA-C-N 123.478 2.854 . . . . 0.029999999999999999 106.858 -177.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 919' ' ' VAL . . . . . 0.411 ' CG1' ' CB ' ' B' ' 913' ' ' SER . 80.5 t 51.44 94.91 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.233 0 O-C-N 121.419 -1.047 . . . . 1.3899999999999999 109.189 -178.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 920' ' ' ALA . . . . . . . . . . . . . . . -92.4 92.85 8.3 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.324 -0.951 . . . . 0.029999999999999999 110.823 -179.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 921' ' ' ARG . . . . . 0.426 ' HB3' ' CZ ' ' B' ' 950' ' ' PHE . 23.2 ptt180 -84.12 -42.11 16.4 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 105.885 -1.894 . . . . 4.4199999999999999 105.885 176.163 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 922' ' ' VAL . . . . . . . . . . . . . 95.7 t -101.52 72.64 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 N-CA-C 105.92 -1.882 . . . . 0.84999999999999998 105.92 175.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -88.19 133.47 34.02 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.615 0.721 . . . . 2.46 111.495 -177.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 924' ' ' SER . . . . . . . . . . . . . 9.9 t -148.68 105.72 3.6 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.76 -0.829 . . . . 0.69999999999999996 108.76 179.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -101.5 82.62 0.47 Allowed Glycine 0 N--CA 1.487 2.049 0 N-CA-C 108.176 -1.97 . . . . 0.040000000000000001 108.176 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.143 0 N-CA-C 109.026 -1.629 . . . . 0.040000000000000001 109.026 -179.562 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 76.9 m . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.016 0.436 . . . . 13.779999999999999 110.215 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 96.7 mt -112.24 129.87 56.12 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.546 -0.722 . . . . 13.76 110.4 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -151.65 167.5 30.96 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.153 -1.579 . . . . 9.1300000000000008 109.153 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 949' ' ' VAL . . . . . . . . . . . . . 32.1 m -118.69 129.85 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.548 -0.972 . . . . 7.0800000000000001 110.845 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 950' ' ' PHE . . . . . 0.435 ' CE1' ' HD2' ' B' ' 955' ' ' PRO . 27.9 p90 -132.74 148.17 52.33 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.586 -0.696 . . . . 7.5899999999999999 109.267 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 58.5 m -121.16 -51.92 2.09 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.452 -0.78 . . . . 5.0300000000000002 112.13 -178.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 952' ' ' LEU . . . . . 0.41 ' O ' ' O ' ' B' ' 953' ' ' ILE . 20.3 tp -60.52 -73.88 0.08 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.396 -0.815 . . . . 1.01 112.347 -177.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 953' ' ' ILE . . . . . 0.466 ' O ' ' HB3' ' B' ' 954' ' ' LEU . 49.3 pt -53.18 -143.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.754 0 N-CA-C 114.082 1.141 . . . . 2.6000000000000001 114.082 -176.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 954' ' ' LEU . . . . . 0.544 ' N ' ' CD1' ' B' ' 954' ' ' LEU . 0.0 OUTLIER 172.31 74.69 0.04 OUTLIER Pre-proline 0 N--CA 1.509 2.496 0 O-C-N 120.793 -1.192 . . . . 0.050000000000000003 110.955 179.68 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 955' ' ' PRO . . . . . 0.435 ' HD2' ' CE1' ' B' ' 950' ' ' PHE . 48.1 Cg_endo -74.64 95.95 0.97 Allowed 'Trans proline' 0 C--N 1.315 -1.218 0 N-CA-C 109.714 -0.918 . . . . 0.83999999999999997 109.714 179.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 956' ' ' LEU . . . . . . . . . . . . . 7.1 mp -125.23 149.88 47.56 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.232 -0.917 . . . . 0.040000000000000001 110.258 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -82.78 150.94 26.35 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 117.824 -1.084 . . . . 1.28 111.375 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -68.42 119.15 12.44 Favored 'General case' 0 N--CA 1.509 2.492 0 CA-C-N 122.913 2.597 . . . . 0.17000000000000001 111.389 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 93.07 -21.92 37.31 Favored Glycine 0 N--CA 1.5 2.942 0 N-CA-C 110.792 -0.923 . . . . 0.040000000000000001 110.792 178.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 960' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.02 172.38 0.08 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.473 -1.016 . . . . 0.040000000000000001 110.166 -179.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 961' ' ' THR . . . . . 0.492 ' HA ' ' O ' ' B' ' 886' ' ' PHE . 38.8 m -135.83 139.03 43.13 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.942 -1.099 . . . . 1.78 112.338 -178.074 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 962' ' ' VAL . . . . . 0.422 ' CG2' ' CB ' ' B' ' 886' ' ' PHE . 32.2 m -99.09 144.02 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 C-N-CA 120.112 -0.635 . . . . 0.040000000000000001 110.032 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 5.4 t -139.37 143.88 37.93 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.682 -0.636 . . . . 0.71999999999999997 109.982 -178.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 964' ' ' VAL . . . . . 0.503 ' HA ' ' HA ' ' B' ' 911' ' ' VAL . 59.0 t -95.2 137.02 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.208 -0.933 . . . . 1.05 110.696 -179.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -91.51 128.43 37.34 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 103.898 -2.631 . . . . 3.02 103.898 173.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 966' ' ' LEU . . . . . 0.408 ' O ' ' CG2' ' B' ' 967' ' ' VAL . 1.5 tp -130.9 59.89 1.66 Allowed 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.228 -1.027 . . . . 1.46 108.228 177.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 967' ' ' VAL . . . . . 0.408 ' CG2' ' O ' ' B' ' 966' ' ' LEU . 98.3 t -158.27 96.47 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 108.08 -1.081 . . . . 1.9399999999999999 108.08 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 87.1 mmm -143.49 58.95 1.39 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.804 -1.185 . . . . 0.0 108.265 178.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 134.99 119.38 1.93 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 107.111 -2.396 . . . . 2.1099999999999999 107.111 -178.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -82.07 -58.22 3.06 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.085 -1.244 . . . . 5.8899999999999997 110.338 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 44.2 tp -58.97 90.57 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.377 -0.827 . . . . 4.3600000000000003 110.19 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -141.47 -154.63 0.53 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.589 -0.694 . . . . 1.8300000000000001 110.27 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -119.95 172.54 7.65 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.455 -0.778 . . . . 4.3499999999999996 110.275 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 38.6 t -101.56 130.02 47.77 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.525 -0.734 . . . . 1.27 109.961 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -155.99 157.74 36.7 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.474 -0.767 . . . . 5.0199999999999996 110.495 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.15 85.33 19.0 Favored Pre-proline 0 N--CA 1.5 2.05 0 O-C-N 121.633 -0.667 . . . . 2.4100000000000001 109.622 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -72.82 -172.59 0.99 Allowed 'Trans proline' 0 C--N 1.317 -1.083 0 O-C-N 123.282 1.148 . . . . 0.95999999999999996 111.219 -179.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 978' ' ' LEU . . . . . . . . . . . . . 5.9 mp -127.82 154.51 45.36 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.653 -1.24 . . . . 0.62 107.653 177.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 979' ' ' THR . . . . . . . . . . . . . 42.8 p -150.03 142.08 23.96 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.842 -1.161 . . . . 3.5699999999999998 111.142 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 980' ' ' ILE . . . . . . . . . . . . . 46.8 mm -105.99 127.4 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 108.732 -0.84 . . . . 1.3300000000000001 108.732 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -120.0 98.0 5.88 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 119.649 -0.821 . . . . 0.050000000000000003 111.746 -178.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 53.8 p -108.4 158.81 17.18 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 109.154 -0.684 . . . . 0.87 109.154 178.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 983' ' ' GLY . . . . . 0.424 ' HA3' ' CE1' ' B' ' 852' ' ' PHE . . . -175.25 107.41 0.24 Allowed Glycine 0 N--CA 1.498 2.821 0 N-CA-C 106.469 -2.652 . . . . 0.029999999999999999 106.469 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -109.16 152.53 25.0 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 114.587 1.328 . . . . 0.69999999999999996 114.587 -175.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 985' ' ' LEU . . . . . . . . . . . . . 30.5 tp -72.24 134.1 45.43 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.93 -1.106 . . . . 0.040000000000000001 109.805 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 986' ' ' LEU . . . . . . . . . . . . . 48.1 tp -107.82 -57.79 2.05 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.541 -0.725 . . . . 0.040000000000000001 110.259 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -144.31 145.23 31.87 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.621 -1.252 . . . . 0.040000000000000001 107.621 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.49 163.07 12.2 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 108.255 -1.938 . . . . 0.040000000000000001 108.255 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -74.27 112.72 18.23 Favored Pre-proline 0 N--CA 1.498 1.956 0 O-C-N 121.204 -1.174 . . . . 0.040000000000000001 109.442 179.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 990' ' ' PRO . . . . . 0.418 ' O ' ' HB2' ' B' ' 991' ' ' GLU . 50.0 Cg_endo -89.2 71.04 2.09 Favored 'Trans proline' 0 C--N 1.319 -0.985 0 O-C-N 123.093 1.049 . . . . 0.45000000000000001 111.459 -178.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 991' ' ' GLU . . . . . 0.418 ' HB2' ' O ' ' B' ' 990' ' ' PRO . 77.3 mt-10 67.0 -73.84 0.07 Allowed 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 108.603 -0.888 . . . . 1.97 108.603 -177.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 992' ' ' LEU . . . . . . . . . . . . . 10.6 mt 51.29 20.4 0.93 Allowed 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.614 -0.679 . . . . 2.3799999999999999 111.634 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -92.95 157.13 16.49 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.869 -1.144 . . . . 3.79 110.055 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 71.2 m80 -146.91 92.1 2.09 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.511 -0.743 . . . . 3.5099999999999998 110.329 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 995' ' ' ALA . . . . . . . . . . . . 2.52 . . . . . . . 0 N--CA 1.503 2.208 0 O-C-N 120.886 -1.134 . . . . 2.73 110.655 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo . . . . . 0 N--CA 1.488 1.154 0 N-CA-C 109.496 -1.001 . . . . 3.8300000000000001 109.496 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 847' ' ' VAL . . . . . . . . . . . . . 61.8 t -128.75 103.89 19.09 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.579 -0.7 . . . . 1.8300000000000001 110.093 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 848' ' ' PRO . . . . . 0.4 ' O ' ' C ' ' C' ' 849' ' ' GLN . 44.3 Cg_endo -70.34 -22.23 29.68 Favored 'Trans proline' 0 N--CA 1.488 1.185 0 O-C-N 123.285 1.15 . . . . 0.65000000000000002 111.254 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 849' ' ' GLN . . . . . 0.4 ' C ' ' O ' ' C' ' 848' ' ' PRO . 57.2 tt0 26.88 68.79 0.06 Allowed 'General case' 0 N--CA 1.519 2.998 0 N-CA-C 112.92 0.711 . . . . 2.5800000000000001 112.92 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 850' ' ' VAL . . . . . . . . . . . . . 94.3 t -119.76 135.4 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.129 -0.982 . . . . 1.0900000000000001 111.57 -178.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 851' ' ' ALA . . . . . . . . . . . . . . . -127.86 155.53 43.98 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 105.795 -1.928 . . . . 0.040000000000000001 105.795 176.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 852' ' ' PHE . . . . . 0.454 ' CD1' ' N ' ' C' ' 852' ' ' PHE . 13.6 p90 -159.61 127.79 4.94 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 121.018 1.736 . . . . 0.050000000000000003 108.522 178.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 12.1 t -176.51 134.37 0.23 Allowed 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.246 -1.02 . . . . 0.040000000000000001 108.246 -178.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -132.84 156.76 46.56 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.142 -0.974 . . . . 0.67000000000000004 109.693 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 855' ' ' ALA . . . . . 0.417 ' O ' ' HB2' ' C' ' 870' ' ' ARG . . . -122.96 140.95 52.47 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 122.035 0.921 . . . . 0.51000000000000001 111.419 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 856' ' ' LEU . . . . . 0.407 HD21 ' CG1' ' C' ' 866' ' ' VAL . 3.5 tm? -113.39 137.71 51.13 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.687 -0.633 . . . . 0.050000000000000003 109.936 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 857' ' ' SER . . . . . 0.423 ' O ' ' O ' ' C' ' 858' ' ' LEU . 1.9 m -157.08 19.25 0.3 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.548 -0.72 . . . . 1.3300000000000001 111.084 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 858' ' ' LEU . . . . . 0.423 ' O ' ' O ' ' C' ' 857' ' ' SER . 4.1 pp -35.54 160.26 0.04 OUTLIER Pre-proline 0 N--CA 1.517 2.886 0 N-CA-C 112.729 0.64 . . . . 2.3300000000000001 112.729 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -59.25 -88.9 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.455 0 O-C-N 122.99 0.995 . . . . 2.3199999999999998 113.386 -177.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 54.5 ptt85 -129.26 -142.56 0.25 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.883 -1.136 . . . . 0.040000000000000001 111.635 -177.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 9.9 m -36.57 126.65 0.84 Allowed 'General case' 0 N--CA 1.51 2.536 0 O-C-N 121.61 -0.681 . . . . 1.3100000000000001 112.634 -178.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.76 159.28 30.03 Favored Pre-proline 0 N--CA 1.489 1.514 0 N-CA-C 108.177 -1.046 . . . . 4.5099999999999998 108.177 177.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -71.93 -14.1 29.3 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 O-C-N 123.11 1.058 . . . . 2.2400000000000002 111.523 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -177.72 -136.35 2.47 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 110.04 -1.224 . . . . 0.040000000000000001 110.04 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 25.7 m -65.37 154.85 37.17 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.355 -1.085 . . . . 1.51 110.247 -179.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 866' ' ' VAL . . . . . 0.407 ' CG1' HD21 ' C' ' 856' ' ' LEU . 20.7 t -95.62 138.68 21.77 Favored Pre-proline 0 N--CA 1.496 1.874 0 N-CA-C 113.917 1.08 . . . . 0.78000000000000003 113.917 -174.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 867' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -94.07 -151.33 0.03 OUTLIER 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 121.417 1.412 . . . . 0.92000000000000004 109.002 177.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 868' ' ' PHE . . . . . 0.441 ' N ' ' CD1' ' C' ' 868' ' ' PHE . 13.7 p90 -150.05 124.65 9.71 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.556 -1.34 . . . . 0.050000000000000003 110.036 179.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 50.7 p-10 -112.34 -2.79 14.7 Favored 'General case' 0 N--CA 1.5 2.044 0 C-N-CA 119.216 -0.994 . . . . 1.7 112.715 -178.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 870' ' ' ARG . . . . . 0.417 ' HB2' ' O ' ' C' ' 855' ' ' ALA . 25.7 mmm180 -92.08 88.16 6.43 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 120.844 -1.16 . . . . 2.5899999999999999 111.36 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 65.3 t -72.45 97.09 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 120.949 -1.094 . . . . 1.9399999999999999 109.132 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 872' ' ' LEU . . . . . . . . . . . . . 95.0 mt -86.98 -45.42 10.79 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.572 -0.705 . . . . 1.0600000000000001 110.82 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 873' ' ' LEU . . . . . 0.413 ' O ' ' HB2' ' C' ' 874' ' ' ASN . 30.4 tp -172.91 101.98 0.13 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.153 -0.967 . . . . 4.1799999999999997 108.788 178.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 874' ' ' ASN . . . . . 0.413 ' HB2' ' O ' ' C' ' 873' ' ' LEU . 32.8 t-20 176.99 82.5 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 108.833 -0.803 . . . . 0.040000000000000001 108.833 -178.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -65.15 -46.41 80.98 Favored 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 119.267 -0.973 . . . . 3.3799999999999999 111.244 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 876' ' ' GLY . . . . . 0.405 ' HA3' ' CE2' ' C' ' 878' ' ' TYR . . . -73.5 -25.65 72.0 Favored Glycine 0 N--CA 1.492 2.403 0 O-C-N 121.257 -0.902 . . . . 0.040000000000000001 111.643 -178.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 81.04 -62.22 4.47 Favored Glycine 0 N--CA 1.501 3.023 0 N-CA-C 107.769 -2.132 . . . . 0.040000000000000001 107.769 -178.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 878' ' ' TYR . . . . . 0.405 ' CE2' ' HA3' ' C' ' 876' ' ' GLY . 85.6 m-85 60.61 -66.29 0.05 Allowed 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 114.497 1.295 . . . . 3.46 114.497 177.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 879' ' ' TYR . . . . . 0.46 ' CB ' ' CD2' ' C' ' 886' ' ' PHE . 25.1 p90 -109.49 109.3 20.07 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 115.271 1.582 . . . . 0.040000000000000001 115.271 -176.094 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.03 115.82 29.38 Favored Pre-proline 0 N--CA 1.498 1.932 0 O-C-N 121.637 -0.664 . . . . 0.02 109.98 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 881' ' ' PRO . . . . . 0.439 ' HG2' ' CD1' ' C' ' 868' ' ' PHE . 53.8 Cg_endo -76.65 0.65 9.34 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 O-C-N 123.361 1.19 . . . . 0.39000000000000001 112.137 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -74.51 -66.02 0.79 Allowed 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 106.796 -1.557 . . . . 0.81000000000000005 106.796 178.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 2.6 p -95.45 -14.79 23.45 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.813 -0.81 . . . . 0.040000000000000001 108.813 177.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.14 21.98 55.82 Favored Glycine 0 N--CA 1.493 2.476 0 O-C-N 121.042 -1.036 . . . . 0.029999999999999999 111.029 178.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 68.9 t -72.9 87.98 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 C-N-CA 118.189 -1.404 . . . . 1.01 107.492 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 886' ' ' PHE . . . . . 0.491 ' O ' ' HA ' ' C' ' 961' ' ' THR . 0.9 OUTLIER -88.61 103.71 16.17 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-N 115.157 -0.929 . . . . 0.050000000000000003 112.038 -177.075 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 887' ' ' THR . . . . . 0.406 ' O ' ' HD3' ' C' ' 889' ' ' PRO . 88.5 m -99.28 100.24 11.3 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.834 -1.172 . . . . 0.68000000000000005 107.834 177.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 888' ' ' ALA . . . . . . . . . . . . . . . -99.05 102.63 16.07 Favored Pre-proline 0 N--CA 1.502 2.158 0 N-CA-C 114.505 1.298 . . . . 0.25 114.505 -176.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 889' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' C' ' 887' ' ' THR . 55.9 Cg_endo -83.6 -15.37 7.37 Favored 'Trans proline' 0 CA--C 1.545 1.061 0 N-CA-C 108.827 -1.259 . . . . 1.6399999999999999 108.827 175.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 890' ' ' LEU . . . . . . . . . . . . . 65.7 mt -38.09 -48.78 1.26 Allowed 'General case' 0 N--CA 1.508 2.45 0 N-CA-C 113.389 0.885 . . . . 2.29 113.389 -177.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 53.28 97.55 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.182 -0.949 . . . . 0.63 110.248 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . 158.83 -155.4 26.46 Favored Glycine 0 N--CA 1.476 1.364 0 N-CA-C 107.12 -2.392 . . . . 0.040000000000000001 107.12 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 74.5 ttt-85 -116.33 125.11 51.66 Favored 'General case' 0 C--N 1.295 -1.803 0 O-C-N 121.537 -0.978 . . . . 3.0 108.855 177.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 894' ' ' TYR . . . . . 0.419 ' CE2' HD22 ' C' ' 954' ' ' LEU . 20.5 p90 -133.35 156.41 47.68 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.083 -1.011 . . . . 0.040000000000000001 111.237 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 895' ' ' LEU . . . . . . . . . . . . . 48.1 tp -99.06 117.13 32.87 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.733 -0.604 . . . . 1.27 110.043 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 896' ' ' LEU . . . . . . . . . . . . . 9.6 tt -120.85 144.51 48.33 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.638 -0.664 . . . . 0.93999999999999995 109.787 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 897' ' ' SER . . . . . . . . . . . . . 19.5 m -141.9 123.97 15.44 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.383 -0.823 . . . . 0.040000000000000001 111.226 -179.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -100.55 148.26 24.99 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.731 -0.84 . . . . 0.47999999999999998 108.731 178.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 899' ' ' VAL . . . . . . . . . . . . . 93.8 t -91.47 120.26 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 C-N-CA 119.66 -0.816 . . . . 0.55000000000000004 111.023 -179.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 86.7 mt -92.95 112.1 23.94 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 114.011 1.115 . . . . 1.5900000000000001 114.011 -175.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 23.7 m -63.11 140.3 58.86 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 107.474 -1.306 . . . . 0.050000000000000003 107.474 177.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -61.05 -64.93 3.64 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.209 -1.156 . . . . 0.029999999999999999 110.209 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 7.7 m170 45.08 64.01 1.54 Allowed 'General case' 0 N--CA 1.507 2.406 0 O-C-N 121.623 -0.927 . . . . 3.2000000000000002 111.36 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 54.4 ptt85 -67.66 -7.88 30.37 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.586 -0.696 . . . . 2.9199999999999999 111.783 -179.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 905' ' ' HIS . . . . . 0.497 ' O ' ' CB ' ' C' ' 906' ' ' GLU . 69.5 t60 -63.06 6.61 0.1 Allowed 'General case' 0 N--CA 1.504 2.266 0 CA-C-O 117.599 -1.191 . . . . 2.8700000000000001 113.412 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 906' ' ' GLU . . . . . 0.497 ' CB ' ' O ' ' C' ' 905' ' ' HIS . 0.7 OUTLIER 93.46 -163.01 0.0 OUTLIER 'General case' 0 N--CA 1.529 3.52 0 CA-C-N 121.299 1.863 . . . . 0.98999999999999999 112.1 179.083 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 907' ' ' LYS . . . . . 0.495 ' CB ' ' O ' ' C' ' 906' ' ' GLU . 57.9 tttt 90.01 160.78 0.05 OUTLIER 'General case' 0 N--CA 1.521 3.11 0 N-CA-C 107.967 -1.123 . . . . 5.25 107.967 -176.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 62.0 t -122.31 116.02 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 120.888 -1.132 . . . . 0.39000000000000001 110.806 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -103.84 130.22 51.38 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 107.209 -1.404 . . . . 1.72 107.209 176.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -157.2 120.29 4.04 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 106.916 -1.513 . . . . 0.67000000000000004 106.916 178.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 911' ' ' VAL . . . . . 0.482 ' HA ' ' HA ' ' C' ' 964' ' ' VAL . 12.3 p -80.65 131.21 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 C-N-CA 120.248 -0.581 . . . . 0.54000000000000004 111.463 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 60.5 mt -67.32 156.39 36.55 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.28 -0.887 . . . . 1.5 108.618 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 913' ' ' SER . . . . . 0.414 ' CB ' ' CG1' ' C' ' 919' ' ' VAL . 2.4 t -125.27 136.44 53.52 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.589 -0.893 . . . . 1.3700000000000001 108.589 177.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 914' ' ' ARG . . . . . 0.432 ' NE ' ' HB3' ' C' ' 960' ' ' ASP . 0.0 OUTLIER -63.41 154.6 31.58 Favored 'General case' 0 N--CA 1.505 2.308 0 O-C-N 120.685 -1.26 . . . . 4.2999999999999998 111.499 -179.095 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 915' ' ' SER . . . . . 0.417 ' CB ' ' O ' ' C' ' 914' ' ' ARG . 1.7 p 83.58 -30.77 0.08 Allowed 'General case' 0 N--CA 1.521 3.101 0 C-N-CA 123.907 0.883 . . . . 2.0499999999999998 111.999 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 916' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -122.87 -21.96 5.41 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 120.967 -1.083 . . . . 2.71 111.309 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 67.17 165.93 0.22 Allowed 'General case' 0 N--CA 1.521 3.08 0 N-CA-C 105.614 -1.995 . . . . 2.6800000000000002 105.614 -174.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.74 -125.64 35.58 Favored Glycine 1 N--CA 1.521 4.32 0 CA-C-N 123.688 2.949 . . . . 0.029999999999999999 107.026 -177.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 919' ' ' VAL . . . . . 0.414 ' CG1' ' CB ' ' C' ' 913' ' ' SER . 96.8 t 50.4 94.2 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.212 0 O-C-N 121.444 -1.033 . . . . 1.3899999999999999 109.397 -178.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 920' ' ' ALA . . . . . . . . . . . . . . . -94.38 94.67 8.4 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.476 -0.89 . . . . 0.029999999999999999 110.661 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 921' ' ' ARG . . . . . 0.425 ' HB3' ' CZ ' ' C' ' 950' ' ' PHE . 23.9 ptt85 -80.61 -41.81 23.31 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 105.792 -1.929 . . . . 4.4199999999999999 105.792 176.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 922' ' ' VAL . . . . . . . . . . . . . 86.3 t -99.37 78.31 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 N-CA-C 105.705 -1.961 . . . . 0.84999999999999998 105.705 175.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -90.73 135.53 33.66 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.836 0.827 . . . . 2.46 112.26 -176.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 9.0 t -147.23 103.32 3.57 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.053 -1.092 . . . . 0.69999999999999996 108.053 178.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -109.81 89.49 0.55 Allowed Glycine 0 N--CA 1.488 2.108 0 N-CA-C 108.97 -1.652 . . . . 0.040000000000000001 108.97 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.387 0 N-CA-C 109.265 -1.534 . . . . 0.040000000000000001 109.265 -179.633 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 10.7 m . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 120.971 0.415 . . . . 13.779999999999999 110.336 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 93.3 mt -114.16 129.87 56.61 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.536 -0.727 . . . . 13.76 110.275 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -152.52 170.6 31.71 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.463 -1.455 . . . . 9.1300000000000008 109.463 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 949' ' ' VAL . . . . . . . . . . . . . 34.8 m -116.69 137.52 50.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.563 -0.963 . . . . 7.0800000000000001 110.829 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 950' ' ' PHE . . . . . 0.425 ' CZ ' ' HB3' ' C' ' 921' ' ' ARG . 51.7 p90 -134.35 151.39 51.2 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.509 -0.744 . . . . 7.5899999999999999 109.558 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 22.3 m -116.59 -60.07 1.89 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.415 -0.803 . . . . 5.0300000000000002 111.625 -179.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 952' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' C' ' 953' ' ' ILE . 53.1 tp -63.1 -75.25 0.08 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.415 -0.803 . . . . 1.01 111.276 -178.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 953' ' ' ILE . . . . . 0.474 ' O ' ' HB3' ' C' ' 954' ' ' LEU . 1.8 pp -47.94 -154.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.768 0 N-CA-C 114.487 1.291 . . . . 2.6000000000000001 114.487 -177.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 954' ' ' LEU . . . . . 0.56 ' N ' ' CD1' ' C' ' 954' ' ' LEU . 0.0 OUTLIER 170.44 85.63 0.04 OUTLIER Pre-proline 0 N--CA 1.514 2.764 0 O-C-N 120.869 -1.144 . . . . 0.050000000000000003 111.922 179.871 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 955' ' ' PRO . . . . . 0.425 ' HD3' ' CD1' ' C' ' 953' ' ' ILE . 52.6 Cg_endo -77.13 92.39 1.12 Allowed 'Trans proline' 0 N--CA 1.488 1.162 0 N-CA-C 109.131 -1.142 . . . . 0.83999999999999997 109.131 178.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 956' ' ' LEU . . . . . . . . . . . . . 89.6 mt -127.94 149.79 50.17 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.086 -1.009 . . . . 0.040000000000000001 110.703 -179.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 957' ' ' GLN . . . . . 0.401 ' HB2' ' HB2' ' C' ' 960' ' ' ASP . 75.9 mt-30 -84.87 153.67 22.75 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 117.994 -1.003 . . . . 1.28 111.634 -179.04 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -67.45 120.44 13.92 Favored 'General case' 0 N--CA 1.508 2.469 0 CA-C-N 122.542 2.428 . . . . 0.17000000000000001 111.471 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.89 -18.86 54.88 Favored Glycine 0 N--CA 1.501 3.003 0 O-C-N 121.52 -0.738 . . . . 0.040000000000000001 111.278 178.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 960' ' ' ASP . . . . . 0.432 ' HB3' ' NE ' ' C' ' 914' ' ' ARG . 0.6 OUTLIER -51.64 172.12 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.369 -1.077 . . . . 0.040000000000000001 110.717 -179.222 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 961' ' ' THR . . . . . 0.491 ' HA ' ' O ' ' C' ' 886' ' ' PHE . 7.4 t -135.61 137.58 42.06 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.092 -1.005 . . . . 1.78 112.141 -178.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 962' ' ' VAL . . . . . 0.439 ' CG2' ' CB ' ' C' ' 886' ' ' PHE . 23.6 m -99.99 146.06 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 C-N-CA 120.031 -0.668 . . . . 0.040000000000000001 110.497 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 5.2 t -139.15 144.75 38.75 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.785 -0.572 . . . . 0.71999999999999997 110.028 -178.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 964' ' ' VAL . . . . . 0.482 ' HA ' ' HA ' ' C' ' 911' ' ' VAL . 57.8 t -94.96 137.39 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.108 -0.995 . . . . 1.05 110.627 -179.074 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -94.09 126.72 39.48 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 104.068 -2.568 . . . . 3.02 104.068 173.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 966' ' ' LEU . . . . . 0.404 ' O ' ' CG2' ' C' ' 967' ' ' VAL . 0.1 OUTLIER -132.92 60.09 1.71 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.29 -1.004 . . . . 1.46 108.29 177.398 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 967' ' ' VAL . . . . . 0.404 ' CG2' ' O ' ' C' ' 966' ' ' LEU . 96.1 t -157.82 96.31 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 108.258 -1.016 . . . . 1.9399999999999999 108.258 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 92.0 mmm -142.74 58.77 1.43 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.748 -1.22 . . . . 0.0 108.382 179.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 134.41 119.38 1.96 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 107.192 -2.363 . . . . 2.1099999999999999 107.192 -178.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -82.18 -58.38 2.97 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.015 -1.285 . . . . 5.8899999999999997 110.591 -179.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 45.1 tp -59.29 90.01 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.445 -0.784 . . . . 4.3600000000000003 110.209 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -142.33 -152.55 0.42 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.613 -0.68 . . . . 1.8300000000000001 110.208 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -116.41 167.47 11.01 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.438 -0.789 . . . . 4.3499999999999996 110.068 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 29.5 t -101.89 130.4 48.36 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.548 -0.72 . . . . 1.27 110.129 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -156.29 155.64 32.66 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.507 -0.745 . . . . 5.0199999999999996 110.459 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.29 85.08 18.86 Favored Pre-proline 0 N--CA 1.5 2.043 0 O-C-N 121.627 -0.671 . . . . 2.4100000000000001 109.642 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -74.8 -171.47 0.97 Allowed 'Trans proline' 0 C--N 1.317 -1.113 0 O-C-N 123.356 1.188 . . . . 0.95999999999999996 111.331 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 978' ' ' LEU . . . . . . . . . . . . . 5.5 mp -125.21 156.38 38.56 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.542 -1.281 . . . . 0.62 107.542 177.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 979' ' ' THR . . . . . . . . . . . . . 43.2 p -149.42 141.6 24.03 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.822 -1.174 . . . . 3.5699999999999998 111.184 -179.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 980' ' ' ILE . . . . . . . . . . . . . 50.2 mm -106.89 128.27 61.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 108.948 -0.76 . . . . 1.3300000000000001 108.948 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 981' ' ' PHE . . . . . 0.417 ' CD1' ' CE2' ' C' ' 879' ' ' TYR . 3.4 t80 -117.53 97.56 5.94 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.428 -0.795 . . . . 0.050000000000000003 111.564 -178.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 982' ' ' SER . . . . . . . . . . . . . 34.5 p -107.2 158.25 17.25 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 109.042 -0.725 . . . . 0.87 109.042 178.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 983' ' ' GLY . . . . . 0.432 ' HA3' ' CE2' ' C' ' 852' ' ' PHE . . . -173.06 113.7 0.48 Allowed Glycine 0 N--CA 1.497 2.727 0 N-CA-C 106.644 -2.582 . . . . 0.029999999999999999 106.644 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 984' ' ' ALA . . . . . 0.4 ' CB ' ' CZ ' ' A' ' 893' ' ' ARG . . . -109.11 152.38 25.15 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 114.319 1.229 . . . . 0.69999999999999996 114.319 -175.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 985' ' ' LEU . . . . . . . . . . . . . 52.1 tp -75.89 135.75 40.13 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.871 -1.143 . . . . 0.040000000000000001 109.691 179.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 986' ' ' LEU . . . . . . . . . . . . . 40.7 tp -106.26 -62.63 1.36 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.442 -0.786 . . . . 0.040000000000000001 110.299 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -144.7 146.78 32.38 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.753 -1.203 . . . . 0.040000000000000001 107.753 179.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -111.91 162.67 12.35 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 108.079 -2.008 . . . . 0.040000000000000001 108.079 179.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -73.7 112.86 18.05 Favored Pre-proline 0 N--CA 1.499 1.999 0 O-C-N 121.23 -1.159 . . . . 0.040000000000000001 109.44 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 990' ' ' PRO . . . . . 0.414 ' O ' ' HB2' ' C' ' 991' ' ' GLU . 51.1 Cg_endo -88.08 70.83 2.88 Favored 'Trans proline' 0 C--N 1.319 -0.984 0 O-C-N 123.201 1.106 . . . . 0.45000000000000001 111.408 -179.017 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 991' ' ' GLU . . . . . 0.414 ' HB2' ' O ' ' C' ' 990' ' ' PRO . 80.6 mt-10 67.14 -73.65 0.08 Allowed 'General case' 0 N--CA 1.502 2.148 0 N-CA-C 108.645 -0.872 . . . . 1.97 108.645 -177.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 992' ' ' LEU . . . . . . . . . . . . . 11.1 mt 50.86 20.91 0.85 Allowed 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.62 -0.675 . . . . 2.3799999999999999 111.58 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -92.43 156.91 16.88 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.991 -1.068 . . . . 3.79 110.042 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -146.66 91.62 2.05 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.567 -0.708 . . . . 3.5099999999999998 110.245 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 995' ' ' ALA . . . . . . . . . . . . 2.518 . . . . . . . 0 N--CA 1.503 2.213 0 O-C-N 120.983 -1.073 . . . . 2.73 110.646 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo . . . . . 0 N--CA 1.488 1.154 0 N-CA-C 109.497 -1.001 . . . . 3.8300000000000001 109.497 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 847' ' ' VAL . . . . . . . . . . . . . 63.4 t -135.3 102.68 10.68 Favored Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 121.504 -0.747 . . . . 1.8300000000000001 110.04 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 848' ' ' PRO . . . . . 0.4 ' O ' ' C ' ' A' ' 849' ' ' GLN . 44.3 Cg_endo -69.94 -18.12 36.35 Favored 'Trans proline' 0 N--CA 1.488 1.161 0 O-C-N 123.308 1.162 . . . . 0.65000000000000002 111.196 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 849' ' ' GLN . . . . . 0.4 ' C ' ' O ' ' A' ' 848' ' ' PRO . 56.4 tt0 28.07 69.42 0.07 Allowed 'General case' 0 N--CA 1.518 2.96 0 N-CA-C 112.837 0.68 . . . . 2.5800000000000001 112.837 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 850' ' ' VAL . . . . . . . . . . . . . 64.8 t -120.38 137.5 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 121.216 -0.927 . . . . 1.0900000000000001 111.7 -178.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 851' ' ' ALA . . . . . . . . . . . . . . . -125.94 159.18 33.29 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 105.909 -1.885 . . . . 0.040000000000000001 105.909 176.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 852' ' ' PHE . . . . . 0.423 ' CE1' ' HA3' ' A' ' 983' ' ' GLY . 48.1 p90 -158.73 130.72 6.67 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 121.075 1.762 . . . . 0.050000000000000003 108.864 178.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 46.9 t -175.5 134.05 0.3 Allowed 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.209 -1.034 . . . . 0.040000000000000001 108.209 -179.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -133.55 155.09 50.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.091 -1.006 . . . . 0.67000000000000004 109.498 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 855' ' ' ALA . . . . . . . . . . . . . . . -124.1 142.7 50.97 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.973 0.892 . . . . 0.51000000000000001 111.651 -179.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 856' ' ' LEU . . . . . 0.425 ' HG ' ' CG1' ' A' ' 866' ' ' VAL . 3.3 tm? -111.62 137.88 48.91 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.717 -0.614 . . . . 0.050000000000000003 110.214 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 857' ' ' SER . . . . . 0.408 ' O ' ' O ' ' A' ' 858' ' ' LEU . 76.5 p -155.48 15.41 0.38 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.594 -0.691 . . . . 1.3300000000000001 111.466 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 858' ' ' LEU . . . . . 0.408 ' O ' ' O ' ' A' ' 857' ' ' SER . 4.3 pp -36.51 160.65 0.05 OUTLIER Pre-proline 0 N--CA 1.515 2.822 0 CA-C-N 118.799 0.727 . . . . 2.3300000000000001 112.581 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -59.68 -89.16 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.491 0 O-C-N 123.005 1.003 . . . . 2.3199999999999998 114.016 -177.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 54.3 ptt85 -128.08 -144.58 0.29 Allowed 'General case' 0 N--CA 1.502 2.137 0 O-C-N 120.774 -1.204 . . . . 0.040000000000000001 112.394 -177.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 69.7 m -33.91 127.56 0.4 Allowed 'General case' 0 N--CA 1.511 2.604 0 N-CA-C 112.987 0.736 . . . . 1.3100000000000001 112.987 -178.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.67 158.22 32.19 Favored Pre-proline 0 N--CA 1.489 1.477 0 N-CA-C 108.288 -1.004 . . . . 4.5099999999999998 108.288 177.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.27 -13.39 25.61 Favored 'Trans proline' 0 C--N 1.315 -1.236 0 O-C-N 123.069 1.036 . . . . 2.2400000000000002 111.687 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -177.55 -135.1 2.15 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 110.06 -1.216 . . . . 0.040000000000000001 110.06 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 28.4 m -67.58 151.21 47.7 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.382 -1.07 . . . . 1.51 109.923 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 866' ' ' VAL . . . . . 0.425 ' CG1' ' HG ' ' A' ' 856' ' ' LEU . 33.4 t -94.67 139.67 22.34 Favored Pre-proline 0 N--CA 1.496 1.869 0 N-CA-C 113.764 1.024 . . . . 0.78000000000000003 113.764 -174.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 867' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 866' ' ' VAL . 55.3 Cg_endo -91.96 -151.31 0.04 OUTLIER 'Trans proline' 0 CA--C 1.544 0.999 0 O-C-N 123.673 1.354 . . . . 0.92000000000000004 109.275 177.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 868' ' ' PHE . . . . . 0.448 ' N ' ' CD1' ' A' ' 868' ' ' PHE . 20.1 p90 -151.1 124.16 8.73 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.662 -1.274 . . . . 0.050000000000000003 109.806 179.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 50.5 p-10 -113.75 -2.17 13.77 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.226 -0.921 . . . . 1.7 112.731 -178.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 870' ' ' ARG . . . . . . . . . . . . . 28.8 mmm180 -90.64 90.08 7.81 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.883 -1.135 . . . . 2.5899999999999999 110.944 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 60.3 t -72.3 96.48 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 120.998 -1.064 . . . . 1.9399999999999999 109.944 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 872' ' ' LEU . . . . . . . . . . . . . 96.9 mt -83.09 -47.35 11.75 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.495 -0.753 . . . . 1.0600000000000001 110.188 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 873' ' ' LEU . . . . . 0.401 ' O ' ' HB2' ' A' ' 874' ' ' ASN . 44.3 tp -174.61 103.51 0.1 Allowed 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 108.729 -0.841 . . . . 4.1799999999999997 108.729 178.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 874' ' ' ASN . . . . . 0.402 ' CB ' ' HA ' ' A' ' 852' ' ' PHE . 33.3 t-20 177.92 81.74 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.31 0 O-C-N 121.681 -0.637 . . . . 0.040000000000000001 109.301 -178.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -66.33 -47.27 74.04 Favored 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 119.317 -0.953 . . . . 3.3799999999999999 111.143 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 876' ' ' GLY . . . . . 0.415 ' HA3' ' CE2' ' A' ' 878' ' ' TYR . . . -74.53 -24.68 72.12 Favored Glycine 0 N--CA 1.494 2.552 0 O-C-N 121.309 -0.87 . . . . 0.040000000000000001 111.546 -178.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 82.22 -61.95 4.63 Favored Glycine 0 N--CA 1.501 2.973 0 N-CA-C 108.005 -2.038 . . . . 0.040000000000000001 108.005 -178.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 878' ' ' TYR . . . . . 0.415 ' CE2' ' HA3' ' A' ' 876' ' ' GLY . 97.9 m-85 60.91 -62.25 0.07 Allowed 'General case' 0 N--CA 1.503 2.211 0 N-CA-C 114.542 1.312 . . . . 3.46 114.542 177.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 879' ' ' TYR . . . . . 0.484 ' CB ' ' CD2' ' A' ' 886' ' ' PHE . 18.2 p90 -110.63 109.7 20.09 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 114.849 1.426 . . . . 0.040000000000000001 114.849 -176.085 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -68.05 115.55 29.7 Favored Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 121.405 -0.809 . . . . 0.02 109.971 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 881' ' ' PRO . . . . . 0.428 ' HG2' ' CD1' ' A' ' 868' ' ' PHE . 55.2 Cg_endo -75.93 0.6 9.09 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 O-C-N 123.39 1.205 . . . . 0.39000000000000001 112.309 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -76.92 -62.27 1.7 Allowed 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 106.617 -1.623 . . . . 0.81000000000000005 106.617 178.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 64.4 p -94.49 -19.27 20.69 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.617 -0.882 . . . . 0.040000000000000001 108.617 177.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.66 19.77 59.36 Favored Glycine 0 N--CA 1.496 2.677 0 O-C-N 121.064 -1.022 . . . . 0.029999999999999999 111.237 178.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 885' ' ' VAL . . . . . . . . . . . . . 95.9 t -74.25 89.0 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 C-N-CA 118.141 -1.424 . . . . 1.01 108.302 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 886' ' ' PHE . . . . . 0.484 ' CD2' ' CB ' ' A' ' 879' ' ' TYR . 1.0 OUTLIER -88.23 105.43 17.53 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 115.306 -0.861 . . . . 0.050000000000000003 111.52 -177.674 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 887' ' ' THR . . . . . 0.409 ' O ' ' HD3' ' A' ' 889' ' ' PRO . 93.1 m -95.43 99.95 11.79 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 107.856 -1.165 . . . . 0.68000000000000005 107.856 177.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 888' ' ' ALA . . . . . . . . . . . . . . . -98.85 106.4 37.27 Favored Pre-proline 0 N--CA 1.5 2.039 0 N-CA-C 114.124 1.157 . . . . 0.25 114.124 -176.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 889' ' ' PRO . . . . . 0.409 ' HD3' ' O ' ' A' ' 887' ' ' THR . 54.1 Cg_endo -89.07 -12.39 3.37 Favored 'Trans proline' 0 CA--C 1.546 1.1 0 N-CA-C 108.92 -1.223 . . . . 1.6399999999999999 108.92 176.084 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 890' ' ' LEU . . . . . . . . . . . . . 76.7 mt -36.11 -50.73 0.72 Allowed 'General case' 0 N--CA 1.508 2.447 0 N-CA-C 113.592 0.96 . . . . 2.29 113.592 -177.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 52.35 95.55 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.236 -0.915 . . . . 0.63 110.195 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 157.67 -153.64 24.83 Favored Glycine 0 N--CA 1.477 1.427 0 N-CA-C 107.111 -2.396 . . . . 0.040000000000000001 107.111 -179.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 71.4 ttt-85 -115.79 126.89 54.6 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 121.557 -0.967 . . . . 3.0 108.539 177.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 894' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -132.24 160.49 36.02 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.11 -0.994 . . . . 0.040000000000000001 111.081 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 895' ' ' LEU . . . . . . . . . . . . . 35.0 tp -90.71 119.08 30.65 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.401 0.62 . . . . 1.27 110.029 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 9.5 tt -109.42 143.21 39.32 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.774 -0.579 . . . . 0.93999999999999995 110.2 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 897' ' ' SER . . . . . . . . . . . . . 67.8 m -149.0 115.1 5.76 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.482 -0.761 . . . . 0.040000000000000001 111.018 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -108.1 146.77 32.16 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 109.07 -0.715 . . . . 0.47999999999999998 109.07 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 899' ' ' VAL . . . . . . . . . . . . . 87.7 t -95.7 119.72 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 C-N-CA 119.63 -0.828 . . . . 0.55000000000000004 111.279 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 900' ' ' LEU . . . . . 0.427 ' CD2' ' N ' ' A' ' 900' ' ' LEU . 4.5 mm? -96.04 112.22 24.02 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 114.384 1.253 . . . . 1.5900000000000001 114.384 -175.05 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 11.8 m -66.28 141.29 58.06 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 107.53 -1.285 . . . . 0.050000000000000003 107.53 176.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -66.72 -66.13 2.51 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 110.573 -1.011 . . . . 0.029999999999999999 110.573 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 11.8 m170 46.91 67.02 0.85 Allowed 'General case' 0 N--CA 1.508 2.438 0 O-C-N 121.476 -1.014 . . . . 3.2000000000000002 111.151 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 43.3 ptt85 -69.71 -5.65 26.47 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.608 -0.683 . . . . 2.9199999999999999 112.063 -179.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 905' ' ' HIS . . . . . 0.486 ' O ' ' CB ' ' A' ' 906' ' ' GLU . 73.8 t60 -62.83 5.32 0.13 Allowed 'General case' 0 N--CA 1.506 2.365 0 O-C-N 120.9 -1.125 . . . . 2.8700000000000001 113.111 -179.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 906' ' ' GLU . . . . . 0.486 ' CB ' ' O ' ' A' ' 905' ' ' HIS . 0.8 OUTLIER 94.86 -164.48 0.0 OUTLIER 'General case' 0 N--CA 1.529 3.478 0 CA-C-N 120.552 1.524 . . . . 0.98999999999999999 111.899 178.944 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 907' ' ' LYS . . . . . 0.46 ' CB ' ' O ' ' A' ' 906' ' ' GLU . 68.4 tttt 85.78 157.56 0.09 Allowed 'General case' 0 N--CA 1.519 3.019 0 N-CA-C 108.156 -1.053 . . . . 5.25 108.156 -177.059 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 60.1 t -121.68 117.08 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 120.756 -1.215 . . . . 0.39000000000000001 111.312 -179.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 71.2 tt0 -100.03 132.77 45.19 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 107.041 -1.466 . . . . 1.72 107.041 176.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -155.09 123.27 5.88 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 106.805 -1.554 . . . . 0.67000000000000004 106.805 178.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 911' ' ' VAL . . . . . 0.484 ' HA ' ' HA ' ' A' ' 964' ' ' VAL . 87.5 t -83.6 131.14 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 C-N-CA 120.52 -0.472 . . . . 0.54000000000000004 110.68 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 86.2 mt -66.34 156.01 35.68 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.333 -0.855 . . . . 1.5 109.264 178.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 913' ' ' SER . . . . . 0.417 ' HB3' ' HB ' ' A' ' 919' ' ' VAL . 0.1 OUTLIER -127.48 133.87 49.86 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 107.542 -1.281 . . . . 1.3700000000000001 107.542 176.547 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 914' ' ' ARG . . . . . 0.439 ' O ' ' CB ' ' A' ' 915' ' ' SER . 0.0 OUTLIER -64.95 158.41 25.49 Favored 'General case' 0 N--CA 1.506 2.373 0 O-C-N 120.558 -1.339 . . . . 4.2999999999999998 112.119 -178.491 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 915' ' ' SER . . . . . 0.439 ' CB ' ' O ' ' A' ' 914' ' ' ARG . 4.6 t 84.39 -32.09 0.07 Allowed 'General case' 0 N--CA 1.522 3.153 0 C-N-CA 124.164 0.985 . . . . 2.0499999999999998 111.943 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 916' ' ' ASN . . . . . 0.404 ' O ' ' HB2' ' A' ' 917' ' ' GLN . 98.9 m-20 -123.88 -21.32 5.16 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.899 -1.126 . . . . 2.71 111.352 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 917' ' ' GLN . . . . . 0.404 ' HB2' ' O ' ' A' ' 916' ' ' ASN . 45.6 mt-30 66.67 166.39 0.21 Allowed 'General case' 0 N--CA 1.52 3.073 0 N-CA-C 105.637 -1.986 . . . . 2.6800000000000002 105.637 -174.072 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 52.93 -124.07 26.32 Favored Glycine 1 N--CA 1.523 4.46 0 CA-C-N 123.383 2.811 . . . . 0.029999999999999999 106.895 -177.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 919' ' ' VAL . . . . . 0.417 ' HB ' ' HB3' ' A' ' 913' ' ' SER . 52.1 t 52.22 93.9 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 121.337 -1.096 . . . . 1.3899999999999999 108.96 -178.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.75 91.28 7.89 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 119.402 -0.919 . . . . 0.029999999999999999 110.917 -178.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 921' ' ' ARG . . . . . 0.434 ' HB3' ' CZ ' ' A' ' 950' ' ' PHE . 17.3 ptt180 -86.64 -42.24 13.59 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 106.104 -1.813 . . . . 4.4199999999999999 106.104 176.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 922' ' ' VAL . . . . . . . . . . . . . 76.7 t -104.29 67.09 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 105.846 -1.909 . . . . 0.84999999999999998 105.846 175.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -86.58 134.18 33.66 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.684 0.755 . . . . 2.46 111.459 -177.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 39.7 t -147.7 106.18 3.79 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.669 -0.863 . . . . 0.69999999999999996 108.669 179.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -101.76 84.74 0.52 Allowed Glycine 0 N--CA 1.486 1.995 0 N-CA-C 108.304 -1.918 . . . . 0.040000000000000001 108.304 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.21 0 N-CA-C 108.877 -1.689 . . . . 0.040000000000000001 108.877 -179.537 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 26.0 m . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.033 0.444 . . . . 13.779999999999999 110.313 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 95.7 mt -112.38 130.88 55.81 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.544 -0.723 . . . . 13.76 110.301 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -151.36 168.25 30.87 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.107 -1.597 . . . . 9.1300000000000008 109.107 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 949' ' ' VAL . . . . . . . . . . . . . 29.8 m -119.11 127.08 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.5 -1.0 . . . . 7.0800000000000001 111.019 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 950' ' ' PHE . . . . . 0.434 ' CZ ' ' HB3' ' A' ' 921' ' ' ARG . 27.1 p90 -133.71 149.28 51.5 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.623 -0.673 . . . . 7.5899999999999999 109.237 179.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 29.1 m -121.27 -51.51 2.09 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.359 -0.838 . . . . 5.0300000000000002 112.191 -178.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 952' ' ' LEU . . . . . 0.418 ' O ' ' O ' ' A' ' 953' ' ' ILE . 14.6 tp -59.4 -73.88 0.08 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.369 -0.832 . . . . 1.01 112.705 -177.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 953' ' ' ILE . . . . . 0.456 ' O ' ' HB3' ' A' ' 954' ' ' LEU . 45.8 pt -52.29 -144.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.848 0 N-CA-C 114.417 1.266 . . . . 2.6000000000000001 114.417 -176.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 954' ' ' LEU . . . . . 0.545 ' N ' ' CD1' ' A' ' 954' ' ' LEU . 0.0 OUTLIER 173.21 75.01 0.04 OUTLIER Pre-proline 0 N--CA 1.507 2.417 0 O-C-N 120.779 -1.201 . . . . 0.050000000000000003 110.869 -179.974 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 955' ' ' PRO . . . . . 0.429 ' HD2' ' CE1' ' A' ' 950' ' ' PHE . 49.6 Cg_endo -77.11 95.51 1.07 Allowed 'Trans proline' 0 C--N 1.316 -1.143 0 O-C-N 122.716 0.85 . . . . 0.83999999999999997 110.2 179.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 956' ' ' LEU . . . . . . . . . . . . . 8.9 mp -125.83 151.12 47.23 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.237 -0.915 . . . . 0.040000000000000001 110.257 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -82.19 150.92 27.13 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-O 117.734 -1.127 . . . . 1.28 111.311 -178.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -68.33 119.47 12.9 Favored 'General case' 0 N--CA 1.509 2.51 0 CA-C-N 123.063 2.665 . . . . 0.17000000000000001 111.234 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.8 -21.68 37.9 Favored Glycine 0 N--CA 1.499 2.874 0 N-CA-C 110.769 -0.932 . . . . 0.040000000000000001 110.769 178.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 960' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.12 171.9 0.06 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.389 -1.066 . . . . 0.040000000000000001 109.993 -179.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 961' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' A' ' 886' ' ' PHE . 41.5 m -133.53 138.73 46.23 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.895 -1.128 . . . . 1.78 112.159 -177.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 962' ' ' VAL . . . . . 0.434 ' CG2' ' CB ' ' A' ' 886' ' ' PHE . 20.3 m -96.57 143.62 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 C-N-CA 120.025 -0.67 . . . . 0.040000000000000001 109.763 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 5.3 t -140.28 145.3 37.1 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.817 -0.552 . . . . 0.71999999999999997 109.981 -178.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 964' ' ' VAL . . . . . 0.484 ' HA ' ' HA ' ' A' ' 911' ' ' VAL . 47.6 t -99.59 136.9 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.141 -0.975 . . . . 1.05 110.785 -178.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -94.05 128.43 40.42 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 103.799 -2.667 . . . . 3.02 103.799 173.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 966' ' ' LEU . . . . . 0.4 ' O ' ' CG2' ' A' ' 967' ' ' VAL . 10.2 tp -131.62 61.99 1.64 Allowed 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.136 -1.061 . . . . 1.46 108.136 177.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 967' ' ' VAL . . . . . 0.4 ' CG2' ' O ' ' A' ' 966' ' ' LEU . 95.4 t -158.01 97.2 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 108.072 -1.084 . . . . 1.9399999999999999 108.072 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 88.2 mmm -143.13 60.02 1.41 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.746 -1.221 . . . . 0.0 108.353 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.78 119.98 1.95 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 107.036 -2.425 . . . . 2.1099999999999999 107.036 -178.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -82.45 -58.68 2.82 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.014 -1.286 . . . . 5.8899999999999997 110.396 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 49.0 tp -59.01 90.74 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.422 -0.799 . . . . 4.3600000000000003 110.209 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -141.93 -154.19 0.5 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.592 -0.693 . . . . 1.8300000000000001 110.235 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -119.64 171.92 8.04 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.511 -0.743 . . . . 4.3499999999999996 110.212 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 39.0 t -101.64 130.42 47.98 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.598 -0.689 . . . . 1.27 110.084 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -156.12 158.75 38.24 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.521 -0.737 . . . . 5.0199999999999996 110.561 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.14 85.75 18.43 Favored Pre-proline 0 N--CA 1.5 2.04 0 O-C-N 121.59 -0.694 . . . . 2.4100000000000001 109.691 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -73.39 -172.43 1.04 Allowed 'Trans proline' 0 C--N 1.317 -1.089 0 O-C-N 123.277 1.146 . . . . 0.95999999999999996 111.345 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 5.7 mp -127.47 155.3 43.92 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 107.688 -1.227 . . . . 0.62 107.688 177.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 979' ' ' THR . . . . . . . . . . . . . 42.7 p -149.83 141.1 23.16 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.847 -1.158 . . . . 3.5699999999999998 111.252 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 980' ' ' ILE . . . . . 0.422 HG22 HD11 ' A' ' 980' ' ' ILE . 46.7 mm -107.7 128.69 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 108.911 -0.774 . . . . 1.3300000000000001 108.911 179.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 981' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -120.95 97.26 5.45 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 119.705 -0.798 . . . . 0.050000000000000003 111.974 -178.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 83.8 p -108.59 158.49 17.53 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.539 -0.726 . . . . 0.87 109.157 178.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 983' ' ' GLY . . . . . 0.423 ' HA3' ' CE1' ' A' ' 852' ' ' PHE . . . -175.18 109.04 0.28 Allowed Glycine 0 N--CA 1.499 2.878 0 N-CA-C 106.39 -2.684 . . . . 0.029999999999999999 106.39 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -108.64 152.42 24.82 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 114.565 1.32 . . . . 0.69999999999999996 114.565 -175.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 45.3 tp -72.28 134.55 45.62 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.777 -1.202 . . . . 0.040000000000000001 110.051 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 50.8 tp -107.49 -55.83 2.3 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.562 -0.711 . . . . 0.040000000000000001 109.905 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -144.82 145.16 31.51 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 107.653 -1.24 . . . . 0.040000000000000001 107.653 179.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.74 163.15 12.18 Favored Glycine 0 N--CA 1.495 2.593 0 N-CA-C 108.155 -1.978 . . . . 0.040000000000000001 108.155 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -75.85 112.16 18.55 Favored Pre-proline 0 N--CA 1.499 1.988 0 O-C-N 121.202 -1.175 . . . . 0.040000000000000001 109.436 179.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 990' ' ' PRO . . . . . 0.414 ' O ' ' HB2' ' A' ' 991' ' ' GLU . 48.8 Cg_endo -91.4 71.23 0.97 Allowed 'Trans proline' 0 C--N 1.319 -0.993 0 O-C-N 123.151 1.079 . . . . 0.45000000000000001 111.418 -178.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 991' ' ' GLU . . . . . 0.414 ' HB2' ' O ' ' A' ' 990' ' ' PRO . 70.4 mt-10 67.25 -73.85 0.07 Allowed 'General case' 0 N--CA 1.503 2.178 0 N-CA-C 108.421 -0.955 . . . . 1.97 108.421 -177.35 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 992' ' ' LEU . . . . . . . . . . . . . 6.6 mt 51.16 20.54 0.89 Allowed 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.574 -0.704 . . . . 2.3799999999999999 111.609 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -94.63 156.68 16.31 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.844 -1.16 . . . . 3.79 109.98 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -146.55 93.77 2.34 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.529 -0.732 . . . . 3.5099999999999998 110.269 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 995' ' ' ALA . . . . . . . . . . . . 2.518 . . . . . . . 0 N--CA 1.504 2.243 0 O-C-N 120.86 -1.15 . . . . 2.73 110.578 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo . . . . . 0 N--CA 1.488 1.177 0 N-CA-C 109.432 -1.026 . . . . 3.8300000000000001 109.432 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 847' ' ' VAL . . . . . . . . . . . . . 63.6 t -135.38 102.69 10.6 Favored Pre-proline 0 N--CA 1.494 1.775 0 O-C-N 121.573 -0.704 . . . . 1.8300000000000001 110.014 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 848' ' ' PRO . . . . . 0.404 ' O ' ' C ' ' B' ' 849' ' ' GLN . 44.1 Cg_endo -69.95 -18.41 36.15 Favored 'Trans proline' 0 N--CA 1.487 1.091 0 O-C-N 123.279 1.147 . . . . 0.65000000000000002 111.192 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 849' ' ' GLN . . . . . 0.404 ' C ' ' O ' ' B' ' 848' ' ' PRO . 56.4 tt0 28.35 69.57 0.07 Allowed 'General case' 0 N--CA 1.518 2.969 0 N-CA-C 112.734 0.642 . . . . 2.5800000000000001 112.734 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 850' ' ' VAL . . . . . . . . . . . . . 65.1 t -120.56 137.57 53.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.15 -0.969 . . . . 1.0900000000000001 111.694 -178.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 851' ' ' ALA . . . . . . . . . . . . . . . -126.37 158.48 35.78 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 105.894 -1.891 . . . . 0.040000000000000001 105.894 176.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 852' ' ' PHE . . . . . 0.427 ' CE1' ' HA3' ' B' ' 983' ' ' GLY . 47.7 p90 -157.9 131.03 7.54 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 121.114 1.779 . . . . 0.050000000000000003 108.803 179.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 47.2 t -175.53 133.72 0.29 Allowed 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.216 -1.031 . . . . 0.040000000000000001 108.216 -179.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -133.17 155.33 49.51 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.071 -1.018 . . . . 0.67000000000000004 109.522 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 855' ' ' ALA . . . . . . . . . . . . . . . -124.37 142.99 50.85 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 122.026 0.917 . . . . 0.51000000000000001 111.553 -179.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 856' ' ' LEU . . . . . 0.421 ' HG ' ' CG1' ' B' ' 866' ' ' VAL . 3.3 tm? -111.96 137.56 49.8 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.719 -0.613 . . . . 0.050000000000000003 110.274 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 857' ' ' SER . . . . . 0.407 ' O ' ' O ' ' B' ' 858' ' ' LEU . 77.1 p -155.15 15.43 0.4 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.615 -0.678 . . . . 1.3300000000000001 111.433 179.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 858' ' ' LEU . . . . . 0.407 ' O ' ' O ' ' B' ' 857' ' ' SER . 4.3 pp -36.54 160.68 0.05 OUTLIER Pre-proline 0 N--CA 1.516 2.869 0 CA-C-N 118.861 0.755 . . . . 2.3300000000000001 112.544 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -59.74 -89.11 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 120.791 0.994 . . . . 2.3199999999999998 114.022 -177.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 54.4 ptt85 -128.18 -144.7 0.29 Allowed 'General case' 0 N--CA 1.501 2.124 0 O-C-N 120.845 -1.159 . . . . 0.040000000000000001 112.386 -177.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 70.1 m -33.81 126.99 0.4 Allowed 'General case' 0 N--CA 1.512 2.642 0 N-CA-C 112.95 0.722 . . . . 1.3100000000000001 112.95 -178.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 862' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.14 158.26 32.11 Favored Pre-proline 0 N--CA 1.489 1.478 0 N-CA-C 108.324 -0.991 . . . . 4.5099999999999998 108.324 177.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -73.19 -13.54 25.8 Favored 'Trans proline' 0 C--N 1.314 -1.283 0 O-C-N 123.114 1.06 . . . . 2.2400000000000002 111.855 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -177.2 -134.14 1.95 Allowed Glycine 0 N--CA 1.495 2.612 0 N-CA-C 110.005 -1.238 . . . . 0.040000000000000001 110.005 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 29.1 m -68.65 151.62 46.46 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.319 -1.106 . . . . 1.51 109.802 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 866' ' ' VAL . . . . . 0.421 ' CG1' ' HG ' ' B' ' 856' ' ' LEU . 33.2 t -94.82 139.7 22.28 Favored Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 113.766 1.024 . . . . 0.78000000000000003 113.766 -174.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 867' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -92.02 -151.49 0.04 OUTLIER 'Trans proline' 0 CA--C 1.545 1.034 0 O-C-N 123.729 1.384 . . . . 0.92000000000000004 109.302 177.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 868' ' ' PHE . . . . . 0.453 ' CD1' ' N ' ' B' ' 868' ' ' PHE . 20.3 p90 -150.91 123.86 8.69 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.644 -1.285 . . . . 0.050000000000000003 109.83 179.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 50.5 p-10 -113.54 -1.66 14.05 Favored 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 119.388 -0.925 . . . . 1.7 112.742 -178.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 870' ' ' ARG . . . . . . . . . . . . . 28.6 mmm180 -91.12 89.96 7.61 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.855 -1.153 . . . . 2.5899999999999999 111.005 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 59.7 t -72.29 96.57 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.011 -1.056 . . . . 1.9399999999999999 109.937 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 872' ' ' LEU . . . . . . . . . . . . . 96.6 mt -83.24 -47.15 11.84 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.504 -0.747 . . . . 1.0600000000000001 110.232 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 873' ' ' LEU . . . . . 0.401 ' O ' ' HB2' ' B' ' 874' ' ' ASN . 44.2 tp -174.61 103.46 0.1 Allowed 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.735 -0.839 . . . . 4.1799999999999997 108.735 178.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 874' ' ' ASN . . . . . 0.401 ' HB2' ' O ' ' B' ' 873' ' ' LEU . 33.0 t-20 177.95 81.84 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.64 -0.663 . . . . 0.040000000000000001 109.42 -178.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -66.45 -47.29 73.62 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 119.272 -0.971 . . . . 3.3799999999999999 111.176 -179.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 876' ' ' GLY . . . . . 0.421 ' HA3' ' CE2' ' B' ' 878' ' ' TYR . . . -74.5 -24.82 71.84 Favored Glycine 0 N--CA 1.494 2.524 0 O-C-N 121.263 -0.898 . . . . 0.040000000000000001 111.534 -178.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 82.36 -61.98 4.64 Favored Glycine 0 N--CA 1.501 3.021 0 N-CA-C 107.983 -2.047 . . . . 0.040000000000000001 107.983 -178.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 878' ' ' TYR . . . . . 0.421 ' CE2' ' HA3' ' B' ' 876' ' ' GLY . 97.8 m-85 60.89 -62.23 0.07 Allowed 'General case' 0 N--CA 1.504 2.251 0 N-CA-C 114.527 1.306 . . . . 3.46 114.527 177.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 879' ' ' TYR . . . . . 0.485 ' CB ' ' CD2' ' B' ' 886' ' ' PHE . 18.2 p90 -110.59 109.69 20.1 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 114.826 1.417 . . . . 0.040000000000000001 114.826 -176.121 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -67.95 115.48 28.72 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.418 -0.801 . . . . 0.02 109.947 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 881' ' ' PRO . . . . . 0.437 ' HG2' ' CD1' ' B' ' 868' ' ' PHE . 55.3 Cg_endo -75.9 0.46 9.24 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 O-C-N 123.361 1.19 . . . . 0.39000000000000001 112.264 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -76.72 -62.52 1.61 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 106.637 -1.616 . . . . 0.81000000000000005 106.637 178.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 63.5 p -94.46 -18.65 21.3 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.711 -0.848 . . . . 0.040000000000000001 108.711 177.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.88 20.28 59.83 Favored Glycine 0 N--CA 1.496 2.648 0 O-C-N 121.101 -1.0 . . . . 0.029999999999999999 111.311 178.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 885' ' ' VAL . . . . . . . . . . . . . 93.9 t -74.53 89.27 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 C-N-CA 118.15 -1.42 . . . . 1.01 108.202 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 886' ' ' PHE . . . . . 0.485 ' CD2' ' CB ' ' B' ' 879' ' ' TYR . 1.0 OUTLIER -88.38 105.55 17.66 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 115.366 -0.833 . . . . 0.050000000000000003 111.546 -177.75 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 887' ' ' THR . . . . . 0.409 ' O ' ' HD3' ' B' ' 889' ' ' PRO . 93.0 m -95.48 100.27 12.05 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 107.745 -1.206 . . . . 0.68000000000000005 107.745 177.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 888' ' ' ALA . . . . . . . . . . . . . . . -99.09 106.23 37.0 Favored Pre-proline 0 N--CA 1.5 2.06 0 N-CA-C 114.059 1.133 . . . . 0.25 114.059 -176.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 889' ' ' PRO . . . . . 0.409 ' HD3' ' O ' ' B' ' 887' ' ' THR . 54.8 Cg_endo -88.92 -12.37 3.48 Favored 'Trans proline' 0 CA--C 1.546 1.079 0 N-CA-C 109.003 -1.191 . . . . 1.6399999999999999 109.003 175.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 890' ' ' LEU . . . . . . . . . . . . . 76.6 mt -36.02 -50.78 0.71 Allowed 'General case' 0 N--CA 1.508 2.462 0 N-CA-C 113.588 0.958 . . . . 2.29 113.588 -177.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 52.16 95.64 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.231 -0.918 . . . . 0.63 110.232 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . 157.63 -153.85 25.01 Favored Glycine 0 N--CA 1.477 1.418 0 N-CA-C 107.061 -2.416 . . . . 0.040000000000000001 107.061 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 71.4 ttt-85 -115.62 126.95 54.82 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 121.61 -0.935 . . . . 3.0 108.587 177.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 894' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -132.18 160.9 34.74 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.117 -0.989 . . . . 0.040000000000000001 111.069 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 895' ' ' LEU . . . . . . . . . . . . . 35.2 tp -91.13 118.93 30.83 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.426 0.631 . . . . 1.27 110.091 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 896' ' ' LEU . . . . . . . . . . . . . 9.5 tt -109.28 142.47 40.11 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.782 -0.574 . . . . 0.93999999999999995 110.251 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 897' ' ' SER . . . . . . . . . . . . . 68.1 m -148.42 114.96 5.95 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.538 -0.726 . . . . 0.040000000000000001 111.022 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.87 146.52 32.21 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 109.179 -0.674 . . . . 0.47999999999999998 109.179 179.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 899' ' ' VAL . . . . . . . . . . . . . 87.9 t -95.46 119.54 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 C-N-CA 119.616 -0.833 . . . . 0.55000000000000004 111.324 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 900' ' ' LEU . . . . . 0.416 ' N ' ' CD2' ' B' ' 900' ' ' LEU . 4.5 mm? -95.95 111.74 23.66 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 114.401 1.259 . . . . 1.5900000000000001 114.401 -174.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 11.9 m -65.87 141.22 58.33 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 107.466 -1.309 . . . . 0.050000000000000003 107.466 176.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -66.87 -66.16 2.49 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 110.615 -0.994 . . . . 0.029999999999999999 110.615 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 11.7 m170 46.9 67.16 0.83 Allowed 'General case' 0 N--CA 1.507 2.414 0 O-C-N 121.519 -0.989 . . . . 3.2000000000000002 111.082 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 43.1 ptt85 -69.69 -5.97 28.53 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.623 -0.673 . . . . 2.9199999999999999 112.068 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 905' ' ' HIS . . . . . 0.482 ' O ' ' CB ' ' B' ' 906' ' ' GLU . 73.6 t60 -62.2 4.79 0.12 Allowed 'General case' 0 N--CA 1.506 2.369 0 O-C-N 120.904 -1.123 . . . . 2.8700000000000001 113.094 -179.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 906' ' ' GLU . . . . . 0.482 ' CB ' ' O ' ' B' ' 905' ' ' HIS . 0.9 OUTLIER 95.1 -164.63 0.0 OUTLIER 'General case' 0 N--CA 1.529 3.478 0 CA-C-N 120.648 1.567 . . . . 0.98999999999999999 111.8 179.1 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 907' ' ' LYS . . . . . 0.466 ' CB ' ' O ' ' B' ' 906' ' ' GLU . 68.6 tttt 85.9 157.29 0.09 Allowed 'General case' 0 N--CA 1.519 3.002 0 N-CA-C 108.212 -1.033 . . . . 5.25 108.212 -177.058 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 60.3 t -121.51 116.71 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 120.779 -1.2 . . . . 0.39000000000000001 111.436 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 71.1 tt0 -99.58 133.09 44.41 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 106.996 -1.483 . . . . 1.72 106.996 176.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -155.51 123.35 5.7 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 106.831 -1.544 . . . . 0.67000000000000004 106.831 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 911' ' ' VAL . . . . . 0.469 ' HA ' ' HA ' ' B' ' 964' ' ' VAL . 86.5 t -83.84 131.5 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 C-N-CA 120.482 -0.487 . . . . 0.54000000000000004 110.668 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 86.1 mt -66.53 156.29 35.32 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.306 -0.871 . . . . 1.5 109.174 178.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 913' ' ' SER . . . . . 0.418 ' HB3' ' HB ' ' B' ' 919' ' ' VAL . 0.1 OUTLIER -127.92 133.26 49.25 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.617 -1.253 . . . . 1.3700000000000001 107.617 176.56 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 914' ' ' ARG . . . . . 0.431 ' O ' ' CB ' ' B' ' 915' ' ' SER . 0.0 OUTLIER -64.36 158.33 23.88 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 120.481 -1.387 . . . . 4.2999999999999998 112.167 -178.346 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 915' ' ' SER . . . . . 0.431 ' CB ' ' O ' ' B' ' 914' ' ' ARG . 4.6 t 84.56 -32.38 0.06 Allowed 'General case' 0 N--CA 1.521 3.104 0 C-N-CA 124.191 0.996 . . . . 2.0499999999999998 111.931 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 916' ' ' ASN . . . . . 0.407 ' O ' ' HB2' ' B' ' 917' ' ' GLN . 98.7 m-20 -123.49 -21.74 5.21 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.987 -1.07 . . . . 2.71 111.382 -179.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 917' ' ' GLN . . . . . 0.407 ' HB2' ' O ' ' B' ' 916' ' ' ASN . 45.1 mt-30 66.72 165.69 0.21 Allowed 'General case' 0 N--CA 1.52 3.049 0 N-CA-C 105.708 -1.96 . . . . 2.6800000000000002 105.708 -173.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 53.81 -124.15 28.79 Favored Glycine 1 N--CA 1.522 4.407 0 CA-C-N 123.446 2.839 . . . . 0.029999999999999999 106.753 -177.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 919' ' ' VAL . . . . . 0.418 ' HB ' ' HB3' ' B' ' 913' ' ' SER . 54.2 t 52.03 94.04 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 O-C-N 121.359 -1.083 . . . . 1.3899999999999999 108.922 -178.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.85 91.17 7.79 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.416 -0.914 . . . . 0.029999999999999999 110.846 -179.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 921' ' ' ARG . . . . . 0.434 ' HB3' ' CZ ' ' B' ' 950' ' ' PHE . 17.3 ptt180 -86.69 -42.15 13.62 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 106.132 -1.803 . . . . 4.4199999999999999 106.132 176.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 922' ' ' VAL . . . . . . . . . . . . . 77.0 t -104.35 67.09 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 N-CA-C 105.812 -1.922 . . . . 0.84999999999999998 105.812 175.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -86.56 134.34 33.66 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.673 0.749 . . . . 2.46 111.423 -177.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 924' ' ' SER . . . . . . . . . . . . . 40.0 t -147.8 106.12 3.77 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.696 -0.853 . . . . 0.69999999999999996 108.696 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -101.68 84.69 0.52 Allowed Glycine 0 N--CA 1.486 2.025 0 N-CA-C 108.358 -1.897 . . . . 0.040000000000000001 108.358 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.191 0 N-CA-C 108.922 -1.671 . . . . 0.040000000000000001 108.922 -179.579 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 26.2 m . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.029 0.442 . . . . 13.779999999999999 110.273 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 95.6 mt -111.66 130.79 55.65 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.545 -0.722 . . . . 13.76 110.379 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -151.09 167.92 30.68 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.088 -1.605 . . . . 9.1300000000000008 109.088 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 949' ' ' VAL . . . . . . . . . . . . . 31.1 m -118.91 127.21 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.426 -1.044 . . . . 7.0800000000000001 110.899 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 950' ' ' PHE . . . . . 0.44 ' CE1' ' HD2' ' B' ' 955' ' ' PRO . 27.2 p90 -133.81 148.99 51.39 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.593 -0.692 . . . . 7.5899999999999999 109.176 179.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 28.6 m -121.15 -50.97 2.12 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.411 -0.806 . . . . 5.0300000000000002 112.065 -178.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 952' ' ' LEU . . . . . 0.408 ' O ' ' O ' ' B' ' 953' ' ' ILE . 14.6 tp -59.71 -74.12 0.08 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.458 -0.776 . . . . 1.01 112.712 -177.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 953' ' ' ILE . . . . . 0.457 ' O ' ' HB3' ' B' ' 954' ' ' LEU . 46.4 pt -52.02 -143.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.851 0 N-CA-C 114.499 1.296 . . . . 2.6000000000000001 114.499 -176.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 954' ' ' LEU . . . . . 0.549 ' N ' ' CD1' ' B' ' 954' ' ' LEU . 0.0 OUTLIER 173.13 74.76 0.04 OUTLIER Pre-proline 0 N--CA 1.508 2.452 0 O-C-N 120.788 -1.195 . . . . 0.050000000000000003 110.772 179.93 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 955' ' ' PRO . . . . . 0.44 ' HD2' ' CE1' ' B' ' 950' ' ' PHE . 49.6 Cg_endo -77.16 95.53 1.07 Allowed 'Trans proline' 0 C--N 1.316 -1.178 0 O-C-N 122.741 0.864 . . . . 0.83999999999999997 110.163 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 956' ' ' LEU . . . . . . . . . . . . . 8.9 mp -125.92 151.08 47.42 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.208 -0.932 . . . . 0.040000000000000001 110.149 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -82.03 150.89 27.35 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 117.822 -1.085 . . . . 1.28 111.325 -179.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -68.36 119.13 12.39 Favored 'General case' 0 N--CA 1.508 2.465 0 CA-C-N 122.946 2.612 . . . . 0.17000000000000001 111.266 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 93.08 -21.85 37.74 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 110.786 -0.926 . . . . 0.040000000000000001 110.786 178.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 960' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.98 172.06 0.05 Allowed 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.39 -1.065 . . . . 0.040000000000000001 109.981 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 961' ' ' THR . . . . . 0.463 ' HA ' ' O ' ' B' ' 886' ' ' PHE . 40.8 m -133.55 138.91 46.29 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.897 -1.127 . . . . 1.78 112.165 -177.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 962' ' ' VAL . . . . . 0.419 ' CG2' ' CB ' ' B' ' 886' ' ' PHE . 20.7 m -96.94 143.5 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 C-N-CA 120.007 -0.677 . . . . 0.040000000000000001 109.737 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 5.3 t -140.03 145.21 37.46 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.79 -0.569 . . . . 0.71999999999999997 110.043 -178.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 964' ' ' VAL . . . . . 0.469 ' HA ' ' HA ' ' B' ' 911' ' ' VAL . 47.5 t -99.59 136.64 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.138 -0.976 . . . . 1.05 110.802 -179.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -94.08 127.95 40.18 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 103.916 -2.624 . . . . 3.02 103.916 173.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 966' ' ' LEU . . . . . 0.408 ' O ' ' CG2' ' B' ' 967' ' ' VAL . 10.1 tp -131.17 62.15 1.62 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.217 -1.031 . . . . 1.46 108.217 177.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 967' ' ' VAL . . . . . 0.408 ' CG2' ' O ' ' B' ' 966' ' ' LEU . 95.4 t -158.14 97.12 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 108.113 -1.069 . . . . 1.9399999999999999 108.113 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 88.2 mmm -142.97 59.76 1.42 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.756 -1.215 . . . . 0.0 108.456 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.85 119.83 1.93 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 107.08 -2.408 . . . . 2.1099999999999999 107.08 -178.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -82.13 -58.66 2.86 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.039 -1.271 . . . . 5.8899999999999997 110.427 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 49.0 tp -59.08 90.64 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.437 -0.789 . . . . 4.3600000000000003 110.152 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -141.89 -154.18 0.5 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.556 -0.715 . . . . 1.8300000000000001 110.179 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -119.55 171.98 7.98 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.486 -0.759 . . . . 4.3499999999999996 110.306 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 39.2 t -101.7 130.39 48.07 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.541 -0.725 . . . . 1.27 110.065 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -156.1 158.69 38.16 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.513 -0.742 . . . . 5.0199999999999996 110.588 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.13 85.7 18.52 Favored Pre-proline 0 N--CA 1.499 2.012 0 O-C-N 121.624 -0.673 . . . . 2.4100000000000001 109.747 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -73.42 -172.43 1.04 Allowed 'Trans proline' 0 C--N 1.318 -1.065 0 O-C-N 123.324 1.171 . . . . 0.95999999999999996 111.44 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 978' ' ' LEU . . . . . . . . . . . . . 5.6 mp -127.34 155.52 43.44 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.707 -1.22 . . . . 0.62 107.707 177.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 979' ' ' THR . . . . . . . . . . . . . 42.3 p -150.0 141.01 22.93 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.782 -1.199 . . . . 3.5699999999999998 111.239 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 980' ' ' ILE . . . . . 0.41 HG22 HD11 ' B' ' 980' ' ' ILE . 46.9 mm -107.76 128.33 63.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 108.885 -0.783 . . . . 1.3300000000000001 108.885 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -120.59 97.49 5.59 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 119.71 -0.796 . . . . 0.050000000000000003 111.982 -178.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 82.9 p -109.0 158.6 17.56 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.611 -0.681 . . . . 0.87 109.28 178.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 983' ' ' GLY . . . . . 0.427 ' HA3' ' CE1' ' B' ' 852' ' ' PHE . . . -175.11 109.14 0.28 Allowed Glycine 0 N--CA 1.499 2.86 0 N-CA-C 106.513 -2.635 . . . . 0.029999999999999999 106.513 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -108.7 152.19 25.16 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 114.526 1.306 . . . . 0.69999999999999996 114.526 -175.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 985' ' ' LEU . . . . . . . . . . . . . 45.4 tp -72.1 134.5 45.83 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.872 -1.143 . . . . 0.040000000000000001 110.055 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 986' ' ' LEU . . . . . . . . . . . . . 51.7 tp -107.52 -55.89 2.29 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.58 -0.7 . . . . 0.040000000000000001 109.917 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -144.82 145.08 31.47 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 107.623 -1.251 . . . . 0.040000000000000001 107.623 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.54 162.95 12.22 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 108.147 -1.981 . . . . 0.040000000000000001 108.147 179.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -75.66 112.16 18.12 Favored Pre-proline 0 N--CA 1.499 1.988 0 O-C-N 121.236 -1.155 . . . . 0.040000000000000001 109.406 179.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 990' ' ' PRO . . . . . 0.416 ' O ' ' HB2' ' B' ' 991' ' ' GLU . 49.8 Cg_endo -91.38 71.31 0.97 Allowed 'Trans proline' 0 C--N 1.319 -0.982 0 O-C-N 123.108 1.057 . . . . 0.45000000000000001 111.411 -178.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 991' ' ' GLU . . . . . 0.416 ' HB2' ' O ' ' B' ' 990' ' ' PRO . 70.5 mt-10 67.21 -73.75 0.08 Allowed 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 108.493 -0.928 . . . . 1.97 108.493 -177.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 992' ' ' LEU . . . . . . . . . . . . . 6.7 mt 51.22 20.29 0.88 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.575 -0.703 . . . . 2.3799999999999999 111.634 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -94.33 156.77 16.35 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.862 -1.149 . . . . 3.79 109.96 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -146.64 93.22 2.26 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.547 -0.721 . . . . 3.5099999999999998 110.403 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 995' ' ' ALA . . . . . . . . . . . . 2.519 . . . . . . . 0 N--CA 1.503 2.209 0 O-C-N 120.897 -1.127 . . . . 2.73 110.624 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo . . . . . 0 N--CA 1.488 1.178 0 N-CA-C 109.5 -1.0 . . . . 3.8300000000000001 109.5 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 847' ' ' VAL . . . . . . . . . . . . . 57.3 t -127.6 103.75 21.9 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.609 -0.682 . . . . 1.8300000000000001 110.121 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 848' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.36 -23.03 33.05 Favored 'Trans proline' 0 N--CA 1.488 1.151 0 O-C-N 123.218 1.115 . . . . 0.65000000000000002 110.911 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 849' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 26.59 68.63 0.06 Allowed 'General case' 0 N--CA 1.519 2.982 0 N-CA-C 112.972 0.73 . . . . 2.5800000000000001 112.972 179.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 850' ' ' VAL . . . . . . . . . . . . . 93.4 t -119.58 134.35 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.158 -0.964 . . . . 1.0900000000000001 111.245 -179.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 851' ' ' ALA . . . . . . . . . . . . . . . -131.56 155.74 46.96 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 106.105 -1.813 . . . . 0.040000000000000001 106.105 176.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 852' ' ' PHE . . . . . 0.51 ' CD1' ' CE1' ' C' ' 879' ' ' TYR . 0.3 OUTLIER -154.36 134.68 13.32 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 120.829 1.65 . . . . 0.050000000000000003 107.931 179.083 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 5.0 t -173.8 130.54 0.42 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.513 -0.921 . . . . 0.040000000000000001 108.513 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -136.39 150.95 49.04 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.256 -0.902 . . . . 0.67000000000000004 108.863 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 855' ' ' ALA . . . . . . . . . . . . . . . -122.77 139.33 54.11 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.813 0.816 . . . . 0.51000000000000001 111.527 -179.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 856' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -104.87 138.88 40.44 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.781 -0.575 . . . . 0.050000000000000003 109.558 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 857' ' ' SER . . . . . 0.417 ' O ' ' O ' ' C' ' 858' ' ' LEU . 1.9 m -155.28 17.49 0.41 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.622 -0.674 . . . . 1.3300000000000001 111.465 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 858' ' ' LEU . . . . . 0.417 ' O ' ' O ' ' C' ' 857' ' ' SER . 3.6 pp -34.55 158.06 0.04 OUTLIER Pre-proline 0 N--CA 1.52 3.047 0 CA-C-N 118.752 0.705 . . . . 2.3300000000000001 112.756 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -60.14 -89.88 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.431 0 O-C-N 123.089 1.047 . . . . 2.3199999999999998 113.828 -177.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 55.4 ptt85 -126.56 -141.92 0.28 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.853 -1.155 . . . . 0.040000000000000001 111.41 -177.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 73.7 m -36.31 120.33 0.65 Allowed 'General case' 0 N--CA 1.511 2.605 0 O-C-N 121.622 -0.674 . . . . 1.3100000000000001 112.26 -179.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.11 158.14 32.82 Favored Pre-proline 0 N--CA 1.488 1.458 0 N-CA-C 108.53 -0.915 . . . . 4.5099999999999998 108.53 178.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -70.92 -15.52 32.73 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 O-C-N 123.225 1.118 . . . . 2.2400000000000002 111.036 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -177.3 -134.77 2.07 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.537 -1.425 . . . . 0.040000000000000001 109.537 179.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 30.2 m -69.31 155.25 40.73 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.34 -1.094 . . . . 1.51 110.786 -179.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 866' ' ' VAL . . . . . . . . . . . . . 33.7 m -89.83 138.29 27.96 Favored Pre-proline 0 N--CA 1.496 1.837 0 N-CA-C 113.423 0.897 . . . . 0.78000000000000003 113.423 -175.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 867' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -88.62 -153.11 0.04 OUTLIER 'Trans proline' 0 C--N 1.324 -0.716 0 N-CA-C 108.128 -1.528 . . . . 0.92000000000000004 108.128 177.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 868' ' ' PHE . . . . . 0.464 ' N ' ' CD1' ' C' ' 868' ' ' PHE . 20.4 p90 -148.47 120.18 8.07 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.54 -1.35 . . . . 0.050000000000000003 110.12 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 50.2 p-10 -112.63 -2.13 14.63 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 119.353 -0.939 . . . . 1.7 111.762 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 870' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 -91.5 87.36 6.36 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.013 -1.054 . . . . 2.5899999999999999 111.057 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 61.9 t -74.77 97.2 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.0 -1.062 . . . . 1.9399999999999999 109.493 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 872' ' ' LEU . . . . . 0.401 ' HB3' ' CD1' ' A' ' 953' ' ' ILE . 52.2 mt -88.64 -44.37 10.66 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.497 -0.752 . . . . 1.0600000000000001 111.151 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 873' ' ' LEU . . . . . 0.437 ' O ' ' HB2' ' C' ' 874' ' ' ASN . 43.9 tp -171.44 102.62 0.2 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.134 -0.979 . . . . 4.1799999999999997 109.087 179.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 874' ' ' ASN . . . . . 0.437 ' HB2' ' O ' ' C' ' 873' ' ' LEU . 36.6 t-20 175.08 83.93 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.333 0 N-CA-C 108.694 -0.854 . . . . 0.040000000000000001 108.694 -178.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 30.1 p-10 -66.46 -48.19 70.71 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.059 -1.026 . . . . 3.3799999999999999 111.966 -178.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 876' ' ' GLY . . . . . 0.422 ' HA3' ' CE2' ' C' ' 878' ' ' TYR . . . -74.45 -24.91 71.72 Favored Glycine 0 N--CA 1.495 2.603 0 O-C-N 121.14 -0.975 . . . . 0.040000000000000001 111.569 -178.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 80.54 -64.86 3.98 Favored Glycine 0 N--CA 1.498 2.789 0 N-CA-C 107.624 -2.191 . . . . 0.040000000000000001 107.624 -178.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 878' ' ' TYR . . . . . 0.422 ' CE2' ' HA3' ' C' ' 876' ' ' GLY . 82.6 m-85 61.01 -56.18 0.09 Allowed 'General case' 0 N--CA 1.507 2.416 0 N-CA-C 114.556 1.317 . . . . 3.46 114.556 177.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 879' ' ' TYR . . . . . 0.51 ' CE1' ' CD1' ' C' ' 852' ' ' PHE . 1.7 p90 -111.53 108.91 18.59 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 114.791 1.404 . . . . 0.040000000000000001 114.791 -176.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -71.68 113.69 22.08 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.262 -0.898 . . . . 0.02 109.529 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 881' ' ' PRO . . . . . 0.454 ' HG2' ' CD1' ' C' ' 868' ' ' PHE . 54.3 Cg_endo -77.03 0.1 10.04 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 O-C-N 123.351 1.184 . . . . 0.39000000000000001 112.011 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 87.8 mt-10 -75.43 -64.55 1.04 Allowed 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 106.682 -1.599 . . . . 0.81000000000000005 106.682 178.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 24.5 p -90.55 -19.36 23.86 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.22 -1.03 . . . . 0.040000000000000001 108.22 176.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.1 19.58 60.71 Favored Glycine 0 N--CA 1.496 2.675 0 O-C-N 121.165 -0.959 . . . . 0.029999999999999999 111.22 178.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 89.3 t -73.93 89.79 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 C-N-CA 118.003 -1.479 . . . . 1.01 108.183 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 886' ' ' PHE . . . . . 0.463 ' CD2' ' HB2' ' C' ' 879' ' ' TYR . 1.3 t80 -88.66 106.9 18.63 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 115.485 -0.78 . . . . 0.050000000000000003 111.385 -178.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 887' ' ' THR . . . . . 0.403 ' O ' ' HD3' ' C' ' 889' ' ' PRO . 93.7 m -96.07 101.43 13.09 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.921 -1.14 . . . . 0.68000000000000005 107.921 177.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 888' ' ' ALA . . . . . . . . . . . . . . . -99.05 106.88 40.97 Favored Pre-proline 0 N--CA 1.502 2.142 0 N-CA-C 113.964 1.098 . . . . 0.25 113.964 -176.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 889' ' ' PRO . . . . . 0.403 ' HD3' ' O ' ' C' ' 887' ' ' THR . 53.8 Cg_endo -90.33 -12.24 2.72 Favored 'Trans proline' 0 CA--C 1.547 1.17 0 C-N-CA 121.073 1.182 . . . . 1.6399999999999999 109.252 176.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 890' ' ' LEU . . . . . . . . . . . . . 72.3 mt -38.01 -50.61 1.34 Allowed 'General case' 0 N--CA 1.507 2.415 0 N-CA-C 113.778 1.029 . . . . 2.29 113.778 -177.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 52.19 97.52 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.379 0 O-C-N 121.152 -0.968 . . . . 0.63 110.386 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . 156.11 -146.52 14.18 Favored Glycine 0 N--CA 1.482 1.703 0 N-CA-C 107.445 -2.262 . . . . 0.040000000000000001 107.445 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 73.3 ttt-85 -106.46 128.79 54.34 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.311 -1.366 . . . . 3.0 107.311 177.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 894' ' ' TYR . . . . . 0.42 ' CZ ' ' HB2' ' C' ' 896' ' ' LEU . 0.4 OUTLIER -130.68 144.29 51.33 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.007 -1.058 . . . . 0.040000000000000001 110.661 -178.499 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 895' ' ' LEU . . . . . 0.417 ' N ' ' CD1' ' C' ' 894' ' ' TYR . 45.2 tp -101.07 117.83 35.8 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.64 -0.662 . . . . 1.27 109.723 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 896' ' ' LEU . . . . . 0.42 ' HB2' ' CZ ' ' C' ' 894' ' ' TYR . 10.4 tt -116.4 145.46 43.23 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.531 -0.731 . . . . 0.93999999999999995 110.783 -179.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 897' ' ' SER . . . . . . . . . . . . . 69.1 m -145.18 119.23 9.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.448 -0.783 . . . . 0.040000000000000001 110.824 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.22 147.93 29.55 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.219 -0.66 . . . . 0.47999999999999998 109.219 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 899' ' ' VAL . . . . . . . . . . . . . 89.4 t -91.12 120.53 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.446 -0.784 . . . . 0.55000000000000004 110.925 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 93.1 mt -94.23 110.35 22.09 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 114.261 1.208 . . . . 1.5900000000000001 114.261 -175.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 18.9 m -64.92 139.71 58.79 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 107.414 -1.328 . . . . 0.050000000000000003 107.414 177.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -62.28 -65.77 2.99 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 110.417 -1.073 . . . . 0.029999999999999999 110.417 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 4.0 m170 46.08 64.61 1.42 Allowed 'General case' 0 N--CA 1.507 2.388 0 O-C-N 121.498 -1.001 . . . . 3.2000000000000002 111.262 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 42.8 ptt85 -68.39 -7.74 34.13 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.579 -0.701 . . . . 2.9199999999999999 111.857 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 905' ' ' HIS . . . . . 0.491 ' O ' ' CB ' ' C' ' 906' ' ' GLU . 72.3 t60 -61.29 6.86 0.05 OUTLIER 'General case' 0 N--CA 1.508 2.442 0 CA-C-O 117.659 -1.162 . . . . 2.8700000000000001 113.798 -179.208 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 906' ' ' GLU . . . . . 0.491 ' CB ' ' O ' ' C' ' 905' ' ' HIS . 0.5 OUTLIER 93.22 -165.15 0.0 OUTLIER 'General case' 0 N--CA 1.529 3.487 0 CA-C-N 121.21 1.823 . . . . 0.98999999999999999 111.955 179.117 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 907' ' ' LYS . . . . . 0.485 ' CB ' ' O ' ' C' ' 906' ' ' GLU . 38.2 tttp 88.13 159.62 0.07 Allowed 'General case' 0 N--CA 1.52 3.062 0 N-CA-C 108.149 -1.056 . . . . 5.25 108.149 -176.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 60.8 t -123.43 116.2 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 120.826 -1.171 . . . . 0.39000000000000001 111.003 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -104.34 132.18 50.87 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 107.711 -1.218 . . . . 1.72 107.711 177.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -155.82 122.44 5.24 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 106.838 -1.542 . . . . 0.67000000000000004 106.838 178.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 911' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' C' ' 964' ' ' VAL . 96.8 t -82.05 131.6 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.831 -0.543 . . . . 0.54000000000000004 111.133 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 57.2 mt -68.2 156.15 38.16 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.348 -0.845 . . . . 1.5 109.12 178.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 913' ' ' SER . . . . . . . . . . . . . 1.2 p -125.19 136.92 54.06 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.428 -0.952 . . . . 1.3700000000000001 108.428 176.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 914' ' ' ARG . . . . . 0.423 ' O ' ' CB ' ' C' ' 915' ' ' SER . 0.1 OUTLIER -63.69 154.93 31.55 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 120.664 -1.272 . . . . 4.2999999999999998 111.482 -179.309 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 915' ' ' SER . . . . . 0.423 ' CB ' ' O ' ' C' ' 914' ' ' ARG . 4.6 t 83.73 -31.48 0.08 Allowed 'General case' 0 N--CA 1.522 3.13 0 C-N-CA 124.054 0.942 . . . . 2.0499999999999998 112.087 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 916' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -122.39 -21.66 5.73 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 120.883 -1.136 . . . . 2.71 111.286 -179.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 67.18 165.65 0.22 Allowed 'General case' 0 N--CA 1.52 3.032 0 N-CA-C 105.664 -1.976 . . . . 2.6800000000000002 105.664 -174.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 55.13 -126.04 37.66 Favored Glycine 1 N--CA 1.52 4.287 0 CA-C-N 123.675 2.943 . . . . 0.029999999999999999 106.962 -177.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 919' ' ' VAL . . . . . . . . . . . . . 91.1 t 50.59 94.01 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 121.447 -1.031 . . . . 1.3899999999999999 109.386 -178.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 920' ' ' ALA . . . . . . . . . . . . . . . -93.31 93.53 8.25 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.29 -0.964 . . . . 0.029999999999999999 110.565 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 921' ' ' ARG . . . . . 0.429 ' HB3' ' CZ ' ' C' ' 950' ' ' PHE . 34.7 ptt85 -80.13 -42.3 23.78 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 105.884 -1.895 . . . . 4.4199999999999999 105.884 176.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 922' ' ' VAL . . . . . . . . . . . . . 78.2 t -101.18 77.06 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 N-CA-C 105.602 -1.999 . . . . 0.84999999999999998 105.602 175.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -87.81 135.03 33.56 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.801 0.81 . . . . 2.46 112.016 -176.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 4.9 t -146.54 102.63 3.59 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.297 -1.001 . . . . 0.69999999999999996 108.297 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -109.49 88.35 0.51 Allowed Glycine 0 N--CA 1.486 2.026 0 N-CA-C 108.494 -1.842 . . . . 0.040000000000000001 108.494 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.353 0 N-CA-C 109.315 -1.514 . . . . 0.040000000000000001 109.315 -179.448 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 8.3 m . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 120.995 0.426 . . . . 13.779999999999999 110.378 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 95.2 mt -114.03 129.51 56.6 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.465 -0.772 . . . . 13.76 110.367 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -152.35 170.46 31.6 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.514 -1.434 . . . . 9.1300000000000008 109.514 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 949' ' ' VAL . . . . . . . . . . . . . 35.1 m -117.74 136.91 53.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.529 -0.983 . . . . 7.0800000000000001 110.904 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 950' ' ' PHE . . . . . 0.429 ' CZ ' ' HB3' ' C' ' 921' ' ' ARG . 44.8 p90 -135.3 152.88 51.91 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.571 -0.706 . . . . 7.5899999999999999 109.525 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 5.6 m -118.23 -54.77 2.28 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.465 -0.772 . . . . 5.0300000000000002 111.65 -179.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 952' ' ' LEU . . . . . 0.447 ' O ' ' O ' ' C' ' 953' ' ' ILE . 58.1 tp -65.71 -78.29 0.05 Allowed 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.439 -0.788 . . . . 1.01 111.375 -178.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 953' ' ' ILE . . . . . 0.481 ' O ' ' HB3' ' C' ' 954' ' ' LEU . 2.9 pp -50.28 -150.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.688 0 N-CA-C 114.312 1.227 . . . . 2.6000000000000001 114.312 -176.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 954' ' ' LEU . . . . . 0.557 ' N ' ' CD1' ' C' ' 954' ' ' LEU . 0.0 OUTLIER 169.19 90.98 0.03 OUTLIER Pre-proline 0 N--CA 1.519 2.992 0 O-C-N 120.879 -1.138 . . . . 0.050000000000000003 112.03 179.902 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 955' ' ' PRO . . . . . 0.43 ' HD3' ' CD1' ' C' ' 953' ' ' ILE . 52.7 Cg_endo -79.55 93.25 1.08 Allowed 'Trans proline' 0 C--N 1.317 -1.103 0 N-CA-C 108.819 -1.262 . . . . 0.83999999999999997 108.819 178.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 956' ' ' LEU . . . . . . . . . . . . . 79.7 mt -126.79 148.22 49.95 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.094 -1.004 . . . . 0.040000000000000001 110.524 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 957' ' ' GLN . . . . . 0.409 ' HB2' ' HB2' ' C' ' 960' ' ' ASP . 90.7 mt-30 -84.04 153.26 23.92 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 117.904 -1.046 . . . . 1.28 111.515 -179.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -68.66 120.81 15.25 Favored 'General case' 0 N--CA 1.509 2.509 0 CA-C-N 122.757 2.526 . . . . 0.17000000000000001 111.879 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 93.16 -20.76 44.02 Favored Glycine 0 N--CA 1.502 3.074 0 N-CA-C 111.193 -0.763 . . . . 0.040000000000000001 111.193 178.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 960' ' ' ASP . . . . . 0.409 ' HB2' ' HB2' ' C' ' 957' ' ' GLN . 0.8 OUTLIER -51.28 172.42 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.482 -1.01 . . . . 0.040000000000000001 110.751 -179.115 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 961' ' ' THR . . . . . 0.444 ' HA ' ' O ' ' C' ' 886' ' ' PHE . 50.0 m -133.09 137.45 46.35 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.002 -1.061 . . . . 1.78 111.887 -178.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 962' ' ' VAL . . . . . 0.417 ' CG2' ' CB ' ' C' ' 886' ' ' PHE . 24.9 m -99.47 144.1 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 C-N-CA 119.985 -0.686 . . . . 0.040000000000000001 110.11 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 5.4 t -140.54 143.8 35.57 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.864 -0.522 . . . . 0.71999999999999997 110.148 -178.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 964' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' C' ' 911' ' ' VAL . 56.9 t -93.8 136.87 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.191 -0.943 . . . . 1.05 110.93 -178.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -95.72 127.01 41.38 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 103.716 -2.698 . . . . 3.02 103.716 173.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 966' ' ' LEU . . . . . . . . . . . . . 11.2 tp -132.81 62.83 1.65 Allowed 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.367 -0.975 . . . . 1.46 108.367 177.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 967' ' ' VAL . . . . . . . . . . . . . 99.5 t -157.53 97.02 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 108.239 -1.022 . . . . 1.9399999999999999 108.239 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 92.8 mmm -142.29 60.01 1.45 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.793 -1.192 . . . . 0.0 108.358 179.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.46 119.51 1.92 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 107.192 -2.363 . . . . 2.1099999999999999 107.192 -178.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 94.7 mm-40 -82.36 -57.54 3.32 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.051 -1.264 . . . . 5.8899999999999997 110.761 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 47.4 tp -58.75 89.84 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.443 -0.786 . . . . 4.3600000000000003 110.358 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -142.41 -152.58 0.42 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.557 -0.714 . . . . 1.8300000000000001 110.118 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -120.31 170.01 9.75 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.425 -0.797 . . . . 4.3499999999999996 110.261 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 29.3 t -101.46 130.36 47.69 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.52 -0.738 . . . . 1.27 110.051 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -155.63 158.87 39.05 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.53 -0.731 . . . . 5.0199999999999996 110.524 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.35 86.51 16.73 Favored Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 121.603 -0.686 . . . . 2.4100000000000001 109.862 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -74.72 -171.65 1.01 Allowed 'Trans proline' 0 C--N 1.317 -1.081 0 O-C-N 123.311 1.164 . . . . 0.95999999999999996 111.19 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 978' ' ' LEU . . . . . . . . . . . . . 5.2 mp -126.25 155.58 41.66 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 107.577 -1.268 . . . . 0.62 107.577 177.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 979' ' ' THR . . . . . . . . . . . . . 39.9 p -150.66 141.08 22.43 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.791 -1.193 . . . . 3.5699999999999998 111.216 -179.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 980' ' ' ILE . . . . . 0.416 HG22 HD11 ' C' ' 980' ' ' ILE . 50.4 mm -107.12 129.07 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 108.991 -0.744 . . . . 1.3300000000000001 108.991 179.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 981' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -118.67 95.76 4.98 Favored 'General case' 0 N--CA 1.497 1.925 0 C-N-CA 119.452 -0.899 . . . . 0.050000000000000003 111.727 -178.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 982' ' ' SER . . . . . . . . . . . . . 12.1 p -109.55 158.68 17.77 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.606 -0.684 . . . . 0.87 109.712 178.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 983' ' ' GLY . . . . . 0.447 ' HA3' ' CZ ' ' C' ' 852' ' ' PHE . . . -172.99 114.71 0.53 Allowed Glycine 0 N--CA 1.498 2.798 0 N-CA-C 106.453 -2.659 . . . . 0.029999999999999999 106.453 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 984' ' ' ALA . . . . . . . . . . . . . . . -106.49 152.45 23.63 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 114.493 1.294 . . . . 0.69999999999999996 114.493 -175.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 985' ' ' LEU . . . . . . . . . . . . . 62.3 tp -75.58 135.65 40.53 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.932 -1.105 . . . . 0.040000000000000001 109.787 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 986' ' ' LEU . . . . . . . . . . . . . 36.1 tp -106.75 -61.17 1.57 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.576 -0.702 . . . . 0.040000000000000001 110.098 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -143.81 146.74 33.3 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 107.647 -1.242 . . . . 0.040000000000000001 107.647 179.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -111.65 162.74 12.34 Favored Glycine 0 N--CA 1.495 2.597 0 N-CA-C 108.179 -1.968 . . . . 0.040000000000000001 108.179 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.01 112.58 18.6 Favored Pre-proline 0 N--CA 1.499 1.982 0 O-C-N 121.243 -1.151 . . . . 0.040000000000000001 109.412 179.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 990' ' ' PRO . . . . . 0.412 ' O ' ' HB2' ' C' ' 991' ' ' GLU . 49.4 Cg_endo -90.22 70.84 1.55 Allowed 'Trans proline' 0 C--N 1.319 -1.018 0 O-C-N 123.152 1.08 . . . . 0.45000000000000001 111.365 -178.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 991' ' ' GLU . . . . . 0.412 ' HB2' ' O ' ' C' ' 990' ' ' PRO . 69.6 mt-10 67.65 -73.27 0.08 Allowed 'General case' 0 N--CA 1.503 2.177 0 N-CA-C 108.603 -0.888 . . . . 1.97 108.603 -177.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 992' ' ' LEU . . . . . . . . . . . . . 11.3 mt 50.56 20.62 0.74 Allowed 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.544 -0.722 . . . . 2.3799999999999999 111.705 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -93.9 156.76 16.46 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.893 -1.13 . . . . 3.79 109.998 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 69.7 m80 -145.75 92.8 2.26 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.567 -0.708 . . . . 3.5099999999999998 110.308 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 995' ' ' ALA . . . . . . . . . . . . 2.518 . . . . . . . 0 N--CA 1.503 2.206 0 O-C-N 120.936 -1.103 . . . . 2.73 110.631 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo . . . . . 0 N--CA 1.488 1.203 0 N-CA-C 109.53 -0.989 . . . . 3.8300000000000001 109.53 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 847' ' ' VAL . . . . . . . . . . . . . 60.2 t -132.17 103.36 14.06 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.555 -0.716 . . . . 1.8300000000000001 110.188 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 848' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -69.84 -20.32 34.61 Favored 'Trans proline' 0 N--CA 1.487 1.145 0 O-C-N 123.28 1.147 . . . . 0.65000000000000002 110.955 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 849' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 27.73 68.79 0.07 Allowed 'General case' 0 N--CA 1.518 2.97 0 N-CA-C 112.821 0.675 . . . . 2.5800000000000001 112.821 179.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 850' ' ' VAL . . . . . . . . . . . . . 57.6 t -119.93 136.06 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.135 -0.978 . . . . 1.0900000000000001 111.65 -178.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 851' ' ' ALA . . . . . . . . . . . . . . . -126.14 157.33 38.37 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 105.749 -1.945 . . . . 0.040000000000000001 105.749 176.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 852' ' ' PHE . . . . . 0.401 ' HA ' ' CB ' ' A' ' 874' ' ' ASN . 22.7 p90 -160.84 127.32 4.04 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 121.009 1.731 . . . . 0.050000000000000003 108.437 179.066 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 5.8 t -176.1 134.7 0.26 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.35 -0.981 . . . . 0.040000000000000001 108.35 -178.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -132.21 155.66 47.85 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.035 -1.04 . . . . 0.67000000000000004 109.541 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 855' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 870' ' ' ARG . . . -121.67 143.91 49.07 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.855 0.836 . . . . 0.51000000000000001 111.258 -179.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 856' ' ' LEU . . . . . 0.4 HD23 ' CG1' ' A' ' 866' ' ' VAL . 3.4 tm? -113.13 134.73 54.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.688 -0.633 . . . . 0.050000000000000003 110.283 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 857' ' ' SER . . . . . 0.402 ' O ' ' O ' ' A' ' 858' ' ' LEU . 60.8 p -151.94 17.74 0.68 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.565 -0.71 . . . . 1.3300000000000001 110.59 178.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 858' ' ' LEU . . . . . 0.402 ' O ' ' O ' ' A' ' 857' ' ' SER . 4.4 pp -33.27 157.11 0.04 OUTLIER Pre-proline 0 N--CA 1.518 2.942 0 N-CA-C 113.159 0.8 . . . . 2.3300000000000001 113.159 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -63.2 -88.3 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.376 0 O-C-N 123.107 1.056 . . . . 2.3199999999999998 113.162 -178.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 55.2 ptt85 -128.68 -143.36 0.27 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.888 -1.132 . . . . 0.040000000000000001 111.647 -177.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 14.0 m -40.18 126.78 2.2 Favored 'General case' 0 N--CA 1.508 2.457 0 O-C-N 121.527 -0.733 . . . . 1.3100000000000001 112.453 -178.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 862' ' ' GLU . . . . . 0.404 ' CG ' ' HD2' ' A' ' 863' ' ' PRO . 0.7 OUTLIER -101.95 157.6 33.37 Favored Pre-proline 0 N--CA 1.489 1.498 0 N-CA-C 107.683 -1.229 . . . . 4.5099999999999998 107.683 176.967 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 863' ' ' PRO . . . . . 0.404 ' HD2' ' CG ' ' A' ' 862' ' ' GLU . 44.2 Cg_endo -71.55 -12.25 29.09 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 O-C-N 123.029 1.015 . . . . 2.2400000000000002 111.472 -179.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -176.02 -136.59 2.38 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 110.143 -1.183 . . . . 0.040000000000000001 110.143 179.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 25.7 m -65.48 155.85 34.3 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.317 -1.108 . . . . 1.51 110.935 -178.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 866' ' ' VAL . . . . . 0.4 ' CG1' HD23 ' A' ' 856' ' ' LEU . 60.1 t -92.14 135.29 27.24 Favored Pre-proline 0 N--CA 1.495 1.788 0 N-CA-C 113.273 0.842 . . . . 0.78000000000000003 113.273 -174.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 867' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -90.61 -153.01 0.04 OUTLIER 'Trans proline' 0 CA--C 1.54 0.805 0 N-CA-C 108.658 -1.324 . . . . 0.92000000000000004 108.658 177.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 868' ' ' PHE . . . . . 0.447 ' CD1' ' N ' ' A' ' 868' ' ' PHE . 27.0 p90 -150.66 122.65 8.2 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.567 -1.333 . . . . 0.050000000000000003 109.632 179.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 49.7 p-10 -114.1 -1.93 13.58 Favored 'General case' 0 N--CA 1.5 2.035 0 C-N-CA 119.299 -0.961 . . . . 1.7 112.549 -178.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 870' ' ' ARG . . . . . 0.401 ' HB2' ' O ' ' A' ' 855' ' ' ALA . 29.1 mmm180 -90.85 88.15 6.94 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.869 -1.144 . . . . 2.5899999999999999 110.83 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 57.5 t -72.94 97.35 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 120.929 -1.107 . . . . 1.9399999999999999 109.858 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 872' ' ' LEU . . . . . . . . . . . . . 96.1 mt -83.15 -47.47 11.57 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.524 -0.735 . . . . 1.0600000000000001 110.109 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 873' ' ' LEU . . . . . . . . . . . . . 30.4 tp -174.65 103.96 0.1 Allowed 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.594 -0.891 . . . . 4.1799999999999997 108.594 178.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 874' ' ' ASN . . . . . 0.401 ' CB ' ' HA ' ' A' ' 852' ' ' PHE . 37.6 t-20 178.59 81.79 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.309 0 O-C-N 121.64 -0.663 . . . . 0.040000000000000001 109.648 -178.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -66.2 -47.05 75.16 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.062 -1.024 . . . . 3.3799999999999999 111.019 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 876' ' ' GLY . . . . . . . . . . . . . . . -74.57 -25.33 70.38 Favored Glycine 0 N--CA 1.494 2.552 0 O-C-N 121.282 -0.886 . . . . 0.040000000000000001 111.712 -178.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 86.42 -58.57 4.69 Favored Glycine 0 N--CA 1.502 3.041 0 N-CA-C 108.043 -2.023 . . . . 0.040000000000000001 108.043 -178.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 878' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 60.37 -67.78 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 114.283 1.216 . . . . 3.46 114.283 177.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 879' ' ' TYR . . . . . 0.471 ' CB ' ' CD2' ' A' ' 886' ' ' PHE . 24.3 p90 -113.08 111.44 22.15 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 114.841 1.422 . . . . 0.040000000000000001 114.841 -176.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -66.19 119.01 58.44 Favored Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 121.526 -0.734 . . . . 0.02 110.257 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 881' ' ' PRO . . . . . 0.428 ' HG2' ' CD1' ' A' ' 868' ' ' PHE . 54.5 Cg_endo -76.44 0.67 9.23 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 O-C-N 123.389 1.205 . . . . 0.39000000000000001 112.128 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -74.77 -65.27 0.89 Allowed 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 106.686 -1.598 . . . . 0.81000000000000005 106.686 178.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 7.0 p -97.22 -15.28 20.93 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 109.014 -0.735 . . . . 0.040000000000000001 109.014 177.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.1 24.2 49.17 Favored Glycine 0 N--CA 1.494 2.523 0 O-C-N 120.947 -1.096 . . . . 0.029999999999999999 110.696 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 885' ' ' VAL . . . . . . . . . . . . . 92.4 t -72.26 88.59 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 C-N-CA 118.453 -1.299 . . . . 1.01 107.823 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 886' ' ' PHE . . . . . 0.471 ' CD2' ' CB ' ' A' ' 879' ' ' TYR . 0.7 OUTLIER -90.73 105.92 18.15 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 115.175 -0.92 . . . . 0.050000000000000003 112.442 -176.942 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 887' ' ' THR . . . . . 0.402 ' O ' ' HD3' ' A' ' 889' ' ' PRO . 89.8 m -96.25 100.42 12.05 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 107.48 -1.304 . . . . 0.68000000000000005 107.48 177.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 888' ' ' ALA . . . . . . . . . . . . . . . -99.15 106.53 39.06 Favored Pre-proline 0 N--CA 1.501 2.112 0 N-CA-C 114.044 1.127 . . . . 0.25 114.044 -176.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 889' ' ' PRO . . . . . 0.402 ' HD3' ' O ' ' A' ' 887' ' ' THR . 53.8 Cg_endo -90.07 -11.98 2.95 Favored 'Trans proline' 0 CA--C 1.546 1.089 0 C-N-CA 121.093 1.195 . . . . 1.6399999999999999 109.213 176.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 890' ' ' LEU . . . . . . . . . . . . . 4.6 tt -34.78 -52.0 0.51 Allowed 'General case' 0 N--CA 1.509 2.482 0 N-CA-C 113.834 1.05 . . . . 2.29 113.834 -177.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 51.38 95.41 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.313 0 O-C-N 121.181 -0.949 . . . . 0.63 110.438 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 156.15 -147.8 16.92 Favored Glycine 0 N--CA 1.479 1.539 0 N-CA-C 107.383 -2.287 . . . . 0.040000000000000001 107.383 -179.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 72.9 ttt-85 -108.96 127.08 53.76 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 107.536 -1.283 . . . . 3.0 107.536 177.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 894' ' ' TYR . . . . . 0.447 ' CD1' ' N ' ' A' ' 895' ' ' LEU . 0.1 OUTLIER -131.42 144.71 51.39 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.03 -1.044 . . . . 0.040000000000000001 110.154 -179.008 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 895' ' ' LEU . . . . . 0.447 ' N ' ' CD1' ' A' ' 894' ' ' TYR . 33.9 tp -99.25 116.64 31.9 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.623 -0.673 . . . . 1.27 109.933 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 896' ' ' LEU . . . . . 0.445 ' HB2' ' CZ ' ' A' ' 894' ' ' TYR . 10.4 tt -112.91 145.87 39.97 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.645 -0.66 . . . . 0.93999999999999995 110.785 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 897' ' ' SER . . . . . . . . . . . . . 63.1 m -143.04 119.02 10.64 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.466 -0.771 . . . . 0.040000000000000001 110.781 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -108.34 146.91 32.28 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.657 -0.652 . . . . 0.47999999999999998 109.387 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 899' ' ' VAL . . . . . . . . . . . . . 88.3 t -93.61 119.69 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 C-N-CA 119.788 -0.765 . . . . 0.55000000000000004 111.031 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 900' ' ' LEU . . . . . 0.436 ' CD2' ' N ' ' A' ' 900' ' ' LEU . 4.4 mm? -94.24 113.13 24.99 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 114.307 1.225 . . . . 1.5900000000000001 114.307 -174.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 18.1 m -67.0 141.65 57.52 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 107.33 -1.359 . . . . 0.050000000000000003 107.33 176.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -66.28 -64.84 3.12 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 110.664 -0.974 . . . . 0.029999999999999999 110.664 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 5.9 m170 46.54 64.65 1.44 Allowed 'General case' 0 N--CA 1.508 2.466 0 O-C-N 121.363 -1.081 . . . . 3.2000000000000002 111.189 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 41.6 ptt85 -68.97 -6.65 29.0 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.563 -0.71 . . . . 2.9199999999999999 112.084 -179.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 905' ' ' HIS . . . . . 0.49 ' O ' ' CB ' ' A' ' 906' ' ' GLU . 70.6 t60 -63.31 5.76 0.15 Allowed 'General case' 0 N--CA 1.505 2.324 0 O-C-N 120.945 -1.097 . . . . 2.8700000000000001 113.214 -179.052 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 906' ' ' GLU . . . . . 0.49 ' CB ' ' O ' ' A' ' 905' ' ' HIS . 0.5 OUTLIER 94.88 -164.24 0.0 OUTLIER 'General case' 0 N--CA 1.529 3.514 0 CA-C-N 120.487 1.494 . . . . 0.98999999999999999 111.789 179.126 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 907' ' ' LYS . . . . . 0.471 ' CB ' ' O ' ' A' ' 906' ' ' GLU . 56.5 tttt 86.69 156.24 0.08 Allowed 'General case' 0 N--CA 1.52 3.031 0 N-CA-C 108.124 -1.065 . . . . 5.25 108.124 -176.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 60.8 t -123.12 115.88 46.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 120.821 -1.174 . . . . 0.39000000000000001 111.173 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -102.65 132.78 48.54 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 107.334 -1.358 . . . . 1.72 107.334 176.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -154.7 123.24 6.09 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 106.715 -1.587 . . . . 0.67000000000000004 106.715 178.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 911' ' ' VAL . . . . . 0.466 ' HA ' ' HA ' ' A' ' 964' ' ' VAL . 79.4 t -82.77 131.06 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 C-N-CA 120.378 -0.529 . . . . 0.54000000000000004 111.028 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 75.3 mt -66.7 156.45 35.28 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.381 -0.824 . . . . 1.5 109.032 178.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 1.1 p -125.34 135.41 52.43 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.23 -1.026 . . . . 1.3700000000000001 108.23 176.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 914' ' ' ARG . . . . . 0.441 ' O ' ' CB ' ' A' ' 915' ' ' SER . 0.0 OUTLIER -64.23 155.11 32.94 Favored 'General case' 0 N--CA 1.506 2.361 0 O-C-N 120.7 -1.25 . . . . 4.2999999999999998 111.63 -179.287 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 915' ' ' SER . . . . . 0.441 ' CB ' ' O ' ' A' ' 914' ' ' ARG . 2.0 t 84.1 -31.75 0.07 Allowed 'General case' 0 N--CA 1.52 3.071 0 C-N-CA 124.036 0.935 . . . . 2.0499999999999998 111.769 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 916' ' ' ASN . . . . . 0.413 ' O ' ' HB2' ' A' ' 917' ' ' GLN . 68.8 m-80 -123.49 -21.3 5.33 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 120.946 -1.096 . . . . 2.71 111.299 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 917' ' ' GLN . . . . . 0.413 ' HB2' ' O ' ' A' ' 916' ' ' ASN . 50.2 mt-30 66.71 166.48 0.21 Allowed 'General case' 0 N--CA 1.52 3.047 0 N-CA-C 105.789 -1.93 . . . . 2.6800000000000002 105.789 -174.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.24 -125.32 33.43 Favored Glycine 1 N--CA 1.522 4.372 0 CA-C-N 123.646 2.93 . . . . 0.029999999999999999 107.041 -177.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 919' ' ' VAL . . . . . . . . . . . . . 78.1 t 51.57 94.14 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 O-C-N 121.357 -1.084 . . . . 1.3899999999999999 109.08 -178.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 920' ' ' ALA . . . . . . . . . . . . . . . -92.31 91.83 7.88 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 119.358 -0.937 . . . . 0.029999999999999999 110.882 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 921' ' ' ARG . . . . . 0.426 ' HB3' ' CZ ' ' A' ' 950' ' ' PHE . 30.7 ptt180 -83.56 -41.42 17.93 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 105.641 -1.985 . . . . 4.4199999999999999 105.641 176.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 922' ' ' VAL . . . . . . . . . . . . . 97.1 t -98.79 78.39 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 N-CA-C 106.041 -1.837 . . . . 0.84999999999999998 106.041 175.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -86.12 133.91 33.85 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.717 0.77 . . . . 2.46 111.381 -177.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 17.8 t -147.35 104.49 3.65 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.869 -0.789 . . . . 0.69999999999999996 108.869 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -103.75 83.35 0.41 Allowed Glycine 0 N--CA 1.487 2.071 0 N-CA-C 108.242 -1.943 . . . . 0.040000000000000001 108.242 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.239 0 N-CA-C 108.98 -1.648 . . . . 0.040000000000000001 108.98 -179.403 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 63.8 m . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.005 0.431 . . . . 13.779999999999999 110.264 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 94.4 mt -109.44 129.41 55.55 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.574 -0.704 . . . . 13.76 110.369 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -152.64 169.33 31.73 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.189 -1.565 . . . . 9.1300000000000008 109.189 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 949' ' ' VAL . . . . . . . . . . . . . 35.1 m -117.99 133.21 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.518 -0.989 . . . . 7.0800000000000001 110.801 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 950' ' ' PHE . . . . . 0.426 ' CZ ' ' HB3' ' A' ' 921' ' ' ARG . 30.7 p90 -130.69 147.06 52.32 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.59 -0.694 . . . . 7.5899999999999999 109.502 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 73.6 m -119.98 -54.68 2.11 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.487 -0.758 . . . . 5.0300000000000002 111.843 -178.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 952' ' ' LEU . . . . . 0.41 ' O ' ' O ' ' A' ' 953' ' ' ILE . 55.9 tp -60.75 -76.87 0.05 OUTLIER 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.417 -0.802 . . . . 1.01 112.178 -177.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 953' ' ' ILE . . . . . 0.463 ' O ' ' HB3' ' A' ' 954' ' ' LEU . 47.6 pt -53.78 -141.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.656 0 N-CA-C 113.81 1.041 . . . . 2.6000000000000001 113.81 -176.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 954' ' ' LEU . . . . . 0.522 ' N ' ' CD1' ' A' ' 954' ' ' LEU . 0.0 OUTLIER 173.79 78.7 0.05 OUTLIER Pre-proline 0 N--CA 1.508 2.451 0 O-C-N 120.777 -1.202 . . . . 0.050000000000000003 111.037 179.427 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 955' ' ' PRO . . . . . 0.423 ' HD2' ' CE1' ' A' ' 950' ' ' PHE . 45.8 Cg_endo -73.61 89.89 0.95 Allowed 'Trans proline' 0 C--N 1.314 -1.255 0 N-CA-C 109.45 -1.019 . . . . 0.83999999999999997 109.45 178.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 956' ' ' LEU . . . . . . . . . . . . . 5.7 mp -125.52 150.17 47.66 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.187 -0.946 . . . . 0.040000000000000001 110.487 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 59.6 mt-30 -81.74 151.9 27.27 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-O 117.784 -1.103 . . . . 1.28 111.793 -179.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -70.2 119.83 14.98 Favored 'General case' 0 N--CA 1.511 2.609 0 CA-C-N 123.048 2.658 . . . . 0.17000000000000001 111.671 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.6 -23.0 30.22 Favored Glycine 0 N--CA 1.501 3.031 0 N-CA-C 111.025 -0.83 . . . . 0.040000000000000001 111.025 178.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 960' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.85 171.45 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.567 -0.96 . . . . 0.040000000000000001 110.202 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 961' ' ' THR . . . . . 0.452 ' HA ' ' O ' ' A' ' 886' ' ' PHE . 46.3 m -133.36 137.87 46.06 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.893 -1.129 . . . . 1.78 112.127 -178.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 962' ' ' VAL . . . . . 0.42 ' CG2' ' CB ' ' A' ' 886' ' ' PHE . 26.3 m -99.03 144.13 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.675 -0.641 . . . . 0.040000000000000001 110.229 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 1.6 m -137.68 144.32 41.76 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.857 -0.527 . . . . 0.71999999999999997 110.031 -178.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 964' ' ' VAL . . . . . 0.466 ' HA ' ' HA ' ' A' ' 911' ' ' VAL . 58.1 t -94.88 136.01 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.13 -0.981 . . . . 1.05 110.538 -179.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -93.98 127.51 39.8 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 103.784 -2.673 . . . . 3.02 103.784 173.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 966' ' ' LEU . . . . . 0.411 ' O ' ' CG2' ' A' ' 967' ' ' VAL . 1.2 tt -132.12 61.43 1.66 Allowed 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.232 -1.025 . . . . 1.46 108.232 177.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 967' ' ' VAL . . . . . 0.411 ' CG2' ' O ' ' A' ' 966' ' ' LEU . 94.2 t -158.28 96.41 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 108.056 -1.09 . . . . 1.9399999999999999 108.056 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 90.6 mmm -142.17 60.1 1.46 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.709 -1.244 . . . . 0.0 108.344 179.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.47 119.83 1.95 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 107.08 -2.408 . . . . 2.1099999999999999 107.08 -178.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -81.96 -58.04 3.15 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.065 -1.256 . . . . 5.8899999999999997 110.562 -179.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 40.6 tp -59.19 90.01 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.442 -0.786 . . . . 4.3600000000000003 110.283 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -141.32 -154.02 0.49 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.613 -0.679 . . . . 1.8300000000000001 110.117 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -120.08 172.34 7.82 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.486 -0.759 . . . . 4.3499999999999996 110.215 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 30.8 t -101.46 130.05 47.63 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.568 -0.707 . . . . 1.27 110.009 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -156.21 156.44 34.15 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.499 -0.75 . . . . 5.0199999999999996 110.529 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.15 85.46 18.8 Favored Pre-proline 0 N--CA 1.5 2.041 0 O-C-N 121.616 -0.677 . . . . 2.4100000000000001 109.613 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -72.82 -172.58 0.99 Allowed 'Trans proline' 0 C--N 1.317 -1.091 0 O-C-N 123.29 1.153 . . . . 0.95999999999999996 111.216 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 6.7 mp -127.25 154.7 44.55 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 107.644 -1.243 . . . . 0.62 107.644 178.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 979' ' ' THR . . . . . . . . . . . . . 41.1 p -150.54 141.16 22.61 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.781 -1.199 . . . . 3.5699999999999998 111.145 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 980' ' ' ILE . . . . . . . . . . . . . 50.7 mm -106.22 127.43 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 108.881 -0.785 . . . . 1.3300000000000001 108.881 179.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 981' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -120.71 99.26 6.43 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.414 -0.804 . . . . 0.050000000000000003 111.782 -178.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 85.9 p -108.16 159.89 16.25 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 109.06 -0.719 . . . . 0.87 109.06 178.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . -171.45 109.55 0.32 Allowed Glycine 0 N--CA 1.498 2.82 0 N-CA-C 106.635 -2.586 . . . . 0.029999999999999999 106.635 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -109.61 148.62 30.98 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 114.561 1.319 . . . . 0.69999999999999996 114.561 -175.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 51.8 tp -68.77 134.4 49.7 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.854 -1.154 . . . . 0.040000000000000001 110.084 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 45.8 tp -107.82 -59.19 1.87 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.563 -0.71 . . . . 0.040000000000000001 109.925 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -144.32 144.91 31.68 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.601 -1.259 . . . . 0.040000000000000001 107.601 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -113.1 162.8 12.24 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 108.187 -1.965 . . . . 0.040000000000000001 108.187 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -75.16 112.97 20.8 Favored Pre-proline 0 N--CA 1.499 1.981 0 O-C-N 121.186 -1.185 . . . . 0.040000000000000001 109.454 179.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 990' ' ' PRO . . . . . 0.418 ' O ' ' HB2' ' A' ' 991' ' ' GLU . 50.9 Cg_endo -88.01 72.09 2.69 Favored 'Trans proline' 0 C--N 1.32 -0.968 0 O-C-N 123.055 1.029 . . . . 0.45000000000000001 111.363 -179.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 991' ' ' GLU . . . . . 0.418 ' HB2' ' O ' ' A' ' 990' ' ' PRO . 71.8 mt-10 67.51 -73.65 0.08 Allowed 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 108.529 -0.915 . . . . 1.97 108.529 -177.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 992' ' ' LEU . . . . . . . . . . . . . 11.1 mt 50.55 20.87 0.77 Allowed 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.612 -0.68 . . . . 2.3799999999999999 111.642 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -93.56 156.7 16.58 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.942 -1.099 . . . . 3.79 110.033 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -145.3 92.6 2.27 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.587 -0.696 . . . . 3.5099999999999998 110.276 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 995' ' ' ALA . . . . . . . . . . . . 2.519 . . . . . . . 0 N--CA 1.503 2.224 0 O-C-N 120.887 -1.133 . . . . 2.73 110.648 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo . . . . . 0 N--CA 1.488 1.172 0 N-CA-C 109.543 -0.983 . . . . 3.8300000000000001 109.543 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 847' ' ' VAL . . . . . . . . . . . . . 61.5 t -132.57 103.42 13.51 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.547 -0.721 . . . . 1.8300000000000001 110.098 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 848' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -69.88 -20.28 34.44 Favored 'Trans proline' 0 N--CA 1.487 1.125 0 O-C-N 123.299 1.157 . . . . 0.65000000000000002 111.003 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 849' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 27.77 68.22 0.07 Allowed 'General case' 0 N--CA 1.518 2.941 0 N-CA-C 112.923 0.712 . . . . 2.5800000000000001 112.923 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 850' ' ' VAL . . . . . . . . . . . . . 57.4 t -119.37 136.14 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.128 -0.983 . . . . 1.0900000000000001 111.679 -178.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 851' ' ' ALA . . . . . . . . . . . . . . . -126.29 157.13 39.16 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 105.776 -1.935 . . . . 0.040000000000000001 105.776 176.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 852' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -160.68 127.4 4.16 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 120.886 1.675 . . . . 0.050000000000000003 108.581 179.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 5.7 t -176.15 134.79 0.26 Allowed 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.305 -0.998 . . . . 0.040000000000000001 108.305 -178.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -132.15 156.1 46.99 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.066 -1.022 . . . . 0.67000000000000004 109.542 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 855' ' ' ALA . . . . . 0.402 ' O ' ' HB2' ' B' ' 870' ' ' ARG . . . -121.92 143.97 49.14 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.864 0.84 . . . . 0.51000000000000001 111.315 -179.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 856' ' ' LEU . . . . . 0.406 HD23 ' CG1' ' B' ' 866' ' ' VAL . 3.4 tm? -113.2 134.88 54.36 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.687 -0.633 . . . . 0.050000000000000003 110.253 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 857' ' ' SER . . . . . 0.41 ' O ' ' O ' ' B' ' 858' ' ' LEU . 60.8 p -152.12 16.96 0.65 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.553 -0.717 . . . . 1.3300000000000001 110.616 178.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 858' ' ' LEU . . . . . 0.41 ' O ' ' O ' ' B' ' 857' ' ' SER . 4.4 pp -32.65 156.92 0.03 OUTLIER Pre-proline 0 N--CA 1.518 2.945 0 N-CA-C 113.276 0.843 . . . . 2.3300000000000001 113.276 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -62.95 -88.39 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.344 0 O-C-N 123.132 1.07 . . . . 2.3199999999999998 113.228 -178.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 55.2 ptt85 -128.65 -143.36 0.27 Allowed 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.852 -1.155 . . . . 0.040000000000000001 111.685 -177.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 14.1 m -40.16 126.83 2.19 Favored 'General case' 0 N--CA 1.508 2.451 0 O-C-N 121.566 -0.709 . . . . 1.3100000000000001 112.408 -178.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 862' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -102.01 157.63 33.32 Favored Pre-proline 0 N--CA 1.489 1.51 0 N-CA-C 107.673 -1.232 . . . . 4.5099999999999998 107.673 176.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -71.63 -11.94 28.56 Favored 'Trans proline' 0 C--N 1.314 -1.268 0 O-C-N 123.006 1.003 . . . . 2.2400000000000002 111.472 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -176.08 -136.61 2.39 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 110.152 -1.179 . . . . 0.040000000000000001 110.152 179.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 26.1 m -65.75 155.95 34.56 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.357 -1.084 . . . . 1.51 110.934 -178.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 866' ' ' VAL . . . . . 0.406 ' CG1' HD23 ' B' ' 856' ' ' LEU . 59.8 t -92.11 135.22 27.36 Favored Pre-proline 0 N--CA 1.494 1.743 0 N-CA-C 113.265 0.839 . . . . 0.78000000000000003 113.265 -174.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 867' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -90.49 -152.7 0.04 OUTLIER 'Trans proline' 0 CA--C 1.54 0.82 0 N-CA-C 108.612 -1.341 . . . . 0.92000000000000004 108.612 177.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 868' ' ' PHE . . . . . 0.449 ' CD1' ' N ' ' B' ' 868' ' ' PHE . 27.0 p90 -150.98 122.47 7.91 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.631 -1.293 . . . . 0.050000000000000003 109.592 179.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 50.3 p-10 -113.86 -1.94 13.75 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 119.343 -0.943 . . . . 1.7 112.519 -178.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 870' ' ' ARG . . . . . 0.402 ' HB2' ' O ' ' B' ' 855' ' ' ALA . 28.9 mmm180 -90.72 88.45 7.09 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.908 -1.12 . . . . 2.5899999999999999 110.773 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 57.3 t -73.28 97.07 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.011 -1.056 . . . . 1.9399999999999999 109.864 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 872' ' ' LEU . . . . . . . . . . . . . 96.2 mt -83.05 -47.57 11.54 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.535 -0.728 . . . . 1.0600000000000001 110.14 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 873' ' ' LEU . . . . . . . . . . . . . 30.4 tp -174.63 103.83 0.1 Allowed 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.545 -0.909 . . . . 4.1799999999999997 108.545 178.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 874' ' ' ASN . . . . . . . . . . . . . 37.5 t-20 178.66 81.66 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.281 0 O-C-N 121.608 -0.682 . . . . 0.040000000000000001 109.698 -178.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -66.03 -47.11 75.49 Favored 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 119.297 -0.961 . . . . 3.3799999999999999 110.994 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 876' ' ' GLY . . . . . . . . . . . . . . . -74.64 -24.78 71.63 Favored Glycine 0 N--CA 1.493 2.486 0 C-N-CA 120.526 -0.845 . . . . 0.040000000000000001 111.842 -178.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 85.91 -58.77 4.78 Favored Glycine 0 N--CA 1.502 3.06 0 N-CA-C 108.105 -1.998 . . . . 0.040000000000000001 108.105 -178.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 878' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 60.45 -67.74 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 114.263 1.209 . . . . 3.46 114.263 177.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 879' ' ' TYR . . . . . 0.463 ' CB ' ' CD2' ' B' ' 886' ' ' PHE . 24.2 p90 -113.2 110.67 20.78 Favored 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 114.955 1.465 . . . . 0.040000000000000001 114.955 -176.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -65.62 118.94 56.09 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 121.494 -0.754 . . . . 0.02 110.196 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 881' ' ' PRO . . . . . 0.417 ' HG2' ' CD1' ' B' ' 868' ' ' PHE . 54.2 Cg_endo -76.34 0.38 9.5 Favored 'Trans proline' 0 N--CA 1.493 1.483 0 O-C-N 123.337 1.178 . . . . 0.39000000000000001 112.221 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -74.44 -65.23 0.88 Allowed 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 106.7 -1.593 . . . . 0.81000000000000005 106.7 178.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 7.0 p -96.99 -15.77 20.92 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 109.0 -0.741 . . . . 0.040000000000000001 109.0 177.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.42 24.09 48.44 Favored Glycine 0 N--CA 1.495 2.569 0 C-N-CA 120.034 -1.079 . . . . 0.029999999999999999 110.596 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 885' ' ' VAL . . . . . . . . . . . . . 92.9 t -72.12 88.64 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 C-N-CA 118.514 -1.274 . . . . 1.01 107.865 -179.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 886' ' ' PHE . . . . . 0.463 ' CD2' ' CB ' ' B' ' 879' ' ' TYR . 0.7 OUTLIER -90.82 105.52 17.88 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 115.249 -0.887 . . . . 0.050000000000000003 112.577 -176.848 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 887' ' ' THR . . . . . 0.404 ' O ' ' HD3' ' B' ' 889' ' ' PRO . 89.6 m -95.93 100.27 11.97 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 107.555 -1.276 . . . . 0.68000000000000005 107.555 177.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 888' ' ' ALA . . . . . . . . . . . . . . . -99.02 106.55 38.76 Favored Pre-proline 0 N--CA 1.501 2.114 0 N-CA-C 114.125 1.157 . . . . 0.25 114.125 -176.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 889' ' ' PRO . . . . . 0.404 ' HD3' ' O ' ' B' ' 887' ' ' THR . 53.4 Cg_endo -90.15 -11.77 2.97 Favored 'Trans proline' 0 CA--C 1.547 1.143 0 C-N-CA 121.143 1.228 . . . . 1.6399999999999999 109.128 176.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 890' ' ' LEU . . . . . . . . . . . . . 4.6 tt -34.96 -51.81 0.53 Allowed 'General case' 0 N--CA 1.509 2.487 0 N-CA-C 113.867 1.062 . . . . 2.29 113.867 -177.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 51.29 95.52 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.373 0 O-C-N 121.131 -0.981 . . . . 0.63 110.425 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . 156.09 -147.68 16.65 Favored Glycine 0 N--CA 1.48 1.581 0 N-CA-C 107.383 -2.287 . . . . 0.040000000000000001 107.383 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 72.9 ttt-85 -109.04 127.06 53.79 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 107.49 -1.3 . . . . 3.0 107.49 177.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 894' ' ' TYR . . . . . 0.448 ' CD1' ' N ' ' B' ' 895' ' ' LEU . 0.1 OUTLIER -131.45 144.81 51.44 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.053 -1.029 . . . . 0.040000000000000001 110.17 -179.112 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 895' ' ' LEU . . . . . 0.448 ' N ' ' CD1' ' B' ' 894' ' ' TYR . 34.1 tp -99.3 116.68 32.04 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.623 -0.673 . . . . 1.27 109.846 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 896' ' ' LEU . . . . . 0.433 ' HB2' ' CZ ' ' B' ' 894' ' ' TYR . 10.4 tt -112.75 146.57 38.53 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.587 -0.696 . . . . 0.93999999999999995 110.704 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 897' ' ' SER . . . . . . . . . . . . . 63.3 m -143.78 118.89 10.08 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.42 -0.8 . . . . 0.040000000000000001 110.741 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -108.2 147.21 31.67 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.689 -0.632 . . . . 0.47999999999999998 109.352 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 899' ' ' VAL . . . . . . . . . . . . . 88.3 t -93.86 120.15 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.417 -0.802 . . . . 0.55000000000000004 110.9 -179.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 900' ' ' LEU . . . . . 0.436 ' N ' ' CD2' ' B' ' 900' ' ' LEU . 4.4 mm? -94.7 112.94 24.67 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 114.257 1.206 . . . . 1.5900000000000001 114.257 -174.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 17.9 m -66.81 141.63 57.63 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 107.348 -1.352 . . . . 0.050000000000000003 107.348 176.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -66.18 -65.18 2.96 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 110.598 -1.001 . . . . 0.029999999999999999 110.598 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 5.9 m170 46.9 64.93 1.36 Allowed 'General case' 0 N--CA 1.507 2.393 0 O-C-N 121.381 -1.07 . . . . 3.2000000000000002 111.122 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 41.6 ptt85 -69.24 -6.71 30.92 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.574 -0.704 . . . . 2.9199999999999999 111.989 -179.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 905' ' ' HIS . . . . . 0.486 ' O ' ' CB ' ' B' ' 906' ' ' GLU . 70.5 t60 -63.48 6.14 0.15 Allowed 'General case' 0 N--CA 1.507 2.387 0 O-C-N 120.867 -1.146 . . . . 2.8700000000000001 113.163 -178.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 906' ' ' GLU . . . . . 0.486 ' CB ' ' O ' ' B' ' 905' ' ' HIS . 0.5 OUTLIER 94.58 -164.31 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.47 0 CA-C-N 120.592 1.542 . . . . 0.98999999999999999 111.848 179.008 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 907' ' ' LYS . . . . . 0.476 ' CB ' ' O ' ' B' ' 906' ' ' GLU . 56.6 tttt 86.62 156.04 0.08 Allowed 'General case' 0 N--CA 1.52 3.067 0 N-CA-C 108.042 -1.096 . . . . 5.25 108.042 -176.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 60.3 t -122.97 115.68 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 120.804 -1.185 . . . . 0.39000000000000001 111.116 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 51.0 tp10 -102.01 133.32 47.0 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 107.328 -1.36 . . . . 1.72 107.328 176.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -155.15 123.04 5.76 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 106.783 -1.562 . . . . 0.67000000000000004 106.783 178.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 911' ' ' VAL . . . . . 0.459 ' HA ' ' HA ' ' B' ' 964' ' ' VAL . 77.9 t -82.53 131.17 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.858 -0.526 . . . . 0.54000000000000004 111.022 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 75.5 mt -66.82 156.53 35.34 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.407 -0.808 . . . . 1.5 108.951 178.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 913' ' ' SER . . . . . 0.404 ' CB ' ' CG1' ' B' ' 919' ' ' VAL . 1.1 p -125.32 135.85 52.89 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.181 -1.044 . . . . 1.3700000000000001 108.181 176.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 914' ' ' ARG . . . . . 0.429 ' O ' ' CB ' ' B' ' 915' ' ' SER . 0.0 OUTLIER -64.61 155.62 32.67 Favored 'General case' 0 N--CA 1.506 2.35 0 O-C-N 120.619 -1.301 . . . . 4.2999999999999998 111.528 -179.295 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 915' ' ' SER . . . . . 0.429 ' CB ' ' O ' ' B' ' 914' ' ' ARG . 2.0 t 83.64 -31.58 0.08 Allowed 'General case' 0 N--CA 1.52 3.07 0 C-N-CA 123.968 0.907 . . . . 2.0499999999999998 111.887 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 916' ' ' ASN . . . . . 0.414 ' O ' ' HB2' ' B' ' 917' ' ' GLN . 68.8 m-80 -123.82 -21.1 5.24 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 120.927 -1.108 . . . . 2.71 111.268 -179.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 917' ' ' GLN . . . . . 0.414 ' HB2' ' O ' ' B' ' 916' ' ' ASN . 50.3 mt-30 66.71 166.41 0.21 Allowed 'General case' 0 N--CA 1.521 3.094 0 N-CA-C 105.74 -1.948 . . . . 2.6800000000000002 105.74 -174.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.07 -125.08 32.37 Favored Glycine 1 N--CA 1.522 4.386 0 CA-C-N 123.397 2.817 . . . . 0.029999999999999999 107.071 -177.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 919' ' ' VAL . . . . . 0.404 ' CG1' ' CB ' ' B' ' 913' ' ' SER . 76.4 t 51.69 94.23 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.262 0 O-C-N 121.407 -1.055 . . . . 1.3899999999999999 109.036 -178.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 920' ' ' ALA . . . . . . . . . . . . . . . -92.31 92.06 7.98 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.335 -0.946 . . . . 0.029999999999999999 110.831 -179.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 921' ' ' ARG . . . . . 0.422 ' HB3' ' CZ ' ' B' ' 950' ' ' PHE . 30.6 ptt180 -83.68 -41.62 17.53 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 105.65 -1.981 . . . . 4.4199999999999999 105.65 175.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 922' ' ' VAL . . . . . . . . . . . . . 96.9 t -98.66 78.81 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 N-CA-C 105.939 -1.874 . . . . 0.84999999999999998 105.939 175.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -86.47 134.05 33.71 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.654 0.74 . . . . 2.46 111.368 -177.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 924' ' ' SER . . . . . . . . . . . . . 17.4 t -147.49 104.84 3.66 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.713 -0.847 . . . . 0.69999999999999996 108.713 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -104.13 83.36 0.4 Allowed Glycine 0 N--CA 1.487 2.041 0 N-CA-C 108.222 -1.951 . . . . 0.040000000000000001 108.222 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 108.973 -1.651 . . . . 0.040000000000000001 108.973 -179.376 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 68.1 m . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.014 0.435 . . . . 13.779999999999999 110.246 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 94.8 mt -108.88 129.44 55.41 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.583 -0.698 . . . . 13.76 110.323 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -152.19 168.83 31.43 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.235 -1.546 . . . . 9.1300000000000008 109.235 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 949' ' ' VAL . . . . . . . . . . . . . 35.0 m -117.85 132.74 66.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.525 -0.985 . . . . 7.0800000000000001 110.717 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 950' ' ' PHE . . . . . 0.422 ' CZ ' ' HB3' ' B' ' 921' ' ' ARG . 30.7 p90 -130.49 146.57 52.05 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.518 -0.739 . . . . 7.5899999999999999 109.55 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 73.4 m -119.38 -54.11 2.2 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.452 -0.78 . . . . 5.0300000000000002 111.808 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 952' ' ' LEU . . . . . 0.409 ' O ' ' O ' ' B' ' 953' ' ' ILE . 56.5 tp -61.42 -77.02 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.465 -0.772 . . . . 1.01 112.285 -177.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 953' ' ' ILE . . . . . 0.469 ' O ' ' HB3' ' B' ' 954' ' ' LEU . 48.9 pt -53.83 -141.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.739 0 N-CA-C 113.701 1.0 . . . . 2.6000000000000001 113.701 -176.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 954' ' ' LEU . . . . . 0.524 ' N ' ' CD1' ' B' ' 954' ' ' LEU . 0.0 OUTLIER 174.07 78.68 0.05 OUTLIER Pre-proline 0 N--CA 1.509 2.495 0 O-C-N 120.654 -1.279 . . . . 0.050000000000000003 110.963 179.47 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 955' ' ' PRO . . . . . 0.422 ' HD2' ' CE1' ' B' ' 950' ' ' PHE . 46.0 Cg_endo -73.51 89.52 0.95 Allowed 'Trans proline' 0 C--N 1.315 -1.236 0 N-CA-C 109.514 -0.995 . . . . 0.83999999999999997 109.514 178.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 956' ' ' LEU . . . . . . . . . . . . . 5.7 mp -125.22 150.22 47.22 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.289 -0.882 . . . . 0.040000000000000001 110.461 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -82.14 151.38 26.99 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 117.729 -1.129 . . . . 1.28 111.828 -179.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -69.77 119.74 14.46 Favored 'General case' 0 N--CA 1.512 2.626 0 CA-C-N 123.14 2.7 . . . . 0.17000000000000001 111.784 -179.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.76 -22.66 32.48 Favored Glycine 0 N--CA 1.502 3.076 0 N-CA-C 111.037 -0.825 . . . . 0.040000000000000001 111.037 178.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 960' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -52.19 171.55 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.54 -0.976 . . . . 0.040000000000000001 110.198 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 961' ' ' THR . . . . . 0.441 ' HA ' ' O ' ' B' ' 886' ' ' PHE . 47.1 m -133.42 137.83 45.96 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.846 -1.159 . . . . 1.78 112.103 -178.084 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 962' ' ' VAL . . . . . 0.425 ' CG2' ' CB ' ' B' ' 886' ' ' PHE . 26.3 m -98.84 144.44 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 C-N-CA 120.169 -0.612 . . . . 0.040000000000000001 110.219 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 1.6 m -137.87 144.72 41.52 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.857 -0.527 . . . . 0.71999999999999997 110.009 -178.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 964' ' ' VAL . . . . . 0.459 ' HA ' ' HA ' ' B' ' 911' ' ' VAL . 58.1 t -95.2 136.34 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.107 -0.995 . . . . 1.05 110.434 -179.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -94.29 127.59 40.25 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 103.758 -2.682 . . . . 3.02 103.758 173.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 966' ' ' LEU . . . . . 0.411 ' O ' ' CG2' ' B' ' 967' ' ' VAL . 1.2 tt -132.24 61.67 1.66 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.123 -1.065 . . . . 1.46 108.123 177.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 967' ' ' VAL . . . . . 0.411 ' CG2' ' O ' ' B' ' 966' ' ' LEU . 94.4 t -158.42 97.02 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 107.917 -1.142 . . . . 1.9399999999999999 107.917 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 90.4 mmm -142.79 59.92 1.43 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.715 -1.24 . . . . 0.0 108.251 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.64 119.98 1.96 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 107.043 -2.423 . . . . 2.1099999999999999 107.043 -178.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -82.12 -58.2 3.06 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.974 -1.31 . . . . 5.8899999999999997 110.492 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 40.0 tp -58.9 90.47 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.407 -0.808 . . . . 4.3600000000000003 110.336 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -141.88 -154.32 0.51 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.565 -0.71 . . . . 1.8300000000000001 110.139 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -120.04 171.84 8.17 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.409 -0.807 . . . . 4.3499999999999996 110.273 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 31.5 t -100.97 130.03 46.9 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.555 -0.716 . . . . 1.27 110.068 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -156.25 156.44 34.09 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.511 -0.743 . . . . 5.0199999999999996 110.553 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.14 85.49 18.82 Favored Pre-proline 0 N--CA 1.5 2.038 0 O-C-N 121.655 -0.653 . . . . 2.4100000000000001 109.671 179.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -72.66 -172.42 0.94 Allowed 'Trans proline' 0 C--N 1.317 -1.098 0 O-C-N 123.299 1.158 . . . . 0.95999999999999996 111.258 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 978' ' ' LEU . . . . . . . . . . . . . 6.6 mp -127.58 154.48 45.14 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 107.639 -1.245 . . . . 0.62 107.639 178.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 979' ' ' THR . . . . . . . . . . . . . 41.3 p -150.28 141.38 23.05 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.79 -1.194 . . . . 3.5699999999999998 111.12 -179.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 980' ' ' ILE . . . . . 0.453 HG22 HD11 ' B' ' 980' ' ' ILE . 50.7 mm -106.4 127.42 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 108.852 -0.796 . . . . 1.3300000000000001 108.852 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -120.63 99.25 6.43 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 119.723 -0.791 . . . . 0.050000000000000003 111.791 -178.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 81.9 p -108.42 159.67 16.49 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.543 -0.723 . . . . 0.87 109.104 178.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 983' ' ' GLY . . . . . . . . . . . . . . . -171.14 110.03 0.34 Allowed Glycine 0 N--CA 1.497 2.759 0 N-CA-C 106.496 -2.641 . . . . 0.029999999999999999 106.496 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -110.03 148.01 32.47 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 114.637 1.347 . . . . 0.69999999999999996 114.637 -175.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 985' ' ' LEU . . . . . . . . . . . . . 51.4 tp -68.17 134.27 50.22 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 120.895 -1.128 . . . . 0.040000000000000001 110.123 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 986' ' ' LEU . . . . . . . . . . . . . 45.8 tp -107.8 -59.11 1.88 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.598 -0.689 . . . . 0.040000000000000001 109.957 179.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -144.48 144.92 31.59 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 107.543 -1.28 . . . . 0.040000000000000001 107.543 179.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.98 163.21 12.16 Favored Glycine 0 N--CA 1.495 2.603 0 N-CA-C 108.271 -1.932 . . . . 0.040000000000000001 108.271 179.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -75.65 113.01 22.44 Favored Pre-proline 0 N--CA 1.498 1.965 0 O-C-N 121.273 -1.133 . . . . 0.040000000000000001 109.443 179.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 990' ' ' PRO . . . . . 0.409 ' O ' ' HB2' ' B' ' 991' ' ' GLU . 50.2 Cg_endo -88.07 72.06 2.65 Favored 'Trans proline' 0 C--N 1.319 -0.996 0 O-C-N 123.141 1.074 . . . . 0.45000000000000001 111.443 -178.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 991' ' ' GLU . . . . . 0.409 ' HB2' ' O ' ' B' ' 990' ' ' PRO . 71.8 mt-10 67.5 -73.68 0.08 Allowed 'General case' 0 N--CA 1.503 2.182 0 N-CA-C 108.502 -0.925 . . . . 1.97 108.502 -177.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 992' ' ' LEU . . . . . . . . . . . . . 11.1 mt 50.5 20.83 0.75 Allowed 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.605 -0.685 . . . . 2.3799999999999999 111.677 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -93.63 156.74 16.54 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.9 -1.125 . . . . 3.79 110.042 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -145.19 92.83 2.3 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.481 -0.762 . . . . 3.5099999999999998 110.211 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 995' ' ' ALA . . . . . . . . . . . . 2.518 . . . . . . . 0 N--CA 1.504 2.232 0 O-C-N 120.949 -1.095 . . . . 2.73 110.603 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo . . . . . 0 N--CA 1.489 1.239 0 N-CA-C 109.52 -0.992 . . . . 3.8300000000000001 109.52 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 847' ' ' VAL . . . . . . . . . . . . . 57.9 t -129.88 104.86 16.91 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.586 -0.696 . . . . 1.8300000000000001 110.088 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 848' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -69.84 -22.05 32.23 Favored 'Trans proline' 0 N--CA 1.488 1.152 0 O-C-N 123.255 1.134 . . . . 0.65000000000000002 111.123 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 849' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 27.53 68.61 0.07 Allowed 'General case' 0 N--CA 1.518 2.952 0 N-CA-C 112.93 0.715 . . . . 2.5800000000000001 112.93 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 850' ' ' VAL . . . . . . . . . . . . . 57.4 t -119.52 135.68 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.157 -0.964 . . . . 1.0900000000000001 111.349 -178.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 851' ' ' ALA . . . . . . . . . . . . . . . -130.2 154.97 47.01 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 106.029 -1.841 . . . . 0.040000000000000001 106.029 176.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 852' ' ' PHE . . . . . 0.411 ' CE2' ' O ' ' C' ' 983' ' ' GLY . 9.1 p90 -158.66 130.34 6.56 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 120.869 1.668 . . . . 0.050000000000000003 108.756 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 42.2 t -175.49 133.37 0.29 Allowed 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.014 -1.106 . . . . 0.040000000000000001 108.014 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -134.42 158.21 44.45 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.158 -0.964 . . . . 0.67000000000000004 109.388 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 855' ' ' ALA . . . . . . . . . . . . . . . -121.07 141.52 50.69 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.9 0.857 . . . . 0.51000000000000001 111.713 -178.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 856' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -106.83 133.84 50.88 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 109.26 -0.645 . . . . 0.050000000000000003 109.26 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 857' ' ' SER . . . . . 0.402 ' O ' ' O ' ' C' ' 858' ' ' LEU . 80.0 p -152.61 15.85 0.59 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.549 -0.719 . . . . 1.3300000000000001 110.959 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 858' ' ' LEU . . . . . 0.402 ' O ' ' O ' ' C' ' 857' ' ' SER . 2.9 pp -34.94 157.49 0.04 OUTLIER Pre-proline 0 N--CA 1.516 2.873 0 N-CA-C 112.692 0.627 . . . . 2.3300000000000001 112.692 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -62.13 -89.43 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 121.048 1.165 . . . . 2.3199999999999998 114.127 -177.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 54.8 ptt85 -130.67 -142.62 0.23 Allowed 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.803 -1.185 . . . . 0.040000000000000001 111.867 -177.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 71.7 m -35.17 118.8 0.46 Allowed 'General case' 0 N--CA 1.511 2.601 0 O-C-N 121.749 -0.595 . . . . 1.3100000000000001 112.515 -178.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -102.67 159.78 28.28 Favored Pre-proline 0 N--CA 1.488 1.448 0 N-CA-C 108.033 -1.099 . . . . 4.5099999999999998 108.033 177.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.86 -14.52 32.67 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 O-C-N 123.176 1.093 . . . . 2.2400000000000002 111.12 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -176.99 -133.94 1.9 Allowed Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.969 -1.252 . . . . 0.040000000000000001 109.969 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 37.5 m -70.0 158.5 35.53 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.38 -1.071 . . . . 1.51 110.924 -178.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 866' ' ' VAL . . . . . . . . . . . . . 30.9 m -94.68 138.43 22.24 Favored Pre-proline 0 N--CA 1.497 1.888 0 N-CA-C 113.641 0.978 . . . . 0.78000000000000003 113.641 -175.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 867' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -89.12 -151.11 0.04 OUTLIER 'Trans proline' 0 CA--C 1.54 0.802 0 N-CA-C 108.262 -1.476 . . . . 0.92000000000000004 108.262 177.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 868' ' ' PHE . . . . . 0.456 ' N ' ' CD1' ' C' ' 868' ' ' PHE . 15.0 p90 -147.97 121.58 9.19 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.512 -1.367 . . . . 0.050000000000000003 109.99 179.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -112.01 -3.5 14.77 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 119.433 -0.907 . . . . 1.7 112.101 -178.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 870' ' ' ARG . . . . . . . . . . . . . 23.8 mmm180 -90.93 87.67 6.72 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.968 -1.083 . . . . 2.5899999999999999 110.774 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 58.3 t -74.43 97.08 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 120.983 -1.073 . . . . 1.9399999999999999 109.43 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 872' ' ' LEU . . . . . . . . . . . . . 80.6 mt -86.38 -45.27 11.34 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.523 -0.736 . . . . 1.0600000000000001 110.557 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 873' ' ' LEU . . . . . 0.405 ' O ' ' HB2' ' C' ' 874' ' ' ASN . 50.2 tp -173.61 103.22 0.12 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.192 -0.942 . . . . 4.1799999999999997 108.769 178.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 874' ' ' ASN . . . . . 0.41 ' CB ' ' HA ' ' C' ' 852' ' ' PHE . 35.3 t-20 177.84 82.75 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.282 0 N-CA-C 109.201 -0.666 . . . . 0.040000000000000001 109.201 -178.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -66.37 -46.58 76.2 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 119.354 -0.938 . . . . 3.3799999999999999 111.351 -179.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 876' ' ' GLY . . . . . 0.42 ' HA3' ' CE2' ' C' ' 878' ' ' TYR . . . -74.29 -25.81 69.81 Favored Glycine 0 N--CA 1.493 2.499 0 O-C-N 121.282 -0.886 . . . . 0.040000000000000001 111.887 -178.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 81.03 -61.57 4.55 Favored Glycine 0 N--CA 1.502 3.073 0 N-CA-C 107.92 -2.072 . . . . 0.040000000000000001 107.92 -178.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 878' ' ' TYR . . . . . 0.42 ' CE2' ' HA3' ' C' ' 876' ' ' GLY . 91.4 m-85 61.67 -65.62 0.07 Allowed 'General case' 0 N--CA 1.503 2.222 0 N-CA-C 114.327 1.232 . . . . 3.46 114.327 177.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 879' ' ' TYR . . . . . 0.46 ' CB ' ' CD2' ' C' ' 886' ' ' PHE . 23.7 p90 -112.04 109.06 18.59 Favored 'General case' 0 N--CA 1.501 2.116 0 N-CA-C 114.938 1.459 . . . . 0.040000000000000001 114.938 -176.019 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -65.24 119.94 63.34 Favored Pre-proline 0 N--CA 1.497 1.913 0 O-C-N 121.548 -0.72 . . . . 0.02 110.369 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 881' ' ' PRO . . . . . 0.452 ' CG ' ' CD1' ' C' ' 868' ' ' PHE . 53.1 Cg_endo -76.13 0.99 8.75 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 O-C-N 123.434 1.229 . . . . 0.39000000000000001 112.285 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 87.4 mt-10 -74.96 -65.53 0.86 Allowed 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 106.829 -1.545 . . . . 0.81000000000000005 106.829 178.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 42.1 p -97.51 -15.1 20.72 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 109.19 -0.67 . . . . 0.040000000000000001 109.19 177.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.35 25.21 44.37 Favored Glycine 0 N--CA 1.494 2.527 0 C-N-CA 119.982 -1.104 . . . . 0.029999999999999999 110.636 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 83.0 t -72.66 88.94 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 C-N-CA 118.4 -1.32 . . . . 1.01 107.833 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 886' ' ' PHE . . . . . 0.46 ' CD2' ' CB ' ' C' ' 879' ' ' TYR . 0.7 OUTLIER -90.73 103.8 16.46 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 115.358 -0.837 . . . . 0.050000000000000003 112.242 -177.014 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 887' ' ' THR . . . . . . . . . . . . . 97.1 m -96.79 100.46 12.0 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 107.601 -1.259 . . . . 0.68000000000000005 107.601 177.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 888' ' ' ALA . . . . . . . . . . . . . . . -99.47 105.37 32.96 Favored Pre-proline 0 N--CA 1.501 2.093 0 N-CA-C 114.197 1.184 . . . . 0.25 114.197 -176.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 889' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -86.9 -13.09 4.8 Favored 'Trans proline' 0 CA--C 1.546 1.077 0 N-CA-C 108.85 -1.25 . . . . 1.6399999999999999 108.85 175.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 890' ' ' LEU . . . . . . . . . . . . . 69.3 mt -38.04 -49.81 1.31 Allowed 'General case' 0 N--CA 1.507 2.378 0 N-CA-C 113.611 0.967 . . . . 2.29 113.611 -177.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 52.42 97.43 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.286 0 O-C-N 121.082 -1.011 . . . . 0.63 110.353 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . 156.53 -148.26 17.92 Favored Glycine 0 N--CA 1.478 1.493 0 N-CA-C 107.292 -2.323 . . . . 0.040000000000000001 107.292 -179.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 73.2 ttt-85 -108.29 128.62 54.9 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 107.763 -1.199 . . . . 3.0 107.763 177.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 894' ' ' TYR . . . . . 0.428 ' CZ ' ' HB2' ' C' ' 896' ' ' LEU . 0.1 OUTLIER -130.49 146.3 52.01 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.14 -0.975 . . . . 0.040000000000000001 110.149 -179.144 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 895' ' ' LEU . . . . . 0.42 ' N ' ' CD1' ' C' ' 894' ' ' TYR . 38.6 tp -97.7 115.8 28.67 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.677 -0.64 . . . . 1.27 109.761 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 896' ' ' LEU . . . . . 0.428 ' HB2' ' CZ ' ' C' ' 894' ' ' TYR . 9.2 tt -109.72 146.17 35.36 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.687 -0.633 . . . . 0.93999999999999995 110.822 -179.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 897' ' ' SER . . . . . . . . . . . . . 19.9 m -147.49 113.66 5.87 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.576 -0.702 . . . . 0.040000000000000001 110.707 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -106.61 147.02 29.99 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.032 -0.729 . . . . 0.47999999999999998 109.032 179.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 899' ' ' VAL . . . . . . . . . . . . . 89.7 t -93.9 119.63 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 C-N-CA 119.617 -0.833 . . . . 0.55000000000000004 111.159 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 95.9 mt -94.54 110.61 22.41 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 114.188 1.181 . . . . 1.5900000000000001 114.188 -175.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 23.8 m -63.81 138.84 58.65 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 107.441 -1.318 . . . . 0.050000000000000003 107.441 177.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -61.48 -65.62 3.15 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 110.456 -1.058 . . . . 0.029999999999999999 110.456 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 46.21 66.48 0.94 Allowed 'General case' 0 N--CA 1.508 2.441 0 O-C-N 121.484 -1.009 . . . . 3.2000000000000002 110.921 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 54.8 ptt85 -67.93 -7.16 26.18 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.597 -0.69 . . . . 2.9199999999999999 112.03 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 905' ' ' HIS . . . . . 0.49 ' O ' ' CB ' ' C' ' 906' ' ' GLU . 77.1 t60 -59.83 4.4 0.05 OUTLIER 'General case' 0 N--CA 1.507 2.399 0 CA-C-O 117.65 -1.167 . . . . 2.8700000000000001 113.428 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 906' ' ' GLU . . . . . 0.49 ' CB ' ' O ' ' C' ' 905' ' ' HIS . 0.7 OUTLIER 93.0 -164.16 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.387 0 CA-C-N 121.272 1.851 . . . . 0.98999999999999999 112.013 179.071 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 907' ' ' LYS . . . . . 0.483 ' CB ' ' O ' ' C' ' 906' ' ' GLU . 68.7 tttt 87.87 160.22 0.07 Allowed 'General case' 0 N--CA 1.518 2.964 0 N-CA-C 107.772 -1.195 . . . . 5.25 107.772 -176.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 59.9 t -122.44 115.71 46.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 120.847 -1.158 . . . . 0.39000000000000001 111.058 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 40.3 tp10 -100.25 132.95 45.33 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 107.077 -1.453 . . . . 1.72 107.077 176.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -156.9 120.5 4.21 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 106.929 -1.508 . . . . 0.67000000000000004 106.929 178.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 911' ' ' VAL . . . . . 0.454 ' HA ' ' HA ' ' C' ' 964' ' ' VAL . 13.2 p -76.5 130.99 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 C-N-CA 120.42 -0.512 . . . . 0.54000000000000004 111.131 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 83.5 mt -65.59 156.13 33.66 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 108.167 -1.049 . . . . 1.5 108.167 178.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 913' ' ' SER . . . . . 0.416 ' CB ' ' CG1' ' C' ' 919' ' ' VAL . 1.2 t -127.98 131.8 49.22 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.414 -0.958 . . . . 1.3700000000000001 108.414 176.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 914' ' ' ARG . . . . . 0.421 ' O ' ' CB ' ' C' ' 915' ' ' SER . 0.0 OUTLIER -63.24 156.22 26.1 Favored 'General case' 0 N--CA 1.506 2.336 0 O-C-N 120.71 -1.244 . . . . 4.2999999999999998 111.381 -179.195 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 915' ' ' SER . . . . . 0.421 ' CB ' ' O ' ' C' ' 914' ' ' ARG . 1.8 p 84.2 -32.07 0.07 Allowed 'General case' 0 N--CA 1.521 3.082 0 C-N-CA 124.033 0.933 . . . . 2.0499999999999998 111.848 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 916' ' ' ASN . . . . . 0.418 ' O ' ' HB2' ' C' ' 917' ' ' GLN . 89.6 m-20 -124.03 -21.86 4.97 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.931 -1.106 . . . . 2.71 111.261 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 917' ' ' GLN . . . . . 0.418 ' HB2' ' O ' ' C' ' 916' ' ' ASN . 56.9 mt-30 66.82 164.86 0.2 Allowed 'General case' 0 N--CA 1.52 3.042 0 N-CA-C 105.707 -1.96 . . . . 2.6800000000000002 105.707 -173.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 55.67 -124.79 34.78 Favored Glycine 1 N--CA 1.52 4.266 0 CA-C-N 123.575 2.898 . . . . 0.029999999999999999 106.682 -177.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 919' ' ' VAL . . . . . 0.416 ' CG1' ' CB ' ' C' ' 913' ' ' SER . 76.8 t 51.24 93.94 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.294 0 O-C-N 121.422 -1.046 . . . . 1.3899999999999999 109.119 -178.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 920' ' ' ALA . . . . . . . . . . . . . . . -93.41 93.69 8.29 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.429 -0.908 . . . . 0.029999999999999999 110.831 -179.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 921' ' ' ARG . . . . . 0.421 ' HB3' ' CZ ' ' C' ' 950' ' ' PHE . 41.8 ptt85 -82.03 -42.29 19.49 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 105.795 -1.928 . . . . 4.4199999999999999 105.795 176.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 922' ' ' VAL . . . . . . . . . . . . . 69.8 t -99.7 77.82 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 105.602 -1.999 . . . . 0.84999999999999998 105.602 175.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -90.73 135.53 33.65 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.814 0.816 . . . . 2.46 112.149 -176.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 14.9 t -147.4 103.93 3.6 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.017 -1.105 . . . . 0.69999999999999996 108.017 178.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -109.94 89.62 0.56 Allowed Glycine 0 N--CA 1.488 2.127 0 N-CA-C 108.882 -1.687 . . . . 0.040000000000000001 108.882 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.318 0 N-CA-C 109.347 -1.501 . . . . 0.040000000000000001 109.347 -179.623 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 55.4 m . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 120.949 0.404 . . . . 13.779999999999999 110.351 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 94.8 mt -114.91 129.25 56.67 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.501 -0.75 . . . . 13.76 110.317 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -152.16 170.67 31.48 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.277 -1.529 . . . . 9.1300000000000008 109.277 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 949' ' ' VAL . . . . . . . . . . . . . 33.4 m -117.22 137.45 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.524 -0.986 . . . . 7.0800000000000001 110.911 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 950' ' ' PHE . . . . . 0.421 ' CZ ' ' HB3' ' C' ' 921' ' ' ARG . 51.7 p90 -133.76 148.39 51.39 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.539 -0.725 . . . . 7.5899999999999999 109.513 179.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 70.4 m -118.54 -55.96 2.17 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.434 -0.791 . . . . 5.0300000000000002 112.137 -178.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 952' ' ' LEU . . . . . 0.47 ' O ' ' O ' ' C' ' 953' ' ' ILE . 49.3 tp -64.22 -76.64 0.07 Allowed 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.293 -0.879 . . . . 1.01 111.713 -178.049 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 953' ' ' ILE . . . . . 0.497 ' O ' ' HB3' ' C' ' 954' ' ' LEU . 2.1 pp -49.05 -151.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.787 0 N-CA-C 114.389 1.255 . . . . 2.6000000000000001 114.389 -176.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 954' ' ' LEU . . . . . 0.551 ' N ' ' CD1' ' C' ' 954' ' ' LEU . 0.0 OUTLIER 169.45 91.24 0.04 OUTLIER Pre-proline 0 N--CA 1.517 2.919 0 O-C-N 120.842 -1.162 . . . . 0.050000000000000003 112.023 179.798 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 955' ' ' PRO . . . . . 0.406 ' HD3' ' CD1' ' C' ' 953' ' ' ILE . 52.7 Cg_endo -79.47 95.48 1.05 Allowed 'Trans proline' 0 C--N 1.316 -1.158 0 N-CA-C 108.665 -1.321 . . . . 0.83999999999999997 108.665 178.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 956' ' ' LEU . . . . . 0.405 ' CD2' ' NH1' ' C' ' 914' ' ' ARG . 6.7 mp -125.7 139.5 53.49 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.939 -1.101 . . . . 0.040000000000000001 110.841 -179.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -81.98 153.38 26.26 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 117.883 -1.056 . . . . 1.28 111.121 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -67.17 118.92 11.25 Favored 'General case' 0 N--CA 1.506 2.366 0 CA-C-N 122.629 2.468 . . . . 0.17000000000000001 111.322 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 95.15 -17.89 58.43 Favored Glycine 0 N--CA 1.501 3.013 0 O-C-N 121.526 -0.734 . . . . 0.040000000000000001 111.506 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 960' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.97 169.89 0.09 Allowed 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.204 -1.174 . . . . 0.040000000000000001 110.784 -179.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 961' ' ' THR . . . . . 0.436 ' HA ' ' O ' ' C' ' 886' ' ' PHE . 57.2 m -135.77 135.92 40.31 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.034 -1.041 . . . . 1.78 111.823 -178.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 962' ' ' VAL . . . . . 0.43 ' CG2' ' CB ' ' C' ' 886' ' ' PHE . 22.3 m -100.19 145.43 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.533 -0.73 . . . . 0.040000000000000001 110.498 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 5.6 t -137.99 148.07 44.83 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.89 -0.506 . . . . 0.71999999999999997 110.056 -178.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 964' ' ' VAL . . . . . 0.454 ' HA ' ' HA ' ' C' ' 911' ' ' VAL . 61.8 t -99.38 136.22 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.074 -1.016 . . . . 1.05 110.403 -179.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -94.73 126.94 40.37 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 103.85 -2.648 . . . . 3.02 103.85 173.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 966' ' ' LEU . . . . . 0.4 ' O ' ' CG2' ' C' ' 967' ' ' VAL . 0.2 OUTLIER -130.57 62.31 1.59 Allowed 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.814 -1.18 . . . . 1.46 107.814 177.431 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 967' ' ' VAL . . . . . 0.4 ' CG2' ' O ' ' C' ' 966' ' ' LEU . 96.3 t -158.18 97.26 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 108.125 -1.065 . . . . 1.9399999999999999 108.125 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 85.9 mmm -142.95 58.62 1.42 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.765 -1.209 . . . . 0.0 108.342 178.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 134.78 119.63 1.96 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 107.075 -2.41 . . . . 2.1099999999999999 107.075 -178.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -82.26 -58.07 3.1 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.033 -1.275 . . . . 5.8899999999999997 110.367 -179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 41.7 tp -58.61 90.45 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.445 -0.784 . . . . 4.3600000000000003 110.231 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -142.29 -154.12 0.5 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.543 -0.723 . . . . 1.8300000000000001 110.216 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -118.75 171.1 8.44 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.478 -0.764 . . . . 4.3499999999999996 110.17 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 32.1 t -101.39 129.9 47.49 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.501 -0.749 . . . . 1.27 110.071 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -156.33 154.29 30.36 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.556 -0.715 . . . . 5.0199999999999996 110.506 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.44 86.97 15.89 Favored Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 121.62 -0.675 . . . . 2.4100000000000001 109.74 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -74.3 -170.06 0.67 Allowed 'Trans proline' 0 C--N 1.318 -1.049 0 O-C-N 123.315 1.166 . . . . 0.95999999999999996 111.285 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 978' ' ' LEU . . . . . . . . . . . . . 4.9 mp -125.86 155.39 41.28 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 107.547 -1.279 . . . . 0.62 107.547 177.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 979' ' ' THR . . . . . . . . . . . . . 39.1 p -150.39 141.64 23.21 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.779 -1.201 . . . . 3.5699999999999998 111.21 -179.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 980' ' ' ILE . . . . . 0.446 HG22 HD11 ' C' ' 980' ' ' ILE . 50.8 mm -106.29 129.16 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 109.08 -0.711 . . . . 1.3300000000000001 109.08 179.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 981' ' ' PHE . . . . . 0.432 ' CD1' ' CE2' ' C' ' 879' ' ' TYR . 2.4 t80 -118.36 97.77 5.94 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.46 -0.775 . . . . 0.050000000000000003 111.638 -178.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 982' ' ' SER . . . . . . . . . . . . . 58.6 p -108.13 157.97 17.83 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 109.002 -0.74 . . . . 0.87 109.002 178.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 983' ' ' GLY . . . . . 0.411 ' O ' ' CE2' ' C' ' 852' ' ' PHE . . . -171.32 112.15 0.44 Allowed Glycine 0 N--CA 1.498 2.803 0 N-CA-C 106.701 -2.56 . . . . 0.029999999999999999 106.701 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 984' ' ' ALA . . . . . . . . . . . . . . . -110.25 149.51 30.05 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 114.315 1.228 . . . . 0.69999999999999996 114.315 -175.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 985' ' ' LEU . . . . . . . . . . . . . 63.9 tp -74.54 135.59 42.14 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.859 -1.151 . . . . 0.040000000000000001 109.805 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 986' ' ' LEU . . . . . . . . . . . . . 45.8 tp -105.9 -62.96 1.3 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.505 -0.747 . . . . 0.040000000000000001 110.327 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 53.6 t80 -144.73 147.05 32.51 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 107.828 -1.175 . . . . 0.040000000000000001 107.828 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.11 162.98 12.24 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 108.085 -2.006 . . . . 0.040000000000000001 108.085 179.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -75.65 112.35 19.07 Favored Pre-proline 0 N--CA 1.5 2.035 0 CA-C-N 118.608 1.204 . . . . 0.040000000000000001 109.462 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 990' ' ' PRO . . . . . 0.417 ' O ' ' HB2' ' C' ' 991' ' ' GLU . 50.6 Cg_endo -91.33 71.44 0.97 Allowed 'Trans proline' 0 C--N 1.319 -0.978 0 O-C-N 123.074 1.039 . . . . 0.45000000000000001 111.464 -178.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 991' ' ' GLU . . . . . 0.417 ' HB2' ' O ' ' C' ' 990' ' ' PRO . 71.2 mt-10 67.11 -73.9 0.07 Allowed 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 108.559 -0.904 . . . . 1.97 108.559 -177.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 992' ' ' LEU . . . . . . . . . . . . . 11.1 mt 51.66 20.46 1.1 Allowed 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.593 -0.692 . . . . 2.3799999999999999 111.596 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -90.65 156.91 17.77 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.964 -1.085 . . . . 3.79 109.952 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 69.1 m80 -147.53 90.21 1.84 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.572 -0.705 . . . . 3.5099999999999998 110.383 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 995' ' ' ALA . . . . . . . . . . . . 2.518 . . . . . . . 0 N--CA 1.503 2.216 0 O-C-N 120.881 -1.137 . . . . 2.73 110.601 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo . . . . . 0 N--CA 1.488 1.156 0 N-CA-C 109.492 -1.003 . . . . 3.8300000000000001 109.492 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 847' ' ' VAL . . . . . . . . . . . . . 60.0 t -128.04 105.5 20.2 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 121.638 -0.664 . . . . 1.8300000000000001 109.986 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 848' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.37 -21.41 35.35 Favored 'Trans proline' 0 N--CA 1.486 1.076 0 O-C-N 123.196 1.103 . . . . 0.65000000000000002 110.985 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 849' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 26.47 67.43 0.06 Allowed 'General case' 0 N--CA 1.518 2.93 0 N-CA-C 113.111 0.782 . . . . 2.5800000000000001 113.111 179.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 850' ' ' VAL . . . . . . . . . . . . . 97.4 t -119.43 134.79 61.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.12 -0.987 . . . . 1.0900000000000001 111.042 -179.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 851' ' ' ALA . . . . . . . . . . . . . . . -132.05 153.65 50.2 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 105.922 -1.881 . . . . 0.040000000000000001 105.922 177.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 852' ' ' PHE . . . . . 0.538 ' HA ' ' HB3' ' A' ' 874' ' ' ASN . 28.4 p90 -155.89 136.75 13.52 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-N 121.109 1.777 . . . . 0.050000000000000003 109.303 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 16.1 t -172.63 133.11 0.59 Allowed 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.168 -1.049 . . . . 0.040000000000000001 108.168 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -135.97 154.22 51.16 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.111 -0.993 . . . . 0.67000000000000004 109.325 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 855' ' ' ALA . . . . . . . . . . . . . . . -123.04 141.3 52.11 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.876 0.846 . . . . 0.51000000000000001 111.976 -178.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 856' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -110.09 138.27 46.7 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.656 -0.652 . . . . 0.050000000000000003 109.427 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 857' ' ' SER . . . . . 0.425 ' O ' ' O ' ' A' ' 858' ' ' LEU . 78.8 p -156.1 19.99 0.37 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.477 -0.765 . . . . 1.3300000000000001 111.325 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 858' ' ' LEU . . . . . 0.425 ' O ' ' O ' ' A' ' 857' ' ' SER . 4.2 pp -34.3 158.95 0.04 OUTLIER Pre-proline 0 N--CA 1.519 3.017 0 N-CA-C 112.816 0.672 . . . . 2.3300000000000001 112.816 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -60.95 -89.62 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 120.968 1.112 . . . . 2.3199999999999998 113.922 -177.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 54.9 ptt85 -127.98 -142.26 0.27 Allowed 'General case' 0 N--CA 1.502 2.127 0 O-C-N 120.809 -1.182 . . . . 0.040000000000000001 111.609 -177.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 27.9 m -36.14 121.15 0.67 Allowed 'General case' 0 N--CA 1.511 2.602 0 O-C-N 121.644 -0.66 . . . . 1.3100000000000001 112.291 -178.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.01 158.91 30.82 Favored Pre-proline 0 N--CA 1.488 1.466 0 N-CA-C 108.313 -0.995 . . . . 4.5099999999999998 108.313 177.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -70.23 -15.19 35.26 Favored 'Trans proline' 0 C--N 1.313 -1.337 0 O-C-N 123.206 1.108 . . . . 2.2400000000000002 111.231 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -176.91 -135.56 2.21 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.786 -1.326 . . . . 0.040000000000000001 109.786 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 23.3 m -69.47 155.88 39.75 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.344 -1.092 . . . . 1.51 111.01 -178.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 866' ' ' VAL . . . . . 0.4 ' CG1' ' CD2' ' A' ' 858' ' ' LEU . 33.7 m -91.35 136.73 26.63 Favored Pre-proline 0 N--CA 1.498 1.954 0 N-CA-C 113.549 0.944 . . . . 0.78000000000000003 113.549 -175.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 867' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -88.62 -150.39 0.04 OUTLIER 'Trans proline' 0 CA--C 1.539 0.767 0 N-CA-C 108.183 -1.507 . . . . 0.92000000000000004 108.183 177.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 868' ' ' PHE . . . . . 0.459 ' CD1' ' HG2' ' A' ' 881' ' ' PRO . 9.9 p90 -148.24 121.2 8.79 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.413 -1.43 . . . . 0.050000000000000003 110.312 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 50.1 p-10 -111.79 -3.52 14.92 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 119.374 -0.93 . . . . 1.7 111.919 -179.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 870' ' ' ARG . . . . . . . . . . . . . 26.1 mmm180 -90.4 88.43 7.18 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.999 -1.063 . . . . 2.5899999999999999 111.109 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 60.1 t -76.42 96.41 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 120.932 -1.105 . . . . 1.9399999999999999 109.173 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 872' ' ' LEU . . . . . . . . . . . . . 87.7 mt -86.97 -44.16 11.83 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.605 -0.684 . . . . 1.0600000000000001 110.921 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 873' ' ' LEU . . . . . . . . . . . . . 48.2 tp -172.3 107.69 0.2 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.159 -0.963 . . . . 4.1799999999999997 108.624 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 874' ' ' ASN . . . . . 0.538 ' HB3' ' HA ' ' A' ' 852' ' ' PHE . 12.0 p-10 174.36 81.36 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.483 0 O-C-N 121.592 -0.692 . . . . 0.040000000000000001 109.378 -178.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -69.69 -49.18 55.91 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.725 -1.234 . . . . 3.3799999999999999 111.37 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 876' ' ' GLY . . . . . 0.415 ' HA3' ' CE2' ' A' ' 878' ' ' TYR . . . -72.8 -26.8 70.4 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 110.642 -0.983 . . . . 0.040000000000000001 110.642 -179.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 78.96 -63.6 3.81 Favored Glycine 0 N--CA 1.497 2.741 0 N-CA-C 108.196 -1.961 . . . . 0.040000000000000001 108.196 -178.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 878' ' ' TYR . . . . . 0.415 ' CE2' ' HA3' ' A' ' 876' ' ' GLY . 92.6 m-85 61.7 -60.11 0.1 Allowed 'General case' 0 N--CA 1.504 2.265 0 N-CA-C 113.532 0.938 . . . . 3.46 113.532 178.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 879' ' ' TYR . . . . . 0.504 ' O ' ' CG ' ' A' ' 879' ' ' TYR . 9.8 p90 -111.24 104.69 13.21 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.919 -1.113 . . . . 0.040000000000000001 113.58 -177.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 880' ' ' ASP . . . . . 0.418 ' O ' ' N ' ' A' ' 884' ' ' GLY . 0.8 OUTLIER -69.77 112.86 13.63 Favored Pre-proline 0 N--CA 1.497 1.895 0 O-C-N 121.19 -0.944 . . . . 0.02 110.662 -178.807 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 881' ' ' PRO . . . . . 0.459 ' HG2' ' CD1' ' A' ' 868' ' ' PHE . 51.9 Cg_endo -78.33 -3.27 13.24 Favored 'Trans proline' 0 N--CA 1.489 1.221 0 O-C-N 123.489 1.257 . . . . 0.39000000000000001 111.102 179.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -77.62 -34.51 53.31 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 107.897 -1.149 . . . . 0.81000000000000005 107.897 178.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 71.0 p -112.07 -19.08 12.44 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.423 -0.808 . . . . 0.040000000000000001 109.072 176.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 884' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 880' ' ' ASP . . . 79.6 4.12 89.16 Favored Glycine 0 N--CA 1.495 2.603 0 N-CA-C 110.161 -1.176 . . . . 0.029999999999999999 110.161 -178.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 885' ' ' VAL . . . . . . . . . . . . . 66.5 t -73.3 95.08 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 C-N-CA 118.737 -1.185 . . . . 1.01 108.408 -178.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 886' ' ' PHE . . . . . 0.468 ' CD2' ' HB2' ' A' ' 879' ' ' TYR . 2.2 t80 -88.86 105.54 17.81 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 115.307 -0.86 . . . . 0.050000000000000003 111.746 -177.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 887' ' ' THR . . . . . 0.4 ' O ' ' HD3' ' A' ' 889' ' ' PRO . 35.3 m -98.03 100.31 11.64 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 107.588 -1.264 . . . . 0.68000000000000005 107.588 177.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 888' ' ' ALA . . . . . . . . . . . . . . . -99.28 106.63 40.14 Favored Pre-proline 0 N--CA 1.501 2.085 0 N-CA-C 114.049 1.129 . . . . 0.25 114.049 -176.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 889' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' A' ' 887' ' ' THR . 55.2 Cg_endo -90.18 -12.61 2.69 Favored 'Trans proline' 0 CA--C 1.546 1.093 0 C-N-CA 121.086 1.191 . . . . 1.6399999999999999 109.157 176.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 890' ' ' LEU . . . . . . . . . . . . . 72.4 mt -36.38 -50.13 0.75 Allowed 'General case' 0 N--CA 1.508 2.44 0 N-CA-C 113.855 1.057 . . . . 2.29 113.855 -177.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 51.8 96.17 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.117 -0.989 . . . . 0.63 110.321 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 156.21 -148.86 19.45 Favored Glycine 0 N--CA 1.48 1.624 0 N-CA-C 107.296 -2.322 . . . . 0.040000000000000001 107.296 -179.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 71.6 ttt-85 -111.44 127.6 55.73 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 107.753 -1.202 . . . . 3.0 107.753 177.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 894' ' ' TYR . . . . . 0.429 ' CD1' ' N ' ' A' ' 895' ' ' LEU . 0.0 OUTLIER -130.2 153.88 48.12 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.0 -1.063 . . . . 0.040000000000000001 110.876 -178.681 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 895' ' ' LEU . . . . . 0.429 ' N ' ' CD1' ' A' ' 894' ' ' TYR . 39.7 tp -96.58 114.11 25.74 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.405 -0.809 . . . . 1.27 109.961 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 896' ' ' LEU . . . . . 0.428 ' HB2' ' CZ ' ' A' ' 894' ' ' TYR . 10.3 tt -109.35 142.47 40.23 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.684 -0.635 . . . . 0.93999999999999995 111.18 -179.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 897' ' ' SER . . . . . . . . . . . . . 49.8 m -147.91 115.43 6.31 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.578 -0.701 . . . . 0.040000000000000001 110.838 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.7 147.22 31.04 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.633 -0.667 . . . . 0.47999999999999998 109.254 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 899' ' ' VAL . . . . . . . . . . . . . 99.1 t -92.69 120.1 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 C-N-CA 119.68 -0.808 . . . . 0.55000000000000004 111.237 -179.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 900' ' ' LEU . . . . . 0.406 ' N ' ' CD2' ' A' ' 900' ' ' LEU . 4.6 mm? -91.33 112.18 23.98 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 114.349 1.241 . . . . 1.5900000000000001 114.349 -175.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 23.3 m -67.52 141.72 56.79 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 107.077 -1.453 . . . . 0.050000000000000003 107.077 176.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -67.71 -66.45 2.33 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.506 -1.037 . . . . 0.029999999999999999 110.506 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 5.0 m170 46.08 65.88 1.07 Allowed 'General case' 0 N--CA 1.508 2.467 0 O-C-N 121.448 -1.03 . . . . 3.2000000000000002 111.253 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 43.2 ptt85 -69.23 -5.85 25.39 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.621 -0.675 . . . . 2.9199999999999999 112.152 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 905' ' ' HIS . . . . . 0.491 ' O ' ' CB ' ' A' ' 906' ' ' GLU . 76.2 t60 -61.86 4.37 0.12 Allowed 'General case' 0 N--CA 1.507 2.386 0 O-C-N 120.857 -1.152 . . . . 2.8700000000000001 113.141 -179.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 906' ' ' GLU . . . . . 0.491 ' CB ' ' O ' ' A' ' 905' ' ' HIS . 0.9 OUTLIER 94.7 -164.54 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.425 0 CA-C-N 120.593 1.542 . . . . 0.98999999999999999 112.076 178.984 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 907' ' ' LYS . . . . . 0.474 ' CB ' ' O ' ' A' ' 906' ' ' GLU . 29.5 ttmt 88.87 160.84 0.06 Allowed 'General case' 0 N--CA 1.522 3.137 0 N-CA-C 108.353 -0.98 . . . . 5.25 108.353 -177.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 61.4 t -122.4 116.74 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 120.818 -1.177 . . . . 0.39000000000000001 110.862 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 39.9 tp10 -105.12 131.78 52.18 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 107.629 -1.248 . . . . 1.72 107.629 177.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -156.54 120.78 4.43 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 106.819 -1.548 . . . . 0.67000000000000004 106.819 178.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 911' ' ' VAL . . . . . 0.437 ' HA ' ' HA ' ' A' ' 964' ' ' VAL . 14.4 p -77.3 132.96 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.713 -0.617 . . . . 0.54000000000000004 111.417 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 86.4 mt -65.47 156.26 32.98 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 108.193 -1.039 . . . . 1.5 108.193 178.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 913' ' ' SER . . . . . 0.43 ' CB ' ' HB ' ' A' ' 919' ' ' VAL . 1.4 t -125.66 136.27 53.05 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.462 -0.94 . . . . 1.3700000000000001 108.462 177.038 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 914' ' ' ARG . . . . . 0.427 ' O ' ' CB ' ' A' ' 915' ' ' SER . 0.0 OUTLIER -62.37 152.58 33.64 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.011 -1.056 . . . . 4.2999999999999998 111.827 -178.97 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 915' ' ' SER . . . . . 0.427 ' CB ' ' O ' ' A' ' 914' ' ' ARG . 3.5 t 83.41 -30.38 0.09 Allowed 'General case' 0 N--CA 1.52 3.056 0 C-N-CA 124.004 0.922 . . . . 2.0499999999999998 112.315 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 916' ' ' ASN . . . . . 0.422 ' O ' ' HB2' ' A' ' 917' ' ' GLN . 72.9 m-20 -126.46 -21.87 4.09 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 120.849 -1.157 . . . . 2.71 111.471 -179.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 917' ' ' GLN . . . . . 0.422 ' HB2' ' O ' ' A' ' 916' ' ' ASN . 58.6 mt-30 66.97 168.93 0.24 Allowed 'General case' 0 N--CA 1.518 2.955 0 N-CA-C 105.903 -1.888 . . . . 2.6800000000000002 105.903 -173.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 55.25 -128.87 45.1 Favored Glycine 1 N--CA 1.52 4.28 0 CA-C-N 123.64 2.927 . . . . 0.029999999999999999 106.388 -177.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 919' ' ' VAL . . . . . 0.43 ' HB ' ' CB ' ' A' ' 913' ' ' SER . 85.7 t 50.25 94.59 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.299 0 CA-C-N 118.573 1.187 . . . . 1.3899999999999999 109.249 -178.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 920' ' ' ALA . . . . . . . . . . . . . . . -92.64 94.08 8.84 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.266 -0.974 . . . . 0.029999999999999999 111.154 -179.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 921' ' ' ARG . . . . . 0.439 ' HB3' ' CZ ' ' A' ' 950' ' ' PHE . 35.1 ptt85 -80.3 -43.14 21.77 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 105.602 -1.999 . . . . 4.4199999999999999 105.602 176.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 922' ' ' VAL . . . . . . . . . . . . . 94.9 t -101.75 77.07 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 N-CA-C 105.041 -2.207 . . . . 0.84999999999999998 105.041 174.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -87.14 135.61 33.23 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 122.068 0.937 . . . . 2.46 112.39 -176.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 10.4 t -145.54 103.15 3.78 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.471 -1.307 . . . . 0.69999999999999996 107.471 178.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -103.39 81.75 0.37 Allowed Glycine 0 N--CA 1.486 2.023 0 N-CA-C 109.04 -1.624 . . . . 0.040000000000000001 109.04 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.967 0 N-CA-C 108.743 -1.743 . . . . 0.040000000000000001 108.743 179.877 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 21.7 m . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 120.963 0.411 . . . . 13.779999999999999 110.299 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 95.9 mt -109.88 129.28 55.67 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.506 -0.746 . . . . 13.76 110.325 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -152.08 169.83 31.4 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.347 -1.501 . . . . 9.1300000000000008 109.347 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 949' ' ' VAL . . . . . . . . . . . . . 34.3 m -118.4 132.4 68.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.465 -1.021 . . . . 7.0800000000000001 111.05 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 950' ' ' PHE . . . . . 0.439 ' CZ ' ' HB3' ' A' ' 921' ' ' ARG . 40.0 p90 -134.82 153.24 52.12 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.549 -0.719 . . . . 7.5899999999999999 109.124 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 69.3 m -121.59 -53.16 2.0 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.245 -0.91 . . . . 5.0300000000000002 112.356 -178.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 952' ' ' LEU . . . . . 0.425 ' O ' ' O ' ' A' ' 953' ' ' ILE . 56.6 tp -61.72 -76.33 0.06 Allowed 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.356 -0.84 . . . . 1.01 112.328 -177.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 953' ' ' ILE . . . . . 0.469 ' O ' ' HB3' ' A' ' 954' ' ' LEU . 44.6 pt -52.32 -145.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.753 0 N-CA-C 114.016 1.117 . . . . 2.6000000000000001 114.016 -176.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 954' ' ' LEU . . . . . 0.562 ' N ' ' CD1' ' A' ' 954' ' ' LEU . 0.0 OUTLIER 170.73 83.74 0.04 OUTLIER Pre-proline 0 N--CA 1.509 2.514 0 O-C-N 120.812 -1.18 . . . . 0.050000000000000003 111.66 179.441 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 955' ' ' PRO . . . . . 0.425 ' HD2' ' CE1' ' A' ' 950' ' ' PHE . 48.6 Cg_endo -76.24 95.45 1.04 Allowed 'Trans proline' 0 C--N 1.314 -1.271 0 N-CA-C 108.689 -1.312 . . . . 0.83999999999999997 108.689 177.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 956' ' ' LEU . . . . . 0.411 ' CD2' ' NH1' ' A' ' 914' ' ' ARG . 10.3 mp -122.47 143.73 49.51 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.133 -0.979 . . . . 0.040000000000000001 110.19 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -85.65 151.76 23.64 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 117.82 -1.086 . . . . 1.28 111.613 -179.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -68.95 119.75 13.75 Favored 'General case' 0 N--CA 1.509 2.48 0 CA-C-N 122.86 2.573 . . . . 0.17000000000000001 111.799 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 93.23 -21.75 38.57 Favored Glycine 0 N--CA 1.501 3.006 0 N-CA-C 111.127 -0.789 . . . . 0.040000000000000001 111.127 178.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 960' ' ' ASP . . . . . 0.403 ' HB3' ' NE ' ' A' ' 914' ' ' ARG . 0.5 OUTLIER -55.17 169.47 0.25 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.473 -1.016 . . . . 0.040000000000000001 110.201 -179.411 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 961' ' ' THR . . . . . 0.457 ' HA ' ' O ' ' A' ' 886' ' ' PHE . 44.0 m -136.52 139.55 42.34 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.903 -1.123 . . . . 1.78 112.432 -177.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 962' ' ' VAL . . . . . 0.403 ' CG2' ' CB ' ' A' ' 886' ' ' PHE . 31.9 m -100.08 144.82 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.649 -0.657 . . . . 0.040000000000000001 111.131 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 5.4 t -137.58 145.04 42.36 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.917 -0.49 . . . . 0.71999999999999997 109.991 -179.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 964' ' ' VAL . . . . . 0.437 ' HA ' ' HA ' ' A' ' 911' ' ' VAL . 61.9 t -92.17 136.3 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.028 -1.045 . . . . 1.05 111.297 -178.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -95.51 126.35 40.74 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 103.5 -2.778 . . . . 3.02 103.5 172.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 966' ' ' LEU . . . . . 0.406 ' O ' ' CG2' ' A' ' 967' ' ' VAL . 0.2 OUTLIER -133.42 61.3 1.68 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.453 -0.943 . . . . 1.46 108.453 177.362 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 967' ' ' VAL . . . . . 0.406 ' CG2' ' O ' ' A' ' 966' ' ' LEU . 97.8 t -157.65 96.26 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 108.366 -0.975 . . . . 1.9399999999999999 108.366 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 92.9 mmm -142.96 58.65 1.42 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.734 -1.229 . . . . 0.0 108.277 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 133.72 119.48 2.0 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 107.139 -2.385 . . . . 2.1099999999999999 107.139 -178.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -82.19 -57.03 3.57 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.028 -1.277 . . . . 5.8899999999999997 110.597 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 48.4 tp -58.76 89.7 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.429 -0.794 . . . . 4.3600000000000003 110.342 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -142.67 -152.57 0.42 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.561 -0.712 . . . . 1.8300000000000001 110.049 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -118.07 167.57 11.35 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.393 -0.817 . . . . 4.3499999999999996 110.211 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 30.3 t -101.98 130.29 48.47 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.578 -0.701 . . . . 1.27 110.067 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -156.05 159.01 38.76 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.485 -0.759 . . . . 5.0199999999999996 110.65 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.78 85.12 20.63 Favored Pre-proline 0 N--CA 1.5 2.042 0 O-C-N 121.701 -0.624 . . . . 2.4100000000000001 109.712 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -73.58 -172.11 0.99 Allowed 'Trans proline' 0 C--N 1.317 -1.1 0 O-C-N 123.253 1.133 . . . . 0.95999999999999996 111.3 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 5.2 mp -126.43 156.09 41.17 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 107.557 -1.275 . . . . 0.62 107.557 177.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 979' ' ' THR . . . . . . . . . . . . . 46.5 p -149.57 141.37 23.67 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.763 -1.211 . . . . 3.5699999999999998 111.155 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 980' ' ' ILE . . . . . 0.414 HG22 HD11 ' A' ' 980' ' ' ILE . 50.7 mm -107.31 128.92 61.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 N-CA-C 109.088 -0.708 . . . . 1.3300000000000001 109.088 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 981' ' ' PHE . . . . . 0.502 ' CD1' ' CE2' ' A' ' 879' ' ' TYR . 10.6 t80 -119.93 97.46 5.62 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 119.572 -0.851 . . . . 0.050000000000000003 111.899 -178.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 15.5 p -108.64 158.59 17.45 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.592 -0.693 . . . . 0.87 109.199 178.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 983' ' ' GLY . . . . . 0.429 ' HA3' ' CE1' ' A' ' 852' ' ' PHE . . . -174.29 110.78 0.34 Allowed Glycine 0 N--CA 1.498 2.783 0 N-CA-C 106.81 -2.516 . . . . 0.029999999999999999 106.81 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -107.85 149.41 28.29 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 114.245 1.202 . . . . 0.69999999999999996 114.245 -175.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 66.8 tp -72.04 136.51 46.69 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.75 -1.219 . . . . 0.040000000000000001 110.088 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 49.3 tp -106.66 -58.03 1.98 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.689 -0.632 . . . . 0.040000000000000001 110.02 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -143.9 145.87 32.6 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 107.739 -1.208 . . . . 0.040000000000000001 107.739 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.33 162.54 12.37 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 108.078 -2.009 . . . . 0.040000000000000001 108.078 179.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -76.9 111.79 18.54 Favored Pre-proline 0 N--CA 1.498 1.951 0 CA-C-N 118.536 1.168 . . . . 0.040000000000000001 109.536 179.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 990' ' ' PRO . . . . . 0.409 ' O ' ' HB2' ' A' ' 991' ' ' GLU . 49.2 Cg_endo -92.34 71.79 0.64 Allowed 'Trans proline' 0 C--N 1.318 -1.038 0 O-C-N 123.057 1.03 . . . . 0.45000000000000001 111.338 -179.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 991' ' ' GLU . . . . . 0.409 ' HB2' ' O ' ' A' ' 990' ' ' PRO . 72.3 mt-10 67.82 -73.33 0.08 Allowed 'General case' 0 N--CA 1.503 2.182 0 N-CA-C 108.345 -0.983 . . . . 1.97 108.345 -177.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 992' ' ' LEU . . . . . . . . . . . . . 4.1 mt 50.51 20.38 0.69 Allowed 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.577 -0.702 . . . . 2.3799999999999999 111.754 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -95.69 156.87 16.15 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.914 -1.116 . . . . 3.79 110.089 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 67.9 m80 -144.19 94.4 2.57 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.526 -0.734 . . . . 3.5099999999999998 110.269 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 995' ' ' ALA . . . . . . . . . . . . 2.517 . . . . . . . 0 N--CA 1.503 2.201 0 O-C-N 120.928 -1.108 . . . . 2.73 110.588 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo . . . . . 0 N--CA 1.488 1.172 0 N-CA-C 109.471 -1.011 . . . . 3.8300000000000001 109.471 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 847' ' ' VAL . . . . . . . . . . . . . 61.1 t -128.26 105.57 19.73 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.629 -0.669 . . . . 1.8300000000000001 109.93 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 848' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.29 -21.41 35.7 Favored 'Trans proline' 0 N--CA 1.486 1.087 0 O-C-N 123.253 1.133 . . . . 0.65000000000000002 111.042 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 849' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 26.48 66.9 0.06 Allowed 'General case' 0 N--CA 1.518 2.939 0 N-CA-C 113.151 0.797 . . . . 2.5800000000000001 113.151 179.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 850' ' ' VAL . . . . . . . . . . . . . 97.1 t -118.98 134.93 61.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.193 -0.942 . . . . 1.0900000000000001 111.06 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 851' ' ' ALA . . . . . . . . . . . . . . . -131.93 154.02 49.69 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 105.911 -1.885 . . . . 0.040000000000000001 105.911 177.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 852' ' ' PHE . . . . . 0.519 ' HA ' ' HB3' ' B' ' 874' ' ' ASN . 28.3 p90 -156.26 136.8 13.19 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-N 121.02 1.736 . . . . 0.050000000000000003 109.431 179.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 18.6 t -172.71 133.37 0.58 Allowed 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.046 -1.094 . . . . 0.040000000000000001 108.046 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -136.14 154.34 51.01 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.118 -0.989 . . . . 0.67000000000000004 109.339 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 855' ' ' ALA . . . . . . . . . . . . . . . -123.18 140.96 52.48 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.853 0.835 . . . . 0.51000000000000001 111.996 -178.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 856' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -109.79 138.74 45.73 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.729 -0.607 . . . . 0.050000000000000003 109.366 179.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 857' ' ' SER . . . . . 0.427 ' O ' ' O ' ' B' ' 858' ' ' LEU . 78.7 p -156.58 19.58 0.34 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.457 -0.777 . . . . 1.3300000000000001 111.345 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 858' ' ' LEU . . . . . 0.427 ' O ' ' O ' ' B' ' 857' ' ' SER . 4.2 pp -33.95 158.83 0.04 OUTLIER Pre-proline 0 N--CA 1.519 2.984 0 N-CA-C 112.888 0.699 . . . . 2.3300000000000001 112.888 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -60.77 -89.66 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 120.948 1.099 . . . . 2.3199999999999998 113.971 -177.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 55.0 ptt85 -127.91 -142.25 0.27 Allowed 'General case' 0 N--CA 1.501 2.1 0 O-C-N 120.753 -1.217 . . . . 0.040000000000000001 111.676 -177.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 28.4 m -36.24 121.4 0.69 Allowed 'General case' 0 N--CA 1.512 2.629 0 O-C-N 121.682 -0.637 . . . . 1.3100000000000001 112.354 -178.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 862' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.25 159.09 30.38 Favored Pre-proline 0 N--CA 1.488 1.461 0 N-CA-C 108.414 -0.958 . . . . 4.5099999999999998 108.414 177.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -70.28 -15.15 35.08 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 O-C-N 123.255 1.134 . . . . 2.2400000000000002 111.163 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -176.86 -135.55 2.21 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.901 -1.279 . . . . 0.040000000000000001 109.901 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 23.6 m -69.65 156.0 39.63 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.43 -1.041 . . . . 1.51 110.964 -178.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 866' ' ' VAL . . . . . 0.402 ' CG1' ' CD2' ' B' ' 858' ' ' LEU . 33.7 m -91.4 136.75 26.54 Favored Pre-proline 0 N--CA 1.498 1.935 0 N-CA-C 113.59 0.959 . . . . 0.78000000000000003 113.59 -175.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 867' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -88.52 -150.07 0.04 OUTLIER 'Trans proline' 0 CA--C 1.539 0.759 0 N-CA-C 108.134 -1.525 . . . . 0.92000000000000004 108.134 177.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 868' ' ' PHE . . . . . 0.461 ' CD1' ' N ' ' B' ' 868' ' ' PHE . 9.8 p90 -148.5 121.26 8.67 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.388 -1.445 . . . . 0.050000000000000003 110.246 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 50.0 p-10 -111.82 -3.81 14.81 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 119.373 -0.931 . . . . 1.7 111.991 -179.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 870' ' ' ARG . . . . . . . . . . . . . 26.3 mmm180 -90.08 88.92 7.46 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.074 -1.016 . . . . 2.5899999999999999 111.028 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 61.6 t -76.87 96.09 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 120.918 -1.113 . . . . 1.9399999999999999 109.159 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 872' ' ' LEU . . . . . . . . . . . . . 86.3 mt -86.63 -44.31 11.96 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.658 -0.651 . . . . 1.0600000000000001 110.988 -179.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 873' ' ' LEU . . . . . . . . . . . . . 48.3 tp -172.16 107.44 0.21 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.219 -0.926 . . . . 4.1799999999999997 108.528 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 874' ' ' ASN . . . . . 0.519 ' HB3' ' HA ' ' B' ' 852' ' ' PHE . 12.1 p-10 174.6 81.2 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.473 0 O-C-N 121.551 -0.718 . . . . 0.040000000000000001 109.429 -178.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -69.5 -49.2 56.9 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.826 -1.171 . . . . 3.3799999999999999 111.352 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 876' ' ' GLY . . . . . 0.413 ' HA3' ' CE2' ' B' ' 878' ' ' TYR . . . -73.03 -26.38 71.13 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 110.642 -0.983 . . . . 0.040000000000000001 110.642 -179.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 78.65 -63.58 3.72 Favored Glycine 0 N--CA 1.498 2.77 0 N-CA-C 108.258 -1.937 . . . . 0.040000000000000001 108.258 -178.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 878' ' ' TYR . . . . . 0.413 ' CE2' ' HA3' ' B' ' 876' ' ' GLY . 92.3 m-85 61.74 -60.12 0.11 Allowed 'General case' 0 N--CA 1.504 2.256 0 N-CA-C 113.545 0.942 . . . . 3.46 113.545 178.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 879' ' ' TYR . . . . . 0.516 ' CG ' ' O ' ' B' ' 879' ' ' TYR . 10.0 p90 -111.31 104.06 12.5 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.94 -1.1 . . . . 0.040000000000000001 113.601 -177.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 880' ' ' ASP . . . . . 0.421 ' O ' ' N ' ' B' ' 884' ' ' GLY . 0.8 OUTLIER -69.14 112.91 13.19 Favored Pre-proline 0 N--CA 1.497 1.914 0 O-C-N 121.165 -0.96 . . . . 0.02 110.645 -178.805 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 881' ' ' PRO . . . . . 0.461 ' HG2' ' CD1' ' B' ' 868' ' ' PHE . 51.6 Cg_endo -78.33 -3.32 13.28 Favored 'Trans proline' 0 N--CA 1.49 1.27 0 O-C-N 123.442 1.232 . . . . 0.39000000000000001 111.061 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -77.66 -34.68 52.95 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 107.935 -1.135 . . . . 0.81000000000000005 107.935 178.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 74.2 p -111.59 -19.72 12.41 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.3 -0.863 . . . . 0.040000000000000001 108.975 176.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 884' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' B' ' 880' ' ' ASP . . . 79.88 4.17 89.46 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 110.087 -1.205 . . . . 0.029999999999999999 110.087 -178.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 885' ' ' VAL . . . . . . . . . . . . . 69.0 t -73.3 95.2 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 C-N-CA 118.671 -1.212 . . . . 1.01 108.447 -178.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 886' ' ' PHE . . . . . 0.463 ' CD2' ' HB2' ' B' ' 879' ' ' TYR . 2.2 t80 -88.76 105.18 17.54 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 115.318 -0.856 . . . . 0.050000000000000003 111.86 -177.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 887' ' ' THR . . . . . 0.404 ' O ' ' HD3' ' B' ' 889' ' ' PRO . 35.3 m -97.72 100.05 11.42 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 107.655 -1.239 . . . . 0.68000000000000005 107.655 177.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 888' ' ' ALA . . . . . . . . . . . . . . . -99.14 106.64 39.73 Favored Pre-proline 0 N--CA 1.502 2.132 0 N-CA-C 114.1 1.148 . . . . 0.25 114.1 -176.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 889' ' ' PRO . . . . . 0.404 ' HD3' ' O ' ' B' ' 887' ' ' THR . 54.6 Cg_endo -90.25 -12.49 2.69 Favored 'Trans proline' 0 CA--C 1.546 1.121 0 C-N-CA 121.084 1.19 . . . . 1.6399999999999999 109.181 176.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 890' ' ' LEU . . . . . . . . . . . . . 71.9 mt -36.44 -49.99 0.75 Allowed 'General case' 0 N--CA 1.508 2.469 0 N-CA-C 113.851 1.056 . . . . 2.29 113.851 -177.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 51.75 96.27 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.41 0 O-C-N 121.159 -0.963 . . . . 0.63 110.346 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . 156.08 -148.77 19.27 Favored Glycine 0 N--CA 1.481 1.638 0 N-CA-C 107.26 -2.336 . . . . 0.040000000000000001 107.26 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 71.6 ttt-85 -111.49 127.73 55.79 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.762 -1.199 . . . . 3.0 107.762 177.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 894' ' ' TYR . . . . . 0.444 ' CZ ' ' HB2' ' B' ' 896' ' ' LEU . 0.0 OUTLIER -130.41 154.1 48.06 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.032 -1.043 . . . . 0.040000000000000001 110.903 -178.663 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 895' ' ' LEU . . . . . 0.44 ' N ' ' CD1' ' B' ' 894' ' ' TYR . 38.9 tp -96.82 114.08 25.68 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.464 -0.773 . . . . 1.27 110.033 -179.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 896' ' ' LEU . . . . . 0.444 ' HB2' ' CZ ' ' B' ' 894' ' ' TYR . 10.4 tt -109.19 143.91 37.99 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.634 -0.666 . . . . 0.93999999999999995 110.994 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 897' ' ' SER . . . . . . . . . . . . . 50.5 m -149.29 115.05 5.64 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.584 -0.697 . . . . 0.040000000000000001 110.748 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.39 147.55 30.22 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.173 -0.677 . . . . 0.47999999999999998 109.173 179.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 899' ' ' VAL . . . . . . . . . . . . . 97.5 t -93.0 120.53 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 C-N-CA 119.672 -0.811 . . . . 0.55000000000000004 111.123 -179.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 900' ' ' LEU . . . . . 0.402 ' N ' ' CD2' ' B' ' 900' ' ' LEU . 4.6 mm? -91.64 112.17 23.98 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 114.326 1.232 . . . . 1.5900000000000001 114.326 -175.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 23.0 m -67.43 141.64 56.94 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 107.109 -1.441 . . . . 0.050000000000000003 107.109 176.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -67.63 -66.53 2.3 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 110.469 -1.052 . . . . 0.029999999999999999 110.469 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 5.0 m170 46.22 66.09 1.03 Allowed 'General case' 0 N--CA 1.508 2.439 0 O-C-N 121.456 -1.026 . . . . 3.2000000000000002 111.215 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 43.3 ptt85 -69.5 -5.7 25.78 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.634 -0.666 . . . . 2.9199999999999999 112.052 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 905' ' ' HIS . . . . . 0.492 ' O ' ' CB ' ' B' ' 906' ' ' GLU . 76.4 t60 -62.17 4.71 0.12 Allowed 'General case' 0 N--CA 1.506 2.359 0 O-C-N 120.811 -1.18 . . . . 2.8700000000000001 113.065 -179.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 906' ' ' GLU . . . . . 0.492 ' CB ' ' O ' ' B' ' 905' ' ' HIS . 0.8 OUTLIER 94.51 -164.57 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.388 0 CA-C-N 120.589 1.541 . . . . 0.98999999999999999 112.094 178.82 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 907' ' ' LYS . . . . . 0.475 ' CB ' ' O ' ' B' ' 906' ' ' GLU . 29.4 ttmt 88.88 160.84 0.06 Allowed 'General case' 0 N--CA 1.521 3.123 0 N-CA-C 108.321 -0.992 . . . . 5.25 108.321 -177.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 61.1 t -122.29 116.7 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 120.848 -1.158 . . . . 0.39000000000000001 110.864 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 39.9 tp10 -104.78 131.97 51.6 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 107.565 -1.272 . . . . 1.72 107.565 177.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -156.67 120.73 4.36 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 106.778 -1.564 . . . . 0.67000000000000004 106.778 178.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 911' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' B' ' 964' ' ' VAL . 14.4 p -77.31 132.97 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.75 -0.594 . . . . 0.54000000000000004 111.406 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 86.7 mt -65.6 156.04 33.95 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.18 -1.044 . . . . 1.5 108.18 178.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 913' ' ' SER . . . . . 0.426 ' CB ' ' HB ' ' B' ' 919' ' ' VAL . 1.4 t -125.1 137.37 54.18 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.329 -0.989 . . . . 1.3700000000000001 108.329 177.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 914' ' ' ARG . . . . . 0.426 ' O ' ' CB ' ' B' ' 915' ' ' SER . 0.0 OUTLIER -63.47 153.01 36.78 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.917 -1.114 . . . . 4.2999999999999998 111.757 -179.059 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 915' ' ' SER . . . . . 0.426 ' CB ' ' O ' ' B' ' 914' ' ' ARG . 3.5 t 83.24 -30.21 0.09 Allowed 'General case' 0 N--CA 1.521 3.1 0 C-N-CA 123.977 0.911 . . . . 2.0499999999999998 112.359 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 916' ' ' ASN . . . . . 0.436 ' O ' ' HB2' ' B' ' 917' ' ' GLN . 72.9 m-20 -126.8 -21.41 4.06 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 120.892 -1.13 . . . . 2.71 111.394 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 917' ' ' GLN . . . . . 0.436 ' HB2' ' O ' ' B' ' 916' ' ' ASN . 58.7 mt-30 66.99 168.97 0.24 Allowed 'General case' 0 N--CA 1.519 2.977 0 N-CA-C 105.892 -1.892 . . . . 2.6800000000000002 105.892 -173.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.9 -128.79 44.13 Favored Glycine 1 N--CA 1.521 4.302 0 CA-C-N 123.455 2.843 . . . . 0.029999999999999999 106.442 -177.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 919' ' ' VAL . . . . . 0.426 ' HB ' ' CB ' ' B' ' 913' ' ' SER . 84.1 t 50.55 94.57 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.3 0 CA-C-N 118.608 1.204 . . . . 1.3899999999999999 109.191 -178.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 920' ' ' ALA . . . . . . . . . . . . . . . -92.5 94.47 9.09 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.274 -0.97 . . . . 0.029999999999999999 111.116 -179.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 921' ' ' ARG . . . . . 0.438 ' HB3' ' CZ ' ' B' ' 950' ' ' PHE . 34.9 ptt85 -80.73 -43.29 20.48 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 105.553 -2.017 . . . . 4.4199999999999999 105.553 176.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 922' ' ' VAL . . . . . . . . . . . . . 94.0 t -101.68 77.59 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 N-CA-C 104.935 -2.246 . . . . 0.84999999999999998 104.935 174.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -87.56 135.78 33.21 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 122.105 0.955 . . . . 2.46 112.427 -176.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 924' ' ' SER . . . . . . . . . . . . . 10.2 t -145.6 103.4 3.79 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.461 -1.311 . . . . 0.69999999999999996 107.461 178.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -103.77 81.81 0.36 Allowed Glycine 0 N--CA 1.486 2.023 0 N-CA-C 108.965 -1.654 . . . . 0.040000000000000001 108.965 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.958 0 N-CA-C 108.74 -1.744 . . . . 0.040000000000000001 108.74 179.849 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 21.9 m . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 120.923 0.392 . . . . 13.779999999999999 110.412 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 95.5 mt -110.43 129.72 55.71 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.5 -0.75 . . . . 13.76 110.324 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -152.36 169.85 31.58 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.381 -1.487 . . . . 9.1300000000000008 109.381 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 949' ' ' VAL . . . . . . . . . . . . . 34.4 m -118.46 132.36 68.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.548 -0.972 . . . . 7.0800000000000001 111.077 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 950' ' ' PHE . . . . . 0.438 ' CZ ' ' HB3' ' B' ' 921' ' ' ARG . 39.8 p90 -134.98 152.6 51.88 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 109.127 -0.694 . . . . 7.5899999999999999 109.127 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 67.9 m -120.97 -53.03 2.07 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.318 -0.864 . . . . 5.0300000000000002 112.362 -178.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 952' ' ' LEU . . . . . 0.431 ' O ' ' O ' ' B' ' 953' ' ' ILE . 56.3 tp -61.91 -76.44 0.06 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.32 -0.862 . . . . 1.01 112.357 -177.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 953' ' ' ILE . . . . . 0.473 ' O ' ' HB3' ' B' ' 954' ' ' LEU . 43.9 pt -52.22 -145.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.749 0 N-CA-C 114.038 1.125 . . . . 2.6000000000000001 114.038 -176.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 954' ' ' LEU . . . . . 0.554 ' N ' ' CD1' ' B' ' 954' ' ' LEU . 0.0 OUTLIER 170.96 83.74 0.04 OUTLIER Pre-proline 0 N--CA 1.508 2.475 0 O-C-N 120.852 -1.155 . . . . 0.050000000000000003 111.609 179.494 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 955' ' ' PRO . . . . . 0.431 ' HD2' ' CE1' ' B' ' 950' ' ' PHE . 48.7 Cg_endo -76.34 95.23 1.03 Allowed 'Trans proline' 0 C--N 1.313 -1.292 0 N-CA-C 108.759 -1.285 . . . . 0.83999999999999997 108.759 177.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 956' ' ' LEU . . . . . 0.414 ' CD2' ' NH1' ' B' ' 914' ' ' ARG . 10.3 mp -122.3 143.9 49.33 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.151 -0.968 . . . . 0.040000000000000001 110.183 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -86.01 151.18 23.93 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 117.81 -1.09 . . . . 1.28 111.639 -179.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -68.61 119.72 13.49 Favored 'General case' 0 N--CA 1.51 2.54 0 CA-C-N 122.862 2.574 . . . . 0.17000000000000001 111.843 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 93.36 -21.5 40.24 Favored Glycine 0 N--CA 1.5 2.962 0 N-CA-C 111.15 -0.78 . . . . 0.040000000000000001 111.15 178.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 960' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.68 169.77 0.31 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.457 -1.025 . . . . 0.040000000000000001 110.203 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 961' ' ' THR . . . . . 0.452 ' HA ' ' O ' ' B' ' 886' ' ' PHE . 46.0 m -136.86 139.49 41.7 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 120.835 -1.165 . . . . 1.78 112.408 -177.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 962' ' ' VAL . . . . . 0.409 ' CG2' ' CB ' ' B' ' 886' ' ' PHE . 31.8 m -99.87 145.15 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 C-N-CA 120.023 -0.671 . . . . 0.040000000000000001 111.116 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 5.4 t -137.96 145.42 41.98 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.907 -0.496 . . . . 0.71999999999999997 109.981 -179.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 964' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' B' ' 911' ' ' VAL . 61.7 t -92.23 136.71 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.052 -1.03 . . . . 1.05 111.279 -178.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -95.69 126.42 40.96 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 103.464 -2.791 . . . . 3.02 103.464 172.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 966' ' ' LEU . . . . . 0.406 ' O ' ' CG2' ' B' ' 967' ' ' VAL . 0.2 OUTLIER -133.6 61.39 1.68 Allowed 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.408 -0.96 . . . . 1.46 108.408 177.365 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 967' ' ' VAL . . . . . 0.406 ' CG2' ' O ' ' B' ' 966' ' ' LEU . 97.6 t -157.73 96.64 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 108.283 -1.006 . . . . 1.9399999999999999 108.283 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 92.8 mmm -143.4 58.68 1.39 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.752 -1.217 . . . . 0.0 108.251 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 133.87 119.75 2.02 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 107.05 -2.42 . . . . 2.1099999999999999 107.05 -178.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -82.46 -57.1 3.5 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.971 -1.311 . . . . 5.8899999999999997 110.499 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 47.8 tp -58.68 90.03 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.402 -0.811 . . . . 4.3600000000000003 110.318 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -143.03 -152.92 0.43 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.637 -0.665 . . . . 1.8300000000000001 110.079 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -117.83 167.41 11.42 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.473 -0.767 . . . . 4.3499999999999996 110.278 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 30.2 t -101.79 130.26 48.18 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.554 -0.716 . . . . 1.27 110.082 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -156.07 158.99 38.71 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.535 -0.728 . . . . 5.0199999999999996 110.643 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.71 85.08 20.94 Favored Pre-proline 0 N--CA 1.5 2.056 0 O-C-N 121.62 -0.675 . . . . 2.4100000000000001 109.72 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -73.41 -171.89 0.92 Allowed 'Trans proline' 0 C--N 1.317 -1.129 0 O-C-N 123.3 1.158 . . . . 0.95999999999999996 111.283 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 978' ' ' LEU . . . . . . . . . . . . . 5.2 mp -126.82 155.93 42.1 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 107.546 -1.279 . . . . 0.62 107.546 177.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 979' ' ' THR . . . . . . . . . . . . . 47.6 p -149.47 141.59 23.98 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.837 -1.165 . . . . 3.5699999999999998 111.184 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 980' ' ' ILE . . . . . 0.411 HG22 HD11 ' B' ' 980' ' ' ILE . 50.6 mm -107.47 129.09 61.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 109.062 -0.718 . . . . 1.3300000000000001 109.062 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 981' ' ' PHE . . . . . 0.496 ' CD1' ' CE2' ' B' ' 879' ' ' TYR . 10.5 t80 -119.99 97.38 5.58 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 119.594 -0.843 . . . . 0.050000000000000003 111.926 -178.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 16.0 p -108.78 158.25 17.82 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 109.163 -0.68 . . . . 0.87 109.163 178.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 983' ' ' GLY . . . . . 0.425 ' HA3' ' CE1' ' B' ' 852' ' ' PHE . . . -173.98 111.09 0.35 Allowed Glycine 0 N--CA 1.498 2.812 0 N-CA-C 106.655 -2.578 . . . . 0.029999999999999999 106.655 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -108.28 149.27 28.86 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 114.32 1.23 . . . . 0.69999999999999996 114.32 -175.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 985' ' ' LEU . . . . . . . . . . . . . 66.4 tp -71.75 136.28 47.09 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.728 -1.233 . . . . 0.040000000000000001 110.201 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 986' ' ' LEU . . . . . . . . . . . . . 49.3 tp -106.53 -58.07 1.97 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.671 -0.643 . . . . 0.040000000000000001 109.946 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -143.87 146.07 32.76 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.71 -1.218 . . . . 0.040000000000000001 107.71 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.46 162.96 12.22 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 108.088 -2.005 . . . . 0.040000000000000001 108.088 179.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -77.38 111.88 20.08 Favored Pre-proline 0 N--CA 1.499 1.988 0 O-C-N 121.226 -1.161 . . . . 0.040000000000000001 109.524 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 990' ' ' PRO . . . . . 0.415 ' O ' ' HB2' ' B' ' 991' ' ' GLU . 48.7 Cg_endo -92.55 72.01 0.57 Allowed 'Trans proline' 0 C--N 1.318 -1.031 0 O-C-N 123.063 1.033 . . . . 0.45000000000000001 111.328 -178.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 991' ' ' GLU . . . . . 0.415 ' HB2' ' O ' ' B' ' 990' ' ' PRO . 72.4 mt-10 67.67 -73.43 0.08 Allowed 'General case' 0 N--CA 1.503 2.179 0 N-CA-C 108.251 -1.018 . . . . 1.97 108.251 -177.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 992' ' ' LEU . . . . . . . . . . . . . 4.1 mt 50.47 20.48 0.7 Allowed 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.58 -0.7 . . . . 2.3799999999999999 111.731 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 76.4 mt-10 -95.87 156.88 16.14 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.893 -1.13 . . . . 3.79 110.082 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 68.0 m80 -144.16 94.76 2.62 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.515 -0.741 . . . . 3.5099999999999998 110.2 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 995' ' ' ALA . . . . . . . . . . . . 2.517 . . . . . . . 0 N--CA 1.503 2.207 0 O-C-N 120.873 -1.142 . . . . 2.73 110.591 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo . . . . . 0 N--CA 1.488 1.152 0 N-CA-C 109.559 -0.977 . . . . 3.8300000000000001 109.559 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 847' ' ' VAL . . . . . . . . . . . . . 68.8 t -131.34 104.66 14.8 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.592 -0.692 . . . . 1.8300000000000001 109.819 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 848' ' ' PRO . . . . . 0.411 ' O ' ' C ' ' C' ' 849' ' ' GLN . 43.7 Cg_endo -69.7 -19.56 36.26 Favored 'Trans proline' 0 N--CA 1.487 1.118 0 O-C-N 123.295 1.155 . . . . 0.65000000000000002 111.264 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 849' ' ' GLN . . . . . 0.411 ' C ' ' O ' ' C' ' 848' ' ' PRO . 56.2 tt0 26.24 68.49 0.05 Allowed 'General case' 0 N--CA 1.52 3.037 0 N-CA-C 112.893 0.701 . . . . 2.5800000000000001 112.893 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 850' ' ' VAL . . . . . 0.436 ' CG1' ' CE2' ' C' ' 878' ' ' TYR . 93.5 t -117.21 135.24 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.245 -0.909 . . . . 1.0900000000000001 111.201 -178.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 851' ' ' ALA . . . . . . . . . . . . . . . -133.41 151.2 51.79 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 105.74 -1.948 . . . . 0.040000000000000001 105.74 177.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 852' ' ' PHE . . . . . 0.409 ' O ' ' CD1' ' C' ' 852' ' ' PHE . 11.2 p90 -158.89 133.27 7.89 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 120.865 1.666 . . . . 0.050000000000000003 108.914 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 7.4 t -174.09 134.04 0.43 Allowed 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 107.954 -1.128 . . . . 0.040000000000000001 107.954 -179.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -136.44 159.25 42.33 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.167 -0.958 . . . . 0.67000000000000004 109.671 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 855' ' ' ALA . . . . . . . . . . . . . . . -122.86 140.64 52.74 Favored 'General case' 0 N--CA 1.499 1.994 0 CA-C-O 121.939 0.876 . . . . 0.51000000000000001 112.254 -178.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 856' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -106.6 138.52 42.63 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.645 -0.659 . . . . 0.050000000000000003 109.578 179.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 857' ' ' SER . . . . . 0.43 ' O ' ' O ' ' C' ' 858' ' ' LEU . 1.3 m -159.23 18.65 0.18 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.443 -0.786 . . . . 1.3300000000000001 111.836 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 858' ' ' LEU . . . . . 0.43 ' O ' ' O ' ' C' ' 857' ' ' SER . 2.7 pp -34.57 160.0 0.04 OUTLIER Pre-proline 0 N--CA 1.519 3.02 0 CA-C-N 118.603 0.638 . . . . 2.3300000000000001 112.689 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -60.19 -88.52 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 120.734 0.956 . . . . 2.3199999999999998 113.348 -178.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 55.4 ptt85 -130.47 -143.35 0.25 Allowed 'General case' 0 N--CA 1.5 2.052 0 O-C-N 120.883 -1.135 . . . . 0.040000000000000001 111.978 -177.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 41.2 m -33.31 120.55 0.38 Allowed 'General case' 0 N--CA 1.511 2.617 0 N-CA-C 113.241 0.83 . . . . 1.3100000000000001 113.241 -178.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.79 159.49 29.16 Favored Pre-proline 0 N--CA 1.486 1.342 0 N-CA-C 107.626 -1.25 . . . . 4.5099999999999998 107.626 176.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -69.78 -13.66 34.93 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 O-C-N 123.104 1.055 . . . . 2.2400000000000002 111.524 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -176.65 -135.26 2.13 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.911 -1.275 . . . . 0.040000000000000001 109.911 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 30.1 m -70.41 157.76 37.22 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.332 -1.099 . . . . 1.51 110.416 -179.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 866' ' ' VAL . . . . . . . . . . . . . 30.7 m -95.23 142.67 24.92 Favored Pre-proline 0 N--CA 1.498 1.964 0 N-CA-C 114.233 1.197 . . . . 0.78000000000000003 114.233 -174.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 867' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -89.91 -150.69 0.04 OUTLIER 'Trans proline' 0 CA--C 1.541 0.871 0 N-CA-C 108.339 -1.446 . . . . 0.92000000000000004 108.339 177.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 868' ' ' PHE . . . . . 0.453 ' N ' ' CD1' ' C' ' 868' ' ' PHE . 14.1 p90 -148.32 121.05 8.64 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.48 -1.387 . . . . 0.050000000000000003 109.865 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 50.0 p-10 -112.03 -3.97 14.62 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.15 -0.969 . . . . 1.7 112.471 -178.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 870' ' ' ARG . . . . . . . . . . . . . 22.7 mmm180 -90.93 89.19 7.34 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.96 -1.087 . . . . 2.5899999999999999 111.031 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 61.2 t -76.51 96.52 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 120.979 -1.075 . . . . 1.9399999999999999 109.238 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 872' ' ' LEU . . . . . . . . . . . . . 66.8 mt -85.78 -44.61 12.35 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.546 -0.721 . . . . 1.0600000000000001 110.559 -179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 873' ' ' LEU . . . . . 0.41 ' O ' ' HB2' ' C' ' 874' ' ' ASN . 47.5 tp -172.21 104.33 0.17 Allowed 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.209 -0.932 . . . . 4.1799999999999997 108.71 178.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 874' ' ' ASN . . . . . 0.41 ' HB2' ' O ' ' C' ' 873' ' ' LEU . 49.5 t-20 178.25 82.65 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.33 0 O-C-N 121.733 -0.604 . . . . 0.040000000000000001 109.588 -178.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 33.0 p-10 -72.07 -49.44 36.48 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.092 -1.005 . . . . 3.3799999999999999 111.705 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 876' ' ' GLY . . . . . . . . . . . . . . . -73.24 -26.43 70.53 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 110.617 -0.993 . . . . 0.040000000000000001 110.617 -179.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 81.34 -61.46 4.6 Favored Glycine 0 N--CA 1.497 2.742 0 N-CA-C 108.27 -1.932 . . . . 0.040000000000000001 108.27 -178.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 878' ' ' TYR . . . . . 0.436 ' CE2' ' CG1' ' C' ' 850' ' ' VAL . 85.6 m-85 61.62 -61.95 0.09 Allowed 'General case' 0 N--CA 1.504 2.25 0 N-CA-C 113.426 0.899 . . . . 3.46 113.426 178.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 879' ' ' TYR . . . . . 0.494 ' O ' ' CG ' ' C' ' 879' ' ' TYR . 12.2 p90 -110.97 105.33 14.07 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.991 -1.068 . . . . 0.040000000000000001 113.259 -177.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 880' ' ' ASP . . . . . 0.419 ' O ' ' N ' ' C' ' 884' ' ' GLY . 1.2 m-20 -66.69 112.68 10.17 Favored Pre-proline 0 N--CA 1.497 1.883 0 O-C-N 121.161 -0.962 . . . . 0.02 110.526 -178.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 881' ' ' PRO . . . . . 0.448 ' HG2' ' CD1' ' C' ' 868' ' ' PHE . 52.2 Cg_endo -79.05 -3.33 13.1 Favored 'Trans proline' 0 N--CA 1.489 1.238 0 O-C-N 123.531 1.279 . . . . 0.39000000000000001 111.213 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -80.31 -34.57 36.65 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 108.033 -1.099 . . . . 0.81000000000000005 108.033 178.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 69.6 p -110.36 -20.31 12.66 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 115.462 -0.79 . . . . 0.040000000000000001 108.984 176.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 884' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' C' ' 880' ' ' ASP . . . 80.07 4.88 89.78 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 110.232 -1.147 . . . . 0.029999999999999999 110.232 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 71.0 t -74.39 94.61 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 C-N-CA 118.695 -1.202 . . . . 1.01 108.532 -178.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 886' ' ' PHE . . . . . 0.464 ' CD2' ' CB ' ' C' ' 879' ' ' TYR . 2.1 t80 -88.74 105.8 17.94 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 115.513 -0.767 . . . . 0.050000000000000003 111.785 -177.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 887' ' ' THR . . . . . . . . . . . . . 28.0 m -98.53 99.99 11.2 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.787 -1.19 . . . . 0.68000000000000005 107.787 177.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 888' ' ' ALA . . . . . . . . . . . . . . . -97.87 108.3 45.31 Favored Pre-proline 0 N--CA 1.5 2.062 0 N-CA-C 113.606 0.965 . . . . 0.25 113.606 -176.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 889' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -89.87 -12.77 2.81 Favored 'Trans proline' 0 CA--C 1.544 1.02 0 C-N-CA 120.999 1.133 . . . . 1.6399999999999999 109.246 176.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 890' ' ' LEU . . . . . 0.41 ' CD1' ' N ' ' C' ' 891' ' ' ALA . 3.0 pp -36.87 -48.34 0.74 Allowed 'General case' 0 N--CA 1.508 2.47 0 N-CA-C 113.819 1.044 . . . . 2.29 113.819 -177.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 891' ' ' ALA . . . . . 0.41 ' N ' ' CD1' ' C' ' 890' ' ' LEU . . . 51.17 95.49 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.34 0 O-C-N 120.998 -1.064 . . . . 0.63 110.472 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . 155.43 -146.9 15.1 Favored Glycine 0 N--CA 1.479 1.566 0 N-CA-C 107.274 -2.33 . . . . 0.040000000000000001 107.274 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 76.5 ttt-85 -108.52 127.06 53.6 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 107.223 -1.399 . . . . 3.0 107.223 176.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 894' ' ' TYR . . . . . 0.428 ' CE1' ' O ' ' C' ' 895' ' ' LEU . 0.5 OUTLIER -130.75 155.09 47.24 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.099 -1.001 . . . . 0.040000000000000001 110.841 -178.547 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 895' ' ' LEU . . . . . 0.428 ' O ' ' CE1' ' C' ' 894' ' ' TYR . 41.5 tp -99.79 117.3 33.82 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.652 -0.655 . . . . 1.27 110.539 -179.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 896' ' ' LEU . . . . . . . . . . . . . 4.5 tt -115.59 140.56 49.06 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.509 -0.745 . . . . 0.93999999999999995 110.35 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 897' ' ' SER . . . . . . . . . . . . . 50.3 m -147.07 118.44 7.87 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.376 -0.828 . . . . 0.040000000000000001 111.286 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -108.64 147.41 31.91 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 109.401 -0.592 . . . . 0.47999999999999998 109.401 178.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 899' ' ' VAL . . . . . . . . . . . . . 97.9 t -93.19 121.53 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 C-N-CA 119.68 -0.808 . . . . 0.55000000000000004 111.29 -179.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -90.52 111.59 22.93 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 114.564 1.32 . . . . 1.5900000000000001 114.564 -175.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 21.6 m -67.09 142.09 57.23 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 106.974 -1.491 . . . . 0.050000000000000003 106.974 176.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -69.14 -67.71 1.86 Allowed Glycine 0 N--CA 1.494 2.549 0 N-CA-C 110.435 -1.066 . . . . 0.029999999999999999 110.435 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 5.2 t-80 46.24 66.46 0.95 Allowed 'General case' 0 N--CA 1.509 2.483 0 O-C-N 121.442 -1.034 . . . . 3.2000000000000002 111.122 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 46.4 ptt85 -69.12 -6.9 31.42 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.611 -0.681 . . . . 2.9199999999999999 112.043 -179.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 905' ' ' HIS . . . . . 0.488 ' O ' ' CB ' ' C' ' 906' ' ' GLU . 78.1 t60 -58.24 4.58 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.516 0 CA-C-O 117.653 -1.165 . . . . 2.8700000000000001 113.953 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 906' ' ' GLU . . . . . 0.488 ' CB ' ' O ' ' C' ' 905' ' ' HIS . 0.0 OUTLIER 94.02 -167.1 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.413 0 CA-C-N 121.264 1.847 . . . . 0.98999999999999999 112.011 179.096 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 907' ' ' LYS . . . . . 0.476 ' CB ' ' O ' ' C' ' 906' ' ' GLU . 30.3 ttmt 87.89 160.42 0.07 Allowed 'General case' 0 N--CA 1.518 2.969 0 N-CA-C 108.026 -1.102 . . . . 5.25 108.026 -177.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 59.2 t -120.9 116.38 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 120.947 -1.095 . . . . 0.39000000000000001 110.652 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 75.7 tt0 -103.66 131.65 50.62 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 107.298 -1.371 . . . . 1.72 107.298 176.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -155.34 122.36 5.45 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 106.445 -1.687 . . . . 0.67000000000000004 106.445 178.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 911' ' ' VAL . . . . . 0.47 ' HA ' ' HA ' ' C' ' 964' ' ' VAL . 70.1 t -77.41 131.95 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.826 -0.546 . . . . 0.54000000000000004 110.679 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 84.0 mt -65.67 157.07 31.0 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.279 -0.888 . . . . 1.5 108.718 178.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 913' ' ' SER . . . . . 0.403 ' CB ' ' CG1' ' C' ' 919' ' ' VAL . 1.3 p -127.17 132.65 50.46 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.174 -1.047 . . . . 1.3700000000000001 108.174 176.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 914' ' ' ARG . . . . . 0.428 ' O ' ' CB ' ' C' ' 915' ' ' SER . 0.0 OUTLIER -58.81 154.45 14.92 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 120.764 -1.21 . . . . 4.2999999999999998 112.097 -178.848 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 915' ' ' SER . . . . . 0.428 ' CB ' ' O ' ' C' ' 914' ' ' ARG . 1.8 t 83.13 -30.29 0.09 Allowed 'General case' 0 N--CA 1.519 3.022 0 C-N-CA 123.869 0.868 . . . . 2.0499999999999998 112.476 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 916' ' ' ASN . . . . . 0.413 ' O ' ' HB2' ' C' ' 917' ' ' GLN . 97.2 m-20 -126.8 -23.5 3.67 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 120.891 -1.13 . . . . 2.71 111.173 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 917' ' ' GLN . . . . . 0.413 ' HB2' ' O ' ' C' ' 916' ' ' ASN . 41.8 mt-30 68.49 168.23 0.27 Allowed 'General case' 0 N--CA 1.517 2.917 0 N-CA-C 105.776 -1.935 . . . . 2.6800000000000002 105.776 -174.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 56.45 -127.72 44.56 Favored Glycine 1 N--CA 1.519 4.19 0 CA-C-N 123.397 2.817 . . . . 0.029999999999999999 106.467 -177.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 919' ' ' VAL . . . . . 0.403 ' CG1' ' CB ' ' C' ' 913' ' ' SER . 95.0 t 50.45 94.83 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.336 0 CA-C-N 118.534 1.167 . . . . 1.3899999999999999 109.426 -178.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 920' ' ' ALA . . . . . . . . . . . . . . . -93.93 93.7 8.05 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.336 -0.946 . . . . 0.029999999999999999 111.049 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 921' ' ' ARG . . . . . 0.432 ' HB3' ' CZ ' ' C' ' 950' ' ' PHE . 45.4 ptt85 -83.19 -42.96 16.67 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 105.582 -2.007 . . . . 4.4199999999999999 105.582 176.154 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 922' ' ' VAL . . . . . . . . . . . . . 77.3 t -101.05 74.65 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 104.71 -2.33 . . . . 0.84999999999999998 104.71 174.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -86.74 136.87 32.85 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 122.074 0.94 . . . . 2.46 112.614 -176.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 6.4 t -145.8 103.17 3.75 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 107.719 -1.215 . . . . 0.69999999999999996 107.719 178.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -107.48 85.75 0.43 Allowed Glycine 0 N--CA 1.488 2.123 0 N-CA-C 108.905 -1.678 . . . . 0.040000000000000001 108.905 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.278 0 N-CA-C 109.151 -1.58 . . . . 0.040000000000000001 109.151 -179.707 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 31.1 m . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 120.971 0.415 . . . . 13.779999999999999 110.335 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 92.5 mt -110.37 129.56 55.73 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.487 -0.758 . . . . 13.76 110.312 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -152.25 169.71 31.51 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.348 -1.501 . . . . 9.1300000000000008 109.348 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 949' ' ' VAL . . . . . . . . . . . . . 33.5 m -118.69 131.74 70.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.551 -0.97 . . . . 7.0800000000000001 110.843 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 950' ' ' PHE . . . . . 0.432 ' CZ ' ' HB3' ' C' ' 921' ' ' ARG . 48.2 p90 -133.36 151.14 51.82 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.579 -0.7 . . . . 7.5899999999999999 109.113 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 7.3 m -119.64 -53.19 2.21 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.401 -0.812 . . . . 5.0300000000000002 112.096 -178.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 952' ' ' LEU . . . . . 0.425 ' O ' ' O ' ' C' ' 953' ' ' ILE . 15.4 tp -62.99 -74.78 0.09 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.354 -0.841 . . . . 1.01 112.018 -177.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 953' ' ' ILE . . . . . 0.476 ' O ' ' HB3' ' C' ' 954' ' ' LEU . 41.8 pt -52.42 -146.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.77 0 N-CA-C 114.145 1.165 . . . . 2.6000000000000001 114.145 -176.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 954' ' ' LEU . . . . . 0.558 ' N ' ' CD1' ' C' ' 954' ' ' LEU . 0.0 OUTLIER 169.0 80.38 0.03 OUTLIER Pre-proline 0 N--CA 1.512 2.674 0 O-C-N 120.957 -1.089 . . . . 0.050000000000000003 111.695 179.563 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 955' ' ' PRO . . . . . 0.414 ' HD2' ' CE1' ' C' ' 950' ' ' PHE . 44.4 Cg_endo -72.66 98.84 1.0 Allowed 'Trans proline' 0 C--N 1.313 -1.325 0 N-CA-C 109.193 -1.118 . . . . 0.83999999999999997 109.193 178.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 956' ' ' LEU . . . . . . . . . . . . . 92.0 mt -125.26 142.29 51.59 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.052 -1.03 . . . . 0.040000000000000001 110.492 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 957' ' ' GLN . . . . . 0.407 ' HB2' ' HB3' ' C' ' 960' ' ' ASP . 87.2 mt-30 -84.98 149.49 25.57 Favored 'General case' 0 N--CA 1.501 2.124 0 CA-C-O 117.997 -1.001 . . . . 1.28 111.919 -178.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -62.11 122.29 15.19 Favored 'General case' 0 N--CA 1.512 2.635 0 CA-C-N 122.751 2.523 . . . . 0.17000000000000001 110.799 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 91.48 -10.31 75.09 Favored Glycine 0 N--CA 1.501 3.011 0 N-CA-C 110.167 -1.173 . . . . 0.040000000000000001 110.167 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 960' ' ' ASP . . . . . 0.407 ' HB3' ' HB2' ' C' ' 957' ' ' GLN . 16.3 p-10 -47.96 167.92 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.546 -0.973 . . . . 0.040000000000000001 111.98 -179.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 961' ' ' THR . . . . . 0.427 ' HA ' ' O ' ' C' ' 886' ' ' PHE . 91.1 m -137.96 127.15 24.42 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.403 -0.811 . . . . 1.78 110.087 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 962' ' ' VAL . . . . . 0.441 ' CG2' ' CB ' ' C' ' 886' ' ' PHE . 12.0 m -100.96 142.95 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 C-N-CA 119.392 -0.923 . . . . 0.040000000000000001 110.45 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 5.5 t -140.41 145.77 37.47 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.968 -0.457 . . . . 0.71999999999999997 109.875 -178.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 964' ' ' VAL . . . . . 0.47 ' HA ' ' HA ' ' C' ' 911' ' ' VAL . 60.1 t -100.71 136.96 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.041 -1.037 . . . . 1.05 111.296 -178.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -96.42 128.11 43.04 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 103.967 -2.605 . . . . 3.02 103.967 173.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 966' ' ' LEU . . . . . 0.4 ' O ' ' CG2' ' C' ' 967' ' ' VAL . 11.7 tp -132.38 64.33 1.61 Allowed 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.254 -1.017 . . . . 1.46 108.254 177.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 967' ' ' VAL . . . . . 0.4 ' CG2' ' O ' ' C' ' 966' ' ' LEU . 96.9 t -157.81 97.19 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 108.041 -1.096 . . . . 1.9399999999999999 108.041 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 91.1 mmm -143.17 59.13 1.41 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.713 -1.242 . . . . 0.0 108.359 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.35 119.93 1.97 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 107.124 -2.39 . . . . 2.1099999999999999 107.124 -178.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -81.56 -57.94 3.24 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.01 -1.288 . . . . 5.8899999999999997 110.574 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 45.4 tp -58.64 90.24 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.433 -0.792 . . . . 4.3600000000000003 110.395 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -142.97 -153.47 0.47 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.573 -0.704 . . . . 1.8300000000000001 110.188 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -118.69 166.86 12.24 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.501 -0.75 . . . . 4.3499999999999996 110.323 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 31.1 t -102.14 130.18 48.7 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.522 -0.736 . . . . 1.27 109.944 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 66.8 tt0 -156.25 159.53 38.98 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.466 -0.771 . . . . 5.0199999999999996 110.628 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.1 85.82 21.59 Favored Pre-proline 0 N--CA 1.5 2.067 0 O-C-N 121.646 -0.659 . . . . 2.4100000000000001 109.755 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -72.97 -170.74 0.66 Allowed 'Trans proline' 0 C--N 1.316 -1.138 0 O-C-N 123.323 1.17 . . . . 0.95999999999999996 111.159 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 978' ' ' LEU . . . . . . . . . . . . . 5.8 mp -126.17 155.88 41.03 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 107.703 -1.221 . . . . 0.62 107.703 178.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 979' ' ' THR . . . . . . . . . . . . . 63.7 p -148.83 141.17 24.15 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.853 -1.154 . . . . 3.5699999999999998 111.09 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 980' ' ' ILE . . . . . 0.43 HG22 HD11 ' C' ' 980' ' ' ILE . 49.2 mm -107.06 129.24 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 108.982 -0.747 . . . . 1.3300000000000001 108.982 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 981' ' ' PHE . . . . . 0.454 ' CD1' ' CE2' ' C' ' 879' ' ' TYR . 5.3 t80 -119.92 96.44 5.18 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 119.606 -0.837 . . . . 0.050000000000000003 111.796 -178.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 982' ' ' SER . . . . . . . . . . . . . 94.8 p -108.55 157.19 18.7 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.831 -0.803 . . . . 0.87 108.831 178.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 983' ' ' GLY . . . . . . . . . . . . . . . -172.86 112.86 0.45 Allowed Glycine 0 N--CA 1.496 2.671 0 N-CA-C 106.841 -2.503 . . . . 0.029999999999999999 106.841 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 984' ' ' ALA . . . . . . . . . . . . . . . -109.83 146.98 34.13 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 114.142 1.164 . . . . 0.69999999999999996 114.142 -176.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 985' ' ' LEU . . . . . . . . . . . . . 56.6 tp -71.24 136.88 48.21 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 120.788 -1.195 . . . . 0.040000000000000001 110.2 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 986' ' ' LEU . . . . . . . . . . . . . 51.7 tp -106.21 -60.65 1.62 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.597 -0.689 . . . . 0.040000000000000001 110.285 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -143.82 146.46 33.09 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.896 -1.15 . . . . 0.040000000000000001 107.896 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.79 162.62 12.31 Favored Glycine 0 N--CA 1.496 2.695 0 N-CA-C 108.132 -1.987 . . . . 0.040000000000000001 108.132 179.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.72 111.86 22.62 Favored Pre-proline 0 N--CA 1.499 1.999 0 CA-C-N 118.571 1.186 . . . . 0.040000000000000001 109.539 178.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 990' ' ' PRO . . . . . 0.413 ' O ' ' HB2' ' C' ' 991' ' ' GLU . 48.8 Cg_endo -92.59 74.0 0.48 Allowed 'Trans proline' 0 C--N 1.318 -1.059 0 O-C-N 123.117 1.062 . . . . 0.45000000000000001 111.527 -179.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 991' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' C' ' 990' ' ' PRO . 77.1 mt-10 67.26 -73.67 0.08 Allowed 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 108.48 -0.933 . . . . 1.97 108.48 -177.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 992' ' ' LEU . . . . . . . . . . . . . 6.9 mt 51.65 20.38 1.08 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.521 -0.737 . . . . 2.3799999999999999 111.591 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -95.39 156.88 16.13 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.855 -1.153 . . . . 3.79 110.066 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 67.3 m80 -146.44 94.55 2.47 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.534 -0.729 . . . . 3.5099999999999998 110.345 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 995' ' ' ALA . . . . . . . . . . . . 2.518 . . . . . . . 0 N--CA 1.504 2.225 0 O-C-N 120.955 -1.09 . . . . 2.73 110.616 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo . . . . . 0 N--CA 1.488 1.177 0 N-CA-C 109.482 -1.007 . . . . 3.8300000000000001 109.482 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 847' ' ' VAL . . . . . . . . . . . . . 60.1 t -132.04 103.58 14.16 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.583 -0.698 . . . . 1.8300000000000001 110.073 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 848' ' ' PRO . . . . . 0.403 ' O ' ' C ' ' A' ' 849' ' ' GLN . 43.9 Cg_endo -69.8 -19.89 35.34 Favored 'Trans proline' 0 N--CA 1.487 1.106 0 O-C-N 123.302 1.159 . . . . 0.65000000000000002 111.125 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 849' ' ' GLN . . . . . 0.403 ' C ' ' O ' ' A' ' 848' ' ' PRO . 56.4 tt0 26.42 69.24 0.05 Allowed 'General case' 0 N--CA 1.519 2.989 0 N-CA-C 112.948 0.721 . . . . 2.5800000000000001 112.948 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 850' ' ' VAL . . . . . . . . . . . . . 59.7 t -117.46 137.86 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.292 -0.88 . . . . 1.0900000000000001 111.63 -178.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 851' ' ' ALA . . . . . . . . . . . . . . . -127.69 155.41 44.0 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 105.723 -1.954 . . . . 0.040000000000000001 105.723 176.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 852' ' ' PHE . . . . . 0.413 ' HA ' ' CB ' ' A' ' 874' ' ' ASN . 21.4 p90 -160.4 128.87 4.73 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-N 121.016 1.735 . . . . 0.050000000000000003 108.864 179.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 33.1 t -175.57 134.57 0.3 Allowed 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.071 -1.085 . . . . 0.040000000000000001 108.071 -179.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -134.85 158.42 44.26 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.053 -1.029 . . . . 0.67000000000000004 109.501 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 855' ' ' ALA . . . . . . . . . . . . . . . -122.58 141.02 52.14 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 121.894 0.854 . . . . 0.51000000000000001 111.852 -178.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 856' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -107.64 135.53 48.93 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 109.247 -0.649 . . . . 0.050000000000000003 109.247 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 857' ' ' SER . . . . . 0.428 ' O ' ' O ' ' A' ' 858' ' ' LEU . 16.9 p -153.05 17.82 0.57 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.419 -0.8 . . . . 1.3300000000000001 111.223 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 858' ' ' LEU . . . . . 0.428 ' O ' ' O ' ' A' ' 857' ' ' SER . 3.1 pp -29.66 154.08 0.03 OUTLIER Pre-proline 0 N--CA 1.52 3.046 0 N-CA-C 113.421 0.897 . . . . 2.3300000000000001 113.421 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -61.73 -88.8 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 120.934 1.09 . . . . 2.3199999999999998 113.683 -177.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 53.4 ptt85 -127.16 -142.12 0.27 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.895 -1.128 . . . . 0.040000000000000001 111.429 -177.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 36.8 m -39.11 119.02 0.85 Allowed 'General case' 0 N--CA 1.51 2.543 0 O-C-N 121.549 -0.719 . . . . 1.3100000000000001 111.919 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 862' ' ' GLU . . . . . 0.434 ' CG ' ' HD2' ' A' ' 863' ' ' PRO . 24.6 tt0 -97.35 149.57 35.86 Favored Pre-proline 0 N--CA 1.488 1.453 0 N-CA-C 108.17 -1.048 . . . . 4.5099999999999998 108.17 178.048 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 863' ' ' PRO . . . . . 0.434 ' HD2' ' CG ' ' A' ' 862' ' ' GLU . 41.6 Cg_endo -67.65 -13.31 38.47 Favored 'Trans proline' 0 C--N 1.316 -1.161 0 O-C-N 122.984 0.991 . . . . 2.2400000000000002 111.334 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -174.21 -137.36 2.43 Favored Glycine 0 N--CA 1.493 2.474 0 C-N-CA 119.76 -1.21 . . . . 0.040000000000000001 110.623 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 37.1 m -69.2 159.65 32.63 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.332 -1.099 . . . . 1.51 111.719 -177.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 27.0 m -89.93 132.73 35.48 Favored Pre-proline 0 N--CA 1.495 1.808 0 N-CA-C 113.422 0.897 . . . . 0.78000000000000003 113.422 -175.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 867' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -88.77 -153.82 0.05 OUTLIER 'Trans proline' 0 C--N 1.323 -0.794 0 N-CA-C 107.709 -1.689 . . . . 0.92000000000000004 107.709 177.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 868' ' ' PHE . . . . . 0.449 ' CD1' ' HG2' ' A' ' 881' ' ' PRO . 31.9 p90 -148.55 119.25 7.5 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.51 -1.369 . . . . 0.050000000000000003 109.944 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 50.1 p-10 -112.72 -3.24 14.29 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 119.322 -0.951 . . . . 1.7 112.207 -178.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 870' ' ' ARG . . . . . . . . . . . . . 26.5 mmm180 -89.98 88.69 7.4 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.908 -1.12 . . . . 2.5899999999999999 110.676 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 57.3 t -75.12 96.88 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.028 -1.045 . . . . 1.9399999999999999 109.787 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 872' ' ' LEU . . . . . . . . . . . . . 95.8 mt -83.92 -46.89 11.62 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.553 -0.717 . . . . 1.0600000000000001 110.231 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 873' ' ' LEU . . . . . . . . . . . . . 48.8 tp -174.82 104.48 0.09 Allowed 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.293 -0.879 . . . . 4.1799999999999997 108.676 178.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 874' ' ' ASN . . . . . 0.413 ' CB ' ' HA ' ' A' ' 852' ' ' PHE . 36.5 t-20 178.68 82.1 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.316 0 O-C-N 121.588 -0.695 . . . . 0.040000000000000001 109.675 -178.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -66.91 -47.06 72.93 Favored 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 119.289 -0.965 . . . . 3.3799999999999999 111.283 -179.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 876' ' ' GLY . . . . . 0.414 ' HA3' ' CE2' ' A' ' 878' ' ' TYR . . . -74.62 -25.29 70.35 Favored Glycine 0 N--CA 1.494 2.553 0 O-C-N 121.239 -0.913 . . . . 0.040000000000000001 111.836 -178.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 84.32 -59.8 4.9 Favored Glycine 0 N--CA 1.502 3.084 0 N-CA-C 108.154 -1.979 . . . . 0.040000000000000001 108.154 -178.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 878' ' ' TYR . . . . . 0.414 ' CE2' ' HA3' ' A' ' 876' ' ' GLY . 97.7 m-85 60.67 -66.13 0.05 Allowed 'General case' 0 N--CA 1.503 2.215 0 N-CA-C 114.327 1.232 . . . . 3.46 114.327 177.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 879' ' ' TYR . . . . . 0.469 ' CB ' ' CD2' ' A' ' 886' ' ' PHE . 23.7 p90 -112.37 109.17 18.64 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 114.796 1.406 . . . . 0.040000000000000001 114.796 -176.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -65.18 118.53 50.65 Favored Pre-proline 0 N--CA 1.495 1.816 0 O-C-N 121.369 -0.832 . . . . 0.02 110.026 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 881' ' ' PRO . . . . . 0.449 ' HG2' ' CD1' ' A' ' 868' ' ' PHE . 55.2 Cg_endo -76.87 0.24 9.85 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 O-C-N 123.469 1.247 . . . . 0.39000000000000001 112.094 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 -76.79 -64.81 1.04 Allowed 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 106.98 -1.489 . . . . 0.81000000000000005 106.98 178.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 30.4 p -94.1 -17.7 22.55 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.776 -0.824 . . . . 0.040000000000000001 108.776 177.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.08 22.11 55.65 Favored Glycine 0 N--CA 1.495 2.63 0 O-C-N 121.057 -1.027 . . . . 0.029999999999999999 110.749 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 885' ' ' VAL . . . . . . . . . . . . . 77.6 t -73.15 90.42 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 C-N-CA 118.353 -1.339 . . . . 1.01 108.23 -179.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 886' ' ' PHE . . . . . 0.469 ' CD2' ' CB ' ' A' ' 879' ' ' TYR . 0.7 OUTLIER -90.39 104.34 16.92 Favored 'General case' 0 N--CA 1.495 1.825 0 CA-C-N 115.291 -0.868 . . . . 0.050000000000000003 112.291 -177.298 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 887' ' ' THR . . . . . 0.4 ' O ' ' HD3' ' A' ' 889' ' ' PRO . 89.8 m -95.04 100.77 12.54 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 107.831 -1.174 . . . . 0.68000000000000005 107.831 177.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 888' ' ' ALA . . . . . . . . . . . . . . . -99.17 106.37 38.15 Favored Pre-proline 0 N--CA 1.5 2.047 0 N-CA-C 114.045 1.128 . . . . 0.25 114.045 -176.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 889' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' A' ' 887' ' ' THR . 54.6 Cg_endo -89.2 -11.94 3.45 Favored 'Trans proline' 0 CA--C 1.546 1.109 0 N-CA-C 108.975 -1.202 . . . . 1.6399999999999999 108.975 176.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 890' ' ' LEU . . . . . . . . . . . . . 4.9 tt -35.29 -51.23 0.58 Allowed 'General case' 0 N--CA 1.507 2.397 0 N-CA-C 113.92 1.082 . . . . 2.29 113.92 -177.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 51.79 95.03 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.374 0 O-C-N 121.188 -0.945 . . . . 0.63 110.175 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 156.05 -147.28 15.72 Favored Glycine 0 N--CA 1.478 1.487 0 N-CA-C 107.372 -2.291 . . . . 0.040000000000000001 107.372 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 72.4 ttt-85 -109.0 127.91 54.5 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.86 -1.163 . . . . 3.0 107.86 177.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 894' ' ' TYR . . . . . 0.45 ' CD1' ' N ' ' A' ' 895' ' ' LEU . 0.1 OUTLIER -130.98 144.46 51.49 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.05 -1.032 . . . . 0.040000000000000001 110.085 -179.305 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 895' ' ' LEU . . . . . 0.45 ' N ' ' CD1' ' A' ' 894' ' ' TYR . 34.3 tp -99.37 115.22 28.72 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.625 -0.672 . . . . 1.27 109.807 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 896' ' ' LEU . . . . . 0.426 ' HB2' ' CZ ' ' A' ' 894' ' ' TYR . 9.9 tt -112.16 145.87 39.06 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.579 -0.7 . . . . 0.93999999999999995 110.461 -179.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 897' ' ' SER . . . . . . . . . . . . . 71.2 m -144.74 119.11 9.6 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.379 -0.825 . . . . 0.040000000000000001 110.741 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.97 147.69 30.72 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.708 -0.62 . . . . 0.47999999999999998 109.448 179.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 899' ' ' VAL . . . . . . . . . . . . . 88.0 t -91.95 121.15 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.457 -0.777 . . . . 0.55000000000000004 110.98 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 900' ' ' LEU . . . . . 0.432 ' CD2' ' N ' ' A' ' 900' ' ' LEU . 4.4 mm? -95.02 111.75 23.52 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 114.423 1.268 . . . . 1.5900000000000001 114.423 -174.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 17.3 m -67.8 141.64 56.45 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 107.274 -1.38 . . . . 0.050000000000000003 107.274 176.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -67.92 -65.02 2.87 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 110.718 -0.953 . . . . 0.029999999999999999 110.718 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 5.8 m170 46.83 66.31 1.02 Allowed 'General case' 0 N--CA 1.508 2.437 0 O-C-N 121.464 -1.021 . . . . 3.2000000000000002 111.082 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 54.1 ptt85 -69.26 -5.91 25.94 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.578 -0.701 . . . . 2.9199999999999999 112.178 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 905' ' ' HIS . . . . . 0.489 ' O ' ' CB ' ' A' ' 906' ' ' GLU . 73.9 t60 -62.69 5.06 0.13 Allowed 'General case' 0 N--CA 1.507 2.393 0 O-C-N 120.888 -1.132 . . . . 2.8700000000000001 113.086 -179.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 906' ' ' GLU . . . . . 0.489 ' CB ' ' O ' ' A' ' 905' ' ' HIS . 0.6 OUTLIER 95.07 -164.97 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.452 0 CA-C-N 120.609 1.549 . . . . 0.98999999999999999 111.993 178.903 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 907' ' ' LYS . . . . . 0.463 ' CB ' ' O ' ' A' ' 906' ' ' GLU . 62.0 tttt 86.09 156.78 0.08 Allowed 'General case' 0 N--CA 1.52 3.03 0 N-CA-C 107.961 -1.126 . . . . 5.25 107.961 -176.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 60.7 t -122.1 117.45 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 120.791 -1.193 . . . . 0.39000000000000001 111.224 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 54.0 tp10 -101.56 133.24 46.54 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 107.291 -1.374 . . . . 1.72 107.291 176.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -155.74 123.0 5.45 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 106.811 -1.551 . . . . 0.67000000000000004 106.811 178.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 911' ' ' VAL . . . . . 0.475 ' HA ' ' HA ' ' A' ' 964' ' ' VAL . 93.8 t -84.28 131.83 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.902 -0.499 . . . . 0.54000000000000004 110.984 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 60.6 mt -66.92 157.56 32.92 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.46 -0.775 . . . . 1.5 109.351 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 1.4 p -124.65 137.6 54.36 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.003 -1.11 . . . . 1.3700000000000001 108.003 176.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 914' ' ' ARG . . . . . 0.424 ' O ' ' CB ' ' A' ' 915' ' ' SER . 0.1 OUTLIER -65.32 155.28 35.75 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.638 -1.289 . . . . 4.2999999999999998 111.359 -179.164 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 915' ' ' SER . . . . . 0.424 ' CB ' ' O ' ' A' ' 914' ' ' ARG . 1.7 p 83.42 -31.56 0.08 Allowed 'General case' 0 N--CA 1.521 3.118 0 C-N-CA 123.925 0.89 . . . . 2.0499999999999998 112.068 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -122.78 -21.91 5.47 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 120.953 -1.092 . . . . 2.71 111.192 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 917' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 67.04 166.53 0.22 Allowed 'General case' 0 N--CA 1.52 3.027 0 N-CA-C 105.742 -1.948 . . . . 2.6800000000000002 105.742 -174.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.33 -125.23 33.43 Favored Glycine 1 N--CA 1.521 4.324 0 CA-C-N 123.368 2.804 . . . . 0.029999999999999999 107.07 -177.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 919' ' ' VAL . . . . . . . . . . . . . 88.2 t 52.39 94.98 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 O-C-N 121.382 -1.069 . . . . 1.3899999999999999 109.068 -178.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 920' ' ' ALA . . . . . . . . . . . . . . . -90.87 91.07 8.19 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.246 -0.982 . . . . 0.029999999999999999 110.788 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 921' ' ' ARG . . . . . 0.435 ' HB3' ' CZ ' ' A' ' 950' ' ' PHE . 27.5 ptt85 -84.99 -42.2 15.11 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 106.013 -1.847 . . . . 4.4199999999999999 106.013 176.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 922' ' ' VAL . . . . . . . . . . . . . 74.6 t -101.96 74.29 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 105.76 -1.941 . . . . 0.84999999999999998 105.76 175.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -85.79 134.91 33.91 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.758 0.789 . . . . 2.46 111.545 -177.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 7.0 t -147.09 105.67 3.81 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 108.772 -0.825 . . . . 0.69999999999999996 108.772 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -103.46 83.49 0.42 Allowed Glycine 0 N--CA 1.487 2.035 0 N-CA-C 108.243 -1.943 . . . . 0.040000000000000001 108.243 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.226 0 N-CA-C 108.82 -1.712 . . . . 0.040000000000000001 108.82 -179.543 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 24.8 m . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.054 0.455 . . . . 13.779999999999999 110.29 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 95.7 mt -112.17 130.01 56.05 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.519 -0.738 . . . . 13.76 110.362 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -151.77 168.71 31.16 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.229 -1.548 . . . . 9.1300000000000008 109.229 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 949' ' ' VAL . . . . . . . . . . . . . 32.7 m -118.28 130.1 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.573 -0.957 . . . . 7.0800000000000001 110.691 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 950' ' ' PHE . . . . . 0.441 ' CZ ' ' HD2' ' A' ' 955' ' ' PRO . 50.0 p90 -135.18 152.46 51.61 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.57 -0.706 . . . . 7.5899999999999999 109.508 179.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 23.1 m -118.45 -54.52 2.27 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.44 -0.787 . . . . 5.0300000000000002 112.007 -178.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 952' ' ' LEU . . . . . 0.437 ' O ' ' O ' ' A' ' 953' ' ' ILE . 12.3 tp -62.05 -74.26 0.09 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.432 -0.793 . . . . 1.01 112.081 -177.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 953' ' ' ILE . . . . . 0.505 ' O ' ' HB3' ' A' ' 954' ' ' LEU . 1.5 pp -51.56 -149.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.713 0 N-CA-C 114.18 1.178 . . . . 2.6000000000000001 114.18 -176.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 954' ' ' LEU . . . . . 0.529 ' N ' ' CD1' ' A' ' 954' ' ' LEU . 0.0 OUTLIER 166.32 90.69 0.02 OUTLIER Pre-proline 0 N--CA 1.519 2.982 0 O-C-N 121.179 -0.951 . . . . 0.050000000000000003 111.755 179.174 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 955' ' ' PRO . . . . . 0.441 ' HD2' ' CZ ' ' A' ' 950' ' ' PHE . 51.7 Cg_endo -78.92 98.28 1.18 Allowed 'Trans proline' 0 C--N 1.315 -1.198 0 N-CA-C 109.037 -1.178 . . . . 0.83999999999999997 109.037 178.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 956' ' ' LEU . . . . . 0.408 ' CD2' ' NH1' ' A' ' 914' ' ' ARG . 11.1 mp -121.27 141.93 50.42 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.994 -1.066 . . . . 0.040000000000000001 109.954 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -84.5 150.86 24.98 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 117.782 -1.104 . . . . 1.28 111.842 -178.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -68.43 118.9 12.09 Favored 'General case' 0 N--CA 1.509 2.525 0 CA-C-N 123.034 2.652 . . . . 0.17000000000000001 111.431 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 93.03 -21.25 40.92 Favored Glycine 0 N--CA 1.5 2.959 0 N-CA-C 111.034 -0.826 . . . . 0.040000000000000001 111.034 178.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 960' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -56.57 170.46 0.38 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.426 -1.044 . . . . 0.040000000000000001 110.112 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 961' ' ' THR . . . . . 0.463 ' HA ' ' O ' ' A' ' 886' ' ' PHE . 42.1 m -135.94 137.76 41.65 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.906 -1.121 . . . . 1.78 112.282 -178.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 962' ' ' VAL . . . . . 0.42 ' CG2' ' CB ' ' A' ' 886' ' ' PHE . 33.6 m -98.14 145.37 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 C-N-CA 120.142 -0.623 . . . . 0.040000000000000001 110.352 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 5.2 t -137.4 145.02 42.73 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.792 -0.568 . . . . 0.71999999999999997 110.041 -178.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 964' ' ' VAL . . . . . 0.475 ' HA ' ' HA ' ' A' ' 911' ' ' VAL . 61.2 t -93.21 136.72 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.16 -0.963 . . . . 1.05 110.495 -179.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -93.73 127.42 39.43 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 103.613 -2.736 . . . . 3.02 103.613 173.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 966' ' ' LEU . . . . . 0.401 ' O ' ' CG2' ' A' ' 967' ' ' VAL . 4.1 tt -132.51 61.11 1.67 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.21 -1.033 . . . . 1.46 108.21 177.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 967' ' ' VAL . . . . . 0.401 ' CG2' ' O ' ' A' ' 966' ' ' LEU . 97.2 t -157.87 96.74 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 108.12 -1.067 . . . . 1.9399999999999999 108.12 179.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 88.1 mmm -143.66 59.16 1.38 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.747 -1.22 . . . . 0.0 108.34 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.13 119.64 1.95 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 107.107 -2.397 . . . . 2.1099999999999999 107.107 -178.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -82.17 -58.35 2.99 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.023 -1.281 . . . . 5.8899999999999997 110.378 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 46.7 tp -58.89 90.84 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.434 -0.791 . . . . 4.3600000000000003 110.244 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -142.0 -154.37 0.52 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.595 -0.691 . . . . 1.8300000000000001 110.208 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -119.53 170.7 8.93 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.479 -0.763 . . . . 4.3499999999999996 110.252 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 9.5 t -101.63 130.4 47.96 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.548 -0.72 . . . . 1.27 110.12 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -155.89 158.77 38.54 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.482 -0.761 . . . . 5.0199999999999996 110.41 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.5 85.72 17.32 Favored Pre-proline 0 N--CA 1.501 2.078 0 O-C-N 121.618 -0.676 . . . . 2.4100000000000001 109.87 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -73.61 -172.65 1.12 Allowed 'Trans proline' 0 C--N 1.318 -1.059 0 O-C-N 123.303 1.159 . . . . 0.95999999999999996 111.277 -179.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 5.4 mp -127.47 155.39 43.79 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.728 -1.212 . . . . 0.62 107.728 178.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 979' ' ' THR . . . . . . . . . . . . . 37.1 p -150.23 141.11 22.83 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.762 -1.212 . . . . 3.5699999999999998 111.186 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 980' ' ' ILE . . . . . . . . . . . . . 51.4 mm -107.38 128.76 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 109.099 -0.704 . . . . 1.3300000000000001 109.099 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 981' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -119.39 99.29 6.59 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 119.821 -0.752 . . . . 0.050000000000000003 111.8 -178.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 42.6 p -106.78 158.25 17.13 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.814 -0.81 . . . . 0.87 108.814 178.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . -172.78 110.13 0.33 Allowed Glycine 0 N--CA 1.498 2.803 0 N-CA-C 106.649 -2.58 . . . . 0.029999999999999999 106.649 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -110.67 149.67 30.13 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 114.551 1.315 . . . . 0.69999999999999996 114.551 -175.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 54.4 tp -70.73 133.9 47.0 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.816 -1.177 . . . . 0.040000000000000001 109.808 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 51.0 tp -107.37 -59.04 1.88 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.499 -0.751 . . . . 0.040000000000000001 109.989 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -144.47 145.06 31.67 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.565 -1.272 . . . . 0.040000000000000001 107.565 179.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.97 163.12 12.17 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 108.139 -1.984 . . . . 0.040000000000000001 108.139 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -75.3 112.5 18.97 Favored Pre-proline 0 N--CA 1.498 1.973 0 CA-C-N 118.52 1.16 . . . . 0.040000000000000001 109.482 179.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 990' ' ' PRO . . . . . 0.414 ' O ' ' HB2' ' A' ' 991' ' ' GLU . 50.2 Cg_endo -90.07 71.24 1.59 Allowed 'Trans proline' 0 C--N 1.319 -0.998 0 O-C-N 123.124 1.065 . . . . 0.45000000000000001 111.39 -178.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 991' ' ' GLU . . . . . 0.414 ' HB2' ' O ' ' A' ' 990' ' ' PRO . 69.8 mt-10 67.36 -73.94 0.07 Allowed 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 108.494 -0.928 . . . . 1.97 108.494 -177.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 992' ' ' LEU . . . . . . . . . . . . . 10.4 mt 50.92 20.64 0.82 Allowed 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.579 -0.701 . . . . 2.3799999999999999 111.647 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -94.2 156.85 16.34 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.888 -1.132 . . . . 3.79 109.959 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 72.2 m80 -146.24 93.44 2.32 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.571 -0.706 . . . . 3.5099999999999998 110.23 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 995' ' ' ALA . . . . . . . . . . . . 2.519 . . . . . . . 0 N--CA 1.503 2.219 0 O-C-N 120.821 -1.174 . . . . 2.73 110.574 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo . . . . . 0 N--CA 1.488 1.203 0 N-CA-C 109.502 -0.999 . . . . 3.8300000000000001 109.502 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 847' ' ' VAL . . . . . . . . . . . . . 59.8 t -132.05 103.57 14.15 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.638 -0.664 . . . . 1.8300000000000001 110.074 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 848' ' ' PRO . . . . . 0.41 ' O ' ' C ' ' B' ' 849' ' ' GLN . 44.0 Cg_endo -69.7 -20.23 35.41 Favored 'Trans proline' 0 N--CA 1.487 1.097 0 O-C-N 123.236 1.124 . . . . 0.65000000000000002 111.123 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 849' ' ' GLN . . . . . 0.41 ' C ' ' O ' ' B' ' 848' ' ' PRO . 56.3 tt0 26.67 69.7 0.05 Allowed 'General case' 0 N--CA 1.519 2.979 0 N-CA-C 112.84 0.682 . . . . 2.5800000000000001 112.84 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 850' ' ' VAL . . . . . . . . . . . . . 59.6 t -117.91 137.81 50.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.237 -0.915 . . . . 1.0900000000000001 111.616 -178.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 851' ' ' ALA . . . . . . . . . . . . . . . -128.06 154.76 45.32 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 105.707 -1.96 . . . . 0.040000000000000001 105.707 176.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 852' ' ' PHE . . . . . 0.415 ' HA ' ' CB ' ' B' ' 874' ' ' ASN . 20.8 p90 -159.64 129.35 5.42 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 121.006 1.73 . . . . 0.050000000000000003 108.742 179.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 32.7 t -175.75 134.25 0.28 Allowed 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.137 -1.061 . . . . 0.040000000000000001 108.137 -179.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -134.56 158.63 43.5 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.123 -0.985 . . . . 0.67000000000000004 109.526 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 855' ' ' ALA . . . . . . . . . . . . . . . -122.84 141.17 52.15 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.919 0.866 . . . . 0.51000000000000001 111.843 -178.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 856' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -107.8 135.18 49.65 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.276 -0.638 . . . . 0.050000000000000003 109.276 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 857' ' ' SER . . . . . 0.434 ' O ' ' O ' ' B' ' 858' ' ' LEU . 17.0 p -152.78 17.98 0.6 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.474 -0.766 . . . . 1.3300000000000001 111.144 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 858' ' ' LEU . . . . . 0.434 ' O ' ' O ' ' B' ' 857' ' ' SER . 3.1 pp -29.82 154.14 0.03 OUTLIER Pre-proline 0 N--CA 1.521 3.087 0 N-CA-C 113.337 0.866 . . . . 2.3300000000000001 113.337 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -61.82 -88.75 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.541 0 O-C-N 123.149 1.078 . . . . 2.3199999999999998 113.681 -177.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 53.4 ptt85 -127.2 -142.19 0.27 Allowed 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.86 -1.15 . . . . 0.040000000000000001 111.403 -177.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 37.0 m -39.12 118.63 0.81 Allowed 'General case' 0 N--CA 1.51 2.531 0 O-C-N 121.479 -0.763 . . . . 1.3100000000000001 111.9 -178.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 862' ' ' GLU . . . . . 0.433 ' CG ' ' HD2' ' B' ' 863' ' ' PRO . 24.6 tt0 -96.89 149.68 36.01 Favored Pre-proline 0 N--CA 1.489 1.484 0 N-CA-C 108.162 -1.051 . . . . 4.5099999999999998 108.162 177.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 863' ' ' PRO . . . . . 0.433 ' HD2' ' CG ' ' B' ' 862' ' ' GLU . 41.5 Cg_endo -67.69 -13.38 38.61 Favored 'Trans proline' 0 C--N 1.316 -1.181 0 O-C-N 123.015 1.008 . . . . 2.2400000000000002 111.385 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -174.0 -136.88 2.3 Favored Glycine 0 N--CA 1.494 2.501 0 C-N-CA 119.836 -1.174 . . . . 0.040000000000000001 110.665 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 37.2 m -69.55 160.19 31.95 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.276 -1.132 . . . . 1.51 111.75 -178.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 866' ' ' VAL . . . . . . . . . . . . . 26.9 m -90.31 132.75 34.74 Favored Pre-proline 0 N--CA 1.495 1.782 0 N-CA-C 113.419 0.896 . . . . 0.78000000000000003 113.419 -175.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 867' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -88.83 -154.05 0.05 OUTLIER 'Trans proline' 0 C--N 1.322 -0.817 0 N-CA-C 107.679 -1.7 . . . . 0.92000000000000004 107.679 177.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 868' ' ' PHE . . . . . 0.442 ' CD1' ' HG2' ' B' ' 881' ' ' PRO . 31.6 p90 -148.39 119.13 7.52 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.446 -1.409 . . . . 0.050000000000000003 109.874 179.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 50.1 p-10 -112.57 -2.84 14.49 Favored 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 119.284 -0.967 . . . . 1.7 112.153 -178.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 870' ' ' ARG . . . . . . . . . . . . . 26.0 mmm180 -90.32 88.62 7.28 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.977 -1.077 . . . . 2.5899999999999999 110.682 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 57.5 t -75.23 97.03 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.004 -1.06 . . . . 1.9399999999999999 109.661 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 872' ' ' LEU . . . . . . . . . . . . . 95.4 mt -84.29 -46.75 11.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.541 -0.724 . . . . 1.0600000000000001 110.273 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 873' ' ' LEU . . . . . . . . . . . . . 48.8 tp -174.66 104.43 0.1 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.265 -0.897 . . . . 4.1799999999999997 108.605 178.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 874' ' ' ASN . . . . . 0.415 ' CB ' ' HA ' ' B' ' 852' ' ' PHE . 36.5 t-20 178.67 82.27 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.654 -0.653 . . . . 0.040000000000000001 109.647 -178.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -67.09 -47.1 72.23 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 119.29 -0.964 . . . . 3.3799999999999999 111.244 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 876' ' ' GLY . . . . . 0.419 ' HA3' ' CE2' ' B' ' 878' ' ' TYR . . . -74.49 -25.58 69.93 Favored Glycine 0 N--CA 1.494 2.566 0 O-C-N 121.217 -0.927 . . . . 0.040000000000000001 111.813 -178.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 84.48 -59.74 4.89 Favored Glycine 0 N--CA 1.502 3.038 0 N-CA-C 108.11 -1.996 . . . . 0.040000000000000001 108.11 -178.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 878' ' ' TYR . . . . . 0.419 ' CE2' ' HA3' ' B' ' 876' ' ' GLY . 97.7 m-85 60.74 -66.13 0.05 Allowed 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 114.348 1.24 . . . . 3.46 114.348 177.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 879' ' ' TYR . . . . . 0.46 ' CB ' ' CD2' ' B' ' 886' ' ' PHE . 23.5 p90 -112.39 109.15 18.6 Favored 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 114.773 1.398 . . . . 0.040000000000000001 114.773 -176.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -65.17 118.47 50.03 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.396 -0.815 . . . . 0.02 109.999 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 881' ' ' PRO . . . . . 0.442 ' HG2' ' CD1' ' B' ' 868' ' ' PHE . 55.4 Cg_endo -76.84 0.17 9.91 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 O-C-N 123.432 1.227 . . . . 0.39000000000000001 112.143 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -76.66 -64.95 1.0 Allowed 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 106.963 -1.495 . . . . 0.81000000000000005 106.963 178.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 31.0 p -94.13 -17.25 22.97 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.784 -0.821 . . . . 0.040000000000000001 108.784 177.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.49 22.49 56.27 Favored Glycine 0 N--CA 1.494 2.541 0 O-C-N 121.091 -1.006 . . . . 0.029999999999999999 110.793 178.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 885' ' ' VAL . . . . . . . . . . . . . 79.4 t -73.41 90.74 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 C-N-CA 118.274 -1.371 . . . . 1.01 108.151 -179.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 886' ' ' PHE . . . . . 0.46 ' CD2' ' CB ' ' B' ' 879' ' ' TYR . 0.6 OUTLIER -90.63 104.42 17.01 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 115.281 -0.872 . . . . 0.050000000000000003 112.244 -177.264 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 887' ' ' THR . . . . . 0.401 ' O ' ' HD3' ' B' ' 889' ' ' PRO . 90.3 m -95.06 101.03 12.76 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 107.774 -1.195 . . . . 0.68000000000000005 107.774 177.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 888' ' ' ALA . . . . . . . . . . . . . . . -99.4 106.28 38.32 Favored Pre-proline 0 N--CA 1.499 2.022 0 N-CA-C 114.042 1.127 . . . . 0.25 114.042 -176.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 889' ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' B' ' 887' ' ' THR . 54.4 Cg_endo -89.08 -12.08 3.47 Favored 'Trans proline' 0 CA--C 1.546 1.094 0 N-CA-C 108.981 -1.199 . . . . 1.6399999999999999 108.981 176.094 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 890' ' ' LEU . . . . . . . . . . . . . 4.9 tt -35.2 -51.21 0.56 Allowed 'General case' 0 N--CA 1.507 2.414 0 N-CA-C 113.903 1.075 . . . . 2.29 113.903 -177.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 51.7 95.04 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.347 0 O-C-N 121.192 -0.942 . . . . 0.63 110.193 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . 156.02 -147.36 15.91 Favored Glycine 0 N--CA 1.479 1.548 0 N-CA-C 107.335 -2.306 . . . . 0.040000000000000001 107.335 -178.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 72.5 ttt-85 -108.97 127.94 54.51 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 107.845 -1.168 . . . . 3.0 107.845 177.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 894' ' ' TYR . . . . . 0.456 ' CD1' ' N ' ' B' ' 895' ' ' LEU . 0.2 OUTLIER -130.86 144.63 51.6 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.023 -1.048 . . . . 0.040000000000000001 110.082 -179.258 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 895' ' ' LEU . . . . . 0.456 ' N ' ' CD1' ' B' ' 894' ' ' TYR . 34.4 tp -99.69 115.03 28.52 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.523 -0.736 . . . . 1.27 109.825 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 896' ' ' LEU . . . . . 0.413 ' HB2' ' CZ ' ' B' ' 894' ' ' TYR . 9.9 tt -111.93 145.63 39.23 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.576 -0.703 . . . . 0.93999999999999995 110.537 -179.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 897' ' ' SER . . . . . . . . . . . . . 71.2 m -144.52 118.86 9.58 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.389 -0.819 . . . . 0.040000000000000001 110.812 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.71 147.66 30.45 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.733 -0.604 . . . . 0.47999999999999998 109.489 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 899' ' ' VAL . . . . . . . . . . . . . 88.3 t -91.89 120.92 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.469 -0.769 . . . . 0.55000000000000004 111.006 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 900' ' ' LEU . . . . . 0.434 ' N ' ' CD2' ' B' ' 900' ' ' LEU . 4.4 mm? -94.85 111.3 23.1 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 114.498 1.296 . . . . 1.5900000000000001 114.498 -174.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 17.1 m -67.45 141.47 56.98 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 107.277 -1.379 . . . . 0.050000000000000003 107.277 176.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -68.02 -65.05 2.84 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 110.724 -0.951 . . . . 0.029999999999999999 110.724 -179.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 5.9 m170 46.81 66.43 0.99 Allowed 'General case' 0 N--CA 1.508 2.454 0 O-C-N 121.454 -1.027 . . . . 3.2000000000000002 111.093 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 54.0 ptt85 -69.33 -6.19 28.08 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.645 -0.66 . . . . 2.9199999999999999 112.106 -179.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 905' ' ' HIS . . . . . 0.484 ' O ' ' CB ' ' B' ' 906' ' ' GLU . 73.8 t60 -62.03 4.53 0.12 Allowed 'General case' 0 N--CA 1.506 2.352 0 O-C-N 120.906 -1.122 . . . . 2.8700000000000001 113.131 -179.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 906' ' ' GLU . . . . . 0.484 ' CB ' ' O ' ' B' ' 905' ' ' HIS . 0.7 OUTLIER 95.25 -165.11 0.0 OUTLIER 'General case' 0 N--CA 1.529 3.478 0 CA-C-N 120.605 1.548 . . . . 0.98999999999999999 111.914 179.089 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 907' ' ' LYS . . . . . 0.465 ' CB ' ' O ' ' B' ' 906' ' ' GLU . 61.9 tttt 86.3 156.4 0.08 Allowed 'General case' 0 N--CA 1.519 3.01 0 N-CA-C 107.982 -1.118 . . . . 5.25 107.982 -176.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 60.9 t -121.86 117.21 51.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 120.757 -1.214 . . . . 0.39000000000000001 111.351 -179.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 54.2 tp10 -101.26 133.43 45.84 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 107.295 -1.372 . . . . 1.72 107.295 176.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -156.05 123.32 5.41 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 106.759 -1.571 . . . . 0.67000000000000004 106.759 178.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 911' ' ' VAL . . . . . 0.467 ' HA ' ' HA ' ' B' ' 964' ' ' VAL . 92.5 t -84.65 132.23 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.89 -0.506 . . . . 0.54000000000000004 110.972 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 60.2 mt -67.06 157.78 32.69 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.417 -0.802 . . . . 1.5 109.303 178.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 913' ' ' SER . . . . . 0.405 ' CB ' ' CG1' ' B' ' 919' ' ' VAL . 1.4 p -125.11 136.78 53.98 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.105 -1.072 . . . . 1.3700000000000001 108.105 176.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 914' ' ' ARG . . . . . 0.416 ' O ' ' CB ' ' B' ' 915' ' ' SER . 0.1 OUTLIER -64.53 155.21 33.66 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 120.628 -1.295 . . . . 4.2999999999999998 111.428 -179.034 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 915' ' ' SER . . . . . 0.416 ' CB ' ' O ' ' B' ' 914' ' ' ARG . 1.7 p 83.53 -31.93 0.08 Allowed 'General case' 0 N--CA 1.521 3.119 0 C-N-CA 123.915 0.886 . . . . 2.0499999999999998 112.077 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 916' ' ' ASN . . . . . 0.403 ' O ' ' HB2' ' B' ' 917' ' ' GLN . 99.4 m-20 -122.34 -22.19 5.6 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.895 -1.128 . . . . 2.71 111.2 -179.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 917' ' ' GLN . . . . . 0.403 ' HB2' ' O ' ' B' ' 916' ' ' ASN . 43.8 mt-30 67.08 165.98 0.22 Allowed 'General case' 0 N--CA 1.519 3.021 0 N-CA-C 105.762 -1.94 . . . . 2.6800000000000002 105.762 -174.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.99 -125.29 35.19 Favored Glycine 1 N--CA 1.521 4.322 0 CA-C-N 123.492 2.86 . . . . 0.029999999999999999 106.905 -177.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 919' ' ' VAL . . . . . 0.405 ' CG1' ' CB ' ' B' ' 913' ' ' SER . 91.5 t 52.24 95.1 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 O-C-N 121.393 -1.063 . . . . 1.3899999999999999 109.119 -178.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.06 90.95 8.07 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.249 -0.981 . . . . 0.029999999999999999 110.723 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 921' ' ' ARG . . . . . 0.434 ' HB3' ' CZ ' ' B' ' 950' ' ' PHE . 27.6 ptt85 -84.96 -42.18 15.19 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 106.02 -1.844 . . . . 4.4199999999999999 106.02 176.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 922' ' ' VAL . . . . . . . . . . . . . 75.0 t -101.9 74.02 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 105.833 -1.914 . . . . 0.84999999999999998 105.833 175.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -85.55 135.01 33.99 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.74 0.781 . . . . 2.46 111.553 -177.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 924' ' ' SER . . . . . . . . . . . . . 6.8 t -147.12 105.51 3.78 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 108.77 -0.826 . . . . 0.69999999999999996 108.77 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -103.2 83.42 0.43 Allowed Glycine 0 N--CA 1.487 2.052 0 N-CA-C 108.307 -1.917 . . . . 0.040000000000000001 108.307 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.223 0 N-CA-C 108.865 -1.694 . . . . 0.040000000000000001 108.865 -179.6 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 25.3 m . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.042 0.449 . . . . 13.779999999999999 110.296 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 95.8 mt -111.64 129.96 55.92 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.508 -0.745 . . . . 13.76 110.389 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -151.67 168.33 31.06 Favored Glycine 0 N--CA 1.493 2.5 0 N-CA-C 109.243 -1.543 . . . . 9.1300000000000008 109.243 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 949' ' ' VAL . . . . . . . . . . . . . 31.6 m -118.09 130.17 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.515 -0.991 . . . . 7.0800000000000001 110.666 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 950' ' ' PHE . . . . . 0.434 ' CZ ' ' HB3' ' B' ' 921' ' ' ARG . 49.0 p90 -135.16 152.51 51.67 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.582 -0.699 . . . . 7.5899999999999999 109.466 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 23.3 m -118.52 -54.09 2.29 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.424 -0.797 . . . . 5.0300000000000002 111.922 -178.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 952' ' ' LEU . . . . . 0.434 ' O ' ' O ' ' B' ' 953' ' ' ILE . 12.5 tp -62.3 -74.43 0.09 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.352 -0.842 . . . . 1.01 112.056 -177.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 953' ' ' ILE . . . . . 0.503 ' O ' ' HB3' ' B' ' 954' ' ' LEU . 1.4 pp -51.48 -149.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.782 0 N-CA-C 114.22 1.193 . . . . 2.6000000000000001 114.22 -176.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 954' ' ' LEU . . . . . 0.529 ' N ' ' CD1' ' B' ' 954' ' ' LEU . 0.0 OUTLIER 166.07 90.59 0.02 OUTLIER Pre-proline 0 N--CA 1.518 2.944 0 O-C-N 121.107 -0.996 . . . . 0.050000000000000003 111.67 179.156 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 955' ' ' PRO . . . . . 0.432 ' HD2' ' CZ ' ' B' ' 950' ' ' PHE . 51.6 Cg_endo -78.96 98.48 1.19 Allowed 'Trans proline' 0 C--N 1.315 -1.205 0 N-CA-C 109.014 -1.187 . . . . 0.83999999999999997 109.014 178.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 956' ' ' LEU . . . . . 0.413 ' CD2' ' NH1' ' B' ' 914' ' ' ARG . 11.1 mp -121.47 141.97 50.5 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.973 -1.079 . . . . 0.040000000000000001 109.943 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -84.46 151.11 24.83 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 117.844 -1.074 . . . . 1.28 111.777 -178.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -68.6 118.66 11.91 Favored 'General case' 0 N--CA 1.508 2.466 0 CA-C-N 122.96 2.618 . . . . 0.17000000000000001 111.368 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 93.2 -21.48 40.03 Favored Glycine 0 N--CA 1.5 2.925 0 N-CA-C 111.056 -0.817 . . . . 0.040000000000000001 111.056 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 960' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -56.31 170.55 0.34 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.488 -1.007 . . . . 0.040000000000000001 110.149 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 961' ' ' THR . . . . . 0.457 ' HA ' ' O ' ' B' ' 886' ' ' PHE . 42.1 m -135.96 137.81 41.68 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.945 -1.097 . . . . 1.78 112.291 -178.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 962' ' ' VAL . . . . . 0.426 ' CG2' ' CB ' ' B' ' 886' ' ' PHE . 33.7 m -98.29 145.19 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.712 -0.618 . . . . 0.040000000000000001 110.404 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 5.2 t -137.1 145.13 43.54 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.885 -0.509 . . . . 0.71999999999999997 110.084 -178.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 964' ' ' VAL . . . . . 0.467 ' HA ' ' HA ' ' B' ' 911' ' ' VAL . 61.1 t -93.4 136.39 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.133 -0.98 . . . . 1.05 110.499 -179.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -93.68 127.05 39.19 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 103.651 -2.722 . . . . 3.02 103.651 173.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 966' ' ' LEU . . . . . 0.406 ' O ' ' CG2' ' B' ' 967' ' ' VAL . 4.1 tt -132.14 61.24 1.66 Allowed 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.288 -1.004 . . . . 1.46 108.288 177.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 967' ' ' VAL . . . . . 0.406 ' CG2' ' O ' ' B' ' 966' ' ' LEU . 97.9 t -158.0 96.53 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 108.143 -1.058 . . . . 1.9399999999999999 108.143 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 88.1 mmm -143.39 58.85 1.39 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.733 -1.229 . . . . 0.0 108.375 178.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.24 119.51 1.93 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 107.222 -2.351 . . . . 2.1099999999999999 107.222 -178.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -81.9 -58.31 3.04 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.036 -1.273 . . . . 5.8899999999999997 110.415 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 46.9 tp -58.99 90.62 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.437 -0.789 . . . . 4.3600000000000003 110.249 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -141.78 -154.33 0.51 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.536 -0.728 . . . . 1.8300000000000001 110.24 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -119.51 170.89 8.76 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.498 -0.751 . . . . 4.3499999999999996 110.276 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 9.5 t -101.76 130.44 48.17 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.528 -0.733 . . . . 1.27 110.086 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -155.91 158.81 38.59 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.49 -0.756 . . . . 5.0199999999999996 110.443 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.47 85.67 17.49 Favored Pre-proline 0 N--CA 1.501 2.077 0 O-C-N 121.588 -0.695 . . . . 2.4100000000000001 109.906 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -73.63 -172.73 1.14 Allowed 'Trans proline' 0 C--N 1.317 -1.13 0 O-C-N 123.326 1.172 . . . . 0.95999999999999996 111.248 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 978' ' ' LEU . . . . . . . . . . . . . 5.4 mp -127.34 155.55 43.4 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 107.762 -1.199 . . . . 0.62 107.762 178.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 979' ' ' THR . . . . . . . . . . . . . 37.0 p -150.32 141.12 22.76 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.811 -1.181 . . . . 3.5699999999999998 111.157 -179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 980' ' ' ILE . . . . . 0.442 HG22 HD11 ' B' ' 980' ' ' ILE . 51.4 mm -107.44 128.59 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 109.135 -0.691 . . . . 1.3300000000000001 109.135 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -119.2 99.29 6.62 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.461 -0.774 . . . . 0.050000000000000003 111.802 -178.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 43.2 p -106.79 158.24 17.14 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.834 -0.802 . . . . 0.87 108.834 178.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 983' ' ' GLY . . . . . . . . . . . . . . . -172.77 110.16 0.33 Allowed Glycine 0 N--CA 1.499 2.87 0 N-CA-C 106.685 -2.566 . . . . 0.029999999999999999 106.685 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -110.75 149.61 30.27 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 114.539 1.311 . . . . 0.69999999999999996 114.539 -175.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 985' ' ' LEU . . . . . . . . . . . . . 54.2 tp -70.71 133.84 46.95 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.874 -1.142 . . . . 0.040000000000000001 109.808 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 986' ' ' LEU . . . . . . . . . . . . . 50.6 tp -107.39 -59.01 1.88 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.547 -0.721 . . . . 0.040000000000000001 110.009 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -144.46 144.87 31.59 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.592 -1.262 . . . . 0.040000000000000001 107.592 179.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.84 162.95 12.2 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 108.117 -1.993 . . . . 0.040000000000000001 108.117 179.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -75.15 112.59 19.02 Favored Pre-proline 0 N--CA 1.498 1.938 0 O-C-N 121.226 -1.161 . . . . 0.040000000000000001 109.439 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 990' ' ' PRO . . . . . 0.412 ' O ' ' HB2' ' B' ' 991' ' ' GLU . 49.9 Cg_endo -90.05 71.27 1.6 Allowed 'Trans proline' 0 C--N 1.319 -0.976 0 O-C-N 123.119 1.062 . . . . 0.45000000000000001 111.339 -178.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 991' ' ' GLU . . . . . 0.412 ' HB2' ' O ' ' B' ' 990' ' ' PRO . 70.0 mt-10 67.29 -73.93 0.07 Allowed 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 108.463 -0.94 . . . . 1.97 108.463 -177.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 992' ' ' LEU . . . . . . . . . . . . . 10.4 mt 51.11 20.4 0.85 Allowed 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.587 -0.696 . . . . 2.3799999999999999 111.679 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -93.94 156.95 16.35 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.914 -1.116 . . . . 3.79 109.974 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 71.9 m80 -146.33 92.8 2.22 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.561 -0.712 . . . . 3.5099999999999998 110.382 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 995' ' ' ALA . . . . . . . . . . . . 2.518 . . . . . . . 0 N--CA 1.503 2.223 0 O-C-N 120.924 -1.11 . . . . 2.73 110.581 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo . . . . . 0 N--CA 1.487 1.142 0 N-CA-C 109.526 -0.99 . . . . 3.8300000000000001 109.526 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 847' ' ' VAL . . . . . . . . . . . . . 59.5 t -126.81 106.2 22.84 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 121.68 -0.638 . . . . 1.8300000000000001 109.989 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 848' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -69.52 -22.17 33.57 Favored 'Trans proline' 0 N--CA 1.488 1.152 0 O-C-N 123.238 1.125 . . . . 0.65000000000000002 111.09 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 849' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 24.93 64.6 0.05 Allowed 'General case' 0 N--CA 1.518 2.945 0 N-CA-C 113.605 0.965 . . . . 2.5800000000000001 113.605 179.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 850' ' ' VAL . . . . . . . . . . . . . 78.9 t -120.23 134.91 62.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.105 -0.997 . . . . 1.0900000000000001 110.948 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 851' ' ' ALA . . . . . . . . . . . . . . . -127.78 155.28 44.29 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 105.745 -1.946 . . . . 0.040000000000000001 105.745 176.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 852' ' ' PHE . . . . . 0.413 ' HA ' ' CB ' ' C' ' 874' ' ' ASN . 13.5 p90 -161.56 126.96 3.6 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 121.011 1.732 . . . . 0.050000000000000003 108.683 179.017 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 24.2 t -177.06 135.32 0.2 Allowed 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.039 -1.096 . . . . 0.040000000000000001 108.039 -179.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -132.5 158.32 42.39 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.042 -1.036 . . . . 0.67000000000000004 109.96 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 855' ' ' ALA . . . . . . . . . . . . . . . -122.27 139.75 53.43 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.773 0.797 . . . . 0.51000000000000001 111.051 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 856' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -112.61 139.41 48.23 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.692 -0.63 . . . . 0.050000000000000003 110.252 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 857' ' ' SER . . . . . 0.426 ' O ' ' O ' ' C' ' 858' ' ' LEU . 1.4 m -155.96 19.92 0.38 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.585 -0.697 . . . . 1.3300000000000001 111.07 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 858' ' ' LEU . . . . . 0.426 ' O ' ' O ' ' C' ' 857' ' ' SER . 2.3 pp -34.83 161.44 0.04 OUTLIER Pre-proline 0 N--CA 1.517 2.898 0 N-CA-C 113.171 0.804 . . . . 2.3300000000000001 113.171 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -61.68 -87.72 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 120.894 1.062 . . . . 2.3199999999999998 113.495 -178.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 55.3 ptt85 -130.6 -143.26 0.24 Allowed 'General case' 0 N--CA 1.501 2.122 0 O-C-N 120.811 -1.18 . . . . 0.040000000000000001 111.923 -177.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 14.6 m -37.54 129.17 1.07 Allowed 'General case' 0 N--CA 1.51 2.548 0 O-C-N 121.592 -0.693 . . . . 1.3100000000000001 112.537 -178.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.41 160.51 25.8 Favored Pre-proline 0 N--CA 1.489 1.523 0 N-CA-C 108.263 -1.014 . . . . 4.5099999999999998 108.263 177.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -71.62 -13.82 30.08 Favored 'Trans proline' 0 C--N 1.314 -1.282 0 O-C-N 123.184 1.097 . . . . 2.2400000000000002 111.507 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -177.33 -136.18 2.39 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.658 -1.377 . . . . 0.040000000000000001 109.658 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 22.8 m -68.2 154.5 41.59 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.388 -1.066 . . . . 1.51 110.249 -179.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 866' ' ' VAL . . . . . 0.401 ' CG1' ' CD2' ' C' ' 858' ' ' LEU . 46.0 t -98.68 139.19 20.93 Favored Pre-proline 0 N--CA 1.496 1.845 0 N-CA-C 113.366 0.876 . . . . 0.78000000000000003 113.366 -174.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 867' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -91.35 -147.64 0.03 OUTLIER 'Trans proline' 0 CA--C 1.545 1.065 0 O-C-N 123.583 1.307 . . . . 0.92000000000000004 108.847 177.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 868' ' ' PHE . . . . . 0.456 ' CD1' ' HG2' ' C' ' 881' ' ' PRO . 23.7 p90 -150.01 125.56 10.28 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.584 -1.323 . . . . 0.050000000000000003 110.101 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 42.4 p-10 -112.64 -3.08 14.37 Favored 'General case' 0 N--CA 1.499 2.001 0 C-N-CA 119.281 -0.967 . . . . 1.7 112.467 -178.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 870' ' ' ARG . . . . . . . . . . . . . 23.8 mmm180 -91.72 89.11 6.96 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.905 -1.122 . . . . 2.5899999999999999 110.991 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 57.9 t -70.71 97.47 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.039 -1.038 . . . . 1.9399999999999999 109.951 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 872' ' ' LEU . . . . . . . . . . . . . 82.8 mt -83.44 -47.39 11.45 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.485 -0.759 . . . . 1.0600000000000001 110.272 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 873' ' ' LEU . . . . . 0.4 ' O ' ' HB2' ' C' ' 874' ' ' ASN . 42.7 tp -174.45 103.53 0.1 Allowed 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.507 -0.923 . . . . 4.1799999999999997 108.507 178.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 874' ' ' ASN . . . . . 0.413 ' CB ' ' HA ' ' C' ' 852' ' ' PHE . 35.9 t-20 178.55 82.22 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.612 -0.68 . . . . 0.040000000000000001 109.45 -178.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 22.9 p-10 -67.11 -46.24 74.76 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 119.245 -0.982 . . . . 3.3799999999999999 111.279 -179.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 876' ' ' GLY . . . . . 0.413 ' HA3' ' CE2' ' C' ' 878' ' ' TYR . . . -74.55 -26.09 68.53 Favored Glycine 0 N--CA 1.494 2.551 0 O-C-N 121.28 -0.888 . . . . 0.040000000000000001 111.614 -178.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 82.54 -61.06 4.79 Favored Glycine 0 N--CA 1.502 3.072 0 N-CA-C 108.118 -1.993 . . . . 0.040000000000000001 108.118 -178.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 878' ' ' TYR . . . . . 0.413 ' CE2' ' HA3' ' C' ' 876' ' ' GLY . 97.7 m-85 60.95 -65.39 0.06 Allowed 'General case' 0 N--CA 1.502 2.161 0 N-CA-C 114.384 1.253 . . . . 3.46 114.384 177.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 879' ' ' TYR . . . . . 0.473 ' CB ' ' CG ' ' C' ' 886' ' ' PHE . 22.8 p90 -112.58 109.38 18.9 Favored 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 114.823 1.416 . . . . 0.040000000000000001 114.823 -176.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.63 117.82 51.27 Favored Pre-proline 0 N--CA 1.497 1.894 0 O-C-N 121.377 -0.827 . . . . 0.02 109.89 179.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 881' ' ' PRO . . . . . 0.456 ' HG2' ' CD1' ' C' ' 868' ' ' PHE . 55.2 Cg_endo -77.03 0.45 9.69 Favored 'Trans proline' 0 N--CA 1.494 1.551 0 O-C-N 123.435 1.229 . . . . 0.39000000000000001 112.116 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -73.84 -64.33 1.03 Allowed 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 106.459 -1.682 . . . . 0.81000000000000005 106.459 178.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 9.2 p -94.82 -18.16 21.45 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.502 -0.925 . . . . 0.040000000000000001 108.502 177.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.56 21.16 57.0 Favored Glycine 0 N--CA 1.493 2.499 0 O-C-N 121.167 -0.958 . . . . 0.029999999999999999 111.046 178.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 96.8 t -72.33 89.89 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 C-N-CA 118.256 -1.377 . . . . 1.01 108.25 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 886' ' ' PHE . . . . . 0.473 ' CG ' ' CB ' ' C' ' 879' ' ' TYR . 0.7 OUTLIER -90.48 104.0 16.63 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 115.199 -0.909 . . . . 0.050000000000000003 112.038 -177.468 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 887' ' ' THR . . . . . . . . . . . . . 91.2 m -96.48 101.46 13.09 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 107.888 -1.153 . . . . 0.68000000000000005 107.888 177.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 888' ' ' ALA . . . . . . . . . . . . . . . -99.87 102.59 17.88 Favored Pre-proline 0 N--CA 1.502 2.152 0 N-CA-C 114.297 1.221 . . . . 0.25 114.297 -176.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 889' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -83.04 -13.11 9.26 Favored 'Trans proline' 0 CA--C 1.545 1.07 0 N-CA-C 109.01 -1.188 . . . . 1.6399999999999999 109.01 175.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 890' ' ' LEU . . . . . . . . . . . . . 71.7 mt -37.37 -49.87 1.01 Allowed 'General case' 0 N--CA 1.507 2.422 0 N-CA-C 113.679 0.992 . . . . 2.29 113.679 -177.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 52.63 96.73 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.358 0 O-C-N 121.117 -0.989 . . . . 0.63 110.211 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . 156.26 -147.64 16.51 Favored Glycine 0 N--CA 1.479 1.514 0 N-CA-C 107.252 -2.339 . . . . 0.040000000000000001 107.252 -179.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 74.2 ttt-85 -107.8 129.0 55.09 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 107.934 -1.136 . . . . 3.0 107.934 177.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 894' ' ' TYR . . . . . 0.449 ' CD1' ' N ' ' C' ' 895' ' ' LEU . 0.1 OUTLIER -131.16 144.05 51.07 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.058 -1.026 . . . . 0.040000000000000001 110.151 -179.246 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 895' ' ' LEU . . . . . 0.449 ' N ' ' CD1' ' C' ' 894' ' ' TYR . 37.4 tp -97.83 112.85 24.6 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.735 -0.603 . . . . 1.27 109.531 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 896' ' ' LEU . . . . . 0.432 ' HB2' ' CZ ' ' C' ' 894' ' ' TYR . 10.3 tt -110.27 143.78 39.95 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.583 -0.698 . . . . 0.93999999999999995 110.448 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 897' ' ' SER . . . . . . . . . . . . . 5.2 m -145.23 119.26 9.39 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.471 -0.768 . . . . 0.040000000000000001 111.062 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.87 146.62 32.06 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.965 -0.754 . . . . 0.47999999999999998 108.965 178.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 899' ' ' VAL . . . . . . . . . . . . . 89.6 t -92.1 119.94 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.414 -0.803 . . . . 0.55000000000000004 111.054 -179.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 90.9 mt -92.98 111.21 22.75 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 114.096 1.146 . . . . 1.5900000000000001 114.096 -175.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 22.2 m -64.53 139.68 58.79 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 107.331 -1.359 . . . . 0.050000000000000003 107.331 177.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -61.54 -65.02 3.5 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 110.32 -1.112 . . . . 0.029999999999999999 110.32 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 45.48 64.74 1.32 Allowed 'General case' 0 N--CA 1.508 2.45 0 O-C-N 121.485 -1.009 . . . . 3.2000000000000002 111.298 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 42.4 ptt85 -67.82 -7.14 25.32 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.585 -0.697 . . . . 2.9199999999999999 111.988 -179.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 905' ' ' HIS . . . . . 0.485 ' O ' ' CB ' ' C' ' 906' ' ' GLU . 72.0 t60 -60.37 5.27 0.05 OUTLIER 'General case' 0 N--CA 1.507 2.381 0 O-C-N 120.9 -1.125 . . . . 2.8700000000000001 113.714 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 906' ' ' GLU . . . . . 0.485 ' CB ' ' O ' ' C' ' 905' ' ' HIS . 0.6 OUTLIER 92.11 -164.08 0.01 OUTLIER 'General case' 0 N--CA 1.527 3.38 0 CA-C-N 121.259 1.845 . . . . 0.98999999999999999 112.254 179.053 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 907' ' ' LYS . . . . . 0.485 ' CB ' ' O ' ' C' ' 906' ' ' GLU . 73.5 tttt 89.43 162.03 0.05 Allowed 'General case' 0 N--CA 1.52 3.069 0 N-CA-C 108.146 -1.057 . . . . 5.25 108.146 -177.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 59.0 t -122.31 115.28 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 120.934 -1.104 . . . . 0.39000000000000001 110.883 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 53.0 tp10 -104.07 131.3 51.48 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 107.549 -1.278 . . . . 1.72 107.549 177.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -155.68 120.86 4.83 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 106.882 -1.525 . . . . 0.67000000000000004 106.882 178.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 911' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' C' ' 964' ' ' VAL . 11.0 p -77.82 131.14 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.879 -0.513 . . . . 0.54000000000000004 111.222 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 73.0 mt -67.52 158.29 32.3 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.218 -0.926 . . . . 1.5 108.88 178.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 913' ' ' SER . . . . . 0.403 ' CB ' ' CG1' ' C' ' 919' ' ' VAL . 1.4 p -128.33 135.73 49.99 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.468 -0.938 . . . . 1.3700000000000001 108.468 176.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 914' ' ' ARG . . . . . 0.424 ' O ' ' CB ' ' C' ' 915' ' ' SER . 0.0 OUTLIER -63.29 154.28 32.15 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 120.585 -1.322 . . . . 4.2999999999999998 111.287 -179.223 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 915' ' ' SER . . . . . 0.424 ' CB ' ' O ' ' C' ' 914' ' ' ARG . 0.2 OUTLIER 83.24 -30.45 0.09 Allowed 'General case' 0 N--CA 1.521 3.104 0 C-N-CA 123.724 0.81 . . . . 2.0499999999999998 112.079 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 916' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -123.48 -22.72 4.96 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 120.83 -1.169 . . . . 2.71 111.103 -179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 67.32 166.25 0.23 Allowed 'General case' 0 N--CA 1.519 3.011 0 N-CA-C 105.745 -1.946 . . . . 2.6800000000000002 105.745 -174.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.9 -125.37 35.19 Favored Glycine 1 N--CA 1.522 4.368 0 CA-C-N 123.619 2.918 . . . . 0.029999999999999999 107.069 -177.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 919' ' ' VAL . . . . . 0.403 ' CG1' ' CB ' ' C' ' 913' ' ' SER . 93.0 t 50.75 93.86 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.229 0 O-C-N 121.401 -1.058 . . . . 1.3899999999999999 109.433 -178.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 920' ' ' ALA . . . . . . . . . . . . . . . -96.1 94.96 7.85 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 119.478 -0.889 . . . . 0.029999999999999999 110.953 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 921' ' ' ARG . . . . . 0.44 ' HB3' ' CZ ' ' C' ' 950' ' ' PHE . 45.0 ptt85 -83.83 -41.54 17.4 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 105.626 -1.991 . . . . 4.4199999999999999 105.626 175.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 922' ' ' VAL . . . . . . . . . . . . . 57.6 t -97.11 74.36 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 105.393 -2.077 . . . . 0.84999999999999998 105.393 174.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -90.04 135.79 33.44 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.93 0.871 . . . . 2.46 112.41 -176.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 6.7 t -146.5 102.85 3.62 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.853 -1.166 . . . . 0.69999999999999996 107.853 178.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -111.03 91.86 0.63 Allowed Glycine 0 N--CA 1.488 2.119 0 N-CA-C 108.908 -1.677 . . . . 0.040000000000000001 108.908 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.342 0 N-CA-C 109.372 -1.491 . . . . 0.040000000000000001 109.372 -179.75 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 25.6 m . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 120.982 0.42 . . . . 13.779999999999999 110.366 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 94.4 mt -114.15 131.62 56.37 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.441 -0.787 . . . . 13.76 110.393 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -151.67 170.71 31.17 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.252 -1.539 . . . . 9.1300000000000008 109.252 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 949' ' ' VAL . . . . . . . . . . . . . 34.8 m -118.43 133.34 65.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.571 -0.958 . . . . 7.0800000000000001 111.252 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 950' ' ' PHE . . . . . 0.44 ' CZ ' ' HB3' ' C' ' 921' ' ' ARG . 20.3 p90 -131.88 147.36 52.47 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.969 -0.752 . . . . 7.5899999999999999 108.969 178.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 13.2 m -122.09 -52.82 1.96 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.281 -0.887 . . . . 5.0300000000000002 112.277 -178.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 952' ' ' LEU . . . . . 0.406 ' O ' ' O ' ' C' ' 953' ' ' ILE . 45.2 tp -60.07 -77.84 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.421 -0.8 . . . . 1.01 112.421 -177.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 953' ' ' ILE . . . . . 0.436 ' O ' ' HB3' ' C' ' 954' ' ' LEU . 44.1 pt -54.01 -140.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.734 0 N-CA-C 113.851 1.056 . . . . 2.6000000000000001 113.851 -176.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 954' ' ' LEU . . . . . 0.529 ' N ' ' CD1' ' C' ' 954' ' ' LEU . 0.0 OUTLIER 176.27 76.58 0.09 OUTLIER Pre-proline 0 N--CA 1.507 2.38 0 O-C-N 120.663 -1.273 . . . . 0.050000000000000003 111.192 179.725 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 955' ' ' PRO . . . . . 0.424 ' HD2' ' CE1' ' C' ' 950' ' ' PHE . 44.6 Cg_endo -71.51 86.2 0.85 Allowed 'Trans proline' 0 C--N 1.312 -1.364 0 N-CA-C 109.349 -1.058 . . . . 0.83999999999999997 109.349 178.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 956' ' ' LEU . . . . . . . . . . . . . 7.5 mp -126.06 153.09 44.95 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.293 -0.88 . . . . 0.040000000000000001 110.64 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -81.49 151.01 28.01 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-O 117.737 -1.125 . . . . 1.28 111.574 -179.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -68.88 119.21 12.86 Favored 'General case' 0 N--CA 1.51 2.549 0 CA-C-N 123.083 2.674 . . . . 0.17000000000000001 111.223 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 91.8 -22.65 30.04 Favored Glycine 0 N--CA 1.501 3.019 0 N-CA-C 110.789 -0.924 . . . . 0.040000000000000001 110.789 178.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 960' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -51.82 172.45 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.519 -0.989 . . . . 0.040000000000000001 110.332 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 961' ' ' THR . . . . . 0.472 ' HA ' ' O ' ' C' ' 886' ' ' PHE . 53.5 p -133.18 138.81 46.72 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.087 -1.008 . . . . 1.78 112.307 -177.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 962' ' ' VAL . . . . . 0.417 ' CG2' ' CB ' ' C' ' 886' ' ' PHE . 18.5 m -96.19 144.9 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 C-N-CA 120.208 -0.597 . . . . 0.040000000000000001 109.696 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 6.6 t -137.81 145.64 42.57 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.823 -0.548 . . . . 0.71999999999999997 110.213 -178.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 964' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' C' ' 911' ' ' VAL . 57.5 t -100.17 135.91 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.067 -1.021 . . . . 1.05 110.899 -179.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -96.71 125.62 41.29 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 103.788 -2.671 . . . . 3.02 103.788 173.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 966' ' ' LEU . . . . . 0.401 ' O ' ' CG2' ' C' ' 967' ' ' VAL . 5.1 tt -131.87 62.79 1.63 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.067 -1.086 . . . . 1.46 108.067 177.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 967' ' ' VAL . . . . . 0.401 ' CG2' ' O ' ' C' ' 966' ' ' LEU . 97.6 t -157.79 96.77 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.065 -1.087 . . . . 1.9399999999999999 108.065 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 94.4 mmm -142.26 58.62 1.46 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.769 -1.207 . . . . 0.0 108.375 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 134.58 119.54 1.96 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 107.222 -2.351 . . . . 2.1099999999999999 107.222 -178.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -82.4 -58.12 3.07 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.031 -1.276 . . . . 5.8899999999999997 110.607 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 9.1 tt -58.94 89.84 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.427 -0.796 . . . . 4.3600000000000003 110.378 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -142.33 -152.59 0.42 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.584 -0.698 . . . . 1.8300000000000001 110.144 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -117.17 167.81 10.85 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.415 -0.803 . . . . 4.3499999999999996 110.045 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 29.3 t -101.54 130.19 47.77 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.547 -0.72 . . . . 1.27 110.152 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -156.22 153.68 29.56 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.526 -0.734 . . . . 5.0199999999999996 110.405 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.27 86.08 17.56 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.604 -0.685 . . . . 2.4100000000000001 109.853 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -75.39 -171.44 1.02 Allowed 'Trans proline' 0 C--N 1.318 -1.065 0 O-C-N 123.326 1.172 . . . . 0.95999999999999996 111.309 -179.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 978' ' ' LEU . . . . . . . . . . . . . 5.4 mp -123.36 156.68 34.9 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 107.512 -1.292 . . . . 0.62 107.512 177.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 979' ' ' THR . . . . . . . . . . . . . 45.0 p -149.72 141.65 23.81 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.777 -1.202 . . . . 3.5699999999999998 111.186 -179.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 980' ' ' ILE . . . . . 0.429 HG22 HD11 ' C' ' 980' ' ' ILE . 50.6 mm -105.64 128.47 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 N-CA-C 109.174 -0.676 . . . . 1.3300000000000001 109.174 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 981' ' ' PHE . . . . . 0.439 ' CD1' ' CE2' ' C' ' 879' ' ' TYR . 2.1 t80 -118.99 99.36 6.69 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 119.808 -0.757 . . . . 0.050000000000000003 111.486 -178.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 982' ' ' SER . . . . . . . . . . . . . 10.6 p -109.93 159.71 17.02 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.578 -0.701 . . . . 0.87 109.194 178.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 983' ' ' GLY . . . . . 0.41 ' O ' ' CE2' ' C' ' 852' ' ' PHE . . . -170.8 111.42 0.41 Allowed Glycine 0 N--CA 1.498 2.818 0 N-CA-C 106.594 -2.602 . . . . 0.029999999999999999 106.594 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 984' ' ' ALA . . . . . . . . . . . . . . . -109.01 147.19 32.7 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.199 -1.177 . . . . 0.69999999999999996 114.025 -176.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 985' ' ' LEU . . . . . . . . . . . . . 56.6 tp -72.36 135.72 45.95 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.722 -1.236 . . . . 0.040000000000000001 110.066 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 986' ' ' LEU . . . . . . . . . . . . . 49.1 tp -107.08 -61.58 1.53 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.524 -0.735 . . . . 0.040000000000000001 110.341 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -145.0 146.33 31.87 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.847 -1.168 . . . . 0.040000000000000001 107.847 179.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.35 162.79 12.29 Favored Glycine 0 N--CA 1.495 2.593 0 N-CA-C 108.146 -1.981 . . . . 0.040000000000000001 108.146 179.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -75.44 112.65 20.05 Favored Pre-proline 0 N--CA 1.498 1.965 0 O-C-N 121.19 -1.183 . . . . 0.040000000000000001 109.485 179.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 990' ' ' PRO . . . . . 0.414 ' O ' ' HB2' ' C' ' 991' ' ' GLU . 50.2 Cg_endo -89.82 71.26 1.72 Allowed 'Trans proline' 0 C--N 1.319 -0.985 0 O-C-N 123.132 1.07 . . . . 0.45000000000000001 111.466 -178.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 991' ' ' GLU . . . . . 0.414 ' HB2' ' O ' ' C' ' 990' ' ' PRO . 69.5 mt-10 67.41 -73.31 0.08 Allowed 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 108.662 -0.866 . . . . 1.97 108.662 -177.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 992' ' ' LEU . . . . . . . . . . . . . 11.7 mt 50.62 21.06 0.81 Allowed 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.584 -0.697 . . . . 2.3799999999999999 111.645 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 79.7 mt-10 -93.27 156.94 16.51 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.887 -1.133 . . . . 3.79 110.02 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 68.6 m80 -146.62 92.59 2.17 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.525 -0.734 . . . . 3.5099999999999998 110.21 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 995' ' ' ALA . . . . . . . . . . . . 2.518 . . . . . . . 0 N--CA 1.503 2.197 0 O-C-N 120.94 -1.1 . . . . 2.73 110.569 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo . . . . . 0 N--CA 1.488 1.157 0 N-CA-C 109.503 -0.999 . . . . 3.8300000000000001 109.503 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 847' ' ' VAL . . . . . . . . . . . . . 61.3 t -132.16 102.84 14.24 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.584 -0.697 . . . . 1.8300000000000001 110.06 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 848' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.84 -20.84 33.95 Favored 'Trans proline' 0 N--CA 1.487 1.124 0 O-C-N 123.276 1.145 . . . . 0.65000000000000002 110.973 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 849' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 28.04 68.1 0.07 Allowed 'General case' 0 N--CA 1.518 2.937 0 N-CA-C 112.911 0.708 . . . . 2.5800000000000001 112.911 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 850' ' ' VAL . . . . . . . . . . . . . 72.9 t -119.74 136.13 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.152 -0.968 . . . . 1.0900000000000001 111.413 -178.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 851' ' ' ALA . . . . . . . . . . . . . . . -126.62 159.41 33.65 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 106.043 -1.836 . . . . 0.040000000000000001 106.043 177.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 852' ' ' PHE . . . . . 0.43 ' CE1' ' HA3' ' A' ' 983' ' ' GLY . 46.7 p90 -157.56 131.79 8.3 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 121.019 1.736 . . . . 0.050000000000000003 108.728 178.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 32.5 t -175.67 133.02 0.28 Allowed 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.076 -1.083 . . . . 0.040000000000000001 108.076 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -133.45 156.08 48.37 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.071 -1.018 . . . . 0.67000000000000004 109.472 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 855' ' ' ALA . . . . . . . . . . . . . . . -124.4 140.17 53.21 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.808 0.813 . . . . 0.51000000000000001 111.305 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 856' ' ' LEU . . . . . 0.403 HD21 ' CG1' ' A' ' 866' ' ' VAL . 3.4 tm? -111.96 140.01 46.98 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.607 -0.683 . . . . 0.050000000000000003 110.156 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 857' ' ' SER . . . . . 0.409 ' O ' ' O ' ' A' ' 858' ' ' LEU . 37.0 p -157.59 17.05 0.26 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.543 -0.723 . . . . 1.3300000000000001 111.467 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 858' ' ' LEU . . . . . 0.409 ' O ' ' O ' ' A' ' 857' ' ' SER . 3.1 pp -35.67 161.57 0.04 OUTLIER Pre-proline 0 N--CA 1.518 2.935 0 N-CA-C 112.851 0.686 . . . . 2.3300000000000001 112.851 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -59.87 -89.17 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.453 0 O-C-N 122.938 0.968 . . . . 2.3199999999999998 113.294 -178.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 55.3 ptt85 -134.9 -141.61 0.18 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.839 -1.163 . . . . 0.040000000000000001 111.646 -177.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 73.8 m -32.89 122.09 0.36 Allowed 'General case' 0 N--CA 1.513 2.694 0 N-CA-C 112.996 0.739 . . . . 1.3100000000000001 112.996 -178.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.76 160.13 27.08 Favored Pre-proline 0 N--CA 1.489 1.483 0 N-CA-C 107.93 -1.137 . . . . 4.5099999999999998 107.93 177.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.05 -13.86 34.45 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.134 1.07 . . . . 2.2400000000000002 111.479 -179.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -177.3 -135.45 2.22 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.97 -1.252 . . . . 0.040000000000000001 109.97 179.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 37.2 m -67.56 157.34 34.6 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.35 -1.088 . . . . 1.51 110.53 -178.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 866' ' ' VAL . . . . . 0.404 ' CG1' ' CD2' ' A' ' 858' ' ' LEU . 50.8 t -100.55 139.34 20.54 Favored Pre-proline 0 N--CA 1.495 1.8 0 N-CA-C 113.459 0.911 . . . . 0.78000000000000003 113.459 -174.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 867' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -91.67 -148.19 0.03 OUTLIER 'Trans proline' 0 CA--C 1.548 1.177 0 O-C-N 123.621 1.327 . . . . 0.92000000000000004 109.481 177.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 868' ' ' PHE . . . . . 0.45 ' CD1' ' CG ' ' A' ' 881' ' ' PRO . 26.3 p90 -150.35 124.22 9.26 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.696 -1.253 . . . . 0.050000000000000003 109.539 179.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 50.4 p-10 -113.82 -2.16 13.73 Favored 'General case' 0 N--CA 1.5 2.066 0 C-N-CA 119.265 -0.974 . . . . 1.7 112.852 -178.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 870' ' ' ARG . . . . . . . . . . . . . 28.7 mmm180 -91.27 90.11 7.6 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.865 -1.147 . . . . 2.5899999999999999 110.999 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 57.4 t -71.81 96.72 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 120.971 -1.081 . . . . 1.9399999999999999 110.047 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 872' ' ' LEU . . . . . . . . . . . . . 96.8 mt -83.06 -47.46 11.65 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.456 -0.778 . . . . 1.0600000000000001 110.04 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 873' ' ' LEU . . . . . . . . . . . . . 41.2 tp -175.15 103.19 0.08 Allowed 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 108.381 -0.97 . . . . 4.1799999999999997 108.381 178.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 874' ' ' ASN . . . . . 0.404 ' CB ' ' HA ' ' A' ' 852' ' ' PHE . 36.7 t-20 178.29 81.68 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.324 0 O-C-N 121.681 -0.637 . . . . 0.040000000000000001 109.421 -178.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -66.26 -46.77 75.93 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 119.324 -0.95 . . . . 3.3799999999999999 111.22 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 876' ' ' GLY . . . . . 0.412 ' HA3' ' CE2' ' A' ' 878' ' ' TYR . . . -74.87 -24.56 71.74 Favored Glycine 0 N--CA 1.494 2.555 0 O-C-N 121.318 -0.864 . . . . 0.040000000000000001 111.916 -178.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 82.11 -62.48 4.54 Favored Glycine 0 N--CA 1.501 3.021 0 N-CA-C 107.896 -2.082 . . . . 0.040000000000000001 107.896 -178.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 878' ' ' TYR . . . . . 0.412 ' CE2' ' HA3' ' A' ' 876' ' ' GLY . 93.2 m-85 61.41 -61.99 0.09 Allowed 'General case' 0 N--CA 1.504 2.262 0 N-CA-C 114.596 1.332 . . . . 3.46 114.596 177.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 879' ' ' TYR . . . . . 0.467 ' CB ' ' CD2' ' A' ' 886' ' ' PHE . 20.4 p90 -110.58 109.03 19.17 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 114.849 1.425 . . . . 0.040000000000000001 114.849 -176.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -67.19 118.21 53.77 Favored Pre-proline 0 N--CA 1.495 1.813 0 O-C-N 121.385 -0.822 . . . . 0.02 109.899 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 881' ' ' PRO . . . . . 0.45 ' CG ' ' CD1' ' A' ' 868' ' ' PHE . 51.2 Cg_endo -76.84 1.2 8.84 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 O-C-N 123.443 1.233 . . . . 0.39000000000000001 112.165 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -76.19 -64.75 1.03 Allowed 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 106.78 -1.563 . . . . 0.81000000000000005 106.78 178.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 7.5 p -95.43 -17.91 21.13 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.702 -0.851 . . . . 0.040000000000000001 108.702 177.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 85.17 23.33 48.97 Favored Glycine 0 N--CA 1.495 2.577 0 C-N-CA 120.11 -1.043 . . . . 0.029999999999999999 110.679 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 885' ' ' VAL . . . . . . . . . . . . . 75.4 t -73.39 88.42 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 C-N-CA 118.351 -1.339 . . . . 1.01 108.085 -179.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 886' ' ' PHE . . . . . 0.467 ' CD2' ' CB ' ' A' ' 879' ' ' TYR . 0.6 OUTLIER -89.64 106.55 18.53 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 115.239 -0.891 . . . . 0.050000000000000003 112.135 -177.232 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 887' ' ' THR . . . . . . . . . . . . . 95.4 m -98.48 99.29 10.45 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 107.581 -1.266 . . . . 0.68000000000000005 107.581 177.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 888' ' ' ALA . . . . . . . . . . . . . . . -97.1 107.88 40.59 Favored Pre-proline 0 N--CA 1.502 2.132 0 N-CA-C 113.983 1.105 . . . . 0.25 113.983 -176.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 889' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -89.11 -13.5 2.99 Favored 'Trans proline' 0 CA--C 1.546 1.094 0 N-CA-C 109.093 -1.157 . . . . 1.6399999999999999 109.093 176.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 890' ' ' LEU . . . . . . . . . . . . . 51.8 mt -35.91 -51.08 0.7 Allowed 'General case' 0 N--CA 1.508 2.447 0 N-CA-C 113.735 1.013 . . . . 2.29 113.735 -177.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 51.83 95.76 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.321 0 O-C-N 121.211 -0.93 . . . . 0.63 110.294 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 157.71 -152.99 24.24 Favored Glycine 0 N--CA 1.479 1.531 0 N-CA-C 107.181 -2.368 . . . . 0.040000000000000001 107.181 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 893' ' ' ARG . . . . . 0.405 ' CZ ' ' CB ' ' C' ' 984' ' ' ALA . 71.9 ttt-85 -114.46 126.23 54.73 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 108.286 -1.005 . . . . 3.0 108.286 177.306 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 894' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -132.47 160.06 37.54 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.105 -0.997 . . . . 0.040000000000000001 111.342 -179.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 895' ' ' LEU . . . . . . . . . . . . . 36.4 tp -92.16 119.67 32.03 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.735 -0.603 . . . . 1.27 110.056 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 9.7 tt -109.64 143.67 39.05 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.717 -0.614 . . . . 0.93999999999999995 110.191 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 897' ' ' SER . . . . . . . . . . . . . 64.7 m -149.86 114.07 5.17 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.443 -0.786 . . . . 0.040000000000000001 111.159 -179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.71 146.53 31.97 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.942 -0.762 . . . . 0.47999999999999998 108.942 178.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 899' ' ' VAL . . . . . . . . . . . . . 90.1 t -95.02 120.06 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 C-N-CA 119.588 -0.845 . . . . 0.55000000000000004 111.183 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 900' ' ' LEU . . . . . 0.424 ' CD2' ' N ' ' A' ' 900' ' ' LEU . 4.5 mm? -95.52 112.04 23.83 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 114.331 1.234 . . . . 1.5900000000000001 114.331 -175.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 15.7 m -65.91 141.28 58.29 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 107.506 -1.294 . . . . 0.050000000000000003 107.506 177.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -67.11 -66.71 2.25 Favored Glycine 0 N--CA 1.495 2.597 0 N-CA-C 110.505 -1.038 . . . . 0.029999999999999999 110.505 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 12.0 m170 47.52 67.3 0.83 Allowed 'General case' 0 N--CA 1.507 2.378 0 O-C-N 121.533 -0.981 . . . . 3.2000000000000002 111.017 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 46.5 ptt85 -69.48 -6.82 33.01 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.58 -0.7 . . . . 2.9199999999999999 111.9 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 905' ' ' HIS . . . . . 0.485 ' O ' ' CB ' ' A' ' 906' ' ' GLU . 70.7 t60 -62.86 5.68 0.12 Allowed 'General case' 0 N--CA 1.506 2.35 0 O-C-N 120.943 -1.098 . . . . 2.8700000000000001 113.116 -179.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 906' ' ' GLU . . . . . 0.485 ' CB ' ' O ' ' A' ' 905' ' ' HIS . 0.6 OUTLIER 94.44 -164.29 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.407 0 CA-C-N 120.486 1.494 . . . . 0.98999999999999999 111.906 178.924 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 907' ' ' LYS . . . . . 0.458 ' CB ' ' O ' ' A' ' 906' ' ' GLU . 69.2 tttt 85.34 155.57 0.09 Allowed 'General case' 0 N--CA 1.519 3.01 0 N-CA-C 107.87 -1.159 . . . . 5.25 107.87 -176.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 59.5 t -123.44 115.55 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 120.733 -1.229 . . . . 0.39000000000000001 111.239 -179.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -97.3 135.48 39.16 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 107.077 -1.453 . . . . 1.72 107.077 176.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -154.72 123.66 6.25 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 106.985 -1.487 . . . . 0.67000000000000004 106.985 178.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 911' ' ' VAL . . . . . 0.504 ' HA ' ' HA ' ' A' ' 964' ' ' VAL . 86.1 t -80.43 130.55 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 CA-C-N 116.186 -0.461 . . . . 0.54000000000000004 110.933 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 86.0 mt -63.54 156.74 25.54 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.33 -0.856 . . . . 1.5 108.703 178.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 913' ' ' SER . . . . . 0.409 ' CB ' ' CG1' ' A' ' 919' ' ' VAL . 0.4 OUTLIER -128.38 131.27 48.53 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.17 -1.048 . . . . 1.3700000000000001 108.17 176.653 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 914' ' ' ARG . . . . . 0.432 ' O ' ' CB ' ' A' ' 915' ' ' SER . 0.0 OUTLIER -66.18 156.35 34.36 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 120.651 -1.28 . . . . 4.2999999999999998 111.706 -179.068 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 915' ' ' SER . . . . . 0.432 ' CB ' ' O ' ' A' ' 914' ' ' ARG . 4.2 t 83.19 -32.05 0.08 Allowed 'General case' 0 N--CA 1.522 3.163 0 C-N-CA 123.99 0.916 . . . . 2.0499999999999998 112.003 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 916' ' ' ASN . . . . . 0.403 ' O ' ' HB2' ' A' ' 917' ' ' GLN . 82.6 m-20 -122.73 -20.86 5.78 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.918 -1.114 . . . . 2.71 111.249 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 917' ' ' GLN . . . . . 0.403 ' HB2' ' O ' ' A' ' 916' ' ' ASN . 45.4 mt-30 66.64 164.8 0.2 Allowed 'General case' 0 N--CA 1.521 3.106 0 N-CA-C 105.744 -1.947 . . . . 2.6800000000000002 105.744 -174.2 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 53.94 -124.26 29.47 Favored Glycine 1 N--CA 1.521 4.345 0 CA-C-N 123.455 2.843 . . . . 0.029999999999999999 107.05 -177.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 919' ' ' VAL . . . . . 0.409 ' CG1' ' CB ' ' A' ' 913' ' ' SER . 73.5 t 51.56 94.18 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 O-C-N 121.425 -1.044 . . . . 1.3899999999999999 109.165 -178.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 920' ' ' ALA . . . . . . . . . . . . . . . -92.95 92.19 7.75 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.347 -0.941 . . . . 0.029999999999999999 110.67 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 921' ' ' ARG . . . . . 0.407 ' HB3' ' CZ ' ' A' ' 950' ' ' PHE . 29.2 ptt180 -85.11 -41.75 15.42 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 105.931 -1.877 . . . . 4.4199999999999999 105.931 176.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 922' ' ' VAL . . . . . . . . . . . . . 93.1 t -101.19 73.02 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 N-CA-C 106.021 -1.844 . . . . 0.84999999999999998 106.021 175.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -87.29 133.29 33.71 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.689 0.757 . . . . 2.46 111.381 -177.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 8.7 t -147.99 105.61 3.68 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.59 -0.893 . . . . 0.69999999999999996 108.59 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -102.82 84.41 0.47 Allowed Glycine 0 N--CA 1.487 2.054 0 N-CA-C 108.568 -1.813 . . . . 0.040000000000000001 108.568 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 108.786 -1.725 . . . . 0.040000000000000001 108.786 -179.69 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 67.1 m . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.007 0.432 . . . . 13.779999999999999 110.366 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 95.5 mt -109.52 130.55 55.5 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.509 -0.744 . . . . 13.76 110.276 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -152.79 169.21 31.82 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.388 -1.485 . . . . 9.1300000000000008 109.388 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 949' ' ' VAL . . . . . . . . . . . . . 34.3 m -118.56 130.49 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.577 -0.955 . . . . 7.0800000000000001 110.687 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 950' ' ' PHE . . . . . 0.407 ' CZ ' ' HB3' ' A' ' 921' ' ' ARG . 52.0 p90 -130.22 143.98 51.1 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.454 -0.779 . . . . 7.5899999999999999 109.415 179.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 31.3 m -121.61 -52.3 2.03 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.46 -0.775 . . . . 5.0300000000000002 111.97 -178.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 952' ' ' LEU . . . . . 0.404 ' O ' ' O ' ' A' ' 953' ' ' ILE . 45.7 tp -61.47 -75.88 0.06 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.44 -0.787 . . . . 1.01 112.439 -177.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 953' ' ' ILE . . . . . 0.441 ' O ' ' HB3' ' A' ' 954' ' ' LEU . 47.0 pt -53.65 -141.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.736 0 N-CA-C 113.981 1.104 . . . . 2.6000000000000001 113.981 -176.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 954' ' ' LEU . . . . . 0.539 ' N ' ' CD1' ' A' ' 954' ' ' LEU . 0.0 OUTLIER 174.32 75.09 0.05 OUTLIER Pre-proline 0 N--CA 1.507 2.378 0 O-C-N 120.755 -1.215 . . . . 0.050000000000000003 110.959 179.813 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 955' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -73.04 93.79 0.81 Allowed 'Trans proline' 0 C--N 1.315 -1.215 0 N-CA-C 109.227 -1.105 . . . . 0.83999999999999997 109.227 178.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 956' ' ' LEU . . . . . 0.403 ' CD2' ' NH1' ' A' ' 914' ' ' ARG . 5.0 mp -126.19 140.39 52.59 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.251 -0.906 . . . . 0.040000000000000001 110.624 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -79.77 152.52 29.75 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 117.864 -1.065 . . . . 1.28 111.201 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -67.14 121.2 15.1 Favored 'General case' 0 N--CA 1.511 2.58 0 CA-C-N 122.743 2.52 . . . . 0.17000000000000001 111.925 -179.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 94.31 -18.75 56.29 Favored Glycine 0 N--CA 1.501 3.004 0 N-CA-C 111.135 -0.786 . . . . 0.040000000000000001 111.135 178.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 960' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -52.42 167.56 0.13 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.445 -1.032 . . . . 0.040000000000000001 111.029 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 961' ' ' THR . . . . . 0.456 ' HA ' ' O ' ' A' ' 886' ' ' PHE . 57.3 m -135.66 135.84 40.45 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.936 -1.103 . . . . 1.78 111.623 -178.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 962' ' ' VAL . . . . . 0.404 ' CG2' ' CB ' ' A' ' 886' ' ' PHE . 33.8 m -100.43 145.24 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 O-C-N 121.57 -0.706 . . . . 0.040000000000000001 111.173 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 1.7 m -138.51 148.15 43.96 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.789 -0.569 . . . . 0.71999999999999997 109.964 -178.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 964' ' ' VAL . . . . . 0.504 ' HA ' ' HA ' ' A' ' 911' ' ' VAL . 61.4 t -99.66 137.92 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.128 -0.983 . . . . 1.05 110.584 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -91.68 128.88 37.69 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 104.121 -2.548 . . . . 3.02 104.121 173.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 966' ' ' LEU . . . . . 0.413 ' O ' ' CG2' ' A' ' 967' ' ' VAL . 0.4 OUTLIER -131.54 59.8 1.69 Allowed 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.22 -1.03 . . . . 1.46 108.22 177.078 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 967' ' ' VAL . . . . . 0.413 ' CG2' ' O ' ' A' ' 966' ' ' LEU . 90.6 t -158.64 97.25 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 108.041 -1.096 . . . . 1.9399999999999999 108.041 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 80.2 mmm -143.99 59.47 1.36 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.711 -1.243 . . . . 0.0 108.396 178.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.3 119.77 1.95 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 107.195 -2.362 . . . . 2.1099999999999999 107.195 -178.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -82.18 -59.05 2.69 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.082 -1.246 . . . . 5.8899999999999997 110.333 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 47.3 tp -59.08 90.76 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.437 -0.789 . . . . 4.3600000000000003 110.205 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -141.91 -154.51 0.52 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.56 -0.712 . . . . 1.8300000000000001 110.24 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -120.5 172.53 7.77 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.45 -0.781 . . . . 4.3499999999999996 110.349 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 30.6 t -101.25 130.3 47.35 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.534 -0.729 . . . . 1.27 110.016 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -155.66 159.0 39.22 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.553 -0.717 . . . . 5.0199999999999996 110.52 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.01 85.99 18.47 Favored Pre-proline 0 N--CA 1.5 2.053 0 O-C-N 121.648 -0.658 . . . . 2.4100000000000001 109.632 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -73.15 -173.06 1.15 Allowed 'Trans proline' 0 C--N 1.317 -1.098 0 O-C-N 123.309 1.163 . . . . 0.95999999999999996 111.359 -179.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 4.9 mp -128.52 153.94 46.66 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 107.547 -1.279 . . . . 0.62 107.547 177.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 979' ' ' THR . . . . . . . . . . . . . 41.8 p -149.99 141.57 23.49 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.8 -1.187 . . . . 3.5699999999999998 111.189 -179.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 980' ' ' ILE . . . . . . . . . . . . . 49.4 mm -106.86 128.72 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.893 -0.78 . . . . 1.3300000000000001 108.893 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 981' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -119.0 95.96 5.04 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 119.806 -0.758 . . . . 0.050000000000000003 111.891 -178.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 82.8 p -108.18 157.83 17.97 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.55 -0.719 . . . . 0.87 109.098 178.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 983' ' ' GLY . . . . . 0.43 ' HA3' ' CE1' ' A' ' 852' ' ' PHE . . . -176.84 108.17 0.25 Allowed Glycine 0 N--CA 1.499 2.875 0 N-CA-C 106.411 -2.676 . . . . 0.029999999999999999 106.411 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -108.53 152.33 24.89 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 114.658 1.355 . . . . 0.69999999999999996 114.658 -175.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 36.4 tp -72.15 135.33 46.15 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.829 -1.17 . . . . 0.040000000000000001 109.991 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 51.4 tp -106.09 -59.78 1.73 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.535 -0.728 . . . . 0.040000000000000001 109.879 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -143.15 146.52 33.8 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 107.57 -1.27 . . . . 0.040000000000000001 107.57 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.13 163.66 12.17 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 108.23 -1.948 . . . . 0.040000000000000001 108.23 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -74.56 112.61 18.11 Favored Pre-proline 0 N--CA 1.498 1.951 0 O-C-N 121.227 -1.161 . . . . 0.040000000000000001 109.439 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 990' ' ' PRO . . . . . 0.416 ' O ' ' HB2' ' A' ' 991' ' ' GLU . 50.6 Cg_endo -89.25 71.0 2.07 Favored 'Trans proline' 0 C--N 1.318 -1.036 0 O-C-N 123.132 1.07 . . . . 0.45000000000000001 111.494 -178.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 991' ' ' GLU . . . . . 0.416 ' HB2' ' O ' ' A' ' 990' ' ' PRO . 70.5 mt-10 67.23 -73.97 0.07 Allowed 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 108.562 -0.903 . . . . 1.97 108.562 -177.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 992' ' ' LEU . . . . . . . . . . . . . 11.4 mt 51.19 20.66 0.93 Allowed 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.572 -0.705 . . . . 2.3799999999999999 111.593 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -92.81 156.9 16.69 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.86 -1.15 . . . . 3.79 109.955 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 71.0 m80 -147.1 92.22 2.09 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.525 -0.734 . . . . 3.5099999999999998 110.314 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 995' ' ' ALA . . . . . . . . . . . . 2.516 . . . . . . . 0 N--CA 1.503 2.214 0 O-C-N 120.933 -1.105 . . . . 2.73 110.551 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo . . . . . 0 N--CA 1.488 1.16 0 N-CA-C 109.479 -1.008 . . . . 3.8300000000000001 109.479 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 847' ' ' VAL . . . . . . . . . . . . . 60.4 t -132.1 102.86 14.31 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.632 -0.667 . . . . 1.8300000000000001 110.122 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 848' ' ' PRO . . . . . 0.401 ' O ' ' C ' ' B' ' 849' ' ' GLN . 43.9 Cg_endo -69.76 -21.17 33.85 Favored 'Trans proline' 0 N--CA 1.487 1.1 0 O-C-N 123.328 1.173 . . . . 0.65000000000000002 110.941 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 849' ' ' GLN . . . . . 0.401 ' C ' ' O ' ' B' ' 848' ' ' PRO . 56.1 tt0 28.35 68.34 0.08 Allowed 'General case' 0 N--CA 1.517 2.901 0 N-CA-C 112.856 0.687 . . . . 2.5800000000000001 112.856 179.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 850' ' ' VAL . . . . . . . . . . . . . 74.4 t -120.07 136.11 58.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.213 -0.93 . . . . 1.0900000000000001 111.421 -178.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 851' ' ' ALA . . . . . . . . . . . . . . . -126.93 158.72 36.06 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 106.008 -1.849 . . . . 0.040000000000000001 106.008 177.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 852' ' ' PHE . . . . . 0.421 ' CE1' ' HA3' ' B' ' 983' ' ' GLY . 46.6 p90 -156.87 132.07 9.12 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 121.034 1.743 . . . . 0.050000000000000003 108.713 179.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 33.0 t -175.74 132.71 0.27 Allowed 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.118 -1.067 . . . . 0.040000000000000001 108.118 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -133.13 156.23 47.82 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.118 -0.989 . . . . 0.67000000000000004 109.487 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 855' ' ' ALA . . . . . 0.405 ' O ' ' HB2' ' B' ' 870' ' ' ARG . . . -124.47 140.38 53.01 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.784 0.802 . . . . 0.51000000000000001 111.306 -179.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 856' ' ' LEU . . . . . 0.403 HD21 ' CG1' ' B' ' 866' ' ' VAL . 3.4 tm? -112.24 139.5 47.72 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.622 -0.673 . . . . 0.050000000000000003 110.179 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 857' ' ' SER . . . . . 0.412 ' O ' ' O ' ' B' ' 858' ' ' LEU . 37.4 p -157.27 17.42 0.28 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.544 -0.723 . . . . 1.3300000000000001 111.42 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 858' ' ' LEU . . . . . 0.412 ' O ' ' O ' ' B' ' 857' ' ' SER . 3.2 pp -35.92 161.57 0.04 OUTLIER Pre-proline 0 N--CA 1.518 2.953 0 CA-C-N 118.656 0.662 . . . . 2.3300000000000001 112.784 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -59.86 -89.24 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.49 0 O-C-N 122.901 0.948 . . . . 2.3199999999999998 113.277 -178.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 55.3 ptt85 -134.92 -141.58 0.18 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.836 -1.165 . . . . 0.040000000000000001 111.675 -177.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 73.8 m -32.81 121.68 0.35 Allowed 'General case' 0 N--CA 1.512 2.646 0 N-CA-C 113.042 0.756 . . . . 1.3100000000000001 113.042 -178.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 862' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.47 160.16 27.01 Favored Pre-proline 0 N--CA 1.489 1.524 0 N-CA-C 107.953 -1.129 . . . . 4.5099999999999998 107.953 177.178 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -69.95 -14.01 34.92 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 O-C-N 123.157 1.083 . . . . 2.2400000000000002 111.576 -179.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -177.03 -134.54 2.01 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 110.027 -1.229 . . . . 0.040000000000000001 110.027 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 38.9 m -68.43 157.72 35.21 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.308 -1.113 . . . . 1.51 110.437 -179.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 866' ' ' VAL . . . . . 0.406 ' CG1' ' CD2' ' B' ' 858' ' ' LEU . 50.7 t -100.7 139.34 20.5 Favored Pre-proline 0 N--CA 1.495 1.778 0 N-CA-C 113.509 0.929 . . . . 0.78000000000000003 113.509 -174.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 867' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -91.72 -148.48 0.03 OUTLIER 'Trans proline' 0 CA--C 1.548 1.18 0 O-C-N 123.641 1.337 . . . . 0.92000000000000004 109.446 177.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 868' ' ' PHE . . . . . 0.455 ' CD1' ' CG ' ' B' ' 881' ' ' PRO . 26.1 p90 -150.17 124.1 9.31 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.622 -1.299 . . . . 0.050000000000000003 109.576 179.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 50.4 p-10 -113.68 -1.84 13.91 Favored 'General case' 0 N--CA 1.501 2.089 0 C-N-CA 119.222 -0.991 . . . . 1.7 112.875 -178.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 870' ' ' ARG . . . . . 0.405 ' HB2' ' O ' ' B' ' 855' ' ' ALA . 28.4 mmm180 -91.52 89.88 7.39 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.837 -1.164 . . . . 2.5899999999999999 111.011 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 57.6 t -71.8 96.83 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.009 -1.057 . . . . 1.9399999999999999 110.019 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 872' ' ' LEU . . . . . . . . . . . . . 96.7 mt -83.22 -47.34 11.66 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.535 -0.728 . . . . 1.0600000000000001 110.021 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 873' ' ' LEU . . . . . . . . . . . . . 41.0 tp -175.1 103.22 0.08 Allowed 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.416 -0.957 . . . . 4.1799999999999997 108.416 178.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 874' ' ' ASN . . . . . 0.401 ' CB ' ' HA ' ' B' ' 852' ' ' PHE . 36.5 t-20 178.33 81.78 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.663 -0.648 . . . . 0.040000000000000001 109.443 -178.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -66.44 -46.87 75.01 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 119.32 -0.952 . . . . 3.3799999999999999 111.208 -179.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 876' ' ' GLY . . . . . 0.414 ' HA3' ' CE2' ' B' ' 878' ' ' TYR . . . -74.71 -24.85 71.26 Favored Glycine 0 N--CA 1.494 2.551 0 O-C-N 121.242 -0.912 . . . . 0.040000000000000001 111.888 -178.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 82.27 -62.32 4.58 Favored Glycine 0 N--CA 1.502 3.042 0 N-CA-C 107.877 -2.089 . . . . 0.040000000000000001 107.877 -178.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 878' ' ' TYR . . . . . 0.414 ' CE2' ' HA3' ' B' ' 876' ' ' GLY . 93.2 m-85 61.41 -62.02 0.09 Allowed 'General case' 0 N--CA 1.504 2.252 0 N-CA-C 114.595 1.332 . . . . 3.46 114.595 177.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 879' ' ' TYR . . . . . 0.468 ' CG ' ' O ' ' B' ' 879' ' ' TYR . 20.3 p90 -110.55 109.12 19.32 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 114.826 1.417 . . . . 0.040000000000000001 114.826 -176.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -67.18 118.04 52.08 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.448 -0.783 . . . . 0.02 109.894 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 881' ' ' PRO . . . . . 0.455 ' CG ' ' CD1' ' B' ' 868' ' ' PHE . 53.0 Cg_endo -76.75 1.25 8.75 Favored 'Trans proline' 0 N--CA 1.492 1.431 0 O-C-N 123.426 1.224 . . . . 0.39000000000000001 112.194 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -76.2 -64.79 1.02 Allowed 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 106.8 -1.556 . . . . 0.81000000000000005 106.8 178.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 7.6 p -95.65 -17.3 21.42 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.759 -0.83 . . . . 0.040000000000000001 108.759 177.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.57 23.79 49.09 Favored Glycine 0 N--CA 1.494 2.55 0 C-N-CA 120.091 -1.052 . . . . 0.029999999999999999 110.721 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 885' ' ' VAL . . . . . . . . . . . . . 76.6 t -73.64 88.57 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 C-N-CA 118.315 -1.354 . . . . 1.01 108.022 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 886' ' ' PHE . . . . . 0.468 ' CD2' ' CB ' ' B' ' 879' ' ' TYR . 0.6 OUTLIER -89.82 106.7 18.64 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 115.324 -0.853 . . . . 0.050000000000000003 112.105 -177.293 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 887' ' ' THR . . . . . . . . . . . . . 95.5 m -98.53 99.52 10.68 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 107.539 -1.282 . . . . 0.68000000000000005 107.539 177.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 888' ' ' ALA . . . . . . . . . . . . . . . -97.3 107.73 40.24 Favored Pre-proline 0 N--CA 1.502 2.138 0 N-CA-C 113.992 1.108 . . . . 0.25 113.992 -176.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 889' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -88.92 -13.66 3.06 Favored 'Trans proline' 0 CA--C 1.545 1.056 0 O-C-N 123.29 1.153 . . . . 1.6399999999999999 109.164 176.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 890' ' ' LEU . . . . . . . . . . . . . 51.9 mt -35.68 -51.31 0.66 Allowed 'General case' 0 N--CA 1.508 2.46 0 N-CA-C 113.688 0.995 . . . . 2.29 113.688 -177.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 51.9 95.71 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.275 0 O-C-N 121.192 -0.943 . . . . 0.63 110.358 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . 157.76 -153.17 24.4 Favored Glycine 0 N--CA 1.479 1.515 0 N-CA-C 107.21 -2.356 . . . . 0.040000000000000001 107.21 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 72.1 ttt-85 -114.3 126.17 54.71 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.283 -1.006 . . . . 3.0 108.283 177.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 894' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -132.41 160.28 36.83 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.134 -0.979 . . . . 0.040000000000000001 111.286 -179.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 895' ' ' LEU . . . . . . . . . . . . . 36.6 tp -92.32 119.49 31.94 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.742 -0.599 . . . . 1.27 110.178 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 896' ' ' LEU . . . . . . . . . . . . . 9.7 tt -109.55 142.9 39.97 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.68 -0.637 . . . . 0.93999999999999995 110.279 -179.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 897' ' ' SER . . . . . . . . . . . . . 64.4 m -149.1 113.96 5.4 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.464 -0.773 . . . . 0.040000000000000001 111.187 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.55 146.25 32.11 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.085 -0.709 . . . . 0.47999999999999998 109.085 178.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 899' ' ' VAL . . . . . . . . . . . . . 89.5 t -94.74 119.8 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 C-N-CA 119.602 -0.839 . . . . 0.55000000000000004 111.252 -179.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 900' ' ' LEU . . . . . 0.416 ' N ' ' CD2' ' B' ' 900' ' ' LEU . 4.5 mm? -95.27 111.69 23.5 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 114.416 1.265 . . . . 1.5900000000000001 114.416 -175.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 15.7 m -65.67 141.13 58.48 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 107.468 -1.308 . . . . 0.050000000000000003 107.468 177.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -67.22 -66.7 2.25 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 110.541 -1.024 . . . . 0.029999999999999999 110.541 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 11.9 m170 47.6 67.33 0.83 Allowed 'General case' 0 N--CA 1.507 2.388 0 O-C-N 121.47 -1.017 . . . . 3.2000000000000002 110.977 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 46.6 ptt85 -69.47 -6.99 34.09 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.638 -0.664 . . . . 2.9199999999999999 111.906 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 905' ' ' HIS . . . . . 0.484 ' O ' ' CB ' ' B' ' 906' ' ' GLU . 70.6 t60 -62.34 5.13 0.11 Allowed 'General case' 0 N--CA 1.507 2.382 0 O-C-N 120.915 -1.116 . . . . 2.8700000000000001 113.111 -179.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 906' ' ' GLU . . . . . 0.484 ' CB ' ' O ' ' B' ' 905' ' ' HIS . 0.6 OUTLIER 94.74 -164.31 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.432 0 CA-C-N 120.565 1.53 . . . . 0.98999999999999999 111.796 179.095 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 907' ' ' LYS . . . . . 0.467 ' CB ' ' O ' ' B' ' 906' ' ' GLU . 69.2 tttt 85.4 155.38 0.09 Allowed 'General case' 0 N--CA 1.519 2.985 0 N-CA-C 107.921 -1.14 . . . . 5.25 107.921 -176.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 60.1 t -123.27 115.34 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 120.716 -1.24 . . . . 0.39000000000000001 111.371 -179.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 43.4 tp10 -97.16 135.59 38.89 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 107.014 -1.476 . . . . 1.72 107.014 176.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -154.95 123.85 6.2 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 106.966 -1.494 . . . . 0.67000000000000004 106.966 179.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 911' ' ' VAL . . . . . 0.495 ' HA ' ' HA ' ' B' ' 964' ' ' VAL . 87.2 t -80.71 130.91 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 C-N-CA 120.522 -0.471 . . . . 0.54000000000000004 110.934 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 86.2 mt -63.72 156.92 25.59 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.27 -0.894 . . . . 1.5 108.671 178.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 913' ' ' SER . . . . . 0.4 ' CB ' ' CG1' ' B' ' 919' ' ' VAL . 0.4 OUTLIER -128.77 130.58 47.23 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.251 -1.018 . . . . 1.3700000000000001 108.251 176.647 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 914' ' ' ARG . . . . . 0.425 ' O ' ' CB ' ' B' ' 915' ' ' SER . 0.0 OUTLIER -65.45 156.2 33.14 Favored 'General case' 0 N--CA 1.507 2.387 0 O-C-N 120.674 -1.266 . . . . 4.2999999999999998 111.796 -178.963 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 915' ' ' SER . . . . . 0.425 ' CB ' ' O ' ' B' ' 914' ' ' ARG . 4.2 t 83.3 -32.39 0.08 Allowed 'General case' 0 N--CA 1.522 3.148 0 C-N-CA 123.991 0.917 . . . . 2.0499999999999998 112.019 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 916' ' ' ASN . . . . . 0.403 ' O ' ' HB2' ' B' ' 917' ' ' GLN . 82.5 m-20 -122.24 -21.23 5.93 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 120.87 -1.144 . . . . 2.71 111.328 -179.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 917' ' ' GLN . . . . . 0.403 ' HB2' ' O ' ' B' ' 916' ' ' ASN . 45.3 mt-30 66.77 164.34 0.19 Allowed 'General case' 0 N--CA 1.52 3.065 0 N-CA-C 105.76 -1.941 . . . . 2.6800000000000002 105.76 -174.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.52 -124.38 31.27 Favored Glycine 1 N--CA 1.522 4.368 0 CA-C-N 123.521 2.873 . . . . 0.029999999999999999 106.928 -177.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 919' ' ' VAL . . . . . 0.4 ' CG1' ' CB ' ' B' ' 913' ' ' SER . 75.8 t 51.42 94.25 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 O-C-N 121.413 -1.051 . . . . 1.3899999999999999 109.15 -178.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 920' ' ' ALA . . . . . . . . . . . . . . . -93.02 92.07 7.66 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 119.327 -0.949 . . . . 0.029999999999999999 110.643 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 921' ' ' ARG . . . . . 0.42 ' HB3' ' CZ ' ' B' ' 950' ' ' PHE . 29.3 ptt180 -85.03 -41.64 15.6 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 105.924 -1.88 . . . . 4.4199999999999999 105.924 176.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 922' ' ' VAL . . . . . . . . . . . . . 92.8 t -101.29 72.77 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 N-CA-C 106.052 -1.833 . . . . 0.84999999999999998 106.052 175.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -87.09 133.49 33.61 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.678 0.752 . . . . 2.46 111.376 -177.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 924' ' ' SER . . . . . . . . . . . . . 8.7 t -148.11 105.4 3.64 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.638 -0.875 . . . . 0.69999999999999996 108.638 179.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -102.55 84.36 0.48 Allowed Glycine 0 N--CA 1.487 2.091 0 N-CA-C 108.589 -1.804 . . . . 0.040000000000000001 108.589 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.205 0 N-CA-C 108.805 -1.718 . . . . 0.040000000000000001 108.805 -179.739 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 69.8 m . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.05 0.453 . . . . 13.779999999999999 110.296 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 95.3 mt -108.24 130.19 55.17 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.494 -0.754 . . . . 13.76 110.295 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -152.01 168.53 31.28 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.429 -1.468 . . . . 9.1300000000000008 109.429 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 949' ' ' VAL . . . . . . . . . . . . . 34.2 m -118.27 130.41 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.606 -0.938 . . . . 7.0800000000000001 110.547 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 950' ' ' PHE . . . . . 0.42 ' CZ ' ' HB3' ' B' ' 921' ' ' ARG . 52.0 p90 -130.37 144.11 51.18 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.492 -0.755 . . . . 7.5899999999999999 109.447 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 31.9 m -121.77 -51.91 2.02 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.451 -0.781 . . . . 5.0300000000000002 111.92 -178.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 952' ' ' LEU . . . . . 0.405 ' O ' ' O ' ' B' ' 953' ' ' ILE . 45.3 tp -61.81 -76.06 0.06 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.512 -0.742 . . . . 1.01 112.385 -177.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 953' ' ' ILE . . . . . 0.45 ' O ' ' HB3' ' B' ' 954' ' ' LEU . 47.0 pt -53.53 -141.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.724 0 N-CA-C 113.992 1.108 . . . . 2.6000000000000001 113.992 -176.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 954' ' ' LEU . . . . . 0.545 ' N ' ' CD1' ' B' ' 954' ' ' LEU . 0.0 OUTLIER 174.08 75.05 0.05 OUTLIER Pre-proline 0 N--CA 1.507 2.391 0 O-C-N 120.786 -1.196 . . . . 0.050000000000000003 110.906 179.754 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 955' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -73.07 93.93 0.81 Allowed 'Trans proline' 0 C--N 1.315 -1.212 0 N-CA-C 109.185 -1.121 . . . . 0.83999999999999997 109.185 178.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 956' ' ' LEU . . . . . . . . . . . . . 5.0 mp -126.32 140.39 52.55 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.242 -0.911 . . . . 0.040000000000000001 110.602 -179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -79.68 153.02 29.61 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 117.964 -1.017 . . . . 1.28 111.097 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -67.54 121.1 15.11 Favored 'General case' 0 N--CA 1.51 2.564 0 CA-C-N 122.563 2.438 . . . . 0.17000000000000001 111.838 -179.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 94.38 -19.01 55.79 Favored Glycine 0 N--CA 1.501 3.017 0 N-CA-C 111.132 -0.787 . . . . 0.040000000000000001 111.132 178.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 960' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -52.21 167.67 0.12 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.412 -1.052 . . . . 0.040000000000000001 111.027 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 961' ' ' THR . . . . . 0.456 ' HA ' ' O ' ' B' ' 886' ' ' PHE . 57.3 m -135.73 135.93 40.41 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 120.966 -1.084 . . . . 1.78 111.614 -178.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 962' ' ' VAL . . . . . 0.416 ' CG2' ' CB ' ' B' ' 886' ' ' PHE . 33.9 m -100.64 145.15 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 121.606 -0.684 . . . . 0.040000000000000001 111.13 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 1.8 m -138.39 148.01 44.03 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.816 -0.553 . . . . 0.71999999999999997 109.938 -178.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 964' ' ' VAL . . . . . 0.495 ' HA ' ' HA ' ' B' ' 911' ' ' VAL . 61.8 t -99.66 137.69 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.118 -0.989 . . . . 1.05 110.623 -179.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -91.58 128.57 37.46 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 104.202 -2.518 . . . . 3.02 104.202 173.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 966' ' ' LEU . . . . . 0.418 ' O ' ' CG2' ' B' ' 967' ' ' VAL . 0.4 OUTLIER -131.2 59.84 1.67 Allowed 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.305 -0.998 . . . . 1.46 108.305 177.162 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 967' ' ' VAL . . . . . 0.418 ' CG2' ' O ' ' B' ' 966' ' ' LEU . 90.1 t -158.76 96.97 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 108.104 -1.072 . . . . 1.9399999999999999 108.104 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 80.2 mmm -143.64 59.24 1.38 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.733 -1.229 . . . . 0.0 108.519 178.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.4 119.63 1.93 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 107.318 -2.313 . . . . 2.1099999999999999 107.318 -178.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -81.96 -59.05 2.71 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.095 -1.239 . . . . 5.8899999999999997 110.376 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 47.6 tp -59.14 90.49 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.423 -0.798 . . . . 4.3600000000000003 110.224 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -141.67 -154.51 0.52 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.536 -0.727 . . . . 1.8300000000000001 110.296 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -120.36 172.73 7.6 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.428 -0.795 . . . . 4.3499999999999996 110.315 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 30.3 t -101.47 130.32 47.69 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.517 -0.739 . . . . 1.27 109.983 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -155.68 158.99 39.17 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.457 -0.777 . . . . 5.0199999999999996 110.486 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.99 85.96 18.57 Favored Pre-proline 0 N--CA 1.5 2.048 0 O-C-N 121.607 -0.683 . . . . 2.4100000000000001 109.673 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -73.17 -173.15 1.18 Allowed 'Trans proline' 0 C--N 1.318 -1.078 0 O-C-N 123.286 1.151 . . . . 0.95999999999999996 111.319 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 978' ' ' LEU . . . . . . . . . . . . . 4.9 mp -128.34 154.15 46.27 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 107.565 -1.272 . . . . 0.62 107.565 177.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 979' ' ' THR . . . . . . . . . . . . . 41.6 p -150.17 141.46 23.22 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.788 -1.195 . . . . 3.5699999999999998 111.214 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 980' ' ' ILE . . . . . . . . . . . . . 49.4 mm -106.78 128.41 61.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 108.951 -0.759 . . . . 1.3300000000000001 108.951 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -118.82 96.2 5.16 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.488 -0.758 . . . . 0.050000000000000003 111.852 -178.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 78.7 p -108.6 158.01 17.97 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.557 -0.714 . . . . 0.87 109.159 178.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 983' ' ' GLY . . . . . 0.421 ' HA3' ' CE1' ' B' ' 852' ' ' PHE . . . -176.78 108.16 0.25 Allowed Glycine 0 N--CA 1.498 2.783 0 N-CA-C 106.529 -2.628 . . . . 0.029999999999999999 106.529 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -108.37 152.37 24.76 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 114.627 1.343 . . . . 0.69999999999999996 114.627 -175.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 985' ' ' LEU . . . . . . . . . . . . . 36.4 tp -72.25 135.36 46.01 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.926 -1.109 . . . . 0.040000000000000001 109.94 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 986' ' ' LEU . . . . . . . . . . . . . 51.4 tp -106.21 -59.67 1.75 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.655 -0.653 . . . . 0.040000000000000001 109.914 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -143.13 146.52 33.82 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 107.597 -1.26 . . . . 0.040000000000000001 107.597 178.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.03 163.26 12.21 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 108.278 -1.929 . . . . 0.040000000000000001 108.278 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -74.21 112.65 17.86 Favored Pre-proline 0 N--CA 1.498 1.944 0 O-C-N 121.173 -1.193 . . . . 0.040000000000000001 109.415 179.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 990' ' ' PRO . . . . . 0.414 ' O ' ' HB2' ' B' ' 991' ' ' GLU . 50.3 Cg_endo -89.32 71.06 2.02 Favored 'Trans proline' 0 C--N 1.319 -1.015 0 O-C-N 123.067 1.035 . . . . 0.45000000000000001 111.461 -178.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 991' ' ' GLU . . . . . 0.414 ' HB2' ' O ' ' B' ' 990' ' ' PRO . 70.8 mt-10 67.14 -73.94 0.07 Allowed 'General case' 0 N--CA 1.502 2.164 0 N-CA-C 108.581 -0.896 . . . . 1.97 108.581 -177.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 992' ' ' LEU . . . . . . . . . . . . . 11.5 mt 51.27 20.48 0.94 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.586 -0.697 . . . . 2.3799999999999999 111.621 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -92.53 156.91 16.83 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.912 -1.118 . . . . 3.79 110.019 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 70.7 m80 -147.15 91.73 2.03 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.549 -0.719 . . . . 3.5099999999999998 110.359 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 995' ' ' ALA . . . . . . . . . . . . 2.518 . . . . . . . 0 N--CA 1.503 2.19 0 O-C-N 120.899 -1.125 . . . . 2.73 110.622 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo . . . . . 0 N--CA 1.488 1.158 0 N-CA-C 109.516 -0.994 . . . . 3.8300000000000001 109.516 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 847' ' ' VAL . . . . . . . . . . . . . 60.3 t -126.11 105.48 25.41 Favored Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 121.639 -0.663 . . . . 1.8300000000000001 110.103 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 848' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -69.61 -23.56 31.36 Favored 'Trans proline' 0 N--CA 1.487 1.113 0 O-C-N 123.219 1.115 . . . . 0.65000000000000002 110.949 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 849' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 25.4 66.38 0.05 Allowed 'General case' 0 N--CA 1.518 2.944 0 N-CA-C 113.419 0.896 . . . . 2.5800000000000001 113.419 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 850' ' ' VAL . . . . . . . . . . . . . 77.7 t -120.0 135.74 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 121.113 -0.992 . . . . 1.0900000000000001 111.183 -179.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 851' ' ' ALA . . . . . . . . . . . . . . . -128.17 155.45 44.46 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 105.914 -1.884 . . . . 0.040000000000000001 105.914 176.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 852' ' ' PHE . . . . . 0.456 ' CD1' ' N ' ' C' ' 852' ' ' PHE . 15.2 p90 -160.42 127.03 4.22 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 120.973 1.715 . . . . 0.050000000000000003 108.631 179.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 6.3 t -177.28 134.28 0.18 Allowed 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.162 -1.051 . . . . 0.040000000000000001 108.162 -179.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -130.39 158.14 40.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.087 -1.008 . . . . 0.67000000000000004 109.685 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 855' ' ' ALA . . . . . 0.412 ' O ' ' HB2' ' C' ' 870' ' ' ARG . . . -121.39 140.71 51.77 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.818 0.818 . . . . 0.51000000000000001 111.061 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 856' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -113.23 135.74 53.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.612 -0.68 . . . . 0.050000000000000003 110.084 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 857' ' ' SER . . . . . 0.412 ' O ' ' O ' ' C' ' 858' ' ' LEU . 0.6 OUTLIER -153.35 18.64 0.55 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.502 -0.749 . . . . 1.3300000000000001 110.919 179.581 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 858' ' ' LEU . . . . . 0.412 ' O ' ' O ' ' C' ' 857' ' ' SER . 2.7 pp -34.7 159.65 0.04 OUTLIER Pre-proline 0 N--CA 1.516 2.856 0 N-CA-C 113.008 0.744 . . . . 2.3300000000000001 113.008 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -63.04 -88.39 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.399 0 O-C-N 123.078 1.041 . . . . 2.3199999999999998 113.257 -178.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 54.7 ptt85 -133.18 -142.0 0.2 Allowed 'General case' 0 N--CA 1.499 2.01 0 O-C-N 120.854 -1.154 . . . . 0.040000000000000001 111.422 -177.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 58.2 m -36.68 123.92 0.83 Allowed 'General case' 0 N--CA 1.511 2.586 0 O-C-N 121.609 -0.682 . . . . 1.3100000000000001 112.538 -178.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -104.04 160.24 26.71 Favored Pre-proline 0 N--CA 1.489 1.496 0 N-CA-C 108.052 -1.092 . . . . 4.5099999999999998 108.052 177.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -69.12 -14.41 38.06 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 123.185 1.097 . . . . 2.2400000000000002 111.404 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -177.25 -136.58 2.48 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 110.107 -1.197 . . . . 0.040000000000000001 110.107 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 32.7 m -65.23 156.89 30.43 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.366 -1.079 . . . . 1.51 110.746 -178.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 866' ' ' VAL . . . . . . . . . . . . . 64.5 t -96.58 134.61 23.09 Favored Pre-proline 0 N--CA 1.494 1.73 0 N-CA-C 113.136 0.791 . . . . 0.78000000000000003 113.136 -175.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 867' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -90.36 -149.13 0.03 OUTLIER 'Trans proline' 0 CA--C 1.544 1.022 0 O-C-N 123.577 1.304 . . . . 0.92000000000000004 108.837 177.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 868' ' ' PHE . . . . . 0.472 ' N ' ' CD1' ' C' ' 868' ' ' PHE . 13.8 p90 -150.0 123.65 9.17 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.53 -1.356 . . . . 0.050000000000000003 109.861 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 46.5 p-10 -113.82 -2.48 13.65 Favored 'General case' 0 N--CA 1.499 2.003 0 C-N-CA 119.185 -1.006 . . . . 1.7 112.892 -178.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 870' ' ' ARG . . . . . 0.412 ' HB2' ' O ' ' C' ' 855' ' ' ALA . 29.9 mmm180 -91.22 88.66 7.0 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.912 -1.117 . . . . 2.5899999999999999 110.998 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 57.3 t -72.21 97.48 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 120.94 -1.1 . . . . 1.9399999999999999 109.695 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 872' ' ' LEU . . . . . . . . . . . . . 96.3 mt -86.22 -46.04 10.74 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.611 -0.681 . . . . 1.0600000000000001 110.648 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 873' ' ' LEU . . . . . 0.41 ' O ' ' HB2' ' C' ' 874' ' ' ASN . 35.8 tp -173.61 102.27 0.12 Allowed 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.262 -0.899 . . . . 4.1799999999999997 108.702 178.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 874' ' ' ASN . . . . . 0.41 ' HB2' ' O ' ' C' ' 873' ' ' LEU . 36.3 t-20 177.7 82.68 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.26 0 N-CA-C 109.035 -0.728 . . . . 0.040000000000000001 109.035 -178.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -64.39 -46.15 84.54 Favored 'General case' 0 N--CA 1.497 1.916 0 C-N-CA 119.265 -0.974 . . . . 3.3799999999999999 111.171 -179.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 876' ' ' GLY . . . . . 0.426 ' HA3' ' CE2' ' C' ' 878' ' ' TYR . . . -73.8 -26.47 69.2 Favored Glycine 0 N--CA 1.494 2.519 0 C-N-CA 120.461 -0.876 . . . . 0.040000000000000001 111.977 -178.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 79.49 -63.94 3.89 Favored Glycine 0 N--CA 1.502 3.098 0 N-CA-C 107.868 -2.093 . . . . 0.040000000000000001 107.868 -178.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 878' ' ' TYR . . . . . 0.426 ' CE2' ' HA3' ' C' ' 876' ' ' GLY . 76.5 m-85 60.39 -63.92 0.06 Allowed 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 114.825 1.417 . . . . 3.46 114.825 177.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 879' ' ' TYR . . . . . 0.494 ' CE2' ' CD1' ' C' ' 981' ' ' PHE . 28.8 p90 -108.53 108.29 19.15 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 115.342 1.608 . . . . 0.040000000000000001 115.342 -175.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -70.69 117.55 56.63 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 121.758 -0.589 . . . . 0.02 110.191 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 881' ' ' PRO . . . . . 0.453 ' CG ' ' CD1' ' C' ' 868' ' ' PHE . 55.3 Cg_endo -76.83 1.97 8.01 Favored 'Trans proline' 0 N--CA 1.492 1.402 0 O-C-N 123.452 1.238 . . . . 0.39000000000000001 112.298 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -74.66 -65.02 0.91 Allowed 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 106.359 -1.719 . . . . 0.81000000000000005 106.359 178.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 6.0 p -96.45 -16.3 21.26 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.804 -0.813 . . . . 0.040000000000000001 108.804 177.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.54 23.02 52.25 Favored Glycine 0 N--CA 1.493 2.499 0 O-C-N 120.991 -1.068 . . . . 0.029999999999999999 110.692 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 95.2 t -73.38 87.5 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 C-N-CA 118.299 -1.36 . . . . 1.01 107.775 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 886' ' ' PHE . . . . . 0.497 ' O ' ' HA ' ' C' ' 961' ' ' THR . 0.7 OUTLIER -87.95 108.83 19.39 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-N 115.132 -0.94 . . . . 0.050000000000000003 111.569 -177.587 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 887' ' ' THR . . . . . . . . . . . . . 97.3 m -105.75 99.62 9.21 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 107.596 -1.261 . . . . 0.68000000000000005 107.596 177.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 888' ' ' ALA . . . . . . . . . . . . . . . -98.89 101.56 12.54 Favored Pre-proline 0 N--CA 1.501 2.089 0 N-CA-C 114.523 1.305 . . . . 0.25 114.523 -176.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 889' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -79.83 -15.03 12.2 Favored 'Trans proline' 0 N--CA 1.486 1.048 0 N-CA-C 108.786 -1.275 . . . . 1.6399999999999999 108.786 175.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 890' ' ' LEU . . . . . . . . . . . . . 66.1 mt -37.77 -49.15 1.15 Allowed 'General case' 0 N--CA 1.508 2.438 0 N-CA-C 113.463 0.912 . . . . 2.29 113.463 -177.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 52.66 97.73 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.193 -0.942 . . . . 0.63 110.451 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . 158.86 -154.5 25.59 Favored Glycine 0 N--CA 1.477 1.407 0 N-CA-C 107.29 -2.324 . . . . 0.040000000000000001 107.29 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 77.7 ttt-85 -116.28 123.94 48.94 Favored 'General case' 0 C--N 1.294 -1.825 0 O-C-N 121.671 -0.9 . . . . 3.0 108.589 177.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 894' ' ' TYR . . . . . 0.438 ' CE2' ' CD2' ' C' ' 954' ' ' LEU . 12.9 p90 -132.07 154.04 49.82 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.079 -1.013 . . . . 0.040000000000000001 110.954 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 895' ' ' LEU . . . . . . . . . . . . . 45.0 tp -99.65 113.78 26.44 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.706 -0.621 . . . . 1.27 109.796 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 896' ' ' LEU . . . . . . . . . . . . . 8.4 tt -118.01 145.08 45.02 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.678 -0.639 . . . . 0.93999999999999995 109.985 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 897' ' ' SER . . . . . . . . . . . . . 62.4 m -141.24 124.15 16.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.445 -0.784 . . . . 0.040000000000000001 111.184 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -100.78 148.42 24.94 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.73 -0.841 . . . . 0.47999999999999998 108.73 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 899' ' ' VAL . . . . . . . . . . . . . 96.7 t -92.33 120.53 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.369 -0.832 . . . . 0.55000000000000004 111.079 -179.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 91.4 mt -92.65 113.08 25.26 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 113.99 1.107 . . . . 1.5900000000000001 113.99 -175.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 901' ' ' THR . . . . . 0.41 HG22 ' CE1' ' C' ' 903' ' ' HIS . 16.7 m -62.54 141.28 58.51 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 107.545 -1.28 . . . . 0.050000000000000003 107.545 177.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -60.68 -65.23 3.47 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 110.362 -1.095 . . . . 0.029999999999999999 110.362 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 903' ' ' HIS . . . . . 0.41 ' CE1' HG22 ' C' ' 901' ' ' THR . 1.6 m80 46.23 65.11 1.26 Allowed 'General case' 0 N--CA 1.507 2.4 0 O-C-N 121.485 -1.009 . . . . 3.2000000000000002 111.095 179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 42.4 ptt85 -66.72 -8.19 26.24 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.639 -0.663 . . . . 2.9199999999999999 111.971 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 905' ' ' HIS . . . . . 0.473 ' O ' ' CB ' ' C' ' 906' ' ' GLU . 61.0 t60 -63.67 5.32 0.21 Allowed 'General case' 0 N--CA 1.504 2.229 0 O-C-N 120.946 -1.096 . . . . 2.8700000000000001 112.624 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 906' ' ' GLU . . . . . 0.5 ' O ' ' CB ' ' C' ' 907' ' ' LYS . 2.8 mt-10 89.21 -152.96 0.01 OUTLIER 'General case' 0 N--CA 1.526 3.362 0 CA-C-N 121.215 1.825 . . . . 0.98999999999999999 111.59 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 907' ' ' LYS . . . . . 0.5 ' CB ' ' O ' ' C' ' 906' ' ' GLU . 62.2 tttt 90.19 163.85 0.05 OUTLIER 'General case' 0 N--CA 1.523 3.179 0 N-CA-C 107.925 -1.139 . . . . 5.25 107.925 -176.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 58.4 t -123.33 114.34 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 120.84 -1.162 . . . . 0.39000000000000001 110.843 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 44.3 tp10 -108.68 130.71 55.34 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 107.559 -1.275 . . . . 1.72 107.559 177.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -157.54 121.16 4.1 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 107.098 -1.445 . . . . 0.67000000000000004 107.098 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 911' ' ' VAL . . . . . 0.459 ' HA ' ' HA ' ' C' ' 964' ' ' VAL . 14.0 p -80.94 131.02 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 C-N-CA 120.35 -0.54 . . . . 0.54000000000000004 111.654 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 62.4 mt -67.43 157.94 32.97 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.359 -0.838 . . . . 1.5 109.036 178.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 913' ' ' SER . . . . . 0.4 ' CB ' ' CG1' ' C' ' 919' ' ' VAL . 1.5 p -126.07 138.87 53.74 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.568 -0.901 . . . . 1.3700000000000001 108.568 176.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 914' ' ' ARG . . . . . 0.424 ' O ' ' CB ' ' C' ' 915' ' ' SER . 0.0 OUTLIER -64.16 153.46 37.74 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 120.638 -1.289 . . . . 4.2999999999999998 111.607 -179.152 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 915' ' ' SER . . . . . 0.424 ' CB ' ' O ' ' C' ' 914' ' ' ARG . 0.2 OUTLIER 82.83 -30.37 0.09 Allowed 'General case' 0 N--CA 1.522 3.147 0 C-N-CA 123.766 0.826 . . . . 2.0499999999999998 112.457 179.575 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 916' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -122.17 -22.1 5.71 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.804 -1.185 . . . . 2.71 111.268 -179.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 67.09 166.52 0.22 Allowed 'General case' 0 N--CA 1.52 3.042 0 N-CA-C 105.792 -1.929 . . . . 2.6800000000000002 105.792 -174.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.58 -125.67 35.26 Favored Glycine 1 N--CA 1.522 4.384 0 CA-C-N 123.539 2.882 . . . . 0.029999999999999999 107.087 -177.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 919' ' ' VAL . . . . . 0.4 ' CG1' ' CB ' ' C' ' 913' ' ' SER . 92.4 t 51.01 94.02 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.238 0 O-C-N 121.452 -1.028 . . . . 1.3899999999999999 109.234 -178.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 920' ' ' ALA . . . . . . . . . . . . . . . -94.06 94.32 8.34 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.395 -0.922 . . . . 0.029999999999999999 110.735 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 921' ' ' ARG . . . . . 0.426 ' HB3' ' CZ ' ' C' ' 950' ' ' PHE . 45.2 ptt85 -79.14 -42.1 27.0 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 105.591 -2.003 . . . . 4.4199999999999999 105.591 176.049 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 922' ' ' VAL . . . . . . . . . . . . . 73.9 t -99.7 78.68 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 N-CA-C 105.441 -2.059 . . . . 0.84999999999999998 105.441 174.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -89.92 136.28 33.13 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 122.047 0.927 . . . . 2.46 112.775 -176.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 6.3 t -147.21 103.05 3.55 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 107.576 -1.268 . . . . 0.69999999999999996 107.576 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -107.71 82.27 0.31 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.656 -1.378 . . . . 0.040000000000000001 109.656 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 109.187 -1.565 . . . . 0.040000000000000001 109.187 179.747 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 17.7 m . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 120.937 0.398 . . . . 13.779999999999999 110.377 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 95.3 mt -114.66 131.36 56.75 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.472 -0.767 . . . . 13.76 110.321 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -151.7 170.13 31.17 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.433 -1.467 . . . . 9.1300000000000008 109.433 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 949' ' ' VAL . . . . . . . . . . . . . 26.9 m -117.44 136.26 55.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.488 -1.007 . . . . 7.0800000000000001 111.043 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 950' ' ' PHE . . . . . 0.426 ' CZ ' ' HB3' ' C' ' 921' ' ' ARG . 40.4 p90 -133.36 150.22 51.84 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.561 -0.712 . . . . 7.5899999999999999 109.336 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 68.4 m -118.07 -57.64 2.07 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.399 -0.813 . . . . 5.0300000000000002 111.81 -178.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 952' ' ' LEU . . . . . 0.454 ' O ' ' O ' ' C' ' 953' ' ' ILE . 46.4 tp -62.34 -75.69 0.07 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.423 -0.798 . . . . 1.01 111.505 -178.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 953' ' ' ILE . . . . . 0.47 ' O ' ' HB3' ' C' ' 954' ' ' LEU . 2.8 pp -49.41 -151.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.694 0 N-CA-C 114.563 1.32 . . . . 2.6000000000000001 114.563 -176.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 954' ' ' LEU . . . . . 0.569 ' N ' ' CD1' ' C' ' 954' ' ' LEU . 0.0 OUTLIER 171.22 90.39 0.04 OUTLIER Pre-proline 0 N--CA 1.515 2.807 0 O-C-N 120.659 -1.276 . . . . 0.050000000000000003 111.941 -179.289 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 955' ' ' PRO . . . . . 0.429 ' HD3' ' CD1' ' C' ' 953' ' ' ILE . 52.8 Cg_endo -83.0 92.37 0.9 Allowed 'Trans proline' 0 C--N 1.317 -1.113 0 N-CA-C 109.502 -0.999 . . . . 0.83999999999999997 109.502 178.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 956' ' ' LEU . . . . . . . . . . . . . 6.2 mp -125.11 147.86 48.82 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.066 -1.021 . . . . 0.040000000000000001 110.521 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -82.71 150.93 26.44 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 117.661 -1.162 . . . . 1.28 111.341 -178.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -64.65 118.11 8.41 Favored 'General case' 0 N--CA 1.506 2.365 0 CA-C-N 123.221 2.737 . . . . 0.17000000000000001 110.662 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.25 -18.56 53.89 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 110.903 -0.879 . . . . 0.040000000000000001 110.903 179.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 960' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.41 171.18 0.12 Allowed 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.265 -1.138 . . . . 0.040000000000000001 110.253 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 961' ' ' THR . . . . . 0.497 ' HA ' ' O ' ' C' ' 886' ' ' PHE . 40.7 m -137.71 141.07 41.05 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.95 -1.094 . . . . 1.78 112.844 -177.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 962' ' ' VAL . . . . . 0.409 ' CG2' ' CB ' ' C' ' 886' ' ' PHE . 27.3 m -100.44 145.45 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.88 -0.512 . . . . 0.040000000000000001 110.666 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 5.3 t -138.01 144.14 40.94 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.715 -0.616 . . . . 0.71999999999999997 110.153 -178.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 964' ' ' VAL . . . . . 0.459 ' HA ' ' HA ' ' C' ' 911' ' ' VAL . 58.9 t -91.45 137.29 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.185 -0.947 . . . . 1.05 110.803 -179.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -92.83 125.64 37.53 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 103.441 -2.8 . . . . 3.02 103.441 173.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 966' ' ' LEU . . . . . 0.411 ' O ' ' CG2' ' C' ' 967' ' ' VAL . 0.2 OUTLIER -134.53 56.81 1.83 Allowed 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.578 -0.897 . . . . 1.46 108.578 177.503 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 967' ' ' VAL . . . . . 0.411 ' CG2' ' O ' ' C' ' 966' ' ' LEU . 97.9 t -158.22 95.93 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.248 -1.019 . . . . 1.9399999999999999 108.248 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 92.8 mmm -142.87 59.28 1.43 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.724 -1.235 . . . . 0.0 108.462 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 134.35 119.62 1.98 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 107.282 -2.327 . . . . 2.1099999999999999 107.282 -178.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -82.56 -58.26 2.99 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.004 -1.291 . . . . 5.8899999999999997 110.531 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 48.1 tp -59.14 89.69 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.397 -0.814 . . . . 4.3600000000000003 110.313 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -142.71 -152.08 0.39 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.559 -0.713 . . . . 1.8300000000000001 109.97 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -115.93 166.99 11.35 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.391 -0.818 . . . . 4.3499999999999996 109.842 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 9.8 t -101.61 129.83 47.81 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.52 -0.738 . . . . 1.27 110.079 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -156.45 157.5 35.62 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.528 -0.732 . . . . 5.0199999999999996 110.553 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -143.22 85.91 9.4 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.658 -0.651 . . . . 2.4100000000000001 109.796 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -74.77 -169.86 0.68 Allowed 'Trans proline' 0 C--N 1.318 -1.045 0 O-C-N 123.189 1.099 . . . . 0.95999999999999996 111.325 -179.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 978' ' ' LEU . . . . . . . . . . . . . 5.1 mp -125.86 155.9 40.46 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.474 -1.306 . . . . 0.62 107.474 177.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 979' ' ' THR . . . . . . . . . . . . . 42.8 p -149.88 142.96 24.98 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.759 -1.213 . . . . 3.5699999999999998 111.334 -179.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 980' ' ' ILE . . . . . . . . . . . . . 50.0 mm -105.41 127.88 59.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 108.837 -0.801 . . . . 1.3300000000000001 108.837 179.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 981' ' ' PHE . . . . . 0.494 ' CD1' ' CE2' ' C' ' 879' ' ' TYR . 5.2 t80 -117.9 96.05 5.18 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.311 -0.868 . . . . 0.050000000000000003 111.579 -178.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 982' ' ' SER . . . . . . . . . . . . . 51.3 p -106.3 158.78 16.61 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 109.066 -0.716 . . . . 0.87 109.066 178.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 983' ' ' GLY . . . . . 0.431 ' HA3' ' CE2' ' C' ' 852' ' ' PHE . . . -171.81 113.18 0.48 Allowed Glycine 0 N--CA 1.496 2.662 0 N-CA-C 106.624 -2.59 . . . . 0.029999999999999999 106.624 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 984' ' ' ALA . . . . . 0.405 ' CB ' ' CZ ' ' A' ' 893' ' ' ARG . . . -108.75 152.01 25.43 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 114.323 1.231 . . . . 0.69999999999999996 114.323 -175.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 985' ' ' LEU . . . . . . . . . . . . . 55.6 tp -75.89 136.14 40.13 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.848 -1.157 . . . . 0.040000000000000001 109.832 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 986' ' ' LEU . . . . . . . . . . . . . 51.4 tp -106.35 -62.82 1.34 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.573 -0.704 . . . . 0.040000000000000001 110.302 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -144.92 147.15 32.41 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 107.816 -1.179 . . . . 0.040000000000000001 107.816 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -111.86 162.74 12.33 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 108.071 -2.011 . . . . 0.040000000000000001 108.071 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -72.46 112.96 16.91 Favored Pre-proline 0 N--CA 1.498 1.935 0 O-C-N 121.207 -1.173 . . . . 0.040000000000000001 109.531 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 990' ' ' PRO . . . . . 0.407 ' O ' ' HB2' ' C' ' 991' ' ' GLU . 50.6 Cg_endo -87.66 70.13 3.31 Favored 'Trans proline' 0 C--N 1.319 -0.975 0 O-C-N 123.127 1.067 . . . . 0.45000000000000001 111.356 -178.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 991' ' ' GLU . . . . . 0.407 ' HB2' ' O ' ' C' ' 990' ' ' PRO . 71.4 mt-10 67.12 -74.11 0.07 Allowed 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 108.617 -0.883 . . . . 1.97 108.617 -177.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 992' ' ' LEU . . . . . . . . . . . . . 11.5 mt 50.55 21.03 0.79 Allowed 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.606 -0.684 . . . . 2.3799999999999999 111.646 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -92.54 156.77 16.91 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.89 -1.131 . . . . 3.79 110.038 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 68.6 m80 -146.56 91.84 2.09 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.52 -0.738 . . . . 3.5099999999999998 110.281 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 995' ' ' ALA . . . . . . . . . . . . 2.518 . . . . . . . 0 N--CA 1.504 2.248 0 O-C-N 120.95 -1.094 . . . . 2.73 110.589 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo . . . . . 0 N--CA 1.488 1.153 0 N-CA-C 109.581 -0.969 . . . . 3.8300000000000001 109.581 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 847' ' ' VAL . . . . . . . . . . . . . 61.4 t -132.03 103.56 14.19 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.636 -0.665 . . . . 1.8300000000000001 110.0 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 848' ' ' PRO . . . . . 0.4 ' O ' ' C ' ' A' ' 849' ' ' GLN . 44.1 Cg_endo -69.5 -20.08 36.52 Favored 'Trans proline' 0 N--CA 1.487 1.117 0 O-C-N 123.271 1.142 . . . . 0.65000000000000002 111.139 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 849' ' ' GLN . . . . . 0.4 ' C ' ' O ' ' A' ' 848' ' ' PRO . 55.7 tt0 27.03 68.2 0.06 Allowed 'General case' 0 N--CA 1.518 2.957 0 N-CA-C 112.919 0.711 . . . . 2.5800000000000001 112.919 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 850' ' ' VAL . . . . . . . . . . . . . 59.6 t -117.76 136.72 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.184 -0.948 . . . . 1.0900000000000001 111.459 -178.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 851' ' ' ALA . . . . . . . . . . . . . . . -125.83 156.65 39.22 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 105.783 -1.932 . . . . 0.040000000000000001 105.783 176.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 852' ' ' PHE . . . . . 0.409 ' HA ' ' CB ' ' A' ' 874' ' ' ASN . 24.2 p90 -160.34 128.61 4.7 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 121.014 1.734 . . . . 0.050000000000000003 108.732 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 29.7 t -174.96 134.98 0.35 Allowed 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.053 -1.091 . . . . 0.040000000000000001 108.053 -178.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -132.83 156.48 47.07 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.99 -1.069 . . . . 0.67000000000000004 109.497 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 855' ' ' ALA . . . . . . . . . . . . . . . -122.73 144.61 49.05 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.787 0.803 . . . . 0.51000000000000001 111.65 -178.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 856' ' ' LEU . . . . . 0.406 ' CD2' ' CG1' ' A' ' 866' ' ' VAL . 3.4 tm? -112.05 134.33 53.66 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.787 -0.571 . . . . 0.050000000000000003 110.112 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 857' ' ' SER . . . . . 0.414 ' O ' ' O ' ' A' ' 858' ' ' LEU . 55.8 p -150.63 16.7 0.79 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.531 -0.731 . . . . 1.3300000000000001 110.502 178.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 858' ' ' LEU . . . . . 0.414 ' O ' ' O ' ' A' ' 857' ' ' SER . 4.4 pp -32.94 158.26 0.03 OUTLIER Pre-proline 0 N--CA 1.517 2.924 0 N-CA-C 113.432 0.901 . . . . 2.3300000000000001 113.432 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -64.41 -88.48 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.451 0 O-C-N 123.171 1.09 . . . . 2.3199999999999998 113.075 -178.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 55.8 ptt85 -128.7 -143.37 0.27 Allowed 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.817 -1.177 . . . . 0.040000000000000001 111.691 -177.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 19.4 m -40.4 128.16 2.38 Favored 'General case' 0 N--CA 1.508 2.468 0 O-C-N 121.43 -0.794 . . . . 1.3100000000000001 112.38 -178.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -102.69 156.74 34.9 Favored Pre-proline 0 N--CA 1.489 1.496 0 N-CA-C 107.8 -1.185 . . . . 4.5099999999999998 107.8 177.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -70.03 -12.71 32.9 Favored 'Trans proline' 0 C--N 1.314 -1.288 0 O-C-N 123.032 1.017 . . . . 2.2400000000000002 111.363 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -175.74 -136.38 2.32 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.972 -1.251 . . . . 0.040000000000000001 109.972 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 27.8 m -66.43 156.88 33.43 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.32 -1.106 . . . . 1.51 110.944 -178.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 866' ' ' VAL . . . . . 0.406 ' CG1' ' CD2' ' A' ' 856' ' ' LEU . 48.4 t -93.15 134.61 26.85 Favored Pre-proline 0 N--CA 1.495 1.8 0 N-CA-C 113.273 0.842 . . . . 0.78000000000000003 113.273 -174.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 867' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -90.36 -152.74 0.04 OUTLIER 'Trans proline' 0 CA--C 1.541 0.869 0 N-CA-C 108.761 -1.284 . . . . 0.92000000000000004 108.761 177.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 868' ' ' PHE . . . . . 0.452 ' CD1' ' N ' ' A' ' 868' ' ' PHE . 24.1 p90 -149.76 122.21 8.5 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.573 -1.329 . . . . 0.050000000000000003 109.901 179.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 49.0 p-10 -113.39 -2.33 13.99 Favored 'General case' 0 N--CA 1.498 1.972 0 C-N-CA 119.287 -0.965 . . . . 1.7 112.299 -179.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 870' ' ' ARG . . . . . . . . . . . . . 30.3 mmm180 -90.59 88.91 7.31 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.962 -1.086 . . . . 2.5899999999999999 110.67 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 58.3 t -74.54 97.31 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 120.95 -1.094 . . . . 1.9399999999999999 109.919 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 872' ' ' LEU . . . . . . . . . . . . . 92.8 mt -82.97 -47.24 11.96 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.526 -0.734 . . . . 1.0600000000000001 110.24 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 873' ' ' LEU . . . . . . . . . . . . . 46.9 tp -174.66 103.95 0.1 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.243 -0.911 . . . . 4.1799999999999997 108.689 178.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 874' ' ' ASN . . . . . 0.409 ' CB ' ' HA ' ' A' ' 852' ' ' PHE . 35.7 t-20 178.9 81.71 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.3 0 O-C-N 121.55 -0.719 . . . . 0.040000000000000001 109.751 -178.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -66.91 -47.25 72.35 Favored 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 119.241 -0.984 . . . . 3.3799999999999999 111.128 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 876' ' ' GLY . . . . . 0.413 ' HA3' ' CE2' ' A' ' 878' ' ' TYR . . . -73.95 -25.01 72.62 Favored Glycine 0 N--CA 1.495 2.573 0 O-C-N 121.275 -0.89 . . . . 0.040000000000000001 111.668 -178.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 82.86 -61.38 4.78 Favored Glycine 0 N--CA 1.501 3.023 0 N-CA-C 108.085 -2.006 . . . . 0.040000000000000001 108.085 -178.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 878' ' ' TYR . . . . . 0.413 ' CE2' ' HA3' ' A' ' 876' ' ' GLY . 88.1 m-85 60.41 -64.96 0.05 Allowed 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 114.28 1.215 . . . . 3.46 114.28 177.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 879' ' ' TYR . . . . . 0.479 ' CB ' ' CD2' ' A' ' 886' ' ' PHE . 19.6 p90 -111.53 107.15 16.23 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 114.5 1.296 . . . . 0.040000000000000001 114.5 -176.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -66.03 117.39 42.11 Favored Pre-proline 0 N--CA 1.497 1.903 0 O-C-N 121.402 -0.811 . . . . 0.02 110.1 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 881' ' ' PRO . . . . . 0.408 ' HG2' ' CD1' ' A' ' 868' ' ' PHE . 55.6 Cg_endo -75.92 0.05 9.7 Favored 'Trans proline' 0 N--CA 1.496 1.637 0 O-C-N 123.547 1.288 . . . . 0.39000000000000001 112.195 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -77.77 -63.87 1.28 Allowed 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 106.803 -1.554 . . . . 0.81000000000000005 106.803 178.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 44.9 p -93.03 -19.55 21.44 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.543 -0.91 . . . . 0.040000000000000001 108.543 177.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.7 20.16 60.35 Favored Glycine 0 N--CA 1.497 2.758 0 O-C-N 121.089 -1.007 . . . . 0.029999999999999999 111.545 178.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 885' ' ' VAL . . . . . . . . . . . . . 88.1 t -74.19 91.96 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 C-N-CA 118.16 -1.416 . . . . 1.01 108.197 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 886' ' ' PHE . . . . . 0.479 ' CD2' ' CB ' ' A' ' 879' ' ' TYR . 0.7 OUTLIER -90.27 105.75 18.02 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 115.158 -0.928 . . . . 0.050000000000000003 112.118 -177.248 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 887' ' ' THR . . . . . 0.406 ' O ' ' HD3' ' A' ' 889' ' ' PRO . 70.6 m -96.44 100.96 12.52 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 107.911 -1.144 . . . . 0.68000000000000005 107.911 177.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 888' ' ' ALA . . . . . . . . . . . . . . . -98.61 106.65 38.01 Favored Pre-proline 0 N--CA 1.503 2.201 0 N-CA-C 114.146 1.165 . . . . 0.25 114.146 -176.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 889' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' A' ' 887' ' ' THR . 55.2 Cg_endo -89.08 -12.94 3.17 Favored 'Trans proline' 0 CA--C 1.546 1.098 0 N-CA-C 109.121 -1.146 . . . . 1.6399999999999999 109.121 176.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 890' ' ' LEU . . . . . . . . . . . . . 56.0 mt -34.25 -51.07 0.43 Allowed 'General case' 0 N--CA 1.509 2.482 0 N-CA-C 113.972 1.101 . . . . 2.29 113.972 -177.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 51.51 94.89 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.363 0 O-C-N 121.186 -0.946 . . . . 0.63 110.331 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 156.09 -147.3 15.75 Favored Glycine 0 N--CA 1.48 1.601 0 N-CA-C 107.536 -2.226 . . . . 0.040000000000000001 107.536 -179.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 893' ' ' ARG . . . . . 0.401 ' NH1' ' CD2' ' A' ' 986' ' ' LEU . 71.4 ttt-85 -109.13 127.76 54.44 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 107.576 -1.268 . . . . 3.0 107.576 177.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 894' ' ' TYR . . . . . 0.449 ' CD1' ' N ' ' A' ' 895' ' ' LEU . 0.1 OUTLIER -130.28 144.54 51.43 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.987 -1.071 . . . . 0.040000000000000001 110.041 -179.075 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 895' ' ' LEU . . . . . 0.449 ' N ' ' CD1' ' A' ' 894' ' ' TYR . 39.9 tp -97.25 114.24 25.96 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.59 -0.694 . . . . 1.27 109.616 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 896' ' ' LEU . . . . . 0.431 ' HB2' ' CZ ' ' A' ' 894' ' ' TYR . 9.7 tt -111.24 146.01 37.72 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.625 -0.672 . . . . 0.93999999999999995 110.812 -179.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 897' ' ' SER . . . . . . . . . . . . . 66.9 m -143.86 116.81 8.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.573 -0.705 . . . . 0.040000000000000001 110.503 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -106.57 146.77 30.25 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.258 -0.645 . . . . 0.47999999999999998 109.258 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 899' ' ' VAL . . . . . . . . . . . . . 88.3 t -97.47 119.18 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 C-N-CA 119.716 -0.794 . . . . 0.55000000000000004 111.277 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 900' ' ' LEU . . . . . 0.402 ' CD2' ' N ' ' A' ' 900' ' ' LEU . 4.5 mm? -95.16 112.18 23.92 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 114.175 1.176 . . . . 1.5900000000000001 114.175 -175.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 901' ' ' THR . . . . . 0.407 HG22 ' CE1' ' A' ' 903' ' ' HIS . 17.6 m -64.54 140.99 58.93 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 107.398 -1.334 . . . . 0.050000000000000003 107.398 177.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -63.26 -66.27 2.64 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 110.479 -1.048 . . . . 0.029999999999999999 110.479 -179.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 903' ' ' HIS . . . . . 0.407 ' CE1' HG22 ' A' ' 901' ' ' THR . 2.2 m80 46.52 66.06 1.06 Allowed 'General case' 0 N--CA 1.507 2.42 0 O-C-N 121.474 -1.015 . . . . 3.2000000000000002 111.118 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 54.1 ptt85 -68.72 -6.44 26.32 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.585 -0.697 . . . . 2.9199999999999999 111.916 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 905' ' ' HIS . . . . . 0.483 ' O ' ' CB ' ' A' ' 906' ' ' GLU . 75.9 t60 -60.79 3.4 0.08 Allowed 'General case' 0 N--CA 1.505 2.314 0 O-C-N 120.936 -1.103 . . . . 2.8700000000000001 113.034 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 906' ' ' GLU . . . . . 0.483 ' CB ' ' O ' ' A' ' 905' ' ' HIS . 0.8 OUTLIER 93.4 -163.58 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.377 0 CA-C-N 120.552 1.523 . . . . 0.98999999999999999 112.192 178.789 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 907' ' ' LYS . . . . . 0.481 ' CB ' ' O ' ' A' ' 906' ' ' GLU . 42.6 tttt 88.64 161.73 0.06 Allowed 'General case' 0 N--CA 1.519 2.991 0 N-CA-C 107.675 -1.231 . . . . 5.25 107.675 -176.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 61.0 t -121.97 115.77 47.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 120.876 -1.14 . . . . 0.39000000000000001 110.815 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 52.1 tp10 -100.71 132.62 46.01 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 107.19 -1.411 . . . . 1.72 107.19 176.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -156.82 120.64 4.28 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 106.731 -1.581 . . . . 0.67000000000000004 106.731 178.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 911' ' ' VAL . . . . . 0.467 ' HA ' ' HA ' ' A' ' 964' ' ' VAL . 95.6 t -83.18 131.99 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 C-N-CA 120.34 -0.544 . . . . 0.54000000000000004 110.756 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 72.8 mt -64.63 155.21 34.02 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.316 -0.865 . . . . 1.5 108.709 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 913' ' ' SER . . . . . 0.41 ' CB ' ' HB ' ' A' ' 919' ' ' VAL . 1.5 t -122.95 137.62 54.9 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.101 -1.074 . . . . 1.3700000000000001 108.101 177.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 914' ' ' ARG . . . . . 0.423 ' O ' ' CB ' ' A' ' 915' ' ' SER . 0.0 OUTLIER -64.1 153.73 36.71 Favored 'General case' 0 N--CA 1.505 2.308 0 O-C-N 120.834 -1.166 . . . . 4.2999999999999998 111.895 -178.884 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 915' ' ' SER . . . . . 0.423 ' CB ' ' O ' ' A' ' 914' ' ' ARG . 2.2 t 82.85 -31.91 0.09 Allowed 'General case' 0 N--CA 1.52 3.075 0 C-N-CA 123.977 0.911 . . . . 2.0499999999999998 112.452 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 916' ' ' ASN . . . . . 0.412 ' O ' ' HB2' ' A' ' 917' ' ' GLN . 98.2 m-20 -121.64 -20.59 6.46 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 120.838 -1.164 . . . . 2.71 111.509 -179.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 917' ' ' GLN . . . . . 0.412 ' HB2' ' O ' ' A' ' 916' ' ' ASN . 51.1 mt-30 66.74 165.93 0.21 Allowed 'General case' 0 N--CA 1.52 3.045 0 N-CA-C 105.653 -1.98 . . . . 2.6800000000000002 105.653 -173.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.15 -125.04 32.46 Favored Glycine 1 N--CA 1.521 4.342 0 CA-C-N 123.423 2.828 . . . . 0.029999999999999999 107.1 -177.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 919' ' ' VAL . . . . . 0.41 ' HB ' ' CB ' ' A' ' 913' ' ' SER . 76.7 t 51.71 94.9 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.229 0 O-C-N 121.466 -1.02 . . . . 1.3899999999999999 108.934 -178.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.17 91.93 8.45 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.237 -0.985 . . . . 0.029999999999999999 110.986 -178.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 921' ' ' ARG . . . . . 0.437 ' HB3' ' CZ ' ' A' ' 950' ' ' PHE . 42.4 ptt85 -84.2 -42.04 16.36 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 105.594 -2.002 . . . . 4.4199999999999999 105.594 175.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 922' ' ' VAL . . . . . . . . . . . . . 72.0 t -103.19 69.27 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 N-CA-C 105.446 -2.057 . . . . 0.84999999999999998 105.446 175.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -91.0 135.94 33.41 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.783 0.801 . . . . 2.46 112.139 -176.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 13.8 t -147.6 104.31 3.6 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 108.096 -1.075 . . . . 0.69999999999999996 108.096 178.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -110.93 90.28 0.57 Allowed Glycine 0 N--CA 1.487 2.08 0 N-CA-C 108.988 -1.645 . . . . 0.040000000000000001 108.988 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.403 0 N-CA-C 109.4 -1.48 . . . . 0.040000000000000001 109.4 -179.625 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 31.0 m . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.007 0.432 . . . . 13.779999999999999 110.307 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 97.5 mt -113.55 129.68 56.51 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.519 -0.738 . . . . 13.76 110.46 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -152.28 168.51 31.44 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.103 -1.599 . . . . 9.1300000000000008 109.103 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 949' ' ' VAL . . . . . . . . . . . . . 34.9 m -118.81 130.35 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.48 -1.012 . . . . 7.0800000000000001 110.928 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 950' ' ' PHE . . . . . 0.437 ' CZ ' ' HB3' ' A' ' 921' ' ' ARG . 32.2 p90 -133.42 149.28 51.81 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.563 -0.711 . . . . 7.5899999999999999 109.31 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 19.6 m -119.42 -53.87 2.21 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.446 -0.784 . . . . 5.0300000000000002 112.144 -178.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 952' ' ' LEU . . . . . 0.414 ' O ' ' O ' ' A' ' 953' ' ' ILE . 57.0 tp -59.98 -75.81 0.05 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.342 -0.849 . . . . 1.01 111.974 -177.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 953' ' ' ILE . . . . . 0.481 ' O ' ' HB3' ' A' ' 954' ' ' LEU . 49.3 pt -53.1 -144.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.663 0 N-CA-C 113.718 1.007 . . . . 2.6000000000000001 113.718 -176.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 954' ' ' LEU . . . . . 0.529 ' N ' ' CD1' ' A' ' 954' ' ' LEU . 0.0 OUTLIER 167.5 83.83 0.02 OUTLIER Pre-proline 0 N--CA 1.512 2.66 0 O-C-N 120.998 -1.064 . . . . 0.050000000000000003 111.535 178.976 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 955' ' ' PRO . . . . . 0.427 ' HD2' ' CE1' ' A' ' 950' ' ' PHE . 46.9 Cg_endo -74.02 98.14 1.06 Allowed 'Trans proline' 0 C--N 1.314 -1.285 0 N-CA-C 108.938 -1.216 . . . . 0.83999999999999997 108.938 177.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 956' ' ' LEU . . . . . 0.406 ' CD2' ' NH1' ' A' ' 914' ' ' ARG . 10.0 mp -122.59 144.13 49.31 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.053 -1.029 . . . . 0.040000000000000001 110.276 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -83.61 150.7 25.74 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 117.719 -1.134 . . . . 1.28 111.456 -179.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -69.58 120.08 14.82 Favored 'General case' 0 N--CA 1.509 2.482 0 CA-C-N 122.99 2.632 . . . . 0.17000000000000001 111.373 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 93.34 -21.74 38.83 Favored Glycine 0 N--CA 1.5 2.959 0 N-CA-C 110.94 -0.864 . . . . 0.040000000000000001 110.94 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 960' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -51.88 171.3 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.476 -1.014 . . . . 0.040000000000000001 110.538 -179.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 961' ' ' THR . . . . . 0.441 ' HA ' ' O ' ' A' ' 886' ' ' PHE . 43.7 m -134.81 134.93 41.37 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.953 -1.092 . . . . 1.78 111.641 -178.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 962' ' ' VAL . . . . . 0.422 ' CG2' ' CB ' ' A' ' 886' ' ' PHE . 33.0 m -100.48 145.34 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 C-N-CA 119.851 -0.739 . . . . 0.040000000000000001 110.628 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 5.3 t -138.36 146.52 42.39 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.935 -0.478 . . . . 0.71999999999999997 109.979 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 964' ' ' VAL . . . . . 0.467 ' HA ' ' HA ' ' A' ' 911' ' ' VAL . 60.3 t -94.14 136.63 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.102 -0.999 . . . . 1.05 110.416 -179.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -93.52 126.55 38.73 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 103.547 -2.76 . . . . 3.02 103.547 173.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 966' ' ' LEU . . . . . 0.406 ' O ' ' CG2' ' A' ' 967' ' ' VAL . 0.5 OUTLIER -132.34 60.06 1.7 Allowed 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.251 -1.018 . . . . 1.46 108.251 177.466 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 967' ' ' VAL . . . . . 0.406 ' CG2' ' O ' ' A' ' 966' ' ' LEU . 95.9 t -158.2 96.65 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 N-CA-C 108.143 -1.058 . . . . 1.9399999999999999 108.143 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 90.4 mmm -143.26 59.53 1.4 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.716 -1.24 . . . . 0.0 108.272 178.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.33 119.81 1.96 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 106.994 -2.442 . . . . 2.1099999999999999 106.994 -178.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -82.2 -58.25 3.03 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 118.716 1.258 . . . . 5.8899999999999997 110.308 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 40.8 tp -59.12 90.53 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.493 -0.754 . . . . 4.3600000000000003 110.115 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -141.82 -154.33 0.51 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.588 -0.695 . . . . 1.8300000000000001 110.174 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -119.46 170.98 8.67 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.502 -0.749 . . . . 4.3499999999999996 110.338 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 10.7 t -101.47 130.22 47.67 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.535 -0.728 . . . . 1.27 109.962 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -156.3 158.73 37.96 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.481 -0.762 . . . . 5.0199999999999996 110.608 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.93 85.94 18.77 Favored Pre-proline 0 N--CA 1.5 2.048 0 O-C-N 121.611 -0.681 . . . . 2.4100000000000001 109.516 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -72.75 -171.83 0.83 Allowed 'Trans proline' 0 C--N 1.317 -1.109 0 O-C-N 123.31 1.163 . . . . 0.95999999999999996 111.389 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 4.9 mp -127.89 154.32 45.64 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 107.608 -1.256 . . . . 0.62 107.608 178.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 979' ' ' THR . . . . . . . . . . . . . 42.1 p -149.93 141.32 23.29 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.768 -1.208 . . . . 3.5699999999999998 111.181 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 980' ' ' ILE . . . . . 0.434 HG22 HD11 ' A' ' 980' ' ' ILE . 51.2 mm -107.06 128.06 62.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 109.006 -0.739 . . . . 1.3300000000000001 109.006 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 981' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -121.73 98.22 5.86 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.417 -0.802 . . . . 0.050000000000000003 111.783 -178.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 86.0 p -108.69 158.22 17.81 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.974 -0.75 . . . . 0.87 108.974 178.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . -171.82 108.58 0.28 Allowed Glycine 0 N--CA 1.498 2.78 0 N-CA-C 106.557 -2.617 . . . . 0.029999999999999999 106.557 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -109.4 148.21 31.49 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 114.337 1.236 . . . . 0.69999999999999996 114.337 -175.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 44.7 tp -69.79 135.1 49.3 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 120.796 -1.19 . . . . 0.040000000000000001 110.115 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 986' ' ' LEU . . . . . 0.401 ' CD2' ' NH1' ' A' ' 893' ' ' ARG . 41.8 tp -105.96 -60.29 1.66 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.621 -0.674 . . . . 0.040000000000000001 109.914 179.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -143.88 146.26 32.89 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 107.627 -1.249 . . . . 0.040000000000000001 107.627 179.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.33 163.28 12.19 Favored Glycine 0 N--CA 1.495 2.628 0 N-CA-C 108.094 -2.002 . . . . 0.040000000000000001 108.094 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -76.0 112.52 20.8 Favored Pre-proline 0 N--CA 1.499 2.005 0 O-C-N 121.229 -1.159 . . . . 0.040000000000000001 109.402 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 990' ' ' PRO . . . . . 0.409 ' O ' ' HB2' ' A' ' 991' ' ' GLU . 49.7 Cg_endo -90.27 71.85 1.41 Allowed 'Trans proline' 0 C--N 1.319 -1.006 0 O-C-N 123.164 1.086 . . . . 0.45000000000000001 111.386 -178.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 991' ' ' GLU . . . . . 0.409 ' HB2' ' O ' ' A' ' 990' ' ' PRO . 67.0 mt-10 67.32 -73.69 0.08 Allowed 'General case' 0 N--CA 1.503 2.178 0 N-CA-C 108.483 -0.932 . . . . 1.97 108.483 -177.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 992' ' ' LEU . . . . . . . . . . . . . 10.6 mt 50.91 20.73 0.83 Allowed 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.583 -0.698 . . . . 2.3799999999999999 111.599 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -93.58 156.71 16.57 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.912 -1.117 . . . . 3.79 109.989 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -145.91 92.97 2.27 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.54 -0.725 . . . . 3.5099999999999998 110.312 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 995' ' ' ALA . . . . . . . . . . . . 2.517 . . . . . . . 0 N--CA 1.504 2.254 0 O-C-N 120.85 -1.157 . . . . 2.73 110.575 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo . . . . . 0 N--CA 1.488 1.188 0 N-CA-C 109.523 -0.991 . . . . 3.8300000000000001 109.523 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 847' ' ' VAL . . . . . . . . . . . . . 61.3 t -132.14 103.48 14.07 Favored Pre-proline 0 N--CA 1.494 1.775 0 O-C-N 121.621 -0.674 . . . . 1.8300000000000001 109.989 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 848' ' ' PRO . . . . . 0.408 ' O ' ' C ' ' B' ' 849' ' ' GLN . 43.7 Cg_endo -69.45 -20.16 36.67 Favored 'Trans proline' 0 N--CA 1.487 1.133 0 O-C-N 123.245 1.129 . . . . 0.65000000000000002 111.064 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 849' ' ' GLN . . . . . 0.408 ' C ' ' O ' ' B' ' 848' ' ' PRO . 55.6 tt0 27.06 68.69 0.06 Allowed 'General case' 0 N--CA 1.518 2.96 0 N-CA-C 112.867 0.691 . . . . 2.5800000000000001 112.867 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 850' ' ' VAL . . . . . . . . . . . . . 59.7 t -118.2 136.68 54.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.218 -0.926 . . . . 1.0900000000000001 111.382 -178.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 851' ' ' ALA . . . . . . . . . . . . . . . -126.09 156.11 40.53 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 105.774 -1.936 . . . . 0.040000000000000001 105.774 176.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 852' ' ' PHE . . . . . 0.41 ' HA ' ' CB ' ' B' ' 874' ' ' ASN . 23.8 p90 -159.73 129.1 5.26 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 121.022 1.737 . . . . 0.050000000000000003 108.631 179.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 30.0 t -175.24 134.72 0.33 Allowed 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.176 -1.046 . . . . 0.040000000000000001 108.176 -178.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -132.56 156.75 46.29 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.099 -1.001 . . . . 0.67000000000000004 109.576 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 855' ' ' ALA . . . . . . . . . . . . . . . -122.9 145.13 48.73 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.774 0.797 . . . . 0.51000000000000001 111.697 -178.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 856' ' ' LEU . . . . . 0.407 HD21 ' CG1' ' B' ' 866' ' ' VAL . 3.4 tm? -112.51 134.01 54.27 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.743 -0.598 . . . . 0.050000000000000003 110.105 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 857' ' ' SER . . . . . 0.41 ' O ' ' O ' ' B' ' 858' ' ' LEU . 56.3 p -150.37 16.99 0.83 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.561 -0.712 . . . . 1.3300000000000001 110.513 178.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 858' ' ' LEU . . . . . 0.41 ' O ' ' O ' ' B' ' 857' ' ' SER . 4.4 pp -33.31 158.26 0.04 OUTLIER Pre-proline 0 N--CA 1.517 2.924 0 N-CA-C 113.33 0.863 . . . . 2.3300000000000001 113.33 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -64.5 -88.43 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.421 0 O-C-N 123.207 1.109 . . . . 2.3199999999999998 113.103 -178.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 55.8 ptt85 -128.71 -143.45 0.27 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.87 -1.144 . . . . 0.040000000000000001 111.729 -177.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 19.3 m -40.23 127.53 2.27 Favored 'General case' 0 N--CA 1.509 2.491 0 O-C-N 121.455 -0.778 . . . . 1.3100000000000001 112.359 -178.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 862' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -102.09 156.77 34.82 Favored Pre-proline 0 N--CA 1.488 1.465 0 N-CA-C 107.86 -1.163 . . . . 4.5099999999999998 107.86 177.138 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -69.81 -13.06 34.03 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 O-C-N 123.082 1.043 . . . . 2.2400000000000002 111.419 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -175.61 -135.91 2.21 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.993 -1.243 . . . . 0.040000000000000001 109.993 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 28.0 m -66.71 157.68 32.08 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.253 -1.145 . . . . 1.51 110.925 -178.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 866' ' ' VAL . . . . . 0.407 ' CG1' HD21 ' B' ' 856' ' ' LEU . 48.5 t -93.78 134.53 26.17 Favored Pre-proline 0 N--CA 1.495 1.784 0 N-CA-C 113.302 0.853 . . . . 0.78000000000000003 113.302 -174.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 867' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -90.38 -152.94 0.04 OUTLIER 'Trans proline' 0 CA--C 1.541 0.867 0 O-C-N 123.517 1.272 . . . . 0.92000000000000004 108.831 177.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 868' ' ' PHE . . . . . 0.45 ' CD1' ' N ' ' B' ' 868' ' ' PHE . 23.6 p90 -149.55 122.16 8.59 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 120.633 -1.292 . . . . 0.050000000000000003 109.956 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 49.2 p-10 -113.29 -1.94 14.15 Favored 'General case' 0 N--CA 1.498 1.971 0 C-N-CA 119.27 -0.972 . . . . 1.7 112.289 -179.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 870' ' ' ARG . . . . . . . . . . . . . 30.3 mmm180 -90.96 88.68 7.12 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.899 -1.126 . . . . 2.5899999999999999 110.784 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 58.5 t -74.56 97.32 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.005 -1.059 . . . . 1.9399999999999999 109.884 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 872' ' ' LEU . . . . . . . . . . . . . 94.7 mt -83.16 -46.99 12.07 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.488 -0.757 . . . . 1.0600000000000001 110.14 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 873' ' ' LEU . . . . . . . . . . . . . 46.5 tp -174.65 104.01 0.1 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.305 -0.872 . . . . 4.1799999999999997 108.703 178.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 874' ' ' ASN . . . . . 0.41 ' CB ' ' HA ' ' B' ' 852' ' ' PHE . 35.6 t-20 178.86 81.96 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.304 0 O-C-N 121.643 -0.66 . . . . 0.040000000000000001 109.76 -178.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -67.16 -47.31 71.4 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 119.268 -0.973 . . . . 3.3799999999999999 111.076 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 876' ' ' GLY . . . . . 0.409 ' HA3' ' CE2' ' B' ' 878' ' ' TYR . . . -73.87 -25.27 72.16 Favored Glycine 0 N--CA 1.494 2.562 0 O-C-N 121.336 -0.852 . . . . 0.040000000000000001 111.584 -178.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 83.01 -61.29 4.8 Favored Glycine 0 N--CA 1.501 3.003 0 N-CA-C 108.091 -2.003 . . . . 0.040000000000000001 108.091 -178.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 878' ' ' TYR . . . . . 0.409 ' CE2' ' HA3' ' B' ' 876' ' ' GLY . 88.4 m-85 60.47 -64.93 0.06 Allowed 'General case' 0 N--CA 1.504 2.248 0 N-CA-C 114.303 1.223 . . . . 3.46 114.303 177.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 879' ' ' TYR . . . . . 0.467 ' CB ' ' CD2' ' B' ' 886' ' ' PHE . 19.6 p90 -111.47 107.45 16.66 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 114.457 1.28 . . . . 0.040000000000000001 114.457 -176.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -66.21 117.17 40.6 Favored Pre-proline 0 N--CA 1.497 1.924 0 O-C-N 121.422 -0.798 . . . . 0.02 110.145 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 881' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -75.81 -0.12 9.85 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 O-C-N 123.57 1.3 . . . . 0.39000000000000001 112.15 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 88.4 mt-10 -77.45 -63.65 1.33 Allowed 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 106.801 -1.555 . . . . 0.81000000000000005 106.801 178.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 45.7 p -93.79 -18.82 21.64 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.678 -0.86 . . . . 0.040000000000000001 108.678 177.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.24 20.27 60.95 Favored Glycine 0 N--CA 1.497 2.711 0 O-C-N 121.11 -0.994 . . . . 0.029999999999999999 111.554 178.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 885' ' ' VAL . . . . . . . . . . . . . 87.8 t -74.14 91.9 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 C-N-CA 118.14 -1.424 . . . . 1.01 108.097 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 886' ' ' PHE . . . . . 0.467 ' CD2' ' CB ' ' B' ' 879' ' ' TYR . 0.7 OUTLIER -90.32 105.82 18.07 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-N 115.182 -0.917 . . . . 0.050000000000000003 111.999 -177.259 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 887' ' ' THR . . . . . 0.405 ' O ' ' HD3' ' B' ' 889' ' ' PRO . 69.7 m -96.47 101.15 12.73 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 107.868 -1.16 . . . . 0.68000000000000005 107.868 177.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 888' ' ' ALA . . . . . . . . . . . . . . . -98.78 106.51 37.73 Favored Pre-proline 0 N--CA 1.502 2.146 0 N-CA-C 114.153 1.168 . . . . 0.25 114.153 -176.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 889' ' ' PRO . . . . . 0.405 ' HD3' ' O ' ' B' ' 887' ' ' THR . 55.3 Cg_endo -89.02 -13.07 3.16 Favored 'Trans proline' 0 CA--C 1.546 1.105 0 C-N-CA 121.01 1.14 . . . . 1.6399999999999999 109.183 176.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 890' ' ' LEU . . . . . . . . . . . . . 56.5 mt -34.04 -51.29 0.42 Allowed 'General case' 0 N--CA 1.51 2.535 0 N-CA-C 113.997 1.11 . . . . 2.29 113.997 -177.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 51.54 94.84 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.336 0 O-C-N 121.13 -0.981 . . . . 0.63 110.379 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . 156.13 -147.54 16.32 Favored Glycine 0 N--CA 1.48 1.577 0 N-CA-C 107.451 -2.26 . . . . 0.040000000000000001 107.451 -179.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 72.0 ttt-85 -108.86 127.72 54.28 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 107.609 -1.256 . . . . 3.0 107.609 177.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 894' ' ' TYR . . . . . 0.45 ' CD1' ' N ' ' B' ' 895' ' ' LEU . 0.1 OUTLIER -130.22 144.67 51.5 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.048 -1.032 . . . . 0.040000000000000001 110.056 -179.064 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 895' ' ' LEU . . . . . 0.45 ' N ' ' CD1' ' B' ' 894' ' ' TYR . 39.7 tp -97.58 114.33 26.22 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.628 -0.67 . . . . 1.27 109.621 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 896' ' ' LEU . . . . . 0.428 ' HB2' ' CZ ' ' B' ' 894' ' ' TYR . 9.6 tt -111.34 145.62 38.54 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.574 -0.704 . . . . 0.93999999999999995 110.884 -179.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 897' ' ' SER . . . . . . . . . . . . . 65.9 m -143.53 116.56 8.88 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.636 -0.665 . . . . 0.040000000000000001 110.467 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -106.23 146.68 30.01 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 109.297 -0.631 . . . . 0.47999999999999998 109.297 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 899' ' ' VAL . . . . . . . . . . . . . 87.7 t -97.35 118.76 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 C-N-CA 119.757 -0.777 . . . . 0.55000000000000004 111.403 -179.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 900' ' ' LEU . . . . . 0.401 ' CD2' ' N ' ' B' ' 900' ' ' LEU . 4.5 mm? -94.81 111.9 23.66 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 114.283 1.216 . . . . 1.5900000000000001 114.283 -175.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 17.4 m -64.4 141.06 58.91 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 107.316 -1.365 . . . . 0.050000000000000003 107.316 177.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -63.58 -66.14 2.69 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 110.476 -1.05 . . . . 0.029999999999999999 110.476 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 2.1 m80 46.44 65.99 1.07 Allowed 'General case' 0 N--CA 1.507 2.383 0 O-C-N 121.447 -1.031 . . . . 3.2000000000000002 111.099 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 54.1 ptt85 -68.54 -6.75 27.11 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.64 -0.662 . . . . 2.9199999999999999 111.942 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 905' ' ' HIS . . . . . 0.482 ' O ' ' CB ' ' B' ' 906' ' ' GLU . 75.9 t60 -60.19 2.82 0.08 Allowed 'General case' 0 N--CA 1.506 2.33 0 O-C-N 120.914 -1.116 . . . . 2.8700000000000001 113.073 -179.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 906' ' ' GLU . . . . . 0.482 ' CB ' ' O ' ' B' ' 905' ' ' HIS . 0.8 OUTLIER 93.75 -163.76 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.387 0 CA-C-N 120.6 1.545 . . . . 0.98999999999999999 112.072 178.939 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 907' ' ' LYS . . . . . 0.472 ' CB ' ' O ' ' B' ' 906' ' ' GLU . 42.9 tttt 88.84 161.52 0.06 Allowed 'General case' 0 N--CA 1.519 2.979 0 N-CA-C 107.717 -1.216 . . . . 5.25 107.717 -176.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 61.7 t -121.7 115.65 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 120.901 -1.125 . . . . 0.39000000000000001 110.926 -179.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 52.2 tp10 -100.75 132.64 46.05 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 107.222 -1.399 . . . . 1.72 107.222 176.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -156.99 120.95 4.27 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 106.703 -1.592 . . . . 0.67000000000000004 106.703 178.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 911' ' ' VAL . . . . . 0.456 ' HA ' ' HA ' ' B' ' 964' ' ' VAL . 93.9 t -83.48 132.1 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.835 -0.54 . . . . 0.54000000000000004 110.71 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 72.3 mt -64.58 155.44 33.14 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.326 -0.859 . . . . 1.5 108.694 178.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 913' ' ' SER . . . . . 0.412 ' CB ' ' CG1' ' B' ' 919' ' ' VAL . 1.6 t -123.47 136.69 54.72 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.122 -1.066 . . . . 1.3700000000000001 108.122 177.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 914' ' ' ARG . . . . . 0.416 ' O ' ' CB ' ' B' ' 915' ' ' SER . 0.0 OUTLIER -63.08 153.57 33.71 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 120.839 -1.163 . . . . 4.2999999999999998 111.981 -178.784 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 915' ' ' SER . . . . . 0.416 ' CB ' ' O ' ' B' ' 914' ' ' ARG . 2.2 t 83.02 -32.2 0.08 Allowed 'General case' 0 N--CA 1.521 3.095 0 C-N-CA 124.03 0.932 . . . . 2.0499999999999998 112.404 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 916' ' ' ASN . . . . . 0.415 ' O ' ' HB2' ' B' ' 917' ' ' GLN . 98.1 m-20 -121.26 -20.85 6.57 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.867 -1.146 . . . . 2.71 111.607 -179.094 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 917' ' ' GLN . . . . . 0.415 ' HB2' ' O ' ' B' ' 916' ' ' ASN . 50.8 mt-30 66.75 165.51 0.21 Allowed 'General case' 0 N--CA 1.521 3.103 0 N-CA-C 105.661 -1.977 . . . . 2.6800000000000002 105.661 -173.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.8 -125.23 34.58 Favored Glycine 1 N--CA 1.521 4.304 0 CA-C-N 123.532 2.878 . . . . 0.029999999999999999 106.958 -177.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 919' ' ' VAL . . . . . 0.412 ' CG1' ' CB ' ' B' ' 913' ' ' SER . 79.9 t 51.5 95.08 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 O-C-N 121.456 -1.026 . . . . 1.3899999999999999 108.959 -178.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.26 91.75 8.33 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.207 -0.997 . . . . 0.029999999999999999 110.904 -179.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 921' ' ' ARG . . . . . 0.431 ' HB3' ' CZ ' ' B' ' 950' ' ' PHE . 42.4 ptt85 -84.17 -41.9 16.54 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 105.58 -2.007 . . . . 4.4199999999999999 105.58 175.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 922' ' ' VAL . . . . . . . . . . . . . 71.0 t -103.26 68.96 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 N-CA-C 105.53 -2.026 . . . . 0.84999999999999998 105.53 175.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -90.7 136.04 33.32 Favored 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 121.779 0.8 . . . . 2.46 112.147 -176.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 924' ' ' SER . . . . . . . . . . . . . 14.1 t -147.62 104.04 3.58 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.184 -1.043 . . . . 0.69999999999999996 108.184 178.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -110.63 90.24 0.57 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 108.979 -1.649 . . . . 0.040000000000000001 108.979 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.425 0 N-CA-C 109.386 -1.486 . . . . 0.040000000000000001 109.386 -179.709 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 32.3 m . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.031 0.444 . . . . 13.779999999999999 110.254 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 97.6 mt -112.81 129.64 56.37 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.509 -0.744 . . . . 13.76 110.434 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -151.82 167.89 31.1 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.127 -1.589 . . . . 9.1300000000000008 109.127 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 949' ' ' VAL . . . . . . . . . . . . . 35.3 m -118.62 130.12 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.499 -1.001 . . . . 7.0800000000000001 110.852 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 950' ' ' PHE . . . . . 0.431 ' CZ ' ' HB3' ' B' ' 921' ' ' ARG . 32.6 p90 -133.19 149.44 52.03 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.584 -0.697 . . . . 7.5899999999999999 109.248 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 19.4 m -119.5 -53.7 2.21 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.406 -0.809 . . . . 5.0300000000000002 112.022 -178.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 952' ' ' LEU . . . . . 0.429 ' O ' ' O ' ' B' ' 953' ' ' ILE . 56.5 tp -60.32 -75.67 0.06 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.442 -0.786 . . . . 1.01 111.966 -177.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 953' ' ' ILE . . . . . 0.484 ' O ' ' HB3' ' B' ' 954' ' ' LEU . 49.2 pt -53.02 -144.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.637 0 N-CA-C 113.749 1.018 . . . . 2.6000000000000001 113.749 -176.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 954' ' ' LEU . . . . . 0.538 ' N ' ' CD1' ' B' ' 954' ' ' LEU . 0.0 OUTLIER 167.48 83.58 0.02 OUTLIER Pre-proline 0 N--CA 1.512 2.67 0 O-C-N 120.977 -1.077 . . . . 0.050000000000000003 111.429 178.915 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 955' ' ' PRO . . . . . 0.427 ' HD2' ' CE1' ' B' ' 950' ' ' PHE . 46.2 Cg_endo -74.07 98.4 1.08 Allowed 'Trans proline' 0 C--N 1.313 -1.315 0 N-CA-C 108.863 -1.245 . . . . 0.83999999999999997 108.863 177.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 956' ' ' LEU . . . . . 0.403 ' CD2' ' NH1' ' B' ' 914' ' ' ARG . 10.0 mp -122.85 144.02 49.48 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.056 -1.027 . . . . 0.040000000000000001 110.22 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -83.43 151.1 25.65 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 117.829 -1.082 . . . . 1.28 111.39 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -69.75 119.91 14.7 Favored 'General case' 0 N--CA 1.509 2.479 0 CA-C-N 122.857 2.571 . . . . 0.17000000000000001 111.368 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 93.35 -21.91 37.92 Favored Glycine 0 N--CA 1.501 2.989 0 N-CA-C 110.949 -0.86 . . . . 0.040000000000000001 110.949 178.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 960' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -51.65 171.23 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.46 -1.023 . . . . 0.040000000000000001 110.514 -179.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 961' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' B' ' 886' ' ' PHE . 42.0 m -134.67 135.08 41.8 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.025 -1.047 . . . . 1.78 111.655 -178.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 962' ' ' VAL . . . . . 0.425 ' CG2' ' CB ' ' B' ' 886' ' ' PHE . 33.0 m -100.66 145.22 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 C-N-CA 119.938 -0.705 . . . . 0.040000000000000001 110.661 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 5.2 t -138.27 146.22 42.23 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.943 -0.473 . . . . 0.71999999999999997 110.042 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 964' ' ' VAL . . . . . 0.456 ' HA ' ' HA ' ' B' ' 911' ' ' VAL . 59.9 t -94.01 136.27 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.04 -1.037 . . . . 1.05 110.433 -179.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -93.29 126.32 38.34 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 103.571 -2.752 . . . . 3.02 103.571 173.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 966' ' ' LEU . . . . . 0.409 ' O ' ' CG2' ' B' ' 967' ' ' VAL . 0.5 OUTLIER -132.08 59.98 1.69 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.324 -0.991 . . . . 1.46 108.324 177.512 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 967' ' ' VAL . . . . . 0.409 ' CG2' ' O ' ' B' ' 966' ' ' LEU . 95.7 t -158.23 96.32 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 108.222 -1.029 . . . . 1.9399999999999999 108.222 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 90.5 mmm -142.85 59.54 1.43 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.8 -1.187 . . . . 0.0 108.312 178.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.23 119.67 1.95 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 107.06 -2.416 . . . . 2.1099999999999999 107.06 -178.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -81.92 -58.24 3.07 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.106 -1.232 . . . . 5.8899999999999997 110.353 -179.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 40.9 tp -59.14 90.22 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.423 -0.798 . . . . 4.3600000000000003 110.103 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -141.56 -154.05 0.5 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.574 -0.704 . . . . 1.8300000000000001 110.156 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -119.64 171.2 8.54 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.509 -0.745 . . . . 4.3499999999999996 110.336 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 10.7 t -101.61 130.2 47.88 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.53 -0.731 . . . . 1.27 109.942 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -156.26 158.79 38.12 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.443 -0.786 . . . . 5.0199999999999996 110.598 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.01 85.94 18.55 Favored Pre-proline 0 N--CA 1.5 2.031 0 O-C-N 121.647 -0.658 . . . . 2.4100000000000001 109.541 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -72.76 -171.88 0.84 Allowed 'Trans proline' 0 C--N 1.317 -1.087 0 O-C-N 123.342 1.18 . . . . 0.95999999999999996 111.408 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 978' ' ' LEU . . . . . . . . . . . . . 4.9 mp -127.74 154.56 45.21 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 107.649 -1.241 . . . . 0.62 107.649 178.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 979' ' ' THR . . . . . . . . . . . . . 41.8 p -150.17 141.34 23.11 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.808 -1.183 . . . . 3.5699999999999998 111.17 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 980' ' ' ILE . . . . . 0.412 HG22 HD11 ' B' ' 980' ' ' ILE . 51.3 mm -107.09 127.74 62.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 108.985 -0.746 . . . . 1.3300000000000001 108.985 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -121.56 98.57 6.03 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.395 -0.816 . . . . 0.050000000000000003 111.817 -178.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 98.8 p -109.34 158.73 17.6 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.467 -0.771 . . . . 0.87 109.013 178.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 983' ' ' GLY . . . . . . . . . . . . . . . -171.86 108.84 0.29 Allowed Glycine 0 N--CA 1.497 2.716 0 N-CA-C 106.609 -2.596 . . . . 0.029999999999999999 106.609 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -109.34 147.88 31.99 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 114.177 1.177 . . . . 0.69999999999999996 114.177 -175.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 985' ' ' LEU . . . . . . . . . . . . . 44.2 tp -69.67 135.22 49.6 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.851 -1.155 . . . . 0.040000000000000001 110.057 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 986' ' ' LEU . . . . . . . . . . . . . 42.2 tp -106.12 -60.45 1.64 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.635 -0.665 . . . . 0.040000000000000001 109.895 179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -143.83 146.05 32.78 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.581 -1.266 . . . . 0.040000000000000001 107.581 179.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.27 162.91 12.25 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 108.091 -2.003 . . . . 0.040000000000000001 108.091 179.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -75.55 112.5 19.59 Favored Pre-proline 0 N--CA 1.499 1.991 0 CA-C-N 118.503 1.152 . . . . 0.040000000000000001 109.414 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 990' ' ' PRO . . . . . 0.413 ' O ' ' HB2' ' B' ' 991' ' ' GLU . 49.8 Cg_endo -90.16 71.68 1.49 Allowed 'Trans proline' 0 C--N 1.319 -1.006 0 O-C-N 123.151 1.079 . . . . 0.45000000000000001 111.399 -178.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 991' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' B' ' 990' ' ' PRO . 66.9 mt-10 67.39 -73.65 0.08 Allowed 'General case' 0 N--CA 1.503 2.203 0 N-CA-C 108.516 -0.92 . . . . 1.97 108.516 -177.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 992' ' ' LEU . . . . . . . . . . . . . 10.8 mt 51.03 20.45 0.82 Allowed 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.639 -0.663 . . . . 2.3799999999999999 111.738 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -93.22 156.79 16.62 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.897 -1.127 . . . . 3.79 109.987 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 67.3 m80 -146.05 92.32 2.18 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.538 -0.726 . . . . 3.5099999999999998 110.386 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 995' ' ' ALA . . . . . . . . . . . . 2.516 . . . . . . . 0 N--CA 1.503 2.204 0 O-C-N 120.946 -1.096 . . . . 2.73 110.625 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo . . . . . 0 N--CA 1.487 1.147 0 N-CA-C 109.469 -1.012 . . . . 3.8300000000000001 109.469 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 847' ' ' VAL . . . . . . . . . . . . . 59.1 t -131.62 102.8 15.0 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.621 -0.675 . . . . 1.8300000000000001 110.311 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 848' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -70.49 -21.37 30.17 Favored 'Trans proline' 0 N--CA 1.487 1.1 0 O-C-N 123.331 1.174 . . . . 0.65000000000000002 111.186 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 849' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 27.94 69.25 0.07 Allowed 'General case' 0 N--CA 1.519 2.999 0 N-CA-C 112.703 0.631 . . . . 2.5800000000000001 112.703 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 850' ' ' VAL . . . . . . . . . . . . . 49.5 t -119.62 135.0 61.39 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.152 -0.968 . . . . 1.0900000000000001 111.764 -178.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 851' ' ' ALA . . . . . . . . . . . . . . . -127.17 154.88 44.23 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 105.517 -2.031 . . . . 0.040000000000000001 105.517 176.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 852' ' ' PHE . . . . . 0.449 ' CD1' ' N ' ' C' ' 852' ' ' PHE . 16.8 p90 -160.51 126.68 4.08 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 121.107 1.776 . . . . 0.050000000000000003 108.633 178.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 7.8 t -176.31 134.36 0.24 Allowed 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.012 -1.107 . . . . 0.040000000000000001 108.012 -179.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -130.57 156.37 44.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.141 -0.974 . . . . 0.67000000000000004 109.505 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 855' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' C' ' 870' ' ' ARG . . . -122.09 142.87 49.93 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 121.881 0.848 . . . . 0.51000000000000001 111.266 -179.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 856' ' ' LEU . . . . . 0.418 HD21 ' CG1' ' C' ' 866' ' ' VAL . 3.3 tm? -111.85 136.46 51.1 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.626 -0.672 . . . . 0.050000000000000003 109.923 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 857' ' ' SER . . . . . 0.418 ' O ' ' O ' ' C' ' 858' ' ' LEU . 1.1 m -153.54 15.67 0.51 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.462 -0.774 . . . . 1.3300000000000001 111.661 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 858' ' ' LEU . . . . . 0.418 ' O ' ' O ' ' C' ' 857' ' ' SER . 4.0 pp -34.91 160.8 0.04 OUTLIER Pre-proline 0 N--CA 1.518 2.944 0 N-CA-C 113.172 0.804 . . . . 2.3300000000000001 113.172 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -62.13 -87.12 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 120.992 1.128 . . . . 2.3199999999999998 113.779 -177.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 54.0 ptt85 -129.74 -142.79 0.25 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 120.883 -1.135 . . . . 0.040000000000000001 111.77 -177.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 67.4 m -38.82 130.83 1.41 Allowed 'General case' 0 N--CA 1.51 2.572 0 O-C-N 121.598 -0.689 . . . . 1.3100000000000001 112.17 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.47 158.55 31.59 Favored Pre-proline 0 N--CA 1.487 1.416 0 N-CA-C 108.633 -0.877 . . . . 4.5099999999999998 108.633 177.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -71.47 -14.52 30.81 Favored 'Trans proline' 0 C--N 1.313 -1.314 0 O-C-N 123.185 1.097 . . . . 2.2400000000000002 111.693 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -177.95 -134.28 2.03 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.681 -1.367 . . . . 0.040000000000000001 109.681 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 7.1 m -67.84 151.18 47.6 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.251 -1.146 . . . . 1.51 110.477 -179.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 866' ' ' VAL . . . . . 0.418 ' CG1' HD21 ' C' ' 856' ' ' LEU . 53.7 t -94.87 134.28 25.17 Favored Pre-proline 0 N--CA 1.497 1.888 0 N-CA-C 113.401 0.889 . . . . 0.78000000000000003 113.401 -174.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 867' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -89.07 -150.14 0.04 OUTLIER 'Trans proline' 0 CA--C 1.543 0.936 0 O-C-N 123.526 1.277 . . . . 0.92000000000000004 109.345 178.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 868' ' ' PHE . . . . . 0.433 ' N ' ' CD1' ' C' ' 868' ' ' PHE . 14.9 p90 -148.9 123.76 9.95 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.68 -1.262 . . . . 0.050000000000000003 109.653 179.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 49.5 p-10 -112.61 -3.1 14.39 Favored 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 119.273 -0.971 . . . . 1.7 112.492 -178.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 870' ' ' ARG . . . . . 0.401 ' HB2' ' O ' ' C' ' 855' ' ' ALA . 26.7 mmm180 -91.68 87.65 6.4 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.925 -1.109 . . . . 2.5899999999999999 111.03 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 57.9 t -73.68 97.56 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 120.919 -1.113 . . . . 1.9399999999999999 109.269 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 872' ' ' LEU . . . . . . . . . . . . . 96.3 mt -87.17 -45.04 11.04 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.564 -0.71 . . . . 1.0600000000000001 110.736 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 873' ' ' LEU . . . . . 0.412 ' O ' ' HB2' ' C' ' 874' ' ' ASN . 31.1 tp -171.99 102.3 0.17 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.144 -0.972 . . . . 4.1799999999999997 108.975 178.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 874' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' C' ' 873' ' ' LEU . 35.0 t-20 176.97 82.72 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.265 0 N-CA-C 108.782 -0.821 . . . . 0.040000000000000001 108.782 -179.073 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -65.47 -47.02 77.54 Favored 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 119.282 -0.967 . . . . 3.3799999999999999 111.359 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 876' ' ' GLY . . . . . 0.422 ' HA3' ' CE2' ' C' ' 878' ' ' TYR . . . -72.11 -26.92 71.22 Favored Glycine 0 N--CA 1.492 2.429 0 C-N-CA 120.361 -0.924 . . . . 0.040000000000000001 111.447 -178.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 81.34 -61.93 4.54 Favored Glycine 0 N--CA 1.5 2.905 0 N-CA-C 108.016 -2.034 . . . . 0.040000000000000001 108.016 -178.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 878' ' ' TYR . . . . . 0.422 ' CE2' ' HA3' ' C' ' 876' ' ' GLY . 96.3 m-85 60.39 -66.3 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 114.366 1.247 . . . . 3.46 114.366 177.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 879' ' ' TYR . . . . . 0.47 ' CB ' ' CD2' ' C' ' 886' ' ' PHE . 25.0 p90 -110.55 107.52 17.17 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 115.092 1.516 . . . . 0.040000000000000001 115.092 -175.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -71.82 120.76 81.92 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.437 -0.789 . . . . 0.02 109.939 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 881' ' ' PRO . . . . . 0.422 ' HG2' ' CD1' ' C' ' 868' ' ' PHE . 52.3 Cg_endo -78.25 0.24 10.08 Favored 'Trans proline' 0 N--CA 1.49 1.28 0 O-C-N 123.434 1.228 . . . . 0.39000000000000001 111.786 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -74.92 -63.62 1.22 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 106.083 -1.821 . . . . 0.81000000000000005 106.083 178.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 70.3 p -90.54 -21.73 21.65 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 108.513 -0.921 . . . . 0.040000000000000001 108.513 177.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 82.28 18.45 66.77 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 110.59 -1.004 . . . . 0.029999999999999999 110.59 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 96.6 t -75.54 92.2 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 C-N-CA 118.41 -1.316 . . . . 1.01 108.655 -179.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 886' ' ' PHE . . . . . 0.47 ' CD2' ' CB ' ' C' ' 879' ' ' TYR . 0.8 OUTLIER -87.81 104.34 16.49 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 115.065 -0.97 . . . . 0.050000000000000003 111.541 -177.761 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 887' ' ' THR . . . . . 0.421 ' O ' ' HD3' ' C' ' 889' ' ' PRO . 96.8 m -98.97 99.42 10.46 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 107.38 -1.341 . . . . 0.68000000000000005 107.38 177.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 888' ' ' ALA . . . . . . . . . . . . . . . -97.4 106.64 33.77 Favored Pre-proline 0 N--CA 1.501 2.109 0 N-CA-C 114.413 1.264 . . . . 0.25 114.413 -176.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 889' ' ' PRO . . . . . 0.421 ' HD3' ' O ' ' C' ' 887' ' ' THR . 53.5 Cg_endo -88.06 -15.38 3.11 Favored 'Trans proline' 0 CA--C 1.546 1.078 0 N-CA-C 108.662 -1.322 . . . . 1.6399999999999999 108.662 175.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 890' ' ' LEU . . . . . . . . . . . . . 46.0 mt -38.33 -49.17 1.39 Allowed 'General case' 0 N--CA 1.506 2.346 0 N-CA-C 113.347 0.869 . . . . 2.29 113.347 -177.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 52.69 97.35 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.241 -0.912 . . . . 0.63 110.316 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . 159.41 -155.52 26.61 Favored Glycine 0 N--CA 1.477 1.425 0 N-CA-C 107.151 -2.38 . . . . 0.040000000000000001 107.151 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 73.4 ttt-85 -117.99 123.98 47.05 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.618 -0.93 . . . . 3.0 109.049 177.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 894' ' ' TYR . . . . . 0.43 ' CD1' HD22 ' C' ' 954' ' ' LEU . 49.5 p90 -134.08 156.69 47.81 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.057 -1.027 . . . . 0.040000000000000001 110.922 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 895' ' ' LEU . . . . . . . . . . . . . 40.3 tp -96.47 118.22 32.53 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.691 -0.631 . . . . 1.27 110.379 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 896' ' ' LEU . . . . . . . . . . . . . 9.5 tt -116.1 145.17 43.25 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.645 -0.66 . . . . 0.93999999999999995 109.92 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 897' ' ' SER . . . . . . . . . . . . . 47.4 m -140.0 124.2 17.79 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.431 -0.793 . . . . 0.040000000000000001 111.285 -179.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -105.49 146.8 29.07 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.903 -0.777 . . . . 0.47999999999999998 108.903 178.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 899' ' ' VAL . . . . . . . . . . . . . 93.7 t -90.83 122.24 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 C-N-CA 119.727 -0.789 . . . . 0.55000000000000004 111.255 -178.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 93.8 mt -92.06 111.12 22.55 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 114.375 1.25 . . . . 1.5900000000000001 114.375 -175.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 20.3 m -67.29 140.35 57.31 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 106.98 -1.489 . . . . 0.050000000000000003 106.98 176.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -64.37 -64.73 3.41 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 110.497 -1.041 . . . . 0.029999999999999999 110.497 -179.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 45.1 62.6 2.06 Favored 'General case' 0 N--CA 1.508 2.447 0 O-C-N 121.508 -0.995 . . . . 3.2000000000000002 111.346 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -68.22 -7.5 30.92 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.588 -0.695 . . . . 2.9199999999999999 111.899 -179.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 905' ' ' HIS . . . . . 0.494 ' O ' ' CB ' ' C' ' 906' ' ' GLU . 74.5 t60 -63.34 7.86 0.09 Allowed 'General case' 0 N--CA 1.505 2.323 0 CA-C-O 117.604 -1.188 . . . . 2.8700000000000001 113.567 -179.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 906' ' ' GLU . . . . . 0.494 ' CB ' ' O ' ' C' ' 905' ' ' HIS . 0.8 OUTLIER 94.12 -164.29 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.474 0 CA-C-N 121.292 1.86 . . . . 0.98999999999999999 111.727 179.202 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 907' ' ' LYS . . . . . 0.477 ' CB ' ' O ' ' C' ' 906' ' ' GLU . 34.8 tttp 86.92 156.14 0.07 Allowed 'General case' 0 N--CA 1.519 3.002 0 N-CA-C 108.014 -1.106 . . . . 5.25 108.014 -176.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 60.1 t -122.58 116.11 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 120.835 -1.165 . . . . 0.39000000000000001 110.991 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -104.69 131.47 52.08 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 107.503 -1.295 . . . . 1.72 107.503 177.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -154.73 122.34 5.75 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 106.675 -1.602 . . . . 0.67000000000000004 106.675 178.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 911' ' ' VAL . . . . . 0.467 ' HA ' ' HA ' ' C' ' 964' ' ' VAL . 87.6 t -81.7 131.86 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.871 -0.518 . . . . 0.54000000000000004 110.975 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 52.8 mt -66.83 156.85 34.5 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.354 -0.841 . . . . 1.5 109.091 178.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 913' ' ' SER . . . . . 0.404 ' CB ' ' CG1' ' C' ' 919' ' ' VAL . 1.7 p -124.0 138.24 54.48 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.242 -1.021 . . . . 1.3700000000000001 108.242 177.025 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 914' ' ' ARG . . . . . 0.426 ' O ' ' CB ' ' C' ' 915' ' ' SER . 0.0 OUTLIER -64.79 153.2 40.66 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 120.624 -1.298 . . . . 4.2999999999999998 111.401 -179.112 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 915' ' ' SER . . . . . 0.426 ' CB ' ' O ' ' C' ' 914' ' ' ARG . 1.4 t 83.59 -30.55 0.08 Allowed 'General case' 0 N--CA 1.522 3.144 0 C-N-CA 123.853 0.861 . . . . 2.0499999999999998 112.199 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 916' ' ' ASN . . . . . . . . . . . . . 99.2 m-20 -122.18 -21.8 5.79 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 120.834 -1.166 . . . . 2.71 111.422 -179.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 67.04 167.22 0.23 Allowed 'General case' 0 N--CA 1.52 3.045 0 N-CA-C 105.845 -1.909 . . . . 2.6800000000000002 105.845 -174.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 53.83 -126.37 35.23 Favored Glycine 1 N--CA 1.523 4.437 0 CA-C-N 123.481 2.855 . . . . 0.029999999999999999 107.132 -177.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 919' ' ' VAL . . . . . 0.404 ' CG1' ' CB ' ' C' ' 913' ' ' SER . 95.4 t 50.94 95.26 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 O-C-N 121.467 -1.019 . . . . 1.3899999999999999 109.425 -178.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 920' ' ' ALA . . . . . . . . . . . . . . . -93.05 93.03 8.1 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.27 -0.972 . . . . 0.029999999999999999 110.486 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 921' ' ' ARG . . . . . 0.436 ' HB3' ' CZ ' ' C' ' 950' ' ' PHE . 44.5 ptt85 -83.19 -41.7 18.13 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 105.956 -1.868 . . . . 4.4199999999999999 105.956 176.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 922' ' ' VAL . . . . . . . . . . . . . 84.8 t -98.84 77.54 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 105.712 -1.959 . . . . 0.84999999999999998 105.712 175.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -87.95 133.47 33.93 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.834 0.826 . . . . 2.46 111.755 -177.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 5.6 t -147.23 104.92 3.7 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.383 -0.969 . . . . 0.69999999999999996 108.383 178.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -103.14 89.72 0.72 Allowed Glycine 0 N--CA 1.486 1.978 0 N-CA-C 108.434 -1.866 . . . . 0.040000000000000001 108.434 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.219 0 N-CA-C 108.972 -1.651 . . . . 0.040000000000000001 108.972 -179.657 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 17.5 m . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 120.936 0.398 . . . . 13.779999999999999 110.348 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 92.3 mt -114.32 129.96 56.65 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.479 -0.763 . . . . 13.76 110.238 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -152.41 170.82 31.65 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.495 -1.442 . . . . 9.1300000000000008 109.495 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 949' ' ' VAL . . . . . . . . . . . . . 35.7 m -117.28 135.1 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.644 -0.915 . . . . 7.0800000000000001 110.947 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 950' ' ' PHE . . . . . 0.436 ' CZ ' ' HB3' ' C' ' 921' ' ' ARG . 42.6 p90 -133.61 150.62 51.6 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.603 -0.686 . . . . 7.5899999999999999 109.323 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 67.7 m -118.43 -55.77 2.19 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.385 -0.822 . . . . 5.0300000000000002 111.936 -178.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 952' ' ' LEU . . . . . 0.467 ' O ' ' O ' ' C' ' 953' ' ' ILE . 44.9 tp -64.83 -76.34 0.07 Allowed 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.39 -0.819 . . . . 1.01 111.512 -178.191 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 953' ' ' ILE . . . . . 0.467 ' O ' ' O ' ' C' ' 952' ' ' LEU . 2.1 pp -48.31 -151.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.78 0 N-CA-C 114.687 1.366 . . . . 2.6000000000000001 114.687 -176.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 954' ' ' LEU . . . . . 0.583 ' N ' ' CD1' ' C' ' 954' ' ' LEU . 0.0 OUTLIER 173.57 90.43 0.06 OUTLIER Pre-proline 0 N--CA 1.516 2.864 0 O-C-N 120.567 -1.333 . . . . 0.050000000000000003 112.42 -179.385 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 955' ' ' PRO . . . . . 0.427 ' HD2' ' CZ ' ' C' ' 950' ' ' PHE . 53.8 Cg_endo -82.93 89.68 1.1 Allowed 'Trans proline' 0 C--N 1.316 -1.14 0 N-CA-C 109.182 -1.122 . . . . 0.83999999999999997 109.182 178.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 956' ' ' LEU . . . . . . . . . . . . . 9.9 mp -124.42 146.76 48.71 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.984 -1.073 . . . . 0.040000000000000001 110.406 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -83.44 152.08 25.16 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 117.691 -1.147 . . . . 1.28 111.569 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -66.97 118.5 10.52 Favored 'General case' 0 N--CA 1.507 2.41 0 CA-C-N 122.985 2.63 . . . . 0.17000000000000001 110.896 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.43 -19.82 47.98 Favored Glycine 0 N--CA 1.5 2.923 0 N-CA-C 111.032 -0.827 . . . . 0.040000000000000001 111.032 178.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 960' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.69 170.62 0.16 Allowed 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.283 -1.128 . . . . 0.040000000000000001 110.073 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 961' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' C' ' 886' ' ' PHE . 31.2 m -136.67 140.1 42.48 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.877 -1.14 . . . . 1.78 112.836 -177.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 962' ' ' VAL . . . . . 0.43 ' CG2' ' CB ' ' C' ' 886' ' ' PHE . 33.1 m -98.96 145.84 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.681 -0.637 . . . . 0.040000000000000001 110.934 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 4.8 t -138.63 144.33 39.66 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.811 -0.556 . . . . 0.71999999999999997 109.996 -179.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 964' ' ' VAL . . . . . 0.467 ' HA ' ' HA ' ' C' ' 911' ' ' VAL . 59.7 t -94.95 135.81 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.024 -1.047 . . . . 1.05 110.77 -179.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -96.51 126.48 41.73 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 103.705 -2.702 . . . . 3.02 103.705 173.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 966' ' ' LEU . . . . . . . . . . . . . 2.8 tt -132.21 63.32 1.62 Allowed 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.256 -1.016 . . . . 1.46 108.256 177.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 967' ' ' VAL . . . . . . . . . . . . . 96.8 t -157.53 96.92 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.21 -1.033 . . . . 1.9399999999999999 108.21 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 93.2 mmm -142.37 59.45 1.45 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.742 -1.224 . . . . 0.0 108.316 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 134.73 119.47 1.95 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 107.173 -2.371 . . . . 2.1099999999999999 107.173 -178.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -82.4 -57.7 3.25 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.02 -1.283 . . . . 5.8899999999999997 110.607 -179.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 40.4 tp -58.66 90.12 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.471 -0.768 . . . . 4.3600000000000003 110.312 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -142.29 -153.18 0.45 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.578 -0.701 . . . . 1.8300000000000001 110.122 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 17.5 m80 -118.8 168.68 10.52 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.399 -0.813 . . . . 4.3499999999999996 110.075 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 28.9 t -101.42 130.94 47.73 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.534 -0.728 . . . . 1.27 109.918 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -156.31 157.91 36.54 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.452 -0.78 . . . . 5.0199999999999996 110.717 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.62 86.01 23.68 Favored Pre-proline 0 N--CA 1.5 2.071 0 O-C-N 121.667 -0.646 . . . . 2.4100000000000001 109.277 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.91 -170.15 0.66 Allowed 'Trans proline' 0 C--N 1.318 -1.046 0 O-C-N 123.416 1.219 . . . . 0.95999999999999996 111.49 -179.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 978' ' ' LEU . . . . . . . . . . . . . 6.2 tt -126.43 152.12 46.81 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 107.889 -1.152 . . . . 0.62 107.889 178.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 979' ' ' THR . . . . . . . . . . . . . 47.6 p -150.87 139.42 20.57 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.73 -1.231 . . . . 3.5699999999999998 111.084 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 980' ' ' ILE . . . . . . . . . . . . . 51.2 mm -106.39 129.48 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 109.213 -0.662 . . . . 1.3300000000000001 109.213 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 981' ' ' PHE . . . . . 0.451 ' CD1' ' CE2' ' C' ' 879' ' ' TYR . 4.7 t80 -118.35 95.25 4.79 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 119.703 -0.799 . . . . 0.050000000000000003 111.635 -178.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 982' ' ' SER . . . . . . . . . . . . . 23.1 p -107.85 158.88 16.96 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 109.164 -0.68 . . . . 0.87 109.164 178.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 983' ' ' GLY . . . . . 0.424 ' HA3' ' CE2' ' C' ' 852' ' ' PHE . . . -170.85 115.23 0.57 Allowed Glycine 0 N--CA 1.497 2.745 0 N-CA-C 106.701 -2.56 . . . . 0.029999999999999999 106.701 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 984' ' ' ALA . . . . . . . . . . . . . . . -108.31 150.34 27.46 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 114.352 1.241 . . . . 0.69999999999999996 114.352 -175.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 985' ' ' LEU . . . . . . . . . . . . . 53.5 tp -76.42 135.5 39.44 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.833 -1.167 . . . . 0.040000000000000001 109.637 179.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 986' ' ' LEU . . . . . . . . . . . . . 42.1 tp -106.98 -60.44 1.67 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.402 -0.811 . . . . 0.040000000000000001 110.304 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -142.81 146.73 34.47 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 107.698 -1.223 . . . . 0.040000000000000001 107.698 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.3 163.22 12.2 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 108.395 -1.882 . . . . 0.040000000000000001 108.395 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -75.65 112.85 21.63 Favored Pre-proline 0 N--CA 1.498 1.943 0 O-C-N 121.246 -1.15 . . . . 0.040000000000000001 109.59 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 990' ' ' PRO . . . . . 0.412 ' O ' ' HB2' ' C' ' 991' ' ' GLU . 50.6 Cg_endo -89.58 71.47 1.82 Allowed 'Trans proline' 0 C--N 1.32 -0.961 0 O-C-N 123.106 1.056 . . . . 0.45000000000000001 111.537 -179.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 991' ' ' GLU . . . . . 0.412 ' HB2' ' O ' ' C' ' 990' ' ' PRO . 66.0 mt-10 67.49 -73.29 0.08 Allowed 'General case' 0 N--CA 1.503 2.209 0 N-CA-C 108.593 -0.891 . . . . 1.97 108.593 -177.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 992' ' ' LEU . . . . . . . . . . . . . 11.1 mt 50.65 20.82 0.78 Allowed 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.592 -0.693 . . . . 2.3799999999999999 111.709 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -92.99 156.92 16.59 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.899 -1.126 . . . . 3.79 110.07 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 67.0 m80 -145.93 92.2 2.18 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.537 -0.727 . . . . 3.5099999999999998 110.265 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 995' ' ' ALA . . . . . . . . . . . . 2.517 . . . . . . . 0 N--CA 1.503 2.221 0 O-C-N 120.931 -1.106 . . . . 2.73 110.586 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo . . . . . 0 N--CA 1.488 1.162 0 N-CA-C 109.506 -0.998 . . . . 3.8300000000000001 109.506 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 847' ' ' VAL . . . . . . . . . . . . . 59.9 t -133.0 102.92 13.09 Favored Pre-proline 0 N--CA 1.496 1.835 0 O-C-N 121.603 -0.686 . . . . 1.8300000000000001 110.079 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 848' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -69.82 -19.87 35.27 Favored 'Trans proline' 0 N--CA 1.487 1.125 0 O-C-N 123.274 1.144 . . . . 0.65000000000000002 111.028 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 849' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 27.83 68.85 0.07 Allowed 'General case' 0 N--CA 1.518 2.968 0 N-CA-C 112.861 0.689 . . . . 2.5800000000000001 112.861 179.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 850' ' ' VAL . . . . . . . . . . . . . 83.9 t -119.66 137.26 54.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.151 -0.968 . . . . 1.0900000000000001 111.603 -178.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 851' ' ' ALA . . . . . . . . . . . . . . . -126.99 158.52 36.68 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 105.876 -1.898 . . . . 0.040000000000000001 105.876 176.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 852' ' ' PHE . . . . . 0.425 ' CE1' ' HA3' ' A' ' 983' ' ' GLY . 46.6 p90 -157.59 131.97 8.38 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 120.989 1.722 . . . . 0.050000000000000003 108.613 178.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 19.5 t -175.03 132.84 0.32 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.07 -1.085 . . . . 0.040000000000000001 108.07 -178.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -135.41 153.1 51.91 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.173 -0.955 . . . . 0.67000000000000004 109.182 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 855' ' ' ALA . . . . . . . . . . . . . . . -124.24 140.11 53.27 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.942 0.877 . . . . 0.51000000000000001 111.689 -178.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 856' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -106.8 137.46 44.8 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 109.366 -0.605 . . . . 0.050000000000000003 109.366 179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 857' ' ' SER . . . . . 0.419 ' O ' ' O ' ' A' ' 858' ' ' LEU . 1.3 m -155.02 15.43 0.41 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.323 -0.861 . . . . 1.3300000000000001 111.697 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 858' ' ' LEU . . . . . 0.419 ' O ' ' O ' ' A' ' 857' ' ' SER . 3.0 pp -34.29 159.91 0.04 OUTLIER Pre-proline 0 N--CA 1.518 2.942 0 N-CA-C 113.088 0.773 . . . . 2.3300000000000001 113.088 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -60.87 -88.59 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 120.898 1.066 . . . . 2.3199999999999998 113.686 -177.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 54.3 ptt85 -126.19 -142.77 0.29 Allowed 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.902 -1.124 . . . . 0.040000000000000001 111.575 -177.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 75.1 m -38.53 126.22 1.42 Allowed 'General case' 0 N--CA 1.509 2.507 0 O-C-N 121.63 -0.668 . . . . 1.3100000000000001 112.148 -178.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -101.3 161.15 24.51 Favored Pre-proline 0 N--CA 1.489 1.512 0 N-CA-C 108.579 -0.897 . . . . 4.5099999999999998 108.579 178.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -71.09 -15.34 32.18 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 O-C-N 123.251 1.132 . . . . 2.2400000000000002 111.65 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -177.4 -136.5 2.48 Favored Glycine 0 N--CA 1.495 2.577 0 C-N-CA 119.541 -1.314 . . . . 0.040000000000000001 110.838 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 41.1 m -61.69 162.84 7.97 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.479 -1.012 . . . . 1.51 111.362 -178.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -97.12 127.01 40.09 Favored Pre-proline 0 N--CA 1.504 2.237 0 N-CA-C 113.042 0.756 . . . . 0.78000000000000003 113.042 -174.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 867' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -90.64 -153.18 0.04 OUTLIER 'Trans proline' 0 CA--C 1.54 0.787 0 N-CA-C 108.63 -1.335 . . . . 0.92000000000000004 108.63 177.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 868' ' ' PHE . . . . . 0.459 ' CD1' ' CG ' ' A' ' 881' ' ' PRO . 24.3 p90 -149.93 122.77 8.71 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 120.523 -1.361 . . . . 0.050000000000000003 110.247 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 49.6 p-10 -112.91 -3.19 14.14 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 119.442 -0.903 . . . . 1.7 112.083 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 870' ' ' ARG . . . . . . . . . . . . . 29.4 mmm180 -90.58 89.29 7.48 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.947 -1.096 . . . . 2.5899999999999999 110.675 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 58.1 t -73.13 97.16 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 120.975 -1.078 . . . . 1.9399999999999999 110.091 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 872' ' ' LEU . . . . . . . . . . . . . 96.1 mt -83.13 -47.28 11.8 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.498 -0.751 . . . . 1.0600000000000001 110.099 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 873' ' ' LEU . . . . . . . . . . . . . 43.0 tp -175.06 104.47 0.09 Allowed 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.308 -0.87 . . . . 4.1799999999999997 108.706 178.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 874' ' ' ASN . . . . . 0.402 ' CB ' ' HA ' ' A' ' 852' ' ' PHE . 35.0 t-20 178.33 81.9 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.336 0 O-C-N 121.6 -0.687 . . . . 0.040000000000000001 109.521 -178.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -66.85 -47.33 72.27 Favored 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 119.291 -0.964 . . . . 3.3799999999999999 111.334 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 876' ' ' GLY . . . . . 0.423 ' HA3' ' CE2' ' A' ' 878' ' ' TYR . . . -74.51 -25.19 70.87 Favored Glycine 0 N--CA 1.495 2.568 0 O-C-N 121.22 -0.925 . . . . 0.040000000000000001 111.777 -178.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 81.88 -62.09 4.58 Favored Glycine 0 N--CA 1.502 3.09 0 N-CA-C 107.974 -2.05 . . . . 0.040000000000000001 107.974 -178.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 878' ' ' TYR . . . . . 0.423 ' CE2' ' HA3' ' A' ' 876' ' ' GLY . 95.6 m-85 61.5 -60.27 0.1 Allowed 'General case' 0 N--CA 1.504 2.236 0 N-CA-C 114.498 1.296 . . . . 3.46 114.498 177.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 879' ' ' TYR . . . . . 0.475 ' CB ' ' CD2' ' A' ' 886' ' ' PHE . 21.3 p90 -111.73 108.96 18.57 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 114.66 1.356 . . . . 0.040000000000000001 114.66 -176.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -66.55 117.85 48.33 Favored Pre-proline 0 N--CA 1.497 1.899 0 O-C-N 121.403 -0.811 . . . . 0.02 109.911 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 881' ' ' PRO . . . . . 0.459 ' CG ' ' CD1' ' A' ' 868' ' ' PHE . 52.8 Cg_endo -77.15 -0.33 10.48 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 O-C-N 123.42 1.221 . . . . 0.39000000000000001 112.275 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -75.92 -62.91 1.43 Allowed 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 106.62 -1.622 . . . . 0.81000000000000005 106.62 178.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 19.5 p -94.44 -19.53 20.5 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.659 -0.867 . . . . 0.040000000000000001 108.659 177.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.43 20.83 57.93 Favored Glycine 0 N--CA 1.497 2.731 0 O-C-N 121.154 -0.966 . . . . 0.029999999999999999 111.035 178.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 885' ' ' VAL . . . . . . . . . . . . . 97.7 t -73.0 90.0 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 C-N-CA 118.261 -1.376 . . . . 1.01 108.132 -179.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 886' ' ' PHE . . . . . 0.475 ' CD2' ' CB ' ' A' ' 879' ' ' TYR . 0.8 OUTLIER -89.31 104.04 16.62 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-N 115.298 -0.864 . . . . 0.050000000000000003 111.825 -177.555 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 887' ' ' THR . . . . . 0.406 ' O ' ' HD3' ' A' ' 889' ' ' PRO . 93.1 m -95.26 100.69 12.44 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 107.826 -1.175 . . . . 0.68000000000000005 107.826 177.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 888' ' ' ALA . . . . . . . . . . . . . . . -98.4 106.99 39.49 Favored Pre-proline 0 N--CA 1.502 2.153 0 N-CA-C 114.009 1.114 . . . . 0.25 114.009 -176.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 889' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' A' ' 887' ' ' THR . 53.6 Cg_endo -89.84 -12.67 2.86 Favored 'Trans proline' 0 CA--C 1.546 1.122 0 C-N-CA 121.055 1.17 . . . . 1.6399999999999999 109.111 176.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 890' ' ' LEU . . . . . . . . . . . . . 72.9 mt -36.59 -50.31 0.8 Allowed 'General case' 0 N--CA 1.509 2.479 0 N-CA-C 113.636 0.976 . . . . 2.29 113.636 -177.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 52.19 95.85 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.295 0 O-C-N 121.156 -0.965 . . . . 0.63 110.238 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 157.85 -153.33 24.54 Favored Glycine 0 N--CA 1.478 1.456 0 N-CA-C 107.234 -2.347 . . . . 0.040000000000000001 107.234 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 893' ' ' ARG . . . . . 0.403 ' CZ ' ' CB ' ' C' ' 984' ' ' ALA . 73.2 ttt-85 -115.53 126.3 54.09 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 121.533 -0.981 . . . . 3.0 108.552 177.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 894' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -132.87 160.09 37.97 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.083 -1.011 . . . . 0.040000000000000001 111.083 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 895' ' ' LEU . . . . . . . . . . . . . 36.0 tp -91.73 119.45 31.59 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.728 -0.607 . . . . 1.27 110.1 -179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 9.2 tt -109.69 144.31 38.25 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.7 -0.625 . . . . 0.93999999999999995 110.155 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 897' ' ' SER . . . . . . . . . . . . . 69.5 m -149.95 114.8 5.33 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.49 -0.756 . . . . 0.040000000000000001 111.007 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -106.96 146.84 30.57 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.912 -0.773 . . . . 0.47999999999999998 108.912 178.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 899' ' ' VAL . . . . . . . . . . . . . 88.2 t -96.45 119.13 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 C-N-CA 119.59 -0.844 . . . . 0.55000000000000004 111.255 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 900' ' ' LEU . . . . . 0.407 ' N ' ' CD2' ' A' ' 900' ' ' LEU . 4.5 mm? -95.75 111.18 23.2 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 114.036 1.124 . . . . 1.5900000000000001 114.036 -175.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 18.3 m -64.52 140.19 58.84 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 107.458 -1.312 . . . . 0.050000000000000003 107.458 177.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -63.09 -66.62 2.46 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 110.429 -1.068 . . . . 0.029999999999999999 110.429 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 4.1 m170 46.93 66.9 0.88 Allowed 'General case' 0 N--CA 1.507 2.398 0 O-C-N 121.495 -1.003 . . . . 3.2000000000000002 110.991 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -68.5 -7.17 29.84 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.581 -0.699 . . . . 2.9199999999999999 111.937 -179.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 905' ' ' HIS . . . . . 0.489 ' O ' ' CB ' ' A' ' 906' ' ' GLU . 67.0 t60 -63.55 4.54 0.24 Allowed 'General case' 0 N--CA 1.504 2.272 0 O-C-N 120.942 -1.099 . . . . 2.8700000000000001 112.843 -179.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 906' ' ' GLU . . . . . 0.489 ' CB ' ' O ' ' A' ' 905' ' ' HIS . 0.8 OUTLIER 94.7 -162.95 0.0 OUTLIER 'General case' 0 N--CA 1.53 3.552 0 CA-C-N 120.729 1.604 . . . . 0.98999999999999999 112.218 178.752 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 907' ' ' LYS . . . . . 0.447 ' HB2' ' O ' ' A' ' 906' ' ' GLU . 94.1 mttt 89.27 159.71 0.05 Allowed 'General case' 0 N--CA 1.522 3.162 0 N-CA-C 107.862 -1.162 . . . . 5.25 107.862 -176.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 58.6 t -122.29 116.37 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 120.882 -1.137 . . . . 0.39000000000000001 110.91 -179.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -100.78 132.89 45.96 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.513 -1.292 . . . . 1.72 107.513 176.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -156.99 121.95 4.54 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 106.988 -1.486 . . . . 0.67000000000000004 106.988 178.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 911' ' ' VAL . . . . . 0.489 ' HA ' ' HA ' ' A' ' 964' ' ' VAL . 95.3 t -85.08 131.85 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.85 -0.532 . . . . 0.54000000000000004 111.076 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 73.0 mt -65.76 157.66 29.69 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.432 -0.792 . . . . 1.5 109.011 178.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 913' ' ' SER . . . . . 0.4 ' CB ' ' HB ' ' A' ' 919' ' ' VAL . 2.6 t -124.1 136.61 54.35 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.266 -1.013 . . . . 1.3700000000000001 108.266 177.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 914' ' ' ARG . . . . . 0.427 ' O ' ' CB ' ' A' ' 915' ' ' SER . 0.0 OUTLIER -65.07 154.53 37.58 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 120.612 -1.305 . . . . 4.2999999999999998 111.357 -179.186 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 915' ' ' SER . . . . . 0.427 ' CB ' ' O ' ' A' ' 914' ' ' ARG . 4.3 t 83.14 -31.61 0.08 Allowed 'General case' 0 N--CA 1.521 3.124 0 C-N-CA 123.853 0.861 . . . . 2.0499999999999998 112.089 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 916' ' ' ASN . . . . . 0.435 ' O ' ' HB2' ' A' ' 917' ' ' GLN . 91.0 m-20 -123.61 -21.48 5.23 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 120.85 -1.157 . . . . 2.71 111.274 -179.297 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 917' ' ' GLN . . . . . 0.435 ' HB2' ' O ' ' A' ' 916' ' ' ASN . 44.4 mt-30 65.84 166.45 0.19 Allowed 'General case' 0 N--CA 1.519 2.984 0 N-CA-C 105.957 -1.868 . . . . 2.6800000000000002 105.957 -173.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.54 -125.62 35.0 Favored Glycine 1 N--CA 1.521 4.356 0 CA-C-N 123.382 2.81 . . . . 0.029999999999999999 106.78 -177.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 919' ' ' VAL . . . . . 0.4 ' HB ' ' CB ' ' A' ' 913' ' ' SER . 71.8 t 52.47 93.58 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.241 0 O-C-N 121.31 -1.112 . . . . 1.3899999999999999 108.74 -178.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.14 90.96 8.03 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.219 -0.993 . . . . 0.029999999999999999 110.956 -178.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 921' ' ' ARG . . . . . 0.435 ' HB3' ' CZ ' ' A' ' 950' ' ' PHE . 30.2 ptt180 -86.17 -41.88 14.32 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 105.831 -1.914 . . . . 4.4199999999999999 105.831 175.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 922' ' ' VAL . . . . . . . . . . . . . 85.0 t -103.97 67.45 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 105.979 -1.86 . . . . 0.84999999999999998 105.979 175.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -89.83 134.64 34.08 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.709 0.766 . . . . 2.46 111.655 -177.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 8.5 t -147.18 103.27 3.57 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.477 -0.935 . . . . 0.69999999999999996 108.477 178.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -109.59 90.28 0.59 Allowed Glycine 0 N--CA 1.487 2.063 0 N-CA-C 108.411 -1.875 . . . . 0.040000000000000001 108.411 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.352 0 N-CA-C 109.435 -1.466 . . . . 0.040000000000000001 109.435 -179.186 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 29.5 m . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 120.995 0.426 . . . . 13.779999999999999 110.341 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 95.2 mt -113.03 129.99 56.31 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.492 -0.755 . . . . 13.76 110.455 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -151.91 168.11 31.18 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.197 -1.561 . . . . 9.1300000000000008 109.197 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 949' ' ' VAL . . . . . . . . . . . . . 27.2 m -119.02 128.87 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.532 -0.981 . . . . 7.0800000000000001 110.78 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 950' ' ' PHE . . . . . 0.443 ' CE1' ' HD2' ' A' ' 955' ' ' PRO . 26.2 p90 -131.76 148.13 52.55 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.559 -0.713 . . . . 7.5899999999999999 109.487 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 19.8 m -121.26 -52.06 2.07 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.358 -0.838 . . . . 5.0300000000000002 112.169 -178.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 952' ' ' LEU . . . . . 0.426 ' O ' ' O ' ' A' ' 953' ' ' ILE . 53.8 tp -59.75 -75.1 0.06 Allowed 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.41 -0.806 . . . . 1.01 112.557 -177.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 953' ' ' ILE . . . . . 0.458 ' O ' ' HB3' ' A' ' 954' ' ' LEU . 43.3 pt -52.34 -143.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.784 0 N-CA-C 114.177 1.177 . . . . 2.6000000000000001 114.177 -176.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 954' ' ' LEU . . . . . 0.546 ' N ' ' CD1' ' A' ' 954' ' ' LEU . 0.0 OUTLIER 174.07 77.2 0.05 OUTLIER Pre-proline 0 N--CA 1.506 2.367 0 O-C-N 120.671 -1.268 . . . . 0.050000000000000003 111.291 179.929 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 955' ' ' PRO . . . . . 0.443 ' HD2' ' CE1' ' A' ' 950' ' ' PHE . 48.9 Cg_endo -76.66 91.73 1.13 Allowed 'Trans proline' 0 C--N 1.314 -1.238 0 N-CA-C 109.614 -0.956 . . . . 0.83999999999999997 109.614 178.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 956' ' ' LEU . . . . . 0.411 ' CD2' ' NH1' ' A' ' 914' ' ' ARG . 11.1 mp -121.98 146.14 47.44 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.225 -0.922 . . . . 0.040000000000000001 109.818 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -84.44 150.74 25.1 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 117.831 -1.081 . . . . 1.28 111.876 -178.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -70.2 120.24 15.58 Favored 'General case' 0 N--CA 1.51 2.525 0 CA-C-N 122.788 2.54 . . . . 0.17000000000000001 111.74 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.51 -22.63 31.99 Favored Glycine 0 N--CA 1.5 2.907 0 N-CA-C 111.122 -0.791 . . . . 0.040000000000000001 111.122 178.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 960' ' ' ASP . . . . . 0.414 ' HB3' ' NE ' ' A' ' 914' ' ' ARG . 0.4 OUTLIER -55.38 171.9 0.16 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.451 -1.029 . . . . 0.040000000000000001 110.006 -179.567 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 961' ' ' THR . . . . . 0.452 ' HA ' ' O ' ' A' ' 886' ' ' PHE . 41.5 m -135.06 135.43 41.26 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.879 -1.138 . . . . 1.78 111.884 -178.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 962' ' ' VAL . . . . . 0.401 ' CG2' ' CB ' ' A' ' 886' ' ' PHE . 32.7 m -97.79 145.92 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 C-N-CA 120.094 -0.642 . . . . 0.040000000000000001 110.138 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 5.6 t -138.5 145.98 41.43 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.852 -0.53 . . . . 0.71999999999999997 110.329 -178.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 964' ' ' VAL . . . . . 0.489 ' HA ' ' HA ' ' A' ' 911' ' ' VAL . 59.2 t -94.37 137.37 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.258 -0.901 . . . . 1.05 110.459 -179.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -93.28 127.54 38.91 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 103.791 -2.67 . . . . 3.02 103.791 173.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 966' ' ' LEU . . . . . 0.402 ' O ' ' CG2' ' A' ' 967' ' ' VAL . 0.2 OUTLIER -132.81 60.0 1.71 Allowed 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.35 -0.981 . . . . 1.46 108.35 177.309 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 967' ' ' VAL . . . . . 0.402 ' CG2' ' O ' ' A' ' 966' ' ' LEU . 98.5 t -157.96 96.88 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 108.049 -1.093 . . . . 1.9399999999999999 108.049 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 92.2 mmm -142.65 60.44 1.43 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.725 -1.234 . . . . 0.0 108.434 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.59 120.48 2.01 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 107.203 -2.359 . . . . 2.1099999999999999 107.203 -178.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -82.06 -59.88 2.41 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 118.76 1.28 . . . . 5.8899999999999997 110.189 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 50.9 tp -59.81 90.95 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.44 -0.787 . . . . 4.3600000000000003 109.894 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -141.41 -154.62 0.53 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.571 -0.706 . . . . 1.8300000000000001 110.39 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -118.8 171.27 8.33 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.471 -0.768 . . . . 4.3499999999999996 110.221 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 34.3 t -101.6 130.23 47.88 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.588 -0.695 . . . . 1.27 110.039 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -156.11 157.05 35.36 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.549 -0.719 . . . . 5.0199999999999996 110.485 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.07 85.74 18.67 Favored Pre-proline 0 N--CA 1.5 2.068 0 O-C-N 121.6 -0.688 . . . . 2.4100000000000001 109.721 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.37 -172.33 1.02 Allowed 'Trans proline' 0 C--N 1.318 -1.068 0 O-C-N 123.313 1.165 . . . . 0.95999999999999996 111.345 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 4.9 mp -127.7 154.44 45.31 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 107.691 -1.226 . . . . 0.62 107.691 178.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 979' ' ' THR . . . . . . . . . . . . . 41.4 p -150.18 140.94 22.7 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.696 -1.253 . . . . 3.5699999999999998 111.14 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 980' ' ' ILE . . . . . . . . . . . . . 46.3 mm -107.32 128.98 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 109.022 -0.733 . . . . 1.3300000000000001 109.022 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 981' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -118.95 95.16 4.71 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 119.804 -0.759 . . . . 0.050000000000000003 111.797 -178.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 82.9 p -107.93 157.96 17.76 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.545 -0.722 . . . . 0.87 109.192 178.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 983' ' ' GLY . . . . . 0.425 ' HA3' ' CE1' ' A' ' 852' ' ' PHE . . . -174.75 110.46 0.32 Allowed Glycine 0 N--CA 1.499 2.888 0 N-CA-C 106.356 -2.698 . . . . 0.029999999999999999 106.356 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -108.22 150.87 26.7 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 114.526 1.306 . . . . 0.69999999999999996 114.526 -175.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 33.1 tp -72.29 135.06 45.87 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.822 -1.174 . . . . 0.040000000000000001 110.07 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 51.8 tp -107.47 -55.8 2.3 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.595 -0.691 . . . . 0.040000000000000001 110.06 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -144.57 145.76 31.98 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 107.668 -1.234 . . . . 0.040000000000000001 107.668 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.6 163.32 12.17 Favored Glycine 0 N--CA 1.495 2.633 0 N-CA-C 108.232 -1.947 . . . . 0.040000000000000001 108.232 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -75.26 112.46 18.66 Favored Pre-proline 0 N--CA 1.499 1.989 0 O-C-N 121.195 -1.179 . . . . 0.040000000000000001 109.463 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 990' ' ' PRO . . . . . 0.414 ' O ' ' HB2' ' A' ' 991' ' ' GLU . 50.2 Cg_endo -90.53 70.79 1.39 Allowed 'Trans proline' 0 C--N 1.319 -1.023 0 O-C-N 123.151 1.079 . . . . 0.45000000000000001 111.565 -178.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 991' ' ' GLU . . . . . 0.414 ' HB2' ' O ' ' A' ' 990' ' ' PRO . 69.2 mt-10 67.28 -73.86 0.07 Allowed 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 108.586 -0.894 . . . . 1.97 108.586 -177.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 992' ' ' LEU . . . . . . . . . . . . . 11.0 mt 51.01 20.79 0.86 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.541 -0.724 . . . . 2.3799999999999999 111.641 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -94.11 156.89 16.34 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.818 -1.176 . . . . 3.79 109.993 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 72.2 m80 -146.63 93.49 2.3 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.588 -0.695 . . . . 3.5099999999999998 110.309 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 995' ' ' ALA . . . . . . . . . . . . 2.518 . . . . . . . 0 N--CA 1.503 2.224 0 O-C-N 120.868 -1.145 . . . . 2.73 110.572 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo . . . . . 0 N--CA 1.488 1.156 0 N-CA-C 109.5 -1.0 . . . . 3.8300000000000001 109.5 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 847' ' ' VAL . . . . . . . . . . . . . 60.0 t -133.07 102.87 13.03 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.567 -0.708 . . . . 1.8300000000000001 110.139 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 848' ' ' PRO . . . . . 0.405 ' O ' ' C ' ' B' ' 849' ' ' GLN . 43.6 Cg_endo -69.7 -20.16 35.48 Favored 'Trans proline' 0 N--CA 1.487 1.092 0 O-C-N 123.235 1.124 . . . . 0.65000000000000002 111.033 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 849' ' ' GLN . . . . . 0.405 ' C ' ' O ' ' B' ' 848' ' ' PRO . 56.1 tt0 28.0 69.1 0.07 Allowed 'General case' 0 N--CA 1.519 2.989 0 N-CA-C 112.768 0.655 . . . . 2.5800000000000001 112.768 179.295 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 850' ' ' VAL . . . . . . . . . . . . . 83.1 t -119.85 137.34 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.213 -0.93 . . . . 1.0900000000000001 111.623 -178.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 851' ' ' ALA . . . . . . . . . . . . . . . -127.52 157.67 39.5 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 105.907 -1.886 . . . . 0.040000000000000001 105.907 176.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 852' ' ' PHE . . . . . 0.413 ' CE1' ' HA3' ' B' ' 983' ' ' GLY . 46.4 p90 -156.63 132.43 9.58 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-N 121.04 1.745 . . . . 0.050000000000000003 108.541 179.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 20.8 t -175.11 132.59 0.31 Allowed 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.14 -1.059 . . . . 0.040000000000000001 108.14 -179.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -135.1 153.46 52.01 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.125 -0.985 . . . . 0.67000000000000004 109.211 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 855' ' ' ALA . . . . . . . . . . . . . . . -124.75 140.23 53.12 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.994 0.902 . . . . 0.51000000000000001 111.685 -178.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 856' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -107.04 137.05 45.84 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.391 -0.596 . . . . 0.050000000000000003 109.391 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 857' ' ' SER . . . . . 0.427 ' O ' ' O ' ' B' ' 858' ' ' LEU . 1.3 m -154.63 15.5 0.44 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.442 -0.786 . . . . 1.3300000000000001 111.712 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 858' ' ' LEU . . . . . 0.427 ' O ' ' O ' ' B' ' 857' ' ' SER . 3.1 pp -34.32 159.98 0.04 OUTLIER Pre-proline 0 N--CA 1.518 2.956 0 N-CA-C 113.064 0.765 . . . . 2.3300000000000001 113.064 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -61.04 -88.58 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 120.9 1.067 . . . . 2.3199999999999998 113.661 -177.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 54.2 ptt85 -126.28 -142.8 0.29 Allowed 'General case' 0 N--CA 1.5 2.052 0 O-C-N 120.893 -1.129 . . . . 0.040000000000000001 111.551 -177.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 75.3 m -38.41 125.51 1.35 Allowed 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.597 -0.69 . . . . 1.3100000000000001 112.178 -178.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 862' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.59 161.18 24.78 Favored Pre-proline 0 N--CA 1.488 1.451 0 N-CA-C 108.557 -0.905 . . . . 4.5099999999999998 108.557 178.026 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -71.1 -15.29 32.15 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 O-C-N 123.248 1.13 . . . . 2.2400000000000002 111.73 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -177.15 -135.8 2.29 Favored Glycine 0 N--CA 1.495 2.599 0 C-N-CA 119.549 -1.31 . . . . 0.040000000000000001 110.807 179.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 42.0 m -62.31 163.94 7.78 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.415 -1.05 . . . . 1.51 111.288 -178.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 866' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -98.09 127.03 38.07 Favored Pre-proline 0 N--CA 1.504 2.271 0 C-N-CA 119.796 -0.762 . . . . 0.78000000000000003 112.965 -174.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 867' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -90.6 -153.25 0.04 OUTLIER 'Trans proline' 0 CA--C 1.54 0.789 0 N-CA-C 108.614 -1.341 . . . . 0.92000000000000004 108.614 177.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 868' ' ' PHE . . . . . 0.459 ' CD1' ' CG ' ' B' ' 881' ' ' PRO . 24.4 p90 -149.95 122.56 8.58 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.529 -1.357 . . . . 0.050000000000000003 110.199 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 50.0 p-10 -112.64 -2.76 14.46 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 119.476 -0.89 . . . . 1.7 112.133 -179.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 870' ' ' ARG . . . . . . . . . . . . . 28.8 mmm180 -91.07 89.15 7.27 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.925 -1.109 . . . . 2.5899999999999999 110.694 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 57.3 t -73.05 97.31 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.012 -1.055 . . . . 1.9399999999999999 110.063 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 872' ' ' LEU . . . . . . . . . . . . . 96.0 mt -83.27 -47.11 11.87 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.496 -0.752 . . . . 1.0600000000000001 110.067 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 873' ' ' LEU . . . . . 0.401 ' O ' ' HB2' ' B' ' 874' ' ' ASN . 43.0 tp -175.15 104.43 0.09 Allowed 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 108.709 -0.849 . . . . 4.1799999999999997 108.709 178.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 874' ' ' ASN . . . . . 0.401 ' HB2' ' O ' ' B' ' 873' ' ' LEU . 34.8 t-20 178.37 81.99 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.626 -0.671 . . . . 0.040000000000000001 109.581 -178.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -66.96 -47.34 71.88 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 119.325 -0.95 . . . . 3.3799999999999999 111.327 -179.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 876' ' ' GLY . . . . . 0.42 ' HA3' ' CE2' ' B' ' 878' ' ' TYR . . . -74.59 -25.26 70.52 Favored Glycine 0 N--CA 1.495 2.602 0 O-C-N 121.269 -0.894 . . . . 0.040000000000000001 111.725 -178.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 81.96 -62.08 4.58 Favored Glycine 0 N--CA 1.502 3.05 0 N-CA-C 107.966 -2.054 . . . . 0.040000000000000001 107.966 -178.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 878' ' ' TYR . . . . . 0.42 ' CE2' ' HA3' ' B' ' 876' ' ' GLY . 95.7 m-85 61.52 -60.25 0.1 Allowed 'General case' 0 N--CA 1.504 2.24 0 N-CA-C 114.473 1.286 . . . . 3.46 114.473 177.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 879' ' ' TYR . . . . . 0.477 ' CB ' ' CD2' ' B' ' 886' ' ' PHE . 21.2 p90 -111.68 108.78 18.35 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 114.68 1.363 . . . . 0.040000000000000001 114.68 -176.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -66.41 117.77 47.04 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.354 -0.841 . . . . 0.02 109.925 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 881' ' ' PRO . . . . . 0.459 ' CG ' ' CD1' ' B' ' 868' ' ' PHE . 51.8 Cg_endo -77.09 -0.52 10.67 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 O-C-N 123.409 1.215 . . . . 0.39000000000000001 112.261 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -75.73 -63.1 1.37 Allowed 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 106.639 -1.615 . . . . 0.81000000000000005 106.639 178.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 19.7 p -94.38 -19.06 20.96 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.76 -0.83 . . . . 0.040000000000000001 108.76 177.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.88 21.28 57.9 Favored Glycine 0 N--CA 1.496 2.648 0 O-C-N 121.099 -1.0 . . . . 0.029999999999999999 111.03 178.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 885' ' ' VAL . . . . . . . . . . . . . 96.3 t -73.32 90.28 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 C-N-CA 118.242 -1.383 . . . . 1.01 108.123 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 886' ' ' PHE . . . . . 0.477 ' CD2' ' CB ' ' B' ' 879' ' ' TYR . 0.8 OUTLIER -89.52 104.17 16.75 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 115.323 -0.853 . . . . 0.050000000000000003 111.808 -177.542 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 887' ' ' THR . . . . . 0.404 ' O ' ' HD3' ' B' ' 889' ' ' PRO . 93.4 m -95.34 101.0 12.69 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 107.722 -1.214 . . . . 0.68000000000000005 107.722 177.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 888' ' ' ALA . . . . . . . . . . . . . . . -98.69 106.86 39.61 Favored Pre-proline 0 N--CA 1.503 2.179 0 N-CA-C 114.026 1.121 . . . . 0.25 114.026 -176.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 889' ' ' PRO . . . . . 0.404 ' HD3' ' O ' ' B' ' 887' ' ' THR . 53.2 Cg_endo -89.71 -12.71 2.92 Favored 'Trans proline' 0 CA--C 1.547 1.133 0 C-N-CA 121.028 1.152 . . . . 1.6399999999999999 109.107 176.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 890' ' ' LEU . . . . . . . . . . . . . 73.1 mt -36.51 -50.31 0.78 Allowed 'General case' 0 N--CA 1.508 2.465 0 N-CA-C 113.7 1.0 . . . . 2.29 113.7 -177.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 52.01 95.99 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.162 -0.961 . . . . 0.63 110.258 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . 157.86 -153.29 24.5 Favored Glycine 0 N--CA 1.478 1.478 0 N-CA-C 107.209 -2.357 . . . . 0.040000000000000001 107.209 -179.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 73.4 ttt-85 -115.58 126.12 53.82 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 108.448 -0.945 . . . . 3.0 108.448 177.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 894' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -132.53 160.23 37.13 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.113 -0.992 . . . . 0.040000000000000001 111.155 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 895' ' ' LEU . . . . . . . . . . . . . 36.2 tp -92.1 119.47 31.81 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.709 -0.62 . . . . 1.27 110.025 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 896' ' ' LEU . . . . . . . . . . . . . 9.2 tt -109.85 143.68 39.39 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.671 -0.643 . . . . 0.93999999999999995 110.147 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 897' ' ' SER . . . . . . . . . . . . . 69.6 m -149.3 114.61 5.51 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.49 -0.756 . . . . 0.040000000000000001 110.992 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -106.75 146.76 30.46 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.944 -0.761 . . . . 0.47999999999999998 108.944 178.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 899' ' ' VAL . . . . . . . . . . . . . 88.0 t -96.25 118.94 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 C-N-CA 119.646 -0.822 . . . . 0.55000000000000004 111.302 -179.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 900' ' ' LEU . . . . . 0.4 ' N ' ' CD2' ' B' ' 900' ' ' LEU . 4.5 mm? -95.71 110.65 22.75 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 114.102 1.149 . . . . 1.5900000000000001 114.102 -175.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 18.2 m -64.01 140.21 58.85 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 107.414 -1.328 . . . . 0.050000000000000003 107.414 177.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -63.3 -66.75 2.38 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 110.387 -1.085 . . . . 0.029999999999999999 110.387 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 4.1 m170 46.89 67.11 0.84 Allowed 'General case' 0 N--CA 1.507 2.383 0 O-C-N 121.505 -0.997 . . . . 3.2000000000000002 110.977 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 35.1 ptt180 -68.5 -7.54 33.16 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.642 -0.662 . . . . 2.9199999999999999 111.898 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 905' ' ' HIS . . . . . 0.487 ' O ' ' CB ' ' B' ' 906' ' ' GLU . 66.6 t60 -62.96 4.09 0.2 Allowed 'General case' 0 N--CA 1.505 2.278 0 CA-C-O 117.775 -1.107 . . . . 2.8700000000000001 112.851 -179.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 906' ' ' GLU . . . . . 0.487 ' CB ' ' O ' ' B' ' 905' ' ' HIS . 0.9 OUTLIER 94.89 -163.04 0.0 OUTLIER 'General case' 0 N--CA 1.53 3.533 0 CA-C-N 120.761 1.618 . . . . 0.98999999999999999 112.142 178.908 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 907' ' ' LYS . . . . . 0.46 ' HB2' ' O ' ' B' ' 906' ' ' GLU . 94.2 mttt 89.5 159.51 0.05 Allowed 'General case' 0 N--CA 1.522 3.164 0 N-CA-C 107.817 -1.179 . . . . 5.25 107.817 -177.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 58.4 t -122.25 116.01 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 120.933 -1.104 . . . . 0.39000000000000001 110.956 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 49.2 tp10 -100.2 133.21 44.94 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 107.542 -1.281 . . . . 1.72 107.542 176.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -157.42 122.11 4.4 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 106.98 -1.489 . . . . 0.67000000000000004 106.98 178.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 911' ' ' VAL . . . . . 0.478 ' HA ' ' HA ' ' B' ' 964' ' ' VAL . 94.7 t -85.34 132.14 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 C-N-CA 120.386 -0.526 . . . . 0.54000000000000004 111.11 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 72.3 mt -65.83 157.87 29.29 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.442 -0.787 . . . . 1.5 109.023 178.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 913' ' ' SER . . . . . 0.4 ' CB ' ' CG1' ' B' ' 919' ' ' VAL . 2.6 t -124.56 135.86 53.49 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.365 -0.976 . . . . 1.3700000000000001 108.365 177.052 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 914' ' ' ARG . . . . . 0.419 ' O ' ' CB ' ' B' ' 915' ' ' SER . 0.0 OUTLIER -64.28 154.57 34.77 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 120.596 -1.315 . . . . 4.2999999999999998 111.447 -179.054 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 915' ' ' SER . . . . . 0.419 ' CB ' ' O ' ' B' ' 914' ' ' ARG . 4.3 t 83.19 -31.86 0.08 Allowed 'General case' 0 N--CA 1.522 3.138 0 C-N-CA 123.867 0.867 . . . . 2.0499999999999998 112.131 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 916' ' ' ASN . . . . . 0.434 ' O ' ' HB2' ' B' ' 917' ' ' GLN . 90.8 m-20 -123.3 -21.89 5.25 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.856 -1.152 . . . . 2.71 111.353 -179.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 917' ' ' GLN . . . . . 0.434 ' HB2' ' O ' ' B' ' 916' ' ' ASN . 44.2 mt-30 65.87 165.72 0.19 Allowed 'General case' 0 N--CA 1.518 2.949 0 N-CA-C 106.024 -1.843 . . . . 2.6800000000000002 106.024 -173.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 55.38 -125.66 36.94 Favored Glycine 1 N--CA 1.52 4.267 0 CA-C-N 123.439 2.836 . . . . 0.029999999999999999 106.621 -177.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 919' ' ' VAL . . . . . 0.4 ' CG1' ' CB ' ' B' ' 913' ' ' SER . 68.9 t 52.34 93.72 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.302 0 O-C-N 121.356 -1.085 . . . . 1.3899999999999999 108.752 -178.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.3 90.84 7.91 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.205 -0.998 . . . . 0.029999999999999999 110.881 -178.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 921' ' ' ARG . . . . . 0.437 ' HB3' ' CZ ' ' B' ' 950' ' ' PHE . 30.1 ptt180 -86.15 -41.83 14.38 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 105.907 -1.886 . . . . 4.4199999999999999 105.907 175.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 922' ' ' VAL . . . . . . . . . . . . . 84.8 t -104.04 67.4 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 105.978 -1.86 . . . . 0.84999999999999998 105.978 175.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -89.72 134.68 34.04 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.705 0.764 . . . . 2.46 111.658 -177.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 924' ' ' SER . . . . . . . . . . . . . 8.5 t -147.13 103.33 3.58 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.503 -0.925 . . . . 0.69999999999999996 108.503 178.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -109.62 90.22 0.59 Allowed Glycine 0 N--CA 1.487 2.052 0 N-CA-C 108.349 -1.9 . . . . 0.040000000000000001 108.349 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.318 0 N-CA-C 109.459 -1.456 . . . . 0.040000000000000001 109.459 -179.267 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 29.9 m . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.009 0.433 . . . . 13.779999999999999 110.307 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 95.3 mt -111.87 129.94 55.99 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.543 -0.723 . . . . 13.76 110.379 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -151.39 167.56 30.82 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.256 -1.538 . . . . 9.1300000000000008 109.256 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 949' ' ' VAL . . . . . . . . . . . . . 30.7 m -118.7 129.13 75.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.514 -0.992 . . . . 7.0800000000000001 110.698 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 950' ' ' PHE . . . . . 0.437 ' CZ ' ' HB3' ' B' ' 921' ' ' ARG . 26.6 p90 -132.35 147.87 52.4 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.563 -0.71 . . . . 7.5899999999999999 109.518 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 19.7 m -121.22 -51.46 2.1 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.48 -0.762 . . . . 5.0300000000000002 112.063 -178.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 952' ' ' LEU . . . . . 0.416 ' O ' ' O ' ' B' ' 953' ' ' ILE . 52.5 tp -60.24 -75.28 0.06 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.389 -0.819 . . . . 1.01 112.549 -177.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 953' ' ' ILE . . . . . 0.46 ' O ' ' HB3' ' B' ' 954' ' ' LEU . 45.0 pt -52.1 -143.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.8 0 N-CA-C 114.237 1.199 . . . . 2.6000000000000001 114.237 -176.395 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 954' ' ' LEU . . . . . 0.551 ' N ' ' CD1' ' B' ' 954' ' ' LEU . 0.0 OUTLIER 173.79 77.01 0.05 OUTLIER Pre-proline 0 N--CA 1.507 2.387 0 O-C-N 120.629 -1.294 . . . . 0.050000000000000003 111.209 179.883 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 955' ' ' PRO . . . . . 0.431 ' HD2' ' CE1' ' B' ' 950' ' ' PHE . 49.4 Cg_endo -76.62 91.76 1.13 Allowed 'Trans proline' 0 C--N 1.314 -1.242 0 N-CA-C 109.606 -0.959 . . . . 0.83999999999999997 109.606 178.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 956' ' ' LEU . . . . . 0.409 ' CD2' ' NH1' ' B' ' 914' ' ' ARG . 11.1 mp -122.13 146.13 47.52 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.198 -0.939 . . . . 0.040000000000000001 109.738 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -84.33 150.86 25.1 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 117.964 -1.017 . . . . 1.28 111.84 -178.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -70.3 120.02 15.34 Favored 'General case' 0 N--CA 1.509 2.497 0 CA-C-N 122.658 2.481 . . . . 0.17000000000000001 111.664 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.65 -22.74 31.8 Favored Glycine 0 N--CA 1.5 2.922 0 N-CA-C 111.07 -0.812 . . . . 0.040000000000000001 111.07 178.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 960' ' ' ASP . . . . . 0.413 ' HB3' ' NE ' ' B' ' 914' ' ' ARG . 0.4 OUTLIER -55.27 171.99 0.15 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.455 -1.026 . . . . 0.040000000000000001 110.014 -179.528 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 961' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' B' ' 886' ' ' PHE . 40.7 m -135.02 135.65 41.5 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.993 -1.067 . . . . 1.78 111.845 -178.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 962' ' ' VAL . . . . . 0.403 ' CG2' ' CB ' ' B' ' 886' ' ' PHE . 32.7 m -98.07 145.77 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 C-N-CA 120.102 -0.639 . . . . 0.040000000000000001 110.122 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 5.6 t -138.24 146.01 42.06 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.905 -0.497 . . . . 0.71999999999999997 110.294 -178.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 964' ' ' VAL . . . . . 0.478 ' HA ' ' HA ' ' B' ' 911' ' ' VAL . 59.0 t -94.46 137.17 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.19 -0.943 . . . . 1.05 110.474 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -93.24 127.06 38.67 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 103.869 -2.641 . . . . 3.02 103.869 173.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 966' ' ' LEU . . . . . 0.406 ' O ' ' CG2' ' B' ' 967' ' ' VAL . 0.2 OUTLIER -132.32 60.23 1.69 Allowed 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.392 -0.966 . . . . 1.46 108.392 177.334 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 967' ' ' VAL . . . . . 0.406 ' CG2' ' O ' ' B' ' 966' ' ' LEU . 98.3 t -158.18 96.86 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 108.051 -1.092 . . . . 1.9399999999999999 108.051 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 92.3 mmm -142.52 60.09 1.44 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.735 -1.228 . . . . 0.0 108.571 179.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.62 120.36 2.0 Allowed Glycine 0 N--CA 1.492 2.417 0 N-CA-C 107.259 -2.337 . . . . 2.1099999999999999 107.259 -178.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -81.83 -59.8 2.46 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.073 -1.251 . . . . 5.8899999999999997 110.222 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 50.9 tp -59.83 90.6 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.45 -0.781 . . . . 4.3600000000000003 109.912 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -141.06 -154.69 0.53 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.592 -0.693 . . . . 1.8300000000000001 110.408 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -118.72 171.3 8.3 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.526 -0.734 . . . . 4.3499999999999996 110.245 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 34.5 t -101.58 130.23 47.85 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.572 -0.705 . . . . 1.27 110.065 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -156.12 157.17 35.55 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.48 -0.762 . . . . 5.0199999999999996 110.473 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.17 85.67 18.45 Favored Pre-proline 0 N--CA 1.501 2.082 0 O-C-N 121.623 -0.673 . . . . 2.4100000000000001 109.745 179.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -73.37 -172.44 1.04 Allowed 'Trans proline' 0 C--N 1.318 -1.065 0 O-C-N 123.303 1.16 . . . . 0.95999999999999996 111.386 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 978' ' ' LEU . . . . . . . . . . . . . 4.9 mp -127.52 154.66 44.86 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 107.71 -1.218 . . . . 0.62 107.71 178.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 979' ' ' THR . . . . . . . . . . . . . 41.0 p -150.41 140.89 22.46 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.814 -1.179 . . . . 3.5699999999999998 111.088 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 980' ' ' ILE . . . . . . . . . . . . . 46.2 mm -107.31 128.73 62.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 109.064 -0.717 . . . . 1.3300000000000001 109.064 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -118.84 95.36 4.8 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 119.787 -0.765 . . . . 0.050000000000000003 111.86 -178.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 80.5 p -108.28 158.13 17.74 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.546 -0.721 . . . . 0.87 109.294 178.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 983' ' ' GLY . . . . . 0.413 ' HA3' ' CE1' ' B' ' 852' ' ' PHE . . . -174.76 110.57 0.33 Allowed Glycine 0 N--CA 1.498 2.782 0 N-CA-C 106.514 -2.634 . . . . 0.029999999999999999 106.514 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -108.22 150.58 27.08 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 114.43 1.27 . . . . 0.69999999999999996 114.43 -175.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 985' ' ' LEU . . . . . . . . . . . . . 33.5 tp -72.05 135.01 46.18 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.856 -1.153 . . . . 0.040000000000000001 110.052 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 986' ' ' LEU . . . . . . . . . . . . . 51.6 tp -107.46 -55.77 2.3 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.59 -0.694 . . . . 0.040000000000000001 110.101 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -144.62 145.65 31.89 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.719 -1.215 . . . . 0.040000000000000001 107.719 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.45 163.07 12.2 Favored Glycine 0 N--CA 1.495 2.628 0 N-CA-C 108.289 -1.924 . . . . 0.040000000000000001 108.289 179.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -75.04 112.47 18.18 Favored Pre-proline 0 N--CA 1.498 1.955 0 O-C-N 121.174 -1.192 . . . . 0.040000000000000001 109.475 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 990' ' ' PRO . . . . . 0.413 ' O ' ' HB2' ' B' ' 991' ' ' GLU . 49.8 Cg_endo -90.58 70.89 1.35 Allowed 'Trans proline' 0 C--N 1.318 -1.042 0 O-C-N 123.113 1.06 . . . . 0.45000000000000001 111.517 -178.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 991' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' B' ' 990' ' ' PRO . 69.4 mt-10 67.12 -73.68 0.08 Allowed 'General case' 0 N--CA 1.503 2.183 0 N-CA-C 108.633 -0.877 . . . . 1.97 108.633 -177.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 992' ' ' LEU . . . . . . . . . . . . . 11.1 mt 51.13 20.39 0.86 Allowed 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.552 -0.717 . . . . 2.3799999999999999 111.656 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -93.69 156.97 16.39 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.869 -1.145 . . . . 3.79 110.057 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 71.9 m80 -146.7 92.91 2.21 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.519 -0.738 . . . . 3.5099999999999998 110.415 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 995' ' ' ALA . . . . . . . . . . . . 2.517 . . . . . . . 0 N--CA 1.503 2.22 0 O-C-N 120.886 -1.134 . . . . 2.73 110.603 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo . . . . . 0 N--CA 1.489 1.221 0 N-CA-C 109.521 -0.992 . . . . 3.8300000000000001 109.521 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 847' ' ' VAL . . . . . . . . . . . . . 88.1 t -131.42 102.7 15.31 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.606 -0.684 . . . . 1.8300000000000001 110.131 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 848' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -70.2 -20.41 32.8 Favored 'Trans proline' 0 N--CA 1.487 1.138 0 O-C-N 123.278 1.146 . . . . 0.65000000000000002 111.016 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 849' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 27.29 69.17 0.06 Allowed 'General case' 0 N--CA 1.519 2.979 0 N-CA-C 112.884 0.698 . . . . 2.5800000000000001 112.884 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 850' ' ' VAL . . . . . . . . . . . . . 67.7 t -119.41 133.91 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.258 -0.901 . . . . 1.0900000000000001 111.64 -178.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 851' ' ' ALA . . . . . . . . . . . . . . . -129.88 152.97 48.77 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 105.627 -1.99 . . . . 0.040000000000000001 105.627 176.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 852' ' ' PHE . . . . . 0.413 ' HA ' ' CB ' ' C' ' 874' ' ' ASN . 6.0 p90 -160.31 128.76 4.76 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 120.921 1.691 . . . . 0.050000000000000003 108.589 179.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 29.8 t -175.67 134.32 0.29 Allowed 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.065 -1.087 . . . . 0.040000000000000001 108.065 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -134.64 156.91 47.92 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.136 -0.978 . . . . 0.67000000000000004 109.596 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 855' ' ' ALA . . . . . . . . . . . . . . . -121.83 139.71 53.28 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.864 0.84 . . . . 0.51000000000000001 111.667 -179.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 856' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -103.04 135.85 43.95 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.69 -0.631 . . . . 0.050000000000000003 109.422 179.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 857' ' ' SER . . . . . 0.413 ' O ' ' O ' ' C' ' 858' ' ' LEU . 37.3 p -151.38 15.85 0.71 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.487 -0.758 . . . . 1.3300000000000001 111.206 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 858' ' ' LEU . . . . . 0.413 ' O ' ' O ' ' C' ' 857' ' ' SER . 4.4 pp -33.56 157.47 0.04 OUTLIER Pre-proline 0 N--CA 1.518 2.97 0 N-CA-C 112.899 0.703 . . . . 2.3300000000000001 112.899 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -61.57 -89.27 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 120.897 1.064 . . . . 2.3199999999999998 113.575 -177.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 54.7 ptt85 -127.82 -141.86 0.26 Allowed 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.953 -1.092 . . . . 0.040000000000000001 111.289 -177.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 71.5 m -37.9 123.04 1.04 Allowed 'General case' 0 N--CA 1.51 2.567 0 O-C-N 121.575 -0.703 . . . . 1.3100000000000001 112.064 -179.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.55 158.41 31.95 Favored Pre-proline 0 N--CA 1.488 1.429 0 N-CA-C 108.192 -1.04 . . . . 4.5099999999999998 108.192 177.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.07 -14.58 32.03 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 123.187 1.099 . . . . 2.2400000000000002 111.034 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -176.98 -135.51 2.21 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.725 -1.35 . . . . 0.040000000000000001 109.725 179.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 25.8 m -69.05 154.22 42.44 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.331 -1.1 . . . . 1.51 110.47 -179.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 866' ' ' VAL . . . . . . . . . . . . . 32.7 m -90.68 139.39 26.33 Favored Pre-proline 0 N--CA 1.497 1.881 0 N-CA-C 113.66 0.985 . . . . 0.78000000000000003 113.66 -175.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 867' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -88.92 -152.69 0.04 OUTLIER 'Trans proline' 0 C--N 1.325 -0.662 0 N-CA-C 108.286 -1.467 . . . . 0.92000000000000004 108.286 177.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 868' ' ' PHE . . . . . 0.449 ' CD1' ' N ' ' C' ' 868' ' ' PHE . 23.0 p90 -148.15 120.18 8.25 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.513 -1.367 . . . . 0.050000000000000003 109.625 179.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 50.2 p-10 -113.02 -2.97 14.1 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 119.38 -0.928 . . . . 1.7 112.029 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 870' ' ' ARG . . . . . . . . . . . . . 24.8 mmm180 -90.51 86.88 6.55 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.03 -1.044 . . . . 2.5899999999999999 110.825 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 61.6 t -73.12 96.73 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.074 -1.016 . . . . 1.9399999999999999 109.566 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 872' ' ' LEU . . . . . 0.4 ' HB3' ' CD1' ' A' ' 953' ' ' ILE . 51.9 mt -86.17 -45.18 11.58 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.554 -0.716 . . . . 1.0600000000000001 110.338 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 873' ' ' LEU . . . . . 0.406 ' O ' ' HB2' ' C' ' 874' ' ' ASN . 49.3 tp -173.3 102.8 0.12 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.238 -0.914 . . . . 4.1799999999999997 108.791 178.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 874' ' ' ASN . . . . . 0.413 ' CB ' ' HA ' ' C' ' 852' ' ' PHE . 37.4 t-20 177.98 82.65 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.319 0 O-C-N 121.721 -0.612 . . . . 0.040000000000000001 109.374 -178.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -67.19 -47.41 71.0 Favored 'General case' 0 N--CA 1.497 1.92 0 C-N-CA 119.203 -0.999 . . . . 3.3799999999999999 111.434 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 876' ' ' GLY . . . . . . . . . . . . . . . -73.53 -26.97 68.51 Favored Glycine 0 N--CA 1.494 2.548 0 O-C-N 121.271 -0.893 . . . . 0.040000000000000001 111.66 -178.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 83.13 -60.18 4.91 Favored Glycine 0 N--CA 1.503 3.109 0 N-CA-C 108.061 -2.015 . . . . 0.040000000000000001 108.061 -178.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 878' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 61.41 -66.19 0.06 Allowed 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 114.239 1.2 . . . . 3.46 114.239 177.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 879' ' ' TYR . . . . . 0.471 ' CB ' ' CD2' ' C' ' 886' ' ' PHE . 23.9 p90 -113.92 110.02 19.43 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 114.859 1.429 . . . . 0.040000000000000001 114.859 -176.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -66.83 117.98 50.43 Favored Pre-proline 0 N--CA 1.499 2.018 0 O-C-N 121.434 -0.791 . . . . 0.02 109.897 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 881' ' ' PRO . . . . . 0.447 ' HG2' ' CD1' ' C' ' 868' ' ' PHE . 55.3 Cg_endo -77.43 -0.26 10.44 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 O-C-N 123.386 1.203 . . . . 0.39000000000000001 112.141 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -74.58 -63.31 1.27 Allowed 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 106.538 -1.652 . . . . 0.81000000000000005 106.538 178.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 8.9 p -95.61 -17.62 21.21 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.704 -0.85 . . . . 0.040000000000000001 108.704 177.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.78 20.58 59.43 Favored Glycine 0 N--CA 1.495 2.631 0 O-C-N 121.024 -1.047 . . . . 0.029999999999999999 111.165 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 92.4 t -72.02 90.26 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 C-N-CA 118.135 -1.426 . . . . 1.01 108.019 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 886' ' ' PHE . . . . . 0.471 ' CD2' ' CB ' ' C' ' 879' ' ' TYR . 0.8 OUTLIER -90.93 104.77 17.32 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-N 115.268 -0.878 . . . . 0.050000000000000003 112.037 -177.259 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 887' ' ' THR . . . . . 0.409 ' O ' ' HD3' ' C' ' 889' ' ' PRO . 86.5 m -95.97 101.49 13.16 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 107.697 -1.223 . . . . 0.68000000000000005 107.697 177.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 888' ' ' ALA . . . . . . . . . . . . . . . -98.38 107.01 39.56 Favored Pre-proline 0 N--CA 1.502 2.155 0 N-CA-C 113.998 1.11 . . . . 0.25 113.998 -176.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 889' ' ' PRO . . . . . 0.409 ' HD3' ' O ' ' C' ' 887' ' ' THR . 53.6 Cg_endo -90.03 -13.26 2.59 Favored 'Trans proline' 0 CA--C 1.546 1.095 0 C-N-CA 120.975 1.117 . . . . 1.6399999999999999 109.228 176.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 890' ' ' LEU . . . . . . . . . . . . . 75.6 mt -38.7 -49.33 1.57 Allowed 'General case' 0 N--CA 1.507 2.382 0 N-CA-C 113.719 1.007 . . . . 2.29 113.719 -177.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 52.85 96.78 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.351 0 O-C-N 121.081 -1.012 . . . . 0.63 110.044 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . 155.79 -146.87 14.91 Favored Glycine 0 N--CA 1.48 1.568 0 N-CA-C 107.096 -2.402 . . . . 0.040000000000000001 107.096 -178.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 74.4 ttt-85 -107.17 129.32 54.87 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 107.947 -1.131 . . . . 3.0 107.947 177.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 894' ' ' TYR . . . . . 0.451 ' CD1' ' N ' ' C' ' 895' ' ' LEU . 0.4 OUTLIER -129.53 142.94 50.65 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.064 -1.022 . . . . 0.040000000000000001 110.086 -179.254 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 895' ' ' LEU . . . . . 0.451 ' N ' ' CD1' ' C' ' 894' ' ' TYR . 34.6 tp -102.08 115.39 30.44 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.632 -0.667 . . . . 1.27 109.597 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 896' ' ' LEU . . . . . 0.422 ' HB2' ' CZ ' ' C' ' 894' ' ' TYR . 10.3 tt -112.69 146.76 38.13 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.549 -0.719 . . . . 0.93999999999999995 110.594 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 897' ' ' SER . . . . . . . . . . . . . 8.3 m -141.4 117.26 10.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.523 -0.736 . . . . 0.040000000000000001 110.494 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -106.61 147.19 29.79 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.126 -0.694 . . . . 0.47999999999999998 109.126 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 899' ' ' VAL . . . . . . . . . . . . . 88.9 t -93.56 119.42 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 C-N-CA 119.729 -0.788 . . . . 0.55000000000000004 111.133 -179.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 96.7 mt -93.66 111.53 23.23 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 114.1 1.148 . . . . 1.5900000000000001 114.1 -175.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 16.7 m -64.12 140.12 58.84 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 107.32 -1.363 . . . . 0.050000000000000003 107.32 177.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -61.18 -64.48 4.01 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.29 -1.124 . . . . 0.029999999999999999 110.29 -179.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 45.18 63.77 1.63 Allowed 'General case' 0 N--CA 1.507 2.409 0 O-C-N 121.57 -0.959 . . . . 3.2000000000000002 111.323 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 41.9 ptt85 -67.26 -7.9 27.77 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.573 -0.704 . . . . 2.9199999999999999 111.895 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 905' ' ' HIS . . . . . 0.49 ' O ' ' CB ' ' C' ' 906' ' ' GLU . 74.0 t60 -61.3 5.15 0.07 Allowed 'General case' 0 N--CA 1.505 2.302 0 CA-C-O 117.601 -1.19 . . . . 2.8700000000000001 113.488 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 906' ' ' GLU . . . . . 0.49 ' CB ' ' O ' ' C' ' 905' ' ' HIS . 0.7 OUTLIER 92.58 -163.43 0.01 OUTLIER 'General case' 0 N--CA 1.528 3.447 0 CA-C-N 121.294 1.861 . . . . 0.98999999999999999 112.239 178.919 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 907' ' ' LYS . . . . . 0.488 ' CB ' ' O ' ' C' ' 906' ' ' GLU . 72.4 tttt 89.82 161.96 0.05 OUTLIER 'General case' 0 N--CA 1.52 3.065 0 N-CA-C 108.171 -1.048 . . . . 5.25 108.171 -177.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 59.4 t -122.69 115.39 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 120.927 -1.108 . . . . 0.39000000000000001 110.857 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 47.1 tt0 -108.07 129.99 55.11 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 107.644 -1.243 . . . . 1.72 107.644 177.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -155.93 120.83 4.71 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 106.8 -1.556 . . . . 0.67000000000000004 106.8 178.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 911' ' ' VAL . . . . . 0.453 ' HA ' ' HA ' ' C' ' 964' ' ' VAL . 13.3 p -77.3 131.09 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.79 -0.569 . . . . 0.54000000000000004 111.346 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 46.4 mt -67.81 157.62 34.37 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.284 -0.885 . . . . 1.5 108.717 178.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 913' ' ' SER . . . . . . . . . . . . . 1.6 p -123.72 139.56 53.87 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.67 -0.863 . . . . 1.3700000000000001 108.67 177.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 914' ' ' ARG . . . . . 0.425 ' O ' ' CB ' ' C' ' 915' ' ' SER . 0.0 OUTLIER -65.02 154.1 38.75 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 120.643 -1.286 . . . . 4.2999999999999998 111.568 -179.104 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 915' ' ' SER . . . . . 0.425 ' CB ' ' O ' ' C' ' 914' ' ' ARG . 4.4 t 83.28 -31.25 0.08 Allowed 'General case' 0 N--CA 1.522 3.164 0 C-N-CA 123.916 0.886 . . . . 2.0499999999999998 112.23 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 916' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -121.85 -22.01 5.89 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.889 -1.132 . . . . 2.71 111.226 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 66.99 166.93 0.23 Allowed 'General case' 0 N--CA 1.52 3.04 0 N-CA-C 105.802 -1.925 . . . . 2.6800000000000002 105.802 -174.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.64 -126.38 37.43 Favored Glycine 1 N--CA 1.521 4.344 0 CA-C-N 123.598 2.908 . . . . 0.029999999999999999 107.051 -177.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 919' ' ' VAL . . . . . . . . . . . . . 92.1 t 51.57 93.53 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.238 0 O-C-N 121.307 -1.114 . . . . 1.3899999999999999 109.129 -178.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 920' ' ' ALA . . . . . . . . . . . . . . . -93.42 93.82 8.36 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.332 -0.947 . . . . 0.029999999999999999 110.714 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 921' ' ' ARG . . . . . 0.427 ' HB3' ' CZ ' ' C' ' 950' ' ' PHE . 20.1 ptt85 -80.39 -41.83 23.9 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 105.938 -1.875 . . . . 4.4199999999999999 105.938 176.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 922' ' ' VAL . . . . . . . . . . . . . 90.5 t -101.86 75.11 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 106.088 -1.819 . . . . 0.84999999999999998 106.088 175.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -89.79 135.89 33.36 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.872 0.844 . . . . 2.46 112.355 -176.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 7.9 t -147.16 102.76 3.53 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.063 -1.088 . . . . 0.69999999999999996 108.063 178.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -110.83 88.95 0.53 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.967 -1.653 . . . . 0.040000000000000001 108.967 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.4 0 N-CA-C 109.353 -1.499 . . . . 0.040000000000000001 109.353 -179.713 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 11.2 m . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 120.962 0.411 . . . . 13.779999999999999 110.318 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 95.3 mt -114.22 129.77 56.63 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.505 -0.747 . . . . 13.76 110.319 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -152.16 170.34 31.47 Favored Glycine 0 N--CA 1.493 2.5 0 N-CA-C 109.398 -1.481 . . . . 9.1300000000000008 109.398 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 949' ' ' VAL . . . . . . . . . . . . . 33.7 m -117.17 136.39 54.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.538 -0.977 . . . . 7.0800000000000001 110.832 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 950' ' ' PHE . . . . . 0.427 ' CZ ' ' HB3' ' C' ' 921' ' ' ARG . 36.0 p90 -135.57 152.25 51.09 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.607 -0.683 . . . . 7.5899999999999999 109.622 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 69.4 m -118.32 -54.44 2.29 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.386 -0.821 . . . . 5.0300000000000002 111.514 -179.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 952' ' ' LEU . . . . . 0.448 ' O ' ' O ' ' C' ' 953' ' ' ILE . 46.6 tp -63.78 -77.03 0.06 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.46 -0.775 . . . . 1.01 111.421 -178.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 953' ' ' ILE . . . . . 0.48 ' O ' ' HB3' ' C' ' 954' ' ' LEU . 2.3 pp -49.45 -152.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.735 0 N-CA-C 114.324 1.231 . . . . 2.6000000000000001 114.324 -176.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 954' ' ' LEU . . . . . 0.549 ' N ' ' CD1' ' C' ' 954' ' ' LEU . 0.0 OUTLIER 169.11 92.09 0.03 OUTLIER Pre-proline 0 N--CA 1.516 2.869 0 O-C-N 120.949 -1.094 . . . . 0.050000000000000003 111.651 179.491 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 955' ' ' PRO . . . . . 0.421 ' HD2' ' CZ ' ' C' ' 950' ' ' PHE . 52.1 Cg_endo -80.4 93.0 1.05 Allowed 'Trans proline' 0 C--N 1.317 -1.117 0 N-CA-C 109.138 -1.139 . . . . 0.83999999999999997 109.138 178.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 956' ' ' LEU . . . . . . . . . . . . . 10.9 mp -122.85 144.01 49.49 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.014 -1.054 . . . . 0.040000000000000001 110.144 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -82.11 151.33 27.05 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 117.708 -1.139 . . . . 1.28 111.287 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -67.15 118.63 10.83 Favored 'General case' 0 N--CA 1.508 2.45 0 CA-C-N 123.078 2.672 . . . . 0.17000000000000001 111.082 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.42 -20.43 44.1 Favored Glycine 0 N--CA 1.499 2.888 0 N-CA-C 110.872 -0.891 . . . . 0.040000000000000001 110.872 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 960' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.63 169.69 0.13 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.381 -1.07 . . . . 0.040000000000000001 110.125 -179.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 961' ' ' THR . . . . . 0.462 ' HA ' ' O ' ' C' ' 886' ' ' PHE . 71.1 p -133.41 137.66 45.9 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.056 -1.027 . . . . 1.78 112.167 -177.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 962' ' ' VAL . . . . . 0.436 ' CG2' ' CB ' ' C' ' 886' ' ' PHE . 25.4 m -97.31 146.46 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 C-N-CA 120.13 -0.628 . . . . 0.040000000000000001 110.184 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 5.5 t -138.59 145.23 40.32 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.952 -0.468 . . . . 0.71999999999999997 109.989 -178.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 964' ' ' VAL . . . . . 0.453 ' HA ' ' HA ' ' C' ' 911' ' ' VAL . 65.1 t -97.27 136.0 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.034 -1.041 . . . . 1.05 110.578 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -97.37 125.61 42.09 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 103.906 -2.627 . . . . 3.02 103.906 173.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 966' ' ' LEU . . . . . 0.401 ' O ' ' CG2' ' C' ' 967' ' ' VAL . 1.1 tp -133.11 62.95 1.65 Allowed 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.296 -1.002 . . . . 1.46 108.296 177.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 967' ' ' VAL . . . . . 0.401 ' CG2' ' O ' ' C' ' 966' ' ' LEU . 97.3 t -157.64 97.44 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 108.224 -1.028 . . . . 1.9399999999999999 108.224 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 95.7 mmm -141.9 59.98 1.48 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.741 -1.224 . . . . 0.0 108.541 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.07 119.99 1.99 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 107.235 -2.346 . . . . 2.1099999999999999 107.235 -178.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -82.23 -58.55 2.9 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.053 -1.263 . . . . 5.8899999999999997 110.507 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 49.0 tp -59.43 89.94 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.448 -0.782 . . . . 4.3600000000000003 110.261 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -142.16 -152.66 0.42 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.622 -0.673 . . . . 1.8300000000000001 110.09 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -117.36 167.62 11.09 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.462 -0.774 . . . . 4.3499999999999996 110.022 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 10.3 t -101.7 130.56 48.11 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.557 -0.714 . . . . 1.27 110.2 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -155.96 153.85 30.22 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.532 -0.73 . . . . 5.0199999999999996 110.384 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.27 86.23 14.76 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.588 -0.695 . . . . 2.4100000000000001 109.897 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -75.76 -170.55 0.85 Allowed 'Trans proline' 0 C--N 1.318 -1.07 0 O-C-N 123.324 1.17 . . . . 0.95999999999999996 111.223 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 978' ' ' LEU . . . . . . . . . . . . . 5.0 mp -123.56 156.23 36.11 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 107.497 -1.297 . . . . 0.62 107.497 177.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 979' ' ' THR . . . . . . . . . . . . . 40.6 p -150.54 141.66 23.09 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.779 -1.2 . . . . 3.5699999999999998 111.251 -179.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 980' ' ' ILE . . . . . . . . . . . . . 50.1 mm -106.08 128.55 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 109.216 -0.661 . . . . 1.3300000000000001 109.216 179.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 981' ' ' PHE . . . . . 0.436 ' CD1' ' CE2' ' C' ' 879' ' ' TYR . 2.3 t80 -118.15 97.29 5.72 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.499 -0.751 . . . . 0.050000000000000003 111.256 -178.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 982' ' ' SER . . . . . . . . . . . . . 18.2 p -108.41 159.85 16.35 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.081 -0.711 . . . . 0.87 109.081 178.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 983' ' ' GLY . . . . . 0.411 ' O ' ' CE2' ' C' ' 852' ' ' PHE . . . -169.04 115.01 0.58 Allowed Glycine 0 N--CA 1.497 2.764 0 N-CA-C 106.526 -2.629 . . . . 0.029999999999999999 106.526 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 984' ' ' ALA . . . . . 0.403 ' CB ' ' CZ ' ' A' ' 893' ' ' ARG . . . -109.26 147.95 31.78 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.156 -1.203 . . . . 0.69999999999999996 114.169 -175.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 985' ' ' LEU . . . . . . . . . . . . . 51.4 tp -75.38 135.06 40.82 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.809 -1.182 . . . . 0.040000000000000001 109.425 179.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 986' ' ' LEU . . . . . . . . . . . . . 48.4 tp -107.1 -61.71 1.51 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.477 -0.764 . . . . 0.040000000000000001 110.495 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -144.92 146.31 31.94 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 107.841 -1.17 . . . . 0.040000000000000001 107.841 179.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.25 162.82 12.28 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 108.097 -2.001 . . . . 0.040000000000000001 108.097 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -74.6 112.81 19.07 Favored Pre-proline 0 N--CA 1.498 1.967 0 O-C-N 121.206 -1.173 . . . . 0.040000000000000001 109.455 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 990' ' ' PRO . . . . . 0.41 ' O ' ' HB2' ' C' ' 991' ' ' GLU . 50.5 Cg_endo -88.76 70.98 2.38 Favored 'Trans proline' 0 C--N 1.32 -0.937 0 O-C-N 123.115 1.061 . . . . 0.45000000000000001 111.303 -178.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 991' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' C' ' 990' ' ' PRO . 67.7 mt-10 67.51 -73.31 0.08 Allowed 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 108.582 -0.895 . . . . 1.97 108.582 -177.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 992' ' ' LEU . . . . . . . . . . . . . 11.4 mt 50.45 20.83 0.74 Allowed 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.567 -0.708 . . . . 2.3799999999999999 111.69 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -92.91 157.01 16.58 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.936 -1.103 . . . . 3.79 110.055 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -146.32 92.0 2.12 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.579 -0.701 . . . . 3.5099999999999998 110.254 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 995' ' ' ALA . . . . . . . . . . . . 2.518 . . . . . . . 0 N--CA 1.504 2.23 0 O-C-N 120.913 -1.117 . . . . 2.73 110.564 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo . . . . . 0 N--CA 1.488 1.199 0 N-CA-C 109.451 -1.019 . . . . 3.8300000000000001 109.451 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 847' ' ' VAL . . . . . . . . . . . . . 66.6 t -134.93 102.82 10.98 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.617 -0.677 . . . . 1.8300000000000001 110.004 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 848' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.83 -18.66 36.56 Favored 'Trans proline' 0 N--CA 1.488 1.155 0 O-C-N 123.344 1.181 . . . . 0.65000000000000002 111.168 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 849' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 27.39 67.97 0.07 Allowed 'General case' 0 N--CA 1.518 2.927 0 N-CA-C 113.025 0.75 . . . . 2.5800000000000001 113.025 179.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 850' ' ' VAL . . . . . . . . . . . . . 69.9 t -119.39 137.02 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 121.202 -0.936 . . . . 1.0900000000000001 111.442 -178.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 851' ' ' ALA . . . . . . . . . . . . . . . -124.13 159.0 30.99 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 105.827 -1.916 . . . . 0.040000000000000001 105.827 176.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 852' ' ' PHE . . . . . 0.411 ' CE1' ' HA3' ' A' ' 983' ' ' GLY . 32.7 p90 -159.6 127.96 4.99 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 120.948 1.704 . . . . 0.050000000000000003 108.492 178.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 7.8 t -175.71 134.42 0.29 Allowed 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.152 -1.055 . . . . 0.040000000000000001 108.152 -178.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -131.98 157.41 44.15 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.083 -1.011 . . . . 0.67000000000000004 109.626 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 855' ' ' ALA . . . . . 0.405 ' O ' ' HB2' ' A' ' 870' ' ' ARG . . . -120.78 146.1 46.86 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-O 122.018 0.914 . . . . 0.51000000000000001 111.291 -178.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 856' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -113.01 133.36 54.99 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.738 -0.601 . . . . 0.050000000000000003 109.872 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 857' ' ' SER . . . . . 0.423 ' O ' ' O ' ' A' ' 858' ' ' LEU . 30.3 p -154.37 14.6 0.44 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.526 -0.734 . . . . 1.3300000000000001 111.683 179.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 858' ' ' LEU . . . . . 0.423 ' O ' ' O ' ' A' ' 857' ' ' SER . 4.5 pp -33.22 159.64 0.03 OUTLIER Pre-proline 0 N--CA 1.52 3.028 0 N-CA-C 113.427 0.899 . . . . 2.3300000000000001 113.427 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -61.85 -88.29 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 120.965 1.11 . . . . 2.3199999999999998 113.316 -178.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 53.6 ptt85 -128.01 -142.47 0.27 Allowed 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.887 -1.133 . . . . 0.040000000000000001 111.397 -177.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 8.8 m -41.28 129.04 2.99 Favored 'General case' 0 N--CA 1.509 2.498 0 O-C-N 121.459 -0.776 . . . . 1.3100000000000001 111.902 -179.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -94.81 152.77 39.96 Favored Pre-proline 0 N--CA 1.492 1.626 0 N-CA-C 108.107 -1.071 . . . . 4.5099999999999998 108.107 177.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -70.27 -12.22 31.55 Favored 'Trans proline' 0 C--N 1.314 -1.271 0 O-C-N 123.059 1.031 . . . . 2.2400000000000002 111.161 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -175.74 -136.07 2.25 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 110.107 -1.197 . . . . 0.040000000000000001 110.107 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 39.9 m -64.38 155.77 31.37 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.382 -1.07 . . . . 1.51 111.331 -178.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 866' ' ' VAL . . . . . . . . . . . . . 2.7 t -91.12 128.07 48.97 Favored Pre-proline 0 N--CA 1.5 2.059 0 N-CA-C 113.399 0.889 . . . . 0.78000000000000003 113.399 -174.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 867' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -92.05 -155.62 0.05 OUTLIER 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 121.174 1.25 . . . . 0.92000000000000004 109.516 177.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 868' ' ' PHE . . . . . 0.445 ' N ' ' CD1' ' A' ' 868' ' ' PHE . 21.1 p90 -151.73 123.64 8.06 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.654 -1.279 . . . . 0.050000000000000003 109.994 179.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 44.0 p30 -114.62 -0.72 13.55 Favored 'General case' 0 N--CA 1.501 2.109 0 C-N-CA 119.345 -0.942 . . . . 1.7 112.762 -178.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 870' ' ' ARG . . . . . 0.405 ' HB2' ' O ' ' A' ' 855' ' ' ALA . 26.9 mmm180 -90.97 90.47 7.9 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 120.845 -1.16 . . . . 2.5899999999999999 111.099 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 60.4 t -74.7 97.13 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 120.978 -1.076 . . . . 1.9399999999999999 109.911 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 872' ' ' LEU . . . . . . . . . . . . . 96.3 mt -83.2 -46.81 12.27 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.468 -0.77 . . . . 1.0600000000000001 110.131 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 873' ' ' LEU . . . . . . . . . . . . . 36.9 tp -174.52 102.98 0.1 Allowed 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.521 -0.918 . . . . 4.1799999999999997 108.521 178.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 35.4 t-20 178.73 80.86 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.3 0 O-C-N 121.622 -0.674 . . . . 0.040000000000000001 109.555 -178.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -66.7 -47.27 72.92 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.211 -0.931 . . . . 3.3799999999999999 111.204 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 876' ' ' GLY . . . . . . . . . . . . . . . -73.56 -24.86 73.86 Favored Glycine 0 N--CA 1.494 2.555 0 O-C-N 121.306 -0.871 . . . . 0.040000000000000001 111.509 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 84.0 -59.93 4.9 Favored Glycine 0 N--CA 1.502 3.041 0 N-CA-C 108.088 -2.005 . . . . 0.040000000000000001 108.088 -178.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 878' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 60.78 -65.79 0.06 Allowed 'General case' 0 N--CA 1.503 2.22 0 N-CA-C 114.206 1.188 . . . . 3.46 114.206 177.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 879' ' ' TYR . . . . . 0.478 ' CB ' ' CD2' ' A' ' 886' ' ' PHE . 21.0 p90 -112.73 109.35 18.79 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 114.833 1.42 . . . . 0.040000000000000001 114.833 -176.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.42 116.77 37.28 Favored Pre-proline 0 N--CA 1.496 1.825 0 O-C-N 121.381 -0.825 . . . . 0.02 109.647 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 881' ' ' PRO . . . . . 0.425 ' HG2' ' CD1' ' A' ' 868' ' ' PHE . 53.6 Cg_endo -75.59 -0.02 9.67 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 O-C-N 123.492 1.259 . . . . 0.39000000000000001 112.493 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -75.99 -63.15 1.38 Allowed 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 106.723 -1.584 . . . . 0.81000000000000005 106.723 178.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 41.1 p -94.1 -20.23 20.1 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.482 -0.933 . . . . 0.040000000000000001 108.482 177.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.21 20.94 58.08 Favored Glycine 0 N--CA 1.495 2.573 0 O-C-N 121.034 -1.041 . . . . 0.029999999999999999 111.385 178.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 885' ' ' VAL . . . . . . . . . . . . . 99.3 t -73.67 91.81 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 C-N-CA 118.103 -1.439 . . . . 1.01 108.196 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 886' ' ' PHE . . . . . 0.478 ' CD2' ' CB ' ' A' ' 879' ' ' TYR . 0.7 OUTLIER -89.87 104.75 17.29 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-N 115.118 -0.946 . . . . 0.050000000000000003 112.092 -177.143 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 887' ' ' THR . . . . . 0.423 ' O ' ' HD3' ' A' ' 889' ' ' PRO . 93.7 m -96.29 100.42 12.05 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 107.685 -1.228 . . . . 0.68000000000000005 107.685 177.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 888' ' ' ALA . . . . . . . . . . . . . . . -98.62 105.95 33.61 Favored Pre-proline 0 N--CA 1.502 2.132 0 N-CA-C 114.279 1.215 . . . . 0.25 114.279 -176.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 889' ' ' PRO . . . . . 0.423 ' HD3' ' O ' ' A' ' 887' ' ' THR . 54.1 Cg_endo -89.0 -13.37 3.09 Favored 'Trans proline' 0 CA--C 1.546 1.105 0 N-CA-C 108.935 -1.217 . . . . 1.6399999999999999 108.935 175.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 890' ' ' LEU . . . . . . . . . . . . . 69.3 mt -36.54 -49.97 0.77 Allowed 'General case' 0 N--CA 1.508 2.47 0 N-CA-C 113.612 0.967 . . . . 2.29 113.612 -177.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 52.09 96.03 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.189 -0.944 . . . . 0.63 110.289 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 158.0 -153.61 24.78 Favored Glycine 0 N--CA 1.478 1.468 0 N-CA-C 107.227 -2.349 . . . . 0.040000000000000001 107.227 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 893' ' ' ARG . . . . . 0.4 ' CZ ' ' CB ' ' C' ' 984' ' ' ALA . 72.9 ttt-85 -115.7 126.39 54.05 Favored 'General case' 0 C--N 1.294 -1.82 0 O-C-N 121.601 -0.94 . . . . 3.0 108.512 177.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 894' ' ' TYR . . . . . 0.42 ' CZ ' ' HB2' ' A' ' 896' ' ' LEU . 0.1 OUTLIER -132.26 159.99 37.49 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.177 -0.952 . . . . 0.040000000000000001 111.038 -179.74 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 895' ' ' LEU . . . . . . . . . . . . . 37.8 tp -91.77 118.49 30.74 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.69 -0.631 . . . . 1.27 110.168 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 896' ' ' LEU . . . . . 0.42 ' HB2' ' CZ ' ' A' ' 894' ' ' TYR . 9.2 tt -110.05 142.16 41.88 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.707 -0.621 . . . . 0.93999999999999995 110.047 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 897' ' ' SER . . . . . . . . . . . . . 64.1 m -148.9 115.51 5.92 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.452 -0.78 . . . . 0.040000000000000001 110.982 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.61 146.18 32.3 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.892 -0.781 . . . . 0.47999999999999998 108.892 178.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 899' ' ' VAL . . . . . 0.4 ' CG2' ' HB ' ' A' ' 980' ' ' ILE . 87.5 t -94.73 120.39 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.373 -0.829 . . . . 0.55000000000000004 111.033 -179.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 900' ' ' LEU . . . . . 0.442 ' CD2' ' N ' ' A' ' 900' ' ' LEU . 4.3 mm? -95.23 112.8 24.46 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 114.382 1.252 . . . . 1.5900000000000001 114.382 -174.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 15.6 m -66.85 141.53 57.65 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 107.334 -1.358 . . . . 0.050000000000000003 107.334 176.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -67.02 -65.83 2.62 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 110.583 -1.007 . . . . 0.029999999999999999 110.583 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 8.8 m170 46.72 66.7 0.92 Allowed 'General case' 0 N--CA 1.508 2.437 0 O-C-N 121.493 -1.004 . . . . 3.2000000000000002 111.155 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 43.2 ptt85 -69.38 -5.88 26.38 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.624 -0.672 . . . . 2.9199999999999999 112.108 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 905' ' ' HIS . . . . . 0.487 ' O ' ' CB ' ' A' ' 906' ' ' GLU . 72.7 t60 -62.32 5.03 0.12 Allowed 'General case' 0 N--CA 1.506 2.335 0 O-C-N 120.918 -1.114 . . . . 2.8700000000000001 113.155 -179.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 906' ' ' GLU . . . . . 0.487 ' CB ' ' O ' ' A' ' 905' ' ' HIS . 0.5 OUTLIER 94.63 -164.29 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.449 0 CA-C-N 120.562 1.528 . . . . 0.98999999999999999 111.824 179.007 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 907' ' ' LYS . . . . . 0.465 ' CB ' ' O ' ' A' ' 906' ' ' GLU . 63.1 tttt 85.59 156.59 0.09 Allowed 'General case' 0 N--CA 1.52 3.031 0 N-CA-C 108.024 -1.102 . . . . 5.25 108.024 -176.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 58.9 t -122.02 116.38 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 120.787 -1.196 . . . . 0.39000000000000001 111.099 -179.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -99.82 133.21 44.52 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 107.319 -1.363 . . . . 1.72 107.319 176.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -155.92 121.94 5.04 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 106.842 -1.54 . . . . 0.67000000000000004 106.842 178.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 911' ' ' VAL . . . . . 0.467 ' HA ' ' HA ' ' A' ' 964' ' ' VAL . 87.3 t -84.06 132.15 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.86 -0.525 . . . . 0.54000000000000004 110.783 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 62.2 mt -65.63 156.42 32.84 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.404 -0.81 . . . . 1.5 109.025 178.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 913' ' ' SER . . . . . 0.413 ' CB ' ' CG1' ' A' ' 919' ' ' VAL . 1.3 t -123.02 138.4 54.7 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.316 -0.994 . . . . 1.3700000000000001 108.316 177.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 914' ' ' ARG . . . . . 0.426 ' O ' ' CB ' ' A' ' 915' ' ' SER . 0.0 OUTLIER -65.15 154.79 36.94 Favored 'General case' 0 N--CA 1.505 2.284 0 O-C-N 120.762 -1.211 . . . . 4.2999999999999998 111.751 -179.049 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 915' ' ' SER . . . . . 0.426 ' CB ' ' O ' ' A' ' 914' ' ' ARG . 4.7 t 83.07 -32.71 0.08 Allowed 'General case' 0 N--CA 1.522 3.136 0 C-N-CA 123.979 0.911 . . . . 2.0499999999999998 112.254 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -121.1 -20.46 6.79 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.947 -1.095 . . . . 2.71 111.469 -179.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 917' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 66.82 165.04 0.21 Allowed 'General case' 0 N--CA 1.521 3.111 0 N-CA-C 105.452 -2.055 . . . . 2.6800000000000002 105.452 -173.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.33 -125.38 33.82 Favored Glycine 1 N--CA 1.521 4.357 0 CA-C-N 123.545 2.884 . . . . 0.029999999999999999 106.987 -177.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 919' ' ' VAL . . . . . 0.413 ' CG1' ' CB ' ' A' ' 913' ' ' SER . 78.6 t 51.58 94.9 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 O-C-N 121.513 -0.992 . . . . 1.3899999999999999 108.996 -178.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.38 92.29 8.51 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.246 -0.982 . . . . 0.029999999999999999 110.902 -179.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 921' ' ' ARG . . . . . 0.426 ' HB2' ' CE1' ' A' ' 950' ' ' PHE . 27.5 ptt180 -83.9 -41.76 17.07 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 105.756 -1.942 . . . . 4.4199999999999999 105.756 175.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 922' ' ' VAL . . . . . . . . . . . . . 78.7 t -102.19 73.44 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 106.308 -1.738 . . . . 0.84999999999999998 106.308 175.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -86.82 133.75 33.61 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.643 0.735 . . . . 2.46 111.231 -177.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 28.0 t -147.83 105.9 3.74 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.907 -0.775 . . . . 0.69999999999999996 108.907 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -102.91 83.65 0.44 Allowed Glycine 0 N--CA 1.487 2.043 0 N-CA-C 108.277 -1.929 . . . . 0.040000000000000001 108.277 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.126 0 N-CA-C 108.67 -1.772 . . . . 0.040000000000000001 108.67 -179.709 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 33.0 m . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.012 0.434 . . . . 13.779999999999999 110.21 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 96.2 mt -112.44 129.44 56.32 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.666 -0.646 . . . . 13.76 110.365 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -152.34 168.03 31.41 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 108.967 -1.653 . . . . 9.1300000000000008 108.967 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 949' ' ' VAL . . . . . . . . . . . . . 34.9 m -119.38 130.77 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.502 -0.999 . . . . 7.0800000000000001 110.998 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 950' ' ' PHE . . . . . 0.432 ' CE1' ' HD2' ' A' ' 955' ' ' PRO . 25.5 p90 -133.24 150.51 51.94 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.565 -0.709 . . . . 7.5899999999999999 109.149 179.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 19.5 m -120.66 -53.19 2.1 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.341 -0.85 . . . . 5.0300000000000002 112.314 -178.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 952' ' ' LEU . . . . . 0.427 ' O ' ' O ' ' A' ' 953' ' ' ILE . 13.6 tp -60.39 -73.01 0.1 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.411 -0.805 . . . . 1.01 112.576 -177.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 953' ' ' ILE . . . . . 0.473 ' O ' ' HB3' ' A' ' 954' ' ' LEU . 46.1 pt -52.6 -145.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.768 0 N-CA-C 114.06 1.133 . . . . 2.6000000000000001 114.06 -176.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 954' ' ' LEU . . . . . 0.548 ' N ' ' CD1' ' A' ' 954' ' ' LEU . 0.0 OUTLIER 171.84 77.45 0.04 OUTLIER Pre-proline 0 N--CA 1.51 2.554 0 O-C-N 120.768 -1.208 . . . . 0.050000000000000003 111.461 179.555 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 955' ' ' PRO . . . . . 0.432 ' HD2' ' CE1' ' A' ' 950' ' ' PHE . 48.4 Cg_endo -74.88 96.41 1.01 Allowed 'Trans proline' 0 C--N 1.315 -1.227 0 N-CA-C 109.521 -0.992 . . . . 0.83999999999999997 109.521 178.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 956' ' ' LEU . . . . . . . . . . . . . 10.4 mp -123.03 145.68 48.31 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.197 -0.939 . . . . 0.040000000000000001 110.214 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -83.71 150.41 25.86 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 117.773 -1.108 . . . . 1.28 111.675 -179.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -70.4 119.87 15.22 Favored 'General case' 0 N--CA 1.51 2.526 0 CA-C-N 122.967 2.621 . . . . 0.17000000000000001 111.558 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.6 -22.77 31.5 Favored Glycine 0 N--CA 1.501 3.008 0 N-CA-C 111.16 -0.776 . . . . 0.040000000000000001 111.16 178.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 960' ' ' ASP . . . . . 0.404 ' HB3' ' NE ' ' A' ' 914' ' ' ARG . 0.6 OUTLIER -52.14 172.14 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.49 -1.006 . . . . 0.040000000000000001 110.403 -179.409 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 961' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 886' ' ' PHE . 7.2 t -134.77 134.6 41.11 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.008 -1.058 . . . . 1.78 111.849 -178.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 962' ' ' VAL . . . . . 0.429 ' CG2' ' CB ' ' A' ' 886' ' ' PHE . 31.7 m -99.01 145.91 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 C-N-CA 120.074 -0.65 . . . . 0.040000000000000001 110.44 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 5.3 t -139.0 145.24 39.43 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.853 -0.529 . . . . 0.71999999999999997 110.115 -178.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 964' ' ' VAL . . . . . 0.467 ' HA ' ' HA ' ' A' ' 911' ' ' VAL . 55.5 t -94.12 136.57 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.105 -0.997 . . . . 1.05 110.714 -179.16 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -95.81 126.79 41.31 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 103.665 -2.717 . . . . 3.02 103.665 173.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 966' ' ' LEU . . . . . 0.408 ' O ' ' CG2' ' A' ' 967' ' ' VAL . 20.8 tp -132.6 62.35 1.65 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.304 -0.999 . . . . 1.46 108.304 177.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 967' ' ' VAL . . . . . 0.408 ' CG2' ' O ' ' A' ' 966' ' ' LEU . 89.9 t -158.21 97.19 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 108.049 -1.093 . . . . 1.9399999999999999 108.049 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 88.8 mmm -142.99 59.37 1.42 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.737 -1.227 . . . . 0.0 108.184 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.44 119.91 1.96 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 106.957 -2.457 . . . . 2.1099999999999999 106.957 -178.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -81.55 -57.9 3.26 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 118.696 1.248 . . . . 5.8899999999999997 110.368 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 44.2 tp -58.82 90.58 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.501 -0.75 . . . . 4.3600000000000003 110.203 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -141.43 -155.02 0.55 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.562 -0.711 . . . . 1.8300000000000001 110.344 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -119.79 172.03 7.99 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.476 -0.765 . . . . 4.3499999999999996 110.38 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 29.2 t -101.51 130.32 47.76 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.537 -0.727 . . . . 1.27 110.102 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -156.44 158.35 37.14 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.511 -0.743 . . . . 5.0199999999999996 110.548 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.72 86.36 15.91 Favored Pre-proline 0 N--CA 1.501 2.094 0 O-C-N 121.602 -0.686 . . . . 2.4100000000000001 109.713 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.07 -172.8 1.07 Allowed 'Trans proline' 0 C--N 1.317 -1.093 0 O-C-N 123.271 1.143 . . . . 0.95999999999999996 111.547 -179.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 5.2 mp -127.93 154.73 45.22 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 107.577 -1.268 . . . . 0.62 107.577 178.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 979' ' ' THR . . . . . . . . . . . . . 33.7 p -150.34 142.15 23.75 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.809 -1.182 . . . . 3.5699999999999998 111.368 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 980' ' ' ILE . . . . . 0.409 HG22 HD11 ' A' ' 980' ' ' ILE . 46.8 mm -106.5 127.44 61.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 108.798 -0.815 . . . . 1.3300000000000001 108.798 179.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 981' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -119.49 97.48 5.67 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 119.762 -0.775 . . . . 0.050000000000000003 111.726 -178.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 77.8 p -108.55 158.48 17.52 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.485 -0.759 . . . . 0.87 109.331 178.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 983' ' ' GLY . . . . . 0.411 ' HA3' ' CE1' ' A' ' 852' ' ' PHE . . . -174.98 107.55 0.24 Allowed Glycine 0 N--CA 1.499 2.859 0 N-CA-C 106.452 -2.659 . . . . 0.029999999999999999 106.452 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -108.75 152.5 24.77 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 114.507 1.299 . . . . 0.69999999999999996 114.507 -175.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 53.1 tp -71.29 134.03 46.49 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.793 -1.192 . . . . 0.040000000000000001 110.141 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 45.9 tp -107.61 -56.13 2.26 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.552 -0.718 . . . . 0.040000000000000001 109.804 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -145.26 145.2 31.18 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 107.701 -1.222 . . . . 0.040000000000000001 107.701 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -113.02 163.32 12.15 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 108.293 -1.923 . . . . 0.040000000000000001 108.293 179.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -75.44 112.69 20.27 Favored Pre-proline 0 N--CA 1.5 2.026 0 O-C-N 121.256 -1.144 . . . . 0.040000000000000001 109.485 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 990' ' ' PRO . . . . . 0.408 ' O ' ' HB2' ' A' ' 991' ' ' GLU . 50.7 Cg_endo -90.19 70.92 1.56 Allowed 'Trans proline' 0 C--N 1.319 -1.004 0 O-C-N 123.134 1.07 . . . . 0.45000000000000001 111.514 -179.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 991' ' ' GLU . . . . . 0.408 ' HB2' ' O ' ' A' ' 990' ' ' PRO . 70.6 mt-10 67.37 -73.61 0.08 Allowed 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 108.584 -0.895 . . . . 1.97 108.584 -177.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 992' ' ' LEU . . . . . . . . . . . . . 10.9 mt 51.05 20.58 0.85 Allowed 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.502 -0.749 . . . . 2.3799999999999999 111.638 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 83.6 mt-10 -94.09 156.87 16.36 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.879 -1.138 . . . . 3.79 110.085 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 72.4 m80 -146.63 93.33 2.27 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.526 -0.734 . . . . 3.5099999999999998 110.311 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 995' ' ' ALA . . . . . . . . . . . . 2.518 . . . . . . . 0 N--CA 1.503 2.198 0 O-C-N 120.831 -1.168 . . . . 2.73 110.614 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo . . . . . 0 N--CA 1.488 1.18 0 N-CA-C 109.429 -1.027 . . . . 3.8300000000000001 109.429 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 847' ' ' VAL . . . . . . . . . . . . . 66.4 t -134.93 102.91 10.94 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.557 -0.715 . . . . 1.8300000000000001 110.041 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 848' ' ' PRO . . . . . 0.405 ' O ' ' C ' ' B' ' 849' ' ' GLN . 44.2 Cg_endo -69.81 -18.93 36.51 Favored 'Trans proline' 0 N--CA 1.488 1.167 0 O-C-N 123.319 1.168 . . . . 0.65000000000000002 111.136 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 849' ' ' GLN . . . . . 0.405 ' C ' ' O ' ' B' ' 848' ' ' PRO . 55.9 tt0 27.59 68.22 0.07 Allowed 'General case' 0 N--CA 1.518 2.953 0 N-CA-C 112.951 0.723 . . . . 2.5800000000000001 112.951 179.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 850' ' ' VAL . . . . . . . . . . . . . 68.0 t -119.62 137.13 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.193 -0.942 . . . . 1.0900000000000001 111.427 -179.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 851' ' ' ALA . . . . . . . . . . . . . . . -124.71 158.21 33.77 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 105.828 -1.916 . . . . 0.040000000000000001 105.828 176.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 852' ' ' PHE . . . . . 0.418 ' CE1' ' HA3' ' B' ' 983' ' ' GLY . 32.1 p90 -158.82 128.27 5.61 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 121.056 1.753 . . . . 0.050000000000000003 108.493 179.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 7.6 t -175.79 134.09 0.28 Allowed 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.245 -1.021 . . . . 0.040000000000000001 108.245 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -131.49 157.76 42.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.106 -0.996 . . . . 0.67000000000000004 109.668 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 855' ' ' ALA . . . . . 0.404 ' O ' ' HB2' ' B' ' 870' ' ' ARG . . . -121.1 146.15 47.04 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.997 0.903 . . . . 0.51000000000000001 111.287 -178.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 856' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -113.17 132.83 55.32 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.712 -0.617 . . . . 0.050000000000000003 109.971 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 857' ' ' SER . . . . . 0.428 ' O ' ' O ' ' B' ' 858' ' ' LEU . 30.1 p -153.97 14.92 0.48 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.521 -0.737 . . . . 1.3300000000000001 111.711 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 858' ' ' LEU . . . . . 0.428 ' O ' ' O ' ' B' ' 857' ' ' SER . 4.5 pp -33.46 159.69 0.03 OUTLIER Pre-proline 0 N--CA 1.52 3.052 0 N-CA-C 113.401 0.889 . . . . 2.3300000000000001 113.401 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -61.96 -88.39 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 121.013 1.142 . . . . 2.3199999999999998 113.235 -178.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 53.6 ptt85 -127.94 -142.53 0.27 Allowed 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.893 -1.13 . . . . 0.040000000000000001 111.405 -177.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 8.8 m -41.21 128.29 2.88 Favored 'General case' 0 N--CA 1.509 2.482 0 O-C-N 121.383 -0.823 . . . . 1.3100000000000001 111.909 -179.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 862' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -94.09 152.81 40.67 Favored Pre-proline 0 N--CA 1.491 1.592 0 N-CA-C 108.085 -1.08 . . . . 4.5099999999999998 108.085 177.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -70.14 -12.36 32.03 Favored 'Trans proline' 0 C--N 1.314 -1.248 0 O-C-N 123.086 1.045 . . . . 2.2400000000000002 111.25 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -175.42 -134.92 1.99 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.063 -1.215 . . . . 0.040000000000000001 110.063 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 41.5 m -65.49 156.76 31.49 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.294 -1.121 . . . . 1.51 111.247 -178.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 866' ' ' VAL . . . . . . . . . . . . . 2.7 t -91.96 127.99 47.44 Favored Pre-proline 0 N--CA 1.499 1.995 0 N-CA-C 113.424 0.898 . . . . 0.78000000000000003 113.424 -174.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 867' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -92.01 -155.81 0.05 OUTLIER 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 121.149 1.233 . . . . 0.92000000000000004 109.547 177.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 868' ' ' PHE . . . . . 0.447 ' CD1' ' N ' ' B' ' 868' ' ' PHE . 21.7 p90 -151.56 123.43 8.06 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.636 -1.29 . . . . 0.050000000000000003 110.019 179.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 44.2 p30 -114.46 -0.32 13.79 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.2 -0.938 . . . . 1.7 112.815 -178.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 870' ' ' ARG . . . . . 0.404 ' HB2' ' O ' ' B' ' 855' ' ' ALA . 26.7 mmm180 -91.45 90.16 7.54 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.86 -1.15 . . . . 2.5899999999999999 111.145 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 59.6 t -74.42 97.2 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 120.951 -1.093 . . . . 1.9399999999999999 109.959 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 872' ' ' LEU . . . . . . . . . . . . . 96.2 mt -83.34 -46.67 12.32 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.492 -0.755 . . . . 1.0600000000000001 110.14 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 873' ' ' LEU . . . . . . . . . . . . . 36.9 tp -174.54 102.99 0.1 Allowed 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 108.507 -0.923 . . . . 4.1799999999999997 108.507 178.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 874' ' ' ASN . . . . . . . . . . . . . 35.4 t-20 178.73 81.12 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.337 0 O-C-N 121.63 -0.668 . . . . 0.040000000000000001 109.552 -178.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -66.94 -47.28 72.15 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.127 -0.983 . . . . 3.3799999999999999 111.198 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 876' ' ' GLY . . . . . . . . . . . . . . . -73.56 -24.98 73.6 Favored Glycine 0 N--CA 1.494 2.521 0 O-C-N 121.305 -0.872 . . . . 0.040000000000000001 111.454 -178.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 84.14 -59.78 4.91 Favored Glycine 0 N--CA 1.501 3.001 0 N-CA-C 108.075 -2.01 . . . . 0.040000000000000001 108.075 -178.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 878' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 60.82 -65.73 0.06 Allowed 'General case' 0 N--CA 1.503 2.189 0 N-CA-C 114.226 1.195 . . . . 3.46 114.226 177.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 879' ' ' TYR . . . . . 0.476 ' CB ' ' CD2' ' B' ' 886' ' ' PHE . 21.1 p90 -112.8 109.31 18.7 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 114.769 1.396 . . . . 0.040000000000000001 114.769 -176.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 880' ' ' ASP . . . . . 0.403 ' O ' ' N ' ' B' ' 884' ' ' GLY . 0.7 OUTLIER -66.25 116.72 36.28 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.343 -0.848 . . . . 0.02 109.698 179.799 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 881' ' ' PRO . . . . . 0.43 ' HG2' ' CD1' ' B' ' 868' ' ' PHE . 53.9 Cg_endo -75.53 -0.22 9.88 Favored 'Trans proline' 0 N--CA 1.497 1.709 0 O-C-N 123.47 1.247 . . . . 0.39000000000000001 112.534 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -75.7 -63.55 1.27 Allowed 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 106.716 -1.587 . . . . 0.81000000000000005 106.716 178.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 41.4 p -93.91 -19.9 20.52 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.482 -0.933 . . . . 0.040000000000000001 108.482 177.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 884' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' B' ' 880' ' ' ASP . . . 83.76 21.4 57.85 Favored Glycine 0 N--CA 1.494 2.556 0 O-C-N 121.05 -1.031 . . . . 0.029999999999999999 111.369 178.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 885' ' ' VAL . . . . . . . . . . . . . 98.8 t -73.91 92.14 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 C-N-CA 118.084 -1.446 . . . . 1.01 108.06 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 886' ' ' PHE . . . . . 0.476 ' CD2' ' CB ' ' B' ' 879' ' ' TYR . 0.7 OUTLIER -90.1 104.87 17.4 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 115.119 -0.946 . . . . 0.050000000000000003 112.085 -177.192 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 887' ' ' THR . . . . . 0.421 ' O ' ' HD3' ' B' ' 889' ' ' PRO . 93.9 m -96.41 100.67 12.26 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 107.63 -1.248 . . . . 0.68000000000000005 107.63 177.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 888' ' ' ALA . . . . . . . . . . . . . . . -98.87 105.86 33.91 Favored Pre-proline 0 N--CA 1.502 2.125 0 N-CA-C 114.267 1.21 . . . . 0.25 114.267 -176.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 889' ' ' PRO . . . . . 0.421 ' HD3' ' O ' ' B' ' 887' ' ' THR . 54.1 Cg_endo -88.9 -13.44 3.14 Favored 'Trans proline' 0 CA--C 1.546 1.118 0 N-CA-C 108.982 -1.199 . . . . 1.6399999999999999 108.982 175.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 890' ' ' LEU . . . . . . . . . . . . . 69.7 mt -36.39 -50.09 0.75 Allowed 'General case' 0 N--CA 1.508 2.457 0 N-CA-C 113.612 0.967 . . . . 2.29 113.612 -177.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 52.1 95.95 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.259 0 O-C-N 121.135 -0.978 . . . . 0.63 110.25 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . 158.05 -153.72 24.88 Favored Glycine 0 N--CA 1.478 1.496 0 N-CA-C 107.18 -2.368 . . . . 0.040000000000000001 107.18 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 72.8 ttt-85 -115.61 126.41 54.15 Favored 'General case' 0 C--N 1.295 -1.778 0 O-C-N 121.581 -0.952 . . . . 3.0 108.529 177.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 894' ' ' TYR . . . . . 0.415 ' CD2' HD22 ' B' ' 954' ' ' LEU . 0.1 OUTLIER -132.17 160.19 36.78 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.182 -0.949 . . . . 0.040000000000000001 111.041 -179.754 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 895' ' ' LEU . . . . . . . . . . . . . 37.9 tp -92.1 118.49 30.86 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.654 -0.654 . . . . 1.27 110.141 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 896' ' ' LEU . . . . . 0.414 ' HB2' ' CZ ' ' B' ' 894' ' ' TYR . 9.2 tt -110.0 141.59 42.58 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.761 -0.587 . . . . 0.93999999999999995 110.106 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 897' ' ' SER . . . . . . . . . . . . . 64.4 m -148.35 115.26 6.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.478 -0.764 . . . . 0.040000000000000001 111.032 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.26 146.07 31.93 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.989 -0.745 . . . . 0.47999999999999998 108.989 178.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 899' ' ' VAL . . . . . 0.402 ' CG2' ' HB ' ' B' ' 980' ' ' ILE . 88.0 t -94.64 120.15 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 C-N-CA 119.653 -0.819 . . . . 0.55000000000000004 111.138 -179.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 900' ' ' LEU . . . . . 0.443 ' N ' ' CD2' ' B' ' 900' ' ' LEU . 4.3 mm? -95.02 112.45 24.16 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 114.457 1.281 . . . . 1.5900000000000001 114.457 -174.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 15.3 m -66.58 141.44 57.84 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 107.319 -1.363 . . . . 0.050000000000000003 107.319 176.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -67.24 -65.84 2.6 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 110.608 -0.997 . . . . 0.029999999999999999 110.608 -179.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 8.8 m170 46.73 66.76 0.9 Allowed 'General case' 0 N--CA 1.508 2.453 0 O-C-N 121.492 -1.005 . . . . 3.2000000000000002 111.155 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 43.1 ptt85 -69.32 -6.28 28.58 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.62 -0.675 . . . . 2.9199999999999999 112.084 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 905' ' ' HIS . . . . . 0.485 ' O ' ' CB ' ' B' ' 906' ' ' GLU . 72.6 t60 -61.66 4.47 0.11 Allowed 'General case' 0 N--CA 1.505 2.324 0 O-C-N 120.929 -1.107 . . . . 2.8700000000000001 113.198 -179.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 906' ' ' GLU . . . . . 0.485 ' CB ' ' O ' ' B' ' 905' ' ' HIS . 0.5 OUTLIER 94.96 -164.44 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.439 0 CA-C-N 120.561 1.528 . . . . 0.98999999999999999 111.668 179.063 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 907' ' ' LYS . . . . . 0.472 ' CB ' ' O ' ' B' ' 906' ' ' GLU . 63.2 tttt 85.75 156.3 0.08 Allowed 'General case' 0 N--CA 1.52 3.035 0 N-CA-C 108.095 -1.076 . . . . 5.25 108.095 -176.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 59.2 t -121.81 116.18 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 120.814 -1.179 . . . . 0.39000000000000001 111.152 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -99.57 133.42 43.93 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 107.274 -1.38 . . . . 1.72 107.274 176.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -156.21 122.08 4.95 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 106.879 -1.526 . . . . 0.67000000000000004 106.879 178.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 911' ' ' VAL . . . . . 0.459 ' HA ' ' HA ' ' B' ' 964' ' ' VAL . 87.0 t -84.27 132.38 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.842 -0.536 . . . . 0.54000000000000004 110.813 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 63.0 mt -65.72 156.75 32.07 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.333 -0.854 . . . . 1.5 108.946 178.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 913' ' ' SER . . . . . 0.408 ' CB ' ' CG1' ' B' ' 919' ' ' VAL . 1.4 t -123.57 137.48 54.74 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.393 -0.965 . . . . 1.3700000000000001 108.393 177.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 914' ' ' ARG . . . . . 0.419 ' O ' ' CB ' ' B' ' 915' ' ' SER . 0.0 OUTLIER -64.12 154.64 33.99 Favored 'General case' 0 N--CA 1.505 2.311 0 O-C-N 120.77 -1.206 . . . . 4.2999999999999998 111.888 -178.988 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 915' ' ' SER . . . . . 0.419 ' CB ' ' O ' ' B' ' 914' ' ' ARG . 4.7 t 83.2 -33.0 0.08 Allowed 'General case' 0 N--CA 1.521 3.114 0 C-N-CA 124.017 0.927 . . . . 2.0499999999999998 112.272 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 916' ' ' ASN . . . . . 0.402 ' O ' ' HB2' ' B' ' 917' ' ' GLN . 92.4 m-20 -120.74 -20.76 6.89 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 120.909 -1.119 . . . . 2.71 111.46 -179.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 917' ' ' GLN . . . . . 0.402 ' HB2' ' O ' ' B' ' 916' ' ' ASN . 41.8 mt-30 66.83 164.46 0.2 Allowed 'General case' 0 N--CA 1.521 3.116 0 N-CA-C 105.472 -2.047 . . . . 2.6800000000000002 105.472 -173.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 55.09 -125.5 35.99 Favored Glycine 1 N--CA 1.521 4.349 0 CA-C-N 123.567 2.894 . . . . 0.029999999999999999 106.8 -177.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 919' ' ' VAL . . . . . 0.408 ' CG1' ' CB ' ' B' ' 913' ' ' SER . 82.3 t 51.39 95.05 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.253 0 O-C-N 121.476 -1.014 . . . . 1.3899999999999999 109.062 -178.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.51 92.16 8.39 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.31 -0.956 . . . . 0.029999999999999999 110.844 -179.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 921' ' ' ARG . . . . . 0.423 ' HB2' ' CE1' ' B' ' 950' ' ' PHE . 27.5 ptt180 -83.96 -41.73 17.01 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 105.738 -1.949 . . . . 4.4199999999999999 105.738 175.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 922' ' ' VAL . . . . . . . . . . . . . 77.9 t -102.16 73.14 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 N-CA-C 106.375 -1.713 . . . . 0.84999999999999998 106.375 175.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -86.49 133.76 33.72 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.637 0.732 . . . . 2.46 111.241 -177.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 924' ' ' SER . . . . . . . . . . . . . 27.8 t -147.83 105.77 3.72 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 108.974 -0.75 . . . . 0.69999999999999996 108.974 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -102.69 83.57 0.45 Allowed Glycine 0 N--CA 1.486 1.968 0 N-CA-C 108.37 -1.892 . . . . 0.040000000000000001 108.37 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.156 0 N-CA-C 108.661 -1.776 . . . . 0.040000000000000001 108.661 -179.72 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 32.7 m . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.078 0.466 . . . . 13.779999999999999 110.162 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 96.2 mt -111.03 129.4 55.92 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.581 -0.699 . . . . 13.76 110.325 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -151.73 166.76 30.89 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.114 -1.594 . . . . 9.1300000000000008 109.114 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 949' ' ' VAL . . . . . . . . . . . . . 35.5 m -118.81 130.24 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.519 -0.989 . . . . 7.0800000000000001 110.967 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 950' ' ' PHE . . . . . 0.428 ' CE1' ' HD2' ' B' ' 955' ' ' PRO . 25.5 p90 -133.03 150.41 52.13 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.546 -0.721 . . . . 7.5899999999999999 109.162 179.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 19.5 m -120.67 -52.76 2.11 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.367 -0.833 . . . . 5.0300000000000002 112.252 -178.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 952' ' ' LEU . . . . . 0.418 ' O ' ' O ' ' B' ' 953' ' ' ILE . 13.6 tp -60.62 -73.22 0.09 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.365 -0.835 . . . . 1.01 112.382 -177.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 953' ' ' ILE . . . . . 0.478 ' O ' ' HB3' ' B' ' 954' ' ' LEU . 46.0 pt -52.26 -144.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.779 0 N-CA-C 114.177 1.177 . . . . 2.6000000000000001 114.177 -176.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 954' ' ' LEU . . . . . 0.538 ' N ' ' CD1' ' B' ' 954' ' ' LEU . 0.0 OUTLIER 171.64 77.23 0.04 OUTLIER Pre-proline 0 N--CA 1.51 2.526 0 O-C-N 120.808 -1.183 . . . . 0.050000000000000003 111.39 179.478 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 955' ' ' PRO . . . . . 0.428 ' HD2' ' CE1' ' B' ' 950' ' ' PHE . 48.2 Cg_endo -74.89 96.54 1.02 Allowed 'Trans proline' 0 C--N 1.313 -1.295 0 N-CA-C 109.481 -1.007 . . . . 0.83999999999999997 109.481 178.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 956' ' ' LEU . . . . . 0.41 ' CD2' ' NH1' ' B' ' 914' ' ' ARG . 10.4 mp -123.11 145.62 48.42 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.125 -0.984 . . . . 0.040000000000000001 110.166 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 16.1 mt-30 -83.58 150.66 25.8 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 117.866 -1.064 . . . . 1.28 111.645 -179.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -70.5 119.62 14.93 Favored 'General case' 0 N--CA 1.51 2.545 0 CA-C-N 122.845 2.566 . . . . 0.17000000000000001 111.579 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.74 -22.98 30.72 Favored Glycine 0 N--CA 1.501 3.021 0 N-CA-C 111.111 -0.796 . . . . 0.040000000000000001 111.111 178.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 960' ' ' ASP . . . . . 0.405 ' HB3' ' NE ' ' B' ' 914' ' ' ARG . 0.6 OUTLIER -51.86 172.15 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.53 -0.982 . . . . 0.040000000000000001 110.358 -179.403 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 961' ' ' THR . . . . . 0.456 ' HA ' ' O ' ' B' ' 886' ' ' PHE . 7.1 t -134.73 134.71 41.3 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.986 -1.071 . . . . 1.78 111.855 -178.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 962' ' ' VAL . . . . . 0.436 ' CG2' ' CB ' ' B' ' 886' ' ' PHE . 31.1 m -99.17 145.8 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 C-N-CA 120.072 -0.651 . . . . 0.040000000000000001 110.453 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 5.3 t -138.79 145.23 39.88 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.861 -0.524 . . . . 0.71999999999999997 110.191 -178.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 964' ' ' VAL . . . . . 0.459 ' HA ' ' HA ' ' B' ' 911' ' ' VAL . 55.2 t -94.24 136.32 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.11 -0.994 . . . . 1.05 110.717 -179.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -95.72 126.37 40.94 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 103.755 -2.683 . . . . 3.02 103.755 173.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 966' ' ' LEU . . . . . 0.412 ' O ' ' CG2' ' B' ' 967' ' ' VAL . 20.8 tp -132.23 62.52 1.64 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.35 -0.981 . . . . 1.46 108.35 177.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 967' ' ' VAL . . . . . 0.412 ' CG2' ' O ' ' B' ' 966' ' ' LEU . 89.8 t -158.42 97.01 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 N-CA-C 108.095 -1.076 . . . . 1.9399999999999999 108.095 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 88.7 mmm -142.77 59.19 1.43 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.765 -1.21 . . . . 0.0 108.281 178.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.53 119.69 1.93 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 107.0 -2.44 . . . . 2.1099999999999999 107.0 -178.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -81.22 -57.86 3.32 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.063 -1.257 . . . . 5.8899999999999997 110.435 -179.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 44.2 tp -58.91 90.37 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.465 -0.772 . . . . 4.3600000000000003 110.223 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -141.27 -154.91 0.54 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.575 -0.703 . . . . 1.8300000000000001 110.304 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -119.86 172.1 7.95 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.464 -0.773 . . . . 4.3499999999999996 110.38 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 29.5 t -101.52 130.29 47.77 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.565 -0.709 . . . . 1.27 110.145 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -156.41 158.35 37.18 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.504 -0.747 . . . . 5.0199999999999996 110.553 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.7 86.32 16.0 Favored Pre-proline 0 N--CA 1.5 2.06 0 O-C-N 121.614 -0.679 . . . . 2.4100000000000001 109.7 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -73.12 -172.83 1.09 Allowed 'Trans proline' 0 C--N 1.317 -1.123 0 O-C-N 123.344 1.181 . . . . 0.95999999999999996 111.514 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 978' ' ' LEU . . . . . . . . . . . . . 5.2 mp -127.81 154.91 44.88 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.644 -1.243 . . . . 0.62 107.644 178.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 979' ' ' THR . . . . . . . . . . . . . 33.7 p -150.51 142.16 23.62 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.81 -1.181 . . . . 3.5699999999999998 111.384 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 980' ' ' ILE . . . . . 0.402 ' HB ' ' CG2' ' B' ' 899' ' ' VAL . 47.0 mm -106.49 127.06 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 108.765 -0.828 . . . . 1.3300000000000001 108.765 179.226 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -119.27 97.64 5.76 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.458 -0.776 . . . . 0.050000000000000003 111.767 -178.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 77.8 p -109.02 159.0 17.19 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.544 -0.722 . . . . 0.87 109.428 178.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 983' ' ' GLY . . . . . 0.418 ' HA3' ' CE1' ' B' ' 852' ' ' PHE . . . -175.01 107.77 0.25 Allowed Glycine 0 N--CA 1.499 2.869 0 N-CA-C 106.53 -2.628 . . . . 0.029999999999999999 106.53 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -108.62 152.33 24.93 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 114.44 1.274 . . . . 0.69999999999999996 114.44 -175.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 985' ' ' LEU . . . . . . . . . . . . . 53.3 tp -71.26 134.03 46.52 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.9 -1.125 . . . . 0.040000000000000001 110.108 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 986' ' ' LEU . . . . . . . . . . . . . 45.8 tp -107.62 -56.17 2.26 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.591 -0.693 . . . . 0.040000000000000001 109.923 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -145.34 145.05 31.05 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 107.737 -1.208 . . . . 0.040000000000000001 107.737 178.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.92 163.02 12.18 Favored Glycine 0 N--CA 1.496 2.653 0 N-CA-C 108.21 -1.956 . . . . 0.040000000000000001 108.21 179.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -75.13 112.76 19.73 Favored Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 121.165 -1.197 . . . . 0.040000000000000001 109.535 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 990' ' ' PRO . . . . . 0.407 ' O ' ' HB2' ' B' ' 991' ' ' GLU . 50.9 Cg_endo -90.18 70.95 1.56 Allowed 'Trans proline' 0 C--N 1.319 -0.985 0 O-C-N 123.13 1.068 . . . . 0.45000000000000001 111.423 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 991' ' ' GLU . . . . . 0.407 ' HB2' ' O ' ' B' ' 990' ' ' PRO . 70.6 mt-10 67.25 -73.57 0.08 Allowed 'General case' 0 N--CA 1.503 2.207 0 N-CA-C 108.6 -0.889 . . . . 1.97 108.6 -177.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 992' ' ' LEU . . . . . . . . . . . . . 10.9 mt 51.22 20.31 0.88 Allowed 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.551 -0.718 . . . . 2.3799999999999999 111.621 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 83.6 mt-10 -93.73 156.95 16.4 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.86 -1.15 . . . . 3.79 110.104 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 72.1 m80 -146.67 92.73 2.19 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.534 -0.729 . . . . 3.5099999999999998 110.395 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 995' ' ' ALA . . . . . . . . . . . . 2.517 . . . . . . . 0 N--CA 1.503 2.222 0 O-C-N 120.953 -1.092 . . . . 2.73 110.639 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo . . . . . 0 N--CA 1.488 1.174 0 N-CA-C 109.488 -1.005 . . . . 3.8300000000000001 109.488 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' 847' ' ' VAL . . . . . . . . . . . . . 57.7 t -130.31 103.28 16.67 Favored Pre-proline 0 N--CA 1.496 1.869 0 O-C-N 121.604 -0.685 . . . . 1.8300000000000001 110.133 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 848' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.49 -21.29 30.32 Favored 'Trans proline' 0 N--CA 1.488 1.182 0 O-C-N 123.277 1.146 . . . . 0.65000000000000002 111.269 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 849' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 27.5 69.97 0.06 Allowed 'General case' 0 N--CA 1.519 3.024 0 N-CA-C 112.826 0.676 . . . . 2.5800000000000001 112.826 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 850' ' ' VAL . . . . . . . . . . . . . 61.2 t -119.93 134.57 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.234 -0.916 . . . . 1.0900000000000001 111.648 -178.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 851' ' ' ALA . . . . . . . . . . . . . . . -127.46 155.32 43.88 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 105.772 -1.936 . . . . 0.040000000000000001 105.772 176.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 852' ' ' PHE . . . . . 0.455 ' CD1' ' N ' ' C' ' 852' ' ' PHE . 13.2 p90 -159.96 127.56 4.65 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 121.049 1.75 . . . . 0.050000000000000003 108.557 178.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 29.4 t -176.72 134.13 0.21 Allowed 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.105 -1.072 . . . . 0.040000000000000001 108.105 -179.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -131.13 156.32 45.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.169 -0.957 . . . . 0.67000000000000004 109.642 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 855' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' C' ' 870' ' ' ARG . . . -121.54 141.54 50.96 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.891 0.853 . . . . 0.51000000000000001 111.107 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 856' ' ' LEU . . . . . 0.418 HD21 ' CG1' ' C' ' 866' ' ' VAL . 3.5 tm? -114.53 137.59 51.67 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.402 -0.811 . . . . 0.050000000000000003 110.171 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 857' ' ' SER . . . . . 0.431 ' O ' ' O ' ' C' ' 858' ' ' LEU . 1.9 m -153.8 19.38 0.52 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.52 -0.737 . . . . 1.3300000000000001 110.866 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 858' ' ' LEU . . . . . 0.431 ' O ' ' O ' ' C' ' 857' ' ' SER . 1.4 pp -34.06 160.9 0.04 OUTLIER Pre-proline 0 N--CA 1.516 2.853 0 N-CA-C 113.189 0.811 . . . . 2.3300000000000001 113.189 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -61.6 -88.2 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 120.816 1.011 . . . . 2.3199999999999998 113.306 -178.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 54.6 ptt85 -131.04 -142.33 0.23 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 120.873 -1.142 . . . . 0.040000000000000001 111.435 -177.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 74.5 m -38.42 130.23 1.32 Allowed 'General case' 0 N--CA 1.511 2.589 0 O-C-N 121.563 -0.71 . . . . 1.3100000000000001 112.172 -178.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -102.99 158.79 31.06 Favored Pre-proline 0 N--CA 1.488 1.436 0 N-CA-C 108.237 -1.023 . . . . 4.5099999999999998 108.237 177.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.18 -13.75 33.97 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 O-C-N 123.203 1.107 . . . . 2.2400000000000002 110.829 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -176.7 -136.03 2.31 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.08 -1.608 . . . . 0.040000000000000001 109.08 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 24.7 m -68.83 155.59 39.93 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.27 -1.135 . . . . 1.51 110.164 -179.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 866' ' ' VAL . . . . . 0.418 ' CG1' HD21 ' C' ' 856' ' ' LEU . 60.2 t -99.88 138.05 20.27 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.466 -0.771 . . . . 0.78000000000000003 113.048 -175.003 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 867' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -90.4 -147.05 0.03 OUTLIER 'Trans proline' 0 CA--C 1.546 1.086 0 O-C-N 123.533 1.28 . . . . 0.92000000000000004 109.234 178.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 868' ' ' PHE . . . . . 0.415 ' CE1' ' HD2' ' C' ' 881' ' ' PRO . 24.5 p90 -149.29 125.37 10.68 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.487 -1.383 . . . . 0.050000000000000003 110.032 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 50.9 p-10 -112.46 -2.82 14.59 Favored 'General case' 0 N--CA 1.499 2.013 0 C-N-CA 119.295 -0.962 . . . . 1.7 112.744 -178.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 870' ' ' ARG . . . . . 0.446 ' HB2' ' O ' ' C' ' 855' ' ' ALA . 25.8 mmm180 -91.41 88.84 6.99 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 120.849 -1.157 . . . . 2.5899999999999999 111.112 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 63.1 t -72.86 97.34 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 120.902 -1.123 . . . . 1.9399999999999999 109.288 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 872' ' ' LEU . . . . . . . . . . . . . 72.9 mt -86.48 -45.94 10.66 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.537 -0.727 . . . . 1.0600000000000001 110.561 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 873' ' ' LEU . . . . . 0.407 ' O ' ' HB2' ' C' ' 874' ' ' ASN . 36.8 tp -173.09 102.5 0.13 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.208 -0.932 . . . . 4.1799999999999997 108.715 178.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 874' ' ' ASN . . . . . 0.407 ' HB2' ' O ' ' C' ' 873' ' ' LEU . 35.5 t-20 177.49 82.46 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.231 0 N-CA-C 108.827 -0.805 . . . . 0.040000000000000001 108.827 -178.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -65.05 -46.68 80.23 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.194 -0.941 . . . . 3.3799999999999999 111.521 -178.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 876' ' ' GLY . . . . . 0.42 ' HA3' ' CE2' ' C' ' 878' ' ' TYR . . . -73.01 -26.56 70.7 Favored Glycine 0 N--CA 1.493 2.474 0 O-C-N 121.243 -0.91 . . . . 0.040000000000000001 111.748 -178.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 80.34 -62.38 4.3 Favored Glycine 0 N--CA 1.501 3.007 0 N-CA-C 107.911 -2.075 . . . . 0.040000000000000001 107.911 -178.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 878' ' ' TYR . . . . . 0.42 ' CE2' ' HA3' ' C' ' 876' ' ' GLY . 93.2 m-85 60.61 -65.73 0.05 Allowed 'General case' 0 N--CA 1.503 2.22 0 N-CA-C 114.404 1.261 . . . . 3.46 114.404 177.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 879' ' ' TYR . . . . . 0.505 ' CE2' ' CD1' ' C' ' 981' ' ' PHE . 28.8 p90 -110.27 106.83 16.38 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 114.826 1.417 . . . . 0.040000000000000001 114.826 -176.131 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 880' ' ' ASP . . . . . 0.422 ' O ' ' N ' ' C' ' 884' ' ' GLY . 1.2 t0 -73.75 117.19 58.99 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.489 -0.757 . . . . 0.02 109.806 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 881' ' ' PRO . . . . . 0.415 ' HD2' ' CE1' ' C' ' 868' ' ' PHE . 54.2 Cg_endo -77.07 1.07 9.07 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 O-C-N 123.34 1.179 . . . . 0.39000000000000001 112.351 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 71.5 mt-10 -73.55 -53.61 10.13 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 105.733 -1.951 . . . . 0.81000000000000005 105.733 177.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 14.7 p -99.7 -21.0 16.0 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 115.068 -0.969 . . . . 0.040000000000000001 108.841 177.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 884' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' C' ' 880' ' ' ASP . . . 81.93 15.76 74.25 Favored Glycine 0 N--CA 1.496 2.672 0 N-CA-C 110.434 -1.066 . . . . 0.029999999999999999 110.434 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 58.5 t -74.87 91.94 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 C-N-CA 118.422 -1.311 . . . . 1.01 108.584 -178.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 886' ' ' PHE . . . . . 0.488 ' O ' ' HA ' ' C' ' 961' ' ' THR . 1.0 OUTLIER -88.04 106.18 17.97 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 115.173 -0.921 . . . . 0.050000000000000003 111.531 -177.696 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 887' ' ' THR . . . . . 0.41 ' O ' ' HD3' ' C' ' 889' ' ' PRO . 88.3 m -101.46 99.79 10.16 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.669 -1.234 . . . . 0.68000000000000005 107.669 177.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 888' ' ' ALA . . . . . . . . . . . . . . . -98.45 102.0 13.21 Favored Pre-proline 0 N--CA 1.5 2.061 0 N-CA-C 114.375 1.25 . . . . 0.25 114.375 -176.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 889' ' ' PRO . . . . . 0.41 ' HD3' ' O ' ' C' ' 887' ' ' THR . 55.6 Cg_endo -81.45 -15.27 10.01 Favored 'Trans proline' 0 CA--C 1.544 1.014 0 N-CA-C 108.632 -1.334 . . . . 1.6399999999999999 108.632 175.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 890' ' ' LEU . . . . . . . . . . . . . 67.6 mt -37.27 -49.36 0.94 Allowed 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 113.394 0.887 . . . . 2.29 113.394 -177.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 52.4 96.99 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.241 0 O-C-N 121.268 -0.895 . . . . 0.63 110.196 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . 159.28 -153.64 24.72 Favored Glycine 0 N--CA 1.477 1.411 0 N-CA-C 107.45 -2.26 . . . . 0.040000000000000001 107.45 -179.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 76.0 ttt-85 -117.62 123.1 45.34 Favored 'General case' 0 C--N 1.293 -1.877 0 O-C-N 121.715 -0.874 . . . . 3.0 108.872 178.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 894' ' ' TYR . . . . . 0.447 ' CD2' HD22 ' C' ' 954' ' ' LEU . 13.6 p90 -132.89 155.91 48.17 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.024 -1.047 . . . . 0.040000000000000001 111.193 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 895' ' ' LEU . . . . . . . . . . . . . 46.0 tp -98.58 111.65 23.94 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.694 -0.629 . . . . 1.27 109.87 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 896' ' ' LEU . . . . . . . . . . . . . 10.1 tt -115.66 144.91 43.25 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.618 -0.676 . . . . 0.93999999999999995 109.926 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 897' ' ' SER . . . . . . . . . . . . . 43.3 m -142.03 124.87 16.05 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.393 -0.817 . . . . 0.040000000000000001 111.477 -179.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -101.22 148.13 25.46 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.759 -0.83 . . . . 0.47999999999999998 108.759 178.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 899' ' ' VAL . . . . . . . . . . . . . 84.7 t -92.42 120.79 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.321 -0.862 . . . . 0.55000000000000004 111.23 -179.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 91.6 mt -92.15 113.45 25.73 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 114.006 1.113 . . . . 1.5900000000000001 114.006 -175.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 21.7 m -62.7 140.9 58.74 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 107.527 -1.286 . . . . 0.050000000000000003 107.527 177.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -60.91 -65.37 3.36 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.238 -1.145 . . . . 0.029999999999999999 110.238 -179.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 6.5 m170 46.1 65.62 1.13 Allowed 'General case' 0 N--CA 1.506 2.363 0 O-C-N 121.518 -0.989 . . . . 3.2000000000000002 111.235 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -66.86 -8.28 27.86 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.623 -0.673 . . . . 2.9199999999999999 111.819 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 905' ' ' HIS . . . . . 0.474 ' O ' ' CB ' ' C' ' 906' ' ' GLU . 72.6 t60 -62.94 4.87 0.15 Allowed 'General case' 0 N--CA 1.503 2.215 0 O-C-N 120.915 -1.116 . . . . 2.8700000000000001 112.679 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 906' ' ' GLU . . . . . 0.498 ' O ' ' CB ' ' C' ' 907' ' ' LYS . 2.0 mt-10 89.73 -153.99 0.01 OUTLIER 'General case' 0 N--CA 1.526 3.329 0 CA-C-N 121.136 1.789 . . . . 0.98999999999999999 111.567 179.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 907' ' ' LYS . . . . . 0.498 ' CB ' ' O ' ' C' ' 906' ' ' GLU . 56.5 tttt 88.84 162.85 0.06 Allowed 'General case' 0 N--CA 1.52 3.066 0 N-CA-C 107.759 -1.2 . . . . 5.25 107.759 -176.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 59.7 t -122.7 114.59 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 120.778 -1.202 . . . . 0.39000000000000001 110.781 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -105.79 131.19 53.43 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 107.557 -1.275 . . . . 1.72 107.557 177.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -156.73 120.44 4.27 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 106.943 -1.503 . . . . 0.67000000000000004 106.943 178.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 911' ' ' VAL . . . . . 0.466 ' HA ' ' HA ' ' C' ' 964' ' ' VAL . 12.8 p -80.08 131.57 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 C-N-CA 120.306 -0.558 . . . . 0.54000000000000004 111.321 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 62.4 mt -66.23 156.72 33.4 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.258 -0.901 . . . . 1.5 108.885 178.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 913' ' ' SER . . . . . 0.418 ' CB ' ' CG1' ' C' ' 919' ' ' VAL . 1.7 t -126.19 136.93 53.44 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.377 -0.971 . . . . 1.3700000000000001 108.377 177.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 914' ' ' ARG . . . . . 0.425 ' O ' ' CB ' ' C' ' 915' ' ' SER . 0.0 OUTLIER -63.67 154.0 34.38 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 120.707 -1.246 . . . . 4.2999999999999998 111.708 -178.783 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 915' ' ' SER . . . . . 0.425 ' CB ' ' O ' ' C' ' 914' ' ' ARG . 2.4 t 83.28 -30.61 0.09 Allowed 'General case' 0 N--CA 1.521 3.119 0 C-N-CA 123.808 0.843 . . . . 2.0499999999999998 112.384 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 916' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -122.19 -21.74 5.8 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.868 -1.145 . . . . 2.71 111.362 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 67.36 166.11 0.23 Allowed 'General case' 0 N--CA 1.521 3.082 0 N-CA-C 105.491 -2.04 . . . . 2.6800000000000002 105.491 -173.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.27 -125.18 33.13 Favored Glycine 1 N--CA 1.521 4.362 0 CA-C-N 123.773 2.988 . . . . 0.029999999999999999 107.08 -177.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 919' ' ' VAL . . . . . 0.418 ' CG1' ' CB ' ' C' ' 913' ' ' SER . 96.7 t 49.83 94.06 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.266 0 O-C-N 121.543 -0.975 . . . . 1.3899999999999999 109.334 -178.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 920' ' ' ALA . . . . . . . . . . . . . . . -94.74 95.48 8.75 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.469 -0.892 . . . . 0.029999999999999999 110.886 -179.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 921' ' ' ARG . . . . . 0.434 ' HB3' ' CZ ' ' C' ' 950' ' ' PHE . 42.8 ptt85 -79.9 -42.05 24.92 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 105.538 -2.023 . . . . 4.4199999999999999 105.538 176.015 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 922' ' ' VAL . . . . . . . . . . . . . 84.6 t -99.89 76.8 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 N-CA-C 105.545 -2.02 . . . . 0.84999999999999998 105.545 175.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -90.61 136.7 32.9 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 122.005 0.907 . . . . 2.46 112.794 -176.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 5.1 t -146.99 103.36 3.6 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.619 -1.252 . . . . 0.69999999999999996 107.619 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -109.21 83.83 0.34 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.485 -1.446 . . . . 0.040000000000000001 109.485 -179.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.361 0 N-CA-C 109.172 -1.571 . . . . 0.040000000000000001 109.172 -179.997 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 22.7 m . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 120.997 0.427 . . . . 13.779999999999999 110.303 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 95.2 mt -112.87 129.89 56.3 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.518 -0.739 . . . . 13.76 110.453 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -151.77 169.89 31.21 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.212 -1.555 . . . . 9.1300000000000008 109.212 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 949' ' ' VAL . . . . . . . . . . . . . 34.1 m -118.04 135.73 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.519 -0.989 . . . . 7.0800000000000001 111.034 -179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 950' ' ' PHE . . . . . 0.434 ' CZ ' ' HB3' ' C' ' 921' ' ' ARG . 51.7 p90 -135.06 152.47 51.71 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.555 -0.716 . . . . 7.5899999999999999 109.379 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 7.6 t -119.05 -55.09 2.19 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.386 -0.822 . . . . 5.0300000000000002 111.852 -179.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 952' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' C' ' 953' ' ' ILE . 58.9 tp -62.71 -77.07 0.05 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.433 -0.792 . . . . 1.01 111.472 -178.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 953' ' ' ILE . . . . . 0.473 ' O ' ' HB3' ' C' ' 954' ' ' LEU . 2.1 pp -49.12 -151.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.688 0 N-CA-C 114.615 1.339 . . . . 2.6000000000000001 114.615 -176.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 954' ' ' LEU . . . . . 0.566 ' N ' ' CD1' ' C' ' 954' ' ' LEU . 0.0 OUTLIER 170.02 89.45 0.04 OUTLIER Pre-proline 0 N--CA 1.516 2.85 0 O-C-N 120.78 -1.2 . . . . 0.050000000000000003 112.068 -179.497 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 955' ' ' PRO . . . . . 0.419 ' HD2' ' CZ ' ' C' ' 950' ' ' PHE . 50.0 Cg_endo -83.66 94.65 0.78 Allowed 'Trans proline' 0 C--N 1.315 -1.196 0 N-CA-C 109.506 -0.998 . . . . 0.83999999999999997 109.506 178.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 956' ' ' LEU . . . . . 0.405 ' CD2' ' CZ ' ' C' ' 914' ' ' ARG . 6.6 mp -125.64 150.84 47.24 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.024 -1.047 . . . . 0.040000000000000001 110.622 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -81.89 151.5 27.25 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-O 117.66 -1.162 . . . . 1.28 111.323 -178.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -66.41 118.43 10.04 Favored 'General case' 0 N--CA 1.507 2.393 0 CA-C-N 123.202 2.728 . . . . 0.17000000000000001 110.874 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.54 -19.75 48.72 Favored Glycine 0 N--CA 1.499 2.897 0 N-CA-C 111.067 -0.813 . . . . 0.040000000000000001 111.067 178.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 960' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -52.32 171.91 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.344 -1.092 . . . . 0.040000000000000001 110.505 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 961' ' ' THR . . . . . 0.488 ' HA ' ' O ' ' C' ' 886' ' ' PHE . 26.3 m -136.93 140.38 42.23 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.043 -1.035 . . . . 1.78 112.614 -177.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 962' ' ' VAL . . . . . 0.406 ' CG2' ' CB ' ' C' ' 886' ' ' PHE . 26.8 m -101.07 145.47 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 C-N-CA 120.302 -0.559 . . . . 0.040000000000000001 110.809 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 6.2 t -137.99 144.44 41.13 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.815 -0.553 . . . . 0.71999999999999997 109.858 -179.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 964' ' ' VAL . . . . . 0.466 ' HA ' ' HA ' ' C' ' 911' ' ' VAL . 61.8 t -90.79 137.67 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.043 -1.036 . . . . 1.05 110.713 -178.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -92.67 125.17 37.17 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 103.289 -2.856 . . . . 3.02 103.289 173.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 966' ' ' LEU . . . . . 0.414 ' O ' ' CG2' ' C' ' 967' ' ' VAL . 0.2 OUTLIER -133.68 57.46 1.81 Allowed 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.635 -0.876 . . . . 1.46 108.635 177.76 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 967' ' ' VAL . . . . . 0.414 ' CG2' ' O ' ' C' ' 966' ' ' LEU . 98.1 t -158.48 96.41 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 N-CA-C 108.277 -1.009 . . . . 1.9399999999999999 108.277 179.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 90.2 mmm -142.74 59.22 1.43 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.759 -1.213 . . . . 0.0 108.459 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 134.44 119.53 1.97 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 107.205 -2.358 . . . . 2.1099999999999999 107.205 -178.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 95.4 mm-40 -82.34 -57.71 3.25 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.082 -1.246 . . . . 5.8899999999999997 110.684 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 41.4 tp -58.87 89.74 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.46 -0.775 . . . . 4.3600000000000003 110.401 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -142.63 -152.69 0.42 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.572 -0.705 . . . . 1.8300000000000001 110.129 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 7.7 t60 -116.74 167.43 11.1 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.384 -0.823 . . . . 4.3499999999999996 110.076 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 41.1 t -102.8 130.69 49.86 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.624 -0.673 . . . . 1.27 110.197 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -156.35 158.55 37.6 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.498 -0.751 . . . . 5.0199999999999996 110.753 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.82 86.1 15.9 Favored Pre-proline 0 N--CA 1.501 2.116 0 O-C-N 121.616 -0.677 . . . . 2.4100000000000001 109.716 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -75.71 -170.17 0.79 Allowed 'Trans proline' 0 C--N 1.318 -1.061 0 O-C-N 123.303 1.159 . . . . 0.95999999999999996 111.453 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 978' ' ' LEU . . . . . . . . . . . . . 5.2 mp -124.97 156.39 38.12 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 107.511 -1.292 . . . . 0.62 107.511 177.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 979' ' ' THR . . . . . . . . . . . . . 39.5 p -149.92 141.47 23.45 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.728 -1.232 . . . . 3.5699999999999998 111.325 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 980' ' ' ILE . . . . . 0.401 HG22 HD11 ' C' ' 980' ' ' ILE . 47.5 mm -106.96 128.48 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 109.122 -0.696 . . . . 1.3300000000000001 109.122 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 981' ' ' PHE . . . . . 0.505 ' CD1' ' CE2' ' C' ' 879' ' ' TYR . 3.2 t80 -117.89 95.44 4.92 Favored 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 119.69 -0.804 . . . . 0.050000000000000003 111.568 -178.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 982' ' ' SER . . . . . . . . . . . . . 12.5 p -107.63 158.27 17.39 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.6 -0.688 . . . . 0.87 109.255 178.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 983' ' ' GLY . . . . . 0.432 ' HA3' ' CE2' ' C' ' 852' ' ' PHE . . . -172.18 114.48 0.53 Allowed Glycine 0 N--CA 1.497 2.704 0 N-CA-C 106.601 -2.6 . . . . 0.029999999999999999 106.601 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 984' ' ' ALA . . . . . 0.4 ' CB ' ' CZ ' ' A' ' 893' ' ' ARG . . . -108.4 150.76 26.94 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 114.259 1.207 . . . . 0.69999999999999996 114.259 -175.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 985' ' ' LEU . . . . . . . . . . . . . 47.9 tp -75.32 135.71 40.88 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.814 -1.179 . . . . 0.040000000000000001 109.609 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 986' ' ' LEU . . . . . . . . . . . . . 45.5 tp -106.23 -63.16 1.29 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.461 -0.774 . . . . 0.040000000000000001 110.329 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -144.28 146.94 32.92 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 107.806 -1.183 . . . . 0.040000000000000001 107.806 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -111.96 162.71 12.33 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 107.99 -2.044 . . . . 0.040000000000000001 107.99 179.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.81 112.73 19.0 Favored Pre-proline 0 N--CA 1.497 1.895 0 O-C-N 121.135 -1.215 . . . . 0.040000000000000001 109.452 179.117 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 990' ' ' PRO . . . . . 0.413 ' O ' ' HB2' ' C' ' 991' ' ' GLU . 50.9 Cg_endo -89.29 71.24 2.01 Favored 'Trans proline' 0 C--N 1.319 -1.017 0 O-C-N 123.109 1.057 . . . . 0.45000000000000001 111.301 -178.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 991' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' C' ' 990' ' ' PRO . 85.7 mt-10 67.11 -73.77 0.07 Allowed 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 108.687 -0.857 . . . . 1.97 108.687 -177.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 992' ' ' LEU . . . . . . . . . . . . . 11.3 mt 50.5 21.3 0.83 Allowed 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.594 -0.691 . . . . 2.3799999999999999 111.553 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -93.35 156.97 16.47 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.936 -1.102 . . . . 3.79 110.144 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 68.6 m80 -146.31 92.48 2.18 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.597 -0.689 . . . . 3.5099999999999998 110.202 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 995' ' ' ALA . . . . . . . . . . . . 2.519 . . . . . . . 0 N--CA 1.503 2.224 0 O-C-N 120.917 -1.115 . . . . 2.73 110.614 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo . . . . . 0 N--CA 1.488 1.157 0 N-CA-C 109.525 -0.991 . . . . 3.8300000000000001 109.525 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 847' ' ' VAL . . . . . . . . . . . . . 62.0 t -134.49 103.26 11.34 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.574 -0.704 . . . . 1.8300000000000001 110.014 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 848' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -69.99 -18.64 35.83 Favored 'Trans proline' 0 N--CA 1.488 1.182 0 O-C-N 123.315 1.166 . . . . 0.65000000000000002 111.303 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 849' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 27.58 68.72 0.07 Allowed 'General case' 0 N--CA 1.518 2.975 0 N-CA-C 112.941 0.719 . . . . 2.5800000000000001 112.941 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 850' ' ' VAL . . . . . 0.418 ' CG1' ' CE2' ' A' ' 878' ' ' TYR . 62.1 t -118.92 135.81 58.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.221 -0.924 . . . . 1.0900000000000001 111.429 -178.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 851' ' ' ALA . . . . . . . . . . . . . . . -126.76 156.95 40.38 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 105.868 -1.901 . . . . 0.040000000000000001 105.868 176.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 852' ' ' PHE . . . . . 0.411 ' CE1' ' HA3' ' A' ' 983' ' ' GLY . 33.7 p90 -158.79 130.18 6.38 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 121.022 1.737 . . . . 0.050000000000000003 108.79 179.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 44.1 t -174.93 134.1 0.34 Allowed 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.125 -1.065 . . . . 0.040000000000000001 108.125 -179.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -134.01 155.92 49.12 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.07 -1.019 . . . . 0.67000000000000004 109.423 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 855' ' ' ALA . . . . . 0.412 ' O ' ' HB2' ' A' ' 870' ' ' ARG . . . -122.15 141.6 51.27 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.758 0.79 . . . . 0.51000000000000001 111.362 -179.032 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 856' ' ' LEU . . . . . 0.426 HD21 ' CG1' ' A' ' 866' ' ' VAL . 3.4 tm? -111.27 137.94 48.36 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.649 -0.657 . . . . 0.050000000000000003 109.939 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 857' ' ' SER . . . . . 0.416 ' O ' ' O ' ' A' ' 858' ' ' LEU . 1.5 m -156.77 16.86 0.31 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.579 -0.701 . . . . 1.3300000000000001 111.587 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 858' ' ' LEU . . . . . 0.416 ' O ' ' O ' ' A' ' 857' ' ' SER . 3.8 pp -35.02 160.35 0.04 OUTLIER Pre-proline 0 N--CA 1.519 2.991 0 N-CA-C 113.006 0.743 . . . . 2.3300000000000001 113.006 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -60.69 -88.64 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 120.87 1.046 . . . . 2.3199999999999998 113.796 -177.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 53.6 ptt85 -128.54 -142.72 0.26 Allowed 'General case' 0 N--CA 1.5 2.075 0 O-C-N 120.859 -1.151 . . . . 0.040000000000000001 111.756 -177.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 15.0 m -38.03 126.76 1.28 Allowed 'General case' 0 N--CA 1.51 2.569 0 O-C-N 121.643 -0.661 . . . . 1.3100000000000001 112.26 -178.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.59 158.99 31.17 Favored Pre-proline 0 N--CA 1.489 1.51 0 N-CA-C 108.423 -0.954 . . . . 4.5099999999999998 108.423 177.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -70.99 -14.55 32.25 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 O-C-N 123.245 1.129 . . . . 2.2400000000000002 111.379 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -177.7 -135.89 2.36 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.515 -1.434 . . . . 0.040000000000000001 109.515 179.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 26.8 m -65.97 156.05 34.75 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.33 -1.1 . . . . 1.51 110.134 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 866' ' ' VAL . . . . . 0.426 ' CG1' HD21 ' A' ' 856' ' ' LEU . 61.5 t -98.85 137.33 20.52 Favored Pre-proline 0 N--CA 1.494 1.736 0 N-CA-C 113.547 0.943 . . . . 0.78000000000000003 113.547 -174.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 867' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -92.41 -149.66 0.03 OUTLIER 'Trans proline' 0 CA--C 1.546 1.124 0 C-N-CA 121.335 1.356 . . . . 0.92000000000000004 109.634 178.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 868' ' ' PHE . . . . . 0.445 ' N ' ' CD1' ' A' ' 868' ' ' PHE . 19.3 p90 -150.7 124.0 8.91 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.679 -1.263 . . . . 0.050000000000000003 109.776 179.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 46.6 p30 -113.48 -2.23 13.95 Favored 'General case' 0 N--CA 1.5 2.062 0 C-N-CA 119.285 -0.966 . . . . 1.7 112.483 -178.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 870' ' ' ARG . . . . . 0.412 ' HB2' ' O ' ' A' ' 855' ' ' ALA . 26.7 mmm180 -90.11 89.29 7.61 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 120.889 -1.132 . . . . 2.5899999999999999 110.598 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 58.5 t -72.82 96.95 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 120.971 -1.081 . . . . 1.9399999999999999 109.91 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 872' ' ' LEU . . . . . . . . . . . . . 97.6 mt -82.84 -47.44 11.87 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.514 -0.741 . . . . 1.0600000000000001 110.177 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 873' ' ' LEU . . . . . . . . . . . . . 46.5 tp -174.99 104.26 0.09 Allowed 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 108.637 -0.875 . . . . 4.1799999999999997 108.637 178.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 874' ' ' ASN . . . . . 0.411 ' CB ' ' HA ' ' A' ' 852' ' ' PHE . 35.5 t-20 178.71 81.6 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.571 -0.706 . . . . 0.040000000000000001 109.802 -179.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -67.28 -48.05 68.81 Favored 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 119.321 -0.951 . . . . 3.3799999999999999 111.118 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 876' ' ' GLY . . . . . . . . . . . . . . . -73.58 -25.29 72.74 Favored Glycine 0 N--CA 1.494 2.529 0 O-C-N 121.284 -0.885 . . . . 0.040000000000000001 111.632 -178.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 82.39 -61.37 4.73 Favored Glycine 0 N--CA 1.502 3.044 0 N-CA-C 108.097 -2.001 . . . . 0.040000000000000001 108.097 -178.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 878' ' ' TYR . . . . . 0.418 ' CE2' ' CG1' ' A' ' 850' ' ' VAL . 95.8 m-85 61.15 -62.97 0.08 Allowed 'General case' 0 N--CA 1.503 2.201 0 N-CA-C 114.35 1.241 . . . . 3.46 114.35 177.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 879' ' ' TYR . . . . . 0.47 ' CB ' ' CD2' ' A' ' 886' ' ' PHE . 18.8 p90 -111.33 108.66 18.33 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 114.489 1.292 . . . . 0.040000000000000001 114.489 -176.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -65.0 114.7 15.94 Favored Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 121.402 -0.811 . . . . 0.02 110.094 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 881' ' ' PRO . . . . . 0.444 ' HG2' ' CD1' ' A' ' 868' ' ' PHE . 53.3 Cg_endo -75.15 -0.94 10.61 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 O-C-N 123.525 1.276 . . . . 0.39000000000000001 112.312 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -76.87 -65.4 0.95 Allowed 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.12 -1.437 . . . . 0.81000000000000005 107.12 178.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 31.6 p -92.25 -18.17 23.78 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.62 -0.882 . . . . 0.040000000000000001 108.62 177.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.22 19.79 60.12 Favored Glycine 0 N--CA 1.497 2.729 0 O-C-N 121.093 -1.005 . . . . 0.029999999999999999 111.554 178.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 885' ' ' VAL . . . . . . . . . . . . . 92.2 t -73.43 91.1 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 C-N-CA 118.089 -1.445 . . . . 1.01 108.137 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 886' ' ' PHE . . . . . 0.47 ' CD2' ' CB ' ' A' ' 879' ' ' TYR . 0.6 OUTLIER -89.73 105.11 17.58 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 115.207 -0.906 . . . . 0.050000000000000003 112.081 -177.443 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 887' ' ' THR . . . . . . . . . . . . . 85.0 m -95.96 100.36 12.04 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 107.711 -1.218 . . . . 0.68000000000000005 107.711 177.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 888' ' ' ALA . . . . . . . . . . . . . . . -98.42 107.43 42.01 Favored Pre-proline 0 N--CA 1.501 2.124 0 N-CA-C 114.094 1.146 . . . . 0.25 114.094 -176.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 889' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -90.19 -12.53 2.71 Favored 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 121.066 1.177 . . . . 1.6399999999999999 109.243 176.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 890' ' ' LEU . . . . . . . . . . . . . 63.6 mt -36.11 -50.52 0.71 Allowed 'General case' 0 N--CA 1.508 2.466 0 N-CA-C 113.856 1.058 . . . . 2.29 113.856 -177.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 51.68 95.84 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.342 0 O-C-N 121.158 -0.964 . . . . 0.63 110.314 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 156.58 -149.66 20.59 Favored Glycine 0 N--CA 1.479 1.562 0 N-CA-C 107.301 -2.32 . . . . 0.040000000000000001 107.301 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 70.7 ttt-85 -112.65 126.64 55.6 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 107.945 -1.131 . . . . 3.0 107.945 177.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 894' ' ' TYR . . . . . 0.424 ' CZ ' ' HB2' ' A' ' 896' ' ' LEU . 0.0 OUTLIER -131.21 155.09 47.67 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.045 -1.035 . . . . 0.040000000000000001 110.69 -179.178 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 895' ' ' LEU . . . . . 0.423 ' N ' ' CD1' ' A' ' 894' ' ' TYR . 34.9 tp -95.29 114.16 25.91 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.665 -0.647 . . . . 1.27 110.067 -179.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 896' ' ' LEU . . . . . 0.424 ' HB2' ' CZ ' ' A' ' 894' ' ' TYR . 9.8 tt -108.62 142.67 38.75 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.718 -0.614 . . . . 0.93999999999999995 110.628 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 897' ' ' SER . . . . . . . . . . . . . 69.9 m -147.41 115.4 6.5 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.516 -0.74 . . . . 0.040000000000000001 110.895 -179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.26 146.76 31.06 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.07 -0.715 . . . . 0.47999999999999998 109.07 179.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 899' ' ' VAL . . . . . . . . . . . . . 87.8 t -96.36 119.7 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 C-N-CA 119.627 -0.829 . . . . 0.55000000000000004 111.377 -179.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 900' ' ' LEU . . . . . 0.407 ' N ' ' CD2' ' A' ' 900' ' ' LEU . 4.5 mm? -94.39 111.53 23.28 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 114.057 1.132 . . . . 1.5900000000000001 114.057 -175.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 21.6 m -65.43 140.8 58.65 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 107.322 -1.362 . . . . 0.050000000000000003 107.322 177.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -64.66 -66.75 2.32 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 110.427 -1.069 . . . . 0.029999999999999999 110.427 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 5.9 m170 46.59 66.81 0.89 Allowed 'General case' 0 N--CA 1.507 2.403 0 O-C-N 121.522 -0.987 . . . . 3.2000000000000002 111.093 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 43.3 ptt85 -69.13 -5.76 24.33 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.542 -0.723 . . . . 2.9199999999999999 112.003 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 905' ' ' HIS . . . . . 0.485 ' O ' ' CB ' ' A' ' 906' ' ' GLU . 74.4 t60 -61.06 3.22 0.1 Allowed 'General case' 0 N--CA 1.506 2.328 0 O-C-N 120.834 -1.166 . . . . 2.8700000000000001 112.891 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 906' ' ' GLU . . . . . 0.485 ' CB ' ' O ' ' A' ' 905' ' ' HIS . 0.8 OUTLIER 93.69 -163.62 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.437 0 CA-C-N 120.513 1.506 . . . . 0.98999999999999999 112.425 178.549 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 907' ' ' LYS . . . . . 0.483 ' CB ' ' O ' ' A' ' 906' ' ' GLU . 51.2 tttt 88.95 161.18 0.06 Allowed 'General case' 0 N--CA 1.519 3.018 0 N-CA-C 107.72 -1.215 . . . . 5.25 107.72 -177.014 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 60.0 t -121.7 116.18 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 120.864 -1.148 . . . . 0.39000000000000001 110.787 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 54.1 tp10 -104.49 132.13 51.09 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 107.523 -1.288 . . . . 1.72 107.523 176.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -156.09 121.63 4.87 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 106.536 -1.653 . . . . 0.67000000000000004 106.536 178.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 911' ' ' VAL . . . . . 0.462 ' HA ' ' HA ' ' A' ' 964' ' ' VAL . 92.9 t -81.65 132.44 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.819 -0.551 . . . . 0.54000000000000004 110.753 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 71.6 mt -65.68 155.91 34.52 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.376 -0.828 . . . . 1.5 108.838 178.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 913' ' ' SER . . . . . 0.407 ' CB ' ' HB ' ' A' ' 919' ' ' VAL . 2.4 t -123.39 137.43 54.82 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.076 -1.083 . . . . 1.3700000000000001 108.076 176.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 914' ' ' ARG . . . . . 0.427 ' O ' ' CB ' ' A' ' 915' ' ' SER . 0.0 OUTLIER -64.28 154.14 36.06 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 120.791 -1.193 . . . . 4.2999999999999998 111.58 -179.001 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 915' ' ' SER . . . . . 0.427 ' CB ' ' O ' ' A' ' 914' ' ' ARG . 4.9 t 83.31 -32.27 0.08 Allowed 'General case' 0 N--CA 1.522 3.126 0 C-N-CA 124.016 0.927 . . . . 2.0499999999999998 112.294 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 916' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -122.37 -21.02 5.92 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 120.908 -1.12 . . . . 2.71 111.429 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 917' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 67.1 166.44 0.22 Allowed 'General case' 0 N--CA 1.521 3.102 0 N-CA-C 105.58 -2.007 . . . . 2.6800000000000002 105.58 -174.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.44 -125.79 35.25 Favored Glycine 1 N--CA 1.521 4.349 0 CA-C-N 123.405 2.82 . . . . 0.029999999999999999 107.001 -177.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 919' ' ' VAL . . . . . 0.407 ' HB ' ' CB ' ' A' ' 913' ' ' SER . 82.0 t 51.95 94.52 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.273 0 O-C-N 121.447 -1.031 . . . . 1.3899999999999999 108.915 -178.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.6 92.37 8.45 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.311 -0.955 . . . . 0.029999999999999999 111.12 -178.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 921' ' ' ARG . . . . . 0.434 ' HB3' ' CZ ' ' A' ' 950' ' ' PHE . 16.7 ptt180 -84.31 -42.25 16.0 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 105.752 -1.944 . . . . 4.4199999999999999 105.752 175.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 922' ' ' VAL . . . . . . . . . . . . . 75.1 t -103.75 69.63 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 N-CA-C 105.608 -1.997 . . . . 0.84999999999999998 105.608 175.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -89.68 136.26 33.14 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.887 0.851 . . . . 2.46 112.238 -176.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 13.2 t -146.48 103.4 3.68 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.922 -1.14 . . . . 0.69999999999999996 107.922 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -110.79 89.57 0.55 Allowed Glycine 0 N--CA 1.488 2.106 0 N-CA-C 108.941 -1.664 . . . . 0.040000000000000001 108.941 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.311 0 N-CA-C 109.324 -1.51 . . . . 0.040000000000000001 109.324 -179.604 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 22.8 m . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.063 0.458 . . . . 13.779999999999999 110.272 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 96.2 mt -112.88 129.88 56.3 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.54 -0.725 . . . . 13.76 110.403 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -151.57 167.86 30.95 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.056 -1.618 . . . . 9.1300000000000008 109.056 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 949' ' ' VAL . . . . . . . . . . . . . 32.9 m -118.95 130.34 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.501 -0.999 . . . . 7.0800000000000001 110.947 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 950' ' ' PHE . . . . . 0.434 ' CZ ' ' HB3' ' A' ' 921' ' ' ARG . 27.6 p90 -132.52 149.22 52.36 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.572 -0.705 . . . . 7.5899999999999999 109.283 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 19.5 m -120.19 -53.11 2.15 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.396 -0.815 . . . . 5.0300000000000002 112.04 -178.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 952' ' ' LEU . . . . . 0.417 ' O ' ' O ' ' A' ' 953' ' ' ILE . 16.8 tp -61.25 -74.3 0.08 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.388 -0.82 . . . . 1.01 112.309 -177.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 953' ' ' ILE . . . . . 0.463 ' O ' ' HB3' ' A' ' 954' ' ' LEU . 43.9 pt -53.27 -144.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.755 0 N-CA-C 114.034 1.124 . . . . 2.6000000000000001 114.034 -176.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 954' ' ' LEU . . . . . 0.559 ' N ' ' CD1' ' A' ' 954' ' ' LEU . 0.0 OUTLIER 171.46 78.8 0.04 OUTLIER Pre-proline 0 N--CA 1.51 2.572 0 O-C-N 120.762 -1.211 . . . . 0.050000000000000003 111.54 179.697 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 955' ' ' PRO . . . . . 0.432 ' HD2' ' CE1' ' A' ' 950' ' ' PHE . 47.1 Cg_endo -74.35 95.64 0.94 Allowed 'Trans proline' 0 C--N 1.313 -1.311 0 N-CA-C 109.343 -1.06 . . . . 0.83999999999999997 109.343 178.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 956' ' ' LEU . . . . . 0.403 ' CD2' ' NH1' ' A' ' 914' ' ' ARG . 10.2 mp -123.12 145.25 48.74 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.174 -0.954 . . . . 0.040000000000000001 110.236 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -84.66 151.17 24.64 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 117.814 -1.088 . . . . 1.28 111.856 -178.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -70.24 119.88 15.09 Favored 'General case' 0 N--CA 1.51 2.569 0 CA-C-N 122.926 2.603 . . . . 0.17000000000000001 111.943 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.81 -22.82 31.78 Favored Glycine 0 N--CA 1.502 3.065 0 N-CA-C 111.197 -0.761 . . . . 0.040000000000000001 111.197 178.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 960' ' ' ASP . . . . . 0.4 ' HB3' ' NE ' ' A' ' 914' ' ' ARG . 0.3 OUTLIER -53.3 171.74 0.07 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.505 -0.997 . . . . 0.040000000000000001 110.313 -179.341 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 961' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 886' ' ' PHE . 39.2 m -134.56 135.42 42.26 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.931 -1.106 . . . . 1.78 111.785 -178.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 962' ' ' VAL . . . . . 0.42 ' CG2' ' CB ' ' A' ' 886' ' ' PHE . 31.6 m -98.76 145.23 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 C-N-CA 120.045 -0.662 . . . . 0.040000000000000001 110.389 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 5.0 t -137.86 146.25 43.19 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.906 -0.496 . . . . 0.71999999999999997 110.131 -178.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 964' ' ' VAL . . . . . 0.462 ' HA ' ' HA ' ' A' ' 911' ' ' VAL . 58.3 t -95.06 136.37 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.091 -1.006 . . . . 1.05 110.503 -179.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -95.4 126.48 40.73 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 103.682 -2.71 . . . . 3.02 103.682 173.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 966' ' ' LEU . . . . . 0.4 ' O ' ' CG2' ' A' ' 967' ' ' VAL . 1.4 tt -133.46 61.29 1.68 Allowed 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.271 -1.011 . . . . 1.46 108.271 177.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 967' ' ' VAL . . . . . 0.4 ' CG2' ' O ' ' A' ' 966' ' ' LEU . 98.9 t -157.92 96.44 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 108.138 -1.06 . . . . 1.9399999999999999 108.138 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 93.1 mmm -143.04 58.45 1.41 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.708 -1.245 . . . . 0.0 108.198 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 133.09 119.21 2.0 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 106.538 -2.625 . . . . 2.1099999999999999 106.538 -177.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -84.83 -44.49 13.21 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 119.0 1.4 . . . . 5.8899999999999997 111.364 -179.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 43.0 tp -61.39 89.12 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.921 -1.112 . . . . 4.3600000000000003 110.081 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -141.89 -156.46 0.68 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.525 -0.734 . . . . 1.8300000000000001 110.272 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -121.61 176.05 5.91 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.535 -0.728 . . . . 4.3499999999999996 110.273 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 9.1 t -99.98 129.87 46.09 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.534 -0.728 . . . . 1.27 109.909 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -156.1 157.92 36.85 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.497 -0.752 . . . . 5.0199999999999996 110.671 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.33 86.8 16.41 Favored Pre-proline 0 N--CA 1.499 2.021 0 O-C-N 121.605 -0.684 . . . . 2.4100000000000001 109.506 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -72.91 -172.46 0.98 Allowed 'Trans proline' 0 C--N 1.318 -1.056 0 O-C-N 123.312 1.164 . . . . 0.95999999999999996 111.442 -179.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 5.0 mp -128.05 154.78 45.29 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 107.631 -1.248 . . . . 0.62 107.631 178.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 979' ' ' THR . . . . . . . . . . . . . 44.9 p -149.73 141.17 23.32 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.738 -1.226 . . . . 3.5699999999999998 111.279 -179.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 980' ' ' ILE . . . . . . . . . . . . . 50.3 mm -107.82 128.2 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 108.885 -0.783 . . . . 1.3300000000000001 108.885 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 981' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -121.88 97.33 5.44 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.428 -0.795 . . . . 0.050000000000000003 111.912 -178.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 92.6 p -108.84 158.44 17.66 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 109.041 -0.726 . . . . 0.87 109.041 178.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 983' ' ' GLY . . . . . 0.411 ' HA3' ' CE1' ' A' ' 852' ' ' PHE . . . -173.73 108.91 0.28 Allowed Glycine 0 N--CA 1.498 2.775 0 N-CA-C 106.635 -2.586 . . . . 0.029999999999999999 106.635 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -109.07 148.67 30.45 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 114.409 1.263 . . . . 0.69999999999999996 114.409 -175.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 35.1 tp -68.93 135.24 50.68 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 120.777 -1.202 . . . . 0.040000000000000001 110.275 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 50.8 tp -106.88 -58.8 1.89 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.648 -0.658 . . . . 0.040000000000000001 109.918 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -144.11 145.51 32.19 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 107.553 -1.277 . . . . 0.040000000000000001 107.553 179.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.69 163.29 12.17 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 108.23 -1.948 . . . . 0.040000000000000001 108.23 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -76.11 112.51 21.08 Favored Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.184 -1.186 . . . . 0.040000000000000001 109.41 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 990' ' ' PRO . . . . . 0.41 ' O ' ' HB2' ' A' ' 991' ' ' GLU . 49.8 Cg_endo -90.44 71.79 1.33 Allowed 'Trans proline' 0 C--N 1.318 -1.031 0 O-C-N 123.044 1.023 . . . . 0.45000000000000001 111.435 -178.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 991' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 990' ' ' PRO . 75.1 mt-10 67.44 -73.67 0.08 Allowed 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 108.476 -0.935 . . . . 1.97 108.476 -177.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 992' ' ' LEU . . . . . . . . . . . . . 11.0 mt 51.1 20.51 0.86 Allowed 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.504 -0.748 . . . . 2.3799999999999999 111.652 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 80.3 mt-10 -94.1 156.84 16.37 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.918 -1.114 . . . . 3.79 109.947 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -146.21 93.29 2.3 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.529 -0.732 . . . . 3.5099999999999998 110.333 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 995' ' ' ALA . . . . . . . . . . . . 2.518 . . . . . . . 0 N--CA 1.504 2.24 0 O-C-N 120.935 -1.103 . . . . 2.73 110.57 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo . . . . . 0 N--CA 1.488 1.171 0 N-CA-C 109.537 -0.986 . . . . 3.8300000000000001 109.537 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 847' ' ' VAL . . . . . . . . . . . . . 61.9 t -134.52 103.27 11.31 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.586 -0.696 . . . . 1.8300000000000001 110.054 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 848' ' ' PRO . . . . . 0.407 ' O ' ' C ' ' B' ' 849' ' ' GLN . 44.2 Cg_endo -69.91 -18.84 36.08 Favored 'Trans proline' 0 N--CA 1.488 1.182 0 O-C-N 123.321 1.169 . . . . 0.65000000000000002 111.314 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 849' ' ' GLN . . . . . 0.407 ' C ' ' O ' ' B' ' 848' ' ' PRO . 56.4 tt0 27.64 69.17 0.06 Allowed 'General case' 0 N--CA 1.518 2.957 0 N-CA-C 112.827 0.677 . . . . 2.5800000000000001 112.827 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 850' ' ' VAL . . . . . 0.418 ' CG1' ' CE2' ' B' ' 878' ' ' TYR . 61.9 t -119.27 135.89 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.202 -0.936 . . . . 1.0900000000000001 111.394 -178.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 851' ' ' ALA . . . . . . . . . . . . . . . -127.22 156.22 42.21 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 105.884 -1.895 . . . . 0.040000000000000001 105.884 176.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 852' ' ' PHE . . . . . 0.41 ' HA ' ' CB ' ' B' ' 874' ' ' ASN . 33.2 p90 -157.98 130.59 7.25 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 121.086 1.766 . . . . 0.050000000000000003 108.729 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 44.5 t -174.97 133.7 0.33 Allowed 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.214 -1.032 . . . . 0.040000000000000001 108.214 -179.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -133.65 155.98 48.72 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.096 -1.002 . . . . 0.67000000000000004 109.448 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 855' ' ' ALA . . . . . 0.408 ' O ' ' HB2' ' B' ' 870' ' ' ARG . . . -122.3 141.82 51.13 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.802 0.811 . . . . 0.51000000000000001 111.293 -179.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 856' ' ' LEU . . . . . 0.418 HD21 ' CG1' ' B' ' 866' ' ' VAL . 3.4 tm? -111.4 137.55 49.03 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.602 -0.686 . . . . 0.050000000000000003 110.016 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 857' ' ' SER . . . . . 0.419 ' O ' ' O ' ' B' ' 858' ' ' LEU . 1.5 m -156.43 17.05 0.33 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.543 -0.723 . . . . 1.3300000000000001 111.538 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 858' ' ' LEU . . . . . 0.419 ' O ' ' O ' ' B' ' 857' ' ' SER . 3.8 pp -35.2 160.45 0.04 OUTLIER Pre-proline 0 N--CA 1.52 3.028 0 N-CA-C 112.954 0.724 . . . . 2.3300000000000001 112.954 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -60.82 -88.6 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 120.877 1.051 . . . . 2.3199999999999998 113.803 -177.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 53.6 ptt85 -128.54 -142.74 0.26 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 120.897 -1.127 . . . . 0.040000000000000001 111.801 -177.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 15.2 m -37.96 126.12 1.23 Allowed 'General case' 0 N--CA 1.509 2.516 0 O-C-N 121.619 -0.676 . . . . 1.3100000000000001 112.3 -178.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 862' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.96 159.02 31.28 Favored Pre-proline 0 N--CA 1.489 1.511 0 N-CA-C 108.425 -0.954 . . . . 4.5099999999999998 108.425 177.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -70.9 -14.71 32.67 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 O-C-N 123.193 1.101 . . . . 2.2400000000000002 111.411 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -177.52 -134.97 2.12 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.508 -1.437 . . . . 0.040000000000000001 109.508 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 27.1 m -66.71 156.82 34.27 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.285 -1.126 . . . . 1.51 110.053 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 866' ' ' VAL . . . . . 0.418 ' CG1' HD21 ' B' ' 856' ' ' LEU . 61.1 t -99.44 137.34 20.3 Favored Pre-proline 0 N--CA 1.494 1.742 0 N-CA-C 113.485 0.92 . . . . 0.78000000000000003 113.485 -174.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 867' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -92.52 -149.82 0.03 OUTLIER 'Trans proline' 0 CA--C 1.546 1.121 0 C-N-CA 121.314 1.343 . . . . 0.92000000000000004 109.626 178.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 868' ' ' PHE . . . . . 0.451 ' CD1' ' N ' ' B' ' 868' ' ' PHE . 19.4 p90 -150.55 123.88 8.93 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.645 -1.284 . . . . 0.050000000000000003 109.765 179.158 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 46.5 p30 -113.34 -1.94 14.12 Favored 'General case' 0 N--CA 1.5 2.051 0 C-N-CA 119.287 -0.965 . . . . 1.7 112.56 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 870' ' ' ARG . . . . . 0.408 ' HB2' ' O ' ' B' ' 855' ' ' ALA . 26.4 mmm180 -90.47 89.05 7.41 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.848 -1.157 . . . . 2.5899999999999999 110.634 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 58.7 t -72.71 97.19 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.013 -1.054 . . . . 1.9399999999999999 109.864 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 872' ' ' LEU . . . . . . . . . . . . . 98.6 mt -83.14 -47.5 11.55 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.594 -0.691 . . . . 1.0600000000000001 110.155 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 873' ' ' LEU . . . . . . . . . . . . . 46.6 tp -175.0 104.14 0.09 Allowed 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.625 -0.88 . . . . 4.1799999999999997 108.625 178.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 874' ' ' ASN . . . . . 0.41 ' CB ' ' HA ' ' B' ' 852' ' ' PHE . 35.5 t-20 178.73 81.78 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.303 0 O-C-N 121.681 -0.637 . . . . 0.040000000000000001 109.74 -179.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -67.4 -48.12 68.3 Favored 'General case' 0 N--CA 1.499 1.998 0 C-N-CA 119.281 -0.967 . . . . 3.3799999999999999 111.164 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 876' ' ' GLY . . . . . . . . . . . . . . . -73.52 -25.57 72.17 Favored Glycine 0 N--CA 1.494 2.536 0 O-C-N 121.242 -0.911 . . . . 0.040000000000000001 111.599 -178.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 82.61 -61.15 4.78 Favored Glycine 0 N--CA 1.501 3.02 0 N-CA-C 108.105 -1.998 . . . . 0.040000000000000001 108.105 -178.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 878' ' ' TYR . . . . . 0.418 ' CE2' ' CG1' ' B' ' 850' ' ' VAL . 95.7 m-85 61.11 -62.94 0.08 Allowed 'General case' 0 N--CA 1.503 2.178 0 N-CA-C 114.361 1.245 . . . . 3.46 114.361 177.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 879' ' ' TYR . . . . . 0.477 ' CG ' ' O ' ' B' ' 879' ' ' TYR . 18.8 p90 -111.28 108.77 18.5 Favored 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 114.477 1.288 . . . . 0.040000000000000001 114.477 -176.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -65.09 114.67 16.0 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.37 -0.832 . . . . 0.02 110.085 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 881' ' ' PRO . . . . . 0.444 ' HG2' ' CD1' ' B' ' 868' ' ' PHE . 53.6 Cg_endo -75.14 -0.98 10.66 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 O-C-N 123.557 1.293 . . . . 0.39000000000000001 112.257 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -76.8 -65.48 0.94 Allowed 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 107.071 -1.455 . . . . 0.81000000000000005 107.071 178.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 32.4 p -92.39 -17.71 24.26 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.713 -0.847 . . . . 0.040000000000000001 108.713 177.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.78 20.09 60.33 Favored Glycine 0 N--CA 1.495 2.63 0 O-C-N 121.092 -1.005 . . . . 0.029999999999999999 111.538 178.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 885' ' ' VAL . . . . . . . . . . . . . 93.1 t -73.61 91.24 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 C-N-CA 118.13 -1.428 . . . . 1.01 108.058 -179.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 886' ' ' PHE . . . . . 0.463 ' CD2' ' CB ' ' B' ' 879' ' ' TYR . 0.6 OUTLIER -89.85 105.16 17.62 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 115.211 -0.904 . . . . 0.050000000000000003 112.056 -177.448 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 887' ' ' THR . . . . . . . . . . . . . 84.7 m -96.09 100.71 12.34 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 107.626 -1.25 . . . . 0.68000000000000005 107.626 177.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 888' ' ' ALA . . . . . . . . . . . . . . . -98.67 107.25 41.79 Favored Pre-proline 0 N--CA 1.502 2.148 0 N-CA-C 114.029 1.122 . . . . 0.25 114.029 -176.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 889' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -90.09 -12.6 2.75 Favored 'Trans proline' 0 CA--C 1.546 1.099 0 C-N-CA 121.043 1.162 . . . . 1.6399999999999999 109.274 176.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 890' ' ' LEU . . . . . . . . . . . . . 63.7 mt -36.02 -50.65 0.7 Allowed 'General case' 0 N--CA 1.509 2.481 0 N-CA-C 113.819 1.044 . . . . 2.29 113.819 -177.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 51.68 95.82 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.314 0 O-C-N 121.137 -0.977 . . . . 0.63 110.322 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . 156.6 -149.78 20.75 Favored Glycine 0 N--CA 1.479 1.564 0 N-CA-C 107.26 -2.336 . . . . 0.040000000000000001 107.26 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 71.1 ttt-85 -112.51 126.61 55.51 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 107.979 -1.119 . . . . 3.0 107.979 177.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 894' ' ' TYR . . . . . 0.435 ' CZ ' ' HB2' ' B' ' 896' ' ' LEU . 0.0 OUTLIER -131.1 155.29 47.2 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.122 -0.986 . . . . 0.040000000000000001 110.68 -179.133 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 895' ' ' LEU . . . . . 0.429 ' N ' ' CD1' ' B' ' 894' ' ' TYR . 34.8 tp -95.57 114.04 25.76 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.575 -0.703 . . . . 1.27 110.089 -179.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 896' ' ' LEU . . . . . 0.435 ' HB2' ' CZ ' ' B' ' 894' ' ' TYR . 9.7 tt -108.64 142.03 39.72 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.696 -0.628 . . . . 0.93999999999999995 110.695 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 897' ' ' SER . . . . . . . . . . . . . 69.6 m -146.75 115.27 6.74 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.565 -0.71 . . . . 0.040000000000000001 110.864 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.1 146.6 31.05 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.112 -0.699 . . . . 0.47999999999999998 109.112 179.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 899' ' ' VAL . . . . . . . . . . . . . 87.7 t -96.2 119.39 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 C-N-CA 119.6 -0.84 . . . . 0.55000000000000004 111.466 -179.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 900' ' ' LEU . . . . . 0.4 ' N ' ' CD2' ' B' ' 900' ' ' LEU . 4.5 mm? -94.11 111.11 22.8 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 114.2 1.185 . . . . 1.5900000000000001 114.2 -175.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 21.2 m -65.1 140.74 58.84 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 107.333 -1.358 . . . . 0.050000000000000003 107.333 177.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -64.88 -66.7 2.34 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.445 -1.062 . . . . 0.029999999999999999 110.445 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 5.8 m170 46.54 66.84 0.88 Allowed 'General case' 0 N--CA 1.508 2.428 0 O-C-N 121.439 -1.036 . . . . 3.2000000000000002 111.016 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 43.3 ptt85 -69.02 -6.05 25.56 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.591 -0.693 . . . . 2.9199999999999999 112.043 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 905' ' ' HIS . . . . . 0.48 ' O ' ' CB ' ' B' ' 906' ' ' GLU . 74.1 t60 -60.39 2.61 0.09 Allowed 'General case' 0 N--CA 1.506 2.332 0 O-C-N 120.857 -1.152 . . . . 2.8700000000000001 112.897 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 906' ' ' GLU . . . . . 0.48 ' CB ' ' O ' ' B' ' 905' ' ' HIS . 0.8 OUTLIER 93.95 -163.73 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.44 0 CA-C-N 120.584 1.538 . . . . 0.98999999999999999 112.36 178.741 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 907' ' ' LYS . . . . . 0.471 ' CB ' ' O ' ' B' ' 906' ' ' GLU . 51.5 tttt 89.13 161.01 0.06 Allowed 'General case' 0 N--CA 1.52 3.045 0 N-CA-C 107.755 -1.202 . . . . 5.25 107.755 -177.011 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 58.9 t -121.52 115.93 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 120.86 -1.15 . . . . 0.39000000000000001 110.93 -179.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 54.1 tp10 -104.35 132.21 50.85 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 107.546 -1.279 . . . . 1.72 107.546 177.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -156.25 121.82 4.85 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 106.56 -1.644 . . . . 0.67000000000000004 106.56 178.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 911' ' ' VAL . . . . . 0.454 ' HA ' ' HA ' ' B' ' 964' ' ' VAL . 92.4 t -81.86 132.67 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.791 -0.568 . . . . 0.54000000000000004 110.788 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 71.8 mt -65.76 156.08 34.19 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 108.763 -0.828 . . . . 1.5 108.763 178.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 913' ' ' SER . . . . . 0.41 ' CB ' ' CG1' ' B' ' 919' ' ' VAL . 2.4 t -123.81 136.56 54.47 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.157 -1.053 . . . . 1.3700000000000001 108.157 176.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 914' ' ' ARG . . . . . 0.419 ' O ' ' CB ' ' B' ' 915' ' ' SER . 0.0 OUTLIER -63.36 153.95 33.44 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 120.772 -1.205 . . . . 4.2999999999999998 111.701 -178.909 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 915' ' ' SER . . . . . 0.419 ' CB ' ' O ' ' B' ' 914' ' ' ARG . 4.9 t 83.49 -32.53 0.08 Allowed 'General case' 0 N--CA 1.52 3.06 0 C-N-CA 124.11 0.964 . . . . 2.0499999999999998 112.36 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 916' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -121.98 -21.4 6.01 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 120.797 -1.189 . . . . 2.71 111.461 -179.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 917' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 67.15 165.93 0.22 Allowed 'General case' 0 N--CA 1.52 3.026 0 N-CA-C 105.62 -1.993 . . . . 2.6800000000000002 105.62 -174.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 55.09 -125.86 37.06 Favored Glycine 1 N--CA 1.521 4.301 0 CA-C-N 123.575 2.898 . . . . 0.029999999999999999 106.882 -177.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 919' ' ' VAL . . . . . 0.41 ' CG1' ' CB ' ' B' ' 913' ' ' SER . 85.6 t 51.72 94.57 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.249 0 O-C-N 121.427 -1.043 . . . . 1.3899999999999999 108.96 -178.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.67 92.14 8.31 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 119.298 -0.961 . . . . 0.029999999999999999 111.114 -178.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 921' ' ' ARG . . . . . 0.438 ' HB3' ' CZ ' ' B' ' 950' ' ' PHE . 16.7 ptt180 -84.14 -42.25 16.22 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 105.749 -1.945 . . . . 4.4199999999999999 105.749 175.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 922' ' ' VAL . . . . . . . . . . . . . 75.0 t -103.78 69.42 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 105.563 -2.014 . . . . 0.84999999999999998 105.563 175.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -89.44 136.3 33.1 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.895 0.855 . . . . 2.46 112.22 -176.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 924' ' ' SER . . . . . . . . . . . . . 13.3 t -146.41 103.32 3.68 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 107.957 -1.127 . . . . 0.69999999999999996 107.957 178.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -110.62 89.39 0.54 Allowed Glycine 0 N--CA 1.488 2.154 0 N-CA-C 108.929 -1.668 . . . . 0.040000000000000001 108.929 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.385 0 N-CA-C 109.334 -1.506 . . . . 0.040000000000000001 109.334 -179.658 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 23.3 m . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.044 0.45 . . . . 13.779999999999999 110.218 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 96.2 mt -112.28 129.8 56.16 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.566 -0.709 . . . . 13.76 110.395 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -151.25 167.08 30.69 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.07 -1.612 . . . . 9.1300000000000008 109.07 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 949' ' ' VAL . . . . . . . . . . . . . 32.5 m -118.68 130.21 73.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.469 -1.018 . . . . 7.0800000000000001 110.85 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 950' ' ' PHE . . . . . 0.438 ' CZ ' ' HB3' ' B' ' 921' ' ' ARG . 27.8 p90 -132.41 149.44 52.34 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.591 -0.693 . . . . 7.5899999999999999 109.303 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 19.6 m -120.22 -52.72 2.16 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.413 -0.804 . . . . 5.0300000000000002 112.037 -178.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 952' ' ' LEU . . . . . 0.413 ' O ' ' O ' ' B' ' 953' ' ' ILE . 16.8 tp -61.59 -74.4 0.08 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.378 -0.827 . . . . 1.01 112.324 -177.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 953' ' ' ILE . . . . . 0.476 ' O ' ' HB3' ' B' ' 954' ' ' LEU . 44.8 pt -53.12 -143.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.723 0 N-CA-C 114.122 1.156 . . . . 2.6000000000000001 114.122 -176.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 954' ' ' LEU . . . . . 0.548 ' N ' ' CD1' ' B' ' 954' ' ' LEU . 0.0 OUTLIER 171.25 78.53 0.04 OUTLIER Pre-proline 0 N--CA 1.511 2.606 0 O-C-N 120.772 -1.205 . . . . 0.050000000000000003 111.507 179.609 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 955' ' ' PRO . . . . . 0.431 ' HD2' ' CE1' ' B' ' 950' ' ' PHE . 46.9 Cg_endo -74.28 95.86 0.94 Allowed 'Trans proline' 0 C--N 1.313 -1.306 0 N-CA-C 109.307 -1.074 . . . . 0.83999999999999997 109.307 178.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 956' ' ' LEU . . . . . 0.411 ' CD2' ' NH1' ' B' ' 914' ' ' ARG . 10.2 mp -123.28 145.19 48.89 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.15 -0.969 . . . . 0.040000000000000001 110.212 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -84.51 151.51 24.54 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 117.983 -1.008 . . . . 1.28 111.821 -179.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -70.47 119.66 14.96 Favored 'General case' 0 N--CA 1.51 2.566 0 CA-C-N 122.725 2.511 . . . . 0.17000000000000001 111.919 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.96 -23.1 30.72 Favored Glycine 0 N--CA 1.502 3.046 0 N-CA-C 111.154 -0.779 . . . . 0.040000000000000001 111.154 178.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 960' ' ' ASP . . . . . 0.401 ' HB3' ' NE ' ' B' ' 914' ' ' ARG . 0.4 OUTLIER -52.96 171.86 0.06 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.467 -1.02 . . . . 0.040000000000000001 110.376 -179.312 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 961' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' B' ' 886' ' ' PHE . 38.3 m -134.59 135.55 42.31 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.074 -1.016 . . . . 1.78 111.714 -178.094 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 962' ' ' VAL . . . . . 0.428 ' CG2' ' CB ' ' B' ' 886' ' ' PHE . 31.9 m -99.05 145.13 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 C-N-CA 119.989 -0.684 . . . . 0.040000000000000001 110.343 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 5.0 t -137.64 146.15 43.56 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.936 -0.478 . . . . 0.71999999999999997 110.166 -178.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 964' ' ' VAL . . . . . 0.454 ' HA ' ' HA ' ' B' ' 911' ' ' VAL . 58.3 t -95.13 136.07 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.073 -1.017 . . . . 1.05 110.529 -179.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -95.25 126.11 40.34 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 103.761 -2.681 . . . . 3.02 103.761 173.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 966' ' ' LEU . . . . . 0.402 ' O ' ' CG2' ' B' ' 967' ' ' VAL . 1.4 tt -133.13 61.39 1.68 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.309 -0.997 . . . . 1.46 108.309 177.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 967' ' ' VAL . . . . . 0.402 ' CG2' ' O ' ' B' ' 966' ' ' LEU . 98.5 t -158.04 96.25 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 108.148 -1.056 . . . . 1.9399999999999999 108.148 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 93.3 mmm -142.81 58.32 1.43 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.767 -1.208 . . . . 0.0 108.227 178.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 133.1 119.1 1.99 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 106.654 -2.578 . . . . 2.1099999999999999 106.654 -178.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -84.53 -44.53 13.49 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 118.912 1.356 . . . . 5.8899999999999997 111.404 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 43.3 tp -61.48 88.85 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.882 -1.136 . . . . 4.3600000000000003 110.048 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -141.59 -156.26 0.66 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.575 -0.703 . . . . 1.8300000000000001 110.249 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -121.68 176.28 5.8 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.599 -0.688 . . . . 4.3499999999999996 110.195 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 9.2 t -100.22 129.87 46.28 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.52 -0.738 . . . . 1.27 109.956 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -156.11 157.89 36.79 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.53 -0.731 . . . . 5.0199999999999996 110.629 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.31 86.75 16.51 Favored Pre-proline 0 N--CA 1.5 2.056 0 O-C-N 121.678 -0.639 . . . . 2.4100000000000001 109.521 179.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -72.92 -172.49 0.99 Allowed 'Trans proline' 0 N--CA 1.487 1.089 0 O-C-N 123.32 1.168 . . . . 0.95999999999999996 111.443 -179.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 978' ' ' LEU . . . . . . . . . . . . . 5.0 mp -127.93 154.99 44.92 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 107.619 -1.252 . . . . 0.62 107.619 178.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 979' ' ' THR . . . . . . . . . . . . . 44.3 p -149.9 141.07 23.08 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.746 -1.221 . . . . 3.5699999999999998 111.294 -179.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 980' ' ' ILE . . . . . 0.426 HG22 HD11 ' B' ' 980' ' ' ILE . 50.2 mm -107.84 127.8 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 108.892 -0.781 . . . . 1.3300000000000001 108.892 179.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -121.61 97.53 5.54 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 119.717 -0.793 . . . . 0.050000000000000003 111.906 -178.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 94.1 p -109.22 158.65 17.63 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.552 -0.717 . . . . 0.87 109.104 178.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 983' ' ' GLY . . . . . 0.409 ' HA3' ' CE1' ' B' ' 852' ' ' PHE . . . -173.66 109.07 0.29 Allowed Glycine 0 N--CA 1.499 2.872 0 N-CA-C 106.705 -2.558 . . . . 0.029999999999999999 106.705 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -109.07 148.71 30.4 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 114.361 1.245 . . . . 0.69999999999999996 114.361 -175.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 985' ' ' LEU . . . . . . . . . . . . . 35.0 tp -69.03 135.17 50.43 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.796 -1.19 . . . . 0.040000000000000001 110.255 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 986' ' ' LEU . . . . . . . . . . . . . 50.5 tp -106.88 -58.82 1.89 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.639 -0.663 . . . . 0.040000000000000001 109.932 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -144.07 145.34 32.1 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.591 -1.263 . . . . 0.040000000000000001 107.591 179.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.61 163.03 12.2 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 108.163 -1.975 . . . . 0.040000000000000001 108.163 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -75.76 112.48 20.02 Favored Pre-proline 0 N--CA 1.499 1.984 0 O-C-N 121.243 -1.151 . . . . 0.040000000000000001 109.406 179.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 990' ' ' PRO . . . . . 0.413 ' O ' ' HB2' ' B' ' 991' ' ' GLU . 49.6 Cg_endo -90.38 71.86 1.35 Allowed 'Trans proline' 0 C--N 1.319 -1.005 0 O-C-N 123.133 1.07 . . . . 0.45000000000000001 111.373 -179.012 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 991' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' B' ' 990' ' ' PRO . 74.9 mt-10 67.34 -73.56 0.08 Allowed 'General case' 0 N--CA 1.502 2.149 0 N-CA-C 108.552 -0.907 . . . . 1.97 108.552 -177.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 992' ' ' LEU . . . . . . . . . . . . . 10.9 mt 51.18 20.28 0.86 Allowed 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.536 -0.727 . . . . 2.3799999999999999 111.677 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 80.3 mt-10 -93.75 156.79 16.48 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.895 -1.128 . . . . 3.79 109.976 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 70.6 m80 -146.24 92.79 2.22 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.444 -0.785 . . . . 3.5099999999999998 110.388 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 995' ' ' ALA . . . . . . . . . . . . 2.517 . . . . . . . 0 N--CA 1.504 2.255 0 O-C-N 120.935 -1.103 . . . . 2.73 110.612 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo . . . . . 0 N--CA 1.488 1.158 0 N-CA-C 109.539 -0.985 . . . . 3.8300000000000001 109.539 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 847' ' ' VAL . . . . . . . . . . . . . 58.2 t -126.48 106.41 23.87 Favored Pre-proline 0 N--CA 1.496 1.835 0 O-C-N 121.597 -0.689 . . . . 1.8300000000000001 110.012 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 848' ' ' PRO . . . . . 0.403 ' O ' ' C ' ' C' ' 849' ' ' GLN . 44.4 Cg_endo -69.7 -22.68 32.01 Favored 'Trans proline' 0 N--CA 1.488 1.177 0 O-C-N 123.278 1.146 . . . . 0.65000000000000002 111.034 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 849' ' ' GLN . . . . . 0.403 ' C ' ' O ' ' C' ' 848' ' ' PRO . 54.5 tt0 25.17 64.9 0.06 Allowed 'General case' 0 N--CA 1.519 2.991 0 N-CA-C 113.379 0.881 . . . . 2.5800000000000001 113.379 179.138 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 850' ' ' VAL . . . . . . . . . . . . . 72.1 t -119.06 135.5 59.27 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.117 -0.989 . . . . 1.0900000000000001 111.028 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 851' ' ' ALA . . . . . . . . . . . . . . . -126.96 155.93 42.34 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 105.758 -1.942 . . . . 0.040000000000000001 105.758 176.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 852' ' ' PHE . . . . . 0.451 ' CD1' ' N ' ' C' ' 852' ' ' PHE . 16.0 p90 -160.26 127.38 4.41 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 121.016 1.734 . . . . 0.050000000000000003 108.625 178.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 38.8 t -176.65 134.88 0.22 Allowed 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.18 -1.044 . . . . 0.040000000000000001 108.18 -179.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -132.21 156.96 45.53 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.164 -0.96 . . . . 0.67000000000000004 109.779 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 855' ' ' ALA . . . . . . . . . . . . . . . -122.41 140.53 52.6 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.759 0.79 . . . . 0.51000000000000001 111.179 -179.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 856' ' ' LEU . . . . . 0.423 HD21 ' CG1' ' C' ' 866' ' ' VAL . 3.5 tm? -111.74 138.14 48.71 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.641 -0.662 . . . . 0.050000000000000003 110.036 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 857' ' ' SER . . . . . 0.427 ' O ' ' O ' ' C' ' 858' ' ' LEU . 21.1 m -155.27 18.66 0.42 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.395 -0.815 . . . . 1.3300000000000001 111.347 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 858' ' ' LEU . . . . . 0.427 ' O ' ' O ' ' C' ' 857' ' ' SER . 3.2 pp -34.81 160.87 0.04 OUTLIER Pre-proline 0 N--CA 1.52 3.067 0 N-CA-C 113.066 0.765 . . . . 2.3300000000000001 113.066 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -60.34 -88.22 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.462 0 O-C-N 122.99 0.995 . . . . 2.3199999999999998 113.455 -178.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 55.2 ptt85 -128.31 -143.34 0.27 Allowed 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.823 -1.173 . . . . 0.040000000000000001 111.808 -177.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 69.4 m -37.84 130.32 1.11 Allowed 'General case' 0 N--CA 1.511 2.581 0 O-C-N 121.622 -0.673 . . . . 1.3100000000000001 112.356 -178.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.14 160.45 26.03 Favored Pre-proline 0 N--CA 1.489 1.476 0 N-CA-C 108.326 -0.99 . . . . 4.5099999999999998 108.326 177.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.78 -13.57 26.83 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 O-C-N 123.152 1.08 . . . . 2.2400000000000002 111.453 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -177.78 -136.2 2.44 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.664 -1.374 . . . . 0.040000000000000001 109.664 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 17.0 m -68.23 153.86 42.89 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.329 -1.1 . . . . 1.51 109.92 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 866' ' ' VAL . . . . . 0.423 ' CG1' HD21 ' C' ' 856' ' ' LEU . 39.4 t -97.72 139.78 21.56 Favored Pre-proline 0 N--CA 1.493 1.691 0 N-CA-C 113.507 0.928 . . . . 0.78000000000000003 113.507 -174.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 867' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -91.4 -147.86 0.03 OUTLIER 'Trans proline' 0 CA--C 1.544 0.998 0 O-C-N 123.688 1.362 . . . . 0.92000000000000004 108.95 177.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 868' ' ' PHE . . . . . 0.458 ' CD1' ' HG2' ' C' ' 881' ' ' PRO . 14.0 p90 -149.88 124.12 9.52 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.51 -1.368 . . . . 0.050000000000000003 110.109 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 47.6 p-10 -112.45 -3.08 14.53 Favored 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 119.131 -1.027 . . . . 1.7 112.508 -178.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 870' ' ' ARG . . . . . . . . . . . . . 28.0 mmm180 -91.85 87.86 6.41 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.925 -1.109 . . . . 2.5899999999999999 111.112 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 60.7 t -71.55 96.94 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 120.927 -1.108 . . . . 1.9399999999999999 109.337 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 872' ' ' LEU . . . . . . . . . . . . . 95.3 mt -87.29 -44.73 11.2 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.592 -0.692 . . . . 1.0600000000000001 110.678 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 873' ' ' LEU . . . . . 0.414 ' O ' ' HB2' ' C' ' 874' ' ' ASN . 33.0 tp -172.91 102.02 0.13 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.101 -0.999 . . . . 4.1799999999999997 108.947 178.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 874' ' ' ASN . . . . . 0.414 ' HB2' ' O ' ' C' ' 873' ' ' LEU . 34.0 t-20 176.99 82.09 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.284 0 N-CA-C 108.987 -0.746 . . . . 0.040000000000000001 108.987 -179.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -65.34 -47.27 77.07 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.107 -0.995 . . . . 3.3799999999999999 111.308 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 876' ' ' GLY . . . . . 0.422 ' HA3' ' CE2' ' C' ' 878' ' ' TYR . . . -72.58 -26.47 71.59 Favored Glycine 0 N--CA 1.493 2.483 0 C-N-CA 120.423 -0.894 . . . . 0.040000000000000001 111.436 -178.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 79.61 -63.13 4.03 Favored Glycine 0 N--CA 1.5 2.956 0 N-CA-C 108.102 -1.999 . . . . 0.040000000000000001 108.102 -178.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 878' ' ' TYR . . . . . 0.422 ' CE2' ' HA3' ' C' ' 876' ' ' GLY . 89.4 m-85 60.76 -64.79 0.06 Allowed 'General case' 0 N--CA 1.502 2.146 0 N-CA-C 114.276 1.213 . . . . 3.46 114.276 177.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 879' ' ' TYR . . . . . 0.483 ' CE2' ' CD1' ' C' ' 981' ' ' PHE . 22.3 p90 -109.93 106.93 16.67 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 114.976 1.473 . . . . 0.040000000000000001 114.976 -176.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -69.64 119.22 69.58 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.401 -0.812 . . . . 0.02 109.759 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 881' ' ' PRO . . . . . 0.458 ' HG2' ' CD1' ' C' ' 868' ' ' PHE . 55.3 Cg_endo -79.26 -0.16 10.51 Favored 'Trans proline' 0 N--CA 1.487 1.132 0 O-C-N 123.363 1.191 . . . . 0.39000000000000001 111.563 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -76.31 -62.84 1.48 Allowed 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 106.433 -1.691 . . . . 0.81000000000000005 106.433 178.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 24.3 p -88.46 -21.87 23.98 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.136 -1.061 . . . . 0.040000000000000001 108.136 176.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 81.77 16.35 73.13 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 110.401 -1.079 . . . . 0.029999999999999999 110.401 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 84.4 t -73.93 91.91 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 C-N-CA 118.397 -1.321 . . . . 1.01 108.111 -179.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 886' ' ' PHE . . . . . 0.512 ' O ' ' HA ' ' C' ' 961' ' ' THR . 1.1 t80 -87.46 105.7 17.47 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 115.17 -0.923 . . . . 0.050000000000000003 111.628 -177.436 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 887' ' ' THR . . . . . 0.406 ' O ' ' HD3' ' C' ' 889' ' ' PRO . 86.7 m -102.45 99.72 9.79 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 107.806 -1.183 . . . . 0.68000000000000005 107.806 177.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 888' ' ' ALA . . . . . . . . . . . . . . . -98.66 101.19 11.14 Favored Pre-proline 0 N--CA 1.501 2.084 0 N-CA-C 114.388 1.255 . . . . 0.25 114.388 -176.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 889' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' C' ' 887' ' ' THR . 55.7 Cg_endo -80.06 -15.3 11.76 Favored 'Trans proline' 0 N--CA 1.486 1.042 0 N-CA-C 108.73 -1.296 . . . . 1.6399999999999999 108.73 175.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 890' ' ' LEU . . . . . . . . . . . . . 60.7 mt -37.35 -49.5 0.99 Allowed 'General case' 0 N--CA 1.508 2.425 0 N-CA-C 113.452 0.908 . . . . 2.29 113.452 -177.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 52.36 97.19 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.267 0 O-C-N 121.19 -0.944 . . . . 0.63 110.285 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . 158.94 -154.21 25.3 Favored Glycine 0 N--CA 1.477 1.422 0 N-CA-C 107.272 -2.331 . . . . 0.040000000000000001 107.272 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 74.5 ttt-85 -117.36 123.23 45.96 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.612 -0.934 . . . . 3.0 108.761 177.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 894' ' ' TYR . . . . . 0.43 ' CE2' HD22 ' C' ' 954' ' ' LEU . 20.3 p90 -133.78 155.54 49.62 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.117 -0.989 . . . . 0.040000000000000001 110.956 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 895' ' ' LEU . . . . . . . . . . . . . 49.0 tp -97.82 115.41 28.0 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.719 -0.613 . . . . 1.27 110.268 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 896' ' ' LEU . . . . . . . . . . . . . 9.3 tt -118.36 144.6 45.77 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.654 -0.654 . . . . 0.93999999999999995 109.945 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 897' ' ' SER . . . . . . . . . . . . . 55.4 m -141.82 124.57 16.01 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.429 -0.795 . . . . 0.040000000000000001 111.284 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -101.89 148.17 25.64 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.789 -0.819 . . . . 0.47999999999999998 108.789 178.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 899' ' ' VAL . . . . . . . . . . . . . 87.4 t -92.49 120.31 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.35 -0.844 . . . . 0.55000000000000004 111.256 -179.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 94.6 mt -92.78 112.23 24.11 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 114.036 1.125 . . . . 1.5900000000000001 114.036 -175.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 20.7 m -63.48 140.4 58.87 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 107.472 -1.307 . . . . 0.050000000000000003 107.472 177.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -61.12 -65.23 3.42 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 110.344 -1.103 . . . . 0.029999999999999999 110.344 -179.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 5.9 m170 45.86 64.39 1.48 Allowed 'General case' 0 N--CA 1.507 2.397 0 O-C-N 121.556 -0.967 . . . . 3.2000000000000002 111.239 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 42.7 ptt85 -67.68 -7.96 31.12 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.614 -0.679 . . . . 2.9199999999999999 111.83 -179.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 905' ' ' HIS . . . . . 0.493 ' O ' ' CB ' ' C' ' 906' ' ' GLU . 75.8 t60 -61.97 6.12 0.08 Allowed 'General case' 0 N--CA 1.506 2.342 0 CA-C-O 117.649 -1.167 . . . . 2.8700000000000001 113.468 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 906' ' ' GLU . . . . . 0.493 ' CB ' ' O ' ' C' ' 905' ' ' HIS . 0.8 OUTLIER 93.07 -163.45 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.441 0 CA-C-N 121.252 1.842 . . . . 0.98999999999999999 112.012 178.983 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 907' ' ' LYS . . . . . 0.493 ' CB ' ' O ' ' C' ' 906' ' ' GLU . 25.8 ttmt 89.9 161.91 0.05 OUTLIER 'General case' 0 N--CA 1.522 3.136 0 N-CA-C 108.061 -1.088 . . . . 5.25 108.061 -177.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 59.6 t -121.67 117.34 52.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 120.841 -1.162 . . . . 0.39000000000000001 110.915 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 43.1 tp10 -104.5 130.91 52.4 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 107.486 -1.302 . . . . 1.72 107.486 177.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -157.18 121.13 4.24 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 106.887 -1.523 . . . . 0.67000000000000004 106.887 178.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 911' ' ' VAL . . . . . 0.47 ' HA ' ' HA ' ' C' ' 964' ' ' VAL . 97.8 t -83.42 132.06 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.784 -0.573 . . . . 0.54000000000000004 110.863 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 64.4 mt -66.18 157.41 31.4 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.478 -0.764 . . . . 1.5 109.243 178.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 913' ' ' SER . . . . . 0.417 ' CB ' ' CG1' ' C' ' 919' ' ' VAL . 2.2 t -125.4 137.96 54.02 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.212 -1.033 . . . . 1.3700000000000001 108.212 176.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 914' ' ' ARG . . . . . 0.425 ' O ' ' CB ' ' C' ' 915' ' ' SER . 0.0 OUTLIER -63.94 154.06 35.11 Favored 'General case' 0 N--CA 1.504 2.275 0 O-C-N 120.681 -1.262 . . . . 4.2999999999999998 111.88 -178.714 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 915' ' ' SER . . . . . 0.425 ' CB ' ' O ' ' C' ' 914' ' ' ARG . 4.0 t 83.06 -31.41 0.09 Allowed 'General case' 0 N--CA 1.521 3.124 0 C-N-CA 123.865 0.866 . . . . 2.0499999999999998 112.382 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 916' ' ' ASN . . . . . 0.409 ' O ' ' HB2' ' C' ' 917' ' ' GLN . 94.5 m-20 -122.37 -21.72 5.72 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.785 -1.197 . . . . 2.71 111.252 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 917' ' ' GLN . . . . . 0.409 ' HB2' ' O ' ' C' ' 916' ' ' ASN . 46.5 mt-30 67.36 167.81 0.24 Allowed 'General case' 0 N--CA 1.52 3.044 0 N-CA-C 105.608 -1.997 . . . . 2.6800000000000002 105.608 -174.013 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.91 -127.47 41.08 Favored Glycine 1 N--CA 1.52 4.289 0 CA-C-N 123.589 2.904 . . . . 0.029999999999999999 107.022 -177.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 919' ' ' VAL . . . . . 0.417 ' CG1' ' CB ' ' C' ' 913' ' ' SER . 92.6 t 50.54 94.53 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.233 0 O-C-N 121.466 -1.02 . . . . 1.3899999999999999 109.206 -178.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 920' ' ' ALA . . . . . . . . . . . . . . . -93.21 94.37 8.76 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.395 -0.922 . . . . 0.029999999999999999 110.943 -179.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 921' ' ' ARG . . . . . 0.433 ' HB3' ' CZ ' ' C' ' 950' ' ' PHE . 40.7 ptt85 -81.36 -42.29 20.71 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 105.766 -1.938 . . . . 4.4199999999999999 105.766 176.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 922' ' ' VAL . . . . . . . . . . . . . 73.6 t -100.82 74.92 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 N-CA-C 105.523 -2.029 . . . . 0.84999999999999998 105.523 175.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -89.95 135.08 33.86 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.87 0.843 . . . . 2.46 112.315 -176.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 4.4 t -147.33 102.94 3.52 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.973 -1.121 . . . . 0.69999999999999996 107.973 178.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -110.08 89.84 0.56 Allowed Glycine 0 N--CA 1.488 2.105 0 N-CA-C 108.952 -1.659 . . . . 0.040000000000000001 108.952 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.33 0 N-CA-C 109.3 -1.52 . . . . 0.040000000000000001 109.3 -179.685 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 24.9 m . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 120.928 0.394 . . . . 13.779999999999999 110.355 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 95.6 mt -114.47 129.78 56.68 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.572 -0.705 . . . . 13.76 110.347 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -152.03 169.85 31.37 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.316 -1.514 . . . . 9.1300000000000008 109.316 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 949' ' ' VAL . . . . . . . . . . . . . 34.0 m -118.24 135.65 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.513 -0.993 . . . . 7.0800000000000001 110.985 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 950' ' ' PHE . . . . . 0.433 ' CZ ' ' HB3' ' C' ' 921' ' ' ARG . 49.4 p90 -134.76 151.92 51.35 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.524 -0.735 . . . . 7.5899999999999999 109.348 179.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 26.6 m -119.01 -55.26 2.18 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.375 -0.828 . . . . 5.0300000000000002 111.956 -178.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 952' ' ' LEU . . . . . 0.452 ' O ' ' O ' ' C' ' 953' ' ' ILE . 52.8 tp -63.15 -76.37 0.07 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.359 -0.838 . . . . 1.01 111.688 -178.039 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 953' ' ' ILE . . . . . 0.466 ' O ' ' HB3' ' C' ' 954' ' ' LEU . 2.0 pp -49.12 -150.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.784 0 N-CA-C 114.699 1.37 . . . . 2.6000000000000001 114.699 -176.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 954' ' ' LEU . . . . . 0.576 ' N ' ' CD1' ' C' ' 954' ' ' LEU . 0.0 OUTLIER 170.99 89.14 0.04 OUTLIER Pre-proline 0 N--CA 1.516 2.836 0 O-C-N 120.74 -1.225 . . . . 0.050000000000000003 111.88 -179.477 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 955' ' ' PRO . . . . . 0.422 ' HD3' ' CD1' ' C' ' 953' ' ' ILE . 50.9 Cg_endo -83.41 93.7 0.82 Allowed 'Trans proline' 0 C--N 1.317 -1.1 0 N-CA-C 109.419 -1.031 . . . . 0.83999999999999997 109.419 178.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 956' ' ' LEU . . . . . . . . . . . . . 7.9 mp -126.28 150.13 48.66 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.07 -1.019 . . . . 0.040000000000000001 110.772 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -83.16 151.81 25.54 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 117.743 -1.122 . . . . 1.28 111.518 -178.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -66.88 119.32 11.7 Favored 'General case' 0 N--CA 1.509 2.515 0 CA-C-N 123.022 2.647 . . . . 0.17000000000000001 111.213 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.72 -19.98 47.85 Favored Glycine 0 N--CA 1.499 2.882 0 N-CA-C 110.907 -0.877 . . . . 0.040000000000000001 110.907 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 960' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.44 170.58 0.15 Allowed 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.409 -1.054 . . . . 0.040000000000000001 110.353 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 961' ' ' THR . . . . . 0.512 ' HA ' ' O ' ' C' ' 886' ' ' PHE . 39.3 m -136.93 141.0 42.66 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.989 -1.069 . . . . 1.78 112.614 -177.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 962' ' ' VAL . . . . . 0.41 ' CG2' ' CB ' ' C' ' 886' ' ' PHE . 27.3 m -99.88 145.18 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 C-N-CA 120.395 -0.522 . . . . 0.040000000000000001 110.696 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 5.2 t -137.53 143.85 41.84 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.828 -0.545 . . . . 0.71999999999999997 109.861 -178.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 964' ' ' VAL . . . . . 0.47 ' HA ' ' HA ' ' C' ' 911' ' ' VAL . 61.6 t -91.94 136.94 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.103 -0.998 . . . . 1.05 110.733 -178.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -93.68 126.37 38.81 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 103.566 -2.753 . . . . 3.02 103.566 173.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 966' ' ' LEU . . . . . 0.404 ' O ' ' CG2' ' C' ' 967' ' ' VAL . 0.2 OUTLIER -133.63 59.23 1.74 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.662 -0.866 . . . . 1.46 108.662 177.503 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 967' ' ' VAL . . . . . 0.404 ' CG2' ' O ' ' C' ' 966' ' ' LEU . 99.5 t -157.8 96.31 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 108.327 -0.99 . . . . 1.9399999999999999 108.327 179.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 91.8 mmm -143.04 58.65 1.41 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.736 -1.227 . . . . 0.0 108.562 179.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 134.19 119.46 1.97 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 107.372 -2.291 . . . . 2.1099999999999999 107.372 -178.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 -82.76 -58.12 3.02 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.048 -1.266 . . . . 5.8899999999999997 110.662 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 46.3 tp -58.78 89.74 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.455 -0.778 . . . . 4.3600000000000003 110.449 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -143.33 -151.72 0.38 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.536 -0.727 . . . . 1.8300000000000001 110.011 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -117.0 167.03 11.5 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.352 -0.843 . . . . 4.3499999999999996 110.082 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 30.2 t -101.49 130.3 47.73 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.523 -0.736 . . . . 1.27 110.075 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -155.62 156.55 35.23 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.504 -0.747 . . . . 5.0199999999999996 110.525 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.76 84.82 17.53 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.679 -0.638 . . . . 2.4100000000000001 109.779 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -74.49 -172.19 1.13 Allowed 'Trans proline' 0 C--N 1.316 -1.16 0 O-C-N 123.359 1.189 . . . . 0.95999999999999996 111.074 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 978' ' ' LEU . . . . . . . . . . . . . 6.3 mp -123.32 156.42 35.36 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.456 -1.312 . . . . 0.62 107.456 177.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 979' ' ' THR . . . . . . . . . . . . . 47.6 p -149.33 141.49 23.99 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.733 -1.229 . . . . 3.5699999999999998 111.19 -179.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 980' ' ' ILE . . . . . . . . . . . . . 51.2 mm -105.8 128.22 60.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 108.974 -0.75 . . . . 1.3300000000000001 108.974 179.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 981' ' ' PHE . . . . . 0.483 ' CD1' ' CE2' ' C' ' 879' ' ' TYR . 3.3 t80 -117.95 95.76 5.05 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.394 -0.816 . . . . 0.050000000000000003 111.324 -178.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 982' ' ' SER . . . . . . . . . . . . . 11.6 p -108.18 158.43 17.45 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.599 -0.688 . . . . 0.87 109.213 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 983' ' ' GLY . . . . . 0.427 ' HA3' ' CE2' ' C' ' 852' ' ' PHE . . . -171.65 114.61 0.54 Allowed Glycine 0 N--CA 1.496 2.69 0 N-CA-C 106.648 -2.581 . . . . 0.029999999999999999 106.648 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 984' ' ' ALA . . . . . . . . . . . . . . . -108.92 151.57 26.11 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 114.213 1.19 . . . . 0.69999999999999996 114.213 -175.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 985' ' ' LEU . . . . . . . . . . . . . 55.4 tp -76.43 135.88 39.43 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.819 -1.176 . . . . 0.040000000000000001 109.701 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 986' ' ' LEU . . . . . . . . . . . . . 47.2 tp -106.75 -61.8 1.48 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.491 -0.756 . . . . 0.040000000000000001 110.36 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -144.13 146.67 32.92 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 107.786 -1.191 . . . . 0.040000000000000001 107.786 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.25 162.91 12.25 Favored Glycine 0 N--CA 1.495 2.616 0 N-CA-C 108.071 -2.012 . . . . 0.040000000000000001 108.071 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -74.95 112.76 19.31 Favored Pre-proline 0 N--CA 1.498 1.946 0 O-C-N 121.15 -1.206 . . . . 0.040000000000000001 109.48 179.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 990' ' ' PRO . . . . . 0.416 ' O ' ' HB2' ' C' ' 991' ' ' GLU . 50.2 Cg_endo -89.13 71.26 2.09 Favored 'Trans proline' 0 C--N 1.32 -0.967 0 O-C-N 123.108 1.057 . . . . 0.45000000000000001 111.291 -179.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 991' ' ' GLU . . . . . 0.416 ' HB2' ' O ' ' C' ' 990' ' ' PRO . 73.6 mt-10 67.52 -73.46 0.08 Allowed 'General case' 0 N--CA 1.503 2.182 0 N-CA-C 108.518 -0.919 . . . . 1.97 108.518 -177.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 992' ' ' LEU . . . . . . . . . . . . . 10.8 mt 50.48 20.73 0.73 Allowed 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.568 -0.707 . . . . 2.3799999999999999 111.748 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -93.47 156.75 16.57 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.878 -1.139 . . . . 3.79 110.044 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 68.7 m80 -145.64 92.65 2.25 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.509 -0.745 . . . . 3.5099999999999998 110.254 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 995' ' ' ALA . . . . . . . . . . . . 2.519 . . . . . . . 0 N--CA 1.504 2.249 0 O-C-N 120.968 -1.082 . . . . 2.73 110.637 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo . . . . . 0 N--CA 1.488 1.151 0 N-CA-C 109.491 -1.004 . . . . 3.8300000000000001 109.491 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 847' ' ' VAL . . . . . . . . . . . . . 59.0 t -133.78 102.68 12.32 Favored Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 121.546 -0.721 . . . . 1.8300000000000001 109.993 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 848' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.79 -19.25 36.22 Favored 'Trans proline' 0 N--CA 1.487 1.114 0 O-C-N 123.316 1.166 . . . . 0.65000000000000002 111.272 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 849' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 27.91 68.09 0.07 Allowed 'General case' 0 N--CA 1.518 2.953 0 N-CA-C 112.901 0.704 . . . . 2.5800000000000001 112.901 179.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 850' ' ' VAL . . . . . . . . . . . . . 65.3 t -119.65 137.01 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.148 -0.97 . . . . 1.0900000000000001 111.51 -178.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 851' ' ' ALA . . . . . . . . . . . . . . . -123.79 159.92 28.47 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 105.921 -1.881 . . . . 0.040000000000000001 105.921 176.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 852' ' ' PHE . . . . . 0.416 ' CE1' ' HA3' ' A' ' 983' ' ' GLY . 34.2 p90 -159.29 127.82 5.15 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 120.88 1.673 . . . . 0.050000000000000003 108.465 178.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 8.8 t -175.4 134.49 0.31 Allowed 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.185 -1.042 . . . . 0.040000000000000001 108.185 -178.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -130.24 156.92 43.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.03 -1.044 . . . . 0.67000000000000004 109.739 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 855' ' ' ALA . . . . . 0.422 ' O ' ' HB2' ' A' ' 870' ' ' ARG . . . -119.76 144.11 47.45 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.806 0.813 . . . . 0.51000000000000001 110.809 -179.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 856' ' ' LEU . . . . . 0.412 HD21 ' CG1' ' A' ' 866' ' ' VAL . 2.1 tm? -115.21 134.23 55.33 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.508 -0.745 . . . . 0.050000000000000003 110.45 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 857' ' ' SER . . . . . 0.411 ' N ' HD13 ' A' ' 856' ' ' LEU . 1.7 m -156.74 14.41 0.28 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.486 -0.759 . . . . 1.3300000000000001 111.866 179.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 858' ' ' LEU . . . . . 0.409 ' O ' ' O ' ' A' ' 857' ' ' SER . 0.3 OUTLIER -36.56 162.28 0.04 OUTLIER Pre-proline 0 N--CA 1.524 3.231 0 CA-C-N 119.053 0.842 . . . . 2.3300000000000001 113.07 -179.58 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -61.26 -89.31 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.534 0 O-C-N 123.103 1.054 . . . . 2.3199999999999998 113.841 -177.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 53.9 ptt85 -134.21 -142.42 0.2 Allowed 'General case' 0 N--CA 1.502 2.144 0 O-C-N 120.761 -1.212 . . . . 0.040000000000000001 111.787 -177.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 5.2 m -36.65 126.89 0.86 Allowed 'General case' 0 N--CA 1.511 2.612 0 O-C-N 121.659 -0.651 . . . . 1.3100000000000001 112.366 -178.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -104.73 165.55 13.08 Favored Pre-proline 0 N--CA 1.489 1.496 0 N-CA-C 108.652 -0.87 . . . . 4.5099999999999998 108.652 177.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -73.54 -14.42 24.87 Favored 'Trans proline' 0 C--N 1.313 -1.311 0 O-C-N 123.284 1.149 . . . . 2.2400000000000002 111.388 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -177.93 -135.29 2.23 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 110.162 -1.175 . . . . 0.040000000000000001 110.162 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 26.4 m -64.71 156.65 29.69 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.41 -1.053 . . . . 1.51 110.912 -178.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 866' ' ' VAL . . . . . 0.412 ' CG1' HD21 ' A' ' 856' ' ' LEU . 56.2 t -96.95 132.79 25.22 Favored Pre-proline 0 N--CA 1.496 1.838 0 N-CA-C 113.453 0.908 . . . . 0.78000000000000003 113.453 -174.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 867' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -90.68 -149.51 0.03 OUTLIER 'Trans proline' 0 CA--C 1.545 1.066 0 O-C-N 123.571 1.3 . . . . 0.92000000000000004 109.332 177.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 868' ' ' PHE . . . . . 0.466 ' N ' ' CD1' ' A' ' 868' ' ' PHE . 19.4 p90 -150.34 123.49 8.86 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.584 -1.322 . . . . 0.050000000000000003 109.837 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 49.9 p-10 -113.62 -2.68 13.74 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.129 -0.982 . . . . 1.7 112.841 -178.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 870' ' ' ARG . . . . . 0.422 ' HB2' ' O ' ' A' ' 855' ' ' ALA . 28.2 mmm180 -91.58 89.9 7.37 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 120.819 -1.176 . . . . 2.5899999999999999 111.131 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 57.9 t -72.77 96.66 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 120.984 -1.072 . . . . 1.9399999999999999 109.694 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 872' ' ' LEU . . . . . . . . . . . . . 86.6 mt -83.32 -46.81 12.18 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.505 -0.747 . . . . 1.0600000000000001 110.164 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 873' ' ' LEU . . . . . . . . . . . . . 32.7 tp -174.33 102.35 0.1 Allowed 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 108.595 -0.891 . . . . 4.1799999999999997 108.595 178.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 874' ' ' ASN . . . . . . . . . . . . . 33.9 t-20 178.33 80.98 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.256 0 N-CA-C 109.264 -0.643 . . . . 0.040000000000000001 109.264 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -65.41 -47.03 77.68 Favored 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 119.344 -0.942 . . . . 3.3799999999999999 111.129 -179.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 876' ' ' GLY . . . . . . . . . . . . . . . -73.97 -24.26 74.36 Favored Glycine 0 N--CA 1.494 2.55 0 O-C-N 121.316 -0.865 . . . . 0.040000000000000001 111.672 -178.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 84.41 -60.04 4.87 Favored Glycine 0 N--CA 1.502 3.099 0 N-CA-C 107.949 -2.06 . . . . 0.040000000000000001 107.949 -178.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 878' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 60.32 -66.63 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.14 0 N-CA-C 114.424 1.268 . . . . 3.46 114.424 177.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 879' ' ' TYR . . . . . 0.469 ' CB ' ' CD2' ' A' ' 886' ' ' PHE . 21.3 p90 -110.77 109.69 20.02 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 114.831 1.419 . . . . 0.040000000000000001 114.831 -176.235 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -66.0 117.08 38.97 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 121.534 -0.729 . . . . 0.02 110.191 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 881' ' ' PRO . . . . . 0.433 ' HG2' ' CD1' ' A' ' 868' ' ' PHE . 54.4 Cg_endo -75.88 0.39 9.31 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 O-C-N 123.413 1.217 . . . . 0.39000000000000001 112.222 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -75.35 -65.19 0.92 Allowed 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 106.952 -1.499 . . . . 0.81000000000000005 106.952 178.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 2.2 p -95.74 -17.0 21.57 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.802 -0.814 . . . . 0.040000000000000001 108.802 177.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.68 22.98 52.0 Favored Glycine 0 N--CA 1.494 2.533 0 C-N-CA 120.127 -1.035 . . . . 0.029999999999999999 110.664 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 885' ' ' VAL . . . . . . . . . . . . . 92.0 t -73.2 88.46 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 C-N-CA 118.357 -1.337 . . . . 1.01 107.917 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 886' ' ' PHE . . . . . 0.489 ' O ' ' HA ' ' A' ' 961' ' ' THR . 0.6 OUTLIER -89.13 106.38 18.4 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 115.04 -0.982 . . . . 0.050000000000000003 112.175 -177.053 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 887' ' ' THR . . . . . . . . . . . . . 97.0 m -98.85 99.16 10.2 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 107.495 -1.298 . . . . 0.68000000000000005 107.495 177.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 888' ' ' ALA . . . . . . . . . . . . . . . -97.25 108.11 42.39 Favored Pre-proline 0 N--CA 1.501 2.08 0 N-CA-C 114.207 1.188 . . . . 0.25 114.207 -176.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 889' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -89.39 -13.7 2.8 Favored 'Trans proline' 0 CA--C 1.546 1.076 0 O-C-N 123.288 1.152 . . . . 1.6399999999999999 109.137 176.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 890' ' ' LEU . . . . . . . . . . . . . 63.1 mt -35.93 -50.64 0.68 Allowed 'General case' 0 N--CA 1.509 2.508 0 N-CA-C 113.694 0.998 . . . . 2.29 113.694 -177.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 52.18 95.52 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.189 -0.945 . . . . 0.63 110.269 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 157.59 -154.09 25.23 Favored Glycine 0 N--CA 1.478 1.436 0 N-CA-C 107.055 -2.418 . . . . 0.040000000000000001 107.055 -179.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 893' ' ' ARG . . . . . 0.4 ' CZ ' ' CB ' ' C' ' 984' ' ' ALA . 71.0 ttt-85 -116.4 125.31 51.87 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.529 -0.983 . . . . 3.0 108.567 177.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 894' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -132.05 161.38 33.37 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.134 -0.979 . . . . 0.040000000000000001 111.084 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 895' ' ' LEU . . . . . . . . . . . . . 43.6 tp -91.86 119.48 31.68 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.723 -0.611 . . . . 1.27 110.274 -179.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 9.2 tt -110.18 144.42 38.85 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.742 -0.599 . . . . 0.93999999999999995 109.98 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 897' ' ' SER . . . . . . . . . . . . . 69.2 m -149.45 114.66 5.47 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.51 -0.744 . . . . 0.040000000000000001 111.032 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.41 146.27 31.88 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.915 -0.772 . . . . 0.47999999999999998 108.915 178.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 899' ' ' VAL . . . . . . . . . . . . . 87.3 t -96.52 119.18 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 C-N-CA 119.566 -0.854 . . . . 0.55000000000000004 111.16 -179.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 900' ' ' LEU . . . . . 0.42 ' CD2' ' N ' ' A' ' 900' ' ' LEU . 4.5 mm? -95.95 113.22 24.82 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 114.223 1.194 . . . . 1.5900000000000001 114.223 -175.107 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 18.3 m -65.38 140.92 58.69 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 107.551 -1.277 . . . . 0.050000000000000003 107.551 177.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -64.68 -65.31 3.03 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 110.573 -1.011 . . . . 0.029999999999999999 110.573 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 46.95 66.44 0.99 Allowed 'General case' 0 N--CA 1.507 2.42 0 O-C-N 121.515 -0.991 . . . . 3.2000000000000002 111.01 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 54.3 ptt85 -68.8 -6.49 27.04 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.618 -0.676 . . . . 2.9199999999999999 112.059 -179.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 905' ' ' HIS . . . . . 0.491 ' O ' ' CB ' ' A' ' 906' ' ' GLU . 73.0 t60 -62.64 5.16 0.13 Allowed 'General case' 0 N--CA 1.505 2.293 0 O-C-N 120.91 -1.119 . . . . 2.8700000000000001 113.11 -179.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 906' ' ' GLU . . . . . 0.491 ' CB ' ' O ' ' A' ' 905' ' ' HIS . 0.9 OUTLIER 95.35 -164.82 0.0 OUTLIER 'General case' 0 N--CA 1.529 3.478 0 CA-C-N 120.561 1.528 . . . . 0.98999999999999999 111.947 179.004 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 907' ' ' LYS . . . . . 0.468 ' CB ' ' O ' ' A' ' 906' ' ' GLU . 52.9 tttt 87.21 157.58 0.07 Allowed 'General case' 0 N--CA 1.52 3.039 0 N-CA-C 108.143 -1.058 . . . . 5.25 108.143 -176.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 60.9 t -122.28 117.85 53.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 120.857 -1.152 . . . . 0.39000000000000001 111.179 -179.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -98.82 134.09 42.2 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 107.35 -1.352 . . . . 1.72 107.35 176.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -156.46 122.69 5.0 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 107.028 -1.471 . . . . 0.67000000000000004 107.028 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 911' ' ' VAL . . . . . 0.505 ' HA ' ' HA ' ' A' ' 964' ' ' VAL . 93.8 t -85.15 131.17 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 C-N-CA 120.442 -0.503 . . . . 0.54000000000000004 111.108 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 88.3 mt -65.22 157.97 27.44 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.397 -0.814 . . . . 1.5 109.361 178.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 913' ' ' SER . . . . . 0.404 ' CB ' ' CG1' ' A' ' 919' ' ' VAL . 1.7 t -127.64 134.94 49.64 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.239 -1.023 . . . . 1.3700000000000001 108.239 176.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 914' ' ' ARG . . . . . 0.42 ' O ' ' CB ' ' A' ' 915' ' ' SER . 0.0 OUTLIER -65.12 155.11 35.92 Favored 'General case' 0 N--CA 1.506 2.358 0 O-C-N 120.577 -1.327 . . . . 4.2999999999999998 111.628 -179.128 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 915' ' ' SER . . . . . 0.42 ' CB ' ' O ' ' A' ' 914' ' ' ARG . 1.6 p 82.93 -31.14 0.09 Allowed 'General case' 0 N--CA 1.52 3.046 0 C-N-CA 123.852 0.861 . . . . 2.0499999999999998 112.222 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 916' ' ' ASN . . . . . 0.428 ' O ' ' HB2' ' A' ' 917' ' ' GLN . 89.4 m-20 -122.63 -21.55 5.64 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.903 -1.123 . . . . 2.71 111.267 -179.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 917' ' ' GLN . . . . . 0.428 ' HB2' ' O ' ' A' ' 916' ' ' ASN . 58.9 mt-30 66.37 166.07 0.2 Allowed 'General case' 0 N--CA 1.519 3.018 0 N-CA-C 105.816 -1.92 . . . . 2.6800000000000002 105.816 -173.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.32 -125.32 33.65 Favored Glycine 1 N--CA 1.521 4.348 0 CA-C-N 123.472 2.851 . . . . 0.029999999999999999 106.98 -177.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 919' ' ' VAL . . . . . 0.404 ' CG1' ' CB ' ' A' ' 913' ' ' SER . 77.0 t 51.51 94.9 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 O-C-N 121.39 -1.065 . . . . 1.3899999999999999 109.15 -178.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 920' ' ' ALA . . . . . . . . . . . . . . . -92.34 93.0 8.4 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.318 -0.953 . . . . 0.029999999999999999 110.818 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 921' ' ' ARG . . . . . 0.426 ' HB2' ' CE1' ' A' ' 950' ' ' PHE . 23.1 ptt180 -84.15 -42.15 16.31 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 105.873 -1.899 . . . . 4.4199999999999999 105.873 176.119 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 922' ' ' VAL . . . . . . . . . . . . . 95.7 t -101.53 72.73 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 N-CA-C 105.94 -1.874 . . . . 0.84999999999999998 105.94 175.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -88.32 133.42 34.08 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.663 0.744 . . . . 2.46 111.502 -177.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 9.9 t -148.67 105.68 3.6 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.787 -0.82 . . . . 0.69999999999999996 108.787 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -101.56 82.67 0.47 Allowed Glycine 0 N--CA 1.487 2.037 0 N-CA-C 108.201 -1.96 . . . . 0.040000000000000001 108.201 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.211 0 N-CA-C 108.989 -1.644 . . . . 0.040000000000000001 108.989 -179.523 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 73.8 m . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 120.968 0.413 . . . . 13.779999999999999 110.31 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 96.7 mt -113.4 129.82 56.45 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.504 -0.747 . . . . 13.76 110.393 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -151.97 168.06 31.2 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.098 -1.601 . . . . 9.1300000000000008 109.098 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 949' ' ' VAL . . . . . . . . . . . . . 33.0 m -118.93 129.93 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.5 -1.0 . . . . 7.0800000000000001 110.916 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 950' ' ' PHE . . . . . 0.431 ' CE1' ' HD2' ' A' ' 955' ' ' PRO . 27.7 p90 -132.69 148.15 52.34 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.547 -0.721 . . . . 7.5899999999999999 109.212 179.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 58.5 m -121.15 -52.27 2.08 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.414 -0.804 . . . . 5.0300000000000002 112.103 -178.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 952' ' ' LEU . . . . . 0.414 ' O ' ' O ' ' A' ' 953' ' ' ILE . 20.5 tp -60.31 -73.67 0.09 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.446 -0.784 . . . . 1.01 112.403 -177.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 953' ' ' ILE . . . . . 0.457 ' O ' ' HB3' ' A' ' 954' ' ' LEU . 47.9 pt -53.44 -143.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.738 0 N-CA-C 114.008 1.114 . . . . 2.6000000000000001 114.008 -176.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 954' ' ' LEU . . . . . 0.548 ' N ' ' CD1' ' A' ' 954' ' ' LEU . 0.0 OUTLIER 172.57 75.0 0.04 OUTLIER Pre-proline 0 N--CA 1.508 2.47 0 O-C-N 120.825 -1.172 . . . . 0.050000000000000003 111.01 179.635 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 955' ' ' PRO . . . . . 0.431 ' HD2' ' CE1' ' A' ' 950' ' ' PHE . 47.9 Cg_endo -74.74 95.85 0.98 Allowed 'Trans proline' 0 C--N 1.315 -1.232 0 N-CA-C 109.702 -0.922 . . . . 0.83999999999999997 109.702 179.198 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 956' ' ' LEU . . . . . . . . . . . . . 7.1 mp -125.1 149.88 47.4 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.179 -0.95 . . . . 0.040000000000000001 110.27 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -82.75 150.78 26.48 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 117.701 -1.142 . . . . 1.28 111.468 -179.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -68.36 119.48 12.94 Favored 'General case' 0 N--CA 1.51 2.553 0 CA-C-N 123.098 2.681 . . . . 0.17000000000000001 111.316 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.87 -21.87 37.1 Favored Glycine 0 N--CA 1.5 2.924 0 N-CA-C 110.829 -0.908 . . . . 0.040000000000000001 110.829 178.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 960' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.13 172.27 0.09 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.504 -0.998 . . . . 0.040000000000000001 110.138 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 961' ' ' THR . . . . . 0.489 ' HA ' ' O ' ' A' ' 886' ' ' PHE . 39.3 m -135.87 138.81 42.86 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.963 -1.085 . . . . 1.78 112.377 -178.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 962' ' ' VAL . . . . . 0.416 ' CG2' ' CB ' ' A' ' 886' ' ' PHE . 32.4 m -98.72 144.22 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 C-N-CA 120.149 -0.62 . . . . 0.040000000000000001 110.03 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 5.5 t -139.69 143.88 37.29 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.671 -0.643 . . . . 0.71999999999999997 109.914 -178.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 964' ' ' VAL . . . . . 0.505 ' HA ' ' HA ' ' A' ' 911' ' ' VAL . 59.1 t -95.0 137.19 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.097 -1.002 . . . . 1.05 110.699 -179.108 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -91.5 128.91 37.51 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 103.819 -2.66 . . . . 3.02 103.819 173.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 966' ' ' LEU . . . . . 0.404 ' O ' ' CG2' ' A' ' 967' ' ' VAL . 1.5 tp -131.33 59.71 1.68 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.162 -1.051 . . . . 1.46 108.162 177.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 967' ' ' VAL . . . . . 0.404 ' CG2' ' O ' ' A' ' 966' ' ' LEU . 97.8 t -158.16 96.54 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 108.096 -1.075 . . . . 1.9399999999999999 108.096 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 87.1 mmm -143.58 59.13 1.38 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.761 -1.212 . . . . 0.0 108.262 178.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 134.96 119.52 1.95 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 106.91 -2.476 . . . . 2.1099999999999999 106.91 -178.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -82.34 -58.24 3.02 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.039 -1.271 . . . . 5.8899999999999997 110.327 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 44.0 tp -58.86 90.81 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.406 -0.809 . . . . 4.3600000000000003 110.171 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -141.65 -154.56 0.53 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.614 -0.679 . . . . 1.8300000000000001 110.236 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -120.05 172.42 7.76 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.522 -0.736 . . . . 4.3499999999999996 110.268 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 38.6 t -101.37 130.05 47.48 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.576 -0.703 . . . . 1.27 109.946 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -156.03 157.74 36.64 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.527 -0.733 . . . . 5.0199999999999996 110.515 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.14 85.34 19.04 Favored Pre-proline 0 N--CA 1.5 2.035 0 O-C-N 121.652 -0.655 . . . . 2.4100000000000001 109.662 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -72.81 -172.52 0.98 Allowed 'Trans proline' 0 C--N 1.317 -1.123 0 O-C-N 123.304 1.16 . . . . 0.95999999999999996 111.192 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 5.9 mp -128.04 154.24 45.88 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 107.575 -1.268 . . . . 0.62 107.575 177.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 979' ' ' THR . . . . . . . . . . . . . 43.2 p -149.79 142.07 24.17 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.851 -1.156 . . . . 3.5699999999999998 111.185 -179.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 980' ' ' ILE . . . . . . . . . . . . . 46.9 mm -105.87 127.76 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 108.708 -0.849 . . . . 1.3300000000000001 108.708 179.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 981' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -120.26 97.73 5.72 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 119.641 -0.823 . . . . 0.050000000000000003 111.828 -178.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 59.2 p -107.86 158.66 17.15 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 109.114 -0.699 . . . . 0.87 109.114 178.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 983' ' ' GLY . . . . . 0.416 ' HA3' ' CE1' ' A' ' 852' ' ' PHE . . . -175.36 107.26 0.24 Allowed Glycine 0 N--CA 1.499 2.836 0 N-CA-C 106.354 -2.699 . . . . 0.029999999999999999 106.354 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -109.21 152.64 24.9 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 114.583 1.327 . . . . 0.69999999999999996 114.583 -175.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 30.5 tp -72.23 134.2 45.49 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.887 -1.133 . . . . 0.040000000000000001 109.895 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 48.6 tp -107.9 -57.8 2.06 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.564 -0.71 . . . . 0.040000000000000001 110.208 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -144.28 145.35 31.97 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 107.592 -1.262 . . . . 0.040000000000000001 107.592 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.68 163.22 12.18 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 108.218 -1.953 . . . . 0.040000000000000001 108.218 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -74.43 112.7 18.36 Favored Pre-proline 0 N--CA 1.498 1.932 0 O-C-N 121.259 -1.142 . . . . 0.040000000000000001 109.468 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 990' ' ' PRO . . . . . 0.422 ' O ' ' HB2' ' A' ' 991' ' ' GLU . 50.6 Cg_endo -89.2 70.89 2.11 Favored 'Trans proline' 0 C--N 1.319 -1.022 0 O-C-N 123.199 1.105 . . . . 0.45000000000000001 111.482 -178.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 991' ' ' GLU . . . . . 0.422 ' HB2' ' O ' ' A' ' 990' ' ' PRO . 77.2 mt-10 67.18 -73.91 0.07 Allowed 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 108.524 -0.917 . . . . 1.97 108.524 -177.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 992' ' ' LEU . . . . . . . . . . . . . 10.5 mt 51.19 20.7 0.93 Allowed 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.562 -0.711 . . . . 2.3799999999999999 111.532 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -93.3 157.11 16.41 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.933 -1.105 . . . . 3.79 110.044 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 71.5 m80 -146.85 92.64 2.16 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.515 -0.74 . . . . 3.5099999999999998 110.195 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 995' ' ' ALA . . . . . . . . . . . . 2.519 . . . . . . . 0 N--CA 1.503 2.2 0 O-C-N 120.904 -1.122 . . . . 2.73 110.599 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo . . . . . 0 N--CA 1.487 1.147 0 N-CA-C 109.506 -0.998 . . . . 3.8300000000000001 109.506 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 847' ' ' VAL . . . . . . . . . . . . . 58.9 t -133.85 102.69 12.24 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.619 -0.676 . . . . 1.8300000000000001 109.994 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 848' ' ' PRO . . . . . 0.404 ' O ' ' C ' ' B' ' 849' ' ' GLN . 44.0 Cg_endo -69.68 -19.62 36.25 Favored 'Trans proline' 0 N--CA 1.488 1.152 0 O-C-N 123.279 1.147 . . . . 0.65000000000000002 111.245 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 849' ' ' GLN . . . . . 0.404 ' C ' ' O ' ' B' ' 848' ' ' PRO . 56.0 tt0 28.22 68.33 0.08 Allowed 'General case' 0 N--CA 1.518 2.931 0 N-CA-C 112.831 0.678 . . . . 2.5800000000000001 112.831 179.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 850' ' ' VAL . . . . . . . . . . . . . 66.2 t -119.95 137.07 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.141 -0.974 . . . . 1.0900000000000001 111.445 -178.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 851' ' ' ALA . . . . . . . . . . . . . . . -124.15 159.15 30.68 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 105.945 -1.872 . . . . 0.040000000000000001 105.945 176.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 852' ' ' PHE . . . . . 0.424 ' CE1' ' HA3' ' B' ' 983' ' ' GLY . 33.5 p90 -158.56 128.09 5.73 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 120.943 1.702 . . . . 0.050000000000000003 108.344 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 7.9 t -175.48 134.18 0.3 Allowed 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.281 -1.007 . . . . 0.040000000000000001 108.281 -178.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -129.83 157.22 42.84 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.011 -1.056 . . . . 0.67000000000000004 109.824 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 855' ' ' ALA . . . . . 0.433 ' O ' ' HB2' ' B' ' 870' ' ' ARG . . . -119.92 144.7 47.3 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.843 0.83 . . . . 0.51000000000000001 110.776 -179.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 856' ' ' LEU . . . . . 0.416 HD21 ' CG1' ' B' ' 866' ' ' VAL . 2.1 tm? -115.83 133.72 55.74 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.493 -0.754 . . . . 0.050000000000000003 110.542 -179.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 857' ' ' SER . . . . . 0.409 ' O ' ' O ' ' B' ' 858' ' ' LEU . 1.8 m -156.4 14.45 0.31 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.459 -0.775 . . . . 1.3300000000000001 111.804 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 858' ' ' LEU . . . . . 0.409 ' O ' ' O ' ' B' ' 857' ' ' SER . 0.3 OUTLIER -36.53 162.19 0.04 OUTLIER Pre-proline 0 N--CA 1.524 3.254 0 CA-C-N 119.052 0.842 . . . . 2.3300000000000001 113.074 -179.693 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -61.26 -89.38 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 120.947 1.098 . . . . 2.3199999999999998 113.804 -177.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 53.9 ptt85 -134.19 -142.46 0.2 Allowed 'General case' 0 N--CA 1.501 2.114 0 O-C-N 120.802 -1.186 . . . . 0.040000000000000001 111.815 -177.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 5.2 m -36.56 126.46 0.84 Allowed 'General case' 0 N--CA 1.512 2.645 0 O-C-N 121.671 -0.643 . . . . 1.3100000000000001 112.373 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 862' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -104.34 165.67 12.95 Favored Pre-proline 0 N--CA 1.488 1.451 0 N-CA-C 108.637 -0.875 . . . . 4.5099999999999998 108.637 177.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -73.45 -14.57 25.11 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 O-C-N 123.294 1.155 . . . . 2.2400000000000002 111.396 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -177.68 -133.75 1.91 Allowed Glycine 0 N--CA 1.495 2.592 0 N-CA-C 110.184 -1.167 . . . . 0.040000000000000001 110.184 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 27.1 m -66.07 157.64 30.54 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.351 -1.088 . . . . 1.51 110.733 -178.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 866' ' ' VAL . . . . . 0.416 ' CG1' HD21 ' B' ' 856' ' ' LEU . 56.9 t -97.73 132.71 24.49 Favored Pre-proline 0 N--CA 1.496 1.833 0 N-CA-C 113.402 0.89 . . . . 0.78000000000000003 113.402 -174.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 867' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -90.71 -149.73 0.03 OUTLIER 'Trans proline' 0 CA--C 1.544 1.02 0 C-N-CA 121.219 1.279 . . . . 0.92000000000000004 109.356 177.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 868' ' ' PHE . . . . . 0.462 ' CD1' ' N ' ' B' ' 868' ' ' PHE . 19.4 p90 -150.19 123.25 8.82 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.493 -1.379 . . . . 0.050000000000000003 109.858 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 50.2 p-10 -113.35 -2.32 14.02 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.101 -1.0 . . . . 1.7 112.786 -178.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 870' ' ' ARG . . . . . 0.433 ' HB2' ' O ' ' B' ' 855' ' ' ALA . 28.0 mmm180 -91.74 89.79 7.24 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.861 -1.149 . . . . 2.5899999999999999 111.167 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 57.5 t -72.9 96.75 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 120.978 -1.077 . . . . 1.9399999999999999 109.669 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 872' ' ' LEU . . . . . . . . . . . . . 87.1 mt -83.56 -46.66 12.15 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.508 -0.745 . . . . 1.0600000000000001 110.117 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 873' ' ' LEU . . . . . . . . . . . . . 32.6 tp -174.31 102.25 0.1 Allowed 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.583 -0.895 . . . . 4.1799999999999997 108.583 178.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 874' ' ' ASN . . . . . . . . . . . . . 33.8 t-20 178.36 81.08 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.664 -0.647 . . . . 0.040000000000000001 109.371 -179.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -65.5 -47.1 77.17 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 119.349 -0.941 . . . . 3.3799999999999999 111.102 -179.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 876' ' ' GLY . . . . . . . . . . . . . . . -73.98 -24.27 74.3 Favored Glycine 0 N--CA 1.493 2.477 0 O-C-N 121.285 -0.884 . . . . 0.040000000000000001 111.687 -178.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 84.41 -59.95 4.88 Favored Glycine 0 N--CA 1.502 3.069 0 N-CA-C 107.948 -2.061 . . . . 0.040000000000000001 107.948 -178.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 878' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 60.41 -66.68 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 114.474 1.287 . . . . 3.46 114.474 177.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 879' ' ' TYR . . . . . 0.471 ' CB ' ' CD2' ' B' ' 886' ' ' PHE . 21.3 p90 -110.78 109.62 19.91 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 114.785 1.402 . . . . 0.040000000000000001 114.785 -176.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -65.94 117.06 38.54 Favored Pre-proline 0 N--CA 1.496 1.847 0 O-C-N 121.557 -0.715 . . . . 0.02 110.117 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 881' ' ' PRO . . . . . 0.438 ' HG2' ' CD1' ' B' ' 868' ' ' PHE . 53.8 Cg_endo -75.78 0.23 9.45 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 O-C-N 123.477 1.251 . . . . 0.39000000000000001 112.252 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -75.26 -65.23 0.91 Allowed 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 106.953 -1.499 . . . . 0.81000000000000005 106.953 178.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 2.2 p -95.87 -16.53 21.74 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.88 -0.785 . . . . 0.040000000000000001 108.88 177.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.2 23.34 52.02 Favored Glycine 0 N--CA 1.493 2.489 0 C-N-CA 120.069 -1.063 . . . . 0.029999999999999999 110.719 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 885' ' ' VAL . . . . . . . . . . . . . 92.6 t -73.56 88.7 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 C-N-CA 118.392 -1.323 . . . . 1.01 107.806 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 886' ' ' PHE . . . . . 0.492 ' O ' ' HA ' ' B' ' 961' ' ' THR . 0.6 OUTLIER -89.36 106.28 18.34 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 115.121 -0.945 . . . . 0.050000000000000003 112.234 -177.12 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 887' ' ' THR . . . . . . . . . . . . . 96.9 m -98.67 99.44 10.56 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 107.493 -1.299 . . . . 0.68000000000000005 107.493 176.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 888' ' ' ALA . . . . . . . . . . . . . . . -97.52 108.13 43.31 Favored Pre-proline 0 N--CA 1.502 2.134 0 N-CA-C 114.119 1.155 . . . . 0.25 114.119 -176.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 889' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -89.37 -13.85 2.77 Favored 'Trans proline' 0 CA--C 1.546 1.091 0 N-CA-C 109.135 -1.14 . . . . 1.6399999999999999 109.135 176.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 890' ' ' LEU . . . . . . . . . . . . . 62.9 mt -35.73 -50.64 0.64 Allowed 'General case' 0 N--CA 1.509 2.497 0 N-CA-C 113.68 0.992 . . . . 2.29 113.68 -177.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 52.1 95.44 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.154 -0.966 . . . . 0.63 110.338 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . 157.65 -154.16 25.28 Favored Glycine 0 N--CA 1.478 1.491 0 N-CA-C 107.085 -2.406 . . . . 0.040000000000000001 107.085 -179.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 71.7 ttt-85 -116.34 125.26 51.85 Favored 'General case' 0 C--N 1.294 -1.807 0 O-C-N 121.564 -0.963 . . . . 3.0 108.511 177.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 894' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -131.9 161.63 32.56 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.082 -1.011 . . . . 0.040000000000000001 111.113 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 895' ' ' LEU . . . . . . . . . . . . . 43.3 tp -92.27 119.32 31.75 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.681 -0.637 . . . . 1.27 110.355 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 896' ' ' LEU . . . . . . . . . . . . . 9.1 tt -110.11 143.87 39.55 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.725 -0.609 . . . . 0.93999999999999995 110.053 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 897' ' ' SER . . . . . . . . . . . . . 68.7 m -148.81 114.5 5.66 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.426 -0.796 . . . . 0.040000000000000001 111.098 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.23 145.99 31.97 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.011 -0.737 . . . . 0.47999999999999998 109.011 178.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 899' ' ' VAL . . . . . . . . . . . . . 88.4 t -96.22 119.07 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.356 -0.84 . . . . 0.55000000000000004 111.245 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 900' ' ' LEU . . . . . 0.421 ' N ' ' CD2' ' B' ' 900' ' ' LEU . 4.5 mm? -95.97 112.7 24.36 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 114.288 1.218 . . . . 1.5900000000000001 114.288 -175.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 18.1 m -64.94 140.79 58.9 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 107.531 -1.285 . . . . 0.050000000000000003 107.531 177.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -64.83 -65.26 3.04 Favored Glycine 0 N--CA 1.494 2.515 0 N-CA-C 110.639 -0.985 . . . . 0.029999999999999999 110.639 -179.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 46.89 66.64 0.94 Allowed 'General case' 0 N--CA 1.507 2.411 0 O-C-N 121.472 -1.017 . . . . 3.2000000000000002 110.964 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 54.3 ptt85 -68.85 -6.78 29.05 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.639 -0.663 . . . . 2.9199999999999999 112.073 -179.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 905' ' ' HIS . . . . . 0.488 ' O ' ' CB ' ' B' ' 906' ' ' GLU . 72.8 t60 -62.08 4.74 0.12 Allowed 'General case' 0 N--CA 1.505 2.323 0 O-C-N 120.876 -1.14 . . . . 2.8700000000000001 113.111 -179.132 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 906' ' ' GLU . . . . . 0.488 ' CB ' ' O ' ' B' ' 905' ' ' HIS . 0.9 OUTLIER 95.62 -164.94 0.0 OUTLIER 'General case' 0 N--CA 1.53 3.549 0 CA-C-N 120.612 1.551 . . . . 0.98999999999999999 111.781 179.1 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 907' ' ' LYS . . . . . 0.47 ' CB ' ' O ' ' B' ' 906' ' ' GLU . 53.3 tttt 87.31 157.28 0.07 Allowed 'General case' 0 N--CA 1.52 3.073 0 N-CA-C 108.132 -1.062 . . . . 5.25 108.132 -177.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 60.9 t -122.08 117.5 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 120.894 -1.129 . . . . 0.39000000000000001 111.243 -179.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 52.8 tp10 -98.33 134.37 41.43 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 107.333 -1.358 . . . . 1.72 107.333 176.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -156.83 122.8 4.85 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 106.992 -1.484 . . . . 0.67000000000000004 106.992 178.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 911' ' ' VAL . . . . . 0.503 ' HA ' ' HA ' ' B' ' 964' ' ' VAL . 94.9 t -85.34 131.54 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.906 -0.496 . . . . 0.54000000000000004 111.061 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 88.2 mt -65.44 158.13 27.6 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.362 -0.836 . . . . 1.5 109.359 178.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 913' ' ' SER . . . . . 0.411 ' CB ' ' CG1' ' B' ' 919' ' ' VAL . 1.8 t -127.97 134.39 49.28 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.274 -1.01 . . . . 1.3700000000000001 108.274 176.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 914' ' ' ARG . . . . . 0.411 ' O ' ' CB ' ' B' ' 915' ' ' SER . 0.0 OUTLIER -64.51 155.05 34.11 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 120.577 -1.327 . . . . 4.2999999999999998 111.685 -179.067 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 915' ' ' SER . . . . . 0.411 ' CB ' ' O ' ' B' ' 914' ' ' ARG . 1.6 p 83.05 -31.44 0.09 Allowed 'General case' 0 N--CA 1.521 3.093 0 C-N-CA 123.84 0.856 . . . . 2.0499999999999998 112.224 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 916' ' ' ASN . . . . . 0.428 ' O ' ' HB2' ' B' ' 917' ' ' GLN . 89.2 m-20 -122.25 -21.91 5.73 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.92 -1.112 . . . . 2.71 111.288 -179.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 917' ' ' GLN . . . . . 0.428 ' HB2' ' O ' ' B' ' 916' ' ' ASN . 58.5 mt-30 66.5 165.43 0.2 Allowed 'General case' 0 N--CA 1.52 3.029 0 N-CA-C 105.782 -1.933 . . . . 2.6800000000000002 105.782 -174.012 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 55.05 -125.38 35.58 Favored Glycine 1 N--CA 1.52 4.268 0 CA-C-N 123.478 2.854 . . . . 0.029999999999999999 106.858 -177.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 919' ' ' VAL . . . . . 0.411 ' CG1' ' CB ' ' B' ' 913' ' ' SER . 80.5 t 51.44 94.91 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.233 0 O-C-N 121.419 -1.047 . . . . 1.3899999999999999 109.189 -178.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 920' ' ' ALA . . . . . . . . . . . . . . . -92.4 92.85 8.3 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.324 -0.951 . . . . 0.029999999999999999 110.823 -179.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 921' ' ' ARG . . . . . 0.426 ' HB3' ' CZ ' ' B' ' 950' ' ' PHE . 23.2 ptt180 -84.12 -42.11 16.4 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 105.885 -1.894 . . . . 4.4199999999999999 105.885 176.163 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 922' ' ' VAL . . . . . . . . . . . . . 95.7 t -101.52 72.64 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 N-CA-C 105.92 -1.882 . . . . 0.84999999999999998 105.92 175.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -88.19 133.47 34.02 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.615 0.721 . . . . 2.46 111.495 -177.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 924' ' ' SER . . . . . . . . . . . . . 9.9 t -148.68 105.72 3.6 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.76 -0.829 . . . . 0.69999999999999996 108.76 179.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -101.5 82.62 0.47 Allowed Glycine 0 N--CA 1.487 2.049 0 N-CA-C 108.176 -1.97 . . . . 0.040000000000000001 108.176 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.143 0 N-CA-C 109.026 -1.629 . . . . 0.040000000000000001 109.026 -179.562 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 76.9 m . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.016 0.436 . . . . 13.779999999999999 110.215 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 96.7 mt -112.24 129.87 56.12 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.546 -0.722 . . . . 13.76 110.4 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -151.65 167.5 30.96 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.153 -1.579 . . . . 9.1300000000000008 109.153 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 949' ' ' VAL . . . . . . . . . . . . . 32.1 m -118.69 129.85 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.548 -0.972 . . . . 7.0800000000000001 110.845 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 950' ' ' PHE . . . . . 0.435 ' CE1' ' HD2' ' B' ' 955' ' ' PRO . 27.9 p90 -132.74 148.17 52.33 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.586 -0.696 . . . . 7.5899999999999999 109.267 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 58.5 m -121.16 -51.92 2.09 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.452 -0.78 . . . . 5.0300000000000002 112.13 -178.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 952' ' ' LEU . . . . . 0.41 ' O ' ' O ' ' B' ' 953' ' ' ILE . 20.3 tp -60.52 -73.88 0.08 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.396 -0.815 . . . . 1.01 112.347 -177.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 953' ' ' ILE . . . . . 0.466 ' O ' ' HB3' ' B' ' 954' ' ' LEU . 49.3 pt -53.18 -143.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.754 0 N-CA-C 114.082 1.141 . . . . 2.6000000000000001 114.082 -176.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 954' ' ' LEU . . . . . 0.544 ' N ' ' CD1' ' B' ' 954' ' ' LEU . 0.0 OUTLIER 172.31 74.69 0.04 OUTLIER Pre-proline 0 N--CA 1.509 2.496 0 O-C-N 120.793 -1.192 . . . . 0.050000000000000003 110.955 179.68 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 955' ' ' PRO . . . . . 0.435 ' HD2' ' CE1' ' B' ' 950' ' ' PHE . 48.1 Cg_endo -74.64 95.95 0.97 Allowed 'Trans proline' 0 C--N 1.315 -1.218 0 N-CA-C 109.714 -0.918 . . . . 0.83999999999999997 109.714 179.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 956' ' ' LEU . . . . . . . . . . . . . 7.1 mp -125.23 149.88 47.56 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.232 -0.917 . . . . 0.040000000000000001 110.258 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -82.78 150.94 26.35 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 117.824 -1.084 . . . . 1.28 111.375 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -68.42 119.15 12.44 Favored 'General case' 0 N--CA 1.509 2.492 0 CA-C-N 122.913 2.597 . . . . 0.17000000000000001 111.389 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 93.07 -21.92 37.31 Favored Glycine 0 N--CA 1.5 2.942 0 N-CA-C 110.792 -0.923 . . . . 0.040000000000000001 110.792 178.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 960' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.02 172.38 0.08 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.473 -1.016 . . . . 0.040000000000000001 110.166 -179.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 961' ' ' THR . . . . . 0.492 ' HA ' ' O ' ' B' ' 886' ' ' PHE . 38.8 m -135.83 139.03 43.13 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.942 -1.099 . . . . 1.78 112.338 -178.074 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 962' ' ' VAL . . . . . 0.422 ' CG2' ' CB ' ' B' ' 886' ' ' PHE . 32.2 m -99.09 144.02 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 C-N-CA 120.112 -0.635 . . . . 0.040000000000000001 110.032 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 5.4 t -139.37 143.88 37.93 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.682 -0.636 . . . . 0.71999999999999997 109.982 -178.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 964' ' ' VAL . . . . . 0.503 ' HA ' ' HA ' ' B' ' 911' ' ' VAL . 59.0 t -95.2 137.02 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.208 -0.933 . . . . 1.05 110.696 -179.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -91.51 128.43 37.34 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 103.898 -2.631 . . . . 3.02 103.898 173.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 966' ' ' LEU . . . . . 0.408 ' O ' ' CG2' ' B' ' 967' ' ' VAL . 1.5 tp -130.9 59.89 1.66 Allowed 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.228 -1.027 . . . . 1.46 108.228 177.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 967' ' ' VAL . . . . . 0.408 ' CG2' ' O ' ' B' ' 966' ' ' LEU . 98.3 t -158.27 96.47 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 108.08 -1.081 . . . . 1.9399999999999999 108.08 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 87.1 mmm -143.49 58.95 1.39 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.804 -1.185 . . . . 0.0 108.265 178.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 134.99 119.38 1.93 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 107.111 -2.396 . . . . 2.1099999999999999 107.111 -178.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -82.07 -58.22 3.06 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.085 -1.244 . . . . 5.8899999999999997 110.338 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 44.2 tp -58.97 90.57 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.377 -0.827 . . . . 4.3600000000000003 110.19 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -141.47 -154.63 0.53 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.589 -0.694 . . . . 1.8300000000000001 110.27 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -119.95 172.54 7.65 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.455 -0.778 . . . . 4.3499999999999996 110.275 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 38.6 t -101.56 130.02 47.77 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.525 -0.734 . . . . 1.27 109.961 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -155.99 157.74 36.7 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.474 -0.767 . . . . 5.0199999999999996 110.495 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.15 85.33 19.0 Favored Pre-proline 0 N--CA 1.5 2.05 0 O-C-N 121.633 -0.667 . . . . 2.4100000000000001 109.622 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -72.82 -172.59 0.99 Allowed 'Trans proline' 0 C--N 1.317 -1.083 0 O-C-N 123.282 1.148 . . . . 0.95999999999999996 111.219 -179.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 978' ' ' LEU . . . . . . . . . . . . . 5.9 mp -127.82 154.51 45.36 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.653 -1.24 . . . . 0.62 107.653 177.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 979' ' ' THR . . . . . . . . . . . . . 42.8 p -150.03 142.08 23.96 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.842 -1.161 . . . . 3.5699999999999998 111.142 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 980' ' ' ILE . . . . . . . . . . . . . 46.8 mm -105.99 127.4 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 108.732 -0.84 . . . . 1.3300000000000001 108.732 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -120.0 98.0 5.88 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 119.649 -0.821 . . . . 0.050000000000000003 111.746 -178.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 53.8 p -108.4 158.81 17.18 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 109.154 -0.684 . . . . 0.87 109.154 178.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 983' ' ' GLY . . . . . 0.424 ' HA3' ' CE1' ' B' ' 852' ' ' PHE . . . -175.25 107.41 0.24 Allowed Glycine 0 N--CA 1.498 2.821 0 N-CA-C 106.469 -2.652 . . . . 0.029999999999999999 106.469 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -109.16 152.53 25.0 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 114.587 1.328 . . . . 0.69999999999999996 114.587 -175.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 985' ' ' LEU . . . . . . . . . . . . . 30.5 tp -72.24 134.1 45.43 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.93 -1.106 . . . . 0.040000000000000001 109.805 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 986' ' ' LEU . . . . . . . . . . . . . 48.1 tp -107.82 -57.79 2.05 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.541 -0.725 . . . . 0.040000000000000001 110.259 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -144.31 145.23 31.87 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.621 -1.252 . . . . 0.040000000000000001 107.621 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.49 163.07 12.2 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 108.255 -1.938 . . . . 0.040000000000000001 108.255 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -74.27 112.72 18.23 Favored Pre-proline 0 N--CA 1.498 1.956 0 O-C-N 121.204 -1.174 . . . . 0.040000000000000001 109.442 179.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 990' ' ' PRO . . . . . 0.418 ' O ' ' HB2' ' B' ' 991' ' ' GLU . 50.0 Cg_endo -89.2 71.04 2.09 Favored 'Trans proline' 0 C--N 1.319 -0.985 0 O-C-N 123.093 1.049 . . . . 0.45000000000000001 111.459 -178.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 991' ' ' GLU . . . . . 0.418 ' HB2' ' O ' ' B' ' 990' ' ' PRO . 77.3 mt-10 67.0 -73.84 0.07 Allowed 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 108.603 -0.888 . . . . 1.97 108.603 -177.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 992' ' ' LEU . . . . . . . . . . . . . 10.6 mt 51.29 20.4 0.93 Allowed 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.614 -0.679 . . . . 2.3799999999999999 111.634 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -92.95 157.13 16.49 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.869 -1.144 . . . . 3.79 110.055 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 71.2 m80 -146.91 92.1 2.09 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.511 -0.743 . . . . 3.5099999999999998 110.329 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 995' ' ' ALA . . . . . . . . . . . . 2.52 . . . . . . . 0 N--CA 1.503 2.208 0 O-C-N 120.886 -1.134 . . . . 2.73 110.655 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo . . . . . 0 N--CA 1.488 1.154 0 N-CA-C 109.496 -1.001 . . . . 3.8300000000000001 109.496 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' 847' ' ' VAL . . . . . . . . . . . . . 61.8 t -128.75 103.89 19.09 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.579 -0.7 . . . . 1.8300000000000001 110.093 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 848' ' ' PRO . . . . . 0.4 ' O ' ' C ' ' C' ' 849' ' ' GLN . 44.3 Cg_endo -70.34 -22.23 29.68 Favored 'Trans proline' 0 N--CA 1.488 1.185 0 O-C-N 123.285 1.15 . . . . 0.65000000000000002 111.254 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 849' ' ' GLN . . . . . 0.4 ' C ' ' O ' ' C' ' 848' ' ' PRO . 57.2 tt0 26.88 68.79 0.06 Allowed 'General case' 0 N--CA 1.519 2.998 0 N-CA-C 112.92 0.711 . . . . 2.5800000000000001 112.92 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 850' ' ' VAL . . . . . . . . . . . . . 94.3 t -119.76 135.4 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.129 -0.982 . . . . 1.0900000000000001 111.57 -178.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 851' ' ' ALA . . . . . . . . . . . . . . . -127.86 155.53 43.98 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 105.795 -1.928 . . . . 0.040000000000000001 105.795 176.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 852' ' ' PHE . . . . . 0.454 ' CD1' ' N ' ' C' ' 852' ' ' PHE . 13.6 p90 -159.61 127.79 4.94 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 121.018 1.736 . . . . 0.050000000000000003 108.522 178.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 12.1 t -176.51 134.37 0.23 Allowed 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.246 -1.02 . . . . 0.040000000000000001 108.246 -178.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -132.84 156.76 46.56 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.142 -0.974 . . . . 0.67000000000000004 109.693 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 855' ' ' ALA . . . . . 0.417 ' O ' ' HB2' ' C' ' 870' ' ' ARG . . . -122.96 140.95 52.47 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 122.035 0.921 . . . . 0.51000000000000001 111.419 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 856' ' ' LEU . . . . . 0.407 HD21 ' CG1' ' C' ' 866' ' ' VAL . 3.5 tm? -113.39 137.71 51.13 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.687 -0.633 . . . . 0.050000000000000003 109.936 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 857' ' ' SER . . . . . 0.423 ' O ' ' O ' ' C' ' 858' ' ' LEU . 1.9 m -157.08 19.25 0.3 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.548 -0.72 . . . . 1.3300000000000001 111.084 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 858' ' ' LEU . . . . . 0.423 ' O ' ' O ' ' C' ' 857' ' ' SER . 4.1 pp -35.54 160.26 0.04 OUTLIER Pre-proline 0 N--CA 1.517 2.886 0 N-CA-C 112.729 0.64 . . . . 2.3300000000000001 112.729 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -59.25 -88.9 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.455 0 O-C-N 122.99 0.995 . . . . 2.3199999999999998 113.386 -177.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 54.5 ptt85 -129.26 -142.56 0.25 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.883 -1.136 . . . . 0.040000000000000001 111.635 -177.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 9.9 m -36.57 126.65 0.84 Allowed 'General case' 0 N--CA 1.51 2.536 0 O-C-N 121.61 -0.681 . . . . 1.3100000000000001 112.634 -178.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.76 159.28 30.03 Favored Pre-proline 0 N--CA 1.489 1.514 0 N-CA-C 108.177 -1.046 . . . . 4.5099999999999998 108.177 177.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -71.93 -14.1 29.3 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 O-C-N 123.11 1.058 . . . . 2.2400000000000002 111.523 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -177.72 -136.35 2.47 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 110.04 -1.224 . . . . 0.040000000000000001 110.04 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 25.7 m -65.37 154.85 37.17 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.355 -1.085 . . . . 1.51 110.247 -179.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 866' ' ' VAL . . . . . 0.407 ' CG1' HD21 ' C' ' 856' ' ' LEU . 20.7 t -95.62 138.68 21.77 Favored Pre-proline 0 N--CA 1.496 1.874 0 N-CA-C 113.917 1.08 . . . . 0.78000000000000003 113.917 -174.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 867' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -94.07 -151.33 0.03 OUTLIER 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 121.417 1.412 . . . . 0.92000000000000004 109.002 177.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 868' ' ' PHE . . . . . 0.441 ' N ' ' CD1' ' C' ' 868' ' ' PHE . 13.7 p90 -150.05 124.65 9.71 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.556 -1.34 . . . . 0.050000000000000003 110.036 179.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 50.7 p-10 -112.34 -2.79 14.7 Favored 'General case' 0 N--CA 1.5 2.044 0 C-N-CA 119.216 -0.994 . . . . 1.7 112.715 -178.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 870' ' ' ARG . . . . . 0.417 ' HB2' ' O ' ' C' ' 855' ' ' ALA . 25.7 mmm180 -92.08 88.16 6.43 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 120.844 -1.16 . . . . 2.5899999999999999 111.36 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 65.3 t -72.45 97.09 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 120.949 -1.094 . . . . 1.9399999999999999 109.132 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 872' ' ' LEU . . . . . . . . . . . . . 95.0 mt -86.98 -45.42 10.79 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.572 -0.705 . . . . 1.0600000000000001 110.82 -179.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 873' ' ' LEU . . . . . 0.413 ' O ' ' HB2' ' C' ' 874' ' ' ASN . 30.4 tp -172.91 101.98 0.13 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.153 -0.967 . . . . 4.1799999999999997 108.788 178.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 874' ' ' ASN . . . . . 0.413 ' HB2' ' O ' ' C' ' 873' ' ' LEU . 32.8 t-20 176.99 82.5 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 108.833 -0.803 . . . . 0.040000000000000001 108.833 -178.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -65.15 -46.41 80.98 Favored 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 119.267 -0.973 . . . . 3.3799999999999999 111.244 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 876' ' ' GLY . . . . . 0.405 ' HA3' ' CE2' ' C' ' 878' ' ' TYR . . . -73.5 -25.65 72.0 Favored Glycine 0 N--CA 1.492 2.403 0 O-C-N 121.257 -0.902 . . . . 0.040000000000000001 111.643 -178.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 81.04 -62.22 4.47 Favored Glycine 0 N--CA 1.501 3.023 0 N-CA-C 107.769 -2.132 . . . . 0.040000000000000001 107.769 -178.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 878' ' ' TYR . . . . . 0.405 ' CE2' ' HA3' ' C' ' 876' ' ' GLY . 85.6 m-85 60.61 -66.29 0.05 Allowed 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 114.497 1.295 . . . . 3.46 114.497 177.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 879' ' ' TYR . . . . . 0.46 ' CB ' ' CD2' ' C' ' 886' ' ' PHE . 25.1 p90 -109.49 109.3 20.07 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 115.271 1.582 . . . . 0.040000000000000001 115.271 -176.094 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.03 115.82 29.38 Favored Pre-proline 0 N--CA 1.498 1.932 0 O-C-N 121.637 -0.664 . . . . 0.02 109.98 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 881' ' ' PRO . . . . . 0.439 ' HG2' ' CD1' ' C' ' 868' ' ' PHE . 53.8 Cg_endo -76.65 0.65 9.34 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 O-C-N 123.361 1.19 . . . . 0.39000000000000001 112.137 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -74.51 -66.02 0.79 Allowed 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 106.796 -1.557 . . . . 0.81000000000000005 106.796 178.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 2.6 p -95.45 -14.79 23.45 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.813 -0.81 . . . . 0.040000000000000001 108.813 177.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.14 21.98 55.82 Favored Glycine 0 N--CA 1.493 2.476 0 O-C-N 121.042 -1.036 . . . . 0.029999999999999999 111.029 178.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 68.9 t -72.9 87.98 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 C-N-CA 118.189 -1.404 . . . . 1.01 107.492 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 886' ' ' PHE . . . . . 0.491 ' O ' ' HA ' ' C' ' 961' ' ' THR . 0.9 OUTLIER -88.61 103.71 16.17 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-N 115.157 -0.929 . . . . 0.050000000000000003 112.038 -177.075 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 887' ' ' THR . . . . . 0.406 ' O ' ' HD3' ' C' ' 889' ' ' PRO . 88.5 m -99.28 100.24 11.3 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.834 -1.172 . . . . 0.68000000000000005 107.834 177.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 888' ' ' ALA . . . . . . . . . . . . . . . -99.05 102.63 16.07 Favored Pre-proline 0 N--CA 1.502 2.158 0 N-CA-C 114.505 1.298 . . . . 0.25 114.505 -176.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 889' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' C' ' 887' ' ' THR . 55.9 Cg_endo -83.6 -15.37 7.37 Favored 'Trans proline' 0 CA--C 1.545 1.061 0 N-CA-C 108.827 -1.259 . . . . 1.6399999999999999 108.827 175.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 890' ' ' LEU . . . . . . . . . . . . . 65.7 mt -38.09 -48.78 1.26 Allowed 'General case' 0 N--CA 1.508 2.45 0 N-CA-C 113.389 0.885 . . . . 2.29 113.389 -177.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 53.28 97.55 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.182 -0.949 . . . . 0.63 110.248 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . 158.83 -155.4 26.46 Favored Glycine 0 N--CA 1.476 1.364 0 N-CA-C 107.12 -2.392 . . . . 0.040000000000000001 107.12 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 74.5 ttt-85 -116.33 125.11 51.66 Favored 'General case' 0 C--N 1.295 -1.803 0 O-C-N 121.537 -0.978 . . . . 3.0 108.855 177.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 894' ' ' TYR . . . . . 0.419 ' CE2' HD22 ' C' ' 954' ' ' LEU . 20.5 p90 -133.35 156.41 47.68 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.083 -1.011 . . . . 0.040000000000000001 111.237 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 895' ' ' LEU . . . . . . . . . . . . . 48.1 tp -99.06 117.13 32.87 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.733 -0.604 . . . . 1.27 110.043 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 896' ' ' LEU . . . . . . . . . . . . . 9.6 tt -120.85 144.51 48.33 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.638 -0.664 . . . . 0.93999999999999995 109.787 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 897' ' ' SER . . . . . . . . . . . . . 19.5 m -141.9 123.97 15.44 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.383 -0.823 . . . . 0.040000000000000001 111.226 -179.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -100.55 148.26 24.99 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.731 -0.84 . . . . 0.47999999999999998 108.731 178.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 899' ' ' VAL . . . . . . . . . . . . . 93.8 t -91.47 120.26 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 C-N-CA 119.66 -0.816 . . . . 0.55000000000000004 111.023 -179.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 86.7 mt -92.95 112.1 23.94 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 114.011 1.115 . . . . 1.5900000000000001 114.011 -175.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 23.7 m -63.11 140.3 58.86 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 107.474 -1.306 . . . . 0.050000000000000003 107.474 177.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -61.05 -64.93 3.64 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.209 -1.156 . . . . 0.029999999999999999 110.209 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 7.7 m170 45.08 64.01 1.54 Allowed 'General case' 0 N--CA 1.507 2.406 0 O-C-N 121.623 -0.927 . . . . 3.2000000000000002 111.36 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 54.4 ptt85 -67.66 -7.88 30.37 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.586 -0.696 . . . . 2.9199999999999999 111.783 -179.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 905' ' ' HIS . . . . . 0.497 ' O ' ' CB ' ' C' ' 906' ' ' GLU . 69.5 t60 -63.06 6.61 0.1 Allowed 'General case' 0 N--CA 1.504 2.266 0 CA-C-O 117.599 -1.191 . . . . 2.8700000000000001 113.412 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 906' ' ' GLU . . . . . 0.497 ' CB ' ' O ' ' C' ' 905' ' ' HIS . 0.7 OUTLIER 93.46 -163.01 0.0 OUTLIER 'General case' 0 N--CA 1.529 3.52 0 CA-C-N 121.299 1.863 . . . . 0.98999999999999999 112.1 179.083 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 907' ' ' LYS . . . . . 0.495 ' CB ' ' O ' ' C' ' 906' ' ' GLU . 57.9 tttt 90.01 160.78 0.05 OUTLIER 'General case' 0 N--CA 1.521 3.11 0 N-CA-C 107.967 -1.123 . . . . 5.25 107.967 -176.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 62.0 t -122.31 116.02 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 120.888 -1.132 . . . . 0.39000000000000001 110.806 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -103.84 130.22 51.38 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 107.209 -1.404 . . . . 1.72 107.209 176.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -157.2 120.29 4.04 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 106.916 -1.513 . . . . 0.67000000000000004 106.916 178.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 911' ' ' VAL . . . . . 0.482 ' HA ' ' HA ' ' C' ' 964' ' ' VAL . 12.3 p -80.65 131.21 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 C-N-CA 120.248 -0.581 . . . . 0.54000000000000004 111.463 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 60.5 mt -67.32 156.39 36.55 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.28 -0.887 . . . . 1.5 108.618 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 913' ' ' SER . . . . . 0.414 ' CB ' ' CG1' ' C' ' 919' ' ' VAL . 2.4 t -125.27 136.44 53.52 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.589 -0.893 . . . . 1.3700000000000001 108.589 177.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 914' ' ' ARG . . . . . 0.432 ' NE ' ' HB3' ' C' ' 960' ' ' ASP . 0.0 OUTLIER -63.41 154.6 31.58 Favored 'General case' 0 N--CA 1.505 2.308 0 O-C-N 120.685 -1.26 . . . . 4.2999999999999998 111.499 -179.095 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 915' ' ' SER . . . . . 0.417 ' CB ' ' O ' ' C' ' 914' ' ' ARG . 1.7 p 83.58 -30.77 0.08 Allowed 'General case' 0 N--CA 1.521 3.101 0 C-N-CA 123.907 0.883 . . . . 2.0499999999999998 111.999 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 916' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -122.87 -21.96 5.41 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 120.967 -1.083 . . . . 2.71 111.309 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 67.17 165.93 0.22 Allowed 'General case' 0 N--CA 1.521 3.08 0 N-CA-C 105.614 -1.995 . . . . 2.6800000000000002 105.614 -174.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.74 -125.64 35.58 Favored Glycine 1 N--CA 1.521 4.32 0 CA-C-N 123.688 2.949 . . . . 0.029999999999999999 107.026 -177.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 919' ' ' VAL . . . . . 0.414 ' CG1' ' CB ' ' C' ' 913' ' ' SER . 96.8 t 50.4 94.2 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.212 0 O-C-N 121.444 -1.033 . . . . 1.3899999999999999 109.397 -178.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 920' ' ' ALA . . . . . . . . . . . . . . . -94.38 94.67 8.4 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.476 -0.89 . . . . 0.029999999999999999 110.661 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 921' ' ' ARG . . . . . 0.425 ' HB3' ' CZ ' ' C' ' 950' ' ' PHE . 23.9 ptt85 -80.61 -41.81 23.31 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 105.792 -1.929 . . . . 4.4199999999999999 105.792 176.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 922' ' ' VAL . . . . . . . . . . . . . 86.3 t -99.37 78.31 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 N-CA-C 105.705 -1.961 . . . . 0.84999999999999998 105.705 175.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -90.73 135.53 33.66 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.836 0.827 . . . . 2.46 112.26 -176.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 9.0 t -147.23 103.32 3.57 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.053 -1.092 . . . . 0.69999999999999996 108.053 178.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -109.81 89.49 0.55 Allowed Glycine 0 N--CA 1.488 2.108 0 N-CA-C 108.97 -1.652 . . . . 0.040000000000000001 108.97 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.387 0 N-CA-C 109.265 -1.534 . . . . 0.040000000000000001 109.265 -179.633 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 10.7 m . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 120.971 0.415 . . . . 13.779999999999999 110.336 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 93.3 mt -114.16 129.87 56.61 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.536 -0.727 . . . . 13.76 110.275 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -152.52 170.6 31.71 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.463 -1.455 . . . . 9.1300000000000008 109.463 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 949' ' ' VAL . . . . . . . . . . . . . 34.8 m -116.69 137.52 50.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.563 -0.963 . . . . 7.0800000000000001 110.829 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 950' ' ' PHE . . . . . 0.425 ' CZ ' ' HB3' ' C' ' 921' ' ' ARG . 51.7 p90 -134.35 151.39 51.2 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.509 -0.744 . . . . 7.5899999999999999 109.558 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 22.3 m -116.59 -60.07 1.89 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.415 -0.803 . . . . 5.0300000000000002 111.625 -179.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 952' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' C' ' 953' ' ' ILE . 53.1 tp -63.1 -75.25 0.08 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.415 -0.803 . . . . 1.01 111.276 -178.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 953' ' ' ILE . . . . . 0.474 ' O ' ' HB3' ' C' ' 954' ' ' LEU . 1.8 pp -47.94 -154.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.768 0 N-CA-C 114.487 1.291 . . . . 2.6000000000000001 114.487 -177.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 954' ' ' LEU . . . . . 0.56 ' N ' ' CD1' ' C' ' 954' ' ' LEU . 0.0 OUTLIER 170.44 85.63 0.04 OUTLIER Pre-proline 0 N--CA 1.514 2.764 0 O-C-N 120.869 -1.144 . . . . 0.050000000000000003 111.922 179.871 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 955' ' ' PRO . . . . . 0.425 ' HD3' ' CD1' ' C' ' 953' ' ' ILE . 52.6 Cg_endo -77.13 92.39 1.12 Allowed 'Trans proline' 0 N--CA 1.488 1.162 0 N-CA-C 109.131 -1.142 . . . . 0.83999999999999997 109.131 178.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 956' ' ' LEU . . . . . . . . . . . . . 89.6 mt -127.94 149.79 50.17 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.086 -1.009 . . . . 0.040000000000000001 110.703 -179.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 957' ' ' GLN . . . . . 0.401 ' HB2' ' HB2' ' C' ' 960' ' ' ASP . 75.9 mt-30 -84.87 153.67 22.75 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 117.994 -1.003 . . . . 1.28 111.634 -179.04 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -67.45 120.44 13.92 Favored 'General case' 0 N--CA 1.508 2.469 0 CA-C-N 122.542 2.428 . . . . 0.17000000000000001 111.471 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.89 -18.86 54.88 Favored Glycine 0 N--CA 1.501 3.003 0 O-C-N 121.52 -0.738 . . . . 0.040000000000000001 111.278 178.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 960' ' ' ASP . . . . . 0.432 ' HB3' ' NE ' ' C' ' 914' ' ' ARG . 0.6 OUTLIER -51.64 172.12 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.369 -1.077 . . . . 0.040000000000000001 110.717 -179.222 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 961' ' ' THR . . . . . 0.491 ' HA ' ' O ' ' C' ' 886' ' ' PHE . 7.4 t -135.61 137.58 42.06 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.092 -1.005 . . . . 1.78 112.141 -178.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 962' ' ' VAL . . . . . 0.439 ' CG2' ' CB ' ' C' ' 886' ' ' PHE . 23.6 m -99.99 146.06 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 C-N-CA 120.031 -0.668 . . . . 0.040000000000000001 110.497 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 5.2 t -139.15 144.75 38.75 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.785 -0.572 . . . . 0.71999999999999997 110.028 -178.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 964' ' ' VAL . . . . . 0.482 ' HA ' ' HA ' ' C' ' 911' ' ' VAL . 57.8 t -94.96 137.39 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.108 -0.995 . . . . 1.05 110.627 -179.074 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -94.09 126.72 39.48 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 104.068 -2.568 . . . . 3.02 104.068 173.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 966' ' ' LEU . . . . . 0.404 ' O ' ' CG2' ' C' ' 967' ' ' VAL . 0.1 OUTLIER -132.92 60.09 1.71 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.29 -1.004 . . . . 1.46 108.29 177.398 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 967' ' ' VAL . . . . . 0.404 ' CG2' ' O ' ' C' ' 966' ' ' LEU . 96.1 t -157.82 96.31 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 108.258 -1.016 . . . . 1.9399999999999999 108.258 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 92.0 mmm -142.74 58.77 1.43 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.748 -1.22 . . . . 0.0 108.382 179.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 134.41 119.38 1.96 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 107.192 -2.363 . . . . 2.1099999999999999 107.192 -178.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -82.18 -58.38 2.97 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.015 -1.285 . . . . 5.8899999999999997 110.591 -179.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 45.1 tp -59.29 90.01 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.445 -0.784 . . . . 4.3600000000000003 110.209 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -142.33 -152.55 0.42 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.613 -0.68 . . . . 1.8300000000000001 110.208 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -116.41 167.47 11.01 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.438 -0.789 . . . . 4.3499999999999996 110.068 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 29.5 t -101.89 130.4 48.36 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.548 -0.72 . . . . 1.27 110.129 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -156.29 155.64 32.66 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.507 -0.745 . . . . 5.0199999999999996 110.459 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.29 85.08 18.86 Favored Pre-proline 0 N--CA 1.5 2.043 0 O-C-N 121.627 -0.671 . . . . 2.4100000000000001 109.642 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -74.8 -171.47 0.97 Allowed 'Trans proline' 0 C--N 1.317 -1.113 0 O-C-N 123.356 1.188 . . . . 0.95999999999999996 111.331 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 978' ' ' LEU . . . . . . . . . . . . . 5.5 mp -125.21 156.38 38.56 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.542 -1.281 . . . . 0.62 107.542 177.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 979' ' ' THR . . . . . . . . . . . . . 43.2 p -149.42 141.6 24.03 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.822 -1.174 . . . . 3.5699999999999998 111.184 -179.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 980' ' ' ILE . . . . . . . . . . . . . 50.2 mm -106.89 128.27 61.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 108.948 -0.76 . . . . 1.3300000000000001 108.948 179.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 981' ' ' PHE . . . . . 0.417 ' CD1' ' CE2' ' C' ' 879' ' ' TYR . 3.4 t80 -117.53 97.56 5.94 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.428 -0.795 . . . . 0.050000000000000003 111.564 -178.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 982' ' ' SER . . . . . . . . . . . . . 34.5 p -107.2 158.25 17.25 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 109.042 -0.725 . . . . 0.87 109.042 178.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 983' ' ' GLY . . . . . 0.432 ' HA3' ' CE2' ' C' ' 852' ' ' PHE . . . -173.06 113.7 0.48 Allowed Glycine 0 N--CA 1.497 2.727 0 N-CA-C 106.644 -2.582 . . . . 0.029999999999999999 106.644 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 984' ' ' ALA . . . . . 0.4 ' CB ' ' CZ ' ' A' ' 893' ' ' ARG . . . -109.11 152.38 25.15 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 114.319 1.229 . . . . 0.69999999999999996 114.319 -175.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 985' ' ' LEU . . . . . . . . . . . . . 52.1 tp -75.89 135.75 40.13 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.871 -1.143 . . . . 0.040000000000000001 109.691 179.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 986' ' ' LEU . . . . . . . . . . . . . 40.7 tp -106.26 -62.63 1.36 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.442 -0.786 . . . . 0.040000000000000001 110.299 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -144.7 146.78 32.38 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.753 -1.203 . . . . 0.040000000000000001 107.753 179.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -111.91 162.67 12.35 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 108.079 -2.008 . . . . 0.040000000000000001 108.079 179.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -73.7 112.86 18.05 Favored Pre-proline 0 N--CA 1.499 1.999 0 O-C-N 121.23 -1.159 . . . . 0.040000000000000001 109.44 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 990' ' ' PRO . . . . . 0.414 ' O ' ' HB2' ' C' ' 991' ' ' GLU . 51.1 Cg_endo -88.08 70.83 2.88 Favored 'Trans proline' 0 C--N 1.319 -0.984 0 O-C-N 123.201 1.106 . . . . 0.45000000000000001 111.408 -179.017 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 991' ' ' GLU . . . . . 0.414 ' HB2' ' O ' ' C' ' 990' ' ' PRO . 80.6 mt-10 67.14 -73.65 0.08 Allowed 'General case' 0 N--CA 1.502 2.148 0 N-CA-C 108.645 -0.872 . . . . 1.97 108.645 -177.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 992' ' ' LEU . . . . . . . . . . . . . 11.1 mt 50.86 20.91 0.85 Allowed 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.62 -0.675 . . . . 2.3799999999999999 111.58 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -92.43 156.91 16.88 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.991 -1.068 . . . . 3.79 110.042 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -146.66 91.62 2.05 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.567 -0.708 . . . . 3.5099999999999998 110.245 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 995' ' ' ALA . . . . . . . . . . . . 2.518 . . . . . . . 0 N--CA 1.503 2.213 0 O-C-N 120.983 -1.073 . . . . 2.73 110.646 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo . . . . . 0 N--CA 1.488 1.154 0 N-CA-C 109.497 -1.001 . . . . 3.8300000000000001 109.497 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 847' ' ' VAL . . . . . . . . . . . . . 63.4 t -135.3 102.68 10.68 Favored Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 121.504 -0.747 . . . . 1.8300000000000001 110.04 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 848' ' ' PRO . . . . . 0.4 ' O ' ' C ' ' A' ' 849' ' ' GLN . 44.3 Cg_endo -69.94 -18.12 36.35 Favored 'Trans proline' 0 N--CA 1.488 1.161 0 O-C-N 123.308 1.162 . . . . 0.65000000000000002 111.196 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 849' ' ' GLN . . . . . 0.4 ' C ' ' O ' ' A' ' 848' ' ' PRO . 56.4 tt0 28.07 69.42 0.07 Allowed 'General case' 0 N--CA 1.518 2.96 0 N-CA-C 112.837 0.68 . . . . 2.5800000000000001 112.837 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 850' ' ' VAL . . . . . . . . . . . . . 64.8 t -120.38 137.5 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 121.216 -0.927 . . . . 1.0900000000000001 111.7 -178.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 851' ' ' ALA . . . . . . . . . . . . . . . -125.94 159.18 33.29 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 105.909 -1.885 . . . . 0.040000000000000001 105.909 176.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 852' ' ' PHE . . . . . 0.423 ' CE1' ' HA3' ' A' ' 983' ' ' GLY . 48.1 p90 -158.73 130.72 6.67 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 121.075 1.762 . . . . 0.050000000000000003 108.864 178.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 46.9 t -175.5 134.05 0.3 Allowed 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.209 -1.034 . . . . 0.040000000000000001 108.209 -179.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -133.55 155.09 50.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.091 -1.006 . . . . 0.67000000000000004 109.498 179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 855' ' ' ALA . . . . . . . . . . . . . . . -124.1 142.7 50.97 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.973 0.892 . . . . 0.51000000000000001 111.651 -179.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 856' ' ' LEU . . . . . 0.425 ' HG ' ' CG1' ' A' ' 866' ' ' VAL . 3.3 tm? -111.62 137.88 48.91 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.717 -0.614 . . . . 0.050000000000000003 110.214 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 857' ' ' SER . . . . . 0.408 ' O ' ' O ' ' A' ' 858' ' ' LEU . 76.5 p -155.48 15.41 0.38 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.594 -0.691 . . . . 1.3300000000000001 111.466 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 858' ' ' LEU . . . . . 0.408 ' O ' ' O ' ' A' ' 857' ' ' SER . 4.3 pp -36.51 160.65 0.05 OUTLIER Pre-proline 0 N--CA 1.515 2.822 0 CA-C-N 118.799 0.727 . . . . 2.3300000000000001 112.581 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -59.68 -89.16 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.491 0 O-C-N 123.005 1.003 . . . . 2.3199999999999998 114.016 -177.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 54.3 ptt85 -128.08 -144.58 0.29 Allowed 'General case' 0 N--CA 1.502 2.137 0 O-C-N 120.774 -1.204 . . . . 0.040000000000000001 112.394 -177.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 69.7 m -33.91 127.56 0.4 Allowed 'General case' 0 N--CA 1.511 2.604 0 N-CA-C 112.987 0.736 . . . . 1.3100000000000001 112.987 -178.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.67 158.22 32.19 Favored Pre-proline 0 N--CA 1.489 1.477 0 N-CA-C 108.288 -1.004 . . . . 4.5099999999999998 108.288 177.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.27 -13.39 25.61 Favored 'Trans proline' 0 C--N 1.315 -1.236 0 O-C-N 123.069 1.036 . . . . 2.2400000000000002 111.687 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -177.55 -135.1 2.15 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 110.06 -1.216 . . . . 0.040000000000000001 110.06 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 28.4 m -67.58 151.21 47.7 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.382 -1.07 . . . . 1.51 109.923 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 866' ' ' VAL . . . . . 0.425 ' CG1' ' HG ' ' A' ' 856' ' ' LEU . 33.4 t -94.67 139.67 22.34 Favored Pre-proline 0 N--CA 1.496 1.869 0 N-CA-C 113.764 1.024 . . . . 0.78000000000000003 113.764 -174.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 867' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 866' ' ' VAL . 55.3 Cg_endo -91.96 -151.31 0.04 OUTLIER 'Trans proline' 0 CA--C 1.544 0.999 0 O-C-N 123.673 1.354 . . . . 0.92000000000000004 109.275 177.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 868' ' ' PHE . . . . . 0.448 ' N ' ' CD1' ' A' ' 868' ' ' PHE . 20.1 p90 -151.1 124.16 8.73 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.662 -1.274 . . . . 0.050000000000000003 109.806 179.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 50.5 p-10 -113.75 -2.17 13.77 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.226 -0.921 . . . . 1.7 112.731 -178.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 870' ' ' ARG . . . . . . . . . . . . . 28.8 mmm180 -90.64 90.08 7.81 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.883 -1.135 . . . . 2.5899999999999999 110.944 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 60.3 t -72.3 96.48 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 120.998 -1.064 . . . . 1.9399999999999999 109.944 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 872' ' ' LEU . . . . . . . . . . . . . 96.9 mt -83.09 -47.35 11.75 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.495 -0.753 . . . . 1.0600000000000001 110.188 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 873' ' ' LEU . . . . . 0.401 ' O ' ' HB2' ' A' ' 874' ' ' ASN . 44.3 tp -174.61 103.51 0.1 Allowed 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 108.729 -0.841 . . . . 4.1799999999999997 108.729 178.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 874' ' ' ASN . . . . . 0.402 ' CB ' ' HA ' ' A' ' 852' ' ' PHE . 33.3 t-20 177.92 81.74 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.31 0 O-C-N 121.681 -0.637 . . . . 0.040000000000000001 109.301 -178.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -66.33 -47.27 74.04 Favored 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 119.317 -0.953 . . . . 3.3799999999999999 111.143 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 876' ' ' GLY . . . . . 0.415 ' HA3' ' CE2' ' A' ' 878' ' ' TYR . . . -74.53 -24.68 72.12 Favored Glycine 0 N--CA 1.494 2.552 0 O-C-N 121.309 -0.87 . . . . 0.040000000000000001 111.546 -178.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 82.22 -61.95 4.63 Favored Glycine 0 N--CA 1.501 2.973 0 N-CA-C 108.005 -2.038 . . . . 0.040000000000000001 108.005 -178.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 878' ' ' TYR . . . . . 0.415 ' CE2' ' HA3' ' A' ' 876' ' ' GLY . 97.9 m-85 60.91 -62.25 0.07 Allowed 'General case' 0 N--CA 1.503 2.211 0 N-CA-C 114.542 1.312 . . . . 3.46 114.542 177.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 879' ' ' TYR . . . . . 0.484 ' CB ' ' CD2' ' A' ' 886' ' ' PHE . 18.2 p90 -110.63 109.7 20.09 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 114.849 1.426 . . . . 0.040000000000000001 114.849 -176.085 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -68.05 115.55 29.7 Favored Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 121.405 -0.809 . . . . 0.02 109.971 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 881' ' ' PRO . . . . . 0.428 ' HG2' ' CD1' ' A' ' 868' ' ' PHE . 55.2 Cg_endo -75.93 0.6 9.09 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 O-C-N 123.39 1.205 . . . . 0.39000000000000001 112.309 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -76.92 -62.27 1.7 Allowed 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 106.617 -1.623 . . . . 0.81000000000000005 106.617 178.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 64.4 p -94.49 -19.27 20.69 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.617 -0.882 . . . . 0.040000000000000001 108.617 177.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.66 19.77 59.36 Favored Glycine 0 N--CA 1.496 2.677 0 O-C-N 121.064 -1.022 . . . . 0.029999999999999999 111.237 178.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 885' ' ' VAL . . . . . . . . . . . . . 95.9 t -74.25 89.0 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 C-N-CA 118.141 -1.424 . . . . 1.01 108.302 -179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 886' ' ' PHE . . . . . 0.484 ' CD2' ' CB ' ' A' ' 879' ' ' TYR . 1.0 OUTLIER -88.23 105.43 17.53 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 115.306 -0.861 . . . . 0.050000000000000003 111.52 -177.674 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 887' ' ' THR . . . . . 0.409 ' O ' ' HD3' ' A' ' 889' ' ' PRO . 93.1 m -95.43 99.95 11.79 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 107.856 -1.165 . . . . 0.68000000000000005 107.856 177.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 888' ' ' ALA . . . . . . . . . . . . . . . -98.85 106.4 37.27 Favored Pre-proline 0 N--CA 1.5 2.039 0 N-CA-C 114.124 1.157 . . . . 0.25 114.124 -176.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 889' ' ' PRO . . . . . 0.409 ' HD3' ' O ' ' A' ' 887' ' ' THR . 54.1 Cg_endo -89.07 -12.39 3.37 Favored 'Trans proline' 0 CA--C 1.546 1.1 0 N-CA-C 108.92 -1.223 . . . . 1.6399999999999999 108.92 176.084 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 890' ' ' LEU . . . . . . . . . . . . . 76.7 mt -36.11 -50.73 0.72 Allowed 'General case' 0 N--CA 1.508 2.447 0 N-CA-C 113.592 0.96 . . . . 2.29 113.592 -177.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 52.35 95.55 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.236 -0.915 . . . . 0.63 110.195 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 157.67 -153.64 24.83 Favored Glycine 0 N--CA 1.477 1.427 0 N-CA-C 107.111 -2.396 . . . . 0.040000000000000001 107.111 -179.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 71.4 ttt-85 -115.79 126.89 54.6 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 121.557 -0.967 . . . . 3.0 108.539 177.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 894' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -132.24 160.49 36.02 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.11 -0.994 . . . . 0.040000000000000001 111.081 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 895' ' ' LEU . . . . . . . . . . . . . 35.0 tp -90.71 119.08 30.65 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.401 0.62 . . . . 1.27 110.029 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 896' ' ' LEU . . . . . . . . . . . . . 9.5 tt -109.42 143.21 39.32 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.774 -0.579 . . . . 0.93999999999999995 110.2 -179.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 897' ' ' SER . . . . . . . . . . . . . 67.8 m -149.0 115.1 5.76 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.482 -0.761 . . . . 0.040000000000000001 111.018 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -108.1 146.77 32.16 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 109.07 -0.715 . . . . 0.47999999999999998 109.07 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 899' ' ' VAL . . . . . . . . . . . . . 87.7 t -95.7 119.72 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 C-N-CA 119.63 -0.828 . . . . 0.55000000000000004 111.279 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 900' ' ' LEU . . . . . 0.427 ' CD2' ' N ' ' A' ' 900' ' ' LEU . 4.5 mm? -96.04 112.22 24.02 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 114.384 1.253 . . . . 1.5900000000000001 114.384 -175.05 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 11.8 m -66.28 141.29 58.06 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 107.53 -1.285 . . . . 0.050000000000000003 107.53 176.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -66.72 -66.13 2.51 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 110.573 -1.011 . . . . 0.029999999999999999 110.573 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 11.8 m170 46.91 67.02 0.85 Allowed 'General case' 0 N--CA 1.508 2.438 0 O-C-N 121.476 -1.014 . . . . 3.2000000000000002 111.151 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 43.3 ptt85 -69.71 -5.65 26.47 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.608 -0.683 . . . . 2.9199999999999999 112.063 -179.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 905' ' ' HIS . . . . . 0.486 ' O ' ' CB ' ' A' ' 906' ' ' GLU . 73.8 t60 -62.83 5.32 0.13 Allowed 'General case' 0 N--CA 1.506 2.365 0 O-C-N 120.9 -1.125 . . . . 2.8700000000000001 113.111 -179.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 906' ' ' GLU . . . . . 0.486 ' CB ' ' O ' ' A' ' 905' ' ' HIS . 0.8 OUTLIER 94.86 -164.48 0.0 OUTLIER 'General case' 0 N--CA 1.529 3.478 0 CA-C-N 120.552 1.524 . . . . 0.98999999999999999 111.899 178.944 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 907' ' ' LYS . . . . . 0.46 ' CB ' ' O ' ' A' ' 906' ' ' GLU . 68.4 tttt 85.78 157.56 0.09 Allowed 'General case' 0 N--CA 1.519 3.019 0 N-CA-C 108.156 -1.053 . . . . 5.25 108.156 -177.059 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 60.1 t -121.68 117.08 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 120.756 -1.215 . . . . 0.39000000000000001 111.312 -179.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 71.2 tt0 -100.03 132.77 45.19 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 107.041 -1.466 . . . . 1.72 107.041 176.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -155.09 123.27 5.88 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 106.805 -1.554 . . . . 0.67000000000000004 106.805 178.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 911' ' ' VAL . . . . . 0.484 ' HA ' ' HA ' ' A' ' 964' ' ' VAL . 87.5 t -83.6 131.14 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 C-N-CA 120.52 -0.472 . . . . 0.54000000000000004 110.68 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 86.2 mt -66.34 156.01 35.68 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.333 -0.855 . . . . 1.5 109.264 178.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 913' ' ' SER . . . . . 0.417 ' HB3' ' HB ' ' A' ' 919' ' ' VAL . 0.1 OUTLIER -127.48 133.87 49.86 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 107.542 -1.281 . . . . 1.3700000000000001 107.542 176.547 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 914' ' ' ARG . . . . . 0.439 ' O ' ' CB ' ' A' ' 915' ' ' SER . 0.0 OUTLIER -64.95 158.41 25.49 Favored 'General case' 0 N--CA 1.506 2.373 0 O-C-N 120.558 -1.339 . . . . 4.2999999999999998 112.119 -178.491 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 915' ' ' SER . . . . . 0.439 ' CB ' ' O ' ' A' ' 914' ' ' ARG . 4.6 t 84.39 -32.09 0.07 Allowed 'General case' 0 N--CA 1.522 3.153 0 C-N-CA 124.164 0.985 . . . . 2.0499999999999998 111.943 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 916' ' ' ASN . . . . . 0.404 ' O ' ' HB2' ' A' ' 917' ' ' GLN . 98.9 m-20 -123.88 -21.32 5.16 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.899 -1.126 . . . . 2.71 111.352 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 917' ' ' GLN . . . . . 0.404 ' HB2' ' O ' ' A' ' 916' ' ' ASN . 45.6 mt-30 66.67 166.39 0.21 Allowed 'General case' 0 N--CA 1.52 3.073 0 N-CA-C 105.637 -1.986 . . . . 2.6800000000000002 105.637 -174.072 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 52.93 -124.07 26.32 Favored Glycine 1 N--CA 1.523 4.46 0 CA-C-N 123.383 2.811 . . . . 0.029999999999999999 106.895 -177.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 919' ' ' VAL . . . . . 0.417 ' HB ' ' HB3' ' A' ' 913' ' ' SER . 52.1 t 52.22 93.9 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 121.337 -1.096 . . . . 1.3899999999999999 108.96 -178.696 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.75 91.28 7.89 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 119.402 -0.919 . . . . 0.029999999999999999 110.917 -178.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 921' ' ' ARG . . . . . 0.434 ' HB3' ' CZ ' ' A' ' 950' ' ' PHE . 17.3 ptt180 -86.64 -42.24 13.59 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 106.104 -1.813 . . . . 4.4199999999999999 106.104 176.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 922' ' ' VAL . . . . . . . . . . . . . 76.7 t -104.29 67.09 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 105.846 -1.909 . . . . 0.84999999999999998 105.846 175.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -86.58 134.18 33.66 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.684 0.755 . . . . 2.46 111.459 -177.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 39.7 t -147.7 106.18 3.79 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.669 -0.863 . . . . 0.69999999999999996 108.669 179.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -101.76 84.74 0.52 Allowed Glycine 0 N--CA 1.486 1.995 0 N-CA-C 108.304 -1.918 . . . . 0.040000000000000001 108.304 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.21 0 N-CA-C 108.877 -1.689 . . . . 0.040000000000000001 108.877 -179.537 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 26.0 m . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.033 0.444 . . . . 13.779999999999999 110.313 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 95.7 mt -112.38 130.88 55.81 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.544 -0.723 . . . . 13.76 110.301 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -151.36 168.25 30.87 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.107 -1.597 . . . . 9.1300000000000008 109.107 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 949' ' ' VAL . . . . . . . . . . . . . 29.8 m -119.11 127.08 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.5 -1.0 . . . . 7.0800000000000001 111.019 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 950' ' ' PHE . . . . . 0.434 ' CZ ' ' HB3' ' A' ' 921' ' ' ARG . 27.1 p90 -133.71 149.28 51.5 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.623 -0.673 . . . . 7.5899999999999999 109.237 179.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 29.1 m -121.27 -51.51 2.09 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.359 -0.838 . . . . 5.0300000000000002 112.191 -178.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 952' ' ' LEU . . . . . 0.418 ' O ' ' O ' ' A' ' 953' ' ' ILE . 14.6 tp -59.4 -73.88 0.08 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.369 -0.832 . . . . 1.01 112.705 -177.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 953' ' ' ILE . . . . . 0.456 ' O ' ' HB3' ' A' ' 954' ' ' LEU . 45.8 pt -52.29 -144.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.848 0 N-CA-C 114.417 1.266 . . . . 2.6000000000000001 114.417 -176.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 954' ' ' LEU . . . . . 0.545 ' N ' ' CD1' ' A' ' 954' ' ' LEU . 0.0 OUTLIER 173.21 75.01 0.04 OUTLIER Pre-proline 0 N--CA 1.507 2.417 0 O-C-N 120.779 -1.201 . . . . 0.050000000000000003 110.869 -179.974 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 955' ' ' PRO . . . . . 0.429 ' HD2' ' CE1' ' A' ' 950' ' ' PHE . 49.6 Cg_endo -77.11 95.51 1.07 Allowed 'Trans proline' 0 C--N 1.316 -1.143 0 O-C-N 122.716 0.85 . . . . 0.83999999999999997 110.2 179.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 956' ' ' LEU . . . . . . . . . . . . . 8.9 mp -125.83 151.12 47.23 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.237 -0.915 . . . . 0.040000000000000001 110.257 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -82.19 150.92 27.13 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-O 117.734 -1.127 . . . . 1.28 111.311 -178.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -68.33 119.47 12.9 Favored 'General case' 0 N--CA 1.509 2.51 0 CA-C-N 123.063 2.665 . . . . 0.17000000000000001 111.234 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.8 -21.68 37.9 Favored Glycine 0 N--CA 1.499 2.874 0 N-CA-C 110.769 -0.932 . . . . 0.040000000000000001 110.769 178.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 960' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.12 171.9 0.06 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.389 -1.066 . . . . 0.040000000000000001 109.993 -179.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 961' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' A' ' 886' ' ' PHE . 41.5 m -133.53 138.73 46.23 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.895 -1.128 . . . . 1.78 112.159 -177.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 962' ' ' VAL . . . . . 0.434 ' CG2' ' CB ' ' A' ' 886' ' ' PHE . 20.3 m -96.57 143.62 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 C-N-CA 120.025 -0.67 . . . . 0.040000000000000001 109.763 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 5.3 t -140.28 145.3 37.1 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.817 -0.552 . . . . 0.71999999999999997 109.981 -178.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 964' ' ' VAL . . . . . 0.484 ' HA ' ' HA ' ' A' ' 911' ' ' VAL . 47.6 t -99.59 136.9 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.141 -0.975 . . . . 1.05 110.785 -178.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -94.05 128.43 40.42 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 103.799 -2.667 . . . . 3.02 103.799 173.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 966' ' ' LEU . . . . . 0.4 ' O ' ' CG2' ' A' ' 967' ' ' VAL . 10.2 tp -131.62 61.99 1.64 Allowed 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.136 -1.061 . . . . 1.46 108.136 177.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 967' ' ' VAL . . . . . 0.4 ' CG2' ' O ' ' A' ' 966' ' ' LEU . 95.4 t -158.01 97.2 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 108.072 -1.084 . . . . 1.9399999999999999 108.072 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 88.2 mmm -143.13 60.02 1.41 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.746 -1.221 . . . . 0.0 108.353 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.78 119.98 1.95 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 107.036 -2.425 . . . . 2.1099999999999999 107.036 -178.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -82.45 -58.68 2.82 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.014 -1.286 . . . . 5.8899999999999997 110.396 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 49.0 tp -59.01 90.74 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.422 -0.799 . . . . 4.3600000000000003 110.209 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -141.93 -154.19 0.5 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.592 -0.693 . . . . 1.8300000000000001 110.235 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -119.64 171.92 8.04 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.511 -0.743 . . . . 4.3499999999999996 110.212 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 39.0 t -101.64 130.42 47.98 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.598 -0.689 . . . . 1.27 110.084 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -156.12 158.75 38.24 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.521 -0.737 . . . . 5.0199999999999996 110.561 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.14 85.75 18.43 Favored Pre-proline 0 N--CA 1.5 2.04 0 O-C-N 121.59 -0.694 . . . . 2.4100000000000001 109.691 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -73.39 -172.43 1.04 Allowed 'Trans proline' 0 C--N 1.317 -1.089 0 O-C-N 123.277 1.146 . . . . 0.95999999999999996 111.345 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 5.7 mp -127.47 155.3 43.92 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 107.688 -1.227 . . . . 0.62 107.688 177.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 979' ' ' THR . . . . . . . . . . . . . 42.7 p -149.83 141.1 23.16 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.847 -1.158 . . . . 3.5699999999999998 111.252 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 980' ' ' ILE . . . . . 0.422 HG22 HD11 ' A' ' 980' ' ' ILE . 46.7 mm -107.7 128.69 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 108.911 -0.774 . . . . 1.3300000000000001 108.911 179.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 981' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -120.95 97.26 5.45 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 119.705 -0.798 . . . . 0.050000000000000003 111.974 -178.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 83.8 p -108.59 158.49 17.53 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.539 -0.726 . . . . 0.87 109.157 178.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 983' ' ' GLY . . . . . 0.423 ' HA3' ' CE1' ' A' ' 852' ' ' PHE . . . -175.18 109.04 0.28 Allowed Glycine 0 N--CA 1.499 2.878 0 N-CA-C 106.39 -2.684 . . . . 0.029999999999999999 106.39 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -108.64 152.42 24.82 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 114.565 1.32 . . . . 0.69999999999999996 114.565 -175.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 45.3 tp -72.28 134.55 45.62 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.777 -1.202 . . . . 0.040000000000000001 110.051 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 50.8 tp -107.49 -55.83 2.3 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.562 -0.711 . . . . 0.040000000000000001 109.905 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -144.82 145.16 31.51 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 107.653 -1.24 . . . . 0.040000000000000001 107.653 179.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.74 163.15 12.18 Favored Glycine 0 N--CA 1.495 2.593 0 N-CA-C 108.155 -1.978 . . . . 0.040000000000000001 108.155 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -75.85 112.16 18.55 Favored Pre-proline 0 N--CA 1.499 1.988 0 O-C-N 121.202 -1.175 . . . . 0.040000000000000001 109.436 179.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 990' ' ' PRO . . . . . 0.414 ' O ' ' HB2' ' A' ' 991' ' ' GLU . 48.8 Cg_endo -91.4 71.23 0.97 Allowed 'Trans proline' 0 C--N 1.319 -0.993 0 O-C-N 123.151 1.079 . . . . 0.45000000000000001 111.418 -178.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 991' ' ' GLU . . . . . 0.414 ' HB2' ' O ' ' A' ' 990' ' ' PRO . 70.4 mt-10 67.25 -73.85 0.07 Allowed 'General case' 0 N--CA 1.503 2.178 0 N-CA-C 108.421 -0.955 . . . . 1.97 108.421 -177.35 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 992' ' ' LEU . . . . . . . . . . . . . 6.6 mt 51.16 20.54 0.89 Allowed 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.574 -0.704 . . . . 2.3799999999999999 111.609 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -94.63 156.68 16.31 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.844 -1.16 . . . . 3.79 109.98 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -146.55 93.77 2.34 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.529 -0.732 . . . . 3.5099999999999998 110.269 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 995' ' ' ALA . . . . . . . . . . . . 2.518 . . . . . . . 0 N--CA 1.504 2.243 0 O-C-N 120.86 -1.15 . . . . 2.73 110.578 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo . . . . . 0 N--CA 1.488 1.177 0 N-CA-C 109.432 -1.026 . . . . 3.8300000000000001 109.432 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 847' ' ' VAL . . . . . . . . . . . . . 63.6 t -135.38 102.69 10.6 Favored Pre-proline 0 N--CA 1.494 1.775 0 O-C-N 121.573 -0.704 . . . . 1.8300000000000001 110.014 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 848' ' ' PRO . . . . . 0.404 ' O ' ' C ' ' B' ' 849' ' ' GLN . 44.1 Cg_endo -69.95 -18.41 36.15 Favored 'Trans proline' 0 N--CA 1.487 1.091 0 O-C-N 123.279 1.147 . . . . 0.65000000000000002 111.192 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 849' ' ' GLN . . . . . 0.404 ' C ' ' O ' ' B' ' 848' ' ' PRO . 56.4 tt0 28.35 69.57 0.07 Allowed 'General case' 0 N--CA 1.518 2.969 0 N-CA-C 112.734 0.642 . . . . 2.5800000000000001 112.734 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 850' ' ' VAL . . . . . . . . . . . . . 65.1 t -120.56 137.57 53.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.15 -0.969 . . . . 1.0900000000000001 111.694 -178.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 851' ' ' ALA . . . . . . . . . . . . . . . -126.37 158.48 35.78 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 105.894 -1.891 . . . . 0.040000000000000001 105.894 176.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 852' ' ' PHE . . . . . 0.427 ' CE1' ' HA3' ' B' ' 983' ' ' GLY . 47.7 p90 -157.9 131.03 7.54 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 121.114 1.779 . . . . 0.050000000000000003 108.803 179.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 47.2 t -175.53 133.72 0.29 Allowed 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.216 -1.031 . . . . 0.040000000000000001 108.216 -179.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -133.17 155.33 49.51 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.071 -1.018 . . . . 0.67000000000000004 109.522 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 855' ' ' ALA . . . . . . . . . . . . . . . -124.37 142.99 50.85 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 122.026 0.917 . . . . 0.51000000000000001 111.553 -179.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 856' ' ' LEU . . . . . 0.421 ' HG ' ' CG1' ' B' ' 866' ' ' VAL . 3.3 tm? -111.96 137.56 49.8 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.719 -0.613 . . . . 0.050000000000000003 110.274 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 857' ' ' SER . . . . . 0.407 ' O ' ' O ' ' B' ' 858' ' ' LEU . 77.1 p -155.15 15.43 0.4 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.615 -0.678 . . . . 1.3300000000000001 111.433 179.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 858' ' ' LEU . . . . . 0.407 ' O ' ' O ' ' B' ' 857' ' ' SER . 4.3 pp -36.54 160.68 0.05 OUTLIER Pre-proline 0 N--CA 1.516 2.869 0 CA-C-N 118.861 0.755 . . . . 2.3300000000000001 112.544 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -59.74 -89.11 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 120.791 0.994 . . . . 2.3199999999999998 114.022 -177.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 54.4 ptt85 -128.18 -144.7 0.29 Allowed 'General case' 0 N--CA 1.501 2.124 0 O-C-N 120.845 -1.159 . . . . 0.040000000000000001 112.386 -177.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 70.1 m -33.81 126.99 0.4 Allowed 'General case' 0 N--CA 1.512 2.642 0 N-CA-C 112.95 0.722 . . . . 1.3100000000000001 112.95 -178.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 862' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.14 158.26 32.11 Favored Pre-proline 0 N--CA 1.489 1.478 0 N-CA-C 108.324 -0.991 . . . . 4.5099999999999998 108.324 177.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -73.19 -13.54 25.8 Favored 'Trans proline' 0 C--N 1.314 -1.283 0 O-C-N 123.114 1.06 . . . . 2.2400000000000002 111.855 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -177.2 -134.14 1.95 Allowed Glycine 0 N--CA 1.495 2.612 0 N-CA-C 110.005 -1.238 . . . . 0.040000000000000001 110.005 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 29.1 m -68.65 151.62 46.46 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.319 -1.106 . . . . 1.51 109.802 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 866' ' ' VAL . . . . . 0.421 ' CG1' ' HG ' ' B' ' 856' ' ' LEU . 33.2 t -94.82 139.7 22.28 Favored Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 113.766 1.024 . . . . 0.78000000000000003 113.766 -174.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 867' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -92.02 -151.49 0.04 OUTLIER 'Trans proline' 0 CA--C 1.545 1.034 0 O-C-N 123.729 1.384 . . . . 0.92000000000000004 109.302 177.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 868' ' ' PHE . . . . . 0.453 ' CD1' ' N ' ' B' ' 868' ' ' PHE . 20.3 p90 -150.91 123.86 8.69 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.644 -1.285 . . . . 0.050000000000000003 109.83 179.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 50.5 p-10 -113.54 -1.66 14.05 Favored 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 119.388 -0.925 . . . . 1.7 112.742 -178.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 870' ' ' ARG . . . . . . . . . . . . . 28.6 mmm180 -91.12 89.96 7.61 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.855 -1.153 . . . . 2.5899999999999999 111.005 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 59.7 t -72.29 96.57 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.011 -1.056 . . . . 1.9399999999999999 109.937 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 872' ' ' LEU . . . . . . . . . . . . . 96.6 mt -83.24 -47.15 11.84 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.504 -0.747 . . . . 1.0600000000000001 110.232 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 873' ' ' LEU . . . . . 0.401 ' O ' ' HB2' ' B' ' 874' ' ' ASN . 44.2 tp -174.61 103.46 0.1 Allowed 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.735 -0.839 . . . . 4.1799999999999997 108.735 178.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 874' ' ' ASN . . . . . 0.401 ' HB2' ' O ' ' B' ' 873' ' ' LEU . 33.0 t-20 177.95 81.84 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.64 -0.663 . . . . 0.040000000000000001 109.42 -178.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -66.45 -47.29 73.62 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 119.272 -0.971 . . . . 3.3799999999999999 111.176 -179.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 876' ' ' GLY . . . . . 0.421 ' HA3' ' CE2' ' B' ' 878' ' ' TYR . . . -74.5 -24.82 71.84 Favored Glycine 0 N--CA 1.494 2.524 0 O-C-N 121.263 -0.898 . . . . 0.040000000000000001 111.534 -178.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 82.36 -61.98 4.64 Favored Glycine 0 N--CA 1.501 3.021 0 N-CA-C 107.983 -2.047 . . . . 0.040000000000000001 107.983 -178.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 878' ' ' TYR . . . . . 0.421 ' CE2' ' HA3' ' B' ' 876' ' ' GLY . 97.8 m-85 60.89 -62.23 0.07 Allowed 'General case' 0 N--CA 1.504 2.251 0 N-CA-C 114.527 1.306 . . . . 3.46 114.527 177.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 879' ' ' TYR . . . . . 0.485 ' CB ' ' CD2' ' B' ' 886' ' ' PHE . 18.2 p90 -110.59 109.69 20.1 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 114.826 1.417 . . . . 0.040000000000000001 114.826 -176.121 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -67.95 115.48 28.72 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.418 -0.801 . . . . 0.02 109.947 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 881' ' ' PRO . . . . . 0.437 ' HG2' ' CD1' ' B' ' 868' ' ' PHE . 55.3 Cg_endo -75.9 0.46 9.24 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 O-C-N 123.361 1.19 . . . . 0.39000000000000001 112.264 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -76.72 -62.52 1.61 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 106.637 -1.616 . . . . 0.81000000000000005 106.637 178.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 63.5 p -94.46 -18.65 21.3 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.711 -0.848 . . . . 0.040000000000000001 108.711 177.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.88 20.28 59.83 Favored Glycine 0 N--CA 1.496 2.648 0 O-C-N 121.101 -1.0 . . . . 0.029999999999999999 111.311 178.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 885' ' ' VAL . . . . . . . . . . . . . 93.9 t -74.53 89.27 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 C-N-CA 118.15 -1.42 . . . . 1.01 108.202 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 886' ' ' PHE . . . . . 0.485 ' CD2' ' CB ' ' B' ' 879' ' ' TYR . 1.0 OUTLIER -88.38 105.55 17.66 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 115.366 -0.833 . . . . 0.050000000000000003 111.546 -177.75 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 887' ' ' THR . . . . . 0.409 ' O ' ' HD3' ' B' ' 889' ' ' PRO . 93.0 m -95.48 100.27 12.05 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 107.745 -1.206 . . . . 0.68000000000000005 107.745 177.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 888' ' ' ALA . . . . . . . . . . . . . . . -99.09 106.23 37.0 Favored Pre-proline 0 N--CA 1.5 2.06 0 N-CA-C 114.059 1.133 . . . . 0.25 114.059 -176.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 889' ' ' PRO . . . . . 0.409 ' HD3' ' O ' ' B' ' 887' ' ' THR . 54.8 Cg_endo -88.92 -12.37 3.48 Favored 'Trans proline' 0 CA--C 1.546 1.079 0 N-CA-C 109.003 -1.191 . . . . 1.6399999999999999 109.003 175.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 890' ' ' LEU . . . . . . . . . . . . . 76.6 mt -36.02 -50.78 0.71 Allowed 'General case' 0 N--CA 1.508 2.462 0 N-CA-C 113.588 0.958 . . . . 2.29 113.588 -177.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 52.16 95.64 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.231 -0.918 . . . . 0.63 110.232 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . 157.63 -153.85 25.01 Favored Glycine 0 N--CA 1.477 1.418 0 N-CA-C 107.061 -2.416 . . . . 0.040000000000000001 107.061 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 71.4 ttt-85 -115.62 126.95 54.82 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 121.61 -0.935 . . . . 3.0 108.587 177.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 894' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -132.18 160.9 34.74 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.117 -0.989 . . . . 0.040000000000000001 111.069 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 895' ' ' LEU . . . . . . . . . . . . . 35.2 tp -91.13 118.93 30.83 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.426 0.631 . . . . 1.27 110.091 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 896' ' ' LEU . . . . . . . . . . . . . 9.5 tt -109.28 142.47 40.11 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.782 -0.574 . . . . 0.93999999999999995 110.251 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 897' ' ' SER . . . . . . . . . . . . . 68.1 m -148.42 114.96 5.95 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.538 -0.726 . . . . 0.040000000000000001 111.022 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.87 146.52 32.21 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 109.179 -0.674 . . . . 0.47999999999999998 109.179 179.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 899' ' ' VAL . . . . . . . . . . . . . 87.9 t -95.46 119.54 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 C-N-CA 119.616 -0.833 . . . . 0.55000000000000004 111.324 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 900' ' ' LEU . . . . . 0.416 ' N ' ' CD2' ' B' ' 900' ' ' LEU . 4.5 mm? -95.95 111.74 23.66 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 114.401 1.259 . . . . 1.5900000000000001 114.401 -174.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 11.9 m -65.87 141.22 58.33 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 107.466 -1.309 . . . . 0.050000000000000003 107.466 176.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -66.87 -66.16 2.49 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 110.615 -0.994 . . . . 0.029999999999999999 110.615 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 11.7 m170 46.9 67.16 0.83 Allowed 'General case' 0 N--CA 1.507 2.414 0 O-C-N 121.519 -0.989 . . . . 3.2000000000000002 111.082 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 43.1 ptt85 -69.69 -5.97 28.53 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.623 -0.673 . . . . 2.9199999999999999 112.068 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 905' ' ' HIS . . . . . 0.482 ' O ' ' CB ' ' B' ' 906' ' ' GLU . 73.6 t60 -62.2 4.79 0.12 Allowed 'General case' 0 N--CA 1.506 2.369 0 O-C-N 120.904 -1.123 . . . . 2.8700000000000001 113.094 -179.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 906' ' ' GLU . . . . . 0.482 ' CB ' ' O ' ' B' ' 905' ' ' HIS . 0.9 OUTLIER 95.1 -164.63 0.0 OUTLIER 'General case' 0 N--CA 1.529 3.478 0 CA-C-N 120.648 1.567 . . . . 0.98999999999999999 111.8 179.1 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 907' ' ' LYS . . . . . 0.466 ' CB ' ' O ' ' B' ' 906' ' ' GLU . 68.6 tttt 85.9 157.29 0.09 Allowed 'General case' 0 N--CA 1.519 3.002 0 N-CA-C 108.212 -1.033 . . . . 5.25 108.212 -177.058 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 60.3 t -121.51 116.71 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 120.779 -1.2 . . . . 0.39000000000000001 111.436 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 71.1 tt0 -99.58 133.09 44.41 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 106.996 -1.483 . . . . 1.72 106.996 176.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -155.51 123.35 5.7 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 106.831 -1.544 . . . . 0.67000000000000004 106.831 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 911' ' ' VAL . . . . . 0.469 ' HA ' ' HA ' ' B' ' 964' ' ' VAL . 86.5 t -83.84 131.5 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 C-N-CA 120.482 -0.487 . . . . 0.54000000000000004 110.668 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 86.1 mt -66.53 156.29 35.32 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.306 -0.871 . . . . 1.5 109.174 178.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 913' ' ' SER . . . . . 0.418 ' HB3' ' HB ' ' B' ' 919' ' ' VAL . 0.1 OUTLIER -127.92 133.26 49.25 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.617 -1.253 . . . . 1.3700000000000001 107.617 176.56 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 914' ' ' ARG . . . . . 0.431 ' O ' ' CB ' ' B' ' 915' ' ' SER . 0.0 OUTLIER -64.36 158.33 23.88 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 120.481 -1.387 . . . . 4.2999999999999998 112.167 -178.346 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 915' ' ' SER . . . . . 0.431 ' CB ' ' O ' ' B' ' 914' ' ' ARG . 4.6 t 84.56 -32.38 0.06 Allowed 'General case' 0 N--CA 1.521 3.104 0 C-N-CA 124.191 0.996 . . . . 2.0499999999999998 111.931 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 916' ' ' ASN . . . . . 0.407 ' O ' ' HB2' ' B' ' 917' ' ' GLN . 98.7 m-20 -123.49 -21.74 5.21 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.987 -1.07 . . . . 2.71 111.382 -179.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 917' ' ' GLN . . . . . 0.407 ' HB2' ' O ' ' B' ' 916' ' ' ASN . 45.1 mt-30 66.72 165.69 0.21 Allowed 'General case' 0 N--CA 1.52 3.049 0 N-CA-C 105.708 -1.96 . . . . 2.6800000000000002 105.708 -173.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 53.81 -124.15 28.79 Favored Glycine 1 N--CA 1.522 4.407 0 CA-C-N 123.446 2.839 . . . . 0.029999999999999999 106.753 -177.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 919' ' ' VAL . . . . . 0.418 ' HB ' ' HB3' ' B' ' 913' ' ' SER . 54.2 t 52.03 94.04 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 O-C-N 121.359 -1.083 . . . . 1.3899999999999999 108.922 -178.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 920' ' ' ALA . . . . . . . . . . . . . . . -91.85 91.17 7.79 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.416 -0.914 . . . . 0.029999999999999999 110.846 -179.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 921' ' ' ARG . . . . . 0.434 ' HB3' ' CZ ' ' B' ' 950' ' ' PHE . 17.3 ptt180 -86.69 -42.15 13.62 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 106.132 -1.803 . . . . 4.4199999999999999 106.132 176.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 922' ' ' VAL . . . . . . . . . . . . . 77.0 t -104.35 67.09 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 N-CA-C 105.812 -1.922 . . . . 0.84999999999999998 105.812 175.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -86.56 134.34 33.66 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.673 0.749 . . . . 2.46 111.423 -177.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 924' ' ' SER . . . . . . . . . . . . . 40.0 t -147.8 106.12 3.77 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.696 -0.853 . . . . 0.69999999999999996 108.696 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -101.68 84.69 0.52 Allowed Glycine 0 N--CA 1.486 2.025 0 N-CA-C 108.358 -1.897 . . . . 0.040000000000000001 108.358 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.191 0 N-CA-C 108.922 -1.671 . . . . 0.040000000000000001 108.922 -179.579 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 26.2 m . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.029 0.442 . . . . 13.779999999999999 110.273 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 95.6 mt -111.66 130.79 55.65 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.545 -0.722 . . . . 13.76 110.379 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -151.09 167.92 30.68 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.088 -1.605 . . . . 9.1300000000000008 109.088 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 949' ' ' VAL . . . . . . . . . . . . . 31.1 m -118.91 127.21 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.426 -1.044 . . . . 7.0800000000000001 110.899 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 950' ' ' PHE . . . . . 0.44 ' CE1' ' HD2' ' B' ' 955' ' ' PRO . 27.2 p90 -133.81 148.99 51.39 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.593 -0.692 . . . . 7.5899999999999999 109.176 179.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 28.6 m -121.15 -50.97 2.12 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.411 -0.806 . . . . 5.0300000000000002 112.065 -178.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 952' ' ' LEU . . . . . 0.408 ' O ' ' O ' ' B' ' 953' ' ' ILE . 14.6 tp -59.71 -74.12 0.08 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.458 -0.776 . . . . 1.01 112.712 -177.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 953' ' ' ILE . . . . . 0.457 ' O ' ' HB3' ' B' ' 954' ' ' LEU . 46.4 pt -52.02 -143.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.851 0 N-CA-C 114.499 1.296 . . . . 2.6000000000000001 114.499 -176.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 954' ' ' LEU . . . . . 0.549 ' N ' ' CD1' ' B' ' 954' ' ' LEU . 0.0 OUTLIER 173.13 74.76 0.04 OUTLIER Pre-proline 0 N--CA 1.508 2.452 0 O-C-N 120.788 -1.195 . . . . 0.050000000000000003 110.772 179.93 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 955' ' ' PRO . . . . . 0.44 ' HD2' ' CE1' ' B' ' 950' ' ' PHE . 49.6 Cg_endo -77.16 95.53 1.07 Allowed 'Trans proline' 0 C--N 1.316 -1.178 0 O-C-N 122.741 0.864 . . . . 0.83999999999999997 110.163 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 956' ' ' LEU . . . . . . . . . . . . . 8.9 mp -125.92 151.08 47.42 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.208 -0.932 . . . . 0.040000000000000001 110.149 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -82.03 150.89 27.35 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 117.822 -1.085 . . . . 1.28 111.325 -179.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -68.36 119.13 12.39 Favored 'General case' 0 N--CA 1.508 2.465 0 CA-C-N 122.946 2.612 . . . . 0.17000000000000001 111.266 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 93.08 -21.85 37.74 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 110.786 -0.926 . . . . 0.040000000000000001 110.786 178.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 960' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -52.98 172.06 0.05 Allowed 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.39 -1.065 . . . . 0.040000000000000001 109.981 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 961' ' ' THR . . . . . 0.463 ' HA ' ' O ' ' B' ' 886' ' ' PHE . 40.8 m -133.55 138.91 46.29 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.897 -1.127 . . . . 1.78 112.165 -177.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 962' ' ' VAL . . . . . 0.419 ' CG2' ' CB ' ' B' ' 886' ' ' PHE . 20.7 m -96.94 143.5 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 C-N-CA 120.007 -0.677 . . . . 0.040000000000000001 109.737 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 5.3 t -140.03 145.21 37.46 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.79 -0.569 . . . . 0.71999999999999997 110.043 -178.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 964' ' ' VAL . . . . . 0.469 ' HA ' ' HA ' ' B' ' 911' ' ' VAL . 47.5 t -99.59 136.64 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.138 -0.976 . . . . 1.05 110.802 -179.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -94.08 127.95 40.18 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 103.916 -2.624 . . . . 3.02 103.916 173.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 966' ' ' LEU . . . . . 0.408 ' O ' ' CG2' ' B' ' 967' ' ' VAL . 10.1 tp -131.17 62.15 1.62 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.217 -1.031 . . . . 1.46 108.217 177.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 967' ' ' VAL . . . . . 0.408 ' CG2' ' O ' ' B' ' 966' ' ' LEU . 95.4 t -158.14 97.12 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 108.113 -1.069 . . . . 1.9399999999999999 108.113 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 88.2 mmm -142.97 59.76 1.42 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.756 -1.215 . . . . 0.0 108.456 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.85 119.83 1.93 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 107.08 -2.408 . . . . 2.1099999999999999 107.08 -178.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -82.13 -58.66 2.86 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.039 -1.271 . . . . 5.8899999999999997 110.427 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 49.0 tp -59.08 90.64 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.437 -0.789 . . . . 4.3600000000000003 110.152 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -141.89 -154.18 0.5 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.556 -0.715 . . . . 1.8300000000000001 110.179 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -119.55 171.98 7.98 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.486 -0.759 . . . . 4.3499999999999996 110.306 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 39.2 t -101.7 130.39 48.07 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.541 -0.725 . . . . 1.27 110.065 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -156.1 158.69 38.16 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.513 -0.742 . . . . 5.0199999999999996 110.588 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.13 85.7 18.52 Favored Pre-proline 0 N--CA 1.499 2.012 0 O-C-N 121.624 -0.673 . . . . 2.4100000000000001 109.747 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -73.42 -172.43 1.04 Allowed 'Trans proline' 0 C--N 1.318 -1.065 0 O-C-N 123.324 1.171 . . . . 0.95999999999999996 111.44 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 978' ' ' LEU . . . . . . . . . . . . . 5.6 mp -127.34 155.52 43.44 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.707 -1.22 . . . . 0.62 107.707 177.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 979' ' ' THR . . . . . . . . . . . . . 42.3 p -150.0 141.01 22.93 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.782 -1.199 . . . . 3.5699999999999998 111.239 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 980' ' ' ILE . . . . . 0.41 HG22 HD11 ' B' ' 980' ' ' ILE . 46.9 mm -107.76 128.33 63.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 108.885 -0.783 . . . . 1.3300000000000001 108.885 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -120.59 97.49 5.59 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 119.71 -0.796 . . . . 0.050000000000000003 111.982 -178.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 82.9 p -109.0 158.6 17.56 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.611 -0.681 . . . . 0.87 109.28 178.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 983' ' ' GLY . . . . . 0.427 ' HA3' ' CE1' ' B' ' 852' ' ' PHE . . . -175.11 109.14 0.28 Allowed Glycine 0 N--CA 1.499 2.86 0 N-CA-C 106.513 -2.635 . . . . 0.029999999999999999 106.513 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -108.7 152.19 25.16 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 114.526 1.306 . . . . 0.69999999999999996 114.526 -175.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 985' ' ' LEU . . . . . . . . . . . . . 45.4 tp -72.1 134.5 45.83 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.872 -1.143 . . . . 0.040000000000000001 110.055 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 986' ' ' LEU . . . . . . . . . . . . . 51.7 tp -107.52 -55.89 2.29 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.58 -0.7 . . . . 0.040000000000000001 109.917 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -144.82 145.08 31.47 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 107.623 -1.251 . . . . 0.040000000000000001 107.623 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.54 162.95 12.22 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 108.147 -1.981 . . . . 0.040000000000000001 108.147 179.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -75.66 112.16 18.12 Favored Pre-proline 0 N--CA 1.499 1.988 0 O-C-N 121.236 -1.155 . . . . 0.040000000000000001 109.406 179.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 990' ' ' PRO . . . . . 0.416 ' O ' ' HB2' ' B' ' 991' ' ' GLU . 49.8 Cg_endo -91.38 71.31 0.97 Allowed 'Trans proline' 0 C--N 1.319 -0.982 0 O-C-N 123.108 1.057 . . . . 0.45000000000000001 111.411 -178.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 991' ' ' GLU . . . . . 0.416 ' HB2' ' O ' ' B' ' 990' ' ' PRO . 70.5 mt-10 67.21 -73.75 0.08 Allowed 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 108.493 -0.928 . . . . 1.97 108.493 -177.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 992' ' ' LEU . . . . . . . . . . . . . 6.7 mt 51.22 20.29 0.88 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.575 -0.703 . . . . 2.3799999999999999 111.634 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -94.33 156.77 16.35 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.862 -1.149 . . . . 3.79 109.96 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -146.64 93.22 2.26 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.547 -0.721 . . . . 3.5099999999999998 110.403 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 995' ' ' ALA . . . . . . . . . . . . 2.519 . . . . . . . 0 N--CA 1.503 2.209 0 O-C-N 120.897 -1.127 . . . . 2.73 110.624 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo . . . . . 0 N--CA 1.488 1.178 0 N-CA-C 109.5 -1.0 . . . . 3.8300000000000001 109.5 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' 847' ' ' VAL . . . . . . . . . . . . . 57.3 t -127.6 103.75 21.9 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.609 -0.682 . . . . 1.8300000000000001 110.121 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 848' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.36 -23.03 33.05 Favored 'Trans proline' 0 N--CA 1.488 1.151 0 O-C-N 123.218 1.115 . . . . 0.65000000000000002 110.911 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 849' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 26.59 68.63 0.06 Allowed 'General case' 0 N--CA 1.519 2.982 0 N-CA-C 112.972 0.73 . . . . 2.5800000000000001 112.972 179.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 850' ' ' VAL . . . . . . . . . . . . . 93.4 t -119.58 134.35 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.158 -0.964 . . . . 1.0900000000000001 111.245 -179.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 851' ' ' ALA . . . . . . . . . . . . . . . -131.56 155.74 46.96 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 106.105 -1.813 . . . . 0.040000000000000001 106.105 176.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 852' ' ' PHE . . . . . 0.51 ' CD1' ' CE1' ' C' ' 879' ' ' TYR . 0.3 OUTLIER -154.36 134.68 13.32 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 120.829 1.65 . . . . 0.050000000000000003 107.931 179.083 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 5.0 t -173.8 130.54 0.42 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.513 -0.921 . . . . 0.040000000000000001 108.513 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -136.39 150.95 49.04 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.256 -0.902 . . . . 0.67000000000000004 108.863 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 855' ' ' ALA . . . . . . . . . . . . . . . -122.77 139.33 54.11 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.813 0.816 . . . . 0.51000000000000001 111.527 -179.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 856' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -104.87 138.88 40.44 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.781 -0.575 . . . . 0.050000000000000003 109.558 179.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 857' ' ' SER . . . . . 0.417 ' O ' ' O ' ' C' ' 858' ' ' LEU . 1.9 m -155.28 17.49 0.41 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.622 -0.674 . . . . 1.3300000000000001 111.465 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 858' ' ' LEU . . . . . 0.417 ' O ' ' O ' ' C' ' 857' ' ' SER . 3.6 pp -34.55 158.06 0.04 OUTLIER Pre-proline 0 N--CA 1.52 3.047 0 CA-C-N 118.752 0.705 . . . . 2.3300000000000001 112.756 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -60.14 -89.88 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.431 0 O-C-N 123.089 1.047 . . . . 2.3199999999999998 113.828 -177.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 55.4 ptt85 -126.56 -141.92 0.28 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.853 -1.155 . . . . 0.040000000000000001 111.41 -177.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 73.7 m -36.31 120.33 0.65 Allowed 'General case' 0 N--CA 1.511 2.605 0 O-C-N 121.622 -0.674 . . . . 1.3100000000000001 112.26 -179.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.11 158.14 32.82 Favored Pre-proline 0 N--CA 1.488 1.458 0 N-CA-C 108.53 -0.915 . . . . 4.5099999999999998 108.53 178.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -70.92 -15.52 32.73 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 O-C-N 123.225 1.118 . . . . 2.2400000000000002 111.036 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -177.3 -134.77 2.07 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.537 -1.425 . . . . 0.040000000000000001 109.537 179.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 30.2 m -69.31 155.25 40.73 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.34 -1.094 . . . . 1.51 110.786 -179.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 866' ' ' VAL . . . . . . . . . . . . . 33.7 m -89.83 138.29 27.96 Favored Pre-proline 0 N--CA 1.496 1.837 0 N-CA-C 113.423 0.897 . . . . 0.78000000000000003 113.423 -175.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 867' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -88.62 -153.11 0.04 OUTLIER 'Trans proline' 0 C--N 1.324 -0.716 0 N-CA-C 108.128 -1.528 . . . . 0.92000000000000004 108.128 177.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 868' ' ' PHE . . . . . 0.464 ' N ' ' CD1' ' C' ' 868' ' ' PHE . 20.4 p90 -148.47 120.18 8.07 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.54 -1.35 . . . . 0.050000000000000003 110.12 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 50.2 p-10 -112.63 -2.13 14.63 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 119.353 -0.939 . . . . 1.7 111.762 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 870' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 -91.5 87.36 6.36 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.013 -1.054 . . . . 2.5899999999999999 111.057 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 61.9 t -74.77 97.2 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.0 -1.062 . . . . 1.9399999999999999 109.493 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 872' ' ' LEU . . . . . 0.401 ' HB3' ' CD1' ' A' ' 953' ' ' ILE . 52.2 mt -88.64 -44.37 10.66 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.497 -0.752 . . . . 1.0600000000000001 111.151 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 873' ' ' LEU . . . . . 0.437 ' O ' ' HB2' ' C' ' 874' ' ' ASN . 43.9 tp -171.44 102.62 0.2 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.134 -0.979 . . . . 4.1799999999999997 109.087 179.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 874' ' ' ASN . . . . . 0.437 ' HB2' ' O ' ' C' ' 873' ' ' LEU . 36.6 t-20 175.08 83.93 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.333 0 N-CA-C 108.694 -0.854 . . . . 0.040000000000000001 108.694 -178.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 30.1 p-10 -66.46 -48.19 70.71 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.059 -1.026 . . . . 3.3799999999999999 111.966 -178.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 876' ' ' GLY . . . . . 0.422 ' HA3' ' CE2' ' C' ' 878' ' ' TYR . . . -74.45 -24.91 71.72 Favored Glycine 0 N--CA 1.495 2.603 0 O-C-N 121.14 -0.975 . . . . 0.040000000000000001 111.569 -178.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 80.54 -64.86 3.98 Favored Glycine 0 N--CA 1.498 2.789 0 N-CA-C 107.624 -2.191 . . . . 0.040000000000000001 107.624 -178.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 878' ' ' TYR . . . . . 0.422 ' CE2' ' HA3' ' C' ' 876' ' ' GLY . 82.6 m-85 61.01 -56.18 0.09 Allowed 'General case' 0 N--CA 1.507 2.416 0 N-CA-C 114.556 1.317 . . . . 3.46 114.556 177.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 879' ' ' TYR . . . . . 0.51 ' CE1' ' CD1' ' C' ' 852' ' ' PHE . 1.7 p90 -111.53 108.91 18.59 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 114.791 1.404 . . . . 0.040000000000000001 114.791 -176.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -71.68 113.69 22.08 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.262 -0.898 . . . . 0.02 109.529 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 881' ' ' PRO . . . . . 0.454 ' HG2' ' CD1' ' C' ' 868' ' ' PHE . 54.3 Cg_endo -77.03 0.1 10.04 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 O-C-N 123.351 1.184 . . . . 0.39000000000000001 112.011 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 87.8 mt-10 -75.43 -64.55 1.04 Allowed 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 106.682 -1.599 . . . . 0.81000000000000005 106.682 178.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 24.5 p -90.55 -19.36 23.86 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.22 -1.03 . . . . 0.040000000000000001 108.22 176.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.1 19.58 60.71 Favored Glycine 0 N--CA 1.496 2.675 0 O-C-N 121.165 -0.959 . . . . 0.029999999999999999 111.22 178.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 89.3 t -73.93 89.79 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 C-N-CA 118.003 -1.479 . . . . 1.01 108.183 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 886' ' ' PHE . . . . . 0.463 ' CD2' ' HB2' ' C' ' 879' ' ' TYR . 1.3 t80 -88.66 106.9 18.63 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 115.485 -0.78 . . . . 0.050000000000000003 111.385 -178.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 887' ' ' THR . . . . . 0.403 ' O ' ' HD3' ' C' ' 889' ' ' PRO . 93.7 m -96.07 101.43 13.09 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.921 -1.14 . . . . 0.68000000000000005 107.921 177.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 888' ' ' ALA . . . . . . . . . . . . . . . -99.05 106.88 40.97 Favored Pre-proline 0 N--CA 1.502 2.142 0 N-CA-C 113.964 1.098 . . . . 0.25 113.964 -176.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 889' ' ' PRO . . . . . 0.403 ' HD3' ' O ' ' C' ' 887' ' ' THR . 53.8 Cg_endo -90.33 -12.24 2.72 Favored 'Trans proline' 0 CA--C 1.547 1.17 0 C-N-CA 121.073 1.182 . . . . 1.6399999999999999 109.252 176.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 890' ' ' LEU . . . . . . . . . . . . . 72.3 mt -38.01 -50.61 1.34 Allowed 'General case' 0 N--CA 1.507 2.415 0 N-CA-C 113.778 1.029 . . . . 2.29 113.778 -177.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 52.19 97.52 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.379 0 O-C-N 121.152 -0.968 . . . . 0.63 110.386 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . 156.11 -146.52 14.18 Favored Glycine 0 N--CA 1.482 1.703 0 N-CA-C 107.445 -2.262 . . . . 0.040000000000000001 107.445 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 73.3 ttt-85 -106.46 128.79 54.34 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.311 -1.366 . . . . 3.0 107.311 177.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 894' ' ' TYR . . . . . 0.42 ' CZ ' ' HB2' ' C' ' 896' ' ' LEU . 0.4 OUTLIER -130.68 144.29 51.33 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.007 -1.058 . . . . 0.040000000000000001 110.661 -178.499 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 895' ' ' LEU . . . . . 0.417 ' N ' ' CD1' ' C' ' 894' ' ' TYR . 45.2 tp -101.07 117.83 35.8 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.64 -0.662 . . . . 1.27 109.723 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 896' ' ' LEU . . . . . 0.42 ' HB2' ' CZ ' ' C' ' 894' ' ' TYR . 10.4 tt -116.4 145.46 43.23 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.531 -0.731 . . . . 0.93999999999999995 110.783 -179.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 897' ' ' SER . . . . . . . . . . . . . 69.1 m -145.18 119.23 9.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.448 -0.783 . . . . 0.040000000000000001 110.824 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.22 147.93 29.55 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.219 -0.66 . . . . 0.47999999999999998 109.219 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 899' ' ' VAL . . . . . . . . . . . . . 89.4 t -91.12 120.53 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.446 -0.784 . . . . 0.55000000000000004 110.925 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 93.1 mt -94.23 110.35 22.09 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 114.261 1.208 . . . . 1.5900000000000001 114.261 -175.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 18.9 m -64.92 139.71 58.79 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 107.414 -1.328 . . . . 0.050000000000000003 107.414 177.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -62.28 -65.77 2.99 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 110.417 -1.073 . . . . 0.029999999999999999 110.417 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 4.0 m170 46.08 64.61 1.42 Allowed 'General case' 0 N--CA 1.507 2.388 0 O-C-N 121.498 -1.001 . . . . 3.2000000000000002 111.262 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 42.8 ptt85 -68.39 -7.74 34.13 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.579 -0.701 . . . . 2.9199999999999999 111.857 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 905' ' ' HIS . . . . . 0.491 ' O ' ' CB ' ' C' ' 906' ' ' GLU . 72.3 t60 -61.29 6.86 0.05 OUTLIER 'General case' 0 N--CA 1.508 2.442 0 CA-C-O 117.659 -1.162 . . . . 2.8700000000000001 113.798 -179.208 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 906' ' ' GLU . . . . . 0.491 ' CB ' ' O ' ' C' ' 905' ' ' HIS . 0.5 OUTLIER 93.22 -165.15 0.0 OUTLIER 'General case' 0 N--CA 1.529 3.487 0 CA-C-N 121.21 1.823 . . . . 0.98999999999999999 111.955 179.117 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 907' ' ' LYS . . . . . 0.485 ' CB ' ' O ' ' C' ' 906' ' ' GLU . 38.2 tttp 88.13 159.62 0.07 Allowed 'General case' 0 N--CA 1.52 3.062 0 N-CA-C 108.149 -1.056 . . . . 5.25 108.149 -176.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 60.8 t -123.43 116.2 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 120.826 -1.171 . . . . 0.39000000000000001 111.003 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -104.34 132.18 50.87 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 107.711 -1.218 . . . . 1.72 107.711 177.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -155.82 122.44 5.24 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 106.838 -1.542 . . . . 0.67000000000000004 106.838 178.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 911' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' C' ' 964' ' ' VAL . 96.8 t -82.05 131.6 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.831 -0.543 . . . . 0.54000000000000004 111.133 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 57.2 mt -68.2 156.15 38.16 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.348 -0.845 . . . . 1.5 109.12 178.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 913' ' ' SER . . . . . . . . . . . . . 1.2 p -125.19 136.92 54.06 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.428 -0.952 . . . . 1.3700000000000001 108.428 176.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 914' ' ' ARG . . . . . 0.423 ' O ' ' CB ' ' C' ' 915' ' ' SER . 0.1 OUTLIER -63.69 154.93 31.55 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 120.664 -1.272 . . . . 4.2999999999999998 111.482 -179.309 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 915' ' ' SER . . . . . 0.423 ' CB ' ' O ' ' C' ' 914' ' ' ARG . 4.6 t 83.73 -31.48 0.08 Allowed 'General case' 0 N--CA 1.522 3.13 0 C-N-CA 124.054 0.942 . . . . 2.0499999999999998 112.087 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 916' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -122.39 -21.66 5.73 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 120.883 -1.136 . . . . 2.71 111.286 -179.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 67.18 165.65 0.22 Allowed 'General case' 0 N--CA 1.52 3.032 0 N-CA-C 105.664 -1.976 . . . . 2.6800000000000002 105.664 -174.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 55.13 -126.04 37.66 Favored Glycine 1 N--CA 1.52 4.287 0 CA-C-N 123.675 2.943 . . . . 0.029999999999999999 106.962 -177.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 919' ' ' VAL . . . . . . . . . . . . . 91.1 t 50.59 94.01 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 121.447 -1.031 . . . . 1.3899999999999999 109.386 -178.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 920' ' ' ALA . . . . . . . . . . . . . . . -93.31 93.53 8.25 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.29 -0.964 . . . . 0.029999999999999999 110.565 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 921' ' ' ARG . . . . . 0.429 ' HB3' ' CZ ' ' C' ' 950' ' ' PHE . 34.7 ptt85 -80.13 -42.3 23.78 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 105.884 -1.895 . . . . 4.4199999999999999 105.884 176.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 922' ' ' VAL . . . . . . . . . . . . . 78.2 t -101.18 77.06 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 N-CA-C 105.602 -1.999 . . . . 0.84999999999999998 105.602 175.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -87.81 135.03 33.56 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.801 0.81 . . . . 2.46 112.016 -176.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 4.9 t -146.54 102.63 3.59 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.297 -1.001 . . . . 0.69999999999999996 108.297 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -109.49 88.35 0.51 Allowed Glycine 0 N--CA 1.486 2.026 0 N-CA-C 108.494 -1.842 . . . . 0.040000000000000001 108.494 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.353 0 N-CA-C 109.315 -1.514 . . . . 0.040000000000000001 109.315 -179.448 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 8.3 m . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 120.995 0.426 . . . . 13.779999999999999 110.378 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 95.2 mt -114.03 129.51 56.6 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.465 -0.772 . . . . 13.76 110.367 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -152.35 170.46 31.6 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.514 -1.434 . . . . 9.1300000000000008 109.514 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 949' ' ' VAL . . . . . . . . . . . . . 35.1 m -117.74 136.91 53.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.529 -0.983 . . . . 7.0800000000000001 110.904 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 950' ' ' PHE . . . . . 0.429 ' CZ ' ' HB3' ' C' ' 921' ' ' ARG . 44.8 p90 -135.3 152.88 51.91 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.571 -0.706 . . . . 7.5899999999999999 109.525 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 5.6 m -118.23 -54.77 2.28 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.465 -0.772 . . . . 5.0300000000000002 111.65 -179.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 952' ' ' LEU . . . . . 0.447 ' O ' ' O ' ' C' ' 953' ' ' ILE . 58.1 tp -65.71 -78.29 0.05 Allowed 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.439 -0.788 . . . . 1.01 111.375 -178.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 953' ' ' ILE . . . . . 0.481 ' O ' ' HB3' ' C' ' 954' ' ' LEU . 2.9 pp -50.28 -150.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.688 0 N-CA-C 114.312 1.227 . . . . 2.6000000000000001 114.312 -176.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 954' ' ' LEU . . . . . 0.557 ' N ' ' CD1' ' C' ' 954' ' ' LEU . 0.0 OUTLIER 169.19 90.98 0.03 OUTLIER Pre-proline 0 N--CA 1.519 2.992 0 O-C-N 120.879 -1.138 . . . . 0.050000000000000003 112.03 179.902 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 955' ' ' PRO . . . . . 0.43 ' HD3' ' CD1' ' C' ' 953' ' ' ILE . 52.7 Cg_endo -79.55 93.25 1.08 Allowed 'Trans proline' 0 C--N 1.317 -1.103 0 N-CA-C 108.819 -1.262 . . . . 0.83999999999999997 108.819 178.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 956' ' ' LEU . . . . . . . . . . . . . 79.7 mt -126.79 148.22 49.95 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.094 -1.004 . . . . 0.040000000000000001 110.524 -179.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 957' ' ' GLN . . . . . 0.409 ' HB2' ' HB2' ' C' ' 960' ' ' ASP . 90.7 mt-30 -84.04 153.26 23.92 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 117.904 -1.046 . . . . 1.28 111.515 -179.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -68.66 120.81 15.25 Favored 'General case' 0 N--CA 1.509 2.509 0 CA-C-N 122.757 2.526 . . . . 0.17000000000000001 111.879 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 93.16 -20.76 44.02 Favored Glycine 0 N--CA 1.502 3.074 0 N-CA-C 111.193 -0.763 . . . . 0.040000000000000001 111.193 178.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 960' ' ' ASP . . . . . 0.409 ' HB2' ' HB2' ' C' ' 957' ' ' GLN . 0.8 OUTLIER -51.28 172.42 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.482 -1.01 . . . . 0.040000000000000001 110.751 -179.115 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 961' ' ' THR . . . . . 0.444 ' HA ' ' O ' ' C' ' 886' ' ' PHE . 50.0 m -133.09 137.45 46.35 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.002 -1.061 . . . . 1.78 111.887 -178.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 962' ' ' VAL . . . . . 0.417 ' CG2' ' CB ' ' C' ' 886' ' ' PHE . 24.9 m -99.47 144.1 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 C-N-CA 119.985 -0.686 . . . . 0.040000000000000001 110.11 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 5.4 t -140.54 143.8 35.57 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.864 -0.522 . . . . 0.71999999999999997 110.148 -178.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 964' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' C' ' 911' ' ' VAL . 56.9 t -93.8 136.87 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.191 -0.943 . . . . 1.05 110.93 -178.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -95.72 127.01 41.38 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 103.716 -2.698 . . . . 3.02 103.716 173.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 966' ' ' LEU . . . . . . . . . . . . . 11.2 tp -132.81 62.83 1.65 Allowed 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.367 -0.975 . . . . 1.46 108.367 177.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 967' ' ' VAL . . . . . . . . . . . . . 99.5 t -157.53 97.02 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 108.239 -1.022 . . . . 1.9399999999999999 108.239 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 92.8 mmm -142.29 60.01 1.45 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.793 -1.192 . . . . 0.0 108.358 179.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.46 119.51 1.92 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 107.192 -2.363 . . . . 2.1099999999999999 107.192 -178.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 94.7 mm-40 -82.36 -57.54 3.32 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.051 -1.264 . . . . 5.8899999999999997 110.761 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 47.4 tp -58.75 89.84 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.443 -0.786 . . . . 4.3600000000000003 110.358 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -142.41 -152.58 0.42 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.557 -0.714 . . . . 1.8300000000000001 110.118 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -120.31 170.01 9.75 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.425 -0.797 . . . . 4.3499999999999996 110.261 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 29.3 t -101.46 130.36 47.69 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.52 -0.738 . . . . 1.27 110.051 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -155.63 158.87 39.05 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.53 -0.731 . . . . 5.0199999999999996 110.524 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.35 86.51 16.73 Favored Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 121.603 -0.686 . . . . 2.4100000000000001 109.862 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -74.72 -171.65 1.01 Allowed 'Trans proline' 0 C--N 1.317 -1.081 0 O-C-N 123.311 1.164 . . . . 0.95999999999999996 111.19 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 978' ' ' LEU . . . . . . . . . . . . . 5.2 mp -126.25 155.58 41.66 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 107.577 -1.268 . . . . 0.62 107.577 177.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 979' ' ' THR . . . . . . . . . . . . . 39.9 p -150.66 141.08 22.43 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.791 -1.193 . . . . 3.5699999999999998 111.216 -179.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 980' ' ' ILE . . . . . 0.416 HG22 HD11 ' C' ' 980' ' ' ILE . 50.4 mm -107.12 129.07 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 108.991 -0.744 . . . . 1.3300000000000001 108.991 179.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 981' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -118.67 95.76 4.98 Favored 'General case' 0 N--CA 1.497 1.925 0 C-N-CA 119.452 -0.899 . . . . 0.050000000000000003 111.727 -178.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 982' ' ' SER . . . . . . . . . . . . . 12.1 p -109.55 158.68 17.77 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.606 -0.684 . . . . 0.87 109.712 178.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 983' ' ' GLY . . . . . 0.447 ' HA3' ' CZ ' ' C' ' 852' ' ' PHE . . . -172.99 114.71 0.53 Allowed Glycine 0 N--CA 1.498 2.798 0 N-CA-C 106.453 -2.659 . . . . 0.029999999999999999 106.453 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 984' ' ' ALA . . . . . . . . . . . . . . . -106.49 152.45 23.63 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 114.493 1.294 . . . . 0.69999999999999996 114.493 -175.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 985' ' ' LEU . . . . . . . . . . . . . 62.3 tp -75.58 135.65 40.53 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.932 -1.105 . . . . 0.040000000000000001 109.787 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 986' ' ' LEU . . . . . . . . . . . . . 36.1 tp -106.75 -61.17 1.57 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.576 -0.702 . . . . 0.040000000000000001 110.098 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -143.81 146.74 33.3 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 107.647 -1.242 . . . . 0.040000000000000001 107.647 179.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -111.65 162.74 12.34 Favored Glycine 0 N--CA 1.495 2.597 0 N-CA-C 108.179 -1.968 . . . . 0.040000000000000001 108.179 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.01 112.58 18.6 Favored Pre-proline 0 N--CA 1.499 1.982 0 O-C-N 121.243 -1.151 . . . . 0.040000000000000001 109.412 179.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 990' ' ' PRO . . . . . 0.412 ' O ' ' HB2' ' C' ' 991' ' ' GLU . 49.4 Cg_endo -90.22 70.84 1.55 Allowed 'Trans proline' 0 C--N 1.319 -1.018 0 O-C-N 123.152 1.08 . . . . 0.45000000000000001 111.365 -178.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 991' ' ' GLU . . . . . 0.412 ' HB2' ' O ' ' C' ' 990' ' ' PRO . 69.6 mt-10 67.65 -73.27 0.08 Allowed 'General case' 0 N--CA 1.503 2.177 0 N-CA-C 108.603 -0.888 . . . . 1.97 108.603 -177.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 992' ' ' LEU . . . . . . . . . . . . . 11.3 mt 50.56 20.62 0.74 Allowed 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.544 -0.722 . . . . 2.3799999999999999 111.705 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -93.9 156.76 16.46 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.893 -1.13 . . . . 3.79 109.998 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 69.7 m80 -145.75 92.8 2.26 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.567 -0.708 . . . . 3.5099999999999998 110.308 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 995' ' ' ALA . . . . . . . . . . . . 2.518 . . . . . . . 0 N--CA 1.503 2.206 0 O-C-N 120.936 -1.103 . . . . 2.73 110.631 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo . . . . . 0 N--CA 1.488 1.203 0 N-CA-C 109.53 -0.989 . . . . 3.8300000000000001 109.53 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 847' ' ' VAL . . . . . . . . . . . . . 60.2 t -132.17 103.36 14.06 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.555 -0.716 . . . . 1.8300000000000001 110.188 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 848' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -69.84 -20.32 34.61 Favored 'Trans proline' 0 N--CA 1.487 1.145 0 O-C-N 123.28 1.147 . . . . 0.65000000000000002 110.955 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 849' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 27.73 68.79 0.07 Allowed 'General case' 0 N--CA 1.518 2.97 0 N-CA-C 112.821 0.675 . . . . 2.5800000000000001 112.821 179.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 850' ' ' VAL . . . . . . . . . . . . . 57.6 t -119.93 136.06 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.135 -0.978 . . . . 1.0900000000000001 111.65 -178.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 851' ' ' ALA . . . . . . . . . . . . . . . -126.14 157.33 38.37 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 105.749 -1.945 . . . . 0.040000000000000001 105.749 176.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 852' ' ' PHE . . . . . 0.401 ' HA ' ' CB ' ' A' ' 874' ' ' ASN . 22.7 p90 -160.84 127.32 4.04 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 121.009 1.731 . . . . 0.050000000000000003 108.437 179.066 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 5.8 t -176.1 134.7 0.26 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.35 -0.981 . . . . 0.040000000000000001 108.35 -178.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -132.21 155.66 47.85 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.035 -1.04 . . . . 0.67000000000000004 109.541 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 855' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 870' ' ' ARG . . . -121.67 143.91 49.07 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.855 0.836 . . . . 0.51000000000000001 111.258 -179.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 856' ' ' LEU . . . . . 0.4 HD23 ' CG1' ' A' ' 866' ' ' VAL . 3.4 tm? -113.13 134.73 54.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.688 -0.633 . . . . 0.050000000000000003 110.283 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 857' ' ' SER . . . . . 0.402 ' O ' ' O ' ' A' ' 858' ' ' LEU . 60.8 p -151.94 17.74 0.68 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.565 -0.71 . . . . 1.3300000000000001 110.59 178.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 858' ' ' LEU . . . . . 0.402 ' O ' ' O ' ' A' ' 857' ' ' SER . 4.4 pp -33.27 157.11 0.04 OUTLIER Pre-proline 0 N--CA 1.518 2.942 0 N-CA-C 113.159 0.8 . . . . 2.3300000000000001 113.159 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -63.2 -88.3 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.376 0 O-C-N 123.107 1.056 . . . . 2.3199999999999998 113.162 -178.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 55.2 ptt85 -128.68 -143.36 0.27 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.888 -1.132 . . . . 0.040000000000000001 111.647 -177.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 14.0 m -40.18 126.78 2.2 Favored 'General case' 0 N--CA 1.508 2.457 0 O-C-N 121.527 -0.733 . . . . 1.3100000000000001 112.453 -178.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 862' ' ' GLU . . . . . 0.404 ' CG ' ' HD2' ' A' ' 863' ' ' PRO . 0.7 OUTLIER -101.95 157.6 33.37 Favored Pre-proline 0 N--CA 1.489 1.498 0 N-CA-C 107.683 -1.229 . . . . 4.5099999999999998 107.683 176.967 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 863' ' ' PRO . . . . . 0.404 ' HD2' ' CG ' ' A' ' 862' ' ' GLU . 44.2 Cg_endo -71.55 -12.25 29.09 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 O-C-N 123.029 1.015 . . . . 2.2400000000000002 111.472 -179.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -176.02 -136.59 2.38 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 110.143 -1.183 . . . . 0.040000000000000001 110.143 179.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 25.7 m -65.48 155.85 34.3 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.317 -1.108 . . . . 1.51 110.935 -178.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 866' ' ' VAL . . . . . 0.4 ' CG1' HD23 ' A' ' 856' ' ' LEU . 60.1 t -92.14 135.29 27.24 Favored Pre-proline 0 N--CA 1.495 1.788 0 N-CA-C 113.273 0.842 . . . . 0.78000000000000003 113.273 -174.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 867' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -90.61 -153.01 0.04 OUTLIER 'Trans proline' 0 CA--C 1.54 0.805 0 N-CA-C 108.658 -1.324 . . . . 0.92000000000000004 108.658 177.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 868' ' ' PHE . . . . . 0.447 ' CD1' ' N ' ' A' ' 868' ' ' PHE . 27.0 p90 -150.66 122.65 8.2 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.567 -1.333 . . . . 0.050000000000000003 109.632 179.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 49.7 p-10 -114.1 -1.93 13.58 Favored 'General case' 0 N--CA 1.5 2.035 0 C-N-CA 119.299 -0.961 . . . . 1.7 112.549 -178.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 870' ' ' ARG . . . . . 0.401 ' HB2' ' O ' ' A' ' 855' ' ' ALA . 29.1 mmm180 -90.85 88.15 6.94 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.869 -1.144 . . . . 2.5899999999999999 110.83 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 57.5 t -72.94 97.35 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 120.929 -1.107 . . . . 1.9399999999999999 109.858 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 872' ' ' LEU . . . . . . . . . . . . . 96.1 mt -83.15 -47.47 11.57 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.524 -0.735 . . . . 1.0600000000000001 110.109 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 873' ' ' LEU . . . . . . . . . . . . . 30.4 tp -174.65 103.96 0.1 Allowed 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.594 -0.891 . . . . 4.1799999999999997 108.594 178.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 874' ' ' ASN . . . . . 0.401 ' CB ' ' HA ' ' A' ' 852' ' ' PHE . 37.6 t-20 178.59 81.79 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.309 0 O-C-N 121.64 -0.663 . . . . 0.040000000000000001 109.648 -178.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -66.2 -47.05 75.16 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.062 -1.024 . . . . 3.3799999999999999 111.019 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 876' ' ' GLY . . . . . . . . . . . . . . . -74.57 -25.33 70.38 Favored Glycine 0 N--CA 1.494 2.552 0 O-C-N 121.282 -0.886 . . . . 0.040000000000000001 111.712 -178.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 86.42 -58.57 4.69 Favored Glycine 0 N--CA 1.502 3.041 0 N-CA-C 108.043 -2.023 . . . . 0.040000000000000001 108.043 -178.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 878' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 60.37 -67.78 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 114.283 1.216 . . . . 3.46 114.283 177.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 879' ' ' TYR . . . . . 0.471 ' CB ' ' CD2' ' A' ' 886' ' ' PHE . 24.3 p90 -113.08 111.44 22.15 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 114.841 1.422 . . . . 0.040000000000000001 114.841 -176.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -66.19 119.01 58.44 Favored Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 121.526 -0.734 . . . . 0.02 110.257 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 881' ' ' PRO . . . . . 0.428 ' HG2' ' CD1' ' A' ' 868' ' ' PHE . 54.5 Cg_endo -76.44 0.67 9.23 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 O-C-N 123.389 1.205 . . . . 0.39000000000000001 112.128 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -74.77 -65.27 0.89 Allowed 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 106.686 -1.598 . . . . 0.81000000000000005 106.686 178.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 7.0 p -97.22 -15.28 20.93 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 109.014 -0.735 . . . . 0.040000000000000001 109.014 177.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.1 24.2 49.17 Favored Glycine 0 N--CA 1.494 2.523 0 O-C-N 120.947 -1.096 . . . . 0.029999999999999999 110.696 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 885' ' ' VAL . . . . . . . . . . . . . 92.4 t -72.26 88.59 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 C-N-CA 118.453 -1.299 . . . . 1.01 107.823 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 886' ' ' PHE . . . . . 0.471 ' CD2' ' CB ' ' A' ' 879' ' ' TYR . 0.7 OUTLIER -90.73 105.92 18.15 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 115.175 -0.92 . . . . 0.050000000000000003 112.442 -176.942 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 887' ' ' THR . . . . . 0.402 ' O ' ' HD3' ' A' ' 889' ' ' PRO . 89.8 m -96.25 100.42 12.05 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 107.48 -1.304 . . . . 0.68000000000000005 107.48 177.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 888' ' ' ALA . . . . . . . . . . . . . . . -99.15 106.53 39.06 Favored Pre-proline 0 N--CA 1.501 2.112 0 N-CA-C 114.044 1.127 . . . . 0.25 114.044 -176.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 889' ' ' PRO . . . . . 0.402 ' HD3' ' O ' ' A' ' 887' ' ' THR . 53.8 Cg_endo -90.07 -11.98 2.95 Favored 'Trans proline' 0 CA--C 1.546 1.089 0 C-N-CA 121.093 1.195 . . . . 1.6399999999999999 109.213 176.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 890' ' ' LEU . . . . . . . . . . . . . 4.6 tt -34.78 -52.0 0.51 Allowed 'General case' 0 N--CA 1.509 2.482 0 N-CA-C 113.834 1.05 . . . . 2.29 113.834 -177.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 51.38 95.41 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.313 0 O-C-N 121.181 -0.949 . . . . 0.63 110.438 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 156.15 -147.8 16.92 Favored Glycine 0 N--CA 1.479 1.539 0 N-CA-C 107.383 -2.287 . . . . 0.040000000000000001 107.383 -179.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 72.9 ttt-85 -108.96 127.08 53.76 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 107.536 -1.283 . . . . 3.0 107.536 177.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 894' ' ' TYR . . . . . 0.447 ' CD1' ' N ' ' A' ' 895' ' ' LEU . 0.1 OUTLIER -131.42 144.71 51.39 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.03 -1.044 . . . . 0.040000000000000001 110.154 -179.008 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 895' ' ' LEU . . . . . 0.447 ' N ' ' CD1' ' A' ' 894' ' ' TYR . 33.9 tp -99.25 116.64 31.9 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.623 -0.673 . . . . 1.27 109.933 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 896' ' ' LEU . . . . . 0.445 ' HB2' ' CZ ' ' A' ' 894' ' ' TYR . 10.4 tt -112.91 145.87 39.97 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.645 -0.66 . . . . 0.93999999999999995 110.785 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 897' ' ' SER . . . . . . . . . . . . . 63.1 m -143.04 119.02 10.64 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.466 -0.771 . . . . 0.040000000000000001 110.781 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -108.34 146.91 32.28 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.657 -0.652 . . . . 0.47999999999999998 109.387 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 899' ' ' VAL . . . . . . . . . . . . . 88.3 t -93.61 119.69 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 C-N-CA 119.788 -0.765 . . . . 0.55000000000000004 111.031 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 900' ' ' LEU . . . . . 0.436 ' CD2' ' N ' ' A' ' 900' ' ' LEU . 4.4 mm? -94.24 113.13 24.99 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 114.307 1.225 . . . . 1.5900000000000001 114.307 -174.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 18.1 m -67.0 141.65 57.52 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 107.33 -1.359 . . . . 0.050000000000000003 107.33 176.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -66.28 -64.84 3.12 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 110.664 -0.974 . . . . 0.029999999999999999 110.664 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 5.9 m170 46.54 64.65 1.44 Allowed 'General case' 0 N--CA 1.508 2.466 0 O-C-N 121.363 -1.081 . . . . 3.2000000000000002 111.189 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 41.6 ptt85 -68.97 -6.65 29.0 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.563 -0.71 . . . . 2.9199999999999999 112.084 -179.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 905' ' ' HIS . . . . . 0.49 ' O ' ' CB ' ' A' ' 906' ' ' GLU . 70.6 t60 -63.31 5.76 0.15 Allowed 'General case' 0 N--CA 1.505 2.324 0 O-C-N 120.945 -1.097 . . . . 2.8700000000000001 113.214 -179.052 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 906' ' ' GLU . . . . . 0.49 ' CB ' ' O ' ' A' ' 905' ' ' HIS . 0.5 OUTLIER 94.88 -164.24 0.0 OUTLIER 'General case' 0 N--CA 1.529 3.514 0 CA-C-N 120.487 1.494 . . . . 0.98999999999999999 111.789 179.126 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 907' ' ' LYS . . . . . 0.471 ' CB ' ' O ' ' A' ' 906' ' ' GLU . 56.5 tttt 86.69 156.24 0.08 Allowed 'General case' 0 N--CA 1.52 3.031 0 N-CA-C 108.124 -1.065 . . . . 5.25 108.124 -176.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 60.8 t -123.12 115.88 46.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 120.821 -1.174 . . . . 0.39000000000000001 111.173 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -102.65 132.78 48.54 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 107.334 -1.358 . . . . 1.72 107.334 176.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -154.7 123.24 6.09 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 106.715 -1.587 . . . . 0.67000000000000004 106.715 178.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 911' ' ' VAL . . . . . 0.466 ' HA ' ' HA ' ' A' ' 964' ' ' VAL . 79.4 t -82.77 131.06 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 C-N-CA 120.378 -0.529 . . . . 0.54000000000000004 111.028 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 75.3 mt -66.7 156.45 35.28 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.381 -0.824 . . . . 1.5 109.032 178.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 913' ' ' SER . . . . . . . . . . . . . 1.1 p -125.34 135.41 52.43 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.23 -1.026 . . . . 1.3700000000000001 108.23 176.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 914' ' ' ARG . . . . . 0.441 ' O ' ' CB ' ' A' ' 915' ' ' SER . 0.0 OUTLIER -64.23 155.11 32.94 Favored 'General case' 0 N--CA 1.506 2.361 0 O-C-N 120.7 -1.25 . . . . 4.2999999999999998 111.63 -179.287 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 915' ' ' SER . . . . . 0.441 ' CB ' ' O ' ' A' ' 914' ' ' ARG . 2.0 t 84.1 -31.75 0.07 Allowed 'General case' 0 N--CA 1.52 3.071 0 C-N-CA 124.036 0.935 . . . . 2.0499999999999998 111.769 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 916' ' ' ASN . . . . . 0.413 ' O ' ' HB2' ' A' ' 917' ' ' GLN . 68.8 m-80 -123.49 -21.3 5.33 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 120.946 -1.096 . . . . 2.71 111.299 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 917' ' ' GLN . . . . . 0.413 ' HB2' ' O ' ' A' ' 916' ' ' ASN . 50.2 mt-30 66.71 166.48 0.21 Allowed 'General case' 0 N--CA 1.52 3.047 0 N-CA-C 105.789 -1.93 . . . . 2.6800000000000002 105.789 -174.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.24 -125.32 33.43 Favored Glycine 1 N--CA 1.522 4.372 0 CA-C-N 123.646 2.93 . . . . 0.029999999999999999 107.041 -177.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 919' ' ' VAL . . . . . . . . . . . . . 78.1 t 51.57 94.14 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 O-C-N 121.357 -1.084 . . . . 1.3899999999999999 109.08 -178.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 920' ' ' ALA . . . . . . . . . . . . . . . -92.31 91.83 7.88 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 119.358 -0.937 . . . . 0.029999999999999999 110.882 -179.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 921' ' ' ARG . . . . . 0.426 ' HB3' ' CZ ' ' A' ' 950' ' ' PHE . 30.7 ptt180 -83.56 -41.42 17.93 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 105.641 -1.985 . . . . 4.4199999999999999 105.641 176.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 922' ' ' VAL . . . . . . . . . . . . . 97.1 t -98.79 78.39 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 N-CA-C 106.041 -1.837 . . . . 0.84999999999999998 106.041 175.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -86.12 133.91 33.85 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.717 0.77 . . . . 2.46 111.381 -177.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 17.8 t -147.35 104.49 3.65 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.869 -0.789 . . . . 0.69999999999999996 108.869 179.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -103.75 83.35 0.41 Allowed Glycine 0 N--CA 1.487 2.071 0 N-CA-C 108.242 -1.943 . . . . 0.040000000000000001 108.242 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.239 0 N-CA-C 108.98 -1.648 . . . . 0.040000000000000001 108.98 -179.403 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 63.8 m . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.005 0.431 . . . . 13.779999999999999 110.264 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 94.4 mt -109.44 129.41 55.55 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.574 -0.704 . . . . 13.76 110.369 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -152.64 169.33 31.73 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.189 -1.565 . . . . 9.1300000000000008 109.189 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 949' ' ' VAL . . . . . . . . . . . . . 35.1 m -117.99 133.21 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.518 -0.989 . . . . 7.0800000000000001 110.801 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 950' ' ' PHE . . . . . 0.426 ' CZ ' ' HB3' ' A' ' 921' ' ' ARG . 30.7 p90 -130.69 147.06 52.32 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.59 -0.694 . . . . 7.5899999999999999 109.502 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 73.6 m -119.98 -54.68 2.11 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.487 -0.758 . . . . 5.0300000000000002 111.843 -178.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 952' ' ' LEU . . . . . 0.41 ' O ' ' O ' ' A' ' 953' ' ' ILE . 55.9 tp -60.75 -76.87 0.05 OUTLIER 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.417 -0.802 . . . . 1.01 112.178 -177.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 953' ' ' ILE . . . . . 0.463 ' O ' ' HB3' ' A' ' 954' ' ' LEU . 47.6 pt -53.78 -141.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.656 0 N-CA-C 113.81 1.041 . . . . 2.6000000000000001 113.81 -176.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 954' ' ' LEU . . . . . 0.522 ' N ' ' CD1' ' A' ' 954' ' ' LEU . 0.0 OUTLIER 173.79 78.7 0.05 OUTLIER Pre-proline 0 N--CA 1.508 2.451 0 O-C-N 120.777 -1.202 . . . . 0.050000000000000003 111.037 179.427 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 955' ' ' PRO . . . . . 0.423 ' HD2' ' CE1' ' A' ' 950' ' ' PHE . 45.8 Cg_endo -73.61 89.89 0.95 Allowed 'Trans proline' 0 C--N 1.314 -1.255 0 N-CA-C 109.45 -1.019 . . . . 0.83999999999999997 109.45 178.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 956' ' ' LEU . . . . . . . . . . . . . 5.7 mp -125.52 150.17 47.66 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.187 -0.946 . . . . 0.040000000000000001 110.487 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 59.6 mt-30 -81.74 151.9 27.27 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-O 117.784 -1.103 . . . . 1.28 111.793 -179.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -70.2 119.83 14.98 Favored 'General case' 0 N--CA 1.511 2.609 0 CA-C-N 123.048 2.658 . . . . 0.17000000000000001 111.671 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.6 -23.0 30.22 Favored Glycine 0 N--CA 1.501 3.031 0 N-CA-C 111.025 -0.83 . . . . 0.040000000000000001 111.025 178.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 960' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.85 171.45 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.567 -0.96 . . . . 0.040000000000000001 110.202 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 961' ' ' THR . . . . . 0.452 ' HA ' ' O ' ' A' ' 886' ' ' PHE . 46.3 m -133.36 137.87 46.06 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.893 -1.129 . . . . 1.78 112.127 -178.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 962' ' ' VAL . . . . . 0.42 ' CG2' ' CB ' ' A' ' 886' ' ' PHE . 26.3 m -99.03 144.13 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.675 -0.641 . . . . 0.040000000000000001 110.229 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 1.6 m -137.68 144.32 41.76 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.857 -0.527 . . . . 0.71999999999999997 110.031 -178.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 964' ' ' VAL . . . . . 0.466 ' HA ' ' HA ' ' A' ' 911' ' ' VAL . 58.1 t -94.88 136.01 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.13 -0.981 . . . . 1.05 110.538 -179.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -93.98 127.51 39.8 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 103.784 -2.673 . . . . 3.02 103.784 173.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 966' ' ' LEU . . . . . 0.411 ' O ' ' CG2' ' A' ' 967' ' ' VAL . 1.2 tt -132.12 61.43 1.66 Allowed 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.232 -1.025 . . . . 1.46 108.232 177.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 967' ' ' VAL . . . . . 0.411 ' CG2' ' O ' ' A' ' 966' ' ' LEU . 94.2 t -158.28 96.41 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 108.056 -1.09 . . . . 1.9399999999999999 108.056 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 90.6 mmm -142.17 60.1 1.46 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.709 -1.244 . . . . 0.0 108.344 179.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.47 119.83 1.95 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 107.08 -2.408 . . . . 2.1099999999999999 107.08 -178.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -81.96 -58.04 3.15 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.065 -1.256 . . . . 5.8899999999999997 110.562 -179.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 40.6 tp -59.19 90.01 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.442 -0.786 . . . . 4.3600000000000003 110.283 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -141.32 -154.02 0.49 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.613 -0.679 . . . . 1.8300000000000001 110.117 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -120.08 172.34 7.82 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.486 -0.759 . . . . 4.3499999999999996 110.215 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 30.8 t -101.46 130.05 47.63 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.568 -0.707 . . . . 1.27 110.009 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -156.21 156.44 34.15 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.499 -0.75 . . . . 5.0199999999999996 110.529 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.15 85.46 18.8 Favored Pre-proline 0 N--CA 1.5 2.041 0 O-C-N 121.616 -0.677 . . . . 2.4100000000000001 109.613 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -72.82 -172.58 0.99 Allowed 'Trans proline' 0 C--N 1.317 -1.091 0 O-C-N 123.29 1.153 . . . . 0.95999999999999996 111.216 -179.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 978' ' ' LEU . . . . . . . . . . . . . 6.7 mp -127.25 154.7 44.55 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 107.644 -1.243 . . . . 0.62 107.644 178.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 979' ' ' THR . . . . . . . . . . . . . 41.1 p -150.54 141.16 22.61 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.781 -1.199 . . . . 3.5699999999999998 111.145 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 980' ' ' ILE . . . . . . . . . . . . . 50.7 mm -106.22 127.43 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 108.881 -0.785 . . . . 1.3300000000000001 108.881 179.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 981' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -120.71 99.26 6.43 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.414 -0.804 . . . . 0.050000000000000003 111.782 -178.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 85.9 p -108.16 159.89 16.25 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 109.06 -0.719 . . . . 0.87 109.06 178.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . -171.45 109.55 0.32 Allowed Glycine 0 N--CA 1.498 2.82 0 N-CA-C 106.635 -2.586 . . . . 0.029999999999999999 106.635 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -109.61 148.62 30.98 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 114.561 1.319 . . . . 0.69999999999999996 114.561 -175.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 985' ' ' LEU . . . . . . . . . . . . . 51.8 tp -68.77 134.4 49.7 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.854 -1.154 . . . . 0.040000000000000001 110.084 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 45.8 tp -107.82 -59.19 1.87 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.563 -0.71 . . . . 0.040000000000000001 109.925 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -144.32 144.91 31.68 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.601 -1.259 . . . . 0.040000000000000001 107.601 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -113.1 162.8 12.24 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 108.187 -1.965 . . . . 0.040000000000000001 108.187 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -75.16 112.97 20.8 Favored Pre-proline 0 N--CA 1.499 1.981 0 O-C-N 121.186 -1.185 . . . . 0.040000000000000001 109.454 179.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 990' ' ' PRO . . . . . 0.418 ' O ' ' HB2' ' A' ' 991' ' ' GLU . 50.9 Cg_endo -88.01 72.09 2.69 Favored 'Trans proline' 0 C--N 1.32 -0.968 0 O-C-N 123.055 1.029 . . . . 0.45000000000000001 111.363 -179.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 991' ' ' GLU . . . . . 0.418 ' HB2' ' O ' ' A' ' 990' ' ' PRO . 71.8 mt-10 67.51 -73.65 0.08 Allowed 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 108.529 -0.915 . . . . 1.97 108.529 -177.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 992' ' ' LEU . . . . . . . . . . . . . 11.1 mt 50.55 20.87 0.77 Allowed 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.612 -0.68 . . . . 2.3799999999999999 111.642 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -93.56 156.7 16.58 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.942 -1.099 . . . . 3.79 110.033 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -145.3 92.6 2.27 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.587 -0.696 . . . . 3.5099999999999998 110.276 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 995' ' ' ALA . . . . . . . . . . . . 2.519 . . . . . . . 0 N--CA 1.503 2.224 0 O-C-N 120.887 -1.133 . . . . 2.73 110.648 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo . . . . . 0 N--CA 1.488 1.172 0 N-CA-C 109.543 -0.983 . . . . 3.8300000000000001 109.543 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 847' ' ' VAL . . . . . . . . . . . . . 61.5 t -132.57 103.42 13.51 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.547 -0.721 . . . . 1.8300000000000001 110.098 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 848' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -69.88 -20.28 34.44 Favored 'Trans proline' 0 N--CA 1.487 1.125 0 O-C-N 123.299 1.157 . . . . 0.65000000000000002 111.003 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 849' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 27.77 68.22 0.07 Allowed 'General case' 0 N--CA 1.518 2.941 0 N-CA-C 112.923 0.712 . . . . 2.5800000000000001 112.923 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 850' ' ' VAL . . . . . . . . . . . . . 57.4 t -119.37 136.14 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.128 -0.983 . . . . 1.0900000000000001 111.679 -178.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 851' ' ' ALA . . . . . . . . . . . . . . . -126.29 157.13 39.16 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 105.776 -1.935 . . . . 0.040000000000000001 105.776 176.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 852' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -160.68 127.4 4.16 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 120.886 1.675 . . . . 0.050000000000000003 108.581 179.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 5.7 t -176.15 134.79 0.26 Allowed 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.305 -0.998 . . . . 0.040000000000000001 108.305 -178.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -132.15 156.1 46.99 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.066 -1.022 . . . . 0.67000000000000004 109.542 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 855' ' ' ALA . . . . . 0.402 ' O ' ' HB2' ' B' ' 870' ' ' ARG . . . -121.92 143.97 49.14 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.864 0.84 . . . . 0.51000000000000001 111.315 -179.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 856' ' ' LEU . . . . . 0.406 HD23 ' CG1' ' B' ' 866' ' ' VAL . 3.4 tm? -113.2 134.88 54.36 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.687 -0.633 . . . . 0.050000000000000003 110.253 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 857' ' ' SER . . . . . 0.41 ' O ' ' O ' ' B' ' 858' ' ' LEU . 60.8 p -152.12 16.96 0.65 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.553 -0.717 . . . . 1.3300000000000001 110.616 178.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 858' ' ' LEU . . . . . 0.41 ' O ' ' O ' ' B' ' 857' ' ' SER . 4.4 pp -32.65 156.92 0.03 OUTLIER Pre-proline 0 N--CA 1.518 2.945 0 N-CA-C 113.276 0.843 . . . . 2.3300000000000001 113.276 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -62.95 -88.39 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.344 0 O-C-N 123.132 1.07 . . . . 2.3199999999999998 113.228 -178.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 55.2 ptt85 -128.65 -143.36 0.27 Allowed 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.852 -1.155 . . . . 0.040000000000000001 111.685 -177.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 14.1 m -40.16 126.83 2.19 Favored 'General case' 0 N--CA 1.508 2.451 0 O-C-N 121.566 -0.709 . . . . 1.3100000000000001 112.408 -178.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 862' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -102.01 157.63 33.32 Favored Pre-proline 0 N--CA 1.489 1.51 0 N-CA-C 107.673 -1.232 . . . . 4.5099999999999998 107.673 176.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -71.63 -11.94 28.56 Favored 'Trans proline' 0 C--N 1.314 -1.268 0 O-C-N 123.006 1.003 . . . . 2.2400000000000002 111.472 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -176.08 -136.61 2.39 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 110.152 -1.179 . . . . 0.040000000000000001 110.152 179.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 26.1 m -65.75 155.95 34.56 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.357 -1.084 . . . . 1.51 110.934 -178.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 866' ' ' VAL . . . . . 0.406 ' CG1' HD23 ' B' ' 856' ' ' LEU . 59.8 t -92.11 135.22 27.36 Favored Pre-proline 0 N--CA 1.494 1.743 0 N-CA-C 113.265 0.839 . . . . 0.78000000000000003 113.265 -174.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 867' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -90.49 -152.7 0.04 OUTLIER 'Trans proline' 0 CA--C 1.54 0.82 0 N-CA-C 108.612 -1.341 . . . . 0.92000000000000004 108.612 177.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 868' ' ' PHE . . . . . 0.449 ' CD1' ' N ' ' B' ' 868' ' ' PHE . 27.0 p90 -150.98 122.47 7.91 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.631 -1.293 . . . . 0.050000000000000003 109.592 179.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 50.3 p-10 -113.86 -1.94 13.75 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 119.343 -0.943 . . . . 1.7 112.519 -178.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 870' ' ' ARG . . . . . 0.402 ' HB2' ' O ' ' B' ' 855' ' ' ALA . 28.9 mmm180 -90.72 88.45 7.09 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.908 -1.12 . . . . 2.5899999999999999 110.773 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 57.3 t -73.28 97.07 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.011 -1.056 . . . . 1.9399999999999999 109.864 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 872' ' ' LEU . . . . . . . . . . . . . 96.2 mt -83.05 -47.57 11.54 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.535 -0.728 . . . . 1.0600000000000001 110.14 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 873' ' ' LEU . . . . . . . . . . . . . 30.4 tp -174.63 103.83 0.1 Allowed 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.545 -0.909 . . . . 4.1799999999999997 108.545 178.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 874' ' ' ASN . . . . . . . . . . . . . 37.5 t-20 178.66 81.66 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.281 0 O-C-N 121.608 -0.682 . . . . 0.040000000000000001 109.698 -178.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -66.03 -47.11 75.49 Favored 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 119.297 -0.961 . . . . 3.3799999999999999 110.994 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 876' ' ' GLY . . . . . . . . . . . . . . . -74.64 -24.78 71.63 Favored Glycine 0 N--CA 1.493 2.486 0 C-N-CA 120.526 -0.845 . . . . 0.040000000000000001 111.842 -178.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 85.91 -58.77 4.78 Favored Glycine 0 N--CA 1.502 3.06 0 N-CA-C 108.105 -1.998 . . . . 0.040000000000000001 108.105 -178.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 878' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 60.45 -67.74 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 114.263 1.209 . . . . 3.46 114.263 177.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 879' ' ' TYR . . . . . 0.463 ' CB ' ' CD2' ' B' ' 886' ' ' PHE . 24.2 p90 -113.2 110.67 20.78 Favored 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 114.955 1.465 . . . . 0.040000000000000001 114.955 -176.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -65.62 118.94 56.09 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 121.494 -0.754 . . . . 0.02 110.196 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 881' ' ' PRO . . . . . 0.417 ' HG2' ' CD1' ' B' ' 868' ' ' PHE . 54.2 Cg_endo -76.34 0.38 9.5 Favored 'Trans proline' 0 N--CA 1.493 1.483 0 O-C-N 123.337 1.178 . . . . 0.39000000000000001 112.221 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -74.44 -65.23 0.88 Allowed 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 106.7 -1.593 . . . . 0.81000000000000005 106.7 178.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 7.0 p -96.99 -15.77 20.92 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 109.0 -0.741 . . . . 0.040000000000000001 109.0 177.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.42 24.09 48.44 Favored Glycine 0 N--CA 1.495 2.569 0 C-N-CA 120.034 -1.079 . . . . 0.029999999999999999 110.596 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 885' ' ' VAL . . . . . . . . . . . . . 92.9 t -72.12 88.64 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 C-N-CA 118.514 -1.274 . . . . 1.01 107.865 -179.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 886' ' ' PHE . . . . . 0.463 ' CD2' ' CB ' ' B' ' 879' ' ' TYR . 0.7 OUTLIER -90.82 105.52 17.88 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 115.249 -0.887 . . . . 0.050000000000000003 112.577 -176.848 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 887' ' ' THR . . . . . 0.404 ' O ' ' HD3' ' B' ' 889' ' ' PRO . 89.6 m -95.93 100.27 11.97 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 107.555 -1.276 . . . . 0.68000000000000005 107.555 177.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 888' ' ' ALA . . . . . . . . . . . . . . . -99.02 106.55 38.76 Favored Pre-proline 0 N--CA 1.501 2.114 0 N-CA-C 114.125 1.157 . . . . 0.25 114.125 -176.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 889' ' ' PRO . . . . . 0.404 ' HD3' ' O ' ' B' ' 887' ' ' THR . 53.4 Cg_endo -90.15 -11.77 2.97 Favored 'Trans proline' 0 CA--C 1.547 1.143 0 C-N-CA 121.143 1.228 . . . . 1.6399999999999999 109.128 176.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 890' ' ' LEU . . . . . . . . . . . . . 4.6 tt -34.96 -51.81 0.53 Allowed 'General case' 0 N--CA 1.509 2.487 0 N-CA-C 113.867 1.062 . . . . 2.29 113.867 -177.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 51.29 95.52 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.373 0 O-C-N 121.131 -0.981 . . . . 0.63 110.425 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . 156.09 -147.68 16.65 Favored Glycine 0 N--CA 1.48 1.581 0 N-CA-C 107.383 -2.287 . . . . 0.040000000000000001 107.383 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 72.9 ttt-85 -109.04 127.06 53.79 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 107.49 -1.3 . . . . 3.0 107.49 177.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 894' ' ' TYR . . . . . 0.448 ' CD1' ' N ' ' B' ' 895' ' ' LEU . 0.1 OUTLIER -131.45 144.81 51.44 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.053 -1.029 . . . . 0.040000000000000001 110.17 -179.112 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 895' ' ' LEU . . . . . 0.448 ' N ' ' CD1' ' B' ' 894' ' ' TYR . 34.1 tp -99.3 116.68 32.04 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.623 -0.673 . . . . 1.27 109.846 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 896' ' ' LEU . . . . . 0.433 ' HB2' ' CZ ' ' B' ' 894' ' ' TYR . 10.4 tt -112.75 146.57 38.53 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.587 -0.696 . . . . 0.93999999999999995 110.704 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 897' ' ' SER . . . . . . . . . . . . . 63.3 m -143.78 118.89 10.08 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.42 -0.8 . . . . 0.040000000000000001 110.741 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -108.2 147.21 31.67 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.689 -0.632 . . . . 0.47999999999999998 109.352 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 899' ' ' VAL . . . . . . . . . . . . . 88.3 t -93.86 120.15 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.417 -0.802 . . . . 0.55000000000000004 110.9 -179.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 900' ' ' LEU . . . . . 0.436 ' N ' ' CD2' ' B' ' 900' ' ' LEU . 4.4 mm? -94.7 112.94 24.67 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 114.257 1.206 . . . . 1.5900000000000001 114.257 -174.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 17.9 m -66.81 141.63 57.63 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 107.348 -1.352 . . . . 0.050000000000000003 107.348 176.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -66.18 -65.18 2.96 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 110.598 -1.001 . . . . 0.029999999999999999 110.598 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 5.9 m170 46.9 64.93 1.36 Allowed 'General case' 0 N--CA 1.507 2.393 0 O-C-N 121.381 -1.07 . . . . 3.2000000000000002 111.122 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 41.6 ptt85 -69.24 -6.71 30.92 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.574 -0.704 . . . . 2.9199999999999999 111.989 -179.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 905' ' ' HIS . . . . . 0.486 ' O ' ' CB ' ' B' ' 906' ' ' GLU . 70.5 t60 -63.48 6.14 0.15 Allowed 'General case' 0 N--CA 1.507 2.387 0 O-C-N 120.867 -1.146 . . . . 2.8700000000000001 113.163 -178.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 906' ' ' GLU . . . . . 0.486 ' CB ' ' O ' ' B' ' 905' ' ' HIS . 0.5 OUTLIER 94.58 -164.31 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.47 0 CA-C-N 120.592 1.542 . . . . 0.98999999999999999 111.848 179.008 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 907' ' ' LYS . . . . . 0.476 ' CB ' ' O ' ' B' ' 906' ' ' GLU . 56.6 tttt 86.62 156.04 0.08 Allowed 'General case' 0 N--CA 1.52 3.067 0 N-CA-C 108.042 -1.096 . . . . 5.25 108.042 -176.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 60.3 t -122.97 115.68 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 120.804 -1.185 . . . . 0.39000000000000001 111.116 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 51.0 tp10 -102.01 133.32 47.0 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 107.328 -1.36 . . . . 1.72 107.328 176.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -155.15 123.04 5.76 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 106.783 -1.562 . . . . 0.67000000000000004 106.783 178.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 911' ' ' VAL . . . . . 0.459 ' HA ' ' HA ' ' B' ' 964' ' ' VAL . 77.9 t -82.53 131.17 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.858 -0.526 . . . . 0.54000000000000004 111.022 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 75.5 mt -66.82 156.53 35.34 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.407 -0.808 . . . . 1.5 108.951 178.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 913' ' ' SER . . . . . 0.404 ' CB ' ' CG1' ' B' ' 919' ' ' VAL . 1.1 p -125.32 135.85 52.89 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.181 -1.044 . . . . 1.3700000000000001 108.181 176.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 914' ' ' ARG . . . . . 0.429 ' O ' ' CB ' ' B' ' 915' ' ' SER . 0.0 OUTLIER -64.61 155.62 32.67 Favored 'General case' 0 N--CA 1.506 2.35 0 O-C-N 120.619 -1.301 . . . . 4.2999999999999998 111.528 -179.295 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 915' ' ' SER . . . . . 0.429 ' CB ' ' O ' ' B' ' 914' ' ' ARG . 2.0 t 83.64 -31.58 0.08 Allowed 'General case' 0 N--CA 1.52 3.07 0 C-N-CA 123.968 0.907 . . . . 2.0499999999999998 111.887 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 916' ' ' ASN . . . . . 0.414 ' O ' ' HB2' ' B' ' 917' ' ' GLN . 68.8 m-80 -123.82 -21.1 5.24 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 120.927 -1.108 . . . . 2.71 111.268 -179.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 917' ' ' GLN . . . . . 0.414 ' HB2' ' O ' ' B' ' 916' ' ' ASN . 50.3 mt-30 66.71 166.41 0.21 Allowed 'General case' 0 N--CA 1.521 3.094 0 N-CA-C 105.74 -1.948 . . . . 2.6800000000000002 105.74 -174.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.07 -125.08 32.37 Favored Glycine 1 N--CA 1.522 4.386 0 CA-C-N 123.397 2.817 . . . . 0.029999999999999999 107.071 -177.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 919' ' ' VAL . . . . . 0.404 ' CG1' ' CB ' ' B' ' 913' ' ' SER . 76.4 t 51.69 94.23 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.262 0 O-C-N 121.407 -1.055 . . . . 1.3899999999999999 109.036 -178.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 920' ' ' ALA . . . . . . . . . . . . . . . -92.31 92.06 7.98 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.335 -0.946 . . . . 0.029999999999999999 110.831 -179.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 921' ' ' ARG . . . . . 0.422 ' HB3' ' CZ ' ' B' ' 950' ' ' PHE . 30.6 ptt180 -83.68 -41.62 17.53 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 105.65 -1.981 . . . . 4.4199999999999999 105.65 175.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 922' ' ' VAL . . . . . . . . . . . . . 96.9 t -98.66 78.81 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 N-CA-C 105.939 -1.874 . . . . 0.84999999999999998 105.939 175.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -86.47 134.05 33.71 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.654 0.74 . . . . 2.46 111.368 -177.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 924' ' ' SER . . . . . . . . . . . . . 17.4 t -147.49 104.84 3.66 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.713 -0.847 . . . . 0.69999999999999996 108.713 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -104.13 83.36 0.4 Allowed Glycine 0 N--CA 1.487 2.041 0 N-CA-C 108.222 -1.951 . . . . 0.040000000000000001 108.222 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 108.973 -1.651 . . . . 0.040000000000000001 108.973 -179.376 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 68.1 m . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.014 0.435 . . . . 13.779999999999999 110.246 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 94.8 mt -108.88 129.44 55.41 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.583 -0.698 . . . . 13.76 110.323 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -152.19 168.83 31.43 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.235 -1.546 . . . . 9.1300000000000008 109.235 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 949' ' ' VAL . . . . . . . . . . . . . 35.0 m -117.85 132.74 66.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.525 -0.985 . . . . 7.0800000000000001 110.717 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 950' ' ' PHE . . . . . 0.422 ' CZ ' ' HB3' ' B' ' 921' ' ' ARG . 30.7 p90 -130.49 146.57 52.05 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.518 -0.739 . . . . 7.5899999999999999 109.55 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 73.4 m -119.38 -54.11 2.2 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.452 -0.78 . . . . 5.0300000000000002 111.808 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 952' ' ' LEU . . . . . 0.409 ' O ' ' O ' ' B' ' 953' ' ' ILE . 56.5 tp -61.42 -77.02 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.465 -0.772 . . . . 1.01 112.285 -177.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 953' ' ' ILE . . . . . 0.469 ' O ' ' HB3' ' B' ' 954' ' ' LEU . 48.9 pt -53.83 -141.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.739 0 N-CA-C 113.701 1.0 . . . . 2.6000000000000001 113.701 -176.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 954' ' ' LEU . . . . . 0.524 ' N ' ' CD1' ' B' ' 954' ' ' LEU . 0.0 OUTLIER 174.07 78.68 0.05 OUTLIER Pre-proline 0 N--CA 1.509 2.495 0 O-C-N 120.654 -1.279 . . . . 0.050000000000000003 110.963 179.47 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 955' ' ' PRO . . . . . 0.422 ' HD2' ' CE1' ' B' ' 950' ' ' PHE . 46.0 Cg_endo -73.51 89.52 0.95 Allowed 'Trans proline' 0 C--N 1.315 -1.236 0 N-CA-C 109.514 -0.995 . . . . 0.83999999999999997 109.514 178.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 956' ' ' LEU . . . . . . . . . . . . . 5.7 mp -125.22 150.22 47.22 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.289 -0.882 . . . . 0.040000000000000001 110.461 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -82.14 151.38 26.99 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 117.729 -1.129 . . . . 1.28 111.828 -179.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -69.77 119.74 14.46 Favored 'General case' 0 N--CA 1.512 2.626 0 CA-C-N 123.14 2.7 . . . . 0.17000000000000001 111.784 -179.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.76 -22.66 32.48 Favored Glycine 0 N--CA 1.502 3.076 0 N-CA-C 111.037 -0.825 . . . . 0.040000000000000001 111.037 178.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 960' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -52.19 171.55 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.54 -0.976 . . . . 0.040000000000000001 110.198 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 961' ' ' THR . . . . . 0.441 ' HA ' ' O ' ' B' ' 886' ' ' PHE . 47.1 m -133.42 137.83 45.96 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.846 -1.159 . . . . 1.78 112.103 -178.084 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 962' ' ' VAL . . . . . 0.425 ' CG2' ' CB ' ' B' ' 886' ' ' PHE . 26.3 m -98.84 144.44 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 C-N-CA 120.169 -0.612 . . . . 0.040000000000000001 110.219 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 1.6 m -137.87 144.72 41.52 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.857 -0.527 . . . . 0.71999999999999997 110.009 -178.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 964' ' ' VAL . . . . . 0.459 ' HA ' ' HA ' ' B' ' 911' ' ' VAL . 58.1 t -95.2 136.34 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.107 -0.995 . . . . 1.05 110.434 -179.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -94.29 127.59 40.25 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 103.758 -2.682 . . . . 3.02 103.758 173.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 966' ' ' LEU . . . . . 0.411 ' O ' ' CG2' ' B' ' 967' ' ' VAL . 1.2 tt -132.24 61.67 1.66 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.123 -1.065 . . . . 1.46 108.123 177.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 967' ' ' VAL . . . . . 0.411 ' CG2' ' O ' ' B' ' 966' ' ' LEU . 94.4 t -158.42 97.02 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 107.917 -1.142 . . . . 1.9399999999999999 107.917 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 90.4 mmm -142.79 59.92 1.43 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.715 -1.24 . . . . 0.0 108.251 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.64 119.98 1.96 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 107.043 -2.423 . . . . 2.1099999999999999 107.043 -178.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -82.12 -58.2 3.06 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.974 -1.31 . . . . 5.8899999999999997 110.492 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 40.0 tp -58.9 90.47 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.407 -0.808 . . . . 4.3600000000000003 110.336 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -141.88 -154.32 0.51 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.565 -0.71 . . . . 1.8300000000000001 110.139 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -120.04 171.84 8.17 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.409 -0.807 . . . . 4.3499999999999996 110.273 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 31.5 t -100.97 130.03 46.9 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.555 -0.716 . . . . 1.27 110.068 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -156.25 156.44 34.09 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.511 -0.743 . . . . 5.0199999999999996 110.553 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.14 85.49 18.82 Favored Pre-proline 0 N--CA 1.5 2.038 0 O-C-N 121.655 -0.653 . . . . 2.4100000000000001 109.671 179.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -72.66 -172.42 0.94 Allowed 'Trans proline' 0 C--N 1.317 -1.098 0 O-C-N 123.299 1.158 . . . . 0.95999999999999996 111.258 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 978' ' ' LEU . . . . . . . . . . . . . 6.6 mp -127.58 154.48 45.14 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 107.639 -1.245 . . . . 0.62 107.639 178.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 979' ' ' THR . . . . . . . . . . . . . 41.3 p -150.28 141.38 23.05 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.79 -1.194 . . . . 3.5699999999999998 111.12 -179.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 980' ' ' ILE . . . . . 0.453 HG22 HD11 ' B' ' 980' ' ' ILE . 50.7 mm -106.4 127.42 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 108.852 -0.796 . . . . 1.3300000000000001 108.852 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -120.63 99.25 6.43 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 119.723 -0.791 . . . . 0.050000000000000003 111.791 -178.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 81.9 p -108.42 159.67 16.49 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.543 -0.723 . . . . 0.87 109.104 178.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 983' ' ' GLY . . . . . . . . . . . . . . . -171.14 110.03 0.34 Allowed Glycine 0 N--CA 1.497 2.759 0 N-CA-C 106.496 -2.641 . . . . 0.029999999999999999 106.496 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -110.03 148.01 32.47 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 114.637 1.347 . . . . 0.69999999999999996 114.637 -175.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 985' ' ' LEU . . . . . . . . . . . . . 51.4 tp -68.17 134.27 50.22 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 120.895 -1.128 . . . . 0.040000000000000001 110.123 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 986' ' ' LEU . . . . . . . . . . . . . 45.8 tp -107.8 -59.11 1.88 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.598 -0.689 . . . . 0.040000000000000001 109.957 179.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -144.48 144.92 31.59 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 107.543 -1.28 . . . . 0.040000000000000001 107.543 179.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.98 163.21 12.16 Favored Glycine 0 N--CA 1.495 2.603 0 N-CA-C 108.271 -1.932 . . . . 0.040000000000000001 108.271 179.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -75.65 113.01 22.44 Favored Pre-proline 0 N--CA 1.498 1.965 0 O-C-N 121.273 -1.133 . . . . 0.040000000000000001 109.443 179.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 990' ' ' PRO . . . . . 0.409 ' O ' ' HB2' ' B' ' 991' ' ' GLU . 50.2 Cg_endo -88.07 72.06 2.65 Favored 'Trans proline' 0 C--N 1.319 -0.996 0 O-C-N 123.141 1.074 . . . . 0.45000000000000001 111.443 -178.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 991' ' ' GLU . . . . . 0.409 ' HB2' ' O ' ' B' ' 990' ' ' PRO . 71.8 mt-10 67.5 -73.68 0.08 Allowed 'General case' 0 N--CA 1.503 2.182 0 N-CA-C 108.502 -0.925 . . . . 1.97 108.502 -177.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 992' ' ' LEU . . . . . . . . . . . . . 11.1 mt 50.5 20.83 0.75 Allowed 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.605 -0.685 . . . . 2.3799999999999999 111.677 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -93.63 156.74 16.54 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.9 -1.125 . . . . 3.79 110.042 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -145.19 92.83 2.3 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.481 -0.762 . . . . 3.5099999999999998 110.211 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 995' ' ' ALA . . . . . . . . . . . . 2.518 . . . . . . . 0 N--CA 1.504 2.232 0 O-C-N 120.949 -1.095 . . . . 2.73 110.603 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo . . . . . 0 N--CA 1.489 1.239 0 N-CA-C 109.52 -0.992 . . . . 3.8300000000000001 109.52 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 847' ' ' VAL . . . . . . . . . . . . . 57.9 t -129.88 104.86 16.91 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.586 -0.696 . . . . 1.8300000000000001 110.088 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 848' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -69.84 -22.05 32.23 Favored 'Trans proline' 0 N--CA 1.488 1.152 0 O-C-N 123.255 1.134 . . . . 0.65000000000000002 111.123 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 849' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 27.53 68.61 0.07 Allowed 'General case' 0 N--CA 1.518 2.952 0 N-CA-C 112.93 0.715 . . . . 2.5800000000000001 112.93 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 850' ' ' VAL . . . . . . . . . . . . . 57.4 t -119.52 135.68 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.157 -0.964 . . . . 1.0900000000000001 111.349 -178.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 851' ' ' ALA . . . . . . . . . . . . . . . -130.2 154.97 47.01 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 106.029 -1.841 . . . . 0.040000000000000001 106.029 176.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 852' ' ' PHE . . . . . 0.411 ' CE2' ' O ' ' C' ' 983' ' ' GLY . 9.1 p90 -158.66 130.34 6.56 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 120.869 1.668 . . . . 0.050000000000000003 108.756 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 42.2 t -175.49 133.37 0.29 Allowed 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.014 -1.106 . . . . 0.040000000000000001 108.014 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -134.42 158.21 44.45 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.158 -0.964 . . . . 0.67000000000000004 109.388 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 855' ' ' ALA . . . . . . . . . . . . . . . -121.07 141.52 50.69 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.9 0.857 . . . . 0.51000000000000001 111.713 -178.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 856' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -106.83 133.84 50.88 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 109.26 -0.645 . . . . 0.050000000000000003 109.26 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 857' ' ' SER . . . . . 0.402 ' O ' ' O ' ' C' ' 858' ' ' LEU . 80.0 p -152.61 15.85 0.59 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.549 -0.719 . . . . 1.3300000000000001 110.959 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 858' ' ' LEU . . . . . 0.402 ' O ' ' O ' ' C' ' 857' ' ' SER . 2.9 pp -34.94 157.49 0.04 OUTLIER Pre-proline 0 N--CA 1.516 2.873 0 N-CA-C 112.692 0.627 . . . . 2.3300000000000001 112.692 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -62.13 -89.43 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 121.048 1.165 . . . . 2.3199999999999998 114.127 -177.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 54.8 ptt85 -130.67 -142.62 0.23 Allowed 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.803 -1.185 . . . . 0.040000000000000001 111.867 -177.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 71.7 m -35.17 118.8 0.46 Allowed 'General case' 0 N--CA 1.511 2.601 0 O-C-N 121.749 -0.595 . . . . 1.3100000000000001 112.515 -178.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -102.67 159.78 28.28 Favored Pre-proline 0 N--CA 1.488 1.448 0 N-CA-C 108.033 -1.099 . . . . 4.5099999999999998 108.033 177.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.86 -14.52 32.67 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 O-C-N 123.176 1.093 . . . . 2.2400000000000002 111.12 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -176.99 -133.94 1.9 Allowed Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.969 -1.252 . . . . 0.040000000000000001 109.969 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 37.5 m -70.0 158.5 35.53 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.38 -1.071 . . . . 1.51 110.924 -178.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 866' ' ' VAL . . . . . . . . . . . . . 30.9 m -94.68 138.43 22.24 Favored Pre-proline 0 N--CA 1.497 1.888 0 N-CA-C 113.641 0.978 . . . . 0.78000000000000003 113.641 -175.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 867' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -89.12 -151.11 0.04 OUTLIER 'Trans proline' 0 CA--C 1.54 0.802 0 N-CA-C 108.262 -1.476 . . . . 0.92000000000000004 108.262 177.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 868' ' ' PHE . . . . . 0.456 ' N ' ' CD1' ' C' ' 868' ' ' PHE . 15.0 p90 -147.97 121.58 9.19 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.512 -1.367 . . . . 0.050000000000000003 109.99 179.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -112.01 -3.5 14.77 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 119.433 -0.907 . . . . 1.7 112.101 -178.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 870' ' ' ARG . . . . . . . . . . . . . 23.8 mmm180 -90.93 87.67 6.72 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.968 -1.083 . . . . 2.5899999999999999 110.774 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 58.3 t -74.43 97.08 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 120.983 -1.073 . . . . 1.9399999999999999 109.43 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 872' ' ' LEU . . . . . . . . . . . . . 80.6 mt -86.38 -45.27 11.34 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.523 -0.736 . . . . 1.0600000000000001 110.557 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 873' ' ' LEU . . . . . 0.405 ' O ' ' HB2' ' C' ' 874' ' ' ASN . 50.2 tp -173.61 103.22 0.12 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.192 -0.942 . . . . 4.1799999999999997 108.769 178.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 874' ' ' ASN . . . . . 0.41 ' CB ' ' HA ' ' C' ' 852' ' ' PHE . 35.3 t-20 177.84 82.75 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.282 0 N-CA-C 109.201 -0.666 . . . . 0.040000000000000001 109.201 -178.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -66.37 -46.58 76.2 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 119.354 -0.938 . . . . 3.3799999999999999 111.351 -179.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 876' ' ' GLY . . . . . 0.42 ' HA3' ' CE2' ' C' ' 878' ' ' TYR . . . -74.29 -25.81 69.81 Favored Glycine 0 N--CA 1.493 2.499 0 O-C-N 121.282 -0.886 . . . . 0.040000000000000001 111.887 -178.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 81.03 -61.57 4.55 Favored Glycine 0 N--CA 1.502 3.073 0 N-CA-C 107.92 -2.072 . . . . 0.040000000000000001 107.92 -178.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 878' ' ' TYR . . . . . 0.42 ' CE2' ' HA3' ' C' ' 876' ' ' GLY . 91.4 m-85 61.67 -65.62 0.07 Allowed 'General case' 0 N--CA 1.503 2.222 0 N-CA-C 114.327 1.232 . . . . 3.46 114.327 177.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 879' ' ' TYR . . . . . 0.46 ' CB ' ' CD2' ' C' ' 886' ' ' PHE . 23.7 p90 -112.04 109.06 18.59 Favored 'General case' 0 N--CA 1.501 2.116 0 N-CA-C 114.938 1.459 . . . . 0.040000000000000001 114.938 -176.019 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -65.24 119.94 63.34 Favored Pre-proline 0 N--CA 1.497 1.913 0 O-C-N 121.548 -0.72 . . . . 0.02 110.369 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 881' ' ' PRO . . . . . 0.452 ' CG ' ' CD1' ' C' ' 868' ' ' PHE . 53.1 Cg_endo -76.13 0.99 8.75 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 O-C-N 123.434 1.229 . . . . 0.39000000000000001 112.285 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 87.4 mt-10 -74.96 -65.53 0.86 Allowed 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 106.829 -1.545 . . . . 0.81000000000000005 106.829 178.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 42.1 p -97.51 -15.1 20.72 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 109.19 -0.67 . . . . 0.040000000000000001 109.19 177.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.35 25.21 44.37 Favored Glycine 0 N--CA 1.494 2.527 0 C-N-CA 119.982 -1.104 . . . . 0.029999999999999999 110.636 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 83.0 t -72.66 88.94 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 C-N-CA 118.4 -1.32 . . . . 1.01 107.833 -179.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 886' ' ' PHE . . . . . 0.46 ' CD2' ' CB ' ' C' ' 879' ' ' TYR . 0.7 OUTLIER -90.73 103.8 16.46 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 115.358 -0.837 . . . . 0.050000000000000003 112.242 -177.014 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 887' ' ' THR . . . . . . . . . . . . . 97.1 m -96.79 100.46 12.0 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 107.601 -1.259 . . . . 0.68000000000000005 107.601 177.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 888' ' ' ALA . . . . . . . . . . . . . . . -99.47 105.37 32.96 Favored Pre-proline 0 N--CA 1.501 2.093 0 N-CA-C 114.197 1.184 . . . . 0.25 114.197 -176.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 889' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -86.9 -13.09 4.8 Favored 'Trans proline' 0 CA--C 1.546 1.077 0 N-CA-C 108.85 -1.25 . . . . 1.6399999999999999 108.85 175.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 890' ' ' LEU . . . . . . . . . . . . . 69.3 mt -38.04 -49.81 1.31 Allowed 'General case' 0 N--CA 1.507 2.378 0 N-CA-C 113.611 0.967 . . . . 2.29 113.611 -177.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 52.42 97.43 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.286 0 O-C-N 121.082 -1.011 . . . . 0.63 110.353 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . 156.53 -148.26 17.92 Favored Glycine 0 N--CA 1.478 1.493 0 N-CA-C 107.292 -2.323 . . . . 0.040000000000000001 107.292 -179.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 73.2 ttt-85 -108.29 128.62 54.9 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 107.763 -1.199 . . . . 3.0 107.763 177.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 894' ' ' TYR . . . . . 0.428 ' CZ ' ' HB2' ' C' ' 896' ' ' LEU . 0.1 OUTLIER -130.49 146.3 52.01 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.14 -0.975 . . . . 0.040000000000000001 110.149 -179.144 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 895' ' ' LEU . . . . . 0.42 ' N ' ' CD1' ' C' ' 894' ' ' TYR . 38.6 tp -97.7 115.8 28.67 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.677 -0.64 . . . . 1.27 109.761 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 896' ' ' LEU . . . . . 0.428 ' HB2' ' CZ ' ' C' ' 894' ' ' TYR . 9.2 tt -109.72 146.17 35.36 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.687 -0.633 . . . . 0.93999999999999995 110.822 -179.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 897' ' ' SER . . . . . . . . . . . . . 19.9 m -147.49 113.66 5.87 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.576 -0.702 . . . . 0.040000000000000001 110.707 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -106.61 147.02 29.99 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.032 -0.729 . . . . 0.47999999999999998 109.032 179.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 899' ' ' VAL . . . . . . . . . . . . . 89.7 t -93.9 119.63 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 C-N-CA 119.617 -0.833 . . . . 0.55000000000000004 111.159 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 95.9 mt -94.54 110.61 22.41 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 114.188 1.181 . . . . 1.5900000000000001 114.188 -175.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 23.8 m -63.81 138.84 58.65 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 107.441 -1.318 . . . . 0.050000000000000003 107.441 177.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -61.48 -65.62 3.15 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 110.456 -1.058 . . . . 0.029999999999999999 110.456 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 46.21 66.48 0.94 Allowed 'General case' 0 N--CA 1.508 2.441 0 O-C-N 121.484 -1.009 . . . . 3.2000000000000002 110.921 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 54.8 ptt85 -67.93 -7.16 26.18 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.597 -0.69 . . . . 2.9199999999999999 112.03 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 905' ' ' HIS . . . . . 0.49 ' O ' ' CB ' ' C' ' 906' ' ' GLU . 77.1 t60 -59.83 4.4 0.05 OUTLIER 'General case' 0 N--CA 1.507 2.399 0 CA-C-O 117.65 -1.167 . . . . 2.8700000000000001 113.428 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 906' ' ' GLU . . . . . 0.49 ' CB ' ' O ' ' C' ' 905' ' ' HIS . 0.7 OUTLIER 93.0 -164.16 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.387 0 CA-C-N 121.272 1.851 . . . . 0.98999999999999999 112.013 179.071 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 907' ' ' LYS . . . . . 0.483 ' CB ' ' O ' ' C' ' 906' ' ' GLU . 68.7 tttt 87.87 160.22 0.07 Allowed 'General case' 0 N--CA 1.518 2.964 0 N-CA-C 107.772 -1.195 . . . . 5.25 107.772 -176.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 59.9 t -122.44 115.71 46.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 120.847 -1.158 . . . . 0.39000000000000001 111.058 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 40.3 tp10 -100.25 132.95 45.33 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 107.077 -1.453 . . . . 1.72 107.077 176.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -156.9 120.5 4.21 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 106.929 -1.508 . . . . 0.67000000000000004 106.929 178.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 911' ' ' VAL . . . . . 0.454 ' HA ' ' HA ' ' C' ' 964' ' ' VAL . 13.2 p -76.5 130.99 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 C-N-CA 120.42 -0.512 . . . . 0.54000000000000004 111.131 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 83.5 mt -65.59 156.13 33.66 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 108.167 -1.049 . . . . 1.5 108.167 178.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 913' ' ' SER . . . . . 0.416 ' CB ' ' CG1' ' C' ' 919' ' ' VAL . 1.2 t -127.98 131.8 49.22 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.414 -0.958 . . . . 1.3700000000000001 108.414 176.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 914' ' ' ARG . . . . . 0.421 ' O ' ' CB ' ' C' ' 915' ' ' SER . 0.0 OUTLIER -63.24 156.22 26.1 Favored 'General case' 0 N--CA 1.506 2.336 0 O-C-N 120.71 -1.244 . . . . 4.2999999999999998 111.381 -179.195 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 915' ' ' SER . . . . . 0.421 ' CB ' ' O ' ' C' ' 914' ' ' ARG . 1.8 p 84.2 -32.07 0.07 Allowed 'General case' 0 N--CA 1.521 3.082 0 C-N-CA 124.033 0.933 . . . . 2.0499999999999998 111.848 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 916' ' ' ASN . . . . . 0.418 ' O ' ' HB2' ' C' ' 917' ' ' GLN . 89.6 m-20 -124.03 -21.86 4.97 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.931 -1.106 . . . . 2.71 111.261 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 917' ' ' GLN . . . . . 0.418 ' HB2' ' O ' ' C' ' 916' ' ' ASN . 56.9 mt-30 66.82 164.86 0.2 Allowed 'General case' 0 N--CA 1.52 3.042 0 N-CA-C 105.707 -1.96 . . . . 2.6800000000000002 105.707 -173.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 55.67 -124.79 34.78 Favored Glycine 1 N--CA 1.52 4.266 0 CA-C-N 123.575 2.898 . . . . 0.029999999999999999 106.682 -177.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 919' ' ' VAL . . . . . 0.416 ' CG1' ' CB ' ' C' ' 913' ' ' SER . 76.8 t 51.24 93.94 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.294 0 O-C-N 121.422 -1.046 . . . . 1.3899999999999999 109.119 -178.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 920' ' ' ALA . . . . . . . . . . . . . . . -93.41 93.69 8.29 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.429 -0.908 . . . . 0.029999999999999999 110.831 -179.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 921' ' ' ARG . . . . . 0.421 ' HB3' ' CZ ' ' C' ' 950' ' ' PHE . 41.8 ptt85 -82.03 -42.29 19.49 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 105.795 -1.928 . . . . 4.4199999999999999 105.795 176.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 922' ' ' VAL . . . . . . . . . . . . . 69.8 t -99.7 77.82 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 105.602 -1.999 . . . . 0.84999999999999998 105.602 175.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -90.73 135.53 33.65 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.814 0.816 . . . . 2.46 112.149 -176.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 14.9 t -147.4 103.93 3.6 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.017 -1.105 . . . . 0.69999999999999996 108.017 178.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -109.94 89.62 0.56 Allowed Glycine 0 N--CA 1.488 2.127 0 N-CA-C 108.882 -1.687 . . . . 0.040000000000000001 108.882 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.318 0 N-CA-C 109.347 -1.501 . . . . 0.040000000000000001 109.347 -179.623 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 55.4 m . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 120.949 0.404 . . . . 13.779999999999999 110.351 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 94.8 mt -114.91 129.25 56.67 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.501 -0.75 . . . . 13.76 110.317 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -152.16 170.67 31.48 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.277 -1.529 . . . . 9.1300000000000008 109.277 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 949' ' ' VAL . . . . . . . . . . . . . 33.4 m -117.22 137.45 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.524 -0.986 . . . . 7.0800000000000001 110.911 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 950' ' ' PHE . . . . . 0.421 ' CZ ' ' HB3' ' C' ' 921' ' ' ARG . 51.7 p90 -133.76 148.39 51.39 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.539 -0.725 . . . . 7.5899999999999999 109.513 179.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 70.4 m -118.54 -55.96 2.17 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.434 -0.791 . . . . 5.0300000000000002 112.137 -178.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 952' ' ' LEU . . . . . 0.47 ' O ' ' O ' ' C' ' 953' ' ' ILE . 49.3 tp -64.22 -76.64 0.07 Allowed 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.293 -0.879 . . . . 1.01 111.713 -178.049 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 953' ' ' ILE . . . . . 0.497 ' O ' ' HB3' ' C' ' 954' ' ' LEU . 2.1 pp -49.05 -151.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.787 0 N-CA-C 114.389 1.255 . . . . 2.6000000000000001 114.389 -176.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 954' ' ' LEU . . . . . 0.551 ' N ' ' CD1' ' C' ' 954' ' ' LEU . 0.0 OUTLIER 169.45 91.24 0.04 OUTLIER Pre-proline 0 N--CA 1.517 2.919 0 O-C-N 120.842 -1.162 . . . . 0.050000000000000003 112.023 179.798 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 955' ' ' PRO . . . . . 0.406 ' HD3' ' CD1' ' C' ' 953' ' ' ILE . 52.7 Cg_endo -79.47 95.48 1.05 Allowed 'Trans proline' 0 C--N 1.316 -1.158 0 N-CA-C 108.665 -1.321 . . . . 0.83999999999999997 108.665 178.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 956' ' ' LEU . . . . . 0.405 ' CD2' ' NH1' ' C' ' 914' ' ' ARG . 6.7 mp -125.7 139.5 53.49 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.939 -1.101 . . . . 0.040000000000000001 110.841 -179.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -81.98 153.38 26.26 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 117.883 -1.056 . . . . 1.28 111.121 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -67.17 118.92 11.25 Favored 'General case' 0 N--CA 1.506 2.366 0 CA-C-N 122.629 2.468 . . . . 0.17000000000000001 111.322 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 95.15 -17.89 58.43 Favored Glycine 0 N--CA 1.501 3.013 0 O-C-N 121.526 -0.734 . . . . 0.040000000000000001 111.506 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 960' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -52.97 169.89 0.09 Allowed 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.204 -1.174 . . . . 0.040000000000000001 110.784 -179.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 961' ' ' THR . . . . . 0.436 ' HA ' ' O ' ' C' ' 886' ' ' PHE . 57.2 m -135.77 135.92 40.31 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.034 -1.041 . . . . 1.78 111.823 -178.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 962' ' ' VAL . . . . . 0.43 ' CG2' ' CB ' ' C' ' 886' ' ' PHE . 22.3 m -100.19 145.43 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.533 -0.73 . . . . 0.040000000000000001 110.498 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 5.6 t -137.99 148.07 44.83 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.89 -0.506 . . . . 0.71999999999999997 110.056 -178.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 964' ' ' VAL . . . . . 0.454 ' HA ' ' HA ' ' C' ' 911' ' ' VAL . 61.8 t -99.38 136.22 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.074 -1.016 . . . . 1.05 110.403 -179.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -94.73 126.94 40.37 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 103.85 -2.648 . . . . 3.02 103.85 173.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 966' ' ' LEU . . . . . 0.4 ' O ' ' CG2' ' C' ' 967' ' ' VAL . 0.2 OUTLIER -130.57 62.31 1.59 Allowed 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.814 -1.18 . . . . 1.46 107.814 177.431 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 967' ' ' VAL . . . . . 0.4 ' CG2' ' O ' ' C' ' 966' ' ' LEU . 96.3 t -158.18 97.26 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 108.125 -1.065 . . . . 1.9399999999999999 108.125 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 85.9 mmm -142.95 58.62 1.42 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.765 -1.209 . . . . 0.0 108.342 178.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 134.78 119.63 1.96 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 107.075 -2.41 . . . . 2.1099999999999999 107.075 -178.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -82.26 -58.07 3.1 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.033 -1.275 . . . . 5.8899999999999997 110.367 -179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 41.7 tp -58.61 90.45 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.445 -0.784 . . . . 4.3600000000000003 110.231 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -142.29 -154.12 0.5 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.543 -0.723 . . . . 1.8300000000000001 110.216 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -118.75 171.1 8.44 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.478 -0.764 . . . . 4.3499999999999996 110.17 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 32.1 t -101.39 129.9 47.49 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.501 -0.749 . . . . 1.27 110.071 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -156.33 154.29 30.36 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.556 -0.715 . . . . 5.0199999999999996 110.506 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.44 86.97 15.89 Favored Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 121.62 -0.675 . . . . 2.4100000000000001 109.74 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -74.3 -170.06 0.67 Allowed 'Trans proline' 0 C--N 1.318 -1.049 0 O-C-N 123.315 1.166 . . . . 0.95999999999999996 111.285 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 978' ' ' LEU . . . . . . . . . . . . . 4.9 mp -125.86 155.39 41.28 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 107.547 -1.279 . . . . 0.62 107.547 177.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 979' ' ' THR . . . . . . . . . . . . . 39.1 p -150.39 141.64 23.21 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.779 -1.201 . . . . 3.5699999999999998 111.21 -179.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 980' ' ' ILE . . . . . 0.446 HG22 HD11 ' C' ' 980' ' ' ILE . 50.8 mm -106.29 129.16 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 109.08 -0.711 . . . . 1.3300000000000001 109.08 179.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 981' ' ' PHE . . . . . 0.432 ' CD1' ' CE2' ' C' ' 879' ' ' TYR . 2.4 t80 -118.36 97.77 5.94 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.46 -0.775 . . . . 0.050000000000000003 111.638 -178.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 982' ' ' SER . . . . . . . . . . . . . 58.6 p -108.13 157.97 17.83 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 109.002 -0.74 . . . . 0.87 109.002 178.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 983' ' ' GLY . . . . . 0.411 ' O ' ' CE2' ' C' ' 852' ' ' PHE . . . -171.32 112.15 0.44 Allowed Glycine 0 N--CA 1.498 2.803 0 N-CA-C 106.701 -2.56 . . . . 0.029999999999999999 106.701 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 984' ' ' ALA . . . . . . . . . . . . . . . -110.25 149.51 30.05 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 114.315 1.228 . . . . 0.69999999999999996 114.315 -175.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 985' ' ' LEU . . . . . . . . . . . . . 63.9 tp -74.54 135.59 42.14 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.859 -1.151 . . . . 0.040000000000000001 109.805 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 986' ' ' LEU . . . . . . . . . . . . . 45.8 tp -105.9 -62.96 1.3 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.505 -0.747 . . . . 0.040000000000000001 110.327 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 53.6 t80 -144.73 147.05 32.51 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 107.828 -1.175 . . . . 0.040000000000000001 107.828 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.11 162.98 12.24 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 108.085 -2.006 . . . . 0.040000000000000001 108.085 179.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -75.65 112.35 19.07 Favored Pre-proline 0 N--CA 1.5 2.035 0 CA-C-N 118.608 1.204 . . . . 0.040000000000000001 109.462 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 990' ' ' PRO . . . . . 0.417 ' O ' ' HB2' ' C' ' 991' ' ' GLU . 50.6 Cg_endo -91.33 71.44 0.97 Allowed 'Trans proline' 0 C--N 1.319 -0.978 0 O-C-N 123.074 1.039 . . . . 0.45000000000000001 111.464 -178.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 991' ' ' GLU . . . . . 0.417 ' HB2' ' O ' ' C' ' 990' ' ' PRO . 71.2 mt-10 67.11 -73.9 0.07 Allowed 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 108.559 -0.904 . . . . 1.97 108.559 -177.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 992' ' ' LEU . . . . . . . . . . . . . 11.1 mt 51.66 20.46 1.1 Allowed 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.593 -0.692 . . . . 2.3799999999999999 111.596 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -90.65 156.91 17.77 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.964 -1.085 . . . . 3.79 109.952 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 69.1 m80 -147.53 90.21 1.84 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.572 -0.705 . . . . 3.5099999999999998 110.383 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 995' ' ' ALA . . . . . . . . . . . . 2.518 . . . . . . . 0 N--CA 1.503 2.216 0 O-C-N 120.881 -1.137 . . . . 2.73 110.601 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo . . . . . 0 N--CA 1.488 1.156 0 N-CA-C 109.492 -1.003 . . . . 3.8300000000000001 109.492 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 847' ' ' VAL . . . . . 0.494 HG12 ' HB2' ' A' ' 849' ' ' GLN . 60.0 t -128.04 105.5 20.2 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 121.638 -0.664 . . . . 1.8300000000000001 109.986 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 848' ' ' PRO . . . . . 0.823 ' O ' HG23 ' A' ' 850' ' ' VAL . 43.0 Cg_endo -69.37 -21.41 35.35 Favored 'Trans proline' 0 N--CA 1.486 1.076 0 O-C-N 123.196 1.103 . . . . 0.65000000000000002 110.985 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 849' ' ' GLN . . . . . 0.494 ' HB2' HG12 ' A' ' 847' ' ' VAL . 56.5 tt0 26.47 67.43 0.06 Allowed 'General case' 0 N--CA 1.518 2.93 0 N-CA-C 113.111 0.782 . . . . 2.5800000000000001 113.111 179.175 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 850' ' ' VAL . . . . . 0.823 HG23 ' O ' ' A' ' 848' ' ' PRO . 97.4 t -119.43 134.79 61.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.12 -0.987 . . . . 1.0900000000000001 111.042 -179.098 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 851' ' ' ALA . . . . . . . . . . . . . . . -132.05 153.65 50.2 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 105.922 -1.881 . . . . 0.040000000000000001 105.922 177.067 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 852' ' ' PHE . . . . . 0.626 ' HA ' ' HB3' ' A' ' 874' ' ' ASN . 28.4 p90 -155.89 136.75 13.52 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-N 121.109 1.777 . . . . 0.050000000000000003 109.303 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 16.1 t -172.63 133.11 0.59 Allowed 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.168 -1.049 . . . . 0.040000000000000001 108.168 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 854' ' ' ALA . . . . . 0.488 ' HB1' ' HD2' ' A' ' 868' ' ' PHE . . . -135.97 154.22 51.16 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.111 -0.993 . . . . 0.67000000000000004 109.325 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 855' ' ' ALA . . . . . 0.703 ' HB3' ' CB ' ' A' ' 870' ' ' ARG . . . -123.04 141.3 52.11 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.876 0.846 . . . . 0.51000000000000001 111.976 -178.77 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 856' ' ' LEU . . . . . 0.762 HD23 ' O ' ' A' ' 867' ' ' PRO . 3.5 tm? -110.09 138.27 46.7 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.656 -0.652 . . . . 0.050000000000000003 109.427 179.311 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 857' ' ' SER . . . . . 0.6 ' N ' HD13 ' A' ' 856' ' ' LEU . 78.8 p -156.1 19.99 0.37 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.477 -0.765 . . . . 1.3300000000000001 111.325 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 858' ' ' LEU . . . . . 0.573 HD22 ' HG3' ' A' ' 862' ' ' GLU . 4.2 pp -34.3 158.95 0.04 OUTLIER Pre-proline 0 N--CA 1.519 3.017 0 N-CA-C 112.816 0.672 . . . . 2.3300000000000001 112.816 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -60.95 -89.62 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 120.968 1.112 . . . . 2.3199999999999998 113.922 -177.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 54.9 ptt85 -127.98 -142.26 0.27 Allowed 'General case' 0 N--CA 1.502 2.127 0 O-C-N 120.809 -1.182 . . . . 0.040000000000000001 111.609 -177.321 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 27.9 m -36.14 121.15 0.67 Allowed 'General case' 0 N--CA 1.511 2.602 0 O-C-N 121.644 -0.66 . . . . 1.3100000000000001 112.291 -178.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 862' ' ' GLU . . . . . 0.573 ' HG3' HD22 ' A' ' 858' ' ' LEU . 0.0 OUTLIER -103.01 158.91 30.82 Favored Pre-proline 0 N--CA 1.488 1.466 0 N-CA-C 108.313 -0.995 . . . . 4.5099999999999998 108.313 177.824 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -70.23 -15.19 35.26 Favored 'Trans proline' 0 C--N 1.313 -1.337 0 O-C-N 123.206 1.108 . . . . 2.2400000000000002 111.231 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -176.91 -135.56 2.21 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.786 -1.326 . . . . 0.040000000000000001 109.786 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 23.3 m -69.47 155.88 39.75 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.344 -1.092 . . . . 1.51 111.01 -178.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 866' ' ' VAL . . . . . 0.564 HG12 ' CD2' ' A' ' 858' ' ' LEU . 33.7 m -91.35 136.73 26.63 Favored Pre-proline 0 N--CA 1.498 1.954 0 N-CA-C 113.549 0.944 . . . . 0.78000000000000003 113.549 -175.61 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 867' ' ' PRO . . . . . 0.762 ' O ' HD23 ' A' ' 856' ' ' LEU . 54.9 Cg_endo -88.62 -150.39 0.04 OUTLIER 'Trans proline' 0 CA--C 1.539 0.767 0 N-CA-C 108.183 -1.507 . . . . 0.92000000000000004 108.183 177.242 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 868' ' ' PHE . . . . . 0.488 ' HD2' ' HB1' ' A' ' 854' ' ' ALA . 9.9 p90 -148.24 121.2 8.79 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.413 -1.43 . . . . 0.050000000000000003 110.312 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 50.1 p-10 -111.79 -3.52 14.92 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 119.374 -0.93 . . . . 1.7 111.919 -179.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 870' ' ' ARG . . . . . 0.703 ' CB ' ' HB3' ' A' ' 855' ' ' ALA . 26.1 mmm180 -90.4 88.43 7.18 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.999 -1.063 . . . . 2.5899999999999999 111.109 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 60.1 t -76.42 96.41 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 120.932 -1.105 . . . . 1.9399999999999999 109.173 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 872' ' ' LEU . . . . . 0.45 HD13 HD11 ' B' ' 953' ' ' ILE . 87.7 mt -86.97 -44.16 11.83 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.605 -0.684 . . . . 1.0600000000000001 110.921 -179.334 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 873' ' ' LEU . . . . . . . . . . . . . 48.2 tp -172.3 107.69 0.2 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.159 -0.963 . . . . 4.1799999999999997 108.624 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 874' ' ' ASN . . . . . 0.626 ' HB3' ' HA ' ' A' ' 852' ' ' PHE . 12.0 p-10 174.36 81.36 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.483 0 O-C-N 121.592 -0.692 . . . . 0.040000000000000001 109.378 -178.551 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -69.69 -49.18 55.91 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.725 -1.234 . . . . 3.3799999999999999 111.37 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 876' ' ' GLY . . . . . 0.414 ' HA3' ' CE2' ' A' ' 878' ' ' TYR . . . -72.8 -26.8 70.4 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 110.642 -0.983 . . . . 0.040000000000000001 110.642 -179.315 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 78.96 -63.6 3.81 Favored Glycine 0 N--CA 1.497 2.741 0 N-CA-C 108.196 -1.961 . . . . 0.040000000000000001 108.196 -178.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 878' ' ' TYR . . . . . 0.414 ' CE2' ' HA3' ' A' ' 876' ' ' GLY . 92.6 m-85 61.7 -60.11 0.1 Allowed 'General case' 0 N--CA 1.504 2.265 0 N-CA-C 113.532 0.938 . . . . 3.46 113.532 178.442 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 879' ' ' TYR . . . . . 0.504 ' O ' ' CG ' ' A' ' 879' ' ' TYR . 9.8 p90 -111.24 104.69 13.21 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.919 -1.113 . . . . 0.040000000000000001 113.58 -177.491 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 880' ' ' ASP . . . . . 0.418 ' O ' ' N ' ' A' ' 884' ' ' GLY . 0.8 OUTLIER -69.77 112.86 13.63 Favored Pre-proline 0 N--CA 1.497 1.895 0 O-C-N 121.19 -0.944 . . . . 0.02 110.662 -178.807 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 881' ' ' PRO . . . . . 0.478 ' HG2' ' CD1' ' A' ' 868' ' ' PHE . 51.9 Cg_endo -78.33 -3.27 13.24 Favored 'Trans proline' 0 N--CA 1.489 1.221 0 O-C-N 123.489 1.257 . . . . 0.39000000000000001 111.102 179.312 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -77.62 -34.51 53.31 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 107.897 -1.149 . . . . 0.81000000000000005 107.897 178.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 71.0 p -112.07 -19.08 12.44 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.423 -0.808 . . . . 0.040000000000000001 109.072 176.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 884' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 880' ' ' ASP . . . 79.6 4.12 89.16 Favored Glycine 0 N--CA 1.495 2.603 0 N-CA-C 110.161 -1.176 . . . . 0.029999999999999999 110.161 -178.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 885' ' ' VAL . . . . . 0.452 HG13 HG21 ' A' ' 961' ' ' THR . 66.5 t -73.3 95.08 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 C-N-CA 118.737 -1.185 . . . . 1.01 108.408 -178.769 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 886' ' ' PHE . . . . . 0.924 ' HB3' HG22 ' A' ' 962' ' ' VAL . 2.2 t80 -88.86 105.54 17.81 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 115.307 -0.86 . . . . 0.050000000000000003 111.746 -177.526 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 887' ' ' THR . . . . . 0.42 ' O ' ' HD3' ' A' ' 889' ' ' PRO . 35.3 m -98.03 100.31 11.64 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 107.588 -1.264 . . . . 0.68000000000000005 107.588 177.401 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 888' ' ' ALA . . . . . 0.434 ' HB2' ' CE1' ' A' ' 886' ' ' PHE . . . -99.28 106.63 40.14 Favored Pre-proline 0 N--CA 1.501 2.085 0 N-CA-C 114.049 1.129 . . . . 0.25 114.049 -176.567 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 889' ' ' PRO . . . . . 0.42 ' HD3' ' O ' ' A' ' 887' ' ' THR . 55.2 Cg_endo -90.18 -12.61 2.69 Favored 'Trans proline' 0 CA--C 1.546 1.093 0 C-N-CA 121.086 1.191 . . . . 1.6399999999999999 109.157 176.258 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 890' ' ' LEU . . . . . 0.858 HD22 HD13 ' A' ' 985' ' ' LEU . 72.4 mt -36.38 -50.13 0.75 Allowed 'General case' 0 N--CA 1.508 2.44 0 N-CA-C 113.855 1.057 . . . . 2.29 113.855 -177.257 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 51.8 96.17 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.117 -0.989 . . . . 0.63 110.321 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 156.21 -148.86 19.45 Favored Glycine 0 N--CA 1.48 1.624 0 N-CA-C 107.296 -2.322 . . . . 0.040000000000000001 107.296 -179.196 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 893' ' ' ARG . . . . . 0.416 ' CZ ' ' HB1' ' C' ' 984' ' ' ALA . 71.6 ttt-85 -111.44 127.6 55.73 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 107.753 -1.202 . . . . 3.0 107.753 177.186 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 894' ' ' TYR . . . . . 0.53 ' OH ' HD12 ' A' ' 896' ' ' LEU . 0.0 OUTLIER -130.2 153.88 48.12 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.0 -1.063 . . . . 0.040000000000000001 110.876 -178.681 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 895' ' ' LEU . . . . . 0.429 ' N ' ' CD1' ' A' ' 894' ' ' TYR . 39.7 tp -96.58 114.11 25.74 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.405 -0.809 . . . . 1.27 109.961 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 896' ' ' LEU . . . . . 0.53 HD12 ' OH ' ' A' ' 894' ' ' TYR . 10.3 tt -109.35 142.47 40.23 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.684 -0.635 . . . . 0.93999999999999995 111.18 -179.11 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 897' ' ' SER . . . . . 0.525 ' N ' HD23 ' A' ' 896' ' ' LEU . 49.8 m -147.91 115.43 6.31 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.578 -0.701 . . . . 0.040000000000000001 110.838 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.7 147.22 31.04 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.633 -0.667 . . . . 0.47999999999999998 109.254 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 899' ' ' VAL . . . . . 0.75 HG21 ' HB ' ' A' ' 980' ' ' ILE . 99.1 t -92.69 120.1 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 C-N-CA 119.68 -0.808 . . . . 0.55000000000000004 111.237 -179.206 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 900' ' ' LEU . . . . . 0.442 ' N ' HD22 ' A' ' 900' ' ' LEU . 4.6 mm? -91.33 112.18 23.98 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 114.349 1.241 . . . . 1.5900000000000001 114.349 -175.152 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 23.3 m -67.52 141.72 56.79 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 107.077 -1.453 . . . . 0.050000000000000003 107.077 176.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -67.71 -66.45 2.33 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.506 -1.037 . . . . 0.029999999999999999 110.506 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 5.0 m170 46.08 65.88 1.07 Allowed 'General case' 0 N--CA 1.508 2.467 0 O-C-N 121.448 -1.03 . . . . 3.2000000000000002 111.253 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 43.2 ptt85 -69.23 -5.85 25.39 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.621 -0.675 . . . . 2.9199999999999999 112.152 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 905' ' ' HIS . . . . . 0.491 ' O ' ' CB ' ' A' ' 906' ' ' GLU . 76.2 t60 -61.86 4.37 0.12 Allowed 'General case' 0 N--CA 1.507 2.386 0 O-C-N 120.857 -1.152 . . . . 2.8700000000000001 113.141 -179.249 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 906' ' ' GLU . . . . . 0.491 ' CB ' ' O ' ' A' ' 905' ' ' HIS . 0.9 OUTLIER 94.7 -164.54 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.425 0 CA-C-N 120.593 1.542 . . . . 0.98999999999999999 112.076 178.984 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 907' ' ' LYS . . . . . 0.474 ' CB ' ' O ' ' A' ' 906' ' ' GLU . 29.5 ttmt 88.87 160.84 0.06 Allowed 'General case' 0 N--CA 1.522 3.137 0 N-CA-C 108.353 -0.98 . . . . 5.25 108.353 -177.204 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 61.4 t -122.4 116.74 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 120.818 -1.177 . . . . 0.39000000000000001 110.862 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 909' ' ' GLU . . . . . 0.634 ' OE2' HD12 ' A' ' 966' ' ' LEU . 39.9 tp10 -105.12 131.78 52.18 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 107.629 -1.248 . . . . 1.72 107.629 177.128 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -156.54 120.78 4.43 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 106.819 -1.548 . . . . 0.67000000000000004 106.819 178.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 911' ' ' VAL . . . . . 0.485 ' HA ' ' HA ' ' A' ' 964' ' ' VAL . 14.4 p -77.3 132.96 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.713 -0.617 . . . . 0.54000000000000004 111.417 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 86.4 mt -65.47 156.26 32.98 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 108.193 -1.039 . . . . 1.5 108.193 178.308 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 913' ' ' SER . . . . . 0.445 ' CB ' ' HB ' ' A' ' 919' ' ' VAL . 1.4 t -125.66 136.27 53.05 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.462 -0.94 . . . . 1.3700000000000001 108.462 177.038 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 914' ' ' ARG . . . . . 0.551 ' HD3' HG12 ' A' ' 962' ' ' VAL . 0.0 OUTLIER -62.37 152.58 33.64 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.011 -1.056 . . . . 4.2999999999999998 111.827 -178.97 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 915' ' ' SER . . . . . 0.427 ' CB ' ' O ' ' A' ' 914' ' ' ARG . 3.5 t 83.41 -30.38 0.09 Allowed 'General case' 0 N--CA 1.52 3.056 0 C-N-CA 124.004 0.922 . . . . 2.0499999999999998 112.315 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 916' ' ' ASN . . . . . 0.615 ' HB2' HG21 ' A' ' 919' ' ' VAL . 72.9 m-20 -126.46 -21.87 4.09 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 120.849 -1.157 . . . . 2.71 111.471 -179.348 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 917' ' ' GLN . . . . . 0.428 ' HB2' ' O ' ' A' ' 916' ' ' ASN . 58.6 mt-30 66.97 168.93 0.24 Allowed 'General case' 0 N--CA 1.518 2.955 0 N-CA-C 105.903 -1.888 . . . . 2.6800000000000002 105.903 -173.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 55.25 -128.87 45.1 Favored Glycine 1 N--CA 1.52 4.28 0 CA-C-N 123.64 2.927 . . . . 0.029999999999999999 106.388 -177.216 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 919' ' ' VAL . . . . . 0.615 HG21 ' HB2' ' A' ' 916' ' ' ASN . 85.7 t 50.25 94.59 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.299 0 CA-C-N 118.573 1.187 . . . . 1.3899999999999999 109.249 -178.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 920' ' ' ALA . . . . . 1.005 ' HB3' HG12 ' A' ' 949' ' ' VAL . . . -92.64 94.08 8.84 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.266 -0.974 . . . . 0.029999999999999999 111.154 -179.117 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 921' ' ' ARG . . . . . 0.756 ' HG3' HG23 ' A' ' 922' ' ' VAL . 35.1 ptt85 -80.3 -43.14 21.77 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 105.602 -1.999 . . . . 4.4199999999999999 105.602 176.34 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 922' ' ' VAL . . . . . 0.756 HG23 ' HG3' ' A' ' 921' ' ' ARG . 94.9 t -101.75 77.07 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 N-CA-C 105.041 -2.207 . . . . 0.84999999999999998 105.041 174.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -87.14 135.61 33.23 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 122.068 0.937 . . . . 2.46 112.39 -176.205 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 10.4 t -145.54 103.15 3.78 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.471 -1.307 . . . . 0.69999999999999996 107.471 178.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -103.39 81.75 0.37 Allowed Glycine 0 N--CA 1.486 2.023 0 N-CA-C 109.04 -1.624 . . . . 0.040000000000000001 109.04 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.967 0 N-CA-C 108.743 -1.743 . . . . 0.040000000000000001 108.743 179.877 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 21.7 m . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 120.963 0.411 . . . . 13.779999999999999 110.299 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 95.9 mt -109.88 129.28 55.67 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.506 -0.746 . . . . 13.76 110.325 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -152.08 169.83 31.4 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.347 -1.501 . . . . 9.1300000000000008 109.347 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 949' ' ' VAL . . . . . 1.005 HG12 ' HB3' ' A' ' 920' ' ' ALA . 34.3 m -118.4 132.4 68.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.465 -1.021 . . . . 7.0800000000000001 111.05 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 950' ' ' PHE . . . . . 0.464 ' CZ ' ' HB3' ' A' ' 921' ' ' ARG . 40.0 p90 -134.82 153.24 52.12 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.549 -0.719 . . . . 7.5899999999999999 109.124 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 69.3 m -121.59 -53.16 2.0 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.245 -0.91 . . . . 5.0300000000000002 112.356 -178.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 952' ' ' LEU . . . . . 0.425 ' O ' ' O ' ' A' ' 953' ' ' ILE . 56.6 tp -61.72 -76.33 0.06 Allowed 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.356 -0.84 . . . . 1.01 112.328 -177.563 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 953' ' ' ILE . . . . . 0.496 HD11 HD13 ' C' ' 872' ' ' LEU . 44.6 pt -52.32 -145.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.753 0 N-CA-C 114.016 1.117 . . . . 2.6000000000000001 114.016 -176.339 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 954' ' ' LEU . . . . . 0.726 HD22 ' O ' ' A' ' 954' ' ' LEU . 0.0 OUTLIER 170.73 83.74 0.04 OUTLIER Pre-proline 0 N--CA 1.509 2.514 0 O-C-N 120.812 -1.18 . . . . 0.050000000000000003 111.66 179.441 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 955' ' ' PRO . . . . . 0.677 ' C ' HD12 ' A' ' 956' ' ' LEU . 48.6 Cg_endo -76.24 95.45 1.04 Allowed 'Trans proline' 0 C--N 1.314 -1.271 0 N-CA-C 108.689 -1.312 . . . . 0.83999999999999997 108.689 177.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 956' ' ' LEU . . . . . 0.677 HD12 ' C ' ' A' ' 955' ' ' PRO . 10.3 mp -122.47 143.73 49.51 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.133 -0.979 . . . . 0.040000000000000001 110.19 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -85.65 151.76 23.64 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 117.82 -1.086 . . . . 1.28 111.613 -179.086 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -68.95 119.75 13.75 Favored 'General case' 0 N--CA 1.509 2.48 0 CA-C-N 122.86 2.573 . . . . 0.17000000000000001 111.799 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 93.23 -21.75 38.57 Favored Glycine 0 N--CA 1.501 3.006 0 N-CA-C 111.127 -0.789 . . . . 0.040000000000000001 111.127 178.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 960' ' ' ASP . . . . . 0.434 ' HB3' ' NE ' ' A' ' 914' ' ' ARG . 0.5 OUTLIER -55.17 169.47 0.25 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.473 -1.016 . . . . 0.040000000000000001 110.201 -179.411 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 961' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' A' ' 886' ' ' PHE . 44.0 m -136.52 139.55 42.34 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.903 -1.123 . . . . 1.78 112.432 -177.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 962' ' ' VAL . . . . . 0.924 HG22 ' HB3' ' A' ' 886' ' ' PHE . 31.9 m -100.08 144.82 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.649 -0.657 . . . . 0.040000000000000001 111.131 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 5.4 t -137.58 145.04 42.36 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.917 -0.49 . . . . 0.71999999999999997 109.991 -179.04 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 964' ' ' VAL . . . . . 0.485 ' HA ' ' HA ' ' A' ' 911' ' ' VAL . 61.9 t -92.17 136.3 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.028 -1.045 . . . . 1.05 111.297 -178.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -95.51 126.35 40.74 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 103.5 -2.778 . . . . 3.02 103.5 172.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 966' ' ' LEU . . . . . 0.634 HD12 ' OE2' ' A' ' 909' ' ' GLU . 0.2 OUTLIER -133.42 61.3 1.68 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.453 -0.943 . . . . 1.46 108.453 177.362 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 967' ' ' VAL . . . . . 0.492 HG23 ' C ' ' A' ' 966' ' ' LEU . 97.8 t -157.65 96.26 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 108.366 -0.975 . . . . 1.9399999999999999 108.366 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 92.9 mmm -142.96 58.65 1.42 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.734 -1.229 . . . . 0.0 108.277 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 133.72 119.48 2.0 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 107.139 -2.385 . . . . 2.1099999999999999 107.139 -178.284 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -82.19 -57.03 3.57 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.028 -1.277 . . . . 5.8899999999999997 110.597 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 48.4 tp -58.76 89.7 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.429 -0.794 . . . . 4.3600000000000003 110.342 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -142.67 -152.57 0.42 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.561 -0.712 . . . . 1.8300000000000001 110.049 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -118.07 167.57 11.35 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.393 -0.817 . . . . 4.3499999999999996 110.211 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 30.3 t -101.98 130.29 48.47 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.578 -0.701 . . . . 1.27 110.067 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -156.05 159.01 38.76 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.485 -0.759 . . . . 5.0199999999999996 110.65 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.78 85.12 20.63 Favored Pre-proline 0 N--CA 1.5 2.042 0 O-C-N 121.701 -0.624 . . . . 2.4100000000000001 109.712 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -73.58 -172.11 0.99 Allowed 'Trans proline' 0 C--N 1.317 -1.1 0 O-C-N 123.253 1.133 . . . . 0.95999999999999996 111.3 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 978' ' ' LEU . . . . . 0.576 HD12 ' N ' ' A' ' 978' ' ' LEU . 5.2 mp -126.43 156.09 41.17 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 107.557 -1.275 . . . . 0.62 107.557 177.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 979' ' ' THR . . . . . 0.453 HG23 ' C ' ' A' ' 978' ' ' LEU . 46.5 p -149.57 141.37 23.67 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.763 -1.211 . . . . 3.5699999999999998 111.155 -179.289 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 980' ' ' ILE . . . . . 0.75 ' HB ' HG21 ' A' ' 899' ' ' VAL . 50.7 mm -107.31 128.92 61.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 N-CA-C 109.088 -0.708 . . . . 1.3300000000000001 109.088 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 981' ' ' PHE . . . . . 0.502 ' CD1' ' CE2' ' A' ' 879' ' ' TYR . 10.6 t80 -119.93 97.46 5.62 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 119.572 -0.851 . . . . 0.050000000000000003 111.899 -178.275 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 982' ' ' SER . . . . . 0.457 ' HB2' HD23 ' B' ' 952' ' ' LEU . 15.5 p -108.64 158.59 17.45 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.592 -0.693 . . . . 0.87 109.199 178.406 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 983' ' ' GLY . . . . . 0.41 ' O ' ' CE1' ' A' ' 852' ' ' PHE . . . -174.29 110.78 0.34 Allowed Glycine 0 N--CA 1.498 2.783 0 N-CA-C 106.81 -2.516 . . . . 0.029999999999999999 106.81 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -107.85 149.41 28.29 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 114.245 1.202 . . . . 0.69999999999999996 114.245 -175.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 985' ' ' LEU . . . . . 0.858 HD13 HD22 ' A' ' 890' ' ' LEU . 66.8 tp -72.04 136.51 46.69 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.75 -1.219 . . . . 0.040000000000000001 110.088 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 49.3 tp -106.66 -58.03 1.98 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.689 -0.632 . . . . 0.040000000000000001 110.02 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -143.9 145.87 32.6 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 107.739 -1.208 . . . . 0.040000000000000001 107.739 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.33 162.54 12.37 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 108.078 -2.009 . . . . 0.040000000000000001 108.078 179.132 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -76.9 111.79 18.54 Favored Pre-proline 0 N--CA 1.498 1.951 0 CA-C-N 118.536 1.168 . . . . 0.040000000000000001 109.536 179.06 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 990' ' ' PRO . . . . . 0.615 ' HD2' HD12 ' A' ' 992' ' ' LEU . 49.2 Cg_endo -92.34 71.79 0.64 Allowed 'Trans proline' 0 C--N 1.318 -1.038 0 O-C-N 123.057 1.03 . . . . 0.45000000000000001 111.338 -179.032 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 991' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' A' ' 990' ' ' PRO . 72.3 mt-10 67.82 -73.33 0.08 Allowed 'General case' 0 N--CA 1.503 2.182 0 N-CA-C 108.345 -0.983 . . . . 1.97 108.345 -177.34 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 992' ' ' LEU . . . . . 0.615 HD12 ' HD2' ' A' ' 990' ' ' PRO . 4.1 mt 50.51 20.38 0.69 Allowed 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.577 -0.702 . . . . 2.3799999999999999 111.754 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -95.69 156.87 16.15 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.914 -1.116 . . . . 3.79 110.089 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 67.9 m80 -144.19 94.4 2.57 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.526 -0.734 . . . . 3.5099999999999998 110.269 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 995' ' ' ALA . . . . . . . . . . . . 2.517 . . . . . . . 0 N--CA 1.503 2.201 0 O-C-N 120.928 -1.108 . . . . 2.73 110.588 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo . . . . . 0 N--CA 1.488 1.172 0 N-CA-C 109.471 -1.011 . . . . 3.8300000000000001 109.471 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 847' ' ' VAL . . . . . 0.485 HG12 ' HB2' ' B' ' 849' ' ' GLN . 61.1 t -128.26 105.57 19.73 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.629 -0.669 . . . . 1.8300000000000001 109.93 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 848' ' ' PRO . . . . . 0.823 ' O ' HG23 ' B' ' 850' ' ' VAL . 43.0 Cg_endo -69.29 -21.41 35.7 Favored 'Trans proline' 0 N--CA 1.486 1.087 0 O-C-N 123.253 1.133 . . . . 0.65000000000000002 111.042 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 849' ' ' GLN . . . . . 0.485 ' HB2' HG12 ' B' ' 847' ' ' VAL . 56.3 tt0 26.48 66.9 0.06 Allowed 'General case' 0 N--CA 1.518 2.939 0 N-CA-C 113.151 0.797 . . . . 2.5800000000000001 113.151 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 850' ' ' VAL . . . . . 0.823 HG23 ' O ' ' B' ' 848' ' ' PRO . 97.1 t -118.98 134.93 61.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.193 -0.942 . . . . 1.0900000000000001 111.06 -179.131 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 851' ' ' ALA . . . . . . . . . . . . . . . -131.93 154.02 49.69 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 105.911 -1.885 . . . . 0.040000000000000001 105.911 177.103 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 852' ' ' PHE . . . . . 0.6 ' HA ' ' HB3' ' B' ' 874' ' ' ASN . 28.3 p90 -156.26 136.8 13.19 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-N 121.02 1.736 . . . . 0.050000000000000003 109.431 179.329 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 18.6 t -172.71 133.37 0.58 Allowed 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.046 -1.094 . . . . 0.040000000000000001 108.046 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 854' ' ' ALA . . . . . 0.487 ' HB1' ' HD2' ' B' ' 868' ' ' PHE . . . -136.14 154.34 51.01 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.118 -0.989 . . . . 0.67000000000000004 109.339 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 855' ' ' ALA . . . . . 0.72 ' HB3' ' CB ' ' B' ' 870' ' ' ARG . . . -123.18 140.96 52.48 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.853 0.835 . . . . 0.51000000000000001 111.996 -178.71 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 856' ' ' LEU . . . . . 0.769 HD23 ' O ' ' B' ' 867' ' ' PRO . 3.5 tm? -109.79 138.74 45.73 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.729 -0.607 . . . . 0.050000000000000003 109.366 179.284 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 857' ' ' SER . . . . . 0.614 ' N ' HD13 ' B' ' 856' ' ' LEU . 78.7 p -156.58 19.58 0.34 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.457 -0.777 . . . . 1.3300000000000001 111.345 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 858' ' ' LEU . . . . . 0.567 HD22 ' HG3' ' B' ' 862' ' ' GLU . 4.2 pp -33.95 158.83 0.04 OUTLIER Pre-proline 0 N--CA 1.519 2.984 0 N-CA-C 112.888 0.699 . . . . 2.3300000000000001 112.888 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -60.77 -89.66 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 120.948 1.099 . . . . 2.3199999999999998 113.971 -177.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 55.0 ptt85 -127.91 -142.25 0.27 Allowed 'General case' 0 N--CA 1.501 2.1 0 O-C-N 120.753 -1.217 . . . . 0.040000000000000001 111.676 -177.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 28.4 m -36.24 121.4 0.69 Allowed 'General case' 0 N--CA 1.512 2.629 0 O-C-N 121.682 -0.637 . . . . 1.3100000000000001 112.354 -178.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 862' ' ' GLU . . . . . 0.567 ' HG3' HD22 ' B' ' 858' ' ' LEU . 0.0 OUTLIER -103.25 159.09 30.38 Favored Pre-proline 0 N--CA 1.488 1.461 0 N-CA-C 108.414 -0.958 . . . . 4.5099999999999998 108.414 177.842 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -70.28 -15.15 35.08 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 O-C-N 123.255 1.134 . . . . 2.2400000000000002 111.163 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -176.86 -135.55 2.21 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.901 -1.279 . . . . 0.040000000000000001 109.901 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 23.6 m -69.65 156.0 39.63 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.43 -1.041 . . . . 1.51 110.964 -178.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 866' ' ' VAL . . . . . 0.567 HG12 ' CD2' ' B' ' 858' ' ' LEU . 33.7 m -91.4 136.75 26.54 Favored Pre-proline 0 N--CA 1.498 1.935 0 N-CA-C 113.59 0.959 . . . . 0.78000000000000003 113.59 -175.548 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 867' ' ' PRO . . . . . 0.769 ' O ' HD23 ' B' ' 856' ' ' LEU . 53.9 Cg_endo -88.52 -150.07 0.04 OUTLIER 'Trans proline' 0 CA--C 1.539 0.759 0 N-CA-C 108.134 -1.525 . . . . 0.92000000000000004 108.134 177.304 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 868' ' ' PHE . . . . . 0.487 ' HD2' ' HB1' ' B' ' 854' ' ' ALA . 9.8 p90 -148.5 121.26 8.67 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.388 -1.445 . . . . 0.050000000000000003 110.246 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 50.0 p-10 -111.82 -3.81 14.81 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 119.373 -0.931 . . . . 1.7 111.991 -179.118 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 870' ' ' ARG . . . . . 0.72 ' CB ' ' HB3' ' B' ' 855' ' ' ALA . 26.3 mmm180 -90.08 88.92 7.46 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.074 -1.016 . . . . 2.5899999999999999 111.028 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 61.6 t -76.87 96.09 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 120.918 -1.113 . . . . 1.9399999999999999 109.159 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 872' ' ' LEU . . . . . 0.597 HD13 HD11 ' C' ' 953' ' ' ILE . 86.3 mt -86.63 -44.31 11.96 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.658 -0.651 . . . . 1.0600000000000001 110.988 -179.188 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 873' ' ' LEU . . . . . . . . . . . . . 48.3 tp -172.16 107.44 0.21 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.219 -0.926 . . . . 4.1799999999999997 108.528 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 874' ' ' ASN . . . . . 0.6 ' HB3' ' HA ' ' B' ' 852' ' ' PHE . 12.1 p-10 174.6 81.2 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.473 0 O-C-N 121.551 -0.718 . . . . 0.040000000000000001 109.429 -178.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -69.5 -49.2 56.9 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.826 -1.171 . . . . 3.3799999999999999 111.352 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 876' ' ' GLY . . . . . 0.409 ' HA3' ' CE2' ' B' ' 878' ' ' TYR . . . -73.03 -26.38 71.13 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 110.642 -0.983 . . . . 0.040000000000000001 110.642 -179.28 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 78.65 -63.58 3.72 Favored Glycine 0 N--CA 1.498 2.77 0 N-CA-C 108.258 -1.937 . . . . 0.040000000000000001 108.258 -178.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 878' ' ' TYR . . . . . 0.409 ' CE2' ' HA3' ' B' ' 876' ' ' GLY . 92.3 m-85 61.74 -60.12 0.11 Allowed 'General case' 0 N--CA 1.504 2.256 0 N-CA-C 113.545 0.942 . . . . 3.46 113.545 178.388 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 879' ' ' TYR . . . . . 0.516 ' O ' ' CG ' ' B' ' 879' ' ' TYR . 10.0 p90 -111.31 104.06 12.5 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.94 -1.1 . . . . 0.040000000000000001 113.601 -177.48 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.14 112.91 13.19 Favored Pre-proline 0 N--CA 1.497 1.914 0 O-C-N 121.165 -0.96 . . . . 0.02 110.645 -178.805 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 881' ' ' PRO . . . . . 0.482 ' HG2' ' CD1' ' B' ' 868' ' ' PHE . 51.6 Cg_endo -78.33 -3.32 13.28 Favored 'Trans proline' 0 N--CA 1.49 1.27 0 O-C-N 123.442 1.232 . . . . 0.39000000000000001 111.061 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -77.66 -34.68 52.95 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 107.935 -1.135 . . . . 0.81000000000000005 107.935 178.219 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 74.2 p -111.59 -19.72 12.41 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.3 -0.863 . . . . 0.040000000000000001 108.975 176.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 79.88 4.17 89.46 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 110.087 -1.205 . . . . 0.029999999999999999 110.087 -178.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 885' ' ' VAL . . . . . 0.472 HG13 HG21 ' B' ' 961' ' ' THR . 69.0 t -73.3 95.2 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 C-N-CA 118.671 -1.212 . . . . 1.01 108.447 -178.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 886' ' ' PHE . . . . . 0.958 ' HB3' HG22 ' B' ' 962' ' ' VAL . 2.2 t80 -88.76 105.18 17.54 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 115.318 -0.856 . . . . 0.050000000000000003 111.86 -177.477 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 887' ' ' THR . . . . . 0.418 ' O ' ' HD3' ' B' ' 889' ' ' PRO . 35.3 m -97.72 100.05 11.42 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 107.655 -1.239 . . . . 0.68000000000000005 107.655 177.513 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 888' ' ' ALA . . . . . 0.423 ' HB2' ' CE1' ' B' ' 886' ' ' PHE . . . -99.14 106.64 39.73 Favored Pre-proline 0 N--CA 1.502 2.132 0 N-CA-C 114.1 1.148 . . . . 0.25 114.1 -176.447 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 889' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' B' ' 887' ' ' THR . 54.6 Cg_endo -90.25 -12.49 2.69 Favored 'Trans proline' 0 CA--C 1.546 1.121 0 C-N-CA 121.084 1.19 . . . . 1.6399999999999999 109.181 176.231 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 890' ' ' LEU . . . . . 0.828 HD22 HD13 ' B' ' 985' ' ' LEU . 71.9 mt -36.44 -49.99 0.75 Allowed 'General case' 0 N--CA 1.508 2.469 0 N-CA-C 113.851 1.056 . . . . 2.29 113.851 -177.239 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 51.75 96.27 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.41 0 O-C-N 121.159 -0.963 . . . . 0.63 110.346 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . 156.08 -148.77 19.27 Favored Glycine 0 N--CA 1.481 1.638 0 N-CA-C 107.26 -2.336 . . . . 0.040000000000000001 107.26 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 71.6 ttt-85 -111.49 127.73 55.79 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.762 -1.199 . . . . 3.0 107.762 177.2 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 894' ' ' TYR . . . . . 0.541 ' OH ' HD12 ' B' ' 896' ' ' LEU . 0.0 OUTLIER -130.41 154.1 48.06 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.032 -1.043 . . . . 0.040000000000000001 110.903 -178.663 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 895' ' ' LEU . . . . . 0.44 ' N ' ' CD1' ' B' ' 894' ' ' TYR . 38.9 tp -96.82 114.08 25.68 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.464 -0.773 . . . . 1.27 110.033 -179.284 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 896' ' ' LEU . . . . . 0.541 HD12 ' OH ' ' B' ' 894' ' ' TYR . 10.4 tt -109.19 143.91 37.99 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.634 -0.666 . . . . 0.93999999999999995 110.994 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 897' ' ' SER . . . . . 0.53 ' N ' HD23 ' B' ' 896' ' ' LEU . 50.5 m -149.29 115.05 5.64 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.584 -0.697 . . . . 0.040000000000000001 110.748 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.39 147.55 30.22 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.173 -0.677 . . . . 0.47999999999999998 109.173 179.057 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 899' ' ' VAL . . . . . 0.746 HG21 ' HB ' ' B' ' 980' ' ' ILE . 97.5 t -93.0 120.53 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 C-N-CA 119.672 -0.811 . . . . 0.55000000000000004 111.123 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 900' ' ' LEU . . . . . 0.436 ' N ' HD22 ' B' ' 900' ' ' LEU . 4.6 mm? -91.64 112.17 23.98 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 114.326 1.232 . . . . 1.5900000000000001 114.326 -175.179 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 23.0 m -67.43 141.64 56.94 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 107.109 -1.441 . . . . 0.050000000000000003 107.109 176.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -67.63 -66.53 2.3 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 110.469 -1.052 . . . . 0.029999999999999999 110.469 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 5.0 m170 46.22 66.09 1.03 Allowed 'General case' 0 N--CA 1.508 2.439 0 O-C-N 121.456 -1.026 . . . . 3.2000000000000002 111.215 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 43.3 ptt85 -69.5 -5.7 25.78 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.634 -0.666 . . . . 2.9199999999999999 112.052 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 905' ' ' HIS . . . . . 0.492 ' O ' ' CB ' ' B' ' 906' ' ' GLU . 76.4 t60 -62.17 4.71 0.12 Allowed 'General case' 0 N--CA 1.506 2.359 0 O-C-N 120.811 -1.18 . . . . 2.8700000000000001 113.065 -179.247 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 906' ' ' GLU . . . . . 0.492 ' CB ' ' O ' ' B' ' 905' ' ' HIS . 0.8 OUTLIER 94.51 -164.57 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.388 0 CA-C-N 120.589 1.541 . . . . 0.98999999999999999 112.094 178.82 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 907' ' ' LYS . . . . . 0.475 ' CB ' ' O ' ' B' ' 906' ' ' GLU . 29.4 ttmt 88.88 160.84 0.06 Allowed 'General case' 0 N--CA 1.521 3.123 0 N-CA-C 108.321 -0.992 . . . . 5.25 108.321 -177.178 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 61.1 t -122.29 116.7 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 120.848 -1.158 . . . . 0.39000000000000001 110.864 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 909' ' ' GLU . . . . . 0.645 ' OE2' HD12 ' B' ' 966' ' ' LEU . 39.9 tp10 -104.78 131.97 51.6 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 107.565 -1.272 . . . . 1.72 107.565 177.128 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -156.67 120.73 4.36 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 106.778 -1.564 . . . . 0.67000000000000004 106.778 178.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 911' ' ' VAL . . . . . 0.497 ' HA ' ' HA ' ' B' ' 964' ' ' VAL . 14.4 p -77.31 132.97 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.75 -0.594 . . . . 0.54000000000000004 111.406 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 86.7 mt -65.6 156.04 33.95 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.18 -1.044 . . . . 1.5 108.18 178.338 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 913' ' ' SER . . . . . 0.44 ' CB ' ' HB ' ' B' ' 919' ' ' VAL . 1.4 t -125.1 137.37 54.18 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.329 -0.989 . . . . 1.3700000000000001 108.329 177.061 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 914' ' ' ARG . . . . . 0.552 ' HD3' HG12 ' B' ' 962' ' ' VAL . 0.0 OUTLIER -63.47 153.01 36.78 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.917 -1.114 . . . . 4.2999999999999998 111.757 -179.059 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 915' ' ' SER . . . . . 0.426 ' CB ' ' O ' ' B' ' 914' ' ' ARG . 3.5 t 83.24 -30.21 0.09 Allowed 'General case' 0 N--CA 1.521 3.1 0 C-N-CA 123.977 0.911 . . . . 2.0499999999999998 112.359 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 916' ' ' ASN . . . . . 0.629 ' HB2' HG21 ' B' ' 919' ' ' VAL . 72.9 m-20 -126.8 -21.41 4.06 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 120.892 -1.13 . . . . 2.71 111.394 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 917' ' ' GLN . . . . . 0.442 ' HB2' ' O ' ' B' ' 916' ' ' ASN . 58.7 mt-30 66.99 168.97 0.24 Allowed 'General case' 0 N--CA 1.519 2.977 0 N-CA-C 105.892 -1.892 . . . . 2.6800000000000002 105.892 -173.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.9 -128.79 44.13 Favored Glycine 1 N--CA 1.521 4.302 0 CA-C-N 123.455 2.843 . . . . 0.029999999999999999 106.442 -177.282 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 919' ' ' VAL . . . . . 0.629 HG21 ' HB2' ' B' ' 916' ' ' ASN . 84.1 t 50.55 94.57 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.3 0 CA-C-N 118.608 1.204 . . . . 1.3899999999999999 109.191 -178.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 920' ' ' ALA . . . . . 0.973 ' HB3' HG12 ' B' ' 949' ' ' VAL . . . -92.5 94.47 9.09 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.274 -0.97 . . . . 0.029999999999999999 111.116 -179.149 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 921' ' ' ARG . . . . . 0.761 ' HG3' HG23 ' B' ' 922' ' ' VAL . 34.9 ptt85 -80.73 -43.29 20.48 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 105.553 -2.017 . . . . 4.4199999999999999 105.553 176.352 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 922' ' ' VAL . . . . . 0.761 HG23 ' HG3' ' B' ' 921' ' ' ARG . 94.0 t -101.68 77.59 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 N-CA-C 104.935 -2.246 . . . . 0.84999999999999998 104.935 174.736 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -87.56 135.78 33.21 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 122.105 0.955 . . . . 2.46 112.427 -176.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 924' ' ' SER . . . . . . . . . . . . . 10.2 t -145.6 103.4 3.79 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.461 -1.311 . . . . 0.69999999999999996 107.461 178.341 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -103.77 81.81 0.36 Allowed Glycine 0 N--CA 1.486 2.023 0 N-CA-C 108.965 -1.654 . . . . 0.040000000000000001 108.965 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.958 0 N-CA-C 108.74 -1.744 . . . . 0.040000000000000001 108.74 179.849 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 21.9 m . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 120.923 0.392 . . . . 13.779999999999999 110.412 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 95.5 mt -110.43 129.72 55.71 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.5 -0.75 . . . . 13.76 110.324 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -152.36 169.85 31.58 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.381 -1.487 . . . . 9.1300000000000008 109.381 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 949' ' ' VAL . . . . . 0.973 HG12 ' HB3' ' B' ' 920' ' ' ALA . 34.4 m -118.46 132.36 68.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.548 -0.972 . . . . 7.0800000000000001 111.077 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 950' ' ' PHE . . . . . 0.463 ' CZ ' ' HB3' ' B' ' 921' ' ' ARG . 39.8 p90 -134.98 152.6 51.88 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 109.127 -0.694 . . . . 7.5899999999999999 109.127 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 67.9 m -120.97 -53.03 2.07 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.318 -0.864 . . . . 5.0300000000000002 112.362 -178.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 952' ' ' LEU . . . . . 0.457 HD23 ' HB2' ' A' ' 982' ' ' SER . 56.3 tp -61.91 -76.44 0.06 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.32 -0.862 . . . . 1.01 112.357 -177.509 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 953' ' ' ILE . . . . . 0.495 ' O ' ' HB3' ' B' ' 954' ' ' LEU . 43.9 pt -52.22 -145.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.749 0 N-CA-C 114.038 1.125 . . . . 2.6000000000000001 114.038 -176.434 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 954' ' ' LEU . . . . . 0.719 HD22 ' O ' ' B' ' 954' ' ' LEU . 0.0 OUTLIER 170.96 83.74 0.04 OUTLIER Pre-proline 0 N--CA 1.508 2.475 0 O-C-N 120.852 -1.155 . . . . 0.050000000000000003 111.609 179.494 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 955' ' ' PRO . . . . . 0.679 ' C ' HD12 ' B' ' 956' ' ' LEU . 48.7 Cg_endo -76.34 95.23 1.03 Allowed 'Trans proline' 0 C--N 1.313 -1.292 0 N-CA-C 108.759 -1.285 . . . . 0.83999999999999997 108.759 177.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 956' ' ' LEU . . . . . 0.679 HD12 ' C ' ' B' ' 955' ' ' PRO . 10.3 mp -122.3 143.9 49.33 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.151 -0.968 . . . . 0.040000000000000001 110.183 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -86.01 151.18 23.93 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 117.81 -1.09 . . . . 1.28 111.639 -179.038 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -68.61 119.72 13.49 Favored 'General case' 0 N--CA 1.51 2.54 0 CA-C-N 122.862 2.574 . . . . 0.17000000000000001 111.843 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 93.36 -21.5 40.24 Favored Glycine 0 N--CA 1.5 2.962 0 N-CA-C 111.15 -0.78 . . . . 0.040000000000000001 111.15 178.358 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 960' ' ' ASP . . . . . 0.419 ' HB3' ' NE ' ' B' ' 914' ' ' ARG . 0.5 OUTLIER -55.68 169.77 0.31 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.457 -1.025 . . . . 0.040000000000000001 110.203 -179.489 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 961' ' ' THR . . . . . 0.472 HG21 HG13 ' B' ' 885' ' ' VAL . 46.0 m -136.86 139.49 41.7 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 120.835 -1.165 . . . . 1.78 112.408 -177.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 962' ' ' VAL . . . . . 0.958 HG22 ' HB3' ' B' ' 886' ' ' PHE . 31.8 m -99.87 145.15 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 C-N-CA 120.023 -0.671 . . . . 0.040000000000000001 111.116 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 5.4 t -137.96 145.42 41.98 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.907 -0.496 . . . . 0.71999999999999997 109.981 -179.12 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 964' ' ' VAL . . . . . 0.497 ' HA ' ' HA ' ' B' ' 911' ' ' VAL . 61.7 t -92.23 136.71 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.052 -1.03 . . . . 1.05 111.279 -178.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -95.69 126.42 40.96 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 103.464 -2.791 . . . . 3.02 103.464 172.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 966' ' ' LEU . . . . . 0.645 HD12 ' OE2' ' B' ' 909' ' ' GLU . 0.2 OUTLIER -133.6 61.39 1.68 Allowed 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.408 -0.96 . . . . 1.46 108.408 177.365 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 967' ' ' VAL . . . . . 0.486 HG23 ' C ' ' B' ' 966' ' ' LEU . 97.6 t -157.73 96.64 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 108.283 -1.006 . . . . 1.9399999999999999 108.283 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 92.8 mmm -143.4 58.68 1.39 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.752 -1.217 . . . . 0.0 108.251 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 133.87 119.75 2.02 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 107.05 -2.42 . . . . 2.1099999999999999 107.05 -178.129 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -82.46 -57.1 3.5 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.971 -1.311 . . . . 5.8899999999999997 110.499 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 47.8 tp -58.68 90.03 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.402 -0.811 . . . . 4.3600000000000003 110.318 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -143.03 -152.92 0.43 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.637 -0.665 . . . . 1.8300000000000001 110.079 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -117.83 167.41 11.42 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.473 -0.767 . . . . 4.3499999999999996 110.278 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 30.2 t -101.79 130.26 48.18 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.554 -0.716 . . . . 1.27 110.082 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -156.07 158.99 38.71 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.535 -0.728 . . . . 5.0199999999999996 110.643 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.71 85.08 20.94 Favored Pre-proline 0 N--CA 1.5 2.056 0 O-C-N 121.62 -0.675 . . . . 2.4100000000000001 109.72 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -73.41 -171.89 0.92 Allowed 'Trans proline' 0 C--N 1.317 -1.129 0 O-C-N 123.3 1.158 . . . . 0.95999999999999996 111.283 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 978' ' ' LEU . . . . . 0.57 ' N ' HD12 ' B' ' 978' ' ' LEU . 5.2 mp -126.82 155.93 42.1 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 107.546 -1.279 . . . . 0.62 107.546 177.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 979' ' ' THR . . . . . 0.462 HG23 ' C ' ' B' ' 978' ' ' LEU . 47.6 p -149.47 141.59 23.98 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.837 -1.165 . . . . 3.5699999999999998 111.184 -179.262 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 980' ' ' ILE . . . . . 0.746 ' HB ' HG21 ' B' ' 899' ' ' VAL . 50.6 mm -107.47 129.09 61.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 109.062 -0.718 . . . . 1.3300000000000001 109.062 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 981' ' ' PHE . . . . . 0.496 ' CD1' ' CE2' ' B' ' 879' ' ' TYR . 10.5 t80 -119.99 97.38 5.58 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 119.594 -0.843 . . . . 0.050000000000000003 111.926 -178.341 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 16.0 p -108.78 158.25 17.82 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 109.163 -0.68 . . . . 0.87 109.163 178.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 983' ' ' GLY . . . . . 0.41 ' O ' ' CE1' ' B' ' 852' ' ' PHE . . . -173.98 111.09 0.35 Allowed Glycine 0 N--CA 1.498 2.812 0 N-CA-C 106.655 -2.578 . . . . 0.029999999999999999 106.655 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 984' ' ' ALA . . . . . 0.423 ' HB1' ' CZ ' ' C' ' 893' ' ' ARG . . . -108.28 149.27 28.86 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 114.32 1.23 . . . . 0.69999999999999996 114.32 -175.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 985' ' ' LEU . . . . . 0.828 HD13 HD22 ' B' ' 890' ' ' LEU . 66.4 tp -71.75 136.28 47.09 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.728 -1.233 . . . . 0.040000000000000001 110.201 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 986' ' ' LEU . . . . . . . . . . . . . 49.3 tp -106.53 -58.07 1.97 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.671 -0.643 . . . . 0.040000000000000001 109.946 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -143.87 146.07 32.76 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.71 -1.218 . . . . 0.040000000000000001 107.71 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.46 162.96 12.22 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 108.088 -2.005 . . . . 0.040000000000000001 108.088 179.147 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -77.38 111.88 20.08 Favored Pre-proline 0 N--CA 1.499 1.988 0 O-C-N 121.226 -1.161 . . . . 0.040000000000000001 109.524 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 990' ' ' PRO . . . . . 0.631 ' HD2' HD12 ' B' ' 992' ' ' LEU . 48.7 Cg_endo -92.55 72.01 0.57 Allowed 'Trans proline' 0 C--N 1.318 -1.031 0 O-C-N 123.063 1.033 . . . . 0.45000000000000001 111.328 -178.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 991' ' ' GLU . . . . . 0.421 ' HB2' ' O ' ' B' ' 990' ' ' PRO . 72.4 mt-10 67.67 -73.43 0.08 Allowed 'General case' 0 N--CA 1.503 2.179 0 N-CA-C 108.251 -1.018 . . . . 1.97 108.251 -177.329 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 992' ' ' LEU . . . . . 0.631 HD12 ' HD2' ' B' ' 990' ' ' PRO . 4.1 mt 50.47 20.48 0.7 Allowed 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.58 -0.7 . . . . 2.3799999999999999 111.731 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 76.4 mt-10 -95.87 156.88 16.14 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.893 -1.13 . . . . 3.79 110.082 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 68.0 m80 -144.16 94.76 2.62 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.515 -0.741 . . . . 3.5099999999999998 110.2 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 995' ' ' ALA . . . . . . . . . . . . 2.517 . . . . . . . 0 N--CA 1.503 2.207 0 O-C-N 120.873 -1.142 . . . . 2.73 110.591 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo . . . . . 0 N--CA 1.488 1.152 0 N-CA-C 109.559 -0.977 . . . . 3.8300000000000001 109.559 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 847' ' ' VAL . . . . . 0.401 HG12 ' HB2' ' C' ' 849' ' ' GLN . 68.8 t -131.34 104.66 14.8 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.592 -0.692 . . . . 1.8300000000000001 109.819 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 848' ' ' PRO . . . . . 0.761 ' O ' HG23 ' C' ' 850' ' ' VAL . 43.7 Cg_endo -69.7 -19.56 36.26 Favored 'Trans proline' 0 N--CA 1.487 1.118 0 O-C-N 123.295 1.155 . . . . 0.65000000000000002 111.264 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 849' ' ' GLN . . . . . 0.411 ' C ' ' O ' ' C' ' 848' ' ' PRO . 56.2 tt0 26.24 68.49 0.05 Allowed 'General case' 0 N--CA 1.52 3.037 0 N-CA-C 112.893 0.701 . . . . 2.5800000000000001 112.893 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 850' ' ' VAL . . . . . 0.761 HG23 ' O ' ' C' ' 848' ' ' PRO . 93.5 t -117.21 135.24 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.245 -0.909 . . . . 1.0900000000000001 111.201 -178.708 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 851' ' ' ALA . . . . . . . . . . . . . . . -133.41 151.2 51.79 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 105.74 -1.948 . . . . 0.040000000000000001 105.74 177.084 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 852' ' ' PHE . . . . . 0.427 ' HA ' ' CB ' ' C' ' 874' ' ' ASN . 11.2 p90 -158.89 133.27 7.89 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 120.865 1.666 . . . . 0.050000000000000003 108.914 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 7.4 t -174.09 134.04 0.43 Allowed 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 107.954 -1.128 . . . . 0.040000000000000001 107.954 -179.138 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -136.44 159.25 42.33 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.167 -0.958 . . . . 0.67000000000000004 109.671 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 855' ' ' ALA . . . . . 0.61 ' HB3' ' CB ' ' C' ' 870' ' ' ARG . . . -122.86 140.64 52.74 Favored 'General case' 0 N--CA 1.499 1.994 0 CA-C-O 121.939 0.876 . . . . 0.51000000000000001 112.254 -178.628 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 856' ' ' LEU . . . . . 0.767 HD23 ' O ' ' C' ' 867' ' ' PRO . 3.5 tm? -106.6 138.52 42.63 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.645 -0.659 . . . . 0.050000000000000003 109.578 179.317 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 857' ' ' SER . . . . . 0.613 ' N ' HD13 ' C' ' 856' ' ' LEU . 1.3 m -159.23 18.65 0.18 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.443 -0.786 . . . . 1.3300000000000001 111.836 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 858' ' ' LEU . . . . . 0.724 HD23 HD11 ' C' ' 856' ' ' LEU . 2.7 pp -34.57 160.0 0.04 OUTLIER Pre-proline 0 N--CA 1.519 3.02 0 CA-C-N 118.603 0.638 . . . . 2.3300000000000001 112.689 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -60.19 -88.52 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 120.734 0.956 . . . . 2.3199999999999998 113.348 -178.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 55.4 ptt85 -130.47 -143.35 0.25 Allowed 'General case' 0 N--CA 1.5 2.052 0 O-C-N 120.883 -1.135 . . . . 0.040000000000000001 111.978 -177.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 41.2 m -33.31 120.55 0.38 Allowed 'General case' 0 N--CA 1.511 2.617 0 N-CA-C 113.241 0.83 . . . . 1.3100000000000001 113.241 -178.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.79 159.49 29.16 Favored Pre-proline 0 N--CA 1.486 1.342 0 N-CA-C 107.626 -1.25 . . . . 4.5099999999999998 107.626 176.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -69.78 -13.66 34.93 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 O-C-N 123.104 1.055 . . . . 2.2400000000000002 111.524 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -176.65 -135.26 2.13 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.911 -1.275 . . . . 0.040000000000000001 109.911 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 30.1 m -70.41 157.76 37.22 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.332 -1.099 . . . . 1.51 110.416 -179.134 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 866' ' ' VAL . . . . . 0.465 ' HA ' ' HD3' ' C' ' 867' ' ' PRO . 30.7 m -95.23 142.67 24.92 Favored Pre-proline 0 N--CA 1.498 1.964 0 N-CA-C 114.233 1.197 . . . . 0.78000000000000003 114.233 -174.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 867' ' ' PRO . . . . . 0.767 ' O ' HD23 ' C' ' 856' ' ' LEU . 55.6 Cg_endo -89.91 -150.69 0.04 OUTLIER 'Trans proline' 0 CA--C 1.541 0.871 0 N-CA-C 108.339 -1.446 . . . . 0.92000000000000004 108.339 177.391 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 868' ' ' PHE . . . . . 0.469 ' CD1' ' HG2' ' C' ' 881' ' ' PRO . 14.1 p90 -148.32 121.05 8.64 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.48 -1.387 . . . . 0.050000000000000003 109.865 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 50.0 p-10 -112.03 -3.97 14.62 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.15 -0.969 . . . . 1.7 112.471 -178.344 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 870' ' ' ARG . . . . . 0.61 ' CB ' ' HB3' ' C' ' 855' ' ' ALA . 22.7 mmm180 -90.93 89.19 7.34 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.96 -1.087 . . . . 2.5899999999999999 111.031 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 61.2 t -76.51 96.52 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 120.979 -1.075 . . . . 1.9399999999999999 109.238 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 872' ' ' LEU . . . . . 0.496 HD13 HD11 ' A' ' 953' ' ' ILE . 66.8 mt -85.78 -44.61 12.35 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.546 -0.721 . . . . 1.0600000000000001 110.559 -179.461 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 873' ' ' LEU . . . . . 0.419 ' O ' ' HB2' ' C' ' 874' ' ' ASN . 47.5 tp -172.21 104.33 0.17 Allowed 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.209 -0.932 . . . . 4.1799999999999997 108.71 178.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 874' ' ' ASN . . . . . 0.427 ' CB ' ' HA ' ' C' ' 852' ' ' PHE . 49.5 t-20 178.25 82.65 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.33 0 O-C-N 121.733 -0.604 . . . . 0.040000000000000001 109.588 -178.559 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 33.0 p-10 -72.07 -49.44 36.48 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.092 -1.005 . . . . 3.3799999999999999 111.705 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 876' ' ' GLY . . . . . . . . . . . . . . . -73.24 -26.43 70.53 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 110.617 -0.993 . . . . 0.040000000000000001 110.617 -179.261 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 81.34 -61.46 4.6 Favored Glycine 0 N--CA 1.497 2.742 0 N-CA-C 108.27 -1.932 . . . . 0.040000000000000001 108.27 -178.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 878' ' ' TYR . . . . . 0.54 ' CE2' HG13 ' C' ' 850' ' ' VAL . 85.6 m-85 61.62 -61.95 0.09 Allowed 'General case' 0 N--CA 1.504 2.25 0 N-CA-C 113.426 0.899 . . . . 3.46 113.426 178.457 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 879' ' ' TYR . . . . . 0.494 ' O ' ' CG ' ' C' ' 879' ' ' TYR . 12.2 p90 -110.97 105.33 14.07 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.991 -1.068 . . . . 0.040000000000000001 113.259 -177.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 880' ' ' ASP . . . . . 0.419 ' O ' ' N ' ' C' ' 884' ' ' GLY . 1.2 m-20 -66.69 112.68 10.17 Favored Pre-proline 0 N--CA 1.497 1.883 0 O-C-N 121.161 -0.962 . . . . 0.02 110.526 -178.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 881' ' ' PRO . . . . . 0.469 ' HG2' ' CD1' ' C' ' 868' ' ' PHE . 52.2 Cg_endo -79.05 -3.33 13.1 Favored 'Trans proline' 0 N--CA 1.489 1.238 0 O-C-N 123.531 1.279 . . . . 0.39000000000000001 111.213 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -80.31 -34.57 36.65 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 108.033 -1.099 . . . . 0.81000000000000005 108.033 178.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 69.6 p -110.36 -20.31 12.66 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 115.462 -0.79 . . . . 0.040000000000000001 108.984 176.214 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 884' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' C' ' 880' ' ' ASP . . . 80.07 4.88 89.78 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 110.232 -1.147 . . . . 0.029999999999999999 110.232 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 71.0 t -74.39 94.61 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 C-N-CA 118.695 -1.202 . . . . 1.01 108.532 -178.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 886' ' ' PHE . . . . . 0.865 ' CB ' HG22 ' C' ' 962' ' ' VAL . 2.1 t80 -88.74 105.8 17.94 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 115.513 -0.767 . . . . 0.050000000000000003 111.785 -177.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 887' ' ' THR . . . . . . . . . . . . . 28.0 m -98.53 99.99 11.2 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.787 -1.19 . . . . 0.68000000000000005 107.787 177.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 888' ' ' ALA . . . . . 0.529 ' HB2' ' CE1' ' C' ' 886' ' ' PHE . . . -97.87 108.3 45.31 Favored Pre-proline 0 N--CA 1.5 2.062 0 N-CA-C 113.606 0.965 . . . . 0.25 113.606 -176.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 889' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -89.87 -12.77 2.81 Favored 'Trans proline' 0 CA--C 1.544 1.02 0 C-N-CA 120.999 1.133 . . . . 1.6399999999999999 109.246 176.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 890' ' ' LEU . . . . . 0.734 HD12 ' N ' ' C' ' 891' ' ' ALA . 3.0 pp -36.87 -48.34 0.74 Allowed 'General case' 0 N--CA 1.508 2.47 0 N-CA-C 113.819 1.044 . . . . 2.29 113.819 -177.318 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 891' ' ' ALA . . . . . 0.734 ' N ' HD12 ' C' ' 890' ' ' LEU . . . 51.17 95.49 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.34 0 O-C-N 120.998 -1.064 . . . . 0.63 110.472 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . 155.43 -146.9 15.1 Favored Glycine 0 N--CA 1.479 1.566 0 N-CA-C 107.274 -2.33 . . . . 0.040000000000000001 107.274 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 893' ' ' ARG . . . . . 0.423 ' CZ ' ' HB1' ' B' ' 984' ' ' ALA . 76.5 ttt-85 -108.52 127.06 53.6 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 107.223 -1.399 . . . . 3.0 107.223 176.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 894' ' ' TYR . . . . . 0.55 ' HD2' HD23 ' C' ' 954' ' ' LEU . 0.5 OUTLIER -130.75 155.09 47.24 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.099 -1.001 . . . . 0.040000000000000001 110.841 -178.547 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 895' ' ' LEU . . . . . 0.428 ' O ' ' CE1' ' C' ' 894' ' ' TYR . 41.5 tp -99.79 117.3 33.82 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.652 -0.655 . . . . 1.27 110.539 -179.438 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 896' ' ' LEU . . . . . 0.85 HD23 ' N ' ' C' ' 897' ' ' SER . 4.5 tt -115.59 140.56 49.06 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.509 -0.745 . . . . 0.93999999999999995 110.35 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 897' ' ' SER . . . . . 0.85 ' N ' HD23 ' C' ' 896' ' ' LEU . 50.3 m -147.07 118.44 7.87 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.376 -0.828 . . . . 0.040000000000000001 111.286 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -108.64 147.41 31.91 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 109.401 -0.592 . . . . 0.47999999999999998 109.401 178.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 899' ' ' VAL . . . . . 0.721 HG21 ' HB ' ' C' ' 980' ' ' ILE . 97.9 t -93.19 121.53 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 C-N-CA 119.68 -0.808 . . . . 0.55000000000000004 111.29 -179.282 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 900' ' ' LEU . . . . . 0.44 HD12 ' HB2' ' C' ' 924' ' ' SER . 4.6 mm? -90.52 111.59 22.93 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 114.564 1.32 . . . . 1.5900000000000001 114.564 -175.224 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 21.6 m -67.09 142.09 57.23 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 106.974 -1.491 . . . . 0.050000000000000003 106.974 176.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -69.14 -67.71 1.86 Allowed Glycine 0 N--CA 1.494 2.549 0 N-CA-C 110.435 -1.066 . . . . 0.029999999999999999 110.435 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 5.2 t-80 46.24 66.46 0.95 Allowed 'General case' 0 N--CA 1.509 2.483 0 O-C-N 121.442 -1.034 . . . . 3.2000000000000002 111.122 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 46.4 ptt85 -69.12 -6.9 31.42 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.611 -0.681 . . . . 2.9199999999999999 112.043 -179.064 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 905' ' ' HIS . . . . . 0.488 ' O ' ' CB ' ' C' ' 906' ' ' GLU . 78.1 t60 -58.24 4.58 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.516 0 CA-C-O 117.653 -1.165 . . . . 2.8700000000000001 113.953 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 906' ' ' GLU . . . . . 0.488 ' CB ' ' O ' ' C' ' 905' ' ' HIS . 0.0 OUTLIER 94.02 -167.1 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.413 0 CA-C-N 121.264 1.847 . . . . 0.98999999999999999 112.011 179.096 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 907' ' ' LYS . . . . . 0.476 ' CB ' ' O ' ' C' ' 906' ' ' GLU . 30.3 ttmt 87.89 160.42 0.07 Allowed 'General case' 0 N--CA 1.518 2.969 0 N-CA-C 108.026 -1.102 . . . . 5.25 108.026 -177.062 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 59.2 t -120.9 116.38 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 120.947 -1.095 . . . . 0.39000000000000001 110.652 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 75.7 tt0 -103.66 131.65 50.62 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 107.298 -1.371 . . . . 1.72 107.298 176.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -155.34 122.36 5.45 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 106.445 -1.687 . . . . 0.67000000000000004 106.445 178.595 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 911' ' ' VAL . . . . . 0.722 HG13 HG22 ' C' ' 964' ' ' VAL . 70.1 t -77.41 131.95 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.826 -0.546 . . . . 0.54000000000000004 110.679 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 84.0 mt -65.67 157.07 31.0 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.279 -0.888 . . . . 1.5 108.718 178.624 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 913' ' ' SER . . . . . 0.472 ' OG ' HG11 ' C' ' 919' ' ' VAL . 1.3 p -127.17 132.65 50.46 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.174 -1.047 . . . . 1.3700000000000001 108.174 176.377 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 914' ' ' ARG . . . . . 0.428 ' O ' ' CB ' ' C' ' 915' ' ' SER . 0.0 OUTLIER -58.81 154.45 14.92 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 120.764 -1.21 . . . . 4.2999999999999998 112.097 -178.848 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 915' ' ' SER . . . . . 0.428 ' CB ' ' O ' ' C' ' 914' ' ' ARG . 1.8 t 83.13 -30.29 0.09 Allowed 'General case' 0 N--CA 1.519 3.022 0 C-N-CA 123.869 0.868 . . . . 2.0499999999999998 112.476 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 916' ' ' ASN . . . . . 0.617 ' HB2' HG21 ' C' ' 919' ' ' VAL . 97.2 m-20 -126.8 -23.5 3.67 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 120.891 -1.13 . . . . 2.71 111.173 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 917' ' ' GLN . . . . . 0.412 ' HB2' ' O ' ' C' ' 916' ' ' ASN . 41.8 mt-30 68.49 168.23 0.27 Allowed 'General case' 0 N--CA 1.517 2.917 0 N-CA-C 105.776 -1.935 . . . . 2.6800000000000002 105.776 -174.182 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 56.45 -127.72 44.56 Favored Glycine 1 N--CA 1.519 4.19 0 CA-C-N 123.397 2.817 . . . . 0.029999999999999999 106.467 -177.251 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 919' ' ' VAL . . . . . 0.617 HG21 ' HB2' ' C' ' 916' ' ' ASN . 95.0 t 50.45 94.83 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.336 0 CA-C-N 118.534 1.167 . . . . 1.3899999999999999 109.426 -178.736 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 920' ' ' ALA . . . . . 0.939 ' HB3' HG12 ' C' ' 949' ' ' VAL . . . -93.93 93.7 8.05 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.336 -0.946 . . . . 0.029999999999999999 111.049 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 921' ' ' ARG . . . . . 0.668 ' HG3' HG23 ' C' ' 922' ' ' VAL . 45.4 ptt85 -83.19 -42.96 16.67 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 105.582 -2.007 . . . . 4.4199999999999999 105.582 176.154 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 922' ' ' VAL . . . . . 0.668 HG23 ' HG3' ' C' ' 921' ' ' ARG . 77.3 t -101.05 74.65 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 104.71 -2.33 . . . . 0.84999999999999998 104.71 174.484 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -86.74 136.87 32.85 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 122.074 0.94 . . . . 2.46 112.614 -176.174 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 924' ' ' SER . . . . . 0.44 ' HB2' HD12 ' C' ' 900' ' ' LEU . 6.4 t -145.8 103.17 3.75 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 107.719 -1.215 . . . . 0.69999999999999996 107.719 178.391 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -107.48 85.75 0.43 Allowed Glycine 0 N--CA 1.488 2.123 0 N-CA-C 108.905 -1.678 . . . . 0.040000000000000001 108.905 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.278 0 N-CA-C 109.151 -1.58 . . . . 0.040000000000000001 109.151 -179.707 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 31.1 m . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 120.971 0.415 . . . . 13.779999999999999 110.335 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 947' ' ' LEU . . . . . 0.412 ' CD2' HG23 ' C' ' 919' ' ' VAL . 92.5 mt -110.37 129.56 55.73 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.487 -0.758 . . . . 13.76 110.312 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -152.25 169.71 31.51 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.348 -1.501 . . . . 9.1300000000000008 109.348 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 949' ' ' VAL . . . . . 0.939 HG12 ' HB3' ' C' ' 920' ' ' ALA . 33.5 m -118.69 131.74 70.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.551 -0.97 . . . . 7.0800000000000001 110.843 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 950' ' ' PHE . . . . . 0.457 ' CZ ' ' HB3' ' C' ' 921' ' ' ARG . 48.2 p90 -133.36 151.14 51.82 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.579 -0.7 . . . . 7.5899999999999999 109.113 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 7.3 m -119.64 -53.19 2.21 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.401 -0.812 . . . . 5.0300000000000002 112.096 -178.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 952' ' ' LEU . . . . . 0.425 ' O ' ' O ' ' C' ' 953' ' ' ILE . 15.4 tp -62.99 -74.78 0.09 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.354 -0.841 . . . . 1.01 112.018 -177.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 953' ' ' ILE . . . . . 0.597 HD11 HD13 ' B' ' 872' ' ' LEU . 41.8 pt -52.42 -146.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.77 0 N-CA-C 114.145 1.165 . . . . 2.6000000000000001 114.145 -176.627 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 954' ' ' LEU . . . . . 0.707 HD22 ' O ' ' C' ' 954' ' ' LEU . 0.0 OUTLIER 169.0 80.38 0.03 OUTLIER Pre-proline 0 N--CA 1.512 2.674 0 O-C-N 120.957 -1.089 . . . . 0.050000000000000003 111.695 179.563 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 955' ' ' PRO . . . . . 0.436 ' HD2' ' CE1' ' C' ' 950' ' ' PHE . 44.4 Cg_endo -72.66 98.84 1.0 Allowed 'Trans proline' 0 C--N 1.313 -1.325 0 N-CA-C 109.193 -1.118 . . . . 0.83999999999999997 109.193 178.575 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 956' ' ' LEU . . . . . 0.408 ' HA ' ' NH1' ' C' ' 914' ' ' ARG . 92.0 mt -125.26 142.29 51.59 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.052 -1.03 . . . . 0.040000000000000001 110.492 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 957' ' ' GLN . . . . . 0.447 ' HB2' ' HB3' ' C' ' 960' ' ' ASP . 87.2 mt-30 -84.98 149.49 25.57 Favored 'General case' 0 N--CA 1.501 2.124 0 CA-C-O 117.997 -1.001 . . . . 1.28 111.919 -178.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -62.11 122.29 15.19 Favored 'General case' 0 N--CA 1.512 2.635 0 CA-C-N 122.751 2.523 . . . . 0.17000000000000001 110.799 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 91.48 -10.31 75.09 Favored Glycine 0 N--CA 1.501 3.011 0 N-CA-C 110.167 -1.173 . . . . 0.040000000000000001 110.167 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 960' ' ' ASP . . . . . 0.447 ' HB3' ' HB2' ' C' ' 957' ' ' GLN . 16.3 p-10 -47.96 167.92 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.546 -0.973 . . . . 0.040000000000000001 111.98 -179.014 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 961' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' C' ' 886' ' ' PHE . 91.1 m -137.96 127.15 24.42 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.403 -0.811 . . . . 1.78 110.087 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 962' ' ' VAL . . . . . 0.865 HG22 ' CB ' ' C' ' 886' ' ' PHE . 12.0 m -100.96 142.95 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 C-N-CA 119.392 -0.923 . . . . 0.040000000000000001 110.45 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 5.5 t -140.41 145.77 37.47 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.968 -0.457 . . . . 0.71999999999999997 109.875 -178.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 964' ' ' VAL . . . . . 0.722 HG22 HG13 ' C' ' 911' ' ' VAL . 60.1 t -100.71 136.96 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.041 -1.037 . . . . 1.05 111.296 -178.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -96.42 128.11 43.04 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 103.967 -2.605 . . . . 3.02 103.967 173.079 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 966' ' ' LEU . . . . . 0.489 ' C ' HG23 ' C' ' 967' ' ' VAL . 11.7 tp -132.38 64.33 1.61 Allowed 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.254 -1.017 . . . . 1.46 108.254 177.122 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 967' ' ' VAL . . . . . 0.489 HG23 ' C ' ' C' ' 966' ' ' LEU . 96.9 t -157.81 97.19 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 108.041 -1.096 . . . . 1.9399999999999999 108.041 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 91.1 mmm -143.17 59.13 1.41 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.713 -1.242 . . . . 0.0 108.359 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.35 119.93 1.97 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 107.124 -2.39 . . . . 2.1099999999999999 107.124 -178.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -81.56 -57.94 3.24 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.01 -1.288 . . . . 5.8899999999999997 110.574 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 45.4 tp -58.64 90.24 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.433 -0.792 . . . . 4.3600000000000003 110.395 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -142.97 -153.47 0.47 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.573 -0.704 . . . . 1.8300000000000001 110.188 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -118.69 166.86 12.24 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.501 -0.75 . . . . 4.3499999999999996 110.323 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 31.1 t -102.14 130.18 48.7 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.522 -0.736 . . . . 1.27 109.944 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 66.8 tt0 -156.25 159.53 38.98 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.466 -0.771 . . . . 5.0199999999999996 110.628 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.1 85.82 21.59 Favored Pre-proline 0 N--CA 1.5 2.067 0 O-C-N 121.646 -0.659 . . . . 2.4100000000000001 109.755 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 977' ' ' PRO . . . . . 0.516 ' C ' HD12 ' C' ' 978' ' ' LEU . 47.3 Cg_endo -72.97 -170.74 0.66 Allowed 'Trans proline' 0 C--N 1.316 -1.138 0 O-C-N 123.323 1.17 . . . . 0.95999999999999996 111.159 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 978' ' ' LEU . . . . . 0.516 HD12 ' C ' ' C' ' 977' ' ' PRO . 5.8 mp -126.17 155.88 41.03 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 107.703 -1.221 . . . . 0.62 107.703 178.053 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 979' ' ' THR . . . . . 0.452 HG23 ' C ' ' C' ' 978' ' ' LEU . 63.7 p -148.83 141.17 24.15 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.853 -1.154 . . . . 3.5699999999999998 111.09 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 980' ' ' ILE . . . . . 0.721 ' HB ' HG21 ' C' ' 899' ' ' VAL . 49.2 mm -107.06 129.24 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 108.982 -0.747 . . . . 1.3300000000000001 108.982 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 981' ' ' PHE . . . . . 0.454 ' CD1' ' CE2' ' C' ' 879' ' ' TYR . 5.3 t80 -119.92 96.44 5.18 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 119.606 -0.837 . . . . 0.050000000000000003 111.796 -178.41 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 982' ' ' SER . . . . . . . . . . . . . 94.8 p -108.55 157.19 18.7 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.831 -0.803 . . . . 0.87 108.831 178.476 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 983' ' ' GLY . . . . . . . . . . . . . . . -172.86 112.86 0.45 Allowed Glycine 0 N--CA 1.496 2.671 0 N-CA-C 106.841 -2.503 . . . . 0.029999999999999999 106.841 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 984' ' ' ALA . . . . . 0.416 ' HB1' ' CZ ' ' A' ' 893' ' ' ARG . . . -109.83 146.98 34.13 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 114.142 1.164 . . . . 0.69999999999999996 114.142 -176.546 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 985' ' ' LEU . . . . . . . . . . . . . 56.6 tp -71.24 136.88 48.21 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 120.788 -1.195 . . . . 0.040000000000000001 110.2 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 986' ' ' LEU . . . . . . . . . . . . . 51.7 tp -106.21 -60.65 1.62 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.597 -0.689 . . . . 0.040000000000000001 110.285 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -143.82 146.46 33.09 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.896 -1.15 . . . . 0.040000000000000001 107.896 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.79 162.62 12.31 Favored Glycine 0 N--CA 1.496 2.695 0 N-CA-C 108.132 -1.987 . . . . 0.040000000000000001 108.132 179.095 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.72 111.86 22.62 Favored Pre-proline 0 N--CA 1.499 1.999 0 CA-C-N 118.571 1.186 . . . . 0.040000000000000001 109.539 178.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 990' ' ' PRO . . . . . 0.471 ' HD2' HD12 ' C' ' 992' ' ' LEU . 48.8 Cg_endo -92.59 74.0 0.48 Allowed 'Trans proline' 0 C--N 1.318 -1.059 0 O-C-N 123.117 1.062 . . . . 0.45000000000000001 111.527 -179.022 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 991' ' ' GLU . . . . . 0.417 ' HB2' ' O ' ' C' ' 990' ' ' PRO . 77.1 mt-10 67.26 -73.67 0.08 Allowed 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 108.48 -0.933 . . . . 1.97 108.48 -177.553 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 992' ' ' LEU . . . . . 0.471 HD12 ' HD2' ' C' ' 990' ' ' PRO . 6.9 mt 51.65 20.38 1.08 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.521 -0.737 . . . . 2.3799999999999999 111.591 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -95.39 156.88 16.13 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.855 -1.153 . . . . 3.79 110.066 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 67.3 m80 -146.44 94.55 2.47 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.534 -0.729 . . . . 3.5099999999999998 110.345 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 995' ' ' ALA . . . . . . . . . . . . 2.518 . . . . . . . 0 N--CA 1.504 2.225 0 O-C-N 120.955 -1.09 . . . . 2.73 110.616 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo . . . . . 0 N--CA 1.488 1.177 0 N-CA-C 109.482 -1.007 . . . . 3.8300000000000001 109.482 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 847' ' ' VAL . . . . . 0.432 HG12 ' HB2' ' A' ' 849' ' ' GLN . 60.1 t -132.04 103.58 14.16 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.583 -0.698 . . . . 1.8300000000000001 110.073 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 848' ' ' PRO . . . . . 0.718 ' O ' HG23 ' A' ' 850' ' ' VAL . 43.9 Cg_endo -69.8 -19.89 35.34 Favored 'Trans proline' 0 N--CA 1.487 1.106 0 O-C-N 123.302 1.159 . . . . 0.65000000000000002 111.125 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 849' ' ' GLN . . . . . 0.432 ' HB2' HG12 ' A' ' 847' ' ' VAL . 56.4 tt0 26.42 69.24 0.05 Allowed 'General case' 0 N--CA 1.519 2.989 0 N-CA-C 112.948 0.721 . . . . 2.5800000000000001 112.948 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 850' ' ' VAL . . . . . 0.718 HG23 ' O ' ' A' ' 848' ' ' PRO . 59.7 t -117.46 137.86 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.292 -0.88 . . . . 1.0900000000000001 111.63 -178.514 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 851' ' ' ALA . . . . . 0.495 ' HB3' ' HG ' ' A' ' 873' ' ' LEU . . . -127.69 155.41 44.0 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 105.723 -1.954 . . . . 0.040000000000000001 105.723 176.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 852' ' ' PHE . . . . . 0.446 ' HA ' ' CB ' ' A' ' 874' ' ' ASN . 21.4 p90 -160.4 128.87 4.73 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-N 121.016 1.735 . . . . 0.050000000000000003 108.864 179.286 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 33.1 t -175.57 134.57 0.3 Allowed 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.071 -1.085 . . . . 0.040000000000000001 108.071 -179.191 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -134.85 158.42 44.26 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.053 -1.029 . . . . 0.67000000000000004 109.501 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 855' ' ' ALA . . . . . 0.78 ' HB3' ' CB ' ' A' ' 870' ' ' ARG . . . -122.58 141.02 52.14 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 121.894 0.854 . . . . 0.51000000000000001 111.852 -178.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 856' ' ' LEU . . . . . 0.925 HD11 HD23 ' A' ' 858' ' ' LEU . 3.5 tm? -107.64 135.53 48.93 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 109.247 -0.649 . . . . 0.050000000000000003 109.247 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 857' ' ' SER . . . . . 0.572 ' N ' HD13 ' A' ' 856' ' ' LEU . 16.9 p -153.05 17.82 0.57 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.419 -0.8 . . . . 1.3300000000000001 111.223 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 858' ' ' LEU . . . . . 0.925 HD23 HD11 ' A' ' 856' ' ' LEU . 3.1 pp -29.66 154.08 0.03 OUTLIER Pre-proline 0 N--CA 1.52 3.046 0 N-CA-C 113.421 0.897 . . . . 2.3300000000000001 113.421 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -61.73 -88.8 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 120.934 1.09 . . . . 2.3199999999999998 113.683 -177.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 53.4 ptt85 -127.16 -142.12 0.27 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.895 -1.128 . . . . 0.040000000000000001 111.429 -177.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 36.8 m -39.11 119.02 0.85 Allowed 'General case' 0 N--CA 1.51 2.543 0 O-C-N 121.549 -0.719 . . . . 1.3100000000000001 111.919 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 862' ' ' GLU . . . . . 0.502 ' OE2' HD22 ' A' ' 858' ' ' LEU . 24.6 tt0 -97.35 149.57 35.86 Favored Pre-proline 0 N--CA 1.488 1.453 0 N-CA-C 108.17 -1.048 . . . . 4.5099999999999998 108.17 178.048 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 863' ' ' PRO . . . . . 0.446 ' HD2' ' CG ' ' A' ' 862' ' ' GLU . 41.6 Cg_endo -67.65 -13.31 38.47 Favored 'Trans proline' 0 C--N 1.316 -1.161 0 O-C-N 122.984 0.991 . . . . 2.2400000000000002 111.334 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -174.21 -137.36 2.43 Favored Glycine 0 N--CA 1.493 2.474 0 C-N-CA 119.76 -1.21 . . . . 0.040000000000000001 110.623 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 37.1 m -69.2 159.65 32.63 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.332 -1.099 . . . . 1.51 111.719 -177.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 866' ' ' VAL . . . . . 0.463 ' O ' HG23 ' A' ' 866' ' ' VAL . 27.0 m -89.93 132.73 35.48 Favored Pre-proline 0 N--CA 1.495 1.808 0 N-CA-C 113.422 0.897 . . . . 0.78000000000000003 113.422 -175.304 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 867' ' ' PRO . . . . . 0.841 ' O ' HD23 ' A' ' 856' ' ' LEU . 52.5 Cg_endo -88.77 -153.82 0.05 OUTLIER 'Trans proline' 0 C--N 1.323 -0.794 0 N-CA-C 107.709 -1.689 . . . . 0.92000000000000004 107.709 177.011 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 868' ' ' PHE . . . . . 0.48 ' CD1' ' HG2' ' A' ' 881' ' ' PRO . 31.9 p90 -148.55 119.25 7.5 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.51 -1.369 . . . . 0.050000000000000003 109.944 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 50.1 p-10 -112.72 -3.24 14.29 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 119.322 -0.951 . . . . 1.7 112.207 -178.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 870' ' ' ARG . . . . . 0.78 ' CB ' ' HB3' ' A' ' 855' ' ' ALA . 26.5 mmm180 -89.98 88.69 7.4 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.908 -1.12 . . . . 2.5899999999999999 110.676 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 57.3 t -75.12 96.88 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.028 -1.045 . . . . 1.9399999999999999 109.787 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 872' ' ' LEU . . . . . . . . . . . . . 95.8 mt -83.92 -46.89 11.62 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.553 -0.717 . . . . 1.0600000000000001 110.231 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 873' ' ' LEU . . . . . 0.495 ' HG ' ' HB3' ' A' ' 851' ' ' ALA . 48.8 tp -174.82 104.48 0.09 Allowed 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.293 -0.879 . . . . 4.1799999999999997 108.676 178.688 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 874' ' ' ASN . . . . . 0.446 ' CB ' ' HA ' ' A' ' 852' ' ' PHE . 36.5 t-20 178.68 82.1 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.316 0 O-C-N 121.588 -0.695 . . . . 0.040000000000000001 109.675 -178.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -66.91 -47.06 72.93 Favored 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 119.289 -0.965 . . . . 3.3799999999999999 111.283 -179.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 876' ' ' GLY . . . . . 0.404 ' HA3' ' CE2' ' A' ' 878' ' ' TYR . . . -74.62 -25.29 70.35 Favored Glycine 0 N--CA 1.494 2.553 0 O-C-N 121.239 -0.913 . . . . 0.040000000000000001 111.836 -178.666 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 84.32 -59.8 4.9 Favored Glycine 0 N--CA 1.502 3.084 0 N-CA-C 108.154 -1.979 . . . . 0.040000000000000001 108.154 -178.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 878' ' ' TYR . . . . . 0.404 ' CE2' ' HA3' ' A' ' 876' ' ' GLY . 97.7 m-85 60.67 -66.13 0.05 Allowed 'General case' 0 N--CA 1.503 2.215 0 N-CA-C 114.327 1.232 . . . . 3.46 114.327 177.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 879' ' ' TYR . . . . . 0.469 ' CB ' ' CD2' ' A' ' 886' ' ' PHE . 23.7 p90 -112.37 109.17 18.64 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 114.796 1.406 . . . . 0.040000000000000001 114.796 -176.275 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -65.18 118.53 50.65 Favored Pre-proline 0 N--CA 1.495 1.816 0 O-C-N 121.369 -0.832 . . . . 0.02 110.026 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 881' ' ' PRO . . . . . 0.48 ' HG2' ' CD1' ' A' ' 868' ' ' PHE . 55.2 Cg_endo -76.87 0.24 9.85 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 O-C-N 123.469 1.247 . . . . 0.39000000000000001 112.094 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 -76.79 -64.81 1.04 Allowed 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 106.98 -1.489 . . . . 0.81000000000000005 106.98 178.363 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 883' ' ' THR . . . . . 0.478 ' OG1' HG23 ' A' ' 885' ' ' VAL . 30.4 p -94.1 -17.7 22.55 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.776 -0.824 . . . . 0.040000000000000001 108.776 177.461 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.08 22.11 55.65 Favored Glycine 0 N--CA 1.495 2.63 0 O-C-N 121.057 -1.027 . . . . 0.029999999999999999 110.749 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 885' ' ' VAL . . . . . 0.652 HG13 HG21 ' A' ' 961' ' ' THR . 77.6 t -73.15 90.42 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 C-N-CA 118.353 -1.339 . . . . 1.01 108.23 -179.225 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 886' ' ' PHE . . . . . 0.883 ' HB3' HG22 ' A' ' 962' ' ' VAL . 0.7 OUTLIER -90.39 104.34 16.92 Favored 'General case' 0 N--CA 1.495 1.825 0 CA-C-N 115.291 -0.868 . . . . 0.050000000000000003 112.291 -177.298 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 887' ' ' THR . . . . . 0.418 ' O ' ' HD3' ' A' ' 889' ' ' PRO . 89.8 m -95.04 100.77 12.54 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 107.831 -1.174 . . . . 0.68000000000000005 107.831 177.468 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 888' ' ' ALA . . . . . . . . . . . . . . . -99.17 106.37 38.15 Favored Pre-proline 0 N--CA 1.5 2.047 0 N-CA-C 114.045 1.128 . . . . 0.25 114.045 -176.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 889' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 887' ' ' THR . 54.6 Cg_endo -89.2 -11.94 3.45 Favored 'Trans proline' 0 CA--C 1.546 1.109 0 N-CA-C 108.975 -1.202 . . . . 1.6399999999999999 108.975 176.087 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 890' ' ' LEU . . . . . 0.628 HD11 ' CD1' ' A' ' 985' ' ' LEU . 4.9 tt -35.29 -51.23 0.58 Allowed 'General case' 0 N--CA 1.507 2.397 0 N-CA-C 113.92 1.082 . . . . 2.29 113.92 -177.475 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 51.79 95.03 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.374 0 O-C-N 121.188 -0.945 . . . . 0.63 110.175 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 156.05 -147.28 15.72 Favored Glycine 0 N--CA 1.478 1.487 0 N-CA-C 107.372 -2.291 . . . . 0.040000000000000001 107.372 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 893' ' ' ARG . . . . . 0.44 ' NE ' ' HB1' ' C' ' 984' ' ' ALA . 72.4 ttt-85 -109.0 127.91 54.5 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.86 -1.163 . . . . 3.0 107.86 177.365 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 894' ' ' TYR . . . . . 0.45 ' CD1' ' N ' ' A' ' 895' ' ' LEU . 0.1 OUTLIER -130.98 144.46 51.49 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.05 -1.032 . . . . 0.040000000000000001 110.085 -179.305 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 895' ' ' LEU . . . . . 0.45 ' N ' ' CD1' ' A' ' 894' ' ' TYR . 34.3 tp -99.37 115.22 28.72 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.625 -0.672 . . . . 1.27 109.807 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 896' ' ' LEU . . . . . 0.617 HD23 ' N ' ' A' ' 897' ' ' SER . 9.9 tt -112.16 145.87 39.06 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.579 -0.7 . . . . 0.93999999999999995 110.461 -179.461 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 897' ' ' SER . . . . . 0.617 ' N ' HD23 ' A' ' 896' ' ' LEU . 71.2 m -144.74 119.11 9.6 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.379 -0.825 . . . . 0.040000000000000001 110.741 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.97 147.69 30.72 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.708 -0.62 . . . . 0.47999999999999998 109.448 179.266 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 899' ' ' VAL . . . . . 0.706 HG21 ' HB ' ' A' ' 980' ' ' ILE . 88.0 t -91.95 121.15 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.457 -0.777 . . . . 0.55000000000000004 110.98 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 900' ' ' LEU . . . . . 0.603 HD12 ' HB2' ' A' ' 924' ' ' SER . 4.4 mm? -95.02 111.75 23.52 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 114.423 1.268 . . . . 1.5900000000000001 114.423 -174.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 17.3 m -67.8 141.64 56.45 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 107.274 -1.38 . . . . 0.050000000000000003 107.274 176.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -67.92 -65.02 2.87 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 110.718 -0.953 . . . . 0.029999999999999999 110.718 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 5.8 m170 46.83 66.31 1.02 Allowed 'General case' 0 N--CA 1.508 2.437 0 O-C-N 121.464 -1.021 . . . . 3.2000000000000002 111.082 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 54.1 ptt85 -69.26 -5.91 25.94 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.578 -0.701 . . . . 2.9199999999999999 112.178 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 905' ' ' HIS . . . . . 0.489 ' O ' ' CB ' ' A' ' 906' ' ' GLU . 73.9 t60 -62.69 5.06 0.13 Allowed 'General case' 0 N--CA 1.507 2.393 0 O-C-N 120.888 -1.132 . . . . 2.8700000000000001 113.086 -179.133 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 906' ' ' GLU . . . . . 0.489 ' CB ' ' O ' ' A' ' 905' ' ' HIS . 0.6 OUTLIER 95.07 -164.97 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.452 0 CA-C-N 120.609 1.549 . . . . 0.98999999999999999 111.993 178.903 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 907' ' ' LYS . . . . . 0.463 ' CB ' ' O ' ' A' ' 906' ' ' GLU . 62.0 tttt 86.09 156.78 0.08 Allowed 'General case' 0 N--CA 1.52 3.03 0 N-CA-C 107.961 -1.126 . . . . 5.25 107.961 -176.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 60.7 t -122.1 117.45 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 120.791 -1.193 . . . . 0.39000000000000001 111.224 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 54.0 tp10 -101.56 133.24 46.54 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 107.291 -1.374 . . . . 1.72 107.291 176.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -155.74 123.0 5.45 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 106.811 -1.551 . . . . 0.67000000000000004 106.811 178.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 911' ' ' VAL . . . . . 0.772 HG22 HG13 ' A' ' 964' ' ' VAL . 93.8 t -84.28 131.83 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.902 -0.499 . . . . 0.54000000000000004 110.984 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 60.6 mt -66.92 157.56 32.92 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.46 -0.775 . . . . 1.5 109.351 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 913' ' ' SER . . . . . 0.466 ' OG ' HG11 ' A' ' 919' ' ' VAL . 1.4 p -124.65 137.6 54.36 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.003 -1.11 . . . . 1.3700000000000001 108.003 176.69 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 914' ' ' ARG . . . . . 0.611 ' NH1' HD23 ' A' ' 956' ' ' LEU . 0.1 OUTLIER -65.32 155.28 35.75 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.638 -1.289 . . . . 4.2999999999999998 111.359 -179.164 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 915' ' ' SER . . . . . 0.424 ' CB ' ' O ' ' A' ' 914' ' ' ARG . 1.7 p 83.42 -31.56 0.08 Allowed 'General case' 0 N--CA 1.521 3.118 0 C-N-CA 123.925 0.89 . . . . 2.0499999999999998 112.068 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 916' ' ' ASN . . . . . 0.754 ' HB2' HG21 ' A' ' 919' ' ' VAL . 99.4 m-20 -122.78 -21.91 5.47 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 120.953 -1.092 . . . . 2.71 111.192 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 917' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 67.04 166.53 0.22 Allowed 'General case' 0 N--CA 1.52 3.027 0 N-CA-C 105.742 -1.948 . . . . 2.6800000000000002 105.742 -174.249 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.33 -125.23 33.43 Favored Glycine 1 N--CA 1.521 4.324 0 CA-C-N 123.368 2.804 . . . . 0.029999999999999999 107.07 -177.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 919' ' ' VAL . . . . . 0.754 HG21 ' HB2' ' A' ' 916' ' ' ASN . 88.2 t 52.39 94.98 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 O-C-N 121.382 -1.069 . . . . 1.3899999999999999 109.068 -178.092 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 920' ' ' ALA . . . . . 0.912 ' HB3' HG12 ' A' ' 949' ' ' VAL . . . -90.87 91.07 8.19 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.246 -0.982 . . . . 0.029999999999999999 110.788 -179.173 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 921' ' ' ARG . . . . . 0.763 ' HG3' HG23 ' A' ' 922' ' ' VAL . 27.5 ptt85 -84.99 -42.2 15.11 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 106.013 -1.847 . . . . 4.4199999999999999 106.013 176.374 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 922' ' ' VAL . . . . . 0.763 HG23 ' HG3' ' A' ' 921' ' ' ARG . 74.6 t -101.96 74.29 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 105.76 -1.941 . . . . 0.84999999999999998 105.76 175.561 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -85.79 134.91 33.91 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.758 0.789 . . . . 2.46 111.545 -177.271 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 924' ' ' SER . . . . . 0.603 ' HB2' HD12 ' A' ' 900' ' ' LEU . 7.0 t -147.09 105.67 3.81 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 108.772 -0.825 . . . . 0.69999999999999996 108.772 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -103.46 83.49 0.42 Allowed Glycine 0 N--CA 1.487 2.035 0 N-CA-C 108.243 -1.943 . . . . 0.040000000000000001 108.243 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.226 0 N-CA-C 108.82 -1.712 . . . . 0.040000000000000001 108.82 -179.543 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 24.8 m . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.054 0.455 . . . . 13.779999999999999 110.29 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 95.7 mt -112.17 130.01 56.05 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.519 -0.738 . . . . 13.76 110.362 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -151.77 168.71 31.16 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.229 -1.548 . . . . 9.1300000000000008 109.229 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 949' ' ' VAL . . . . . 0.912 HG12 ' HB3' ' A' ' 920' ' ' ALA . 32.7 m -118.28 130.1 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.573 -0.957 . . . . 7.0800000000000001 110.691 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 950' ' ' PHE . . . . . 0.46 ' CZ ' ' HB3' ' A' ' 921' ' ' ARG . 50.0 p90 -135.18 152.46 51.61 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.57 -0.706 . . . . 7.5899999999999999 109.508 179.732 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 23.1 m -118.45 -54.52 2.27 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.44 -0.787 . . . . 5.0300000000000002 112.007 -178.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 952' ' ' LEU . . . . . 0.437 ' O ' ' O ' ' A' ' 953' ' ' ILE . 12.3 tp -62.05 -74.26 0.09 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.432 -0.793 . . . . 1.01 112.081 -177.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 953' ' ' ILE . . . . . 0.643 HD12 ' HD3' ' A' ' 955' ' ' PRO . 1.5 pp -51.56 -149.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.713 0 N-CA-C 114.18 1.178 . . . . 2.6000000000000001 114.18 -176.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 954' ' ' LEU . . . . . 0.74 HD22 ' O ' ' A' ' 954' ' ' LEU . 0.0 OUTLIER 166.32 90.69 0.02 OUTLIER Pre-proline 0 N--CA 1.519 2.982 0 O-C-N 121.179 -0.951 . . . . 0.050000000000000003 111.755 179.174 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 955' ' ' PRO . . . . . 0.732 ' C ' HD12 ' A' ' 956' ' ' LEU . 51.7 Cg_endo -78.92 98.28 1.18 Allowed 'Trans proline' 0 C--N 1.315 -1.198 0 N-CA-C 109.037 -1.178 . . . . 0.83999999999999997 109.037 178.211 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 956' ' ' LEU . . . . . 0.732 HD12 ' C ' ' A' ' 955' ' ' PRO . 11.1 mp -121.27 141.93 50.42 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.994 -1.066 . . . . 0.040000000000000001 109.954 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -84.5 150.86 24.98 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 117.782 -1.104 . . . . 1.28 111.842 -178.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -68.43 118.9 12.09 Favored 'General case' 0 N--CA 1.509 2.525 0 CA-C-N 123.034 2.652 . . . . 0.17000000000000001 111.431 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 93.03 -21.25 40.92 Favored Glycine 0 N--CA 1.5 2.959 0 N-CA-C 111.034 -0.826 . . . . 0.040000000000000001 111.034 178.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 960' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -56.57 170.46 0.38 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.426 -1.044 . . . . 0.040000000000000001 110.112 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 961' ' ' THR . . . . . 0.652 HG21 HG13 ' A' ' 885' ' ' VAL . 42.1 m -135.94 137.76 41.65 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.906 -1.121 . . . . 1.78 112.282 -178.007 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 962' ' ' VAL . . . . . 0.883 HG22 ' HB3' ' A' ' 886' ' ' PHE . 33.6 m -98.14 145.37 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 C-N-CA 120.142 -0.623 . . . . 0.040000000000000001 110.352 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 5.2 t -137.4 145.02 42.73 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.792 -0.568 . . . . 0.71999999999999997 110.041 -178.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 964' ' ' VAL . . . . . 0.772 HG13 HG22 ' A' ' 911' ' ' VAL . 61.2 t -93.21 136.72 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.16 -0.963 . . . . 1.05 110.495 -179.261 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -93.73 127.42 39.43 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 103.613 -2.736 . . . . 3.02 103.613 173.315 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 966' ' ' LEU . . . . . 0.544 HD23 ' O ' ' A' ' 966' ' ' LEU . 4.1 tt -132.51 61.11 1.67 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.21 -1.033 . . . . 1.46 108.21 177.321 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 967' ' ' VAL . . . . . 0.488 HG23 ' C ' ' A' ' 966' ' ' LEU . 97.2 t -157.87 96.74 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 108.12 -1.067 . . . . 1.9399999999999999 108.12 179.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 88.1 mmm -143.66 59.16 1.38 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.747 -1.22 . . . . 0.0 108.34 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.13 119.64 1.95 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 107.107 -2.397 . . . . 2.1099999999999999 107.107 -178.246 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -82.17 -58.35 2.99 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.023 -1.281 . . . . 5.8899999999999997 110.378 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 46.7 tp -58.89 90.84 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.434 -0.791 . . . . 4.3600000000000003 110.244 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -142.0 -154.37 0.52 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.595 -0.691 . . . . 1.8300000000000001 110.208 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -119.53 170.7 8.93 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.479 -0.763 . . . . 4.3499999999999996 110.252 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 9.5 t -101.63 130.4 47.96 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.548 -0.72 . . . . 1.27 110.12 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -155.89 158.77 38.54 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.482 -0.761 . . . . 5.0199999999999996 110.41 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.5 85.72 17.32 Favored Pre-proline 0 N--CA 1.501 2.078 0 O-C-N 121.618 -0.676 . . . . 2.4100000000000001 109.87 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 977' ' ' PRO . . . . . 0.498 ' C ' HD12 ' A' ' 978' ' ' LEU . 47.8 Cg_endo -73.61 -172.65 1.12 Allowed 'Trans proline' 0 C--N 1.318 -1.059 0 O-C-N 123.303 1.159 . . . . 0.95999999999999996 111.277 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 978' ' ' LEU . . . . . 0.515 HD23 ' CD1' ' A' ' 856' ' ' LEU . 5.4 mp -127.47 155.39 43.79 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.728 -1.212 . . . . 0.62 107.728 178.021 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 979' ' ' THR . . . . . 0.451 HG23 ' C ' ' A' ' 978' ' ' LEU . 37.1 p -150.23 141.11 22.83 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.762 -1.212 . . . . 3.5699999999999998 111.186 -179.364 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 980' ' ' ILE . . . . . 0.706 ' HB ' HG21 ' A' ' 899' ' ' VAL . 51.4 mm -107.38 128.76 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 109.099 -0.704 . . . . 1.3300000000000001 109.099 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 981' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -119.39 99.29 6.59 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 119.821 -0.752 . . . . 0.050000000000000003 111.8 -178.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 42.6 p -106.78 158.25 17.13 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.814 -0.81 . . . . 0.87 108.814 178.314 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . -172.78 110.13 0.33 Allowed Glycine 0 N--CA 1.498 2.803 0 N-CA-C 106.649 -2.58 . . . . 0.029999999999999999 106.649 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -110.67 149.67 30.13 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 114.551 1.315 . . . . 0.69999999999999996 114.551 -175.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 985' ' ' LEU . . . . . 0.628 ' CD1' HD11 ' A' ' 890' ' ' LEU . 54.4 tp -70.73 133.9 47.0 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.816 -1.177 . . . . 0.040000000000000001 109.808 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 51.0 tp -107.37 -59.04 1.88 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.499 -0.751 . . . . 0.040000000000000001 109.989 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -144.47 145.06 31.67 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.565 -1.272 . . . . 0.040000000000000001 107.565 179.054 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.97 163.12 12.17 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 108.139 -1.984 . . . . 0.040000000000000001 108.139 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -75.3 112.5 18.97 Favored Pre-proline 0 N--CA 1.498 1.973 0 CA-C-N 118.52 1.16 . . . . 0.040000000000000001 109.482 179.141 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 990' ' ' PRO . . . . . 0.431 ' HD2' HD12 ' A' ' 992' ' ' LEU . 50.2 Cg_endo -90.07 71.24 1.59 Allowed 'Trans proline' 0 C--N 1.319 -0.998 0 O-C-N 123.124 1.065 . . . . 0.45000000000000001 111.39 -178.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 991' ' ' GLU . . . . . 0.419 ' HB2' ' O ' ' A' ' 990' ' ' PRO . 69.8 mt-10 67.36 -73.94 0.07 Allowed 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 108.494 -0.928 . . . . 1.97 108.494 -177.393 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 992' ' ' LEU . . . . . 0.431 HD12 ' HD2' ' A' ' 990' ' ' PRO . 10.4 mt 50.92 20.64 0.82 Allowed 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.579 -0.701 . . . . 2.3799999999999999 111.647 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -94.2 156.85 16.34 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.888 -1.132 . . . . 3.79 109.959 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 72.2 m80 -146.24 93.44 2.32 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.571 -0.706 . . . . 3.5099999999999998 110.23 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 995' ' ' ALA . . . . . . . . . . . . 2.519 . . . . . . . 0 N--CA 1.503 2.219 0 O-C-N 120.821 -1.174 . . . . 2.73 110.574 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo . . . . . 0 N--CA 1.488 1.203 0 N-CA-C 109.502 -0.999 . . . . 3.8300000000000001 109.502 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 847' ' ' VAL . . . . . 0.415 HG12 ' HB2' ' B' ' 849' ' ' GLN . 59.8 t -132.05 103.57 14.15 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.638 -0.664 . . . . 1.8300000000000001 110.074 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 848' ' ' PRO . . . . . 0.705 ' O ' HG23 ' B' ' 850' ' ' VAL . 44.0 Cg_endo -69.7 -20.23 35.41 Favored 'Trans proline' 0 N--CA 1.487 1.097 0 O-C-N 123.236 1.124 . . . . 0.65000000000000002 111.123 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 849' ' ' GLN . . . . . 0.415 ' HB2' HG12 ' B' ' 847' ' ' VAL . 56.3 tt0 26.67 69.7 0.05 Allowed 'General case' 0 N--CA 1.519 2.979 0 N-CA-C 112.84 0.682 . . . . 2.5800000000000001 112.84 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 850' ' ' VAL . . . . . 0.705 HG23 ' O ' ' B' ' 848' ' ' PRO . 59.6 t -117.91 137.81 50.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.237 -0.915 . . . . 1.0900000000000001 111.616 -178.545 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 851' ' ' ALA . . . . . 0.473 ' HB3' ' HG ' ' B' ' 873' ' ' LEU . . . -128.06 154.76 45.32 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 105.707 -1.96 . . . . 0.040000000000000001 105.707 176.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 852' ' ' PHE . . . . . 0.449 ' HA ' ' CB ' ' B' ' 874' ' ' ASN . 20.8 p90 -159.64 129.35 5.42 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 121.006 1.73 . . . . 0.050000000000000003 108.742 179.337 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 32.7 t -175.75 134.25 0.28 Allowed 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.137 -1.061 . . . . 0.040000000000000001 108.137 -179.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -134.56 158.63 43.5 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.123 -0.985 . . . . 0.67000000000000004 109.526 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 855' ' ' ALA . . . . . 0.788 ' HB3' ' CB ' ' B' ' 870' ' ' ARG . . . -122.84 141.17 52.15 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.919 0.866 . . . . 0.51000000000000001 111.843 -178.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 856' ' ' LEU . . . . . 0.914 HD11 HD23 ' B' ' 858' ' ' LEU . 3.5 tm? -107.8 135.18 49.65 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.276 -0.638 . . . . 0.050000000000000003 109.276 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 857' ' ' SER . . . . . 0.562 ' N ' HD13 ' B' ' 856' ' ' LEU . 17.0 p -152.78 17.98 0.6 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.474 -0.766 . . . . 1.3300000000000001 111.144 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 858' ' ' LEU . . . . . 0.914 HD23 HD11 ' B' ' 856' ' ' LEU . 3.1 pp -29.82 154.14 0.03 OUTLIER Pre-proline 0 N--CA 1.521 3.087 0 N-CA-C 113.337 0.866 . . . . 2.3300000000000001 113.337 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -61.82 -88.75 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.541 0 O-C-N 123.149 1.078 . . . . 2.3199999999999998 113.681 -177.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 53.4 ptt85 -127.2 -142.19 0.27 Allowed 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.86 -1.15 . . . . 0.040000000000000001 111.403 -177.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 37.0 m -39.12 118.63 0.81 Allowed 'General case' 0 N--CA 1.51 2.531 0 O-C-N 121.479 -0.763 . . . . 1.3100000000000001 111.9 -178.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 862' ' ' GLU . . . . . 0.487 ' OE2' HD22 ' B' ' 858' ' ' LEU . 24.6 tt0 -96.89 149.68 36.01 Favored Pre-proline 0 N--CA 1.489 1.484 0 N-CA-C 108.162 -1.051 . . . . 4.5099999999999998 108.162 177.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 863' ' ' PRO . . . . . 0.443 ' HD2' ' CG ' ' B' ' 862' ' ' GLU . 41.5 Cg_endo -67.69 -13.38 38.61 Favored 'Trans proline' 0 C--N 1.316 -1.181 0 O-C-N 123.015 1.008 . . . . 2.2400000000000002 111.385 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -174.0 -136.88 2.3 Favored Glycine 0 N--CA 1.494 2.501 0 C-N-CA 119.836 -1.174 . . . . 0.040000000000000001 110.665 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 37.2 m -69.55 160.19 31.95 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.276 -1.132 . . . . 1.51 111.75 -178.073 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 866' ' ' VAL . . . . . 0.46 ' O ' HG23 ' B' ' 866' ' ' VAL . 26.9 m -90.31 132.75 34.74 Favored Pre-proline 0 N--CA 1.495 1.782 0 N-CA-C 113.419 0.896 . . . . 0.78000000000000003 113.419 -175.36 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 867' ' ' PRO . . . . . 0.818 ' O ' HD23 ' B' ' 856' ' ' LEU . 53.1 Cg_endo -88.83 -154.05 0.05 OUTLIER 'Trans proline' 0 C--N 1.322 -0.817 0 N-CA-C 107.679 -1.7 . . . . 0.92000000000000004 107.679 177.037 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 868' ' ' PHE . . . . . 0.472 ' CD1' ' HG2' ' B' ' 881' ' ' PRO . 31.6 p90 -148.39 119.13 7.52 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.446 -1.409 . . . . 0.050000000000000003 109.874 179.393 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 50.1 p-10 -112.57 -2.84 14.49 Favored 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 119.284 -0.967 . . . . 1.7 112.153 -178.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 870' ' ' ARG . . . . . 0.788 ' CB ' ' HB3' ' B' ' 855' ' ' ALA . 26.0 mmm180 -90.32 88.62 7.28 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.977 -1.077 . . . . 2.5899999999999999 110.682 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 57.5 t -75.23 97.03 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.004 -1.06 . . . . 1.9399999999999999 109.661 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 872' ' ' LEU . . . . . 0.513 ' HB3' HD11 ' C' ' 953' ' ' ILE . 95.4 mt -84.29 -46.75 11.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.541 -0.724 . . . . 1.0600000000000001 110.273 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 873' ' ' LEU . . . . . 0.473 ' HG ' ' HB3' ' B' ' 851' ' ' ALA . 48.8 tp -174.66 104.43 0.1 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.265 -0.897 . . . . 4.1799999999999997 108.605 178.68 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 874' ' ' ASN . . . . . 0.449 ' CB ' ' HA ' ' B' ' 852' ' ' PHE . 36.5 t-20 178.67 82.27 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.654 -0.653 . . . . 0.040000000000000001 109.647 -178.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -67.09 -47.1 72.23 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 119.29 -0.964 . . . . 3.3799999999999999 111.244 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 876' ' ' GLY . . . . . 0.41 ' HA3' ' CE2' ' B' ' 878' ' ' TYR . . . -74.49 -25.58 69.93 Favored Glycine 0 N--CA 1.494 2.566 0 O-C-N 121.217 -0.927 . . . . 0.040000000000000001 111.813 -178.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 84.48 -59.74 4.89 Favored Glycine 0 N--CA 1.502 3.038 0 N-CA-C 108.11 -1.996 . . . . 0.040000000000000001 108.11 -178.198 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 878' ' ' TYR . . . . . 0.41 ' CE2' ' HA3' ' B' ' 876' ' ' GLY . 97.7 m-85 60.74 -66.13 0.05 Allowed 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 114.348 1.24 . . . . 3.46 114.348 177.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 879' ' ' TYR . . . . . 0.46 ' CB ' ' CD2' ' B' ' 886' ' ' PHE . 23.5 p90 -112.39 109.15 18.6 Favored 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 114.773 1.398 . . . . 0.040000000000000001 114.773 -176.294 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -65.17 118.47 50.03 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.396 -0.815 . . . . 0.02 109.999 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 881' ' ' PRO . . . . . 0.472 ' HG2' ' CD1' ' B' ' 868' ' ' PHE . 55.4 Cg_endo -76.84 0.17 9.91 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 O-C-N 123.432 1.227 . . . . 0.39000000000000001 112.143 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -76.66 -64.95 1.0 Allowed 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 106.963 -1.495 . . . . 0.81000000000000005 106.963 178.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 883' ' ' THR . . . . . 0.477 ' OG1' HG23 ' B' ' 885' ' ' VAL . 31.0 p -94.13 -17.25 22.97 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.784 -0.821 . . . . 0.040000000000000001 108.784 177.527 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.49 22.49 56.27 Favored Glycine 0 N--CA 1.494 2.541 0 O-C-N 121.091 -1.006 . . . . 0.029999999999999999 110.793 178.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 885' ' ' VAL . . . . . 0.63 HG13 HG21 ' B' ' 961' ' ' THR . 79.4 t -73.41 90.74 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 C-N-CA 118.274 -1.371 . . . . 1.01 108.151 -179.325 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 886' ' ' PHE . . . . . 0.883 ' HB3' HG22 ' B' ' 962' ' ' VAL . 0.6 OUTLIER -90.63 104.42 17.01 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 115.281 -0.872 . . . . 0.050000000000000003 112.244 -177.264 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 887' ' ' THR . . . . . 0.419 ' O ' ' HD3' ' B' ' 889' ' ' PRO . 90.3 m -95.06 101.03 12.76 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 107.774 -1.195 . . . . 0.68000000000000005 107.774 177.468 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 888' ' ' ALA . . . . . . . . . . . . . . . -99.4 106.28 38.32 Favored Pre-proline 0 N--CA 1.499 2.022 0 N-CA-C 114.042 1.127 . . . . 0.25 114.042 -176.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 889' ' ' PRO . . . . . 0.419 ' HD3' ' O ' ' B' ' 887' ' ' THR . 54.4 Cg_endo -89.08 -12.08 3.47 Favored 'Trans proline' 0 CA--C 1.546 1.094 0 N-CA-C 108.981 -1.199 . . . . 1.6399999999999999 108.981 176.094 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 890' ' ' LEU . . . . . 0.631 HD11 ' CD1' ' B' ' 985' ' ' LEU . 4.9 tt -35.2 -51.21 0.56 Allowed 'General case' 0 N--CA 1.507 2.414 0 N-CA-C 113.903 1.075 . . . . 2.29 113.903 -177.457 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 51.7 95.04 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.347 0 O-C-N 121.192 -0.942 . . . . 0.63 110.193 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . 156.02 -147.36 15.91 Favored Glycine 0 N--CA 1.479 1.548 0 N-CA-C 107.335 -2.306 . . . . 0.040000000000000001 107.335 -178.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 72.5 ttt-85 -108.97 127.94 54.51 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 107.845 -1.168 . . . . 3.0 107.845 177.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 894' ' ' TYR . . . . . 0.456 ' CD1' ' N ' ' B' ' 895' ' ' LEU . 0.2 OUTLIER -130.86 144.63 51.6 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.023 -1.048 . . . . 0.040000000000000001 110.082 -179.258 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 895' ' ' LEU . . . . . 0.456 ' N ' ' CD1' ' B' ' 894' ' ' TYR . 34.4 tp -99.69 115.03 28.52 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.523 -0.736 . . . . 1.27 109.825 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 896' ' ' LEU . . . . . 0.621 HD23 ' N ' ' B' ' 897' ' ' SER . 9.9 tt -111.93 145.63 39.23 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.576 -0.703 . . . . 0.93999999999999995 110.537 -179.445 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 897' ' ' SER . . . . . 0.621 ' N ' HD23 ' B' ' 896' ' ' LEU . 71.2 m -144.52 118.86 9.58 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.389 -0.819 . . . . 0.040000000000000001 110.812 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.71 147.66 30.45 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.733 -0.604 . . . . 0.47999999999999998 109.489 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 899' ' ' VAL . . . . . 0.709 HG21 ' HB ' ' B' ' 980' ' ' ILE . 88.3 t -91.89 120.92 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.469 -0.769 . . . . 0.55000000000000004 111.006 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 900' ' ' LEU . . . . . 0.591 HD12 ' HB2' ' B' ' 924' ' ' SER . 4.4 mm? -94.85 111.3 23.1 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 114.498 1.296 . . . . 1.5900000000000001 114.498 -174.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 17.1 m -67.45 141.47 56.98 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 107.277 -1.379 . . . . 0.050000000000000003 107.277 176.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -68.02 -65.05 2.84 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 110.724 -0.951 . . . . 0.029999999999999999 110.724 -179.14 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 5.9 m170 46.81 66.43 0.99 Allowed 'General case' 0 N--CA 1.508 2.454 0 O-C-N 121.454 -1.027 . . . . 3.2000000000000002 111.093 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 54.0 ptt85 -69.33 -6.19 28.08 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.645 -0.66 . . . . 2.9199999999999999 112.106 -179.15 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 905' ' ' HIS . . . . . 0.484 ' O ' ' CB ' ' B' ' 906' ' ' GLU . 73.8 t60 -62.03 4.53 0.12 Allowed 'General case' 0 N--CA 1.506 2.352 0 O-C-N 120.906 -1.122 . . . . 2.8700000000000001 113.131 -179.209 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 906' ' ' GLU . . . . . 0.484 ' CB ' ' O ' ' B' ' 905' ' ' HIS . 0.7 OUTLIER 95.25 -165.11 0.0 OUTLIER 'General case' 0 N--CA 1.529 3.478 0 CA-C-N 120.605 1.548 . . . . 0.98999999999999999 111.914 179.089 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 907' ' ' LYS . . . . . 0.465 ' CB ' ' O ' ' B' ' 906' ' ' GLU . 61.9 tttt 86.3 156.4 0.08 Allowed 'General case' 0 N--CA 1.519 3.01 0 N-CA-C 107.982 -1.118 . . . . 5.25 107.982 -176.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 60.9 t -121.86 117.21 51.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 120.757 -1.214 . . . . 0.39000000000000001 111.351 -179.188 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 54.2 tp10 -101.26 133.43 45.84 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 107.295 -1.372 . . . . 1.72 107.295 176.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -156.05 123.32 5.41 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 106.759 -1.571 . . . . 0.67000000000000004 106.759 178.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 911' ' ' VAL . . . . . 0.757 HG22 HG13 ' B' ' 964' ' ' VAL . 92.5 t -84.65 132.23 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.89 -0.506 . . . . 0.54000000000000004 110.972 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 60.2 mt -67.06 157.78 32.69 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.417 -0.802 . . . . 1.5 109.303 178.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 913' ' ' SER . . . . . 0.478 ' OG ' HG11 ' B' ' 919' ' ' VAL . 1.4 p -125.11 136.78 53.98 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.105 -1.072 . . . . 1.3700000000000001 108.105 176.664 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 914' ' ' ARG . . . . . 0.609 ' NH1' HD23 ' B' ' 956' ' ' LEU . 0.1 OUTLIER -64.53 155.21 33.66 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 120.628 -1.295 . . . . 4.2999999999999998 111.428 -179.034 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 915' ' ' SER . . . . . 0.416 ' CB ' ' O ' ' B' ' 914' ' ' ARG . 1.7 p 83.53 -31.93 0.08 Allowed 'General case' 0 N--CA 1.521 3.119 0 C-N-CA 123.915 0.886 . . . . 2.0499999999999998 112.077 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 916' ' ' ASN . . . . . 0.757 ' HB2' HG21 ' B' ' 919' ' ' VAL . 99.4 m-20 -122.34 -22.19 5.6 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.895 -1.128 . . . . 2.71 111.2 -179.335 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 917' ' ' GLN . . . . . 0.402 ' HB2' ' O ' ' B' ' 916' ' ' ASN . 43.8 mt-30 67.08 165.98 0.22 Allowed 'General case' 0 N--CA 1.519 3.021 0 N-CA-C 105.762 -1.94 . . . . 2.6800000000000002 105.762 -174.225 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.99 -125.29 35.19 Favored Glycine 1 N--CA 1.521 4.322 0 CA-C-N 123.492 2.86 . . . . 0.029999999999999999 106.905 -177.679 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 919' ' ' VAL . . . . . 0.757 HG21 ' HB2' ' B' ' 916' ' ' ASN . 91.5 t 52.24 95.1 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 O-C-N 121.393 -1.063 . . . . 1.3899999999999999 109.119 -178.067 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 920' ' ' ALA . . . . . 0.88 ' HB3' HG12 ' B' ' 949' ' ' VAL . . . -91.06 90.95 8.07 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.249 -0.981 . . . . 0.029999999999999999 110.723 -179.176 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 921' ' ' ARG . . . . . 0.776 ' HG3' HG23 ' B' ' 922' ' ' VAL . 27.6 ptt85 -84.96 -42.18 15.19 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 106.02 -1.844 . . . . 4.4199999999999999 106.02 176.355 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 922' ' ' VAL . . . . . 0.776 HG23 ' HG3' ' B' ' 921' ' ' ARG . 75.0 t -101.9 74.02 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 105.833 -1.914 . . . . 0.84999999999999998 105.833 175.532 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -85.55 135.01 33.99 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.74 0.781 . . . . 2.46 111.553 -177.318 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 924' ' ' SER . . . . . 0.591 ' HB2' HD12 ' B' ' 900' ' ' LEU . 6.8 t -147.12 105.51 3.78 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 108.77 -0.826 . . . . 0.69999999999999996 108.77 179.392 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -103.2 83.42 0.43 Allowed Glycine 0 N--CA 1.487 2.052 0 N-CA-C 108.307 -1.917 . . . . 0.040000000000000001 108.307 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.223 0 N-CA-C 108.865 -1.694 . . . . 0.040000000000000001 108.865 -179.6 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 25.3 m . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.042 0.449 . . . . 13.779999999999999 110.296 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 95.8 mt -111.64 129.96 55.92 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.508 -0.745 . . . . 13.76 110.389 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -151.67 168.33 31.06 Favored Glycine 0 N--CA 1.493 2.5 0 N-CA-C 109.243 -1.543 . . . . 9.1300000000000008 109.243 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 949' ' ' VAL . . . . . 0.88 HG12 ' HB3' ' B' ' 920' ' ' ALA . 31.6 m -118.09 130.17 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.515 -0.991 . . . . 7.0800000000000001 110.666 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 950' ' ' PHE . . . . . 0.459 ' CZ ' ' HB3' ' B' ' 921' ' ' ARG . 49.0 p90 -135.16 152.51 51.67 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.582 -0.699 . . . . 7.5899999999999999 109.466 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 23.3 m -118.52 -54.09 2.29 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.424 -0.797 . . . . 5.0300000000000002 111.922 -178.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 952' ' ' LEU . . . . . 0.434 ' O ' ' O ' ' B' ' 953' ' ' ILE . 12.5 tp -62.3 -74.43 0.09 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.352 -0.842 . . . . 1.01 112.056 -177.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 953' ' ' ILE . . . . . 0.636 HD12 ' HD3' ' B' ' 955' ' ' PRO . 1.4 pp -51.48 -149.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.782 0 N-CA-C 114.22 1.193 . . . . 2.6000000000000001 114.22 -176.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 954' ' ' LEU . . . . . 0.751 HD22 ' O ' ' B' ' 954' ' ' LEU . 0.0 OUTLIER 166.07 90.59 0.02 OUTLIER Pre-proline 0 N--CA 1.518 2.944 0 O-C-N 121.107 -0.996 . . . . 0.050000000000000003 111.67 179.156 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 955' ' ' PRO . . . . . 0.743 ' C ' HD12 ' B' ' 956' ' ' LEU . 51.6 Cg_endo -78.96 98.48 1.19 Allowed 'Trans proline' 0 C--N 1.315 -1.205 0 N-CA-C 109.014 -1.187 . . . . 0.83999999999999997 109.014 178.209 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 956' ' ' LEU . . . . . 0.743 HD12 ' C ' ' B' ' 955' ' ' PRO . 11.1 mp -121.47 141.97 50.5 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.973 -1.079 . . . . 0.040000000000000001 109.943 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -84.46 151.11 24.83 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 117.844 -1.074 . . . . 1.28 111.777 -178.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -68.6 118.66 11.91 Favored 'General case' 0 N--CA 1.508 2.466 0 CA-C-N 122.96 2.618 . . . . 0.17000000000000001 111.368 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 93.2 -21.48 40.03 Favored Glycine 0 N--CA 1.5 2.925 0 N-CA-C 111.056 -0.817 . . . . 0.040000000000000001 111.056 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 960' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -56.31 170.55 0.34 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.488 -1.007 . . . . 0.040000000000000001 110.149 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 961' ' ' THR . . . . . 0.63 HG21 HG13 ' B' ' 885' ' ' VAL . 42.1 m -135.96 137.81 41.68 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.945 -1.097 . . . . 1.78 112.291 -178.062 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 962' ' ' VAL . . . . . 0.883 HG22 ' HB3' ' B' ' 886' ' ' PHE . 33.7 m -98.29 145.19 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.712 -0.618 . . . . 0.040000000000000001 110.404 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 5.2 t -137.1 145.13 43.54 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.885 -0.509 . . . . 0.71999999999999997 110.084 -178.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 964' ' ' VAL . . . . . 0.757 HG13 HG22 ' B' ' 911' ' ' VAL . 61.1 t -93.4 136.39 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.133 -0.98 . . . . 1.05 110.499 -179.266 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -93.68 127.05 39.19 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 103.651 -2.722 . . . . 3.02 103.651 173.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 966' ' ' LEU . . . . . 0.556 HD23 ' O ' ' B' ' 966' ' ' LEU . 4.1 tt -132.14 61.24 1.66 Allowed 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.288 -1.004 . . . . 1.46 108.288 177.343 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 967' ' ' VAL . . . . . 0.486 HG23 ' C ' ' B' ' 966' ' ' LEU . 97.9 t -158.0 96.53 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 108.143 -1.058 . . . . 1.9399999999999999 108.143 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 88.1 mmm -143.39 58.85 1.39 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.733 -1.229 . . . . 0.0 108.375 178.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.24 119.51 1.93 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 107.222 -2.351 . . . . 2.1099999999999999 107.222 -178.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -81.9 -58.31 3.04 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.036 -1.273 . . . . 5.8899999999999997 110.415 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 46.9 tp -58.99 90.62 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.437 -0.789 . . . . 4.3600000000000003 110.249 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -141.78 -154.33 0.51 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.536 -0.728 . . . . 1.8300000000000001 110.24 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -119.51 170.89 8.76 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.498 -0.751 . . . . 4.3499999999999996 110.276 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 9.5 t -101.76 130.44 48.17 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.528 -0.733 . . . . 1.27 110.086 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -155.91 158.81 38.59 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.49 -0.756 . . . . 5.0199999999999996 110.443 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.47 85.67 17.49 Favored Pre-proline 0 N--CA 1.501 2.077 0 O-C-N 121.588 -0.695 . . . . 2.4100000000000001 109.906 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 977' ' ' PRO . . . . . 0.485 ' C ' HD12 ' B' ' 978' ' ' LEU . 47.7 Cg_endo -73.63 -172.73 1.14 Allowed 'Trans proline' 0 C--N 1.317 -1.13 0 O-C-N 123.326 1.172 . . . . 0.95999999999999996 111.248 -179.511 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 978' ' ' LEU . . . . . 0.502 HD23 ' CD1' ' B' ' 856' ' ' LEU . 5.4 mp -127.34 155.55 43.4 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 107.762 -1.199 . . . . 0.62 107.762 178.013 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 979' ' ' THR . . . . . 0.458 HG23 ' C ' ' B' ' 978' ' ' LEU . 37.0 p -150.32 141.12 22.76 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.811 -1.181 . . . . 3.5699999999999998 111.157 -179.38 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 980' ' ' ILE . . . . . 0.709 ' HB ' HG21 ' B' ' 899' ' ' VAL . 51.4 mm -107.44 128.59 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 109.135 -0.691 . . . . 1.3300000000000001 109.135 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 981' ' ' PHE . . . . . 0.4 ' HD1' ' HH ' ' B' ' 879' ' ' TYR . 4.4 t80 -119.2 99.29 6.62 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.461 -0.774 . . . . 0.050000000000000003 111.802 -178.343 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 43.2 p -106.79 158.24 17.14 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.834 -0.802 . . . . 0.87 108.834 178.35 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 983' ' ' GLY . . . . . . . . . . . . . . . -172.77 110.16 0.33 Allowed Glycine 0 N--CA 1.499 2.87 0 N-CA-C 106.685 -2.566 . . . . 0.029999999999999999 106.685 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 984' ' ' ALA . . . . . 0.469 ' HB1' ' NE ' ' C' ' 893' ' ' ARG . . . -110.75 149.61 30.27 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 114.539 1.311 . . . . 0.69999999999999996 114.539 -175.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 985' ' ' LEU . . . . . 0.631 ' CD1' HD11 ' B' ' 890' ' ' LEU . 54.2 tp -70.71 133.84 46.95 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.874 -1.142 . . . . 0.040000000000000001 109.808 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 986' ' ' LEU . . . . . . . . . . . . . 50.6 tp -107.39 -59.01 1.88 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.547 -0.721 . . . . 0.040000000000000001 110.009 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -144.46 144.87 31.59 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.592 -1.262 . . . . 0.040000000000000001 107.592 179.065 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.84 162.95 12.2 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 108.117 -1.993 . . . . 0.040000000000000001 108.117 179.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -75.15 112.59 19.02 Favored Pre-proline 0 N--CA 1.498 1.938 0 O-C-N 121.226 -1.161 . . . . 0.040000000000000001 109.439 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 990' ' ' PRO . . . . . 0.438 ' HD2' HD12 ' B' ' 992' ' ' LEU . 49.9 Cg_endo -90.05 71.27 1.6 Allowed 'Trans proline' 0 C--N 1.319 -0.976 0 O-C-N 123.119 1.062 . . . . 0.45000000000000001 111.339 -178.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 991' ' ' GLU . . . . . 0.419 ' HB2' ' O ' ' B' ' 990' ' ' PRO . 70.0 mt-10 67.29 -73.93 0.07 Allowed 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 108.463 -0.94 . . . . 1.97 108.463 -177.469 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 992' ' ' LEU . . . . . 0.451 ' HA ' HD23 ' B' ' 992' ' ' LEU . 10.4 mt 51.11 20.4 0.85 Allowed 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.587 -0.696 . . . . 2.3799999999999999 111.679 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -93.94 156.95 16.35 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.914 -1.116 . . . . 3.79 109.974 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 71.9 m80 -146.33 92.8 2.22 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.561 -0.712 . . . . 3.5099999999999998 110.382 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 995' ' ' ALA . . . . . . . . . . . . 2.518 . . . . . . . 0 N--CA 1.503 2.223 0 O-C-N 120.924 -1.11 . . . . 2.73 110.581 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo . . . . . 0 N--CA 1.487 1.142 0 N-CA-C 109.526 -0.99 . . . . 3.8300000000000001 109.526 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 847' ' ' VAL . . . . . 0.5 HG12 ' HB2' ' C' ' 849' ' ' GLN . 59.5 t -126.81 106.2 22.84 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 121.68 -0.638 . . . . 1.8300000000000001 109.989 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 848' ' ' PRO . . . . . 0.893 ' O ' HG23 ' C' ' 850' ' ' VAL . 43.9 Cg_endo -69.52 -22.17 33.57 Favored 'Trans proline' 0 N--CA 1.488 1.152 0 O-C-N 123.238 1.125 . . . . 0.65000000000000002 111.09 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 849' ' ' GLN . . . . . 0.5 ' HB2' HG12 ' C' ' 847' ' ' VAL . 54.6 tt0 24.93 64.6 0.05 Allowed 'General case' 0 N--CA 1.518 2.945 0 N-CA-C 113.605 0.965 . . . . 2.5800000000000001 113.605 179.026 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 850' ' ' VAL . . . . . 0.893 HG23 ' O ' ' C' ' 848' ' ' PRO . 78.9 t -120.23 134.91 62.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.105 -0.997 . . . . 1.0900000000000001 110.948 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 851' ' ' ALA . . . . . 0.526 ' HB3' ' HG ' ' C' ' 873' ' ' LEU . . . -127.78 155.28 44.29 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 105.745 -1.946 . . . . 0.040000000000000001 105.745 176.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 852' ' ' PHE . . . . . 0.448 ' HA ' ' CB ' ' C' ' 874' ' ' ASN . 13.5 p90 -161.56 126.96 3.6 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 121.011 1.732 . . . . 0.050000000000000003 108.683 179.017 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 24.2 t -177.06 135.32 0.2 Allowed 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.039 -1.096 . . . . 0.040000000000000001 108.039 -179.014 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 854' ' ' ALA . . . . . 0.436 ' HB1' ' HD2' ' C' ' 868' ' ' PHE . . . -132.5 158.32 42.39 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.042 -1.036 . . . . 0.67000000000000004 109.96 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 855' ' ' ALA . . . . . 0.732 ' HB2' HD11 ' C' ' 872' ' ' LEU . . . -122.27 139.75 53.43 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.773 0.797 . . . . 0.51000000000000001 111.051 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 856' ' ' LEU . . . . . 1.075 HD11 HD23 ' C' ' 858' ' ' LEU . 3.5 tm? -112.61 139.41 48.23 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.692 -0.63 . . . . 0.050000000000000003 110.252 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 857' ' ' SER . . . . . 0.599 ' N ' HD13 ' C' ' 856' ' ' LEU . 1.4 m -155.96 19.92 0.38 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.585 -0.697 . . . . 1.3300000000000001 111.07 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 858' ' ' LEU . . . . . 1.075 HD23 HD11 ' C' ' 856' ' ' LEU . 2.3 pp -34.83 161.44 0.04 OUTLIER Pre-proline 0 N--CA 1.517 2.898 0 N-CA-C 113.171 0.804 . . . . 2.3300000000000001 113.171 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -61.68 -87.72 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 120.894 1.062 . . . . 2.3199999999999998 113.495 -178.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 55.3 ptt85 -130.6 -143.26 0.24 Allowed 'General case' 0 N--CA 1.501 2.122 0 O-C-N 120.811 -1.18 . . . . 0.040000000000000001 111.923 -177.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 14.6 m -37.54 129.17 1.07 Allowed 'General case' 0 N--CA 1.51 2.548 0 O-C-N 121.592 -0.693 . . . . 1.3100000000000001 112.537 -178.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.41 160.51 25.8 Favored Pre-proline 0 N--CA 1.489 1.523 0 N-CA-C 108.263 -1.014 . . . . 4.5099999999999998 108.263 177.235 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -71.62 -13.82 30.08 Favored 'Trans proline' 0 C--N 1.314 -1.282 0 O-C-N 123.184 1.097 . . . . 2.2400000000000002 111.507 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -177.33 -136.18 2.39 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.658 -1.377 . . . . 0.040000000000000001 109.658 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 22.8 m -68.2 154.5 41.59 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.388 -1.066 . . . . 1.51 110.249 -179.247 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 866' ' ' VAL . . . . . 0.441 ' HA ' ' HD3' ' C' ' 867' ' ' PRO . 46.0 t -98.68 139.19 20.93 Favored Pre-proline 0 N--CA 1.496 1.845 0 N-CA-C 113.366 0.876 . . . . 0.78000000000000003 113.366 -174.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 867' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' C' ' 866' ' ' VAL . 55.4 Cg_endo -91.35 -147.64 0.03 OUTLIER 'Trans proline' 0 CA--C 1.545 1.065 0 O-C-N 123.583 1.307 . . . . 0.92000000000000004 108.847 177.662 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 868' ' ' PHE . . . . . 0.49 ' CD1' ' HG2' ' C' ' 881' ' ' PRO . 23.7 p90 -150.01 125.56 10.28 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.584 -1.323 . . . . 0.050000000000000003 110.101 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 42.4 p-10 -112.64 -3.08 14.37 Favored 'General case' 0 N--CA 1.499 2.001 0 C-N-CA 119.281 -0.967 . . . . 1.7 112.467 -178.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 870' ' ' ARG . . . . . 0.65 ' HB2' ' HB3' ' C' ' 855' ' ' ALA . 23.8 mmm180 -91.72 89.11 6.96 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.905 -1.122 . . . . 2.5899999999999999 110.991 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 57.9 t -70.71 97.47 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.039 -1.038 . . . . 1.9399999999999999 109.951 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 872' ' ' LEU . . . . . 0.732 HD11 ' HB2' ' C' ' 855' ' ' ALA . 82.8 mt -83.44 -47.39 11.45 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.485 -0.759 . . . . 1.0600000000000001 110.272 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 873' ' ' LEU . . . . . 0.526 ' HG ' ' HB3' ' C' ' 851' ' ' ALA . 42.7 tp -174.45 103.53 0.1 Allowed 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.507 -0.923 . . . . 4.1799999999999997 108.507 178.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 874' ' ' ASN . . . . . 0.448 ' CB ' ' HA ' ' C' ' 852' ' ' PHE . 35.9 t-20 178.55 82.22 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.612 -0.68 . . . . 0.040000000000000001 109.45 -178.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 22.9 p-10 -67.11 -46.24 74.76 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 119.245 -0.982 . . . . 3.3799999999999999 111.279 -179.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 876' ' ' GLY . . . . . 0.405 ' HA3' ' CE2' ' C' ' 878' ' ' TYR . . . -74.55 -26.09 68.53 Favored Glycine 0 N--CA 1.494 2.551 0 O-C-N 121.28 -0.888 . . . . 0.040000000000000001 111.614 -178.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 82.54 -61.06 4.79 Favored Glycine 0 N--CA 1.502 3.072 0 N-CA-C 108.118 -1.993 . . . . 0.040000000000000001 108.118 -178.25 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 878' ' ' TYR . . . . . 0.405 ' CE2' ' HA3' ' C' ' 876' ' ' GLY . 97.7 m-85 60.95 -65.39 0.06 Allowed 'General case' 0 N--CA 1.502 2.161 0 N-CA-C 114.384 1.253 . . . . 3.46 114.384 177.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 879' ' ' TYR . . . . . 0.473 ' CB ' ' CG ' ' C' ' 886' ' ' PHE . 22.8 p90 -112.58 109.38 18.9 Favored 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 114.823 1.416 . . . . 0.040000000000000001 114.823 -176.291 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.63 117.82 51.27 Favored Pre-proline 0 N--CA 1.497 1.894 0 O-C-N 121.377 -0.827 . . . . 0.02 109.89 179.649 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 881' ' ' PRO . . . . . 0.49 ' HG2' ' CD1' ' C' ' 868' ' ' PHE . 55.2 Cg_endo -77.03 0.45 9.69 Favored 'Trans proline' 0 N--CA 1.494 1.551 0 O-C-N 123.435 1.229 . . . . 0.39000000000000001 112.116 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -73.84 -64.33 1.03 Allowed 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 106.459 -1.682 . . . . 0.81000000000000005 106.459 178.234 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 9.2 p -94.82 -18.16 21.45 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.502 -0.925 . . . . 0.040000000000000001 108.502 177.204 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.56 21.16 57.0 Favored Glycine 0 N--CA 1.493 2.499 0 O-C-N 121.167 -0.958 . . . . 0.029999999999999999 111.046 178.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 96.8 t -72.33 89.89 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 C-N-CA 118.256 -1.377 . . . . 1.01 108.25 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 886' ' ' PHE . . . . . 0.811 ' CB ' HG22 ' C' ' 962' ' ' VAL . 0.7 OUTLIER -90.48 104.0 16.63 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 115.199 -0.909 . . . . 0.050000000000000003 112.038 -177.468 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 887' ' ' THR . . . . . 0.423 ' O ' ' HD3' ' C' ' 889' ' ' PRO . 91.2 m -96.48 101.46 13.09 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 107.888 -1.153 . . . . 0.68000000000000005 107.888 177.416 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 888' ' ' ALA . . . . . . . . . . . . . . . -99.87 102.59 17.88 Favored Pre-proline 0 N--CA 1.502 2.152 0 N-CA-C 114.297 1.221 . . . . 0.25 114.297 -176.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 889' ' ' PRO . . . . . 0.423 ' HD3' ' O ' ' C' ' 887' ' ' THR . 55.6 Cg_endo -83.04 -13.11 9.26 Favored 'Trans proline' 0 CA--C 1.545 1.07 0 N-CA-C 109.01 -1.188 . . . . 1.6399999999999999 109.01 175.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 890' ' ' LEU . . . . . 1.055 HD22 HD13 ' C' ' 985' ' ' LEU . 71.7 mt -37.37 -49.87 1.01 Allowed 'General case' 0 N--CA 1.507 2.422 0 N-CA-C 113.679 0.992 . . . . 2.29 113.679 -177.421 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 52.63 96.73 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.358 0 O-C-N 121.117 -0.989 . . . . 0.63 110.211 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . 156.26 -147.64 16.51 Favored Glycine 0 N--CA 1.479 1.514 0 N-CA-C 107.252 -2.339 . . . . 0.040000000000000001 107.252 -179.141 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 893' ' ' ARG . . . . . 0.469 ' NE ' ' HB1' ' B' ' 984' ' ' ALA . 74.2 ttt-85 -107.8 129.0 55.09 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 107.934 -1.136 . . . . 3.0 107.934 177.466 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 894' ' ' TYR . . . . . 0.449 ' CD1' ' N ' ' C' ' 895' ' ' LEU . 0.1 OUTLIER -131.16 144.05 51.07 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.058 -1.026 . . . . 0.040000000000000001 110.151 -179.246 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 895' ' ' LEU . . . . . 0.449 ' N ' ' CD1' ' C' ' 894' ' ' TYR . 37.4 tp -97.83 112.85 24.6 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.735 -0.603 . . . . 1.27 109.531 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 896' ' ' LEU . . . . . 0.53 HD23 ' N ' ' C' ' 897' ' ' SER . 10.3 tt -110.27 143.78 39.95 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.583 -0.698 . . . . 0.93999999999999995 110.448 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 897' ' ' SER . . . . . 0.53 ' N ' HD23 ' C' ' 896' ' ' LEU . 5.2 m -145.23 119.26 9.39 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.471 -0.768 . . . . 0.040000000000000001 111.062 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.87 146.62 32.06 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.965 -0.754 . . . . 0.47999999999999998 108.965 178.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 899' ' ' VAL . . . . . 0.729 HG21 ' HB ' ' C' ' 980' ' ' ILE . 89.6 t -92.1 119.94 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.414 -0.803 . . . . 0.55000000000000004 111.054 -179.28 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 90.9 mt -92.98 111.21 22.75 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 114.096 1.146 . . . . 1.5900000000000001 114.096 -175.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 22.2 m -64.53 139.68 58.79 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 107.331 -1.359 . . . . 0.050000000000000003 107.331 177.253 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -61.54 -65.02 3.5 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 110.32 -1.112 . . . . 0.029999999999999999 110.32 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 45.48 64.74 1.32 Allowed 'General case' 0 N--CA 1.508 2.45 0 O-C-N 121.485 -1.009 . . . . 3.2000000000000002 111.298 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 42.4 ptt85 -67.82 -7.14 25.32 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.585 -0.697 . . . . 2.9199999999999999 111.988 -179.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 905' ' ' HIS . . . . . 0.485 ' O ' ' CB ' ' C' ' 906' ' ' GLU . 72.0 t60 -60.37 5.27 0.05 OUTLIER 'General case' 0 N--CA 1.507 2.381 0 O-C-N 120.9 -1.125 . . . . 2.8700000000000001 113.714 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 906' ' ' GLU . . . . . 0.485 ' CB ' ' O ' ' C' ' 905' ' ' HIS . 0.6 OUTLIER 92.11 -164.08 0.01 OUTLIER 'General case' 0 N--CA 1.527 3.38 0 CA-C-N 121.259 1.845 . . . . 0.98999999999999999 112.254 179.053 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 907' ' ' LYS . . . . . 0.485 ' CB ' ' O ' ' C' ' 906' ' ' GLU . 73.5 tttt 89.43 162.03 0.05 Allowed 'General case' 0 N--CA 1.52 3.069 0 N-CA-C 108.146 -1.057 . . . . 5.25 108.146 -177.108 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 59.0 t -122.31 115.28 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 120.934 -1.104 . . . . 0.39000000000000001 110.883 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 53.0 tp10 -104.07 131.3 51.48 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 107.549 -1.278 . . . . 1.72 107.549 177.115 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -155.68 120.86 4.83 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 106.882 -1.525 . . . . 0.67000000000000004 106.882 178.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 911' ' ' VAL . . . . . 0.908 HG23 HG22 ' C' ' 964' ' ' VAL . 11.0 p -77.82 131.14 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.879 -0.513 . . . . 0.54000000000000004 111.222 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 73.0 mt -67.52 158.29 32.3 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.218 -0.926 . . . . 1.5 108.88 178.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 913' ' ' SER . . . . . 0.468 ' OG ' HG11 ' C' ' 919' ' ' VAL . 1.4 p -128.33 135.73 49.99 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.468 -0.938 . . . . 1.3700000000000001 108.468 176.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 914' ' ' ARG . . . . . 0.588 HH11 HG13 ' C' ' 962' ' ' VAL . 0.0 OUTLIER -63.29 154.28 32.15 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 120.585 -1.322 . . . . 4.2999999999999998 111.287 -179.223 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 915' ' ' SER . . . . . 0.424 ' CB ' ' O ' ' C' ' 914' ' ' ARG . 0.2 OUTLIER 83.24 -30.45 0.09 Allowed 'General case' 0 N--CA 1.521 3.104 0 C-N-CA 123.724 0.81 . . . . 2.0499999999999998 112.079 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 916' ' ' ASN . . . . . 0.779 ' HB2' HG21 ' C' ' 919' ' ' VAL . 93.1 m-20 -123.48 -22.72 4.96 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 120.83 -1.169 . . . . 2.71 111.103 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 67.32 166.25 0.23 Allowed 'General case' 0 N--CA 1.519 3.011 0 N-CA-C 105.745 -1.946 . . . . 2.6800000000000002 105.745 -174.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.9 -125.37 35.19 Favored Glycine 1 N--CA 1.522 4.368 0 CA-C-N 123.619 2.918 . . . . 0.029999999999999999 107.069 -177.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 919' ' ' VAL . . . . . 0.779 HG21 ' HB2' ' C' ' 916' ' ' ASN . 93.0 t 50.75 93.86 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.229 0 O-C-N 121.401 -1.058 . . . . 1.3899999999999999 109.433 -178.428 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 920' ' ' ALA . . . . . 0.713 ' HB3' HG12 ' C' ' 949' ' ' VAL . . . -96.1 94.96 7.85 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 119.478 -0.889 . . . . 0.029999999999999999 110.953 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 921' ' ' ARG . . . . . 0.817 ' HG3' HG23 ' C' ' 922' ' ' VAL . 45.0 ptt85 -83.83 -41.54 17.4 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 105.626 -1.991 . . . . 4.4199999999999999 105.626 175.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 922' ' ' VAL . . . . . 0.817 HG23 ' HG3' ' C' ' 921' ' ' ARG . 57.6 t -97.11 74.36 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 105.393 -2.077 . . . . 0.84999999999999998 105.393 174.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -90.04 135.79 33.44 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.93 0.871 . . . . 2.46 112.41 -176.576 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 6.7 t -146.5 102.85 3.62 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.853 -1.166 . . . . 0.69999999999999996 107.853 178.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -111.03 91.86 0.63 Allowed Glycine 0 N--CA 1.488 2.119 0 N-CA-C 108.908 -1.677 . . . . 0.040000000000000001 108.908 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.342 0 N-CA-C 109.372 -1.491 . . . . 0.040000000000000001 109.372 -179.75 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 25.6 m . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 120.982 0.42 . . . . 13.779999999999999 110.366 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 94.4 mt -114.15 131.62 56.37 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.441 -0.787 . . . . 13.76 110.393 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -151.67 170.71 31.17 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.252 -1.539 . . . . 9.1300000000000008 109.252 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 949' ' ' VAL . . . . . 0.713 HG12 ' HB3' ' C' ' 920' ' ' ALA . 34.8 m -118.43 133.34 65.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.571 -0.958 . . . . 7.0800000000000001 111.252 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 950' ' ' PHE . . . . . 0.463 ' CZ ' ' HB3' ' C' ' 921' ' ' ARG . 20.3 p90 -131.88 147.36 52.47 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.969 -0.752 . . . . 7.5899999999999999 108.969 178.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 13.2 m -122.09 -52.82 1.96 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.281 -0.887 . . . . 5.0300000000000002 112.277 -178.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 952' ' ' LEU . . . . . 0.406 ' O ' ' O ' ' C' ' 953' ' ' ILE . 45.2 tp -60.07 -77.84 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.421 -0.8 . . . . 1.01 112.421 -177.394 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 953' ' ' ILE . . . . . 0.513 HD11 ' HB3' ' B' ' 872' ' ' LEU . 44.1 pt -54.01 -140.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.734 0 N-CA-C 113.851 1.056 . . . . 2.6000000000000001 113.851 -176.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 954' ' ' LEU . . . . . 0.786 HD22 ' O ' ' C' ' 954' ' ' LEU . 0.0 OUTLIER 176.27 76.58 0.09 OUTLIER Pre-proline 0 N--CA 1.507 2.38 0 O-C-N 120.663 -1.273 . . . . 0.050000000000000003 111.192 179.725 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 955' ' ' PRO . . . . . 0.688 ' C ' HD12 ' C' ' 956' ' ' LEU . 44.6 Cg_endo -71.51 86.2 0.85 Allowed 'Trans proline' 0 C--N 1.312 -1.364 0 N-CA-C 109.349 -1.058 . . . . 0.83999999999999997 109.349 178.668 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 956' ' ' LEU . . . . . 0.688 HD12 ' C ' ' C' ' 955' ' ' PRO . 7.5 mp -126.06 153.09 44.95 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.293 -0.88 . . . . 0.040000000000000001 110.64 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -81.49 151.01 28.01 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-O 117.737 -1.125 . . . . 1.28 111.574 -179.037 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -68.88 119.21 12.86 Favored 'General case' 0 N--CA 1.51 2.549 0 CA-C-N 123.083 2.674 . . . . 0.17000000000000001 111.223 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 91.8 -22.65 30.04 Favored Glycine 0 N--CA 1.501 3.019 0 N-CA-C 110.789 -0.924 . . . . 0.040000000000000001 110.789 178.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 960' ' ' ASP . . . . . 0.407 ' HB3' ' CZ ' ' C' ' 914' ' ' ARG . 0.1 OUTLIER -51.82 172.45 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.519 -0.989 . . . . 0.040000000000000001 110.332 -179.49 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 961' ' ' THR . . . . . 0.494 ' HA ' ' O ' ' C' ' 886' ' ' PHE . 53.5 p -133.18 138.81 46.72 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.087 -1.008 . . . . 1.78 112.307 -177.694 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 962' ' ' VAL . . . . . 0.811 HG22 ' CB ' ' C' ' 886' ' ' PHE . 18.5 m -96.19 144.9 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 C-N-CA 120.208 -0.597 . . . . 0.040000000000000001 109.696 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 6.6 t -137.81 145.64 42.57 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.823 -0.548 . . . . 0.71999999999999997 110.213 -178.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 964' ' ' VAL . . . . . 0.908 HG22 HG23 ' C' ' 911' ' ' VAL . 57.5 t -100.17 135.91 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.067 -1.021 . . . . 1.05 110.899 -179.044 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -96.71 125.62 41.29 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 103.788 -2.671 . . . . 3.02 103.788 173.041 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 966' ' ' LEU . . . . . 0.645 HD23 ' O ' ' C' ' 966' ' ' LEU . 5.1 tt -131.87 62.79 1.63 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.067 -1.086 . . . . 1.46 108.067 177.489 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 967' ' ' VAL . . . . . 0.491 HG23 ' C ' ' C' ' 966' ' ' LEU . 97.6 t -157.79 96.77 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.065 -1.087 . . . . 1.9399999999999999 108.065 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 94.4 mmm -142.26 58.62 1.46 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.769 -1.207 . . . . 0.0 108.375 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 134.58 119.54 1.96 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 107.222 -2.351 . . . . 2.1099999999999999 107.222 -178.349 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -82.4 -58.12 3.07 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.031 -1.276 . . . . 5.8899999999999997 110.607 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 971' ' ' LEU . . . . . 0.601 HD23 ' O ' ' C' ' 971' ' ' LEU . 9.1 tt -58.94 89.84 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.427 -0.796 . . . . 4.3600000000000003 110.378 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -142.33 -152.59 0.42 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.584 -0.698 . . . . 1.8300000000000001 110.144 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -117.17 167.81 10.85 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.415 -0.803 . . . . 4.3499999999999996 110.045 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 29.3 t -101.54 130.19 47.77 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.547 -0.72 . . . . 1.27 110.152 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -156.22 153.68 29.56 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.526 -0.734 . . . . 5.0199999999999996 110.405 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.27 86.08 17.56 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.604 -0.685 . . . . 2.4100000000000001 109.853 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -75.39 -171.44 1.02 Allowed 'Trans proline' 0 C--N 1.318 -1.065 0 O-C-N 123.326 1.172 . . . . 0.95999999999999996 111.309 -179.386 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 978' ' ' LEU . . . . . 0.582 ' N ' HD12 ' C' ' 978' ' ' LEU . 5.4 mp -123.36 156.68 34.9 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 107.512 -1.292 . . . . 0.62 107.512 177.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 979' ' ' THR . . . . . 0.45 HG23 ' C ' ' C' ' 978' ' ' LEU . 45.0 p -149.72 141.65 23.81 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.777 -1.202 . . . . 3.5699999999999998 111.186 -179.235 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 980' ' ' ILE . . . . . 0.729 ' HB ' HG21 ' C' ' 899' ' ' VAL . 50.6 mm -105.64 128.47 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 N-CA-C 109.174 -0.676 . . . . 1.3300000000000001 109.174 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 981' ' ' PHE . . . . . 0.439 ' CD1' ' CE2' ' C' ' 879' ' ' TYR . 2.1 t80 -118.99 99.36 6.69 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 119.808 -0.757 . . . . 0.050000000000000003 111.486 -178.544 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 982' ' ' SER . . . . . . . . . . . . . 10.6 p -109.93 159.71 17.02 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.578 -0.701 . . . . 0.87 109.194 178.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 983' ' ' GLY . . . . . 0.41 ' O ' ' CE2' ' C' ' 852' ' ' PHE . . . -170.8 111.42 0.41 Allowed Glycine 0 N--CA 1.498 2.818 0 N-CA-C 106.594 -2.602 . . . . 0.029999999999999999 106.594 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 984' ' ' ALA . . . . . 0.44 ' HB1' ' NE ' ' A' ' 893' ' ' ARG . . . -109.01 147.19 32.7 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.199 -1.177 . . . . 0.69999999999999996 114.025 -176.075 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 985' ' ' LEU . . . . . 1.055 HD13 HD22 ' C' ' 890' ' ' LEU . 56.6 tp -72.36 135.72 45.95 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.722 -1.236 . . . . 0.040000000000000001 110.066 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 986' ' ' LEU . . . . . . . . . . . . . 49.1 tp -107.08 -61.58 1.53 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.524 -0.735 . . . . 0.040000000000000001 110.341 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -145.0 146.33 31.87 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.847 -1.168 . . . . 0.040000000000000001 107.847 179.315 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.35 162.79 12.29 Favored Glycine 0 N--CA 1.495 2.593 0 N-CA-C 108.146 -1.981 . . . . 0.040000000000000001 108.146 179.167 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -75.44 112.65 20.05 Favored Pre-proline 0 N--CA 1.498 1.965 0 O-C-N 121.19 -1.183 . . . . 0.040000000000000001 109.485 179.193 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 990' ' ' PRO . . . . . 0.418 ' O ' ' HB2' ' C' ' 991' ' ' GLU . 50.2 Cg_endo -89.82 71.26 1.72 Allowed 'Trans proline' 0 C--N 1.319 -0.985 0 O-C-N 123.132 1.07 . . . . 0.45000000000000001 111.466 -178.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 991' ' ' GLU . . . . . 0.418 ' HB2' ' O ' ' C' ' 990' ' ' PRO . 69.5 mt-10 67.41 -73.31 0.08 Allowed 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 108.662 -0.866 . . . . 1.97 108.662 -177.605 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 992' ' ' LEU . . . . . . . . . . . . . 11.7 mt 50.62 21.06 0.81 Allowed 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.584 -0.697 . . . . 2.3799999999999999 111.645 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 79.7 mt-10 -93.27 156.94 16.51 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.887 -1.133 . . . . 3.79 110.02 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 68.6 m80 -146.62 92.59 2.17 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.525 -0.734 . . . . 3.5099999999999998 110.21 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 995' ' ' ALA . . . . . . . . . . . . 2.518 . . . . . . . 0 N--CA 1.503 2.197 0 O-C-N 120.94 -1.1 . . . . 2.73 110.569 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo . . . . . 0 N--CA 1.488 1.157 0 N-CA-C 109.503 -0.999 . . . . 3.8300000000000001 109.503 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 847' ' ' VAL . . . . . 0.44 HG12 ' HB2' ' A' ' 849' ' ' GLN . 61.3 t -132.16 102.84 14.24 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.584 -0.697 . . . . 1.8300000000000001 110.06 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 848' ' ' PRO . . . . . 0.762 ' O ' HG23 ' A' ' 850' ' ' VAL . 43.5 Cg_endo -69.84 -20.84 33.95 Favored 'Trans proline' 0 N--CA 1.487 1.124 0 O-C-N 123.276 1.145 . . . . 0.65000000000000002 110.973 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 849' ' ' GLN . . . . . 0.44 ' HB2' HG12 ' A' ' 847' ' ' VAL . 56.1 tt0 28.04 68.1 0.07 Allowed 'General case' 0 N--CA 1.518 2.937 0 N-CA-C 112.911 0.708 . . . . 2.5800000000000001 112.911 179.287 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 850' ' ' VAL . . . . . 0.762 HG23 ' O ' ' A' ' 848' ' ' PRO . 72.9 t -119.74 136.13 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.152 -0.968 . . . . 1.0900000000000001 111.413 -178.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 851' ' ' ALA . . . . . 0.482 ' HB3' ' HG ' ' A' ' 873' ' ' LEU . . . -126.62 159.41 33.65 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 106.043 -1.836 . . . . 0.040000000000000001 106.043 177.033 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 852' ' ' PHE . . . . . 0.439 ' HA ' ' CB ' ' A' ' 874' ' ' ASN . 46.7 p90 -157.56 131.79 8.3 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 121.019 1.736 . . . . 0.050000000000000003 108.728 178.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 32.5 t -175.67 133.02 0.28 Allowed 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.076 -1.083 . . . . 0.040000000000000001 108.076 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -133.45 156.08 48.37 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.071 -1.018 . . . . 0.67000000000000004 109.472 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 855' ' ' ALA . . . . . 0.744 ' HB3' ' CB ' ' A' ' 870' ' ' ARG . . . -124.4 140.17 53.21 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.808 0.813 . . . . 0.51000000000000001 111.305 -179.289 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 856' ' ' LEU . . . . . 0.761 HD11 HD23 ' A' ' 858' ' ' LEU . 3.4 tm? -111.96 140.01 46.98 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.607 -0.683 . . . . 0.050000000000000003 110.156 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 857' ' ' SER . . . . . 0.68 ' N ' HD13 ' A' ' 856' ' ' LEU . 37.0 p -157.59 17.05 0.26 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.543 -0.723 . . . . 1.3300000000000001 111.467 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 858' ' ' LEU . . . . . 0.761 HD23 HD11 ' A' ' 856' ' ' LEU . 3.1 pp -35.67 161.57 0.04 OUTLIER Pre-proline 0 N--CA 1.518 2.935 0 N-CA-C 112.851 0.686 . . . . 2.3300000000000001 112.851 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -59.87 -89.17 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.453 0 O-C-N 122.938 0.968 . . . . 2.3199999999999998 113.294 -178.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 55.3 ptt85 -134.9 -141.61 0.18 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.839 -1.163 . . . . 0.040000000000000001 111.646 -177.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 73.8 m -32.89 122.09 0.36 Allowed 'General case' 0 N--CA 1.513 2.694 0 N-CA-C 112.996 0.739 . . . . 1.3100000000000001 112.996 -178.529 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.76 160.13 27.08 Favored Pre-proline 0 N--CA 1.489 1.483 0 N-CA-C 107.93 -1.137 . . . . 4.5099999999999998 107.93 177.199 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.05 -13.86 34.45 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.134 1.07 . . . . 2.2400000000000002 111.479 -179.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -177.3 -135.45 2.22 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.97 -1.252 . . . . 0.040000000000000001 109.97 179.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 37.2 m -67.56 157.34 34.6 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.35 -1.088 . . . . 1.51 110.53 -178.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 866' ' ' VAL . . . . . 0.475 HG13 ' CD2' ' A' ' 858' ' ' LEU . 50.8 t -100.55 139.34 20.54 Favored Pre-proline 0 N--CA 1.495 1.8 0 N-CA-C 113.459 0.911 . . . . 0.78000000000000003 113.459 -174.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 867' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 866' ' ' VAL . 55.6 Cg_endo -91.67 -148.19 0.03 OUTLIER 'Trans proline' 0 CA--C 1.548 1.177 0 O-C-N 123.621 1.327 . . . . 0.92000000000000004 109.481 177.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 868' ' ' PHE . . . . . 0.45 ' CD1' ' CG ' ' A' ' 881' ' ' PRO . 26.3 p90 -150.35 124.22 9.26 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.696 -1.253 . . . . 0.050000000000000003 109.539 179.011 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 50.4 p-10 -113.82 -2.16 13.73 Favored 'General case' 0 N--CA 1.5 2.066 0 C-N-CA 119.265 -0.974 . . . . 1.7 112.852 -178.389 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 870' ' ' ARG . . . . . 0.744 ' CB ' ' HB3' ' A' ' 855' ' ' ALA . 28.7 mmm180 -91.27 90.11 7.6 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.865 -1.147 . . . . 2.5899999999999999 110.999 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 57.4 t -71.81 96.72 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 120.971 -1.081 . . . . 1.9399999999999999 110.047 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 872' ' ' LEU . . . . . 0.538 HD11 ' HB2' ' A' ' 855' ' ' ALA . 96.8 mt -83.06 -47.46 11.65 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.456 -0.778 . . . . 1.0600000000000001 110.04 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 873' ' ' LEU . . . . . 0.482 ' HG ' ' HB3' ' A' ' 851' ' ' ALA . 41.2 tp -175.15 103.19 0.08 Allowed 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 108.381 -0.97 . . . . 4.1799999999999997 108.381 178.582 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 874' ' ' ASN . . . . . 0.439 ' CB ' ' HA ' ' A' ' 852' ' ' PHE . 36.7 t-20 178.29 81.68 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.324 0 O-C-N 121.681 -0.637 . . . . 0.040000000000000001 109.421 -178.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -66.26 -46.77 75.93 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 119.324 -0.95 . . . . 3.3799999999999999 111.22 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 876' ' ' GLY . . . . . 0.4 ' HA3' ' CE2' ' A' ' 878' ' ' TYR . . . -74.87 -24.56 71.74 Favored Glycine 0 N--CA 1.494 2.555 0 O-C-N 121.318 -0.864 . . . . 0.040000000000000001 111.916 -178.686 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 82.11 -62.48 4.54 Favored Glycine 0 N--CA 1.501 3.021 0 N-CA-C 107.896 -2.082 . . . . 0.040000000000000001 107.896 -178.156 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 878' ' ' TYR . . . . . 0.4 ' CE2' ' HA3' ' A' ' 876' ' ' GLY . 93.2 m-85 61.41 -61.99 0.09 Allowed 'General case' 0 N--CA 1.504 2.262 0 N-CA-C 114.596 1.332 . . . . 3.46 114.596 177.565 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 879' ' ' TYR . . . . . 0.467 ' CB ' ' CD2' ' A' ' 886' ' ' PHE . 20.4 p90 -110.58 109.03 19.17 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 114.849 1.425 . . . . 0.040000000000000001 114.849 -176.05 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -67.19 118.21 53.77 Favored Pre-proline 0 N--CA 1.495 1.813 0 O-C-N 121.385 -0.822 . . . . 0.02 109.899 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 881' ' ' PRO . . . . . 0.45 ' CG ' ' CD1' ' A' ' 868' ' ' PHE . 51.2 Cg_endo -76.84 1.2 8.84 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 O-C-N 123.443 1.233 . . . . 0.39000000000000001 112.165 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -76.19 -64.75 1.03 Allowed 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 106.78 -1.563 . . . . 0.81000000000000005 106.78 178.362 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 7.5 p -95.43 -17.91 21.13 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.702 -0.851 . . . . 0.040000000000000001 108.702 177.239 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 85.17 23.33 48.97 Favored Glycine 0 N--CA 1.495 2.577 0 C-N-CA 120.11 -1.043 . . . . 0.029999999999999999 110.679 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 885' ' ' VAL . . . . . . . . . . . . . 75.4 t -73.39 88.42 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 C-N-CA 118.351 -1.339 . . . . 1.01 108.085 -179.345 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 886' ' ' PHE . . . . . 0.905 ' HB3' HG22 ' A' ' 962' ' ' VAL . 0.6 OUTLIER -89.64 106.55 18.53 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 115.239 -0.891 . . . . 0.050000000000000003 112.135 -177.232 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 887' ' ' THR . . . . . 0.41 ' O ' ' HD3' ' A' ' 889' ' ' PRO . 95.4 m -98.48 99.29 10.45 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 107.581 -1.266 . . . . 0.68000000000000005 107.581 177.104 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 888' ' ' ALA . . . . . . . . . . . . . . . -97.1 107.88 40.59 Favored Pre-proline 0 N--CA 1.502 2.132 0 N-CA-C 113.983 1.105 . . . . 0.25 113.983 -176.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 889' ' ' PRO . . . . . 0.41 ' HD3' ' O ' ' A' ' 887' ' ' THR . 54.6 Cg_endo -89.11 -13.5 2.99 Favored 'Trans proline' 0 CA--C 1.546 1.094 0 N-CA-C 109.093 -1.157 . . . . 1.6399999999999999 109.093 176.357 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 890' ' ' LEU . . . . . 0.988 HD22 HD13 ' A' ' 985' ' ' LEU . 51.8 mt -35.91 -51.08 0.7 Allowed 'General case' 0 N--CA 1.508 2.447 0 N-CA-C 113.735 1.013 . . . . 2.29 113.735 -177.493 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 51.83 95.76 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.321 0 O-C-N 121.211 -0.93 . . . . 0.63 110.294 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 157.71 -152.99 24.24 Favored Glycine 0 N--CA 1.479 1.531 0 N-CA-C 107.181 -2.368 . . . . 0.040000000000000001 107.181 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 893' ' ' ARG . . . . . 0.405 ' CZ ' ' CB ' ' C' ' 984' ' ' ALA . 71.9 ttt-85 -114.46 126.23 54.73 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 108.286 -1.005 . . . . 3.0 108.286 177.306 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 894' ' ' TYR . . . . . 0.722 ' OH ' HD12 ' A' ' 896' ' ' LEU . 0.1 OUTLIER -132.47 160.06 37.54 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.105 -0.997 . . . . 0.040000000000000001 111.342 -179.4 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 895' ' ' LEU . . . . . 0.796 HD23 HD11 ' B' ' 952' ' ' LEU . 36.4 tp -92.16 119.67 32.03 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.735 -0.603 . . . . 1.27 110.056 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 896' ' ' LEU . . . . . 0.722 HD12 ' OH ' ' A' ' 894' ' ' TYR . 9.7 tt -109.64 143.67 39.05 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.717 -0.614 . . . . 0.93999999999999995 110.191 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 897' ' ' SER . . . . . 0.527 ' N ' HD23 ' A' ' 896' ' ' LEU . 64.7 m -149.86 114.07 5.17 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.443 -0.786 . . . . 0.040000000000000001 111.159 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.71 146.53 31.97 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.942 -0.762 . . . . 0.47999999999999998 108.942 178.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 899' ' ' VAL . . . . . 0.756 HG21 ' HB ' ' A' ' 980' ' ' ILE . 90.1 t -95.02 120.06 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 C-N-CA 119.588 -0.845 . . . . 0.55000000000000004 111.183 -179.227 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 900' ' ' LEU . . . . . 0.483 ' N ' HD22 ' A' ' 900' ' ' LEU . 4.5 mm? -95.52 112.04 23.83 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 114.331 1.234 . . . . 1.5900000000000001 114.331 -175.098 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 15.7 m -65.91 141.28 58.29 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 107.506 -1.294 . . . . 0.050000000000000003 107.506 177.08 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -67.11 -66.71 2.25 Favored Glycine 0 N--CA 1.495 2.597 0 N-CA-C 110.505 -1.038 . . . . 0.029999999999999999 110.505 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 12.0 m170 47.52 67.3 0.83 Allowed 'General case' 0 N--CA 1.507 2.378 0 O-C-N 121.533 -0.981 . . . . 3.2000000000000002 111.017 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 46.5 ptt85 -69.48 -6.82 33.01 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.58 -0.7 . . . . 2.9199999999999999 111.9 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 905' ' ' HIS . . . . . 0.485 ' O ' ' CB ' ' A' ' 906' ' ' GLU . 70.7 t60 -62.86 5.68 0.12 Allowed 'General case' 0 N--CA 1.506 2.35 0 O-C-N 120.943 -1.098 . . . . 2.8700000000000001 113.116 -179.084 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 906' ' ' GLU . . . . . 0.485 ' CB ' ' O ' ' A' ' 905' ' ' HIS . 0.6 OUTLIER 94.44 -164.29 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.407 0 CA-C-N 120.486 1.494 . . . . 0.98999999999999999 111.906 178.924 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 907' ' ' LYS . . . . . 0.458 ' CB ' ' O ' ' A' ' 906' ' ' GLU . 69.2 tttt 85.34 155.57 0.09 Allowed 'General case' 0 N--CA 1.519 3.01 0 N-CA-C 107.87 -1.159 . . . . 5.25 107.87 -176.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 59.5 t -123.44 115.55 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 120.733 -1.229 . . . . 0.39000000000000001 111.239 -179.326 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 909' ' ' GLU . . . . . 0.646 ' OE2' HD12 ' A' ' 966' ' ' LEU . 43.3 tp10 -97.3 135.48 39.16 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 107.077 -1.453 . . . . 1.72 107.077 176.523 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -154.72 123.66 6.25 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 106.985 -1.487 . . . . 0.67000000000000004 106.985 178.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 911' ' ' VAL . . . . . 0.67 HG22 HG13 ' A' ' 964' ' ' VAL . 86.1 t -80.43 130.55 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 CA-C-N 116.186 -0.461 . . . . 0.54000000000000004 110.933 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 86.0 mt -63.54 156.74 25.54 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.33 -0.856 . . . . 1.5 108.703 178.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 913' ' ' SER . . . . . 0.409 ' CB ' ' CG1' ' A' ' 919' ' ' VAL . 0.4 OUTLIER -128.38 131.27 48.53 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.17 -1.048 . . . . 1.3700000000000001 108.17 176.653 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 914' ' ' ARG . . . . . 0.853 ' NH1' HD23 ' A' ' 956' ' ' LEU . 0.0 OUTLIER -66.18 156.35 34.36 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 120.651 -1.28 . . . . 4.2999999999999998 111.706 -179.068 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 915' ' ' SER . . . . . 0.432 ' CB ' ' O ' ' A' ' 914' ' ' ARG . 4.2 t 83.19 -32.05 0.08 Allowed 'General case' 0 N--CA 1.522 3.163 0 C-N-CA 123.99 0.916 . . . . 2.0499999999999998 112.003 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 916' ' ' ASN . . . . . 0.798 ' HB2' HG21 ' A' ' 919' ' ' VAL . 82.6 m-20 -122.73 -20.86 5.78 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.918 -1.114 . . . . 2.71 111.249 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 917' ' ' GLN . . . . . 0.402 ' HB2' ' O ' ' A' ' 916' ' ' ASN . 45.4 mt-30 66.64 164.8 0.2 Allowed 'General case' 0 N--CA 1.521 3.106 0 N-CA-C 105.744 -1.947 . . . . 2.6800000000000002 105.744 -174.2 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 53.94 -124.26 29.47 Favored Glycine 1 N--CA 1.521 4.345 0 CA-C-N 123.455 2.843 . . . . 0.029999999999999999 107.05 -177.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 919' ' ' VAL . . . . . 0.798 HG21 ' HB2' ' A' ' 916' ' ' ASN . 73.5 t 51.56 94.18 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 O-C-N 121.425 -1.044 . . . . 1.3899999999999999 109.165 -178.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 920' ' ' ALA . . . . . 0.567 ' HB3' HG12 ' A' ' 949' ' ' VAL . . . -92.95 92.19 7.75 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.347 -0.941 . . . . 0.029999999999999999 110.67 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 921' ' ' ARG . . . . . 0.865 ' HG3' HG23 ' A' ' 922' ' ' VAL . 29.2 ptt180 -85.11 -41.75 15.42 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 105.931 -1.877 . . . . 4.4199999999999999 105.931 176.344 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 922' ' ' VAL . . . . . 0.865 HG23 ' HG3' ' A' ' 921' ' ' ARG . 93.1 t -101.19 73.02 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 N-CA-C 106.021 -1.844 . . . . 0.84999999999999998 106.021 175.633 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -87.29 133.29 33.71 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.689 0.757 . . . . 2.46 111.381 -177.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 924' ' ' SER . . . . . 0.408 ' CB ' HD12 ' A' ' 900' ' ' LEU . 8.7 t -147.99 105.61 3.68 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.59 -0.893 . . . . 0.69999999999999996 108.59 179.247 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -102.82 84.41 0.47 Allowed Glycine 0 N--CA 1.487 2.054 0 N-CA-C 108.568 -1.813 . . . . 0.040000000000000001 108.568 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 926' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' A' ' 906' ' ' GLU . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 108.786 -1.725 . . . . 0.040000000000000001 108.786 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 67.1 m . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.007 0.432 . . . . 13.779999999999999 110.366 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 95.5 mt -109.52 130.55 55.5 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.509 -0.744 . . . . 13.76 110.276 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -152.79 169.21 31.82 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.388 -1.485 . . . . 9.1300000000000008 109.388 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 949' ' ' VAL . . . . . 0.567 HG12 ' HB3' ' A' ' 920' ' ' ALA . 34.3 m -118.56 130.49 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.577 -0.955 . . . . 7.0800000000000001 110.687 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 950' ' ' PHE . . . . . 0.428 ' CZ ' ' HB3' ' A' ' 921' ' ' ARG . 52.0 p90 -130.22 143.98 51.1 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.454 -0.779 . . . . 7.5899999999999999 109.415 179.549 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 31.3 m -121.61 -52.3 2.03 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.46 -0.775 . . . . 5.0300000000000002 111.97 -178.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 952' ' ' LEU . . . . . 0.404 ' O ' ' O ' ' A' ' 953' ' ' ILE . 45.7 tp -61.47 -75.88 0.06 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.44 -0.787 . . . . 1.01 112.439 -177.519 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 953' ' ' ILE . . . . . 0.46 ' O ' ' HB3' ' A' ' 954' ' ' LEU . 47.0 pt -53.65 -141.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.736 0 N-CA-C 113.981 1.104 . . . . 2.6000000000000001 113.981 -176.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 954' ' ' LEU . . . . . 0.738 HD22 ' O ' ' A' ' 954' ' ' LEU . 0.0 OUTLIER 174.32 75.09 0.05 OUTLIER Pre-proline 0 N--CA 1.507 2.378 0 O-C-N 120.755 -1.215 . . . . 0.050000000000000003 110.959 179.813 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 955' ' ' PRO . . . . . 0.561 ' C ' HD12 ' A' ' 956' ' ' LEU . 45.3 Cg_endo -73.04 93.79 0.81 Allowed 'Trans proline' 0 C--N 1.315 -1.215 0 N-CA-C 109.227 -1.105 . . . . 0.83999999999999997 109.227 178.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 956' ' ' LEU . . . . . 0.853 HD23 ' NH1' ' A' ' 914' ' ' ARG . 5.0 mp -126.19 140.39 52.59 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.251 -0.906 . . . . 0.040000000000000001 110.624 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -79.77 152.52 29.75 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 117.864 -1.065 . . . . 1.28 111.201 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -67.14 121.2 15.1 Favored 'General case' 0 N--CA 1.511 2.58 0 CA-C-N 122.743 2.52 . . . . 0.17000000000000001 111.925 -179.092 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 94.31 -18.75 56.29 Favored Glycine 0 N--CA 1.501 3.004 0 N-CA-C 111.135 -0.786 . . . . 0.040000000000000001 111.135 178.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 960' ' ' ASP . . . . . 0.406 ' HB3' ' CZ ' ' A' ' 914' ' ' ARG . 1.3 m-20 -52.42 167.56 0.13 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.445 -1.032 . . . . 0.040000000000000001 111.029 -179.189 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 961' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 886' ' ' PHE . 57.3 m -135.66 135.84 40.45 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.936 -1.103 . . . . 1.78 111.623 -178.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 962' ' ' VAL . . . . . 0.905 HG22 ' HB3' ' A' ' 886' ' ' PHE . 33.8 m -100.43 145.24 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 O-C-N 121.57 -0.706 . . . . 0.040000000000000001 111.173 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 1.7 m -138.51 148.15 43.96 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.789 -0.569 . . . . 0.71999999999999997 109.964 -178.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 964' ' ' VAL . . . . . 0.67 HG13 HG22 ' A' ' 911' ' ' VAL . 61.4 t -99.66 137.92 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.128 -0.983 . . . . 1.05 110.584 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -91.68 128.88 37.69 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 104.121 -2.548 . . . . 3.02 104.121 173.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 966' ' ' LEU . . . . . 0.646 HD12 ' OE2' ' A' ' 909' ' ' GLU . 0.4 OUTLIER -131.54 59.8 1.69 Allowed 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.22 -1.03 . . . . 1.46 108.22 177.078 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 967' ' ' VAL . . . . . 0.491 HG23 ' C ' ' A' ' 966' ' ' LEU . 90.6 t -158.64 97.25 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 108.041 -1.096 . . . . 1.9399999999999999 108.041 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 80.2 mmm -143.99 59.47 1.36 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.711 -1.243 . . . . 0.0 108.396 178.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.3 119.77 1.95 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 107.195 -2.362 . . . . 2.1099999999999999 107.195 -178.288 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -82.18 -59.05 2.69 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.082 -1.246 . . . . 5.8899999999999997 110.333 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 47.3 tp -59.08 90.76 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.437 -0.789 . . . . 4.3600000000000003 110.205 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -141.91 -154.51 0.52 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.56 -0.712 . . . . 1.8300000000000001 110.24 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -120.5 172.53 7.77 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.45 -0.781 . . . . 4.3499999999999996 110.349 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 30.6 t -101.25 130.3 47.35 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.534 -0.729 . . . . 1.27 110.016 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -155.66 159.0 39.22 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.553 -0.717 . . . . 5.0199999999999996 110.52 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.01 85.99 18.47 Favored Pre-proline 0 N--CA 1.5 2.053 0 O-C-N 121.648 -0.658 . . . . 2.4100000000000001 109.632 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -73.15 -173.06 1.15 Allowed 'Trans proline' 0 C--N 1.317 -1.098 0 O-C-N 123.309 1.163 . . . . 0.95999999999999996 111.359 -179.351 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 978' ' ' LEU . . . . . 0.568 HD23 HD12 ' A' ' 856' ' ' LEU . 4.9 mp -128.52 153.94 46.66 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 107.547 -1.279 . . . . 0.62 107.547 177.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 979' ' ' THR . . . . . 0.462 HG23 ' C ' ' A' ' 978' ' ' LEU . 41.8 p -149.99 141.57 23.49 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.8 -1.187 . . . . 3.5699999999999998 111.189 -179.26 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 980' ' ' ILE . . . . . 0.756 ' HB ' HG21 ' A' ' 899' ' ' VAL . 49.4 mm -106.86 128.72 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.893 -0.78 . . . . 1.3300000000000001 108.893 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 981' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -119.0 95.96 5.04 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 119.806 -0.758 . . . . 0.050000000000000003 111.891 -178.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 82.8 p -108.18 157.83 17.97 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.55 -0.719 . . . . 0.87 109.098 178.309 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 983' ' ' GLY . . . . . 0.411 ' HA3' ' CE1' ' A' ' 852' ' ' PHE . . . -176.84 108.17 0.25 Allowed Glycine 0 N--CA 1.499 2.875 0 N-CA-C 106.411 -2.676 . . . . 0.029999999999999999 106.411 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -108.53 152.33 24.89 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 114.658 1.355 . . . . 0.69999999999999996 114.658 -175.408 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 985' ' ' LEU . . . . . 0.988 HD13 HD22 ' A' ' 890' ' ' LEU . 36.4 tp -72.15 135.33 46.15 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.829 -1.17 . . . . 0.040000000000000001 109.991 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 51.4 tp -106.09 -59.78 1.73 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.535 -0.728 . . . . 0.040000000000000001 109.879 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -143.15 146.52 33.8 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 107.57 -1.27 . . . . 0.040000000000000001 107.57 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.13 163.66 12.17 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 108.23 -1.948 . . . . 0.040000000000000001 108.23 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -74.56 112.61 18.11 Favored Pre-proline 0 N--CA 1.498 1.951 0 O-C-N 121.227 -1.161 . . . . 0.040000000000000001 109.439 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 990' ' ' PRO . . . . . 0.419 ' O ' ' HB2' ' A' ' 991' ' ' GLU . 50.6 Cg_endo -89.25 71.0 2.07 Favored 'Trans proline' 0 C--N 1.318 -1.036 0 O-C-N 123.132 1.07 . . . . 0.45000000000000001 111.494 -178.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 991' ' ' GLU . . . . . 0.419 ' HB2' ' O ' ' A' ' 990' ' ' PRO . 70.5 mt-10 67.23 -73.97 0.07 Allowed 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 108.562 -0.903 . . . . 1.97 108.562 -177.487 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 992' ' ' LEU . . . . . 0.41 HD12 ' HD2' ' A' ' 990' ' ' PRO . 11.4 mt 51.19 20.66 0.93 Allowed 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.572 -0.705 . . . . 2.3799999999999999 111.593 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -92.81 156.9 16.69 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.86 -1.15 . . . . 3.79 109.955 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 71.0 m80 -147.1 92.22 2.09 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.525 -0.734 . . . . 3.5099999999999998 110.314 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 995' ' ' ALA . . . . . . . . . . . . 2.516 . . . . . . . 0 N--CA 1.503 2.214 0 O-C-N 120.933 -1.105 . . . . 2.73 110.551 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo . . . . . 0 N--CA 1.488 1.16 0 N-CA-C 109.479 -1.008 . . . . 3.8300000000000001 109.479 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 847' ' ' VAL . . . . . 0.424 HG12 ' HB2' ' B' ' 849' ' ' GLN . 60.4 t -132.1 102.86 14.31 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.632 -0.667 . . . . 1.8300000000000001 110.122 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 848' ' ' PRO . . . . . 0.767 ' O ' HG23 ' B' ' 850' ' ' VAL . 43.9 Cg_endo -69.76 -21.17 33.85 Favored 'Trans proline' 0 N--CA 1.487 1.1 0 O-C-N 123.328 1.173 . . . . 0.65000000000000002 110.941 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 849' ' ' GLN . . . . . 0.424 ' HB2' HG12 ' B' ' 847' ' ' VAL . 56.1 tt0 28.35 68.34 0.08 Allowed 'General case' 0 N--CA 1.517 2.901 0 N-CA-C 112.856 0.687 . . . . 2.5800000000000001 112.856 179.283 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 850' ' ' VAL . . . . . 0.767 HG23 ' O ' ' B' ' 848' ' ' PRO . 74.4 t -120.07 136.11 58.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.213 -0.93 . . . . 1.0900000000000001 111.421 -178.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 851' ' ' ALA . . . . . 0.493 ' HB3' ' HG ' ' B' ' 873' ' ' LEU . . . -126.93 158.72 36.06 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 106.008 -1.849 . . . . 0.040000000000000001 106.008 177.113 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 852' ' ' PHE . . . . . 0.432 ' HA ' ' CB ' ' B' ' 874' ' ' ASN . 46.6 p90 -156.87 132.07 9.12 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 121.034 1.743 . . . . 0.050000000000000003 108.713 179.106 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 33.0 t -175.74 132.71 0.27 Allowed 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.118 -1.067 . . . . 0.040000000000000001 108.118 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -133.13 156.23 47.82 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.118 -0.989 . . . . 0.67000000000000004 109.487 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 855' ' ' ALA . . . . . 0.74 ' HB3' ' CB ' ' B' ' 870' ' ' ARG . . . -124.47 140.38 53.01 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.784 0.802 . . . . 0.51000000000000001 111.306 -179.263 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 856' ' ' LEU . . . . . 0.764 HD11 HD23 ' B' ' 858' ' ' LEU . 3.4 tm? -112.24 139.5 47.72 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.622 -0.673 . . . . 0.050000000000000003 110.179 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 857' ' ' SER . . . . . 0.667 ' N ' HD13 ' B' ' 856' ' ' LEU . 37.4 p -157.27 17.42 0.28 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.544 -0.723 . . . . 1.3300000000000001 111.42 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 858' ' ' LEU . . . . . 0.764 HD23 HD11 ' B' ' 856' ' ' LEU . 3.2 pp -35.92 161.57 0.04 OUTLIER Pre-proline 0 N--CA 1.518 2.953 0 CA-C-N 118.656 0.662 . . . . 2.3300000000000001 112.784 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -59.86 -89.24 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.49 0 O-C-N 122.901 0.948 . . . . 2.3199999999999998 113.277 -178.38 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 55.3 ptt85 -134.92 -141.58 0.18 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.836 -1.165 . . . . 0.040000000000000001 111.675 -177.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 73.8 m -32.81 121.68 0.35 Allowed 'General case' 0 N--CA 1.512 2.646 0 N-CA-C 113.042 0.756 . . . . 1.3100000000000001 113.042 -178.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 862' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.47 160.16 27.01 Favored Pre-proline 0 N--CA 1.489 1.524 0 N-CA-C 107.953 -1.129 . . . . 4.5099999999999998 107.953 177.178 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -69.95 -14.01 34.92 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 O-C-N 123.157 1.083 . . . . 2.2400000000000002 111.576 -179.368 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -177.03 -134.54 2.01 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 110.027 -1.229 . . . . 0.040000000000000001 110.027 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 38.9 m -68.43 157.72 35.21 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.308 -1.113 . . . . 1.51 110.437 -179.059 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 866' ' ' VAL . . . . . 0.475 HG13 ' CD2' ' B' ' 858' ' ' LEU . 50.7 t -100.7 139.34 20.5 Favored Pre-proline 0 N--CA 1.495 1.778 0 N-CA-C 113.509 0.929 . . . . 0.78000000000000003 113.509 -174.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 867' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' B' ' 866' ' ' VAL . 55.6 Cg_endo -91.72 -148.48 0.03 OUTLIER 'Trans proline' 0 CA--C 1.548 1.18 0 O-C-N 123.641 1.337 . . . . 0.92000000000000004 109.446 177.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 868' ' ' PHE . . . . . 0.455 ' CD1' ' CG ' ' B' ' 881' ' ' PRO . 26.1 p90 -150.17 124.1 9.31 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.622 -1.299 . . . . 0.050000000000000003 109.576 179.052 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 50.4 p-10 -113.68 -1.84 13.91 Favored 'General case' 0 N--CA 1.501 2.089 0 C-N-CA 119.222 -0.991 . . . . 1.7 112.875 -178.367 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 870' ' ' ARG . . . . . 0.74 ' CB ' ' HB3' ' B' ' 855' ' ' ALA . 28.4 mmm180 -91.52 89.88 7.39 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.837 -1.164 . . . . 2.5899999999999999 111.011 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 57.6 t -71.8 96.83 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.009 -1.057 . . . . 1.9399999999999999 110.019 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 872' ' ' LEU . . . . . 0.538 HD11 ' HB2' ' B' ' 855' ' ' ALA . 96.7 mt -83.22 -47.34 11.66 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.535 -0.728 . . . . 1.0600000000000001 110.021 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 873' ' ' LEU . . . . . 0.493 ' HG ' ' HB3' ' B' ' 851' ' ' ALA . 41.0 tp -175.1 103.22 0.08 Allowed 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.416 -0.957 . . . . 4.1799999999999997 108.416 178.528 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 874' ' ' ASN . . . . . 0.432 ' CB ' ' HA ' ' B' ' 852' ' ' PHE . 36.5 t-20 178.33 81.78 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.663 -0.648 . . . . 0.040000000000000001 109.443 -178.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -66.44 -46.87 75.01 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 119.32 -0.952 . . . . 3.3799999999999999 111.208 -179.314 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 876' ' ' GLY . . . . . 0.403 ' HA3' ' CE2' ' B' ' 878' ' ' TYR . . . -74.71 -24.85 71.26 Favored Glycine 0 N--CA 1.494 2.551 0 O-C-N 121.242 -0.912 . . . . 0.040000000000000001 111.888 -178.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 82.27 -62.32 4.58 Favored Glycine 0 N--CA 1.502 3.042 0 N-CA-C 107.877 -2.089 . . . . 0.040000000000000001 107.877 -178.116 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 878' ' ' TYR . . . . . 0.403 ' CE2' ' HA3' ' B' ' 876' ' ' GLY . 93.2 m-85 61.41 -62.02 0.09 Allowed 'General case' 0 N--CA 1.504 2.252 0 N-CA-C 114.595 1.332 . . . . 3.46 114.595 177.514 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 879' ' ' TYR . . . . . 0.468 ' CB ' ' CD2' ' B' ' 886' ' ' PHE . 20.3 p90 -110.55 109.12 19.32 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 114.826 1.417 . . . . 0.040000000000000001 114.826 -176.073 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -67.18 118.04 52.08 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.448 -0.783 . . . . 0.02 109.894 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 881' ' ' PRO . . . . . 0.455 ' CG ' ' CD1' ' B' ' 868' ' ' PHE . 53.0 Cg_endo -76.75 1.25 8.75 Favored 'Trans proline' 0 N--CA 1.492 1.431 0 O-C-N 123.426 1.224 . . . . 0.39000000000000001 112.194 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -76.2 -64.79 1.02 Allowed 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 106.8 -1.556 . . . . 0.81000000000000005 106.8 178.382 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 7.6 p -95.65 -17.3 21.42 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.759 -0.83 . . . . 0.040000000000000001 108.759 177.207 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.57 23.79 49.09 Favored Glycine 0 N--CA 1.494 2.55 0 C-N-CA 120.091 -1.052 . . . . 0.029999999999999999 110.721 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 885' ' ' VAL . . . . . . . . . . . . . 76.6 t -73.64 88.57 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 C-N-CA 118.315 -1.354 . . . . 1.01 108.022 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 886' ' ' PHE . . . . . 0.885 ' HB3' HG22 ' B' ' 962' ' ' VAL . 0.6 OUTLIER -89.82 106.7 18.64 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 115.324 -0.853 . . . . 0.050000000000000003 112.105 -177.293 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 887' ' ' THR . . . . . 0.409 ' O ' ' HD3' ' B' ' 889' ' ' PRO . 95.5 m -98.53 99.52 10.68 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 107.539 -1.282 . . . . 0.68000000000000005 107.539 177.063 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 888' ' ' ALA . . . . . . . . . . . . . . . -97.3 107.73 40.24 Favored Pre-proline 0 N--CA 1.502 2.138 0 N-CA-C 113.992 1.108 . . . . 0.25 113.992 -176.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 889' ' ' PRO . . . . . 0.409 ' HD3' ' O ' ' B' ' 887' ' ' THR . 55.2 Cg_endo -88.92 -13.66 3.06 Favored 'Trans proline' 0 CA--C 1.545 1.056 0 O-C-N 123.29 1.153 . . . . 1.6399999999999999 109.164 176.319 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 890' ' ' LEU . . . . . 0.957 HD22 HD13 ' B' ' 985' ' ' LEU . 51.9 mt -35.68 -51.31 0.66 Allowed 'General case' 0 N--CA 1.508 2.46 0 N-CA-C 113.688 0.995 . . . . 2.29 113.688 -177.529 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 51.9 95.71 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.275 0 O-C-N 121.192 -0.943 . . . . 0.63 110.358 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . 157.76 -153.17 24.4 Favored Glycine 0 N--CA 1.479 1.515 0 N-CA-C 107.21 -2.356 . . . . 0.040000000000000001 107.21 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 72.1 ttt-85 -114.3 126.17 54.71 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.283 -1.006 . . . . 3.0 108.283 177.302 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 894' ' ' TYR . . . . . 0.717 ' OH ' HD12 ' B' ' 896' ' ' LEU . 0.1 OUTLIER -132.41 160.28 36.83 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.134 -0.979 . . . . 0.040000000000000001 111.286 -179.391 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 895' ' ' LEU . . . . . 0.41 HD23 HD11 ' C' ' 952' ' ' LEU . 36.6 tp -92.32 119.49 31.94 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.742 -0.599 . . . . 1.27 110.178 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 896' ' ' LEU . . . . . 0.717 HD12 ' OH ' ' B' ' 894' ' ' TYR . 9.7 tt -109.55 142.9 39.97 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.68 -0.637 . . . . 0.93999999999999995 110.279 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 897' ' ' SER . . . . . 0.516 ' N ' HD23 ' B' ' 896' ' ' LEU . 64.4 m -149.1 113.96 5.4 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.464 -0.773 . . . . 0.040000000000000001 111.187 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.55 146.25 32.11 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.085 -0.709 . . . . 0.47999999999999998 109.085 178.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 899' ' ' VAL . . . . . 0.745 HG21 ' HB ' ' B' ' 980' ' ' ILE . 89.5 t -94.74 119.8 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 C-N-CA 119.602 -0.839 . . . . 0.55000000000000004 111.252 -179.156 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 900' ' ' LEU . . . . . 0.483 ' N ' HD22 ' B' ' 900' ' ' LEU . 4.5 mm? -95.27 111.69 23.5 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 114.416 1.265 . . . . 1.5900000000000001 114.416 -175.07 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 15.7 m -65.67 141.13 58.48 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 107.468 -1.308 . . . . 0.050000000000000003 107.468 177.107 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -67.22 -66.7 2.25 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 110.541 -1.024 . . . . 0.029999999999999999 110.541 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 47.6 67.33 0.83 Allowed 'General case' 0 N--CA 1.507 2.388 0 O-C-N 121.47 -1.017 . . . . 3.2000000000000002 110.977 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 46.6 ptt85 -69.47 -6.99 34.09 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.638 -0.664 . . . . 2.9199999999999999 111.906 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 905' ' ' HIS . . . . . 0.484 ' O ' ' CB ' ' B' ' 906' ' ' GLU . 70.6 t60 -62.34 5.13 0.11 Allowed 'General case' 0 N--CA 1.507 2.382 0 O-C-N 120.915 -1.116 . . . . 2.8700000000000001 113.111 -179.118 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 906' ' ' GLU . . . . . 0.484 ' CB ' ' O ' ' B' ' 905' ' ' HIS . 0.6 OUTLIER 94.74 -164.31 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.432 0 CA-C-N 120.565 1.53 . . . . 0.98999999999999999 111.796 179.095 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 907' ' ' LYS . . . . . 0.467 ' CB ' ' O ' ' B' ' 906' ' ' GLU . 69.2 tttt 85.4 155.38 0.09 Allowed 'General case' 0 N--CA 1.519 2.985 0 N-CA-C 107.921 -1.14 . . . . 5.25 107.921 -176.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 60.1 t -123.27 115.34 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 120.716 -1.24 . . . . 0.39000000000000001 111.371 -179.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 909' ' ' GLU . . . . . 0.654 ' OE2' HD12 ' B' ' 966' ' ' LEU . 43.4 tp10 -97.16 135.59 38.89 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 107.014 -1.476 . . . . 1.72 107.014 176.534 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -154.95 123.85 6.2 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 106.966 -1.494 . . . . 0.67000000000000004 106.966 179.014 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 911' ' ' VAL . . . . . 0.66 HG22 HG13 ' B' ' 964' ' ' VAL . 87.2 t -80.71 130.91 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 C-N-CA 120.522 -0.471 . . . . 0.54000000000000004 110.934 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 86.2 mt -63.72 156.92 25.59 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.27 -0.894 . . . . 1.5 108.671 178.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 913' ' ' SER . . . . . 0.417 ' CB ' ' HB ' ' B' ' 919' ' ' VAL . 0.4 OUTLIER -128.77 130.58 47.23 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.251 -1.018 . . . . 1.3700000000000001 108.251 176.647 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 914' ' ' ARG . . . . . 0.854 ' NH1' HD23 ' B' ' 956' ' ' LEU . 0.0 OUTLIER -65.45 156.2 33.14 Favored 'General case' 0 N--CA 1.507 2.387 0 O-C-N 120.674 -1.266 . . . . 4.2999999999999998 111.796 -178.963 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 915' ' ' SER . . . . . 0.425 ' CB ' ' O ' ' B' ' 914' ' ' ARG . 4.2 t 83.3 -32.39 0.08 Allowed 'General case' 0 N--CA 1.522 3.148 0 C-N-CA 123.991 0.917 . . . . 2.0499999999999998 112.019 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 916' ' ' ASN . . . . . 0.817 ' HB2' HG21 ' B' ' 919' ' ' VAL . 82.5 m-20 -122.24 -21.23 5.93 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 120.87 -1.144 . . . . 2.71 111.328 -179.109 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 917' ' ' GLN . . . . . 0.402 ' HB2' ' O ' ' B' ' 916' ' ' ASN . 45.3 mt-30 66.77 164.34 0.19 Allowed 'General case' 0 N--CA 1.52 3.065 0 N-CA-C 105.76 -1.941 . . . . 2.6800000000000002 105.76 -174.167 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.52 -124.38 31.27 Favored Glycine 1 N--CA 1.522 4.368 0 CA-C-N 123.521 2.873 . . . . 0.029999999999999999 106.928 -177.675 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 919' ' ' VAL . . . . . 0.817 HG21 ' HB2' ' B' ' 916' ' ' ASN . 75.8 t 51.42 94.25 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 O-C-N 121.413 -1.051 . . . . 1.3899999999999999 109.15 -178.456 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 920' ' ' ALA . . . . . 0.562 ' HB3' HG12 ' B' ' 949' ' ' VAL . . . -93.02 92.07 7.66 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 119.327 -0.949 . . . . 0.029999999999999999 110.643 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 921' ' ' ARG . . . . . 0.851 ' HG3' HG23 ' B' ' 922' ' ' VAL . 29.3 ptt180 -85.03 -41.64 15.6 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 105.924 -1.88 . . . . 4.4199999999999999 105.924 176.399 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 922' ' ' VAL . . . . . 0.851 HG23 ' HG3' ' B' ' 921' ' ' ARG . 92.8 t -101.29 72.77 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 N-CA-C 106.052 -1.833 . . . . 0.84999999999999998 106.052 175.679 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -87.09 133.49 33.61 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.678 0.752 . . . . 2.46 111.376 -177.57 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 924' ' ' SER . . . . . 0.404 ' HB2' HD12 ' B' ' 900' ' ' LEU . 8.7 t -148.11 105.4 3.64 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.638 -0.875 . . . . 0.69999999999999996 108.638 179.281 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -102.55 84.36 0.48 Allowed Glycine 0 N--CA 1.487 2.091 0 N-CA-C 108.589 -1.804 . . . . 0.040000000000000001 108.589 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 926' ' ' GLY . . . . . 0.411 ' O ' ' HA ' ' B' ' 906' ' ' GLU . . . . . . . . 0 N--CA 1.489 2.205 0 N-CA-C 108.805 -1.718 . . . . 0.040000000000000001 108.805 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 69.8 m . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.05 0.453 . . . . 13.779999999999999 110.296 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 95.3 mt -108.24 130.19 55.17 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.494 -0.754 . . . . 13.76 110.295 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -152.01 168.53 31.28 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.429 -1.468 . . . . 9.1300000000000008 109.429 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 949' ' ' VAL . . . . . 0.562 HG12 ' HB3' ' B' ' 920' ' ' ALA . 34.2 m -118.27 130.41 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.606 -0.938 . . . . 7.0800000000000001 110.547 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 950' ' ' PHE . . . . . 0.441 ' CZ ' ' HB3' ' B' ' 921' ' ' ARG . 52.0 p90 -130.37 144.11 51.18 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.492 -0.755 . . . . 7.5899999999999999 109.447 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 31.9 m -121.77 -51.91 2.02 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.451 -0.781 . . . . 5.0300000000000002 111.92 -178.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 952' ' ' LEU . . . . . 0.796 HD11 HD23 ' A' ' 895' ' ' LEU . 45.3 tp -61.81 -76.06 0.06 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.512 -0.742 . . . . 1.01 112.385 -177.56 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 953' ' ' ILE . . . . . 0.469 ' O ' ' HB3' ' B' ' 954' ' ' LEU . 47.0 pt -53.53 -141.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.724 0 N-CA-C 113.992 1.108 . . . . 2.6000000000000001 113.992 -176.545 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 954' ' ' LEU . . . . . 0.742 HD22 ' O ' ' B' ' 954' ' ' LEU . 0.0 OUTLIER 174.08 75.05 0.05 OUTLIER Pre-proline 0 N--CA 1.507 2.391 0 O-C-N 120.786 -1.196 . . . . 0.050000000000000003 110.906 179.754 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 955' ' ' PRO . . . . . 0.557 ' C ' HD12 ' B' ' 956' ' ' LEU . 45.3 Cg_endo -73.07 93.93 0.81 Allowed 'Trans proline' 0 C--N 1.315 -1.212 0 N-CA-C 109.185 -1.121 . . . . 0.83999999999999997 109.185 178.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 956' ' ' LEU . . . . . 0.854 HD23 ' NH1' ' B' ' 914' ' ' ARG . 5.0 mp -126.32 140.39 52.55 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.242 -0.911 . . . . 0.040000000000000001 110.602 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -79.68 153.02 29.61 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 117.964 -1.017 . . . . 1.28 111.097 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -67.54 121.1 15.11 Favored 'General case' 0 N--CA 1.51 2.564 0 CA-C-N 122.563 2.438 . . . . 0.17000000000000001 111.838 -179.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 94.38 -19.01 55.79 Favored Glycine 0 N--CA 1.501 3.017 0 N-CA-C 111.132 -0.787 . . . . 0.040000000000000001 111.132 178.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 960' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -52.21 167.67 0.12 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.412 -1.052 . . . . 0.040000000000000001 111.027 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 961' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' B' ' 886' ' ' PHE . 57.3 m -135.73 135.93 40.41 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 120.966 -1.084 . . . . 1.78 111.614 -178.667 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 962' ' ' VAL . . . . . 0.885 HG22 ' HB3' ' B' ' 886' ' ' PHE . 33.9 m -100.64 145.15 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 121.606 -0.684 . . . . 0.040000000000000001 111.13 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 1.8 m -138.39 148.01 44.03 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.816 -0.553 . . . . 0.71999999999999997 109.938 -178.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 964' ' ' VAL . . . . . 0.66 HG13 HG22 ' B' ' 911' ' ' VAL . 61.8 t -99.66 137.69 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.118 -0.989 . . . . 1.05 110.623 -179.23 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -91.58 128.57 37.46 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 104.202 -2.518 . . . . 3.02 104.202 173.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 966' ' ' LEU . . . . . 0.654 HD12 ' OE2' ' B' ' 909' ' ' GLU . 0.4 OUTLIER -131.2 59.84 1.67 Allowed 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.305 -0.998 . . . . 1.46 108.305 177.162 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 967' ' ' VAL . . . . . 0.49 HG23 ' C ' ' B' ' 966' ' ' LEU . 90.1 t -158.76 96.97 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 108.104 -1.072 . . . . 1.9399999999999999 108.104 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 80.2 mmm -143.64 59.24 1.38 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.733 -1.229 . . . . 0.0 108.519 178.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.4 119.63 1.93 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 107.318 -2.313 . . . . 2.1099999999999999 107.318 -178.327 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -81.96 -59.05 2.71 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.095 -1.239 . . . . 5.8899999999999997 110.376 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 47.6 tp -59.14 90.49 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.423 -0.798 . . . . 4.3600000000000003 110.224 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -141.67 -154.51 0.52 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.536 -0.727 . . . . 1.8300000000000001 110.296 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -120.36 172.73 7.6 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.428 -0.795 . . . . 4.3499999999999996 110.315 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 30.3 t -101.47 130.32 47.69 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.517 -0.739 . . . . 1.27 109.983 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -155.68 158.99 39.17 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.457 -0.777 . . . . 5.0199999999999996 110.486 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.99 85.96 18.57 Favored Pre-proline 0 N--CA 1.5 2.048 0 O-C-N 121.607 -0.683 . . . . 2.4100000000000001 109.673 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -73.17 -173.15 1.18 Allowed 'Trans proline' 0 C--N 1.318 -1.078 0 O-C-N 123.286 1.151 . . . . 0.95999999999999996 111.319 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 978' ' ' LEU . . . . . 0.582 HD23 HD12 ' B' ' 856' ' ' LEU . 4.9 mp -128.34 154.15 46.27 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 107.565 -1.272 . . . . 0.62 107.565 177.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 979' ' ' THR . . . . . 0.469 HG23 ' C ' ' B' ' 978' ' ' LEU . 41.6 p -150.17 141.46 23.22 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.788 -1.195 . . . . 3.5699999999999998 111.214 -179.303 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 980' ' ' ILE . . . . . 0.745 ' HB ' HG21 ' B' ' 899' ' ' VAL . 49.4 mm -106.78 128.41 61.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 108.951 -0.759 . . . . 1.3300000000000001 108.951 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -118.82 96.2 5.16 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.488 -0.758 . . . . 0.050000000000000003 111.852 -178.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 78.7 p -108.6 158.01 17.97 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.557 -0.714 . . . . 0.87 109.159 178.306 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 983' ' ' GLY . . . . . 0.403 ' HA3' ' CE1' ' B' ' 852' ' ' PHE . . . -176.78 108.16 0.25 Allowed Glycine 0 N--CA 1.498 2.783 0 N-CA-C 106.529 -2.628 . . . . 0.029999999999999999 106.529 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 984' ' ' ALA . . . . . 0.433 ' HB1' ' NH1' ' C' ' 893' ' ' ARG . . . -108.37 152.37 24.76 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 114.627 1.343 . . . . 0.69999999999999996 114.627 -175.459 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 985' ' ' LEU . . . . . 0.957 HD13 HD22 ' B' ' 890' ' ' LEU . 36.4 tp -72.25 135.36 46.01 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.926 -1.109 . . . . 0.040000000000000001 109.94 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 986' ' ' LEU . . . . . 0.476 ' CD1' HD11 ' C' ' 986' ' ' LEU . 51.4 tp -106.21 -59.67 1.75 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.655 -0.653 . . . . 0.040000000000000001 109.914 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -143.13 146.52 33.82 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 107.597 -1.26 . . . . 0.040000000000000001 107.597 178.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.03 163.26 12.21 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 108.278 -1.929 . . . . 0.040000000000000001 108.278 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -74.21 112.65 17.86 Favored Pre-proline 0 N--CA 1.498 1.944 0 O-C-N 121.173 -1.193 . . . . 0.040000000000000001 109.415 179.144 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 990' ' ' PRO . . . . . 0.421 ' O ' ' HB2' ' B' ' 991' ' ' GLU . 50.3 Cg_endo -89.32 71.06 2.02 Favored 'Trans proline' 0 C--N 1.319 -1.015 0 O-C-N 123.067 1.035 . . . . 0.45000000000000001 111.461 -178.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 991' ' ' GLU . . . . . 0.421 ' HB2' ' O ' ' B' ' 990' ' ' PRO . 70.8 mt-10 67.14 -73.94 0.07 Allowed 'General case' 0 N--CA 1.502 2.164 0 N-CA-C 108.581 -0.896 . . . . 1.97 108.581 -177.514 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 992' ' ' LEU . . . . . 0.463 HD23 ' HA ' ' B' ' 992' ' ' LEU . 11.5 mt 51.27 20.48 0.94 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.586 -0.697 . . . . 2.3799999999999999 111.621 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -92.53 156.91 16.83 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.912 -1.118 . . . . 3.79 110.019 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 70.7 m80 -147.15 91.73 2.03 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.549 -0.719 . . . . 3.5099999999999998 110.359 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 995' ' ' ALA . . . . . . . . . . . . 2.518 . . . . . . . 0 N--CA 1.503 2.19 0 O-C-N 120.899 -1.125 . . . . 2.73 110.622 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo . . . . . 0 N--CA 1.488 1.158 0 N-CA-C 109.516 -0.994 . . . . 3.8300000000000001 109.516 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 847' ' ' VAL . . . . . 0.526 HG12 ' HB2' ' C' ' 849' ' ' GLN . 60.3 t -126.11 105.48 25.41 Favored Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 121.639 -0.663 . . . . 1.8300000000000001 110.103 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 848' ' ' PRO . . . . . 0.878 ' O ' HG23 ' C' ' 850' ' ' VAL . 43.8 Cg_endo -69.61 -23.56 31.36 Favored 'Trans proline' 0 N--CA 1.487 1.113 0 O-C-N 123.219 1.115 . . . . 0.65000000000000002 110.949 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 849' ' ' GLN . . . . . 0.526 ' HB2' HG12 ' C' ' 847' ' ' VAL . 55.5 tt0 25.4 66.38 0.05 Allowed 'General case' 0 N--CA 1.518 2.944 0 N-CA-C 113.419 0.896 . . . . 2.5800000000000001 113.419 179.006 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 850' ' ' VAL . . . . . 0.878 HG23 ' O ' ' C' ' 848' ' ' PRO . 77.7 t -120.0 135.74 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 121.113 -0.992 . . . . 1.0900000000000001 111.183 -179.341 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 851' ' ' ALA . . . . . 0.588 ' HB3' ' HG ' ' C' ' 873' ' ' LEU . . . -128.17 155.45 44.46 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 105.914 -1.884 . . . . 0.040000000000000001 105.914 176.65 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 852' ' ' PHE . . . . . 0.456 ' CD1' ' N ' ' C' ' 852' ' ' PHE . 15.2 p90 -160.42 127.03 4.22 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 120.973 1.715 . . . . 0.050000000000000003 108.631 179.024 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 6.3 t -177.28 134.28 0.18 Allowed 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.162 -1.051 . . . . 0.040000000000000001 108.162 -179.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -130.39 158.14 40.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.087 -1.008 . . . . 0.67000000000000004 109.685 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 855' ' ' ALA . . . . . 0.771 ' HB3' ' CB ' ' C' ' 870' ' ' ARG . . . -121.39 140.71 51.77 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.818 0.818 . . . . 0.51000000000000001 111.061 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 856' ' ' LEU . . . . . 0.937 HD11 HD23 ' C' ' 858' ' ' LEU . 3.5 tm? -113.23 135.74 53.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.612 -0.68 . . . . 0.050000000000000003 110.084 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 857' ' ' SER . . . . . 0.584 ' N ' HD13 ' C' ' 856' ' ' LEU . 0.6 OUTLIER -153.35 18.64 0.55 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.502 -0.749 . . . . 1.3300000000000001 110.919 179.581 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 858' ' ' LEU . . . . . 0.937 HD23 HD11 ' C' ' 856' ' ' LEU . 2.7 pp -34.7 159.65 0.04 OUTLIER Pre-proline 0 N--CA 1.516 2.856 0 N-CA-C 113.008 0.744 . . . . 2.3300000000000001 113.008 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -63.04 -88.39 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.399 0 O-C-N 123.078 1.041 . . . . 2.3199999999999998 113.257 -178.293 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 54.7 ptt85 -133.18 -142.0 0.2 Allowed 'General case' 0 N--CA 1.499 2.01 0 O-C-N 120.854 -1.154 . . . . 0.040000000000000001 111.422 -177.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 58.2 m -36.68 123.92 0.83 Allowed 'General case' 0 N--CA 1.511 2.586 0 O-C-N 121.609 -0.682 . . . . 1.3100000000000001 112.538 -178.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -104.04 160.24 26.71 Favored Pre-proline 0 N--CA 1.489 1.496 0 N-CA-C 108.052 -1.092 . . . . 4.5099999999999998 108.052 177.283 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -69.12 -14.41 38.06 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 123.185 1.097 . . . . 2.2400000000000002 111.404 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -177.25 -136.58 2.48 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 110.107 -1.197 . . . . 0.040000000000000001 110.107 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 32.7 m -65.23 156.89 30.43 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.366 -1.079 . . . . 1.51 110.746 -178.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 866' ' ' VAL . . . . . 0.431 HG13 ' CD2' ' C' ' 858' ' ' LEU . 64.5 t -96.58 134.61 23.09 Favored Pre-proline 0 N--CA 1.494 1.73 0 N-CA-C 113.136 0.791 . . . . 0.78000000000000003 113.136 -175.141 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 867' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' C' ' 866' ' ' VAL . 55.3 Cg_endo -90.36 -149.13 0.03 OUTLIER 'Trans proline' 0 CA--C 1.544 1.022 0 O-C-N 123.577 1.304 . . . . 0.92000000000000004 108.837 177.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 868' ' ' PHE . . . . . 0.472 ' CD1' ' N ' ' C' ' 868' ' ' PHE . 13.8 p90 -150.0 123.65 9.17 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.53 -1.356 . . . . 0.050000000000000003 109.861 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 46.5 p-10 -113.82 -2.48 13.65 Favored 'General case' 0 N--CA 1.499 2.003 0 C-N-CA 119.185 -1.006 . . . . 1.7 112.892 -178.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 870' ' ' ARG . . . . . 0.771 ' CB ' ' HB3' ' C' ' 855' ' ' ALA . 29.9 mmm180 -91.22 88.66 7.0 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.912 -1.117 . . . . 2.5899999999999999 110.998 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 57.3 t -72.21 97.48 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 120.94 -1.1 . . . . 1.9399999999999999 109.695 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 872' ' ' LEU . . . . . 0.645 HD11 ' HB2' ' C' ' 855' ' ' ALA . 96.3 mt -86.22 -46.04 10.74 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.611 -0.681 . . . . 1.0600000000000001 110.648 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 873' ' ' LEU . . . . . 0.588 ' HG ' ' HB3' ' C' ' 851' ' ' ALA . 35.8 tp -173.61 102.27 0.12 Allowed 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.262 -0.899 . . . . 4.1799999999999997 108.702 178.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 874' ' ' ASN . . . . . 0.437 ' CB ' ' HA ' ' C' ' 852' ' ' PHE . 36.3 t-20 177.7 82.68 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.26 0 N-CA-C 109.035 -0.728 . . . . 0.040000000000000001 109.035 -178.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -64.39 -46.15 84.54 Favored 'General case' 0 N--CA 1.497 1.916 0 C-N-CA 119.265 -0.974 . . . . 3.3799999999999999 111.171 -179.079 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 876' ' ' GLY . . . . . 0.422 ' HA3' ' CE2' ' C' ' 878' ' ' TYR . . . -73.8 -26.47 69.2 Favored Glycine 0 N--CA 1.494 2.519 0 C-N-CA 120.461 -0.876 . . . . 0.040000000000000001 111.977 -178.672 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 79.49 -63.94 3.89 Favored Glycine 0 N--CA 1.502 3.098 0 N-CA-C 107.868 -2.093 . . . . 0.040000000000000001 107.868 -178.193 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 878' ' ' TYR . . . . . 0.422 ' CE2' ' HA3' ' C' ' 876' ' ' GLY . 76.5 m-85 60.39 -63.92 0.06 Allowed 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 114.825 1.417 . . . . 3.46 114.825 177.533 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 879' ' ' TYR . . . . . 0.494 ' CE2' ' CD1' ' C' ' 981' ' ' PHE . 28.8 p90 -108.53 108.29 19.15 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 115.342 1.608 . . . . 0.040000000000000001 115.342 -175.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -70.69 117.55 56.63 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 121.758 -0.589 . . . . 0.02 110.191 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 881' ' ' PRO . . . . . 0.453 ' CG ' ' CD1' ' C' ' 868' ' ' PHE . 55.3 Cg_endo -76.83 1.97 8.01 Favored 'Trans proline' 0 N--CA 1.492 1.402 0 O-C-N 123.452 1.238 . . . . 0.39000000000000001 112.298 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -74.66 -65.02 0.91 Allowed 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 106.359 -1.719 . . . . 0.81000000000000005 106.359 178.272 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 6.0 p -96.45 -16.3 21.26 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.804 -0.813 . . . . 0.040000000000000001 108.804 177.174 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.54 23.02 52.25 Favored Glycine 0 N--CA 1.493 2.499 0 O-C-N 120.991 -1.068 . . . . 0.029999999999999999 110.692 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 95.2 t -73.38 87.5 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 C-N-CA 118.299 -1.36 . . . . 1.01 107.775 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 886' ' ' PHE . . . . . 0.846 ' HB3' HG22 ' C' ' 962' ' ' VAL . 0.7 OUTLIER -87.95 108.83 19.39 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-N 115.132 -0.94 . . . . 0.050000000000000003 111.569 -177.587 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 887' ' ' THR . . . . . 0.423 ' O ' ' HD3' ' C' ' 889' ' ' PRO . 97.3 m -105.75 99.62 9.21 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 107.596 -1.261 . . . . 0.68000000000000005 107.596 177.541 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 888' ' ' ALA . . . . . . . . . . . . . . . -98.89 101.56 12.54 Favored Pre-proline 0 N--CA 1.501 2.089 0 N-CA-C 114.523 1.305 . . . . 0.25 114.523 -176.112 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 889' ' ' PRO . . . . . 0.423 ' HD3' ' O ' ' C' ' 887' ' ' THR . 55.5 Cg_endo -79.83 -15.03 12.2 Favored 'Trans proline' 0 N--CA 1.486 1.048 0 N-CA-C 108.786 -1.275 . . . . 1.6399999999999999 108.786 175.491 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 890' ' ' LEU . . . . . 0.763 HD21 HG11 ' C' ' 850' ' ' VAL . 66.1 mt -37.77 -49.15 1.15 Allowed 'General case' 0 N--CA 1.508 2.438 0 N-CA-C 113.463 0.912 . . . . 2.29 113.463 -177.48 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 52.66 97.73 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.193 -0.942 . . . . 0.63 110.451 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . 158.86 -154.5 25.59 Favored Glycine 0 N--CA 1.477 1.407 0 N-CA-C 107.29 -2.324 . . . . 0.040000000000000001 107.29 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 893' ' ' ARG . . . . . 0.463 ' HG3' HD11 ' C' ' 954' ' ' LEU . 77.7 ttt-85 -116.28 123.94 48.94 Favored 'General case' 0 C--N 1.294 -1.825 0 O-C-N 121.671 -0.9 . . . . 3.0 108.589 177.714 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 894' ' ' TYR . . . . . 0.868 ' CE2' HD23 ' C' ' 954' ' ' LEU . 12.9 p90 -132.07 154.04 49.82 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.079 -1.013 . . . . 0.040000000000000001 110.954 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 895' ' ' LEU . . . . . . . . . . . . . 45.0 tp -99.65 113.78 26.44 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.706 -0.621 . . . . 1.27 109.796 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 896' ' ' LEU . . . . . 0.576 HD11 ' CE1' ' C' ' 981' ' ' PHE . 8.4 tt -118.01 145.08 45.02 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.678 -0.639 . . . . 0.93999999999999995 109.985 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 897' ' ' SER . . . . . . . . . . . . . 62.4 m -141.24 124.15 16.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.445 -0.784 . . . . 0.040000000000000001 111.184 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -100.78 148.42 24.94 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.73 -0.841 . . . . 0.47999999999999998 108.73 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 899' ' ' VAL . . . . . 0.691 HG21 ' HB ' ' C' ' 980' ' ' ILE . 96.7 t -92.33 120.53 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.369 -0.832 . . . . 0.55000000000000004 111.079 -179.137 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 91.4 mt -92.65 113.08 25.26 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 113.99 1.107 . . . . 1.5900000000000001 113.99 -175.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 16.7 m -62.54 141.28 58.51 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 107.545 -1.28 . . . . 0.050000000000000003 107.545 177.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -60.68 -65.23 3.47 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 110.362 -1.095 . . . . 0.029999999999999999 110.362 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 1.6 m80 46.23 65.11 1.26 Allowed 'General case' 0 N--CA 1.507 2.4 0 O-C-N 121.485 -1.009 . . . . 3.2000000000000002 111.095 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 42.4 ptt85 -66.72 -8.19 26.24 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.639 -0.663 . . . . 2.9199999999999999 111.971 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 905' ' ' HIS . . . . . 0.473 ' O ' ' CB ' ' C' ' 906' ' ' GLU . 61.0 t60 -63.67 5.32 0.21 Allowed 'General case' 0 N--CA 1.504 2.229 0 O-C-N 120.946 -1.096 . . . . 2.8700000000000001 112.624 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 906' ' ' GLU . . . . . 0.5 ' O ' ' CB ' ' C' ' 907' ' ' LYS . 2.8 mt-10 89.21 -152.96 0.01 OUTLIER 'General case' 0 N--CA 1.526 3.362 0 CA-C-N 121.215 1.825 . . . . 0.98999999999999999 111.59 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 907' ' ' LYS . . . . . 0.5 ' CB ' ' O ' ' C' ' 906' ' ' GLU . 62.2 tttt 90.19 163.85 0.05 OUTLIER 'General case' 0 N--CA 1.523 3.179 0 N-CA-C 107.925 -1.139 . . . . 5.25 107.925 -176.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 58.4 t -123.33 114.34 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 120.84 -1.162 . . . . 0.39000000000000001 110.843 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 909' ' ' GLU . . . . . 0.573 ' OE2' HD12 ' C' ' 966' ' ' LEU . 44.3 tp10 -108.68 130.71 55.34 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 107.559 -1.275 . . . . 1.72 107.559 177.092 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -157.54 121.16 4.1 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 107.098 -1.445 . . . . 0.67000000000000004 107.098 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 911' ' ' VAL . . . . . 0.506 ' HA ' ' HA ' ' C' ' 964' ' ' VAL . 14.0 p -80.94 131.02 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 C-N-CA 120.35 -0.54 . . . . 0.54000000000000004 111.654 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 62.4 mt -67.43 157.94 32.97 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.359 -0.838 . . . . 1.5 109.036 178.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 913' ' ' SER . . . . . 0.478 ' OG ' HG11 ' C' ' 919' ' ' VAL . 1.5 p -126.07 138.87 53.74 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.568 -0.901 . . . . 1.3700000000000001 108.568 176.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 914' ' ' ARG . . . . . 0.723 ' CZ ' HD23 ' C' ' 956' ' ' LEU . 0.0 OUTLIER -64.16 153.46 37.74 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 120.638 -1.289 . . . . 4.2999999999999998 111.607 -179.152 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 915' ' ' SER . . . . . 0.424 ' CB ' ' O ' ' C' ' 914' ' ' ARG . 0.2 OUTLIER 82.83 -30.37 0.09 Allowed 'General case' 0 N--CA 1.522 3.147 0 C-N-CA 123.766 0.826 . . . . 2.0499999999999998 112.457 179.575 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 916' ' ' ASN . . . . . 0.768 ' HB2' HG21 ' C' ' 919' ' ' VAL . 98.7 m-20 -122.17 -22.1 5.71 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.804 -1.185 . . . . 2.71 111.268 -179.158 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 67.09 166.52 0.22 Allowed 'General case' 0 N--CA 1.52 3.042 0 N-CA-C 105.792 -1.929 . . . . 2.6800000000000002 105.792 -174.074 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.58 -125.67 35.26 Favored Glycine 1 N--CA 1.522 4.384 0 CA-C-N 123.539 2.882 . . . . 0.029999999999999999 107.087 -177.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 919' ' ' VAL . . . . . 0.768 HG21 ' HB2' ' C' ' 916' ' ' ASN . 92.4 t 51.01 94.02 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.238 0 O-C-N 121.452 -1.028 . . . . 1.3899999999999999 109.234 -178.261 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 920' ' ' ALA . . . . . 0.951 ' HB3' HG12 ' C' ' 949' ' ' VAL . . . -94.06 94.32 8.34 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.395 -0.922 . . . . 0.029999999999999999 110.735 -179.323 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 921' ' ' ARG . . . . . 0.698 ' HG3' HG23 ' C' ' 922' ' ' VAL . 45.2 ptt85 -79.14 -42.1 27.0 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 105.591 -2.003 . . . . 4.4199999999999999 105.591 176.049 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 922' ' ' VAL . . . . . 0.698 HG23 ' HG3' ' C' ' 921' ' ' ARG . 73.9 t -99.7 78.68 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 N-CA-C 105.441 -2.059 . . . . 0.84999999999999998 105.441 174.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -89.92 136.28 33.13 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 122.047 0.927 . . . . 2.46 112.775 -176.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 6.3 t -147.21 103.05 3.55 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 107.576 -1.268 . . . . 0.69999999999999996 107.576 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -107.71 82.27 0.31 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.656 -1.378 . . . . 0.040000000000000001 109.656 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 109.187 -1.565 . . . . 0.040000000000000001 109.187 179.747 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 17.7 m . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 120.937 0.398 . . . . 13.779999999999999 110.377 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 95.3 mt -114.66 131.36 56.75 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.472 -0.767 . . . . 13.76 110.321 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -151.7 170.13 31.17 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.433 -1.467 . . . . 9.1300000000000008 109.433 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 949' ' ' VAL . . . . . 0.951 HG12 ' HB3' ' C' ' 920' ' ' ALA . 26.9 m -117.44 136.26 55.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.488 -1.007 . . . . 7.0800000000000001 111.043 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 950' ' ' PHE . . . . . 0.447 ' CZ ' ' HB3' ' C' ' 921' ' ' ARG . 40.4 p90 -133.36 150.22 51.84 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.561 -0.712 . . . . 7.5899999999999999 109.336 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 68.4 m -118.07 -57.64 2.07 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.399 -0.813 . . . . 5.0300000000000002 111.81 -178.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 952' ' ' LEU . . . . . 0.454 ' O ' ' O ' ' C' ' 953' ' ' ILE . 46.4 tp -62.34 -75.69 0.07 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.423 -0.798 . . . . 1.01 111.505 -178.267 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 953' ' ' ILE . . . . . 0.57 HD12 ' N ' ' C' ' 954' ' ' LEU . 2.8 pp -49.41 -151.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.694 0 N-CA-C 114.563 1.32 . . . . 2.6000000000000001 114.563 -176.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 954' ' ' LEU . . . . . 0.868 HD23 ' CE2' ' C' ' 894' ' ' TYR . 0.0 OUTLIER 171.22 90.39 0.04 OUTLIER Pre-proline 0 N--CA 1.515 2.807 0 O-C-N 120.659 -1.276 . . . . 0.050000000000000003 111.941 -179.289 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 955' ' ' PRO . . . . . 0.629 ' C ' HD12 ' C' ' 956' ' ' LEU . 52.8 Cg_endo -83.0 92.37 0.9 Allowed 'Trans proline' 0 C--N 1.317 -1.113 0 N-CA-C 109.502 -0.999 . . . . 0.83999999999999997 109.502 178.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 956' ' ' LEU . . . . . 0.811 HD22 ' OH ' ' C' ' 894' ' ' TYR . 6.2 mp -125.11 147.86 48.82 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.066 -1.021 . . . . 0.040000000000000001 110.521 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -82.71 150.93 26.44 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 117.661 -1.162 . . . . 1.28 111.341 -178.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -64.65 118.11 8.41 Favored 'General case' 0 N--CA 1.506 2.365 0 CA-C-N 123.221 2.737 . . . . 0.17000000000000001 110.662 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.25 -18.56 53.89 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 110.903 -0.879 . . . . 0.040000000000000001 110.903 179.102 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 960' ' ' ASP . . . . . 0.418 ' HB3' ' NE ' ' C' ' 914' ' ' ARG . 0.4 OUTLIER -54.41 171.18 0.12 Allowed 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.265 -1.138 . . . . 0.040000000000000001 110.253 -179.55 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 961' ' ' THR . . . . . 0.543 HG23 ' O ' ' C' ' 886' ' ' PHE . 40.7 m -137.71 141.07 41.05 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.95 -1.094 . . . . 1.78 112.844 -177.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 962' ' ' VAL . . . . . 0.846 HG22 ' HB3' ' C' ' 886' ' ' PHE . 27.3 m -100.44 145.45 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.88 -0.512 . . . . 0.040000000000000001 110.666 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 5.3 t -138.01 144.14 40.94 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.715 -0.616 . . . . 0.71999999999999997 110.153 -178.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 964' ' ' VAL . . . . . 0.506 ' HA ' ' HA ' ' C' ' 911' ' ' VAL . 58.9 t -91.45 137.29 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.185 -0.947 . . . . 1.05 110.803 -179.02 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -92.83 125.64 37.53 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 103.441 -2.8 . . . . 3.02 103.441 173.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 966' ' ' LEU . . . . . 0.573 HD12 ' OE2' ' C' ' 909' ' ' GLU . 0.2 OUTLIER -134.53 56.81 1.83 Allowed 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.578 -0.897 . . . . 1.46 108.578 177.503 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 967' ' ' VAL . . . . . 0.488 HG23 ' C ' ' C' ' 966' ' ' LEU . 97.9 t -158.22 95.93 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.248 -1.019 . . . . 1.9399999999999999 108.248 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 92.8 mmm -142.87 59.28 1.43 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.724 -1.235 . . . . 0.0 108.462 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 134.35 119.62 1.98 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 107.282 -2.327 . . . . 2.1099999999999999 107.282 -178.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -82.56 -58.26 2.99 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.004 -1.291 . . . . 5.8899999999999997 110.531 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 48.1 tp -59.14 89.69 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.397 -0.814 . . . . 4.3600000000000003 110.313 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -142.71 -152.08 0.39 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.559 -0.713 . . . . 1.8300000000000001 109.97 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -115.93 166.99 11.35 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.391 -0.818 . . . . 4.3499999999999996 109.842 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 9.8 t -101.61 129.83 47.81 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.52 -0.738 . . . . 1.27 110.079 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -156.45 157.5 35.62 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.528 -0.732 . . . . 5.0199999999999996 110.553 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -143.22 85.91 9.4 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.658 -0.651 . . . . 2.4100000000000001 109.796 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -74.77 -169.86 0.68 Allowed 'Trans proline' 0 C--N 1.318 -1.045 0 O-C-N 123.189 1.099 . . . . 0.95999999999999996 111.325 -179.329 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 978' ' ' LEU . . . . . 0.514 ' N ' HD12 ' C' ' 978' ' ' LEU . 5.1 mp -125.86 155.9 40.46 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.474 -1.306 . . . . 0.62 107.474 177.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 979' ' ' THR . . . . . 0.46 HG23 ' C ' ' C' ' 978' ' ' LEU . 42.8 p -149.88 142.96 24.98 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.759 -1.213 . . . . 3.5699999999999998 111.334 -179.098 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 980' ' ' ILE . . . . . 0.691 ' HB ' HG21 ' C' ' 899' ' ' VAL . 50.0 mm -105.41 127.88 59.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 108.837 -0.801 . . . . 1.3300000000000001 108.837 179.335 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 981' ' ' PHE . . . . . 0.576 ' CE1' HD11 ' C' ' 896' ' ' LEU . 5.2 t80 -117.9 96.05 5.18 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.311 -0.868 . . . . 0.050000000000000003 111.579 -178.453 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 982' ' ' SER . . . . . . . . . . . . . 51.3 p -106.3 158.78 16.61 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 109.066 -0.716 . . . . 0.87 109.066 178.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 983' ' ' GLY . . . . . 0.418 ' HA3' ' CE2' ' C' ' 852' ' ' PHE . . . -171.81 113.18 0.48 Allowed Glycine 0 N--CA 1.496 2.662 0 N-CA-C 106.624 -2.59 . . . . 0.029999999999999999 106.624 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 984' ' ' ALA . . . . . 0.405 ' CB ' ' CZ ' ' A' ' 893' ' ' ARG . . . -108.75 152.01 25.43 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 114.323 1.231 . . . . 0.69999999999999996 114.323 -175.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 985' ' ' LEU . . . . . 0.47 HD13 HD22 ' C' ' 890' ' ' LEU . 55.6 tp -75.89 136.14 40.13 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.848 -1.157 . . . . 0.040000000000000001 109.832 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 986' ' ' LEU . . . . . 0.476 HD11 ' CD1' ' B' ' 986' ' ' LEU . 51.4 tp -106.35 -62.82 1.34 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.573 -0.704 . . . . 0.040000000000000001 110.302 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -144.92 147.15 32.41 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 107.816 -1.179 . . . . 0.040000000000000001 107.816 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -111.86 162.74 12.33 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 108.071 -2.011 . . . . 0.040000000000000001 108.071 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -72.46 112.96 16.91 Favored Pre-proline 0 N--CA 1.498 1.935 0 O-C-N 121.207 -1.173 . . . . 0.040000000000000001 109.531 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 990' ' ' PRO . . . . . 0.455 ' HD2' HD12 ' C' ' 992' ' ' LEU . 50.6 Cg_endo -87.66 70.13 3.31 Favored 'Trans proline' 0 C--N 1.319 -0.975 0 O-C-N 123.127 1.067 . . . . 0.45000000000000001 111.356 -178.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 991' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' C' ' 990' ' ' PRO . 71.4 mt-10 67.12 -74.11 0.07 Allowed 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 108.617 -0.883 . . . . 1.97 108.617 -177.512 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 992' ' ' LEU . . . . . 0.455 HD12 ' HD2' ' C' ' 990' ' ' PRO . 11.5 mt 50.55 21.03 0.79 Allowed 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.606 -0.684 . . . . 2.3799999999999999 111.646 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -92.54 156.77 16.91 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.89 -1.131 . . . . 3.79 110.038 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 68.6 m80 -146.56 91.84 2.09 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.52 -0.738 . . . . 3.5099999999999998 110.281 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 995' ' ' ALA . . . . . . . . . . . . 2.518 . . . . . . . 0 N--CA 1.504 2.248 0 O-C-N 120.95 -1.094 . . . . 2.73 110.589 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo . . . . . 0 N--CA 1.488 1.153 0 N-CA-C 109.581 -0.969 . . . . 3.8300000000000001 109.581 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 847' ' ' VAL . . . . . 0.432 HG12 ' HB2' ' A' ' 849' ' ' GLN . 61.4 t -132.03 103.56 14.19 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.636 -0.665 . . . . 1.8300000000000001 110.0 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 848' ' ' PRO . . . . . 0.722 ' O ' HG23 ' A' ' 850' ' ' VAL . 44.1 Cg_endo -69.5 -20.08 36.52 Favored 'Trans proline' 0 N--CA 1.487 1.117 0 O-C-N 123.271 1.142 . . . . 0.65000000000000002 111.139 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 849' ' ' GLN . . . . . 0.432 ' HB2' HG12 ' A' ' 847' ' ' VAL . 55.7 tt0 27.03 68.2 0.06 Allowed 'General case' 0 N--CA 1.518 2.957 0 N-CA-C 112.919 0.711 . . . . 2.5800000000000001 112.919 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 850' ' ' VAL . . . . . 0.722 HG23 ' O ' ' A' ' 848' ' ' PRO . 59.6 t -117.76 136.72 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.184 -0.948 . . . . 1.0900000000000001 111.459 -178.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 851' ' ' ALA . . . . . 0.534 ' HB3' ' HG ' ' A' ' 873' ' ' LEU . . . -125.83 156.65 39.22 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 105.783 -1.932 . . . . 0.040000000000000001 105.783 176.779 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 852' ' ' PHE . . . . . 0.468 ' CE2' HD11 ' A' ' 890' ' ' LEU . 24.2 p90 -160.34 128.61 4.7 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 121.014 1.734 . . . . 0.050000000000000003 108.732 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 853' ' ' SER . . . . . 0.401 ' CB ' ' HA ' ' A' ' 982' ' ' SER . 29.7 t -174.96 134.98 0.35 Allowed 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.053 -1.091 . . . . 0.040000000000000001 108.053 -178.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -132.83 156.48 47.07 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.99 -1.069 . . . . 0.67000000000000004 109.497 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 855' ' ' ALA . . . . . 0.744 ' HB3' ' CB ' ' A' ' 870' ' ' ARG . . . -122.73 144.61 49.05 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.787 0.803 . . . . 0.51000000000000001 111.65 -178.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 856' ' ' LEU . . . . . 0.692 ' CD1' HD23 ' A' ' 978' ' ' LEU . 3.4 tm? -112.05 134.33 53.66 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.787 -0.571 . . . . 0.050000000000000003 110.112 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 857' ' ' SER . . . . . 0.54 ' N ' HD13 ' A' ' 856' ' ' LEU . 55.8 p -150.63 16.7 0.79 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.531 -0.731 . . . . 1.3300000000000001 110.502 178.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 858' ' ' LEU . . . . . 0.762 HD22 ' OE2' ' A' ' 862' ' ' GLU . 4.4 pp -32.94 158.26 0.03 OUTLIER Pre-proline 0 N--CA 1.517 2.924 0 N-CA-C 113.432 0.901 . . . . 2.3300000000000001 113.432 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -64.41 -88.48 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.451 0 O-C-N 123.171 1.09 . . . . 2.3199999999999998 113.075 -178.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 55.8 ptt85 -128.7 -143.37 0.27 Allowed 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.817 -1.177 . . . . 0.040000000000000001 111.691 -177.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 19.4 m -40.4 128.16 2.38 Favored 'General case' 0 N--CA 1.508 2.468 0 O-C-N 121.43 -0.794 . . . . 1.3100000000000001 112.38 -178.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 862' ' ' GLU . . . . . 0.762 ' OE2' HD22 ' A' ' 858' ' ' LEU . 0.9 OUTLIER -102.69 156.74 34.9 Favored Pre-proline 0 N--CA 1.489 1.496 0 N-CA-C 107.8 -1.185 . . . . 4.5099999999999998 107.8 177.236 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 863' ' ' PRO . . . . . 0.412 ' HD2' ' CG ' ' A' ' 862' ' ' GLU . 43.6 Cg_endo -70.03 -12.71 32.9 Favored 'Trans proline' 0 C--N 1.314 -1.288 0 O-C-N 123.032 1.017 . . . . 2.2400000000000002 111.363 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -175.74 -136.38 2.32 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.972 -1.251 . . . . 0.040000000000000001 109.972 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 27.8 m -66.43 156.88 33.43 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.32 -1.106 . . . . 1.51 110.944 -178.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 866' ' ' VAL . . . . . 0.703 HG22 ' OE1' ' A' ' 862' ' ' GLU . 48.4 t -93.15 134.61 26.85 Favored Pre-proline 0 N--CA 1.495 1.8 0 N-CA-C 113.273 0.842 . . . . 0.78000000000000003 113.273 -174.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 867' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 866' ' ' VAL . 54.5 Cg_endo -90.36 -152.74 0.04 OUTLIER 'Trans proline' 0 CA--C 1.541 0.869 0 N-CA-C 108.761 -1.284 . . . . 0.92000000000000004 108.761 177.517 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 868' ' ' PHE . . . . . 0.452 ' CD1' ' N ' ' A' ' 868' ' ' PHE . 24.1 p90 -149.76 122.21 8.5 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.573 -1.329 . . . . 0.050000000000000003 109.901 179.336 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 49.0 p-10 -113.39 -2.33 13.99 Favored 'General case' 0 N--CA 1.498 1.972 0 C-N-CA 119.287 -0.965 . . . . 1.7 112.299 -179.001 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 870' ' ' ARG . . . . . 0.744 ' CB ' ' HB3' ' A' ' 855' ' ' ALA . 30.3 mmm180 -90.59 88.91 7.31 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.962 -1.086 . . . . 2.5899999999999999 110.67 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 58.3 t -74.54 97.31 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 120.95 -1.094 . . . . 1.9399999999999999 109.919 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 872' ' ' LEU . . . . . 0.456 HD11 ' HB2' ' A' ' 855' ' ' ALA . 92.8 mt -82.97 -47.24 11.96 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.526 -0.734 . . . . 1.0600000000000001 110.24 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 873' ' ' LEU . . . . . 0.534 ' HG ' ' HB3' ' A' ' 851' ' ' ALA . 46.9 tp -174.66 103.95 0.1 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.243 -0.911 . . . . 4.1799999999999997 108.689 178.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 874' ' ' ASN . . . . . 0.444 ' CB ' ' HA ' ' A' ' 852' ' ' PHE . 35.7 t-20 178.9 81.71 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.3 0 O-C-N 121.55 -0.719 . . . . 0.040000000000000001 109.751 -178.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -66.91 -47.25 72.35 Favored 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 119.241 -0.984 . . . . 3.3799999999999999 111.128 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 876' ' ' GLY . . . . . 0.411 ' HA3' ' CE2' ' A' ' 878' ' ' TYR . . . -73.95 -25.01 72.62 Favored Glycine 0 N--CA 1.495 2.573 0 O-C-N 121.275 -0.89 . . . . 0.040000000000000001 111.668 -178.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 82.86 -61.38 4.78 Favored Glycine 0 N--CA 1.501 3.023 0 N-CA-C 108.085 -2.006 . . . . 0.040000000000000001 108.085 -178.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 878' ' ' TYR . . . . . 0.411 ' CE2' ' HA3' ' A' ' 876' ' ' GLY . 88.1 m-85 60.41 -64.96 0.05 Allowed 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 114.28 1.215 . . . . 3.46 114.28 177.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 879' ' ' TYR . . . . . 0.479 ' CB ' ' CD2' ' A' ' 886' ' ' PHE . 19.6 p90 -111.53 107.15 16.23 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 114.5 1.296 . . . . 0.040000000000000001 114.5 -176.456 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -66.03 117.39 42.11 Favored Pre-proline 0 N--CA 1.497 1.903 0 O-C-N 121.402 -0.811 . . . . 0.02 110.1 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 881' ' ' PRO . . . . . 0.433 ' HG2' ' CD1' ' A' ' 868' ' ' PHE . 55.6 Cg_endo -75.92 0.05 9.7 Favored 'Trans proline' 0 N--CA 1.496 1.637 0 O-C-N 123.547 1.288 . . . . 0.39000000000000001 112.195 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -77.77 -63.87 1.28 Allowed 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 106.803 -1.554 . . . . 0.81000000000000005 106.803 178.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 44.9 p -93.03 -19.55 21.44 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.543 -0.91 . . . . 0.040000000000000001 108.543 177.163 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.7 20.16 60.35 Favored Glycine 0 N--CA 1.497 2.758 0 O-C-N 121.089 -1.007 . . . . 0.029999999999999999 111.545 178.425 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 885' ' ' VAL . . . . . 0.539 HG13 HG21 ' A' ' 961' ' ' THR . 88.1 t -74.19 91.96 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 C-N-CA 118.16 -1.416 . . . . 1.01 108.197 -179.475 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 886' ' ' PHE . . . . . 0.917 ' HB3' HG22 ' A' ' 962' ' ' VAL . 0.7 OUTLIER -90.27 105.75 18.02 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 115.158 -0.928 . . . . 0.050000000000000003 112.118 -177.248 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 887' ' ' THR . . . . . 0.425 ' O ' ' HD3' ' A' ' 889' ' ' PRO . 70.6 m -96.44 100.96 12.52 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 107.911 -1.144 . . . . 0.68000000000000005 107.911 177.383 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 888' ' ' ALA . . . . . . . . . . . . . . . -98.61 106.65 38.01 Favored Pre-proline 0 N--CA 1.503 2.201 0 N-CA-C 114.146 1.165 . . . . 0.25 114.146 -176.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 889' ' ' PRO . . . . . 0.425 ' HD3' ' O ' ' A' ' 887' ' ' THR . 55.2 Cg_endo -89.08 -12.94 3.17 Favored 'Trans proline' 0 CA--C 1.546 1.098 0 N-CA-C 109.121 -1.146 . . . . 1.6399999999999999 109.121 176.219 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 890' ' ' LEU . . . . . 1.077 HD22 HD13 ' A' ' 985' ' ' LEU . 56.0 mt -34.25 -51.07 0.43 Allowed 'General case' 0 N--CA 1.509 2.482 0 N-CA-C 113.972 1.101 . . . . 2.29 113.972 -177.452 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 51.51 94.89 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.363 0 O-C-N 121.186 -0.946 . . . . 0.63 110.331 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 156.09 -147.3 15.75 Favored Glycine 0 N--CA 1.48 1.601 0 N-CA-C 107.536 -2.226 . . . . 0.040000000000000001 107.536 -179.127 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 893' ' ' ARG . . . . . 0.465 ' CZ ' ' HB1' ' C' ' 984' ' ' ALA . 71.4 ttt-85 -109.13 127.76 54.44 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 107.576 -1.268 . . . . 3.0 107.576 177.367 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 894' ' ' TYR . . . . . 0.543 ' OH ' HD12 ' A' ' 896' ' ' LEU . 0.1 OUTLIER -130.28 144.54 51.43 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.987 -1.071 . . . . 0.040000000000000001 110.041 -179.075 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 895' ' ' LEU . . . . . 0.449 ' N ' ' CD1' ' A' ' 894' ' ' TYR . 39.9 tp -97.25 114.24 25.96 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.59 -0.694 . . . . 1.27 109.616 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 896' ' ' LEU . . . . . 0.543 HD12 ' OH ' ' A' ' 894' ' ' TYR . 9.7 tt -111.24 146.01 37.72 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.625 -0.672 . . . . 0.93999999999999995 110.812 -179.364 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 897' ' ' SER . . . . . . . . . . . . . 66.9 m -143.86 116.81 8.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.573 -0.705 . . . . 0.040000000000000001 110.503 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -106.57 146.77 30.25 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.258 -0.645 . . . . 0.47999999999999998 109.258 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 899' ' ' VAL . . . . . 0.725 HG21 ' HB ' ' A' ' 980' ' ' ILE . 88.3 t -97.47 119.18 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 C-N-CA 119.716 -0.794 . . . . 0.55000000000000004 111.277 -179.155 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 900' ' ' LEU . . . . . 0.437 ' N ' HD22 ' A' ' 900' ' ' LEU . 4.5 mm? -95.16 112.18 23.92 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 114.175 1.176 . . . . 1.5900000000000001 114.175 -175.564 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 17.6 m -64.54 140.99 58.93 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 107.398 -1.334 . . . . 0.050000000000000003 107.398 177.176 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -63.26 -66.27 2.64 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 110.479 -1.048 . . . . 0.029999999999999999 110.479 -179.403 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 2.2 m80 46.52 66.06 1.06 Allowed 'General case' 0 N--CA 1.507 2.42 0 O-C-N 121.474 -1.015 . . . . 3.2000000000000002 111.118 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 54.1 ptt85 -68.72 -6.44 26.32 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.585 -0.697 . . . . 2.9199999999999999 111.916 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 905' ' ' HIS . . . . . 0.483 ' O ' ' CB ' ' A' ' 906' ' ' GLU . 75.9 t60 -60.79 3.4 0.08 Allowed 'General case' 0 N--CA 1.505 2.314 0 O-C-N 120.936 -1.103 . . . . 2.8700000000000001 113.034 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 906' ' ' GLU . . . . . 0.483 ' CB ' ' O ' ' A' ' 905' ' ' HIS . 0.8 OUTLIER 93.4 -163.58 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.377 0 CA-C-N 120.552 1.523 . . . . 0.98999999999999999 112.192 178.789 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 907' ' ' LYS . . . . . 0.481 ' CB ' ' O ' ' A' ' 906' ' ' GLU . 42.6 tttt 88.64 161.73 0.06 Allowed 'General case' 0 N--CA 1.519 2.991 0 N-CA-C 107.675 -1.231 . . . . 5.25 107.675 -176.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 61.0 t -121.97 115.77 47.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 120.876 -1.14 . . . . 0.39000000000000001 110.815 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 909' ' ' GLU . . . . . 0.564 ' OE2' HD12 ' A' ' 966' ' ' LEU . 52.1 tp10 -100.71 132.62 46.01 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 107.19 -1.411 . . . . 1.72 107.19 176.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -156.82 120.64 4.28 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 106.731 -1.581 . . . . 0.67000000000000004 106.731 178.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 911' ' ' VAL . . . . . 0.684 HG22 HG13 ' A' ' 964' ' ' VAL . 95.6 t -83.18 131.99 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 C-N-CA 120.34 -0.544 . . . . 0.54000000000000004 110.756 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 72.8 mt -64.63 155.21 34.02 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.316 -0.865 . . . . 1.5 108.709 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 913' ' ' SER . . . . . 0.421 ' CB ' ' HB ' ' A' ' 919' ' ' VAL . 1.5 t -122.95 137.62 54.9 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.101 -1.074 . . . . 1.3700000000000001 108.101 177.01 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 914' ' ' ARG . . . . . 0.56 ' NH1' HD23 ' A' ' 956' ' ' LEU . 0.0 OUTLIER -64.1 153.73 36.71 Favored 'General case' 0 N--CA 1.505 2.308 0 O-C-N 120.834 -1.166 . . . . 4.2999999999999998 111.895 -178.884 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 915' ' ' SER . . . . . 0.423 ' CB ' ' O ' ' A' ' 914' ' ' ARG . 2.2 t 82.85 -31.91 0.09 Allowed 'General case' 0 N--CA 1.52 3.075 0 C-N-CA 123.977 0.911 . . . . 2.0499999999999998 112.452 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 916' ' ' ASN . . . . . 0.754 ' HB2' HG21 ' A' ' 919' ' ' VAL . 98.2 m-20 -121.64 -20.59 6.46 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 120.838 -1.164 . . . . 2.71 111.509 -179.123 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 917' ' ' GLN . . . . . 0.412 ' HB2' ' O ' ' A' ' 916' ' ' ASN . 51.1 mt-30 66.74 165.93 0.21 Allowed 'General case' 0 N--CA 1.52 3.045 0 N-CA-C 105.653 -1.98 . . . . 2.6800000000000002 105.653 -173.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.15 -125.04 32.46 Favored Glycine 1 N--CA 1.521 4.342 0 CA-C-N 123.423 2.828 . . . . 0.029999999999999999 107.1 -177.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 919' ' ' VAL . . . . . 0.754 HG21 ' HB2' ' A' ' 916' ' ' ASN . 76.7 t 51.71 94.9 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.229 0 O-C-N 121.466 -1.02 . . . . 1.3899999999999999 108.934 -178.106 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 920' ' ' ALA . . . . . 0.837 ' HB3' HG12 ' A' ' 949' ' ' VAL . . . -91.17 91.93 8.45 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.237 -0.985 . . . . 0.029999999999999999 110.986 -178.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 921' ' ' ARG . . . . . 0.719 ' HG3' HG23 ' A' ' 922' ' ' VAL . 42.4 ptt85 -84.2 -42.04 16.36 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 105.594 -2.002 . . . . 4.4199999999999999 105.594 175.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 922' ' ' VAL . . . . . 0.719 HG23 ' HG3' ' A' ' 921' ' ' ARG . 72.0 t -103.19 69.27 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 N-CA-C 105.446 -2.057 . . . . 0.84999999999999998 105.446 175.051 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 923' ' ' ASP . . . . . 0.643 ' HB2' ' HB1' ' A' ' 920' ' ' ALA . 19.4 t0 -91.0 135.94 33.41 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.783 0.801 . . . . 2.46 112.139 -176.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 13.8 t -147.6 104.31 3.6 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 108.096 -1.075 . . . . 0.69999999999999996 108.096 178.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -110.93 90.28 0.57 Allowed Glycine 0 N--CA 1.487 2.08 0 N-CA-C 108.988 -1.645 . . . . 0.040000000000000001 108.988 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.403 0 N-CA-C 109.4 -1.48 . . . . 0.040000000000000001 109.4 -179.625 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 31.0 m . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.007 0.432 . . . . 13.779999999999999 110.307 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 97.5 mt -113.55 129.68 56.51 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.519 -0.738 . . . . 13.76 110.46 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -152.28 168.51 31.44 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.103 -1.599 . . . . 9.1300000000000008 109.103 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 949' ' ' VAL . . . . . 0.837 HG12 ' HB3' ' A' ' 920' ' ' ALA . 34.9 m -118.81 130.35 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.48 -1.012 . . . . 7.0800000000000001 110.928 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 950' ' ' PHE . . . . . 0.463 ' CZ ' ' HB3' ' A' ' 921' ' ' ARG . 32.2 p90 -133.42 149.28 51.81 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.563 -0.711 . . . . 7.5899999999999999 109.31 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 19.6 m -119.42 -53.87 2.21 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.446 -0.784 . . . . 5.0300000000000002 112.144 -178.522 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 952' ' ' LEU . . . . . 0.505 HD23 ' HB2' ' C' ' 982' ' ' SER . 57.0 tp -59.98 -75.81 0.05 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.342 -0.849 . . . . 1.01 111.974 -177.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 953' ' ' ILE . . . . . 0.936 HD11 HD13 ' C' ' 872' ' ' LEU . 49.3 pt -53.1 -144.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.663 0 N-CA-C 113.718 1.007 . . . . 2.6000000000000001 113.718 -176.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 954' ' ' LEU . . . . . 0.715 HD22 ' O ' ' A' ' 954' ' ' LEU . 0.0 OUTLIER 167.5 83.83 0.02 OUTLIER Pre-proline 0 N--CA 1.512 2.66 0 O-C-N 120.998 -1.064 . . . . 0.050000000000000003 111.535 178.976 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 955' ' ' PRO . . . . . 0.65 ' C ' HD12 ' A' ' 956' ' ' LEU . 46.9 Cg_endo -74.02 98.14 1.06 Allowed 'Trans proline' 0 C--N 1.314 -1.285 0 N-CA-C 108.938 -1.216 . . . . 0.83999999999999997 108.938 177.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 956' ' ' LEU . . . . . 0.65 HD12 ' C ' ' A' ' 955' ' ' PRO . 10.0 mp -122.59 144.13 49.31 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.053 -1.029 . . . . 0.040000000000000001 110.276 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -83.61 150.7 25.74 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 117.719 -1.134 . . . . 1.28 111.456 -179.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -69.58 120.08 14.82 Favored 'General case' 0 N--CA 1.509 2.482 0 CA-C-N 122.99 2.632 . . . . 0.17000000000000001 111.373 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 93.34 -21.74 38.83 Favored Glycine 0 N--CA 1.5 2.959 0 N-CA-C 110.94 -0.864 . . . . 0.040000000000000001 110.94 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 960' ' ' ASP . . . . . 0.432 ' HB3' ' NE ' ' A' ' 914' ' ' ARG . 0.9 OUTLIER -51.88 171.3 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.476 -1.014 . . . . 0.040000000000000001 110.538 -179.481 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 961' ' ' THR . . . . . 0.539 HG21 HG13 ' A' ' 885' ' ' VAL . 43.7 m -134.81 134.93 41.37 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.953 -1.092 . . . . 1.78 111.641 -178.342 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 962' ' ' VAL . . . . . 0.917 HG22 ' HB3' ' A' ' 886' ' ' PHE . 33.0 m -100.48 145.34 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 C-N-CA 119.851 -0.739 . . . . 0.040000000000000001 110.628 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 5.3 t -138.36 146.52 42.39 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.935 -0.478 . . . . 0.71999999999999997 109.979 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 964' ' ' VAL . . . . . 0.684 HG13 HG22 ' A' ' 911' ' ' VAL . 60.3 t -94.14 136.63 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.102 -0.999 . . . . 1.05 110.416 -179.318 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -93.52 126.55 38.73 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 103.547 -2.76 . . . . 3.02 103.547 173.364 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 966' ' ' LEU . . . . . 0.564 HD12 ' OE2' ' A' ' 909' ' ' GLU . 0.5 OUTLIER -132.34 60.06 1.7 Allowed 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.251 -1.018 . . . . 1.46 108.251 177.466 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 967' ' ' VAL . . . . . 0.492 HG23 ' C ' ' A' ' 966' ' ' LEU . 95.9 t -158.2 96.65 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 N-CA-C 108.143 -1.058 . . . . 1.9399999999999999 108.143 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 90.4 mmm -143.26 59.53 1.4 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.716 -1.24 . . . . 0.0 108.272 178.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.33 119.81 1.96 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 106.994 -2.442 . . . . 2.1099999999999999 106.994 -178.155 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -82.2 -58.25 3.03 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 118.716 1.258 . . . . 5.8899999999999997 110.308 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 40.8 tp -59.12 90.53 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.493 -0.754 . . . . 4.3600000000000003 110.115 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -141.82 -154.33 0.51 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.588 -0.695 . . . . 1.8300000000000001 110.174 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -119.46 170.98 8.67 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.502 -0.749 . . . . 4.3499999999999996 110.338 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 10.7 t -101.47 130.22 47.67 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.535 -0.728 . . . . 1.27 109.962 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -156.3 158.73 37.96 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.481 -0.762 . . . . 5.0199999999999996 110.608 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.93 85.94 18.77 Favored Pre-proline 0 N--CA 1.5 2.048 0 O-C-N 121.611 -0.681 . . . . 2.4100000000000001 109.516 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -72.75 -171.83 0.83 Allowed 'Trans proline' 0 C--N 1.317 -1.109 0 O-C-N 123.31 1.163 . . . . 0.95999999999999996 111.389 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 978' ' ' LEU . . . . . 0.692 HD23 ' CD1' ' A' ' 856' ' ' LEU . 4.9 mp -127.89 154.32 45.64 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 107.608 -1.256 . . . . 0.62 107.608 178.067 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 979' ' ' THR . . . . . 0.456 HG23 ' C ' ' A' ' 978' ' ' LEU . 42.1 p -149.93 141.32 23.29 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.768 -1.208 . . . . 3.5699999999999998 111.181 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 980' ' ' ILE . . . . . 0.725 ' HB ' HG21 ' A' ' 899' ' ' VAL . 51.2 mm -107.06 128.06 62.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 109.006 -0.739 . . . . 1.3300000000000001 109.006 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 981' ' ' PHE . . . . . 0.431 ' HD1' ' HH ' ' A' ' 879' ' ' TYR . 5.7 t80 -121.73 98.22 5.86 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.417 -0.802 . . . . 0.050000000000000003 111.783 -178.383 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 982' ' ' SER . . . . . 0.401 ' HA ' ' CB ' ' A' ' 853' ' ' SER . 86.0 p -108.69 158.22 17.81 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.974 -0.75 . . . . 0.87 108.974 178.248 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . -171.82 108.58 0.28 Allowed Glycine 0 N--CA 1.498 2.78 0 N-CA-C 106.557 -2.617 . . . . 0.029999999999999999 106.557 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -109.4 148.21 31.49 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 114.337 1.236 . . . . 0.69999999999999996 114.337 -175.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 985' ' ' LEU . . . . . 1.077 HD13 HD22 ' A' ' 890' ' ' LEU . 44.7 tp -69.79 135.1 49.3 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 120.796 -1.19 . . . . 0.040000000000000001 110.115 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 986' ' ' LEU . . . . . 0.401 ' CD2' ' NH1' ' A' ' 893' ' ' ARG . 41.8 tp -105.96 -60.29 1.66 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.621 -0.674 . . . . 0.040000000000000001 109.914 179.582 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -143.88 146.26 32.89 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 107.627 -1.249 . . . . 0.040000000000000001 107.627 179.013 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.33 163.28 12.19 Favored Glycine 0 N--CA 1.495 2.628 0 N-CA-C 108.094 -2.002 . . . . 0.040000000000000001 108.094 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -76.0 112.52 20.8 Favored Pre-proline 0 N--CA 1.499 2.005 0 O-C-N 121.229 -1.159 . . . . 0.040000000000000001 109.402 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 990' ' ' PRO . . . . . 0.412 ' O ' ' HB2' ' A' ' 991' ' ' GLU . 49.7 Cg_endo -90.27 71.85 1.41 Allowed 'Trans proline' 0 C--N 1.319 -1.006 0 O-C-N 123.164 1.086 . . . . 0.45000000000000001 111.386 -178.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 991' ' ' GLU . . . . . 0.412 ' HB2' ' O ' ' A' ' 990' ' ' PRO . 67.0 mt-10 67.32 -73.69 0.08 Allowed 'General case' 0 N--CA 1.503 2.178 0 N-CA-C 108.483 -0.932 . . . . 1.97 108.483 -177.434 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 992' ' ' LEU . . . . . 0.402 HD12 ' HD2' ' A' ' 990' ' ' PRO . 10.6 mt 50.91 20.73 0.83 Allowed 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.583 -0.698 . . . . 2.3799999999999999 111.599 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -93.58 156.71 16.57 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.912 -1.117 . . . . 3.79 109.989 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -145.91 92.97 2.27 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.54 -0.725 . . . . 3.5099999999999998 110.312 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 995' ' ' ALA . . . . . . . . . . . . 2.517 . . . . . . . 0 N--CA 1.504 2.254 0 O-C-N 120.85 -1.157 . . . . 2.73 110.575 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo . . . . . 0 N--CA 1.488 1.188 0 N-CA-C 109.523 -0.991 . . . . 3.8300000000000001 109.523 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 847' ' ' VAL . . . . . 0.416 HG12 ' HB2' ' B' ' 849' ' ' GLN . 61.3 t -132.14 103.48 14.07 Favored Pre-proline 0 N--CA 1.494 1.775 0 O-C-N 121.621 -0.674 . . . . 1.8300000000000001 109.989 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 848' ' ' PRO . . . . . 0.708 ' O ' HG23 ' B' ' 850' ' ' VAL . 43.7 Cg_endo -69.45 -20.16 36.67 Favored 'Trans proline' 0 N--CA 1.487 1.133 0 O-C-N 123.245 1.129 . . . . 0.65000000000000002 111.064 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 849' ' ' GLN . . . . . 0.416 ' HB2' HG12 ' B' ' 847' ' ' VAL . 55.6 tt0 27.06 68.69 0.06 Allowed 'General case' 0 N--CA 1.518 2.96 0 N-CA-C 112.867 0.691 . . . . 2.5800000000000001 112.867 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 850' ' ' VAL . . . . . 0.708 HG23 ' O ' ' B' ' 848' ' ' PRO . 59.7 t -118.2 136.68 54.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.218 -0.926 . . . . 1.0900000000000001 111.382 -178.694 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 851' ' ' ALA . . . . . 0.512 ' HB3' ' HG ' ' B' ' 873' ' ' LEU . . . -126.09 156.11 40.53 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 105.774 -1.936 . . . . 0.040000000000000001 105.774 176.696 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 852' ' ' PHE . . . . . 0.472 ' CE2' HD11 ' B' ' 890' ' ' LEU . 23.8 p90 -159.73 129.1 5.26 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 121.022 1.737 . . . . 0.050000000000000003 108.631 179.342 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 30.0 t -175.24 134.72 0.33 Allowed 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.176 -1.046 . . . . 0.040000000000000001 108.176 -178.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -132.56 156.75 46.29 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.099 -1.001 . . . . 0.67000000000000004 109.576 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 855' ' ' ALA . . . . . 0.739 ' HB3' ' CB ' ' B' ' 870' ' ' ARG . . . -122.9 145.13 48.73 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.774 0.797 . . . . 0.51000000000000001 111.697 -178.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 856' ' ' LEU . . . . . 0.684 ' CD1' HD23 ' B' ' 978' ' ' LEU . 3.4 tm? -112.51 134.01 54.27 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.743 -0.598 . . . . 0.050000000000000003 110.105 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 857' ' ' SER . . . . . 0.526 ' N ' HD13 ' B' ' 856' ' ' LEU . 56.3 p -150.37 16.99 0.83 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.561 -0.712 . . . . 1.3300000000000001 110.513 178.716 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 858' ' ' LEU . . . . . 0.763 HD22 ' OE2' ' B' ' 862' ' ' GLU . 4.4 pp -33.31 158.26 0.04 OUTLIER Pre-proline 0 N--CA 1.517 2.924 0 N-CA-C 113.33 0.863 . . . . 2.3300000000000001 113.33 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -64.5 -88.43 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.421 0 O-C-N 123.207 1.109 . . . . 2.3199999999999998 113.103 -178.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 55.8 ptt85 -128.71 -143.45 0.27 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.87 -1.144 . . . . 0.040000000000000001 111.729 -177.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 19.3 m -40.23 127.53 2.27 Favored 'General case' 0 N--CA 1.509 2.491 0 O-C-N 121.455 -0.778 . . . . 1.3100000000000001 112.359 -178.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 862' ' ' GLU . . . . . 0.763 ' OE2' HD22 ' B' ' 858' ' ' LEU . 0.9 OUTLIER -102.09 156.77 34.82 Favored Pre-proline 0 N--CA 1.488 1.465 0 N-CA-C 107.86 -1.163 . . . . 4.5099999999999998 107.86 177.138 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 863' ' ' PRO . . . . . 0.414 ' HD2' ' CG ' ' B' ' 862' ' ' GLU . 43.7 Cg_endo -69.81 -13.06 34.03 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 O-C-N 123.082 1.043 . . . . 2.2400000000000002 111.419 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -175.61 -135.91 2.21 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.993 -1.243 . . . . 0.040000000000000001 109.993 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 28.0 m -66.71 157.68 32.08 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.253 -1.145 . . . . 1.51 110.925 -178.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 866' ' ' VAL . . . . . 0.688 HG22 ' OE1' ' B' ' 862' ' ' GLU . 48.5 t -93.78 134.53 26.17 Favored Pre-proline 0 N--CA 1.495 1.784 0 N-CA-C 113.302 0.853 . . . . 0.78000000000000003 113.302 -174.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 867' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' B' ' 866' ' ' VAL . 55.2 Cg_endo -90.38 -152.94 0.04 OUTLIER 'Trans proline' 0 CA--C 1.541 0.867 0 O-C-N 123.517 1.272 . . . . 0.92000000000000004 108.831 177.472 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 868' ' ' PHE . . . . . 0.45 ' CD1' ' N ' ' B' ' 868' ' ' PHE . 23.6 p90 -149.55 122.16 8.59 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 120.633 -1.292 . . . . 0.050000000000000003 109.956 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 49.2 p-10 -113.29 -1.94 14.15 Favored 'General case' 0 N--CA 1.498 1.971 0 C-N-CA 119.27 -0.972 . . . . 1.7 112.289 -179.014 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 870' ' ' ARG . . . . . 0.739 ' CB ' ' HB3' ' B' ' 855' ' ' ALA . 30.3 mmm180 -90.96 88.68 7.12 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.899 -1.126 . . . . 2.5899999999999999 110.784 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 58.5 t -74.56 97.32 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.005 -1.059 . . . . 1.9399999999999999 109.884 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 872' ' ' LEU . . . . . 0.446 HD11 ' HB2' ' B' ' 855' ' ' ALA . 94.7 mt -83.16 -46.99 12.07 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.488 -0.757 . . . . 1.0600000000000001 110.14 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 873' ' ' LEU . . . . . 0.512 ' HG ' ' HB3' ' B' ' 851' ' ' ALA . 46.5 tp -174.65 104.01 0.1 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.305 -0.872 . . . . 4.1799999999999997 108.703 178.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 874' ' ' ASN . . . . . 0.444 ' CB ' ' HA ' ' B' ' 852' ' ' PHE . 35.6 t-20 178.86 81.96 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.304 0 O-C-N 121.643 -0.66 . . . . 0.040000000000000001 109.76 -178.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -67.16 -47.31 71.4 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 119.268 -0.973 . . . . 3.3799999999999999 111.076 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 876' ' ' GLY . . . . . 0.404 ' HA3' ' CE2' ' B' ' 878' ' ' TYR . . . -73.87 -25.27 72.16 Favored Glycine 0 N--CA 1.494 2.562 0 O-C-N 121.336 -0.852 . . . . 0.040000000000000001 111.584 -178.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 83.01 -61.29 4.8 Favored Glycine 0 N--CA 1.501 3.003 0 N-CA-C 108.091 -2.003 . . . . 0.040000000000000001 108.091 -178.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 878' ' ' TYR . . . . . 0.404 ' CE2' ' HA3' ' B' ' 876' ' ' GLY . 88.4 m-85 60.47 -64.93 0.06 Allowed 'General case' 0 N--CA 1.504 2.248 0 N-CA-C 114.303 1.223 . . . . 3.46 114.303 177.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 879' ' ' TYR . . . . . 0.467 ' CB ' ' CD2' ' B' ' 886' ' ' PHE . 19.6 p90 -111.47 107.45 16.66 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 114.457 1.28 . . . . 0.040000000000000001 114.457 -176.518 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -66.21 117.17 40.6 Favored Pre-proline 0 N--CA 1.497 1.924 0 O-C-N 121.422 -0.798 . . . . 0.02 110.145 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 881' ' ' PRO . . . . . 0.42 ' HG2' ' CD1' ' B' ' 868' ' ' PHE . 55.5 Cg_endo -75.81 -0.12 9.85 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 O-C-N 123.57 1.3 . . . . 0.39000000000000001 112.15 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 88.4 mt-10 -77.45 -63.65 1.33 Allowed 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 106.801 -1.555 . . . . 0.81000000000000005 106.801 178.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 45.7 p -93.79 -18.82 21.64 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.678 -0.86 . . . . 0.040000000000000001 108.678 177.23 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.24 20.27 60.95 Favored Glycine 0 N--CA 1.497 2.711 0 O-C-N 121.11 -0.994 . . . . 0.029999999999999999 111.554 178.155 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 885' ' ' VAL . . . . . 0.524 HG13 HG21 ' B' ' 961' ' ' THR . 87.8 t -74.14 91.9 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 C-N-CA 118.14 -1.424 . . . . 1.01 108.097 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 886' ' ' PHE . . . . . 0.901 ' HB3' HG22 ' B' ' 962' ' ' VAL . 0.7 OUTLIER -90.32 105.82 18.07 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-N 115.182 -0.917 . . . . 0.050000000000000003 111.999 -177.259 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 887' ' ' THR . . . . . 0.423 ' O ' ' HD3' ' B' ' 889' ' ' PRO . 69.7 m -96.47 101.15 12.73 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 107.868 -1.16 . . . . 0.68000000000000005 107.868 177.313 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 888' ' ' ALA . . . . . . . . . . . . . . . -98.78 106.51 37.73 Favored Pre-proline 0 N--CA 1.502 2.146 0 N-CA-C 114.153 1.168 . . . . 0.25 114.153 -176.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 889' ' ' PRO . . . . . 0.423 ' HD3' ' O ' ' B' ' 887' ' ' THR . 55.3 Cg_endo -89.02 -13.07 3.16 Favored 'Trans proline' 0 CA--C 1.546 1.105 0 C-N-CA 121.01 1.14 . . . . 1.6399999999999999 109.183 176.273 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 890' ' ' LEU . . . . . 1.077 HD22 HD13 ' B' ' 985' ' ' LEU . 56.5 mt -34.04 -51.29 0.42 Allowed 'General case' 0 N--CA 1.51 2.535 0 N-CA-C 113.997 1.11 . . . . 2.29 113.997 -177.525 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 51.54 94.84 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.336 0 O-C-N 121.13 -0.981 . . . . 0.63 110.379 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . 156.13 -147.54 16.32 Favored Glycine 0 N--CA 1.48 1.577 0 N-CA-C 107.451 -2.26 . . . . 0.040000000000000001 107.451 -179.102 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 72.0 ttt-85 -108.86 127.72 54.28 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 107.609 -1.256 . . . . 3.0 107.609 177.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 894' ' ' TYR . . . . . 0.542 ' OH ' HD12 ' B' ' 896' ' ' LEU . 0.1 OUTLIER -130.22 144.67 51.5 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.048 -1.032 . . . . 0.040000000000000001 110.056 -179.064 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 895' ' ' LEU . . . . . 0.45 ' N ' ' CD1' ' B' ' 894' ' ' TYR . 39.7 tp -97.58 114.33 26.22 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.628 -0.67 . . . . 1.27 109.621 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 896' ' ' LEU . . . . . 0.542 HD12 ' OH ' ' B' ' 894' ' ' TYR . 9.6 tt -111.34 145.62 38.54 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.574 -0.704 . . . . 0.93999999999999995 110.884 -179.245 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 897' ' ' SER . . . . . . . . . . . . . 65.9 m -143.53 116.56 8.88 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.636 -0.665 . . . . 0.040000000000000001 110.467 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -106.23 146.68 30.01 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 109.297 -0.631 . . . . 0.47999999999999998 109.297 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 899' ' ' VAL . . . . . 0.731 HG21 ' HB ' ' B' ' 980' ' ' ILE . 87.7 t -97.35 118.76 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 C-N-CA 119.757 -0.777 . . . . 0.55000000000000004 111.403 -179.143 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 900' ' ' LEU . . . . . 0.446 HD13 ' HA ' ' B' ' 900' ' ' LEU . 4.5 mm? -94.81 111.9 23.66 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 114.283 1.216 . . . . 1.5900000000000001 114.283 -175.501 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 17.4 m -64.4 141.06 58.91 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 107.316 -1.365 . . . . 0.050000000000000003 107.316 177.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -63.58 -66.14 2.69 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 110.476 -1.05 . . . . 0.029999999999999999 110.476 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 2.1 m80 46.44 65.99 1.07 Allowed 'General case' 0 N--CA 1.507 2.383 0 O-C-N 121.447 -1.031 . . . . 3.2000000000000002 111.099 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 54.1 ptt85 -68.54 -6.75 27.11 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.64 -0.662 . . . . 2.9199999999999999 111.942 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 905' ' ' HIS . . . . . 0.482 ' O ' ' CB ' ' B' ' 906' ' ' GLU . 75.9 t60 -60.19 2.82 0.08 Allowed 'General case' 0 N--CA 1.506 2.33 0 O-C-N 120.914 -1.116 . . . . 2.8700000000000001 113.073 -179.366 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 906' ' ' GLU . . . . . 0.482 ' CB ' ' O ' ' B' ' 905' ' ' HIS . 0.8 OUTLIER 93.75 -163.76 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.387 0 CA-C-N 120.6 1.545 . . . . 0.98999999999999999 112.072 178.939 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 907' ' ' LYS . . . . . 0.472 ' CB ' ' O ' ' B' ' 906' ' ' GLU . 42.9 tttt 88.84 161.52 0.06 Allowed 'General case' 0 N--CA 1.519 2.979 0 N-CA-C 107.717 -1.216 . . . . 5.25 107.717 -176.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 61.7 t -121.7 115.65 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 120.901 -1.125 . . . . 0.39000000000000001 110.926 -179.39 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 909' ' ' GLU . . . . . 0.551 ' OE2' HD12 ' B' ' 966' ' ' LEU . 52.2 tp10 -100.75 132.64 46.05 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 107.222 -1.399 . . . . 1.72 107.222 176.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -156.99 120.95 4.27 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 106.703 -1.592 . . . . 0.67000000000000004 106.703 178.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 911' ' ' VAL . . . . . 0.681 HG22 HG13 ' B' ' 964' ' ' VAL . 93.9 t -83.48 132.1 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.835 -0.54 . . . . 0.54000000000000004 110.71 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 72.3 mt -64.58 155.44 33.14 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.326 -0.859 . . . . 1.5 108.694 178.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 913' ' ' SER . . . . . 0.413 ' CB ' ' HB ' ' B' ' 919' ' ' VAL . 1.6 t -123.47 136.69 54.72 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.122 -1.066 . . . . 1.3700000000000001 108.122 177.023 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 914' ' ' ARG . . . . . 0.56 ' NH1' HD23 ' B' ' 956' ' ' LEU . 0.0 OUTLIER -63.08 153.57 33.71 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 120.839 -1.163 . . . . 4.2999999999999998 111.981 -178.784 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 915' ' ' SER . . . . . 0.416 ' CB ' ' O ' ' B' ' 914' ' ' ARG . 2.2 t 83.02 -32.2 0.08 Allowed 'General case' 0 N--CA 1.521 3.095 0 C-N-CA 124.03 0.932 . . . . 2.0499999999999998 112.404 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 916' ' ' ASN . . . . . 0.789 ' HB2' HG21 ' B' ' 919' ' ' VAL . 98.1 m-20 -121.26 -20.85 6.57 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.867 -1.146 . . . . 2.71 111.607 -179.094 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 917' ' ' GLN . . . . . 0.415 ' HB2' ' O ' ' B' ' 916' ' ' ASN . 50.8 mt-30 66.75 165.51 0.21 Allowed 'General case' 0 N--CA 1.521 3.103 0 N-CA-C 105.661 -1.977 . . . . 2.6800000000000002 105.661 -173.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.8 -125.23 34.58 Favored Glycine 1 N--CA 1.521 4.304 0 CA-C-N 123.532 2.878 . . . . 0.029999999999999999 106.958 -177.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 919' ' ' VAL . . . . . 0.789 HG21 ' HB2' ' B' ' 916' ' ' ASN . 79.9 t 51.5 95.08 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 O-C-N 121.456 -1.026 . . . . 1.3899999999999999 108.959 -178.032 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 920' ' ' ALA . . . . . 0.851 ' HB3' HG12 ' B' ' 949' ' ' VAL . . . -91.26 91.75 8.33 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.207 -0.997 . . . . 0.029999999999999999 110.904 -179.009 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 921' ' ' ARG . . . . . 0.712 ' HG3' HG23 ' B' ' 922' ' ' VAL . 42.4 ptt85 -84.17 -41.9 16.54 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 105.58 -2.007 . . . . 4.4199999999999999 105.58 175.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 922' ' ' VAL . . . . . 0.712 HG23 ' HG3' ' B' ' 921' ' ' ARG . 71.0 t -103.26 68.96 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 N-CA-C 105.53 -2.026 . . . . 0.84999999999999998 105.53 175.072 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 923' ' ' ASP . . . . . 0.64 ' HB2' ' HB1' ' B' ' 920' ' ' ALA . 19.4 t0 -90.7 136.04 33.32 Favored 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 121.779 0.8 . . . . 2.46 112.147 -176.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 924' ' ' SER . . . . . . . . . . . . . 14.1 t -147.62 104.04 3.58 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.184 -1.043 . . . . 0.69999999999999996 108.184 178.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -110.63 90.24 0.57 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 108.979 -1.649 . . . . 0.040000000000000001 108.979 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.425 0 N-CA-C 109.386 -1.486 . . . . 0.040000000000000001 109.386 -179.709 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 32.3 m . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.031 0.444 . . . . 13.779999999999999 110.254 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 97.6 mt -112.81 129.64 56.37 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.509 -0.744 . . . . 13.76 110.434 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -151.82 167.89 31.1 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.127 -1.589 . . . . 9.1300000000000008 109.127 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 949' ' ' VAL . . . . . 0.851 HG12 ' HB3' ' B' ' 920' ' ' ALA . 35.3 m -118.62 130.12 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.499 -1.001 . . . . 7.0800000000000001 110.852 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 950' ' ' PHE . . . . . 0.455 ' CZ ' ' HB3' ' B' ' 921' ' ' ARG . 32.6 p90 -133.19 149.44 52.03 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.584 -0.697 . . . . 7.5899999999999999 109.248 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 19.4 m -119.5 -53.7 2.21 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.406 -0.809 . . . . 5.0300000000000002 112.022 -178.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 952' ' ' LEU . . . . . 0.429 ' O ' ' O ' ' B' ' 953' ' ' ILE . 56.5 tp -60.32 -75.67 0.06 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.442 -0.786 . . . . 1.01 111.966 -177.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 953' ' ' ILE . . . . . 0.508 ' O ' ' HB3' ' B' ' 954' ' ' LEU . 49.2 pt -53.02 -144.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.637 0 N-CA-C 113.749 1.018 . . . . 2.6000000000000001 113.749 -176.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 954' ' ' LEU . . . . . 0.711 HD22 ' O ' ' B' ' 954' ' ' LEU . 0.0 OUTLIER 167.48 83.58 0.02 OUTLIER Pre-proline 0 N--CA 1.512 2.67 0 O-C-N 120.977 -1.077 . . . . 0.050000000000000003 111.429 178.915 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 955' ' ' PRO . . . . . 0.654 ' C ' HD12 ' B' ' 956' ' ' LEU . 46.2 Cg_endo -74.07 98.4 1.08 Allowed 'Trans proline' 0 C--N 1.313 -1.315 0 N-CA-C 108.863 -1.245 . . . . 0.83999999999999997 108.863 177.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 956' ' ' LEU . . . . . 0.654 HD12 ' C ' ' B' ' 955' ' ' PRO . 10.0 mp -122.85 144.02 49.48 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.056 -1.027 . . . . 0.040000000000000001 110.22 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -83.43 151.1 25.65 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 117.829 -1.082 . . . . 1.28 111.39 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -69.75 119.91 14.7 Favored 'General case' 0 N--CA 1.509 2.479 0 CA-C-N 122.857 2.571 . . . . 0.17000000000000001 111.368 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 93.35 -21.91 37.92 Favored Glycine 0 N--CA 1.501 2.989 0 N-CA-C 110.949 -0.86 . . . . 0.040000000000000001 110.949 178.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 960' ' ' ASP . . . . . 0.433 ' HB3' ' NE ' ' B' ' 914' ' ' ARG . 0.9 OUTLIER -51.65 171.23 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.46 -1.023 . . . . 0.040000000000000001 110.514 -179.411 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 961' ' ' THR . . . . . 0.524 HG21 HG13 ' B' ' 885' ' ' VAL . 42.0 m -134.67 135.08 41.8 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.025 -1.047 . . . . 1.78 111.655 -178.3 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 962' ' ' VAL . . . . . 0.901 HG22 ' HB3' ' B' ' 886' ' ' PHE . 33.0 m -100.66 145.22 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 C-N-CA 119.938 -0.705 . . . . 0.040000000000000001 110.661 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 5.2 t -138.27 146.22 42.23 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.943 -0.473 . . . . 0.71999999999999997 110.042 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 964' ' ' VAL . . . . . 0.681 HG13 HG22 ' B' ' 911' ' ' VAL . 59.9 t -94.01 136.27 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.04 -1.037 . . . . 1.05 110.433 -179.25 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -93.29 126.32 38.34 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 103.571 -2.752 . . . . 3.02 103.571 173.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 966' ' ' LEU . . . . . 0.551 HD12 ' OE2' ' B' ' 909' ' ' GLU . 0.5 OUTLIER -132.08 59.98 1.69 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.324 -0.991 . . . . 1.46 108.324 177.512 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 967' ' ' VAL . . . . . 0.491 HG23 ' C ' ' B' ' 966' ' ' LEU . 95.7 t -158.23 96.32 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 108.222 -1.029 . . . . 1.9399999999999999 108.222 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 90.5 mmm -142.85 59.54 1.43 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.8 -1.187 . . . . 0.0 108.312 178.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.23 119.67 1.95 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 107.06 -2.416 . . . . 2.1099999999999999 107.06 -178.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -81.92 -58.24 3.07 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.106 -1.232 . . . . 5.8899999999999997 110.353 -179.481 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 40.9 tp -59.14 90.22 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.423 -0.798 . . . . 4.3600000000000003 110.103 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -141.56 -154.05 0.5 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.574 -0.704 . . . . 1.8300000000000001 110.156 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -119.64 171.2 8.54 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.509 -0.745 . . . . 4.3499999999999996 110.336 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 10.7 t -101.61 130.2 47.88 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.53 -0.731 . . . . 1.27 109.942 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -156.26 158.79 38.12 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.443 -0.786 . . . . 5.0199999999999996 110.598 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.01 85.94 18.55 Favored Pre-proline 0 N--CA 1.5 2.031 0 O-C-N 121.647 -0.658 . . . . 2.4100000000000001 109.541 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -72.76 -171.88 0.84 Allowed 'Trans proline' 0 C--N 1.317 -1.087 0 O-C-N 123.342 1.18 . . . . 0.95999999999999996 111.408 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 978' ' ' LEU . . . . . 0.684 HD23 ' CD1' ' B' ' 856' ' ' LEU . 4.9 mp -127.74 154.56 45.21 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 107.649 -1.241 . . . . 0.62 107.649 178.055 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 979' ' ' THR . . . . . 0.464 HG23 ' C ' ' B' ' 978' ' ' LEU . 41.8 p -150.17 141.34 23.11 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.808 -1.183 . . . . 3.5699999999999998 111.17 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 980' ' ' ILE . . . . . 0.731 ' HB ' HG21 ' B' ' 899' ' ' VAL . 51.3 mm -107.09 127.74 62.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 108.985 -0.746 . . . . 1.3300000000000001 108.985 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -121.56 98.57 6.03 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.395 -0.816 . . . . 0.050000000000000003 111.817 -178.362 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 98.8 p -109.34 158.73 17.6 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.467 -0.771 . . . . 0.87 109.013 178.226 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 983' ' ' GLY . . . . . . . . . . . . . . . -171.86 108.84 0.29 Allowed Glycine 0 N--CA 1.497 2.716 0 N-CA-C 106.609 -2.596 . . . . 0.029999999999999999 106.609 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -109.34 147.88 31.99 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 114.177 1.177 . . . . 0.69999999999999996 114.177 -175.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 985' ' ' LEU . . . . . 1.077 HD13 HD22 ' B' ' 890' ' ' LEU . 44.2 tp -69.67 135.22 49.6 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.851 -1.155 . . . . 0.040000000000000001 110.057 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 986' ' ' LEU . . . . . 0.568 HD11 HD11 ' C' ' 986' ' ' LEU . 42.2 tp -106.12 -60.45 1.64 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.635 -0.665 . . . . 0.040000000000000001 109.895 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -143.83 146.05 32.78 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.581 -1.266 . . . . 0.040000000000000001 107.581 179.07 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.27 162.91 12.25 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 108.091 -2.003 . . . . 0.040000000000000001 108.091 179.165 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -75.55 112.5 19.59 Favored Pre-proline 0 N--CA 1.499 1.991 0 CA-C-N 118.503 1.152 . . . . 0.040000000000000001 109.414 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 990' ' ' PRO . . . . . 0.417 ' O ' ' HB2' ' B' ' 991' ' ' GLU . 49.8 Cg_endo -90.16 71.68 1.49 Allowed 'Trans proline' 0 C--N 1.319 -1.006 0 O-C-N 123.151 1.079 . . . . 0.45000000000000001 111.399 -178.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 991' ' ' GLU . . . . . 0.417 ' HB2' ' O ' ' B' ' 990' ' ' PRO . 66.9 mt-10 67.39 -73.65 0.08 Allowed 'General case' 0 N--CA 1.503 2.203 0 N-CA-C 108.516 -0.92 . . . . 1.97 108.516 -177.438 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 992' ' ' LEU . . . . . 0.461 ' HA ' HD23 ' B' ' 992' ' ' LEU . 10.8 mt 51.03 20.45 0.82 Allowed 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.639 -0.663 . . . . 2.3799999999999999 111.738 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -93.22 156.79 16.62 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.897 -1.127 . . . . 3.79 109.987 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 67.3 m80 -146.05 92.32 2.18 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.538 -0.726 . . . . 3.5099999999999998 110.386 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 995' ' ' ALA . . . . . . . . . . . . 2.516 . . . . . . . 0 N--CA 1.503 2.204 0 O-C-N 120.946 -1.096 . . . . 2.73 110.625 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo . . . . . 0 N--CA 1.487 1.147 0 N-CA-C 109.469 -1.012 . . . . 3.8300000000000001 109.469 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 847' ' ' VAL . . . . . . . . . . . . . 59.1 t -131.62 102.8 15.0 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.621 -0.675 . . . . 1.8300000000000001 110.311 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 848' ' ' PRO . . . . . 0.686 ' O ' HG23 ' C' ' 850' ' ' VAL . 44.7 Cg_endo -70.49 -21.37 30.17 Favored 'Trans proline' 0 N--CA 1.487 1.1 0 O-C-N 123.331 1.174 . . . . 0.65000000000000002 111.186 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 849' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 27.94 69.25 0.07 Allowed 'General case' 0 N--CA 1.519 2.999 0 N-CA-C 112.703 0.631 . . . . 2.5800000000000001 112.703 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 850' ' ' VAL . . . . . 0.686 HG23 ' O ' ' C' ' 848' ' ' PRO . 49.5 t -119.62 135.0 61.39 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.152 -0.968 . . . . 1.0900000000000001 111.764 -178.613 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 851' ' ' ALA . . . . . 0.59 ' HB3' ' HG ' ' C' ' 873' ' ' LEU . . . -127.17 154.88 44.23 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 105.517 -2.031 . . . . 0.040000000000000001 105.517 176.403 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 852' ' ' PHE . . . . . 0.449 ' CD1' ' N ' ' C' ' 852' ' ' PHE . 16.8 p90 -160.51 126.68 4.08 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 121.107 1.776 . . . . 0.050000000000000003 108.633 178.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 7.8 t -176.31 134.36 0.24 Allowed 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.012 -1.107 . . . . 0.040000000000000001 108.012 -179.007 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 854' ' ' ALA . . . . . 0.463 ' HB1' ' HD2' ' C' ' 868' ' ' PHE . . . -130.57 156.37 44.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.141 -0.974 . . . . 0.67000000000000004 109.505 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 855' ' ' ALA . . . . . 0.755 ' HB3' ' CB ' ' C' ' 870' ' ' ARG . . . -122.09 142.87 49.93 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 121.881 0.848 . . . . 0.51000000000000001 111.266 -179.212 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 856' ' ' LEU . . . . . 0.786 HD12 ' HG ' ' C' ' 978' ' ' LEU . 3.3 tm? -111.85 136.46 51.1 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.626 -0.672 . . . . 0.050000000000000003 109.923 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 857' ' ' SER . . . . . 0.629 ' N ' HD13 ' C' ' 856' ' ' LEU . 1.1 m -153.54 15.67 0.51 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.462 -0.774 . . . . 1.3300000000000001 111.661 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 858' ' ' LEU . . . . . 0.711 ' CD2' HD11 ' C' ' 856' ' ' LEU . 4.0 pp -34.91 160.8 0.04 OUTLIER Pre-proline 0 N--CA 1.518 2.944 0 N-CA-C 113.172 0.804 . . . . 2.3300000000000001 113.172 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -62.13 -87.12 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 120.992 1.128 . . . . 2.3199999999999998 113.779 -177.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 54.0 ptt85 -129.74 -142.79 0.25 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 120.883 -1.135 . . . . 0.040000000000000001 111.77 -177.298 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 67.4 m -38.82 130.83 1.41 Allowed 'General case' 0 N--CA 1.51 2.572 0 O-C-N 121.598 -0.689 . . . . 1.3100000000000001 112.17 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.47 158.55 31.59 Favored Pre-proline 0 N--CA 1.487 1.416 0 N-CA-C 108.633 -0.877 . . . . 4.5099999999999998 108.633 177.718 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -71.47 -14.52 30.81 Favored 'Trans proline' 0 C--N 1.313 -1.314 0 O-C-N 123.185 1.097 . . . . 2.2400000000000002 111.693 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -177.95 -134.28 2.03 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.681 -1.367 . . . . 0.040000000000000001 109.681 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 7.1 m -67.84 151.18 47.6 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.251 -1.146 . . . . 1.51 110.477 -179.169 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 866' ' ' VAL . . . . . 0.444 HG13 ' CD2' ' C' ' 858' ' ' LEU . 53.7 t -94.87 134.28 25.17 Favored Pre-proline 0 N--CA 1.497 1.888 0 N-CA-C 113.401 0.889 . . . . 0.78000000000000003 113.401 -174.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 867' ' ' PRO . . . . . 0.524 ' O ' HD23 ' C' ' 856' ' ' LEU . 55.2 Cg_endo -89.07 -150.14 0.04 OUTLIER 'Trans proline' 0 CA--C 1.543 0.936 0 O-C-N 123.526 1.277 . . . . 0.92000000000000004 109.345 178.017 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 868' ' ' PHE . . . . . 0.463 ' HD2' ' HB1' ' C' ' 854' ' ' ALA . 14.9 p90 -148.9 123.76 9.95 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.68 -1.262 . . . . 0.050000000000000003 109.653 179.157 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 49.5 p-10 -112.61 -3.1 14.39 Favored 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 119.273 -0.971 . . . . 1.7 112.492 -178.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 870' ' ' ARG . . . . . 0.755 ' CB ' ' HB3' ' C' ' 855' ' ' ALA . 26.7 mmm180 -91.68 87.65 6.4 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.925 -1.109 . . . . 2.5899999999999999 111.03 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 57.9 t -73.68 97.56 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 120.919 -1.113 . . . . 1.9399999999999999 109.269 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 872' ' ' LEU . . . . . 0.936 HD13 HD11 ' A' ' 953' ' ' ILE . 96.3 mt -87.17 -45.04 11.04 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.564 -0.71 . . . . 1.0600000000000001 110.736 -179.511 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 873' ' ' LEU . . . . . 0.59 ' HG ' ' HB3' ' C' ' 851' ' ' ALA . 31.1 tp -171.99 102.3 0.17 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.144 -0.972 . . . . 4.1799999999999997 108.975 178.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 874' ' ' ASN . . . . . 0.439 ' CB ' ' HA ' ' C' ' 852' ' ' PHE . 35.0 t-20 176.97 82.72 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.265 0 N-CA-C 108.782 -0.821 . . . . 0.040000000000000001 108.782 -179.073 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -65.47 -47.02 77.54 Favored 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 119.282 -0.967 . . . . 3.3799999999999999 111.359 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 876' ' ' GLY . . . . . 0.416 ' HA3' ' CE2' ' C' ' 878' ' ' TYR . . . -72.11 -26.92 71.22 Favored Glycine 0 N--CA 1.492 2.429 0 C-N-CA 120.361 -0.924 . . . . 0.040000000000000001 111.447 -178.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 81.34 -61.93 4.54 Favored Glycine 0 N--CA 1.5 2.905 0 N-CA-C 108.016 -2.034 . . . . 0.040000000000000001 108.016 -178.354 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 878' ' ' TYR . . . . . 0.416 ' CE2' ' HA3' ' C' ' 876' ' ' GLY . 96.3 m-85 60.39 -66.3 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 114.366 1.247 . . . . 3.46 114.366 177.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 879' ' ' TYR . . . . . 0.47 ' CB ' ' CD2' ' C' ' 886' ' ' PHE . 25.0 p90 -110.55 107.52 17.17 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 115.092 1.516 . . . . 0.040000000000000001 115.092 -175.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -71.82 120.76 81.92 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.437 -0.789 . . . . 0.02 109.939 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 881' ' ' PRO . . . . . 0.443 ' HG2' ' CD1' ' C' ' 868' ' ' PHE . 52.3 Cg_endo -78.25 0.24 10.08 Favored 'Trans proline' 0 N--CA 1.49 1.28 0 O-C-N 123.434 1.228 . . . . 0.39000000000000001 111.786 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -74.92 -63.62 1.22 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 106.083 -1.821 . . . . 0.81000000000000005 106.083 178.041 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 70.3 p -90.54 -21.73 21.65 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 108.513 -0.921 . . . . 0.040000000000000001 108.513 177.211 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 82.28 18.45 66.77 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 110.59 -1.004 . . . . 0.029999999999999999 110.59 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 885' ' ' VAL . . . . . 0.414 HG13 HG21 ' C' ' 961' ' ' THR . 96.6 t -75.54 92.2 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 C-N-CA 118.41 -1.316 . . . . 1.01 108.655 -179.041 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 886' ' ' PHE . . . . . 0.908 ' HB3' HG22 ' C' ' 962' ' ' VAL . 0.8 OUTLIER -87.81 104.34 16.49 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 115.065 -0.97 . . . . 0.050000000000000003 111.541 -177.761 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 887' ' ' THR . . . . . 0.441 ' O ' ' HD3' ' C' ' 889' ' ' PRO . 96.8 m -98.97 99.42 10.46 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 107.38 -1.341 . . . . 0.68000000000000005 107.38 177.309 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 888' ' ' ALA . . . . . . . . . . . . . . . -97.4 106.64 33.77 Favored Pre-proline 0 N--CA 1.501 2.109 0 N-CA-C 114.413 1.264 . . . . 0.25 114.413 -176.002 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 889' ' ' PRO . . . . . 0.441 ' HD3' ' O ' ' C' ' 887' ' ' THR . 53.5 Cg_endo -88.06 -15.38 3.11 Favored 'Trans proline' 0 CA--C 1.546 1.078 0 N-CA-C 108.662 -1.322 . . . . 1.6399999999999999 108.662 175.811 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 890' ' ' LEU . . . . . 0.633 HD22 HD13 ' C' ' 985' ' ' LEU . 46.0 mt -38.33 -49.17 1.39 Allowed 'General case' 0 N--CA 1.506 2.346 0 N-CA-C 113.347 0.869 . . . . 2.29 113.347 -177.596 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 52.69 97.35 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.241 -0.912 . . . . 0.63 110.316 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . 159.41 -155.52 26.61 Favored Glycine 0 N--CA 1.477 1.425 0 N-CA-C 107.151 -2.38 . . . . 0.040000000000000001 107.151 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 73.4 ttt-85 -117.99 123.98 47.05 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.618 -0.93 . . . . 3.0 109.049 177.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 894' ' ' TYR . . . . . 0.871 ' CE1' HD23 ' C' ' 954' ' ' LEU . 49.5 p90 -134.08 156.69 47.81 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.057 -1.027 . . . . 0.040000000000000001 110.922 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 895' ' ' LEU . . . . . . . . . . . . . 40.3 tp -96.47 118.22 32.53 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.691 -0.631 . . . . 1.27 110.379 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 896' ' ' LEU . . . . . 0.576 HD23 ' N ' ' C' ' 897' ' ' SER . 9.5 tt -116.1 145.17 43.25 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.645 -0.66 . . . . 0.93999999999999995 109.92 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 897' ' ' SER . . . . . 0.576 ' N ' HD23 ' C' ' 896' ' ' LEU . 47.4 m -140.0 124.2 17.79 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.431 -0.793 . . . . 0.040000000000000001 111.285 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -105.49 146.8 29.07 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.903 -0.777 . . . . 0.47999999999999998 108.903 178.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 899' ' ' VAL . . . . . 0.73 HG21 ' HB ' ' C' ' 980' ' ' ILE . 93.7 t -90.83 122.24 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 C-N-CA 119.727 -0.789 . . . . 0.55000000000000004 111.255 -178.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 900' ' ' LEU . . . . . 0.405 HD22 ' HB2' ' C' ' 924' ' ' SER . 93.8 mt -92.06 111.12 22.55 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 114.375 1.25 . . . . 1.5900000000000001 114.375 -175.166 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 20.3 m -67.29 140.35 57.31 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 106.98 -1.489 . . . . 0.050000000000000003 106.98 176.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -64.37 -64.73 3.41 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 110.497 -1.041 . . . . 0.029999999999999999 110.497 -179.308 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 45.1 62.6 2.06 Favored 'General case' 0 N--CA 1.508 2.447 0 O-C-N 121.508 -0.995 . . . . 3.2000000000000002 111.346 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -68.22 -7.5 30.92 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.588 -0.695 . . . . 2.9199999999999999 111.899 -179.241 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 905' ' ' HIS . . . . . 0.494 ' O ' ' CB ' ' C' ' 906' ' ' GLU . 74.5 t60 -63.34 7.86 0.09 Allowed 'General case' 0 N--CA 1.505 2.323 0 CA-C-O 117.604 -1.188 . . . . 2.8700000000000001 113.567 -179.326 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 906' ' ' GLU . . . . . 0.494 ' CB ' ' O ' ' C' ' 905' ' ' HIS . 0.8 OUTLIER 94.12 -164.29 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.474 0 CA-C-N 121.292 1.86 . . . . 0.98999999999999999 111.727 179.202 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 907' ' ' LYS . . . . . 0.477 ' CB ' ' O ' ' C' ' 906' ' ' GLU . 34.8 tttp 86.92 156.14 0.07 Allowed 'General case' 0 N--CA 1.519 3.002 0 N-CA-C 108.014 -1.106 . . . . 5.25 108.014 -176.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 60.1 t -122.58 116.11 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 120.835 -1.165 . . . . 0.39000000000000001 110.991 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -104.69 131.47 52.08 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 107.503 -1.295 . . . . 1.72 107.503 177.022 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -154.73 122.34 5.75 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 106.675 -1.602 . . . . 0.67000000000000004 106.675 178.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 911' ' ' VAL . . . . . 0.736 HG22 HG13 ' C' ' 964' ' ' VAL . 87.6 t -81.7 131.86 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.871 -0.518 . . . . 0.54000000000000004 110.975 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 52.8 mt -66.83 156.85 34.5 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.354 -0.841 . . . . 1.5 109.091 178.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 913' ' ' SER . . . . . 0.454 ' OG ' HG11 ' C' ' 919' ' ' VAL . 1.7 p -124.0 138.24 54.48 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.242 -1.021 . . . . 1.3700000000000001 108.242 177.025 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 914' ' ' ARG . . . . . 0.872 ' NH1' HD23 ' C' ' 956' ' ' LEU . 0.0 OUTLIER -64.79 153.2 40.66 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 120.624 -1.298 . . . . 4.2999999999999998 111.401 -179.112 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 915' ' ' SER . . . . . 0.426 ' CB ' ' O ' ' C' ' 914' ' ' ARG . 1.4 t 83.59 -30.55 0.08 Allowed 'General case' 0 N--CA 1.522 3.144 0 C-N-CA 123.853 0.861 . . . . 2.0499999999999998 112.199 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 916' ' ' ASN . . . . . 0.717 ' HB2' HG21 ' C' ' 919' ' ' VAL . 99.2 m-20 -122.18 -21.8 5.79 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 120.834 -1.166 . . . . 2.71 111.422 -179.256 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 67.04 167.22 0.23 Allowed 'General case' 0 N--CA 1.52 3.045 0 N-CA-C 105.845 -1.909 . . . . 2.6800000000000002 105.845 -174.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 53.83 -126.37 35.23 Favored Glycine 1 N--CA 1.523 4.437 0 CA-C-N 123.481 2.855 . . . . 0.029999999999999999 107.132 -177.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 919' ' ' VAL . . . . . 0.717 HG21 ' HB2' ' C' ' 916' ' ' ASN . 95.4 t 50.94 95.26 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 O-C-N 121.467 -1.019 . . . . 1.3899999999999999 109.425 -178.437 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 920' ' ' ALA . . . . . 0.956 ' HB3' HG12 ' C' ' 949' ' ' VAL . . . -93.05 93.03 8.1 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.27 -0.972 . . . . 0.029999999999999999 110.486 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 921' ' ' ARG . . . . . 0.846 ' HG3' HG23 ' C' ' 922' ' ' VAL . 44.5 ptt85 -83.19 -41.7 18.13 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 105.956 -1.868 . . . . 4.4199999999999999 105.956 176.408 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 922' ' ' VAL . . . . . 0.846 HG23 ' HG3' ' C' ' 921' ' ' ARG . 84.8 t -98.84 77.54 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 105.712 -1.959 . . . . 0.84999999999999998 105.712 175.375 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -87.95 133.47 33.93 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.834 0.826 . . . . 2.46 111.755 -177.16 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 924' ' ' SER . . . . . 0.405 ' HB2' HD22 ' C' ' 900' ' ' LEU . 5.6 t -147.23 104.92 3.7 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.383 -0.969 . . . . 0.69999999999999996 108.383 178.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -103.14 89.72 0.72 Allowed Glycine 0 N--CA 1.486 1.978 0 N-CA-C 108.434 -1.866 . . . . 0.040000000000000001 108.434 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.219 0 N-CA-C 108.972 -1.651 . . . . 0.040000000000000001 108.972 -179.657 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 17.5 m . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 120.936 0.398 . . . . 13.779999999999999 110.348 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 92.3 mt -114.32 129.96 56.65 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.479 -0.763 . . . . 13.76 110.238 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -152.41 170.82 31.65 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.495 -1.442 . . . . 9.1300000000000008 109.495 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 949' ' ' VAL . . . . . 0.956 HG12 ' HB3' ' C' ' 920' ' ' ALA . 35.7 m -117.28 135.1 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.644 -0.915 . . . . 7.0800000000000001 110.947 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 950' ' ' PHE . . . . . 0.46 ' CZ ' ' HB3' ' C' ' 921' ' ' ARG . 42.6 p90 -133.61 150.62 51.6 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.603 -0.686 . . . . 7.5899999999999999 109.323 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 67.7 m -118.43 -55.77 2.19 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.385 -0.822 . . . . 5.0300000000000002 111.936 -178.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 952' ' ' LEU . . . . . 0.467 ' O ' ' O ' ' C' ' 953' ' ' ILE . 44.9 tp -64.83 -76.34 0.07 Allowed 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.39 -0.819 . . . . 1.01 111.512 -178.191 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 953' ' ' ILE . . . . . 0.593 HD12 ' HD3' ' C' ' 955' ' ' PRO . 2.1 pp -48.31 -151.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.78 0 N-CA-C 114.687 1.366 . . . . 2.6000000000000001 114.687 -176.693 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 954' ' ' LEU . . . . . 0.871 HD23 ' CE1' ' C' ' 894' ' ' TYR . 0.0 OUTLIER 173.57 90.43 0.06 OUTLIER Pre-proline 0 N--CA 1.516 2.864 0 O-C-N 120.567 -1.333 . . . . 0.050000000000000003 112.42 -179.385 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 955' ' ' PRO . . . . . 0.788 ' C ' HD12 ' C' ' 956' ' ' LEU . 53.8 Cg_endo -82.93 89.68 1.1 Allowed 'Trans proline' 0 C--N 1.316 -1.14 0 N-CA-C 109.182 -1.122 . . . . 0.83999999999999997 109.182 178.456 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 956' ' ' LEU . . . . . 0.872 HD23 ' NH1' ' C' ' 914' ' ' ARG . 9.9 mp -124.42 146.76 48.71 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.984 -1.073 . . . . 0.040000000000000001 110.406 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -83.44 152.08 25.16 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 117.691 -1.147 . . . . 1.28 111.569 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -66.97 118.5 10.52 Favored 'General case' 0 N--CA 1.507 2.41 0 CA-C-N 122.985 2.63 . . . . 0.17000000000000001 110.896 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.43 -19.82 47.98 Favored Glycine 0 N--CA 1.5 2.923 0 N-CA-C 111.032 -0.827 . . . . 0.040000000000000001 111.032 178.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 960' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.69 170.62 0.16 Allowed 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.283 -1.128 . . . . 0.040000000000000001 110.073 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 961' ' ' THR . . . . . 0.476 ' HA ' ' O ' ' C' ' 886' ' ' PHE . 31.2 m -136.67 140.1 42.48 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.877 -1.14 . . . . 1.78 112.836 -177.35 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 962' ' ' VAL . . . . . 0.908 HG22 ' HB3' ' C' ' 886' ' ' PHE . 33.1 m -98.96 145.84 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.681 -0.637 . . . . 0.040000000000000001 110.934 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 4.8 t -138.63 144.33 39.66 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.811 -0.556 . . . . 0.71999999999999997 109.996 -179.021 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 964' ' ' VAL . . . . . 0.736 HG13 HG22 ' C' ' 911' ' ' VAL . 59.7 t -94.95 135.81 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.024 -1.047 . . . . 1.05 110.77 -179.061 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -96.51 126.48 41.73 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 103.705 -2.702 . . . . 3.02 103.705 173.075 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 966' ' ' LEU . . . . . 0.493 ' C ' HG23 ' C' ' 967' ' ' VAL . 2.8 tt -132.21 63.32 1.62 Allowed 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.256 -1.016 . . . . 1.46 108.256 177.407 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 967' ' ' VAL . . . . . 0.493 HG23 ' C ' ' C' ' 966' ' ' LEU . 96.8 t -157.53 96.92 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.21 -1.033 . . . . 1.9399999999999999 108.21 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 93.2 mmm -142.37 59.45 1.45 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.742 -1.224 . . . . 0.0 108.316 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 134.73 119.47 1.95 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 107.173 -2.371 . . . . 2.1099999999999999 107.173 -178.231 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -82.4 -57.7 3.25 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.02 -1.283 . . . . 5.8899999999999997 110.607 -179.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 40.4 tp -58.66 90.12 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.471 -0.768 . . . . 4.3600000000000003 110.312 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -142.29 -153.18 0.45 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.578 -0.701 . . . . 1.8300000000000001 110.122 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 17.5 m80 -118.8 168.68 10.52 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.399 -0.813 . . . . 4.3499999999999996 110.075 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 28.9 t -101.42 130.94 47.73 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.534 -0.728 . . . . 1.27 109.918 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -156.31 157.91 36.54 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.452 -0.78 . . . . 5.0199999999999996 110.717 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.62 86.01 23.68 Favored Pre-proline 0 N--CA 1.5 2.071 0 O-C-N 121.667 -0.646 . . . . 2.4100000000000001 109.277 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.91 -170.15 0.66 Allowed 'Trans proline' 0 C--N 1.318 -1.046 0 O-C-N 123.416 1.219 . . . . 0.95999999999999996 111.49 -179.15 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 978' ' ' LEU . . . . . 0.786 ' HG ' HD12 ' C' ' 856' ' ' LEU . 6.2 tt -126.43 152.12 46.81 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 107.889 -1.152 . . . . 0.62 107.889 178.53 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 979' ' ' THR . . . . . 0.464 HG23 ' C ' ' C' ' 978' ' ' LEU . 47.6 p -150.87 139.42 20.57 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.73 -1.231 . . . . 3.5699999999999998 111.084 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 980' ' ' ILE . . . . . 0.73 ' HB ' HG21 ' C' ' 899' ' ' VAL . 51.2 mm -106.39 129.48 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 109.213 -0.662 . . . . 1.3300000000000001 109.213 179.465 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 981' ' ' PHE . . . . . 0.451 ' CD1' ' CE2' ' C' ' 879' ' ' TYR . 4.7 t80 -118.35 95.25 4.79 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 119.703 -0.799 . . . . 0.050000000000000003 111.635 -178.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 982' ' ' SER . . . . . 0.505 ' HB2' HD23 ' A' ' 952' ' ' LEU . 23.1 p -107.85 158.88 16.96 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 109.164 -0.68 . . . . 0.87 109.164 178.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 983' ' ' GLY . . . . . 0.413 ' O ' ' CZ ' ' C' ' 852' ' ' PHE . . . -170.85 115.23 0.57 Allowed Glycine 0 N--CA 1.497 2.745 0 N-CA-C 106.701 -2.56 . . . . 0.029999999999999999 106.701 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 984' ' ' ALA . . . . . 0.465 ' HB1' ' CZ ' ' A' ' 893' ' ' ARG . . . -108.31 150.34 27.46 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 114.352 1.241 . . . . 0.69999999999999996 114.352 -175.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 985' ' ' LEU . . . . . 0.633 HD13 HD22 ' C' ' 890' ' ' LEU . 53.5 tp -76.42 135.5 39.44 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.833 -1.167 . . . . 0.040000000000000001 109.637 179.226 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 986' ' ' LEU . . . . . 0.568 HD11 HD11 ' B' ' 986' ' ' LEU . 42.1 tp -106.98 -60.44 1.67 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.402 -0.811 . . . . 0.040000000000000001 110.304 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -142.81 146.73 34.47 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 107.698 -1.223 . . . . 0.040000000000000001 107.698 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.3 163.22 12.2 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 108.395 -1.882 . . . . 0.040000000000000001 108.395 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -75.65 112.85 21.63 Favored Pre-proline 0 N--CA 1.498 1.943 0 O-C-N 121.246 -1.15 . . . . 0.040000000000000001 109.59 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 990' ' ' PRO . . . . . 0.418 ' O ' ' HB2' ' C' ' 991' ' ' GLU . 50.6 Cg_endo -89.58 71.47 1.82 Allowed 'Trans proline' 0 C--N 1.32 -0.961 0 O-C-N 123.106 1.056 . . . . 0.45000000000000001 111.537 -179.044 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 991' ' ' GLU . . . . . 0.418 ' HB2' ' O ' ' C' ' 990' ' ' PRO . 66.0 mt-10 67.49 -73.29 0.08 Allowed 'General case' 0 N--CA 1.503 2.209 0 N-CA-C 108.593 -0.891 . . . . 1.97 108.593 -177.475 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 992' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' C' ' 992' ' ' LEU . 11.1 mt 50.65 20.82 0.78 Allowed 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.592 -0.693 . . . . 2.3799999999999999 111.709 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -92.99 156.92 16.59 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.899 -1.126 . . . . 3.79 110.07 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 67.0 m80 -145.93 92.2 2.18 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.537 -0.727 . . . . 3.5099999999999998 110.265 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 995' ' ' ALA . . . . . . . . . . . . 2.517 . . . . . . . 0 N--CA 1.503 2.221 0 O-C-N 120.931 -1.106 . . . . 2.73 110.586 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo . . . . . 0 N--CA 1.488 1.162 0 N-CA-C 109.506 -0.998 . . . . 3.8300000000000001 109.506 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 847' ' ' VAL . . . . . 0.416 HG12 ' HB2' ' A' ' 849' ' ' GLN . 59.9 t -133.0 102.92 13.09 Favored Pre-proline 0 N--CA 1.496 1.835 0 O-C-N 121.603 -0.686 . . . . 1.8300000000000001 110.079 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 848' ' ' PRO . . . . . 0.756 ' O ' HG23 ' A' ' 850' ' ' VAL . 43.7 Cg_endo -69.82 -19.87 35.27 Favored 'Trans proline' 0 N--CA 1.487 1.125 0 O-C-N 123.274 1.144 . . . . 0.65000000000000002 111.028 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 849' ' ' GLN . . . . . 0.416 ' HB2' HG12 ' A' ' 847' ' ' VAL . 56.0 tt0 27.83 68.85 0.07 Allowed 'General case' 0 N--CA 1.518 2.968 0 N-CA-C 112.861 0.689 . . . . 2.5800000000000001 112.861 179.247 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 850' ' ' VAL . . . . . 0.756 HG23 ' O ' ' A' ' 848' ' ' PRO . 83.9 t -119.66 137.26 54.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.151 -0.968 . . . . 1.0900000000000001 111.603 -178.696 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 851' ' ' ALA . . . . . 0.477 ' HB3' ' HG ' ' A' ' 873' ' ' LEU . . . -126.99 158.52 36.68 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 105.876 -1.898 . . . . 0.040000000000000001 105.876 176.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 852' ' ' PHE . . . . . 0.436 ' HA ' ' CB ' ' A' ' 874' ' ' ASN . 46.6 p90 -157.59 131.97 8.38 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 120.989 1.722 . . . . 0.050000000000000003 108.613 178.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 19.5 t -175.03 132.84 0.32 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.07 -1.085 . . . . 0.040000000000000001 108.07 -178.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -135.41 153.1 51.91 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.173 -0.955 . . . . 0.67000000000000004 109.182 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 855' ' ' ALA . . . . . 0.701 ' HB3' ' CB ' ' A' ' 870' ' ' ARG . . . -124.24 140.11 53.27 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.942 0.877 . . . . 0.51000000000000001 111.689 -178.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 856' ' ' LEU . . . . . 0.815 HD11 HD23 ' A' ' 858' ' ' LEU . 3.3 tm? -106.8 137.46 44.8 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 109.366 -0.605 . . . . 0.050000000000000003 109.366 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 857' ' ' SER . . . . . 0.686 ' N ' HD13 ' A' ' 856' ' ' LEU . 1.3 m -155.02 15.43 0.41 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.323 -0.861 . . . . 1.3300000000000001 111.697 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 858' ' ' LEU . . . . . 0.815 HD23 HD11 ' A' ' 856' ' ' LEU . 3.0 pp -34.29 159.91 0.04 OUTLIER Pre-proline 0 N--CA 1.518 2.942 0 N-CA-C 113.088 0.773 . . . . 2.3300000000000001 113.088 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -60.87 -88.59 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 120.898 1.066 . . . . 2.3199999999999998 113.686 -177.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 54.3 ptt85 -126.19 -142.77 0.29 Allowed 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.902 -1.124 . . . . 0.040000000000000001 111.575 -177.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 75.1 m -38.53 126.22 1.42 Allowed 'General case' 0 N--CA 1.509 2.507 0 O-C-N 121.63 -0.668 . . . . 1.3100000000000001 112.148 -178.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -101.3 161.15 24.51 Favored Pre-proline 0 N--CA 1.489 1.512 0 N-CA-C 108.579 -0.897 . . . . 4.5099999999999998 108.579 178.062 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -71.09 -15.34 32.18 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 O-C-N 123.251 1.132 . . . . 2.2400000000000002 111.65 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -177.4 -136.5 2.48 Favored Glycine 0 N--CA 1.495 2.577 0 C-N-CA 119.541 -1.314 . . . . 0.040000000000000001 110.838 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 865' ' ' THR . . . . . 0.433 HG22 ' N ' ' A' ' 866' ' ' VAL . 41.1 m -61.69 162.84 7.97 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.479 -1.012 . . . . 1.51 111.362 -178.141 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 866' ' ' VAL . . . . . 0.433 ' N ' HG22 ' A' ' 865' ' ' THR . 0.1 OUTLIER -97.12 127.01 40.09 Favored Pre-proline 0 N--CA 1.504 2.237 0 N-CA-C 113.042 0.756 . . . . 0.78000000000000003 113.042 -174.41 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 867' ' ' PRO . . . . . 0.803 ' O ' HD23 ' A' ' 856' ' ' LEU . 54.1 Cg_endo -90.64 -153.18 0.04 OUTLIER 'Trans proline' 0 CA--C 1.54 0.787 0 N-CA-C 108.63 -1.335 . . . . 0.92000000000000004 108.63 177.479 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 868' ' ' PHE . . . . . 0.468 ' CD1' ' HG2' ' A' ' 881' ' ' PRO . 24.3 p90 -149.93 122.77 8.71 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 120.523 -1.361 . . . . 0.050000000000000003 110.247 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 49.6 p-10 -112.91 -3.19 14.14 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 119.442 -0.903 . . . . 1.7 112.083 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 870' ' ' ARG . . . . . 0.701 ' CB ' ' HB3' ' A' ' 855' ' ' ALA . 29.4 mmm180 -90.58 89.29 7.48 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.947 -1.096 . . . . 2.5899999999999999 110.675 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 58.1 t -73.13 97.16 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 120.975 -1.078 . . . . 1.9399999999999999 110.091 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 872' ' ' LEU . . . . . . . . . . . . . 96.1 mt -83.13 -47.28 11.8 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.498 -0.751 . . . . 1.0600000000000001 110.099 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 873' ' ' LEU . . . . . 0.477 ' HG ' ' HB3' ' A' ' 851' ' ' ALA . 43.0 tp -175.06 104.47 0.09 Allowed 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.308 -0.87 . . . . 4.1799999999999997 108.706 178.641 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 874' ' ' ASN . . . . . 0.436 ' CB ' ' HA ' ' A' ' 852' ' ' PHE . 35.0 t-20 178.33 81.9 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.336 0 O-C-N 121.6 -0.687 . . . . 0.040000000000000001 109.521 -178.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -66.85 -47.33 72.27 Favored 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 119.291 -0.964 . . . . 3.3799999999999999 111.334 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 876' ' ' GLY . . . . . 0.414 ' HA3' ' CE2' ' A' ' 878' ' ' TYR . . . -74.51 -25.19 70.87 Favored Glycine 0 N--CA 1.495 2.568 0 O-C-N 121.22 -0.925 . . . . 0.040000000000000001 111.777 -178.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 81.88 -62.09 4.58 Favored Glycine 0 N--CA 1.502 3.09 0 N-CA-C 107.974 -2.05 . . . . 0.040000000000000001 107.974 -178.246 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 878' ' ' TYR . . . . . 0.414 ' CE2' ' HA3' ' A' ' 876' ' ' GLY . 95.6 m-85 61.5 -60.27 0.1 Allowed 'General case' 0 N--CA 1.504 2.236 0 N-CA-C 114.498 1.296 . . . . 3.46 114.498 177.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 879' ' ' TYR . . . . . 0.475 ' CB ' ' CD2' ' A' ' 886' ' ' PHE . 21.3 p90 -111.73 108.96 18.57 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 114.66 1.356 . . . . 0.040000000000000001 114.66 -176.318 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -66.55 117.85 48.33 Favored Pre-proline 0 N--CA 1.497 1.899 0 O-C-N 121.403 -0.811 . . . . 0.02 109.911 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 881' ' ' PRO . . . . . 0.468 ' HG2' ' CD1' ' A' ' 868' ' ' PHE . 52.8 Cg_endo -77.15 -0.33 10.48 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 O-C-N 123.42 1.221 . . . . 0.39000000000000001 112.275 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -75.92 -62.91 1.43 Allowed 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 106.62 -1.622 . . . . 0.81000000000000005 106.62 178.362 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 19.5 p -94.44 -19.53 20.5 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.659 -0.867 . . . . 0.040000000000000001 108.659 177.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.43 20.83 57.93 Favored Glycine 0 N--CA 1.497 2.731 0 O-C-N 121.154 -0.966 . . . . 0.029999999999999999 111.035 178.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 885' ' ' VAL . . . . . 0.737 HG13 HG21 ' A' ' 961' ' ' THR . 97.7 t -73.0 90.0 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 C-N-CA 118.261 -1.376 . . . . 1.01 108.132 -179.386 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 886' ' ' PHE . . . . . 0.928 ' HB3' HG22 ' A' ' 962' ' ' VAL . 0.8 OUTLIER -89.31 104.04 16.62 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-N 115.298 -0.864 . . . . 0.050000000000000003 111.825 -177.555 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 887' ' ' THR . . . . . 0.422 ' O ' ' HD3' ' A' ' 889' ' ' PRO . 93.1 m -95.26 100.69 12.44 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 107.826 -1.175 . . . . 0.68000000000000005 107.826 177.601 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 888' ' ' ALA . . . . . . . . . . . . . . . -98.4 106.99 39.49 Favored Pre-proline 0 N--CA 1.502 2.153 0 N-CA-C 114.009 1.114 . . . . 0.25 114.009 -176.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 889' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 887' ' ' THR . 53.6 Cg_endo -89.84 -12.67 2.86 Favored 'Trans proline' 0 CA--C 1.546 1.122 0 C-N-CA 121.055 1.17 . . . . 1.6399999999999999 109.111 176.236 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 890' ' ' LEU . . . . . 0.934 HD22 HD13 ' A' ' 985' ' ' LEU . 72.9 mt -36.59 -50.31 0.8 Allowed 'General case' 0 N--CA 1.509 2.479 0 N-CA-C 113.636 0.976 . . . . 2.29 113.636 -177.377 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 52.19 95.85 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.295 0 O-C-N 121.156 -0.965 . . . . 0.63 110.238 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 157.85 -153.33 24.54 Favored Glycine 0 N--CA 1.478 1.456 0 N-CA-C 107.234 -2.347 . . . . 0.040000000000000001 107.234 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 893' ' ' ARG . . . . . 0.459 ' CZ ' ' HB1' ' C' ' 984' ' ' ALA . 73.2 ttt-85 -115.53 126.3 54.09 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 121.533 -0.981 . . . . 3.0 108.552 177.552 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 894' ' ' TYR . . . . . 0.77 ' OH ' HD12 ' A' ' 896' ' ' LEU . 0.1 OUTLIER -132.87 160.09 37.97 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.083 -1.011 . . . . 0.040000000000000001 111.083 -179.703 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 895' ' ' LEU . . . . . 0.836 HD23 HD11 ' B' ' 952' ' ' LEU . 36.0 tp -91.73 119.45 31.59 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.728 -0.607 . . . . 1.27 110.1 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 896' ' ' LEU . . . . . 0.77 HD12 ' OH ' ' A' ' 894' ' ' TYR . 9.2 tt -109.69 144.31 38.25 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.7 -0.625 . . . . 0.93999999999999995 110.155 -179.489 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 897' ' ' SER . . . . . 0.489 ' N ' HD23 ' A' ' 896' ' ' LEU . 69.5 m -149.95 114.8 5.33 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.49 -0.756 . . . . 0.040000000000000001 111.007 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -106.96 146.84 30.57 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.912 -0.773 . . . . 0.47999999999999998 108.912 178.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 899' ' ' VAL . . . . . 0.754 HG21 ' HB ' ' A' ' 980' ' ' ILE . 88.2 t -96.45 119.13 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 C-N-CA 119.59 -0.844 . . . . 0.55000000000000004 111.255 -179.192 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 900' ' ' LEU . . . . . 0.488 HD12 ' HB2' ' A' ' 924' ' ' SER . 4.5 mm? -95.75 111.18 23.2 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 114.036 1.124 . . . . 1.5900000000000001 114.036 -175.568 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 18.3 m -64.52 140.19 58.84 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 107.458 -1.312 . . . . 0.050000000000000003 107.458 177.227 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -63.09 -66.62 2.46 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 110.429 -1.068 . . . . 0.029999999999999999 110.429 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 4.1 m170 46.93 66.9 0.88 Allowed 'General case' 0 N--CA 1.507 2.398 0 O-C-N 121.495 -1.003 . . . . 3.2000000000000002 110.991 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -68.5 -7.17 29.84 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.581 -0.699 . . . . 2.9199999999999999 111.937 -179.333 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 905' ' ' HIS . . . . . 0.489 ' O ' ' CB ' ' A' ' 906' ' ' GLU . 67.0 t60 -63.55 4.54 0.24 Allowed 'General case' 0 N--CA 1.504 2.272 0 O-C-N 120.942 -1.099 . . . . 2.8700000000000001 112.843 -179.268 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 906' ' ' GLU . . . . . 0.489 ' CB ' ' O ' ' A' ' 905' ' ' HIS . 0.8 OUTLIER 94.7 -162.95 0.0 OUTLIER 'General case' 0 N--CA 1.53 3.552 0 CA-C-N 120.729 1.604 . . . . 0.98999999999999999 112.218 178.752 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 907' ' ' LYS . . . . . 0.492 ' HE2' ' HB1' ' A' ' 972' ' ' ALA . 94.1 mttt 89.27 159.71 0.05 Allowed 'General case' 0 N--CA 1.522 3.162 0 N-CA-C 107.862 -1.162 . . . . 5.25 107.862 -176.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 58.6 t -122.29 116.37 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 120.882 -1.137 . . . . 0.39000000000000001 110.91 -179.307 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 909' ' ' GLU . . . . . 0.685 ' OE2' HD12 ' A' ' 966' ' ' LEU . 48.9 tp10 -100.78 132.89 45.96 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.513 -1.292 . . . . 1.72 107.513 176.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -156.99 121.95 4.54 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 106.988 -1.486 . . . . 0.67000000000000004 106.988 178.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 911' ' ' VAL . . . . . 0.723 HG22 HG13 ' A' ' 964' ' ' VAL . 95.3 t -85.08 131.85 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.85 -0.532 . . . . 0.54000000000000004 111.076 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 73.0 mt -65.76 157.66 29.69 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.432 -0.792 . . . . 1.5 109.011 178.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 913' ' ' SER . . . . . 0.409 ' CB ' ' HB ' ' A' ' 919' ' ' VAL . 2.6 t -124.1 136.61 54.35 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.266 -1.013 . . . . 1.3700000000000001 108.266 177.051 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 914' ' ' ARG . . . . . 0.685 ' NH1' HD23 ' A' ' 956' ' ' LEU . 0.0 OUTLIER -65.07 154.53 37.58 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 120.612 -1.305 . . . . 4.2999999999999998 111.357 -179.186 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 915' ' ' SER . . . . . 0.427 ' CB ' ' O ' ' A' ' 914' ' ' ARG . 4.3 t 83.14 -31.61 0.08 Allowed 'General case' 0 N--CA 1.521 3.124 0 C-N-CA 123.853 0.861 . . . . 2.0499999999999998 112.089 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 916' ' ' ASN . . . . . 0.743 ' HB2' HG21 ' A' ' 919' ' ' VAL . 91.0 m-20 -123.61 -21.48 5.23 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 120.85 -1.157 . . . . 2.71 111.274 -179.297 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 917' ' ' GLN . . . . . 0.438 ' HB2' ' O ' ' A' ' 916' ' ' ASN . 44.4 mt-30 65.84 166.45 0.19 Allowed 'General case' 0 N--CA 1.519 2.984 0 N-CA-C 105.957 -1.868 . . . . 2.6800000000000002 105.957 -173.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.54 -125.62 35.0 Favored Glycine 1 N--CA 1.521 4.356 0 CA-C-N 123.382 2.81 . . . . 0.029999999999999999 106.78 -177.609 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 919' ' ' VAL . . . . . 0.743 HG21 ' HB2' ' A' ' 916' ' ' ASN . 71.8 t 52.47 93.58 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.241 0 O-C-N 121.31 -1.112 . . . . 1.3899999999999999 108.74 -178.17 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 920' ' ' ALA . . . . . 0.802 ' HB3' HG12 ' A' ' 949' ' ' VAL . . . -91.14 90.96 8.03 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.219 -0.993 . . . . 0.029999999999999999 110.956 -178.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 921' ' ' ARG . . . . . 0.834 ' HG3' HG23 ' A' ' 922' ' ' VAL . 30.2 ptt180 -86.17 -41.88 14.32 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 105.831 -1.914 . . . . 4.4199999999999999 105.831 175.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 922' ' ' VAL . . . . . 0.834 HG23 ' HG3' ' A' ' 921' ' ' ARG . 85.0 t -103.97 67.45 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 105.979 -1.86 . . . . 0.84999999999999998 105.979 175.622 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 923' ' ' ASP . . . . . 0.719 ' HB2' ' HB1' ' A' ' 920' ' ' ALA . 22.5 t0 -89.83 134.64 34.08 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.709 0.766 . . . . 2.46 111.655 -177.358 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 924' ' ' SER . . . . . 0.488 ' HB2' HD12 ' A' ' 900' ' ' LEU . 8.5 t -147.18 103.27 3.57 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.477 -0.935 . . . . 0.69999999999999996 108.477 178.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -109.59 90.28 0.59 Allowed Glycine 0 N--CA 1.487 2.063 0 N-CA-C 108.411 -1.875 . . . . 0.040000000000000001 108.411 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.352 0 N-CA-C 109.435 -1.466 . . . . 0.040000000000000001 109.435 -179.186 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 29.5 m . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 120.995 0.426 . . . . 13.779999999999999 110.341 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 95.2 mt -113.03 129.99 56.31 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.492 -0.755 . . . . 13.76 110.455 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -151.91 168.11 31.18 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.197 -1.561 . . . . 9.1300000000000008 109.197 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 949' ' ' VAL . . . . . 0.802 HG12 ' HB3' ' A' ' 920' ' ' ALA . 27.2 m -119.02 128.87 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.532 -0.981 . . . . 7.0800000000000001 110.78 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 950' ' ' PHE . . . . . 0.463 ' CE1' ' HD2' ' A' ' 955' ' ' PRO . 26.2 p90 -131.76 148.13 52.55 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.559 -0.713 . . . . 7.5899999999999999 109.487 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 19.8 m -121.26 -52.06 2.07 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.358 -0.838 . . . . 5.0300000000000002 112.169 -178.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 952' ' ' LEU . . . . . 0.426 ' O ' ' O ' ' A' ' 953' ' ' ILE . 53.8 tp -59.75 -75.1 0.06 Allowed 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.41 -0.806 . . . . 1.01 112.557 -177.426 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 953' ' ' ILE . . . . . 0.482 HD11 HD13 ' C' ' 872' ' ' LEU . 43.3 pt -52.34 -143.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.784 0 N-CA-C 114.177 1.177 . . . . 2.6000000000000001 114.177 -176.385 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 954' ' ' LEU . . . . . 0.725 HD22 ' O ' ' A' ' 954' ' ' LEU . 0.0 OUTLIER 174.07 77.2 0.05 OUTLIER Pre-proline 0 N--CA 1.506 2.367 0 O-C-N 120.671 -1.268 . . . . 0.050000000000000003 111.291 179.929 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 955' ' ' PRO . . . . . 0.746 ' C ' HD12 ' A' ' 956' ' ' LEU . 48.9 Cg_endo -76.66 91.73 1.13 Allowed 'Trans proline' 0 C--N 1.314 -1.238 0 N-CA-C 109.614 -0.956 . . . . 0.83999999999999997 109.614 178.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 956' ' ' LEU . . . . . 0.746 HD12 ' C ' ' A' ' 955' ' ' PRO . 11.1 mp -121.98 146.14 47.44 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.225 -0.922 . . . . 0.040000000000000001 109.818 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -84.44 150.74 25.1 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 117.831 -1.081 . . . . 1.28 111.876 -178.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -70.2 120.24 15.58 Favored 'General case' 0 N--CA 1.51 2.525 0 CA-C-N 122.788 2.54 . . . . 0.17000000000000001 111.74 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.51 -22.63 31.99 Favored Glycine 0 N--CA 1.5 2.907 0 N-CA-C 111.122 -0.791 . . . . 0.040000000000000001 111.122 178.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 960' ' ' ASP . . . . . 0.451 ' HB3' ' NE ' ' A' ' 914' ' ' ARG . 0.4 OUTLIER -55.38 171.9 0.16 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.451 -1.029 . . . . 0.040000000000000001 110.006 -179.567 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 961' ' ' THR . . . . . 0.737 HG21 HG13 ' A' ' 885' ' ' VAL . 41.5 m -135.06 135.43 41.26 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.879 -1.138 . . . . 1.78 111.884 -178.194 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 962' ' ' VAL . . . . . 0.928 HG22 ' HB3' ' A' ' 886' ' ' PHE . 32.7 m -97.79 145.92 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 C-N-CA 120.094 -0.642 . . . . 0.040000000000000001 110.138 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 5.6 t -138.5 145.98 41.43 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.852 -0.53 . . . . 0.71999999999999997 110.329 -178.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 964' ' ' VAL . . . . . 0.723 HG13 HG22 ' A' ' 911' ' ' VAL . 59.2 t -94.37 137.37 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.258 -0.901 . . . . 1.05 110.459 -179.302 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -93.28 127.54 38.91 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 103.791 -2.67 . . . . 3.02 103.791 173.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 966' ' ' LEU . . . . . 0.685 HD12 ' OE2' ' A' ' 909' ' ' GLU . 0.2 OUTLIER -132.81 60.0 1.71 Allowed 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.35 -0.981 . . . . 1.46 108.35 177.309 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 967' ' ' VAL . . . . . 0.49 HG23 ' C ' ' A' ' 966' ' ' LEU . 98.5 t -157.96 96.88 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 108.049 -1.093 . . . . 1.9399999999999999 108.049 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 92.2 mmm -142.65 60.44 1.43 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.725 -1.234 . . . . 0.0 108.434 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.59 120.48 2.01 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 107.203 -2.359 . . . . 2.1099999999999999 107.203 -178.268 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -82.06 -59.88 2.41 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 118.76 1.28 . . . . 5.8899999999999997 110.189 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 50.9 tp -59.81 90.95 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.44 -0.787 . . . . 4.3600000000000003 109.894 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 972' ' ' ALA . . . . . 0.492 ' HB1' ' HE2' ' A' ' 907' ' ' LYS . . . -141.41 -154.62 0.53 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.571 -0.706 . . . . 1.8300000000000001 110.39 -179.457 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -118.8 171.27 8.33 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.471 -0.768 . . . . 4.3499999999999996 110.221 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 34.3 t -101.6 130.23 47.88 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.588 -0.695 . . . . 1.27 110.039 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -156.11 157.05 35.36 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.549 -0.719 . . . . 5.0199999999999996 110.485 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.07 85.74 18.67 Favored Pre-proline 0 N--CA 1.5 2.068 0 O-C-N 121.6 -0.688 . . . . 2.4100000000000001 109.721 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.37 -172.33 1.02 Allowed 'Trans proline' 0 C--N 1.318 -1.068 0 O-C-N 123.313 1.165 . . . . 0.95999999999999996 111.345 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 978' ' ' LEU . . . . . 0.668 HD23 HD12 ' A' ' 856' ' ' LEU . 4.9 mp -127.7 154.44 45.31 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 107.691 -1.226 . . . . 0.62 107.691 178.107 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 979' ' ' THR . . . . . 0.464 HG23 ' C ' ' A' ' 978' ' ' LEU . 41.4 p -150.18 140.94 22.7 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.696 -1.253 . . . . 3.5699999999999998 111.14 -179.388 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 980' ' ' ILE . . . . . 0.754 ' HB ' HG21 ' A' ' 899' ' ' VAL . 46.3 mm -107.32 128.98 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 109.022 -0.733 . . . . 1.3300000000000001 109.022 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 981' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -118.95 95.16 4.71 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 119.804 -0.759 . . . . 0.050000000000000003 111.797 -178.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 82.9 p -107.93 157.96 17.76 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.545 -0.722 . . . . 0.87 109.192 178.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 983' ' ' GLY . . . . . 0.404 ' HA3' ' CE1' ' A' ' 852' ' ' PHE . . . -174.75 110.46 0.32 Allowed Glycine 0 N--CA 1.499 2.888 0 N-CA-C 106.356 -2.698 . . . . 0.029999999999999999 106.356 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -108.22 150.87 26.7 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 114.526 1.306 . . . . 0.69999999999999996 114.526 -175.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 985' ' ' LEU . . . . . 0.934 HD13 HD22 ' A' ' 890' ' ' LEU . 33.1 tp -72.29 135.06 45.87 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.822 -1.174 . . . . 0.040000000000000001 110.07 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 51.8 tp -107.47 -55.8 2.3 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.595 -0.691 . . . . 0.040000000000000001 110.06 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -144.57 145.76 31.98 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 107.668 -1.234 . . . . 0.040000000000000001 107.668 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.6 163.32 12.17 Favored Glycine 0 N--CA 1.495 2.633 0 N-CA-C 108.232 -1.947 . . . . 0.040000000000000001 108.232 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -75.26 112.46 18.66 Favored Pre-proline 0 N--CA 1.499 1.989 0 O-C-N 121.195 -1.179 . . . . 0.040000000000000001 109.463 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 990' ' ' PRO . . . . . 0.418 ' HD2' HD12 ' A' ' 992' ' ' LEU . 50.2 Cg_endo -90.53 70.79 1.39 Allowed 'Trans proline' 0 C--N 1.319 -1.023 0 O-C-N 123.151 1.079 . . . . 0.45000000000000001 111.565 -178.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 991' ' ' GLU . . . . . 0.417 ' HB2' ' O ' ' A' ' 990' ' ' PRO . 69.2 mt-10 67.28 -73.86 0.07 Allowed 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 108.586 -0.894 . . . . 1.97 108.586 -177.443 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 992' ' ' LEU . . . . . 0.418 HD12 ' HD2' ' A' ' 990' ' ' PRO . 11.0 mt 51.01 20.79 0.86 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.541 -0.724 . . . . 2.3799999999999999 111.641 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -94.11 156.89 16.34 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.818 -1.176 . . . . 3.79 109.993 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 72.2 m80 -146.63 93.49 2.3 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.588 -0.695 . . . . 3.5099999999999998 110.309 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 995' ' ' ALA . . . . . . . . . . . . 2.518 . . . . . . . 0 N--CA 1.503 2.224 0 O-C-N 120.868 -1.145 . . . . 2.73 110.572 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo . . . . . 0 N--CA 1.488 1.156 0 N-CA-C 109.5 -1.0 . . . . 3.8300000000000001 109.5 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 847' ' ' VAL . . . . . 0.401 HG12 ' HB2' ' B' ' 849' ' ' GLN . 60.0 t -133.07 102.87 13.03 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.567 -0.708 . . . . 1.8300000000000001 110.139 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 848' ' ' PRO . . . . . 0.758 ' O ' HG23 ' B' ' 850' ' ' VAL . 43.6 Cg_endo -69.7 -20.16 35.48 Favored 'Trans proline' 0 N--CA 1.487 1.092 0 O-C-N 123.235 1.124 . . . . 0.65000000000000002 111.033 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 849' ' ' GLN . . . . . 0.405 ' C ' ' O ' ' B' ' 848' ' ' PRO . 56.1 tt0 28.0 69.1 0.07 Allowed 'General case' 0 N--CA 1.519 2.989 0 N-CA-C 112.768 0.655 . . . . 2.5800000000000001 112.768 179.295 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 850' ' ' VAL . . . . . 0.758 HG23 ' O ' ' B' ' 848' ' ' PRO . 83.1 t -119.85 137.34 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.213 -0.93 . . . . 1.0900000000000001 111.623 -178.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 851' ' ' ALA . . . . . 0.488 ' HB3' ' HG ' ' B' ' 873' ' ' LEU . . . -127.52 157.67 39.5 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 105.907 -1.886 . . . . 0.040000000000000001 105.907 176.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 852' ' ' PHE . . . . . 0.432 ' HA ' ' CB ' ' B' ' 874' ' ' ASN . 46.4 p90 -156.63 132.43 9.58 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-N 121.04 1.745 . . . . 0.050000000000000003 108.541 179.088 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 20.8 t -175.11 132.59 0.31 Allowed 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.14 -1.059 . . . . 0.040000000000000001 108.14 -179.05 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -135.1 153.46 52.01 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.125 -0.985 . . . . 0.67000000000000004 109.211 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 855' ' ' ALA . . . . . 0.714 ' HB3' ' CB ' ' B' ' 870' ' ' ARG . . . -124.75 140.23 53.12 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.994 0.902 . . . . 0.51000000000000001 111.685 -178.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 856' ' ' LEU . . . . . 0.828 HD11 HD23 ' B' ' 858' ' ' LEU . 3.3 tm? -107.04 137.05 45.84 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.391 -0.596 . . . . 0.050000000000000003 109.391 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 857' ' ' SER . . . . . 0.683 ' N ' HD13 ' B' ' 856' ' ' LEU . 1.3 m -154.63 15.5 0.44 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.442 -0.786 . . . . 1.3300000000000001 111.712 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 858' ' ' LEU . . . . . 0.828 HD23 HD11 ' B' ' 856' ' ' LEU . 3.1 pp -34.32 159.98 0.04 OUTLIER Pre-proline 0 N--CA 1.518 2.956 0 N-CA-C 113.064 0.765 . . . . 2.3300000000000001 113.064 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -61.04 -88.58 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 120.9 1.067 . . . . 2.3199999999999998 113.661 -177.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 54.2 ptt85 -126.28 -142.8 0.29 Allowed 'General case' 0 N--CA 1.5 2.052 0 O-C-N 120.893 -1.129 . . . . 0.040000000000000001 111.551 -177.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 75.3 m -38.41 125.51 1.35 Allowed 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.597 -0.69 . . . . 1.3100000000000001 112.178 -178.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 862' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.59 161.18 24.78 Favored Pre-proline 0 N--CA 1.488 1.451 0 N-CA-C 108.557 -0.905 . . . . 4.5099999999999998 108.557 178.026 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -71.1 -15.29 32.15 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 O-C-N 123.248 1.13 . . . . 2.2400000000000002 111.73 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -177.15 -135.8 2.29 Favored Glycine 0 N--CA 1.495 2.599 0 C-N-CA 119.549 -1.31 . . . . 0.040000000000000001 110.807 179.395 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 865' ' ' THR . . . . . 0.446 HG22 ' N ' ' B' ' 866' ' ' VAL . 42.0 m -62.31 163.94 7.78 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.415 -1.05 . . . . 1.51 111.288 -178.287 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 866' ' ' VAL . . . . . 0.446 ' N ' HG22 ' B' ' 865' ' ' THR . 0.1 OUTLIER -98.09 127.03 38.07 Favored Pre-proline 0 N--CA 1.504 2.271 0 C-N-CA 119.796 -0.762 . . . . 0.78000000000000003 112.965 -174.464 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 867' ' ' PRO . . . . . 0.807 ' O ' HD23 ' B' ' 856' ' ' LEU . 53.6 Cg_endo -90.6 -153.25 0.04 OUTLIER 'Trans proline' 0 CA--C 1.54 0.789 0 N-CA-C 108.614 -1.341 . . . . 0.92000000000000004 108.614 177.514 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 868' ' ' PHE . . . . . 0.462 ' CD1' ' HG2' ' B' ' 881' ' ' PRO . 24.4 p90 -149.95 122.56 8.58 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.529 -1.357 . . . . 0.050000000000000003 110.199 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 50.0 p-10 -112.64 -2.76 14.46 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 119.476 -0.89 . . . . 1.7 112.133 -179.125 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 870' ' ' ARG . . . . . 0.714 ' CB ' ' HB3' ' B' ' 855' ' ' ALA . 28.8 mmm180 -91.07 89.15 7.27 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.925 -1.109 . . . . 2.5899999999999999 110.694 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 57.3 t -73.05 97.31 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.012 -1.055 . . . . 1.9399999999999999 110.063 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 872' ' ' LEU . . . . . 0.532 HD22 HD11 ' C' ' 953' ' ' ILE . 96.0 mt -83.27 -47.11 11.87 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.496 -0.752 . . . . 1.0600000000000001 110.067 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 873' ' ' LEU . . . . . 0.488 ' HG ' ' HB3' ' B' ' 851' ' ' ALA . 43.0 tp -175.15 104.43 0.09 Allowed 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 108.709 -0.849 . . . . 4.1799999999999997 108.709 178.624 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 874' ' ' ASN . . . . . 0.432 ' CB ' ' HA ' ' B' ' 852' ' ' PHE . 34.8 t-20 178.37 81.99 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.626 -0.671 . . . . 0.040000000000000001 109.581 -178.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -66.96 -47.34 71.88 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 119.325 -0.95 . . . . 3.3799999999999999 111.327 -179.286 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 876' ' ' GLY . . . . . 0.411 ' HA3' ' CE2' ' B' ' 878' ' ' TYR . . . -74.59 -25.26 70.52 Favored Glycine 0 N--CA 1.495 2.602 0 O-C-N 121.269 -0.894 . . . . 0.040000000000000001 111.725 -178.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 81.96 -62.08 4.58 Favored Glycine 0 N--CA 1.502 3.05 0 N-CA-C 107.966 -2.054 . . . . 0.040000000000000001 107.966 -178.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 878' ' ' TYR . . . . . 0.411 ' CE2' ' HA3' ' B' ' 876' ' ' GLY . 95.7 m-85 61.52 -60.25 0.1 Allowed 'General case' 0 N--CA 1.504 2.24 0 N-CA-C 114.473 1.286 . . . . 3.46 114.473 177.677 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 879' ' ' TYR . . . . . 0.477 ' CB ' ' CD2' ' B' ' 886' ' ' PHE . 21.2 p90 -111.68 108.78 18.35 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 114.68 1.363 . . . . 0.040000000000000001 114.68 -176.354 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -66.41 117.77 47.04 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.354 -0.841 . . . . 0.02 109.925 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 881' ' ' PRO . . . . . 0.462 ' HG2' ' CD1' ' B' ' 868' ' ' PHE . 51.8 Cg_endo -77.09 -0.52 10.67 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 O-C-N 123.409 1.215 . . . . 0.39000000000000001 112.261 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -75.73 -63.1 1.37 Allowed 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 106.639 -1.615 . . . . 0.81000000000000005 106.639 178.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 19.7 p -94.38 -19.06 20.96 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.76 -0.83 . . . . 0.040000000000000001 108.76 177.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.88 21.28 57.9 Favored Glycine 0 N--CA 1.496 2.648 0 O-C-N 121.099 -1.0 . . . . 0.029999999999999999 111.03 178.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 885' ' ' VAL . . . . . 0.74 HG13 HG21 ' B' ' 961' ' ' THR . 96.3 t -73.32 90.28 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 C-N-CA 118.242 -1.383 . . . . 1.01 108.123 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 886' ' ' PHE . . . . . 0.878 ' HB3' HG22 ' B' ' 962' ' ' VAL . 0.8 OUTLIER -89.52 104.17 16.75 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 115.323 -0.853 . . . . 0.050000000000000003 111.808 -177.542 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 887' ' ' THR . . . . . 0.418 ' O ' ' HD3' ' B' ' 889' ' ' PRO . 93.4 m -95.34 101.0 12.69 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 107.722 -1.214 . . . . 0.68000000000000005 107.722 177.551 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 888' ' ' ALA . . . . . . . . . . . . . . . -98.69 106.86 39.61 Favored Pre-proline 0 N--CA 1.503 2.179 0 N-CA-C 114.026 1.121 . . . . 0.25 114.026 -176.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 889' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' B' ' 887' ' ' THR . 53.2 Cg_endo -89.71 -12.71 2.92 Favored 'Trans proline' 0 CA--C 1.547 1.133 0 C-N-CA 121.028 1.152 . . . . 1.6399999999999999 109.107 176.266 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 890' ' ' LEU . . . . . 0.935 HD22 HD13 ' B' ' 985' ' ' LEU . 73.1 mt -36.51 -50.31 0.78 Allowed 'General case' 0 N--CA 1.508 2.465 0 N-CA-C 113.7 1.0 . . . . 2.29 113.7 -177.419 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 52.01 95.99 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.162 -0.961 . . . . 0.63 110.258 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . 157.86 -153.29 24.5 Favored Glycine 0 N--CA 1.478 1.478 0 N-CA-C 107.209 -2.357 . . . . 0.040000000000000001 107.209 -179.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 73.4 ttt-85 -115.58 126.12 53.82 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 108.448 -0.945 . . . . 3.0 108.448 177.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 894' ' ' TYR . . . . . 0.777 ' OH ' HD12 ' B' ' 896' ' ' LEU . 0.1 OUTLIER -132.53 160.23 37.13 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.113 -0.992 . . . . 0.040000000000000001 111.155 -179.702 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 895' ' ' LEU . . . . . 0.402 HD12 ' HA ' ' B' ' 895' ' ' LEU . 36.2 tp -92.1 119.47 31.81 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.709 -0.62 . . . . 1.27 110.025 -179.494 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 896' ' ' LEU . . . . . 0.777 HD12 ' OH ' ' B' ' 894' ' ' TYR . 9.2 tt -109.85 143.68 39.39 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.671 -0.643 . . . . 0.93999999999999995 110.147 -179.494 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 897' ' ' SER . . . . . 0.484 ' N ' HD23 ' B' ' 896' ' ' LEU . 69.6 m -149.3 114.61 5.51 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.49 -0.756 . . . . 0.040000000000000001 110.992 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -106.75 146.76 30.46 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.944 -0.761 . . . . 0.47999999999999998 108.944 178.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 899' ' ' VAL . . . . . 0.748 HG21 ' HB ' ' B' ' 980' ' ' ILE . 88.0 t -96.25 118.94 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 C-N-CA 119.646 -0.822 . . . . 0.55000000000000004 111.302 -179.155 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 900' ' ' LEU . . . . . 0.478 HD12 ' HB2' ' B' ' 924' ' ' SER . 4.5 mm? -95.71 110.65 22.75 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 114.102 1.149 . . . . 1.5900000000000001 114.102 -175.495 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 18.2 m -64.01 140.21 58.85 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 107.414 -1.328 . . . . 0.050000000000000003 107.414 177.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -63.3 -66.75 2.38 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 110.387 -1.085 . . . . 0.029999999999999999 110.387 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 4.1 m170 46.89 67.11 0.84 Allowed 'General case' 0 N--CA 1.507 2.383 0 O-C-N 121.505 -0.997 . . . . 3.2000000000000002 110.977 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 35.1 ptt180 -68.5 -7.54 33.16 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.642 -0.662 . . . . 2.9199999999999999 111.898 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 905' ' ' HIS . . . . . 0.487 ' O ' ' CB ' ' B' ' 906' ' ' GLU . 66.6 t60 -62.96 4.09 0.2 Allowed 'General case' 0 N--CA 1.505 2.278 0 CA-C-O 117.775 -1.107 . . . . 2.8700000000000001 112.851 -179.217 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 906' ' ' GLU . . . . . 0.487 ' CB ' ' O ' ' B' ' 905' ' ' HIS . 0.9 OUTLIER 94.89 -163.04 0.0 OUTLIER 'General case' 0 N--CA 1.53 3.533 0 CA-C-N 120.761 1.618 . . . . 0.98999999999999999 112.142 178.908 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 907' ' ' LYS . . . . . 0.511 ' HE2' ' HB1' ' B' ' 972' ' ' ALA . 94.2 mttt 89.5 159.51 0.05 Allowed 'General case' 0 N--CA 1.522 3.164 0 N-CA-C 107.817 -1.179 . . . . 5.25 107.817 -177.054 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 58.4 t -122.25 116.01 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 120.933 -1.104 . . . . 0.39000000000000001 110.956 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 909' ' ' GLU . . . . . 0.686 ' OE2' HD12 ' B' ' 966' ' ' LEU . 49.2 tp10 -100.2 133.21 44.94 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 107.542 -1.281 . . . . 1.72 107.542 176.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -157.42 122.11 4.4 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 106.98 -1.489 . . . . 0.67000000000000004 106.98 178.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 911' ' ' VAL . . . . . 0.705 HG22 HG13 ' B' ' 964' ' ' VAL . 94.7 t -85.34 132.14 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 C-N-CA 120.386 -0.526 . . . . 0.54000000000000004 111.11 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 72.3 mt -65.83 157.87 29.29 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.442 -0.787 . . . . 1.5 109.023 178.488 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 913' ' ' SER . . . . . 0.405 ' CB ' ' HB ' ' B' ' 919' ' ' VAL . 2.6 t -124.56 135.86 53.49 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.365 -0.976 . . . . 1.3700000000000001 108.365 177.052 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 914' ' ' ARG . . . . . 0.687 ' NH1' HD23 ' B' ' 956' ' ' LEU . 0.0 OUTLIER -64.28 154.57 34.77 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 120.596 -1.315 . . . . 4.2999999999999998 111.447 -179.054 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 915' ' ' SER . . . . . 0.419 ' CB ' ' O ' ' B' ' 914' ' ' ARG . 4.3 t 83.19 -31.86 0.08 Allowed 'General case' 0 N--CA 1.522 3.138 0 C-N-CA 123.867 0.867 . . . . 2.0499999999999998 112.131 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 916' ' ' ASN . . . . . 0.765 ' HB2' HG21 ' B' ' 919' ' ' VAL . 90.8 m-20 -123.3 -21.89 5.25 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.856 -1.152 . . . . 2.71 111.353 -179.283 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 917' ' ' GLN . . . . . 0.439 ' HB2' ' O ' ' B' ' 916' ' ' ASN . 44.2 mt-30 65.87 165.72 0.19 Allowed 'General case' 0 N--CA 1.518 2.949 0 N-CA-C 106.024 -1.843 . . . . 2.6800000000000002 106.024 -173.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 55.38 -125.66 36.94 Favored Glycine 1 N--CA 1.52 4.267 0 CA-C-N 123.439 2.836 . . . . 0.029999999999999999 106.621 -177.38 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 919' ' ' VAL . . . . . 0.765 HG21 ' HB2' ' B' ' 916' ' ' ASN . 68.9 t 52.34 93.72 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.302 0 O-C-N 121.356 -1.085 . . . . 1.3899999999999999 108.752 -178.177 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 920' ' ' ALA . . . . . 0.789 ' HB3' HG12 ' B' ' 949' ' ' VAL . . . -91.3 90.84 7.91 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.205 -0.998 . . . . 0.029999999999999999 110.881 -178.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 921' ' ' ARG . . . . . 0.862 ' HG3' HG23 ' B' ' 922' ' ' VAL . 30.1 ptt180 -86.15 -41.83 14.38 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 105.907 -1.886 . . . . 4.4199999999999999 105.907 175.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 922' ' ' VAL . . . . . 0.862 HG23 ' HG3' ' B' ' 921' ' ' ARG . 84.8 t -104.04 67.4 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 105.978 -1.86 . . . . 0.84999999999999998 105.978 175.619 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 923' ' ' ASP . . . . . 0.716 ' HB2' ' HB1' ' B' ' 920' ' ' ALA . 22.5 t0 -89.72 134.68 34.04 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.705 0.764 . . . . 2.46 111.658 -177.391 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 924' ' ' SER . . . . . 0.478 ' HB2' HD12 ' B' ' 900' ' ' LEU . 8.5 t -147.13 103.33 3.58 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.503 -0.925 . . . . 0.69999999999999996 108.503 178.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -109.62 90.22 0.59 Allowed Glycine 0 N--CA 1.487 2.052 0 N-CA-C 108.349 -1.9 . . . . 0.040000000000000001 108.349 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.318 0 N-CA-C 109.459 -1.456 . . . . 0.040000000000000001 109.459 -179.267 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 29.9 m . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.009 0.433 . . . . 13.779999999999999 110.307 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 95.3 mt -111.87 129.94 55.99 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.543 -0.723 . . . . 13.76 110.379 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -151.39 167.56 30.82 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.256 -1.538 . . . . 9.1300000000000008 109.256 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 949' ' ' VAL . . . . . 0.789 HG12 ' HB3' ' B' ' 920' ' ' ALA . 30.7 m -118.7 129.13 75.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.514 -0.992 . . . . 7.0800000000000001 110.698 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 950' ' ' PHE . . . . . 0.462 ' CZ ' ' HB3' ' B' ' 921' ' ' ARG . 26.6 p90 -132.35 147.87 52.4 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.563 -0.71 . . . . 7.5899999999999999 109.518 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 19.7 m -121.22 -51.46 2.1 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.48 -0.762 . . . . 5.0300000000000002 112.063 -178.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 952' ' ' LEU . . . . . 0.836 HD11 HD23 ' A' ' 895' ' ' LEU . 52.5 tp -60.24 -75.28 0.06 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.389 -0.819 . . . . 1.01 112.549 -177.505 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 953' ' ' ILE . . . . . 0.479 ' O ' ' HB3' ' B' ' 954' ' ' LEU . 45.0 pt -52.1 -143.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.8 0 N-CA-C 114.237 1.199 . . . . 2.6000000000000001 114.237 -176.395 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 954' ' ' LEU . . . . . 0.729 HD22 ' O ' ' B' ' 954' ' ' LEU . 0.0 OUTLIER 173.79 77.01 0.05 OUTLIER Pre-proline 0 N--CA 1.507 2.387 0 O-C-N 120.629 -1.294 . . . . 0.050000000000000003 111.209 179.883 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 955' ' ' PRO . . . . . 0.746 ' C ' HD12 ' B' ' 956' ' ' LEU . 49.4 Cg_endo -76.62 91.76 1.13 Allowed 'Trans proline' 0 C--N 1.314 -1.242 0 N-CA-C 109.606 -0.959 . . . . 0.83999999999999997 109.606 178.7 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 956' ' ' LEU . . . . . 0.746 HD12 ' C ' ' B' ' 955' ' ' PRO . 11.1 mp -122.13 146.13 47.52 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.198 -0.939 . . . . 0.040000000000000001 109.738 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -84.33 150.86 25.1 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 117.964 -1.017 . . . . 1.28 111.84 -178.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -70.3 120.02 15.34 Favored 'General case' 0 N--CA 1.509 2.497 0 CA-C-N 122.658 2.481 . . . . 0.17000000000000001 111.664 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.65 -22.74 31.8 Favored Glycine 0 N--CA 1.5 2.922 0 N-CA-C 111.07 -0.812 . . . . 0.040000000000000001 111.07 178.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 960' ' ' ASP . . . . . 0.449 ' HB3' ' NE ' ' B' ' 914' ' ' ARG . 0.4 OUTLIER -55.27 171.99 0.15 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.455 -1.026 . . . . 0.040000000000000001 110.014 -179.528 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 961' ' ' THR . . . . . 0.74 HG21 HG13 ' B' ' 885' ' ' VAL . 40.7 m -135.02 135.65 41.5 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.993 -1.067 . . . . 1.78 111.845 -178.226 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 962' ' ' VAL . . . . . 0.878 HG22 ' HB3' ' B' ' 886' ' ' PHE . 32.7 m -98.07 145.77 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 C-N-CA 120.102 -0.639 . . . . 0.040000000000000001 110.122 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 5.6 t -138.24 146.01 42.06 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.905 -0.497 . . . . 0.71999999999999997 110.294 -178.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 964' ' ' VAL . . . . . 0.705 HG13 HG22 ' B' ' 911' ' ' VAL . 59.0 t -94.46 137.17 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.19 -0.943 . . . . 1.05 110.474 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -93.24 127.06 38.67 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 103.869 -2.641 . . . . 3.02 103.869 173.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 966' ' ' LEU . . . . . 0.686 HD12 ' OE2' ' B' ' 909' ' ' GLU . 0.2 OUTLIER -132.32 60.23 1.69 Allowed 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.392 -0.966 . . . . 1.46 108.392 177.334 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 967' ' ' VAL . . . . . 0.489 HG23 ' C ' ' B' ' 966' ' ' LEU . 98.3 t -158.18 96.86 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 108.051 -1.092 . . . . 1.9399999999999999 108.051 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 92.3 mmm -142.52 60.09 1.44 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.735 -1.228 . . . . 0.0 108.571 179.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.62 120.36 2.0 Allowed Glycine 0 N--CA 1.492 2.417 0 N-CA-C 107.259 -2.337 . . . . 2.1099999999999999 107.259 -178.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -81.83 -59.8 2.46 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.073 -1.251 . . . . 5.8899999999999997 110.222 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 50.9 tp -59.83 90.6 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.45 -0.781 . . . . 4.3600000000000003 109.912 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 972' ' ' ALA . . . . . 0.511 ' HB1' ' HE2' ' B' ' 907' ' ' LYS . . . -141.06 -154.69 0.53 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.592 -0.693 . . . . 1.8300000000000001 110.408 -179.508 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -118.72 171.3 8.3 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.526 -0.734 . . . . 4.3499999999999996 110.245 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 34.5 t -101.58 130.23 47.85 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.572 -0.705 . . . . 1.27 110.065 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -156.12 157.17 35.55 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.48 -0.762 . . . . 5.0199999999999996 110.473 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.17 85.67 18.45 Favored Pre-proline 0 N--CA 1.501 2.082 0 O-C-N 121.623 -0.673 . . . . 2.4100000000000001 109.745 179.643 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -73.37 -172.44 1.04 Allowed 'Trans proline' 0 C--N 1.318 -1.065 0 O-C-N 123.303 1.16 . . . . 0.95999999999999996 111.386 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 978' ' ' LEU . . . . . 0.66 HD23 HD12 ' B' ' 856' ' ' LEU . 4.9 mp -127.52 154.66 44.86 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 107.71 -1.218 . . . . 0.62 107.71 178.099 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 979' ' ' THR . . . . . 0.471 HG23 ' C ' ' B' ' 978' ' ' LEU . 41.0 p -150.41 140.89 22.46 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.814 -1.179 . . . . 3.5699999999999998 111.088 -179.412 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 980' ' ' ILE . . . . . 0.748 ' HB ' HG21 ' B' ' 899' ' ' VAL . 46.2 mm -107.31 128.73 62.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 109.064 -0.717 . . . . 1.3300000000000001 109.064 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -118.84 95.36 4.8 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 119.787 -0.765 . . . . 0.050000000000000003 111.86 -178.315 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 80.5 p -108.28 158.13 17.74 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.546 -0.721 . . . . 0.87 109.294 178.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 983' ' ' GLY . . . . . 0.405 ' O ' ' CE2' ' B' ' 852' ' ' PHE . . . -174.76 110.57 0.33 Allowed Glycine 0 N--CA 1.498 2.782 0 N-CA-C 106.514 -2.634 . . . . 0.029999999999999999 106.514 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -108.22 150.58 27.08 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 114.43 1.27 . . . . 0.69999999999999996 114.43 -175.562 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 985' ' ' LEU . . . . . 0.935 HD13 HD22 ' B' ' 890' ' ' LEU . 33.5 tp -72.05 135.01 46.18 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.856 -1.153 . . . . 0.040000000000000001 110.052 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 986' ' ' LEU . . . . . 0.483 ' CD1' HD11 ' C' ' 986' ' ' LEU . 51.6 tp -107.46 -55.77 2.3 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.59 -0.694 . . . . 0.040000000000000001 110.101 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -144.62 145.65 31.89 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.719 -1.215 . . . . 0.040000000000000001 107.719 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.45 163.07 12.2 Favored Glycine 0 N--CA 1.495 2.628 0 N-CA-C 108.289 -1.924 . . . . 0.040000000000000001 108.289 179.219 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -75.04 112.47 18.18 Favored Pre-proline 0 N--CA 1.498 1.955 0 O-C-N 121.174 -1.192 . . . . 0.040000000000000001 109.475 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 990' ' ' PRO . . . . . 0.423 ' HD2' HD12 ' B' ' 992' ' ' LEU . 49.8 Cg_endo -90.58 70.89 1.35 Allowed 'Trans proline' 0 C--N 1.318 -1.042 0 O-C-N 123.113 1.06 . . . . 0.45000000000000001 111.517 -178.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 991' ' ' GLU . . . . . 0.419 ' HB2' ' O ' ' B' ' 990' ' ' PRO . 69.4 mt-10 67.12 -73.68 0.08 Allowed 'General case' 0 N--CA 1.503 2.183 0 N-CA-C 108.633 -0.877 . . . . 1.97 108.633 -177.527 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 992' ' ' LEU . . . . . 0.461 ' HA ' HD23 ' B' ' 992' ' ' LEU . 11.1 mt 51.13 20.39 0.86 Allowed 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.552 -0.717 . . . . 2.3799999999999999 111.656 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -93.69 156.97 16.39 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.869 -1.145 . . . . 3.79 110.057 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 71.9 m80 -146.7 92.91 2.21 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.519 -0.738 . . . . 3.5099999999999998 110.415 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 995' ' ' ALA . . . . . . . . . . . . 2.517 . . . . . . . 0 N--CA 1.503 2.22 0 O-C-N 120.886 -1.134 . . . . 2.73 110.603 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo . . . . . 0 N--CA 1.489 1.221 0 N-CA-C 109.521 -0.992 . . . . 3.8300000000000001 109.521 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 847' ' ' VAL . . . . . 0.424 HG12 ' HB2' ' C' ' 849' ' ' GLN . 88.1 t -131.42 102.7 15.31 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.606 -0.684 . . . . 1.8300000000000001 110.131 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 848' ' ' PRO . . . . . 0.753 ' O ' HG23 ' C' ' 850' ' ' VAL . 44.7 Cg_endo -70.2 -20.41 32.8 Favored 'Trans proline' 0 N--CA 1.487 1.138 0 O-C-N 123.278 1.146 . . . . 0.65000000000000002 111.016 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 849' ' ' GLN . . . . . 0.424 ' HB2' HG12 ' C' ' 847' ' ' VAL . 56.2 tt0 27.29 69.17 0.06 Allowed 'General case' 0 N--CA 1.519 2.979 0 N-CA-C 112.884 0.698 . . . . 2.5800000000000001 112.884 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 850' ' ' VAL . . . . . 0.753 HG23 ' O ' ' C' ' 848' ' ' PRO . 67.7 t -119.41 133.91 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.258 -0.901 . . . . 1.0900000000000001 111.64 -178.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 851' ' ' ALA . . . . . 0.447 ' HB3' ' HG ' ' C' ' 873' ' ' LEU . . . -129.88 152.97 48.77 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 105.627 -1.99 . . . . 0.040000000000000001 105.627 176.703 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 852' ' ' PHE . . . . . 0.448 ' HA ' ' CB ' ' C' ' 874' ' ' ASN . 6.0 p90 -160.31 128.76 4.76 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 120.921 1.691 . . . . 0.050000000000000003 108.589 179.242 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 29.8 t -175.67 134.32 0.29 Allowed 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.065 -1.087 . . . . 0.040000000000000001 108.065 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -134.64 156.91 47.92 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.136 -0.978 . . . . 0.67000000000000004 109.596 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 855' ' ' ALA . . . . . 0.593 ' HB3' ' CB ' ' C' ' 870' ' ' ARG . . . -121.83 139.71 53.28 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.864 0.84 . . . . 0.51000000000000001 111.667 -179.017 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 856' ' ' LEU . . . . . 0.713 HD23 ' O ' ' C' ' 867' ' ' PRO . 3.5 tm? -103.04 135.85 43.95 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.69 -0.631 . . . . 0.050000000000000003 109.422 179.386 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 857' ' ' SER . . . . . 0.576 ' N ' HD13 ' C' ' 856' ' ' LEU . 37.3 p -151.38 15.85 0.71 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.487 -0.758 . . . . 1.3300000000000001 111.206 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 858' ' ' LEU . . . . . 0.57 ' CD2' HD11 ' C' ' 856' ' ' LEU . 4.4 pp -33.56 157.47 0.04 OUTLIER Pre-proline 0 N--CA 1.518 2.97 0 N-CA-C 112.899 0.703 . . . . 2.3300000000000001 112.899 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -61.57 -89.27 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 120.897 1.064 . . . . 2.3199999999999998 113.575 -177.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 54.7 ptt85 -127.82 -141.86 0.26 Allowed 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.953 -1.092 . . . . 0.040000000000000001 111.289 -177.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 71.5 m -37.9 123.04 1.04 Allowed 'General case' 0 N--CA 1.51 2.567 0 O-C-N 121.575 -0.703 . . . . 1.3100000000000001 112.064 -179.074 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 862' ' ' GLU . . . . . 0.514 ' HG3' HD22 ' C' ' 858' ' ' LEU . 0.0 OUTLIER -100.55 158.41 31.95 Favored Pre-proline 0 N--CA 1.488 1.429 0 N-CA-C 108.192 -1.04 . . . . 4.5099999999999998 108.192 177.767 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.07 -14.58 32.03 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 123.187 1.099 . . . . 2.2400000000000002 111.034 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -176.98 -135.51 2.21 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.725 -1.35 . . . . 0.040000000000000001 109.725 179.139 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 25.8 m -69.05 154.22 42.44 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.331 -1.1 . . . . 1.51 110.47 -179.088 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 866' ' ' VAL . . . . . 0.46 ' HA ' ' HD3' ' C' ' 867' ' ' PRO . 32.7 m -90.68 139.39 26.33 Favored Pre-proline 0 N--CA 1.497 1.881 0 N-CA-C 113.66 0.985 . . . . 0.78000000000000003 113.66 -175.33 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 867' ' ' PRO . . . . . 0.713 ' O ' HD23 ' C' ' 856' ' ' LEU . 53.9 Cg_endo -88.92 -152.69 0.04 OUTLIER 'Trans proline' 0 C--N 1.325 -0.662 0 N-CA-C 108.286 -1.467 . . . . 0.92000000000000004 108.286 177.391 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 868' ' ' PHE . . . . . 0.471 ' CD1' ' HG2' ' C' ' 881' ' ' PRO . 23.0 p90 -148.15 120.18 8.25 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.513 -1.367 . . . . 0.050000000000000003 109.625 179.365 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 50.2 p-10 -113.02 -2.97 14.1 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 119.38 -0.928 . . . . 1.7 112.029 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 870' ' ' ARG . . . . . 0.593 ' CB ' ' HB3' ' C' ' 855' ' ' ALA . 24.8 mmm180 -90.51 86.88 6.55 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.03 -1.044 . . . . 2.5899999999999999 110.825 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 61.6 t -73.12 96.73 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.074 -1.016 . . . . 1.9399999999999999 109.566 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 872' ' ' LEU . . . . . 0.507 HD11 ' HB2' ' C' ' 855' ' ' ALA . 51.9 mt -86.17 -45.18 11.58 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.554 -0.716 . . . . 1.0600000000000001 110.338 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 873' ' ' LEU . . . . . 0.447 ' HG ' ' HB3' ' C' ' 851' ' ' ALA . 49.3 tp -173.3 102.8 0.12 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.238 -0.914 . . . . 4.1799999999999997 108.791 178.589 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 874' ' ' ASN . . . . . 0.448 ' CB ' ' HA ' ' C' ' 852' ' ' PHE . 37.4 t-20 177.98 82.65 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.319 0 O-C-N 121.721 -0.612 . . . . 0.040000000000000001 109.374 -178.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -67.19 -47.41 71.0 Favored 'General case' 0 N--CA 1.497 1.92 0 C-N-CA 119.203 -0.999 . . . . 3.3799999999999999 111.434 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 876' ' ' GLY . . . . . . . . . . . . . . . -73.53 -26.97 68.51 Favored Glycine 0 N--CA 1.494 2.548 0 O-C-N 121.271 -0.893 . . . . 0.040000000000000001 111.66 -178.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 83.13 -60.18 4.91 Favored Glycine 0 N--CA 1.503 3.109 0 N-CA-C 108.061 -2.015 . . . . 0.040000000000000001 108.061 -178.176 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 878' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 61.41 -66.19 0.06 Allowed 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 114.239 1.2 . . . . 3.46 114.239 177.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 879' ' ' TYR . . . . . 0.471 ' CB ' ' CD2' ' C' ' 886' ' ' PHE . 23.9 p90 -113.92 110.02 19.43 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 114.859 1.429 . . . . 0.040000000000000001 114.859 -176.351 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -66.83 117.98 50.43 Favored Pre-proline 0 N--CA 1.499 2.018 0 O-C-N 121.434 -0.791 . . . . 0.02 109.897 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 881' ' ' PRO . . . . . 0.471 ' HG2' ' CD1' ' C' ' 868' ' ' PHE . 55.3 Cg_endo -77.43 -0.26 10.44 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 O-C-N 123.386 1.203 . . . . 0.39000000000000001 112.141 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -74.58 -63.31 1.27 Allowed 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 106.538 -1.652 . . . . 0.81000000000000005 106.538 178.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 8.9 p -95.61 -17.62 21.21 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.704 -0.85 . . . . 0.040000000000000001 108.704 177.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.78 20.58 59.43 Favored Glycine 0 N--CA 1.495 2.631 0 O-C-N 121.024 -1.047 . . . . 0.029999999999999999 111.165 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 92.4 t -72.02 90.26 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 C-N-CA 118.135 -1.426 . . . . 1.01 108.019 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 886' ' ' PHE . . . . . 0.841 ' HB3' HG22 ' C' ' 962' ' ' VAL . 0.8 OUTLIER -90.93 104.77 17.32 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-N 115.268 -0.878 . . . . 0.050000000000000003 112.037 -177.259 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 887' ' ' THR . . . . . 0.426 ' O ' ' HD3' ' C' ' 889' ' ' PRO . 86.5 m -95.97 101.49 13.16 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 107.697 -1.223 . . . . 0.68000000000000005 107.697 177.246 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 888' ' ' ALA . . . . . . . . . . . . . . . -98.38 107.01 39.56 Favored Pre-proline 0 N--CA 1.502 2.155 0 N-CA-C 113.998 1.11 . . . . 0.25 113.998 -176.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 889' ' ' PRO . . . . . 0.426 ' HD3' ' O ' ' C' ' 887' ' ' THR . 53.6 Cg_endo -90.03 -13.26 2.59 Favored 'Trans proline' 0 CA--C 1.546 1.095 0 C-N-CA 120.975 1.117 . . . . 1.6399999999999999 109.228 176.423 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 890' ' ' LEU . . . . . 1.04 HD22 HD13 ' C' ' 985' ' ' LEU . 75.6 mt -38.7 -49.33 1.57 Allowed 'General case' 0 N--CA 1.507 2.382 0 N-CA-C 113.719 1.007 . . . . 2.29 113.719 -177.366 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 52.85 96.78 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.351 0 O-C-N 121.081 -1.012 . . . . 0.63 110.044 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . 155.79 -146.87 14.91 Favored Glycine 0 N--CA 1.48 1.568 0 N-CA-C 107.096 -2.402 . . . . 0.040000000000000001 107.096 -178.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 74.4 ttt-85 -107.17 129.32 54.87 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 107.947 -1.131 . . . . 3.0 107.947 177.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 894' ' ' TYR . . . . . 0.451 ' CD1' ' N ' ' C' ' 895' ' ' LEU . 0.4 OUTLIER -129.53 142.94 50.65 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.064 -1.022 . . . . 0.040000000000000001 110.086 -179.254 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 895' ' ' LEU . . . . . 0.451 ' N ' ' CD1' ' C' ' 894' ' ' TYR . 34.6 tp -102.08 115.39 30.44 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.632 -0.667 . . . . 1.27 109.597 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 896' ' ' LEU . . . . . 0.609 HD23 ' N ' ' C' ' 897' ' ' SER . 10.3 tt -112.69 146.76 38.13 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.549 -0.719 . . . . 0.93999999999999995 110.594 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 897' ' ' SER . . . . . 0.609 ' N ' HD23 ' C' ' 896' ' ' LEU . 8.3 m -141.4 117.26 10.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.523 -0.736 . . . . 0.040000000000000001 110.494 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -106.61 147.19 29.79 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.126 -0.694 . . . . 0.47999999999999998 109.126 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 899' ' ' VAL . . . . . 0.74 HG21 ' HB ' ' C' ' 980' ' ' ILE . 88.9 t -93.56 119.42 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 C-N-CA 119.729 -0.788 . . . . 0.55000000000000004 111.133 -179.198 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 96.7 mt -93.66 111.53 23.23 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 114.1 1.148 . . . . 1.5900000000000001 114.1 -175.49 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 16.7 m -64.12 140.12 58.84 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 107.32 -1.363 . . . . 0.050000000000000003 107.32 177.231 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -61.18 -64.48 4.01 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.29 -1.124 . . . . 0.029999999999999999 110.29 -179.3 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 45.18 63.77 1.63 Allowed 'General case' 0 N--CA 1.507 2.409 0 O-C-N 121.57 -0.959 . . . . 3.2000000000000002 111.323 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 41.9 ptt85 -67.26 -7.9 27.77 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.573 -0.704 . . . . 2.9199999999999999 111.895 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 905' ' ' HIS . . . . . 0.49 ' O ' ' CB ' ' C' ' 906' ' ' GLU . 74.0 t60 -61.3 5.15 0.07 Allowed 'General case' 0 N--CA 1.505 2.302 0 CA-C-O 117.601 -1.19 . . . . 2.8700000000000001 113.488 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 906' ' ' GLU . . . . . 0.49 ' CB ' ' O ' ' C' ' 905' ' ' HIS . 0.7 OUTLIER 92.58 -163.43 0.01 OUTLIER 'General case' 0 N--CA 1.528 3.447 0 CA-C-N 121.294 1.861 . . . . 0.98999999999999999 112.239 178.919 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 907' ' ' LYS . . . . . 0.488 ' CB ' ' O ' ' C' ' 906' ' ' GLU . 72.4 tttt 89.82 161.96 0.05 OUTLIER 'General case' 0 N--CA 1.52 3.065 0 N-CA-C 108.171 -1.048 . . . . 5.25 108.171 -177.111 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 59.4 t -122.69 115.39 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 120.927 -1.108 . . . . 0.39000000000000001 110.857 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 909' ' ' GLU . . . . . 0.474 ' HG3' HD12 ' C' ' 966' ' ' LEU . 47.1 tt0 -108.07 129.99 55.11 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 107.644 -1.243 . . . . 1.72 107.644 177.152 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -155.93 120.83 4.71 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 106.8 -1.556 . . . . 0.67000000000000004 106.8 178.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 911' ' ' VAL . . . . . 0.896 HG23 HG22 ' C' ' 964' ' ' VAL . 13.3 p -77.3 131.09 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.79 -0.569 . . . . 0.54000000000000004 111.346 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 46.4 mt -67.81 157.62 34.37 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.284 -0.885 . . . . 1.5 108.717 178.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 913' ' ' SER . . . . . 0.475 ' OG ' HG11 ' C' ' 919' ' ' VAL . 1.6 p -123.72 139.56 53.87 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.67 -0.863 . . . . 1.3700000000000001 108.67 177.271 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 914' ' ' ARG . . . . . 0.821 ' NH1' HD23 ' C' ' 956' ' ' LEU . 0.0 OUTLIER -65.02 154.1 38.75 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 120.643 -1.286 . . . . 4.2999999999999998 111.568 -179.104 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 915' ' ' SER . . . . . 0.425 ' CB ' ' O ' ' C' ' 914' ' ' ARG . 4.4 t 83.28 -31.25 0.08 Allowed 'General case' 0 N--CA 1.522 3.164 0 C-N-CA 123.916 0.886 . . . . 2.0499999999999998 112.23 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 916' ' ' ASN . . . . . 0.741 ' HB2' HG21 ' C' ' 919' ' ' VAL . 99.1 m-20 -121.85 -22.01 5.89 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.889 -1.132 . . . . 2.71 111.226 -179.294 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 66.99 166.93 0.23 Allowed 'General case' 0 N--CA 1.52 3.04 0 N-CA-C 105.802 -1.925 . . . . 2.6800000000000002 105.802 -174.075 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.64 -126.38 37.43 Favored Glycine 1 N--CA 1.521 4.344 0 CA-C-N 123.598 2.908 . . . . 0.029999999999999999 107.051 -177.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 919' ' ' VAL . . . . . 0.741 HG21 ' HB2' ' C' ' 916' ' ' ASN . 92.1 t 51.57 93.53 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.238 0 O-C-N 121.307 -1.114 . . . . 1.3899999999999999 109.129 -178.199 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 920' ' ' ALA . . . . . 0.937 ' HB3' HG12 ' C' ' 949' ' ' VAL . . . -93.42 93.82 8.36 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.332 -0.947 . . . . 0.029999999999999999 110.714 -179.265 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 921' ' ' ARG . . . . . 0.811 ' HG3' HG23 ' C' ' 922' ' ' VAL . 20.1 ptt85 -80.39 -41.83 23.9 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 105.938 -1.875 . . . . 4.4199999999999999 105.938 176.233 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 922' ' ' VAL . . . . . 0.811 HG23 ' HG3' ' C' ' 921' ' ' ARG . 90.5 t -101.86 75.11 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 106.088 -1.819 . . . . 0.84999999999999998 106.088 175.451 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -89.79 135.89 33.36 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.872 0.844 . . . . 2.46 112.355 -176.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 7.9 t -147.16 102.76 3.53 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.063 -1.088 . . . . 0.69999999999999996 108.063 178.49 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -110.83 88.95 0.53 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.967 -1.653 . . . . 0.040000000000000001 108.967 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.4 0 N-CA-C 109.353 -1.499 . . . . 0.040000000000000001 109.353 -179.713 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 11.2 m . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 120.962 0.411 . . . . 13.779999999999999 110.318 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 95.3 mt -114.22 129.77 56.63 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.505 -0.747 . . . . 13.76 110.319 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -152.16 170.34 31.47 Favored Glycine 0 N--CA 1.493 2.5 0 N-CA-C 109.398 -1.481 . . . . 9.1300000000000008 109.398 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 949' ' ' VAL . . . . . 0.937 HG12 ' HB3' ' C' ' 920' ' ' ALA . 33.7 m -117.17 136.39 54.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.538 -0.977 . . . . 7.0800000000000001 110.832 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 950' ' ' PHE . . . . . 0.448 ' CZ ' ' HB3' ' C' ' 921' ' ' ARG . 36.0 p90 -135.57 152.25 51.09 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.607 -0.683 . . . . 7.5899999999999999 109.622 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 69.4 m -118.32 -54.44 2.29 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.386 -0.821 . . . . 5.0300000000000002 111.514 -179.26 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 952' ' ' LEU . . . . . 0.448 ' O ' ' O ' ' C' ' 953' ' ' ILE . 46.6 tp -63.78 -77.03 0.06 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.46 -0.775 . . . . 1.01 111.421 -178.453 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 953' ' ' ILE . . . . . 0.544 HD12 ' N ' ' C' ' 954' ' ' LEU . 2.3 pp -49.45 -152.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.735 0 N-CA-C 114.324 1.231 . . . . 2.6000000000000001 114.324 -176.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 954' ' ' LEU . . . . . 0.726 HD22 ' O ' ' C' ' 954' ' ' LEU . 0.0 OUTLIER 169.11 92.09 0.03 OUTLIER Pre-proline 0 N--CA 1.516 2.869 0 O-C-N 120.949 -1.094 . . . . 0.050000000000000003 111.651 179.491 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 955' ' ' PRO . . . . . 0.761 ' C ' HD12 ' C' ' 956' ' ' LEU . 52.1 Cg_endo -80.4 93.0 1.05 Allowed 'Trans proline' 0 C--N 1.317 -1.117 0 N-CA-C 109.138 -1.139 . . . . 0.83999999999999997 109.138 178.598 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 956' ' ' LEU . . . . . 0.821 HD23 ' NH1' ' C' ' 914' ' ' ARG . 10.9 mp -122.85 144.01 49.49 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.014 -1.054 . . . . 0.040000000000000001 110.144 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -82.11 151.33 27.05 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 117.708 -1.139 . . . . 1.28 111.287 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -67.15 118.63 10.83 Favored 'General case' 0 N--CA 1.508 2.45 0 CA-C-N 123.078 2.672 . . . . 0.17000000000000001 111.082 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.42 -20.43 44.1 Favored Glycine 0 N--CA 1.499 2.888 0 N-CA-C 110.872 -0.891 . . . . 0.040000000000000001 110.872 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 960' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.63 169.69 0.13 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.381 -1.07 . . . . 0.040000000000000001 110.125 -179.445 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 961' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' C' ' 886' ' ' PHE . 71.1 p -133.41 137.66 45.9 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.056 -1.027 . . . . 1.78 112.167 -177.682 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 962' ' ' VAL . . . . . 0.841 HG22 ' HB3' ' C' ' 886' ' ' PHE . 25.4 m -97.31 146.46 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 C-N-CA 120.13 -0.628 . . . . 0.040000000000000001 110.184 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 5.5 t -138.59 145.23 40.32 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.952 -0.468 . . . . 0.71999999999999997 109.989 -178.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 964' ' ' VAL . . . . . 0.896 HG22 HG23 ' C' ' 911' ' ' VAL . 65.1 t -97.27 136.0 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.034 -1.041 . . . . 1.05 110.578 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -97.37 125.61 42.09 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 103.906 -2.627 . . . . 3.02 103.906 173.275 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 966' ' ' LEU . . . . . 0.49 ' C ' HG23 ' C' ' 967' ' ' VAL . 1.1 tp -133.11 62.95 1.65 Allowed 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.296 -1.002 . . . . 1.46 108.296 177.519 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 967' ' ' VAL . . . . . 0.49 HG23 ' C ' ' C' ' 966' ' ' LEU . 97.3 t -157.64 97.44 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 108.224 -1.028 . . . . 1.9399999999999999 108.224 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 95.7 mmm -141.9 59.98 1.48 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.741 -1.224 . . . . 0.0 108.541 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.07 119.99 1.99 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 107.235 -2.346 . . . . 2.1099999999999999 107.235 -178.371 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -82.23 -58.55 2.9 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.053 -1.263 . . . . 5.8899999999999997 110.507 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 49.0 tp -59.43 89.94 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.448 -0.782 . . . . 4.3600000000000003 110.261 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -142.16 -152.66 0.42 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.622 -0.673 . . . . 1.8300000000000001 110.09 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -117.36 167.62 11.09 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.462 -0.774 . . . . 4.3499999999999996 110.022 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 10.3 t -101.7 130.56 48.11 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.557 -0.714 . . . . 1.27 110.2 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -155.96 153.85 30.22 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.532 -0.73 . . . . 5.0199999999999996 110.384 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.27 86.23 14.76 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.588 -0.695 . . . . 2.4100000000000001 109.897 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -75.76 -170.55 0.85 Allowed 'Trans proline' 0 C--N 1.318 -1.07 0 O-C-N 123.324 1.17 . . . . 0.95999999999999996 111.223 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 978' ' ' LEU . . . . . 0.46 ' C ' HG23 ' C' ' 979' ' ' THR . 5.0 mp -123.56 156.23 36.11 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 107.497 -1.297 . . . . 0.62 107.497 177.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 979' ' ' THR . . . . . 0.46 HG23 ' C ' ' C' ' 978' ' ' LEU . 40.6 p -150.54 141.66 23.09 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.779 -1.2 . . . . 3.5699999999999998 111.251 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 980' ' ' ILE . . . . . 0.74 ' HB ' HG21 ' C' ' 899' ' ' VAL . 50.1 mm -106.08 128.55 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 109.216 -0.661 . . . . 1.3300000000000001 109.216 179.428 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 981' ' ' PHE . . . . . 0.436 ' CD1' ' CE2' ' C' ' 879' ' ' TYR . 2.3 t80 -118.15 97.29 5.72 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.499 -0.751 . . . . 0.050000000000000003 111.256 -178.637 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 982' ' ' SER . . . . . 0.42 ' HB2' HD23 ' A' ' 952' ' ' LEU . 18.2 p -108.41 159.85 16.35 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.081 -0.711 . . . . 0.87 109.081 178.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 983' ' ' GLY . . . . . 0.411 ' O ' ' CE2' ' C' ' 852' ' ' PHE . . . -169.04 115.01 0.58 Allowed Glycine 0 N--CA 1.497 2.764 0 N-CA-C 106.526 -2.629 . . . . 0.029999999999999999 106.526 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 984' ' ' ALA . . . . . 0.459 ' HB1' ' CZ ' ' A' ' 893' ' ' ARG . . . -109.26 147.95 31.78 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.156 -1.203 . . . . 0.69999999999999996 114.169 -175.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 985' ' ' LEU . . . . . 1.04 HD13 HD22 ' C' ' 890' ' ' LEU . 51.4 tp -75.38 135.06 40.82 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.809 -1.182 . . . . 0.040000000000000001 109.425 179.233 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 986' ' ' LEU . . . . . 0.483 HD11 ' CD1' ' B' ' 986' ' ' LEU . 48.4 tp -107.1 -61.71 1.51 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.477 -0.764 . . . . 0.040000000000000001 110.495 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -144.92 146.31 31.94 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 107.841 -1.17 . . . . 0.040000000000000001 107.841 179.381 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.25 162.82 12.28 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 108.097 -2.001 . . . . 0.040000000000000001 108.097 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -74.6 112.81 19.07 Favored Pre-proline 0 N--CA 1.498 1.967 0 O-C-N 121.206 -1.173 . . . . 0.040000000000000001 109.455 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 990' ' ' PRO . . . . . 0.416 ' O ' ' HB2' ' C' ' 991' ' ' GLU . 50.5 Cg_endo -88.76 70.98 2.38 Favored 'Trans proline' 0 C--N 1.32 -0.937 0 O-C-N 123.115 1.061 . . . . 0.45000000000000001 111.303 -178.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 991' ' ' GLU . . . . . 0.416 ' HB2' ' O ' ' C' ' 990' ' ' PRO . 67.7 mt-10 67.51 -73.31 0.08 Allowed 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 108.582 -0.895 . . . . 1.97 108.582 -177.506 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 992' ' ' LEU . . . . . . . . . . . . . 11.4 mt 50.45 20.83 0.74 Allowed 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.567 -0.708 . . . . 2.3799999999999999 111.69 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -92.91 157.01 16.58 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.936 -1.103 . . . . 3.79 110.055 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -146.32 92.0 2.12 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.579 -0.701 . . . . 3.5099999999999998 110.254 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 995' ' ' ALA . . . . . . . . . . . . 2.518 . . . . . . . 0 N--CA 1.504 2.23 0 O-C-N 120.913 -1.117 . . . . 2.73 110.564 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo . . . . . 0 N--CA 1.488 1.199 0 N-CA-C 109.451 -1.019 . . . . 3.8300000000000001 109.451 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 847' ' ' VAL . . . . . 0.401 HG12 ' HB2' ' A' ' 849' ' ' GLN . 66.6 t -134.93 102.82 10.98 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.617 -0.677 . . . . 1.8300000000000001 110.004 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 848' ' ' PRO . . . . . 0.765 ' O ' HG23 ' A' ' 850' ' ' VAL . 44.2 Cg_endo -69.83 -18.66 36.56 Favored 'Trans proline' 0 N--CA 1.488 1.155 0 O-C-N 123.344 1.181 . . . . 0.65000000000000002 111.168 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 849' ' ' GLN . . . . . 0.401 ' HB2' HG12 ' A' ' 847' ' ' VAL . 55.8 tt0 27.39 67.97 0.07 Allowed 'General case' 0 N--CA 1.518 2.927 0 N-CA-C 113.025 0.75 . . . . 2.5800000000000001 113.025 179.221 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 850' ' ' VAL . . . . . 0.765 HG23 ' O ' ' A' ' 848' ' ' PRO . 69.9 t -119.39 137.02 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 121.202 -0.936 . . . . 1.0900000000000001 111.442 -178.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 851' ' ' ALA . . . . . 0.641 ' HB3' ' HG ' ' A' ' 873' ' ' LEU . . . -124.13 159.0 30.99 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 105.827 -1.916 . . . . 0.040000000000000001 105.827 176.749 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 852' ' ' PHE . . . . . 0.431 ' HA ' ' CB ' ' A' ' 874' ' ' ASN . 32.7 p90 -159.6 127.96 4.99 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 120.948 1.704 . . . . 0.050000000000000003 108.492 178.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 7.8 t -175.71 134.42 0.29 Allowed 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.152 -1.055 . . . . 0.040000000000000001 108.152 -178.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -131.98 157.41 44.15 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.083 -1.011 . . . . 0.67000000000000004 109.626 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 855' ' ' ALA . . . . . 0.863 ' HB3' ' CB ' ' A' ' 870' ' ' ARG . . . -120.78 146.1 46.86 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-O 122.018 0.914 . . . . 0.51000000000000001 111.291 -178.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 856' ' ' LEU . . . . . 0.754 HD12 HD23 ' A' ' 978' ' ' LEU . 2.7 tm? -113.01 133.36 54.99 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.738 -0.601 . . . . 0.050000000000000003 109.872 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 857' ' ' SER . . . . . 0.659 ' N ' HD13 ' A' ' 856' ' ' LEU . 30.3 p -154.37 14.6 0.44 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.526 -0.734 . . . . 1.3300000000000001 111.683 179.373 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 858' ' ' LEU . . . . . 0.562 HD12 ' C ' ' A' ' 858' ' ' LEU . 4.5 pp -33.22 159.64 0.03 OUTLIER Pre-proline 0 N--CA 1.52 3.028 0 N-CA-C 113.427 0.899 . . . . 2.3300000000000001 113.427 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -61.85 -88.29 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 120.965 1.11 . . . . 2.3199999999999998 113.316 -178.361 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 53.6 ptt85 -128.01 -142.47 0.27 Allowed 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.887 -1.133 . . . . 0.040000000000000001 111.397 -177.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 8.8 m -41.28 129.04 2.99 Favored 'General case' 0 N--CA 1.509 2.498 0 O-C-N 121.459 -0.776 . . . . 1.3100000000000001 111.902 -179.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 862' ' ' GLU . . . . . 0.592 ' OE1' HG22 ' A' ' 866' ' ' VAL . 1.9 tt0 -94.81 152.77 39.96 Favored Pre-proline 0 N--CA 1.492 1.626 0 N-CA-C 108.107 -1.071 . . . . 4.5099999999999998 108.107 177.506 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 863' ' ' PRO . . . . . 0.413 ' HD2' ' CG ' ' A' ' 862' ' ' GLU . 43.5 Cg_endo -70.27 -12.22 31.55 Favored 'Trans proline' 0 C--N 1.314 -1.271 0 O-C-N 123.059 1.031 . . . . 2.2400000000000002 111.161 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -175.74 -136.07 2.25 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 110.107 -1.197 . . . . 0.040000000000000001 110.107 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 39.9 m -64.38 155.77 31.37 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.382 -1.07 . . . . 1.51 111.331 -178.395 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 866' ' ' VAL . . . . . 0.592 HG22 ' OE1' ' A' ' 862' ' ' GLU . 2.7 t -91.12 128.07 48.97 Favored Pre-proline 0 N--CA 1.5 2.059 0 N-CA-C 113.399 0.889 . . . . 0.78000000000000003 113.399 -174.385 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 867' ' ' PRO . . . . . 0.614 ' O ' HD23 ' A' ' 856' ' ' LEU . 51.3 Cg_endo -92.05 -155.62 0.05 OUTLIER 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 121.174 1.25 . . . . 0.92000000000000004 109.516 177.442 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 868' ' ' PHE . . . . . 0.454 ' CD1' ' HG2' ' A' ' 881' ' ' PRO . 21.1 p90 -151.73 123.64 8.06 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.654 -1.279 . . . . 0.050000000000000003 109.994 179.294 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 44.0 p30 -114.62 -0.72 13.55 Favored 'General case' 0 N--CA 1.501 2.109 0 C-N-CA 119.345 -0.942 . . . . 1.7 112.762 -178.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 870' ' ' ARG . . . . . 0.863 ' CB ' ' HB3' ' A' ' 855' ' ' ALA . 26.9 mmm180 -90.97 90.47 7.9 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 120.845 -1.16 . . . . 2.5899999999999999 111.099 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 60.4 t -74.7 97.13 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 120.978 -1.076 . . . . 1.9399999999999999 109.911 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 872' ' ' LEU . . . . . 0.623 HD11 ' HB2' ' A' ' 855' ' ' ALA . 96.3 mt -83.2 -46.81 12.27 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.468 -0.77 . . . . 1.0600000000000001 110.131 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 873' ' ' LEU . . . . . 0.641 ' HG ' ' HB3' ' A' ' 851' ' ' ALA . 36.9 tp -174.52 102.98 0.1 Allowed 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.521 -0.918 . . . . 4.1799999999999997 108.521 178.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 874' ' ' ASN . . . . . 0.431 ' CB ' ' HA ' ' A' ' 852' ' ' PHE . 35.4 t-20 178.73 80.86 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.3 0 O-C-N 121.622 -0.674 . . . . 0.040000000000000001 109.555 -178.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -66.7 -47.27 72.92 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.211 -0.931 . . . . 3.3799999999999999 111.204 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 876' ' ' GLY . . . . . . . . . . . . . . . -73.56 -24.86 73.86 Favored Glycine 0 N--CA 1.494 2.555 0 O-C-N 121.306 -0.871 . . . . 0.040000000000000001 111.509 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 84.0 -59.93 4.9 Favored Glycine 0 N--CA 1.502 3.041 0 N-CA-C 108.088 -2.005 . . . . 0.040000000000000001 108.088 -178.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 878' ' ' TYR . . . . . 0.447 ' CZ ' HG11 ' A' ' 850' ' ' VAL . 97.7 m-85 60.78 -65.79 0.06 Allowed 'General case' 0 N--CA 1.503 2.22 0 N-CA-C 114.206 1.188 . . . . 3.46 114.206 177.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 879' ' ' TYR . . . . . 0.555 ' HH ' ' HD1' ' A' ' 981' ' ' PHE . 21.0 p90 -112.73 109.35 18.79 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 114.833 1.42 . . . . 0.040000000000000001 114.833 -176.357 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.42 116.77 37.28 Favored Pre-proline 0 N--CA 1.496 1.825 0 O-C-N 121.381 -0.825 . . . . 0.02 109.647 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 881' ' ' PRO . . . . . 0.454 ' HG2' ' CD1' ' A' ' 868' ' ' PHE . 53.6 Cg_endo -75.59 -0.02 9.67 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 O-C-N 123.492 1.259 . . . . 0.39000000000000001 112.493 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -75.99 -63.15 1.38 Allowed 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 106.723 -1.584 . . . . 0.81000000000000005 106.723 178.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 41.1 p -94.1 -20.23 20.1 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.482 -0.933 . . . . 0.040000000000000001 108.482 177.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.21 20.94 58.08 Favored Glycine 0 N--CA 1.495 2.573 0 O-C-N 121.034 -1.041 . . . . 0.029999999999999999 111.385 178.446 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 885' ' ' VAL . . . . . . . . . . . . . 99.3 t -73.67 91.81 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 C-N-CA 118.103 -1.439 . . . . 1.01 108.196 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 886' ' ' PHE . . . . . 0.834 ' HB3' HG22 ' A' ' 962' ' ' VAL . 0.7 OUTLIER -89.87 104.75 17.29 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-N 115.118 -0.946 . . . . 0.050000000000000003 112.092 -177.143 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 887' ' ' THR . . . . . 0.445 ' O ' ' HD3' ' A' ' 889' ' ' PRO . 93.7 m -96.29 100.42 12.05 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 107.685 -1.228 . . . . 0.68000000000000005 107.685 177.36 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 888' ' ' ALA . . . . . . . . . . . . . . . -98.62 105.95 33.61 Favored Pre-proline 0 N--CA 1.502 2.132 0 N-CA-C 114.279 1.215 . . . . 0.25 114.279 -176.324 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 889' ' ' PRO . . . . . 0.445 ' HD3' ' O ' ' A' ' 887' ' ' THR . 54.1 Cg_endo -89.0 -13.37 3.09 Favored 'Trans proline' 0 CA--C 1.546 1.105 0 N-CA-C 108.935 -1.217 . . . . 1.6399999999999999 108.935 175.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 890' ' ' LEU . . . . . 0.709 HD22 HD13 ' A' ' 985' ' ' LEU . 69.3 mt -36.54 -49.97 0.77 Allowed 'General case' 0 N--CA 1.508 2.47 0 N-CA-C 113.612 0.967 . . . . 2.29 113.612 -177.472 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 52.09 96.03 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.189 -0.944 . . . . 0.63 110.289 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 158.0 -153.61 24.78 Favored Glycine 0 N--CA 1.478 1.468 0 N-CA-C 107.227 -2.349 . . . . 0.040000000000000001 107.227 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 893' ' ' ARG . . . . . 0.438 ' CZ ' ' HB1' ' C' ' 984' ' ' ALA . 72.9 ttt-85 -115.7 126.39 54.05 Favored 'General case' 0 C--N 1.294 -1.82 0 O-C-N 121.601 -0.94 . . . . 3.0 108.512 177.559 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 894' ' ' TYR . . . . . 0.742 ' OH ' HD12 ' A' ' 896' ' ' LEU . 0.1 OUTLIER -132.26 159.99 37.49 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.177 -0.952 . . . . 0.040000000000000001 111.038 -179.74 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 895' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' A' ' 895' ' ' LEU . 37.8 tp -91.77 118.49 30.74 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.69 -0.631 . . . . 1.27 110.168 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 896' ' ' LEU . . . . . 0.742 HD12 ' OH ' ' A' ' 894' ' ' TYR . 9.2 tt -110.05 142.16 41.88 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.707 -0.621 . . . . 0.93999999999999995 110.047 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 897' ' ' SER . . . . . 0.442 ' N ' HD23 ' A' ' 896' ' ' LEU . 64.1 m -148.9 115.51 5.92 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.452 -0.78 . . . . 0.040000000000000001 110.982 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.61 146.18 32.3 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.892 -0.781 . . . . 0.47999999999999998 108.892 178.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 899' ' ' VAL . . . . . 0.732 HG21 ' HB ' ' A' ' 980' ' ' ILE . 87.5 t -94.73 120.39 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.373 -0.829 . . . . 0.55000000000000004 111.033 -179.298 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 900' ' ' LEU . . . . . 0.619 HD12 ' HB2' ' A' ' 924' ' ' SER . 4.3 mm? -95.23 112.8 24.46 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 114.382 1.252 . . . . 1.5900000000000001 114.382 -174.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 15.6 m -66.85 141.53 57.65 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 107.334 -1.358 . . . . 0.050000000000000003 107.334 176.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -67.02 -65.83 2.62 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 110.583 -1.007 . . . . 0.029999999999999999 110.583 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 8.8 m170 46.72 66.7 0.92 Allowed 'General case' 0 N--CA 1.508 2.437 0 O-C-N 121.493 -1.004 . . . . 3.2000000000000002 111.155 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 43.2 ptt85 -69.38 -5.88 26.38 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.624 -0.672 . . . . 2.9199999999999999 112.108 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 905' ' ' HIS . . . . . 0.487 ' O ' ' CB ' ' A' ' 906' ' ' GLU . 72.7 t60 -62.32 5.03 0.12 Allowed 'General case' 0 N--CA 1.506 2.335 0 O-C-N 120.918 -1.114 . . . . 2.8700000000000001 113.155 -179.149 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 906' ' ' GLU . . . . . 0.487 ' CB ' ' O ' ' A' ' 905' ' ' HIS . 0.5 OUTLIER 94.63 -164.29 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.449 0 CA-C-N 120.562 1.528 . . . . 0.98999999999999999 111.824 179.007 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 907' ' ' LYS . . . . . 0.465 ' CB ' ' O ' ' A' ' 906' ' ' GLU . 63.1 tttt 85.59 156.59 0.09 Allowed 'General case' 0 N--CA 1.52 3.031 0 N-CA-C 108.024 -1.102 . . . . 5.25 108.024 -176.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 58.9 t -122.02 116.38 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 120.787 -1.196 . . . . 0.39000000000000001 111.099 -179.314 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -99.82 133.21 44.52 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 107.319 -1.363 . . . . 1.72 107.319 176.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -155.92 121.94 5.04 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 106.842 -1.54 . . . . 0.67000000000000004 106.842 178.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 911' ' ' VAL . . . . . 0.814 HG22 HG13 ' A' ' 964' ' ' VAL . 87.3 t -84.06 132.15 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.86 -0.525 . . . . 0.54000000000000004 110.783 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 62.2 mt -65.63 156.42 32.84 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.404 -0.81 . . . . 1.5 109.025 178.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 913' ' ' SER . . . . . 0.413 ' CB ' ' CG1' ' A' ' 919' ' ' VAL . 1.3 t -123.02 138.4 54.7 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.316 -0.994 . . . . 1.3700000000000001 108.316 177.177 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 914' ' ' ARG . . . . . 0.624 ' NH1' HD23 ' A' ' 956' ' ' LEU . 0.0 OUTLIER -65.15 154.79 36.94 Favored 'General case' 0 N--CA 1.505 2.284 0 O-C-N 120.762 -1.211 . . . . 4.2999999999999998 111.751 -179.049 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 915' ' ' SER . . . . . 0.426 ' CB ' ' O ' ' A' ' 914' ' ' ARG . 4.7 t 83.07 -32.71 0.08 Allowed 'General case' 0 N--CA 1.522 3.136 0 C-N-CA 123.979 0.911 . . . . 2.0499999999999998 112.254 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 916' ' ' ASN . . . . . 0.767 ' HB2' HG21 ' A' ' 919' ' ' VAL . 92.9 m-20 -121.1 -20.46 6.79 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.947 -1.095 . . . . 2.71 111.469 -179.033 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 917' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 66.82 165.04 0.21 Allowed 'General case' 0 N--CA 1.521 3.111 0 N-CA-C 105.452 -2.055 . . . . 2.6800000000000002 105.452 -173.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.33 -125.38 33.82 Favored Glycine 1 N--CA 1.521 4.357 0 CA-C-N 123.545 2.884 . . . . 0.029999999999999999 106.987 -177.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 919' ' ' VAL . . . . . 0.767 HG21 ' HB2' ' A' ' 916' ' ' ASN . 78.6 t 51.58 94.9 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 O-C-N 121.513 -0.992 . . . . 1.3899999999999999 108.996 -178.14 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 920' ' ' ALA . . . . . 0.858 ' HB3' HG12 ' A' ' 949' ' ' VAL . . . -91.38 92.29 8.51 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.246 -0.982 . . . . 0.029999999999999999 110.902 -179.012 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 921' ' ' ARG . . . . . 0.886 ' HG3' HG23 ' A' ' 922' ' ' VAL . 27.5 ptt180 -83.9 -41.76 17.07 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 105.756 -1.942 . . . . 4.4199999999999999 105.756 175.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 922' ' ' VAL . . . . . 0.886 HG23 ' HG3' ' A' ' 921' ' ' ARG . 78.7 t -102.19 73.44 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 106.308 -1.738 . . . . 0.84999999999999998 106.308 175.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -86.82 133.75 33.61 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.643 0.735 . . . . 2.46 111.231 -177.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 924' ' ' SER . . . . . 0.619 ' HB2' HD12 ' A' ' 900' ' ' LEU . 28.0 t -147.83 105.9 3.74 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.907 -0.775 . . . . 0.69999999999999996 108.907 179.443 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -102.91 83.65 0.44 Allowed Glycine 0 N--CA 1.487 2.043 0 N-CA-C 108.277 -1.929 . . . . 0.040000000000000001 108.277 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.126 0 N-CA-C 108.67 -1.772 . . . . 0.040000000000000001 108.67 -179.709 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 33.0 m . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.012 0.434 . . . . 13.779999999999999 110.21 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 96.2 mt -112.44 129.44 56.32 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.666 -0.646 . . . . 13.76 110.365 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -152.34 168.03 31.41 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 108.967 -1.653 . . . . 9.1300000000000008 108.967 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 949' ' ' VAL . . . . . 0.858 HG12 ' HB3' ' A' ' 920' ' ' ALA . 34.9 m -119.38 130.77 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.502 -0.999 . . . . 7.0800000000000001 110.998 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 950' ' ' PHE . . . . . 0.455 ' CE1' ' HD2' ' A' ' 955' ' ' PRO . 25.5 p90 -133.24 150.51 51.94 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.565 -0.709 . . . . 7.5899999999999999 109.149 179.311 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 19.5 m -120.66 -53.19 2.1 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.341 -0.85 . . . . 5.0300000000000002 112.314 -178.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 952' ' ' LEU . . . . . 0.427 ' O ' ' O ' ' A' ' 953' ' ' ILE . 13.6 tp -60.39 -73.01 0.1 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.411 -0.805 . . . . 1.01 112.576 -177.446 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 953' ' ' ILE . . . . . 0.948 HD11 HD13 ' C' ' 872' ' ' LEU . 46.1 pt -52.6 -145.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.768 0 N-CA-C 114.06 1.133 . . . . 2.6000000000000001 114.06 -176.566 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 954' ' ' LEU . . . . . 0.708 HD22 ' O ' ' A' ' 954' ' ' LEU . 0.0 OUTLIER 171.84 77.45 0.04 OUTLIER Pre-proline 0 N--CA 1.51 2.554 0 O-C-N 120.768 -1.208 . . . . 0.050000000000000003 111.461 179.555 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 955' ' ' PRO . . . . . 0.69 ' C ' HD12 ' A' ' 956' ' ' LEU . 48.4 Cg_endo -74.88 96.41 1.01 Allowed 'Trans proline' 0 C--N 1.315 -1.227 0 N-CA-C 109.521 -0.992 . . . . 0.83999999999999997 109.521 178.541 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 956' ' ' LEU . . . . . 0.69 HD12 ' C ' ' A' ' 955' ' ' PRO . 10.4 mp -123.03 145.68 48.31 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.197 -0.939 . . . . 0.040000000000000001 110.214 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -83.71 150.41 25.86 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 117.773 -1.108 . . . . 1.28 111.675 -179.162 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -70.4 119.87 15.22 Favored 'General case' 0 N--CA 1.51 2.526 0 CA-C-N 122.967 2.621 . . . . 0.17000000000000001 111.558 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.6 -22.77 31.5 Favored Glycine 0 N--CA 1.501 3.008 0 N-CA-C 111.16 -0.776 . . . . 0.040000000000000001 111.16 178.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 960' ' ' ASP . . . . . 0.438 ' HB3' ' NE ' ' A' ' 914' ' ' ARG . 0.6 OUTLIER -52.14 172.14 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.49 -1.006 . . . . 0.040000000000000001 110.403 -179.409 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 961' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 886' ' ' PHE . 7.2 t -134.77 134.6 41.11 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.008 -1.058 . . . . 1.78 111.849 -178.382 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 962' ' ' VAL . . . . . 0.834 HG22 ' HB3' ' A' ' 886' ' ' PHE . 31.7 m -99.01 145.91 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 C-N-CA 120.074 -0.65 . . . . 0.040000000000000001 110.44 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 5.3 t -139.0 145.24 39.43 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.853 -0.529 . . . . 0.71999999999999997 110.115 -178.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 964' ' ' VAL . . . . . 0.814 HG13 HG22 ' A' ' 911' ' ' VAL . 55.5 t -94.12 136.57 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.105 -0.997 . . . . 1.05 110.714 -179.16 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -95.81 126.79 41.31 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 103.665 -2.717 . . . . 3.02 103.665 173.194 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 966' ' ' LEU . . . . . 0.492 ' C ' HG23 ' A' ' 967' ' ' VAL . 20.8 tp -132.6 62.35 1.65 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.304 -0.999 . . . . 1.46 108.304 177.357 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 967' ' ' VAL . . . . . 0.492 HG23 ' C ' ' A' ' 966' ' ' LEU . 89.9 t -158.21 97.19 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 108.049 -1.093 . . . . 1.9399999999999999 108.049 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 88.8 mmm -142.99 59.37 1.42 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.737 -1.227 . . . . 0.0 108.184 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.44 119.91 1.96 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 106.957 -2.457 . . . . 2.1099999999999999 106.957 -178.039 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -81.55 -57.9 3.26 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 118.696 1.248 . . . . 5.8899999999999997 110.368 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 44.2 tp -58.82 90.58 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.501 -0.75 . . . . 4.3600000000000003 110.203 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -141.43 -155.02 0.55 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.562 -0.711 . . . . 1.8300000000000001 110.344 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -119.79 172.03 7.99 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.476 -0.765 . . . . 4.3499999999999996 110.38 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 29.2 t -101.51 130.32 47.76 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.537 -0.727 . . . . 1.27 110.102 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -156.44 158.35 37.14 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.511 -0.743 . . . . 5.0199999999999996 110.548 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.72 86.36 15.91 Favored Pre-proline 0 N--CA 1.501 2.094 0 O-C-N 121.602 -0.686 . . . . 2.4100000000000001 109.713 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.07 -172.8 1.07 Allowed 'Trans proline' 0 C--N 1.317 -1.093 0 O-C-N 123.271 1.143 . . . . 0.95999999999999996 111.547 -179.266 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 978' ' ' LEU . . . . . 0.754 HD23 HD12 ' A' ' 856' ' ' LEU . 5.2 mp -127.93 154.73 45.22 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 107.577 -1.268 . . . . 0.62 107.577 178.036 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 979' ' ' THR . . . . . 0.449 HG23 ' C ' ' A' ' 978' ' ' LEU . 33.7 p -150.34 142.15 23.75 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.809 -1.182 . . . . 3.5699999999999998 111.368 -179.23 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 980' ' ' ILE . . . . . 0.732 ' HB ' HG21 ' A' ' 899' ' ' VAL . 46.8 mm -106.5 127.44 61.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 108.798 -0.815 . . . . 1.3300000000000001 108.798 179.222 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 981' ' ' PHE . . . . . 0.555 ' HD1' ' HH ' ' A' ' 879' ' ' TYR . 5.7 t80 -119.49 97.48 5.67 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 119.762 -0.775 . . . . 0.050000000000000003 111.726 -178.476 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 77.8 p -108.55 158.48 17.52 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.485 -0.759 . . . . 0.87 109.331 178.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 983' ' ' GLY . . . . . 0.403 ' O ' ' CE1' ' A' ' 852' ' ' PHE . . . -174.98 107.55 0.24 Allowed Glycine 0 N--CA 1.499 2.859 0 N-CA-C 106.452 -2.659 . . . . 0.029999999999999999 106.452 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -108.75 152.5 24.77 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 114.507 1.299 . . . . 0.69999999999999996 114.507 -175.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 985' ' ' LEU . . . . . 0.709 HD13 HD22 ' A' ' 890' ' ' LEU . 53.1 tp -71.29 134.03 46.49 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.793 -1.192 . . . . 0.040000000000000001 110.141 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 45.9 tp -107.61 -56.13 2.26 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.552 -0.718 . . . . 0.040000000000000001 109.804 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -145.26 145.2 31.18 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 107.701 -1.222 . . . . 0.040000000000000001 107.701 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -113.02 163.32 12.15 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 108.293 -1.923 . . . . 0.040000000000000001 108.293 179.201 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -75.44 112.69 20.27 Favored Pre-proline 0 N--CA 1.5 2.026 0 O-C-N 121.256 -1.144 . . . . 0.040000000000000001 109.485 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 990' ' ' PRO . . . . . 0.417 ' HD2' HD12 ' A' ' 992' ' ' LEU . 50.7 Cg_endo -90.19 70.92 1.56 Allowed 'Trans proline' 0 C--N 1.319 -1.004 0 O-C-N 123.134 1.07 . . . . 0.45000000000000001 111.514 -179.074 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 991' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 990' ' ' PRO . 70.6 mt-10 67.37 -73.61 0.08 Allowed 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 108.584 -0.895 . . . . 1.97 108.584 -177.424 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 992' ' ' LEU . . . . . 0.417 HD12 ' HD2' ' A' ' 990' ' ' PRO . 10.9 mt 51.05 20.58 0.85 Allowed 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.502 -0.749 . . . . 2.3799999999999999 111.638 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 83.6 mt-10 -94.09 156.87 16.36 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.879 -1.138 . . . . 3.79 110.085 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 72.4 m80 -146.63 93.33 2.27 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.526 -0.734 . . . . 3.5099999999999998 110.311 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 995' ' ' ALA . . . . . . . . . . . . 2.518 . . . . . . . 0 N--CA 1.503 2.198 0 O-C-N 120.831 -1.168 . . . . 2.73 110.614 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo . . . . . 0 N--CA 1.488 1.18 0 N-CA-C 109.429 -1.027 . . . . 3.8300000000000001 109.429 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 847' ' ' VAL . . . . . . . . . . . . . 66.4 t -134.93 102.91 10.94 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.557 -0.715 . . . . 1.8300000000000001 110.041 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 848' ' ' PRO . . . . . 0.772 ' O ' HG23 ' B' ' 850' ' ' VAL . 44.2 Cg_endo -69.81 -18.93 36.51 Favored 'Trans proline' 0 N--CA 1.488 1.167 0 O-C-N 123.319 1.168 . . . . 0.65000000000000002 111.136 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 849' ' ' GLN . . . . . 0.405 ' C ' ' O ' ' B' ' 848' ' ' PRO . 55.9 tt0 27.59 68.22 0.07 Allowed 'General case' 0 N--CA 1.518 2.953 0 N-CA-C 112.951 0.723 . . . . 2.5800000000000001 112.951 179.257 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 850' ' ' VAL . . . . . 0.772 HG23 ' O ' ' B' ' 848' ' ' PRO . 68.0 t -119.62 137.13 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.193 -0.942 . . . . 1.0900000000000001 111.427 -179.002 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 851' ' ' ALA . . . . . 0.643 ' HB3' ' HG ' ' B' ' 873' ' ' LEU . . . -124.71 158.21 33.77 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 105.828 -1.916 . . . . 0.040000000000000001 105.828 176.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 852' ' ' PHE . . . . . 0.425 ' HA ' ' CB ' ' B' ' 874' ' ' ASN . 32.1 p90 -158.82 128.27 5.61 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 121.056 1.753 . . . . 0.050000000000000003 108.493 179.091 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 7.6 t -175.79 134.09 0.28 Allowed 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.245 -1.021 . . . . 0.040000000000000001 108.245 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -131.49 157.76 42.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.106 -0.996 . . . . 0.67000000000000004 109.668 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 855' ' ' ALA . . . . . 0.854 ' HB3' ' CB ' ' B' ' 870' ' ' ARG . . . -121.1 146.15 47.04 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.997 0.903 . . . . 0.51000000000000001 111.287 -178.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 856' ' ' LEU . . . . . 0.726 HD12 HD23 ' B' ' 978' ' ' LEU . 2.7 tm? -113.17 132.83 55.32 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.712 -0.617 . . . . 0.050000000000000003 109.971 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 857' ' ' SER . . . . . 0.654 ' N ' HD13 ' B' ' 856' ' ' LEU . 30.1 p -153.97 14.92 0.48 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.521 -0.737 . . . . 1.3300000000000001 111.711 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 858' ' ' LEU . . . . . 0.56 HD12 ' C ' ' B' ' 858' ' ' LEU . 4.5 pp -33.46 159.69 0.03 OUTLIER Pre-proline 0 N--CA 1.52 3.052 0 N-CA-C 113.401 0.889 . . . . 2.3300000000000001 113.401 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -61.96 -88.39 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 121.013 1.142 . . . . 2.3199999999999998 113.235 -178.344 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 53.6 ptt85 -127.94 -142.53 0.27 Allowed 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.893 -1.13 . . . . 0.040000000000000001 111.405 -177.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 8.8 m -41.21 128.29 2.88 Favored 'General case' 0 N--CA 1.509 2.482 0 O-C-N 121.383 -0.823 . . . . 1.3100000000000001 111.909 -179.027 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 862' ' ' GLU . . . . . 0.589 ' OE1' HG22 ' B' ' 866' ' ' VAL . 1.9 tt0 -94.09 152.81 40.67 Favored Pre-proline 0 N--CA 1.491 1.592 0 N-CA-C 108.085 -1.08 . . . . 4.5099999999999998 108.085 177.488 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 863' ' ' PRO . . . . . 0.411 ' HD2' ' CG ' ' B' ' 862' ' ' GLU . 43.1 Cg_endo -70.14 -12.36 32.03 Favored 'Trans proline' 0 C--N 1.314 -1.248 0 O-C-N 123.086 1.045 . . . . 2.2400000000000002 111.25 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -175.42 -134.92 1.99 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.063 -1.215 . . . . 0.040000000000000001 110.063 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 41.5 m -65.49 156.76 31.49 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.294 -1.121 . . . . 1.51 111.247 -178.457 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 866' ' ' VAL . . . . . 0.589 HG22 ' OE1' ' B' ' 862' ' ' GLU . 2.7 t -91.96 127.99 47.44 Favored Pre-proline 0 N--CA 1.499 1.995 0 N-CA-C 113.424 0.898 . . . . 0.78000000000000003 113.424 -174.302 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 867' ' ' PRO . . . . . 0.617 ' O ' HD23 ' B' ' 856' ' ' LEU . 51.8 Cg_endo -92.01 -155.81 0.05 OUTLIER 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 121.149 1.233 . . . . 0.92000000000000004 109.547 177.528 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 868' ' ' PHE . . . . . 0.46 ' CD1' ' HG2' ' B' ' 881' ' ' PRO . 21.7 p90 -151.56 123.43 8.06 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.636 -1.29 . . . . 0.050000000000000003 110.019 179.279 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 44.2 p30 -114.46 -0.32 13.79 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.2 -0.938 . . . . 1.7 112.815 -178.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 870' ' ' ARG . . . . . 0.854 ' CB ' ' HB3' ' B' ' 855' ' ' ALA . 26.7 mmm180 -91.45 90.16 7.54 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.86 -1.15 . . . . 2.5899999999999999 111.145 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 59.6 t -74.42 97.2 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 120.951 -1.093 . . . . 1.9399999999999999 109.959 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 872' ' ' LEU . . . . . 0.628 HD11 ' HB2' ' B' ' 855' ' ' ALA . 96.2 mt -83.34 -46.67 12.32 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.492 -0.755 . . . . 1.0600000000000001 110.14 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 873' ' ' LEU . . . . . 0.643 ' HG ' ' HB3' ' B' ' 851' ' ' ALA . 36.9 tp -174.54 102.99 0.1 Allowed 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 108.507 -0.923 . . . . 4.1799999999999997 108.507 178.612 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 874' ' ' ASN . . . . . 0.425 ' CB ' ' HA ' ' B' ' 852' ' ' PHE . 35.4 t-20 178.73 81.12 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.337 0 O-C-N 121.63 -0.668 . . . . 0.040000000000000001 109.552 -178.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -66.94 -47.28 72.15 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.127 -0.983 . . . . 3.3799999999999999 111.198 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 876' ' ' GLY . . . . . . . . . . . . . . . -73.56 -24.98 73.6 Favored Glycine 0 N--CA 1.494 2.521 0 O-C-N 121.305 -0.872 . . . . 0.040000000000000001 111.454 -178.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 84.14 -59.78 4.91 Favored Glycine 0 N--CA 1.501 3.001 0 N-CA-C 108.075 -2.01 . . . . 0.040000000000000001 108.075 -178.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 878' ' ' TYR . . . . . 0.44 ' CZ ' HG11 ' B' ' 850' ' ' VAL . 97.7 m-85 60.82 -65.73 0.06 Allowed 'General case' 0 N--CA 1.503 2.189 0 N-CA-C 114.226 1.195 . . . . 3.46 114.226 177.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 879' ' ' TYR . . . . . 0.495 ' HH ' ' HD1' ' B' ' 981' ' ' PHE . 21.1 p90 -112.8 109.31 18.7 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 114.769 1.396 . . . . 0.040000000000000001 114.769 -176.381 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.25 116.72 36.28 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.343 -0.848 . . . . 0.02 109.698 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 881' ' ' PRO . . . . . 0.46 ' HG2' ' CD1' ' B' ' 868' ' ' PHE . 53.9 Cg_endo -75.53 -0.22 9.88 Favored 'Trans proline' 0 N--CA 1.497 1.709 0 O-C-N 123.47 1.247 . . . . 0.39000000000000001 112.534 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -75.7 -63.55 1.27 Allowed 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 106.716 -1.587 . . . . 0.81000000000000005 106.716 178.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 41.4 p -93.91 -19.9 20.52 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.482 -0.933 . . . . 0.040000000000000001 108.482 177.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.76 21.4 57.85 Favored Glycine 0 N--CA 1.494 2.556 0 O-C-N 121.05 -1.031 . . . . 0.029999999999999999 111.369 178.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 885' ' ' VAL . . . . . . . . . . . . . 98.8 t -73.91 92.14 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 C-N-CA 118.084 -1.446 . . . . 1.01 108.06 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 886' ' ' PHE . . . . . 0.879 ' HB3' HG22 ' B' ' 962' ' ' VAL . 0.7 OUTLIER -90.1 104.87 17.4 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 115.119 -0.946 . . . . 0.050000000000000003 112.085 -177.192 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 887' ' ' THR . . . . . 0.442 ' O ' ' HD3' ' B' ' 889' ' ' PRO . 93.9 m -96.41 100.67 12.26 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 107.63 -1.248 . . . . 0.68000000000000005 107.63 177.358 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 888' ' ' ALA . . . . . . . . . . . . . . . -98.87 105.86 33.91 Favored Pre-proline 0 N--CA 1.502 2.125 0 N-CA-C 114.267 1.21 . . . . 0.25 114.267 -176.306 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 889' ' ' PRO . . . . . 0.442 ' HD3' ' O ' ' B' ' 887' ' ' THR . 54.1 Cg_endo -88.9 -13.44 3.14 Favored 'Trans proline' 0 CA--C 1.546 1.118 0 N-CA-C 108.982 -1.199 . . . . 1.6399999999999999 108.982 175.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 890' ' ' LEU . . . . . 0.72 HD22 HD13 ' B' ' 985' ' ' LEU . 69.7 mt -36.39 -50.09 0.75 Allowed 'General case' 0 N--CA 1.508 2.457 0 N-CA-C 113.612 0.967 . . . . 2.29 113.612 -177.522 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 52.1 95.95 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.259 0 O-C-N 121.135 -0.978 . . . . 0.63 110.25 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . 158.05 -153.72 24.88 Favored Glycine 0 N--CA 1.478 1.496 0 N-CA-C 107.18 -2.368 . . . . 0.040000000000000001 107.18 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 72.8 ttt-85 -115.61 126.41 54.15 Favored 'General case' 0 C--N 1.295 -1.778 0 O-C-N 121.581 -0.952 . . . . 3.0 108.529 177.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 894' ' ' TYR . . . . . 0.74 ' OH ' HD12 ' B' ' 896' ' ' LEU . 0.1 OUTLIER -132.17 160.19 36.78 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.182 -0.949 . . . . 0.040000000000000001 111.041 -179.754 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 895' ' ' LEU . . . . . 0.4 HD23 HD11 ' C' ' 952' ' ' LEU . 37.9 tp -92.1 118.49 30.86 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.654 -0.654 . . . . 1.27 110.141 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 896' ' ' LEU . . . . . 0.74 HD12 ' OH ' ' B' ' 894' ' ' TYR . 9.2 tt -110.0 141.59 42.58 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.761 -0.587 . . . . 0.93999999999999995 110.106 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 897' ' ' SER . . . . . 0.433 ' N ' HD23 ' B' ' 896' ' ' LEU . 64.4 m -148.35 115.26 6.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.478 -0.764 . . . . 0.040000000000000001 111.032 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.26 146.07 31.93 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.989 -0.745 . . . . 0.47999999999999998 108.989 178.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 899' ' ' VAL . . . . . 0.721 HG21 ' HB ' ' B' ' 980' ' ' ILE . 88.0 t -94.64 120.15 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 C-N-CA 119.653 -0.819 . . . . 0.55000000000000004 111.138 -179.329 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 900' ' ' LEU . . . . . 0.619 HD12 ' HB2' ' B' ' 924' ' ' SER . 4.3 mm? -95.02 112.45 24.16 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 114.457 1.281 . . . . 1.5900000000000001 114.457 -174.611 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 15.3 m -66.58 141.44 57.84 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 107.319 -1.363 . . . . 0.050000000000000003 107.319 176.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -67.24 -65.84 2.6 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 110.608 -0.997 . . . . 0.029999999999999999 110.608 -179.341 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 8.8 m170 46.73 66.76 0.9 Allowed 'General case' 0 N--CA 1.508 2.453 0 O-C-N 121.492 -1.005 . . . . 3.2000000000000002 111.155 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 43.1 ptt85 -69.32 -6.28 28.58 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.62 -0.675 . . . . 2.9199999999999999 112.084 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 905' ' ' HIS . . . . . 0.485 ' O ' ' CB ' ' B' ' 906' ' ' GLU . 72.6 t60 -61.66 4.47 0.11 Allowed 'General case' 0 N--CA 1.505 2.324 0 O-C-N 120.929 -1.107 . . . . 2.8700000000000001 113.198 -179.134 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 906' ' ' GLU . . . . . 0.485 ' CB ' ' O ' ' B' ' 905' ' ' HIS . 0.5 OUTLIER 94.96 -164.44 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.439 0 CA-C-N 120.561 1.528 . . . . 0.98999999999999999 111.668 179.063 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 907' ' ' LYS . . . . . 0.472 ' CB ' ' O ' ' B' ' 906' ' ' GLU . 63.2 tttt 85.75 156.3 0.08 Allowed 'General case' 0 N--CA 1.52 3.035 0 N-CA-C 108.095 -1.076 . . . . 5.25 108.095 -176.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 59.2 t -121.81 116.18 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 120.814 -1.179 . . . . 0.39000000000000001 111.152 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -99.57 133.42 43.93 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 107.274 -1.38 . . . . 1.72 107.274 176.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -156.21 122.08 4.95 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 106.879 -1.526 . . . . 0.67000000000000004 106.879 178.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 911' ' ' VAL . . . . . 0.795 HG22 HG13 ' B' ' 964' ' ' VAL . 87.0 t -84.27 132.38 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.842 -0.536 . . . . 0.54000000000000004 110.813 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 63.0 mt -65.72 156.75 32.07 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.333 -0.854 . . . . 1.5 108.946 178.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 913' ' ' SER . . . . . 0.408 ' CB ' ' CG1' ' B' ' 919' ' ' VAL . 1.4 t -123.57 137.48 54.74 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.393 -0.965 . . . . 1.3700000000000001 108.393 177.165 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 914' ' ' ARG . . . . . 0.621 ' NH1' HD23 ' B' ' 956' ' ' LEU . 0.0 OUTLIER -64.12 154.64 33.99 Favored 'General case' 0 N--CA 1.505 2.311 0 O-C-N 120.77 -1.206 . . . . 4.2999999999999998 111.888 -178.988 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 915' ' ' SER . . . . . 0.419 ' CB ' ' O ' ' B' ' 914' ' ' ARG . 4.7 t 83.2 -33.0 0.08 Allowed 'General case' 0 N--CA 1.521 3.114 0 C-N-CA 124.017 0.927 . . . . 2.0499999999999998 112.272 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 916' ' ' ASN . . . . . 0.806 ' HB2' HG21 ' B' ' 919' ' ' VAL . 92.4 m-20 -120.74 -20.76 6.89 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 120.909 -1.119 . . . . 2.71 111.46 -179.041 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 917' ' ' GLN . . . . . 0.4 ' HB2' ' O ' ' B' ' 916' ' ' ASN . 41.8 mt-30 66.83 164.46 0.2 Allowed 'General case' 0 N--CA 1.521 3.116 0 N-CA-C 105.472 -2.047 . . . . 2.6800000000000002 105.472 -173.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 55.09 -125.5 35.99 Favored Glycine 1 N--CA 1.521 4.349 0 CA-C-N 123.567 2.894 . . . . 0.029999999999999999 106.8 -177.628 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 919' ' ' VAL . . . . . 0.806 HG21 ' HB2' ' B' ' 916' ' ' ASN . 82.3 t 51.39 95.05 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.253 0 O-C-N 121.476 -1.014 . . . . 1.3899999999999999 109.062 -178.046 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 920' ' ' ALA . . . . . 0.845 ' HB3' HG12 ' B' ' 949' ' ' VAL . . . -91.51 92.16 8.39 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.31 -0.956 . . . . 0.029999999999999999 110.844 -179.031 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 921' ' ' ARG . . . . . 0.87 ' HG3' HG23 ' B' ' 922' ' ' VAL . 27.5 ptt180 -83.96 -41.73 17.01 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 105.738 -1.949 . . . . 4.4199999999999999 105.738 175.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 922' ' ' VAL . . . . . 0.87 HG23 ' HG3' ' B' ' 921' ' ' ARG . 77.9 t -102.16 73.14 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 N-CA-C 106.375 -1.713 . . . . 0.84999999999999998 106.375 175.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -86.49 133.76 33.72 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.637 0.732 . . . . 2.46 111.241 -177.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 924' ' ' SER . . . . . 0.619 ' HB2' HD12 ' B' ' 900' ' ' LEU . 27.8 t -147.83 105.77 3.72 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 108.974 -0.75 . . . . 0.69999999999999996 108.974 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -102.69 83.57 0.45 Allowed Glycine 0 N--CA 1.486 1.968 0 N-CA-C 108.37 -1.892 . . . . 0.040000000000000001 108.37 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 926' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' B' ' 906' ' ' GLU . . . . . . . . 0 N--CA 1.488 2.156 0 N-CA-C 108.661 -1.776 . . . . 0.040000000000000001 108.661 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 32.7 m . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.078 0.466 . . . . 13.779999999999999 110.162 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 96.2 mt -111.03 129.4 55.92 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.581 -0.699 . . . . 13.76 110.325 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -151.73 166.76 30.89 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.114 -1.594 . . . . 9.1300000000000008 109.114 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 949' ' ' VAL . . . . . 0.845 HG12 ' HB3' ' B' ' 920' ' ' ALA . 35.5 m -118.81 130.24 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.519 -0.989 . . . . 7.0800000000000001 110.967 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 950' ' ' PHE . . . . . 0.448 ' CE1' ' HD2' ' B' ' 955' ' ' PRO . 25.5 p90 -133.03 150.41 52.13 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.546 -0.721 . . . . 7.5899999999999999 109.162 179.359 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 19.5 m -120.67 -52.76 2.11 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.367 -0.833 . . . . 5.0300000000000002 112.252 -178.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 952' ' ' LEU . . . . . 0.418 ' O ' ' O ' ' B' ' 953' ' ' ILE . 13.6 tp -60.62 -73.22 0.09 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.365 -0.835 . . . . 1.01 112.382 -177.557 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 953' ' ' ILE . . . . . 0.5 ' O ' ' HB3' ' B' ' 954' ' ' LEU . 46.0 pt -52.26 -144.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.779 0 N-CA-C 114.177 1.177 . . . . 2.6000000000000001 114.177 -176.456 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 954' ' ' LEU . . . . . 0.726 HD22 ' O ' ' B' ' 954' ' ' LEU . 0.0 OUTLIER 171.64 77.23 0.04 OUTLIER Pre-proline 0 N--CA 1.51 2.526 0 O-C-N 120.808 -1.183 . . . . 0.050000000000000003 111.39 179.478 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 955' ' ' PRO . . . . . 0.699 ' C ' HD12 ' B' ' 956' ' ' LEU . 48.2 Cg_endo -74.89 96.54 1.02 Allowed 'Trans proline' 0 C--N 1.313 -1.295 0 N-CA-C 109.481 -1.007 . . . . 0.83999999999999997 109.481 178.598 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 956' ' ' LEU . . . . . 0.699 HD12 ' C ' ' B' ' 955' ' ' PRO . 10.4 mp -123.11 145.62 48.42 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.125 -0.984 . . . . 0.040000000000000001 110.166 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 16.1 mt-30 -83.58 150.66 25.8 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 117.866 -1.064 . . . . 1.28 111.645 -179.209 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -70.5 119.62 14.93 Favored 'General case' 0 N--CA 1.51 2.545 0 CA-C-N 122.845 2.566 . . . . 0.17000000000000001 111.579 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.74 -22.98 30.72 Favored Glycine 0 N--CA 1.501 3.021 0 N-CA-C 111.111 -0.796 . . . . 0.040000000000000001 111.111 178.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 960' ' ' ASP . . . . . 0.44 ' HB3' ' NE ' ' B' ' 914' ' ' ARG . 0.6 OUTLIER -51.86 172.15 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.53 -0.982 . . . . 0.040000000000000001 110.358 -179.403 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 961' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' B' ' 886' ' ' PHE . 7.1 t -134.73 134.71 41.3 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.986 -1.071 . . . . 1.78 111.855 -178.476 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 962' ' ' VAL . . . . . 0.879 HG22 ' HB3' ' B' ' 886' ' ' PHE . 31.1 m -99.17 145.8 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 C-N-CA 120.072 -0.651 . . . . 0.040000000000000001 110.453 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 5.3 t -138.79 145.23 39.88 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.861 -0.524 . . . . 0.71999999999999997 110.191 -178.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 964' ' ' VAL . . . . . 0.795 HG13 HG22 ' B' ' 911' ' ' VAL . 55.2 t -94.24 136.32 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.11 -0.994 . . . . 1.05 110.717 -179.191 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -95.72 126.37 40.94 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 103.755 -2.683 . . . . 3.02 103.755 173.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 966' ' ' LEU . . . . . 0.494 ' C ' HG23 ' B' ' 967' ' ' VAL . 20.8 tp -132.23 62.52 1.64 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.35 -0.981 . . . . 1.46 108.35 177.478 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 967' ' ' VAL . . . . . 0.494 HG23 ' C ' ' B' ' 966' ' ' LEU . 89.8 t -158.42 97.01 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 N-CA-C 108.095 -1.076 . . . . 1.9399999999999999 108.095 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 88.7 mmm -142.77 59.19 1.43 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.765 -1.21 . . . . 0.0 108.281 178.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.53 119.69 1.93 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 107.0 -2.44 . . . . 2.1099999999999999 107.0 -178.147 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -81.22 -57.86 3.32 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.063 -1.257 . . . . 5.8899999999999997 110.435 -179.325 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 44.2 tp -58.91 90.37 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.465 -0.772 . . . . 4.3600000000000003 110.223 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -141.27 -154.91 0.54 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.575 -0.703 . . . . 1.8300000000000001 110.304 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -119.86 172.1 7.95 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.464 -0.773 . . . . 4.3499999999999996 110.38 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 29.5 t -101.52 130.29 47.77 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.565 -0.709 . . . . 1.27 110.145 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -156.41 158.35 37.18 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.504 -0.747 . . . . 5.0199999999999996 110.553 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.7 86.32 16.0 Favored Pre-proline 0 N--CA 1.5 2.06 0 O-C-N 121.614 -0.679 . . . . 2.4100000000000001 109.7 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -73.12 -172.83 1.09 Allowed 'Trans proline' 0 C--N 1.317 -1.123 0 O-C-N 123.344 1.181 . . . . 0.95999999999999996 111.514 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 978' ' ' LEU . . . . . 0.726 HD23 HD12 ' B' ' 856' ' ' LEU . 5.2 mp -127.81 154.91 44.88 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.644 -1.243 . . . . 0.62 107.644 178.029 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 979' ' ' THR . . . . . 0.453 HG23 ' C ' ' B' ' 978' ' ' LEU . 33.7 p -150.51 142.16 23.62 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.81 -1.181 . . . . 3.5699999999999998 111.384 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 980' ' ' ILE . . . . . 0.721 ' HB ' HG21 ' B' ' 899' ' ' VAL . 47.0 mm -106.49 127.06 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 108.765 -0.828 . . . . 1.3300000000000001 108.765 179.226 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 981' ' ' PHE . . . . . 0.495 ' HD1' ' HH ' ' B' ' 879' ' ' TYR . 5.6 t80 -119.27 97.64 5.76 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.458 -0.776 . . . . 0.050000000000000003 111.767 -178.459 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 982' ' ' SER . . . . . 0.4 ' HB2' HD23 ' C' ' 952' ' ' LEU . 77.8 p -109.02 159.0 17.19 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.544 -0.722 . . . . 0.87 109.428 178.397 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 983' ' ' GLY . . . . . 0.402 ' HA3' ' CE1' ' B' ' 852' ' ' PHE . . . -175.01 107.77 0.25 Allowed Glycine 0 N--CA 1.499 2.869 0 N-CA-C 106.53 -2.628 . . . . 0.029999999999999999 106.53 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -108.62 152.33 24.93 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 114.44 1.274 . . . . 0.69999999999999996 114.44 -175.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 985' ' ' LEU . . . . . 0.72 HD13 HD22 ' B' ' 890' ' ' LEU . 53.3 tp -71.26 134.03 46.52 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.9 -1.125 . . . . 0.040000000000000001 110.108 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 986' ' ' LEU . . . . . 0.488 ' CD1' HD11 ' C' ' 986' ' ' LEU . 45.8 tp -107.62 -56.17 2.26 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.591 -0.693 . . . . 0.040000000000000001 109.923 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -145.34 145.05 31.05 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 107.737 -1.208 . . . . 0.040000000000000001 107.737 178.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.92 163.02 12.18 Favored Glycine 0 N--CA 1.496 2.653 0 N-CA-C 108.21 -1.956 . . . . 0.040000000000000001 108.21 179.269 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -75.13 112.76 19.73 Favored Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 121.165 -1.197 . . . . 0.040000000000000001 109.535 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 990' ' ' PRO . . . . . 0.425 ' HD2' HD12 ' B' ' 992' ' ' LEU . 50.9 Cg_endo -90.18 70.95 1.56 Allowed 'Trans proline' 0 C--N 1.319 -0.985 0 O-C-N 123.13 1.068 . . . . 0.45000000000000001 111.423 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 991' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' B' ' 990' ' ' PRO . 70.6 mt-10 67.25 -73.57 0.08 Allowed 'General case' 0 N--CA 1.503 2.207 0 N-CA-C 108.6 -0.889 . . . . 1.97 108.6 -177.492 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 992' ' ' LEU . . . . . 0.434 ' HA ' HD23 ' B' ' 992' ' ' LEU . 10.9 mt 51.22 20.31 0.88 Allowed 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.551 -0.718 . . . . 2.3799999999999999 111.621 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 83.6 mt-10 -93.73 156.95 16.4 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.86 -1.15 . . . . 3.79 110.104 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 72.1 m80 -146.67 92.73 2.19 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.534 -0.729 . . . . 3.5099999999999998 110.395 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 995' ' ' ALA . . . . . . . . . . . . 2.517 . . . . . . . 0 N--CA 1.503 2.222 0 O-C-N 120.953 -1.092 . . . . 2.73 110.639 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo . . . . . 0 N--CA 1.488 1.174 0 N-CA-C 109.488 -1.005 . . . . 3.8300000000000001 109.488 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 847' ' ' VAL . . . . . . . . . . . . . 57.7 t -130.31 103.28 16.67 Favored Pre-proline 0 N--CA 1.496 1.869 0 O-C-N 121.604 -0.685 . . . . 1.8300000000000001 110.133 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 848' ' ' PRO . . . . . 0.708 ' O ' HG23 ' C' ' 850' ' ' VAL . 44.2 Cg_endo -70.49 -21.29 30.32 Favored 'Trans proline' 0 N--CA 1.488 1.182 0 O-C-N 123.277 1.146 . . . . 0.65000000000000002 111.269 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 849' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 27.5 69.97 0.06 Allowed 'General case' 0 N--CA 1.519 3.024 0 N-CA-C 112.826 0.676 . . . . 2.5800000000000001 112.826 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 850' ' ' VAL . . . . . 0.708 HG23 ' O ' ' C' ' 848' ' ' PRO . 61.2 t -119.93 134.57 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.234 -0.916 . . . . 1.0900000000000001 111.648 -178.63 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 851' ' ' ALA . . . . . 0.584 ' HB3' ' HG ' ' C' ' 873' ' ' LEU . . . -127.46 155.32 43.88 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 105.772 -1.936 . . . . 0.040000000000000001 105.772 176.638 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 852' ' ' PHE . . . . . 0.455 ' CD1' ' N ' ' C' ' 852' ' ' PHE . 13.2 p90 -159.96 127.56 4.65 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 121.049 1.75 . . . . 0.050000000000000003 108.557 178.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 29.4 t -176.72 134.13 0.21 Allowed 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.105 -1.072 . . . . 0.040000000000000001 108.105 -179.125 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 854' ' ' ALA . . . . . 0.529 ' HB1' ' HD2' ' C' ' 868' ' ' PHE . . . -131.13 156.32 45.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.169 -0.957 . . . . 0.67000000000000004 109.642 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 855' ' ' ALA . . . . . 0.779 ' HB3' ' CB ' ' C' ' 870' ' ' ARG . . . -121.54 141.54 50.96 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.891 0.853 . . . . 0.51000000000000001 111.107 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 856' ' ' LEU . . . . . 0.995 HD11 HD23 ' C' ' 858' ' ' LEU . 3.5 tm? -114.53 137.59 51.67 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.402 -0.811 . . . . 0.050000000000000003 110.171 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 857' ' ' SER . . . . . 0.57 ' N ' HD13 ' C' ' 856' ' ' LEU . 1.9 m -153.8 19.38 0.52 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.52 -0.737 . . . . 1.3300000000000001 110.866 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 858' ' ' LEU . . . . . 0.995 HD23 HD11 ' C' ' 856' ' ' LEU . 1.4 pp -34.06 160.9 0.04 OUTLIER Pre-proline 0 N--CA 1.516 2.853 0 N-CA-C 113.189 0.811 . . . . 2.3300000000000001 113.189 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -61.6 -88.2 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 120.816 1.011 . . . . 2.3199999999999998 113.306 -178.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 54.6 ptt85 -131.04 -142.33 0.23 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 120.873 -1.142 . . . . 0.040000000000000001 111.435 -177.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 74.5 m -38.42 130.23 1.32 Allowed 'General case' 0 N--CA 1.511 2.589 0 O-C-N 121.563 -0.71 . . . . 1.3100000000000001 112.172 -178.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 862' ' ' GLU . . . . . 0.522 ' HG2' HD13 ' C' ' 858' ' ' LEU . 1.5 mm-40 -102.99 158.79 31.06 Favored Pre-proline 0 N--CA 1.488 1.436 0 N-CA-C 108.237 -1.023 . . . . 4.5099999999999998 108.237 177.477 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.18 -13.75 33.97 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 O-C-N 123.203 1.107 . . . . 2.2400000000000002 110.829 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -176.7 -136.03 2.31 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.08 -1.608 . . . . 0.040000000000000001 109.08 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 24.7 m -68.83 155.59 39.93 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.27 -1.135 . . . . 1.51 110.164 -179.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 866' ' ' VAL . . . . . 0.445 HG11 ' CD2' ' C' ' 858' ' ' LEU . 60.2 t -99.88 138.05 20.27 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.466 -0.771 . . . . 0.78000000000000003 113.048 -175.003 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 867' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' C' ' 866' ' ' VAL . 55.4 Cg_endo -90.4 -147.05 0.03 OUTLIER 'Trans proline' 0 CA--C 1.546 1.086 0 O-C-N 123.533 1.28 . . . . 0.92000000000000004 109.234 178.225 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 868' ' ' PHE . . . . . 0.529 ' HD2' ' HB1' ' C' ' 854' ' ' ALA . 24.5 p90 -149.29 125.37 10.68 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.487 -1.383 . . . . 0.050000000000000003 110.032 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 50.9 p-10 -112.46 -2.82 14.59 Favored 'General case' 0 N--CA 1.499 2.013 0 C-N-CA 119.295 -0.962 . . . . 1.7 112.744 -178.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 870' ' ' ARG . . . . . 0.779 ' CB ' ' HB3' ' C' ' 855' ' ' ALA . 25.8 mmm180 -91.41 88.84 6.99 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 120.849 -1.157 . . . . 2.5899999999999999 111.112 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 63.1 t -72.86 97.34 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 120.902 -1.123 . . . . 1.9399999999999999 109.288 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 872' ' ' LEU . . . . . 0.948 HD13 HD11 ' A' ' 953' ' ' ILE . 72.9 mt -86.48 -45.94 10.66 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.537 -0.727 . . . . 1.0600000000000001 110.561 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 873' ' ' LEU . . . . . 0.584 ' HG ' ' HB3' ' C' ' 851' ' ' ALA . 36.8 tp -173.09 102.5 0.13 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.208 -0.932 . . . . 4.1799999999999997 108.715 178.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 874' ' ' ASN . . . . . 0.435 ' CB ' ' HA ' ' C' ' 852' ' ' PHE . 35.5 t-20 177.49 82.46 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.231 0 N-CA-C 108.827 -0.805 . . . . 0.040000000000000001 108.827 -178.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -65.05 -46.68 80.23 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.194 -0.941 . . . . 3.3799999999999999 111.521 -178.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 876' ' ' GLY . . . . . 0.414 ' HA3' ' CE2' ' C' ' 878' ' ' TYR . . . -73.01 -26.56 70.7 Favored Glycine 0 N--CA 1.493 2.474 0 O-C-N 121.243 -0.91 . . . . 0.040000000000000001 111.748 -178.639 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 80.34 -62.38 4.3 Favored Glycine 0 N--CA 1.501 3.007 0 N-CA-C 107.911 -2.075 . . . . 0.040000000000000001 107.911 -178.256 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 878' ' ' TYR . . . . . 0.414 ' CE2' ' HA3' ' C' ' 876' ' ' GLY . 93.2 m-85 60.61 -65.73 0.05 Allowed 'General case' 0 N--CA 1.503 2.22 0 N-CA-C 114.404 1.261 . . . . 3.46 114.404 177.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 879' ' ' TYR . . . . . 0.505 ' CE2' ' CD1' ' C' ' 981' ' ' PHE . 28.8 p90 -110.27 106.83 16.38 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 114.826 1.417 . . . . 0.040000000000000001 114.826 -176.131 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -73.75 117.19 58.99 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.489 -0.757 . . . . 0.02 109.806 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 881' ' ' PRO . . . . . 0.429 ' HD2' ' CE1' ' C' ' 868' ' ' PHE . 54.2 Cg_endo -77.07 1.07 9.07 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 O-C-N 123.34 1.179 . . . . 0.39000000000000001 112.351 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 71.5 mt-10 -73.55 -53.61 10.13 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 105.733 -1.951 . . . . 0.81000000000000005 105.733 177.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 14.7 p -99.7 -21.0 16.0 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 115.068 -0.969 . . . . 0.040000000000000001 108.841 177.1 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 81.93 15.76 74.25 Favored Glycine 0 N--CA 1.496 2.672 0 N-CA-C 110.434 -1.066 . . . . 0.029999999999999999 110.434 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 58.5 t -74.87 91.94 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 C-N-CA 118.422 -1.311 . . . . 1.01 108.584 -178.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 886' ' ' PHE . . . . . 0.894 ' HB3' HG22 ' C' ' 962' ' ' VAL . 1.0 OUTLIER -88.04 106.18 17.97 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 115.173 -0.921 . . . . 0.050000000000000003 111.531 -177.696 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 887' ' ' THR . . . . . 0.439 ' O ' ' HD3' ' C' ' 889' ' ' PRO . 88.3 m -101.46 99.79 10.16 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.669 -1.234 . . . . 0.68000000000000005 107.669 177.404 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 888' ' ' ALA . . . . . . . . . . . . . . . -98.45 102.0 13.21 Favored Pre-proline 0 N--CA 1.5 2.061 0 N-CA-C 114.375 1.25 . . . . 0.25 114.375 -176.171 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 889' ' ' PRO . . . . . 0.439 ' HD3' ' O ' ' C' ' 887' ' ' THR . 55.6 Cg_endo -81.45 -15.27 10.01 Favored 'Trans proline' 0 CA--C 1.544 1.014 0 N-CA-C 108.632 -1.334 . . . . 1.6399999999999999 108.632 175.721 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 890' ' ' LEU . . . . . 0.613 HD21 HG11 ' C' ' 850' ' ' VAL . 67.6 mt -37.27 -49.36 0.94 Allowed 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 113.394 0.887 . . . . 2.29 113.394 -177.559 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 52.4 96.99 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.241 0 O-C-N 121.268 -0.895 . . . . 0.63 110.196 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . 159.28 -153.64 24.72 Favored Glycine 0 N--CA 1.477 1.411 0 N-CA-C 107.45 -2.26 . . . . 0.040000000000000001 107.45 -179.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 76.0 ttt-85 -117.62 123.1 45.34 Favored 'General case' 0 C--N 1.293 -1.877 0 O-C-N 121.715 -0.874 . . . . 3.0 108.872 178.071 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 894' ' ' TYR . . . . . 0.786 ' CE2' HD23 ' C' ' 954' ' ' LEU . 13.6 p90 -132.89 155.91 48.17 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.024 -1.047 . . . . 0.040000000000000001 111.193 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 895' ' ' LEU . . . . . . . . . . . . . 46.0 tp -98.58 111.65 23.94 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.694 -0.629 . . . . 1.27 109.87 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 896' ' ' LEU . . . . . 0.507 HD22 HH12 ' C' ' 921' ' ' ARG . 10.1 tt -115.66 144.91 43.25 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.618 -0.676 . . . . 0.93999999999999995 109.926 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 897' ' ' SER . . . . . 0.437 ' N ' HD23 ' C' ' 896' ' ' LEU . 43.3 m -142.03 124.87 16.05 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.393 -0.817 . . . . 0.040000000000000001 111.477 -179.076 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -101.22 148.13 25.46 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.759 -0.83 . . . . 0.47999999999999998 108.759 178.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 899' ' ' VAL . . . . . 0.716 HG21 ' HB ' ' C' ' 980' ' ' ILE . 84.7 t -92.42 120.79 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.321 -0.862 . . . . 0.55000000000000004 111.23 -179.11 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 91.6 mt -92.15 113.45 25.73 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 114.006 1.113 . . . . 1.5900000000000001 114.006 -175.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 21.7 m -62.7 140.9 58.74 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 107.527 -1.286 . . . . 0.050000000000000003 107.527 177.461 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -60.91 -65.37 3.36 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.238 -1.145 . . . . 0.029999999999999999 110.238 -179.287 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 46.1 65.62 1.13 Allowed 'General case' 0 N--CA 1.506 2.363 0 O-C-N 121.518 -0.989 . . . . 3.2000000000000002 111.235 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -66.86 -8.28 27.86 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.623 -0.673 . . . . 2.9199999999999999 111.819 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 905' ' ' HIS . . . . . 0.474 ' O ' ' CB ' ' C' ' 906' ' ' GLU . 72.6 t60 -62.94 4.87 0.15 Allowed 'General case' 0 N--CA 1.503 2.215 0 O-C-N 120.915 -1.116 . . . . 2.8700000000000001 112.679 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 906' ' ' GLU . . . . . 0.498 ' O ' ' CB ' ' C' ' 907' ' ' LYS . 2.0 mt-10 89.73 -153.99 0.01 OUTLIER 'General case' 0 N--CA 1.526 3.329 0 CA-C-N 121.136 1.789 . . . . 0.98999999999999999 111.567 179.209 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 907' ' ' LYS . . . . . 0.498 ' CB ' ' O ' ' C' ' 906' ' ' GLU . 56.5 tttt 88.84 162.85 0.06 Allowed 'General case' 0 N--CA 1.52 3.066 0 N-CA-C 107.759 -1.2 . . . . 5.25 107.759 -176.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 59.7 t -122.7 114.59 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 120.778 -1.202 . . . . 0.39000000000000001 110.781 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 909' ' ' GLU . . . . . 0.62 ' OE2' HD12 ' C' ' 966' ' ' LEU . 42.8 tp10 -105.79 131.19 53.43 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 107.557 -1.275 . . . . 1.72 107.557 177.1 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -156.73 120.44 4.27 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 106.943 -1.503 . . . . 0.67000000000000004 106.943 178.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 911' ' ' VAL . . . . . 0.521 ' HA ' ' HA ' ' C' ' 964' ' ' VAL . 12.8 p -80.08 131.57 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 C-N-CA 120.306 -0.558 . . . . 0.54000000000000004 111.321 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 62.4 mt -66.23 156.72 33.4 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.258 -0.901 . . . . 1.5 108.885 178.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 913' ' ' SER . . . . . 0.418 ' CB ' ' CG1' ' C' ' 919' ' ' VAL . 1.7 t -126.19 136.93 53.44 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.377 -0.971 . . . . 1.3700000000000001 108.377 177.031 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 914' ' ' ARG . . . . . 0.844 ' CZ ' HD23 ' C' ' 956' ' ' LEU . 0.0 OUTLIER -63.67 154.0 34.38 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 120.707 -1.246 . . . . 4.2999999999999998 111.708 -178.783 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 915' ' ' SER . . . . . 0.425 ' CB ' ' O ' ' C' ' 914' ' ' ARG . 2.4 t 83.28 -30.61 0.09 Allowed 'General case' 0 N--CA 1.521 3.119 0 C-N-CA 123.808 0.843 . . . . 2.0499999999999998 112.384 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 916' ' ' ASN . . . . . 0.785 ' HB2' HG21 ' C' ' 919' ' ' VAL . 94.8 m-20 -122.19 -21.74 5.8 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.868 -1.145 . . . . 2.71 111.362 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 67.36 166.11 0.23 Allowed 'General case' 0 N--CA 1.521 3.082 0 N-CA-C 105.491 -2.04 . . . . 2.6800000000000002 105.491 -173.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.27 -125.18 33.13 Favored Glycine 1 N--CA 1.521 4.362 0 CA-C-N 123.773 2.988 . . . . 0.029999999999999999 107.08 -177.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 919' ' ' VAL . . . . . 0.785 HG21 ' HB2' ' C' ' 916' ' ' ASN . 96.7 t 49.83 94.06 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.266 0 O-C-N 121.543 -0.975 . . . . 1.3899999999999999 109.334 -178.225 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 920' ' ' ALA . . . . . 0.91 ' HB3' HG12 ' C' ' 949' ' ' VAL . . . -94.74 95.48 8.75 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.469 -0.892 . . . . 0.029999999999999999 110.886 -179.238 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 921' ' ' ARG . . . . . 0.726 ' HG3' HG23 ' C' ' 922' ' ' VAL . 42.8 ptt85 -79.9 -42.05 24.92 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 105.538 -2.023 . . . . 4.4199999999999999 105.538 176.015 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 922' ' ' VAL . . . . . 0.726 HG23 ' HG3' ' C' ' 921' ' ' ARG . 84.6 t -99.89 76.8 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 N-CA-C 105.545 -2.02 . . . . 0.84999999999999998 105.545 175.049 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -90.61 136.7 32.9 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 122.005 0.907 . . . . 2.46 112.794 -176.195 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 5.1 t -146.99 103.36 3.6 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.619 -1.252 . . . . 0.69999999999999996 107.619 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -109.21 83.83 0.34 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.485 -1.446 . . . . 0.040000000000000001 109.485 -179.524 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.361 0 N-CA-C 109.172 -1.571 . . . . 0.040000000000000001 109.172 -179.997 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 22.7 m . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 120.997 0.427 . . . . 13.779999999999999 110.303 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 95.2 mt -112.87 129.89 56.3 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.518 -0.739 . . . . 13.76 110.453 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -151.77 169.89 31.21 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.212 -1.555 . . . . 9.1300000000000008 109.212 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 949' ' ' VAL . . . . . 0.91 HG12 ' HB3' ' C' ' 920' ' ' ALA . 34.1 m -118.04 135.73 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.519 -0.989 . . . . 7.0800000000000001 111.034 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 950' ' ' PHE . . . . . 0.457 ' CZ ' ' HB3' ' C' ' 921' ' ' ARG . 51.7 p90 -135.06 152.47 51.71 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.555 -0.716 . . . . 7.5899999999999999 109.379 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 7.6 t -119.05 -55.09 2.19 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.386 -0.822 . . . . 5.0300000000000002 111.852 -179.035 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 952' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' C' ' 953' ' ' ILE . 58.9 tp -62.71 -77.07 0.05 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.433 -0.792 . . . . 1.01 111.472 -178.218 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 953' ' ' ILE . . . . . 0.571 HD12 ' HD3' ' C' ' 955' ' ' PRO . 2.1 pp -49.12 -151.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.688 0 N-CA-C 114.615 1.339 . . . . 2.6000000000000001 114.615 -176.654 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 954' ' ' LEU . . . . . 0.786 HD23 ' CE2' ' C' ' 894' ' ' TYR . 0.0 OUTLIER 170.02 89.45 0.04 OUTLIER Pre-proline 0 N--CA 1.516 2.85 0 O-C-N 120.78 -1.2 . . . . 0.050000000000000003 112.068 -179.497 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 955' ' ' PRO . . . . . 0.649 ' C ' HD12 ' C' ' 956' ' ' LEU . 50.0 Cg_endo -83.66 94.65 0.78 Allowed 'Trans proline' 0 C--N 1.315 -1.196 0 N-CA-C 109.506 -0.998 . . . . 0.83999999999999997 109.506 178.61 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 956' ' ' LEU . . . . . 0.844 HD23 ' CZ ' ' C' ' 914' ' ' ARG . 6.6 mp -125.64 150.84 47.24 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.024 -1.047 . . . . 0.040000000000000001 110.622 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -81.89 151.5 27.25 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-O 117.66 -1.162 . . . . 1.28 111.323 -178.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -66.41 118.43 10.04 Favored 'General case' 0 N--CA 1.507 2.393 0 CA-C-N 123.202 2.728 . . . . 0.17000000000000001 110.874 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.54 -19.75 48.72 Favored Glycine 0 N--CA 1.499 2.897 0 N-CA-C 111.067 -0.813 . . . . 0.040000000000000001 111.067 178.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 960' ' ' ASP . . . . . 0.425 ' HB3' ' NE ' ' C' ' 914' ' ' ARG . 0.5 OUTLIER -52.32 171.91 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.344 -1.092 . . . . 0.040000000000000001 110.505 -179.473 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 961' ' ' THR . . . . . 0.488 ' HA ' ' O ' ' C' ' 886' ' ' PHE . 26.3 m -136.93 140.38 42.23 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.043 -1.035 . . . . 1.78 112.614 -177.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 962' ' ' VAL . . . . . 0.894 HG22 ' HB3' ' C' ' 886' ' ' PHE . 26.8 m -101.07 145.47 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 C-N-CA 120.302 -0.559 . . . . 0.040000000000000001 110.809 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 6.2 t -137.99 144.44 41.13 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.815 -0.553 . . . . 0.71999999999999997 109.858 -179.043 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 964' ' ' VAL . . . . . 0.521 ' HA ' ' HA ' ' C' ' 911' ' ' VAL . 61.8 t -90.79 137.67 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.043 -1.036 . . . . 1.05 110.713 -178.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -92.67 125.17 37.17 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 103.289 -2.856 . . . . 3.02 103.289 173.211 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 966' ' ' LEU . . . . . 0.62 HD12 ' OE2' ' C' ' 909' ' ' GLU . 0.2 OUTLIER -133.68 57.46 1.81 Allowed 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.635 -0.876 . . . . 1.46 108.635 177.76 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 967' ' ' VAL . . . . . 0.489 HG23 ' C ' ' C' ' 966' ' ' LEU . 98.1 t -158.48 96.41 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 N-CA-C 108.277 -1.009 . . . . 1.9399999999999999 108.277 179.386 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 90.2 mmm -142.74 59.22 1.43 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.759 -1.213 . . . . 0.0 108.459 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 134.44 119.53 1.97 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 107.205 -2.358 . . . . 2.1099999999999999 107.205 -178.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 95.4 mm-40 -82.34 -57.71 3.25 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.082 -1.246 . . . . 5.8899999999999997 110.684 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 41.4 tp -58.87 89.74 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.46 -0.775 . . . . 4.3600000000000003 110.401 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -142.63 -152.69 0.42 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.572 -0.705 . . . . 1.8300000000000001 110.129 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 7.7 t60 -116.74 167.43 11.1 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.384 -0.823 . . . . 4.3499999999999996 110.076 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 41.1 t -102.8 130.69 49.86 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.624 -0.673 . . . . 1.27 110.197 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -156.35 158.55 37.6 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.498 -0.751 . . . . 5.0199999999999996 110.753 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.82 86.1 15.9 Favored Pre-proline 0 N--CA 1.501 2.116 0 O-C-N 121.616 -0.677 . . . . 2.4100000000000001 109.716 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -75.71 -170.17 0.79 Allowed 'Trans proline' 0 C--N 1.318 -1.061 0 O-C-N 123.303 1.159 . . . . 0.95999999999999996 111.453 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 978' ' ' LEU . . . . . 0.524 ' N ' HD12 ' C' ' 978' ' ' LEU . 5.2 mp -124.97 156.39 38.12 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 107.511 -1.292 . . . . 0.62 107.511 177.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 979' ' ' THR . . . . . 0.445 HG23 ' C ' ' C' ' 978' ' ' LEU . 39.5 p -149.92 141.47 23.45 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.728 -1.232 . . . . 3.5699999999999998 111.325 -179.283 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 980' ' ' ILE . . . . . 0.716 ' HB ' HG21 ' C' ' 899' ' ' VAL . 47.5 mm -106.96 128.48 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 109.122 -0.696 . . . . 1.3300000000000001 109.122 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 981' ' ' PHE . . . . . 0.505 ' CD1' ' CE2' ' C' ' 879' ' ' TYR . 3.2 t80 -117.89 95.44 4.92 Favored 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 119.69 -0.804 . . . . 0.050000000000000003 111.568 -178.638 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 982' ' ' SER . . . . . . . . . . . . . 12.5 p -107.63 158.27 17.39 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.6 -0.688 . . . . 0.87 109.255 178.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 983' ' ' GLY . . . . . 0.417 ' HA3' ' CE2' ' C' ' 852' ' ' PHE . . . -172.18 114.48 0.53 Allowed Glycine 0 N--CA 1.497 2.704 0 N-CA-C 106.601 -2.6 . . . . 0.029999999999999999 106.601 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 984' ' ' ALA . . . . . 0.438 ' HB1' ' CZ ' ' A' ' 893' ' ' ARG . . . -108.4 150.76 26.94 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 114.259 1.207 . . . . 0.69999999999999996 114.259 -175.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 985' ' ' LEU . . . . . 0.583 HD13 HD22 ' C' ' 890' ' ' LEU . 47.9 tp -75.32 135.71 40.88 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.814 -1.179 . . . . 0.040000000000000001 109.609 179.419 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 986' ' ' LEU . . . . . 0.488 HD11 ' CD1' ' B' ' 986' ' ' LEU . 45.5 tp -106.23 -63.16 1.29 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.461 -0.774 . . . . 0.040000000000000001 110.329 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -144.28 146.94 32.92 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 107.806 -1.183 . . . . 0.040000000000000001 107.806 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -111.96 162.71 12.33 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 107.99 -2.044 . . . . 0.040000000000000001 107.99 179.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.81 112.73 19.0 Favored Pre-proline 0 N--CA 1.497 1.895 0 O-C-N 121.135 -1.215 . . . . 0.040000000000000001 109.452 179.117 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 990' ' ' PRO . . . . . 0.419 ' HD2' HD12 ' C' ' 992' ' ' LEU . 50.9 Cg_endo -89.29 71.24 2.01 Favored 'Trans proline' 0 C--N 1.319 -1.017 0 O-C-N 123.109 1.057 . . . . 0.45000000000000001 111.301 -178.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 991' ' ' GLU . . . . . 0.417 ' HB2' ' O ' ' C' ' 990' ' ' PRO . 85.7 mt-10 67.11 -73.77 0.07 Allowed 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 108.687 -0.857 . . . . 1.97 108.687 -177.465 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 992' ' ' LEU . . . . . 0.419 HD12 ' HD2' ' C' ' 990' ' ' PRO . 11.3 mt 50.5 21.3 0.83 Allowed 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.594 -0.691 . . . . 2.3799999999999999 111.553 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -93.35 156.97 16.47 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.936 -1.102 . . . . 3.79 110.144 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 68.6 m80 -146.31 92.48 2.18 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.597 -0.689 . . . . 3.5099999999999998 110.202 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 995' ' ' ALA . . . . . . . . . . . . 2.519 . . . . . . . 0 N--CA 1.503 2.224 0 O-C-N 120.917 -1.115 . . . . 2.73 110.614 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo . . . . . 0 N--CA 1.488 1.157 0 N-CA-C 109.525 -0.991 . . . . 3.8300000000000001 109.525 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 847' ' ' VAL . . . . . . . . . . . . . 62.0 t -134.49 103.26 11.34 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.574 -0.704 . . . . 1.8300000000000001 110.014 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 848' ' ' PRO . . . . . 0.707 ' O ' HG23 ' A' ' 850' ' ' VAL . 44.1 Cg_endo -69.99 -18.64 35.83 Favored 'Trans proline' 0 N--CA 1.488 1.182 0 O-C-N 123.315 1.166 . . . . 0.65000000000000002 111.303 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 849' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 27.58 68.72 0.07 Allowed 'General case' 0 N--CA 1.518 2.975 0 N-CA-C 112.941 0.719 . . . . 2.5800000000000001 112.941 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 850' ' ' VAL . . . . . 0.707 HG23 ' O ' ' A' ' 848' ' ' PRO . 62.1 t -118.92 135.81 58.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.221 -0.924 . . . . 1.0900000000000001 111.429 -178.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 851' ' ' ALA . . . . . 0.464 ' HB3' ' HG ' ' A' ' 873' ' ' LEU . . . -126.76 156.95 40.38 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 105.868 -1.901 . . . . 0.040000000000000001 105.868 176.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 852' ' ' PHE . . . . . 0.443 ' HA ' ' CB ' ' A' ' 874' ' ' ASN . 33.7 p90 -158.79 130.18 6.38 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 121.022 1.737 . . . . 0.050000000000000003 108.79 179.053 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 44.1 t -174.93 134.1 0.34 Allowed 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.125 -1.065 . . . . 0.040000000000000001 108.125 -179.103 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 854' ' ' ALA . . . . . 0.461 ' HB1' ' HD2' ' A' ' 868' ' ' PHE . . . -134.01 155.92 49.12 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.07 -1.019 . . . . 0.67000000000000004 109.423 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 855' ' ' ALA . . . . . 0.761 ' HB3' ' CB ' ' A' ' 870' ' ' ARG . . . -122.15 141.6 51.27 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.758 0.79 . . . . 0.51000000000000001 111.362 -179.032 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 856' ' ' LEU . . . . . 0.671 HD13 ' N ' ' A' ' 857' ' ' SER . 3.4 tm? -111.27 137.94 48.36 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.649 -0.657 . . . . 0.050000000000000003 109.939 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 857' ' ' SER . . . . . 0.671 ' N ' HD13 ' A' ' 856' ' ' LEU . 1.5 m -156.77 16.86 0.31 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.579 -0.701 . . . . 1.3300000000000001 111.587 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 858' ' ' LEU . . . . . 0.609 HD22 ' HG3' ' A' ' 862' ' ' GLU . 3.8 pp -35.02 160.35 0.04 OUTLIER Pre-proline 0 N--CA 1.519 2.991 0 N-CA-C 113.006 0.743 . . . . 2.3300000000000001 113.006 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -60.69 -88.64 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 120.87 1.046 . . . . 2.3199999999999998 113.796 -177.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 53.6 ptt85 -128.54 -142.72 0.26 Allowed 'General case' 0 N--CA 1.5 2.075 0 O-C-N 120.859 -1.151 . . . . 0.040000000000000001 111.756 -177.304 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 15.0 m -38.03 126.76 1.28 Allowed 'General case' 0 N--CA 1.51 2.569 0 O-C-N 121.643 -0.661 . . . . 1.3100000000000001 112.26 -178.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 862' ' ' GLU . . . . . 0.609 ' HG3' HD22 ' A' ' 858' ' ' LEU . 0.0 OUTLIER -99.59 158.99 31.17 Favored Pre-proline 0 N--CA 1.489 1.51 0 N-CA-C 108.423 -0.954 . . . . 4.5099999999999998 108.423 177.754 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -70.99 -14.55 32.25 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 O-C-N 123.245 1.129 . . . . 2.2400000000000002 111.379 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -177.7 -135.89 2.36 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.515 -1.434 . . . . 0.040000000000000001 109.515 179.24 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 26.8 m -65.97 156.05 34.75 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.33 -1.1 . . . . 1.51 110.134 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 866' ' ' VAL . . . . . 0.498 HG13 ' CD2' ' A' ' 858' ' ' LEU . 61.5 t -98.85 137.33 20.52 Favored Pre-proline 0 N--CA 1.494 1.736 0 N-CA-C 113.547 0.943 . . . . 0.78000000000000003 113.547 -174.332 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 867' ' ' PRO . . . . . 0.553 ' O ' HD23 ' A' ' 856' ' ' LEU . 55.5 Cg_endo -92.41 -149.66 0.03 OUTLIER 'Trans proline' 0 CA--C 1.546 1.124 0 C-N-CA 121.335 1.356 . . . . 0.92000000000000004 109.634 178.088 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 868' ' ' PHE . . . . . 0.475 ' CD1' ' HG2' ' A' ' 881' ' ' PRO . 19.3 p90 -150.7 124.0 8.91 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.679 -1.263 . . . . 0.050000000000000003 109.776 179.157 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 46.6 p30 -113.48 -2.23 13.95 Favored 'General case' 0 N--CA 1.5 2.062 0 C-N-CA 119.285 -0.966 . . . . 1.7 112.483 -178.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 870' ' ' ARG . . . . . 0.761 ' CB ' ' HB3' ' A' ' 855' ' ' ALA . 26.7 mmm180 -90.11 89.29 7.61 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 120.889 -1.132 . . . . 2.5899999999999999 110.598 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 58.5 t -72.82 96.95 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 120.971 -1.081 . . . . 1.9399999999999999 109.91 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 872' ' ' LEU . . . . . 0.497 HD11 ' HB2' ' A' ' 855' ' ' ALA . 97.6 mt -82.84 -47.44 11.87 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.514 -0.741 . . . . 1.0600000000000001 110.177 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 873' ' ' LEU . . . . . 0.464 ' HG ' ' HB3' ' A' ' 851' ' ' ALA . 46.5 tp -174.99 104.26 0.09 Allowed 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 108.637 -0.875 . . . . 4.1799999999999997 108.637 178.696 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 874' ' ' ASN . . . . . 0.443 ' CB ' ' HA ' ' A' ' 852' ' ' PHE . 35.5 t-20 178.71 81.6 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.571 -0.706 . . . . 0.040000000000000001 109.802 -179.02 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -67.28 -48.05 68.81 Favored 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 119.321 -0.951 . . . . 3.3799999999999999 111.118 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 876' ' ' GLY . . . . . . . . . . . . . . . -73.58 -25.29 72.74 Favored Glycine 0 N--CA 1.494 2.529 0 O-C-N 121.284 -0.885 . . . . 0.040000000000000001 111.632 -178.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 82.39 -61.37 4.73 Favored Glycine 0 N--CA 1.502 3.044 0 N-CA-C 108.097 -2.001 . . . . 0.040000000000000001 108.097 -178.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 878' ' ' TYR . . . . . 0.418 ' CE2' ' CG1' ' A' ' 850' ' ' VAL . 95.8 m-85 61.15 -62.97 0.08 Allowed 'General case' 0 N--CA 1.503 2.201 0 N-CA-C 114.35 1.241 . . . . 3.46 114.35 177.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 879' ' ' TYR . . . . . 0.47 ' CB ' ' CD2' ' A' ' 886' ' ' PHE . 18.8 p90 -111.33 108.66 18.33 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 114.489 1.292 . . . . 0.040000000000000001 114.489 -176.585 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -65.0 114.7 15.94 Favored Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 121.402 -0.811 . . . . 0.02 110.094 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 881' ' ' PRO . . . . . 0.475 ' HG2' ' CD1' ' A' ' 868' ' ' PHE . 53.3 Cg_endo -75.15 -0.94 10.61 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 O-C-N 123.525 1.276 . . . . 0.39000000000000001 112.312 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -76.87 -65.4 0.95 Allowed 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.12 -1.437 . . . . 0.81000000000000005 107.12 178.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 31.6 p -92.25 -18.17 23.78 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.62 -0.882 . . . . 0.040000000000000001 108.62 177.393 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.22 19.79 60.12 Favored Glycine 0 N--CA 1.497 2.729 0 O-C-N 121.093 -1.005 . . . . 0.029999999999999999 111.554 178.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 885' ' ' VAL . . . . . 0.679 HG13 HG21 ' A' ' 961' ' ' THR . 92.2 t -73.43 91.1 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 C-N-CA 118.089 -1.445 . . . . 1.01 108.137 -179.501 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 886' ' ' PHE . . . . . 0.878 ' HB3' HG22 ' A' ' 962' ' ' VAL . 0.6 OUTLIER -89.73 105.11 17.58 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 115.207 -0.906 . . . . 0.050000000000000003 112.081 -177.443 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 887' ' ' THR . . . . . 0.406 ' O ' ' HD3' ' A' ' 889' ' ' PRO . 85.0 m -95.96 100.36 12.04 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 107.711 -1.218 . . . . 0.68000000000000005 107.711 177.25 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 888' ' ' ALA . . . . . . . . . . . . . . . -98.42 107.43 42.01 Favored Pre-proline 0 N--CA 1.501 2.124 0 N-CA-C 114.094 1.146 . . . . 0.25 114.094 -176.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 889' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' A' ' 887' ' ' THR . 53.8 Cg_endo -90.19 -12.53 2.71 Favored 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 121.066 1.177 . . . . 1.6399999999999999 109.243 176.362 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 890' ' ' LEU . . . . . 0.994 HD22 HD13 ' A' ' 985' ' ' LEU . 63.6 mt -36.11 -50.52 0.71 Allowed 'General case' 0 N--CA 1.508 2.466 0 N-CA-C 113.856 1.058 . . . . 2.29 113.856 -177.338 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 51.68 95.84 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.342 0 O-C-N 121.158 -0.964 . . . . 0.63 110.314 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 156.58 -149.66 20.59 Favored Glycine 0 N--CA 1.479 1.562 0 N-CA-C 107.301 -2.32 . . . . 0.040000000000000001 107.301 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 70.7 ttt-85 -112.65 126.64 55.6 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 107.945 -1.131 . . . . 3.0 107.945 177.205 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 894' ' ' TYR . . . . . 0.541 ' OH ' HD12 ' A' ' 896' ' ' LEU . 0.0 OUTLIER -131.21 155.09 47.67 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.045 -1.035 . . . . 0.040000000000000001 110.69 -179.178 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 895' ' ' LEU . . . . . 0.423 ' N ' ' CD1' ' A' ' 894' ' ' TYR . 34.9 tp -95.29 114.16 25.91 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.665 -0.647 . . . . 1.27 110.067 -179.161 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 896' ' ' LEU . . . . . 0.567 HD23 ' N ' ' A' ' 897' ' ' SER . 9.8 tt -108.62 142.67 38.75 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.718 -0.614 . . . . 0.93999999999999995 110.628 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 897' ' ' SER . . . . . 0.567 ' N ' HD23 ' A' ' 896' ' ' LEU . 69.9 m -147.41 115.4 6.5 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.516 -0.74 . . . . 0.040000000000000001 110.895 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.26 146.76 31.06 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.07 -0.715 . . . . 0.47999999999999998 109.07 179.028 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 899' ' ' VAL . . . . . 0.766 HG21 ' HB ' ' A' ' 980' ' ' ILE . 87.8 t -96.36 119.7 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 C-N-CA 119.627 -0.829 . . . . 0.55000000000000004 111.377 -179.122 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 900' ' ' LEU . . . . . 0.548 HD12 ' HB2' ' A' ' 924' ' ' SER . 4.5 mm? -94.39 111.53 23.28 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 114.057 1.132 . . . . 1.5900000000000001 114.057 -175.387 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 21.6 m -65.43 140.8 58.65 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 107.322 -1.362 . . . . 0.050000000000000003 107.322 177.062 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -64.66 -66.75 2.32 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 110.427 -1.069 . . . . 0.029999999999999999 110.427 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 5.9 m170 46.59 66.81 0.89 Allowed 'General case' 0 N--CA 1.507 2.403 0 O-C-N 121.522 -0.987 . . . . 3.2000000000000002 111.093 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 43.3 ptt85 -69.13 -5.76 24.33 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.542 -0.723 . . . . 2.9199999999999999 112.003 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 905' ' ' HIS . . . . . 0.485 ' O ' ' CB ' ' A' ' 906' ' ' GLU . 74.4 t60 -61.06 3.22 0.1 Allowed 'General case' 0 N--CA 1.506 2.328 0 O-C-N 120.834 -1.166 . . . . 2.8700000000000001 112.891 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 906' ' ' GLU . . . . . 0.485 ' CB ' ' O ' ' A' ' 905' ' ' HIS . 0.8 OUTLIER 93.69 -163.62 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.437 0 CA-C-N 120.513 1.506 . . . . 0.98999999999999999 112.425 178.549 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 907' ' ' LYS . . . . . 0.483 ' CB ' ' O ' ' A' ' 906' ' ' GLU . 51.2 tttt 88.95 161.18 0.06 Allowed 'General case' 0 N--CA 1.519 3.018 0 N-CA-C 107.72 -1.215 . . . . 5.25 107.72 -177.014 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 60.0 t -121.7 116.18 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 120.864 -1.148 . . . . 0.39000000000000001 110.787 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 54.1 tp10 -104.49 132.13 51.09 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 107.523 -1.288 . . . . 1.72 107.523 176.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -156.09 121.63 4.87 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 106.536 -1.653 . . . . 0.67000000000000004 106.536 178.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 911' ' ' VAL . . . . . 0.732 HG22 HG13 ' A' ' 964' ' ' VAL . 92.9 t -81.65 132.44 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.819 -0.551 . . . . 0.54000000000000004 110.753 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 71.6 mt -65.68 155.91 34.52 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.376 -0.828 . . . . 1.5 108.838 178.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 913' ' ' SER . . . . . 0.417 ' CB ' ' HB ' ' A' ' 919' ' ' VAL . 2.4 t -123.39 137.43 54.82 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.076 -1.083 . . . . 1.3700000000000001 108.076 176.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 914' ' ' ARG . . . . . 0.625 ' NH1' HD23 ' A' ' 956' ' ' LEU . 0.0 OUTLIER -64.28 154.14 36.06 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 120.791 -1.193 . . . . 4.2999999999999998 111.58 -179.001 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 915' ' ' SER . . . . . 0.427 ' CB ' ' O ' ' A' ' 914' ' ' ARG . 4.9 t 83.31 -32.27 0.08 Allowed 'General case' 0 N--CA 1.522 3.126 0 C-N-CA 124.016 0.927 . . . . 2.0499999999999998 112.294 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 916' ' ' ASN . . . . . 0.755 ' HB2' HG21 ' A' ' 919' ' ' VAL . 98.7 m-20 -122.37 -21.02 5.92 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 120.908 -1.12 . . . . 2.71 111.429 -179.248 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 917' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 67.1 166.44 0.22 Allowed 'General case' 0 N--CA 1.521 3.102 0 N-CA-C 105.58 -2.007 . . . . 2.6800000000000002 105.58 -174.135 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.44 -125.79 35.25 Favored Glycine 1 N--CA 1.521 4.349 0 CA-C-N 123.405 2.82 . . . . 0.029999999999999999 107.001 -177.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 919' ' ' VAL . . . . . 0.755 HG21 ' HB2' ' A' ' 916' ' ' ASN . 82.0 t 51.95 94.52 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.273 0 O-C-N 121.447 -1.031 . . . . 1.3899999999999999 108.915 -178.21 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 920' ' ' ALA . . . . . 0.888 ' HB3' HG12 ' A' ' 949' ' ' VAL . . . -91.6 92.37 8.45 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.311 -0.955 . . . . 0.029999999999999999 111.12 -178.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 921' ' ' ARG . . . . . 0.747 ' HG3' HG23 ' A' ' 922' ' ' VAL . 16.7 ptt180 -84.31 -42.25 16.0 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 105.752 -1.944 . . . . 4.4199999999999999 105.752 175.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 922' ' ' VAL . . . . . 0.747 HG23 ' HG3' ' A' ' 921' ' ' ARG . 75.1 t -103.75 69.63 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 N-CA-C 105.608 -1.997 . . . . 0.84999999999999998 105.608 175.204 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 923' ' ' ASP . . . . . 0.655 ' HB2' ' HB1' ' A' ' 920' ' ' ALA . 22.0 t0 -89.68 136.26 33.14 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.887 0.851 . . . . 2.46 112.238 -176.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 924' ' ' SER . . . . . 0.548 ' HB2' HD12 ' A' ' 900' ' ' LEU . 13.2 t -146.48 103.4 3.68 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.922 -1.14 . . . . 0.69999999999999996 107.922 178.592 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -110.79 89.57 0.55 Allowed Glycine 0 N--CA 1.488 2.106 0 N-CA-C 108.941 -1.664 . . . . 0.040000000000000001 108.941 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.311 0 N-CA-C 109.324 -1.51 . . . . 0.040000000000000001 109.324 -179.604 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 22.8 m . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.063 0.458 . . . . 13.779999999999999 110.272 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 96.2 mt -112.88 129.88 56.3 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.54 -0.725 . . . . 13.76 110.403 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -151.57 167.86 30.95 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.056 -1.618 . . . . 9.1300000000000008 109.056 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 949' ' ' VAL . . . . . 0.888 HG12 ' HB3' ' A' ' 920' ' ' ALA . 32.9 m -118.95 130.34 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.501 -0.999 . . . . 7.0800000000000001 110.947 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 950' ' ' PHE . . . . . 0.459 ' CZ ' ' HB3' ' A' ' 921' ' ' ARG . 27.6 p90 -132.52 149.22 52.36 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.572 -0.705 . . . . 7.5899999999999999 109.283 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 19.5 m -120.19 -53.11 2.15 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.396 -0.815 . . . . 5.0300000000000002 112.04 -178.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 952' ' ' LEU . . . . . 0.417 ' O ' ' O ' ' A' ' 953' ' ' ILE . 16.8 tp -61.25 -74.3 0.08 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.388 -0.82 . . . . 1.01 112.309 -177.63 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 953' ' ' ILE . . . . . 0.804 HD11 HD13 ' C' ' 872' ' ' LEU . 43.9 pt -53.27 -144.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.755 0 N-CA-C 114.034 1.124 . . . . 2.6000000000000001 114.034 -176.742 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 954' ' ' LEU . . . . . 0.702 HD22 ' O ' ' A' ' 954' ' ' LEU . 0.0 OUTLIER 171.46 78.8 0.04 OUTLIER Pre-proline 0 N--CA 1.51 2.572 0 O-C-N 120.762 -1.211 . . . . 0.050000000000000003 111.54 179.697 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 955' ' ' PRO . . . . . 0.689 ' C ' HD12 ' A' ' 956' ' ' LEU . 47.1 Cg_endo -74.35 95.64 0.94 Allowed 'Trans proline' 0 C--N 1.313 -1.311 0 N-CA-C 109.343 -1.06 . . . . 0.83999999999999997 109.343 178.49 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 956' ' ' LEU . . . . . 0.689 HD12 ' C ' ' A' ' 955' ' ' PRO . 10.2 mp -123.12 145.25 48.74 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.174 -0.954 . . . . 0.040000000000000001 110.236 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -84.66 151.17 24.64 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 117.814 -1.088 . . . . 1.28 111.856 -178.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -70.24 119.88 15.09 Favored 'General case' 0 N--CA 1.51 2.569 0 CA-C-N 122.926 2.603 . . . . 0.17000000000000001 111.943 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.81 -22.82 31.78 Favored Glycine 0 N--CA 1.502 3.065 0 N-CA-C 111.197 -0.761 . . . . 0.040000000000000001 111.197 178.184 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 960' ' ' ASP . . . . . 0.435 ' HB3' ' NE ' ' A' ' 914' ' ' ARG . 0.3 OUTLIER -53.3 171.74 0.07 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.505 -0.997 . . . . 0.040000000000000001 110.313 -179.341 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 961' ' ' THR . . . . . 0.679 HG21 HG13 ' A' ' 885' ' ' VAL . 39.2 m -134.56 135.42 42.26 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.931 -1.106 . . . . 1.78 111.785 -178.087 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 962' ' ' VAL . . . . . 0.878 HG22 ' HB3' ' A' ' 886' ' ' PHE . 31.6 m -98.76 145.23 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 C-N-CA 120.045 -0.662 . . . . 0.040000000000000001 110.389 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 5.0 t -137.86 146.25 43.19 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.906 -0.496 . . . . 0.71999999999999997 110.131 -178.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 964' ' ' VAL . . . . . 0.732 HG13 HG22 ' A' ' 911' ' ' VAL . 58.3 t -95.06 136.37 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.091 -1.006 . . . . 1.05 110.503 -179.258 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -95.4 126.48 40.73 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 103.682 -2.71 . . . . 3.02 103.682 173.2 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 966' ' ' LEU . . . . . 0.493 ' C ' HG23 ' A' ' 967' ' ' VAL . 1.4 tt -133.46 61.29 1.68 Allowed 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.271 -1.011 . . . . 1.46 108.271 177.216 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 967' ' ' VAL . . . . . 0.493 HG23 ' C ' ' A' ' 966' ' ' LEU . 98.9 t -157.92 96.44 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 108.138 -1.06 . . . . 1.9399999999999999 108.138 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 93.1 mmm -143.04 58.45 1.41 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.708 -1.245 . . . . 0.0 108.198 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 133.09 119.21 2.0 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 106.538 -2.625 . . . . 2.1099999999999999 106.538 -177.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -84.83 -44.49 13.21 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 119.0 1.4 . . . . 5.8899999999999997 111.364 -179.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 43.0 tp -61.39 89.12 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.921 -1.112 . . . . 4.3600000000000003 110.081 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -141.89 -156.46 0.68 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.525 -0.734 . . . . 1.8300000000000001 110.272 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -121.61 176.05 5.91 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.535 -0.728 . . . . 4.3499999999999996 110.273 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 9.1 t -99.98 129.87 46.09 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.534 -0.728 . . . . 1.27 109.909 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -156.1 157.92 36.85 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.497 -0.752 . . . . 5.0199999999999996 110.671 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.33 86.8 16.41 Favored Pre-proline 0 N--CA 1.499 2.021 0 O-C-N 121.605 -0.684 . . . . 2.4100000000000001 109.506 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -72.91 -172.46 0.98 Allowed 'Trans proline' 0 C--N 1.318 -1.056 0 O-C-N 123.312 1.164 . . . . 0.95999999999999996 111.442 -179.158 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 978' ' ' LEU . . . . . 0.542 HD12 ' N ' ' A' ' 978' ' ' LEU . 5.0 mp -128.05 154.78 45.29 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 107.631 -1.248 . . . . 0.62 107.631 178.033 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 979' ' ' THR . . . . . 0.45 HG23 ' C ' ' A' ' 978' ' ' LEU . 44.9 p -149.73 141.17 23.32 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.738 -1.226 . . . . 3.5699999999999998 111.279 -179.259 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 980' ' ' ILE . . . . . 0.766 ' HB ' HG21 ' A' ' 899' ' ' VAL . 50.3 mm -107.82 128.2 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 108.885 -0.783 . . . . 1.3300000000000001 108.885 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 981' ' ' PHE . . . . . 0.461 ' HD1' ' HH ' ' A' ' 879' ' ' TYR . 6.4 t80 -121.88 97.33 5.44 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.428 -0.795 . . . . 0.050000000000000003 111.912 -178.394 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 92.6 p -108.84 158.44 17.66 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 109.041 -0.726 . . . . 0.87 109.041 178.379 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . -173.73 108.91 0.28 Allowed Glycine 0 N--CA 1.498 2.775 0 N-CA-C 106.635 -2.586 . . . . 0.029999999999999999 106.635 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -109.07 148.67 30.45 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 114.409 1.263 . . . . 0.69999999999999996 114.409 -175.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 985' ' ' LEU . . . . . 0.994 HD13 HD22 ' A' ' 890' ' ' LEU . 35.1 tp -68.93 135.24 50.68 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 120.777 -1.202 . . . . 0.040000000000000001 110.275 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 50.8 tp -106.88 -58.8 1.89 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.648 -0.658 . . . . 0.040000000000000001 109.918 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -144.11 145.51 32.19 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 107.553 -1.277 . . . . 0.040000000000000001 107.553 179.027 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.69 163.29 12.17 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 108.23 -1.948 . . . . 0.040000000000000001 108.23 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -76.11 112.51 21.08 Favored Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.184 -1.186 . . . . 0.040000000000000001 109.41 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 990' ' ' PRO . . . . . 0.414 ' O ' ' HB2' ' A' ' 991' ' ' GLU . 49.8 Cg_endo -90.44 71.79 1.33 Allowed 'Trans proline' 0 C--N 1.318 -1.031 0 O-C-N 123.044 1.023 . . . . 0.45000000000000001 111.435 -178.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 991' ' ' GLU . . . . . 0.414 ' HB2' ' O ' ' A' ' 990' ' ' PRO . 75.1 mt-10 67.44 -73.67 0.08 Allowed 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 108.476 -0.935 . . . . 1.97 108.476 -177.405 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 992' ' ' LEU . . . . . . . . . . . . . 11.0 mt 51.1 20.51 0.86 Allowed 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.504 -0.748 . . . . 2.3799999999999999 111.652 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 80.3 mt-10 -94.1 156.84 16.37 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.918 -1.114 . . . . 3.79 109.947 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -146.21 93.29 2.3 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.529 -0.732 . . . . 3.5099999999999998 110.333 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 995' ' ' ALA . . . . . . . . . . . . 2.518 . . . . . . . 0 N--CA 1.504 2.24 0 O-C-N 120.935 -1.103 . . . . 2.73 110.57 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo . . . . . 0 N--CA 1.488 1.171 0 N-CA-C 109.537 -0.986 . . . . 3.8300000000000001 109.537 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 847' ' ' VAL . . . . . . . . . . . . . 61.9 t -134.52 103.27 11.31 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.586 -0.696 . . . . 1.8300000000000001 110.054 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 848' ' ' PRO . . . . . 0.695 ' O ' HG23 ' B' ' 850' ' ' VAL . 44.2 Cg_endo -69.91 -18.84 36.08 Favored 'Trans proline' 0 N--CA 1.488 1.182 0 O-C-N 123.321 1.169 . . . . 0.65000000000000002 111.314 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 849' ' ' GLN . . . . . 0.407 ' C ' ' O ' ' B' ' 848' ' ' PRO . 56.4 tt0 27.64 69.17 0.06 Allowed 'General case' 0 N--CA 1.518 2.957 0 N-CA-C 112.827 0.677 . . . . 2.5800000000000001 112.827 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 850' ' ' VAL . . . . . 0.695 HG23 ' O ' ' B' ' 848' ' ' PRO . 61.9 t -119.27 135.89 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.202 -0.936 . . . . 1.0900000000000001 111.394 -178.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 851' ' ' ALA . . . . . 0.463 ' HB3' ' HG ' ' B' ' 873' ' ' LEU . . . -127.22 156.22 42.21 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 105.884 -1.895 . . . . 0.040000000000000001 105.884 176.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 852' ' ' PHE . . . . . 0.44 ' HA ' ' CB ' ' B' ' 874' ' ' ASN . 33.2 p90 -157.98 130.59 7.25 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 121.086 1.766 . . . . 0.050000000000000003 108.729 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 44.5 t -174.97 133.7 0.33 Allowed 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.214 -1.032 . . . . 0.040000000000000001 108.214 -179.121 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 854' ' ' ALA . . . . . 0.446 ' HB1' ' HD2' ' B' ' 868' ' ' PHE . . . -133.65 155.98 48.72 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.096 -1.002 . . . . 0.67000000000000004 109.448 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 855' ' ' ALA . . . . . 0.747 ' HB3' ' CB ' ' B' ' 870' ' ' ARG . . . -122.3 141.82 51.13 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.802 0.811 . . . . 0.51000000000000001 111.293 -179.078 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 856' ' ' LEU . . . . . 0.659 HD13 ' N ' ' B' ' 857' ' ' SER . 3.4 tm? -111.4 137.55 49.03 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.602 -0.686 . . . . 0.050000000000000003 110.016 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 857' ' ' SER . . . . . 0.659 ' N ' HD13 ' B' ' 856' ' ' LEU . 1.5 m -156.43 17.05 0.33 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.543 -0.723 . . . . 1.3300000000000001 111.538 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 858' ' ' LEU . . . . . 0.611 HD22 ' HG3' ' B' ' 862' ' ' GLU . 3.8 pp -35.2 160.45 0.04 OUTLIER Pre-proline 0 N--CA 1.52 3.028 0 N-CA-C 112.954 0.724 . . . . 2.3300000000000001 112.954 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -60.82 -88.6 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 120.877 1.051 . . . . 2.3199999999999998 113.803 -177.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 53.6 ptt85 -128.54 -142.74 0.26 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 120.897 -1.127 . . . . 0.040000000000000001 111.801 -177.314 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 15.2 m -37.96 126.12 1.23 Allowed 'General case' 0 N--CA 1.509 2.516 0 O-C-N 121.619 -0.676 . . . . 1.3100000000000001 112.3 -178.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 862' ' ' GLU . . . . . 0.611 ' HG3' HD22 ' B' ' 858' ' ' LEU . 0.0 OUTLIER -98.96 159.02 31.28 Favored Pre-proline 0 N--CA 1.489 1.511 0 N-CA-C 108.425 -0.954 . . . . 4.5099999999999998 108.425 177.7 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -70.9 -14.71 32.67 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 O-C-N 123.193 1.101 . . . . 2.2400000000000002 111.411 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -177.52 -134.97 2.12 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.508 -1.437 . . . . 0.040000000000000001 109.508 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 27.1 m -66.71 156.82 34.27 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.285 -1.126 . . . . 1.51 110.053 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 866' ' ' VAL . . . . . 0.496 HG13 ' CD2' ' B' ' 858' ' ' LEU . 61.1 t -99.44 137.34 20.3 Favored Pre-proline 0 N--CA 1.494 1.742 0 N-CA-C 113.485 0.92 . . . . 0.78000000000000003 113.485 -174.348 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 867' ' ' PRO . . . . . 0.564 ' O ' HD23 ' B' ' 856' ' ' LEU . 55.4 Cg_endo -92.52 -149.82 0.03 OUTLIER 'Trans proline' 0 CA--C 1.546 1.121 0 C-N-CA 121.314 1.343 . . . . 0.92000000000000004 109.626 178.12 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 868' ' ' PHE . . . . . 0.476 ' CD1' ' HG2' ' B' ' 881' ' ' PRO . 19.4 p90 -150.55 123.88 8.93 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.645 -1.284 . . . . 0.050000000000000003 109.765 179.158 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 46.5 p30 -113.34 -1.94 14.12 Favored 'General case' 0 N--CA 1.5 2.051 0 C-N-CA 119.287 -0.965 . . . . 1.7 112.56 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 870' ' ' ARG . . . . . 0.747 ' CB ' ' HB3' ' B' ' 855' ' ' ALA . 26.4 mmm180 -90.47 89.05 7.41 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.848 -1.157 . . . . 2.5899999999999999 110.634 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 58.7 t -72.71 97.19 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.013 -1.054 . . . . 1.9399999999999999 109.864 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 872' ' ' LEU . . . . . 0.492 HD11 ' HB2' ' B' ' 855' ' ' ALA . 98.6 mt -83.14 -47.5 11.55 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.594 -0.691 . . . . 1.0600000000000001 110.155 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 873' ' ' LEU . . . . . 0.463 ' HG ' ' HB3' ' B' ' 851' ' ' ALA . 46.6 tp -175.0 104.14 0.09 Allowed 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.625 -0.88 . . . . 4.1799999999999997 108.625 178.72 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 874' ' ' ASN . . . . . 0.44 ' CB ' ' HA ' ' B' ' 852' ' ' PHE . 35.5 t-20 178.73 81.78 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.303 0 O-C-N 121.681 -0.637 . . . . 0.040000000000000001 109.74 -179.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -67.4 -48.12 68.3 Favored 'General case' 0 N--CA 1.499 1.998 0 C-N-CA 119.281 -0.967 . . . . 3.3799999999999999 111.164 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 876' ' ' GLY . . . . . . . . . . . . . . . -73.52 -25.57 72.17 Favored Glycine 0 N--CA 1.494 2.536 0 O-C-N 121.242 -0.911 . . . . 0.040000000000000001 111.599 -178.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 82.61 -61.15 4.78 Favored Glycine 0 N--CA 1.501 3.02 0 N-CA-C 108.105 -1.998 . . . . 0.040000000000000001 108.105 -178.223 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 878' ' ' TYR . . . . . 0.418 ' CE2' ' CG1' ' B' ' 850' ' ' VAL . 95.7 m-85 61.11 -62.94 0.08 Allowed 'General case' 0 N--CA 1.503 2.178 0 N-CA-C 114.361 1.245 . . . . 3.46 114.361 177.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 879' ' ' TYR . . . . . 0.485 ' HH ' ' HD1' ' B' ' 981' ' ' PHE . 18.8 p90 -111.28 108.77 18.5 Favored 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 114.477 1.288 . . . . 0.040000000000000001 114.477 -176.627 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -65.09 114.67 16.0 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.37 -0.832 . . . . 0.02 110.085 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 881' ' ' PRO . . . . . 0.476 ' HG2' ' CD1' ' B' ' 868' ' ' PHE . 53.6 Cg_endo -75.14 -0.98 10.66 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 O-C-N 123.557 1.293 . . . . 0.39000000000000001 112.257 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -76.8 -65.48 0.94 Allowed 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 107.071 -1.455 . . . . 0.81000000000000005 107.071 178.569 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 32.4 p -92.39 -17.71 24.26 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.713 -0.847 . . . . 0.040000000000000001 108.713 177.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.78 20.09 60.33 Favored Glycine 0 N--CA 1.495 2.63 0 O-C-N 121.092 -1.005 . . . . 0.029999999999999999 111.538 178.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 885' ' ' VAL . . . . . 0.684 HG13 HG21 ' B' ' 961' ' ' THR . 93.1 t -73.61 91.24 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 C-N-CA 118.13 -1.428 . . . . 1.01 108.058 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 886' ' ' PHE . . . . . 0.906 ' HB3' HG22 ' B' ' 962' ' ' VAL . 0.6 OUTLIER -89.85 105.16 17.62 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 115.211 -0.904 . . . . 0.050000000000000003 112.056 -177.448 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 887' ' ' THR . . . . . 0.406 ' O ' ' HD3' ' B' ' 889' ' ' PRO . 84.7 m -96.09 100.71 12.34 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 107.626 -1.25 . . . . 0.68000000000000005 107.626 177.249 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 888' ' ' ALA . . . . . . . . . . . . . . . -98.67 107.25 41.79 Favored Pre-proline 0 N--CA 1.502 2.148 0 N-CA-C 114.029 1.122 . . . . 0.25 114.029 -176.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 889' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' B' ' 887' ' ' THR . 53.4 Cg_endo -90.09 -12.6 2.75 Favored 'Trans proline' 0 CA--C 1.546 1.099 0 C-N-CA 121.043 1.162 . . . . 1.6399999999999999 109.274 176.355 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 890' ' ' LEU . . . . . 0.985 HD22 HD13 ' B' ' 985' ' ' LEU . 63.7 mt -36.02 -50.65 0.7 Allowed 'General case' 0 N--CA 1.509 2.481 0 N-CA-C 113.819 1.044 . . . . 2.29 113.819 -177.353 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 51.68 95.82 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.314 0 O-C-N 121.137 -0.977 . . . . 0.63 110.322 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . 156.6 -149.78 20.75 Favored Glycine 0 N--CA 1.479 1.564 0 N-CA-C 107.26 -2.336 . . . . 0.040000000000000001 107.26 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 71.1 ttt-85 -112.51 126.61 55.51 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 107.979 -1.119 . . . . 3.0 107.979 177.24 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 894' ' ' TYR . . . . . 0.545 ' OH ' HD12 ' B' ' 896' ' ' LEU . 0.0 OUTLIER -131.1 155.29 47.2 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.122 -0.986 . . . . 0.040000000000000001 110.68 -179.133 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 895' ' ' LEU . . . . . 0.429 ' N ' ' CD1' ' B' ' 894' ' ' TYR . 34.8 tp -95.57 114.04 25.76 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.575 -0.703 . . . . 1.27 110.089 -179.171 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 896' ' ' LEU . . . . . 0.559 HD23 ' N ' ' B' ' 897' ' ' SER . 9.7 tt -108.64 142.03 39.72 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.696 -0.628 . . . . 0.93999999999999995 110.695 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 897' ' ' SER . . . . . 0.559 ' N ' HD23 ' B' ' 896' ' ' LEU . 69.6 m -146.75 115.27 6.74 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.565 -0.71 . . . . 0.040000000000000001 110.864 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.1 146.6 31.05 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.112 -0.699 . . . . 0.47999999999999998 109.112 179.013 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 899' ' ' VAL . . . . . 0.767 HG21 ' HB ' ' B' ' 980' ' ' ILE . 87.7 t -96.2 119.39 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 C-N-CA 119.6 -0.84 . . . . 0.55000000000000004 111.466 -179.086 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 900' ' ' LEU . . . . . 0.545 HD12 ' HB2' ' B' ' 924' ' ' SER . 4.5 mm? -94.11 111.11 22.8 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 114.2 1.185 . . . . 1.5900000000000001 114.2 -175.339 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 21.2 m -65.1 140.74 58.84 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 107.333 -1.358 . . . . 0.050000000000000003 107.333 177.053 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -64.88 -66.7 2.34 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.445 -1.062 . . . . 0.029999999999999999 110.445 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 5.8 m170 46.54 66.84 0.88 Allowed 'General case' 0 N--CA 1.508 2.428 0 O-C-N 121.439 -1.036 . . . . 3.2000000000000002 111.016 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 43.3 ptt85 -69.02 -6.05 25.56 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.591 -0.693 . . . . 2.9199999999999999 112.043 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 905' ' ' HIS . . . . . 0.48 ' O ' ' CB ' ' B' ' 906' ' ' GLU . 74.1 t60 -60.39 2.61 0.09 Allowed 'General case' 0 N--CA 1.506 2.332 0 O-C-N 120.857 -1.152 . . . . 2.8700000000000001 112.897 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 906' ' ' GLU . . . . . 0.48 ' CB ' ' O ' ' B' ' 905' ' ' HIS . 0.8 OUTLIER 93.95 -163.73 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.44 0 CA-C-N 120.584 1.538 . . . . 0.98999999999999999 112.36 178.741 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 907' ' ' LYS . . . . . 0.471 ' CB ' ' O ' ' B' ' 906' ' ' GLU . 51.5 tttt 89.13 161.01 0.06 Allowed 'General case' 0 N--CA 1.52 3.045 0 N-CA-C 107.755 -1.202 . . . . 5.25 107.755 -177.011 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 58.9 t -121.52 115.93 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 120.86 -1.15 . . . . 0.39000000000000001 110.93 -179.272 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 54.1 tp10 -104.35 132.21 50.85 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 107.546 -1.279 . . . . 1.72 107.546 177.006 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -156.25 121.82 4.85 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 106.56 -1.644 . . . . 0.67000000000000004 106.56 178.509 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 911' ' ' VAL . . . . . 0.717 HG22 HG13 ' B' ' 964' ' ' VAL . 92.4 t -81.86 132.67 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.791 -0.568 . . . . 0.54000000000000004 110.788 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 71.8 mt -65.76 156.08 34.19 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 108.763 -0.828 . . . . 1.5 108.763 178.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 913' ' ' SER . . . . . 0.413 ' CB ' ' HB ' ' B' ' 919' ' ' VAL . 2.4 t -123.81 136.56 54.47 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.157 -1.053 . . . . 1.3700000000000001 108.157 176.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 914' ' ' ARG . . . . . 0.625 ' NH1' HD23 ' B' ' 956' ' ' LEU . 0.0 OUTLIER -63.36 153.95 33.44 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 120.772 -1.205 . . . . 4.2999999999999998 111.701 -178.909 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 915' ' ' SER . . . . . 0.419 ' CB ' ' O ' ' B' ' 914' ' ' ARG . 4.9 t 83.49 -32.53 0.08 Allowed 'General case' 0 N--CA 1.52 3.06 0 C-N-CA 124.11 0.964 . . . . 2.0499999999999998 112.36 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 916' ' ' ASN . . . . . 0.767 ' HB2' HG21 ' B' ' 919' ' ' VAL . 98.6 m-20 -121.98 -21.4 6.01 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 120.797 -1.189 . . . . 2.71 111.461 -179.233 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 917' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 67.15 165.93 0.22 Allowed 'General case' 0 N--CA 1.52 3.026 0 N-CA-C 105.62 -1.993 . . . . 2.6800000000000002 105.62 -174.093 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 55.09 -125.86 37.06 Favored Glycine 1 N--CA 1.521 4.301 0 CA-C-N 123.575 2.898 . . . . 0.029999999999999999 106.882 -177.604 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 919' ' ' VAL . . . . . 0.767 HG21 ' HB2' ' B' ' 916' ' ' ASN . 85.6 t 51.72 94.57 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.249 0 O-C-N 121.427 -1.043 . . . . 1.3899999999999999 108.96 -178.191 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 920' ' ' ALA . . . . . 0.875 ' HB3' HG12 ' B' ' 949' ' ' VAL . . . -91.67 92.14 8.31 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 119.298 -0.961 . . . . 0.029999999999999999 111.114 -178.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 921' ' ' ARG . . . . . 0.737 ' HG3' HG23 ' B' ' 922' ' ' VAL . 16.7 ptt180 -84.14 -42.25 16.22 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 105.749 -1.945 . . . . 4.4199999999999999 105.749 175.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 922' ' ' VAL . . . . . 0.737 HG23 ' HG3' ' B' ' 921' ' ' ARG . 75.0 t -103.78 69.42 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 105.563 -2.014 . . . . 0.84999999999999998 105.563 175.316 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 923' ' ' ASP . . . . . 0.654 ' HB2' ' HB1' ' B' ' 920' ' ' ALA . 22.0 t0 -89.44 136.3 33.1 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.895 0.855 . . . . 2.46 112.22 -176.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 924' ' ' SER . . . . . 0.545 ' HB2' HD12 ' B' ' 900' ' ' LEU . 13.3 t -146.41 103.32 3.68 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 107.957 -1.127 . . . . 0.69999999999999996 107.957 178.531 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -110.62 89.39 0.54 Allowed Glycine 0 N--CA 1.488 2.154 0 N-CA-C 108.929 -1.668 . . . . 0.040000000000000001 108.929 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.385 0 N-CA-C 109.334 -1.506 . . . . 0.040000000000000001 109.334 -179.658 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 23.3 m . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.044 0.45 . . . . 13.779999999999999 110.218 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 96.2 mt -112.28 129.8 56.16 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.566 -0.709 . . . . 13.76 110.395 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -151.25 167.08 30.69 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.07 -1.612 . . . . 9.1300000000000008 109.07 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 949' ' ' VAL . . . . . 0.875 HG12 ' HB3' ' B' ' 920' ' ' ALA . 32.5 m -118.68 130.21 73.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.469 -1.018 . . . . 7.0800000000000001 110.85 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 950' ' ' PHE . . . . . 0.462 ' CZ ' ' HB3' ' B' ' 921' ' ' ARG . 27.8 p90 -132.41 149.44 52.34 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.591 -0.693 . . . . 7.5899999999999999 109.303 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 19.6 m -120.22 -52.72 2.16 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.413 -0.804 . . . . 5.0300000000000002 112.037 -178.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 952' ' ' LEU . . . . . 0.413 ' O ' ' O ' ' B' ' 953' ' ' ILE . 16.8 tp -61.59 -74.4 0.08 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.378 -0.827 . . . . 1.01 112.324 -177.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 953' ' ' ILE . . . . . 0.496 ' O ' ' HB3' ' B' ' 954' ' ' LEU . 44.8 pt -53.12 -143.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.723 0 N-CA-C 114.122 1.156 . . . . 2.6000000000000001 114.122 -176.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 954' ' ' LEU . . . . . 0.714 HD22 ' O ' ' B' ' 954' ' ' LEU . 0.0 OUTLIER 171.25 78.53 0.04 OUTLIER Pre-proline 0 N--CA 1.511 2.606 0 O-C-N 120.772 -1.205 . . . . 0.050000000000000003 111.507 179.609 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 955' ' ' PRO . . . . . 0.694 ' C ' HD12 ' B' ' 956' ' ' LEU . 46.9 Cg_endo -74.28 95.86 0.94 Allowed 'Trans proline' 0 C--N 1.313 -1.306 0 N-CA-C 109.307 -1.074 . . . . 0.83999999999999997 109.307 178.522 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 956' ' ' LEU . . . . . 0.694 HD12 ' C ' ' B' ' 955' ' ' PRO . 10.2 mp -123.28 145.19 48.89 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.15 -0.969 . . . . 0.040000000000000001 110.212 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -84.51 151.51 24.54 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 117.983 -1.008 . . . . 1.28 111.821 -179.037 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -70.47 119.66 14.96 Favored 'General case' 0 N--CA 1.51 2.566 0 CA-C-N 122.725 2.511 . . . . 0.17000000000000001 111.919 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.96 -23.1 30.72 Favored Glycine 0 N--CA 1.502 3.046 0 N-CA-C 111.154 -0.779 . . . . 0.040000000000000001 111.154 178.206 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 960' ' ' ASP . . . . . 0.437 ' HB3' ' NE ' ' B' ' 914' ' ' ARG . 0.4 OUTLIER -52.96 171.86 0.06 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.467 -1.02 . . . . 0.040000000000000001 110.376 -179.312 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 961' ' ' THR . . . . . 0.684 HG21 HG13 ' B' ' 885' ' ' VAL . 38.3 m -134.59 135.55 42.31 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.074 -1.016 . . . . 1.78 111.714 -178.094 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 962' ' ' VAL . . . . . 0.906 HG22 ' HB3' ' B' ' 886' ' ' PHE . 31.9 m -99.05 145.13 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 C-N-CA 119.989 -0.684 . . . . 0.040000000000000001 110.343 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 5.0 t -137.64 146.15 43.56 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.936 -0.478 . . . . 0.71999999999999997 110.166 -178.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 964' ' ' VAL . . . . . 0.717 HG13 HG22 ' B' ' 911' ' ' VAL . 58.3 t -95.13 136.07 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.073 -1.017 . . . . 1.05 110.529 -179.253 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -95.25 126.11 40.34 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 103.761 -2.681 . . . . 3.02 103.761 173.289 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 966' ' ' LEU . . . . . 0.488 ' C ' HG23 ' B' ' 967' ' ' VAL . 1.4 tt -133.13 61.39 1.68 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.309 -0.997 . . . . 1.46 108.309 177.303 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 967' ' ' VAL . . . . . 0.488 HG23 ' C ' ' B' ' 966' ' ' LEU . 98.5 t -158.04 96.25 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 108.148 -1.056 . . . . 1.9399999999999999 108.148 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 93.3 mmm -142.81 58.32 1.43 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.767 -1.208 . . . . 0.0 108.227 178.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 133.1 119.1 1.99 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 106.654 -2.578 . . . . 2.1099999999999999 106.654 -178.058 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -84.53 -44.53 13.49 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 118.912 1.356 . . . . 5.8899999999999997 111.404 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 43.3 tp -61.48 88.85 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.882 -1.136 . . . . 4.3600000000000003 110.048 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -141.59 -156.26 0.66 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.575 -0.703 . . . . 1.8300000000000001 110.249 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -121.68 176.28 5.8 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.599 -0.688 . . . . 4.3499999999999996 110.195 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 9.2 t -100.22 129.87 46.28 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.52 -0.738 . . . . 1.27 109.956 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -156.11 157.89 36.79 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.53 -0.731 . . . . 5.0199999999999996 110.629 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.31 86.75 16.51 Favored Pre-proline 0 N--CA 1.5 2.056 0 O-C-N 121.678 -0.639 . . . . 2.4100000000000001 109.521 179.53 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -72.92 -172.49 0.99 Allowed 'Trans proline' 0 N--CA 1.487 1.089 0 O-C-N 123.32 1.168 . . . . 0.95999999999999996 111.443 -179.172 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 978' ' ' LEU . . . . . 0.539 ' N ' HD12 ' B' ' 978' ' ' LEU . 5.0 mp -127.93 154.99 44.92 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 107.619 -1.252 . . . . 0.62 107.619 178.05 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 979' ' ' THR . . . . . 0.462 HG23 ' C ' ' B' ' 978' ' ' LEU . 44.3 p -149.9 141.07 23.08 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.746 -1.221 . . . . 3.5699999999999998 111.294 -179.269 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 980' ' ' ILE . . . . . 0.767 ' HB ' HG21 ' B' ' 899' ' ' VAL . 50.2 mm -107.84 127.8 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 108.892 -0.781 . . . . 1.3300000000000001 108.892 179.328 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 981' ' ' PHE . . . . . 0.485 ' HD1' ' HH ' ' B' ' 879' ' ' TYR . 6.4 t80 -121.61 97.53 5.54 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 119.717 -0.793 . . . . 0.050000000000000003 111.906 -178.29 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 94.1 p -109.22 158.65 17.63 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.552 -0.717 . . . . 0.87 109.104 178.37 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 983' ' ' GLY . . . . . . . . . . . . . . . -173.66 109.07 0.29 Allowed Glycine 0 N--CA 1.499 2.872 0 N-CA-C 106.705 -2.558 . . . . 0.029999999999999999 106.705 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -109.07 148.71 30.4 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 114.361 1.245 . . . . 0.69999999999999996 114.361 -175.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 985' ' ' LEU . . . . . 0.985 HD13 HD22 ' B' ' 890' ' ' LEU . 35.0 tp -69.03 135.17 50.43 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.796 -1.19 . . . . 0.040000000000000001 110.255 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 986' ' ' LEU . . . . . 0.463 ' CD1' HD11 ' C' ' 986' ' ' LEU . 50.5 tp -106.88 -58.82 1.89 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.639 -0.663 . . . . 0.040000000000000001 109.932 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -144.07 145.34 32.1 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.591 -1.263 . . . . 0.040000000000000001 107.591 179.089 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.61 163.03 12.2 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 108.163 -1.975 . . . . 0.040000000000000001 108.163 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -75.76 112.48 20.02 Favored Pre-proline 0 N--CA 1.499 1.984 0 O-C-N 121.243 -1.151 . . . . 0.040000000000000001 109.406 179.097 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 990' ' ' PRO . . . . . 0.416 ' O ' ' HB2' ' B' ' 991' ' ' GLU . 49.6 Cg_endo -90.38 71.86 1.35 Allowed 'Trans proline' 0 C--N 1.319 -1.005 0 O-C-N 123.133 1.07 . . . . 0.45000000000000001 111.373 -179.012 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 991' ' ' GLU . . . . . 0.416 ' HB2' ' O ' ' B' ' 990' ' ' PRO . 74.9 mt-10 67.34 -73.56 0.08 Allowed 'General case' 0 N--CA 1.502 2.149 0 N-CA-C 108.552 -0.907 . . . . 1.97 108.552 -177.475 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 992' ' ' LEU . . . . . 0.434 ' HA ' HD23 ' B' ' 992' ' ' LEU . 10.9 mt 51.18 20.28 0.86 Allowed 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.536 -0.727 . . . . 2.3799999999999999 111.677 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 80.3 mt-10 -93.75 156.79 16.48 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.895 -1.128 . . . . 3.79 109.976 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 70.6 m80 -146.24 92.79 2.22 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.444 -0.785 . . . . 3.5099999999999998 110.388 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 995' ' ' ALA . . . . . . . . . . . . 2.517 . . . . . . . 0 N--CA 1.504 2.255 0 O-C-N 120.935 -1.103 . . . . 2.73 110.612 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo . . . . . 0 N--CA 1.488 1.158 0 N-CA-C 109.539 -0.985 . . . . 3.8300000000000001 109.539 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 847' ' ' VAL . . . . . 0.506 HG12 ' HB2' ' C' ' 849' ' ' GLN . 58.2 t -126.48 106.41 23.87 Favored Pre-proline 0 N--CA 1.496 1.835 0 O-C-N 121.597 -0.689 . . . . 1.8300000000000001 110.012 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 848' ' ' PRO . . . . . 0.886 ' O ' HG23 ' C' ' 850' ' ' VAL . 44.4 Cg_endo -69.7 -22.68 32.01 Favored 'Trans proline' 0 N--CA 1.488 1.177 0 O-C-N 123.278 1.146 . . . . 0.65000000000000002 111.034 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 849' ' ' GLN . . . . . 0.506 ' HB2' HG12 ' C' ' 847' ' ' VAL . 54.5 tt0 25.17 64.9 0.06 Allowed 'General case' 0 N--CA 1.519 2.991 0 N-CA-C 113.379 0.881 . . . . 2.5800000000000001 113.379 179.138 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 850' ' ' VAL . . . . . 0.886 HG23 ' O ' ' C' ' 848' ' ' PRO . 72.1 t -119.06 135.5 59.27 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.117 -0.989 . . . . 1.0900000000000001 111.028 -179.357 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 851' ' ' ALA . . . . . 0.573 ' HB3' ' HG ' ' C' ' 873' ' ' LEU . . . -126.96 155.93 42.34 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 105.758 -1.942 . . . . 0.040000000000000001 105.758 176.554 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 852' ' ' PHE . . . . . 0.451 ' CD1' ' N ' ' C' ' 852' ' ' PHE . 16.0 p90 -160.26 127.38 4.41 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 121.016 1.734 . . . . 0.050000000000000003 108.625 178.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 38.8 t -176.65 134.88 0.22 Allowed 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.18 -1.044 . . . . 0.040000000000000001 108.18 -179.018 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 854' ' ' ALA . . . . . 0.447 ' HB1' ' HD2' ' C' ' 868' ' ' PHE . . . -132.21 156.96 45.53 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.164 -0.96 . . . . 0.67000000000000004 109.779 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 855' ' ' ALA . . . . . 0.683 ' HB3' ' CB ' ' C' ' 870' ' ' ARG . . . -122.41 140.53 52.6 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.759 0.79 . . . . 0.51000000000000001 111.179 -179.256 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 856' ' ' LEU . . . . . 0.734 HD11 HD23 ' C' ' 858' ' ' LEU . 3.5 tm? -111.74 138.14 48.71 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.641 -0.662 . . . . 0.050000000000000003 110.036 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 857' ' ' SER . . . . . 0.636 ' N ' HD13 ' C' ' 856' ' ' LEU . 21.1 m -155.27 18.66 0.42 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.395 -0.815 . . . . 1.3300000000000001 111.347 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 858' ' ' LEU . . . . . 0.734 HD23 HD11 ' C' ' 856' ' ' LEU . 3.2 pp -34.81 160.87 0.04 OUTLIER Pre-proline 0 N--CA 1.52 3.067 0 N-CA-C 113.066 0.765 . . . . 2.3300000000000001 113.066 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -60.34 -88.22 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.462 0 O-C-N 122.99 0.995 . . . . 2.3199999999999998 113.455 -178.333 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 55.2 ptt85 -128.31 -143.34 0.27 Allowed 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.823 -1.173 . . . . 0.040000000000000001 111.808 -177.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 69.4 m -37.84 130.32 1.11 Allowed 'General case' 0 N--CA 1.511 2.581 0 O-C-N 121.622 -0.673 . . . . 1.3100000000000001 112.356 -178.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.14 160.45 26.03 Favored Pre-proline 0 N--CA 1.489 1.476 0 N-CA-C 108.326 -0.99 . . . . 4.5099999999999998 108.326 177.298 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.78 -13.57 26.83 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 O-C-N 123.152 1.08 . . . . 2.2400000000000002 111.453 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -177.78 -136.2 2.44 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.664 -1.374 . . . . 0.040000000000000001 109.664 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 17.0 m -68.23 153.86 42.89 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.329 -1.1 . . . . 1.51 109.92 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 866' ' ' VAL . . . . . 0.444 ' HA ' ' HD3' ' C' ' 867' ' ' PRO . 39.4 t -97.72 139.78 21.56 Favored Pre-proline 0 N--CA 1.493 1.691 0 N-CA-C 113.507 0.928 . . . . 0.78000000000000003 113.507 -174.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 867' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' C' ' 866' ' ' VAL . 55.8 Cg_endo -91.4 -147.86 0.03 OUTLIER 'Trans proline' 0 CA--C 1.544 0.998 0 O-C-N 123.688 1.362 . . . . 0.92000000000000004 108.95 177.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 868' ' ' PHE . . . . . 0.485 ' CD1' ' HG2' ' C' ' 881' ' ' PRO . 14.0 p90 -149.88 124.12 9.52 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.51 -1.368 . . . . 0.050000000000000003 110.109 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 47.6 p-10 -112.45 -3.08 14.53 Favored 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 119.131 -1.027 . . . . 1.7 112.508 -178.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 870' ' ' ARG . . . . . 0.683 ' CB ' ' HB3' ' C' ' 855' ' ' ALA . 28.0 mmm180 -91.85 87.86 6.41 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.925 -1.109 . . . . 2.5899999999999999 111.112 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 60.7 t -71.55 96.94 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 120.927 -1.108 . . . . 1.9399999999999999 109.337 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 872' ' ' LEU . . . . . 0.804 HD13 HD11 ' A' ' 953' ' ' ILE . 95.3 mt -87.29 -44.73 11.2 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.592 -0.692 . . . . 1.0600000000000001 110.678 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 873' ' ' LEU . . . . . 0.573 ' HG ' ' HB3' ' C' ' 851' ' ' ALA . 33.0 tp -172.91 102.02 0.13 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.101 -0.999 . . . . 4.1799999999999997 108.947 178.601 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 874' ' ' ASN . . . . . 0.443 ' CB ' ' HA ' ' C' ' 852' ' ' PHE . 34.0 t-20 176.99 82.09 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.284 0 N-CA-C 108.987 -0.746 . . . . 0.040000000000000001 108.987 -179.073 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -65.34 -47.27 77.07 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.107 -0.995 . . . . 3.3799999999999999 111.308 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 876' ' ' GLY . . . . . 0.417 ' HA3' ' CE2' ' C' ' 878' ' ' TYR . . . -72.58 -26.47 71.59 Favored Glycine 0 N--CA 1.493 2.483 0 C-N-CA 120.423 -0.894 . . . . 0.040000000000000001 111.436 -178.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 79.61 -63.13 4.03 Favored Glycine 0 N--CA 1.5 2.956 0 N-CA-C 108.102 -1.999 . . . . 0.040000000000000001 108.102 -178.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 878' ' ' TYR . . . . . 0.417 ' CE2' ' HA3' ' C' ' 876' ' ' GLY . 89.4 m-85 60.76 -64.79 0.06 Allowed 'General case' 0 N--CA 1.502 2.146 0 N-CA-C 114.276 1.213 . . . . 3.46 114.276 177.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 879' ' ' TYR . . . . . 0.483 ' CE2' ' CD1' ' C' ' 981' ' ' PHE . 22.3 p90 -109.93 106.93 16.67 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 114.976 1.473 . . . . 0.040000000000000001 114.976 -176.203 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -69.64 119.22 69.58 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.401 -0.812 . . . . 0.02 109.759 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 881' ' ' PRO . . . . . 0.485 ' HG2' ' CD1' ' C' ' 868' ' ' PHE . 55.3 Cg_endo -79.26 -0.16 10.51 Favored 'Trans proline' 0 N--CA 1.487 1.132 0 O-C-N 123.363 1.191 . . . . 0.39000000000000001 111.563 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -76.31 -62.84 1.48 Allowed 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 106.433 -1.691 . . . . 0.81000000000000005 106.433 178.218 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 24.3 p -88.46 -21.87 23.98 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.136 -1.061 . . . . 0.040000000000000001 108.136 176.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 81.77 16.35 73.13 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 110.401 -1.079 . . . . 0.029999999999999999 110.401 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 84.4 t -73.93 91.91 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 C-N-CA 118.397 -1.321 . . . . 1.01 108.111 -179.151 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 886' ' ' PHE . . . . . 0.875 ' HB3' HG22 ' C' ' 962' ' ' VAL . 1.1 t80 -87.46 105.7 17.47 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 115.17 -0.923 . . . . 0.050000000000000003 111.628 -177.436 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 887' ' ' THR . . . . . 0.438 ' O ' ' HD3' ' C' ' 889' ' ' PRO . 86.7 m -102.45 99.72 9.79 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 107.806 -1.183 . . . . 0.68000000000000005 107.806 177.66 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 888' ' ' ALA . . . . . . . . . . . . . . . -98.66 101.19 11.14 Favored Pre-proline 0 N--CA 1.501 2.084 0 N-CA-C 114.388 1.255 . . . . 0.25 114.388 -176.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 889' ' ' PRO . . . . . 0.438 ' HD3' ' O ' ' C' ' 887' ' ' THR . 55.7 Cg_endo -80.06 -15.3 11.76 Favored 'Trans proline' 0 N--CA 1.486 1.042 0 N-CA-C 108.73 -1.296 . . . . 1.6399999999999999 108.73 175.555 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 890' ' ' LEU . . . . . 0.619 HD21 HG11 ' C' ' 850' ' ' VAL . 60.7 mt -37.35 -49.5 0.99 Allowed 'General case' 0 N--CA 1.508 2.425 0 N-CA-C 113.452 0.908 . . . . 2.29 113.452 -177.552 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 52.36 97.19 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.267 0 O-C-N 121.19 -0.944 . . . . 0.63 110.285 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . 158.94 -154.21 25.3 Favored Glycine 0 N--CA 1.477 1.422 0 N-CA-C 107.272 -2.331 . . . . 0.040000000000000001 107.272 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 74.5 ttt-85 -117.36 123.23 45.96 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.612 -0.934 . . . . 3.0 108.761 177.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 894' ' ' TYR . . . . . 0.761 ' CZ ' HD23 ' C' ' 954' ' ' LEU . 20.3 p90 -133.78 155.54 49.62 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.117 -0.989 . . . . 0.040000000000000001 110.956 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 895' ' ' LEU . . . . . . . . . . . . . 49.0 tp -97.82 115.41 28.0 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.719 -0.613 . . . . 1.27 110.268 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 896' ' ' LEU . . . . . 0.435 HD11 ' HE1' ' C' ' 981' ' ' PHE . 9.3 tt -118.36 144.6 45.77 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.654 -0.654 . . . . 0.93999999999999995 109.945 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 897' ' ' SER . . . . . . . . . . . . . 55.4 m -141.82 124.57 16.01 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.429 -0.795 . . . . 0.040000000000000001 111.284 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -101.89 148.17 25.64 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.789 -0.819 . . . . 0.47999999999999998 108.789 178.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 899' ' ' VAL . . . . . 0.705 HG21 ' HB ' ' C' ' 980' ' ' ILE . 87.4 t -92.49 120.31 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.35 -0.844 . . . . 0.55000000000000004 111.256 -179.037 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 94.6 mt -92.78 112.23 24.11 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 114.036 1.125 . . . . 1.5900000000000001 114.036 -175.646 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 20.7 m -63.48 140.4 58.87 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 107.472 -1.307 . . . . 0.050000000000000003 107.472 177.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -61.12 -65.23 3.42 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 110.344 -1.103 . . . . 0.029999999999999999 110.344 -179.312 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 45.86 64.39 1.48 Allowed 'General case' 0 N--CA 1.507 2.397 0 O-C-N 121.556 -0.967 . . . . 3.2000000000000002 111.239 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 42.7 ptt85 -67.68 -7.96 31.12 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.614 -0.679 . . . . 2.9199999999999999 111.83 -179.259 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 905' ' ' HIS . . . . . 0.493 ' O ' ' CB ' ' C' ' 906' ' ' GLU . 75.8 t60 -61.97 6.12 0.08 Allowed 'General case' 0 N--CA 1.506 2.342 0 CA-C-O 117.649 -1.167 . . . . 2.8700000000000001 113.468 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 906' ' ' GLU . . . . . 0.493 ' CB ' ' O ' ' C' ' 905' ' ' HIS . 0.8 OUTLIER 93.07 -163.45 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.441 0 CA-C-N 121.252 1.842 . . . . 0.98999999999999999 112.012 178.983 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 907' ' ' LYS . . . . . 0.493 ' CB ' ' O ' ' C' ' 906' ' ' GLU . 25.8 ttmt 89.9 161.91 0.05 OUTLIER 'General case' 0 N--CA 1.522 3.136 0 N-CA-C 108.061 -1.088 . . . . 5.25 108.061 -177.029 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 59.6 t -121.67 117.34 52.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 120.841 -1.162 . . . . 0.39000000000000001 110.915 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 909' ' ' GLU . . . . . 0.54 ' OE2' HD12 ' C' ' 966' ' ' LEU . 43.1 tp10 -104.5 130.91 52.4 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 107.486 -1.302 . . . . 1.72 107.486 177.083 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -157.18 121.13 4.24 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 106.887 -1.523 . . . . 0.67000000000000004 106.887 178.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 911' ' ' VAL . . . . . 0.739 HG22 HG13 ' C' ' 964' ' ' VAL . 97.8 t -83.42 132.06 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.784 -0.573 . . . . 0.54000000000000004 110.863 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 64.4 mt -66.18 157.41 31.4 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.478 -0.764 . . . . 1.5 109.243 178.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 913' ' ' SER . . . . . 0.417 ' CB ' ' CG1' ' C' ' 919' ' ' VAL . 2.2 t -125.4 137.96 54.02 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.212 -1.033 . . . . 1.3700000000000001 108.212 176.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 914' ' ' ARG . . . . . 0.891 ' NH1' HD23 ' C' ' 956' ' ' LEU . 0.0 OUTLIER -63.94 154.06 35.11 Favored 'General case' 0 N--CA 1.504 2.275 0 O-C-N 120.681 -1.262 . . . . 4.2999999999999998 111.88 -178.714 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 915' ' ' SER . . . . . 0.425 ' CB ' ' O ' ' C' ' 914' ' ' ARG . 4.0 t 83.06 -31.41 0.09 Allowed 'General case' 0 N--CA 1.521 3.124 0 C-N-CA 123.865 0.866 . . . . 2.0499999999999998 112.382 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 916' ' ' ASN . . . . . 0.618 ' HB2' HG21 ' C' ' 919' ' ' VAL . 94.5 m-20 -122.37 -21.72 5.72 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.785 -1.197 . . . . 2.71 111.252 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 917' ' ' GLN . . . . . 0.41 ' HB2' ' O ' ' C' ' 916' ' ' ASN . 46.5 mt-30 67.36 167.81 0.24 Allowed 'General case' 0 N--CA 1.52 3.044 0 N-CA-C 105.608 -1.997 . . . . 2.6800000000000002 105.608 -174.013 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.91 -127.47 41.08 Favored Glycine 1 N--CA 1.52 4.289 0 CA-C-N 123.589 2.904 . . . . 0.029999999999999999 107.022 -177.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 919' ' ' VAL . . . . . 0.618 HG21 ' HB2' ' C' ' 916' ' ' ASN . 92.6 t 50.54 94.53 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.233 0 O-C-N 121.466 -1.02 . . . . 1.3899999999999999 109.206 -178.283 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 920' ' ' ALA . . . . . 0.998 ' HB3' HG12 ' C' ' 949' ' ' VAL . . . -93.21 94.37 8.76 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.395 -0.922 . . . . 0.029999999999999999 110.943 -179.068 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 921' ' ' ARG . . . . . 0.694 ' HG3' HG23 ' C' ' 922' ' ' VAL . 40.7 ptt85 -81.36 -42.29 20.71 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 105.766 -1.938 . . . . 4.4199999999999999 105.766 176.178 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 922' ' ' VAL . . . . . 0.694 HG23 ' HG3' ' C' ' 921' ' ' ARG . 73.6 t -100.82 74.92 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 N-CA-C 105.523 -2.029 . . . . 0.84999999999999998 105.523 175.122 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -89.95 135.08 33.86 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.87 0.843 . . . . 2.46 112.315 -176.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 4.4 t -147.33 102.94 3.52 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.973 -1.121 . . . . 0.69999999999999996 107.973 178.5 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -110.08 89.84 0.56 Allowed Glycine 0 N--CA 1.488 2.105 0 N-CA-C 108.952 -1.659 . . . . 0.040000000000000001 108.952 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.33 0 N-CA-C 109.3 -1.52 . . . . 0.040000000000000001 109.3 -179.685 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 24.9 m . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 120.928 0.394 . . . . 13.779999999999999 110.355 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 95.6 mt -114.47 129.78 56.68 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.572 -0.705 . . . . 13.76 110.347 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -152.03 169.85 31.37 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.316 -1.514 . . . . 9.1300000000000008 109.316 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 949' ' ' VAL . . . . . 0.998 HG12 ' HB3' ' C' ' 920' ' ' ALA . 34.0 m -118.24 135.65 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.513 -0.993 . . . . 7.0800000000000001 110.985 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 950' ' ' PHE . . . . . 0.456 ' CZ ' ' HB3' ' C' ' 921' ' ' ARG . 49.4 p90 -134.76 151.92 51.35 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.524 -0.735 . . . . 7.5899999999999999 109.348 179.363 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 26.6 m -119.01 -55.26 2.18 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.375 -0.828 . . . . 5.0300000000000002 111.956 -178.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 952' ' ' LEU . . . . . 0.452 ' O ' ' O ' ' C' ' 953' ' ' ILE . 52.8 tp -63.15 -76.37 0.07 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.359 -0.838 . . . . 1.01 111.688 -178.039 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 953' ' ' ILE . . . . . 0.574 HD12 ' HD3' ' C' ' 955' ' ' PRO . 2.0 pp -49.12 -150.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.784 0 N-CA-C 114.699 1.37 . . . . 2.6000000000000001 114.699 -176.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 954' ' ' LEU . . . . . 0.761 HD23 ' CZ ' ' C' ' 894' ' ' TYR . 0.0 OUTLIER 170.99 89.14 0.04 OUTLIER Pre-proline 0 N--CA 1.516 2.836 0 O-C-N 120.74 -1.225 . . . . 0.050000000000000003 111.88 -179.477 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 955' ' ' PRO . . . . . 0.754 ' C ' HD12 ' C' ' 956' ' ' LEU . 50.9 Cg_endo -83.41 93.7 0.82 Allowed 'Trans proline' 0 C--N 1.317 -1.1 0 N-CA-C 109.419 -1.031 . . . . 0.83999999999999997 109.419 178.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 956' ' ' LEU . . . . . 0.891 HD23 ' NH1' ' C' ' 914' ' ' ARG . 7.9 mp -126.28 150.13 48.66 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.07 -1.019 . . . . 0.040000000000000001 110.772 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -83.16 151.81 25.54 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 117.743 -1.122 . . . . 1.28 111.518 -178.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -66.88 119.32 11.7 Favored 'General case' 0 N--CA 1.509 2.515 0 CA-C-N 123.022 2.647 . . . . 0.17000000000000001 111.213 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.72 -19.98 47.85 Favored Glycine 0 N--CA 1.499 2.882 0 N-CA-C 110.907 -0.877 . . . . 0.040000000000000001 110.907 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 960' ' ' ASP . . . . . 0.409 ' HB3' ' NE ' ' C' ' 914' ' ' ARG . 0.4 OUTLIER -54.44 170.58 0.15 Allowed 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.409 -1.054 . . . . 0.040000000000000001 110.353 -179.456 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 961' ' ' THR . . . . . 0.507 ' HA ' ' O ' ' C' ' 886' ' ' PHE . 39.3 m -136.93 141.0 42.66 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.989 -1.069 . . . . 1.78 112.614 -177.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 962' ' ' VAL . . . . . 0.875 HG22 ' HB3' ' C' ' 886' ' ' PHE . 27.3 m -99.88 145.18 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 C-N-CA 120.395 -0.522 . . . . 0.040000000000000001 110.696 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 5.2 t -137.53 143.85 41.84 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.828 -0.545 . . . . 0.71999999999999997 109.861 -178.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 964' ' ' VAL . . . . . 0.739 HG13 HG22 ' C' ' 911' ' ' VAL . 61.6 t -91.94 136.94 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.103 -0.998 . . . . 1.05 110.733 -178.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -93.68 126.37 38.81 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 103.566 -2.753 . . . . 3.02 103.566 173.295 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 966' ' ' LEU . . . . . 0.54 HD12 ' OE2' ' C' ' 909' ' ' GLU . 0.2 OUTLIER -133.63 59.23 1.74 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.662 -0.866 . . . . 1.46 108.662 177.503 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 967' ' ' VAL . . . . . 0.488 HG23 ' C ' ' C' ' 966' ' ' LEU . 99.5 t -157.8 96.31 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 108.327 -0.99 . . . . 1.9399999999999999 108.327 179.538 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 91.8 mmm -143.04 58.65 1.41 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.736 -1.227 . . . . 0.0 108.562 179.064 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 134.19 119.46 1.97 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 107.372 -2.291 . . . . 2.1099999999999999 107.372 -178.463 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 -82.76 -58.12 3.02 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.048 -1.266 . . . . 5.8899999999999997 110.662 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 46.3 tp -58.78 89.74 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.455 -0.778 . . . . 4.3600000000000003 110.449 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -143.33 -151.72 0.38 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.536 -0.727 . . . . 1.8300000000000001 110.011 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -117.0 167.03 11.5 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.352 -0.843 . . . . 4.3499999999999996 110.082 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 30.2 t -101.49 130.3 47.73 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.523 -0.736 . . . . 1.27 110.075 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -155.62 156.55 35.23 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.504 -0.747 . . . . 5.0199999999999996 110.525 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.76 84.82 17.53 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.679 -0.638 . . . . 2.4100000000000001 109.779 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 977' ' ' PRO . . . . . 0.55 ' C ' HD12 ' C' ' 978' ' ' LEU . 48.9 Cg_endo -74.49 -172.19 1.13 Allowed 'Trans proline' 0 C--N 1.316 -1.16 0 O-C-N 123.359 1.189 . . . . 0.95999999999999996 111.074 -179.502 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 978' ' ' LEU . . . . . 0.55 HD12 ' C ' ' C' ' 977' ' ' PRO . 6.3 mp -123.32 156.42 35.36 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.456 -1.312 . . . . 0.62 107.456 177.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 979' ' ' THR . . . . . 0.45 HG23 ' C ' ' C' ' 978' ' ' LEU . 47.6 p -149.33 141.49 23.99 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.733 -1.229 . . . . 3.5699999999999998 111.19 -179.269 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 980' ' ' ILE . . . . . 0.705 ' HB ' HG21 ' C' ' 899' ' ' VAL . 51.2 mm -105.8 128.22 60.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 108.974 -0.75 . . . . 1.3300000000000001 108.974 179.363 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 981' ' ' PHE . . . . . 0.483 ' CD1' ' CE2' ' C' ' 879' ' ' TYR . 3.3 t80 -117.95 95.76 5.05 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.394 -0.816 . . . . 0.050000000000000003 111.324 -178.623 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 982' ' ' SER . . . . . . . . . . . . . 11.6 p -108.18 158.43 17.45 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.599 -0.688 . . . . 0.87 109.213 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 983' ' ' GLY . . . . . 0.416 ' O ' ' CZ ' ' C' ' 852' ' ' PHE . . . -171.65 114.61 0.54 Allowed Glycine 0 N--CA 1.496 2.69 0 N-CA-C 106.648 -2.581 . . . . 0.029999999999999999 106.648 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 984' ' ' ALA . . . . . . . . . . . . . . . -108.92 151.57 26.11 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 114.213 1.19 . . . . 0.69999999999999996 114.213 -175.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 985' ' ' LEU . . . . . 0.586 HD13 HD22 ' C' ' 890' ' ' LEU . 55.4 tp -76.43 135.88 39.43 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.819 -1.176 . . . . 0.040000000000000001 109.701 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 986' ' ' LEU . . . . . 0.463 HD11 ' CD1' ' B' ' 986' ' ' LEU . 47.2 tp -106.75 -61.8 1.48 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.491 -0.756 . . . . 0.040000000000000001 110.36 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -144.13 146.67 32.92 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 107.786 -1.191 . . . . 0.040000000000000001 107.786 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.25 162.91 12.25 Favored Glycine 0 N--CA 1.495 2.616 0 N-CA-C 108.071 -2.012 . . . . 0.040000000000000001 108.071 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -74.95 112.76 19.31 Favored Pre-proline 0 N--CA 1.498 1.946 0 O-C-N 121.15 -1.206 . . . . 0.040000000000000001 109.48 179.214 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 990' ' ' PRO . . . . . 0.423 ' O ' ' HB2' ' C' ' 991' ' ' GLU . 50.2 Cg_endo -89.13 71.26 2.09 Favored 'Trans proline' 0 C--N 1.32 -0.967 0 O-C-N 123.108 1.057 . . . . 0.45000000000000001 111.291 -179.033 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 991' ' ' GLU . . . . . 0.423 ' HB2' ' O ' ' C' ' 990' ' ' PRO . 73.6 mt-10 67.52 -73.46 0.08 Allowed 'General case' 0 N--CA 1.503 2.182 0 N-CA-C 108.518 -0.919 . . . . 1.97 108.518 -177.486 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 992' ' ' LEU . . . . . 0.414 HD12 ' HD2' ' C' ' 990' ' ' PRO . 10.8 mt 50.48 20.73 0.73 Allowed 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.568 -0.707 . . . . 2.3799999999999999 111.748 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -93.47 156.75 16.57 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.878 -1.139 . . . . 3.79 110.044 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 68.7 m80 -145.64 92.65 2.25 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.509 -0.745 . . . . 3.5099999999999998 110.254 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 995' ' ' ALA . . . . . . . . . . . . 2.519 . . . . . . . 0 N--CA 1.504 2.249 0 O-C-N 120.968 -1.082 . . . . 2.73 110.637 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo . . . . . 0 N--CA 1.488 1.151 0 N-CA-C 109.491 -1.004 . . . . 3.8300000000000001 109.491 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 847' ' ' VAL . . . . . . . . . . . . . 59.0 t -133.78 102.68 12.32 Favored Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 121.546 -0.721 . . . . 1.8300000000000001 109.993 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 848' ' ' PRO . . . . . 0.757 ' O ' HG23 ' A' ' 850' ' ' VAL . 44.2 Cg_endo -69.79 -19.25 36.22 Favored 'Trans proline' 0 N--CA 1.487 1.114 0 O-C-N 123.316 1.166 . . . . 0.65000000000000002 111.272 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 849' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 27.91 68.09 0.07 Allowed 'General case' 0 N--CA 1.518 2.953 0 N-CA-C 112.901 0.704 . . . . 2.5800000000000001 112.901 179.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 850' ' ' VAL . . . . . 0.757 HG23 ' O ' ' A' ' 848' ' ' PRO . 65.3 t -119.65 137.01 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.148 -0.97 . . . . 1.0900000000000001 111.51 -178.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 851' ' ' ALA . . . . . 0.58 ' HB3' ' HG ' ' A' ' 873' ' ' LEU . . . -123.79 159.92 28.47 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 105.921 -1.881 . . . . 0.040000000000000001 105.921 176.776 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 852' ' ' PHE . . . . . 0.431 ' HA ' ' CB ' ' A' ' 874' ' ' ASN . 34.2 p90 -159.29 127.82 5.15 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 120.88 1.673 . . . . 0.050000000000000003 108.465 178.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 8.8 t -175.4 134.49 0.31 Allowed 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.185 -1.042 . . . . 0.040000000000000001 108.185 -178.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -130.24 156.92 43.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.03 -1.044 . . . . 0.67000000000000004 109.739 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 855' ' ' ALA . . . . . 0.843 ' HB3' ' CB ' ' A' ' 870' ' ' ARG . . . -119.76 144.11 47.45 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.806 0.813 . . . . 0.51000000000000001 110.809 -179.345 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 856' ' ' LEU . . . . . 0.677 HD13 ' N ' ' A' ' 857' ' ' SER . 2.1 tm? -115.21 134.23 55.33 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.508 -0.745 . . . . 0.050000000000000003 110.45 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 857' ' ' SER . . . . . 0.677 ' N ' HD13 ' A' ' 856' ' ' LEU . 1.7 m -156.74 14.41 0.28 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.486 -0.759 . . . . 1.3300000000000001 111.866 179.516 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 858' ' ' LEU . . . . . 0.557 ' HG ' HD11 ' A' ' 856' ' ' LEU . 0.3 OUTLIER -36.56 162.28 0.04 OUTLIER Pre-proline 0 N--CA 1.524 3.231 0 CA-C-N 119.053 0.842 . . . . 2.3300000000000001 113.07 -179.58 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -61.26 -89.31 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.534 0 O-C-N 123.103 1.054 . . . . 2.3199999999999998 113.841 -177.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 53.9 ptt85 -134.21 -142.42 0.2 Allowed 'General case' 0 N--CA 1.502 2.144 0 O-C-N 120.761 -1.212 . . . . 0.040000000000000001 111.787 -177.429 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 5.2 m -36.65 126.89 0.86 Allowed 'General case' 0 N--CA 1.511 2.612 0 O-C-N 121.659 -0.651 . . . . 1.3100000000000001 112.366 -178.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 862' ' ' GLU . . . . . 0.779 ' OE1' HG22 ' A' ' 866' ' ' VAL . 1.3 mt-10 -104.73 165.55 13.08 Favored Pre-proline 0 N--CA 1.489 1.496 0 N-CA-C 108.652 -0.87 . . . . 4.5099999999999998 108.652 177.594 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -73.54 -14.42 24.87 Favored 'Trans proline' 0 C--N 1.313 -1.311 0 O-C-N 123.284 1.149 . . . . 2.2400000000000002 111.388 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -177.93 -135.29 2.23 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 110.162 -1.175 . . . . 0.040000000000000001 110.162 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 26.4 m -64.71 156.65 29.69 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.41 -1.053 . . . . 1.51 110.912 -178.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 866' ' ' VAL . . . . . 0.779 HG22 ' OE1' ' A' ' 862' ' ' GLU . 56.2 t -96.95 132.79 25.22 Favored Pre-proline 0 N--CA 1.496 1.838 0 N-CA-C 113.453 0.908 . . . . 0.78000000000000003 113.453 -174.709 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 867' ' ' PRO . . . . . 0.443 ' O ' HD23 ' A' ' 856' ' ' LEU . 55.4 Cg_endo -90.68 -149.51 0.03 OUTLIER 'Trans proline' 0 CA--C 1.545 1.066 0 O-C-N 123.571 1.3 . . . . 0.92000000000000004 109.332 177.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 868' ' ' PHE . . . . . 0.466 ' CD1' ' N ' ' A' ' 868' ' ' PHE . 19.4 p90 -150.34 123.49 8.86 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.584 -1.322 . . . . 0.050000000000000003 109.837 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 49.9 p-10 -113.62 -2.68 13.74 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.129 -0.982 . . . . 1.7 112.841 -178.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 870' ' ' ARG . . . . . 0.843 ' CB ' ' HB3' ' A' ' 855' ' ' ALA . 28.2 mmm180 -91.58 89.9 7.37 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 120.819 -1.176 . . . . 2.5899999999999999 111.131 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 57.9 t -72.77 96.66 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 120.984 -1.072 . . . . 1.9399999999999999 109.694 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 872' ' ' LEU . . . . . 0.833 HD11 ' HB2' ' A' ' 855' ' ' ALA . 86.6 mt -83.32 -46.81 12.18 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.505 -0.747 . . . . 1.0600000000000001 110.164 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 873' ' ' LEU . . . . . 0.58 ' HG ' ' HB3' ' A' ' 851' ' ' ALA . 32.7 tp -174.33 102.35 0.1 Allowed 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 108.595 -0.891 . . . . 4.1799999999999997 108.595 178.58 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 874' ' ' ASN . . . . . 0.431 ' CB ' ' HA ' ' A' ' 852' ' ' PHE . 33.9 t-20 178.33 80.98 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.256 0 N-CA-C 109.264 -0.643 . . . . 0.040000000000000001 109.264 -179.005 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -65.41 -47.03 77.68 Favored 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 119.344 -0.942 . . . . 3.3799999999999999 111.129 -179.321 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 876' ' ' GLY . . . . . . . . . . . . . . . -73.97 -24.26 74.36 Favored Glycine 0 N--CA 1.494 2.55 0 O-C-N 121.316 -0.865 . . . . 0.040000000000000001 111.672 -178.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 84.41 -60.04 4.87 Favored Glycine 0 N--CA 1.502 3.099 0 N-CA-C 107.949 -2.06 . . . . 0.040000000000000001 107.949 -178.146 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 878' ' ' TYR . . . . . 0.4 ' CZ ' HG11 ' A' ' 850' ' ' VAL . 97.8 m-85 60.32 -66.63 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.14 0 N-CA-C 114.424 1.268 . . . . 3.46 114.424 177.732 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 879' ' ' TYR . . . . . 0.469 ' CB ' ' CD2' ' A' ' 886' ' ' PHE . 21.3 p90 -110.77 109.69 20.02 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 114.831 1.419 . . . . 0.040000000000000001 114.831 -176.235 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -66.0 117.08 38.97 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 121.534 -0.729 . . . . 0.02 110.191 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 881' ' ' PRO . . . . . 0.463 ' HG2' ' CD1' ' A' ' 868' ' ' PHE . 54.4 Cg_endo -75.88 0.39 9.31 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 O-C-N 123.413 1.217 . . . . 0.39000000000000001 112.222 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -75.35 -65.19 0.92 Allowed 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 106.952 -1.499 . . . . 0.81000000000000005 106.952 178.334 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 2.2 p -95.74 -17.0 21.57 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.802 -0.814 . . . . 0.040000000000000001 108.802 177.397 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.68 22.98 52.0 Favored Glycine 0 N--CA 1.494 2.533 0 C-N-CA 120.127 -1.035 . . . . 0.029999999999999999 110.664 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 885' ' ' VAL . . . . . . . . . . . . . 92.0 t -73.2 88.46 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 C-N-CA 118.357 -1.337 . . . . 1.01 107.917 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 886' ' ' PHE . . . . . 0.875 ' HB3' HG22 ' A' ' 962' ' ' VAL . 0.6 OUTLIER -89.13 106.38 18.4 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 115.04 -0.982 . . . . 0.050000000000000003 112.175 -177.053 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 887' ' ' THR . . . . . . . . . . . . . 97.0 m -98.85 99.16 10.2 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 107.495 -1.298 . . . . 0.68000000000000005 107.495 177.046 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 888' ' ' ALA . . . . . . . . . . . . . . . -97.25 108.11 42.39 Favored Pre-proline 0 N--CA 1.501 2.08 0 N-CA-C 114.207 1.188 . . . . 0.25 114.207 -176.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 889' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -89.39 -13.7 2.8 Favored 'Trans proline' 0 CA--C 1.546 1.076 0 O-C-N 123.288 1.152 . . . . 1.6399999999999999 109.137 176.185 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 890' ' ' LEU . . . . . 0.977 HD22 HD13 ' A' ' 985' ' ' LEU . 63.1 mt -35.93 -50.64 0.68 Allowed 'General case' 0 N--CA 1.509 2.508 0 N-CA-C 113.694 0.998 . . . . 2.29 113.694 -177.451 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 52.18 95.52 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.189 -0.945 . . . . 0.63 110.269 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 157.59 -154.09 25.23 Favored Glycine 0 N--CA 1.478 1.436 0 N-CA-C 107.055 -2.418 . . . . 0.040000000000000001 107.055 -179.233 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 893' ' ' ARG . . . . . 0.4 ' CZ ' ' CB ' ' C' ' 984' ' ' ALA . 71.0 ttt-85 -116.4 125.31 51.87 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.529 -0.983 . . . . 3.0 108.567 177.464 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 894' ' ' TYR . . . . . 0.825 ' OH ' HD12 ' A' ' 896' ' ' LEU . 0.1 OUTLIER -132.05 161.38 33.37 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.134 -0.979 . . . . 0.040000000000000001 111.084 -179.843 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 895' ' ' LEU . . . . . . . . . . . . . 43.6 tp -91.86 119.48 31.68 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.723 -0.611 . . . . 1.27 110.274 -179.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 896' ' ' LEU . . . . . 0.825 HD12 ' OH ' ' A' ' 894' ' ' TYR . 9.2 tt -110.18 144.42 38.85 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.742 -0.599 . . . . 0.93999999999999995 109.98 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 897' ' ' SER . . . . . 0.506 ' N ' HD23 ' A' ' 896' ' ' LEU . 69.2 m -149.45 114.66 5.47 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.51 -0.744 . . . . 0.040000000000000001 111.032 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.41 146.27 31.88 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.915 -0.772 . . . . 0.47999999999999998 108.915 178.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 899' ' ' VAL . . . . . 0.72 HG21 ' HB ' ' A' ' 980' ' ' ILE . 87.3 t -96.52 119.18 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 C-N-CA 119.566 -0.854 . . . . 0.55000000000000004 111.16 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 900' ' ' LEU . . . . . 0.641 HD12 ' HB2' ' A' ' 924' ' ' SER . 4.5 mm? -95.95 113.22 24.82 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 114.223 1.194 . . . . 1.5900000000000001 114.223 -175.107 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 18.3 m -65.38 140.92 58.69 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 107.551 -1.277 . . . . 0.050000000000000003 107.551 177.187 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -64.68 -65.31 3.03 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 110.573 -1.011 . . . . 0.029999999999999999 110.573 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 46.95 66.44 0.99 Allowed 'General case' 0 N--CA 1.507 2.42 0 O-C-N 121.515 -0.991 . . . . 3.2000000000000002 111.01 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 54.3 ptt85 -68.8 -6.49 27.04 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.618 -0.676 . . . . 2.9199999999999999 112.059 -179.123 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 905' ' ' HIS . . . . . 0.491 ' O ' ' CB ' ' A' ' 906' ' ' GLU . 73.0 t60 -62.64 5.16 0.13 Allowed 'General case' 0 N--CA 1.505 2.293 0 O-C-N 120.91 -1.119 . . . . 2.8700000000000001 113.11 -179.14 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 906' ' ' GLU . . . . . 0.491 ' CB ' ' O ' ' A' ' 905' ' ' HIS . 0.9 OUTLIER 95.35 -164.82 0.0 OUTLIER 'General case' 0 N--CA 1.529 3.478 0 CA-C-N 120.561 1.528 . . . . 0.98999999999999999 111.947 179.004 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 907' ' ' LYS . . . . . 0.468 ' CB ' ' O ' ' A' ' 906' ' ' GLU . 52.9 tttt 87.21 157.58 0.07 Allowed 'General case' 0 N--CA 1.52 3.039 0 N-CA-C 108.143 -1.058 . . . . 5.25 108.143 -176.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 60.9 t -122.28 117.85 53.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 120.857 -1.152 . . . . 0.39000000000000001 111.179 -179.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 909' ' ' GLU . . . . . 0.438 ' OE1' HD12 ' A' ' 966' ' ' LEU . 52.8 tp10 -98.82 134.09 42.2 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 107.35 -1.352 . . . . 1.72 107.35 176.612 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -156.46 122.69 5.0 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 107.028 -1.471 . . . . 0.67000000000000004 107.028 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 911' ' ' VAL . . . . . 0.721 HG22 HG13 ' A' ' 964' ' ' VAL . 93.8 t -85.15 131.17 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 C-N-CA 120.442 -0.503 . . . . 0.54000000000000004 111.108 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 88.3 mt -65.22 157.97 27.44 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.397 -0.814 . . . . 1.5 109.361 178.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 913' ' ' SER . . . . . 0.409 ' CB ' ' HB ' ' A' ' 919' ' ' VAL . 1.7 t -127.64 134.94 49.64 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.239 -1.023 . . . . 1.3700000000000001 108.239 176.733 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 914' ' ' ARG . . . . . 0.433 HH11 HG13 ' A' ' 962' ' ' VAL . 0.0 OUTLIER -65.12 155.11 35.92 Favored 'General case' 0 N--CA 1.506 2.358 0 O-C-N 120.577 -1.327 . . . . 4.2999999999999998 111.628 -179.128 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 915' ' ' SER . . . . . 0.42 ' CB ' ' O ' ' A' ' 914' ' ' ARG . 1.6 p 82.93 -31.14 0.09 Allowed 'General case' 0 N--CA 1.52 3.046 0 C-N-CA 123.852 0.861 . . . . 2.0499999999999998 112.222 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 916' ' ' ASN . . . . . 0.747 ' HB2' HG21 ' A' ' 919' ' ' VAL . 89.4 m-20 -122.63 -21.55 5.64 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.903 -1.123 . . . . 2.71 111.267 -179.262 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 917' ' ' GLN . . . . . 0.433 ' HB2' ' O ' ' A' ' 916' ' ' ASN . 58.9 mt-30 66.37 166.07 0.2 Allowed 'General case' 0 N--CA 1.519 3.018 0 N-CA-C 105.816 -1.92 . . . . 2.6800000000000002 105.816 -173.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.32 -125.32 33.65 Favored Glycine 1 N--CA 1.521 4.348 0 CA-C-N 123.472 2.851 . . . . 0.029999999999999999 106.98 -177.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 919' ' ' VAL . . . . . 0.747 HG21 ' HB2' ' A' ' 916' ' ' ASN . 77.0 t 51.51 94.9 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 O-C-N 121.39 -1.065 . . . . 1.3899999999999999 109.15 -178.243 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 920' ' ' ALA . . . . . 0.807 ' HB3' HG12 ' A' ' 949' ' ' VAL . . . -92.34 93.0 8.4 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.318 -0.953 . . . . 0.029999999999999999 110.818 -179.285 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 921' ' ' ARG . . . . . 0.851 ' HG3' HG23 ' A' ' 922' ' ' VAL . 23.1 ptt180 -84.15 -42.15 16.31 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 105.873 -1.899 . . . . 4.4199999999999999 105.873 176.119 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 922' ' ' VAL . . . . . 0.851 HG23 ' HG3' ' A' ' 921' ' ' ARG . 95.7 t -101.53 72.73 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 N-CA-C 105.94 -1.874 . . . . 0.84999999999999998 105.94 175.473 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -88.32 133.42 34.08 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.663 0.744 . . . . 2.46 111.502 -177.374 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 924' ' ' SER . . . . . 0.641 ' HB2' HD12 ' A' ' 900' ' ' LEU . 9.9 t -148.67 105.68 3.6 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.787 -0.82 . . . . 0.69999999999999996 108.787 179.144 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -101.56 82.67 0.47 Allowed Glycine 0 N--CA 1.487 2.037 0 N-CA-C 108.201 -1.96 . . . . 0.040000000000000001 108.201 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.211 0 N-CA-C 108.989 -1.644 . . . . 0.040000000000000001 108.989 -179.523 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 73.8 m . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 120.968 0.413 . . . . 13.779999999999999 110.31 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 96.7 mt -113.4 129.82 56.45 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.504 -0.747 . . . . 13.76 110.393 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -151.97 168.06 31.2 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.098 -1.601 . . . . 9.1300000000000008 109.098 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 949' ' ' VAL . . . . . 0.807 HG12 ' HB3' ' A' ' 920' ' ' ALA . 33.0 m -118.93 129.93 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.5 -1.0 . . . . 7.0800000000000001 110.916 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 950' ' ' PHE . . . . . 0.451 ' CE1' ' HD2' ' A' ' 955' ' ' PRO . 27.7 p90 -132.69 148.15 52.34 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.547 -0.721 . . . . 7.5899999999999999 109.212 179.376 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 58.5 m -121.15 -52.27 2.08 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.414 -0.804 . . . . 5.0300000000000002 112.103 -178.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 952' ' ' LEU . . . . . 0.414 ' O ' ' O ' ' A' ' 953' ' ' ILE . 20.5 tp -60.31 -73.67 0.09 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.446 -0.784 . . . . 1.01 112.403 -177.406 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 953' ' ' ILE . . . . . 0.662 HD11 HD13 ' C' ' 872' ' ' LEU . 47.9 pt -53.44 -143.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.738 0 N-CA-C 114.008 1.114 . . . . 2.6000000000000001 114.008 -176.61 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 954' ' ' LEU . . . . . 0.718 HD22 ' O ' ' A' ' 954' ' ' LEU . 0.0 OUTLIER 172.57 75.0 0.04 OUTLIER Pre-proline 0 N--CA 1.508 2.47 0 O-C-N 120.825 -1.172 . . . . 0.050000000000000003 111.01 179.635 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 955' ' ' PRO . . . . . 0.642 ' C ' HD12 ' A' ' 956' ' ' LEU . 47.9 Cg_endo -74.74 95.85 0.98 Allowed 'Trans proline' 0 C--N 1.315 -1.232 0 N-CA-C 109.702 -0.922 . . . . 0.83999999999999997 109.702 179.198 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 956' ' ' LEU . . . . . 0.642 HD12 ' C ' ' A' ' 955' ' ' PRO . 7.1 mp -125.1 149.88 47.4 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.179 -0.95 . . . . 0.040000000000000001 110.27 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -82.75 150.78 26.48 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 117.701 -1.142 . . . . 1.28 111.468 -179.154 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -68.36 119.48 12.94 Favored 'General case' 0 N--CA 1.51 2.553 0 CA-C-N 123.098 2.681 . . . . 0.17000000000000001 111.316 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.87 -21.87 37.1 Favored Glycine 0 N--CA 1.5 2.924 0 N-CA-C 110.829 -0.908 . . . . 0.040000000000000001 110.829 178.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 960' ' ' ASP . . . . . 0.42 ' HB3' ' CZ ' ' A' ' 914' ' ' ARG . 0.3 OUTLIER -54.13 172.27 0.09 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.504 -0.998 . . . . 0.040000000000000001 110.138 -179.598 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 961' ' ' THR . . . . . 0.485 ' HA ' ' O ' ' A' ' 886' ' ' PHE . 39.3 m -135.87 138.81 42.86 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.963 -1.085 . . . . 1.78 112.377 -178.032 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 962' ' ' VAL . . . . . 0.875 HG22 ' HB3' ' A' ' 886' ' ' PHE . 32.4 m -98.72 144.22 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 C-N-CA 120.149 -0.62 . . . . 0.040000000000000001 110.03 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 5.5 t -139.69 143.88 37.29 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.671 -0.643 . . . . 0.71999999999999997 109.914 -178.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 964' ' ' VAL . . . . . 0.721 HG13 HG22 ' A' ' 911' ' ' VAL . 59.1 t -95.0 137.19 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.097 -1.002 . . . . 1.05 110.699 -179.108 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -91.5 128.91 37.51 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 103.819 -2.66 . . . . 3.02 103.819 173.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 966' ' ' LEU . . . . . 0.487 ' C ' HG23 ' A' ' 967' ' ' VAL . 1.5 tp -131.33 59.71 1.68 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.162 -1.051 . . . . 1.46 108.162 177.246 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 967' ' ' VAL . . . . . 0.487 HG23 ' C ' ' A' ' 966' ' ' LEU . 97.8 t -158.16 96.54 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 108.096 -1.075 . . . . 1.9399999999999999 108.096 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 87.1 mmm -143.58 59.13 1.38 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.761 -1.212 . . . . 0.0 108.262 178.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 134.96 119.52 1.95 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 106.91 -2.476 . . . . 2.1099999999999999 106.91 -178.113 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -82.34 -58.24 3.02 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.039 -1.271 . . . . 5.8899999999999997 110.327 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 44.0 tp -58.86 90.81 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.406 -0.809 . . . . 4.3600000000000003 110.171 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -141.65 -154.56 0.53 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.614 -0.679 . . . . 1.8300000000000001 110.236 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -120.05 172.42 7.76 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.522 -0.736 . . . . 4.3499999999999996 110.268 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 38.6 t -101.37 130.05 47.48 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.576 -0.703 . . . . 1.27 109.946 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -156.03 157.74 36.64 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.527 -0.733 . . . . 5.0199999999999996 110.515 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.14 85.34 19.04 Favored Pre-proline 0 N--CA 1.5 2.035 0 O-C-N 121.652 -0.655 . . . . 2.4100000000000001 109.662 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 977' ' ' PRO . . . . . 0.6 ' C ' HD12 ' A' ' 978' ' ' LEU . 47.5 Cg_endo -72.81 -172.52 0.98 Allowed 'Trans proline' 0 C--N 1.317 -1.123 0 O-C-N 123.304 1.16 . . . . 0.95999999999999996 111.192 -179.406 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 978' ' ' LEU . . . . . 0.635 HD23 HD12 ' A' ' 856' ' ' LEU . 5.9 mp -128.04 154.24 45.88 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 107.575 -1.268 . . . . 0.62 107.575 177.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 979' ' ' THR . . . . . 0.462 HG23 ' C ' ' A' ' 978' ' ' LEU . 43.2 p -149.79 142.07 24.17 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.851 -1.156 . . . . 3.5699999999999998 111.185 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 980' ' ' ILE . . . . . 0.72 ' HB ' HG21 ' A' ' 899' ' ' VAL . 46.9 mm -105.87 127.76 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 108.708 -0.849 . . . . 1.3300000000000001 108.708 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 981' ' ' PHE . . . . . 0.46 ' HD1' ' HH ' ' A' ' 879' ' ' TYR . 7.3 t80 -120.26 97.73 5.72 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 119.641 -0.823 . . . . 0.050000000000000003 111.828 -178.427 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 59.2 p -107.86 158.66 17.15 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 109.114 -0.699 . . . . 0.87 109.114 178.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 983' ' ' GLY . . . . . 0.415 ' O ' ' CZ ' ' A' ' 852' ' ' PHE . . . -175.36 107.26 0.24 Allowed Glycine 0 N--CA 1.499 2.836 0 N-CA-C 106.354 -2.699 . . . . 0.029999999999999999 106.354 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -109.21 152.64 24.9 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 114.583 1.327 . . . . 0.69999999999999996 114.583 -175.273 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 985' ' ' LEU . . . . . 0.977 HD13 HD22 ' A' ' 890' ' ' LEU . 30.5 tp -72.23 134.2 45.49 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.887 -1.133 . . . . 0.040000000000000001 109.895 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 48.6 tp -107.9 -57.8 2.06 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.564 -0.71 . . . . 0.040000000000000001 110.208 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -144.28 145.35 31.97 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 107.592 -1.262 . . . . 0.040000000000000001 107.592 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.68 163.22 12.18 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 108.218 -1.953 . . . . 0.040000000000000001 108.218 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -74.43 112.7 18.36 Favored Pre-proline 0 N--CA 1.498 1.932 0 O-C-N 121.259 -1.142 . . . . 0.040000000000000001 109.468 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 990' ' ' PRO . . . . . 0.446 ' HD2' HD12 ' A' ' 992' ' ' LEU . 50.6 Cg_endo -89.2 70.89 2.11 Favored 'Trans proline' 0 C--N 1.319 -1.022 0 O-C-N 123.199 1.105 . . . . 0.45000000000000001 111.482 -178.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 991' ' ' GLU . . . . . 0.427 ' HB2' ' O ' ' A' ' 990' ' ' PRO . 77.2 mt-10 67.18 -73.91 0.07 Allowed 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 108.524 -0.917 . . . . 1.97 108.524 -177.449 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 992' ' ' LEU . . . . . 0.446 HD12 ' HD2' ' A' ' 990' ' ' PRO . 10.5 mt 51.19 20.7 0.93 Allowed 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.562 -0.711 . . . . 2.3799999999999999 111.532 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -93.3 157.11 16.41 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.933 -1.105 . . . . 3.79 110.044 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 71.5 m80 -146.85 92.64 2.16 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.515 -0.74 . . . . 3.5099999999999998 110.195 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 995' ' ' ALA . . . . . . . . . . . . 2.519 . . . . . . . 0 N--CA 1.503 2.2 0 O-C-N 120.904 -1.122 . . . . 2.73 110.599 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo . . . . . 0 N--CA 1.487 1.147 0 N-CA-C 109.506 -0.998 . . . . 3.8300000000000001 109.506 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 847' ' ' VAL . . . . . . . . . . . . . 58.9 t -133.85 102.69 12.24 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.619 -0.676 . . . . 1.8300000000000001 109.994 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 848' ' ' PRO . . . . . 0.761 ' O ' HG23 ' B' ' 850' ' ' VAL . 44.0 Cg_endo -69.68 -19.62 36.25 Favored 'Trans proline' 0 N--CA 1.488 1.152 0 O-C-N 123.279 1.147 . . . . 0.65000000000000002 111.245 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 849' ' ' GLN . . . . . 0.404 ' C ' ' O ' ' B' ' 848' ' ' PRO . 56.0 tt0 28.22 68.33 0.08 Allowed 'General case' 0 N--CA 1.518 2.931 0 N-CA-C 112.831 0.678 . . . . 2.5800000000000001 112.831 179.295 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 850' ' ' VAL . . . . . 0.761 HG23 ' O ' ' B' ' 848' ' ' PRO . 66.2 t -119.95 137.07 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.141 -0.974 . . . . 1.0900000000000001 111.445 -178.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 851' ' ' ALA . . . . . 0.596 ' HB3' ' HG ' ' B' ' 873' ' ' LEU . . . -124.15 159.15 30.68 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 105.945 -1.872 . . . . 0.040000000000000001 105.945 176.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 852' ' ' PHE . . . . . 0.426 ' HA ' ' CB ' ' B' ' 874' ' ' ASN . 33.5 p90 -158.56 128.09 5.73 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 120.943 1.702 . . . . 0.050000000000000003 108.344 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 7.9 t -175.48 134.18 0.3 Allowed 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.281 -1.007 . . . . 0.040000000000000001 108.281 -178.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -129.83 157.22 42.84 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.011 -1.056 . . . . 0.67000000000000004 109.824 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 855' ' ' ALA . . . . . 0.856 ' HB3' ' CB ' ' B' ' 870' ' ' ARG . . . -119.92 144.7 47.3 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.843 0.83 . . . . 0.51000000000000001 110.776 -179.288 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 856' ' ' LEU . . . . . 0.668 HD13 ' N ' ' B' ' 857' ' ' SER . 2.1 tm? -115.83 133.72 55.74 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.493 -0.754 . . . . 0.050000000000000003 110.542 -179.416 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 857' ' ' SER . . . . . 0.668 ' N ' HD13 ' B' ' 856' ' ' LEU . 1.8 m -156.4 14.45 0.31 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.459 -0.775 . . . . 1.3300000000000001 111.804 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 858' ' ' LEU . . . . . 0.558 ' HG ' HD11 ' B' ' 856' ' ' LEU . 0.3 OUTLIER -36.53 162.19 0.04 OUTLIER Pre-proline 0 N--CA 1.524 3.254 0 CA-C-N 119.052 0.842 . . . . 2.3300000000000001 113.074 -179.693 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -61.26 -89.38 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 120.947 1.098 . . . . 2.3199999999999998 113.804 -177.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 53.9 ptt85 -134.19 -142.46 0.2 Allowed 'General case' 0 N--CA 1.501 2.114 0 O-C-N 120.802 -1.186 . . . . 0.040000000000000001 111.815 -177.387 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 5.2 m -36.56 126.46 0.84 Allowed 'General case' 0 N--CA 1.512 2.645 0 O-C-N 121.671 -0.643 . . . . 1.3100000000000001 112.373 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 862' ' ' GLU . . . . . 0.787 ' OE1' HG22 ' B' ' 866' ' ' VAL . 1.3 mt-10 -104.34 165.67 12.95 Favored Pre-proline 0 N--CA 1.488 1.451 0 N-CA-C 108.637 -0.875 . . . . 4.5099999999999998 108.637 177.578 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -73.45 -14.57 25.11 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 O-C-N 123.294 1.155 . . . . 2.2400000000000002 111.396 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -177.68 -133.75 1.91 Allowed Glycine 0 N--CA 1.495 2.592 0 N-CA-C 110.184 -1.167 . . . . 0.040000000000000001 110.184 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 27.1 m -66.07 157.64 30.54 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.351 -1.088 . . . . 1.51 110.733 -178.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 866' ' ' VAL . . . . . 0.787 HG22 ' OE1' ' B' ' 862' ' ' GLU . 56.9 t -97.73 132.71 24.49 Favored Pre-proline 0 N--CA 1.496 1.833 0 N-CA-C 113.402 0.89 . . . . 0.78000000000000003 113.402 -174.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 867' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' B' ' 866' ' ' VAL . 55.2 Cg_endo -90.71 -149.73 0.03 OUTLIER 'Trans proline' 0 CA--C 1.544 1.02 0 C-N-CA 121.219 1.279 . . . . 0.92000000000000004 109.356 177.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 868' ' ' PHE . . . . . 0.469 ' CD1' ' HG2' ' B' ' 881' ' ' PRO . 19.4 p90 -150.19 123.25 8.82 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.493 -1.379 . . . . 0.050000000000000003 109.858 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 50.2 p-10 -113.35 -2.32 14.02 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.101 -1.0 . . . . 1.7 112.786 -178.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 870' ' ' ARG . . . . . 0.856 ' CB ' ' HB3' ' B' ' 855' ' ' ALA . 28.0 mmm180 -91.74 89.79 7.24 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.861 -1.149 . . . . 2.5899999999999999 111.167 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 57.5 t -72.9 96.75 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 120.978 -1.077 . . . . 1.9399999999999999 109.669 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 872' ' ' LEU . . . . . 0.844 HD11 ' HB2' ' B' ' 855' ' ' ALA . 87.1 mt -83.56 -46.66 12.15 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.508 -0.745 . . . . 1.0600000000000001 110.117 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 873' ' ' LEU . . . . . 0.596 ' HG ' ' HB3' ' B' ' 851' ' ' ALA . 32.6 tp -174.31 102.25 0.1 Allowed 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.583 -0.895 . . . . 4.1799999999999997 108.583 178.619 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 874' ' ' ASN . . . . . 0.426 ' CB ' ' HA ' ' B' ' 852' ' ' PHE . 33.8 t-20 178.36 81.08 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.664 -0.647 . . . . 0.040000000000000001 109.371 -179.067 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -65.5 -47.1 77.17 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 119.349 -0.941 . . . . 3.3799999999999999 111.102 -179.293 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 876' ' ' GLY . . . . . . . . . . . . . . . -73.98 -24.27 74.3 Favored Glycine 0 N--CA 1.493 2.477 0 O-C-N 121.285 -0.884 . . . . 0.040000000000000001 111.687 -178.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 84.41 -59.95 4.88 Favored Glycine 0 N--CA 1.502 3.069 0 N-CA-C 107.948 -2.061 . . . . 0.040000000000000001 107.948 -178.15 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 878' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 60.41 -66.68 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 114.474 1.287 . . . . 3.46 114.474 177.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 879' ' ' TYR . . . . . 0.471 ' CB ' ' CD2' ' B' ' 886' ' ' PHE . 21.3 p90 -110.78 109.62 19.91 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 114.785 1.402 . . . . 0.040000000000000001 114.785 -176.242 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -65.94 117.06 38.54 Favored Pre-proline 0 N--CA 1.496 1.847 0 O-C-N 121.557 -0.715 . . . . 0.02 110.117 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 881' ' ' PRO . . . . . 0.469 ' HG2' ' CD1' ' B' ' 868' ' ' PHE . 53.8 Cg_endo -75.78 0.23 9.45 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 O-C-N 123.477 1.251 . . . . 0.39000000000000001 112.252 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -75.26 -65.23 0.91 Allowed 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 106.953 -1.499 . . . . 0.81000000000000005 106.953 178.369 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 2.2 p -95.87 -16.53 21.74 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.88 -0.785 . . . . 0.040000000000000001 108.88 177.434 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.2 23.34 52.02 Favored Glycine 0 N--CA 1.493 2.489 0 C-N-CA 120.069 -1.063 . . . . 0.029999999999999999 110.719 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 885' ' ' VAL . . . . . . . . . . . . . 92.6 t -73.56 88.7 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 C-N-CA 118.392 -1.323 . . . . 1.01 107.806 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 886' ' ' PHE . . . . . 0.897 ' HB3' HG22 ' B' ' 962' ' ' VAL . 0.6 OUTLIER -89.36 106.28 18.34 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 115.121 -0.945 . . . . 0.050000000000000003 112.234 -177.12 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 887' ' ' THR . . . . . . . . . . . . . 96.9 m -98.67 99.44 10.56 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 107.493 -1.299 . . . . 0.68000000000000005 107.493 176.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 888' ' ' ALA . . . . . . . . . . . . . . . -97.52 108.13 43.31 Favored Pre-proline 0 N--CA 1.502 2.134 0 N-CA-C 114.119 1.155 . . . . 0.25 114.119 -176.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 889' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -89.37 -13.85 2.77 Favored 'Trans proline' 0 CA--C 1.546 1.091 0 N-CA-C 109.135 -1.14 . . . . 1.6399999999999999 109.135 176.147 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 890' ' ' LEU . . . . . 1.004 HD22 HD13 ' B' ' 985' ' ' LEU . 62.9 mt -35.73 -50.64 0.64 Allowed 'General case' 0 N--CA 1.509 2.497 0 N-CA-C 113.68 0.992 . . . . 2.29 113.68 -177.473 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 52.1 95.44 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.154 -0.966 . . . . 0.63 110.338 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . 157.65 -154.16 25.28 Favored Glycine 0 N--CA 1.478 1.491 0 N-CA-C 107.085 -2.406 . . . . 0.040000000000000001 107.085 -179.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 71.7 ttt-85 -116.34 125.26 51.85 Favored 'General case' 0 C--N 1.294 -1.807 0 O-C-N 121.564 -0.963 . . . . 3.0 108.511 177.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 894' ' ' TYR . . . . . 0.821 ' OH ' HD12 ' B' ' 896' ' ' LEU . 0.1 OUTLIER -131.9 161.63 32.56 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.082 -1.011 . . . . 0.040000000000000001 111.113 -179.854 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 895' ' ' LEU . . . . . . . . . . . . . 43.3 tp -92.27 119.32 31.75 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.681 -0.637 . . . . 1.27 110.355 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 896' ' ' LEU . . . . . 0.821 HD12 ' OH ' ' B' ' 894' ' ' TYR . 9.1 tt -110.11 143.87 39.55 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.725 -0.609 . . . . 0.93999999999999995 110.053 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 897' ' ' SER . . . . . 0.505 ' N ' HD23 ' B' ' 896' ' ' LEU . 68.7 m -148.81 114.5 5.66 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.426 -0.796 . . . . 0.040000000000000001 111.098 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.23 145.99 31.97 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.011 -0.737 . . . . 0.47999999999999998 109.011 178.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 899' ' ' VAL . . . . . 0.711 HG21 ' HB ' ' B' ' 980' ' ' ILE . 88.4 t -96.22 119.07 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.356 -0.84 . . . . 0.55000000000000004 111.245 -179.228 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 900' ' ' LEU . . . . . 0.655 HD12 ' HB2' ' B' ' 924' ' ' SER . 4.5 mm? -95.97 112.7 24.36 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 114.288 1.218 . . . . 1.5900000000000001 114.288 -175.02 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 18.1 m -64.94 140.79 58.9 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 107.531 -1.285 . . . . 0.050000000000000003 107.531 177.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -64.83 -65.26 3.04 Favored Glycine 0 N--CA 1.494 2.515 0 N-CA-C 110.639 -0.985 . . . . 0.029999999999999999 110.639 -179.303 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 46.89 66.64 0.94 Allowed 'General case' 0 N--CA 1.507 2.411 0 O-C-N 121.472 -1.017 . . . . 3.2000000000000002 110.964 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 54.3 ptt85 -68.85 -6.78 29.05 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.639 -0.663 . . . . 2.9199999999999999 112.073 -179.091 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 905' ' ' HIS . . . . . 0.488 ' O ' ' CB ' ' B' ' 906' ' ' GLU . 72.8 t60 -62.08 4.74 0.12 Allowed 'General case' 0 N--CA 1.505 2.323 0 O-C-N 120.876 -1.14 . . . . 2.8700000000000001 113.111 -179.132 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 906' ' ' GLU . . . . . 0.488 ' CB ' ' O ' ' B' ' 905' ' ' HIS . 0.9 OUTLIER 95.62 -164.94 0.0 OUTLIER 'General case' 0 N--CA 1.53 3.549 0 CA-C-N 120.612 1.551 . . . . 0.98999999999999999 111.781 179.1 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 907' ' ' LYS . . . . . 0.47 ' CB ' ' O ' ' B' ' 906' ' ' GLU . 53.3 tttt 87.31 157.28 0.07 Allowed 'General case' 0 N--CA 1.52 3.073 0 N-CA-C 108.132 -1.062 . . . . 5.25 108.132 -177.063 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 60.9 t -122.08 117.5 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 120.894 -1.129 . . . . 0.39000000000000001 111.243 -179.153 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 909' ' ' GLU . . . . . 0.429 ' OE1' HD12 ' B' ' 966' ' ' LEU . 52.8 tp10 -98.33 134.37 41.43 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 107.333 -1.358 . . . . 1.72 107.333 176.574 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -156.83 122.8 4.85 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 106.992 -1.484 . . . . 0.67000000000000004 106.992 178.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 911' ' ' VAL . . . . . 0.706 HG22 HG13 ' B' ' 964' ' ' VAL . 94.9 t -85.34 131.54 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.906 -0.496 . . . . 0.54000000000000004 111.061 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 88.2 mt -65.44 158.13 27.6 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.362 -0.836 . . . . 1.5 109.359 178.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 913' ' ' SER . . . . . 0.411 ' CB ' ' CG1' ' B' ' 919' ' ' VAL . 1.8 t -127.97 134.39 49.28 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.274 -1.01 . . . . 1.3700000000000001 108.274 176.766 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 914' ' ' ARG . . . . . 0.421 HH11 HG13 ' B' ' 962' ' ' VAL . 0.0 OUTLIER -64.51 155.05 34.11 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 120.577 -1.327 . . . . 4.2999999999999998 111.685 -179.067 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 915' ' ' SER . . . . . 0.411 ' CB ' ' O ' ' B' ' 914' ' ' ARG . 1.6 p 83.05 -31.44 0.09 Allowed 'General case' 0 N--CA 1.521 3.093 0 C-N-CA 123.84 0.856 . . . . 2.0499999999999998 112.224 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 916' ' ' ASN . . . . . 0.785 ' HB2' HG21 ' B' ' 919' ' ' VAL . 89.2 m-20 -122.25 -21.91 5.73 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.92 -1.112 . . . . 2.71 111.288 -179.247 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 917' ' ' GLN . . . . . 0.433 ' HB2' ' O ' ' B' ' 916' ' ' ASN . 58.5 mt-30 66.5 165.43 0.2 Allowed 'General case' 0 N--CA 1.52 3.029 0 N-CA-C 105.782 -1.933 . . . . 2.6800000000000002 105.782 -174.012 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 55.05 -125.38 35.58 Favored Glycine 1 N--CA 1.52 4.268 0 CA-C-N 123.478 2.854 . . . . 0.029999999999999999 106.858 -177.566 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 919' ' ' VAL . . . . . 0.785 HG21 ' HB2' ' B' ' 916' ' ' ASN . 80.5 t 51.44 94.91 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.233 0 O-C-N 121.419 -1.047 . . . . 1.3899999999999999 109.189 -178.271 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 920' ' ' ALA . . . . . 0.805 ' HB3' HG12 ' B' ' 949' ' ' VAL . . . -92.4 92.85 8.3 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.324 -0.951 . . . . 0.029999999999999999 110.823 -179.286 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 921' ' ' ARG . . . . . 0.842 ' HG3' HG23 ' B' ' 922' ' ' VAL . 23.2 ptt180 -84.12 -42.11 16.4 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 105.885 -1.894 . . . . 4.4199999999999999 105.885 176.163 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 922' ' ' VAL . . . . . 0.842 HG23 ' HG3' ' B' ' 921' ' ' ARG . 95.7 t -101.52 72.64 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 N-CA-C 105.92 -1.882 . . . . 0.84999999999999998 105.92 175.523 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -88.19 133.47 34.02 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.615 0.721 . . . . 2.46 111.495 -177.397 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 924' ' ' SER . . . . . 0.655 ' HB2' HD12 ' B' ' 900' ' ' LEU . 9.9 t -148.68 105.72 3.6 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.76 -0.829 . . . . 0.69999999999999996 108.76 179.094 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -101.5 82.62 0.47 Allowed Glycine 0 N--CA 1.487 2.049 0 N-CA-C 108.176 -1.97 . . . . 0.040000000000000001 108.176 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.143 0 N-CA-C 109.026 -1.629 . . . . 0.040000000000000001 109.026 -179.562 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 76.9 m . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.016 0.436 . . . . 13.779999999999999 110.215 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 96.7 mt -112.24 129.87 56.12 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.546 -0.722 . . . . 13.76 110.4 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -151.65 167.5 30.96 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.153 -1.579 . . . . 9.1300000000000008 109.153 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 949' ' ' VAL . . . . . 0.805 HG12 ' HB3' ' B' ' 920' ' ' ALA . 32.1 m -118.69 129.85 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.548 -0.972 . . . . 7.0800000000000001 110.845 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 950' ' ' PHE . . . . . 0.454 ' CE1' ' HD2' ' B' ' 955' ' ' PRO . 27.9 p90 -132.74 148.17 52.33 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.586 -0.696 . . . . 7.5899999999999999 109.267 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 58.5 m -121.16 -51.92 2.09 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.452 -0.78 . . . . 5.0300000000000002 112.13 -178.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 952' ' ' LEU . . . . . 0.43 HD12 ' HA ' ' B' ' 952' ' ' LEU . 20.3 tp -60.52 -73.88 0.08 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.396 -0.815 . . . . 1.01 112.347 -177.528 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 953' ' ' ILE . . . . . 0.486 ' O ' ' HB3' ' B' ' 954' ' ' LEU . 49.3 pt -53.18 -143.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.754 0 N-CA-C 114.082 1.141 . . . . 2.6000000000000001 114.082 -176.569 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 954' ' ' LEU . . . . . 0.723 HD22 ' O ' ' B' ' 954' ' ' LEU . 0.0 OUTLIER 172.31 74.69 0.04 OUTLIER Pre-proline 0 N--CA 1.509 2.496 0 O-C-N 120.793 -1.192 . . . . 0.050000000000000003 110.955 179.68 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 955' ' ' PRO . . . . . 0.646 ' C ' HD12 ' B' ' 956' ' ' LEU . 48.1 Cg_endo -74.64 95.95 0.97 Allowed 'Trans proline' 0 C--N 1.315 -1.218 0 N-CA-C 109.714 -0.918 . . . . 0.83999999999999997 109.714 179.165 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 956' ' ' LEU . . . . . 0.646 HD12 ' C ' ' B' ' 955' ' ' PRO . 7.1 mp -125.23 149.88 47.56 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.232 -0.917 . . . . 0.040000000000000001 110.258 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -82.78 150.94 26.35 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 117.824 -1.084 . . . . 1.28 111.375 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -68.42 119.15 12.44 Favored 'General case' 0 N--CA 1.509 2.492 0 CA-C-N 122.913 2.597 . . . . 0.17000000000000001 111.389 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 93.07 -21.92 37.31 Favored Glycine 0 N--CA 1.5 2.942 0 N-CA-C 110.792 -0.923 . . . . 0.040000000000000001 110.792 178.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 960' ' ' ASP . . . . . 0.417 ' HB3' ' CZ ' ' B' ' 914' ' ' ARG . 0.3 OUTLIER -54.02 172.38 0.08 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.473 -1.016 . . . . 0.040000000000000001 110.166 -179.602 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 961' ' ' THR . . . . . 0.492 ' HA ' ' O ' ' B' ' 886' ' ' PHE . 38.8 m -135.83 139.03 43.13 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.942 -1.099 . . . . 1.78 112.338 -178.074 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 962' ' ' VAL . . . . . 0.897 HG22 ' HB3' ' B' ' 886' ' ' PHE . 32.2 m -99.09 144.02 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 C-N-CA 120.112 -0.635 . . . . 0.040000000000000001 110.032 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 5.4 t -139.37 143.88 37.93 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.682 -0.636 . . . . 0.71999999999999997 109.982 -178.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 964' ' ' VAL . . . . . 0.706 HG13 HG22 ' B' ' 911' ' ' VAL . 59.0 t -95.2 137.02 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.208 -0.933 . . . . 1.05 110.696 -179.141 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -91.51 128.43 37.34 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 103.898 -2.631 . . . . 3.02 103.898 173.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 966' ' ' LEU . . . . . 0.485 ' C ' HG23 ' B' ' 967' ' ' VAL . 1.5 tp -130.9 59.89 1.66 Allowed 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.228 -1.027 . . . . 1.46 108.228 177.345 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 967' ' ' VAL . . . . . 0.485 HG23 ' C ' ' B' ' 966' ' ' LEU . 98.3 t -158.27 96.47 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 108.08 -1.081 . . . . 1.9399999999999999 108.08 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 87.1 mmm -143.49 58.95 1.39 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.804 -1.185 . . . . 0.0 108.265 178.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 134.99 119.38 1.93 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 107.111 -2.396 . . . . 2.1099999999999999 107.111 -178.212 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -82.07 -58.22 3.06 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.085 -1.244 . . . . 5.8899999999999997 110.338 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 44.2 tp -58.97 90.57 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.377 -0.827 . . . . 4.3600000000000003 110.19 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -141.47 -154.63 0.53 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.589 -0.694 . . . . 1.8300000000000001 110.27 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -119.95 172.54 7.65 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.455 -0.778 . . . . 4.3499999999999996 110.275 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 38.6 t -101.56 130.02 47.77 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.525 -0.734 . . . . 1.27 109.961 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -155.99 157.74 36.7 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.474 -0.767 . . . . 5.0199999999999996 110.495 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.15 85.33 19.0 Favored Pre-proline 0 N--CA 1.5 2.05 0 O-C-N 121.633 -0.667 . . . . 2.4100000000000001 109.622 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 977' ' ' PRO . . . . . 0.601 ' C ' HD12 ' B' ' 978' ' ' LEU . 47.6 Cg_endo -72.82 -172.59 0.99 Allowed 'Trans proline' 0 C--N 1.317 -1.083 0 O-C-N 123.282 1.148 . . . . 0.95999999999999996 111.219 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 978' ' ' LEU . . . . . 0.647 HD23 HD12 ' B' ' 856' ' ' LEU . 5.9 mp -127.82 154.51 45.36 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.653 -1.24 . . . . 0.62 107.653 177.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 979' ' ' THR . . . . . 0.467 HG23 ' C ' ' B' ' 978' ' ' LEU . 42.8 p -150.03 142.08 23.96 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.842 -1.161 . . . . 3.5699999999999998 111.142 -179.277 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 980' ' ' ILE . . . . . 0.711 ' HB ' HG21 ' B' ' 899' ' ' VAL . 46.8 mm -105.99 127.4 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 108.732 -0.84 . . . . 1.3300000000000001 108.732 179.276 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 981' ' ' PHE . . . . . 0.451 ' HD1' ' HH ' ' B' ' 879' ' ' TYR . 7.3 t80 -120.0 98.0 5.88 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 119.649 -0.821 . . . . 0.050000000000000003 111.746 -178.323 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 53.8 p -108.4 158.81 17.18 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 109.154 -0.684 . . . . 0.87 109.154 178.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 983' ' ' GLY . . . . . 0.411 ' HA3' ' CE1' ' B' ' 852' ' ' PHE . . . -175.25 107.41 0.24 Allowed Glycine 0 N--CA 1.498 2.821 0 N-CA-C 106.469 -2.652 . . . . 0.029999999999999999 106.469 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -109.16 152.53 25.0 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 114.587 1.328 . . . . 0.69999999999999996 114.587 -175.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 985' ' ' LEU . . . . . 1.004 HD13 HD22 ' B' ' 890' ' ' LEU . 30.5 tp -72.24 134.1 45.43 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.93 -1.106 . . . . 0.040000000000000001 109.805 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 986' ' ' LEU . . . . . 0.524 ' CD1' HD11 ' C' ' 986' ' ' LEU . 48.1 tp -107.82 -57.79 2.05 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.541 -0.725 . . . . 0.040000000000000001 110.259 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -144.31 145.23 31.87 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.621 -1.252 . . . . 0.040000000000000001 107.621 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.49 163.07 12.2 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 108.255 -1.938 . . . . 0.040000000000000001 108.255 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -74.27 112.72 18.23 Favored Pre-proline 0 N--CA 1.498 1.956 0 O-C-N 121.204 -1.174 . . . . 0.040000000000000001 109.442 179.218 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 990' ' ' PRO . . . . . 0.444 ' HD2' HD12 ' B' ' 992' ' ' LEU . 50.0 Cg_endo -89.2 71.04 2.09 Favored 'Trans proline' 0 C--N 1.319 -0.985 0 O-C-N 123.093 1.049 . . . . 0.45000000000000001 111.459 -178.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 991' ' ' GLU . . . . . 0.423 ' HB2' ' O ' ' B' ' 990' ' ' PRO . 77.3 mt-10 67.0 -73.84 0.07 Allowed 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 108.603 -0.888 . . . . 1.97 108.603 -177.453 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 992' ' ' LEU . . . . . 0.451 ' HA ' HD23 ' B' ' 992' ' ' LEU . 10.6 mt 51.29 20.4 0.93 Allowed 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.614 -0.679 . . . . 2.3799999999999999 111.634 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -92.95 157.13 16.49 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.869 -1.144 . . . . 3.79 110.055 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 71.2 m80 -146.91 92.1 2.09 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.511 -0.743 . . . . 3.5099999999999998 110.329 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 995' ' ' ALA . . . . . . . . . . . . 2.52 . . . . . . . 0 N--CA 1.503 2.208 0 O-C-N 120.886 -1.134 . . . . 2.73 110.655 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo . . . . . 0 N--CA 1.488 1.154 0 N-CA-C 109.496 -1.001 . . . . 3.8300000000000001 109.496 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 847' ' ' VAL . . . . . 0.409 HG12 ' HB2' ' C' ' 849' ' ' GLN . 61.8 t -128.75 103.89 19.09 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.579 -0.7 . . . . 1.8300000000000001 110.093 -179.622 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 848' ' ' PRO . . . . . 0.777 ' O ' HG23 ' C' ' 850' ' ' VAL . 44.3 Cg_endo -70.34 -22.23 29.68 Favored 'Trans proline' 0 N--CA 1.488 1.185 0 O-C-N 123.285 1.15 . . . . 0.65000000000000002 111.254 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 849' ' ' GLN . . . . . 0.409 ' HB2' HG12 ' C' ' 847' ' ' VAL . 57.2 tt0 26.88 68.79 0.06 Allowed 'General case' 0 N--CA 1.519 2.998 0 N-CA-C 112.92 0.711 . . . . 2.5800000000000001 112.92 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 850' ' ' VAL . . . . . 0.777 HG23 ' O ' ' C' ' 848' ' ' PRO . 94.3 t -119.76 135.4 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.129 -0.982 . . . . 1.0900000000000001 111.57 -178.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 851' ' ' ALA . . . . . 0.592 ' HB3' ' HG ' ' C' ' 873' ' ' LEU . . . -127.86 155.53 43.98 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 105.795 -1.928 . . . . 0.040000000000000001 105.795 176.54 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 852' ' ' PHE . . . . . 0.454 ' CD1' ' N ' ' C' ' 852' ' ' PHE . 13.6 p90 -159.61 127.79 4.94 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 121.018 1.736 . . . . 0.050000000000000003 108.522 178.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 12.1 t -176.51 134.37 0.23 Allowed 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.246 -1.02 . . . . 0.040000000000000001 108.246 -178.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 854' ' ' ALA . . . . . 0.492 ' HB1' ' HD2' ' C' ' 868' ' ' PHE . . . -132.84 156.76 46.56 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.142 -0.974 . . . . 0.67000000000000004 109.693 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 855' ' ' ALA . . . . . 0.762 ' HB3' ' CB ' ' C' ' 870' ' ' ARG . . . -122.96 140.95 52.47 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 122.035 0.921 . . . . 0.51000000000000001 111.419 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 856' ' ' LEU . . . . . 0.618 HD13 ' N ' ' C' ' 857' ' ' SER . 3.5 tm? -113.39 137.71 51.13 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.687 -0.633 . . . . 0.050000000000000003 109.936 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 857' ' ' SER . . . . . 0.618 ' N ' HD13 ' C' ' 856' ' ' LEU . 1.9 m -157.08 19.25 0.3 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.548 -0.72 . . . . 1.3300000000000001 111.084 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 858' ' ' LEU . . . . . 0.705 HD22 ' HG3' ' C' ' 862' ' ' GLU . 4.1 pp -35.54 160.26 0.04 OUTLIER Pre-proline 0 N--CA 1.517 2.886 0 N-CA-C 112.729 0.64 . . . . 2.3300000000000001 112.729 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -59.25 -88.9 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.455 0 O-C-N 122.99 0.995 . . . . 2.3199999999999998 113.386 -177.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 54.5 ptt85 -129.26 -142.56 0.25 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.883 -1.136 . . . . 0.040000000000000001 111.635 -177.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 9.9 m -36.57 126.65 0.84 Allowed 'General case' 0 N--CA 1.51 2.536 0 O-C-N 121.61 -0.681 . . . . 1.3100000000000001 112.634 -178.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 862' ' ' GLU . . . . . 0.705 ' HG3' HD22 ' C' ' 858' ' ' LEU . 0.0 OUTLIER -100.76 159.28 30.03 Favored Pre-proline 0 N--CA 1.489 1.514 0 N-CA-C 108.177 -1.046 . . . . 4.5099999999999998 108.177 177.506 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -71.93 -14.1 29.3 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 O-C-N 123.11 1.058 . . . . 2.2400000000000002 111.523 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -177.72 -136.35 2.47 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 110.04 -1.224 . . . . 0.040000000000000001 110.04 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 25.7 m -65.37 154.85 37.17 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.355 -1.085 . . . . 1.51 110.247 -179.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 866' ' ' VAL . . . . . 0.464 ' HA ' ' HD3' ' C' ' 867' ' ' PRO . 20.7 t -95.62 138.68 21.77 Favored Pre-proline 0 N--CA 1.496 1.874 0 N-CA-C 113.917 1.08 . . . . 0.78000000000000003 113.917 -174.303 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 867' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' C' ' 866' ' ' VAL . 55.3 Cg_endo -94.07 -151.33 0.03 OUTLIER 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 121.417 1.412 . . . . 0.92000000000000004 109.002 177.548 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 868' ' ' PHE . . . . . 0.492 ' HD2' ' HB1' ' C' ' 854' ' ' ALA . 13.7 p90 -150.05 124.65 9.71 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.556 -1.34 . . . . 0.050000000000000003 110.036 179.117 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 50.7 p-10 -112.34 -2.79 14.7 Favored 'General case' 0 N--CA 1.5 2.044 0 C-N-CA 119.216 -0.994 . . . . 1.7 112.715 -178.451 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 870' ' ' ARG . . . . . 0.762 ' CB ' ' HB3' ' C' ' 855' ' ' ALA . 25.7 mmm180 -92.08 88.16 6.43 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 120.844 -1.16 . . . . 2.5899999999999999 111.36 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 65.3 t -72.45 97.09 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 120.949 -1.094 . . . . 1.9399999999999999 109.132 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 872' ' ' LEU . . . . . 0.662 HD13 HD11 ' A' ' 953' ' ' ILE . 95.0 mt -86.98 -45.42 10.79 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.572 -0.705 . . . . 1.0600000000000001 110.82 -179.345 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 873' ' ' LEU . . . . . 0.592 ' HG ' ' HB3' ' C' ' 851' ' ' ALA . 30.4 tp -172.91 101.98 0.13 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.153 -0.967 . . . . 4.1799999999999997 108.788 178.762 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 874' ' ' ASN . . . . . 0.439 ' CB ' ' HA ' ' C' ' 852' ' ' PHE . 32.8 t-20 176.99 82.5 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 108.833 -0.803 . . . . 0.040000000000000001 108.833 -178.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -65.15 -46.41 80.98 Favored 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 119.267 -0.973 . . . . 3.3799999999999999 111.244 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 876' ' ' GLY . . . . . 0.401 ' HA3' ' CE2' ' C' ' 878' ' ' TYR . . . -73.5 -25.65 72.0 Favored Glycine 0 N--CA 1.492 2.403 0 O-C-N 121.257 -0.902 . . . . 0.040000000000000001 111.643 -178.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 81.04 -62.22 4.47 Favored Glycine 0 N--CA 1.501 3.023 0 N-CA-C 107.769 -2.132 . . . . 0.040000000000000001 107.769 -178.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 878' ' ' TYR . . . . . 0.401 ' CE2' ' HA3' ' C' ' 876' ' ' GLY . 85.6 m-85 60.61 -66.29 0.05 Allowed 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 114.497 1.295 . . . . 3.46 114.497 177.612 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 879' ' ' TYR . . . . . 0.46 ' CB ' ' CD2' ' C' ' 886' ' ' PHE . 25.1 p90 -109.49 109.3 20.07 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 115.271 1.582 . . . . 0.040000000000000001 115.271 -176.094 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.03 115.82 29.38 Favored Pre-proline 0 N--CA 1.498 1.932 0 O-C-N 121.637 -0.664 . . . . 0.02 109.98 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 881' ' ' PRO . . . . . 0.464 ' HG2' ' CD1' ' C' ' 868' ' ' PHE . 53.8 Cg_endo -76.65 0.65 9.34 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 O-C-N 123.361 1.19 . . . . 0.39000000000000001 112.137 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -74.51 -66.02 0.79 Allowed 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 106.796 -1.557 . . . . 0.81000000000000005 106.796 178.369 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 2.6 p -95.45 -14.79 23.45 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.813 -0.81 . . . . 0.040000000000000001 108.813 177.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.14 21.98 55.82 Favored Glycine 0 N--CA 1.493 2.476 0 O-C-N 121.042 -1.036 . . . . 0.029999999999999999 111.029 178.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 68.9 t -72.9 87.98 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 C-N-CA 118.189 -1.404 . . . . 1.01 107.492 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 886' ' ' PHE . . . . . 0.927 ' HB3' HG22 ' C' ' 962' ' ' VAL . 0.9 OUTLIER -88.61 103.71 16.17 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-N 115.157 -0.929 . . . . 0.050000000000000003 112.038 -177.075 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 887' ' ' THR . . . . . 0.432 ' O ' ' HD3' ' C' ' 889' ' ' PRO . 88.5 m -99.28 100.24 11.3 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.834 -1.172 . . . . 0.68000000000000005 107.834 177.511 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 888' ' ' ALA . . . . . . . . . . . . . . . -99.05 102.63 16.07 Favored Pre-proline 0 N--CA 1.502 2.158 0 N-CA-C 114.505 1.298 . . . . 0.25 114.505 -176.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 889' ' ' PRO . . . . . 0.432 ' HD3' ' O ' ' C' ' 887' ' ' THR . 55.9 Cg_endo -83.6 -15.37 7.37 Favored 'Trans proline' 0 CA--C 1.545 1.061 0 N-CA-C 108.827 -1.259 . . . . 1.6399999999999999 108.827 175.711 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 890' ' ' LEU . . . . . 0.646 HD21 HG11 ' C' ' 850' ' ' VAL . 65.7 mt -38.09 -48.78 1.26 Allowed 'General case' 0 N--CA 1.508 2.45 0 N-CA-C 113.389 0.885 . . . . 2.29 113.389 -177.492 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 53.28 97.55 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.182 -0.949 . . . . 0.63 110.248 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . 158.83 -155.4 26.46 Favored Glycine 0 N--CA 1.476 1.364 0 N-CA-C 107.12 -2.392 . . . . 0.040000000000000001 107.12 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 74.5 ttt-85 -116.33 125.11 51.66 Favored 'General case' 0 C--N 1.295 -1.803 0 O-C-N 121.537 -0.978 . . . . 3.0 108.855 177.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 894' ' ' TYR . . . . . 0.716 ' CE2' HD23 ' C' ' 954' ' ' LEU . 20.5 p90 -133.35 156.41 47.68 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.083 -1.011 . . . . 0.040000000000000001 111.237 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 895' ' ' LEU . . . . . . . . . . . . . 48.1 tp -99.06 117.13 32.87 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.733 -0.604 . . . . 1.27 110.043 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 896' ' ' LEU . . . . . 0.539 HD11 ' HE1' ' C' ' 981' ' ' PHE . 9.6 tt -120.85 144.51 48.33 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.638 -0.664 . . . . 0.93999999999999995 109.787 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 897' ' ' SER . . . . . . . . . . . . . 19.5 m -141.9 123.97 15.44 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.383 -0.823 . . . . 0.040000000000000001 111.226 -179.215 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -100.55 148.26 24.99 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.731 -0.84 . . . . 0.47999999999999998 108.731 178.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 899' ' ' VAL . . . . . 0.683 HG21 ' HB ' ' C' ' 980' ' ' ILE . 93.8 t -91.47 120.26 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 C-N-CA 119.66 -0.816 . . . . 0.55000000000000004 111.023 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 86.7 mt -92.95 112.1 23.94 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 114.011 1.115 . . . . 1.5900000000000001 114.011 -175.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 23.7 m -63.11 140.3 58.86 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 107.474 -1.306 . . . . 0.050000000000000003 107.474 177.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -61.05 -64.93 3.64 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.209 -1.156 . . . . 0.029999999999999999 110.209 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 45.08 64.01 1.54 Allowed 'General case' 0 N--CA 1.507 2.406 0 O-C-N 121.623 -0.927 . . . . 3.2000000000000002 111.36 179.466 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 54.4 ptt85 -67.66 -7.88 30.37 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.586 -0.696 . . . . 2.9199999999999999 111.783 -179.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 905' ' ' HIS . . . . . 0.497 ' O ' ' CB ' ' C' ' 906' ' ' GLU . 69.5 t60 -63.06 6.61 0.1 Allowed 'General case' 0 N--CA 1.504 2.266 0 CA-C-O 117.599 -1.191 . . . . 2.8700000000000001 113.412 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 906' ' ' GLU . . . . . 0.497 ' CB ' ' O ' ' C' ' 905' ' ' HIS . 0.7 OUTLIER 93.46 -163.01 0.0 OUTLIER 'General case' 0 N--CA 1.529 3.52 0 CA-C-N 121.299 1.863 . . . . 0.98999999999999999 112.1 179.083 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 907' ' ' LYS . . . . . 0.495 ' CB ' ' O ' ' C' ' 906' ' ' GLU . 57.9 tttt 90.01 160.78 0.05 OUTLIER 'General case' 0 N--CA 1.521 3.11 0 N-CA-C 107.967 -1.123 . . . . 5.25 107.967 -176.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 62.0 t -122.31 116.02 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 120.888 -1.132 . . . . 0.39000000000000001 110.806 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -103.84 130.22 51.38 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 107.209 -1.404 . . . . 1.72 107.209 176.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -157.2 120.29 4.04 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 106.916 -1.513 . . . . 0.67000000000000004 106.916 178.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 911' ' ' VAL . . . . . 0.784 HG23 HG22 ' C' ' 964' ' ' VAL . 12.3 p -80.65 131.21 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 C-N-CA 120.248 -0.581 . . . . 0.54000000000000004 111.463 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 60.5 mt -67.32 156.39 36.55 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.28 -0.887 . . . . 1.5 108.618 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 913' ' ' SER . . . . . 0.414 ' CB ' ' CG1' ' C' ' 919' ' ' VAL . 2.4 t -125.27 136.44 53.52 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.589 -0.893 . . . . 1.3700000000000001 108.589 177.334 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 914' ' ' ARG . . . . . 0.837 ' NH1' HD13 ' C' ' 956' ' ' LEU . 0.0 OUTLIER -63.41 154.6 31.58 Favored 'General case' 0 N--CA 1.505 2.308 0 O-C-N 120.685 -1.26 . . . . 4.2999999999999998 111.499 -179.095 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 915' ' ' SER . . . . . 0.417 ' CB ' ' O ' ' C' ' 914' ' ' ARG . 1.7 p 83.58 -30.77 0.08 Allowed 'General case' 0 N--CA 1.521 3.101 0 C-N-CA 123.907 0.883 . . . . 2.0499999999999998 111.999 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 916' ' ' ASN . . . . . 0.792 ' HB2' HG21 ' C' ' 919' ' ' VAL . 93.9 m-20 -122.87 -21.96 5.41 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 120.967 -1.083 . . . . 2.71 111.309 -179.212 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 67.17 165.93 0.22 Allowed 'General case' 0 N--CA 1.521 3.08 0 N-CA-C 105.614 -1.995 . . . . 2.6800000000000002 105.614 -174.008 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.74 -125.64 35.58 Favored Glycine 1 N--CA 1.521 4.32 0 CA-C-N 123.688 2.949 . . . . 0.029999999999999999 107.026 -177.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 919' ' ' VAL . . . . . 0.792 HG21 ' HB2' ' C' ' 916' ' ' ASN . 96.8 t 50.4 94.2 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.212 0 O-C-N 121.444 -1.033 . . . . 1.3899999999999999 109.397 -178.341 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 920' ' ' ALA . . . . . 0.859 ' HB3' HG12 ' C' ' 949' ' ' VAL . . . -94.38 94.67 8.4 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.476 -0.89 . . . . 0.029999999999999999 110.661 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 921' ' ' ARG . . . . . 0.729 ' HG3' HG23 ' C' ' 922' ' ' VAL . 23.9 ptt85 -80.61 -41.81 23.31 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 105.792 -1.929 . . . . 4.4199999999999999 105.792 176.298 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 922' ' ' VAL . . . . . 0.729 HG23 ' HG3' ' C' ' 921' ' ' ARG . 86.3 t -99.37 78.31 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 N-CA-C 105.705 -1.961 . . . . 0.84999999999999998 105.705 175.187 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -90.73 135.53 33.66 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.836 0.827 . . . . 2.46 112.26 -176.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 9.0 t -147.23 103.32 3.57 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.053 -1.092 . . . . 0.69999999999999996 108.053 178.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -109.81 89.49 0.55 Allowed Glycine 0 N--CA 1.488 2.108 0 N-CA-C 108.97 -1.652 . . . . 0.040000000000000001 108.97 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.387 0 N-CA-C 109.265 -1.534 . . . . 0.040000000000000001 109.265 -179.633 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 10.7 m . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 120.971 0.415 . . . . 13.779999999999999 110.336 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 93.3 mt -114.16 129.87 56.61 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.536 -0.727 . . . . 13.76 110.275 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -152.52 170.6 31.71 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.463 -1.455 . . . . 9.1300000000000008 109.463 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 949' ' ' VAL . . . . . 0.859 HG12 ' HB3' ' C' ' 920' ' ' ALA . 34.8 m -116.69 137.52 50.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.563 -0.963 . . . . 7.0800000000000001 110.829 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 950' ' ' PHE . . . . . 0.485 ' CB ' HD11 ' C' ' 953' ' ' ILE . 51.7 p90 -134.35 151.39 51.2 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.509 -0.744 . . . . 7.5899999999999999 109.558 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 22.3 m -116.59 -60.07 1.89 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.415 -0.803 . . . . 5.0300000000000002 111.625 -179.083 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 952' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' C' ' 953' ' ' ILE . 53.1 tp -63.1 -75.25 0.08 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.415 -0.803 . . . . 1.01 111.276 -178.517 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 953' ' ' ILE . . . . . 0.543 HD12 ' HD3' ' C' ' 955' ' ' PRO . 1.8 pp -47.94 -154.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.768 0 N-CA-C 114.487 1.291 . . . . 2.6000000000000001 114.487 -177.053 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 954' ' ' LEU . . . . . 0.716 HD23 ' CE2' ' C' ' 894' ' ' TYR . 0.0 OUTLIER 170.44 85.63 0.04 OUTLIER Pre-proline 0 N--CA 1.514 2.764 0 O-C-N 120.869 -1.144 . . . . 0.050000000000000003 111.922 179.871 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 955' ' ' PRO . . . . . 0.543 ' HD3' HD12 ' C' ' 953' ' ' ILE . 52.6 Cg_endo -77.13 92.39 1.12 Allowed 'Trans proline' 0 N--CA 1.488 1.162 0 N-CA-C 109.131 -1.142 . . . . 0.83999999999999997 109.131 178.626 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 956' ' ' LEU . . . . . 0.837 HD13 ' NH1' ' C' ' 914' ' ' ARG . 89.6 mt -127.94 149.79 50.17 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.086 -1.009 . . . . 0.040000000000000001 110.703 -179.287 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 957' ' ' GLN . . . . . 0.411 ' HB2' ' HB2' ' C' ' 960' ' ' ASP . 33.3 mt-30 -84.87 153.67 22.75 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 117.994 -1.003 . . . . 1.28 111.634 -179.04 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -67.45 120.44 13.92 Favored 'General case' 0 N--CA 1.508 2.469 0 CA-C-N 122.542 2.428 . . . . 0.17000000000000001 111.471 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.89 -18.86 54.88 Favored Glycine 0 N--CA 1.501 3.003 0 O-C-N 121.52 -0.738 . . . . 0.040000000000000001 111.278 178.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 960' ' ' ASP . . . . . 0.454 ' HB3' ' NE ' ' C' ' 914' ' ' ARG . 0.6 OUTLIER -51.64 172.12 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.369 -1.077 . . . . 0.040000000000000001 110.717 -179.222 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 961' ' ' THR . . . . . 0.492 ' HA ' ' O ' ' C' ' 886' ' ' PHE . 7.4 t -135.61 137.58 42.06 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.092 -1.005 . . . . 1.78 112.141 -178.32 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 962' ' ' VAL . . . . . 0.927 HG22 ' HB3' ' C' ' 886' ' ' PHE . 23.6 m -99.99 146.06 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 C-N-CA 120.031 -0.668 . . . . 0.040000000000000001 110.497 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 5.2 t -139.15 144.75 38.75 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.785 -0.572 . . . . 0.71999999999999997 110.028 -178.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 964' ' ' VAL . . . . . 0.784 HG22 HG23 ' C' ' 911' ' ' VAL . 57.8 t -94.96 137.39 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.108 -0.995 . . . . 1.05 110.627 -179.074 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -94.09 126.72 39.48 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 104.068 -2.568 . . . . 3.02 104.068 173.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 966' ' ' LEU . . . . . 0.488 ' C ' HG23 ' C' ' 967' ' ' VAL . 0.1 OUTLIER -132.92 60.09 1.71 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.29 -1.004 . . . . 1.46 108.29 177.398 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 967' ' ' VAL . . . . . 0.488 HG23 ' C ' ' C' ' 966' ' ' LEU . 96.1 t -157.82 96.31 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 108.258 -1.016 . . . . 1.9399999999999999 108.258 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 92.0 mmm -142.74 58.77 1.43 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.748 -1.22 . . . . 0.0 108.382 179.242 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 134.41 119.38 1.96 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 107.192 -2.363 . . . . 2.1099999999999999 107.192 -178.261 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -82.18 -58.38 2.97 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.015 -1.285 . . . . 5.8899999999999997 110.591 -179.425 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 45.1 tp -59.29 90.01 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.445 -0.784 . . . . 4.3600000000000003 110.209 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -142.33 -152.55 0.42 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.613 -0.68 . . . . 1.8300000000000001 110.208 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -116.41 167.47 11.01 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.438 -0.789 . . . . 4.3499999999999996 110.068 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 29.5 t -101.89 130.4 48.36 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.548 -0.72 . . . . 1.27 110.129 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -156.29 155.64 32.66 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.507 -0.745 . . . . 5.0199999999999996 110.459 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.29 85.08 18.86 Favored Pre-proline 0 N--CA 1.5 2.043 0 O-C-N 121.627 -0.671 . . . . 2.4100000000000001 109.642 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 977' ' ' PRO . . . . . 0.488 ' C ' HD12 ' C' ' 978' ' ' LEU . 49.5 Cg_endo -74.8 -171.47 0.97 Allowed 'Trans proline' 0 C--N 1.317 -1.113 0 O-C-N 123.356 1.188 . . . . 0.95999999999999996 111.331 -179.323 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 978' ' ' LEU . . . . . 0.488 HD12 ' C ' ' C' ' 977' ' ' PRO . 5.5 mp -125.21 156.38 38.56 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.542 -1.281 . . . . 0.62 107.542 177.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 979' ' ' THR . . . . . 0.445 HG23 ' C ' ' C' ' 978' ' ' LEU . 43.2 p -149.42 141.6 24.03 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.822 -1.174 . . . . 3.5699999999999998 111.184 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 980' ' ' ILE . . . . . 0.683 ' HB ' HG21 ' C' ' 899' ' ' VAL . 50.2 mm -106.89 128.27 61.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 108.948 -0.76 . . . . 1.3300000000000001 108.948 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 981' ' ' PHE . . . . . 0.539 ' HE1' HD11 ' C' ' 896' ' ' LEU . 3.4 t80 -117.53 97.56 5.94 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.428 -0.795 . . . . 0.050000000000000003 111.564 -178.47 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 982' ' ' SER . . . . . . . . . . . . . 34.5 p -107.2 158.25 17.25 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 109.042 -0.725 . . . . 0.87 109.042 178.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 983' ' ' GLY . . . . . 0.419 ' O ' ' CZ ' ' C' ' 852' ' ' PHE . . . -173.06 113.7 0.48 Allowed Glycine 0 N--CA 1.497 2.727 0 N-CA-C 106.644 -2.582 . . . . 0.029999999999999999 106.644 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 984' ' ' ALA . . . . . 0.4 ' CB ' ' CZ ' ' A' ' 893' ' ' ARG . . . -109.11 152.38 25.15 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 114.319 1.229 . . . . 0.69999999999999996 114.319 -175.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 985' ' ' LEU . . . . . 0.556 HD13 HD22 ' C' ' 890' ' ' LEU . 52.1 tp -75.89 135.75 40.13 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.871 -1.143 . . . . 0.040000000000000001 109.691 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 986' ' ' LEU . . . . . 0.524 HD11 ' CD1' ' B' ' 986' ' ' LEU . 40.7 tp -106.26 -62.63 1.36 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.442 -0.786 . . . . 0.040000000000000001 110.299 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -144.7 146.78 32.38 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.753 -1.203 . . . . 0.040000000000000001 107.753 179.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -111.91 162.67 12.35 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 108.079 -2.008 . . . . 0.040000000000000001 108.079 179.051 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -73.7 112.86 18.05 Favored Pre-proline 0 N--CA 1.499 1.999 0 O-C-N 121.23 -1.159 . . . . 0.040000000000000001 109.44 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 990' ' ' PRO . . . . . 0.435 ' HD2' HD12 ' C' ' 992' ' ' LEU . 51.1 Cg_endo -88.08 70.83 2.88 Favored 'Trans proline' 0 C--N 1.319 -0.984 0 O-C-N 123.201 1.106 . . . . 0.45000000000000001 111.408 -179.017 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 991' ' ' GLU . . . . . 0.421 ' HB2' ' O ' ' C' ' 990' ' ' PRO . 80.6 mt-10 67.14 -73.65 0.08 Allowed 'General case' 0 N--CA 1.502 2.148 0 N-CA-C 108.645 -0.872 . . . . 1.97 108.645 -177.478 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 992' ' ' LEU . . . . . 0.435 HD12 ' HD2' ' C' ' 990' ' ' PRO . 11.1 mt 50.86 20.91 0.85 Allowed 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.62 -0.675 . . . . 2.3799999999999999 111.58 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -92.43 156.91 16.88 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.991 -1.068 . . . . 3.79 110.042 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -146.66 91.62 2.05 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.567 -0.708 . . . . 3.5099999999999998 110.245 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 995' ' ' ALA . . . . . . . . . . . . 2.518 . . . . . . . 0 N--CA 1.503 2.213 0 O-C-N 120.983 -1.073 . . . . 2.73 110.646 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo . . . . . 0 N--CA 1.488 1.154 0 N-CA-C 109.497 -1.001 . . . . 3.8300000000000001 109.497 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 847' ' ' VAL . . . . . . . . . . . . . 63.4 t -135.3 102.68 10.68 Favored Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 121.504 -0.747 . . . . 1.8300000000000001 110.04 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 848' ' ' PRO . . . . . 0.744 ' O ' HG23 ' A' ' 850' ' ' VAL . 44.3 Cg_endo -69.94 -18.12 36.35 Favored 'Trans proline' 0 N--CA 1.488 1.161 0 O-C-N 123.308 1.162 . . . . 0.65000000000000002 111.196 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 849' ' ' GLN . . . . . 0.4 ' C ' ' O ' ' A' ' 848' ' ' PRO . 56.4 tt0 28.07 69.42 0.07 Allowed 'General case' 0 N--CA 1.518 2.96 0 N-CA-C 112.837 0.68 . . . . 2.5800000000000001 112.837 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 850' ' ' VAL . . . . . 0.744 HG23 ' O ' ' A' ' 848' ' ' PRO . 64.8 t -120.38 137.5 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 121.216 -0.927 . . . . 1.0900000000000001 111.7 -178.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 851' ' ' ALA . . . . . 0.562 ' HB3' ' HG ' ' A' ' 873' ' ' LEU . . . -125.94 159.18 33.29 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 105.909 -1.885 . . . . 0.040000000000000001 105.909 176.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 852' ' ' PHE . . . . . 0.434 ' HA ' ' CB ' ' A' ' 874' ' ' ASN . 48.1 p90 -158.73 130.72 6.67 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 121.075 1.762 . . . . 0.050000000000000003 108.864 178.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 46.9 t -175.5 134.05 0.3 Allowed 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.209 -1.034 . . . . 0.040000000000000001 108.209 -179.115 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 854' ' ' ALA . . . . . 0.49 ' HB1' ' HD2' ' A' ' 868' ' ' PHE . . . -133.55 155.09 50.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.091 -1.006 . . . . 0.67000000000000004 109.498 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 855' ' ' ALA . . . . . 0.745 ' HB3' ' CB ' ' A' ' 870' ' ' ARG . . . -124.1 142.7 50.97 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.973 0.892 . . . . 0.51000000000000001 111.651 -179.005 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 856' ' ' LEU . . . . . 0.765 HD12 HD23 ' A' ' 978' ' ' LEU . 3.3 tm? -111.62 137.88 48.91 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.717 -0.614 . . . . 0.050000000000000003 110.214 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 857' ' ' SER . . . . . 0.66 ' N ' HD13 ' A' ' 856' ' ' LEU . 76.5 p -155.48 15.41 0.38 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.594 -0.691 . . . . 1.3300000000000001 111.466 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 858' ' ' LEU . . . . . 0.535 HD12 ' C ' ' A' ' 858' ' ' LEU . 4.3 pp -36.51 160.65 0.05 OUTLIER Pre-proline 0 N--CA 1.515 2.822 0 CA-C-N 118.799 0.727 . . . . 2.3300000000000001 112.581 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -59.68 -89.16 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.491 0 O-C-N 123.005 1.003 . . . . 2.3199999999999998 114.016 -177.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 54.3 ptt85 -128.08 -144.58 0.29 Allowed 'General case' 0 N--CA 1.502 2.137 0 O-C-N 120.774 -1.204 . . . . 0.040000000000000001 112.394 -177.059 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 69.7 m -33.91 127.56 0.4 Allowed 'General case' 0 N--CA 1.511 2.604 0 N-CA-C 112.987 0.736 . . . . 1.3100000000000001 112.987 -178.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 862' ' ' GLU . . . . . 0.456 ' HG3' HD22 ' A' ' 858' ' ' LEU . 0.0 OUTLIER -102.67 158.22 32.19 Favored Pre-proline 0 N--CA 1.489 1.477 0 N-CA-C 108.288 -1.004 . . . . 4.5099999999999998 108.288 177.457 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.27 -13.39 25.61 Favored 'Trans proline' 0 C--N 1.315 -1.236 0 O-C-N 123.069 1.036 . . . . 2.2400000000000002 111.687 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -177.55 -135.1 2.15 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 110.06 -1.216 . . . . 0.040000000000000001 110.06 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 28.4 m -67.58 151.21 47.7 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.382 -1.07 . . . . 1.51 109.923 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 866' ' ' VAL . . . . . 0.497 HG13 ' CD2' ' A' ' 858' ' ' LEU . 33.4 t -94.67 139.67 22.34 Favored Pre-proline 0 N--CA 1.496 1.869 0 N-CA-C 113.764 1.024 . . . . 0.78000000000000003 113.764 -174.527 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 867' ' ' PRO . . . . . 0.486 ' HD3' ' HA ' ' A' ' 866' ' ' VAL . 55.3 Cg_endo -91.96 -151.31 0.04 OUTLIER 'Trans proline' 0 CA--C 1.544 0.999 0 O-C-N 123.673 1.354 . . . . 0.92000000000000004 109.275 177.699 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 868' ' ' PHE . . . . . 0.49 ' HD2' ' HB1' ' A' ' 854' ' ' ALA . 20.1 p90 -151.1 124.16 8.73 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.662 -1.274 . . . . 0.050000000000000003 109.806 179.173 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 50.5 p-10 -113.75 -2.17 13.77 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.226 -0.921 . . . . 1.7 112.731 -178.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 870' ' ' ARG . . . . . 0.745 ' CB ' ' HB3' ' A' ' 855' ' ' ALA . 28.8 mmm180 -90.64 90.08 7.81 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.883 -1.135 . . . . 2.5899999999999999 110.944 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 60.3 t -72.3 96.48 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 120.998 -1.064 . . . . 1.9399999999999999 109.944 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 872' ' ' LEU . . . . . 0.546 HD11 ' HB2' ' A' ' 855' ' ' ALA . 96.9 mt -83.09 -47.35 11.75 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.495 -0.753 . . . . 1.0600000000000001 110.188 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 873' ' ' LEU . . . . . 0.562 ' HG ' ' HB3' ' A' ' 851' ' ' ALA . 44.3 tp -174.61 103.51 0.1 Allowed 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 108.729 -0.841 . . . . 4.1799999999999997 108.729 178.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 874' ' ' ASN . . . . . 0.434 ' CB ' ' HA ' ' A' ' 852' ' ' PHE . 33.3 t-20 177.92 81.74 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.31 0 O-C-N 121.681 -0.637 . . . . 0.040000000000000001 109.301 -178.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -66.33 -47.27 74.04 Favored 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 119.317 -0.953 . . . . 3.3799999999999999 111.143 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 876' ' ' GLY . . . . . 0.41 ' HA3' ' CE2' ' A' ' 878' ' ' TYR . . . -74.53 -24.68 72.12 Favored Glycine 0 N--CA 1.494 2.552 0 O-C-N 121.309 -0.87 . . . . 0.040000000000000001 111.546 -178.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 82.22 -61.95 4.63 Favored Glycine 0 N--CA 1.501 2.973 0 N-CA-C 108.005 -2.038 . . . . 0.040000000000000001 108.005 -178.231 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 878' ' ' TYR . . . . . 0.41 ' CE2' ' HA3' ' A' ' 876' ' ' GLY . 97.9 m-85 60.91 -62.25 0.07 Allowed 'General case' 0 N--CA 1.503 2.211 0 N-CA-C 114.542 1.312 . . . . 3.46 114.542 177.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 879' ' ' TYR . . . . . 0.484 ' CB ' ' CD2' ' A' ' 886' ' ' PHE . 18.2 p90 -110.63 109.7 20.09 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 114.849 1.426 . . . . 0.040000000000000001 114.849 -176.085 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -68.05 115.55 29.7 Favored Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 121.405 -0.809 . . . . 0.02 109.971 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 881' ' ' PRO . . . . . 0.457 ' HG2' ' CD1' ' A' ' 868' ' ' PHE . 55.2 Cg_endo -75.93 0.6 9.09 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 O-C-N 123.39 1.205 . . . . 0.39000000000000001 112.309 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -76.92 -62.27 1.7 Allowed 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 106.617 -1.623 . . . . 0.81000000000000005 106.617 178.27 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 883' ' ' THR . . . . . 0.575 ' OG1' HG23 ' A' ' 885' ' ' VAL . 64.4 p -94.49 -19.27 20.69 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.617 -0.882 . . . . 0.040000000000000001 108.617 177.308 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.66 19.77 59.36 Favored Glycine 0 N--CA 1.496 2.677 0 O-C-N 121.064 -1.022 . . . . 0.029999999999999999 111.237 178.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 885' ' ' VAL . . . . . 0.575 HG23 ' OG1' ' A' ' 883' ' ' THR . 95.9 t -74.25 89.0 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 C-N-CA 118.141 -1.424 . . . . 1.01 108.302 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 886' ' ' PHE . . . . . 0.905 ' HB3' HG22 ' A' ' 962' ' ' VAL . 1.0 OUTLIER -88.23 105.43 17.53 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 115.306 -0.861 . . . . 0.050000000000000003 111.52 -177.674 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 887' ' ' THR . . . . . 0.429 ' O ' ' HD3' ' A' ' 889' ' ' PRO . 93.1 m -95.43 99.95 11.79 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 107.856 -1.165 . . . . 0.68000000000000005 107.856 177.527 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 888' ' ' ALA . . . . . . . . . . . . . . . -98.85 106.4 37.27 Favored Pre-proline 0 N--CA 1.5 2.039 0 N-CA-C 114.124 1.157 . . . . 0.25 114.124 -176.564 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 889' ' ' PRO . . . . . 0.429 ' HD3' ' O ' ' A' ' 887' ' ' THR . 54.1 Cg_endo -89.07 -12.39 3.37 Favored 'Trans proline' 0 CA--C 1.546 1.1 0 N-CA-C 108.92 -1.223 . . . . 1.6399999999999999 108.92 176.084 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 890' ' ' LEU . . . . . 0.856 HD22 HD13 ' A' ' 985' ' ' LEU . 76.7 mt -36.11 -50.73 0.72 Allowed 'General case' 0 N--CA 1.508 2.447 0 N-CA-C 113.592 0.96 . . . . 2.29 113.592 -177.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 52.35 95.55 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.236 -0.915 . . . . 0.63 110.195 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 157.67 -153.64 24.83 Favored Glycine 0 N--CA 1.477 1.427 0 N-CA-C 107.111 -2.396 . . . . 0.040000000000000001 107.111 -179.178 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 71.4 ttt-85 -115.79 126.89 54.6 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 121.557 -0.967 . . . . 3.0 108.539 177.542 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 894' ' ' TYR . . . . . 0.762 ' OH ' HD12 ' A' ' 896' ' ' LEU . 0.1 OUTLIER -132.24 160.49 36.02 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.11 -0.994 . . . . 0.040000000000000001 111.081 -179.939 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 895' ' ' LEU . . . . . 0.506 HD23 HD11 ' B' ' 952' ' ' LEU . 35.0 tp -90.71 119.08 30.65 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.401 0.62 . . . . 1.27 110.029 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 896' ' ' LEU . . . . . 0.762 HD12 ' OH ' ' A' ' 894' ' ' TYR . 9.5 tt -109.42 143.21 39.32 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.774 -0.579 . . . . 0.93999999999999995 110.2 -179.396 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 897' ' ' SER . . . . . 0.505 ' N ' HD23 ' A' ' 896' ' ' LEU . 67.8 m -149.0 115.1 5.76 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.482 -0.761 . . . . 0.040000000000000001 111.018 -179.573 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -108.1 146.77 32.16 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 109.07 -0.715 . . . . 0.47999999999999998 109.07 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 899' ' ' VAL . . . . . 0.748 HG21 ' HB ' ' A' ' 980' ' ' ILE . 87.7 t -95.7 119.72 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 C-N-CA 119.63 -0.828 . . . . 0.55000000000000004 111.279 -179.347 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 900' ' ' LEU . . . . . 0.511 HD12 ' HB2' ' A' ' 924' ' ' SER . 4.5 mm? -96.04 112.22 24.02 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 114.384 1.253 . . . . 1.5900000000000001 114.384 -175.05 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 11.8 m -66.28 141.29 58.06 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 107.53 -1.285 . . . . 0.050000000000000003 107.53 176.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -66.72 -66.13 2.51 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 110.573 -1.011 . . . . 0.029999999999999999 110.573 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 11.8 m170 46.91 67.02 0.85 Allowed 'General case' 0 N--CA 1.508 2.438 0 O-C-N 121.476 -1.014 . . . . 3.2000000000000002 111.151 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 43.3 ptt85 -69.71 -5.65 26.47 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.608 -0.683 . . . . 2.9199999999999999 112.063 -179.069 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 905' ' ' HIS . . . . . 0.486 ' O ' ' CB ' ' A' ' 906' ' ' GLU . 73.8 t60 -62.83 5.32 0.13 Allowed 'General case' 0 N--CA 1.506 2.365 0 O-C-N 120.9 -1.125 . . . . 2.8700000000000001 113.111 -179.243 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 906' ' ' GLU . . . . . 0.486 ' CB ' ' O ' ' A' ' 905' ' ' HIS . 0.8 OUTLIER 94.86 -164.48 0.0 OUTLIER 'General case' 0 N--CA 1.529 3.478 0 CA-C-N 120.552 1.524 . . . . 0.98999999999999999 111.899 178.944 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 907' ' ' LYS . . . . . 0.46 ' CB ' ' O ' ' A' ' 906' ' ' GLU . 68.4 tttt 85.78 157.56 0.09 Allowed 'General case' 0 N--CA 1.519 3.019 0 N-CA-C 108.156 -1.053 . . . . 5.25 108.156 -177.059 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 60.1 t -121.68 117.08 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 120.756 -1.215 . . . . 0.39000000000000001 111.312 -179.23 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 71.2 tt0 -100.03 132.77 45.19 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 107.041 -1.466 . . . . 1.72 107.041 176.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -155.09 123.27 5.88 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 106.805 -1.554 . . . . 0.67000000000000004 106.805 178.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 911' ' ' VAL . . . . . 0.842 HG22 HG13 ' A' ' 964' ' ' VAL . 87.5 t -83.6 131.14 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 C-N-CA 120.52 -0.472 . . . . 0.54000000000000004 110.68 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 86.2 mt -66.34 156.01 35.68 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.333 -0.855 . . . . 1.5 109.264 178.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 913' ' ' SER . . . . . 0.474 ' OG ' HG11 ' A' ' 919' ' ' VAL . 0.1 OUTLIER -127.48 133.87 49.86 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 107.542 -1.281 . . . . 1.3700000000000001 107.542 176.547 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 914' ' ' ARG . . . . . 0.578 HH11 HG13 ' A' ' 962' ' ' VAL . 0.0 OUTLIER -64.95 158.41 25.49 Favored 'General case' 0 N--CA 1.506 2.373 0 O-C-N 120.558 -1.339 . . . . 4.2999999999999998 112.119 -178.491 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 915' ' ' SER . . . . . 0.439 ' CB ' ' O ' ' A' ' 914' ' ' ARG . 4.6 t 84.39 -32.09 0.07 Allowed 'General case' 0 N--CA 1.522 3.153 0 C-N-CA 124.164 0.985 . . . . 2.0499999999999998 111.943 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 916' ' ' ASN . . . . . 0.785 ' HB2' HG21 ' A' ' 919' ' ' VAL . 98.9 m-20 -123.88 -21.32 5.16 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.899 -1.126 . . . . 2.71 111.352 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 917' ' ' GLN . . . . . 0.405 ' HB2' ' O ' ' A' ' 916' ' ' ASN . 45.6 mt-30 66.67 166.39 0.21 Allowed 'General case' 0 N--CA 1.52 3.073 0 N-CA-C 105.637 -1.986 . . . . 2.6800000000000002 105.637 -174.072 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 52.93 -124.07 26.32 Favored Glycine 1 N--CA 1.523 4.46 0 CA-C-N 123.383 2.811 . . . . 0.029999999999999999 106.895 -177.721 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 919' ' ' VAL . . . . . 0.785 HG21 ' HB2' ' A' ' 916' ' ' ASN . 52.1 t 52.22 93.9 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 121.337 -1.096 . . . . 1.3899999999999999 108.96 -178.696 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 920' ' ' ALA . . . . . 0.816 ' HB3' HG12 ' A' ' 949' ' ' VAL . . . -91.75 91.28 7.89 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 119.402 -0.919 . . . . 0.029999999999999999 110.917 -178.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 921' ' ' ARG . . . . . 0.721 ' HG3' HG23 ' A' ' 922' ' ' VAL . 17.3 ptt180 -86.64 -42.24 13.59 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 106.104 -1.813 . . . . 4.4199999999999999 106.104 176.098 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 922' ' ' VAL . . . . . 0.721 HG23 ' HG3' ' A' ' 921' ' ' ARG . 76.7 t -104.29 67.09 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 105.846 -1.909 . . . . 0.84999999999999998 105.846 175.546 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 923' ' ' ASP . . . . . 0.659 ' HB2' ' HB1' ' A' ' 920' ' ' ALA . 25.6 t0 -86.58 134.18 33.66 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.684 0.755 . . . . 2.46 111.459 -177.504 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 924' ' ' SER . . . . . 0.511 ' HB2' HD12 ' A' ' 900' ' ' LEU . 39.7 t -147.7 106.18 3.79 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.669 -0.863 . . . . 0.69999999999999996 108.669 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -101.76 84.74 0.52 Allowed Glycine 0 N--CA 1.486 1.995 0 N-CA-C 108.304 -1.918 . . . . 0.040000000000000001 108.304 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.21 0 N-CA-C 108.877 -1.689 . . . . 0.040000000000000001 108.877 -179.537 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 26.0 m . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.033 0.444 . . . . 13.779999999999999 110.313 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 95.7 mt -112.38 130.88 55.81 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.544 -0.723 . . . . 13.76 110.301 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -151.36 168.25 30.87 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.107 -1.597 . . . . 9.1300000000000008 109.107 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 949' ' ' VAL . . . . . 0.816 HG12 ' HB3' ' A' ' 920' ' ' ALA . 29.8 m -119.11 127.08 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.5 -1.0 . . . . 7.0800000000000001 111.019 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 950' ' ' PHE . . . . . 0.458 ' CZ ' ' HB3' ' A' ' 921' ' ' ARG . 27.1 p90 -133.71 149.28 51.5 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.623 -0.673 . . . . 7.5899999999999999 109.237 179.212 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 29.1 m -121.27 -51.51 2.09 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.359 -0.838 . . . . 5.0300000000000002 112.191 -178.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 952' ' ' LEU . . . . . 0.418 ' O ' ' O ' ' A' ' 953' ' ' ILE . 14.6 tp -59.4 -73.88 0.08 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.369 -0.832 . . . . 1.01 112.705 -177.277 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 953' ' ' ILE . . . . . 0.582 HD11 HD13 ' C' ' 872' ' ' LEU . 45.8 pt -52.29 -144.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.848 0 N-CA-C 114.417 1.266 . . . . 2.6000000000000001 114.417 -176.29 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 954' ' ' LEU . . . . . 0.717 HD22 ' O ' ' A' ' 954' ' ' LEU . 0.0 OUTLIER 173.21 75.01 0.04 OUTLIER Pre-proline 0 N--CA 1.507 2.417 0 O-C-N 120.779 -1.201 . . . . 0.050000000000000003 110.869 -179.974 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 955' ' ' PRO . . . . . 0.755 ' C ' HD12 ' A' ' 956' ' ' LEU . 49.6 Cg_endo -77.11 95.51 1.07 Allowed 'Trans proline' 0 C--N 1.316 -1.143 0 O-C-N 122.716 0.85 . . . . 0.83999999999999997 110.2 179.38 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 956' ' ' LEU . . . . . 0.755 HD12 ' C ' ' A' ' 955' ' ' PRO . 8.9 mp -125.83 151.12 47.23 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.237 -0.915 . . . . 0.040000000000000001 110.257 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -82.19 150.92 27.13 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-O 117.734 -1.127 . . . . 1.28 111.311 -178.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -68.33 119.47 12.9 Favored 'General case' 0 N--CA 1.509 2.51 0 CA-C-N 123.063 2.665 . . . . 0.17000000000000001 111.234 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.8 -21.68 37.9 Favored Glycine 0 N--CA 1.499 2.874 0 N-CA-C 110.769 -0.932 . . . . 0.040000000000000001 110.769 178.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 960' ' ' ASP . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 914' ' ' ARG . 0.4 OUTLIER -53.12 171.9 0.06 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.389 -1.066 . . . . 0.040000000000000001 109.993 -179.707 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 961' ' ' THR . . . . . 0.463 ' HA ' ' O ' ' A' ' 886' ' ' PHE . 41.5 m -133.53 138.73 46.23 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.895 -1.128 . . . . 1.78 112.159 -177.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 962' ' ' VAL . . . . . 0.905 HG22 ' HB3' ' A' ' 886' ' ' PHE . 20.3 m -96.57 143.62 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 C-N-CA 120.025 -0.67 . . . . 0.040000000000000001 109.763 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 5.3 t -140.28 145.3 37.1 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.817 -0.552 . . . . 0.71999999999999997 109.981 -178.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 964' ' ' VAL . . . . . 0.842 HG13 HG22 ' A' ' 911' ' ' VAL . 47.6 t -99.59 136.9 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.141 -0.975 . . . . 1.05 110.785 -178.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -94.05 128.43 40.42 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 103.799 -2.667 . . . . 3.02 103.799 173.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 966' ' ' LEU . . . . . 0.493 ' C ' HG23 ' A' ' 967' ' ' VAL . 10.2 tp -131.62 61.99 1.64 Allowed 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.136 -1.061 . . . . 1.46 108.136 177.192 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 967' ' ' VAL . . . . . 0.493 HG23 ' C ' ' A' ' 966' ' ' LEU . 95.4 t -158.01 97.2 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 108.072 -1.084 . . . . 1.9399999999999999 108.072 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 88.2 mmm -143.13 60.02 1.41 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.746 -1.221 . . . . 0.0 108.353 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.78 119.98 1.95 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 107.036 -2.425 . . . . 2.1099999999999999 107.036 -178.172 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -82.45 -58.68 2.82 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.014 -1.286 . . . . 5.8899999999999997 110.396 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 49.0 tp -59.01 90.74 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.422 -0.799 . . . . 4.3600000000000003 110.209 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -141.93 -154.19 0.5 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.592 -0.693 . . . . 1.8300000000000001 110.235 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -119.64 171.92 8.04 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.511 -0.743 . . . . 4.3499999999999996 110.212 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 39.0 t -101.64 130.42 47.98 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.598 -0.689 . . . . 1.27 110.084 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -156.12 158.75 38.24 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.521 -0.737 . . . . 5.0199999999999996 110.561 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.14 85.75 18.43 Favored Pre-proline 0 N--CA 1.5 2.04 0 O-C-N 121.59 -0.694 . . . . 2.4100000000000001 109.691 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 977' ' ' PRO . . . . . 0.543 ' C ' HD12 ' A' ' 978' ' ' LEU . 48.2 Cg_endo -73.39 -172.43 1.04 Allowed 'Trans proline' 0 C--N 1.317 -1.089 0 O-C-N 123.277 1.146 . . . . 0.95999999999999996 111.345 -179.439 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 978' ' ' LEU . . . . . 0.765 HD23 HD12 ' A' ' 856' ' ' LEU . 5.7 mp -127.47 155.3 43.92 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 107.688 -1.227 . . . . 0.62 107.688 177.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 979' ' ' THR . . . . . 0.461 HG23 ' C ' ' A' ' 978' ' ' LEU . 42.7 p -149.83 141.1 23.16 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.847 -1.158 . . . . 3.5699999999999998 111.252 -179.349 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 980' ' ' ILE . . . . . 0.748 ' HB ' HG21 ' A' ' 899' ' ' VAL . 46.7 mm -107.7 128.69 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 108.911 -0.774 . . . . 1.3300000000000001 108.911 179.408 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 981' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -120.95 97.26 5.45 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 119.705 -0.798 . . . . 0.050000000000000003 111.974 -178.293 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 83.8 p -108.59 158.49 17.53 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.539 -0.726 . . . . 0.87 109.157 178.39 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 983' ' ' GLY . . . . . 0.402 ' HA3' ' CE1' ' A' ' 852' ' ' PHE . . . -175.18 109.04 0.28 Allowed Glycine 0 N--CA 1.499 2.878 0 N-CA-C 106.39 -2.684 . . . . 0.029999999999999999 106.39 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -108.64 152.42 24.82 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 114.565 1.32 . . . . 0.69999999999999996 114.565 -175.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 985' ' ' LEU . . . . . 0.856 HD13 HD22 ' A' ' 890' ' ' LEU . 45.3 tp -72.28 134.55 45.62 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.777 -1.202 . . . . 0.040000000000000001 110.051 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 50.8 tp -107.49 -55.83 2.3 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.562 -0.711 . . . . 0.040000000000000001 109.905 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -144.82 145.16 31.51 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 107.653 -1.24 . . . . 0.040000000000000001 107.653 179.099 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.74 163.15 12.18 Favored Glycine 0 N--CA 1.495 2.593 0 N-CA-C 108.155 -1.978 . . . . 0.040000000000000001 108.155 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -75.85 112.16 18.55 Favored Pre-proline 0 N--CA 1.499 1.988 0 O-C-N 121.202 -1.175 . . . . 0.040000000000000001 109.436 179.111 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 990' ' ' PRO . . . . . 0.528 ' HD2' HD12 ' A' ' 992' ' ' LEU . 48.8 Cg_endo -91.4 71.23 0.97 Allowed 'Trans proline' 0 C--N 1.319 -0.993 0 O-C-N 123.151 1.079 . . . . 0.45000000000000001 111.418 -178.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 991' ' ' GLU . . . . . 0.418 ' HB2' ' O ' ' A' ' 990' ' ' PRO . 70.4 mt-10 67.25 -73.85 0.07 Allowed 'General case' 0 N--CA 1.503 2.178 0 N-CA-C 108.421 -0.955 . . . . 1.97 108.421 -177.35 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 992' ' ' LEU . . . . . 0.528 HD12 ' HD2' ' A' ' 990' ' ' PRO . 6.6 mt 51.16 20.54 0.89 Allowed 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.574 -0.704 . . . . 2.3799999999999999 111.609 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -94.63 156.68 16.31 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.844 -1.16 . . . . 3.79 109.98 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -146.55 93.77 2.34 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.529 -0.732 . . . . 3.5099999999999998 110.269 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 995' ' ' ALA . . . . . . . . . . . . 2.518 . . . . . . . 0 N--CA 1.504 2.243 0 O-C-N 120.86 -1.15 . . . . 2.73 110.578 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo . . . . . 0 N--CA 1.488 1.177 0 N-CA-C 109.432 -1.026 . . . . 3.8300000000000001 109.432 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 847' ' ' VAL . . . . . . . . . . . . . 63.6 t -135.38 102.69 10.6 Favored Pre-proline 0 N--CA 1.494 1.775 0 O-C-N 121.573 -0.704 . . . . 1.8300000000000001 110.014 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 848' ' ' PRO . . . . . 0.741 ' O ' HG23 ' B' ' 850' ' ' VAL . 44.1 Cg_endo -69.95 -18.41 36.15 Favored 'Trans proline' 0 N--CA 1.487 1.091 0 O-C-N 123.279 1.147 . . . . 0.65000000000000002 111.192 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 849' ' ' GLN . . . . . 0.404 ' C ' ' O ' ' B' ' 848' ' ' PRO . 56.4 tt0 28.35 69.57 0.07 Allowed 'General case' 0 N--CA 1.518 2.969 0 N-CA-C 112.734 0.642 . . . . 2.5800000000000001 112.734 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 850' ' ' VAL . . . . . 0.741 HG23 ' O ' ' B' ' 848' ' ' PRO . 65.1 t -120.56 137.57 53.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.15 -0.969 . . . . 1.0900000000000001 111.694 -178.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 851' ' ' ALA . . . . . 0.557 ' HB3' ' HG ' ' B' ' 873' ' ' LEU . . . -126.37 158.48 35.78 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 105.894 -1.891 . . . . 0.040000000000000001 105.894 176.759 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 852' ' ' PHE . . . . . 0.427 ' HA ' ' CB ' ' B' ' 874' ' ' ASN . 47.7 p90 -157.9 131.03 7.54 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 121.114 1.779 . . . . 0.050000000000000003 108.803 179.028 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 47.2 t -175.53 133.72 0.29 Allowed 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.216 -1.031 . . . . 0.040000000000000001 108.216 -179.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 854' ' ' ALA . . . . . 0.467 ' HB1' ' HD2' ' B' ' 868' ' ' PHE . . . -133.17 155.33 49.51 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.071 -1.018 . . . . 0.67000000000000004 109.522 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 855' ' ' ALA . . . . . 0.742 ' HB3' ' CB ' ' B' ' 870' ' ' ARG . . . -124.37 142.99 50.85 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 122.026 0.917 . . . . 0.51000000000000001 111.553 -179.012 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 856' ' ' LEU . . . . . 0.785 HD12 HD23 ' B' ' 978' ' ' LEU . 3.3 tm? -111.96 137.56 49.8 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.719 -0.613 . . . . 0.050000000000000003 110.274 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 857' ' ' SER . . . . . 0.649 ' N ' HD13 ' B' ' 856' ' ' LEU . 77.1 p -155.15 15.43 0.4 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.615 -0.678 . . . . 1.3300000000000001 111.433 179.488 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 858' ' ' LEU . . . . . 0.525 HD12 ' C ' ' B' ' 858' ' ' LEU . 4.3 pp -36.54 160.68 0.05 OUTLIER Pre-proline 0 N--CA 1.516 2.869 0 CA-C-N 118.861 0.755 . . . . 2.3300000000000001 112.544 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -59.74 -89.11 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 120.791 0.994 . . . . 2.3199999999999998 114.022 -177.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 54.4 ptt85 -128.18 -144.7 0.29 Allowed 'General case' 0 N--CA 1.501 2.124 0 O-C-N 120.845 -1.159 . . . . 0.040000000000000001 112.386 -177.056 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 70.1 m -33.81 126.99 0.4 Allowed 'General case' 0 N--CA 1.512 2.642 0 N-CA-C 112.95 0.722 . . . . 1.3100000000000001 112.95 -178.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 862' ' ' GLU . . . . . 0.463 ' HG3' HD22 ' B' ' 858' ' ' LEU . 0.0 OUTLIER -102.14 158.26 32.11 Favored Pre-proline 0 N--CA 1.489 1.478 0 N-CA-C 108.324 -0.991 . . . . 4.5099999999999998 108.324 177.362 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -73.19 -13.54 25.8 Favored 'Trans proline' 0 C--N 1.314 -1.283 0 O-C-N 123.114 1.06 . . . . 2.2400000000000002 111.855 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -177.2 -134.14 1.95 Allowed Glycine 0 N--CA 1.495 2.612 0 N-CA-C 110.005 -1.238 . . . . 0.040000000000000001 110.005 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 29.1 m -68.65 151.62 46.46 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.319 -1.106 . . . . 1.51 109.802 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 866' ' ' VAL . . . . . 0.499 HG13 ' CD2' ' B' ' 858' ' ' LEU . 33.2 t -94.82 139.7 22.28 Favored Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 113.766 1.024 . . . . 0.78000000000000003 113.766 -174.554 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 867' ' ' PRO . . . . . 0.493 ' HD3' ' HA ' ' B' ' 866' ' ' VAL . 55.5 Cg_endo -92.02 -151.49 0.04 OUTLIER 'Trans proline' 0 CA--C 1.545 1.034 0 O-C-N 123.729 1.384 . . . . 0.92000000000000004 109.302 177.692 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 868' ' ' PHE . . . . . 0.467 ' CD1' ' HG2' ' B' ' 881' ' ' PRO . 20.3 p90 -150.91 123.86 8.69 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.644 -1.285 . . . . 0.050000000000000003 109.83 179.157 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 50.5 p-10 -113.54 -1.66 14.05 Favored 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 119.388 -0.925 . . . . 1.7 112.742 -178.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 870' ' ' ARG . . . . . 0.742 ' CB ' ' HB3' ' B' ' 855' ' ' ALA . 28.6 mmm180 -91.12 89.96 7.61 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.855 -1.153 . . . . 2.5899999999999999 111.005 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 59.7 t -72.29 96.57 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.011 -1.056 . . . . 1.9399999999999999 109.937 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 872' ' ' LEU . . . . . 0.541 HD11 ' HB2' ' B' ' 855' ' ' ALA . 96.6 mt -83.24 -47.15 11.84 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.504 -0.747 . . . . 1.0600000000000001 110.232 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 873' ' ' LEU . . . . . 0.557 ' HG ' ' HB3' ' B' ' 851' ' ' ALA . 44.2 tp -174.61 103.46 0.1 Allowed 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.735 -0.839 . . . . 4.1799999999999997 108.735 178.67 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 874' ' ' ASN . . . . . 0.427 ' CB ' ' HA ' ' B' ' 852' ' ' PHE . 33.0 t-20 177.95 81.84 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.64 -0.663 . . . . 0.040000000000000001 109.42 -178.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -66.45 -47.29 73.62 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 119.272 -0.971 . . . . 3.3799999999999999 111.176 -179.296 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 876' ' ' GLY . . . . . 0.414 ' HA3' ' CE2' ' B' ' 878' ' ' TYR . . . -74.5 -24.82 71.84 Favored Glycine 0 N--CA 1.494 2.524 0 O-C-N 121.263 -0.898 . . . . 0.040000000000000001 111.534 -178.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 82.36 -61.98 4.64 Favored Glycine 0 N--CA 1.501 3.021 0 N-CA-C 107.983 -2.047 . . . . 0.040000000000000001 107.983 -178.207 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 878' ' ' TYR . . . . . 0.414 ' CE2' ' HA3' ' B' ' 876' ' ' GLY . 97.8 m-85 60.89 -62.23 0.07 Allowed 'General case' 0 N--CA 1.504 2.251 0 N-CA-C 114.527 1.306 . . . . 3.46 114.527 177.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 879' ' ' TYR . . . . . 0.485 ' CB ' ' CD2' ' B' ' 886' ' ' PHE . 18.2 p90 -110.59 109.69 20.1 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 114.826 1.417 . . . . 0.040000000000000001 114.826 -176.121 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -67.95 115.48 28.72 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.418 -0.801 . . . . 0.02 109.947 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 881' ' ' PRO . . . . . 0.467 ' HG2' ' CD1' ' B' ' 868' ' ' PHE . 55.3 Cg_endo -75.9 0.46 9.24 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 O-C-N 123.361 1.19 . . . . 0.39000000000000001 112.264 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -76.72 -62.52 1.61 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 106.637 -1.616 . . . . 0.81000000000000005 106.637 178.249 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 883' ' ' THR . . . . . 0.567 ' OG1' HG23 ' B' ' 885' ' ' VAL . 63.5 p -94.46 -18.65 21.3 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.711 -0.848 . . . . 0.040000000000000001 108.711 177.314 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.88 20.28 59.83 Favored Glycine 0 N--CA 1.496 2.648 0 O-C-N 121.101 -1.0 . . . . 0.029999999999999999 111.311 178.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 885' ' ' VAL . . . . . 0.567 HG23 ' OG1' ' B' ' 883' ' ' THR . 93.9 t -74.53 89.27 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 C-N-CA 118.15 -1.42 . . . . 1.01 108.202 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 886' ' ' PHE . . . . . 0.885 ' HB3' HG22 ' B' ' 962' ' ' VAL . 1.0 OUTLIER -88.38 105.55 17.66 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 115.366 -0.833 . . . . 0.050000000000000003 111.546 -177.75 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 887' ' ' THR . . . . . 0.427 ' O ' ' HD3' ' B' ' 889' ' ' PRO . 93.0 m -95.48 100.27 12.05 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 107.745 -1.206 . . . . 0.68000000000000005 107.745 177.48 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 888' ' ' ALA . . . . . . . . . . . . . . . -99.09 106.23 37.0 Favored Pre-proline 0 N--CA 1.5 2.06 0 N-CA-C 114.059 1.133 . . . . 0.25 114.059 -176.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 889' ' ' PRO . . . . . 0.427 ' HD3' ' O ' ' B' ' 887' ' ' THR . 54.8 Cg_endo -88.92 -12.37 3.48 Favored 'Trans proline' 0 CA--C 1.546 1.079 0 N-CA-C 109.003 -1.191 . . . . 1.6399999999999999 109.003 175.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 890' ' ' LEU . . . . . 0.835 HD22 HD13 ' B' ' 985' ' ' LEU . 76.6 mt -36.02 -50.78 0.71 Allowed 'General case' 0 N--CA 1.508 2.462 0 N-CA-C 113.588 0.958 . . . . 2.29 113.588 -177.644 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 52.16 95.64 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.231 -0.918 . . . . 0.63 110.232 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . 157.63 -153.85 25.01 Favored Glycine 0 N--CA 1.477 1.418 0 N-CA-C 107.061 -2.416 . . . . 0.040000000000000001 107.061 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 71.4 ttt-85 -115.62 126.95 54.82 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 121.61 -0.935 . . . . 3.0 108.587 177.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 894' ' ' TYR . . . . . 0.77 ' OH ' HD12 ' B' ' 896' ' ' LEU . 0.1 OUTLIER -132.18 160.9 34.74 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.117 -0.989 . . . . 0.040000000000000001 111.069 -179.828 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 895' ' ' LEU . . . . . . . . . . . . . 35.2 tp -91.13 118.93 30.83 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.426 0.631 . . . . 1.27 110.091 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 896' ' ' LEU . . . . . 0.77 HD12 ' OH ' ' B' ' 894' ' ' TYR . 9.5 tt -109.28 142.47 40.11 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.782 -0.574 . . . . 0.93999999999999995 110.251 -179.38 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 897' ' ' SER . . . . . 0.496 ' N ' HD23 ' B' ' 896' ' ' LEU . 68.1 m -148.42 114.96 5.95 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.538 -0.726 . . . . 0.040000000000000001 111.022 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.87 146.52 32.21 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 109.179 -0.674 . . . . 0.47999999999999998 109.179 179.01 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 899' ' ' VAL . . . . . 0.738 HG21 ' HB ' ' B' ' 980' ' ' ILE . 87.9 t -95.46 119.54 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 C-N-CA 119.616 -0.833 . . . . 0.55000000000000004 111.324 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 900' ' ' LEU . . . . . 0.528 HD12 ' HB2' ' B' ' 924' ' ' SER . 4.5 mm? -95.95 111.74 23.66 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 114.401 1.259 . . . . 1.5900000000000001 114.401 -174.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 11.9 m -65.87 141.22 58.33 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 107.466 -1.309 . . . . 0.050000000000000003 107.466 176.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -66.87 -66.16 2.49 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 110.615 -0.994 . . . . 0.029999999999999999 110.615 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 11.7 m170 46.9 67.16 0.83 Allowed 'General case' 0 N--CA 1.507 2.414 0 O-C-N 121.519 -0.989 . . . . 3.2000000000000002 111.082 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 43.1 ptt85 -69.69 -5.97 28.53 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.623 -0.673 . . . . 2.9199999999999999 112.068 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 905' ' ' HIS . . . . . 0.482 ' O ' ' CB ' ' B' ' 906' ' ' GLU . 73.6 t60 -62.2 4.79 0.12 Allowed 'General case' 0 N--CA 1.506 2.369 0 O-C-N 120.904 -1.123 . . . . 2.8700000000000001 113.094 -179.237 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 906' ' ' GLU . . . . . 0.482 ' CB ' ' O ' ' B' ' 905' ' ' HIS . 0.9 OUTLIER 95.1 -164.63 0.0 OUTLIER 'General case' 0 N--CA 1.529 3.478 0 CA-C-N 120.648 1.567 . . . . 0.98999999999999999 111.8 179.1 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 907' ' ' LYS . . . . . 0.466 ' CB ' ' O ' ' B' ' 906' ' ' GLU . 68.6 tttt 85.9 157.29 0.09 Allowed 'General case' 0 N--CA 1.519 3.002 0 N-CA-C 108.212 -1.033 . . . . 5.25 108.212 -177.058 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 60.3 t -121.51 116.71 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 120.779 -1.2 . . . . 0.39000000000000001 111.436 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 71.1 tt0 -99.58 133.09 44.41 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 106.996 -1.483 . . . . 1.72 106.996 176.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -155.51 123.35 5.7 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 106.831 -1.544 . . . . 0.67000000000000004 106.831 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 911' ' ' VAL . . . . . 0.843 HG22 HG13 ' B' ' 964' ' ' VAL . 86.5 t -83.84 131.5 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 C-N-CA 120.482 -0.487 . . . . 0.54000000000000004 110.668 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 86.1 mt -66.53 156.29 35.32 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.306 -0.871 . . . . 1.5 109.174 178.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 913' ' ' SER . . . . . 0.465 ' OG ' HG11 ' B' ' 919' ' ' VAL . 0.1 OUTLIER -127.92 133.26 49.25 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.617 -1.253 . . . . 1.3700000000000001 107.617 176.56 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 914' ' ' ARG . . . . . 0.575 HH11 HG13 ' B' ' 962' ' ' VAL . 0.0 OUTLIER -64.36 158.33 23.88 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 120.481 -1.387 . . . . 4.2999999999999998 112.167 -178.346 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 915' ' ' SER . . . . . 0.431 ' CB ' ' O ' ' B' ' 914' ' ' ARG . 4.6 t 84.56 -32.38 0.06 Allowed 'General case' 0 N--CA 1.521 3.104 0 C-N-CA 124.191 0.996 . . . . 2.0499999999999998 111.931 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 916' ' ' ASN . . . . . 0.804 ' HB2' HG21 ' B' ' 919' ' ' VAL . 98.7 m-20 -123.49 -21.74 5.21 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.987 -1.07 . . . . 2.71 111.382 -179.234 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 917' ' ' GLN . . . . . 0.407 ' HB2' ' O ' ' B' ' 916' ' ' ASN . 45.1 mt-30 66.72 165.69 0.21 Allowed 'General case' 0 N--CA 1.52 3.049 0 N-CA-C 105.708 -1.96 . . . . 2.6800000000000002 105.708 -173.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 53.81 -124.15 28.79 Favored Glycine 1 N--CA 1.522 4.407 0 CA-C-N 123.446 2.839 . . . . 0.029999999999999999 106.753 -177.557 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 919' ' ' VAL . . . . . 0.804 HG21 ' HB2' ' B' ' 916' ' ' ASN . 54.2 t 52.03 94.04 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 O-C-N 121.359 -1.083 . . . . 1.3899999999999999 108.922 -178.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 920' ' ' ALA . . . . . 0.801 ' HB3' HG12 ' B' ' 949' ' ' VAL . . . -91.85 91.17 7.79 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.416 -0.914 . . . . 0.029999999999999999 110.846 -179.034 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 921' ' ' ARG . . . . . 0.703 ' HG3' HG23 ' B' ' 922' ' ' VAL . 17.3 ptt180 -86.69 -42.15 13.62 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 106.132 -1.803 . . . . 4.4199999999999999 106.132 176.094 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 922' ' ' VAL . . . . . 0.703 HG23 ' HG3' ' B' ' 921' ' ' ARG . 77.0 t -104.35 67.09 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 N-CA-C 105.812 -1.922 . . . . 0.84999999999999998 105.812 175.521 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 923' ' ' ASP . . . . . 0.656 ' HB2' ' HB1' ' B' ' 920' ' ' ALA . 25.7 t0 -86.56 134.34 33.66 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.673 0.749 . . . . 2.46 111.423 -177.549 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 924' ' ' SER . . . . . 0.528 ' HB2' HD12 ' B' ' 900' ' ' LEU . 40.0 t -147.8 106.12 3.77 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.696 -0.853 . . . . 0.69999999999999996 108.696 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -101.68 84.69 0.52 Allowed Glycine 0 N--CA 1.486 2.025 0 N-CA-C 108.358 -1.897 . . . . 0.040000000000000001 108.358 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 926' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' B' ' 906' ' ' GLU . . . . . . . . 0 N--CA 1.489 2.191 0 N-CA-C 108.922 -1.671 . . . . 0.040000000000000001 108.922 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 26.2 m . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.029 0.442 . . . . 13.779999999999999 110.273 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 95.6 mt -111.66 130.79 55.65 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.545 -0.722 . . . . 13.76 110.379 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -151.09 167.92 30.68 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.088 -1.605 . . . . 9.1300000000000008 109.088 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 949' ' ' VAL . . . . . 0.801 HG12 ' HB3' ' B' ' 920' ' ' ALA . 31.1 m -118.91 127.21 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.426 -1.044 . . . . 7.0800000000000001 110.899 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 950' ' ' PHE . . . . . 0.463 ' CE1' ' HD2' ' B' ' 955' ' ' PRO . 27.2 p90 -133.81 148.99 51.39 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.593 -0.692 . . . . 7.5899999999999999 109.176 179.192 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 28.6 m -121.15 -50.97 2.12 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.411 -0.806 . . . . 5.0300000000000002 112.065 -178.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 952' ' ' LEU . . . . . 0.506 HD11 HD23 ' A' ' 895' ' ' LEU . 14.6 tp -59.71 -74.12 0.08 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.458 -0.776 . . . . 1.01 112.712 -177.453 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 953' ' ' ILE . . . . . 0.476 ' O ' ' HB3' ' B' ' 954' ' ' LEU . 46.4 pt -52.02 -143.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.851 0 N-CA-C 114.499 1.296 . . . . 2.6000000000000001 114.499 -176.281 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 954' ' ' LEU . . . . . 0.721 HD22 ' O ' ' B' ' 954' ' ' LEU . 0.0 OUTLIER 173.13 74.76 0.04 OUTLIER Pre-proline 0 N--CA 1.508 2.452 0 O-C-N 120.788 -1.195 . . . . 0.050000000000000003 110.772 179.93 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 955' ' ' PRO . . . . . 0.765 ' C ' HD12 ' B' ' 956' ' ' LEU . 49.6 Cg_endo -77.16 95.53 1.07 Allowed 'Trans proline' 0 C--N 1.316 -1.178 0 O-C-N 122.741 0.864 . . . . 0.83999999999999997 110.163 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 956' ' ' LEU . . . . . 0.765 HD12 ' C ' ' B' ' 955' ' ' PRO . 8.9 mp -125.92 151.08 47.42 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.208 -0.932 . . . . 0.040000000000000001 110.149 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -82.03 150.89 27.35 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 117.822 -1.085 . . . . 1.28 111.325 -179.062 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -68.36 119.13 12.39 Favored 'General case' 0 N--CA 1.508 2.465 0 CA-C-N 122.946 2.612 . . . . 0.17000000000000001 111.266 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 93.08 -21.85 37.74 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 110.786 -0.926 . . . . 0.040000000000000001 110.786 178.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 960' ' ' ASP . . . . . 0.427 ' HB3' ' CZ ' ' B' ' 914' ' ' ARG . 0.4 OUTLIER -52.98 172.06 0.05 Allowed 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.39 -1.065 . . . . 0.040000000000000001 109.981 -179.747 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 961' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' B' ' 886' ' ' PHE . 40.8 m -133.55 138.91 46.29 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.897 -1.127 . . . . 1.78 112.165 -177.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 962' ' ' VAL . . . . . 0.885 HG22 ' HB3' ' B' ' 886' ' ' PHE . 20.7 m -96.94 143.5 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 C-N-CA 120.007 -0.677 . . . . 0.040000000000000001 109.737 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 5.3 t -140.03 145.21 37.46 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.79 -0.569 . . . . 0.71999999999999997 110.043 -178.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 964' ' ' VAL . . . . . 0.843 HG13 HG22 ' B' ' 911' ' ' VAL . 47.5 t -99.59 136.64 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.138 -0.976 . . . . 1.05 110.802 -179.033 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -94.08 127.95 40.18 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 103.916 -2.624 . . . . 3.02 103.916 173.264 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 966' ' ' LEU . . . . . 0.491 ' C ' HG23 ' B' ' 967' ' ' VAL . 10.1 tp -131.17 62.15 1.62 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.217 -1.031 . . . . 1.46 108.217 177.33 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 967' ' ' VAL . . . . . 0.491 HG23 ' C ' ' B' ' 966' ' ' LEU . 95.4 t -158.14 97.12 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 108.113 -1.069 . . . . 1.9399999999999999 108.113 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 88.2 mmm -142.97 59.76 1.42 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.756 -1.215 . . . . 0.0 108.456 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.85 119.83 1.93 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 107.08 -2.408 . . . . 2.1099999999999999 107.08 -178.262 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -82.13 -58.66 2.86 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.039 -1.271 . . . . 5.8899999999999997 110.427 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 49.0 tp -59.08 90.64 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.437 -0.789 . . . . 4.3600000000000003 110.152 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -141.89 -154.18 0.5 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.556 -0.715 . . . . 1.8300000000000001 110.179 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -119.55 171.98 7.98 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.486 -0.759 . . . . 4.3499999999999996 110.306 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 39.2 t -101.7 130.39 48.07 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.541 -0.725 . . . . 1.27 110.065 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -156.1 158.69 38.16 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.513 -0.742 . . . . 5.0199999999999996 110.588 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.13 85.7 18.52 Favored Pre-proline 0 N--CA 1.499 2.012 0 O-C-N 121.624 -0.673 . . . . 2.4100000000000001 109.747 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 977' ' ' PRO . . . . . 0.538 ' C ' HD12 ' B' ' 978' ' ' LEU . 48.2 Cg_endo -73.42 -172.43 1.04 Allowed 'Trans proline' 0 C--N 1.318 -1.065 0 O-C-N 123.324 1.171 . . . . 0.95999999999999996 111.44 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 978' ' ' LEU . . . . . 0.785 HD23 HD12 ' B' ' 856' ' ' LEU . 5.6 mp -127.34 155.52 43.44 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.707 -1.22 . . . . 0.62 107.707 177.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 979' ' ' THR . . . . . 0.466 HG23 ' C ' ' B' ' 978' ' ' LEU . 42.3 p -150.0 141.01 22.93 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.782 -1.199 . . . . 3.5699999999999998 111.239 -179.311 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 980' ' ' ILE . . . . . 0.738 ' HB ' HG21 ' B' ' 899' ' ' VAL . 46.9 mm -107.76 128.33 63.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 108.885 -0.783 . . . . 1.3300000000000001 108.885 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -120.59 97.49 5.59 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 119.71 -0.796 . . . . 0.050000000000000003 111.982 -178.302 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 82.9 p -109.0 158.6 17.56 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.611 -0.681 . . . . 0.87 109.28 178.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 983' ' ' GLY . . . . . 0.411 ' HA3' ' CE1' ' B' ' 852' ' ' PHE . . . -175.11 109.14 0.28 Allowed Glycine 0 N--CA 1.499 2.86 0 N-CA-C 106.513 -2.635 . . . . 0.029999999999999999 106.513 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -108.7 152.19 25.16 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 114.526 1.306 . . . . 0.69999999999999996 114.526 -175.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 985' ' ' LEU . . . . . 0.835 HD13 HD22 ' B' ' 890' ' ' LEU . 45.4 tp -72.1 134.5 45.83 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.872 -1.143 . . . . 0.040000000000000001 110.055 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 986' ' ' LEU . . . . . 0.687 ' CD1' HD11 ' C' ' 986' ' ' LEU . 51.7 tp -107.52 -55.89 2.29 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.58 -0.7 . . . . 0.040000000000000001 109.917 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -144.82 145.08 31.47 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 107.623 -1.251 . . . . 0.040000000000000001 107.623 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.54 162.95 12.22 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 108.147 -1.981 . . . . 0.040000000000000001 108.147 179.248 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -75.66 112.16 18.12 Favored Pre-proline 0 N--CA 1.499 1.988 0 O-C-N 121.236 -1.155 . . . . 0.040000000000000001 109.406 179.053 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 990' ' ' PRO . . . . . 0.526 ' HD2' HD12 ' B' ' 992' ' ' LEU . 49.8 Cg_endo -91.38 71.31 0.97 Allowed 'Trans proline' 0 C--N 1.319 -0.982 0 O-C-N 123.108 1.057 . . . . 0.45000000000000001 111.411 -178.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 991' ' ' GLU . . . . . 0.421 ' HB2' ' O ' ' B' ' 990' ' ' PRO . 70.5 mt-10 67.21 -73.75 0.08 Allowed 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 108.493 -0.928 . . . . 1.97 108.493 -177.46 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 992' ' ' LEU . . . . . 0.526 HD12 ' HD2' ' B' ' 990' ' ' PRO . 6.7 mt 51.22 20.29 0.88 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.575 -0.703 . . . . 2.3799999999999999 111.634 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -94.33 156.77 16.35 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.862 -1.149 . . . . 3.79 109.96 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -146.64 93.22 2.26 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.547 -0.721 . . . . 3.5099999999999998 110.403 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 995' ' ' ALA . . . . . . . . . . . . 2.519 . . . . . . . 0 N--CA 1.503 2.209 0 O-C-N 120.897 -1.127 . . . . 2.73 110.624 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo . . . . . 0 N--CA 1.488 1.178 0 N-CA-C 109.5 -1.0 . . . . 3.8300000000000001 109.5 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 847' ' ' VAL . . . . . 0.473 HG12 ' HB2' ' C' ' 849' ' ' GLN . 57.3 t -127.6 103.75 21.9 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.609 -0.682 . . . . 1.8300000000000001 110.121 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 848' ' ' PRO . . . . . 0.786 ' O ' HG23 ' C' ' 850' ' ' VAL . 43.4 Cg_endo -69.36 -23.03 33.05 Favored 'Trans proline' 0 N--CA 1.488 1.151 0 O-C-N 123.218 1.115 . . . . 0.65000000000000002 110.911 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 849' ' ' GLN . . . . . 0.473 ' HB2' HG12 ' C' ' 847' ' ' VAL . 55.2 tt0 26.59 68.63 0.06 Allowed 'General case' 0 N--CA 1.519 2.982 0 N-CA-C 112.972 0.73 . . . . 2.5800000000000001 112.972 179.368 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 850' ' ' VAL . . . . . 0.786 HG23 ' O ' ' C' ' 848' ' ' PRO . 93.4 t -119.58 134.35 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.158 -0.964 . . . . 1.0900000000000001 111.245 -179.015 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 851' ' ' ALA . . . . . 0.417 ' HB3' ' HG ' ' C' ' 873' ' ' LEU . . . -131.56 155.74 46.96 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 106.105 -1.813 . . . . 0.040000000000000001 106.105 176.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 852' ' ' PHE . . . . . 0.51 ' CD1' ' CE1' ' C' ' 879' ' ' TYR . 0.3 OUTLIER -154.36 134.68 13.32 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 120.829 1.65 . . . . 0.050000000000000003 107.931 179.083 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 5.0 t -173.8 130.54 0.42 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.513 -0.921 . . . . 0.040000000000000001 108.513 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -136.39 150.95 49.04 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.256 -0.902 . . . . 0.67000000000000004 108.863 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 855' ' ' ALA . . . . . 0.658 ' HB3' ' CB ' ' C' ' 870' ' ' ARG . . . -122.77 139.33 54.11 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.813 0.816 . . . . 0.51000000000000001 111.527 -179.018 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 856' ' ' LEU . . . . . 0.778 HD23 ' O ' ' C' ' 867' ' ' PRO . 3.4 tm? -104.87 138.88 40.44 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.781 -0.575 . . . . 0.050000000000000003 109.558 179.44 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 857' ' ' SER . . . . . 0.623 ' N ' HD13 ' C' ' 856' ' ' LEU . 1.9 m -155.28 17.49 0.41 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.622 -0.674 . . . . 1.3300000000000001 111.465 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 858' ' ' LEU . . . . . 0.705 HD22 ' HG3' ' C' ' 862' ' ' GLU . 3.6 pp -34.55 158.06 0.04 OUTLIER Pre-proline 0 N--CA 1.52 3.047 0 CA-C-N 118.752 0.705 . . . . 2.3300000000000001 112.756 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -60.14 -89.88 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.431 0 O-C-N 123.089 1.047 . . . . 2.3199999999999998 113.828 -177.194 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 55.4 ptt85 -126.56 -141.92 0.28 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.853 -1.155 . . . . 0.040000000000000001 111.41 -177.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 73.7 m -36.31 120.33 0.65 Allowed 'General case' 0 N--CA 1.511 2.605 0 O-C-N 121.622 -0.674 . . . . 1.3100000000000001 112.26 -179.042 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 862' ' ' GLU . . . . . 0.705 ' HG3' HD22 ' C' ' 858' ' ' LEU . 0.0 OUTLIER -99.11 158.14 32.82 Favored Pre-proline 0 N--CA 1.488 1.458 0 N-CA-C 108.53 -0.915 . . . . 4.5099999999999998 108.53 178.069 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -70.92 -15.52 32.73 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 O-C-N 123.225 1.118 . . . . 2.2400000000000002 111.036 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -177.3 -134.77 2.07 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.537 -1.425 . . . . 0.040000000000000001 109.537 179.401 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 30.2 m -69.31 155.25 40.73 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.34 -1.094 . . . . 1.51 110.786 -179.019 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 866' ' ' VAL . . . . . 0.516 HG12 ' CD2' ' C' ' 858' ' ' LEU . 33.7 m -89.83 138.29 27.96 Favored Pre-proline 0 N--CA 1.496 1.837 0 N-CA-C 113.423 0.897 . . . . 0.78000000000000003 113.423 -175.34 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 867' ' ' PRO . . . . . 0.778 ' O ' HD23 ' C' ' 856' ' ' LEU . 54.9 Cg_endo -88.62 -153.11 0.04 OUTLIER 'Trans proline' 0 C--N 1.324 -0.716 0 N-CA-C 108.128 -1.528 . . . . 0.92000000000000004 108.128 177.414 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 868' ' ' PHE . . . . . 0.48 ' CD1' ' HG2' ' C' ' 881' ' ' PRO . 20.4 p90 -148.47 120.18 8.07 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.54 -1.35 . . . . 0.050000000000000003 110.12 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 50.2 p-10 -112.63 -2.13 14.63 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 119.353 -0.939 . . . . 1.7 111.762 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 870' ' ' ARG . . . . . 0.658 ' CB ' ' HB3' ' C' ' 855' ' ' ALA . 24.2 mmm180 -91.5 87.36 6.36 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.013 -1.054 . . . . 2.5899999999999999 111.057 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 61.9 t -74.77 97.2 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.0 -1.062 . . . . 1.9399999999999999 109.493 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 872' ' ' LEU . . . . . 0.582 HD13 HD11 ' A' ' 953' ' ' ILE . 52.2 mt -88.64 -44.37 10.66 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.497 -0.752 . . . . 1.0600000000000001 111.151 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 873' ' ' LEU . . . . . 0.449 ' O ' ' HB2' ' C' ' 874' ' ' ASN . 43.9 tp -171.44 102.62 0.2 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.134 -0.979 . . . . 4.1799999999999997 109.087 179.019 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 874' ' ' ASN . . . . . 0.449 ' HB2' ' O ' ' C' ' 873' ' ' LEU . 36.6 t-20 175.08 83.93 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.333 0 N-CA-C 108.694 -0.854 . . . . 0.040000000000000001 108.694 -178.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 30.1 p-10 -66.46 -48.19 70.71 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.059 -1.026 . . . . 3.3799999999999999 111.966 -178.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 876' ' ' GLY . . . . . 0.423 ' HA3' ' CE2' ' C' ' 878' ' ' TYR . . . -74.45 -24.91 71.72 Favored Glycine 0 N--CA 1.495 2.603 0 O-C-N 121.14 -0.975 . . . . 0.040000000000000001 111.569 -178.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 80.54 -64.86 3.98 Favored Glycine 0 N--CA 1.498 2.789 0 N-CA-C 107.624 -2.191 . . . . 0.040000000000000001 107.624 -178.143 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 878' ' ' TYR . . . . . 0.423 ' CE2' ' HA3' ' C' ' 876' ' ' GLY . 82.6 m-85 61.01 -56.18 0.09 Allowed 'General case' 0 N--CA 1.507 2.416 0 N-CA-C 114.556 1.317 . . . . 3.46 114.556 177.668 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 879' ' ' TYR . . . . . 0.51 ' CE1' ' CD1' ' C' ' 852' ' ' PHE . 1.7 p90 -111.53 108.91 18.59 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 114.791 1.404 . . . . 0.040000000000000001 114.791 -176.397 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -71.68 113.69 22.08 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.262 -0.898 . . . . 0.02 109.529 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 881' ' ' PRO . . . . . 0.48 ' HG2' ' CD1' ' C' ' 868' ' ' PHE . 54.3 Cg_endo -77.03 0.1 10.04 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 O-C-N 123.351 1.184 . . . . 0.39000000000000001 112.011 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 87.8 mt-10 -75.43 -64.55 1.04 Allowed 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 106.682 -1.599 . . . . 0.81000000000000005 106.682 178.105 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 24.5 p -90.55 -19.36 23.86 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.22 -1.03 . . . . 0.040000000000000001 108.22 176.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.1 19.58 60.71 Favored Glycine 0 N--CA 1.496 2.675 0 O-C-N 121.165 -0.959 . . . . 0.029999999999999999 111.22 178.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 885' ' ' VAL . . . . . 0.461 HG13 HG21 ' C' ' 961' ' ' THR . 89.3 t -73.93 89.79 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 C-N-CA 118.003 -1.479 . . . . 1.01 108.183 -179.541 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 886' ' ' PHE . . . . . 0.937 ' HB3' HG22 ' C' ' 962' ' ' VAL . 1.3 t80 -88.66 106.9 18.63 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 115.485 -0.78 . . . . 0.050000000000000003 111.385 -178.039 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 887' ' ' THR . . . . . 0.42 ' O ' ' HD3' ' C' ' 889' ' ' PRO . 93.7 m -96.07 101.43 13.09 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.921 -1.14 . . . . 0.68000000000000005 107.921 177.679 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 888' ' ' ALA . . . . . . . . . . . . . . . -99.05 106.88 40.97 Favored Pre-proline 0 N--CA 1.502 2.142 0 N-CA-C 113.964 1.098 . . . . 0.25 113.964 -176.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 889' ' ' PRO . . . . . 0.42 ' HD3' ' O ' ' C' ' 887' ' ' THR . 53.8 Cg_endo -90.33 -12.24 2.72 Favored 'Trans proline' 0 CA--C 1.547 1.17 0 C-N-CA 121.073 1.182 . . . . 1.6399999999999999 109.252 176.382 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 890' ' ' LEU . . . . . 0.841 HD22 HD13 ' C' ' 985' ' ' LEU . 72.3 mt -38.01 -50.61 1.34 Allowed 'General case' 0 N--CA 1.507 2.415 0 N-CA-C 113.778 1.029 . . . . 2.29 113.778 -177.286 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 52.19 97.52 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.379 0 O-C-N 121.152 -0.968 . . . . 0.63 110.386 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . 156.11 -146.52 14.18 Favored Glycine 0 N--CA 1.482 1.703 0 N-CA-C 107.445 -2.262 . . . . 0.040000000000000001 107.445 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 73.3 ttt-85 -106.46 128.79 54.34 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.311 -1.366 . . . . 3.0 107.311 177.157 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 894' ' ' TYR . . . . . 0.417 ' CD1' ' N ' ' C' ' 895' ' ' LEU . 0.4 OUTLIER -130.68 144.29 51.33 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.007 -1.058 . . . . 0.040000000000000001 110.661 -178.499 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 895' ' ' LEU . . . . . 0.417 ' N ' ' CD1' ' C' ' 894' ' ' TYR . 45.2 tp -101.07 117.83 35.8 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.64 -0.662 . . . . 1.27 109.723 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 896' ' ' LEU . . . . . 0.5 HD23 ' C ' ' C' ' 896' ' ' LEU . 10.4 tt -116.4 145.46 43.23 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.531 -0.731 . . . . 0.93999999999999995 110.783 -179.361 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 897' ' ' SER . . . . . 0.494 ' N ' HD23 ' C' ' 896' ' ' LEU . 69.1 m -145.18 119.23 9.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.448 -0.783 . . . . 0.040000000000000001 110.824 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.22 147.93 29.55 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.219 -0.66 . . . . 0.47999999999999998 109.219 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 899' ' ' VAL . . . . . 0.739 HG21 ' HB ' ' C' ' 980' ' ' ILE . 89.4 t -91.12 120.53 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.446 -0.784 . . . . 0.55000000000000004 110.925 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 900' ' ' LEU . . . . . 0.438 HD22 ' HB2' ' C' ' 924' ' ' SER . 93.1 mt -94.23 110.35 22.09 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 114.261 1.208 . . . . 1.5900000000000001 114.261 -175.462 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 18.9 m -64.92 139.71 58.79 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 107.414 -1.328 . . . . 0.050000000000000003 107.414 177.141 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -62.28 -65.77 2.99 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 110.417 -1.073 . . . . 0.029999999999999999 110.417 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 4.0 m170 46.08 64.61 1.42 Allowed 'General case' 0 N--CA 1.507 2.388 0 O-C-N 121.498 -1.001 . . . . 3.2000000000000002 111.262 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 42.8 ptt85 -68.39 -7.74 34.13 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.579 -0.701 . . . . 2.9199999999999999 111.857 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 905' ' ' HIS . . . . . 0.491 ' O ' ' CB ' ' C' ' 906' ' ' GLU . 72.3 t60 -61.29 6.86 0.05 OUTLIER 'General case' 0 N--CA 1.508 2.442 0 CA-C-O 117.659 -1.162 . . . . 2.8700000000000001 113.798 -179.208 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 906' ' ' GLU . . . . . 0.491 ' CB ' ' O ' ' C' ' 905' ' ' HIS . 0.5 OUTLIER 93.22 -165.15 0.0 OUTLIER 'General case' 0 N--CA 1.529 3.487 0 CA-C-N 121.21 1.823 . . . . 0.98999999999999999 111.955 179.117 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 907' ' ' LYS . . . . . 0.485 ' CB ' ' O ' ' C' ' 906' ' ' GLU . 38.2 tttp 88.13 159.62 0.07 Allowed 'General case' 0 N--CA 1.52 3.062 0 N-CA-C 108.149 -1.056 . . . . 5.25 108.149 -176.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 60.8 t -123.43 116.2 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 120.826 -1.171 . . . . 0.39000000000000001 111.003 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -104.34 132.18 50.87 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 107.711 -1.218 . . . . 1.72 107.711 177.085 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -155.82 122.44 5.24 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 106.838 -1.542 . . . . 0.67000000000000004 106.838 178.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 911' ' ' VAL . . . . . 0.86 HG22 HG13 ' C' ' 964' ' ' VAL . 96.8 t -82.05 131.6 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.831 -0.543 . . . . 0.54000000000000004 111.133 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 57.2 mt -68.2 156.15 38.16 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.348 -0.845 . . . . 1.5 109.12 178.363 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 913' ' ' SER . . . . . 0.488 ' OG ' HG11 ' C' ' 919' ' ' VAL . 1.2 p -125.19 136.92 54.06 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.428 -0.952 . . . . 1.3700000000000001 108.428 176.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 914' ' ' ARG . . . . . 0.745 ' NH1' HD13 ' C' ' 956' ' ' LEU . 0.1 OUTLIER -63.69 154.93 31.55 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 120.664 -1.272 . . . . 4.2999999999999998 111.482 -179.309 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 915' ' ' SER . . . . . 0.423 ' CB ' ' O ' ' C' ' 914' ' ' ARG . 4.6 t 83.73 -31.48 0.08 Allowed 'General case' 0 N--CA 1.522 3.13 0 C-N-CA 124.054 0.942 . . . . 2.0499999999999998 112.087 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 916' ' ' ASN . . . . . 0.788 ' HB2' HG21 ' C' ' 919' ' ' VAL . 93.8 m-20 -122.39 -21.66 5.73 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 120.883 -1.136 . . . . 2.71 111.286 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 67.18 165.65 0.22 Allowed 'General case' 0 N--CA 1.52 3.032 0 N-CA-C 105.664 -1.976 . . . . 2.6800000000000002 105.664 -174.059 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 55.13 -126.04 37.66 Favored Glycine 1 N--CA 1.52 4.287 0 CA-C-N 123.675 2.943 . . . . 0.029999999999999999 106.962 -177.609 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 919' ' ' VAL . . . . . 0.788 HG21 ' HB2' ' C' ' 916' ' ' ASN . 91.1 t 50.59 94.01 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 121.447 -1.031 . . . . 1.3899999999999999 109.386 -178.28 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 920' ' ' ALA . . . . . 0.985 ' HB3' HG12 ' C' ' 949' ' ' VAL . . . -93.31 93.53 8.25 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.29 -0.964 . . . . 0.029999999999999999 110.565 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 921' ' ' ARG . . . . . 0.667 ' HG3' HG23 ' C' ' 922' ' ' VAL . 34.7 ptt85 -80.13 -42.3 23.78 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 105.884 -1.895 . . . . 4.4199999999999999 105.884 176.468 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 922' ' ' VAL . . . . . 0.667 HG23 ' HG3' ' C' ' 921' ' ' ARG . 78.2 t -101.18 77.06 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 N-CA-C 105.602 -1.999 . . . . 0.84999999999999998 105.602 175.155 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -87.81 135.03 33.56 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.801 0.81 . . . . 2.46 112.016 -176.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 924' ' ' SER . . . . . 0.438 ' HB2' HD22 ' C' ' 900' ' ' LEU . 4.9 t -146.54 102.63 3.59 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.297 -1.001 . . . . 0.69999999999999996 108.297 178.773 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -109.49 88.35 0.51 Allowed Glycine 0 N--CA 1.486 2.026 0 N-CA-C 108.494 -1.842 . . . . 0.040000000000000001 108.494 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.353 0 N-CA-C 109.315 -1.514 . . . . 0.040000000000000001 109.315 -179.448 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 8.3 m . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 120.995 0.426 . . . . 13.779999999999999 110.378 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 95.2 mt -114.03 129.51 56.6 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.465 -0.772 . . . . 13.76 110.367 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -152.35 170.46 31.6 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.514 -1.434 . . . . 9.1300000000000008 109.514 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 949' ' ' VAL . . . . . 0.985 HG12 ' HB3' ' C' ' 920' ' ' ALA . 35.1 m -117.74 136.91 53.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.529 -0.983 . . . . 7.0800000000000001 110.904 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 950' ' ' PHE . . . . . 0.453 ' CZ ' ' HB3' ' C' ' 921' ' ' ARG . 44.8 p90 -135.3 152.88 51.91 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.571 -0.706 . . . . 7.5899999999999999 109.525 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 5.6 m -118.23 -54.77 2.28 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.465 -0.772 . . . . 5.0300000000000002 111.65 -179.18 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 952' ' ' LEU . . . . . 0.447 ' O ' ' O ' ' C' ' 953' ' ' ILE . 58.1 tp -65.71 -78.29 0.05 Allowed 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.439 -0.788 . . . . 1.01 111.375 -178.333 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 953' ' ' ILE . . . . . 0.646 HD12 ' N ' ' C' ' 954' ' ' LEU . 2.9 pp -50.28 -150.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.688 0 N-CA-C 114.312 1.227 . . . . 2.6000000000000001 114.312 -176.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 954' ' ' LEU . . . . . 0.718 HD22 ' O ' ' C' ' 954' ' ' LEU . 0.0 OUTLIER 169.19 90.98 0.03 OUTLIER Pre-proline 0 N--CA 1.519 2.992 0 O-C-N 120.879 -1.138 . . . . 0.050000000000000003 112.03 179.902 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 955' ' ' PRO . . . . . 0.452 ' HD3' ' CD1' ' C' ' 953' ' ' ILE . 52.7 Cg_endo -79.55 93.25 1.08 Allowed 'Trans proline' 0 C--N 1.317 -1.103 0 N-CA-C 108.819 -1.262 . . . . 0.83999999999999997 108.819 178.379 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 956' ' ' LEU . . . . . 0.745 HD13 ' NH1' ' C' ' 914' ' ' ARG . 79.7 mt -126.79 148.22 49.95 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.094 -1.004 . . . . 0.040000000000000001 110.524 -179.195 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 957' ' ' GLN . . . . . 0.436 ' HB2' ' HB2' ' C' ' 960' ' ' ASP . 28.4 mt-30 -84.04 153.26 23.92 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 117.904 -1.046 . . . . 1.28 111.515 -179.096 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -68.66 120.81 15.25 Favored 'General case' 0 N--CA 1.509 2.509 0 CA-C-N 122.757 2.526 . . . . 0.17000000000000001 111.879 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 93.16 -20.76 44.02 Favored Glycine 0 N--CA 1.502 3.074 0 N-CA-C 111.193 -0.763 . . . . 0.040000000000000001 111.193 178.392 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 960' ' ' ASP . . . . . 0.436 ' HB2' ' HB2' ' C' ' 957' ' ' GLN . 0.8 OUTLIER -51.28 172.42 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.482 -1.01 . . . . 0.040000000000000001 110.751 -179.115 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 961' ' ' THR . . . . . 0.461 HG21 HG13 ' C' ' 885' ' ' VAL . 50.0 m -133.09 137.45 46.35 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.002 -1.061 . . . . 1.78 111.887 -178.105 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 962' ' ' VAL . . . . . 0.937 HG22 ' HB3' ' C' ' 886' ' ' PHE . 24.9 m -99.47 144.1 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 C-N-CA 119.985 -0.686 . . . . 0.040000000000000001 110.11 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 5.4 t -140.54 143.8 35.57 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.864 -0.522 . . . . 0.71999999999999997 110.148 -178.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 964' ' ' VAL . . . . . 0.86 HG13 HG22 ' C' ' 911' ' ' VAL . 56.9 t -93.8 136.87 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.191 -0.943 . . . . 1.05 110.93 -178.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -95.72 127.01 41.38 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 103.716 -2.698 . . . . 3.02 103.716 173.035 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 966' ' ' LEU . . . . . 0.49 ' C ' HG23 ' C' ' 967' ' ' VAL . 11.2 tp -132.81 62.83 1.65 Allowed 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.367 -0.975 . . . . 1.46 108.367 177.411 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 967' ' ' VAL . . . . . 0.49 HG23 ' C ' ' C' ' 966' ' ' LEU . 99.5 t -157.53 97.02 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 108.239 -1.022 . . . . 1.9399999999999999 108.239 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 92.8 mmm -142.29 60.01 1.45 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.793 -1.192 . . . . 0.0 108.358 179.126 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.46 119.51 1.92 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 107.192 -2.363 . . . . 2.1099999999999999 107.192 -178.252 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 94.7 mm-40 -82.36 -57.54 3.32 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.051 -1.264 . . . . 5.8899999999999997 110.761 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 47.4 tp -58.75 89.84 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.443 -0.786 . . . . 4.3600000000000003 110.358 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -142.41 -152.58 0.42 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.557 -0.714 . . . . 1.8300000000000001 110.118 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -120.31 170.01 9.75 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.425 -0.797 . . . . 4.3499999999999996 110.261 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 29.3 t -101.46 130.36 47.69 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.52 -0.738 . . . . 1.27 110.051 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -155.63 158.87 39.05 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.53 -0.731 . . . . 5.0199999999999996 110.524 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.35 86.51 16.73 Favored Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 121.603 -0.686 . . . . 2.4100000000000001 109.862 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -74.72 -171.65 1.01 Allowed 'Trans proline' 0 C--N 1.317 -1.081 0 O-C-N 123.311 1.164 . . . . 0.95999999999999996 111.19 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 978' ' ' LEU . . . . . 0.539 ' N ' HD12 ' C' ' 978' ' ' LEU . 5.2 mp -126.25 155.58 41.66 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 107.577 -1.268 . . . . 0.62 107.577 177.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 979' ' ' THR . . . . . 0.458 HG23 ' C ' ' C' ' 978' ' ' LEU . 39.9 p -150.66 141.08 22.43 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.791 -1.193 . . . . 3.5699999999999998 111.216 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 980' ' ' ILE . . . . . 0.739 ' HB ' HG21 ' C' ' 899' ' ' VAL . 50.4 mm -107.12 129.07 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 108.991 -0.744 . . . . 1.3300000000000001 108.991 179.333 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 981' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -118.67 95.76 4.98 Favored 'General case' 0 N--CA 1.497 1.925 0 C-N-CA 119.452 -0.899 . . . . 0.050000000000000003 111.727 -178.209 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 982' ' ' SER . . . . . 0.407 ' HB2' HD23 ' A' ' 952' ' ' LEU . 12.1 p -109.55 158.68 17.77 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.606 -0.684 . . . . 0.87 109.712 178.792 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 983' ' ' GLY . . . . . 0.437 ' HA3' ' CZ ' ' C' ' 852' ' ' PHE . . . -172.99 114.71 0.53 Allowed Glycine 0 N--CA 1.498 2.798 0 N-CA-C 106.453 -2.659 . . . . 0.029999999999999999 106.453 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 984' ' ' ALA . . . . . . . . . . . . . . . -106.49 152.45 23.63 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 114.493 1.294 . . . . 0.69999999999999996 114.493 -175.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 985' ' ' LEU . . . . . 0.841 HD13 HD22 ' C' ' 890' ' ' LEU . 62.3 tp -75.58 135.65 40.53 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.932 -1.105 . . . . 0.040000000000000001 109.787 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 986' ' ' LEU . . . . . 0.687 HD11 ' CD1' ' B' ' 986' ' ' LEU . 36.1 tp -106.75 -61.17 1.57 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.576 -0.702 . . . . 0.040000000000000001 110.098 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -143.81 146.74 33.3 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 107.647 -1.242 . . . . 0.040000000000000001 107.647 179.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -111.65 162.74 12.34 Favored Glycine 0 N--CA 1.495 2.597 0 N-CA-C 108.179 -1.968 . . . . 0.040000000000000001 108.179 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.01 112.58 18.6 Favored Pre-proline 0 N--CA 1.499 1.982 0 O-C-N 121.243 -1.151 . . . . 0.040000000000000001 109.412 179.244 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 990' ' ' PRO . . . . . 0.418 ' O ' ' HB2' ' C' ' 991' ' ' GLU . 49.4 Cg_endo -90.22 70.84 1.55 Allowed 'Trans proline' 0 C--N 1.319 -1.018 0 O-C-N 123.152 1.08 . . . . 0.45000000000000001 111.365 -178.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 991' ' ' GLU . . . . . 0.418 ' HB2' ' O ' ' C' ' 990' ' ' PRO . 69.6 mt-10 67.65 -73.27 0.08 Allowed 'General case' 0 N--CA 1.503 2.177 0 N-CA-C 108.603 -0.888 . . . . 1.97 108.603 -177.548 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 992' ' ' LEU . . . . . . . . . . . . . 11.3 mt 50.56 20.62 0.74 Allowed 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.544 -0.722 . . . . 2.3799999999999999 111.705 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -93.9 156.76 16.46 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.893 -1.13 . . . . 3.79 109.998 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 69.7 m80 -145.75 92.8 2.26 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.567 -0.708 . . . . 3.5099999999999998 110.308 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 995' ' ' ALA . . . . . . . . . . . . 2.518 . . . . . . . 0 N--CA 1.503 2.206 0 O-C-N 120.936 -1.103 . . . . 2.73 110.631 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo . . . . . 0 N--CA 1.488 1.203 0 N-CA-C 109.53 -0.989 . . . . 3.8300000000000001 109.53 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 847' ' ' VAL . . . . . 0.442 HG12 ' HB2' ' A' ' 849' ' ' GLN . 60.2 t -132.17 103.36 14.06 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.555 -0.716 . . . . 1.8300000000000001 110.188 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 848' ' ' PRO . . . . . 0.74 ' O ' HG23 ' A' ' 850' ' ' VAL . 43.7 Cg_endo -69.84 -20.32 34.61 Favored 'Trans proline' 0 N--CA 1.487 1.145 0 O-C-N 123.28 1.147 . . . . 0.65000000000000002 110.955 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 849' ' ' GLN . . . . . 0.442 ' HB2' HG12 ' A' ' 847' ' ' VAL . 57.0 tt0 27.73 68.79 0.07 Allowed 'General case' 0 N--CA 1.518 2.97 0 N-CA-C 112.821 0.675 . . . . 2.5800000000000001 112.821 179.247 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 850' ' ' VAL . . . . . 0.74 HG23 ' O ' ' A' ' 848' ' ' PRO . 57.6 t -119.93 136.06 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.135 -0.978 . . . . 1.0900000000000001 111.65 -178.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 851' ' ' ALA . . . . . 0.584 ' HB3' ' HG ' ' A' ' 873' ' ' LEU . . . -126.14 157.33 38.37 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 105.749 -1.945 . . . . 0.040000000000000001 105.749 176.658 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 852' ' ' PHE . . . . . 0.432 ' HA ' ' CB ' ' A' ' 874' ' ' ASN . 22.7 p90 -160.84 127.32 4.04 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 121.009 1.731 . . . . 0.050000000000000003 108.437 179.066 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 5.8 t -176.1 134.7 0.26 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.35 -0.981 . . . . 0.040000000000000001 108.35 -178.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -132.21 155.66 47.85 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.035 -1.04 . . . . 0.67000000000000004 109.541 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 855' ' ' ALA . . . . . 0.809 ' HB3' ' CB ' ' A' ' 870' ' ' ARG . . . -121.67 143.91 49.07 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.855 0.836 . . . . 0.51000000000000001 111.258 -179.043 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 856' ' ' LEU . . . . . 0.594 ' C ' HD13 ' A' ' 856' ' ' LEU . 3.4 tm? -113.13 134.73 54.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.688 -0.633 . . . . 0.050000000000000003 110.283 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 857' ' ' SER . . . . . 0.55 ' N ' HD13 ' A' ' 856' ' ' LEU . 60.8 p -151.94 17.74 0.68 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.565 -0.71 . . . . 1.3300000000000001 110.59 178.712 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 858' ' ' LEU . . . . . 0.761 HD22 ' OE1' ' A' ' 862' ' ' GLU . 4.4 pp -33.27 157.11 0.04 OUTLIER Pre-proline 0 N--CA 1.518 2.942 0 N-CA-C 113.159 0.8 . . . . 2.3300000000000001 113.159 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -63.2 -88.3 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.376 0 O-C-N 123.107 1.056 . . . . 2.3199999999999998 113.162 -178.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 55.2 ptt85 -128.68 -143.36 0.27 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.888 -1.132 . . . . 0.040000000000000001 111.647 -177.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 14.0 m -40.18 126.78 2.2 Favored 'General case' 0 N--CA 1.508 2.457 0 O-C-N 121.527 -0.733 . . . . 1.3100000000000001 112.453 -178.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 862' ' ' GLU . . . . . 0.761 ' OE1' HD22 ' A' ' 858' ' ' LEU . 0.7 OUTLIER -101.95 157.6 33.37 Favored Pre-proline 0 N--CA 1.489 1.498 0 N-CA-C 107.683 -1.229 . . . . 4.5099999999999998 107.683 176.967 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 863' ' ' PRO . . . . . 0.425 ' HD2' ' CG ' ' A' ' 862' ' ' GLU . 44.2 Cg_endo -71.55 -12.25 29.09 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 O-C-N 123.029 1.015 . . . . 2.2400000000000002 111.472 -179.315 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -176.02 -136.59 2.38 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 110.143 -1.183 . . . . 0.040000000000000001 110.143 179.263 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 25.7 m -65.48 155.85 34.3 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.317 -1.108 . . . . 1.51 110.935 -178.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 866' ' ' VAL . . . . . 0.567 HG11 ' HG ' ' A' ' 856' ' ' LEU . 60.1 t -92.14 135.29 27.24 Favored Pre-proline 0 N--CA 1.495 1.788 0 N-CA-C 113.273 0.842 . . . . 0.78000000000000003 113.273 -174.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 867' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 866' ' ' VAL . 54.9 Cg_endo -90.61 -153.01 0.04 OUTLIER 'Trans proline' 0 CA--C 1.54 0.805 0 N-CA-C 108.658 -1.324 . . . . 0.92000000000000004 108.658 177.51 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 868' ' ' PHE . . . . . 0.456 ' CD1' ' HG2' ' A' ' 881' ' ' PRO . 27.0 p90 -150.66 122.65 8.2 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.567 -1.333 . . . . 0.050000000000000003 109.632 179.226 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 49.7 p-10 -114.1 -1.93 13.58 Favored 'General case' 0 N--CA 1.5 2.035 0 C-N-CA 119.299 -0.961 . . . . 1.7 112.549 -178.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 870' ' ' ARG . . . . . 0.809 ' CB ' ' HB3' ' A' ' 855' ' ' ALA . 29.1 mmm180 -90.85 88.15 6.94 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.869 -1.144 . . . . 2.5899999999999999 110.83 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 57.5 t -72.94 97.35 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 120.929 -1.107 . . . . 1.9399999999999999 109.858 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 872' ' ' LEU . . . . . 0.617 HD11 ' HB2' ' A' ' 855' ' ' ALA . 96.1 mt -83.15 -47.47 11.57 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.524 -0.735 . . . . 1.0600000000000001 110.109 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 873' ' ' LEU . . . . . 0.584 ' HG ' ' HB3' ' A' ' 851' ' ' ALA . 30.4 tp -174.65 103.96 0.1 Allowed 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.594 -0.891 . . . . 4.1799999999999997 108.594 178.666 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 874' ' ' ASN . . . . . 0.432 ' CB ' ' HA ' ' A' ' 852' ' ' PHE . 37.6 t-20 178.59 81.79 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.309 0 O-C-N 121.64 -0.663 . . . . 0.040000000000000001 109.648 -178.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -66.2 -47.05 75.16 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.062 -1.024 . . . . 3.3799999999999999 111.019 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 876' ' ' GLY . . . . . . . . . . . . . . . -74.57 -25.33 70.38 Favored Glycine 0 N--CA 1.494 2.552 0 O-C-N 121.282 -0.886 . . . . 0.040000000000000001 111.712 -178.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 86.42 -58.57 4.69 Favored Glycine 0 N--CA 1.502 3.041 0 N-CA-C 108.043 -2.023 . . . . 0.040000000000000001 108.043 -178.18 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 878' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 60.37 -67.78 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 114.283 1.216 . . . . 3.46 114.283 177.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 879' ' ' TYR . . . . . 0.471 ' CB ' ' CD2' ' A' ' 886' ' ' PHE . 24.3 p90 -113.08 111.44 22.15 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 114.841 1.422 . . . . 0.040000000000000001 114.841 -176.434 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -66.19 119.01 58.44 Favored Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 121.526 -0.734 . . . . 0.02 110.257 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 881' ' ' PRO . . . . . 0.456 ' HG2' ' CD1' ' A' ' 868' ' ' PHE . 54.5 Cg_endo -76.44 0.67 9.23 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 O-C-N 123.389 1.205 . . . . 0.39000000000000001 112.128 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -74.77 -65.27 0.89 Allowed 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 106.686 -1.598 . . . . 0.81000000000000005 106.686 178.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 7.0 p -97.22 -15.28 20.93 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 109.014 -0.735 . . . . 0.040000000000000001 109.014 177.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.1 24.2 49.17 Favored Glycine 0 N--CA 1.494 2.523 0 O-C-N 120.947 -1.096 . . . . 0.029999999999999999 110.696 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 885' ' ' VAL . . . . . . . . . . . . . 92.4 t -72.26 88.59 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 C-N-CA 118.453 -1.299 . . . . 1.01 107.823 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 886' ' ' PHE . . . . . 0.924 ' HB3' HG22 ' A' ' 962' ' ' VAL . 0.7 OUTLIER -90.73 105.92 18.15 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 115.175 -0.92 . . . . 0.050000000000000003 112.442 -176.942 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 887' ' ' THR . . . . . 0.418 ' O ' ' HD3' ' A' ' 889' ' ' PRO . 89.8 m -96.25 100.42 12.05 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 107.48 -1.304 . . . . 0.68000000000000005 107.48 177.035 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 888' ' ' ALA . . . . . . . . . . . . . . . -99.15 106.53 39.06 Favored Pre-proline 0 N--CA 1.501 2.112 0 N-CA-C 114.044 1.127 . . . . 0.25 114.044 -176.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 889' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 887' ' ' THR . 53.8 Cg_endo -90.07 -11.98 2.95 Favored 'Trans proline' 0 CA--C 1.546 1.089 0 C-N-CA 121.093 1.195 . . . . 1.6399999999999999 109.213 176.22 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 890' ' ' LEU . . . . . 0.537 HD11 ' CD1' ' A' ' 985' ' ' LEU . 4.6 tt -34.78 -52.0 0.51 Allowed 'General case' 0 N--CA 1.509 2.482 0 N-CA-C 113.834 1.05 . . . . 2.29 113.834 -177.429 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 51.38 95.41 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.313 0 O-C-N 121.181 -0.949 . . . . 0.63 110.438 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 156.15 -147.8 16.92 Favored Glycine 0 N--CA 1.479 1.539 0 N-CA-C 107.383 -2.287 . . . . 0.040000000000000001 107.383 -179.183 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 893' ' ' ARG . . . . . 0.479 ' NE ' ' HB1' ' C' ' 984' ' ' ALA . 72.9 ttt-85 -108.96 127.08 53.76 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 107.536 -1.283 . . . . 3.0 107.536 177.222 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 894' ' ' TYR . . . . . 0.462 ' OH ' HD12 ' A' ' 896' ' ' LEU . 0.1 OUTLIER -131.42 144.71 51.39 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.03 -1.044 . . . . 0.040000000000000001 110.154 -179.008 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 895' ' ' LEU . . . . . 0.447 ' N ' ' CD1' ' A' ' 894' ' ' TYR . 33.9 tp -99.25 116.64 31.9 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.623 -0.673 . . . . 1.27 109.933 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 896' ' ' LEU . . . . . 0.523 HD23 ' N ' ' A' ' 897' ' ' SER . 10.4 tt -112.91 145.87 39.97 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.645 -0.66 . . . . 0.93999999999999995 110.785 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 897' ' ' SER . . . . . 0.523 ' N ' HD23 ' A' ' 896' ' ' LEU . 63.1 m -143.04 119.02 10.64 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.466 -0.771 . . . . 0.040000000000000001 110.781 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -108.34 146.91 32.28 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.657 -0.652 . . . . 0.47999999999999998 109.387 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 899' ' ' VAL . . . . . 0.72 HG21 ' HB ' ' A' ' 980' ' ' ILE . 88.3 t -93.61 119.69 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 C-N-CA 119.788 -0.765 . . . . 0.55000000000000004 111.031 -179.392 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 900' ' ' LEU . . . . . 0.57 HD12 ' HB2' ' A' ' 924' ' ' SER . 4.4 mm? -94.24 113.13 24.99 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 114.307 1.225 . . . . 1.5900000000000001 114.307 -174.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 18.1 m -67.0 141.65 57.52 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 107.33 -1.359 . . . . 0.050000000000000003 107.33 176.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -66.28 -64.84 3.12 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 110.664 -0.974 . . . . 0.029999999999999999 110.664 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 5.9 m170 46.54 64.65 1.44 Allowed 'General case' 0 N--CA 1.508 2.466 0 O-C-N 121.363 -1.081 . . . . 3.2000000000000002 111.189 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 41.6 ptt85 -68.97 -6.65 29.0 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.563 -0.71 . . . . 2.9199999999999999 112.084 -179.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 905' ' ' HIS . . . . . 0.49 ' O ' ' CB ' ' A' ' 906' ' ' GLU . 70.6 t60 -63.31 5.76 0.15 Allowed 'General case' 0 N--CA 1.505 2.324 0 O-C-N 120.945 -1.097 . . . . 2.8700000000000001 113.214 -179.052 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 906' ' ' GLU . . . . . 0.49 ' CB ' ' O ' ' A' ' 905' ' ' HIS . 0.5 OUTLIER 94.88 -164.24 0.0 OUTLIER 'General case' 0 N--CA 1.529 3.514 0 CA-C-N 120.487 1.494 . . . . 0.98999999999999999 111.789 179.126 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 907' ' ' LYS . . . . . 0.471 ' CB ' ' O ' ' A' ' 906' ' ' GLU . 56.5 tttt 86.69 156.24 0.08 Allowed 'General case' 0 N--CA 1.52 3.031 0 N-CA-C 108.124 -1.065 . . . . 5.25 108.124 -176.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 60.8 t -123.12 115.88 46.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 120.821 -1.174 . . . . 0.39000000000000001 111.173 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -102.65 132.78 48.54 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 107.334 -1.358 . . . . 1.72 107.334 176.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -154.7 123.24 6.09 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 106.715 -1.587 . . . . 0.67000000000000004 106.715 178.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 911' ' ' VAL . . . . . 0.79 HG22 HG13 ' A' ' 964' ' ' VAL . 79.4 t -82.77 131.06 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 C-N-CA 120.378 -0.529 . . . . 0.54000000000000004 111.028 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 75.3 mt -66.7 156.45 35.28 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.381 -0.824 . . . . 1.5 109.032 178.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 913' ' ' SER . . . . . 0.491 ' OG ' HG11 ' A' ' 919' ' ' VAL . 1.1 p -125.34 135.41 52.43 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.23 -1.026 . . . . 1.3700000000000001 108.23 176.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 914' ' ' ARG . . . . . 0.88 ' NH1' HD23 ' A' ' 956' ' ' LEU . 0.0 OUTLIER -64.23 155.11 32.94 Favored 'General case' 0 N--CA 1.506 2.361 0 O-C-N 120.7 -1.25 . . . . 4.2999999999999998 111.63 -179.287 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 915' ' ' SER . . . . . 0.441 ' CB ' ' O ' ' A' ' 914' ' ' ARG . 2.0 t 84.1 -31.75 0.07 Allowed 'General case' 0 N--CA 1.52 3.071 0 C-N-CA 124.036 0.935 . . . . 2.0499999999999998 111.769 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 916' ' ' ASN . . . . . 0.77 ' HB2' HG21 ' A' ' 919' ' ' VAL . 68.8 m-80 -123.49 -21.3 5.33 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 120.946 -1.096 . . . . 2.71 111.299 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 917' ' ' GLN . . . . . 0.413 ' HB2' ' O ' ' A' ' 916' ' ' ASN . 50.2 mt-30 66.71 166.48 0.21 Allowed 'General case' 0 N--CA 1.52 3.047 0 N-CA-C 105.789 -1.93 . . . . 2.6800000000000002 105.789 -174.097 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.24 -125.32 33.43 Favored Glycine 1 N--CA 1.522 4.372 0 CA-C-N 123.646 2.93 . . . . 0.029999999999999999 107.041 -177.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 919' ' ' VAL . . . . . 0.77 HG21 ' HB2' ' A' ' 916' ' ' ASN . 78.1 t 51.57 94.14 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 O-C-N 121.357 -1.084 . . . . 1.3899999999999999 109.08 -178.269 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 920' ' ' ALA . . . . . 0.74 ' HB3' HG12 ' A' ' 949' ' ' VAL . . . -92.31 91.83 7.88 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 119.358 -0.937 . . . . 0.029999999999999999 110.882 -179.166 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 921' ' ' ARG . . . . . 0.841 ' HG3' HG23 ' A' ' 922' ' ' VAL . 30.7 ptt180 -83.56 -41.42 17.93 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 105.641 -1.985 . . . . 4.4199999999999999 105.641 176.016 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 922' ' ' VAL . . . . . 0.841 HG23 ' HG3' ' A' ' 921' ' ' ARG . 97.1 t -98.79 78.39 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 N-CA-C 106.041 -1.837 . . . . 0.84999999999999998 106.041 175.562 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -86.12 133.91 33.85 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.717 0.77 . . . . 2.46 111.381 -177.385 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 924' ' ' SER . . . . . 0.57 ' HB2' HD12 ' A' ' 900' ' ' LEU . 17.8 t -147.35 104.49 3.65 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.869 -0.789 . . . . 0.69999999999999996 108.869 179.396 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -103.75 83.35 0.41 Allowed Glycine 0 N--CA 1.487 2.071 0 N-CA-C 108.242 -1.943 . . . . 0.040000000000000001 108.242 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.239 0 N-CA-C 108.98 -1.648 . . . . 0.040000000000000001 108.98 -179.403 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 63.8 m . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.005 0.431 . . . . 13.779999999999999 110.264 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 94.4 mt -109.44 129.41 55.55 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.574 -0.704 . . . . 13.76 110.369 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -152.64 169.33 31.73 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.189 -1.565 . . . . 9.1300000000000008 109.189 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 949' ' ' VAL . . . . . 0.74 HG12 ' HB3' ' A' ' 920' ' ' ALA . 35.1 m -117.99 133.21 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.518 -0.989 . . . . 7.0800000000000001 110.801 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 950' ' ' PHE . . . . . 0.449 ' CZ ' ' HB3' ' A' ' 921' ' ' ARG . 30.7 p90 -130.69 147.06 52.32 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.59 -0.694 . . . . 7.5899999999999999 109.502 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 73.6 m -119.98 -54.68 2.11 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.487 -0.758 . . . . 5.0300000000000002 111.843 -178.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 952' ' ' LEU . . . . . 0.41 ' O ' ' O ' ' A' ' 953' ' ' ILE . 55.9 tp -60.75 -76.87 0.05 OUTLIER 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.417 -0.802 . . . . 1.01 112.178 -177.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 953' ' ' ILE . . . . . 0.488 HD11 HD13 ' C' ' 872' ' ' LEU . 47.6 pt -53.78 -141.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.656 0 N-CA-C 113.81 1.041 . . . . 2.6000000000000001 113.81 -176.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 954' ' ' LEU . . . . . 0.793 HD22 ' O ' ' A' ' 954' ' ' LEU . 0.0 OUTLIER 173.79 78.7 0.05 OUTLIER Pre-proline 0 N--CA 1.508 2.451 0 O-C-N 120.777 -1.202 . . . . 0.050000000000000003 111.037 179.427 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 955' ' ' PRO . . . . . 0.553 ' C ' HD12 ' A' ' 956' ' ' LEU . 45.8 Cg_endo -73.61 89.89 0.95 Allowed 'Trans proline' 0 C--N 1.314 -1.255 0 N-CA-C 109.45 -1.019 . . . . 0.83999999999999997 109.45 178.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 956' ' ' LEU . . . . . 0.88 HD23 ' NH1' ' A' ' 914' ' ' ARG . 5.7 mp -125.52 150.17 47.66 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.187 -0.946 . . . . 0.040000000000000001 110.487 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 59.6 mt-30 -81.74 151.9 27.27 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-O 117.784 -1.103 . . . . 1.28 111.793 -179.108 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -70.2 119.83 14.98 Favored 'General case' 0 N--CA 1.511 2.609 0 CA-C-N 123.048 2.658 . . . . 0.17000000000000001 111.671 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.6 -23.0 30.22 Favored Glycine 0 N--CA 1.501 3.031 0 N-CA-C 111.025 -0.83 . . . . 0.040000000000000001 111.025 178.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 960' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.85 171.45 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.567 -0.96 . . . . 0.040000000000000001 110.202 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 961' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' A' ' 886' ' ' PHE . 46.3 m -133.36 137.87 46.06 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.893 -1.129 . . . . 1.78 112.127 -178.01 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 962' ' ' VAL . . . . . 0.924 HG22 ' HB3' ' A' ' 886' ' ' PHE . 26.3 m -99.03 144.13 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.675 -0.641 . . . . 0.040000000000000001 110.229 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 1.6 m -137.68 144.32 41.76 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.857 -0.527 . . . . 0.71999999999999997 110.031 -178.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 964' ' ' VAL . . . . . 0.79 HG13 HG22 ' A' ' 911' ' ' VAL . 58.1 t -94.88 136.01 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.13 -0.981 . . . . 1.05 110.538 -179.193 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -93.98 127.51 39.8 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 103.784 -2.673 . . . . 3.02 103.784 173.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 966' ' ' LEU . . . . . 0.49 ' C ' HG23 ' A' ' 967' ' ' VAL . 1.2 tt -132.12 61.43 1.66 Allowed 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.232 -1.025 . . . . 1.46 108.232 177.267 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 967' ' ' VAL . . . . . 0.49 HG23 ' C ' ' A' ' 966' ' ' LEU . 94.2 t -158.28 96.41 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 108.056 -1.09 . . . . 1.9399999999999999 108.056 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 90.6 mmm -142.17 60.1 1.46 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.709 -1.244 . . . . 0.0 108.344 179.238 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.47 119.83 1.95 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 107.08 -2.408 . . . . 2.1099999999999999 107.08 -178.266 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -81.96 -58.04 3.15 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.065 -1.256 . . . . 5.8899999999999997 110.562 -179.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 40.6 tp -59.19 90.01 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.442 -0.786 . . . . 4.3600000000000003 110.283 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -141.32 -154.02 0.49 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.613 -0.679 . . . . 1.8300000000000001 110.117 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -120.08 172.34 7.82 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.486 -0.759 . . . . 4.3499999999999996 110.215 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 30.8 t -101.46 130.05 47.63 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.568 -0.707 . . . . 1.27 110.009 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -156.21 156.44 34.15 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.499 -0.75 . . . . 5.0199999999999996 110.529 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.15 85.46 18.8 Favored Pre-proline 0 N--CA 1.5 2.041 0 O-C-N 121.616 -0.677 . . . . 2.4100000000000001 109.613 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 977' ' ' PRO . . . . . 0.665 ' C ' HD12 ' A' ' 978' ' ' LEU . 47.2 Cg_endo -72.82 -172.58 0.99 Allowed 'Trans proline' 0 C--N 1.317 -1.091 0 O-C-N 123.29 1.153 . . . . 0.95999999999999996 111.216 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 978' ' ' LEU . . . . . 0.665 HD12 ' C ' ' A' ' 977' ' ' PRO . 6.7 mp -127.25 154.7 44.55 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 107.644 -1.243 . . . . 0.62 107.644 178.045 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 979' ' ' THR . . . . . 0.466 HG23 ' C ' ' A' ' 978' ' ' LEU . 41.1 p -150.54 141.16 22.61 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.781 -1.199 . . . . 3.5699999999999998 111.145 -179.439 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 980' ' ' ILE . . . . . 0.72 ' HB ' HG21 ' A' ' 899' ' ' VAL . 50.7 mm -106.22 127.43 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 108.881 -0.785 . . . . 1.3300000000000001 108.881 179.351 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 981' ' ' PHE . . . . . 0.401 ' HD1' ' HH ' ' A' ' 879' ' ' TYR . 6.7 t80 -120.71 99.26 6.43 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.414 -0.804 . . . . 0.050000000000000003 111.782 -178.323 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 85.9 p -108.16 159.89 16.25 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 109.06 -0.719 . . . . 0.87 109.06 178.507 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . -171.45 109.55 0.32 Allowed Glycine 0 N--CA 1.498 2.82 0 N-CA-C 106.635 -2.586 . . . . 0.029999999999999999 106.635 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -109.61 148.62 30.98 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 114.561 1.319 . . . . 0.69999999999999996 114.561 -175.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 985' ' ' LEU . . . . . 0.537 ' CD1' HD11 ' A' ' 890' ' ' LEU . 51.8 tp -68.77 134.4 49.7 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.854 -1.154 . . . . 0.040000000000000001 110.084 179.498 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 45.8 tp -107.82 -59.19 1.87 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.563 -0.71 . . . . 0.040000000000000001 109.925 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -144.32 144.91 31.68 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.601 -1.259 . . . . 0.040000000000000001 107.601 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -113.1 162.8 12.24 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 108.187 -1.965 . . . . 0.040000000000000001 108.187 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -75.16 112.97 20.8 Favored Pre-proline 0 N--CA 1.499 1.981 0 O-C-N 121.186 -1.185 . . . . 0.040000000000000001 109.454 179.069 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 990' ' ' PRO . . . . . 0.424 ' O ' ' HB2' ' A' ' 991' ' ' GLU . 50.9 Cg_endo -88.01 72.09 2.69 Favored 'Trans proline' 0 C--N 1.32 -0.968 0 O-C-N 123.055 1.029 . . . . 0.45000000000000001 111.363 -179.004 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 991' ' ' GLU . . . . . 0.424 ' HB2' ' O ' ' A' ' 990' ' ' PRO . 71.8 mt-10 67.51 -73.65 0.08 Allowed 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 108.529 -0.915 . . . . 1.97 108.529 -177.533 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 992' ' ' LEU . . . . . 0.404 ' HA ' HD23 ' A' ' 992' ' ' LEU . 11.1 mt 50.55 20.87 0.77 Allowed 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.612 -0.68 . . . . 2.3799999999999999 111.642 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -93.56 156.7 16.58 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.942 -1.099 . . . . 3.79 110.033 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -145.3 92.6 2.27 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.587 -0.696 . . . . 3.5099999999999998 110.276 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 995' ' ' ALA . . . . . . . . . . . . 2.519 . . . . . . . 0 N--CA 1.503 2.224 0 O-C-N 120.887 -1.133 . . . . 2.73 110.648 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo . . . . . 0 N--CA 1.488 1.172 0 N-CA-C 109.543 -0.983 . . . . 3.8300000000000001 109.543 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 847' ' ' VAL . . . . . 0.423 HG12 ' HB2' ' B' ' 849' ' ' GLN . 61.5 t -132.57 103.42 13.51 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.547 -0.721 . . . . 1.8300000000000001 110.098 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 848' ' ' PRO . . . . . 0.734 ' O ' HG23 ' B' ' 850' ' ' VAL . 43.7 Cg_endo -69.88 -20.28 34.44 Favored 'Trans proline' 0 N--CA 1.487 1.125 0 O-C-N 123.299 1.157 . . . . 0.65000000000000002 111.003 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 849' ' ' GLN . . . . . 0.423 ' HB2' HG12 ' B' ' 847' ' ' VAL . 56.9 tt0 27.77 68.22 0.07 Allowed 'General case' 0 N--CA 1.518 2.941 0 N-CA-C 112.923 0.712 . . . . 2.5800000000000001 112.923 179.156 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 850' ' ' VAL . . . . . 0.734 HG23 ' O ' ' B' ' 848' ' ' PRO . 57.4 t -119.37 136.14 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.128 -0.983 . . . . 1.0900000000000001 111.679 -178.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 851' ' ' ALA . . . . . 0.596 ' HB3' ' HG ' ' B' ' 873' ' ' LEU . . . -126.29 157.13 39.16 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 105.776 -1.935 . . . . 0.040000000000000001 105.776 176.67 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 852' ' ' PHE . . . . . 0.424 ' HA ' ' CB ' ' B' ' 874' ' ' ASN . 23.0 p90 -160.68 127.4 4.16 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 120.886 1.675 . . . . 0.050000000000000003 108.581 179.105 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 5.7 t -176.15 134.79 0.26 Allowed 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.305 -0.998 . . . . 0.040000000000000001 108.305 -178.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -132.15 156.1 46.99 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.066 -1.022 . . . . 0.67000000000000004 109.542 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 855' ' ' ALA . . . . . 0.808 ' HB3' ' CB ' ' B' ' 870' ' ' ARG . . . -121.92 143.97 49.14 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.864 0.84 . . . . 0.51000000000000001 111.315 -179.016 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 856' ' ' LEU . . . . . 0.603 ' C ' HD13 ' B' ' 856' ' ' LEU . 3.4 tm? -113.2 134.88 54.36 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.687 -0.633 . . . . 0.050000000000000003 110.253 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 857' ' ' SER . . . . . 0.54 ' N ' HD13 ' B' ' 856' ' ' LEU . 60.8 p -152.12 16.96 0.65 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.553 -0.717 . . . . 1.3300000000000001 110.616 178.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 858' ' ' LEU . . . . . 0.744 HD22 ' OE1' ' B' ' 862' ' ' GLU . 4.4 pp -32.65 156.92 0.03 OUTLIER Pre-proline 0 N--CA 1.518 2.945 0 N-CA-C 113.276 0.843 . . . . 2.3300000000000001 113.276 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -62.95 -88.39 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.344 0 O-C-N 123.132 1.07 . . . . 2.3199999999999998 113.228 -178.211 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 55.2 ptt85 -128.65 -143.36 0.27 Allowed 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.852 -1.155 . . . . 0.040000000000000001 111.685 -177.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 14.1 m -40.16 126.83 2.19 Favored 'General case' 0 N--CA 1.508 2.451 0 O-C-N 121.566 -0.709 . . . . 1.3100000000000001 112.408 -178.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 862' ' ' GLU . . . . . 0.744 ' OE1' HD22 ' B' ' 858' ' ' LEU . 0.7 OUTLIER -102.01 157.63 33.32 Favored Pre-proline 0 N--CA 1.489 1.51 0 N-CA-C 107.673 -1.232 . . . . 4.5099999999999998 107.673 176.954 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 863' ' ' PRO . . . . . 0.417 ' HD2' ' CG ' ' B' ' 862' ' ' GLU . 44.4 Cg_endo -71.63 -11.94 28.56 Favored 'Trans proline' 0 C--N 1.314 -1.268 0 O-C-N 123.006 1.003 . . . . 2.2400000000000002 111.472 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -176.08 -136.61 2.39 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 110.152 -1.179 . . . . 0.040000000000000001 110.152 179.303 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 26.1 m -65.75 155.95 34.56 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.357 -1.084 . . . . 1.51 110.934 -178.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 866' ' ' VAL . . . . . 0.564 HG11 ' HG ' ' B' ' 856' ' ' LEU . 59.8 t -92.11 135.22 27.36 Favored Pre-proline 0 N--CA 1.494 1.743 0 N-CA-C 113.265 0.839 . . . . 0.78000000000000003 113.265 -174.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 867' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' B' ' 866' ' ' VAL . 54.9 Cg_endo -90.49 -152.7 0.04 OUTLIER 'Trans proline' 0 CA--C 1.54 0.82 0 N-CA-C 108.612 -1.341 . . . . 0.92000000000000004 108.612 177.502 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 868' ' ' PHE . . . . . 0.449 ' CD1' ' N ' ' B' ' 868' ' ' PHE . 27.0 p90 -150.98 122.47 7.91 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.631 -1.293 . . . . 0.050000000000000003 109.592 179.218 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 50.3 p-10 -113.86 -1.94 13.75 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 119.343 -0.943 . . . . 1.7 112.519 -178.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 870' ' ' ARG . . . . . 0.808 ' CB ' ' HB3' ' B' ' 855' ' ' ALA . 28.9 mmm180 -90.72 88.45 7.09 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.908 -1.12 . . . . 2.5899999999999999 110.773 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 57.3 t -73.28 97.07 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.011 -1.056 . . . . 1.9399999999999999 109.864 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 872' ' ' LEU . . . . . 0.615 HD11 ' HB2' ' B' ' 855' ' ' ALA . 96.2 mt -83.05 -47.57 11.54 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.535 -0.728 . . . . 1.0600000000000001 110.14 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 873' ' ' LEU . . . . . 0.596 ' HG ' ' HB3' ' B' ' 851' ' ' ALA . 30.4 tp -174.63 103.83 0.1 Allowed 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.545 -0.909 . . . . 4.1799999999999997 108.545 178.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 874' ' ' ASN . . . . . 0.424 ' CB ' ' HA ' ' B' ' 852' ' ' PHE . 37.5 t-20 178.66 81.66 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.281 0 O-C-N 121.608 -0.682 . . . . 0.040000000000000001 109.698 -178.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -66.03 -47.11 75.49 Favored 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 119.297 -0.961 . . . . 3.3799999999999999 110.994 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 876' ' ' GLY . . . . . . . . . . . . . . . -74.64 -24.78 71.63 Favored Glycine 0 N--CA 1.493 2.486 0 C-N-CA 120.526 -0.845 . . . . 0.040000000000000001 111.842 -178.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 85.91 -58.77 4.78 Favored Glycine 0 N--CA 1.502 3.06 0 N-CA-C 108.105 -1.998 . . . . 0.040000000000000001 108.105 -178.199 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 878' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 60.45 -67.74 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 114.263 1.209 . . . . 3.46 114.263 177.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 879' ' ' TYR . . . . . 0.463 ' CB ' ' CD2' ' B' ' 886' ' ' PHE . 24.2 p90 -113.2 110.67 20.78 Favored 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 114.955 1.465 . . . . 0.040000000000000001 114.955 -176.344 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -65.62 118.94 56.09 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 121.494 -0.754 . . . . 0.02 110.196 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 881' ' ' PRO . . . . . 0.445 ' HG2' ' CD1' ' B' ' 868' ' ' PHE . 54.2 Cg_endo -76.34 0.38 9.5 Favored 'Trans proline' 0 N--CA 1.493 1.483 0 O-C-N 123.337 1.178 . . . . 0.39000000000000001 112.221 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -74.44 -65.23 0.88 Allowed 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 106.7 -1.593 . . . . 0.81000000000000005 106.7 178.433 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 7.0 p -96.99 -15.77 20.92 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 109.0 -0.741 . . . . 0.040000000000000001 109.0 177.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.42 24.09 48.44 Favored Glycine 0 N--CA 1.495 2.569 0 C-N-CA 120.034 -1.079 . . . . 0.029999999999999999 110.596 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 885' ' ' VAL . . . . . . . . . . . . . 92.9 t -72.12 88.64 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 C-N-CA 118.514 -1.274 . . . . 1.01 107.865 -179.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 886' ' ' PHE . . . . . 0.892 ' HB3' HG22 ' B' ' 962' ' ' VAL . 0.7 OUTLIER -90.82 105.52 17.88 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 115.249 -0.887 . . . . 0.050000000000000003 112.577 -176.848 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 887' ' ' THR . . . . . 0.418 ' O ' ' HD3' ' B' ' 889' ' ' PRO . 89.6 m -95.93 100.27 11.97 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 107.555 -1.276 . . . . 0.68000000000000005 107.555 177.19 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 888' ' ' ALA . . . . . . . . . . . . . . . -99.02 106.55 38.76 Favored Pre-proline 0 N--CA 1.501 2.114 0 N-CA-C 114.125 1.157 . . . . 0.25 114.125 -176.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 889' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' B' ' 887' ' ' THR . 53.4 Cg_endo -90.15 -11.77 2.97 Favored 'Trans proline' 0 CA--C 1.547 1.143 0 C-N-CA 121.143 1.228 . . . . 1.6399999999999999 109.128 176.224 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 890' ' ' LEU . . . . . 0.537 HD11 ' CD1' ' B' ' 985' ' ' LEU . 4.6 tt -34.96 -51.81 0.53 Allowed 'General case' 0 N--CA 1.509 2.487 0 N-CA-C 113.867 1.062 . . . . 2.29 113.867 -177.422 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 51.29 95.52 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.373 0 O-C-N 121.131 -0.981 . . . . 0.63 110.425 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . 156.09 -147.68 16.65 Favored Glycine 0 N--CA 1.48 1.581 0 N-CA-C 107.383 -2.287 . . . . 0.040000000000000001 107.383 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 72.9 ttt-85 -109.04 127.06 53.79 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 107.49 -1.3 . . . . 3.0 107.49 177.188 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 894' ' ' TYR . . . . . 0.468 ' OH ' HD12 ' B' ' 896' ' ' LEU . 0.1 OUTLIER -131.45 144.81 51.44 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.053 -1.029 . . . . 0.040000000000000001 110.17 -179.112 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 895' ' ' LEU . . . . . 0.448 ' N ' ' CD1' ' B' ' 894' ' ' TYR . 34.1 tp -99.3 116.68 32.04 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.623 -0.673 . . . . 1.27 109.846 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 896' ' ' LEU . . . . . 0.536 HD23 ' N ' ' B' ' 897' ' ' SER . 10.4 tt -112.75 146.57 38.53 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.587 -0.696 . . . . 0.93999999999999995 110.704 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 897' ' ' SER . . . . . 0.536 ' N ' HD23 ' B' ' 896' ' ' LEU . 63.3 m -143.78 118.89 10.08 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.42 -0.8 . . . . 0.040000000000000001 110.741 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -108.2 147.21 31.67 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.689 -0.632 . . . . 0.47999999999999998 109.352 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 899' ' ' VAL . . . . . 0.71 HG21 ' HB ' ' B' ' 980' ' ' ILE . 88.3 t -93.86 120.15 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.417 -0.802 . . . . 0.55000000000000004 110.9 -179.501 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 900' ' ' LEU . . . . . 0.571 HD12 ' HB2' ' B' ' 924' ' ' SER . 4.4 mm? -94.7 112.94 24.67 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 114.257 1.206 . . . . 1.5900000000000001 114.257 -174.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 17.9 m -66.81 141.63 57.63 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 107.348 -1.352 . . . . 0.050000000000000003 107.348 176.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -66.18 -65.18 2.96 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 110.598 -1.001 . . . . 0.029999999999999999 110.598 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 5.9 m170 46.9 64.93 1.36 Allowed 'General case' 0 N--CA 1.507 2.393 0 O-C-N 121.381 -1.07 . . . . 3.2000000000000002 111.122 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 41.6 ptt85 -69.24 -6.71 30.92 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.574 -0.704 . . . . 2.9199999999999999 111.989 -179.229 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 905' ' ' HIS . . . . . 0.486 ' O ' ' CB ' ' B' ' 906' ' ' GLU . 70.5 t60 -63.48 6.14 0.15 Allowed 'General case' 0 N--CA 1.507 2.387 0 O-C-N 120.867 -1.146 . . . . 2.8700000000000001 113.163 -178.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 906' ' ' GLU . . . . . 0.486 ' CB ' ' O ' ' B' ' 905' ' ' HIS . 0.5 OUTLIER 94.58 -164.31 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.47 0 CA-C-N 120.592 1.542 . . . . 0.98999999999999999 111.848 179.008 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 907' ' ' LYS . . . . . 0.476 ' CB ' ' O ' ' B' ' 906' ' ' GLU . 56.6 tttt 86.62 156.04 0.08 Allowed 'General case' 0 N--CA 1.52 3.067 0 N-CA-C 108.042 -1.096 . . . . 5.25 108.042 -176.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 60.3 t -122.97 115.68 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 120.804 -1.185 . . . . 0.39000000000000001 111.116 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 51.0 tp10 -102.01 133.32 47.0 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 107.328 -1.36 . . . . 1.72 107.328 176.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -155.15 123.04 5.76 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 106.783 -1.562 . . . . 0.67000000000000004 106.783 178.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 911' ' ' VAL . . . . . 0.775 HG22 HG13 ' B' ' 964' ' ' VAL . 77.9 t -82.53 131.17 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.858 -0.526 . . . . 0.54000000000000004 111.022 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 75.5 mt -66.82 156.53 35.34 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.407 -0.808 . . . . 1.5 108.951 178.433 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 913' ' ' SER . . . . . 0.499 ' OG ' HG11 ' B' ' 919' ' ' VAL . 1.1 p -125.32 135.85 52.89 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.181 -1.044 . . . . 1.3700000000000001 108.181 176.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 914' ' ' ARG . . . . . 0.875 ' NH1' HD23 ' B' ' 956' ' ' LEU . 0.0 OUTLIER -64.61 155.62 32.67 Favored 'General case' 0 N--CA 1.506 2.35 0 O-C-N 120.619 -1.301 . . . . 4.2999999999999998 111.528 -179.295 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 915' ' ' SER . . . . . 0.429 ' CB ' ' O ' ' B' ' 914' ' ' ARG . 2.0 t 83.64 -31.58 0.08 Allowed 'General case' 0 N--CA 1.52 3.07 0 C-N-CA 123.968 0.907 . . . . 2.0499999999999998 111.887 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 916' ' ' ASN . . . . . 0.774 ' HB2' HG21 ' B' ' 919' ' ' VAL . 68.8 m-80 -123.82 -21.1 5.24 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 120.927 -1.108 . . . . 2.71 111.268 -179.378 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 917' ' ' GLN . . . . . 0.416 ' HB2' ' O ' ' B' ' 916' ' ' ASN . 50.3 mt-30 66.71 166.41 0.21 Allowed 'General case' 0 N--CA 1.521 3.094 0 N-CA-C 105.74 -1.948 . . . . 2.6800000000000002 105.74 -174.18 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.07 -125.08 32.37 Favored Glycine 1 N--CA 1.522 4.386 0 CA-C-N 123.397 2.817 . . . . 0.029999999999999999 107.071 -177.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 919' ' ' VAL . . . . . 0.774 HG21 ' HB2' ' B' ' 916' ' ' ASN . 76.4 t 51.69 94.23 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.262 0 O-C-N 121.407 -1.055 . . . . 1.3899999999999999 109.036 -178.294 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 920' ' ' ALA . . . . . 0.73 ' HB3' HG12 ' B' ' 949' ' ' VAL . . . -92.31 92.06 7.98 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.335 -0.946 . . . . 0.029999999999999999 110.831 -179.195 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 921' ' ' ARG . . . . . 0.863 ' HG3' HG23 ' B' ' 922' ' ' VAL . 30.6 ptt180 -83.68 -41.62 17.53 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 105.65 -1.981 . . . . 4.4199999999999999 105.65 175.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 922' ' ' VAL . . . . . 0.863 HG23 ' HG3' ' B' ' 921' ' ' ARG . 96.9 t -98.66 78.81 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 N-CA-C 105.939 -1.874 . . . . 0.84999999999999998 105.939 175.525 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -86.47 134.05 33.71 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.654 0.74 . . . . 2.46 111.368 -177.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 924' ' ' SER . . . . . 0.571 ' HB2' HD12 ' B' ' 900' ' ' LEU . 17.4 t -147.49 104.84 3.66 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.713 -0.847 . . . . 0.69999999999999996 108.713 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -104.13 83.36 0.4 Allowed Glycine 0 N--CA 1.487 2.041 0 N-CA-C 108.222 -1.951 . . . . 0.040000000000000001 108.222 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 108.973 -1.651 . . . . 0.040000000000000001 108.973 -179.376 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 68.1 m . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.014 0.435 . . . . 13.779999999999999 110.246 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 94.8 mt -108.88 129.44 55.41 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.583 -0.698 . . . . 13.76 110.323 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -152.19 168.83 31.43 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.235 -1.546 . . . . 9.1300000000000008 109.235 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 949' ' ' VAL . . . . . 0.73 HG12 ' HB3' ' B' ' 920' ' ' ALA . 35.0 m -117.85 132.74 66.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.525 -0.985 . . . . 7.0800000000000001 110.717 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 950' ' ' PHE . . . . . 0.445 ' CZ ' ' HB3' ' B' ' 921' ' ' ARG . 30.7 p90 -130.49 146.57 52.05 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.518 -0.739 . . . . 7.5899999999999999 109.55 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 73.4 m -119.38 -54.11 2.2 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.452 -0.78 . . . . 5.0300000000000002 111.808 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 952' ' ' LEU . . . . . 0.409 ' O ' ' O ' ' B' ' 953' ' ' ILE . 56.5 tp -61.42 -77.02 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.465 -0.772 . . . . 1.01 112.285 -177.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 953' ' ' ILE . . . . . 0.491 ' O ' ' HB3' ' B' ' 954' ' ' LEU . 48.9 pt -53.83 -141.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.739 0 N-CA-C 113.701 1.0 . . . . 2.6000000000000001 113.701 -176.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 954' ' ' LEU . . . . . 0.789 HD22 ' O ' ' B' ' 954' ' ' LEU . 0.0 OUTLIER 174.07 78.68 0.05 OUTLIER Pre-proline 0 N--CA 1.509 2.495 0 O-C-N 120.654 -1.279 . . . . 0.050000000000000003 110.963 179.47 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 955' ' ' PRO . . . . . 0.545 ' C ' HD12 ' B' ' 956' ' ' LEU . 46.0 Cg_endo -73.51 89.52 0.95 Allowed 'Trans proline' 0 C--N 1.315 -1.236 0 N-CA-C 109.514 -0.995 . . . . 0.83999999999999997 109.514 178.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 956' ' ' LEU . . . . . 0.875 HD23 ' NH1' ' B' ' 914' ' ' ARG . 5.7 mp -125.22 150.22 47.22 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.289 -0.882 . . . . 0.040000000000000001 110.461 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -82.14 151.38 26.99 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 117.729 -1.129 . . . . 1.28 111.828 -179.094 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -69.77 119.74 14.46 Favored 'General case' 0 N--CA 1.512 2.626 0 CA-C-N 123.14 2.7 . . . . 0.17000000000000001 111.784 -179.423 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.76 -22.66 32.48 Favored Glycine 0 N--CA 1.502 3.076 0 N-CA-C 111.037 -0.825 . . . . 0.040000000000000001 111.037 178.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 960' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -52.19 171.55 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.54 -0.976 . . . . 0.040000000000000001 110.198 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 961' ' ' THR . . . . . 0.461 ' HA ' ' O ' ' B' ' 886' ' ' PHE . 47.1 m -133.42 137.83 45.96 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.846 -1.159 . . . . 1.78 112.103 -178.084 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 962' ' ' VAL . . . . . 0.892 HG22 ' HB3' ' B' ' 886' ' ' PHE . 26.3 m -98.84 144.44 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 C-N-CA 120.169 -0.612 . . . . 0.040000000000000001 110.219 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 1.6 m -137.87 144.72 41.52 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.857 -0.527 . . . . 0.71999999999999997 110.009 -178.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 964' ' ' VAL . . . . . 0.775 HG13 HG22 ' B' ' 911' ' ' VAL . 58.1 t -95.2 136.34 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.107 -0.995 . . . . 1.05 110.434 -179.268 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -94.29 127.59 40.25 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 103.758 -2.682 . . . . 3.02 103.758 173.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 966' ' ' LEU . . . . . 0.494 ' C ' HG23 ' B' ' 967' ' ' VAL . 1.2 tt -132.24 61.67 1.66 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.123 -1.065 . . . . 1.46 108.123 177.315 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 967' ' ' VAL . . . . . 0.494 HG23 ' C ' ' B' ' 966' ' ' LEU . 94.4 t -158.42 97.02 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 107.917 -1.142 . . . . 1.9399999999999999 107.917 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 90.4 mmm -142.79 59.92 1.43 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.715 -1.24 . . . . 0.0 108.251 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.64 119.98 1.96 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 107.043 -2.423 . . . . 2.1099999999999999 107.043 -178.141 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -82.12 -58.2 3.06 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.974 -1.31 . . . . 5.8899999999999997 110.492 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 40.0 tp -58.9 90.47 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.407 -0.808 . . . . 4.3600000000000003 110.336 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -141.88 -154.32 0.51 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.565 -0.71 . . . . 1.8300000000000001 110.139 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -120.04 171.84 8.17 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.409 -0.807 . . . . 4.3499999999999996 110.273 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 31.5 t -100.97 130.03 46.9 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.555 -0.716 . . . . 1.27 110.068 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -156.25 156.44 34.09 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.511 -0.743 . . . . 5.0199999999999996 110.553 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.14 85.49 18.82 Favored Pre-proline 0 N--CA 1.5 2.038 0 O-C-N 121.655 -0.653 . . . . 2.4100000000000001 109.671 179.467 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 977' ' ' PRO . . . . . 0.673 ' C ' HD12 ' B' ' 978' ' ' LEU . 47.5 Cg_endo -72.66 -172.42 0.94 Allowed 'Trans proline' 0 C--N 1.317 -1.098 0 O-C-N 123.299 1.158 . . . . 0.95999999999999996 111.258 -179.407 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 978' ' ' LEU . . . . . 0.673 HD12 ' C ' ' B' ' 977' ' ' PRO . 6.6 mp -127.58 154.48 45.14 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 107.639 -1.245 . . . . 0.62 107.639 178.006 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 979' ' ' THR . . . . . 0.47 HG23 ' C ' ' B' ' 978' ' ' LEU . 41.3 p -150.28 141.38 23.05 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.79 -1.194 . . . . 3.5699999999999998 111.12 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 980' ' ' ILE . . . . . 0.71 ' HB ' HG21 ' B' ' 899' ' ' VAL . 50.7 mm -106.4 127.42 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 108.852 -0.796 . . . . 1.3300000000000001 108.852 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -120.63 99.25 6.43 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 119.723 -0.791 . . . . 0.050000000000000003 111.791 -178.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 81.9 p -108.42 159.67 16.49 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.543 -0.723 . . . . 0.87 109.104 178.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 983' ' ' GLY . . . . . . . . . . . . . . . -171.14 110.03 0.34 Allowed Glycine 0 N--CA 1.497 2.759 0 N-CA-C 106.496 -2.641 . . . . 0.029999999999999999 106.496 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -110.03 148.01 32.47 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 114.637 1.347 . . . . 0.69999999999999996 114.637 -175.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 985' ' ' LEU . . . . . 0.537 ' CD1' HD11 ' B' ' 890' ' ' LEU . 51.4 tp -68.17 134.27 50.22 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 120.895 -1.128 . . . . 0.040000000000000001 110.123 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 986' ' ' LEU . . . . . . . . . . . . . 45.8 tp -107.8 -59.11 1.88 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.598 -0.689 . . . . 0.040000000000000001 109.957 179.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -144.48 144.92 31.59 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 107.543 -1.28 . . . . 0.040000000000000001 107.543 179.088 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.98 163.21 12.16 Favored Glycine 0 N--CA 1.495 2.603 0 N-CA-C 108.271 -1.932 . . . . 0.040000000000000001 108.271 179.273 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -75.65 113.01 22.44 Favored Pre-proline 0 N--CA 1.498 1.965 0 O-C-N 121.273 -1.133 . . . . 0.040000000000000001 109.443 179.085 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 990' ' ' PRO . . . . . 0.415 ' O ' ' HB2' ' B' ' 991' ' ' GLU . 50.2 Cg_endo -88.07 72.06 2.65 Favored 'Trans proline' 0 C--N 1.319 -0.996 0 O-C-N 123.141 1.074 . . . . 0.45000000000000001 111.443 -178.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 991' ' ' GLU . . . . . 0.415 ' HB2' ' O ' ' B' ' 990' ' ' PRO . 71.8 mt-10 67.5 -73.68 0.08 Allowed 'General case' 0 N--CA 1.503 2.182 0 N-CA-C 108.502 -0.925 . . . . 1.97 108.502 -177.418 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 992' ' ' LEU . . . . . 0.443 HD23 ' HA ' ' B' ' 992' ' ' LEU . 11.1 mt 50.5 20.83 0.75 Allowed 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.605 -0.685 . . . . 2.3799999999999999 111.677 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -93.63 156.74 16.54 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.9 -1.125 . . . . 3.79 110.042 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -145.19 92.83 2.3 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.481 -0.762 . . . . 3.5099999999999998 110.211 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 995' ' ' ALA . . . . . . . . . . . . 2.518 . . . . . . . 0 N--CA 1.504 2.232 0 O-C-N 120.949 -1.095 . . . . 2.73 110.603 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo . . . . . 0 N--CA 1.489 1.239 0 N-CA-C 109.52 -0.992 . . . . 3.8300000000000001 109.52 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 847' ' ' VAL . . . . . 0.436 HG12 ' HB2' ' C' ' 849' ' ' GLN . 57.9 t -129.88 104.86 16.91 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.586 -0.696 . . . . 1.8300000000000001 110.088 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 848' ' ' PRO . . . . . 0.74 ' O ' HG23 ' C' ' 850' ' ' VAL . 44.3 Cg_endo -69.84 -22.05 32.23 Favored 'Trans proline' 0 N--CA 1.488 1.152 0 O-C-N 123.255 1.134 . . . . 0.65000000000000002 111.123 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 849' ' ' GLN . . . . . 0.436 ' HB2' HG12 ' C' ' 847' ' ' VAL . 55.6 tt0 27.53 68.61 0.07 Allowed 'General case' 0 N--CA 1.518 2.952 0 N-CA-C 112.93 0.715 . . . . 2.5800000000000001 112.93 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 850' ' ' VAL . . . . . 0.74 HG23 ' O ' ' C' ' 848' ' ' PRO . 57.4 t -119.52 135.68 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.157 -0.964 . . . . 1.0900000000000001 111.349 -178.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 851' ' ' ALA . . . . . . . . . . . . . . . -130.2 154.97 47.01 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 106.029 -1.841 . . . . 0.040000000000000001 106.029 176.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 852' ' ' PHE . . . . . 0.444 ' HA ' ' CB ' ' C' ' 874' ' ' ASN . 9.1 p90 -158.66 130.34 6.56 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 120.869 1.668 . . . . 0.050000000000000003 108.756 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 42.2 t -175.49 133.37 0.29 Allowed 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.014 -1.106 . . . . 0.040000000000000001 108.014 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -134.42 158.21 44.45 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.158 -0.964 . . . . 0.67000000000000004 109.388 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 855' ' ' ALA . . . . . 0.697 ' HB3' ' CB ' ' C' ' 870' ' ' ARG . . . -121.07 141.52 50.69 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.9 0.857 . . . . 0.51000000000000001 111.713 -178.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 856' ' ' LEU . . . . . 0.808 HD23 ' O ' ' C' ' 867' ' ' PRO . 3.4 tm? -106.83 133.84 50.88 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 109.26 -0.645 . . . . 0.050000000000000003 109.26 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 857' ' ' SER . . . . . 0.6 ' N ' HD13 ' C' ' 856' ' ' LEU . 80.0 p -152.61 15.85 0.59 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.549 -0.719 . . . . 1.3300000000000001 110.959 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 858' ' ' LEU . . . . . 0.786 ' CD2' HD11 ' C' ' 856' ' ' LEU . 2.9 pp -34.94 157.49 0.04 OUTLIER Pre-proline 0 N--CA 1.516 2.873 0 N-CA-C 112.692 0.627 . . . . 2.3300000000000001 112.692 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -62.13 -89.43 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 121.048 1.165 . . . . 2.3199999999999998 114.127 -177.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 54.8 ptt85 -130.67 -142.62 0.23 Allowed 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.803 -1.185 . . . . 0.040000000000000001 111.867 -177.089 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 71.7 m -35.17 118.8 0.46 Allowed 'General case' 0 N--CA 1.511 2.601 0 O-C-N 121.749 -0.595 . . . . 1.3100000000000001 112.515 -178.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -102.67 159.78 28.28 Favored Pre-proline 0 N--CA 1.488 1.448 0 N-CA-C 108.033 -1.099 . . . . 4.5099999999999998 108.033 177.55 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.86 -14.52 32.67 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 O-C-N 123.176 1.093 . . . . 2.2400000000000002 111.12 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -176.99 -133.94 1.9 Allowed Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.969 -1.252 . . . . 0.040000000000000001 109.969 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 37.5 m -70.0 158.5 35.53 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.38 -1.071 . . . . 1.51 110.924 -178.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 866' ' ' VAL . . . . . 0.468 ' HA ' ' HD3' ' C' ' 867' ' ' PRO . 30.9 m -94.68 138.43 22.24 Favored Pre-proline 0 N--CA 1.497 1.888 0 N-CA-C 113.641 0.978 . . . . 0.78000000000000003 113.641 -175.25 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 867' ' ' PRO . . . . . 0.808 ' O ' HD23 ' C' ' 856' ' ' LEU . 53.8 Cg_endo -89.12 -151.11 0.04 OUTLIER 'Trans proline' 0 CA--C 1.54 0.802 0 N-CA-C 108.262 -1.476 . . . . 0.92000000000000004 108.262 177.286 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 868' ' ' PHE . . . . . 0.456 ' CD1' ' N ' ' C' ' 868' ' ' PHE . 15.0 p90 -147.97 121.58 9.19 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.512 -1.367 . . . . 0.050000000000000003 109.99 179.341 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -112.01 -3.5 14.77 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 119.433 -0.907 . . . . 1.7 112.101 -178.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 870' ' ' ARG . . . . . 0.697 ' CB ' ' HB3' ' C' ' 855' ' ' ALA . 23.8 mmm180 -90.93 87.67 6.72 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.968 -1.083 . . . . 2.5899999999999999 110.774 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 58.3 t -74.43 97.08 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 120.983 -1.073 . . . . 1.9399999999999999 109.43 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 872' ' ' LEU . . . . . 0.488 HD13 HD11 ' A' ' 953' ' ' ILE . 80.6 mt -86.38 -45.27 11.34 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.523 -0.736 . . . . 1.0600000000000001 110.557 -179.56 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 873' ' ' LEU . . . . . 0.411 ' O ' ' HB2' ' C' ' 874' ' ' ASN . 50.2 tp -173.61 103.22 0.12 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.192 -0.942 . . . . 4.1799999999999997 108.769 178.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 874' ' ' ASN . . . . . 0.444 ' CB ' ' HA ' ' C' ' 852' ' ' PHE . 35.3 t-20 177.84 82.75 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.282 0 N-CA-C 109.201 -0.666 . . . . 0.040000000000000001 109.201 -178.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -66.37 -46.58 76.2 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 119.354 -0.938 . . . . 3.3799999999999999 111.351 -179.052 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 876' ' ' GLY . . . . . 0.413 ' HA3' ' CE2' ' C' ' 878' ' ' TYR . . . -74.29 -25.81 69.81 Favored Glycine 0 N--CA 1.493 2.499 0 O-C-N 121.282 -0.886 . . . . 0.040000000000000001 111.887 -178.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 81.03 -61.57 4.55 Favored Glycine 0 N--CA 1.502 3.073 0 N-CA-C 107.92 -2.072 . . . . 0.040000000000000001 107.92 -178.055 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 878' ' ' TYR . . . . . 0.413 ' CE2' ' HA3' ' C' ' 876' ' ' GLY . 91.4 m-85 61.67 -65.62 0.07 Allowed 'General case' 0 N--CA 1.503 2.222 0 N-CA-C 114.327 1.232 . . . . 3.46 114.327 177.486 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 879' ' ' TYR . . . . . 0.46 ' CB ' ' CD2' ' C' ' 886' ' ' PHE . 23.7 p90 -112.04 109.06 18.59 Favored 'General case' 0 N--CA 1.501 2.116 0 N-CA-C 114.938 1.459 . . . . 0.040000000000000001 114.938 -176.019 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -65.24 119.94 63.34 Favored Pre-proline 0 N--CA 1.497 1.913 0 O-C-N 121.548 -0.72 . . . . 0.02 110.369 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 881' ' ' PRO . . . . . 0.452 ' CG ' ' CD1' ' C' ' 868' ' ' PHE . 53.1 Cg_endo -76.13 0.99 8.75 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 O-C-N 123.434 1.229 . . . . 0.39000000000000001 112.285 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 87.4 mt-10 -74.96 -65.53 0.86 Allowed 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 106.829 -1.545 . . . . 0.81000000000000005 106.829 178.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 883' ' ' THR . . . . . 0.653 ' OG1' HG23 ' C' ' 885' ' ' VAL . 42.1 p -97.51 -15.1 20.72 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 109.19 -0.67 . . . . 0.040000000000000001 109.19 177.669 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.35 25.21 44.37 Favored Glycine 0 N--CA 1.494 2.527 0 C-N-CA 119.982 -1.104 . . . . 0.029999999999999999 110.636 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 885' ' ' VAL . . . . . 0.653 HG23 ' OG1' ' C' ' 883' ' ' THR . 83.0 t -72.66 88.94 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 C-N-CA 118.4 -1.32 . . . . 1.01 107.833 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 886' ' ' PHE . . . . . 0.902 ' HB3' HG22 ' C' ' 962' ' ' VAL . 0.7 OUTLIER -90.73 103.8 16.46 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 115.358 -0.837 . . . . 0.050000000000000003 112.242 -177.014 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 887' ' ' THR . . . . . 0.421 ' O ' ' HD3' ' C' ' 889' ' ' PRO . 97.1 m -96.79 100.46 12.0 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 107.601 -1.259 . . . . 0.68000000000000005 107.601 177.355 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 888' ' ' ALA . . . . . . . . . . . . . . . -99.47 105.37 32.96 Favored Pre-proline 0 N--CA 1.501 2.093 0 N-CA-C 114.197 1.184 . . . . 0.25 114.197 -176.424 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 889' ' ' PRO . . . . . 0.421 ' HD3' ' O ' ' C' ' 887' ' ' THR . 55.3 Cg_endo -86.9 -13.09 4.8 Favored 'Trans proline' 0 CA--C 1.546 1.077 0 N-CA-C 108.85 -1.25 . . . . 1.6399999999999999 108.85 175.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 890' ' ' LEU . . . . . 0.87 HD22 HD13 ' C' ' 985' ' ' LEU . 69.3 mt -38.04 -49.81 1.31 Allowed 'General case' 0 N--CA 1.507 2.378 0 N-CA-C 113.611 0.967 . . . . 2.29 113.611 -177.455 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 52.42 97.43 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.286 0 O-C-N 121.082 -1.011 . . . . 0.63 110.353 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . 156.53 -148.26 17.92 Favored Glycine 0 N--CA 1.478 1.493 0 N-CA-C 107.292 -2.323 . . . . 0.040000000000000001 107.292 -179.136 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 73.2 ttt-85 -108.29 128.62 54.9 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 107.763 -1.199 . . . . 3.0 107.763 177.401 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 894' ' ' TYR . . . . . 0.592 ' OH ' HD12 ' C' ' 896' ' ' LEU . 0.1 OUTLIER -130.49 146.3 52.01 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.14 -0.975 . . . . 0.040000000000000001 110.149 -179.144 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 895' ' ' LEU . . . . . 0.42 ' N ' ' CD1' ' C' ' 894' ' ' TYR . 38.6 tp -97.7 115.8 28.67 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.677 -0.64 . . . . 1.27 109.761 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 896' ' ' LEU . . . . . 0.592 HD12 ' OH ' ' C' ' 894' ' ' TYR . 9.2 tt -109.72 146.17 35.36 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.687 -0.633 . . . . 0.93999999999999995 110.822 -179.228 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 897' ' ' SER . . . . . . . . . . . . . 19.9 m -147.49 113.66 5.87 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.576 -0.702 . . . . 0.040000000000000001 110.707 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -106.61 147.02 29.99 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.032 -0.729 . . . . 0.47999999999999998 109.032 179.06 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 899' ' ' VAL . . . . . 0.704 HG21 ' HB ' ' C' ' 980' ' ' ILE . 89.7 t -93.9 119.63 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 C-N-CA 119.617 -0.833 . . . . 0.55000000000000004 111.159 -179.208 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 95.9 mt -94.54 110.61 22.41 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 114.188 1.181 . . . . 1.5900000000000001 114.188 -175.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 23.8 m -63.81 138.84 58.65 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 107.441 -1.318 . . . . 0.050000000000000003 107.441 177.226 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -61.48 -65.62 3.15 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 110.456 -1.058 . . . . 0.029999999999999999 110.456 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 46.21 66.48 0.94 Allowed 'General case' 0 N--CA 1.508 2.441 0 O-C-N 121.484 -1.009 . . . . 3.2000000000000002 110.921 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 54.8 ptt85 -67.93 -7.16 26.18 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.597 -0.69 . . . . 2.9199999999999999 112.03 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 905' ' ' HIS . . . . . 0.49 ' O ' ' CB ' ' C' ' 906' ' ' GLU . 77.1 t60 -59.83 4.4 0.05 OUTLIER 'General case' 0 N--CA 1.507 2.399 0 CA-C-O 117.65 -1.167 . . . . 2.8700000000000001 113.428 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 906' ' ' GLU . . . . . 0.49 ' CB ' ' O ' ' C' ' 905' ' ' HIS . 0.7 OUTLIER 93.0 -164.16 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.387 0 CA-C-N 121.272 1.851 . . . . 0.98999999999999999 112.013 179.071 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 907' ' ' LYS . . . . . 0.483 ' CB ' ' O ' ' C' ' 906' ' ' GLU . 68.7 tttt 87.87 160.22 0.07 Allowed 'General case' 0 N--CA 1.518 2.964 0 N-CA-C 107.772 -1.195 . . . . 5.25 107.772 -176.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 59.9 t -122.44 115.71 46.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 120.847 -1.158 . . . . 0.39000000000000001 111.058 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 909' ' ' GLU . . . . . 0.646 ' OE2' HD12 ' C' ' 966' ' ' LEU . 40.3 tp10 -100.25 132.95 45.33 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 107.077 -1.453 . . . . 1.72 107.077 176.61 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -156.9 120.5 4.21 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 106.929 -1.508 . . . . 0.67000000000000004 106.929 178.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 911' ' ' VAL . . . . . 0.858 HG23 HG22 ' C' ' 964' ' ' VAL . 13.2 p -76.5 130.99 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 C-N-CA 120.42 -0.512 . . . . 0.54000000000000004 111.131 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 83.5 mt -65.59 156.13 33.66 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 108.167 -1.049 . . . . 1.5 108.167 178.234 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 913' ' ' SER . . . . . 0.416 ' CB ' ' CG1' ' C' ' 919' ' ' VAL . 1.2 t -127.98 131.8 49.22 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.414 -0.958 . . . . 1.3700000000000001 108.414 176.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 914' ' ' ARG . . . . . 0.839 ' NH1' HD23 ' C' ' 956' ' ' LEU . 0.0 OUTLIER -63.24 156.22 26.1 Favored 'General case' 0 N--CA 1.506 2.336 0 O-C-N 120.71 -1.244 . . . . 4.2999999999999998 111.381 -179.195 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 915' ' ' SER . . . . . 0.421 ' CB ' ' O ' ' C' ' 914' ' ' ARG . 1.8 p 84.2 -32.07 0.07 Allowed 'General case' 0 N--CA 1.521 3.082 0 C-N-CA 124.033 0.933 . . . . 2.0499999999999998 111.848 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 916' ' ' ASN . . . . . 0.79 ' HB2' HG21 ' C' ' 919' ' ' VAL . 89.6 m-20 -124.03 -21.86 4.97 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.931 -1.106 . . . . 2.71 111.261 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 917' ' ' GLN . . . . . 0.422 ' HB2' ' O ' ' C' ' 916' ' ' ASN . 56.9 mt-30 66.82 164.86 0.2 Allowed 'General case' 0 N--CA 1.52 3.042 0 N-CA-C 105.707 -1.96 . . . . 2.6800000000000002 105.707 -173.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 55.67 -124.79 34.78 Favored Glycine 1 N--CA 1.52 4.266 0 CA-C-N 123.575 2.898 . . . . 0.029999999999999999 106.682 -177.387 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 919' ' ' VAL . . . . . 0.79 HG21 ' HB2' ' C' ' 916' ' ' ASN . 76.8 t 51.24 93.94 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.294 0 O-C-N 121.422 -1.046 . . . . 1.3899999999999999 109.119 -178.328 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 920' ' ' ALA . . . . . 0.818 ' HB3' HG12 ' C' ' 949' ' ' VAL . . . -93.41 93.69 8.29 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.429 -0.908 . . . . 0.029999999999999999 110.831 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 921' ' ' ARG . . . . . 0.683 ' HG3' HG23 ' C' ' 922' ' ' VAL . 41.8 ptt85 -82.03 -42.29 19.49 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 105.795 -1.928 . . . . 4.4199999999999999 105.795 176.246 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 922' ' ' VAL . . . . . 0.683 HG23 ' HG3' ' C' ' 921' ' ' ARG . 69.8 t -99.7 77.82 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 105.602 -1.999 . . . . 0.84999999999999998 105.602 175.078 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -90.73 135.53 33.65 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.814 0.816 . . . . 2.46 112.149 -176.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 14.9 t -147.4 103.93 3.6 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.017 -1.105 . . . . 0.69999999999999996 108.017 178.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -109.94 89.62 0.56 Allowed Glycine 0 N--CA 1.488 2.127 0 N-CA-C 108.882 -1.687 . . . . 0.040000000000000001 108.882 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.318 0 N-CA-C 109.347 -1.501 . . . . 0.040000000000000001 109.347 -179.623 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 55.4 m . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 120.949 0.404 . . . . 13.779999999999999 110.351 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 94.8 mt -114.91 129.25 56.67 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.501 -0.75 . . . . 13.76 110.317 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -152.16 170.67 31.48 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.277 -1.529 . . . . 9.1300000000000008 109.277 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 949' ' ' VAL . . . . . 0.818 HG12 ' HB3' ' C' ' 920' ' ' ALA . 33.4 m -117.22 137.45 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.524 -0.986 . . . . 7.0800000000000001 110.911 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 950' ' ' PHE . . . . . 0.444 ' CZ ' ' HB3' ' C' ' 921' ' ' ARG . 51.7 p90 -133.76 148.39 51.39 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.539 -0.725 . . . . 7.5899999999999999 109.513 179.411 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 70.4 m -118.54 -55.96 2.17 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.434 -0.791 . . . . 5.0300000000000002 112.137 -178.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 952' ' ' LEU . . . . . 0.47 ' O ' ' O ' ' C' ' 953' ' ' ILE . 49.3 tp -64.22 -76.64 0.07 Allowed 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.293 -0.879 . . . . 1.01 111.713 -178.049 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 953' ' ' ILE . . . . . 0.529 HD12 ' N ' ' C' ' 954' ' ' LEU . 2.1 pp -49.05 -151.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.787 0 N-CA-C 114.389 1.255 . . . . 2.6000000000000001 114.389 -176.764 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 954' ' ' LEU . . . . . 0.748 HD22 ' O ' ' C' ' 954' ' ' LEU . 0.0 OUTLIER 169.45 91.24 0.04 OUTLIER Pre-proline 0 N--CA 1.517 2.919 0 O-C-N 120.842 -1.162 . . . . 0.050000000000000003 112.023 179.798 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 955' ' ' PRO . . . . . 0.671 ' C ' HD12 ' C' ' 956' ' ' LEU . 52.7 Cg_endo -79.47 95.48 1.05 Allowed 'Trans proline' 0 C--N 1.316 -1.158 0 N-CA-C 108.665 -1.321 . . . . 0.83999999999999997 108.665 178.169 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 956' ' ' LEU . . . . . 0.839 HD23 ' NH1' ' C' ' 914' ' ' ARG . 6.7 mp -125.7 139.5 53.49 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.939 -1.101 . . . . 0.040000000000000001 110.841 -179.319 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -81.98 153.38 26.26 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 117.883 -1.056 . . . . 1.28 111.121 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -67.17 118.92 11.25 Favored 'General case' 0 N--CA 1.506 2.366 0 CA-C-N 122.629 2.468 . . . . 0.17000000000000001 111.322 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 95.15 -17.89 58.43 Favored Glycine 0 N--CA 1.501 3.013 0 O-C-N 121.526 -0.734 . . . . 0.040000000000000001 111.506 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 960' ' ' ASP . . . . . 0.416 ' HB3' ' NH2' ' C' ' 914' ' ' ARG . 0.2 OUTLIER -52.97 169.89 0.09 Allowed 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.204 -1.174 . . . . 0.040000000000000001 110.784 -179.169 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 961' ' ' THR . . . . . 0.457 ' HA ' ' O ' ' C' ' 886' ' ' PHE . 57.2 m -135.77 135.92 40.31 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.034 -1.041 . . . . 1.78 111.823 -178.603 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 962' ' ' VAL . . . . . 0.902 HG22 ' HB3' ' C' ' 886' ' ' PHE . 22.3 m -100.19 145.43 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.533 -0.73 . . . . 0.040000000000000001 110.498 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 5.6 t -137.99 148.07 44.83 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.89 -0.506 . . . . 0.71999999999999997 110.056 -178.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 964' ' ' VAL . . . . . 0.858 HG22 HG23 ' C' ' 911' ' ' VAL . 61.8 t -99.38 136.22 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.074 -1.016 . . . . 1.05 110.403 -179.31 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -94.73 126.94 40.37 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 103.85 -2.648 . . . . 3.02 103.85 173.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 966' ' ' LEU . . . . . 0.646 HD12 ' OE2' ' C' ' 909' ' ' GLU . 0.2 OUTLIER -130.57 62.31 1.59 Allowed 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.814 -1.18 . . . . 1.46 107.814 177.431 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 967' ' ' VAL . . . . . 0.491 HG23 ' C ' ' C' ' 966' ' ' LEU . 96.3 t -158.18 97.26 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 108.125 -1.065 . . . . 1.9399999999999999 108.125 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 85.9 mmm -142.95 58.62 1.42 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.765 -1.209 . . . . 0.0 108.342 178.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 134.78 119.63 1.96 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 107.075 -2.41 . . . . 2.1099999999999999 107.075 -178.249 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -82.26 -58.07 3.1 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.033 -1.275 . . . . 5.8899999999999997 110.367 -179.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 41.7 tp -58.61 90.45 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.445 -0.784 . . . . 4.3600000000000003 110.231 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -142.29 -154.12 0.5 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.543 -0.723 . . . . 1.8300000000000001 110.216 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -118.75 171.1 8.44 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.478 -0.764 . . . . 4.3499999999999996 110.17 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 32.1 t -101.39 129.9 47.49 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.501 -0.749 . . . . 1.27 110.071 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -156.33 154.29 30.36 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.556 -0.715 . . . . 5.0199999999999996 110.506 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.44 86.97 15.89 Favored Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 121.62 -0.675 . . . . 2.4100000000000001 109.74 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -74.3 -170.06 0.67 Allowed 'Trans proline' 0 C--N 1.318 -1.049 0 O-C-N 123.315 1.166 . . . . 0.95999999999999996 111.285 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 978' ' ' LEU . . . . . 0.471 ' N ' HD12 ' C' ' 978' ' ' LEU . 4.9 mp -125.86 155.39 41.28 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 107.547 -1.279 . . . . 0.62 107.547 177.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 979' ' ' THR . . . . . 0.456 HG23 ' C ' ' C' ' 978' ' ' LEU . 39.1 p -150.39 141.64 23.21 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.779 -1.201 . . . . 3.5699999999999998 111.21 -179.255 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 980' ' ' ILE . . . . . 0.704 ' HB ' HG21 ' C' ' 899' ' ' VAL . 50.8 mm -106.29 129.16 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 109.08 -0.711 . . . . 1.3300000000000001 109.08 179.426 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 981' ' ' PHE . . . . . 0.432 ' CD1' ' CE2' ' C' ' 879' ' ' TYR . 2.4 t80 -118.36 97.77 5.94 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.46 -0.775 . . . . 0.050000000000000003 111.638 -178.421 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 982' ' ' SER . . . . . . . . . . . . . 58.6 p -108.13 157.97 17.83 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 109.002 -0.74 . . . . 0.87 109.002 178.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 983' ' ' GLY . . . . . 0.411 ' O ' ' CE2' ' C' ' 852' ' ' PHE . . . -171.32 112.15 0.44 Allowed Glycine 0 N--CA 1.498 2.803 0 N-CA-C 106.701 -2.56 . . . . 0.029999999999999999 106.701 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 984' ' ' ALA . . . . . 0.479 ' HB1' ' NE ' ' A' ' 893' ' ' ARG . . . -110.25 149.51 30.05 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 114.315 1.228 . . . . 0.69999999999999996 114.315 -175.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 985' ' ' LEU . . . . . 0.87 HD13 HD22 ' C' ' 890' ' ' LEU . 63.9 tp -74.54 135.59 42.14 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.859 -1.151 . . . . 0.040000000000000001 109.805 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 986' ' ' LEU . . . . . . . . . . . . . 45.8 tp -105.9 -62.96 1.3 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.505 -0.747 . . . . 0.040000000000000001 110.327 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 53.6 t80 -144.73 147.05 32.51 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 107.828 -1.175 . . . . 0.040000000000000001 107.828 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.11 162.98 12.24 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 108.085 -2.006 . . . . 0.040000000000000001 108.085 179.014 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -75.65 112.35 19.07 Favored Pre-proline 0 N--CA 1.5 2.035 0 CA-C-N 118.608 1.204 . . . . 0.040000000000000001 109.462 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 990' ' ' PRO . . . . . 0.421 ' O ' ' HB2' ' C' ' 991' ' ' GLU . 50.6 Cg_endo -91.33 71.44 0.97 Allowed 'Trans proline' 0 C--N 1.319 -0.978 0 O-C-N 123.074 1.039 . . . . 0.45000000000000001 111.464 -178.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 991' ' ' GLU . . . . . 0.421 ' HB2' ' O ' ' C' ' 990' ' ' PRO . 71.2 mt-10 67.11 -73.9 0.07 Allowed 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 108.559 -0.904 . . . . 1.97 108.559 -177.508 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 992' ' ' LEU . . . . . 0.403 HD12 ' HD2' ' C' ' 990' ' ' PRO . 11.1 mt 51.66 20.46 1.1 Allowed 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.593 -0.692 . . . . 2.3799999999999999 111.596 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -90.65 156.91 17.77 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.964 -1.085 . . . . 3.79 109.952 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 69.1 m80 -147.53 90.21 1.84 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.572 -0.705 . . . . 3.5099999999999998 110.383 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 995' ' ' ALA . . . . . . . . . . . . 2.518 . . . . . . . 0 N--CA 1.503 2.216 0 O-C-N 120.881 -1.137 . . . . 2.73 110.601 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo . . . . . 0 N--CA 1.488 1.156 0 N-CA-C 109.492 -1.003 . . . . 3.8300000000000001 109.492 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 847' ' ' VAL . . . . . 0.494 HG12 ' HB2' ' A' ' 849' ' ' GLN . 60.0 t -128.04 105.5 20.2 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 121.638 -0.664 . . . . 1.8300000000000001 109.986 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 848' ' ' PRO . . . . . 0.823 ' O ' HG23 ' A' ' 850' ' ' VAL . 43.0 Cg_endo -69.37 -21.41 35.35 Favored 'Trans proline' 0 N--CA 1.486 1.076 0 O-C-N 123.196 1.103 . . . . 0.65000000000000002 110.985 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 849' ' ' GLN . . . . . 0.494 ' HB2' HG12 ' A' ' 847' ' ' VAL . 56.5 tt0 26.47 67.43 0.06 Allowed 'General case' 0 N--CA 1.518 2.93 0 N-CA-C 113.111 0.782 . . . . 2.5800000000000001 113.111 179.175 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 850' ' ' VAL . . . . . 0.823 HG23 ' O ' ' A' ' 848' ' ' PRO . 97.4 t -119.43 134.79 61.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.12 -0.987 . . . . 1.0900000000000001 111.042 -179.098 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 851' ' ' ALA . . . . . . . . . . . . . . . -132.05 153.65 50.2 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 105.922 -1.881 . . . . 0.040000000000000001 105.922 177.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 852' ' ' PHE . . . . . 0.626 ' HA ' ' HB3' ' A' ' 874' ' ' ASN . 28.4 p90 -155.89 136.75 13.52 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-N 121.109 1.777 . . . . 0.050000000000000003 109.303 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 16.1 t -172.63 133.11 0.59 Allowed 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.168 -1.049 . . . . 0.040000000000000001 108.168 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 854' ' ' ALA . . . . . 0.488 ' HB1' ' HD2' ' A' ' 868' ' ' PHE . . . -135.97 154.22 51.16 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.111 -0.993 . . . . 0.67000000000000004 109.325 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 855' ' ' ALA . . . . . 0.703 ' HB3' ' CB ' ' A' ' 870' ' ' ARG . . . -123.04 141.3 52.11 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.876 0.846 . . . . 0.51000000000000001 111.976 -178.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 856' ' ' LEU . . . . . 0.762 HD23 ' O ' ' A' ' 867' ' ' PRO . 3.5 tm? -110.09 138.27 46.7 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.656 -0.652 . . . . 0.050000000000000003 109.427 179.311 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 857' ' ' SER . . . . . 0.6 ' N ' HD13 ' A' ' 856' ' ' LEU . 78.8 p -156.1 19.99 0.37 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.477 -0.765 . . . . 1.3300000000000001 111.325 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 858' ' ' LEU . . . . . 0.573 HD22 ' HG3' ' A' ' 862' ' ' GLU . 4.2 pp -34.3 158.95 0.04 OUTLIER Pre-proline 0 N--CA 1.519 3.017 0 N-CA-C 112.816 0.672 . . . . 2.3300000000000001 112.816 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -60.95 -89.62 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 120.968 1.112 . . . . 2.3199999999999998 113.922 -177.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 54.9 ptt85 -127.98 -142.26 0.27 Allowed 'General case' 0 N--CA 1.502 2.127 0 O-C-N 120.809 -1.182 . . . . 0.040000000000000001 111.609 -177.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 27.9 m -36.14 121.15 0.67 Allowed 'General case' 0 N--CA 1.511 2.602 0 O-C-N 121.644 -0.66 . . . . 1.3100000000000001 112.291 -178.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 862' ' ' GLU . . . . . 0.573 ' HG3' HD22 ' A' ' 858' ' ' LEU . 0.0 OUTLIER -103.01 158.91 30.82 Favored Pre-proline 0 N--CA 1.488 1.466 0 N-CA-C 108.313 -0.995 . . . . 4.5099999999999998 108.313 177.824 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -70.23 -15.19 35.26 Favored 'Trans proline' 0 C--N 1.313 -1.337 0 O-C-N 123.206 1.108 . . . . 2.2400000000000002 111.231 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -176.91 -135.56 2.21 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.786 -1.326 . . . . 0.040000000000000001 109.786 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 23.3 m -69.47 155.88 39.75 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.344 -1.092 . . . . 1.51 111.01 -178.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 866' ' ' VAL . . . . . 0.564 HG12 ' CD2' ' A' ' 858' ' ' LEU . 33.7 m -91.35 136.73 26.63 Favored Pre-proline 0 N--CA 1.498 1.954 0 N-CA-C 113.549 0.944 . . . . 0.78000000000000003 113.549 -175.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 867' ' ' PRO . . . . . 0.762 ' O ' HD23 ' A' ' 856' ' ' LEU . 54.9 Cg_endo -88.62 -150.39 0.04 OUTLIER 'Trans proline' 0 CA--C 1.539 0.767 0 N-CA-C 108.183 -1.507 . . . . 0.92000000000000004 108.183 177.242 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 868' ' ' PHE . . . . . 0.488 ' HD2' ' HB1' ' A' ' 854' ' ' ALA . 9.9 p90 -148.24 121.2 8.79 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.413 -1.43 . . . . 0.050000000000000003 110.312 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 50.1 p-10 -111.79 -3.52 14.92 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 119.374 -0.93 . . . . 1.7 111.919 -179.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 870' ' ' ARG . . . . . 0.703 ' CB ' ' HB3' ' A' ' 855' ' ' ALA . 26.1 mmm180 -90.4 88.43 7.18 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.999 -1.063 . . . . 2.5899999999999999 111.109 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 60.1 t -76.42 96.41 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 120.932 -1.105 . . . . 1.9399999999999999 109.173 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 872' ' ' LEU . . . . . 0.45 HD13 HD11 ' B' ' 953' ' ' ILE . 87.7 mt -86.97 -44.16 11.83 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.605 -0.684 . . . . 1.0600000000000001 110.921 -179.334 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 873' ' ' LEU . . . . . . . . . . . . . 48.2 tp -172.3 107.69 0.2 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.159 -0.963 . . . . 4.1799999999999997 108.624 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 874' ' ' ASN . . . . . 0.626 ' HB3' ' HA ' ' A' ' 852' ' ' PHE . 12.0 p-10 174.36 81.36 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.483 0 O-C-N 121.592 -0.692 . . . . 0.040000000000000001 109.378 -178.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -69.69 -49.18 55.91 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.725 -1.234 . . . . 3.3799999999999999 111.37 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 876' ' ' GLY . . . . . 0.414 ' HA3' ' CE2' ' A' ' 878' ' ' TYR . . . -72.8 -26.8 70.4 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 110.642 -0.983 . . . . 0.040000000000000001 110.642 -179.315 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 78.96 -63.6 3.81 Favored Glycine 0 N--CA 1.497 2.741 0 N-CA-C 108.196 -1.961 . . . . 0.040000000000000001 108.196 -178.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 878' ' ' TYR . . . . . 0.414 ' CE2' ' HA3' ' A' ' 876' ' ' GLY . 92.6 m-85 61.7 -60.11 0.1 Allowed 'General case' 0 N--CA 1.504 2.265 0 N-CA-C 113.532 0.938 . . . . 3.46 113.532 178.442 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 879' ' ' TYR . . . . . 0.504 ' O ' ' CG ' ' A' ' 879' ' ' TYR . 9.8 p90 -111.24 104.69 13.21 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.919 -1.113 . . . . 0.040000000000000001 113.58 -177.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 880' ' ' ASP . . . . . 0.418 ' O ' ' N ' ' A' ' 884' ' ' GLY . 0.8 OUTLIER -69.77 112.86 13.63 Favored Pre-proline 0 N--CA 1.497 1.895 0 O-C-N 121.19 -0.944 . . . . 0.02 110.662 -178.807 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 881' ' ' PRO . . . . . 0.478 ' HG2' ' CD1' ' A' ' 868' ' ' PHE . 51.9 Cg_endo -78.33 -3.27 13.24 Favored 'Trans proline' 0 N--CA 1.489 1.221 0 O-C-N 123.489 1.257 . . . . 0.39000000000000001 111.102 179.312 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -77.62 -34.51 53.31 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 107.897 -1.149 . . . . 0.81000000000000005 107.897 178.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 71.0 p -112.07 -19.08 12.44 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.423 -0.808 . . . . 0.040000000000000001 109.072 176.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 884' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 880' ' ' ASP . . . 79.6 4.12 89.16 Favored Glycine 0 N--CA 1.495 2.603 0 N-CA-C 110.161 -1.176 . . . . 0.029999999999999999 110.161 -178.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 885' ' ' VAL . . . . . 0.452 HG13 HG21 ' A' ' 961' ' ' THR . 66.5 t -73.3 95.08 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 C-N-CA 118.737 -1.185 . . . . 1.01 108.408 -178.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 886' ' ' PHE . . . . . 0.924 ' HB3' HG22 ' A' ' 962' ' ' VAL . 2.2 t80 -88.86 105.54 17.81 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 115.307 -0.86 . . . . 0.050000000000000003 111.746 -177.526 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 887' ' ' THR . . . . . 0.42 ' O ' ' HD3' ' A' ' 889' ' ' PRO . 35.3 m -98.03 100.31 11.64 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 107.588 -1.264 . . . . 0.68000000000000005 107.588 177.401 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 888' ' ' ALA . . . . . 0.434 ' HB2' ' CE1' ' A' ' 886' ' ' PHE . . . -99.28 106.63 40.14 Favored Pre-proline 0 N--CA 1.501 2.085 0 N-CA-C 114.049 1.129 . . . . 0.25 114.049 -176.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 889' ' ' PRO . . . . . 0.42 ' HD3' ' O ' ' A' ' 887' ' ' THR . 55.2 Cg_endo -90.18 -12.61 2.69 Favored 'Trans proline' 0 CA--C 1.546 1.093 0 C-N-CA 121.086 1.191 . . . . 1.6399999999999999 109.157 176.258 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 890' ' ' LEU . . . . . 0.858 HD22 HD13 ' A' ' 985' ' ' LEU . 72.4 mt -36.38 -50.13 0.75 Allowed 'General case' 0 N--CA 1.508 2.44 0 N-CA-C 113.855 1.057 . . . . 2.29 113.855 -177.257 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 51.8 96.17 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.117 -0.989 . . . . 0.63 110.321 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 156.21 -148.86 19.45 Favored Glycine 0 N--CA 1.48 1.624 0 N-CA-C 107.296 -2.322 . . . . 0.040000000000000001 107.296 -179.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 893' ' ' ARG . . . . . 0.416 ' CZ ' ' HB1' ' C' ' 984' ' ' ALA . 71.6 ttt-85 -111.44 127.6 55.73 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 107.753 -1.202 . . . . 3.0 107.753 177.186 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 894' ' ' TYR . . . . . 0.53 ' OH ' HD12 ' A' ' 896' ' ' LEU . 0.0 OUTLIER -130.2 153.88 48.12 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.0 -1.063 . . . . 0.040000000000000001 110.876 -178.681 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 895' ' ' LEU . . . . . 0.429 ' N ' ' CD1' ' A' ' 894' ' ' TYR . 39.7 tp -96.58 114.11 25.74 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.405 -0.809 . . . . 1.27 109.961 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 896' ' ' LEU . . . . . 0.53 HD12 ' OH ' ' A' ' 894' ' ' TYR . 10.3 tt -109.35 142.47 40.23 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.684 -0.635 . . . . 0.93999999999999995 111.18 -179.11 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 897' ' ' SER . . . . . 0.525 ' N ' HD23 ' A' ' 896' ' ' LEU . 49.8 m -147.91 115.43 6.31 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.578 -0.701 . . . . 0.040000000000000001 110.838 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.7 147.22 31.04 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.633 -0.667 . . . . 0.47999999999999998 109.254 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 899' ' ' VAL . . . . . 0.75 HG21 ' HB ' ' A' ' 980' ' ' ILE . 99.1 t -92.69 120.1 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 C-N-CA 119.68 -0.808 . . . . 0.55000000000000004 111.237 -179.206 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 900' ' ' LEU . . . . . 0.442 ' N ' HD22 ' A' ' 900' ' ' LEU . 4.6 mm? -91.33 112.18 23.98 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 114.349 1.241 . . . . 1.5900000000000001 114.349 -175.152 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 23.3 m -67.52 141.72 56.79 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 107.077 -1.453 . . . . 0.050000000000000003 107.077 176.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -67.71 -66.45 2.33 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.506 -1.037 . . . . 0.029999999999999999 110.506 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 5.0 m170 46.08 65.88 1.07 Allowed 'General case' 0 N--CA 1.508 2.467 0 O-C-N 121.448 -1.03 . . . . 3.2000000000000002 111.253 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 43.2 ptt85 -69.23 -5.85 25.39 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.621 -0.675 . . . . 2.9199999999999999 112.152 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 905' ' ' HIS . . . . . 0.491 ' O ' ' CB ' ' A' ' 906' ' ' GLU . 76.2 t60 -61.86 4.37 0.12 Allowed 'General case' 0 N--CA 1.507 2.386 0 O-C-N 120.857 -1.152 . . . . 2.8700000000000001 113.141 -179.249 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 906' ' ' GLU . . . . . 0.491 ' CB ' ' O ' ' A' ' 905' ' ' HIS . 0.9 OUTLIER 94.7 -164.54 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.425 0 CA-C-N 120.593 1.542 . . . . 0.98999999999999999 112.076 178.984 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 907' ' ' LYS . . . . . 0.474 ' CB ' ' O ' ' A' ' 906' ' ' GLU . 29.5 ttmt 88.87 160.84 0.06 Allowed 'General case' 0 N--CA 1.522 3.137 0 N-CA-C 108.353 -0.98 . . . . 5.25 108.353 -177.204 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 61.4 t -122.4 116.74 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 120.818 -1.177 . . . . 0.39000000000000001 110.862 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 909' ' ' GLU . . . . . 0.634 ' OE2' HD12 ' A' ' 966' ' ' LEU . 39.9 tp10 -105.12 131.78 52.18 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 107.629 -1.248 . . . . 1.72 107.629 177.128 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -156.54 120.78 4.43 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 106.819 -1.548 . . . . 0.67000000000000004 106.819 178.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 911' ' ' VAL . . . . . 0.485 ' HA ' ' HA ' ' A' ' 964' ' ' VAL . 14.4 p -77.3 132.96 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.713 -0.617 . . . . 0.54000000000000004 111.417 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 86.4 mt -65.47 156.26 32.98 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 108.193 -1.039 . . . . 1.5 108.193 178.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 913' ' ' SER . . . . . 0.445 ' CB ' ' HB ' ' A' ' 919' ' ' VAL . 1.4 t -125.66 136.27 53.05 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.462 -0.94 . . . . 1.3700000000000001 108.462 177.038 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 914' ' ' ARG . . . . . 0.551 ' HD3' HG12 ' A' ' 962' ' ' VAL . 0.0 OUTLIER -62.37 152.58 33.64 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.011 -1.056 . . . . 4.2999999999999998 111.827 -178.97 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 915' ' ' SER . . . . . 0.427 ' CB ' ' O ' ' A' ' 914' ' ' ARG . 3.5 t 83.41 -30.38 0.09 Allowed 'General case' 0 N--CA 1.52 3.056 0 C-N-CA 124.004 0.922 . . . . 2.0499999999999998 112.315 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 916' ' ' ASN . . . . . 0.615 ' HB2' HG21 ' A' ' 919' ' ' VAL . 72.9 m-20 -126.46 -21.87 4.09 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 120.849 -1.157 . . . . 2.71 111.471 -179.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 917' ' ' GLN . . . . . 0.428 ' HB2' ' O ' ' A' ' 916' ' ' ASN . 58.6 mt-30 66.97 168.93 0.24 Allowed 'General case' 0 N--CA 1.518 2.955 0 N-CA-C 105.903 -1.888 . . . . 2.6800000000000002 105.903 -173.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 55.25 -128.87 45.1 Favored Glycine 1 N--CA 1.52 4.28 0 CA-C-N 123.64 2.927 . . . . 0.029999999999999999 106.388 -177.216 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 919' ' ' VAL . . . . . 0.615 HG21 ' HB2' ' A' ' 916' ' ' ASN . 85.7 t 50.25 94.59 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.299 0 CA-C-N 118.573 1.187 . . . . 1.3899999999999999 109.249 -178.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 920' ' ' ALA . . . . . 1.005 ' HB3' HG12 ' A' ' 949' ' ' VAL . . . -92.64 94.08 8.84 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.266 -0.974 . . . . 0.029999999999999999 111.154 -179.117 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 921' ' ' ARG . . . . . 0.756 ' HG3' HG23 ' A' ' 922' ' ' VAL . 35.1 ptt85 -80.3 -43.14 21.77 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 105.602 -1.999 . . . . 4.4199999999999999 105.602 176.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 922' ' ' VAL . . . . . 0.756 HG23 ' HG3' ' A' ' 921' ' ' ARG . 94.9 t -101.75 77.07 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 N-CA-C 105.041 -2.207 . . . . 0.84999999999999998 105.041 174.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -87.14 135.61 33.23 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 122.068 0.937 . . . . 2.46 112.39 -176.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 10.4 t -145.54 103.15 3.78 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.471 -1.307 . . . . 0.69999999999999996 107.471 178.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -103.39 81.75 0.37 Allowed Glycine 0 N--CA 1.486 2.023 0 N-CA-C 109.04 -1.624 . . . . 0.040000000000000001 109.04 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.967 0 N-CA-C 108.743 -1.743 . . . . 0.040000000000000001 108.743 179.877 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 21.7 m . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 120.963 0.411 . . . . 13.779999999999999 110.299 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 95.9 mt -109.88 129.28 55.67 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.506 -0.746 . . . . 13.76 110.325 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -152.08 169.83 31.4 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.347 -1.501 . . . . 9.1300000000000008 109.347 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 949' ' ' VAL . . . . . 1.005 HG12 ' HB3' ' A' ' 920' ' ' ALA . 34.3 m -118.4 132.4 68.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.465 -1.021 . . . . 7.0800000000000001 111.05 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 950' ' ' PHE . . . . . 0.464 ' CZ ' ' HB3' ' A' ' 921' ' ' ARG . 40.0 p90 -134.82 153.24 52.12 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.549 -0.719 . . . . 7.5899999999999999 109.124 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 69.3 m -121.59 -53.16 2.0 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.245 -0.91 . . . . 5.0300000000000002 112.356 -178.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 952' ' ' LEU . . . . . 0.425 ' O ' ' O ' ' A' ' 953' ' ' ILE . 56.6 tp -61.72 -76.33 0.06 Allowed 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.356 -0.84 . . . . 1.01 112.328 -177.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 953' ' ' ILE . . . . . 0.496 HD11 HD13 ' C' ' 872' ' ' LEU . 44.6 pt -52.32 -145.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.753 0 N-CA-C 114.016 1.117 . . . . 2.6000000000000001 114.016 -176.339 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 954' ' ' LEU . . . . . 0.726 HD22 ' O ' ' A' ' 954' ' ' LEU . 0.0 OUTLIER 170.73 83.74 0.04 OUTLIER Pre-proline 0 N--CA 1.509 2.514 0 O-C-N 120.812 -1.18 . . . . 0.050000000000000003 111.66 179.441 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 955' ' ' PRO . . . . . 0.677 ' C ' HD12 ' A' ' 956' ' ' LEU . 48.6 Cg_endo -76.24 95.45 1.04 Allowed 'Trans proline' 0 C--N 1.314 -1.271 0 N-CA-C 108.689 -1.312 . . . . 0.83999999999999997 108.689 177.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 956' ' ' LEU . . . . . 0.677 HD12 ' C ' ' A' ' 955' ' ' PRO . 10.3 mp -122.47 143.73 49.51 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.133 -0.979 . . . . 0.040000000000000001 110.19 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -85.65 151.76 23.64 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 117.82 -1.086 . . . . 1.28 111.613 -179.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -68.95 119.75 13.75 Favored 'General case' 0 N--CA 1.509 2.48 0 CA-C-N 122.86 2.573 . . . . 0.17000000000000001 111.799 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 93.23 -21.75 38.57 Favored Glycine 0 N--CA 1.501 3.006 0 N-CA-C 111.127 -0.789 . . . . 0.040000000000000001 111.127 178.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 960' ' ' ASP . . . . . 0.434 ' HB3' ' NE ' ' A' ' 914' ' ' ARG . 0.5 OUTLIER -55.17 169.47 0.25 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.473 -1.016 . . . . 0.040000000000000001 110.201 -179.411 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 961' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' A' ' 886' ' ' PHE . 44.0 m -136.52 139.55 42.34 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.903 -1.123 . . . . 1.78 112.432 -177.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 962' ' ' VAL . . . . . 0.924 HG22 ' HB3' ' A' ' 886' ' ' PHE . 31.9 m -100.08 144.82 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.649 -0.657 . . . . 0.040000000000000001 111.131 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 5.4 t -137.58 145.04 42.36 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.917 -0.49 . . . . 0.71999999999999997 109.991 -179.04 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 964' ' ' VAL . . . . . 0.485 ' HA ' ' HA ' ' A' ' 911' ' ' VAL . 61.9 t -92.17 136.3 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.028 -1.045 . . . . 1.05 111.297 -178.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -95.51 126.35 40.74 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 103.5 -2.778 . . . . 3.02 103.5 172.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 966' ' ' LEU . . . . . 0.634 HD12 ' OE2' ' A' ' 909' ' ' GLU . 0.2 OUTLIER -133.42 61.3 1.68 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.453 -0.943 . . . . 1.46 108.453 177.362 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 967' ' ' VAL . . . . . 0.492 HG23 ' C ' ' A' ' 966' ' ' LEU . 97.8 t -157.65 96.26 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 108.366 -0.975 . . . . 1.9399999999999999 108.366 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 92.9 mmm -142.96 58.65 1.42 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.734 -1.229 . . . . 0.0 108.277 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 133.72 119.48 2.0 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 107.139 -2.385 . . . . 2.1099999999999999 107.139 -178.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -82.19 -57.03 3.57 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.028 -1.277 . . . . 5.8899999999999997 110.597 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 48.4 tp -58.76 89.7 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.429 -0.794 . . . . 4.3600000000000003 110.342 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -142.67 -152.57 0.42 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.561 -0.712 . . . . 1.8300000000000001 110.049 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -118.07 167.57 11.35 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.393 -0.817 . . . . 4.3499999999999996 110.211 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 30.3 t -101.98 130.29 48.47 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.578 -0.701 . . . . 1.27 110.067 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -156.05 159.01 38.76 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.485 -0.759 . . . . 5.0199999999999996 110.65 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.78 85.12 20.63 Favored Pre-proline 0 N--CA 1.5 2.042 0 O-C-N 121.701 -0.624 . . . . 2.4100000000000001 109.712 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -73.58 -172.11 0.99 Allowed 'Trans proline' 0 C--N 1.317 -1.1 0 O-C-N 123.253 1.133 . . . . 0.95999999999999996 111.3 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 978' ' ' LEU . . . . . 0.576 HD12 ' N ' ' A' ' 978' ' ' LEU . 5.2 mp -126.43 156.09 41.17 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 107.557 -1.275 . . . . 0.62 107.557 177.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 979' ' ' THR . . . . . 0.453 HG23 ' C ' ' A' ' 978' ' ' LEU . 46.5 p -149.57 141.37 23.67 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.763 -1.211 . . . . 3.5699999999999998 111.155 -179.289 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 980' ' ' ILE . . . . . 0.75 ' HB ' HG21 ' A' ' 899' ' ' VAL . 50.7 mm -107.31 128.92 61.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 N-CA-C 109.088 -0.708 . . . . 1.3300000000000001 109.088 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 981' ' ' PHE . . . . . 0.502 ' CD1' ' CE2' ' A' ' 879' ' ' TYR . 10.6 t80 -119.93 97.46 5.62 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 119.572 -0.851 . . . . 0.050000000000000003 111.899 -178.275 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 982' ' ' SER . . . . . 0.457 ' HB2' HD23 ' B' ' 952' ' ' LEU . 15.5 p -108.64 158.59 17.45 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.592 -0.693 . . . . 0.87 109.199 178.406 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 983' ' ' GLY . . . . . 0.41 ' O ' ' CE1' ' A' ' 852' ' ' PHE . . . -174.29 110.78 0.34 Allowed Glycine 0 N--CA 1.498 2.783 0 N-CA-C 106.81 -2.516 . . . . 0.029999999999999999 106.81 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -107.85 149.41 28.29 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 114.245 1.202 . . . . 0.69999999999999996 114.245 -175.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 985' ' ' LEU . . . . . 0.858 HD13 HD22 ' A' ' 890' ' ' LEU . 66.8 tp -72.04 136.51 46.69 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.75 -1.219 . . . . 0.040000000000000001 110.088 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 49.3 tp -106.66 -58.03 1.98 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.689 -0.632 . . . . 0.040000000000000001 110.02 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -143.9 145.87 32.6 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 107.739 -1.208 . . . . 0.040000000000000001 107.739 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.33 162.54 12.37 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 108.078 -2.009 . . . . 0.040000000000000001 108.078 179.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -76.9 111.79 18.54 Favored Pre-proline 0 N--CA 1.498 1.951 0 CA-C-N 118.536 1.168 . . . . 0.040000000000000001 109.536 179.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 990' ' ' PRO . . . . . 0.615 ' HD2' HD12 ' A' ' 992' ' ' LEU . 49.2 Cg_endo -92.34 71.79 0.64 Allowed 'Trans proline' 0 C--N 1.318 -1.038 0 O-C-N 123.057 1.03 . . . . 0.45000000000000001 111.338 -179.032 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 991' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' A' ' 990' ' ' PRO . 72.3 mt-10 67.82 -73.33 0.08 Allowed 'General case' 0 N--CA 1.503 2.182 0 N-CA-C 108.345 -0.983 . . . . 1.97 108.345 -177.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 992' ' ' LEU . . . . . 0.615 HD12 ' HD2' ' A' ' 990' ' ' PRO . 4.1 mt 50.51 20.38 0.69 Allowed 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.577 -0.702 . . . . 2.3799999999999999 111.754 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -95.69 156.87 16.15 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.914 -1.116 . . . . 3.79 110.089 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 67.9 m80 -144.19 94.4 2.57 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.526 -0.734 . . . . 3.5099999999999998 110.269 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 995' ' ' ALA . . . . . . . . . . . . 2.517 . . . . . . . 0 N--CA 1.503 2.201 0 O-C-N 120.928 -1.108 . . . . 2.73 110.588 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo . . . . . 0 N--CA 1.488 1.172 0 N-CA-C 109.471 -1.011 . . . . 3.8300000000000001 109.471 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 847' ' ' VAL . . . . . 0.485 HG12 ' HB2' ' B' ' 849' ' ' GLN . 61.1 t -128.26 105.57 19.73 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.629 -0.669 . . . . 1.8300000000000001 109.93 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 848' ' ' PRO . . . . . 0.823 ' O ' HG23 ' B' ' 850' ' ' VAL . 43.0 Cg_endo -69.29 -21.41 35.7 Favored 'Trans proline' 0 N--CA 1.486 1.087 0 O-C-N 123.253 1.133 . . . . 0.65000000000000002 111.042 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 849' ' ' GLN . . . . . 0.485 ' HB2' HG12 ' B' ' 847' ' ' VAL . 56.3 tt0 26.48 66.9 0.06 Allowed 'General case' 0 N--CA 1.518 2.939 0 N-CA-C 113.151 0.797 . . . . 2.5800000000000001 113.151 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 850' ' ' VAL . . . . . 0.823 HG23 ' O ' ' B' ' 848' ' ' PRO . 97.1 t -118.98 134.93 61.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.193 -0.942 . . . . 1.0900000000000001 111.06 -179.131 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 851' ' ' ALA . . . . . . . . . . . . . . . -131.93 154.02 49.69 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 105.911 -1.885 . . . . 0.040000000000000001 105.911 177.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 852' ' ' PHE . . . . . 0.6 ' HA ' ' HB3' ' B' ' 874' ' ' ASN . 28.3 p90 -156.26 136.8 13.19 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-N 121.02 1.736 . . . . 0.050000000000000003 109.431 179.329 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 18.6 t -172.71 133.37 0.58 Allowed 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.046 -1.094 . . . . 0.040000000000000001 108.046 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 854' ' ' ALA . . . . . 0.487 ' HB1' ' HD2' ' B' ' 868' ' ' PHE . . . -136.14 154.34 51.01 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.118 -0.989 . . . . 0.67000000000000004 109.339 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 855' ' ' ALA . . . . . 0.72 ' HB3' ' CB ' ' B' ' 870' ' ' ARG . . . -123.18 140.96 52.48 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.853 0.835 . . . . 0.51000000000000001 111.996 -178.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 856' ' ' LEU . . . . . 0.769 HD23 ' O ' ' B' ' 867' ' ' PRO . 3.5 tm? -109.79 138.74 45.73 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.729 -0.607 . . . . 0.050000000000000003 109.366 179.284 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 857' ' ' SER . . . . . 0.614 ' N ' HD13 ' B' ' 856' ' ' LEU . 78.7 p -156.58 19.58 0.34 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.457 -0.777 . . . . 1.3300000000000001 111.345 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 858' ' ' LEU . . . . . 0.567 HD22 ' HG3' ' B' ' 862' ' ' GLU . 4.2 pp -33.95 158.83 0.04 OUTLIER Pre-proline 0 N--CA 1.519 2.984 0 N-CA-C 112.888 0.699 . . . . 2.3300000000000001 112.888 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -60.77 -89.66 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 120.948 1.099 . . . . 2.3199999999999998 113.971 -177.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 55.0 ptt85 -127.91 -142.25 0.27 Allowed 'General case' 0 N--CA 1.501 2.1 0 O-C-N 120.753 -1.217 . . . . 0.040000000000000001 111.676 -177.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 28.4 m -36.24 121.4 0.69 Allowed 'General case' 0 N--CA 1.512 2.629 0 O-C-N 121.682 -0.637 . . . . 1.3100000000000001 112.354 -178.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 862' ' ' GLU . . . . . 0.567 ' HG3' HD22 ' B' ' 858' ' ' LEU . 0.0 OUTLIER -103.25 159.09 30.38 Favored Pre-proline 0 N--CA 1.488 1.461 0 N-CA-C 108.414 -0.958 . . . . 4.5099999999999998 108.414 177.842 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -70.28 -15.15 35.08 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 O-C-N 123.255 1.134 . . . . 2.2400000000000002 111.163 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -176.86 -135.55 2.21 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.901 -1.279 . . . . 0.040000000000000001 109.901 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 23.6 m -69.65 156.0 39.63 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.43 -1.041 . . . . 1.51 110.964 -178.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 866' ' ' VAL . . . . . 0.567 HG12 ' CD2' ' B' ' 858' ' ' LEU . 33.7 m -91.4 136.75 26.54 Favored Pre-proline 0 N--CA 1.498 1.935 0 N-CA-C 113.59 0.959 . . . . 0.78000000000000003 113.59 -175.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 867' ' ' PRO . . . . . 0.769 ' O ' HD23 ' B' ' 856' ' ' LEU . 53.9 Cg_endo -88.52 -150.07 0.04 OUTLIER 'Trans proline' 0 CA--C 1.539 0.759 0 N-CA-C 108.134 -1.525 . . . . 0.92000000000000004 108.134 177.304 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 868' ' ' PHE . . . . . 0.487 ' HD2' ' HB1' ' B' ' 854' ' ' ALA . 9.8 p90 -148.5 121.26 8.67 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.388 -1.445 . . . . 0.050000000000000003 110.246 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 50.0 p-10 -111.82 -3.81 14.81 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 119.373 -0.931 . . . . 1.7 111.991 -179.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 870' ' ' ARG . . . . . 0.72 ' CB ' ' HB3' ' B' ' 855' ' ' ALA . 26.3 mmm180 -90.08 88.92 7.46 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.074 -1.016 . . . . 2.5899999999999999 111.028 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 61.6 t -76.87 96.09 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 120.918 -1.113 . . . . 1.9399999999999999 109.159 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 872' ' ' LEU . . . . . 0.597 HD13 HD11 ' C' ' 953' ' ' ILE . 86.3 mt -86.63 -44.31 11.96 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.658 -0.651 . . . . 1.0600000000000001 110.988 -179.188 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 873' ' ' LEU . . . . . . . . . . . . . 48.3 tp -172.16 107.44 0.21 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.219 -0.926 . . . . 4.1799999999999997 108.528 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 874' ' ' ASN . . . . . 0.6 ' HB3' ' HA ' ' B' ' 852' ' ' PHE . 12.1 p-10 174.6 81.2 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.473 0 O-C-N 121.551 -0.718 . . . . 0.040000000000000001 109.429 -178.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -69.5 -49.2 56.9 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.826 -1.171 . . . . 3.3799999999999999 111.352 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 876' ' ' GLY . . . . . 0.409 ' HA3' ' CE2' ' B' ' 878' ' ' TYR . . . -73.03 -26.38 71.13 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 110.642 -0.983 . . . . 0.040000000000000001 110.642 -179.28 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 78.65 -63.58 3.72 Favored Glycine 0 N--CA 1.498 2.77 0 N-CA-C 108.258 -1.937 . . . . 0.040000000000000001 108.258 -178.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 878' ' ' TYR . . . . . 0.409 ' CE2' ' HA3' ' B' ' 876' ' ' GLY . 92.3 m-85 61.74 -60.12 0.11 Allowed 'General case' 0 N--CA 1.504 2.256 0 N-CA-C 113.545 0.942 . . . . 3.46 113.545 178.388 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 879' ' ' TYR . . . . . 0.516 ' O ' ' CG ' ' B' ' 879' ' ' TYR . 10.0 p90 -111.31 104.06 12.5 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.94 -1.1 . . . . 0.040000000000000001 113.601 -177.48 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.14 112.91 13.19 Favored Pre-proline 0 N--CA 1.497 1.914 0 O-C-N 121.165 -0.96 . . . . 0.02 110.645 -178.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 881' ' ' PRO . . . . . 0.482 ' HG2' ' CD1' ' B' ' 868' ' ' PHE . 51.6 Cg_endo -78.33 -3.32 13.28 Favored 'Trans proline' 0 N--CA 1.49 1.27 0 O-C-N 123.442 1.232 . . . . 0.39000000000000001 111.061 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -77.66 -34.68 52.95 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 107.935 -1.135 . . . . 0.81000000000000005 107.935 178.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 74.2 p -111.59 -19.72 12.41 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.3 -0.863 . . . . 0.040000000000000001 108.975 176.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 79.88 4.17 89.46 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 110.087 -1.205 . . . . 0.029999999999999999 110.087 -178.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 885' ' ' VAL . . . . . 0.472 HG13 HG21 ' B' ' 961' ' ' THR . 69.0 t -73.3 95.2 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 C-N-CA 118.671 -1.212 . . . . 1.01 108.447 -178.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 886' ' ' PHE . . . . . 0.958 ' HB3' HG22 ' B' ' 962' ' ' VAL . 2.2 t80 -88.76 105.18 17.54 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 115.318 -0.856 . . . . 0.050000000000000003 111.86 -177.477 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 887' ' ' THR . . . . . 0.418 ' O ' ' HD3' ' B' ' 889' ' ' PRO . 35.3 m -97.72 100.05 11.42 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 107.655 -1.239 . . . . 0.68000000000000005 107.655 177.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 888' ' ' ALA . . . . . 0.423 ' HB2' ' CE1' ' B' ' 886' ' ' PHE . . . -99.14 106.64 39.73 Favored Pre-proline 0 N--CA 1.502 2.132 0 N-CA-C 114.1 1.148 . . . . 0.25 114.1 -176.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 889' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' B' ' 887' ' ' THR . 54.6 Cg_endo -90.25 -12.49 2.69 Favored 'Trans proline' 0 CA--C 1.546 1.121 0 C-N-CA 121.084 1.19 . . . . 1.6399999999999999 109.181 176.231 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 890' ' ' LEU . . . . . 0.828 HD22 HD13 ' B' ' 985' ' ' LEU . 71.9 mt -36.44 -49.99 0.75 Allowed 'General case' 0 N--CA 1.508 2.469 0 N-CA-C 113.851 1.056 . . . . 2.29 113.851 -177.239 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 51.75 96.27 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.41 0 O-C-N 121.159 -0.963 . . . . 0.63 110.346 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . 156.08 -148.77 19.27 Favored Glycine 0 N--CA 1.481 1.638 0 N-CA-C 107.26 -2.336 . . . . 0.040000000000000001 107.26 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 71.6 ttt-85 -111.49 127.73 55.79 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.762 -1.199 . . . . 3.0 107.762 177.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 894' ' ' TYR . . . . . 0.541 ' OH ' HD12 ' B' ' 896' ' ' LEU . 0.0 OUTLIER -130.41 154.1 48.06 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.032 -1.043 . . . . 0.040000000000000001 110.903 -178.663 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 895' ' ' LEU . . . . . 0.44 ' N ' ' CD1' ' B' ' 894' ' ' TYR . 38.9 tp -96.82 114.08 25.68 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.464 -0.773 . . . . 1.27 110.033 -179.284 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 896' ' ' LEU . . . . . 0.541 HD12 ' OH ' ' B' ' 894' ' ' TYR . 10.4 tt -109.19 143.91 37.99 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.634 -0.666 . . . . 0.93999999999999995 110.994 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 897' ' ' SER . . . . . 0.53 ' N ' HD23 ' B' ' 896' ' ' LEU . 50.5 m -149.29 115.05 5.64 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.584 -0.697 . . . . 0.040000000000000001 110.748 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.39 147.55 30.22 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.173 -0.677 . . . . 0.47999999999999998 109.173 179.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 899' ' ' VAL . . . . . 0.746 HG21 ' HB ' ' B' ' 980' ' ' ILE . 97.5 t -93.0 120.53 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 C-N-CA 119.672 -0.811 . . . . 0.55000000000000004 111.123 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 900' ' ' LEU . . . . . 0.436 ' N ' HD22 ' B' ' 900' ' ' LEU . 4.6 mm? -91.64 112.17 23.98 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 114.326 1.232 . . . . 1.5900000000000001 114.326 -175.179 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 23.0 m -67.43 141.64 56.94 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 107.109 -1.441 . . . . 0.050000000000000003 107.109 176.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -67.63 -66.53 2.3 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 110.469 -1.052 . . . . 0.029999999999999999 110.469 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 5.0 m170 46.22 66.09 1.03 Allowed 'General case' 0 N--CA 1.508 2.439 0 O-C-N 121.456 -1.026 . . . . 3.2000000000000002 111.215 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 43.3 ptt85 -69.5 -5.7 25.78 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.634 -0.666 . . . . 2.9199999999999999 112.052 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 905' ' ' HIS . . . . . 0.492 ' O ' ' CB ' ' B' ' 906' ' ' GLU . 76.4 t60 -62.17 4.71 0.12 Allowed 'General case' 0 N--CA 1.506 2.359 0 O-C-N 120.811 -1.18 . . . . 2.8700000000000001 113.065 -179.247 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 906' ' ' GLU . . . . . 0.492 ' CB ' ' O ' ' B' ' 905' ' ' HIS . 0.8 OUTLIER 94.51 -164.57 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.388 0 CA-C-N 120.589 1.541 . . . . 0.98999999999999999 112.094 178.82 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 907' ' ' LYS . . . . . 0.475 ' CB ' ' O ' ' B' ' 906' ' ' GLU . 29.4 ttmt 88.88 160.84 0.06 Allowed 'General case' 0 N--CA 1.521 3.123 0 N-CA-C 108.321 -0.992 . . . . 5.25 108.321 -177.178 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 61.1 t -122.29 116.7 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 120.848 -1.158 . . . . 0.39000000000000001 110.864 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 909' ' ' GLU . . . . . 0.645 ' OE2' HD12 ' B' ' 966' ' ' LEU . 39.9 tp10 -104.78 131.97 51.6 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 107.565 -1.272 . . . . 1.72 107.565 177.128 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -156.67 120.73 4.36 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 106.778 -1.564 . . . . 0.67000000000000004 106.778 178.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 911' ' ' VAL . . . . . 0.497 ' HA ' ' HA ' ' B' ' 964' ' ' VAL . 14.4 p -77.31 132.97 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.75 -0.594 . . . . 0.54000000000000004 111.406 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 86.7 mt -65.6 156.04 33.95 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.18 -1.044 . . . . 1.5 108.18 178.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 913' ' ' SER . . . . . 0.44 ' CB ' ' HB ' ' B' ' 919' ' ' VAL . 1.4 t -125.1 137.37 54.18 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.329 -0.989 . . . . 1.3700000000000001 108.329 177.061 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 914' ' ' ARG . . . . . 0.552 ' HD3' HG12 ' B' ' 962' ' ' VAL . 0.0 OUTLIER -63.47 153.01 36.78 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.917 -1.114 . . . . 4.2999999999999998 111.757 -179.059 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 915' ' ' SER . . . . . 0.426 ' CB ' ' O ' ' B' ' 914' ' ' ARG . 3.5 t 83.24 -30.21 0.09 Allowed 'General case' 0 N--CA 1.521 3.1 0 C-N-CA 123.977 0.911 . . . . 2.0499999999999998 112.359 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 916' ' ' ASN . . . . . 0.629 ' HB2' HG21 ' B' ' 919' ' ' VAL . 72.9 m-20 -126.8 -21.41 4.06 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 120.892 -1.13 . . . . 2.71 111.394 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 917' ' ' GLN . . . . . 0.442 ' HB2' ' O ' ' B' ' 916' ' ' ASN . 58.7 mt-30 66.99 168.97 0.24 Allowed 'General case' 0 N--CA 1.519 2.977 0 N-CA-C 105.892 -1.892 . . . . 2.6800000000000002 105.892 -173.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.9 -128.79 44.13 Favored Glycine 1 N--CA 1.521 4.302 0 CA-C-N 123.455 2.843 . . . . 0.029999999999999999 106.442 -177.282 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 919' ' ' VAL . . . . . 0.629 HG21 ' HB2' ' B' ' 916' ' ' ASN . 84.1 t 50.55 94.57 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.3 0 CA-C-N 118.608 1.204 . . . . 1.3899999999999999 109.191 -178.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 920' ' ' ALA . . . . . 0.973 ' HB3' HG12 ' B' ' 949' ' ' VAL . . . -92.5 94.47 9.09 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.274 -0.97 . . . . 0.029999999999999999 111.116 -179.149 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 921' ' ' ARG . . . . . 0.761 ' HG3' HG23 ' B' ' 922' ' ' VAL . 34.9 ptt85 -80.73 -43.29 20.48 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 105.553 -2.017 . . . . 4.4199999999999999 105.553 176.352 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 922' ' ' VAL . . . . . 0.761 HG23 ' HG3' ' B' ' 921' ' ' ARG . 94.0 t -101.68 77.59 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 N-CA-C 104.935 -2.246 . . . . 0.84999999999999998 104.935 174.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -87.56 135.78 33.21 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 122.105 0.955 . . . . 2.46 112.427 -176.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 924' ' ' SER . . . . . . . . . . . . . 10.2 t -145.6 103.4 3.79 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.461 -1.311 . . . . 0.69999999999999996 107.461 178.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -103.77 81.81 0.36 Allowed Glycine 0 N--CA 1.486 2.023 0 N-CA-C 108.965 -1.654 . . . . 0.040000000000000001 108.965 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.958 0 N-CA-C 108.74 -1.744 . . . . 0.040000000000000001 108.74 179.849 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 21.9 m . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 120.923 0.392 . . . . 13.779999999999999 110.412 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 95.5 mt -110.43 129.72 55.71 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.5 -0.75 . . . . 13.76 110.324 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -152.36 169.85 31.58 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.381 -1.487 . . . . 9.1300000000000008 109.381 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 949' ' ' VAL . . . . . 0.973 HG12 ' HB3' ' B' ' 920' ' ' ALA . 34.4 m -118.46 132.36 68.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.548 -0.972 . . . . 7.0800000000000001 111.077 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 950' ' ' PHE . . . . . 0.463 ' CZ ' ' HB3' ' B' ' 921' ' ' ARG . 39.8 p90 -134.98 152.6 51.88 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 109.127 -0.694 . . . . 7.5899999999999999 109.127 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 67.9 m -120.97 -53.03 2.07 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.318 -0.864 . . . . 5.0300000000000002 112.362 -178.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 952' ' ' LEU . . . . . 0.457 HD23 ' HB2' ' A' ' 982' ' ' SER . 56.3 tp -61.91 -76.44 0.06 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.32 -0.862 . . . . 1.01 112.357 -177.509 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 953' ' ' ILE . . . . . 0.495 ' O ' ' HB3' ' B' ' 954' ' ' LEU . 43.9 pt -52.22 -145.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.749 0 N-CA-C 114.038 1.125 . . . . 2.6000000000000001 114.038 -176.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 954' ' ' LEU . . . . . 0.719 HD22 ' O ' ' B' ' 954' ' ' LEU . 0.0 OUTLIER 170.96 83.74 0.04 OUTLIER Pre-proline 0 N--CA 1.508 2.475 0 O-C-N 120.852 -1.155 . . . . 0.050000000000000003 111.609 179.494 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 955' ' ' PRO . . . . . 0.679 ' C ' HD12 ' B' ' 956' ' ' LEU . 48.7 Cg_endo -76.34 95.23 1.03 Allowed 'Trans proline' 0 C--N 1.313 -1.292 0 N-CA-C 108.759 -1.285 . . . . 0.83999999999999997 108.759 177.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 956' ' ' LEU . . . . . 0.679 HD12 ' C ' ' B' ' 955' ' ' PRO . 10.3 mp -122.3 143.9 49.33 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.151 -0.968 . . . . 0.040000000000000001 110.183 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -86.01 151.18 23.93 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 117.81 -1.09 . . . . 1.28 111.639 -179.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -68.61 119.72 13.49 Favored 'General case' 0 N--CA 1.51 2.54 0 CA-C-N 122.862 2.574 . . . . 0.17000000000000001 111.843 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 93.36 -21.5 40.24 Favored Glycine 0 N--CA 1.5 2.962 0 N-CA-C 111.15 -0.78 . . . . 0.040000000000000001 111.15 178.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 960' ' ' ASP . . . . . 0.419 ' HB3' ' NE ' ' B' ' 914' ' ' ARG . 0.5 OUTLIER -55.68 169.77 0.31 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.457 -1.025 . . . . 0.040000000000000001 110.203 -179.489 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 961' ' ' THR . . . . . 0.472 HG21 HG13 ' B' ' 885' ' ' VAL . 46.0 m -136.86 139.49 41.7 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 120.835 -1.165 . . . . 1.78 112.408 -177.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 962' ' ' VAL . . . . . 0.958 HG22 ' HB3' ' B' ' 886' ' ' PHE . 31.8 m -99.87 145.15 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 C-N-CA 120.023 -0.671 . . . . 0.040000000000000001 111.116 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 5.4 t -137.96 145.42 41.98 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.907 -0.496 . . . . 0.71999999999999997 109.981 -179.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 964' ' ' VAL . . . . . 0.497 ' HA ' ' HA ' ' B' ' 911' ' ' VAL . 61.7 t -92.23 136.71 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.052 -1.03 . . . . 1.05 111.279 -178.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -95.69 126.42 40.96 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 103.464 -2.791 . . . . 3.02 103.464 172.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 966' ' ' LEU . . . . . 0.645 HD12 ' OE2' ' B' ' 909' ' ' GLU . 0.2 OUTLIER -133.6 61.39 1.68 Allowed 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.408 -0.96 . . . . 1.46 108.408 177.365 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 967' ' ' VAL . . . . . 0.486 HG23 ' C ' ' B' ' 966' ' ' LEU . 97.6 t -157.73 96.64 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 108.283 -1.006 . . . . 1.9399999999999999 108.283 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 92.8 mmm -143.4 58.68 1.39 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.752 -1.217 . . . . 0.0 108.251 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 133.87 119.75 2.02 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 107.05 -2.42 . . . . 2.1099999999999999 107.05 -178.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -82.46 -57.1 3.5 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.971 -1.311 . . . . 5.8899999999999997 110.499 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 47.8 tp -58.68 90.03 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.402 -0.811 . . . . 4.3600000000000003 110.318 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -143.03 -152.92 0.43 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.637 -0.665 . . . . 1.8300000000000001 110.079 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -117.83 167.41 11.42 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.473 -0.767 . . . . 4.3499999999999996 110.278 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 30.2 t -101.79 130.26 48.18 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.554 -0.716 . . . . 1.27 110.082 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -156.07 158.99 38.71 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.535 -0.728 . . . . 5.0199999999999996 110.643 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.71 85.08 20.94 Favored Pre-proline 0 N--CA 1.5 2.056 0 O-C-N 121.62 -0.675 . . . . 2.4100000000000001 109.72 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -73.41 -171.89 0.92 Allowed 'Trans proline' 0 C--N 1.317 -1.129 0 O-C-N 123.3 1.158 . . . . 0.95999999999999996 111.283 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 978' ' ' LEU . . . . . 0.57 ' N ' HD12 ' B' ' 978' ' ' LEU . 5.2 mp -126.82 155.93 42.1 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 107.546 -1.279 . . . . 0.62 107.546 177.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 979' ' ' THR . . . . . 0.462 HG23 ' C ' ' B' ' 978' ' ' LEU . 47.6 p -149.47 141.59 23.98 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.837 -1.165 . . . . 3.5699999999999998 111.184 -179.262 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 980' ' ' ILE . . . . . 0.746 ' HB ' HG21 ' B' ' 899' ' ' VAL . 50.6 mm -107.47 129.09 61.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 109.062 -0.718 . . . . 1.3300000000000001 109.062 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 981' ' ' PHE . . . . . 0.496 ' CD1' ' CE2' ' B' ' 879' ' ' TYR . 10.5 t80 -119.99 97.38 5.58 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 119.594 -0.843 . . . . 0.050000000000000003 111.926 -178.341 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 16.0 p -108.78 158.25 17.82 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 109.163 -0.68 . . . . 0.87 109.163 178.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 983' ' ' GLY . . . . . 0.41 ' O ' ' CE1' ' B' ' 852' ' ' PHE . . . -173.98 111.09 0.35 Allowed Glycine 0 N--CA 1.498 2.812 0 N-CA-C 106.655 -2.578 . . . . 0.029999999999999999 106.655 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 984' ' ' ALA . . . . . 0.423 ' HB1' ' CZ ' ' C' ' 893' ' ' ARG . . . -108.28 149.27 28.86 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 114.32 1.23 . . . . 0.69999999999999996 114.32 -175.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 985' ' ' LEU . . . . . 0.828 HD13 HD22 ' B' ' 890' ' ' LEU . 66.4 tp -71.75 136.28 47.09 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.728 -1.233 . . . . 0.040000000000000001 110.201 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 986' ' ' LEU . . . . . . . . . . . . . 49.3 tp -106.53 -58.07 1.97 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.671 -0.643 . . . . 0.040000000000000001 109.946 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -143.87 146.07 32.76 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.71 -1.218 . . . . 0.040000000000000001 107.71 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.46 162.96 12.22 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 108.088 -2.005 . . . . 0.040000000000000001 108.088 179.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -77.38 111.88 20.08 Favored Pre-proline 0 N--CA 1.499 1.988 0 O-C-N 121.226 -1.161 . . . . 0.040000000000000001 109.524 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 990' ' ' PRO . . . . . 0.631 ' HD2' HD12 ' B' ' 992' ' ' LEU . 48.7 Cg_endo -92.55 72.01 0.57 Allowed 'Trans proline' 0 C--N 1.318 -1.031 0 O-C-N 123.063 1.033 . . . . 0.45000000000000001 111.328 -178.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 991' ' ' GLU . . . . . 0.421 ' HB2' ' O ' ' B' ' 990' ' ' PRO . 72.4 mt-10 67.67 -73.43 0.08 Allowed 'General case' 0 N--CA 1.503 2.179 0 N-CA-C 108.251 -1.018 . . . . 1.97 108.251 -177.329 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 992' ' ' LEU . . . . . 0.631 HD12 ' HD2' ' B' ' 990' ' ' PRO . 4.1 mt 50.47 20.48 0.7 Allowed 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.58 -0.7 . . . . 2.3799999999999999 111.731 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 76.4 mt-10 -95.87 156.88 16.14 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.893 -1.13 . . . . 3.79 110.082 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 68.0 m80 -144.16 94.76 2.62 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.515 -0.741 . . . . 3.5099999999999998 110.2 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 995' ' ' ALA . . . . . . . . . . . . 2.517 . . . . . . . 0 N--CA 1.503 2.207 0 O-C-N 120.873 -1.142 . . . . 2.73 110.591 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo . . . . . 0 N--CA 1.488 1.152 0 N-CA-C 109.559 -0.977 . . . . 3.8300000000000001 109.559 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 847' ' ' VAL . . . . . 0.401 HG12 ' HB2' ' C' ' 849' ' ' GLN . 68.8 t -131.34 104.66 14.8 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.592 -0.692 . . . . 1.8300000000000001 109.819 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 848' ' ' PRO . . . . . 0.761 ' O ' HG23 ' C' ' 850' ' ' VAL . 43.7 Cg_endo -69.7 -19.56 36.26 Favored 'Trans proline' 0 N--CA 1.487 1.118 0 O-C-N 123.295 1.155 . . . . 0.65000000000000002 111.264 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 849' ' ' GLN . . . . . 0.411 ' C ' ' O ' ' C' ' 848' ' ' PRO . 56.2 tt0 26.24 68.49 0.05 Allowed 'General case' 0 N--CA 1.52 3.037 0 N-CA-C 112.893 0.701 . . . . 2.5800000000000001 112.893 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 850' ' ' VAL . . . . . 0.761 HG23 ' O ' ' C' ' 848' ' ' PRO . 93.5 t -117.21 135.24 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.245 -0.909 . . . . 1.0900000000000001 111.201 -178.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 851' ' ' ALA . . . . . . . . . . . . . . . -133.41 151.2 51.79 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 105.74 -1.948 . . . . 0.040000000000000001 105.74 177.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 852' ' ' PHE . . . . . 0.427 ' HA ' ' CB ' ' C' ' 874' ' ' ASN . 11.2 p90 -158.89 133.27 7.89 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 120.865 1.666 . . . . 0.050000000000000003 108.914 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 7.4 t -174.09 134.04 0.43 Allowed 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 107.954 -1.128 . . . . 0.040000000000000001 107.954 -179.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -136.44 159.25 42.33 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.167 -0.958 . . . . 0.67000000000000004 109.671 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 855' ' ' ALA . . . . . 0.61 ' HB3' ' CB ' ' C' ' 870' ' ' ARG . . . -122.86 140.64 52.74 Favored 'General case' 0 N--CA 1.499 1.994 0 CA-C-O 121.939 0.876 . . . . 0.51000000000000001 112.254 -178.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 856' ' ' LEU . . . . . 0.767 HD23 ' O ' ' C' ' 867' ' ' PRO . 3.5 tm? -106.6 138.52 42.63 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.645 -0.659 . . . . 0.050000000000000003 109.578 179.317 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 857' ' ' SER . . . . . 0.613 ' N ' HD13 ' C' ' 856' ' ' LEU . 1.3 m -159.23 18.65 0.18 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.443 -0.786 . . . . 1.3300000000000001 111.836 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 858' ' ' LEU . . . . . 0.724 HD23 HD11 ' C' ' 856' ' ' LEU . 2.7 pp -34.57 160.0 0.04 OUTLIER Pre-proline 0 N--CA 1.519 3.02 0 CA-C-N 118.603 0.638 . . . . 2.3300000000000001 112.689 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -60.19 -88.52 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 120.734 0.956 . . . . 2.3199999999999998 113.348 -178.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 55.4 ptt85 -130.47 -143.35 0.25 Allowed 'General case' 0 N--CA 1.5 2.052 0 O-C-N 120.883 -1.135 . . . . 0.040000000000000001 111.978 -177.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 41.2 m -33.31 120.55 0.38 Allowed 'General case' 0 N--CA 1.511 2.617 0 N-CA-C 113.241 0.83 . . . . 1.3100000000000001 113.241 -178.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.79 159.49 29.16 Favored Pre-proline 0 N--CA 1.486 1.342 0 N-CA-C 107.626 -1.25 . . . . 4.5099999999999998 107.626 176.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -69.78 -13.66 34.93 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 O-C-N 123.104 1.055 . . . . 2.2400000000000002 111.524 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -176.65 -135.26 2.13 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.911 -1.275 . . . . 0.040000000000000001 109.911 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 30.1 m -70.41 157.76 37.22 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.332 -1.099 . . . . 1.51 110.416 -179.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 866' ' ' VAL . . . . . 0.465 ' HA ' ' HD3' ' C' ' 867' ' ' PRO . 30.7 m -95.23 142.67 24.92 Favored Pre-proline 0 N--CA 1.498 1.964 0 N-CA-C 114.233 1.197 . . . . 0.78000000000000003 114.233 -174.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 867' ' ' PRO . . . . . 0.767 ' O ' HD23 ' C' ' 856' ' ' LEU . 55.6 Cg_endo -89.91 -150.69 0.04 OUTLIER 'Trans proline' 0 CA--C 1.541 0.871 0 N-CA-C 108.339 -1.446 . . . . 0.92000000000000004 108.339 177.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 868' ' ' PHE . . . . . 0.469 ' CD1' ' HG2' ' C' ' 881' ' ' PRO . 14.1 p90 -148.32 121.05 8.64 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.48 -1.387 . . . . 0.050000000000000003 109.865 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 50.0 p-10 -112.03 -3.97 14.62 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.15 -0.969 . . . . 1.7 112.471 -178.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 870' ' ' ARG . . . . . 0.61 ' CB ' ' HB3' ' C' ' 855' ' ' ALA . 22.7 mmm180 -90.93 89.19 7.34 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.96 -1.087 . . . . 2.5899999999999999 111.031 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 61.2 t -76.51 96.52 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 120.979 -1.075 . . . . 1.9399999999999999 109.238 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 872' ' ' LEU . . . . . 0.496 HD13 HD11 ' A' ' 953' ' ' ILE . 66.8 mt -85.78 -44.61 12.35 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.546 -0.721 . . . . 1.0600000000000001 110.559 -179.461 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 873' ' ' LEU . . . . . 0.419 ' O ' ' HB2' ' C' ' 874' ' ' ASN . 47.5 tp -172.21 104.33 0.17 Allowed 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.209 -0.932 . . . . 4.1799999999999997 108.71 178.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 874' ' ' ASN . . . . . 0.427 ' CB ' ' HA ' ' C' ' 852' ' ' PHE . 49.5 t-20 178.25 82.65 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.33 0 O-C-N 121.733 -0.604 . . . . 0.040000000000000001 109.588 -178.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 33.0 p-10 -72.07 -49.44 36.48 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.092 -1.005 . . . . 3.3799999999999999 111.705 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 876' ' ' GLY . . . . . . . . . . . . . . . -73.24 -26.43 70.53 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 110.617 -0.993 . . . . 0.040000000000000001 110.617 -179.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 81.34 -61.46 4.6 Favored Glycine 0 N--CA 1.497 2.742 0 N-CA-C 108.27 -1.932 . . . . 0.040000000000000001 108.27 -178.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 878' ' ' TYR . . . . . 0.54 ' CE2' HG13 ' C' ' 850' ' ' VAL . 85.6 m-85 61.62 -61.95 0.09 Allowed 'General case' 0 N--CA 1.504 2.25 0 N-CA-C 113.426 0.899 . . . . 3.46 113.426 178.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 879' ' ' TYR . . . . . 0.494 ' O ' ' CG ' ' C' ' 879' ' ' TYR . 12.2 p90 -110.97 105.33 14.07 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.991 -1.068 . . . . 0.040000000000000001 113.259 -177.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 880' ' ' ASP . . . . . 0.419 ' O ' ' N ' ' C' ' 884' ' ' GLY . 1.2 m-20 -66.69 112.68 10.17 Favored Pre-proline 0 N--CA 1.497 1.883 0 O-C-N 121.161 -0.962 . . . . 0.02 110.526 -178.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 881' ' ' PRO . . . . . 0.469 ' HG2' ' CD1' ' C' ' 868' ' ' PHE . 52.2 Cg_endo -79.05 -3.33 13.1 Favored 'Trans proline' 0 N--CA 1.489 1.238 0 O-C-N 123.531 1.279 . . . . 0.39000000000000001 111.213 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -80.31 -34.57 36.65 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 108.033 -1.099 . . . . 0.81000000000000005 108.033 178.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 69.6 p -110.36 -20.31 12.66 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 115.462 -0.79 . . . . 0.040000000000000001 108.984 176.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 884' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' C' ' 880' ' ' ASP . . . 80.07 4.88 89.78 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 110.232 -1.147 . . . . 0.029999999999999999 110.232 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 71.0 t -74.39 94.61 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 C-N-CA 118.695 -1.202 . . . . 1.01 108.532 -178.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 886' ' ' PHE . . . . . 0.865 ' CB ' HG22 ' C' ' 962' ' ' VAL . 2.1 t80 -88.74 105.8 17.94 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 115.513 -0.767 . . . . 0.050000000000000003 111.785 -177.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 887' ' ' THR . . . . . . . . . . . . . 28.0 m -98.53 99.99 11.2 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.787 -1.19 . . . . 0.68000000000000005 107.787 177.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 888' ' ' ALA . . . . . 0.529 ' HB2' ' CE1' ' C' ' 886' ' ' PHE . . . -97.87 108.3 45.31 Favored Pre-proline 0 N--CA 1.5 2.062 0 N-CA-C 113.606 0.965 . . . . 0.25 113.606 -176.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 889' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -89.87 -12.77 2.81 Favored 'Trans proline' 0 CA--C 1.544 1.02 0 C-N-CA 120.999 1.133 . . . . 1.6399999999999999 109.246 176.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 890' ' ' LEU . . . . . 0.734 HD12 ' N ' ' C' ' 891' ' ' ALA . 3.0 pp -36.87 -48.34 0.74 Allowed 'General case' 0 N--CA 1.508 2.47 0 N-CA-C 113.819 1.044 . . . . 2.29 113.819 -177.318 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 891' ' ' ALA . . . . . 0.734 ' N ' HD12 ' C' ' 890' ' ' LEU . . . 51.17 95.49 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.34 0 O-C-N 120.998 -1.064 . . . . 0.63 110.472 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . 155.43 -146.9 15.1 Favored Glycine 0 N--CA 1.479 1.566 0 N-CA-C 107.274 -2.33 . . . . 0.040000000000000001 107.274 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 893' ' ' ARG . . . . . 0.423 ' CZ ' ' HB1' ' B' ' 984' ' ' ALA . 76.5 ttt-85 -108.52 127.06 53.6 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 107.223 -1.399 . . . . 3.0 107.223 176.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 894' ' ' TYR . . . . . 0.55 ' HD2' HD23 ' C' ' 954' ' ' LEU . 0.5 OUTLIER -130.75 155.09 47.24 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.099 -1.001 . . . . 0.040000000000000001 110.841 -178.547 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 895' ' ' LEU . . . . . 0.428 ' O ' ' CE1' ' C' ' 894' ' ' TYR . 41.5 tp -99.79 117.3 33.82 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.652 -0.655 . . . . 1.27 110.539 -179.438 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 896' ' ' LEU . . . . . 0.85 HD23 ' N ' ' C' ' 897' ' ' SER . 4.5 tt -115.59 140.56 49.06 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.509 -0.745 . . . . 0.93999999999999995 110.35 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 897' ' ' SER . . . . . 0.85 ' N ' HD23 ' C' ' 896' ' ' LEU . 50.3 m -147.07 118.44 7.87 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.376 -0.828 . . . . 0.040000000000000001 111.286 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -108.64 147.41 31.91 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 109.401 -0.592 . . . . 0.47999999999999998 109.401 178.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 899' ' ' VAL . . . . . 0.721 HG21 ' HB ' ' C' ' 980' ' ' ILE . 97.9 t -93.19 121.53 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 C-N-CA 119.68 -0.808 . . . . 0.55000000000000004 111.29 -179.282 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 900' ' ' LEU . . . . . 0.44 HD12 ' HB2' ' C' ' 924' ' ' SER . 4.6 mm? -90.52 111.59 22.93 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 114.564 1.32 . . . . 1.5900000000000001 114.564 -175.224 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 21.6 m -67.09 142.09 57.23 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 106.974 -1.491 . . . . 0.050000000000000003 106.974 176.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -69.14 -67.71 1.86 Allowed Glycine 0 N--CA 1.494 2.549 0 N-CA-C 110.435 -1.066 . . . . 0.029999999999999999 110.435 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 5.2 t-80 46.24 66.46 0.95 Allowed 'General case' 0 N--CA 1.509 2.483 0 O-C-N 121.442 -1.034 . . . . 3.2000000000000002 111.122 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 46.4 ptt85 -69.12 -6.9 31.42 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.611 -0.681 . . . . 2.9199999999999999 112.043 -179.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 905' ' ' HIS . . . . . 0.488 ' O ' ' CB ' ' C' ' 906' ' ' GLU . 78.1 t60 -58.24 4.58 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.516 0 CA-C-O 117.653 -1.165 . . . . 2.8700000000000001 113.953 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 906' ' ' GLU . . . . . 0.488 ' CB ' ' O ' ' C' ' 905' ' ' HIS . 0.0 OUTLIER 94.02 -167.1 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.413 0 CA-C-N 121.264 1.847 . . . . 0.98999999999999999 112.011 179.096 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 907' ' ' LYS . . . . . 0.476 ' CB ' ' O ' ' C' ' 906' ' ' GLU . 30.3 ttmt 87.89 160.42 0.07 Allowed 'General case' 0 N--CA 1.518 2.969 0 N-CA-C 108.026 -1.102 . . . . 5.25 108.026 -177.062 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 59.2 t -120.9 116.38 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 120.947 -1.095 . . . . 0.39000000000000001 110.652 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 75.7 tt0 -103.66 131.65 50.62 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 107.298 -1.371 . . . . 1.72 107.298 176.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -155.34 122.36 5.45 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 106.445 -1.687 . . . . 0.67000000000000004 106.445 178.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 911' ' ' VAL . . . . . 0.722 HG13 HG22 ' C' ' 964' ' ' VAL . 70.1 t -77.41 131.95 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.826 -0.546 . . . . 0.54000000000000004 110.679 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 84.0 mt -65.67 157.07 31.0 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.279 -0.888 . . . . 1.5 108.718 178.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 913' ' ' SER . . . . . 0.472 ' OG ' HG11 ' C' ' 919' ' ' VAL . 1.3 p -127.17 132.65 50.46 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.174 -1.047 . . . . 1.3700000000000001 108.174 176.377 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 914' ' ' ARG . . . . . 0.428 ' O ' ' CB ' ' C' ' 915' ' ' SER . 0.0 OUTLIER -58.81 154.45 14.92 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 120.764 -1.21 . . . . 4.2999999999999998 112.097 -178.848 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 915' ' ' SER . . . . . 0.428 ' CB ' ' O ' ' C' ' 914' ' ' ARG . 1.8 t 83.13 -30.29 0.09 Allowed 'General case' 0 N--CA 1.519 3.022 0 C-N-CA 123.869 0.868 . . . . 2.0499999999999998 112.476 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 916' ' ' ASN . . . . . 0.617 ' HB2' HG21 ' C' ' 919' ' ' VAL . 97.2 m-20 -126.8 -23.5 3.67 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 120.891 -1.13 . . . . 2.71 111.173 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 917' ' ' GLN . . . . . 0.412 ' HB2' ' O ' ' C' ' 916' ' ' ASN . 41.8 mt-30 68.49 168.23 0.27 Allowed 'General case' 0 N--CA 1.517 2.917 0 N-CA-C 105.776 -1.935 . . . . 2.6800000000000002 105.776 -174.182 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 56.45 -127.72 44.56 Favored Glycine 1 N--CA 1.519 4.19 0 CA-C-N 123.397 2.817 . . . . 0.029999999999999999 106.467 -177.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 919' ' ' VAL . . . . . 0.617 HG21 ' HB2' ' C' ' 916' ' ' ASN . 95.0 t 50.45 94.83 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.336 0 CA-C-N 118.534 1.167 . . . . 1.3899999999999999 109.426 -178.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 920' ' ' ALA . . . . . 0.939 ' HB3' HG12 ' C' ' 949' ' ' VAL . . . -93.93 93.7 8.05 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.336 -0.946 . . . . 0.029999999999999999 111.049 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 921' ' ' ARG . . . . . 0.668 ' HG3' HG23 ' C' ' 922' ' ' VAL . 45.4 ptt85 -83.19 -42.96 16.67 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 105.582 -2.007 . . . . 4.4199999999999999 105.582 176.154 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 922' ' ' VAL . . . . . 0.668 HG23 ' HG3' ' C' ' 921' ' ' ARG . 77.3 t -101.05 74.65 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 104.71 -2.33 . . . . 0.84999999999999998 104.71 174.484 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -86.74 136.87 32.85 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 122.074 0.94 . . . . 2.46 112.614 -176.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 924' ' ' SER . . . . . 0.44 ' HB2' HD12 ' C' ' 900' ' ' LEU . 6.4 t -145.8 103.17 3.75 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 107.719 -1.215 . . . . 0.69999999999999996 107.719 178.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -107.48 85.75 0.43 Allowed Glycine 0 N--CA 1.488 2.123 0 N-CA-C 108.905 -1.678 . . . . 0.040000000000000001 108.905 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.278 0 N-CA-C 109.151 -1.58 . . . . 0.040000000000000001 109.151 -179.707 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 31.1 m . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 120.971 0.415 . . . . 13.779999999999999 110.335 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 947' ' ' LEU . . . . . 0.412 ' CD2' HG23 ' C' ' 919' ' ' VAL . 92.5 mt -110.37 129.56 55.73 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.487 -0.758 . . . . 13.76 110.312 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -152.25 169.71 31.51 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.348 -1.501 . . . . 9.1300000000000008 109.348 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 949' ' ' VAL . . . . . 0.939 HG12 ' HB3' ' C' ' 920' ' ' ALA . 33.5 m -118.69 131.74 70.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.551 -0.97 . . . . 7.0800000000000001 110.843 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 950' ' ' PHE . . . . . 0.457 ' CZ ' ' HB3' ' C' ' 921' ' ' ARG . 48.2 p90 -133.36 151.14 51.82 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.579 -0.7 . . . . 7.5899999999999999 109.113 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 7.3 m -119.64 -53.19 2.21 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.401 -0.812 . . . . 5.0300000000000002 112.096 -178.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 952' ' ' LEU . . . . . 0.425 ' O ' ' O ' ' C' ' 953' ' ' ILE . 15.4 tp -62.99 -74.78 0.09 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.354 -0.841 . . . . 1.01 112.018 -177.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 953' ' ' ILE . . . . . 0.597 HD11 HD13 ' B' ' 872' ' ' LEU . 41.8 pt -52.42 -146.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.77 0 N-CA-C 114.145 1.165 . . . . 2.6000000000000001 114.145 -176.627 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 954' ' ' LEU . . . . . 0.707 HD22 ' O ' ' C' ' 954' ' ' LEU . 0.0 OUTLIER 169.0 80.38 0.03 OUTLIER Pre-proline 0 N--CA 1.512 2.674 0 O-C-N 120.957 -1.089 . . . . 0.050000000000000003 111.695 179.563 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 955' ' ' PRO . . . . . 0.436 ' HD2' ' CE1' ' C' ' 950' ' ' PHE . 44.4 Cg_endo -72.66 98.84 1.0 Allowed 'Trans proline' 0 C--N 1.313 -1.325 0 N-CA-C 109.193 -1.118 . . . . 0.83999999999999997 109.193 178.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 956' ' ' LEU . . . . . 0.408 ' HA ' ' NH1' ' C' ' 914' ' ' ARG . 92.0 mt -125.26 142.29 51.59 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.052 -1.03 . . . . 0.040000000000000001 110.492 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 957' ' ' GLN . . . . . 0.447 ' HB2' ' HB3' ' C' ' 960' ' ' ASP . 87.2 mt-30 -84.98 149.49 25.57 Favored 'General case' 0 N--CA 1.501 2.124 0 CA-C-O 117.997 -1.001 . . . . 1.28 111.919 -178.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -62.11 122.29 15.19 Favored 'General case' 0 N--CA 1.512 2.635 0 CA-C-N 122.751 2.523 . . . . 0.17000000000000001 110.799 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 91.48 -10.31 75.09 Favored Glycine 0 N--CA 1.501 3.011 0 N-CA-C 110.167 -1.173 . . . . 0.040000000000000001 110.167 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 960' ' ' ASP . . . . . 0.447 ' HB3' ' HB2' ' C' ' 957' ' ' GLN . 16.3 p-10 -47.96 167.92 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.546 -0.973 . . . . 0.040000000000000001 111.98 -179.014 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 961' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' C' ' 886' ' ' PHE . 91.1 m -137.96 127.15 24.42 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.403 -0.811 . . . . 1.78 110.087 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 962' ' ' VAL . . . . . 0.865 HG22 ' CB ' ' C' ' 886' ' ' PHE . 12.0 m -100.96 142.95 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 C-N-CA 119.392 -0.923 . . . . 0.040000000000000001 110.45 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 5.5 t -140.41 145.77 37.47 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.968 -0.457 . . . . 0.71999999999999997 109.875 -178.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 964' ' ' VAL . . . . . 0.722 HG22 HG13 ' C' ' 911' ' ' VAL . 60.1 t -100.71 136.96 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.041 -1.037 . . . . 1.05 111.296 -178.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -96.42 128.11 43.04 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 103.967 -2.605 . . . . 3.02 103.967 173.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 966' ' ' LEU . . . . . 0.489 ' C ' HG23 ' C' ' 967' ' ' VAL . 11.7 tp -132.38 64.33 1.61 Allowed 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.254 -1.017 . . . . 1.46 108.254 177.122 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 967' ' ' VAL . . . . . 0.489 HG23 ' C ' ' C' ' 966' ' ' LEU . 96.9 t -157.81 97.19 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 108.041 -1.096 . . . . 1.9399999999999999 108.041 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 91.1 mmm -143.17 59.13 1.41 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.713 -1.242 . . . . 0.0 108.359 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.35 119.93 1.97 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 107.124 -2.39 . . . . 2.1099999999999999 107.124 -178.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -81.56 -57.94 3.24 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.01 -1.288 . . . . 5.8899999999999997 110.574 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 45.4 tp -58.64 90.24 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.433 -0.792 . . . . 4.3600000000000003 110.395 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -142.97 -153.47 0.47 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.573 -0.704 . . . . 1.8300000000000001 110.188 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -118.69 166.86 12.24 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.501 -0.75 . . . . 4.3499999999999996 110.323 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 31.1 t -102.14 130.18 48.7 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.522 -0.736 . . . . 1.27 109.944 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 66.8 tt0 -156.25 159.53 38.98 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.466 -0.771 . . . . 5.0199999999999996 110.628 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.1 85.82 21.59 Favored Pre-proline 0 N--CA 1.5 2.067 0 O-C-N 121.646 -0.659 . . . . 2.4100000000000001 109.755 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 977' ' ' PRO . . . . . 0.516 ' C ' HD12 ' C' ' 978' ' ' LEU . 47.3 Cg_endo -72.97 -170.74 0.66 Allowed 'Trans proline' 0 C--N 1.316 -1.138 0 O-C-N 123.323 1.17 . . . . 0.95999999999999996 111.159 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 978' ' ' LEU . . . . . 0.516 HD12 ' C ' ' C' ' 977' ' ' PRO . 5.8 mp -126.17 155.88 41.03 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 107.703 -1.221 . . . . 0.62 107.703 178.053 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 979' ' ' THR . . . . . 0.452 HG23 ' C ' ' C' ' 978' ' ' LEU . 63.7 p -148.83 141.17 24.15 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.853 -1.154 . . . . 3.5699999999999998 111.09 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 980' ' ' ILE . . . . . 0.721 ' HB ' HG21 ' C' ' 899' ' ' VAL . 49.2 mm -107.06 129.24 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 108.982 -0.747 . . . . 1.3300000000000001 108.982 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 981' ' ' PHE . . . . . 0.454 ' CD1' ' CE2' ' C' ' 879' ' ' TYR . 5.3 t80 -119.92 96.44 5.18 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 119.606 -0.837 . . . . 0.050000000000000003 111.796 -178.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 982' ' ' SER . . . . . . . . . . . . . 94.8 p -108.55 157.19 18.7 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.831 -0.803 . . . . 0.87 108.831 178.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 983' ' ' GLY . . . . . . . . . . . . . . . -172.86 112.86 0.45 Allowed Glycine 0 N--CA 1.496 2.671 0 N-CA-C 106.841 -2.503 . . . . 0.029999999999999999 106.841 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 984' ' ' ALA . . . . . 0.416 ' HB1' ' CZ ' ' A' ' 893' ' ' ARG . . . -109.83 146.98 34.13 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 114.142 1.164 . . . . 0.69999999999999996 114.142 -176.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 985' ' ' LEU . . . . . . . . . . . . . 56.6 tp -71.24 136.88 48.21 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 120.788 -1.195 . . . . 0.040000000000000001 110.2 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 986' ' ' LEU . . . . . . . . . . . . . 51.7 tp -106.21 -60.65 1.62 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.597 -0.689 . . . . 0.040000000000000001 110.285 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -143.82 146.46 33.09 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.896 -1.15 . . . . 0.040000000000000001 107.896 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.79 162.62 12.31 Favored Glycine 0 N--CA 1.496 2.695 0 N-CA-C 108.132 -1.987 . . . . 0.040000000000000001 108.132 179.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.72 111.86 22.62 Favored Pre-proline 0 N--CA 1.499 1.999 0 CA-C-N 118.571 1.186 . . . . 0.040000000000000001 109.539 178.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 990' ' ' PRO . . . . . 0.471 ' HD2' HD12 ' C' ' 992' ' ' LEU . 48.8 Cg_endo -92.59 74.0 0.48 Allowed 'Trans proline' 0 C--N 1.318 -1.059 0 O-C-N 123.117 1.062 . . . . 0.45000000000000001 111.527 -179.022 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 991' ' ' GLU . . . . . 0.417 ' HB2' ' O ' ' C' ' 990' ' ' PRO . 77.1 mt-10 67.26 -73.67 0.08 Allowed 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 108.48 -0.933 . . . . 1.97 108.48 -177.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 992' ' ' LEU . . . . . 0.471 HD12 ' HD2' ' C' ' 990' ' ' PRO . 6.9 mt 51.65 20.38 1.08 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.521 -0.737 . . . . 2.3799999999999999 111.591 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -95.39 156.88 16.13 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.855 -1.153 . . . . 3.79 110.066 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 67.3 m80 -146.44 94.55 2.47 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.534 -0.729 . . . . 3.5099999999999998 110.345 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 995' ' ' ALA . . . . . . . . . . . . 2.518 . . . . . . . 0 N--CA 1.504 2.225 0 O-C-N 120.955 -1.09 . . . . 2.73 110.616 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo . . . . . 0 N--CA 1.488 1.177 0 N-CA-C 109.482 -1.007 . . . . 3.8300000000000001 109.482 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 847' ' ' VAL . . . . . 0.432 HG12 ' HB2' ' A' ' 849' ' ' GLN . 60.1 t -132.04 103.58 14.16 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.583 -0.698 . . . . 1.8300000000000001 110.073 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 848' ' ' PRO . . . . . 0.718 ' O ' HG23 ' A' ' 850' ' ' VAL . 43.9 Cg_endo -69.8 -19.89 35.34 Favored 'Trans proline' 0 N--CA 1.487 1.106 0 O-C-N 123.302 1.159 . . . . 0.65000000000000002 111.125 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 849' ' ' GLN . . . . . 0.432 ' HB2' HG12 ' A' ' 847' ' ' VAL . 56.4 tt0 26.42 69.24 0.05 Allowed 'General case' 0 N--CA 1.519 2.989 0 N-CA-C 112.948 0.721 . . . . 2.5800000000000001 112.948 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 850' ' ' VAL . . . . . 0.718 HG23 ' O ' ' A' ' 848' ' ' PRO . 59.7 t -117.46 137.86 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.292 -0.88 . . . . 1.0900000000000001 111.63 -178.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 851' ' ' ALA . . . . . 0.495 ' HB3' ' HG ' ' A' ' 873' ' ' LEU . . . -127.69 155.41 44.0 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 105.723 -1.954 . . . . 0.040000000000000001 105.723 176.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 852' ' ' PHE . . . . . 0.446 ' HA ' ' CB ' ' A' ' 874' ' ' ASN . 21.4 p90 -160.4 128.87 4.73 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-N 121.016 1.735 . . . . 0.050000000000000003 108.864 179.286 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 33.1 t -175.57 134.57 0.3 Allowed 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.071 -1.085 . . . . 0.040000000000000001 108.071 -179.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -134.85 158.42 44.26 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.053 -1.029 . . . . 0.67000000000000004 109.501 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 855' ' ' ALA . . . . . 0.78 ' HB3' ' CB ' ' A' ' 870' ' ' ARG . . . -122.58 141.02 52.14 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 121.894 0.854 . . . . 0.51000000000000001 111.852 -178.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 856' ' ' LEU . . . . . 0.925 HD11 HD23 ' A' ' 858' ' ' LEU . 3.5 tm? -107.64 135.53 48.93 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 109.247 -0.649 . . . . 0.050000000000000003 109.247 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 857' ' ' SER . . . . . 0.572 ' N ' HD13 ' A' ' 856' ' ' LEU . 16.9 p -153.05 17.82 0.57 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.419 -0.8 . . . . 1.3300000000000001 111.223 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 858' ' ' LEU . . . . . 0.925 HD23 HD11 ' A' ' 856' ' ' LEU . 3.1 pp -29.66 154.08 0.03 OUTLIER Pre-proline 0 N--CA 1.52 3.046 0 N-CA-C 113.421 0.897 . . . . 2.3300000000000001 113.421 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -61.73 -88.8 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 120.934 1.09 . . . . 2.3199999999999998 113.683 -177.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 53.4 ptt85 -127.16 -142.12 0.27 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.895 -1.128 . . . . 0.040000000000000001 111.429 -177.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 36.8 m -39.11 119.02 0.85 Allowed 'General case' 0 N--CA 1.51 2.543 0 O-C-N 121.549 -0.719 . . . . 1.3100000000000001 111.919 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 862' ' ' GLU . . . . . 0.502 ' OE2' HD22 ' A' ' 858' ' ' LEU . 24.6 tt0 -97.35 149.57 35.86 Favored Pre-proline 0 N--CA 1.488 1.453 0 N-CA-C 108.17 -1.048 . . . . 4.5099999999999998 108.17 178.048 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 863' ' ' PRO . . . . . 0.446 ' HD2' ' CG ' ' A' ' 862' ' ' GLU . 41.6 Cg_endo -67.65 -13.31 38.47 Favored 'Trans proline' 0 C--N 1.316 -1.161 0 O-C-N 122.984 0.991 . . . . 2.2400000000000002 111.334 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -174.21 -137.36 2.43 Favored Glycine 0 N--CA 1.493 2.474 0 C-N-CA 119.76 -1.21 . . . . 0.040000000000000001 110.623 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 37.1 m -69.2 159.65 32.63 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.332 -1.099 . . . . 1.51 111.719 -177.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 866' ' ' VAL . . . . . 0.463 ' O ' HG23 ' A' ' 866' ' ' VAL . 27.0 m -89.93 132.73 35.48 Favored Pre-proline 0 N--CA 1.495 1.808 0 N-CA-C 113.422 0.897 . . . . 0.78000000000000003 113.422 -175.304 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 867' ' ' PRO . . . . . 0.841 ' O ' HD23 ' A' ' 856' ' ' LEU . 52.5 Cg_endo -88.77 -153.82 0.05 OUTLIER 'Trans proline' 0 C--N 1.323 -0.794 0 N-CA-C 107.709 -1.689 . . . . 0.92000000000000004 107.709 177.011 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 868' ' ' PHE . . . . . 0.48 ' CD1' ' HG2' ' A' ' 881' ' ' PRO . 31.9 p90 -148.55 119.25 7.5 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.51 -1.369 . . . . 0.050000000000000003 109.944 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 50.1 p-10 -112.72 -3.24 14.29 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 119.322 -0.951 . . . . 1.7 112.207 -178.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 870' ' ' ARG . . . . . 0.78 ' CB ' ' HB3' ' A' ' 855' ' ' ALA . 26.5 mmm180 -89.98 88.69 7.4 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.908 -1.12 . . . . 2.5899999999999999 110.676 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 57.3 t -75.12 96.88 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.028 -1.045 . . . . 1.9399999999999999 109.787 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 872' ' ' LEU . . . . . . . . . . . . . 95.8 mt -83.92 -46.89 11.62 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.553 -0.717 . . . . 1.0600000000000001 110.231 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 873' ' ' LEU . . . . . 0.495 ' HG ' ' HB3' ' A' ' 851' ' ' ALA . 48.8 tp -174.82 104.48 0.09 Allowed 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.293 -0.879 . . . . 4.1799999999999997 108.676 178.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 874' ' ' ASN . . . . . 0.446 ' CB ' ' HA ' ' A' ' 852' ' ' PHE . 36.5 t-20 178.68 82.1 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.316 0 O-C-N 121.588 -0.695 . . . . 0.040000000000000001 109.675 -178.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -66.91 -47.06 72.93 Favored 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 119.289 -0.965 . . . . 3.3799999999999999 111.283 -179.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 876' ' ' GLY . . . . . 0.404 ' HA3' ' CE2' ' A' ' 878' ' ' TYR . . . -74.62 -25.29 70.35 Favored Glycine 0 N--CA 1.494 2.553 0 O-C-N 121.239 -0.913 . . . . 0.040000000000000001 111.836 -178.666 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 84.32 -59.8 4.9 Favored Glycine 0 N--CA 1.502 3.084 0 N-CA-C 108.154 -1.979 . . . . 0.040000000000000001 108.154 -178.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 878' ' ' TYR . . . . . 0.404 ' CE2' ' HA3' ' A' ' 876' ' ' GLY . 97.7 m-85 60.67 -66.13 0.05 Allowed 'General case' 0 N--CA 1.503 2.215 0 N-CA-C 114.327 1.232 . . . . 3.46 114.327 177.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 879' ' ' TYR . . . . . 0.469 ' CB ' ' CD2' ' A' ' 886' ' ' PHE . 23.7 p90 -112.37 109.17 18.64 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 114.796 1.406 . . . . 0.040000000000000001 114.796 -176.275 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -65.18 118.53 50.65 Favored Pre-proline 0 N--CA 1.495 1.816 0 O-C-N 121.369 -0.832 . . . . 0.02 110.026 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 881' ' ' PRO . . . . . 0.48 ' HG2' ' CD1' ' A' ' 868' ' ' PHE . 55.2 Cg_endo -76.87 0.24 9.85 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 O-C-N 123.469 1.247 . . . . 0.39000000000000001 112.094 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 -76.79 -64.81 1.04 Allowed 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 106.98 -1.489 . . . . 0.81000000000000005 106.98 178.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 883' ' ' THR . . . . . 0.478 ' OG1' HG23 ' A' ' 885' ' ' VAL . 30.4 p -94.1 -17.7 22.55 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.776 -0.824 . . . . 0.040000000000000001 108.776 177.461 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.08 22.11 55.65 Favored Glycine 0 N--CA 1.495 2.63 0 O-C-N 121.057 -1.027 . . . . 0.029999999999999999 110.749 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 885' ' ' VAL . . . . . 0.652 HG13 HG21 ' A' ' 961' ' ' THR . 77.6 t -73.15 90.42 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 C-N-CA 118.353 -1.339 . . . . 1.01 108.23 -179.225 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 886' ' ' PHE . . . . . 0.883 ' HB3' HG22 ' A' ' 962' ' ' VAL . 0.7 OUTLIER -90.39 104.34 16.92 Favored 'General case' 0 N--CA 1.495 1.825 0 CA-C-N 115.291 -0.868 . . . . 0.050000000000000003 112.291 -177.298 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 887' ' ' THR . . . . . 0.418 ' O ' ' HD3' ' A' ' 889' ' ' PRO . 89.8 m -95.04 100.77 12.54 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 107.831 -1.174 . . . . 0.68000000000000005 107.831 177.468 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 888' ' ' ALA . . . . . . . . . . . . . . . -99.17 106.37 38.15 Favored Pre-proline 0 N--CA 1.5 2.047 0 N-CA-C 114.045 1.128 . . . . 0.25 114.045 -176.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 889' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 887' ' ' THR . 54.6 Cg_endo -89.2 -11.94 3.45 Favored 'Trans proline' 0 CA--C 1.546 1.109 0 N-CA-C 108.975 -1.202 . . . . 1.6399999999999999 108.975 176.087 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 890' ' ' LEU . . . . . 0.628 HD11 ' CD1' ' A' ' 985' ' ' LEU . 4.9 tt -35.29 -51.23 0.58 Allowed 'General case' 0 N--CA 1.507 2.397 0 N-CA-C 113.92 1.082 . . . . 2.29 113.92 -177.475 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 51.79 95.03 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.374 0 O-C-N 121.188 -0.945 . . . . 0.63 110.175 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 156.05 -147.28 15.72 Favored Glycine 0 N--CA 1.478 1.487 0 N-CA-C 107.372 -2.291 . . . . 0.040000000000000001 107.372 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 893' ' ' ARG . . . . . 0.44 ' NE ' ' HB1' ' C' ' 984' ' ' ALA . 72.4 ttt-85 -109.0 127.91 54.5 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.86 -1.163 . . . . 3.0 107.86 177.365 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 894' ' ' TYR . . . . . 0.45 ' CD1' ' N ' ' A' ' 895' ' ' LEU . 0.1 OUTLIER -130.98 144.46 51.49 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.05 -1.032 . . . . 0.040000000000000001 110.085 -179.305 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 895' ' ' LEU . . . . . 0.45 ' N ' ' CD1' ' A' ' 894' ' ' TYR . 34.3 tp -99.37 115.22 28.72 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.625 -0.672 . . . . 1.27 109.807 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 896' ' ' LEU . . . . . 0.617 HD23 ' N ' ' A' ' 897' ' ' SER . 9.9 tt -112.16 145.87 39.06 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.579 -0.7 . . . . 0.93999999999999995 110.461 -179.461 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 897' ' ' SER . . . . . 0.617 ' N ' HD23 ' A' ' 896' ' ' LEU . 71.2 m -144.74 119.11 9.6 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.379 -0.825 . . . . 0.040000000000000001 110.741 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.97 147.69 30.72 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.708 -0.62 . . . . 0.47999999999999998 109.448 179.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 899' ' ' VAL . . . . . 0.706 HG21 ' HB ' ' A' ' 980' ' ' ILE . 88.0 t -91.95 121.15 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.457 -0.777 . . . . 0.55000000000000004 110.98 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 900' ' ' LEU . . . . . 0.603 HD12 ' HB2' ' A' ' 924' ' ' SER . 4.4 mm? -95.02 111.75 23.52 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 114.423 1.268 . . . . 1.5900000000000001 114.423 -174.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 17.3 m -67.8 141.64 56.45 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 107.274 -1.38 . . . . 0.050000000000000003 107.274 176.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -67.92 -65.02 2.87 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 110.718 -0.953 . . . . 0.029999999999999999 110.718 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 5.8 m170 46.83 66.31 1.02 Allowed 'General case' 0 N--CA 1.508 2.437 0 O-C-N 121.464 -1.021 . . . . 3.2000000000000002 111.082 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 54.1 ptt85 -69.26 -5.91 25.94 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.578 -0.701 . . . . 2.9199999999999999 112.178 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 905' ' ' HIS . . . . . 0.489 ' O ' ' CB ' ' A' ' 906' ' ' GLU . 73.9 t60 -62.69 5.06 0.13 Allowed 'General case' 0 N--CA 1.507 2.393 0 O-C-N 120.888 -1.132 . . . . 2.8700000000000001 113.086 -179.133 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 906' ' ' GLU . . . . . 0.489 ' CB ' ' O ' ' A' ' 905' ' ' HIS . 0.6 OUTLIER 95.07 -164.97 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.452 0 CA-C-N 120.609 1.549 . . . . 0.98999999999999999 111.993 178.903 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 907' ' ' LYS . . . . . 0.463 ' CB ' ' O ' ' A' ' 906' ' ' GLU . 62.0 tttt 86.09 156.78 0.08 Allowed 'General case' 0 N--CA 1.52 3.03 0 N-CA-C 107.961 -1.126 . . . . 5.25 107.961 -176.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 60.7 t -122.1 117.45 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 120.791 -1.193 . . . . 0.39000000000000001 111.224 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 54.0 tp10 -101.56 133.24 46.54 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 107.291 -1.374 . . . . 1.72 107.291 176.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -155.74 123.0 5.45 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 106.811 -1.551 . . . . 0.67000000000000004 106.811 178.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 911' ' ' VAL . . . . . 0.772 HG22 HG13 ' A' ' 964' ' ' VAL . 93.8 t -84.28 131.83 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.902 -0.499 . . . . 0.54000000000000004 110.984 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 60.6 mt -66.92 157.56 32.92 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.46 -0.775 . . . . 1.5 109.351 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 913' ' ' SER . . . . . 0.466 ' OG ' HG11 ' A' ' 919' ' ' VAL . 1.4 p -124.65 137.6 54.36 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.003 -1.11 . . . . 1.3700000000000001 108.003 176.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 914' ' ' ARG . . . . . 0.611 ' NH1' HD23 ' A' ' 956' ' ' LEU . 0.1 OUTLIER -65.32 155.28 35.75 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.638 -1.289 . . . . 4.2999999999999998 111.359 -179.164 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 915' ' ' SER . . . . . 0.424 ' CB ' ' O ' ' A' ' 914' ' ' ARG . 1.7 p 83.42 -31.56 0.08 Allowed 'General case' 0 N--CA 1.521 3.118 0 C-N-CA 123.925 0.89 . . . . 2.0499999999999998 112.068 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 916' ' ' ASN . . . . . 0.754 ' HB2' HG21 ' A' ' 919' ' ' VAL . 99.4 m-20 -122.78 -21.91 5.47 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 120.953 -1.092 . . . . 2.71 111.192 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 917' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 67.04 166.53 0.22 Allowed 'General case' 0 N--CA 1.52 3.027 0 N-CA-C 105.742 -1.948 . . . . 2.6800000000000002 105.742 -174.249 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.33 -125.23 33.43 Favored Glycine 1 N--CA 1.521 4.324 0 CA-C-N 123.368 2.804 . . . . 0.029999999999999999 107.07 -177.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 919' ' ' VAL . . . . . 0.754 HG21 ' HB2' ' A' ' 916' ' ' ASN . 88.2 t 52.39 94.98 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 O-C-N 121.382 -1.069 . . . . 1.3899999999999999 109.068 -178.092 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 920' ' ' ALA . . . . . 0.912 ' HB3' HG12 ' A' ' 949' ' ' VAL . . . -90.87 91.07 8.19 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.246 -0.982 . . . . 0.029999999999999999 110.788 -179.173 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 921' ' ' ARG . . . . . 0.763 ' HG3' HG23 ' A' ' 922' ' ' VAL . 27.5 ptt85 -84.99 -42.2 15.11 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 106.013 -1.847 . . . . 4.4199999999999999 106.013 176.374 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 922' ' ' VAL . . . . . 0.763 HG23 ' HG3' ' A' ' 921' ' ' ARG . 74.6 t -101.96 74.29 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 105.76 -1.941 . . . . 0.84999999999999998 105.76 175.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -85.79 134.91 33.91 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.758 0.789 . . . . 2.46 111.545 -177.271 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 924' ' ' SER . . . . . 0.603 ' HB2' HD12 ' A' ' 900' ' ' LEU . 7.0 t -147.09 105.67 3.81 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 108.772 -0.825 . . . . 0.69999999999999996 108.772 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -103.46 83.49 0.42 Allowed Glycine 0 N--CA 1.487 2.035 0 N-CA-C 108.243 -1.943 . . . . 0.040000000000000001 108.243 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.226 0 N-CA-C 108.82 -1.712 . . . . 0.040000000000000001 108.82 -179.543 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 24.8 m . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.054 0.455 . . . . 13.779999999999999 110.29 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 95.7 mt -112.17 130.01 56.05 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.519 -0.738 . . . . 13.76 110.362 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -151.77 168.71 31.16 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.229 -1.548 . . . . 9.1300000000000008 109.229 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 949' ' ' VAL . . . . . 0.912 HG12 ' HB3' ' A' ' 920' ' ' ALA . 32.7 m -118.28 130.1 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.573 -0.957 . . . . 7.0800000000000001 110.691 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 950' ' ' PHE . . . . . 0.46 ' CZ ' ' HB3' ' A' ' 921' ' ' ARG . 50.0 p90 -135.18 152.46 51.61 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.57 -0.706 . . . . 7.5899999999999999 109.508 179.732 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 23.1 m -118.45 -54.52 2.27 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.44 -0.787 . . . . 5.0300000000000002 112.007 -178.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 952' ' ' LEU . . . . . 0.437 ' O ' ' O ' ' A' ' 953' ' ' ILE . 12.3 tp -62.05 -74.26 0.09 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.432 -0.793 . . . . 1.01 112.081 -177.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 953' ' ' ILE . . . . . 0.643 HD12 ' HD3' ' A' ' 955' ' ' PRO . 1.5 pp -51.56 -149.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.713 0 N-CA-C 114.18 1.178 . . . . 2.6000000000000001 114.18 -176.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 954' ' ' LEU . . . . . 0.74 HD22 ' O ' ' A' ' 954' ' ' LEU . 0.0 OUTLIER 166.32 90.69 0.02 OUTLIER Pre-proline 0 N--CA 1.519 2.982 0 O-C-N 121.179 -0.951 . . . . 0.050000000000000003 111.755 179.174 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 955' ' ' PRO . . . . . 0.732 ' C ' HD12 ' A' ' 956' ' ' LEU . 51.7 Cg_endo -78.92 98.28 1.18 Allowed 'Trans proline' 0 C--N 1.315 -1.198 0 N-CA-C 109.037 -1.178 . . . . 0.83999999999999997 109.037 178.211 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 956' ' ' LEU . . . . . 0.732 HD12 ' C ' ' A' ' 955' ' ' PRO . 11.1 mp -121.27 141.93 50.42 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.994 -1.066 . . . . 0.040000000000000001 109.954 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -84.5 150.86 24.98 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 117.782 -1.104 . . . . 1.28 111.842 -178.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -68.43 118.9 12.09 Favored 'General case' 0 N--CA 1.509 2.525 0 CA-C-N 123.034 2.652 . . . . 0.17000000000000001 111.431 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 93.03 -21.25 40.92 Favored Glycine 0 N--CA 1.5 2.959 0 N-CA-C 111.034 -0.826 . . . . 0.040000000000000001 111.034 178.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 960' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -56.57 170.46 0.38 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.426 -1.044 . . . . 0.040000000000000001 110.112 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 961' ' ' THR . . . . . 0.652 HG21 HG13 ' A' ' 885' ' ' VAL . 42.1 m -135.94 137.76 41.65 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.906 -1.121 . . . . 1.78 112.282 -178.007 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 962' ' ' VAL . . . . . 0.883 HG22 ' HB3' ' A' ' 886' ' ' PHE . 33.6 m -98.14 145.37 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 C-N-CA 120.142 -0.623 . . . . 0.040000000000000001 110.352 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 5.2 t -137.4 145.02 42.73 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.792 -0.568 . . . . 0.71999999999999997 110.041 -178.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 964' ' ' VAL . . . . . 0.772 HG13 HG22 ' A' ' 911' ' ' VAL . 61.2 t -93.21 136.72 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.16 -0.963 . . . . 1.05 110.495 -179.261 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -93.73 127.42 39.43 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 103.613 -2.736 . . . . 3.02 103.613 173.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 966' ' ' LEU . . . . . 0.544 HD23 ' O ' ' A' ' 966' ' ' LEU . 4.1 tt -132.51 61.11 1.67 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.21 -1.033 . . . . 1.46 108.21 177.321 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 967' ' ' VAL . . . . . 0.488 HG23 ' C ' ' A' ' 966' ' ' LEU . 97.2 t -157.87 96.74 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 108.12 -1.067 . . . . 1.9399999999999999 108.12 179.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 88.1 mmm -143.66 59.16 1.38 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.747 -1.22 . . . . 0.0 108.34 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.13 119.64 1.95 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 107.107 -2.397 . . . . 2.1099999999999999 107.107 -178.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -82.17 -58.35 2.99 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.023 -1.281 . . . . 5.8899999999999997 110.378 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 46.7 tp -58.89 90.84 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.434 -0.791 . . . . 4.3600000000000003 110.244 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -142.0 -154.37 0.52 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.595 -0.691 . . . . 1.8300000000000001 110.208 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -119.53 170.7 8.93 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.479 -0.763 . . . . 4.3499999999999996 110.252 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 9.5 t -101.63 130.4 47.96 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.548 -0.72 . . . . 1.27 110.12 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -155.89 158.77 38.54 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.482 -0.761 . . . . 5.0199999999999996 110.41 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.5 85.72 17.32 Favored Pre-proline 0 N--CA 1.501 2.078 0 O-C-N 121.618 -0.676 . . . . 2.4100000000000001 109.87 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 977' ' ' PRO . . . . . 0.498 ' C ' HD12 ' A' ' 978' ' ' LEU . 47.8 Cg_endo -73.61 -172.65 1.12 Allowed 'Trans proline' 0 C--N 1.318 -1.059 0 O-C-N 123.303 1.159 . . . . 0.95999999999999996 111.277 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 978' ' ' LEU . . . . . 0.515 HD23 ' CD1' ' A' ' 856' ' ' LEU . 5.4 mp -127.47 155.39 43.79 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.728 -1.212 . . . . 0.62 107.728 178.021 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 979' ' ' THR . . . . . 0.451 HG23 ' C ' ' A' ' 978' ' ' LEU . 37.1 p -150.23 141.11 22.83 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.762 -1.212 . . . . 3.5699999999999998 111.186 -179.364 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 980' ' ' ILE . . . . . 0.706 ' HB ' HG21 ' A' ' 899' ' ' VAL . 51.4 mm -107.38 128.76 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 109.099 -0.704 . . . . 1.3300000000000001 109.099 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 981' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -119.39 99.29 6.59 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 119.821 -0.752 . . . . 0.050000000000000003 111.8 -178.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 42.6 p -106.78 158.25 17.13 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.814 -0.81 . . . . 0.87 108.814 178.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . -172.78 110.13 0.33 Allowed Glycine 0 N--CA 1.498 2.803 0 N-CA-C 106.649 -2.58 . . . . 0.029999999999999999 106.649 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -110.67 149.67 30.13 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 114.551 1.315 . . . . 0.69999999999999996 114.551 -175.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 985' ' ' LEU . . . . . 0.628 ' CD1' HD11 ' A' ' 890' ' ' LEU . 54.4 tp -70.73 133.9 47.0 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.816 -1.177 . . . . 0.040000000000000001 109.808 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 51.0 tp -107.37 -59.04 1.88 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.499 -0.751 . . . . 0.040000000000000001 109.989 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -144.47 145.06 31.67 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.565 -1.272 . . . . 0.040000000000000001 107.565 179.054 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.97 163.12 12.17 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 108.139 -1.984 . . . . 0.040000000000000001 108.139 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -75.3 112.5 18.97 Favored Pre-proline 0 N--CA 1.498 1.973 0 CA-C-N 118.52 1.16 . . . . 0.040000000000000001 109.482 179.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 990' ' ' PRO . . . . . 0.431 ' HD2' HD12 ' A' ' 992' ' ' LEU . 50.2 Cg_endo -90.07 71.24 1.59 Allowed 'Trans proline' 0 C--N 1.319 -0.998 0 O-C-N 123.124 1.065 . . . . 0.45000000000000001 111.39 -178.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 991' ' ' GLU . . . . . 0.419 ' HB2' ' O ' ' A' ' 990' ' ' PRO . 69.8 mt-10 67.36 -73.94 0.07 Allowed 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 108.494 -0.928 . . . . 1.97 108.494 -177.393 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 992' ' ' LEU . . . . . 0.431 HD12 ' HD2' ' A' ' 990' ' ' PRO . 10.4 mt 50.92 20.64 0.82 Allowed 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.579 -0.701 . . . . 2.3799999999999999 111.647 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -94.2 156.85 16.34 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.888 -1.132 . . . . 3.79 109.959 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 72.2 m80 -146.24 93.44 2.32 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.571 -0.706 . . . . 3.5099999999999998 110.23 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 995' ' ' ALA . . . . . . . . . . . . 2.519 . . . . . . . 0 N--CA 1.503 2.219 0 O-C-N 120.821 -1.174 . . . . 2.73 110.574 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo . . . . . 0 N--CA 1.488 1.203 0 N-CA-C 109.502 -0.999 . . . . 3.8300000000000001 109.502 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 847' ' ' VAL . . . . . 0.415 HG12 ' HB2' ' B' ' 849' ' ' GLN . 59.8 t -132.05 103.57 14.15 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.638 -0.664 . . . . 1.8300000000000001 110.074 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 848' ' ' PRO . . . . . 0.705 ' O ' HG23 ' B' ' 850' ' ' VAL . 44.0 Cg_endo -69.7 -20.23 35.41 Favored 'Trans proline' 0 N--CA 1.487 1.097 0 O-C-N 123.236 1.124 . . . . 0.65000000000000002 111.123 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 849' ' ' GLN . . . . . 0.415 ' HB2' HG12 ' B' ' 847' ' ' VAL . 56.3 tt0 26.67 69.7 0.05 Allowed 'General case' 0 N--CA 1.519 2.979 0 N-CA-C 112.84 0.682 . . . . 2.5800000000000001 112.84 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 850' ' ' VAL . . . . . 0.705 HG23 ' O ' ' B' ' 848' ' ' PRO . 59.6 t -117.91 137.81 50.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.237 -0.915 . . . . 1.0900000000000001 111.616 -178.545 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 851' ' ' ALA . . . . . 0.473 ' HB3' ' HG ' ' B' ' 873' ' ' LEU . . . -128.06 154.76 45.32 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 105.707 -1.96 . . . . 0.040000000000000001 105.707 176.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 852' ' ' PHE . . . . . 0.449 ' HA ' ' CB ' ' B' ' 874' ' ' ASN . 20.8 p90 -159.64 129.35 5.42 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 121.006 1.73 . . . . 0.050000000000000003 108.742 179.337 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 32.7 t -175.75 134.25 0.28 Allowed 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.137 -1.061 . . . . 0.040000000000000001 108.137 -179.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -134.56 158.63 43.5 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.123 -0.985 . . . . 0.67000000000000004 109.526 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 855' ' ' ALA . . . . . 0.788 ' HB3' ' CB ' ' B' ' 870' ' ' ARG . . . -122.84 141.17 52.15 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.919 0.866 . . . . 0.51000000000000001 111.843 -178.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 856' ' ' LEU . . . . . 0.914 HD11 HD23 ' B' ' 858' ' ' LEU . 3.5 tm? -107.8 135.18 49.65 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.276 -0.638 . . . . 0.050000000000000003 109.276 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 857' ' ' SER . . . . . 0.562 ' N ' HD13 ' B' ' 856' ' ' LEU . 17.0 p -152.78 17.98 0.6 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.474 -0.766 . . . . 1.3300000000000001 111.144 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 858' ' ' LEU . . . . . 0.914 HD23 HD11 ' B' ' 856' ' ' LEU . 3.1 pp -29.82 154.14 0.03 OUTLIER Pre-proline 0 N--CA 1.521 3.087 0 N-CA-C 113.337 0.866 . . . . 2.3300000000000001 113.337 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -61.82 -88.75 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.541 0 O-C-N 123.149 1.078 . . . . 2.3199999999999998 113.681 -177.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 53.4 ptt85 -127.2 -142.19 0.27 Allowed 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.86 -1.15 . . . . 0.040000000000000001 111.403 -177.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 37.0 m -39.12 118.63 0.81 Allowed 'General case' 0 N--CA 1.51 2.531 0 O-C-N 121.479 -0.763 . . . . 1.3100000000000001 111.9 -178.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 862' ' ' GLU . . . . . 0.487 ' OE2' HD22 ' B' ' 858' ' ' LEU . 24.6 tt0 -96.89 149.68 36.01 Favored Pre-proline 0 N--CA 1.489 1.484 0 N-CA-C 108.162 -1.051 . . . . 4.5099999999999998 108.162 177.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 863' ' ' PRO . . . . . 0.443 ' HD2' ' CG ' ' B' ' 862' ' ' GLU . 41.5 Cg_endo -67.69 -13.38 38.61 Favored 'Trans proline' 0 C--N 1.316 -1.181 0 O-C-N 123.015 1.008 . . . . 2.2400000000000002 111.385 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -174.0 -136.88 2.3 Favored Glycine 0 N--CA 1.494 2.501 0 C-N-CA 119.836 -1.174 . . . . 0.040000000000000001 110.665 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 37.2 m -69.55 160.19 31.95 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.276 -1.132 . . . . 1.51 111.75 -178.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 866' ' ' VAL . . . . . 0.46 ' O ' HG23 ' B' ' 866' ' ' VAL . 26.9 m -90.31 132.75 34.74 Favored Pre-proline 0 N--CA 1.495 1.782 0 N-CA-C 113.419 0.896 . . . . 0.78000000000000003 113.419 -175.36 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 867' ' ' PRO . . . . . 0.818 ' O ' HD23 ' B' ' 856' ' ' LEU . 53.1 Cg_endo -88.83 -154.05 0.05 OUTLIER 'Trans proline' 0 C--N 1.322 -0.817 0 N-CA-C 107.679 -1.7 . . . . 0.92000000000000004 107.679 177.037 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 868' ' ' PHE . . . . . 0.472 ' CD1' ' HG2' ' B' ' 881' ' ' PRO . 31.6 p90 -148.39 119.13 7.52 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.446 -1.409 . . . . 0.050000000000000003 109.874 179.393 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 50.1 p-10 -112.57 -2.84 14.49 Favored 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 119.284 -0.967 . . . . 1.7 112.153 -178.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 870' ' ' ARG . . . . . 0.788 ' CB ' ' HB3' ' B' ' 855' ' ' ALA . 26.0 mmm180 -90.32 88.62 7.28 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.977 -1.077 . . . . 2.5899999999999999 110.682 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 57.5 t -75.23 97.03 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.004 -1.06 . . . . 1.9399999999999999 109.661 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 872' ' ' LEU . . . . . 0.513 ' HB3' HD11 ' C' ' 953' ' ' ILE . 95.4 mt -84.29 -46.75 11.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.541 -0.724 . . . . 1.0600000000000001 110.273 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 873' ' ' LEU . . . . . 0.473 ' HG ' ' HB3' ' B' ' 851' ' ' ALA . 48.8 tp -174.66 104.43 0.1 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.265 -0.897 . . . . 4.1799999999999997 108.605 178.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 874' ' ' ASN . . . . . 0.449 ' CB ' ' HA ' ' B' ' 852' ' ' PHE . 36.5 t-20 178.67 82.27 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.654 -0.653 . . . . 0.040000000000000001 109.647 -178.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -67.09 -47.1 72.23 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 119.29 -0.964 . . . . 3.3799999999999999 111.244 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 876' ' ' GLY . . . . . 0.41 ' HA3' ' CE2' ' B' ' 878' ' ' TYR . . . -74.49 -25.58 69.93 Favored Glycine 0 N--CA 1.494 2.566 0 O-C-N 121.217 -0.927 . . . . 0.040000000000000001 111.813 -178.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 84.48 -59.74 4.89 Favored Glycine 0 N--CA 1.502 3.038 0 N-CA-C 108.11 -1.996 . . . . 0.040000000000000001 108.11 -178.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 878' ' ' TYR . . . . . 0.41 ' CE2' ' HA3' ' B' ' 876' ' ' GLY . 97.7 m-85 60.74 -66.13 0.05 Allowed 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 114.348 1.24 . . . . 3.46 114.348 177.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 879' ' ' TYR . . . . . 0.46 ' CB ' ' CD2' ' B' ' 886' ' ' PHE . 23.5 p90 -112.39 109.15 18.6 Favored 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 114.773 1.398 . . . . 0.040000000000000001 114.773 -176.294 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -65.17 118.47 50.03 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.396 -0.815 . . . . 0.02 109.999 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 881' ' ' PRO . . . . . 0.472 ' HG2' ' CD1' ' B' ' 868' ' ' PHE . 55.4 Cg_endo -76.84 0.17 9.91 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 O-C-N 123.432 1.227 . . . . 0.39000000000000001 112.143 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -76.66 -64.95 1.0 Allowed 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 106.963 -1.495 . . . . 0.81000000000000005 106.963 178.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 883' ' ' THR . . . . . 0.477 ' OG1' HG23 ' B' ' 885' ' ' VAL . 31.0 p -94.13 -17.25 22.97 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.784 -0.821 . . . . 0.040000000000000001 108.784 177.527 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.49 22.49 56.27 Favored Glycine 0 N--CA 1.494 2.541 0 O-C-N 121.091 -1.006 . . . . 0.029999999999999999 110.793 178.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 885' ' ' VAL . . . . . 0.63 HG13 HG21 ' B' ' 961' ' ' THR . 79.4 t -73.41 90.74 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 C-N-CA 118.274 -1.371 . . . . 1.01 108.151 -179.325 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 886' ' ' PHE . . . . . 0.883 ' HB3' HG22 ' B' ' 962' ' ' VAL . 0.6 OUTLIER -90.63 104.42 17.01 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 115.281 -0.872 . . . . 0.050000000000000003 112.244 -177.264 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 887' ' ' THR . . . . . 0.419 ' O ' ' HD3' ' B' ' 889' ' ' PRO . 90.3 m -95.06 101.03 12.76 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 107.774 -1.195 . . . . 0.68000000000000005 107.774 177.468 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 888' ' ' ALA . . . . . . . . . . . . . . . -99.4 106.28 38.32 Favored Pre-proline 0 N--CA 1.499 2.022 0 N-CA-C 114.042 1.127 . . . . 0.25 114.042 -176.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 889' ' ' PRO . . . . . 0.419 ' HD3' ' O ' ' B' ' 887' ' ' THR . 54.4 Cg_endo -89.08 -12.08 3.47 Favored 'Trans proline' 0 CA--C 1.546 1.094 0 N-CA-C 108.981 -1.199 . . . . 1.6399999999999999 108.981 176.094 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 890' ' ' LEU . . . . . 0.631 HD11 ' CD1' ' B' ' 985' ' ' LEU . 4.9 tt -35.2 -51.21 0.56 Allowed 'General case' 0 N--CA 1.507 2.414 0 N-CA-C 113.903 1.075 . . . . 2.29 113.903 -177.457 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 51.7 95.04 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.347 0 O-C-N 121.192 -0.942 . . . . 0.63 110.193 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . 156.02 -147.36 15.91 Favored Glycine 0 N--CA 1.479 1.548 0 N-CA-C 107.335 -2.306 . . . . 0.040000000000000001 107.335 -178.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 72.5 ttt-85 -108.97 127.94 54.51 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 107.845 -1.168 . . . . 3.0 107.845 177.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 894' ' ' TYR . . . . . 0.456 ' CD1' ' N ' ' B' ' 895' ' ' LEU . 0.2 OUTLIER -130.86 144.63 51.6 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.023 -1.048 . . . . 0.040000000000000001 110.082 -179.258 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 895' ' ' LEU . . . . . 0.456 ' N ' ' CD1' ' B' ' 894' ' ' TYR . 34.4 tp -99.69 115.03 28.52 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.523 -0.736 . . . . 1.27 109.825 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 896' ' ' LEU . . . . . 0.621 HD23 ' N ' ' B' ' 897' ' ' SER . 9.9 tt -111.93 145.63 39.23 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.576 -0.703 . . . . 0.93999999999999995 110.537 -179.445 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 897' ' ' SER . . . . . 0.621 ' N ' HD23 ' B' ' 896' ' ' LEU . 71.2 m -144.52 118.86 9.58 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.389 -0.819 . . . . 0.040000000000000001 110.812 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.71 147.66 30.45 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.733 -0.604 . . . . 0.47999999999999998 109.489 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 899' ' ' VAL . . . . . 0.709 HG21 ' HB ' ' B' ' 980' ' ' ILE . 88.3 t -91.89 120.92 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.469 -0.769 . . . . 0.55000000000000004 111.006 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 900' ' ' LEU . . . . . 0.591 HD12 ' HB2' ' B' ' 924' ' ' SER . 4.4 mm? -94.85 111.3 23.1 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 114.498 1.296 . . . . 1.5900000000000001 114.498 -174.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 17.1 m -67.45 141.47 56.98 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 107.277 -1.379 . . . . 0.050000000000000003 107.277 176.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -68.02 -65.05 2.84 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 110.724 -0.951 . . . . 0.029999999999999999 110.724 -179.14 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 5.9 m170 46.81 66.43 0.99 Allowed 'General case' 0 N--CA 1.508 2.454 0 O-C-N 121.454 -1.027 . . . . 3.2000000000000002 111.093 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 54.0 ptt85 -69.33 -6.19 28.08 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.645 -0.66 . . . . 2.9199999999999999 112.106 -179.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 905' ' ' HIS . . . . . 0.484 ' O ' ' CB ' ' B' ' 906' ' ' GLU . 73.8 t60 -62.03 4.53 0.12 Allowed 'General case' 0 N--CA 1.506 2.352 0 O-C-N 120.906 -1.122 . . . . 2.8700000000000001 113.131 -179.209 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 906' ' ' GLU . . . . . 0.484 ' CB ' ' O ' ' B' ' 905' ' ' HIS . 0.7 OUTLIER 95.25 -165.11 0.0 OUTLIER 'General case' 0 N--CA 1.529 3.478 0 CA-C-N 120.605 1.548 . . . . 0.98999999999999999 111.914 179.089 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 907' ' ' LYS . . . . . 0.465 ' CB ' ' O ' ' B' ' 906' ' ' GLU . 61.9 tttt 86.3 156.4 0.08 Allowed 'General case' 0 N--CA 1.519 3.01 0 N-CA-C 107.982 -1.118 . . . . 5.25 107.982 -176.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 60.9 t -121.86 117.21 51.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 120.757 -1.214 . . . . 0.39000000000000001 111.351 -179.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 54.2 tp10 -101.26 133.43 45.84 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 107.295 -1.372 . . . . 1.72 107.295 176.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -156.05 123.32 5.41 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 106.759 -1.571 . . . . 0.67000000000000004 106.759 178.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 911' ' ' VAL . . . . . 0.757 HG22 HG13 ' B' ' 964' ' ' VAL . 92.5 t -84.65 132.23 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.89 -0.506 . . . . 0.54000000000000004 110.972 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 60.2 mt -67.06 157.78 32.69 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.417 -0.802 . . . . 1.5 109.303 178.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 913' ' ' SER . . . . . 0.478 ' OG ' HG11 ' B' ' 919' ' ' VAL . 1.4 p -125.11 136.78 53.98 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.105 -1.072 . . . . 1.3700000000000001 108.105 176.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 914' ' ' ARG . . . . . 0.609 ' NH1' HD23 ' B' ' 956' ' ' LEU . 0.1 OUTLIER -64.53 155.21 33.66 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 120.628 -1.295 . . . . 4.2999999999999998 111.428 -179.034 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 915' ' ' SER . . . . . 0.416 ' CB ' ' O ' ' B' ' 914' ' ' ARG . 1.7 p 83.53 -31.93 0.08 Allowed 'General case' 0 N--CA 1.521 3.119 0 C-N-CA 123.915 0.886 . . . . 2.0499999999999998 112.077 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 916' ' ' ASN . . . . . 0.757 ' HB2' HG21 ' B' ' 919' ' ' VAL . 99.4 m-20 -122.34 -22.19 5.6 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.895 -1.128 . . . . 2.71 111.2 -179.335 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 917' ' ' GLN . . . . . 0.402 ' HB2' ' O ' ' B' ' 916' ' ' ASN . 43.8 mt-30 67.08 165.98 0.22 Allowed 'General case' 0 N--CA 1.519 3.021 0 N-CA-C 105.762 -1.94 . . . . 2.6800000000000002 105.762 -174.225 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.99 -125.29 35.19 Favored Glycine 1 N--CA 1.521 4.322 0 CA-C-N 123.492 2.86 . . . . 0.029999999999999999 106.905 -177.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 919' ' ' VAL . . . . . 0.757 HG21 ' HB2' ' B' ' 916' ' ' ASN . 91.5 t 52.24 95.1 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 O-C-N 121.393 -1.063 . . . . 1.3899999999999999 109.119 -178.067 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 920' ' ' ALA . . . . . 0.88 ' HB3' HG12 ' B' ' 949' ' ' VAL . . . -91.06 90.95 8.07 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.249 -0.981 . . . . 0.029999999999999999 110.723 -179.176 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 921' ' ' ARG . . . . . 0.776 ' HG3' HG23 ' B' ' 922' ' ' VAL . 27.6 ptt85 -84.96 -42.18 15.19 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 106.02 -1.844 . . . . 4.4199999999999999 106.02 176.355 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 922' ' ' VAL . . . . . 0.776 HG23 ' HG3' ' B' ' 921' ' ' ARG . 75.0 t -101.9 74.02 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 105.833 -1.914 . . . . 0.84999999999999998 105.833 175.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -85.55 135.01 33.99 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.74 0.781 . . . . 2.46 111.553 -177.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 924' ' ' SER . . . . . 0.591 ' HB2' HD12 ' B' ' 900' ' ' LEU . 6.8 t -147.12 105.51 3.78 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 108.77 -0.826 . . . . 0.69999999999999996 108.77 179.392 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -103.2 83.42 0.43 Allowed Glycine 0 N--CA 1.487 2.052 0 N-CA-C 108.307 -1.917 . . . . 0.040000000000000001 108.307 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.223 0 N-CA-C 108.865 -1.694 . . . . 0.040000000000000001 108.865 -179.6 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 25.3 m . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.042 0.449 . . . . 13.779999999999999 110.296 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 95.8 mt -111.64 129.96 55.92 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.508 -0.745 . . . . 13.76 110.389 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -151.67 168.33 31.06 Favored Glycine 0 N--CA 1.493 2.5 0 N-CA-C 109.243 -1.543 . . . . 9.1300000000000008 109.243 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 949' ' ' VAL . . . . . 0.88 HG12 ' HB3' ' B' ' 920' ' ' ALA . 31.6 m -118.09 130.17 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.515 -0.991 . . . . 7.0800000000000001 110.666 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 950' ' ' PHE . . . . . 0.459 ' CZ ' ' HB3' ' B' ' 921' ' ' ARG . 49.0 p90 -135.16 152.51 51.67 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.582 -0.699 . . . . 7.5899999999999999 109.466 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 23.3 m -118.52 -54.09 2.29 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.424 -0.797 . . . . 5.0300000000000002 111.922 -178.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 952' ' ' LEU . . . . . 0.434 ' O ' ' O ' ' B' ' 953' ' ' ILE . 12.5 tp -62.3 -74.43 0.09 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.352 -0.842 . . . . 1.01 112.056 -177.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 953' ' ' ILE . . . . . 0.636 HD12 ' HD3' ' B' ' 955' ' ' PRO . 1.4 pp -51.48 -149.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.782 0 N-CA-C 114.22 1.193 . . . . 2.6000000000000001 114.22 -176.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 954' ' ' LEU . . . . . 0.751 HD22 ' O ' ' B' ' 954' ' ' LEU . 0.0 OUTLIER 166.07 90.59 0.02 OUTLIER Pre-proline 0 N--CA 1.518 2.944 0 O-C-N 121.107 -0.996 . . . . 0.050000000000000003 111.67 179.156 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 955' ' ' PRO . . . . . 0.743 ' C ' HD12 ' B' ' 956' ' ' LEU . 51.6 Cg_endo -78.96 98.48 1.19 Allowed 'Trans proline' 0 C--N 1.315 -1.205 0 N-CA-C 109.014 -1.187 . . . . 0.83999999999999997 109.014 178.209 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 956' ' ' LEU . . . . . 0.743 HD12 ' C ' ' B' ' 955' ' ' PRO . 11.1 mp -121.47 141.97 50.5 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.973 -1.079 . . . . 0.040000000000000001 109.943 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -84.46 151.11 24.83 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 117.844 -1.074 . . . . 1.28 111.777 -178.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -68.6 118.66 11.91 Favored 'General case' 0 N--CA 1.508 2.466 0 CA-C-N 122.96 2.618 . . . . 0.17000000000000001 111.368 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 93.2 -21.48 40.03 Favored Glycine 0 N--CA 1.5 2.925 0 N-CA-C 111.056 -0.817 . . . . 0.040000000000000001 111.056 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 960' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -56.31 170.55 0.34 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.488 -1.007 . . . . 0.040000000000000001 110.149 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 961' ' ' THR . . . . . 0.63 HG21 HG13 ' B' ' 885' ' ' VAL . 42.1 m -135.96 137.81 41.68 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.945 -1.097 . . . . 1.78 112.291 -178.062 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 962' ' ' VAL . . . . . 0.883 HG22 ' HB3' ' B' ' 886' ' ' PHE . 33.7 m -98.29 145.19 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.712 -0.618 . . . . 0.040000000000000001 110.404 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 5.2 t -137.1 145.13 43.54 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.885 -0.509 . . . . 0.71999999999999997 110.084 -178.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 964' ' ' VAL . . . . . 0.757 HG13 HG22 ' B' ' 911' ' ' VAL . 61.1 t -93.4 136.39 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.133 -0.98 . . . . 1.05 110.499 -179.266 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -93.68 127.05 39.19 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 103.651 -2.722 . . . . 3.02 103.651 173.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 966' ' ' LEU . . . . . 0.556 HD23 ' O ' ' B' ' 966' ' ' LEU . 4.1 tt -132.14 61.24 1.66 Allowed 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.288 -1.004 . . . . 1.46 108.288 177.343 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 967' ' ' VAL . . . . . 0.486 HG23 ' C ' ' B' ' 966' ' ' LEU . 97.9 t -158.0 96.53 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 108.143 -1.058 . . . . 1.9399999999999999 108.143 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 88.1 mmm -143.39 58.85 1.39 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.733 -1.229 . . . . 0.0 108.375 178.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.24 119.51 1.93 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 107.222 -2.351 . . . . 2.1099999999999999 107.222 -178.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -81.9 -58.31 3.04 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.036 -1.273 . . . . 5.8899999999999997 110.415 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 46.9 tp -58.99 90.62 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.437 -0.789 . . . . 4.3600000000000003 110.249 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -141.78 -154.33 0.51 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.536 -0.728 . . . . 1.8300000000000001 110.24 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -119.51 170.89 8.76 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.498 -0.751 . . . . 4.3499999999999996 110.276 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 9.5 t -101.76 130.44 48.17 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.528 -0.733 . . . . 1.27 110.086 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -155.91 158.81 38.59 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.49 -0.756 . . . . 5.0199999999999996 110.443 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.47 85.67 17.49 Favored Pre-proline 0 N--CA 1.501 2.077 0 O-C-N 121.588 -0.695 . . . . 2.4100000000000001 109.906 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 977' ' ' PRO . . . . . 0.485 ' C ' HD12 ' B' ' 978' ' ' LEU . 47.7 Cg_endo -73.63 -172.73 1.14 Allowed 'Trans proline' 0 C--N 1.317 -1.13 0 O-C-N 123.326 1.172 . . . . 0.95999999999999996 111.248 -179.511 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 978' ' ' LEU . . . . . 0.502 HD23 ' CD1' ' B' ' 856' ' ' LEU . 5.4 mp -127.34 155.55 43.4 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 107.762 -1.199 . . . . 0.62 107.762 178.013 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 979' ' ' THR . . . . . 0.458 HG23 ' C ' ' B' ' 978' ' ' LEU . 37.0 p -150.32 141.12 22.76 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.811 -1.181 . . . . 3.5699999999999998 111.157 -179.38 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 980' ' ' ILE . . . . . 0.709 ' HB ' HG21 ' B' ' 899' ' ' VAL . 51.4 mm -107.44 128.59 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 109.135 -0.691 . . . . 1.3300000000000001 109.135 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 981' ' ' PHE . . . . . 0.4 ' HD1' ' HH ' ' B' ' 879' ' ' TYR . 4.4 t80 -119.2 99.29 6.62 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.461 -0.774 . . . . 0.050000000000000003 111.802 -178.343 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 43.2 p -106.79 158.24 17.14 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.834 -0.802 . . . . 0.87 108.834 178.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 983' ' ' GLY . . . . . . . . . . . . . . . -172.77 110.16 0.33 Allowed Glycine 0 N--CA 1.499 2.87 0 N-CA-C 106.685 -2.566 . . . . 0.029999999999999999 106.685 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 984' ' ' ALA . . . . . 0.469 ' HB1' ' NE ' ' C' ' 893' ' ' ARG . . . -110.75 149.61 30.27 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 114.539 1.311 . . . . 0.69999999999999996 114.539 -175.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 985' ' ' LEU . . . . . 0.631 ' CD1' HD11 ' B' ' 890' ' ' LEU . 54.2 tp -70.71 133.84 46.95 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.874 -1.142 . . . . 0.040000000000000001 109.808 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 986' ' ' LEU . . . . . . . . . . . . . 50.6 tp -107.39 -59.01 1.88 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.547 -0.721 . . . . 0.040000000000000001 110.009 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -144.46 144.87 31.59 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.592 -1.262 . . . . 0.040000000000000001 107.592 179.065 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.84 162.95 12.2 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 108.117 -1.993 . . . . 0.040000000000000001 108.117 179.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -75.15 112.59 19.02 Favored Pre-proline 0 N--CA 1.498 1.938 0 O-C-N 121.226 -1.161 . . . . 0.040000000000000001 109.439 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 990' ' ' PRO . . . . . 0.438 ' HD2' HD12 ' B' ' 992' ' ' LEU . 49.9 Cg_endo -90.05 71.27 1.6 Allowed 'Trans proline' 0 C--N 1.319 -0.976 0 O-C-N 123.119 1.062 . . . . 0.45000000000000001 111.339 -178.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 991' ' ' GLU . . . . . 0.419 ' HB2' ' O ' ' B' ' 990' ' ' PRO . 70.0 mt-10 67.29 -73.93 0.07 Allowed 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 108.463 -0.94 . . . . 1.97 108.463 -177.469 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 992' ' ' LEU . . . . . 0.451 ' HA ' HD23 ' B' ' 992' ' ' LEU . 10.4 mt 51.11 20.4 0.85 Allowed 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.587 -0.696 . . . . 2.3799999999999999 111.679 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -93.94 156.95 16.35 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.914 -1.116 . . . . 3.79 109.974 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 71.9 m80 -146.33 92.8 2.22 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.561 -0.712 . . . . 3.5099999999999998 110.382 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 995' ' ' ALA . . . . . . . . . . . . 2.518 . . . . . . . 0 N--CA 1.503 2.223 0 O-C-N 120.924 -1.11 . . . . 2.73 110.581 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo . . . . . 0 N--CA 1.487 1.142 0 N-CA-C 109.526 -0.99 . . . . 3.8300000000000001 109.526 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 847' ' ' VAL . . . . . 0.5 HG12 ' HB2' ' C' ' 849' ' ' GLN . 59.5 t -126.81 106.2 22.84 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 121.68 -0.638 . . . . 1.8300000000000001 109.989 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 848' ' ' PRO . . . . . 0.893 ' O ' HG23 ' C' ' 850' ' ' VAL . 43.9 Cg_endo -69.52 -22.17 33.57 Favored 'Trans proline' 0 N--CA 1.488 1.152 0 O-C-N 123.238 1.125 . . . . 0.65000000000000002 111.09 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 849' ' ' GLN . . . . . 0.5 ' HB2' HG12 ' C' ' 847' ' ' VAL . 54.6 tt0 24.93 64.6 0.05 Allowed 'General case' 0 N--CA 1.518 2.945 0 N-CA-C 113.605 0.965 . . . . 2.5800000000000001 113.605 179.026 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 850' ' ' VAL . . . . . 0.893 HG23 ' O ' ' C' ' 848' ' ' PRO . 78.9 t -120.23 134.91 62.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.105 -0.997 . . . . 1.0900000000000001 110.948 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 851' ' ' ALA . . . . . 0.526 ' HB3' ' HG ' ' C' ' 873' ' ' LEU . . . -127.78 155.28 44.29 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 105.745 -1.946 . . . . 0.040000000000000001 105.745 176.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 852' ' ' PHE . . . . . 0.448 ' HA ' ' CB ' ' C' ' 874' ' ' ASN . 13.5 p90 -161.56 126.96 3.6 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 121.011 1.732 . . . . 0.050000000000000003 108.683 179.017 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 24.2 t -177.06 135.32 0.2 Allowed 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.039 -1.096 . . . . 0.040000000000000001 108.039 -179.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 854' ' ' ALA . . . . . 0.436 ' HB1' ' HD2' ' C' ' 868' ' ' PHE . . . -132.5 158.32 42.39 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.042 -1.036 . . . . 0.67000000000000004 109.96 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 855' ' ' ALA . . . . . 0.732 ' HB2' HD11 ' C' ' 872' ' ' LEU . . . -122.27 139.75 53.43 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.773 0.797 . . . . 0.51000000000000001 111.051 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 856' ' ' LEU . . . . . 1.075 HD11 HD23 ' C' ' 858' ' ' LEU . 3.5 tm? -112.61 139.41 48.23 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.692 -0.63 . . . . 0.050000000000000003 110.252 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 857' ' ' SER . . . . . 0.599 ' N ' HD13 ' C' ' 856' ' ' LEU . 1.4 m -155.96 19.92 0.38 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.585 -0.697 . . . . 1.3300000000000001 111.07 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 858' ' ' LEU . . . . . 1.075 HD23 HD11 ' C' ' 856' ' ' LEU . 2.3 pp -34.83 161.44 0.04 OUTLIER Pre-proline 0 N--CA 1.517 2.898 0 N-CA-C 113.171 0.804 . . . . 2.3300000000000001 113.171 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -61.68 -87.72 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 120.894 1.062 . . . . 2.3199999999999998 113.495 -178.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 55.3 ptt85 -130.6 -143.26 0.24 Allowed 'General case' 0 N--CA 1.501 2.122 0 O-C-N 120.811 -1.18 . . . . 0.040000000000000001 111.923 -177.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 14.6 m -37.54 129.17 1.07 Allowed 'General case' 0 N--CA 1.51 2.548 0 O-C-N 121.592 -0.693 . . . . 1.3100000000000001 112.537 -178.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.41 160.51 25.8 Favored Pre-proline 0 N--CA 1.489 1.523 0 N-CA-C 108.263 -1.014 . . . . 4.5099999999999998 108.263 177.235 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -71.62 -13.82 30.08 Favored 'Trans proline' 0 C--N 1.314 -1.282 0 O-C-N 123.184 1.097 . . . . 2.2400000000000002 111.507 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -177.33 -136.18 2.39 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.658 -1.377 . . . . 0.040000000000000001 109.658 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 22.8 m -68.2 154.5 41.59 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.388 -1.066 . . . . 1.51 110.249 -179.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 866' ' ' VAL . . . . . 0.441 ' HA ' ' HD3' ' C' ' 867' ' ' PRO . 46.0 t -98.68 139.19 20.93 Favored Pre-proline 0 N--CA 1.496 1.845 0 N-CA-C 113.366 0.876 . . . . 0.78000000000000003 113.366 -174.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 867' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' C' ' 866' ' ' VAL . 55.4 Cg_endo -91.35 -147.64 0.03 OUTLIER 'Trans proline' 0 CA--C 1.545 1.065 0 O-C-N 123.583 1.307 . . . . 0.92000000000000004 108.847 177.662 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 868' ' ' PHE . . . . . 0.49 ' CD1' ' HG2' ' C' ' 881' ' ' PRO . 23.7 p90 -150.01 125.56 10.28 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.584 -1.323 . . . . 0.050000000000000003 110.101 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 42.4 p-10 -112.64 -3.08 14.37 Favored 'General case' 0 N--CA 1.499 2.001 0 C-N-CA 119.281 -0.967 . . . . 1.7 112.467 -178.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 870' ' ' ARG . . . . . 0.65 ' HB2' ' HB3' ' C' ' 855' ' ' ALA . 23.8 mmm180 -91.72 89.11 6.96 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.905 -1.122 . . . . 2.5899999999999999 110.991 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 57.9 t -70.71 97.47 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.039 -1.038 . . . . 1.9399999999999999 109.951 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 872' ' ' LEU . . . . . 0.732 HD11 ' HB2' ' C' ' 855' ' ' ALA . 82.8 mt -83.44 -47.39 11.45 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.485 -0.759 . . . . 1.0600000000000001 110.272 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 873' ' ' LEU . . . . . 0.526 ' HG ' ' HB3' ' C' ' 851' ' ' ALA . 42.7 tp -174.45 103.53 0.1 Allowed 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.507 -0.923 . . . . 4.1799999999999997 108.507 178.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 874' ' ' ASN . . . . . 0.448 ' CB ' ' HA ' ' C' ' 852' ' ' PHE . 35.9 t-20 178.55 82.22 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.612 -0.68 . . . . 0.040000000000000001 109.45 -178.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 22.9 p-10 -67.11 -46.24 74.76 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 119.245 -0.982 . . . . 3.3799999999999999 111.279 -179.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 876' ' ' GLY . . . . . 0.405 ' HA3' ' CE2' ' C' ' 878' ' ' TYR . . . -74.55 -26.09 68.53 Favored Glycine 0 N--CA 1.494 2.551 0 O-C-N 121.28 -0.888 . . . . 0.040000000000000001 111.614 -178.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 82.54 -61.06 4.79 Favored Glycine 0 N--CA 1.502 3.072 0 N-CA-C 108.118 -1.993 . . . . 0.040000000000000001 108.118 -178.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 878' ' ' TYR . . . . . 0.405 ' CE2' ' HA3' ' C' ' 876' ' ' GLY . 97.7 m-85 60.95 -65.39 0.06 Allowed 'General case' 0 N--CA 1.502 2.161 0 N-CA-C 114.384 1.253 . . . . 3.46 114.384 177.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 879' ' ' TYR . . . . . 0.473 ' CB ' ' CG ' ' C' ' 886' ' ' PHE . 22.8 p90 -112.58 109.38 18.9 Favored 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 114.823 1.416 . . . . 0.040000000000000001 114.823 -176.291 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.63 117.82 51.27 Favored Pre-proline 0 N--CA 1.497 1.894 0 O-C-N 121.377 -0.827 . . . . 0.02 109.89 179.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 881' ' ' PRO . . . . . 0.49 ' HG2' ' CD1' ' C' ' 868' ' ' PHE . 55.2 Cg_endo -77.03 0.45 9.69 Favored 'Trans proline' 0 N--CA 1.494 1.551 0 O-C-N 123.435 1.229 . . . . 0.39000000000000001 112.116 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -73.84 -64.33 1.03 Allowed 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 106.459 -1.682 . . . . 0.81000000000000005 106.459 178.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 9.2 p -94.82 -18.16 21.45 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.502 -0.925 . . . . 0.040000000000000001 108.502 177.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.56 21.16 57.0 Favored Glycine 0 N--CA 1.493 2.499 0 O-C-N 121.167 -0.958 . . . . 0.029999999999999999 111.046 178.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 96.8 t -72.33 89.89 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 C-N-CA 118.256 -1.377 . . . . 1.01 108.25 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 886' ' ' PHE . . . . . 0.811 ' CB ' HG22 ' C' ' 962' ' ' VAL . 0.7 OUTLIER -90.48 104.0 16.63 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 115.199 -0.909 . . . . 0.050000000000000003 112.038 -177.468 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 887' ' ' THR . . . . . 0.423 ' O ' ' HD3' ' C' ' 889' ' ' PRO . 91.2 m -96.48 101.46 13.09 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 107.888 -1.153 . . . . 0.68000000000000005 107.888 177.416 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 888' ' ' ALA . . . . . . . . . . . . . . . -99.87 102.59 17.88 Favored Pre-proline 0 N--CA 1.502 2.152 0 N-CA-C 114.297 1.221 . . . . 0.25 114.297 -176.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 889' ' ' PRO . . . . . 0.423 ' HD3' ' O ' ' C' ' 887' ' ' THR . 55.6 Cg_endo -83.04 -13.11 9.26 Favored 'Trans proline' 0 CA--C 1.545 1.07 0 N-CA-C 109.01 -1.188 . . . . 1.6399999999999999 109.01 175.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 890' ' ' LEU . . . . . 1.055 HD22 HD13 ' C' ' 985' ' ' LEU . 71.7 mt -37.37 -49.87 1.01 Allowed 'General case' 0 N--CA 1.507 2.422 0 N-CA-C 113.679 0.992 . . . . 2.29 113.679 -177.421 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 52.63 96.73 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.358 0 O-C-N 121.117 -0.989 . . . . 0.63 110.211 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . 156.26 -147.64 16.51 Favored Glycine 0 N--CA 1.479 1.514 0 N-CA-C 107.252 -2.339 . . . . 0.040000000000000001 107.252 -179.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 893' ' ' ARG . . . . . 0.469 ' NE ' ' HB1' ' B' ' 984' ' ' ALA . 74.2 ttt-85 -107.8 129.0 55.09 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 107.934 -1.136 . . . . 3.0 107.934 177.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 894' ' ' TYR . . . . . 0.449 ' CD1' ' N ' ' C' ' 895' ' ' LEU . 0.1 OUTLIER -131.16 144.05 51.07 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.058 -1.026 . . . . 0.040000000000000001 110.151 -179.246 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 895' ' ' LEU . . . . . 0.449 ' N ' ' CD1' ' C' ' 894' ' ' TYR . 37.4 tp -97.83 112.85 24.6 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.735 -0.603 . . . . 1.27 109.531 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 896' ' ' LEU . . . . . 0.53 HD23 ' N ' ' C' ' 897' ' ' SER . 10.3 tt -110.27 143.78 39.95 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.583 -0.698 . . . . 0.93999999999999995 110.448 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 897' ' ' SER . . . . . 0.53 ' N ' HD23 ' C' ' 896' ' ' LEU . 5.2 m -145.23 119.26 9.39 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.471 -0.768 . . . . 0.040000000000000001 111.062 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.87 146.62 32.06 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.965 -0.754 . . . . 0.47999999999999998 108.965 178.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 899' ' ' VAL . . . . . 0.729 HG21 ' HB ' ' C' ' 980' ' ' ILE . 89.6 t -92.1 119.94 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.414 -0.803 . . . . 0.55000000000000004 111.054 -179.28 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 90.9 mt -92.98 111.21 22.75 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 114.096 1.146 . . . . 1.5900000000000001 114.096 -175.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 22.2 m -64.53 139.68 58.79 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 107.331 -1.359 . . . . 0.050000000000000003 107.331 177.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -61.54 -65.02 3.5 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 110.32 -1.112 . . . . 0.029999999999999999 110.32 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 45.48 64.74 1.32 Allowed 'General case' 0 N--CA 1.508 2.45 0 O-C-N 121.485 -1.009 . . . . 3.2000000000000002 111.298 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 42.4 ptt85 -67.82 -7.14 25.32 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.585 -0.697 . . . . 2.9199999999999999 111.988 -179.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 905' ' ' HIS . . . . . 0.485 ' O ' ' CB ' ' C' ' 906' ' ' GLU . 72.0 t60 -60.37 5.27 0.05 OUTLIER 'General case' 0 N--CA 1.507 2.381 0 O-C-N 120.9 -1.125 . . . . 2.8700000000000001 113.714 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 906' ' ' GLU . . . . . 0.485 ' CB ' ' O ' ' C' ' 905' ' ' HIS . 0.6 OUTLIER 92.11 -164.08 0.01 OUTLIER 'General case' 0 N--CA 1.527 3.38 0 CA-C-N 121.259 1.845 . . . . 0.98999999999999999 112.254 179.053 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 907' ' ' LYS . . . . . 0.485 ' CB ' ' O ' ' C' ' 906' ' ' GLU . 73.5 tttt 89.43 162.03 0.05 Allowed 'General case' 0 N--CA 1.52 3.069 0 N-CA-C 108.146 -1.057 . . . . 5.25 108.146 -177.108 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 59.0 t -122.31 115.28 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 120.934 -1.104 . . . . 0.39000000000000001 110.883 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 53.0 tp10 -104.07 131.3 51.48 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 107.549 -1.278 . . . . 1.72 107.549 177.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -155.68 120.86 4.83 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 106.882 -1.525 . . . . 0.67000000000000004 106.882 178.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 911' ' ' VAL . . . . . 0.908 HG23 HG22 ' C' ' 964' ' ' VAL . 11.0 p -77.82 131.14 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.879 -0.513 . . . . 0.54000000000000004 111.222 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 73.0 mt -67.52 158.29 32.3 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.218 -0.926 . . . . 1.5 108.88 178.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 913' ' ' SER . . . . . 0.468 ' OG ' HG11 ' C' ' 919' ' ' VAL . 1.4 p -128.33 135.73 49.99 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.468 -0.938 . . . . 1.3700000000000001 108.468 176.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 914' ' ' ARG . . . . . 0.588 HH11 HG13 ' C' ' 962' ' ' VAL . 0.0 OUTLIER -63.29 154.28 32.15 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 120.585 -1.322 . . . . 4.2999999999999998 111.287 -179.223 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 915' ' ' SER . . . . . 0.424 ' CB ' ' O ' ' C' ' 914' ' ' ARG . 0.2 OUTLIER 83.24 -30.45 0.09 Allowed 'General case' 0 N--CA 1.521 3.104 0 C-N-CA 123.724 0.81 . . . . 2.0499999999999998 112.079 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 916' ' ' ASN . . . . . 0.779 ' HB2' HG21 ' C' ' 919' ' ' VAL . 93.1 m-20 -123.48 -22.72 4.96 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 120.83 -1.169 . . . . 2.71 111.103 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 67.32 166.25 0.23 Allowed 'General case' 0 N--CA 1.519 3.011 0 N-CA-C 105.745 -1.946 . . . . 2.6800000000000002 105.745 -174.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.9 -125.37 35.19 Favored Glycine 1 N--CA 1.522 4.368 0 CA-C-N 123.619 2.918 . . . . 0.029999999999999999 107.069 -177.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 919' ' ' VAL . . . . . 0.779 HG21 ' HB2' ' C' ' 916' ' ' ASN . 93.0 t 50.75 93.86 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.229 0 O-C-N 121.401 -1.058 . . . . 1.3899999999999999 109.433 -178.428 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 920' ' ' ALA . . . . . 0.713 ' HB3' HG12 ' C' ' 949' ' ' VAL . . . -96.1 94.96 7.85 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 119.478 -0.889 . . . . 0.029999999999999999 110.953 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 921' ' ' ARG . . . . . 0.817 ' HG3' HG23 ' C' ' 922' ' ' VAL . 45.0 ptt85 -83.83 -41.54 17.4 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 105.626 -1.991 . . . . 4.4199999999999999 105.626 175.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 922' ' ' VAL . . . . . 0.817 HG23 ' HG3' ' C' ' 921' ' ' ARG . 57.6 t -97.11 74.36 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 105.393 -2.077 . . . . 0.84999999999999998 105.393 174.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -90.04 135.79 33.44 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.93 0.871 . . . . 2.46 112.41 -176.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 6.7 t -146.5 102.85 3.62 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.853 -1.166 . . . . 0.69999999999999996 107.853 178.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -111.03 91.86 0.63 Allowed Glycine 0 N--CA 1.488 2.119 0 N-CA-C 108.908 -1.677 . . . . 0.040000000000000001 108.908 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.342 0 N-CA-C 109.372 -1.491 . . . . 0.040000000000000001 109.372 -179.75 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 25.6 m . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 120.982 0.42 . . . . 13.779999999999999 110.366 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 94.4 mt -114.15 131.62 56.37 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.441 -0.787 . . . . 13.76 110.393 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -151.67 170.71 31.17 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.252 -1.539 . . . . 9.1300000000000008 109.252 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 949' ' ' VAL . . . . . 0.713 HG12 ' HB3' ' C' ' 920' ' ' ALA . 34.8 m -118.43 133.34 65.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.571 -0.958 . . . . 7.0800000000000001 111.252 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 950' ' ' PHE . . . . . 0.463 ' CZ ' ' HB3' ' C' ' 921' ' ' ARG . 20.3 p90 -131.88 147.36 52.47 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.969 -0.752 . . . . 7.5899999999999999 108.969 178.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 13.2 m -122.09 -52.82 1.96 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.281 -0.887 . . . . 5.0300000000000002 112.277 -178.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 952' ' ' LEU . . . . . 0.406 ' O ' ' O ' ' C' ' 953' ' ' ILE . 45.2 tp -60.07 -77.84 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.421 -0.8 . . . . 1.01 112.421 -177.394 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 953' ' ' ILE . . . . . 0.513 HD11 ' HB3' ' B' ' 872' ' ' LEU . 44.1 pt -54.01 -140.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.734 0 N-CA-C 113.851 1.056 . . . . 2.6000000000000001 113.851 -176.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 954' ' ' LEU . . . . . 0.786 HD22 ' O ' ' C' ' 954' ' ' LEU . 0.0 OUTLIER 176.27 76.58 0.09 OUTLIER Pre-proline 0 N--CA 1.507 2.38 0 O-C-N 120.663 -1.273 . . . . 0.050000000000000003 111.192 179.725 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 955' ' ' PRO . . . . . 0.688 ' C ' HD12 ' C' ' 956' ' ' LEU . 44.6 Cg_endo -71.51 86.2 0.85 Allowed 'Trans proline' 0 C--N 1.312 -1.364 0 N-CA-C 109.349 -1.058 . . . . 0.83999999999999997 109.349 178.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 956' ' ' LEU . . . . . 0.688 HD12 ' C ' ' C' ' 955' ' ' PRO . 7.5 mp -126.06 153.09 44.95 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.293 -0.88 . . . . 0.040000000000000001 110.64 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -81.49 151.01 28.01 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-O 117.737 -1.125 . . . . 1.28 111.574 -179.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -68.88 119.21 12.86 Favored 'General case' 0 N--CA 1.51 2.549 0 CA-C-N 123.083 2.674 . . . . 0.17000000000000001 111.223 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 91.8 -22.65 30.04 Favored Glycine 0 N--CA 1.501 3.019 0 N-CA-C 110.789 -0.924 . . . . 0.040000000000000001 110.789 178.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 960' ' ' ASP . . . . . 0.407 ' HB3' ' CZ ' ' C' ' 914' ' ' ARG . 0.1 OUTLIER -51.82 172.45 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.519 -0.989 . . . . 0.040000000000000001 110.332 -179.49 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 961' ' ' THR . . . . . 0.494 ' HA ' ' O ' ' C' ' 886' ' ' PHE . 53.5 p -133.18 138.81 46.72 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.087 -1.008 . . . . 1.78 112.307 -177.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 962' ' ' VAL . . . . . 0.811 HG22 ' CB ' ' C' ' 886' ' ' PHE . 18.5 m -96.19 144.9 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 C-N-CA 120.208 -0.597 . . . . 0.040000000000000001 109.696 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 6.6 t -137.81 145.64 42.57 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.823 -0.548 . . . . 0.71999999999999997 110.213 -178.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 964' ' ' VAL . . . . . 0.908 HG22 HG23 ' C' ' 911' ' ' VAL . 57.5 t -100.17 135.91 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.067 -1.021 . . . . 1.05 110.899 -179.044 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -96.71 125.62 41.29 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 103.788 -2.671 . . . . 3.02 103.788 173.041 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 966' ' ' LEU . . . . . 0.645 HD23 ' O ' ' C' ' 966' ' ' LEU . 5.1 tt -131.87 62.79 1.63 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.067 -1.086 . . . . 1.46 108.067 177.489 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 967' ' ' VAL . . . . . 0.491 HG23 ' C ' ' C' ' 966' ' ' LEU . 97.6 t -157.79 96.77 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.065 -1.087 . . . . 1.9399999999999999 108.065 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 94.4 mmm -142.26 58.62 1.46 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.769 -1.207 . . . . 0.0 108.375 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 134.58 119.54 1.96 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 107.222 -2.351 . . . . 2.1099999999999999 107.222 -178.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -82.4 -58.12 3.07 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.031 -1.276 . . . . 5.8899999999999997 110.607 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 971' ' ' LEU . . . . . 0.601 HD23 ' O ' ' C' ' 971' ' ' LEU . 9.1 tt -58.94 89.84 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.427 -0.796 . . . . 4.3600000000000003 110.378 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -142.33 -152.59 0.42 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.584 -0.698 . . . . 1.8300000000000001 110.144 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -117.17 167.81 10.85 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.415 -0.803 . . . . 4.3499999999999996 110.045 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 29.3 t -101.54 130.19 47.77 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.547 -0.72 . . . . 1.27 110.152 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -156.22 153.68 29.56 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.526 -0.734 . . . . 5.0199999999999996 110.405 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.27 86.08 17.56 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.604 -0.685 . . . . 2.4100000000000001 109.853 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -75.39 -171.44 1.02 Allowed 'Trans proline' 0 C--N 1.318 -1.065 0 O-C-N 123.326 1.172 . . . . 0.95999999999999996 111.309 -179.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 978' ' ' LEU . . . . . 0.582 ' N ' HD12 ' C' ' 978' ' ' LEU . 5.4 mp -123.36 156.68 34.9 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 107.512 -1.292 . . . . 0.62 107.512 177.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 979' ' ' THR . . . . . 0.45 HG23 ' C ' ' C' ' 978' ' ' LEU . 45.0 p -149.72 141.65 23.81 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.777 -1.202 . . . . 3.5699999999999998 111.186 -179.235 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 980' ' ' ILE . . . . . 0.729 ' HB ' HG21 ' C' ' 899' ' ' VAL . 50.6 mm -105.64 128.47 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 N-CA-C 109.174 -0.676 . . . . 1.3300000000000001 109.174 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 981' ' ' PHE . . . . . 0.439 ' CD1' ' CE2' ' C' ' 879' ' ' TYR . 2.1 t80 -118.99 99.36 6.69 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 119.808 -0.757 . . . . 0.050000000000000003 111.486 -178.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 982' ' ' SER . . . . . . . . . . . . . 10.6 p -109.93 159.71 17.02 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.578 -0.701 . . . . 0.87 109.194 178.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 983' ' ' GLY . . . . . 0.41 ' O ' ' CE2' ' C' ' 852' ' ' PHE . . . -170.8 111.42 0.41 Allowed Glycine 0 N--CA 1.498 2.818 0 N-CA-C 106.594 -2.602 . . . . 0.029999999999999999 106.594 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 984' ' ' ALA . . . . . 0.44 ' HB1' ' NE ' ' A' ' 893' ' ' ARG . . . -109.01 147.19 32.7 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.199 -1.177 . . . . 0.69999999999999996 114.025 -176.075 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 985' ' ' LEU . . . . . 1.055 HD13 HD22 ' C' ' 890' ' ' LEU . 56.6 tp -72.36 135.72 45.95 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.722 -1.236 . . . . 0.040000000000000001 110.066 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 986' ' ' LEU . . . . . . . . . . . . . 49.1 tp -107.08 -61.58 1.53 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.524 -0.735 . . . . 0.040000000000000001 110.341 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -145.0 146.33 31.87 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.847 -1.168 . . . . 0.040000000000000001 107.847 179.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.35 162.79 12.29 Favored Glycine 0 N--CA 1.495 2.593 0 N-CA-C 108.146 -1.981 . . . . 0.040000000000000001 108.146 179.167 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -75.44 112.65 20.05 Favored Pre-proline 0 N--CA 1.498 1.965 0 O-C-N 121.19 -1.183 . . . . 0.040000000000000001 109.485 179.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 990' ' ' PRO . . . . . 0.418 ' O ' ' HB2' ' C' ' 991' ' ' GLU . 50.2 Cg_endo -89.82 71.26 1.72 Allowed 'Trans proline' 0 C--N 1.319 -0.985 0 O-C-N 123.132 1.07 . . . . 0.45000000000000001 111.466 -178.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 991' ' ' GLU . . . . . 0.418 ' HB2' ' O ' ' C' ' 990' ' ' PRO . 69.5 mt-10 67.41 -73.31 0.08 Allowed 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 108.662 -0.866 . . . . 1.97 108.662 -177.605 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 992' ' ' LEU . . . . . . . . . . . . . 11.7 mt 50.62 21.06 0.81 Allowed 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.584 -0.697 . . . . 2.3799999999999999 111.645 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 79.7 mt-10 -93.27 156.94 16.51 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.887 -1.133 . . . . 3.79 110.02 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 68.6 m80 -146.62 92.59 2.17 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.525 -0.734 . . . . 3.5099999999999998 110.21 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 995' ' ' ALA . . . . . . . . . . . . 2.518 . . . . . . . 0 N--CA 1.503 2.197 0 O-C-N 120.94 -1.1 . . . . 2.73 110.569 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo . . . . . 0 N--CA 1.488 1.157 0 N-CA-C 109.503 -0.999 . . . . 3.8300000000000001 109.503 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 847' ' ' VAL . . . . . 0.44 HG12 ' HB2' ' A' ' 849' ' ' GLN . 61.3 t -132.16 102.84 14.24 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.584 -0.697 . . . . 1.8300000000000001 110.06 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 848' ' ' PRO . . . . . 0.762 ' O ' HG23 ' A' ' 850' ' ' VAL . 43.5 Cg_endo -69.84 -20.84 33.95 Favored 'Trans proline' 0 N--CA 1.487 1.124 0 O-C-N 123.276 1.145 . . . . 0.65000000000000002 110.973 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 849' ' ' GLN . . . . . 0.44 ' HB2' HG12 ' A' ' 847' ' ' VAL . 56.1 tt0 28.04 68.1 0.07 Allowed 'General case' 0 N--CA 1.518 2.937 0 N-CA-C 112.911 0.708 . . . . 2.5800000000000001 112.911 179.287 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 850' ' ' VAL . . . . . 0.762 HG23 ' O ' ' A' ' 848' ' ' PRO . 72.9 t -119.74 136.13 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.152 -0.968 . . . . 1.0900000000000001 111.413 -178.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 851' ' ' ALA . . . . . 0.482 ' HB3' ' HG ' ' A' ' 873' ' ' LEU . . . -126.62 159.41 33.65 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 106.043 -1.836 . . . . 0.040000000000000001 106.043 177.033 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 852' ' ' PHE . . . . . 0.439 ' HA ' ' CB ' ' A' ' 874' ' ' ASN . 46.7 p90 -157.56 131.79 8.3 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 121.019 1.736 . . . . 0.050000000000000003 108.728 178.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 32.5 t -175.67 133.02 0.28 Allowed 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.076 -1.083 . . . . 0.040000000000000001 108.076 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -133.45 156.08 48.37 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.071 -1.018 . . . . 0.67000000000000004 109.472 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 855' ' ' ALA . . . . . 0.744 ' HB3' ' CB ' ' A' ' 870' ' ' ARG . . . -124.4 140.17 53.21 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.808 0.813 . . . . 0.51000000000000001 111.305 -179.289 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 856' ' ' LEU . . . . . 0.761 HD11 HD23 ' A' ' 858' ' ' LEU . 3.4 tm? -111.96 140.01 46.98 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.607 -0.683 . . . . 0.050000000000000003 110.156 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 857' ' ' SER . . . . . 0.68 ' N ' HD13 ' A' ' 856' ' ' LEU . 37.0 p -157.59 17.05 0.26 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.543 -0.723 . . . . 1.3300000000000001 111.467 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 858' ' ' LEU . . . . . 0.761 HD23 HD11 ' A' ' 856' ' ' LEU . 3.1 pp -35.67 161.57 0.04 OUTLIER Pre-proline 0 N--CA 1.518 2.935 0 N-CA-C 112.851 0.686 . . . . 2.3300000000000001 112.851 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -59.87 -89.17 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.453 0 O-C-N 122.938 0.968 . . . . 2.3199999999999998 113.294 -178.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 55.3 ptt85 -134.9 -141.61 0.18 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.839 -1.163 . . . . 0.040000000000000001 111.646 -177.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 73.8 m -32.89 122.09 0.36 Allowed 'General case' 0 N--CA 1.513 2.694 0 N-CA-C 112.996 0.739 . . . . 1.3100000000000001 112.996 -178.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.76 160.13 27.08 Favored Pre-proline 0 N--CA 1.489 1.483 0 N-CA-C 107.93 -1.137 . . . . 4.5099999999999998 107.93 177.199 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.05 -13.86 34.45 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.134 1.07 . . . . 2.2400000000000002 111.479 -179.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -177.3 -135.45 2.22 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.97 -1.252 . . . . 0.040000000000000001 109.97 179.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 37.2 m -67.56 157.34 34.6 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.35 -1.088 . . . . 1.51 110.53 -178.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 866' ' ' VAL . . . . . 0.475 HG13 ' CD2' ' A' ' 858' ' ' LEU . 50.8 t -100.55 139.34 20.54 Favored Pre-proline 0 N--CA 1.495 1.8 0 N-CA-C 113.459 0.911 . . . . 0.78000000000000003 113.459 -174.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 867' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 866' ' ' VAL . 55.6 Cg_endo -91.67 -148.19 0.03 OUTLIER 'Trans proline' 0 CA--C 1.548 1.177 0 O-C-N 123.621 1.327 . . . . 0.92000000000000004 109.481 177.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 868' ' ' PHE . . . . . 0.45 ' CD1' ' CG ' ' A' ' 881' ' ' PRO . 26.3 p90 -150.35 124.22 9.26 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.696 -1.253 . . . . 0.050000000000000003 109.539 179.011 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 50.4 p-10 -113.82 -2.16 13.73 Favored 'General case' 0 N--CA 1.5 2.066 0 C-N-CA 119.265 -0.974 . . . . 1.7 112.852 -178.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 870' ' ' ARG . . . . . 0.744 ' CB ' ' HB3' ' A' ' 855' ' ' ALA . 28.7 mmm180 -91.27 90.11 7.6 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.865 -1.147 . . . . 2.5899999999999999 110.999 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 57.4 t -71.81 96.72 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 120.971 -1.081 . . . . 1.9399999999999999 110.047 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 872' ' ' LEU . . . . . 0.538 HD11 ' HB2' ' A' ' 855' ' ' ALA . 96.8 mt -83.06 -47.46 11.65 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.456 -0.778 . . . . 1.0600000000000001 110.04 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 873' ' ' LEU . . . . . 0.482 ' HG ' ' HB3' ' A' ' 851' ' ' ALA . 41.2 tp -175.15 103.19 0.08 Allowed 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 108.381 -0.97 . . . . 4.1799999999999997 108.381 178.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 874' ' ' ASN . . . . . 0.439 ' CB ' ' HA ' ' A' ' 852' ' ' PHE . 36.7 t-20 178.29 81.68 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.324 0 O-C-N 121.681 -0.637 . . . . 0.040000000000000001 109.421 -178.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -66.26 -46.77 75.93 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 119.324 -0.95 . . . . 3.3799999999999999 111.22 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 876' ' ' GLY . . . . . 0.4 ' HA3' ' CE2' ' A' ' 878' ' ' TYR . . . -74.87 -24.56 71.74 Favored Glycine 0 N--CA 1.494 2.555 0 O-C-N 121.318 -0.864 . . . . 0.040000000000000001 111.916 -178.686 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 82.11 -62.48 4.54 Favored Glycine 0 N--CA 1.501 3.021 0 N-CA-C 107.896 -2.082 . . . . 0.040000000000000001 107.896 -178.156 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 878' ' ' TYR . . . . . 0.4 ' CE2' ' HA3' ' A' ' 876' ' ' GLY . 93.2 m-85 61.41 -61.99 0.09 Allowed 'General case' 0 N--CA 1.504 2.262 0 N-CA-C 114.596 1.332 . . . . 3.46 114.596 177.565 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 879' ' ' TYR . . . . . 0.467 ' CB ' ' CD2' ' A' ' 886' ' ' PHE . 20.4 p90 -110.58 109.03 19.17 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 114.849 1.425 . . . . 0.040000000000000001 114.849 -176.05 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -67.19 118.21 53.77 Favored Pre-proline 0 N--CA 1.495 1.813 0 O-C-N 121.385 -0.822 . . . . 0.02 109.899 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 881' ' ' PRO . . . . . 0.45 ' CG ' ' CD1' ' A' ' 868' ' ' PHE . 51.2 Cg_endo -76.84 1.2 8.84 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 O-C-N 123.443 1.233 . . . . 0.39000000000000001 112.165 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -76.19 -64.75 1.03 Allowed 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 106.78 -1.563 . . . . 0.81000000000000005 106.78 178.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 7.5 p -95.43 -17.91 21.13 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.702 -0.851 . . . . 0.040000000000000001 108.702 177.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 85.17 23.33 48.97 Favored Glycine 0 N--CA 1.495 2.577 0 C-N-CA 120.11 -1.043 . . . . 0.029999999999999999 110.679 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 885' ' ' VAL . . . . . . . . . . . . . 75.4 t -73.39 88.42 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 C-N-CA 118.351 -1.339 . . . . 1.01 108.085 -179.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 886' ' ' PHE . . . . . 0.905 ' HB3' HG22 ' A' ' 962' ' ' VAL . 0.6 OUTLIER -89.64 106.55 18.53 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 115.239 -0.891 . . . . 0.050000000000000003 112.135 -177.232 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 887' ' ' THR . . . . . 0.41 ' O ' ' HD3' ' A' ' 889' ' ' PRO . 95.4 m -98.48 99.29 10.45 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 107.581 -1.266 . . . . 0.68000000000000005 107.581 177.104 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 888' ' ' ALA . . . . . . . . . . . . . . . -97.1 107.88 40.59 Favored Pre-proline 0 N--CA 1.502 2.132 0 N-CA-C 113.983 1.105 . . . . 0.25 113.983 -176.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 889' ' ' PRO . . . . . 0.41 ' HD3' ' O ' ' A' ' 887' ' ' THR . 54.6 Cg_endo -89.11 -13.5 2.99 Favored 'Trans proline' 0 CA--C 1.546 1.094 0 N-CA-C 109.093 -1.157 . . . . 1.6399999999999999 109.093 176.357 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 890' ' ' LEU . . . . . 0.988 HD22 HD13 ' A' ' 985' ' ' LEU . 51.8 mt -35.91 -51.08 0.7 Allowed 'General case' 0 N--CA 1.508 2.447 0 N-CA-C 113.735 1.013 . . . . 2.29 113.735 -177.493 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 51.83 95.76 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.321 0 O-C-N 121.211 -0.93 . . . . 0.63 110.294 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 157.71 -152.99 24.24 Favored Glycine 0 N--CA 1.479 1.531 0 N-CA-C 107.181 -2.368 . . . . 0.040000000000000001 107.181 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 893' ' ' ARG . . . . . 0.405 ' CZ ' ' CB ' ' C' ' 984' ' ' ALA . 71.9 ttt-85 -114.46 126.23 54.73 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 108.286 -1.005 . . . . 3.0 108.286 177.306 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 894' ' ' TYR . . . . . 0.722 ' OH ' HD12 ' A' ' 896' ' ' LEU . 0.1 OUTLIER -132.47 160.06 37.54 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.105 -0.997 . . . . 0.040000000000000001 111.342 -179.4 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 895' ' ' LEU . . . . . 0.796 HD23 HD11 ' B' ' 952' ' ' LEU . 36.4 tp -92.16 119.67 32.03 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.735 -0.603 . . . . 1.27 110.056 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 896' ' ' LEU . . . . . 0.722 HD12 ' OH ' ' A' ' 894' ' ' TYR . 9.7 tt -109.64 143.67 39.05 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.717 -0.614 . . . . 0.93999999999999995 110.191 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 897' ' ' SER . . . . . 0.527 ' N ' HD23 ' A' ' 896' ' ' LEU . 64.7 m -149.86 114.07 5.17 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.443 -0.786 . . . . 0.040000000000000001 111.159 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.71 146.53 31.97 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.942 -0.762 . . . . 0.47999999999999998 108.942 178.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 899' ' ' VAL . . . . . 0.756 HG21 ' HB ' ' A' ' 980' ' ' ILE . 90.1 t -95.02 120.06 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 C-N-CA 119.588 -0.845 . . . . 0.55000000000000004 111.183 -179.227 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 900' ' ' LEU . . . . . 0.483 ' N ' HD22 ' A' ' 900' ' ' LEU . 4.5 mm? -95.52 112.04 23.83 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 114.331 1.234 . . . . 1.5900000000000001 114.331 -175.098 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 15.7 m -65.91 141.28 58.29 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 107.506 -1.294 . . . . 0.050000000000000003 107.506 177.08 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -67.11 -66.71 2.25 Favored Glycine 0 N--CA 1.495 2.597 0 N-CA-C 110.505 -1.038 . . . . 0.029999999999999999 110.505 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 12.0 m170 47.52 67.3 0.83 Allowed 'General case' 0 N--CA 1.507 2.378 0 O-C-N 121.533 -0.981 . . . . 3.2000000000000002 111.017 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 46.5 ptt85 -69.48 -6.82 33.01 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.58 -0.7 . . . . 2.9199999999999999 111.9 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 905' ' ' HIS . . . . . 0.485 ' O ' ' CB ' ' A' ' 906' ' ' GLU . 70.7 t60 -62.86 5.68 0.12 Allowed 'General case' 0 N--CA 1.506 2.35 0 O-C-N 120.943 -1.098 . . . . 2.8700000000000001 113.116 -179.084 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 906' ' ' GLU . . . . . 0.485 ' CB ' ' O ' ' A' ' 905' ' ' HIS . 0.6 OUTLIER 94.44 -164.29 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.407 0 CA-C-N 120.486 1.494 . . . . 0.98999999999999999 111.906 178.924 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 907' ' ' LYS . . . . . 0.458 ' CB ' ' O ' ' A' ' 906' ' ' GLU . 69.2 tttt 85.34 155.57 0.09 Allowed 'General case' 0 N--CA 1.519 3.01 0 N-CA-C 107.87 -1.159 . . . . 5.25 107.87 -176.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 59.5 t -123.44 115.55 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 120.733 -1.229 . . . . 0.39000000000000001 111.239 -179.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 909' ' ' GLU . . . . . 0.646 ' OE2' HD12 ' A' ' 966' ' ' LEU . 43.3 tp10 -97.3 135.48 39.16 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 107.077 -1.453 . . . . 1.72 107.077 176.523 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -154.72 123.66 6.25 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 106.985 -1.487 . . . . 0.67000000000000004 106.985 178.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 911' ' ' VAL . . . . . 0.67 HG22 HG13 ' A' ' 964' ' ' VAL . 86.1 t -80.43 130.55 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 CA-C-N 116.186 -0.461 . . . . 0.54000000000000004 110.933 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 86.0 mt -63.54 156.74 25.54 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.33 -0.856 . . . . 1.5 108.703 178.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 913' ' ' SER . . . . . 0.409 ' CB ' ' CG1' ' A' ' 919' ' ' VAL . 0.4 OUTLIER -128.38 131.27 48.53 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.17 -1.048 . . . . 1.3700000000000001 108.17 176.653 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 914' ' ' ARG . . . . . 0.853 ' NH1' HD23 ' A' ' 956' ' ' LEU . 0.0 OUTLIER -66.18 156.35 34.36 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 120.651 -1.28 . . . . 4.2999999999999998 111.706 -179.068 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 915' ' ' SER . . . . . 0.432 ' CB ' ' O ' ' A' ' 914' ' ' ARG . 4.2 t 83.19 -32.05 0.08 Allowed 'General case' 0 N--CA 1.522 3.163 0 C-N-CA 123.99 0.916 . . . . 2.0499999999999998 112.003 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 916' ' ' ASN . . . . . 0.798 ' HB2' HG21 ' A' ' 919' ' ' VAL . 82.6 m-20 -122.73 -20.86 5.78 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.918 -1.114 . . . . 2.71 111.249 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 917' ' ' GLN . . . . . 0.402 ' HB2' ' O ' ' A' ' 916' ' ' ASN . 45.4 mt-30 66.64 164.8 0.2 Allowed 'General case' 0 N--CA 1.521 3.106 0 N-CA-C 105.744 -1.947 . . . . 2.6800000000000002 105.744 -174.2 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 53.94 -124.26 29.47 Favored Glycine 1 N--CA 1.521 4.345 0 CA-C-N 123.455 2.843 . . . . 0.029999999999999999 107.05 -177.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 919' ' ' VAL . . . . . 0.798 HG21 ' HB2' ' A' ' 916' ' ' ASN . 73.5 t 51.56 94.18 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 O-C-N 121.425 -1.044 . . . . 1.3899999999999999 109.165 -178.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 920' ' ' ALA . . . . . 0.567 ' HB3' HG12 ' A' ' 949' ' ' VAL . . . -92.95 92.19 7.75 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.347 -0.941 . . . . 0.029999999999999999 110.67 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 921' ' ' ARG . . . . . 0.865 ' HG3' HG23 ' A' ' 922' ' ' VAL . 29.2 ptt180 -85.11 -41.75 15.42 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 105.931 -1.877 . . . . 4.4199999999999999 105.931 176.344 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 922' ' ' VAL . . . . . 0.865 HG23 ' HG3' ' A' ' 921' ' ' ARG . 93.1 t -101.19 73.02 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 N-CA-C 106.021 -1.844 . . . . 0.84999999999999998 106.021 175.633 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -87.29 133.29 33.71 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.689 0.757 . . . . 2.46 111.381 -177.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 924' ' ' SER . . . . . 0.408 ' CB ' HD12 ' A' ' 900' ' ' LEU . 8.7 t -147.99 105.61 3.68 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.59 -0.893 . . . . 0.69999999999999996 108.59 179.247 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -102.82 84.41 0.47 Allowed Glycine 0 N--CA 1.487 2.054 0 N-CA-C 108.568 -1.813 . . . . 0.040000000000000001 108.568 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 926' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' A' ' 906' ' ' GLU . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 108.786 -1.725 . . . . 0.040000000000000001 108.786 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 67.1 m . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.007 0.432 . . . . 13.779999999999999 110.366 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 95.5 mt -109.52 130.55 55.5 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.509 -0.744 . . . . 13.76 110.276 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -152.79 169.21 31.82 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.388 -1.485 . . . . 9.1300000000000008 109.388 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 949' ' ' VAL . . . . . 0.567 HG12 ' HB3' ' A' ' 920' ' ' ALA . 34.3 m -118.56 130.49 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.577 -0.955 . . . . 7.0800000000000001 110.687 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 950' ' ' PHE . . . . . 0.428 ' CZ ' ' HB3' ' A' ' 921' ' ' ARG . 52.0 p90 -130.22 143.98 51.1 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.454 -0.779 . . . . 7.5899999999999999 109.415 179.549 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 31.3 m -121.61 -52.3 2.03 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.46 -0.775 . . . . 5.0300000000000002 111.97 -178.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 952' ' ' LEU . . . . . 0.404 ' O ' ' O ' ' A' ' 953' ' ' ILE . 45.7 tp -61.47 -75.88 0.06 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.44 -0.787 . . . . 1.01 112.439 -177.519 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 953' ' ' ILE . . . . . 0.46 ' O ' ' HB3' ' A' ' 954' ' ' LEU . 47.0 pt -53.65 -141.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.736 0 N-CA-C 113.981 1.104 . . . . 2.6000000000000001 113.981 -176.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 954' ' ' LEU . . . . . 0.738 HD22 ' O ' ' A' ' 954' ' ' LEU . 0.0 OUTLIER 174.32 75.09 0.05 OUTLIER Pre-proline 0 N--CA 1.507 2.378 0 O-C-N 120.755 -1.215 . . . . 0.050000000000000003 110.959 179.813 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 955' ' ' PRO . . . . . 0.561 ' C ' HD12 ' A' ' 956' ' ' LEU . 45.3 Cg_endo -73.04 93.79 0.81 Allowed 'Trans proline' 0 C--N 1.315 -1.215 0 N-CA-C 109.227 -1.105 . . . . 0.83999999999999997 109.227 178.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 956' ' ' LEU . . . . . 0.853 HD23 ' NH1' ' A' ' 914' ' ' ARG . 5.0 mp -126.19 140.39 52.59 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.251 -0.906 . . . . 0.040000000000000001 110.624 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -79.77 152.52 29.75 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 117.864 -1.065 . . . . 1.28 111.201 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -67.14 121.2 15.1 Favored 'General case' 0 N--CA 1.511 2.58 0 CA-C-N 122.743 2.52 . . . . 0.17000000000000001 111.925 -179.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 94.31 -18.75 56.29 Favored Glycine 0 N--CA 1.501 3.004 0 N-CA-C 111.135 -0.786 . . . . 0.040000000000000001 111.135 178.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 960' ' ' ASP . . . . . 0.406 ' HB3' ' CZ ' ' A' ' 914' ' ' ARG . 1.3 m-20 -52.42 167.56 0.13 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.445 -1.032 . . . . 0.040000000000000001 111.029 -179.189 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 961' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 886' ' ' PHE . 57.3 m -135.66 135.84 40.45 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.936 -1.103 . . . . 1.78 111.623 -178.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 962' ' ' VAL . . . . . 0.905 HG22 ' HB3' ' A' ' 886' ' ' PHE . 33.8 m -100.43 145.24 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 O-C-N 121.57 -0.706 . . . . 0.040000000000000001 111.173 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 1.7 m -138.51 148.15 43.96 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.789 -0.569 . . . . 0.71999999999999997 109.964 -178.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 964' ' ' VAL . . . . . 0.67 HG13 HG22 ' A' ' 911' ' ' VAL . 61.4 t -99.66 137.92 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.128 -0.983 . . . . 1.05 110.584 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -91.68 128.88 37.69 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 104.121 -2.548 . . . . 3.02 104.121 173.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 966' ' ' LEU . . . . . 0.646 HD12 ' OE2' ' A' ' 909' ' ' GLU . 0.4 OUTLIER -131.54 59.8 1.69 Allowed 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.22 -1.03 . . . . 1.46 108.22 177.078 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 967' ' ' VAL . . . . . 0.491 HG23 ' C ' ' A' ' 966' ' ' LEU . 90.6 t -158.64 97.25 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 108.041 -1.096 . . . . 1.9399999999999999 108.041 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 80.2 mmm -143.99 59.47 1.36 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.711 -1.243 . . . . 0.0 108.396 178.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.3 119.77 1.95 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 107.195 -2.362 . . . . 2.1099999999999999 107.195 -178.288 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -82.18 -59.05 2.69 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.082 -1.246 . . . . 5.8899999999999997 110.333 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 47.3 tp -59.08 90.76 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.437 -0.789 . . . . 4.3600000000000003 110.205 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -141.91 -154.51 0.52 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.56 -0.712 . . . . 1.8300000000000001 110.24 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -120.5 172.53 7.77 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.45 -0.781 . . . . 4.3499999999999996 110.349 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 30.6 t -101.25 130.3 47.35 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.534 -0.729 . . . . 1.27 110.016 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -155.66 159.0 39.22 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.553 -0.717 . . . . 5.0199999999999996 110.52 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.01 85.99 18.47 Favored Pre-proline 0 N--CA 1.5 2.053 0 O-C-N 121.648 -0.658 . . . . 2.4100000000000001 109.632 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -73.15 -173.06 1.15 Allowed 'Trans proline' 0 C--N 1.317 -1.098 0 O-C-N 123.309 1.163 . . . . 0.95999999999999996 111.359 -179.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 978' ' ' LEU . . . . . 0.568 HD23 HD12 ' A' ' 856' ' ' LEU . 4.9 mp -128.52 153.94 46.66 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 107.547 -1.279 . . . . 0.62 107.547 177.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 979' ' ' THR . . . . . 0.462 HG23 ' C ' ' A' ' 978' ' ' LEU . 41.8 p -149.99 141.57 23.49 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.8 -1.187 . . . . 3.5699999999999998 111.189 -179.26 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 980' ' ' ILE . . . . . 0.756 ' HB ' HG21 ' A' ' 899' ' ' VAL . 49.4 mm -106.86 128.72 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.893 -0.78 . . . . 1.3300000000000001 108.893 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 981' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -119.0 95.96 5.04 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 119.806 -0.758 . . . . 0.050000000000000003 111.891 -178.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 82.8 p -108.18 157.83 17.97 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.55 -0.719 . . . . 0.87 109.098 178.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 983' ' ' GLY . . . . . 0.411 ' HA3' ' CE1' ' A' ' 852' ' ' PHE . . . -176.84 108.17 0.25 Allowed Glycine 0 N--CA 1.499 2.875 0 N-CA-C 106.411 -2.676 . . . . 0.029999999999999999 106.411 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -108.53 152.33 24.89 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 114.658 1.355 . . . . 0.69999999999999996 114.658 -175.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 985' ' ' LEU . . . . . 0.988 HD13 HD22 ' A' ' 890' ' ' LEU . 36.4 tp -72.15 135.33 46.15 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.829 -1.17 . . . . 0.040000000000000001 109.991 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 51.4 tp -106.09 -59.78 1.73 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.535 -0.728 . . . . 0.040000000000000001 109.879 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -143.15 146.52 33.8 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 107.57 -1.27 . . . . 0.040000000000000001 107.57 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.13 163.66 12.17 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 108.23 -1.948 . . . . 0.040000000000000001 108.23 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -74.56 112.61 18.11 Favored Pre-proline 0 N--CA 1.498 1.951 0 O-C-N 121.227 -1.161 . . . . 0.040000000000000001 109.439 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 990' ' ' PRO . . . . . 0.419 ' O ' ' HB2' ' A' ' 991' ' ' GLU . 50.6 Cg_endo -89.25 71.0 2.07 Favored 'Trans proline' 0 C--N 1.318 -1.036 0 O-C-N 123.132 1.07 . . . . 0.45000000000000001 111.494 -178.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 991' ' ' GLU . . . . . 0.419 ' HB2' ' O ' ' A' ' 990' ' ' PRO . 70.5 mt-10 67.23 -73.97 0.07 Allowed 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 108.562 -0.903 . . . . 1.97 108.562 -177.487 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 992' ' ' LEU . . . . . 0.41 HD12 ' HD2' ' A' ' 990' ' ' PRO . 11.4 mt 51.19 20.66 0.93 Allowed 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.572 -0.705 . . . . 2.3799999999999999 111.593 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -92.81 156.9 16.69 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.86 -1.15 . . . . 3.79 109.955 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 71.0 m80 -147.1 92.22 2.09 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.525 -0.734 . . . . 3.5099999999999998 110.314 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 995' ' ' ALA . . . . . . . . . . . . 2.516 . . . . . . . 0 N--CA 1.503 2.214 0 O-C-N 120.933 -1.105 . . . . 2.73 110.551 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo . . . . . 0 N--CA 1.488 1.16 0 N-CA-C 109.479 -1.008 . . . . 3.8300000000000001 109.479 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 847' ' ' VAL . . . . . 0.424 HG12 ' HB2' ' B' ' 849' ' ' GLN . 60.4 t -132.1 102.86 14.31 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.632 -0.667 . . . . 1.8300000000000001 110.122 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 848' ' ' PRO . . . . . 0.767 ' O ' HG23 ' B' ' 850' ' ' VAL . 43.9 Cg_endo -69.76 -21.17 33.85 Favored 'Trans proline' 0 N--CA 1.487 1.1 0 O-C-N 123.328 1.173 . . . . 0.65000000000000002 110.941 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 849' ' ' GLN . . . . . 0.424 ' HB2' HG12 ' B' ' 847' ' ' VAL . 56.1 tt0 28.35 68.34 0.08 Allowed 'General case' 0 N--CA 1.517 2.901 0 N-CA-C 112.856 0.687 . . . . 2.5800000000000001 112.856 179.283 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 850' ' ' VAL . . . . . 0.767 HG23 ' O ' ' B' ' 848' ' ' PRO . 74.4 t -120.07 136.11 58.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.213 -0.93 . . . . 1.0900000000000001 111.421 -178.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 851' ' ' ALA . . . . . 0.493 ' HB3' ' HG ' ' B' ' 873' ' ' LEU . . . -126.93 158.72 36.06 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 106.008 -1.849 . . . . 0.040000000000000001 106.008 177.113 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 852' ' ' PHE . . . . . 0.432 ' HA ' ' CB ' ' B' ' 874' ' ' ASN . 46.6 p90 -156.87 132.07 9.12 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 121.034 1.743 . . . . 0.050000000000000003 108.713 179.106 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 33.0 t -175.74 132.71 0.27 Allowed 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.118 -1.067 . . . . 0.040000000000000001 108.118 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -133.13 156.23 47.82 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.118 -0.989 . . . . 0.67000000000000004 109.487 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 855' ' ' ALA . . . . . 0.74 ' HB3' ' CB ' ' B' ' 870' ' ' ARG . . . -124.47 140.38 53.01 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.784 0.802 . . . . 0.51000000000000001 111.306 -179.263 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 856' ' ' LEU . . . . . 0.764 HD11 HD23 ' B' ' 858' ' ' LEU . 3.4 tm? -112.24 139.5 47.72 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.622 -0.673 . . . . 0.050000000000000003 110.179 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 857' ' ' SER . . . . . 0.667 ' N ' HD13 ' B' ' 856' ' ' LEU . 37.4 p -157.27 17.42 0.28 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.544 -0.723 . . . . 1.3300000000000001 111.42 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 858' ' ' LEU . . . . . 0.764 HD23 HD11 ' B' ' 856' ' ' LEU . 3.2 pp -35.92 161.57 0.04 OUTLIER Pre-proline 0 N--CA 1.518 2.953 0 CA-C-N 118.656 0.662 . . . . 2.3300000000000001 112.784 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -59.86 -89.24 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.49 0 O-C-N 122.901 0.948 . . . . 2.3199999999999998 113.277 -178.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 55.3 ptt85 -134.92 -141.58 0.18 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.836 -1.165 . . . . 0.040000000000000001 111.675 -177.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 73.8 m -32.81 121.68 0.35 Allowed 'General case' 0 N--CA 1.512 2.646 0 N-CA-C 113.042 0.756 . . . . 1.3100000000000001 113.042 -178.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 862' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.47 160.16 27.01 Favored Pre-proline 0 N--CA 1.489 1.524 0 N-CA-C 107.953 -1.129 . . . . 4.5099999999999998 107.953 177.178 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -69.95 -14.01 34.92 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 O-C-N 123.157 1.083 . . . . 2.2400000000000002 111.576 -179.368 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -177.03 -134.54 2.01 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 110.027 -1.229 . . . . 0.040000000000000001 110.027 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 38.9 m -68.43 157.72 35.21 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.308 -1.113 . . . . 1.51 110.437 -179.059 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 866' ' ' VAL . . . . . 0.475 HG13 ' CD2' ' B' ' 858' ' ' LEU . 50.7 t -100.7 139.34 20.5 Favored Pre-proline 0 N--CA 1.495 1.778 0 N-CA-C 113.509 0.929 . . . . 0.78000000000000003 113.509 -174.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 867' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' B' ' 866' ' ' VAL . 55.6 Cg_endo -91.72 -148.48 0.03 OUTLIER 'Trans proline' 0 CA--C 1.548 1.18 0 O-C-N 123.641 1.337 . . . . 0.92000000000000004 109.446 177.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 868' ' ' PHE . . . . . 0.455 ' CD1' ' CG ' ' B' ' 881' ' ' PRO . 26.1 p90 -150.17 124.1 9.31 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.622 -1.299 . . . . 0.050000000000000003 109.576 179.052 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 50.4 p-10 -113.68 -1.84 13.91 Favored 'General case' 0 N--CA 1.501 2.089 0 C-N-CA 119.222 -0.991 . . . . 1.7 112.875 -178.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 870' ' ' ARG . . . . . 0.74 ' CB ' ' HB3' ' B' ' 855' ' ' ALA . 28.4 mmm180 -91.52 89.88 7.39 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.837 -1.164 . . . . 2.5899999999999999 111.011 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 57.6 t -71.8 96.83 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.009 -1.057 . . . . 1.9399999999999999 110.019 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 872' ' ' LEU . . . . . 0.538 HD11 ' HB2' ' B' ' 855' ' ' ALA . 96.7 mt -83.22 -47.34 11.66 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.535 -0.728 . . . . 1.0600000000000001 110.021 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 873' ' ' LEU . . . . . 0.493 ' HG ' ' HB3' ' B' ' 851' ' ' ALA . 41.0 tp -175.1 103.22 0.08 Allowed 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.416 -0.957 . . . . 4.1799999999999997 108.416 178.528 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 874' ' ' ASN . . . . . 0.432 ' CB ' ' HA ' ' B' ' 852' ' ' PHE . 36.5 t-20 178.33 81.78 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.663 -0.648 . . . . 0.040000000000000001 109.443 -178.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -66.44 -46.87 75.01 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 119.32 -0.952 . . . . 3.3799999999999999 111.208 -179.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 876' ' ' GLY . . . . . 0.403 ' HA3' ' CE2' ' B' ' 878' ' ' TYR . . . -74.71 -24.85 71.26 Favored Glycine 0 N--CA 1.494 2.551 0 O-C-N 121.242 -0.912 . . . . 0.040000000000000001 111.888 -178.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 82.27 -62.32 4.58 Favored Glycine 0 N--CA 1.502 3.042 0 N-CA-C 107.877 -2.089 . . . . 0.040000000000000001 107.877 -178.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 878' ' ' TYR . . . . . 0.403 ' CE2' ' HA3' ' B' ' 876' ' ' GLY . 93.2 m-85 61.41 -62.02 0.09 Allowed 'General case' 0 N--CA 1.504 2.252 0 N-CA-C 114.595 1.332 . . . . 3.46 114.595 177.514 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 879' ' ' TYR . . . . . 0.468 ' CB ' ' CD2' ' B' ' 886' ' ' PHE . 20.3 p90 -110.55 109.12 19.32 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 114.826 1.417 . . . . 0.040000000000000001 114.826 -176.073 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -67.18 118.04 52.08 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.448 -0.783 . . . . 0.02 109.894 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 881' ' ' PRO . . . . . 0.455 ' CG ' ' CD1' ' B' ' 868' ' ' PHE . 53.0 Cg_endo -76.75 1.25 8.75 Favored 'Trans proline' 0 N--CA 1.492 1.431 0 O-C-N 123.426 1.224 . . . . 0.39000000000000001 112.194 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -76.2 -64.79 1.02 Allowed 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 106.8 -1.556 . . . . 0.81000000000000005 106.8 178.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 7.6 p -95.65 -17.3 21.42 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.759 -0.83 . . . . 0.040000000000000001 108.759 177.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.57 23.79 49.09 Favored Glycine 0 N--CA 1.494 2.55 0 C-N-CA 120.091 -1.052 . . . . 0.029999999999999999 110.721 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 885' ' ' VAL . . . . . . . . . . . . . 76.6 t -73.64 88.57 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 C-N-CA 118.315 -1.354 . . . . 1.01 108.022 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 886' ' ' PHE . . . . . 0.885 ' HB3' HG22 ' B' ' 962' ' ' VAL . 0.6 OUTLIER -89.82 106.7 18.64 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 115.324 -0.853 . . . . 0.050000000000000003 112.105 -177.293 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 887' ' ' THR . . . . . 0.409 ' O ' ' HD3' ' B' ' 889' ' ' PRO . 95.5 m -98.53 99.52 10.68 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 107.539 -1.282 . . . . 0.68000000000000005 107.539 177.063 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 888' ' ' ALA . . . . . . . . . . . . . . . -97.3 107.73 40.24 Favored Pre-proline 0 N--CA 1.502 2.138 0 N-CA-C 113.992 1.108 . . . . 0.25 113.992 -176.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 889' ' ' PRO . . . . . 0.409 ' HD3' ' O ' ' B' ' 887' ' ' THR . 55.2 Cg_endo -88.92 -13.66 3.06 Favored 'Trans proline' 0 CA--C 1.545 1.056 0 O-C-N 123.29 1.153 . . . . 1.6399999999999999 109.164 176.319 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 890' ' ' LEU . . . . . 0.957 HD22 HD13 ' B' ' 985' ' ' LEU . 51.9 mt -35.68 -51.31 0.66 Allowed 'General case' 0 N--CA 1.508 2.46 0 N-CA-C 113.688 0.995 . . . . 2.29 113.688 -177.529 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 51.9 95.71 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.275 0 O-C-N 121.192 -0.943 . . . . 0.63 110.358 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . 157.76 -153.17 24.4 Favored Glycine 0 N--CA 1.479 1.515 0 N-CA-C 107.21 -2.356 . . . . 0.040000000000000001 107.21 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 72.1 ttt-85 -114.3 126.17 54.71 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.283 -1.006 . . . . 3.0 108.283 177.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 894' ' ' TYR . . . . . 0.717 ' OH ' HD12 ' B' ' 896' ' ' LEU . 0.1 OUTLIER -132.41 160.28 36.83 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.134 -0.979 . . . . 0.040000000000000001 111.286 -179.391 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 895' ' ' LEU . . . . . 0.41 HD23 HD11 ' C' ' 952' ' ' LEU . 36.6 tp -92.32 119.49 31.94 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.742 -0.599 . . . . 1.27 110.178 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 896' ' ' LEU . . . . . 0.717 HD12 ' OH ' ' B' ' 894' ' ' TYR . 9.7 tt -109.55 142.9 39.97 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.68 -0.637 . . . . 0.93999999999999995 110.279 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 897' ' ' SER . . . . . 0.516 ' N ' HD23 ' B' ' 896' ' ' LEU . 64.4 m -149.1 113.96 5.4 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.464 -0.773 . . . . 0.040000000000000001 111.187 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.55 146.25 32.11 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.085 -0.709 . . . . 0.47999999999999998 109.085 178.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 899' ' ' VAL . . . . . 0.745 HG21 ' HB ' ' B' ' 980' ' ' ILE . 89.5 t -94.74 119.8 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 C-N-CA 119.602 -0.839 . . . . 0.55000000000000004 111.252 -179.156 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 900' ' ' LEU . . . . . 0.483 ' N ' HD22 ' B' ' 900' ' ' LEU . 4.5 mm? -95.27 111.69 23.5 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 114.416 1.265 . . . . 1.5900000000000001 114.416 -175.07 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 15.7 m -65.67 141.13 58.48 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 107.468 -1.308 . . . . 0.050000000000000003 107.468 177.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -67.22 -66.7 2.25 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 110.541 -1.024 . . . . 0.029999999999999999 110.541 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 47.6 67.33 0.83 Allowed 'General case' 0 N--CA 1.507 2.388 0 O-C-N 121.47 -1.017 . . . . 3.2000000000000002 110.977 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 46.6 ptt85 -69.47 -6.99 34.09 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.638 -0.664 . . . . 2.9199999999999999 111.906 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 905' ' ' HIS . . . . . 0.484 ' O ' ' CB ' ' B' ' 906' ' ' GLU . 70.6 t60 -62.34 5.13 0.11 Allowed 'General case' 0 N--CA 1.507 2.382 0 O-C-N 120.915 -1.116 . . . . 2.8700000000000001 113.111 -179.118 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 906' ' ' GLU . . . . . 0.484 ' CB ' ' O ' ' B' ' 905' ' ' HIS . 0.6 OUTLIER 94.74 -164.31 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.432 0 CA-C-N 120.565 1.53 . . . . 0.98999999999999999 111.796 179.095 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 907' ' ' LYS . . . . . 0.467 ' CB ' ' O ' ' B' ' 906' ' ' GLU . 69.2 tttt 85.4 155.38 0.09 Allowed 'General case' 0 N--CA 1.519 2.985 0 N-CA-C 107.921 -1.14 . . . . 5.25 107.921 -176.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 60.1 t -123.27 115.34 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 120.716 -1.24 . . . . 0.39000000000000001 111.371 -179.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 909' ' ' GLU . . . . . 0.654 ' OE2' HD12 ' B' ' 966' ' ' LEU . 43.4 tp10 -97.16 135.59 38.89 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 107.014 -1.476 . . . . 1.72 107.014 176.534 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -154.95 123.85 6.2 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 106.966 -1.494 . . . . 0.67000000000000004 106.966 179.014 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 911' ' ' VAL . . . . . 0.66 HG22 HG13 ' B' ' 964' ' ' VAL . 87.2 t -80.71 130.91 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 C-N-CA 120.522 -0.471 . . . . 0.54000000000000004 110.934 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 86.2 mt -63.72 156.92 25.59 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.27 -0.894 . . . . 1.5 108.671 178.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 913' ' ' SER . . . . . 0.417 ' CB ' ' HB ' ' B' ' 919' ' ' VAL . 0.4 OUTLIER -128.77 130.58 47.23 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.251 -1.018 . . . . 1.3700000000000001 108.251 176.647 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 914' ' ' ARG . . . . . 0.854 ' NH1' HD23 ' B' ' 956' ' ' LEU . 0.0 OUTLIER -65.45 156.2 33.14 Favored 'General case' 0 N--CA 1.507 2.387 0 O-C-N 120.674 -1.266 . . . . 4.2999999999999998 111.796 -178.963 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 915' ' ' SER . . . . . 0.425 ' CB ' ' O ' ' B' ' 914' ' ' ARG . 4.2 t 83.3 -32.39 0.08 Allowed 'General case' 0 N--CA 1.522 3.148 0 C-N-CA 123.991 0.917 . . . . 2.0499999999999998 112.019 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 916' ' ' ASN . . . . . 0.817 ' HB2' HG21 ' B' ' 919' ' ' VAL . 82.5 m-20 -122.24 -21.23 5.93 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 120.87 -1.144 . . . . 2.71 111.328 -179.109 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 917' ' ' GLN . . . . . 0.402 ' HB2' ' O ' ' B' ' 916' ' ' ASN . 45.3 mt-30 66.77 164.34 0.19 Allowed 'General case' 0 N--CA 1.52 3.065 0 N-CA-C 105.76 -1.941 . . . . 2.6800000000000002 105.76 -174.167 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.52 -124.38 31.27 Favored Glycine 1 N--CA 1.522 4.368 0 CA-C-N 123.521 2.873 . . . . 0.029999999999999999 106.928 -177.675 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 919' ' ' VAL . . . . . 0.817 HG21 ' HB2' ' B' ' 916' ' ' ASN . 75.8 t 51.42 94.25 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 O-C-N 121.413 -1.051 . . . . 1.3899999999999999 109.15 -178.456 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 920' ' ' ALA . . . . . 0.562 ' HB3' HG12 ' B' ' 949' ' ' VAL . . . -93.02 92.07 7.66 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 119.327 -0.949 . . . . 0.029999999999999999 110.643 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 921' ' ' ARG . . . . . 0.851 ' HG3' HG23 ' B' ' 922' ' ' VAL . 29.3 ptt180 -85.03 -41.64 15.6 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 105.924 -1.88 . . . . 4.4199999999999999 105.924 176.399 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 922' ' ' VAL . . . . . 0.851 HG23 ' HG3' ' B' ' 921' ' ' ARG . 92.8 t -101.29 72.77 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 N-CA-C 106.052 -1.833 . . . . 0.84999999999999998 106.052 175.679 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -87.09 133.49 33.61 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.678 0.752 . . . . 2.46 111.376 -177.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 924' ' ' SER . . . . . 0.404 ' HB2' HD12 ' B' ' 900' ' ' LEU . 8.7 t -148.11 105.4 3.64 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.638 -0.875 . . . . 0.69999999999999996 108.638 179.281 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -102.55 84.36 0.48 Allowed Glycine 0 N--CA 1.487 2.091 0 N-CA-C 108.589 -1.804 . . . . 0.040000000000000001 108.589 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 926' ' ' GLY . . . . . 0.411 ' O ' ' HA ' ' B' ' 906' ' ' GLU . . . . . . . . 0 N--CA 1.489 2.205 0 N-CA-C 108.805 -1.718 . . . . 0.040000000000000001 108.805 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 69.8 m . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.05 0.453 . . . . 13.779999999999999 110.296 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 95.3 mt -108.24 130.19 55.17 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.494 -0.754 . . . . 13.76 110.295 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -152.01 168.53 31.28 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.429 -1.468 . . . . 9.1300000000000008 109.429 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 949' ' ' VAL . . . . . 0.562 HG12 ' HB3' ' B' ' 920' ' ' ALA . 34.2 m -118.27 130.41 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.606 -0.938 . . . . 7.0800000000000001 110.547 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 950' ' ' PHE . . . . . 0.441 ' CZ ' ' HB3' ' B' ' 921' ' ' ARG . 52.0 p90 -130.37 144.11 51.18 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.492 -0.755 . . . . 7.5899999999999999 109.447 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 31.9 m -121.77 -51.91 2.02 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.451 -0.781 . . . . 5.0300000000000002 111.92 -178.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 952' ' ' LEU . . . . . 0.796 HD11 HD23 ' A' ' 895' ' ' LEU . 45.3 tp -61.81 -76.06 0.06 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.512 -0.742 . . . . 1.01 112.385 -177.56 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 953' ' ' ILE . . . . . 0.469 ' O ' ' HB3' ' B' ' 954' ' ' LEU . 47.0 pt -53.53 -141.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.724 0 N-CA-C 113.992 1.108 . . . . 2.6000000000000001 113.992 -176.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 954' ' ' LEU . . . . . 0.742 HD22 ' O ' ' B' ' 954' ' ' LEU . 0.0 OUTLIER 174.08 75.05 0.05 OUTLIER Pre-proline 0 N--CA 1.507 2.391 0 O-C-N 120.786 -1.196 . . . . 0.050000000000000003 110.906 179.754 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 955' ' ' PRO . . . . . 0.557 ' C ' HD12 ' B' ' 956' ' ' LEU . 45.3 Cg_endo -73.07 93.93 0.81 Allowed 'Trans proline' 0 C--N 1.315 -1.212 0 N-CA-C 109.185 -1.121 . . . . 0.83999999999999997 109.185 178.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 956' ' ' LEU . . . . . 0.854 HD23 ' NH1' ' B' ' 914' ' ' ARG . 5.0 mp -126.32 140.39 52.55 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.242 -0.911 . . . . 0.040000000000000001 110.602 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -79.68 153.02 29.61 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 117.964 -1.017 . . . . 1.28 111.097 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -67.54 121.1 15.11 Favored 'General case' 0 N--CA 1.51 2.564 0 CA-C-N 122.563 2.438 . . . . 0.17000000000000001 111.838 -179.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 94.38 -19.01 55.79 Favored Glycine 0 N--CA 1.501 3.017 0 N-CA-C 111.132 -0.787 . . . . 0.040000000000000001 111.132 178.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 960' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -52.21 167.67 0.12 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.412 -1.052 . . . . 0.040000000000000001 111.027 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 961' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' B' ' 886' ' ' PHE . 57.3 m -135.73 135.93 40.41 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 120.966 -1.084 . . . . 1.78 111.614 -178.667 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 962' ' ' VAL . . . . . 0.885 HG22 ' HB3' ' B' ' 886' ' ' PHE . 33.9 m -100.64 145.15 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 121.606 -0.684 . . . . 0.040000000000000001 111.13 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 1.8 m -138.39 148.01 44.03 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.816 -0.553 . . . . 0.71999999999999997 109.938 -178.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 964' ' ' VAL . . . . . 0.66 HG13 HG22 ' B' ' 911' ' ' VAL . 61.8 t -99.66 137.69 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.118 -0.989 . . . . 1.05 110.623 -179.23 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -91.58 128.57 37.46 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 104.202 -2.518 . . . . 3.02 104.202 173.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 966' ' ' LEU . . . . . 0.654 HD12 ' OE2' ' B' ' 909' ' ' GLU . 0.4 OUTLIER -131.2 59.84 1.67 Allowed 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.305 -0.998 . . . . 1.46 108.305 177.162 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 967' ' ' VAL . . . . . 0.49 HG23 ' C ' ' B' ' 966' ' ' LEU . 90.1 t -158.76 96.97 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 108.104 -1.072 . . . . 1.9399999999999999 108.104 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 80.2 mmm -143.64 59.24 1.38 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.733 -1.229 . . . . 0.0 108.519 178.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.4 119.63 1.93 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 107.318 -2.313 . . . . 2.1099999999999999 107.318 -178.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -81.96 -59.05 2.71 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.095 -1.239 . . . . 5.8899999999999997 110.376 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 47.6 tp -59.14 90.49 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.423 -0.798 . . . . 4.3600000000000003 110.224 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -141.67 -154.51 0.52 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.536 -0.727 . . . . 1.8300000000000001 110.296 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -120.36 172.73 7.6 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.428 -0.795 . . . . 4.3499999999999996 110.315 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 30.3 t -101.47 130.32 47.69 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.517 -0.739 . . . . 1.27 109.983 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -155.68 158.99 39.17 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.457 -0.777 . . . . 5.0199999999999996 110.486 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.99 85.96 18.57 Favored Pre-proline 0 N--CA 1.5 2.048 0 O-C-N 121.607 -0.683 . . . . 2.4100000000000001 109.673 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -73.17 -173.15 1.18 Allowed 'Trans proline' 0 C--N 1.318 -1.078 0 O-C-N 123.286 1.151 . . . . 0.95999999999999996 111.319 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 978' ' ' LEU . . . . . 0.582 HD23 HD12 ' B' ' 856' ' ' LEU . 4.9 mp -128.34 154.15 46.27 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 107.565 -1.272 . . . . 0.62 107.565 177.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 979' ' ' THR . . . . . 0.469 HG23 ' C ' ' B' ' 978' ' ' LEU . 41.6 p -150.17 141.46 23.22 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.788 -1.195 . . . . 3.5699999999999998 111.214 -179.303 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 980' ' ' ILE . . . . . 0.745 ' HB ' HG21 ' B' ' 899' ' ' VAL . 49.4 mm -106.78 128.41 61.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 108.951 -0.759 . . . . 1.3300000000000001 108.951 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -118.82 96.2 5.16 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.488 -0.758 . . . . 0.050000000000000003 111.852 -178.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 78.7 p -108.6 158.01 17.97 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.557 -0.714 . . . . 0.87 109.159 178.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 983' ' ' GLY . . . . . 0.403 ' HA3' ' CE1' ' B' ' 852' ' ' PHE . . . -176.78 108.16 0.25 Allowed Glycine 0 N--CA 1.498 2.783 0 N-CA-C 106.529 -2.628 . . . . 0.029999999999999999 106.529 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 984' ' ' ALA . . . . . 0.433 ' HB1' ' NH1' ' C' ' 893' ' ' ARG . . . -108.37 152.37 24.76 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 114.627 1.343 . . . . 0.69999999999999996 114.627 -175.459 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 985' ' ' LEU . . . . . 0.957 HD13 HD22 ' B' ' 890' ' ' LEU . 36.4 tp -72.25 135.36 46.01 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.926 -1.109 . . . . 0.040000000000000001 109.94 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 986' ' ' LEU . . . . . 0.476 ' CD1' HD11 ' C' ' 986' ' ' LEU . 51.4 tp -106.21 -59.67 1.75 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.655 -0.653 . . . . 0.040000000000000001 109.914 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -143.13 146.52 33.82 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 107.597 -1.26 . . . . 0.040000000000000001 107.597 178.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.03 163.26 12.21 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 108.278 -1.929 . . . . 0.040000000000000001 108.278 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -74.21 112.65 17.86 Favored Pre-proline 0 N--CA 1.498 1.944 0 O-C-N 121.173 -1.193 . . . . 0.040000000000000001 109.415 179.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 990' ' ' PRO . . . . . 0.421 ' O ' ' HB2' ' B' ' 991' ' ' GLU . 50.3 Cg_endo -89.32 71.06 2.02 Favored 'Trans proline' 0 C--N 1.319 -1.015 0 O-C-N 123.067 1.035 . . . . 0.45000000000000001 111.461 -178.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 991' ' ' GLU . . . . . 0.421 ' HB2' ' O ' ' B' ' 990' ' ' PRO . 70.8 mt-10 67.14 -73.94 0.07 Allowed 'General case' 0 N--CA 1.502 2.164 0 N-CA-C 108.581 -0.896 . . . . 1.97 108.581 -177.514 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 992' ' ' LEU . . . . . 0.463 HD23 ' HA ' ' B' ' 992' ' ' LEU . 11.5 mt 51.27 20.48 0.94 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.586 -0.697 . . . . 2.3799999999999999 111.621 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -92.53 156.91 16.83 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.912 -1.118 . . . . 3.79 110.019 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 70.7 m80 -147.15 91.73 2.03 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.549 -0.719 . . . . 3.5099999999999998 110.359 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 995' ' ' ALA . . . . . . . . . . . . 2.518 . . . . . . . 0 N--CA 1.503 2.19 0 O-C-N 120.899 -1.125 . . . . 2.73 110.622 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo . . . . . 0 N--CA 1.488 1.158 0 N-CA-C 109.516 -0.994 . . . . 3.8300000000000001 109.516 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' 847' ' ' VAL . . . . . 0.526 HG12 ' HB2' ' C' ' 849' ' ' GLN . 60.3 t -126.11 105.48 25.41 Favored Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 121.639 -0.663 . . . . 1.8300000000000001 110.103 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 848' ' ' PRO . . . . . 0.878 ' O ' HG23 ' C' ' 850' ' ' VAL . 43.8 Cg_endo -69.61 -23.56 31.36 Favored 'Trans proline' 0 N--CA 1.487 1.113 0 O-C-N 123.219 1.115 . . . . 0.65000000000000002 110.949 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 849' ' ' GLN . . . . . 0.526 ' HB2' HG12 ' C' ' 847' ' ' VAL . 55.5 tt0 25.4 66.38 0.05 Allowed 'General case' 0 N--CA 1.518 2.944 0 N-CA-C 113.419 0.896 . . . . 2.5800000000000001 113.419 179.006 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 850' ' ' VAL . . . . . 0.878 HG23 ' O ' ' C' ' 848' ' ' PRO . 77.7 t -120.0 135.74 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 121.113 -0.992 . . . . 1.0900000000000001 111.183 -179.341 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 851' ' ' ALA . . . . . 0.588 ' HB3' ' HG ' ' C' ' 873' ' ' LEU . . . -128.17 155.45 44.46 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 105.914 -1.884 . . . . 0.040000000000000001 105.914 176.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 852' ' ' PHE . . . . . 0.456 ' CD1' ' N ' ' C' ' 852' ' ' PHE . 15.2 p90 -160.42 127.03 4.22 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 120.973 1.715 . . . . 0.050000000000000003 108.631 179.024 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 6.3 t -177.28 134.28 0.18 Allowed 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.162 -1.051 . . . . 0.040000000000000001 108.162 -179.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -130.39 158.14 40.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.087 -1.008 . . . . 0.67000000000000004 109.685 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 855' ' ' ALA . . . . . 0.771 ' HB3' ' CB ' ' C' ' 870' ' ' ARG . . . -121.39 140.71 51.77 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.818 0.818 . . . . 0.51000000000000001 111.061 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 856' ' ' LEU . . . . . 0.937 HD11 HD23 ' C' ' 858' ' ' LEU . 3.5 tm? -113.23 135.74 53.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.612 -0.68 . . . . 0.050000000000000003 110.084 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 857' ' ' SER . . . . . 0.584 ' N ' HD13 ' C' ' 856' ' ' LEU . 0.6 OUTLIER -153.35 18.64 0.55 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.502 -0.749 . . . . 1.3300000000000001 110.919 179.581 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 858' ' ' LEU . . . . . 0.937 HD23 HD11 ' C' ' 856' ' ' LEU . 2.7 pp -34.7 159.65 0.04 OUTLIER Pre-proline 0 N--CA 1.516 2.856 0 N-CA-C 113.008 0.744 . . . . 2.3300000000000001 113.008 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -63.04 -88.39 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.399 0 O-C-N 123.078 1.041 . . . . 2.3199999999999998 113.257 -178.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 54.7 ptt85 -133.18 -142.0 0.2 Allowed 'General case' 0 N--CA 1.499 2.01 0 O-C-N 120.854 -1.154 . . . . 0.040000000000000001 111.422 -177.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 58.2 m -36.68 123.92 0.83 Allowed 'General case' 0 N--CA 1.511 2.586 0 O-C-N 121.609 -0.682 . . . . 1.3100000000000001 112.538 -178.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -104.04 160.24 26.71 Favored Pre-proline 0 N--CA 1.489 1.496 0 N-CA-C 108.052 -1.092 . . . . 4.5099999999999998 108.052 177.283 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -69.12 -14.41 38.06 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 123.185 1.097 . . . . 2.2400000000000002 111.404 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -177.25 -136.58 2.48 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 110.107 -1.197 . . . . 0.040000000000000001 110.107 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 32.7 m -65.23 156.89 30.43 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.366 -1.079 . . . . 1.51 110.746 -178.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 866' ' ' VAL . . . . . 0.431 HG13 ' CD2' ' C' ' 858' ' ' LEU . 64.5 t -96.58 134.61 23.09 Favored Pre-proline 0 N--CA 1.494 1.73 0 N-CA-C 113.136 0.791 . . . . 0.78000000000000003 113.136 -175.141 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 867' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' C' ' 866' ' ' VAL . 55.3 Cg_endo -90.36 -149.13 0.03 OUTLIER 'Trans proline' 0 CA--C 1.544 1.022 0 O-C-N 123.577 1.304 . . . . 0.92000000000000004 108.837 177.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 868' ' ' PHE . . . . . 0.472 ' CD1' ' N ' ' C' ' 868' ' ' PHE . 13.8 p90 -150.0 123.65 9.17 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.53 -1.356 . . . . 0.050000000000000003 109.861 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 46.5 p-10 -113.82 -2.48 13.65 Favored 'General case' 0 N--CA 1.499 2.003 0 C-N-CA 119.185 -1.006 . . . . 1.7 112.892 -178.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 870' ' ' ARG . . . . . 0.771 ' CB ' ' HB3' ' C' ' 855' ' ' ALA . 29.9 mmm180 -91.22 88.66 7.0 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.912 -1.117 . . . . 2.5899999999999999 110.998 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 57.3 t -72.21 97.48 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 120.94 -1.1 . . . . 1.9399999999999999 109.695 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 872' ' ' LEU . . . . . 0.645 HD11 ' HB2' ' C' ' 855' ' ' ALA . 96.3 mt -86.22 -46.04 10.74 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.611 -0.681 . . . . 1.0600000000000001 110.648 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 873' ' ' LEU . . . . . 0.588 ' HG ' ' HB3' ' C' ' 851' ' ' ALA . 35.8 tp -173.61 102.27 0.12 Allowed 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.262 -0.899 . . . . 4.1799999999999997 108.702 178.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 874' ' ' ASN . . . . . 0.437 ' CB ' ' HA ' ' C' ' 852' ' ' PHE . 36.3 t-20 177.7 82.68 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.26 0 N-CA-C 109.035 -0.728 . . . . 0.040000000000000001 109.035 -178.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -64.39 -46.15 84.54 Favored 'General case' 0 N--CA 1.497 1.916 0 C-N-CA 119.265 -0.974 . . . . 3.3799999999999999 111.171 -179.079 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 876' ' ' GLY . . . . . 0.422 ' HA3' ' CE2' ' C' ' 878' ' ' TYR . . . -73.8 -26.47 69.2 Favored Glycine 0 N--CA 1.494 2.519 0 C-N-CA 120.461 -0.876 . . . . 0.040000000000000001 111.977 -178.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 79.49 -63.94 3.89 Favored Glycine 0 N--CA 1.502 3.098 0 N-CA-C 107.868 -2.093 . . . . 0.040000000000000001 107.868 -178.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 878' ' ' TYR . . . . . 0.422 ' CE2' ' HA3' ' C' ' 876' ' ' GLY . 76.5 m-85 60.39 -63.92 0.06 Allowed 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 114.825 1.417 . . . . 3.46 114.825 177.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 879' ' ' TYR . . . . . 0.494 ' CE2' ' CD1' ' C' ' 981' ' ' PHE . 28.8 p90 -108.53 108.29 19.15 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 115.342 1.608 . . . . 0.040000000000000001 115.342 -175.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -70.69 117.55 56.63 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 121.758 -0.589 . . . . 0.02 110.191 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 881' ' ' PRO . . . . . 0.453 ' CG ' ' CD1' ' C' ' 868' ' ' PHE . 55.3 Cg_endo -76.83 1.97 8.01 Favored 'Trans proline' 0 N--CA 1.492 1.402 0 O-C-N 123.452 1.238 . . . . 0.39000000000000001 112.298 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -74.66 -65.02 0.91 Allowed 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 106.359 -1.719 . . . . 0.81000000000000005 106.359 178.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 6.0 p -96.45 -16.3 21.26 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.804 -0.813 . . . . 0.040000000000000001 108.804 177.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.54 23.02 52.25 Favored Glycine 0 N--CA 1.493 2.499 0 O-C-N 120.991 -1.068 . . . . 0.029999999999999999 110.692 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 95.2 t -73.38 87.5 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 C-N-CA 118.299 -1.36 . . . . 1.01 107.775 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 886' ' ' PHE . . . . . 0.846 ' HB3' HG22 ' C' ' 962' ' ' VAL . 0.7 OUTLIER -87.95 108.83 19.39 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-N 115.132 -0.94 . . . . 0.050000000000000003 111.569 -177.587 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 887' ' ' THR . . . . . 0.423 ' O ' ' HD3' ' C' ' 889' ' ' PRO . 97.3 m -105.75 99.62 9.21 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 107.596 -1.261 . . . . 0.68000000000000005 107.596 177.541 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 888' ' ' ALA . . . . . . . . . . . . . . . -98.89 101.56 12.54 Favored Pre-proline 0 N--CA 1.501 2.089 0 N-CA-C 114.523 1.305 . . . . 0.25 114.523 -176.112 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 889' ' ' PRO . . . . . 0.423 ' HD3' ' O ' ' C' ' 887' ' ' THR . 55.5 Cg_endo -79.83 -15.03 12.2 Favored 'Trans proline' 0 N--CA 1.486 1.048 0 N-CA-C 108.786 -1.275 . . . . 1.6399999999999999 108.786 175.491 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 890' ' ' LEU . . . . . 0.763 HD21 HG11 ' C' ' 850' ' ' VAL . 66.1 mt -37.77 -49.15 1.15 Allowed 'General case' 0 N--CA 1.508 2.438 0 N-CA-C 113.463 0.912 . . . . 2.29 113.463 -177.48 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 52.66 97.73 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.193 -0.942 . . . . 0.63 110.451 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . 158.86 -154.5 25.59 Favored Glycine 0 N--CA 1.477 1.407 0 N-CA-C 107.29 -2.324 . . . . 0.040000000000000001 107.29 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 893' ' ' ARG . . . . . 0.463 ' HG3' HD11 ' C' ' 954' ' ' LEU . 77.7 ttt-85 -116.28 123.94 48.94 Favored 'General case' 0 C--N 1.294 -1.825 0 O-C-N 121.671 -0.9 . . . . 3.0 108.589 177.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 894' ' ' TYR . . . . . 0.868 ' CE2' HD23 ' C' ' 954' ' ' LEU . 12.9 p90 -132.07 154.04 49.82 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.079 -1.013 . . . . 0.040000000000000001 110.954 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 895' ' ' LEU . . . . . . . . . . . . . 45.0 tp -99.65 113.78 26.44 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.706 -0.621 . . . . 1.27 109.796 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 896' ' ' LEU . . . . . 0.576 HD11 ' CE1' ' C' ' 981' ' ' PHE . 8.4 tt -118.01 145.08 45.02 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.678 -0.639 . . . . 0.93999999999999995 109.985 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 897' ' ' SER . . . . . . . . . . . . . 62.4 m -141.24 124.15 16.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.445 -0.784 . . . . 0.040000000000000001 111.184 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -100.78 148.42 24.94 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.73 -0.841 . . . . 0.47999999999999998 108.73 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 899' ' ' VAL . . . . . 0.691 HG21 ' HB ' ' C' ' 980' ' ' ILE . 96.7 t -92.33 120.53 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.369 -0.832 . . . . 0.55000000000000004 111.079 -179.137 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 91.4 mt -92.65 113.08 25.26 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 113.99 1.107 . . . . 1.5900000000000001 113.99 -175.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 16.7 m -62.54 141.28 58.51 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 107.545 -1.28 . . . . 0.050000000000000003 107.545 177.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -60.68 -65.23 3.47 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 110.362 -1.095 . . . . 0.029999999999999999 110.362 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 1.6 m80 46.23 65.11 1.26 Allowed 'General case' 0 N--CA 1.507 2.4 0 O-C-N 121.485 -1.009 . . . . 3.2000000000000002 111.095 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 42.4 ptt85 -66.72 -8.19 26.24 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.639 -0.663 . . . . 2.9199999999999999 111.971 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 905' ' ' HIS . . . . . 0.473 ' O ' ' CB ' ' C' ' 906' ' ' GLU . 61.0 t60 -63.67 5.32 0.21 Allowed 'General case' 0 N--CA 1.504 2.229 0 O-C-N 120.946 -1.096 . . . . 2.8700000000000001 112.624 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 906' ' ' GLU . . . . . 0.5 ' O ' ' CB ' ' C' ' 907' ' ' LYS . 2.8 mt-10 89.21 -152.96 0.01 OUTLIER 'General case' 0 N--CA 1.526 3.362 0 CA-C-N 121.215 1.825 . . . . 0.98999999999999999 111.59 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 907' ' ' LYS . . . . . 0.5 ' CB ' ' O ' ' C' ' 906' ' ' GLU . 62.2 tttt 90.19 163.85 0.05 OUTLIER 'General case' 0 N--CA 1.523 3.179 0 N-CA-C 107.925 -1.139 . . . . 5.25 107.925 -176.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 58.4 t -123.33 114.34 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 120.84 -1.162 . . . . 0.39000000000000001 110.843 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 909' ' ' GLU . . . . . 0.573 ' OE2' HD12 ' C' ' 966' ' ' LEU . 44.3 tp10 -108.68 130.71 55.34 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 107.559 -1.275 . . . . 1.72 107.559 177.092 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -157.54 121.16 4.1 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 107.098 -1.445 . . . . 0.67000000000000004 107.098 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 911' ' ' VAL . . . . . 0.506 ' HA ' ' HA ' ' C' ' 964' ' ' VAL . 14.0 p -80.94 131.02 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 C-N-CA 120.35 -0.54 . . . . 0.54000000000000004 111.654 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 62.4 mt -67.43 157.94 32.97 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.359 -0.838 . . . . 1.5 109.036 178.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 913' ' ' SER . . . . . 0.478 ' OG ' HG11 ' C' ' 919' ' ' VAL . 1.5 p -126.07 138.87 53.74 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.568 -0.901 . . . . 1.3700000000000001 108.568 176.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 914' ' ' ARG . . . . . 0.723 ' CZ ' HD23 ' C' ' 956' ' ' LEU . 0.0 OUTLIER -64.16 153.46 37.74 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 120.638 -1.289 . . . . 4.2999999999999998 111.607 -179.152 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 915' ' ' SER . . . . . 0.424 ' CB ' ' O ' ' C' ' 914' ' ' ARG . 0.2 OUTLIER 82.83 -30.37 0.09 Allowed 'General case' 0 N--CA 1.522 3.147 0 C-N-CA 123.766 0.826 . . . . 2.0499999999999998 112.457 179.575 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 916' ' ' ASN . . . . . 0.768 ' HB2' HG21 ' C' ' 919' ' ' VAL . 98.7 m-20 -122.17 -22.1 5.71 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.804 -1.185 . . . . 2.71 111.268 -179.158 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 67.09 166.52 0.22 Allowed 'General case' 0 N--CA 1.52 3.042 0 N-CA-C 105.792 -1.929 . . . . 2.6800000000000002 105.792 -174.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.58 -125.67 35.26 Favored Glycine 1 N--CA 1.522 4.384 0 CA-C-N 123.539 2.882 . . . . 0.029999999999999999 107.087 -177.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 919' ' ' VAL . . . . . 0.768 HG21 ' HB2' ' C' ' 916' ' ' ASN . 92.4 t 51.01 94.02 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.238 0 O-C-N 121.452 -1.028 . . . . 1.3899999999999999 109.234 -178.261 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 920' ' ' ALA . . . . . 0.951 ' HB3' HG12 ' C' ' 949' ' ' VAL . . . -94.06 94.32 8.34 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.395 -0.922 . . . . 0.029999999999999999 110.735 -179.323 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 921' ' ' ARG . . . . . 0.698 ' HG3' HG23 ' C' ' 922' ' ' VAL . 45.2 ptt85 -79.14 -42.1 27.0 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 105.591 -2.003 . . . . 4.4199999999999999 105.591 176.049 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 922' ' ' VAL . . . . . 0.698 HG23 ' HG3' ' C' ' 921' ' ' ARG . 73.9 t -99.7 78.68 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 N-CA-C 105.441 -2.059 . . . . 0.84999999999999998 105.441 174.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -89.92 136.28 33.13 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 122.047 0.927 . . . . 2.46 112.775 -176.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 6.3 t -147.21 103.05 3.55 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 107.576 -1.268 . . . . 0.69999999999999996 107.576 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -107.71 82.27 0.31 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.656 -1.378 . . . . 0.040000000000000001 109.656 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 109.187 -1.565 . . . . 0.040000000000000001 109.187 179.747 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 17.7 m . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 120.937 0.398 . . . . 13.779999999999999 110.377 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 95.3 mt -114.66 131.36 56.75 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.472 -0.767 . . . . 13.76 110.321 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -151.7 170.13 31.17 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.433 -1.467 . . . . 9.1300000000000008 109.433 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 949' ' ' VAL . . . . . 0.951 HG12 ' HB3' ' C' ' 920' ' ' ALA . 26.9 m -117.44 136.26 55.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.488 -1.007 . . . . 7.0800000000000001 111.043 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 950' ' ' PHE . . . . . 0.447 ' CZ ' ' HB3' ' C' ' 921' ' ' ARG . 40.4 p90 -133.36 150.22 51.84 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.561 -0.712 . . . . 7.5899999999999999 109.336 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 68.4 m -118.07 -57.64 2.07 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.399 -0.813 . . . . 5.0300000000000002 111.81 -178.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 952' ' ' LEU . . . . . 0.454 ' O ' ' O ' ' C' ' 953' ' ' ILE . 46.4 tp -62.34 -75.69 0.07 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.423 -0.798 . . . . 1.01 111.505 -178.267 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 953' ' ' ILE . . . . . 0.57 HD12 ' N ' ' C' ' 954' ' ' LEU . 2.8 pp -49.41 -151.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.694 0 N-CA-C 114.563 1.32 . . . . 2.6000000000000001 114.563 -176.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 954' ' ' LEU . . . . . 0.868 HD23 ' CE2' ' C' ' 894' ' ' TYR . 0.0 OUTLIER 171.22 90.39 0.04 OUTLIER Pre-proline 0 N--CA 1.515 2.807 0 O-C-N 120.659 -1.276 . . . . 0.050000000000000003 111.941 -179.289 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 955' ' ' PRO . . . . . 0.629 ' C ' HD12 ' C' ' 956' ' ' LEU . 52.8 Cg_endo -83.0 92.37 0.9 Allowed 'Trans proline' 0 C--N 1.317 -1.113 0 N-CA-C 109.502 -0.999 . . . . 0.83999999999999997 109.502 178.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 956' ' ' LEU . . . . . 0.811 HD22 ' OH ' ' C' ' 894' ' ' TYR . 6.2 mp -125.11 147.86 48.82 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.066 -1.021 . . . . 0.040000000000000001 110.521 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -82.71 150.93 26.44 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 117.661 -1.162 . . . . 1.28 111.341 -178.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -64.65 118.11 8.41 Favored 'General case' 0 N--CA 1.506 2.365 0 CA-C-N 123.221 2.737 . . . . 0.17000000000000001 110.662 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.25 -18.56 53.89 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 110.903 -0.879 . . . . 0.040000000000000001 110.903 179.102 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 960' ' ' ASP . . . . . 0.418 ' HB3' ' NE ' ' C' ' 914' ' ' ARG . 0.4 OUTLIER -54.41 171.18 0.12 Allowed 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.265 -1.138 . . . . 0.040000000000000001 110.253 -179.55 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 961' ' ' THR . . . . . 0.543 HG23 ' O ' ' C' ' 886' ' ' PHE . 40.7 m -137.71 141.07 41.05 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.95 -1.094 . . . . 1.78 112.844 -177.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 962' ' ' VAL . . . . . 0.846 HG22 ' HB3' ' C' ' 886' ' ' PHE . 27.3 m -100.44 145.45 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.88 -0.512 . . . . 0.040000000000000001 110.666 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 5.3 t -138.01 144.14 40.94 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.715 -0.616 . . . . 0.71999999999999997 110.153 -178.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 964' ' ' VAL . . . . . 0.506 ' HA ' ' HA ' ' C' ' 911' ' ' VAL . 58.9 t -91.45 137.29 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.185 -0.947 . . . . 1.05 110.803 -179.02 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -92.83 125.64 37.53 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 103.441 -2.8 . . . . 3.02 103.441 173.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 966' ' ' LEU . . . . . 0.573 HD12 ' OE2' ' C' ' 909' ' ' GLU . 0.2 OUTLIER -134.53 56.81 1.83 Allowed 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.578 -0.897 . . . . 1.46 108.578 177.503 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 967' ' ' VAL . . . . . 0.488 HG23 ' C ' ' C' ' 966' ' ' LEU . 97.9 t -158.22 95.93 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.248 -1.019 . . . . 1.9399999999999999 108.248 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 92.8 mmm -142.87 59.28 1.43 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.724 -1.235 . . . . 0.0 108.462 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 134.35 119.62 1.98 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 107.282 -2.327 . . . . 2.1099999999999999 107.282 -178.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -82.56 -58.26 2.99 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.004 -1.291 . . . . 5.8899999999999997 110.531 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 48.1 tp -59.14 89.69 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.397 -0.814 . . . . 4.3600000000000003 110.313 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -142.71 -152.08 0.39 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.559 -0.713 . . . . 1.8300000000000001 109.97 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -115.93 166.99 11.35 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.391 -0.818 . . . . 4.3499999999999996 109.842 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 9.8 t -101.61 129.83 47.81 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.52 -0.738 . . . . 1.27 110.079 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -156.45 157.5 35.62 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.528 -0.732 . . . . 5.0199999999999996 110.553 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -143.22 85.91 9.4 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.658 -0.651 . . . . 2.4100000000000001 109.796 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -74.77 -169.86 0.68 Allowed 'Trans proline' 0 C--N 1.318 -1.045 0 O-C-N 123.189 1.099 . . . . 0.95999999999999996 111.325 -179.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 978' ' ' LEU . . . . . 0.514 ' N ' HD12 ' C' ' 978' ' ' LEU . 5.1 mp -125.86 155.9 40.46 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.474 -1.306 . . . . 0.62 107.474 177.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 979' ' ' THR . . . . . 0.46 HG23 ' C ' ' C' ' 978' ' ' LEU . 42.8 p -149.88 142.96 24.98 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.759 -1.213 . . . . 3.5699999999999998 111.334 -179.098 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 980' ' ' ILE . . . . . 0.691 ' HB ' HG21 ' C' ' 899' ' ' VAL . 50.0 mm -105.41 127.88 59.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 108.837 -0.801 . . . . 1.3300000000000001 108.837 179.335 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 981' ' ' PHE . . . . . 0.576 ' CE1' HD11 ' C' ' 896' ' ' LEU . 5.2 t80 -117.9 96.05 5.18 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.311 -0.868 . . . . 0.050000000000000003 111.579 -178.453 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 982' ' ' SER . . . . . . . . . . . . . 51.3 p -106.3 158.78 16.61 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 109.066 -0.716 . . . . 0.87 109.066 178.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 983' ' ' GLY . . . . . 0.418 ' HA3' ' CE2' ' C' ' 852' ' ' PHE . . . -171.81 113.18 0.48 Allowed Glycine 0 N--CA 1.496 2.662 0 N-CA-C 106.624 -2.59 . . . . 0.029999999999999999 106.624 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 984' ' ' ALA . . . . . 0.405 ' CB ' ' CZ ' ' A' ' 893' ' ' ARG . . . -108.75 152.01 25.43 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 114.323 1.231 . . . . 0.69999999999999996 114.323 -175.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 985' ' ' LEU . . . . . 0.47 HD13 HD22 ' C' ' 890' ' ' LEU . 55.6 tp -75.89 136.14 40.13 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.848 -1.157 . . . . 0.040000000000000001 109.832 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 986' ' ' LEU . . . . . 0.476 HD11 ' CD1' ' B' ' 986' ' ' LEU . 51.4 tp -106.35 -62.82 1.34 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.573 -0.704 . . . . 0.040000000000000001 110.302 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -144.92 147.15 32.41 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 107.816 -1.179 . . . . 0.040000000000000001 107.816 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -111.86 162.74 12.33 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 108.071 -2.011 . . . . 0.040000000000000001 108.071 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -72.46 112.96 16.91 Favored Pre-proline 0 N--CA 1.498 1.935 0 O-C-N 121.207 -1.173 . . . . 0.040000000000000001 109.531 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 990' ' ' PRO . . . . . 0.455 ' HD2' HD12 ' C' ' 992' ' ' LEU . 50.6 Cg_endo -87.66 70.13 3.31 Favored 'Trans proline' 0 C--N 1.319 -0.975 0 O-C-N 123.127 1.067 . . . . 0.45000000000000001 111.356 -178.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 991' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' C' ' 990' ' ' PRO . 71.4 mt-10 67.12 -74.11 0.07 Allowed 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 108.617 -0.883 . . . . 1.97 108.617 -177.512 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 992' ' ' LEU . . . . . 0.455 HD12 ' HD2' ' C' ' 990' ' ' PRO . 11.5 mt 50.55 21.03 0.79 Allowed 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.606 -0.684 . . . . 2.3799999999999999 111.646 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -92.54 156.77 16.91 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.89 -1.131 . . . . 3.79 110.038 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 68.6 m80 -146.56 91.84 2.09 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.52 -0.738 . . . . 3.5099999999999998 110.281 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 995' ' ' ALA . . . . . . . . . . . . 2.518 . . . . . . . 0 N--CA 1.504 2.248 0 O-C-N 120.95 -1.094 . . . . 2.73 110.589 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo . . . . . 0 N--CA 1.488 1.153 0 N-CA-C 109.581 -0.969 . . . . 3.8300000000000001 109.581 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 847' ' ' VAL . . . . . 0.432 HG12 ' HB2' ' A' ' 849' ' ' GLN . 61.4 t -132.03 103.56 14.19 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.636 -0.665 . . . . 1.8300000000000001 110.0 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 848' ' ' PRO . . . . . 0.722 ' O ' HG23 ' A' ' 850' ' ' VAL . 44.1 Cg_endo -69.5 -20.08 36.52 Favored 'Trans proline' 0 N--CA 1.487 1.117 0 O-C-N 123.271 1.142 . . . . 0.65000000000000002 111.139 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 849' ' ' GLN . . . . . 0.432 ' HB2' HG12 ' A' ' 847' ' ' VAL . 55.7 tt0 27.03 68.2 0.06 Allowed 'General case' 0 N--CA 1.518 2.957 0 N-CA-C 112.919 0.711 . . . . 2.5800000000000001 112.919 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 850' ' ' VAL . . . . . 0.722 HG23 ' O ' ' A' ' 848' ' ' PRO . 59.6 t -117.76 136.72 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.184 -0.948 . . . . 1.0900000000000001 111.459 -178.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 851' ' ' ALA . . . . . 0.534 ' HB3' ' HG ' ' A' ' 873' ' ' LEU . . . -125.83 156.65 39.22 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 105.783 -1.932 . . . . 0.040000000000000001 105.783 176.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 852' ' ' PHE . . . . . 0.468 ' CE2' HD11 ' A' ' 890' ' ' LEU . 24.2 p90 -160.34 128.61 4.7 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 121.014 1.734 . . . . 0.050000000000000003 108.732 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 853' ' ' SER . . . . . 0.401 ' CB ' ' HA ' ' A' ' 982' ' ' SER . 29.7 t -174.96 134.98 0.35 Allowed 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.053 -1.091 . . . . 0.040000000000000001 108.053 -178.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -132.83 156.48 47.07 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.99 -1.069 . . . . 0.67000000000000004 109.497 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 855' ' ' ALA . . . . . 0.744 ' HB3' ' CB ' ' A' ' 870' ' ' ARG . . . -122.73 144.61 49.05 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.787 0.803 . . . . 0.51000000000000001 111.65 -178.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 856' ' ' LEU . . . . . 0.692 ' CD1' HD23 ' A' ' 978' ' ' LEU . 3.4 tm? -112.05 134.33 53.66 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.787 -0.571 . . . . 0.050000000000000003 110.112 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 857' ' ' SER . . . . . 0.54 ' N ' HD13 ' A' ' 856' ' ' LEU . 55.8 p -150.63 16.7 0.79 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.531 -0.731 . . . . 1.3300000000000001 110.502 178.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 858' ' ' LEU . . . . . 0.762 HD22 ' OE2' ' A' ' 862' ' ' GLU . 4.4 pp -32.94 158.26 0.03 OUTLIER Pre-proline 0 N--CA 1.517 2.924 0 N-CA-C 113.432 0.901 . . . . 2.3300000000000001 113.432 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -64.41 -88.48 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.451 0 O-C-N 123.171 1.09 . . . . 2.3199999999999998 113.075 -178.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 55.8 ptt85 -128.7 -143.37 0.27 Allowed 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.817 -1.177 . . . . 0.040000000000000001 111.691 -177.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 19.4 m -40.4 128.16 2.38 Favored 'General case' 0 N--CA 1.508 2.468 0 O-C-N 121.43 -0.794 . . . . 1.3100000000000001 112.38 -178.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 862' ' ' GLU . . . . . 0.762 ' OE2' HD22 ' A' ' 858' ' ' LEU . 0.9 OUTLIER -102.69 156.74 34.9 Favored Pre-proline 0 N--CA 1.489 1.496 0 N-CA-C 107.8 -1.185 . . . . 4.5099999999999998 107.8 177.236 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 863' ' ' PRO . . . . . 0.412 ' HD2' ' CG ' ' A' ' 862' ' ' GLU . 43.6 Cg_endo -70.03 -12.71 32.9 Favored 'Trans proline' 0 C--N 1.314 -1.288 0 O-C-N 123.032 1.017 . . . . 2.2400000000000002 111.363 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -175.74 -136.38 2.32 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.972 -1.251 . . . . 0.040000000000000001 109.972 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 27.8 m -66.43 156.88 33.43 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.32 -1.106 . . . . 1.51 110.944 -178.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 866' ' ' VAL . . . . . 0.703 HG22 ' OE1' ' A' ' 862' ' ' GLU . 48.4 t -93.15 134.61 26.85 Favored Pre-proline 0 N--CA 1.495 1.8 0 N-CA-C 113.273 0.842 . . . . 0.78000000000000003 113.273 -174.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 867' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 866' ' ' VAL . 54.5 Cg_endo -90.36 -152.74 0.04 OUTLIER 'Trans proline' 0 CA--C 1.541 0.869 0 N-CA-C 108.761 -1.284 . . . . 0.92000000000000004 108.761 177.517 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 868' ' ' PHE . . . . . 0.452 ' CD1' ' N ' ' A' ' 868' ' ' PHE . 24.1 p90 -149.76 122.21 8.5 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.573 -1.329 . . . . 0.050000000000000003 109.901 179.336 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 49.0 p-10 -113.39 -2.33 13.99 Favored 'General case' 0 N--CA 1.498 1.972 0 C-N-CA 119.287 -0.965 . . . . 1.7 112.299 -179.001 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 870' ' ' ARG . . . . . 0.744 ' CB ' ' HB3' ' A' ' 855' ' ' ALA . 30.3 mmm180 -90.59 88.91 7.31 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.962 -1.086 . . . . 2.5899999999999999 110.67 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 58.3 t -74.54 97.31 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 120.95 -1.094 . . . . 1.9399999999999999 109.919 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 872' ' ' LEU . . . . . 0.456 HD11 ' HB2' ' A' ' 855' ' ' ALA . 92.8 mt -82.97 -47.24 11.96 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.526 -0.734 . . . . 1.0600000000000001 110.24 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 873' ' ' LEU . . . . . 0.534 ' HG ' ' HB3' ' A' ' 851' ' ' ALA . 46.9 tp -174.66 103.95 0.1 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.243 -0.911 . . . . 4.1799999999999997 108.689 178.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 874' ' ' ASN . . . . . 0.444 ' CB ' ' HA ' ' A' ' 852' ' ' PHE . 35.7 t-20 178.9 81.71 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.3 0 O-C-N 121.55 -0.719 . . . . 0.040000000000000001 109.751 -178.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -66.91 -47.25 72.35 Favored 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 119.241 -0.984 . . . . 3.3799999999999999 111.128 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 876' ' ' GLY . . . . . 0.411 ' HA3' ' CE2' ' A' ' 878' ' ' TYR . . . -73.95 -25.01 72.62 Favored Glycine 0 N--CA 1.495 2.573 0 O-C-N 121.275 -0.89 . . . . 0.040000000000000001 111.668 -178.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 82.86 -61.38 4.78 Favored Glycine 0 N--CA 1.501 3.023 0 N-CA-C 108.085 -2.006 . . . . 0.040000000000000001 108.085 -178.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 878' ' ' TYR . . . . . 0.411 ' CE2' ' HA3' ' A' ' 876' ' ' GLY . 88.1 m-85 60.41 -64.96 0.05 Allowed 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 114.28 1.215 . . . . 3.46 114.28 177.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 879' ' ' TYR . . . . . 0.479 ' CB ' ' CD2' ' A' ' 886' ' ' PHE . 19.6 p90 -111.53 107.15 16.23 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 114.5 1.296 . . . . 0.040000000000000001 114.5 -176.456 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -66.03 117.39 42.11 Favored Pre-proline 0 N--CA 1.497 1.903 0 O-C-N 121.402 -0.811 . . . . 0.02 110.1 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 881' ' ' PRO . . . . . 0.433 ' HG2' ' CD1' ' A' ' 868' ' ' PHE . 55.6 Cg_endo -75.92 0.05 9.7 Favored 'Trans proline' 0 N--CA 1.496 1.637 0 O-C-N 123.547 1.288 . . . . 0.39000000000000001 112.195 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -77.77 -63.87 1.28 Allowed 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 106.803 -1.554 . . . . 0.81000000000000005 106.803 178.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 44.9 p -93.03 -19.55 21.44 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.543 -0.91 . . . . 0.040000000000000001 108.543 177.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.7 20.16 60.35 Favored Glycine 0 N--CA 1.497 2.758 0 O-C-N 121.089 -1.007 . . . . 0.029999999999999999 111.545 178.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 885' ' ' VAL . . . . . 0.539 HG13 HG21 ' A' ' 961' ' ' THR . 88.1 t -74.19 91.96 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 C-N-CA 118.16 -1.416 . . . . 1.01 108.197 -179.475 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 886' ' ' PHE . . . . . 0.917 ' HB3' HG22 ' A' ' 962' ' ' VAL . 0.7 OUTLIER -90.27 105.75 18.02 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 115.158 -0.928 . . . . 0.050000000000000003 112.118 -177.248 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 887' ' ' THR . . . . . 0.425 ' O ' ' HD3' ' A' ' 889' ' ' PRO . 70.6 m -96.44 100.96 12.52 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 107.911 -1.144 . . . . 0.68000000000000005 107.911 177.383 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 888' ' ' ALA . . . . . . . . . . . . . . . -98.61 106.65 38.01 Favored Pre-proline 0 N--CA 1.503 2.201 0 N-CA-C 114.146 1.165 . . . . 0.25 114.146 -176.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 889' ' ' PRO . . . . . 0.425 ' HD3' ' O ' ' A' ' 887' ' ' THR . 55.2 Cg_endo -89.08 -12.94 3.17 Favored 'Trans proline' 0 CA--C 1.546 1.098 0 N-CA-C 109.121 -1.146 . . . . 1.6399999999999999 109.121 176.219 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 890' ' ' LEU . . . . . 1.077 HD22 HD13 ' A' ' 985' ' ' LEU . 56.0 mt -34.25 -51.07 0.43 Allowed 'General case' 0 N--CA 1.509 2.482 0 N-CA-C 113.972 1.101 . . . . 2.29 113.972 -177.452 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 51.51 94.89 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.363 0 O-C-N 121.186 -0.946 . . . . 0.63 110.331 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 156.09 -147.3 15.75 Favored Glycine 0 N--CA 1.48 1.601 0 N-CA-C 107.536 -2.226 . . . . 0.040000000000000001 107.536 -179.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 893' ' ' ARG . . . . . 0.465 ' CZ ' ' HB1' ' C' ' 984' ' ' ALA . 71.4 ttt-85 -109.13 127.76 54.44 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 107.576 -1.268 . . . . 3.0 107.576 177.367 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 894' ' ' TYR . . . . . 0.543 ' OH ' HD12 ' A' ' 896' ' ' LEU . 0.1 OUTLIER -130.28 144.54 51.43 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.987 -1.071 . . . . 0.040000000000000001 110.041 -179.075 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 895' ' ' LEU . . . . . 0.449 ' N ' ' CD1' ' A' ' 894' ' ' TYR . 39.9 tp -97.25 114.24 25.96 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.59 -0.694 . . . . 1.27 109.616 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 896' ' ' LEU . . . . . 0.543 HD12 ' OH ' ' A' ' 894' ' ' TYR . 9.7 tt -111.24 146.01 37.72 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.625 -0.672 . . . . 0.93999999999999995 110.812 -179.364 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 897' ' ' SER . . . . . . . . . . . . . 66.9 m -143.86 116.81 8.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.573 -0.705 . . . . 0.040000000000000001 110.503 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -106.57 146.77 30.25 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.258 -0.645 . . . . 0.47999999999999998 109.258 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 899' ' ' VAL . . . . . 0.725 HG21 ' HB ' ' A' ' 980' ' ' ILE . 88.3 t -97.47 119.18 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 C-N-CA 119.716 -0.794 . . . . 0.55000000000000004 111.277 -179.155 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 900' ' ' LEU . . . . . 0.437 ' N ' HD22 ' A' ' 900' ' ' LEU . 4.5 mm? -95.16 112.18 23.92 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 114.175 1.176 . . . . 1.5900000000000001 114.175 -175.564 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 17.6 m -64.54 140.99 58.93 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 107.398 -1.334 . . . . 0.050000000000000003 107.398 177.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -63.26 -66.27 2.64 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 110.479 -1.048 . . . . 0.029999999999999999 110.479 -179.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 2.2 m80 46.52 66.06 1.06 Allowed 'General case' 0 N--CA 1.507 2.42 0 O-C-N 121.474 -1.015 . . . . 3.2000000000000002 111.118 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 54.1 ptt85 -68.72 -6.44 26.32 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.585 -0.697 . . . . 2.9199999999999999 111.916 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 905' ' ' HIS . . . . . 0.483 ' O ' ' CB ' ' A' ' 906' ' ' GLU . 75.9 t60 -60.79 3.4 0.08 Allowed 'General case' 0 N--CA 1.505 2.314 0 O-C-N 120.936 -1.103 . . . . 2.8700000000000001 113.034 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 906' ' ' GLU . . . . . 0.483 ' CB ' ' O ' ' A' ' 905' ' ' HIS . 0.8 OUTLIER 93.4 -163.58 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.377 0 CA-C-N 120.552 1.523 . . . . 0.98999999999999999 112.192 178.789 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 907' ' ' LYS . . . . . 0.481 ' CB ' ' O ' ' A' ' 906' ' ' GLU . 42.6 tttt 88.64 161.73 0.06 Allowed 'General case' 0 N--CA 1.519 2.991 0 N-CA-C 107.675 -1.231 . . . . 5.25 107.675 -176.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 61.0 t -121.97 115.77 47.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 120.876 -1.14 . . . . 0.39000000000000001 110.815 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 909' ' ' GLU . . . . . 0.564 ' OE2' HD12 ' A' ' 966' ' ' LEU . 52.1 tp10 -100.71 132.62 46.01 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 107.19 -1.411 . . . . 1.72 107.19 176.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -156.82 120.64 4.28 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 106.731 -1.581 . . . . 0.67000000000000004 106.731 178.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 911' ' ' VAL . . . . . 0.684 HG22 HG13 ' A' ' 964' ' ' VAL . 95.6 t -83.18 131.99 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 C-N-CA 120.34 -0.544 . . . . 0.54000000000000004 110.756 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 72.8 mt -64.63 155.21 34.02 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.316 -0.865 . . . . 1.5 108.709 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 913' ' ' SER . . . . . 0.421 ' CB ' ' HB ' ' A' ' 919' ' ' VAL . 1.5 t -122.95 137.62 54.9 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.101 -1.074 . . . . 1.3700000000000001 108.101 177.01 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 914' ' ' ARG . . . . . 0.56 ' NH1' HD23 ' A' ' 956' ' ' LEU . 0.0 OUTLIER -64.1 153.73 36.71 Favored 'General case' 0 N--CA 1.505 2.308 0 O-C-N 120.834 -1.166 . . . . 4.2999999999999998 111.895 -178.884 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 915' ' ' SER . . . . . 0.423 ' CB ' ' O ' ' A' ' 914' ' ' ARG . 2.2 t 82.85 -31.91 0.09 Allowed 'General case' 0 N--CA 1.52 3.075 0 C-N-CA 123.977 0.911 . . . . 2.0499999999999998 112.452 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 916' ' ' ASN . . . . . 0.754 ' HB2' HG21 ' A' ' 919' ' ' VAL . 98.2 m-20 -121.64 -20.59 6.46 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 120.838 -1.164 . . . . 2.71 111.509 -179.123 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 917' ' ' GLN . . . . . 0.412 ' HB2' ' O ' ' A' ' 916' ' ' ASN . 51.1 mt-30 66.74 165.93 0.21 Allowed 'General case' 0 N--CA 1.52 3.045 0 N-CA-C 105.653 -1.98 . . . . 2.6800000000000002 105.653 -173.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.15 -125.04 32.46 Favored Glycine 1 N--CA 1.521 4.342 0 CA-C-N 123.423 2.828 . . . . 0.029999999999999999 107.1 -177.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 919' ' ' VAL . . . . . 0.754 HG21 ' HB2' ' A' ' 916' ' ' ASN . 76.7 t 51.71 94.9 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.229 0 O-C-N 121.466 -1.02 . . . . 1.3899999999999999 108.934 -178.106 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 920' ' ' ALA . . . . . 0.837 ' HB3' HG12 ' A' ' 949' ' ' VAL . . . -91.17 91.93 8.45 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.237 -0.985 . . . . 0.029999999999999999 110.986 -178.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 921' ' ' ARG . . . . . 0.719 ' HG3' HG23 ' A' ' 922' ' ' VAL . 42.4 ptt85 -84.2 -42.04 16.36 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 105.594 -2.002 . . . . 4.4199999999999999 105.594 175.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 922' ' ' VAL . . . . . 0.719 HG23 ' HG3' ' A' ' 921' ' ' ARG . 72.0 t -103.19 69.27 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 N-CA-C 105.446 -2.057 . . . . 0.84999999999999998 105.446 175.051 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 923' ' ' ASP . . . . . 0.643 ' HB2' ' HB1' ' A' ' 920' ' ' ALA . 19.4 t0 -91.0 135.94 33.41 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.783 0.801 . . . . 2.46 112.139 -176.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 13.8 t -147.6 104.31 3.6 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 108.096 -1.075 . . . . 0.69999999999999996 108.096 178.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -110.93 90.28 0.57 Allowed Glycine 0 N--CA 1.487 2.08 0 N-CA-C 108.988 -1.645 . . . . 0.040000000000000001 108.988 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.403 0 N-CA-C 109.4 -1.48 . . . . 0.040000000000000001 109.4 -179.625 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 31.0 m . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.007 0.432 . . . . 13.779999999999999 110.307 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 97.5 mt -113.55 129.68 56.51 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.519 -0.738 . . . . 13.76 110.46 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -152.28 168.51 31.44 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.103 -1.599 . . . . 9.1300000000000008 109.103 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 949' ' ' VAL . . . . . 0.837 HG12 ' HB3' ' A' ' 920' ' ' ALA . 34.9 m -118.81 130.35 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.48 -1.012 . . . . 7.0800000000000001 110.928 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 950' ' ' PHE . . . . . 0.463 ' CZ ' ' HB3' ' A' ' 921' ' ' ARG . 32.2 p90 -133.42 149.28 51.81 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.563 -0.711 . . . . 7.5899999999999999 109.31 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 19.6 m -119.42 -53.87 2.21 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.446 -0.784 . . . . 5.0300000000000002 112.144 -178.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 952' ' ' LEU . . . . . 0.505 HD23 ' HB2' ' C' ' 982' ' ' SER . 57.0 tp -59.98 -75.81 0.05 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.342 -0.849 . . . . 1.01 111.974 -177.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 953' ' ' ILE . . . . . 0.936 HD11 HD13 ' C' ' 872' ' ' LEU . 49.3 pt -53.1 -144.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.663 0 N-CA-C 113.718 1.007 . . . . 2.6000000000000001 113.718 -176.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 954' ' ' LEU . . . . . 0.715 HD22 ' O ' ' A' ' 954' ' ' LEU . 0.0 OUTLIER 167.5 83.83 0.02 OUTLIER Pre-proline 0 N--CA 1.512 2.66 0 O-C-N 120.998 -1.064 . . . . 0.050000000000000003 111.535 178.976 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 955' ' ' PRO . . . . . 0.65 ' C ' HD12 ' A' ' 956' ' ' LEU . 46.9 Cg_endo -74.02 98.14 1.06 Allowed 'Trans proline' 0 C--N 1.314 -1.285 0 N-CA-C 108.938 -1.216 . . . . 0.83999999999999997 108.938 177.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 956' ' ' LEU . . . . . 0.65 HD12 ' C ' ' A' ' 955' ' ' PRO . 10.0 mp -122.59 144.13 49.31 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.053 -1.029 . . . . 0.040000000000000001 110.276 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -83.61 150.7 25.74 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 117.719 -1.134 . . . . 1.28 111.456 -179.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -69.58 120.08 14.82 Favored 'General case' 0 N--CA 1.509 2.482 0 CA-C-N 122.99 2.632 . . . . 0.17000000000000001 111.373 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 93.34 -21.74 38.83 Favored Glycine 0 N--CA 1.5 2.959 0 N-CA-C 110.94 -0.864 . . . . 0.040000000000000001 110.94 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 960' ' ' ASP . . . . . 0.432 ' HB3' ' NE ' ' A' ' 914' ' ' ARG . 0.9 OUTLIER -51.88 171.3 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.476 -1.014 . . . . 0.040000000000000001 110.538 -179.481 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 961' ' ' THR . . . . . 0.539 HG21 HG13 ' A' ' 885' ' ' VAL . 43.7 m -134.81 134.93 41.37 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.953 -1.092 . . . . 1.78 111.641 -178.342 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 962' ' ' VAL . . . . . 0.917 HG22 ' HB3' ' A' ' 886' ' ' PHE . 33.0 m -100.48 145.34 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 C-N-CA 119.851 -0.739 . . . . 0.040000000000000001 110.628 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 5.3 t -138.36 146.52 42.39 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.935 -0.478 . . . . 0.71999999999999997 109.979 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 964' ' ' VAL . . . . . 0.684 HG13 HG22 ' A' ' 911' ' ' VAL . 60.3 t -94.14 136.63 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.102 -0.999 . . . . 1.05 110.416 -179.318 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -93.52 126.55 38.73 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 103.547 -2.76 . . . . 3.02 103.547 173.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 966' ' ' LEU . . . . . 0.564 HD12 ' OE2' ' A' ' 909' ' ' GLU . 0.5 OUTLIER -132.34 60.06 1.7 Allowed 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.251 -1.018 . . . . 1.46 108.251 177.466 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 967' ' ' VAL . . . . . 0.492 HG23 ' C ' ' A' ' 966' ' ' LEU . 95.9 t -158.2 96.65 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 N-CA-C 108.143 -1.058 . . . . 1.9399999999999999 108.143 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 90.4 mmm -143.26 59.53 1.4 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.716 -1.24 . . . . 0.0 108.272 178.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.33 119.81 1.96 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 106.994 -2.442 . . . . 2.1099999999999999 106.994 -178.155 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -82.2 -58.25 3.03 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 118.716 1.258 . . . . 5.8899999999999997 110.308 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 40.8 tp -59.12 90.53 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.493 -0.754 . . . . 4.3600000000000003 110.115 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -141.82 -154.33 0.51 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.588 -0.695 . . . . 1.8300000000000001 110.174 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -119.46 170.98 8.67 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.502 -0.749 . . . . 4.3499999999999996 110.338 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 10.7 t -101.47 130.22 47.67 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.535 -0.728 . . . . 1.27 109.962 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -156.3 158.73 37.96 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.481 -0.762 . . . . 5.0199999999999996 110.608 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.93 85.94 18.77 Favored Pre-proline 0 N--CA 1.5 2.048 0 O-C-N 121.611 -0.681 . . . . 2.4100000000000001 109.516 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -72.75 -171.83 0.83 Allowed 'Trans proline' 0 C--N 1.317 -1.109 0 O-C-N 123.31 1.163 . . . . 0.95999999999999996 111.389 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 978' ' ' LEU . . . . . 0.692 HD23 ' CD1' ' A' ' 856' ' ' LEU . 4.9 mp -127.89 154.32 45.64 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 107.608 -1.256 . . . . 0.62 107.608 178.067 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 979' ' ' THR . . . . . 0.456 HG23 ' C ' ' A' ' 978' ' ' LEU . 42.1 p -149.93 141.32 23.29 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.768 -1.208 . . . . 3.5699999999999998 111.181 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 980' ' ' ILE . . . . . 0.725 ' HB ' HG21 ' A' ' 899' ' ' VAL . 51.2 mm -107.06 128.06 62.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 109.006 -0.739 . . . . 1.3300000000000001 109.006 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 981' ' ' PHE . . . . . 0.431 ' HD1' ' HH ' ' A' ' 879' ' ' TYR . 5.7 t80 -121.73 98.22 5.86 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.417 -0.802 . . . . 0.050000000000000003 111.783 -178.383 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 982' ' ' SER . . . . . 0.401 ' HA ' ' CB ' ' A' ' 853' ' ' SER . 86.0 p -108.69 158.22 17.81 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.974 -0.75 . . . . 0.87 108.974 178.248 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . -171.82 108.58 0.28 Allowed Glycine 0 N--CA 1.498 2.78 0 N-CA-C 106.557 -2.617 . . . . 0.029999999999999999 106.557 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -109.4 148.21 31.49 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 114.337 1.236 . . . . 0.69999999999999996 114.337 -175.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 985' ' ' LEU . . . . . 1.077 HD13 HD22 ' A' ' 890' ' ' LEU . 44.7 tp -69.79 135.1 49.3 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 120.796 -1.19 . . . . 0.040000000000000001 110.115 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 986' ' ' LEU . . . . . 0.401 ' CD2' ' NH1' ' A' ' 893' ' ' ARG . 41.8 tp -105.96 -60.29 1.66 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.621 -0.674 . . . . 0.040000000000000001 109.914 179.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -143.88 146.26 32.89 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 107.627 -1.249 . . . . 0.040000000000000001 107.627 179.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.33 163.28 12.19 Favored Glycine 0 N--CA 1.495 2.628 0 N-CA-C 108.094 -2.002 . . . . 0.040000000000000001 108.094 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -76.0 112.52 20.8 Favored Pre-proline 0 N--CA 1.499 2.005 0 O-C-N 121.229 -1.159 . . . . 0.040000000000000001 109.402 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 990' ' ' PRO . . . . . 0.412 ' O ' ' HB2' ' A' ' 991' ' ' GLU . 49.7 Cg_endo -90.27 71.85 1.41 Allowed 'Trans proline' 0 C--N 1.319 -1.006 0 O-C-N 123.164 1.086 . . . . 0.45000000000000001 111.386 -178.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 991' ' ' GLU . . . . . 0.412 ' HB2' ' O ' ' A' ' 990' ' ' PRO . 67.0 mt-10 67.32 -73.69 0.08 Allowed 'General case' 0 N--CA 1.503 2.178 0 N-CA-C 108.483 -0.932 . . . . 1.97 108.483 -177.434 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 992' ' ' LEU . . . . . 0.402 HD12 ' HD2' ' A' ' 990' ' ' PRO . 10.6 mt 50.91 20.73 0.83 Allowed 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.583 -0.698 . . . . 2.3799999999999999 111.599 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -93.58 156.71 16.57 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.912 -1.117 . . . . 3.79 109.989 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -145.91 92.97 2.27 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.54 -0.725 . . . . 3.5099999999999998 110.312 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 995' ' ' ALA . . . . . . . . . . . . 2.517 . . . . . . . 0 N--CA 1.504 2.254 0 O-C-N 120.85 -1.157 . . . . 2.73 110.575 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo . . . . . 0 N--CA 1.488 1.188 0 N-CA-C 109.523 -0.991 . . . . 3.8300000000000001 109.523 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 847' ' ' VAL . . . . . 0.416 HG12 ' HB2' ' B' ' 849' ' ' GLN . 61.3 t -132.14 103.48 14.07 Favored Pre-proline 0 N--CA 1.494 1.775 0 O-C-N 121.621 -0.674 . . . . 1.8300000000000001 109.989 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 848' ' ' PRO . . . . . 0.708 ' O ' HG23 ' B' ' 850' ' ' VAL . 43.7 Cg_endo -69.45 -20.16 36.67 Favored 'Trans proline' 0 N--CA 1.487 1.133 0 O-C-N 123.245 1.129 . . . . 0.65000000000000002 111.064 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 849' ' ' GLN . . . . . 0.416 ' HB2' HG12 ' B' ' 847' ' ' VAL . 55.6 tt0 27.06 68.69 0.06 Allowed 'General case' 0 N--CA 1.518 2.96 0 N-CA-C 112.867 0.691 . . . . 2.5800000000000001 112.867 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 850' ' ' VAL . . . . . 0.708 HG23 ' O ' ' B' ' 848' ' ' PRO . 59.7 t -118.2 136.68 54.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.218 -0.926 . . . . 1.0900000000000001 111.382 -178.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 851' ' ' ALA . . . . . 0.512 ' HB3' ' HG ' ' B' ' 873' ' ' LEU . . . -126.09 156.11 40.53 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 105.774 -1.936 . . . . 0.040000000000000001 105.774 176.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 852' ' ' PHE . . . . . 0.472 ' CE2' HD11 ' B' ' 890' ' ' LEU . 23.8 p90 -159.73 129.1 5.26 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 121.022 1.737 . . . . 0.050000000000000003 108.631 179.342 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 30.0 t -175.24 134.72 0.33 Allowed 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.176 -1.046 . . . . 0.040000000000000001 108.176 -178.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -132.56 156.75 46.29 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.099 -1.001 . . . . 0.67000000000000004 109.576 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 855' ' ' ALA . . . . . 0.739 ' HB3' ' CB ' ' B' ' 870' ' ' ARG . . . -122.9 145.13 48.73 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.774 0.797 . . . . 0.51000000000000001 111.697 -178.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 856' ' ' LEU . . . . . 0.684 ' CD1' HD23 ' B' ' 978' ' ' LEU . 3.4 tm? -112.51 134.01 54.27 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.743 -0.598 . . . . 0.050000000000000003 110.105 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 857' ' ' SER . . . . . 0.526 ' N ' HD13 ' B' ' 856' ' ' LEU . 56.3 p -150.37 16.99 0.83 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.561 -0.712 . . . . 1.3300000000000001 110.513 178.716 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 858' ' ' LEU . . . . . 0.763 HD22 ' OE2' ' B' ' 862' ' ' GLU . 4.4 pp -33.31 158.26 0.04 OUTLIER Pre-proline 0 N--CA 1.517 2.924 0 N-CA-C 113.33 0.863 . . . . 2.3300000000000001 113.33 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -64.5 -88.43 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.421 0 O-C-N 123.207 1.109 . . . . 2.3199999999999998 113.103 -178.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 55.8 ptt85 -128.71 -143.45 0.27 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.87 -1.144 . . . . 0.040000000000000001 111.729 -177.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 19.3 m -40.23 127.53 2.27 Favored 'General case' 0 N--CA 1.509 2.491 0 O-C-N 121.455 -0.778 . . . . 1.3100000000000001 112.359 -178.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 862' ' ' GLU . . . . . 0.763 ' OE2' HD22 ' B' ' 858' ' ' LEU . 0.9 OUTLIER -102.09 156.77 34.82 Favored Pre-proline 0 N--CA 1.488 1.465 0 N-CA-C 107.86 -1.163 . . . . 4.5099999999999998 107.86 177.138 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 863' ' ' PRO . . . . . 0.414 ' HD2' ' CG ' ' B' ' 862' ' ' GLU . 43.7 Cg_endo -69.81 -13.06 34.03 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 O-C-N 123.082 1.043 . . . . 2.2400000000000002 111.419 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -175.61 -135.91 2.21 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.993 -1.243 . . . . 0.040000000000000001 109.993 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 28.0 m -66.71 157.68 32.08 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.253 -1.145 . . . . 1.51 110.925 -178.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 866' ' ' VAL . . . . . 0.688 HG22 ' OE1' ' B' ' 862' ' ' GLU . 48.5 t -93.78 134.53 26.17 Favored Pre-proline 0 N--CA 1.495 1.784 0 N-CA-C 113.302 0.853 . . . . 0.78000000000000003 113.302 -174.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 867' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' B' ' 866' ' ' VAL . 55.2 Cg_endo -90.38 -152.94 0.04 OUTLIER 'Trans proline' 0 CA--C 1.541 0.867 0 O-C-N 123.517 1.272 . . . . 0.92000000000000004 108.831 177.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 868' ' ' PHE . . . . . 0.45 ' CD1' ' N ' ' B' ' 868' ' ' PHE . 23.6 p90 -149.55 122.16 8.59 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 120.633 -1.292 . . . . 0.050000000000000003 109.956 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 49.2 p-10 -113.29 -1.94 14.15 Favored 'General case' 0 N--CA 1.498 1.971 0 C-N-CA 119.27 -0.972 . . . . 1.7 112.289 -179.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 870' ' ' ARG . . . . . 0.739 ' CB ' ' HB3' ' B' ' 855' ' ' ALA . 30.3 mmm180 -90.96 88.68 7.12 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.899 -1.126 . . . . 2.5899999999999999 110.784 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 58.5 t -74.56 97.32 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.005 -1.059 . . . . 1.9399999999999999 109.884 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 872' ' ' LEU . . . . . 0.446 HD11 ' HB2' ' B' ' 855' ' ' ALA . 94.7 mt -83.16 -46.99 12.07 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.488 -0.757 . . . . 1.0600000000000001 110.14 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 873' ' ' LEU . . . . . 0.512 ' HG ' ' HB3' ' B' ' 851' ' ' ALA . 46.5 tp -174.65 104.01 0.1 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.305 -0.872 . . . . 4.1799999999999997 108.703 178.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 874' ' ' ASN . . . . . 0.444 ' CB ' ' HA ' ' B' ' 852' ' ' PHE . 35.6 t-20 178.86 81.96 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.304 0 O-C-N 121.643 -0.66 . . . . 0.040000000000000001 109.76 -178.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -67.16 -47.31 71.4 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 119.268 -0.973 . . . . 3.3799999999999999 111.076 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 876' ' ' GLY . . . . . 0.404 ' HA3' ' CE2' ' B' ' 878' ' ' TYR . . . -73.87 -25.27 72.16 Favored Glycine 0 N--CA 1.494 2.562 0 O-C-N 121.336 -0.852 . . . . 0.040000000000000001 111.584 -178.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 83.01 -61.29 4.8 Favored Glycine 0 N--CA 1.501 3.003 0 N-CA-C 108.091 -2.003 . . . . 0.040000000000000001 108.091 -178.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 878' ' ' TYR . . . . . 0.404 ' CE2' ' HA3' ' B' ' 876' ' ' GLY . 88.4 m-85 60.47 -64.93 0.06 Allowed 'General case' 0 N--CA 1.504 2.248 0 N-CA-C 114.303 1.223 . . . . 3.46 114.303 177.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 879' ' ' TYR . . . . . 0.467 ' CB ' ' CD2' ' B' ' 886' ' ' PHE . 19.6 p90 -111.47 107.45 16.66 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 114.457 1.28 . . . . 0.040000000000000001 114.457 -176.518 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -66.21 117.17 40.6 Favored Pre-proline 0 N--CA 1.497 1.924 0 O-C-N 121.422 -0.798 . . . . 0.02 110.145 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 881' ' ' PRO . . . . . 0.42 ' HG2' ' CD1' ' B' ' 868' ' ' PHE . 55.5 Cg_endo -75.81 -0.12 9.85 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 O-C-N 123.57 1.3 . . . . 0.39000000000000001 112.15 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 88.4 mt-10 -77.45 -63.65 1.33 Allowed 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 106.801 -1.555 . . . . 0.81000000000000005 106.801 178.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 45.7 p -93.79 -18.82 21.64 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.678 -0.86 . . . . 0.040000000000000001 108.678 177.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.24 20.27 60.95 Favored Glycine 0 N--CA 1.497 2.711 0 O-C-N 121.11 -0.994 . . . . 0.029999999999999999 111.554 178.155 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 885' ' ' VAL . . . . . 0.524 HG13 HG21 ' B' ' 961' ' ' THR . 87.8 t -74.14 91.9 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 C-N-CA 118.14 -1.424 . . . . 1.01 108.097 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 886' ' ' PHE . . . . . 0.901 ' HB3' HG22 ' B' ' 962' ' ' VAL . 0.7 OUTLIER -90.32 105.82 18.07 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-N 115.182 -0.917 . . . . 0.050000000000000003 111.999 -177.259 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 887' ' ' THR . . . . . 0.423 ' O ' ' HD3' ' B' ' 889' ' ' PRO . 69.7 m -96.47 101.15 12.73 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 107.868 -1.16 . . . . 0.68000000000000005 107.868 177.313 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 888' ' ' ALA . . . . . . . . . . . . . . . -98.78 106.51 37.73 Favored Pre-proline 0 N--CA 1.502 2.146 0 N-CA-C 114.153 1.168 . . . . 0.25 114.153 -176.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 889' ' ' PRO . . . . . 0.423 ' HD3' ' O ' ' B' ' 887' ' ' THR . 55.3 Cg_endo -89.02 -13.07 3.16 Favored 'Trans proline' 0 CA--C 1.546 1.105 0 C-N-CA 121.01 1.14 . . . . 1.6399999999999999 109.183 176.273 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 890' ' ' LEU . . . . . 1.077 HD22 HD13 ' B' ' 985' ' ' LEU . 56.5 mt -34.04 -51.29 0.42 Allowed 'General case' 0 N--CA 1.51 2.535 0 N-CA-C 113.997 1.11 . . . . 2.29 113.997 -177.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 51.54 94.84 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.336 0 O-C-N 121.13 -0.981 . . . . 0.63 110.379 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . 156.13 -147.54 16.32 Favored Glycine 0 N--CA 1.48 1.577 0 N-CA-C 107.451 -2.26 . . . . 0.040000000000000001 107.451 -179.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 72.0 ttt-85 -108.86 127.72 54.28 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 107.609 -1.256 . . . . 3.0 107.609 177.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 894' ' ' TYR . . . . . 0.542 ' OH ' HD12 ' B' ' 896' ' ' LEU . 0.1 OUTLIER -130.22 144.67 51.5 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.048 -1.032 . . . . 0.040000000000000001 110.056 -179.064 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 895' ' ' LEU . . . . . 0.45 ' N ' ' CD1' ' B' ' 894' ' ' TYR . 39.7 tp -97.58 114.33 26.22 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.628 -0.67 . . . . 1.27 109.621 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 896' ' ' LEU . . . . . 0.542 HD12 ' OH ' ' B' ' 894' ' ' TYR . 9.6 tt -111.34 145.62 38.54 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.574 -0.704 . . . . 0.93999999999999995 110.884 -179.245 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 897' ' ' SER . . . . . . . . . . . . . 65.9 m -143.53 116.56 8.88 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.636 -0.665 . . . . 0.040000000000000001 110.467 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -106.23 146.68 30.01 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 109.297 -0.631 . . . . 0.47999999999999998 109.297 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 899' ' ' VAL . . . . . 0.731 HG21 ' HB ' ' B' ' 980' ' ' ILE . 87.7 t -97.35 118.76 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 C-N-CA 119.757 -0.777 . . . . 0.55000000000000004 111.403 -179.143 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 900' ' ' LEU . . . . . 0.446 HD13 ' HA ' ' B' ' 900' ' ' LEU . 4.5 mm? -94.81 111.9 23.66 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 114.283 1.216 . . . . 1.5900000000000001 114.283 -175.501 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 17.4 m -64.4 141.06 58.91 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 107.316 -1.365 . . . . 0.050000000000000003 107.316 177.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -63.58 -66.14 2.69 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 110.476 -1.05 . . . . 0.029999999999999999 110.476 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 2.1 m80 46.44 65.99 1.07 Allowed 'General case' 0 N--CA 1.507 2.383 0 O-C-N 121.447 -1.031 . . . . 3.2000000000000002 111.099 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 54.1 ptt85 -68.54 -6.75 27.11 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.64 -0.662 . . . . 2.9199999999999999 111.942 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 905' ' ' HIS . . . . . 0.482 ' O ' ' CB ' ' B' ' 906' ' ' GLU . 75.9 t60 -60.19 2.82 0.08 Allowed 'General case' 0 N--CA 1.506 2.33 0 O-C-N 120.914 -1.116 . . . . 2.8700000000000001 113.073 -179.366 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 906' ' ' GLU . . . . . 0.482 ' CB ' ' O ' ' B' ' 905' ' ' HIS . 0.8 OUTLIER 93.75 -163.76 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.387 0 CA-C-N 120.6 1.545 . . . . 0.98999999999999999 112.072 178.939 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 907' ' ' LYS . . . . . 0.472 ' CB ' ' O ' ' B' ' 906' ' ' GLU . 42.9 tttt 88.84 161.52 0.06 Allowed 'General case' 0 N--CA 1.519 2.979 0 N-CA-C 107.717 -1.216 . . . . 5.25 107.717 -176.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 61.7 t -121.7 115.65 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 120.901 -1.125 . . . . 0.39000000000000001 110.926 -179.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 909' ' ' GLU . . . . . 0.551 ' OE2' HD12 ' B' ' 966' ' ' LEU . 52.2 tp10 -100.75 132.64 46.05 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 107.222 -1.399 . . . . 1.72 107.222 176.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -156.99 120.95 4.27 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 106.703 -1.592 . . . . 0.67000000000000004 106.703 178.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 911' ' ' VAL . . . . . 0.681 HG22 HG13 ' B' ' 964' ' ' VAL . 93.9 t -83.48 132.1 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.835 -0.54 . . . . 0.54000000000000004 110.71 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 72.3 mt -64.58 155.44 33.14 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.326 -0.859 . . . . 1.5 108.694 178.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 913' ' ' SER . . . . . 0.413 ' CB ' ' HB ' ' B' ' 919' ' ' VAL . 1.6 t -123.47 136.69 54.72 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.122 -1.066 . . . . 1.3700000000000001 108.122 177.023 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 914' ' ' ARG . . . . . 0.56 ' NH1' HD23 ' B' ' 956' ' ' LEU . 0.0 OUTLIER -63.08 153.57 33.71 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 120.839 -1.163 . . . . 4.2999999999999998 111.981 -178.784 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 915' ' ' SER . . . . . 0.416 ' CB ' ' O ' ' B' ' 914' ' ' ARG . 2.2 t 83.02 -32.2 0.08 Allowed 'General case' 0 N--CA 1.521 3.095 0 C-N-CA 124.03 0.932 . . . . 2.0499999999999998 112.404 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 916' ' ' ASN . . . . . 0.789 ' HB2' HG21 ' B' ' 919' ' ' VAL . 98.1 m-20 -121.26 -20.85 6.57 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.867 -1.146 . . . . 2.71 111.607 -179.094 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 917' ' ' GLN . . . . . 0.415 ' HB2' ' O ' ' B' ' 916' ' ' ASN . 50.8 mt-30 66.75 165.51 0.21 Allowed 'General case' 0 N--CA 1.521 3.103 0 N-CA-C 105.661 -1.977 . . . . 2.6800000000000002 105.661 -173.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.8 -125.23 34.58 Favored Glycine 1 N--CA 1.521 4.304 0 CA-C-N 123.532 2.878 . . . . 0.029999999999999999 106.958 -177.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 919' ' ' VAL . . . . . 0.789 HG21 ' HB2' ' B' ' 916' ' ' ASN . 79.9 t 51.5 95.08 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 O-C-N 121.456 -1.026 . . . . 1.3899999999999999 108.959 -178.032 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 920' ' ' ALA . . . . . 0.851 ' HB3' HG12 ' B' ' 949' ' ' VAL . . . -91.26 91.75 8.33 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.207 -0.997 . . . . 0.029999999999999999 110.904 -179.009 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 921' ' ' ARG . . . . . 0.712 ' HG3' HG23 ' B' ' 922' ' ' VAL . 42.4 ptt85 -84.17 -41.9 16.54 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 105.58 -2.007 . . . . 4.4199999999999999 105.58 175.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 922' ' ' VAL . . . . . 0.712 HG23 ' HG3' ' B' ' 921' ' ' ARG . 71.0 t -103.26 68.96 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 N-CA-C 105.53 -2.026 . . . . 0.84999999999999998 105.53 175.072 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 923' ' ' ASP . . . . . 0.64 ' HB2' ' HB1' ' B' ' 920' ' ' ALA . 19.4 t0 -90.7 136.04 33.32 Favored 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 121.779 0.8 . . . . 2.46 112.147 -176.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 924' ' ' SER . . . . . . . . . . . . . 14.1 t -147.62 104.04 3.58 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.184 -1.043 . . . . 0.69999999999999996 108.184 178.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -110.63 90.24 0.57 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 108.979 -1.649 . . . . 0.040000000000000001 108.979 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.425 0 N-CA-C 109.386 -1.486 . . . . 0.040000000000000001 109.386 -179.709 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 32.3 m . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.031 0.444 . . . . 13.779999999999999 110.254 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 97.6 mt -112.81 129.64 56.37 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.509 -0.744 . . . . 13.76 110.434 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -151.82 167.89 31.1 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.127 -1.589 . . . . 9.1300000000000008 109.127 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 949' ' ' VAL . . . . . 0.851 HG12 ' HB3' ' B' ' 920' ' ' ALA . 35.3 m -118.62 130.12 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.499 -1.001 . . . . 7.0800000000000001 110.852 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 950' ' ' PHE . . . . . 0.455 ' CZ ' ' HB3' ' B' ' 921' ' ' ARG . 32.6 p90 -133.19 149.44 52.03 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.584 -0.697 . . . . 7.5899999999999999 109.248 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 19.4 m -119.5 -53.7 2.21 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.406 -0.809 . . . . 5.0300000000000002 112.022 -178.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 952' ' ' LEU . . . . . 0.429 ' O ' ' O ' ' B' ' 953' ' ' ILE . 56.5 tp -60.32 -75.67 0.06 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.442 -0.786 . . . . 1.01 111.966 -177.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 953' ' ' ILE . . . . . 0.508 ' O ' ' HB3' ' B' ' 954' ' ' LEU . 49.2 pt -53.02 -144.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.637 0 N-CA-C 113.749 1.018 . . . . 2.6000000000000001 113.749 -176.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 954' ' ' LEU . . . . . 0.711 HD22 ' O ' ' B' ' 954' ' ' LEU . 0.0 OUTLIER 167.48 83.58 0.02 OUTLIER Pre-proline 0 N--CA 1.512 2.67 0 O-C-N 120.977 -1.077 . . . . 0.050000000000000003 111.429 178.915 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 955' ' ' PRO . . . . . 0.654 ' C ' HD12 ' B' ' 956' ' ' LEU . 46.2 Cg_endo -74.07 98.4 1.08 Allowed 'Trans proline' 0 C--N 1.313 -1.315 0 N-CA-C 108.863 -1.245 . . . . 0.83999999999999997 108.863 177.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 956' ' ' LEU . . . . . 0.654 HD12 ' C ' ' B' ' 955' ' ' PRO . 10.0 mp -122.85 144.02 49.48 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.056 -1.027 . . . . 0.040000000000000001 110.22 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -83.43 151.1 25.65 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 117.829 -1.082 . . . . 1.28 111.39 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -69.75 119.91 14.7 Favored 'General case' 0 N--CA 1.509 2.479 0 CA-C-N 122.857 2.571 . . . . 0.17000000000000001 111.368 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 93.35 -21.91 37.92 Favored Glycine 0 N--CA 1.501 2.989 0 N-CA-C 110.949 -0.86 . . . . 0.040000000000000001 110.949 178.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 960' ' ' ASP . . . . . 0.433 ' HB3' ' NE ' ' B' ' 914' ' ' ARG . 0.9 OUTLIER -51.65 171.23 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.46 -1.023 . . . . 0.040000000000000001 110.514 -179.411 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 961' ' ' THR . . . . . 0.524 HG21 HG13 ' B' ' 885' ' ' VAL . 42.0 m -134.67 135.08 41.8 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.025 -1.047 . . . . 1.78 111.655 -178.3 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 962' ' ' VAL . . . . . 0.901 HG22 ' HB3' ' B' ' 886' ' ' PHE . 33.0 m -100.66 145.22 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 C-N-CA 119.938 -0.705 . . . . 0.040000000000000001 110.661 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 5.2 t -138.27 146.22 42.23 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.943 -0.473 . . . . 0.71999999999999997 110.042 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 964' ' ' VAL . . . . . 0.681 HG13 HG22 ' B' ' 911' ' ' VAL . 59.9 t -94.01 136.27 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.04 -1.037 . . . . 1.05 110.433 -179.25 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -93.29 126.32 38.34 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 103.571 -2.752 . . . . 3.02 103.571 173.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 966' ' ' LEU . . . . . 0.551 HD12 ' OE2' ' B' ' 909' ' ' GLU . 0.5 OUTLIER -132.08 59.98 1.69 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.324 -0.991 . . . . 1.46 108.324 177.512 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 967' ' ' VAL . . . . . 0.491 HG23 ' C ' ' B' ' 966' ' ' LEU . 95.7 t -158.23 96.32 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 108.222 -1.029 . . . . 1.9399999999999999 108.222 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 90.5 mmm -142.85 59.54 1.43 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.8 -1.187 . . . . 0.0 108.312 178.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.23 119.67 1.95 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 107.06 -2.416 . . . . 2.1099999999999999 107.06 -178.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -81.92 -58.24 3.07 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.106 -1.232 . . . . 5.8899999999999997 110.353 -179.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 40.9 tp -59.14 90.22 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.423 -0.798 . . . . 4.3600000000000003 110.103 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -141.56 -154.05 0.5 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.574 -0.704 . . . . 1.8300000000000001 110.156 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -119.64 171.2 8.54 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.509 -0.745 . . . . 4.3499999999999996 110.336 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 10.7 t -101.61 130.2 47.88 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.53 -0.731 . . . . 1.27 109.942 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -156.26 158.79 38.12 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.443 -0.786 . . . . 5.0199999999999996 110.598 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.01 85.94 18.55 Favored Pre-proline 0 N--CA 1.5 2.031 0 O-C-N 121.647 -0.658 . . . . 2.4100000000000001 109.541 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -72.76 -171.88 0.84 Allowed 'Trans proline' 0 C--N 1.317 -1.087 0 O-C-N 123.342 1.18 . . . . 0.95999999999999996 111.408 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 978' ' ' LEU . . . . . 0.684 HD23 ' CD1' ' B' ' 856' ' ' LEU . 4.9 mp -127.74 154.56 45.21 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 107.649 -1.241 . . . . 0.62 107.649 178.055 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 979' ' ' THR . . . . . 0.464 HG23 ' C ' ' B' ' 978' ' ' LEU . 41.8 p -150.17 141.34 23.11 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.808 -1.183 . . . . 3.5699999999999998 111.17 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 980' ' ' ILE . . . . . 0.731 ' HB ' HG21 ' B' ' 899' ' ' VAL . 51.3 mm -107.09 127.74 62.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 108.985 -0.746 . . . . 1.3300000000000001 108.985 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -121.56 98.57 6.03 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.395 -0.816 . . . . 0.050000000000000003 111.817 -178.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 98.8 p -109.34 158.73 17.6 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.467 -0.771 . . . . 0.87 109.013 178.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 983' ' ' GLY . . . . . . . . . . . . . . . -171.86 108.84 0.29 Allowed Glycine 0 N--CA 1.497 2.716 0 N-CA-C 106.609 -2.596 . . . . 0.029999999999999999 106.609 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -109.34 147.88 31.99 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 114.177 1.177 . . . . 0.69999999999999996 114.177 -175.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 985' ' ' LEU . . . . . 1.077 HD13 HD22 ' B' ' 890' ' ' LEU . 44.2 tp -69.67 135.22 49.6 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.851 -1.155 . . . . 0.040000000000000001 110.057 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 986' ' ' LEU . . . . . 0.568 HD11 HD11 ' C' ' 986' ' ' LEU . 42.2 tp -106.12 -60.45 1.64 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.635 -0.665 . . . . 0.040000000000000001 109.895 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -143.83 146.05 32.78 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.581 -1.266 . . . . 0.040000000000000001 107.581 179.07 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.27 162.91 12.25 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 108.091 -2.003 . . . . 0.040000000000000001 108.091 179.165 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -75.55 112.5 19.59 Favored Pre-proline 0 N--CA 1.499 1.991 0 CA-C-N 118.503 1.152 . . . . 0.040000000000000001 109.414 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 990' ' ' PRO . . . . . 0.417 ' O ' ' HB2' ' B' ' 991' ' ' GLU . 49.8 Cg_endo -90.16 71.68 1.49 Allowed 'Trans proline' 0 C--N 1.319 -1.006 0 O-C-N 123.151 1.079 . . . . 0.45000000000000001 111.399 -178.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 991' ' ' GLU . . . . . 0.417 ' HB2' ' O ' ' B' ' 990' ' ' PRO . 66.9 mt-10 67.39 -73.65 0.08 Allowed 'General case' 0 N--CA 1.503 2.203 0 N-CA-C 108.516 -0.92 . . . . 1.97 108.516 -177.438 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 992' ' ' LEU . . . . . 0.461 ' HA ' HD23 ' B' ' 992' ' ' LEU . 10.8 mt 51.03 20.45 0.82 Allowed 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.639 -0.663 . . . . 2.3799999999999999 111.738 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -93.22 156.79 16.62 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.897 -1.127 . . . . 3.79 109.987 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 67.3 m80 -146.05 92.32 2.18 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.538 -0.726 . . . . 3.5099999999999998 110.386 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 995' ' ' ALA . . . . . . . . . . . . 2.516 . . . . . . . 0 N--CA 1.503 2.204 0 O-C-N 120.946 -1.096 . . . . 2.73 110.625 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo . . . . . 0 N--CA 1.487 1.147 0 N-CA-C 109.469 -1.012 . . . . 3.8300000000000001 109.469 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 847' ' ' VAL . . . . . . . . . . . . . 59.1 t -131.62 102.8 15.0 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.621 -0.675 . . . . 1.8300000000000001 110.311 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 848' ' ' PRO . . . . . 0.686 ' O ' HG23 ' C' ' 850' ' ' VAL . 44.7 Cg_endo -70.49 -21.37 30.17 Favored 'Trans proline' 0 N--CA 1.487 1.1 0 O-C-N 123.331 1.174 . . . . 0.65000000000000002 111.186 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 849' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 27.94 69.25 0.07 Allowed 'General case' 0 N--CA 1.519 2.999 0 N-CA-C 112.703 0.631 . . . . 2.5800000000000001 112.703 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 850' ' ' VAL . . . . . 0.686 HG23 ' O ' ' C' ' 848' ' ' PRO . 49.5 t -119.62 135.0 61.39 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.152 -0.968 . . . . 1.0900000000000001 111.764 -178.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 851' ' ' ALA . . . . . 0.59 ' HB3' ' HG ' ' C' ' 873' ' ' LEU . . . -127.17 154.88 44.23 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 105.517 -2.031 . . . . 0.040000000000000001 105.517 176.403 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 852' ' ' PHE . . . . . 0.449 ' CD1' ' N ' ' C' ' 852' ' ' PHE . 16.8 p90 -160.51 126.68 4.08 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 121.107 1.776 . . . . 0.050000000000000003 108.633 178.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 7.8 t -176.31 134.36 0.24 Allowed 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.012 -1.107 . . . . 0.040000000000000001 108.012 -179.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 854' ' ' ALA . . . . . 0.463 ' HB1' ' HD2' ' C' ' 868' ' ' PHE . . . -130.57 156.37 44.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.141 -0.974 . . . . 0.67000000000000004 109.505 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 855' ' ' ALA . . . . . 0.755 ' HB3' ' CB ' ' C' ' 870' ' ' ARG . . . -122.09 142.87 49.93 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 121.881 0.848 . . . . 0.51000000000000001 111.266 -179.212 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 856' ' ' LEU . . . . . 0.786 HD12 ' HG ' ' C' ' 978' ' ' LEU . 3.3 tm? -111.85 136.46 51.1 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.626 -0.672 . . . . 0.050000000000000003 109.923 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 857' ' ' SER . . . . . 0.629 ' N ' HD13 ' C' ' 856' ' ' LEU . 1.1 m -153.54 15.67 0.51 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.462 -0.774 . . . . 1.3300000000000001 111.661 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 858' ' ' LEU . . . . . 0.711 ' CD2' HD11 ' C' ' 856' ' ' LEU . 4.0 pp -34.91 160.8 0.04 OUTLIER Pre-proline 0 N--CA 1.518 2.944 0 N-CA-C 113.172 0.804 . . . . 2.3300000000000001 113.172 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -62.13 -87.12 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 120.992 1.128 . . . . 2.3199999999999998 113.779 -177.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 54.0 ptt85 -129.74 -142.79 0.25 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 120.883 -1.135 . . . . 0.040000000000000001 111.77 -177.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 67.4 m -38.82 130.83 1.41 Allowed 'General case' 0 N--CA 1.51 2.572 0 O-C-N 121.598 -0.689 . . . . 1.3100000000000001 112.17 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.47 158.55 31.59 Favored Pre-proline 0 N--CA 1.487 1.416 0 N-CA-C 108.633 -0.877 . . . . 4.5099999999999998 108.633 177.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -71.47 -14.52 30.81 Favored 'Trans proline' 0 C--N 1.313 -1.314 0 O-C-N 123.185 1.097 . . . . 2.2400000000000002 111.693 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -177.95 -134.28 2.03 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.681 -1.367 . . . . 0.040000000000000001 109.681 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 7.1 m -67.84 151.18 47.6 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.251 -1.146 . . . . 1.51 110.477 -179.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 866' ' ' VAL . . . . . 0.444 HG13 ' CD2' ' C' ' 858' ' ' LEU . 53.7 t -94.87 134.28 25.17 Favored Pre-proline 0 N--CA 1.497 1.888 0 N-CA-C 113.401 0.889 . . . . 0.78000000000000003 113.401 -174.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 867' ' ' PRO . . . . . 0.524 ' O ' HD23 ' C' ' 856' ' ' LEU . 55.2 Cg_endo -89.07 -150.14 0.04 OUTLIER 'Trans proline' 0 CA--C 1.543 0.936 0 O-C-N 123.526 1.277 . . . . 0.92000000000000004 109.345 178.017 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 868' ' ' PHE . . . . . 0.463 ' HD2' ' HB1' ' C' ' 854' ' ' ALA . 14.9 p90 -148.9 123.76 9.95 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.68 -1.262 . . . . 0.050000000000000003 109.653 179.157 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 49.5 p-10 -112.61 -3.1 14.39 Favored 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 119.273 -0.971 . . . . 1.7 112.492 -178.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 870' ' ' ARG . . . . . 0.755 ' CB ' ' HB3' ' C' ' 855' ' ' ALA . 26.7 mmm180 -91.68 87.65 6.4 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.925 -1.109 . . . . 2.5899999999999999 111.03 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 57.9 t -73.68 97.56 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 120.919 -1.113 . . . . 1.9399999999999999 109.269 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 872' ' ' LEU . . . . . 0.936 HD13 HD11 ' A' ' 953' ' ' ILE . 96.3 mt -87.17 -45.04 11.04 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.564 -0.71 . . . . 1.0600000000000001 110.736 -179.511 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 873' ' ' LEU . . . . . 0.59 ' HG ' ' HB3' ' C' ' 851' ' ' ALA . 31.1 tp -171.99 102.3 0.17 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.144 -0.972 . . . . 4.1799999999999997 108.975 178.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 874' ' ' ASN . . . . . 0.439 ' CB ' ' HA ' ' C' ' 852' ' ' PHE . 35.0 t-20 176.97 82.72 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.265 0 N-CA-C 108.782 -0.821 . . . . 0.040000000000000001 108.782 -179.073 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -65.47 -47.02 77.54 Favored 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 119.282 -0.967 . . . . 3.3799999999999999 111.359 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 876' ' ' GLY . . . . . 0.416 ' HA3' ' CE2' ' C' ' 878' ' ' TYR . . . -72.11 -26.92 71.22 Favored Glycine 0 N--CA 1.492 2.429 0 C-N-CA 120.361 -0.924 . . . . 0.040000000000000001 111.447 -178.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 81.34 -61.93 4.54 Favored Glycine 0 N--CA 1.5 2.905 0 N-CA-C 108.016 -2.034 . . . . 0.040000000000000001 108.016 -178.354 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 878' ' ' TYR . . . . . 0.416 ' CE2' ' HA3' ' C' ' 876' ' ' GLY . 96.3 m-85 60.39 -66.3 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 114.366 1.247 . . . . 3.46 114.366 177.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 879' ' ' TYR . . . . . 0.47 ' CB ' ' CD2' ' C' ' 886' ' ' PHE . 25.0 p90 -110.55 107.52 17.17 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 115.092 1.516 . . . . 0.040000000000000001 115.092 -175.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -71.82 120.76 81.92 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.437 -0.789 . . . . 0.02 109.939 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 881' ' ' PRO . . . . . 0.443 ' HG2' ' CD1' ' C' ' 868' ' ' PHE . 52.3 Cg_endo -78.25 0.24 10.08 Favored 'Trans proline' 0 N--CA 1.49 1.28 0 O-C-N 123.434 1.228 . . . . 0.39000000000000001 111.786 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -74.92 -63.62 1.22 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 106.083 -1.821 . . . . 0.81000000000000005 106.083 178.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 70.3 p -90.54 -21.73 21.65 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 108.513 -0.921 . . . . 0.040000000000000001 108.513 177.211 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 82.28 18.45 66.77 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 110.59 -1.004 . . . . 0.029999999999999999 110.59 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 885' ' ' VAL . . . . . 0.414 HG13 HG21 ' C' ' 961' ' ' THR . 96.6 t -75.54 92.2 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 C-N-CA 118.41 -1.316 . . . . 1.01 108.655 -179.041 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 886' ' ' PHE . . . . . 0.908 ' HB3' HG22 ' C' ' 962' ' ' VAL . 0.8 OUTLIER -87.81 104.34 16.49 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 115.065 -0.97 . . . . 0.050000000000000003 111.541 -177.761 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 887' ' ' THR . . . . . 0.441 ' O ' ' HD3' ' C' ' 889' ' ' PRO . 96.8 m -98.97 99.42 10.46 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 107.38 -1.341 . . . . 0.68000000000000005 107.38 177.309 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 888' ' ' ALA . . . . . . . . . . . . . . . -97.4 106.64 33.77 Favored Pre-proline 0 N--CA 1.501 2.109 0 N-CA-C 114.413 1.264 . . . . 0.25 114.413 -176.002 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 889' ' ' PRO . . . . . 0.441 ' HD3' ' O ' ' C' ' 887' ' ' THR . 53.5 Cg_endo -88.06 -15.38 3.11 Favored 'Trans proline' 0 CA--C 1.546 1.078 0 N-CA-C 108.662 -1.322 . . . . 1.6399999999999999 108.662 175.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 890' ' ' LEU . . . . . 0.633 HD22 HD13 ' C' ' 985' ' ' LEU . 46.0 mt -38.33 -49.17 1.39 Allowed 'General case' 0 N--CA 1.506 2.346 0 N-CA-C 113.347 0.869 . . . . 2.29 113.347 -177.596 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 52.69 97.35 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.241 -0.912 . . . . 0.63 110.316 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . 159.41 -155.52 26.61 Favored Glycine 0 N--CA 1.477 1.425 0 N-CA-C 107.151 -2.38 . . . . 0.040000000000000001 107.151 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 73.4 ttt-85 -117.99 123.98 47.05 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.618 -0.93 . . . . 3.0 109.049 177.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 894' ' ' TYR . . . . . 0.871 ' CE1' HD23 ' C' ' 954' ' ' LEU . 49.5 p90 -134.08 156.69 47.81 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.057 -1.027 . . . . 0.040000000000000001 110.922 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 895' ' ' LEU . . . . . . . . . . . . . 40.3 tp -96.47 118.22 32.53 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.691 -0.631 . . . . 1.27 110.379 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 896' ' ' LEU . . . . . 0.576 HD23 ' N ' ' C' ' 897' ' ' SER . 9.5 tt -116.1 145.17 43.25 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.645 -0.66 . . . . 0.93999999999999995 109.92 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 897' ' ' SER . . . . . 0.576 ' N ' HD23 ' C' ' 896' ' ' LEU . 47.4 m -140.0 124.2 17.79 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.431 -0.793 . . . . 0.040000000000000001 111.285 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -105.49 146.8 29.07 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.903 -0.777 . . . . 0.47999999999999998 108.903 178.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 899' ' ' VAL . . . . . 0.73 HG21 ' HB ' ' C' ' 980' ' ' ILE . 93.7 t -90.83 122.24 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 C-N-CA 119.727 -0.789 . . . . 0.55000000000000004 111.255 -178.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 900' ' ' LEU . . . . . 0.405 HD22 ' HB2' ' C' ' 924' ' ' SER . 93.8 mt -92.06 111.12 22.55 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 114.375 1.25 . . . . 1.5900000000000001 114.375 -175.166 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 20.3 m -67.29 140.35 57.31 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 106.98 -1.489 . . . . 0.050000000000000003 106.98 176.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -64.37 -64.73 3.41 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 110.497 -1.041 . . . . 0.029999999999999999 110.497 -179.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 45.1 62.6 2.06 Favored 'General case' 0 N--CA 1.508 2.447 0 O-C-N 121.508 -0.995 . . . . 3.2000000000000002 111.346 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -68.22 -7.5 30.92 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.588 -0.695 . . . . 2.9199999999999999 111.899 -179.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 905' ' ' HIS . . . . . 0.494 ' O ' ' CB ' ' C' ' 906' ' ' GLU . 74.5 t60 -63.34 7.86 0.09 Allowed 'General case' 0 N--CA 1.505 2.323 0 CA-C-O 117.604 -1.188 . . . . 2.8700000000000001 113.567 -179.326 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 906' ' ' GLU . . . . . 0.494 ' CB ' ' O ' ' C' ' 905' ' ' HIS . 0.8 OUTLIER 94.12 -164.29 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.474 0 CA-C-N 121.292 1.86 . . . . 0.98999999999999999 111.727 179.202 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 907' ' ' LYS . . . . . 0.477 ' CB ' ' O ' ' C' ' 906' ' ' GLU . 34.8 tttp 86.92 156.14 0.07 Allowed 'General case' 0 N--CA 1.519 3.002 0 N-CA-C 108.014 -1.106 . . . . 5.25 108.014 -176.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 60.1 t -122.58 116.11 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 120.835 -1.165 . . . . 0.39000000000000001 110.991 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -104.69 131.47 52.08 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 107.503 -1.295 . . . . 1.72 107.503 177.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -154.73 122.34 5.75 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 106.675 -1.602 . . . . 0.67000000000000004 106.675 178.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 911' ' ' VAL . . . . . 0.736 HG22 HG13 ' C' ' 964' ' ' VAL . 87.6 t -81.7 131.86 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.871 -0.518 . . . . 0.54000000000000004 110.975 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 52.8 mt -66.83 156.85 34.5 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.354 -0.841 . . . . 1.5 109.091 178.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 913' ' ' SER . . . . . 0.454 ' OG ' HG11 ' C' ' 919' ' ' VAL . 1.7 p -124.0 138.24 54.48 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.242 -1.021 . . . . 1.3700000000000001 108.242 177.025 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 914' ' ' ARG . . . . . 0.872 ' NH1' HD23 ' C' ' 956' ' ' LEU . 0.0 OUTLIER -64.79 153.2 40.66 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 120.624 -1.298 . . . . 4.2999999999999998 111.401 -179.112 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 915' ' ' SER . . . . . 0.426 ' CB ' ' O ' ' C' ' 914' ' ' ARG . 1.4 t 83.59 -30.55 0.08 Allowed 'General case' 0 N--CA 1.522 3.144 0 C-N-CA 123.853 0.861 . . . . 2.0499999999999998 112.199 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 916' ' ' ASN . . . . . 0.717 ' HB2' HG21 ' C' ' 919' ' ' VAL . 99.2 m-20 -122.18 -21.8 5.79 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 120.834 -1.166 . . . . 2.71 111.422 -179.256 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 67.04 167.22 0.23 Allowed 'General case' 0 N--CA 1.52 3.045 0 N-CA-C 105.845 -1.909 . . . . 2.6800000000000002 105.845 -174.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 53.83 -126.37 35.23 Favored Glycine 1 N--CA 1.523 4.437 0 CA-C-N 123.481 2.855 . . . . 0.029999999999999999 107.132 -177.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 919' ' ' VAL . . . . . 0.717 HG21 ' HB2' ' C' ' 916' ' ' ASN . 95.4 t 50.94 95.26 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 O-C-N 121.467 -1.019 . . . . 1.3899999999999999 109.425 -178.437 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 920' ' ' ALA . . . . . 0.956 ' HB3' HG12 ' C' ' 949' ' ' VAL . . . -93.05 93.03 8.1 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.27 -0.972 . . . . 0.029999999999999999 110.486 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 921' ' ' ARG . . . . . 0.846 ' HG3' HG23 ' C' ' 922' ' ' VAL . 44.5 ptt85 -83.19 -41.7 18.13 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 105.956 -1.868 . . . . 4.4199999999999999 105.956 176.408 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 922' ' ' VAL . . . . . 0.846 HG23 ' HG3' ' C' ' 921' ' ' ARG . 84.8 t -98.84 77.54 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 105.712 -1.959 . . . . 0.84999999999999998 105.712 175.375 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -87.95 133.47 33.93 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.834 0.826 . . . . 2.46 111.755 -177.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 924' ' ' SER . . . . . 0.405 ' HB2' HD22 ' C' ' 900' ' ' LEU . 5.6 t -147.23 104.92 3.7 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.383 -0.969 . . . . 0.69999999999999996 108.383 178.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -103.14 89.72 0.72 Allowed Glycine 0 N--CA 1.486 1.978 0 N-CA-C 108.434 -1.866 . . . . 0.040000000000000001 108.434 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.219 0 N-CA-C 108.972 -1.651 . . . . 0.040000000000000001 108.972 -179.657 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 17.5 m . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 120.936 0.398 . . . . 13.779999999999999 110.348 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 92.3 mt -114.32 129.96 56.65 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.479 -0.763 . . . . 13.76 110.238 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -152.41 170.82 31.65 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.495 -1.442 . . . . 9.1300000000000008 109.495 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 949' ' ' VAL . . . . . 0.956 HG12 ' HB3' ' C' ' 920' ' ' ALA . 35.7 m -117.28 135.1 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.644 -0.915 . . . . 7.0800000000000001 110.947 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 950' ' ' PHE . . . . . 0.46 ' CZ ' ' HB3' ' C' ' 921' ' ' ARG . 42.6 p90 -133.61 150.62 51.6 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.603 -0.686 . . . . 7.5899999999999999 109.323 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 67.7 m -118.43 -55.77 2.19 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.385 -0.822 . . . . 5.0300000000000002 111.936 -178.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 952' ' ' LEU . . . . . 0.467 ' O ' ' O ' ' C' ' 953' ' ' ILE . 44.9 tp -64.83 -76.34 0.07 Allowed 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.39 -0.819 . . . . 1.01 111.512 -178.191 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 953' ' ' ILE . . . . . 0.593 HD12 ' HD3' ' C' ' 955' ' ' PRO . 2.1 pp -48.31 -151.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.78 0 N-CA-C 114.687 1.366 . . . . 2.6000000000000001 114.687 -176.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 954' ' ' LEU . . . . . 0.871 HD23 ' CE1' ' C' ' 894' ' ' TYR . 0.0 OUTLIER 173.57 90.43 0.06 OUTLIER Pre-proline 0 N--CA 1.516 2.864 0 O-C-N 120.567 -1.333 . . . . 0.050000000000000003 112.42 -179.385 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 955' ' ' PRO . . . . . 0.788 ' C ' HD12 ' C' ' 956' ' ' LEU . 53.8 Cg_endo -82.93 89.68 1.1 Allowed 'Trans proline' 0 C--N 1.316 -1.14 0 N-CA-C 109.182 -1.122 . . . . 0.83999999999999997 109.182 178.456 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 956' ' ' LEU . . . . . 0.872 HD23 ' NH1' ' C' ' 914' ' ' ARG . 9.9 mp -124.42 146.76 48.71 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.984 -1.073 . . . . 0.040000000000000001 110.406 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -83.44 152.08 25.16 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 117.691 -1.147 . . . . 1.28 111.569 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -66.97 118.5 10.52 Favored 'General case' 0 N--CA 1.507 2.41 0 CA-C-N 122.985 2.63 . . . . 0.17000000000000001 110.896 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.43 -19.82 47.98 Favored Glycine 0 N--CA 1.5 2.923 0 N-CA-C 111.032 -0.827 . . . . 0.040000000000000001 111.032 178.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 960' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.69 170.62 0.16 Allowed 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.283 -1.128 . . . . 0.040000000000000001 110.073 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 961' ' ' THR . . . . . 0.476 ' HA ' ' O ' ' C' ' 886' ' ' PHE . 31.2 m -136.67 140.1 42.48 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.877 -1.14 . . . . 1.78 112.836 -177.35 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 962' ' ' VAL . . . . . 0.908 HG22 ' HB3' ' C' ' 886' ' ' PHE . 33.1 m -98.96 145.84 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.681 -0.637 . . . . 0.040000000000000001 110.934 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 4.8 t -138.63 144.33 39.66 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.811 -0.556 . . . . 0.71999999999999997 109.996 -179.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 964' ' ' VAL . . . . . 0.736 HG13 HG22 ' C' ' 911' ' ' VAL . 59.7 t -94.95 135.81 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.024 -1.047 . . . . 1.05 110.77 -179.061 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -96.51 126.48 41.73 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 103.705 -2.702 . . . . 3.02 103.705 173.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 966' ' ' LEU . . . . . 0.493 ' C ' HG23 ' C' ' 967' ' ' VAL . 2.8 tt -132.21 63.32 1.62 Allowed 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.256 -1.016 . . . . 1.46 108.256 177.407 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 967' ' ' VAL . . . . . 0.493 HG23 ' C ' ' C' ' 966' ' ' LEU . 96.8 t -157.53 96.92 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.21 -1.033 . . . . 1.9399999999999999 108.21 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 93.2 mmm -142.37 59.45 1.45 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.742 -1.224 . . . . 0.0 108.316 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 134.73 119.47 1.95 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 107.173 -2.371 . . . . 2.1099999999999999 107.173 -178.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -82.4 -57.7 3.25 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.02 -1.283 . . . . 5.8899999999999997 110.607 -179.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 40.4 tp -58.66 90.12 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.471 -0.768 . . . . 4.3600000000000003 110.312 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -142.29 -153.18 0.45 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.578 -0.701 . . . . 1.8300000000000001 110.122 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 17.5 m80 -118.8 168.68 10.52 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.399 -0.813 . . . . 4.3499999999999996 110.075 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 28.9 t -101.42 130.94 47.73 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.534 -0.728 . . . . 1.27 109.918 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -156.31 157.91 36.54 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.452 -0.78 . . . . 5.0199999999999996 110.717 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.62 86.01 23.68 Favored Pre-proline 0 N--CA 1.5 2.071 0 O-C-N 121.667 -0.646 . . . . 2.4100000000000001 109.277 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.91 -170.15 0.66 Allowed 'Trans proline' 0 C--N 1.318 -1.046 0 O-C-N 123.416 1.219 . . . . 0.95999999999999996 111.49 -179.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 978' ' ' LEU . . . . . 0.786 ' HG ' HD12 ' C' ' 856' ' ' LEU . 6.2 tt -126.43 152.12 46.81 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 107.889 -1.152 . . . . 0.62 107.889 178.53 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 979' ' ' THR . . . . . 0.464 HG23 ' C ' ' C' ' 978' ' ' LEU . 47.6 p -150.87 139.42 20.57 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.73 -1.231 . . . . 3.5699999999999998 111.084 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 980' ' ' ILE . . . . . 0.73 ' HB ' HG21 ' C' ' 899' ' ' VAL . 51.2 mm -106.39 129.48 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 109.213 -0.662 . . . . 1.3300000000000001 109.213 179.465 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 981' ' ' PHE . . . . . 0.451 ' CD1' ' CE2' ' C' ' 879' ' ' TYR . 4.7 t80 -118.35 95.25 4.79 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 119.703 -0.799 . . . . 0.050000000000000003 111.635 -178.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 982' ' ' SER . . . . . 0.505 ' HB2' HD23 ' A' ' 952' ' ' LEU . 23.1 p -107.85 158.88 16.96 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 109.164 -0.68 . . . . 0.87 109.164 178.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 983' ' ' GLY . . . . . 0.413 ' O ' ' CZ ' ' C' ' 852' ' ' PHE . . . -170.85 115.23 0.57 Allowed Glycine 0 N--CA 1.497 2.745 0 N-CA-C 106.701 -2.56 . . . . 0.029999999999999999 106.701 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 984' ' ' ALA . . . . . 0.465 ' HB1' ' CZ ' ' A' ' 893' ' ' ARG . . . -108.31 150.34 27.46 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 114.352 1.241 . . . . 0.69999999999999996 114.352 -175.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 985' ' ' LEU . . . . . 0.633 HD13 HD22 ' C' ' 890' ' ' LEU . 53.5 tp -76.42 135.5 39.44 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.833 -1.167 . . . . 0.040000000000000001 109.637 179.226 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 986' ' ' LEU . . . . . 0.568 HD11 HD11 ' B' ' 986' ' ' LEU . 42.1 tp -106.98 -60.44 1.67 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.402 -0.811 . . . . 0.040000000000000001 110.304 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -142.81 146.73 34.47 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 107.698 -1.223 . . . . 0.040000000000000001 107.698 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.3 163.22 12.2 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 108.395 -1.882 . . . . 0.040000000000000001 108.395 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -75.65 112.85 21.63 Favored Pre-proline 0 N--CA 1.498 1.943 0 O-C-N 121.246 -1.15 . . . . 0.040000000000000001 109.59 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 990' ' ' PRO . . . . . 0.418 ' O ' ' HB2' ' C' ' 991' ' ' GLU . 50.6 Cg_endo -89.58 71.47 1.82 Allowed 'Trans proline' 0 C--N 1.32 -0.961 0 O-C-N 123.106 1.056 . . . . 0.45000000000000001 111.537 -179.044 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 991' ' ' GLU . . . . . 0.418 ' HB2' ' O ' ' C' ' 990' ' ' PRO . 66.0 mt-10 67.49 -73.29 0.08 Allowed 'General case' 0 N--CA 1.503 2.209 0 N-CA-C 108.593 -0.891 . . . . 1.97 108.593 -177.475 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 992' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' C' ' 992' ' ' LEU . 11.1 mt 50.65 20.82 0.78 Allowed 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.592 -0.693 . . . . 2.3799999999999999 111.709 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -92.99 156.92 16.59 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.899 -1.126 . . . . 3.79 110.07 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 67.0 m80 -145.93 92.2 2.18 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.537 -0.727 . . . . 3.5099999999999998 110.265 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 995' ' ' ALA . . . . . . . . . . . . 2.517 . . . . . . . 0 N--CA 1.503 2.221 0 O-C-N 120.931 -1.106 . . . . 2.73 110.586 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo . . . . . 0 N--CA 1.488 1.162 0 N-CA-C 109.506 -0.998 . . . . 3.8300000000000001 109.506 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 847' ' ' VAL . . . . . 0.416 HG12 ' HB2' ' A' ' 849' ' ' GLN . 59.9 t -133.0 102.92 13.09 Favored Pre-proline 0 N--CA 1.496 1.835 0 O-C-N 121.603 -0.686 . . . . 1.8300000000000001 110.079 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 848' ' ' PRO . . . . . 0.756 ' O ' HG23 ' A' ' 850' ' ' VAL . 43.7 Cg_endo -69.82 -19.87 35.27 Favored 'Trans proline' 0 N--CA 1.487 1.125 0 O-C-N 123.274 1.144 . . . . 0.65000000000000002 111.028 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 849' ' ' GLN . . . . . 0.416 ' HB2' HG12 ' A' ' 847' ' ' VAL . 56.0 tt0 27.83 68.85 0.07 Allowed 'General case' 0 N--CA 1.518 2.968 0 N-CA-C 112.861 0.689 . . . . 2.5800000000000001 112.861 179.247 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 850' ' ' VAL . . . . . 0.756 HG23 ' O ' ' A' ' 848' ' ' PRO . 83.9 t -119.66 137.26 54.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.151 -0.968 . . . . 1.0900000000000001 111.603 -178.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 851' ' ' ALA . . . . . 0.477 ' HB3' ' HG ' ' A' ' 873' ' ' LEU . . . -126.99 158.52 36.68 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 105.876 -1.898 . . . . 0.040000000000000001 105.876 176.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 852' ' ' PHE . . . . . 0.436 ' HA ' ' CB ' ' A' ' 874' ' ' ASN . 46.6 p90 -157.59 131.97 8.38 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 120.989 1.722 . . . . 0.050000000000000003 108.613 178.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 19.5 t -175.03 132.84 0.32 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.07 -1.085 . . . . 0.040000000000000001 108.07 -178.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -135.41 153.1 51.91 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.173 -0.955 . . . . 0.67000000000000004 109.182 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 855' ' ' ALA . . . . . 0.701 ' HB3' ' CB ' ' A' ' 870' ' ' ARG . . . -124.24 140.11 53.27 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.942 0.877 . . . . 0.51000000000000001 111.689 -178.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 856' ' ' LEU . . . . . 0.815 HD11 HD23 ' A' ' 858' ' ' LEU . 3.3 tm? -106.8 137.46 44.8 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 109.366 -0.605 . . . . 0.050000000000000003 109.366 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 857' ' ' SER . . . . . 0.686 ' N ' HD13 ' A' ' 856' ' ' LEU . 1.3 m -155.02 15.43 0.41 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.323 -0.861 . . . . 1.3300000000000001 111.697 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 858' ' ' LEU . . . . . 0.815 HD23 HD11 ' A' ' 856' ' ' LEU . 3.0 pp -34.29 159.91 0.04 OUTLIER Pre-proline 0 N--CA 1.518 2.942 0 N-CA-C 113.088 0.773 . . . . 2.3300000000000001 113.088 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -60.87 -88.59 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 120.898 1.066 . . . . 2.3199999999999998 113.686 -177.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 54.3 ptt85 -126.19 -142.77 0.29 Allowed 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.902 -1.124 . . . . 0.040000000000000001 111.575 -177.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 75.1 m -38.53 126.22 1.42 Allowed 'General case' 0 N--CA 1.509 2.507 0 O-C-N 121.63 -0.668 . . . . 1.3100000000000001 112.148 -178.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -101.3 161.15 24.51 Favored Pre-proline 0 N--CA 1.489 1.512 0 N-CA-C 108.579 -0.897 . . . . 4.5099999999999998 108.579 178.062 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -71.09 -15.34 32.18 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 O-C-N 123.251 1.132 . . . . 2.2400000000000002 111.65 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -177.4 -136.5 2.48 Favored Glycine 0 N--CA 1.495 2.577 0 C-N-CA 119.541 -1.314 . . . . 0.040000000000000001 110.838 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 865' ' ' THR . . . . . 0.433 HG22 ' N ' ' A' ' 866' ' ' VAL . 41.1 m -61.69 162.84 7.97 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.479 -1.012 . . . . 1.51 111.362 -178.141 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 866' ' ' VAL . . . . . 0.433 ' N ' HG22 ' A' ' 865' ' ' THR . 0.1 OUTLIER -97.12 127.01 40.09 Favored Pre-proline 0 N--CA 1.504 2.237 0 N-CA-C 113.042 0.756 . . . . 0.78000000000000003 113.042 -174.41 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 867' ' ' PRO . . . . . 0.803 ' O ' HD23 ' A' ' 856' ' ' LEU . 54.1 Cg_endo -90.64 -153.18 0.04 OUTLIER 'Trans proline' 0 CA--C 1.54 0.787 0 N-CA-C 108.63 -1.335 . . . . 0.92000000000000004 108.63 177.479 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 868' ' ' PHE . . . . . 0.468 ' CD1' ' HG2' ' A' ' 881' ' ' PRO . 24.3 p90 -149.93 122.77 8.71 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 120.523 -1.361 . . . . 0.050000000000000003 110.247 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 49.6 p-10 -112.91 -3.19 14.14 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 119.442 -0.903 . . . . 1.7 112.083 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 870' ' ' ARG . . . . . 0.701 ' CB ' ' HB3' ' A' ' 855' ' ' ALA . 29.4 mmm180 -90.58 89.29 7.48 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.947 -1.096 . . . . 2.5899999999999999 110.675 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 58.1 t -73.13 97.16 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 120.975 -1.078 . . . . 1.9399999999999999 110.091 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 872' ' ' LEU . . . . . . . . . . . . . 96.1 mt -83.13 -47.28 11.8 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.498 -0.751 . . . . 1.0600000000000001 110.099 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 873' ' ' LEU . . . . . 0.477 ' HG ' ' HB3' ' A' ' 851' ' ' ALA . 43.0 tp -175.06 104.47 0.09 Allowed 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.308 -0.87 . . . . 4.1799999999999997 108.706 178.641 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 874' ' ' ASN . . . . . 0.436 ' CB ' ' HA ' ' A' ' 852' ' ' PHE . 35.0 t-20 178.33 81.9 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.336 0 O-C-N 121.6 -0.687 . . . . 0.040000000000000001 109.521 -178.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -66.85 -47.33 72.27 Favored 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 119.291 -0.964 . . . . 3.3799999999999999 111.334 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 876' ' ' GLY . . . . . 0.414 ' HA3' ' CE2' ' A' ' 878' ' ' TYR . . . -74.51 -25.19 70.87 Favored Glycine 0 N--CA 1.495 2.568 0 O-C-N 121.22 -0.925 . . . . 0.040000000000000001 111.777 -178.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 81.88 -62.09 4.58 Favored Glycine 0 N--CA 1.502 3.09 0 N-CA-C 107.974 -2.05 . . . . 0.040000000000000001 107.974 -178.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 878' ' ' TYR . . . . . 0.414 ' CE2' ' HA3' ' A' ' 876' ' ' GLY . 95.6 m-85 61.5 -60.27 0.1 Allowed 'General case' 0 N--CA 1.504 2.236 0 N-CA-C 114.498 1.296 . . . . 3.46 114.498 177.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 879' ' ' TYR . . . . . 0.475 ' CB ' ' CD2' ' A' ' 886' ' ' PHE . 21.3 p90 -111.73 108.96 18.57 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 114.66 1.356 . . . . 0.040000000000000001 114.66 -176.318 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -66.55 117.85 48.33 Favored Pre-proline 0 N--CA 1.497 1.899 0 O-C-N 121.403 -0.811 . . . . 0.02 109.911 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 881' ' ' PRO . . . . . 0.468 ' HG2' ' CD1' ' A' ' 868' ' ' PHE . 52.8 Cg_endo -77.15 -0.33 10.48 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 O-C-N 123.42 1.221 . . . . 0.39000000000000001 112.275 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -75.92 -62.91 1.43 Allowed 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 106.62 -1.622 . . . . 0.81000000000000005 106.62 178.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 19.5 p -94.44 -19.53 20.5 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.659 -0.867 . . . . 0.040000000000000001 108.659 177.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.43 20.83 57.93 Favored Glycine 0 N--CA 1.497 2.731 0 O-C-N 121.154 -0.966 . . . . 0.029999999999999999 111.035 178.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 885' ' ' VAL . . . . . 0.737 HG13 HG21 ' A' ' 961' ' ' THR . 97.7 t -73.0 90.0 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 C-N-CA 118.261 -1.376 . . . . 1.01 108.132 -179.386 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 886' ' ' PHE . . . . . 0.928 ' HB3' HG22 ' A' ' 962' ' ' VAL . 0.8 OUTLIER -89.31 104.04 16.62 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-N 115.298 -0.864 . . . . 0.050000000000000003 111.825 -177.555 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 887' ' ' THR . . . . . 0.422 ' O ' ' HD3' ' A' ' 889' ' ' PRO . 93.1 m -95.26 100.69 12.44 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 107.826 -1.175 . . . . 0.68000000000000005 107.826 177.601 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 888' ' ' ALA . . . . . . . . . . . . . . . -98.4 106.99 39.49 Favored Pre-proline 0 N--CA 1.502 2.153 0 N-CA-C 114.009 1.114 . . . . 0.25 114.009 -176.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 889' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 887' ' ' THR . 53.6 Cg_endo -89.84 -12.67 2.86 Favored 'Trans proline' 0 CA--C 1.546 1.122 0 C-N-CA 121.055 1.17 . . . . 1.6399999999999999 109.111 176.236 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 890' ' ' LEU . . . . . 0.934 HD22 HD13 ' A' ' 985' ' ' LEU . 72.9 mt -36.59 -50.31 0.8 Allowed 'General case' 0 N--CA 1.509 2.479 0 N-CA-C 113.636 0.976 . . . . 2.29 113.636 -177.377 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 52.19 95.85 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.295 0 O-C-N 121.156 -0.965 . . . . 0.63 110.238 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 157.85 -153.33 24.54 Favored Glycine 0 N--CA 1.478 1.456 0 N-CA-C 107.234 -2.347 . . . . 0.040000000000000001 107.234 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 893' ' ' ARG . . . . . 0.459 ' CZ ' ' HB1' ' C' ' 984' ' ' ALA . 73.2 ttt-85 -115.53 126.3 54.09 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 121.533 -0.981 . . . . 3.0 108.552 177.552 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 894' ' ' TYR . . . . . 0.77 ' OH ' HD12 ' A' ' 896' ' ' LEU . 0.1 OUTLIER -132.87 160.09 37.97 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.083 -1.011 . . . . 0.040000000000000001 111.083 -179.703 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 895' ' ' LEU . . . . . 0.836 HD23 HD11 ' B' ' 952' ' ' LEU . 36.0 tp -91.73 119.45 31.59 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.728 -0.607 . . . . 1.27 110.1 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 896' ' ' LEU . . . . . 0.77 HD12 ' OH ' ' A' ' 894' ' ' TYR . 9.2 tt -109.69 144.31 38.25 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.7 -0.625 . . . . 0.93999999999999995 110.155 -179.489 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 897' ' ' SER . . . . . 0.489 ' N ' HD23 ' A' ' 896' ' ' LEU . 69.5 m -149.95 114.8 5.33 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.49 -0.756 . . . . 0.040000000000000001 111.007 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -106.96 146.84 30.57 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.912 -0.773 . . . . 0.47999999999999998 108.912 178.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 899' ' ' VAL . . . . . 0.754 HG21 ' HB ' ' A' ' 980' ' ' ILE . 88.2 t -96.45 119.13 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 C-N-CA 119.59 -0.844 . . . . 0.55000000000000004 111.255 -179.192 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 900' ' ' LEU . . . . . 0.488 HD12 ' HB2' ' A' ' 924' ' ' SER . 4.5 mm? -95.75 111.18 23.2 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 114.036 1.124 . . . . 1.5900000000000001 114.036 -175.568 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 18.3 m -64.52 140.19 58.84 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 107.458 -1.312 . . . . 0.050000000000000003 107.458 177.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -63.09 -66.62 2.46 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 110.429 -1.068 . . . . 0.029999999999999999 110.429 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 4.1 m170 46.93 66.9 0.88 Allowed 'General case' 0 N--CA 1.507 2.398 0 O-C-N 121.495 -1.003 . . . . 3.2000000000000002 110.991 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -68.5 -7.17 29.84 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.581 -0.699 . . . . 2.9199999999999999 111.937 -179.333 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 905' ' ' HIS . . . . . 0.489 ' O ' ' CB ' ' A' ' 906' ' ' GLU . 67.0 t60 -63.55 4.54 0.24 Allowed 'General case' 0 N--CA 1.504 2.272 0 O-C-N 120.942 -1.099 . . . . 2.8700000000000001 112.843 -179.268 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 906' ' ' GLU . . . . . 0.489 ' CB ' ' O ' ' A' ' 905' ' ' HIS . 0.8 OUTLIER 94.7 -162.95 0.0 OUTLIER 'General case' 0 N--CA 1.53 3.552 0 CA-C-N 120.729 1.604 . . . . 0.98999999999999999 112.218 178.752 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 907' ' ' LYS . . . . . 0.492 ' HE2' ' HB1' ' A' ' 972' ' ' ALA . 94.1 mttt 89.27 159.71 0.05 Allowed 'General case' 0 N--CA 1.522 3.162 0 N-CA-C 107.862 -1.162 . . . . 5.25 107.862 -176.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 58.6 t -122.29 116.37 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 120.882 -1.137 . . . . 0.39000000000000001 110.91 -179.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 909' ' ' GLU . . . . . 0.685 ' OE2' HD12 ' A' ' 966' ' ' LEU . 48.9 tp10 -100.78 132.89 45.96 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.513 -1.292 . . . . 1.72 107.513 176.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -156.99 121.95 4.54 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 106.988 -1.486 . . . . 0.67000000000000004 106.988 178.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 911' ' ' VAL . . . . . 0.723 HG22 HG13 ' A' ' 964' ' ' VAL . 95.3 t -85.08 131.85 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.85 -0.532 . . . . 0.54000000000000004 111.076 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 73.0 mt -65.76 157.66 29.69 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.432 -0.792 . . . . 1.5 109.011 178.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 913' ' ' SER . . . . . 0.409 ' CB ' ' HB ' ' A' ' 919' ' ' VAL . 2.6 t -124.1 136.61 54.35 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.266 -1.013 . . . . 1.3700000000000001 108.266 177.051 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 914' ' ' ARG . . . . . 0.685 ' NH1' HD23 ' A' ' 956' ' ' LEU . 0.0 OUTLIER -65.07 154.53 37.58 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 120.612 -1.305 . . . . 4.2999999999999998 111.357 -179.186 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 915' ' ' SER . . . . . 0.427 ' CB ' ' O ' ' A' ' 914' ' ' ARG . 4.3 t 83.14 -31.61 0.08 Allowed 'General case' 0 N--CA 1.521 3.124 0 C-N-CA 123.853 0.861 . . . . 2.0499999999999998 112.089 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 916' ' ' ASN . . . . . 0.743 ' HB2' HG21 ' A' ' 919' ' ' VAL . 91.0 m-20 -123.61 -21.48 5.23 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 120.85 -1.157 . . . . 2.71 111.274 -179.297 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 917' ' ' GLN . . . . . 0.438 ' HB2' ' O ' ' A' ' 916' ' ' ASN . 44.4 mt-30 65.84 166.45 0.19 Allowed 'General case' 0 N--CA 1.519 2.984 0 N-CA-C 105.957 -1.868 . . . . 2.6800000000000002 105.957 -173.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.54 -125.62 35.0 Favored Glycine 1 N--CA 1.521 4.356 0 CA-C-N 123.382 2.81 . . . . 0.029999999999999999 106.78 -177.609 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 919' ' ' VAL . . . . . 0.743 HG21 ' HB2' ' A' ' 916' ' ' ASN . 71.8 t 52.47 93.58 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.241 0 O-C-N 121.31 -1.112 . . . . 1.3899999999999999 108.74 -178.17 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 920' ' ' ALA . . . . . 0.802 ' HB3' HG12 ' A' ' 949' ' ' VAL . . . -91.14 90.96 8.03 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.219 -0.993 . . . . 0.029999999999999999 110.956 -178.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 921' ' ' ARG . . . . . 0.834 ' HG3' HG23 ' A' ' 922' ' ' VAL . 30.2 ptt180 -86.17 -41.88 14.32 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 105.831 -1.914 . . . . 4.4199999999999999 105.831 175.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 922' ' ' VAL . . . . . 0.834 HG23 ' HG3' ' A' ' 921' ' ' ARG . 85.0 t -103.97 67.45 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 105.979 -1.86 . . . . 0.84999999999999998 105.979 175.622 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 923' ' ' ASP . . . . . 0.719 ' HB2' ' HB1' ' A' ' 920' ' ' ALA . 22.5 t0 -89.83 134.64 34.08 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.709 0.766 . . . . 2.46 111.655 -177.358 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 924' ' ' SER . . . . . 0.488 ' HB2' HD12 ' A' ' 900' ' ' LEU . 8.5 t -147.18 103.27 3.57 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.477 -0.935 . . . . 0.69999999999999996 108.477 178.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -109.59 90.28 0.59 Allowed Glycine 0 N--CA 1.487 2.063 0 N-CA-C 108.411 -1.875 . . . . 0.040000000000000001 108.411 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.352 0 N-CA-C 109.435 -1.466 . . . . 0.040000000000000001 109.435 -179.186 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 29.5 m . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 120.995 0.426 . . . . 13.779999999999999 110.341 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 95.2 mt -113.03 129.99 56.31 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.492 -0.755 . . . . 13.76 110.455 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -151.91 168.11 31.18 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.197 -1.561 . . . . 9.1300000000000008 109.197 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 949' ' ' VAL . . . . . 0.802 HG12 ' HB3' ' A' ' 920' ' ' ALA . 27.2 m -119.02 128.87 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.532 -0.981 . . . . 7.0800000000000001 110.78 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 950' ' ' PHE . . . . . 0.463 ' CE1' ' HD2' ' A' ' 955' ' ' PRO . 26.2 p90 -131.76 148.13 52.55 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.559 -0.713 . . . . 7.5899999999999999 109.487 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 19.8 m -121.26 -52.06 2.07 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.358 -0.838 . . . . 5.0300000000000002 112.169 -178.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 952' ' ' LEU . . . . . 0.426 ' O ' ' O ' ' A' ' 953' ' ' ILE . 53.8 tp -59.75 -75.1 0.06 Allowed 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.41 -0.806 . . . . 1.01 112.557 -177.426 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 953' ' ' ILE . . . . . 0.482 HD11 HD13 ' C' ' 872' ' ' LEU . 43.3 pt -52.34 -143.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.784 0 N-CA-C 114.177 1.177 . . . . 2.6000000000000001 114.177 -176.385 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 954' ' ' LEU . . . . . 0.725 HD22 ' O ' ' A' ' 954' ' ' LEU . 0.0 OUTLIER 174.07 77.2 0.05 OUTLIER Pre-proline 0 N--CA 1.506 2.367 0 O-C-N 120.671 -1.268 . . . . 0.050000000000000003 111.291 179.929 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 955' ' ' PRO . . . . . 0.746 ' C ' HD12 ' A' ' 956' ' ' LEU . 48.9 Cg_endo -76.66 91.73 1.13 Allowed 'Trans proline' 0 C--N 1.314 -1.238 0 N-CA-C 109.614 -0.956 . . . . 0.83999999999999997 109.614 178.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 956' ' ' LEU . . . . . 0.746 HD12 ' C ' ' A' ' 955' ' ' PRO . 11.1 mp -121.98 146.14 47.44 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.225 -0.922 . . . . 0.040000000000000001 109.818 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -84.44 150.74 25.1 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 117.831 -1.081 . . . . 1.28 111.876 -178.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -70.2 120.24 15.58 Favored 'General case' 0 N--CA 1.51 2.525 0 CA-C-N 122.788 2.54 . . . . 0.17000000000000001 111.74 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.51 -22.63 31.99 Favored Glycine 0 N--CA 1.5 2.907 0 N-CA-C 111.122 -0.791 . . . . 0.040000000000000001 111.122 178.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 960' ' ' ASP . . . . . 0.451 ' HB3' ' NE ' ' A' ' 914' ' ' ARG . 0.4 OUTLIER -55.38 171.9 0.16 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.451 -1.029 . . . . 0.040000000000000001 110.006 -179.567 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 961' ' ' THR . . . . . 0.737 HG21 HG13 ' A' ' 885' ' ' VAL . 41.5 m -135.06 135.43 41.26 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.879 -1.138 . . . . 1.78 111.884 -178.194 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 962' ' ' VAL . . . . . 0.928 HG22 ' HB3' ' A' ' 886' ' ' PHE . 32.7 m -97.79 145.92 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 C-N-CA 120.094 -0.642 . . . . 0.040000000000000001 110.138 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 5.6 t -138.5 145.98 41.43 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.852 -0.53 . . . . 0.71999999999999997 110.329 -178.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 964' ' ' VAL . . . . . 0.723 HG13 HG22 ' A' ' 911' ' ' VAL . 59.2 t -94.37 137.37 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.258 -0.901 . . . . 1.05 110.459 -179.302 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -93.28 127.54 38.91 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 103.791 -2.67 . . . . 3.02 103.791 173.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 966' ' ' LEU . . . . . 0.685 HD12 ' OE2' ' A' ' 909' ' ' GLU . 0.2 OUTLIER -132.81 60.0 1.71 Allowed 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.35 -0.981 . . . . 1.46 108.35 177.309 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 967' ' ' VAL . . . . . 0.49 HG23 ' C ' ' A' ' 966' ' ' LEU . 98.5 t -157.96 96.88 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 108.049 -1.093 . . . . 1.9399999999999999 108.049 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 92.2 mmm -142.65 60.44 1.43 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.725 -1.234 . . . . 0.0 108.434 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.59 120.48 2.01 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 107.203 -2.359 . . . . 2.1099999999999999 107.203 -178.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -82.06 -59.88 2.41 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 118.76 1.28 . . . . 5.8899999999999997 110.189 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 50.9 tp -59.81 90.95 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.44 -0.787 . . . . 4.3600000000000003 109.894 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 972' ' ' ALA . . . . . 0.492 ' HB1' ' HE2' ' A' ' 907' ' ' LYS . . . -141.41 -154.62 0.53 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.571 -0.706 . . . . 1.8300000000000001 110.39 -179.457 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -118.8 171.27 8.33 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.471 -0.768 . . . . 4.3499999999999996 110.221 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 34.3 t -101.6 130.23 47.88 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.588 -0.695 . . . . 1.27 110.039 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -156.11 157.05 35.36 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.549 -0.719 . . . . 5.0199999999999996 110.485 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.07 85.74 18.67 Favored Pre-proline 0 N--CA 1.5 2.068 0 O-C-N 121.6 -0.688 . . . . 2.4100000000000001 109.721 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.37 -172.33 1.02 Allowed 'Trans proline' 0 C--N 1.318 -1.068 0 O-C-N 123.313 1.165 . . . . 0.95999999999999996 111.345 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 978' ' ' LEU . . . . . 0.668 HD23 HD12 ' A' ' 856' ' ' LEU . 4.9 mp -127.7 154.44 45.31 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 107.691 -1.226 . . . . 0.62 107.691 178.107 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 979' ' ' THR . . . . . 0.464 HG23 ' C ' ' A' ' 978' ' ' LEU . 41.4 p -150.18 140.94 22.7 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.696 -1.253 . . . . 3.5699999999999998 111.14 -179.388 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 980' ' ' ILE . . . . . 0.754 ' HB ' HG21 ' A' ' 899' ' ' VAL . 46.3 mm -107.32 128.98 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 109.022 -0.733 . . . . 1.3300000000000001 109.022 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 981' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -118.95 95.16 4.71 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 119.804 -0.759 . . . . 0.050000000000000003 111.797 -178.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 82.9 p -107.93 157.96 17.76 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.545 -0.722 . . . . 0.87 109.192 178.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 983' ' ' GLY . . . . . 0.404 ' HA3' ' CE1' ' A' ' 852' ' ' PHE . . . -174.75 110.46 0.32 Allowed Glycine 0 N--CA 1.499 2.888 0 N-CA-C 106.356 -2.698 . . . . 0.029999999999999999 106.356 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -108.22 150.87 26.7 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 114.526 1.306 . . . . 0.69999999999999996 114.526 -175.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 985' ' ' LEU . . . . . 0.934 HD13 HD22 ' A' ' 890' ' ' LEU . 33.1 tp -72.29 135.06 45.87 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.822 -1.174 . . . . 0.040000000000000001 110.07 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 51.8 tp -107.47 -55.8 2.3 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.595 -0.691 . . . . 0.040000000000000001 110.06 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -144.57 145.76 31.98 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 107.668 -1.234 . . . . 0.040000000000000001 107.668 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.6 163.32 12.17 Favored Glycine 0 N--CA 1.495 2.633 0 N-CA-C 108.232 -1.947 . . . . 0.040000000000000001 108.232 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -75.26 112.46 18.66 Favored Pre-proline 0 N--CA 1.499 1.989 0 O-C-N 121.195 -1.179 . . . . 0.040000000000000001 109.463 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 990' ' ' PRO . . . . . 0.418 ' HD2' HD12 ' A' ' 992' ' ' LEU . 50.2 Cg_endo -90.53 70.79 1.39 Allowed 'Trans proline' 0 C--N 1.319 -1.023 0 O-C-N 123.151 1.079 . . . . 0.45000000000000001 111.565 -178.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 991' ' ' GLU . . . . . 0.417 ' HB2' ' O ' ' A' ' 990' ' ' PRO . 69.2 mt-10 67.28 -73.86 0.07 Allowed 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 108.586 -0.894 . . . . 1.97 108.586 -177.443 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 992' ' ' LEU . . . . . 0.418 HD12 ' HD2' ' A' ' 990' ' ' PRO . 11.0 mt 51.01 20.79 0.86 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.541 -0.724 . . . . 2.3799999999999999 111.641 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -94.11 156.89 16.34 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.818 -1.176 . . . . 3.79 109.993 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 72.2 m80 -146.63 93.49 2.3 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.588 -0.695 . . . . 3.5099999999999998 110.309 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 995' ' ' ALA . . . . . . . . . . . . 2.518 . . . . . . . 0 N--CA 1.503 2.224 0 O-C-N 120.868 -1.145 . . . . 2.73 110.572 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo . . . . . 0 N--CA 1.488 1.156 0 N-CA-C 109.5 -1.0 . . . . 3.8300000000000001 109.5 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 847' ' ' VAL . . . . . 0.401 HG12 ' HB2' ' B' ' 849' ' ' GLN . 60.0 t -133.07 102.87 13.03 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.567 -0.708 . . . . 1.8300000000000001 110.139 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 848' ' ' PRO . . . . . 0.758 ' O ' HG23 ' B' ' 850' ' ' VAL . 43.6 Cg_endo -69.7 -20.16 35.48 Favored 'Trans proline' 0 N--CA 1.487 1.092 0 O-C-N 123.235 1.124 . . . . 0.65000000000000002 111.033 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 849' ' ' GLN . . . . . 0.405 ' C ' ' O ' ' B' ' 848' ' ' PRO . 56.1 tt0 28.0 69.1 0.07 Allowed 'General case' 0 N--CA 1.519 2.989 0 N-CA-C 112.768 0.655 . . . . 2.5800000000000001 112.768 179.295 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 850' ' ' VAL . . . . . 0.758 HG23 ' O ' ' B' ' 848' ' ' PRO . 83.1 t -119.85 137.34 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.213 -0.93 . . . . 1.0900000000000001 111.623 -178.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 851' ' ' ALA . . . . . 0.488 ' HB3' ' HG ' ' B' ' 873' ' ' LEU . . . -127.52 157.67 39.5 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 105.907 -1.886 . . . . 0.040000000000000001 105.907 176.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 852' ' ' PHE . . . . . 0.432 ' HA ' ' CB ' ' B' ' 874' ' ' ASN . 46.4 p90 -156.63 132.43 9.58 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-N 121.04 1.745 . . . . 0.050000000000000003 108.541 179.088 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 20.8 t -175.11 132.59 0.31 Allowed 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.14 -1.059 . . . . 0.040000000000000001 108.14 -179.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -135.1 153.46 52.01 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.125 -0.985 . . . . 0.67000000000000004 109.211 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 855' ' ' ALA . . . . . 0.714 ' HB3' ' CB ' ' B' ' 870' ' ' ARG . . . -124.75 140.23 53.12 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.994 0.902 . . . . 0.51000000000000001 111.685 -178.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 856' ' ' LEU . . . . . 0.828 HD11 HD23 ' B' ' 858' ' ' LEU . 3.3 tm? -107.04 137.05 45.84 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.391 -0.596 . . . . 0.050000000000000003 109.391 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 857' ' ' SER . . . . . 0.683 ' N ' HD13 ' B' ' 856' ' ' LEU . 1.3 m -154.63 15.5 0.44 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.442 -0.786 . . . . 1.3300000000000001 111.712 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 858' ' ' LEU . . . . . 0.828 HD23 HD11 ' B' ' 856' ' ' LEU . 3.1 pp -34.32 159.98 0.04 OUTLIER Pre-proline 0 N--CA 1.518 2.956 0 N-CA-C 113.064 0.765 . . . . 2.3300000000000001 113.064 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -61.04 -88.58 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 120.9 1.067 . . . . 2.3199999999999998 113.661 -177.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 54.2 ptt85 -126.28 -142.8 0.29 Allowed 'General case' 0 N--CA 1.5 2.052 0 O-C-N 120.893 -1.129 . . . . 0.040000000000000001 111.551 -177.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 75.3 m -38.41 125.51 1.35 Allowed 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.597 -0.69 . . . . 1.3100000000000001 112.178 -178.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 862' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.59 161.18 24.78 Favored Pre-proline 0 N--CA 1.488 1.451 0 N-CA-C 108.557 -0.905 . . . . 4.5099999999999998 108.557 178.026 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -71.1 -15.29 32.15 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 O-C-N 123.248 1.13 . . . . 2.2400000000000002 111.73 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -177.15 -135.8 2.29 Favored Glycine 0 N--CA 1.495 2.599 0 C-N-CA 119.549 -1.31 . . . . 0.040000000000000001 110.807 179.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 865' ' ' THR . . . . . 0.446 HG22 ' N ' ' B' ' 866' ' ' VAL . 42.0 m -62.31 163.94 7.78 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.415 -1.05 . . . . 1.51 111.288 -178.287 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 866' ' ' VAL . . . . . 0.446 ' N ' HG22 ' B' ' 865' ' ' THR . 0.1 OUTLIER -98.09 127.03 38.07 Favored Pre-proline 0 N--CA 1.504 2.271 0 C-N-CA 119.796 -0.762 . . . . 0.78000000000000003 112.965 -174.464 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 867' ' ' PRO . . . . . 0.807 ' O ' HD23 ' B' ' 856' ' ' LEU . 53.6 Cg_endo -90.6 -153.25 0.04 OUTLIER 'Trans proline' 0 CA--C 1.54 0.789 0 N-CA-C 108.614 -1.341 . . . . 0.92000000000000004 108.614 177.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 868' ' ' PHE . . . . . 0.462 ' CD1' ' HG2' ' B' ' 881' ' ' PRO . 24.4 p90 -149.95 122.56 8.58 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.529 -1.357 . . . . 0.050000000000000003 110.199 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 50.0 p-10 -112.64 -2.76 14.46 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 119.476 -0.89 . . . . 1.7 112.133 -179.125 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 870' ' ' ARG . . . . . 0.714 ' CB ' ' HB3' ' B' ' 855' ' ' ALA . 28.8 mmm180 -91.07 89.15 7.27 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.925 -1.109 . . . . 2.5899999999999999 110.694 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 57.3 t -73.05 97.31 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.012 -1.055 . . . . 1.9399999999999999 110.063 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 872' ' ' LEU . . . . . 0.532 HD22 HD11 ' C' ' 953' ' ' ILE . 96.0 mt -83.27 -47.11 11.87 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.496 -0.752 . . . . 1.0600000000000001 110.067 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 873' ' ' LEU . . . . . 0.488 ' HG ' ' HB3' ' B' ' 851' ' ' ALA . 43.0 tp -175.15 104.43 0.09 Allowed 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 108.709 -0.849 . . . . 4.1799999999999997 108.709 178.624 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 874' ' ' ASN . . . . . 0.432 ' CB ' ' HA ' ' B' ' 852' ' ' PHE . 34.8 t-20 178.37 81.99 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.626 -0.671 . . . . 0.040000000000000001 109.581 -178.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -66.96 -47.34 71.88 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 119.325 -0.95 . . . . 3.3799999999999999 111.327 -179.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 876' ' ' GLY . . . . . 0.411 ' HA3' ' CE2' ' B' ' 878' ' ' TYR . . . -74.59 -25.26 70.52 Favored Glycine 0 N--CA 1.495 2.602 0 O-C-N 121.269 -0.894 . . . . 0.040000000000000001 111.725 -178.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 81.96 -62.08 4.58 Favored Glycine 0 N--CA 1.502 3.05 0 N-CA-C 107.966 -2.054 . . . . 0.040000000000000001 107.966 -178.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 878' ' ' TYR . . . . . 0.411 ' CE2' ' HA3' ' B' ' 876' ' ' GLY . 95.7 m-85 61.52 -60.25 0.1 Allowed 'General case' 0 N--CA 1.504 2.24 0 N-CA-C 114.473 1.286 . . . . 3.46 114.473 177.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 879' ' ' TYR . . . . . 0.477 ' CB ' ' CD2' ' B' ' 886' ' ' PHE . 21.2 p90 -111.68 108.78 18.35 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 114.68 1.363 . . . . 0.040000000000000001 114.68 -176.354 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -66.41 117.77 47.04 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.354 -0.841 . . . . 0.02 109.925 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 881' ' ' PRO . . . . . 0.462 ' HG2' ' CD1' ' B' ' 868' ' ' PHE . 51.8 Cg_endo -77.09 -0.52 10.67 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 O-C-N 123.409 1.215 . . . . 0.39000000000000001 112.261 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -75.73 -63.1 1.37 Allowed 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 106.639 -1.615 . . . . 0.81000000000000005 106.639 178.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 19.7 p -94.38 -19.06 20.96 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.76 -0.83 . . . . 0.040000000000000001 108.76 177.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.88 21.28 57.9 Favored Glycine 0 N--CA 1.496 2.648 0 O-C-N 121.099 -1.0 . . . . 0.029999999999999999 111.03 178.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 885' ' ' VAL . . . . . 0.74 HG13 HG21 ' B' ' 961' ' ' THR . 96.3 t -73.32 90.28 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 C-N-CA 118.242 -1.383 . . . . 1.01 108.123 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 886' ' ' PHE . . . . . 0.878 ' HB3' HG22 ' B' ' 962' ' ' VAL . 0.8 OUTLIER -89.52 104.17 16.75 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 115.323 -0.853 . . . . 0.050000000000000003 111.808 -177.542 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 887' ' ' THR . . . . . 0.418 ' O ' ' HD3' ' B' ' 889' ' ' PRO . 93.4 m -95.34 101.0 12.69 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 107.722 -1.214 . . . . 0.68000000000000005 107.722 177.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 888' ' ' ALA . . . . . . . . . . . . . . . -98.69 106.86 39.61 Favored Pre-proline 0 N--CA 1.503 2.179 0 N-CA-C 114.026 1.121 . . . . 0.25 114.026 -176.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 889' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' B' ' 887' ' ' THR . 53.2 Cg_endo -89.71 -12.71 2.92 Favored 'Trans proline' 0 CA--C 1.547 1.133 0 C-N-CA 121.028 1.152 . . . . 1.6399999999999999 109.107 176.266 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 890' ' ' LEU . . . . . 0.935 HD22 HD13 ' B' ' 985' ' ' LEU . 73.1 mt -36.51 -50.31 0.78 Allowed 'General case' 0 N--CA 1.508 2.465 0 N-CA-C 113.7 1.0 . . . . 2.29 113.7 -177.419 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 52.01 95.99 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.162 -0.961 . . . . 0.63 110.258 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . 157.86 -153.29 24.5 Favored Glycine 0 N--CA 1.478 1.478 0 N-CA-C 107.209 -2.357 . . . . 0.040000000000000001 107.209 -179.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 73.4 ttt-85 -115.58 126.12 53.82 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 108.448 -0.945 . . . . 3.0 108.448 177.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 894' ' ' TYR . . . . . 0.777 ' OH ' HD12 ' B' ' 896' ' ' LEU . 0.1 OUTLIER -132.53 160.23 37.13 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.113 -0.992 . . . . 0.040000000000000001 111.155 -179.702 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 895' ' ' LEU . . . . . 0.402 HD12 ' HA ' ' B' ' 895' ' ' LEU . 36.2 tp -92.1 119.47 31.81 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.709 -0.62 . . . . 1.27 110.025 -179.494 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 896' ' ' LEU . . . . . 0.777 HD12 ' OH ' ' B' ' 894' ' ' TYR . 9.2 tt -109.85 143.68 39.39 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.671 -0.643 . . . . 0.93999999999999995 110.147 -179.494 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 897' ' ' SER . . . . . 0.484 ' N ' HD23 ' B' ' 896' ' ' LEU . 69.6 m -149.3 114.61 5.51 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.49 -0.756 . . . . 0.040000000000000001 110.992 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -106.75 146.76 30.46 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.944 -0.761 . . . . 0.47999999999999998 108.944 178.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 899' ' ' VAL . . . . . 0.748 HG21 ' HB ' ' B' ' 980' ' ' ILE . 88.0 t -96.25 118.94 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 C-N-CA 119.646 -0.822 . . . . 0.55000000000000004 111.302 -179.155 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 900' ' ' LEU . . . . . 0.478 HD12 ' HB2' ' B' ' 924' ' ' SER . 4.5 mm? -95.71 110.65 22.75 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 114.102 1.149 . . . . 1.5900000000000001 114.102 -175.495 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 18.2 m -64.01 140.21 58.85 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 107.414 -1.328 . . . . 0.050000000000000003 107.414 177.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -63.3 -66.75 2.38 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 110.387 -1.085 . . . . 0.029999999999999999 110.387 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 4.1 m170 46.89 67.11 0.84 Allowed 'General case' 0 N--CA 1.507 2.383 0 O-C-N 121.505 -0.997 . . . . 3.2000000000000002 110.977 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 35.1 ptt180 -68.5 -7.54 33.16 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.642 -0.662 . . . . 2.9199999999999999 111.898 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 905' ' ' HIS . . . . . 0.487 ' O ' ' CB ' ' B' ' 906' ' ' GLU . 66.6 t60 -62.96 4.09 0.2 Allowed 'General case' 0 N--CA 1.505 2.278 0 CA-C-O 117.775 -1.107 . . . . 2.8700000000000001 112.851 -179.217 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 906' ' ' GLU . . . . . 0.487 ' CB ' ' O ' ' B' ' 905' ' ' HIS . 0.9 OUTLIER 94.89 -163.04 0.0 OUTLIER 'General case' 0 N--CA 1.53 3.533 0 CA-C-N 120.761 1.618 . . . . 0.98999999999999999 112.142 178.908 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 907' ' ' LYS . . . . . 0.511 ' HE2' ' HB1' ' B' ' 972' ' ' ALA . 94.2 mttt 89.5 159.51 0.05 Allowed 'General case' 0 N--CA 1.522 3.164 0 N-CA-C 107.817 -1.179 . . . . 5.25 107.817 -177.054 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 58.4 t -122.25 116.01 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 120.933 -1.104 . . . . 0.39000000000000001 110.956 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 909' ' ' GLU . . . . . 0.686 ' OE2' HD12 ' B' ' 966' ' ' LEU . 49.2 tp10 -100.2 133.21 44.94 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 107.542 -1.281 . . . . 1.72 107.542 176.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -157.42 122.11 4.4 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 106.98 -1.489 . . . . 0.67000000000000004 106.98 178.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 911' ' ' VAL . . . . . 0.705 HG22 HG13 ' B' ' 964' ' ' VAL . 94.7 t -85.34 132.14 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 C-N-CA 120.386 -0.526 . . . . 0.54000000000000004 111.11 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 72.3 mt -65.83 157.87 29.29 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.442 -0.787 . . . . 1.5 109.023 178.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 913' ' ' SER . . . . . 0.405 ' CB ' ' HB ' ' B' ' 919' ' ' VAL . 2.6 t -124.56 135.86 53.49 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.365 -0.976 . . . . 1.3700000000000001 108.365 177.052 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 914' ' ' ARG . . . . . 0.687 ' NH1' HD23 ' B' ' 956' ' ' LEU . 0.0 OUTLIER -64.28 154.57 34.77 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 120.596 -1.315 . . . . 4.2999999999999998 111.447 -179.054 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 915' ' ' SER . . . . . 0.419 ' CB ' ' O ' ' B' ' 914' ' ' ARG . 4.3 t 83.19 -31.86 0.08 Allowed 'General case' 0 N--CA 1.522 3.138 0 C-N-CA 123.867 0.867 . . . . 2.0499999999999998 112.131 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 916' ' ' ASN . . . . . 0.765 ' HB2' HG21 ' B' ' 919' ' ' VAL . 90.8 m-20 -123.3 -21.89 5.25 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.856 -1.152 . . . . 2.71 111.353 -179.283 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 917' ' ' GLN . . . . . 0.439 ' HB2' ' O ' ' B' ' 916' ' ' ASN . 44.2 mt-30 65.87 165.72 0.19 Allowed 'General case' 0 N--CA 1.518 2.949 0 N-CA-C 106.024 -1.843 . . . . 2.6800000000000002 106.024 -173.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 55.38 -125.66 36.94 Favored Glycine 1 N--CA 1.52 4.267 0 CA-C-N 123.439 2.836 . . . . 0.029999999999999999 106.621 -177.38 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 919' ' ' VAL . . . . . 0.765 HG21 ' HB2' ' B' ' 916' ' ' ASN . 68.9 t 52.34 93.72 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.302 0 O-C-N 121.356 -1.085 . . . . 1.3899999999999999 108.752 -178.177 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 920' ' ' ALA . . . . . 0.789 ' HB3' HG12 ' B' ' 949' ' ' VAL . . . -91.3 90.84 7.91 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.205 -0.998 . . . . 0.029999999999999999 110.881 -178.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 921' ' ' ARG . . . . . 0.862 ' HG3' HG23 ' B' ' 922' ' ' VAL . 30.1 ptt180 -86.15 -41.83 14.38 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 105.907 -1.886 . . . . 4.4199999999999999 105.907 175.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 922' ' ' VAL . . . . . 0.862 HG23 ' HG3' ' B' ' 921' ' ' ARG . 84.8 t -104.04 67.4 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 105.978 -1.86 . . . . 0.84999999999999998 105.978 175.619 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 923' ' ' ASP . . . . . 0.716 ' HB2' ' HB1' ' B' ' 920' ' ' ALA . 22.5 t0 -89.72 134.68 34.04 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.705 0.764 . . . . 2.46 111.658 -177.391 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 924' ' ' SER . . . . . 0.478 ' HB2' HD12 ' B' ' 900' ' ' LEU . 8.5 t -147.13 103.33 3.58 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.503 -0.925 . . . . 0.69999999999999996 108.503 178.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -109.62 90.22 0.59 Allowed Glycine 0 N--CA 1.487 2.052 0 N-CA-C 108.349 -1.9 . . . . 0.040000000000000001 108.349 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.318 0 N-CA-C 109.459 -1.456 . . . . 0.040000000000000001 109.459 -179.267 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 29.9 m . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.009 0.433 . . . . 13.779999999999999 110.307 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 95.3 mt -111.87 129.94 55.99 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.543 -0.723 . . . . 13.76 110.379 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -151.39 167.56 30.82 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.256 -1.538 . . . . 9.1300000000000008 109.256 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 949' ' ' VAL . . . . . 0.789 HG12 ' HB3' ' B' ' 920' ' ' ALA . 30.7 m -118.7 129.13 75.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.514 -0.992 . . . . 7.0800000000000001 110.698 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 950' ' ' PHE . . . . . 0.462 ' CZ ' ' HB3' ' B' ' 921' ' ' ARG . 26.6 p90 -132.35 147.87 52.4 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.563 -0.71 . . . . 7.5899999999999999 109.518 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 19.7 m -121.22 -51.46 2.1 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.48 -0.762 . . . . 5.0300000000000002 112.063 -178.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 952' ' ' LEU . . . . . 0.836 HD11 HD23 ' A' ' 895' ' ' LEU . 52.5 tp -60.24 -75.28 0.06 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.389 -0.819 . . . . 1.01 112.549 -177.505 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 953' ' ' ILE . . . . . 0.479 ' O ' ' HB3' ' B' ' 954' ' ' LEU . 45.0 pt -52.1 -143.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.8 0 N-CA-C 114.237 1.199 . . . . 2.6000000000000001 114.237 -176.395 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 954' ' ' LEU . . . . . 0.729 HD22 ' O ' ' B' ' 954' ' ' LEU . 0.0 OUTLIER 173.79 77.01 0.05 OUTLIER Pre-proline 0 N--CA 1.507 2.387 0 O-C-N 120.629 -1.294 . . . . 0.050000000000000003 111.209 179.883 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 955' ' ' PRO . . . . . 0.746 ' C ' HD12 ' B' ' 956' ' ' LEU . 49.4 Cg_endo -76.62 91.76 1.13 Allowed 'Trans proline' 0 C--N 1.314 -1.242 0 N-CA-C 109.606 -0.959 . . . . 0.83999999999999997 109.606 178.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 956' ' ' LEU . . . . . 0.746 HD12 ' C ' ' B' ' 955' ' ' PRO . 11.1 mp -122.13 146.13 47.52 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.198 -0.939 . . . . 0.040000000000000001 109.738 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -84.33 150.86 25.1 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 117.964 -1.017 . . . . 1.28 111.84 -178.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -70.3 120.02 15.34 Favored 'General case' 0 N--CA 1.509 2.497 0 CA-C-N 122.658 2.481 . . . . 0.17000000000000001 111.664 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.65 -22.74 31.8 Favored Glycine 0 N--CA 1.5 2.922 0 N-CA-C 111.07 -0.812 . . . . 0.040000000000000001 111.07 178.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 960' ' ' ASP . . . . . 0.449 ' HB3' ' NE ' ' B' ' 914' ' ' ARG . 0.4 OUTLIER -55.27 171.99 0.15 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.455 -1.026 . . . . 0.040000000000000001 110.014 -179.528 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 961' ' ' THR . . . . . 0.74 HG21 HG13 ' B' ' 885' ' ' VAL . 40.7 m -135.02 135.65 41.5 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.993 -1.067 . . . . 1.78 111.845 -178.226 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 962' ' ' VAL . . . . . 0.878 HG22 ' HB3' ' B' ' 886' ' ' PHE . 32.7 m -98.07 145.77 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 C-N-CA 120.102 -0.639 . . . . 0.040000000000000001 110.122 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 5.6 t -138.24 146.01 42.06 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.905 -0.497 . . . . 0.71999999999999997 110.294 -178.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 964' ' ' VAL . . . . . 0.705 HG13 HG22 ' B' ' 911' ' ' VAL . 59.0 t -94.46 137.17 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.19 -0.943 . . . . 1.05 110.474 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -93.24 127.06 38.67 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 103.869 -2.641 . . . . 3.02 103.869 173.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 966' ' ' LEU . . . . . 0.686 HD12 ' OE2' ' B' ' 909' ' ' GLU . 0.2 OUTLIER -132.32 60.23 1.69 Allowed 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.392 -0.966 . . . . 1.46 108.392 177.334 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 967' ' ' VAL . . . . . 0.489 HG23 ' C ' ' B' ' 966' ' ' LEU . 98.3 t -158.18 96.86 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 108.051 -1.092 . . . . 1.9399999999999999 108.051 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 92.3 mmm -142.52 60.09 1.44 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.735 -1.228 . . . . 0.0 108.571 179.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.62 120.36 2.0 Allowed Glycine 0 N--CA 1.492 2.417 0 N-CA-C 107.259 -2.337 . . . . 2.1099999999999999 107.259 -178.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -81.83 -59.8 2.46 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.073 -1.251 . . . . 5.8899999999999997 110.222 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 50.9 tp -59.83 90.6 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.45 -0.781 . . . . 4.3600000000000003 109.912 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 972' ' ' ALA . . . . . 0.511 ' HB1' ' HE2' ' B' ' 907' ' ' LYS . . . -141.06 -154.69 0.53 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.592 -0.693 . . . . 1.8300000000000001 110.408 -179.508 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -118.72 171.3 8.3 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.526 -0.734 . . . . 4.3499999999999996 110.245 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 34.5 t -101.58 130.23 47.85 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.572 -0.705 . . . . 1.27 110.065 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -156.12 157.17 35.55 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.48 -0.762 . . . . 5.0199999999999996 110.473 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.17 85.67 18.45 Favored Pre-proline 0 N--CA 1.501 2.082 0 O-C-N 121.623 -0.673 . . . . 2.4100000000000001 109.745 179.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -73.37 -172.44 1.04 Allowed 'Trans proline' 0 C--N 1.318 -1.065 0 O-C-N 123.303 1.16 . . . . 0.95999999999999996 111.386 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 978' ' ' LEU . . . . . 0.66 HD23 HD12 ' B' ' 856' ' ' LEU . 4.9 mp -127.52 154.66 44.86 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 107.71 -1.218 . . . . 0.62 107.71 178.099 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 979' ' ' THR . . . . . 0.471 HG23 ' C ' ' B' ' 978' ' ' LEU . 41.0 p -150.41 140.89 22.46 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.814 -1.179 . . . . 3.5699999999999998 111.088 -179.412 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 980' ' ' ILE . . . . . 0.748 ' HB ' HG21 ' B' ' 899' ' ' VAL . 46.2 mm -107.31 128.73 62.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 109.064 -0.717 . . . . 1.3300000000000001 109.064 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -118.84 95.36 4.8 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 119.787 -0.765 . . . . 0.050000000000000003 111.86 -178.315 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 80.5 p -108.28 158.13 17.74 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.546 -0.721 . . . . 0.87 109.294 178.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 983' ' ' GLY . . . . . 0.405 ' O ' ' CE2' ' B' ' 852' ' ' PHE . . . -174.76 110.57 0.33 Allowed Glycine 0 N--CA 1.498 2.782 0 N-CA-C 106.514 -2.634 . . . . 0.029999999999999999 106.514 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -108.22 150.58 27.08 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 114.43 1.27 . . . . 0.69999999999999996 114.43 -175.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 985' ' ' LEU . . . . . 0.935 HD13 HD22 ' B' ' 890' ' ' LEU . 33.5 tp -72.05 135.01 46.18 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.856 -1.153 . . . . 0.040000000000000001 110.052 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 986' ' ' LEU . . . . . 0.483 ' CD1' HD11 ' C' ' 986' ' ' LEU . 51.6 tp -107.46 -55.77 2.3 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.59 -0.694 . . . . 0.040000000000000001 110.101 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -144.62 145.65 31.89 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.719 -1.215 . . . . 0.040000000000000001 107.719 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.45 163.07 12.2 Favored Glycine 0 N--CA 1.495 2.628 0 N-CA-C 108.289 -1.924 . . . . 0.040000000000000001 108.289 179.219 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -75.04 112.47 18.18 Favored Pre-proline 0 N--CA 1.498 1.955 0 O-C-N 121.174 -1.192 . . . . 0.040000000000000001 109.475 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 990' ' ' PRO . . . . . 0.423 ' HD2' HD12 ' B' ' 992' ' ' LEU . 49.8 Cg_endo -90.58 70.89 1.35 Allowed 'Trans proline' 0 C--N 1.318 -1.042 0 O-C-N 123.113 1.06 . . . . 0.45000000000000001 111.517 -178.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 991' ' ' GLU . . . . . 0.419 ' HB2' ' O ' ' B' ' 990' ' ' PRO . 69.4 mt-10 67.12 -73.68 0.08 Allowed 'General case' 0 N--CA 1.503 2.183 0 N-CA-C 108.633 -0.877 . . . . 1.97 108.633 -177.527 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 992' ' ' LEU . . . . . 0.461 ' HA ' HD23 ' B' ' 992' ' ' LEU . 11.1 mt 51.13 20.39 0.86 Allowed 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.552 -0.717 . . . . 2.3799999999999999 111.656 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -93.69 156.97 16.39 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.869 -1.145 . . . . 3.79 110.057 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 71.9 m80 -146.7 92.91 2.21 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.519 -0.738 . . . . 3.5099999999999998 110.415 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 995' ' ' ALA . . . . . . . . . . . . 2.517 . . . . . . . 0 N--CA 1.503 2.22 0 O-C-N 120.886 -1.134 . . . . 2.73 110.603 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo . . . . . 0 N--CA 1.489 1.221 0 N-CA-C 109.521 -0.992 . . . . 3.8300000000000001 109.521 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' 847' ' ' VAL . . . . . 0.424 HG12 ' HB2' ' C' ' 849' ' ' GLN . 88.1 t -131.42 102.7 15.31 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.606 -0.684 . . . . 1.8300000000000001 110.131 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 848' ' ' PRO . . . . . 0.753 ' O ' HG23 ' C' ' 850' ' ' VAL . 44.7 Cg_endo -70.2 -20.41 32.8 Favored 'Trans proline' 0 N--CA 1.487 1.138 0 O-C-N 123.278 1.146 . . . . 0.65000000000000002 111.016 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 849' ' ' GLN . . . . . 0.424 ' HB2' HG12 ' C' ' 847' ' ' VAL . 56.2 tt0 27.29 69.17 0.06 Allowed 'General case' 0 N--CA 1.519 2.979 0 N-CA-C 112.884 0.698 . . . . 2.5800000000000001 112.884 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 850' ' ' VAL . . . . . 0.753 HG23 ' O ' ' C' ' 848' ' ' PRO . 67.7 t -119.41 133.91 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.258 -0.901 . . . . 1.0900000000000001 111.64 -178.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 851' ' ' ALA . . . . . 0.447 ' HB3' ' HG ' ' C' ' 873' ' ' LEU . . . -129.88 152.97 48.77 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 105.627 -1.99 . . . . 0.040000000000000001 105.627 176.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 852' ' ' PHE . . . . . 0.448 ' HA ' ' CB ' ' C' ' 874' ' ' ASN . 6.0 p90 -160.31 128.76 4.76 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 120.921 1.691 . . . . 0.050000000000000003 108.589 179.242 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 29.8 t -175.67 134.32 0.29 Allowed 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.065 -1.087 . . . . 0.040000000000000001 108.065 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -134.64 156.91 47.92 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.136 -0.978 . . . . 0.67000000000000004 109.596 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 855' ' ' ALA . . . . . 0.593 ' HB3' ' CB ' ' C' ' 870' ' ' ARG . . . -121.83 139.71 53.28 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.864 0.84 . . . . 0.51000000000000001 111.667 -179.017 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 856' ' ' LEU . . . . . 0.713 HD23 ' O ' ' C' ' 867' ' ' PRO . 3.5 tm? -103.04 135.85 43.95 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.69 -0.631 . . . . 0.050000000000000003 109.422 179.386 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 857' ' ' SER . . . . . 0.576 ' N ' HD13 ' C' ' 856' ' ' LEU . 37.3 p -151.38 15.85 0.71 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.487 -0.758 . . . . 1.3300000000000001 111.206 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 858' ' ' LEU . . . . . 0.57 ' CD2' HD11 ' C' ' 856' ' ' LEU . 4.4 pp -33.56 157.47 0.04 OUTLIER Pre-proline 0 N--CA 1.518 2.97 0 N-CA-C 112.899 0.703 . . . . 2.3300000000000001 112.899 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -61.57 -89.27 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 120.897 1.064 . . . . 2.3199999999999998 113.575 -177.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 54.7 ptt85 -127.82 -141.86 0.26 Allowed 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.953 -1.092 . . . . 0.040000000000000001 111.289 -177.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 71.5 m -37.9 123.04 1.04 Allowed 'General case' 0 N--CA 1.51 2.567 0 O-C-N 121.575 -0.703 . . . . 1.3100000000000001 112.064 -179.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 862' ' ' GLU . . . . . 0.514 ' HG3' HD22 ' C' ' 858' ' ' LEU . 0.0 OUTLIER -100.55 158.41 31.95 Favored Pre-proline 0 N--CA 1.488 1.429 0 N-CA-C 108.192 -1.04 . . . . 4.5099999999999998 108.192 177.767 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.07 -14.58 32.03 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 123.187 1.099 . . . . 2.2400000000000002 111.034 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -176.98 -135.51 2.21 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.725 -1.35 . . . . 0.040000000000000001 109.725 179.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 25.8 m -69.05 154.22 42.44 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.331 -1.1 . . . . 1.51 110.47 -179.088 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 866' ' ' VAL . . . . . 0.46 ' HA ' ' HD3' ' C' ' 867' ' ' PRO . 32.7 m -90.68 139.39 26.33 Favored Pre-proline 0 N--CA 1.497 1.881 0 N-CA-C 113.66 0.985 . . . . 0.78000000000000003 113.66 -175.33 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 867' ' ' PRO . . . . . 0.713 ' O ' HD23 ' C' ' 856' ' ' LEU . 53.9 Cg_endo -88.92 -152.69 0.04 OUTLIER 'Trans proline' 0 C--N 1.325 -0.662 0 N-CA-C 108.286 -1.467 . . . . 0.92000000000000004 108.286 177.391 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 868' ' ' PHE . . . . . 0.471 ' CD1' ' HG2' ' C' ' 881' ' ' PRO . 23.0 p90 -148.15 120.18 8.25 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.513 -1.367 . . . . 0.050000000000000003 109.625 179.365 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 50.2 p-10 -113.02 -2.97 14.1 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 119.38 -0.928 . . . . 1.7 112.029 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 870' ' ' ARG . . . . . 0.593 ' CB ' ' HB3' ' C' ' 855' ' ' ALA . 24.8 mmm180 -90.51 86.88 6.55 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.03 -1.044 . . . . 2.5899999999999999 110.825 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 61.6 t -73.12 96.73 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.074 -1.016 . . . . 1.9399999999999999 109.566 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 872' ' ' LEU . . . . . 0.507 HD11 ' HB2' ' C' ' 855' ' ' ALA . 51.9 mt -86.17 -45.18 11.58 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.554 -0.716 . . . . 1.0600000000000001 110.338 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 873' ' ' LEU . . . . . 0.447 ' HG ' ' HB3' ' C' ' 851' ' ' ALA . 49.3 tp -173.3 102.8 0.12 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.238 -0.914 . . . . 4.1799999999999997 108.791 178.589 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 874' ' ' ASN . . . . . 0.448 ' CB ' ' HA ' ' C' ' 852' ' ' PHE . 37.4 t-20 177.98 82.65 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.319 0 O-C-N 121.721 -0.612 . . . . 0.040000000000000001 109.374 -178.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -67.19 -47.41 71.0 Favored 'General case' 0 N--CA 1.497 1.92 0 C-N-CA 119.203 -0.999 . . . . 3.3799999999999999 111.434 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 876' ' ' GLY . . . . . . . . . . . . . . . -73.53 -26.97 68.51 Favored Glycine 0 N--CA 1.494 2.548 0 O-C-N 121.271 -0.893 . . . . 0.040000000000000001 111.66 -178.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 83.13 -60.18 4.91 Favored Glycine 0 N--CA 1.503 3.109 0 N-CA-C 108.061 -2.015 . . . . 0.040000000000000001 108.061 -178.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 878' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 61.41 -66.19 0.06 Allowed 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 114.239 1.2 . . . . 3.46 114.239 177.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 879' ' ' TYR . . . . . 0.471 ' CB ' ' CD2' ' C' ' 886' ' ' PHE . 23.9 p90 -113.92 110.02 19.43 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 114.859 1.429 . . . . 0.040000000000000001 114.859 -176.351 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -66.83 117.98 50.43 Favored Pre-proline 0 N--CA 1.499 2.018 0 O-C-N 121.434 -0.791 . . . . 0.02 109.897 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 881' ' ' PRO . . . . . 0.471 ' HG2' ' CD1' ' C' ' 868' ' ' PHE . 55.3 Cg_endo -77.43 -0.26 10.44 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 O-C-N 123.386 1.203 . . . . 0.39000000000000001 112.141 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -74.58 -63.31 1.27 Allowed 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 106.538 -1.652 . . . . 0.81000000000000005 106.538 178.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 8.9 p -95.61 -17.62 21.21 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.704 -0.85 . . . . 0.040000000000000001 108.704 177.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.78 20.58 59.43 Favored Glycine 0 N--CA 1.495 2.631 0 O-C-N 121.024 -1.047 . . . . 0.029999999999999999 111.165 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 92.4 t -72.02 90.26 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 C-N-CA 118.135 -1.426 . . . . 1.01 108.019 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 886' ' ' PHE . . . . . 0.841 ' HB3' HG22 ' C' ' 962' ' ' VAL . 0.8 OUTLIER -90.93 104.77 17.32 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-N 115.268 -0.878 . . . . 0.050000000000000003 112.037 -177.259 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 887' ' ' THR . . . . . 0.426 ' O ' ' HD3' ' C' ' 889' ' ' PRO . 86.5 m -95.97 101.49 13.16 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 107.697 -1.223 . . . . 0.68000000000000005 107.697 177.246 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 888' ' ' ALA . . . . . . . . . . . . . . . -98.38 107.01 39.56 Favored Pre-proline 0 N--CA 1.502 2.155 0 N-CA-C 113.998 1.11 . . . . 0.25 113.998 -176.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 889' ' ' PRO . . . . . 0.426 ' HD3' ' O ' ' C' ' 887' ' ' THR . 53.6 Cg_endo -90.03 -13.26 2.59 Favored 'Trans proline' 0 CA--C 1.546 1.095 0 C-N-CA 120.975 1.117 . . . . 1.6399999999999999 109.228 176.423 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 890' ' ' LEU . . . . . 1.04 HD22 HD13 ' C' ' 985' ' ' LEU . 75.6 mt -38.7 -49.33 1.57 Allowed 'General case' 0 N--CA 1.507 2.382 0 N-CA-C 113.719 1.007 . . . . 2.29 113.719 -177.366 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 52.85 96.78 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.351 0 O-C-N 121.081 -1.012 . . . . 0.63 110.044 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . 155.79 -146.87 14.91 Favored Glycine 0 N--CA 1.48 1.568 0 N-CA-C 107.096 -2.402 . . . . 0.040000000000000001 107.096 -178.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 74.4 ttt-85 -107.17 129.32 54.87 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 107.947 -1.131 . . . . 3.0 107.947 177.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 894' ' ' TYR . . . . . 0.451 ' CD1' ' N ' ' C' ' 895' ' ' LEU . 0.4 OUTLIER -129.53 142.94 50.65 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.064 -1.022 . . . . 0.040000000000000001 110.086 -179.254 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 895' ' ' LEU . . . . . 0.451 ' N ' ' CD1' ' C' ' 894' ' ' TYR . 34.6 tp -102.08 115.39 30.44 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.632 -0.667 . . . . 1.27 109.597 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 896' ' ' LEU . . . . . 0.609 HD23 ' N ' ' C' ' 897' ' ' SER . 10.3 tt -112.69 146.76 38.13 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.549 -0.719 . . . . 0.93999999999999995 110.594 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 897' ' ' SER . . . . . 0.609 ' N ' HD23 ' C' ' 896' ' ' LEU . 8.3 m -141.4 117.26 10.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.523 -0.736 . . . . 0.040000000000000001 110.494 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -106.61 147.19 29.79 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.126 -0.694 . . . . 0.47999999999999998 109.126 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 899' ' ' VAL . . . . . 0.74 HG21 ' HB ' ' C' ' 980' ' ' ILE . 88.9 t -93.56 119.42 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 C-N-CA 119.729 -0.788 . . . . 0.55000000000000004 111.133 -179.198 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 96.7 mt -93.66 111.53 23.23 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 114.1 1.148 . . . . 1.5900000000000001 114.1 -175.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 16.7 m -64.12 140.12 58.84 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 107.32 -1.363 . . . . 0.050000000000000003 107.32 177.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -61.18 -64.48 4.01 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.29 -1.124 . . . . 0.029999999999999999 110.29 -179.3 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 45.18 63.77 1.63 Allowed 'General case' 0 N--CA 1.507 2.409 0 O-C-N 121.57 -0.959 . . . . 3.2000000000000002 111.323 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 41.9 ptt85 -67.26 -7.9 27.77 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.573 -0.704 . . . . 2.9199999999999999 111.895 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 905' ' ' HIS . . . . . 0.49 ' O ' ' CB ' ' C' ' 906' ' ' GLU . 74.0 t60 -61.3 5.15 0.07 Allowed 'General case' 0 N--CA 1.505 2.302 0 CA-C-O 117.601 -1.19 . . . . 2.8700000000000001 113.488 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 906' ' ' GLU . . . . . 0.49 ' CB ' ' O ' ' C' ' 905' ' ' HIS . 0.7 OUTLIER 92.58 -163.43 0.01 OUTLIER 'General case' 0 N--CA 1.528 3.447 0 CA-C-N 121.294 1.861 . . . . 0.98999999999999999 112.239 178.919 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 907' ' ' LYS . . . . . 0.488 ' CB ' ' O ' ' C' ' 906' ' ' GLU . 72.4 tttt 89.82 161.96 0.05 OUTLIER 'General case' 0 N--CA 1.52 3.065 0 N-CA-C 108.171 -1.048 . . . . 5.25 108.171 -177.111 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 59.4 t -122.69 115.39 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 120.927 -1.108 . . . . 0.39000000000000001 110.857 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 909' ' ' GLU . . . . . 0.474 ' HG3' HD12 ' C' ' 966' ' ' LEU . 47.1 tt0 -108.07 129.99 55.11 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 107.644 -1.243 . . . . 1.72 107.644 177.152 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -155.93 120.83 4.71 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 106.8 -1.556 . . . . 0.67000000000000004 106.8 178.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 911' ' ' VAL . . . . . 0.896 HG23 HG22 ' C' ' 964' ' ' VAL . 13.3 p -77.3 131.09 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.79 -0.569 . . . . 0.54000000000000004 111.346 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 46.4 mt -67.81 157.62 34.37 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.284 -0.885 . . . . 1.5 108.717 178.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 913' ' ' SER . . . . . 0.475 ' OG ' HG11 ' C' ' 919' ' ' VAL . 1.6 p -123.72 139.56 53.87 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.67 -0.863 . . . . 1.3700000000000001 108.67 177.271 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 914' ' ' ARG . . . . . 0.821 ' NH1' HD23 ' C' ' 956' ' ' LEU . 0.0 OUTLIER -65.02 154.1 38.75 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 120.643 -1.286 . . . . 4.2999999999999998 111.568 -179.104 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 915' ' ' SER . . . . . 0.425 ' CB ' ' O ' ' C' ' 914' ' ' ARG . 4.4 t 83.28 -31.25 0.08 Allowed 'General case' 0 N--CA 1.522 3.164 0 C-N-CA 123.916 0.886 . . . . 2.0499999999999998 112.23 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 916' ' ' ASN . . . . . 0.741 ' HB2' HG21 ' C' ' 919' ' ' VAL . 99.1 m-20 -121.85 -22.01 5.89 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.889 -1.132 . . . . 2.71 111.226 -179.294 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 66.99 166.93 0.23 Allowed 'General case' 0 N--CA 1.52 3.04 0 N-CA-C 105.802 -1.925 . . . . 2.6800000000000002 105.802 -174.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.64 -126.38 37.43 Favored Glycine 1 N--CA 1.521 4.344 0 CA-C-N 123.598 2.908 . . . . 0.029999999999999999 107.051 -177.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 919' ' ' VAL . . . . . 0.741 HG21 ' HB2' ' C' ' 916' ' ' ASN . 92.1 t 51.57 93.53 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.238 0 O-C-N 121.307 -1.114 . . . . 1.3899999999999999 109.129 -178.199 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 920' ' ' ALA . . . . . 0.937 ' HB3' HG12 ' C' ' 949' ' ' VAL . . . -93.42 93.82 8.36 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.332 -0.947 . . . . 0.029999999999999999 110.714 -179.265 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 921' ' ' ARG . . . . . 0.811 ' HG3' HG23 ' C' ' 922' ' ' VAL . 20.1 ptt85 -80.39 -41.83 23.9 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 105.938 -1.875 . . . . 4.4199999999999999 105.938 176.233 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 922' ' ' VAL . . . . . 0.811 HG23 ' HG3' ' C' ' 921' ' ' ARG . 90.5 t -101.86 75.11 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 106.088 -1.819 . . . . 0.84999999999999998 106.088 175.451 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -89.79 135.89 33.36 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.872 0.844 . . . . 2.46 112.355 -176.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 7.9 t -147.16 102.76 3.53 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.063 -1.088 . . . . 0.69999999999999996 108.063 178.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -110.83 88.95 0.53 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.967 -1.653 . . . . 0.040000000000000001 108.967 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.4 0 N-CA-C 109.353 -1.499 . . . . 0.040000000000000001 109.353 -179.713 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 11.2 m . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 120.962 0.411 . . . . 13.779999999999999 110.318 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 95.3 mt -114.22 129.77 56.63 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.505 -0.747 . . . . 13.76 110.319 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -152.16 170.34 31.47 Favored Glycine 0 N--CA 1.493 2.5 0 N-CA-C 109.398 -1.481 . . . . 9.1300000000000008 109.398 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 949' ' ' VAL . . . . . 0.937 HG12 ' HB3' ' C' ' 920' ' ' ALA . 33.7 m -117.17 136.39 54.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.538 -0.977 . . . . 7.0800000000000001 110.832 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 950' ' ' PHE . . . . . 0.448 ' CZ ' ' HB3' ' C' ' 921' ' ' ARG . 36.0 p90 -135.57 152.25 51.09 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.607 -0.683 . . . . 7.5899999999999999 109.622 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 69.4 m -118.32 -54.44 2.29 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.386 -0.821 . . . . 5.0300000000000002 111.514 -179.26 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 952' ' ' LEU . . . . . 0.448 ' O ' ' O ' ' C' ' 953' ' ' ILE . 46.6 tp -63.78 -77.03 0.06 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.46 -0.775 . . . . 1.01 111.421 -178.453 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 953' ' ' ILE . . . . . 0.544 HD12 ' N ' ' C' ' 954' ' ' LEU . 2.3 pp -49.45 -152.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.735 0 N-CA-C 114.324 1.231 . . . . 2.6000000000000001 114.324 -176.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 954' ' ' LEU . . . . . 0.726 HD22 ' O ' ' C' ' 954' ' ' LEU . 0.0 OUTLIER 169.11 92.09 0.03 OUTLIER Pre-proline 0 N--CA 1.516 2.869 0 O-C-N 120.949 -1.094 . . . . 0.050000000000000003 111.651 179.491 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 955' ' ' PRO . . . . . 0.761 ' C ' HD12 ' C' ' 956' ' ' LEU . 52.1 Cg_endo -80.4 93.0 1.05 Allowed 'Trans proline' 0 C--N 1.317 -1.117 0 N-CA-C 109.138 -1.139 . . . . 0.83999999999999997 109.138 178.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 956' ' ' LEU . . . . . 0.821 HD23 ' NH1' ' C' ' 914' ' ' ARG . 10.9 mp -122.85 144.01 49.49 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.014 -1.054 . . . . 0.040000000000000001 110.144 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -82.11 151.33 27.05 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 117.708 -1.139 . . . . 1.28 111.287 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -67.15 118.63 10.83 Favored 'General case' 0 N--CA 1.508 2.45 0 CA-C-N 123.078 2.672 . . . . 0.17000000000000001 111.082 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.42 -20.43 44.1 Favored Glycine 0 N--CA 1.499 2.888 0 N-CA-C 110.872 -0.891 . . . . 0.040000000000000001 110.872 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 960' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.63 169.69 0.13 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.381 -1.07 . . . . 0.040000000000000001 110.125 -179.445 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 961' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' C' ' 886' ' ' PHE . 71.1 p -133.41 137.66 45.9 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.056 -1.027 . . . . 1.78 112.167 -177.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 962' ' ' VAL . . . . . 0.841 HG22 ' HB3' ' C' ' 886' ' ' PHE . 25.4 m -97.31 146.46 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 C-N-CA 120.13 -0.628 . . . . 0.040000000000000001 110.184 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 5.5 t -138.59 145.23 40.32 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.952 -0.468 . . . . 0.71999999999999997 109.989 -178.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 964' ' ' VAL . . . . . 0.896 HG22 HG23 ' C' ' 911' ' ' VAL . 65.1 t -97.27 136.0 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.034 -1.041 . . . . 1.05 110.578 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -97.37 125.61 42.09 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 103.906 -2.627 . . . . 3.02 103.906 173.275 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 966' ' ' LEU . . . . . 0.49 ' C ' HG23 ' C' ' 967' ' ' VAL . 1.1 tp -133.11 62.95 1.65 Allowed 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.296 -1.002 . . . . 1.46 108.296 177.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 967' ' ' VAL . . . . . 0.49 HG23 ' C ' ' C' ' 966' ' ' LEU . 97.3 t -157.64 97.44 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 108.224 -1.028 . . . . 1.9399999999999999 108.224 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 95.7 mmm -141.9 59.98 1.48 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.741 -1.224 . . . . 0.0 108.541 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.07 119.99 1.99 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 107.235 -2.346 . . . . 2.1099999999999999 107.235 -178.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -82.23 -58.55 2.9 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.053 -1.263 . . . . 5.8899999999999997 110.507 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 49.0 tp -59.43 89.94 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.448 -0.782 . . . . 4.3600000000000003 110.261 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -142.16 -152.66 0.42 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.622 -0.673 . . . . 1.8300000000000001 110.09 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -117.36 167.62 11.09 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.462 -0.774 . . . . 4.3499999999999996 110.022 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 10.3 t -101.7 130.56 48.11 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.557 -0.714 . . . . 1.27 110.2 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -155.96 153.85 30.22 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.532 -0.73 . . . . 5.0199999999999996 110.384 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.27 86.23 14.76 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.588 -0.695 . . . . 2.4100000000000001 109.897 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -75.76 -170.55 0.85 Allowed 'Trans proline' 0 C--N 1.318 -1.07 0 O-C-N 123.324 1.17 . . . . 0.95999999999999996 111.223 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 978' ' ' LEU . . . . . 0.46 ' C ' HG23 ' C' ' 979' ' ' THR . 5.0 mp -123.56 156.23 36.11 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 107.497 -1.297 . . . . 0.62 107.497 177.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 979' ' ' THR . . . . . 0.46 HG23 ' C ' ' C' ' 978' ' ' LEU . 40.6 p -150.54 141.66 23.09 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.779 -1.2 . . . . 3.5699999999999998 111.251 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 980' ' ' ILE . . . . . 0.74 ' HB ' HG21 ' C' ' 899' ' ' VAL . 50.1 mm -106.08 128.55 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 109.216 -0.661 . . . . 1.3300000000000001 109.216 179.428 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 981' ' ' PHE . . . . . 0.436 ' CD1' ' CE2' ' C' ' 879' ' ' TYR . 2.3 t80 -118.15 97.29 5.72 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.499 -0.751 . . . . 0.050000000000000003 111.256 -178.637 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 982' ' ' SER . . . . . 0.42 ' HB2' HD23 ' A' ' 952' ' ' LEU . 18.2 p -108.41 159.85 16.35 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.081 -0.711 . . . . 0.87 109.081 178.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 983' ' ' GLY . . . . . 0.411 ' O ' ' CE2' ' C' ' 852' ' ' PHE . . . -169.04 115.01 0.58 Allowed Glycine 0 N--CA 1.497 2.764 0 N-CA-C 106.526 -2.629 . . . . 0.029999999999999999 106.526 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 984' ' ' ALA . . . . . 0.459 ' HB1' ' CZ ' ' A' ' 893' ' ' ARG . . . -109.26 147.95 31.78 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.156 -1.203 . . . . 0.69999999999999996 114.169 -175.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 985' ' ' LEU . . . . . 1.04 HD13 HD22 ' C' ' 890' ' ' LEU . 51.4 tp -75.38 135.06 40.82 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.809 -1.182 . . . . 0.040000000000000001 109.425 179.233 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 986' ' ' LEU . . . . . 0.483 HD11 ' CD1' ' B' ' 986' ' ' LEU . 48.4 tp -107.1 -61.71 1.51 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.477 -0.764 . . . . 0.040000000000000001 110.495 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -144.92 146.31 31.94 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 107.841 -1.17 . . . . 0.040000000000000001 107.841 179.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.25 162.82 12.28 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 108.097 -2.001 . . . . 0.040000000000000001 108.097 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -74.6 112.81 19.07 Favored Pre-proline 0 N--CA 1.498 1.967 0 O-C-N 121.206 -1.173 . . . . 0.040000000000000001 109.455 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 990' ' ' PRO . . . . . 0.416 ' O ' ' HB2' ' C' ' 991' ' ' GLU . 50.5 Cg_endo -88.76 70.98 2.38 Favored 'Trans proline' 0 C--N 1.32 -0.937 0 O-C-N 123.115 1.061 . . . . 0.45000000000000001 111.303 -178.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 991' ' ' GLU . . . . . 0.416 ' HB2' ' O ' ' C' ' 990' ' ' PRO . 67.7 mt-10 67.51 -73.31 0.08 Allowed 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 108.582 -0.895 . . . . 1.97 108.582 -177.506 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 992' ' ' LEU . . . . . . . . . . . . . 11.4 mt 50.45 20.83 0.74 Allowed 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.567 -0.708 . . . . 2.3799999999999999 111.69 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -92.91 157.01 16.58 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.936 -1.103 . . . . 3.79 110.055 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -146.32 92.0 2.12 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.579 -0.701 . . . . 3.5099999999999998 110.254 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 995' ' ' ALA . . . . . . . . . . . . 2.518 . . . . . . . 0 N--CA 1.504 2.23 0 O-C-N 120.913 -1.117 . . . . 2.73 110.564 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo . . . . . 0 N--CA 1.488 1.199 0 N-CA-C 109.451 -1.019 . . . . 3.8300000000000001 109.451 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 847' ' ' VAL . . . . . 0.401 HG12 ' HB2' ' A' ' 849' ' ' GLN . 66.6 t -134.93 102.82 10.98 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.617 -0.677 . . . . 1.8300000000000001 110.004 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 848' ' ' PRO . . . . . 0.765 ' O ' HG23 ' A' ' 850' ' ' VAL . 44.2 Cg_endo -69.83 -18.66 36.56 Favored 'Trans proline' 0 N--CA 1.488 1.155 0 O-C-N 123.344 1.181 . . . . 0.65000000000000002 111.168 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 849' ' ' GLN . . . . . 0.401 ' HB2' HG12 ' A' ' 847' ' ' VAL . 55.8 tt0 27.39 67.97 0.07 Allowed 'General case' 0 N--CA 1.518 2.927 0 N-CA-C 113.025 0.75 . . . . 2.5800000000000001 113.025 179.221 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 850' ' ' VAL . . . . . 0.765 HG23 ' O ' ' A' ' 848' ' ' PRO . 69.9 t -119.39 137.02 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 121.202 -0.936 . . . . 1.0900000000000001 111.442 -178.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 851' ' ' ALA . . . . . 0.641 ' HB3' ' HG ' ' A' ' 873' ' ' LEU . . . -124.13 159.0 30.99 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 105.827 -1.916 . . . . 0.040000000000000001 105.827 176.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 852' ' ' PHE . . . . . 0.431 ' HA ' ' CB ' ' A' ' 874' ' ' ASN . 32.7 p90 -159.6 127.96 4.99 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 120.948 1.704 . . . . 0.050000000000000003 108.492 178.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 7.8 t -175.71 134.42 0.29 Allowed 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.152 -1.055 . . . . 0.040000000000000001 108.152 -178.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -131.98 157.41 44.15 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.083 -1.011 . . . . 0.67000000000000004 109.626 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 855' ' ' ALA . . . . . 0.863 ' HB3' ' CB ' ' A' ' 870' ' ' ARG . . . -120.78 146.1 46.86 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-O 122.018 0.914 . . . . 0.51000000000000001 111.291 -178.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 856' ' ' LEU . . . . . 0.754 HD12 HD23 ' A' ' 978' ' ' LEU . 2.7 tm? -113.01 133.36 54.99 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.738 -0.601 . . . . 0.050000000000000003 109.872 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 857' ' ' SER . . . . . 0.659 ' N ' HD13 ' A' ' 856' ' ' LEU . 30.3 p -154.37 14.6 0.44 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.526 -0.734 . . . . 1.3300000000000001 111.683 179.373 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 858' ' ' LEU . . . . . 0.562 HD12 ' C ' ' A' ' 858' ' ' LEU . 4.5 pp -33.22 159.64 0.03 OUTLIER Pre-proline 0 N--CA 1.52 3.028 0 N-CA-C 113.427 0.899 . . . . 2.3300000000000001 113.427 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -61.85 -88.29 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 120.965 1.11 . . . . 2.3199999999999998 113.316 -178.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 53.6 ptt85 -128.01 -142.47 0.27 Allowed 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.887 -1.133 . . . . 0.040000000000000001 111.397 -177.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 8.8 m -41.28 129.04 2.99 Favored 'General case' 0 N--CA 1.509 2.498 0 O-C-N 121.459 -0.776 . . . . 1.3100000000000001 111.902 -179.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 862' ' ' GLU . . . . . 0.592 ' OE1' HG22 ' A' ' 866' ' ' VAL . 1.9 tt0 -94.81 152.77 39.96 Favored Pre-proline 0 N--CA 1.492 1.626 0 N-CA-C 108.107 -1.071 . . . . 4.5099999999999998 108.107 177.506 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 863' ' ' PRO . . . . . 0.413 ' HD2' ' CG ' ' A' ' 862' ' ' GLU . 43.5 Cg_endo -70.27 -12.22 31.55 Favored 'Trans proline' 0 C--N 1.314 -1.271 0 O-C-N 123.059 1.031 . . . . 2.2400000000000002 111.161 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -175.74 -136.07 2.25 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 110.107 -1.197 . . . . 0.040000000000000001 110.107 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 39.9 m -64.38 155.77 31.37 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.382 -1.07 . . . . 1.51 111.331 -178.395 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 866' ' ' VAL . . . . . 0.592 HG22 ' OE1' ' A' ' 862' ' ' GLU . 2.7 t -91.12 128.07 48.97 Favored Pre-proline 0 N--CA 1.5 2.059 0 N-CA-C 113.399 0.889 . . . . 0.78000000000000003 113.399 -174.385 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 867' ' ' PRO . . . . . 0.614 ' O ' HD23 ' A' ' 856' ' ' LEU . 51.3 Cg_endo -92.05 -155.62 0.05 OUTLIER 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 121.174 1.25 . . . . 0.92000000000000004 109.516 177.442 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 868' ' ' PHE . . . . . 0.454 ' CD1' ' HG2' ' A' ' 881' ' ' PRO . 21.1 p90 -151.73 123.64 8.06 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.654 -1.279 . . . . 0.050000000000000003 109.994 179.294 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 44.0 p30 -114.62 -0.72 13.55 Favored 'General case' 0 N--CA 1.501 2.109 0 C-N-CA 119.345 -0.942 . . . . 1.7 112.762 -178.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 870' ' ' ARG . . . . . 0.863 ' CB ' ' HB3' ' A' ' 855' ' ' ALA . 26.9 mmm180 -90.97 90.47 7.9 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 120.845 -1.16 . . . . 2.5899999999999999 111.099 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 60.4 t -74.7 97.13 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 120.978 -1.076 . . . . 1.9399999999999999 109.911 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 872' ' ' LEU . . . . . 0.623 HD11 ' HB2' ' A' ' 855' ' ' ALA . 96.3 mt -83.2 -46.81 12.27 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.468 -0.77 . . . . 1.0600000000000001 110.131 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 873' ' ' LEU . . . . . 0.641 ' HG ' ' HB3' ' A' ' 851' ' ' ALA . 36.9 tp -174.52 102.98 0.1 Allowed 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.521 -0.918 . . . . 4.1799999999999997 108.521 178.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 874' ' ' ASN . . . . . 0.431 ' CB ' ' HA ' ' A' ' 852' ' ' PHE . 35.4 t-20 178.73 80.86 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.3 0 O-C-N 121.622 -0.674 . . . . 0.040000000000000001 109.555 -178.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -66.7 -47.27 72.92 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.211 -0.931 . . . . 3.3799999999999999 111.204 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 876' ' ' GLY . . . . . . . . . . . . . . . -73.56 -24.86 73.86 Favored Glycine 0 N--CA 1.494 2.555 0 O-C-N 121.306 -0.871 . . . . 0.040000000000000001 111.509 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 84.0 -59.93 4.9 Favored Glycine 0 N--CA 1.502 3.041 0 N-CA-C 108.088 -2.005 . . . . 0.040000000000000001 108.088 -178.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 878' ' ' TYR . . . . . 0.447 ' CZ ' HG11 ' A' ' 850' ' ' VAL . 97.7 m-85 60.78 -65.79 0.06 Allowed 'General case' 0 N--CA 1.503 2.22 0 N-CA-C 114.206 1.188 . . . . 3.46 114.206 177.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 879' ' ' TYR . . . . . 0.555 ' HH ' ' HD1' ' A' ' 981' ' ' PHE . 21.0 p90 -112.73 109.35 18.79 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 114.833 1.42 . . . . 0.040000000000000001 114.833 -176.357 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.42 116.77 37.28 Favored Pre-proline 0 N--CA 1.496 1.825 0 O-C-N 121.381 -0.825 . . . . 0.02 109.647 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 881' ' ' PRO . . . . . 0.454 ' HG2' ' CD1' ' A' ' 868' ' ' PHE . 53.6 Cg_endo -75.59 -0.02 9.67 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 O-C-N 123.492 1.259 . . . . 0.39000000000000001 112.493 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -75.99 -63.15 1.38 Allowed 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 106.723 -1.584 . . . . 0.81000000000000005 106.723 178.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 41.1 p -94.1 -20.23 20.1 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.482 -0.933 . . . . 0.040000000000000001 108.482 177.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.21 20.94 58.08 Favored Glycine 0 N--CA 1.495 2.573 0 O-C-N 121.034 -1.041 . . . . 0.029999999999999999 111.385 178.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 885' ' ' VAL . . . . . . . . . . . . . 99.3 t -73.67 91.81 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 C-N-CA 118.103 -1.439 . . . . 1.01 108.196 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 886' ' ' PHE . . . . . 0.834 ' HB3' HG22 ' A' ' 962' ' ' VAL . 0.7 OUTLIER -89.87 104.75 17.29 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-N 115.118 -0.946 . . . . 0.050000000000000003 112.092 -177.143 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 887' ' ' THR . . . . . 0.445 ' O ' ' HD3' ' A' ' 889' ' ' PRO . 93.7 m -96.29 100.42 12.05 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 107.685 -1.228 . . . . 0.68000000000000005 107.685 177.36 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 888' ' ' ALA . . . . . . . . . . . . . . . -98.62 105.95 33.61 Favored Pre-proline 0 N--CA 1.502 2.132 0 N-CA-C 114.279 1.215 . . . . 0.25 114.279 -176.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 889' ' ' PRO . . . . . 0.445 ' HD3' ' O ' ' A' ' 887' ' ' THR . 54.1 Cg_endo -89.0 -13.37 3.09 Favored 'Trans proline' 0 CA--C 1.546 1.105 0 N-CA-C 108.935 -1.217 . . . . 1.6399999999999999 108.935 175.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 890' ' ' LEU . . . . . 0.709 HD22 HD13 ' A' ' 985' ' ' LEU . 69.3 mt -36.54 -49.97 0.77 Allowed 'General case' 0 N--CA 1.508 2.47 0 N-CA-C 113.612 0.967 . . . . 2.29 113.612 -177.472 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 52.09 96.03 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.189 -0.944 . . . . 0.63 110.289 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 158.0 -153.61 24.78 Favored Glycine 0 N--CA 1.478 1.468 0 N-CA-C 107.227 -2.349 . . . . 0.040000000000000001 107.227 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 893' ' ' ARG . . . . . 0.438 ' CZ ' ' HB1' ' C' ' 984' ' ' ALA . 72.9 ttt-85 -115.7 126.39 54.05 Favored 'General case' 0 C--N 1.294 -1.82 0 O-C-N 121.601 -0.94 . . . . 3.0 108.512 177.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 894' ' ' TYR . . . . . 0.742 ' OH ' HD12 ' A' ' 896' ' ' LEU . 0.1 OUTLIER -132.26 159.99 37.49 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.177 -0.952 . . . . 0.040000000000000001 111.038 -179.74 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 895' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' A' ' 895' ' ' LEU . 37.8 tp -91.77 118.49 30.74 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.69 -0.631 . . . . 1.27 110.168 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 896' ' ' LEU . . . . . 0.742 HD12 ' OH ' ' A' ' 894' ' ' TYR . 9.2 tt -110.05 142.16 41.88 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.707 -0.621 . . . . 0.93999999999999995 110.047 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 897' ' ' SER . . . . . 0.442 ' N ' HD23 ' A' ' 896' ' ' LEU . 64.1 m -148.9 115.51 5.92 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.452 -0.78 . . . . 0.040000000000000001 110.982 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.61 146.18 32.3 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.892 -0.781 . . . . 0.47999999999999998 108.892 178.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 899' ' ' VAL . . . . . 0.732 HG21 ' HB ' ' A' ' 980' ' ' ILE . 87.5 t -94.73 120.39 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.373 -0.829 . . . . 0.55000000000000004 111.033 -179.298 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 900' ' ' LEU . . . . . 0.619 HD12 ' HB2' ' A' ' 924' ' ' SER . 4.3 mm? -95.23 112.8 24.46 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 114.382 1.252 . . . . 1.5900000000000001 114.382 -174.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 15.6 m -66.85 141.53 57.65 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 107.334 -1.358 . . . . 0.050000000000000003 107.334 176.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -67.02 -65.83 2.62 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 110.583 -1.007 . . . . 0.029999999999999999 110.583 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 8.8 m170 46.72 66.7 0.92 Allowed 'General case' 0 N--CA 1.508 2.437 0 O-C-N 121.493 -1.004 . . . . 3.2000000000000002 111.155 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 43.2 ptt85 -69.38 -5.88 26.38 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.624 -0.672 . . . . 2.9199999999999999 112.108 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 905' ' ' HIS . . . . . 0.487 ' O ' ' CB ' ' A' ' 906' ' ' GLU . 72.7 t60 -62.32 5.03 0.12 Allowed 'General case' 0 N--CA 1.506 2.335 0 O-C-N 120.918 -1.114 . . . . 2.8700000000000001 113.155 -179.149 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 906' ' ' GLU . . . . . 0.487 ' CB ' ' O ' ' A' ' 905' ' ' HIS . 0.5 OUTLIER 94.63 -164.29 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.449 0 CA-C-N 120.562 1.528 . . . . 0.98999999999999999 111.824 179.007 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 907' ' ' LYS . . . . . 0.465 ' CB ' ' O ' ' A' ' 906' ' ' GLU . 63.1 tttt 85.59 156.59 0.09 Allowed 'General case' 0 N--CA 1.52 3.031 0 N-CA-C 108.024 -1.102 . . . . 5.25 108.024 -176.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 58.9 t -122.02 116.38 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 120.787 -1.196 . . . . 0.39000000000000001 111.099 -179.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -99.82 133.21 44.52 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 107.319 -1.363 . . . . 1.72 107.319 176.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -155.92 121.94 5.04 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 106.842 -1.54 . . . . 0.67000000000000004 106.842 178.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 911' ' ' VAL . . . . . 0.814 HG22 HG13 ' A' ' 964' ' ' VAL . 87.3 t -84.06 132.15 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.86 -0.525 . . . . 0.54000000000000004 110.783 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 62.2 mt -65.63 156.42 32.84 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.404 -0.81 . . . . 1.5 109.025 178.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 913' ' ' SER . . . . . 0.413 ' CB ' ' CG1' ' A' ' 919' ' ' VAL . 1.3 t -123.02 138.4 54.7 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.316 -0.994 . . . . 1.3700000000000001 108.316 177.177 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 914' ' ' ARG . . . . . 0.624 ' NH1' HD23 ' A' ' 956' ' ' LEU . 0.0 OUTLIER -65.15 154.79 36.94 Favored 'General case' 0 N--CA 1.505 2.284 0 O-C-N 120.762 -1.211 . . . . 4.2999999999999998 111.751 -179.049 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 915' ' ' SER . . . . . 0.426 ' CB ' ' O ' ' A' ' 914' ' ' ARG . 4.7 t 83.07 -32.71 0.08 Allowed 'General case' 0 N--CA 1.522 3.136 0 C-N-CA 123.979 0.911 . . . . 2.0499999999999998 112.254 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 916' ' ' ASN . . . . . 0.767 ' HB2' HG21 ' A' ' 919' ' ' VAL . 92.9 m-20 -121.1 -20.46 6.79 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.947 -1.095 . . . . 2.71 111.469 -179.033 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 917' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 66.82 165.04 0.21 Allowed 'General case' 0 N--CA 1.521 3.111 0 N-CA-C 105.452 -2.055 . . . . 2.6800000000000002 105.452 -173.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.33 -125.38 33.82 Favored Glycine 1 N--CA 1.521 4.357 0 CA-C-N 123.545 2.884 . . . . 0.029999999999999999 106.987 -177.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 919' ' ' VAL . . . . . 0.767 HG21 ' HB2' ' A' ' 916' ' ' ASN . 78.6 t 51.58 94.9 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 O-C-N 121.513 -0.992 . . . . 1.3899999999999999 108.996 -178.14 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 920' ' ' ALA . . . . . 0.858 ' HB3' HG12 ' A' ' 949' ' ' VAL . . . -91.38 92.29 8.51 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.246 -0.982 . . . . 0.029999999999999999 110.902 -179.012 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 921' ' ' ARG . . . . . 0.886 ' HG3' HG23 ' A' ' 922' ' ' VAL . 27.5 ptt180 -83.9 -41.76 17.07 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 105.756 -1.942 . . . . 4.4199999999999999 105.756 175.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 922' ' ' VAL . . . . . 0.886 HG23 ' HG3' ' A' ' 921' ' ' ARG . 78.7 t -102.19 73.44 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 106.308 -1.738 . . . . 0.84999999999999998 106.308 175.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -86.82 133.75 33.61 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.643 0.735 . . . . 2.46 111.231 -177.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 924' ' ' SER . . . . . 0.619 ' HB2' HD12 ' A' ' 900' ' ' LEU . 28.0 t -147.83 105.9 3.74 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.907 -0.775 . . . . 0.69999999999999996 108.907 179.443 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -102.91 83.65 0.44 Allowed Glycine 0 N--CA 1.487 2.043 0 N-CA-C 108.277 -1.929 . . . . 0.040000000000000001 108.277 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.126 0 N-CA-C 108.67 -1.772 . . . . 0.040000000000000001 108.67 -179.709 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 33.0 m . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.012 0.434 . . . . 13.779999999999999 110.21 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 96.2 mt -112.44 129.44 56.32 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.666 -0.646 . . . . 13.76 110.365 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -152.34 168.03 31.41 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 108.967 -1.653 . . . . 9.1300000000000008 108.967 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 949' ' ' VAL . . . . . 0.858 HG12 ' HB3' ' A' ' 920' ' ' ALA . 34.9 m -119.38 130.77 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.502 -0.999 . . . . 7.0800000000000001 110.998 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 950' ' ' PHE . . . . . 0.455 ' CE1' ' HD2' ' A' ' 955' ' ' PRO . 25.5 p90 -133.24 150.51 51.94 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.565 -0.709 . . . . 7.5899999999999999 109.149 179.311 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 19.5 m -120.66 -53.19 2.1 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.341 -0.85 . . . . 5.0300000000000002 112.314 -178.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 952' ' ' LEU . . . . . 0.427 ' O ' ' O ' ' A' ' 953' ' ' ILE . 13.6 tp -60.39 -73.01 0.1 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.411 -0.805 . . . . 1.01 112.576 -177.446 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 953' ' ' ILE . . . . . 0.948 HD11 HD13 ' C' ' 872' ' ' LEU . 46.1 pt -52.6 -145.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.768 0 N-CA-C 114.06 1.133 . . . . 2.6000000000000001 114.06 -176.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 954' ' ' LEU . . . . . 0.708 HD22 ' O ' ' A' ' 954' ' ' LEU . 0.0 OUTLIER 171.84 77.45 0.04 OUTLIER Pre-proline 0 N--CA 1.51 2.554 0 O-C-N 120.768 -1.208 . . . . 0.050000000000000003 111.461 179.555 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 955' ' ' PRO . . . . . 0.69 ' C ' HD12 ' A' ' 956' ' ' LEU . 48.4 Cg_endo -74.88 96.41 1.01 Allowed 'Trans proline' 0 C--N 1.315 -1.227 0 N-CA-C 109.521 -0.992 . . . . 0.83999999999999997 109.521 178.541 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 956' ' ' LEU . . . . . 0.69 HD12 ' C ' ' A' ' 955' ' ' PRO . 10.4 mp -123.03 145.68 48.31 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.197 -0.939 . . . . 0.040000000000000001 110.214 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -83.71 150.41 25.86 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 117.773 -1.108 . . . . 1.28 111.675 -179.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -70.4 119.87 15.22 Favored 'General case' 0 N--CA 1.51 2.526 0 CA-C-N 122.967 2.621 . . . . 0.17000000000000001 111.558 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.6 -22.77 31.5 Favored Glycine 0 N--CA 1.501 3.008 0 N-CA-C 111.16 -0.776 . . . . 0.040000000000000001 111.16 178.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 960' ' ' ASP . . . . . 0.438 ' HB3' ' NE ' ' A' ' 914' ' ' ARG . 0.6 OUTLIER -52.14 172.14 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.49 -1.006 . . . . 0.040000000000000001 110.403 -179.409 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 961' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 886' ' ' PHE . 7.2 t -134.77 134.6 41.11 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.008 -1.058 . . . . 1.78 111.849 -178.382 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 962' ' ' VAL . . . . . 0.834 HG22 ' HB3' ' A' ' 886' ' ' PHE . 31.7 m -99.01 145.91 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 C-N-CA 120.074 -0.65 . . . . 0.040000000000000001 110.44 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 5.3 t -139.0 145.24 39.43 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.853 -0.529 . . . . 0.71999999999999997 110.115 -178.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 964' ' ' VAL . . . . . 0.814 HG13 HG22 ' A' ' 911' ' ' VAL . 55.5 t -94.12 136.57 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.105 -0.997 . . . . 1.05 110.714 -179.16 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -95.81 126.79 41.31 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 103.665 -2.717 . . . . 3.02 103.665 173.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 966' ' ' LEU . . . . . 0.492 ' C ' HG23 ' A' ' 967' ' ' VAL . 20.8 tp -132.6 62.35 1.65 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.304 -0.999 . . . . 1.46 108.304 177.357 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 967' ' ' VAL . . . . . 0.492 HG23 ' C ' ' A' ' 966' ' ' LEU . 89.9 t -158.21 97.19 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 108.049 -1.093 . . . . 1.9399999999999999 108.049 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 88.8 mmm -142.99 59.37 1.42 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.737 -1.227 . . . . 0.0 108.184 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.44 119.91 1.96 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 106.957 -2.457 . . . . 2.1099999999999999 106.957 -178.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -81.55 -57.9 3.26 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 118.696 1.248 . . . . 5.8899999999999997 110.368 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 44.2 tp -58.82 90.58 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.501 -0.75 . . . . 4.3600000000000003 110.203 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -141.43 -155.02 0.55 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.562 -0.711 . . . . 1.8300000000000001 110.344 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -119.79 172.03 7.99 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.476 -0.765 . . . . 4.3499999999999996 110.38 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 29.2 t -101.51 130.32 47.76 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.537 -0.727 . . . . 1.27 110.102 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -156.44 158.35 37.14 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.511 -0.743 . . . . 5.0199999999999996 110.548 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.72 86.36 15.91 Favored Pre-proline 0 N--CA 1.501 2.094 0 O-C-N 121.602 -0.686 . . . . 2.4100000000000001 109.713 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.07 -172.8 1.07 Allowed 'Trans proline' 0 C--N 1.317 -1.093 0 O-C-N 123.271 1.143 . . . . 0.95999999999999996 111.547 -179.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 978' ' ' LEU . . . . . 0.754 HD23 HD12 ' A' ' 856' ' ' LEU . 5.2 mp -127.93 154.73 45.22 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 107.577 -1.268 . . . . 0.62 107.577 178.036 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 979' ' ' THR . . . . . 0.449 HG23 ' C ' ' A' ' 978' ' ' LEU . 33.7 p -150.34 142.15 23.75 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.809 -1.182 . . . . 3.5699999999999998 111.368 -179.23 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 980' ' ' ILE . . . . . 0.732 ' HB ' HG21 ' A' ' 899' ' ' VAL . 46.8 mm -106.5 127.44 61.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 108.798 -0.815 . . . . 1.3300000000000001 108.798 179.222 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 981' ' ' PHE . . . . . 0.555 ' HD1' ' HH ' ' A' ' 879' ' ' TYR . 5.7 t80 -119.49 97.48 5.67 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 119.762 -0.775 . . . . 0.050000000000000003 111.726 -178.476 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 77.8 p -108.55 158.48 17.52 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.485 -0.759 . . . . 0.87 109.331 178.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 983' ' ' GLY . . . . . 0.403 ' O ' ' CE1' ' A' ' 852' ' ' PHE . . . -174.98 107.55 0.24 Allowed Glycine 0 N--CA 1.499 2.859 0 N-CA-C 106.452 -2.659 . . . . 0.029999999999999999 106.452 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -108.75 152.5 24.77 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 114.507 1.299 . . . . 0.69999999999999996 114.507 -175.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 985' ' ' LEU . . . . . 0.709 HD13 HD22 ' A' ' 890' ' ' LEU . 53.1 tp -71.29 134.03 46.49 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.793 -1.192 . . . . 0.040000000000000001 110.141 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 45.9 tp -107.61 -56.13 2.26 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.552 -0.718 . . . . 0.040000000000000001 109.804 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -145.26 145.2 31.18 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 107.701 -1.222 . . . . 0.040000000000000001 107.701 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -113.02 163.32 12.15 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 108.293 -1.923 . . . . 0.040000000000000001 108.293 179.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -75.44 112.69 20.27 Favored Pre-proline 0 N--CA 1.5 2.026 0 O-C-N 121.256 -1.144 . . . . 0.040000000000000001 109.485 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 990' ' ' PRO . . . . . 0.417 ' HD2' HD12 ' A' ' 992' ' ' LEU . 50.7 Cg_endo -90.19 70.92 1.56 Allowed 'Trans proline' 0 C--N 1.319 -1.004 0 O-C-N 123.134 1.07 . . . . 0.45000000000000001 111.514 -179.074 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 991' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 990' ' ' PRO . 70.6 mt-10 67.37 -73.61 0.08 Allowed 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 108.584 -0.895 . . . . 1.97 108.584 -177.424 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 992' ' ' LEU . . . . . 0.417 HD12 ' HD2' ' A' ' 990' ' ' PRO . 10.9 mt 51.05 20.58 0.85 Allowed 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.502 -0.749 . . . . 2.3799999999999999 111.638 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 83.6 mt-10 -94.09 156.87 16.36 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.879 -1.138 . . . . 3.79 110.085 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 72.4 m80 -146.63 93.33 2.27 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.526 -0.734 . . . . 3.5099999999999998 110.311 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 995' ' ' ALA . . . . . . . . . . . . 2.518 . . . . . . . 0 N--CA 1.503 2.198 0 O-C-N 120.831 -1.168 . . . . 2.73 110.614 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo . . . . . 0 N--CA 1.488 1.18 0 N-CA-C 109.429 -1.027 . . . . 3.8300000000000001 109.429 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 847' ' ' VAL . . . . . . . . . . . . . 66.4 t -134.93 102.91 10.94 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.557 -0.715 . . . . 1.8300000000000001 110.041 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 848' ' ' PRO . . . . . 0.772 ' O ' HG23 ' B' ' 850' ' ' VAL . 44.2 Cg_endo -69.81 -18.93 36.51 Favored 'Trans proline' 0 N--CA 1.488 1.167 0 O-C-N 123.319 1.168 . . . . 0.65000000000000002 111.136 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 849' ' ' GLN . . . . . 0.405 ' C ' ' O ' ' B' ' 848' ' ' PRO . 55.9 tt0 27.59 68.22 0.07 Allowed 'General case' 0 N--CA 1.518 2.953 0 N-CA-C 112.951 0.723 . . . . 2.5800000000000001 112.951 179.257 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 850' ' ' VAL . . . . . 0.772 HG23 ' O ' ' B' ' 848' ' ' PRO . 68.0 t -119.62 137.13 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.193 -0.942 . . . . 1.0900000000000001 111.427 -179.002 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 851' ' ' ALA . . . . . 0.643 ' HB3' ' HG ' ' B' ' 873' ' ' LEU . . . -124.71 158.21 33.77 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 105.828 -1.916 . . . . 0.040000000000000001 105.828 176.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 852' ' ' PHE . . . . . 0.425 ' HA ' ' CB ' ' B' ' 874' ' ' ASN . 32.1 p90 -158.82 128.27 5.61 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 121.056 1.753 . . . . 0.050000000000000003 108.493 179.091 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 7.6 t -175.79 134.09 0.28 Allowed 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.245 -1.021 . . . . 0.040000000000000001 108.245 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -131.49 157.76 42.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.106 -0.996 . . . . 0.67000000000000004 109.668 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 855' ' ' ALA . . . . . 0.854 ' HB3' ' CB ' ' B' ' 870' ' ' ARG . . . -121.1 146.15 47.04 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.997 0.903 . . . . 0.51000000000000001 111.287 -178.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 856' ' ' LEU . . . . . 0.726 HD12 HD23 ' B' ' 978' ' ' LEU . 2.7 tm? -113.17 132.83 55.32 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.712 -0.617 . . . . 0.050000000000000003 109.971 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 857' ' ' SER . . . . . 0.654 ' N ' HD13 ' B' ' 856' ' ' LEU . 30.1 p -153.97 14.92 0.48 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.521 -0.737 . . . . 1.3300000000000001 111.711 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 858' ' ' LEU . . . . . 0.56 HD12 ' C ' ' B' ' 858' ' ' LEU . 4.5 pp -33.46 159.69 0.03 OUTLIER Pre-proline 0 N--CA 1.52 3.052 0 N-CA-C 113.401 0.889 . . . . 2.3300000000000001 113.401 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -61.96 -88.39 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 121.013 1.142 . . . . 2.3199999999999998 113.235 -178.344 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 53.6 ptt85 -127.94 -142.53 0.27 Allowed 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.893 -1.13 . . . . 0.040000000000000001 111.405 -177.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 8.8 m -41.21 128.29 2.88 Favored 'General case' 0 N--CA 1.509 2.482 0 O-C-N 121.383 -0.823 . . . . 1.3100000000000001 111.909 -179.027 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 862' ' ' GLU . . . . . 0.589 ' OE1' HG22 ' B' ' 866' ' ' VAL . 1.9 tt0 -94.09 152.81 40.67 Favored Pre-proline 0 N--CA 1.491 1.592 0 N-CA-C 108.085 -1.08 . . . . 4.5099999999999998 108.085 177.488 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 863' ' ' PRO . . . . . 0.411 ' HD2' ' CG ' ' B' ' 862' ' ' GLU . 43.1 Cg_endo -70.14 -12.36 32.03 Favored 'Trans proline' 0 C--N 1.314 -1.248 0 O-C-N 123.086 1.045 . . . . 2.2400000000000002 111.25 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -175.42 -134.92 1.99 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.063 -1.215 . . . . 0.040000000000000001 110.063 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 41.5 m -65.49 156.76 31.49 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.294 -1.121 . . . . 1.51 111.247 -178.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 866' ' ' VAL . . . . . 0.589 HG22 ' OE1' ' B' ' 862' ' ' GLU . 2.7 t -91.96 127.99 47.44 Favored Pre-proline 0 N--CA 1.499 1.995 0 N-CA-C 113.424 0.898 . . . . 0.78000000000000003 113.424 -174.302 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 867' ' ' PRO . . . . . 0.617 ' O ' HD23 ' B' ' 856' ' ' LEU . 51.8 Cg_endo -92.01 -155.81 0.05 OUTLIER 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 121.149 1.233 . . . . 0.92000000000000004 109.547 177.528 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 868' ' ' PHE . . . . . 0.46 ' CD1' ' HG2' ' B' ' 881' ' ' PRO . 21.7 p90 -151.56 123.43 8.06 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.636 -1.29 . . . . 0.050000000000000003 110.019 179.279 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 44.2 p30 -114.46 -0.32 13.79 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.2 -0.938 . . . . 1.7 112.815 -178.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 870' ' ' ARG . . . . . 0.854 ' CB ' ' HB3' ' B' ' 855' ' ' ALA . 26.7 mmm180 -91.45 90.16 7.54 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.86 -1.15 . . . . 2.5899999999999999 111.145 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 59.6 t -74.42 97.2 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 120.951 -1.093 . . . . 1.9399999999999999 109.959 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 872' ' ' LEU . . . . . 0.628 HD11 ' HB2' ' B' ' 855' ' ' ALA . 96.2 mt -83.34 -46.67 12.32 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.492 -0.755 . . . . 1.0600000000000001 110.14 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 873' ' ' LEU . . . . . 0.643 ' HG ' ' HB3' ' B' ' 851' ' ' ALA . 36.9 tp -174.54 102.99 0.1 Allowed 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 108.507 -0.923 . . . . 4.1799999999999997 108.507 178.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 874' ' ' ASN . . . . . 0.425 ' CB ' ' HA ' ' B' ' 852' ' ' PHE . 35.4 t-20 178.73 81.12 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.337 0 O-C-N 121.63 -0.668 . . . . 0.040000000000000001 109.552 -178.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -66.94 -47.28 72.15 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.127 -0.983 . . . . 3.3799999999999999 111.198 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 876' ' ' GLY . . . . . . . . . . . . . . . -73.56 -24.98 73.6 Favored Glycine 0 N--CA 1.494 2.521 0 O-C-N 121.305 -0.872 . . . . 0.040000000000000001 111.454 -178.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 84.14 -59.78 4.91 Favored Glycine 0 N--CA 1.501 3.001 0 N-CA-C 108.075 -2.01 . . . . 0.040000000000000001 108.075 -178.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 878' ' ' TYR . . . . . 0.44 ' CZ ' HG11 ' B' ' 850' ' ' VAL . 97.7 m-85 60.82 -65.73 0.06 Allowed 'General case' 0 N--CA 1.503 2.189 0 N-CA-C 114.226 1.195 . . . . 3.46 114.226 177.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 879' ' ' TYR . . . . . 0.495 ' HH ' ' HD1' ' B' ' 981' ' ' PHE . 21.1 p90 -112.8 109.31 18.7 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 114.769 1.396 . . . . 0.040000000000000001 114.769 -176.381 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.25 116.72 36.28 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.343 -0.848 . . . . 0.02 109.698 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 881' ' ' PRO . . . . . 0.46 ' HG2' ' CD1' ' B' ' 868' ' ' PHE . 53.9 Cg_endo -75.53 -0.22 9.88 Favored 'Trans proline' 0 N--CA 1.497 1.709 0 O-C-N 123.47 1.247 . . . . 0.39000000000000001 112.534 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -75.7 -63.55 1.27 Allowed 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 106.716 -1.587 . . . . 0.81000000000000005 106.716 178.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 41.4 p -93.91 -19.9 20.52 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.482 -0.933 . . . . 0.040000000000000001 108.482 177.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.76 21.4 57.85 Favored Glycine 0 N--CA 1.494 2.556 0 O-C-N 121.05 -1.031 . . . . 0.029999999999999999 111.369 178.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 885' ' ' VAL . . . . . . . . . . . . . 98.8 t -73.91 92.14 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 C-N-CA 118.084 -1.446 . . . . 1.01 108.06 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 886' ' ' PHE . . . . . 0.879 ' HB3' HG22 ' B' ' 962' ' ' VAL . 0.7 OUTLIER -90.1 104.87 17.4 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 115.119 -0.946 . . . . 0.050000000000000003 112.085 -177.192 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 887' ' ' THR . . . . . 0.442 ' O ' ' HD3' ' B' ' 889' ' ' PRO . 93.9 m -96.41 100.67 12.26 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 107.63 -1.248 . . . . 0.68000000000000005 107.63 177.358 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 888' ' ' ALA . . . . . . . . . . . . . . . -98.87 105.86 33.91 Favored Pre-proline 0 N--CA 1.502 2.125 0 N-CA-C 114.267 1.21 . . . . 0.25 114.267 -176.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 889' ' ' PRO . . . . . 0.442 ' HD3' ' O ' ' B' ' 887' ' ' THR . 54.1 Cg_endo -88.9 -13.44 3.14 Favored 'Trans proline' 0 CA--C 1.546 1.118 0 N-CA-C 108.982 -1.199 . . . . 1.6399999999999999 108.982 175.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 890' ' ' LEU . . . . . 0.72 HD22 HD13 ' B' ' 985' ' ' LEU . 69.7 mt -36.39 -50.09 0.75 Allowed 'General case' 0 N--CA 1.508 2.457 0 N-CA-C 113.612 0.967 . . . . 2.29 113.612 -177.522 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 52.1 95.95 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.259 0 O-C-N 121.135 -0.978 . . . . 0.63 110.25 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . 158.05 -153.72 24.88 Favored Glycine 0 N--CA 1.478 1.496 0 N-CA-C 107.18 -2.368 . . . . 0.040000000000000001 107.18 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 72.8 ttt-85 -115.61 126.41 54.15 Favored 'General case' 0 C--N 1.295 -1.778 0 O-C-N 121.581 -0.952 . . . . 3.0 108.529 177.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 894' ' ' TYR . . . . . 0.74 ' OH ' HD12 ' B' ' 896' ' ' LEU . 0.1 OUTLIER -132.17 160.19 36.78 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.182 -0.949 . . . . 0.040000000000000001 111.041 -179.754 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 895' ' ' LEU . . . . . 0.4 HD23 HD11 ' C' ' 952' ' ' LEU . 37.9 tp -92.1 118.49 30.86 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.654 -0.654 . . . . 1.27 110.141 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 896' ' ' LEU . . . . . 0.74 HD12 ' OH ' ' B' ' 894' ' ' TYR . 9.2 tt -110.0 141.59 42.58 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.761 -0.587 . . . . 0.93999999999999995 110.106 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 897' ' ' SER . . . . . 0.433 ' N ' HD23 ' B' ' 896' ' ' LEU . 64.4 m -148.35 115.26 6.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.478 -0.764 . . . . 0.040000000000000001 111.032 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.26 146.07 31.93 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.989 -0.745 . . . . 0.47999999999999998 108.989 178.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 899' ' ' VAL . . . . . 0.721 HG21 ' HB ' ' B' ' 980' ' ' ILE . 88.0 t -94.64 120.15 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 C-N-CA 119.653 -0.819 . . . . 0.55000000000000004 111.138 -179.329 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 900' ' ' LEU . . . . . 0.619 HD12 ' HB2' ' B' ' 924' ' ' SER . 4.3 mm? -95.02 112.45 24.16 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 114.457 1.281 . . . . 1.5900000000000001 114.457 -174.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 15.3 m -66.58 141.44 57.84 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 107.319 -1.363 . . . . 0.050000000000000003 107.319 176.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -67.24 -65.84 2.6 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 110.608 -0.997 . . . . 0.029999999999999999 110.608 -179.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 8.8 m170 46.73 66.76 0.9 Allowed 'General case' 0 N--CA 1.508 2.453 0 O-C-N 121.492 -1.005 . . . . 3.2000000000000002 111.155 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 43.1 ptt85 -69.32 -6.28 28.58 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.62 -0.675 . . . . 2.9199999999999999 112.084 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 905' ' ' HIS . . . . . 0.485 ' O ' ' CB ' ' B' ' 906' ' ' GLU . 72.6 t60 -61.66 4.47 0.11 Allowed 'General case' 0 N--CA 1.505 2.324 0 O-C-N 120.929 -1.107 . . . . 2.8700000000000001 113.198 -179.134 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 906' ' ' GLU . . . . . 0.485 ' CB ' ' O ' ' B' ' 905' ' ' HIS . 0.5 OUTLIER 94.96 -164.44 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.439 0 CA-C-N 120.561 1.528 . . . . 0.98999999999999999 111.668 179.063 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 907' ' ' LYS . . . . . 0.472 ' CB ' ' O ' ' B' ' 906' ' ' GLU . 63.2 tttt 85.75 156.3 0.08 Allowed 'General case' 0 N--CA 1.52 3.035 0 N-CA-C 108.095 -1.076 . . . . 5.25 108.095 -176.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 59.2 t -121.81 116.18 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 120.814 -1.179 . . . . 0.39000000000000001 111.152 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -99.57 133.42 43.93 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 107.274 -1.38 . . . . 1.72 107.274 176.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -156.21 122.08 4.95 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 106.879 -1.526 . . . . 0.67000000000000004 106.879 178.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 911' ' ' VAL . . . . . 0.795 HG22 HG13 ' B' ' 964' ' ' VAL . 87.0 t -84.27 132.38 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.842 -0.536 . . . . 0.54000000000000004 110.813 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 63.0 mt -65.72 156.75 32.07 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.333 -0.854 . . . . 1.5 108.946 178.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 913' ' ' SER . . . . . 0.408 ' CB ' ' CG1' ' B' ' 919' ' ' VAL . 1.4 t -123.57 137.48 54.74 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.393 -0.965 . . . . 1.3700000000000001 108.393 177.165 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 914' ' ' ARG . . . . . 0.621 ' NH1' HD23 ' B' ' 956' ' ' LEU . 0.0 OUTLIER -64.12 154.64 33.99 Favored 'General case' 0 N--CA 1.505 2.311 0 O-C-N 120.77 -1.206 . . . . 4.2999999999999998 111.888 -178.988 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 915' ' ' SER . . . . . 0.419 ' CB ' ' O ' ' B' ' 914' ' ' ARG . 4.7 t 83.2 -33.0 0.08 Allowed 'General case' 0 N--CA 1.521 3.114 0 C-N-CA 124.017 0.927 . . . . 2.0499999999999998 112.272 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 916' ' ' ASN . . . . . 0.806 ' HB2' HG21 ' B' ' 919' ' ' VAL . 92.4 m-20 -120.74 -20.76 6.89 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 120.909 -1.119 . . . . 2.71 111.46 -179.041 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 917' ' ' GLN . . . . . 0.4 ' HB2' ' O ' ' B' ' 916' ' ' ASN . 41.8 mt-30 66.83 164.46 0.2 Allowed 'General case' 0 N--CA 1.521 3.116 0 N-CA-C 105.472 -2.047 . . . . 2.6800000000000002 105.472 -173.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 55.09 -125.5 35.99 Favored Glycine 1 N--CA 1.521 4.349 0 CA-C-N 123.567 2.894 . . . . 0.029999999999999999 106.8 -177.628 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 919' ' ' VAL . . . . . 0.806 HG21 ' HB2' ' B' ' 916' ' ' ASN . 82.3 t 51.39 95.05 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.253 0 O-C-N 121.476 -1.014 . . . . 1.3899999999999999 109.062 -178.046 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 920' ' ' ALA . . . . . 0.845 ' HB3' HG12 ' B' ' 949' ' ' VAL . . . -91.51 92.16 8.39 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.31 -0.956 . . . . 0.029999999999999999 110.844 -179.031 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 921' ' ' ARG . . . . . 0.87 ' HG3' HG23 ' B' ' 922' ' ' VAL . 27.5 ptt180 -83.96 -41.73 17.01 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 105.738 -1.949 . . . . 4.4199999999999999 105.738 175.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 922' ' ' VAL . . . . . 0.87 HG23 ' HG3' ' B' ' 921' ' ' ARG . 77.9 t -102.16 73.14 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 N-CA-C 106.375 -1.713 . . . . 0.84999999999999998 106.375 175.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -86.49 133.76 33.72 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.637 0.732 . . . . 2.46 111.241 -177.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 924' ' ' SER . . . . . 0.619 ' HB2' HD12 ' B' ' 900' ' ' LEU . 27.8 t -147.83 105.77 3.72 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 108.974 -0.75 . . . . 0.69999999999999996 108.974 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -102.69 83.57 0.45 Allowed Glycine 0 N--CA 1.486 1.968 0 N-CA-C 108.37 -1.892 . . . . 0.040000000000000001 108.37 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 926' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' B' ' 906' ' ' GLU . . . . . . . . 0 N--CA 1.488 2.156 0 N-CA-C 108.661 -1.776 . . . . 0.040000000000000001 108.661 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 32.7 m . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.078 0.466 . . . . 13.779999999999999 110.162 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 96.2 mt -111.03 129.4 55.92 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.581 -0.699 . . . . 13.76 110.325 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -151.73 166.76 30.89 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.114 -1.594 . . . . 9.1300000000000008 109.114 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 949' ' ' VAL . . . . . 0.845 HG12 ' HB3' ' B' ' 920' ' ' ALA . 35.5 m -118.81 130.24 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.519 -0.989 . . . . 7.0800000000000001 110.967 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 950' ' ' PHE . . . . . 0.448 ' CE1' ' HD2' ' B' ' 955' ' ' PRO . 25.5 p90 -133.03 150.41 52.13 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.546 -0.721 . . . . 7.5899999999999999 109.162 179.359 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 19.5 m -120.67 -52.76 2.11 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.367 -0.833 . . . . 5.0300000000000002 112.252 -178.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 952' ' ' LEU . . . . . 0.418 ' O ' ' O ' ' B' ' 953' ' ' ILE . 13.6 tp -60.62 -73.22 0.09 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.365 -0.835 . . . . 1.01 112.382 -177.557 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 953' ' ' ILE . . . . . 0.5 ' O ' ' HB3' ' B' ' 954' ' ' LEU . 46.0 pt -52.26 -144.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.779 0 N-CA-C 114.177 1.177 . . . . 2.6000000000000001 114.177 -176.456 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 954' ' ' LEU . . . . . 0.726 HD22 ' O ' ' B' ' 954' ' ' LEU . 0.0 OUTLIER 171.64 77.23 0.04 OUTLIER Pre-proline 0 N--CA 1.51 2.526 0 O-C-N 120.808 -1.183 . . . . 0.050000000000000003 111.39 179.478 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 955' ' ' PRO . . . . . 0.699 ' C ' HD12 ' B' ' 956' ' ' LEU . 48.2 Cg_endo -74.89 96.54 1.02 Allowed 'Trans proline' 0 C--N 1.313 -1.295 0 N-CA-C 109.481 -1.007 . . . . 0.83999999999999997 109.481 178.598 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 956' ' ' LEU . . . . . 0.699 HD12 ' C ' ' B' ' 955' ' ' PRO . 10.4 mp -123.11 145.62 48.42 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.125 -0.984 . . . . 0.040000000000000001 110.166 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 16.1 mt-30 -83.58 150.66 25.8 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 117.866 -1.064 . . . . 1.28 111.645 -179.209 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -70.5 119.62 14.93 Favored 'General case' 0 N--CA 1.51 2.545 0 CA-C-N 122.845 2.566 . . . . 0.17000000000000001 111.579 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.74 -22.98 30.72 Favored Glycine 0 N--CA 1.501 3.021 0 N-CA-C 111.111 -0.796 . . . . 0.040000000000000001 111.111 178.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 960' ' ' ASP . . . . . 0.44 ' HB3' ' NE ' ' B' ' 914' ' ' ARG . 0.6 OUTLIER -51.86 172.15 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.53 -0.982 . . . . 0.040000000000000001 110.358 -179.403 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 961' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' B' ' 886' ' ' PHE . 7.1 t -134.73 134.71 41.3 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.986 -1.071 . . . . 1.78 111.855 -178.476 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 962' ' ' VAL . . . . . 0.879 HG22 ' HB3' ' B' ' 886' ' ' PHE . 31.1 m -99.17 145.8 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 C-N-CA 120.072 -0.651 . . . . 0.040000000000000001 110.453 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 5.3 t -138.79 145.23 39.88 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.861 -0.524 . . . . 0.71999999999999997 110.191 -178.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 964' ' ' VAL . . . . . 0.795 HG13 HG22 ' B' ' 911' ' ' VAL . 55.2 t -94.24 136.32 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.11 -0.994 . . . . 1.05 110.717 -179.191 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -95.72 126.37 40.94 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 103.755 -2.683 . . . . 3.02 103.755 173.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 966' ' ' LEU . . . . . 0.494 ' C ' HG23 ' B' ' 967' ' ' VAL . 20.8 tp -132.23 62.52 1.64 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.35 -0.981 . . . . 1.46 108.35 177.478 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 967' ' ' VAL . . . . . 0.494 HG23 ' C ' ' B' ' 966' ' ' LEU . 89.8 t -158.42 97.01 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 N-CA-C 108.095 -1.076 . . . . 1.9399999999999999 108.095 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 88.7 mmm -142.77 59.19 1.43 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.765 -1.21 . . . . 0.0 108.281 178.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.53 119.69 1.93 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 107.0 -2.44 . . . . 2.1099999999999999 107.0 -178.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -81.22 -57.86 3.32 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.063 -1.257 . . . . 5.8899999999999997 110.435 -179.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 44.2 tp -58.91 90.37 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.465 -0.772 . . . . 4.3600000000000003 110.223 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -141.27 -154.91 0.54 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.575 -0.703 . . . . 1.8300000000000001 110.304 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -119.86 172.1 7.95 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.464 -0.773 . . . . 4.3499999999999996 110.38 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 29.5 t -101.52 130.29 47.77 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.565 -0.709 . . . . 1.27 110.145 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -156.41 158.35 37.18 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.504 -0.747 . . . . 5.0199999999999996 110.553 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.7 86.32 16.0 Favored Pre-proline 0 N--CA 1.5 2.06 0 O-C-N 121.614 -0.679 . . . . 2.4100000000000001 109.7 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -73.12 -172.83 1.09 Allowed 'Trans proline' 0 C--N 1.317 -1.123 0 O-C-N 123.344 1.181 . . . . 0.95999999999999996 111.514 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 978' ' ' LEU . . . . . 0.726 HD23 HD12 ' B' ' 856' ' ' LEU . 5.2 mp -127.81 154.91 44.88 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.644 -1.243 . . . . 0.62 107.644 178.029 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 979' ' ' THR . . . . . 0.453 HG23 ' C ' ' B' ' 978' ' ' LEU . 33.7 p -150.51 142.16 23.62 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.81 -1.181 . . . . 3.5699999999999998 111.384 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 980' ' ' ILE . . . . . 0.721 ' HB ' HG21 ' B' ' 899' ' ' VAL . 47.0 mm -106.49 127.06 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 108.765 -0.828 . . . . 1.3300000000000001 108.765 179.226 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 981' ' ' PHE . . . . . 0.495 ' HD1' ' HH ' ' B' ' 879' ' ' TYR . 5.6 t80 -119.27 97.64 5.76 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.458 -0.776 . . . . 0.050000000000000003 111.767 -178.459 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 982' ' ' SER . . . . . 0.4 ' HB2' HD23 ' C' ' 952' ' ' LEU . 77.8 p -109.02 159.0 17.19 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.544 -0.722 . . . . 0.87 109.428 178.397 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 983' ' ' GLY . . . . . 0.402 ' HA3' ' CE1' ' B' ' 852' ' ' PHE . . . -175.01 107.77 0.25 Allowed Glycine 0 N--CA 1.499 2.869 0 N-CA-C 106.53 -2.628 . . . . 0.029999999999999999 106.53 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -108.62 152.33 24.93 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 114.44 1.274 . . . . 0.69999999999999996 114.44 -175.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 985' ' ' LEU . . . . . 0.72 HD13 HD22 ' B' ' 890' ' ' LEU . 53.3 tp -71.26 134.03 46.52 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.9 -1.125 . . . . 0.040000000000000001 110.108 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 986' ' ' LEU . . . . . 0.488 ' CD1' HD11 ' C' ' 986' ' ' LEU . 45.8 tp -107.62 -56.17 2.26 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.591 -0.693 . . . . 0.040000000000000001 109.923 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -145.34 145.05 31.05 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 107.737 -1.208 . . . . 0.040000000000000001 107.737 178.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.92 163.02 12.18 Favored Glycine 0 N--CA 1.496 2.653 0 N-CA-C 108.21 -1.956 . . . . 0.040000000000000001 108.21 179.269 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -75.13 112.76 19.73 Favored Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 121.165 -1.197 . . . . 0.040000000000000001 109.535 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 990' ' ' PRO . . . . . 0.425 ' HD2' HD12 ' B' ' 992' ' ' LEU . 50.9 Cg_endo -90.18 70.95 1.56 Allowed 'Trans proline' 0 C--N 1.319 -0.985 0 O-C-N 123.13 1.068 . . . . 0.45000000000000001 111.423 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 991' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' B' ' 990' ' ' PRO . 70.6 mt-10 67.25 -73.57 0.08 Allowed 'General case' 0 N--CA 1.503 2.207 0 N-CA-C 108.6 -0.889 . . . . 1.97 108.6 -177.492 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 992' ' ' LEU . . . . . 0.434 ' HA ' HD23 ' B' ' 992' ' ' LEU . 10.9 mt 51.22 20.31 0.88 Allowed 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.551 -0.718 . . . . 2.3799999999999999 111.621 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 83.6 mt-10 -93.73 156.95 16.4 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.86 -1.15 . . . . 3.79 110.104 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 72.1 m80 -146.67 92.73 2.19 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.534 -0.729 . . . . 3.5099999999999998 110.395 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 995' ' ' ALA . . . . . . . . . . . . 2.517 . . . . . . . 0 N--CA 1.503 2.222 0 O-C-N 120.953 -1.092 . . . . 2.73 110.639 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo . . . . . 0 N--CA 1.488 1.174 0 N-CA-C 109.488 -1.005 . . . . 3.8300000000000001 109.488 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' C' C ' 847' ' ' VAL . . . . . . . . . . . . . 57.7 t -130.31 103.28 16.67 Favored Pre-proline 0 N--CA 1.496 1.869 0 O-C-N 121.604 -0.685 . . . . 1.8300000000000001 110.133 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 848' ' ' PRO . . . . . 0.708 ' O ' HG23 ' C' ' 850' ' ' VAL . 44.2 Cg_endo -70.49 -21.29 30.32 Favored 'Trans proline' 0 N--CA 1.488 1.182 0 O-C-N 123.277 1.146 . . . . 0.65000000000000002 111.269 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 849' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 27.5 69.97 0.06 Allowed 'General case' 0 N--CA 1.519 3.024 0 N-CA-C 112.826 0.676 . . . . 2.5800000000000001 112.826 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 850' ' ' VAL . . . . . 0.708 HG23 ' O ' ' C' ' 848' ' ' PRO . 61.2 t -119.93 134.57 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.234 -0.916 . . . . 1.0900000000000001 111.648 -178.63 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 851' ' ' ALA . . . . . 0.584 ' HB3' ' HG ' ' C' ' 873' ' ' LEU . . . -127.46 155.32 43.88 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 105.772 -1.936 . . . . 0.040000000000000001 105.772 176.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 852' ' ' PHE . . . . . 0.455 ' CD1' ' N ' ' C' ' 852' ' ' PHE . 13.2 p90 -159.96 127.56 4.65 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 121.049 1.75 . . . . 0.050000000000000003 108.557 178.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 29.4 t -176.72 134.13 0.21 Allowed 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.105 -1.072 . . . . 0.040000000000000001 108.105 -179.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 854' ' ' ALA . . . . . 0.529 ' HB1' ' HD2' ' C' ' 868' ' ' PHE . . . -131.13 156.32 45.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.169 -0.957 . . . . 0.67000000000000004 109.642 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 855' ' ' ALA . . . . . 0.779 ' HB3' ' CB ' ' C' ' 870' ' ' ARG . . . -121.54 141.54 50.96 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.891 0.853 . . . . 0.51000000000000001 111.107 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 856' ' ' LEU . . . . . 0.995 HD11 HD23 ' C' ' 858' ' ' LEU . 3.5 tm? -114.53 137.59 51.67 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.402 -0.811 . . . . 0.050000000000000003 110.171 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 857' ' ' SER . . . . . 0.57 ' N ' HD13 ' C' ' 856' ' ' LEU . 1.9 m -153.8 19.38 0.52 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.52 -0.737 . . . . 1.3300000000000001 110.866 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 858' ' ' LEU . . . . . 0.995 HD23 HD11 ' C' ' 856' ' ' LEU . 1.4 pp -34.06 160.9 0.04 OUTLIER Pre-proline 0 N--CA 1.516 2.853 0 N-CA-C 113.189 0.811 . . . . 2.3300000000000001 113.189 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -61.6 -88.2 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 120.816 1.011 . . . . 2.3199999999999998 113.306 -178.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 54.6 ptt85 -131.04 -142.33 0.23 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 120.873 -1.142 . . . . 0.040000000000000001 111.435 -177.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 74.5 m -38.42 130.23 1.32 Allowed 'General case' 0 N--CA 1.511 2.589 0 O-C-N 121.563 -0.71 . . . . 1.3100000000000001 112.172 -178.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 862' ' ' GLU . . . . . 0.522 ' HG2' HD13 ' C' ' 858' ' ' LEU . 1.5 mm-40 -102.99 158.79 31.06 Favored Pre-proline 0 N--CA 1.488 1.436 0 N-CA-C 108.237 -1.023 . . . . 4.5099999999999998 108.237 177.477 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.18 -13.75 33.97 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 O-C-N 123.203 1.107 . . . . 2.2400000000000002 110.829 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -176.7 -136.03 2.31 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.08 -1.608 . . . . 0.040000000000000001 109.08 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 24.7 m -68.83 155.59 39.93 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.27 -1.135 . . . . 1.51 110.164 -179.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 866' ' ' VAL . . . . . 0.445 HG11 ' CD2' ' C' ' 858' ' ' LEU . 60.2 t -99.88 138.05 20.27 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.466 -0.771 . . . . 0.78000000000000003 113.048 -175.003 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 867' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' C' ' 866' ' ' VAL . 55.4 Cg_endo -90.4 -147.05 0.03 OUTLIER 'Trans proline' 0 CA--C 1.546 1.086 0 O-C-N 123.533 1.28 . . . . 0.92000000000000004 109.234 178.225 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 868' ' ' PHE . . . . . 0.529 ' HD2' ' HB1' ' C' ' 854' ' ' ALA . 24.5 p90 -149.29 125.37 10.68 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.487 -1.383 . . . . 0.050000000000000003 110.032 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 50.9 p-10 -112.46 -2.82 14.59 Favored 'General case' 0 N--CA 1.499 2.013 0 C-N-CA 119.295 -0.962 . . . . 1.7 112.744 -178.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 870' ' ' ARG . . . . . 0.779 ' CB ' ' HB3' ' C' ' 855' ' ' ALA . 25.8 mmm180 -91.41 88.84 6.99 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 120.849 -1.157 . . . . 2.5899999999999999 111.112 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 63.1 t -72.86 97.34 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 120.902 -1.123 . . . . 1.9399999999999999 109.288 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 872' ' ' LEU . . . . . 0.948 HD13 HD11 ' A' ' 953' ' ' ILE . 72.9 mt -86.48 -45.94 10.66 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.537 -0.727 . . . . 1.0600000000000001 110.561 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 873' ' ' LEU . . . . . 0.584 ' HG ' ' HB3' ' C' ' 851' ' ' ALA . 36.8 tp -173.09 102.5 0.13 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.208 -0.932 . . . . 4.1799999999999997 108.715 178.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 874' ' ' ASN . . . . . 0.435 ' CB ' ' HA ' ' C' ' 852' ' ' PHE . 35.5 t-20 177.49 82.46 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.231 0 N-CA-C 108.827 -0.805 . . . . 0.040000000000000001 108.827 -178.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -65.05 -46.68 80.23 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.194 -0.941 . . . . 3.3799999999999999 111.521 -178.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 876' ' ' GLY . . . . . 0.414 ' HA3' ' CE2' ' C' ' 878' ' ' TYR . . . -73.01 -26.56 70.7 Favored Glycine 0 N--CA 1.493 2.474 0 O-C-N 121.243 -0.91 . . . . 0.040000000000000001 111.748 -178.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 80.34 -62.38 4.3 Favored Glycine 0 N--CA 1.501 3.007 0 N-CA-C 107.911 -2.075 . . . . 0.040000000000000001 107.911 -178.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 878' ' ' TYR . . . . . 0.414 ' CE2' ' HA3' ' C' ' 876' ' ' GLY . 93.2 m-85 60.61 -65.73 0.05 Allowed 'General case' 0 N--CA 1.503 2.22 0 N-CA-C 114.404 1.261 . . . . 3.46 114.404 177.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 879' ' ' TYR . . . . . 0.505 ' CE2' ' CD1' ' C' ' 981' ' ' PHE . 28.8 p90 -110.27 106.83 16.38 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 114.826 1.417 . . . . 0.040000000000000001 114.826 -176.131 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -73.75 117.19 58.99 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.489 -0.757 . . . . 0.02 109.806 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 881' ' ' PRO . . . . . 0.429 ' HD2' ' CE1' ' C' ' 868' ' ' PHE . 54.2 Cg_endo -77.07 1.07 9.07 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 O-C-N 123.34 1.179 . . . . 0.39000000000000001 112.351 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 71.5 mt-10 -73.55 -53.61 10.13 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 105.733 -1.951 . . . . 0.81000000000000005 105.733 177.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 14.7 p -99.7 -21.0 16.0 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 115.068 -0.969 . . . . 0.040000000000000001 108.841 177.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 81.93 15.76 74.25 Favored Glycine 0 N--CA 1.496 2.672 0 N-CA-C 110.434 -1.066 . . . . 0.029999999999999999 110.434 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 58.5 t -74.87 91.94 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 C-N-CA 118.422 -1.311 . . . . 1.01 108.584 -178.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 886' ' ' PHE . . . . . 0.894 ' HB3' HG22 ' C' ' 962' ' ' VAL . 1.0 OUTLIER -88.04 106.18 17.97 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 115.173 -0.921 . . . . 0.050000000000000003 111.531 -177.696 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 887' ' ' THR . . . . . 0.439 ' O ' ' HD3' ' C' ' 889' ' ' PRO . 88.3 m -101.46 99.79 10.16 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.669 -1.234 . . . . 0.68000000000000005 107.669 177.404 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 888' ' ' ALA . . . . . . . . . . . . . . . -98.45 102.0 13.21 Favored Pre-proline 0 N--CA 1.5 2.061 0 N-CA-C 114.375 1.25 . . . . 0.25 114.375 -176.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 889' ' ' PRO . . . . . 0.439 ' HD3' ' O ' ' C' ' 887' ' ' THR . 55.6 Cg_endo -81.45 -15.27 10.01 Favored 'Trans proline' 0 CA--C 1.544 1.014 0 N-CA-C 108.632 -1.334 . . . . 1.6399999999999999 108.632 175.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 890' ' ' LEU . . . . . 0.613 HD21 HG11 ' C' ' 850' ' ' VAL . 67.6 mt -37.27 -49.36 0.94 Allowed 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 113.394 0.887 . . . . 2.29 113.394 -177.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 52.4 96.99 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.241 0 O-C-N 121.268 -0.895 . . . . 0.63 110.196 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . 159.28 -153.64 24.72 Favored Glycine 0 N--CA 1.477 1.411 0 N-CA-C 107.45 -2.26 . . . . 0.040000000000000001 107.45 -179.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 76.0 ttt-85 -117.62 123.1 45.34 Favored 'General case' 0 C--N 1.293 -1.877 0 O-C-N 121.715 -0.874 . . . . 3.0 108.872 178.071 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 894' ' ' TYR . . . . . 0.786 ' CE2' HD23 ' C' ' 954' ' ' LEU . 13.6 p90 -132.89 155.91 48.17 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.024 -1.047 . . . . 0.040000000000000001 111.193 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 895' ' ' LEU . . . . . . . . . . . . . 46.0 tp -98.58 111.65 23.94 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.694 -0.629 . . . . 1.27 109.87 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 896' ' ' LEU . . . . . 0.507 HD22 HH12 ' C' ' 921' ' ' ARG . 10.1 tt -115.66 144.91 43.25 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.618 -0.676 . . . . 0.93999999999999995 109.926 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 897' ' ' SER . . . . . 0.437 ' N ' HD23 ' C' ' 896' ' ' LEU . 43.3 m -142.03 124.87 16.05 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.393 -0.817 . . . . 0.040000000000000001 111.477 -179.076 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -101.22 148.13 25.46 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.759 -0.83 . . . . 0.47999999999999998 108.759 178.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 899' ' ' VAL . . . . . 0.716 HG21 ' HB ' ' C' ' 980' ' ' ILE . 84.7 t -92.42 120.79 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.321 -0.862 . . . . 0.55000000000000004 111.23 -179.11 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 91.6 mt -92.15 113.45 25.73 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 114.006 1.113 . . . . 1.5900000000000001 114.006 -175.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 21.7 m -62.7 140.9 58.74 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 107.527 -1.286 . . . . 0.050000000000000003 107.527 177.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -60.91 -65.37 3.36 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.238 -1.145 . . . . 0.029999999999999999 110.238 -179.287 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 46.1 65.62 1.13 Allowed 'General case' 0 N--CA 1.506 2.363 0 O-C-N 121.518 -0.989 . . . . 3.2000000000000002 111.235 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -66.86 -8.28 27.86 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.623 -0.673 . . . . 2.9199999999999999 111.819 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 905' ' ' HIS . . . . . 0.474 ' O ' ' CB ' ' C' ' 906' ' ' GLU . 72.6 t60 -62.94 4.87 0.15 Allowed 'General case' 0 N--CA 1.503 2.215 0 O-C-N 120.915 -1.116 . . . . 2.8700000000000001 112.679 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 906' ' ' GLU . . . . . 0.498 ' O ' ' CB ' ' C' ' 907' ' ' LYS . 2.0 mt-10 89.73 -153.99 0.01 OUTLIER 'General case' 0 N--CA 1.526 3.329 0 CA-C-N 121.136 1.789 . . . . 0.98999999999999999 111.567 179.209 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 907' ' ' LYS . . . . . 0.498 ' CB ' ' O ' ' C' ' 906' ' ' GLU . 56.5 tttt 88.84 162.85 0.06 Allowed 'General case' 0 N--CA 1.52 3.066 0 N-CA-C 107.759 -1.2 . . . . 5.25 107.759 -176.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 59.7 t -122.7 114.59 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 120.778 -1.202 . . . . 0.39000000000000001 110.781 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 909' ' ' GLU . . . . . 0.62 ' OE2' HD12 ' C' ' 966' ' ' LEU . 42.8 tp10 -105.79 131.19 53.43 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 107.557 -1.275 . . . . 1.72 107.557 177.1 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -156.73 120.44 4.27 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 106.943 -1.503 . . . . 0.67000000000000004 106.943 178.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 911' ' ' VAL . . . . . 0.521 ' HA ' ' HA ' ' C' ' 964' ' ' VAL . 12.8 p -80.08 131.57 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 C-N-CA 120.306 -0.558 . . . . 0.54000000000000004 111.321 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 62.4 mt -66.23 156.72 33.4 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.258 -0.901 . . . . 1.5 108.885 178.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 913' ' ' SER . . . . . 0.418 ' CB ' ' CG1' ' C' ' 919' ' ' VAL . 1.7 t -126.19 136.93 53.44 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.377 -0.971 . . . . 1.3700000000000001 108.377 177.031 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 914' ' ' ARG . . . . . 0.844 ' CZ ' HD23 ' C' ' 956' ' ' LEU . 0.0 OUTLIER -63.67 154.0 34.38 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 120.707 -1.246 . . . . 4.2999999999999998 111.708 -178.783 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 915' ' ' SER . . . . . 0.425 ' CB ' ' O ' ' C' ' 914' ' ' ARG . 2.4 t 83.28 -30.61 0.09 Allowed 'General case' 0 N--CA 1.521 3.119 0 C-N-CA 123.808 0.843 . . . . 2.0499999999999998 112.384 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 916' ' ' ASN . . . . . 0.785 ' HB2' HG21 ' C' ' 919' ' ' VAL . 94.8 m-20 -122.19 -21.74 5.8 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.868 -1.145 . . . . 2.71 111.362 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 67.36 166.11 0.23 Allowed 'General case' 0 N--CA 1.521 3.082 0 N-CA-C 105.491 -2.04 . . . . 2.6800000000000002 105.491 -173.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.27 -125.18 33.13 Favored Glycine 1 N--CA 1.521 4.362 0 CA-C-N 123.773 2.988 . . . . 0.029999999999999999 107.08 -177.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 919' ' ' VAL . . . . . 0.785 HG21 ' HB2' ' C' ' 916' ' ' ASN . 96.7 t 49.83 94.06 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.266 0 O-C-N 121.543 -0.975 . . . . 1.3899999999999999 109.334 -178.225 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 920' ' ' ALA . . . . . 0.91 ' HB3' HG12 ' C' ' 949' ' ' VAL . . . -94.74 95.48 8.75 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.469 -0.892 . . . . 0.029999999999999999 110.886 -179.238 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 921' ' ' ARG . . . . . 0.726 ' HG3' HG23 ' C' ' 922' ' ' VAL . 42.8 ptt85 -79.9 -42.05 24.92 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 105.538 -2.023 . . . . 4.4199999999999999 105.538 176.015 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 922' ' ' VAL . . . . . 0.726 HG23 ' HG3' ' C' ' 921' ' ' ARG . 84.6 t -99.89 76.8 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 N-CA-C 105.545 -2.02 . . . . 0.84999999999999998 105.545 175.049 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -90.61 136.7 32.9 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 122.005 0.907 . . . . 2.46 112.794 -176.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 5.1 t -146.99 103.36 3.6 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.619 -1.252 . . . . 0.69999999999999996 107.619 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -109.21 83.83 0.34 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.485 -1.446 . . . . 0.040000000000000001 109.485 -179.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.361 0 N-CA-C 109.172 -1.571 . . . . 0.040000000000000001 109.172 -179.997 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 22.7 m . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 120.997 0.427 . . . . 13.779999999999999 110.303 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 95.2 mt -112.87 129.89 56.3 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.518 -0.739 . . . . 13.76 110.453 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -151.77 169.89 31.21 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.212 -1.555 . . . . 9.1300000000000008 109.212 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 949' ' ' VAL . . . . . 0.91 HG12 ' HB3' ' C' ' 920' ' ' ALA . 34.1 m -118.04 135.73 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.519 -0.989 . . . . 7.0800000000000001 111.034 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 950' ' ' PHE . . . . . 0.457 ' CZ ' ' HB3' ' C' ' 921' ' ' ARG . 51.7 p90 -135.06 152.47 51.71 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.555 -0.716 . . . . 7.5899999999999999 109.379 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 7.6 t -119.05 -55.09 2.19 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.386 -0.822 . . . . 5.0300000000000002 111.852 -179.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 952' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' C' ' 953' ' ' ILE . 58.9 tp -62.71 -77.07 0.05 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.433 -0.792 . . . . 1.01 111.472 -178.218 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 953' ' ' ILE . . . . . 0.571 HD12 ' HD3' ' C' ' 955' ' ' PRO . 2.1 pp -49.12 -151.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.688 0 N-CA-C 114.615 1.339 . . . . 2.6000000000000001 114.615 -176.654 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 954' ' ' LEU . . . . . 0.786 HD23 ' CE2' ' C' ' 894' ' ' TYR . 0.0 OUTLIER 170.02 89.45 0.04 OUTLIER Pre-proline 0 N--CA 1.516 2.85 0 O-C-N 120.78 -1.2 . . . . 0.050000000000000003 112.068 -179.497 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 955' ' ' PRO . . . . . 0.649 ' C ' HD12 ' C' ' 956' ' ' LEU . 50.0 Cg_endo -83.66 94.65 0.78 Allowed 'Trans proline' 0 C--N 1.315 -1.196 0 N-CA-C 109.506 -0.998 . . . . 0.83999999999999997 109.506 178.61 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 956' ' ' LEU . . . . . 0.844 HD23 ' CZ ' ' C' ' 914' ' ' ARG . 6.6 mp -125.64 150.84 47.24 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.024 -1.047 . . . . 0.040000000000000001 110.622 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -81.89 151.5 27.25 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-O 117.66 -1.162 . . . . 1.28 111.323 -178.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -66.41 118.43 10.04 Favored 'General case' 0 N--CA 1.507 2.393 0 CA-C-N 123.202 2.728 . . . . 0.17000000000000001 110.874 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.54 -19.75 48.72 Favored Glycine 0 N--CA 1.499 2.897 0 N-CA-C 111.067 -0.813 . . . . 0.040000000000000001 111.067 178.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 960' ' ' ASP . . . . . 0.425 ' HB3' ' NE ' ' C' ' 914' ' ' ARG . 0.5 OUTLIER -52.32 171.91 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.344 -1.092 . . . . 0.040000000000000001 110.505 -179.473 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 961' ' ' THR . . . . . 0.488 ' HA ' ' O ' ' C' ' 886' ' ' PHE . 26.3 m -136.93 140.38 42.23 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.043 -1.035 . . . . 1.78 112.614 -177.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 962' ' ' VAL . . . . . 0.894 HG22 ' HB3' ' C' ' 886' ' ' PHE . 26.8 m -101.07 145.47 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 C-N-CA 120.302 -0.559 . . . . 0.040000000000000001 110.809 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 6.2 t -137.99 144.44 41.13 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.815 -0.553 . . . . 0.71999999999999997 109.858 -179.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 964' ' ' VAL . . . . . 0.521 ' HA ' ' HA ' ' C' ' 911' ' ' VAL . 61.8 t -90.79 137.67 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.043 -1.036 . . . . 1.05 110.713 -178.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -92.67 125.17 37.17 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 103.289 -2.856 . . . . 3.02 103.289 173.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 966' ' ' LEU . . . . . 0.62 HD12 ' OE2' ' C' ' 909' ' ' GLU . 0.2 OUTLIER -133.68 57.46 1.81 Allowed 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.635 -0.876 . . . . 1.46 108.635 177.76 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 967' ' ' VAL . . . . . 0.489 HG23 ' C ' ' C' ' 966' ' ' LEU . 98.1 t -158.48 96.41 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 N-CA-C 108.277 -1.009 . . . . 1.9399999999999999 108.277 179.386 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 90.2 mmm -142.74 59.22 1.43 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.759 -1.213 . . . . 0.0 108.459 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 134.44 119.53 1.97 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 107.205 -2.358 . . . . 2.1099999999999999 107.205 -178.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 95.4 mm-40 -82.34 -57.71 3.25 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.082 -1.246 . . . . 5.8899999999999997 110.684 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 41.4 tp -58.87 89.74 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.46 -0.775 . . . . 4.3600000000000003 110.401 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -142.63 -152.69 0.42 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.572 -0.705 . . . . 1.8300000000000001 110.129 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 7.7 t60 -116.74 167.43 11.1 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.384 -0.823 . . . . 4.3499999999999996 110.076 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 41.1 t -102.8 130.69 49.86 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.624 -0.673 . . . . 1.27 110.197 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -156.35 158.55 37.6 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.498 -0.751 . . . . 5.0199999999999996 110.753 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.82 86.1 15.9 Favored Pre-proline 0 N--CA 1.501 2.116 0 O-C-N 121.616 -0.677 . . . . 2.4100000000000001 109.716 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -75.71 -170.17 0.79 Allowed 'Trans proline' 0 C--N 1.318 -1.061 0 O-C-N 123.303 1.159 . . . . 0.95999999999999996 111.453 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 978' ' ' LEU . . . . . 0.524 ' N ' HD12 ' C' ' 978' ' ' LEU . 5.2 mp -124.97 156.39 38.12 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 107.511 -1.292 . . . . 0.62 107.511 177.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 979' ' ' THR . . . . . 0.445 HG23 ' C ' ' C' ' 978' ' ' LEU . 39.5 p -149.92 141.47 23.45 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.728 -1.232 . . . . 3.5699999999999998 111.325 -179.283 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 980' ' ' ILE . . . . . 0.716 ' HB ' HG21 ' C' ' 899' ' ' VAL . 47.5 mm -106.96 128.48 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 109.122 -0.696 . . . . 1.3300000000000001 109.122 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 981' ' ' PHE . . . . . 0.505 ' CD1' ' CE2' ' C' ' 879' ' ' TYR . 3.2 t80 -117.89 95.44 4.92 Favored 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 119.69 -0.804 . . . . 0.050000000000000003 111.568 -178.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 982' ' ' SER . . . . . . . . . . . . . 12.5 p -107.63 158.27 17.39 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.6 -0.688 . . . . 0.87 109.255 178.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 983' ' ' GLY . . . . . 0.417 ' HA3' ' CE2' ' C' ' 852' ' ' PHE . . . -172.18 114.48 0.53 Allowed Glycine 0 N--CA 1.497 2.704 0 N-CA-C 106.601 -2.6 . . . . 0.029999999999999999 106.601 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 984' ' ' ALA . . . . . 0.438 ' HB1' ' CZ ' ' A' ' 893' ' ' ARG . . . -108.4 150.76 26.94 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 114.259 1.207 . . . . 0.69999999999999996 114.259 -175.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 985' ' ' LEU . . . . . 0.583 HD13 HD22 ' C' ' 890' ' ' LEU . 47.9 tp -75.32 135.71 40.88 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.814 -1.179 . . . . 0.040000000000000001 109.609 179.419 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 986' ' ' LEU . . . . . 0.488 HD11 ' CD1' ' B' ' 986' ' ' LEU . 45.5 tp -106.23 -63.16 1.29 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.461 -0.774 . . . . 0.040000000000000001 110.329 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -144.28 146.94 32.92 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 107.806 -1.183 . . . . 0.040000000000000001 107.806 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -111.96 162.71 12.33 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 107.99 -2.044 . . . . 0.040000000000000001 107.99 179.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.81 112.73 19.0 Favored Pre-proline 0 N--CA 1.497 1.895 0 O-C-N 121.135 -1.215 . . . . 0.040000000000000001 109.452 179.117 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 990' ' ' PRO . . . . . 0.419 ' HD2' HD12 ' C' ' 992' ' ' LEU . 50.9 Cg_endo -89.29 71.24 2.01 Favored 'Trans proline' 0 C--N 1.319 -1.017 0 O-C-N 123.109 1.057 . . . . 0.45000000000000001 111.301 -178.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 991' ' ' GLU . . . . . 0.417 ' HB2' ' O ' ' C' ' 990' ' ' PRO . 85.7 mt-10 67.11 -73.77 0.07 Allowed 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 108.687 -0.857 . . . . 1.97 108.687 -177.465 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 992' ' ' LEU . . . . . 0.419 HD12 ' HD2' ' C' ' 990' ' ' PRO . 11.3 mt 50.5 21.3 0.83 Allowed 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.594 -0.691 . . . . 2.3799999999999999 111.553 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -93.35 156.97 16.47 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.936 -1.102 . . . . 3.79 110.144 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 68.6 m80 -146.31 92.48 2.18 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.597 -0.689 . . . . 3.5099999999999998 110.202 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 995' ' ' ALA . . . . . . . . . . . . 2.519 . . . . . . . 0 N--CA 1.503 2.224 0 O-C-N 120.917 -1.115 . . . . 2.73 110.614 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo . . . . . 0 N--CA 1.488 1.157 0 N-CA-C 109.525 -0.991 . . . . 3.8300000000000001 109.525 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 847' ' ' VAL . . . . . . . . . . . . . 62.0 t -134.49 103.26 11.34 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.574 -0.704 . . . . 1.8300000000000001 110.014 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 848' ' ' PRO . . . . . 0.707 ' O ' HG23 ' A' ' 850' ' ' VAL . 44.1 Cg_endo -69.99 -18.64 35.83 Favored 'Trans proline' 0 N--CA 1.488 1.182 0 O-C-N 123.315 1.166 . . . . 0.65000000000000002 111.303 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 849' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 27.58 68.72 0.07 Allowed 'General case' 0 N--CA 1.518 2.975 0 N-CA-C 112.941 0.719 . . . . 2.5800000000000001 112.941 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 850' ' ' VAL . . . . . 0.707 HG23 ' O ' ' A' ' 848' ' ' PRO . 62.1 t -118.92 135.81 58.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.221 -0.924 . . . . 1.0900000000000001 111.429 -178.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 851' ' ' ALA . . . . . 0.464 ' HB3' ' HG ' ' A' ' 873' ' ' LEU . . . -126.76 156.95 40.38 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 105.868 -1.901 . . . . 0.040000000000000001 105.868 176.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 852' ' ' PHE . . . . . 0.443 ' HA ' ' CB ' ' A' ' 874' ' ' ASN . 33.7 p90 -158.79 130.18 6.38 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 121.022 1.737 . . . . 0.050000000000000003 108.79 179.053 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 44.1 t -174.93 134.1 0.34 Allowed 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.125 -1.065 . . . . 0.040000000000000001 108.125 -179.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 854' ' ' ALA . . . . . 0.461 ' HB1' ' HD2' ' A' ' 868' ' ' PHE . . . -134.01 155.92 49.12 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.07 -1.019 . . . . 0.67000000000000004 109.423 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 855' ' ' ALA . . . . . 0.761 ' HB3' ' CB ' ' A' ' 870' ' ' ARG . . . -122.15 141.6 51.27 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.758 0.79 . . . . 0.51000000000000001 111.362 -179.032 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 856' ' ' LEU . . . . . 0.671 HD13 ' N ' ' A' ' 857' ' ' SER . 3.4 tm? -111.27 137.94 48.36 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.649 -0.657 . . . . 0.050000000000000003 109.939 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 857' ' ' SER . . . . . 0.671 ' N ' HD13 ' A' ' 856' ' ' LEU . 1.5 m -156.77 16.86 0.31 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.579 -0.701 . . . . 1.3300000000000001 111.587 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 858' ' ' LEU . . . . . 0.609 HD22 ' HG3' ' A' ' 862' ' ' GLU . 3.8 pp -35.02 160.35 0.04 OUTLIER Pre-proline 0 N--CA 1.519 2.991 0 N-CA-C 113.006 0.743 . . . . 2.3300000000000001 113.006 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -60.69 -88.64 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 120.87 1.046 . . . . 2.3199999999999998 113.796 -177.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 53.6 ptt85 -128.54 -142.72 0.26 Allowed 'General case' 0 N--CA 1.5 2.075 0 O-C-N 120.859 -1.151 . . . . 0.040000000000000001 111.756 -177.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 15.0 m -38.03 126.76 1.28 Allowed 'General case' 0 N--CA 1.51 2.569 0 O-C-N 121.643 -0.661 . . . . 1.3100000000000001 112.26 -178.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 862' ' ' GLU . . . . . 0.609 ' HG3' HD22 ' A' ' 858' ' ' LEU . 0.0 OUTLIER -99.59 158.99 31.17 Favored Pre-proline 0 N--CA 1.489 1.51 0 N-CA-C 108.423 -0.954 . . . . 4.5099999999999998 108.423 177.754 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -70.99 -14.55 32.25 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 O-C-N 123.245 1.129 . . . . 2.2400000000000002 111.379 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -177.7 -135.89 2.36 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.515 -1.434 . . . . 0.040000000000000001 109.515 179.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 26.8 m -65.97 156.05 34.75 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.33 -1.1 . . . . 1.51 110.134 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 866' ' ' VAL . . . . . 0.498 HG13 ' CD2' ' A' ' 858' ' ' LEU . 61.5 t -98.85 137.33 20.52 Favored Pre-proline 0 N--CA 1.494 1.736 0 N-CA-C 113.547 0.943 . . . . 0.78000000000000003 113.547 -174.332 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 867' ' ' PRO . . . . . 0.553 ' O ' HD23 ' A' ' 856' ' ' LEU . 55.5 Cg_endo -92.41 -149.66 0.03 OUTLIER 'Trans proline' 0 CA--C 1.546 1.124 0 C-N-CA 121.335 1.356 . . . . 0.92000000000000004 109.634 178.088 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 868' ' ' PHE . . . . . 0.475 ' CD1' ' HG2' ' A' ' 881' ' ' PRO . 19.3 p90 -150.7 124.0 8.91 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.679 -1.263 . . . . 0.050000000000000003 109.776 179.157 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 46.6 p30 -113.48 -2.23 13.95 Favored 'General case' 0 N--CA 1.5 2.062 0 C-N-CA 119.285 -0.966 . . . . 1.7 112.483 -178.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 870' ' ' ARG . . . . . 0.761 ' CB ' ' HB3' ' A' ' 855' ' ' ALA . 26.7 mmm180 -90.11 89.29 7.61 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 120.889 -1.132 . . . . 2.5899999999999999 110.598 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 58.5 t -72.82 96.95 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 120.971 -1.081 . . . . 1.9399999999999999 109.91 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 872' ' ' LEU . . . . . 0.497 HD11 ' HB2' ' A' ' 855' ' ' ALA . 97.6 mt -82.84 -47.44 11.87 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.514 -0.741 . . . . 1.0600000000000001 110.177 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 873' ' ' LEU . . . . . 0.464 ' HG ' ' HB3' ' A' ' 851' ' ' ALA . 46.5 tp -174.99 104.26 0.09 Allowed 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 108.637 -0.875 . . . . 4.1799999999999997 108.637 178.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 874' ' ' ASN . . . . . 0.443 ' CB ' ' HA ' ' A' ' 852' ' ' PHE . 35.5 t-20 178.71 81.6 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.571 -0.706 . . . . 0.040000000000000001 109.802 -179.02 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -67.28 -48.05 68.81 Favored 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 119.321 -0.951 . . . . 3.3799999999999999 111.118 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 876' ' ' GLY . . . . . . . . . . . . . . . -73.58 -25.29 72.74 Favored Glycine 0 N--CA 1.494 2.529 0 O-C-N 121.284 -0.885 . . . . 0.040000000000000001 111.632 -178.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 82.39 -61.37 4.73 Favored Glycine 0 N--CA 1.502 3.044 0 N-CA-C 108.097 -2.001 . . . . 0.040000000000000001 108.097 -178.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 878' ' ' TYR . . . . . 0.418 ' CE2' ' CG1' ' A' ' 850' ' ' VAL . 95.8 m-85 61.15 -62.97 0.08 Allowed 'General case' 0 N--CA 1.503 2.201 0 N-CA-C 114.35 1.241 . . . . 3.46 114.35 177.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 879' ' ' TYR . . . . . 0.47 ' CB ' ' CD2' ' A' ' 886' ' ' PHE . 18.8 p90 -111.33 108.66 18.33 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 114.489 1.292 . . . . 0.040000000000000001 114.489 -176.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -65.0 114.7 15.94 Favored Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 121.402 -0.811 . . . . 0.02 110.094 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 881' ' ' PRO . . . . . 0.475 ' HG2' ' CD1' ' A' ' 868' ' ' PHE . 53.3 Cg_endo -75.15 -0.94 10.61 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 O-C-N 123.525 1.276 . . . . 0.39000000000000001 112.312 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -76.87 -65.4 0.95 Allowed 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.12 -1.437 . . . . 0.81000000000000005 107.12 178.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 31.6 p -92.25 -18.17 23.78 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.62 -0.882 . . . . 0.040000000000000001 108.62 177.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.22 19.79 60.12 Favored Glycine 0 N--CA 1.497 2.729 0 O-C-N 121.093 -1.005 . . . . 0.029999999999999999 111.554 178.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 885' ' ' VAL . . . . . 0.679 HG13 HG21 ' A' ' 961' ' ' THR . 92.2 t -73.43 91.1 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 C-N-CA 118.089 -1.445 . . . . 1.01 108.137 -179.501 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 886' ' ' PHE . . . . . 0.878 ' HB3' HG22 ' A' ' 962' ' ' VAL . 0.6 OUTLIER -89.73 105.11 17.58 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 115.207 -0.906 . . . . 0.050000000000000003 112.081 -177.443 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 887' ' ' THR . . . . . 0.406 ' O ' ' HD3' ' A' ' 889' ' ' PRO . 85.0 m -95.96 100.36 12.04 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 107.711 -1.218 . . . . 0.68000000000000005 107.711 177.25 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 888' ' ' ALA . . . . . . . . . . . . . . . -98.42 107.43 42.01 Favored Pre-proline 0 N--CA 1.501 2.124 0 N-CA-C 114.094 1.146 . . . . 0.25 114.094 -176.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 889' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' A' ' 887' ' ' THR . 53.8 Cg_endo -90.19 -12.53 2.71 Favored 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 121.066 1.177 . . . . 1.6399999999999999 109.243 176.362 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 890' ' ' LEU . . . . . 0.994 HD22 HD13 ' A' ' 985' ' ' LEU . 63.6 mt -36.11 -50.52 0.71 Allowed 'General case' 0 N--CA 1.508 2.466 0 N-CA-C 113.856 1.058 . . . . 2.29 113.856 -177.338 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 51.68 95.84 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.342 0 O-C-N 121.158 -0.964 . . . . 0.63 110.314 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 156.58 -149.66 20.59 Favored Glycine 0 N--CA 1.479 1.562 0 N-CA-C 107.301 -2.32 . . . . 0.040000000000000001 107.301 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 70.7 ttt-85 -112.65 126.64 55.6 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 107.945 -1.131 . . . . 3.0 107.945 177.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 894' ' ' TYR . . . . . 0.541 ' OH ' HD12 ' A' ' 896' ' ' LEU . 0.0 OUTLIER -131.21 155.09 47.67 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.045 -1.035 . . . . 0.040000000000000001 110.69 -179.178 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 895' ' ' LEU . . . . . 0.423 ' N ' ' CD1' ' A' ' 894' ' ' TYR . 34.9 tp -95.29 114.16 25.91 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.665 -0.647 . . . . 1.27 110.067 -179.161 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 896' ' ' LEU . . . . . 0.567 HD23 ' N ' ' A' ' 897' ' ' SER . 9.8 tt -108.62 142.67 38.75 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.718 -0.614 . . . . 0.93999999999999995 110.628 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 897' ' ' SER . . . . . 0.567 ' N ' HD23 ' A' ' 896' ' ' LEU . 69.9 m -147.41 115.4 6.5 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.516 -0.74 . . . . 0.040000000000000001 110.895 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.26 146.76 31.06 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.07 -0.715 . . . . 0.47999999999999998 109.07 179.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 899' ' ' VAL . . . . . 0.766 HG21 ' HB ' ' A' ' 980' ' ' ILE . 87.8 t -96.36 119.7 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 C-N-CA 119.627 -0.829 . . . . 0.55000000000000004 111.377 -179.122 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 900' ' ' LEU . . . . . 0.548 HD12 ' HB2' ' A' ' 924' ' ' SER . 4.5 mm? -94.39 111.53 23.28 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 114.057 1.132 . . . . 1.5900000000000001 114.057 -175.387 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 21.6 m -65.43 140.8 58.65 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 107.322 -1.362 . . . . 0.050000000000000003 107.322 177.062 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -64.66 -66.75 2.32 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 110.427 -1.069 . . . . 0.029999999999999999 110.427 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 5.9 m170 46.59 66.81 0.89 Allowed 'General case' 0 N--CA 1.507 2.403 0 O-C-N 121.522 -0.987 . . . . 3.2000000000000002 111.093 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 43.3 ptt85 -69.13 -5.76 24.33 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.542 -0.723 . . . . 2.9199999999999999 112.003 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 905' ' ' HIS . . . . . 0.485 ' O ' ' CB ' ' A' ' 906' ' ' GLU . 74.4 t60 -61.06 3.22 0.1 Allowed 'General case' 0 N--CA 1.506 2.328 0 O-C-N 120.834 -1.166 . . . . 2.8700000000000001 112.891 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 906' ' ' GLU . . . . . 0.485 ' CB ' ' O ' ' A' ' 905' ' ' HIS . 0.8 OUTLIER 93.69 -163.62 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.437 0 CA-C-N 120.513 1.506 . . . . 0.98999999999999999 112.425 178.549 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 907' ' ' LYS . . . . . 0.483 ' CB ' ' O ' ' A' ' 906' ' ' GLU . 51.2 tttt 88.95 161.18 0.06 Allowed 'General case' 0 N--CA 1.519 3.018 0 N-CA-C 107.72 -1.215 . . . . 5.25 107.72 -177.014 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 60.0 t -121.7 116.18 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 120.864 -1.148 . . . . 0.39000000000000001 110.787 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 54.1 tp10 -104.49 132.13 51.09 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 107.523 -1.288 . . . . 1.72 107.523 176.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -156.09 121.63 4.87 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 106.536 -1.653 . . . . 0.67000000000000004 106.536 178.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 911' ' ' VAL . . . . . 0.732 HG22 HG13 ' A' ' 964' ' ' VAL . 92.9 t -81.65 132.44 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.819 -0.551 . . . . 0.54000000000000004 110.753 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 71.6 mt -65.68 155.91 34.52 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.376 -0.828 . . . . 1.5 108.838 178.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 913' ' ' SER . . . . . 0.417 ' CB ' ' HB ' ' A' ' 919' ' ' VAL . 2.4 t -123.39 137.43 54.82 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.076 -1.083 . . . . 1.3700000000000001 108.076 176.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 914' ' ' ARG . . . . . 0.625 ' NH1' HD23 ' A' ' 956' ' ' LEU . 0.0 OUTLIER -64.28 154.14 36.06 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 120.791 -1.193 . . . . 4.2999999999999998 111.58 -179.001 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 915' ' ' SER . . . . . 0.427 ' CB ' ' O ' ' A' ' 914' ' ' ARG . 4.9 t 83.31 -32.27 0.08 Allowed 'General case' 0 N--CA 1.522 3.126 0 C-N-CA 124.016 0.927 . . . . 2.0499999999999998 112.294 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 916' ' ' ASN . . . . . 0.755 ' HB2' HG21 ' A' ' 919' ' ' VAL . 98.7 m-20 -122.37 -21.02 5.92 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 120.908 -1.12 . . . . 2.71 111.429 -179.248 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 917' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 67.1 166.44 0.22 Allowed 'General case' 0 N--CA 1.521 3.102 0 N-CA-C 105.58 -2.007 . . . . 2.6800000000000002 105.58 -174.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.44 -125.79 35.25 Favored Glycine 1 N--CA 1.521 4.349 0 CA-C-N 123.405 2.82 . . . . 0.029999999999999999 107.001 -177.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 919' ' ' VAL . . . . . 0.755 HG21 ' HB2' ' A' ' 916' ' ' ASN . 82.0 t 51.95 94.52 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.273 0 O-C-N 121.447 -1.031 . . . . 1.3899999999999999 108.915 -178.21 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 920' ' ' ALA . . . . . 0.888 ' HB3' HG12 ' A' ' 949' ' ' VAL . . . -91.6 92.37 8.45 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.311 -0.955 . . . . 0.029999999999999999 111.12 -178.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 921' ' ' ARG . . . . . 0.747 ' HG3' HG23 ' A' ' 922' ' ' VAL . 16.7 ptt180 -84.31 -42.25 16.0 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 105.752 -1.944 . . . . 4.4199999999999999 105.752 175.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 922' ' ' VAL . . . . . 0.747 HG23 ' HG3' ' A' ' 921' ' ' ARG . 75.1 t -103.75 69.63 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 N-CA-C 105.608 -1.997 . . . . 0.84999999999999998 105.608 175.204 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 923' ' ' ASP . . . . . 0.655 ' HB2' ' HB1' ' A' ' 920' ' ' ALA . 22.0 t0 -89.68 136.26 33.14 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.887 0.851 . . . . 2.46 112.238 -176.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 924' ' ' SER . . . . . 0.548 ' HB2' HD12 ' A' ' 900' ' ' LEU . 13.2 t -146.48 103.4 3.68 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.922 -1.14 . . . . 0.69999999999999996 107.922 178.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -110.79 89.57 0.55 Allowed Glycine 0 N--CA 1.488 2.106 0 N-CA-C 108.941 -1.664 . . . . 0.040000000000000001 108.941 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.311 0 N-CA-C 109.324 -1.51 . . . . 0.040000000000000001 109.324 -179.604 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 22.8 m . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.063 0.458 . . . . 13.779999999999999 110.272 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 96.2 mt -112.88 129.88 56.3 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.54 -0.725 . . . . 13.76 110.403 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -151.57 167.86 30.95 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.056 -1.618 . . . . 9.1300000000000008 109.056 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 949' ' ' VAL . . . . . 0.888 HG12 ' HB3' ' A' ' 920' ' ' ALA . 32.9 m -118.95 130.34 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.501 -0.999 . . . . 7.0800000000000001 110.947 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 950' ' ' PHE . . . . . 0.459 ' CZ ' ' HB3' ' A' ' 921' ' ' ARG . 27.6 p90 -132.52 149.22 52.36 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.572 -0.705 . . . . 7.5899999999999999 109.283 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 19.5 m -120.19 -53.11 2.15 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.396 -0.815 . . . . 5.0300000000000002 112.04 -178.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 952' ' ' LEU . . . . . 0.417 ' O ' ' O ' ' A' ' 953' ' ' ILE . 16.8 tp -61.25 -74.3 0.08 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.388 -0.82 . . . . 1.01 112.309 -177.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 953' ' ' ILE . . . . . 0.804 HD11 HD13 ' C' ' 872' ' ' LEU . 43.9 pt -53.27 -144.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.755 0 N-CA-C 114.034 1.124 . . . . 2.6000000000000001 114.034 -176.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 954' ' ' LEU . . . . . 0.702 HD22 ' O ' ' A' ' 954' ' ' LEU . 0.0 OUTLIER 171.46 78.8 0.04 OUTLIER Pre-proline 0 N--CA 1.51 2.572 0 O-C-N 120.762 -1.211 . . . . 0.050000000000000003 111.54 179.697 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 955' ' ' PRO . . . . . 0.689 ' C ' HD12 ' A' ' 956' ' ' LEU . 47.1 Cg_endo -74.35 95.64 0.94 Allowed 'Trans proline' 0 C--N 1.313 -1.311 0 N-CA-C 109.343 -1.06 . . . . 0.83999999999999997 109.343 178.49 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 956' ' ' LEU . . . . . 0.689 HD12 ' C ' ' A' ' 955' ' ' PRO . 10.2 mp -123.12 145.25 48.74 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.174 -0.954 . . . . 0.040000000000000001 110.236 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -84.66 151.17 24.64 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 117.814 -1.088 . . . . 1.28 111.856 -178.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -70.24 119.88 15.09 Favored 'General case' 0 N--CA 1.51 2.569 0 CA-C-N 122.926 2.603 . . . . 0.17000000000000001 111.943 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.81 -22.82 31.78 Favored Glycine 0 N--CA 1.502 3.065 0 N-CA-C 111.197 -0.761 . . . . 0.040000000000000001 111.197 178.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 960' ' ' ASP . . . . . 0.435 ' HB3' ' NE ' ' A' ' 914' ' ' ARG . 0.3 OUTLIER -53.3 171.74 0.07 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.505 -0.997 . . . . 0.040000000000000001 110.313 -179.341 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 961' ' ' THR . . . . . 0.679 HG21 HG13 ' A' ' 885' ' ' VAL . 39.2 m -134.56 135.42 42.26 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.931 -1.106 . . . . 1.78 111.785 -178.087 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 962' ' ' VAL . . . . . 0.878 HG22 ' HB3' ' A' ' 886' ' ' PHE . 31.6 m -98.76 145.23 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 C-N-CA 120.045 -0.662 . . . . 0.040000000000000001 110.389 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 5.0 t -137.86 146.25 43.19 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.906 -0.496 . . . . 0.71999999999999997 110.131 -178.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 964' ' ' VAL . . . . . 0.732 HG13 HG22 ' A' ' 911' ' ' VAL . 58.3 t -95.06 136.37 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.091 -1.006 . . . . 1.05 110.503 -179.258 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -95.4 126.48 40.73 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 103.682 -2.71 . . . . 3.02 103.682 173.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 966' ' ' LEU . . . . . 0.493 ' C ' HG23 ' A' ' 967' ' ' VAL . 1.4 tt -133.46 61.29 1.68 Allowed 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.271 -1.011 . . . . 1.46 108.271 177.216 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 967' ' ' VAL . . . . . 0.493 HG23 ' C ' ' A' ' 966' ' ' LEU . 98.9 t -157.92 96.44 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 108.138 -1.06 . . . . 1.9399999999999999 108.138 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 93.1 mmm -143.04 58.45 1.41 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.708 -1.245 . . . . 0.0 108.198 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 133.09 119.21 2.0 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 106.538 -2.625 . . . . 2.1099999999999999 106.538 -177.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -84.83 -44.49 13.21 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 119.0 1.4 . . . . 5.8899999999999997 111.364 -179.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 43.0 tp -61.39 89.12 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.921 -1.112 . . . . 4.3600000000000003 110.081 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -141.89 -156.46 0.68 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.525 -0.734 . . . . 1.8300000000000001 110.272 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -121.61 176.05 5.91 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.535 -0.728 . . . . 4.3499999999999996 110.273 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 9.1 t -99.98 129.87 46.09 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.534 -0.728 . . . . 1.27 109.909 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -156.1 157.92 36.85 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.497 -0.752 . . . . 5.0199999999999996 110.671 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.33 86.8 16.41 Favored Pre-proline 0 N--CA 1.499 2.021 0 O-C-N 121.605 -0.684 . . . . 2.4100000000000001 109.506 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -72.91 -172.46 0.98 Allowed 'Trans proline' 0 C--N 1.318 -1.056 0 O-C-N 123.312 1.164 . . . . 0.95999999999999996 111.442 -179.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 978' ' ' LEU . . . . . 0.542 HD12 ' N ' ' A' ' 978' ' ' LEU . 5.0 mp -128.05 154.78 45.29 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 107.631 -1.248 . . . . 0.62 107.631 178.033 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 979' ' ' THR . . . . . 0.45 HG23 ' C ' ' A' ' 978' ' ' LEU . 44.9 p -149.73 141.17 23.32 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.738 -1.226 . . . . 3.5699999999999998 111.279 -179.259 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 980' ' ' ILE . . . . . 0.766 ' HB ' HG21 ' A' ' 899' ' ' VAL . 50.3 mm -107.82 128.2 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 108.885 -0.783 . . . . 1.3300000000000001 108.885 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 981' ' ' PHE . . . . . 0.461 ' HD1' ' HH ' ' A' ' 879' ' ' TYR . 6.4 t80 -121.88 97.33 5.44 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.428 -0.795 . . . . 0.050000000000000003 111.912 -178.394 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 92.6 p -108.84 158.44 17.66 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 109.041 -0.726 . . . . 0.87 109.041 178.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . -173.73 108.91 0.28 Allowed Glycine 0 N--CA 1.498 2.775 0 N-CA-C 106.635 -2.586 . . . . 0.029999999999999999 106.635 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -109.07 148.67 30.45 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 114.409 1.263 . . . . 0.69999999999999996 114.409 -175.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 985' ' ' LEU . . . . . 0.994 HD13 HD22 ' A' ' 890' ' ' LEU . 35.1 tp -68.93 135.24 50.68 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 120.777 -1.202 . . . . 0.040000000000000001 110.275 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 50.8 tp -106.88 -58.8 1.89 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.648 -0.658 . . . . 0.040000000000000001 109.918 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -144.11 145.51 32.19 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 107.553 -1.277 . . . . 0.040000000000000001 107.553 179.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.69 163.29 12.17 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 108.23 -1.948 . . . . 0.040000000000000001 108.23 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -76.11 112.51 21.08 Favored Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.184 -1.186 . . . . 0.040000000000000001 109.41 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 990' ' ' PRO . . . . . 0.414 ' O ' ' HB2' ' A' ' 991' ' ' GLU . 49.8 Cg_endo -90.44 71.79 1.33 Allowed 'Trans proline' 0 C--N 1.318 -1.031 0 O-C-N 123.044 1.023 . . . . 0.45000000000000001 111.435 -178.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 991' ' ' GLU . . . . . 0.414 ' HB2' ' O ' ' A' ' 990' ' ' PRO . 75.1 mt-10 67.44 -73.67 0.08 Allowed 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 108.476 -0.935 . . . . 1.97 108.476 -177.405 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 992' ' ' LEU . . . . . . . . . . . . . 11.0 mt 51.1 20.51 0.86 Allowed 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.504 -0.748 . . . . 2.3799999999999999 111.652 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 80.3 mt-10 -94.1 156.84 16.37 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.918 -1.114 . . . . 3.79 109.947 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -146.21 93.29 2.3 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.529 -0.732 . . . . 3.5099999999999998 110.333 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 995' ' ' ALA . . . . . . . . . . . . 2.518 . . . . . . . 0 N--CA 1.504 2.24 0 O-C-N 120.935 -1.103 . . . . 2.73 110.57 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo . . . . . 0 N--CA 1.488 1.171 0 N-CA-C 109.537 -0.986 . . . . 3.8300000000000001 109.537 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 847' ' ' VAL . . . . . . . . . . . . . 61.9 t -134.52 103.27 11.31 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.586 -0.696 . . . . 1.8300000000000001 110.054 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 848' ' ' PRO . . . . . 0.695 ' O ' HG23 ' B' ' 850' ' ' VAL . 44.2 Cg_endo -69.91 -18.84 36.08 Favored 'Trans proline' 0 N--CA 1.488 1.182 0 O-C-N 123.321 1.169 . . . . 0.65000000000000002 111.314 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 849' ' ' GLN . . . . . 0.407 ' C ' ' O ' ' B' ' 848' ' ' PRO . 56.4 tt0 27.64 69.17 0.06 Allowed 'General case' 0 N--CA 1.518 2.957 0 N-CA-C 112.827 0.677 . . . . 2.5800000000000001 112.827 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 850' ' ' VAL . . . . . 0.695 HG23 ' O ' ' B' ' 848' ' ' PRO . 61.9 t -119.27 135.89 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.202 -0.936 . . . . 1.0900000000000001 111.394 -178.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 851' ' ' ALA . . . . . 0.463 ' HB3' ' HG ' ' B' ' 873' ' ' LEU . . . -127.22 156.22 42.21 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 105.884 -1.895 . . . . 0.040000000000000001 105.884 176.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 852' ' ' PHE . . . . . 0.44 ' HA ' ' CB ' ' B' ' 874' ' ' ASN . 33.2 p90 -157.98 130.59 7.25 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 121.086 1.766 . . . . 0.050000000000000003 108.729 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 44.5 t -174.97 133.7 0.33 Allowed 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.214 -1.032 . . . . 0.040000000000000001 108.214 -179.121 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 854' ' ' ALA . . . . . 0.446 ' HB1' ' HD2' ' B' ' 868' ' ' PHE . . . -133.65 155.98 48.72 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.096 -1.002 . . . . 0.67000000000000004 109.448 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 855' ' ' ALA . . . . . 0.747 ' HB3' ' CB ' ' B' ' 870' ' ' ARG . . . -122.3 141.82 51.13 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.802 0.811 . . . . 0.51000000000000001 111.293 -179.078 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 856' ' ' LEU . . . . . 0.659 HD13 ' N ' ' B' ' 857' ' ' SER . 3.4 tm? -111.4 137.55 49.03 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.602 -0.686 . . . . 0.050000000000000003 110.016 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 857' ' ' SER . . . . . 0.659 ' N ' HD13 ' B' ' 856' ' ' LEU . 1.5 m -156.43 17.05 0.33 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.543 -0.723 . . . . 1.3300000000000001 111.538 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 858' ' ' LEU . . . . . 0.611 HD22 ' HG3' ' B' ' 862' ' ' GLU . 3.8 pp -35.2 160.45 0.04 OUTLIER Pre-proline 0 N--CA 1.52 3.028 0 N-CA-C 112.954 0.724 . . . . 2.3300000000000001 112.954 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -60.82 -88.6 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 120.877 1.051 . . . . 2.3199999999999998 113.803 -177.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 53.6 ptt85 -128.54 -142.74 0.26 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 120.897 -1.127 . . . . 0.040000000000000001 111.801 -177.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 15.2 m -37.96 126.12 1.23 Allowed 'General case' 0 N--CA 1.509 2.516 0 O-C-N 121.619 -0.676 . . . . 1.3100000000000001 112.3 -178.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 862' ' ' GLU . . . . . 0.611 ' HG3' HD22 ' B' ' 858' ' ' LEU . 0.0 OUTLIER -98.96 159.02 31.28 Favored Pre-proline 0 N--CA 1.489 1.511 0 N-CA-C 108.425 -0.954 . . . . 4.5099999999999998 108.425 177.7 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -70.9 -14.71 32.67 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 O-C-N 123.193 1.101 . . . . 2.2400000000000002 111.411 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -177.52 -134.97 2.12 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.508 -1.437 . . . . 0.040000000000000001 109.508 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 27.1 m -66.71 156.82 34.27 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.285 -1.126 . . . . 1.51 110.053 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 866' ' ' VAL . . . . . 0.496 HG13 ' CD2' ' B' ' 858' ' ' LEU . 61.1 t -99.44 137.34 20.3 Favored Pre-proline 0 N--CA 1.494 1.742 0 N-CA-C 113.485 0.92 . . . . 0.78000000000000003 113.485 -174.348 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 867' ' ' PRO . . . . . 0.564 ' O ' HD23 ' B' ' 856' ' ' LEU . 55.4 Cg_endo -92.52 -149.82 0.03 OUTLIER 'Trans proline' 0 CA--C 1.546 1.121 0 C-N-CA 121.314 1.343 . . . . 0.92000000000000004 109.626 178.12 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 868' ' ' PHE . . . . . 0.476 ' CD1' ' HG2' ' B' ' 881' ' ' PRO . 19.4 p90 -150.55 123.88 8.93 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.645 -1.284 . . . . 0.050000000000000003 109.765 179.158 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 46.5 p30 -113.34 -1.94 14.12 Favored 'General case' 0 N--CA 1.5 2.051 0 C-N-CA 119.287 -0.965 . . . . 1.7 112.56 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 870' ' ' ARG . . . . . 0.747 ' CB ' ' HB3' ' B' ' 855' ' ' ALA . 26.4 mmm180 -90.47 89.05 7.41 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.848 -1.157 . . . . 2.5899999999999999 110.634 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 58.7 t -72.71 97.19 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.013 -1.054 . . . . 1.9399999999999999 109.864 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 872' ' ' LEU . . . . . 0.492 HD11 ' HB2' ' B' ' 855' ' ' ALA . 98.6 mt -83.14 -47.5 11.55 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.594 -0.691 . . . . 1.0600000000000001 110.155 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 873' ' ' LEU . . . . . 0.463 ' HG ' ' HB3' ' B' ' 851' ' ' ALA . 46.6 tp -175.0 104.14 0.09 Allowed 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.625 -0.88 . . . . 4.1799999999999997 108.625 178.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 874' ' ' ASN . . . . . 0.44 ' CB ' ' HA ' ' B' ' 852' ' ' PHE . 35.5 t-20 178.73 81.78 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.303 0 O-C-N 121.681 -0.637 . . . . 0.040000000000000001 109.74 -179.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -67.4 -48.12 68.3 Favored 'General case' 0 N--CA 1.499 1.998 0 C-N-CA 119.281 -0.967 . . . . 3.3799999999999999 111.164 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 876' ' ' GLY . . . . . . . . . . . . . . . -73.52 -25.57 72.17 Favored Glycine 0 N--CA 1.494 2.536 0 O-C-N 121.242 -0.911 . . . . 0.040000000000000001 111.599 -178.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 82.61 -61.15 4.78 Favored Glycine 0 N--CA 1.501 3.02 0 N-CA-C 108.105 -1.998 . . . . 0.040000000000000001 108.105 -178.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 878' ' ' TYR . . . . . 0.418 ' CE2' ' CG1' ' B' ' 850' ' ' VAL . 95.7 m-85 61.11 -62.94 0.08 Allowed 'General case' 0 N--CA 1.503 2.178 0 N-CA-C 114.361 1.245 . . . . 3.46 114.361 177.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 879' ' ' TYR . . . . . 0.485 ' HH ' ' HD1' ' B' ' 981' ' ' PHE . 18.8 p90 -111.28 108.77 18.5 Favored 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 114.477 1.288 . . . . 0.040000000000000001 114.477 -176.627 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -65.09 114.67 16.0 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.37 -0.832 . . . . 0.02 110.085 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 881' ' ' PRO . . . . . 0.476 ' HG2' ' CD1' ' B' ' 868' ' ' PHE . 53.6 Cg_endo -75.14 -0.98 10.66 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 O-C-N 123.557 1.293 . . . . 0.39000000000000001 112.257 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -76.8 -65.48 0.94 Allowed 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 107.071 -1.455 . . . . 0.81000000000000005 107.071 178.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 32.4 p -92.39 -17.71 24.26 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.713 -0.847 . . . . 0.040000000000000001 108.713 177.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.78 20.09 60.33 Favored Glycine 0 N--CA 1.495 2.63 0 O-C-N 121.092 -1.005 . . . . 0.029999999999999999 111.538 178.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 885' ' ' VAL . . . . . 0.684 HG13 HG21 ' B' ' 961' ' ' THR . 93.1 t -73.61 91.24 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 C-N-CA 118.13 -1.428 . . . . 1.01 108.058 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 886' ' ' PHE . . . . . 0.906 ' HB3' HG22 ' B' ' 962' ' ' VAL . 0.6 OUTLIER -89.85 105.16 17.62 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 115.211 -0.904 . . . . 0.050000000000000003 112.056 -177.448 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 887' ' ' THR . . . . . 0.406 ' O ' ' HD3' ' B' ' 889' ' ' PRO . 84.7 m -96.09 100.71 12.34 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 107.626 -1.25 . . . . 0.68000000000000005 107.626 177.249 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 888' ' ' ALA . . . . . . . . . . . . . . . -98.67 107.25 41.79 Favored Pre-proline 0 N--CA 1.502 2.148 0 N-CA-C 114.029 1.122 . . . . 0.25 114.029 -176.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 889' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' B' ' 887' ' ' THR . 53.4 Cg_endo -90.09 -12.6 2.75 Favored 'Trans proline' 0 CA--C 1.546 1.099 0 C-N-CA 121.043 1.162 . . . . 1.6399999999999999 109.274 176.355 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 890' ' ' LEU . . . . . 0.985 HD22 HD13 ' B' ' 985' ' ' LEU . 63.7 mt -36.02 -50.65 0.7 Allowed 'General case' 0 N--CA 1.509 2.481 0 N-CA-C 113.819 1.044 . . . . 2.29 113.819 -177.353 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 51.68 95.82 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.314 0 O-C-N 121.137 -0.977 . . . . 0.63 110.322 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . 156.6 -149.78 20.75 Favored Glycine 0 N--CA 1.479 1.564 0 N-CA-C 107.26 -2.336 . . . . 0.040000000000000001 107.26 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 71.1 ttt-85 -112.51 126.61 55.51 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 107.979 -1.119 . . . . 3.0 107.979 177.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 894' ' ' TYR . . . . . 0.545 ' OH ' HD12 ' B' ' 896' ' ' LEU . 0.0 OUTLIER -131.1 155.29 47.2 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.122 -0.986 . . . . 0.040000000000000001 110.68 -179.133 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 895' ' ' LEU . . . . . 0.429 ' N ' ' CD1' ' B' ' 894' ' ' TYR . 34.8 tp -95.57 114.04 25.76 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.575 -0.703 . . . . 1.27 110.089 -179.171 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 896' ' ' LEU . . . . . 0.559 HD23 ' N ' ' B' ' 897' ' ' SER . 9.7 tt -108.64 142.03 39.72 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.696 -0.628 . . . . 0.93999999999999995 110.695 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 897' ' ' SER . . . . . 0.559 ' N ' HD23 ' B' ' 896' ' ' LEU . 69.6 m -146.75 115.27 6.74 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.565 -0.71 . . . . 0.040000000000000001 110.864 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.1 146.6 31.05 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.112 -0.699 . . . . 0.47999999999999998 109.112 179.013 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 899' ' ' VAL . . . . . 0.767 HG21 ' HB ' ' B' ' 980' ' ' ILE . 87.7 t -96.2 119.39 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 C-N-CA 119.6 -0.84 . . . . 0.55000000000000004 111.466 -179.086 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 900' ' ' LEU . . . . . 0.545 HD12 ' HB2' ' B' ' 924' ' ' SER . 4.5 mm? -94.11 111.11 22.8 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 114.2 1.185 . . . . 1.5900000000000001 114.2 -175.339 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 21.2 m -65.1 140.74 58.84 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 107.333 -1.358 . . . . 0.050000000000000003 107.333 177.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -64.88 -66.7 2.34 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.445 -1.062 . . . . 0.029999999999999999 110.445 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 5.8 m170 46.54 66.84 0.88 Allowed 'General case' 0 N--CA 1.508 2.428 0 O-C-N 121.439 -1.036 . . . . 3.2000000000000002 111.016 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 43.3 ptt85 -69.02 -6.05 25.56 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.591 -0.693 . . . . 2.9199999999999999 112.043 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 905' ' ' HIS . . . . . 0.48 ' O ' ' CB ' ' B' ' 906' ' ' GLU . 74.1 t60 -60.39 2.61 0.09 Allowed 'General case' 0 N--CA 1.506 2.332 0 O-C-N 120.857 -1.152 . . . . 2.8700000000000001 112.897 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 906' ' ' GLU . . . . . 0.48 ' CB ' ' O ' ' B' ' 905' ' ' HIS . 0.8 OUTLIER 93.95 -163.73 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.44 0 CA-C-N 120.584 1.538 . . . . 0.98999999999999999 112.36 178.741 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 907' ' ' LYS . . . . . 0.471 ' CB ' ' O ' ' B' ' 906' ' ' GLU . 51.5 tttt 89.13 161.01 0.06 Allowed 'General case' 0 N--CA 1.52 3.045 0 N-CA-C 107.755 -1.202 . . . . 5.25 107.755 -177.011 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 58.9 t -121.52 115.93 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 120.86 -1.15 . . . . 0.39000000000000001 110.93 -179.272 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 54.1 tp10 -104.35 132.21 50.85 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 107.546 -1.279 . . . . 1.72 107.546 177.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -156.25 121.82 4.85 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 106.56 -1.644 . . . . 0.67000000000000004 106.56 178.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 911' ' ' VAL . . . . . 0.717 HG22 HG13 ' B' ' 964' ' ' VAL . 92.4 t -81.86 132.67 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.791 -0.568 . . . . 0.54000000000000004 110.788 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 71.8 mt -65.76 156.08 34.19 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 108.763 -0.828 . . . . 1.5 108.763 178.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 913' ' ' SER . . . . . 0.413 ' CB ' ' HB ' ' B' ' 919' ' ' VAL . 2.4 t -123.81 136.56 54.47 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.157 -1.053 . . . . 1.3700000000000001 108.157 176.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 914' ' ' ARG . . . . . 0.625 ' NH1' HD23 ' B' ' 956' ' ' LEU . 0.0 OUTLIER -63.36 153.95 33.44 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 120.772 -1.205 . . . . 4.2999999999999998 111.701 -178.909 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 915' ' ' SER . . . . . 0.419 ' CB ' ' O ' ' B' ' 914' ' ' ARG . 4.9 t 83.49 -32.53 0.08 Allowed 'General case' 0 N--CA 1.52 3.06 0 C-N-CA 124.11 0.964 . . . . 2.0499999999999998 112.36 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 916' ' ' ASN . . . . . 0.767 ' HB2' HG21 ' B' ' 919' ' ' VAL . 98.6 m-20 -121.98 -21.4 6.01 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 120.797 -1.189 . . . . 2.71 111.461 -179.233 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 917' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 67.15 165.93 0.22 Allowed 'General case' 0 N--CA 1.52 3.026 0 N-CA-C 105.62 -1.993 . . . . 2.6800000000000002 105.62 -174.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 55.09 -125.86 37.06 Favored Glycine 1 N--CA 1.521 4.301 0 CA-C-N 123.575 2.898 . . . . 0.029999999999999999 106.882 -177.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 919' ' ' VAL . . . . . 0.767 HG21 ' HB2' ' B' ' 916' ' ' ASN . 85.6 t 51.72 94.57 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.249 0 O-C-N 121.427 -1.043 . . . . 1.3899999999999999 108.96 -178.191 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 920' ' ' ALA . . . . . 0.875 ' HB3' HG12 ' B' ' 949' ' ' VAL . . . -91.67 92.14 8.31 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 119.298 -0.961 . . . . 0.029999999999999999 111.114 -178.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 921' ' ' ARG . . . . . 0.737 ' HG3' HG23 ' B' ' 922' ' ' VAL . 16.7 ptt180 -84.14 -42.25 16.22 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 105.749 -1.945 . . . . 4.4199999999999999 105.749 175.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 922' ' ' VAL . . . . . 0.737 HG23 ' HG3' ' B' ' 921' ' ' ARG . 75.0 t -103.78 69.42 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 105.563 -2.014 . . . . 0.84999999999999998 105.563 175.316 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 923' ' ' ASP . . . . . 0.654 ' HB2' ' HB1' ' B' ' 920' ' ' ALA . 22.0 t0 -89.44 136.3 33.1 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.895 0.855 . . . . 2.46 112.22 -176.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 924' ' ' SER . . . . . 0.545 ' HB2' HD12 ' B' ' 900' ' ' LEU . 13.3 t -146.41 103.32 3.68 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 107.957 -1.127 . . . . 0.69999999999999996 107.957 178.531 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -110.62 89.39 0.54 Allowed Glycine 0 N--CA 1.488 2.154 0 N-CA-C 108.929 -1.668 . . . . 0.040000000000000001 108.929 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.385 0 N-CA-C 109.334 -1.506 . . . . 0.040000000000000001 109.334 -179.658 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 23.3 m . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.044 0.45 . . . . 13.779999999999999 110.218 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 96.2 mt -112.28 129.8 56.16 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.566 -0.709 . . . . 13.76 110.395 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -151.25 167.08 30.69 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.07 -1.612 . . . . 9.1300000000000008 109.07 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 949' ' ' VAL . . . . . 0.875 HG12 ' HB3' ' B' ' 920' ' ' ALA . 32.5 m -118.68 130.21 73.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.469 -1.018 . . . . 7.0800000000000001 110.85 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 950' ' ' PHE . . . . . 0.462 ' CZ ' ' HB3' ' B' ' 921' ' ' ARG . 27.8 p90 -132.41 149.44 52.34 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.591 -0.693 . . . . 7.5899999999999999 109.303 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 19.6 m -120.22 -52.72 2.16 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.413 -0.804 . . . . 5.0300000000000002 112.037 -178.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 952' ' ' LEU . . . . . 0.413 ' O ' ' O ' ' B' ' 953' ' ' ILE . 16.8 tp -61.59 -74.4 0.08 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.378 -0.827 . . . . 1.01 112.324 -177.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 953' ' ' ILE . . . . . 0.496 ' O ' ' HB3' ' B' ' 954' ' ' LEU . 44.8 pt -53.12 -143.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.723 0 N-CA-C 114.122 1.156 . . . . 2.6000000000000001 114.122 -176.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 954' ' ' LEU . . . . . 0.714 HD22 ' O ' ' B' ' 954' ' ' LEU . 0.0 OUTLIER 171.25 78.53 0.04 OUTLIER Pre-proline 0 N--CA 1.511 2.606 0 O-C-N 120.772 -1.205 . . . . 0.050000000000000003 111.507 179.609 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 955' ' ' PRO . . . . . 0.694 ' C ' HD12 ' B' ' 956' ' ' LEU . 46.9 Cg_endo -74.28 95.86 0.94 Allowed 'Trans proline' 0 C--N 1.313 -1.306 0 N-CA-C 109.307 -1.074 . . . . 0.83999999999999997 109.307 178.522 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 956' ' ' LEU . . . . . 0.694 HD12 ' C ' ' B' ' 955' ' ' PRO . 10.2 mp -123.28 145.19 48.89 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.15 -0.969 . . . . 0.040000000000000001 110.212 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -84.51 151.51 24.54 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 117.983 -1.008 . . . . 1.28 111.821 -179.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -70.47 119.66 14.96 Favored 'General case' 0 N--CA 1.51 2.566 0 CA-C-N 122.725 2.511 . . . . 0.17000000000000001 111.919 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.96 -23.1 30.72 Favored Glycine 0 N--CA 1.502 3.046 0 N-CA-C 111.154 -0.779 . . . . 0.040000000000000001 111.154 178.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 960' ' ' ASP . . . . . 0.437 ' HB3' ' NE ' ' B' ' 914' ' ' ARG . 0.4 OUTLIER -52.96 171.86 0.06 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.467 -1.02 . . . . 0.040000000000000001 110.376 -179.312 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 961' ' ' THR . . . . . 0.684 HG21 HG13 ' B' ' 885' ' ' VAL . 38.3 m -134.59 135.55 42.31 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.074 -1.016 . . . . 1.78 111.714 -178.094 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 962' ' ' VAL . . . . . 0.906 HG22 ' HB3' ' B' ' 886' ' ' PHE . 31.9 m -99.05 145.13 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 C-N-CA 119.989 -0.684 . . . . 0.040000000000000001 110.343 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 5.0 t -137.64 146.15 43.56 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.936 -0.478 . . . . 0.71999999999999997 110.166 -178.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 964' ' ' VAL . . . . . 0.717 HG13 HG22 ' B' ' 911' ' ' VAL . 58.3 t -95.13 136.07 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.073 -1.017 . . . . 1.05 110.529 -179.253 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -95.25 126.11 40.34 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 103.761 -2.681 . . . . 3.02 103.761 173.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 966' ' ' LEU . . . . . 0.488 ' C ' HG23 ' B' ' 967' ' ' VAL . 1.4 tt -133.13 61.39 1.68 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.309 -0.997 . . . . 1.46 108.309 177.303 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 967' ' ' VAL . . . . . 0.488 HG23 ' C ' ' B' ' 966' ' ' LEU . 98.5 t -158.04 96.25 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 108.148 -1.056 . . . . 1.9399999999999999 108.148 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 93.3 mmm -142.81 58.32 1.43 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.767 -1.208 . . . . 0.0 108.227 178.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 133.1 119.1 1.99 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 106.654 -2.578 . . . . 2.1099999999999999 106.654 -178.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -84.53 -44.53 13.49 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 118.912 1.356 . . . . 5.8899999999999997 111.404 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 43.3 tp -61.48 88.85 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.882 -1.136 . . . . 4.3600000000000003 110.048 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -141.59 -156.26 0.66 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.575 -0.703 . . . . 1.8300000000000001 110.249 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -121.68 176.28 5.8 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.599 -0.688 . . . . 4.3499999999999996 110.195 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 9.2 t -100.22 129.87 46.28 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.52 -0.738 . . . . 1.27 109.956 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -156.11 157.89 36.79 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.53 -0.731 . . . . 5.0199999999999996 110.629 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.31 86.75 16.51 Favored Pre-proline 0 N--CA 1.5 2.056 0 O-C-N 121.678 -0.639 . . . . 2.4100000000000001 109.521 179.53 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -72.92 -172.49 0.99 Allowed 'Trans proline' 0 N--CA 1.487 1.089 0 O-C-N 123.32 1.168 . . . . 0.95999999999999996 111.443 -179.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 978' ' ' LEU . . . . . 0.539 ' N ' HD12 ' B' ' 978' ' ' LEU . 5.0 mp -127.93 154.99 44.92 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 107.619 -1.252 . . . . 0.62 107.619 178.05 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 979' ' ' THR . . . . . 0.462 HG23 ' C ' ' B' ' 978' ' ' LEU . 44.3 p -149.9 141.07 23.08 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.746 -1.221 . . . . 3.5699999999999998 111.294 -179.269 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 980' ' ' ILE . . . . . 0.767 ' HB ' HG21 ' B' ' 899' ' ' VAL . 50.2 mm -107.84 127.8 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 108.892 -0.781 . . . . 1.3300000000000001 108.892 179.328 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 981' ' ' PHE . . . . . 0.485 ' HD1' ' HH ' ' B' ' 879' ' ' TYR . 6.4 t80 -121.61 97.53 5.54 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 119.717 -0.793 . . . . 0.050000000000000003 111.906 -178.29 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 94.1 p -109.22 158.65 17.63 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.552 -0.717 . . . . 0.87 109.104 178.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 983' ' ' GLY . . . . . . . . . . . . . . . -173.66 109.07 0.29 Allowed Glycine 0 N--CA 1.499 2.872 0 N-CA-C 106.705 -2.558 . . . . 0.029999999999999999 106.705 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -109.07 148.71 30.4 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 114.361 1.245 . . . . 0.69999999999999996 114.361 -175.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 985' ' ' LEU . . . . . 0.985 HD13 HD22 ' B' ' 890' ' ' LEU . 35.0 tp -69.03 135.17 50.43 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.796 -1.19 . . . . 0.040000000000000001 110.255 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 986' ' ' LEU . . . . . 0.463 ' CD1' HD11 ' C' ' 986' ' ' LEU . 50.5 tp -106.88 -58.82 1.89 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.639 -0.663 . . . . 0.040000000000000001 109.932 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -144.07 145.34 32.1 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.591 -1.263 . . . . 0.040000000000000001 107.591 179.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.61 163.03 12.2 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 108.163 -1.975 . . . . 0.040000000000000001 108.163 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -75.76 112.48 20.02 Favored Pre-proline 0 N--CA 1.499 1.984 0 O-C-N 121.243 -1.151 . . . . 0.040000000000000001 109.406 179.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 990' ' ' PRO . . . . . 0.416 ' O ' ' HB2' ' B' ' 991' ' ' GLU . 49.6 Cg_endo -90.38 71.86 1.35 Allowed 'Trans proline' 0 C--N 1.319 -1.005 0 O-C-N 123.133 1.07 . . . . 0.45000000000000001 111.373 -179.012 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 991' ' ' GLU . . . . . 0.416 ' HB2' ' O ' ' B' ' 990' ' ' PRO . 74.9 mt-10 67.34 -73.56 0.08 Allowed 'General case' 0 N--CA 1.502 2.149 0 N-CA-C 108.552 -0.907 . . . . 1.97 108.552 -177.475 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 992' ' ' LEU . . . . . 0.434 ' HA ' HD23 ' B' ' 992' ' ' LEU . 10.9 mt 51.18 20.28 0.86 Allowed 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.536 -0.727 . . . . 2.3799999999999999 111.677 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 80.3 mt-10 -93.75 156.79 16.48 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.895 -1.128 . . . . 3.79 109.976 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 70.6 m80 -146.24 92.79 2.22 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.444 -0.785 . . . . 3.5099999999999998 110.388 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 995' ' ' ALA . . . . . . . . . . . . 2.517 . . . . . . . 0 N--CA 1.504 2.255 0 O-C-N 120.935 -1.103 . . . . 2.73 110.612 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo . . . . . 0 N--CA 1.488 1.158 0 N-CA-C 109.539 -0.985 . . . . 3.8300000000000001 109.539 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' C' C ' 847' ' ' VAL . . . . . 0.506 HG12 ' HB2' ' C' ' 849' ' ' GLN . 58.2 t -126.48 106.41 23.87 Favored Pre-proline 0 N--CA 1.496 1.835 0 O-C-N 121.597 -0.689 . . . . 1.8300000000000001 110.012 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 848' ' ' PRO . . . . . 0.886 ' O ' HG23 ' C' ' 850' ' ' VAL . 44.4 Cg_endo -69.7 -22.68 32.01 Favored 'Trans proline' 0 N--CA 1.488 1.177 0 O-C-N 123.278 1.146 . . . . 0.65000000000000002 111.034 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 849' ' ' GLN . . . . . 0.506 ' HB2' HG12 ' C' ' 847' ' ' VAL . 54.5 tt0 25.17 64.9 0.06 Allowed 'General case' 0 N--CA 1.519 2.991 0 N-CA-C 113.379 0.881 . . . . 2.5800000000000001 113.379 179.138 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 850' ' ' VAL . . . . . 0.886 HG23 ' O ' ' C' ' 848' ' ' PRO . 72.1 t -119.06 135.5 59.27 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.117 -0.989 . . . . 1.0900000000000001 111.028 -179.357 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 851' ' ' ALA . . . . . 0.573 ' HB3' ' HG ' ' C' ' 873' ' ' LEU . . . -126.96 155.93 42.34 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 105.758 -1.942 . . . . 0.040000000000000001 105.758 176.554 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 852' ' ' PHE . . . . . 0.451 ' CD1' ' N ' ' C' ' 852' ' ' PHE . 16.0 p90 -160.26 127.38 4.41 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 121.016 1.734 . . . . 0.050000000000000003 108.625 178.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 38.8 t -176.65 134.88 0.22 Allowed 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.18 -1.044 . . . . 0.040000000000000001 108.18 -179.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 854' ' ' ALA . . . . . 0.447 ' HB1' ' HD2' ' C' ' 868' ' ' PHE . . . -132.21 156.96 45.53 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.164 -0.96 . . . . 0.67000000000000004 109.779 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 855' ' ' ALA . . . . . 0.683 ' HB3' ' CB ' ' C' ' 870' ' ' ARG . . . -122.41 140.53 52.6 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.759 0.79 . . . . 0.51000000000000001 111.179 -179.256 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 856' ' ' LEU . . . . . 0.734 HD11 HD23 ' C' ' 858' ' ' LEU . 3.5 tm? -111.74 138.14 48.71 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.641 -0.662 . . . . 0.050000000000000003 110.036 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 857' ' ' SER . . . . . 0.636 ' N ' HD13 ' C' ' 856' ' ' LEU . 21.1 m -155.27 18.66 0.42 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.395 -0.815 . . . . 1.3300000000000001 111.347 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 858' ' ' LEU . . . . . 0.734 HD23 HD11 ' C' ' 856' ' ' LEU . 3.2 pp -34.81 160.87 0.04 OUTLIER Pre-proline 0 N--CA 1.52 3.067 0 N-CA-C 113.066 0.765 . . . . 2.3300000000000001 113.066 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -60.34 -88.22 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.462 0 O-C-N 122.99 0.995 . . . . 2.3199999999999998 113.455 -178.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 55.2 ptt85 -128.31 -143.34 0.27 Allowed 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.823 -1.173 . . . . 0.040000000000000001 111.808 -177.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 69.4 m -37.84 130.32 1.11 Allowed 'General case' 0 N--CA 1.511 2.581 0 O-C-N 121.622 -0.673 . . . . 1.3100000000000001 112.356 -178.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.14 160.45 26.03 Favored Pre-proline 0 N--CA 1.489 1.476 0 N-CA-C 108.326 -0.99 . . . . 4.5099999999999998 108.326 177.298 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.78 -13.57 26.83 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 O-C-N 123.152 1.08 . . . . 2.2400000000000002 111.453 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -177.78 -136.2 2.44 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.664 -1.374 . . . . 0.040000000000000001 109.664 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 17.0 m -68.23 153.86 42.89 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.329 -1.1 . . . . 1.51 109.92 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 866' ' ' VAL . . . . . 0.444 ' HA ' ' HD3' ' C' ' 867' ' ' PRO . 39.4 t -97.72 139.78 21.56 Favored Pre-proline 0 N--CA 1.493 1.691 0 N-CA-C 113.507 0.928 . . . . 0.78000000000000003 113.507 -174.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 867' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' C' ' 866' ' ' VAL . 55.8 Cg_endo -91.4 -147.86 0.03 OUTLIER 'Trans proline' 0 CA--C 1.544 0.998 0 O-C-N 123.688 1.362 . . . . 0.92000000000000004 108.95 177.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 868' ' ' PHE . . . . . 0.485 ' CD1' ' HG2' ' C' ' 881' ' ' PRO . 14.0 p90 -149.88 124.12 9.52 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.51 -1.368 . . . . 0.050000000000000003 110.109 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 47.6 p-10 -112.45 -3.08 14.53 Favored 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 119.131 -1.027 . . . . 1.7 112.508 -178.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 870' ' ' ARG . . . . . 0.683 ' CB ' ' HB3' ' C' ' 855' ' ' ALA . 28.0 mmm180 -91.85 87.86 6.41 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.925 -1.109 . . . . 2.5899999999999999 111.112 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 60.7 t -71.55 96.94 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 120.927 -1.108 . . . . 1.9399999999999999 109.337 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 872' ' ' LEU . . . . . 0.804 HD13 HD11 ' A' ' 953' ' ' ILE . 95.3 mt -87.29 -44.73 11.2 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.592 -0.692 . . . . 1.0600000000000001 110.678 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 873' ' ' LEU . . . . . 0.573 ' HG ' ' HB3' ' C' ' 851' ' ' ALA . 33.0 tp -172.91 102.02 0.13 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.101 -0.999 . . . . 4.1799999999999997 108.947 178.601 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 874' ' ' ASN . . . . . 0.443 ' CB ' ' HA ' ' C' ' 852' ' ' PHE . 34.0 t-20 176.99 82.09 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.284 0 N-CA-C 108.987 -0.746 . . . . 0.040000000000000001 108.987 -179.073 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -65.34 -47.27 77.07 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.107 -0.995 . . . . 3.3799999999999999 111.308 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 876' ' ' GLY . . . . . 0.417 ' HA3' ' CE2' ' C' ' 878' ' ' TYR . . . -72.58 -26.47 71.59 Favored Glycine 0 N--CA 1.493 2.483 0 C-N-CA 120.423 -0.894 . . . . 0.040000000000000001 111.436 -178.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 79.61 -63.13 4.03 Favored Glycine 0 N--CA 1.5 2.956 0 N-CA-C 108.102 -1.999 . . . . 0.040000000000000001 108.102 -178.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 878' ' ' TYR . . . . . 0.417 ' CE2' ' HA3' ' C' ' 876' ' ' GLY . 89.4 m-85 60.76 -64.79 0.06 Allowed 'General case' 0 N--CA 1.502 2.146 0 N-CA-C 114.276 1.213 . . . . 3.46 114.276 177.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 879' ' ' TYR . . . . . 0.483 ' CE2' ' CD1' ' C' ' 981' ' ' PHE . 22.3 p90 -109.93 106.93 16.67 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 114.976 1.473 . . . . 0.040000000000000001 114.976 -176.203 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -69.64 119.22 69.58 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.401 -0.812 . . . . 0.02 109.759 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 881' ' ' PRO . . . . . 0.485 ' HG2' ' CD1' ' C' ' 868' ' ' PHE . 55.3 Cg_endo -79.26 -0.16 10.51 Favored 'Trans proline' 0 N--CA 1.487 1.132 0 O-C-N 123.363 1.191 . . . . 0.39000000000000001 111.563 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -76.31 -62.84 1.48 Allowed 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 106.433 -1.691 . . . . 0.81000000000000005 106.433 178.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 24.3 p -88.46 -21.87 23.98 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.136 -1.061 . . . . 0.040000000000000001 108.136 176.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 81.77 16.35 73.13 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 110.401 -1.079 . . . . 0.029999999999999999 110.401 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 84.4 t -73.93 91.91 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 C-N-CA 118.397 -1.321 . . . . 1.01 108.111 -179.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 886' ' ' PHE . . . . . 0.875 ' HB3' HG22 ' C' ' 962' ' ' VAL . 1.1 t80 -87.46 105.7 17.47 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 115.17 -0.923 . . . . 0.050000000000000003 111.628 -177.436 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 887' ' ' THR . . . . . 0.438 ' O ' ' HD3' ' C' ' 889' ' ' PRO . 86.7 m -102.45 99.72 9.79 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 107.806 -1.183 . . . . 0.68000000000000005 107.806 177.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 888' ' ' ALA . . . . . . . . . . . . . . . -98.66 101.19 11.14 Favored Pre-proline 0 N--CA 1.501 2.084 0 N-CA-C 114.388 1.255 . . . . 0.25 114.388 -176.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 889' ' ' PRO . . . . . 0.438 ' HD3' ' O ' ' C' ' 887' ' ' THR . 55.7 Cg_endo -80.06 -15.3 11.76 Favored 'Trans proline' 0 N--CA 1.486 1.042 0 N-CA-C 108.73 -1.296 . . . . 1.6399999999999999 108.73 175.555 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 890' ' ' LEU . . . . . 0.619 HD21 HG11 ' C' ' 850' ' ' VAL . 60.7 mt -37.35 -49.5 0.99 Allowed 'General case' 0 N--CA 1.508 2.425 0 N-CA-C 113.452 0.908 . . . . 2.29 113.452 -177.552 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 52.36 97.19 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.267 0 O-C-N 121.19 -0.944 . . . . 0.63 110.285 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . 158.94 -154.21 25.3 Favored Glycine 0 N--CA 1.477 1.422 0 N-CA-C 107.272 -2.331 . . . . 0.040000000000000001 107.272 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 74.5 ttt-85 -117.36 123.23 45.96 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.612 -0.934 . . . . 3.0 108.761 177.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 894' ' ' TYR . . . . . 0.761 ' CZ ' HD23 ' C' ' 954' ' ' LEU . 20.3 p90 -133.78 155.54 49.62 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.117 -0.989 . . . . 0.040000000000000001 110.956 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 895' ' ' LEU . . . . . . . . . . . . . 49.0 tp -97.82 115.41 28.0 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.719 -0.613 . . . . 1.27 110.268 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 896' ' ' LEU . . . . . 0.435 HD11 ' HE1' ' C' ' 981' ' ' PHE . 9.3 tt -118.36 144.6 45.77 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.654 -0.654 . . . . 0.93999999999999995 109.945 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 897' ' ' SER . . . . . . . . . . . . . 55.4 m -141.82 124.57 16.01 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.429 -0.795 . . . . 0.040000000000000001 111.284 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -101.89 148.17 25.64 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.789 -0.819 . . . . 0.47999999999999998 108.789 178.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 899' ' ' VAL . . . . . 0.705 HG21 ' HB ' ' C' ' 980' ' ' ILE . 87.4 t -92.49 120.31 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.35 -0.844 . . . . 0.55000000000000004 111.256 -179.037 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 94.6 mt -92.78 112.23 24.11 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 114.036 1.125 . . . . 1.5900000000000001 114.036 -175.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 20.7 m -63.48 140.4 58.87 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 107.472 -1.307 . . . . 0.050000000000000003 107.472 177.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -61.12 -65.23 3.42 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 110.344 -1.103 . . . . 0.029999999999999999 110.344 -179.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 45.86 64.39 1.48 Allowed 'General case' 0 N--CA 1.507 2.397 0 O-C-N 121.556 -0.967 . . . . 3.2000000000000002 111.239 179.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 42.7 ptt85 -67.68 -7.96 31.12 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.614 -0.679 . . . . 2.9199999999999999 111.83 -179.259 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 905' ' ' HIS . . . . . 0.493 ' O ' ' CB ' ' C' ' 906' ' ' GLU . 75.8 t60 -61.97 6.12 0.08 Allowed 'General case' 0 N--CA 1.506 2.342 0 CA-C-O 117.649 -1.167 . . . . 2.8700000000000001 113.468 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 906' ' ' GLU . . . . . 0.493 ' CB ' ' O ' ' C' ' 905' ' ' HIS . 0.8 OUTLIER 93.07 -163.45 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.441 0 CA-C-N 121.252 1.842 . . . . 0.98999999999999999 112.012 178.983 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 907' ' ' LYS . . . . . 0.493 ' CB ' ' O ' ' C' ' 906' ' ' GLU . 25.8 ttmt 89.9 161.91 0.05 OUTLIER 'General case' 0 N--CA 1.522 3.136 0 N-CA-C 108.061 -1.088 . . . . 5.25 108.061 -177.029 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 59.6 t -121.67 117.34 52.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 120.841 -1.162 . . . . 0.39000000000000001 110.915 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 909' ' ' GLU . . . . . 0.54 ' OE2' HD12 ' C' ' 966' ' ' LEU . 43.1 tp10 -104.5 130.91 52.4 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 107.486 -1.302 . . . . 1.72 107.486 177.083 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -157.18 121.13 4.24 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 106.887 -1.523 . . . . 0.67000000000000004 106.887 178.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 911' ' ' VAL . . . . . 0.739 HG22 HG13 ' C' ' 964' ' ' VAL . 97.8 t -83.42 132.06 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.784 -0.573 . . . . 0.54000000000000004 110.863 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 64.4 mt -66.18 157.41 31.4 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.478 -0.764 . . . . 1.5 109.243 178.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 913' ' ' SER . . . . . 0.417 ' CB ' ' CG1' ' C' ' 919' ' ' VAL . 2.2 t -125.4 137.96 54.02 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.212 -1.033 . . . . 1.3700000000000001 108.212 176.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 914' ' ' ARG . . . . . 0.891 ' NH1' HD23 ' C' ' 956' ' ' LEU . 0.0 OUTLIER -63.94 154.06 35.11 Favored 'General case' 0 N--CA 1.504 2.275 0 O-C-N 120.681 -1.262 . . . . 4.2999999999999998 111.88 -178.714 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 915' ' ' SER . . . . . 0.425 ' CB ' ' O ' ' C' ' 914' ' ' ARG . 4.0 t 83.06 -31.41 0.09 Allowed 'General case' 0 N--CA 1.521 3.124 0 C-N-CA 123.865 0.866 . . . . 2.0499999999999998 112.382 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 916' ' ' ASN . . . . . 0.618 ' HB2' HG21 ' C' ' 919' ' ' VAL . 94.5 m-20 -122.37 -21.72 5.72 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.785 -1.197 . . . . 2.71 111.252 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 917' ' ' GLN . . . . . 0.41 ' HB2' ' O ' ' C' ' 916' ' ' ASN . 46.5 mt-30 67.36 167.81 0.24 Allowed 'General case' 0 N--CA 1.52 3.044 0 N-CA-C 105.608 -1.997 . . . . 2.6800000000000002 105.608 -174.013 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.91 -127.47 41.08 Favored Glycine 1 N--CA 1.52 4.289 0 CA-C-N 123.589 2.904 . . . . 0.029999999999999999 107.022 -177.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 919' ' ' VAL . . . . . 0.618 HG21 ' HB2' ' C' ' 916' ' ' ASN . 92.6 t 50.54 94.53 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.233 0 O-C-N 121.466 -1.02 . . . . 1.3899999999999999 109.206 -178.283 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 920' ' ' ALA . . . . . 0.998 ' HB3' HG12 ' C' ' 949' ' ' VAL . . . -93.21 94.37 8.76 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.395 -0.922 . . . . 0.029999999999999999 110.943 -179.068 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 921' ' ' ARG . . . . . 0.694 ' HG3' HG23 ' C' ' 922' ' ' VAL . 40.7 ptt85 -81.36 -42.29 20.71 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 105.766 -1.938 . . . . 4.4199999999999999 105.766 176.178 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 922' ' ' VAL . . . . . 0.694 HG23 ' HG3' ' C' ' 921' ' ' ARG . 73.6 t -100.82 74.92 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 N-CA-C 105.523 -2.029 . . . . 0.84999999999999998 105.523 175.122 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -89.95 135.08 33.86 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.87 0.843 . . . . 2.46 112.315 -176.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 4.4 t -147.33 102.94 3.52 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.973 -1.121 . . . . 0.69999999999999996 107.973 178.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -110.08 89.84 0.56 Allowed Glycine 0 N--CA 1.488 2.105 0 N-CA-C 108.952 -1.659 . . . . 0.040000000000000001 108.952 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.33 0 N-CA-C 109.3 -1.52 . . . . 0.040000000000000001 109.3 -179.685 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 24.9 m . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 120.928 0.394 . . . . 13.779999999999999 110.355 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 95.6 mt -114.47 129.78 56.68 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.572 -0.705 . . . . 13.76 110.347 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -152.03 169.85 31.37 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.316 -1.514 . . . . 9.1300000000000008 109.316 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 949' ' ' VAL . . . . . 0.998 HG12 ' HB3' ' C' ' 920' ' ' ALA . 34.0 m -118.24 135.65 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.513 -0.993 . . . . 7.0800000000000001 110.985 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 950' ' ' PHE . . . . . 0.456 ' CZ ' ' HB3' ' C' ' 921' ' ' ARG . 49.4 p90 -134.76 151.92 51.35 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.524 -0.735 . . . . 7.5899999999999999 109.348 179.363 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 26.6 m -119.01 -55.26 2.18 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.375 -0.828 . . . . 5.0300000000000002 111.956 -178.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 952' ' ' LEU . . . . . 0.452 ' O ' ' O ' ' C' ' 953' ' ' ILE . 52.8 tp -63.15 -76.37 0.07 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.359 -0.838 . . . . 1.01 111.688 -178.039 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 953' ' ' ILE . . . . . 0.574 HD12 ' HD3' ' C' ' 955' ' ' PRO . 2.0 pp -49.12 -150.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.784 0 N-CA-C 114.699 1.37 . . . . 2.6000000000000001 114.699 -176.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 954' ' ' LEU . . . . . 0.761 HD23 ' CZ ' ' C' ' 894' ' ' TYR . 0.0 OUTLIER 170.99 89.14 0.04 OUTLIER Pre-proline 0 N--CA 1.516 2.836 0 O-C-N 120.74 -1.225 . . . . 0.050000000000000003 111.88 -179.477 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 955' ' ' PRO . . . . . 0.754 ' C ' HD12 ' C' ' 956' ' ' LEU . 50.9 Cg_endo -83.41 93.7 0.82 Allowed 'Trans proline' 0 C--N 1.317 -1.1 0 N-CA-C 109.419 -1.031 . . . . 0.83999999999999997 109.419 178.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 956' ' ' LEU . . . . . 0.891 HD23 ' NH1' ' C' ' 914' ' ' ARG . 7.9 mp -126.28 150.13 48.66 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.07 -1.019 . . . . 0.040000000000000001 110.772 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -83.16 151.81 25.54 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 117.743 -1.122 . . . . 1.28 111.518 -178.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -66.88 119.32 11.7 Favored 'General case' 0 N--CA 1.509 2.515 0 CA-C-N 123.022 2.647 . . . . 0.17000000000000001 111.213 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.72 -19.98 47.85 Favored Glycine 0 N--CA 1.499 2.882 0 N-CA-C 110.907 -0.877 . . . . 0.040000000000000001 110.907 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 960' ' ' ASP . . . . . 0.409 ' HB3' ' NE ' ' C' ' 914' ' ' ARG . 0.4 OUTLIER -54.44 170.58 0.15 Allowed 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.409 -1.054 . . . . 0.040000000000000001 110.353 -179.456 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 961' ' ' THR . . . . . 0.507 ' HA ' ' O ' ' C' ' 886' ' ' PHE . 39.3 m -136.93 141.0 42.66 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.989 -1.069 . . . . 1.78 112.614 -177.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 962' ' ' VAL . . . . . 0.875 HG22 ' HB3' ' C' ' 886' ' ' PHE . 27.3 m -99.88 145.18 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 C-N-CA 120.395 -0.522 . . . . 0.040000000000000001 110.696 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 5.2 t -137.53 143.85 41.84 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.828 -0.545 . . . . 0.71999999999999997 109.861 -178.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 964' ' ' VAL . . . . . 0.739 HG13 HG22 ' C' ' 911' ' ' VAL . 61.6 t -91.94 136.94 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.103 -0.998 . . . . 1.05 110.733 -178.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -93.68 126.37 38.81 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 103.566 -2.753 . . . . 3.02 103.566 173.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 966' ' ' LEU . . . . . 0.54 HD12 ' OE2' ' C' ' 909' ' ' GLU . 0.2 OUTLIER -133.63 59.23 1.74 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.662 -0.866 . . . . 1.46 108.662 177.503 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 967' ' ' VAL . . . . . 0.488 HG23 ' C ' ' C' ' 966' ' ' LEU . 99.5 t -157.8 96.31 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 108.327 -0.99 . . . . 1.9399999999999999 108.327 179.538 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 91.8 mmm -143.04 58.65 1.41 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.736 -1.227 . . . . 0.0 108.562 179.064 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 134.19 119.46 1.97 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 107.372 -2.291 . . . . 2.1099999999999999 107.372 -178.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 -82.76 -58.12 3.02 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.048 -1.266 . . . . 5.8899999999999997 110.662 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 46.3 tp -58.78 89.74 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.455 -0.778 . . . . 4.3600000000000003 110.449 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -143.33 -151.72 0.38 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.536 -0.727 . . . . 1.8300000000000001 110.011 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -117.0 167.03 11.5 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.352 -0.843 . . . . 4.3499999999999996 110.082 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 30.2 t -101.49 130.3 47.73 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.523 -0.736 . . . . 1.27 110.075 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -155.62 156.55 35.23 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.504 -0.747 . . . . 5.0199999999999996 110.525 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.76 84.82 17.53 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.679 -0.638 . . . . 2.4100000000000001 109.779 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 977' ' ' PRO . . . . . 0.55 ' C ' HD12 ' C' ' 978' ' ' LEU . 48.9 Cg_endo -74.49 -172.19 1.13 Allowed 'Trans proline' 0 C--N 1.316 -1.16 0 O-C-N 123.359 1.189 . . . . 0.95999999999999996 111.074 -179.502 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 978' ' ' LEU . . . . . 0.55 HD12 ' C ' ' C' ' 977' ' ' PRO . 6.3 mp -123.32 156.42 35.36 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.456 -1.312 . . . . 0.62 107.456 177.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 979' ' ' THR . . . . . 0.45 HG23 ' C ' ' C' ' 978' ' ' LEU . 47.6 p -149.33 141.49 23.99 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.733 -1.229 . . . . 3.5699999999999998 111.19 -179.269 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 980' ' ' ILE . . . . . 0.705 ' HB ' HG21 ' C' ' 899' ' ' VAL . 51.2 mm -105.8 128.22 60.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 108.974 -0.75 . . . . 1.3300000000000001 108.974 179.363 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 981' ' ' PHE . . . . . 0.483 ' CD1' ' CE2' ' C' ' 879' ' ' TYR . 3.3 t80 -117.95 95.76 5.05 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.394 -0.816 . . . . 0.050000000000000003 111.324 -178.623 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 982' ' ' SER . . . . . . . . . . . . . 11.6 p -108.18 158.43 17.45 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.599 -0.688 . . . . 0.87 109.213 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 983' ' ' GLY . . . . . 0.416 ' O ' ' CZ ' ' C' ' 852' ' ' PHE . . . -171.65 114.61 0.54 Allowed Glycine 0 N--CA 1.496 2.69 0 N-CA-C 106.648 -2.581 . . . . 0.029999999999999999 106.648 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 984' ' ' ALA . . . . . . . . . . . . . . . -108.92 151.57 26.11 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 114.213 1.19 . . . . 0.69999999999999996 114.213 -175.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 985' ' ' LEU . . . . . 0.586 HD13 HD22 ' C' ' 890' ' ' LEU . 55.4 tp -76.43 135.88 39.43 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.819 -1.176 . . . . 0.040000000000000001 109.701 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 986' ' ' LEU . . . . . 0.463 HD11 ' CD1' ' B' ' 986' ' ' LEU . 47.2 tp -106.75 -61.8 1.48 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.491 -0.756 . . . . 0.040000000000000001 110.36 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -144.13 146.67 32.92 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 107.786 -1.191 . . . . 0.040000000000000001 107.786 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.25 162.91 12.25 Favored Glycine 0 N--CA 1.495 2.616 0 N-CA-C 108.071 -2.012 . . . . 0.040000000000000001 108.071 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -74.95 112.76 19.31 Favored Pre-proline 0 N--CA 1.498 1.946 0 O-C-N 121.15 -1.206 . . . . 0.040000000000000001 109.48 179.214 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 990' ' ' PRO . . . . . 0.423 ' O ' ' HB2' ' C' ' 991' ' ' GLU . 50.2 Cg_endo -89.13 71.26 2.09 Favored 'Trans proline' 0 C--N 1.32 -0.967 0 O-C-N 123.108 1.057 . . . . 0.45000000000000001 111.291 -179.033 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 991' ' ' GLU . . . . . 0.423 ' HB2' ' O ' ' C' ' 990' ' ' PRO . 73.6 mt-10 67.52 -73.46 0.08 Allowed 'General case' 0 N--CA 1.503 2.182 0 N-CA-C 108.518 -0.919 . . . . 1.97 108.518 -177.486 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 992' ' ' LEU . . . . . 0.414 HD12 ' HD2' ' C' ' 990' ' ' PRO . 10.8 mt 50.48 20.73 0.73 Allowed 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.568 -0.707 . . . . 2.3799999999999999 111.748 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -93.47 156.75 16.57 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.878 -1.139 . . . . 3.79 110.044 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 68.7 m80 -145.64 92.65 2.25 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.509 -0.745 . . . . 3.5099999999999998 110.254 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 995' ' ' ALA . . . . . . . . . . . . 2.519 . . . . . . . 0 N--CA 1.504 2.249 0 O-C-N 120.968 -1.082 . . . . 2.73 110.637 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo . . . . . 0 N--CA 1.488 1.151 0 N-CA-C 109.491 -1.004 . . . . 3.8300000000000001 109.491 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 847' ' ' VAL . . . . . . . . . . . . . 59.0 t -133.78 102.68 12.32 Favored Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 121.546 -0.721 . . . . 1.8300000000000001 109.993 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 848' ' ' PRO . . . . . 0.757 ' O ' HG23 ' A' ' 850' ' ' VAL . 44.2 Cg_endo -69.79 -19.25 36.22 Favored 'Trans proline' 0 N--CA 1.487 1.114 0 O-C-N 123.316 1.166 . . . . 0.65000000000000002 111.272 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 849' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 27.91 68.09 0.07 Allowed 'General case' 0 N--CA 1.518 2.953 0 N-CA-C 112.901 0.704 . . . . 2.5800000000000001 112.901 179.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 850' ' ' VAL . . . . . 0.757 HG23 ' O ' ' A' ' 848' ' ' PRO . 65.3 t -119.65 137.01 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.148 -0.97 . . . . 1.0900000000000001 111.51 -178.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 851' ' ' ALA . . . . . 0.58 ' HB3' ' HG ' ' A' ' 873' ' ' LEU . . . -123.79 159.92 28.47 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 105.921 -1.881 . . . . 0.040000000000000001 105.921 176.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 852' ' ' PHE . . . . . 0.431 ' HA ' ' CB ' ' A' ' 874' ' ' ASN . 34.2 p90 -159.29 127.82 5.15 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 120.88 1.673 . . . . 0.050000000000000003 108.465 178.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 8.8 t -175.4 134.49 0.31 Allowed 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.185 -1.042 . . . . 0.040000000000000001 108.185 -178.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -130.24 156.92 43.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.03 -1.044 . . . . 0.67000000000000004 109.739 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 855' ' ' ALA . . . . . 0.843 ' HB3' ' CB ' ' A' ' 870' ' ' ARG . . . -119.76 144.11 47.45 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.806 0.813 . . . . 0.51000000000000001 110.809 -179.345 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 856' ' ' LEU . . . . . 0.677 HD13 ' N ' ' A' ' 857' ' ' SER . 2.1 tm? -115.21 134.23 55.33 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.508 -0.745 . . . . 0.050000000000000003 110.45 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 857' ' ' SER . . . . . 0.677 ' N ' HD13 ' A' ' 856' ' ' LEU . 1.7 m -156.74 14.41 0.28 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.486 -0.759 . . . . 1.3300000000000001 111.866 179.516 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 858' ' ' LEU . . . . . 0.557 ' HG ' HD11 ' A' ' 856' ' ' LEU . 0.3 OUTLIER -36.56 162.28 0.04 OUTLIER Pre-proline 0 N--CA 1.524 3.231 0 CA-C-N 119.053 0.842 . . . . 2.3300000000000001 113.07 -179.58 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -61.26 -89.31 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.534 0 O-C-N 123.103 1.054 . . . . 2.3199999999999998 113.841 -177.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 53.9 ptt85 -134.21 -142.42 0.2 Allowed 'General case' 0 N--CA 1.502 2.144 0 O-C-N 120.761 -1.212 . . . . 0.040000000000000001 111.787 -177.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 5.2 m -36.65 126.89 0.86 Allowed 'General case' 0 N--CA 1.511 2.612 0 O-C-N 121.659 -0.651 . . . . 1.3100000000000001 112.366 -178.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 862' ' ' GLU . . . . . 0.779 ' OE1' HG22 ' A' ' 866' ' ' VAL . 1.3 mt-10 -104.73 165.55 13.08 Favored Pre-proline 0 N--CA 1.489 1.496 0 N-CA-C 108.652 -0.87 . . . . 4.5099999999999998 108.652 177.594 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -73.54 -14.42 24.87 Favored 'Trans proline' 0 C--N 1.313 -1.311 0 O-C-N 123.284 1.149 . . . . 2.2400000000000002 111.388 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -177.93 -135.29 2.23 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 110.162 -1.175 . . . . 0.040000000000000001 110.162 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 26.4 m -64.71 156.65 29.69 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.41 -1.053 . . . . 1.51 110.912 -178.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 866' ' ' VAL . . . . . 0.779 HG22 ' OE1' ' A' ' 862' ' ' GLU . 56.2 t -96.95 132.79 25.22 Favored Pre-proline 0 N--CA 1.496 1.838 0 N-CA-C 113.453 0.908 . . . . 0.78000000000000003 113.453 -174.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 867' ' ' PRO . . . . . 0.443 ' O ' HD23 ' A' ' 856' ' ' LEU . 55.4 Cg_endo -90.68 -149.51 0.03 OUTLIER 'Trans proline' 0 CA--C 1.545 1.066 0 O-C-N 123.571 1.3 . . . . 0.92000000000000004 109.332 177.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 868' ' ' PHE . . . . . 0.466 ' CD1' ' N ' ' A' ' 868' ' ' PHE . 19.4 p90 -150.34 123.49 8.86 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.584 -1.322 . . . . 0.050000000000000003 109.837 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 49.9 p-10 -113.62 -2.68 13.74 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.129 -0.982 . . . . 1.7 112.841 -178.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 870' ' ' ARG . . . . . 0.843 ' CB ' ' HB3' ' A' ' 855' ' ' ALA . 28.2 mmm180 -91.58 89.9 7.37 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 120.819 -1.176 . . . . 2.5899999999999999 111.131 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 57.9 t -72.77 96.66 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 120.984 -1.072 . . . . 1.9399999999999999 109.694 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 872' ' ' LEU . . . . . 0.833 HD11 ' HB2' ' A' ' 855' ' ' ALA . 86.6 mt -83.32 -46.81 12.18 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.505 -0.747 . . . . 1.0600000000000001 110.164 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 873' ' ' LEU . . . . . 0.58 ' HG ' ' HB3' ' A' ' 851' ' ' ALA . 32.7 tp -174.33 102.35 0.1 Allowed 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 108.595 -0.891 . . . . 4.1799999999999997 108.595 178.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 874' ' ' ASN . . . . . 0.431 ' CB ' ' HA ' ' A' ' 852' ' ' PHE . 33.9 t-20 178.33 80.98 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.256 0 N-CA-C 109.264 -0.643 . . . . 0.040000000000000001 109.264 -179.005 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -65.41 -47.03 77.68 Favored 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 119.344 -0.942 . . . . 3.3799999999999999 111.129 -179.321 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 876' ' ' GLY . . . . . . . . . . . . . . . -73.97 -24.26 74.36 Favored Glycine 0 N--CA 1.494 2.55 0 O-C-N 121.316 -0.865 . . . . 0.040000000000000001 111.672 -178.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 84.41 -60.04 4.87 Favored Glycine 0 N--CA 1.502 3.099 0 N-CA-C 107.949 -2.06 . . . . 0.040000000000000001 107.949 -178.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 878' ' ' TYR . . . . . 0.4 ' CZ ' HG11 ' A' ' 850' ' ' VAL . 97.8 m-85 60.32 -66.63 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.14 0 N-CA-C 114.424 1.268 . . . . 3.46 114.424 177.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 879' ' ' TYR . . . . . 0.469 ' CB ' ' CD2' ' A' ' 886' ' ' PHE . 21.3 p90 -110.77 109.69 20.02 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 114.831 1.419 . . . . 0.040000000000000001 114.831 -176.235 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -66.0 117.08 38.97 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 121.534 -0.729 . . . . 0.02 110.191 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 881' ' ' PRO . . . . . 0.463 ' HG2' ' CD1' ' A' ' 868' ' ' PHE . 54.4 Cg_endo -75.88 0.39 9.31 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 O-C-N 123.413 1.217 . . . . 0.39000000000000001 112.222 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -75.35 -65.19 0.92 Allowed 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 106.952 -1.499 . . . . 0.81000000000000005 106.952 178.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 2.2 p -95.74 -17.0 21.57 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.802 -0.814 . . . . 0.040000000000000001 108.802 177.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.68 22.98 52.0 Favored Glycine 0 N--CA 1.494 2.533 0 C-N-CA 120.127 -1.035 . . . . 0.029999999999999999 110.664 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 885' ' ' VAL . . . . . . . . . . . . . 92.0 t -73.2 88.46 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 C-N-CA 118.357 -1.337 . . . . 1.01 107.917 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 886' ' ' PHE . . . . . 0.875 ' HB3' HG22 ' A' ' 962' ' ' VAL . 0.6 OUTLIER -89.13 106.38 18.4 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 115.04 -0.982 . . . . 0.050000000000000003 112.175 -177.053 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 887' ' ' THR . . . . . . . . . . . . . 97.0 m -98.85 99.16 10.2 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 107.495 -1.298 . . . . 0.68000000000000005 107.495 177.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 888' ' ' ALA . . . . . . . . . . . . . . . -97.25 108.11 42.39 Favored Pre-proline 0 N--CA 1.501 2.08 0 N-CA-C 114.207 1.188 . . . . 0.25 114.207 -176.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 889' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -89.39 -13.7 2.8 Favored 'Trans proline' 0 CA--C 1.546 1.076 0 O-C-N 123.288 1.152 . . . . 1.6399999999999999 109.137 176.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 890' ' ' LEU . . . . . 0.977 HD22 HD13 ' A' ' 985' ' ' LEU . 63.1 mt -35.93 -50.64 0.68 Allowed 'General case' 0 N--CA 1.509 2.508 0 N-CA-C 113.694 0.998 . . . . 2.29 113.694 -177.451 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 52.18 95.52 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.189 -0.945 . . . . 0.63 110.269 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 157.59 -154.09 25.23 Favored Glycine 0 N--CA 1.478 1.436 0 N-CA-C 107.055 -2.418 . . . . 0.040000000000000001 107.055 -179.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 893' ' ' ARG . . . . . 0.4 ' CZ ' ' CB ' ' C' ' 984' ' ' ALA . 71.0 ttt-85 -116.4 125.31 51.87 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.529 -0.983 . . . . 3.0 108.567 177.464 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 894' ' ' TYR . . . . . 0.825 ' OH ' HD12 ' A' ' 896' ' ' LEU . 0.1 OUTLIER -132.05 161.38 33.37 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.134 -0.979 . . . . 0.040000000000000001 111.084 -179.843 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 895' ' ' LEU . . . . . . . . . . . . . 43.6 tp -91.86 119.48 31.68 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.723 -0.611 . . . . 1.27 110.274 -179.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 896' ' ' LEU . . . . . 0.825 HD12 ' OH ' ' A' ' 894' ' ' TYR . 9.2 tt -110.18 144.42 38.85 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.742 -0.599 . . . . 0.93999999999999995 109.98 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 897' ' ' SER . . . . . 0.506 ' N ' HD23 ' A' ' 896' ' ' LEU . 69.2 m -149.45 114.66 5.47 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.51 -0.744 . . . . 0.040000000000000001 111.032 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.41 146.27 31.88 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.915 -0.772 . . . . 0.47999999999999998 108.915 178.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 899' ' ' VAL . . . . . 0.72 HG21 ' HB ' ' A' ' 980' ' ' ILE . 87.3 t -96.52 119.18 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 C-N-CA 119.566 -0.854 . . . . 0.55000000000000004 111.16 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 900' ' ' LEU . . . . . 0.641 HD12 ' HB2' ' A' ' 924' ' ' SER . 4.5 mm? -95.95 113.22 24.82 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 114.223 1.194 . . . . 1.5900000000000001 114.223 -175.107 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 18.3 m -65.38 140.92 58.69 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 107.551 -1.277 . . . . 0.050000000000000003 107.551 177.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -64.68 -65.31 3.03 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 110.573 -1.011 . . . . 0.029999999999999999 110.573 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 46.95 66.44 0.99 Allowed 'General case' 0 N--CA 1.507 2.42 0 O-C-N 121.515 -0.991 . . . . 3.2000000000000002 111.01 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 54.3 ptt85 -68.8 -6.49 27.04 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.618 -0.676 . . . . 2.9199999999999999 112.059 -179.123 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 905' ' ' HIS . . . . . 0.491 ' O ' ' CB ' ' A' ' 906' ' ' GLU . 73.0 t60 -62.64 5.16 0.13 Allowed 'General case' 0 N--CA 1.505 2.293 0 O-C-N 120.91 -1.119 . . . . 2.8700000000000001 113.11 -179.14 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 906' ' ' GLU . . . . . 0.491 ' CB ' ' O ' ' A' ' 905' ' ' HIS . 0.9 OUTLIER 95.35 -164.82 0.0 OUTLIER 'General case' 0 N--CA 1.529 3.478 0 CA-C-N 120.561 1.528 . . . . 0.98999999999999999 111.947 179.004 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 907' ' ' LYS . . . . . 0.468 ' CB ' ' O ' ' A' ' 906' ' ' GLU . 52.9 tttt 87.21 157.58 0.07 Allowed 'General case' 0 N--CA 1.52 3.039 0 N-CA-C 108.143 -1.058 . . . . 5.25 108.143 -176.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 60.9 t -122.28 117.85 53.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 120.857 -1.152 . . . . 0.39000000000000001 111.179 -179.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 909' ' ' GLU . . . . . 0.438 ' OE1' HD12 ' A' ' 966' ' ' LEU . 52.8 tp10 -98.82 134.09 42.2 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 107.35 -1.352 . . . . 1.72 107.35 176.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -156.46 122.69 5.0 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 107.028 -1.471 . . . . 0.67000000000000004 107.028 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 911' ' ' VAL . . . . . 0.721 HG22 HG13 ' A' ' 964' ' ' VAL . 93.8 t -85.15 131.17 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 C-N-CA 120.442 -0.503 . . . . 0.54000000000000004 111.108 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 88.3 mt -65.22 157.97 27.44 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.397 -0.814 . . . . 1.5 109.361 178.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 913' ' ' SER . . . . . 0.409 ' CB ' ' HB ' ' A' ' 919' ' ' VAL . 1.7 t -127.64 134.94 49.64 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.239 -1.023 . . . . 1.3700000000000001 108.239 176.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 914' ' ' ARG . . . . . 0.433 HH11 HG13 ' A' ' 962' ' ' VAL . 0.0 OUTLIER -65.12 155.11 35.92 Favored 'General case' 0 N--CA 1.506 2.358 0 O-C-N 120.577 -1.327 . . . . 4.2999999999999998 111.628 -179.128 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 915' ' ' SER . . . . . 0.42 ' CB ' ' O ' ' A' ' 914' ' ' ARG . 1.6 p 82.93 -31.14 0.09 Allowed 'General case' 0 N--CA 1.52 3.046 0 C-N-CA 123.852 0.861 . . . . 2.0499999999999998 112.222 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 916' ' ' ASN . . . . . 0.747 ' HB2' HG21 ' A' ' 919' ' ' VAL . 89.4 m-20 -122.63 -21.55 5.64 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.903 -1.123 . . . . 2.71 111.267 -179.262 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 917' ' ' GLN . . . . . 0.433 ' HB2' ' O ' ' A' ' 916' ' ' ASN . 58.9 mt-30 66.37 166.07 0.2 Allowed 'General case' 0 N--CA 1.519 3.018 0 N-CA-C 105.816 -1.92 . . . . 2.6800000000000002 105.816 -173.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.32 -125.32 33.65 Favored Glycine 1 N--CA 1.521 4.348 0 CA-C-N 123.472 2.851 . . . . 0.029999999999999999 106.98 -177.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 919' ' ' VAL . . . . . 0.747 HG21 ' HB2' ' A' ' 916' ' ' ASN . 77.0 t 51.51 94.9 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 O-C-N 121.39 -1.065 . . . . 1.3899999999999999 109.15 -178.243 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 920' ' ' ALA . . . . . 0.807 ' HB3' HG12 ' A' ' 949' ' ' VAL . . . -92.34 93.0 8.4 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.318 -0.953 . . . . 0.029999999999999999 110.818 -179.285 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 921' ' ' ARG . . . . . 0.851 ' HG3' HG23 ' A' ' 922' ' ' VAL . 23.1 ptt180 -84.15 -42.15 16.31 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 105.873 -1.899 . . . . 4.4199999999999999 105.873 176.119 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 922' ' ' VAL . . . . . 0.851 HG23 ' HG3' ' A' ' 921' ' ' ARG . 95.7 t -101.53 72.73 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 N-CA-C 105.94 -1.874 . . . . 0.84999999999999998 105.94 175.473 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -88.32 133.42 34.08 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.663 0.744 . . . . 2.46 111.502 -177.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 924' ' ' SER . . . . . 0.641 ' HB2' HD12 ' A' ' 900' ' ' LEU . 9.9 t -148.67 105.68 3.6 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.787 -0.82 . . . . 0.69999999999999996 108.787 179.144 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -101.56 82.67 0.47 Allowed Glycine 0 N--CA 1.487 2.037 0 N-CA-C 108.201 -1.96 . . . . 0.040000000000000001 108.201 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.211 0 N-CA-C 108.989 -1.644 . . . . 0.040000000000000001 108.989 -179.523 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 73.8 m . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 120.968 0.413 . . . . 13.779999999999999 110.31 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 96.7 mt -113.4 129.82 56.45 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.504 -0.747 . . . . 13.76 110.393 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -151.97 168.06 31.2 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.098 -1.601 . . . . 9.1300000000000008 109.098 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 949' ' ' VAL . . . . . 0.807 HG12 ' HB3' ' A' ' 920' ' ' ALA . 33.0 m -118.93 129.93 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.5 -1.0 . . . . 7.0800000000000001 110.916 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 950' ' ' PHE . . . . . 0.451 ' CE1' ' HD2' ' A' ' 955' ' ' PRO . 27.7 p90 -132.69 148.15 52.34 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.547 -0.721 . . . . 7.5899999999999999 109.212 179.376 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 58.5 m -121.15 -52.27 2.08 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.414 -0.804 . . . . 5.0300000000000002 112.103 -178.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 952' ' ' LEU . . . . . 0.414 ' O ' ' O ' ' A' ' 953' ' ' ILE . 20.5 tp -60.31 -73.67 0.09 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.446 -0.784 . . . . 1.01 112.403 -177.406 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 953' ' ' ILE . . . . . 0.662 HD11 HD13 ' C' ' 872' ' ' LEU . 47.9 pt -53.44 -143.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.738 0 N-CA-C 114.008 1.114 . . . . 2.6000000000000001 114.008 -176.61 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 954' ' ' LEU . . . . . 0.718 HD22 ' O ' ' A' ' 954' ' ' LEU . 0.0 OUTLIER 172.57 75.0 0.04 OUTLIER Pre-proline 0 N--CA 1.508 2.47 0 O-C-N 120.825 -1.172 . . . . 0.050000000000000003 111.01 179.635 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 955' ' ' PRO . . . . . 0.642 ' C ' HD12 ' A' ' 956' ' ' LEU . 47.9 Cg_endo -74.74 95.85 0.98 Allowed 'Trans proline' 0 C--N 1.315 -1.232 0 N-CA-C 109.702 -0.922 . . . . 0.83999999999999997 109.702 179.198 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 956' ' ' LEU . . . . . 0.642 HD12 ' C ' ' A' ' 955' ' ' PRO . 7.1 mp -125.1 149.88 47.4 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.179 -0.95 . . . . 0.040000000000000001 110.27 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -82.75 150.78 26.48 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 117.701 -1.142 . . . . 1.28 111.468 -179.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -68.36 119.48 12.94 Favored 'General case' 0 N--CA 1.51 2.553 0 CA-C-N 123.098 2.681 . . . . 0.17000000000000001 111.316 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.87 -21.87 37.1 Favored Glycine 0 N--CA 1.5 2.924 0 N-CA-C 110.829 -0.908 . . . . 0.040000000000000001 110.829 178.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 960' ' ' ASP . . . . . 0.42 ' HB3' ' CZ ' ' A' ' 914' ' ' ARG . 0.3 OUTLIER -54.13 172.27 0.09 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.504 -0.998 . . . . 0.040000000000000001 110.138 -179.598 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 961' ' ' THR . . . . . 0.485 ' HA ' ' O ' ' A' ' 886' ' ' PHE . 39.3 m -135.87 138.81 42.86 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.963 -1.085 . . . . 1.78 112.377 -178.032 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 962' ' ' VAL . . . . . 0.875 HG22 ' HB3' ' A' ' 886' ' ' PHE . 32.4 m -98.72 144.22 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 C-N-CA 120.149 -0.62 . . . . 0.040000000000000001 110.03 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 5.5 t -139.69 143.88 37.29 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.671 -0.643 . . . . 0.71999999999999997 109.914 -178.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 964' ' ' VAL . . . . . 0.721 HG13 HG22 ' A' ' 911' ' ' VAL . 59.1 t -95.0 137.19 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.097 -1.002 . . . . 1.05 110.699 -179.108 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -91.5 128.91 37.51 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 103.819 -2.66 . . . . 3.02 103.819 173.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 966' ' ' LEU . . . . . 0.487 ' C ' HG23 ' A' ' 967' ' ' VAL . 1.5 tp -131.33 59.71 1.68 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.162 -1.051 . . . . 1.46 108.162 177.246 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 967' ' ' VAL . . . . . 0.487 HG23 ' C ' ' A' ' 966' ' ' LEU . 97.8 t -158.16 96.54 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 108.096 -1.075 . . . . 1.9399999999999999 108.096 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 87.1 mmm -143.58 59.13 1.38 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.761 -1.212 . . . . 0.0 108.262 178.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 134.96 119.52 1.95 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 106.91 -2.476 . . . . 2.1099999999999999 106.91 -178.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -82.34 -58.24 3.02 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.039 -1.271 . . . . 5.8899999999999997 110.327 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 44.0 tp -58.86 90.81 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.406 -0.809 . . . . 4.3600000000000003 110.171 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -141.65 -154.56 0.53 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.614 -0.679 . . . . 1.8300000000000001 110.236 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -120.05 172.42 7.76 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.522 -0.736 . . . . 4.3499999999999996 110.268 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 38.6 t -101.37 130.05 47.48 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.576 -0.703 . . . . 1.27 109.946 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -156.03 157.74 36.64 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.527 -0.733 . . . . 5.0199999999999996 110.515 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.14 85.34 19.04 Favored Pre-proline 0 N--CA 1.5 2.035 0 O-C-N 121.652 -0.655 . . . . 2.4100000000000001 109.662 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 977' ' ' PRO . . . . . 0.6 ' C ' HD12 ' A' ' 978' ' ' LEU . 47.5 Cg_endo -72.81 -172.52 0.98 Allowed 'Trans proline' 0 C--N 1.317 -1.123 0 O-C-N 123.304 1.16 . . . . 0.95999999999999996 111.192 -179.406 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 978' ' ' LEU . . . . . 0.635 HD23 HD12 ' A' ' 856' ' ' LEU . 5.9 mp -128.04 154.24 45.88 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 107.575 -1.268 . . . . 0.62 107.575 177.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 979' ' ' THR . . . . . 0.462 HG23 ' C ' ' A' ' 978' ' ' LEU . 43.2 p -149.79 142.07 24.17 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.851 -1.156 . . . . 3.5699999999999998 111.185 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 980' ' ' ILE . . . . . 0.72 ' HB ' HG21 ' A' ' 899' ' ' VAL . 46.9 mm -105.87 127.76 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 108.708 -0.849 . . . . 1.3300000000000001 108.708 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 981' ' ' PHE . . . . . 0.46 ' HD1' ' HH ' ' A' ' 879' ' ' TYR . 7.3 t80 -120.26 97.73 5.72 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 119.641 -0.823 . . . . 0.050000000000000003 111.828 -178.427 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 59.2 p -107.86 158.66 17.15 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 109.114 -0.699 . . . . 0.87 109.114 178.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 983' ' ' GLY . . . . . 0.415 ' O ' ' CZ ' ' A' ' 852' ' ' PHE . . . -175.36 107.26 0.24 Allowed Glycine 0 N--CA 1.499 2.836 0 N-CA-C 106.354 -2.699 . . . . 0.029999999999999999 106.354 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -109.21 152.64 24.9 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 114.583 1.327 . . . . 0.69999999999999996 114.583 -175.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 985' ' ' LEU . . . . . 0.977 HD13 HD22 ' A' ' 890' ' ' LEU . 30.5 tp -72.23 134.2 45.49 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.887 -1.133 . . . . 0.040000000000000001 109.895 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 48.6 tp -107.9 -57.8 2.06 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.564 -0.71 . . . . 0.040000000000000001 110.208 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -144.28 145.35 31.97 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 107.592 -1.262 . . . . 0.040000000000000001 107.592 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.68 163.22 12.18 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 108.218 -1.953 . . . . 0.040000000000000001 108.218 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -74.43 112.7 18.36 Favored Pre-proline 0 N--CA 1.498 1.932 0 O-C-N 121.259 -1.142 . . . . 0.040000000000000001 109.468 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 990' ' ' PRO . . . . . 0.446 ' HD2' HD12 ' A' ' 992' ' ' LEU . 50.6 Cg_endo -89.2 70.89 2.11 Favored 'Trans proline' 0 C--N 1.319 -1.022 0 O-C-N 123.199 1.105 . . . . 0.45000000000000001 111.482 -178.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 991' ' ' GLU . . . . . 0.427 ' HB2' ' O ' ' A' ' 990' ' ' PRO . 77.2 mt-10 67.18 -73.91 0.07 Allowed 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 108.524 -0.917 . . . . 1.97 108.524 -177.449 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 992' ' ' LEU . . . . . 0.446 HD12 ' HD2' ' A' ' 990' ' ' PRO . 10.5 mt 51.19 20.7 0.93 Allowed 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.562 -0.711 . . . . 2.3799999999999999 111.532 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -93.3 157.11 16.41 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.933 -1.105 . . . . 3.79 110.044 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 71.5 m80 -146.85 92.64 2.16 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.515 -0.74 . . . . 3.5099999999999998 110.195 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 995' ' ' ALA . . . . . . . . . . . . 2.519 . . . . . . . 0 N--CA 1.503 2.2 0 O-C-N 120.904 -1.122 . . . . 2.73 110.599 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo . . . . . 0 N--CA 1.487 1.147 0 N-CA-C 109.506 -0.998 . . . . 3.8300000000000001 109.506 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 847' ' ' VAL . . . . . . . . . . . . . 58.9 t -133.85 102.69 12.24 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.619 -0.676 . . . . 1.8300000000000001 109.994 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 848' ' ' PRO . . . . . 0.761 ' O ' HG23 ' B' ' 850' ' ' VAL . 44.0 Cg_endo -69.68 -19.62 36.25 Favored 'Trans proline' 0 N--CA 1.488 1.152 0 O-C-N 123.279 1.147 . . . . 0.65000000000000002 111.245 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 849' ' ' GLN . . . . . 0.404 ' C ' ' O ' ' B' ' 848' ' ' PRO . 56.0 tt0 28.22 68.33 0.08 Allowed 'General case' 0 N--CA 1.518 2.931 0 N-CA-C 112.831 0.678 . . . . 2.5800000000000001 112.831 179.295 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 850' ' ' VAL . . . . . 0.761 HG23 ' O ' ' B' ' 848' ' ' PRO . 66.2 t -119.95 137.07 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.141 -0.974 . . . . 1.0900000000000001 111.445 -178.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 851' ' ' ALA . . . . . 0.596 ' HB3' ' HG ' ' B' ' 873' ' ' LEU . . . -124.15 159.15 30.68 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 105.945 -1.872 . . . . 0.040000000000000001 105.945 176.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 852' ' ' PHE . . . . . 0.426 ' HA ' ' CB ' ' B' ' 874' ' ' ASN . 33.5 p90 -158.56 128.09 5.73 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 120.943 1.702 . . . . 0.050000000000000003 108.344 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 7.9 t -175.48 134.18 0.3 Allowed 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.281 -1.007 . . . . 0.040000000000000001 108.281 -178.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -129.83 157.22 42.84 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.011 -1.056 . . . . 0.67000000000000004 109.824 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 855' ' ' ALA . . . . . 0.856 ' HB3' ' CB ' ' B' ' 870' ' ' ARG . . . -119.92 144.7 47.3 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.843 0.83 . . . . 0.51000000000000001 110.776 -179.288 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 856' ' ' LEU . . . . . 0.668 HD13 ' N ' ' B' ' 857' ' ' SER . 2.1 tm? -115.83 133.72 55.74 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.493 -0.754 . . . . 0.050000000000000003 110.542 -179.416 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 857' ' ' SER . . . . . 0.668 ' N ' HD13 ' B' ' 856' ' ' LEU . 1.8 m -156.4 14.45 0.31 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.459 -0.775 . . . . 1.3300000000000001 111.804 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 858' ' ' LEU . . . . . 0.558 ' HG ' HD11 ' B' ' 856' ' ' LEU . 0.3 OUTLIER -36.53 162.19 0.04 OUTLIER Pre-proline 0 N--CA 1.524 3.254 0 CA-C-N 119.052 0.842 . . . . 2.3300000000000001 113.074 -179.693 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -61.26 -89.38 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 120.947 1.098 . . . . 2.3199999999999998 113.804 -177.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 53.9 ptt85 -134.19 -142.46 0.2 Allowed 'General case' 0 N--CA 1.501 2.114 0 O-C-N 120.802 -1.186 . . . . 0.040000000000000001 111.815 -177.387 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 5.2 m -36.56 126.46 0.84 Allowed 'General case' 0 N--CA 1.512 2.645 0 O-C-N 121.671 -0.643 . . . . 1.3100000000000001 112.373 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 862' ' ' GLU . . . . . 0.787 ' OE1' HG22 ' B' ' 866' ' ' VAL . 1.3 mt-10 -104.34 165.67 12.95 Favored Pre-proline 0 N--CA 1.488 1.451 0 N-CA-C 108.637 -0.875 . . . . 4.5099999999999998 108.637 177.578 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -73.45 -14.57 25.11 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 O-C-N 123.294 1.155 . . . . 2.2400000000000002 111.396 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -177.68 -133.75 1.91 Allowed Glycine 0 N--CA 1.495 2.592 0 N-CA-C 110.184 -1.167 . . . . 0.040000000000000001 110.184 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 27.1 m -66.07 157.64 30.54 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.351 -1.088 . . . . 1.51 110.733 -178.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 866' ' ' VAL . . . . . 0.787 HG22 ' OE1' ' B' ' 862' ' ' GLU . 56.9 t -97.73 132.71 24.49 Favored Pre-proline 0 N--CA 1.496 1.833 0 N-CA-C 113.402 0.89 . . . . 0.78000000000000003 113.402 -174.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 867' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' B' ' 866' ' ' VAL . 55.2 Cg_endo -90.71 -149.73 0.03 OUTLIER 'Trans proline' 0 CA--C 1.544 1.02 0 C-N-CA 121.219 1.279 . . . . 0.92000000000000004 109.356 177.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 868' ' ' PHE . . . . . 0.469 ' CD1' ' HG2' ' B' ' 881' ' ' PRO . 19.4 p90 -150.19 123.25 8.82 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.493 -1.379 . . . . 0.050000000000000003 109.858 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 50.2 p-10 -113.35 -2.32 14.02 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.101 -1.0 . . . . 1.7 112.786 -178.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 870' ' ' ARG . . . . . 0.856 ' CB ' ' HB3' ' B' ' 855' ' ' ALA . 28.0 mmm180 -91.74 89.79 7.24 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.861 -1.149 . . . . 2.5899999999999999 111.167 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 57.5 t -72.9 96.75 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 120.978 -1.077 . . . . 1.9399999999999999 109.669 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 872' ' ' LEU . . . . . 0.844 HD11 ' HB2' ' B' ' 855' ' ' ALA . 87.1 mt -83.56 -46.66 12.15 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.508 -0.745 . . . . 1.0600000000000001 110.117 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 873' ' ' LEU . . . . . 0.596 ' HG ' ' HB3' ' B' ' 851' ' ' ALA . 32.6 tp -174.31 102.25 0.1 Allowed 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.583 -0.895 . . . . 4.1799999999999997 108.583 178.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 874' ' ' ASN . . . . . 0.426 ' CB ' ' HA ' ' B' ' 852' ' ' PHE . 33.8 t-20 178.36 81.08 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.664 -0.647 . . . . 0.040000000000000001 109.371 -179.067 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -65.5 -47.1 77.17 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 119.349 -0.941 . . . . 3.3799999999999999 111.102 -179.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 876' ' ' GLY . . . . . . . . . . . . . . . -73.98 -24.27 74.3 Favored Glycine 0 N--CA 1.493 2.477 0 O-C-N 121.285 -0.884 . . . . 0.040000000000000001 111.687 -178.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 84.41 -59.95 4.88 Favored Glycine 0 N--CA 1.502 3.069 0 N-CA-C 107.948 -2.061 . . . . 0.040000000000000001 107.948 -178.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 878' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 60.41 -66.68 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 114.474 1.287 . . . . 3.46 114.474 177.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 879' ' ' TYR . . . . . 0.471 ' CB ' ' CD2' ' B' ' 886' ' ' PHE . 21.3 p90 -110.78 109.62 19.91 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 114.785 1.402 . . . . 0.040000000000000001 114.785 -176.242 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -65.94 117.06 38.54 Favored Pre-proline 0 N--CA 1.496 1.847 0 O-C-N 121.557 -0.715 . . . . 0.02 110.117 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 881' ' ' PRO . . . . . 0.469 ' HG2' ' CD1' ' B' ' 868' ' ' PHE . 53.8 Cg_endo -75.78 0.23 9.45 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 O-C-N 123.477 1.251 . . . . 0.39000000000000001 112.252 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -75.26 -65.23 0.91 Allowed 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 106.953 -1.499 . . . . 0.81000000000000005 106.953 178.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 2.2 p -95.87 -16.53 21.74 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.88 -0.785 . . . . 0.040000000000000001 108.88 177.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.2 23.34 52.02 Favored Glycine 0 N--CA 1.493 2.489 0 C-N-CA 120.069 -1.063 . . . . 0.029999999999999999 110.719 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 885' ' ' VAL . . . . . . . . . . . . . 92.6 t -73.56 88.7 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 C-N-CA 118.392 -1.323 . . . . 1.01 107.806 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 886' ' ' PHE . . . . . 0.897 ' HB3' HG22 ' B' ' 962' ' ' VAL . 0.6 OUTLIER -89.36 106.28 18.34 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 115.121 -0.945 . . . . 0.050000000000000003 112.234 -177.12 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 887' ' ' THR . . . . . . . . . . . . . 96.9 m -98.67 99.44 10.56 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 107.493 -1.299 . . . . 0.68000000000000005 107.493 176.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 888' ' ' ALA . . . . . . . . . . . . . . . -97.52 108.13 43.31 Favored Pre-proline 0 N--CA 1.502 2.134 0 N-CA-C 114.119 1.155 . . . . 0.25 114.119 -176.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 889' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -89.37 -13.85 2.77 Favored 'Trans proline' 0 CA--C 1.546 1.091 0 N-CA-C 109.135 -1.14 . . . . 1.6399999999999999 109.135 176.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 890' ' ' LEU . . . . . 1.004 HD22 HD13 ' B' ' 985' ' ' LEU . 62.9 mt -35.73 -50.64 0.64 Allowed 'General case' 0 N--CA 1.509 2.497 0 N-CA-C 113.68 0.992 . . . . 2.29 113.68 -177.473 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 52.1 95.44 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.154 -0.966 . . . . 0.63 110.338 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . 157.65 -154.16 25.28 Favored Glycine 0 N--CA 1.478 1.491 0 N-CA-C 107.085 -2.406 . . . . 0.040000000000000001 107.085 -179.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 71.7 ttt-85 -116.34 125.26 51.85 Favored 'General case' 0 C--N 1.294 -1.807 0 O-C-N 121.564 -0.963 . . . . 3.0 108.511 177.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 894' ' ' TYR . . . . . 0.821 ' OH ' HD12 ' B' ' 896' ' ' LEU . 0.1 OUTLIER -131.9 161.63 32.56 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.082 -1.011 . . . . 0.040000000000000001 111.113 -179.854 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 895' ' ' LEU . . . . . . . . . . . . . 43.3 tp -92.27 119.32 31.75 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.681 -0.637 . . . . 1.27 110.355 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 896' ' ' LEU . . . . . 0.821 HD12 ' OH ' ' B' ' 894' ' ' TYR . 9.1 tt -110.11 143.87 39.55 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.725 -0.609 . . . . 0.93999999999999995 110.053 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 897' ' ' SER . . . . . 0.505 ' N ' HD23 ' B' ' 896' ' ' LEU . 68.7 m -148.81 114.5 5.66 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.426 -0.796 . . . . 0.040000000000000001 111.098 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.23 145.99 31.97 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.011 -0.737 . . . . 0.47999999999999998 109.011 178.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 899' ' ' VAL . . . . . 0.711 HG21 ' HB ' ' B' ' 980' ' ' ILE . 88.4 t -96.22 119.07 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.356 -0.84 . . . . 0.55000000000000004 111.245 -179.228 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 900' ' ' LEU . . . . . 0.655 HD12 ' HB2' ' B' ' 924' ' ' SER . 4.5 mm? -95.97 112.7 24.36 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 114.288 1.218 . . . . 1.5900000000000001 114.288 -175.02 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 18.1 m -64.94 140.79 58.9 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 107.531 -1.285 . . . . 0.050000000000000003 107.531 177.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -64.83 -65.26 3.04 Favored Glycine 0 N--CA 1.494 2.515 0 N-CA-C 110.639 -0.985 . . . . 0.029999999999999999 110.639 -179.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 46.89 66.64 0.94 Allowed 'General case' 0 N--CA 1.507 2.411 0 O-C-N 121.472 -1.017 . . . . 3.2000000000000002 110.964 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 54.3 ptt85 -68.85 -6.78 29.05 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.639 -0.663 . . . . 2.9199999999999999 112.073 -179.091 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 905' ' ' HIS . . . . . 0.488 ' O ' ' CB ' ' B' ' 906' ' ' GLU . 72.8 t60 -62.08 4.74 0.12 Allowed 'General case' 0 N--CA 1.505 2.323 0 O-C-N 120.876 -1.14 . . . . 2.8700000000000001 113.111 -179.132 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 906' ' ' GLU . . . . . 0.488 ' CB ' ' O ' ' B' ' 905' ' ' HIS . 0.9 OUTLIER 95.62 -164.94 0.0 OUTLIER 'General case' 0 N--CA 1.53 3.549 0 CA-C-N 120.612 1.551 . . . . 0.98999999999999999 111.781 179.1 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 907' ' ' LYS . . . . . 0.47 ' CB ' ' O ' ' B' ' 906' ' ' GLU . 53.3 tttt 87.31 157.28 0.07 Allowed 'General case' 0 N--CA 1.52 3.073 0 N-CA-C 108.132 -1.062 . . . . 5.25 108.132 -177.063 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 60.9 t -122.08 117.5 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 120.894 -1.129 . . . . 0.39000000000000001 111.243 -179.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 909' ' ' GLU . . . . . 0.429 ' OE1' HD12 ' B' ' 966' ' ' LEU . 52.8 tp10 -98.33 134.37 41.43 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 107.333 -1.358 . . . . 1.72 107.333 176.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -156.83 122.8 4.85 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 106.992 -1.484 . . . . 0.67000000000000004 106.992 178.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 911' ' ' VAL . . . . . 0.706 HG22 HG13 ' B' ' 964' ' ' VAL . 94.9 t -85.34 131.54 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.906 -0.496 . . . . 0.54000000000000004 111.061 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 88.2 mt -65.44 158.13 27.6 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.362 -0.836 . . . . 1.5 109.359 178.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 913' ' ' SER . . . . . 0.411 ' CB ' ' CG1' ' B' ' 919' ' ' VAL . 1.8 t -127.97 134.39 49.28 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.274 -1.01 . . . . 1.3700000000000001 108.274 176.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 914' ' ' ARG . . . . . 0.421 HH11 HG13 ' B' ' 962' ' ' VAL . 0.0 OUTLIER -64.51 155.05 34.11 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 120.577 -1.327 . . . . 4.2999999999999998 111.685 -179.067 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 915' ' ' SER . . . . . 0.411 ' CB ' ' O ' ' B' ' 914' ' ' ARG . 1.6 p 83.05 -31.44 0.09 Allowed 'General case' 0 N--CA 1.521 3.093 0 C-N-CA 123.84 0.856 . . . . 2.0499999999999998 112.224 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 916' ' ' ASN . . . . . 0.785 ' HB2' HG21 ' B' ' 919' ' ' VAL . 89.2 m-20 -122.25 -21.91 5.73 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.92 -1.112 . . . . 2.71 111.288 -179.247 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 917' ' ' GLN . . . . . 0.433 ' HB2' ' O ' ' B' ' 916' ' ' ASN . 58.5 mt-30 66.5 165.43 0.2 Allowed 'General case' 0 N--CA 1.52 3.029 0 N-CA-C 105.782 -1.933 . . . . 2.6800000000000002 105.782 -174.012 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 55.05 -125.38 35.58 Favored Glycine 1 N--CA 1.52 4.268 0 CA-C-N 123.478 2.854 . . . . 0.029999999999999999 106.858 -177.566 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 919' ' ' VAL . . . . . 0.785 HG21 ' HB2' ' B' ' 916' ' ' ASN . 80.5 t 51.44 94.91 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.233 0 O-C-N 121.419 -1.047 . . . . 1.3899999999999999 109.189 -178.271 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 920' ' ' ALA . . . . . 0.805 ' HB3' HG12 ' B' ' 949' ' ' VAL . . . -92.4 92.85 8.3 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.324 -0.951 . . . . 0.029999999999999999 110.823 -179.286 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 921' ' ' ARG . . . . . 0.842 ' HG3' HG23 ' B' ' 922' ' ' VAL . 23.2 ptt180 -84.12 -42.11 16.4 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 105.885 -1.894 . . . . 4.4199999999999999 105.885 176.163 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 922' ' ' VAL . . . . . 0.842 HG23 ' HG3' ' B' ' 921' ' ' ARG . 95.7 t -101.52 72.64 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 N-CA-C 105.92 -1.882 . . . . 0.84999999999999998 105.92 175.523 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -88.19 133.47 34.02 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.615 0.721 . . . . 2.46 111.495 -177.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 924' ' ' SER . . . . . 0.655 ' HB2' HD12 ' B' ' 900' ' ' LEU . 9.9 t -148.68 105.72 3.6 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.76 -0.829 . . . . 0.69999999999999996 108.76 179.094 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -101.5 82.62 0.47 Allowed Glycine 0 N--CA 1.487 2.049 0 N-CA-C 108.176 -1.97 . . . . 0.040000000000000001 108.176 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.143 0 N-CA-C 109.026 -1.629 . . . . 0.040000000000000001 109.026 -179.562 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 76.9 m . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.016 0.436 . . . . 13.779999999999999 110.215 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 96.7 mt -112.24 129.87 56.12 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.546 -0.722 . . . . 13.76 110.4 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -151.65 167.5 30.96 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.153 -1.579 . . . . 9.1300000000000008 109.153 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 949' ' ' VAL . . . . . 0.805 HG12 ' HB3' ' B' ' 920' ' ' ALA . 32.1 m -118.69 129.85 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.548 -0.972 . . . . 7.0800000000000001 110.845 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 950' ' ' PHE . . . . . 0.454 ' CE1' ' HD2' ' B' ' 955' ' ' PRO . 27.9 p90 -132.74 148.17 52.33 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.586 -0.696 . . . . 7.5899999999999999 109.267 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 58.5 m -121.16 -51.92 2.09 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.452 -0.78 . . . . 5.0300000000000002 112.13 -178.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 952' ' ' LEU . . . . . 0.43 HD12 ' HA ' ' B' ' 952' ' ' LEU . 20.3 tp -60.52 -73.88 0.08 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.396 -0.815 . . . . 1.01 112.347 -177.528 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 953' ' ' ILE . . . . . 0.486 ' O ' ' HB3' ' B' ' 954' ' ' LEU . 49.3 pt -53.18 -143.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.754 0 N-CA-C 114.082 1.141 . . . . 2.6000000000000001 114.082 -176.569 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 954' ' ' LEU . . . . . 0.723 HD22 ' O ' ' B' ' 954' ' ' LEU . 0.0 OUTLIER 172.31 74.69 0.04 OUTLIER Pre-proline 0 N--CA 1.509 2.496 0 O-C-N 120.793 -1.192 . . . . 0.050000000000000003 110.955 179.68 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 955' ' ' PRO . . . . . 0.646 ' C ' HD12 ' B' ' 956' ' ' LEU . 48.1 Cg_endo -74.64 95.95 0.97 Allowed 'Trans proline' 0 C--N 1.315 -1.218 0 N-CA-C 109.714 -0.918 . . . . 0.83999999999999997 109.714 179.165 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 956' ' ' LEU . . . . . 0.646 HD12 ' C ' ' B' ' 955' ' ' PRO . 7.1 mp -125.23 149.88 47.56 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.232 -0.917 . . . . 0.040000000000000001 110.258 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -82.78 150.94 26.35 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 117.824 -1.084 . . . . 1.28 111.375 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -68.42 119.15 12.44 Favored 'General case' 0 N--CA 1.509 2.492 0 CA-C-N 122.913 2.597 . . . . 0.17000000000000001 111.389 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 93.07 -21.92 37.31 Favored Glycine 0 N--CA 1.5 2.942 0 N-CA-C 110.792 -0.923 . . . . 0.040000000000000001 110.792 178.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 960' ' ' ASP . . . . . 0.417 ' HB3' ' CZ ' ' B' ' 914' ' ' ARG . 0.3 OUTLIER -54.02 172.38 0.08 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.473 -1.016 . . . . 0.040000000000000001 110.166 -179.602 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 961' ' ' THR . . . . . 0.492 ' HA ' ' O ' ' B' ' 886' ' ' PHE . 38.8 m -135.83 139.03 43.13 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.942 -1.099 . . . . 1.78 112.338 -178.074 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 962' ' ' VAL . . . . . 0.897 HG22 ' HB3' ' B' ' 886' ' ' PHE . 32.2 m -99.09 144.02 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 C-N-CA 120.112 -0.635 . . . . 0.040000000000000001 110.032 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 5.4 t -139.37 143.88 37.93 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.682 -0.636 . . . . 0.71999999999999997 109.982 -178.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 964' ' ' VAL . . . . . 0.706 HG13 HG22 ' B' ' 911' ' ' VAL . 59.0 t -95.2 137.02 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.208 -0.933 . . . . 1.05 110.696 -179.141 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -91.51 128.43 37.34 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 103.898 -2.631 . . . . 3.02 103.898 173.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 966' ' ' LEU . . . . . 0.485 ' C ' HG23 ' B' ' 967' ' ' VAL . 1.5 tp -130.9 59.89 1.66 Allowed 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.228 -1.027 . . . . 1.46 108.228 177.345 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 967' ' ' VAL . . . . . 0.485 HG23 ' C ' ' B' ' 966' ' ' LEU . 98.3 t -158.27 96.47 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 108.08 -1.081 . . . . 1.9399999999999999 108.08 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 87.1 mmm -143.49 58.95 1.39 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.804 -1.185 . . . . 0.0 108.265 178.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 134.99 119.38 1.93 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 107.111 -2.396 . . . . 2.1099999999999999 107.111 -178.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -82.07 -58.22 3.06 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.085 -1.244 . . . . 5.8899999999999997 110.338 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 44.2 tp -58.97 90.57 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.377 -0.827 . . . . 4.3600000000000003 110.19 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -141.47 -154.63 0.53 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.589 -0.694 . . . . 1.8300000000000001 110.27 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -119.95 172.54 7.65 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.455 -0.778 . . . . 4.3499999999999996 110.275 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 38.6 t -101.56 130.02 47.77 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.525 -0.734 . . . . 1.27 109.961 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -155.99 157.74 36.7 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.474 -0.767 . . . . 5.0199999999999996 110.495 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.15 85.33 19.0 Favored Pre-proline 0 N--CA 1.5 2.05 0 O-C-N 121.633 -0.667 . . . . 2.4100000000000001 109.622 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 977' ' ' PRO . . . . . 0.601 ' C ' HD12 ' B' ' 978' ' ' LEU . 47.6 Cg_endo -72.82 -172.59 0.99 Allowed 'Trans proline' 0 C--N 1.317 -1.083 0 O-C-N 123.282 1.148 . . . . 0.95999999999999996 111.219 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 978' ' ' LEU . . . . . 0.647 HD23 HD12 ' B' ' 856' ' ' LEU . 5.9 mp -127.82 154.51 45.36 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.653 -1.24 . . . . 0.62 107.653 177.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 979' ' ' THR . . . . . 0.467 HG23 ' C ' ' B' ' 978' ' ' LEU . 42.8 p -150.03 142.08 23.96 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.842 -1.161 . . . . 3.5699999999999998 111.142 -179.277 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 980' ' ' ILE . . . . . 0.711 ' HB ' HG21 ' B' ' 899' ' ' VAL . 46.8 mm -105.99 127.4 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 108.732 -0.84 . . . . 1.3300000000000001 108.732 179.276 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 981' ' ' PHE . . . . . 0.451 ' HD1' ' HH ' ' B' ' 879' ' ' TYR . 7.3 t80 -120.0 98.0 5.88 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 119.649 -0.821 . . . . 0.050000000000000003 111.746 -178.323 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 53.8 p -108.4 158.81 17.18 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 109.154 -0.684 . . . . 0.87 109.154 178.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 983' ' ' GLY . . . . . 0.411 ' HA3' ' CE1' ' B' ' 852' ' ' PHE . . . -175.25 107.41 0.24 Allowed Glycine 0 N--CA 1.498 2.821 0 N-CA-C 106.469 -2.652 . . . . 0.029999999999999999 106.469 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -109.16 152.53 25.0 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 114.587 1.328 . . . . 0.69999999999999996 114.587 -175.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 985' ' ' LEU . . . . . 1.004 HD13 HD22 ' B' ' 890' ' ' LEU . 30.5 tp -72.24 134.1 45.43 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.93 -1.106 . . . . 0.040000000000000001 109.805 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 986' ' ' LEU . . . . . 0.524 ' CD1' HD11 ' C' ' 986' ' ' LEU . 48.1 tp -107.82 -57.79 2.05 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.541 -0.725 . . . . 0.040000000000000001 110.259 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -144.31 145.23 31.87 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.621 -1.252 . . . . 0.040000000000000001 107.621 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.49 163.07 12.2 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 108.255 -1.938 . . . . 0.040000000000000001 108.255 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -74.27 112.72 18.23 Favored Pre-proline 0 N--CA 1.498 1.956 0 O-C-N 121.204 -1.174 . . . . 0.040000000000000001 109.442 179.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 990' ' ' PRO . . . . . 0.444 ' HD2' HD12 ' B' ' 992' ' ' LEU . 50.0 Cg_endo -89.2 71.04 2.09 Favored 'Trans proline' 0 C--N 1.319 -0.985 0 O-C-N 123.093 1.049 . . . . 0.45000000000000001 111.459 -178.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 991' ' ' GLU . . . . . 0.423 ' HB2' ' O ' ' B' ' 990' ' ' PRO . 77.3 mt-10 67.0 -73.84 0.07 Allowed 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 108.603 -0.888 . . . . 1.97 108.603 -177.453 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 992' ' ' LEU . . . . . 0.451 ' HA ' HD23 ' B' ' 992' ' ' LEU . 10.6 mt 51.29 20.4 0.93 Allowed 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.614 -0.679 . . . . 2.3799999999999999 111.634 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -92.95 157.13 16.49 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.869 -1.144 . . . . 3.79 110.055 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 71.2 m80 -146.91 92.1 2.09 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.511 -0.743 . . . . 3.5099999999999998 110.329 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 995' ' ' ALA . . . . . . . . . . . . 2.52 . . . . . . . 0 N--CA 1.503 2.208 0 O-C-N 120.886 -1.134 . . . . 2.73 110.655 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo . . . . . 0 N--CA 1.488 1.154 0 N-CA-C 109.496 -1.001 . . . . 3.8300000000000001 109.496 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' C' C ' 847' ' ' VAL . . . . . 0.409 HG12 ' HB2' ' C' ' 849' ' ' GLN . 61.8 t -128.75 103.89 19.09 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.579 -0.7 . . . . 1.8300000000000001 110.093 -179.622 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 848' ' ' PRO . . . . . 0.777 ' O ' HG23 ' C' ' 850' ' ' VAL . 44.3 Cg_endo -70.34 -22.23 29.68 Favored 'Trans proline' 0 N--CA 1.488 1.185 0 O-C-N 123.285 1.15 . . . . 0.65000000000000002 111.254 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 849' ' ' GLN . . . . . 0.409 ' HB2' HG12 ' C' ' 847' ' ' VAL . 57.2 tt0 26.88 68.79 0.06 Allowed 'General case' 0 N--CA 1.519 2.998 0 N-CA-C 112.92 0.711 . . . . 2.5800000000000001 112.92 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 850' ' ' VAL . . . . . 0.777 HG23 ' O ' ' C' ' 848' ' ' PRO . 94.3 t -119.76 135.4 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.129 -0.982 . . . . 1.0900000000000001 111.57 -178.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 851' ' ' ALA . . . . . 0.592 ' HB3' ' HG ' ' C' ' 873' ' ' LEU . . . -127.86 155.53 43.98 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 105.795 -1.928 . . . . 0.040000000000000001 105.795 176.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 852' ' ' PHE . . . . . 0.454 ' CD1' ' N ' ' C' ' 852' ' ' PHE . 13.6 p90 -159.61 127.79 4.94 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 121.018 1.736 . . . . 0.050000000000000003 108.522 178.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 12.1 t -176.51 134.37 0.23 Allowed 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.246 -1.02 . . . . 0.040000000000000001 108.246 -178.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 854' ' ' ALA . . . . . 0.492 ' HB1' ' HD2' ' C' ' 868' ' ' PHE . . . -132.84 156.76 46.56 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.142 -0.974 . . . . 0.67000000000000004 109.693 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 855' ' ' ALA . . . . . 0.762 ' HB3' ' CB ' ' C' ' 870' ' ' ARG . . . -122.96 140.95 52.47 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 122.035 0.921 . . . . 0.51000000000000001 111.419 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 856' ' ' LEU . . . . . 0.618 HD13 ' N ' ' C' ' 857' ' ' SER . 3.5 tm? -113.39 137.71 51.13 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.687 -0.633 . . . . 0.050000000000000003 109.936 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 857' ' ' SER . . . . . 0.618 ' N ' HD13 ' C' ' 856' ' ' LEU . 1.9 m -157.08 19.25 0.3 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.548 -0.72 . . . . 1.3300000000000001 111.084 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 858' ' ' LEU . . . . . 0.705 HD22 ' HG3' ' C' ' 862' ' ' GLU . 4.1 pp -35.54 160.26 0.04 OUTLIER Pre-proline 0 N--CA 1.517 2.886 0 N-CA-C 112.729 0.64 . . . . 2.3300000000000001 112.729 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -59.25 -88.9 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.455 0 O-C-N 122.99 0.995 . . . . 2.3199999999999998 113.386 -177.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 54.5 ptt85 -129.26 -142.56 0.25 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.883 -1.136 . . . . 0.040000000000000001 111.635 -177.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 9.9 m -36.57 126.65 0.84 Allowed 'General case' 0 N--CA 1.51 2.536 0 O-C-N 121.61 -0.681 . . . . 1.3100000000000001 112.634 -178.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 862' ' ' GLU . . . . . 0.705 ' HG3' HD22 ' C' ' 858' ' ' LEU . 0.0 OUTLIER -100.76 159.28 30.03 Favored Pre-proline 0 N--CA 1.489 1.514 0 N-CA-C 108.177 -1.046 . . . . 4.5099999999999998 108.177 177.506 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -71.93 -14.1 29.3 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 O-C-N 123.11 1.058 . . . . 2.2400000000000002 111.523 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -177.72 -136.35 2.47 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 110.04 -1.224 . . . . 0.040000000000000001 110.04 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 25.7 m -65.37 154.85 37.17 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.355 -1.085 . . . . 1.51 110.247 -179.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 866' ' ' VAL . . . . . 0.464 ' HA ' ' HD3' ' C' ' 867' ' ' PRO . 20.7 t -95.62 138.68 21.77 Favored Pre-proline 0 N--CA 1.496 1.874 0 N-CA-C 113.917 1.08 . . . . 0.78000000000000003 113.917 -174.303 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 867' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' C' ' 866' ' ' VAL . 55.3 Cg_endo -94.07 -151.33 0.03 OUTLIER 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 121.417 1.412 . . . . 0.92000000000000004 109.002 177.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 868' ' ' PHE . . . . . 0.492 ' HD2' ' HB1' ' C' ' 854' ' ' ALA . 13.7 p90 -150.05 124.65 9.71 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.556 -1.34 . . . . 0.050000000000000003 110.036 179.117 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 50.7 p-10 -112.34 -2.79 14.7 Favored 'General case' 0 N--CA 1.5 2.044 0 C-N-CA 119.216 -0.994 . . . . 1.7 112.715 -178.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 870' ' ' ARG . . . . . 0.762 ' CB ' ' HB3' ' C' ' 855' ' ' ALA . 25.7 mmm180 -92.08 88.16 6.43 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 120.844 -1.16 . . . . 2.5899999999999999 111.36 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 65.3 t -72.45 97.09 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 120.949 -1.094 . . . . 1.9399999999999999 109.132 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 872' ' ' LEU . . . . . 0.662 HD13 HD11 ' A' ' 953' ' ' ILE . 95.0 mt -86.98 -45.42 10.79 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.572 -0.705 . . . . 1.0600000000000001 110.82 -179.345 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 873' ' ' LEU . . . . . 0.592 ' HG ' ' HB3' ' C' ' 851' ' ' ALA . 30.4 tp -172.91 101.98 0.13 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.153 -0.967 . . . . 4.1799999999999997 108.788 178.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 874' ' ' ASN . . . . . 0.439 ' CB ' ' HA ' ' C' ' 852' ' ' PHE . 32.8 t-20 176.99 82.5 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 108.833 -0.803 . . . . 0.040000000000000001 108.833 -178.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -65.15 -46.41 80.98 Favored 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 119.267 -0.973 . . . . 3.3799999999999999 111.244 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 876' ' ' GLY . . . . . 0.401 ' HA3' ' CE2' ' C' ' 878' ' ' TYR . . . -73.5 -25.65 72.0 Favored Glycine 0 N--CA 1.492 2.403 0 O-C-N 121.257 -0.902 . . . . 0.040000000000000001 111.643 -178.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 81.04 -62.22 4.47 Favored Glycine 0 N--CA 1.501 3.023 0 N-CA-C 107.769 -2.132 . . . . 0.040000000000000001 107.769 -178.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 878' ' ' TYR . . . . . 0.401 ' CE2' ' HA3' ' C' ' 876' ' ' GLY . 85.6 m-85 60.61 -66.29 0.05 Allowed 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 114.497 1.295 . . . . 3.46 114.497 177.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 879' ' ' TYR . . . . . 0.46 ' CB ' ' CD2' ' C' ' 886' ' ' PHE . 25.1 p90 -109.49 109.3 20.07 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 115.271 1.582 . . . . 0.040000000000000001 115.271 -176.094 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.03 115.82 29.38 Favored Pre-proline 0 N--CA 1.498 1.932 0 O-C-N 121.637 -0.664 . . . . 0.02 109.98 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 881' ' ' PRO . . . . . 0.464 ' HG2' ' CD1' ' C' ' 868' ' ' PHE . 53.8 Cg_endo -76.65 0.65 9.34 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 O-C-N 123.361 1.19 . . . . 0.39000000000000001 112.137 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -74.51 -66.02 0.79 Allowed 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 106.796 -1.557 . . . . 0.81000000000000005 106.796 178.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 2.6 p -95.45 -14.79 23.45 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.813 -0.81 . . . . 0.040000000000000001 108.813 177.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.14 21.98 55.82 Favored Glycine 0 N--CA 1.493 2.476 0 O-C-N 121.042 -1.036 . . . . 0.029999999999999999 111.029 178.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 68.9 t -72.9 87.98 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 C-N-CA 118.189 -1.404 . . . . 1.01 107.492 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 886' ' ' PHE . . . . . 0.927 ' HB3' HG22 ' C' ' 962' ' ' VAL . 0.9 OUTLIER -88.61 103.71 16.17 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-N 115.157 -0.929 . . . . 0.050000000000000003 112.038 -177.075 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 887' ' ' THR . . . . . 0.432 ' O ' ' HD3' ' C' ' 889' ' ' PRO . 88.5 m -99.28 100.24 11.3 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.834 -1.172 . . . . 0.68000000000000005 107.834 177.511 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 888' ' ' ALA . . . . . . . . . . . . . . . -99.05 102.63 16.07 Favored Pre-proline 0 N--CA 1.502 2.158 0 N-CA-C 114.505 1.298 . . . . 0.25 114.505 -176.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 889' ' ' PRO . . . . . 0.432 ' HD3' ' O ' ' C' ' 887' ' ' THR . 55.9 Cg_endo -83.6 -15.37 7.37 Favored 'Trans proline' 0 CA--C 1.545 1.061 0 N-CA-C 108.827 -1.259 . . . . 1.6399999999999999 108.827 175.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 890' ' ' LEU . . . . . 0.646 HD21 HG11 ' C' ' 850' ' ' VAL . 65.7 mt -38.09 -48.78 1.26 Allowed 'General case' 0 N--CA 1.508 2.45 0 N-CA-C 113.389 0.885 . . . . 2.29 113.389 -177.492 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 53.28 97.55 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.182 -0.949 . . . . 0.63 110.248 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . 158.83 -155.4 26.46 Favored Glycine 0 N--CA 1.476 1.364 0 N-CA-C 107.12 -2.392 . . . . 0.040000000000000001 107.12 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 74.5 ttt-85 -116.33 125.11 51.66 Favored 'General case' 0 C--N 1.295 -1.803 0 O-C-N 121.537 -0.978 . . . . 3.0 108.855 177.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 894' ' ' TYR . . . . . 0.716 ' CE2' HD23 ' C' ' 954' ' ' LEU . 20.5 p90 -133.35 156.41 47.68 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.083 -1.011 . . . . 0.040000000000000001 111.237 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 895' ' ' LEU . . . . . . . . . . . . . 48.1 tp -99.06 117.13 32.87 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.733 -0.604 . . . . 1.27 110.043 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 896' ' ' LEU . . . . . 0.539 HD11 ' HE1' ' C' ' 981' ' ' PHE . 9.6 tt -120.85 144.51 48.33 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.638 -0.664 . . . . 0.93999999999999995 109.787 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 897' ' ' SER . . . . . . . . . . . . . 19.5 m -141.9 123.97 15.44 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.383 -0.823 . . . . 0.040000000000000001 111.226 -179.215 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -100.55 148.26 24.99 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.731 -0.84 . . . . 0.47999999999999998 108.731 178.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 899' ' ' VAL . . . . . 0.683 HG21 ' HB ' ' C' ' 980' ' ' ILE . 93.8 t -91.47 120.26 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 C-N-CA 119.66 -0.816 . . . . 0.55000000000000004 111.023 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 86.7 mt -92.95 112.1 23.94 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 114.011 1.115 . . . . 1.5900000000000001 114.011 -175.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 23.7 m -63.11 140.3 58.86 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 107.474 -1.306 . . . . 0.050000000000000003 107.474 177.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -61.05 -64.93 3.64 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.209 -1.156 . . . . 0.029999999999999999 110.209 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 45.08 64.01 1.54 Allowed 'General case' 0 N--CA 1.507 2.406 0 O-C-N 121.623 -0.927 . . . . 3.2000000000000002 111.36 179.466 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 54.4 ptt85 -67.66 -7.88 30.37 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.586 -0.696 . . . . 2.9199999999999999 111.783 -179.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 905' ' ' HIS . . . . . 0.497 ' O ' ' CB ' ' C' ' 906' ' ' GLU . 69.5 t60 -63.06 6.61 0.1 Allowed 'General case' 0 N--CA 1.504 2.266 0 CA-C-O 117.599 -1.191 . . . . 2.8700000000000001 113.412 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 906' ' ' GLU . . . . . 0.497 ' CB ' ' O ' ' C' ' 905' ' ' HIS . 0.7 OUTLIER 93.46 -163.01 0.0 OUTLIER 'General case' 0 N--CA 1.529 3.52 0 CA-C-N 121.299 1.863 . . . . 0.98999999999999999 112.1 179.083 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 907' ' ' LYS . . . . . 0.495 ' CB ' ' O ' ' C' ' 906' ' ' GLU . 57.9 tttt 90.01 160.78 0.05 OUTLIER 'General case' 0 N--CA 1.521 3.11 0 N-CA-C 107.967 -1.123 . . . . 5.25 107.967 -176.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 62.0 t -122.31 116.02 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 120.888 -1.132 . . . . 0.39000000000000001 110.806 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -103.84 130.22 51.38 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 107.209 -1.404 . . . . 1.72 107.209 176.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -157.2 120.29 4.04 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 106.916 -1.513 . . . . 0.67000000000000004 106.916 178.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 911' ' ' VAL . . . . . 0.784 HG23 HG22 ' C' ' 964' ' ' VAL . 12.3 p -80.65 131.21 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 C-N-CA 120.248 -0.581 . . . . 0.54000000000000004 111.463 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 60.5 mt -67.32 156.39 36.55 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.28 -0.887 . . . . 1.5 108.618 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 913' ' ' SER . . . . . 0.414 ' CB ' ' CG1' ' C' ' 919' ' ' VAL . 2.4 t -125.27 136.44 53.52 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.589 -0.893 . . . . 1.3700000000000001 108.589 177.334 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 914' ' ' ARG . . . . . 0.837 ' NH1' HD13 ' C' ' 956' ' ' LEU . 0.0 OUTLIER -63.41 154.6 31.58 Favored 'General case' 0 N--CA 1.505 2.308 0 O-C-N 120.685 -1.26 . . . . 4.2999999999999998 111.499 -179.095 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 915' ' ' SER . . . . . 0.417 ' CB ' ' O ' ' C' ' 914' ' ' ARG . 1.7 p 83.58 -30.77 0.08 Allowed 'General case' 0 N--CA 1.521 3.101 0 C-N-CA 123.907 0.883 . . . . 2.0499999999999998 111.999 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 916' ' ' ASN . . . . . 0.792 ' HB2' HG21 ' C' ' 919' ' ' VAL . 93.9 m-20 -122.87 -21.96 5.41 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 120.967 -1.083 . . . . 2.71 111.309 -179.212 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 67.17 165.93 0.22 Allowed 'General case' 0 N--CA 1.521 3.08 0 N-CA-C 105.614 -1.995 . . . . 2.6800000000000002 105.614 -174.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.74 -125.64 35.58 Favored Glycine 1 N--CA 1.521 4.32 0 CA-C-N 123.688 2.949 . . . . 0.029999999999999999 107.026 -177.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 919' ' ' VAL . . . . . 0.792 HG21 ' HB2' ' C' ' 916' ' ' ASN . 96.8 t 50.4 94.2 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.212 0 O-C-N 121.444 -1.033 . . . . 1.3899999999999999 109.397 -178.341 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 920' ' ' ALA . . . . . 0.859 ' HB3' HG12 ' C' ' 949' ' ' VAL . . . -94.38 94.67 8.4 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.476 -0.89 . . . . 0.029999999999999999 110.661 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 921' ' ' ARG . . . . . 0.729 ' HG3' HG23 ' C' ' 922' ' ' VAL . 23.9 ptt85 -80.61 -41.81 23.31 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 105.792 -1.929 . . . . 4.4199999999999999 105.792 176.298 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 922' ' ' VAL . . . . . 0.729 HG23 ' HG3' ' C' ' 921' ' ' ARG . 86.3 t -99.37 78.31 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 N-CA-C 105.705 -1.961 . . . . 0.84999999999999998 105.705 175.187 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -90.73 135.53 33.66 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.836 0.827 . . . . 2.46 112.26 -176.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 9.0 t -147.23 103.32 3.57 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.053 -1.092 . . . . 0.69999999999999996 108.053 178.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -109.81 89.49 0.55 Allowed Glycine 0 N--CA 1.488 2.108 0 N-CA-C 108.97 -1.652 . . . . 0.040000000000000001 108.97 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.387 0 N-CA-C 109.265 -1.534 . . . . 0.040000000000000001 109.265 -179.633 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 10.7 m . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 120.971 0.415 . . . . 13.779999999999999 110.336 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 93.3 mt -114.16 129.87 56.61 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.536 -0.727 . . . . 13.76 110.275 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -152.52 170.6 31.71 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.463 -1.455 . . . . 9.1300000000000008 109.463 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 949' ' ' VAL . . . . . 0.859 HG12 ' HB3' ' C' ' 920' ' ' ALA . 34.8 m -116.69 137.52 50.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.563 -0.963 . . . . 7.0800000000000001 110.829 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 950' ' ' PHE . . . . . 0.485 ' CB ' HD11 ' C' ' 953' ' ' ILE . 51.7 p90 -134.35 151.39 51.2 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.509 -0.744 . . . . 7.5899999999999999 109.558 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 22.3 m -116.59 -60.07 1.89 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.415 -0.803 . . . . 5.0300000000000002 111.625 -179.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 952' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' C' ' 953' ' ' ILE . 53.1 tp -63.1 -75.25 0.08 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.415 -0.803 . . . . 1.01 111.276 -178.517 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 953' ' ' ILE . . . . . 0.543 HD12 ' HD3' ' C' ' 955' ' ' PRO . 1.8 pp -47.94 -154.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.768 0 N-CA-C 114.487 1.291 . . . . 2.6000000000000001 114.487 -177.053 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 954' ' ' LEU . . . . . 0.716 HD23 ' CE2' ' C' ' 894' ' ' TYR . 0.0 OUTLIER 170.44 85.63 0.04 OUTLIER Pre-proline 0 N--CA 1.514 2.764 0 O-C-N 120.869 -1.144 . . . . 0.050000000000000003 111.922 179.871 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 955' ' ' PRO . . . . . 0.543 ' HD3' HD12 ' C' ' 953' ' ' ILE . 52.6 Cg_endo -77.13 92.39 1.12 Allowed 'Trans proline' 0 N--CA 1.488 1.162 0 N-CA-C 109.131 -1.142 . . . . 0.83999999999999997 109.131 178.626 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 956' ' ' LEU . . . . . 0.837 HD13 ' NH1' ' C' ' 914' ' ' ARG . 89.6 mt -127.94 149.79 50.17 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.086 -1.009 . . . . 0.040000000000000001 110.703 -179.287 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 957' ' ' GLN . . . . . 0.411 ' HB2' ' HB2' ' C' ' 960' ' ' ASP . 33.3 mt-30 -84.87 153.67 22.75 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 117.994 -1.003 . . . . 1.28 111.634 -179.04 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -67.45 120.44 13.92 Favored 'General case' 0 N--CA 1.508 2.469 0 CA-C-N 122.542 2.428 . . . . 0.17000000000000001 111.471 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.89 -18.86 54.88 Favored Glycine 0 N--CA 1.501 3.003 0 O-C-N 121.52 -0.738 . . . . 0.040000000000000001 111.278 178.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 960' ' ' ASP . . . . . 0.454 ' HB3' ' NE ' ' C' ' 914' ' ' ARG . 0.6 OUTLIER -51.64 172.12 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.369 -1.077 . . . . 0.040000000000000001 110.717 -179.222 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 961' ' ' THR . . . . . 0.492 ' HA ' ' O ' ' C' ' 886' ' ' PHE . 7.4 t -135.61 137.58 42.06 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.092 -1.005 . . . . 1.78 112.141 -178.32 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 962' ' ' VAL . . . . . 0.927 HG22 ' HB3' ' C' ' 886' ' ' PHE . 23.6 m -99.99 146.06 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 C-N-CA 120.031 -0.668 . . . . 0.040000000000000001 110.497 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 5.2 t -139.15 144.75 38.75 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.785 -0.572 . . . . 0.71999999999999997 110.028 -178.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 964' ' ' VAL . . . . . 0.784 HG22 HG23 ' C' ' 911' ' ' VAL . 57.8 t -94.96 137.39 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.108 -0.995 . . . . 1.05 110.627 -179.074 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -94.09 126.72 39.48 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 104.068 -2.568 . . . . 3.02 104.068 173.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 966' ' ' LEU . . . . . 0.488 ' C ' HG23 ' C' ' 967' ' ' VAL . 0.1 OUTLIER -132.92 60.09 1.71 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.29 -1.004 . . . . 1.46 108.29 177.398 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 967' ' ' VAL . . . . . 0.488 HG23 ' C ' ' C' ' 966' ' ' LEU . 96.1 t -157.82 96.31 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 108.258 -1.016 . . . . 1.9399999999999999 108.258 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 92.0 mmm -142.74 58.77 1.43 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.748 -1.22 . . . . 0.0 108.382 179.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 134.41 119.38 1.96 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 107.192 -2.363 . . . . 2.1099999999999999 107.192 -178.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -82.18 -58.38 2.97 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.015 -1.285 . . . . 5.8899999999999997 110.591 -179.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 45.1 tp -59.29 90.01 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.445 -0.784 . . . . 4.3600000000000003 110.209 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -142.33 -152.55 0.42 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.613 -0.68 . . . . 1.8300000000000001 110.208 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -116.41 167.47 11.01 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.438 -0.789 . . . . 4.3499999999999996 110.068 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 29.5 t -101.89 130.4 48.36 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.548 -0.72 . . . . 1.27 110.129 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -156.29 155.64 32.66 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.507 -0.745 . . . . 5.0199999999999996 110.459 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.29 85.08 18.86 Favored Pre-proline 0 N--CA 1.5 2.043 0 O-C-N 121.627 -0.671 . . . . 2.4100000000000001 109.642 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 977' ' ' PRO . . . . . 0.488 ' C ' HD12 ' C' ' 978' ' ' LEU . 49.5 Cg_endo -74.8 -171.47 0.97 Allowed 'Trans proline' 0 C--N 1.317 -1.113 0 O-C-N 123.356 1.188 . . . . 0.95999999999999996 111.331 -179.323 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 978' ' ' LEU . . . . . 0.488 HD12 ' C ' ' C' ' 977' ' ' PRO . 5.5 mp -125.21 156.38 38.56 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.542 -1.281 . . . . 0.62 107.542 177.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 979' ' ' THR . . . . . 0.445 HG23 ' C ' ' C' ' 978' ' ' LEU . 43.2 p -149.42 141.6 24.03 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.822 -1.174 . . . . 3.5699999999999998 111.184 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 980' ' ' ILE . . . . . 0.683 ' HB ' HG21 ' C' ' 899' ' ' VAL . 50.2 mm -106.89 128.27 61.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 108.948 -0.76 . . . . 1.3300000000000001 108.948 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 981' ' ' PHE . . . . . 0.539 ' HE1' HD11 ' C' ' 896' ' ' LEU . 3.4 t80 -117.53 97.56 5.94 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.428 -0.795 . . . . 0.050000000000000003 111.564 -178.47 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 982' ' ' SER . . . . . . . . . . . . . 34.5 p -107.2 158.25 17.25 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 109.042 -0.725 . . . . 0.87 109.042 178.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 983' ' ' GLY . . . . . 0.419 ' O ' ' CZ ' ' C' ' 852' ' ' PHE . . . -173.06 113.7 0.48 Allowed Glycine 0 N--CA 1.497 2.727 0 N-CA-C 106.644 -2.582 . . . . 0.029999999999999999 106.644 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 984' ' ' ALA . . . . . 0.4 ' CB ' ' CZ ' ' A' ' 893' ' ' ARG . . . -109.11 152.38 25.15 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 114.319 1.229 . . . . 0.69999999999999996 114.319 -175.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 985' ' ' LEU . . . . . 0.556 HD13 HD22 ' C' ' 890' ' ' LEU . 52.1 tp -75.89 135.75 40.13 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.871 -1.143 . . . . 0.040000000000000001 109.691 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 986' ' ' LEU . . . . . 0.524 HD11 ' CD1' ' B' ' 986' ' ' LEU . 40.7 tp -106.26 -62.63 1.36 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.442 -0.786 . . . . 0.040000000000000001 110.299 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -144.7 146.78 32.38 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.753 -1.203 . . . . 0.040000000000000001 107.753 179.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -111.91 162.67 12.35 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 108.079 -2.008 . . . . 0.040000000000000001 108.079 179.051 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -73.7 112.86 18.05 Favored Pre-proline 0 N--CA 1.499 1.999 0 O-C-N 121.23 -1.159 . . . . 0.040000000000000001 109.44 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 990' ' ' PRO . . . . . 0.435 ' HD2' HD12 ' C' ' 992' ' ' LEU . 51.1 Cg_endo -88.08 70.83 2.88 Favored 'Trans proline' 0 C--N 1.319 -0.984 0 O-C-N 123.201 1.106 . . . . 0.45000000000000001 111.408 -179.017 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 991' ' ' GLU . . . . . 0.421 ' HB2' ' O ' ' C' ' 990' ' ' PRO . 80.6 mt-10 67.14 -73.65 0.08 Allowed 'General case' 0 N--CA 1.502 2.148 0 N-CA-C 108.645 -0.872 . . . . 1.97 108.645 -177.478 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 992' ' ' LEU . . . . . 0.435 HD12 ' HD2' ' C' ' 990' ' ' PRO . 11.1 mt 50.86 20.91 0.85 Allowed 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.62 -0.675 . . . . 2.3799999999999999 111.58 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -92.43 156.91 16.88 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.991 -1.068 . . . . 3.79 110.042 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -146.66 91.62 2.05 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.567 -0.708 . . . . 3.5099999999999998 110.245 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 995' ' ' ALA . . . . . . . . . . . . 2.518 . . . . . . . 0 N--CA 1.503 2.213 0 O-C-N 120.983 -1.073 . . . . 2.73 110.646 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo . . . . . 0 N--CA 1.488 1.154 0 N-CA-C 109.497 -1.001 . . . . 3.8300000000000001 109.497 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 847' ' ' VAL . . . . . . . . . . . . . 63.4 t -135.3 102.68 10.68 Favored Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 121.504 -0.747 . . . . 1.8300000000000001 110.04 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 848' ' ' PRO . . . . . 0.744 ' O ' HG23 ' A' ' 850' ' ' VAL . 44.3 Cg_endo -69.94 -18.12 36.35 Favored 'Trans proline' 0 N--CA 1.488 1.161 0 O-C-N 123.308 1.162 . . . . 0.65000000000000002 111.196 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 849' ' ' GLN . . . . . 0.4 ' C ' ' O ' ' A' ' 848' ' ' PRO . 56.4 tt0 28.07 69.42 0.07 Allowed 'General case' 0 N--CA 1.518 2.96 0 N-CA-C 112.837 0.68 . . . . 2.5800000000000001 112.837 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 850' ' ' VAL . . . . . 0.744 HG23 ' O ' ' A' ' 848' ' ' PRO . 64.8 t -120.38 137.5 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 121.216 -0.927 . . . . 1.0900000000000001 111.7 -178.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 851' ' ' ALA . . . . . 0.562 ' HB3' ' HG ' ' A' ' 873' ' ' LEU . . . -125.94 159.18 33.29 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 105.909 -1.885 . . . . 0.040000000000000001 105.909 176.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 852' ' ' PHE . . . . . 0.434 ' HA ' ' CB ' ' A' ' 874' ' ' ASN . 48.1 p90 -158.73 130.72 6.67 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 121.075 1.762 . . . . 0.050000000000000003 108.864 178.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 46.9 t -175.5 134.05 0.3 Allowed 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.209 -1.034 . . . . 0.040000000000000001 108.209 -179.115 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 854' ' ' ALA . . . . . 0.49 ' HB1' ' HD2' ' A' ' 868' ' ' PHE . . . -133.55 155.09 50.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.091 -1.006 . . . . 0.67000000000000004 109.498 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 855' ' ' ALA . . . . . 0.745 ' HB3' ' CB ' ' A' ' 870' ' ' ARG . . . -124.1 142.7 50.97 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.973 0.892 . . . . 0.51000000000000001 111.651 -179.005 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 856' ' ' LEU . . . . . 0.765 HD12 HD23 ' A' ' 978' ' ' LEU . 3.3 tm? -111.62 137.88 48.91 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.717 -0.614 . . . . 0.050000000000000003 110.214 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 857' ' ' SER . . . . . 0.66 ' N ' HD13 ' A' ' 856' ' ' LEU . 76.5 p -155.48 15.41 0.38 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.594 -0.691 . . . . 1.3300000000000001 111.466 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 858' ' ' LEU . . . . . 0.535 HD12 ' C ' ' A' ' 858' ' ' LEU . 4.3 pp -36.51 160.65 0.05 OUTLIER Pre-proline 0 N--CA 1.515 2.822 0 CA-C-N 118.799 0.727 . . . . 2.3300000000000001 112.581 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -59.68 -89.16 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.491 0 O-C-N 123.005 1.003 . . . . 2.3199999999999998 114.016 -177.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 54.3 ptt85 -128.08 -144.58 0.29 Allowed 'General case' 0 N--CA 1.502 2.137 0 O-C-N 120.774 -1.204 . . . . 0.040000000000000001 112.394 -177.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 69.7 m -33.91 127.56 0.4 Allowed 'General case' 0 N--CA 1.511 2.604 0 N-CA-C 112.987 0.736 . . . . 1.3100000000000001 112.987 -178.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 862' ' ' GLU . . . . . 0.456 ' HG3' HD22 ' A' ' 858' ' ' LEU . 0.0 OUTLIER -102.67 158.22 32.19 Favored Pre-proline 0 N--CA 1.489 1.477 0 N-CA-C 108.288 -1.004 . . . . 4.5099999999999998 108.288 177.457 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.27 -13.39 25.61 Favored 'Trans proline' 0 C--N 1.315 -1.236 0 O-C-N 123.069 1.036 . . . . 2.2400000000000002 111.687 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -177.55 -135.1 2.15 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 110.06 -1.216 . . . . 0.040000000000000001 110.06 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 28.4 m -67.58 151.21 47.7 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.382 -1.07 . . . . 1.51 109.923 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 866' ' ' VAL . . . . . 0.497 HG13 ' CD2' ' A' ' 858' ' ' LEU . 33.4 t -94.67 139.67 22.34 Favored Pre-proline 0 N--CA 1.496 1.869 0 N-CA-C 113.764 1.024 . . . . 0.78000000000000003 113.764 -174.527 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 867' ' ' PRO . . . . . 0.486 ' HD3' ' HA ' ' A' ' 866' ' ' VAL . 55.3 Cg_endo -91.96 -151.31 0.04 OUTLIER 'Trans proline' 0 CA--C 1.544 0.999 0 O-C-N 123.673 1.354 . . . . 0.92000000000000004 109.275 177.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 868' ' ' PHE . . . . . 0.49 ' HD2' ' HB1' ' A' ' 854' ' ' ALA . 20.1 p90 -151.1 124.16 8.73 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.662 -1.274 . . . . 0.050000000000000003 109.806 179.173 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 50.5 p-10 -113.75 -2.17 13.77 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.226 -0.921 . . . . 1.7 112.731 -178.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 870' ' ' ARG . . . . . 0.745 ' CB ' ' HB3' ' A' ' 855' ' ' ALA . 28.8 mmm180 -90.64 90.08 7.81 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.883 -1.135 . . . . 2.5899999999999999 110.944 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 60.3 t -72.3 96.48 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 120.998 -1.064 . . . . 1.9399999999999999 109.944 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 872' ' ' LEU . . . . . 0.546 HD11 ' HB2' ' A' ' 855' ' ' ALA . 96.9 mt -83.09 -47.35 11.75 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.495 -0.753 . . . . 1.0600000000000001 110.188 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 873' ' ' LEU . . . . . 0.562 ' HG ' ' HB3' ' A' ' 851' ' ' ALA . 44.3 tp -174.61 103.51 0.1 Allowed 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 108.729 -0.841 . . . . 4.1799999999999997 108.729 178.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 874' ' ' ASN . . . . . 0.434 ' CB ' ' HA ' ' A' ' 852' ' ' PHE . 33.3 t-20 177.92 81.74 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.31 0 O-C-N 121.681 -0.637 . . . . 0.040000000000000001 109.301 -178.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -66.33 -47.27 74.04 Favored 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 119.317 -0.953 . . . . 3.3799999999999999 111.143 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 876' ' ' GLY . . . . . 0.41 ' HA3' ' CE2' ' A' ' 878' ' ' TYR . . . -74.53 -24.68 72.12 Favored Glycine 0 N--CA 1.494 2.552 0 O-C-N 121.309 -0.87 . . . . 0.040000000000000001 111.546 -178.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 82.22 -61.95 4.63 Favored Glycine 0 N--CA 1.501 2.973 0 N-CA-C 108.005 -2.038 . . . . 0.040000000000000001 108.005 -178.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 878' ' ' TYR . . . . . 0.41 ' CE2' ' HA3' ' A' ' 876' ' ' GLY . 97.9 m-85 60.91 -62.25 0.07 Allowed 'General case' 0 N--CA 1.503 2.211 0 N-CA-C 114.542 1.312 . . . . 3.46 114.542 177.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 879' ' ' TYR . . . . . 0.484 ' CB ' ' CD2' ' A' ' 886' ' ' PHE . 18.2 p90 -110.63 109.7 20.09 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 114.849 1.426 . . . . 0.040000000000000001 114.849 -176.085 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -68.05 115.55 29.7 Favored Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 121.405 -0.809 . . . . 0.02 109.971 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 881' ' ' PRO . . . . . 0.457 ' HG2' ' CD1' ' A' ' 868' ' ' PHE . 55.2 Cg_endo -75.93 0.6 9.09 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 O-C-N 123.39 1.205 . . . . 0.39000000000000001 112.309 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -76.92 -62.27 1.7 Allowed 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 106.617 -1.623 . . . . 0.81000000000000005 106.617 178.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 883' ' ' THR . . . . . 0.575 ' OG1' HG23 ' A' ' 885' ' ' VAL . 64.4 p -94.49 -19.27 20.69 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.617 -0.882 . . . . 0.040000000000000001 108.617 177.308 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.66 19.77 59.36 Favored Glycine 0 N--CA 1.496 2.677 0 O-C-N 121.064 -1.022 . . . . 0.029999999999999999 111.237 178.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 885' ' ' VAL . . . . . 0.575 HG23 ' OG1' ' A' ' 883' ' ' THR . 95.9 t -74.25 89.0 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 C-N-CA 118.141 -1.424 . . . . 1.01 108.302 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 886' ' ' PHE . . . . . 0.905 ' HB3' HG22 ' A' ' 962' ' ' VAL . 1.0 OUTLIER -88.23 105.43 17.53 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 115.306 -0.861 . . . . 0.050000000000000003 111.52 -177.674 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 887' ' ' THR . . . . . 0.429 ' O ' ' HD3' ' A' ' 889' ' ' PRO . 93.1 m -95.43 99.95 11.79 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 107.856 -1.165 . . . . 0.68000000000000005 107.856 177.527 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 888' ' ' ALA . . . . . . . . . . . . . . . -98.85 106.4 37.27 Favored Pre-proline 0 N--CA 1.5 2.039 0 N-CA-C 114.124 1.157 . . . . 0.25 114.124 -176.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 889' ' ' PRO . . . . . 0.429 ' HD3' ' O ' ' A' ' 887' ' ' THR . 54.1 Cg_endo -89.07 -12.39 3.37 Favored 'Trans proline' 0 CA--C 1.546 1.1 0 N-CA-C 108.92 -1.223 . . . . 1.6399999999999999 108.92 176.084 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 890' ' ' LEU . . . . . 0.856 HD22 HD13 ' A' ' 985' ' ' LEU . 76.7 mt -36.11 -50.73 0.72 Allowed 'General case' 0 N--CA 1.508 2.447 0 N-CA-C 113.592 0.96 . . . . 2.29 113.592 -177.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 52.35 95.55 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.236 -0.915 . . . . 0.63 110.195 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 157.67 -153.64 24.83 Favored Glycine 0 N--CA 1.477 1.427 0 N-CA-C 107.111 -2.396 . . . . 0.040000000000000001 107.111 -179.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 71.4 ttt-85 -115.79 126.89 54.6 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 121.557 -0.967 . . . . 3.0 108.539 177.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 894' ' ' TYR . . . . . 0.762 ' OH ' HD12 ' A' ' 896' ' ' LEU . 0.1 OUTLIER -132.24 160.49 36.02 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.11 -0.994 . . . . 0.040000000000000001 111.081 -179.939 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 895' ' ' LEU . . . . . 0.506 HD23 HD11 ' B' ' 952' ' ' LEU . 35.0 tp -90.71 119.08 30.65 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.401 0.62 . . . . 1.27 110.029 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 896' ' ' LEU . . . . . 0.762 HD12 ' OH ' ' A' ' 894' ' ' TYR . 9.5 tt -109.42 143.21 39.32 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.774 -0.579 . . . . 0.93999999999999995 110.2 -179.396 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 897' ' ' SER . . . . . 0.505 ' N ' HD23 ' A' ' 896' ' ' LEU . 67.8 m -149.0 115.1 5.76 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.482 -0.761 . . . . 0.040000000000000001 111.018 -179.573 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -108.1 146.77 32.16 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 109.07 -0.715 . . . . 0.47999999999999998 109.07 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 899' ' ' VAL . . . . . 0.748 HG21 ' HB ' ' A' ' 980' ' ' ILE . 87.7 t -95.7 119.72 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 C-N-CA 119.63 -0.828 . . . . 0.55000000000000004 111.279 -179.347 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 900' ' ' LEU . . . . . 0.511 HD12 ' HB2' ' A' ' 924' ' ' SER . 4.5 mm? -96.04 112.22 24.02 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 114.384 1.253 . . . . 1.5900000000000001 114.384 -175.05 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 11.8 m -66.28 141.29 58.06 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 107.53 -1.285 . . . . 0.050000000000000003 107.53 176.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -66.72 -66.13 2.51 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 110.573 -1.011 . . . . 0.029999999999999999 110.573 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 11.8 m170 46.91 67.02 0.85 Allowed 'General case' 0 N--CA 1.508 2.438 0 O-C-N 121.476 -1.014 . . . . 3.2000000000000002 111.151 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 43.3 ptt85 -69.71 -5.65 26.47 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.608 -0.683 . . . . 2.9199999999999999 112.063 -179.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 905' ' ' HIS . . . . . 0.486 ' O ' ' CB ' ' A' ' 906' ' ' GLU . 73.8 t60 -62.83 5.32 0.13 Allowed 'General case' 0 N--CA 1.506 2.365 0 O-C-N 120.9 -1.125 . . . . 2.8700000000000001 113.111 -179.243 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 906' ' ' GLU . . . . . 0.486 ' CB ' ' O ' ' A' ' 905' ' ' HIS . 0.8 OUTLIER 94.86 -164.48 0.0 OUTLIER 'General case' 0 N--CA 1.529 3.478 0 CA-C-N 120.552 1.524 . . . . 0.98999999999999999 111.899 178.944 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 907' ' ' LYS . . . . . 0.46 ' CB ' ' O ' ' A' ' 906' ' ' GLU . 68.4 tttt 85.78 157.56 0.09 Allowed 'General case' 0 N--CA 1.519 3.019 0 N-CA-C 108.156 -1.053 . . . . 5.25 108.156 -177.059 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 60.1 t -121.68 117.08 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 120.756 -1.215 . . . . 0.39000000000000001 111.312 -179.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 71.2 tt0 -100.03 132.77 45.19 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 107.041 -1.466 . . . . 1.72 107.041 176.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -155.09 123.27 5.88 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 106.805 -1.554 . . . . 0.67000000000000004 106.805 178.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 911' ' ' VAL . . . . . 0.842 HG22 HG13 ' A' ' 964' ' ' VAL . 87.5 t -83.6 131.14 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 C-N-CA 120.52 -0.472 . . . . 0.54000000000000004 110.68 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 86.2 mt -66.34 156.01 35.68 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.333 -0.855 . . . . 1.5 109.264 178.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 913' ' ' SER . . . . . 0.474 ' OG ' HG11 ' A' ' 919' ' ' VAL . 0.1 OUTLIER -127.48 133.87 49.86 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 107.542 -1.281 . . . . 1.3700000000000001 107.542 176.547 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 914' ' ' ARG . . . . . 0.578 HH11 HG13 ' A' ' 962' ' ' VAL . 0.0 OUTLIER -64.95 158.41 25.49 Favored 'General case' 0 N--CA 1.506 2.373 0 O-C-N 120.558 -1.339 . . . . 4.2999999999999998 112.119 -178.491 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 915' ' ' SER . . . . . 0.439 ' CB ' ' O ' ' A' ' 914' ' ' ARG . 4.6 t 84.39 -32.09 0.07 Allowed 'General case' 0 N--CA 1.522 3.153 0 C-N-CA 124.164 0.985 . . . . 2.0499999999999998 111.943 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 916' ' ' ASN . . . . . 0.785 ' HB2' HG21 ' A' ' 919' ' ' VAL . 98.9 m-20 -123.88 -21.32 5.16 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.899 -1.126 . . . . 2.71 111.352 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 917' ' ' GLN . . . . . 0.405 ' HB2' ' O ' ' A' ' 916' ' ' ASN . 45.6 mt-30 66.67 166.39 0.21 Allowed 'General case' 0 N--CA 1.52 3.073 0 N-CA-C 105.637 -1.986 . . . . 2.6800000000000002 105.637 -174.072 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 52.93 -124.07 26.32 Favored Glycine 1 N--CA 1.523 4.46 0 CA-C-N 123.383 2.811 . . . . 0.029999999999999999 106.895 -177.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 919' ' ' VAL . . . . . 0.785 HG21 ' HB2' ' A' ' 916' ' ' ASN . 52.1 t 52.22 93.9 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 121.337 -1.096 . . . . 1.3899999999999999 108.96 -178.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 920' ' ' ALA . . . . . 0.816 ' HB3' HG12 ' A' ' 949' ' ' VAL . . . -91.75 91.28 7.89 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 119.402 -0.919 . . . . 0.029999999999999999 110.917 -178.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 921' ' ' ARG . . . . . 0.721 ' HG3' HG23 ' A' ' 922' ' ' VAL . 17.3 ptt180 -86.64 -42.24 13.59 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 106.104 -1.813 . . . . 4.4199999999999999 106.104 176.098 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 922' ' ' VAL . . . . . 0.721 HG23 ' HG3' ' A' ' 921' ' ' ARG . 76.7 t -104.29 67.09 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 105.846 -1.909 . . . . 0.84999999999999998 105.846 175.546 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 923' ' ' ASP . . . . . 0.659 ' HB2' ' HB1' ' A' ' 920' ' ' ALA . 25.6 t0 -86.58 134.18 33.66 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.684 0.755 . . . . 2.46 111.459 -177.504 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 924' ' ' SER . . . . . 0.511 ' HB2' HD12 ' A' ' 900' ' ' LEU . 39.7 t -147.7 106.18 3.79 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.669 -0.863 . . . . 0.69999999999999996 108.669 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -101.76 84.74 0.52 Allowed Glycine 0 N--CA 1.486 1.995 0 N-CA-C 108.304 -1.918 . . . . 0.040000000000000001 108.304 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.21 0 N-CA-C 108.877 -1.689 . . . . 0.040000000000000001 108.877 -179.537 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 26.0 m . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.033 0.444 . . . . 13.779999999999999 110.313 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 95.7 mt -112.38 130.88 55.81 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.544 -0.723 . . . . 13.76 110.301 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -151.36 168.25 30.87 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.107 -1.597 . . . . 9.1300000000000008 109.107 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 949' ' ' VAL . . . . . 0.816 HG12 ' HB3' ' A' ' 920' ' ' ALA . 29.8 m -119.11 127.08 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.5 -1.0 . . . . 7.0800000000000001 111.019 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 950' ' ' PHE . . . . . 0.458 ' CZ ' ' HB3' ' A' ' 921' ' ' ARG . 27.1 p90 -133.71 149.28 51.5 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.623 -0.673 . . . . 7.5899999999999999 109.237 179.212 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 29.1 m -121.27 -51.51 2.09 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.359 -0.838 . . . . 5.0300000000000002 112.191 -178.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 952' ' ' LEU . . . . . 0.418 ' O ' ' O ' ' A' ' 953' ' ' ILE . 14.6 tp -59.4 -73.88 0.08 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.369 -0.832 . . . . 1.01 112.705 -177.277 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 953' ' ' ILE . . . . . 0.582 HD11 HD13 ' C' ' 872' ' ' LEU . 45.8 pt -52.29 -144.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.848 0 N-CA-C 114.417 1.266 . . . . 2.6000000000000001 114.417 -176.29 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 954' ' ' LEU . . . . . 0.717 HD22 ' O ' ' A' ' 954' ' ' LEU . 0.0 OUTLIER 173.21 75.01 0.04 OUTLIER Pre-proline 0 N--CA 1.507 2.417 0 O-C-N 120.779 -1.201 . . . . 0.050000000000000003 110.869 -179.974 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 955' ' ' PRO . . . . . 0.755 ' C ' HD12 ' A' ' 956' ' ' LEU . 49.6 Cg_endo -77.11 95.51 1.07 Allowed 'Trans proline' 0 C--N 1.316 -1.143 0 O-C-N 122.716 0.85 . . . . 0.83999999999999997 110.2 179.38 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 956' ' ' LEU . . . . . 0.755 HD12 ' C ' ' A' ' 955' ' ' PRO . 8.9 mp -125.83 151.12 47.23 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.237 -0.915 . . . . 0.040000000000000001 110.257 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -82.19 150.92 27.13 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-O 117.734 -1.127 . . . . 1.28 111.311 -178.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -68.33 119.47 12.9 Favored 'General case' 0 N--CA 1.509 2.51 0 CA-C-N 123.063 2.665 . . . . 0.17000000000000001 111.234 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.8 -21.68 37.9 Favored Glycine 0 N--CA 1.499 2.874 0 N-CA-C 110.769 -0.932 . . . . 0.040000000000000001 110.769 178.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 960' ' ' ASP . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 914' ' ' ARG . 0.4 OUTLIER -53.12 171.9 0.06 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.389 -1.066 . . . . 0.040000000000000001 109.993 -179.707 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 961' ' ' THR . . . . . 0.463 ' HA ' ' O ' ' A' ' 886' ' ' PHE . 41.5 m -133.53 138.73 46.23 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.895 -1.128 . . . . 1.78 112.159 -177.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 962' ' ' VAL . . . . . 0.905 HG22 ' HB3' ' A' ' 886' ' ' PHE . 20.3 m -96.57 143.62 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 C-N-CA 120.025 -0.67 . . . . 0.040000000000000001 109.763 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 5.3 t -140.28 145.3 37.1 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.817 -0.552 . . . . 0.71999999999999997 109.981 -178.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 964' ' ' VAL . . . . . 0.842 HG13 HG22 ' A' ' 911' ' ' VAL . 47.6 t -99.59 136.9 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.141 -0.975 . . . . 1.05 110.785 -178.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -94.05 128.43 40.42 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 103.799 -2.667 . . . . 3.02 103.799 173.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 966' ' ' LEU . . . . . 0.493 ' C ' HG23 ' A' ' 967' ' ' VAL . 10.2 tp -131.62 61.99 1.64 Allowed 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.136 -1.061 . . . . 1.46 108.136 177.192 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 967' ' ' VAL . . . . . 0.493 HG23 ' C ' ' A' ' 966' ' ' LEU . 95.4 t -158.01 97.2 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 108.072 -1.084 . . . . 1.9399999999999999 108.072 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 88.2 mmm -143.13 60.02 1.41 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.746 -1.221 . . . . 0.0 108.353 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.78 119.98 1.95 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 107.036 -2.425 . . . . 2.1099999999999999 107.036 -178.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -82.45 -58.68 2.82 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.014 -1.286 . . . . 5.8899999999999997 110.396 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 49.0 tp -59.01 90.74 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.422 -0.799 . . . . 4.3600000000000003 110.209 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -141.93 -154.19 0.5 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.592 -0.693 . . . . 1.8300000000000001 110.235 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -119.64 171.92 8.04 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.511 -0.743 . . . . 4.3499999999999996 110.212 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 39.0 t -101.64 130.42 47.98 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.598 -0.689 . . . . 1.27 110.084 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -156.12 158.75 38.24 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.521 -0.737 . . . . 5.0199999999999996 110.561 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.14 85.75 18.43 Favored Pre-proline 0 N--CA 1.5 2.04 0 O-C-N 121.59 -0.694 . . . . 2.4100000000000001 109.691 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 977' ' ' PRO . . . . . 0.543 ' C ' HD12 ' A' ' 978' ' ' LEU . 48.2 Cg_endo -73.39 -172.43 1.04 Allowed 'Trans proline' 0 C--N 1.317 -1.089 0 O-C-N 123.277 1.146 . . . . 0.95999999999999996 111.345 -179.439 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 978' ' ' LEU . . . . . 0.765 HD23 HD12 ' A' ' 856' ' ' LEU . 5.7 mp -127.47 155.3 43.92 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 107.688 -1.227 . . . . 0.62 107.688 177.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 979' ' ' THR . . . . . 0.461 HG23 ' C ' ' A' ' 978' ' ' LEU . 42.7 p -149.83 141.1 23.16 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.847 -1.158 . . . . 3.5699999999999998 111.252 -179.349 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 980' ' ' ILE . . . . . 0.748 ' HB ' HG21 ' A' ' 899' ' ' VAL . 46.7 mm -107.7 128.69 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 108.911 -0.774 . . . . 1.3300000000000001 108.911 179.408 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 981' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -120.95 97.26 5.45 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 119.705 -0.798 . . . . 0.050000000000000003 111.974 -178.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 83.8 p -108.59 158.49 17.53 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.539 -0.726 . . . . 0.87 109.157 178.39 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 983' ' ' GLY . . . . . 0.402 ' HA3' ' CE1' ' A' ' 852' ' ' PHE . . . -175.18 109.04 0.28 Allowed Glycine 0 N--CA 1.499 2.878 0 N-CA-C 106.39 -2.684 . . . . 0.029999999999999999 106.39 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -108.64 152.42 24.82 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 114.565 1.32 . . . . 0.69999999999999996 114.565 -175.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 985' ' ' LEU . . . . . 0.856 HD13 HD22 ' A' ' 890' ' ' LEU . 45.3 tp -72.28 134.55 45.62 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.777 -1.202 . . . . 0.040000000000000001 110.051 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 50.8 tp -107.49 -55.83 2.3 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.562 -0.711 . . . . 0.040000000000000001 109.905 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -144.82 145.16 31.51 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 107.653 -1.24 . . . . 0.040000000000000001 107.653 179.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.74 163.15 12.18 Favored Glycine 0 N--CA 1.495 2.593 0 N-CA-C 108.155 -1.978 . . . . 0.040000000000000001 108.155 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -75.85 112.16 18.55 Favored Pre-proline 0 N--CA 1.499 1.988 0 O-C-N 121.202 -1.175 . . . . 0.040000000000000001 109.436 179.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 990' ' ' PRO . . . . . 0.528 ' HD2' HD12 ' A' ' 992' ' ' LEU . 48.8 Cg_endo -91.4 71.23 0.97 Allowed 'Trans proline' 0 C--N 1.319 -0.993 0 O-C-N 123.151 1.079 . . . . 0.45000000000000001 111.418 -178.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 991' ' ' GLU . . . . . 0.418 ' HB2' ' O ' ' A' ' 990' ' ' PRO . 70.4 mt-10 67.25 -73.85 0.07 Allowed 'General case' 0 N--CA 1.503 2.178 0 N-CA-C 108.421 -0.955 . . . . 1.97 108.421 -177.35 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 992' ' ' LEU . . . . . 0.528 HD12 ' HD2' ' A' ' 990' ' ' PRO . 6.6 mt 51.16 20.54 0.89 Allowed 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.574 -0.704 . . . . 2.3799999999999999 111.609 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -94.63 156.68 16.31 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.844 -1.16 . . . . 3.79 109.98 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -146.55 93.77 2.34 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.529 -0.732 . . . . 3.5099999999999998 110.269 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 995' ' ' ALA . . . . . . . . . . . . 2.518 . . . . . . . 0 N--CA 1.504 2.243 0 O-C-N 120.86 -1.15 . . . . 2.73 110.578 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo . . . . . 0 N--CA 1.488 1.177 0 N-CA-C 109.432 -1.026 . . . . 3.8300000000000001 109.432 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 847' ' ' VAL . . . . . . . . . . . . . 63.6 t -135.38 102.69 10.6 Favored Pre-proline 0 N--CA 1.494 1.775 0 O-C-N 121.573 -0.704 . . . . 1.8300000000000001 110.014 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 848' ' ' PRO . . . . . 0.741 ' O ' HG23 ' B' ' 850' ' ' VAL . 44.1 Cg_endo -69.95 -18.41 36.15 Favored 'Trans proline' 0 N--CA 1.487 1.091 0 O-C-N 123.279 1.147 . . . . 0.65000000000000002 111.192 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 849' ' ' GLN . . . . . 0.404 ' C ' ' O ' ' B' ' 848' ' ' PRO . 56.4 tt0 28.35 69.57 0.07 Allowed 'General case' 0 N--CA 1.518 2.969 0 N-CA-C 112.734 0.642 . . . . 2.5800000000000001 112.734 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 850' ' ' VAL . . . . . 0.741 HG23 ' O ' ' B' ' 848' ' ' PRO . 65.1 t -120.56 137.57 53.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.15 -0.969 . . . . 1.0900000000000001 111.694 -178.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 851' ' ' ALA . . . . . 0.557 ' HB3' ' HG ' ' B' ' 873' ' ' LEU . . . -126.37 158.48 35.78 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 105.894 -1.891 . . . . 0.040000000000000001 105.894 176.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 852' ' ' PHE . . . . . 0.427 ' HA ' ' CB ' ' B' ' 874' ' ' ASN . 47.7 p90 -157.9 131.03 7.54 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 121.114 1.779 . . . . 0.050000000000000003 108.803 179.028 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 47.2 t -175.53 133.72 0.29 Allowed 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.216 -1.031 . . . . 0.040000000000000001 108.216 -179.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 854' ' ' ALA . . . . . 0.467 ' HB1' ' HD2' ' B' ' 868' ' ' PHE . . . -133.17 155.33 49.51 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.071 -1.018 . . . . 0.67000000000000004 109.522 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 855' ' ' ALA . . . . . 0.742 ' HB3' ' CB ' ' B' ' 870' ' ' ARG . . . -124.37 142.99 50.85 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 122.026 0.917 . . . . 0.51000000000000001 111.553 -179.012 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 856' ' ' LEU . . . . . 0.785 HD12 HD23 ' B' ' 978' ' ' LEU . 3.3 tm? -111.96 137.56 49.8 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.719 -0.613 . . . . 0.050000000000000003 110.274 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 857' ' ' SER . . . . . 0.649 ' N ' HD13 ' B' ' 856' ' ' LEU . 77.1 p -155.15 15.43 0.4 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.615 -0.678 . . . . 1.3300000000000001 111.433 179.488 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 858' ' ' LEU . . . . . 0.525 HD12 ' C ' ' B' ' 858' ' ' LEU . 4.3 pp -36.54 160.68 0.05 OUTLIER Pre-proline 0 N--CA 1.516 2.869 0 CA-C-N 118.861 0.755 . . . . 2.3300000000000001 112.544 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -59.74 -89.11 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 120.791 0.994 . . . . 2.3199999999999998 114.022 -177.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 54.4 ptt85 -128.18 -144.7 0.29 Allowed 'General case' 0 N--CA 1.501 2.124 0 O-C-N 120.845 -1.159 . . . . 0.040000000000000001 112.386 -177.056 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 70.1 m -33.81 126.99 0.4 Allowed 'General case' 0 N--CA 1.512 2.642 0 N-CA-C 112.95 0.722 . . . . 1.3100000000000001 112.95 -178.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 862' ' ' GLU . . . . . 0.463 ' HG3' HD22 ' B' ' 858' ' ' LEU . 0.0 OUTLIER -102.14 158.26 32.11 Favored Pre-proline 0 N--CA 1.489 1.478 0 N-CA-C 108.324 -0.991 . . . . 4.5099999999999998 108.324 177.362 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -73.19 -13.54 25.8 Favored 'Trans proline' 0 C--N 1.314 -1.283 0 O-C-N 123.114 1.06 . . . . 2.2400000000000002 111.855 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -177.2 -134.14 1.95 Allowed Glycine 0 N--CA 1.495 2.612 0 N-CA-C 110.005 -1.238 . . . . 0.040000000000000001 110.005 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 29.1 m -68.65 151.62 46.46 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.319 -1.106 . . . . 1.51 109.802 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 866' ' ' VAL . . . . . 0.499 HG13 ' CD2' ' B' ' 858' ' ' LEU . 33.2 t -94.82 139.7 22.28 Favored Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 113.766 1.024 . . . . 0.78000000000000003 113.766 -174.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 867' ' ' PRO . . . . . 0.493 ' HD3' ' HA ' ' B' ' 866' ' ' VAL . 55.5 Cg_endo -92.02 -151.49 0.04 OUTLIER 'Trans proline' 0 CA--C 1.545 1.034 0 O-C-N 123.729 1.384 . . . . 0.92000000000000004 109.302 177.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 868' ' ' PHE . . . . . 0.467 ' CD1' ' HG2' ' B' ' 881' ' ' PRO . 20.3 p90 -150.91 123.86 8.69 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.644 -1.285 . . . . 0.050000000000000003 109.83 179.157 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 50.5 p-10 -113.54 -1.66 14.05 Favored 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 119.388 -0.925 . . . . 1.7 112.742 -178.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 870' ' ' ARG . . . . . 0.742 ' CB ' ' HB3' ' B' ' 855' ' ' ALA . 28.6 mmm180 -91.12 89.96 7.61 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.855 -1.153 . . . . 2.5899999999999999 111.005 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 59.7 t -72.29 96.57 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.011 -1.056 . . . . 1.9399999999999999 109.937 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 872' ' ' LEU . . . . . 0.541 HD11 ' HB2' ' B' ' 855' ' ' ALA . 96.6 mt -83.24 -47.15 11.84 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.504 -0.747 . . . . 1.0600000000000001 110.232 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 873' ' ' LEU . . . . . 0.557 ' HG ' ' HB3' ' B' ' 851' ' ' ALA . 44.2 tp -174.61 103.46 0.1 Allowed 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.735 -0.839 . . . . 4.1799999999999997 108.735 178.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 874' ' ' ASN . . . . . 0.427 ' CB ' ' HA ' ' B' ' 852' ' ' PHE . 33.0 t-20 177.95 81.84 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.64 -0.663 . . . . 0.040000000000000001 109.42 -178.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -66.45 -47.29 73.62 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 119.272 -0.971 . . . . 3.3799999999999999 111.176 -179.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 876' ' ' GLY . . . . . 0.414 ' HA3' ' CE2' ' B' ' 878' ' ' TYR . . . -74.5 -24.82 71.84 Favored Glycine 0 N--CA 1.494 2.524 0 O-C-N 121.263 -0.898 . . . . 0.040000000000000001 111.534 -178.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 82.36 -61.98 4.64 Favored Glycine 0 N--CA 1.501 3.021 0 N-CA-C 107.983 -2.047 . . . . 0.040000000000000001 107.983 -178.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 878' ' ' TYR . . . . . 0.414 ' CE2' ' HA3' ' B' ' 876' ' ' GLY . 97.8 m-85 60.89 -62.23 0.07 Allowed 'General case' 0 N--CA 1.504 2.251 0 N-CA-C 114.527 1.306 . . . . 3.46 114.527 177.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 879' ' ' TYR . . . . . 0.485 ' CB ' ' CD2' ' B' ' 886' ' ' PHE . 18.2 p90 -110.59 109.69 20.1 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 114.826 1.417 . . . . 0.040000000000000001 114.826 -176.121 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -67.95 115.48 28.72 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.418 -0.801 . . . . 0.02 109.947 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 881' ' ' PRO . . . . . 0.467 ' HG2' ' CD1' ' B' ' 868' ' ' PHE . 55.3 Cg_endo -75.9 0.46 9.24 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 O-C-N 123.361 1.19 . . . . 0.39000000000000001 112.264 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -76.72 -62.52 1.61 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 106.637 -1.616 . . . . 0.81000000000000005 106.637 178.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 883' ' ' THR . . . . . 0.567 ' OG1' HG23 ' B' ' 885' ' ' VAL . 63.5 p -94.46 -18.65 21.3 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.711 -0.848 . . . . 0.040000000000000001 108.711 177.314 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.88 20.28 59.83 Favored Glycine 0 N--CA 1.496 2.648 0 O-C-N 121.101 -1.0 . . . . 0.029999999999999999 111.311 178.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 885' ' ' VAL . . . . . 0.567 HG23 ' OG1' ' B' ' 883' ' ' THR . 93.9 t -74.53 89.27 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 C-N-CA 118.15 -1.42 . . . . 1.01 108.202 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 886' ' ' PHE . . . . . 0.885 ' HB3' HG22 ' B' ' 962' ' ' VAL . 1.0 OUTLIER -88.38 105.55 17.66 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 115.366 -0.833 . . . . 0.050000000000000003 111.546 -177.75 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 887' ' ' THR . . . . . 0.427 ' O ' ' HD3' ' B' ' 889' ' ' PRO . 93.0 m -95.48 100.27 12.05 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 107.745 -1.206 . . . . 0.68000000000000005 107.745 177.48 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 888' ' ' ALA . . . . . . . . . . . . . . . -99.09 106.23 37.0 Favored Pre-proline 0 N--CA 1.5 2.06 0 N-CA-C 114.059 1.133 . . . . 0.25 114.059 -176.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 889' ' ' PRO . . . . . 0.427 ' HD3' ' O ' ' B' ' 887' ' ' THR . 54.8 Cg_endo -88.92 -12.37 3.48 Favored 'Trans proline' 0 CA--C 1.546 1.079 0 N-CA-C 109.003 -1.191 . . . . 1.6399999999999999 109.003 175.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 890' ' ' LEU . . . . . 0.835 HD22 HD13 ' B' ' 985' ' ' LEU . 76.6 mt -36.02 -50.78 0.71 Allowed 'General case' 0 N--CA 1.508 2.462 0 N-CA-C 113.588 0.958 . . . . 2.29 113.588 -177.644 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 52.16 95.64 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.231 -0.918 . . . . 0.63 110.232 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . 157.63 -153.85 25.01 Favored Glycine 0 N--CA 1.477 1.418 0 N-CA-C 107.061 -2.416 . . . . 0.040000000000000001 107.061 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 71.4 ttt-85 -115.62 126.95 54.82 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 121.61 -0.935 . . . . 3.0 108.587 177.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 894' ' ' TYR . . . . . 0.77 ' OH ' HD12 ' B' ' 896' ' ' LEU . 0.1 OUTLIER -132.18 160.9 34.74 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.117 -0.989 . . . . 0.040000000000000001 111.069 -179.828 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 895' ' ' LEU . . . . . . . . . . . . . 35.2 tp -91.13 118.93 30.83 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.426 0.631 . . . . 1.27 110.091 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 896' ' ' LEU . . . . . 0.77 HD12 ' OH ' ' B' ' 894' ' ' TYR . 9.5 tt -109.28 142.47 40.11 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.782 -0.574 . . . . 0.93999999999999995 110.251 -179.38 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 897' ' ' SER . . . . . 0.496 ' N ' HD23 ' B' ' 896' ' ' LEU . 68.1 m -148.42 114.96 5.95 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.538 -0.726 . . . . 0.040000000000000001 111.022 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.87 146.52 32.21 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 109.179 -0.674 . . . . 0.47999999999999998 109.179 179.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 899' ' ' VAL . . . . . 0.738 HG21 ' HB ' ' B' ' 980' ' ' ILE . 87.9 t -95.46 119.54 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 C-N-CA 119.616 -0.833 . . . . 0.55000000000000004 111.324 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 900' ' ' LEU . . . . . 0.528 HD12 ' HB2' ' B' ' 924' ' ' SER . 4.5 mm? -95.95 111.74 23.66 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 114.401 1.259 . . . . 1.5900000000000001 114.401 -174.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 11.9 m -65.87 141.22 58.33 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 107.466 -1.309 . . . . 0.050000000000000003 107.466 176.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -66.87 -66.16 2.49 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 110.615 -0.994 . . . . 0.029999999999999999 110.615 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 11.7 m170 46.9 67.16 0.83 Allowed 'General case' 0 N--CA 1.507 2.414 0 O-C-N 121.519 -0.989 . . . . 3.2000000000000002 111.082 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 43.1 ptt85 -69.69 -5.97 28.53 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.623 -0.673 . . . . 2.9199999999999999 112.068 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 905' ' ' HIS . . . . . 0.482 ' O ' ' CB ' ' B' ' 906' ' ' GLU . 73.6 t60 -62.2 4.79 0.12 Allowed 'General case' 0 N--CA 1.506 2.369 0 O-C-N 120.904 -1.123 . . . . 2.8700000000000001 113.094 -179.237 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 906' ' ' GLU . . . . . 0.482 ' CB ' ' O ' ' B' ' 905' ' ' HIS . 0.9 OUTLIER 95.1 -164.63 0.0 OUTLIER 'General case' 0 N--CA 1.529 3.478 0 CA-C-N 120.648 1.567 . . . . 0.98999999999999999 111.8 179.1 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 907' ' ' LYS . . . . . 0.466 ' CB ' ' O ' ' B' ' 906' ' ' GLU . 68.6 tttt 85.9 157.29 0.09 Allowed 'General case' 0 N--CA 1.519 3.002 0 N-CA-C 108.212 -1.033 . . . . 5.25 108.212 -177.058 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 60.3 t -121.51 116.71 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 120.779 -1.2 . . . . 0.39000000000000001 111.436 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 71.1 tt0 -99.58 133.09 44.41 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 106.996 -1.483 . . . . 1.72 106.996 176.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -155.51 123.35 5.7 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 106.831 -1.544 . . . . 0.67000000000000004 106.831 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 911' ' ' VAL . . . . . 0.843 HG22 HG13 ' B' ' 964' ' ' VAL . 86.5 t -83.84 131.5 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 C-N-CA 120.482 -0.487 . . . . 0.54000000000000004 110.668 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 86.1 mt -66.53 156.29 35.32 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.306 -0.871 . . . . 1.5 109.174 178.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 913' ' ' SER . . . . . 0.465 ' OG ' HG11 ' B' ' 919' ' ' VAL . 0.1 OUTLIER -127.92 133.26 49.25 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.617 -1.253 . . . . 1.3700000000000001 107.617 176.56 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 914' ' ' ARG . . . . . 0.575 HH11 HG13 ' B' ' 962' ' ' VAL . 0.0 OUTLIER -64.36 158.33 23.88 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 120.481 -1.387 . . . . 4.2999999999999998 112.167 -178.346 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 915' ' ' SER . . . . . 0.431 ' CB ' ' O ' ' B' ' 914' ' ' ARG . 4.6 t 84.56 -32.38 0.06 Allowed 'General case' 0 N--CA 1.521 3.104 0 C-N-CA 124.191 0.996 . . . . 2.0499999999999998 111.931 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 916' ' ' ASN . . . . . 0.804 ' HB2' HG21 ' B' ' 919' ' ' VAL . 98.7 m-20 -123.49 -21.74 5.21 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.987 -1.07 . . . . 2.71 111.382 -179.234 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 917' ' ' GLN . . . . . 0.407 ' HB2' ' O ' ' B' ' 916' ' ' ASN . 45.1 mt-30 66.72 165.69 0.21 Allowed 'General case' 0 N--CA 1.52 3.049 0 N-CA-C 105.708 -1.96 . . . . 2.6800000000000002 105.708 -173.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 53.81 -124.15 28.79 Favored Glycine 1 N--CA 1.522 4.407 0 CA-C-N 123.446 2.839 . . . . 0.029999999999999999 106.753 -177.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 919' ' ' VAL . . . . . 0.804 HG21 ' HB2' ' B' ' 916' ' ' ASN . 54.2 t 52.03 94.04 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 O-C-N 121.359 -1.083 . . . . 1.3899999999999999 108.922 -178.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 920' ' ' ALA . . . . . 0.801 ' HB3' HG12 ' B' ' 949' ' ' VAL . . . -91.85 91.17 7.79 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.416 -0.914 . . . . 0.029999999999999999 110.846 -179.034 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 921' ' ' ARG . . . . . 0.703 ' HG3' HG23 ' B' ' 922' ' ' VAL . 17.3 ptt180 -86.69 -42.15 13.62 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 106.132 -1.803 . . . . 4.4199999999999999 106.132 176.094 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 922' ' ' VAL . . . . . 0.703 HG23 ' HG3' ' B' ' 921' ' ' ARG . 77.0 t -104.35 67.09 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 N-CA-C 105.812 -1.922 . . . . 0.84999999999999998 105.812 175.521 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 923' ' ' ASP . . . . . 0.656 ' HB2' ' HB1' ' B' ' 920' ' ' ALA . 25.7 t0 -86.56 134.34 33.66 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.673 0.749 . . . . 2.46 111.423 -177.549 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 924' ' ' SER . . . . . 0.528 ' HB2' HD12 ' B' ' 900' ' ' LEU . 40.0 t -147.8 106.12 3.77 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.696 -0.853 . . . . 0.69999999999999996 108.696 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -101.68 84.69 0.52 Allowed Glycine 0 N--CA 1.486 2.025 0 N-CA-C 108.358 -1.897 . . . . 0.040000000000000001 108.358 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 926' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' B' ' 906' ' ' GLU . . . . . . . . 0 N--CA 1.489 2.191 0 N-CA-C 108.922 -1.671 . . . . 0.040000000000000001 108.922 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 26.2 m . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.029 0.442 . . . . 13.779999999999999 110.273 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 95.6 mt -111.66 130.79 55.65 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.545 -0.722 . . . . 13.76 110.379 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -151.09 167.92 30.68 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.088 -1.605 . . . . 9.1300000000000008 109.088 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 949' ' ' VAL . . . . . 0.801 HG12 ' HB3' ' B' ' 920' ' ' ALA . 31.1 m -118.91 127.21 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.426 -1.044 . . . . 7.0800000000000001 110.899 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 950' ' ' PHE . . . . . 0.463 ' CE1' ' HD2' ' B' ' 955' ' ' PRO . 27.2 p90 -133.81 148.99 51.39 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.593 -0.692 . . . . 7.5899999999999999 109.176 179.192 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 28.6 m -121.15 -50.97 2.12 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.411 -0.806 . . . . 5.0300000000000002 112.065 -178.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 952' ' ' LEU . . . . . 0.506 HD11 HD23 ' A' ' 895' ' ' LEU . 14.6 tp -59.71 -74.12 0.08 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.458 -0.776 . . . . 1.01 112.712 -177.453 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 953' ' ' ILE . . . . . 0.476 ' O ' ' HB3' ' B' ' 954' ' ' LEU . 46.4 pt -52.02 -143.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.851 0 N-CA-C 114.499 1.296 . . . . 2.6000000000000001 114.499 -176.281 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 954' ' ' LEU . . . . . 0.721 HD22 ' O ' ' B' ' 954' ' ' LEU . 0.0 OUTLIER 173.13 74.76 0.04 OUTLIER Pre-proline 0 N--CA 1.508 2.452 0 O-C-N 120.788 -1.195 . . . . 0.050000000000000003 110.772 179.93 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 955' ' ' PRO . . . . . 0.765 ' C ' HD12 ' B' ' 956' ' ' LEU . 49.6 Cg_endo -77.16 95.53 1.07 Allowed 'Trans proline' 0 C--N 1.316 -1.178 0 O-C-N 122.741 0.864 . . . . 0.83999999999999997 110.163 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 956' ' ' LEU . . . . . 0.765 HD12 ' C ' ' B' ' 955' ' ' PRO . 8.9 mp -125.92 151.08 47.42 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.208 -0.932 . . . . 0.040000000000000001 110.149 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -82.03 150.89 27.35 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 117.822 -1.085 . . . . 1.28 111.325 -179.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -68.36 119.13 12.39 Favored 'General case' 0 N--CA 1.508 2.465 0 CA-C-N 122.946 2.612 . . . . 0.17000000000000001 111.266 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 93.08 -21.85 37.74 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 110.786 -0.926 . . . . 0.040000000000000001 110.786 178.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 960' ' ' ASP . . . . . 0.427 ' HB3' ' CZ ' ' B' ' 914' ' ' ARG . 0.4 OUTLIER -52.98 172.06 0.05 Allowed 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.39 -1.065 . . . . 0.040000000000000001 109.981 -179.747 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 961' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' B' ' 886' ' ' PHE . 40.8 m -133.55 138.91 46.29 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.897 -1.127 . . . . 1.78 112.165 -177.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 962' ' ' VAL . . . . . 0.885 HG22 ' HB3' ' B' ' 886' ' ' PHE . 20.7 m -96.94 143.5 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 C-N-CA 120.007 -0.677 . . . . 0.040000000000000001 109.737 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 5.3 t -140.03 145.21 37.46 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.79 -0.569 . . . . 0.71999999999999997 110.043 -178.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 964' ' ' VAL . . . . . 0.843 HG13 HG22 ' B' ' 911' ' ' VAL . 47.5 t -99.59 136.64 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.138 -0.976 . . . . 1.05 110.802 -179.033 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -94.08 127.95 40.18 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 103.916 -2.624 . . . . 3.02 103.916 173.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 966' ' ' LEU . . . . . 0.491 ' C ' HG23 ' B' ' 967' ' ' VAL . 10.1 tp -131.17 62.15 1.62 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.217 -1.031 . . . . 1.46 108.217 177.33 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 967' ' ' VAL . . . . . 0.491 HG23 ' C ' ' B' ' 966' ' ' LEU . 95.4 t -158.14 97.12 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 108.113 -1.069 . . . . 1.9399999999999999 108.113 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 88.2 mmm -142.97 59.76 1.42 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.756 -1.215 . . . . 0.0 108.456 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.85 119.83 1.93 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 107.08 -2.408 . . . . 2.1099999999999999 107.08 -178.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -82.13 -58.66 2.86 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.039 -1.271 . . . . 5.8899999999999997 110.427 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 49.0 tp -59.08 90.64 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.437 -0.789 . . . . 4.3600000000000003 110.152 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -141.89 -154.18 0.5 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.556 -0.715 . . . . 1.8300000000000001 110.179 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -119.55 171.98 7.98 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.486 -0.759 . . . . 4.3499999999999996 110.306 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 39.2 t -101.7 130.39 48.07 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.541 -0.725 . . . . 1.27 110.065 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -156.1 158.69 38.16 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.513 -0.742 . . . . 5.0199999999999996 110.588 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.13 85.7 18.52 Favored Pre-proline 0 N--CA 1.499 2.012 0 O-C-N 121.624 -0.673 . . . . 2.4100000000000001 109.747 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 977' ' ' PRO . . . . . 0.538 ' C ' HD12 ' B' ' 978' ' ' LEU . 48.2 Cg_endo -73.42 -172.43 1.04 Allowed 'Trans proline' 0 C--N 1.318 -1.065 0 O-C-N 123.324 1.171 . . . . 0.95999999999999996 111.44 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 978' ' ' LEU . . . . . 0.785 HD23 HD12 ' B' ' 856' ' ' LEU . 5.6 mp -127.34 155.52 43.44 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.707 -1.22 . . . . 0.62 107.707 177.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 979' ' ' THR . . . . . 0.466 HG23 ' C ' ' B' ' 978' ' ' LEU . 42.3 p -150.0 141.01 22.93 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.782 -1.199 . . . . 3.5699999999999998 111.239 -179.311 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 980' ' ' ILE . . . . . 0.738 ' HB ' HG21 ' B' ' 899' ' ' VAL . 46.9 mm -107.76 128.33 63.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 108.885 -0.783 . . . . 1.3300000000000001 108.885 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -120.59 97.49 5.59 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 119.71 -0.796 . . . . 0.050000000000000003 111.982 -178.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 82.9 p -109.0 158.6 17.56 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.611 -0.681 . . . . 0.87 109.28 178.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 983' ' ' GLY . . . . . 0.411 ' HA3' ' CE1' ' B' ' 852' ' ' PHE . . . -175.11 109.14 0.28 Allowed Glycine 0 N--CA 1.499 2.86 0 N-CA-C 106.513 -2.635 . . . . 0.029999999999999999 106.513 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -108.7 152.19 25.16 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 114.526 1.306 . . . . 0.69999999999999996 114.526 -175.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 985' ' ' LEU . . . . . 0.835 HD13 HD22 ' B' ' 890' ' ' LEU . 45.4 tp -72.1 134.5 45.83 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.872 -1.143 . . . . 0.040000000000000001 110.055 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 986' ' ' LEU . . . . . 0.687 ' CD1' HD11 ' C' ' 986' ' ' LEU . 51.7 tp -107.52 -55.89 2.29 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.58 -0.7 . . . . 0.040000000000000001 109.917 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -144.82 145.08 31.47 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 107.623 -1.251 . . . . 0.040000000000000001 107.623 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.54 162.95 12.22 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 108.147 -1.981 . . . . 0.040000000000000001 108.147 179.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -75.66 112.16 18.12 Favored Pre-proline 0 N--CA 1.499 1.988 0 O-C-N 121.236 -1.155 . . . . 0.040000000000000001 109.406 179.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 990' ' ' PRO . . . . . 0.526 ' HD2' HD12 ' B' ' 992' ' ' LEU . 49.8 Cg_endo -91.38 71.31 0.97 Allowed 'Trans proline' 0 C--N 1.319 -0.982 0 O-C-N 123.108 1.057 . . . . 0.45000000000000001 111.411 -178.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 991' ' ' GLU . . . . . 0.421 ' HB2' ' O ' ' B' ' 990' ' ' PRO . 70.5 mt-10 67.21 -73.75 0.08 Allowed 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 108.493 -0.928 . . . . 1.97 108.493 -177.46 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 992' ' ' LEU . . . . . 0.526 HD12 ' HD2' ' B' ' 990' ' ' PRO . 6.7 mt 51.22 20.29 0.88 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.575 -0.703 . . . . 2.3799999999999999 111.634 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -94.33 156.77 16.35 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.862 -1.149 . . . . 3.79 109.96 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -146.64 93.22 2.26 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.547 -0.721 . . . . 3.5099999999999998 110.403 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 995' ' ' ALA . . . . . . . . . . . . 2.519 . . . . . . . 0 N--CA 1.503 2.209 0 O-C-N 120.897 -1.127 . . . . 2.73 110.624 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo . . . . . 0 N--CA 1.488 1.178 0 N-CA-C 109.5 -1.0 . . . . 3.8300000000000001 109.5 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' C' C ' 847' ' ' VAL . . . . . 0.473 HG12 ' HB2' ' C' ' 849' ' ' GLN . 57.3 t -127.6 103.75 21.9 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.609 -0.682 . . . . 1.8300000000000001 110.121 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 848' ' ' PRO . . . . . 0.786 ' O ' HG23 ' C' ' 850' ' ' VAL . 43.4 Cg_endo -69.36 -23.03 33.05 Favored 'Trans proline' 0 N--CA 1.488 1.151 0 O-C-N 123.218 1.115 . . . . 0.65000000000000002 110.911 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 849' ' ' GLN . . . . . 0.473 ' HB2' HG12 ' C' ' 847' ' ' VAL . 55.2 tt0 26.59 68.63 0.06 Allowed 'General case' 0 N--CA 1.519 2.982 0 N-CA-C 112.972 0.73 . . . . 2.5800000000000001 112.972 179.368 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 850' ' ' VAL . . . . . 0.786 HG23 ' O ' ' C' ' 848' ' ' PRO . 93.4 t -119.58 134.35 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.158 -0.964 . . . . 1.0900000000000001 111.245 -179.015 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 851' ' ' ALA . . . . . 0.417 ' HB3' ' HG ' ' C' ' 873' ' ' LEU . . . -131.56 155.74 46.96 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 106.105 -1.813 . . . . 0.040000000000000001 106.105 176.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 852' ' ' PHE . . . . . 0.51 ' CD1' ' CE1' ' C' ' 879' ' ' TYR . 0.3 OUTLIER -154.36 134.68 13.32 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 120.829 1.65 . . . . 0.050000000000000003 107.931 179.083 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 5.0 t -173.8 130.54 0.42 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.513 -0.921 . . . . 0.040000000000000001 108.513 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -136.39 150.95 49.04 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.256 -0.902 . . . . 0.67000000000000004 108.863 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 855' ' ' ALA . . . . . 0.658 ' HB3' ' CB ' ' C' ' 870' ' ' ARG . . . -122.77 139.33 54.11 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.813 0.816 . . . . 0.51000000000000001 111.527 -179.018 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 856' ' ' LEU . . . . . 0.778 HD23 ' O ' ' C' ' 867' ' ' PRO . 3.4 tm? -104.87 138.88 40.44 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.781 -0.575 . . . . 0.050000000000000003 109.558 179.44 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 857' ' ' SER . . . . . 0.623 ' N ' HD13 ' C' ' 856' ' ' LEU . 1.9 m -155.28 17.49 0.41 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.622 -0.674 . . . . 1.3300000000000001 111.465 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 858' ' ' LEU . . . . . 0.705 HD22 ' HG3' ' C' ' 862' ' ' GLU . 3.6 pp -34.55 158.06 0.04 OUTLIER Pre-proline 0 N--CA 1.52 3.047 0 CA-C-N 118.752 0.705 . . . . 2.3300000000000001 112.756 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -60.14 -89.88 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.431 0 O-C-N 123.089 1.047 . . . . 2.3199999999999998 113.828 -177.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 55.4 ptt85 -126.56 -141.92 0.28 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.853 -1.155 . . . . 0.040000000000000001 111.41 -177.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 73.7 m -36.31 120.33 0.65 Allowed 'General case' 0 N--CA 1.511 2.605 0 O-C-N 121.622 -0.674 . . . . 1.3100000000000001 112.26 -179.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 862' ' ' GLU . . . . . 0.705 ' HG3' HD22 ' C' ' 858' ' ' LEU . 0.0 OUTLIER -99.11 158.14 32.82 Favored Pre-proline 0 N--CA 1.488 1.458 0 N-CA-C 108.53 -0.915 . . . . 4.5099999999999998 108.53 178.069 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -70.92 -15.52 32.73 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 O-C-N 123.225 1.118 . . . . 2.2400000000000002 111.036 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -177.3 -134.77 2.07 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.537 -1.425 . . . . 0.040000000000000001 109.537 179.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 30.2 m -69.31 155.25 40.73 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.34 -1.094 . . . . 1.51 110.786 -179.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 866' ' ' VAL . . . . . 0.516 HG12 ' CD2' ' C' ' 858' ' ' LEU . 33.7 m -89.83 138.29 27.96 Favored Pre-proline 0 N--CA 1.496 1.837 0 N-CA-C 113.423 0.897 . . . . 0.78000000000000003 113.423 -175.34 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 867' ' ' PRO . . . . . 0.778 ' O ' HD23 ' C' ' 856' ' ' LEU . 54.9 Cg_endo -88.62 -153.11 0.04 OUTLIER 'Trans proline' 0 C--N 1.324 -0.716 0 N-CA-C 108.128 -1.528 . . . . 0.92000000000000004 108.128 177.414 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 868' ' ' PHE . . . . . 0.48 ' CD1' ' HG2' ' C' ' 881' ' ' PRO . 20.4 p90 -148.47 120.18 8.07 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.54 -1.35 . . . . 0.050000000000000003 110.12 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 50.2 p-10 -112.63 -2.13 14.63 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 119.353 -0.939 . . . . 1.7 111.762 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 870' ' ' ARG . . . . . 0.658 ' CB ' ' HB3' ' C' ' 855' ' ' ALA . 24.2 mmm180 -91.5 87.36 6.36 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.013 -1.054 . . . . 2.5899999999999999 111.057 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 61.9 t -74.77 97.2 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.0 -1.062 . . . . 1.9399999999999999 109.493 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 872' ' ' LEU . . . . . 0.582 HD13 HD11 ' A' ' 953' ' ' ILE . 52.2 mt -88.64 -44.37 10.66 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.497 -0.752 . . . . 1.0600000000000001 111.151 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 873' ' ' LEU . . . . . 0.449 ' O ' ' HB2' ' C' ' 874' ' ' ASN . 43.9 tp -171.44 102.62 0.2 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.134 -0.979 . . . . 4.1799999999999997 109.087 179.019 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 874' ' ' ASN . . . . . 0.449 ' HB2' ' O ' ' C' ' 873' ' ' LEU . 36.6 t-20 175.08 83.93 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.333 0 N-CA-C 108.694 -0.854 . . . . 0.040000000000000001 108.694 -178.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 30.1 p-10 -66.46 -48.19 70.71 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.059 -1.026 . . . . 3.3799999999999999 111.966 -178.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 876' ' ' GLY . . . . . 0.423 ' HA3' ' CE2' ' C' ' 878' ' ' TYR . . . -74.45 -24.91 71.72 Favored Glycine 0 N--CA 1.495 2.603 0 O-C-N 121.14 -0.975 . . . . 0.040000000000000001 111.569 -178.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 80.54 -64.86 3.98 Favored Glycine 0 N--CA 1.498 2.789 0 N-CA-C 107.624 -2.191 . . . . 0.040000000000000001 107.624 -178.143 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 878' ' ' TYR . . . . . 0.423 ' CE2' ' HA3' ' C' ' 876' ' ' GLY . 82.6 m-85 61.01 -56.18 0.09 Allowed 'General case' 0 N--CA 1.507 2.416 0 N-CA-C 114.556 1.317 . . . . 3.46 114.556 177.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 879' ' ' TYR . . . . . 0.51 ' CE1' ' CD1' ' C' ' 852' ' ' PHE . 1.7 p90 -111.53 108.91 18.59 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 114.791 1.404 . . . . 0.040000000000000001 114.791 -176.397 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -71.68 113.69 22.08 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.262 -0.898 . . . . 0.02 109.529 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 881' ' ' PRO . . . . . 0.48 ' HG2' ' CD1' ' C' ' 868' ' ' PHE . 54.3 Cg_endo -77.03 0.1 10.04 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 O-C-N 123.351 1.184 . . . . 0.39000000000000001 112.011 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 87.8 mt-10 -75.43 -64.55 1.04 Allowed 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 106.682 -1.599 . . . . 0.81000000000000005 106.682 178.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 24.5 p -90.55 -19.36 23.86 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.22 -1.03 . . . . 0.040000000000000001 108.22 176.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.1 19.58 60.71 Favored Glycine 0 N--CA 1.496 2.675 0 O-C-N 121.165 -0.959 . . . . 0.029999999999999999 111.22 178.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 885' ' ' VAL . . . . . 0.461 HG13 HG21 ' C' ' 961' ' ' THR . 89.3 t -73.93 89.79 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 C-N-CA 118.003 -1.479 . . . . 1.01 108.183 -179.541 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 886' ' ' PHE . . . . . 0.937 ' HB3' HG22 ' C' ' 962' ' ' VAL . 1.3 t80 -88.66 106.9 18.63 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 115.485 -0.78 . . . . 0.050000000000000003 111.385 -178.039 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 887' ' ' THR . . . . . 0.42 ' O ' ' HD3' ' C' ' 889' ' ' PRO . 93.7 m -96.07 101.43 13.09 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.921 -1.14 . . . . 0.68000000000000005 107.921 177.679 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 888' ' ' ALA . . . . . . . . . . . . . . . -99.05 106.88 40.97 Favored Pre-proline 0 N--CA 1.502 2.142 0 N-CA-C 113.964 1.098 . . . . 0.25 113.964 -176.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 889' ' ' PRO . . . . . 0.42 ' HD3' ' O ' ' C' ' 887' ' ' THR . 53.8 Cg_endo -90.33 -12.24 2.72 Favored 'Trans proline' 0 CA--C 1.547 1.17 0 C-N-CA 121.073 1.182 . . . . 1.6399999999999999 109.252 176.382 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 890' ' ' LEU . . . . . 0.841 HD22 HD13 ' C' ' 985' ' ' LEU . 72.3 mt -38.01 -50.61 1.34 Allowed 'General case' 0 N--CA 1.507 2.415 0 N-CA-C 113.778 1.029 . . . . 2.29 113.778 -177.286 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 52.19 97.52 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.379 0 O-C-N 121.152 -0.968 . . . . 0.63 110.386 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . 156.11 -146.52 14.18 Favored Glycine 0 N--CA 1.482 1.703 0 N-CA-C 107.445 -2.262 . . . . 0.040000000000000001 107.445 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 73.3 ttt-85 -106.46 128.79 54.34 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.311 -1.366 . . . . 3.0 107.311 177.157 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 894' ' ' TYR . . . . . 0.417 ' CD1' ' N ' ' C' ' 895' ' ' LEU . 0.4 OUTLIER -130.68 144.29 51.33 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.007 -1.058 . . . . 0.040000000000000001 110.661 -178.499 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 895' ' ' LEU . . . . . 0.417 ' N ' ' CD1' ' C' ' 894' ' ' TYR . 45.2 tp -101.07 117.83 35.8 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.64 -0.662 . . . . 1.27 109.723 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 896' ' ' LEU . . . . . 0.5 HD23 ' C ' ' C' ' 896' ' ' LEU . 10.4 tt -116.4 145.46 43.23 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.531 -0.731 . . . . 0.93999999999999995 110.783 -179.361 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 897' ' ' SER . . . . . 0.494 ' N ' HD23 ' C' ' 896' ' ' LEU . 69.1 m -145.18 119.23 9.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.448 -0.783 . . . . 0.040000000000000001 110.824 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.22 147.93 29.55 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.219 -0.66 . . . . 0.47999999999999998 109.219 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 899' ' ' VAL . . . . . 0.739 HG21 ' HB ' ' C' ' 980' ' ' ILE . 89.4 t -91.12 120.53 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.446 -0.784 . . . . 0.55000000000000004 110.925 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 900' ' ' LEU . . . . . 0.438 HD22 ' HB2' ' C' ' 924' ' ' SER . 93.1 mt -94.23 110.35 22.09 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 114.261 1.208 . . . . 1.5900000000000001 114.261 -175.462 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 18.9 m -64.92 139.71 58.79 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 107.414 -1.328 . . . . 0.050000000000000003 107.414 177.141 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -62.28 -65.77 2.99 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 110.417 -1.073 . . . . 0.029999999999999999 110.417 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 4.0 m170 46.08 64.61 1.42 Allowed 'General case' 0 N--CA 1.507 2.388 0 O-C-N 121.498 -1.001 . . . . 3.2000000000000002 111.262 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 42.8 ptt85 -68.39 -7.74 34.13 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.579 -0.701 . . . . 2.9199999999999999 111.857 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 905' ' ' HIS . . . . . 0.491 ' O ' ' CB ' ' C' ' 906' ' ' GLU . 72.3 t60 -61.29 6.86 0.05 OUTLIER 'General case' 0 N--CA 1.508 2.442 0 CA-C-O 117.659 -1.162 . . . . 2.8700000000000001 113.798 -179.208 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 906' ' ' GLU . . . . . 0.491 ' CB ' ' O ' ' C' ' 905' ' ' HIS . 0.5 OUTLIER 93.22 -165.15 0.0 OUTLIER 'General case' 0 N--CA 1.529 3.487 0 CA-C-N 121.21 1.823 . . . . 0.98999999999999999 111.955 179.117 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 907' ' ' LYS . . . . . 0.485 ' CB ' ' O ' ' C' ' 906' ' ' GLU . 38.2 tttp 88.13 159.62 0.07 Allowed 'General case' 0 N--CA 1.52 3.062 0 N-CA-C 108.149 -1.056 . . . . 5.25 108.149 -176.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 60.8 t -123.43 116.2 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 120.826 -1.171 . . . . 0.39000000000000001 111.003 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -104.34 132.18 50.87 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 107.711 -1.218 . . . . 1.72 107.711 177.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -155.82 122.44 5.24 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 106.838 -1.542 . . . . 0.67000000000000004 106.838 178.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 911' ' ' VAL . . . . . 0.86 HG22 HG13 ' C' ' 964' ' ' VAL . 96.8 t -82.05 131.6 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.831 -0.543 . . . . 0.54000000000000004 111.133 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 57.2 mt -68.2 156.15 38.16 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.348 -0.845 . . . . 1.5 109.12 178.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 913' ' ' SER . . . . . 0.488 ' OG ' HG11 ' C' ' 919' ' ' VAL . 1.2 p -125.19 136.92 54.06 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.428 -0.952 . . . . 1.3700000000000001 108.428 176.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 914' ' ' ARG . . . . . 0.745 ' NH1' HD13 ' C' ' 956' ' ' LEU . 0.1 OUTLIER -63.69 154.93 31.55 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 120.664 -1.272 . . . . 4.2999999999999998 111.482 -179.309 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 915' ' ' SER . . . . . 0.423 ' CB ' ' O ' ' C' ' 914' ' ' ARG . 4.6 t 83.73 -31.48 0.08 Allowed 'General case' 0 N--CA 1.522 3.13 0 C-N-CA 124.054 0.942 . . . . 2.0499999999999998 112.087 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 916' ' ' ASN . . . . . 0.788 ' HB2' HG21 ' C' ' 919' ' ' VAL . 93.8 m-20 -122.39 -21.66 5.73 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 120.883 -1.136 . . . . 2.71 111.286 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 67.18 165.65 0.22 Allowed 'General case' 0 N--CA 1.52 3.032 0 N-CA-C 105.664 -1.976 . . . . 2.6800000000000002 105.664 -174.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 55.13 -126.04 37.66 Favored Glycine 1 N--CA 1.52 4.287 0 CA-C-N 123.675 2.943 . . . . 0.029999999999999999 106.962 -177.609 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 919' ' ' VAL . . . . . 0.788 HG21 ' HB2' ' C' ' 916' ' ' ASN . 91.1 t 50.59 94.01 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 121.447 -1.031 . . . . 1.3899999999999999 109.386 -178.28 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 920' ' ' ALA . . . . . 0.985 ' HB3' HG12 ' C' ' 949' ' ' VAL . . . -93.31 93.53 8.25 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.29 -0.964 . . . . 0.029999999999999999 110.565 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 921' ' ' ARG . . . . . 0.667 ' HG3' HG23 ' C' ' 922' ' ' VAL . 34.7 ptt85 -80.13 -42.3 23.78 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 105.884 -1.895 . . . . 4.4199999999999999 105.884 176.468 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 922' ' ' VAL . . . . . 0.667 HG23 ' HG3' ' C' ' 921' ' ' ARG . 78.2 t -101.18 77.06 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 N-CA-C 105.602 -1.999 . . . . 0.84999999999999998 105.602 175.155 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -87.81 135.03 33.56 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.801 0.81 . . . . 2.46 112.016 -176.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 924' ' ' SER . . . . . 0.438 ' HB2' HD22 ' C' ' 900' ' ' LEU . 4.9 t -146.54 102.63 3.59 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.297 -1.001 . . . . 0.69999999999999996 108.297 178.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -109.49 88.35 0.51 Allowed Glycine 0 N--CA 1.486 2.026 0 N-CA-C 108.494 -1.842 . . . . 0.040000000000000001 108.494 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.353 0 N-CA-C 109.315 -1.514 . . . . 0.040000000000000001 109.315 -179.448 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 8.3 m . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 120.995 0.426 . . . . 13.779999999999999 110.378 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 95.2 mt -114.03 129.51 56.6 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.465 -0.772 . . . . 13.76 110.367 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -152.35 170.46 31.6 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.514 -1.434 . . . . 9.1300000000000008 109.514 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 949' ' ' VAL . . . . . 0.985 HG12 ' HB3' ' C' ' 920' ' ' ALA . 35.1 m -117.74 136.91 53.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.529 -0.983 . . . . 7.0800000000000001 110.904 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 950' ' ' PHE . . . . . 0.453 ' CZ ' ' HB3' ' C' ' 921' ' ' ARG . 44.8 p90 -135.3 152.88 51.91 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.571 -0.706 . . . . 7.5899999999999999 109.525 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 5.6 m -118.23 -54.77 2.28 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.465 -0.772 . . . . 5.0300000000000002 111.65 -179.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 952' ' ' LEU . . . . . 0.447 ' O ' ' O ' ' C' ' 953' ' ' ILE . 58.1 tp -65.71 -78.29 0.05 Allowed 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.439 -0.788 . . . . 1.01 111.375 -178.333 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 953' ' ' ILE . . . . . 0.646 HD12 ' N ' ' C' ' 954' ' ' LEU . 2.9 pp -50.28 -150.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.688 0 N-CA-C 114.312 1.227 . . . . 2.6000000000000001 114.312 -176.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 954' ' ' LEU . . . . . 0.718 HD22 ' O ' ' C' ' 954' ' ' LEU . 0.0 OUTLIER 169.19 90.98 0.03 OUTLIER Pre-proline 0 N--CA 1.519 2.992 0 O-C-N 120.879 -1.138 . . . . 0.050000000000000003 112.03 179.902 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 955' ' ' PRO . . . . . 0.452 ' HD3' ' CD1' ' C' ' 953' ' ' ILE . 52.7 Cg_endo -79.55 93.25 1.08 Allowed 'Trans proline' 0 C--N 1.317 -1.103 0 N-CA-C 108.819 -1.262 . . . . 0.83999999999999997 108.819 178.379 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 956' ' ' LEU . . . . . 0.745 HD13 ' NH1' ' C' ' 914' ' ' ARG . 79.7 mt -126.79 148.22 49.95 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.094 -1.004 . . . . 0.040000000000000001 110.524 -179.195 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 957' ' ' GLN . . . . . 0.436 ' HB2' ' HB2' ' C' ' 960' ' ' ASP . 28.4 mt-30 -84.04 153.26 23.92 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 117.904 -1.046 . . . . 1.28 111.515 -179.096 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -68.66 120.81 15.25 Favored 'General case' 0 N--CA 1.509 2.509 0 CA-C-N 122.757 2.526 . . . . 0.17000000000000001 111.879 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 93.16 -20.76 44.02 Favored Glycine 0 N--CA 1.502 3.074 0 N-CA-C 111.193 -0.763 . . . . 0.040000000000000001 111.193 178.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 960' ' ' ASP . . . . . 0.436 ' HB2' ' HB2' ' C' ' 957' ' ' GLN . 0.8 OUTLIER -51.28 172.42 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.482 -1.01 . . . . 0.040000000000000001 110.751 -179.115 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 961' ' ' THR . . . . . 0.461 HG21 HG13 ' C' ' 885' ' ' VAL . 50.0 m -133.09 137.45 46.35 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.002 -1.061 . . . . 1.78 111.887 -178.105 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 962' ' ' VAL . . . . . 0.937 HG22 ' HB3' ' C' ' 886' ' ' PHE . 24.9 m -99.47 144.1 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 C-N-CA 119.985 -0.686 . . . . 0.040000000000000001 110.11 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 5.4 t -140.54 143.8 35.57 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.864 -0.522 . . . . 0.71999999999999997 110.148 -178.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 964' ' ' VAL . . . . . 0.86 HG13 HG22 ' C' ' 911' ' ' VAL . 56.9 t -93.8 136.87 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.191 -0.943 . . . . 1.05 110.93 -178.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -95.72 127.01 41.38 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 103.716 -2.698 . . . . 3.02 103.716 173.035 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 966' ' ' LEU . . . . . 0.49 ' C ' HG23 ' C' ' 967' ' ' VAL . 11.2 tp -132.81 62.83 1.65 Allowed 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.367 -0.975 . . . . 1.46 108.367 177.411 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 967' ' ' VAL . . . . . 0.49 HG23 ' C ' ' C' ' 966' ' ' LEU . 99.5 t -157.53 97.02 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 108.239 -1.022 . . . . 1.9399999999999999 108.239 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 92.8 mmm -142.29 60.01 1.45 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.793 -1.192 . . . . 0.0 108.358 179.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.46 119.51 1.92 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 107.192 -2.363 . . . . 2.1099999999999999 107.192 -178.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 94.7 mm-40 -82.36 -57.54 3.32 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.051 -1.264 . . . . 5.8899999999999997 110.761 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 47.4 tp -58.75 89.84 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.443 -0.786 . . . . 4.3600000000000003 110.358 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -142.41 -152.58 0.42 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.557 -0.714 . . . . 1.8300000000000001 110.118 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -120.31 170.01 9.75 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.425 -0.797 . . . . 4.3499999999999996 110.261 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 29.3 t -101.46 130.36 47.69 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.52 -0.738 . . . . 1.27 110.051 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -155.63 158.87 39.05 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.53 -0.731 . . . . 5.0199999999999996 110.524 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.35 86.51 16.73 Favored Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 121.603 -0.686 . . . . 2.4100000000000001 109.862 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -74.72 -171.65 1.01 Allowed 'Trans proline' 0 C--N 1.317 -1.081 0 O-C-N 123.311 1.164 . . . . 0.95999999999999996 111.19 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 978' ' ' LEU . . . . . 0.539 ' N ' HD12 ' C' ' 978' ' ' LEU . 5.2 mp -126.25 155.58 41.66 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 107.577 -1.268 . . . . 0.62 107.577 177.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 979' ' ' THR . . . . . 0.458 HG23 ' C ' ' C' ' 978' ' ' LEU . 39.9 p -150.66 141.08 22.43 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.791 -1.193 . . . . 3.5699999999999998 111.216 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 980' ' ' ILE . . . . . 0.739 ' HB ' HG21 ' C' ' 899' ' ' VAL . 50.4 mm -107.12 129.07 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 108.991 -0.744 . . . . 1.3300000000000001 108.991 179.333 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 981' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -118.67 95.76 4.98 Favored 'General case' 0 N--CA 1.497 1.925 0 C-N-CA 119.452 -0.899 . . . . 0.050000000000000003 111.727 -178.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 982' ' ' SER . . . . . 0.407 ' HB2' HD23 ' A' ' 952' ' ' LEU . 12.1 p -109.55 158.68 17.77 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.606 -0.684 . . . . 0.87 109.712 178.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 983' ' ' GLY . . . . . 0.437 ' HA3' ' CZ ' ' C' ' 852' ' ' PHE . . . -172.99 114.71 0.53 Allowed Glycine 0 N--CA 1.498 2.798 0 N-CA-C 106.453 -2.659 . . . . 0.029999999999999999 106.453 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 984' ' ' ALA . . . . . . . . . . . . . . . -106.49 152.45 23.63 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 114.493 1.294 . . . . 0.69999999999999996 114.493 -175.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 985' ' ' LEU . . . . . 0.841 HD13 HD22 ' C' ' 890' ' ' LEU . 62.3 tp -75.58 135.65 40.53 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.932 -1.105 . . . . 0.040000000000000001 109.787 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 986' ' ' LEU . . . . . 0.687 HD11 ' CD1' ' B' ' 986' ' ' LEU . 36.1 tp -106.75 -61.17 1.57 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.576 -0.702 . . . . 0.040000000000000001 110.098 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -143.81 146.74 33.3 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 107.647 -1.242 . . . . 0.040000000000000001 107.647 179.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -111.65 162.74 12.34 Favored Glycine 0 N--CA 1.495 2.597 0 N-CA-C 108.179 -1.968 . . . . 0.040000000000000001 108.179 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.01 112.58 18.6 Favored Pre-proline 0 N--CA 1.499 1.982 0 O-C-N 121.243 -1.151 . . . . 0.040000000000000001 109.412 179.244 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 990' ' ' PRO . . . . . 0.418 ' O ' ' HB2' ' C' ' 991' ' ' GLU . 49.4 Cg_endo -90.22 70.84 1.55 Allowed 'Trans proline' 0 C--N 1.319 -1.018 0 O-C-N 123.152 1.08 . . . . 0.45000000000000001 111.365 -178.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 991' ' ' GLU . . . . . 0.418 ' HB2' ' O ' ' C' ' 990' ' ' PRO . 69.6 mt-10 67.65 -73.27 0.08 Allowed 'General case' 0 N--CA 1.503 2.177 0 N-CA-C 108.603 -0.888 . . . . 1.97 108.603 -177.548 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 992' ' ' LEU . . . . . . . . . . . . . 11.3 mt 50.56 20.62 0.74 Allowed 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.544 -0.722 . . . . 2.3799999999999999 111.705 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -93.9 156.76 16.46 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.893 -1.13 . . . . 3.79 109.998 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 69.7 m80 -145.75 92.8 2.26 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.567 -0.708 . . . . 3.5099999999999998 110.308 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 995' ' ' ALA . . . . . . . . . . . . 2.518 . . . . . . . 0 N--CA 1.503 2.206 0 O-C-N 120.936 -1.103 . . . . 2.73 110.631 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo . . . . . 0 N--CA 1.488 1.203 0 N-CA-C 109.53 -0.989 . . . . 3.8300000000000001 109.53 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 847' ' ' VAL . . . . . 0.442 HG12 ' HB2' ' A' ' 849' ' ' GLN . 60.2 t -132.17 103.36 14.06 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.555 -0.716 . . . . 1.8300000000000001 110.188 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 848' ' ' PRO . . . . . 0.74 ' O ' HG23 ' A' ' 850' ' ' VAL . 43.7 Cg_endo -69.84 -20.32 34.61 Favored 'Trans proline' 0 N--CA 1.487 1.145 0 O-C-N 123.28 1.147 . . . . 0.65000000000000002 110.955 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 849' ' ' GLN . . . . . 0.442 ' HB2' HG12 ' A' ' 847' ' ' VAL . 57.0 tt0 27.73 68.79 0.07 Allowed 'General case' 0 N--CA 1.518 2.97 0 N-CA-C 112.821 0.675 . . . . 2.5800000000000001 112.821 179.247 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 850' ' ' VAL . . . . . 0.74 HG23 ' O ' ' A' ' 848' ' ' PRO . 57.6 t -119.93 136.06 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.135 -0.978 . . . . 1.0900000000000001 111.65 -178.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 851' ' ' ALA . . . . . 0.584 ' HB3' ' HG ' ' A' ' 873' ' ' LEU . . . -126.14 157.33 38.37 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 105.749 -1.945 . . . . 0.040000000000000001 105.749 176.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 852' ' ' PHE . . . . . 0.432 ' HA ' ' CB ' ' A' ' 874' ' ' ASN . 22.7 p90 -160.84 127.32 4.04 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 121.009 1.731 . . . . 0.050000000000000003 108.437 179.066 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 5.8 t -176.1 134.7 0.26 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.35 -0.981 . . . . 0.040000000000000001 108.35 -178.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -132.21 155.66 47.85 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.035 -1.04 . . . . 0.67000000000000004 109.541 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 855' ' ' ALA . . . . . 0.809 ' HB3' ' CB ' ' A' ' 870' ' ' ARG . . . -121.67 143.91 49.07 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.855 0.836 . . . . 0.51000000000000001 111.258 -179.043 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 856' ' ' LEU . . . . . 0.594 ' C ' HD13 ' A' ' 856' ' ' LEU . 3.4 tm? -113.13 134.73 54.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.688 -0.633 . . . . 0.050000000000000003 110.283 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 857' ' ' SER . . . . . 0.55 ' N ' HD13 ' A' ' 856' ' ' LEU . 60.8 p -151.94 17.74 0.68 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.565 -0.71 . . . . 1.3300000000000001 110.59 178.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 858' ' ' LEU . . . . . 0.761 HD22 ' OE1' ' A' ' 862' ' ' GLU . 4.4 pp -33.27 157.11 0.04 OUTLIER Pre-proline 0 N--CA 1.518 2.942 0 N-CA-C 113.159 0.8 . . . . 2.3300000000000001 113.159 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -63.2 -88.3 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.376 0 O-C-N 123.107 1.056 . . . . 2.3199999999999998 113.162 -178.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 55.2 ptt85 -128.68 -143.36 0.27 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.888 -1.132 . . . . 0.040000000000000001 111.647 -177.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 14.0 m -40.18 126.78 2.2 Favored 'General case' 0 N--CA 1.508 2.457 0 O-C-N 121.527 -0.733 . . . . 1.3100000000000001 112.453 -178.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 862' ' ' GLU . . . . . 0.761 ' OE1' HD22 ' A' ' 858' ' ' LEU . 0.7 OUTLIER -101.95 157.6 33.37 Favored Pre-proline 0 N--CA 1.489 1.498 0 N-CA-C 107.683 -1.229 . . . . 4.5099999999999998 107.683 176.967 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 863' ' ' PRO . . . . . 0.425 ' HD2' ' CG ' ' A' ' 862' ' ' GLU . 44.2 Cg_endo -71.55 -12.25 29.09 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 O-C-N 123.029 1.015 . . . . 2.2400000000000002 111.472 -179.315 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -176.02 -136.59 2.38 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 110.143 -1.183 . . . . 0.040000000000000001 110.143 179.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 25.7 m -65.48 155.85 34.3 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.317 -1.108 . . . . 1.51 110.935 -178.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 866' ' ' VAL . . . . . 0.567 HG11 ' HG ' ' A' ' 856' ' ' LEU . 60.1 t -92.14 135.29 27.24 Favored Pre-proline 0 N--CA 1.495 1.788 0 N-CA-C 113.273 0.842 . . . . 0.78000000000000003 113.273 -174.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 867' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 866' ' ' VAL . 54.9 Cg_endo -90.61 -153.01 0.04 OUTLIER 'Trans proline' 0 CA--C 1.54 0.805 0 N-CA-C 108.658 -1.324 . . . . 0.92000000000000004 108.658 177.51 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 868' ' ' PHE . . . . . 0.456 ' CD1' ' HG2' ' A' ' 881' ' ' PRO . 27.0 p90 -150.66 122.65 8.2 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.567 -1.333 . . . . 0.050000000000000003 109.632 179.226 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 49.7 p-10 -114.1 -1.93 13.58 Favored 'General case' 0 N--CA 1.5 2.035 0 C-N-CA 119.299 -0.961 . . . . 1.7 112.549 -178.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 870' ' ' ARG . . . . . 0.809 ' CB ' ' HB3' ' A' ' 855' ' ' ALA . 29.1 mmm180 -90.85 88.15 6.94 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.869 -1.144 . . . . 2.5899999999999999 110.83 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 57.5 t -72.94 97.35 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 120.929 -1.107 . . . . 1.9399999999999999 109.858 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 872' ' ' LEU . . . . . 0.617 HD11 ' HB2' ' A' ' 855' ' ' ALA . 96.1 mt -83.15 -47.47 11.57 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.524 -0.735 . . . . 1.0600000000000001 110.109 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 873' ' ' LEU . . . . . 0.584 ' HG ' ' HB3' ' A' ' 851' ' ' ALA . 30.4 tp -174.65 103.96 0.1 Allowed 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.594 -0.891 . . . . 4.1799999999999997 108.594 178.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 874' ' ' ASN . . . . . 0.432 ' CB ' ' HA ' ' A' ' 852' ' ' PHE . 37.6 t-20 178.59 81.79 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.309 0 O-C-N 121.64 -0.663 . . . . 0.040000000000000001 109.648 -178.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -66.2 -47.05 75.16 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.062 -1.024 . . . . 3.3799999999999999 111.019 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 876' ' ' GLY . . . . . . . . . . . . . . . -74.57 -25.33 70.38 Favored Glycine 0 N--CA 1.494 2.552 0 O-C-N 121.282 -0.886 . . . . 0.040000000000000001 111.712 -178.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 86.42 -58.57 4.69 Favored Glycine 0 N--CA 1.502 3.041 0 N-CA-C 108.043 -2.023 . . . . 0.040000000000000001 108.043 -178.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 878' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 60.37 -67.78 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 114.283 1.216 . . . . 3.46 114.283 177.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 879' ' ' TYR . . . . . 0.471 ' CB ' ' CD2' ' A' ' 886' ' ' PHE . 24.3 p90 -113.08 111.44 22.15 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 114.841 1.422 . . . . 0.040000000000000001 114.841 -176.434 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -66.19 119.01 58.44 Favored Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 121.526 -0.734 . . . . 0.02 110.257 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 881' ' ' PRO . . . . . 0.456 ' HG2' ' CD1' ' A' ' 868' ' ' PHE . 54.5 Cg_endo -76.44 0.67 9.23 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 O-C-N 123.389 1.205 . . . . 0.39000000000000001 112.128 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -74.77 -65.27 0.89 Allowed 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 106.686 -1.598 . . . . 0.81000000000000005 106.686 178.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 7.0 p -97.22 -15.28 20.93 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 109.014 -0.735 . . . . 0.040000000000000001 109.014 177.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.1 24.2 49.17 Favored Glycine 0 N--CA 1.494 2.523 0 O-C-N 120.947 -1.096 . . . . 0.029999999999999999 110.696 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 885' ' ' VAL . . . . . . . . . . . . . 92.4 t -72.26 88.59 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 C-N-CA 118.453 -1.299 . . . . 1.01 107.823 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 886' ' ' PHE . . . . . 0.924 ' HB3' HG22 ' A' ' 962' ' ' VAL . 0.7 OUTLIER -90.73 105.92 18.15 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 115.175 -0.92 . . . . 0.050000000000000003 112.442 -176.942 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 887' ' ' THR . . . . . 0.418 ' O ' ' HD3' ' A' ' 889' ' ' PRO . 89.8 m -96.25 100.42 12.05 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 107.48 -1.304 . . . . 0.68000000000000005 107.48 177.035 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 888' ' ' ALA . . . . . . . . . . . . . . . -99.15 106.53 39.06 Favored Pre-proline 0 N--CA 1.501 2.112 0 N-CA-C 114.044 1.127 . . . . 0.25 114.044 -176.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 889' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 887' ' ' THR . 53.8 Cg_endo -90.07 -11.98 2.95 Favored 'Trans proline' 0 CA--C 1.546 1.089 0 C-N-CA 121.093 1.195 . . . . 1.6399999999999999 109.213 176.22 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 890' ' ' LEU . . . . . 0.537 HD11 ' CD1' ' A' ' 985' ' ' LEU . 4.6 tt -34.78 -52.0 0.51 Allowed 'General case' 0 N--CA 1.509 2.482 0 N-CA-C 113.834 1.05 . . . . 2.29 113.834 -177.429 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 51.38 95.41 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.313 0 O-C-N 121.181 -0.949 . . . . 0.63 110.438 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 156.15 -147.8 16.92 Favored Glycine 0 N--CA 1.479 1.539 0 N-CA-C 107.383 -2.287 . . . . 0.040000000000000001 107.383 -179.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 893' ' ' ARG . . . . . 0.479 ' NE ' ' HB1' ' C' ' 984' ' ' ALA . 72.9 ttt-85 -108.96 127.08 53.76 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 107.536 -1.283 . . . . 3.0 107.536 177.222 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 894' ' ' TYR . . . . . 0.462 ' OH ' HD12 ' A' ' 896' ' ' LEU . 0.1 OUTLIER -131.42 144.71 51.39 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.03 -1.044 . . . . 0.040000000000000001 110.154 -179.008 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 895' ' ' LEU . . . . . 0.447 ' N ' ' CD1' ' A' ' 894' ' ' TYR . 33.9 tp -99.25 116.64 31.9 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.623 -0.673 . . . . 1.27 109.933 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 896' ' ' LEU . . . . . 0.523 HD23 ' N ' ' A' ' 897' ' ' SER . 10.4 tt -112.91 145.87 39.97 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.645 -0.66 . . . . 0.93999999999999995 110.785 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 897' ' ' SER . . . . . 0.523 ' N ' HD23 ' A' ' 896' ' ' LEU . 63.1 m -143.04 119.02 10.64 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.466 -0.771 . . . . 0.040000000000000001 110.781 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -108.34 146.91 32.28 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.657 -0.652 . . . . 0.47999999999999998 109.387 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 899' ' ' VAL . . . . . 0.72 HG21 ' HB ' ' A' ' 980' ' ' ILE . 88.3 t -93.61 119.69 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 C-N-CA 119.788 -0.765 . . . . 0.55000000000000004 111.031 -179.392 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 900' ' ' LEU . . . . . 0.57 HD12 ' HB2' ' A' ' 924' ' ' SER . 4.4 mm? -94.24 113.13 24.99 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 114.307 1.225 . . . . 1.5900000000000001 114.307 -174.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 18.1 m -67.0 141.65 57.52 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 107.33 -1.359 . . . . 0.050000000000000003 107.33 176.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -66.28 -64.84 3.12 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 110.664 -0.974 . . . . 0.029999999999999999 110.664 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 5.9 m170 46.54 64.65 1.44 Allowed 'General case' 0 N--CA 1.508 2.466 0 O-C-N 121.363 -1.081 . . . . 3.2000000000000002 111.189 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 41.6 ptt85 -68.97 -6.65 29.0 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.563 -0.71 . . . . 2.9199999999999999 112.084 -179.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 905' ' ' HIS . . . . . 0.49 ' O ' ' CB ' ' A' ' 906' ' ' GLU . 70.6 t60 -63.31 5.76 0.15 Allowed 'General case' 0 N--CA 1.505 2.324 0 O-C-N 120.945 -1.097 . . . . 2.8700000000000001 113.214 -179.052 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 906' ' ' GLU . . . . . 0.49 ' CB ' ' O ' ' A' ' 905' ' ' HIS . 0.5 OUTLIER 94.88 -164.24 0.0 OUTLIER 'General case' 0 N--CA 1.529 3.514 0 CA-C-N 120.487 1.494 . . . . 0.98999999999999999 111.789 179.126 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 907' ' ' LYS . . . . . 0.471 ' CB ' ' O ' ' A' ' 906' ' ' GLU . 56.5 tttt 86.69 156.24 0.08 Allowed 'General case' 0 N--CA 1.52 3.031 0 N-CA-C 108.124 -1.065 . . . . 5.25 108.124 -176.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 60.8 t -123.12 115.88 46.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 120.821 -1.174 . . . . 0.39000000000000001 111.173 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -102.65 132.78 48.54 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 107.334 -1.358 . . . . 1.72 107.334 176.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -154.7 123.24 6.09 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 106.715 -1.587 . . . . 0.67000000000000004 106.715 178.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 911' ' ' VAL . . . . . 0.79 HG22 HG13 ' A' ' 964' ' ' VAL . 79.4 t -82.77 131.06 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 C-N-CA 120.378 -0.529 . . . . 0.54000000000000004 111.028 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 75.3 mt -66.7 156.45 35.28 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.381 -0.824 . . . . 1.5 109.032 178.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 913' ' ' SER . . . . . 0.491 ' OG ' HG11 ' A' ' 919' ' ' VAL . 1.1 p -125.34 135.41 52.43 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.23 -1.026 . . . . 1.3700000000000001 108.23 176.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 914' ' ' ARG . . . . . 0.88 ' NH1' HD23 ' A' ' 956' ' ' LEU . 0.0 OUTLIER -64.23 155.11 32.94 Favored 'General case' 0 N--CA 1.506 2.361 0 O-C-N 120.7 -1.25 . . . . 4.2999999999999998 111.63 -179.287 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 915' ' ' SER . . . . . 0.441 ' CB ' ' O ' ' A' ' 914' ' ' ARG . 2.0 t 84.1 -31.75 0.07 Allowed 'General case' 0 N--CA 1.52 3.071 0 C-N-CA 124.036 0.935 . . . . 2.0499999999999998 111.769 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 916' ' ' ASN . . . . . 0.77 ' HB2' HG21 ' A' ' 919' ' ' VAL . 68.8 m-80 -123.49 -21.3 5.33 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 120.946 -1.096 . . . . 2.71 111.299 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 917' ' ' GLN . . . . . 0.413 ' HB2' ' O ' ' A' ' 916' ' ' ASN . 50.2 mt-30 66.71 166.48 0.21 Allowed 'General case' 0 N--CA 1.52 3.047 0 N-CA-C 105.789 -1.93 . . . . 2.6800000000000002 105.789 -174.097 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.24 -125.32 33.43 Favored Glycine 1 N--CA 1.522 4.372 0 CA-C-N 123.646 2.93 . . . . 0.029999999999999999 107.041 -177.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 919' ' ' VAL . . . . . 0.77 HG21 ' HB2' ' A' ' 916' ' ' ASN . 78.1 t 51.57 94.14 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 O-C-N 121.357 -1.084 . . . . 1.3899999999999999 109.08 -178.269 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 920' ' ' ALA . . . . . 0.74 ' HB3' HG12 ' A' ' 949' ' ' VAL . . . -92.31 91.83 7.88 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 119.358 -0.937 . . . . 0.029999999999999999 110.882 -179.166 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 921' ' ' ARG . . . . . 0.841 ' HG3' HG23 ' A' ' 922' ' ' VAL . 30.7 ptt180 -83.56 -41.42 17.93 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 105.641 -1.985 . . . . 4.4199999999999999 105.641 176.016 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 922' ' ' VAL . . . . . 0.841 HG23 ' HG3' ' A' ' 921' ' ' ARG . 97.1 t -98.79 78.39 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 N-CA-C 106.041 -1.837 . . . . 0.84999999999999998 106.041 175.562 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -86.12 133.91 33.85 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.717 0.77 . . . . 2.46 111.381 -177.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 924' ' ' SER . . . . . 0.57 ' HB2' HD12 ' A' ' 900' ' ' LEU . 17.8 t -147.35 104.49 3.65 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.869 -0.789 . . . . 0.69999999999999996 108.869 179.396 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -103.75 83.35 0.41 Allowed Glycine 0 N--CA 1.487 2.071 0 N-CA-C 108.242 -1.943 . . . . 0.040000000000000001 108.242 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.239 0 N-CA-C 108.98 -1.648 . . . . 0.040000000000000001 108.98 -179.403 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 63.8 m . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.005 0.431 . . . . 13.779999999999999 110.264 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 94.4 mt -109.44 129.41 55.55 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.574 -0.704 . . . . 13.76 110.369 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -152.64 169.33 31.73 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.189 -1.565 . . . . 9.1300000000000008 109.189 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 949' ' ' VAL . . . . . 0.74 HG12 ' HB3' ' A' ' 920' ' ' ALA . 35.1 m -117.99 133.21 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.518 -0.989 . . . . 7.0800000000000001 110.801 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 950' ' ' PHE . . . . . 0.449 ' CZ ' ' HB3' ' A' ' 921' ' ' ARG . 30.7 p90 -130.69 147.06 52.32 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.59 -0.694 . . . . 7.5899999999999999 109.502 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 73.6 m -119.98 -54.68 2.11 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.487 -0.758 . . . . 5.0300000000000002 111.843 -178.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 952' ' ' LEU . . . . . 0.41 ' O ' ' O ' ' A' ' 953' ' ' ILE . 55.9 tp -60.75 -76.87 0.05 OUTLIER 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.417 -0.802 . . . . 1.01 112.178 -177.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 953' ' ' ILE . . . . . 0.488 HD11 HD13 ' C' ' 872' ' ' LEU . 47.6 pt -53.78 -141.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.656 0 N-CA-C 113.81 1.041 . . . . 2.6000000000000001 113.81 -176.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 954' ' ' LEU . . . . . 0.793 HD22 ' O ' ' A' ' 954' ' ' LEU . 0.0 OUTLIER 173.79 78.7 0.05 OUTLIER Pre-proline 0 N--CA 1.508 2.451 0 O-C-N 120.777 -1.202 . . . . 0.050000000000000003 111.037 179.427 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 955' ' ' PRO . . . . . 0.553 ' C ' HD12 ' A' ' 956' ' ' LEU . 45.8 Cg_endo -73.61 89.89 0.95 Allowed 'Trans proline' 0 C--N 1.314 -1.255 0 N-CA-C 109.45 -1.019 . . . . 0.83999999999999997 109.45 178.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 956' ' ' LEU . . . . . 0.88 HD23 ' NH1' ' A' ' 914' ' ' ARG . 5.7 mp -125.52 150.17 47.66 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.187 -0.946 . . . . 0.040000000000000001 110.487 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 59.6 mt-30 -81.74 151.9 27.27 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-O 117.784 -1.103 . . . . 1.28 111.793 -179.108 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -70.2 119.83 14.98 Favored 'General case' 0 N--CA 1.511 2.609 0 CA-C-N 123.048 2.658 . . . . 0.17000000000000001 111.671 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.6 -23.0 30.22 Favored Glycine 0 N--CA 1.501 3.031 0 N-CA-C 111.025 -0.83 . . . . 0.040000000000000001 111.025 178.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 960' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.85 171.45 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.567 -0.96 . . . . 0.040000000000000001 110.202 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 961' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' A' ' 886' ' ' PHE . 46.3 m -133.36 137.87 46.06 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.893 -1.129 . . . . 1.78 112.127 -178.01 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 962' ' ' VAL . . . . . 0.924 HG22 ' HB3' ' A' ' 886' ' ' PHE . 26.3 m -99.03 144.13 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.675 -0.641 . . . . 0.040000000000000001 110.229 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 1.6 m -137.68 144.32 41.76 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.857 -0.527 . . . . 0.71999999999999997 110.031 -178.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 964' ' ' VAL . . . . . 0.79 HG13 HG22 ' A' ' 911' ' ' VAL . 58.1 t -94.88 136.01 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.13 -0.981 . . . . 1.05 110.538 -179.193 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -93.98 127.51 39.8 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 103.784 -2.673 . . . . 3.02 103.784 173.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 966' ' ' LEU . . . . . 0.49 ' C ' HG23 ' A' ' 967' ' ' VAL . 1.2 tt -132.12 61.43 1.66 Allowed 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.232 -1.025 . . . . 1.46 108.232 177.267 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 967' ' ' VAL . . . . . 0.49 HG23 ' C ' ' A' ' 966' ' ' LEU . 94.2 t -158.28 96.41 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 108.056 -1.09 . . . . 1.9399999999999999 108.056 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 90.6 mmm -142.17 60.1 1.46 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.709 -1.244 . . . . 0.0 108.344 179.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.47 119.83 1.95 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 107.08 -2.408 . . . . 2.1099999999999999 107.08 -178.266 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -81.96 -58.04 3.15 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.065 -1.256 . . . . 5.8899999999999997 110.562 -179.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 40.6 tp -59.19 90.01 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.442 -0.786 . . . . 4.3600000000000003 110.283 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -141.32 -154.02 0.49 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.613 -0.679 . . . . 1.8300000000000001 110.117 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -120.08 172.34 7.82 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.486 -0.759 . . . . 4.3499999999999996 110.215 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 30.8 t -101.46 130.05 47.63 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.568 -0.707 . . . . 1.27 110.009 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -156.21 156.44 34.15 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.499 -0.75 . . . . 5.0199999999999996 110.529 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.15 85.46 18.8 Favored Pre-proline 0 N--CA 1.5 2.041 0 O-C-N 121.616 -0.677 . . . . 2.4100000000000001 109.613 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 977' ' ' PRO . . . . . 0.665 ' C ' HD12 ' A' ' 978' ' ' LEU . 47.2 Cg_endo -72.82 -172.58 0.99 Allowed 'Trans proline' 0 C--N 1.317 -1.091 0 O-C-N 123.29 1.153 . . . . 0.95999999999999996 111.216 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 978' ' ' LEU . . . . . 0.665 HD12 ' C ' ' A' ' 977' ' ' PRO . 6.7 mp -127.25 154.7 44.55 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 107.644 -1.243 . . . . 0.62 107.644 178.045 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 979' ' ' THR . . . . . 0.466 HG23 ' C ' ' A' ' 978' ' ' LEU . 41.1 p -150.54 141.16 22.61 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.781 -1.199 . . . . 3.5699999999999998 111.145 -179.439 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 980' ' ' ILE . . . . . 0.72 ' HB ' HG21 ' A' ' 899' ' ' VAL . 50.7 mm -106.22 127.43 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 108.881 -0.785 . . . . 1.3300000000000001 108.881 179.351 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 981' ' ' PHE . . . . . 0.401 ' HD1' ' HH ' ' A' ' 879' ' ' TYR . 6.7 t80 -120.71 99.26 6.43 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.414 -0.804 . . . . 0.050000000000000003 111.782 -178.323 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 85.9 p -108.16 159.89 16.25 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 109.06 -0.719 . . . . 0.87 109.06 178.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . -171.45 109.55 0.32 Allowed Glycine 0 N--CA 1.498 2.82 0 N-CA-C 106.635 -2.586 . . . . 0.029999999999999999 106.635 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -109.61 148.62 30.98 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 114.561 1.319 . . . . 0.69999999999999996 114.561 -175.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 985' ' ' LEU . . . . . 0.537 ' CD1' HD11 ' A' ' 890' ' ' LEU . 51.8 tp -68.77 134.4 49.7 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.854 -1.154 . . . . 0.040000000000000001 110.084 179.498 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 45.8 tp -107.82 -59.19 1.87 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.563 -0.71 . . . . 0.040000000000000001 109.925 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -144.32 144.91 31.68 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.601 -1.259 . . . . 0.040000000000000001 107.601 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -113.1 162.8 12.24 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 108.187 -1.965 . . . . 0.040000000000000001 108.187 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -75.16 112.97 20.8 Favored Pre-proline 0 N--CA 1.499 1.981 0 O-C-N 121.186 -1.185 . . . . 0.040000000000000001 109.454 179.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 990' ' ' PRO . . . . . 0.424 ' O ' ' HB2' ' A' ' 991' ' ' GLU . 50.9 Cg_endo -88.01 72.09 2.69 Favored 'Trans proline' 0 C--N 1.32 -0.968 0 O-C-N 123.055 1.029 . . . . 0.45000000000000001 111.363 -179.004 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 991' ' ' GLU . . . . . 0.424 ' HB2' ' O ' ' A' ' 990' ' ' PRO . 71.8 mt-10 67.51 -73.65 0.08 Allowed 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 108.529 -0.915 . . . . 1.97 108.529 -177.533 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 992' ' ' LEU . . . . . 0.404 ' HA ' HD23 ' A' ' 992' ' ' LEU . 11.1 mt 50.55 20.87 0.77 Allowed 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.612 -0.68 . . . . 2.3799999999999999 111.642 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -93.56 156.7 16.58 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.942 -1.099 . . . . 3.79 110.033 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -145.3 92.6 2.27 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.587 -0.696 . . . . 3.5099999999999998 110.276 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 995' ' ' ALA . . . . . . . . . . . . 2.519 . . . . . . . 0 N--CA 1.503 2.224 0 O-C-N 120.887 -1.133 . . . . 2.73 110.648 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo . . . . . 0 N--CA 1.488 1.172 0 N-CA-C 109.543 -0.983 . . . . 3.8300000000000001 109.543 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 847' ' ' VAL . . . . . 0.423 HG12 ' HB2' ' B' ' 849' ' ' GLN . 61.5 t -132.57 103.42 13.51 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.547 -0.721 . . . . 1.8300000000000001 110.098 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 848' ' ' PRO . . . . . 0.734 ' O ' HG23 ' B' ' 850' ' ' VAL . 43.7 Cg_endo -69.88 -20.28 34.44 Favored 'Trans proline' 0 N--CA 1.487 1.125 0 O-C-N 123.299 1.157 . . . . 0.65000000000000002 111.003 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 849' ' ' GLN . . . . . 0.423 ' HB2' HG12 ' B' ' 847' ' ' VAL . 56.9 tt0 27.77 68.22 0.07 Allowed 'General case' 0 N--CA 1.518 2.941 0 N-CA-C 112.923 0.712 . . . . 2.5800000000000001 112.923 179.156 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 850' ' ' VAL . . . . . 0.734 HG23 ' O ' ' B' ' 848' ' ' PRO . 57.4 t -119.37 136.14 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.128 -0.983 . . . . 1.0900000000000001 111.679 -178.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 851' ' ' ALA . . . . . 0.596 ' HB3' ' HG ' ' B' ' 873' ' ' LEU . . . -126.29 157.13 39.16 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 105.776 -1.935 . . . . 0.040000000000000001 105.776 176.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 852' ' ' PHE . . . . . 0.424 ' HA ' ' CB ' ' B' ' 874' ' ' ASN . 23.0 p90 -160.68 127.4 4.16 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 120.886 1.675 . . . . 0.050000000000000003 108.581 179.105 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 5.7 t -176.15 134.79 0.26 Allowed 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.305 -0.998 . . . . 0.040000000000000001 108.305 -178.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -132.15 156.1 46.99 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.066 -1.022 . . . . 0.67000000000000004 109.542 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 855' ' ' ALA . . . . . 0.808 ' HB3' ' CB ' ' B' ' 870' ' ' ARG . . . -121.92 143.97 49.14 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.864 0.84 . . . . 0.51000000000000001 111.315 -179.016 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 856' ' ' LEU . . . . . 0.603 ' C ' HD13 ' B' ' 856' ' ' LEU . 3.4 tm? -113.2 134.88 54.36 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.687 -0.633 . . . . 0.050000000000000003 110.253 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 857' ' ' SER . . . . . 0.54 ' N ' HD13 ' B' ' 856' ' ' LEU . 60.8 p -152.12 16.96 0.65 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.553 -0.717 . . . . 1.3300000000000001 110.616 178.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 858' ' ' LEU . . . . . 0.744 HD22 ' OE1' ' B' ' 862' ' ' GLU . 4.4 pp -32.65 156.92 0.03 OUTLIER Pre-proline 0 N--CA 1.518 2.945 0 N-CA-C 113.276 0.843 . . . . 2.3300000000000001 113.276 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -62.95 -88.39 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.344 0 O-C-N 123.132 1.07 . . . . 2.3199999999999998 113.228 -178.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 55.2 ptt85 -128.65 -143.36 0.27 Allowed 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.852 -1.155 . . . . 0.040000000000000001 111.685 -177.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 14.1 m -40.16 126.83 2.19 Favored 'General case' 0 N--CA 1.508 2.451 0 O-C-N 121.566 -0.709 . . . . 1.3100000000000001 112.408 -178.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 862' ' ' GLU . . . . . 0.744 ' OE1' HD22 ' B' ' 858' ' ' LEU . 0.7 OUTLIER -102.01 157.63 33.32 Favored Pre-proline 0 N--CA 1.489 1.51 0 N-CA-C 107.673 -1.232 . . . . 4.5099999999999998 107.673 176.954 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 863' ' ' PRO . . . . . 0.417 ' HD2' ' CG ' ' B' ' 862' ' ' GLU . 44.4 Cg_endo -71.63 -11.94 28.56 Favored 'Trans proline' 0 C--N 1.314 -1.268 0 O-C-N 123.006 1.003 . . . . 2.2400000000000002 111.472 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -176.08 -136.61 2.39 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 110.152 -1.179 . . . . 0.040000000000000001 110.152 179.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 26.1 m -65.75 155.95 34.56 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.357 -1.084 . . . . 1.51 110.934 -178.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 866' ' ' VAL . . . . . 0.564 HG11 ' HG ' ' B' ' 856' ' ' LEU . 59.8 t -92.11 135.22 27.36 Favored Pre-proline 0 N--CA 1.494 1.743 0 N-CA-C 113.265 0.839 . . . . 0.78000000000000003 113.265 -174.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 867' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' B' ' 866' ' ' VAL . 54.9 Cg_endo -90.49 -152.7 0.04 OUTLIER 'Trans proline' 0 CA--C 1.54 0.82 0 N-CA-C 108.612 -1.341 . . . . 0.92000000000000004 108.612 177.502 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 868' ' ' PHE . . . . . 0.449 ' CD1' ' N ' ' B' ' 868' ' ' PHE . 27.0 p90 -150.98 122.47 7.91 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.631 -1.293 . . . . 0.050000000000000003 109.592 179.218 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 50.3 p-10 -113.86 -1.94 13.75 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 119.343 -0.943 . . . . 1.7 112.519 -178.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 870' ' ' ARG . . . . . 0.808 ' CB ' ' HB3' ' B' ' 855' ' ' ALA . 28.9 mmm180 -90.72 88.45 7.09 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.908 -1.12 . . . . 2.5899999999999999 110.773 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 57.3 t -73.28 97.07 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.011 -1.056 . . . . 1.9399999999999999 109.864 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 872' ' ' LEU . . . . . 0.615 HD11 ' HB2' ' B' ' 855' ' ' ALA . 96.2 mt -83.05 -47.57 11.54 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.535 -0.728 . . . . 1.0600000000000001 110.14 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 873' ' ' LEU . . . . . 0.596 ' HG ' ' HB3' ' B' ' 851' ' ' ALA . 30.4 tp -174.63 103.83 0.1 Allowed 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.545 -0.909 . . . . 4.1799999999999997 108.545 178.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 874' ' ' ASN . . . . . 0.424 ' CB ' ' HA ' ' B' ' 852' ' ' PHE . 37.5 t-20 178.66 81.66 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.281 0 O-C-N 121.608 -0.682 . . . . 0.040000000000000001 109.698 -178.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -66.03 -47.11 75.49 Favored 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 119.297 -0.961 . . . . 3.3799999999999999 110.994 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 876' ' ' GLY . . . . . . . . . . . . . . . -74.64 -24.78 71.63 Favored Glycine 0 N--CA 1.493 2.486 0 C-N-CA 120.526 -0.845 . . . . 0.040000000000000001 111.842 -178.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 85.91 -58.77 4.78 Favored Glycine 0 N--CA 1.502 3.06 0 N-CA-C 108.105 -1.998 . . . . 0.040000000000000001 108.105 -178.199 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 878' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 60.45 -67.74 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 114.263 1.209 . . . . 3.46 114.263 177.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 879' ' ' TYR . . . . . 0.463 ' CB ' ' CD2' ' B' ' 886' ' ' PHE . 24.2 p90 -113.2 110.67 20.78 Favored 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 114.955 1.465 . . . . 0.040000000000000001 114.955 -176.344 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -65.62 118.94 56.09 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 121.494 -0.754 . . . . 0.02 110.196 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 881' ' ' PRO . . . . . 0.445 ' HG2' ' CD1' ' B' ' 868' ' ' PHE . 54.2 Cg_endo -76.34 0.38 9.5 Favored 'Trans proline' 0 N--CA 1.493 1.483 0 O-C-N 123.337 1.178 . . . . 0.39000000000000001 112.221 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -74.44 -65.23 0.88 Allowed 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 106.7 -1.593 . . . . 0.81000000000000005 106.7 178.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 7.0 p -96.99 -15.77 20.92 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 109.0 -0.741 . . . . 0.040000000000000001 109.0 177.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.42 24.09 48.44 Favored Glycine 0 N--CA 1.495 2.569 0 C-N-CA 120.034 -1.079 . . . . 0.029999999999999999 110.596 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 885' ' ' VAL . . . . . . . . . . . . . 92.9 t -72.12 88.64 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 C-N-CA 118.514 -1.274 . . . . 1.01 107.865 -179.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 886' ' ' PHE . . . . . 0.892 ' HB3' HG22 ' B' ' 962' ' ' VAL . 0.7 OUTLIER -90.82 105.52 17.88 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 115.249 -0.887 . . . . 0.050000000000000003 112.577 -176.848 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 887' ' ' THR . . . . . 0.418 ' O ' ' HD3' ' B' ' 889' ' ' PRO . 89.6 m -95.93 100.27 11.97 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 107.555 -1.276 . . . . 0.68000000000000005 107.555 177.19 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 888' ' ' ALA . . . . . . . . . . . . . . . -99.02 106.55 38.76 Favored Pre-proline 0 N--CA 1.501 2.114 0 N-CA-C 114.125 1.157 . . . . 0.25 114.125 -176.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 889' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' B' ' 887' ' ' THR . 53.4 Cg_endo -90.15 -11.77 2.97 Favored 'Trans proline' 0 CA--C 1.547 1.143 0 C-N-CA 121.143 1.228 . . . . 1.6399999999999999 109.128 176.224 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 890' ' ' LEU . . . . . 0.537 HD11 ' CD1' ' B' ' 985' ' ' LEU . 4.6 tt -34.96 -51.81 0.53 Allowed 'General case' 0 N--CA 1.509 2.487 0 N-CA-C 113.867 1.062 . . . . 2.29 113.867 -177.422 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 51.29 95.52 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.373 0 O-C-N 121.131 -0.981 . . . . 0.63 110.425 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . 156.09 -147.68 16.65 Favored Glycine 0 N--CA 1.48 1.581 0 N-CA-C 107.383 -2.287 . . . . 0.040000000000000001 107.383 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 72.9 ttt-85 -109.04 127.06 53.79 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 107.49 -1.3 . . . . 3.0 107.49 177.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 894' ' ' TYR . . . . . 0.468 ' OH ' HD12 ' B' ' 896' ' ' LEU . 0.1 OUTLIER -131.45 144.81 51.44 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.053 -1.029 . . . . 0.040000000000000001 110.17 -179.112 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 895' ' ' LEU . . . . . 0.448 ' N ' ' CD1' ' B' ' 894' ' ' TYR . 34.1 tp -99.3 116.68 32.04 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.623 -0.673 . . . . 1.27 109.846 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 896' ' ' LEU . . . . . 0.536 HD23 ' N ' ' B' ' 897' ' ' SER . 10.4 tt -112.75 146.57 38.53 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.587 -0.696 . . . . 0.93999999999999995 110.704 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 897' ' ' SER . . . . . 0.536 ' N ' HD23 ' B' ' 896' ' ' LEU . 63.3 m -143.78 118.89 10.08 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.42 -0.8 . . . . 0.040000000000000001 110.741 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -108.2 147.21 31.67 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.689 -0.632 . . . . 0.47999999999999998 109.352 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 899' ' ' VAL . . . . . 0.71 HG21 ' HB ' ' B' ' 980' ' ' ILE . 88.3 t -93.86 120.15 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.417 -0.802 . . . . 0.55000000000000004 110.9 -179.501 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 900' ' ' LEU . . . . . 0.571 HD12 ' HB2' ' B' ' 924' ' ' SER . 4.4 mm? -94.7 112.94 24.67 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 114.257 1.206 . . . . 1.5900000000000001 114.257 -174.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 17.9 m -66.81 141.63 57.63 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 107.348 -1.352 . . . . 0.050000000000000003 107.348 176.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -66.18 -65.18 2.96 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 110.598 -1.001 . . . . 0.029999999999999999 110.598 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 5.9 m170 46.9 64.93 1.36 Allowed 'General case' 0 N--CA 1.507 2.393 0 O-C-N 121.381 -1.07 . . . . 3.2000000000000002 111.122 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 41.6 ptt85 -69.24 -6.71 30.92 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.574 -0.704 . . . . 2.9199999999999999 111.989 -179.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 905' ' ' HIS . . . . . 0.486 ' O ' ' CB ' ' B' ' 906' ' ' GLU . 70.5 t60 -63.48 6.14 0.15 Allowed 'General case' 0 N--CA 1.507 2.387 0 O-C-N 120.867 -1.146 . . . . 2.8700000000000001 113.163 -178.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 906' ' ' GLU . . . . . 0.486 ' CB ' ' O ' ' B' ' 905' ' ' HIS . 0.5 OUTLIER 94.58 -164.31 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.47 0 CA-C-N 120.592 1.542 . . . . 0.98999999999999999 111.848 179.008 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 907' ' ' LYS . . . . . 0.476 ' CB ' ' O ' ' B' ' 906' ' ' GLU . 56.6 tttt 86.62 156.04 0.08 Allowed 'General case' 0 N--CA 1.52 3.067 0 N-CA-C 108.042 -1.096 . . . . 5.25 108.042 -176.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 60.3 t -122.97 115.68 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 120.804 -1.185 . . . . 0.39000000000000001 111.116 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 51.0 tp10 -102.01 133.32 47.0 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 107.328 -1.36 . . . . 1.72 107.328 176.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -155.15 123.04 5.76 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 106.783 -1.562 . . . . 0.67000000000000004 106.783 178.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 911' ' ' VAL . . . . . 0.775 HG22 HG13 ' B' ' 964' ' ' VAL . 77.9 t -82.53 131.17 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.858 -0.526 . . . . 0.54000000000000004 111.022 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 75.5 mt -66.82 156.53 35.34 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.407 -0.808 . . . . 1.5 108.951 178.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 913' ' ' SER . . . . . 0.499 ' OG ' HG11 ' B' ' 919' ' ' VAL . 1.1 p -125.32 135.85 52.89 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.181 -1.044 . . . . 1.3700000000000001 108.181 176.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 914' ' ' ARG . . . . . 0.875 ' NH1' HD23 ' B' ' 956' ' ' LEU . 0.0 OUTLIER -64.61 155.62 32.67 Favored 'General case' 0 N--CA 1.506 2.35 0 O-C-N 120.619 -1.301 . . . . 4.2999999999999998 111.528 -179.295 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 915' ' ' SER . . . . . 0.429 ' CB ' ' O ' ' B' ' 914' ' ' ARG . 2.0 t 83.64 -31.58 0.08 Allowed 'General case' 0 N--CA 1.52 3.07 0 C-N-CA 123.968 0.907 . . . . 2.0499999999999998 111.887 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 916' ' ' ASN . . . . . 0.774 ' HB2' HG21 ' B' ' 919' ' ' VAL . 68.8 m-80 -123.82 -21.1 5.24 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 120.927 -1.108 . . . . 2.71 111.268 -179.378 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 917' ' ' GLN . . . . . 0.416 ' HB2' ' O ' ' B' ' 916' ' ' ASN . 50.3 mt-30 66.71 166.41 0.21 Allowed 'General case' 0 N--CA 1.521 3.094 0 N-CA-C 105.74 -1.948 . . . . 2.6800000000000002 105.74 -174.18 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.07 -125.08 32.37 Favored Glycine 1 N--CA 1.522 4.386 0 CA-C-N 123.397 2.817 . . . . 0.029999999999999999 107.071 -177.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 919' ' ' VAL . . . . . 0.774 HG21 ' HB2' ' B' ' 916' ' ' ASN . 76.4 t 51.69 94.23 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.262 0 O-C-N 121.407 -1.055 . . . . 1.3899999999999999 109.036 -178.294 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 920' ' ' ALA . . . . . 0.73 ' HB3' HG12 ' B' ' 949' ' ' VAL . . . -92.31 92.06 7.98 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.335 -0.946 . . . . 0.029999999999999999 110.831 -179.195 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 921' ' ' ARG . . . . . 0.863 ' HG3' HG23 ' B' ' 922' ' ' VAL . 30.6 ptt180 -83.68 -41.62 17.53 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 105.65 -1.981 . . . . 4.4199999999999999 105.65 175.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 922' ' ' VAL . . . . . 0.863 HG23 ' HG3' ' B' ' 921' ' ' ARG . 96.9 t -98.66 78.81 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 N-CA-C 105.939 -1.874 . . . . 0.84999999999999998 105.939 175.525 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -86.47 134.05 33.71 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.654 0.74 . . . . 2.46 111.368 -177.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 924' ' ' SER . . . . . 0.571 ' HB2' HD12 ' B' ' 900' ' ' LEU . 17.4 t -147.49 104.84 3.66 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.713 -0.847 . . . . 0.69999999999999996 108.713 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -104.13 83.36 0.4 Allowed Glycine 0 N--CA 1.487 2.041 0 N-CA-C 108.222 -1.951 . . . . 0.040000000000000001 108.222 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 108.973 -1.651 . . . . 0.040000000000000001 108.973 -179.376 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 68.1 m . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.014 0.435 . . . . 13.779999999999999 110.246 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 94.8 mt -108.88 129.44 55.41 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.583 -0.698 . . . . 13.76 110.323 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -152.19 168.83 31.43 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.235 -1.546 . . . . 9.1300000000000008 109.235 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 949' ' ' VAL . . . . . 0.73 HG12 ' HB3' ' B' ' 920' ' ' ALA . 35.0 m -117.85 132.74 66.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.525 -0.985 . . . . 7.0800000000000001 110.717 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 950' ' ' PHE . . . . . 0.445 ' CZ ' ' HB3' ' B' ' 921' ' ' ARG . 30.7 p90 -130.49 146.57 52.05 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.518 -0.739 . . . . 7.5899999999999999 109.55 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 73.4 m -119.38 -54.11 2.2 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.452 -0.78 . . . . 5.0300000000000002 111.808 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 952' ' ' LEU . . . . . 0.409 ' O ' ' O ' ' B' ' 953' ' ' ILE . 56.5 tp -61.42 -77.02 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.465 -0.772 . . . . 1.01 112.285 -177.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 953' ' ' ILE . . . . . 0.491 ' O ' ' HB3' ' B' ' 954' ' ' LEU . 48.9 pt -53.83 -141.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.739 0 N-CA-C 113.701 1.0 . . . . 2.6000000000000001 113.701 -176.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 954' ' ' LEU . . . . . 0.789 HD22 ' O ' ' B' ' 954' ' ' LEU . 0.0 OUTLIER 174.07 78.68 0.05 OUTLIER Pre-proline 0 N--CA 1.509 2.495 0 O-C-N 120.654 -1.279 . . . . 0.050000000000000003 110.963 179.47 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 955' ' ' PRO . . . . . 0.545 ' C ' HD12 ' B' ' 956' ' ' LEU . 46.0 Cg_endo -73.51 89.52 0.95 Allowed 'Trans proline' 0 C--N 1.315 -1.236 0 N-CA-C 109.514 -0.995 . . . . 0.83999999999999997 109.514 178.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 956' ' ' LEU . . . . . 0.875 HD23 ' NH1' ' B' ' 914' ' ' ARG . 5.7 mp -125.22 150.22 47.22 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.289 -0.882 . . . . 0.040000000000000001 110.461 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -82.14 151.38 26.99 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 117.729 -1.129 . . . . 1.28 111.828 -179.094 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -69.77 119.74 14.46 Favored 'General case' 0 N--CA 1.512 2.626 0 CA-C-N 123.14 2.7 . . . . 0.17000000000000001 111.784 -179.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.76 -22.66 32.48 Favored Glycine 0 N--CA 1.502 3.076 0 N-CA-C 111.037 -0.825 . . . . 0.040000000000000001 111.037 178.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 960' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -52.19 171.55 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.54 -0.976 . . . . 0.040000000000000001 110.198 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 961' ' ' THR . . . . . 0.461 ' HA ' ' O ' ' B' ' 886' ' ' PHE . 47.1 m -133.42 137.83 45.96 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.846 -1.159 . . . . 1.78 112.103 -178.084 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 962' ' ' VAL . . . . . 0.892 HG22 ' HB3' ' B' ' 886' ' ' PHE . 26.3 m -98.84 144.44 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 C-N-CA 120.169 -0.612 . . . . 0.040000000000000001 110.219 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 1.6 m -137.87 144.72 41.52 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.857 -0.527 . . . . 0.71999999999999997 110.009 -178.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 964' ' ' VAL . . . . . 0.775 HG13 HG22 ' B' ' 911' ' ' VAL . 58.1 t -95.2 136.34 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.107 -0.995 . . . . 1.05 110.434 -179.268 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -94.29 127.59 40.25 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 103.758 -2.682 . . . . 3.02 103.758 173.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 966' ' ' LEU . . . . . 0.494 ' C ' HG23 ' B' ' 967' ' ' VAL . 1.2 tt -132.24 61.67 1.66 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.123 -1.065 . . . . 1.46 108.123 177.315 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 967' ' ' VAL . . . . . 0.494 HG23 ' C ' ' B' ' 966' ' ' LEU . 94.4 t -158.42 97.02 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 107.917 -1.142 . . . . 1.9399999999999999 107.917 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 90.4 mmm -142.79 59.92 1.43 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.715 -1.24 . . . . 0.0 108.251 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.64 119.98 1.96 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 107.043 -2.423 . . . . 2.1099999999999999 107.043 -178.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -82.12 -58.2 3.06 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.974 -1.31 . . . . 5.8899999999999997 110.492 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 40.0 tp -58.9 90.47 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.407 -0.808 . . . . 4.3600000000000003 110.336 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -141.88 -154.32 0.51 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.565 -0.71 . . . . 1.8300000000000001 110.139 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -120.04 171.84 8.17 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.409 -0.807 . . . . 4.3499999999999996 110.273 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 31.5 t -100.97 130.03 46.9 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.555 -0.716 . . . . 1.27 110.068 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -156.25 156.44 34.09 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.511 -0.743 . . . . 5.0199999999999996 110.553 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.14 85.49 18.82 Favored Pre-proline 0 N--CA 1.5 2.038 0 O-C-N 121.655 -0.653 . . . . 2.4100000000000001 109.671 179.467 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 977' ' ' PRO . . . . . 0.673 ' C ' HD12 ' B' ' 978' ' ' LEU . 47.5 Cg_endo -72.66 -172.42 0.94 Allowed 'Trans proline' 0 C--N 1.317 -1.098 0 O-C-N 123.299 1.158 . . . . 0.95999999999999996 111.258 -179.407 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 978' ' ' LEU . . . . . 0.673 HD12 ' C ' ' B' ' 977' ' ' PRO . 6.6 mp -127.58 154.48 45.14 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 107.639 -1.245 . . . . 0.62 107.639 178.006 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 979' ' ' THR . . . . . 0.47 HG23 ' C ' ' B' ' 978' ' ' LEU . 41.3 p -150.28 141.38 23.05 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.79 -1.194 . . . . 3.5699999999999998 111.12 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 980' ' ' ILE . . . . . 0.71 ' HB ' HG21 ' B' ' 899' ' ' VAL . 50.7 mm -106.4 127.42 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 108.852 -0.796 . . . . 1.3300000000000001 108.852 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -120.63 99.25 6.43 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 119.723 -0.791 . . . . 0.050000000000000003 111.791 -178.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 81.9 p -108.42 159.67 16.49 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.543 -0.723 . . . . 0.87 109.104 178.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 983' ' ' GLY . . . . . . . . . . . . . . . -171.14 110.03 0.34 Allowed Glycine 0 N--CA 1.497 2.759 0 N-CA-C 106.496 -2.641 . . . . 0.029999999999999999 106.496 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -110.03 148.01 32.47 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 114.637 1.347 . . . . 0.69999999999999996 114.637 -175.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 985' ' ' LEU . . . . . 0.537 ' CD1' HD11 ' B' ' 890' ' ' LEU . 51.4 tp -68.17 134.27 50.22 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 120.895 -1.128 . . . . 0.040000000000000001 110.123 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 986' ' ' LEU . . . . . . . . . . . . . 45.8 tp -107.8 -59.11 1.88 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.598 -0.689 . . . . 0.040000000000000001 109.957 179.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -144.48 144.92 31.59 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 107.543 -1.28 . . . . 0.040000000000000001 107.543 179.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.98 163.21 12.16 Favored Glycine 0 N--CA 1.495 2.603 0 N-CA-C 108.271 -1.932 . . . . 0.040000000000000001 108.271 179.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -75.65 113.01 22.44 Favored Pre-proline 0 N--CA 1.498 1.965 0 O-C-N 121.273 -1.133 . . . . 0.040000000000000001 109.443 179.085 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 990' ' ' PRO . . . . . 0.415 ' O ' ' HB2' ' B' ' 991' ' ' GLU . 50.2 Cg_endo -88.07 72.06 2.65 Favored 'Trans proline' 0 C--N 1.319 -0.996 0 O-C-N 123.141 1.074 . . . . 0.45000000000000001 111.443 -178.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 991' ' ' GLU . . . . . 0.415 ' HB2' ' O ' ' B' ' 990' ' ' PRO . 71.8 mt-10 67.5 -73.68 0.08 Allowed 'General case' 0 N--CA 1.503 2.182 0 N-CA-C 108.502 -0.925 . . . . 1.97 108.502 -177.418 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 992' ' ' LEU . . . . . 0.443 HD23 ' HA ' ' B' ' 992' ' ' LEU . 11.1 mt 50.5 20.83 0.75 Allowed 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.605 -0.685 . . . . 2.3799999999999999 111.677 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -93.63 156.74 16.54 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.9 -1.125 . . . . 3.79 110.042 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -145.19 92.83 2.3 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.481 -0.762 . . . . 3.5099999999999998 110.211 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 995' ' ' ALA . . . . . . . . . . . . 2.518 . . . . . . . 0 N--CA 1.504 2.232 0 O-C-N 120.949 -1.095 . . . . 2.73 110.603 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo . . . . . 0 N--CA 1.489 1.239 0 N-CA-C 109.52 -0.992 . . . . 3.8300000000000001 109.52 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' 847' ' ' VAL . . . . . 0.436 HG12 ' HB2' ' C' ' 849' ' ' GLN . 57.9 t -129.88 104.86 16.91 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.586 -0.696 . . . . 1.8300000000000001 110.088 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 848' ' ' PRO . . . . . 0.74 ' O ' HG23 ' C' ' 850' ' ' VAL . 44.3 Cg_endo -69.84 -22.05 32.23 Favored 'Trans proline' 0 N--CA 1.488 1.152 0 O-C-N 123.255 1.134 . . . . 0.65000000000000002 111.123 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 849' ' ' GLN . . . . . 0.436 ' HB2' HG12 ' C' ' 847' ' ' VAL . 55.6 tt0 27.53 68.61 0.07 Allowed 'General case' 0 N--CA 1.518 2.952 0 N-CA-C 112.93 0.715 . . . . 2.5800000000000001 112.93 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 850' ' ' VAL . . . . . 0.74 HG23 ' O ' ' C' ' 848' ' ' PRO . 57.4 t -119.52 135.68 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.157 -0.964 . . . . 1.0900000000000001 111.349 -178.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 851' ' ' ALA . . . . . . . . . . . . . . . -130.2 154.97 47.01 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 106.029 -1.841 . . . . 0.040000000000000001 106.029 176.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 852' ' ' PHE . . . . . 0.444 ' HA ' ' CB ' ' C' ' 874' ' ' ASN . 9.1 p90 -158.66 130.34 6.56 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 120.869 1.668 . . . . 0.050000000000000003 108.756 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 42.2 t -175.49 133.37 0.29 Allowed 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.014 -1.106 . . . . 0.040000000000000001 108.014 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -134.42 158.21 44.45 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.158 -0.964 . . . . 0.67000000000000004 109.388 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 855' ' ' ALA . . . . . 0.697 ' HB3' ' CB ' ' C' ' 870' ' ' ARG . . . -121.07 141.52 50.69 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.9 0.857 . . . . 0.51000000000000001 111.713 -178.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 856' ' ' LEU . . . . . 0.808 HD23 ' O ' ' C' ' 867' ' ' PRO . 3.4 tm? -106.83 133.84 50.88 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 109.26 -0.645 . . . . 0.050000000000000003 109.26 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 857' ' ' SER . . . . . 0.6 ' N ' HD13 ' C' ' 856' ' ' LEU . 80.0 p -152.61 15.85 0.59 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.549 -0.719 . . . . 1.3300000000000001 110.959 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 858' ' ' LEU . . . . . 0.786 ' CD2' HD11 ' C' ' 856' ' ' LEU . 2.9 pp -34.94 157.49 0.04 OUTLIER Pre-proline 0 N--CA 1.516 2.873 0 N-CA-C 112.692 0.627 . . . . 2.3300000000000001 112.692 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -62.13 -89.43 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 121.048 1.165 . . . . 2.3199999999999998 114.127 -177.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 54.8 ptt85 -130.67 -142.62 0.23 Allowed 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.803 -1.185 . . . . 0.040000000000000001 111.867 -177.089 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 71.7 m -35.17 118.8 0.46 Allowed 'General case' 0 N--CA 1.511 2.601 0 O-C-N 121.749 -0.595 . . . . 1.3100000000000001 112.515 -178.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -102.67 159.78 28.28 Favored Pre-proline 0 N--CA 1.488 1.448 0 N-CA-C 108.033 -1.099 . . . . 4.5099999999999998 108.033 177.55 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.86 -14.52 32.67 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 O-C-N 123.176 1.093 . . . . 2.2400000000000002 111.12 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -176.99 -133.94 1.9 Allowed Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.969 -1.252 . . . . 0.040000000000000001 109.969 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 37.5 m -70.0 158.5 35.53 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.38 -1.071 . . . . 1.51 110.924 -178.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 866' ' ' VAL . . . . . 0.468 ' HA ' ' HD3' ' C' ' 867' ' ' PRO . 30.9 m -94.68 138.43 22.24 Favored Pre-proline 0 N--CA 1.497 1.888 0 N-CA-C 113.641 0.978 . . . . 0.78000000000000003 113.641 -175.25 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 867' ' ' PRO . . . . . 0.808 ' O ' HD23 ' C' ' 856' ' ' LEU . 53.8 Cg_endo -89.12 -151.11 0.04 OUTLIER 'Trans proline' 0 CA--C 1.54 0.802 0 N-CA-C 108.262 -1.476 . . . . 0.92000000000000004 108.262 177.286 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 868' ' ' PHE . . . . . 0.456 ' CD1' ' N ' ' C' ' 868' ' ' PHE . 15.0 p90 -147.97 121.58 9.19 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.512 -1.367 . . . . 0.050000000000000003 109.99 179.341 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -112.01 -3.5 14.77 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 119.433 -0.907 . . . . 1.7 112.101 -178.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 870' ' ' ARG . . . . . 0.697 ' CB ' ' HB3' ' C' ' 855' ' ' ALA . 23.8 mmm180 -90.93 87.67 6.72 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.968 -1.083 . . . . 2.5899999999999999 110.774 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 58.3 t -74.43 97.08 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 120.983 -1.073 . . . . 1.9399999999999999 109.43 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 872' ' ' LEU . . . . . 0.488 HD13 HD11 ' A' ' 953' ' ' ILE . 80.6 mt -86.38 -45.27 11.34 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.523 -0.736 . . . . 1.0600000000000001 110.557 -179.56 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 873' ' ' LEU . . . . . 0.411 ' O ' ' HB2' ' C' ' 874' ' ' ASN . 50.2 tp -173.61 103.22 0.12 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.192 -0.942 . . . . 4.1799999999999997 108.769 178.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 874' ' ' ASN . . . . . 0.444 ' CB ' ' HA ' ' C' ' 852' ' ' PHE . 35.3 t-20 177.84 82.75 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.282 0 N-CA-C 109.201 -0.666 . . . . 0.040000000000000001 109.201 -178.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -66.37 -46.58 76.2 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 119.354 -0.938 . . . . 3.3799999999999999 111.351 -179.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 876' ' ' GLY . . . . . 0.413 ' HA3' ' CE2' ' C' ' 878' ' ' TYR . . . -74.29 -25.81 69.81 Favored Glycine 0 N--CA 1.493 2.499 0 O-C-N 121.282 -0.886 . . . . 0.040000000000000001 111.887 -178.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 81.03 -61.57 4.55 Favored Glycine 0 N--CA 1.502 3.073 0 N-CA-C 107.92 -2.072 . . . . 0.040000000000000001 107.92 -178.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 878' ' ' TYR . . . . . 0.413 ' CE2' ' HA3' ' C' ' 876' ' ' GLY . 91.4 m-85 61.67 -65.62 0.07 Allowed 'General case' 0 N--CA 1.503 2.222 0 N-CA-C 114.327 1.232 . . . . 3.46 114.327 177.486 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 879' ' ' TYR . . . . . 0.46 ' CB ' ' CD2' ' C' ' 886' ' ' PHE . 23.7 p90 -112.04 109.06 18.59 Favored 'General case' 0 N--CA 1.501 2.116 0 N-CA-C 114.938 1.459 . . . . 0.040000000000000001 114.938 -176.019 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -65.24 119.94 63.34 Favored Pre-proline 0 N--CA 1.497 1.913 0 O-C-N 121.548 -0.72 . . . . 0.02 110.369 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 881' ' ' PRO . . . . . 0.452 ' CG ' ' CD1' ' C' ' 868' ' ' PHE . 53.1 Cg_endo -76.13 0.99 8.75 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 O-C-N 123.434 1.229 . . . . 0.39000000000000001 112.285 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 87.4 mt-10 -74.96 -65.53 0.86 Allowed 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 106.829 -1.545 . . . . 0.81000000000000005 106.829 178.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 883' ' ' THR . . . . . 0.653 ' OG1' HG23 ' C' ' 885' ' ' VAL . 42.1 p -97.51 -15.1 20.72 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 109.19 -0.67 . . . . 0.040000000000000001 109.19 177.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.35 25.21 44.37 Favored Glycine 0 N--CA 1.494 2.527 0 C-N-CA 119.982 -1.104 . . . . 0.029999999999999999 110.636 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 885' ' ' VAL . . . . . 0.653 HG23 ' OG1' ' C' ' 883' ' ' THR . 83.0 t -72.66 88.94 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 C-N-CA 118.4 -1.32 . . . . 1.01 107.833 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 886' ' ' PHE . . . . . 0.902 ' HB3' HG22 ' C' ' 962' ' ' VAL . 0.7 OUTLIER -90.73 103.8 16.46 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 115.358 -0.837 . . . . 0.050000000000000003 112.242 -177.014 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 887' ' ' THR . . . . . 0.421 ' O ' ' HD3' ' C' ' 889' ' ' PRO . 97.1 m -96.79 100.46 12.0 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 107.601 -1.259 . . . . 0.68000000000000005 107.601 177.355 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 888' ' ' ALA . . . . . . . . . . . . . . . -99.47 105.37 32.96 Favored Pre-proline 0 N--CA 1.501 2.093 0 N-CA-C 114.197 1.184 . . . . 0.25 114.197 -176.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 889' ' ' PRO . . . . . 0.421 ' HD3' ' O ' ' C' ' 887' ' ' THR . 55.3 Cg_endo -86.9 -13.09 4.8 Favored 'Trans proline' 0 CA--C 1.546 1.077 0 N-CA-C 108.85 -1.25 . . . . 1.6399999999999999 108.85 175.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 890' ' ' LEU . . . . . 0.87 HD22 HD13 ' C' ' 985' ' ' LEU . 69.3 mt -38.04 -49.81 1.31 Allowed 'General case' 0 N--CA 1.507 2.378 0 N-CA-C 113.611 0.967 . . . . 2.29 113.611 -177.455 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 52.42 97.43 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.286 0 O-C-N 121.082 -1.011 . . . . 0.63 110.353 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . 156.53 -148.26 17.92 Favored Glycine 0 N--CA 1.478 1.493 0 N-CA-C 107.292 -2.323 . . . . 0.040000000000000001 107.292 -179.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 73.2 ttt-85 -108.29 128.62 54.9 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 107.763 -1.199 . . . . 3.0 107.763 177.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 894' ' ' TYR . . . . . 0.592 ' OH ' HD12 ' C' ' 896' ' ' LEU . 0.1 OUTLIER -130.49 146.3 52.01 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.14 -0.975 . . . . 0.040000000000000001 110.149 -179.144 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 895' ' ' LEU . . . . . 0.42 ' N ' ' CD1' ' C' ' 894' ' ' TYR . 38.6 tp -97.7 115.8 28.67 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.677 -0.64 . . . . 1.27 109.761 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 896' ' ' LEU . . . . . 0.592 HD12 ' OH ' ' C' ' 894' ' ' TYR . 9.2 tt -109.72 146.17 35.36 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.687 -0.633 . . . . 0.93999999999999995 110.822 -179.228 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 897' ' ' SER . . . . . . . . . . . . . 19.9 m -147.49 113.66 5.87 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.576 -0.702 . . . . 0.040000000000000001 110.707 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -106.61 147.02 29.99 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.032 -0.729 . . . . 0.47999999999999998 109.032 179.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 899' ' ' VAL . . . . . 0.704 HG21 ' HB ' ' C' ' 980' ' ' ILE . 89.7 t -93.9 119.63 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 C-N-CA 119.617 -0.833 . . . . 0.55000000000000004 111.159 -179.208 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 95.9 mt -94.54 110.61 22.41 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 114.188 1.181 . . . . 1.5900000000000001 114.188 -175.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 23.8 m -63.81 138.84 58.65 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 107.441 -1.318 . . . . 0.050000000000000003 107.441 177.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -61.48 -65.62 3.15 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 110.456 -1.058 . . . . 0.029999999999999999 110.456 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 46.21 66.48 0.94 Allowed 'General case' 0 N--CA 1.508 2.441 0 O-C-N 121.484 -1.009 . . . . 3.2000000000000002 110.921 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 54.8 ptt85 -67.93 -7.16 26.18 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.597 -0.69 . . . . 2.9199999999999999 112.03 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 905' ' ' HIS . . . . . 0.49 ' O ' ' CB ' ' C' ' 906' ' ' GLU . 77.1 t60 -59.83 4.4 0.05 OUTLIER 'General case' 0 N--CA 1.507 2.399 0 CA-C-O 117.65 -1.167 . . . . 2.8700000000000001 113.428 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 906' ' ' GLU . . . . . 0.49 ' CB ' ' O ' ' C' ' 905' ' ' HIS . 0.7 OUTLIER 93.0 -164.16 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.387 0 CA-C-N 121.272 1.851 . . . . 0.98999999999999999 112.013 179.071 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 907' ' ' LYS . . . . . 0.483 ' CB ' ' O ' ' C' ' 906' ' ' GLU . 68.7 tttt 87.87 160.22 0.07 Allowed 'General case' 0 N--CA 1.518 2.964 0 N-CA-C 107.772 -1.195 . . . . 5.25 107.772 -176.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 59.9 t -122.44 115.71 46.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 120.847 -1.158 . . . . 0.39000000000000001 111.058 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 909' ' ' GLU . . . . . 0.646 ' OE2' HD12 ' C' ' 966' ' ' LEU . 40.3 tp10 -100.25 132.95 45.33 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 107.077 -1.453 . . . . 1.72 107.077 176.61 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -156.9 120.5 4.21 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 106.929 -1.508 . . . . 0.67000000000000004 106.929 178.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 911' ' ' VAL . . . . . 0.858 HG23 HG22 ' C' ' 964' ' ' VAL . 13.2 p -76.5 130.99 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 C-N-CA 120.42 -0.512 . . . . 0.54000000000000004 111.131 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 83.5 mt -65.59 156.13 33.66 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 108.167 -1.049 . . . . 1.5 108.167 178.234 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 913' ' ' SER . . . . . 0.416 ' CB ' ' CG1' ' C' ' 919' ' ' VAL . 1.2 t -127.98 131.8 49.22 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.414 -0.958 . . . . 1.3700000000000001 108.414 176.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 914' ' ' ARG . . . . . 0.839 ' NH1' HD23 ' C' ' 956' ' ' LEU . 0.0 OUTLIER -63.24 156.22 26.1 Favored 'General case' 0 N--CA 1.506 2.336 0 O-C-N 120.71 -1.244 . . . . 4.2999999999999998 111.381 -179.195 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 915' ' ' SER . . . . . 0.421 ' CB ' ' O ' ' C' ' 914' ' ' ARG . 1.8 p 84.2 -32.07 0.07 Allowed 'General case' 0 N--CA 1.521 3.082 0 C-N-CA 124.033 0.933 . . . . 2.0499999999999998 111.848 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 916' ' ' ASN . . . . . 0.79 ' HB2' HG21 ' C' ' 919' ' ' VAL . 89.6 m-20 -124.03 -21.86 4.97 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.931 -1.106 . . . . 2.71 111.261 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 917' ' ' GLN . . . . . 0.422 ' HB2' ' O ' ' C' ' 916' ' ' ASN . 56.9 mt-30 66.82 164.86 0.2 Allowed 'General case' 0 N--CA 1.52 3.042 0 N-CA-C 105.707 -1.96 . . . . 2.6800000000000002 105.707 -173.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 55.67 -124.79 34.78 Favored Glycine 1 N--CA 1.52 4.266 0 CA-C-N 123.575 2.898 . . . . 0.029999999999999999 106.682 -177.387 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 919' ' ' VAL . . . . . 0.79 HG21 ' HB2' ' C' ' 916' ' ' ASN . 76.8 t 51.24 93.94 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.294 0 O-C-N 121.422 -1.046 . . . . 1.3899999999999999 109.119 -178.328 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 920' ' ' ALA . . . . . 0.818 ' HB3' HG12 ' C' ' 949' ' ' VAL . . . -93.41 93.69 8.29 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.429 -0.908 . . . . 0.029999999999999999 110.831 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 921' ' ' ARG . . . . . 0.683 ' HG3' HG23 ' C' ' 922' ' ' VAL . 41.8 ptt85 -82.03 -42.29 19.49 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 105.795 -1.928 . . . . 4.4199999999999999 105.795 176.246 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 922' ' ' VAL . . . . . 0.683 HG23 ' HG3' ' C' ' 921' ' ' ARG . 69.8 t -99.7 77.82 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 105.602 -1.999 . . . . 0.84999999999999998 105.602 175.078 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -90.73 135.53 33.65 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.814 0.816 . . . . 2.46 112.149 -176.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 14.9 t -147.4 103.93 3.6 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.017 -1.105 . . . . 0.69999999999999996 108.017 178.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -109.94 89.62 0.56 Allowed Glycine 0 N--CA 1.488 2.127 0 N-CA-C 108.882 -1.687 . . . . 0.040000000000000001 108.882 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.318 0 N-CA-C 109.347 -1.501 . . . . 0.040000000000000001 109.347 -179.623 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 55.4 m . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 120.949 0.404 . . . . 13.779999999999999 110.351 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 94.8 mt -114.91 129.25 56.67 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.501 -0.75 . . . . 13.76 110.317 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -152.16 170.67 31.48 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.277 -1.529 . . . . 9.1300000000000008 109.277 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 949' ' ' VAL . . . . . 0.818 HG12 ' HB3' ' C' ' 920' ' ' ALA . 33.4 m -117.22 137.45 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.524 -0.986 . . . . 7.0800000000000001 110.911 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 950' ' ' PHE . . . . . 0.444 ' CZ ' ' HB3' ' C' ' 921' ' ' ARG . 51.7 p90 -133.76 148.39 51.39 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.539 -0.725 . . . . 7.5899999999999999 109.513 179.411 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 70.4 m -118.54 -55.96 2.17 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.434 -0.791 . . . . 5.0300000000000002 112.137 -178.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 952' ' ' LEU . . . . . 0.47 ' O ' ' O ' ' C' ' 953' ' ' ILE . 49.3 tp -64.22 -76.64 0.07 Allowed 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.293 -0.879 . . . . 1.01 111.713 -178.049 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 953' ' ' ILE . . . . . 0.529 HD12 ' N ' ' C' ' 954' ' ' LEU . 2.1 pp -49.05 -151.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.787 0 N-CA-C 114.389 1.255 . . . . 2.6000000000000001 114.389 -176.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 954' ' ' LEU . . . . . 0.748 HD22 ' O ' ' C' ' 954' ' ' LEU . 0.0 OUTLIER 169.45 91.24 0.04 OUTLIER Pre-proline 0 N--CA 1.517 2.919 0 O-C-N 120.842 -1.162 . . . . 0.050000000000000003 112.023 179.798 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 955' ' ' PRO . . . . . 0.671 ' C ' HD12 ' C' ' 956' ' ' LEU . 52.7 Cg_endo -79.47 95.48 1.05 Allowed 'Trans proline' 0 C--N 1.316 -1.158 0 N-CA-C 108.665 -1.321 . . . . 0.83999999999999997 108.665 178.169 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 956' ' ' LEU . . . . . 0.839 HD23 ' NH1' ' C' ' 914' ' ' ARG . 6.7 mp -125.7 139.5 53.49 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.939 -1.101 . . . . 0.040000000000000001 110.841 -179.319 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -81.98 153.38 26.26 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 117.883 -1.056 . . . . 1.28 111.121 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -67.17 118.92 11.25 Favored 'General case' 0 N--CA 1.506 2.366 0 CA-C-N 122.629 2.468 . . . . 0.17000000000000001 111.322 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 95.15 -17.89 58.43 Favored Glycine 0 N--CA 1.501 3.013 0 O-C-N 121.526 -0.734 . . . . 0.040000000000000001 111.506 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 960' ' ' ASP . . . . . 0.416 ' HB3' ' NH2' ' C' ' 914' ' ' ARG . 0.2 OUTLIER -52.97 169.89 0.09 Allowed 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.204 -1.174 . . . . 0.040000000000000001 110.784 -179.169 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 961' ' ' THR . . . . . 0.457 ' HA ' ' O ' ' C' ' 886' ' ' PHE . 57.2 m -135.77 135.92 40.31 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.034 -1.041 . . . . 1.78 111.823 -178.603 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 962' ' ' VAL . . . . . 0.902 HG22 ' HB3' ' C' ' 886' ' ' PHE . 22.3 m -100.19 145.43 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.533 -0.73 . . . . 0.040000000000000001 110.498 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 5.6 t -137.99 148.07 44.83 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.89 -0.506 . . . . 0.71999999999999997 110.056 -178.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 964' ' ' VAL . . . . . 0.858 HG22 HG23 ' C' ' 911' ' ' VAL . 61.8 t -99.38 136.22 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.074 -1.016 . . . . 1.05 110.403 -179.31 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -94.73 126.94 40.37 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 103.85 -2.648 . . . . 3.02 103.85 173.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 966' ' ' LEU . . . . . 0.646 HD12 ' OE2' ' C' ' 909' ' ' GLU . 0.2 OUTLIER -130.57 62.31 1.59 Allowed 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.814 -1.18 . . . . 1.46 107.814 177.431 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 967' ' ' VAL . . . . . 0.491 HG23 ' C ' ' C' ' 966' ' ' LEU . 96.3 t -158.18 97.26 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 108.125 -1.065 . . . . 1.9399999999999999 108.125 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 85.9 mmm -142.95 58.62 1.42 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.765 -1.209 . . . . 0.0 108.342 178.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 134.78 119.63 1.96 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 107.075 -2.41 . . . . 2.1099999999999999 107.075 -178.249 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -82.26 -58.07 3.1 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.033 -1.275 . . . . 5.8899999999999997 110.367 -179.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 41.7 tp -58.61 90.45 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.445 -0.784 . . . . 4.3600000000000003 110.231 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -142.29 -154.12 0.5 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.543 -0.723 . . . . 1.8300000000000001 110.216 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -118.75 171.1 8.44 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.478 -0.764 . . . . 4.3499999999999996 110.17 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 32.1 t -101.39 129.9 47.49 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.501 -0.749 . . . . 1.27 110.071 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -156.33 154.29 30.36 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.556 -0.715 . . . . 5.0199999999999996 110.506 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.44 86.97 15.89 Favored Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 121.62 -0.675 . . . . 2.4100000000000001 109.74 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -74.3 -170.06 0.67 Allowed 'Trans proline' 0 C--N 1.318 -1.049 0 O-C-N 123.315 1.166 . . . . 0.95999999999999996 111.285 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 978' ' ' LEU . . . . . 0.471 ' N ' HD12 ' C' ' 978' ' ' LEU . 4.9 mp -125.86 155.39 41.28 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 107.547 -1.279 . . . . 0.62 107.547 177.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 979' ' ' THR . . . . . 0.456 HG23 ' C ' ' C' ' 978' ' ' LEU . 39.1 p -150.39 141.64 23.21 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.779 -1.201 . . . . 3.5699999999999998 111.21 -179.255 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 980' ' ' ILE . . . . . 0.704 ' HB ' HG21 ' C' ' 899' ' ' VAL . 50.8 mm -106.29 129.16 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 109.08 -0.711 . . . . 1.3300000000000001 109.08 179.426 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 981' ' ' PHE . . . . . 0.432 ' CD1' ' CE2' ' C' ' 879' ' ' TYR . 2.4 t80 -118.36 97.77 5.94 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.46 -0.775 . . . . 0.050000000000000003 111.638 -178.421 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 982' ' ' SER . . . . . . . . . . . . . 58.6 p -108.13 157.97 17.83 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 109.002 -0.74 . . . . 0.87 109.002 178.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 983' ' ' GLY . . . . . 0.411 ' O ' ' CE2' ' C' ' 852' ' ' PHE . . . -171.32 112.15 0.44 Allowed Glycine 0 N--CA 1.498 2.803 0 N-CA-C 106.701 -2.56 . . . . 0.029999999999999999 106.701 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 984' ' ' ALA . . . . . 0.479 ' HB1' ' NE ' ' A' ' 893' ' ' ARG . . . -110.25 149.51 30.05 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 114.315 1.228 . . . . 0.69999999999999996 114.315 -175.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 985' ' ' LEU . . . . . 0.87 HD13 HD22 ' C' ' 890' ' ' LEU . 63.9 tp -74.54 135.59 42.14 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.859 -1.151 . . . . 0.040000000000000001 109.805 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 986' ' ' LEU . . . . . . . . . . . . . 45.8 tp -105.9 -62.96 1.3 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.505 -0.747 . . . . 0.040000000000000001 110.327 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 53.6 t80 -144.73 147.05 32.51 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 107.828 -1.175 . . . . 0.040000000000000001 107.828 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.11 162.98 12.24 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 108.085 -2.006 . . . . 0.040000000000000001 108.085 179.014 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -75.65 112.35 19.07 Favored Pre-proline 0 N--CA 1.5 2.035 0 CA-C-N 118.608 1.204 . . . . 0.040000000000000001 109.462 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 990' ' ' PRO . . . . . 0.421 ' O ' ' HB2' ' C' ' 991' ' ' GLU . 50.6 Cg_endo -91.33 71.44 0.97 Allowed 'Trans proline' 0 C--N 1.319 -0.978 0 O-C-N 123.074 1.039 . . . . 0.45000000000000001 111.464 -178.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 991' ' ' GLU . . . . . 0.421 ' HB2' ' O ' ' C' ' 990' ' ' PRO . 71.2 mt-10 67.11 -73.9 0.07 Allowed 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 108.559 -0.904 . . . . 1.97 108.559 -177.508 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 992' ' ' LEU . . . . . 0.403 HD12 ' HD2' ' C' ' 990' ' ' PRO . 11.1 mt 51.66 20.46 1.1 Allowed 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.593 -0.692 . . . . 2.3799999999999999 111.596 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -90.65 156.91 17.77 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.964 -1.085 . . . . 3.79 109.952 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 69.1 m80 -147.53 90.21 1.84 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.572 -0.705 . . . . 3.5099999999999998 110.383 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 995' ' ' ALA . . . . . . . . . . . . 2.518 . . . . . . . 0 N--CA 1.503 2.216 0 O-C-N 120.881 -1.137 . . . . 2.73 110.601 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo . . . . . 0 N--CA 1.488 1.156 0 N-CA-C 109.492 -1.003 . . . . 3.8300000000000001 109.492 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 847' ' ' VAL . . . . . 0.494 HG12 ' HB2' ' A' ' 849' ' ' GLN . 60.0 t -128.04 105.5 20.2 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 121.638 -0.664 . . . . 1.8300000000000001 109.986 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 848' ' ' PRO . . . . . 0.823 ' O ' HG23 ' A' ' 850' ' ' VAL . 43.0 Cg_endo -69.37 -21.41 35.35 Favored 'Trans proline' 0 N--CA 1.486 1.076 0 O-C-N 123.196 1.103 . . . . 0.65000000000000002 110.985 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 849' ' ' GLN . . . . . 0.494 ' HB2' HG12 ' A' ' 847' ' ' VAL . 56.5 tt0 26.47 67.43 0.06 Allowed 'General case' 0 N--CA 1.518 2.93 0 N-CA-C 113.111 0.782 . . . . 2.5800000000000001 113.111 179.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 850' ' ' VAL . . . . . 0.823 HG23 ' O ' ' A' ' 848' ' ' PRO . 97.4 t -119.43 134.79 61.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.12 -0.987 . . . . 1.0900000000000001 111.042 -179.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 851' ' ' ALA . . . . . . . . . . . . . . . -132.05 153.65 50.2 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 105.922 -1.881 . . . . 0.040000000000000001 105.922 177.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 852' ' ' PHE . . . . . 0.626 ' HA ' ' HB3' ' A' ' 874' ' ' ASN . 28.4 p90 -155.89 136.75 13.52 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-N 121.109 1.777 . . . . 0.050000000000000003 109.303 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 16.1 t -172.63 133.11 0.59 Allowed 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.168 -1.049 . . . . 0.040000000000000001 108.168 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 854' ' ' ALA . . . . . 0.488 ' HB1' ' HD2' ' A' ' 868' ' ' PHE . . . -135.97 154.22 51.16 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.111 -0.993 . . . . 0.67000000000000004 109.325 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 855' ' ' ALA . . . . . 0.703 ' HB3' ' CB ' ' A' ' 870' ' ' ARG . . . -123.04 141.3 52.11 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.876 0.846 . . . . 0.51000000000000001 111.976 -178.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 856' ' ' LEU . . . . . 0.762 HD23 ' O ' ' A' ' 867' ' ' PRO . 3.5 tm? -110.09 138.27 46.7 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.656 -0.652 . . . . 0.050000000000000003 109.427 179.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 857' ' ' SER . . . . . 0.6 ' N ' HD13 ' A' ' 856' ' ' LEU . 78.8 p -156.1 19.99 0.37 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.477 -0.765 . . . . 1.3300000000000001 111.325 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 858' ' ' LEU . . . . . 0.573 HD22 ' HG3' ' A' ' 862' ' ' GLU . 4.2 pp -34.3 158.95 0.04 OUTLIER Pre-proline 0 N--CA 1.519 3.017 0 N-CA-C 112.816 0.672 . . . . 2.3300000000000001 112.816 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -60.95 -89.62 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 120.968 1.112 . . . . 2.3199999999999998 113.922 -177.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 54.9 ptt85 -127.98 -142.26 0.27 Allowed 'General case' 0 N--CA 1.502 2.127 0 O-C-N 120.809 -1.182 . . . . 0.040000000000000001 111.609 -177.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 27.9 m -36.14 121.15 0.67 Allowed 'General case' 0 N--CA 1.511 2.602 0 O-C-N 121.644 -0.66 . . . . 1.3100000000000001 112.291 -178.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 862' ' ' GLU . . . . . 0.573 ' HG3' HD22 ' A' ' 858' ' ' LEU . 0.0 OUTLIER -103.01 158.91 30.82 Favored Pre-proline 0 N--CA 1.488 1.466 0 N-CA-C 108.313 -0.995 . . . . 4.5099999999999998 108.313 177.824 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -70.23 -15.19 35.26 Favored 'Trans proline' 0 C--N 1.313 -1.337 0 O-C-N 123.206 1.108 . . . . 2.2400000000000002 111.231 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -176.91 -135.56 2.21 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.786 -1.326 . . . . 0.040000000000000001 109.786 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 23.3 m -69.47 155.88 39.75 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.344 -1.092 . . . . 1.51 111.01 -178.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 866' ' ' VAL . . . . . 0.564 HG12 ' CD2' ' A' ' 858' ' ' LEU . 33.7 m -91.35 136.73 26.63 Favored Pre-proline 0 N--CA 1.498 1.954 0 N-CA-C 113.549 0.944 . . . . 0.78000000000000003 113.549 -175.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 867' ' ' PRO . . . . . 0.762 ' O ' HD23 ' A' ' 856' ' ' LEU . 54.9 Cg_endo -88.62 -150.39 0.04 OUTLIER 'Trans proline' 0 CA--C 1.539 0.767 0 N-CA-C 108.183 -1.507 . . . . 0.92000000000000004 108.183 177.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 868' ' ' PHE . . . . . 0.488 ' HD2' ' HB1' ' A' ' 854' ' ' ALA . 9.9 p90 -148.24 121.2 8.79 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.413 -1.43 . . . . 0.050000000000000003 110.312 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 50.1 p-10 -111.79 -3.52 14.92 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 119.374 -0.93 . . . . 1.7 111.919 -179.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 870' ' ' ARG . . . . . 0.703 ' CB ' ' HB3' ' A' ' 855' ' ' ALA . 26.1 mmm180 -90.4 88.43 7.18 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.999 -1.063 . . . . 2.5899999999999999 111.109 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 60.1 t -76.42 96.41 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 120.932 -1.105 . . . . 1.9399999999999999 109.173 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 872' ' ' LEU . . . . . 0.45 HD13 HD11 ' B' ' 953' ' ' ILE . 87.7 mt -86.97 -44.16 11.83 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.605 -0.684 . . . . 1.0600000000000001 110.921 -179.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 873' ' ' LEU . . . . . . . . . . . . . 48.2 tp -172.3 107.69 0.2 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.159 -0.963 . . . . 4.1799999999999997 108.624 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 874' ' ' ASN . . . . . 0.626 ' HB3' ' HA ' ' A' ' 852' ' ' PHE . 12.0 p-10 174.36 81.36 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.483 0 O-C-N 121.592 -0.692 . . . . 0.040000000000000001 109.378 -178.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -69.69 -49.18 55.91 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.725 -1.234 . . . . 3.3799999999999999 111.37 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 876' ' ' GLY . . . . . 0.414 ' HA3' ' CE2' ' A' ' 878' ' ' TYR . . . -72.8 -26.8 70.4 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 110.642 -0.983 . . . . 0.040000000000000001 110.642 -179.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 78.96 -63.6 3.81 Favored Glycine 0 N--CA 1.497 2.741 0 N-CA-C 108.196 -1.961 . . . . 0.040000000000000001 108.196 -178.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 878' ' ' TYR . . . . . 0.414 ' CE2' ' HA3' ' A' ' 876' ' ' GLY . 92.6 m-85 61.7 -60.11 0.1 Allowed 'General case' 0 N--CA 1.504 2.265 0 N-CA-C 113.532 0.938 . . . . 3.46 113.532 178.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 879' ' ' TYR . . . . . 0.504 ' O ' ' CG ' ' A' ' 879' ' ' TYR . 9.8 p90 -111.24 104.69 13.21 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.919 -1.113 . . . . 0.040000000000000001 113.58 -177.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 880' ' ' ASP . . . . . 0.418 ' O ' ' N ' ' A' ' 884' ' ' GLY . 0.8 OUTLIER -69.77 112.86 13.63 Favored Pre-proline 0 N--CA 1.497 1.895 0 O-C-N 121.19 -0.944 . . . . 0.02 110.662 -178.807 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 881' ' ' PRO . . . . . 0.478 ' HG2' ' CD1' ' A' ' 868' ' ' PHE . 51.9 Cg_endo -78.33 -3.27 13.24 Favored 'Trans proline' 0 N--CA 1.489 1.221 0 O-C-N 123.489 1.257 . . . . 0.39000000000000001 111.102 179.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -77.62 -34.51 53.31 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 107.897 -1.149 . . . . 0.81000000000000005 107.897 178.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 71.0 p -112.07 -19.08 12.44 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.423 -0.808 . . . . 0.040000000000000001 109.072 176.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 884' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 880' ' ' ASP . . . 79.6 4.12 89.16 Favored Glycine 0 N--CA 1.495 2.603 0 N-CA-C 110.161 -1.176 . . . . 0.029999999999999999 110.161 -178.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 885' ' ' VAL . . . . . 0.452 HG13 HG21 ' A' ' 961' ' ' THR . 66.5 t -73.3 95.08 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 C-N-CA 118.737 -1.185 . . . . 1.01 108.408 -178.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 886' ' ' PHE . . . . . 0.924 ' HB3' HG22 ' A' ' 962' ' ' VAL . 2.2 t80 -88.86 105.54 17.81 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 115.307 -0.86 . . . . 0.050000000000000003 111.746 -177.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 887' ' ' THR . . . . . 0.42 ' O ' ' HD3' ' A' ' 889' ' ' PRO . 35.3 m -98.03 100.31 11.64 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 107.588 -1.264 . . . . 0.68000000000000005 107.588 177.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 888' ' ' ALA . . . . . 0.434 ' HB2' ' CE1' ' A' ' 886' ' ' PHE . . . -99.28 106.63 40.14 Favored Pre-proline 0 N--CA 1.501 2.085 0 N-CA-C 114.049 1.129 . . . . 0.25 114.049 -176.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 889' ' ' PRO . . . . . 0.42 ' HD3' ' O ' ' A' ' 887' ' ' THR . 55.2 Cg_endo -90.18 -12.61 2.69 Favored 'Trans proline' 0 CA--C 1.546 1.093 0 C-N-CA 121.086 1.191 . . . . 1.6399999999999999 109.157 176.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 890' ' ' LEU . . . . . 0.858 HD22 HD13 ' A' ' 985' ' ' LEU . 72.4 mt -36.38 -50.13 0.75 Allowed 'General case' 0 N--CA 1.508 2.44 0 N-CA-C 113.855 1.057 . . . . 2.29 113.855 -177.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 51.8 96.17 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.117 -0.989 . . . . 0.63 110.321 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 156.21 -148.86 19.45 Favored Glycine 0 N--CA 1.48 1.624 0 N-CA-C 107.296 -2.322 . . . . 0.040000000000000001 107.296 -179.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 893' ' ' ARG . . . . . 0.416 ' CZ ' ' HB1' ' C' ' 984' ' ' ALA . 71.6 ttt-85 -111.44 127.6 55.73 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 107.753 -1.202 . . . . 3.0 107.753 177.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 894' ' ' TYR . . . . . 0.53 ' OH ' HD12 ' A' ' 896' ' ' LEU . 0.0 OUTLIER -130.2 153.88 48.12 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.0 -1.063 . . . . 0.040000000000000001 110.876 -178.681 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 895' ' ' LEU . . . . . 0.429 ' N ' ' CD1' ' A' ' 894' ' ' TYR . 39.7 tp -96.58 114.11 25.74 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.405 -0.809 . . . . 1.27 109.961 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 896' ' ' LEU . . . . . 0.53 HD12 ' OH ' ' A' ' 894' ' ' TYR . 10.3 tt -109.35 142.47 40.23 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.684 -0.635 . . . . 0.93999999999999995 111.18 -179.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 897' ' ' SER . . . . . 0.525 ' N ' HD23 ' A' ' 896' ' ' LEU . 49.8 m -147.91 115.43 6.31 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.578 -0.701 . . . . 0.040000000000000001 110.838 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.7 147.22 31.04 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.633 -0.667 . . . . 0.47999999999999998 109.254 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 899' ' ' VAL . . . . . 0.75 HG21 ' HB ' ' A' ' 980' ' ' ILE . 99.1 t -92.69 120.1 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 C-N-CA 119.68 -0.808 . . . . 0.55000000000000004 111.237 -179.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 900' ' ' LEU . . . . . 0.442 ' N ' HD22 ' A' ' 900' ' ' LEU . 4.6 mm? -91.33 112.18 23.98 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 114.349 1.241 . . . . 1.5900000000000001 114.349 -175.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 23.3 m -67.52 141.72 56.79 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 107.077 -1.453 . . . . 0.050000000000000003 107.077 176.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -67.71 -66.45 2.33 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.506 -1.037 . . . . 0.029999999999999999 110.506 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 5.0 m170 46.08 65.88 1.07 Allowed 'General case' 0 N--CA 1.508 2.467 0 O-C-N 121.448 -1.03 . . . . 3.2000000000000002 111.253 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 43.2 ptt85 -69.23 -5.85 25.39 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.621 -0.675 . . . . 2.9199999999999999 112.152 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 905' ' ' HIS . . . . . 0.491 ' O ' ' CB ' ' A' ' 906' ' ' GLU . 76.2 t60 -61.86 4.37 0.12 Allowed 'General case' 0 N--CA 1.507 2.386 0 O-C-N 120.857 -1.152 . . . . 2.8700000000000001 113.141 -179.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 906' ' ' GLU . . . . . 0.491 ' CB ' ' O ' ' A' ' 905' ' ' HIS . 0.9 OUTLIER 94.7 -164.54 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.425 0 CA-C-N 120.593 1.542 . . . . 0.98999999999999999 112.076 178.984 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 907' ' ' LYS . . . . . 0.474 ' CB ' ' O ' ' A' ' 906' ' ' GLU . 29.5 ttmt 88.87 160.84 0.06 Allowed 'General case' 0 N--CA 1.522 3.137 0 N-CA-C 108.353 -0.98 . . . . 5.25 108.353 -177.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 61.4 t -122.4 116.74 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 120.818 -1.177 . . . . 0.39000000000000001 110.862 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 909' ' ' GLU . . . . . 0.634 ' OE2' HD12 ' A' ' 966' ' ' LEU . 39.9 tp10 -105.12 131.78 52.18 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 107.629 -1.248 . . . . 1.72 107.629 177.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -156.54 120.78 4.43 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 106.819 -1.548 . . . . 0.67000000000000004 106.819 178.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 911' ' ' VAL . . . . . 0.485 ' HA ' ' HA ' ' A' ' 964' ' ' VAL . 14.4 p -77.3 132.96 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.713 -0.617 . . . . 0.54000000000000004 111.417 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 86.4 mt -65.47 156.26 32.98 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 108.193 -1.039 . . . . 1.5 108.193 178.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 913' ' ' SER . . . . . 0.445 ' CB ' ' HB ' ' A' ' 919' ' ' VAL . 1.4 t -125.66 136.27 53.05 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.462 -0.94 . . . . 1.3700000000000001 108.462 177.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 914' ' ' ARG . . . . . 0.551 ' HD3' HG12 ' A' ' 962' ' ' VAL . 0.0 OUTLIER -62.37 152.58 33.64 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.011 -1.056 . . . . 4.2999999999999998 111.827 -178.97 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 915' ' ' SER . . . . . 0.427 ' CB ' ' O ' ' A' ' 914' ' ' ARG . 3.5 t 83.41 -30.38 0.09 Allowed 'General case' 0 N--CA 1.52 3.056 0 C-N-CA 124.004 0.922 . . . . 2.0499999999999998 112.315 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 916' ' ' ASN . . . . . 0.615 ' HB2' HG21 ' A' ' 919' ' ' VAL . 72.9 m-20 -126.46 -21.87 4.09 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 120.849 -1.157 . . . . 2.71 111.471 -179.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 917' ' ' GLN . . . . . 0.428 ' HB2' ' O ' ' A' ' 916' ' ' ASN . 58.6 mt-30 66.97 168.93 0.24 Allowed 'General case' 0 N--CA 1.518 2.955 0 N-CA-C 105.903 -1.888 . . . . 2.6800000000000002 105.903 -173.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 55.25 -128.87 45.1 Favored Glycine 1 N--CA 1.52 4.28 0 CA-C-N 123.64 2.927 . . . . 0.029999999999999999 106.388 -177.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 919' ' ' VAL . . . . . 0.615 HG21 ' HB2' ' A' ' 916' ' ' ASN . 85.7 t 50.25 94.59 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.299 0 CA-C-N 118.573 1.187 . . . . 1.3899999999999999 109.249 -178.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 920' ' ' ALA . . . . . 1.005 ' HB3' HG12 ' A' ' 949' ' ' VAL . . . -92.64 94.08 8.84 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.266 -0.974 . . . . 0.029999999999999999 111.154 -179.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 921' ' ' ARG . . . . . 0.756 ' HG3' HG23 ' A' ' 922' ' ' VAL . 35.1 ptt85 -80.3 -43.14 21.77 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 105.602 -1.999 . . . . 4.4199999999999999 105.602 176.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 922' ' ' VAL . . . . . 0.756 HG23 ' HG3' ' A' ' 921' ' ' ARG . 94.9 t -101.75 77.07 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 N-CA-C 105.041 -2.207 . . . . 0.84999999999999998 105.041 174.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -87.14 135.61 33.23 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 122.068 0.937 . . . . 2.46 112.39 -176.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 10.4 t -145.54 103.15 3.78 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.471 -1.307 . . . . 0.69999999999999996 107.471 178.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -103.39 81.75 0.37 Allowed Glycine 0 N--CA 1.486 2.023 0 N-CA-C 109.04 -1.624 . . . . 0.040000000000000001 109.04 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.967 0 N-CA-C 108.743 -1.743 . . . . 0.040000000000000001 108.743 179.877 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 21.7 m . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 120.963 0.411 . . . . 13.779999999999999 110.299 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 95.9 mt -109.88 129.28 55.67 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.506 -0.746 . . . . 13.76 110.325 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -152.08 169.83 31.4 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.347 -1.501 . . . . 9.1300000000000008 109.347 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 949' ' ' VAL . . . . . 1.005 HG12 ' HB3' ' A' ' 920' ' ' ALA . 34.3 m -118.4 132.4 68.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.465 -1.021 . . . . 7.0800000000000001 111.05 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 950' ' ' PHE . . . . . 0.464 ' CZ ' ' HB3' ' A' ' 921' ' ' ARG . 40.0 p90 -134.82 153.24 52.12 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.549 -0.719 . . . . 7.5899999999999999 109.124 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 69.3 m -121.59 -53.16 2.0 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.245 -0.91 . . . . 5.0300000000000002 112.356 -178.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 952' ' ' LEU . . . . . 0.425 ' O ' ' O ' ' A' ' 953' ' ' ILE . 56.6 tp -61.72 -76.33 0.06 Allowed 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.356 -0.84 . . . . 1.01 112.328 -177.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 953' ' ' ILE . . . . . 0.496 HD11 HD13 ' C' ' 872' ' ' LEU . 44.6 pt -52.32 -145.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.753 0 N-CA-C 114.016 1.117 . . . . 2.6000000000000001 114.016 -176.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 954' ' ' LEU . . . . . 0.726 HD22 ' O ' ' A' ' 954' ' ' LEU . 0.0 OUTLIER 170.73 83.74 0.04 OUTLIER Pre-proline 0 N--CA 1.509 2.514 0 O-C-N 120.812 -1.18 . . . . 0.050000000000000003 111.66 179.441 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 955' ' ' PRO . . . . . 0.677 ' C ' HD12 ' A' ' 956' ' ' LEU . 48.6 Cg_endo -76.24 95.45 1.04 Allowed 'Trans proline' 0 C--N 1.314 -1.271 0 N-CA-C 108.689 -1.312 . . . . 0.83999999999999997 108.689 177.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 956' ' ' LEU . . . . . 0.677 HD12 ' C ' ' A' ' 955' ' ' PRO . 10.3 mp -122.47 143.73 49.51 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.133 -0.979 . . . . 0.040000000000000001 110.19 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -85.65 151.76 23.64 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 117.82 -1.086 . . . . 1.28 111.613 -179.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -68.95 119.75 13.75 Favored 'General case' 0 N--CA 1.509 2.48 0 CA-C-N 122.86 2.573 . . . . 0.17000000000000001 111.799 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 93.23 -21.75 38.57 Favored Glycine 0 N--CA 1.501 3.006 0 N-CA-C 111.127 -0.789 . . . . 0.040000000000000001 111.127 178.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 960' ' ' ASP . . . . . 0.434 ' HB3' ' NE ' ' A' ' 914' ' ' ARG . 0.5 OUTLIER -55.17 169.47 0.25 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.473 -1.016 . . . . 0.040000000000000001 110.201 -179.411 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 961' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' A' ' 886' ' ' PHE . 44.0 m -136.52 139.55 42.34 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.903 -1.123 . . . . 1.78 112.432 -177.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 962' ' ' VAL . . . . . 0.924 HG22 ' HB3' ' A' ' 886' ' ' PHE . 31.9 m -100.08 144.82 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.649 -0.657 . . . . 0.040000000000000001 111.131 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 5.4 t -137.58 145.04 42.36 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.917 -0.49 . . . . 0.71999999999999997 109.991 -179.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 964' ' ' VAL . . . . . 0.485 ' HA ' ' HA ' ' A' ' 911' ' ' VAL . 61.9 t -92.17 136.3 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.028 -1.045 . . . . 1.05 111.297 -178.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -95.51 126.35 40.74 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 103.5 -2.778 . . . . 3.02 103.5 172.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 966' ' ' LEU . . . . . 0.634 HD12 ' OE2' ' A' ' 909' ' ' GLU . 0.2 OUTLIER -133.42 61.3 1.68 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.453 -0.943 . . . . 1.46 108.453 177.362 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 967' ' ' VAL . . . . . 0.492 HG23 ' C ' ' A' ' 966' ' ' LEU . 97.8 t -157.65 96.26 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 108.366 -0.975 . . . . 1.9399999999999999 108.366 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 92.9 mmm -142.96 58.65 1.42 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.734 -1.229 . . . . 0.0 108.277 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 133.72 119.48 2.0 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 107.139 -2.385 . . . . 2.1099999999999999 107.139 -178.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -82.19 -57.03 3.57 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.028 -1.277 . . . . 5.8899999999999997 110.597 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 48.4 tp -58.76 89.7 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.429 -0.794 . . . . 4.3600000000000003 110.342 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -142.67 -152.57 0.42 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.561 -0.712 . . . . 1.8300000000000001 110.049 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -118.07 167.57 11.35 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.393 -0.817 . . . . 4.3499999999999996 110.211 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 30.3 t -101.98 130.29 48.47 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.578 -0.701 . . . . 1.27 110.067 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -156.05 159.01 38.76 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.485 -0.759 . . . . 5.0199999999999996 110.65 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.78 85.12 20.63 Favored Pre-proline 0 N--CA 1.5 2.042 0 O-C-N 121.701 -0.624 . . . . 2.4100000000000001 109.712 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -73.58 -172.11 0.99 Allowed 'Trans proline' 0 C--N 1.317 -1.1 0 O-C-N 123.253 1.133 . . . . 0.95999999999999996 111.3 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 978' ' ' LEU . . . . . 0.576 HD12 ' N ' ' A' ' 978' ' ' LEU . 5.2 mp -126.43 156.09 41.17 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 107.557 -1.275 . . . . 0.62 107.557 177.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 979' ' ' THR . . . . . 0.453 HG23 ' C ' ' A' ' 978' ' ' LEU . 46.5 p -149.57 141.37 23.67 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.763 -1.211 . . . . 3.5699999999999998 111.155 -179.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 980' ' ' ILE . . . . . 0.75 ' HB ' HG21 ' A' ' 899' ' ' VAL . 50.7 mm -107.31 128.92 61.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 N-CA-C 109.088 -0.708 . . . . 1.3300000000000001 109.088 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 981' ' ' PHE . . . . . 0.502 ' CD1' ' CE2' ' A' ' 879' ' ' TYR . 10.6 t80 -119.93 97.46 5.62 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 119.572 -0.851 . . . . 0.050000000000000003 111.899 -178.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 982' ' ' SER . . . . . 0.457 ' HB2' HD23 ' B' ' 952' ' ' LEU . 15.5 p -108.64 158.59 17.45 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.592 -0.693 . . . . 0.87 109.199 178.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 983' ' ' GLY . . . . . 0.41 ' O ' ' CE1' ' A' ' 852' ' ' PHE . . . -174.29 110.78 0.34 Allowed Glycine 0 N--CA 1.498 2.783 0 N-CA-C 106.81 -2.516 . . . . 0.029999999999999999 106.81 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -107.85 149.41 28.29 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 114.245 1.202 . . . . 0.69999999999999996 114.245 -175.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 985' ' ' LEU . . . . . 0.858 HD13 HD22 ' A' ' 890' ' ' LEU . 66.8 tp -72.04 136.51 46.69 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.75 -1.219 . . . . 0.040000000000000001 110.088 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 49.3 tp -106.66 -58.03 1.98 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.689 -0.632 . . . . 0.040000000000000001 110.02 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -143.9 145.87 32.6 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 107.739 -1.208 . . . . 0.040000000000000001 107.739 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.33 162.54 12.37 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 108.078 -2.009 . . . . 0.040000000000000001 108.078 179.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -76.9 111.79 18.54 Favored Pre-proline 0 N--CA 1.498 1.951 0 CA-C-N 118.536 1.168 . . . . 0.040000000000000001 109.536 179.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 990' ' ' PRO . . . . . 0.615 ' HD2' HD12 ' A' ' 992' ' ' LEU . 49.2 Cg_endo -92.34 71.79 0.64 Allowed 'Trans proline' 0 C--N 1.318 -1.038 0 O-C-N 123.057 1.03 . . . . 0.45000000000000001 111.338 -179.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 991' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' A' ' 990' ' ' PRO . 72.3 mt-10 67.82 -73.33 0.08 Allowed 'General case' 0 N--CA 1.503 2.182 0 N-CA-C 108.345 -0.983 . . . . 1.97 108.345 -177.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 992' ' ' LEU . . . . . 0.615 HD12 ' HD2' ' A' ' 990' ' ' PRO . 4.1 mt 50.51 20.38 0.69 Allowed 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.577 -0.702 . . . . 2.3799999999999999 111.754 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -95.69 156.87 16.15 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.914 -1.116 . . . . 3.79 110.089 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 67.9 m80 -144.19 94.4 2.57 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.526 -0.734 . . . . 3.5099999999999998 110.269 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 995' ' ' ALA . . . . . . . . . . . . 2.517 . . . . . . . 0 N--CA 1.503 2.201 0 O-C-N 120.928 -1.108 . . . . 2.73 110.588 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo . . . . . 0 N--CA 1.488 1.172 0 N-CA-C 109.471 -1.011 . . . . 3.8300000000000001 109.471 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 847' ' ' VAL . . . . . 0.485 HG12 ' HB2' ' B' ' 849' ' ' GLN . 61.1 t -128.26 105.57 19.73 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.629 -0.669 . . . . 1.8300000000000001 109.93 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 848' ' ' PRO . . . . . 0.823 ' O ' HG23 ' B' ' 850' ' ' VAL . 43.0 Cg_endo -69.29 -21.41 35.7 Favored 'Trans proline' 0 N--CA 1.486 1.087 0 O-C-N 123.253 1.133 . . . . 0.65000000000000002 111.042 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 849' ' ' GLN . . . . . 0.485 ' HB2' HG12 ' B' ' 847' ' ' VAL . 56.3 tt0 26.48 66.9 0.06 Allowed 'General case' 0 N--CA 1.518 2.939 0 N-CA-C 113.151 0.797 . . . . 2.5800000000000001 113.151 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 850' ' ' VAL . . . . . 0.823 HG23 ' O ' ' B' ' 848' ' ' PRO . 97.1 t -118.98 134.93 61.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.193 -0.942 . . . . 1.0900000000000001 111.06 -179.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 851' ' ' ALA . . . . . . . . . . . . . . . -131.93 154.02 49.69 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 105.911 -1.885 . . . . 0.040000000000000001 105.911 177.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 852' ' ' PHE . . . . . 0.6 ' HA ' ' HB3' ' B' ' 874' ' ' ASN . 28.3 p90 -156.26 136.8 13.19 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-N 121.02 1.736 . . . . 0.050000000000000003 109.431 179.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 18.6 t -172.71 133.37 0.58 Allowed 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.046 -1.094 . . . . 0.040000000000000001 108.046 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 854' ' ' ALA . . . . . 0.487 ' HB1' ' HD2' ' B' ' 868' ' ' PHE . . . -136.14 154.34 51.01 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.118 -0.989 . . . . 0.67000000000000004 109.339 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 855' ' ' ALA . . . . . 0.72 ' HB3' ' CB ' ' B' ' 870' ' ' ARG . . . -123.18 140.96 52.48 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.853 0.835 . . . . 0.51000000000000001 111.996 -178.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 856' ' ' LEU . . . . . 0.769 HD23 ' O ' ' B' ' 867' ' ' PRO . 3.5 tm? -109.79 138.74 45.73 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.729 -0.607 . . . . 0.050000000000000003 109.366 179.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 857' ' ' SER . . . . . 0.614 ' N ' HD13 ' B' ' 856' ' ' LEU . 78.7 p -156.58 19.58 0.34 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.457 -0.777 . . . . 1.3300000000000001 111.345 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 858' ' ' LEU . . . . . 0.567 HD22 ' HG3' ' B' ' 862' ' ' GLU . 4.2 pp -33.95 158.83 0.04 OUTLIER Pre-proline 0 N--CA 1.519 2.984 0 N-CA-C 112.888 0.699 . . . . 2.3300000000000001 112.888 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -60.77 -89.66 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 120.948 1.099 . . . . 2.3199999999999998 113.971 -177.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 55.0 ptt85 -127.91 -142.25 0.27 Allowed 'General case' 0 N--CA 1.501 2.1 0 O-C-N 120.753 -1.217 . . . . 0.040000000000000001 111.676 -177.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 28.4 m -36.24 121.4 0.69 Allowed 'General case' 0 N--CA 1.512 2.629 0 O-C-N 121.682 -0.637 . . . . 1.3100000000000001 112.354 -178.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 862' ' ' GLU . . . . . 0.567 ' HG3' HD22 ' B' ' 858' ' ' LEU . 0.0 OUTLIER -103.25 159.09 30.38 Favored Pre-proline 0 N--CA 1.488 1.461 0 N-CA-C 108.414 -0.958 . . . . 4.5099999999999998 108.414 177.842 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -70.28 -15.15 35.08 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 O-C-N 123.255 1.134 . . . . 2.2400000000000002 111.163 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -176.86 -135.55 2.21 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.901 -1.279 . . . . 0.040000000000000001 109.901 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 23.6 m -69.65 156.0 39.63 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.43 -1.041 . . . . 1.51 110.964 -178.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 866' ' ' VAL . . . . . 0.567 HG12 ' CD2' ' B' ' 858' ' ' LEU . 33.7 m -91.4 136.75 26.54 Favored Pre-proline 0 N--CA 1.498 1.935 0 N-CA-C 113.59 0.959 . . . . 0.78000000000000003 113.59 -175.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 867' ' ' PRO . . . . . 0.769 ' O ' HD23 ' B' ' 856' ' ' LEU . 53.9 Cg_endo -88.52 -150.07 0.04 OUTLIER 'Trans proline' 0 CA--C 1.539 0.759 0 N-CA-C 108.134 -1.525 . . . . 0.92000000000000004 108.134 177.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 868' ' ' PHE . . . . . 0.487 ' HD2' ' HB1' ' B' ' 854' ' ' ALA . 9.8 p90 -148.5 121.26 8.67 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.388 -1.445 . . . . 0.050000000000000003 110.246 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 50.0 p-10 -111.82 -3.81 14.81 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 119.373 -0.931 . . . . 1.7 111.991 -179.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 870' ' ' ARG . . . . . 0.72 ' CB ' ' HB3' ' B' ' 855' ' ' ALA . 26.3 mmm180 -90.08 88.92 7.46 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.074 -1.016 . . . . 2.5899999999999999 111.028 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 61.6 t -76.87 96.09 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 120.918 -1.113 . . . . 1.9399999999999999 109.159 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 872' ' ' LEU . . . . . 0.597 HD13 HD11 ' C' ' 953' ' ' ILE . 86.3 mt -86.63 -44.31 11.96 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.658 -0.651 . . . . 1.0600000000000001 110.988 -179.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 873' ' ' LEU . . . . . . . . . . . . . 48.3 tp -172.16 107.44 0.21 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.219 -0.926 . . . . 4.1799999999999997 108.528 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 874' ' ' ASN . . . . . 0.6 ' HB3' ' HA ' ' B' ' 852' ' ' PHE . 12.1 p-10 174.6 81.2 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.473 0 O-C-N 121.551 -0.718 . . . . 0.040000000000000001 109.429 -178.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -69.5 -49.2 56.9 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.826 -1.171 . . . . 3.3799999999999999 111.352 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 876' ' ' GLY . . . . . 0.409 ' HA3' ' CE2' ' B' ' 878' ' ' TYR . . . -73.03 -26.38 71.13 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 110.642 -0.983 . . . . 0.040000000000000001 110.642 -179.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 78.65 -63.58 3.72 Favored Glycine 0 N--CA 1.498 2.77 0 N-CA-C 108.258 -1.937 . . . . 0.040000000000000001 108.258 -178.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 878' ' ' TYR . . . . . 0.409 ' CE2' ' HA3' ' B' ' 876' ' ' GLY . 92.3 m-85 61.74 -60.12 0.11 Allowed 'General case' 0 N--CA 1.504 2.256 0 N-CA-C 113.545 0.942 . . . . 3.46 113.545 178.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 879' ' ' TYR . . . . . 0.516 ' O ' ' CG ' ' B' ' 879' ' ' TYR . 10.0 p90 -111.31 104.06 12.5 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.94 -1.1 . . . . 0.040000000000000001 113.601 -177.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.14 112.91 13.19 Favored Pre-proline 0 N--CA 1.497 1.914 0 O-C-N 121.165 -0.96 . . . . 0.02 110.645 -178.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 881' ' ' PRO . . . . . 0.482 ' HG2' ' CD1' ' B' ' 868' ' ' PHE . 51.6 Cg_endo -78.33 -3.32 13.28 Favored 'Trans proline' 0 N--CA 1.49 1.27 0 O-C-N 123.442 1.232 . . . . 0.39000000000000001 111.061 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -77.66 -34.68 52.95 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 107.935 -1.135 . . . . 0.81000000000000005 107.935 178.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 74.2 p -111.59 -19.72 12.41 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.3 -0.863 . . . . 0.040000000000000001 108.975 176.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 79.88 4.17 89.46 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 110.087 -1.205 . . . . 0.029999999999999999 110.087 -178.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 885' ' ' VAL . . . . . 0.472 HG13 HG21 ' B' ' 961' ' ' THR . 69.0 t -73.3 95.2 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 C-N-CA 118.671 -1.212 . . . . 1.01 108.447 -178.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 886' ' ' PHE . . . . . 0.958 ' HB3' HG22 ' B' ' 962' ' ' VAL . 2.2 t80 -88.76 105.18 17.54 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 115.318 -0.856 . . . . 0.050000000000000003 111.86 -177.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 887' ' ' THR . . . . . 0.418 ' O ' ' HD3' ' B' ' 889' ' ' PRO . 35.3 m -97.72 100.05 11.42 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 107.655 -1.239 . . . . 0.68000000000000005 107.655 177.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 888' ' ' ALA . . . . . 0.423 ' HB2' ' CE1' ' B' ' 886' ' ' PHE . . . -99.14 106.64 39.73 Favored Pre-proline 0 N--CA 1.502 2.132 0 N-CA-C 114.1 1.148 . . . . 0.25 114.1 -176.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 889' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' B' ' 887' ' ' THR . 54.6 Cg_endo -90.25 -12.49 2.69 Favored 'Trans proline' 0 CA--C 1.546 1.121 0 C-N-CA 121.084 1.19 . . . . 1.6399999999999999 109.181 176.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 890' ' ' LEU . . . . . 0.828 HD22 HD13 ' B' ' 985' ' ' LEU . 71.9 mt -36.44 -49.99 0.75 Allowed 'General case' 0 N--CA 1.508 2.469 0 N-CA-C 113.851 1.056 . . . . 2.29 113.851 -177.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 51.75 96.27 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.41 0 O-C-N 121.159 -0.963 . . . . 0.63 110.346 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . 156.08 -148.77 19.27 Favored Glycine 0 N--CA 1.481 1.638 0 N-CA-C 107.26 -2.336 . . . . 0.040000000000000001 107.26 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 71.6 ttt-85 -111.49 127.73 55.79 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.762 -1.199 . . . . 3.0 107.762 177.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 894' ' ' TYR . . . . . 0.541 ' OH ' HD12 ' B' ' 896' ' ' LEU . 0.0 OUTLIER -130.41 154.1 48.06 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.032 -1.043 . . . . 0.040000000000000001 110.903 -178.663 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 895' ' ' LEU . . . . . 0.44 ' N ' ' CD1' ' B' ' 894' ' ' TYR . 38.9 tp -96.82 114.08 25.68 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.464 -0.773 . . . . 1.27 110.033 -179.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 896' ' ' LEU . . . . . 0.541 HD12 ' OH ' ' B' ' 894' ' ' TYR . 10.4 tt -109.19 143.91 37.99 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.634 -0.666 . . . . 0.93999999999999995 110.994 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 897' ' ' SER . . . . . 0.53 ' N ' HD23 ' B' ' 896' ' ' LEU . 50.5 m -149.29 115.05 5.64 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.584 -0.697 . . . . 0.040000000000000001 110.748 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.39 147.55 30.22 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.173 -0.677 . . . . 0.47999999999999998 109.173 179.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 899' ' ' VAL . . . . . 0.746 HG21 ' HB ' ' B' ' 980' ' ' ILE . 97.5 t -93.0 120.53 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 C-N-CA 119.672 -0.811 . . . . 0.55000000000000004 111.123 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 900' ' ' LEU . . . . . 0.436 ' N ' HD22 ' B' ' 900' ' ' LEU . 4.6 mm? -91.64 112.17 23.98 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 114.326 1.232 . . . . 1.5900000000000001 114.326 -175.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 23.0 m -67.43 141.64 56.94 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 107.109 -1.441 . . . . 0.050000000000000003 107.109 176.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -67.63 -66.53 2.3 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 110.469 -1.052 . . . . 0.029999999999999999 110.469 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 5.0 m170 46.22 66.09 1.03 Allowed 'General case' 0 N--CA 1.508 2.439 0 O-C-N 121.456 -1.026 . . . . 3.2000000000000002 111.215 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 43.3 ptt85 -69.5 -5.7 25.78 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.634 -0.666 . . . . 2.9199999999999999 112.052 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 905' ' ' HIS . . . . . 0.492 ' O ' ' CB ' ' B' ' 906' ' ' GLU . 76.4 t60 -62.17 4.71 0.12 Allowed 'General case' 0 N--CA 1.506 2.359 0 O-C-N 120.811 -1.18 . . . . 2.8700000000000001 113.065 -179.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 906' ' ' GLU . . . . . 0.492 ' CB ' ' O ' ' B' ' 905' ' ' HIS . 0.8 OUTLIER 94.51 -164.57 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.388 0 CA-C-N 120.589 1.541 . . . . 0.98999999999999999 112.094 178.82 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 907' ' ' LYS . . . . . 0.475 ' CB ' ' O ' ' B' ' 906' ' ' GLU . 29.4 ttmt 88.88 160.84 0.06 Allowed 'General case' 0 N--CA 1.521 3.123 0 N-CA-C 108.321 -0.992 . . . . 5.25 108.321 -177.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 61.1 t -122.29 116.7 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 120.848 -1.158 . . . . 0.39000000000000001 110.864 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 909' ' ' GLU . . . . . 0.645 ' OE2' HD12 ' B' ' 966' ' ' LEU . 39.9 tp10 -104.78 131.97 51.6 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 107.565 -1.272 . . . . 1.72 107.565 177.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -156.67 120.73 4.36 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 106.778 -1.564 . . . . 0.67000000000000004 106.778 178.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 911' ' ' VAL . . . . . 0.497 ' HA ' ' HA ' ' B' ' 964' ' ' VAL . 14.4 p -77.31 132.97 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.75 -0.594 . . . . 0.54000000000000004 111.406 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 86.7 mt -65.6 156.04 33.95 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.18 -1.044 . . . . 1.5 108.18 178.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 913' ' ' SER . . . . . 0.44 ' CB ' ' HB ' ' B' ' 919' ' ' VAL . 1.4 t -125.1 137.37 54.18 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.329 -0.989 . . . . 1.3700000000000001 108.329 177.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 914' ' ' ARG . . . . . 0.552 ' HD3' HG12 ' B' ' 962' ' ' VAL . 0.0 OUTLIER -63.47 153.01 36.78 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.917 -1.114 . . . . 4.2999999999999998 111.757 -179.059 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 915' ' ' SER . . . . . 0.426 ' CB ' ' O ' ' B' ' 914' ' ' ARG . 3.5 t 83.24 -30.21 0.09 Allowed 'General case' 0 N--CA 1.521 3.1 0 C-N-CA 123.977 0.911 . . . . 2.0499999999999998 112.359 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 916' ' ' ASN . . . . . 0.629 ' HB2' HG21 ' B' ' 919' ' ' VAL . 72.9 m-20 -126.8 -21.41 4.06 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 120.892 -1.13 . . . . 2.71 111.394 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 917' ' ' GLN . . . . . 0.442 ' HB2' ' O ' ' B' ' 916' ' ' ASN . 58.7 mt-30 66.99 168.97 0.24 Allowed 'General case' 0 N--CA 1.519 2.977 0 N-CA-C 105.892 -1.892 . . . . 2.6800000000000002 105.892 -173.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.9 -128.79 44.13 Favored Glycine 1 N--CA 1.521 4.302 0 CA-C-N 123.455 2.843 . . . . 0.029999999999999999 106.442 -177.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 919' ' ' VAL . . . . . 0.629 HG21 ' HB2' ' B' ' 916' ' ' ASN . 84.1 t 50.55 94.57 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.3 0 CA-C-N 118.608 1.204 . . . . 1.3899999999999999 109.191 -178.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 920' ' ' ALA . . . . . 0.973 ' HB3' HG12 ' B' ' 949' ' ' VAL . . . -92.5 94.47 9.09 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.274 -0.97 . . . . 0.029999999999999999 111.116 -179.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 921' ' ' ARG . . . . . 0.761 ' HG3' HG23 ' B' ' 922' ' ' VAL . 34.9 ptt85 -80.73 -43.29 20.48 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 105.553 -2.017 . . . . 4.4199999999999999 105.553 176.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 922' ' ' VAL . . . . . 0.761 HG23 ' HG3' ' B' ' 921' ' ' ARG . 94.0 t -101.68 77.59 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 N-CA-C 104.935 -2.246 . . . . 0.84999999999999998 104.935 174.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -87.56 135.78 33.21 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 122.105 0.955 . . . . 2.46 112.427 -176.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 924' ' ' SER . . . . . . . . . . . . . 10.2 t -145.6 103.4 3.79 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.461 -1.311 . . . . 0.69999999999999996 107.461 178.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -103.77 81.81 0.36 Allowed Glycine 0 N--CA 1.486 2.023 0 N-CA-C 108.965 -1.654 . . . . 0.040000000000000001 108.965 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.958 0 N-CA-C 108.74 -1.744 . . . . 0.040000000000000001 108.74 179.849 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 21.9 m . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 120.923 0.392 . . . . 13.779999999999999 110.412 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 95.5 mt -110.43 129.72 55.71 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.5 -0.75 . . . . 13.76 110.324 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -152.36 169.85 31.58 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.381 -1.487 . . . . 9.1300000000000008 109.381 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 949' ' ' VAL . . . . . 0.973 HG12 ' HB3' ' B' ' 920' ' ' ALA . 34.4 m -118.46 132.36 68.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.548 -0.972 . . . . 7.0800000000000001 111.077 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 950' ' ' PHE . . . . . 0.463 ' CZ ' ' HB3' ' B' ' 921' ' ' ARG . 39.8 p90 -134.98 152.6 51.88 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 109.127 -0.694 . . . . 7.5899999999999999 109.127 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 67.9 m -120.97 -53.03 2.07 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.318 -0.864 . . . . 5.0300000000000002 112.362 -178.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 952' ' ' LEU . . . . . 0.457 HD23 ' HB2' ' A' ' 982' ' ' SER . 56.3 tp -61.91 -76.44 0.06 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.32 -0.862 . . . . 1.01 112.357 -177.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 953' ' ' ILE . . . . . 0.495 ' O ' ' HB3' ' B' ' 954' ' ' LEU . 43.9 pt -52.22 -145.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.749 0 N-CA-C 114.038 1.125 . . . . 2.6000000000000001 114.038 -176.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 954' ' ' LEU . . . . . 0.719 HD22 ' O ' ' B' ' 954' ' ' LEU . 0.0 OUTLIER 170.96 83.74 0.04 OUTLIER Pre-proline 0 N--CA 1.508 2.475 0 O-C-N 120.852 -1.155 . . . . 0.050000000000000003 111.609 179.494 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 955' ' ' PRO . . . . . 0.679 ' C ' HD12 ' B' ' 956' ' ' LEU . 48.7 Cg_endo -76.34 95.23 1.03 Allowed 'Trans proline' 0 C--N 1.313 -1.292 0 N-CA-C 108.759 -1.285 . . . . 0.83999999999999997 108.759 177.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 956' ' ' LEU . . . . . 0.679 HD12 ' C ' ' B' ' 955' ' ' PRO . 10.3 mp -122.3 143.9 49.33 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.151 -0.968 . . . . 0.040000000000000001 110.183 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -86.01 151.18 23.93 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 117.81 -1.09 . . . . 1.28 111.639 -179.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -68.61 119.72 13.49 Favored 'General case' 0 N--CA 1.51 2.54 0 CA-C-N 122.862 2.574 . . . . 0.17000000000000001 111.843 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 93.36 -21.5 40.24 Favored Glycine 0 N--CA 1.5 2.962 0 N-CA-C 111.15 -0.78 . . . . 0.040000000000000001 111.15 178.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 960' ' ' ASP . . . . . 0.419 ' HB3' ' NE ' ' B' ' 914' ' ' ARG . 0.5 OUTLIER -55.68 169.77 0.31 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.457 -1.025 . . . . 0.040000000000000001 110.203 -179.489 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 961' ' ' THR . . . . . 0.472 HG21 HG13 ' B' ' 885' ' ' VAL . 46.0 m -136.86 139.49 41.7 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 120.835 -1.165 . . . . 1.78 112.408 -177.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 962' ' ' VAL . . . . . 0.958 HG22 ' HB3' ' B' ' 886' ' ' PHE . 31.8 m -99.87 145.15 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 C-N-CA 120.023 -0.671 . . . . 0.040000000000000001 111.116 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 5.4 t -137.96 145.42 41.98 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.907 -0.496 . . . . 0.71999999999999997 109.981 -179.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 964' ' ' VAL . . . . . 0.497 ' HA ' ' HA ' ' B' ' 911' ' ' VAL . 61.7 t -92.23 136.71 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.052 -1.03 . . . . 1.05 111.279 -178.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -95.69 126.42 40.96 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 103.464 -2.791 . . . . 3.02 103.464 172.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 966' ' ' LEU . . . . . 0.645 HD12 ' OE2' ' B' ' 909' ' ' GLU . 0.2 OUTLIER -133.6 61.39 1.68 Allowed 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.408 -0.96 . . . . 1.46 108.408 177.365 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 967' ' ' VAL . . . . . 0.486 HG23 ' C ' ' B' ' 966' ' ' LEU . 97.6 t -157.73 96.64 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 108.283 -1.006 . . . . 1.9399999999999999 108.283 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 92.8 mmm -143.4 58.68 1.39 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.752 -1.217 . . . . 0.0 108.251 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 133.87 119.75 2.02 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 107.05 -2.42 . . . . 2.1099999999999999 107.05 -178.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -82.46 -57.1 3.5 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.971 -1.311 . . . . 5.8899999999999997 110.499 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 47.8 tp -58.68 90.03 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.402 -0.811 . . . . 4.3600000000000003 110.318 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -143.03 -152.92 0.43 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.637 -0.665 . . . . 1.8300000000000001 110.079 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -117.83 167.41 11.42 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.473 -0.767 . . . . 4.3499999999999996 110.278 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 30.2 t -101.79 130.26 48.18 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.554 -0.716 . . . . 1.27 110.082 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -156.07 158.99 38.71 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.535 -0.728 . . . . 5.0199999999999996 110.643 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.71 85.08 20.94 Favored Pre-proline 0 N--CA 1.5 2.056 0 O-C-N 121.62 -0.675 . . . . 2.4100000000000001 109.72 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -73.41 -171.89 0.92 Allowed 'Trans proline' 0 C--N 1.317 -1.129 0 O-C-N 123.3 1.158 . . . . 0.95999999999999996 111.283 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 978' ' ' LEU . . . . . 0.57 ' N ' HD12 ' B' ' 978' ' ' LEU . 5.2 mp -126.82 155.93 42.1 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 107.546 -1.279 . . . . 0.62 107.546 177.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 979' ' ' THR . . . . . 0.462 HG23 ' C ' ' B' ' 978' ' ' LEU . 47.6 p -149.47 141.59 23.98 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.837 -1.165 . . . . 3.5699999999999998 111.184 -179.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 980' ' ' ILE . . . . . 0.746 ' HB ' HG21 ' B' ' 899' ' ' VAL . 50.6 mm -107.47 129.09 61.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 109.062 -0.718 . . . . 1.3300000000000001 109.062 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 981' ' ' PHE . . . . . 0.496 ' CD1' ' CE2' ' B' ' 879' ' ' TYR . 10.5 t80 -119.99 97.38 5.58 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 119.594 -0.843 . . . . 0.050000000000000003 111.926 -178.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 16.0 p -108.78 158.25 17.82 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 109.163 -0.68 . . . . 0.87 109.163 178.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 983' ' ' GLY . . . . . 0.41 ' O ' ' CE1' ' B' ' 852' ' ' PHE . . . -173.98 111.09 0.35 Allowed Glycine 0 N--CA 1.498 2.812 0 N-CA-C 106.655 -2.578 . . . . 0.029999999999999999 106.655 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 984' ' ' ALA . . . . . 0.423 ' HB1' ' CZ ' ' C' ' 893' ' ' ARG . . . -108.28 149.27 28.86 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 114.32 1.23 . . . . 0.69999999999999996 114.32 -175.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 985' ' ' LEU . . . . . 0.828 HD13 HD22 ' B' ' 890' ' ' LEU . 66.4 tp -71.75 136.28 47.09 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.728 -1.233 . . . . 0.040000000000000001 110.201 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 986' ' ' LEU . . . . . . . . . . . . . 49.3 tp -106.53 -58.07 1.97 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.671 -0.643 . . . . 0.040000000000000001 109.946 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -143.87 146.07 32.76 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.71 -1.218 . . . . 0.040000000000000001 107.71 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.46 162.96 12.22 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 108.088 -2.005 . . . . 0.040000000000000001 108.088 179.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -77.38 111.88 20.08 Favored Pre-proline 0 N--CA 1.499 1.988 0 O-C-N 121.226 -1.161 . . . . 0.040000000000000001 109.524 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 990' ' ' PRO . . . . . 0.631 ' HD2' HD12 ' B' ' 992' ' ' LEU . 48.7 Cg_endo -92.55 72.01 0.57 Allowed 'Trans proline' 0 C--N 1.318 -1.031 0 O-C-N 123.063 1.033 . . . . 0.45000000000000001 111.328 -178.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 991' ' ' GLU . . . . . 0.421 ' HB2' ' O ' ' B' ' 990' ' ' PRO . 72.4 mt-10 67.67 -73.43 0.08 Allowed 'General case' 0 N--CA 1.503 2.179 0 N-CA-C 108.251 -1.018 . . . . 1.97 108.251 -177.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 992' ' ' LEU . . . . . 0.631 HD12 ' HD2' ' B' ' 990' ' ' PRO . 4.1 mt 50.47 20.48 0.7 Allowed 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.58 -0.7 . . . . 2.3799999999999999 111.731 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 76.4 mt-10 -95.87 156.88 16.14 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.893 -1.13 . . . . 3.79 110.082 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 68.0 m80 -144.16 94.76 2.62 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.515 -0.741 . . . . 3.5099999999999998 110.2 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 995' ' ' ALA . . . . . . . . . . . . 2.517 . . . . . . . 0 N--CA 1.503 2.207 0 O-C-N 120.873 -1.142 . . . . 2.73 110.591 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo . . . . . 0 N--CA 1.488 1.152 0 N-CA-C 109.559 -0.977 . . . . 3.8300000000000001 109.559 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 847' ' ' VAL . . . . . 0.401 HG12 ' HB2' ' C' ' 849' ' ' GLN . 68.8 t -131.34 104.66 14.8 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.592 -0.692 . . . . 1.8300000000000001 109.819 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 848' ' ' PRO . . . . . 0.761 ' O ' HG23 ' C' ' 850' ' ' VAL . 43.7 Cg_endo -69.7 -19.56 36.26 Favored 'Trans proline' 0 N--CA 1.487 1.118 0 O-C-N 123.295 1.155 . . . . 0.65000000000000002 111.264 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 849' ' ' GLN . . . . . 0.411 ' C ' ' O ' ' C' ' 848' ' ' PRO . 56.2 tt0 26.24 68.49 0.05 Allowed 'General case' 0 N--CA 1.52 3.037 0 N-CA-C 112.893 0.701 . . . . 2.5800000000000001 112.893 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 850' ' ' VAL . . . . . 0.761 HG23 ' O ' ' C' ' 848' ' ' PRO . 93.5 t -117.21 135.24 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.245 -0.909 . . . . 1.0900000000000001 111.201 -178.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 851' ' ' ALA . . . . . . . . . . . . . . . -133.41 151.2 51.79 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 105.74 -1.948 . . . . 0.040000000000000001 105.74 177.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 852' ' ' PHE . . . . . 0.427 ' HA ' ' CB ' ' C' ' 874' ' ' ASN . 11.2 p90 -158.89 133.27 7.89 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 120.865 1.666 . . . . 0.050000000000000003 108.914 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 7.4 t -174.09 134.04 0.43 Allowed 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 107.954 -1.128 . . . . 0.040000000000000001 107.954 -179.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -136.44 159.25 42.33 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.167 -0.958 . . . . 0.67000000000000004 109.671 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 855' ' ' ALA . . . . . 0.61 ' HB3' ' CB ' ' C' ' 870' ' ' ARG . . . -122.86 140.64 52.74 Favored 'General case' 0 N--CA 1.499 1.994 0 CA-C-O 121.939 0.876 . . . . 0.51000000000000001 112.254 -178.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 856' ' ' LEU . . . . . 0.767 HD23 ' O ' ' C' ' 867' ' ' PRO . 3.5 tm? -106.6 138.52 42.63 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.645 -0.659 . . . . 0.050000000000000003 109.578 179.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 857' ' ' SER . . . . . 0.613 ' N ' HD13 ' C' ' 856' ' ' LEU . 1.3 m -159.23 18.65 0.18 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.443 -0.786 . . . . 1.3300000000000001 111.836 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 858' ' ' LEU . . . . . 0.724 HD23 HD11 ' C' ' 856' ' ' LEU . 2.7 pp -34.57 160.0 0.04 OUTLIER Pre-proline 0 N--CA 1.519 3.02 0 CA-C-N 118.603 0.638 . . . . 2.3300000000000001 112.689 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -60.19 -88.52 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 120.734 0.956 . . . . 2.3199999999999998 113.348 -178.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 55.4 ptt85 -130.47 -143.35 0.25 Allowed 'General case' 0 N--CA 1.5 2.052 0 O-C-N 120.883 -1.135 . . . . 0.040000000000000001 111.978 -177.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 41.2 m -33.31 120.55 0.38 Allowed 'General case' 0 N--CA 1.511 2.617 0 N-CA-C 113.241 0.83 . . . . 1.3100000000000001 113.241 -178.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.79 159.49 29.16 Favored Pre-proline 0 N--CA 1.486 1.342 0 N-CA-C 107.626 -1.25 . . . . 4.5099999999999998 107.626 176.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -69.78 -13.66 34.93 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 O-C-N 123.104 1.055 . . . . 2.2400000000000002 111.524 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -176.65 -135.26 2.13 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.911 -1.275 . . . . 0.040000000000000001 109.911 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 30.1 m -70.41 157.76 37.22 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.332 -1.099 . . . . 1.51 110.416 -179.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 866' ' ' VAL . . . . . 0.465 ' HA ' ' HD3' ' C' ' 867' ' ' PRO . 30.7 m -95.23 142.67 24.92 Favored Pre-proline 0 N--CA 1.498 1.964 0 N-CA-C 114.233 1.197 . . . . 0.78000000000000003 114.233 -174.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 867' ' ' PRO . . . . . 0.767 ' O ' HD23 ' C' ' 856' ' ' LEU . 55.6 Cg_endo -89.91 -150.69 0.04 OUTLIER 'Trans proline' 0 CA--C 1.541 0.871 0 N-CA-C 108.339 -1.446 . . . . 0.92000000000000004 108.339 177.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 868' ' ' PHE . . . . . 0.469 ' CD1' ' HG2' ' C' ' 881' ' ' PRO . 14.1 p90 -148.32 121.05 8.64 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.48 -1.387 . . . . 0.050000000000000003 109.865 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 50.0 p-10 -112.03 -3.97 14.62 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.15 -0.969 . . . . 1.7 112.471 -178.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 870' ' ' ARG . . . . . 0.61 ' CB ' ' HB3' ' C' ' 855' ' ' ALA . 22.7 mmm180 -90.93 89.19 7.34 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.96 -1.087 . . . . 2.5899999999999999 111.031 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 61.2 t -76.51 96.52 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 120.979 -1.075 . . . . 1.9399999999999999 109.238 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 872' ' ' LEU . . . . . 0.496 HD13 HD11 ' A' ' 953' ' ' ILE . 66.8 mt -85.78 -44.61 12.35 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.546 -0.721 . . . . 1.0600000000000001 110.559 -179.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 873' ' ' LEU . . . . . 0.419 ' O ' ' HB2' ' C' ' 874' ' ' ASN . 47.5 tp -172.21 104.33 0.17 Allowed 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.209 -0.932 . . . . 4.1799999999999997 108.71 178.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 874' ' ' ASN . . . . . 0.427 ' CB ' ' HA ' ' C' ' 852' ' ' PHE . 49.5 t-20 178.25 82.65 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.33 0 O-C-N 121.733 -0.604 . . . . 0.040000000000000001 109.588 -178.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 33.0 p-10 -72.07 -49.44 36.48 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.092 -1.005 . . . . 3.3799999999999999 111.705 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 876' ' ' GLY . . . . . . . . . . . . . . . -73.24 -26.43 70.53 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 110.617 -0.993 . . . . 0.040000000000000001 110.617 -179.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 81.34 -61.46 4.6 Favored Glycine 0 N--CA 1.497 2.742 0 N-CA-C 108.27 -1.932 . . . . 0.040000000000000001 108.27 -178.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 878' ' ' TYR . . . . . 0.54 ' CE2' HG13 ' C' ' 850' ' ' VAL . 85.6 m-85 61.62 -61.95 0.09 Allowed 'General case' 0 N--CA 1.504 2.25 0 N-CA-C 113.426 0.899 . . . . 3.46 113.426 178.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 879' ' ' TYR . . . . . 0.494 ' O ' ' CG ' ' C' ' 879' ' ' TYR . 12.2 p90 -110.97 105.33 14.07 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.991 -1.068 . . . . 0.040000000000000001 113.259 -177.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 880' ' ' ASP . . . . . 0.419 ' O ' ' N ' ' C' ' 884' ' ' GLY . 1.2 m-20 -66.69 112.68 10.17 Favored Pre-proline 0 N--CA 1.497 1.883 0 O-C-N 121.161 -0.962 . . . . 0.02 110.526 -178.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 881' ' ' PRO . . . . . 0.469 ' HG2' ' CD1' ' C' ' 868' ' ' PHE . 52.2 Cg_endo -79.05 -3.33 13.1 Favored 'Trans proline' 0 N--CA 1.489 1.238 0 O-C-N 123.531 1.279 . . . . 0.39000000000000001 111.213 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -80.31 -34.57 36.65 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 108.033 -1.099 . . . . 0.81000000000000005 108.033 178.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 69.6 p -110.36 -20.31 12.66 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 115.462 -0.79 . . . . 0.040000000000000001 108.984 176.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 884' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' C' ' 880' ' ' ASP . . . 80.07 4.88 89.78 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 110.232 -1.147 . . . . 0.029999999999999999 110.232 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 71.0 t -74.39 94.61 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 C-N-CA 118.695 -1.202 . . . . 1.01 108.532 -178.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 886' ' ' PHE . . . . . 0.865 ' CB ' HG22 ' C' ' 962' ' ' VAL . 2.1 t80 -88.74 105.8 17.94 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 115.513 -0.767 . . . . 0.050000000000000003 111.785 -177.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 887' ' ' THR . . . . . . . . . . . . . 28.0 m -98.53 99.99 11.2 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.787 -1.19 . . . . 0.68000000000000005 107.787 177.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 888' ' ' ALA . . . . . 0.529 ' HB2' ' CE1' ' C' ' 886' ' ' PHE . . . -97.87 108.3 45.31 Favored Pre-proline 0 N--CA 1.5 2.062 0 N-CA-C 113.606 0.965 . . . . 0.25 113.606 -176.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 889' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -89.87 -12.77 2.81 Favored 'Trans proline' 0 CA--C 1.544 1.02 0 C-N-CA 120.999 1.133 . . . . 1.6399999999999999 109.246 176.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 890' ' ' LEU . . . . . 0.734 HD12 ' N ' ' C' ' 891' ' ' ALA . 3.0 pp -36.87 -48.34 0.74 Allowed 'General case' 0 N--CA 1.508 2.47 0 N-CA-C 113.819 1.044 . . . . 2.29 113.819 -177.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 891' ' ' ALA . . . . . 0.734 ' N ' HD12 ' C' ' 890' ' ' LEU . . . 51.17 95.49 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.34 0 O-C-N 120.998 -1.064 . . . . 0.63 110.472 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . 155.43 -146.9 15.1 Favored Glycine 0 N--CA 1.479 1.566 0 N-CA-C 107.274 -2.33 . . . . 0.040000000000000001 107.274 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 893' ' ' ARG . . . . . 0.423 ' CZ ' ' HB1' ' B' ' 984' ' ' ALA . 76.5 ttt-85 -108.52 127.06 53.6 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 107.223 -1.399 . . . . 3.0 107.223 176.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 894' ' ' TYR . . . . . 0.55 ' HD2' HD23 ' C' ' 954' ' ' LEU . 0.5 OUTLIER -130.75 155.09 47.24 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.099 -1.001 . . . . 0.040000000000000001 110.841 -178.547 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 895' ' ' LEU . . . . . 0.428 ' O ' ' CE1' ' C' ' 894' ' ' TYR . 41.5 tp -99.79 117.3 33.82 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.652 -0.655 . . . . 1.27 110.539 -179.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 896' ' ' LEU . . . . . 0.85 HD23 ' N ' ' C' ' 897' ' ' SER . 4.5 tt -115.59 140.56 49.06 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.509 -0.745 . . . . 0.93999999999999995 110.35 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 897' ' ' SER . . . . . 0.85 ' N ' HD23 ' C' ' 896' ' ' LEU . 50.3 m -147.07 118.44 7.87 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.376 -0.828 . . . . 0.040000000000000001 111.286 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -108.64 147.41 31.91 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 109.401 -0.592 . . . . 0.47999999999999998 109.401 178.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 899' ' ' VAL . . . . . 0.721 HG21 ' HB ' ' C' ' 980' ' ' ILE . 97.9 t -93.19 121.53 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 C-N-CA 119.68 -0.808 . . . . 0.55000000000000004 111.29 -179.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 900' ' ' LEU . . . . . 0.44 HD12 ' HB2' ' C' ' 924' ' ' SER . 4.6 mm? -90.52 111.59 22.93 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 114.564 1.32 . . . . 1.5900000000000001 114.564 -175.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 21.6 m -67.09 142.09 57.23 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 106.974 -1.491 . . . . 0.050000000000000003 106.974 176.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -69.14 -67.71 1.86 Allowed Glycine 0 N--CA 1.494 2.549 0 N-CA-C 110.435 -1.066 . . . . 0.029999999999999999 110.435 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 5.2 t-80 46.24 66.46 0.95 Allowed 'General case' 0 N--CA 1.509 2.483 0 O-C-N 121.442 -1.034 . . . . 3.2000000000000002 111.122 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 46.4 ptt85 -69.12 -6.9 31.42 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.611 -0.681 . . . . 2.9199999999999999 112.043 -179.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 905' ' ' HIS . . . . . 0.488 ' O ' ' CB ' ' C' ' 906' ' ' GLU . 78.1 t60 -58.24 4.58 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.516 0 CA-C-O 117.653 -1.165 . . . . 2.8700000000000001 113.953 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 906' ' ' GLU . . . . . 0.488 ' CB ' ' O ' ' C' ' 905' ' ' HIS . 0.0 OUTLIER 94.02 -167.1 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.413 0 CA-C-N 121.264 1.847 . . . . 0.98999999999999999 112.011 179.096 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 907' ' ' LYS . . . . . 0.476 ' CB ' ' O ' ' C' ' 906' ' ' GLU . 30.3 ttmt 87.89 160.42 0.07 Allowed 'General case' 0 N--CA 1.518 2.969 0 N-CA-C 108.026 -1.102 . . . . 5.25 108.026 -177.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 59.2 t -120.9 116.38 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 120.947 -1.095 . . . . 0.39000000000000001 110.652 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 75.7 tt0 -103.66 131.65 50.62 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 107.298 -1.371 . . . . 1.72 107.298 176.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -155.34 122.36 5.45 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 106.445 -1.687 . . . . 0.67000000000000004 106.445 178.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 911' ' ' VAL . . . . . 0.722 HG13 HG22 ' C' ' 964' ' ' VAL . 70.1 t -77.41 131.95 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.826 -0.546 . . . . 0.54000000000000004 110.679 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 84.0 mt -65.67 157.07 31.0 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.279 -0.888 . . . . 1.5 108.718 178.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 913' ' ' SER . . . . . 0.472 ' OG ' HG11 ' C' ' 919' ' ' VAL . 1.3 p -127.17 132.65 50.46 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.174 -1.047 . . . . 1.3700000000000001 108.174 176.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 914' ' ' ARG . . . . . 0.428 ' O ' ' CB ' ' C' ' 915' ' ' SER . 0.0 OUTLIER -58.81 154.45 14.92 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 120.764 -1.21 . . . . 4.2999999999999998 112.097 -178.848 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 915' ' ' SER . . . . . 0.428 ' CB ' ' O ' ' C' ' 914' ' ' ARG . 1.8 t 83.13 -30.29 0.09 Allowed 'General case' 0 N--CA 1.519 3.022 0 C-N-CA 123.869 0.868 . . . . 2.0499999999999998 112.476 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 916' ' ' ASN . . . . . 0.617 ' HB2' HG21 ' C' ' 919' ' ' VAL . 97.2 m-20 -126.8 -23.5 3.67 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 120.891 -1.13 . . . . 2.71 111.173 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 917' ' ' GLN . . . . . 0.412 ' HB2' ' O ' ' C' ' 916' ' ' ASN . 41.8 mt-30 68.49 168.23 0.27 Allowed 'General case' 0 N--CA 1.517 2.917 0 N-CA-C 105.776 -1.935 . . . . 2.6800000000000002 105.776 -174.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 56.45 -127.72 44.56 Favored Glycine 1 N--CA 1.519 4.19 0 CA-C-N 123.397 2.817 . . . . 0.029999999999999999 106.467 -177.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 919' ' ' VAL . . . . . 0.617 HG21 ' HB2' ' C' ' 916' ' ' ASN . 95.0 t 50.45 94.83 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.336 0 CA-C-N 118.534 1.167 . . . . 1.3899999999999999 109.426 -178.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 920' ' ' ALA . . . . . 0.939 ' HB3' HG12 ' C' ' 949' ' ' VAL . . . -93.93 93.7 8.05 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.336 -0.946 . . . . 0.029999999999999999 111.049 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 921' ' ' ARG . . . . . 0.668 ' HG3' HG23 ' C' ' 922' ' ' VAL . 45.4 ptt85 -83.19 -42.96 16.67 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 105.582 -2.007 . . . . 4.4199999999999999 105.582 176.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 922' ' ' VAL . . . . . 0.668 HG23 ' HG3' ' C' ' 921' ' ' ARG . 77.3 t -101.05 74.65 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 104.71 -2.33 . . . . 0.84999999999999998 104.71 174.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -86.74 136.87 32.85 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 122.074 0.94 . . . . 2.46 112.614 -176.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 924' ' ' SER . . . . . 0.44 ' HB2' HD12 ' C' ' 900' ' ' LEU . 6.4 t -145.8 103.17 3.75 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 107.719 -1.215 . . . . 0.69999999999999996 107.719 178.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -107.48 85.75 0.43 Allowed Glycine 0 N--CA 1.488 2.123 0 N-CA-C 108.905 -1.678 . . . . 0.040000000000000001 108.905 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.278 0 N-CA-C 109.151 -1.58 . . . . 0.040000000000000001 109.151 -179.707 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 31.1 m . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 120.971 0.415 . . . . 13.779999999999999 110.335 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 947' ' ' LEU . . . . . 0.412 ' CD2' HG23 ' C' ' 919' ' ' VAL . 92.5 mt -110.37 129.56 55.73 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.487 -0.758 . . . . 13.76 110.312 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -152.25 169.71 31.51 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.348 -1.501 . . . . 9.1300000000000008 109.348 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 949' ' ' VAL . . . . . 0.939 HG12 ' HB3' ' C' ' 920' ' ' ALA . 33.5 m -118.69 131.74 70.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.551 -0.97 . . . . 7.0800000000000001 110.843 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 950' ' ' PHE . . . . . 0.457 ' CZ ' ' HB3' ' C' ' 921' ' ' ARG . 48.2 p90 -133.36 151.14 51.82 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.579 -0.7 . . . . 7.5899999999999999 109.113 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 7.3 m -119.64 -53.19 2.21 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.401 -0.812 . . . . 5.0300000000000002 112.096 -178.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 952' ' ' LEU . . . . . 0.425 ' O ' ' O ' ' C' ' 953' ' ' ILE . 15.4 tp -62.99 -74.78 0.09 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.354 -0.841 . . . . 1.01 112.018 -177.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 953' ' ' ILE . . . . . 0.597 HD11 HD13 ' B' ' 872' ' ' LEU . 41.8 pt -52.42 -146.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.77 0 N-CA-C 114.145 1.165 . . . . 2.6000000000000001 114.145 -176.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 954' ' ' LEU . . . . . 0.707 HD22 ' O ' ' C' ' 954' ' ' LEU . 0.0 OUTLIER 169.0 80.38 0.03 OUTLIER Pre-proline 0 N--CA 1.512 2.674 0 O-C-N 120.957 -1.089 . . . . 0.050000000000000003 111.695 179.563 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 955' ' ' PRO . . . . . 0.436 ' HD2' ' CE1' ' C' ' 950' ' ' PHE . 44.4 Cg_endo -72.66 98.84 1.0 Allowed 'Trans proline' 0 C--N 1.313 -1.325 0 N-CA-C 109.193 -1.118 . . . . 0.83999999999999997 109.193 178.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 956' ' ' LEU . . . . . 0.408 ' HA ' ' NH1' ' C' ' 914' ' ' ARG . 92.0 mt -125.26 142.29 51.59 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.052 -1.03 . . . . 0.040000000000000001 110.492 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 957' ' ' GLN . . . . . 0.447 ' HB2' ' HB3' ' C' ' 960' ' ' ASP . 87.2 mt-30 -84.98 149.49 25.57 Favored 'General case' 0 N--CA 1.501 2.124 0 CA-C-O 117.997 -1.001 . . . . 1.28 111.919 -178.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -62.11 122.29 15.19 Favored 'General case' 0 N--CA 1.512 2.635 0 CA-C-N 122.751 2.523 . . . . 0.17000000000000001 110.799 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 91.48 -10.31 75.09 Favored Glycine 0 N--CA 1.501 3.011 0 N-CA-C 110.167 -1.173 . . . . 0.040000000000000001 110.167 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 960' ' ' ASP . . . . . 0.447 ' HB3' ' HB2' ' C' ' 957' ' ' GLN . 16.3 p-10 -47.96 167.92 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.546 -0.973 . . . . 0.040000000000000001 111.98 -179.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 961' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' C' ' 886' ' ' PHE . 91.1 m -137.96 127.15 24.42 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.403 -0.811 . . . . 1.78 110.087 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 962' ' ' VAL . . . . . 0.865 HG22 ' CB ' ' C' ' 886' ' ' PHE . 12.0 m -100.96 142.95 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 C-N-CA 119.392 -0.923 . . . . 0.040000000000000001 110.45 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 5.5 t -140.41 145.77 37.47 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.968 -0.457 . . . . 0.71999999999999997 109.875 -178.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 964' ' ' VAL . . . . . 0.722 HG22 HG13 ' C' ' 911' ' ' VAL . 60.1 t -100.71 136.96 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.041 -1.037 . . . . 1.05 111.296 -178.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -96.42 128.11 43.04 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 103.967 -2.605 . . . . 3.02 103.967 173.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 966' ' ' LEU . . . . . 0.489 ' C ' HG23 ' C' ' 967' ' ' VAL . 11.7 tp -132.38 64.33 1.61 Allowed 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.254 -1.017 . . . . 1.46 108.254 177.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 967' ' ' VAL . . . . . 0.489 HG23 ' C ' ' C' ' 966' ' ' LEU . 96.9 t -157.81 97.19 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 108.041 -1.096 . . . . 1.9399999999999999 108.041 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 91.1 mmm -143.17 59.13 1.41 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.713 -1.242 . . . . 0.0 108.359 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.35 119.93 1.97 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 107.124 -2.39 . . . . 2.1099999999999999 107.124 -178.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -81.56 -57.94 3.24 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.01 -1.288 . . . . 5.8899999999999997 110.574 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 45.4 tp -58.64 90.24 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.433 -0.792 . . . . 4.3600000000000003 110.395 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -142.97 -153.47 0.47 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.573 -0.704 . . . . 1.8300000000000001 110.188 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -118.69 166.86 12.24 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.501 -0.75 . . . . 4.3499999999999996 110.323 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 31.1 t -102.14 130.18 48.7 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.522 -0.736 . . . . 1.27 109.944 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 66.8 tt0 -156.25 159.53 38.98 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.466 -0.771 . . . . 5.0199999999999996 110.628 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.1 85.82 21.59 Favored Pre-proline 0 N--CA 1.5 2.067 0 O-C-N 121.646 -0.659 . . . . 2.4100000000000001 109.755 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 977' ' ' PRO . . . . . 0.516 ' C ' HD12 ' C' ' 978' ' ' LEU . 47.3 Cg_endo -72.97 -170.74 0.66 Allowed 'Trans proline' 0 C--N 1.316 -1.138 0 O-C-N 123.323 1.17 . . . . 0.95999999999999996 111.159 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 978' ' ' LEU . . . . . 0.516 HD12 ' C ' ' C' ' 977' ' ' PRO . 5.8 mp -126.17 155.88 41.03 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 107.703 -1.221 . . . . 0.62 107.703 178.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 979' ' ' THR . . . . . 0.452 HG23 ' C ' ' C' ' 978' ' ' LEU . 63.7 p -148.83 141.17 24.15 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.853 -1.154 . . . . 3.5699999999999998 111.09 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 980' ' ' ILE . . . . . 0.721 ' HB ' HG21 ' C' ' 899' ' ' VAL . 49.2 mm -107.06 129.24 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 108.982 -0.747 . . . . 1.3300000000000001 108.982 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 981' ' ' PHE . . . . . 0.454 ' CD1' ' CE2' ' C' ' 879' ' ' TYR . 5.3 t80 -119.92 96.44 5.18 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 119.606 -0.837 . . . . 0.050000000000000003 111.796 -178.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 982' ' ' SER . . . . . . . . . . . . . 94.8 p -108.55 157.19 18.7 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.831 -0.803 . . . . 0.87 108.831 178.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 983' ' ' GLY . . . . . . . . . . . . . . . -172.86 112.86 0.45 Allowed Glycine 0 N--CA 1.496 2.671 0 N-CA-C 106.841 -2.503 . . . . 0.029999999999999999 106.841 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 984' ' ' ALA . . . . . 0.416 ' HB1' ' CZ ' ' A' ' 893' ' ' ARG . . . -109.83 146.98 34.13 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 114.142 1.164 . . . . 0.69999999999999996 114.142 -176.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 985' ' ' LEU . . . . . . . . . . . . . 56.6 tp -71.24 136.88 48.21 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 120.788 -1.195 . . . . 0.040000000000000001 110.2 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 986' ' ' LEU . . . . . . . . . . . . . 51.7 tp -106.21 -60.65 1.62 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.597 -0.689 . . . . 0.040000000000000001 110.285 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -143.82 146.46 33.09 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.896 -1.15 . . . . 0.040000000000000001 107.896 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.79 162.62 12.31 Favored Glycine 0 N--CA 1.496 2.695 0 N-CA-C 108.132 -1.987 . . . . 0.040000000000000001 108.132 179.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.72 111.86 22.62 Favored Pre-proline 0 N--CA 1.499 1.999 0 CA-C-N 118.571 1.186 . . . . 0.040000000000000001 109.539 178.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 990' ' ' PRO . . . . . 0.471 ' HD2' HD12 ' C' ' 992' ' ' LEU . 48.8 Cg_endo -92.59 74.0 0.48 Allowed 'Trans proline' 0 C--N 1.318 -1.059 0 O-C-N 123.117 1.062 . . . . 0.45000000000000001 111.527 -179.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 991' ' ' GLU . . . . . 0.417 ' HB2' ' O ' ' C' ' 990' ' ' PRO . 77.1 mt-10 67.26 -73.67 0.08 Allowed 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 108.48 -0.933 . . . . 1.97 108.48 -177.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 992' ' ' LEU . . . . . 0.471 HD12 ' HD2' ' C' ' 990' ' ' PRO . 6.9 mt 51.65 20.38 1.08 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.521 -0.737 . . . . 2.3799999999999999 111.591 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -95.39 156.88 16.13 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.855 -1.153 . . . . 3.79 110.066 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 67.3 m80 -146.44 94.55 2.47 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.534 -0.729 . . . . 3.5099999999999998 110.345 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 995' ' ' ALA . . . . . . . . . . . . 2.518 . . . . . . . 0 N--CA 1.504 2.225 0 O-C-N 120.955 -1.09 . . . . 2.73 110.616 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo . . . . . 0 N--CA 1.488 1.177 0 N-CA-C 109.482 -1.007 . . . . 3.8300000000000001 109.482 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 847' ' ' VAL . . . . . 0.432 HG12 ' HB2' ' A' ' 849' ' ' GLN . 60.1 t -132.04 103.58 14.16 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.583 -0.698 . . . . 1.8300000000000001 110.073 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 848' ' ' PRO . . . . . 0.718 ' O ' HG23 ' A' ' 850' ' ' VAL . 43.9 Cg_endo -69.8 -19.89 35.34 Favored 'Trans proline' 0 N--CA 1.487 1.106 0 O-C-N 123.302 1.159 . . . . 0.65000000000000002 111.125 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 849' ' ' GLN . . . . . 0.432 ' HB2' HG12 ' A' ' 847' ' ' VAL . 56.4 tt0 26.42 69.24 0.05 Allowed 'General case' 0 N--CA 1.519 2.989 0 N-CA-C 112.948 0.721 . . . . 2.5800000000000001 112.948 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 850' ' ' VAL . . . . . 0.718 HG23 ' O ' ' A' ' 848' ' ' PRO . 59.7 t -117.46 137.86 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.292 -0.88 . . . . 1.0900000000000001 111.63 -178.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 851' ' ' ALA . . . . . 0.495 ' HB3' ' HG ' ' A' ' 873' ' ' LEU . . . -127.69 155.41 44.0 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 105.723 -1.954 . . . . 0.040000000000000001 105.723 176.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 852' ' ' PHE . . . . . 0.446 ' HA ' ' CB ' ' A' ' 874' ' ' ASN . 21.4 p90 -160.4 128.87 4.73 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-N 121.016 1.735 . . . . 0.050000000000000003 108.864 179.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 33.1 t -175.57 134.57 0.3 Allowed 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.071 -1.085 . . . . 0.040000000000000001 108.071 -179.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -134.85 158.42 44.26 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.053 -1.029 . . . . 0.67000000000000004 109.501 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 855' ' ' ALA . . . . . 0.78 ' HB3' ' CB ' ' A' ' 870' ' ' ARG . . . -122.58 141.02 52.14 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 121.894 0.854 . . . . 0.51000000000000001 111.852 -178.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 856' ' ' LEU . . . . . 0.925 HD11 HD23 ' A' ' 858' ' ' LEU . 3.5 tm? -107.64 135.53 48.93 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 109.247 -0.649 . . . . 0.050000000000000003 109.247 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 857' ' ' SER . . . . . 0.572 ' N ' HD13 ' A' ' 856' ' ' LEU . 16.9 p -153.05 17.82 0.57 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.419 -0.8 . . . . 1.3300000000000001 111.223 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 858' ' ' LEU . . . . . 0.925 HD23 HD11 ' A' ' 856' ' ' LEU . 3.1 pp -29.66 154.08 0.03 OUTLIER Pre-proline 0 N--CA 1.52 3.046 0 N-CA-C 113.421 0.897 . . . . 2.3300000000000001 113.421 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -61.73 -88.8 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 120.934 1.09 . . . . 2.3199999999999998 113.683 -177.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 53.4 ptt85 -127.16 -142.12 0.27 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.895 -1.128 . . . . 0.040000000000000001 111.429 -177.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 36.8 m -39.11 119.02 0.85 Allowed 'General case' 0 N--CA 1.51 2.543 0 O-C-N 121.549 -0.719 . . . . 1.3100000000000001 111.919 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 862' ' ' GLU . . . . . 0.502 ' OE2' HD22 ' A' ' 858' ' ' LEU . 24.6 tt0 -97.35 149.57 35.86 Favored Pre-proline 0 N--CA 1.488 1.453 0 N-CA-C 108.17 -1.048 . . . . 4.5099999999999998 108.17 178.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 863' ' ' PRO . . . . . 0.446 ' HD2' ' CG ' ' A' ' 862' ' ' GLU . 41.6 Cg_endo -67.65 -13.31 38.47 Favored 'Trans proline' 0 C--N 1.316 -1.161 0 O-C-N 122.984 0.991 . . . . 2.2400000000000002 111.334 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -174.21 -137.36 2.43 Favored Glycine 0 N--CA 1.493 2.474 0 C-N-CA 119.76 -1.21 . . . . 0.040000000000000001 110.623 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 37.1 m -69.2 159.65 32.63 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.332 -1.099 . . . . 1.51 111.719 -177.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 866' ' ' VAL . . . . . 0.463 ' O ' HG23 ' A' ' 866' ' ' VAL . 27.0 m -89.93 132.73 35.48 Favored Pre-proline 0 N--CA 1.495 1.808 0 N-CA-C 113.422 0.897 . . . . 0.78000000000000003 113.422 -175.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 867' ' ' PRO . . . . . 0.841 ' O ' HD23 ' A' ' 856' ' ' LEU . 52.5 Cg_endo -88.77 -153.82 0.05 OUTLIER 'Trans proline' 0 C--N 1.323 -0.794 0 N-CA-C 107.709 -1.689 . . . . 0.92000000000000004 107.709 177.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 868' ' ' PHE . . . . . 0.48 ' CD1' ' HG2' ' A' ' 881' ' ' PRO . 31.9 p90 -148.55 119.25 7.5 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.51 -1.369 . . . . 0.050000000000000003 109.944 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 50.1 p-10 -112.72 -3.24 14.29 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 119.322 -0.951 . . . . 1.7 112.207 -178.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 870' ' ' ARG . . . . . 0.78 ' CB ' ' HB3' ' A' ' 855' ' ' ALA . 26.5 mmm180 -89.98 88.69 7.4 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.908 -1.12 . . . . 2.5899999999999999 110.676 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 57.3 t -75.12 96.88 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.028 -1.045 . . . . 1.9399999999999999 109.787 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 872' ' ' LEU . . . . . . . . . . . . . 95.8 mt -83.92 -46.89 11.62 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.553 -0.717 . . . . 1.0600000000000001 110.231 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 873' ' ' LEU . . . . . 0.495 ' HG ' ' HB3' ' A' ' 851' ' ' ALA . 48.8 tp -174.82 104.48 0.09 Allowed 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.293 -0.879 . . . . 4.1799999999999997 108.676 178.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 874' ' ' ASN . . . . . 0.446 ' CB ' ' HA ' ' A' ' 852' ' ' PHE . 36.5 t-20 178.68 82.1 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.316 0 O-C-N 121.588 -0.695 . . . . 0.040000000000000001 109.675 -178.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -66.91 -47.06 72.93 Favored 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 119.289 -0.965 . . . . 3.3799999999999999 111.283 -179.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 876' ' ' GLY . . . . . 0.404 ' HA3' ' CE2' ' A' ' 878' ' ' TYR . . . -74.62 -25.29 70.35 Favored Glycine 0 N--CA 1.494 2.553 0 O-C-N 121.239 -0.913 . . . . 0.040000000000000001 111.836 -178.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 84.32 -59.8 4.9 Favored Glycine 0 N--CA 1.502 3.084 0 N-CA-C 108.154 -1.979 . . . . 0.040000000000000001 108.154 -178.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 878' ' ' TYR . . . . . 0.404 ' CE2' ' HA3' ' A' ' 876' ' ' GLY . 97.7 m-85 60.67 -66.13 0.05 Allowed 'General case' 0 N--CA 1.503 2.215 0 N-CA-C 114.327 1.232 . . . . 3.46 114.327 177.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 879' ' ' TYR . . . . . 0.469 ' CB ' ' CD2' ' A' ' 886' ' ' PHE . 23.7 p90 -112.37 109.17 18.64 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 114.796 1.406 . . . . 0.040000000000000001 114.796 -176.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -65.18 118.53 50.65 Favored Pre-proline 0 N--CA 1.495 1.816 0 O-C-N 121.369 -0.832 . . . . 0.02 110.026 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 881' ' ' PRO . . . . . 0.48 ' HG2' ' CD1' ' A' ' 868' ' ' PHE . 55.2 Cg_endo -76.87 0.24 9.85 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 O-C-N 123.469 1.247 . . . . 0.39000000000000001 112.094 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 -76.79 -64.81 1.04 Allowed 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 106.98 -1.489 . . . . 0.81000000000000005 106.98 178.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 883' ' ' THR . . . . . 0.478 ' OG1' HG23 ' A' ' 885' ' ' VAL . 30.4 p -94.1 -17.7 22.55 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.776 -0.824 . . . . 0.040000000000000001 108.776 177.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.08 22.11 55.65 Favored Glycine 0 N--CA 1.495 2.63 0 O-C-N 121.057 -1.027 . . . . 0.029999999999999999 110.749 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 885' ' ' VAL . . . . . 0.652 HG13 HG21 ' A' ' 961' ' ' THR . 77.6 t -73.15 90.42 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 C-N-CA 118.353 -1.339 . . . . 1.01 108.23 -179.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 886' ' ' PHE . . . . . 0.883 ' HB3' HG22 ' A' ' 962' ' ' VAL . 0.7 OUTLIER -90.39 104.34 16.92 Favored 'General case' 0 N--CA 1.495 1.825 0 CA-C-N 115.291 -0.868 . . . . 0.050000000000000003 112.291 -177.298 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 887' ' ' THR . . . . . 0.418 ' O ' ' HD3' ' A' ' 889' ' ' PRO . 89.8 m -95.04 100.77 12.54 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 107.831 -1.174 . . . . 0.68000000000000005 107.831 177.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 888' ' ' ALA . . . . . . . . . . . . . . . -99.17 106.37 38.15 Favored Pre-proline 0 N--CA 1.5 2.047 0 N-CA-C 114.045 1.128 . . . . 0.25 114.045 -176.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 889' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 887' ' ' THR . 54.6 Cg_endo -89.2 -11.94 3.45 Favored 'Trans proline' 0 CA--C 1.546 1.109 0 N-CA-C 108.975 -1.202 . . . . 1.6399999999999999 108.975 176.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 890' ' ' LEU . . . . . 0.628 HD11 ' CD1' ' A' ' 985' ' ' LEU . 4.9 tt -35.29 -51.23 0.58 Allowed 'General case' 0 N--CA 1.507 2.397 0 N-CA-C 113.92 1.082 . . . . 2.29 113.92 -177.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 51.79 95.03 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.374 0 O-C-N 121.188 -0.945 . . . . 0.63 110.175 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 156.05 -147.28 15.72 Favored Glycine 0 N--CA 1.478 1.487 0 N-CA-C 107.372 -2.291 . . . . 0.040000000000000001 107.372 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 893' ' ' ARG . . . . . 0.44 ' NE ' ' HB1' ' C' ' 984' ' ' ALA . 72.4 ttt-85 -109.0 127.91 54.5 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.86 -1.163 . . . . 3.0 107.86 177.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 894' ' ' TYR . . . . . 0.45 ' CD1' ' N ' ' A' ' 895' ' ' LEU . 0.1 OUTLIER -130.98 144.46 51.49 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.05 -1.032 . . . . 0.040000000000000001 110.085 -179.305 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 895' ' ' LEU . . . . . 0.45 ' N ' ' CD1' ' A' ' 894' ' ' TYR . 34.3 tp -99.37 115.22 28.72 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.625 -0.672 . . . . 1.27 109.807 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 896' ' ' LEU . . . . . 0.617 HD23 ' N ' ' A' ' 897' ' ' SER . 9.9 tt -112.16 145.87 39.06 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.579 -0.7 . . . . 0.93999999999999995 110.461 -179.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 897' ' ' SER . . . . . 0.617 ' N ' HD23 ' A' ' 896' ' ' LEU . 71.2 m -144.74 119.11 9.6 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.379 -0.825 . . . . 0.040000000000000001 110.741 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.97 147.69 30.72 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.708 -0.62 . . . . 0.47999999999999998 109.448 179.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 899' ' ' VAL . . . . . 0.706 HG21 ' HB ' ' A' ' 980' ' ' ILE . 88.0 t -91.95 121.15 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.457 -0.777 . . . . 0.55000000000000004 110.98 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 900' ' ' LEU . . . . . 0.603 HD12 ' HB2' ' A' ' 924' ' ' SER . 4.4 mm? -95.02 111.75 23.52 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 114.423 1.268 . . . . 1.5900000000000001 114.423 -174.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 17.3 m -67.8 141.64 56.45 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 107.274 -1.38 . . . . 0.050000000000000003 107.274 176.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -67.92 -65.02 2.87 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 110.718 -0.953 . . . . 0.029999999999999999 110.718 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 5.8 m170 46.83 66.31 1.02 Allowed 'General case' 0 N--CA 1.508 2.437 0 O-C-N 121.464 -1.021 . . . . 3.2000000000000002 111.082 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 54.1 ptt85 -69.26 -5.91 25.94 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.578 -0.701 . . . . 2.9199999999999999 112.178 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 905' ' ' HIS . . . . . 0.489 ' O ' ' CB ' ' A' ' 906' ' ' GLU . 73.9 t60 -62.69 5.06 0.13 Allowed 'General case' 0 N--CA 1.507 2.393 0 O-C-N 120.888 -1.132 . . . . 2.8700000000000001 113.086 -179.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 906' ' ' GLU . . . . . 0.489 ' CB ' ' O ' ' A' ' 905' ' ' HIS . 0.6 OUTLIER 95.07 -164.97 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.452 0 CA-C-N 120.609 1.549 . . . . 0.98999999999999999 111.993 178.903 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 907' ' ' LYS . . . . . 0.463 ' CB ' ' O ' ' A' ' 906' ' ' GLU . 62.0 tttt 86.09 156.78 0.08 Allowed 'General case' 0 N--CA 1.52 3.03 0 N-CA-C 107.961 -1.126 . . . . 5.25 107.961 -176.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 60.7 t -122.1 117.45 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 120.791 -1.193 . . . . 0.39000000000000001 111.224 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 54.0 tp10 -101.56 133.24 46.54 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 107.291 -1.374 . . . . 1.72 107.291 176.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -155.74 123.0 5.45 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 106.811 -1.551 . . . . 0.67000000000000004 106.811 178.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 911' ' ' VAL . . . . . 0.772 HG22 HG13 ' A' ' 964' ' ' VAL . 93.8 t -84.28 131.83 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.902 -0.499 . . . . 0.54000000000000004 110.984 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 60.6 mt -66.92 157.56 32.92 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.46 -0.775 . . . . 1.5 109.351 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 913' ' ' SER . . . . . 0.466 ' OG ' HG11 ' A' ' 919' ' ' VAL . 1.4 p -124.65 137.6 54.36 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.003 -1.11 . . . . 1.3700000000000001 108.003 176.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 914' ' ' ARG . . . . . 0.611 ' NH1' HD23 ' A' ' 956' ' ' LEU . 0.1 OUTLIER -65.32 155.28 35.75 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.638 -1.289 . . . . 4.2999999999999998 111.359 -179.164 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 915' ' ' SER . . . . . 0.424 ' CB ' ' O ' ' A' ' 914' ' ' ARG . 1.7 p 83.42 -31.56 0.08 Allowed 'General case' 0 N--CA 1.521 3.118 0 C-N-CA 123.925 0.89 . . . . 2.0499999999999998 112.068 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 916' ' ' ASN . . . . . 0.754 ' HB2' HG21 ' A' ' 919' ' ' VAL . 99.4 m-20 -122.78 -21.91 5.47 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 120.953 -1.092 . . . . 2.71 111.192 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 917' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 67.04 166.53 0.22 Allowed 'General case' 0 N--CA 1.52 3.027 0 N-CA-C 105.742 -1.948 . . . . 2.6800000000000002 105.742 -174.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.33 -125.23 33.43 Favored Glycine 1 N--CA 1.521 4.324 0 CA-C-N 123.368 2.804 . . . . 0.029999999999999999 107.07 -177.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 919' ' ' VAL . . . . . 0.754 HG21 ' HB2' ' A' ' 916' ' ' ASN . 88.2 t 52.39 94.98 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 O-C-N 121.382 -1.069 . . . . 1.3899999999999999 109.068 -178.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 920' ' ' ALA . . . . . 0.912 ' HB3' HG12 ' A' ' 949' ' ' VAL . . . -90.87 91.07 8.19 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.246 -0.982 . . . . 0.029999999999999999 110.788 -179.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 921' ' ' ARG . . . . . 0.763 ' HG3' HG23 ' A' ' 922' ' ' VAL . 27.5 ptt85 -84.99 -42.2 15.11 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 106.013 -1.847 . . . . 4.4199999999999999 106.013 176.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 922' ' ' VAL . . . . . 0.763 HG23 ' HG3' ' A' ' 921' ' ' ARG . 74.6 t -101.96 74.29 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 105.76 -1.941 . . . . 0.84999999999999998 105.76 175.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -85.79 134.91 33.91 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.758 0.789 . . . . 2.46 111.545 -177.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 924' ' ' SER . . . . . 0.603 ' HB2' HD12 ' A' ' 900' ' ' LEU . 7.0 t -147.09 105.67 3.81 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 108.772 -0.825 . . . . 0.69999999999999996 108.772 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -103.46 83.49 0.42 Allowed Glycine 0 N--CA 1.487 2.035 0 N-CA-C 108.243 -1.943 . . . . 0.040000000000000001 108.243 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.226 0 N-CA-C 108.82 -1.712 . . . . 0.040000000000000001 108.82 -179.543 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 24.8 m . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.054 0.455 . . . . 13.779999999999999 110.29 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 95.7 mt -112.17 130.01 56.05 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.519 -0.738 . . . . 13.76 110.362 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -151.77 168.71 31.16 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.229 -1.548 . . . . 9.1300000000000008 109.229 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 949' ' ' VAL . . . . . 0.912 HG12 ' HB3' ' A' ' 920' ' ' ALA . 32.7 m -118.28 130.1 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.573 -0.957 . . . . 7.0800000000000001 110.691 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 950' ' ' PHE . . . . . 0.46 ' CZ ' ' HB3' ' A' ' 921' ' ' ARG . 50.0 p90 -135.18 152.46 51.61 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.57 -0.706 . . . . 7.5899999999999999 109.508 179.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 23.1 m -118.45 -54.52 2.27 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.44 -0.787 . . . . 5.0300000000000002 112.007 -178.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 952' ' ' LEU . . . . . 0.437 ' O ' ' O ' ' A' ' 953' ' ' ILE . 12.3 tp -62.05 -74.26 0.09 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.432 -0.793 . . . . 1.01 112.081 -177.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 953' ' ' ILE . . . . . 0.643 HD12 ' HD3' ' A' ' 955' ' ' PRO . 1.5 pp -51.56 -149.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.713 0 N-CA-C 114.18 1.178 . . . . 2.6000000000000001 114.18 -176.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 954' ' ' LEU . . . . . 0.74 HD22 ' O ' ' A' ' 954' ' ' LEU . 0.0 OUTLIER 166.32 90.69 0.02 OUTLIER Pre-proline 0 N--CA 1.519 2.982 0 O-C-N 121.179 -0.951 . . . . 0.050000000000000003 111.755 179.174 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 955' ' ' PRO . . . . . 0.732 ' C ' HD12 ' A' ' 956' ' ' LEU . 51.7 Cg_endo -78.92 98.28 1.18 Allowed 'Trans proline' 0 C--N 1.315 -1.198 0 N-CA-C 109.037 -1.178 . . . . 0.83999999999999997 109.037 178.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 956' ' ' LEU . . . . . 0.732 HD12 ' C ' ' A' ' 955' ' ' PRO . 11.1 mp -121.27 141.93 50.42 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.994 -1.066 . . . . 0.040000000000000001 109.954 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -84.5 150.86 24.98 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 117.782 -1.104 . . . . 1.28 111.842 -178.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -68.43 118.9 12.09 Favored 'General case' 0 N--CA 1.509 2.525 0 CA-C-N 123.034 2.652 . . . . 0.17000000000000001 111.431 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 93.03 -21.25 40.92 Favored Glycine 0 N--CA 1.5 2.959 0 N-CA-C 111.034 -0.826 . . . . 0.040000000000000001 111.034 178.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 960' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -56.57 170.46 0.38 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.426 -1.044 . . . . 0.040000000000000001 110.112 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 961' ' ' THR . . . . . 0.652 HG21 HG13 ' A' ' 885' ' ' VAL . 42.1 m -135.94 137.76 41.65 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.906 -1.121 . . . . 1.78 112.282 -178.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 962' ' ' VAL . . . . . 0.883 HG22 ' HB3' ' A' ' 886' ' ' PHE . 33.6 m -98.14 145.37 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 C-N-CA 120.142 -0.623 . . . . 0.040000000000000001 110.352 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 5.2 t -137.4 145.02 42.73 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.792 -0.568 . . . . 0.71999999999999997 110.041 -178.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 964' ' ' VAL . . . . . 0.772 HG13 HG22 ' A' ' 911' ' ' VAL . 61.2 t -93.21 136.72 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.16 -0.963 . . . . 1.05 110.495 -179.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -93.73 127.42 39.43 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 103.613 -2.736 . . . . 3.02 103.613 173.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 966' ' ' LEU . . . . . 0.544 HD23 ' O ' ' A' ' 966' ' ' LEU . 4.1 tt -132.51 61.11 1.67 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.21 -1.033 . . . . 1.46 108.21 177.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 967' ' ' VAL . . . . . 0.488 HG23 ' C ' ' A' ' 966' ' ' LEU . 97.2 t -157.87 96.74 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 108.12 -1.067 . . . . 1.9399999999999999 108.12 179.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 88.1 mmm -143.66 59.16 1.38 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.747 -1.22 . . . . 0.0 108.34 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.13 119.64 1.95 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 107.107 -2.397 . . . . 2.1099999999999999 107.107 -178.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -82.17 -58.35 2.99 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.023 -1.281 . . . . 5.8899999999999997 110.378 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 46.7 tp -58.89 90.84 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.434 -0.791 . . . . 4.3600000000000003 110.244 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -142.0 -154.37 0.52 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.595 -0.691 . . . . 1.8300000000000001 110.208 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -119.53 170.7 8.93 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.479 -0.763 . . . . 4.3499999999999996 110.252 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 9.5 t -101.63 130.4 47.96 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.548 -0.72 . . . . 1.27 110.12 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -155.89 158.77 38.54 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.482 -0.761 . . . . 5.0199999999999996 110.41 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.5 85.72 17.32 Favored Pre-proline 0 N--CA 1.501 2.078 0 O-C-N 121.618 -0.676 . . . . 2.4100000000000001 109.87 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 977' ' ' PRO . . . . . 0.498 ' C ' HD12 ' A' ' 978' ' ' LEU . 47.8 Cg_endo -73.61 -172.65 1.12 Allowed 'Trans proline' 0 C--N 1.318 -1.059 0 O-C-N 123.303 1.159 . . . . 0.95999999999999996 111.277 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 978' ' ' LEU . . . . . 0.515 HD23 ' CD1' ' A' ' 856' ' ' LEU . 5.4 mp -127.47 155.39 43.79 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.728 -1.212 . . . . 0.62 107.728 178.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 979' ' ' THR . . . . . 0.451 HG23 ' C ' ' A' ' 978' ' ' LEU . 37.1 p -150.23 141.11 22.83 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.762 -1.212 . . . . 3.5699999999999998 111.186 -179.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 980' ' ' ILE . . . . . 0.706 ' HB ' HG21 ' A' ' 899' ' ' VAL . 51.4 mm -107.38 128.76 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 109.099 -0.704 . . . . 1.3300000000000001 109.099 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 981' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -119.39 99.29 6.59 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 119.821 -0.752 . . . . 0.050000000000000003 111.8 -178.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 42.6 p -106.78 158.25 17.13 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.814 -0.81 . . . . 0.87 108.814 178.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . -172.78 110.13 0.33 Allowed Glycine 0 N--CA 1.498 2.803 0 N-CA-C 106.649 -2.58 . . . . 0.029999999999999999 106.649 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -110.67 149.67 30.13 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 114.551 1.315 . . . . 0.69999999999999996 114.551 -175.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 985' ' ' LEU . . . . . 0.628 ' CD1' HD11 ' A' ' 890' ' ' LEU . 54.4 tp -70.73 133.9 47.0 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.816 -1.177 . . . . 0.040000000000000001 109.808 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 51.0 tp -107.37 -59.04 1.88 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.499 -0.751 . . . . 0.040000000000000001 109.989 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -144.47 145.06 31.67 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.565 -1.272 . . . . 0.040000000000000001 107.565 179.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.97 163.12 12.17 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 108.139 -1.984 . . . . 0.040000000000000001 108.139 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -75.3 112.5 18.97 Favored Pre-proline 0 N--CA 1.498 1.973 0 CA-C-N 118.52 1.16 . . . . 0.040000000000000001 109.482 179.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 990' ' ' PRO . . . . . 0.431 ' HD2' HD12 ' A' ' 992' ' ' LEU . 50.2 Cg_endo -90.07 71.24 1.59 Allowed 'Trans proline' 0 C--N 1.319 -0.998 0 O-C-N 123.124 1.065 . . . . 0.45000000000000001 111.39 -178.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 991' ' ' GLU . . . . . 0.419 ' HB2' ' O ' ' A' ' 990' ' ' PRO . 69.8 mt-10 67.36 -73.94 0.07 Allowed 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 108.494 -0.928 . . . . 1.97 108.494 -177.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 992' ' ' LEU . . . . . 0.431 HD12 ' HD2' ' A' ' 990' ' ' PRO . 10.4 mt 50.92 20.64 0.82 Allowed 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.579 -0.701 . . . . 2.3799999999999999 111.647 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -94.2 156.85 16.34 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.888 -1.132 . . . . 3.79 109.959 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 72.2 m80 -146.24 93.44 2.32 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.571 -0.706 . . . . 3.5099999999999998 110.23 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 995' ' ' ALA . . . . . . . . . . . . 2.519 . . . . . . . 0 N--CA 1.503 2.219 0 O-C-N 120.821 -1.174 . . . . 2.73 110.574 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo . . . . . 0 N--CA 1.488 1.203 0 N-CA-C 109.502 -0.999 . . . . 3.8300000000000001 109.502 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 847' ' ' VAL . . . . . 0.415 HG12 ' HB2' ' B' ' 849' ' ' GLN . 59.8 t -132.05 103.57 14.15 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.638 -0.664 . . . . 1.8300000000000001 110.074 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 848' ' ' PRO . . . . . 0.705 ' O ' HG23 ' B' ' 850' ' ' VAL . 44.0 Cg_endo -69.7 -20.23 35.41 Favored 'Trans proline' 0 N--CA 1.487 1.097 0 O-C-N 123.236 1.124 . . . . 0.65000000000000002 111.123 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 849' ' ' GLN . . . . . 0.415 ' HB2' HG12 ' B' ' 847' ' ' VAL . 56.3 tt0 26.67 69.7 0.05 Allowed 'General case' 0 N--CA 1.519 2.979 0 N-CA-C 112.84 0.682 . . . . 2.5800000000000001 112.84 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 850' ' ' VAL . . . . . 0.705 HG23 ' O ' ' B' ' 848' ' ' PRO . 59.6 t -117.91 137.81 50.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.237 -0.915 . . . . 1.0900000000000001 111.616 -178.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 851' ' ' ALA . . . . . 0.473 ' HB3' ' HG ' ' B' ' 873' ' ' LEU . . . -128.06 154.76 45.32 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 105.707 -1.96 . . . . 0.040000000000000001 105.707 176.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 852' ' ' PHE . . . . . 0.449 ' HA ' ' CB ' ' B' ' 874' ' ' ASN . 20.8 p90 -159.64 129.35 5.42 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 121.006 1.73 . . . . 0.050000000000000003 108.742 179.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 32.7 t -175.75 134.25 0.28 Allowed 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.137 -1.061 . . . . 0.040000000000000001 108.137 -179.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -134.56 158.63 43.5 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.123 -0.985 . . . . 0.67000000000000004 109.526 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 855' ' ' ALA . . . . . 0.788 ' HB3' ' CB ' ' B' ' 870' ' ' ARG . . . -122.84 141.17 52.15 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.919 0.866 . . . . 0.51000000000000001 111.843 -178.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 856' ' ' LEU . . . . . 0.914 HD11 HD23 ' B' ' 858' ' ' LEU . 3.5 tm? -107.8 135.18 49.65 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.276 -0.638 . . . . 0.050000000000000003 109.276 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 857' ' ' SER . . . . . 0.562 ' N ' HD13 ' B' ' 856' ' ' LEU . 17.0 p -152.78 17.98 0.6 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.474 -0.766 . . . . 1.3300000000000001 111.144 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 858' ' ' LEU . . . . . 0.914 HD23 HD11 ' B' ' 856' ' ' LEU . 3.1 pp -29.82 154.14 0.03 OUTLIER Pre-proline 0 N--CA 1.521 3.087 0 N-CA-C 113.337 0.866 . . . . 2.3300000000000001 113.337 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -61.82 -88.75 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.541 0 O-C-N 123.149 1.078 . . . . 2.3199999999999998 113.681 -177.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 53.4 ptt85 -127.2 -142.19 0.27 Allowed 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.86 -1.15 . . . . 0.040000000000000001 111.403 -177.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 37.0 m -39.12 118.63 0.81 Allowed 'General case' 0 N--CA 1.51 2.531 0 O-C-N 121.479 -0.763 . . . . 1.3100000000000001 111.9 -178.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 862' ' ' GLU . . . . . 0.487 ' OE2' HD22 ' B' ' 858' ' ' LEU . 24.6 tt0 -96.89 149.68 36.01 Favored Pre-proline 0 N--CA 1.489 1.484 0 N-CA-C 108.162 -1.051 . . . . 4.5099999999999998 108.162 177.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 863' ' ' PRO . . . . . 0.443 ' HD2' ' CG ' ' B' ' 862' ' ' GLU . 41.5 Cg_endo -67.69 -13.38 38.61 Favored 'Trans proline' 0 C--N 1.316 -1.181 0 O-C-N 123.015 1.008 . . . . 2.2400000000000002 111.385 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -174.0 -136.88 2.3 Favored Glycine 0 N--CA 1.494 2.501 0 C-N-CA 119.836 -1.174 . . . . 0.040000000000000001 110.665 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 37.2 m -69.55 160.19 31.95 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.276 -1.132 . . . . 1.51 111.75 -178.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 866' ' ' VAL . . . . . 0.46 ' O ' HG23 ' B' ' 866' ' ' VAL . 26.9 m -90.31 132.75 34.74 Favored Pre-proline 0 N--CA 1.495 1.782 0 N-CA-C 113.419 0.896 . . . . 0.78000000000000003 113.419 -175.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 867' ' ' PRO . . . . . 0.818 ' O ' HD23 ' B' ' 856' ' ' LEU . 53.1 Cg_endo -88.83 -154.05 0.05 OUTLIER 'Trans proline' 0 C--N 1.322 -0.817 0 N-CA-C 107.679 -1.7 . . . . 0.92000000000000004 107.679 177.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 868' ' ' PHE . . . . . 0.472 ' CD1' ' HG2' ' B' ' 881' ' ' PRO . 31.6 p90 -148.39 119.13 7.52 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.446 -1.409 . . . . 0.050000000000000003 109.874 179.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 50.1 p-10 -112.57 -2.84 14.49 Favored 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 119.284 -0.967 . . . . 1.7 112.153 -178.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 870' ' ' ARG . . . . . 0.788 ' CB ' ' HB3' ' B' ' 855' ' ' ALA . 26.0 mmm180 -90.32 88.62 7.28 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.977 -1.077 . . . . 2.5899999999999999 110.682 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 57.5 t -75.23 97.03 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.004 -1.06 . . . . 1.9399999999999999 109.661 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 872' ' ' LEU . . . . . 0.513 ' HB3' HD11 ' C' ' 953' ' ' ILE . 95.4 mt -84.29 -46.75 11.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.541 -0.724 . . . . 1.0600000000000001 110.273 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 873' ' ' LEU . . . . . 0.473 ' HG ' ' HB3' ' B' ' 851' ' ' ALA . 48.8 tp -174.66 104.43 0.1 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.265 -0.897 . . . . 4.1799999999999997 108.605 178.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 874' ' ' ASN . . . . . 0.449 ' CB ' ' HA ' ' B' ' 852' ' ' PHE . 36.5 t-20 178.67 82.27 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.654 -0.653 . . . . 0.040000000000000001 109.647 -178.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -67.09 -47.1 72.23 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 119.29 -0.964 . . . . 3.3799999999999999 111.244 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 876' ' ' GLY . . . . . 0.41 ' HA3' ' CE2' ' B' ' 878' ' ' TYR . . . -74.49 -25.58 69.93 Favored Glycine 0 N--CA 1.494 2.566 0 O-C-N 121.217 -0.927 . . . . 0.040000000000000001 111.813 -178.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 84.48 -59.74 4.89 Favored Glycine 0 N--CA 1.502 3.038 0 N-CA-C 108.11 -1.996 . . . . 0.040000000000000001 108.11 -178.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 878' ' ' TYR . . . . . 0.41 ' CE2' ' HA3' ' B' ' 876' ' ' GLY . 97.7 m-85 60.74 -66.13 0.05 Allowed 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 114.348 1.24 . . . . 3.46 114.348 177.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 879' ' ' TYR . . . . . 0.46 ' CB ' ' CD2' ' B' ' 886' ' ' PHE . 23.5 p90 -112.39 109.15 18.6 Favored 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 114.773 1.398 . . . . 0.040000000000000001 114.773 -176.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -65.17 118.47 50.03 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.396 -0.815 . . . . 0.02 109.999 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 881' ' ' PRO . . . . . 0.472 ' HG2' ' CD1' ' B' ' 868' ' ' PHE . 55.4 Cg_endo -76.84 0.17 9.91 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 O-C-N 123.432 1.227 . . . . 0.39000000000000001 112.143 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -76.66 -64.95 1.0 Allowed 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 106.963 -1.495 . . . . 0.81000000000000005 106.963 178.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 883' ' ' THR . . . . . 0.477 ' OG1' HG23 ' B' ' 885' ' ' VAL . 31.0 p -94.13 -17.25 22.97 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.784 -0.821 . . . . 0.040000000000000001 108.784 177.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.49 22.49 56.27 Favored Glycine 0 N--CA 1.494 2.541 0 O-C-N 121.091 -1.006 . . . . 0.029999999999999999 110.793 178.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 885' ' ' VAL . . . . . 0.63 HG13 HG21 ' B' ' 961' ' ' THR . 79.4 t -73.41 90.74 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 C-N-CA 118.274 -1.371 . . . . 1.01 108.151 -179.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 886' ' ' PHE . . . . . 0.883 ' HB3' HG22 ' B' ' 962' ' ' VAL . 0.6 OUTLIER -90.63 104.42 17.01 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 115.281 -0.872 . . . . 0.050000000000000003 112.244 -177.264 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 887' ' ' THR . . . . . 0.419 ' O ' ' HD3' ' B' ' 889' ' ' PRO . 90.3 m -95.06 101.03 12.76 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 107.774 -1.195 . . . . 0.68000000000000005 107.774 177.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 888' ' ' ALA . . . . . . . . . . . . . . . -99.4 106.28 38.32 Favored Pre-proline 0 N--CA 1.499 2.022 0 N-CA-C 114.042 1.127 . . . . 0.25 114.042 -176.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 889' ' ' PRO . . . . . 0.419 ' HD3' ' O ' ' B' ' 887' ' ' THR . 54.4 Cg_endo -89.08 -12.08 3.47 Favored 'Trans proline' 0 CA--C 1.546 1.094 0 N-CA-C 108.981 -1.199 . . . . 1.6399999999999999 108.981 176.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 890' ' ' LEU . . . . . 0.631 HD11 ' CD1' ' B' ' 985' ' ' LEU . 4.9 tt -35.2 -51.21 0.56 Allowed 'General case' 0 N--CA 1.507 2.414 0 N-CA-C 113.903 1.075 . . . . 2.29 113.903 -177.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 51.7 95.04 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.347 0 O-C-N 121.192 -0.942 . . . . 0.63 110.193 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . 156.02 -147.36 15.91 Favored Glycine 0 N--CA 1.479 1.548 0 N-CA-C 107.335 -2.306 . . . . 0.040000000000000001 107.335 -178.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 72.5 ttt-85 -108.97 127.94 54.51 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 107.845 -1.168 . . . . 3.0 107.845 177.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 894' ' ' TYR . . . . . 0.456 ' CD1' ' N ' ' B' ' 895' ' ' LEU . 0.2 OUTLIER -130.86 144.63 51.6 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.023 -1.048 . . . . 0.040000000000000001 110.082 -179.258 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 895' ' ' LEU . . . . . 0.456 ' N ' ' CD1' ' B' ' 894' ' ' TYR . 34.4 tp -99.69 115.03 28.52 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.523 -0.736 . . . . 1.27 109.825 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 896' ' ' LEU . . . . . 0.621 HD23 ' N ' ' B' ' 897' ' ' SER . 9.9 tt -111.93 145.63 39.23 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.576 -0.703 . . . . 0.93999999999999995 110.537 -179.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 897' ' ' SER . . . . . 0.621 ' N ' HD23 ' B' ' 896' ' ' LEU . 71.2 m -144.52 118.86 9.58 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.389 -0.819 . . . . 0.040000000000000001 110.812 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.71 147.66 30.45 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.733 -0.604 . . . . 0.47999999999999998 109.489 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 899' ' ' VAL . . . . . 0.709 HG21 ' HB ' ' B' ' 980' ' ' ILE . 88.3 t -91.89 120.92 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.469 -0.769 . . . . 0.55000000000000004 111.006 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 900' ' ' LEU . . . . . 0.591 HD12 ' HB2' ' B' ' 924' ' ' SER . 4.4 mm? -94.85 111.3 23.1 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 114.498 1.296 . . . . 1.5900000000000001 114.498 -174.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 17.1 m -67.45 141.47 56.98 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 107.277 -1.379 . . . . 0.050000000000000003 107.277 176.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -68.02 -65.05 2.84 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 110.724 -0.951 . . . . 0.029999999999999999 110.724 -179.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 5.9 m170 46.81 66.43 0.99 Allowed 'General case' 0 N--CA 1.508 2.454 0 O-C-N 121.454 -1.027 . . . . 3.2000000000000002 111.093 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 54.0 ptt85 -69.33 -6.19 28.08 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.645 -0.66 . . . . 2.9199999999999999 112.106 -179.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 905' ' ' HIS . . . . . 0.484 ' O ' ' CB ' ' B' ' 906' ' ' GLU . 73.8 t60 -62.03 4.53 0.12 Allowed 'General case' 0 N--CA 1.506 2.352 0 O-C-N 120.906 -1.122 . . . . 2.8700000000000001 113.131 -179.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 906' ' ' GLU . . . . . 0.484 ' CB ' ' O ' ' B' ' 905' ' ' HIS . 0.7 OUTLIER 95.25 -165.11 0.0 OUTLIER 'General case' 0 N--CA 1.529 3.478 0 CA-C-N 120.605 1.548 . . . . 0.98999999999999999 111.914 179.089 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 907' ' ' LYS . . . . . 0.465 ' CB ' ' O ' ' B' ' 906' ' ' GLU . 61.9 tttt 86.3 156.4 0.08 Allowed 'General case' 0 N--CA 1.519 3.01 0 N-CA-C 107.982 -1.118 . . . . 5.25 107.982 -176.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 60.9 t -121.86 117.21 51.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 120.757 -1.214 . . . . 0.39000000000000001 111.351 -179.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 54.2 tp10 -101.26 133.43 45.84 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 107.295 -1.372 . . . . 1.72 107.295 176.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -156.05 123.32 5.41 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 106.759 -1.571 . . . . 0.67000000000000004 106.759 178.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 911' ' ' VAL . . . . . 0.757 HG22 HG13 ' B' ' 964' ' ' VAL . 92.5 t -84.65 132.23 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.89 -0.506 . . . . 0.54000000000000004 110.972 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 60.2 mt -67.06 157.78 32.69 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.417 -0.802 . . . . 1.5 109.303 178.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 913' ' ' SER . . . . . 0.478 ' OG ' HG11 ' B' ' 919' ' ' VAL . 1.4 p -125.11 136.78 53.98 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.105 -1.072 . . . . 1.3700000000000001 108.105 176.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 914' ' ' ARG . . . . . 0.609 ' NH1' HD23 ' B' ' 956' ' ' LEU . 0.1 OUTLIER -64.53 155.21 33.66 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 120.628 -1.295 . . . . 4.2999999999999998 111.428 -179.034 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 915' ' ' SER . . . . . 0.416 ' CB ' ' O ' ' B' ' 914' ' ' ARG . 1.7 p 83.53 -31.93 0.08 Allowed 'General case' 0 N--CA 1.521 3.119 0 C-N-CA 123.915 0.886 . . . . 2.0499999999999998 112.077 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 916' ' ' ASN . . . . . 0.757 ' HB2' HG21 ' B' ' 919' ' ' VAL . 99.4 m-20 -122.34 -22.19 5.6 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.895 -1.128 . . . . 2.71 111.2 -179.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 917' ' ' GLN . . . . . 0.402 ' HB2' ' O ' ' B' ' 916' ' ' ASN . 43.8 mt-30 67.08 165.98 0.22 Allowed 'General case' 0 N--CA 1.519 3.021 0 N-CA-C 105.762 -1.94 . . . . 2.6800000000000002 105.762 -174.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.99 -125.29 35.19 Favored Glycine 1 N--CA 1.521 4.322 0 CA-C-N 123.492 2.86 . . . . 0.029999999999999999 106.905 -177.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 919' ' ' VAL . . . . . 0.757 HG21 ' HB2' ' B' ' 916' ' ' ASN . 91.5 t 52.24 95.1 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 O-C-N 121.393 -1.063 . . . . 1.3899999999999999 109.119 -178.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 920' ' ' ALA . . . . . 0.88 ' HB3' HG12 ' B' ' 949' ' ' VAL . . . -91.06 90.95 8.07 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.249 -0.981 . . . . 0.029999999999999999 110.723 -179.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 921' ' ' ARG . . . . . 0.776 ' HG3' HG23 ' B' ' 922' ' ' VAL . 27.6 ptt85 -84.96 -42.18 15.19 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 106.02 -1.844 . . . . 4.4199999999999999 106.02 176.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 922' ' ' VAL . . . . . 0.776 HG23 ' HG3' ' B' ' 921' ' ' ARG . 75.0 t -101.9 74.02 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 105.833 -1.914 . . . . 0.84999999999999998 105.833 175.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -85.55 135.01 33.99 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.74 0.781 . . . . 2.46 111.553 -177.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 924' ' ' SER . . . . . 0.591 ' HB2' HD12 ' B' ' 900' ' ' LEU . 6.8 t -147.12 105.51 3.78 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 108.77 -0.826 . . . . 0.69999999999999996 108.77 179.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -103.2 83.42 0.43 Allowed Glycine 0 N--CA 1.487 2.052 0 N-CA-C 108.307 -1.917 . . . . 0.040000000000000001 108.307 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.223 0 N-CA-C 108.865 -1.694 . . . . 0.040000000000000001 108.865 -179.6 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 25.3 m . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.042 0.449 . . . . 13.779999999999999 110.296 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 95.8 mt -111.64 129.96 55.92 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.508 -0.745 . . . . 13.76 110.389 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -151.67 168.33 31.06 Favored Glycine 0 N--CA 1.493 2.5 0 N-CA-C 109.243 -1.543 . . . . 9.1300000000000008 109.243 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 949' ' ' VAL . . . . . 0.88 HG12 ' HB3' ' B' ' 920' ' ' ALA . 31.6 m -118.09 130.17 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.515 -0.991 . . . . 7.0800000000000001 110.666 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 950' ' ' PHE . . . . . 0.459 ' CZ ' ' HB3' ' B' ' 921' ' ' ARG . 49.0 p90 -135.16 152.51 51.67 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.582 -0.699 . . . . 7.5899999999999999 109.466 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 23.3 m -118.52 -54.09 2.29 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.424 -0.797 . . . . 5.0300000000000002 111.922 -178.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 952' ' ' LEU . . . . . 0.434 ' O ' ' O ' ' B' ' 953' ' ' ILE . 12.5 tp -62.3 -74.43 0.09 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.352 -0.842 . . . . 1.01 112.056 -177.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 953' ' ' ILE . . . . . 0.636 HD12 ' HD3' ' B' ' 955' ' ' PRO . 1.4 pp -51.48 -149.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.782 0 N-CA-C 114.22 1.193 . . . . 2.6000000000000001 114.22 -176.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 954' ' ' LEU . . . . . 0.751 HD22 ' O ' ' B' ' 954' ' ' LEU . 0.0 OUTLIER 166.07 90.59 0.02 OUTLIER Pre-proline 0 N--CA 1.518 2.944 0 O-C-N 121.107 -0.996 . . . . 0.050000000000000003 111.67 179.156 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 955' ' ' PRO . . . . . 0.743 ' C ' HD12 ' B' ' 956' ' ' LEU . 51.6 Cg_endo -78.96 98.48 1.19 Allowed 'Trans proline' 0 C--N 1.315 -1.205 0 N-CA-C 109.014 -1.187 . . . . 0.83999999999999997 109.014 178.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 956' ' ' LEU . . . . . 0.743 HD12 ' C ' ' B' ' 955' ' ' PRO . 11.1 mp -121.47 141.97 50.5 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.973 -1.079 . . . . 0.040000000000000001 109.943 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -84.46 151.11 24.83 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 117.844 -1.074 . . . . 1.28 111.777 -178.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -68.6 118.66 11.91 Favored 'General case' 0 N--CA 1.508 2.466 0 CA-C-N 122.96 2.618 . . . . 0.17000000000000001 111.368 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 93.2 -21.48 40.03 Favored Glycine 0 N--CA 1.5 2.925 0 N-CA-C 111.056 -0.817 . . . . 0.040000000000000001 111.056 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 960' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -56.31 170.55 0.34 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.488 -1.007 . . . . 0.040000000000000001 110.149 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 961' ' ' THR . . . . . 0.63 HG21 HG13 ' B' ' 885' ' ' VAL . 42.1 m -135.96 137.81 41.68 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.945 -1.097 . . . . 1.78 112.291 -178.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 962' ' ' VAL . . . . . 0.883 HG22 ' HB3' ' B' ' 886' ' ' PHE . 33.7 m -98.29 145.19 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.712 -0.618 . . . . 0.040000000000000001 110.404 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 5.2 t -137.1 145.13 43.54 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.885 -0.509 . . . . 0.71999999999999997 110.084 -178.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 964' ' ' VAL . . . . . 0.757 HG13 HG22 ' B' ' 911' ' ' VAL . 61.1 t -93.4 136.39 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.133 -0.98 . . . . 1.05 110.499 -179.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -93.68 127.05 39.19 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 103.651 -2.722 . . . . 3.02 103.651 173.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 966' ' ' LEU . . . . . 0.556 HD23 ' O ' ' B' ' 966' ' ' LEU . 4.1 tt -132.14 61.24 1.66 Allowed 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.288 -1.004 . . . . 1.46 108.288 177.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 967' ' ' VAL . . . . . 0.486 HG23 ' C ' ' B' ' 966' ' ' LEU . 97.9 t -158.0 96.53 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 108.143 -1.058 . . . . 1.9399999999999999 108.143 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 88.1 mmm -143.39 58.85 1.39 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.733 -1.229 . . . . 0.0 108.375 178.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.24 119.51 1.93 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 107.222 -2.351 . . . . 2.1099999999999999 107.222 -178.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -81.9 -58.31 3.04 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.036 -1.273 . . . . 5.8899999999999997 110.415 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 46.9 tp -58.99 90.62 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.437 -0.789 . . . . 4.3600000000000003 110.249 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -141.78 -154.33 0.51 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.536 -0.728 . . . . 1.8300000000000001 110.24 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -119.51 170.89 8.76 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.498 -0.751 . . . . 4.3499999999999996 110.276 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 9.5 t -101.76 130.44 48.17 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.528 -0.733 . . . . 1.27 110.086 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -155.91 158.81 38.59 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.49 -0.756 . . . . 5.0199999999999996 110.443 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.47 85.67 17.49 Favored Pre-proline 0 N--CA 1.501 2.077 0 O-C-N 121.588 -0.695 . . . . 2.4100000000000001 109.906 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 977' ' ' PRO . . . . . 0.485 ' C ' HD12 ' B' ' 978' ' ' LEU . 47.7 Cg_endo -73.63 -172.73 1.14 Allowed 'Trans proline' 0 C--N 1.317 -1.13 0 O-C-N 123.326 1.172 . . . . 0.95999999999999996 111.248 -179.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 978' ' ' LEU . . . . . 0.502 HD23 ' CD1' ' B' ' 856' ' ' LEU . 5.4 mp -127.34 155.55 43.4 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 107.762 -1.199 . . . . 0.62 107.762 178.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 979' ' ' THR . . . . . 0.458 HG23 ' C ' ' B' ' 978' ' ' LEU . 37.0 p -150.32 141.12 22.76 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.811 -1.181 . . . . 3.5699999999999998 111.157 -179.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 980' ' ' ILE . . . . . 0.709 ' HB ' HG21 ' B' ' 899' ' ' VAL . 51.4 mm -107.44 128.59 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 109.135 -0.691 . . . . 1.3300000000000001 109.135 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 981' ' ' PHE . . . . . 0.4 ' HD1' ' HH ' ' B' ' 879' ' ' TYR . 4.4 t80 -119.2 99.29 6.62 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.461 -0.774 . . . . 0.050000000000000003 111.802 -178.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 43.2 p -106.79 158.24 17.14 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.834 -0.802 . . . . 0.87 108.834 178.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 983' ' ' GLY . . . . . . . . . . . . . . . -172.77 110.16 0.33 Allowed Glycine 0 N--CA 1.499 2.87 0 N-CA-C 106.685 -2.566 . . . . 0.029999999999999999 106.685 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 984' ' ' ALA . . . . . 0.469 ' HB1' ' NE ' ' C' ' 893' ' ' ARG . . . -110.75 149.61 30.27 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 114.539 1.311 . . . . 0.69999999999999996 114.539 -175.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 985' ' ' LEU . . . . . 0.631 ' CD1' HD11 ' B' ' 890' ' ' LEU . 54.2 tp -70.71 133.84 46.95 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.874 -1.142 . . . . 0.040000000000000001 109.808 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 986' ' ' LEU . . . . . . . . . . . . . 50.6 tp -107.39 -59.01 1.88 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.547 -0.721 . . . . 0.040000000000000001 110.009 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -144.46 144.87 31.59 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.592 -1.262 . . . . 0.040000000000000001 107.592 179.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.84 162.95 12.2 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 108.117 -1.993 . . . . 0.040000000000000001 108.117 179.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -75.15 112.59 19.02 Favored Pre-proline 0 N--CA 1.498 1.938 0 O-C-N 121.226 -1.161 . . . . 0.040000000000000001 109.439 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 990' ' ' PRO . . . . . 0.438 ' HD2' HD12 ' B' ' 992' ' ' LEU . 49.9 Cg_endo -90.05 71.27 1.6 Allowed 'Trans proline' 0 C--N 1.319 -0.976 0 O-C-N 123.119 1.062 . . . . 0.45000000000000001 111.339 -178.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 991' ' ' GLU . . . . . 0.419 ' HB2' ' O ' ' B' ' 990' ' ' PRO . 70.0 mt-10 67.29 -73.93 0.07 Allowed 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 108.463 -0.94 . . . . 1.97 108.463 -177.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 992' ' ' LEU . . . . . 0.451 ' HA ' HD23 ' B' ' 992' ' ' LEU . 10.4 mt 51.11 20.4 0.85 Allowed 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.587 -0.696 . . . . 2.3799999999999999 111.679 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -93.94 156.95 16.35 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.914 -1.116 . . . . 3.79 109.974 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 71.9 m80 -146.33 92.8 2.22 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.561 -0.712 . . . . 3.5099999999999998 110.382 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 995' ' ' ALA . . . . . . . . . . . . 2.518 . . . . . . . 0 N--CA 1.503 2.223 0 O-C-N 120.924 -1.11 . . . . 2.73 110.581 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo . . . . . 0 N--CA 1.487 1.142 0 N-CA-C 109.526 -0.99 . . . . 3.8300000000000001 109.526 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 847' ' ' VAL . . . . . 0.5 HG12 ' HB2' ' C' ' 849' ' ' GLN . 59.5 t -126.81 106.2 22.84 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 121.68 -0.638 . . . . 1.8300000000000001 109.989 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 848' ' ' PRO . . . . . 0.893 ' O ' HG23 ' C' ' 850' ' ' VAL . 43.9 Cg_endo -69.52 -22.17 33.57 Favored 'Trans proline' 0 N--CA 1.488 1.152 0 O-C-N 123.238 1.125 . . . . 0.65000000000000002 111.09 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 849' ' ' GLN . . . . . 0.5 ' HB2' HG12 ' C' ' 847' ' ' VAL . 54.6 tt0 24.93 64.6 0.05 Allowed 'General case' 0 N--CA 1.518 2.945 0 N-CA-C 113.605 0.965 . . . . 2.5800000000000001 113.605 179.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 850' ' ' VAL . . . . . 0.893 HG23 ' O ' ' C' ' 848' ' ' PRO . 78.9 t -120.23 134.91 62.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.105 -0.997 . . . . 1.0900000000000001 110.948 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 851' ' ' ALA . . . . . 0.526 ' HB3' ' HG ' ' C' ' 873' ' ' LEU . . . -127.78 155.28 44.29 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 105.745 -1.946 . . . . 0.040000000000000001 105.745 176.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 852' ' ' PHE . . . . . 0.448 ' HA ' ' CB ' ' C' ' 874' ' ' ASN . 13.5 p90 -161.56 126.96 3.6 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 121.011 1.732 . . . . 0.050000000000000003 108.683 179.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 24.2 t -177.06 135.32 0.2 Allowed 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.039 -1.096 . . . . 0.040000000000000001 108.039 -179.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 854' ' ' ALA . . . . . 0.436 ' HB1' ' HD2' ' C' ' 868' ' ' PHE . . . -132.5 158.32 42.39 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.042 -1.036 . . . . 0.67000000000000004 109.96 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 855' ' ' ALA . . . . . 0.732 ' HB2' HD11 ' C' ' 872' ' ' LEU . . . -122.27 139.75 53.43 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.773 0.797 . . . . 0.51000000000000001 111.051 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 856' ' ' LEU . . . . . 1.075 HD11 HD23 ' C' ' 858' ' ' LEU . 3.5 tm? -112.61 139.41 48.23 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.692 -0.63 . . . . 0.050000000000000003 110.252 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 857' ' ' SER . . . . . 0.599 ' N ' HD13 ' C' ' 856' ' ' LEU . 1.4 m -155.96 19.92 0.38 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.585 -0.697 . . . . 1.3300000000000001 111.07 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 858' ' ' LEU . . . . . 1.075 HD23 HD11 ' C' ' 856' ' ' LEU . 2.3 pp -34.83 161.44 0.04 OUTLIER Pre-proline 0 N--CA 1.517 2.898 0 N-CA-C 113.171 0.804 . . . . 2.3300000000000001 113.171 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -61.68 -87.72 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 120.894 1.062 . . . . 2.3199999999999998 113.495 -178.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 55.3 ptt85 -130.6 -143.26 0.24 Allowed 'General case' 0 N--CA 1.501 2.122 0 O-C-N 120.811 -1.18 . . . . 0.040000000000000001 111.923 -177.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 14.6 m -37.54 129.17 1.07 Allowed 'General case' 0 N--CA 1.51 2.548 0 O-C-N 121.592 -0.693 . . . . 1.3100000000000001 112.537 -178.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.41 160.51 25.8 Favored Pre-proline 0 N--CA 1.489 1.523 0 N-CA-C 108.263 -1.014 . . . . 4.5099999999999998 108.263 177.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -71.62 -13.82 30.08 Favored 'Trans proline' 0 C--N 1.314 -1.282 0 O-C-N 123.184 1.097 . . . . 2.2400000000000002 111.507 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -177.33 -136.18 2.39 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.658 -1.377 . . . . 0.040000000000000001 109.658 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 22.8 m -68.2 154.5 41.59 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.388 -1.066 . . . . 1.51 110.249 -179.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 866' ' ' VAL . . . . . 0.441 ' HA ' ' HD3' ' C' ' 867' ' ' PRO . 46.0 t -98.68 139.19 20.93 Favored Pre-proline 0 N--CA 1.496 1.845 0 N-CA-C 113.366 0.876 . . . . 0.78000000000000003 113.366 -174.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 867' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' C' ' 866' ' ' VAL . 55.4 Cg_endo -91.35 -147.64 0.03 OUTLIER 'Trans proline' 0 CA--C 1.545 1.065 0 O-C-N 123.583 1.307 . . . . 0.92000000000000004 108.847 177.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 868' ' ' PHE . . . . . 0.49 ' CD1' ' HG2' ' C' ' 881' ' ' PRO . 23.7 p90 -150.01 125.56 10.28 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.584 -1.323 . . . . 0.050000000000000003 110.101 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 42.4 p-10 -112.64 -3.08 14.37 Favored 'General case' 0 N--CA 1.499 2.001 0 C-N-CA 119.281 -0.967 . . . . 1.7 112.467 -178.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 870' ' ' ARG . . . . . 0.65 ' HB2' ' HB3' ' C' ' 855' ' ' ALA . 23.8 mmm180 -91.72 89.11 6.96 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.905 -1.122 . . . . 2.5899999999999999 110.991 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 57.9 t -70.71 97.47 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.039 -1.038 . . . . 1.9399999999999999 109.951 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 872' ' ' LEU . . . . . 0.732 HD11 ' HB2' ' C' ' 855' ' ' ALA . 82.8 mt -83.44 -47.39 11.45 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.485 -0.759 . . . . 1.0600000000000001 110.272 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 873' ' ' LEU . . . . . 0.526 ' HG ' ' HB3' ' C' ' 851' ' ' ALA . 42.7 tp -174.45 103.53 0.1 Allowed 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.507 -0.923 . . . . 4.1799999999999997 108.507 178.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 874' ' ' ASN . . . . . 0.448 ' CB ' ' HA ' ' C' ' 852' ' ' PHE . 35.9 t-20 178.55 82.22 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.612 -0.68 . . . . 0.040000000000000001 109.45 -178.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 22.9 p-10 -67.11 -46.24 74.76 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 119.245 -0.982 . . . . 3.3799999999999999 111.279 -179.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 876' ' ' GLY . . . . . 0.405 ' HA3' ' CE2' ' C' ' 878' ' ' TYR . . . -74.55 -26.09 68.53 Favored Glycine 0 N--CA 1.494 2.551 0 O-C-N 121.28 -0.888 . . . . 0.040000000000000001 111.614 -178.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 82.54 -61.06 4.79 Favored Glycine 0 N--CA 1.502 3.072 0 N-CA-C 108.118 -1.993 . . . . 0.040000000000000001 108.118 -178.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 878' ' ' TYR . . . . . 0.405 ' CE2' ' HA3' ' C' ' 876' ' ' GLY . 97.7 m-85 60.95 -65.39 0.06 Allowed 'General case' 0 N--CA 1.502 2.161 0 N-CA-C 114.384 1.253 . . . . 3.46 114.384 177.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 879' ' ' TYR . . . . . 0.473 ' CB ' ' CG ' ' C' ' 886' ' ' PHE . 22.8 p90 -112.58 109.38 18.9 Favored 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 114.823 1.416 . . . . 0.040000000000000001 114.823 -176.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.63 117.82 51.27 Favored Pre-proline 0 N--CA 1.497 1.894 0 O-C-N 121.377 -0.827 . . . . 0.02 109.89 179.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 881' ' ' PRO . . . . . 0.49 ' HG2' ' CD1' ' C' ' 868' ' ' PHE . 55.2 Cg_endo -77.03 0.45 9.69 Favored 'Trans proline' 0 N--CA 1.494 1.551 0 O-C-N 123.435 1.229 . . . . 0.39000000000000001 112.116 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -73.84 -64.33 1.03 Allowed 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 106.459 -1.682 . . . . 0.81000000000000005 106.459 178.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 9.2 p -94.82 -18.16 21.45 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.502 -0.925 . . . . 0.040000000000000001 108.502 177.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.56 21.16 57.0 Favored Glycine 0 N--CA 1.493 2.499 0 O-C-N 121.167 -0.958 . . . . 0.029999999999999999 111.046 178.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 96.8 t -72.33 89.89 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 C-N-CA 118.256 -1.377 . . . . 1.01 108.25 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 886' ' ' PHE . . . . . 0.811 ' CB ' HG22 ' C' ' 962' ' ' VAL . 0.7 OUTLIER -90.48 104.0 16.63 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 115.199 -0.909 . . . . 0.050000000000000003 112.038 -177.468 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 887' ' ' THR . . . . . 0.423 ' O ' ' HD3' ' C' ' 889' ' ' PRO . 91.2 m -96.48 101.46 13.09 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 107.888 -1.153 . . . . 0.68000000000000005 107.888 177.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 888' ' ' ALA . . . . . . . . . . . . . . . -99.87 102.59 17.88 Favored Pre-proline 0 N--CA 1.502 2.152 0 N-CA-C 114.297 1.221 . . . . 0.25 114.297 -176.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 889' ' ' PRO . . . . . 0.423 ' HD3' ' O ' ' C' ' 887' ' ' THR . 55.6 Cg_endo -83.04 -13.11 9.26 Favored 'Trans proline' 0 CA--C 1.545 1.07 0 N-CA-C 109.01 -1.188 . . . . 1.6399999999999999 109.01 175.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 890' ' ' LEU . . . . . 1.055 HD22 HD13 ' C' ' 985' ' ' LEU . 71.7 mt -37.37 -49.87 1.01 Allowed 'General case' 0 N--CA 1.507 2.422 0 N-CA-C 113.679 0.992 . . . . 2.29 113.679 -177.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 52.63 96.73 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.358 0 O-C-N 121.117 -0.989 . . . . 0.63 110.211 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . 156.26 -147.64 16.51 Favored Glycine 0 N--CA 1.479 1.514 0 N-CA-C 107.252 -2.339 . . . . 0.040000000000000001 107.252 -179.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 893' ' ' ARG . . . . . 0.469 ' NE ' ' HB1' ' B' ' 984' ' ' ALA . 74.2 ttt-85 -107.8 129.0 55.09 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 107.934 -1.136 . . . . 3.0 107.934 177.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 894' ' ' TYR . . . . . 0.449 ' CD1' ' N ' ' C' ' 895' ' ' LEU . 0.1 OUTLIER -131.16 144.05 51.07 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.058 -1.026 . . . . 0.040000000000000001 110.151 -179.246 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 895' ' ' LEU . . . . . 0.449 ' N ' ' CD1' ' C' ' 894' ' ' TYR . 37.4 tp -97.83 112.85 24.6 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.735 -0.603 . . . . 1.27 109.531 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 896' ' ' LEU . . . . . 0.53 HD23 ' N ' ' C' ' 897' ' ' SER . 10.3 tt -110.27 143.78 39.95 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.583 -0.698 . . . . 0.93999999999999995 110.448 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 897' ' ' SER . . . . . 0.53 ' N ' HD23 ' C' ' 896' ' ' LEU . 5.2 m -145.23 119.26 9.39 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.471 -0.768 . . . . 0.040000000000000001 111.062 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.87 146.62 32.06 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.965 -0.754 . . . . 0.47999999999999998 108.965 178.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 899' ' ' VAL . . . . . 0.729 HG21 ' HB ' ' C' ' 980' ' ' ILE . 89.6 t -92.1 119.94 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.414 -0.803 . . . . 0.55000000000000004 111.054 -179.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 90.9 mt -92.98 111.21 22.75 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 114.096 1.146 . . . . 1.5900000000000001 114.096 -175.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 22.2 m -64.53 139.68 58.79 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 107.331 -1.359 . . . . 0.050000000000000003 107.331 177.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -61.54 -65.02 3.5 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 110.32 -1.112 . . . . 0.029999999999999999 110.32 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 45.48 64.74 1.32 Allowed 'General case' 0 N--CA 1.508 2.45 0 O-C-N 121.485 -1.009 . . . . 3.2000000000000002 111.298 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 42.4 ptt85 -67.82 -7.14 25.32 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.585 -0.697 . . . . 2.9199999999999999 111.988 -179.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 905' ' ' HIS . . . . . 0.485 ' O ' ' CB ' ' C' ' 906' ' ' GLU . 72.0 t60 -60.37 5.27 0.05 OUTLIER 'General case' 0 N--CA 1.507 2.381 0 O-C-N 120.9 -1.125 . . . . 2.8700000000000001 113.714 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 906' ' ' GLU . . . . . 0.485 ' CB ' ' O ' ' C' ' 905' ' ' HIS . 0.6 OUTLIER 92.11 -164.08 0.01 OUTLIER 'General case' 0 N--CA 1.527 3.38 0 CA-C-N 121.259 1.845 . . . . 0.98999999999999999 112.254 179.053 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 907' ' ' LYS . . . . . 0.485 ' CB ' ' O ' ' C' ' 906' ' ' GLU . 73.5 tttt 89.43 162.03 0.05 Allowed 'General case' 0 N--CA 1.52 3.069 0 N-CA-C 108.146 -1.057 . . . . 5.25 108.146 -177.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 59.0 t -122.31 115.28 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 120.934 -1.104 . . . . 0.39000000000000001 110.883 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 53.0 tp10 -104.07 131.3 51.48 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 107.549 -1.278 . . . . 1.72 107.549 177.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -155.68 120.86 4.83 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 106.882 -1.525 . . . . 0.67000000000000004 106.882 178.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 911' ' ' VAL . . . . . 0.908 HG23 HG22 ' C' ' 964' ' ' VAL . 11.0 p -77.82 131.14 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.879 -0.513 . . . . 0.54000000000000004 111.222 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 73.0 mt -67.52 158.29 32.3 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.218 -0.926 . . . . 1.5 108.88 178.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 913' ' ' SER . . . . . 0.468 ' OG ' HG11 ' C' ' 919' ' ' VAL . 1.4 p -128.33 135.73 49.99 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.468 -0.938 . . . . 1.3700000000000001 108.468 176.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 914' ' ' ARG . . . . . 0.588 HH11 HG13 ' C' ' 962' ' ' VAL . 0.0 OUTLIER -63.29 154.28 32.15 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 120.585 -1.322 . . . . 4.2999999999999998 111.287 -179.223 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 915' ' ' SER . . . . . 0.424 ' CB ' ' O ' ' C' ' 914' ' ' ARG . 0.2 OUTLIER 83.24 -30.45 0.09 Allowed 'General case' 0 N--CA 1.521 3.104 0 C-N-CA 123.724 0.81 . . . . 2.0499999999999998 112.079 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 916' ' ' ASN . . . . . 0.779 ' HB2' HG21 ' C' ' 919' ' ' VAL . 93.1 m-20 -123.48 -22.72 4.96 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 120.83 -1.169 . . . . 2.71 111.103 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 67.32 166.25 0.23 Allowed 'General case' 0 N--CA 1.519 3.011 0 N-CA-C 105.745 -1.946 . . . . 2.6800000000000002 105.745 -174.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.9 -125.37 35.19 Favored Glycine 1 N--CA 1.522 4.368 0 CA-C-N 123.619 2.918 . . . . 0.029999999999999999 107.069 -177.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 919' ' ' VAL . . . . . 0.779 HG21 ' HB2' ' C' ' 916' ' ' ASN . 93.0 t 50.75 93.86 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.229 0 O-C-N 121.401 -1.058 . . . . 1.3899999999999999 109.433 -178.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 920' ' ' ALA . . . . . 0.713 ' HB3' HG12 ' C' ' 949' ' ' VAL . . . -96.1 94.96 7.85 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 119.478 -0.889 . . . . 0.029999999999999999 110.953 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 921' ' ' ARG . . . . . 0.817 ' HG3' HG23 ' C' ' 922' ' ' VAL . 45.0 ptt85 -83.83 -41.54 17.4 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 105.626 -1.991 . . . . 4.4199999999999999 105.626 175.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 922' ' ' VAL . . . . . 0.817 HG23 ' HG3' ' C' ' 921' ' ' ARG . 57.6 t -97.11 74.36 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 105.393 -2.077 . . . . 0.84999999999999998 105.393 174.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -90.04 135.79 33.44 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.93 0.871 . . . . 2.46 112.41 -176.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 6.7 t -146.5 102.85 3.62 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.853 -1.166 . . . . 0.69999999999999996 107.853 178.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -111.03 91.86 0.63 Allowed Glycine 0 N--CA 1.488 2.119 0 N-CA-C 108.908 -1.677 . . . . 0.040000000000000001 108.908 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.342 0 N-CA-C 109.372 -1.491 . . . . 0.040000000000000001 109.372 -179.75 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 25.6 m . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 120.982 0.42 . . . . 13.779999999999999 110.366 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 94.4 mt -114.15 131.62 56.37 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.441 -0.787 . . . . 13.76 110.393 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -151.67 170.71 31.17 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.252 -1.539 . . . . 9.1300000000000008 109.252 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 949' ' ' VAL . . . . . 0.713 HG12 ' HB3' ' C' ' 920' ' ' ALA . 34.8 m -118.43 133.34 65.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.571 -0.958 . . . . 7.0800000000000001 111.252 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 950' ' ' PHE . . . . . 0.463 ' CZ ' ' HB3' ' C' ' 921' ' ' ARG . 20.3 p90 -131.88 147.36 52.47 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.969 -0.752 . . . . 7.5899999999999999 108.969 178.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 13.2 m -122.09 -52.82 1.96 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.281 -0.887 . . . . 5.0300000000000002 112.277 -178.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 952' ' ' LEU . . . . . 0.406 ' O ' ' O ' ' C' ' 953' ' ' ILE . 45.2 tp -60.07 -77.84 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.421 -0.8 . . . . 1.01 112.421 -177.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 953' ' ' ILE . . . . . 0.513 HD11 ' HB3' ' B' ' 872' ' ' LEU . 44.1 pt -54.01 -140.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.734 0 N-CA-C 113.851 1.056 . . . . 2.6000000000000001 113.851 -176.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 954' ' ' LEU . . . . . 0.786 HD22 ' O ' ' C' ' 954' ' ' LEU . 0.0 OUTLIER 176.27 76.58 0.09 OUTLIER Pre-proline 0 N--CA 1.507 2.38 0 O-C-N 120.663 -1.273 . . . . 0.050000000000000003 111.192 179.725 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 955' ' ' PRO . . . . . 0.688 ' C ' HD12 ' C' ' 956' ' ' LEU . 44.6 Cg_endo -71.51 86.2 0.85 Allowed 'Trans proline' 0 C--N 1.312 -1.364 0 N-CA-C 109.349 -1.058 . . . . 0.83999999999999997 109.349 178.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 956' ' ' LEU . . . . . 0.688 HD12 ' C ' ' C' ' 955' ' ' PRO . 7.5 mp -126.06 153.09 44.95 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.293 -0.88 . . . . 0.040000000000000001 110.64 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -81.49 151.01 28.01 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-O 117.737 -1.125 . . . . 1.28 111.574 -179.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -68.88 119.21 12.86 Favored 'General case' 0 N--CA 1.51 2.549 0 CA-C-N 123.083 2.674 . . . . 0.17000000000000001 111.223 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 91.8 -22.65 30.04 Favored Glycine 0 N--CA 1.501 3.019 0 N-CA-C 110.789 -0.924 . . . . 0.040000000000000001 110.789 178.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 960' ' ' ASP . . . . . 0.407 ' HB3' ' CZ ' ' C' ' 914' ' ' ARG . 0.1 OUTLIER -51.82 172.45 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.519 -0.989 . . . . 0.040000000000000001 110.332 -179.49 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 961' ' ' THR . . . . . 0.494 ' HA ' ' O ' ' C' ' 886' ' ' PHE . 53.5 p -133.18 138.81 46.72 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.087 -1.008 . . . . 1.78 112.307 -177.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 962' ' ' VAL . . . . . 0.811 HG22 ' CB ' ' C' ' 886' ' ' PHE . 18.5 m -96.19 144.9 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 C-N-CA 120.208 -0.597 . . . . 0.040000000000000001 109.696 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 6.6 t -137.81 145.64 42.57 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.823 -0.548 . . . . 0.71999999999999997 110.213 -178.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 964' ' ' VAL . . . . . 0.908 HG22 HG23 ' C' ' 911' ' ' VAL . 57.5 t -100.17 135.91 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.067 -1.021 . . . . 1.05 110.899 -179.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -96.71 125.62 41.29 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 103.788 -2.671 . . . . 3.02 103.788 173.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 966' ' ' LEU . . . . . 0.645 HD23 ' O ' ' C' ' 966' ' ' LEU . 5.1 tt -131.87 62.79 1.63 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.067 -1.086 . . . . 1.46 108.067 177.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 967' ' ' VAL . . . . . 0.491 HG23 ' C ' ' C' ' 966' ' ' LEU . 97.6 t -157.79 96.77 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.065 -1.087 . . . . 1.9399999999999999 108.065 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 94.4 mmm -142.26 58.62 1.46 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.769 -1.207 . . . . 0.0 108.375 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 134.58 119.54 1.96 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 107.222 -2.351 . . . . 2.1099999999999999 107.222 -178.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -82.4 -58.12 3.07 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.031 -1.276 . . . . 5.8899999999999997 110.607 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 971' ' ' LEU . . . . . 0.601 HD23 ' O ' ' C' ' 971' ' ' LEU . 9.1 tt -58.94 89.84 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.427 -0.796 . . . . 4.3600000000000003 110.378 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -142.33 -152.59 0.42 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.584 -0.698 . . . . 1.8300000000000001 110.144 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -117.17 167.81 10.85 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.415 -0.803 . . . . 4.3499999999999996 110.045 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 29.3 t -101.54 130.19 47.77 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.547 -0.72 . . . . 1.27 110.152 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -156.22 153.68 29.56 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.526 -0.734 . . . . 5.0199999999999996 110.405 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.27 86.08 17.56 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.604 -0.685 . . . . 2.4100000000000001 109.853 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -75.39 -171.44 1.02 Allowed 'Trans proline' 0 C--N 1.318 -1.065 0 O-C-N 123.326 1.172 . . . . 0.95999999999999996 111.309 -179.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 978' ' ' LEU . . . . . 0.582 ' N ' HD12 ' C' ' 978' ' ' LEU . 5.4 mp -123.36 156.68 34.9 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 107.512 -1.292 . . . . 0.62 107.512 177.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 979' ' ' THR . . . . . 0.45 HG23 ' C ' ' C' ' 978' ' ' LEU . 45.0 p -149.72 141.65 23.81 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.777 -1.202 . . . . 3.5699999999999998 111.186 -179.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 980' ' ' ILE . . . . . 0.729 ' HB ' HG21 ' C' ' 899' ' ' VAL . 50.6 mm -105.64 128.47 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 N-CA-C 109.174 -0.676 . . . . 1.3300000000000001 109.174 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 981' ' ' PHE . . . . . 0.439 ' CD1' ' CE2' ' C' ' 879' ' ' TYR . 2.1 t80 -118.99 99.36 6.69 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 119.808 -0.757 . . . . 0.050000000000000003 111.486 -178.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 982' ' ' SER . . . . . . . . . . . . . 10.6 p -109.93 159.71 17.02 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.578 -0.701 . . . . 0.87 109.194 178.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 983' ' ' GLY . . . . . 0.41 ' O ' ' CE2' ' C' ' 852' ' ' PHE . . . -170.8 111.42 0.41 Allowed Glycine 0 N--CA 1.498 2.818 0 N-CA-C 106.594 -2.602 . . . . 0.029999999999999999 106.594 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 984' ' ' ALA . . . . . 0.44 ' HB1' ' NE ' ' A' ' 893' ' ' ARG . . . -109.01 147.19 32.7 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.199 -1.177 . . . . 0.69999999999999996 114.025 -176.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 985' ' ' LEU . . . . . 1.055 HD13 HD22 ' C' ' 890' ' ' LEU . 56.6 tp -72.36 135.72 45.95 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.722 -1.236 . . . . 0.040000000000000001 110.066 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 986' ' ' LEU . . . . . . . . . . . . . 49.1 tp -107.08 -61.58 1.53 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.524 -0.735 . . . . 0.040000000000000001 110.341 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -145.0 146.33 31.87 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.847 -1.168 . . . . 0.040000000000000001 107.847 179.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.35 162.79 12.29 Favored Glycine 0 N--CA 1.495 2.593 0 N-CA-C 108.146 -1.981 . . . . 0.040000000000000001 108.146 179.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -75.44 112.65 20.05 Favored Pre-proline 0 N--CA 1.498 1.965 0 O-C-N 121.19 -1.183 . . . . 0.040000000000000001 109.485 179.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 990' ' ' PRO . . . . . 0.418 ' O ' ' HB2' ' C' ' 991' ' ' GLU . 50.2 Cg_endo -89.82 71.26 1.72 Allowed 'Trans proline' 0 C--N 1.319 -0.985 0 O-C-N 123.132 1.07 . . . . 0.45000000000000001 111.466 -178.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 991' ' ' GLU . . . . . 0.418 ' HB2' ' O ' ' C' ' 990' ' ' PRO . 69.5 mt-10 67.41 -73.31 0.08 Allowed 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 108.662 -0.866 . . . . 1.97 108.662 -177.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 992' ' ' LEU . . . . . . . . . . . . . 11.7 mt 50.62 21.06 0.81 Allowed 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.584 -0.697 . . . . 2.3799999999999999 111.645 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 79.7 mt-10 -93.27 156.94 16.51 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.887 -1.133 . . . . 3.79 110.02 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 68.6 m80 -146.62 92.59 2.17 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.525 -0.734 . . . . 3.5099999999999998 110.21 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 995' ' ' ALA . . . . . . . . . . . . 2.518 . . . . . . . 0 N--CA 1.503 2.197 0 O-C-N 120.94 -1.1 . . . . 2.73 110.569 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo . . . . . 0 N--CA 1.488 1.157 0 N-CA-C 109.503 -0.999 . . . . 3.8300000000000001 109.503 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 847' ' ' VAL . . . . . 0.44 HG12 ' HB2' ' A' ' 849' ' ' GLN . 61.3 t -132.16 102.84 14.24 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.584 -0.697 . . . . 1.8300000000000001 110.06 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 848' ' ' PRO . . . . . 0.762 ' O ' HG23 ' A' ' 850' ' ' VAL . 43.5 Cg_endo -69.84 -20.84 33.95 Favored 'Trans proline' 0 N--CA 1.487 1.124 0 O-C-N 123.276 1.145 . . . . 0.65000000000000002 110.973 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 849' ' ' GLN . . . . . 0.44 ' HB2' HG12 ' A' ' 847' ' ' VAL . 56.1 tt0 28.04 68.1 0.07 Allowed 'General case' 0 N--CA 1.518 2.937 0 N-CA-C 112.911 0.708 . . . . 2.5800000000000001 112.911 179.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 850' ' ' VAL . . . . . 0.762 HG23 ' O ' ' A' ' 848' ' ' PRO . 72.9 t -119.74 136.13 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.152 -0.968 . . . . 1.0900000000000001 111.413 -178.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 851' ' ' ALA . . . . . 0.482 ' HB3' ' HG ' ' A' ' 873' ' ' LEU . . . -126.62 159.41 33.65 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 106.043 -1.836 . . . . 0.040000000000000001 106.043 177.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 852' ' ' PHE . . . . . 0.439 ' HA ' ' CB ' ' A' ' 874' ' ' ASN . 46.7 p90 -157.56 131.79 8.3 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 121.019 1.736 . . . . 0.050000000000000003 108.728 178.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 32.5 t -175.67 133.02 0.28 Allowed 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.076 -1.083 . . . . 0.040000000000000001 108.076 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -133.45 156.08 48.37 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.071 -1.018 . . . . 0.67000000000000004 109.472 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 855' ' ' ALA . . . . . 0.744 ' HB3' ' CB ' ' A' ' 870' ' ' ARG . . . -124.4 140.17 53.21 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.808 0.813 . . . . 0.51000000000000001 111.305 -179.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 856' ' ' LEU . . . . . 0.761 HD11 HD23 ' A' ' 858' ' ' LEU . 3.4 tm? -111.96 140.01 46.98 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.607 -0.683 . . . . 0.050000000000000003 110.156 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 857' ' ' SER . . . . . 0.68 ' N ' HD13 ' A' ' 856' ' ' LEU . 37.0 p -157.59 17.05 0.26 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.543 -0.723 . . . . 1.3300000000000001 111.467 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 858' ' ' LEU . . . . . 0.761 HD23 HD11 ' A' ' 856' ' ' LEU . 3.1 pp -35.67 161.57 0.04 OUTLIER Pre-proline 0 N--CA 1.518 2.935 0 N-CA-C 112.851 0.686 . . . . 2.3300000000000001 112.851 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -59.87 -89.17 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.453 0 O-C-N 122.938 0.968 . . . . 2.3199999999999998 113.294 -178.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 55.3 ptt85 -134.9 -141.61 0.18 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.839 -1.163 . . . . 0.040000000000000001 111.646 -177.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 73.8 m -32.89 122.09 0.36 Allowed 'General case' 0 N--CA 1.513 2.694 0 N-CA-C 112.996 0.739 . . . . 1.3100000000000001 112.996 -178.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.76 160.13 27.08 Favored Pre-proline 0 N--CA 1.489 1.483 0 N-CA-C 107.93 -1.137 . . . . 4.5099999999999998 107.93 177.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.05 -13.86 34.45 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.134 1.07 . . . . 2.2400000000000002 111.479 -179.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -177.3 -135.45 2.22 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.97 -1.252 . . . . 0.040000000000000001 109.97 179.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 37.2 m -67.56 157.34 34.6 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.35 -1.088 . . . . 1.51 110.53 -178.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 866' ' ' VAL . . . . . 0.475 HG13 ' CD2' ' A' ' 858' ' ' LEU . 50.8 t -100.55 139.34 20.54 Favored Pre-proline 0 N--CA 1.495 1.8 0 N-CA-C 113.459 0.911 . . . . 0.78000000000000003 113.459 -174.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 867' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 866' ' ' VAL . 55.6 Cg_endo -91.67 -148.19 0.03 OUTLIER 'Trans proline' 0 CA--C 1.548 1.177 0 O-C-N 123.621 1.327 . . . . 0.92000000000000004 109.481 177.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 868' ' ' PHE . . . . . 0.45 ' CD1' ' CG ' ' A' ' 881' ' ' PRO . 26.3 p90 -150.35 124.22 9.26 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.696 -1.253 . . . . 0.050000000000000003 109.539 179.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 50.4 p-10 -113.82 -2.16 13.73 Favored 'General case' 0 N--CA 1.5 2.066 0 C-N-CA 119.265 -0.974 . . . . 1.7 112.852 -178.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 870' ' ' ARG . . . . . 0.744 ' CB ' ' HB3' ' A' ' 855' ' ' ALA . 28.7 mmm180 -91.27 90.11 7.6 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.865 -1.147 . . . . 2.5899999999999999 110.999 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 57.4 t -71.81 96.72 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 120.971 -1.081 . . . . 1.9399999999999999 110.047 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 872' ' ' LEU . . . . . 0.538 HD11 ' HB2' ' A' ' 855' ' ' ALA . 96.8 mt -83.06 -47.46 11.65 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.456 -0.778 . . . . 1.0600000000000001 110.04 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 873' ' ' LEU . . . . . 0.482 ' HG ' ' HB3' ' A' ' 851' ' ' ALA . 41.2 tp -175.15 103.19 0.08 Allowed 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 108.381 -0.97 . . . . 4.1799999999999997 108.381 178.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 874' ' ' ASN . . . . . 0.439 ' CB ' ' HA ' ' A' ' 852' ' ' PHE . 36.7 t-20 178.29 81.68 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.324 0 O-C-N 121.681 -0.637 . . . . 0.040000000000000001 109.421 -178.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -66.26 -46.77 75.93 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 119.324 -0.95 . . . . 3.3799999999999999 111.22 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 876' ' ' GLY . . . . . 0.4 ' HA3' ' CE2' ' A' ' 878' ' ' TYR . . . -74.87 -24.56 71.74 Favored Glycine 0 N--CA 1.494 2.555 0 O-C-N 121.318 -0.864 . . . . 0.040000000000000001 111.916 -178.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 82.11 -62.48 4.54 Favored Glycine 0 N--CA 1.501 3.021 0 N-CA-C 107.896 -2.082 . . . . 0.040000000000000001 107.896 -178.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 878' ' ' TYR . . . . . 0.4 ' CE2' ' HA3' ' A' ' 876' ' ' GLY . 93.2 m-85 61.41 -61.99 0.09 Allowed 'General case' 0 N--CA 1.504 2.262 0 N-CA-C 114.596 1.332 . . . . 3.46 114.596 177.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 879' ' ' TYR . . . . . 0.467 ' CB ' ' CD2' ' A' ' 886' ' ' PHE . 20.4 p90 -110.58 109.03 19.17 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 114.849 1.425 . . . . 0.040000000000000001 114.849 -176.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -67.19 118.21 53.77 Favored Pre-proline 0 N--CA 1.495 1.813 0 O-C-N 121.385 -0.822 . . . . 0.02 109.899 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 881' ' ' PRO . . . . . 0.45 ' CG ' ' CD1' ' A' ' 868' ' ' PHE . 51.2 Cg_endo -76.84 1.2 8.84 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 O-C-N 123.443 1.233 . . . . 0.39000000000000001 112.165 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -76.19 -64.75 1.03 Allowed 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 106.78 -1.563 . . . . 0.81000000000000005 106.78 178.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 7.5 p -95.43 -17.91 21.13 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.702 -0.851 . . . . 0.040000000000000001 108.702 177.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 85.17 23.33 48.97 Favored Glycine 0 N--CA 1.495 2.577 0 C-N-CA 120.11 -1.043 . . . . 0.029999999999999999 110.679 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 885' ' ' VAL . . . . . . . . . . . . . 75.4 t -73.39 88.42 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 C-N-CA 118.351 -1.339 . . . . 1.01 108.085 -179.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 886' ' ' PHE . . . . . 0.905 ' HB3' HG22 ' A' ' 962' ' ' VAL . 0.6 OUTLIER -89.64 106.55 18.53 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 115.239 -0.891 . . . . 0.050000000000000003 112.135 -177.232 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 887' ' ' THR . . . . . 0.41 ' O ' ' HD3' ' A' ' 889' ' ' PRO . 95.4 m -98.48 99.29 10.45 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 107.581 -1.266 . . . . 0.68000000000000005 107.581 177.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 888' ' ' ALA . . . . . . . . . . . . . . . -97.1 107.88 40.59 Favored Pre-proline 0 N--CA 1.502 2.132 0 N-CA-C 113.983 1.105 . . . . 0.25 113.983 -176.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 889' ' ' PRO . . . . . 0.41 ' HD3' ' O ' ' A' ' 887' ' ' THR . 54.6 Cg_endo -89.11 -13.5 2.99 Favored 'Trans proline' 0 CA--C 1.546 1.094 0 N-CA-C 109.093 -1.157 . . . . 1.6399999999999999 109.093 176.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 890' ' ' LEU . . . . . 0.988 HD22 HD13 ' A' ' 985' ' ' LEU . 51.8 mt -35.91 -51.08 0.7 Allowed 'General case' 0 N--CA 1.508 2.447 0 N-CA-C 113.735 1.013 . . . . 2.29 113.735 -177.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 51.83 95.76 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.321 0 O-C-N 121.211 -0.93 . . . . 0.63 110.294 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 157.71 -152.99 24.24 Favored Glycine 0 N--CA 1.479 1.531 0 N-CA-C 107.181 -2.368 . . . . 0.040000000000000001 107.181 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 893' ' ' ARG . . . . . 0.405 ' CZ ' ' CB ' ' C' ' 984' ' ' ALA . 71.9 ttt-85 -114.46 126.23 54.73 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 108.286 -1.005 . . . . 3.0 108.286 177.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 894' ' ' TYR . . . . . 0.722 ' OH ' HD12 ' A' ' 896' ' ' LEU . 0.1 OUTLIER -132.47 160.06 37.54 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.105 -0.997 . . . . 0.040000000000000001 111.342 -179.4 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 895' ' ' LEU . . . . . 0.796 HD23 HD11 ' B' ' 952' ' ' LEU . 36.4 tp -92.16 119.67 32.03 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.735 -0.603 . . . . 1.27 110.056 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 896' ' ' LEU . . . . . 0.722 HD12 ' OH ' ' A' ' 894' ' ' TYR . 9.7 tt -109.64 143.67 39.05 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.717 -0.614 . . . . 0.93999999999999995 110.191 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 897' ' ' SER . . . . . 0.527 ' N ' HD23 ' A' ' 896' ' ' LEU . 64.7 m -149.86 114.07 5.17 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.443 -0.786 . . . . 0.040000000000000001 111.159 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.71 146.53 31.97 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.942 -0.762 . . . . 0.47999999999999998 108.942 178.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 899' ' ' VAL . . . . . 0.756 HG21 ' HB ' ' A' ' 980' ' ' ILE . 90.1 t -95.02 120.06 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 C-N-CA 119.588 -0.845 . . . . 0.55000000000000004 111.183 -179.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 900' ' ' LEU . . . . . 0.483 ' N ' HD22 ' A' ' 900' ' ' LEU . 4.5 mm? -95.52 112.04 23.83 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 114.331 1.234 . . . . 1.5900000000000001 114.331 -175.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 15.7 m -65.91 141.28 58.29 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 107.506 -1.294 . . . . 0.050000000000000003 107.506 177.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -67.11 -66.71 2.25 Favored Glycine 0 N--CA 1.495 2.597 0 N-CA-C 110.505 -1.038 . . . . 0.029999999999999999 110.505 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 12.0 m170 47.52 67.3 0.83 Allowed 'General case' 0 N--CA 1.507 2.378 0 O-C-N 121.533 -0.981 . . . . 3.2000000000000002 111.017 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 46.5 ptt85 -69.48 -6.82 33.01 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.58 -0.7 . . . . 2.9199999999999999 111.9 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 905' ' ' HIS . . . . . 0.485 ' O ' ' CB ' ' A' ' 906' ' ' GLU . 70.7 t60 -62.86 5.68 0.12 Allowed 'General case' 0 N--CA 1.506 2.35 0 O-C-N 120.943 -1.098 . . . . 2.8700000000000001 113.116 -179.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 906' ' ' GLU . . . . . 0.485 ' CB ' ' O ' ' A' ' 905' ' ' HIS . 0.6 OUTLIER 94.44 -164.29 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.407 0 CA-C-N 120.486 1.494 . . . . 0.98999999999999999 111.906 178.924 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 907' ' ' LYS . . . . . 0.458 ' CB ' ' O ' ' A' ' 906' ' ' GLU . 69.2 tttt 85.34 155.57 0.09 Allowed 'General case' 0 N--CA 1.519 3.01 0 N-CA-C 107.87 -1.159 . . . . 5.25 107.87 -176.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 59.5 t -123.44 115.55 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 120.733 -1.229 . . . . 0.39000000000000001 111.239 -179.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 909' ' ' GLU . . . . . 0.646 ' OE2' HD12 ' A' ' 966' ' ' LEU . 43.3 tp10 -97.3 135.48 39.16 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 107.077 -1.453 . . . . 1.72 107.077 176.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -154.72 123.66 6.25 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 106.985 -1.487 . . . . 0.67000000000000004 106.985 178.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 911' ' ' VAL . . . . . 0.67 HG22 HG13 ' A' ' 964' ' ' VAL . 86.1 t -80.43 130.55 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 CA-C-N 116.186 -0.461 . . . . 0.54000000000000004 110.933 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 86.0 mt -63.54 156.74 25.54 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.33 -0.856 . . . . 1.5 108.703 178.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 913' ' ' SER . . . . . 0.409 ' CB ' ' CG1' ' A' ' 919' ' ' VAL . 0.4 OUTLIER -128.38 131.27 48.53 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.17 -1.048 . . . . 1.3700000000000001 108.17 176.653 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 914' ' ' ARG . . . . . 0.853 ' NH1' HD23 ' A' ' 956' ' ' LEU . 0.0 OUTLIER -66.18 156.35 34.36 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 120.651 -1.28 . . . . 4.2999999999999998 111.706 -179.068 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 915' ' ' SER . . . . . 0.432 ' CB ' ' O ' ' A' ' 914' ' ' ARG . 4.2 t 83.19 -32.05 0.08 Allowed 'General case' 0 N--CA 1.522 3.163 0 C-N-CA 123.99 0.916 . . . . 2.0499999999999998 112.003 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 916' ' ' ASN . . . . . 0.798 ' HB2' HG21 ' A' ' 919' ' ' VAL . 82.6 m-20 -122.73 -20.86 5.78 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.918 -1.114 . . . . 2.71 111.249 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 917' ' ' GLN . . . . . 0.402 ' HB2' ' O ' ' A' ' 916' ' ' ASN . 45.4 mt-30 66.64 164.8 0.2 Allowed 'General case' 0 N--CA 1.521 3.106 0 N-CA-C 105.744 -1.947 . . . . 2.6800000000000002 105.744 -174.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 53.94 -124.26 29.47 Favored Glycine 1 N--CA 1.521 4.345 0 CA-C-N 123.455 2.843 . . . . 0.029999999999999999 107.05 -177.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 919' ' ' VAL . . . . . 0.798 HG21 ' HB2' ' A' ' 916' ' ' ASN . 73.5 t 51.56 94.18 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 O-C-N 121.425 -1.044 . . . . 1.3899999999999999 109.165 -178.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 920' ' ' ALA . . . . . 0.567 ' HB3' HG12 ' A' ' 949' ' ' VAL . . . -92.95 92.19 7.75 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.347 -0.941 . . . . 0.029999999999999999 110.67 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 921' ' ' ARG . . . . . 0.865 ' HG3' HG23 ' A' ' 922' ' ' VAL . 29.2 ptt180 -85.11 -41.75 15.42 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 105.931 -1.877 . . . . 4.4199999999999999 105.931 176.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 922' ' ' VAL . . . . . 0.865 HG23 ' HG3' ' A' ' 921' ' ' ARG . 93.1 t -101.19 73.02 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 N-CA-C 106.021 -1.844 . . . . 0.84999999999999998 106.021 175.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -87.29 133.29 33.71 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.689 0.757 . . . . 2.46 111.381 -177.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 924' ' ' SER . . . . . 0.408 ' CB ' HD12 ' A' ' 900' ' ' LEU . 8.7 t -147.99 105.61 3.68 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.59 -0.893 . . . . 0.69999999999999996 108.59 179.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -102.82 84.41 0.47 Allowed Glycine 0 N--CA 1.487 2.054 0 N-CA-C 108.568 -1.813 . . . . 0.040000000000000001 108.568 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 926' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' A' ' 906' ' ' GLU . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 108.786 -1.725 . . . . 0.040000000000000001 108.786 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 67.1 m . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.007 0.432 . . . . 13.779999999999999 110.366 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 95.5 mt -109.52 130.55 55.5 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.509 -0.744 . . . . 13.76 110.276 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -152.79 169.21 31.82 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.388 -1.485 . . . . 9.1300000000000008 109.388 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 949' ' ' VAL . . . . . 0.567 HG12 ' HB3' ' A' ' 920' ' ' ALA . 34.3 m -118.56 130.49 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.577 -0.955 . . . . 7.0800000000000001 110.687 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 950' ' ' PHE . . . . . 0.428 ' CZ ' ' HB3' ' A' ' 921' ' ' ARG . 52.0 p90 -130.22 143.98 51.1 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.454 -0.779 . . . . 7.5899999999999999 109.415 179.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 31.3 m -121.61 -52.3 2.03 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.46 -0.775 . . . . 5.0300000000000002 111.97 -178.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 952' ' ' LEU . . . . . 0.404 ' O ' ' O ' ' A' ' 953' ' ' ILE . 45.7 tp -61.47 -75.88 0.06 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.44 -0.787 . . . . 1.01 112.439 -177.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 953' ' ' ILE . . . . . 0.46 ' O ' ' HB3' ' A' ' 954' ' ' LEU . 47.0 pt -53.65 -141.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.736 0 N-CA-C 113.981 1.104 . . . . 2.6000000000000001 113.981 -176.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 954' ' ' LEU . . . . . 0.738 HD22 ' O ' ' A' ' 954' ' ' LEU . 0.0 OUTLIER 174.32 75.09 0.05 OUTLIER Pre-proline 0 N--CA 1.507 2.378 0 O-C-N 120.755 -1.215 . . . . 0.050000000000000003 110.959 179.813 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 955' ' ' PRO . . . . . 0.561 ' C ' HD12 ' A' ' 956' ' ' LEU . 45.3 Cg_endo -73.04 93.79 0.81 Allowed 'Trans proline' 0 C--N 1.315 -1.215 0 N-CA-C 109.227 -1.105 . . . . 0.83999999999999997 109.227 178.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 956' ' ' LEU . . . . . 0.853 HD23 ' NH1' ' A' ' 914' ' ' ARG . 5.0 mp -126.19 140.39 52.59 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.251 -0.906 . . . . 0.040000000000000001 110.624 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -79.77 152.52 29.75 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 117.864 -1.065 . . . . 1.28 111.201 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -67.14 121.2 15.1 Favored 'General case' 0 N--CA 1.511 2.58 0 CA-C-N 122.743 2.52 . . . . 0.17000000000000001 111.925 -179.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 94.31 -18.75 56.29 Favored Glycine 0 N--CA 1.501 3.004 0 N-CA-C 111.135 -0.786 . . . . 0.040000000000000001 111.135 178.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 960' ' ' ASP . . . . . 0.406 ' HB3' ' CZ ' ' A' ' 914' ' ' ARG . 1.3 m-20 -52.42 167.56 0.13 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.445 -1.032 . . . . 0.040000000000000001 111.029 -179.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 961' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 886' ' ' PHE . 57.3 m -135.66 135.84 40.45 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.936 -1.103 . . . . 1.78 111.623 -178.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 962' ' ' VAL . . . . . 0.905 HG22 ' HB3' ' A' ' 886' ' ' PHE . 33.8 m -100.43 145.24 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 O-C-N 121.57 -0.706 . . . . 0.040000000000000001 111.173 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 1.7 m -138.51 148.15 43.96 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.789 -0.569 . . . . 0.71999999999999997 109.964 -178.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 964' ' ' VAL . . . . . 0.67 HG13 HG22 ' A' ' 911' ' ' VAL . 61.4 t -99.66 137.92 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.128 -0.983 . . . . 1.05 110.584 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -91.68 128.88 37.69 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 104.121 -2.548 . . . . 3.02 104.121 173.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 966' ' ' LEU . . . . . 0.646 HD12 ' OE2' ' A' ' 909' ' ' GLU . 0.4 OUTLIER -131.54 59.8 1.69 Allowed 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.22 -1.03 . . . . 1.46 108.22 177.078 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 967' ' ' VAL . . . . . 0.491 HG23 ' C ' ' A' ' 966' ' ' LEU . 90.6 t -158.64 97.25 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 108.041 -1.096 . . . . 1.9399999999999999 108.041 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 80.2 mmm -143.99 59.47 1.36 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.711 -1.243 . . . . 0.0 108.396 178.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.3 119.77 1.95 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 107.195 -2.362 . . . . 2.1099999999999999 107.195 -178.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -82.18 -59.05 2.69 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.082 -1.246 . . . . 5.8899999999999997 110.333 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 47.3 tp -59.08 90.76 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.437 -0.789 . . . . 4.3600000000000003 110.205 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -141.91 -154.51 0.52 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.56 -0.712 . . . . 1.8300000000000001 110.24 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -120.5 172.53 7.77 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.45 -0.781 . . . . 4.3499999999999996 110.349 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 30.6 t -101.25 130.3 47.35 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.534 -0.729 . . . . 1.27 110.016 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -155.66 159.0 39.22 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.553 -0.717 . . . . 5.0199999999999996 110.52 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.01 85.99 18.47 Favored Pre-proline 0 N--CA 1.5 2.053 0 O-C-N 121.648 -0.658 . . . . 2.4100000000000001 109.632 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -73.15 -173.06 1.15 Allowed 'Trans proline' 0 C--N 1.317 -1.098 0 O-C-N 123.309 1.163 . . . . 0.95999999999999996 111.359 -179.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 978' ' ' LEU . . . . . 0.568 HD23 HD12 ' A' ' 856' ' ' LEU . 4.9 mp -128.52 153.94 46.66 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 107.547 -1.279 . . . . 0.62 107.547 177.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 979' ' ' THR . . . . . 0.462 HG23 ' C ' ' A' ' 978' ' ' LEU . 41.8 p -149.99 141.57 23.49 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.8 -1.187 . . . . 3.5699999999999998 111.189 -179.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 980' ' ' ILE . . . . . 0.756 ' HB ' HG21 ' A' ' 899' ' ' VAL . 49.4 mm -106.86 128.72 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.893 -0.78 . . . . 1.3300000000000001 108.893 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 981' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -119.0 95.96 5.04 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 119.806 -0.758 . . . . 0.050000000000000003 111.891 -178.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 82.8 p -108.18 157.83 17.97 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.55 -0.719 . . . . 0.87 109.098 178.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 983' ' ' GLY . . . . . 0.411 ' HA3' ' CE1' ' A' ' 852' ' ' PHE . . . -176.84 108.17 0.25 Allowed Glycine 0 N--CA 1.499 2.875 0 N-CA-C 106.411 -2.676 . . . . 0.029999999999999999 106.411 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -108.53 152.33 24.89 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 114.658 1.355 . . . . 0.69999999999999996 114.658 -175.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 985' ' ' LEU . . . . . 0.988 HD13 HD22 ' A' ' 890' ' ' LEU . 36.4 tp -72.15 135.33 46.15 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.829 -1.17 . . . . 0.040000000000000001 109.991 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 51.4 tp -106.09 -59.78 1.73 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.535 -0.728 . . . . 0.040000000000000001 109.879 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -143.15 146.52 33.8 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 107.57 -1.27 . . . . 0.040000000000000001 107.57 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.13 163.66 12.17 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 108.23 -1.948 . . . . 0.040000000000000001 108.23 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -74.56 112.61 18.11 Favored Pre-proline 0 N--CA 1.498 1.951 0 O-C-N 121.227 -1.161 . . . . 0.040000000000000001 109.439 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 990' ' ' PRO . . . . . 0.419 ' O ' ' HB2' ' A' ' 991' ' ' GLU . 50.6 Cg_endo -89.25 71.0 2.07 Favored 'Trans proline' 0 C--N 1.318 -1.036 0 O-C-N 123.132 1.07 . . . . 0.45000000000000001 111.494 -178.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 991' ' ' GLU . . . . . 0.419 ' HB2' ' O ' ' A' ' 990' ' ' PRO . 70.5 mt-10 67.23 -73.97 0.07 Allowed 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 108.562 -0.903 . . . . 1.97 108.562 -177.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 992' ' ' LEU . . . . . 0.41 HD12 ' HD2' ' A' ' 990' ' ' PRO . 11.4 mt 51.19 20.66 0.93 Allowed 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.572 -0.705 . . . . 2.3799999999999999 111.593 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -92.81 156.9 16.69 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.86 -1.15 . . . . 3.79 109.955 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 71.0 m80 -147.1 92.22 2.09 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.525 -0.734 . . . . 3.5099999999999998 110.314 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 995' ' ' ALA . . . . . . . . . . . . 2.516 . . . . . . . 0 N--CA 1.503 2.214 0 O-C-N 120.933 -1.105 . . . . 2.73 110.551 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo . . . . . 0 N--CA 1.488 1.16 0 N-CA-C 109.479 -1.008 . . . . 3.8300000000000001 109.479 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 847' ' ' VAL . . . . . 0.424 HG12 ' HB2' ' B' ' 849' ' ' GLN . 60.4 t -132.1 102.86 14.31 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.632 -0.667 . . . . 1.8300000000000001 110.122 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 848' ' ' PRO . . . . . 0.767 ' O ' HG23 ' B' ' 850' ' ' VAL . 43.9 Cg_endo -69.76 -21.17 33.85 Favored 'Trans proline' 0 N--CA 1.487 1.1 0 O-C-N 123.328 1.173 . . . . 0.65000000000000002 110.941 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 849' ' ' GLN . . . . . 0.424 ' HB2' HG12 ' B' ' 847' ' ' VAL . 56.1 tt0 28.35 68.34 0.08 Allowed 'General case' 0 N--CA 1.517 2.901 0 N-CA-C 112.856 0.687 . . . . 2.5800000000000001 112.856 179.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 850' ' ' VAL . . . . . 0.767 HG23 ' O ' ' B' ' 848' ' ' PRO . 74.4 t -120.07 136.11 58.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.213 -0.93 . . . . 1.0900000000000001 111.421 -178.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 851' ' ' ALA . . . . . 0.493 ' HB3' ' HG ' ' B' ' 873' ' ' LEU . . . -126.93 158.72 36.06 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 106.008 -1.849 . . . . 0.040000000000000001 106.008 177.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 852' ' ' PHE . . . . . 0.432 ' HA ' ' CB ' ' B' ' 874' ' ' ASN . 46.6 p90 -156.87 132.07 9.12 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 121.034 1.743 . . . . 0.050000000000000003 108.713 179.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 33.0 t -175.74 132.71 0.27 Allowed 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.118 -1.067 . . . . 0.040000000000000001 108.118 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -133.13 156.23 47.82 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.118 -0.989 . . . . 0.67000000000000004 109.487 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 855' ' ' ALA . . . . . 0.74 ' HB3' ' CB ' ' B' ' 870' ' ' ARG . . . -124.47 140.38 53.01 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.784 0.802 . . . . 0.51000000000000001 111.306 -179.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 856' ' ' LEU . . . . . 0.764 HD11 HD23 ' B' ' 858' ' ' LEU . 3.4 tm? -112.24 139.5 47.72 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.622 -0.673 . . . . 0.050000000000000003 110.179 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 857' ' ' SER . . . . . 0.667 ' N ' HD13 ' B' ' 856' ' ' LEU . 37.4 p -157.27 17.42 0.28 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.544 -0.723 . . . . 1.3300000000000001 111.42 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 858' ' ' LEU . . . . . 0.764 HD23 HD11 ' B' ' 856' ' ' LEU . 3.2 pp -35.92 161.57 0.04 OUTLIER Pre-proline 0 N--CA 1.518 2.953 0 CA-C-N 118.656 0.662 . . . . 2.3300000000000001 112.784 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -59.86 -89.24 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.49 0 O-C-N 122.901 0.948 . . . . 2.3199999999999998 113.277 -178.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 55.3 ptt85 -134.92 -141.58 0.18 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.836 -1.165 . . . . 0.040000000000000001 111.675 -177.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 73.8 m -32.81 121.68 0.35 Allowed 'General case' 0 N--CA 1.512 2.646 0 N-CA-C 113.042 0.756 . . . . 1.3100000000000001 113.042 -178.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 862' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.47 160.16 27.01 Favored Pre-proline 0 N--CA 1.489 1.524 0 N-CA-C 107.953 -1.129 . . . . 4.5099999999999998 107.953 177.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -69.95 -14.01 34.92 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 O-C-N 123.157 1.083 . . . . 2.2400000000000002 111.576 -179.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -177.03 -134.54 2.01 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 110.027 -1.229 . . . . 0.040000000000000001 110.027 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 38.9 m -68.43 157.72 35.21 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.308 -1.113 . . . . 1.51 110.437 -179.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 866' ' ' VAL . . . . . 0.475 HG13 ' CD2' ' B' ' 858' ' ' LEU . 50.7 t -100.7 139.34 20.5 Favored Pre-proline 0 N--CA 1.495 1.778 0 N-CA-C 113.509 0.929 . . . . 0.78000000000000003 113.509 -174.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 867' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' B' ' 866' ' ' VAL . 55.6 Cg_endo -91.72 -148.48 0.03 OUTLIER 'Trans proline' 0 CA--C 1.548 1.18 0 O-C-N 123.641 1.337 . . . . 0.92000000000000004 109.446 177.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 868' ' ' PHE . . . . . 0.455 ' CD1' ' CG ' ' B' ' 881' ' ' PRO . 26.1 p90 -150.17 124.1 9.31 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.622 -1.299 . . . . 0.050000000000000003 109.576 179.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 50.4 p-10 -113.68 -1.84 13.91 Favored 'General case' 0 N--CA 1.501 2.089 0 C-N-CA 119.222 -0.991 . . . . 1.7 112.875 -178.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 870' ' ' ARG . . . . . 0.74 ' CB ' ' HB3' ' B' ' 855' ' ' ALA . 28.4 mmm180 -91.52 89.88 7.39 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.837 -1.164 . . . . 2.5899999999999999 111.011 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 57.6 t -71.8 96.83 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.009 -1.057 . . . . 1.9399999999999999 110.019 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 872' ' ' LEU . . . . . 0.538 HD11 ' HB2' ' B' ' 855' ' ' ALA . 96.7 mt -83.22 -47.34 11.66 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.535 -0.728 . . . . 1.0600000000000001 110.021 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 873' ' ' LEU . . . . . 0.493 ' HG ' ' HB3' ' B' ' 851' ' ' ALA . 41.0 tp -175.1 103.22 0.08 Allowed 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.416 -0.957 . . . . 4.1799999999999997 108.416 178.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 874' ' ' ASN . . . . . 0.432 ' CB ' ' HA ' ' B' ' 852' ' ' PHE . 36.5 t-20 178.33 81.78 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.663 -0.648 . . . . 0.040000000000000001 109.443 -178.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -66.44 -46.87 75.01 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 119.32 -0.952 . . . . 3.3799999999999999 111.208 -179.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 876' ' ' GLY . . . . . 0.403 ' HA3' ' CE2' ' B' ' 878' ' ' TYR . . . -74.71 -24.85 71.26 Favored Glycine 0 N--CA 1.494 2.551 0 O-C-N 121.242 -0.912 . . . . 0.040000000000000001 111.888 -178.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 82.27 -62.32 4.58 Favored Glycine 0 N--CA 1.502 3.042 0 N-CA-C 107.877 -2.089 . . . . 0.040000000000000001 107.877 -178.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 878' ' ' TYR . . . . . 0.403 ' CE2' ' HA3' ' B' ' 876' ' ' GLY . 93.2 m-85 61.41 -62.02 0.09 Allowed 'General case' 0 N--CA 1.504 2.252 0 N-CA-C 114.595 1.332 . . . . 3.46 114.595 177.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 879' ' ' TYR . . . . . 0.468 ' CB ' ' CD2' ' B' ' 886' ' ' PHE . 20.3 p90 -110.55 109.12 19.32 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 114.826 1.417 . . . . 0.040000000000000001 114.826 -176.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -67.18 118.04 52.08 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.448 -0.783 . . . . 0.02 109.894 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 881' ' ' PRO . . . . . 0.455 ' CG ' ' CD1' ' B' ' 868' ' ' PHE . 53.0 Cg_endo -76.75 1.25 8.75 Favored 'Trans proline' 0 N--CA 1.492 1.431 0 O-C-N 123.426 1.224 . . . . 0.39000000000000001 112.194 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -76.2 -64.79 1.02 Allowed 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 106.8 -1.556 . . . . 0.81000000000000005 106.8 178.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 7.6 p -95.65 -17.3 21.42 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.759 -0.83 . . . . 0.040000000000000001 108.759 177.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.57 23.79 49.09 Favored Glycine 0 N--CA 1.494 2.55 0 C-N-CA 120.091 -1.052 . . . . 0.029999999999999999 110.721 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 885' ' ' VAL . . . . . . . . . . . . . 76.6 t -73.64 88.57 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 C-N-CA 118.315 -1.354 . . . . 1.01 108.022 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 886' ' ' PHE . . . . . 0.885 ' HB3' HG22 ' B' ' 962' ' ' VAL . 0.6 OUTLIER -89.82 106.7 18.64 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 115.324 -0.853 . . . . 0.050000000000000003 112.105 -177.293 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 887' ' ' THR . . . . . 0.409 ' O ' ' HD3' ' B' ' 889' ' ' PRO . 95.5 m -98.53 99.52 10.68 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 107.539 -1.282 . . . . 0.68000000000000005 107.539 177.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 888' ' ' ALA . . . . . . . . . . . . . . . -97.3 107.73 40.24 Favored Pre-proline 0 N--CA 1.502 2.138 0 N-CA-C 113.992 1.108 . . . . 0.25 113.992 -176.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 889' ' ' PRO . . . . . 0.409 ' HD3' ' O ' ' B' ' 887' ' ' THR . 55.2 Cg_endo -88.92 -13.66 3.06 Favored 'Trans proline' 0 CA--C 1.545 1.056 0 O-C-N 123.29 1.153 . . . . 1.6399999999999999 109.164 176.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 890' ' ' LEU . . . . . 0.957 HD22 HD13 ' B' ' 985' ' ' LEU . 51.9 mt -35.68 -51.31 0.66 Allowed 'General case' 0 N--CA 1.508 2.46 0 N-CA-C 113.688 0.995 . . . . 2.29 113.688 -177.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 51.9 95.71 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.275 0 O-C-N 121.192 -0.943 . . . . 0.63 110.358 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . 157.76 -153.17 24.4 Favored Glycine 0 N--CA 1.479 1.515 0 N-CA-C 107.21 -2.356 . . . . 0.040000000000000001 107.21 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 72.1 ttt-85 -114.3 126.17 54.71 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.283 -1.006 . . . . 3.0 108.283 177.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 894' ' ' TYR . . . . . 0.717 ' OH ' HD12 ' B' ' 896' ' ' LEU . 0.1 OUTLIER -132.41 160.28 36.83 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.134 -0.979 . . . . 0.040000000000000001 111.286 -179.391 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 895' ' ' LEU . . . . . 0.41 HD23 HD11 ' C' ' 952' ' ' LEU . 36.6 tp -92.32 119.49 31.94 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.742 -0.599 . . . . 1.27 110.178 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 896' ' ' LEU . . . . . 0.717 HD12 ' OH ' ' B' ' 894' ' ' TYR . 9.7 tt -109.55 142.9 39.97 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.68 -0.637 . . . . 0.93999999999999995 110.279 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 897' ' ' SER . . . . . 0.516 ' N ' HD23 ' B' ' 896' ' ' LEU . 64.4 m -149.1 113.96 5.4 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.464 -0.773 . . . . 0.040000000000000001 111.187 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.55 146.25 32.11 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.085 -0.709 . . . . 0.47999999999999998 109.085 178.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 899' ' ' VAL . . . . . 0.745 HG21 ' HB ' ' B' ' 980' ' ' ILE . 89.5 t -94.74 119.8 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 C-N-CA 119.602 -0.839 . . . . 0.55000000000000004 111.252 -179.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 900' ' ' LEU . . . . . 0.483 ' N ' HD22 ' B' ' 900' ' ' LEU . 4.5 mm? -95.27 111.69 23.5 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 114.416 1.265 . . . . 1.5900000000000001 114.416 -175.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 15.7 m -65.67 141.13 58.48 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 107.468 -1.308 . . . . 0.050000000000000003 107.468 177.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -67.22 -66.7 2.25 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 110.541 -1.024 . . . . 0.029999999999999999 110.541 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 11.9 m170 47.6 67.33 0.83 Allowed 'General case' 0 N--CA 1.507 2.388 0 O-C-N 121.47 -1.017 . . . . 3.2000000000000002 110.977 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 46.6 ptt85 -69.47 -6.99 34.09 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.638 -0.664 . . . . 2.9199999999999999 111.906 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 905' ' ' HIS . . . . . 0.484 ' O ' ' CB ' ' B' ' 906' ' ' GLU . 70.6 t60 -62.34 5.13 0.11 Allowed 'General case' 0 N--CA 1.507 2.382 0 O-C-N 120.915 -1.116 . . . . 2.8700000000000001 113.111 -179.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 906' ' ' GLU . . . . . 0.484 ' CB ' ' O ' ' B' ' 905' ' ' HIS . 0.6 OUTLIER 94.74 -164.31 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.432 0 CA-C-N 120.565 1.53 . . . . 0.98999999999999999 111.796 179.095 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 907' ' ' LYS . . . . . 0.467 ' CB ' ' O ' ' B' ' 906' ' ' GLU . 69.2 tttt 85.4 155.38 0.09 Allowed 'General case' 0 N--CA 1.519 2.985 0 N-CA-C 107.921 -1.14 . . . . 5.25 107.921 -176.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 60.1 t -123.27 115.34 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 120.716 -1.24 . . . . 0.39000000000000001 111.371 -179.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 909' ' ' GLU . . . . . 0.654 ' OE2' HD12 ' B' ' 966' ' ' LEU . 43.4 tp10 -97.16 135.59 38.89 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 107.014 -1.476 . . . . 1.72 107.014 176.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -154.95 123.85 6.2 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 106.966 -1.494 . . . . 0.67000000000000004 106.966 179.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 911' ' ' VAL . . . . . 0.66 HG22 HG13 ' B' ' 964' ' ' VAL . 87.2 t -80.71 130.91 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 C-N-CA 120.522 -0.471 . . . . 0.54000000000000004 110.934 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 86.2 mt -63.72 156.92 25.59 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.27 -0.894 . . . . 1.5 108.671 178.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 913' ' ' SER . . . . . 0.417 ' CB ' ' HB ' ' B' ' 919' ' ' VAL . 0.4 OUTLIER -128.77 130.58 47.23 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.251 -1.018 . . . . 1.3700000000000001 108.251 176.647 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 914' ' ' ARG . . . . . 0.854 ' NH1' HD23 ' B' ' 956' ' ' LEU . 0.0 OUTLIER -65.45 156.2 33.14 Favored 'General case' 0 N--CA 1.507 2.387 0 O-C-N 120.674 -1.266 . . . . 4.2999999999999998 111.796 -178.963 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 915' ' ' SER . . . . . 0.425 ' CB ' ' O ' ' B' ' 914' ' ' ARG . 4.2 t 83.3 -32.39 0.08 Allowed 'General case' 0 N--CA 1.522 3.148 0 C-N-CA 123.991 0.917 . . . . 2.0499999999999998 112.019 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 916' ' ' ASN . . . . . 0.817 ' HB2' HG21 ' B' ' 919' ' ' VAL . 82.5 m-20 -122.24 -21.23 5.93 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 120.87 -1.144 . . . . 2.71 111.328 -179.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 917' ' ' GLN . . . . . 0.402 ' HB2' ' O ' ' B' ' 916' ' ' ASN . 45.3 mt-30 66.77 164.34 0.19 Allowed 'General case' 0 N--CA 1.52 3.065 0 N-CA-C 105.76 -1.941 . . . . 2.6800000000000002 105.76 -174.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.52 -124.38 31.27 Favored Glycine 1 N--CA 1.522 4.368 0 CA-C-N 123.521 2.873 . . . . 0.029999999999999999 106.928 -177.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 919' ' ' VAL . . . . . 0.817 HG21 ' HB2' ' B' ' 916' ' ' ASN . 75.8 t 51.42 94.25 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 O-C-N 121.413 -1.051 . . . . 1.3899999999999999 109.15 -178.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 920' ' ' ALA . . . . . 0.562 ' HB3' HG12 ' B' ' 949' ' ' VAL . . . -93.02 92.07 7.66 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 119.327 -0.949 . . . . 0.029999999999999999 110.643 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 921' ' ' ARG . . . . . 0.851 ' HG3' HG23 ' B' ' 922' ' ' VAL . 29.3 ptt180 -85.03 -41.64 15.6 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 105.924 -1.88 . . . . 4.4199999999999999 105.924 176.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 922' ' ' VAL . . . . . 0.851 HG23 ' HG3' ' B' ' 921' ' ' ARG . 92.8 t -101.29 72.77 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 N-CA-C 106.052 -1.833 . . . . 0.84999999999999998 106.052 175.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -87.09 133.49 33.61 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.678 0.752 . . . . 2.46 111.376 -177.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 924' ' ' SER . . . . . 0.404 ' HB2' HD12 ' B' ' 900' ' ' LEU . 8.7 t -148.11 105.4 3.64 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.638 -0.875 . . . . 0.69999999999999996 108.638 179.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -102.55 84.36 0.48 Allowed Glycine 0 N--CA 1.487 2.091 0 N-CA-C 108.589 -1.804 . . . . 0.040000000000000001 108.589 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 926' ' ' GLY . . . . . 0.411 ' O ' ' HA ' ' B' ' 906' ' ' GLU . . . . . . . . 0 N--CA 1.489 2.205 0 N-CA-C 108.805 -1.718 . . . . 0.040000000000000001 108.805 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 69.8 m . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.05 0.453 . . . . 13.779999999999999 110.296 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 95.3 mt -108.24 130.19 55.17 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.494 -0.754 . . . . 13.76 110.295 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -152.01 168.53 31.28 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.429 -1.468 . . . . 9.1300000000000008 109.429 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 949' ' ' VAL . . . . . 0.562 HG12 ' HB3' ' B' ' 920' ' ' ALA . 34.2 m -118.27 130.41 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.606 -0.938 . . . . 7.0800000000000001 110.547 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 950' ' ' PHE . . . . . 0.441 ' CZ ' ' HB3' ' B' ' 921' ' ' ARG . 52.0 p90 -130.37 144.11 51.18 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.492 -0.755 . . . . 7.5899999999999999 109.447 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 31.9 m -121.77 -51.91 2.02 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.451 -0.781 . . . . 5.0300000000000002 111.92 -178.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 952' ' ' LEU . . . . . 0.796 HD11 HD23 ' A' ' 895' ' ' LEU . 45.3 tp -61.81 -76.06 0.06 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.512 -0.742 . . . . 1.01 112.385 -177.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 953' ' ' ILE . . . . . 0.469 ' O ' ' HB3' ' B' ' 954' ' ' LEU . 47.0 pt -53.53 -141.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.724 0 N-CA-C 113.992 1.108 . . . . 2.6000000000000001 113.992 -176.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 954' ' ' LEU . . . . . 0.742 HD22 ' O ' ' B' ' 954' ' ' LEU . 0.0 OUTLIER 174.08 75.05 0.05 OUTLIER Pre-proline 0 N--CA 1.507 2.391 0 O-C-N 120.786 -1.196 . . . . 0.050000000000000003 110.906 179.754 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 955' ' ' PRO . . . . . 0.557 ' C ' HD12 ' B' ' 956' ' ' LEU . 45.3 Cg_endo -73.07 93.93 0.81 Allowed 'Trans proline' 0 C--N 1.315 -1.212 0 N-CA-C 109.185 -1.121 . . . . 0.83999999999999997 109.185 178.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 956' ' ' LEU . . . . . 0.854 HD23 ' NH1' ' B' ' 914' ' ' ARG . 5.0 mp -126.32 140.39 52.55 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.242 -0.911 . . . . 0.040000000000000001 110.602 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -79.68 153.02 29.61 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 117.964 -1.017 . . . . 1.28 111.097 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -67.54 121.1 15.11 Favored 'General case' 0 N--CA 1.51 2.564 0 CA-C-N 122.563 2.438 . . . . 0.17000000000000001 111.838 -179.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 94.38 -19.01 55.79 Favored Glycine 0 N--CA 1.501 3.017 0 N-CA-C 111.132 -0.787 . . . . 0.040000000000000001 111.132 178.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 960' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -52.21 167.67 0.12 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.412 -1.052 . . . . 0.040000000000000001 111.027 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 961' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' B' ' 886' ' ' PHE . 57.3 m -135.73 135.93 40.41 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 120.966 -1.084 . . . . 1.78 111.614 -178.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 962' ' ' VAL . . . . . 0.885 HG22 ' HB3' ' B' ' 886' ' ' PHE . 33.9 m -100.64 145.15 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 121.606 -0.684 . . . . 0.040000000000000001 111.13 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 1.8 m -138.39 148.01 44.03 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.816 -0.553 . . . . 0.71999999999999997 109.938 -178.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 964' ' ' VAL . . . . . 0.66 HG13 HG22 ' B' ' 911' ' ' VAL . 61.8 t -99.66 137.69 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.118 -0.989 . . . . 1.05 110.623 -179.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -91.58 128.57 37.46 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 104.202 -2.518 . . . . 3.02 104.202 173.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 966' ' ' LEU . . . . . 0.654 HD12 ' OE2' ' B' ' 909' ' ' GLU . 0.4 OUTLIER -131.2 59.84 1.67 Allowed 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.305 -0.998 . . . . 1.46 108.305 177.162 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 967' ' ' VAL . . . . . 0.49 HG23 ' C ' ' B' ' 966' ' ' LEU . 90.1 t -158.76 96.97 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 108.104 -1.072 . . . . 1.9399999999999999 108.104 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 80.2 mmm -143.64 59.24 1.38 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.733 -1.229 . . . . 0.0 108.519 178.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.4 119.63 1.93 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 107.318 -2.313 . . . . 2.1099999999999999 107.318 -178.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -81.96 -59.05 2.71 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.095 -1.239 . . . . 5.8899999999999997 110.376 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 47.6 tp -59.14 90.49 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.423 -0.798 . . . . 4.3600000000000003 110.224 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -141.67 -154.51 0.52 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.536 -0.727 . . . . 1.8300000000000001 110.296 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -120.36 172.73 7.6 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.428 -0.795 . . . . 4.3499999999999996 110.315 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 30.3 t -101.47 130.32 47.69 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.517 -0.739 . . . . 1.27 109.983 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -155.68 158.99 39.17 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.457 -0.777 . . . . 5.0199999999999996 110.486 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.99 85.96 18.57 Favored Pre-proline 0 N--CA 1.5 2.048 0 O-C-N 121.607 -0.683 . . . . 2.4100000000000001 109.673 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -73.17 -173.15 1.18 Allowed 'Trans proline' 0 C--N 1.318 -1.078 0 O-C-N 123.286 1.151 . . . . 0.95999999999999996 111.319 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 978' ' ' LEU . . . . . 0.582 HD23 HD12 ' B' ' 856' ' ' LEU . 4.9 mp -128.34 154.15 46.27 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 107.565 -1.272 . . . . 0.62 107.565 177.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 979' ' ' THR . . . . . 0.469 HG23 ' C ' ' B' ' 978' ' ' LEU . 41.6 p -150.17 141.46 23.22 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.788 -1.195 . . . . 3.5699999999999998 111.214 -179.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 980' ' ' ILE . . . . . 0.745 ' HB ' HG21 ' B' ' 899' ' ' VAL . 49.4 mm -106.78 128.41 61.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 108.951 -0.759 . . . . 1.3300000000000001 108.951 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -118.82 96.2 5.16 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.488 -0.758 . . . . 0.050000000000000003 111.852 -178.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 78.7 p -108.6 158.01 17.97 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.557 -0.714 . . . . 0.87 109.159 178.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 983' ' ' GLY . . . . . 0.403 ' HA3' ' CE1' ' B' ' 852' ' ' PHE . . . -176.78 108.16 0.25 Allowed Glycine 0 N--CA 1.498 2.783 0 N-CA-C 106.529 -2.628 . . . . 0.029999999999999999 106.529 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 984' ' ' ALA . . . . . 0.433 ' HB1' ' NH1' ' C' ' 893' ' ' ARG . . . -108.37 152.37 24.76 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 114.627 1.343 . . . . 0.69999999999999996 114.627 -175.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 985' ' ' LEU . . . . . 0.957 HD13 HD22 ' B' ' 890' ' ' LEU . 36.4 tp -72.25 135.36 46.01 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.926 -1.109 . . . . 0.040000000000000001 109.94 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 986' ' ' LEU . . . . . 0.476 ' CD1' HD11 ' C' ' 986' ' ' LEU . 51.4 tp -106.21 -59.67 1.75 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.655 -0.653 . . . . 0.040000000000000001 109.914 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -143.13 146.52 33.82 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 107.597 -1.26 . . . . 0.040000000000000001 107.597 178.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.03 163.26 12.21 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 108.278 -1.929 . . . . 0.040000000000000001 108.278 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -74.21 112.65 17.86 Favored Pre-proline 0 N--CA 1.498 1.944 0 O-C-N 121.173 -1.193 . . . . 0.040000000000000001 109.415 179.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 990' ' ' PRO . . . . . 0.421 ' O ' ' HB2' ' B' ' 991' ' ' GLU . 50.3 Cg_endo -89.32 71.06 2.02 Favored 'Trans proline' 0 C--N 1.319 -1.015 0 O-C-N 123.067 1.035 . . . . 0.45000000000000001 111.461 -178.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 991' ' ' GLU . . . . . 0.421 ' HB2' ' O ' ' B' ' 990' ' ' PRO . 70.8 mt-10 67.14 -73.94 0.07 Allowed 'General case' 0 N--CA 1.502 2.164 0 N-CA-C 108.581 -0.896 . . . . 1.97 108.581 -177.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 992' ' ' LEU . . . . . 0.463 HD23 ' HA ' ' B' ' 992' ' ' LEU . 11.5 mt 51.27 20.48 0.94 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.586 -0.697 . . . . 2.3799999999999999 111.621 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -92.53 156.91 16.83 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.912 -1.118 . . . . 3.79 110.019 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 70.7 m80 -147.15 91.73 2.03 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.549 -0.719 . . . . 3.5099999999999998 110.359 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 995' ' ' ALA . . . . . . . . . . . . 2.518 . . . . . . . 0 N--CA 1.503 2.19 0 O-C-N 120.899 -1.125 . . . . 2.73 110.622 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo . . . . . 0 N--CA 1.488 1.158 0 N-CA-C 109.516 -0.994 . . . . 3.8300000000000001 109.516 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 847' ' ' VAL . . . . . 0.526 HG12 ' HB2' ' C' ' 849' ' ' GLN . 60.3 t -126.11 105.48 25.41 Favored Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 121.639 -0.663 . . . . 1.8300000000000001 110.103 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 848' ' ' PRO . . . . . 0.878 ' O ' HG23 ' C' ' 850' ' ' VAL . 43.8 Cg_endo -69.61 -23.56 31.36 Favored 'Trans proline' 0 N--CA 1.487 1.113 0 O-C-N 123.219 1.115 . . . . 0.65000000000000002 110.949 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 849' ' ' GLN . . . . . 0.526 ' HB2' HG12 ' C' ' 847' ' ' VAL . 55.5 tt0 25.4 66.38 0.05 Allowed 'General case' 0 N--CA 1.518 2.944 0 N-CA-C 113.419 0.896 . . . . 2.5800000000000001 113.419 179.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 850' ' ' VAL . . . . . 0.878 HG23 ' O ' ' C' ' 848' ' ' PRO . 77.7 t -120.0 135.74 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 121.113 -0.992 . . . . 1.0900000000000001 111.183 -179.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 851' ' ' ALA . . . . . 0.588 ' HB3' ' HG ' ' C' ' 873' ' ' LEU . . . -128.17 155.45 44.46 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 105.914 -1.884 . . . . 0.040000000000000001 105.914 176.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 852' ' ' PHE . . . . . 0.456 ' CD1' ' N ' ' C' ' 852' ' ' PHE . 15.2 p90 -160.42 127.03 4.22 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 120.973 1.715 . . . . 0.050000000000000003 108.631 179.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 6.3 t -177.28 134.28 0.18 Allowed 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.162 -1.051 . . . . 0.040000000000000001 108.162 -179.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -130.39 158.14 40.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.087 -1.008 . . . . 0.67000000000000004 109.685 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 855' ' ' ALA . . . . . 0.771 ' HB3' ' CB ' ' C' ' 870' ' ' ARG . . . -121.39 140.71 51.77 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.818 0.818 . . . . 0.51000000000000001 111.061 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 856' ' ' LEU . . . . . 0.937 HD11 HD23 ' C' ' 858' ' ' LEU . 3.5 tm? -113.23 135.74 53.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.612 -0.68 . . . . 0.050000000000000003 110.084 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 857' ' ' SER . . . . . 0.584 ' N ' HD13 ' C' ' 856' ' ' LEU . 0.6 OUTLIER -153.35 18.64 0.55 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.502 -0.749 . . . . 1.3300000000000001 110.919 179.581 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 858' ' ' LEU . . . . . 0.937 HD23 HD11 ' C' ' 856' ' ' LEU . 2.7 pp -34.7 159.65 0.04 OUTLIER Pre-proline 0 N--CA 1.516 2.856 0 N-CA-C 113.008 0.744 . . . . 2.3300000000000001 113.008 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -63.04 -88.39 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.399 0 O-C-N 123.078 1.041 . . . . 2.3199999999999998 113.257 -178.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 54.7 ptt85 -133.18 -142.0 0.2 Allowed 'General case' 0 N--CA 1.499 2.01 0 O-C-N 120.854 -1.154 . . . . 0.040000000000000001 111.422 -177.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 58.2 m -36.68 123.92 0.83 Allowed 'General case' 0 N--CA 1.511 2.586 0 O-C-N 121.609 -0.682 . . . . 1.3100000000000001 112.538 -178.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -104.04 160.24 26.71 Favored Pre-proline 0 N--CA 1.489 1.496 0 N-CA-C 108.052 -1.092 . . . . 4.5099999999999998 108.052 177.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -69.12 -14.41 38.06 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 123.185 1.097 . . . . 2.2400000000000002 111.404 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -177.25 -136.58 2.48 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 110.107 -1.197 . . . . 0.040000000000000001 110.107 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 32.7 m -65.23 156.89 30.43 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.366 -1.079 . . . . 1.51 110.746 -178.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 866' ' ' VAL . . . . . 0.431 HG13 ' CD2' ' C' ' 858' ' ' LEU . 64.5 t -96.58 134.61 23.09 Favored Pre-proline 0 N--CA 1.494 1.73 0 N-CA-C 113.136 0.791 . . . . 0.78000000000000003 113.136 -175.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 867' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' C' ' 866' ' ' VAL . 55.3 Cg_endo -90.36 -149.13 0.03 OUTLIER 'Trans proline' 0 CA--C 1.544 1.022 0 O-C-N 123.577 1.304 . . . . 0.92000000000000004 108.837 177.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 868' ' ' PHE . . . . . 0.472 ' CD1' ' N ' ' C' ' 868' ' ' PHE . 13.8 p90 -150.0 123.65 9.17 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.53 -1.356 . . . . 0.050000000000000003 109.861 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 46.5 p-10 -113.82 -2.48 13.65 Favored 'General case' 0 N--CA 1.499 2.003 0 C-N-CA 119.185 -1.006 . . . . 1.7 112.892 -178.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 870' ' ' ARG . . . . . 0.771 ' CB ' ' HB3' ' C' ' 855' ' ' ALA . 29.9 mmm180 -91.22 88.66 7.0 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.912 -1.117 . . . . 2.5899999999999999 110.998 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 57.3 t -72.21 97.48 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 120.94 -1.1 . . . . 1.9399999999999999 109.695 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 872' ' ' LEU . . . . . 0.645 HD11 ' HB2' ' C' ' 855' ' ' ALA . 96.3 mt -86.22 -46.04 10.74 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.611 -0.681 . . . . 1.0600000000000001 110.648 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 873' ' ' LEU . . . . . 0.588 ' HG ' ' HB3' ' C' ' 851' ' ' ALA . 35.8 tp -173.61 102.27 0.12 Allowed 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.262 -0.899 . . . . 4.1799999999999997 108.702 178.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 874' ' ' ASN . . . . . 0.437 ' CB ' ' HA ' ' C' ' 852' ' ' PHE . 36.3 t-20 177.7 82.68 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.26 0 N-CA-C 109.035 -0.728 . . . . 0.040000000000000001 109.035 -178.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -64.39 -46.15 84.54 Favored 'General case' 0 N--CA 1.497 1.916 0 C-N-CA 119.265 -0.974 . . . . 3.3799999999999999 111.171 -179.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 876' ' ' GLY . . . . . 0.422 ' HA3' ' CE2' ' C' ' 878' ' ' TYR . . . -73.8 -26.47 69.2 Favored Glycine 0 N--CA 1.494 2.519 0 C-N-CA 120.461 -0.876 . . . . 0.040000000000000001 111.977 -178.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 79.49 -63.94 3.89 Favored Glycine 0 N--CA 1.502 3.098 0 N-CA-C 107.868 -2.093 . . . . 0.040000000000000001 107.868 -178.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 878' ' ' TYR . . . . . 0.422 ' CE2' ' HA3' ' C' ' 876' ' ' GLY . 76.5 m-85 60.39 -63.92 0.06 Allowed 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 114.825 1.417 . . . . 3.46 114.825 177.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 879' ' ' TYR . . . . . 0.494 ' CE2' ' CD1' ' C' ' 981' ' ' PHE . 28.8 p90 -108.53 108.29 19.15 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 115.342 1.608 . . . . 0.040000000000000001 115.342 -175.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -70.69 117.55 56.63 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 121.758 -0.589 . . . . 0.02 110.191 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 881' ' ' PRO . . . . . 0.453 ' CG ' ' CD1' ' C' ' 868' ' ' PHE . 55.3 Cg_endo -76.83 1.97 8.01 Favored 'Trans proline' 0 N--CA 1.492 1.402 0 O-C-N 123.452 1.238 . . . . 0.39000000000000001 112.298 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -74.66 -65.02 0.91 Allowed 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 106.359 -1.719 . . . . 0.81000000000000005 106.359 178.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 6.0 p -96.45 -16.3 21.26 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.804 -0.813 . . . . 0.040000000000000001 108.804 177.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.54 23.02 52.25 Favored Glycine 0 N--CA 1.493 2.499 0 O-C-N 120.991 -1.068 . . . . 0.029999999999999999 110.692 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 95.2 t -73.38 87.5 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 C-N-CA 118.299 -1.36 . . . . 1.01 107.775 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 886' ' ' PHE . . . . . 0.846 ' HB3' HG22 ' C' ' 962' ' ' VAL . 0.7 OUTLIER -87.95 108.83 19.39 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-N 115.132 -0.94 . . . . 0.050000000000000003 111.569 -177.587 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 887' ' ' THR . . . . . 0.423 ' O ' ' HD3' ' C' ' 889' ' ' PRO . 97.3 m -105.75 99.62 9.21 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 107.596 -1.261 . . . . 0.68000000000000005 107.596 177.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 888' ' ' ALA . . . . . . . . . . . . . . . -98.89 101.56 12.54 Favored Pre-proline 0 N--CA 1.501 2.089 0 N-CA-C 114.523 1.305 . . . . 0.25 114.523 -176.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 889' ' ' PRO . . . . . 0.423 ' HD3' ' O ' ' C' ' 887' ' ' THR . 55.5 Cg_endo -79.83 -15.03 12.2 Favored 'Trans proline' 0 N--CA 1.486 1.048 0 N-CA-C 108.786 -1.275 . . . . 1.6399999999999999 108.786 175.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 890' ' ' LEU . . . . . 0.763 HD21 HG11 ' C' ' 850' ' ' VAL . 66.1 mt -37.77 -49.15 1.15 Allowed 'General case' 0 N--CA 1.508 2.438 0 N-CA-C 113.463 0.912 . . . . 2.29 113.463 -177.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 52.66 97.73 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.193 -0.942 . . . . 0.63 110.451 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . 158.86 -154.5 25.59 Favored Glycine 0 N--CA 1.477 1.407 0 N-CA-C 107.29 -2.324 . . . . 0.040000000000000001 107.29 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 893' ' ' ARG . . . . . 0.463 ' HG3' HD11 ' C' ' 954' ' ' LEU . 77.7 ttt-85 -116.28 123.94 48.94 Favored 'General case' 0 C--N 1.294 -1.825 0 O-C-N 121.671 -0.9 . . . . 3.0 108.589 177.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 894' ' ' TYR . . . . . 0.868 ' CE2' HD23 ' C' ' 954' ' ' LEU . 12.9 p90 -132.07 154.04 49.82 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.079 -1.013 . . . . 0.040000000000000001 110.954 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 895' ' ' LEU . . . . . . . . . . . . . 45.0 tp -99.65 113.78 26.44 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.706 -0.621 . . . . 1.27 109.796 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 896' ' ' LEU . . . . . 0.576 HD11 ' CE1' ' C' ' 981' ' ' PHE . 8.4 tt -118.01 145.08 45.02 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.678 -0.639 . . . . 0.93999999999999995 109.985 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 897' ' ' SER . . . . . . . . . . . . . 62.4 m -141.24 124.15 16.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.445 -0.784 . . . . 0.040000000000000001 111.184 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -100.78 148.42 24.94 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.73 -0.841 . . . . 0.47999999999999998 108.73 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 899' ' ' VAL . . . . . 0.691 HG21 ' HB ' ' C' ' 980' ' ' ILE . 96.7 t -92.33 120.53 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.369 -0.832 . . . . 0.55000000000000004 111.079 -179.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 91.4 mt -92.65 113.08 25.26 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 113.99 1.107 . . . . 1.5900000000000001 113.99 -175.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 16.7 m -62.54 141.28 58.51 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 107.545 -1.28 . . . . 0.050000000000000003 107.545 177.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -60.68 -65.23 3.47 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 110.362 -1.095 . . . . 0.029999999999999999 110.362 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 1.6 m80 46.23 65.11 1.26 Allowed 'General case' 0 N--CA 1.507 2.4 0 O-C-N 121.485 -1.009 . . . . 3.2000000000000002 111.095 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 42.4 ptt85 -66.72 -8.19 26.24 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.639 -0.663 . . . . 2.9199999999999999 111.971 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 905' ' ' HIS . . . . . 0.473 ' O ' ' CB ' ' C' ' 906' ' ' GLU . 61.0 t60 -63.67 5.32 0.21 Allowed 'General case' 0 N--CA 1.504 2.229 0 O-C-N 120.946 -1.096 . . . . 2.8700000000000001 112.624 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 906' ' ' GLU . . . . . 0.5 ' O ' ' CB ' ' C' ' 907' ' ' LYS . 2.8 mt-10 89.21 -152.96 0.01 OUTLIER 'General case' 0 N--CA 1.526 3.362 0 CA-C-N 121.215 1.825 . . . . 0.98999999999999999 111.59 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 907' ' ' LYS . . . . . 0.5 ' CB ' ' O ' ' C' ' 906' ' ' GLU . 62.2 tttt 90.19 163.85 0.05 OUTLIER 'General case' 0 N--CA 1.523 3.179 0 N-CA-C 107.925 -1.139 . . . . 5.25 107.925 -176.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 58.4 t -123.33 114.34 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 120.84 -1.162 . . . . 0.39000000000000001 110.843 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 909' ' ' GLU . . . . . 0.573 ' OE2' HD12 ' C' ' 966' ' ' LEU . 44.3 tp10 -108.68 130.71 55.34 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 107.559 -1.275 . . . . 1.72 107.559 177.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -157.54 121.16 4.1 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 107.098 -1.445 . . . . 0.67000000000000004 107.098 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 911' ' ' VAL . . . . . 0.506 ' HA ' ' HA ' ' C' ' 964' ' ' VAL . 14.0 p -80.94 131.02 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 C-N-CA 120.35 -0.54 . . . . 0.54000000000000004 111.654 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 62.4 mt -67.43 157.94 32.97 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.359 -0.838 . . . . 1.5 109.036 178.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 913' ' ' SER . . . . . 0.478 ' OG ' HG11 ' C' ' 919' ' ' VAL . 1.5 p -126.07 138.87 53.74 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.568 -0.901 . . . . 1.3700000000000001 108.568 176.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 914' ' ' ARG . . . . . 0.723 ' CZ ' HD23 ' C' ' 956' ' ' LEU . 0.0 OUTLIER -64.16 153.46 37.74 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 120.638 -1.289 . . . . 4.2999999999999998 111.607 -179.152 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 915' ' ' SER . . . . . 0.424 ' CB ' ' O ' ' C' ' 914' ' ' ARG . 0.2 OUTLIER 82.83 -30.37 0.09 Allowed 'General case' 0 N--CA 1.522 3.147 0 C-N-CA 123.766 0.826 . . . . 2.0499999999999998 112.457 179.575 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 916' ' ' ASN . . . . . 0.768 ' HB2' HG21 ' C' ' 919' ' ' VAL . 98.7 m-20 -122.17 -22.1 5.71 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.804 -1.185 . . . . 2.71 111.268 -179.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 67.09 166.52 0.22 Allowed 'General case' 0 N--CA 1.52 3.042 0 N-CA-C 105.792 -1.929 . . . . 2.6800000000000002 105.792 -174.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.58 -125.67 35.26 Favored Glycine 1 N--CA 1.522 4.384 0 CA-C-N 123.539 2.882 . . . . 0.029999999999999999 107.087 -177.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 919' ' ' VAL . . . . . 0.768 HG21 ' HB2' ' C' ' 916' ' ' ASN . 92.4 t 51.01 94.02 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.238 0 O-C-N 121.452 -1.028 . . . . 1.3899999999999999 109.234 -178.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 920' ' ' ALA . . . . . 0.951 ' HB3' HG12 ' C' ' 949' ' ' VAL . . . -94.06 94.32 8.34 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.395 -0.922 . . . . 0.029999999999999999 110.735 -179.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 921' ' ' ARG . . . . . 0.698 ' HG3' HG23 ' C' ' 922' ' ' VAL . 45.2 ptt85 -79.14 -42.1 27.0 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 105.591 -2.003 . . . . 4.4199999999999999 105.591 176.049 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 922' ' ' VAL . . . . . 0.698 HG23 ' HG3' ' C' ' 921' ' ' ARG . 73.9 t -99.7 78.68 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 N-CA-C 105.441 -2.059 . . . . 0.84999999999999998 105.441 174.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -89.92 136.28 33.13 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 122.047 0.927 . . . . 2.46 112.775 -176.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 6.3 t -147.21 103.05 3.55 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 107.576 -1.268 . . . . 0.69999999999999996 107.576 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -107.71 82.27 0.31 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.656 -1.378 . . . . 0.040000000000000001 109.656 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 109.187 -1.565 . . . . 0.040000000000000001 109.187 179.747 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 17.7 m . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 120.937 0.398 . . . . 13.779999999999999 110.377 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 95.3 mt -114.66 131.36 56.75 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.472 -0.767 . . . . 13.76 110.321 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -151.7 170.13 31.17 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.433 -1.467 . . . . 9.1300000000000008 109.433 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 949' ' ' VAL . . . . . 0.951 HG12 ' HB3' ' C' ' 920' ' ' ALA . 26.9 m -117.44 136.26 55.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.488 -1.007 . . . . 7.0800000000000001 111.043 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 950' ' ' PHE . . . . . 0.447 ' CZ ' ' HB3' ' C' ' 921' ' ' ARG . 40.4 p90 -133.36 150.22 51.84 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.561 -0.712 . . . . 7.5899999999999999 109.336 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 68.4 m -118.07 -57.64 2.07 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.399 -0.813 . . . . 5.0300000000000002 111.81 -178.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 952' ' ' LEU . . . . . 0.454 ' O ' ' O ' ' C' ' 953' ' ' ILE . 46.4 tp -62.34 -75.69 0.07 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.423 -0.798 . . . . 1.01 111.505 -178.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 953' ' ' ILE . . . . . 0.57 HD12 ' N ' ' C' ' 954' ' ' LEU . 2.8 pp -49.41 -151.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.694 0 N-CA-C 114.563 1.32 . . . . 2.6000000000000001 114.563 -176.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 954' ' ' LEU . . . . . 0.868 HD23 ' CE2' ' C' ' 894' ' ' TYR . 0.0 OUTLIER 171.22 90.39 0.04 OUTLIER Pre-proline 0 N--CA 1.515 2.807 0 O-C-N 120.659 -1.276 . . . . 0.050000000000000003 111.941 -179.289 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 955' ' ' PRO . . . . . 0.629 ' C ' HD12 ' C' ' 956' ' ' LEU . 52.8 Cg_endo -83.0 92.37 0.9 Allowed 'Trans proline' 0 C--N 1.317 -1.113 0 N-CA-C 109.502 -0.999 . . . . 0.83999999999999997 109.502 178.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 956' ' ' LEU . . . . . 0.811 HD22 ' OH ' ' C' ' 894' ' ' TYR . 6.2 mp -125.11 147.86 48.82 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.066 -1.021 . . . . 0.040000000000000001 110.521 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -82.71 150.93 26.44 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 117.661 -1.162 . . . . 1.28 111.341 -178.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -64.65 118.11 8.41 Favored 'General case' 0 N--CA 1.506 2.365 0 CA-C-N 123.221 2.737 . . . . 0.17000000000000001 110.662 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.25 -18.56 53.89 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 110.903 -0.879 . . . . 0.040000000000000001 110.903 179.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 960' ' ' ASP . . . . . 0.418 ' HB3' ' NE ' ' C' ' 914' ' ' ARG . 0.4 OUTLIER -54.41 171.18 0.12 Allowed 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.265 -1.138 . . . . 0.040000000000000001 110.253 -179.55 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 961' ' ' THR . . . . . 0.543 HG23 ' O ' ' C' ' 886' ' ' PHE . 40.7 m -137.71 141.07 41.05 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.95 -1.094 . . . . 1.78 112.844 -177.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 962' ' ' VAL . . . . . 0.846 HG22 ' HB3' ' C' ' 886' ' ' PHE . 27.3 m -100.44 145.45 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.88 -0.512 . . . . 0.040000000000000001 110.666 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 5.3 t -138.01 144.14 40.94 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.715 -0.616 . . . . 0.71999999999999997 110.153 -178.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 964' ' ' VAL . . . . . 0.506 ' HA ' ' HA ' ' C' ' 911' ' ' VAL . 58.9 t -91.45 137.29 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.185 -0.947 . . . . 1.05 110.803 -179.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -92.83 125.64 37.53 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 103.441 -2.8 . . . . 3.02 103.441 173.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 966' ' ' LEU . . . . . 0.573 HD12 ' OE2' ' C' ' 909' ' ' GLU . 0.2 OUTLIER -134.53 56.81 1.83 Allowed 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.578 -0.897 . . . . 1.46 108.578 177.503 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 967' ' ' VAL . . . . . 0.488 HG23 ' C ' ' C' ' 966' ' ' LEU . 97.9 t -158.22 95.93 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.248 -1.019 . . . . 1.9399999999999999 108.248 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 92.8 mmm -142.87 59.28 1.43 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.724 -1.235 . . . . 0.0 108.462 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 134.35 119.62 1.98 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 107.282 -2.327 . . . . 2.1099999999999999 107.282 -178.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -82.56 -58.26 2.99 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.004 -1.291 . . . . 5.8899999999999997 110.531 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 48.1 tp -59.14 89.69 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.397 -0.814 . . . . 4.3600000000000003 110.313 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -142.71 -152.08 0.39 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.559 -0.713 . . . . 1.8300000000000001 109.97 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -115.93 166.99 11.35 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.391 -0.818 . . . . 4.3499999999999996 109.842 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 9.8 t -101.61 129.83 47.81 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.52 -0.738 . . . . 1.27 110.079 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -156.45 157.5 35.62 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.528 -0.732 . . . . 5.0199999999999996 110.553 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -143.22 85.91 9.4 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.658 -0.651 . . . . 2.4100000000000001 109.796 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -74.77 -169.86 0.68 Allowed 'Trans proline' 0 C--N 1.318 -1.045 0 O-C-N 123.189 1.099 . . . . 0.95999999999999996 111.325 -179.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 978' ' ' LEU . . . . . 0.514 ' N ' HD12 ' C' ' 978' ' ' LEU . 5.1 mp -125.86 155.9 40.46 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.474 -1.306 . . . . 0.62 107.474 177.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 979' ' ' THR . . . . . 0.46 HG23 ' C ' ' C' ' 978' ' ' LEU . 42.8 p -149.88 142.96 24.98 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.759 -1.213 . . . . 3.5699999999999998 111.334 -179.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 980' ' ' ILE . . . . . 0.691 ' HB ' HG21 ' C' ' 899' ' ' VAL . 50.0 mm -105.41 127.88 59.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 108.837 -0.801 . . . . 1.3300000000000001 108.837 179.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 981' ' ' PHE . . . . . 0.576 ' CE1' HD11 ' C' ' 896' ' ' LEU . 5.2 t80 -117.9 96.05 5.18 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.311 -0.868 . . . . 0.050000000000000003 111.579 -178.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 982' ' ' SER . . . . . . . . . . . . . 51.3 p -106.3 158.78 16.61 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 109.066 -0.716 . . . . 0.87 109.066 178.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 983' ' ' GLY . . . . . 0.418 ' HA3' ' CE2' ' C' ' 852' ' ' PHE . . . -171.81 113.18 0.48 Allowed Glycine 0 N--CA 1.496 2.662 0 N-CA-C 106.624 -2.59 . . . . 0.029999999999999999 106.624 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 984' ' ' ALA . . . . . 0.405 ' CB ' ' CZ ' ' A' ' 893' ' ' ARG . . . -108.75 152.01 25.43 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 114.323 1.231 . . . . 0.69999999999999996 114.323 -175.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 985' ' ' LEU . . . . . 0.47 HD13 HD22 ' C' ' 890' ' ' LEU . 55.6 tp -75.89 136.14 40.13 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.848 -1.157 . . . . 0.040000000000000001 109.832 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 986' ' ' LEU . . . . . 0.476 HD11 ' CD1' ' B' ' 986' ' ' LEU . 51.4 tp -106.35 -62.82 1.34 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.573 -0.704 . . . . 0.040000000000000001 110.302 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -144.92 147.15 32.41 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 107.816 -1.179 . . . . 0.040000000000000001 107.816 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -111.86 162.74 12.33 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 108.071 -2.011 . . . . 0.040000000000000001 108.071 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -72.46 112.96 16.91 Favored Pre-proline 0 N--CA 1.498 1.935 0 O-C-N 121.207 -1.173 . . . . 0.040000000000000001 109.531 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 990' ' ' PRO . . . . . 0.455 ' HD2' HD12 ' C' ' 992' ' ' LEU . 50.6 Cg_endo -87.66 70.13 3.31 Favored 'Trans proline' 0 C--N 1.319 -0.975 0 O-C-N 123.127 1.067 . . . . 0.45000000000000001 111.356 -178.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 991' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' C' ' 990' ' ' PRO . 71.4 mt-10 67.12 -74.11 0.07 Allowed 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 108.617 -0.883 . . . . 1.97 108.617 -177.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 992' ' ' LEU . . . . . 0.455 HD12 ' HD2' ' C' ' 990' ' ' PRO . 11.5 mt 50.55 21.03 0.79 Allowed 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.606 -0.684 . . . . 2.3799999999999999 111.646 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -92.54 156.77 16.91 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.89 -1.131 . . . . 3.79 110.038 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 68.6 m80 -146.56 91.84 2.09 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.52 -0.738 . . . . 3.5099999999999998 110.281 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 995' ' ' ALA . . . . . . . . . . . . 2.518 . . . . . . . 0 N--CA 1.504 2.248 0 O-C-N 120.95 -1.094 . . . . 2.73 110.589 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo . . . . . 0 N--CA 1.488 1.153 0 N-CA-C 109.581 -0.969 . . . . 3.8300000000000001 109.581 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 847' ' ' VAL . . . . . 0.432 HG12 ' HB2' ' A' ' 849' ' ' GLN . 61.4 t -132.03 103.56 14.19 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.636 -0.665 . . . . 1.8300000000000001 110.0 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 848' ' ' PRO . . . . . 0.722 ' O ' HG23 ' A' ' 850' ' ' VAL . 44.1 Cg_endo -69.5 -20.08 36.52 Favored 'Trans proline' 0 N--CA 1.487 1.117 0 O-C-N 123.271 1.142 . . . . 0.65000000000000002 111.139 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 849' ' ' GLN . . . . . 0.432 ' HB2' HG12 ' A' ' 847' ' ' VAL . 55.7 tt0 27.03 68.2 0.06 Allowed 'General case' 0 N--CA 1.518 2.957 0 N-CA-C 112.919 0.711 . . . . 2.5800000000000001 112.919 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 850' ' ' VAL . . . . . 0.722 HG23 ' O ' ' A' ' 848' ' ' PRO . 59.6 t -117.76 136.72 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.184 -0.948 . . . . 1.0900000000000001 111.459 -178.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 851' ' ' ALA . . . . . 0.534 ' HB3' ' HG ' ' A' ' 873' ' ' LEU . . . -125.83 156.65 39.22 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 105.783 -1.932 . . . . 0.040000000000000001 105.783 176.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 852' ' ' PHE . . . . . 0.468 ' CE2' HD11 ' A' ' 890' ' ' LEU . 24.2 p90 -160.34 128.61 4.7 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 121.014 1.734 . . . . 0.050000000000000003 108.732 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 853' ' ' SER . . . . . 0.401 ' CB ' ' HA ' ' A' ' 982' ' ' SER . 29.7 t -174.96 134.98 0.35 Allowed 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.053 -1.091 . . . . 0.040000000000000001 108.053 -178.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -132.83 156.48 47.07 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.99 -1.069 . . . . 0.67000000000000004 109.497 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 855' ' ' ALA . . . . . 0.744 ' HB3' ' CB ' ' A' ' 870' ' ' ARG . . . -122.73 144.61 49.05 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.787 0.803 . . . . 0.51000000000000001 111.65 -178.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 856' ' ' LEU . . . . . 0.692 ' CD1' HD23 ' A' ' 978' ' ' LEU . 3.4 tm? -112.05 134.33 53.66 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.787 -0.571 . . . . 0.050000000000000003 110.112 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 857' ' ' SER . . . . . 0.54 ' N ' HD13 ' A' ' 856' ' ' LEU . 55.8 p -150.63 16.7 0.79 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.531 -0.731 . . . . 1.3300000000000001 110.502 178.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 858' ' ' LEU . . . . . 0.762 HD22 ' OE2' ' A' ' 862' ' ' GLU . 4.4 pp -32.94 158.26 0.03 OUTLIER Pre-proline 0 N--CA 1.517 2.924 0 N-CA-C 113.432 0.901 . . . . 2.3300000000000001 113.432 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -64.41 -88.48 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.451 0 O-C-N 123.171 1.09 . . . . 2.3199999999999998 113.075 -178.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 55.8 ptt85 -128.7 -143.37 0.27 Allowed 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.817 -1.177 . . . . 0.040000000000000001 111.691 -177.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 19.4 m -40.4 128.16 2.38 Favored 'General case' 0 N--CA 1.508 2.468 0 O-C-N 121.43 -0.794 . . . . 1.3100000000000001 112.38 -178.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 862' ' ' GLU . . . . . 0.762 ' OE2' HD22 ' A' ' 858' ' ' LEU . 0.9 OUTLIER -102.69 156.74 34.9 Favored Pre-proline 0 N--CA 1.489 1.496 0 N-CA-C 107.8 -1.185 . . . . 4.5099999999999998 107.8 177.236 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 863' ' ' PRO . . . . . 0.412 ' HD2' ' CG ' ' A' ' 862' ' ' GLU . 43.6 Cg_endo -70.03 -12.71 32.9 Favored 'Trans proline' 0 C--N 1.314 -1.288 0 O-C-N 123.032 1.017 . . . . 2.2400000000000002 111.363 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -175.74 -136.38 2.32 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.972 -1.251 . . . . 0.040000000000000001 109.972 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 27.8 m -66.43 156.88 33.43 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.32 -1.106 . . . . 1.51 110.944 -178.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 866' ' ' VAL . . . . . 0.703 HG22 ' OE1' ' A' ' 862' ' ' GLU . 48.4 t -93.15 134.61 26.85 Favored Pre-proline 0 N--CA 1.495 1.8 0 N-CA-C 113.273 0.842 . . . . 0.78000000000000003 113.273 -174.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 867' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 866' ' ' VAL . 54.5 Cg_endo -90.36 -152.74 0.04 OUTLIER 'Trans proline' 0 CA--C 1.541 0.869 0 N-CA-C 108.761 -1.284 . . . . 0.92000000000000004 108.761 177.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 868' ' ' PHE . . . . . 0.452 ' CD1' ' N ' ' A' ' 868' ' ' PHE . 24.1 p90 -149.76 122.21 8.5 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.573 -1.329 . . . . 0.050000000000000003 109.901 179.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 49.0 p-10 -113.39 -2.33 13.99 Favored 'General case' 0 N--CA 1.498 1.972 0 C-N-CA 119.287 -0.965 . . . . 1.7 112.299 -179.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 870' ' ' ARG . . . . . 0.744 ' CB ' ' HB3' ' A' ' 855' ' ' ALA . 30.3 mmm180 -90.59 88.91 7.31 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.962 -1.086 . . . . 2.5899999999999999 110.67 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 58.3 t -74.54 97.31 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 120.95 -1.094 . . . . 1.9399999999999999 109.919 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 872' ' ' LEU . . . . . 0.456 HD11 ' HB2' ' A' ' 855' ' ' ALA . 92.8 mt -82.97 -47.24 11.96 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.526 -0.734 . . . . 1.0600000000000001 110.24 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 873' ' ' LEU . . . . . 0.534 ' HG ' ' HB3' ' A' ' 851' ' ' ALA . 46.9 tp -174.66 103.95 0.1 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.243 -0.911 . . . . 4.1799999999999997 108.689 178.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 874' ' ' ASN . . . . . 0.444 ' CB ' ' HA ' ' A' ' 852' ' ' PHE . 35.7 t-20 178.9 81.71 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.3 0 O-C-N 121.55 -0.719 . . . . 0.040000000000000001 109.751 -178.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -66.91 -47.25 72.35 Favored 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 119.241 -0.984 . . . . 3.3799999999999999 111.128 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 876' ' ' GLY . . . . . 0.411 ' HA3' ' CE2' ' A' ' 878' ' ' TYR . . . -73.95 -25.01 72.62 Favored Glycine 0 N--CA 1.495 2.573 0 O-C-N 121.275 -0.89 . . . . 0.040000000000000001 111.668 -178.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 82.86 -61.38 4.78 Favored Glycine 0 N--CA 1.501 3.023 0 N-CA-C 108.085 -2.006 . . . . 0.040000000000000001 108.085 -178.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 878' ' ' TYR . . . . . 0.411 ' CE2' ' HA3' ' A' ' 876' ' ' GLY . 88.1 m-85 60.41 -64.96 0.05 Allowed 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 114.28 1.215 . . . . 3.46 114.28 177.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 879' ' ' TYR . . . . . 0.479 ' CB ' ' CD2' ' A' ' 886' ' ' PHE . 19.6 p90 -111.53 107.15 16.23 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 114.5 1.296 . . . . 0.040000000000000001 114.5 -176.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -66.03 117.39 42.11 Favored Pre-proline 0 N--CA 1.497 1.903 0 O-C-N 121.402 -0.811 . . . . 0.02 110.1 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 881' ' ' PRO . . . . . 0.433 ' HG2' ' CD1' ' A' ' 868' ' ' PHE . 55.6 Cg_endo -75.92 0.05 9.7 Favored 'Trans proline' 0 N--CA 1.496 1.637 0 O-C-N 123.547 1.288 . . . . 0.39000000000000001 112.195 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -77.77 -63.87 1.28 Allowed 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 106.803 -1.554 . . . . 0.81000000000000005 106.803 178.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 44.9 p -93.03 -19.55 21.44 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.543 -0.91 . . . . 0.040000000000000001 108.543 177.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.7 20.16 60.35 Favored Glycine 0 N--CA 1.497 2.758 0 O-C-N 121.089 -1.007 . . . . 0.029999999999999999 111.545 178.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 885' ' ' VAL . . . . . 0.539 HG13 HG21 ' A' ' 961' ' ' THR . 88.1 t -74.19 91.96 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 C-N-CA 118.16 -1.416 . . . . 1.01 108.197 -179.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 886' ' ' PHE . . . . . 0.917 ' HB3' HG22 ' A' ' 962' ' ' VAL . 0.7 OUTLIER -90.27 105.75 18.02 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 115.158 -0.928 . . . . 0.050000000000000003 112.118 -177.248 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 887' ' ' THR . . . . . 0.425 ' O ' ' HD3' ' A' ' 889' ' ' PRO . 70.6 m -96.44 100.96 12.52 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 107.911 -1.144 . . . . 0.68000000000000005 107.911 177.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 888' ' ' ALA . . . . . . . . . . . . . . . -98.61 106.65 38.01 Favored Pre-proline 0 N--CA 1.503 2.201 0 N-CA-C 114.146 1.165 . . . . 0.25 114.146 -176.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 889' ' ' PRO . . . . . 0.425 ' HD3' ' O ' ' A' ' 887' ' ' THR . 55.2 Cg_endo -89.08 -12.94 3.17 Favored 'Trans proline' 0 CA--C 1.546 1.098 0 N-CA-C 109.121 -1.146 . . . . 1.6399999999999999 109.121 176.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 890' ' ' LEU . . . . . 1.077 HD22 HD13 ' A' ' 985' ' ' LEU . 56.0 mt -34.25 -51.07 0.43 Allowed 'General case' 0 N--CA 1.509 2.482 0 N-CA-C 113.972 1.101 . . . . 2.29 113.972 -177.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 51.51 94.89 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.363 0 O-C-N 121.186 -0.946 . . . . 0.63 110.331 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 156.09 -147.3 15.75 Favored Glycine 0 N--CA 1.48 1.601 0 N-CA-C 107.536 -2.226 . . . . 0.040000000000000001 107.536 -179.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 893' ' ' ARG . . . . . 0.465 ' CZ ' ' HB1' ' C' ' 984' ' ' ALA . 71.4 ttt-85 -109.13 127.76 54.44 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 107.576 -1.268 . . . . 3.0 107.576 177.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 894' ' ' TYR . . . . . 0.543 ' OH ' HD12 ' A' ' 896' ' ' LEU . 0.1 OUTLIER -130.28 144.54 51.43 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.987 -1.071 . . . . 0.040000000000000001 110.041 -179.075 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 895' ' ' LEU . . . . . 0.449 ' N ' ' CD1' ' A' ' 894' ' ' TYR . 39.9 tp -97.25 114.24 25.96 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.59 -0.694 . . . . 1.27 109.616 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 896' ' ' LEU . . . . . 0.543 HD12 ' OH ' ' A' ' 894' ' ' TYR . 9.7 tt -111.24 146.01 37.72 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.625 -0.672 . . . . 0.93999999999999995 110.812 -179.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 897' ' ' SER . . . . . . . . . . . . . 66.9 m -143.86 116.81 8.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.573 -0.705 . . . . 0.040000000000000001 110.503 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -106.57 146.77 30.25 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.258 -0.645 . . . . 0.47999999999999998 109.258 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 899' ' ' VAL . . . . . 0.725 HG21 ' HB ' ' A' ' 980' ' ' ILE . 88.3 t -97.47 119.18 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 C-N-CA 119.716 -0.794 . . . . 0.55000000000000004 111.277 -179.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 900' ' ' LEU . . . . . 0.437 ' N ' HD22 ' A' ' 900' ' ' LEU . 4.5 mm? -95.16 112.18 23.92 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 114.175 1.176 . . . . 1.5900000000000001 114.175 -175.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 17.6 m -64.54 140.99 58.93 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 107.398 -1.334 . . . . 0.050000000000000003 107.398 177.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -63.26 -66.27 2.64 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 110.479 -1.048 . . . . 0.029999999999999999 110.479 -179.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 2.2 m80 46.52 66.06 1.06 Allowed 'General case' 0 N--CA 1.507 2.42 0 O-C-N 121.474 -1.015 . . . . 3.2000000000000002 111.118 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 54.1 ptt85 -68.72 -6.44 26.32 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.585 -0.697 . . . . 2.9199999999999999 111.916 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 905' ' ' HIS . . . . . 0.483 ' O ' ' CB ' ' A' ' 906' ' ' GLU . 75.9 t60 -60.79 3.4 0.08 Allowed 'General case' 0 N--CA 1.505 2.314 0 O-C-N 120.936 -1.103 . . . . 2.8700000000000001 113.034 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 906' ' ' GLU . . . . . 0.483 ' CB ' ' O ' ' A' ' 905' ' ' HIS . 0.8 OUTLIER 93.4 -163.58 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.377 0 CA-C-N 120.552 1.523 . . . . 0.98999999999999999 112.192 178.789 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 907' ' ' LYS . . . . . 0.481 ' CB ' ' O ' ' A' ' 906' ' ' GLU . 42.6 tttt 88.64 161.73 0.06 Allowed 'General case' 0 N--CA 1.519 2.991 0 N-CA-C 107.675 -1.231 . . . . 5.25 107.675 -176.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 61.0 t -121.97 115.77 47.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 120.876 -1.14 . . . . 0.39000000000000001 110.815 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 909' ' ' GLU . . . . . 0.564 ' OE2' HD12 ' A' ' 966' ' ' LEU . 52.1 tp10 -100.71 132.62 46.01 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 107.19 -1.411 . . . . 1.72 107.19 176.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -156.82 120.64 4.28 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 106.731 -1.581 . . . . 0.67000000000000004 106.731 178.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 911' ' ' VAL . . . . . 0.684 HG22 HG13 ' A' ' 964' ' ' VAL . 95.6 t -83.18 131.99 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 C-N-CA 120.34 -0.544 . . . . 0.54000000000000004 110.756 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 72.8 mt -64.63 155.21 34.02 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.316 -0.865 . . . . 1.5 108.709 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 913' ' ' SER . . . . . 0.421 ' CB ' ' HB ' ' A' ' 919' ' ' VAL . 1.5 t -122.95 137.62 54.9 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.101 -1.074 . . . . 1.3700000000000001 108.101 177.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 914' ' ' ARG . . . . . 0.56 ' NH1' HD23 ' A' ' 956' ' ' LEU . 0.0 OUTLIER -64.1 153.73 36.71 Favored 'General case' 0 N--CA 1.505 2.308 0 O-C-N 120.834 -1.166 . . . . 4.2999999999999998 111.895 -178.884 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 915' ' ' SER . . . . . 0.423 ' CB ' ' O ' ' A' ' 914' ' ' ARG . 2.2 t 82.85 -31.91 0.09 Allowed 'General case' 0 N--CA 1.52 3.075 0 C-N-CA 123.977 0.911 . . . . 2.0499999999999998 112.452 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 916' ' ' ASN . . . . . 0.754 ' HB2' HG21 ' A' ' 919' ' ' VAL . 98.2 m-20 -121.64 -20.59 6.46 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 120.838 -1.164 . . . . 2.71 111.509 -179.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 917' ' ' GLN . . . . . 0.412 ' HB2' ' O ' ' A' ' 916' ' ' ASN . 51.1 mt-30 66.74 165.93 0.21 Allowed 'General case' 0 N--CA 1.52 3.045 0 N-CA-C 105.653 -1.98 . . . . 2.6800000000000002 105.653 -173.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.15 -125.04 32.46 Favored Glycine 1 N--CA 1.521 4.342 0 CA-C-N 123.423 2.828 . . . . 0.029999999999999999 107.1 -177.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 919' ' ' VAL . . . . . 0.754 HG21 ' HB2' ' A' ' 916' ' ' ASN . 76.7 t 51.71 94.9 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.229 0 O-C-N 121.466 -1.02 . . . . 1.3899999999999999 108.934 -178.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 920' ' ' ALA . . . . . 0.837 ' HB3' HG12 ' A' ' 949' ' ' VAL . . . -91.17 91.93 8.45 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.237 -0.985 . . . . 0.029999999999999999 110.986 -178.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 921' ' ' ARG . . . . . 0.719 ' HG3' HG23 ' A' ' 922' ' ' VAL . 42.4 ptt85 -84.2 -42.04 16.36 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 105.594 -2.002 . . . . 4.4199999999999999 105.594 175.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 922' ' ' VAL . . . . . 0.719 HG23 ' HG3' ' A' ' 921' ' ' ARG . 72.0 t -103.19 69.27 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 N-CA-C 105.446 -2.057 . . . . 0.84999999999999998 105.446 175.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 923' ' ' ASP . . . . . 0.643 ' HB2' ' HB1' ' A' ' 920' ' ' ALA . 19.4 t0 -91.0 135.94 33.41 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.783 0.801 . . . . 2.46 112.139 -176.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 13.8 t -147.6 104.31 3.6 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 108.096 -1.075 . . . . 0.69999999999999996 108.096 178.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -110.93 90.28 0.57 Allowed Glycine 0 N--CA 1.487 2.08 0 N-CA-C 108.988 -1.645 . . . . 0.040000000000000001 108.988 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.403 0 N-CA-C 109.4 -1.48 . . . . 0.040000000000000001 109.4 -179.625 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 31.0 m . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.007 0.432 . . . . 13.779999999999999 110.307 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 97.5 mt -113.55 129.68 56.51 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.519 -0.738 . . . . 13.76 110.46 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -152.28 168.51 31.44 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.103 -1.599 . . . . 9.1300000000000008 109.103 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 949' ' ' VAL . . . . . 0.837 HG12 ' HB3' ' A' ' 920' ' ' ALA . 34.9 m -118.81 130.35 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.48 -1.012 . . . . 7.0800000000000001 110.928 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 950' ' ' PHE . . . . . 0.463 ' CZ ' ' HB3' ' A' ' 921' ' ' ARG . 32.2 p90 -133.42 149.28 51.81 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.563 -0.711 . . . . 7.5899999999999999 109.31 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 19.6 m -119.42 -53.87 2.21 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.446 -0.784 . . . . 5.0300000000000002 112.144 -178.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 952' ' ' LEU . . . . . 0.505 HD23 ' HB2' ' C' ' 982' ' ' SER . 57.0 tp -59.98 -75.81 0.05 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.342 -0.849 . . . . 1.01 111.974 -177.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 953' ' ' ILE . . . . . 0.936 HD11 HD13 ' C' ' 872' ' ' LEU . 49.3 pt -53.1 -144.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.663 0 N-CA-C 113.718 1.007 . . . . 2.6000000000000001 113.718 -176.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 954' ' ' LEU . . . . . 0.715 HD22 ' O ' ' A' ' 954' ' ' LEU . 0.0 OUTLIER 167.5 83.83 0.02 OUTLIER Pre-proline 0 N--CA 1.512 2.66 0 O-C-N 120.998 -1.064 . . . . 0.050000000000000003 111.535 178.976 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 955' ' ' PRO . . . . . 0.65 ' C ' HD12 ' A' ' 956' ' ' LEU . 46.9 Cg_endo -74.02 98.14 1.06 Allowed 'Trans proline' 0 C--N 1.314 -1.285 0 N-CA-C 108.938 -1.216 . . . . 0.83999999999999997 108.938 177.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 956' ' ' LEU . . . . . 0.65 HD12 ' C ' ' A' ' 955' ' ' PRO . 10.0 mp -122.59 144.13 49.31 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.053 -1.029 . . . . 0.040000000000000001 110.276 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -83.61 150.7 25.74 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 117.719 -1.134 . . . . 1.28 111.456 -179.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -69.58 120.08 14.82 Favored 'General case' 0 N--CA 1.509 2.482 0 CA-C-N 122.99 2.632 . . . . 0.17000000000000001 111.373 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 93.34 -21.74 38.83 Favored Glycine 0 N--CA 1.5 2.959 0 N-CA-C 110.94 -0.864 . . . . 0.040000000000000001 110.94 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 960' ' ' ASP . . . . . 0.432 ' HB3' ' NE ' ' A' ' 914' ' ' ARG . 0.9 OUTLIER -51.88 171.3 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.476 -1.014 . . . . 0.040000000000000001 110.538 -179.481 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 961' ' ' THR . . . . . 0.539 HG21 HG13 ' A' ' 885' ' ' VAL . 43.7 m -134.81 134.93 41.37 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.953 -1.092 . . . . 1.78 111.641 -178.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 962' ' ' VAL . . . . . 0.917 HG22 ' HB3' ' A' ' 886' ' ' PHE . 33.0 m -100.48 145.34 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 C-N-CA 119.851 -0.739 . . . . 0.040000000000000001 110.628 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 5.3 t -138.36 146.52 42.39 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.935 -0.478 . . . . 0.71999999999999997 109.979 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 964' ' ' VAL . . . . . 0.684 HG13 HG22 ' A' ' 911' ' ' VAL . 60.3 t -94.14 136.63 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.102 -0.999 . . . . 1.05 110.416 -179.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -93.52 126.55 38.73 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 103.547 -2.76 . . . . 3.02 103.547 173.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 966' ' ' LEU . . . . . 0.564 HD12 ' OE2' ' A' ' 909' ' ' GLU . 0.5 OUTLIER -132.34 60.06 1.7 Allowed 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.251 -1.018 . . . . 1.46 108.251 177.466 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 967' ' ' VAL . . . . . 0.492 HG23 ' C ' ' A' ' 966' ' ' LEU . 95.9 t -158.2 96.65 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 N-CA-C 108.143 -1.058 . . . . 1.9399999999999999 108.143 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 90.4 mmm -143.26 59.53 1.4 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.716 -1.24 . . . . 0.0 108.272 178.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.33 119.81 1.96 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 106.994 -2.442 . . . . 2.1099999999999999 106.994 -178.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -82.2 -58.25 3.03 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 118.716 1.258 . . . . 5.8899999999999997 110.308 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 40.8 tp -59.12 90.53 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.493 -0.754 . . . . 4.3600000000000003 110.115 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -141.82 -154.33 0.51 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.588 -0.695 . . . . 1.8300000000000001 110.174 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -119.46 170.98 8.67 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.502 -0.749 . . . . 4.3499999999999996 110.338 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 10.7 t -101.47 130.22 47.67 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.535 -0.728 . . . . 1.27 109.962 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -156.3 158.73 37.96 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.481 -0.762 . . . . 5.0199999999999996 110.608 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.93 85.94 18.77 Favored Pre-proline 0 N--CA 1.5 2.048 0 O-C-N 121.611 -0.681 . . . . 2.4100000000000001 109.516 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -72.75 -171.83 0.83 Allowed 'Trans proline' 0 C--N 1.317 -1.109 0 O-C-N 123.31 1.163 . . . . 0.95999999999999996 111.389 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 978' ' ' LEU . . . . . 0.692 HD23 ' CD1' ' A' ' 856' ' ' LEU . 4.9 mp -127.89 154.32 45.64 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 107.608 -1.256 . . . . 0.62 107.608 178.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 979' ' ' THR . . . . . 0.456 HG23 ' C ' ' A' ' 978' ' ' LEU . 42.1 p -149.93 141.32 23.29 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.768 -1.208 . . . . 3.5699999999999998 111.181 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 980' ' ' ILE . . . . . 0.725 ' HB ' HG21 ' A' ' 899' ' ' VAL . 51.2 mm -107.06 128.06 62.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 109.006 -0.739 . . . . 1.3300000000000001 109.006 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 981' ' ' PHE . . . . . 0.431 ' HD1' ' HH ' ' A' ' 879' ' ' TYR . 5.7 t80 -121.73 98.22 5.86 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.417 -0.802 . . . . 0.050000000000000003 111.783 -178.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 982' ' ' SER . . . . . 0.401 ' HA ' ' CB ' ' A' ' 853' ' ' SER . 86.0 p -108.69 158.22 17.81 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.974 -0.75 . . . . 0.87 108.974 178.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . -171.82 108.58 0.28 Allowed Glycine 0 N--CA 1.498 2.78 0 N-CA-C 106.557 -2.617 . . . . 0.029999999999999999 106.557 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -109.4 148.21 31.49 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 114.337 1.236 . . . . 0.69999999999999996 114.337 -175.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 985' ' ' LEU . . . . . 1.077 HD13 HD22 ' A' ' 890' ' ' LEU . 44.7 tp -69.79 135.1 49.3 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 120.796 -1.19 . . . . 0.040000000000000001 110.115 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 986' ' ' LEU . . . . . 0.401 ' CD2' ' NH1' ' A' ' 893' ' ' ARG . 41.8 tp -105.96 -60.29 1.66 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.621 -0.674 . . . . 0.040000000000000001 109.914 179.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -143.88 146.26 32.89 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 107.627 -1.249 . . . . 0.040000000000000001 107.627 179.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.33 163.28 12.19 Favored Glycine 0 N--CA 1.495 2.628 0 N-CA-C 108.094 -2.002 . . . . 0.040000000000000001 108.094 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -76.0 112.52 20.8 Favored Pre-proline 0 N--CA 1.499 2.005 0 O-C-N 121.229 -1.159 . . . . 0.040000000000000001 109.402 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 990' ' ' PRO . . . . . 0.412 ' O ' ' HB2' ' A' ' 991' ' ' GLU . 49.7 Cg_endo -90.27 71.85 1.41 Allowed 'Trans proline' 0 C--N 1.319 -1.006 0 O-C-N 123.164 1.086 . . . . 0.45000000000000001 111.386 -178.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 991' ' ' GLU . . . . . 0.412 ' HB2' ' O ' ' A' ' 990' ' ' PRO . 67.0 mt-10 67.32 -73.69 0.08 Allowed 'General case' 0 N--CA 1.503 2.178 0 N-CA-C 108.483 -0.932 . . . . 1.97 108.483 -177.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 992' ' ' LEU . . . . . 0.402 HD12 ' HD2' ' A' ' 990' ' ' PRO . 10.6 mt 50.91 20.73 0.83 Allowed 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.583 -0.698 . . . . 2.3799999999999999 111.599 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -93.58 156.71 16.57 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.912 -1.117 . . . . 3.79 109.989 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -145.91 92.97 2.27 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.54 -0.725 . . . . 3.5099999999999998 110.312 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 995' ' ' ALA . . . . . . . . . . . . 2.517 . . . . . . . 0 N--CA 1.504 2.254 0 O-C-N 120.85 -1.157 . . . . 2.73 110.575 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo . . . . . 0 N--CA 1.488 1.188 0 N-CA-C 109.523 -0.991 . . . . 3.8300000000000001 109.523 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 847' ' ' VAL . . . . . 0.416 HG12 ' HB2' ' B' ' 849' ' ' GLN . 61.3 t -132.14 103.48 14.07 Favored Pre-proline 0 N--CA 1.494 1.775 0 O-C-N 121.621 -0.674 . . . . 1.8300000000000001 109.989 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 848' ' ' PRO . . . . . 0.708 ' O ' HG23 ' B' ' 850' ' ' VAL . 43.7 Cg_endo -69.45 -20.16 36.67 Favored 'Trans proline' 0 N--CA 1.487 1.133 0 O-C-N 123.245 1.129 . . . . 0.65000000000000002 111.064 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 849' ' ' GLN . . . . . 0.416 ' HB2' HG12 ' B' ' 847' ' ' VAL . 55.6 tt0 27.06 68.69 0.06 Allowed 'General case' 0 N--CA 1.518 2.96 0 N-CA-C 112.867 0.691 . . . . 2.5800000000000001 112.867 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 850' ' ' VAL . . . . . 0.708 HG23 ' O ' ' B' ' 848' ' ' PRO . 59.7 t -118.2 136.68 54.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.218 -0.926 . . . . 1.0900000000000001 111.382 -178.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 851' ' ' ALA . . . . . 0.512 ' HB3' ' HG ' ' B' ' 873' ' ' LEU . . . -126.09 156.11 40.53 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 105.774 -1.936 . . . . 0.040000000000000001 105.774 176.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 852' ' ' PHE . . . . . 0.472 ' CE2' HD11 ' B' ' 890' ' ' LEU . 23.8 p90 -159.73 129.1 5.26 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 121.022 1.737 . . . . 0.050000000000000003 108.631 179.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 30.0 t -175.24 134.72 0.33 Allowed 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.176 -1.046 . . . . 0.040000000000000001 108.176 -178.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -132.56 156.75 46.29 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.099 -1.001 . . . . 0.67000000000000004 109.576 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 855' ' ' ALA . . . . . 0.739 ' HB3' ' CB ' ' B' ' 870' ' ' ARG . . . -122.9 145.13 48.73 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.774 0.797 . . . . 0.51000000000000001 111.697 -178.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 856' ' ' LEU . . . . . 0.684 ' CD1' HD23 ' B' ' 978' ' ' LEU . 3.4 tm? -112.51 134.01 54.27 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.743 -0.598 . . . . 0.050000000000000003 110.105 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 857' ' ' SER . . . . . 0.526 ' N ' HD13 ' B' ' 856' ' ' LEU . 56.3 p -150.37 16.99 0.83 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.561 -0.712 . . . . 1.3300000000000001 110.513 178.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 858' ' ' LEU . . . . . 0.763 HD22 ' OE2' ' B' ' 862' ' ' GLU . 4.4 pp -33.31 158.26 0.04 OUTLIER Pre-proline 0 N--CA 1.517 2.924 0 N-CA-C 113.33 0.863 . . . . 2.3300000000000001 113.33 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -64.5 -88.43 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.421 0 O-C-N 123.207 1.109 . . . . 2.3199999999999998 113.103 -178.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 55.8 ptt85 -128.71 -143.45 0.27 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.87 -1.144 . . . . 0.040000000000000001 111.729 -177.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 19.3 m -40.23 127.53 2.27 Favored 'General case' 0 N--CA 1.509 2.491 0 O-C-N 121.455 -0.778 . . . . 1.3100000000000001 112.359 -178.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 862' ' ' GLU . . . . . 0.763 ' OE2' HD22 ' B' ' 858' ' ' LEU . 0.9 OUTLIER -102.09 156.77 34.82 Favored Pre-proline 0 N--CA 1.488 1.465 0 N-CA-C 107.86 -1.163 . . . . 4.5099999999999998 107.86 177.138 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 863' ' ' PRO . . . . . 0.414 ' HD2' ' CG ' ' B' ' 862' ' ' GLU . 43.7 Cg_endo -69.81 -13.06 34.03 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 O-C-N 123.082 1.043 . . . . 2.2400000000000002 111.419 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -175.61 -135.91 2.21 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.993 -1.243 . . . . 0.040000000000000001 109.993 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 28.0 m -66.71 157.68 32.08 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.253 -1.145 . . . . 1.51 110.925 -178.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 866' ' ' VAL . . . . . 0.688 HG22 ' OE1' ' B' ' 862' ' ' GLU . 48.5 t -93.78 134.53 26.17 Favored Pre-proline 0 N--CA 1.495 1.784 0 N-CA-C 113.302 0.853 . . . . 0.78000000000000003 113.302 -174.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 867' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' B' ' 866' ' ' VAL . 55.2 Cg_endo -90.38 -152.94 0.04 OUTLIER 'Trans proline' 0 CA--C 1.541 0.867 0 O-C-N 123.517 1.272 . . . . 0.92000000000000004 108.831 177.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 868' ' ' PHE . . . . . 0.45 ' CD1' ' N ' ' B' ' 868' ' ' PHE . 23.6 p90 -149.55 122.16 8.59 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 120.633 -1.292 . . . . 0.050000000000000003 109.956 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 49.2 p-10 -113.29 -1.94 14.15 Favored 'General case' 0 N--CA 1.498 1.971 0 C-N-CA 119.27 -0.972 . . . . 1.7 112.289 -179.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 870' ' ' ARG . . . . . 0.739 ' CB ' ' HB3' ' B' ' 855' ' ' ALA . 30.3 mmm180 -90.96 88.68 7.12 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.899 -1.126 . . . . 2.5899999999999999 110.784 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 58.5 t -74.56 97.32 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.005 -1.059 . . . . 1.9399999999999999 109.884 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 872' ' ' LEU . . . . . 0.446 HD11 ' HB2' ' B' ' 855' ' ' ALA . 94.7 mt -83.16 -46.99 12.07 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.488 -0.757 . . . . 1.0600000000000001 110.14 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 873' ' ' LEU . . . . . 0.512 ' HG ' ' HB3' ' B' ' 851' ' ' ALA . 46.5 tp -174.65 104.01 0.1 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.305 -0.872 . . . . 4.1799999999999997 108.703 178.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 874' ' ' ASN . . . . . 0.444 ' CB ' ' HA ' ' B' ' 852' ' ' PHE . 35.6 t-20 178.86 81.96 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.304 0 O-C-N 121.643 -0.66 . . . . 0.040000000000000001 109.76 -178.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -67.16 -47.31 71.4 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 119.268 -0.973 . . . . 3.3799999999999999 111.076 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 876' ' ' GLY . . . . . 0.404 ' HA3' ' CE2' ' B' ' 878' ' ' TYR . . . -73.87 -25.27 72.16 Favored Glycine 0 N--CA 1.494 2.562 0 O-C-N 121.336 -0.852 . . . . 0.040000000000000001 111.584 -178.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 83.01 -61.29 4.8 Favored Glycine 0 N--CA 1.501 3.003 0 N-CA-C 108.091 -2.003 . . . . 0.040000000000000001 108.091 -178.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 878' ' ' TYR . . . . . 0.404 ' CE2' ' HA3' ' B' ' 876' ' ' GLY . 88.4 m-85 60.47 -64.93 0.06 Allowed 'General case' 0 N--CA 1.504 2.248 0 N-CA-C 114.303 1.223 . . . . 3.46 114.303 177.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 879' ' ' TYR . . . . . 0.467 ' CB ' ' CD2' ' B' ' 886' ' ' PHE . 19.6 p90 -111.47 107.45 16.66 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 114.457 1.28 . . . . 0.040000000000000001 114.457 -176.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -66.21 117.17 40.6 Favored Pre-proline 0 N--CA 1.497 1.924 0 O-C-N 121.422 -0.798 . . . . 0.02 110.145 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 881' ' ' PRO . . . . . 0.42 ' HG2' ' CD1' ' B' ' 868' ' ' PHE . 55.5 Cg_endo -75.81 -0.12 9.85 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 O-C-N 123.57 1.3 . . . . 0.39000000000000001 112.15 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 88.4 mt-10 -77.45 -63.65 1.33 Allowed 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 106.801 -1.555 . . . . 0.81000000000000005 106.801 178.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 45.7 p -93.79 -18.82 21.64 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.678 -0.86 . . . . 0.040000000000000001 108.678 177.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.24 20.27 60.95 Favored Glycine 0 N--CA 1.497 2.711 0 O-C-N 121.11 -0.994 . . . . 0.029999999999999999 111.554 178.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 885' ' ' VAL . . . . . 0.524 HG13 HG21 ' B' ' 961' ' ' THR . 87.8 t -74.14 91.9 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 C-N-CA 118.14 -1.424 . . . . 1.01 108.097 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 886' ' ' PHE . . . . . 0.901 ' HB3' HG22 ' B' ' 962' ' ' VAL . 0.7 OUTLIER -90.32 105.82 18.07 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-N 115.182 -0.917 . . . . 0.050000000000000003 111.999 -177.259 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 887' ' ' THR . . . . . 0.423 ' O ' ' HD3' ' B' ' 889' ' ' PRO . 69.7 m -96.47 101.15 12.73 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 107.868 -1.16 . . . . 0.68000000000000005 107.868 177.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 888' ' ' ALA . . . . . . . . . . . . . . . -98.78 106.51 37.73 Favored Pre-proline 0 N--CA 1.502 2.146 0 N-CA-C 114.153 1.168 . . . . 0.25 114.153 -176.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 889' ' ' PRO . . . . . 0.423 ' HD3' ' O ' ' B' ' 887' ' ' THR . 55.3 Cg_endo -89.02 -13.07 3.16 Favored 'Trans proline' 0 CA--C 1.546 1.105 0 C-N-CA 121.01 1.14 . . . . 1.6399999999999999 109.183 176.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 890' ' ' LEU . . . . . 1.077 HD22 HD13 ' B' ' 985' ' ' LEU . 56.5 mt -34.04 -51.29 0.42 Allowed 'General case' 0 N--CA 1.51 2.535 0 N-CA-C 113.997 1.11 . . . . 2.29 113.997 -177.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 51.54 94.84 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.336 0 O-C-N 121.13 -0.981 . . . . 0.63 110.379 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . 156.13 -147.54 16.32 Favored Glycine 0 N--CA 1.48 1.577 0 N-CA-C 107.451 -2.26 . . . . 0.040000000000000001 107.451 -179.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 72.0 ttt-85 -108.86 127.72 54.28 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 107.609 -1.256 . . . . 3.0 107.609 177.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 894' ' ' TYR . . . . . 0.542 ' OH ' HD12 ' B' ' 896' ' ' LEU . 0.1 OUTLIER -130.22 144.67 51.5 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.048 -1.032 . . . . 0.040000000000000001 110.056 -179.064 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 895' ' ' LEU . . . . . 0.45 ' N ' ' CD1' ' B' ' 894' ' ' TYR . 39.7 tp -97.58 114.33 26.22 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.628 -0.67 . . . . 1.27 109.621 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 896' ' ' LEU . . . . . 0.542 HD12 ' OH ' ' B' ' 894' ' ' TYR . 9.6 tt -111.34 145.62 38.54 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.574 -0.704 . . . . 0.93999999999999995 110.884 -179.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 897' ' ' SER . . . . . . . . . . . . . 65.9 m -143.53 116.56 8.88 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.636 -0.665 . . . . 0.040000000000000001 110.467 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -106.23 146.68 30.01 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 109.297 -0.631 . . . . 0.47999999999999998 109.297 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 899' ' ' VAL . . . . . 0.731 HG21 ' HB ' ' B' ' 980' ' ' ILE . 87.7 t -97.35 118.76 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 C-N-CA 119.757 -0.777 . . . . 0.55000000000000004 111.403 -179.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 900' ' ' LEU . . . . . 0.446 HD13 ' HA ' ' B' ' 900' ' ' LEU . 4.5 mm? -94.81 111.9 23.66 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 114.283 1.216 . . . . 1.5900000000000001 114.283 -175.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 17.4 m -64.4 141.06 58.91 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 107.316 -1.365 . . . . 0.050000000000000003 107.316 177.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -63.58 -66.14 2.69 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 110.476 -1.05 . . . . 0.029999999999999999 110.476 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 2.1 m80 46.44 65.99 1.07 Allowed 'General case' 0 N--CA 1.507 2.383 0 O-C-N 121.447 -1.031 . . . . 3.2000000000000002 111.099 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 54.1 ptt85 -68.54 -6.75 27.11 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.64 -0.662 . . . . 2.9199999999999999 111.942 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 905' ' ' HIS . . . . . 0.482 ' O ' ' CB ' ' B' ' 906' ' ' GLU . 75.9 t60 -60.19 2.82 0.08 Allowed 'General case' 0 N--CA 1.506 2.33 0 O-C-N 120.914 -1.116 . . . . 2.8700000000000001 113.073 -179.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 906' ' ' GLU . . . . . 0.482 ' CB ' ' O ' ' B' ' 905' ' ' HIS . 0.8 OUTLIER 93.75 -163.76 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.387 0 CA-C-N 120.6 1.545 . . . . 0.98999999999999999 112.072 178.939 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 907' ' ' LYS . . . . . 0.472 ' CB ' ' O ' ' B' ' 906' ' ' GLU . 42.9 tttt 88.84 161.52 0.06 Allowed 'General case' 0 N--CA 1.519 2.979 0 N-CA-C 107.717 -1.216 . . . . 5.25 107.717 -176.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 61.7 t -121.7 115.65 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 120.901 -1.125 . . . . 0.39000000000000001 110.926 -179.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 909' ' ' GLU . . . . . 0.551 ' OE2' HD12 ' B' ' 966' ' ' LEU . 52.2 tp10 -100.75 132.64 46.05 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 107.222 -1.399 . . . . 1.72 107.222 176.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -156.99 120.95 4.27 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 106.703 -1.592 . . . . 0.67000000000000004 106.703 178.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 911' ' ' VAL . . . . . 0.681 HG22 HG13 ' B' ' 964' ' ' VAL . 93.9 t -83.48 132.1 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.835 -0.54 . . . . 0.54000000000000004 110.71 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 72.3 mt -64.58 155.44 33.14 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.326 -0.859 . . . . 1.5 108.694 178.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 913' ' ' SER . . . . . 0.413 ' CB ' ' HB ' ' B' ' 919' ' ' VAL . 1.6 t -123.47 136.69 54.72 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.122 -1.066 . . . . 1.3700000000000001 108.122 177.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 914' ' ' ARG . . . . . 0.56 ' NH1' HD23 ' B' ' 956' ' ' LEU . 0.0 OUTLIER -63.08 153.57 33.71 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 120.839 -1.163 . . . . 4.2999999999999998 111.981 -178.784 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 915' ' ' SER . . . . . 0.416 ' CB ' ' O ' ' B' ' 914' ' ' ARG . 2.2 t 83.02 -32.2 0.08 Allowed 'General case' 0 N--CA 1.521 3.095 0 C-N-CA 124.03 0.932 . . . . 2.0499999999999998 112.404 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 916' ' ' ASN . . . . . 0.789 ' HB2' HG21 ' B' ' 919' ' ' VAL . 98.1 m-20 -121.26 -20.85 6.57 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.867 -1.146 . . . . 2.71 111.607 -179.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 917' ' ' GLN . . . . . 0.415 ' HB2' ' O ' ' B' ' 916' ' ' ASN . 50.8 mt-30 66.75 165.51 0.21 Allowed 'General case' 0 N--CA 1.521 3.103 0 N-CA-C 105.661 -1.977 . . . . 2.6800000000000002 105.661 -173.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.8 -125.23 34.58 Favored Glycine 1 N--CA 1.521 4.304 0 CA-C-N 123.532 2.878 . . . . 0.029999999999999999 106.958 -177.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 919' ' ' VAL . . . . . 0.789 HG21 ' HB2' ' B' ' 916' ' ' ASN . 79.9 t 51.5 95.08 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 O-C-N 121.456 -1.026 . . . . 1.3899999999999999 108.959 -178.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 920' ' ' ALA . . . . . 0.851 ' HB3' HG12 ' B' ' 949' ' ' VAL . . . -91.26 91.75 8.33 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.207 -0.997 . . . . 0.029999999999999999 110.904 -179.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 921' ' ' ARG . . . . . 0.712 ' HG3' HG23 ' B' ' 922' ' ' VAL . 42.4 ptt85 -84.17 -41.9 16.54 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 105.58 -2.007 . . . . 4.4199999999999999 105.58 175.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 922' ' ' VAL . . . . . 0.712 HG23 ' HG3' ' B' ' 921' ' ' ARG . 71.0 t -103.26 68.96 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 N-CA-C 105.53 -2.026 . . . . 0.84999999999999998 105.53 175.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 923' ' ' ASP . . . . . 0.64 ' HB2' ' HB1' ' B' ' 920' ' ' ALA . 19.4 t0 -90.7 136.04 33.32 Favored 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 121.779 0.8 . . . . 2.46 112.147 -176.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 924' ' ' SER . . . . . . . . . . . . . 14.1 t -147.62 104.04 3.58 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.184 -1.043 . . . . 0.69999999999999996 108.184 178.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -110.63 90.24 0.57 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 108.979 -1.649 . . . . 0.040000000000000001 108.979 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.425 0 N-CA-C 109.386 -1.486 . . . . 0.040000000000000001 109.386 -179.709 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 32.3 m . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.031 0.444 . . . . 13.779999999999999 110.254 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 97.6 mt -112.81 129.64 56.37 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.509 -0.744 . . . . 13.76 110.434 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -151.82 167.89 31.1 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.127 -1.589 . . . . 9.1300000000000008 109.127 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 949' ' ' VAL . . . . . 0.851 HG12 ' HB3' ' B' ' 920' ' ' ALA . 35.3 m -118.62 130.12 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.499 -1.001 . . . . 7.0800000000000001 110.852 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 950' ' ' PHE . . . . . 0.455 ' CZ ' ' HB3' ' B' ' 921' ' ' ARG . 32.6 p90 -133.19 149.44 52.03 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.584 -0.697 . . . . 7.5899999999999999 109.248 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 19.4 m -119.5 -53.7 2.21 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.406 -0.809 . . . . 5.0300000000000002 112.022 -178.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 952' ' ' LEU . . . . . 0.429 ' O ' ' O ' ' B' ' 953' ' ' ILE . 56.5 tp -60.32 -75.67 0.06 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.442 -0.786 . . . . 1.01 111.966 -177.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 953' ' ' ILE . . . . . 0.508 ' O ' ' HB3' ' B' ' 954' ' ' LEU . 49.2 pt -53.02 -144.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.637 0 N-CA-C 113.749 1.018 . . . . 2.6000000000000001 113.749 -176.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 954' ' ' LEU . . . . . 0.711 HD22 ' O ' ' B' ' 954' ' ' LEU . 0.0 OUTLIER 167.48 83.58 0.02 OUTLIER Pre-proline 0 N--CA 1.512 2.67 0 O-C-N 120.977 -1.077 . . . . 0.050000000000000003 111.429 178.915 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 955' ' ' PRO . . . . . 0.654 ' C ' HD12 ' B' ' 956' ' ' LEU . 46.2 Cg_endo -74.07 98.4 1.08 Allowed 'Trans proline' 0 C--N 1.313 -1.315 0 N-CA-C 108.863 -1.245 . . . . 0.83999999999999997 108.863 177.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 956' ' ' LEU . . . . . 0.654 HD12 ' C ' ' B' ' 955' ' ' PRO . 10.0 mp -122.85 144.02 49.48 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.056 -1.027 . . . . 0.040000000000000001 110.22 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -83.43 151.1 25.65 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 117.829 -1.082 . . . . 1.28 111.39 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -69.75 119.91 14.7 Favored 'General case' 0 N--CA 1.509 2.479 0 CA-C-N 122.857 2.571 . . . . 0.17000000000000001 111.368 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 93.35 -21.91 37.92 Favored Glycine 0 N--CA 1.501 2.989 0 N-CA-C 110.949 -0.86 . . . . 0.040000000000000001 110.949 178.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 960' ' ' ASP . . . . . 0.433 ' HB3' ' NE ' ' B' ' 914' ' ' ARG . 0.9 OUTLIER -51.65 171.23 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.46 -1.023 . . . . 0.040000000000000001 110.514 -179.411 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 961' ' ' THR . . . . . 0.524 HG21 HG13 ' B' ' 885' ' ' VAL . 42.0 m -134.67 135.08 41.8 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.025 -1.047 . . . . 1.78 111.655 -178.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 962' ' ' VAL . . . . . 0.901 HG22 ' HB3' ' B' ' 886' ' ' PHE . 33.0 m -100.66 145.22 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 C-N-CA 119.938 -0.705 . . . . 0.040000000000000001 110.661 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 5.2 t -138.27 146.22 42.23 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.943 -0.473 . . . . 0.71999999999999997 110.042 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 964' ' ' VAL . . . . . 0.681 HG13 HG22 ' B' ' 911' ' ' VAL . 59.9 t -94.01 136.27 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.04 -1.037 . . . . 1.05 110.433 -179.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -93.29 126.32 38.34 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 103.571 -2.752 . . . . 3.02 103.571 173.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 966' ' ' LEU . . . . . 0.551 HD12 ' OE2' ' B' ' 909' ' ' GLU . 0.5 OUTLIER -132.08 59.98 1.69 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.324 -0.991 . . . . 1.46 108.324 177.512 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 967' ' ' VAL . . . . . 0.491 HG23 ' C ' ' B' ' 966' ' ' LEU . 95.7 t -158.23 96.32 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 108.222 -1.029 . . . . 1.9399999999999999 108.222 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 90.5 mmm -142.85 59.54 1.43 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.8 -1.187 . . . . 0.0 108.312 178.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.23 119.67 1.95 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 107.06 -2.416 . . . . 2.1099999999999999 107.06 -178.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -81.92 -58.24 3.07 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.106 -1.232 . . . . 5.8899999999999997 110.353 -179.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 40.9 tp -59.14 90.22 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.423 -0.798 . . . . 4.3600000000000003 110.103 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -141.56 -154.05 0.5 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.574 -0.704 . . . . 1.8300000000000001 110.156 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -119.64 171.2 8.54 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.509 -0.745 . . . . 4.3499999999999996 110.336 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 10.7 t -101.61 130.2 47.88 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.53 -0.731 . . . . 1.27 109.942 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -156.26 158.79 38.12 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.443 -0.786 . . . . 5.0199999999999996 110.598 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.01 85.94 18.55 Favored Pre-proline 0 N--CA 1.5 2.031 0 O-C-N 121.647 -0.658 . . . . 2.4100000000000001 109.541 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -72.76 -171.88 0.84 Allowed 'Trans proline' 0 C--N 1.317 -1.087 0 O-C-N 123.342 1.18 . . . . 0.95999999999999996 111.408 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 978' ' ' LEU . . . . . 0.684 HD23 ' CD1' ' B' ' 856' ' ' LEU . 4.9 mp -127.74 154.56 45.21 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 107.649 -1.241 . . . . 0.62 107.649 178.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 979' ' ' THR . . . . . 0.464 HG23 ' C ' ' B' ' 978' ' ' LEU . 41.8 p -150.17 141.34 23.11 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.808 -1.183 . . . . 3.5699999999999998 111.17 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 980' ' ' ILE . . . . . 0.731 ' HB ' HG21 ' B' ' 899' ' ' VAL . 51.3 mm -107.09 127.74 62.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 108.985 -0.746 . . . . 1.3300000000000001 108.985 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -121.56 98.57 6.03 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.395 -0.816 . . . . 0.050000000000000003 111.817 -178.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 98.8 p -109.34 158.73 17.6 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.467 -0.771 . . . . 0.87 109.013 178.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 983' ' ' GLY . . . . . . . . . . . . . . . -171.86 108.84 0.29 Allowed Glycine 0 N--CA 1.497 2.716 0 N-CA-C 106.609 -2.596 . . . . 0.029999999999999999 106.609 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -109.34 147.88 31.99 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 114.177 1.177 . . . . 0.69999999999999996 114.177 -175.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 985' ' ' LEU . . . . . 1.077 HD13 HD22 ' B' ' 890' ' ' LEU . 44.2 tp -69.67 135.22 49.6 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.851 -1.155 . . . . 0.040000000000000001 110.057 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 986' ' ' LEU . . . . . 0.568 HD11 HD11 ' C' ' 986' ' ' LEU . 42.2 tp -106.12 -60.45 1.64 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.635 -0.665 . . . . 0.040000000000000001 109.895 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -143.83 146.05 32.78 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.581 -1.266 . . . . 0.040000000000000001 107.581 179.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.27 162.91 12.25 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 108.091 -2.003 . . . . 0.040000000000000001 108.091 179.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -75.55 112.5 19.59 Favored Pre-proline 0 N--CA 1.499 1.991 0 CA-C-N 118.503 1.152 . . . . 0.040000000000000001 109.414 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 990' ' ' PRO . . . . . 0.417 ' O ' ' HB2' ' B' ' 991' ' ' GLU . 49.8 Cg_endo -90.16 71.68 1.49 Allowed 'Trans proline' 0 C--N 1.319 -1.006 0 O-C-N 123.151 1.079 . . . . 0.45000000000000001 111.399 -178.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 991' ' ' GLU . . . . . 0.417 ' HB2' ' O ' ' B' ' 990' ' ' PRO . 66.9 mt-10 67.39 -73.65 0.08 Allowed 'General case' 0 N--CA 1.503 2.203 0 N-CA-C 108.516 -0.92 . . . . 1.97 108.516 -177.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 992' ' ' LEU . . . . . 0.461 ' HA ' HD23 ' B' ' 992' ' ' LEU . 10.8 mt 51.03 20.45 0.82 Allowed 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.639 -0.663 . . . . 2.3799999999999999 111.738 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -93.22 156.79 16.62 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.897 -1.127 . . . . 3.79 109.987 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 67.3 m80 -146.05 92.32 2.18 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.538 -0.726 . . . . 3.5099999999999998 110.386 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 995' ' ' ALA . . . . . . . . . . . . 2.516 . . . . . . . 0 N--CA 1.503 2.204 0 O-C-N 120.946 -1.096 . . . . 2.73 110.625 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo . . . . . 0 N--CA 1.487 1.147 0 N-CA-C 109.469 -1.012 . . . . 3.8300000000000001 109.469 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 847' ' ' VAL . . . . . . . . . . . . . 59.1 t -131.62 102.8 15.0 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.621 -0.675 . . . . 1.8300000000000001 110.311 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 848' ' ' PRO . . . . . 0.686 ' O ' HG23 ' C' ' 850' ' ' VAL . 44.7 Cg_endo -70.49 -21.37 30.17 Favored 'Trans proline' 0 N--CA 1.487 1.1 0 O-C-N 123.331 1.174 . . . . 0.65000000000000002 111.186 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 849' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 27.94 69.25 0.07 Allowed 'General case' 0 N--CA 1.519 2.999 0 N-CA-C 112.703 0.631 . . . . 2.5800000000000001 112.703 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 850' ' ' VAL . . . . . 0.686 HG23 ' O ' ' C' ' 848' ' ' PRO . 49.5 t -119.62 135.0 61.39 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.152 -0.968 . . . . 1.0900000000000001 111.764 -178.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 851' ' ' ALA . . . . . 0.59 ' HB3' ' HG ' ' C' ' 873' ' ' LEU . . . -127.17 154.88 44.23 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 105.517 -2.031 . . . . 0.040000000000000001 105.517 176.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 852' ' ' PHE . . . . . 0.449 ' CD1' ' N ' ' C' ' 852' ' ' PHE . 16.8 p90 -160.51 126.68 4.08 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 121.107 1.776 . . . . 0.050000000000000003 108.633 178.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 7.8 t -176.31 134.36 0.24 Allowed 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.012 -1.107 . . . . 0.040000000000000001 108.012 -179.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 854' ' ' ALA . . . . . 0.463 ' HB1' ' HD2' ' C' ' 868' ' ' PHE . . . -130.57 156.37 44.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.141 -0.974 . . . . 0.67000000000000004 109.505 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 855' ' ' ALA . . . . . 0.755 ' HB3' ' CB ' ' C' ' 870' ' ' ARG . . . -122.09 142.87 49.93 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 121.881 0.848 . . . . 0.51000000000000001 111.266 -179.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 856' ' ' LEU . . . . . 0.786 HD12 ' HG ' ' C' ' 978' ' ' LEU . 3.3 tm? -111.85 136.46 51.1 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.626 -0.672 . . . . 0.050000000000000003 109.923 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 857' ' ' SER . . . . . 0.629 ' N ' HD13 ' C' ' 856' ' ' LEU . 1.1 m -153.54 15.67 0.51 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.462 -0.774 . . . . 1.3300000000000001 111.661 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 858' ' ' LEU . . . . . 0.711 ' CD2' HD11 ' C' ' 856' ' ' LEU . 4.0 pp -34.91 160.8 0.04 OUTLIER Pre-proline 0 N--CA 1.518 2.944 0 N-CA-C 113.172 0.804 . . . . 2.3300000000000001 113.172 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -62.13 -87.12 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 120.992 1.128 . . . . 2.3199999999999998 113.779 -177.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 54.0 ptt85 -129.74 -142.79 0.25 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 120.883 -1.135 . . . . 0.040000000000000001 111.77 -177.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 67.4 m -38.82 130.83 1.41 Allowed 'General case' 0 N--CA 1.51 2.572 0 O-C-N 121.598 -0.689 . . . . 1.3100000000000001 112.17 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.47 158.55 31.59 Favored Pre-proline 0 N--CA 1.487 1.416 0 N-CA-C 108.633 -0.877 . . . . 4.5099999999999998 108.633 177.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -71.47 -14.52 30.81 Favored 'Trans proline' 0 C--N 1.313 -1.314 0 O-C-N 123.185 1.097 . . . . 2.2400000000000002 111.693 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -177.95 -134.28 2.03 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.681 -1.367 . . . . 0.040000000000000001 109.681 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 7.1 m -67.84 151.18 47.6 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.251 -1.146 . . . . 1.51 110.477 -179.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 866' ' ' VAL . . . . . 0.444 HG13 ' CD2' ' C' ' 858' ' ' LEU . 53.7 t -94.87 134.28 25.17 Favored Pre-proline 0 N--CA 1.497 1.888 0 N-CA-C 113.401 0.889 . . . . 0.78000000000000003 113.401 -174.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 867' ' ' PRO . . . . . 0.524 ' O ' HD23 ' C' ' 856' ' ' LEU . 55.2 Cg_endo -89.07 -150.14 0.04 OUTLIER 'Trans proline' 0 CA--C 1.543 0.936 0 O-C-N 123.526 1.277 . . . . 0.92000000000000004 109.345 178.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 868' ' ' PHE . . . . . 0.463 ' HD2' ' HB1' ' C' ' 854' ' ' ALA . 14.9 p90 -148.9 123.76 9.95 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.68 -1.262 . . . . 0.050000000000000003 109.653 179.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 49.5 p-10 -112.61 -3.1 14.39 Favored 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 119.273 -0.971 . . . . 1.7 112.492 -178.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 870' ' ' ARG . . . . . 0.755 ' CB ' ' HB3' ' C' ' 855' ' ' ALA . 26.7 mmm180 -91.68 87.65 6.4 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.925 -1.109 . . . . 2.5899999999999999 111.03 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 57.9 t -73.68 97.56 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 120.919 -1.113 . . . . 1.9399999999999999 109.269 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 872' ' ' LEU . . . . . 0.936 HD13 HD11 ' A' ' 953' ' ' ILE . 96.3 mt -87.17 -45.04 11.04 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.564 -0.71 . . . . 1.0600000000000001 110.736 -179.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 873' ' ' LEU . . . . . 0.59 ' HG ' ' HB3' ' C' ' 851' ' ' ALA . 31.1 tp -171.99 102.3 0.17 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.144 -0.972 . . . . 4.1799999999999997 108.975 178.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 874' ' ' ASN . . . . . 0.439 ' CB ' ' HA ' ' C' ' 852' ' ' PHE . 35.0 t-20 176.97 82.72 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.265 0 N-CA-C 108.782 -0.821 . . . . 0.040000000000000001 108.782 -179.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -65.47 -47.02 77.54 Favored 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 119.282 -0.967 . . . . 3.3799999999999999 111.359 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 876' ' ' GLY . . . . . 0.416 ' HA3' ' CE2' ' C' ' 878' ' ' TYR . . . -72.11 -26.92 71.22 Favored Glycine 0 N--CA 1.492 2.429 0 C-N-CA 120.361 -0.924 . . . . 0.040000000000000001 111.447 -178.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 81.34 -61.93 4.54 Favored Glycine 0 N--CA 1.5 2.905 0 N-CA-C 108.016 -2.034 . . . . 0.040000000000000001 108.016 -178.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 878' ' ' TYR . . . . . 0.416 ' CE2' ' HA3' ' C' ' 876' ' ' GLY . 96.3 m-85 60.39 -66.3 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 114.366 1.247 . . . . 3.46 114.366 177.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 879' ' ' TYR . . . . . 0.47 ' CB ' ' CD2' ' C' ' 886' ' ' PHE . 25.0 p90 -110.55 107.52 17.17 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 115.092 1.516 . . . . 0.040000000000000001 115.092 -175.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -71.82 120.76 81.92 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.437 -0.789 . . . . 0.02 109.939 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 881' ' ' PRO . . . . . 0.443 ' HG2' ' CD1' ' C' ' 868' ' ' PHE . 52.3 Cg_endo -78.25 0.24 10.08 Favored 'Trans proline' 0 N--CA 1.49 1.28 0 O-C-N 123.434 1.228 . . . . 0.39000000000000001 111.786 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -74.92 -63.62 1.22 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 106.083 -1.821 . . . . 0.81000000000000005 106.083 178.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 70.3 p -90.54 -21.73 21.65 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 108.513 -0.921 . . . . 0.040000000000000001 108.513 177.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 82.28 18.45 66.77 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 110.59 -1.004 . . . . 0.029999999999999999 110.59 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 885' ' ' VAL . . . . . 0.414 HG13 HG21 ' C' ' 961' ' ' THR . 96.6 t -75.54 92.2 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 C-N-CA 118.41 -1.316 . . . . 1.01 108.655 -179.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 886' ' ' PHE . . . . . 0.908 ' HB3' HG22 ' C' ' 962' ' ' VAL . 0.8 OUTLIER -87.81 104.34 16.49 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 115.065 -0.97 . . . . 0.050000000000000003 111.541 -177.761 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 887' ' ' THR . . . . . 0.441 ' O ' ' HD3' ' C' ' 889' ' ' PRO . 96.8 m -98.97 99.42 10.46 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 107.38 -1.341 . . . . 0.68000000000000005 107.38 177.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 888' ' ' ALA . . . . . . . . . . . . . . . -97.4 106.64 33.77 Favored Pre-proline 0 N--CA 1.501 2.109 0 N-CA-C 114.413 1.264 . . . . 0.25 114.413 -176.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 889' ' ' PRO . . . . . 0.441 ' HD3' ' O ' ' C' ' 887' ' ' THR . 53.5 Cg_endo -88.06 -15.38 3.11 Favored 'Trans proline' 0 CA--C 1.546 1.078 0 N-CA-C 108.662 -1.322 . . . . 1.6399999999999999 108.662 175.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 890' ' ' LEU . . . . . 0.633 HD22 HD13 ' C' ' 985' ' ' LEU . 46.0 mt -38.33 -49.17 1.39 Allowed 'General case' 0 N--CA 1.506 2.346 0 N-CA-C 113.347 0.869 . . . . 2.29 113.347 -177.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 52.69 97.35 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.241 -0.912 . . . . 0.63 110.316 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . 159.41 -155.52 26.61 Favored Glycine 0 N--CA 1.477 1.425 0 N-CA-C 107.151 -2.38 . . . . 0.040000000000000001 107.151 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 73.4 ttt-85 -117.99 123.98 47.05 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.618 -0.93 . . . . 3.0 109.049 177.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 894' ' ' TYR . . . . . 0.871 ' CE1' HD23 ' C' ' 954' ' ' LEU . 49.5 p90 -134.08 156.69 47.81 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.057 -1.027 . . . . 0.040000000000000001 110.922 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 895' ' ' LEU . . . . . . . . . . . . . 40.3 tp -96.47 118.22 32.53 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.691 -0.631 . . . . 1.27 110.379 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 896' ' ' LEU . . . . . 0.576 HD23 ' N ' ' C' ' 897' ' ' SER . 9.5 tt -116.1 145.17 43.25 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.645 -0.66 . . . . 0.93999999999999995 109.92 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 897' ' ' SER . . . . . 0.576 ' N ' HD23 ' C' ' 896' ' ' LEU . 47.4 m -140.0 124.2 17.79 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.431 -0.793 . . . . 0.040000000000000001 111.285 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -105.49 146.8 29.07 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.903 -0.777 . . . . 0.47999999999999998 108.903 178.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 899' ' ' VAL . . . . . 0.73 HG21 ' HB ' ' C' ' 980' ' ' ILE . 93.7 t -90.83 122.24 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 C-N-CA 119.727 -0.789 . . . . 0.55000000000000004 111.255 -178.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 900' ' ' LEU . . . . . 0.405 HD22 ' HB2' ' C' ' 924' ' ' SER . 93.8 mt -92.06 111.12 22.55 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 114.375 1.25 . . . . 1.5900000000000001 114.375 -175.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 20.3 m -67.29 140.35 57.31 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 106.98 -1.489 . . . . 0.050000000000000003 106.98 176.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -64.37 -64.73 3.41 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 110.497 -1.041 . . . . 0.029999999999999999 110.497 -179.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 45.1 62.6 2.06 Favored 'General case' 0 N--CA 1.508 2.447 0 O-C-N 121.508 -0.995 . . . . 3.2000000000000002 111.346 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -68.22 -7.5 30.92 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.588 -0.695 . . . . 2.9199999999999999 111.899 -179.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 905' ' ' HIS . . . . . 0.494 ' O ' ' CB ' ' C' ' 906' ' ' GLU . 74.5 t60 -63.34 7.86 0.09 Allowed 'General case' 0 N--CA 1.505 2.323 0 CA-C-O 117.604 -1.188 . . . . 2.8700000000000001 113.567 -179.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 906' ' ' GLU . . . . . 0.494 ' CB ' ' O ' ' C' ' 905' ' ' HIS . 0.8 OUTLIER 94.12 -164.29 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.474 0 CA-C-N 121.292 1.86 . . . . 0.98999999999999999 111.727 179.202 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 907' ' ' LYS . . . . . 0.477 ' CB ' ' O ' ' C' ' 906' ' ' GLU . 34.8 tttp 86.92 156.14 0.07 Allowed 'General case' 0 N--CA 1.519 3.002 0 N-CA-C 108.014 -1.106 . . . . 5.25 108.014 -176.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 60.1 t -122.58 116.11 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 120.835 -1.165 . . . . 0.39000000000000001 110.991 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -104.69 131.47 52.08 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 107.503 -1.295 . . . . 1.72 107.503 177.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -154.73 122.34 5.75 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 106.675 -1.602 . . . . 0.67000000000000004 106.675 178.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 911' ' ' VAL . . . . . 0.736 HG22 HG13 ' C' ' 964' ' ' VAL . 87.6 t -81.7 131.86 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.871 -0.518 . . . . 0.54000000000000004 110.975 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 52.8 mt -66.83 156.85 34.5 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.354 -0.841 . . . . 1.5 109.091 178.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 913' ' ' SER . . . . . 0.454 ' OG ' HG11 ' C' ' 919' ' ' VAL . 1.7 p -124.0 138.24 54.48 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.242 -1.021 . . . . 1.3700000000000001 108.242 177.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 914' ' ' ARG . . . . . 0.872 ' NH1' HD23 ' C' ' 956' ' ' LEU . 0.0 OUTLIER -64.79 153.2 40.66 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 120.624 -1.298 . . . . 4.2999999999999998 111.401 -179.112 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 915' ' ' SER . . . . . 0.426 ' CB ' ' O ' ' C' ' 914' ' ' ARG . 1.4 t 83.59 -30.55 0.08 Allowed 'General case' 0 N--CA 1.522 3.144 0 C-N-CA 123.853 0.861 . . . . 2.0499999999999998 112.199 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 916' ' ' ASN . . . . . 0.717 ' HB2' HG21 ' C' ' 919' ' ' VAL . 99.2 m-20 -122.18 -21.8 5.79 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 120.834 -1.166 . . . . 2.71 111.422 -179.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 67.04 167.22 0.23 Allowed 'General case' 0 N--CA 1.52 3.045 0 N-CA-C 105.845 -1.909 . . . . 2.6800000000000002 105.845 -174.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 53.83 -126.37 35.23 Favored Glycine 1 N--CA 1.523 4.437 0 CA-C-N 123.481 2.855 . . . . 0.029999999999999999 107.132 -177.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 919' ' ' VAL . . . . . 0.717 HG21 ' HB2' ' C' ' 916' ' ' ASN . 95.4 t 50.94 95.26 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 O-C-N 121.467 -1.019 . . . . 1.3899999999999999 109.425 -178.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 920' ' ' ALA . . . . . 0.956 ' HB3' HG12 ' C' ' 949' ' ' VAL . . . -93.05 93.03 8.1 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.27 -0.972 . . . . 0.029999999999999999 110.486 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 921' ' ' ARG . . . . . 0.846 ' HG3' HG23 ' C' ' 922' ' ' VAL . 44.5 ptt85 -83.19 -41.7 18.13 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 105.956 -1.868 . . . . 4.4199999999999999 105.956 176.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 922' ' ' VAL . . . . . 0.846 HG23 ' HG3' ' C' ' 921' ' ' ARG . 84.8 t -98.84 77.54 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 105.712 -1.959 . . . . 0.84999999999999998 105.712 175.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -87.95 133.47 33.93 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.834 0.826 . . . . 2.46 111.755 -177.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 924' ' ' SER . . . . . 0.405 ' HB2' HD22 ' C' ' 900' ' ' LEU . 5.6 t -147.23 104.92 3.7 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.383 -0.969 . . . . 0.69999999999999996 108.383 178.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -103.14 89.72 0.72 Allowed Glycine 0 N--CA 1.486 1.978 0 N-CA-C 108.434 -1.866 . . . . 0.040000000000000001 108.434 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.219 0 N-CA-C 108.972 -1.651 . . . . 0.040000000000000001 108.972 -179.657 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 17.5 m . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 120.936 0.398 . . . . 13.779999999999999 110.348 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 92.3 mt -114.32 129.96 56.65 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.479 -0.763 . . . . 13.76 110.238 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -152.41 170.82 31.65 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.495 -1.442 . . . . 9.1300000000000008 109.495 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 949' ' ' VAL . . . . . 0.956 HG12 ' HB3' ' C' ' 920' ' ' ALA . 35.7 m -117.28 135.1 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.644 -0.915 . . . . 7.0800000000000001 110.947 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 950' ' ' PHE . . . . . 0.46 ' CZ ' ' HB3' ' C' ' 921' ' ' ARG . 42.6 p90 -133.61 150.62 51.6 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.603 -0.686 . . . . 7.5899999999999999 109.323 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 67.7 m -118.43 -55.77 2.19 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.385 -0.822 . . . . 5.0300000000000002 111.936 -178.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 952' ' ' LEU . . . . . 0.467 ' O ' ' O ' ' C' ' 953' ' ' ILE . 44.9 tp -64.83 -76.34 0.07 Allowed 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.39 -0.819 . . . . 1.01 111.512 -178.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 953' ' ' ILE . . . . . 0.593 HD12 ' HD3' ' C' ' 955' ' ' PRO . 2.1 pp -48.31 -151.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.78 0 N-CA-C 114.687 1.366 . . . . 2.6000000000000001 114.687 -176.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 954' ' ' LEU . . . . . 0.871 HD23 ' CE1' ' C' ' 894' ' ' TYR . 0.0 OUTLIER 173.57 90.43 0.06 OUTLIER Pre-proline 0 N--CA 1.516 2.864 0 O-C-N 120.567 -1.333 . . . . 0.050000000000000003 112.42 -179.385 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 955' ' ' PRO . . . . . 0.788 ' C ' HD12 ' C' ' 956' ' ' LEU . 53.8 Cg_endo -82.93 89.68 1.1 Allowed 'Trans proline' 0 C--N 1.316 -1.14 0 N-CA-C 109.182 -1.122 . . . . 0.83999999999999997 109.182 178.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 956' ' ' LEU . . . . . 0.872 HD23 ' NH1' ' C' ' 914' ' ' ARG . 9.9 mp -124.42 146.76 48.71 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.984 -1.073 . . . . 0.040000000000000001 110.406 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -83.44 152.08 25.16 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 117.691 -1.147 . . . . 1.28 111.569 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -66.97 118.5 10.52 Favored 'General case' 0 N--CA 1.507 2.41 0 CA-C-N 122.985 2.63 . . . . 0.17000000000000001 110.896 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.43 -19.82 47.98 Favored Glycine 0 N--CA 1.5 2.923 0 N-CA-C 111.032 -0.827 . . . . 0.040000000000000001 111.032 178.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 960' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.69 170.62 0.16 Allowed 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.283 -1.128 . . . . 0.040000000000000001 110.073 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 961' ' ' THR . . . . . 0.476 ' HA ' ' O ' ' C' ' 886' ' ' PHE . 31.2 m -136.67 140.1 42.48 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.877 -1.14 . . . . 1.78 112.836 -177.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 962' ' ' VAL . . . . . 0.908 HG22 ' HB3' ' C' ' 886' ' ' PHE . 33.1 m -98.96 145.84 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.681 -0.637 . . . . 0.040000000000000001 110.934 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 4.8 t -138.63 144.33 39.66 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.811 -0.556 . . . . 0.71999999999999997 109.996 -179.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 964' ' ' VAL . . . . . 0.736 HG13 HG22 ' C' ' 911' ' ' VAL . 59.7 t -94.95 135.81 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.024 -1.047 . . . . 1.05 110.77 -179.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -96.51 126.48 41.73 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 103.705 -2.702 . . . . 3.02 103.705 173.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 966' ' ' LEU . . . . . 0.493 ' C ' HG23 ' C' ' 967' ' ' VAL . 2.8 tt -132.21 63.32 1.62 Allowed 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.256 -1.016 . . . . 1.46 108.256 177.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 967' ' ' VAL . . . . . 0.493 HG23 ' C ' ' C' ' 966' ' ' LEU . 96.8 t -157.53 96.92 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.21 -1.033 . . . . 1.9399999999999999 108.21 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 93.2 mmm -142.37 59.45 1.45 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.742 -1.224 . . . . 0.0 108.316 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 134.73 119.47 1.95 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 107.173 -2.371 . . . . 2.1099999999999999 107.173 -178.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -82.4 -57.7 3.25 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.02 -1.283 . . . . 5.8899999999999997 110.607 -179.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 40.4 tp -58.66 90.12 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.471 -0.768 . . . . 4.3600000000000003 110.312 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -142.29 -153.18 0.45 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.578 -0.701 . . . . 1.8300000000000001 110.122 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 17.5 m80 -118.8 168.68 10.52 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.399 -0.813 . . . . 4.3499999999999996 110.075 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 28.9 t -101.42 130.94 47.73 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.534 -0.728 . . . . 1.27 109.918 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -156.31 157.91 36.54 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.452 -0.78 . . . . 5.0199999999999996 110.717 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.62 86.01 23.68 Favored Pre-proline 0 N--CA 1.5 2.071 0 O-C-N 121.667 -0.646 . . . . 2.4100000000000001 109.277 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.91 -170.15 0.66 Allowed 'Trans proline' 0 C--N 1.318 -1.046 0 O-C-N 123.416 1.219 . . . . 0.95999999999999996 111.49 -179.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 978' ' ' LEU . . . . . 0.786 ' HG ' HD12 ' C' ' 856' ' ' LEU . 6.2 tt -126.43 152.12 46.81 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 107.889 -1.152 . . . . 0.62 107.889 178.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 979' ' ' THR . . . . . 0.464 HG23 ' C ' ' C' ' 978' ' ' LEU . 47.6 p -150.87 139.42 20.57 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.73 -1.231 . . . . 3.5699999999999998 111.084 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 980' ' ' ILE . . . . . 0.73 ' HB ' HG21 ' C' ' 899' ' ' VAL . 51.2 mm -106.39 129.48 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 109.213 -0.662 . . . . 1.3300000000000001 109.213 179.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 981' ' ' PHE . . . . . 0.451 ' CD1' ' CE2' ' C' ' 879' ' ' TYR . 4.7 t80 -118.35 95.25 4.79 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 119.703 -0.799 . . . . 0.050000000000000003 111.635 -178.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 982' ' ' SER . . . . . 0.505 ' HB2' HD23 ' A' ' 952' ' ' LEU . 23.1 p -107.85 158.88 16.96 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 109.164 -0.68 . . . . 0.87 109.164 178.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 983' ' ' GLY . . . . . 0.413 ' O ' ' CZ ' ' C' ' 852' ' ' PHE . . . -170.85 115.23 0.57 Allowed Glycine 0 N--CA 1.497 2.745 0 N-CA-C 106.701 -2.56 . . . . 0.029999999999999999 106.701 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 984' ' ' ALA . . . . . 0.465 ' HB1' ' CZ ' ' A' ' 893' ' ' ARG . . . -108.31 150.34 27.46 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 114.352 1.241 . . . . 0.69999999999999996 114.352 -175.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 985' ' ' LEU . . . . . 0.633 HD13 HD22 ' C' ' 890' ' ' LEU . 53.5 tp -76.42 135.5 39.44 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.833 -1.167 . . . . 0.040000000000000001 109.637 179.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 986' ' ' LEU . . . . . 0.568 HD11 HD11 ' B' ' 986' ' ' LEU . 42.1 tp -106.98 -60.44 1.67 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.402 -0.811 . . . . 0.040000000000000001 110.304 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -142.81 146.73 34.47 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 107.698 -1.223 . . . . 0.040000000000000001 107.698 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.3 163.22 12.2 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 108.395 -1.882 . . . . 0.040000000000000001 108.395 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -75.65 112.85 21.63 Favored Pre-proline 0 N--CA 1.498 1.943 0 O-C-N 121.246 -1.15 . . . . 0.040000000000000001 109.59 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 990' ' ' PRO . . . . . 0.418 ' O ' ' HB2' ' C' ' 991' ' ' GLU . 50.6 Cg_endo -89.58 71.47 1.82 Allowed 'Trans proline' 0 C--N 1.32 -0.961 0 O-C-N 123.106 1.056 . . . . 0.45000000000000001 111.537 -179.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 991' ' ' GLU . . . . . 0.418 ' HB2' ' O ' ' C' ' 990' ' ' PRO . 66.0 mt-10 67.49 -73.29 0.08 Allowed 'General case' 0 N--CA 1.503 2.209 0 N-CA-C 108.593 -0.891 . . . . 1.97 108.593 -177.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 992' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' C' ' 992' ' ' LEU . 11.1 mt 50.65 20.82 0.78 Allowed 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.592 -0.693 . . . . 2.3799999999999999 111.709 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -92.99 156.92 16.59 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.899 -1.126 . . . . 3.79 110.07 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 67.0 m80 -145.93 92.2 2.18 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.537 -0.727 . . . . 3.5099999999999998 110.265 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 995' ' ' ALA . . . . . . . . . . . . 2.517 . . . . . . . 0 N--CA 1.503 2.221 0 O-C-N 120.931 -1.106 . . . . 2.73 110.586 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo . . . . . 0 N--CA 1.488 1.162 0 N-CA-C 109.506 -0.998 . . . . 3.8300000000000001 109.506 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 847' ' ' VAL . . . . . 0.416 HG12 ' HB2' ' A' ' 849' ' ' GLN . 59.9 t -133.0 102.92 13.09 Favored Pre-proline 0 N--CA 1.496 1.835 0 O-C-N 121.603 -0.686 . . . . 1.8300000000000001 110.079 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 848' ' ' PRO . . . . . 0.756 ' O ' HG23 ' A' ' 850' ' ' VAL . 43.7 Cg_endo -69.82 -19.87 35.27 Favored 'Trans proline' 0 N--CA 1.487 1.125 0 O-C-N 123.274 1.144 . . . . 0.65000000000000002 111.028 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 849' ' ' GLN . . . . . 0.416 ' HB2' HG12 ' A' ' 847' ' ' VAL . 56.0 tt0 27.83 68.85 0.07 Allowed 'General case' 0 N--CA 1.518 2.968 0 N-CA-C 112.861 0.689 . . . . 2.5800000000000001 112.861 179.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 850' ' ' VAL . . . . . 0.756 HG23 ' O ' ' A' ' 848' ' ' PRO . 83.9 t -119.66 137.26 54.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.151 -0.968 . . . . 1.0900000000000001 111.603 -178.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 851' ' ' ALA . . . . . 0.477 ' HB3' ' HG ' ' A' ' 873' ' ' LEU . . . -126.99 158.52 36.68 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 105.876 -1.898 . . . . 0.040000000000000001 105.876 176.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 852' ' ' PHE . . . . . 0.436 ' HA ' ' CB ' ' A' ' 874' ' ' ASN . 46.6 p90 -157.59 131.97 8.38 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 120.989 1.722 . . . . 0.050000000000000003 108.613 178.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 19.5 t -175.03 132.84 0.32 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.07 -1.085 . . . . 0.040000000000000001 108.07 -178.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -135.41 153.1 51.91 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.173 -0.955 . . . . 0.67000000000000004 109.182 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 855' ' ' ALA . . . . . 0.701 ' HB3' ' CB ' ' A' ' 870' ' ' ARG . . . -124.24 140.11 53.27 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.942 0.877 . . . . 0.51000000000000001 111.689 -178.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 856' ' ' LEU . . . . . 0.815 HD11 HD23 ' A' ' 858' ' ' LEU . 3.3 tm? -106.8 137.46 44.8 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 109.366 -0.605 . . . . 0.050000000000000003 109.366 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 857' ' ' SER . . . . . 0.686 ' N ' HD13 ' A' ' 856' ' ' LEU . 1.3 m -155.02 15.43 0.41 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.323 -0.861 . . . . 1.3300000000000001 111.697 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 858' ' ' LEU . . . . . 0.815 HD23 HD11 ' A' ' 856' ' ' LEU . 3.0 pp -34.29 159.91 0.04 OUTLIER Pre-proline 0 N--CA 1.518 2.942 0 N-CA-C 113.088 0.773 . . . . 2.3300000000000001 113.088 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -60.87 -88.59 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 120.898 1.066 . . . . 2.3199999999999998 113.686 -177.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 54.3 ptt85 -126.19 -142.77 0.29 Allowed 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.902 -1.124 . . . . 0.040000000000000001 111.575 -177.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 75.1 m -38.53 126.22 1.42 Allowed 'General case' 0 N--CA 1.509 2.507 0 O-C-N 121.63 -0.668 . . . . 1.3100000000000001 112.148 -178.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -101.3 161.15 24.51 Favored Pre-proline 0 N--CA 1.489 1.512 0 N-CA-C 108.579 -0.897 . . . . 4.5099999999999998 108.579 178.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -71.09 -15.34 32.18 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 O-C-N 123.251 1.132 . . . . 2.2400000000000002 111.65 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -177.4 -136.5 2.48 Favored Glycine 0 N--CA 1.495 2.577 0 C-N-CA 119.541 -1.314 . . . . 0.040000000000000001 110.838 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 865' ' ' THR . . . . . 0.433 HG22 ' N ' ' A' ' 866' ' ' VAL . 41.1 m -61.69 162.84 7.97 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.479 -1.012 . . . . 1.51 111.362 -178.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 866' ' ' VAL . . . . . 0.433 ' N ' HG22 ' A' ' 865' ' ' THR . 0.1 OUTLIER -97.12 127.01 40.09 Favored Pre-proline 0 N--CA 1.504 2.237 0 N-CA-C 113.042 0.756 . . . . 0.78000000000000003 113.042 -174.41 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 867' ' ' PRO . . . . . 0.803 ' O ' HD23 ' A' ' 856' ' ' LEU . 54.1 Cg_endo -90.64 -153.18 0.04 OUTLIER 'Trans proline' 0 CA--C 1.54 0.787 0 N-CA-C 108.63 -1.335 . . . . 0.92000000000000004 108.63 177.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 868' ' ' PHE . . . . . 0.468 ' CD1' ' HG2' ' A' ' 881' ' ' PRO . 24.3 p90 -149.93 122.77 8.71 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 120.523 -1.361 . . . . 0.050000000000000003 110.247 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 49.6 p-10 -112.91 -3.19 14.14 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 119.442 -0.903 . . . . 1.7 112.083 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 870' ' ' ARG . . . . . 0.701 ' CB ' ' HB3' ' A' ' 855' ' ' ALA . 29.4 mmm180 -90.58 89.29 7.48 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.947 -1.096 . . . . 2.5899999999999999 110.675 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 58.1 t -73.13 97.16 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 120.975 -1.078 . . . . 1.9399999999999999 110.091 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 872' ' ' LEU . . . . . . . . . . . . . 96.1 mt -83.13 -47.28 11.8 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.498 -0.751 . . . . 1.0600000000000001 110.099 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 873' ' ' LEU . . . . . 0.477 ' HG ' ' HB3' ' A' ' 851' ' ' ALA . 43.0 tp -175.06 104.47 0.09 Allowed 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.308 -0.87 . . . . 4.1799999999999997 108.706 178.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 874' ' ' ASN . . . . . 0.436 ' CB ' ' HA ' ' A' ' 852' ' ' PHE . 35.0 t-20 178.33 81.9 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.336 0 O-C-N 121.6 -0.687 . . . . 0.040000000000000001 109.521 -178.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -66.85 -47.33 72.27 Favored 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 119.291 -0.964 . . . . 3.3799999999999999 111.334 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 876' ' ' GLY . . . . . 0.414 ' HA3' ' CE2' ' A' ' 878' ' ' TYR . . . -74.51 -25.19 70.87 Favored Glycine 0 N--CA 1.495 2.568 0 O-C-N 121.22 -0.925 . . . . 0.040000000000000001 111.777 -178.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 81.88 -62.09 4.58 Favored Glycine 0 N--CA 1.502 3.09 0 N-CA-C 107.974 -2.05 . . . . 0.040000000000000001 107.974 -178.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 878' ' ' TYR . . . . . 0.414 ' CE2' ' HA3' ' A' ' 876' ' ' GLY . 95.6 m-85 61.5 -60.27 0.1 Allowed 'General case' 0 N--CA 1.504 2.236 0 N-CA-C 114.498 1.296 . . . . 3.46 114.498 177.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 879' ' ' TYR . . . . . 0.475 ' CB ' ' CD2' ' A' ' 886' ' ' PHE . 21.3 p90 -111.73 108.96 18.57 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 114.66 1.356 . . . . 0.040000000000000001 114.66 -176.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -66.55 117.85 48.33 Favored Pre-proline 0 N--CA 1.497 1.899 0 O-C-N 121.403 -0.811 . . . . 0.02 109.911 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 881' ' ' PRO . . . . . 0.468 ' HG2' ' CD1' ' A' ' 868' ' ' PHE . 52.8 Cg_endo -77.15 -0.33 10.48 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 O-C-N 123.42 1.221 . . . . 0.39000000000000001 112.275 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -75.92 -62.91 1.43 Allowed 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 106.62 -1.622 . . . . 0.81000000000000005 106.62 178.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 19.5 p -94.44 -19.53 20.5 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.659 -0.867 . . . . 0.040000000000000001 108.659 177.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.43 20.83 57.93 Favored Glycine 0 N--CA 1.497 2.731 0 O-C-N 121.154 -0.966 . . . . 0.029999999999999999 111.035 178.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 885' ' ' VAL . . . . . 0.737 HG13 HG21 ' A' ' 961' ' ' THR . 97.7 t -73.0 90.0 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 C-N-CA 118.261 -1.376 . . . . 1.01 108.132 -179.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 886' ' ' PHE . . . . . 0.928 ' HB3' HG22 ' A' ' 962' ' ' VAL . 0.8 OUTLIER -89.31 104.04 16.62 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-N 115.298 -0.864 . . . . 0.050000000000000003 111.825 -177.555 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 887' ' ' THR . . . . . 0.422 ' O ' ' HD3' ' A' ' 889' ' ' PRO . 93.1 m -95.26 100.69 12.44 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 107.826 -1.175 . . . . 0.68000000000000005 107.826 177.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 888' ' ' ALA . . . . . . . . . . . . . . . -98.4 106.99 39.49 Favored Pre-proline 0 N--CA 1.502 2.153 0 N-CA-C 114.009 1.114 . . . . 0.25 114.009 -176.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 889' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 887' ' ' THR . 53.6 Cg_endo -89.84 -12.67 2.86 Favored 'Trans proline' 0 CA--C 1.546 1.122 0 C-N-CA 121.055 1.17 . . . . 1.6399999999999999 109.111 176.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 890' ' ' LEU . . . . . 0.934 HD22 HD13 ' A' ' 985' ' ' LEU . 72.9 mt -36.59 -50.31 0.8 Allowed 'General case' 0 N--CA 1.509 2.479 0 N-CA-C 113.636 0.976 . . . . 2.29 113.636 -177.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 52.19 95.85 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.295 0 O-C-N 121.156 -0.965 . . . . 0.63 110.238 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 157.85 -153.33 24.54 Favored Glycine 0 N--CA 1.478 1.456 0 N-CA-C 107.234 -2.347 . . . . 0.040000000000000001 107.234 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 893' ' ' ARG . . . . . 0.459 ' CZ ' ' HB1' ' C' ' 984' ' ' ALA . 73.2 ttt-85 -115.53 126.3 54.09 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 121.533 -0.981 . . . . 3.0 108.552 177.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 894' ' ' TYR . . . . . 0.77 ' OH ' HD12 ' A' ' 896' ' ' LEU . 0.1 OUTLIER -132.87 160.09 37.97 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.083 -1.011 . . . . 0.040000000000000001 111.083 -179.703 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 895' ' ' LEU . . . . . 0.836 HD23 HD11 ' B' ' 952' ' ' LEU . 36.0 tp -91.73 119.45 31.59 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.728 -0.607 . . . . 1.27 110.1 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 896' ' ' LEU . . . . . 0.77 HD12 ' OH ' ' A' ' 894' ' ' TYR . 9.2 tt -109.69 144.31 38.25 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.7 -0.625 . . . . 0.93999999999999995 110.155 -179.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 897' ' ' SER . . . . . 0.489 ' N ' HD23 ' A' ' 896' ' ' LEU . 69.5 m -149.95 114.8 5.33 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.49 -0.756 . . . . 0.040000000000000001 111.007 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -106.96 146.84 30.57 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.912 -0.773 . . . . 0.47999999999999998 108.912 178.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 899' ' ' VAL . . . . . 0.754 HG21 ' HB ' ' A' ' 980' ' ' ILE . 88.2 t -96.45 119.13 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 C-N-CA 119.59 -0.844 . . . . 0.55000000000000004 111.255 -179.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 900' ' ' LEU . . . . . 0.488 HD12 ' HB2' ' A' ' 924' ' ' SER . 4.5 mm? -95.75 111.18 23.2 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 114.036 1.124 . . . . 1.5900000000000001 114.036 -175.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 18.3 m -64.52 140.19 58.84 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 107.458 -1.312 . . . . 0.050000000000000003 107.458 177.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -63.09 -66.62 2.46 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 110.429 -1.068 . . . . 0.029999999999999999 110.429 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 4.1 m170 46.93 66.9 0.88 Allowed 'General case' 0 N--CA 1.507 2.398 0 O-C-N 121.495 -1.003 . . . . 3.2000000000000002 110.991 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -68.5 -7.17 29.84 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.581 -0.699 . . . . 2.9199999999999999 111.937 -179.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 905' ' ' HIS . . . . . 0.489 ' O ' ' CB ' ' A' ' 906' ' ' GLU . 67.0 t60 -63.55 4.54 0.24 Allowed 'General case' 0 N--CA 1.504 2.272 0 O-C-N 120.942 -1.099 . . . . 2.8700000000000001 112.843 -179.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 906' ' ' GLU . . . . . 0.489 ' CB ' ' O ' ' A' ' 905' ' ' HIS . 0.8 OUTLIER 94.7 -162.95 0.0 OUTLIER 'General case' 0 N--CA 1.53 3.552 0 CA-C-N 120.729 1.604 . . . . 0.98999999999999999 112.218 178.752 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 907' ' ' LYS . . . . . 0.492 ' HE2' ' HB1' ' A' ' 972' ' ' ALA . 94.1 mttt 89.27 159.71 0.05 Allowed 'General case' 0 N--CA 1.522 3.162 0 N-CA-C 107.862 -1.162 . . . . 5.25 107.862 -176.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 58.6 t -122.29 116.37 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 120.882 -1.137 . . . . 0.39000000000000001 110.91 -179.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 909' ' ' GLU . . . . . 0.685 ' OE2' HD12 ' A' ' 966' ' ' LEU . 48.9 tp10 -100.78 132.89 45.96 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.513 -1.292 . . . . 1.72 107.513 176.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -156.99 121.95 4.54 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 106.988 -1.486 . . . . 0.67000000000000004 106.988 178.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 911' ' ' VAL . . . . . 0.723 HG22 HG13 ' A' ' 964' ' ' VAL . 95.3 t -85.08 131.85 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.85 -0.532 . . . . 0.54000000000000004 111.076 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 73.0 mt -65.76 157.66 29.69 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.432 -0.792 . . . . 1.5 109.011 178.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 913' ' ' SER . . . . . 0.409 ' CB ' ' HB ' ' A' ' 919' ' ' VAL . 2.6 t -124.1 136.61 54.35 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.266 -1.013 . . . . 1.3700000000000001 108.266 177.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 914' ' ' ARG . . . . . 0.685 ' NH1' HD23 ' A' ' 956' ' ' LEU . 0.0 OUTLIER -65.07 154.53 37.58 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 120.612 -1.305 . . . . 4.2999999999999998 111.357 -179.186 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 915' ' ' SER . . . . . 0.427 ' CB ' ' O ' ' A' ' 914' ' ' ARG . 4.3 t 83.14 -31.61 0.08 Allowed 'General case' 0 N--CA 1.521 3.124 0 C-N-CA 123.853 0.861 . . . . 2.0499999999999998 112.089 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 916' ' ' ASN . . . . . 0.743 ' HB2' HG21 ' A' ' 919' ' ' VAL . 91.0 m-20 -123.61 -21.48 5.23 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 120.85 -1.157 . . . . 2.71 111.274 -179.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 917' ' ' GLN . . . . . 0.438 ' HB2' ' O ' ' A' ' 916' ' ' ASN . 44.4 mt-30 65.84 166.45 0.19 Allowed 'General case' 0 N--CA 1.519 2.984 0 N-CA-C 105.957 -1.868 . . . . 2.6800000000000002 105.957 -173.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.54 -125.62 35.0 Favored Glycine 1 N--CA 1.521 4.356 0 CA-C-N 123.382 2.81 . . . . 0.029999999999999999 106.78 -177.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 919' ' ' VAL . . . . . 0.743 HG21 ' HB2' ' A' ' 916' ' ' ASN . 71.8 t 52.47 93.58 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.241 0 O-C-N 121.31 -1.112 . . . . 1.3899999999999999 108.74 -178.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 920' ' ' ALA . . . . . 0.802 ' HB3' HG12 ' A' ' 949' ' ' VAL . . . -91.14 90.96 8.03 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.219 -0.993 . . . . 0.029999999999999999 110.956 -178.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 921' ' ' ARG . . . . . 0.834 ' HG3' HG23 ' A' ' 922' ' ' VAL . 30.2 ptt180 -86.17 -41.88 14.32 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 105.831 -1.914 . . . . 4.4199999999999999 105.831 175.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 922' ' ' VAL . . . . . 0.834 HG23 ' HG3' ' A' ' 921' ' ' ARG . 85.0 t -103.97 67.45 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 105.979 -1.86 . . . . 0.84999999999999998 105.979 175.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 923' ' ' ASP . . . . . 0.719 ' HB2' ' HB1' ' A' ' 920' ' ' ALA . 22.5 t0 -89.83 134.64 34.08 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.709 0.766 . . . . 2.46 111.655 -177.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 924' ' ' SER . . . . . 0.488 ' HB2' HD12 ' A' ' 900' ' ' LEU . 8.5 t -147.18 103.27 3.57 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.477 -0.935 . . . . 0.69999999999999996 108.477 178.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -109.59 90.28 0.59 Allowed Glycine 0 N--CA 1.487 2.063 0 N-CA-C 108.411 -1.875 . . . . 0.040000000000000001 108.411 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.352 0 N-CA-C 109.435 -1.466 . . . . 0.040000000000000001 109.435 -179.186 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 29.5 m . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 120.995 0.426 . . . . 13.779999999999999 110.341 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 95.2 mt -113.03 129.99 56.31 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.492 -0.755 . . . . 13.76 110.455 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -151.91 168.11 31.18 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.197 -1.561 . . . . 9.1300000000000008 109.197 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 949' ' ' VAL . . . . . 0.802 HG12 ' HB3' ' A' ' 920' ' ' ALA . 27.2 m -119.02 128.87 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.532 -0.981 . . . . 7.0800000000000001 110.78 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 950' ' ' PHE . . . . . 0.463 ' CE1' ' HD2' ' A' ' 955' ' ' PRO . 26.2 p90 -131.76 148.13 52.55 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.559 -0.713 . . . . 7.5899999999999999 109.487 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 19.8 m -121.26 -52.06 2.07 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.358 -0.838 . . . . 5.0300000000000002 112.169 -178.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 952' ' ' LEU . . . . . 0.426 ' O ' ' O ' ' A' ' 953' ' ' ILE . 53.8 tp -59.75 -75.1 0.06 Allowed 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.41 -0.806 . . . . 1.01 112.557 -177.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 953' ' ' ILE . . . . . 0.482 HD11 HD13 ' C' ' 872' ' ' LEU . 43.3 pt -52.34 -143.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.784 0 N-CA-C 114.177 1.177 . . . . 2.6000000000000001 114.177 -176.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 954' ' ' LEU . . . . . 0.725 HD22 ' O ' ' A' ' 954' ' ' LEU . 0.0 OUTLIER 174.07 77.2 0.05 OUTLIER Pre-proline 0 N--CA 1.506 2.367 0 O-C-N 120.671 -1.268 . . . . 0.050000000000000003 111.291 179.929 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 955' ' ' PRO . . . . . 0.746 ' C ' HD12 ' A' ' 956' ' ' LEU . 48.9 Cg_endo -76.66 91.73 1.13 Allowed 'Trans proline' 0 C--N 1.314 -1.238 0 N-CA-C 109.614 -0.956 . . . . 0.83999999999999997 109.614 178.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 956' ' ' LEU . . . . . 0.746 HD12 ' C ' ' A' ' 955' ' ' PRO . 11.1 mp -121.98 146.14 47.44 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.225 -0.922 . . . . 0.040000000000000001 109.818 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -84.44 150.74 25.1 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 117.831 -1.081 . . . . 1.28 111.876 -178.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -70.2 120.24 15.58 Favored 'General case' 0 N--CA 1.51 2.525 0 CA-C-N 122.788 2.54 . . . . 0.17000000000000001 111.74 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.51 -22.63 31.99 Favored Glycine 0 N--CA 1.5 2.907 0 N-CA-C 111.122 -0.791 . . . . 0.040000000000000001 111.122 178.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 960' ' ' ASP . . . . . 0.451 ' HB3' ' NE ' ' A' ' 914' ' ' ARG . 0.4 OUTLIER -55.38 171.9 0.16 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.451 -1.029 . . . . 0.040000000000000001 110.006 -179.567 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 961' ' ' THR . . . . . 0.737 HG21 HG13 ' A' ' 885' ' ' VAL . 41.5 m -135.06 135.43 41.26 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.879 -1.138 . . . . 1.78 111.884 -178.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 962' ' ' VAL . . . . . 0.928 HG22 ' HB3' ' A' ' 886' ' ' PHE . 32.7 m -97.79 145.92 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 C-N-CA 120.094 -0.642 . . . . 0.040000000000000001 110.138 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 5.6 t -138.5 145.98 41.43 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.852 -0.53 . . . . 0.71999999999999997 110.329 -178.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 964' ' ' VAL . . . . . 0.723 HG13 HG22 ' A' ' 911' ' ' VAL . 59.2 t -94.37 137.37 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.258 -0.901 . . . . 1.05 110.459 -179.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -93.28 127.54 38.91 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 103.791 -2.67 . . . . 3.02 103.791 173.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 966' ' ' LEU . . . . . 0.685 HD12 ' OE2' ' A' ' 909' ' ' GLU . 0.2 OUTLIER -132.81 60.0 1.71 Allowed 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.35 -0.981 . . . . 1.46 108.35 177.309 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 967' ' ' VAL . . . . . 0.49 HG23 ' C ' ' A' ' 966' ' ' LEU . 98.5 t -157.96 96.88 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 108.049 -1.093 . . . . 1.9399999999999999 108.049 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 92.2 mmm -142.65 60.44 1.43 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.725 -1.234 . . . . 0.0 108.434 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.59 120.48 2.01 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 107.203 -2.359 . . . . 2.1099999999999999 107.203 -178.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -82.06 -59.88 2.41 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 118.76 1.28 . . . . 5.8899999999999997 110.189 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 50.9 tp -59.81 90.95 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.44 -0.787 . . . . 4.3600000000000003 109.894 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 972' ' ' ALA . . . . . 0.492 ' HB1' ' HE2' ' A' ' 907' ' ' LYS . . . -141.41 -154.62 0.53 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.571 -0.706 . . . . 1.8300000000000001 110.39 -179.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -118.8 171.27 8.33 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.471 -0.768 . . . . 4.3499999999999996 110.221 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 34.3 t -101.6 130.23 47.88 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.588 -0.695 . . . . 1.27 110.039 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -156.11 157.05 35.36 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.549 -0.719 . . . . 5.0199999999999996 110.485 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.07 85.74 18.67 Favored Pre-proline 0 N--CA 1.5 2.068 0 O-C-N 121.6 -0.688 . . . . 2.4100000000000001 109.721 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.37 -172.33 1.02 Allowed 'Trans proline' 0 C--N 1.318 -1.068 0 O-C-N 123.313 1.165 . . . . 0.95999999999999996 111.345 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 978' ' ' LEU . . . . . 0.668 HD23 HD12 ' A' ' 856' ' ' LEU . 4.9 mp -127.7 154.44 45.31 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 107.691 -1.226 . . . . 0.62 107.691 178.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 979' ' ' THR . . . . . 0.464 HG23 ' C ' ' A' ' 978' ' ' LEU . 41.4 p -150.18 140.94 22.7 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.696 -1.253 . . . . 3.5699999999999998 111.14 -179.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 980' ' ' ILE . . . . . 0.754 ' HB ' HG21 ' A' ' 899' ' ' VAL . 46.3 mm -107.32 128.98 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 109.022 -0.733 . . . . 1.3300000000000001 109.022 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 981' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -118.95 95.16 4.71 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 119.804 -0.759 . . . . 0.050000000000000003 111.797 -178.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 82.9 p -107.93 157.96 17.76 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.545 -0.722 . . . . 0.87 109.192 178.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 983' ' ' GLY . . . . . 0.404 ' HA3' ' CE1' ' A' ' 852' ' ' PHE . . . -174.75 110.46 0.32 Allowed Glycine 0 N--CA 1.499 2.888 0 N-CA-C 106.356 -2.698 . . . . 0.029999999999999999 106.356 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -108.22 150.87 26.7 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 114.526 1.306 . . . . 0.69999999999999996 114.526 -175.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 985' ' ' LEU . . . . . 0.934 HD13 HD22 ' A' ' 890' ' ' LEU . 33.1 tp -72.29 135.06 45.87 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.822 -1.174 . . . . 0.040000000000000001 110.07 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 51.8 tp -107.47 -55.8 2.3 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.595 -0.691 . . . . 0.040000000000000001 110.06 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -144.57 145.76 31.98 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 107.668 -1.234 . . . . 0.040000000000000001 107.668 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.6 163.32 12.17 Favored Glycine 0 N--CA 1.495 2.633 0 N-CA-C 108.232 -1.947 . . . . 0.040000000000000001 108.232 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -75.26 112.46 18.66 Favored Pre-proline 0 N--CA 1.499 1.989 0 O-C-N 121.195 -1.179 . . . . 0.040000000000000001 109.463 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 990' ' ' PRO . . . . . 0.418 ' HD2' HD12 ' A' ' 992' ' ' LEU . 50.2 Cg_endo -90.53 70.79 1.39 Allowed 'Trans proline' 0 C--N 1.319 -1.023 0 O-C-N 123.151 1.079 . . . . 0.45000000000000001 111.565 -178.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 991' ' ' GLU . . . . . 0.417 ' HB2' ' O ' ' A' ' 990' ' ' PRO . 69.2 mt-10 67.28 -73.86 0.07 Allowed 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 108.586 -0.894 . . . . 1.97 108.586 -177.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 992' ' ' LEU . . . . . 0.418 HD12 ' HD2' ' A' ' 990' ' ' PRO . 11.0 mt 51.01 20.79 0.86 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.541 -0.724 . . . . 2.3799999999999999 111.641 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -94.11 156.89 16.34 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.818 -1.176 . . . . 3.79 109.993 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 72.2 m80 -146.63 93.49 2.3 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.588 -0.695 . . . . 3.5099999999999998 110.309 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 995' ' ' ALA . . . . . . . . . . . . 2.518 . . . . . . . 0 N--CA 1.503 2.224 0 O-C-N 120.868 -1.145 . . . . 2.73 110.572 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo . . . . . 0 N--CA 1.488 1.156 0 N-CA-C 109.5 -1.0 . . . . 3.8300000000000001 109.5 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 847' ' ' VAL . . . . . 0.401 HG12 ' HB2' ' B' ' 849' ' ' GLN . 60.0 t -133.07 102.87 13.03 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.567 -0.708 . . . . 1.8300000000000001 110.139 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 848' ' ' PRO . . . . . 0.758 ' O ' HG23 ' B' ' 850' ' ' VAL . 43.6 Cg_endo -69.7 -20.16 35.48 Favored 'Trans proline' 0 N--CA 1.487 1.092 0 O-C-N 123.235 1.124 . . . . 0.65000000000000002 111.033 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 849' ' ' GLN . . . . . 0.405 ' C ' ' O ' ' B' ' 848' ' ' PRO . 56.1 tt0 28.0 69.1 0.07 Allowed 'General case' 0 N--CA 1.519 2.989 0 N-CA-C 112.768 0.655 . . . . 2.5800000000000001 112.768 179.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 850' ' ' VAL . . . . . 0.758 HG23 ' O ' ' B' ' 848' ' ' PRO . 83.1 t -119.85 137.34 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.213 -0.93 . . . . 1.0900000000000001 111.623 -178.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 851' ' ' ALA . . . . . 0.488 ' HB3' ' HG ' ' B' ' 873' ' ' LEU . . . -127.52 157.67 39.5 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 105.907 -1.886 . . . . 0.040000000000000001 105.907 176.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 852' ' ' PHE . . . . . 0.432 ' HA ' ' CB ' ' B' ' 874' ' ' ASN . 46.4 p90 -156.63 132.43 9.58 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-N 121.04 1.745 . . . . 0.050000000000000003 108.541 179.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 20.8 t -175.11 132.59 0.31 Allowed 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.14 -1.059 . . . . 0.040000000000000001 108.14 -179.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -135.1 153.46 52.01 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.125 -0.985 . . . . 0.67000000000000004 109.211 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 855' ' ' ALA . . . . . 0.714 ' HB3' ' CB ' ' B' ' 870' ' ' ARG . . . -124.75 140.23 53.12 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.994 0.902 . . . . 0.51000000000000001 111.685 -178.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 856' ' ' LEU . . . . . 0.828 HD11 HD23 ' B' ' 858' ' ' LEU . 3.3 tm? -107.04 137.05 45.84 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.391 -0.596 . . . . 0.050000000000000003 109.391 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 857' ' ' SER . . . . . 0.683 ' N ' HD13 ' B' ' 856' ' ' LEU . 1.3 m -154.63 15.5 0.44 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.442 -0.786 . . . . 1.3300000000000001 111.712 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 858' ' ' LEU . . . . . 0.828 HD23 HD11 ' B' ' 856' ' ' LEU . 3.1 pp -34.32 159.98 0.04 OUTLIER Pre-proline 0 N--CA 1.518 2.956 0 N-CA-C 113.064 0.765 . . . . 2.3300000000000001 113.064 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -61.04 -88.58 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 120.9 1.067 . . . . 2.3199999999999998 113.661 -177.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 54.2 ptt85 -126.28 -142.8 0.29 Allowed 'General case' 0 N--CA 1.5 2.052 0 O-C-N 120.893 -1.129 . . . . 0.040000000000000001 111.551 -177.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 75.3 m -38.41 125.51 1.35 Allowed 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.597 -0.69 . . . . 1.3100000000000001 112.178 -178.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 862' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.59 161.18 24.78 Favored Pre-proline 0 N--CA 1.488 1.451 0 N-CA-C 108.557 -0.905 . . . . 4.5099999999999998 108.557 178.026 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -71.1 -15.29 32.15 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 O-C-N 123.248 1.13 . . . . 2.2400000000000002 111.73 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -177.15 -135.8 2.29 Favored Glycine 0 N--CA 1.495 2.599 0 C-N-CA 119.549 -1.31 . . . . 0.040000000000000001 110.807 179.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 865' ' ' THR . . . . . 0.446 HG22 ' N ' ' B' ' 866' ' ' VAL . 42.0 m -62.31 163.94 7.78 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.415 -1.05 . . . . 1.51 111.288 -178.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 866' ' ' VAL . . . . . 0.446 ' N ' HG22 ' B' ' 865' ' ' THR . 0.1 OUTLIER -98.09 127.03 38.07 Favored Pre-proline 0 N--CA 1.504 2.271 0 C-N-CA 119.796 -0.762 . . . . 0.78000000000000003 112.965 -174.464 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 867' ' ' PRO . . . . . 0.807 ' O ' HD23 ' B' ' 856' ' ' LEU . 53.6 Cg_endo -90.6 -153.25 0.04 OUTLIER 'Trans proline' 0 CA--C 1.54 0.789 0 N-CA-C 108.614 -1.341 . . . . 0.92000000000000004 108.614 177.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 868' ' ' PHE . . . . . 0.462 ' CD1' ' HG2' ' B' ' 881' ' ' PRO . 24.4 p90 -149.95 122.56 8.58 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.529 -1.357 . . . . 0.050000000000000003 110.199 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 50.0 p-10 -112.64 -2.76 14.46 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 119.476 -0.89 . . . . 1.7 112.133 -179.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 870' ' ' ARG . . . . . 0.714 ' CB ' ' HB3' ' B' ' 855' ' ' ALA . 28.8 mmm180 -91.07 89.15 7.27 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.925 -1.109 . . . . 2.5899999999999999 110.694 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 57.3 t -73.05 97.31 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.012 -1.055 . . . . 1.9399999999999999 110.063 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 872' ' ' LEU . . . . . 0.532 HD22 HD11 ' C' ' 953' ' ' ILE . 96.0 mt -83.27 -47.11 11.87 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.496 -0.752 . . . . 1.0600000000000001 110.067 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 873' ' ' LEU . . . . . 0.488 ' HG ' ' HB3' ' B' ' 851' ' ' ALA . 43.0 tp -175.15 104.43 0.09 Allowed 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 108.709 -0.849 . . . . 4.1799999999999997 108.709 178.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 874' ' ' ASN . . . . . 0.432 ' CB ' ' HA ' ' B' ' 852' ' ' PHE . 34.8 t-20 178.37 81.99 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.626 -0.671 . . . . 0.040000000000000001 109.581 -178.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -66.96 -47.34 71.88 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 119.325 -0.95 . . . . 3.3799999999999999 111.327 -179.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 876' ' ' GLY . . . . . 0.411 ' HA3' ' CE2' ' B' ' 878' ' ' TYR . . . -74.59 -25.26 70.52 Favored Glycine 0 N--CA 1.495 2.602 0 O-C-N 121.269 -0.894 . . . . 0.040000000000000001 111.725 -178.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 81.96 -62.08 4.58 Favored Glycine 0 N--CA 1.502 3.05 0 N-CA-C 107.966 -2.054 . . . . 0.040000000000000001 107.966 -178.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 878' ' ' TYR . . . . . 0.411 ' CE2' ' HA3' ' B' ' 876' ' ' GLY . 95.7 m-85 61.52 -60.25 0.1 Allowed 'General case' 0 N--CA 1.504 2.24 0 N-CA-C 114.473 1.286 . . . . 3.46 114.473 177.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 879' ' ' TYR . . . . . 0.477 ' CB ' ' CD2' ' B' ' 886' ' ' PHE . 21.2 p90 -111.68 108.78 18.35 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 114.68 1.363 . . . . 0.040000000000000001 114.68 -176.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -66.41 117.77 47.04 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.354 -0.841 . . . . 0.02 109.925 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 881' ' ' PRO . . . . . 0.462 ' HG2' ' CD1' ' B' ' 868' ' ' PHE . 51.8 Cg_endo -77.09 -0.52 10.67 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 O-C-N 123.409 1.215 . . . . 0.39000000000000001 112.261 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -75.73 -63.1 1.37 Allowed 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 106.639 -1.615 . . . . 0.81000000000000005 106.639 178.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 19.7 p -94.38 -19.06 20.96 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.76 -0.83 . . . . 0.040000000000000001 108.76 177.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.88 21.28 57.9 Favored Glycine 0 N--CA 1.496 2.648 0 O-C-N 121.099 -1.0 . . . . 0.029999999999999999 111.03 178.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 885' ' ' VAL . . . . . 0.74 HG13 HG21 ' B' ' 961' ' ' THR . 96.3 t -73.32 90.28 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 C-N-CA 118.242 -1.383 . . . . 1.01 108.123 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 886' ' ' PHE . . . . . 0.878 ' HB3' HG22 ' B' ' 962' ' ' VAL . 0.8 OUTLIER -89.52 104.17 16.75 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 115.323 -0.853 . . . . 0.050000000000000003 111.808 -177.542 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 887' ' ' THR . . . . . 0.418 ' O ' ' HD3' ' B' ' 889' ' ' PRO . 93.4 m -95.34 101.0 12.69 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 107.722 -1.214 . . . . 0.68000000000000005 107.722 177.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 888' ' ' ALA . . . . . . . . . . . . . . . -98.69 106.86 39.61 Favored Pre-proline 0 N--CA 1.503 2.179 0 N-CA-C 114.026 1.121 . . . . 0.25 114.026 -176.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 889' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' B' ' 887' ' ' THR . 53.2 Cg_endo -89.71 -12.71 2.92 Favored 'Trans proline' 0 CA--C 1.547 1.133 0 C-N-CA 121.028 1.152 . . . . 1.6399999999999999 109.107 176.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 890' ' ' LEU . . . . . 0.935 HD22 HD13 ' B' ' 985' ' ' LEU . 73.1 mt -36.51 -50.31 0.78 Allowed 'General case' 0 N--CA 1.508 2.465 0 N-CA-C 113.7 1.0 . . . . 2.29 113.7 -177.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 52.01 95.99 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.162 -0.961 . . . . 0.63 110.258 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . 157.86 -153.29 24.5 Favored Glycine 0 N--CA 1.478 1.478 0 N-CA-C 107.209 -2.357 . . . . 0.040000000000000001 107.209 -179.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 73.4 ttt-85 -115.58 126.12 53.82 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 108.448 -0.945 . . . . 3.0 108.448 177.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 894' ' ' TYR . . . . . 0.777 ' OH ' HD12 ' B' ' 896' ' ' LEU . 0.1 OUTLIER -132.53 160.23 37.13 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.113 -0.992 . . . . 0.040000000000000001 111.155 -179.702 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 895' ' ' LEU . . . . . 0.402 HD12 ' HA ' ' B' ' 895' ' ' LEU . 36.2 tp -92.1 119.47 31.81 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.709 -0.62 . . . . 1.27 110.025 -179.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 896' ' ' LEU . . . . . 0.777 HD12 ' OH ' ' B' ' 894' ' ' TYR . 9.2 tt -109.85 143.68 39.39 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.671 -0.643 . . . . 0.93999999999999995 110.147 -179.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 897' ' ' SER . . . . . 0.484 ' N ' HD23 ' B' ' 896' ' ' LEU . 69.6 m -149.3 114.61 5.51 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.49 -0.756 . . . . 0.040000000000000001 110.992 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -106.75 146.76 30.46 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.944 -0.761 . . . . 0.47999999999999998 108.944 178.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 899' ' ' VAL . . . . . 0.748 HG21 ' HB ' ' B' ' 980' ' ' ILE . 88.0 t -96.25 118.94 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 C-N-CA 119.646 -0.822 . . . . 0.55000000000000004 111.302 -179.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 900' ' ' LEU . . . . . 0.478 HD12 ' HB2' ' B' ' 924' ' ' SER . 4.5 mm? -95.71 110.65 22.75 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 114.102 1.149 . . . . 1.5900000000000001 114.102 -175.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 18.2 m -64.01 140.21 58.85 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 107.414 -1.328 . . . . 0.050000000000000003 107.414 177.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -63.3 -66.75 2.38 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 110.387 -1.085 . . . . 0.029999999999999999 110.387 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 4.1 m170 46.89 67.11 0.84 Allowed 'General case' 0 N--CA 1.507 2.383 0 O-C-N 121.505 -0.997 . . . . 3.2000000000000002 110.977 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 35.1 ptt180 -68.5 -7.54 33.16 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.642 -0.662 . . . . 2.9199999999999999 111.898 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 905' ' ' HIS . . . . . 0.487 ' O ' ' CB ' ' B' ' 906' ' ' GLU . 66.6 t60 -62.96 4.09 0.2 Allowed 'General case' 0 N--CA 1.505 2.278 0 CA-C-O 117.775 -1.107 . . . . 2.8700000000000001 112.851 -179.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 906' ' ' GLU . . . . . 0.487 ' CB ' ' O ' ' B' ' 905' ' ' HIS . 0.9 OUTLIER 94.89 -163.04 0.0 OUTLIER 'General case' 0 N--CA 1.53 3.533 0 CA-C-N 120.761 1.618 . . . . 0.98999999999999999 112.142 178.908 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 907' ' ' LYS . . . . . 0.511 ' HE2' ' HB1' ' B' ' 972' ' ' ALA . 94.2 mttt 89.5 159.51 0.05 Allowed 'General case' 0 N--CA 1.522 3.164 0 N-CA-C 107.817 -1.179 . . . . 5.25 107.817 -177.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 58.4 t -122.25 116.01 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 120.933 -1.104 . . . . 0.39000000000000001 110.956 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 909' ' ' GLU . . . . . 0.686 ' OE2' HD12 ' B' ' 966' ' ' LEU . 49.2 tp10 -100.2 133.21 44.94 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 107.542 -1.281 . . . . 1.72 107.542 176.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -157.42 122.11 4.4 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 106.98 -1.489 . . . . 0.67000000000000004 106.98 178.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 911' ' ' VAL . . . . . 0.705 HG22 HG13 ' B' ' 964' ' ' VAL . 94.7 t -85.34 132.14 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 C-N-CA 120.386 -0.526 . . . . 0.54000000000000004 111.11 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 72.3 mt -65.83 157.87 29.29 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.442 -0.787 . . . . 1.5 109.023 178.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 913' ' ' SER . . . . . 0.405 ' CB ' ' HB ' ' B' ' 919' ' ' VAL . 2.6 t -124.56 135.86 53.49 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.365 -0.976 . . . . 1.3700000000000001 108.365 177.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 914' ' ' ARG . . . . . 0.687 ' NH1' HD23 ' B' ' 956' ' ' LEU . 0.0 OUTLIER -64.28 154.57 34.77 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 120.596 -1.315 . . . . 4.2999999999999998 111.447 -179.054 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 915' ' ' SER . . . . . 0.419 ' CB ' ' O ' ' B' ' 914' ' ' ARG . 4.3 t 83.19 -31.86 0.08 Allowed 'General case' 0 N--CA 1.522 3.138 0 C-N-CA 123.867 0.867 . . . . 2.0499999999999998 112.131 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 916' ' ' ASN . . . . . 0.765 ' HB2' HG21 ' B' ' 919' ' ' VAL . 90.8 m-20 -123.3 -21.89 5.25 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.856 -1.152 . . . . 2.71 111.353 -179.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 917' ' ' GLN . . . . . 0.439 ' HB2' ' O ' ' B' ' 916' ' ' ASN . 44.2 mt-30 65.87 165.72 0.19 Allowed 'General case' 0 N--CA 1.518 2.949 0 N-CA-C 106.024 -1.843 . . . . 2.6800000000000002 106.024 -173.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 55.38 -125.66 36.94 Favored Glycine 1 N--CA 1.52 4.267 0 CA-C-N 123.439 2.836 . . . . 0.029999999999999999 106.621 -177.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 919' ' ' VAL . . . . . 0.765 HG21 ' HB2' ' B' ' 916' ' ' ASN . 68.9 t 52.34 93.72 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.302 0 O-C-N 121.356 -1.085 . . . . 1.3899999999999999 108.752 -178.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 920' ' ' ALA . . . . . 0.789 ' HB3' HG12 ' B' ' 949' ' ' VAL . . . -91.3 90.84 7.91 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.205 -0.998 . . . . 0.029999999999999999 110.881 -178.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 921' ' ' ARG . . . . . 0.862 ' HG3' HG23 ' B' ' 922' ' ' VAL . 30.1 ptt180 -86.15 -41.83 14.38 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 105.907 -1.886 . . . . 4.4199999999999999 105.907 175.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 922' ' ' VAL . . . . . 0.862 HG23 ' HG3' ' B' ' 921' ' ' ARG . 84.8 t -104.04 67.4 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 105.978 -1.86 . . . . 0.84999999999999998 105.978 175.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 923' ' ' ASP . . . . . 0.716 ' HB2' ' HB1' ' B' ' 920' ' ' ALA . 22.5 t0 -89.72 134.68 34.04 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.705 0.764 . . . . 2.46 111.658 -177.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 924' ' ' SER . . . . . 0.478 ' HB2' HD12 ' B' ' 900' ' ' LEU . 8.5 t -147.13 103.33 3.58 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.503 -0.925 . . . . 0.69999999999999996 108.503 178.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -109.62 90.22 0.59 Allowed Glycine 0 N--CA 1.487 2.052 0 N-CA-C 108.349 -1.9 . . . . 0.040000000000000001 108.349 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.318 0 N-CA-C 109.459 -1.456 . . . . 0.040000000000000001 109.459 -179.267 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 29.9 m . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.009 0.433 . . . . 13.779999999999999 110.307 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 95.3 mt -111.87 129.94 55.99 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.543 -0.723 . . . . 13.76 110.379 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -151.39 167.56 30.82 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.256 -1.538 . . . . 9.1300000000000008 109.256 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 949' ' ' VAL . . . . . 0.789 HG12 ' HB3' ' B' ' 920' ' ' ALA . 30.7 m -118.7 129.13 75.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.514 -0.992 . . . . 7.0800000000000001 110.698 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 950' ' ' PHE . . . . . 0.462 ' CZ ' ' HB3' ' B' ' 921' ' ' ARG . 26.6 p90 -132.35 147.87 52.4 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.563 -0.71 . . . . 7.5899999999999999 109.518 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 19.7 m -121.22 -51.46 2.1 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.48 -0.762 . . . . 5.0300000000000002 112.063 -178.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 952' ' ' LEU . . . . . 0.836 HD11 HD23 ' A' ' 895' ' ' LEU . 52.5 tp -60.24 -75.28 0.06 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.389 -0.819 . . . . 1.01 112.549 -177.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 953' ' ' ILE . . . . . 0.479 ' O ' ' HB3' ' B' ' 954' ' ' LEU . 45.0 pt -52.1 -143.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.8 0 N-CA-C 114.237 1.199 . . . . 2.6000000000000001 114.237 -176.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 954' ' ' LEU . . . . . 0.729 HD22 ' O ' ' B' ' 954' ' ' LEU . 0.0 OUTLIER 173.79 77.01 0.05 OUTLIER Pre-proline 0 N--CA 1.507 2.387 0 O-C-N 120.629 -1.294 . . . . 0.050000000000000003 111.209 179.883 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 955' ' ' PRO . . . . . 0.746 ' C ' HD12 ' B' ' 956' ' ' LEU . 49.4 Cg_endo -76.62 91.76 1.13 Allowed 'Trans proline' 0 C--N 1.314 -1.242 0 N-CA-C 109.606 -0.959 . . . . 0.83999999999999997 109.606 178.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 956' ' ' LEU . . . . . 0.746 HD12 ' C ' ' B' ' 955' ' ' PRO . 11.1 mp -122.13 146.13 47.52 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.198 -0.939 . . . . 0.040000000000000001 109.738 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -84.33 150.86 25.1 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 117.964 -1.017 . . . . 1.28 111.84 -178.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -70.3 120.02 15.34 Favored 'General case' 0 N--CA 1.509 2.497 0 CA-C-N 122.658 2.481 . . . . 0.17000000000000001 111.664 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.65 -22.74 31.8 Favored Glycine 0 N--CA 1.5 2.922 0 N-CA-C 111.07 -0.812 . . . . 0.040000000000000001 111.07 178.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 960' ' ' ASP . . . . . 0.449 ' HB3' ' NE ' ' B' ' 914' ' ' ARG . 0.4 OUTLIER -55.27 171.99 0.15 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.455 -1.026 . . . . 0.040000000000000001 110.014 -179.528 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 961' ' ' THR . . . . . 0.74 HG21 HG13 ' B' ' 885' ' ' VAL . 40.7 m -135.02 135.65 41.5 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.993 -1.067 . . . . 1.78 111.845 -178.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 962' ' ' VAL . . . . . 0.878 HG22 ' HB3' ' B' ' 886' ' ' PHE . 32.7 m -98.07 145.77 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 C-N-CA 120.102 -0.639 . . . . 0.040000000000000001 110.122 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 5.6 t -138.24 146.01 42.06 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.905 -0.497 . . . . 0.71999999999999997 110.294 -178.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 964' ' ' VAL . . . . . 0.705 HG13 HG22 ' B' ' 911' ' ' VAL . 59.0 t -94.46 137.17 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.19 -0.943 . . . . 1.05 110.474 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -93.24 127.06 38.67 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 103.869 -2.641 . . . . 3.02 103.869 173.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 966' ' ' LEU . . . . . 0.686 HD12 ' OE2' ' B' ' 909' ' ' GLU . 0.2 OUTLIER -132.32 60.23 1.69 Allowed 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.392 -0.966 . . . . 1.46 108.392 177.334 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 967' ' ' VAL . . . . . 0.489 HG23 ' C ' ' B' ' 966' ' ' LEU . 98.3 t -158.18 96.86 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 108.051 -1.092 . . . . 1.9399999999999999 108.051 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 92.3 mmm -142.52 60.09 1.44 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.735 -1.228 . . . . 0.0 108.571 179.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.62 120.36 2.0 Allowed Glycine 0 N--CA 1.492 2.417 0 N-CA-C 107.259 -2.337 . . . . 2.1099999999999999 107.259 -178.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -81.83 -59.8 2.46 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.073 -1.251 . . . . 5.8899999999999997 110.222 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 50.9 tp -59.83 90.6 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.45 -0.781 . . . . 4.3600000000000003 109.912 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 972' ' ' ALA . . . . . 0.511 ' HB1' ' HE2' ' B' ' 907' ' ' LYS . . . -141.06 -154.69 0.53 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.592 -0.693 . . . . 1.8300000000000001 110.408 -179.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -118.72 171.3 8.3 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.526 -0.734 . . . . 4.3499999999999996 110.245 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 34.5 t -101.58 130.23 47.85 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.572 -0.705 . . . . 1.27 110.065 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -156.12 157.17 35.55 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.48 -0.762 . . . . 5.0199999999999996 110.473 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.17 85.67 18.45 Favored Pre-proline 0 N--CA 1.501 2.082 0 O-C-N 121.623 -0.673 . . . . 2.4100000000000001 109.745 179.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -73.37 -172.44 1.04 Allowed 'Trans proline' 0 C--N 1.318 -1.065 0 O-C-N 123.303 1.16 . . . . 0.95999999999999996 111.386 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 978' ' ' LEU . . . . . 0.66 HD23 HD12 ' B' ' 856' ' ' LEU . 4.9 mp -127.52 154.66 44.86 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 107.71 -1.218 . . . . 0.62 107.71 178.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 979' ' ' THR . . . . . 0.471 HG23 ' C ' ' B' ' 978' ' ' LEU . 41.0 p -150.41 140.89 22.46 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.814 -1.179 . . . . 3.5699999999999998 111.088 -179.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 980' ' ' ILE . . . . . 0.748 ' HB ' HG21 ' B' ' 899' ' ' VAL . 46.2 mm -107.31 128.73 62.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 109.064 -0.717 . . . . 1.3300000000000001 109.064 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -118.84 95.36 4.8 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 119.787 -0.765 . . . . 0.050000000000000003 111.86 -178.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 80.5 p -108.28 158.13 17.74 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.546 -0.721 . . . . 0.87 109.294 178.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 983' ' ' GLY . . . . . 0.405 ' O ' ' CE2' ' B' ' 852' ' ' PHE . . . -174.76 110.57 0.33 Allowed Glycine 0 N--CA 1.498 2.782 0 N-CA-C 106.514 -2.634 . . . . 0.029999999999999999 106.514 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -108.22 150.58 27.08 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 114.43 1.27 . . . . 0.69999999999999996 114.43 -175.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 985' ' ' LEU . . . . . 0.935 HD13 HD22 ' B' ' 890' ' ' LEU . 33.5 tp -72.05 135.01 46.18 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.856 -1.153 . . . . 0.040000000000000001 110.052 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 986' ' ' LEU . . . . . 0.483 ' CD1' HD11 ' C' ' 986' ' ' LEU . 51.6 tp -107.46 -55.77 2.3 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.59 -0.694 . . . . 0.040000000000000001 110.101 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -144.62 145.65 31.89 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.719 -1.215 . . . . 0.040000000000000001 107.719 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.45 163.07 12.2 Favored Glycine 0 N--CA 1.495 2.628 0 N-CA-C 108.289 -1.924 . . . . 0.040000000000000001 108.289 179.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -75.04 112.47 18.18 Favored Pre-proline 0 N--CA 1.498 1.955 0 O-C-N 121.174 -1.192 . . . . 0.040000000000000001 109.475 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 990' ' ' PRO . . . . . 0.423 ' HD2' HD12 ' B' ' 992' ' ' LEU . 49.8 Cg_endo -90.58 70.89 1.35 Allowed 'Trans proline' 0 C--N 1.318 -1.042 0 O-C-N 123.113 1.06 . . . . 0.45000000000000001 111.517 -178.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 991' ' ' GLU . . . . . 0.419 ' HB2' ' O ' ' B' ' 990' ' ' PRO . 69.4 mt-10 67.12 -73.68 0.08 Allowed 'General case' 0 N--CA 1.503 2.183 0 N-CA-C 108.633 -0.877 . . . . 1.97 108.633 -177.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 992' ' ' LEU . . . . . 0.461 ' HA ' HD23 ' B' ' 992' ' ' LEU . 11.1 mt 51.13 20.39 0.86 Allowed 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.552 -0.717 . . . . 2.3799999999999999 111.656 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -93.69 156.97 16.39 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.869 -1.145 . . . . 3.79 110.057 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 71.9 m80 -146.7 92.91 2.21 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.519 -0.738 . . . . 3.5099999999999998 110.415 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 995' ' ' ALA . . . . . . . . . . . . 2.517 . . . . . . . 0 N--CA 1.503 2.22 0 O-C-N 120.886 -1.134 . . . . 2.73 110.603 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo . . . . . 0 N--CA 1.489 1.221 0 N-CA-C 109.521 -0.992 . . . . 3.8300000000000001 109.521 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 847' ' ' VAL . . . . . 0.424 HG12 ' HB2' ' C' ' 849' ' ' GLN . 88.1 t -131.42 102.7 15.31 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.606 -0.684 . . . . 1.8300000000000001 110.131 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 848' ' ' PRO . . . . . 0.753 ' O ' HG23 ' C' ' 850' ' ' VAL . 44.7 Cg_endo -70.2 -20.41 32.8 Favored 'Trans proline' 0 N--CA 1.487 1.138 0 O-C-N 123.278 1.146 . . . . 0.65000000000000002 111.016 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 849' ' ' GLN . . . . . 0.424 ' HB2' HG12 ' C' ' 847' ' ' VAL . 56.2 tt0 27.29 69.17 0.06 Allowed 'General case' 0 N--CA 1.519 2.979 0 N-CA-C 112.884 0.698 . . . . 2.5800000000000001 112.884 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 850' ' ' VAL . . . . . 0.753 HG23 ' O ' ' C' ' 848' ' ' PRO . 67.7 t -119.41 133.91 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.258 -0.901 . . . . 1.0900000000000001 111.64 -178.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 851' ' ' ALA . . . . . 0.447 ' HB3' ' HG ' ' C' ' 873' ' ' LEU . . . -129.88 152.97 48.77 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 105.627 -1.99 . . . . 0.040000000000000001 105.627 176.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 852' ' ' PHE . . . . . 0.448 ' HA ' ' CB ' ' C' ' 874' ' ' ASN . 6.0 p90 -160.31 128.76 4.76 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 120.921 1.691 . . . . 0.050000000000000003 108.589 179.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 29.8 t -175.67 134.32 0.29 Allowed 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.065 -1.087 . . . . 0.040000000000000001 108.065 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -134.64 156.91 47.92 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.136 -0.978 . . . . 0.67000000000000004 109.596 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 855' ' ' ALA . . . . . 0.593 ' HB3' ' CB ' ' C' ' 870' ' ' ARG . . . -121.83 139.71 53.28 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.864 0.84 . . . . 0.51000000000000001 111.667 -179.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 856' ' ' LEU . . . . . 0.713 HD23 ' O ' ' C' ' 867' ' ' PRO . 3.5 tm? -103.04 135.85 43.95 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.69 -0.631 . . . . 0.050000000000000003 109.422 179.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 857' ' ' SER . . . . . 0.576 ' N ' HD13 ' C' ' 856' ' ' LEU . 37.3 p -151.38 15.85 0.71 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.487 -0.758 . . . . 1.3300000000000001 111.206 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 858' ' ' LEU . . . . . 0.57 ' CD2' HD11 ' C' ' 856' ' ' LEU . 4.4 pp -33.56 157.47 0.04 OUTLIER Pre-proline 0 N--CA 1.518 2.97 0 N-CA-C 112.899 0.703 . . . . 2.3300000000000001 112.899 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -61.57 -89.27 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 120.897 1.064 . . . . 2.3199999999999998 113.575 -177.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 54.7 ptt85 -127.82 -141.86 0.26 Allowed 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.953 -1.092 . . . . 0.040000000000000001 111.289 -177.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 71.5 m -37.9 123.04 1.04 Allowed 'General case' 0 N--CA 1.51 2.567 0 O-C-N 121.575 -0.703 . . . . 1.3100000000000001 112.064 -179.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 862' ' ' GLU . . . . . 0.514 ' HG3' HD22 ' C' ' 858' ' ' LEU . 0.0 OUTLIER -100.55 158.41 31.95 Favored Pre-proline 0 N--CA 1.488 1.429 0 N-CA-C 108.192 -1.04 . . . . 4.5099999999999998 108.192 177.767 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.07 -14.58 32.03 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 123.187 1.099 . . . . 2.2400000000000002 111.034 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -176.98 -135.51 2.21 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.725 -1.35 . . . . 0.040000000000000001 109.725 179.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 25.8 m -69.05 154.22 42.44 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.331 -1.1 . . . . 1.51 110.47 -179.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 866' ' ' VAL . . . . . 0.46 ' HA ' ' HD3' ' C' ' 867' ' ' PRO . 32.7 m -90.68 139.39 26.33 Favored Pre-proline 0 N--CA 1.497 1.881 0 N-CA-C 113.66 0.985 . . . . 0.78000000000000003 113.66 -175.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 867' ' ' PRO . . . . . 0.713 ' O ' HD23 ' C' ' 856' ' ' LEU . 53.9 Cg_endo -88.92 -152.69 0.04 OUTLIER 'Trans proline' 0 C--N 1.325 -0.662 0 N-CA-C 108.286 -1.467 . . . . 0.92000000000000004 108.286 177.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 868' ' ' PHE . . . . . 0.471 ' CD1' ' HG2' ' C' ' 881' ' ' PRO . 23.0 p90 -148.15 120.18 8.25 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.513 -1.367 . . . . 0.050000000000000003 109.625 179.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 50.2 p-10 -113.02 -2.97 14.1 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 119.38 -0.928 . . . . 1.7 112.029 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 870' ' ' ARG . . . . . 0.593 ' CB ' ' HB3' ' C' ' 855' ' ' ALA . 24.8 mmm180 -90.51 86.88 6.55 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.03 -1.044 . . . . 2.5899999999999999 110.825 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 61.6 t -73.12 96.73 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.074 -1.016 . . . . 1.9399999999999999 109.566 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 872' ' ' LEU . . . . . 0.507 HD11 ' HB2' ' C' ' 855' ' ' ALA . 51.9 mt -86.17 -45.18 11.58 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.554 -0.716 . . . . 1.0600000000000001 110.338 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 873' ' ' LEU . . . . . 0.447 ' HG ' ' HB3' ' C' ' 851' ' ' ALA . 49.3 tp -173.3 102.8 0.12 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.238 -0.914 . . . . 4.1799999999999997 108.791 178.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 874' ' ' ASN . . . . . 0.448 ' CB ' ' HA ' ' C' ' 852' ' ' PHE . 37.4 t-20 177.98 82.65 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.319 0 O-C-N 121.721 -0.612 . . . . 0.040000000000000001 109.374 -178.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -67.19 -47.41 71.0 Favored 'General case' 0 N--CA 1.497 1.92 0 C-N-CA 119.203 -0.999 . . . . 3.3799999999999999 111.434 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 876' ' ' GLY . . . . . . . . . . . . . . . -73.53 -26.97 68.51 Favored Glycine 0 N--CA 1.494 2.548 0 O-C-N 121.271 -0.893 . . . . 0.040000000000000001 111.66 -178.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 83.13 -60.18 4.91 Favored Glycine 0 N--CA 1.503 3.109 0 N-CA-C 108.061 -2.015 . . . . 0.040000000000000001 108.061 -178.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 878' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 61.41 -66.19 0.06 Allowed 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 114.239 1.2 . . . . 3.46 114.239 177.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 879' ' ' TYR . . . . . 0.471 ' CB ' ' CD2' ' C' ' 886' ' ' PHE . 23.9 p90 -113.92 110.02 19.43 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 114.859 1.429 . . . . 0.040000000000000001 114.859 -176.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -66.83 117.98 50.43 Favored Pre-proline 0 N--CA 1.499 2.018 0 O-C-N 121.434 -0.791 . . . . 0.02 109.897 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 881' ' ' PRO . . . . . 0.471 ' HG2' ' CD1' ' C' ' 868' ' ' PHE . 55.3 Cg_endo -77.43 -0.26 10.44 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 O-C-N 123.386 1.203 . . . . 0.39000000000000001 112.141 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -74.58 -63.31 1.27 Allowed 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 106.538 -1.652 . . . . 0.81000000000000005 106.538 178.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 8.9 p -95.61 -17.62 21.21 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.704 -0.85 . . . . 0.040000000000000001 108.704 177.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.78 20.58 59.43 Favored Glycine 0 N--CA 1.495 2.631 0 O-C-N 121.024 -1.047 . . . . 0.029999999999999999 111.165 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 92.4 t -72.02 90.26 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 C-N-CA 118.135 -1.426 . . . . 1.01 108.019 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 886' ' ' PHE . . . . . 0.841 ' HB3' HG22 ' C' ' 962' ' ' VAL . 0.8 OUTLIER -90.93 104.77 17.32 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-N 115.268 -0.878 . . . . 0.050000000000000003 112.037 -177.259 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 887' ' ' THR . . . . . 0.426 ' O ' ' HD3' ' C' ' 889' ' ' PRO . 86.5 m -95.97 101.49 13.16 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 107.697 -1.223 . . . . 0.68000000000000005 107.697 177.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 888' ' ' ALA . . . . . . . . . . . . . . . -98.38 107.01 39.56 Favored Pre-proline 0 N--CA 1.502 2.155 0 N-CA-C 113.998 1.11 . . . . 0.25 113.998 -176.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 889' ' ' PRO . . . . . 0.426 ' HD3' ' O ' ' C' ' 887' ' ' THR . 53.6 Cg_endo -90.03 -13.26 2.59 Favored 'Trans proline' 0 CA--C 1.546 1.095 0 C-N-CA 120.975 1.117 . . . . 1.6399999999999999 109.228 176.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 890' ' ' LEU . . . . . 1.04 HD22 HD13 ' C' ' 985' ' ' LEU . 75.6 mt -38.7 -49.33 1.57 Allowed 'General case' 0 N--CA 1.507 2.382 0 N-CA-C 113.719 1.007 . . . . 2.29 113.719 -177.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 52.85 96.78 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.351 0 O-C-N 121.081 -1.012 . . . . 0.63 110.044 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . 155.79 -146.87 14.91 Favored Glycine 0 N--CA 1.48 1.568 0 N-CA-C 107.096 -2.402 . . . . 0.040000000000000001 107.096 -178.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 74.4 ttt-85 -107.17 129.32 54.87 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 107.947 -1.131 . . . . 3.0 107.947 177.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 894' ' ' TYR . . . . . 0.451 ' CD1' ' N ' ' C' ' 895' ' ' LEU . 0.4 OUTLIER -129.53 142.94 50.65 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.064 -1.022 . . . . 0.040000000000000001 110.086 -179.254 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 895' ' ' LEU . . . . . 0.451 ' N ' ' CD1' ' C' ' 894' ' ' TYR . 34.6 tp -102.08 115.39 30.44 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.632 -0.667 . . . . 1.27 109.597 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 896' ' ' LEU . . . . . 0.609 HD23 ' N ' ' C' ' 897' ' ' SER . 10.3 tt -112.69 146.76 38.13 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.549 -0.719 . . . . 0.93999999999999995 110.594 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 897' ' ' SER . . . . . 0.609 ' N ' HD23 ' C' ' 896' ' ' LEU . 8.3 m -141.4 117.26 10.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.523 -0.736 . . . . 0.040000000000000001 110.494 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -106.61 147.19 29.79 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.126 -0.694 . . . . 0.47999999999999998 109.126 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 899' ' ' VAL . . . . . 0.74 HG21 ' HB ' ' C' ' 980' ' ' ILE . 88.9 t -93.56 119.42 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 C-N-CA 119.729 -0.788 . . . . 0.55000000000000004 111.133 -179.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 96.7 mt -93.66 111.53 23.23 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 114.1 1.148 . . . . 1.5900000000000001 114.1 -175.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 16.7 m -64.12 140.12 58.84 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 107.32 -1.363 . . . . 0.050000000000000003 107.32 177.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -61.18 -64.48 4.01 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.29 -1.124 . . . . 0.029999999999999999 110.29 -179.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 45.18 63.77 1.63 Allowed 'General case' 0 N--CA 1.507 2.409 0 O-C-N 121.57 -0.959 . . . . 3.2000000000000002 111.323 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 41.9 ptt85 -67.26 -7.9 27.77 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.573 -0.704 . . . . 2.9199999999999999 111.895 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 905' ' ' HIS . . . . . 0.49 ' O ' ' CB ' ' C' ' 906' ' ' GLU . 74.0 t60 -61.3 5.15 0.07 Allowed 'General case' 0 N--CA 1.505 2.302 0 CA-C-O 117.601 -1.19 . . . . 2.8700000000000001 113.488 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 906' ' ' GLU . . . . . 0.49 ' CB ' ' O ' ' C' ' 905' ' ' HIS . 0.7 OUTLIER 92.58 -163.43 0.01 OUTLIER 'General case' 0 N--CA 1.528 3.447 0 CA-C-N 121.294 1.861 . . . . 0.98999999999999999 112.239 178.919 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 907' ' ' LYS . . . . . 0.488 ' CB ' ' O ' ' C' ' 906' ' ' GLU . 72.4 tttt 89.82 161.96 0.05 OUTLIER 'General case' 0 N--CA 1.52 3.065 0 N-CA-C 108.171 -1.048 . . . . 5.25 108.171 -177.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 59.4 t -122.69 115.39 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 120.927 -1.108 . . . . 0.39000000000000001 110.857 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 909' ' ' GLU . . . . . 0.474 ' HG3' HD12 ' C' ' 966' ' ' LEU . 47.1 tt0 -108.07 129.99 55.11 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 107.644 -1.243 . . . . 1.72 107.644 177.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -155.93 120.83 4.71 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 106.8 -1.556 . . . . 0.67000000000000004 106.8 178.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 911' ' ' VAL . . . . . 0.896 HG23 HG22 ' C' ' 964' ' ' VAL . 13.3 p -77.3 131.09 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.79 -0.569 . . . . 0.54000000000000004 111.346 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 46.4 mt -67.81 157.62 34.37 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.284 -0.885 . . . . 1.5 108.717 178.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 913' ' ' SER . . . . . 0.475 ' OG ' HG11 ' C' ' 919' ' ' VAL . 1.6 p -123.72 139.56 53.87 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.67 -0.863 . . . . 1.3700000000000001 108.67 177.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 914' ' ' ARG . . . . . 0.821 ' NH1' HD23 ' C' ' 956' ' ' LEU . 0.0 OUTLIER -65.02 154.1 38.75 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 120.643 -1.286 . . . . 4.2999999999999998 111.568 -179.104 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 915' ' ' SER . . . . . 0.425 ' CB ' ' O ' ' C' ' 914' ' ' ARG . 4.4 t 83.28 -31.25 0.08 Allowed 'General case' 0 N--CA 1.522 3.164 0 C-N-CA 123.916 0.886 . . . . 2.0499999999999998 112.23 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 916' ' ' ASN . . . . . 0.741 ' HB2' HG21 ' C' ' 919' ' ' VAL . 99.1 m-20 -121.85 -22.01 5.89 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.889 -1.132 . . . . 2.71 111.226 -179.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 66.99 166.93 0.23 Allowed 'General case' 0 N--CA 1.52 3.04 0 N-CA-C 105.802 -1.925 . . . . 2.6800000000000002 105.802 -174.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.64 -126.38 37.43 Favored Glycine 1 N--CA 1.521 4.344 0 CA-C-N 123.598 2.908 . . . . 0.029999999999999999 107.051 -177.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 919' ' ' VAL . . . . . 0.741 HG21 ' HB2' ' C' ' 916' ' ' ASN . 92.1 t 51.57 93.53 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.238 0 O-C-N 121.307 -1.114 . . . . 1.3899999999999999 109.129 -178.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 920' ' ' ALA . . . . . 0.937 ' HB3' HG12 ' C' ' 949' ' ' VAL . . . -93.42 93.82 8.36 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.332 -0.947 . . . . 0.029999999999999999 110.714 -179.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 921' ' ' ARG . . . . . 0.811 ' HG3' HG23 ' C' ' 922' ' ' VAL . 20.1 ptt85 -80.39 -41.83 23.9 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 105.938 -1.875 . . . . 4.4199999999999999 105.938 176.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 922' ' ' VAL . . . . . 0.811 HG23 ' HG3' ' C' ' 921' ' ' ARG . 90.5 t -101.86 75.11 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 106.088 -1.819 . . . . 0.84999999999999998 106.088 175.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -89.79 135.89 33.36 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.872 0.844 . . . . 2.46 112.355 -176.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 7.9 t -147.16 102.76 3.53 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.063 -1.088 . . . . 0.69999999999999996 108.063 178.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -110.83 88.95 0.53 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.967 -1.653 . . . . 0.040000000000000001 108.967 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.4 0 N-CA-C 109.353 -1.499 . . . . 0.040000000000000001 109.353 -179.713 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 11.2 m . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 120.962 0.411 . . . . 13.779999999999999 110.318 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 95.3 mt -114.22 129.77 56.63 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.505 -0.747 . . . . 13.76 110.319 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -152.16 170.34 31.47 Favored Glycine 0 N--CA 1.493 2.5 0 N-CA-C 109.398 -1.481 . . . . 9.1300000000000008 109.398 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 949' ' ' VAL . . . . . 0.937 HG12 ' HB3' ' C' ' 920' ' ' ALA . 33.7 m -117.17 136.39 54.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.538 -0.977 . . . . 7.0800000000000001 110.832 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 950' ' ' PHE . . . . . 0.448 ' CZ ' ' HB3' ' C' ' 921' ' ' ARG . 36.0 p90 -135.57 152.25 51.09 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.607 -0.683 . . . . 7.5899999999999999 109.622 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 69.4 m -118.32 -54.44 2.29 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.386 -0.821 . . . . 5.0300000000000002 111.514 -179.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 952' ' ' LEU . . . . . 0.448 ' O ' ' O ' ' C' ' 953' ' ' ILE . 46.6 tp -63.78 -77.03 0.06 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.46 -0.775 . . . . 1.01 111.421 -178.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 953' ' ' ILE . . . . . 0.544 HD12 ' N ' ' C' ' 954' ' ' LEU . 2.3 pp -49.45 -152.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.735 0 N-CA-C 114.324 1.231 . . . . 2.6000000000000001 114.324 -176.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 954' ' ' LEU . . . . . 0.726 HD22 ' O ' ' C' ' 954' ' ' LEU . 0.0 OUTLIER 169.11 92.09 0.03 OUTLIER Pre-proline 0 N--CA 1.516 2.869 0 O-C-N 120.949 -1.094 . . . . 0.050000000000000003 111.651 179.491 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 955' ' ' PRO . . . . . 0.761 ' C ' HD12 ' C' ' 956' ' ' LEU . 52.1 Cg_endo -80.4 93.0 1.05 Allowed 'Trans proline' 0 C--N 1.317 -1.117 0 N-CA-C 109.138 -1.139 . . . . 0.83999999999999997 109.138 178.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 956' ' ' LEU . . . . . 0.821 HD23 ' NH1' ' C' ' 914' ' ' ARG . 10.9 mp -122.85 144.01 49.49 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.014 -1.054 . . . . 0.040000000000000001 110.144 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -82.11 151.33 27.05 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 117.708 -1.139 . . . . 1.28 111.287 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -67.15 118.63 10.83 Favored 'General case' 0 N--CA 1.508 2.45 0 CA-C-N 123.078 2.672 . . . . 0.17000000000000001 111.082 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.42 -20.43 44.1 Favored Glycine 0 N--CA 1.499 2.888 0 N-CA-C 110.872 -0.891 . . . . 0.040000000000000001 110.872 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 960' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.63 169.69 0.13 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.381 -1.07 . . . . 0.040000000000000001 110.125 -179.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 961' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' C' ' 886' ' ' PHE . 71.1 p -133.41 137.66 45.9 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.056 -1.027 . . . . 1.78 112.167 -177.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 962' ' ' VAL . . . . . 0.841 HG22 ' HB3' ' C' ' 886' ' ' PHE . 25.4 m -97.31 146.46 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 C-N-CA 120.13 -0.628 . . . . 0.040000000000000001 110.184 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 5.5 t -138.59 145.23 40.32 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.952 -0.468 . . . . 0.71999999999999997 109.989 -178.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 964' ' ' VAL . . . . . 0.896 HG22 HG23 ' C' ' 911' ' ' VAL . 65.1 t -97.27 136.0 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.034 -1.041 . . . . 1.05 110.578 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -97.37 125.61 42.09 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 103.906 -2.627 . . . . 3.02 103.906 173.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 966' ' ' LEU . . . . . 0.49 ' C ' HG23 ' C' ' 967' ' ' VAL . 1.1 tp -133.11 62.95 1.65 Allowed 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.296 -1.002 . . . . 1.46 108.296 177.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 967' ' ' VAL . . . . . 0.49 HG23 ' C ' ' C' ' 966' ' ' LEU . 97.3 t -157.64 97.44 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 108.224 -1.028 . . . . 1.9399999999999999 108.224 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 95.7 mmm -141.9 59.98 1.48 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.741 -1.224 . . . . 0.0 108.541 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.07 119.99 1.99 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 107.235 -2.346 . . . . 2.1099999999999999 107.235 -178.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -82.23 -58.55 2.9 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.053 -1.263 . . . . 5.8899999999999997 110.507 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 49.0 tp -59.43 89.94 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.448 -0.782 . . . . 4.3600000000000003 110.261 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -142.16 -152.66 0.42 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.622 -0.673 . . . . 1.8300000000000001 110.09 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -117.36 167.62 11.09 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.462 -0.774 . . . . 4.3499999999999996 110.022 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 10.3 t -101.7 130.56 48.11 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.557 -0.714 . . . . 1.27 110.2 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -155.96 153.85 30.22 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.532 -0.73 . . . . 5.0199999999999996 110.384 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.27 86.23 14.76 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.588 -0.695 . . . . 2.4100000000000001 109.897 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -75.76 -170.55 0.85 Allowed 'Trans proline' 0 C--N 1.318 -1.07 0 O-C-N 123.324 1.17 . . . . 0.95999999999999996 111.223 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 978' ' ' LEU . . . . . 0.46 ' C ' HG23 ' C' ' 979' ' ' THR . 5.0 mp -123.56 156.23 36.11 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 107.497 -1.297 . . . . 0.62 107.497 177.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 979' ' ' THR . . . . . 0.46 HG23 ' C ' ' C' ' 978' ' ' LEU . 40.6 p -150.54 141.66 23.09 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.779 -1.2 . . . . 3.5699999999999998 111.251 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 980' ' ' ILE . . . . . 0.74 ' HB ' HG21 ' C' ' 899' ' ' VAL . 50.1 mm -106.08 128.55 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 109.216 -0.661 . . . . 1.3300000000000001 109.216 179.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 981' ' ' PHE . . . . . 0.436 ' CD1' ' CE2' ' C' ' 879' ' ' TYR . 2.3 t80 -118.15 97.29 5.72 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.499 -0.751 . . . . 0.050000000000000003 111.256 -178.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 982' ' ' SER . . . . . 0.42 ' HB2' HD23 ' A' ' 952' ' ' LEU . 18.2 p -108.41 159.85 16.35 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.081 -0.711 . . . . 0.87 109.081 178.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 983' ' ' GLY . . . . . 0.411 ' O ' ' CE2' ' C' ' 852' ' ' PHE . . . -169.04 115.01 0.58 Allowed Glycine 0 N--CA 1.497 2.764 0 N-CA-C 106.526 -2.629 . . . . 0.029999999999999999 106.526 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 984' ' ' ALA . . . . . 0.459 ' HB1' ' CZ ' ' A' ' 893' ' ' ARG . . . -109.26 147.95 31.78 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.156 -1.203 . . . . 0.69999999999999996 114.169 -175.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 985' ' ' LEU . . . . . 1.04 HD13 HD22 ' C' ' 890' ' ' LEU . 51.4 tp -75.38 135.06 40.82 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.809 -1.182 . . . . 0.040000000000000001 109.425 179.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 986' ' ' LEU . . . . . 0.483 HD11 ' CD1' ' B' ' 986' ' ' LEU . 48.4 tp -107.1 -61.71 1.51 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.477 -0.764 . . . . 0.040000000000000001 110.495 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -144.92 146.31 31.94 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 107.841 -1.17 . . . . 0.040000000000000001 107.841 179.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.25 162.82 12.28 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 108.097 -2.001 . . . . 0.040000000000000001 108.097 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -74.6 112.81 19.07 Favored Pre-proline 0 N--CA 1.498 1.967 0 O-C-N 121.206 -1.173 . . . . 0.040000000000000001 109.455 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 990' ' ' PRO . . . . . 0.416 ' O ' ' HB2' ' C' ' 991' ' ' GLU . 50.5 Cg_endo -88.76 70.98 2.38 Favored 'Trans proline' 0 C--N 1.32 -0.937 0 O-C-N 123.115 1.061 . . . . 0.45000000000000001 111.303 -178.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 991' ' ' GLU . . . . . 0.416 ' HB2' ' O ' ' C' ' 990' ' ' PRO . 67.7 mt-10 67.51 -73.31 0.08 Allowed 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 108.582 -0.895 . . . . 1.97 108.582 -177.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 992' ' ' LEU . . . . . . . . . . . . . 11.4 mt 50.45 20.83 0.74 Allowed 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.567 -0.708 . . . . 2.3799999999999999 111.69 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -92.91 157.01 16.58 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.936 -1.103 . . . . 3.79 110.055 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -146.32 92.0 2.12 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.579 -0.701 . . . . 3.5099999999999998 110.254 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 995' ' ' ALA . . . . . . . . . . . . 2.518 . . . . . . . 0 N--CA 1.504 2.23 0 O-C-N 120.913 -1.117 . . . . 2.73 110.564 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo . . . . . 0 N--CA 1.488 1.199 0 N-CA-C 109.451 -1.019 . . . . 3.8300000000000001 109.451 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 847' ' ' VAL . . . . . 0.401 HG12 ' HB2' ' A' ' 849' ' ' GLN . 66.6 t -134.93 102.82 10.98 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.617 -0.677 . . . . 1.8300000000000001 110.004 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 848' ' ' PRO . . . . . 0.765 ' O ' HG23 ' A' ' 850' ' ' VAL . 44.2 Cg_endo -69.83 -18.66 36.56 Favored 'Trans proline' 0 N--CA 1.488 1.155 0 O-C-N 123.344 1.181 . . . . 0.65000000000000002 111.168 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 849' ' ' GLN . . . . . 0.401 ' HB2' HG12 ' A' ' 847' ' ' VAL . 55.8 tt0 27.39 67.97 0.07 Allowed 'General case' 0 N--CA 1.518 2.927 0 N-CA-C 113.025 0.75 . . . . 2.5800000000000001 113.025 179.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 850' ' ' VAL . . . . . 0.765 HG23 ' O ' ' A' ' 848' ' ' PRO . 69.9 t -119.39 137.02 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 121.202 -0.936 . . . . 1.0900000000000001 111.442 -178.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 851' ' ' ALA . . . . . 0.641 ' HB3' ' HG ' ' A' ' 873' ' ' LEU . . . -124.13 159.0 30.99 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 105.827 -1.916 . . . . 0.040000000000000001 105.827 176.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 852' ' ' PHE . . . . . 0.431 ' HA ' ' CB ' ' A' ' 874' ' ' ASN . 32.7 p90 -159.6 127.96 4.99 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 120.948 1.704 . . . . 0.050000000000000003 108.492 178.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 7.8 t -175.71 134.42 0.29 Allowed 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.152 -1.055 . . . . 0.040000000000000001 108.152 -178.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -131.98 157.41 44.15 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.083 -1.011 . . . . 0.67000000000000004 109.626 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 855' ' ' ALA . . . . . 0.863 ' HB3' ' CB ' ' A' ' 870' ' ' ARG . . . -120.78 146.1 46.86 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-O 122.018 0.914 . . . . 0.51000000000000001 111.291 -178.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 856' ' ' LEU . . . . . 0.754 HD12 HD23 ' A' ' 978' ' ' LEU . 2.7 tm? -113.01 133.36 54.99 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.738 -0.601 . . . . 0.050000000000000003 109.872 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 857' ' ' SER . . . . . 0.659 ' N ' HD13 ' A' ' 856' ' ' LEU . 30.3 p -154.37 14.6 0.44 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.526 -0.734 . . . . 1.3300000000000001 111.683 179.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 858' ' ' LEU . . . . . 0.562 HD12 ' C ' ' A' ' 858' ' ' LEU . 4.5 pp -33.22 159.64 0.03 OUTLIER Pre-proline 0 N--CA 1.52 3.028 0 N-CA-C 113.427 0.899 . . . . 2.3300000000000001 113.427 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -61.85 -88.29 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 120.965 1.11 . . . . 2.3199999999999998 113.316 -178.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 53.6 ptt85 -128.01 -142.47 0.27 Allowed 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.887 -1.133 . . . . 0.040000000000000001 111.397 -177.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 8.8 m -41.28 129.04 2.99 Favored 'General case' 0 N--CA 1.509 2.498 0 O-C-N 121.459 -0.776 . . . . 1.3100000000000001 111.902 -179.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 862' ' ' GLU . . . . . 0.592 ' OE1' HG22 ' A' ' 866' ' ' VAL . 1.9 tt0 -94.81 152.77 39.96 Favored Pre-proline 0 N--CA 1.492 1.626 0 N-CA-C 108.107 -1.071 . . . . 4.5099999999999998 108.107 177.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 863' ' ' PRO . . . . . 0.413 ' HD2' ' CG ' ' A' ' 862' ' ' GLU . 43.5 Cg_endo -70.27 -12.22 31.55 Favored 'Trans proline' 0 C--N 1.314 -1.271 0 O-C-N 123.059 1.031 . . . . 2.2400000000000002 111.161 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -175.74 -136.07 2.25 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 110.107 -1.197 . . . . 0.040000000000000001 110.107 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 39.9 m -64.38 155.77 31.37 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.382 -1.07 . . . . 1.51 111.331 -178.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 866' ' ' VAL . . . . . 0.592 HG22 ' OE1' ' A' ' 862' ' ' GLU . 2.7 t -91.12 128.07 48.97 Favored Pre-proline 0 N--CA 1.5 2.059 0 N-CA-C 113.399 0.889 . . . . 0.78000000000000003 113.399 -174.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 867' ' ' PRO . . . . . 0.614 ' O ' HD23 ' A' ' 856' ' ' LEU . 51.3 Cg_endo -92.05 -155.62 0.05 OUTLIER 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 121.174 1.25 . . . . 0.92000000000000004 109.516 177.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 868' ' ' PHE . . . . . 0.454 ' CD1' ' HG2' ' A' ' 881' ' ' PRO . 21.1 p90 -151.73 123.64 8.06 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.654 -1.279 . . . . 0.050000000000000003 109.994 179.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 44.0 p30 -114.62 -0.72 13.55 Favored 'General case' 0 N--CA 1.501 2.109 0 C-N-CA 119.345 -0.942 . . . . 1.7 112.762 -178.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 870' ' ' ARG . . . . . 0.863 ' CB ' ' HB3' ' A' ' 855' ' ' ALA . 26.9 mmm180 -90.97 90.47 7.9 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 120.845 -1.16 . . . . 2.5899999999999999 111.099 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 60.4 t -74.7 97.13 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 120.978 -1.076 . . . . 1.9399999999999999 109.911 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 872' ' ' LEU . . . . . 0.623 HD11 ' HB2' ' A' ' 855' ' ' ALA . 96.3 mt -83.2 -46.81 12.27 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.468 -0.77 . . . . 1.0600000000000001 110.131 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 873' ' ' LEU . . . . . 0.641 ' HG ' ' HB3' ' A' ' 851' ' ' ALA . 36.9 tp -174.52 102.98 0.1 Allowed 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.521 -0.918 . . . . 4.1799999999999997 108.521 178.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 874' ' ' ASN . . . . . 0.431 ' CB ' ' HA ' ' A' ' 852' ' ' PHE . 35.4 t-20 178.73 80.86 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.3 0 O-C-N 121.622 -0.674 . . . . 0.040000000000000001 109.555 -178.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -66.7 -47.27 72.92 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.211 -0.931 . . . . 3.3799999999999999 111.204 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 876' ' ' GLY . . . . . . . . . . . . . . . -73.56 -24.86 73.86 Favored Glycine 0 N--CA 1.494 2.555 0 O-C-N 121.306 -0.871 . . . . 0.040000000000000001 111.509 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 84.0 -59.93 4.9 Favored Glycine 0 N--CA 1.502 3.041 0 N-CA-C 108.088 -2.005 . . . . 0.040000000000000001 108.088 -178.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 878' ' ' TYR . . . . . 0.447 ' CZ ' HG11 ' A' ' 850' ' ' VAL . 97.7 m-85 60.78 -65.79 0.06 Allowed 'General case' 0 N--CA 1.503 2.22 0 N-CA-C 114.206 1.188 . . . . 3.46 114.206 177.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 879' ' ' TYR . . . . . 0.555 ' HH ' ' HD1' ' A' ' 981' ' ' PHE . 21.0 p90 -112.73 109.35 18.79 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 114.833 1.42 . . . . 0.040000000000000001 114.833 -176.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.42 116.77 37.28 Favored Pre-proline 0 N--CA 1.496 1.825 0 O-C-N 121.381 -0.825 . . . . 0.02 109.647 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 881' ' ' PRO . . . . . 0.454 ' HG2' ' CD1' ' A' ' 868' ' ' PHE . 53.6 Cg_endo -75.59 -0.02 9.67 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 O-C-N 123.492 1.259 . . . . 0.39000000000000001 112.493 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -75.99 -63.15 1.38 Allowed 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 106.723 -1.584 . . . . 0.81000000000000005 106.723 178.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 41.1 p -94.1 -20.23 20.1 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.482 -0.933 . . . . 0.040000000000000001 108.482 177.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.21 20.94 58.08 Favored Glycine 0 N--CA 1.495 2.573 0 O-C-N 121.034 -1.041 . . . . 0.029999999999999999 111.385 178.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 885' ' ' VAL . . . . . . . . . . . . . 99.3 t -73.67 91.81 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 C-N-CA 118.103 -1.439 . . . . 1.01 108.196 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 886' ' ' PHE . . . . . 0.834 ' HB3' HG22 ' A' ' 962' ' ' VAL . 0.7 OUTLIER -89.87 104.75 17.29 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-N 115.118 -0.946 . . . . 0.050000000000000003 112.092 -177.143 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 887' ' ' THR . . . . . 0.445 ' O ' ' HD3' ' A' ' 889' ' ' PRO . 93.7 m -96.29 100.42 12.05 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 107.685 -1.228 . . . . 0.68000000000000005 107.685 177.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 888' ' ' ALA . . . . . . . . . . . . . . . -98.62 105.95 33.61 Favored Pre-proline 0 N--CA 1.502 2.132 0 N-CA-C 114.279 1.215 . . . . 0.25 114.279 -176.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 889' ' ' PRO . . . . . 0.445 ' HD3' ' O ' ' A' ' 887' ' ' THR . 54.1 Cg_endo -89.0 -13.37 3.09 Favored 'Trans proline' 0 CA--C 1.546 1.105 0 N-CA-C 108.935 -1.217 . . . . 1.6399999999999999 108.935 175.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 890' ' ' LEU . . . . . 0.709 HD22 HD13 ' A' ' 985' ' ' LEU . 69.3 mt -36.54 -49.97 0.77 Allowed 'General case' 0 N--CA 1.508 2.47 0 N-CA-C 113.612 0.967 . . . . 2.29 113.612 -177.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 52.09 96.03 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.189 -0.944 . . . . 0.63 110.289 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 158.0 -153.61 24.78 Favored Glycine 0 N--CA 1.478 1.468 0 N-CA-C 107.227 -2.349 . . . . 0.040000000000000001 107.227 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 893' ' ' ARG . . . . . 0.438 ' CZ ' ' HB1' ' C' ' 984' ' ' ALA . 72.9 ttt-85 -115.7 126.39 54.05 Favored 'General case' 0 C--N 1.294 -1.82 0 O-C-N 121.601 -0.94 . . . . 3.0 108.512 177.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 894' ' ' TYR . . . . . 0.742 ' OH ' HD12 ' A' ' 896' ' ' LEU . 0.1 OUTLIER -132.26 159.99 37.49 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.177 -0.952 . . . . 0.040000000000000001 111.038 -179.74 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 895' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' A' ' 895' ' ' LEU . 37.8 tp -91.77 118.49 30.74 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.69 -0.631 . . . . 1.27 110.168 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 896' ' ' LEU . . . . . 0.742 HD12 ' OH ' ' A' ' 894' ' ' TYR . 9.2 tt -110.05 142.16 41.88 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.707 -0.621 . . . . 0.93999999999999995 110.047 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 897' ' ' SER . . . . . 0.442 ' N ' HD23 ' A' ' 896' ' ' LEU . 64.1 m -148.9 115.51 5.92 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.452 -0.78 . . . . 0.040000000000000001 110.982 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.61 146.18 32.3 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.892 -0.781 . . . . 0.47999999999999998 108.892 178.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 899' ' ' VAL . . . . . 0.732 HG21 ' HB ' ' A' ' 980' ' ' ILE . 87.5 t -94.73 120.39 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.373 -0.829 . . . . 0.55000000000000004 111.033 -179.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 900' ' ' LEU . . . . . 0.619 HD12 ' HB2' ' A' ' 924' ' ' SER . 4.3 mm? -95.23 112.8 24.46 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 114.382 1.252 . . . . 1.5900000000000001 114.382 -174.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 15.6 m -66.85 141.53 57.65 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 107.334 -1.358 . . . . 0.050000000000000003 107.334 176.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -67.02 -65.83 2.62 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 110.583 -1.007 . . . . 0.029999999999999999 110.583 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 8.8 m170 46.72 66.7 0.92 Allowed 'General case' 0 N--CA 1.508 2.437 0 O-C-N 121.493 -1.004 . . . . 3.2000000000000002 111.155 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 43.2 ptt85 -69.38 -5.88 26.38 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.624 -0.672 . . . . 2.9199999999999999 112.108 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 905' ' ' HIS . . . . . 0.487 ' O ' ' CB ' ' A' ' 906' ' ' GLU . 72.7 t60 -62.32 5.03 0.12 Allowed 'General case' 0 N--CA 1.506 2.335 0 O-C-N 120.918 -1.114 . . . . 2.8700000000000001 113.155 -179.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 906' ' ' GLU . . . . . 0.487 ' CB ' ' O ' ' A' ' 905' ' ' HIS . 0.5 OUTLIER 94.63 -164.29 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.449 0 CA-C-N 120.562 1.528 . . . . 0.98999999999999999 111.824 179.007 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 907' ' ' LYS . . . . . 0.465 ' CB ' ' O ' ' A' ' 906' ' ' GLU . 63.1 tttt 85.59 156.59 0.09 Allowed 'General case' 0 N--CA 1.52 3.031 0 N-CA-C 108.024 -1.102 . . . . 5.25 108.024 -176.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 58.9 t -122.02 116.38 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 120.787 -1.196 . . . . 0.39000000000000001 111.099 -179.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -99.82 133.21 44.52 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 107.319 -1.363 . . . . 1.72 107.319 176.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -155.92 121.94 5.04 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 106.842 -1.54 . . . . 0.67000000000000004 106.842 178.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 911' ' ' VAL . . . . . 0.814 HG22 HG13 ' A' ' 964' ' ' VAL . 87.3 t -84.06 132.15 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.86 -0.525 . . . . 0.54000000000000004 110.783 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 62.2 mt -65.63 156.42 32.84 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.404 -0.81 . . . . 1.5 109.025 178.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 913' ' ' SER . . . . . 0.413 ' CB ' ' CG1' ' A' ' 919' ' ' VAL . 1.3 t -123.02 138.4 54.7 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.316 -0.994 . . . . 1.3700000000000001 108.316 177.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 914' ' ' ARG . . . . . 0.624 ' NH1' HD23 ' A' ' 956' ' ' LEU . 0.0 OUTLIER -65.15 154.79 36.94 Favored 'General case' 0 N--CA 1.505 2.284 0 O-C-N 120.762 -1.211 . . . . 4.2999999999999998 111.751 -179.049 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 915' ' ' SER . . . . . 0.426 ' CB ' ' O ' ' A' ' 914' ' ' ARG . 4.7 t 83.07 -32.71 0.08 Allowed 'General case' 0 N--CA 1.522 3.136 0 C-N-CA 123.979 0.911 . . . . 2.0499999999999998 112.254 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 916' ' ' ASN . . . . . 0.767 ' HB2' HG21 ' A' ' 919' ' ' VAL . 92.9 m-20 -121.1 -20.46 6.79 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.947 -1.095 . . . . 2.71 111.469 -179.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 917' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 66.82 165.04 0.21 Allowed 'General case' 0 N--CA 1.521 3.111 0 N-CA-C 105.452 -2.055 . . . . 2.6800000000000002 105.452 -173.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.33 -125.38 33.82 Favored Glycine 1 N--CA 1.521 4.357 0 CA-C-N 123.545 2.884 . . . . 0.029999999999999999 106.987 -177.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 919' ' ' VAL . . . . . 0.767 HG21 ' HB2' ' A' ' 916' ' ' ASN . 78.6 t 51.58 94.9 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 O-C-N 121.513 -0.992 . . . . 1.3899999999999999 108.996 -178.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 920' ' ' ALA . . . . . 0.858 ' HB3' HG12 ' A' ' 949' ' ' VAL . . . -91.38 92.29 8.51 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.246 -0.982 . . . . 0.029999999999999999 110.902 -179.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 921' ' ' ARG . . . . . 0.886 ' HG3' HG23 ' A' ' 922' ' ' VAL . 27.5 ptt180 -83.9 -41.76 17.07 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 105.756 -1.942 . . . . 4.4199999999999999 105.756 175.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 922' ' ' VAL . . . . . 0.886 HG23 ' HG3' ' A' ' 921' ' ' ARG . 78.7 t -102.19 73.44 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 106.308 -1.738 . . . . 0.84999999999999998 106.308 175.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -86.82 133.75 33.61 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.643 0.735 . . . . 2.46 111.231 -177.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 924' ' ' SER . . . . . 0.619 ' HB2' HD12 ' A' ' 900' ' ' LEU . 28.0 t -147.83 105.9 3.74 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.907 -0.775 . . . . 0.69999999999999996 108.907 179.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -102.91 83.65 0.44 Allowed Glycine 0 N--CA 1.487 2.043 0 N-CA-C 108.277 -1.929 . . . . 0.040000000000000001 108.277 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.126 0 N-CA-C 108.67 -1.772 . . . . 0.040000000000000001 108.67 -179.709 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 33.0 m . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.012 0.434 . . . . 13.779999999999999 110.21 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 96.2 mt -112.44 129.44 56.32 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.666 -0.646 . . . . 13.76 110.365 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -152.34 168.03 31.41 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 108.967 -1.653 . . . . 9.1300000000000008 108.967 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 949' ' ' VAL . . . . . 0.858 HG12 ' HB3' ' A' ' 920' ' ' ALA . 34.9 m -119.38 130.77 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.502 -0.999 . . . . 7.0800000000000001 110.998 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 950' ' ' PHE . . . . . 0.455 ' CE1' ' HD2' ' A' ' 955' ' ' PRO . 25.5 p90 -133.24 150.51 51.94 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.565 -0.709 . . . . 7.5899999999999999 109.149 179.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 19.5 m -120.66 -53.19 2.1 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.341 -0.85 . . . . 5.0300000000000002 112.314 -178.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 952' ' ' LEU . . . . . 0.427 ' O ' ' O ' ' A' ' 953' ' ' ILE . 13.6 tp -60.39 -73.01 0.1 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.411 -0.805 . . . . 1.01 112.576 -177.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 953' ' ' ILE . . . . . 0.948 HD11 HD13 ' C' ' 872' ' ' LEU . 46.1 pt -52.6 -145.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.768 0 N-CA-C 114.06 1.133 . . . . 2.6000000000000001 114.06 -176.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 954' ' ' LEU . . . . . 0.708 HD22 ' O ' ' A' ' 954' ' ' LEU . 0.0 OUTLIER 171.84 77.45 0.04 OUTLIER Pre-proline 0 N--CA 1.51 2.554 0 O-C-N 120.768 -1.208 . . . . 0.050000000000000003 111.461 179.555 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 955' ' ' PRO . . . . . 0.69 ' C ' HD12 ' A' ' 956' ' ' LEU . 48.4 Cg_endo -74.88 96.41 1.01 Allowed 'Trans proline' 0 C--N 1.315 -1.227 0 N-CA-C 109.521 -0.992 . . . . 0.83999999999999997 109.521 178.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 956' ' ' LEU . . . . . 0.69 HD12 ' C ' ' A' ' 955' ' ' PRO . 10.4 mp -123.03 145.68 48.31 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.197 -0.939 . . . . 0.040000000000000001 110.214 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -83.71 150.41 25.86 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 117.773 -1.108 . . . . 1.28 111.675 -179.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -70.4 119.87 15.22 Favored 'General case' 0 N--CA 1.51 2.526 0 CA-C-N 122.967 2.621 . . . . 0.17000000000000001 111.558 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.6 -22.77 31.5 Favored Glycine 0 N--CA 1.501 3.008 0 N-CA-C 111.16 -0.776 . . . . 0.040000000000000001 111.16 178.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 960' ' ' ASP . . . . . 0.438 ' HB3' ' NE ' ' A' ' 914' ' ' ARG . 0.6 OUTLIER -52.14 172.14 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.49 -1.006 . . . . 0.040000000000000001 110.403 -179.409 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 961' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 886' ' ' PHE . 7.2 t -134.77 134.6 41.11 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.008 -1.058 . . . . 1.78 111.849 -178.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 962' ' ' VAL . . . . . 0.834 HG22 ' HB3' ' A' ' 886' ' ' PHE . 31.7 m -99.01 145.91 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 C-N-CA 120.074 -0.65 . . . . 0.040000000000000001 110.44 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 5.3 t -139.0 145.24 39.43 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.853 -0.529 . . . . 0.71999999999999997 110.115 -178.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 964' ' ' VAL . . . . . 0.814 HG13 HG22 ' A' ' 911' ' ' VAL . 55.5 t -94.12 136.57 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.105 -0.997 . . . . 1.05 110.714 -179.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -95.81 126.79 41.31 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 103.665 -2.717 . . . . 3.02 103.665 173.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 966' ' ' LEU . . . . . 0.492 ' C ' HG23 ' A' ' 967' ' ' VAL . 20.8 tp -132.6 62.35 1.65 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.304 -0.999 . . . . 1.46 108.304 177.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 967' ' ' VAL . . . . . 0.492 HG23 ' C ' ' A' ' 966' ' ' LEU . 89.9 t -158.21 97.19 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 108.049 -1.093 . . . . 1.9399999999999999 108.049 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 88.8 mmm -142.99 59.37 1.42 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.737 -1.227 . . . . 0.0 108.184 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.44 119.91 1.96 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 106.957 -2.457 . . . . 2.1099999999999999 106.957 -178.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -81.55 -57.9 3.26 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 118.696 1.248 . . . . 5.8899999999999997 110.368 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 44.2 tp -58.82 90.58 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.501 -0.75 . . . . 4.3600000000000003 110.203 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -141.43 -155.02 0.55 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.562 -0.711 . . . . 1.8300000000000001 110.344 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -119.79 172.03 7.99 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.476 -0.765 . . . . 4.3499999999999996 110.38 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 29.2 t -101.51 130.32 47.76 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.537 -0.727 . . . . 1.27 110.102 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -156.44 158.35 37.14 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.511 -0.743 . . . . 5.0199999999999996 110.548 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.72 86.36 15.91 Favored Pre-proline 0 N--CA 1.501 2.094 0 O-C-N 121.602 -0.686 . . . . 2.4100000000000001 109.713 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.07 -172.8 1.07 Allowed 'Trans proline' 0 C--N 1.317 -1.093 0 O-C-N 123.271 1.143 . . . . 0.95999999999999996 111.547 -179.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 978' ' ' LEU . . . . . 0.754 HD23 HD12 ' A' ' 856' ' ' LEU . 5.2 mp -127.93 154.73 45.22 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 107.577 -1.268 . . . . 0.62 107.577 178.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 979' ' ' THR . . . . . 0.449 HG23 ' C ' ' A' ' 978' ' ' LEU . 33.7 p -150.34 142.15 23.75 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.809 -1.182 . . . . 3.5699999999999998 111.368 -179.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 980' ' ' ILE . . . . . 0.732 ' HB ' HG21 ' A' ' 899' ' ' VAL . 46.8 mm -106.5 127.44 61.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 108.798 -0.815 . . . . 1.3300000000000001 108.798 179.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 981' ' ' PHE . . . . . 0.555 ' HD1' ' HH ' ' A' ' 879' ' ' TYR . 5.7 t80 -119.49 97.48 5.67 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 119.762 -0.775 . . . . 0.050000000000000003 111.726 -178.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 77.8 p -108.55 158.48 17.52 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.485 -0.759 . . . . 0.87 109.331 178.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 983' ' ' GLY . . . . . 0.403 ' O ' ' CE1' ' A' ' 852' ' ' PHE . . . -174.98 107.55 0.24 Allowed Glycine 0 N--CA 1.499 2.859 0 N-CA-C 106.452 -2.659 . . . . 0.029999999999999999 106.452 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -108.75 152.5 24.77 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 114.507 1.299 . . . . 0.69999999999999996 114.507 -175.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 985' ' ' LEU . . . . . 0.709 HD13 HD22 ' A' ' 890' ' ' LEU . 53.1 tp -71.29 134.03 46.49 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.793 -1.192 . . . . 0.040000000000000001 110.141 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 45.9 tp -107.61 -56.13 2.26 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.552 -0.718 . . . . 0.040000000000000001 109.804 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -145.26 145.2 31.18 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 107.701 -1.222 . . . . 0.040000000000000001 107.701 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -113.02 163.32 12.15 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 108.293 -1.923 . . . . 0.040000000000000001 108.293 179.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -75.44 112.69 20.27 Favored Pre-proline 0 N--CA 1.5 2.026 0 O-C-N 121.256 -1.144 . . . . 0.040000000000000001 109.485 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 990' ' ' PRO . . . . . 0.417 ' HD2' HD12 ' A' ' 992' ' ' LEU . 50.7 Cg_endo -90.19 70.92 1.56 Allowed 'Trans proline' 0 C--N 1.319 -1.004 0 O-C-N 123.134 1.07 . . . . 0.45000000000000001 111.514 -179.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 991' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 990' ' ' PRO . 70.6 mt-10 67.37 -73.61 0.08 Allowed 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 108.584 -0.895 . . . . 1.97 108.584 -177.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 992' ' ' LEU . . . . . 0.417 HD12 ' HD2' ' A' ' 990' ' ' PRO . 10.9 mt 51.05 20.58 0.85 Allowed 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.502 -0.749 . . . . 2.3799999999999999 111.638 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 83.6 mt-10 -94.09 156.87 16.36 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.879 -1.138 . . . . 3.79 110.085 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 72.4 m80 -146.63 93.33 2.27 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.526 -0.734 . . . . 3.5099999999999998 110.311 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 995' ' ' ALA . . . . . . . . . . . . 2.518 . . . . . . . 0 N--CA 1.503 2.198 0 O-C-N 120.831 -1.168 . . . . 2.73 110.614 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo . . . . . 0 N--CA 1.488 1.18 0 N-CA-C 109.429 -1.027 . . . . 3.8300000000000001 109.429 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 847' ' ' VAL . . . . . . . . . . . . . 66.4 t -134.93 102.91 10.94 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.557 -0.715 . . . . 1.8300000000000001 110.041 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 848' ' ' PRO . . . . . 0.772 ' O ' HG23 ' B' ' 850' ' ' VAL . 44.2 Cg_endo -69.81 -18.93 36.51 Favored 'Trans proline' 0 N--CA 1.488 1.167 0 O-C-N 123.319 1.168 . . . . 0.65000000000000002 111.136 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 849' ' ' GLN . . . . . 0.405 ' C ' ' O ' ' B' ' 848' ' ' PRO . 55.9 tt0 27.59 68.22 0.07 Allowed 'General case' 0 N--CA 1.518 2.953 0 N-CA-C 112.951 0.723 . . . . 2.5800000000000001 112.951 179.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 850' ' ' VAL . . . . . 0.772 HG23 ' O ' ' B' ' 848' ' ' PRO . 68.0 t -119.62 137.13 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.193 -0.942 . . . . 1.0900000000000001 111.427 -179.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 851' ' ' ALA . . . . . 0.643 ' HB3' ' HG ' ' B' ' 873' ' ' LEU . . . -124.71 158.21 33.77 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 105.828 -1.916 . . . . 0.040000000000000001 105.828 176.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 852' ' ' PHE . . . . . 0.425 ' HA ' ' CB ' ' B' ' 874' ' ' ASN . 32.1 p90 -158.82 128.27 5.61 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 121.056 1.753 . . . . 0.050000000000000003 108.493 179.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 7.6 t -175.79 134.09 0.28 Allowed 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.245 -1.021 . . . . 0.040000000000000001 108.245 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -131.49 157.76 42.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.106 -0.996 . . . . 0.67000000000000004 109.668 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 855' ' ' ALA . . . . . 0.854 ' HB3' ' CB ' ' B' ' 870' ' ' ARG . . . -121.1 146.15 47.04 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.997 0.903 . . . . 0.51000000000000001 111.287 -178.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 856' ' ' LEU . . . . . 0.726 HD12 HD23 ' B' ' 978' ' ' LEU . 2.7 tm? -113.17 132.83 55.32 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.712 -0.617 . . . . 0.050000000000000003 109.971 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 857' ' ' SER . . . . . 0.654 ' N ' HD13 ' B' ' 856' ' ' LEU . 30.1 p -153.97 14.92 0.48 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.521 -0.737 . . . . 1.3300000000000001 111.711 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 858' ' ' LEU . . . . . 0.56 HD12 ' C ' ' B' ' 858' ' ' LEU . 4.5 pp -33.46 159.69 0.03 OUTLIER Pre-proline 0 N--CA 1.52 3.052 0 N-CA-C 113.401 0.889 . . . . 2.3300000000000001 113.401 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -61.96 -88.39 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 121.013 1.142 . . . . 2.3199999999999998 113.235 -178.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 53.6 ptt85 -127.94 -142.53 0.27 Allowed 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.893 -1.13 . . . . 0.040000000000000001 111.405 -177.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 8.8 m -41.21 128.29 2.88 Favored 'General case' 0 N--CA 1.509 2.482 0 O-C-N 121.383 -0.823 . . . . 1.3100000000000001 111.909 -179.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 862' ' ' GLU . . . . . 0.589 ' OE1' HG22 ' B' ' 866' ' ' VAL . 1.9 tt0 -94.09 152.81 40.67 Favored Pre-proline 0 N--CA 1.491 1.592 0 N-CA-C 108.085 -1.08 . . . . 4.5099999999999998 108.085 177.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 863' ' ' PRO . . . . . 0.411 ' HD2' ' CG ' ' B' ' 862' ' ' GLU . 43.1 Cg_endo -70.14 -12.36 32.03 Favored 'Trans proline' 0 C--N 1.314 -1.248 0 O-C-N 123.086 1.045 . . . . 2.2400000000000002 111.25 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -175.42 -134.92 1.99 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.063 -1.215 . . . . 0.040000000000000001 110.063 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 41.5 m -65.49 156.76 31.49 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.294 -1.121 . . . . 1.51 111.247 -178.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 866' ' ' VAL . . . . . 0.589 HG22 ' OE1' ' B' ' 862' ' ' GLU . 2.7 t -91.96 127.99 47.44 Favored Pre-proline 0 N--CA 1.499 1.995 0 N-CA-C 113.424 0.898 . . . . 0.78000000000000003 113.424 -174.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 867' ' ' PRO . . . . . 0.617 ' O ' HD23 ' B' ' 856' ' ' LEU . 51.8 Cg_endo -92.01 -155.81 0.05 OUTLIER 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 121.149 1.233 . . . . 0.92000000000000004 109.547 177.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 868' ' ' PHE . . . . . 0.46 ' CD1' ' HG2' ' B' ' 881' ' ' PRO . 21.7 p90 -151.56 123.43 8.06 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.636 -1.29 . . . . 0.050000000000000003 110.019 179.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 44.2 p30 -114.46 -0.32 13.79 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.2 -0.938 . . . . 1.7 112.815 -178.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 870' ' ' ARG . . . . . 0.854 ' CB ' ' HB3' ' B' ' 855' ' ' ALA . 26.7 mmm180 -91.45 90.16 7.54 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.86 -1.15 . . . . 2.5899999999999999 111.145 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 59.6 t -74.42 97.2 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 120.951 -1.093 . . . . 1.9399999999999999 109.959 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 872' ' ' LEU . . . . . 0.628 HD11 ' HB2' ' B' ' 855' ' ' ALA . 96.2 mt -83.34 -46.67 12.32 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.492 -0.755 . . . . 1.0600000000000001 110.14 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 873' ' ' LEU . . . . . 0.643 ' HG ' ' HB3' ' B' ' 851' ' ' ALA . 36.9 tp -174.54 102.99 0.1 Allowed 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 108.507 -0.923 . . . . 4.1799999999999997 108.507 178.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 874' ' ' ASN . . . . . 0.425 ' CB ' ' HA ' ' B' ' 852' ' ' PHE . 35.4 t-20 178.73 81.12 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.337 0 O-C-N 121.63 -0.668 . . . . 0.040000000000000001 109.552 -178.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -66.94 -47.28 72.15 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.127 -0.983 . . . . 3.3799999999999999 111.198 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 876' ' ' GLY . . . . . . . . . . . . . . . -73.56 -24.98 73.6 Favored Glycine 0 N--CA 1.494 2.521 0 O-C-N 121.305 -0.872 . . . . 0.040000000000000001 111.454 -178.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 84.14 -59.78 4.91 Favored Glycine 0 N--CA 1.501 3.001 0 N-CA-C 108.075 -2.01 . . . . 0.040000000000000001 108.075 -178.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 878' ' ' TYR . . . . . 0.44 ' CZ ' HG11 ' B' ' 850' ' ' VAL . 97.7 m-85 60.82 -65.73 0.06 Allowed 'General case' 0 N--CA 1.503 2.189 0 N-CA-C 114.226 1.195 . . . . 3.46 114.226 177.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 879' ' ' TYR . . . . . 0.495 ' HH ' ' HD1' ' B' ' 981' ' ' PHE . 21.1 p90 -112.8 109.31 18.7 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 114.769 1.396 . . . . 0.040000000000000001 114.769 -176.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.25 116.72 36.28 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.343 -0.848 . . . . 0.02 109.698 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 881' ' ' PRO . . . . . 0.46 ' HG2' ' CD1' ' B' ' 868' ' ' PHE . 53.9 Cg_endo -75.53 -0.22 9.88 Favored 'Trans proline' 0 N--CA 1.497 1.709 0 O-C-N 123.47 1.247 . . . . 0.39000000000000001 112.534 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -75.7 -63.55 1.27 Allowed 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 106.716 -1.587 . . . . 0.81000000000000005 106.716 178.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 41.4 p -93.91 -19.9 20.52 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.482 -0.933 . . . . 0.040000000000000001 108.482 177.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.76 21.4 57.85 Favored Glycine 0 N--CA 1.494 2.556 0 O-C-N 121.05 -1.031 . . . . 0.029999999999999999 111.369 178.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 885' ' ' VAL . . . . . . . . . . . . . 98.8 t -73.91 92.14 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 C-N-CA 118.084 -1.446 . . . . 1.01 108.06 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 886' ' ' PHE . . . . . 0.879 ' HB3' HG22 ' B' ' 962' ' ' VAL . 0.7 OUTLIER -90.1 104.87 17.4 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 115.119 -0.946 . . . . 0.050000000000000003 112.085 -177.192 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 887' ' ' THR . . . . . 0.442 ' O ' ' HD3' ' B' ' 889' ' ' PRO . 93.9 m -96.41 100.67 12.26 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 107.63 -1.248 . . . . 0.68000000000000005 107.63 177.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 888' ' ' ALA . . . . . . . . . . . . . . . -98.87 105.86 33.91 Favored Pre-proline 0 N--CA 1.502 2.125 0 N-CA-C 114.267 1.21 . . . . 0.25 114.267 -176.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 889' ' ' PRO . . . . . 0.442 ' HD3' ' O ' ' B' ' 887' ' ' THR . 54.1 Cg_endo -88.9 -13.44 3.14 Favored 'Trans proline' 0 CA--C 1.546 1.118 0 N-CA-C 108.982 -1.199 . . . . 1.6399999999999999 108.982 175.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 890' ' ' LEU . . . . . 0.72 HD22 HD13 ' B' ' 985' ' ' LEU . 69.7 mt -36.39 -50.09 0.75 Allowed 'General case' 0 N--CA 1.508 2.457 0 N-CA-C 113.612 0.967 . . . . 2.29 113.612 -177.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 52.1 95.95 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.259 0 O-C-N 121.135 -0.978 . . . . 0.63 110.25 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . 158.05 -153.72 24.88 Favored Glycine 0 N--CA 1.478 1.496 0 N-CA-C 107.18 -2.368 . . . . 0.040000000000000001 107.18 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 72.8 ttt-85 -115.61 126.41 54.15 Favored 'General case' 0 C--N 1.295 -1.778 0 O-C-N 121.581 -0.952 . . . . 3.0 108.529 177.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 894' ' ' TYR . . . . . 0.74 ' OH ' HD12 ' B' ' 896' ' ' LEU . 0.1 OUTLIER -132.17 160.19 36.78 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.182 -0.949 . . . . 0.040000000000000001 111.041 -179.754 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 895' ' ' LEU . . . . . 0.4 HD23 HD11 ' C' ' 952' ' ' LEU . 37.9 tp -92.1 118.49 30.86 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.654 -0.654 . . . . 1.27 110.141 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 896' ' ' LEU . . . . . 0.74 HD12 ' OH ' ' B' ' 894' ' ' TYR . 9.2 tt -110.0 141.59 42.58 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.761 -0.587 . . . . 0.93999999999999995 110.106 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 897' ' ' SER . . . . . 0.433 ' N ' HD23 ' B' ' 896' ' ' LEU . 64.4 m -148.35 115.26 6.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.478 -0.764 . . . . 0.040000000000000001 111.032 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.26 146.07 31.93 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.989 -0.745 . . . . 0.47999999999999998 108.989 178.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 899' ' ' VAL . . . . . 0.721 HG21 ' HB ' ' B' ' 980' ' ' ILE . 88.0 t -94.64 120.15 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 C-N-CA 119.653 -0.819 . . . . 0.55000000000000004 111.138 -179.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 900' ' ' LEU . . . . . 0.619 HD12 ' HB2' ' B' ' 924' ' ' SER . 4.3 mm? -95.02 112.45 24.16 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 114.457 1.281 . . . . 1.5900000000000001 114.457 -174.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 15.3 m -66.58 141.44 57.84 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 107.319 -1.363 . . . . 0.050000000000000003 107.319 176.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -67.24 -65.84 2.6 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 110.608 -0.997 . . . . 0.029999999999999999 110.608 -179.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 8.8 m170 46.73 66.76 0.9 Allowed 'General case' 0 N--CA 1.508 2.453 0 O-C-N 121.492 -1.005 . . . . 3.2000000000000002 111.155 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 43.1 ptt85 -69.32 -6.28 28.58 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.62 -0.675 . . . . 2.9199999999999999 112.084 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 905' ' ' HIS . . . . . 0.485 ' O ' ' CB ' ' B' ' 906' ' ' GLU . 72.6 t60 -61.66 4.47 0.11 Allowed 'General case' 0 N--CA 1.505 2.324 0 O-C-N 120.929 -1.107 . . . . 2.8700000000000001 113.198 -179.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 906' ' ' GLU . . . . . 0.485 ' CB ' ' O ' ' B' ' 905' ' ' HIS . 0.5 OUTLIER 94.96 -164.44 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.439 0 CA-C-N 120.561 1.528 . . . . 0.98999999999999999 111.668 179.063 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 907' ' ' LYS . . . . . 0.472 ' CB ' ' O ' ' B' ' 906' ' ' GLU . 63.2 tttt 85.75 156.3 0.08 Allowed 'General case' 0 N--CA 1.52 3.035 0 N-CA-C 108.095 -1.076 . . . . 5.25 108.095 -176.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 59.2 t -121.81 116.18 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 120.814 -1.179 . . . . 0.39000000000000001 111.152 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -99.57 133.42 43.93 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 107.274 -1.38 . . . . 1.72 107.274 176.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -156.21 122.08 4.95 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 106.879 -1.526 . . . . 0.67000000000000004 106.879 178.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 911' ' ' VAL . . . . . 0.795 HG22 HG13 ' B' ' 964' ' ' VAL . 87.0 t -84.27 132.38 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.842 -0.536 . . . . 0.54000000000000004 110.813 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 63.0 mt -65.72 156.75 32.07 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.333 -0.854 . . . . 1.5 108.946 178.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 913' ' ' SER . . . . . 0.408 ' CB ' ' CG1' ' B' ' 919' ' ' VAL . 1.4 t -123.57 137.48 54.74 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.393 -0.965 . . . . 1.3700000000000001 108.393 177.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 914' ' ' ARG . . . . . 0.621 ' NH1' HD23 ' B' ' 956' ' ' LEU . 0.0 OUTLIER -64.12 154.64 33.99 Favored 'General case' 0 N--CA 1.505 2.311 0 O-C-N 120.77 -1.206 . . . . 4.2999999999999998 111.888 -178.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 915' ' ' SER . . . . . 0.419 ' CB ' ' O ' ' B' ' 914' ' ' ARG . 4.7 t 83.2 -33.0 0.08 Allowed 'General case' 0 N--CA 1.521 3.114 0 C-N-CA 124.017 0.927 . . . . 2.0499999999999998 112.272 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 916' ' ' ASN . . . . . 0.806 ' HB2' HG21 ' B' ' 919' ' ' VAL . 92.4 m-20 -120.74 -20.76 6.89 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 120.909 -1.119 . . . . 2.71 111.46 -179.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 917' ' ' GLN . . . . . 0.4 ' HB2' ' O ' ' B' ' 916' ' ' ASN . 41.8 mt-30 66.83 164.46 0.2 Allowed 'General case' 0 N--CA 1.521 3.116 0 N-CA-C 105.472 -2.047 . . . . 2.6800000000000002 105.472 -173.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 55.09 -125.5 35.99 Favored Glycine 1 N--CA 1.521 4.349 0 CA-C-N 123.567 2.894 . . . . 0.029999999999999999 106.8 -177.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 919' ' ' VAL . . . . . 0.806 HG21 ' HB2' ' B' ' 916' ' ' ASN . 82.3 t 51.39 95.05 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.253 0 O-C-N 121.476 -1.014 . . . . 1.3899999999999999 109.062 -178.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 920' ' ' ALA . . . . . 0.845 ' HB3' HG12 ' B' ' 949' ' ' VAL . . . -91.51 92.16 8.39 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.31 -0.956 . . . . 0.029999999999999999 110.844 -179.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 921' ' ' ARG . . . . . 0.87 ' HG3' HG23 ' B' ' 922' ' ' VAL . 27.5 ptt180 -83.96 -41.73 17.01 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 105.738 -1.949 . . . . 4.4199999999999999 105.738 175.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 922' ' ' VAL . . . . . 0.87 HG23 ' HG3' ' B' ' 921' ' ' ARG . 77.9 t -102.16 73.14 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 N-CA-C 106.375 -1.713 . . . . 0.84999999999999998 106.375 175.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -86.49 133.76 33.72 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.637 0.732 . . . . 2.46 111.241 -177.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 924' ' ' SER . . . . . 0.619 ' HB2' HD12 ' B' ' 900' ' ' LEU . 27.8 t -147.83 105.77 3.72 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 108.974 -0.75 . . . . 0.69999999999999996 108.974 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -102.69 83.57 0.45 Allowed Glycine 0 N--CA 1.486 1.968 0 N-CA-C 108.37 -1.892 . . . . 0.040000000000000001 108.37 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 926' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' B' ' 906' ' ' GLU . . . . . . . . 0 N--CA 1.488 2.156 0 N-CA-C 108.661 -1.776 . . . . 0.040000000000000001 108.661 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 32.7 m . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.078 0.466 . . . . 13.779999999999999 110.162 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 96.2 mt -111.03 129.4 55.92 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.581 -0.699 . . . . 13.76 110.325 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -151.73 166.76 30.89 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.114 -1.594 . . . . 9.1300000000000008 109.114 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 949' ' ' VAL . . . . . 0.845 HG12 ' HB3' ' B' ' 920' ' ' ALA . 35.5 m -118.81 130.24 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.519 -0.989 . . . . 7.0800000000000001 110.967 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 950' ' ' PHE . . . . . 0.448 ' CE1' ' HD2' ' B' ' 955' ' ' PRO . 25.5 p90 -133.03 150.41 52.13 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.546 -0.721 . . . . 7.5899999999999999 109.162 179.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 19.5 m -120.67 -52.76 2.11 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.367 -0.833 . . . . 5.0300000000000002 112.252 -178.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 952' ' ' LEU . . . . . 0.418 ' O ' ' O ' ' B' ' 953' ' ' ILE . 13.6 tp -60.62 -73.22 0.09 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.365 -0.835 . . . . 1.01 112.382 -177.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 953' ' ' ILE . . . . . 0.5 ' O ' ' HB3' ' B' ' 954' ' ' LEU . 46.0 pt -52.26 -144.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.779 0 N-CA-C 114.177 1.177 . . . . 2.6000000000000001 114.177 -176.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 954' ' ' LEU . . . . . 0.726 HD22 ' O ' ' B' ' 954' ' ' LEU . 0.0 OUTLIER 171.64 77.23 0.04 OUTLIER Pre-proline 0 N--CA 1.51 2.526 0 O-C-N 120.808 -1.183 . . . . 0.050000000000000003 111.39 179.478 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 955' ' ' PRO . . . . . 0.699 ' C ' HD12 ' B' ' 956' ' ' LEU . 48.2 Cg_endo -74.89 96.54 1.02 Allowed 'Trans proline' 0 C--N 1.313 -1.295 0 N-CA-C 109.481 -1.007 . . . . 0.83999999999999997 109.481 178.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 956' ' ' LEU . . . . . 0.699 HD12 ' C ' ' B' ' 955' ' ' PRO . 10.4 mp -123.11 145.62 48.42 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.125 -0.984 . . . . 0.040000000000000001 110.166 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 16.1 mt-30 -83.58 150.66 25.8 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 117.866 -1.064 . . . . 1.28 111.645 -179.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -70.5 119.62 14.93 Favored 'General case' 0 N--CA 1.51 2.545 0 CA-C-N 122.845 2.566 . . . . 0.17000000000000001 111.579 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.74 -22.98 30.72 Favored Glycine 0 N--CA 1.501 3.021 0 N-CA-C 111.111 -0.796 . . . . 0.040000000000000001 111.111 178.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 960' ' ' ASP . . . . . 0.44 ' HB3' ' NE ' ' B' ' 914' ' ' ARG . 0.6 OUTLIER -51.86 172.15 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.53 -0.982 . . . . 0.040000000000000001 110.358 -179.403 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 961' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' B' ' 886' ' ' PHE . 7.1 t -134.73 134.71 41.3 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.986 -1.071 . . . . 1.78 111.855 -178.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 962' ' ' VAL . . . . . 0.879 HG22 ' HB3' ' B' ' 886' ' ' PHE . 31.1 m -99.17 145.8 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 C-N-CA 120.072 -0.651 . . . . 0.040000000000000001 110.453 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 5.3 t -138.79 145.23 39.88 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.861 -0.524 . . . . 0.71999999999999997 110.191 -178.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 964' ' ' VAL . . . . . 0.795 HG13 HG22 ' B' ' 911' ' ' VAL . 55.2 t -94.24 136.32 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.11 -0.994 . . . . 1.05 110.717 -179.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -95.72 126.37 40.94 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 103.755 -2.683 . . . . 3.02 103.755 173.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 966' ' ' LEU . . . . . 0.494 ' C ' HG23 ' B' ' 967' ' ' VAL . 20.8 tp -132.23 62.52 1.64 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.35 -0.981 . . . . 1.46 108.35 177.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 967' ' ' VAL . . . . . 0.494 HG23 ' C ' ' B' ' 966' ' ' LEU . 89.8 t -158.42 97.01 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 N-CA-C 108.095 -1.076 . . . . 1.9399999999999999 108.095 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 88.7 mmm -142.77 59.19 1.43 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.765 -1.21 . . . . 0.0 108.281 178.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.53 119.69 1.93 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 107.0 -2.44 . . . . 2.1099999999999999 107.0 -178.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -81.22 -57.86 3.32 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.063 -1.257 . . . . 5.8899999999999997 110.435 -179.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 44.2 tp -58.91 90.37 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.465 -0.772 . . . . 4.3600000000000003 110.223 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -141.27 -154.91 0.54 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.575 -0.703 . . . . 1.8300000000000001 110.304 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -119.86 172.1 7.95 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.464 -0.773 . . . . 4.3499999999999996 110.38 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 29.5 t -101.52 130.29 47.77 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.565 -0.709 . . . . 1.27 110.145 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -156.41 158.35 37.18 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.504 -0.747 . . . . 5.0199999999999996 110.553 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.7 86.32 16.0 Favored Pre-proline 0 N--CA 1.5 2.06 0 O-C-N 121.614 -0.679 . . . . 2.4100000000000001 109.7 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -73.12 -172.83 1.09 Allowed 'Trans proline' 0 C--N 1.317 -1.123 0 O-C-N 123.344 1.181 . . . . 0.95999999999999996 111.514 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 978' ' ' LEU . . . . . 0.726 HD23 HD12 ' B' ' 856' ' ' LEU . 5.2 mp -127.81 154.91 44.88 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.644 -1.243 . . . . 0.62 107.644 178.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 979' ' ' THR . . . . . 0.453 HG23 ' C ' ' B' ' 978' ' ' LEU . 33.7 p -150.51 142.16 23.62 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.81 -1.181 . . . . 3.5699999999999998 111.384 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 980' ' ' ILE . . . . . 0.721 ' HB ' HG21 ' B' ' 899' ' ' VAL . 47.0 mm -106.49 127.06 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 108.765 -0.828 . . . . 1.3300000000000001 108.765 179.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 981' ' ' PHE . . . . . 0.495 ' HD1' ' HH ' ' B' ' 879' ' ' TYR . 5.6 t80 -119.27 97.64 5.76 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.458 -0.776 . . . . 0.050000000000000003 111.767 -178.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 982' ' ' SER . . . . . 0.4 ' HB2' HD23 ' C' ' 952' ' ' LEU . 77.8 p -109.02 159.0 17.19 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.544 -0.722 . . . . 0.87 109.428 178.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 983' ' ' GLY . . . . . 0.402 ' HA3' ' CE1' ' B' ' 852' ' ' PHE . . . -175.01 107.77 0.25 Allowed Glycine 0 N--CA 1.499 2.869 0 N-CA-C 106.53 -2.628 . . . . 0.029999999999999999 106.53 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -108.62 152.33 24.93 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 114.44 1.274 . . . . 0.69999999999999996 114.44 -175.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 985' ' ' LEU . . . . . 0.72 HD13 HD22 ' B' ' 890' ' ' LEU . 53.3 tp -71.26 134.03 46.52 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.9 -1.125 . . . . 0.040000000000000001 110.108 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 986' ' ' LEU . . . . . 0.488 ' CD1' HD11 ' C' ' 986' ' ' LEU . 45.8 tp -107.62 -56.17 2.26 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.591 -0.693 . . . . 0.040000000000000001 109.923 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -145.34 145.05 31.05 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 107.737 -1.208 . . . . 0.040000000000000001 107.737 178.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.92 163.02 12.18 Favored Glycine 0 N--CA 1.496 2.653 0 N-CA-C 108.21 -1.956 . . . . 0.040000000000000001 108.21 179.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -75.13 112.76 19.73 Favored Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 121.165 -1.197 . . . . 0.040000000000000001 109.535 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 990' ' ' PRO . . . . . 0.425 ' HD2' HD12 ' B' ' 992' ' ' LEU . 50.9 Cg_endo -90.18 70.95 1.56 Allowed 'Trans proline' 0 C--N 1.319 -0.985 0 O-C-N 123.13 1.068 . . . . 0.45000000000000001 111.423 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 991' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' B' ' 990' ' ' PRO . 70.6 mt-10 67.25 -73.57 0.08 Allowed 'General case' 0 N--CA 1.503 2.207 0 N-CA-C 108.6 -0.889 . . . . 1.97 108.6 -177.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 992' ' ' LEU . . . . . 0.434 ' HA ' HD23 ' B' ' 992' ' ' LEU . 10.9 mt 51.22 20.31 0.88 Allowed 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.551 -0.718 . . . . 2.3799999999999999 111.621 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 83.6 mt-10 -93.73 156.95 16.4 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.86 -1.15 . . . . 3.79 110.104 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 72.1 m80 -146.67 92.73 2.19 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.534 -0.729 . . . . 3.5099999999999998 110.395 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 995' ' ' ALA . . . . . . . . . . . . 2.517 . . . . . . . 0 N--CA 1.503 2.222 0 O-C-N 120.953 -1.092 . . . . 2.73 110.639 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo . . . . . 0 N--CA 1.488 1.174 0 N-CA-C 109.488 -1.005 . . . . 3.8300000000000001 109.488 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 847' ' ' VAL . . . . . . . . . . . . . 57.7 t -130.31 103.28 16.67 Favored Pre-proline 0 N--CA 1.496 1.869 0 O-C-N 121.604 -0.685 . . . . 1.8300000000000001 110.133 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 848' ' ' PRO . . . . . 0.708 ' O ' HG23 ' C' ' 850' ' ' VAL . 44.2 Cg_endo -70.49 -21.29 30.32 Favored 'Trans proline' 0 N--CA 1.488 1.182 0 O-C-N 123.277 1.146 . . . . 0.65000000000000002 111.269 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 849' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 27.5 69.97 0.06 Allowed 'General case' 0 N--CA 1.519 3.024 0 N-CA-C 112.826 0.676 . . . . 2.5800000000000001 112.826 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 850' ' ' VAL . . . . . 0.708 HG23 ' O ' ' C' ' 848' ' ' PRO . 61.2 t -119.93 134.57 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.234 -0.916 . . . . 1.0900000000000001 111.648 -178.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 851' ' ' ALA . . . . . 0.584 ' HB3' ' HG ' ' C' ' 873' ' ' LEU . . . -127.46 155.32 43.88 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 105.772 -1.936 . . . . 0.040000000000000001 105.772 176.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 852' ' ' PHE . . . . . 0.455 ' CD1' ' N ' ' C' ' 852' ' ' PHE . 13.2 p90 -159.96 127.56 4.65 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 121.049 1.75 . . . . 0.050000000000000003 108.557 178.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 29.4 t -176.72 134.13 0.21 Allowed 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.105 -1.072 . . . . 0.040000000000000001 108.105 -179.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 854' ' ' ALA . . . . . 0.529 ' HB1' ' HD2' ' C' ' 868' ' ' PHE . . . -131.13 156.32 45.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.169 -0.957 . . . . 0.67000000000000004 109.642 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 855' ' ' ALA . . . . . 0.779 ' HB3' ' CB ' ' C' ' 870' ' ' ARG . . . -121.54 141.54 50.96 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.891 0.853 . . . . 0.51000000000000001 111.107 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 856' ' ' LEU . . . . . 0.995 HD11 HD23 ' C' ' 858' ' ' LEU . 3.5 tm? -114.53 137.59 51.67 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.402 -0.811 . . . . 0.050000000000000003 110.171 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 857' ' ' SER . . . . . 0.57 ' N ' HD13 ' C' ' 856' ' ' LEU . 1.9 m -153.8 19.38 0.52 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.52 -0.737 . . . . 1.3300000000000001 110.866 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 858' ' ' LEU . . . . . 0.995 HD23 HD11 ' C' ' 856' ' ' LEU . 1.4 pp -34.06 160.9 0.04 OUTLIER Pre-proline 0 N--CA 1.516 2.853 0 N-CA-C 113.189 0.811 . . . . 2.3300000000000001 113.189 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -61.6 -88.2 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 120.816 1.011 . . . . 2.3199999999999998 113.306 -178.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 54.6 ptt85 -131.04 -142.33 0.23 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 120.873 -1.142 . . . . 0.040000000000000001 111.435 -177.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 74.5 m -38.42 130.23 1.32 Allowed 'General case' 0 N--CA 1.511 2.589 0 O-C-N 121.563 -0.71 . . . . 1.3100000000000001 112.172 -178.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 862' ' ' GLU . . . . . 0.522 ' HG2' HD13 ' C' ' 858' ' ' LEU . 1.5 mm-40 -102.99 158.79 31.06 Favored Pre-proline 0 N--CA 1.488 1.436 0 N-CA-C 108.237 -1.023 . . . . 4.5099999999999998 108.237 177.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.18 -13.75 33.97 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 O-C-N 123.203 1.107 . . . . 2.2400000000000002 110.829 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -176.7 -136.03 2.31 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.08 -1.608 . . . . 0.040000000000000001 109.08 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 24.7 m -68.83 155.59 39.93 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.27 -1.135 . . . . 1.51 110.164 -179.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 866' ' ' VAL . . . . . 0.445 HG11 ' CD2' ' C' ' 858' ' ' LEU . 60.2 t -99.88 138.05 20.27 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.466 -0.771 . . . . 0.78000000000000003 113.048 -175.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 867' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' C' ' 866' ' ' VAL . 55.4 Cg_endo -90.4 -147.05 0.03 OUTLIER 'Trans proline' 0 CA--C 1.546 1.086 0 O-C-N 123.533 1.28 . . . . 0.92000000000000004 109.234 178.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 868' ' ' PHE . . . . . 0.529 ' HD2' ' HB1' ' C' ' 854' ' ' ALA . 24.5 p90 -149.29 125.37 10.68 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.487 -1.383 . . . . 0.050000000000000003 110.032 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 50.9 p-10 -112.46 -2.82 14.59 Favored 'General case' 0 N--CA 1.499 2.013 0 C-N-CA 119.295 -0.962 . . . . 1.7 112.744 -178.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 870' ' ' ARG . . . . . 0.779 ' CB ' ' HB3' ' C' ' 855' ' ' ALA . 25.8 mmm180 -91.41 88.84 6.99 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 120.849 -1.157 . . . . 2.5899999999999999 111.112 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 63.1 t -72.86 97.34 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 120.902 -1.123 . . . . 1.9399999999999999 109.288 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 872' ' ' LEU . . . . . 0.948 HD13 HD11 ' A' ' 953' ' ' ILE . 72.9 mt -86.48 -45.94 10.66 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.537 -0.727 . . . . 1.0600000000000001 110.561 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 873' ' ' LEU . . . . . 0.584 ' HG ' ' HB3' ' C' ' 851' ' ' ALA . 36.8 tp -173.09 102.5 0.13 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.208 -0.932 . . . . 4.1799999999999997 108.715 178.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 874' ' ' ASN . . . . . 0.435 ' CB ' ' HA ' ' C' ' 852' ' ' PHE . 35.5 t-20 177.49 82.46 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.231 0 N-CA-C 108.827 -0.805 . . . . 0.040000000000000001 108.827 -178.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -65.05 -46.68 80.23 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.194 -0.941 . . . . 3.3799999999999999 111.521 -178.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 876' ' ' GLY . . . . . 0.414 ' HA3' ' CE2' ' C' ' 878' ' ' TYR . . . -73.01 -26.56 70.7 Favored Glycine 0 N--CA 1.493 2.474 0 O-C-N 121.243 -0.91 . . . . 0.040000000000000001 111.748 -178.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 80.34 -62.38 4.3 Favored Glycine 0 N--CA 1.501 3.007 0 N-CA-C 107.911 -2.075 . . . . 0.040000000000000001 107.911 -178.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 878' ' ' TYR . . . . . 0.414 ' CE2' ' HA3' ' C' ' 876' ' ' GLY . 93.2 m-85 60.61 -65.73 0.05 Allowed 'General case' 0 N--CA 1.503 2.22 0 N-CA-C 114.404 1.261 . . . . 3.46 114.404 177.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 879' ' ' TYR . . . . . 0.505 ' CE2' ' CD1' ' C' ' 981' ' ' PHE . 28.8 p90 -110.27 106.83 16.38 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 114.826 1.417 . . . . 0.040000000000000001 114.826 -176.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -73.75 117.19 58.99 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.489 -0.757 . . . . 0.02 109.806 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 881' ' ' PRO . . . . . 0.429 ' HD2' ' CE1' ' C' ' 868' ' ' PHE . 54.2 Cg_endo -77.07 1.07 9.07 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 O-C-N 123.34 1.179 . . . . 0.39000000000000001 112.351 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 71.5 mt-10 -73.55 -53.61 10.13 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 105.733 -1.951 . . . . 0.81000000000000005 105.733 177.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 14.7 p -99.7 -21.0 16.0 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 115.068 -0.969 . . . . 0.040000000000000001 108.841 177.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 81.93 15.76 74.25 Favored Glycine 0 N--CA 1.496 2.672 0 N-CA-C 110.434 -1.066 . . . . 0.029999999999999999 110.434 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 58.5 t -74.87 91.94 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 C-N-CA 118.422 -1.311 . . . . 1.01 108.584 -178.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 886' ' ' PHE . . . . . 0.894 ' HB3' HG22 ' C' ' 962' ' ' VAL . 1.0 OUTLIER -88.04 106.18 17.97 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 115.173 -0.921 . . . . 0.050000000000000003 111.531 -177.696 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 887' ' ' THR . . . . . 0.439 ' O ' ' HD3' ' C' ' 889' ' ' PRO . 88.3 m -101.46 99.79 10.16 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.669 -1.234 . . . . 0.68000000000000005 107.669 177.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 888' ' ' ALA . . . . . . . . . . . . . . . -98.45 102.0 13.21 Favored Pre-proline 0 N--CA 1.5 2.061 0 N-CA-C 114.375 1.25 . . . . 0.25 114.375 -176.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 889' ' ' PRO . . . . . 0.439 ' HD3' ' O ' ' C' ' 887' ' ' THR . 55.6 Cg_endo -81.45 -15.27 10.01 Favored 'Trans proline' 0 CA--C 1.544 1.014 0 N-CA-C 108.632 -1.334 . . . . 1.6399999999999999 108.632 175.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 890' ' ' LEU . . . . . 0.613 HD21 HG11 ' C' ' 850' ' ' VAL . 67.6 mt -37.27 -49.36 0.94 Allowed 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 113.394 0.887 . . . . 2.29 113.394 -177.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 52.4 96.99 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.241 0 O-C-N 121.268 -0.895 . . . . 0.63 110.196 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . 159.28 -153.64 24.72 Favored Glycine 0 N--CA 1.477 1.411 0 N-CA-C 107.45 -2.26 . . . . 0.040000000000000001 107.45 -179.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 76.0 ttt-85 -117.62 123.1 45.34 Favored 'General case' 0 C--N 1.293 -1.877 0 O-C-N 121.715 -0.874 . . . . 3.0 108.872 178.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 894' ' ' TYR . . . . . 0.786 ' CE2' HD23 ' C' ' 954' ' ' LEU . 13.6 p90 -132.89 155.91 48.17 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.024 -1.047 . . . . 0.040000000000000001 111.193 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 895' ' ' LEU . . . . . . . . . . . . . 46.0 tp -98.58 111.65 23.94 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.694 -0.629 . . . . 1.27 109.87 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 896' ' ' LEU . . . . . 0.507 HD22 HH12 ' C' ' 921' ' ' ARG . 10.1 tt -115.66 144.91 43.25 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.618 -0.676 . . . . 0.93999999999999995 109.926 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 897' ' ' SER . . . . . 0.437 ' N ' HD23 ' C' ' 896' ' ' LEU . 43.3 m -142.03 124.87 16.05 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.393 -0.817 . . . . 0.040000000000000001 111.477 -179.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -101.22 148.13 25.46 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.759 -0.83 . . . . 0.47999999999999998 108.759 178.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 899' ' ' VAL . . . . . 0.716 HG21 ' HB ' ' C' ' 980' ' ' ILE . 84.7 t -92.42 120.79 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.321 -0.862 . . . . 0.55000000000000004 111.23 -179.11 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 91.6 mt -92.15 113.45 25.73 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 114.006 1.113 . . . . 1.5900000000000001 114.006 -175.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 21.7 m -62.7 140.9 58.74 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 107.527 -1.286 . . . . 0.050000000000000003 107.527 177.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -60.91 -65.37 3.36 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.238 -1.145 . . . . 0.029999999999999999 110.238 -179.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 6.5 m170 46.1 65.62 1.13 Allowed 'General case' 0 N--CA 1.506 2.363 0 O-C-N 121.518 -0.989 . . . . 3.2000000000000002 111.235 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -66.86 -8.28 27.86 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.623 -0.673 . . . . 2.9199999999999999 111.819 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 905' ' ' HIS . . . . . 0.474 ' O ' ' CB ' ' C' ' 906' ' ' GLU . 72.6 t60 -62.94 4.87 0.15 Allowed 'General case' 0 N--CA 1.503 2.215 0 O-C-N 120.915 -1.116 . . . . 2.8700000000000001 112.679 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 906' ' ' GLU . . . . . 0.498 ' O ' ' CB ' ' C' ' 907' ' ' LYS . 2.0 mt-10 89.73 -153.99 0.01 OUTLIER 'General case' 0 N--CA 1.526 3.329 0 CA-C-N 121.136 1.789 . . . . 0.98999999999999999 111.567 179.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 907' ' ' LYS . . . . . 0.498 ' CB ' ' O ' ' C' ' 906' ' ' GLU . 56.5 tttt 88.84 162.85 0.06 Allowed 'General case' 0 N--CA 1.52 3.066 0 N-CA-C 107.759 -1.2 . . . . 5.25 107.759 -176.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 59.7 t -122.7 114.59 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 120.778 -1.202 . . . . 0.39000000000000001 110.781 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 909' ' ' GLU . . . . . 0.62 ' OE2' HD12 ' C' ' 966' ' ' LEU . 42.8 tp10 -105.79 131.19 53.43 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 107.557 -1.275 . . . . 1.72 107.557 177.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -156.73 120.44 4.27 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 106.943 -1.503 . . . . 0.67000000000000004 106.943 178.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 911' ' ' VAL . . . . . 0.521 ' HA ' ' HA ' ' C' ' 964' ' ' VAL . 12.8 p -80.08 131.57 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 C-N-CA 120.306 -0.558 . . . . 0.54000000000000004 111.321 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 62.4 mt -66.23 156.72 33.4 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.258 -0.901 . . . . 1.5 108.885 178.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 913' ' ' SER . . . . . 0.418 ' CB ' ' CG1' ' C' ' 919' ' ' VAL . 1.7 t -126.19 136.93 53.44 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.377 -0.971 . . . . 1.3700000000000001 108.377 177.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 914' ' ' ARG . . . . . 0.844 ' CZ ' HD23 ' C' ' 956' ' ' LEU . 0.0 OUTLIER -63.67 154.0 34.38 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 120.707 -1.246 . . . . 4.2999999999999998 111.708 -178.783 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 915' ' ' SER . . . . . 0.425 ' CB ' ' O ' ' C' ' 914' ' ' ARG . 2.4 t 83.28 -30.61 0.09 Allowed 'General case' 0 N--CA 1.521 3.119 0 C-N-CA 123.808 0.843 . . . . 2.0499999999999998 112.384 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 916' ' ' ASN . . . . . 0.785 ' HB2' HG21 ' C' ' 919' ' ' VAL . 94.8 m-20 -122.19 -21.74 5.8 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.868 -1.145 . . . . 2.71 111.362 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 67.36 166.11 0.23 Allowed 'General case' 0 N--CA 1.521 3.082 0 N-CA-C 105.491 -2.04 . . . . 2.6800000000000002 105.491 -173.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.27 -125.18 33.13 Favored Glycine 1 N--CA 1.521 4.362 0 CA-C-N 123.773 2.988 . . . . 0.029999999999999999 107.08 -177.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 919' ' ' VAL . . . . . 0.785 HG21 ' HB2' ' C' ' 916' ' ' ASN . 96.7 t 49.83 94.06 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.266 0 O-C-N 121.543 -0.975 . . . . 1.3899999999999999 109.334 -178.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 920' ' ' ALA . . . . . 0.91 ' HB3' HG12 ' C' ' 949' ' ' VAL . . . -94.74 95.48 8.75 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.469 -0.892 . . . . 0.029999999999999999 110.886 -179.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 921' ' ' ARG . . . . . 0.726 ' HG3' HG23 ' C' ' 922' ' ' VAL . 42.8 ptt85 -79.9 -42.05 24.92 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 105.538 -2.023 . . . . 4.4199999999999999 105.538 176.015 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 922' ' ' VAL . . . . . 0.726 HG23 ' HG3' ' C' ' 921' ' ' ARG . 84.6 t -99.89 76.8 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 N-CA-C 105.545 -2.02 . . . . 0.84999999999999998 105.545 175.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -90.61 136.7 32.9 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 122.005 0.907 . . . . 2.46 112.794 -176.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 5.1 t -146.99 103.36 3.6 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.619 -1.252 . . . . 0.69999999999999996 107.619 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -109.21 83.83 0.34 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.485 -1.446 . . . . 0.040000000000000001 109.485 -179.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.361 0 N-CA-C 109.172 -1.571 . . . . 0.040000000000000001 109.172 -179.997 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 22.7 m . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 120.997 0.427 . . . . 13.779999999999999 110.303 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 95.2 mt -112.87 129.89 56.3 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.518 -0.739 . . . . 13.76 110.453 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -151.77 169.89 31.21 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.212 -1.555 . . . . 9.1300000000000008 109.212 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 949' ' ' VAL . . . . . 0.91 HG12 ' HB3' ' C' ' 920' ' ' ALA . 34.1 m -118.04 135.73 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.519 -0.989 . . . . 7.0800000000000001 111.034 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 950' ' ' PHE . . . . . 0.457 ' CZ ' ' HB3' ' C' ' 921' ' ' ARG . 51.7 p90 -135.06 152.47 51.71 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.555 -0.716 . . . . 7.5899999999999999 109.379 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 7.6 t -119.05 -55.09 2.19 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.386 -0.822 . . . . 5.0300000000000002 111.852 -179.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 952' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' C' ' 953' ' ' ILE . 58.9 tp -62.71 -77.07 0.05 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.433 -0.792 . . . . 1.01 111.472 -178.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 953' ' ' ILE . . . . . 0.571 HD12 ' HD3' ' C' ' 955' ' ' PRO . 2.1 pp -49.12 -151.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.688 0 N-CA-C 114.615 1.339 . . . . 2.6000000000000001 114.615 -176.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 954' ' ' LEU . . . . . 0.786 HD23 ' CE2' ' C' ' 894' ' ' TYR . 0.0 OUTLIER 170.02 89.45 0.04 OUTLIER Pre-proline 0 N--CA 1.516 2.85 0 O-C-N 120.78 -1.2 . . . . 0.050000000000000003 112.068 -179.497 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 955' ' ' PRO . . . . . 0.649 ' C ' HD12 ' C' ' 956' ' ' LEU . 50.0 Cg_endo -83.66 94.65 0.78 Allowed 'Trans proline' 0 C--N 1.315 -1.196 0 N-CA-C 109.506 -0.998 . . . . 0.83999999999999997 109.506 178.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 956' ' ' LEU . . . . . 0.844 HD23 ' CZ ' ' C' ' 914' ' ' ARG . 6.6 mp -125.64 150.84 47.24 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.024 -1.047 . . . . 0.040000000000000001 110.622 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -81.89 151.5 27.25 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-O 117.66 -1.162 . . . . 1.28 111.323 -178.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -66.41 118.43 10.04 Favored 'General case' 0 N--CA 1.507 2.393 0 CA-C-N 123.202 2.728 . . . . 0.17000000000000001 110.874 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.54 -19.75 48.72 Favored Glycine 0 N--CA 1.499 2.897 0 N-CA-C 111.067 -0.813 . . . . 0.040000000000000001 111.067 178.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 960' ' ' ASP . . . . . 0.425 ' HB3' ' NE ' ' C' ' 914' ' ' ARG . 0.5 OUTLIER -52.32 171.91 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.344 -1.092 . . . . 0.040000000000000001 110.505 -179.473 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 961' ' ' THR . . . . . 0.488 ' HA ' ' O ' ' C' ' 886' ' ' PHE . 26.3 m -136.93 140.38 42.23 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.043 -1.035 . . . . 1.78 112.614 -177.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 962' ' ' VAL . . . . . 0.894 HG22 ' HB3' ' C' ' 886' ' ' PHE . 26.8 m -101.07 145.47 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 C-N-CA 120.302 -0.559 . . . . 0.040000000000000001 110.809 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 6.2 t -137.99 144.44 41.13 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.815 -0.553 . . . . 0.71999999999999997 109.858 -179.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 964' ' ' VAL . . . . . 0.521 ' HA ' ' HA ' ' C' ' 911' ' ' VAL . 61.8 t -90.79 137.67 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.043 -1.036 . . . . 1.05 110.713 -178.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -92.67 125.17 37.17 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 103.289 -2.856 . . . . 3.02 103.289 173.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 966' ' ' LEU . . . . . 0.62 HD12 ' OE2' ' C' ' 909' ' ' GLU . 0.2 OUTLIER -133.68 57.46 1.81 Allowed 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.635 -0.876 . . . . 1.46 108.635 177.76 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 967' ' ' VAL . . . . . 0.489 HG23 ' C ' ' C' ' 966' ' ' LEU . 98.1 t -158.48 96.41 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 N-CA-C 108.277 -1.009 . . . . 1.9399999999999999 108.277 179.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 90.2 mmm -142.74 59.22 1.43 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.759 -1.213 . . . . 0.0 108.459 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 134.44 119.53 1.97 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 107.205 -2.358 . . . . 2.1099999999999999 107.205 -178.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 95.4 mm-40 -82.34 -57.71 3.25 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.082 -1.246 . . . . 5.8899999999999997 110.684 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 41.4 tp -58.87 89.74 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.46 -0.775 . . . . 4.3600000000000003 110.401 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -142.63 -152.69 0.42 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.572 -0.705 . . . . 1.8300000000000001 110.129 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 7.7 t60 -116.74 167.43 11.1 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.384 -0.823 . . . . 4.3499999999999996 110.076 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 41.1 t -102.8 130.69 49.86 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.624 -0.673 . . . . 1.27 110.197 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -156.35 158.55 37.6 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.498 -0.751 . . . . 5.0199999999999996 110.753 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.82 86.1 15.9 Favored Pre-proline 0 N--CA 1.501 2.116 0 O-C-N 121.616 -0.677 . . . . 2.4100000000000001 109.716 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -75.71 -170.17 0.79 Allowed 'Trans proline' 0 C--N 1.318 -1.061 0 O-C-N 123.303 1.159 . . . . 0.95999999999999996 111.453 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 978' ' ' LEU . . . . . 0.524 ' N ' HD12 ' C' ' 978' ' ' LEU . 5.2 mp -124.97 156.39 38.12 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 107.511 -1.292 . . . . 0.62 107.511 177.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 979' ' ' THR . . . . . 0.445 HG23 ' C ' ' C' ' 978' ' ' LEU . 39.5 p -149.92 141.47 23.45 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.728 -1.232 . . . . 3.5699999999999998 111.325 -179.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 980' ' ' ILE . . . . . 0.716 ' HB ' HG21 ' C' ' 899' ' ' VAL . 47.5 mm -106.96 128.48 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 109.122 -0.696 . . . . 1.3300000000000001 109.122 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 981' ' ' PHE . . . . . 0.505 ' CD1' ' CE2' ' C' ' 879' ' ' TYR . 3.2 t80 -117.89 95.44 4.92 Favored 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 119.69 -0.804 . . . . 0.050000000000000003 111.568 -178.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 982' ' ' SER . . . . . . . . . . . . . 12.5 p -107.63 158.27 17.39 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.6 -0.688 . . . . 0.87 109.255 178.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 983' ' ' GLY . . . . . 0.417 ' HA3' ' CE2' ' C' ' 852' ' ' PHE . . . -172.18 114.48 0.53 Allowed Glycine 0 N--CA 1.497 2.704 0 N-CA-C 106.601 -2.6 . . . . 0.029999999999999999 106.601 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 984' ' ' ALA . . . . . 0.438 ' HB1' ' CZ ' ' A' ' 893' ' ' ARG . . . -108.4 150.76 26.94 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 114.259 1.207 . . . . 0.69999999999999996 114.259 -175.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 985' ' ' LEU . . . . . 0.583 HD13 HD22 ' C' ' 890' ' ' LEU . 47.9 tp -75.32 135.71 40.88 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.814 -1.179 . . . . 0.040000000000000001 109.609 179.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 986' ' ' LEU . . . . . 0.488 HD11 ' CD1' ' B' ' 986' ' ' LEU . 45.5 tp -106.23 -63.16 1.29 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.461 -0.774 . . . . 0.040000000000000001 110.329 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -144.28 146.94 32.92 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 107.806 -1.183 . . . . 0.040000000000000001 107.806 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -111.96 162.71 12.33 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 107.99 -2.044 . . . . 0.040000000000000001 107.99 179.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.81 112.73 19.0 Favored Pre-proline 0 N--CA 1.497 1.895 0 O-C-N 121.135 -1.215 . . . . 0.040000000000000001 109.452 179.117 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 990' ' ' PRO . . . . . 0.419 ' HD2' HD12 ' C' ' 992' ' ' LEU . 50.9 Cg_endo -89.29 71.24 2.01 Favored 'Trans proline' 0 C--N 1.319 -1.017 0 O-C-N 123.109 1.057 . . . . 0.45000000000000001 111.301 -178.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 991' ' ' GLU . . . . . 0.417 ' HB2' ' O ' ' C' ' 990' ' ' PRO . 85.7 mt-10 67.11 -73.77 0.07 Allowed 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 108.687 -0.857 . . . . 1.97 108.687 -177.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 992' ' ' LEU . . . . . 0.419 HD12 ' HD2' ' C' ' 990' ' ' PRO . 11.3 mt 50.5 21.3 0.83 Allowed 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.594 -0.691 . . . . 2.3799999999999999 111.553 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -93.35 156.97 16.47 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.936 -1.102 . . . . 3.79 110.144 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 68.6 m80 -146.31 92.48 2.18 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.597 -0.689 . . . . 3.5099999999999998 110.202 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 995' ' ' ALA . . . . . . . . . . . . 2.519 . . . . . . . 0 N--CA 1.503 2.224 0 O-C-N 120.917 -1.115 . . . . 2.73 110.614 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo . . . . . 0 N--CA 1.488 1.157 0 N-CA-C 109.525 -0.991 . . . . 3.8300000000000001 109.525 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 847' ' ' VAL . . . . . . . . . . . . . 62.0 t -134.49 103.26 11.34 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.574 -0.704 . . . . 1.8300000000000001 110.014 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 848' ' ' PRO . . . . . 0.707 ' O ' HG23 ' A' ' 850' ' ' VAL . 44.1 Cg_endo -69.99 -18.64 35.83 Favored 'Trans proline' 0 N--CA 1.488 1.182 0 O-C-N 123.315 1.166 . . . . 0.65000000000000002 111.303 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 849' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 27.58 68.72 0.07 Allowed 'General case' 0 N--CA 1.518 2.975 0 N-CA-C 112.941 0.719 . . . . 2.5800000000000001 112.941 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 850' ' ' VAL . . . . . 0.707 HG23 ' O ' ' A' ' 848' ' ' PRO . 62.1 t -118.92 135.81 58.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.221 -0.924 . . . . 1.0900000000000001 111.429 -178.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 851' ' ' ALA . . . . . 0.464 ' HB3' ' HG ' ' A' ' 873' ' ' LEU . . . -126.76 156.95 40.38 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 105.868 -1.901 . . . . 0.040000000000000001 105.868 176.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 852' ' ' PHE . . . . . 0.443 ' HA ' ' CB ' ' A' ' 874' ' ' ASN . 33.7 p90 -158.79 130.18 6.38 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 121.022 1.737 . . . . 0.050000000000000003 108.79 179.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 44.1 t -174.93 134.1 0.34 Allowed 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.125 -1.065 . . . . 0.040000000000000001 108.125 -179.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 854' ' ' ALA . . . . . 0.461 ' HB1' ' HD2' ' A' ' 868' ' ' PHE . . . -134.01 155.92 49.12 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.07 -1.019 . . . . 0.67000000000000004 109.423 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 855' ' ' ALA . . . . . 0.761 ' HB3' ' CB ' ' A' ' 870' ' ' ARG . . . -122.15 141.6 51.27 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.758 0.79 . . . . 0.51000000000000001 111.362 -179.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 856' ' ' LEU . . . . . 0.671 HD13 ' N ' ' A' ' 857' ' ' SER . 3.4 tm? -111.27 137.94 48.36 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.649 -0.657 . . . . 0.050000000000000003 109.939 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 857' ' ' SER . . . . . 0.671 ' N ' HD13 ' A' ' 856' ' ' LEU . 1.5 m -156.77 16.86 0.31 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.579 -0.701 . . . . 1.3300000000000001 111.587 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 858' ' ' LEU . . . . . 0.609 HD22 ' HG3' ' A' ' 862' ' ' GLU . 3.8 pp -35.02 160.35 0.04 OUTLIER Pre-proline 0 N--CA 1.519 2.991 0 N-CA-C 113.006 0.743 . . . . 2.3300000000000001 113.006 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -60.69 -88.64 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 120.87 1.046 . . . . 2.3199999999999998 113.796 -177.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 53.6 ptt85 -128.54 -142.72 0.26 Allowed 'General case' 0 N--CA 1.5 2.075 0 O-C-N 120.859 -1.151 . . . . 0.040000000000000001 111.756 -177.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 15.0 m -38.03 126.76 1.28 Allowed 'General case' 0 N--CA 1.51 2.569 0 O-C-N 121.643 -0.661 . . . . 1.3100000000000001 112.26 -178.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 862' ' ' GLU . . . . . 0.609 ' HG3' HD22 ' A' ' 858' ' ' LEU . 0.0 OUTLIER -99.59 158.99 31.17 Favored Pre-proline 0 N--CA 1.489 1.51 0 N-CA-C 108.423 -0.954 . . . . 4.5099999999999998 108.423 177.754 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -70.99 -14.55 32.25 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 O-C-N 123.245 1.129 . . . . 2.2400000000000002 111.379 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -177.7 -135.89 2.36 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.515 -1.434 . . . . 0.040000000000000001 109.515 179.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 26.8 m -65.97 156.05 34.75 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.33 -1.1 . . . . 1.51 110.134 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 866' ' ' VAL . . . . . 0.498 HG13 ' CD2' ' A' ' 858' ' ' LEU . 61.5 t -98.85 137.33 20.52 Favored Pre-proline 0 N--CA 1.494 1.736 0 N-CA-C 113.547 0.943 . . . . 0.78000000000000003 113.547 -174.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 867' ' ' PRO . . . . . 0.553 ' O ' HD23 ' A' ' 856' ' ' LEU . 55.5 Cg_endo -92.41 -149.66 0.03 OUTLIER 'Trans proline' 0 CA--C 1.546 1.124 0 C-N-CA 121.335 1.356 . . . . 0.92000000000000004 109.634 178.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 868' ' ' PHE . . . . . 0.475 ' CD1' ' HG2' ' A' ' 881' ' ' PRO . 19.3 p90 -150.7 124.0 8.91 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.679 -1.263 . . . . 0.050000000000000003 109.776 179.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 46.6 p30 -113.48 -2.23 13.95 Favored 'General case' 0 N--CA 1.5 2.062 0 C-N-CA 119.285 -0.966 . . . . 1.7 112.483 -178.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 870' ' ' ARG . . . . . 0.761 ' CB ' ' HB3' ' A' ' 855' ' ' ALA . 26.7 mmm180 -90.11 89.29 7.61 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 120.889 -1.132 . . . . 2.5899999999999999 110.598 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 58.5 t -72.82 96.95 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 120.971 -1.081 . . . . 1.9399999999999999 109.91 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 872' ' ' LEU . . . . . 0.497 HD11 ' HB2' ' A' ' 855' ' ' ALA . 97.6 mt -82.84 -47.44 11.87 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.514 -0.741 . . . . 1.0600000000000001 110.177 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 873' ' ' LEU . . . . . 0.464 ' HG ' ' HB3' ' A' ' 851' ' ' ALA . 46.5 tp -174.99 104.26 0.09 Allowed 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 108.637 -0.875 . . . . 4.1799999999999997 108.637 178.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 874' ' ' ASN . . . . . 0.443 ' CB ' ' HA ' ' A' ' 852' ' ' PHE . 35.5 t-20 178.71 81.6 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.571 -0.706 . . . . 0.040000000000000001 109.802 -179.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -67.28 -48.05 68.81 Favored 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 119.321 -0.951 . . . . 3.3799999999999999 111.118 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 876' ' ' GLY . . . . . . . . . . . . . . . -73.58 -25.29 72.74 Favored Glycine 0 N--CA 1.494 2.529 0 O-C-N 121.284 -0.885 . . . . 0.040000000000000001 111.632 -178.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 82.39 -61.37 4.73 Favored Glycine 0 N--CA 1.502 3.044 0 N-CA-C 108.097 -2.001 . . . . 0.040000000000000001 108.097 -178.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 878' ' ' TYR . . . . . 0.418 ' CE2' ' CG1' ' A' ' 850' ' ' VAL . 95.8 m-85 61.15 -62.97 0.08 Allowed 'General case' 0 N--CA 1.503 2.201 0 N-CA-C 114.35 1.241 . . . . 3.46 114.35 177.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 879' ' ' TYR . . . . . 0.47 ' CB ' ' CD2' ' A' ' 886' ' ' PHE . 18.8 p90 -111.33 108.66 18.33 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 114.489 1.292 . . . . 0.040000000000000001 114.489 -176.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -65.0 114.7 15.94 Favored Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 121.402 -0.811 . . . . 0.02 110.094 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 881' ' ' PRO . . . . . 0.475 ' HG2' ' CD1' ' A' ' 868' ' ' PHE . 53.3 Cg_endo -75.15 -0.94 10.61 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 O-C-N 123.525 1.276 . . . . 0.39000000000000001 112.312 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -76.87 -65.4 0.95 Allowed 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.12 -1.437 . . . . 0.81000000000000005 107.12 178.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 31.6 p -92.25 -18.17 23.78 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.62 -0.882 . . . . 0.040000000000000001 108.62 177.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.22 19.79 60.12 Favored Glycine 0 N--CA 1.497 2.729 0 O-C-N 121.093 -1.005 . . . . 0.029999999999999999 111.554 178.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 885' ' ' VAL . . . . . 0.679 HG13 HG21 ' A' ' 961' ' ' THR . 92.2 t -73.43 91.1 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 C-N-CA 118.089 -1.445 . . . . 1.01 108.137 -179.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 886' ' ' PHE . . . . . 0.878 ' HB3' HG22 ' A' ' 962' ' ' VAL . 0.6 OUTLIER -89.73 105.11 17.58 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 115.207 -0.906 . . . . 0.050000000000000003 112.081 -177.443 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 887' ' ' THR . . . . . 0.406 ' O ' ' HD3' ' A' ' 889' ' ' PRO . 85.0 m -95.96 100.36 12.04 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 107.711 -1.218 . . . . 0.68000000000000005 107.711 177.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 888' ' ' ALA . . . . . . . . . . . . . . . -98.42 107.43 42.01 Favored Pre-proline 0 N--CA 1.501 2.124 0 N-CA-C 114.094 1.146 . . . . 0.25 114.094 -176.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 889' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' A' ' 887' ' ' THR . 53.8 Cg_endo -90.19 -12.53 2.71 Favored 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 121.066 1.177 . . . . 1.6399999999999999 109.243 176.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 890' ' ' LEU . . . . . 0.994 HD22 HD13 ' A' ' 985' ' ' LEU . 63.6 mt -36.11 -50.52 0.71 Allowed 'General case' 0 N--CA 1.508 2.466 0 N-CA-C 113.856 1.058 . . . . 2.29 113.856 -177.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 51.68 95.84 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.342 0 O-C-N 121.158 -0.964 . . . . 0.63 110.314 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 156.58 -149.66 20.59 Favored Glycine 0 N--CA 1.479 1.562 0 N-CA-C 107.301 -2.32 . . . . 0.040000000000000001 107.301 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 70.7 ttt-85 -112.65 126.64 55.6 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 107.945 -1.131 . . . . 3.0 107.945 177.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 894' ' ' TYR . . . . . 0.541 ' OH ' HD12 ' A' ' 896' ' ' LEU . 0.0 OUTLIER -131.21 155.09 47.67 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.045 -1.035 . . . . 0.040000000000000001 110.69 -179.178 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 895' ' ' LEU . . . . . 0.423 ' N ' ' CD1' ' A' ' 894' ' ' TYR . 34.9 tp -95.29 114.16 25.91 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.665 -0.647 . . . . 1.27 110.067 -179.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 896' ' ' LEU . . . . . 0.567 HD23 ' N ' ' A' ' 897' ' ' SER . 9.8 tt -108.62 142.67 38.75 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.718 -0.614 . . . . 0.93999999999999995 110.628 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 897' ' ' SER . . . . . 0.567 ' N ' HD23 ' A' ' 896' ' ' LEU . 69.9 m -147.41 115.4 6.5 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.516 -0.74 . . . . 0.040000000000000001 110.895 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.26 146.76 31.06 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.07 -0.715 . . . . 0.47999999999999998 109.07 179.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 899' ' ' VAL . . . . . 0.766 HG21 ' HB ' ' A' ' 980' ' ' ILE . 87.8 t -96.36 119.7 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 C-N-CA 119.627 -0.829 . . . . 0.55000000000000004 111.377 -179.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 900' ' ' LEU . . . . . 0.548 HD12 ' HB2' ' A' ' 924' ' ' SER . 4.5 mm? -94.39 111.53 23.28 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 114.057 1.132 . . . . 1.5900000000000001 114.057 -175.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 21.6 m -65.43 140.8 58.65 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 107.322 -1.362 . . . . 0.050000000000000003 107.322 177.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -64.66 -66.75 2.32 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 110.427 -1.069 . . . . 0.029999999999999999 110.427 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 5.9 m170 46.59 66.81 0.89 Allowed 'General case' 0 N--CA 1.507 2.403 0 O-C-N 121.522 -0.987 . . . . 3.2000000000000002 111.093 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 43.3 ptt85 -69.13 -5.76 24.33 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.542 -0.723 . . . . 2.9199999999999999 112.003 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 905' ' ' HIS . . . . . 0.485 ' O ' ' CB ' ' A' ' 906' ' ' GLU . 74.4 t60 -61.06 3.22 0.1 Allowed 'General case' 0 N--CA 1.506 2.328 0 O-C-N 120.834 -1.166 . . . . 2.8700000000000001 112.891 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 906' ' ' GLU . . . . . 0.485 ' CB ' ' O ' ' A' ' 905' ' ' HIS . 0.8 OUTLIER 93.69 -163.62 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.437 0 CA-C-N 120.513 1.506 . . . . 0.98999999999999999 112.425 178.549 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 907' ' ' LYS . . . . . 0.483 ' CB ' ' O ' ' A' ' 906' ' ' GLU . 51.2 tttt 88.95 161.18 0.06 Allowed 'General case' 0 N--CA 1.519 3.018 0 N-CA-C 107.72 -1.215 . . . . 5.25 107.72 -177.014 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 60.0 t -121.7 116.18 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 120.864 -1.148 . . . . 0.39000000000000001 110.787 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 54.1 tp10 -104.49 132.13 51.09 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 107.523 -1.288 . . . . 1.72 107.523 176.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -156.09 121.63 4.87 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 106.536 -1.653 . . . . 0.67000000000000004 106.536 178.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 911' ' ' VAL . . . . . 0.732 HG22 HG13 ' A' ' 964' ' ' VAL . 92.9 t -81.65 132.44 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.819 -0.551 . . . . 0.54000000000000004 110.753 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 71.6 mt -65.68 155.91 34.52 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.376 -0.828 . . . . 1.5 108.838 178.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 913' ' ' SER . . . . . 0.417 ' CB ' ' HB ' ' A' ' 919' ' ' VAL . 2.4 t -123.39 137.43 54.82 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.076 -1.083 . . . . 1.3700000000000001 108.076 176.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 914' ' ' ARG . . . . . 0.625 ' NH1' HD23 ' A' ' 956' ' ' LEU . 0.0 OUTLIER -64.28 154.14 36.06 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 120.791 -1.193 . . . . 4.2999999999999998 111.58 -179.001 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 915' ' ' SER . . . . . 0.427 ' CB ' ' O ' ' A' ' 914' ' ' ARG . 4.9 t 83.31 -32.27 0.08 Allowed 'General case' 0 N--CA 1.522 3.126 0 C-N-CA 124.016 0.927 . . . . 2.0499999999999998 112.294 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 916' ' ' ASN . . . . . 0.755 ' HB2' HG21 ' A' ' 919' ' ' VAL . 98.7 m-20 -122.37 -21.02 5.92 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 120.908 -1.12 . . . . 2.71 111.429 -179.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 917' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 67.1 166.44 0.22 Allowed 'General case' 0 N--CA 1.521 3.102 0 N-CA-C 105.58 -2.007 . . . . 2.6800000000000002 105.58 -174.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.44 -125.79 35.25 Favored Glycine 1 N--CA 1.521 4.349 0 CA-C-N 123.405 2.82 . . . . 0.029999999999999999 107.001 -177.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 919' ' ' VAL . . . . . 0.755 HG21 ' HB2' ' A' ' 916' ' ' ASN . 82.0 t 51.95 94.52 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.273 0 O-C-N 121.447 -1.031 . . . . 1.3899999999999999 108.915 -178.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 920' ' ' ALA . . . . . 0.888 ' HB3' HG12 ' A' ' 949' ' ' VAL . . . -91.6 92.37 8.45 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.311 -0.955 . . . . 0.029999999999999999 111.12 -178.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 921' ' ' ARG . . . . . 0.747 ' HG3' HG23 ' A' ' 922' ' ' VAL . 16.7 ptt180 -84.31 -42.25 16.0 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 105.752 -1.944 . . . . 4.4199999999999999 105.752 175.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 922' ' ' VAL . . . . . 0.747 HG23 ' HG3' ' A' ' 921' ' ' ARG . 75.1 t -103.75 69.63 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 N-CA-C 105.608 -1.997 . . . . 0.84999999999999998 105.608 175.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 923' ' ' ASP . . . . . 0.655 ' HB2' ' HB1' ' A' ' 920' ' ' ALA . 22.0 t0 -89.68 136.26 33.14 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.887 0.851 . . . . 2.46 112.238 -176.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 924' ' ' SER . . . . . 0.548 ' HB2' HD12 ' A' ' 900' ' ' LEU . 13.2 t -146.48 103.4 3.68 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.922 -1.14 . . . . 0.69999999999999996 107.922 178.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -110.79 89.57 0.55 Allowed Glycine 0 N--CA 1.488 2.106 0 N-CA-C 108.941 -1.664 . . . . 0.040000000000000001 108.941 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.311 0 N-CA-C 109.324 -1.51 . . . . 0.040000000000000001 109.324 -179.604 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 22.8 m . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.063 0.458 . . . . 13.779999999999999 110.272 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 96.2 mt -112.88 129.88 56.3 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.54 -0.725 . . . . 13.76 110.403 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -151.57 167.86 30.95 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.056 -1.618 . . . . 9.1300000000000008 109.056 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 949' ' ' VAL . . . . . 0.888 HG12 ' HB3' ' A' ' 920' ' ' ALA . 32.9 m -118.95 130.34 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.501 -0.999 . . . . 7.0800000000000001 110.947 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 950' ' ' PHE . . . . . 0.459 ' CZ ' ' HB3' ' A' ' 921' ' ' ARG . 27.6 p90 -132.52 149.22 52.36 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.572 -0.705 . . . . 7.5899999999999999 109.283 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 19.5 m -120.19 -53.11 2.15 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.396 -0.815 . . . . 5.0300000000000002 112.04 -178.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 952' ' ' LEU . . . . . 0.417 ' O ' ' O ' ' A' ' 953' ' ' ILE . 16.8 tp -61.25 -74.3 0.08 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.388 -0.82 . . . . 1.01 112.309 -177.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 953' ' ' ILE . . . . . 0.804 HD11 HD13 ' C' ' 872' ' ' LEU . 43.9 pt -53.27 -144.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.755 0 N-CA-C 114.034 1.124 . . . . 2.6000000000000001 114.034 -176.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 954' ' ' LEU . . . . . 0.702 HD22 ' O ' ' A' ' 954' ' ' LEU . 0.0 OUTLIER 171.46 78.8 0.04 OUTLIER Pre-proline 0 N--CA 1.51 2.572 0 O-C-N 120.762 -1.211 . . . . 0.050000000000000003 111.54 179.697 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 955' ' ' PRO . . . . . 0.689 ' C ' HD12 ' A' ' 956' ' ' LEU . 47.1 Cg_endo -74.35 95.64 0.94 Allowed 'Trans proline' 0 C--N 1.313 -1.311 0 N-CA-C 109.343 -1.06 . . . . 0.83999999999999997 109.343 178.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 956' ' ' LEU . . . . . 0.689 HD12 ' C ' ' A' ' 955' ' ' PRO . 10.2 mp -123.12 145.25 48.74 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.174 -0.954 . . . . 0.040000000000000001 110.236 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -84.66 151.17 24.64 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 117.814 -1.088 . . . . 1.28 111.856 -178.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -70.24 119.88 15.09 Favored 'General case' 0 N--CA 1.51 2.569 0 CA-C-N 122.926 2.603 . . . . 0.17000000000000001 111.943 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.81 -22.82 31.78 Favored Glycine 0 N--CA 1.502 3.065 0 N-CA-C 111.197 -0.761 . . . . 0.040000000000000001 111.197 178.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 960' ' ' ASP . . . . . 0.435 ' HB3' ' NE ' ' A' ' 914' ' ' ARG . 0.3 OUTLIER -53.3 171.74 0.07 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.505 -0.997 . . . . 0.040000000000000001 110.313 -179.341 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 961' ' ' THR . . . . . 0.679 HG21 HG13 ' A' ' 885' ' ' VAL . 39.2 m -134.56 135.42 42.26 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.931 -1.106 . . . . 1.78 111.785 -178.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 962' ' ' VAL . . . . . 0.878 HG22 ' HB3' ' A' ' 886' ' ' PHE . 31.6 m -98.76 145.23 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 C-N-CA 120.045 -0.662 . . . . 0.040000000000000001 110.389 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 5.0 t -137.86 146.25 43.19 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.906 -0.496 . . . . 0.71999999999999997 110.131 -178.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 964' ' ' VAL . . . . . 0.732 HG13 HG22 ' A' ' 911' ' ' VAL . 58.3 t -95.06 136.37 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.091 -1.006 . . . . 1.05 110.503 -179.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -95.4 126.48 40.73 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 103.682 -2.71 . . . . 3.02 103.682 173.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 966' ' ' LEU . . . . . 0.493 ' C ' HG23 ' A' ' 967' ' ' VAL . 1.4 tt -133.46 61.29 1.68 Allowed 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.271 -1.011 . . . . 1.46 108.271 177.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 967' ' ' VAL . . . . . 0.493 HG23 ' C ' ' A' ' 966' ' ' LEU . 98.9 t -157.92 96.44 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 108.138 -1.06 . . . . 1.9399999999999999 108.138 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 93.1 mmm -143.04 58.45 1.41 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.708 -1.245 . . . . 0.0 108.198 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 133.09 119.21 2.0 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 106.538 -2.625 . . . . 2.1099999999999999 106.538 -177.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -84.83 -44.49 13.21 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 119.0 1.4 . . . . 5.8899999999999997 111.364 -179.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 43.0 tp -61.39 89.12 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.921 -1.112 . . . . 4.3600000000000003 110.081 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -141.89 -156.46 0.68 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.525 -0.734 . . . . 1.8300000000000001 110.272 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -121.61 176.05 5.91 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.535 -0.728 . . . . 4.3499999999999996 110.273 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 9.1 t -99.98 129.87 46.09 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.534 -0.728 . . . . 1.27 109.909 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -156.1 157.92 36.85 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.497 -0.752 . . . . 5.0199999999999996 110.671 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.33 86.8 16.41 Favored Pre-proline 0 N--CA 1.499 2.021 0 O-C-N 121.605 -0.684 . . . . 2.4100000000000001 109.506 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -72.91 -172.46 0.98 Allowed 'Trans proline' 0 C--N 1.318 -1.056 0 O-C-N 123.312 1.164 . . . . 0.95999999999999996 111.442 -179.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 978' ' ' LEU . . . . . 0.542 HD12 ' N ' ' A' ' 978' ' ' LEU . 5.0 mp -128.05 154.78 45.29 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 107.631 -1.248 . . . . 0.62 107.631 178.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 979' ' ' THR . . . . . 0.45 HG23 ' C ' ' A' ' 978' ' ' LEU . 44.9 p -149.73 141.17 23.32 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.738 -1.226 . . . . 3.5699999999999998 111.279 -179.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 980' ' ' ILE . . . . . 0.766 ' HB ' HG21 ' A' ' 899' ' ' VAL . 50.3 mm -107.82 128.2 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 108.885 -0.783 . . . . 1.3300000000000001 108.885 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 981' ' ' PHE . . . . . 0.461 ' HD1' ' HH ' ' A' ' 879' ' ' TYR . 6.4 t80 -121.88 97.33 5.44 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.428 -0.795 . . . . 0.050000000000000003 111.912 -178.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 92.6 p -108.84 158.44 17.66 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 109.041 -0.726 . . . . 0.87 109.041 178.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . -173.73 108.91 0.28 Allowed Glycine 0 N--CA 1.498 2.775 0 N-CA-C 106.635 -2.586 . . . . 0.029999999999999999 106.635 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -109.07 148.67 30.45 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 114.409 1.263 . . . . 0.69999999999999996 114.409 -175.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 985' ' ' LEU . . . . . 0.994 HD13 HD22 ' A' ' 890' ' ' LEU . 35.1 tp -68.93 135.24 50.68 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 120.777 -1.202 . . . . 0.040000000000000001 110.275 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 50.8 tp -106.88 -58.8 1.89 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.648 -0.658 . . . . 0.040000000000000001 109.918 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -144.11 145.51 32.19 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 107.553 -1.277 . . . . 0.040000000000000001 107.553 179.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.69 163.29 12.17 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 108.23 -1.948 . . . . 0.040000000000000001 108.23 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -76.11 112.51 21.08 Favored Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.184 -1.186 . . . . 0.040000000000000001 109.41 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 990' ' ' PRO . . . . . 0.414 ' O ' ' HB2' ' A' ' 991' ' ' GLU . 49.8 Cg_endo -90.44 71.79 1.33 Allowed 'Trans proline' 0 C--N 1.318 -1.031 0 O-C-N 123.044 1.023 . . . . 0.45000000000000001 111.435 -178.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 991' ' ' GLU . . . . . 0.414 ' HB2' ' O ' ' A' ' 990' ' ' PRO . 75.1 mt-10 67.44 -73.67 0.08 Allowed 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 108.476 -0.935 . . . . 1.97 108.476 -177.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 992' ' ' LEU . . . . . . . . . . . . . 11.0 mt 51.1 20.51 0.86 Allowed 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.504 -0.748 . . . . 2.3799999999999999 111.652 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 80.3 mt-10 -94.1 156.84 16.37 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.918 -1.114 . . . . 3.79 109.947 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -146.21 93.29 2.3 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.529 -0.732 . . . . 3.5099999999999998 110.333 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 995' ' ' ALA . . . . . . . . . . . . 2.518 . . . . . . . 0 N--CA 1.504 2.24 0 O-C-N 120.935 -1.103 . . . . 2.73 110.57 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo . . . . . 0 N--CA 1.488 1.171 0 N-CA-C 109.537 -0.986 . . . . 3.8300000000000001 109.537 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 847' ' ' VAL . . . . . . . . . . . . . 61.9 t -134.52 103.27 11.31 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.586 -0.696 . . . . 1.8300000000000001 110.054 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 848' ' ' PRO . . . . . 0.695 ' O ' HG23 ' B' ' 850' ' ' VAL . 44.2 Cg_endo -69.91 -18.84 36.08 Favored 'Trans proline' 0 N--CA 1.488 1.182 0 O-C-N 123.321 1.169 . . . . 0.65000000000000002 111.314 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 849' ' ' GLN . . . . . 0.407 ' C ' ' O ' ' B' ' 848' ' ' PRO . 56.4 tt0 27.64 69.17 0.06 Allowed 'General case' 0 N--CA 1.518 2.957 0 N-CA-C 112.827 0.677 . . . . 2.5800000000000001 112.827 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 850' ' ' VAL . . . . . 0.695 HG23 ' O ' ' B' ' 848' ' ' PRO . 61.9 t -119.27 135.89 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.202 -0.936 . . . . 1.0900000000000001 111.394 -178.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 851' ' ' ALA . . . . . 0.463 ' HB3' ' HG ' ' B' ' 873' ' ' LEU . . . -127.22 156.22 42.21 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 105.884 -1.895 . . . . 0.040000000000000001 105.884 176.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 852' ' ' PHE . . . . . 0.44 ' HA ' ' CB ' ' B' ' 874' ' ' ASN . 33.2 p90 -157.98 130.59 7.25 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 121.086 1.766 . . . . 0.050000000000000003 108.729 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 44.5 t -174.97 133.7 0.33 Allowed 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.214 -1.032 . . . . 0.040000000000000001 108.214 -179.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 854' ' ' ALA . . . . . 0.446 ' HB1' ' HD2' ' B' ' 868' ' ' PHE . . . -133.65 155.98 48.72 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.096 -1.002 . . . . 0.67000000000000004 109.448 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 855' ' ' ALA . . . . . 0.747 ' HB3' ' CB ' ' B' ' 870' ' ' ARG . . . -122.3 141.82 51.13 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.802 0.811 . . . . 0.51000000000000001 111.293 -179.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 856' ' ' LEU . . . . . 0.659 HD13 ' N ' ' B' ' 857' ' ' SER . 3.4 tm? -111.4 137.55 49.03 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.602 -0.686 . . . . 0.050000000000000003 110.016 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 857' ' ' SER . . . . . 0.659 ' N ' HD13 ' B' ' 856' ' ' LEU . 1.5 m -156.43 17.05 0.33 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.543 -0.723 . . . . 1.3300000000000001 111.538 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 858' ' ' LEU . . . . . 0.611 HD22 ' HG3' ' B' ' 862' ' ' GLU . 3.8 pp -35.2 160.45 0.04 OUTLIER Pre-proline 0 N--CA 1.52 3.028 0 N-CA-C 112.954 0.724 . . . . 2.3300000000000001 112.954 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -60.82 -88.6 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 120.877 1.051 . . . . 2.3199999999999998 113.803 -177.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 53.6 ptt85 -128.54 -142.74 0.26 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 120.897 -1.127 . . . . 0.040000000000000001 111.801 -177.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 15.2 m -37.96 126.12 1.23 Allowed 'General case' 0 N--CA 1.509 2.516 0 O-C-N 121.619 -0.676 . . . . 1.3100000000000001 112.3 -178.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 862' ' ' GLU . . . . . 0.611 ' HG3' HD22 ' B' ' 858' ' ' LEU . 0.0 OUTLIER -98.96 159.02 31.28 Favored Pre-proline 0 N--CA 1.489 1.511 0 N-CA-C 108.425 -0.954 . . . . 4.5099999999999998 108.425 177.7 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -70.9 -14.71 32.67 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 O-C-N 123.193 1.101 . . . . 2.2400000000000002 111.411 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -177.52 -134.97 2.12 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.508 -1.437 . . . . 0.040000000000000001 109.508 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 27.1 m -66.71 156.82 34.27 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.285 -1.126 . . . . 1.51 110.053 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 866' ' ' VAL . . . . . 0.496 HG13 ' CD2' ' B' ' 858' ' ' LEU . 61.1 t -99.44 137.34 20.3 Favored Pre-proline 0 N--CA 1.494 1.742 0 N-CA-C 113.485 0.92 . . . . 0.78000000000000003 113.485 -174.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 867' ' ' PRO . . . . . 0.564 ' O ' HD23 ' B' ' 856' ' ' LEU . 55.4 Cg_endo -92.52 -149.82 0.03 OUTLIER 'Trans proline' 0 CA--C 1.546 1.121 0 C-N-CA 121.314 1.343 . . . . 0.92000000000000004 109.626 178.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 868' ' ' PHE . . . . . 0.476 ' CD1' ' HG2' ' B' ' 881' ' ' PRO . 19.4 p90 -150.55 123.88 8.93 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.645 -1.284 . . . . 0.050000000000000003 109.765 179.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 46.5 p30 -113.34 -1.94 14.12 Favored 'General case' 0 N--CA 1.5 2.051 0 C-N-CA 119.287 -0.965 . . . . 1.7 112.56 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 870' ' ' ARG . . . . . 0.747 ' CB ' ' HB3' ' B' ' 855' ' ' ALA . 26.4 mmm180 -90.47 89.05 7.41 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.848 -1.157 . . . . 2.5899999999999999 110.634 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 58.7 t -72.71 97.19 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.013 -1.054 . . . . 1.9399999999999999 109.864 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 872' ' ' LEU . . . . . 0.492 HD11 ' HB2' ' B' ' 855' ' ' ALA . 98.6 mt -83.14 -47.5 11.55 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.594 -0.691 . . . . 1.0600000000000001 110.155 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 873' ' ' LEU . . . . . 0.463 ' HG ' ' HB3' ' B' ' 851' ' ' ALA . 46.6 tp -175.0 104.14 0.09 Allowed 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.625 -0.88 . . . . 4.1799999999999997 108.625 178.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 874' ' ' ASN . . . . . 0.44 ' CB ' ' HA ' ' B' ' 852' ' ' PHE . 35.5 t-20 178.73 81.78 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.303 0 O-C-N 121.681 -0.637 . . . . 0.040000000000000001 109.74 -179.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -67.4 -48.12 68.3 Favored 'General case' 0 N--CA 1.499 1.998 0 C-N-CA 119.281 -0.967 . . . . 3.3799999999999999 111.164 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 876' ' ' GLY . . . . . . . . . . . . . . . -73.52 -25.57 72.17 Favored Glycine 0 N--CA 1.494 2.536 0 O-C-N 121.242 -0.911 . . . . 0.040000000000000001 111.599 -178.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 82.61 -61.15 4.78 Favored Glycine 0 N--CA 1.501 3.02 0 N-CA-C 108.105 -1.998 . . . . 0.040000000000000001 108.105 -178.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 878' ' ' TYR . . . . . 0.418 ' CE2' ' CG1' ' B' ' 850' ' ' VAL . 95.7 m-85 61.11 -62.94 0.08 Allowed 'General case' 0 N--CA 1.503 2.178 0 N-CA-C 114.361 1.245 . . . . 3.46 114.361 177.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 879' ' ' TYR . . . . . 0.485 ' HH ' ' HD1' ' B' ' 981' ' ' PHE . 18.8 p90 -111.28 108.77 18.5 Favored 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 114.477 1.288 . . . . 0.040000000000000001 114.477 -176.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -65.09 114.67 16.0 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.37 -0.832 . . . . 0.02 110.085 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 881' ' ' PRO . . . . . 0.476 ' HG2' ' CD1' ' B' ' 868' ' ' PHE . 53.6 Cg_endo -75.14 -0.98 10.66 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 O-C-N 123.557 1.293 . . . . 0.39000000000000001 112.257 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -76.8 -65.48 0.94 Allowed 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 107.071 -1.455 . . . . 0.81000000000000005 107.071 178.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 32.4 p -92.39 -17.71 24.26 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.713 -0.847 . . . . 0.040000000000000001 108.713 177.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.78 20.09 60.33 Favored Glycine 0 N--CA 1.495 2.63 0 O-C-N 121.092 -1.005 . . . . 0.029999999999999999 111.538 178.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 885' ' ' VAL . . . . . 0.684 HG13 HG21 ' B' ' 961' ' ' THR . 93.1 t -73.61 91.24 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 C-N-CA 118.13 -1.428 . . . . 1.01 108.058 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 886' ' ' PHE . . . . . 0.906 ' HB3' HG22 ' B' ' 962' ' ' VAL . 0.6 OUTLIER -89.85 105.16 17.62 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 115.211 -0.904 . . . . 0.050000000000000003 112.056 -177.448 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 887' ' ' THR . . . . . 0.406 ' O ' ' HD3' ' B' ' 889' ' ' PRO . 84.7 m -96.09 100.71 12.34 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 107.626 -1.25 . . . . 0.68000000000000005 107.626 177.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 888' ' ' ALA . . . . . . . . . . . . . . . -98.67 107.25 41.79 Favored Pre-proline 0 N--CA 1.502 2.148 0 N-CA-C 114.029 1.122 . . . . 0.25 114.029 -176.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 889' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' B' ' 887' ' ' THR . 53.4 Cg_endo -90.09 -12.6 2.75 Favored 'Trans proline' 0 CA--C 1.546 1.099 0 C-N-CA 121.043 1.162 . . . . 1.6399999999999999 109.274 176.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 890' ' ' LEU . . . . . 0.985 HD22 HD13 ' B' ' 985' ' ' LEU . 63.7 mt -36.02 -50.65 0.7 Allowed 'General case' 0 N--CA 1.509 2.481 0 N-CA-C 113.819 1.044 . . . . 2.29 113.819 -177.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 51.68 95.82 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.314 0 O-C-N 121.137 -0.977 . . . . 0.63 110.322 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . 156.6 -149.78 20.75 Favored Glycine 0 N--CA 1.479 1.564 0 N-CA-C 107.26 -2.336 . . . . 0.040000000000000001 107.26 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 71.1 ttt-85 -112.51 126.61 55.51 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 107.979 -1.119 . . . . 3.0 107.979 177.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 894' ' ' TYR . . . . . 0.545 ' OH ' HD12 ' B' ' 896' ' ' LEU . 0.0 OUTLIER -131.1 155.29 47.2 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.122 -0.986 . . . . 0.040000000000000001 110.68 -179.133 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 895' ' ' LEU . . . . . 0.429 ' N ' ' CD1' ' B' ' 894' ' ' TYR . 34.8 tp -95.57 114.04 25.76 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.575 -0.703 . . . . 1.27 110.089 -179.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 896' ' ' LEU . . . . . 0.559 HD23 ' N ' ' B' ' 897' ' ' SER . 9.7 tt -108.64 142.03 39.72 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.696 -0.628 . . . . 0.93999999999999995 110.695 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 897' ' ' SER . . . . . 0.559 ' N ' HD23 ' B' ' 896' ' ' LEU . 69.6 m -146.75 115.27 6.74 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.565 -0.71 . . . . 0.040000000000000001 110.864 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.1 146.6 31.05 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.112 -0.699 . . . . 0.47999999999999998 109.112 179.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 899' ' ' VAL . . . . . 0.767 HG21 ' HB ' ' B' ' 980' ' ' ILE . 87.7 t -96.2 119.39 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 C-N-CA 119.6 -0.84 . . . . 0.55000000000000004 111.466 -179.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 900' ' ' LEU . . . . . 0.545 HD12 ' HB2' ' B' ' 924' ' ' SER . 4.5 mm? -94.11 111.11 22.8 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 114.2 1.185 . . . . 1.5900000000000001 114.2 -175.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 21.2 m -65.1 140.74 58.84 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 107.333 -1.358 . . . . 0.050000000000000003 107.333 177.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -64.88 -66.7 2.34 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.445 -1.062 . . . . 0.029999999999999999 110.445 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 5.8 m170 46.54 66.84 0.88 Allowed 'General case' 0 N--CA 1.508 2.428 0 O-C-N 121.439 -1.036 . . . . 3.2000000000000002 111.016 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 43.3 ptt85 -69.02 -6.05 25.56 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.591 -0.693 . . . . 2.9199999999999999 112.043 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 905' ' ' HIS . . . . . 0.48 ' O ' ' CB ' ' B' ' 906' ' ' GLU . 74.1 t60 -60.39 2.61 0.09 Allowed 'General case' 0 N--CA 1.506 2.332 0 O-C-N 120.857 -1.152 . . . . 2.8700000000000001 112.897 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 906' ' ' GLU . . . . . 0.48 ' CB ' ' O ' ' B' ' 905' ' ' HIS . 0.8 OUTLIER 93.95 -163.73 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.44 0 CA-C-N 120.584 1.538 . . . . 0.98999999999999999 112.36 178.741 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 907' ' ' LYS . . . . . 0.471 ' CB ' ' O ' ' B' ' 906' ' ' GLU . 51.5 tttt 89.13 161.01 0.06 Allowed 'General case' 0 N--CA 1.52 3.045 0 N-CA-C 107.755 -1.202 . . . . 5.25 107.755 -177.011 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 58.9 t -121.52 115.93 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 120.86 -1.15 . . . . 0.39000000000000001 110.93 -179.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 54.1 tp10 -104.35 132.21 50.85 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 107.546 -1.279 . . . . 1.72 107.546 177.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -156.25 121.82 4.85 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 106.56 -1.644 . . . . 0.67000000000000004 106.56 178.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 911' ' ' VAL . . . . . 0.717 HG22 HG13 ' B' ' 964' ' ' VAL . 92.4 t -81.86 132.67 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.791 -0.568 . . . . 0.54000000000000004 110.788 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 71.8 mt -65.76 156.08 34.19 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 108.763 -0.828 . . . . 1.5 108.763 178.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 913' ' ' SER . . . . . 0.413 ' CB ' ' HB ' ' B' ' 919' ' ' VAL . 2.4 t -123.81 136.56 54.47 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.157 -1.053 . . . . 1.3700000000000001 108.157 176.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 914' ' ' ARG . . . . . 0.625 ' NH1' HD23 ' B' ' 956' ' ' LEU . 0.0 OUTLIER -63.36 153.95 33.44 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 120.772 -1.205 . . . . 4.2999999999999998 111.701 -178.909 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 915' ' ' SER . . . . . 0.419 ' CB ' ' O ' ' B' ' 914' ' ' ARG . 4.9 t 83.49 -32.53 0.08 Allowed 'General case' 0 N--CA 1.52 3.06 0 C-N-CA 124.11 0.964 . . . . 2.0499999999999998 112.36 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 916' ' ' ASN . . . . . 0.767 ' HB2' HG21 ' B' ' 919' ' ' VAL . 98.6 m-20 -121.98 -21.4 6.01 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 120.797 -1.189 . . . . 2.71 111.461 -179.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 917' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 67.15 165.93 0.22 Allowed 'General case' 0 N--CA 1.52 3.026 0 N-CA-C 105.62 -1.993 . . . . 2.6800000000000002 105.62 -174.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 55.09 -125.86 37.06 Favored Glycine 1 N--CA 1.521 4.301 0 CA-C-N 123.575 2.898 . . . . 0.029999999999999999 106.882 -177.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 919' ' ' VAL . . . . . 0.767 HG21 ' HB2' ' B' ' 916' ' ' ASN . 85.6 t 51.72 94.57 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.249 0 O-C-N 121.427 -1.043 . . . . 1.3899999999999999 108.96 -178.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 920' ' ' ALA . . . . . 0.875 ' HB3' HG12 ' B' ' 949' ' ' VAL . . . -91.67 92.14 8.31 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 119.298 -0.961 . . . . 0.029999999999999999 111.114 -178.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 921' ' ' ARG . . . . . 0.737 ' HG3' HG23 ' B' ' 922' ' ' VAL . 16.7 ptt180 -84.14 -42.25 16.22 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 105.749 -1.945 . . . . 4.4199999999999999 105.749 175.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 922' ' ' VAL . . . . . 0.737 HG23 ' HG3' ' B' ' 921' ' ' ARG . 75.0 t -103.78 69.42 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 105.563 -2.014 . . . . 0.84999999999999998 105.563 175.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 923' ' ' ASP . . . . . 0.654 ' HB2' ' HB1' ' B' ' 920' ' ' ALA . 22.0 t0 -89.44 136.3 33.1 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.895 0.855 . . . . 2.46 112.22 -176.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 924' ' ' SER . . . . . 0.545 ' HB2' HD12 ' B' ' 900' ' ' LEU . 13.3 t -146.41 103.32 3.68 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 107.957 -1.127 . . . . 0.69999999999999996 107.957 178.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -110.62 89.39 0.54 Allowed Glycine 0 N--CA 1.488 2.154 0 N-CA-C 108.929 -1.668 . . . . 0.040000000000000001 108.929 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.385 0 N-CA-C 109.334 -1.506 . . . . 0.040000000000000001 109.334 -179.658 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 23.3 m . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.044 0.45 . . . . 13.779999999999999 110.218 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 96.2 mt -112.28 129.8 56.16 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.566 -0.709 . . . . 13.76 110.395 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -151.25 167.08 30.69 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.07 -1.612 . . . . 9.1300000000000008 109.07 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 949' ' ' VAL . . . . . 0.875 HG12 ' HB3' ' B' ' 920' ' ' ALA . 32.5 m -118.68 130.21 73.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.469 -1.018 . . . . 7.0800000000000001 110.85 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 950' ' ' PHE . . . . . 0.462 ' CZ ' ' HB3' ' B' ' 921' ' ' ARG . 27.8 p90 -132.41 149.44 52.34 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.591 -0.693 . . . . 7.5899999999999999 109.303 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 19.6 m -120.22 -52.72 2.16 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.413 -0.804 . . . . 5.0300000000000002 112.037 -178.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 952' ' ' LEU . . . . . 0.413 ' O ' ' O ' ' B' ' 953' ' ' ILE . 16.8 tp -61.59 -74.4 0.08 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.378 -0.827 . . . . 1.01 112.324 -177.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 953' ' ' ILE . . . . . 0.496 ' O ' ' HB3' ' B' ' 954' ' ' LEU . 44.8 pt -53.12 -143.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.723 0 N-CA-C 114.122 1.156 . . . . 2.6000000000000001 114.122 -176.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 954' ' ' LEU . . . . . 0.714 HD22 ' O ' ' B' ' 954' ' ' LEU . 0.0 OUTLIER 171.25 78.53 0.04 OUTLIER Pre-proline 0 N--CA 1.511 2.606 0 O-C-N 120.772 -1.205 . . . . 0.050000000000000003 111.507 179.609 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 955' ' ' PRO . . . . . 0.694 ' C ' HD12 ' B' ' 956' ' ' LEU . 46.9 Cg_endo -74.28 95.86 0.94 Allowed 'Trans proline' 0 C--N 1.313 -1.306 0 N-CA-C 109.307 -1.074 . . . . 0.83999999999999997 109.307 178.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 956' ' ' LEU . . . . . 0.694 HD12 ' C ' ' B' ' 955' ' ' PRO . 10.2 mp -123.28 145.19 48.89 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.15 -0.969 . . . . 0.040000000000000001 110.212 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -84.51 151.51 24.54 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 117.983 -1.008 . . . . 1.28 111.821 -179.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -70.47 119.66 14.96 Favored 'General case' 0 N--CA 1.51 2.566 0 CA-C-N 122.725 2.511 . . . . 0.17000000000000001 111.919 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.96 -23.1 30.72 Favored Glycine 0 N--CA 1.502 3.046 0 N-CA-C 111.154 -0.779 . . . . 0.040000000000000001 111.154 178.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 960' ' ' ASP . . . . . 0.437 ' HB3' ' NE ' ' B' ' 914' ' ' ARG . 0.4 OUTLIER -52.96 171.86 0.06 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.467 -1.02 . . . . 0.040000000000000001 110.376 -179.312 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 961' ' ' THR . . . . . 0.684 HG21 HG13 ' B' ' 885' ' ' VAL . 38.3 m -134.59 135.55 42.31 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.074 -1.016 . . . . 1.78 111.714 -178.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 962' ' ' VAL . . . . . 0.906 HG22 ' HB3' ' B' ' 886' ' ' PHE . 31.9 m -99.05 145.13 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 C-N-CA 119.989 -0.684 . . . . 0.040000000000000001 110.343 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 5.0 t -137.64 146.15 43.56 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.936 -0.478 . . . . 0.71999999999999997 110.166 -178.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 964' ' ' VAL . . . . . 0.717 HG13 HG22 ' B' ' 911' ' ' VAL . 58.3 t -95.13 136.07 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.073 -1.017 . . . . 1.05 110.529 -179.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -95.25 126.11 40.34 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 103.761 -2.681 . . . . 3.02 103.761 173.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 966' ' ' LEU . . . . . 0.488 ' C ' HG23 ' B' ' 967' ' ' VAL . 1.4 tt -133.13 61.39 1.68 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.309 -0.997 . . . . 1.46 108.309 177.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 967' ' ' VAL . . . . . 0.488 HG23 ' C ' ' B' ' 966' ' ' LEU . 98.5 t -158.04 96.25 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 108.148 -1.056 . . . . 1.9399999999999999 108.148 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 93.3 mmm -142.81 58.32 1.43 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.767 -1.208 . . . . 0.0 108.227 178.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 133.1 119.1 1.99 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 106.654 -2.578 . . . . 2.1099999999999999 106.654 -178.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -84.53 -44.53 13.49 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 118.912 1.356 . . . . 5.8899999999999997 111.404 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 43.3 tp -61.48 88.85 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.882 -1.136 . . . . 4.3600000000000003 110.048 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -141.59 -156.26 0.66 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.575 -0.703 . . . . 1.8300000000000001 110.249 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -121.68 176.28 5.8 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.599 -0.688 . . . . 4.3499999999999996 110.195 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 9.2 t -100.22 129.87 46.28 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.52 -0.738 . . . . 1.27 109.956 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -156.11 157.89 36.79 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.53 -0.731 . . . . 5.0199999999999996 110.629 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.31 86.75 16.51 Favored Pre-proline 0 N--CA 1.5 2.056 0 O-C-N 121.678 -0.639 . . . . 2.4100000000000001 109.521 179.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -72.92 -172.49 0.99 Allowed 'Trans proline' 0 N--CA 1.487 1.089 0 O-C-N 123.32 1.168 . . . . 0.95999999999999996 111.443 -179.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 978' ' ' LEU . . . . . 0.539 ' N ' HD12 ' B' ' 978' ' ' LEU . 5.0 mp -127.93 154.99 44.92 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 107.619 -1.252 . . . . 0.62 107.619 178.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 979' ' ' THR . . . . . 0.462 HG23 ' C ' ' B' ' 978' ' ' LEU . 44.3 p -149.9 141.07 23.08 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.746 -1.221 . . . . 3.5699999999999998 111.294 -179.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 980' ' ' ILE . . . . . 0.767 ' HB ' HG21 ' B' ' 899' ' ' VAL . 50.2 mm -107.84 127.8 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 108.892 -0.781 . . . . 1.3300000000000001 108.892 179.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 981' ' ' PHE . . . . . 0.485 ' HD1' ' HH ' ' B' ' 879' ' ' TYR . 6.4 t80 -121.61 97.53 5.54 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 119.717 -0.793 . . . . 0.050000000000000003 111.906 -178.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 94.1 p -109.22 158.65 17.63 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.552 -0.717 . . . . 0.87 109.104 178.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 983' ' ' GLY . . . . . . . . . . . . . . . -173.66 109.07 0.29 Allowed Glycine 0 N--CA 1.499 2.872 0 N-CA-C 106.705 -2.558 . . . . 0.029999999999999999 106.705 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -109.07 148.71 30.4 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 114.361 1.245 . . . . 0.69999999999999996 114.361 -175.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 985' ' ' LEU . . . . . 0.985 HD13 HD22 ' B' ' 890' ' ' LEU . 35.0 tp -69.03 135.17 50.43 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.796 -1.19 . . . . 0.040000000000000001 110.255 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 986' ' ' LEU . . . . . 0.463 ' CD1' HD11 ' C' ' 986' ' ' LEU . 50.5 tp -106.88 -58.82 1.89 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.639 -0.663 . . . . 0.040000000000000001 109.932 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -144.07 145.34 32.1 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.591 -1.263 . . . . 0.040000000000000001 107.591 179.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.61 163.03 12.2 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 108.163 -1.975 . . . . 0.040000000000000001 108.163 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -75.76 112.48 20.02 Favored Pre-proline 0 N--CA 1.499 1.984 0 O-C-N 121.243 -1.151 . . . . 0.040000000000000001 109.406 179.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 990' ' ' PRO . . . . . 0.416 ' O ' ' HB2' ' B' ' 991' ' ' GLU . 49.6 Cg_endo -90.38 71.86 1.35 Allowed 'Trans proline' 0 C--N 1.319 -1.005 0 O-C-N 123.133 1.07 . . . . 0.45000000000000001 111.373 -179.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 991' ' ' GLU . . . . . 0.416 ' HB2' ' O ' ' B' ' 990' ' ' PRO . 74.9 mt-10 67.34 -73.56 0.08 Allowed 'General case' 0 N--CA 1.502 2.149 0 N-CA-C 108.552 -0.907 . . . . 1.97 108.552 -177.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 992' ' ' LEU . . . . . 0.434 ' HA ' HD23 ' B' ' 992' ' ' LEU . 10.9 mt 51.18 20.28 0.86 Allowed 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.536 -0.727 . . . . 2.3799999999999999 111.677 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 80.3 mt-10 -93.75 156.79 16.48 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.895 -1.128 . . . . 3.79 109.976 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 70.6 m80 -146.24 92.79 2.22 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.444 -0.785 . . . . 3.5099999999999998 110.388 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 995' ' ' ALA . . . . . . . . . . . . 2.517 . . . . . . . 0 N--CA 1.504 2.255 0 O-C-N 120.935 -1.103 . . . . 2.73 110.612 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo . . . . . 0 N--CA 1.488 1.158 0 N-CA-C 109.539 -0.985 . . . . 3.8300000000000001 109.539 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 847' ' ' VAL . . . . . 0.506 HG12 ' HB2' ' C' ' 849' ' ' GLN . 58.2 t -126.48 106.41 23.87 Favored Pre-proline 0 N--CA 1.496 1.835 0 O-C-N 121.597 -0.689 . . . . 1.8300000000000001 110.012 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 848' ' ' PRO . . . . . 0.886 ' O ' HG23 ' C' ' 850' ' ' VAL . 44.4 Cg_endo -69.7 -22.68 32.01 Favored 'Trans proline' 0 N--CA 1.488 1.177 0 O-C-N 123.278 1.146 . . . . 0.65000000000000002 111.034 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 849' ' ' GLN . . . . . 0.506 ' HB2' HG12 ' C' ' 847' ' ' VAL . 54.5 tt0 25.17 64.9 0.06 Allowed 'General case' 0 N--CA 1.519 2.991 0 N-CA-C 113.379 0.881 . . . . 2.5800000000000001 113.379 179.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 850' ' ' VAL . . . . . 0.886 HG23 ' O ' ' C' ' 848' ' ' PRO . 72.1 t -119.06 135.5 59.27 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.117 -0.989 . . . . 1.0900000000000001 111.028 -179.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 851' ' ' ALA . . . . . 0.573 ' HB3' ' HG ' ' C' ' 873' ' ' LEU . . . -126.96 155.93 42.34 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 105.758 -1.942 . . . . 0.040000000000000001 105.758 176.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 852' ' ' PHE . . . . . 0.451 ' CD1' ' N ' ' C' ' 852' ' ' PHE . 16.0 p90 -160.26 127.38 4.41 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 121.016 1.734 . . . . 0.050000000000000003 108.625 178.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 38.8 t -176.65 134.88 0.22 Allowed 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.18 -1.044 . . . . 0.040000000000000001 108.18 -179.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 854' ' ' ALA . . . . . 0.447 ' HB1' ' HD2' ' C' ' 868' ' ' PHE . . . -132.21 156.96 45.53 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.164 -0.96 . . . . 0.67000000000000004 109.779 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 855' ' ' ALA . . . . . 0.683 ' HB3' ' CB ' ' C' ' 870' ' ' ARG . . . -122.41 140.53 52.6 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.759 0.79 . . . . 0.51000000000000001 111.179 -179.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 856' ' ' LEU . . . . . 0.734 HD11 HD23 ' C' ' 858' ' ' LEU . 3.5 tm? -111.74 138.14 48.71 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.641 -0.662 . . . . 0.050000000000000003 110.036 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 857' ' ' SER . . . . . 0.636 ' N ' HD13 ' C' ' 856' ' ' LEU . 21.1 m -155.27 18.66 0.42 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.395 -0.815 . . . . 1.3300000000000001 111.347 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 858' ' ' LEU . . . . . 0.734 HD23 HD11 ' C' ' 856' ' ' LEU . 3.2 pp -34.81 160.87 0.04 OUTLIER Pre-proline 0 N--CA 1.52 3.067 0 N-CA-C 113.066 0.765 . . . . 2.3300000000000001 113.066 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -60.34 -88.22 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.462 0 O-C-N 122.99 0.995 . . . . 2.3199999999999998 113.455 -178.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 55.2 ptt85 -128.31 -143.34 0.27 Allowed 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.823 -1.173 . . . . 0.040000000000000001 111.808 -177.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 69.4 m -37.84 130.32 1.11 Allowed 'General case' 0 N--CA 1.511 2.581 0 O-C-N 121.622 -0.673 . . . . 1.3100000000000001 112.356 -178.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.14 160.45 26.03 Favored Pre-proline 0 N--CA 1.489 1.476 0 N-CA-C 108.326 -0.99 . . . . 4.5099999999999998 108.326 177.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.78 -13.57 26.83 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 O-C-N 123.152 1.08 . . . . 2.2400000000000002 111.453 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -177.78 -136.2 2.44 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.664 -1.374 . . . . 0.040000000000000001 109.664 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 17.0 m -68.23 153.86 42.89 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.329 -1.1 . . . . 1.51 109.92 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 866' ' ' VAL . . . . . 0.444 ' HA ' ' HD3' ' C' ' 867' ' ' PRO . 39.4 t -97.72 139.78 21.56 Favored Pre-proline 0 N--CA 1.493 1.691 0 N-CA-C 113.507 0.928 . . . . 0.78000000000000003 113.507 -174.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 867' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' C' ' 866' ' ' VAL . 55.8 Cg_endo -91.4 -147.86 0.03 OUTLIER 'Trans proline' 0 CA--C 1.544 0.998 0 O-C-N 123.688 1.362 . . . . 0.92000000000000004 108.95 177.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 868' ' ' PHE . . . . . 0.485 ' CD1' ' HG2' ' C' ' 881' ' ' PRO . 14.0 p90 -149.88 124.12 9.52 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.51 -1.368 . . . . 0.050000000000000003 110.109 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 47.6 p-10 -112.45 -3.08 14.53 Favored 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 119.131 -1.027 . . . . 1.7 112.508 -178.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 870' ' ' ARG . . . . . 0.683 ' CB ' ' HB3' ' C' ' 855' ' ' ALA . 28.0 mmm180 -91.85 87.86 6.41 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.925 -1.109 . . . . 2.5899999999999999 111.112 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 60.7 t -71.55 96.94 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 120.927 -1.108 . . . . 1.9399999999999999 109.337 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 872' ' ' LEU . . . . . 0.804 HD13 HD11 ' A' ' 953' ' ' ILE . 95.3 mt -87.29 -44.73 11.2 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.592 -0.692 . . . . 1.0600000000000001 110.678 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 873' ' ' LEU . . . . . 0.573 ' HG ' ' HB3' ' C' ' 851' ' ' ALA . 33.0 tp -172.91 102.02 0.13 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.101 -0.999 . . . . 4.1799999999999997 108.947 178.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 874' ' ' ASN . . . . . 0.443 ' CB ' ' HA ' ' C' ' 852' ' ' PHE . 34.0 t-20 176.99 82.09 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.284 0 N-CA-C 108.987 -0.746 . . . . 0.040000000000000001 108.987 -179.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -65.34 -47.27 77.07 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.107 -0.995 . . . . 3.3799999999999999 111.308 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 876' ' ' GLY . . . . . 0.417 ' HA3' ' CE2' ' C' ' 878' ' ' TYR . . . -72.58 -26.47 71.59 Favored Glycine 0 N--CA 1.493 2.483 0 C-N-CA 120.423 -0.894 . . . . 0.040000000000000001 111.436 -178.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 79.61 -63.13 4.03 Favored Glycine 0 N--CA 1.5 2.956 0 N-CA-C 108.102 -1.999 . . . . 0.040000000000000001 108.102 -178.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 878' ' ' TYR . . . . . 0.417 ' CE2' ' HA3' ' C' ' 876' ' ' GLY . 89.4 m-85 60.76 -64.79 0.06 Allowed 'General case' 0 N--CA 1.502 2.146 0 N-CA-C 114.276 1.213 . . . . 3.46 114.276 177.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 879' ' ' TYR . . . . . 0.483 ' CE2' ' CD1' ' C' ' 981' ' ' PHE . 22.3 p90 -109.93 106.93 16.67 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 114.976 1.473 . . . . 0.040000000000000001 114.976 -176.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -69.64 119.22 69.58 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.401 -0.812 . . . . 0.02 109.759 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 881' ' ' PRO . . . . . 0.485 ' HG2' ' CD1' ' C' ' 868' ' ' PHE . 55.3 Cg_endo -79.26 -0.16 10.51 Favored 'Trans proline' 0 N--CA 1.487 1.132 0 O-C-N 123.363 1.191 . . . . 0.39000000000000001 111.563 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -76.31 -62.84 1.48 Allowed 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 106.433 -1.691 . . . . 0.81000000000000005 106.433 178.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 24.3 p -88.46 -21.87 23.98 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.136 -1.061 . . . . 0.040000000000000001 108.136 176.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 81.77 16.35 73.13 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 110.401 -1.079 . . . . 0.029999999999999999 110.401 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 84.4 t -73.93 91.91 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 C-N-CA 118.397 -1.321 . . . . 1.01 108.111 -179.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 886' ' ' PHE . . . . . 0.875 ' HB3' HG22 ' C' ' 962' ' ' VAL . 1.1 t80 -87.46 105.7 17.47 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 115.17 -0.923 . . . . 0.050000000000000003 111.628 -177.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 887' ' ' THR . . . . . 0.438 ' O ' ' HD3' ' C' ' 889' ' ' PRO . 86.7 m -102.45 99.72 9.79 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 107.806 -1.183 . . . . 0.68000000000000005 107.806 177.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 888' ' ' ALA . . . . . . . . . . . . . . . -98.66 101.19 11.14 Favored Pre-proline 0 N--CA 1.501 2.084 0 N-CA-C 114.388 1.255 . . . . 0.25 114.388 -176.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 889' ' ' PRO . . . . . 0.438 ' HD3' ' O ' ' C' ' 887' ' ' THR . 55.7 Cg_endo -80.06 -15.3 11.76 Favored 'Trans proline' 0 N--CA 1.486 1.042 0 N-CA-C 108.73 -1.296 . . . . 1.6399999999999999 108.73 175.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 890' ' ' LEU . . . . . 0.619 HD21 HG11 ' C' ' 850' ' ' VAL . 60.7 mt -37.35 -49.5 0.99 Allowed 'General case' 0 N--CA 1.508 2.425 0 N-CA-C 113.452 0.908 . . . . 2.29 113.452 -177.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 52.36 97.19 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.267 0 O-C-N 121.19 -0.944 . . . . 0.63 110.285 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . 158.94 -154.21 25.3 Favored Glycine 0 N--CA 1.477 1.422 0 N-CA-C 107.272 -2.331 . . . . 0.040000000000000001 107.272 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 74.5 ttt-85 -117.36 123.23 45.96 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.612 -0.934 . . . . 3.0 108.761 177.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 894' ' ' TYR . . . . . 0.761 ' CZ ' HD23 ' C' ' 954' ' ' LEU . 20.3 p90 -133.78 155.54 49.62 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.117 -0.989 . . . . 0.040000000000000001 110.956 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 895' ' ' LEU . . . . . . . . . . . . . 49.0 tp -97.82 115.41 28.0 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.719 -0.613 . . . . 1.27 110.268 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 896' ' ' LEU . . . . . 0.435 HD11 ' HE1' ' C' ' 981' ' ' PHE . 9.3 tt -118.36 144.6 45.77 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.654 -0.654 . . . . 0.93999999999999995 109.945 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 897' ' ' SER . . . . . . . . . . . . . 55.4 m -141.82 124.57 16.01 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.429 -0.795 . . . . 0.040000000000000001 111.284 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -101.89 148.17 25.64 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.789 -0.819 . . . . 0.47999999999999998 108.789 178.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 899' ' ' VAL . . . . . 0.705 HG21 ' HB ' ' C' ' 980' ' ' ILE . 87.4 t -92.49 120.31 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.35 -0.844 . . . . 0.55000000000000004 111.256 -179.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 94.6 mt -92.78 112.23 24.11 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 114.036 1.125 . . . . 1.5900000000000001 114.036 -175.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 20.7 m -63.48 140.4 58.87 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 107.472 -1.307 . . . . 0.050000000000000003 107.472 177.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -61.12 -65.23 3.42 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 110.344 -1.103 . . . . 0.029999999999999999 110.344 -179.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 5.9 m170 45.86 64.39 1.48 Allowed 'General case' 0 N--CA 1.507 2.397 0 O-C-N 121.556 -0.967 . . . . 3.2000000000000002 111.239 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 42.7 ptt85 -67.68 -7.96 31.12 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.614 -0.679 . . . . 2.9199999999999999 111.83 -179.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 905' ' ' HIS . . . . . 0.493 ' O ' ' CB ' ' C' ' 906' ' ' GLU . 75.8 t60 -61.97 6.12 0.08 Allowed 'General case' 0 N--CA 1.506 2.342 0 CA-C-O 117.649 -1.167 . . . . 2.8700000000000001 113.468 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 906' ' ' GLU . . . . . 0.493 ' CB ' ' O ' ' C' ' 905' ' ' HIS . 0.8 OUTLIER 93.07 -163.45 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.441 0 CA-C-N 121.252 1.842 . . . . 0.98999999999999999 112.012 178.983 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 907' ' ' LYS . . . . . 0.493 ' CB ' ' O ' ' C' ' 906' ' ' GLU . 25.8 ttmt 89.9 161.91 0.05 OUTLIER 'General case' 0 N--CA 1.522 3.136 0 N-CA-C 108.061 -1.088 . . . . 5.25 108.061 -177.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 59.6 t -121.67 117.34 52.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 120.841 -1.162 . . . . 0.39000000000000001 110.915 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 909' ' ' GLU . . . . . 0.54 ' OE2' HD12 ' C' ' 966' ' ' LEU . 43.1 tp10 -104.5 130.91 52.4 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 107.486 -1.302 . . . . 1.72 107.486 177.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -157.18 121.13 4.24 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 106.887 -1.523 . . . . 0.67000000000000004 106.887 178.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 911' ' ' VAL . . . . . 0.739 HG22 HG13 ' C' ' 964' ' ' VAL . 97.8 t -83.42 132.06 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.784 -0.573 . . . . 0.54000000000000004 110.863 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 64.4 mt -66.18 157.41 31.4 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.478 -0.764 . . . . 1.5 109.243 178.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 913' ' ' SER . . . . . 0.417 ' CB ' ' CG1' ' C' ' 919' ' ' VAL . 2.2 t -125.4 137.96 54.02 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.212 -1.033 . . . . 1.3700000000000001 108.212 176.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 914' ' ' ARG . . . . . 0.891 ' NH1' HD23 ' C' ' 956' ' ' LEU . 0.0 OUTLIER -63.94 154.06 35.11 Favored 'General case' 0 N--CA 1.504 2.275 0 O-C-N 120.681 -1.262 . . . . 4.2999999999999998 111.88 -178.714 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 915' ' ' SER . . . . . 0.425 ' CB ' ' O ' ' C' ' 914' ' ' ARG . 4.0 t 83.06 -31.41 0.09 Allowed 'General case' 0 N--CA 1.521 3.124 0 C-N-CA 123.865 0.866 . . . . 2.0499999999999998 112.382 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 916' ' ' ASN . . . . . 0.618 ' HB2' HG21 ' C' ' 919' ' ' VAL . 94.5 m-20 -122.37 -21.72 5.72 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.785 -1.197 . . . . 2.71 111.252 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 917' ' ' GLN . . . . . 0.41 ' HB2' ' O ' ' C' ' 916' ' ' ASN . 46.5 mt-30 67.36 167.81 0.24 Allowed 'General case' 0 N--CA 1.52 3.044 0 N-CA-C 105.608 -1.997 . . . . 2.6800000000000002 105.608 -174.013 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.91 -127.47 41.08 Favored Glycine 1 N--CA 1.52 4.289 0 CA-C-N 123.589 2.904 . . . . 0.029999999999999999 107.022 -177.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 919' ' ' VAL . . . . . 0.618 HG21 ' HB2' ' C' ' 916' ' ' ASN . 92.6 t 50.54 94.53 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.233 0 O-C-N 121.466 -1.02 . . . . 1.3899999999999999 109.206 -178.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 920' ' ' ALA . . . . . 0.998 ' HB3' HG12 ' C' ' 949' ' ' VAL . . . -93.21 94.37 8.76 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.395 -0.922 . . . . 0.029999999999999999 110.943 -179.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 921' ' ' ARG . . . . . 0.694 ' HG3' HG23 ' C' ' 922' ' ' VAL . 40.7 ptt85 -81.36 -42.29 20.71 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 105.766 -1.938 . . . . 4.4199999999999999 105.766 176.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 922' ' ' VAL . . . . . 0.694 HG23 ' HG3' ' C' ' 921' ' ' ARG . 73.6 t -100.82 74.92 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 N-CA-C 105.523 -2.029 . . . . 0.84999999999999998 105.523 175.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -89.95 135.08 33.86 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.87 0.843 . . . . 2.46 112.315 -176.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 4.4 t -147.33 102.94 3.52 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.973 -1.121 . . . . 0.69999999999999996 107.973 178.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -110.08 89.84 0.56 Allowed Glycine 0 N--CA 1.488 2.105 0 N-CA-C 108.952 -1.659 . . . . 0.040000000000000001 108.952 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.33 0 N-CA-C 109.3 -1.52 . . . . 0.040000000000000001 109.3 -179.685 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 24.9 m . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 120.928 0.394 . . . . 13.779999999999999 110.355 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 95.6 mt -114.47 129.78 56.68 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.572 -0.705 . . . . 13.76 110.347 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -152.03 169.85 31.37 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.316 -1.514 . . . . 9.1300000000000008 109.316 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 949' ' ' VAL . . . . . 0.998 HG12 ' HB3' ' C' ' 920' ' ' ALA . 34.0 m -118.24 135.65 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.513 -0.993 . . . . 7.0800000000000001 110.985 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 950' ' ' PHE . . . . . 0.456 ' CZ ' ' HB3' ' C' ' 921' ' ' ARG . 49.4 p90 -134.76 151.92 51.35 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.524 -0.735 . . . . 7.5899999999999999 109.348 179.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 26.6 m -119.01 -55.26 2.18 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.375 -0.828 . . . . 5.0300000000000002 111.956 -178.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 952' ' ' LEU . . . . . 0.452 ' O ' ' O ' ' C' ' 953' ' ' ILE . 52.8 tp -63.15 -76.37 0.07 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.359 -0.838 . . . . 1.01 111.688 -178.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 953' ' ' ILE . . . . . 0.574 HD12 ' HD3' ' C' ' 955' ' ' PRO . 2.0 pp -49.12 -150.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.784 0 N-CA-C 114.699 1.37 . . . . 2.6000000000000001 114.699 -176.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 954' ' ' LEU . . . . . 0.761 HD23 ' CZ ' ' C' ' 894' ' ' TYR . 0.0 OUTLIER 170.99 89.14 0.04 OUTLIER Pre-proline 0 N--CA 1.516 2.836 0 O-C-N 120.74 -1.225 . . . . 0.050000000000000003 111.88 -179.477 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 955' ' ' PRO . . . . . 0.754 ' C ' HD12 ' C' ' 956' ' ' LEU . 50.9 Cg_endo -83.41 93.7 0.82 Allowed 'Trans proline' 0 C--N 1.317 -1.1 0 N-CA-C 109.419 -1.031 . . . . 0.83999999999999997 109.419 178.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 956' ' ' LEU . . . . . 0.891 HD23 ' NH1' ' C' ' 914' ' ' ARG . 7.9 mp -126.28 150.13 48.66 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.07 -1.019 . . . . 0.040000000000000001 110.772 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -83.16 151.81 25.54 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 117.743 -1.122 . . . . 1.28 111.518 -178.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -66.88 119.32 11.7 Favored 'General case' 0 N--CA 1.509 2.515 0 CA-C-N 123.022 2.647 . . . . 0.17000000000000001 111.213 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.72 -19.98 47.85 Favored Glycine 0 N--CA 1.499 2.882 0 N-CA-C 110.907 -0.877 . . . . 0.040000000000000001 110.907 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 960' ' ' ASP . . . . . 0.409 ' HB3' ' NE ' ' C' ' 914' ' ' ARG . 0.4 OUTLIER -54.44 170.58 0.15 Allowed 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.409 -1.054 . . . . 0.040000000000000001 110.353 -179.456 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 961' ' ' THR . . . . . 0.507 ' HA ' ' O ' ' C' ' 886' ' ' PHE . 39.3 m -136.93 141.0 42.66 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.989 -1.069 . . . . 1.78 112.614 -177.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 962' ' ' VAL . . . . . 0.875 HG22 ' HB3' ' C' ' 886' ' ' PHE . 27.3 m -99.88 145.18 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 C-N-CA 120.395 -0.522 . . . . 0.040000000000000001 110.696 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 5.2 t -137.53 143.85 41.84 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.828 -0.545 . . . . 0.71999999999999997 109.861 -178.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 964' ' ' VAL . . . . . 0.739 HG13 HG22 ' C' ' 911' ' ' VAL . 61.6 t -91.94 136.94 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.103 -0.998 . . . . 1.05 110.733 -178.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -93.68 126.37 38.81 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 103.566 -2.753 . . . . 3.02 103.566 173.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 966' ' ' LEU . . . . . 0.54 HD12 ' OE2' ' C' ' 909' ' ' GLU . 0.2 OUTLIER -133.63 59.23 1.74 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.662 -0.866 . . . . 1.46 108.662 177.503 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 967' ' ' VAL . . . . . 0.488 HG23 ' C ' ' C' ' 966' ' ' LEU . 99.5 t -157.8 96.31 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 108.327 -0.99 . . . . 1.9399999999999999 108.327 179.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 91.8 mmm -143.04 58.65 1.41 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.736 -1.227 . . . . 0.0 108.562 179.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 134.19 119.46 1.97 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 107.372 -2.291 . . . . 2.1099999999999999 107.372 -178.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 -82.76 -58.12 3.02 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.048 -1.266 . . . . 5.8899999999999997 110.662 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 46.3 tp -58.78 89.74 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.455 -0.778 . . . . 4.3600000000000003 110.449 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -143.33 -151.72 0.38 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.536 -0.727 . . . . 1.8300000000000001 110.011 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -117.0 167.03 11.5 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.352 -0.843 . . . . 4.3499999999999996 110.082 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 30.2 t -101.49 130.3 47.73 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.523 -0.736 . . . . 1.27 110.075 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -155.62 156.55 35.23 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.504 -0.747 . . . . 5.0199999999999996 110.525 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.76 84.82 17.53 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.679 -0.638 . . . . 2.4100000000000001 109.779 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 977' ' ' PRO . . . . . 0.55 ' C ' HD12 ' C' ' 978' ' ' LEU . 48.9 Cg_endo -74.49 -172.19 1.13 Allowed 'Trans proline' 0 C--N 1.316 -1.16 0 O-C-N 123.359 1.189 . . . . 0.95999999999999996 111.074 -179.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 978' ' ' LEU . . . . . 0.55 HD12 ' C ' ' C' ' 977' ' ' PRO . 6.3 mp -123.32 156.42 35.36 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.456 -1.312 . . . . 0.62 107.456 177.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 979' ' ' THR . . . . . 0.45 HG23 ' C ' ' C' ' 978' ' ' LEU . 47.6 p -149.33 141.49 23.99 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.733 -1.229 . . . . 3.5699999999999998 111.19 -179.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 980' ' ' ILE . . . . . 0.705 ' HB ' HG21 ' C' ' 899' ' ' VAL . 51.2 mm -105.8 128.22 60.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 108.974 -0.75 . . . . 1.3300000000000001 108.974 179.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 981' ' ' PHE . . . . . 0.483 ' CD1' ' CE2' ' C' ' 879' ' ' TYR . 3.3 t80 -117.95 95.76 5.05 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.394 -0.816 . . . . 0.050000000000000003 111.324 -178.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 982' ' ' SER . . . . . . . . . . . . . 11.6 p -108.18 158.43 17.45 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.599 -0.688 . . . . 0.87 109.213 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 983' ' ' GLY . . . . . 0.416 ' O ' ' CZ ' ' C' ' 852' ' ' PHE . . . -171.65 114.61 0.54 Allowed Glycine 0 N--CA 1.496 2.69 0 N-CA-C 106.648 -2.581 . . . . 0.029999999999999999 106.648 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 984' ' ' ALA . . . . . . . . . . . . . . . -108.92 151.57 26.11 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 114.213 1.19 . . . . 0.69999999999999996 114.213 -175.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 985' ' ' LEU . . . . . 0.586 HD13 HD22 ' C' ' 890' ' ' LEU . 55.4 tp -76.43 135.88 39.43 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.819 -1.176 . . . . 0.040000000000000001 109.701 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 986' ' ' LEU . . . . . 0.463 HD11 ' CD1' ' B' ' 986' ' ' LEU . 47.2 tp -106.75 -61.8 1.48 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.491 -0.756 . . . . 0.040000000000000001 110.36 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -144.13 146.67 32.92 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 107.786 -1.191 . . . . 0.040000000000000001 107.786 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.25 162.91 12.25 Favored Glycine 0 N--CA 1.495 2.616 0 N-CA-C 108.071 -2.012 . . . . 0.040000000000000001 108.071 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -74.95 112.76 19.31 Favored Pre-proline 0 N--CA 1.498 1.946 0 O-C-N 121.15 -1.206 . . . . 0.040000000000000001 109.48 179.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 990' ' ' PRO . . . . . 0.423 ' O ' ' HB2' ' C' ' 991' ' ' GLU . 50.2 Cg_endo -89.13 71.26 2.09 Favored 'Trans proline' 0 C--N 1.32 -0.967 0 O-C-N 123.108 1.057 . . . . 0.45000000000000001 111.291 -179.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 991' ' ' GLU . . . . . 0.423 ' HB2' ' O ' ' C' ' 990' ' ' PRO . 73.6 mt-10 67.52 -73.46 0.08 Allowed 'General case' 0 N--CA 1.503 2.182 0 N-CA-C 108.518 -0.919 . . . . 1.97 108.518 -177.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 992' ' ' LEU . . . . . 0.414 HD12 ' HD2' ' C' ' 990' ' ' PRO . 10.8 mt 50.48 20.73 0.73 Allowed 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.568 -0.707 . . . . 2.3799999999999999 111.748 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -93.47 156.75 16.57 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.878 -1.139 . . . . 3.79 110.044 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 68.7 m80 -145.64 92.65 2.25 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.509 -0.745 . . . . 3.5099999999999998 110.254 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 995' ' ' ALA . . . . . . . . . . . . 2.519 . . . . . . . 0 N--CA 1.504 2.249 0 O-C-N 120.968 -1.082 . . . . 2.73 110.637 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo . . . . . 0 N--CA 1.488 1.151 0 N-CA-C 109.491 -1.004 . . . . 3.8300000000000001 109.491 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 847' ' ' VAL . . . . . . . . . . . . . 59.0 t -133.78 102.68 12.32 Favored Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 121.546 -0.721 . . . . 1.8300000000000001 109.993 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 848' ' ' PRO . . . . . 0.757 ' O ' HG23 ' A' ' 850' ' ' VAL . 44.2 Cg_endo -69.79 -19.25 36.22 Favored 'Trans proline' 0 N--CA 1.487 1.114 0 O-C-N 123.316 1.166 . . . . 0.65000000000000002 111.272 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 849' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 27.91 68.09 0.07 Allowed 'General case' 0 N--CA 1.518 2.953 0 N-CA-C 112.901 0.704 . . . . 2.5800000000000001 112.901 179.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 850' ' ' VAL . . . . . 0.757 HG23 ' O ' ' A' ' 848' ' ' PRO . 65.3 t -119.65 137.01 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.148 -0.97 . . . . 1.0900000000000001 111.51 -178.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 851' ' ' ALA . . . . . 0.58 ' HB3' ' HG ' ' A' ' 873' ' ' LEU . . . -123.79 159.92 28.47 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 105.921 -1.881 . . . . 0.040000000000000001 105.921 176.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 852' ' ' PHE . . . . . 0.431 ' HA ' ' CB ' ' A' ' 874' ' ' ASN . 34.2 p90 -159.29 127.82 5.15 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 120.88 1.673 . . . . 0.050000000000000003 108.465 178.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 8.8 t -175.4 134.49 0.31 Allowed 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.185 -1.042 . . . . 0.040000000000000001 108.185 -178.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -130.24 156.92 43.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.03 -1.044 . . . . 0.67000000000000004 109.739 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 855' ' ' ALA . . . . . 0.843 ' HB3' ' CB ' ' A' ' 870' ' ' ARG . . . -119.76 144.11 47.45 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.806 0.813 . . . . 0.51000000000000001 110.809 -179.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 856' ' ' LEU . . . . . 0.677 HD13 ' N ' ' A' ' 857' ' ' SER . 2.1 tm? -115.21 134.23 55.33 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.508 -0.745 . . . . 0.050000000000000003 110.45 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 857' ' ' SER . . . . . 0.677 ' N ' HD13 ' A' ' 856' ' ' LEU . 1.7 m -156.74 14.41 0.28 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.486 -0.759 . . . . 1.3300000000000001 111.866 179.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 858' ' ' LEU . . . . . 0.557 ' HG ' HD11 ' A' ' 856' ' ' LEU . 0.3 OUTLIER -36.56 162.28 0.04 OUTLIER Pre-proline 0 N--CA 1.524 3.231 0 CA-C-N 119.053 0.842 . . . . 2.3300000000000001 113.07 -179.58 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -61.26 -89.31 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.534 0 O-C-N 123.103 1.054 . . . . 2.3199999999999998 113.841 -177.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 53.9 ptt85 -134.21 -142.42 0.2 Allowed 'General case' 0 N--CA 1.502 2.144 0 O-C-N 120.761 -1.212 . . . . 0.040000000000000001 111.787 -177.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 5.2 m -36.65 126.89 0.86 Allowed 'General case' 0 N--CA 1.511 2.612 0 O-C-N 121.659 -0.651 . . . . 1.3100000000000001 112.366 -178.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 862' ' ' GLU . . . . . 0.779 ' OE1' HG22 ' A' ' 866' ' ' VAL . 1.3 mt-10 -104.73 165.55 13.08 Favored Pre-proline 0 N--CA 1.489 1.496 0 N-CA-C 108.652 -0.87 . . . . 4.5099999999999998 108.652 177.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -73.54 -14.42 24.87 Favored 'Trans proline' 0 C--N 1.313 -1.311 0 O-C-N 123.284 1.149 . . . . 2.2400000000000002 111.388 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -177.93 -135.29 2.23 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 110.162 -1.175 . . . . 0.040000000000000001 110.162 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 26.4 m -64.71 156.65 29.69 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.41 -1.053 . . . . 1.51 110.912 -178.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 866' ' ' VAL . . . . . 0.779 HG22 ' OE1' ' A' ' 862' ' ' GLU . 56.2 t -96.95 132.79 25.22 Favored Pre-proline 0 N--CA 1.496 1.838 0 N-CA-C 113.453 0.908 . . . . 0.78000000000000003 113.453 -174.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 867' ' ' PRO . . . . . 0.443 ' O ' HD23 ' A' ' 856' ' ' LEU . 55.4 Cg_endo -90.68 -149.51 0.03 OUTLIER 'Trans proline' 0 CA--C 1.545 1.066 0 O-C-N 123.571 1.3 . . . . 0.92000000000000004 109.332 177.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 868' ' ' PHE . . . . . 0.466 ' CD1' ' N ' ' A' ' 868' ' ' PHE . 19.4 p90 -150.34 123.49 8.86 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.584 -1.322 . . . . 0.050000000000000003 109.837 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 49.9 p-10 -113.62 -2.68 13.74 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.129 -0.982 . . . . 1.7 112.841 -178.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 870' ' ' ARG . . . . . 0.843 ' CB ' ' HB3' ' A' ' 855' ' ' ALA . 28.2 mmm180 -91.58 89.9 7.37 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 120.819 -1.176 . . . . 2.5899999999999999 111.131 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 57.9 t -72.77 96.66 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 120.984 -1.072 . . . . 1.9399999999999999 109.694 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 872' ' ' LEU . . . . . 0.833 HD11 ' HB2' ' A' ' 855' ' ' ALA . 86.6 mt -83.32 -46.81 12.18 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.505 -0.747 . . . . 1.0600000000000001 110.164 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 873' ' ' LEU . . . . . 0.58 ' HG ' ' HB3' ' A' ' 851' ' ' ALA . 32.7 tp -174.33 102.35 0.1 Allowed 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 108.595 -0.891 . . . . 4.1799999999999997 108.595 178.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 874' ' ' ASN . . . . . 0.431 ' CB ' ' HA ' ' A' ' 852' ' ' PHE . 33.9 t-20 178.33 80.98 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.256 0 N-CA-C 109.264 -0.643 . . . . 0.040000000000000001 109.264 -179.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -65.41 -47.03 77.68 Favored 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 119.344 -0.942 . . . . 3.3799999999999999 111.129 -179.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 876' ' ' GLY . . . . . . . . . . . . . . . -73.97 -24.26 74.36 Favored Glycine 0 N--CA 1.494 2.55 0 O-C-N 121.316 -0.865 . . . . 0.040000000000000001 111.672 -178.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 84.41 -60.04 4.87 Favored Glycine 0 N--CA 1.502 3.099 0 N-CA-C 107.949 -2.06 . . . . 0.040000000000000001 107.949 -178.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 878' ' ' TYR . . . . . 0.4 ' CZ ' HG11 ' A' ' 850' ' ' VAL . 97.8 m-85 60.32 -66.63 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.14 0 N-CA-C 114.424 1.268 . . . . 3.46 114.424 177.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 879' ' ' TYR . . . . . 0.469 ' CB ' ' CD2' ' A' ' 886' ' ' PHE . 21.3 p90 -110.77 109.69 20.02 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 114.831 1.419 . . . . 0.040000000000000001 114.831 -176.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -66.0 117.08 38.97 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 121.534 -0.729 . . . . 0.02 110.191 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 881' ' ' PRO . . . . . 0.463 ' HG2' ' CD1' ' A' ' 868' ' ' PHE . 54.4 Cg_endo -75.88 0.39 9.31 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 O-C-N 123.413 1.217 . . . . 0.39000000000000001 112.222 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -75.35 -65.19 0.92 Allowed 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 106.952 -1.499 . . . . 0.81000000000000005 106.952 178.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 2.2 p -95.74 -17.0 21.57 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.802 -0.814 . . . . 0.040000000000000001 108.802 177.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.68 22.98 52.0 Favored Glycine 0 N--CA 1.494 2.533 0 C-N-CA 120.127 -1.035 . . . . 0.029999999999999999 110.664 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 885' ' ' VAL . . . . . . . . . . . . . 92.0 t -73.2 88.46 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 C-N-CA 118.357 -1.337 . . . . 1.01 107.917 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 886' ' ' PHE . . . . . 0.875 ' HB3' HG22 ' A' ' 962' ' ' VAL . 0.6 OUTLIER -89.13 106.38 18.4 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 115.04 -0.982 . . . . 0.050000000000000003 112.175 -177.053 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 887' ' ' THR . . . . . . . . . . . . . 97.0 m -98.85 99.16 10.2 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 107.495 -1.298 . . . . 0.68000000000000005 107.495 177.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 888' ' ' ALA . . . . . . . . . . . . . . . -97.25 108.11 42.39 Favored Pre-proline 0 N--CA 1.501 2.08 0 N-CA-C 114.207 1.188 . . . . 0.25 114.207 -176.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 889' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -89.39 -13.7 2.8 Favored 'Trans proline' 0 CA--C 1.546 1.076 0 O-C-N 123.288 1.152 . . . . 1.6399999999999999 109.137 176.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 890' ' ' LEU . . . . . 0.977 HD22 HD13 ' A' ' 985' ' ' LEU . 63.1 mt -35.93 -50.64 0.68 Allowed 'General case' 0 N--CA 1.509 2.508 0 N-CA-C 113.694 0.998 . . . . 2.29 113.694 -177.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 52.18 95.52 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.189 -0.945 . . . . 0.63 110.269 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 157.59 -154.09 25.23 Favored Glycine 0 N--CA 1.478 1.436 0 N-CA-C 107.055 -2.418 . . . . 0.040000000000000001 107.055 -179.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 893' ' ' ARG . . . . . 0.4 ' CZ ' ' CB ' ' C' ' 984' ' ' ALA . 71.0 ttt-85 -116.4 125.31 51.87 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.529 -0.983 . . . . 3.0 108.567 177.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 894' ' ' TYR . . . . . 0.825 ' OH ' HD12 ' A' ' 896' ' ' LEU . 0.1 OUTLIER -132.05 161.38 33.37 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.134 -0.979 . . . . 0.040000000000000001 111.084 -179.843 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 895' ' ' LEU . . . . . . . . . . . . . 43.6 tp -91.86 119.48 31.68 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.723 -0.611 . . . . 1.27 110.274 -179.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 896' ' ' LEU . . . . . 0.825 HD12 ' OH ' ' A' ' 894' ' ' TYR . 9.2 tt -110.18 144.42 38.85 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.742 -0.599 . . . . 0.93999999999999995 109.98 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 897' ' ' SER . . . . . 0.506 ' N ' HD23 ' A' ' 896' ' ' LEU . 69.2 m -149.45 114.66 5.47 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.51 -0.744 . . . . 0.040000000000000001 111.032 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.41 146.27 31.88 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.915 -0.772 . . . . 0.47999999999999998 108.915 178.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 899' ' ' VAL . . . . . 0.72 HG21 ' HB ' ' A' ' 980' ' ' ILE . 87.3 t -96.52 119.18 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 C-N-CA 119.566 -0.854 . . . . 0.55000000000000004 111.16 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 900' ' ' LEU . . . . . 0.641 HD12 ' HB2' ' A' ' 924' ' ' SER . 4.5 mm? -95.95 113.22 24.82 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 114.223 1.194 . . . . 1.5900000000000001 114.223 -175.107 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 18.3 m -65.38 140.92 58.69 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 107.551 -1.277 . . . . 0.050000000000000003 107.551 177.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -64.68 -65.31 3.03 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 110.573 -1.011 . . . . 0.029999999999999999 110.573 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 46.95 66.44 0.99 Allowed 'General case' 0 N--CA 1.507 2.42 0 O-C-N 121.515 -0.991 . . . . 3.2000000000000002 111.01 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 54.3 ptt85 -68.8 -6.49 27.04 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.618 -0.676 . . . . 2.9199999999999999 112.059 -179.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 905' ' ' HIS . . . . . 0.491 ' O ' ' CB ' ' A' ' 906' ' ' GLU . 73.0 t60 -62.64 5.16 0.13 Allowed 'General case' 0 N--CA 1.505 2.293 0 O-C-N 120.91 -1.119 . . . . 2.8700000000000001 113.11 -179.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 906' ' ' GLU . . . . . 0.491 ' CB ' ' O ' ' A' ' 905' ' ' HIS . 0.9 OUTLIER 95.35 -164.82 0.0 OUTLIER 'General case' 0 N--CA 1.529 3.478 0 CA-C-N 120.561 1.528 . . . . 0.98999999999999999 111.947 179.004 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 907' ' ' LYS . . . . . 0.468 ' CB ' ' O ' ' A' ' 906' ' ' GLU . 52.9 tttt 87.21 157.58 0.07 Allowed 'General case' 0 N--CA 1.52 3.039 0 N-CA-C 108.143 -1.058 . . . . 5.25 108.143 -176.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 60.9 t -122.28 117.85 53.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 120.857 -1.152 . . . . 0.39000000000000001 111.179 -179.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 909' ' ' GLU . . . . . 0.438 ' OE1' HD12 ' A' ' 966' ' ' LEU . 52.8 tp10 -98.82 134.09 42.2 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 107.35 -1.352 . . . . 1.72 107.35 176.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -156.46 122.69 5.0 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 107.028 -1.471 . . . . 0.67000000000000004 107.028 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 911' ' ' VAL . . . . . 0.721 HG22 HG13 ' A' ' 964' ' ' VAL . 93.8 t -85.15 131.17 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 C-N-CA 120.442 -0.503 . . . . 0.54000000000000004 111.108 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 88.3 mt -65.22 157.97 27.44 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.397 -0.814 . . . . 1.5 109.361 178.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 913' ' ' SER . . . . . 0.409 ' CB ' ' HB ' ' A' ' 919' ' ' VAL . 1.7 t -127.64 134.94 49.64 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.239 -1.023 . . . . 1.3700000000000001 108.239 176.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 914' ' ' ARG . . . . . 0.433 HH11 HG13 ' A' ' 962' ' ' VAL . 0.0 OUTLIER -65.12 155.11 35.92 Favored 'General case' 0 N--CA 1.506 2.358 0 O-C-N 120.577 -1.327 . . . . 4.2999999999999998 111.628 -179.128 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 915' ' ' SER . . . . . 0.42 ' CB ' ' O ' ' A' ' 914' ' ' ARG . 1.6 p 82.93 -31.14 0.09 Allowed 'General case' 0 N--CA 1.52 3.046 0 C-N-CA 123.852 0.861 . . . . 2.0499999999999998 112.222 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 916' ' ' ASN . . . . . 0.747 ' HB2' HG21 ' A' ' 919' ' ' VAL . 89.4 m-20 -122.63 -21.55 5.64 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.903 -1.123 . . . . 2.71 111.267 -179.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 917' ' ' GLN . . . . . 0.433 ' HB2' ' O ' ' A' ' 916' ' ' ASN . 58.9 mt-30 66.37 166.07 0.2 Allowed 'General case' 0 N--CA 1.519 3.018 0 N-CA-C 105.816 -1.92 . . . . 2.6800000000000002 105.816 -173.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.32 -125.32 33.65 Favored Glycine 1 N--CA 1.521 4.348 0 CA-C-N 123.472 2.851 . . . . 0.029999999999999999 106.98 -177.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 919' ' ' VAL . . . . . 0.747 HG21 ' HB2' ' A' ' 916' ' ' ASN . 77.0 t 51.51 94.9 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 O-C-N 121.39 -1.065 . . . . 1.3899999999999999 109.15 -178.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 920' ' ' ALA . . . . . 0.807 ' HB3' HG12 ' A' ' 949' ' ' VAL . . . -92.34 93.0 8.4 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.318 -0.953 . . . . 0.029999999999999999 110.818 -179.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 921' ' ' ARG . . . . . 0.851 ' HG3' HG23 ' A' ' 922' ' ' VAL . 23.1 ptt180 -84.15 -42.15 16.31 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 105.873 -1.899 . . . . 4.4199999999999999 105.873 176.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 922' ' ' VAL . . . . . 0.851 HG23 ' HG3' ' A' ' 921' ' ' ARG . 95.7 t -101.53 72.73 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 N-CA-C 105.94 -1.874 . . . . 0.84999999999999998 105.94 175.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -88.32 133.42 34.08 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.663 0.744 . . . . 2.46 111.502 -177.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 924' ' ' SER . . . . . 0.641 ' HB2' HD12 ' A' ' 900' ' ' LEU . 9.9 t -148.67 105.68 3.6 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.787 -0.82 . . . . 0.69999999999999996 108.787 179.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -101.56 82.67 0.47 Allowed Glycine 0 N--CA 1.487 2.037 0 N-CA-C 108.201 -1.96 . . . . 0.040000000000000001 108.201 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.211 0 N-CA-C 108.989 -1.644 . . . . 0.040000000000000001 108.989 -179.523 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 73.8 m . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 120.968 0.413 . . . . 13.779999999999999 110.31 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 96.7 mt -113.4 129.82 56.45 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.504 -0.747 . . . . 13.76 110.393 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -151.97 168.06 31.2 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.098 -1.601 . . . . 9.1300000000000008 109.098 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 949' ' ' VAL . . . . . 0.807 HG12 ' HB3' ' A' ' 920' ' ' ALA . 33.0 m -118.93 129.93 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.5 -1.0 . . . . 7.0800000000000001 110.916 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 950' ' ' PHE . . . . . 0.451 ' CE1' ' HD2' ' A' ' 955' ' ' PRO . 27.7 p90 -132.69 148.15 52.34 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.547 -0.721 . . . . 7.5899999999999999 109.212 179.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 58.5 m -121.15 -52.27 2.08 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.414 -0.804 . . . . 5.0300000000000002 112.103 -178.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 952' ' ' LEU . . . . . 0.414 ' O ' ' O ' ' A' ' 953' ' ' ILE . 20.5 tp -60.31 -73.67 0.09 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.446 -0.784 . . . . 1.01 112.403 -177.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 953' ' ' ILE . . . . . 0.662 HD11 HD13 ' C' ' 872' ' ' LEU . 47.9 pt -53.44 -143.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.738 0 N-CA-C 114.008 1.114 . . . . 2.6000000000000001 114.008 -176.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 954' ' ' LEU . . . . . 0.718 HD22 ' O ' ' A' ' 954' ' ' LEU . 0.0 OUTLIER 172.57 75.0 0.04 OUTLIER Pre-proline 0 N--CA 1.508 2.47 0 O-C-N 120.825 -1.172 . . . . 0.050000000000000003 111.01 179.635 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 955' ' ' PRO . . . . . 0.642 ' C ' HD12 ' A' ' 956' ' ' LEU . 47.9 Cg_endo -74.74 95.85 0.98 Allowed 'Trans proline' 0 C--N 1.315 -1.232 0 N-CA-C 109.702 -0.922 . . . . 0.83999999999999997 109.702 179.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 956' ' ' LEU . . . . . 0.642 HD12 ' C ' ' A' ' 955' ' ' PRO . 7.1 mp -125.1 149.88 47.4 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.179 -0.95 . . . . 0.040000000000000001 110.27 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -82.75 150.78 26.48 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 117.701 -1.142 . . . . 1.28 111.468 -179.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -68.36 119.48 12.94 Favored 'General case' 0 N--CA 1.51 2.553 0 CA-C-N 123.098 2.681 . . . . 0.17000000000000001 111.316 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.87 -21.87 37.1 Favored Glycine 0 N--CA 1.5 2.924 0 N-CA-C 110.829 -0.908 . . . . 0.040000000000000001 110.829 178.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 960' ' ' ASP . . . . . 0.42 ' HB3' ' CZ ' ' A' ' 914' ' ' ARG . 0.3 OUTLIER -54.13 172.27 0.09 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.504 -0.998 . . . . 0.040000000000000001 110.138 -179.598 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 961' ' ' THR . . . . . 0.485 ' HA ' ' O ' ' A' ' 886' ' ' PHE . 39.3 m -135.87 138.81 42.86 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.963 -1.085 . . . . 1.78 112.377 -178.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 962' ' ' VAL . . . . . 0.875 HG22 ' HB3' ' A' ' 886' ' ' PHE . 32.4 m -98.72 144.22 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 C-N-CA 120.149 -0.62 . . . . 0.040000000000000001 110.03 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 5.5 t -139.69 143.88 37.29 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.671 -0.643 . . . . 0.71999999999999997 109.914 -178.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 964' ' ' VAL . . . . . 0.721 HG13 HG22 ' A' ' 911' ' ' VAL . 59.1 t -95.0 137.19 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.097 -1.002 . . . . 1.05 110.699 -179.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -91.5 128.91 37.51 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 103.819 -2.66 . . . . 3.02 103.819 173.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 966' ' ' LEU . . . . . 0.487 ' C ' HG23 ' A' ' 967' ' ' VAL . 1.5 tp -131.33 59.71 1.68 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.162 -1.051 . . . . 1.46 108.162 177.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 967' ' ' VAL . . . . . 0.487 HG23 ' C ' ' A' ' 966' ' ' LEU . 97.8 t -158.16 96.54 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 108.096 -1.075 . . . . 1.9399999999999999 108.096 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 87.1 mmm -143.58 59.13 1.38 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.761 -1.212 . . . . 0.0 108.262 178.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 134.96 119.52 1.95 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 106.91 -2.476 . . . . 2.1099999999999999 106.91 -178.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -82.34 -58.24 3.02 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.039 -1.271 . . . . 5.8899999999999997 110.327 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 44.0 tp -58.86 90.81 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.406 -0.809 . . . . 4.3600000000000003 110.171 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -141.65 -154.56 0.53 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.614 -0.679 . . . . 1.8300000000000001 110.236 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -120.05 172.42 7.76 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.522 -0.736 . . . . 4.3499999999999996 110.268 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 38.6 t -101.37 130.05 47.48 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.576 -0.703 . . . . 1.27 109.946 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -156.03 157.74 36.64 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.527 -0.733 . . . . 5.0199999999999996 110.515 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.14 85.34 19.04 Favored Pre-proline 0 N--CA 1.5 2.035 0 O-C-N 121.652 -0.655 . . . . 2.4100000000000001 109.662 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 977' ' ' PRO . . . . . 0.6 ' C ' HD12 ' A' ' 978' ' ' LEU . 47.5 Cg_endo -72.81 -172.52 0.98 Allowed 'Trans proline' 0 C--N 1.317 -1.123 0 O-C-N 123.304 1.16 . . . . 0.95999999999999996 111.192 -179.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 978' ' ' LEU . . . . . 0.635 HD23 HD12 ' A' ' 856' ' ' LEU . 5.9 mp -128.04 154.24 45.88 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 107.575 -1.268 . . . . 0.62 107.575 177.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 979' ' ' THR . . . . . 0.462 HG23 ' C ' ' A' ' 978' ' ' LEU . 43.2 p -149.79 142.07 24.17 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.851 -1.156 . . . . 3.5699999999999998 111.185 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 980' ' ' ILE . . . . . 0.72 ' HB ' HG21 ' A' ' 899' ' ' VAL . 46.9 mm -105.87 127.76 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 108.708 -0.849 . . . . 1.3300000000000001 108.708 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 981' ' ' PHE . . . . . 0.46 ' HD1' ' HH ' ' A' ' 879' ' ' TYR . 7.3 t80 -120.26 97.73 5.72 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 119.641 -0.823 . . . . 0.050000000000000003 111.828 -178.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 59.2 p -107.86 158.66 17.15 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 109.114 -0.699 . . . . 0.87 109.114 178.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 983' ' ' GLY . . . . . 0.415 ' O ' ' CZ ' ' A' ' 852' ' ' PHE . . . -175.36 107.26 0.24 Allowed Glycine 0 N--CA 1.499 2.836 0 N-CA-C 106.354 -2.699 . . . . 0.029999999999999999 106.354 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -109.21 152.64 24.9 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 114.583 1.327 . . . . 0.69999999999999996 114.583 -175.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 985' ' ' LEU . . . . . 0.977 HD13 HD22 ' A' ' 890' ' ' LEU . 30.5 tp -72.23 134.2 45.49 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.887 -1.133 . . . . 0.040000000000000001 109.895 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 48.6 tp -107.9 -57.8 2.06 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.564 -0.71 . . . . 0.040000000000000001 110.208 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -144.28 145.35 31.97 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 107.592 -1.262 . . . . 0.040000000000000001 107.592 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.68 163.22 12.18 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 108.218 -1.953 . . . . 0.040000000000000001 108.218 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -74.43 112.7 18.36 Favored Pre-proline 0 N--CA 1.498 1.932 0 O-C-N 121.259 -1.142 . . . . 0.040000000000000001 109.468 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 990' ' ' PRO . . . . . 0.446 ' HD2' HD12 ' A' ' 992' ' ' LEU . 50.6 Cg_endo -89.2 70.89 2.11 Favored 'Trans proline' 0 C--N 1.319 -1.022 0 O-C-N 123.199 1.105 . . . . 0.45000000000000001 111.482 -178.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 991' ' ' GLU . . . . . 0.427 ' HB2' ' O ' ' A' ' 990' ' ' PRO . 77.2 mt-10 67.18 -73.91 0.07 Allowed 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 108.524 -0.917 . . . . 1.97 108.524 -177.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 992' ' ' LEU . . . . . 0.446 HD12 ' HD2' ' A' ' 990' ' ' PRO . 10.5 mt 51.19 20.7 0.93 Allowed 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.562 -0.711 . . . . 2.3799999999999999 111.532 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -93.3 157.11 16.41 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.933 -1.105 . . . . 3.79 110.044 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 71.5 m80 -146.85 92.64 2.16 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.515 -0.74 . . . . 3.5099999999999998 110.195 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 995' ' ' ALA . . . . . . . . . . . . 2.519 . . . . . . . 0 N--CA 1.503 2.2 0 O-C-N 120.904 -1.122 . . . . 2.73 110.599 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo . . . . . 0 N--CA 1.487 1.147 0 N-CA-C 109.506 -0.998 . . . . 3.8300000000000001 109.506 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 847' ' ' VAL . . . . . . . . . . . . . 58.9 t -133.85 102.69 12.24 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.619 -0.676 . . . . 1.8300000000000001 109.994 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 848' ' ' PRO . . . . . 0.761 ' O ' HG23 ' B' ' 850' ' ' VAL . 44.0 Cg_endo -69.68 -19.62 36.25 Favored 'Trans proline' 0 N--CA 1.488 1.152 0 O-C-N 123.279 1.147 . . . . 0.65000000000000002 111.245 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 849' ' ' GLN . . . . . 0.404 ' C ' ' O ' ' B' ' 848' ' ' PRO . 56.0 tt0 28.22 68.33 0.08 Allowed 'General case' 0 N--CA 1.518 2.931 0 N-CA-C 112.831 0.678 . . . . 2.5800000000000001 112.831 179.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 850' ' ' VAL . . . . . 0.761 HG23 ' O ' ' B' ' 848' ' ' PRO . 66.2 t -119.95 137.07 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.141 -0.974 . . . . 1.0900000000000001 111.445 -178.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 851' ' ' ALA . . . . . 0.596 ' HB3' ' HG ' ' B' ' 873' ' ' LEU . . . -124.15 159.15 30.68 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 105.945 -1.872 . . . . 0.040000000000000001 105.945 176.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 852' ' ' PHE . . . . . 0.426 ' HA ' ' CB ' ' B' ' 874' ' ' ASN . 33.5 p90 -158.56 128.09 5.73 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 120.943 1.702 . . . . 0.050000000000000003 108.344 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 7.9 t -175.48 134.18 0.3 Allowed 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.281 -1.007 . . . . 0.040000000000000001 108.281 -178.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -129.83 157.22 42.84 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.011 -1.056 . . . . 0.67000000000000004 109.824 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 855' ' ' ALA . . . . . 0.856 ' HB3' ' CB ' ' B' ' 870' ' ' ARG . . . -119.92 144.7 47.3 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.843 0.83 . . . . 0.51000000000000001 110.776 -179.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 856' ' ' LEU . . . . . 0.668 HD13 ' N ' ' B' ' 857' ' ' SER . 2.1 tm? -115.83 133.72 55.74 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.493 -0.754 . . . . 0.050000000000000003 110.542 -179.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 857' ' ' SER . . . . . 0.668 ' N ' HD13 ' B' ' 856' ' ' LEU . 1.8 m -156.4 14.45 0.31 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.459 -0.775 . . . . 1.3300000000000001 111.804 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 858' ' ' LEU . . . . . 0.558 ' HG ' HD11 ' B' ' 856' ' ' LEU . 0.3 OUTLIER -36.53 162.19 0.04 OUTLIER Pre-proline 0 N--CA 1.524 3.254 0 CA-C-N 119.052 0.842 . . . . 2.3300000000000001 113.074 -179.693 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -61.26 -89.38 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 120.947 1.098 . . . . 2.3199999999999998 113.804 -177.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 53.9 ptt85 -134.19 -142.46 0.2 Allowed 'General case' 0 N--CA 1.501 2.114 0 O-C-N 120.802 -1.186 . . . . 0.040000000000000001 111.815 -177.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 5.2 m -36.56 126.46 0.84 Allowed 'General case' 0 N--CA 1.512 2.645 0 O-C-N 121.671 -0.643 . . . . 1.3100000000000001 112.373 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 862' ' ' GLU . . . . . 0.787 ' OE1' HG22 ' B' ' 866' ' ' VAL . 1.3 mt-10 -104.34 165.67 12.95 Favored Pre-proline 0 N--CA 1.488 1.451 0 N-CA-C 108.637 -0.875 . . . . 4.5099999999999998 108.637 177.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -73.45 -14.57 25.11 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 O-C-N 123.294 1.155 . . . . 2.2400000000000002 111.396 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -177.68 -133.75 1.91 Allowed Glycine 0 N--CA 1.495 2.592 0 N-CA-C 110.184 -1.167 . . . . 0.040000000000000001 110.184 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 27.1 m -66.07 157.64 30.54 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.351 -1.088 . . . . 1.51 110.733 -178.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 866' ' ' VAL . . . . . 0.787 HG22 ' OE1' ' B' ' 862' ' ' GLU . 56.9 t -97.73 132.71 24.49 Favored Pre-proline 0 N--CA 1.496 1.833 0 N-CA-C 113.402 0.89 . . . . 0.78000000000000003 113.402 -174.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 867' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' B' ' 866' ' ' VAL . 55.2 Cg_endo -90.71 -149.73 0.03 OUTLIER 'Trans proline' 0 CA--C 1.544 1.02 0 C-N-CA 121.219 1.279 . . . . 0.92000000000000004 109.356 177.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 868' ' ' PHE . . . . . 0.469 ' CD1' ' HG2' ' B' ' 881' ' ' PRO . 19.4 p90 -150.19 123.25 8.82 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.493 -1.379 . . . . 0.050000000000000003 109.858 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 50.2 p-10 -113.35 -2.32 14.02 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.101 -1.0 . . . . 1.7 112.786 -178.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 870' ' ' ARG . . . . . 0.856 ' CB ' ' HB3' ' B' ' 855' ' ' ALA . 28.0 mmm180 -91.74 89.79 7.24 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.861 -1.149 . . . . 2.5899999999999999 111.167 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 57.5 t -72.9 96.75 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 120.978 -1.077 . . . . 1.9399999999999999 109.669 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 872' ' ' LEU . . . . . 0.844 HD11 ' HB2' ' B' ' 855' ' ' ALA . 87.1 mt -83.56 -46.66 12.15 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.508 -0.745 . . . . 1.0600000000000001 110.117 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 873' ' ' LEU . . . . . 0.596 ' HG ' ' HB3' ' B' ' 851' ' ' ALA . 32.6 tp -174.31 102.25 0.1 Allowed 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.583 -0.895 . . . . 4.1799999999999997 108.583 178.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 874' ' ' ASN . . . . . 0.426 ' CB ' ' HA ' ' B' ' 852' ' ' PHE . 33.8 t-20 178.36 81.08 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.664 -0.647 . . . . 0.040000000000000001 109.371 -179.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -65.5 -47.1 77.17 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 119.349 -0.941 . . . . 3.3799999999999999 111.102 -179.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 876' ' ' GLY . . . . . . . . . . . . . . . -73.98 -24.27 74.3 Favored Glycine 0 N--CA 1.493 2.477 0 O-C-N 121.285 -0.884 . . . . 0.040000000000000001 111.687 -178.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 84.41 -59.95 4.88 Favored Glycine 0 N--CA 1.502 3.069 0 N-CA-C 107.948 -2.061 . . . . 0.040000000000000001 107.948 -178.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 878' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 60.41 -66.68 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 114.474 1.287 . . . . 3.46 114.474 177.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 879' ' ' TYR . . . . . 0.471 ' CB ' ' CD2' ' B' ' 886' ' ' PHE . 21.3 p90 -110.78 109.62 19.91 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 114.785 1.402 . . . . 0.040000000000000001 114.785 -176.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -65.94 117.06 38.54 Favored Pre-proline 0 N--CA 1.496 1.847 0 O-C-N 121.557 -0.715 . . . . 0.02 110.117 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 881' ' ' PRO . . . . . 0.469 ' HG2' ' CD1' ' B' ' 868' ' ' PHE . 53.8 Cg_endo -75.78 0.23 9.45 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 O-C-N 123.477 1.251 . . . . 0.39000000000000001 112.252 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -75.26 -65.23 0.91 Allowed 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 106.953 -1.499 . . . . 0.81000000000000005 106.953 178.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 2.2 p -95.87 -16.53 21.74 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.88 -0.785 . . . . 0.040000000000000001 108.88 177.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.2 23.34 52.02 Favored Glycine 0 N--CA 1.493 2.489 0 C-N-CA 120.069 -1.063 . . . . 0.029999999999999999 110.719 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 885' ' ' VAL . . . . . . . . . . . . . 92.6 t -73.56 88.7 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 C-N-CA 118.392 -1.323 . . . . 1.01 107.806 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 886' ' ' PHE . . . . . 0.897 ' HB3' HG22 ' B' ' 962' ' ' VAL . 0.6 OUTLIER -89.36 106.28 18.34 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 115.121 -0.945 . . . . 0.050000000000000003 112.234 -177.12 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 887' ' ' THR . . . . . . . . . . . . . 96.9 m -98.67 99.44 10.56 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 107.493 -1.299 . . . . 0.68000000000000005 107.493 176.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 888' ' ' ALA . . . . . . . . . . . . . . . -97.52 108.13 43.31 Favored Pre-proline 0 N--CA 1.502 2.134 0 N-CA-C 114.119 1.155 . . . . 0.25 114.119 -176.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 889' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -89.37 -13.85 2.77 Favored 'Trans proline' 0 CA--C 1.546 1.091 0 N-CA-C 109.135 -1.14 . . . . 1.6399999999999999 109.135 176.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 890' ' ' LEU . . . . . 1.004 HD22 HD13 ' B' ' 985' ' ' LEU . 62.9 mt -35.73 -50.64 0.64 Allowed 'General case' 0 N--CA 1.509 2.497 0 N-CA-C 113.68 0.992 . . . . 2.29 113.68 -177.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 52.1 95.44 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.154 -0.966 . . . . 0.63 110.338 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . 157.65 -154.16 25.28 Favored Glycine 0 N--CA 1.478 1.491 0 N-CA-C 107.085 -2.406 . . . . 0.040000000000000001 107.085 -179.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 71.7 ttt-85 -116.34 125.26 51.85 Favored 'General case' 0 C--N 1.294 -1.807 0 O-C-N 121.564 -0.963 . . . . 3.0 108.511 177.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 894' ' ' TYR . . . . . 0.821 ' OH ' HD12 ' B' ' 896' ' ' LEU . 0.1 OUTLIER -131.9 161.63 32.56 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.082 -1.011 . . . . 0.040000000000000001 111.113 -179.854 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 895' ' ' LEU . . . . . . . . . . . . . 43.3 tp -92.27 119.32 31.75 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.681 -0.637 . . . . 1.27 110.355 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 896' ' ' LEU . . . . . 0.821 HD12 ' OH ' ' B' ' 894' ' ' TYR . 9.1 tt -110.11 143.87 39.55 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.725 -0.609 . . . . 0.93999999999999995 110.053 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 897' ' ' SER . . . . . 0.505 ' N ' HD23 ' B' ' 896' ' ' LEU . 68.7 m -148.81 114.5 5.66 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.426 -0.796 . . . . 0.040000000000000001 111.098 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.23 145.99 31.97 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.011 -0.737 . . . . 0.47999999999999998 109.011 178.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 899' ' ' VAL . . . . . 0.711 HG21 ' HB ' ' B' ' 980' ' ' ILE . 88.4 t -96.22 119.07 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.356 -0.84 . . . . 0.55000000000000004 111.245 -179.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 900' ' ' LEU . . . . . 0.655 HD12 ' HB2' ' B' ' 924' ' ' SER . 4.5 mm? -95.97 112.7 24.36 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 114.288 1.218 . . . . 1.5900000000000001 114.288 -175.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 18.1 m -64.94 140.79 58.9 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 107.531 -1.285 . . . . 0.050000000000000003 107.531 177.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -64.83 -65.26 3.04 Favored Glycine 0 N--CA 1.494 2.515 0 N-CA-C 110.639 -0.985 . . . . 0.029999999999999999 110.639 -179.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 46.89 66.64 0.94 Allowed 'General case' 0 N--CA 1.507 2.411 0 O-C-N 121.472 -1.017 . . . . 3.2000000000000002 110.964 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 54.3 ptt85 -68.85 -6.78 29.05 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.639 -0.663 . . . . 2.9199999999999999 112.073 -179.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 905' ' ' HIS . . . . . 0.488 ' O ' ' CB ' ' B' ' 906' ' ' GLU . 72.8 t60 -62.08 4.74 0.12 Allowed 'General case' 0 N--CA 1.505 2.323 0 O-C-N 120.876 -1.14 . . . . 2.8700000000000001 113.111 -179.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 906' ' ' GLU . . . . . 0.488 ' CB ' ' O ' ' B' ' 905' ' ' HIS . 0.9 OUTLIER 95.62 -164.94 0.0 OUTLIER 'General case' 0 N--CA 1.53 3.549 0 CA-C-N 120.612 1.551 . . . . 0.98999999999999999 111.781 179.1 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 907' ' ' LYS . . . . . 0.47 ' CB ' ' O ' ' B' ' 906' ' ' GLU . 53.3 tttt 87.31 157.28 0.07 Allowed 'General case' 0 N--CA 1.52 3.073 0 N-CA-C 108.132 -1.062 . . . . 5.25 108.132 -177.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 60.9 t -122.08 117.5 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 120.894 -1.129 . . . . 0.39000000000000001 111.243 -179.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 909' ' ' GLU . . . . . 0.429 ' OE1' HD12 ' B' ' 966' ' ' LEU . 52.8 tp10 -98.33 134.37 41.43 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 107.333 -1.358 . . . . 1.72 107.333 176.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -156.83 122.8 4.85 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 106.992 -1.484 . . . . 0.67000000000000004 106.992 178.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 911' ' ' VAL . . . . . 0.706 HG22 HG13 ' B' ' 964' ' ' VAL . 94.9 t -85.34 131.54 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.906 -0.496 . . . . 0.54000000000000004 111.061 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 88.2 mt -65.44 158.13 27.6 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.362 -0.836 . . . . 1.5 109.359 178.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 913' ' ' SER . . . . . 0.411 ' CB ' ' CG1' ' B' ' 919' ' ' VAL . 1.8 t -127.97 134.39 49.28 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.274 -1.01 . . . . 1.3700000000000001 108.274 176.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 914' ' ' ARG . . . . . 0.421 HH11 HG13 ' B' ' 962' ' ' VAL . 0.0 OUTLIER -64.51 155.05 34.11 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 120.577 -1.327 . . . . 4.2999999999999998 111.685 -179.067 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 915' ' ' SER . . . . . 0.411 ' CB ' ' O ' ' B' ' 914' ' ' ARG . 1.6 p 83.05 -31.44 0.09 Allowed 'General case' 0 N--CA 1.521 3.093 0 C-N-CA 123.84 0.856 . . . . 2.0499999999999998 112.224 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 916' ' ' ASN . . . . . 0.785 ' HB2' HG21 ' B' ' 919' ' ' VAL . 89.2 m-20 -122.25 -21.91 5.73 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.92 -1.112 . . . . 2.71 111.288 -179.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 917' ' ' GLN . . . . . 0.433 ' HB2' ' O ' ' B' ' 916' ' ' ASN . 58.5 mt-30 66.5 165.43 0.2 Allowed 'General case' 0 N--CA 1.52 3.029 0 N-CA-C 105.782 -1.933 . . . . 2.6800000000000002 105.782 -174.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 55.05 -125.38 35.58 Favored Glycine 1 N--CA 1.52 4.268 0 CA-C-N 123.478 2.854 . . . . 0.029999999999999999 106.858 -177.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 919' ' ' VAL . . . . . 0.785 HG21 ' HB2' ' B' ' 916' ' ' ASN . 80.5 t 51.44 94.91 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.233 0 O-C-N 121.419 -1.047 . . . . 1.3899999999999999 109.189 -178.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 920' ' ' ALA . . . . . 0.805 ' HB3' HG12 ' B' ' 949' ' ' VAL . . . -92.4 92.85 8.3 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.324 -0.951 . . . . 0.029999999999999999 110.823 -179.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 921' ' ' ARG . . . . . 0.842 ' HG3' HG23 ' B' ' 922' ' ' VAL . 23.2 ptt180 -84.12 -42.11 16.4 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 105.885 -1.894 . . . . 4.4199999999999999 105.885 176.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 922' ' ' VAL . . . . . 0.842 HG23 ' HG3' ' B' ' 921' ' ' ARG . 95.7 t -101.52 72.64 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 N-CA-C 105.92 -1.882 . . . . 0.84999999999999998 105.92 175.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -88.19 133.47 34.02 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.615 0.721 . . . . 2.46 111.495 -177.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 924' ' ' SER . . . . . 0.655 ' HB2' HD12 ' B' ' 900' ' ' LEU . 9.9 t -148.68 105.72 3.6 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.76 -0.829 . . . . 0.69999999999999996 108.76 179.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -101.5 82.62 0.47 Allowed Glycine 0 N--CA 1.487 2.049 0 N-CA-C 108.176 -1.97 . . . . 0.040000000000000001 108.176 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.143 0 N-CA-C 109.026 -1.629 . . . . 0.040000000000000001 109.026 -179.562 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 76.9 m . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.016 0.436 . . . . 13.779999999999999 110.215 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 96.7 mt -112.24 129.87 56.12 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.546 -0.722 . . . . 13.76 110.4 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -151.65 167.5 30.96 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.153 -1.579 . . . . 9.1300000000000008 109.153 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 949' ' ' VAL . . . . . 0.805 HG12 ' HB3' ' B' ' 920' ' ' ALA . 32.1 m -118.69 129.85 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.548 -0.972 . . . . 7.0800000000000001 110.845 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 950' ' ' PHE . . . . . 0.454 ' CE1' ' HD2' ' B' ' 955' ' ' PRO . 27.9 p90 -132.74 148.17 52.33 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.586 -0.696 . . . . 7.5899999999999999 109.267 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 58.5 m -121.16 -51.92 2.09 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.452 -0.78 . . . . 5.0300000000000002 112.13 -178.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 952' ' ' LEU . . . . . 0.43 HD12 ' HA ' ' B' ' 952' ' ' LEU . 20.3 tp -60.52 -73.88 0.08 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.396 -0.815 . . . . 1.01 112.347 -177.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 953' ' ' ILE . . . . . 0.486 ' O ' ' HB3' ' B' ' 954' ' ' LEU . 49.3 pt -53.18 -143.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.754 0 N-CA-C 114.082 1.141 . . . . 2.6000000000000001 114.082 -176.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 954' ' ' LEU . . . . . 0.723 HD22 ' O ' ' B' ' 954' ' ' LEU . 0.0 OUTLIER 172.31 74.69 0.04 OUTLIER Pre-proline 0 N--CA 1.509 2.496 0 O-C-N 120.793 -1.192 . . . . 0.050000000000000003 110.955 179.68 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 955' ' ' PRO . . . . . 0.646 ' C ' HD12 ' B' ' 956' ' ' LEU . 48.1 Cg_endo -74.64 95.95 0.97 Allowed 'Trans proline' 0 C--N 1.315 -1.218 0 N-CA-C 109.714 -0.918 . . . . 0.83999999999999997 109.714 179.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 956' ' ' LEU . . . . . 0.646 HD12 ' C ' ' B' ' 955' ' ' PRO . 7.1 mp -125.23 149.88 47.56 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.232 -0.917 . . . . 0.040000000000000001 110.258 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -82.78 150.94 26.35 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 117.824 -1.084 . . . . 1.28 111.375 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -68.42 119.15 12.44 Favored 'General case' 0 N--CA 1.509 2.492 0 CA-C-N 122.913 2.597 . . . . 0.17000000000000001 111.389 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 93.07 -21.92 37.31 Favored Glycine 0 N--CA 1.5 2.942 0 N-CA-C 110.792 -0.923 . . . . 0.040000000000000001 110.792 178.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 960' ' ' ASP . . . . . 0.417 ' HB3' ' CZ ' ' B' ' 914' ' ' ARG . 0.3 OUTLIER -54.02 172.38 0.08 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.473 -1.016 . . . . 0.040000000000000001 110.166 -179.602 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 961' ' ' THR . . . . . 0.492 ' HA ' ' O ' ' B' ' 886' ' ' PHE . 38.8 m -135.83 139.03 43.13 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.942 -1.099 . . . . 1.78 112.338 -178.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 962' ' ' VAL . . . . . 0.897 HG22 ' HB3' ' B' ' 886' ' ' PHE . 32.2 m -99.09 144.02 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 C-N-CA 120.112 -0.635 . . . . 0.040000000000000001 110.032 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 5.4 t -139.37 143.88 37.93 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.682 -0.636 . . . . 0.71999999999999997 109.982 -178.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 964' ' ' VAL . . . . . 0.706 HG13 HG22 ' B' ' 911' ' ' VAL . 59.0 t -95.2 137.02 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.208 -0.933 . . . . 1.05 110.696 -179.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -91.51 128.43 37.34 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 103.898 -2.631 . . . . 3.02 103.898 173.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 966' ' ' LEU . . . . . 0.485 ' C ' HG23 ' B' ' 967' ' ' VAL . 1.5 tp -130.9 59.89 1.66 Allowed 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.228 -1.027 . . . . 1.46 108.228 177.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 967' ' ' VAL . . . . . 0.485 HG23 ' C ' ' B' ' 966' ' ' LEU . 98.3 t -158.27 96.47 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 108.08 -1.081 . . . . 1.9399999999999999 108.08 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 87.1 mmm -143.49 58.95 1.39 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.804 -1.185 . . . . 0.0 108.265 178.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 134.99 119.38 1.93 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 107.111 -2.396 . . . . 2.1099999999999999 107.111 -178.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -82.07 -58.22 3.06 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.085 -1.244 . . . . 5.8899999999999997 110.338 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 44.2 tp -58.97 90.57 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.377 -0.827 . . . . 4.3600000000000003 110.19 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -141.47 -154.63 0.53 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.589 -0.694 . . . . 1.8300000000000001 110.27 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -119.95 172.54 7.65 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.455 -0.778 . . . . 4.3499999999999996 110.275 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 38.6 t -101.56 130.02 47.77 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.525 -0.734 . . . . 1.27 109.961 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -155.99 157.74 36.7 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.474 -0.767 . . . . 5.0199999999999996 110.495 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.15 85.33 19.0 Favored Pre-proline 0 N--CA 1.5 2.05 0 O-C-N 121.633 -0.667 . . . . 2.4100000000000001 109.622 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 977' ' ' PRO . . . . . 0.601 ' C ' HD12 ' B' ' 978' ' ' LEU . 47.6 Cg_endo -72.82 -172.59 0.99 Allowed 'Trans proline' 0 C--N 1.317 -1.083 0 O-C-N 123.282 1.148 . . . . 0.95999999999999996 111.219 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 978' ' ' LEU . . . . . 0.647 HD23 HD12 ' B' ' 856' ' ' LEU . 5.9 mp -127.82 154.51 45.36 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.653 -1.24 . . . . 0.62 107.653 177.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 979' ' ' THR . . . . . 0.467 HG23 ' C ' ' B' ' 978' ' ' LEU . 42.8 p -150.03 142.08 23.96 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.842 -1.161 . . . . 3.5699999999999998 111.142 -179.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 980' ' ' ILE . . . . . 0.711 ' HB ' HG21 ' B' ' 899' ' ' VAL . 46.8 mm -105.99 127.4 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 108.732 -0.84 . . . . 1.3300000000000001 108.732 179.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 981' ' ' PHE . . . . . 0.451 ' HD1' ' HH ' ' B' ' 879' ' ' TYR . 7.3 t80 -120.0 98.0 5.88 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 119.649 -0.821 . . . . 0.050000000000000003 111.746 -178.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 53.8 p -108.4 158.81 17.18 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 109.154 -0.684 . . . . 0.87 109.154 178.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 983' ' ' GLY . . . . . 0.411 ' HA3' ' CE1' ' B' ' 852' ' ' PHE . . . -175.25 107.41 0.24 Allowed Glycine 0 N--CA 1.498 2.821 0 N-CA-C 106.469 -2.652 . . . . 0.029999999999999999 106.469 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -109.16 152.53 25.0 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 114.587 1.328 . . . . 0.69999999999999996 114.587 -175.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 985' ' ' LEU . . . . . 1.004 HD13 HD22 ' B' ' 890' ' ' LEU . 30.5 tp -72.24 134.1 45.43 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.93 -1.106 . . . . 0.040000000000000001 109.805 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 986' ' ' LEU . . . . . 0.524 ' CD1' HD11 ' C' ' 986' ' ' LEU . 48.1 tp -107.82 -57.79 2.05 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.541 -0.725 . . . . 0.040000000000000001 110.259 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -144.31 145.23 31.87 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.621 -1.252 . . . . 0.040000000000000001 107.621 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.49 163.07 12.2 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 108.255 -1.938 . . . . 0.040000000000000001 108.255 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -74.27 112.72 18.23 Favored Pre-proline 0 N--CA 1.498 1.956 0 O-C-N 121.204 -1.174 . . . . 0.040000000000000001 109.442 179.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 990' ' ' PRO . . . . . 0.444 ' HD2' HD12 ' B' ' 992' ' ' LEU . 50.0 Cg_endo -89.2 71.04 2.09 Favored 'Trans proline' 0 C--N 1.319 -0.985 0 O-C-N 123.093 1.049 . . . . 0.45000000000000001 111.459 -178.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 991' ' ' GLU . . . . . 0.423 ' HB2' ' O ' ' B' ' 990' ' ' PRO . 77.3 mt-10 67.0 -73.84 0.07 Allowed 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 108.603 -0.888 . . . . 1.97 108.603 -177.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 992' ' ' LEU . . . . . 0.451 ' HA ' HD23 ' B' ' 992' ' ' LEU . 10.6 mt 51.29 20.4 0.93 Allowed 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.614 -0.679 . . . . 2.3799999999999999 111.634 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -92.95 157.13 16.49 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.869 -1.144 . . . . 3.79 110.055 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 71.2 m80 -146.91 92.1 2.09 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.511 -0.743 . . . . 3.5099999999999998 110.329 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 995' ' ' ALA . . . . . . . . . . . . 2.52 . . . . . . . 0 N--CA 1.503 2.208 0 O-C-N 120.886 -1.134 . . . . 2.73 110.655 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo . . . . . 0 N--CA 1.488 1.154 0 N-CA-C 109.496 -1.001 . . . . 3.8300000000000001 109.496 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 847' ' ' VAL . . . . . 0.409 HG12 ' HB2' ' C' ' 849' ' ' GLN . 61.8 t -128.75 103.89 19.09 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.579 -0.7 . . . . 1.8300000000000001 110.093 -179.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 848' ' ' PRO . . . . . 0.777 ' O ' HG23 ' C' ' 850' ' ' VAL . 44.3 Cg_endo -70.34 -22.23 29.68 Favored 'Trans proline' 0 N--CA 1.488 1.185 0 O-C-N 123.285 1.15 . . . . 0.65000000000000002 111.254 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 849' ' ' GLN . . . . . 0.409 ' HB2' HG12 ' C' ' 847' ' ' VAL . 57.2 tt0 26.88 68.79 0.06 Allowed 'General case' 0 N--CA 1.519 2.998 0 N-CA-C 112.92 0.711 . . . . 2.5800000000000001 112.92 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 850' ' ' VAL . . . . . 0.777 HG23 ' O ' ' C' ' 848' ' ' PRO . 94.3 t -119.76 135.4 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.129 -0.982 . . . . 1.0900000000000001 111.57 -178.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 851' ' ' ALA . . . . . 0.592 ' HB3' ' HG ' ' C' ' 873' ' ' LEU . . . -127.86 155.53 43.98 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 105.795 -1.928 . . . . 0.040000000000000001 105.795 176.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 852' ' ' PHE . . . . . 0.454 ' CD1' ' N ' ' C' ' 852' ' ' PHE . 13.6 p90 -159.61 127.79 4.94 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 121.018 1.736 . . . . 0.050000000000000003 108.522 178.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 12.1 t -176.51 134.37 0.23 Allowed 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.246 -1.02 . . . . 0.040000000000000001 108.246 -178.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 854' ' ' ALA . . . . . 0.492 ' HB1' ' HD2' ' C' ' 868' ' ' PHE . . . -132.84 156.76 46.56 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.142 -0.974 . . . . 0.67000000000000004 109.693 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 855' ' ' ALA . . . . . 0.762 ' HB3' ' CB ' ' C' ' 870' ' ' ARG . . . -122.96 140.95 52.47 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 122.035 0.921 . . . . 0.51000000000000001 111.419 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 856' ' ' LEU . . . . . 0.618 HD13 ' N ' ' C' ' 857' ' ' SER . 3.5 tm? -113.39 137.71 51.13 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.687 -0.633 . . . . 0.050000000000000003 109.936 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 857' ' ' SER . . . . . 0.618 ' N ' HD13 ' C' ' 856' ' ' LEU . 1.9 m -157.08 19.25 0.3 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.548 -0.72 . . . . 1.3300000000000001 111.084 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 858' ' ' LEU . . . . . 0.705 HD22 ' HG3' ' C' ' 862' ' ' GLU . 4.1 pp -35.54 160.26 0.04 OUTLIER Pre-proline 0 N--CA 1.517 2.886 0 N-CA-C 112.729 0.64 . . . . 2.3300000000000001 112.729 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -59.25 -88.9 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.455 0 O-C-N 122.99 0.995 . . . . 2.3199999999999998 113.386 -177.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 54.5 ptt85 -129.26 -142.56 0.25 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.883 -1.136 . . . . 0.040000000000000001 111.635 -177.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 9.9 m -36.57 126.65 0.84 Allowed 'General case' 0 N--CA 1.51 2.536 0 O-C-N 121.61 -0.681 . . . . 1.3100000000000001 112.634 -178.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 862' ' ' GLU . . . . . 0.705 ' HG3' HD22 ' C' ' 858' ' ' LEU . 0.0 OUTLIER -100.76 159.28 30.03 Favored Pre-proline 0 N--CA 1.489 1.514 0 N-CA-C 108.177 -1.046 . . . . 4.5099999999999998 108.177 177.506 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -71.93 -14.1 29.3 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 O-C-N 123.11 1.058 . . . . 2.2400000000000002 111.523 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -177.72 -136.35 2.47 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 110.04 -1.224 . . . . 0.040000000000000001 110.04 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 25.7 m -65.37 154.85 37.17 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.355 -1.085 . . . . 1.51 110.247 -179.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 866' ' ' VAL . . . . . 0.464 ' HA ' ' HD3' ' C' ' 867' ' ' PRO . 20.7 t -95.62 138.68 21.77 Favored Pre-proline 0 N--CA 1.496 1.874 0 N-CA-C 113.917 1.08 . . . . 0.78000000000000003 113.917 -174.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 867' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' C' ' 866' ' ' VAL . 55.3 Cg_endo -94.07 -151.33 0.03 OUTLIER 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 121.417 1.412 . . . . 0.92000000000000004 109.002 177.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 868' ' ' PHE . . . . . 0.492 ' HD2' ' HB1' ' C' ' 854' ' ' ALA . 13.7 p90 -150.05 124.65 9.71 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.556 -1.34 . . . . 0.050000000000000003 110.036 179.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 50.7 p-10 -112.34 -2.79 14.7 Favored 'General case' 0 N--CA 1.5 2.044 0 C-N-CA 119.216 -0.994 . . . . 1.7 112.715 -178.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 870' ' ' ARG . . . . . 0.762 ' CB ' ' HB3' ' C' ' 855' ' ' ALA . 25.7 mmm180 -92.08 88.16 6.43 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 120.844 -1.16 . . . . 2.5899999999999999 111.36 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 65.3 t -72.45 97.09 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 120.949 -1.094 . . . . 1.9399999999999999 109.132 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 872' ' ' LEU . . . . . 0.662 HD13 HD11 ' A' ' 953' ' ' ILE . 95.0 mt -86.98 -45.42 10.79 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.572 -0.705 . . . . 1.0600000000000001 110.82 -179.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 873' ' ' LEU . . . . . 0.592 ' HG ' ' HB3' ' C' ' 851' ' ' ALA . 30.4 tp -172.91 101.98 0.13 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.153 -0.967 . . . . 4.1799999999999997 108.788 178.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 874' ' ' ASN . . . . . 0.439 ' CB ' ' HA ' ' C' ' 852' ' ' PHE . 32.8 t-20 176.99 82.5 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 108.833 -0.803 . . . . 0.040000000000000001 108.833 -178.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -65.15 -46.41 80.98 Favored 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 119.267 -0.973 . . . . 3.3799999999999999 111.244 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 876' ' ' GLY . . . . . 0.401 ' HA3' ' CE2' ' C' ' 878' ' ' TYR . . . -73.5 -25.65 72.0 Favored Glycine 0 N--CA 1.492 2.403 0 O-C-N 121.257 -0.902 . . . . 0.040000000000000001 111.643 -178.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 81.04 -62.22 4.47 Favored Glycine 0 N--CA 1.501 3.023 0 N-CA-C 107.769 -2.132 . . . . 0.040000000000000001 107.769 -178.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 878' ' ' TYR . . . . . 0.401 ' CE2' ' HA3' ' C' ' 876' ' ' GLY . 85.6 m-85 60.61 -66.29 0.05 Allowed 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 114.497 1.295 . . . . 3.46 114.497 177.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 879' ' ' TYR . . . . . 0.46 ' CB ' ' CD2' ' C' ' 886' ' ' PHE . 25.1 p90 -109.49 109.3 20.07 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 115.271 1.582 . . . . 0.040000000000000001 115.271 -176.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.03 115.82 29.38 Favored Pre-proline 0 N--CA 1.498 1.932 0 O-C-N 121.637 -0.664 . . . . 0.02 109.98 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 881' ' ' PRO . . . . . 0.464 ' HG2' ' CD1' ' C' ' 868' ' ' PHE . 53.8 Cg_endo -76.65 0.65 9.34 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 O-C-N 123.361 1.19 . . . . 0.39000000000000001 112.137 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -74.51 -66.02 0.79 Allowed 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 106.796 -1.557 . . . . 0.81000000000000005 106.796 178.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 2.6 p -95.45 -14.79 23.45 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.813 -0.81 . . . . 0.040000000000000001 108.813 177.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.14 21.98 55.82 Favored Glycine 0 N--CA 1.493 2.476 0 O-C-N 121.042 -1.036 . . . . 0.029999999999999999 111.029 178.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 68.9 t -72.9 87.98 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 C-N-CA 118.189 -1.404 . . . . 1.01 107.492 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 886' ' ' PHE . . . . . 0.927 ' HB3' HG22 ' C' ' 962' ' ' VAL . 0.9 OUTLIER -88.61 103.71 16.17 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-N 115.157 -0.929 . . . . 0.050000000000000003 112.038 -177.075 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 887' ' ' THR . . . . . 0.432 ' O ' ' HD3' ' C' ' 889' ' ' PRO . 88.5 m -99.28 100.24 11.3 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.834 -1.172 . . . . 0.68000000000000005 107.834 177.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 888' ' ' ALA . . . . . . . . . . . . . . . -99.05 102.63 16.07 Favored Pre-proline 0 N--CA 1.502 2.158 0 N-CA-C 114.505 1.298 . . . . 0.25 114.505 -176.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 889' ' ' PRO . . . . . 0.432 ' HD3' ' O ' ' C' ' 887' ' ' THR . 55.9 Cg_endo -83.6 -15.37 7.37 Favored 'Trans proline' 0 CA--C 1.545 1.061 0 N-CA-C 108.827 -1.259 . . . . 1.6399999999999999 108.827 175.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 890' ' ' LEU . . . . . 0.646 HD21 HG11 ' C' ' 850' ' ' VAL . 65.7 mt -38.09 -48.78 1.26 Allowed 'General case' 0 N--CA 1.508 2.45 0 N-CA-C 113.389 0.885 . . . . 2.29 113.389 -177.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 53.28 97.55 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.182 -0.949 . . . . 0.63 110.248 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . 158.83 -155.4 26.46 Favored Glycine 0 N--CA 1.476 1.364 0 N-CA-C 107.12 -2.392 . . . . 0.040000000000000001 107.12 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 74.5 ttt-85 -116.33 125.11 51.66 Favored 'General case' 0 C--N 1.295 -1.803 0 O-C-N 121.537 -0.978 . . . . 3.0 108.855 177.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 894' ' ' TYR . . . . . 0.716 ' CE2' HD23 ' C' ' 954' ' ' LEU . 20.5 p90 -133.35 156.41 47.68 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.083 -1.011 . . . . 0.040000000000000001 111.237 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 895' ' ' LEU . . . . . . . . . . . . . 48.1 tp -99.06 117.13 32.87 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.733 -0.604 . . . . 1.27 110.043 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 896' ' ' LEU . . . . . 0.539 HD11 ' HE1' ' C' ' 981' ' ' PHE . 9.6 tt -120.85 144.51 48.33 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.638 -0.664 . . . . 0.93999999999999995 109.787 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 897' ' ' SER . . . . . . . . . . . . . 19.5 m -141.9 123.97 15.44 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.383 -0.823 . . . . 0.040000000000000001 111.226 -179.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -100.55 148.26 24.99 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.731 -0.84 . . . . 0.47999999999999998 108.731 178.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 899' ' ' VAL . . . . . 0.683 HG21 ' HB ' ' C' ' 980' ' ' ILE . 93.8 t -91.47 120.26 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 C-N-CA 119.66 -0.816 . . . . 0.55000000000000004 111.023 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 86.7 mt -92.95 112.1 23.94 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 114.011 1.115 . . . . 1.5900000000000001 114.011 -175.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 23.7 m -63.11 140.3 58.86 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 107.474 -1.306 . . . . 0.050000000000000003 107.474 177.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -61.05 -64.93 3.64 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.209 -1.156 . . . . 0.029999999999999999 110.209 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 7.7 m170 45.08 64.01 1.54 Allowed 'General case' 0 N--CA 1.507 2.406 0 O-C-N 121.623 -0.927 . . . . 3.2000000000000002 111.36 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 54.4 ptt85 -67.66 -7.88 30.37 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.586 -0.696 . . . . 2.9199999999999999 111.783 -179.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 905' ' ' HIS . . . . . 0.497 ' O ' ' CB ' ' C' ' 906' ' ' GLU . 69.5 t60 -63.06 6.61 0.1 Allowed 'General case' 0 N--CA 1.504 2.266 0 CA-C-O 117.599 -1.191 . . . . 2.8700000000000001 113.412 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 906' ' ' GLU . . . . . 0.497 ' CB ' ' O ' ' C' ' 905' ' ' HIS . 0.7 OUTLIER 93.46 -163.01 0.0 OUTLIER 'General case' 0 N--CA 1.529 3.52 0 CA-C-N 121.299 1.863 . . . . 0.98999999999999999 112.1 179.083 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 907' ' ' LYS . . . . . 0.495 ' CB ' ' O ' ' C' ' 906' ' ' GLU . 57.9 tttt 90.01 160.78 0.05 OUTLIER 'General case' 0 N--CA 1.521 3.11 0 N-CA-C 107.967 -1.123 . . . . 5.25 107.967 -176.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 62.0 t -122.31 116.02 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 120.888 -1.132 . . . . 0.39000000000000001 110.806 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -103.84 130.22 51.38 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 107.209 -1.404 . . . . 1.72 107.209 176.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -157.2 120.29 4.04 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 106.916 -1.513 . . . . 0.67000000000000004 106.916 178.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 911' ' ' VAL . . . . . 0.784 HG23 HG22 ' C' ' 964' ' ' VAL . 12.3 p -80.65 131.21 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 C-N-CA 120.248 -0.581 . . . . 0.54000000000000004 111.463 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 60.5 mt -67.32 156.39 36.55 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.28 -0.887 . . . . 1.5 108.618 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 913' ' ' SER . . . . . 0.414 ' CB ' ' CG1' ' C' ' 919' ' ' VAL . 2.4 t -125.27 136.44 53.52 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.589 -0.893 . . . . 1.3700000000000001 108.589 177.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 914' ' ' ARG . . . . . 0.837 ' NH1' HD13 ' C' ' 956' ' ' LEU . 0.0 OUTLIER -63.41 154.6 31.58 Favored 'General case' 0 N--CA 1.505 2.308 0 O-C-N 120.685 -1.26 . . . . 4.2999999999999998 111.499 -179.095 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 915' ' ' SER . . . . . 0.417 ' CB ' ' O ' ' C' ' 914' ' ' ARG . 1.7 p 83.58 -30.77 0.08 Allowed 'General case' 0 N--CA 1.521 3.101 0 C-N-CA 123.907 0.883 . . . . 2.0499999999999998 111.999 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 916' ' ' ASN . . . . . 0.792 ' HB2' HG21 ' C' ' 919' ' ' VAL . 93.9 m-20 -122.87 -21.96 5.41 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 120.967 -1.083 . . . . 2.71 111.309 -179.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 67.17 165.93 0.22 Allowed 'General case' 0 N--CA 1.521 3.08 0 N-CA-C 105.614 -1.995 . . . . 2.6800000000000002 105.614 -174.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.74 -125.64 35.58 Favored Glycine 1 N--CA 1.521 4.32 0 CA-C-N 123.688 2.949 . . . . 0.029999999999999999 107.026 -177.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 919' ' ' VAL . . . . . 0.792 HG21 ' HB2' ' C' ' 916' ' ' ASN . 96.8 t 50.4 94.2 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.212 0 O-C-N 121.444 -1.033 . . . . 1.3899999999999999 109.397 -178.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 920' ' ' ALA . . . . . 0.859 ' HB3' HG12 ' C' ' 949' ' ' VAL . . . -94.38 94.67 8.4 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.476 -0.89 . . . . 0.029999999999999999 110.661 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 921' ' ' ARG . . . . . 0.729 ' HG3' HG23 ' C' ' 922' ' ' VAL . 23.9 ptt85 -80.61 -41.81 23.31 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 105.792 -1.929 . . . . 4.4199999999999999 105.792 176.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 922' ' ' VAL . . . . . 0.729 HG23 ' HG3' ' C' ' 921' ' ' ARG . 86.3 t -99.37 78.31 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 N-CA-C 105.705 -1.961 . . . . 0.84999999999999998 105.705 175.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -90.73 135.53 33.66 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.836 0.827 . . . . 2.46 112.26 -176.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 9.0 t -147.23 103.32 3.57 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.053 -1.092 . . . . 0.69999999999999996 108.053 178.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -109.81 89.49 0.55 Allowed Glycine 0 N--CA 1.488 2.108 0 N-CA-C 108.97 -1.652 . . . . 0.040000000000000001 108.97 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.387 0 N-CA-C 109.265 -1.534 . . . . 0.040000000000000001 109.265 -179.633 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 10.7 m . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 120.971 0.415 . . . . 13.779999999999999 110.336 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 93.3 mt -114.16 129.87 56.61 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.536 -0.727 . . . . 13.76 110.275 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -152.52 170.6 31.71 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.463 -1.455 . . . . 9.1300000000000008 109.463 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 949' ' ' VAL . . . . . 0.859 HG12 ' HB3' ' C' ' 920' ' ' ALA . 34.8 m -116.69 137.52 50.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.563 -0.963 . . . . 7.0800000000000001 110.829 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 950' ' ' PHE . . . . . 0.485 ' CB ' HD11 ' C' ' 953' ' ' ILE . 51.7 p90 -134.35 151.39 51.2 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.509 -0.744 . . . . 7.5899999999999999 109.558 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 22.3 m -116.59 -60.07 1.89 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.415 -0.803 . . . . 5.0300000000000002 111.625 -179.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 952' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' C' ' 953' ' ' ILE . 53.1 tp -63.1 -75.25 0.08 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.415 -0.803 . . . . 1.01 111.276 -178.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 953' ' ' ILE . . . . . 0.543 HD12 ' HD3' ' C' ' 955' ' ' PRO . 1.8 pp -47.94 -154.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.768 0 N-CA-C 114.487 1.291 . . . . 2.6000000000000001 114.487 -177.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 954' ' ' LEU . . . . . 0.716 HD23 ' CE2' ' C' ' 894' ' ' TYR . 0.0 OUTLIER 170.44 85.63 0.04 OUTLIER Pre-proline 0 N--CA 1.514 2.764 0 O-C-N 120.869 -1.144 . . . . 0.050000000000000003 111.922 179.871 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 955' ' ' PRO . . . . . 0.543 ' HD3' HD12 ' C' ' 953' ' ' ILE . 52.6 Cg_endo -77.13 92.39 1.12 Allowed 'Trans proline' 0 N--CA 1.488 1.162 0 N-CA-C 109.131 -1.142 . . . . 0.83999999999999997 109.131 178.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 956' ' ' LEU . . . . . 0.837 HD13 ' NH1' ' C' ' 914' ' ' ARG . 89.6 mt -127.94 149.79 50.17 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.086 -1.009 . . . . 0.040000000000000001 110.703 -179.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 957' ' ' GLN . . . . . 0.411 ' HB2' ' HB2' ' C' ' 960' ' ' ASP . 75.9 mt-30 -84.87 153.67 22.75 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 117.994 -1.003 . . . . 1.28 111.634 -179.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -67.45 120.44 13.92 Favored 'General case' 0 N--CA 1.508 2.469 0 CA-C-N 122.542 2.428 . . . . 0.17000000000000001 111.471 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.89 -18.86 54.88 Favored Glycine 0 N--CA 1.501 3.003 0 O-C-N 121.52 -0.738 . . . . 0.040000000000000001 111.278 178.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 960' ' ' ASP . . . . . 0.454 ' HB3' ' NE ' ' C' ' 914' ' ' ARG . 0.6 OUTLIER -51.64 172.12 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.369 -1.077 . . . . 0.040000000000000001 110.717 -179.222 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 961' ' ' THR . . . . . 0.492 ' HA ' ' O ' ' C' ' 886' ' ' PHE . 7.4 t -135.61 137.58 42.06 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.092 -1.005 . . . . 1.78 112.141 -178.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 962' ' ' VAL . . . . . 0.927 HG22 ' HB3' ' C' ' 886' ' ' PHE . 23.6 m -99.99 146.06 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 C-N-CA 120.031 -0.668 . . . . 0.040000000000000001 110.497 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 5.2 t -139.15 144.75 38.75 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.785 -0.572 . . . . 0.71999999999999997 110.028 -178.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 964' ' ' VAL . . . . . 0.784 HG22 HG23 ' C' ' 911' ' ' VAL . 57.8 t -94.96 137.39 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.108 -0.995 . . . . 1.05 110.627 -179.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -94.09 126.72 39.48 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 104.068 -2.568 . . . . 3.02 104.068 173.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 966' ' ' LEU . . . . . 0.488 ' C ' HG23 ' C' ' 967' ' ' VAL . 0.1 OUTLIER -132.92 60.09 1.71 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.29 -1.004 . . . . 1.46 108.29 177.398 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 967' ' ' VAL . . . . . 0.488 HG23 ' C ' ' C' ' 966' ' ' LEU . 96.1 t -157.82 96.31 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 108.258 -1.016 . . . . 1.9399999999999999 108.258 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 92.0 mmm -142.74 58.77 1.43 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.748 -1.22 . . . . 0.0 108.382 179.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 134.41 119.38 1.96 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 107.192 -2.363 . . . . 2.1099999999999999 107.192 -178.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -82.18 -58.38 2.97 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.015 -1.285 . . . . 5.8899999999999997 110.591 -179.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 45.1 tp -59.29 90.01 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.445 -0.784 . . . . 4.3600000000000003 110.209 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -142.33 -152.55 0.42 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.613 -0.68 . . . . 1.8300000000000001 110.208 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -116.41 167.47 11.01 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.438 -0.789 . . . . 4.3499999999999996 110.068 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 29.5 t -101.89 130.4 48.36 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.548 -0.72 . . . . 1.27 110.129 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -156.29 155.64 32.66 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.507 -0.745 . . . . 5.0199999999999996 110.459 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.29 85.08 18.86 Favored Pre-proline 0 N--CA 1.5 2.043 0 O-C-N 121.627 -0.671 . . . . 2.4100000000000001 109.642 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 977' ' ' PRO . . . . . 0.488 ' C ' HD12 ' C' ' 978' ' ' LEU . 49.5 Cg_endo -74.8 -171.47 0.97 Allowed 'Trans proline' 0 C--N 1.317 -1.113 0 O-C-N 123.356 1.188 . . . . 0.95999999999999996 111.331 -179.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 978' ' ' LEU . . . . . 0.488 HD12 ' C ' ' C' ' 977' ' ' PRO . 5.5 mp -125.21 156.38 38.56 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.542 -1.281 . . . . 0.62 107.542 177.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 979' ' ' THR . . . . . 0.445 HG23 ' C ' ' C' ' 978' ' ' LEU . 43.2 p -149.42 141.6 24.03 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.822 -1.174 . . . . 3.5699999999999998 111.184 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 980' ' ' ILE . . . . . 0.683 ' HB ' HG21 ' C' ' 899' ' ' VAL . 50.2 mm -106.89 128.27 61.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 108.948 -0.76 . . . . 1.3300000000000001 108.948 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 981' ' ' PHE . . . . . 0.539 ' HE1' HD11 ' C' ' 896' ' ' LEU . 3.4 t80 -117.53 97.56 5.94 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.428 -0.795 . . . . 0.050000000000000003 111.564 -178.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 982' ' ' SER . . . . . . . . . . . . . 34.5 p -107.2 158.25 17.25 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 109.042 -0.725 . . . . 0.87 109.042 178.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 983' ' ' GLY . . . . . 0.419 ' O ' ' CZ ' ' C' ' 852' ' ' PHE . . . -173.06 113.7 0.48 Allowed Glycine 0 N--CA 1.497 2.727 0 N-CA-C 106.644 -2.582 . . . . 0.029999999999999999 106.644 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 984' ' ' ALA . . . . . 0.4 ' CB ' ' CZ ' ' A' ' 893' ' ' ARG . . . -109.11 152.38 25.15 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 114.319 1.229 . . . . 0.69999999999999996 114.319 -175.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 985' ' ' LEU . . . . . 0.556 HD13 HD22 ' C' ' 890' ' ' LEU . 52.1 tp -75.89 135.75 40.13 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.871 -1.143 . . . . 0.040000000000000001 109.691 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 986' ' ' LEU . . . . . 0.524 HD11 ' CD1' ' B' ' 986' ' ' LEU . 40.7 tp -106.26 -62.63 1.36 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.442 -0.786 . . . . 0.040000000000000001 110.299 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -144.7 146.78 32.38 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.753 -1.203 . . . . 0.040000000000000001 107.753 179.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -111.91 162.67 12.35 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 108.079 -2.008 . . . . 0.040000000000000001 108.079 179.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -73.7 112.86 18.05 Favored Pre-proline 0 N--CA 1.499 1.999 0 O-C-N 121.23 -1.159 . . . . 0.040000000000000001 109.44 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 990' ' ' PRO . . . . . 0.435 ' HD2' HD12 ' C' ' 992' ' ' LEU . 51.1 Cg_endo -88.08 70.83 2.88 Favored 'Trans proline' 0 C--N 1.319 -0.984 0 O-C-N 123.201 1.106 . . . . 0.45000000000000001 111.408 -179.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 991' ' ' GLU . . . . . 0.421 ' HB2' ' O ' ' C' ' 990' ' ' PRO . 80.6 mt-10 67.14 -73.65 0.08 Allowed 'General case' 0 N--CA 1.502 2.148 0 N-CA-C 108.645 -0.872 . . . . 1.97 108.645 -177.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 992' ' ' LEU . . . . . 0.435 HD12 ' HD2' ' C' ' 990' ' ' PRO . 11.1 mt 50.86 20.91 0.85 Allowed 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.62 -0.675 . . . . 2.3799999999999999 111.58 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -92.43 156.91 16.88 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.991 -1.068 . . . . 3.79 110.042 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -146.66 91.62 2.05 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.567 -0.708 . . . . 3.5099999999999998 110.245 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 995' ' ' ALA . . . . . . . . . . . . 2.518 . . . . . . . 0 N--CA 1.503 2.213 0 O-C-N 120.983 -1.073 . . . . 2.73 110.646 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo . . . . . 0 N--CA 1.488 1.154 0 N-CA-C 109.497 -1.001 . . . . 3.8300000000000001 109.497 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 847' ' ' VAL . . . . . . . . . . . . . 63.4 t -135.3 102.68 10.68 Favored Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 121.504 -0.747 . . . . 1.8300000000000001 110.04 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 848' ' ' PRO . . . . . 0.744 ' O ' HG23 ' A' ' 850' ' ' VAL . 44.3 Cg_endo -69.94 -18.12 36.35 Favored 'Trans proline' 0 N--CA 1.488 1.161 0 O-C-N 123.308 1.162 . . . . 0.65000000000000002 111.196 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 849' ' ' GLN . . . . . 0.4 ' C ' ' O ' ' A' ' 848' ' ' PRO . 56.4 tt0 28.07 69.42 0.07 Allowed 'General case' 0 N--CA 1.518 2.96 0 N-CA-C 112.837 0.68 . . . . 2.5800000000000001 112.837 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 850' ' ' VAL . . . . . 0.744 HG23 ' O ' ' A' ' 848' ' ' PRO . 64.8 t -120.38 137.5 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 121.216 -0.927 . . . . 1.0900000000000001 111.7 -178.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 851' ' ' ALA . . . . . 0.562 ' HB3' ' HG ' ' A' ' 873' ' ' LEU . . . -125.94 159.18 33.29 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 105.909 -1.885 . . . . 0.040000000000000001 105.909 176.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 852' ' ' PHE . . . . . 0.434 ' HA ' ' CB ' ' A' ' 874' ' ' ASN . 48.1 p90 -158.73 130.72 6.67 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 121.075 1.762 . . . . 0.050000000000000003 108.864 178.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 46.9 t -175.5 134.05 0.3 Allowed 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.209 -1.034 . . . . 0.040000000000000001 108.209 -179.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 854' ' ' ALA . . . . . 0.49 ' HB1' ' HD2' ' A' ' 868' ' ' PHE . . . -133.55 155.09 50.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.091 -1.006 . . . . 0.67000000000000004 109.498 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 855' ' ' ALA . . . . . 0.745 ' HB3' ' CB ' ' A' ' 870' ' ' ARG . . . -124.1 142.7 50.97 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.973 0.892 . . . . 0.51000000000000001 111.651 -179.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 856' ' ' LEU . . . . . 0.765 HD12 HD23 ' A' ' 978' ' ' LEU . 3.3 tm? -111.62 137.88 48.91 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.717 -0.614 . . . . 0.050000000000000003 110.214 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 857' ' ' SER . . . . . 0.66 ' N ' HD13 ' A' ' 856' ' ' LEU . 76.5 p -155.48 15.41 0.38 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.594 -0.691 . . . . 1.3300000000000001 111.466 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 858' ' ' LEU . . . . . 0.535 HD12 ' C ' ' A' ' 858' ' ' LEU . 4.3 pp -36.51 160.65 0.05 OUTLIER Pre-proline 0 N--CA 1.515 2.822 0 CA-C-N 118.799 0.727 . . . . 2.3300000000000001 112.581 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -59.68 -89.16 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.491 0 O-C-N 123.005 1.003 . . . . 2.3199999999999998 114.016 -177.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 54.3 ptt85 -128.08 -144.58 0.29 Allowed 'General case' 0 N--CA 1.502 2.137 0 O-C-N 120.774 -1.204 . . . . 0.040000000000000001 112.394 -177.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 69.7 m -33.91 127.56 0.4 Allowed 'General case' 0 N--CA 1.511 2.604 0 N-CA-C 112.987 0.736 . . . . 1.3100000000000001 112.987 -178.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 862' ' ' GLU . . . . . 0.456 ' HG3' HD22 ' A' ' 858' ' ' LEU . 0.0 OUTLIER -102.67 158.22 32.19 Favored Pre-proline 0 N--CA 1.489 1.477 0 N-CA-C 108.288 -1.004 . . . . 4.5099999999999998 108.288 177.457 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.27 -13.39 25.61 Favored 'Trans proline' 0 C--N 1.315 -1.236 0 O-C-N 123.069 1.036 . . . . 2.2400000000000002 111.687 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -177.55 -135.1 2.15 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 110.06 -1.216 . . . . 0.040000000000000001 110.06 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 28.4 m -67.58 151.21 47.7 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.382 -1.07 . . . . 1.51 109.923 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 866' ' ' VAL . . . . . 0.497 HG13 ' CD2' ' A' ' 858' ' ' LEU . 33.4 t -94.67 139.67 22.34 Favored Pre-proline 0 N--CA 1.496 1.869 0 N-CA-C 113.764 1.024 . . . . 0.78000000000000003 113.764 -174.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 867' ' ' PRO . . . . . 0.486 ' HD3' ' HA ' ' A' ' 866' ' ' VAL . 55.3 Cg_endo -91.96 -151.31 0.04 OUTLIER 'Trans proline' 0 CA--C 1.544 0.999 0 O-C-N 123.673 1.354 . . . . 0.92000000000000004 109.275 177.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 868' ' ' PHE . . . . . 0.49 ' HD2' ' HB1' ' A' ' 854' ' ' ALA . 20.1 p90 -151.1 124.16 8.73 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.662 -1.274 . . . . 0.050000000000000003 109.806 179.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 50.5 p-10 -113.75 -2.17 13.77 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.226 -0.921 . . . . 1.7 112.731 -178.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 870' ' ' ARG . . . . . 0.745 ' CB ' ' HB3' ' A' ' 855' ' ' ALA . 28.8 mmm180 -90.64 90.08 7.81 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.883 -1.135 . . . . 2.5899999999999999 110.944 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 60.3 t -72.3 96.48 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 120.998 -1.064 . . . . 1.9399999999999999 109.944 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 872' ' ' LEU . . . . . 0.546 HD11 ' HB2' ' A' ' 855' ' ' ALA . 96.9 mt -83.09 -47.35 11.75 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.495 -0.753 . . . . 1.0600000000000001 110.188 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 873' ' ' LEU . . . . . 0.562 ' HG ' ' HB3' ' A' ' 851' ' ' ALA . 44.3 tp -174.61 103.51 0.1 Allowed 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 108.729 -0.841 . . . . 4.1799999999999997 108.729 178.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 874' ' ' ASN . . . . . 0.434 ' CB ' ' HA ' ' A' ' 852' ' ' PHE . 33.3 t-20 177.92 81.74 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.31 0 O-C-N 121.681 -0.637 . . . . 0.040000000000000001 109.301 -178.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -66.33 -47.27 74.04 Favored 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 119.317 -0.953 . . . . 3.3799999999999999 111.143 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 876' ' ' GLY . . . . . 0.41 ' HA3' ' CE2' ' A' ' 878' ' ' TYR . . . -74.53 -24.68 72.12 Favored Glycine 0 N--CA 1.494 2.552 0 O-C-N 121.309 -0.87 . . . . 0.040000000000000001 111.546 -178.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 82.22 -61.95 4.63 Favored Glycine 0 N--CA 1.501 2.973 0 N-CA-C 108.005 -2.038 . . . . 0.040000000000000001 108.005 -178.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 878' ' ' TYR . . . . . 0.41 ' CE2' ' HA3' ' A' ' 876' ' ' GLY . 97.9 m-85 60.91 -62.25 0.07 Allowed 'General case' 0 N--CA 1.503 2.211 0 N-CA-C 114.542 1.312 . . . . 3.46 114.542 177.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 879' ' ' TYR . . . . . 0.484 ' CB ' ' CD2' ' A' ' 886' ' ' PHE . 18.2 p90 -110.63 109.7 20.09 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 114.849 1.426 . . . . 0.040000000000000001 114.849 -176.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -68.05 115.55 29.7 Favored Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 121.405 -0.809 . . . . 0.02 109.971 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 881' ' ' PRO . . . . . 0.457 ' HG2' ' CD1' ' A' ' 868' ' ' PHE . 55.2 Cg_endo -75.93 0.6 9.09 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 O-C-N 123.39 1.205 . . . . 0.39000000000000001 112.309 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -76.92 -62.27 1.7 Allowed 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 106.617 -1.623 . . . . 0.81000000000000005 106.617 178.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 883' ' ' THR . . . . . 0.575 ' OG1' HG23 ' A' ' 885' ' ' VAL . 64.4 p -94.49 -19.27 20.69 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.617 -0.882 . . . . 0.040000000000000001 108.617 177.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.66 19.77 59.36 Favored Glycine 0 N--CA 1.496 2.677 0 O-C-N 121.064 -1.022 . . . . 0.029999999999999999 111.237 178.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 885' ' ' VAL . . . . . 0.575 HG23 ' OG1' ' A' ' 883' ' ' THR . 95.9 t -74.25 89.0 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 C-N-CA 118.141 -1.424 . . . . 1.01 108.302 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 886' ' ' PHE . . . . . 0.905 ' HB3' HG22 ' A' ' 962' ' ' VAL . 1.0 OUTLIER -88.23 105.43 17.53 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 115.306 -0.861 . . . . 0.050000000000000003 111.52 -177.674 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 887' ' ' THR . . . . . 0.429 ' O ' ' HD3' ' A' ' 889' ' ' PRO . 93.1 m -95.43 99.95 11.79 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 107.856 -1.165 . . . . 0.68000000000000005 107.856 177.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 888' ' ' ALA . . . . . . . . . . . . . . . -98.85 106.4 37.27 Favored Pre-proline 0 N--CA 1.5 2.039 0 N-CA-C 114.124 1.157 . . . . 0.25 114.124 -176.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 889' ' ' PRO . . . . . 0.429 ' HD3' ' O ' ' A' ' 887' ' ' THR . 54.1 Cg_endo -89.07 -12.39 3.37 Favored 'Trans proline' 0 CA--C 1.546 1.1 0 N-CA-C 108.92 -1.223 . . . . 1.6399999999999999 108.92 176.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 890' ' ' LEU . . . . . 0.856 HD22 HD13 ' A' ' 985' ' ' LEU . 76.7 mt -36.11 -50.73 0.72 Allowed 'General case' 0 N--CA 1.508 2.447 0 N-CA-C 113.592 0.96 . . . . 2.29 113.592 -177.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 52.35 95.55 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.236 -0.915 . . . . 0.63 110.195 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 157.67 -153.64 24.83 Favored Glycine 0 N--CA 1.477 1.427 0 N-CA-C 107.111 -2.396 . . . . 0.040000000000000001 107.111 -179.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 71.4 ttt-85 -115.79 126.89 54.6 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 121.557 -0.967 . . . . 3.0 108.539 177.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 894' ' ' TYR . . . . . 0.762 ' OH ' HD12 ' A' ' 896' ' ' LEU . 0.1 OUTLIER -132.24 160.49 36.02 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.11 -0.994 . . . . 0.040000000000000001 111.081 -179.939 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 895' ' ' LEU . . . . . 0.506 HD23 HD11 ' B' ' 952' ' ' LEU . 35.0 tp -90.71 119.08 30.65 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.401 0.62 . . . . 1.27 110.029 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 896' ' ' LEU . . . . . 0.762 HD12 ' OH ' ' A' ' 894' ' ' TYR . 9.5 tt -109.42 143.21 39.32 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.774 -0.579 . . . . 0.93999999999999995 110.2 -179.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 897' ' ' SER . . . . . 0.505 ' N ' HD23 ' A' ' 896' ' ' LEU . 67.8 m -149.0 115.1 5.76 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.482 -0.761 . . . . 0.040000000000000001 111.018 -179.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -108.1 146.77 32.16 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 109.07 -0.715 . . . . 0.47999999999999998 109.07 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 899' ' ' VAL . . . . . 0.748 HG21 ' HB ' ' A' ' 980' ' ' ILE . 87.7 t -95.7 119.72 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 C-N-CA 119.63 -0.828 . . . . 0.55000000000000004 111.279 -179.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 900' ' ' LEU . . . . . 0.511 HD12 ' HB2' ' A' ' 924' ' ' SER . 4.5 mm? -96.04 112.22 24.02 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 114.384 1.253 . . . . 1.5900000000000001 114.384 -175.05 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 11.8 m -66.28 141.29 58.06 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 107.53 -1.285 . . . . 0.050000000000000003 107.53 176.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -66.72 -66.13 2.51 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 110.573 -1.011 . . . . 0.029999999999999999 110.573 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 11.8 m170 46.91 67.02 0.85 Allowed 'General case' 0 N--CA 1.508 2.438 0 O-C-N 121.476 -1.014 . . . . 3.2000000000000002 111.151 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 43.3 ptt85 -69.71 -5.65 26.47 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.608 -0.683 . . . . 2.9199999999999999 112.063 -179.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 905' ' ' HIS . . . . . 0.486 ' O ' ' CB ' ' A' ' 906' ' ' GLU . 73.8 t60 -62.83 5.32 0.13 Allowed 'General case' 0 N--CA 1.506 2.365 0 O-C-N 120.9 -1.125 . . . . 2.8700000000000001 113.111 -179.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 906' ' ' GLU . . . . . 0.486 ' CB ' ' O ' ' A' ' 905' ' ' HIS . 0.8 OUTLIER 94.86 -164.48 0.0 OUTLIER 'General case' 0 N--CA 1.529 3.478 0 CA-C-N 120.552 1.524 . . . . 0.98999999999999999 111.899 178.944 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 907' ' ' LYS . . . . . 0.46 ' CB ' ' O ' ' A' ' 906' ' ' GLU . 68.4 tttt 85.78 157.56 0.09 Allowed 'General case' 0 N--CA 1.519 3.019 0 N-CA-C 108.156 -1.053 . . . . 5.25 108.156 -177.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 60.1 t -121.68 117.08 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 120.756 -1.215 . . . . 0.39000000000000001 111.312 -179.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 71.2 tt0 -100.03 132.77 45.19 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 107.041 -1.466 . . . . 1.72 107.041 176.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -155.09 123.27 5.88 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 106.805 -1.554 . . . . 0.67000000000000004 106.805 178.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 911' ' ' VAL . . . . . 0.842 HG22 HG13 ' A' ' 964' ' ' VAL . 87.5 t -83.6 131.14 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 C-N-CA 120.52 -0.472 . . . . 0.54000000000000004 110.68 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 86.2 mt -66.34 156.01 35.68 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.333 -0.855 . . . . 1.5 109.264 178.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 913' ' ' SER . . . . . 0.474 ' OG ' HG11 ' A' ' 919' ' ' VAL . 0.1 OUTLIER -127.48 133.87 49.86 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 107.542 -1.281 . . . . 1.3700000000000001 107.542 176.547 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 914' ' ' ARG . . . . . 0.578 HH11 HG13 ' A' ' 962' ' ' VAL . 0.0 OUTLIER -64.95 158.41 25.49 Favored 'General case' 0 N--CA 1.506 2.373 0 O-C-N 120.558 -1.339 . . . . 4.2999999999999998 112.119 -178.491 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 915' ' ' SER . . . . . 0.439 ' CB ' ' O ' ' A' ' 914' ' ' ARG . 4.6 t 84.39 -32.09 0.07 Allowed 'General case' 0 N--CA 1.522 3.153 0 C-N-CA 124.164 0.985 . . . . 2.0499999999999998 111.943 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 916' ' ' ASN . . . . . 0.785 ' HB2' HG21 ' A' ' 919' ' ' VAL . 98.9 m-20 -123.88 -21.32 5.16 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.899 -1.126 . . . . 2.71 111.352 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 917' ' ' GLN . . . . . 0.405 ' HB2' ' O ' ' A' ' 916' ' ' ASN . 45.6 mt-30 66.67 166.39 0.21 Allowed 'General case' 0 N--CA 1.52 3.073 0 N-CA-C 105.637 -1.986 . . . . 2.6800000000000002 105.637 -174.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 52.93 -124.07 26.32 Favored Glycine 1 N--CA 1.523 4.46 0 CA-C-N 123.383 2.811 . . . . 0.029999999999999999 106.895 -177.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 919' ' ' VAL . . . . . 0.785 HG21 ' HB2' ' A' ' 916' ' ' ASN . 52.1 t 52.22 93.9 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 121.337 -1.096 . . . . 1.3899999999999999 108.96 -178.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 920' ' ' ALA . . . . . 0.816 ' HB3' HG12 ' A' ' 949' ' ' VAL . . . -91.75 91.28 7.89 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 119.402 -0.919 . . . . 0.029999999999999999 110.917 -178.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 921' ' ' ARG . . . . . 0.721 ' HG3' HG23 ' A' ' 922' ' ' VAL . 17.3 ptt180 -86.64 -42.24 13.59 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 106.104 -1.813 . . . . 4.4199999999999999 106.104 176.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 922' ' ' VAL . . . . . 0.721 HG23 ' HG3' ' A' ' 921' ' ' ARG . 76.7 t -104.29 67.09 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 105.846 -1.909 . . . . 0.84999999999999998 105.846 175.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 923' ' ' ASP . . . . . 0.659 ' HB2' ' HB1' ' A' ' 920' ' ' ALA . 25.6 t0 -86.58 134.18 33.66 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.684 0.755 . . . . 2.46 111.459 -177.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 924' ' ' SER . . . . . 0.511 ' HB2' HD12 ' A' ' 900' ' ' LEU . 39.7 t -147.7 106.18 3.79 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.669 -0.863 . . . . 0.69999999999999996 108.669 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -101.76 84.74 0.52 Allowed Glycine 0 N--CA 1.486 1.995 0 N-CA-C 108.304 -1.918 . . . . 0.040000000000000001 108.304 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.21 0 N-CA-C 108.877 -1.689 . . . . 0.040000000000000001 108.877 -179.537 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 26.0 m . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.033 0.444 . . . . 13.779999999999999 110.313 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 95.7 mt -112.38 130.88 55.81 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.544 -0.723 . . . . 13.76 110.301 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -151.36 168.25 30.87 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.107 -1.597 . . . . 9.1300000000000008 109.107 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 949' ' ' VAL . . . . . 0.816 HG12 ' HB3' ' A' ' 920' ' ' ALA . 29.8 m -119.11 127.08 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.5 -1.0 . . . . 7.0800000000000001 111.019 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 950' ' ' PHE . . . . . 0.458 ' CZ ' ' HB3' ' A' ' 921' ' ' ARG . 27.1 p90 -133.71 149.28 51.5 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.623 -0.673 . . . . 7.5899999999999999 109.237 179.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 29.1 m -121.27 -51.51 2.09 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.359 -0.838 . . . . 5.0300000000000002 112.191 -178.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 952' ' ' LEU . . . . . 0.418 ' O ' ' O ' ' A' ' 953' ' ' ILE . 14.6 tp -59.4 -73.88 0.08 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.369 -0.832 . . . . 1.01 112.705 -177.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 953' ' ' ILE . . . . . 0.582 HD11 HD13 ' C' ' 872' ' ' LEU . 45.8 pt -52.29 -144.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.848 0 N-CA-C 114.417 1.266 . . . . 2.6000000000000001 114.417 -176.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 954' ' ' LEU . . . . . 0.717 HD22 ' O ' ' A' ' 954' ' ' LEU . 0.0 OUTLIER 173.21 75.01 0.04 OUTLIER Pre-proline 0 N--CA 1.507 2.417 0 O-C-N 120.779 -1.201 . . . . 0.050000000000000003 110.869 -179.974 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 955' ' ' PRO . . . . . 0.755 ' C ' HD12 ' A' ' 956' ' ' LEU . 49.6 Cg_endo -77.11 95.51 1.07 Allowed 'Trans proline' 0 C--N 1.316 -1.143 0 O-C-N 122.716 0.85 . . . . 0.83999999999999997 110.2 179.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 956' ' ' LEU . . . . . 0.755 HD12 ' C ' ' A' ' 955' ' ' PRO . 8.9 mp -125.83 151.12 47.23 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.237 -0.915 . . . . 0.040000000000000001 110.257 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -82.19 150.92 27.13 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-O 117.734 -1.127 . . . . 1.28 111.311 -178.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -68.33 119.47 12.9 Favored 'General case' 0 N--CA 1.509 2.51 0 CA-C-N 123.063 2.665 . . . . 0.17000000000000001 111.234 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.8 -21.68 37.9 Favored Glycine 0 N--CA 1.499 2.874 0 N-CA-C 110.769 -0.932 . . . . 0.040000000000000001 110.769 178.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 960' ' ' ASP . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 914' ' ' ARG . 0.4 OUTLIER -53.12 171.9 0.06 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.389 -1.066 . . . . 0.040000000000000001 109.993 -179.707 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 961' ' ' THR . . . . . 0.463 ' HA ' ' O ' ' A' ' 886' ' ' PHE . 41.5 m -133.53 138.73 46.23 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.895 -1.128 . . . . 1.78 112.159 -177.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 962' ' ' VAL . . . . . 0.905 HG22 ' HB3' ' A' ' 886' ' ' PHE . 20.3 m -96.57 143.62 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 C-N-CA 120.025 -0.67 . . . . 0.040000000000000001 109.763 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 5.3 t -140.28 145.3 37.1 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.817 -0.552 . . . . 0.71999999999999997 109.981 -178.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 964' ' ' VAL . . . . . 0.842 HG13 HG22 ' A' ' 911' ' ' VAL . 47.6 t -99.59 136.9 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.141 -0.975 . . . . 1.05 110.785 -178.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -94.05 128.43 40.42 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 103.799 -2.667 . . . . 3.02 103.799 173.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 966' ' ' LEU . . . . . 0.493 ' C ' HG23 ' A' ' 967' ' ' VAL . 10.2 tp -131.62 61.99 1.64 Allowed 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.136 -1.061 . . . . 1.46 108.136 177.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 967' ' ' VAL . . . . . 0.493 HG23 ' C ' ' A' ' 966' ' ' LEU . 95.4 t -158.01 97.2 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 108.072 -1.084 . . . . 1.9399999999999999 108.072 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 88.2 mmm -143.13 60.02 1.41 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.746 -1.221 . . . . 0.0 108.353 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.78 119.98 1.95 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 107.036 -2.425 . . . . 2.1099999999999999 107.036 -178.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -82.45 -58.68 2.82 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.014 -1.286 . . . . 5.8899999999999997 110.396 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 49.0 tp -59.01 90.74 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.422 -0.799 . . . . 4.3600000000000003 110.209 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -141.93 -154.19 0.5 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.592 -0.693 . . . . 1.8300000000000001 110.235 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -119.64 171.92 8.04 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.511 -0.743 . . . . 4.3499999999999996 110.212 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 39.0 t -101.64 130.42 47.98 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.598 -0.689 . . . . 1.27 110.084 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -156.12 158.75 38.24 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.521 -0.737 . . . . 5.0199999999999996 110.561 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.14 85.75 18.43 Favored Pre-proline 0 N--CA 1.5 2.04 0 O-C-N 121.59 -0.694 . . . . 2.4100000000000001 109.691 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 977' ' ' PRO . . . . . 0.543 ' C ' HD12 ' A' ' 978' ' ' LEU . 48.2 Cg_endo -73.39 -172.43 1.04 Allowed 'Trans proline' 0 C--N 1.317 -1.089 0 O-C-N 123.277 1.146 . . . . 0.95999999999999996 111.345 -179.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 978' ' ' LEU . . . . . 0.765 HD23 HD12 ' A' ' 856' ' ' LEU . 5.7 mp -127.47 155.3 43.92 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 107.688 -1.227 . . . . 0.62 107.688 177.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 979' ' ' THR . . . . . 0.461 HG23 ' C ' ' A' ' 978' ' ' LEU . 42.7 p -149.83 141.1 23.16 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.847 -1.158 . . . . 3.5699999999999998 111.252 -179.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 980' ' ' ILE . . . . . 0.748 ' HB ' HG21 ' A' ' 899' ' ' VAL . 46.7 mm -107.7 128.69 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 108.911 -0.774 . . . . 1.3300000000000001 108.911 179.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 981' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -120.95 97.26 5.45 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 119.705 -0.798 . . . . 0.050000000000000003 111.974 -178.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 83.8 p -108.59 158.49 17.53 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.539 -0.726 . . . . 0.87 109.157 178.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 983' ' ' GLY . . . . . 0.402 ' HA3' ' CE1' ' A' ' 852' ' ' PHE . . . -175.18 109.04 0.28 Allowed Glycine 0 N--CA 1.499 2.878 0 N-CA-C 106.39 -2.684 . . . . 0.029999999999999999 106.39 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -108.64 152.42 24.82 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 114.565 1.32 . . . . 0.69999999999999996 114.565 -175.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 985' ' ' LEU . . . . . 0.856 HD13 HD22 ' A' ' 890' ' ' LEU . 45.3 tp -72.28 134.55 45.62 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.777 -1.202 . . . . 0.040000000000000001 110.051 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 50.8 tp -107.49 -55.83 2.3 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.562 -0.711 . . . . 0.040000000000000001 109.905 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -144.82 145.16 31.51 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 107.653 -1.24 . . . . 0.040000000000000001 107.653 179.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.74 163.15 12.18 Favored Glycine 0 N--CA 1.495 2.593 0 N-CA-C 108.155 -1.978 . . . . 0.040000000000000001 108.155 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -75.85 112.16 18.55 Favored Pre-proline 0 N--CA 1.499 1.988 0 O-C-N 121.202 -1.175 . . . . 0.040000000000000001 109.436 179.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 990' ' ' PRO . . . . . 0.528 ' HD2' HD12 ' A' ' 992' ' ' LEU . 48.8 Cg_endo -91.4 71.23 0.97 Allowed 'Trans proline' 0 C--N 1.319 -0.993 0 O-C-N 123.151 1.079 . . . . 0.45000000000000001 111.418 -178.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 991' ' ' GLU . . . . . 0.418 ' HB2' ' O ' ' A' ' 990' ' ' PRO . 70.4 mt-10 67.25 -73.85 0.07 Allowed 'General case' 0 N--CA 1.503 2.178 0 N-CA-C 108.421 -0.955 . . . . 1.97 108.421 -177.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 992' ' ' LEU . . . . . 0.528 HD12 ' HD2' ' A' ' 990' ' ' PRO . 6.6 mt 51.16 20.54 0.89 Allowed 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.574 -0.704 . . . . 2.3799999999999999 111.609 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -94.63 156.68 16.31 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.844 -1.16 . . . . 3.79 109.98 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -146.55 93.77 2.34 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.529 -0.732 . . . . 3.5099999999999998 110.269 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 995' ' ' ALA . . . . . . . . . . . . 2.518 . . . . . . . 0 N--CA 1.504 2.243 0 O-C-N 120.86 -1.15 . . . . 2.73 110.578 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo . . . . . 0 N--CA 1.488 1.177 0 N-CA-C 109.432 -1.026 . . . . 3.8300000000000001 109.432 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 847' ' ' VAL . . . . . . . . . . . . . 63.6 t -135.38 102.69 10.6 Favored Pre-proline 0 N--CA 1.494 1.775 0 O-C-N 121.573 -0.704 . . . . 1.8300000000000001 110.014 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 848' ' ' PRO . . . . . 0.741 ' O ' HG23 ' B' ' 850' ' ' VAL . 44.1 Cg_endo -69.95 -18.41 36.15 Favored 'Trans proline' 0 N--CA 1.487 1.091 0 O-C-N 123.279 1.147 . . . . 0.65000000000000002 111.192 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 849' ' ' GLN . . . . . 0.404 ' C ' ' O ' ' B' ' 848' ' ' PRO . 56.4 tt0 28.35 69.57 0.07 Allowed 'General case' 0 N--CA 1.518 2.969 0 N-CA-C 112.734 0.642 . . . . 2.5800000000000001 112.734 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 850' ' ' VAL . . . . . 0.741 HG23 ' O ' ' B' ' 848' ' ' PRO . 65.1 t -120.56 137.57 53.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.15 -0.969 . . . . 1.0900000000000001 111.694 -178.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 851' ' ' ALA . . . . . 0.557 ' HB3' ' HG ' ' B' ' 873' ' ' LEU . . . -126.37 158.48 35.78 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 105.894 -1.891 . . . . 0.040000000000000001 105.894 176.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 852' ' ' PHE . . . . . 0.427 ' HA ' ' CB ' ' B' ' 874' ' ' ASN . 47.7 p90 -157.9 131.03 7.54 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 121.114 1.779 . . . . 0.050000000000000003 108.803 179.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 47.2 t -175.53 133.72 0.29 Allowed 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.216 -1.031 . . . . 0.040000000000000001 108.216 -179.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 854' ' ' ALA . . . . . 0.467 ' HB1' ' HD2' ' B' ' 868' ' ' PHE . . . -133.17 155.33 49.51 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.071 -1.018 . . . . 0.67000000000000004 109.522 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 855' ' ' ALA . . . . . 0.742 ' HB3' ' CB ' ' B' ' 870' ' ' ARG . . . -124.37 142.99 50.85 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 122.026 0.917 . . . . 0.51000000000000001 111.553 -179.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 856' ' ' LEU . . . . . 0.785 HD12 HD23 ' B' ' 978' ' ' LEU . 3.3 tm? -111.96 137.56 49.8 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.719 -0.613 . . . . 0.050000000000000003 110.274 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 857' ' ' SER . . . . . 0.649 ' N ' HD13 ' B' ' 856' ' ' LEU . 77.1 p -155.15 15.43 0.4 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.615 -0.678 . . . . 1.3300000000000001 111.433 179.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 858' ' ' LEU . . . . . 0.525 HD12 ' C ' ' B' ' 858' ' ' LEU . 4.3 pp -36.54 160.68 0.05 OUTLIER Pre-proline 0 N--CA 1.516 2.869 0 CA-C-N 118.861 0.755 . . . . 2.3300000000000001 112.544 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -59.74 -89.11 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 120.791 0.994 . . . . 2.3199999999999998 114.022 -177.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 54.4 ptt85 -128.18 -144.7 0.29 Allowed 'General case' 0 N--CA 1.501 2.124 0 O-C-N 120.845 -1.159 . . . . 0.040000000000000001 112.386 -177.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 70.1 m -33.81 126.99 0.4 Allowed 'General case' 0 N--CA 1.512 2.642 0 N-CA-C 112.95 0.722 . . . . 1.3100000000000001 112.95 -178.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 862' ' ' GLU . . . . . 0.463 ' HG3' HD22 ' B' ' 858' ' ' LEU . 0.0 OUTLIER -102.14 158.26 32.11 Favored Pre-proline 0 N--CA 1.489 1.478 0 N-CA-C 108.324 -0.991 . . . . 4.5099999999999998 108.324 177.362 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -73.19 -13.54 25.8 Favored 'Trans proline' 0 C--N 1.314 -1.283 0 O-C-N 123.114 1.06 . . . . 2.2400000000000002 111.855 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -177.2 -134.14 1.95 Allowed Glycine 0 N--CA 1.495 2.612 0 N-CA-C 110.005 -1.238 . . . . 0.040000000000000001 110.005 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 29.1 m -68.65 151.62 46.46 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.319 -1.106 . . . . 1.51 109.802 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 866' ' ' VAL . . . . . 0.499 HG13 ' CD2' ' B' ' 858' ' ' LEU . 33.2 t -94.82 139.7 22.28 Favored Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 113.766 1.024 . . . . 0.78000000000000003 113.766 -174.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 867' ' ' PRO . . . . . 0.493 ' HD3' ' HA ' ' B' ' 866' ' ' VAL . 55.5 Cg_endo -92.02 -151.49 0.04 OUTLIER 'Trans proline' 0 CA--C 1.545 1.034 0 O-C-N 123.729 1.384 . . . . 0.92000000000000004 109.302 177.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 868' ' ' PHE . . . . . 0.467 ' CD1' ' HG2' ' B' ' 881' ' ' PRO . 20.3 p90 -150.91 123.86 8.69 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.644 -1.285 . . . . 0.050000000000000003 109.83 179.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 50.5 p-10 -113.54 -1.66 14.05 Favored 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 119.388 -0.925 . . . . 1.7 112.742 -178.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 870' ' ' ARG . . . . . 0.742 ' CB ' ' HB3' ' B' ' 855' ' ' ALA . 28.6 mmm180 -91.12 89.96 7.61 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.855 -1.153 . . . . 2.5899999999999999 111.005 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 59.7 t -72.29 96.57 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.011 -1.056 . . . . 1.9399999999999999 109.937 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 872' ' ' LEU . . . . . 0.541 HD11 ' HB2' ' B' ' 855' ' ' ALA . 96.6 mt -83.24 -47.15 11.84 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.504 -0.747 . . . . 1.0600000000000001 110.232 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 873' ' ' LEU . . . . . 0.557 ' HG ' ' HB3' ' B' ' 851' ' ' ALA . 44.2 tp -174.61 103.46 0.1 Allowed 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.735 -0.839 . . . . 4.1799999999999997 108.735 178.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 874' ' ' ASN . . . . . 0.427 ' CB ' ' HA ' ' B' ' 852' ' ' PHE . 33.0 t-20 177.95 81.84 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.64 -0.663 . . . . 0.040000000000000001 109.42 -178.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -66.45 -47.29 73.62 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 119.272 -0.971 . . . . 3.3799999999999999 111.176 -179.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 876' ' ' GLY . . . . . 0.414 ' HA3' ' CE2' ' B' ' 878' ' ' TYR . . . -74.5 -24.82 71.84 Favored Glycine 0 N--CA 1.494 2.524 0 O-C-N 121.263 -0.898 . . . . 0.040000000000000001 111.534 -178.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 82.36 -61.98 4.64 Favored Glycine 0 N--CA 1.501 3.021 0 N-CA-C 107.983 -2.047 . . . . 0.040000000000000001 107.983 -178.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 878' ' ' TYR . . . . . 0.414 ' CE2' ' HA3' ' B' ' 876' ' ' GLY . 97.8 m-85 60.89 -62.23 0.07 Allowed 'General case' 0 N--CA 1.504 2.251 0 N-CA-C 114.527 1.306 . . . . 3.46 114.527 177.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 879' ' ' TYR . . . . . 0.485 ' CB ' ' CD2' ' B' ' 886' ' ' PHE . 18.2 p90 -110.59 109.69 20.1 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 114.826 1.417 . . . . 0.040000000000000001 114.826 -176.121 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -67.95 115.48 28.72 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.418 -0.801 . . . . 0.02 109.947 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 881' ' ' PRO . . . . . 0.467 ' HG2' ' CD1' ' B' ' 868' ' ' PHE . 55.3 Cg_endo -75.9 0.46 9.24 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 O-C-N 123.361 1.19 . . . . 0.39000000000000001 112.264 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -76.72 -62.52 1.61 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 106.637 -1.616 . . . . 0.81000000000000005 106.637 178.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 883' ' ' THR . . . . . 0.567 ' OG1' HG23 ' B' ' 885' ' ' VAL . 63.5 p -94.46 -18.65 21.3 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.711 -0.848 . . . . 0.040000000000000001 108.711 177.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.88 20.28 59.83 Favored Glycine 0 N--CA 1.496 2.648 0 O-C-N 121.101 -1.0 . . . . 0.029999999999999999 111.311 178.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 885' ' ' VAL . . . . . 0.567 HG23 ' OG1' ' B' ' 883' ' ' THR . 93.9 t -74.53 89.27 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 C-N-CA 118.15 -1.42 . . . . 1.01 108.202 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 886' ' ' PHE . . . . . 0.885 ' HB3' HG22 ' B' ' 962' ' ' VAL . 1.0 OUTLIER -88.38 105.55 17.66 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 115.366 -0.833 . . . . 0.050000000000000003 111.546 -177.75 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 887' ' ' THR . . . . . 0.427 ' O ' ' HD3' ' B' ' 889' ' ' PRO . 93.0 m -95.48 100.27 12.05 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 107.745 -1.206 . . . . 0.68000000000000005 107.745 177.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 888' ' ' ALA . . . . . . . . . . . . . . . -99.09 106.23 37.0 Favored Pre-proline 0 N--CA 1.5 2.06 0 N-CA-C 114.059 1.133 . . . . 0.25 114.059 -176.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 889' ' ' PRO . . . . . 0.427 ' HD3' ' O ' ' B' ' 887' ' ' THR . 54.8 Cg_endo -88.92 -12.37 3.48 Favored 'Trans proline' 0 CA--C 1.546 1.079 0 N-CA-C 109.003 -1.191 . . . . 1.6399999999999999 109.003 175.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 890' ' ' LEU . . . . . 0.835 HD22 HD13 ' B' ' 985' ' ' LEU . 76.6 mt -36.02 -50.78 0.71 Allowed 'General case' 0 N--CA 1.508 2.462 0 N-CA-C 113.588 0.958 . . . . 2.29 113.588 -177.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 52.16 95.64 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.231 -0.918 . . . . 0.63 110.232 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . 157.63 -153.85 25.01 Favored Glycine 0 N--CA 1.477 1.418 0 N-CA-C 107.061 -2.416 . . . . 0.040000000000000001 107.061 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 71.4 ttt-85 -115.62 126.95 54.82 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 121.61 -0.935 . . . . 3.0 108.587 177.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 894' ' ' TYR . . . . . 0.77 ' OH ' HD12 ' B' ' 896' ' ' LEU . 0.1 OUTLIER -132.18 160.9 34.74 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.117 -0.989 . . . . 0.040000000000000001 111.069 -179.828 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 895' ' ' LEU . . . . . . . . . . . . . 35.2 tp -91.13 118.93 30.83 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.426 0.631 . . . . 1.27 110.091 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 896' ' ' LEU . . . . . 0.77 HD12 ' OH ' ' B' ' 894' ' ' TYR . 9.5 tt -109.28 142.47 40.11 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.782 -0.574 . . . . 0.93999999999999995 110.251 -179.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 897' ' ' SER . . . . . 0.496 ' N ' HD23 ' B' ' 896' ' ' LEU . 68.1 m -148.42 114.96 5.95 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.538 -0.726 . . . . 0.040000000000000001 111.022 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.87 146.52 32.21 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 109.179 -0.674 . . . . 0.47999999999999998 109.179 179.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 899' ' ' VAL . . . . . 0.738 HG21 ' HB ' ' B' ' 980' ' ' ILE . 87.9 t -95.46 119.54 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 C-N-CA 119.616 -0.833 . . . . 0.55000000000000004 111.324 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 900' ' ' LEU . . . . . 0.528 HD12 ' HB2' ' B' ' 924' ' ' SER . 4.5 mm? -95.95 111.74 23.66 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 114.401 1.259 . . . . 1.5900000000000001 114.401 -174.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 11.9 m -65.87 141.22 58.33 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 107.466 -1.309 . . . . 0.050000000000000003 107.466 176.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -66.87 -66.16 2.49 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 110.615 -0.994 . . . . 0.029999999999999999 110.615 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 11.7 m170 46.9 67.16 0.83 Allowed 'General case' 0 N--CA 1.507 2.414 0 O-C-N 121.519 -0.989 . . . . 3.2000000000000002 111.082 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 43.1 ptt85 -69.69 -5.97 28.53 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.623 -0.673 . . . . 2.9199999999999999 112.068 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 905' ' ' HIS . . . . . 0.482 ' O ' ' CB ' ' B' ' 906' ' ' GLU . 73.6 t60 -62.2 4.79 0.12 Allowed 'General case' 0 N--CA 1.506 2.369 0 O-C-N 120.904 -1.123 . . . . 2.8700000000000001 113.094 -179.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 906' ' ' GLU . . . . . 0.482 ' CB ' ' O ' ' B' ' 905' ' ' HIS . 0.9 OUTLIER 95.1 -164.63 0.0 OUTLIER 'General case' 0 N--CA 1.529 3.478 0 CA-C-N 120.648 1.567 . . . . 0.98999999999999999 111.8 179.1 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 907' ' ' LYS . . . . . 0.466 ' CB ' ' O ' ' B' ' 906' ' ' GLU . 68.6 tttt 85.9 157.29 0.09 Allowed 'General case' 0 N--CA 1.519 3.002 0 N-CA-C 108.212 -1.033 . . . . 5.25 108.212 -177.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 60.3 t -121.51 116.71 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 120.779 -1.2 . . . . 0.39000000000000001 111.436 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 71.1 tt0 -99.58 133.09 44.41 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 106.996 -1.483 . . . . 1.72 106.996 176.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -155.51 123.35 5.7 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 106.831 -1.544 . . . . 0.67000000000000004 106.831 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 911' ' ' VAL . . . . . 0.843 HG22 HG13 ' B' ' 964' ' ' VAL . 86.5 t -83.84 131.5 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 C-N-CA 120.482 -0.487 . . . . 0.54000000000000004 110.668 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 86.1 mt -66.53 156.29 35.32 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.306 -0.871 . . . . 1.5 109.174 178.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 913' ' ' SER . . . . . 0.465 ' OG ' HG11 ' B' ' 919' ' ' VAL . 0.1 OUTLIER -127.92 133.26 49.25 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.617 -1.253 . . . . 1.3700000000000001 107.617 176.56 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 914' ' ' ARG . . . . . 0.575 HH11 HG13 ' B' ' 962' ' ' VAL . 0.0 OUTLIER -64.36 158.33 23.88 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 120.481 -1.387 . . . . 4.2999999999999998 112.167 -178.346 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 915' ' ' SER . . . . . 0.431 ' CB ' ' O ' ' B' ' 914' ' ' ARG . 4.6 t 84.56 -32.38 0.06 Allowed 'General case' 0 N--CA 1.521 3.104 0 C-N-CA 124.191 0.996 . . . . 2.0499999999999998 111.931 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 916' ' ' ASN . . . . . 0.804 ' HB2' HG21 ' B' ' 919' ' ' VAL . 98.7 m-20 -123.49 -21.74 5.21 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.987 -1.07 . . . . 2.71 111.382 -179.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 917' ' ' GLN . . . . . 0.407 ' HB2' ' O ' ' B' ' 916' ' ' ASN . 45.1 mt-30 66.72 165.69 0.21 Allowed 'General case' 0 N--CA 1.52 3.049 0 N-CA-C 105.708 -1.96 . . . . 2.6800000000000002 105.708 -173.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 53.81 -124.15 28.79 Favored Glycine 1 N--CA 1.522 4.407 0 CA-C-N 123.446 2.839 . . . . 0.029999999999999999 106.753 -177.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 919' ' ' VAL . . . . . 0.804 HG21 ' HB2' ' B' ' 916' ' ' ASN . 54.2 t 52.03 94.04 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 O-C-N 121.359 -1.083 . . . . 1.3899999999999999 108.922 -178.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 920' ' ' ALA . . . . . 0.801 ' HB3' HG12 ' B' ' 949' ' ' VAL . . . -91.85 91.17 7.79 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.416 -0.914 . . . . 0.029999999999999999 110.846 -179.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 921' ' ' ARG . . . . . 0.703 ' HG3' HG23 ' B' ' 922' ' ' VAL . 17.3 ptt180 -86.69 -42.15 13.62 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 106.132 -1.803 . . . . 4.4199999999999999 106.132 176.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 922' ' ' VAL . . . . . 0.703 HG23 ' HG3' ' B' ' 921' ' ' ARG . 77.0 t -104.35 67.09 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 N-CA-C 105.812 -1.922 . . . . 0.84999999999999998 105.812 175.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 923' ' ' ASP . . . . . 0.656 ' HB2' ' HB1' ' B' ' 920' ' ' ALA . 25.7 t0 -86.56 134.34 33.66 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.673 0.749 . . . . 2.46 111.423 -177.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 924' ' ' SER . . . . . 0.528 ' HB2' HD12 ' B' ' 900' ' ' LEU . 40.0 t -147.8 106.12 3.77 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.696 -0.853 . . . . 0.69999999999999996 108.696 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -101.68 84.69 0.52 Allowed Glycine 0 N--CA 1.486 2.025 0 N-CA-C 108.358 -1.897 . . . . 0.040000000000000001 108.358 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 926' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' B' ' 906' ' ' GLU . . . . . . . . 0 N--CA 1.489 2.191 0 N-CA-C 108.922 -1.671 . . . . 0.040000000000000001 108.922 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 26.2 m . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.029 0.442 . . . . 13.779999999999999 110.273 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 95.6 mt -111.66 130.79 55.65 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.545 -0.722 . . . . 13.76 110.379 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -151.09 167.92 30.68 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.088 -1.605 . . . . 9.1300000000000008 109.088 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 949' ' ' VAL . . . . . 0.801 HG12 ' HB3' ' B' ' 920' ' ' ALA . 31.1 m -118.91 127.21 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.426 -1.044 . . . . 7.0800000000000001 110.899 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 950' ' ' PHE . . . . . 0.463 ' CE1' ' HD2' ' B' ' 955' ' ' PRO . 27.2 p90 -133.81 148.99 51.39 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.593 -0.692 . . . . 7.5899999999999999 109.176 179.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 28.6 m -121.15 -50.97 2.12 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.411 -0.806 . . . . 5.0300000000000002 112.065 -178.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 952' ' ' LEU . . . . . 0.506 HD11 HD23 ' A' ' 895' ' ' LEU . 14.6 tp -59.71 -74.12 0.08 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.458 -0.776 . . . . 1.01 112.712 -177.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 953' ' ' ILE . . . . . 0.476 ' O ' ' HB3' ' B' ' 954' ' ' LEU . 46.4 pt -52.02 -143.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.851 0 N-CA-C 114.499 1.296 . . . . 2.6000000000000001 114.499 -176.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 954' ' ' LEU . . . . . 0.721 HD22 ' O ' ' B' ' 954' ' ' LEU . 0.0 OUTLIER 173.13 74.76 0.04 OUTLIER Pre-proline 0 N--CA 1.508 2.452 0 O-C-N 120.788 -1.195 . . . . 0.050000000000000003 110.772 179.93 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 955' ' ' PRO . . . . . 0.765 ' C ' HD12 ' B' ' 956' ' ' LEU . 49.6 Cg_endo -77.16 95.53 1.07 Allowed 'Trans proline' 0 C--N 1.316 -1.178 0 O-C-N 122.741 0.864 . . . . 0.83999999999999997 110.163 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 956' ' ' LEU . . . . . 0.765 HD12 ' C ' ' B' ' 955' ' ' PRO . 8.9 mp -125.92 151.08 47.42 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.208 -0.932 . . . . 0.040000000000000001 110.149 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -82.03 150.89 27.35 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 117.822 -1.085 . . . . 1.28 111.325 -179.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -68.36 119.13 12.39 Favored 'General case' 0 N--CA 1.508 2.465 0 CA-C-N 122.946 2.612 . . . . 0.17000000000000001 111.266 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 93.08 -21.85 37.74 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 110.786 -0.926 . . . . 0.040000000000000001 110.786 178.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 960' ' ' ASP . . . . . 0.427 ' HB3' ' CZ ' ' B' ' 914' ' ' ARG . 0.4 OUTLIER -52.98 172.06 0.05 Allowed 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.39 -1.065 . . . . 0.040000000000000001 109.981 -179.747 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 961' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' B' ' 886' ' ' PHE . 40.8 m -133.55 138.91 46.29 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.897 -1.127 . . . . 1.78 112.165 -177.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 962' ' ' VAL . . . . . 0.885 HG22 ' HB3' ' B' ' 886' ' ' PHE . 20.7 m -96.94 143.5 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 C-N-CA 120.007 -0.677 . . . . 0.040000000000000001 109.737 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 5.3 t -140.03 145.21 37.46 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.79 -0.569 . . . . 0.71999999999999997 110.043 -178.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 964' ' ' VAL . . . . . 0.843 HG13 HG22 ' B' ' 911' ' ' VAL . 47.5 t -99.59 136.64 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.138 -0.976 . . . . 1.05 110.802 -179.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -94.08 127.95 40.18 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 103.916 -2.624 . . . . 3.02 103.916 173.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 966' ' ' LEU . . . . . 0.491 ' C ' HG23 ' B' ' 967' ' ' VAL . 10.1 tp -131.17 62.15 1.62 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.217 -1.031 . . . . 1.46 108.217 177.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 967' ' ' VAL . . . . . 0.491 HG23 ' C ' ' B' ' 966' ' ' LEU . 95.4 t -158.14 97.12 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 108.113 -1.069 . . . . 1.9399999999999999 108.113 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 88.2 mmm -142.97 59.76 1.42 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.756 -1.215 . . . . 0.0 108.456 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.85 119.83 1.93 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 107.08 -2.408 . . . . 2.1099999999999999 107.08 -178.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -82.13 -58.66 2.86 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.039 -1.271 . . . . 5.8899999999999997 110.427 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 49.0 tp -59.08 90.64 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.437 -0.789 . . . . 4.3600000000000003 110.152 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -141.89 -154.18 0.5 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.556 -0.715 . . . . 1.8300000000000001 110.179 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -119.55 171.98 7.98 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.486 -0.759 . . . . 4.3499999999999996 110.306 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 39.2 t -101.7 130.39 48.07 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.541 -0.725 . . . . 1.27 110.065 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -156.1 158.69 38.16 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.513 -0.742 . . . . 5.0199999999999996 110.588 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.13 85.7 18.52 Favored Pre-proline 0 N--CA 1.499 2.012 0 O-C-N 121.624 -0.673 . . . . 2.4100000000000001 109.747 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 977' ' ' PRO . . . . . 0.538 ' C ' HD12 ' B' ' 978' ' ' LEU . 48.2 Cg_endo -73.42 -172.43 1.04 Allowed 'Trans proline' 0 C--N 1.318 -1.065 0 O-C-N 123.324 1.171 . . . . 0.95999999999999996 111.44 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 978' ' ' LEU . . . . . 0.785 HD23 HD12 ' B' ' 856' ' ' LEU . 5.6 mp -127.34 155.52 43.44 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.707 -1.22 . . . . 0.62 107.707 177.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 979' ' ' THR . . . . . 0.466 HG23 ' C ' ' B' ' 978' ' ' LEU . 42.3 p -150.0 141.01 22.93 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.782 -1.199 . . . . 3.5699999999999998 111.239 -179.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 980' ' ' ILE . . . . . 0.738 ' HB ' HG21 ' B' ' 899' ' ' VAL . 46.9 mm -107.76 128.33 63.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 108.885 -0.783 . . . . 1.3300000000000001 108.885 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -120.59 97.49 5.59 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 119.71 -0.796 . . . . 0.050000000000000003 111.982 -178.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 82.9 p -109.0 158.6 17.56 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.611 -0.681 . . . . 0.87 109.28 178.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 983' ' ' GLY . . . . . 0.411 ' HA3' ' CE1' ' B' ' 852' ' ' PHE . . . -175.11 109.14 0.28 Allowed Glycine 0 N--CA 1.499 2.86 0 N-CA-C 106.513 -2.635 . . . . 0.029999999999999999 106.513 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -108.7 152.19 25.16 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 114.526 1.306 . . . . 0.69999999999999996 114.526 -175.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 985' ' ' LEU . . . . . 0.835 HD13 HD22 ' B' ' 890' ' ' LEU . 45.4 tp -72.1 134.5 45.83 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.872 -1.143 . . . . 0.040000000000000001 110.055 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 986' ' ' LEU . . . . . 0.687 ' CD1' HD11 ' C' ' 986' ' ' LEU . 51.7 tp -107.52 -55.89 2.29 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.58 -0.7 . . . . 0.040000000000000001 109.917 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -144.82 145.08 31.47 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 107.623 -1.251 . . . . 0.040000000000000001 107.623 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.54 162.95 12.22 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 108.147 -1.981 . . . . 0.040000000000000001 108.147 179.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -75.66 112.16 18.12 Favored Pre-proline 0 N--CA 1.499 1.988 0 O-C-N 121.236 -1.155 . . . . 0.040000000000000001 109.406 179.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 990' ' ' PRO . . . . . 0.526 ' HD2' HD12 ' B' ' 992' ' ' LEU . 49.8 Cg_endo -91.38 71.31 0.97 Allowed 'Trans proline' 0 C--N 1.319 -0.982 0 O-C-N 123.108 1.057 . . . . 0.45000000000000001 111.411 -178.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 991' ' ' GLU . . . . . 0.421 ' HB2' ' O ' ' B' ' 990' ' ' PRO . 70.5 mt-10 67.21 -73.75 0.08 Allowed 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 108.493 -0.928 . . . . 1.97 108.493 -177.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 992' ' ' LEU . . . . . 0.526 HD12 ' HD2' ' B' ' 990' ' ' PRO . 6.7 mt 51.22 20.29 0.88 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.575 -0.703 . . . . 2.3799999999999999 111.634 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -94.33 156.77 16.35 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.862 -1.149 . . . . 3.79 109.96 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -146.64 93.22 2.26 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.547 -0.721 . . . . 3.5099999999999998 110.403 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 995' ' ' ALA . . . . . . . . . . . . 2.519 . . . . . . . 0 N--CA 1.503 2.209 0 O-C-N 120.897 -1.127 . . . . 2.73 110.624 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo . . . . . 0 N--CA 1.488 1.178 0 N-CA-C 109.5 -1.0 . . . . 3.8300000000000001 109.5 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 847' ' ' VAL . . . . . 0.473 HG12 ' HB2' ' C' ' 849' ' ' GLN . 57.3 t -127.6 103.75 21.9 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.609 -0.682 . . . . 1.8300000000000001 110.121 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 848' ' ' PRO . . . . . 0.786 ' O ' HG23 ' C' ' 850' ' ' VAL . 43.4 Cg_endo -69.36 -23.03 33.05 Favored 'Trans proline' 0 N--CA 1.488 1.151 0 O-C-N 123.218 1.115 . . . . 0.65000000000000002 110.911 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 849' ' ' GLN . . . . . 0.473 ' HB2' HG12 ' C' ' 847' ' ' VAL . 55.2 tt0 26.59 68.63 0.06 Allowed 'General case' 0 N--CA 1.519 2.982 0 N-CA-C 112.972 0.73 . . . . 2.5800000000000001 112.972 179.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 850' ' ' VAL . . . . . 0.786 HG23 ' O ' ' C' ' 848' ' ' PRO . 93.4 t -119.58 134.35 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.158 -0.964 . . . . 1.0900000000000001 111.245 -179.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 851' ' ' ALA . . . . . 0.417 ' HB3' ' HG ' ' C' ' 873' ' ' LEU . . . -131.56 155.74 46.96 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 106.105 -1.813 . . . . 0.040000000000000001 106.105 176.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 852' ' ' PHE . . . . . 0.51 ' CD1' ' CE1' ' C' ' 879' ' ' TYR . 0.3 OUTLIER -154.36 134.68 13.32 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 120.829 1.65 . . . . 0.050000000000000003 107.931 179.083 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 5.0 t -173.8 130.54 0.42 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.513 -0.921 . . . . 0.040000000000000001 108.513 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -136.39 150.95 49.04 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.256 -0.902 . . . . 0.67000000000000004 108.863 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 855' ' ' ALA . . . . . 0.658 ' HB3' ' CB ' ' C' ' 870' ' ' ARG . . . -122.77 139.33 54.11 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.813 0.816 . . . . 0.51000000000000001 111.527 -179.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 856' ' ' LEU . . . . . 0.778 HD23 ' O ' ' C' ' 867' ' ' PRO . 3.4 tm? -104.87 138.88 40.44 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.781 -0.575 . . . . 0.050000000000000003 109.558 179.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 857' ' ' SER . . . . . 0.623 ' N ' HD13 ' C' ' 856' ' ' LEU . 1.9 m -155.28 17.49 0.41 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.622 -0.674 . . . . 1.3300000000000001 111.465 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 858' ' ' LEU . . . . . 0.705 HD22 ' HG3' ' C' ' 862' ' ' GLU . 3.6 pp -34.55 158.06 0.04 OUTLIER Pre-proline 0 N--CA 1.52 3.047 0 CA-C-N 118.752 0.705 . . . . 2.3300000000000001 112.756 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -60.14 -89.88 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.431 0 O-C-N 123.089 1.047 . . . . 2.3199999999999998 113.828 -177.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 55.4 ptt85 -126.56 -141.92 0.28 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.853 -1.155 . . . . 0.040000000000000001 111.41 -177.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 73.7 m -36.31 120.33 0.65 Allowed 'General case' 0 N--CA 1.511 2.605 0 O-C-N 121.622 -0.674 . . . . 1.3100000000000001 112.26 -179.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 862' ' ' GLU . . . . . 0.705 ' HG3' HD22 ' C' ' 858' ' ' LEU . 0.0 OUTLIER -99.11 158.14 32.82 Favored Pre-proline 0 N--CA 1.488 1.458 0 N-CA-C 108.53 -0.915 . . . . 4.5099999999999998 108.53 178.069 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -70.92 -15.52 32.73 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 O-C-N 123.225 1.118 . . . . 2.2400000000000002 111.036 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -177.3 -134.77 2.07 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.537 -1.425 . . . . 0.040000000000000001 109.537 179.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 30.2 m -69.31 155.25 40.73 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.34 -1.094 . . . . 1.51 110.786 -179.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 866' ' ' VAL . . . . . 0.516 HG12 ' CD2' ' C' ' 858' ' ' LEU . 33.7 m -89.83 138.29 27.96 Favored Pre-proline 0 N--CA 1.496 1.837 0 N-CA-C 113.423 0.897 . . . . 0.78000000000000003 113.423 -175.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 867' ' ' PRO . . . . . 0.778 ' O ' HD23 ' C' ' 856' ' ' LEU . 54.9 Cg_endo -88.62 -153.11 0.04 OUTLIER 'Trans proline' 0 C--N 1.324 -0.716 0 N-CA-C 108.128 -1.528 . . . . 0.92000000000000004 108.128 177.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 868' ' ' PHE . . . . . 0.48 ' CD1' ' HG2' ' C' ' 881' ' ' PRO . 20.4 p90 -148.47 120.18 8.07 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.54 -1.35 . . . . 0.050000000000000003 110.12 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 50.2 p-10 -112.63 -2.13 14.63 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 119.353 -0.939 . . . . 1.7 111.762 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 870' ' ' ARG . . . . . 0.658 ' CB ' ' HB3' ' C' ' 855' ' ' ALA . 24.2 mmm180 -91.5 87.36 6.36 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.013 -1.054 . . . . 2.5899999999999999 111.057 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 61.9 t -74.77 97.2 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.0 -1.062 . . . . 1.9399999999999999 109.493 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 872' ' ' LEU . . . . . 0.582 HD13 HD11 ' A' ' 953' ' ' ILE . 52.2 mt -88.64 -44.37 10.66 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.497 -0.752 . . . . 1.0600000000000001 111.151 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 873' ' ' LEU . . . . . 0.449 ' O ' ' HB2' ' C' ' 874' ' ' ASN . 43.9 tp -171.44 102.62 0.2 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.134 -0.979 . . . . 4.1799999999999997 109.087 179.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 874' ' ' ASN . . . . . 0.449 ' HB2' ' O ' ' C' ' 873' ' ' LEU . 36.6 t-20 175.08 83.93 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.333 0 N-CA-C 108.694 -0.854 . . . . 0.040000000000000001 108.694 -178.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 30.1 p-10 -66.46 -48.19 70.71 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.059 -1.026 . . . . 3.3799999999999999 111.966 -178.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 876' ' ' GLY . . . . . 0.423 ' HA3' ' CE2' ' C' ' 878' ' ' TYR . . . -74.45 -24.91 71.72 Favored Glycine 0 N--CA 1.495 2.603 0 O-C-N 121.14 -0.975 . . . . 0.040000000000000001 111.569 -178.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 80.54 -64.86 3.98 Favored Glycine 0 N--CA 1.498 2.789 0 N-CA-C 107.624 -2.191 . . . . 0.040000000000000001 107.624 -178.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 878' ' ' TYR . . . . . 0.423 ' CE2' ' HA3' ' C' ' 876' ' ' GLY . 82.6 m-85 61.01 -56.18 0.09 Allowed 'General case' 0 N--CA 1.507 2.416 0 N-CA-C 114.556 1.317 . . . . 3.46 114.556 177.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 879' ' ' TYR . . . . . 0.51 ' CE1' ' CD1' ' C' ' 852' ' ' PHE . 1.7 p90 -111.53 108.91 18.59 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 114.791 1.404 . . . . 0.040000000000000001 114.791 -176.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -71.68 113.69 22.08 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.262 -0.898 . . . . 0.02 109.529 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 881' ' ' PRO . . . . . 0.48 ' HG2' ' CD1' ' C' ' 868' ' ' PHE . 54.3 Cg_endo -77.03 0.1 10.04 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 O-C-N 123.351 1.184 . . . . 0.39000000000000001 112.011 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 87.8 mt-10 -75.43 -64.55 1.04 Allowed 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 106.682 -1.599 . . . . 0.81000000000000005 106.682 178.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 24.5 p -90.55 -19.36 23.86 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.22 -1.03 . . . . 0.040000000000000001 108.22 176.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.1 19.58 60.71 Favored Glycine 0 N--CA 1.496 2.675 0 O-C-N 121.165 -0.959 . . . . 0.029999999999999999 111.22 178.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 885' ' ' VAL . . . . . 0.461 HG13 HG21 ' C' ' 961' ' ' THR . 89.3 t -73.93 89.79 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 C-N-CA 118.003 -1.479 . . . . 1.01 108.183 -179.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 886' ' ' PHE . . . . . 0.937 ' HB3' HG22 ' C' ' 962' ' ' VAL . 1.3 t80 -88.66 106.9 18.63 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 115.485 -0.78 . . . . 0.050000000000000003 111.385 -178.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 887' ' ' THR . . . . . 0.42 ' O ' ' HD3' ' C' ' 889' ' ' PRO . 93.7 m -96.07 101.43 13.09 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.921 -1.14 . . . . 0.68000000000000005 107.921 177.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 888' ' ' ALA . . . . . . . . . . . . . . . -99.05 106.88 40.97 Favored Pre-proline 0 N--CA 1.502 2.142 0 N-CA-C 113.964 1.098 . . . . 0.25 113.964 -176.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 889' ' ' PRO . . . . . 0.42 ' HD3' ' O ' ' C' ' 887' ' ' THR . 53.8 Cg_endo -90.33 -12.24 2.72 Favored 'Trans proline' 0 CA--C 1.547 1.17 0 C-N-CA 121.073 1.182 . . . . 1.6399999999999999 109.252 176.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 890' ' ' LEU . . . . . 0.841 HD22 HD13 ' C' ' 985' ' ' LEU . 72.3 mt -38.01 -50.61 1.34 Allowed 'General case' 0 N--CA 1.507 2.415 0 N-CA-C 113.778 1.029 . . . . 2.29 113.778 -177.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 52.19 97.52 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.379 0 O-C-N 121.152 -0.968 . . . . 0.63 110.386 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . 156.11 -146.52 14.18 Favored Glycine 0 N--CA 1.482 1.703 0 N-CA-C 107.445 -2.262 . . . . 0.040000000000000001 107.445 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 73.3 ttt-85 -106.46 128.79 54.34 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.311 -1.366 . . . . 3.0 107.311 177.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 894' ' ' TYR . . . . . 0.417 ' CD1' ' N ' ' C' ' 895' ' ' LEU . 0.4 OUTLIER -130.68 144.29 51.33 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.007 -1.058 . . . . 0.040000000000000001 110.661 -178.499 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 895' ' ' LEU . . . . . 0.417 ' N ' ' CD1' ' C' ' 894' ' ' TYR . 45.2 tp -101.07 117.83 35.8 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.64 -0.662 . . . . 1.27 109.723 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 896' ' ' LEU . . . . . 0.5 HD23 ' C ' ' C' ' 896' ' ' LEU . 10.4 tt -116.4 145.46 43.23 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.531 -0.731 . . . . 0.93999999999999995 110.783 -179.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 897' ' ' SER . . . . . 0.494 ' N ' HD23 ' C' ' 896' ' ' LEU . 69.1 m -145.18 119.23 9.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.448 -0.783 . . . . 0.040000000000000001 110.824 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.22 147.93 29.55 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.219 -0.66 . . . . 0.47999999999999998 109.219 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 899' ' ' VAL . . . . . 0.739 HG21 ' HB ' ' C' ' 980' ' ' ILE . 89.4 t -91.12 120.53 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.446 -0.784 . . . . 0.55000000000000004 110.925 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 900' ' ' LEU . . . . . 0.438 HD22 ' HB2' ' C' ' 924' ' ' SER . 93.1 mt -94.23 110.35 22.09 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 114.261 1.208 . . . . 1.5900000000000001 114.261 -175.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 18.9 m -64.92 139.71 58.79 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 107.414 -1.328 . . . . 0.050000000000000003 107.414 177.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -62.28 -65.77 2.99 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 110.417 -1.073 . . . . 0.029999999999999999 110.417 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 4.0 m170 46.08 64.61 1.42 Allowed 'General case' 0 N--CA 1.507 2.388 0 O-C-N 121.498 -1.001 . . . . 3.2000000000000002 111.262 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 42.8 ptt85 -68.39 -7.74 34.13 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.579 -0.701 . . . . 2.9199999999999999 111.857 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 905' ' ' HIS . . . . . 0.491 ' O ' ' CB ' ' C' ' 906' ' ' GLU . 72.3 t60 -61.29 6.86 0.05 OUTLIER 'General case' 0 N--CA 1.508 2.442 0 CA-C-O 117.659 -1.162 . . . . 2.8700000000000001 113.798 -179.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 906' ' ' GLU . . . . . 0.491 ' CB ' ' O ' ' C' ' 905' ' ' HIS . 0.5 OUTLIER 93.22 -165.15 0.0 OUTLIER 'General case' 0 N--CA 1.529 3.487 0 CA-C-N 121.21 1.823 . . . . 0.98999999999999999 111.955 179.117 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 907' ' ' LYS . . . . . 0.485 ' CB ' ' O ' ' C' ' 906' ' ' GLU . 38.2 tttp 88.13 159.62 0.07 Allowed 'General case' 0 N--CA 1.52 3.062 0 N-CA-C 108.149 -1.056 . . . . 5.25 108.149 -176.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 60.8 t -123.43 116.2 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 120.826 -1.171 . . . . 0.39000000000000001 111.003 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -104.34 132.18 50.87 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 107.711 -1.218 . . . . 1.72 107.711 177.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -155.82 122.44 5.24 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 106.838 -1.542 . . . . 0.67000000000000004 106.838 178.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 911' ' ' VAL . . . . . 0.86 HG22 HG13 ' C' ' 964' ' ' VAL . 96.8 t -82.05 131.6 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.831 -0.543 . . . . 0.54000000000000004 111.133 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 57.2 mt -68.2 156.15 38.16 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.348 -0.845 . . . . 1.5 109.12 178.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 913' ' ' SER . . . . . 0.488 ' OG ' HG11 ' C' ' 919' ' ' VAL . 1.2 p -125.19 136.92 54.06 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.428 -0.952 . . . . 1.3700000000000001 108.428 176.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 914' ' ' ARG . . . . . 0.745 ' NH1' HD13 ' C' ' 956' ' ' LEU . 0.1 OUTLIER -63.69 154.93 31.55 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 120.664 -1.272 . . . . 4.2999999999999998 111.482 -179.309 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 915' ' ' SER . . . . . 0.423 ' CB ' ' O ' ' C' ' 914' ' ' ARG . 4.6 t 83.73 -31.48 0.08 Allowed 'General case' 0 N--CA 1.522 3.13 0 C-N-CA 124.054 0.942 . . . . 2.0499999999999998 112.087 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 916' ' ' ASN . . . . . 0.788 ' HB2' HG21 ' C' ' 919' ' ' VAL . 93.8 m-20 -122.39 -21.66 5.73 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 120.883 -1.136 . . . . 2.71 111.286 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 67.18 165.65 0.22 Allowed 'General case' 0 N--CA 1.52 3.032 0 N-CA-C 105.664 -1.976 . . . . 2.6800000000000002 105.664 -174.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 55.13 -126.04 37.66 Favored Glycine 1 N--CA 1.52 4.287 0 CA-C-N 123.675 2.943 . . . . 0.029999999999999999 106.962 -177.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 919' ' ' VAL . . . . . 0.788 HG21 ' HB2' ' C' ' 916' ' ' ASN . 91.1 t 50.59 94.01 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 121.447 -1.031 . . . . 1.3899999999999999 109.386 -178.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 920' ' ' ALA . . . . . 0.985 ' HB3' HG12 ' C' ' 949' ' ' VAL . . . -93.31 93.53 8.25 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.29 -0.964 . . . . 0.029999999999999999 110.565 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 921' ' ' ARG . . . . . 0.667 ' HG3' HG23 ' C' ' 922' ' ' VAL . 34.7 ptt85 -80.13 -42.3 23.78 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 105.884 -1.895 . . . . 4.4199999999999999 105.884 176.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 922' ' ' VAL . . . . . 0.667 HG23 ' HG3' ' C' ' 921' ' ' ARG . 78.2 t -101.18 77.06 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 N-CA-C 105.602 -1.999 . . . . 0.84999999999999998 105.602 175.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -87.81 135.03 33.56 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.801 0.81 . . . . 2.46 112.016 -176.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 924' ' ' SER . . . . . 0.438 ' HB2' HD22 ' C' ' 900' ' ' LEU . 4.9 t -146.54 102.63 3.59 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.297 -1.001 . . . . 0.69999999999999996 108.297 178.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -109.49 88.35 0.51 Allowed Glycine 0 N--CA 1.486 2.026 0 N-CA-C 108.494 -1.842 . . . . 0.040000000000000001 108.494 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.353 0 N-CA-C 109.315 -1.514 . . . . 0.040000000000000001 109.315 -179.448 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 8.3 m . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 120.995 0.426 . . . . 13.779999999999999 110.378 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 95.2 mt -114.03 129.51 56.6 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.465 -0.772 . . . . 13.76 110.367 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -152.35 170.46 31.6 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.514 -1.434 . . . . 9.1300000000000008 109.514 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 949' ' ' VAL . . . . . 0.985 HG12 ' HB3' ' C' ' 920' ' ' ALA . 35.1 m -117.74 136.91 53.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.529 -0.983 . . . . 7.0800000000000001 110.904 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 950' ' ' PHE . . . . . 0.453 ' CZ ' ' HB3' ' C' ' 921' ' ' ARG . 44.8 p90 -135.3 152.88 51.91 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.571 -0.706 . . . . 7.5899999999999999 109.525 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 5.6 m -118.23 -54.77 2.28 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.465 -0.772 . . . . 5.0300000000000002 111.65 -179.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 952' ' ' LEU . . . . . 0.447 ' O ' ' O ' ' C' ' 953' ' ' ILE . 58.1 tp -65.71 -78.29 0.05 Allowed 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.439 -0.788 . . . . 1.01 111.375 -178.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 953' ' ' ILE . . . . . 0.646 HD12 ' N ' ' C' ' 954' ' ' LEU . 2.9 pp -50.28 -150.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.688 0 N-CA-C 114.312 1.227 . . . . 2.6000000000000001 114.312 -176.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 954' ' ' LEU . . . . . 0.718 HD22 ' O ' ' C' ' 954' ' ' LEU . 0.0 OUTLIER 169.19 90.98 0.03 OUTLIER Pre-proline 0 N--CA 1.519 2.992 0 O-C-N 120.879 -1.138 . . . . 0.050000000000000003 112.03 179.902 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 955' ' ' PRO . . . . . 0.452 ' HD3' ' CD1' ' C' ' 953' ' ' ILE . 52.7 Cg_endo -79.55 93.25 1.08 Allowed 'Trans proline' 0 C--N 1.317 -1.103 0 N-CA-C 108.819 -1.262 . . . . 0.83999999999999997 108.819 178.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 956' ' ' LEU . . . . . 0.745 HD13 ' NH1' ' C' ' 914' ' ' ARG . 79.7 mt -126.79 148.22 49.95 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.094 -1.004 . . . . 0.040000000000000001 110.524 -179.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 957' ' ' GLN . . . . . 0.436 ' HB2' ' HB2' ' C' ' 960' ' ' ASP . 90.7 mt-30 -84.04 153.26 23.92 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 117.904 -1.046 . . . . 1.28 111.515 -179.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -68.66 120.81 15.25 Favored 'General case' 0 N--CA 1.509 2.509 0 CA-C-N 122.757 2.526 . . . . 0.17000000000000001 111.879 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 93.16 -20.76 44.02 Favored Glycine 0 N--CA 1.502 3.074 0 N-CA-C 111.193 -0.763 . . . . 0.040000000000000001 111.193 178.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 960' ' ' ASP . . . . . 0.436 ' HB2' ' HB2' ' C' ' 957' ' ' GLN . 0.8 OUTLIER -51.28 172.42 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.482 -1.01 . . . . 0.040000000000000001 110.751 -179.115 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 961' ' ' THR . . . . . 0.461 HG21 HG13 ' C' ' 885' ' ' VAL . 50.0 m -133.09 137.45 46.35 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.002 -1.061 . . . . 1.78 111.887 -178.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 962' ' ' VAL . . . . . 0.937 HG22 ' HB3' ' C' ' 886' ' ' PHE . 24.9 m -99.47 144.1 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 C-N-CA 119.985 -0.686 . . . . 0.040000000000000001 110.11 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 5.4 t -140.54 143.8 35.57 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.864 -0.522 . . . . 0.71999999999999997 110.148 -178.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 964' ' ' VAL . . . . . 0.86 HG13 HG22 ' C' ' 911' ' ' VAL . 56.9 t -93.8 136.87 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.191 -0.943 . . . . 1.05 110.93 -178.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -95.72 127.01 41.38 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 103.716 -2.698 . . . . 3.02 103.716 173.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 966' ' ' LEU . . . . . 0.49 ' C ' HG23 ' C' ' 967' ' ' VAL . 11.2 tp -132.81 62.83 1.65 Allowed 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.367 -0.975 . . . . 1.46 108.367 177.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 967' ' ' VAL . . . . . 0.49 HG23 ' C ' ' C' ' 966' ' ' LEU . 99.5 t -157.53 97.02 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 108.239 -1.022 . . . . 1.9399999999999999 108.239 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 92.8 mmm -142.29 60.01 1.45 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.793 -1.192 . . . . 0.0 108.358 179.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.46 119.51 1.92 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 107.192 -2.363 . . . . 2.1099999999999999 107.192 -178.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 94.7 mm-40 -82.36 -57.54 3.32 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.051 -1.264 . . . . 5.8899999999999997 110.761 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 47.4 tp -58.75 89.84 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.443 -0.786 . . . . 4.3600000000000003 110.358 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -142.41 -152.58 0.42 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.557 -0.714 . . . . 1.8300000000000001 110.118 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -120.31 170.01 9.75 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.425 -0.797 . . . . 4.3499999999999996 110.261 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 29.3 t -101.46 130.36 47.69 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.52 -0.738 . . . . 1.27 110.051 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -155.63 158.87 39.05 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.53 -0.731 . . . . 5.0199999999999996 110.524 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.35 86.51 16.73 Favored Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 121.603 -0.686 . . . . 2.4100000000000001 109.862 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -74.72 -171.65 1.01 Allowed 'Trans proline' 0 C--N 1.317 -1.081 0 O-C-N 123.311 1.164 . . . . 0.95999999999999996 111.19 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 978' ' ' LEU . . . . . 0.539 ' N ' HD12 ' C' ' 978' ' ' LEU . 5.2 mp -126.25 155.58 41.66 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 107.577 -1.268 . . . . 0.62 107.577 177.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 979' ' ' THR . . . . . 0.458 HG23 ' C ' ' C' ' 978' ' ' LEU . 39.9 p -150.66 141.08 22.43 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.791 -1.193 . . . . 3.5699999999999998 111.216 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 980' ' ' ILE . . . . . 0.739 ' HB ' HG21 ' C' ' 899' ' ' VAL . 50.4 mm -107.12 129.07 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 108.991 -0.744 . . . . 1.3300000000000001 108.991 179.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 981' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -118.67 95.76 4.98 Favored 'General case' 0 N--CA 1.497 1.925 0 C-N-CA 119.452 -0.899 . . . . 0.050000000000000003 111.727 -178.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 982' ' ' SER . . . . . 0.407 ' HB2' HD23 ' A' ' 952' ' ' LEU . 12.1 p -109.55 158.68 17.77 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.606 -0.684 . . . . 0.87 109.712 178.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 983' ' ' GLY . . . . . 0.437 ' HA3' ' CZ ' ' C' ' 852' ' ' PHE . . . -172.99 114.71 0.53 Allowed Glycine 0 N--CA 1.498 2.798 0 N-CA-C 106.453 -2.659 . . . . 0.029999999999999999 106.453 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 984' ' ' ALA . . . . . . . . . . . . . . . -106.49 152.45 23.63 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 114.493 1.294 . . . . 0.69999999999999996 114.493 -175.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 985' ' ' LEU . . . . . 0.841 HD13 HD22 ' C' ' 890' ' ' LEU . 62.3 tp -75.58 135.65 40.53 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.932 -1.105 . . . . 0.040000000000000001 109.787 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 986' ' ' LEU . . . . . 0.687 HD11 ' CD1' ' B' ' 986' ' ' LEU . 36.1 tp -106.75 -61.17 1.57 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.576 -0.702 . . . . 0.040000000000000001 110.098 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -143.81 146.74 33.3 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 107.647 -1.242 . . . . 0.040000000000000001 107.647 179.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -111.65 162.74 12.34 Favored Glycine 0 N--CA 1.495 2.597 0 N-CA-C 108.179 -1.968 . . . . 0.040000000000000001 108.179 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.01 112.58 18.6 Favored Pre-proline 0 N--CA 1.499 1.982 0 O-C-N 121.243 -1.151 . . . . 0.040000000000000001 109.412 179.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 990' ' ' PRO . . . . . 0.418 ' O ' ' HB2' ' C' ' 991' ' ' GLU . 49.4 Cg_endo -90.22 70.84 1.55 Allowed 'Trans proline' 0 C--N 1.319 -1.018 0 O-C-N 123.152 1.08 . . . . 0.45000000000000001 111.365 -178.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 991' ' ' GLU . . . . . 0.418 ' HB2' ' O ' ' C' ' 990' ' ' PRO . 69.6 mt-10 67.65 -73.27 0.08 Allowed 'General case' 0 N--CA 1.503 2.177 0 N-CA-C 108.603 -0.888 . . . . 1.97 108.603 -177.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 992' ' ' LEU . . . . . . . . . . . . . 11.3 mt 50.56 20.62 0.74 Allowed 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.544 -0.722 . . . . 2.3799999999999999 111.705 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -93.9 156.76 16.46 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.893 -1.13 . . . . 3.79 109.998 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 69.7 m80 -145.75 92.8 2.26 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.567 -0.708 . . . . 3.5099999999999998 110.308 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 995' ' ' ALA . . . . . . . . . . . . 2.518 . . . . . . . 0 N--CA 1.503 2.206 0 O-C-N 120.936 -1.103 . . . . 2.73 110.631 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo . . . . . 0 N--CA 1.488 1.203 0 N-CA-C 109.53 -0.989 . . . . 3.8300000000000001 109.53 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 847' ' ' VAL . . . . . 0.442 HG12 ' HB2' ' A' ' 849' ' ' GLN . 60.2 t -132.17 103.36 14.06 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.555 -0.716 . . . . 1.8300000000000001 110.188 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 848' ' ' PRO . . . . . 0.74 ' O ' HG23 ' A' ' 850' ' ' VAL . 43.7 Cg_endo -69.84 -20.32 34.61 Favored 'Trans proline' 0 N--CA 1.487 1.145 0 O-C-N 123.28 1.147 . . . . 0.65000000000000002 110.955 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 849' ' ' GLN . . . . . 0.442 ' HB2' HG12 ' A' ' 847' ' ' VAL . 57.0 tt0 27.73 68.79 0.07 Allowed 'General case' 0 N--CA 1.518 2.97 0 N-CA-C 112.821 0.675 . . . . 2.5800000000000001 112.821 179.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 850' ' ' VAL . . . . . 0.74 HG23 ' O ' ' A' ' 848' ' ' PRO . 57.6 t -119.93 136.06 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.135 -0.978 . . . . 1.0900000000000001 111.65 -178.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 851' ' ' ALA . . . . . 0.584 ' HB3' ' HG ' ' A' ' 873' ' ' LEU . . . -126.14 157.33 38.37 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 105.749 -1.945 . . . . 0.040000000000000001 105.749 176.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 852' ' ' PHE . . . . . 0.432 ' HA ' ' CB ' ' A' ' 874' ' ' ASN . 22.7 p90 -160.84 127.32 4.04 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 121.009 1.731 . . . . 0.050000000000000003 108.437 179.066 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 5.8 t -176.1 134.7 0.26 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.35 -0.981 . . . . 0.040000000000000001 108.35 -178.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -132.21 155.66 47.85 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.035 -1.04 . . . . 0.67000000000000004 109.541 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 855' ' ' ALA . . . . . 0.809 ' HB3' ' CB ' ' A' ' 870' ' ' ARG . . . -121.67 143.91 49.07 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.855 0.836 . . . . 0.51000000000000001 111.258 -179.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 856' ' ' LEU . . . . . 0.594 ' C ' HD13 ' A' ' 856' ' ' LEU . 3.4 tm? -113.13 134.73 54.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.688 -0.633 . . . . 0.050000000000000003 110.283 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 857' ' ' SER . . . . . 0.55 ' N ' HD13 ' A' ' 856' ' ' LEU . 60.8 p -151.94 17.74 0.68 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.565 -0.71 . . . . 1.3300000000000001 110.59 178.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 858' ' ' LEU . . . . . 0.761 HD22 ' OE1' ' A' ' 862' ' ' GLU . 4.4 pp -33.27 157.11 0.04 OUTLIER Pre-proline 0 N--CA 1.518 2.942 0 N-CA-C 113.159 0.8 . . . . 2.3300000000000001 113.159 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -63.2 -88.3 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.376 0 O-C-N 123.107 1.056 . . . . 2.3199999999999998 113.162 -178.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 55.2 ptt85 -128.68 -143.36 0.27 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.888 -1.132 . . . . 0.040000000000000001 111.647 -177.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 14.0 m -40.18 126.78 2.2 Favored 'General case' 0 N--CA 1.508 2.457 0 O-C-N 121.527 -0.733 . . . . 1.3100000000000001 112.453 -178.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 862' ' ' GLU . . . . . 0.761 ' OE1' HD22 ' A' ' 858' ' ' LEU . 0.7 OUTLIER -101.95 157.6 33.37 Favored Pre-proline 0 N--CA 1.489 1.498 0 N-CA-C 107.683 -1.229 . . . . 4.5099999999999998 107.683 176.967 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 863' ' ' PRO . . . . . 0.425 ' HD2' ' CG ' ' A' ' 862' ' ' GLU . 44.2 Cg_endo -71.55 -12.25 29.09 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 O-C-N 123.029 1.015 . . . . 2.2400000000000002 111.472 -179.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -176.02 -136.59 2.38 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 110.143 -1.183 . . . . 0.040000000000000001 110.143 179.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 25.7 m -65.48 155.85 34.3 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.317 -1.108 . . . . 1.51 110.935 -178.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 866' ' ' VAL . . . . . 0.567 HG11 ' HG ' ' A' ' 856' ' ' LEU . 60.1 t -92.14 135.29 27.24 Favored Pre-proline 0 N--CA 1.495 1.788 0 N-CA-C 113.273 0.842 . . . . 0.78000000000000003 113.273 -174.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 867' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 866' ' ' VAL . 54.9 Cg_endo -90.61 -153.01 0.04 OUTLIER 'Trans proline' 0 CA--C 1.54 0.805 0 N-CA-C 108.658 -1.324 . . . . 0.92000000000000004 108.658 177.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 868' ' ' PHE . . . . . 0.456 ' CD1' ' HG2' ' A' ' 881' ' ' PRO . 27.0 p90 -150.66 122.65 8.2 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.567 -1.333 . . . . 0.050000000000000003 109.632 179.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 49.7 p-10 -114.1 -1.93 13.58 Favored 'General case' 0 N--CA 1.5 2.035 0 C-N-CA 119.299 -0.961 . . . . 1.7 112.549 -178.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 870' ' ' ARG . . . . . 0.809 ' CB ' ' HB3' ' A' ' 855' ' ' ALA . 29.1 mmm180 -90.85 88.15 6.94 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.869 -1.144 . . . . 2.5899999999999999 110.83 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 57.5 t -72.94 97.35 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 120.929 -1.107 . . . . 1.9399999999999999 109.858 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 872' ' ' LEU . . . . . 0.617 HD11 ' HB2' ' A' ' 855' ' ' ALA . 96.1 mt -83.15 -47.47 11.57 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.524 -0.735 . . . . 1.0600000000000001 110.109 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 873' ' ' LEU . . . . . 0.584 ' HG ' ' HB3' ' A' ' 851' ' ' ALA . 30.4 tp -174.65 103.96 0.1 Allowed 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.594 -0.891 . . . . 4.1799999999999997 108.594 178.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 874' ' ' ASN . . . . . 0.432 ' CB ' ' HA ' ' A' ' 852' ' ' PHE . 37.6 t-20 178.59 81.79 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.309 0 O-C-N 121.64 -0.663 . . . . 0.040000000000000001 109.648 -178.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -66.2 -47.05 75.16 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.062 -1.024 . . . . 3.3799999999999999 111.019 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 876' ' ' GLY . . . . . . . . . . . . . . . -74.57 -25.33 70.38 Favored Glycine 0 N--CA 1.494 2.552 0 O-C-N 121.282 -0.886 . . . . 0.040000000000000001 111.712 -178.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 86.42 -58.57 4.69 Favored Glycine 0 N--CA 1.502 3.041 0 N-CA-C 108.043 -2.023 . . . . 0.040000000000000001 108.043 -178.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 878' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 60.37 -67.78 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 114.283 1.216 . . . . 3.46 114.283 177.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 879' ' ' TYR . . . . . 0.471 ' CB ' ' CD2' ' A' ' 886' ' ' PHE . 24.3 p90 -113.08 111.44 22.15 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 114.841 1.422 . . . . 0.040000000000000001 114.841 -176.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -66.19 119.01 58.44 Favored Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 121.526 -0.734 . . . . 0.02 110.257 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 881' ' ' PRO . . . . . 0.456 ' HG2' ' CD1' ' A' ' 868' ' ' PHE . 54.5 Cg_endo -76.44 0.67 9.23 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 O-C-N 123.389 1.205 . . . . 0.39000000000000001 112.128 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -74.77 -65.27 0.89 Allowed 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 106.686 -1.598 . . . . 0.81000000000000005 106.686 178.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 7.0 p -97.22 -15.28 20.93 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 109.014 -0.735 . . . . 0.040000000000000001 109.014 177.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.1 24.2 49.17 Favored Glycine 0 N--CA 1.494 2.523 0 O-C-N 120.947 -1.096 . . . . 0.029999999999999999 110.696 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 885' ' ' VAL . . . . . . . . . . . . . 92.4 t -72.26 88.59 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 C-N-CA 118.453 -1.299 . . . . 1.01 107.823 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 886' ' ' PHE . . . . . 0.924 ' HB3' HG22 ' A' ' 962' ' ' VAL . 0.7 OUTLIER -90.73 105.92 18.15 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 115.175 -0.92 . . . . 0.050000000000000003 112.442 -176.942 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 887' ' ' THR . . . . . 0.418 ' O ' ' HD3' ' A' ' 889' ' ' PRO . 89.8 m -96.25 100.42 12.05 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 107.48 -1.304 . . . . 0.68000000000000005 107.48 177.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 888' ' ' ALA . . . . . . . . . . . . . . . -99.15 106.53 39.06 Favored Pre-proline 0 N--CA 1.501 2.112 0 N-CA-C 114.044 1.127 . . . . 0.25 114.044 -176.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 889' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 887' ' ' THR . 53.8 Cg_endo -90.07 -11.98 2.95 Favored 'Trans proline' 0 CA--C 1.546 1.089 0 C-N-CA 121.093 1.195 . . . . 1.6399999999999999 109.213 176.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 890' ' ' LEU . . . . . 0.537 HD11 ' CD1' ' A' ' 985' ' ' LEU . 4.6 tt -34.78 -52.0 0.51 Allowed 'General case' 0 N--CA 1.509 2.482 0 N-CA-C 113.834 1.05 . . . . 2.29 113.834 -177.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 51.38 95.41 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.313 0 O-C-N 121.181 -0.949 . . . . 0.63 110.438 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 156.15 -147.8 16.92 Favored Glycine 0 N--CA 1.479 1.539 0 N-CA-C 107.383 -2.287 . . . . 0.040000000000000001 107.383 -179.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 893' ' ' ARG . . . . . 0.479 ' NE ' ' HB1' ' C' ' 984' ' ' ALA . 72.9 ttt-85 -108.96 127.08 53.76 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 107.536 -1.283 . . . . 3.0 107.536 177.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 894' ' ' TYR . . . . . 0.462 ' OH ' HD12 ' A' ' 896' ' ' LEU . 0.1 OUTLIER -131.42 144.71 51.39 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.03 -1.044 . . . . 0.040000000000000001 110.154 -179.008 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 895' ' ' LEU . . . . . 0.447 ' N ' ' CD1' ' A' ' 894' ' ' TYR . 33.9 tp -99.25 116.64 31.9 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.623 -0.673 . . . . 1.27 109.933 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 896' ' ' LEU . . . . . 0.523 HD23 ' N ' ' A' ' 897' ' ' SER . 10.4 tt -112.91 145.87 39.97 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.645 -0.66 . . . . 0.93999999999999995 110.785 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 897' ' ' SER . . . . . 0.523 ' N ' HD23 ' A' ' 896' ' ' LEU . 63.1 m -143.04 119.02 10.64 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.466 -0.771 . . . . 0.040000000000000001 110.781 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -108.34 146.91 32.28 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.657 -0.652 . . . . 0.47999999999999998 109.387 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 899' ' ' VAL . . . . . 0.72 HG21 ' HB ' ' A' ' 980' ' ' ILE . 88.3 t -93.61 119.69 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 C-N-CA 119.788 -0.765 . . . . 0.55000000000000004 111.031 -179.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 900' ' ' LEU . . . . . 0.57 HD12 ' HB2' ' A' ' 924' ' ' SER . 4.4 mm? -94.24 113.13 24.99 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 114.307 1.225 . . . . 1.5900000000000001 114.307 -174.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 18.1 m -67.0 141.65 57.52 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 107.33 -1.359 . . . . 0.050000000000000003 107.33 176.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -66.28 -64.84 3.12 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 110.664 -0.974 . . . . 0.029999999999999999 110.664 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 5.9 m170 46.54 64.65 1.44 Allowed 'General case' 0 N--CA 1.508 2.466 0 O-C-N 121.363 -1.081 . . . . 3.2000000000000002 111.189 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 41.6 ptt85 -68.97 -6.65 29.0 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.563 -0.71 . . . . 2.9199999999999999 112.084 -179.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 905' ' ' HIS . . . . . 0.49 ' O ' ' CB ' ' A' ' 906' ' ' GLU . 70.6 t60 -63.31 5.76 0.15 Allowed 'General case' 0 N--CA 1.505 2.324 0 O-C-N 120.945 -1.097 . . . . 2.8700000000000001 113.214 -179.052 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 906' ' ' GLU . . . . . 0.49 ' CB ' ' O ' ' A' ' 905' ' ' HIS . 0.5 OUTLIER 94.88 -164.24 0.0 OUTLIER 'General case' 0 N--CA 1.529 3.514 0 CA-C-N 120.487 1.494 . . . . 0.98999999999999999 111.789 179.126 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 907' ' ' LYS . . . . . 0.471 ' CB ' ' O ' ' A' ' 906' ' ' GLU . 56.5 tttt 86.69 156.24 0.08 Allowed 'General case' 0 N--CA 1.52 3.031 0 N-CA-C 108.124 -1.065 . . . . 5.25 108.124 -176.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 60.8 t -123.12 115.88 46.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 120.821 -1.174 . . . . 0.39000000000000001 111.173 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -102.65 132.78 48.54 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 107.334 -1.358 . . . . 1.72 107.334 176.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -154.7 123.24 6.09 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 106.715 -1.587 . . . . 0.67000000000000004 106.715 178.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 911' ' ' VAL . . . . . 0.79 HG22 HG13 ' A' ' 964' ' ' VAL . 79.4 t -82.77 131.06 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 C-N-CA 120.378 -0.529 . . . . 0.54000000000000004 111.028 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 75.3 mt -66.7 156.45 35.28 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.381 -0.824 . . . . 1.5 109.032 178.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 913' ' ' SER . . . . . 0.491 ' OG ' HG11 ' A' ' 919' ' ' VAL . 1.1 p -125.34 135.41 52.43 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.23 -1.026 . . . . 1.3700000000000001 108.23 176.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 914' ' ' ARG . . . . . 0.88 ' NH1' HD23 ' A' ' 956' ' ' LEU . 0.0 OUTLIER -64.23 155.11 32.94 Favored 'General case' 0 N--CA 1.506 2.361 0 O-C-N 120.7 -1.25 . . . . 4.2999999999999998 111.63 -179.287 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 915' ' ' SER . . . . . 0.441 ' CB ' ' O ' ' A' ' 914' ' ' ARG . 2.0 t 84.1 -31.75 0.07 Allowed 'General case' 0 N--CA 1.52 3.071 0 C-N-CA 124.036 0.935 . . . . 2.0499999999999998 111.769 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 916' ' ' ASN . . . . . 0.77 ' HB2' HG21 ' A' ' 919' ' ' VAL . 68.8 m-80 -123.49 -21.3 5.33 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 120.946 -1.096 . . . . 2.71 111.299 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 917' ' ' GLN . . . . . 0.413 ' HB2' ' O ' ' A' ' 916' ' ' ASN . 50.2 mt-30 66.71 166.48 0.21 Allowed 'General case' 0 N--CA 1.52 3.047 0 N-CA-C 105.789 -1.93 . . . . 2.6800000000000002 105.789 -174.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.24 -125.32 33.43 Favored Glycine 1 N--CA 1.522 4.372 0 CA-C-N 123.646 2.93 . . . . 0.029999999999999999 107.041 -177.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 919' ' ' VAL . . . . . 0.77 HG21 ' HB2' ' A' ' 916' ' ' ASN . 78.1 t 51.57 94.14 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 O-C-N 121.357 -1.084 . . . . 1.3899999999999999 109.08 -178.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 920' ' ' ALA . . . . . 0.74 ' HB3' HG12 ' A' ' 949' ' ' VAL . . . -92.31 91.83 7.88 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 119.358 -0.937 . . . . 0.029999999999999999 110.882 -179.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 921' ' ' ARG . . . . . 0.841 ' HG3' HG23 ' A' ' 922' ' ' VAL . 30.7 ptt180 -83.56 -41.42 17.93 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 105.641 -1.985 . . . . 4.4199999999999999 105.641 176.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 922' ' ' VAL . . . . . 0.841 HG23 ' HG3' ' A' ' 921' ' ' ARG . 97.1 t -98.79 78.39 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 N-CA-C 106.041 -1.837 . . . . 0.84999999999999998 106.041 175.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -86.12 133.91 33.85 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.717 0.77 . . . . 2.46 111.381 -177.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 924' ' ' SER . . . . . 0.57 ' HB2' HD12 ' A' ' 900' ' ' LEU . 17.8 t -147.35 104.49 3.65 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.869 -0.789 . . . . 0.69999999999999996 108.869 179.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -103.75 83.35 0.41 Allowed Glycine 0 N--CA 1.487 2.071 0 N-CA-C 108.242 -1.943 . . . . 0.040000000000000001 108.242 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.239 0 N-CA-C 108.98 -1.648 . . . . 0.040000000000000001 108.98 -179.403 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 63.8 m . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.005 0.431 . . . . 13.779999999999999 110.264 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 94.4 mt -109.44 129.41 55.55 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.574 -0.704 . . . . 13.76 110.369 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -152.64 169.33 31.73 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.189 -1.565 . . . . 9.1300000000000008 109.189 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 949' ' ' VAL . . . . . 0.74 HG12 ' HB3' ' A' ' 920' ' ' ALA . 35.1 m -117.99 133.21 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.518 -0.989 . . . . 7.0800000000000001 110.801 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 950' ' ' PHE . . . . . 0.449 ' CZ ' ' HB3' ' A' ' 921' ' ' ARG . 30.7 p90 -130.69 147.06 52.32 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.59 -0.694 . . . . 7.5899999999999999 109.502 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 73.6 m -119.98 -54.68 2.11 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.487 -0.758 . . . . 5.0300000000000002 111.843 -178.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 952' ' ' LEU . . . . . 0.41 ' O ' ' O ' ' A' ' 953' ' ' ILE . 55.9 tp -60.75 -76.87 0.05 OUTLIER 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.417 -0.802 . . . . 1.01 112.178 -177.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 953' ' ' ILE . . . . . 0.488 HD11 HD13 ' C' ' 872' ' ' LEU . 47.6 pt -53.78 -141.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.656 0 N-CA-C 113.81 1.041 . . . . 2.6000000000000001 113.81 -176.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 954' ' ' LEU . . . . . 0.793 HD22 ' O ' ' A' ' 954' ' ' LEU . 0.0 OUTLIER 173.79 78.7 0.05 OUTLIER Pre-proline 0 N--CA 1.508 2.451 0 O-C-N 120.777 -1.202 . . . . 0.050000000000000003 111.037 179.427 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 955' ' ' PRO . . . . . 0.553 ' C ' HD12 ' A' ' 956' ' ' LEU . 45.8 Cg_endo -73.61 89.89 0.95 Allowed 'Trans proline' 0 C--N 1.314 -1.255 0 N-CA-C 109.45 -1.019 . . . . 0.83999999999999997 109.45 178.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 956' ' ' LEU . . . . . 0.88 HD23 ' NH1' ' A' ' 914' ' ' ARG . 5.7 mp -125.52 150.17 47.66 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.187 -0.946 . . . . 0.040000000000000001 110.487 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 59.6 mt-30 -81.74 151.9 27.27 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-O 117.784 -1.103 . . . . 1.28 111.793 -179.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -70.2 119.83 14.98 Favored 'General case' 0 N--CA 1.511 2.609 0 CA-C-N 123.048 2.658 . . . . 0.17000000000000001 111.671 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.6 -23.0 30.22 Favored Glycine 0 N--CA 1.501 3.031 0 N-CA-C 111.025 -0.83 . . . . 0.040000000000000001 111.025 178.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 960' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.85 171.45 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.567 -0.96 . . . . 0.040000000000000001 110.202 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 961' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' A' ' 886' ' ' PHE . 46.3 m -133.36 137.87 46.06 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.893 -1.129 . . . . 1.78 112.127 -178.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 962' ' ' VAL . . . . . 0.924 HG22 ' HB3' ' A' ' 886' ' ' PHE . 26.3 m -99.03 144.13 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.675 -0.641 . . . . 0.040000000000000001 110.229 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 1.6 m -137.68 144.32 41.76 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.857 -0.527 . . . . 0.71999999999999997 110.031 -178.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 964' ' ' VAL . . . . . 0.79 HG13 HG22 ' A' ' 911' ' ' VAL . 58.1 t -94.88 136.01 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.13 -0.981 . . . . 1.05 110.538 -179.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -93.98 127.51 39.8 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 103.784 -2.673 . . . . 3.02 103.784 173.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 966' ' ' LEU . . . . . 0.49 ' C ' HG23 ' A' ' 967' ' ' VAL . 1.2 tt -132.12 61.43 1.66 Allowed 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.232 -1.025 . . . . 1.46 108.232 177.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 967' ' ' VAL . . . . . 0.49 HG23 ' C ' ' A' ' 966' ' ' LEU . 94.2 t -158.28 96.41 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 108.056 -1.09 . . . . 1.9399999999999999 108.056 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 90.6 mmm -142.17 60.1 1.46 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.709 -1.244 . . . . 0.0 108.344 179.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.47 119.83 1.95 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 107.08 -2.408 . . . . 2.1099999999999999 107.08 -178.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -81.96 -58.04 3.15 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.065 -1.256 . . . . 5.8899999999999997 110.562 -179.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 40.6 tp -59.19 90.01 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.442 -0.786 . . . . 4.3600000000000003 110.283 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -141.32 -154.02 0.49 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.613 -0.679 . . . . 1.8300000000000001 110.117 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -120.08 172.34 7.82 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.486 -0.759 . . . . 4.3499999999999996 110.215 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 30.8 t -101.46 130.05 47.63 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.568 -0.707 . . . . 1.27 110.009 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -156.21 156.44 34.15 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.499 -0.75 . . . . 5.0199999999999996 110.529 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.15 85.46 18.8 Favored Pre-proline 0 N--CA 1.5 2.041 0 O-C-N 121.616 -0.677 . . . . 2.4100000000000001 109.613 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 977' ' ' PRO . . . . . 0.665 ' C ' HD12 ' A' ' 978' ' ' LEU . 47.2 Cg_endo -72.82 -172.58 0.99 Allowed 'Trans proline' 0 C--N 1.317 -1.091 0 O-C-N 123.29 1.153 . . . . 0.95999999999999996 111.216 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 978' ' ' LEU . . . . . 0.665 HD12 ' C ' ' A' ' 977' ' ' PRO . 6.7 mp -127.25 154.7 44.55 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 107.644 -1.243 . . . . 0.62 107.644 178.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 979' ' ' THR . . . . . 0.466 HG23 ' C ' ' A' ' 978' ' ' LEU . 41.1 p -150.54 141.16 22.61 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.781 -1.199 . . . . 3.5699999999999998 111.145 -179.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 980' ' ' ILE . . . . . 0.72 ' HB ' HG21 ' A' ' 899' ' ' VAL . 50.7 mm -106.22 127.43 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 108.881 -0.785 . . . . 1.3300000000000001 108.881 179.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 981' ' ' PHE . . . . . 0.401 ' HD1' ' HH ' ' A' ' 879' ' ' TYR . 6.7 t80 -120.71 99.26 6.43 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.414 -0.804 . . . . 0.050000000000000003 111.782 -178.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 85.9 p -108.16 159.89 16.25 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 109.06 -0.719 . . . . 0.87 109.06 178.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . -171.45 109.55 0.32 Allowed Glycine 0 N--CA 1.498 2.82 0 N-CA-C 106.635 -2.586 . . . . 0.029999999999999999 106.635 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -109.61 148.62 30.98 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 114.561 1.319 . . . . 0.69999999999999996 114.561 -175.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 985' ' ' LEU . . . . . 0.537 ' CD1' HD11 ' A' ' 890' ' ' LEU . 51.8 tp -68.77 134.4 49.7 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.854 -1.154 . . . . 0.040000000000000001 110.084 179.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 45.8 tp -107.82 -59.19 1.87 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.563 -0.71 . . . . 0.040000000000000001 109.925 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -144.32 144.91 31.68 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.601 -1.259 . . . . 0.040000000000000001 107.601 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -113.1 162.8 12.24 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 108.187 -1.965 . . . . 0.040000000000000001 108.187 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -75.16 112.97 20.8 Favored Pre-proline 0 N--CA 1.499 1.981 0 O-C-N 121.186 -1.185 . . . . 0.040000000000000001 109.454 179.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 990' ' ' PRO . . . . . 0.424 ' O ' ' HB2' ' A' ' 991' ' ' GLU . 50.9 Cg_endo -88.01 72.09 2.69 Favored 'Trans proline' 0 C--N 1.32 -0.968 0 O-C-N 123.055 1.029 . . . . 0.45000000000000001 111.363 -179.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 991' ' ' GLU . . . . . 0.424 ' HB2' ' O ' ' A' ' 990' ' ' PRO . 71.8 mt-10 67.51 -73.65 0.08 Allowed 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 108.529 -0.915 . . . . 1.97 108.529 -177.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 992' ' ' LEU . . . . . 0.404 ' HA ' HD23 ' A' ' 992' ' ' LEU . 11.1 mt 50.55 20.87 0.77 Allowed 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.612 -0.68 . . . . 2.3799999999999999 111.642 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -93.56 156.7 16.58 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.942 -1.099 . . . . 3.79 110.033 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -145.3 92.6 2.27 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.587 -0.696 . . . . 3.5099999999999998 110.276 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 995' ' ' ALA . . . . . . . . . . . . 2.519 . . . . . . . 0 N--CA 1.503 2.224 0 O-C-N 120.887 -1.133 . . . . 2.73 110.648 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo . . . . . 0 N--CA 1.488 1.172 0 N-CA-C 109.543 -0.983 . . . . 3.8300000000000001 109.543 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 847' ' ' VAL . . . . . 0.423 HG12 ' HB2' ' B' ' 849' ' ' GLN . 61.5 t -132.57 103.42 13.51 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.547 -0.721 . . . . 1.8300000000000001 110.098 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 848' ' ' PRO . . . . . 0.734 ' O ' HG23 ' B' ' 850' ' ' VAL . 43.7 Cg_endo -69.88 -20.28 34.44 Favored 'Trans proline' 0 N--CA 1.487 1.125 0 O-C-N 123.299 1.157 . . . . 0.65000000000000002 111.003 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 849' ' ' GLN . . . . . 0.423 ' HB2' HG12 ' B' ' 847' ' ' VAL . 56.9 tt0 27.77 68.22 0.07 Allowed 'General case' 0 N--CA 1.518 2.941 0 N-CA-C 112.923 0.712 . . . . 2.5800000000000001 112.923 179.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 850' ' ' VAL . . . . . 0.734 HG23 ' O ' ' B' ' 848' ' ' PRO . 57.4 t -119.37 136.14 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.128 -0.983 . . . . 1.0900000000000001 111.679 -178.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 851' ' ' ALA . . . . . 0.596 ' HB3' ' HG ' ' B' ' 873' ' ' LEU . . . -126.29 157.13 39.16 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 105.776 -1.935 . . . . 0.040000000000000001 105.776 176.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 852' ' ' PHE . . . . . 0.424 ' HA ' ' CB ' ' B' ' 874' ' ' ASN . 23.0 p90 -160.68 127.4 4.16 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 120.886 1.675 . . . . 0.050000000000000003 108.581 179.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 5.7 t -176.15 134.79 0.26 Allowed 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.305 -0.998 . . . . 0.040000000000000001 108.305 -178.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -132.15 156.1 46.99 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.066 -1.022 . . . . 0.67000000000000004 109.542 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 855' ' ' ALA . . . . . 0.808 ' HB3' ' CB ' ' B' ' 870' ' ' ARG . . . -121.92 143.97 49.14 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.864 0.84 . . . . 0.51000000000000001 111.315 -179.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 856' ' ' LEU . . . . . 0.603 ' C ' HD13 ' B' ' 856' ' ' LEU . 3.4 tm? -113.2 134.88 54.36 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.687 -0.633 . . . . 0.050000000000000003 110.253 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 857' ' ' SER . . . . . 0.54 ' N ' HD13 ' B' ' 856' ' ' LEU . 60.8 p -152.12 16.96 0.65 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.553 -0.717 . . . . 1.3300000000000001 110.616 178.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 858' ' ' LEU . . . . . 0.744 HD22 ' OE1' ' B' ' 862' ' ' GLU . 4.4 pp -32.65 156.92 0.03 OUTLIER Pre-proline 0 N--CA 1.518 2.945 0 N-CA-C 113.276 0.843 . . . . 2.3300000000000001 113.276 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -62.95 -88.39 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.344 0 O-C-N 123.132 1.07 . . . . 2.3199999999999998 113.228 -178.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 55.2 ptt85 -128.65 -143.36 0.27 Allowed 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.852 -1.155 . . . . 0.040000000000000001 111.685 -177.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 14.1 m -40.16 126.83 2.19 Favored 'General case' 0 N--CA 1.508 2.451 0 O-C-N 121.566 -0.709 . . . . 1.3100000000000001 112.408 -178.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 862' ' ' GLU . . . . . 0.744 ' OE1' HD22 ' B' ' 858' ' ' LEU . 0.7 OUTLIER -102.01 157.63 33.32 Favored Pre-proline 0 N--CA 1.489 1.51 0 N-CA-C 107.673 -1.232 . . . . 4.5099999999999998 107.673 176.954 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 863' ' ' PRO . . . . . 0.417 ' HD2' ' CG ' ' B' ' 862' ' ' GLU . 44.4 Cg_endo -71.63 -11.94 28.56 Favored 'Trans proline' 0 C--N 1.314 -1.268 0 O-C-N 123.006 1.003 . . . . 2.2400000000000002 111.472 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -176.08 -136.61 2.39 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 110.152 -1.179 . . . . 0.040000000000000001 110.152 179.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 26.1 m -65.75 155.95 34.56 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.357 -1.084 . . . . 1.51 110.934 -178.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 866' ' ' VAL . . . . . 0.564 HG11 ' HG ' ' B' ' 856' ' ' LEU . 59.8 t -92.11 135.22 27.36 Favored Pre-proline 0 N--CA 1.494 1.743 0 N-CA-C 113.265 0.839 . . . . 0.78000000000000003 113.265 -174.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 867' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' B' ' 866' ' ' VAL . 54.9 Cg_endo -90.49 -152.7 0.04 OUTLIER 'Trans proline' 0 CA--C 1.54 0.82 0 N-CA-C 108.612 -1.341 . . . . 0.92000000000000004 108.612 177.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 868' ' ' PHE . . . . . 0.449 ' CD1' ' N ' ' B' ' 868' ' ' PHE . 27.0 p90 -150.98 122.47 7.91 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.631 -1.293 . . . . 0.050000000000000003 109.592 179.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 50.3 p-10 -113.86 -1.94 13.75 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 119.343 -0.943 . . . . 1.7 112.519 -178.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 870' ' ' ARG . . . . . 0.808 ' CB ' ' HB3' ' B' ' 855' ' ' ALA . 28.9 mmm180 -90.72 88.45 7.09 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.908 -1.12 . . . . 2.5899999999999999 110.773 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 57.3 t -73.28 97.07 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.011 -1.056 . . . . 1.9399999999999999 109.864 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 872' ' ' LEU . . . . . 0.615 HD11 ' HB2' ' B' ' 855' ' ' ALA . 96.2 mt -83.05 -47.57 11.54 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.535 -0.728 . . . . 1.0600000000000001 110.14 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 873' ' ' LEU . . . . . 0.596 ' HG ' ' HB3' ' B' ' 851' ' ' ALA . 30.4 tp -174.63 103.83 0.1 Allowed 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.545 -0.909 . . . . 4.1799999999999997 108.545 178.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 874' ' ' ASN . . . . . 0.424 ' CB ' ' HA ' ' B' ' 852' ' ' PHE . 37.5 t-20 178.66 81.66 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.281 0 O-C-N 121.608 -0.682 . . . . 0.040000000000000001 109.698 -178.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -66.03 -47.11 75.49 Favored 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 119.297 -0.961 . . . . 3.3799999999999999 110.994 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 876' ' ' GLY . . . . . . . . . . . . . . . -74.64 -24.78 71.63 Favored Glycine 0 N--CA 1.493 2.486 0 C-N-CA 120.526 -0.845 . . . . 0.040000000000000001 111.842 -178.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 85.91 -58.77 4.78 Favored Glycine 0 N--CA 1.502 3.06 0 N-CA-C 108.105 -1.998 . . . . 0.040000000000000001 108.105 -178.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 878' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 60.45 -67.74 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 114.263 1.209 . . . . 3.46 114.263 177.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 879' ' ' TYR . . . . . 0.463 ' CB ' ' CD2' ' B' ' 886' ' ' PHE . 24.2 p90 -113.2 110.67 20.78 Favored 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 114.955 1.465 . . . . 0.040000000000000001 114.955 -176.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -65.62 118.94 56.09 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 121.494 -0.754 . . . . 0.02 110.196 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 881' ' ' PRO . . . . . 0.445 ' HG2' ' CD1' ' B' ' 868' ' ' PHE . 54.2 Cg_endo -76.34 0.38 9.5 Favored 'Trans proline' 0 N--CA 1.493 1.483 0 O-C-N 123.337 1.178 . . . . 0.39000000000000001 112.221 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -74.44 -65.23 0.88 Allowed 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 106.7 -1.593 . . . . 0.81000000000000005 106.7 178.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 7.0 p -96.99 -15.77 20.92 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 109.0 -0.741 . . . . 0.040000000000000001 109.0 177.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.42 24.09 48.44 Favored Glycine 0 N--CA 1.495 2.569 0 C-N-CA 120.034 -1.079 . . . . 0.029999999999999999 110.596 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 885' ' ' VAL . . . . . . . . . . . . . 92.9 t -72.12 88.64 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 C-N-CA 118.514 -1.274 . . . . 1.01 107.865 -179.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 886' ' ' PHE . . . . . 0.892 ' HB3' HG22 ' B' ' 962' ' ' VAL . 0.7 OUTLIER -90.82 105.52 17.88 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 115.249 -0.887 . . . . 0.050000000000000003 112.577 -176.848 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 887' ' ' THR . . . . . 0.418 ' O ' ' HD3' ' B' ' 889' ' ' PRO . 89.6 m -95.93 100.27 11.97 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 107.555 -1.276 . . . . 0.68000000000000005 107.555 177.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 888' ' ' ALA . . . . . . . . . . . . . . . -99.02 106.55 38.76 Favored Pre-proline 0 N--CA 1.501 2.114 0 N-CA-C 114.125 1.157 . . . . 0.25 114.125 -176.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 889' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' B' ' 887' ' ' THR . 53.4 Cg_endo -90.15 -11.77 2.97 Favored 'Trans proline' 0 CA--C 1.547 1.143 0 C-N-CA 121.143 1.228 . . . . 1.6399999999999999 109.128 176.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 890' ' ' LEU . . . . . 0.537 HD11 ' CD1' ' B' ' 985' ' ' LEU . 4.6 tt -34.96 -51.81 0.53 Allowed 'General case' 0 N--CA 1.509 2.487 0 N-CA-C 113.867 1.062 . . . . 2.29 113.867 -177.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 51.29 95.52 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.373 0 O-C-N 121.131 -0.981 . . . . 0.63 110.425 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . 156.09 -147.68 16.65 Favored Glycine 0 N--CA 1.48 1.581 0 N-CA-C 107.383 -2.287 . . . . 0.040000000000000001 107.383 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 72.9 ttt-85 -109.04 127.06 53.79 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 107.49 -1.3 . . . . 3.0 107.49 177.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 894' ' ' TYR . . . . . 0.468 ' OH ' HD12 ' B' ' 896' ' ' LEU . 0.1 OUTLIER -131.45 144.81 51.44 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.053 -1.029 . . . . 0.040000000000000001 110.17 -179.112 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 895' ' ' LEU . . . . . 0.448 ' N ' ' CD1' ' B' ' 894' ' ' TYR . 34.1 tp -99.3 116.68 32.04 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.623 -0.673 . . . . 1.27 109.846 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 896' ' ' LEU . . . . . 0.536 HD23 ' N ' ' B' ' 897' ' ' SER . 10.4 tt -112.75 146.57 38.53 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.587 -0.696 . . . . 0.93999999999999995 110.704 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 897' ' ' SER . . . . . 0.536 ' N ' HD23 ' B' ' 896' ' ' LEU . 63.3 m -143.78 118.89 10.08 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.42 -0.8 . . . . 0.040000000000000001 110.741 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -108.2 147.21 31.67 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.689 -0.632 . . . . 0.47999999999999998 109.352 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 899' ' ' VAL . . . . . 0.71 HG21 ' HB ' ' B' ' 980' ' ' ILE . 88.3 t -93.86 120.15 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.417 -0.802 . . . . 0.55000000000000004 110.9 -179.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 900' ' ' LEU . . . . . 0.571 HD12 ' HB2' ' B' ' 924' ' ' SER . 4.4 mm? -94.7 112.94 24.67 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 114.257 1.206 . . . . 1.5900000000000001 114.257 -174.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 17.9 m -66.81 141.63 57.63 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 107.348 -1.352 . . . . 0.050000000000000003 107.348 176.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -66.18 -65.18 2.96 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 110.598 -1.001 . . . . 0.029999999999999999 110.598 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 5.9 m170 46.9 64.93 1.36 Allowed 'General case' 0 N--CA 1.507 2.393 0 O-C-N 121.381 -1.07 . . . . 3.2000000000000002 111.122 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 41.6 ptt85 -69.24 -6.71 30.92 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.574 -0.704 . . . . 2.9199999999999999 111.989 -179.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 905' ' ' HIS . . . . . 0.486 ' O ' ' CB ' ' B' ' 906' ' ' GLU . 70.5 t60 -63.48 6.14 0.15 Allowed 'General case' 0 N--CA 1.507 2.387 0 O-C-N 120.867 -1.146 . . . . 2.8700000000000001 113.163 -178.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 906' ' ' GLU . . . . . 0.486 ' CB ' ' O ' ' B' ' 905' ' ' HIS . 0.5 OUTLIER 94.58 -164.31 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.47 0 CA-C-N 120.592 1.542 . . . . 0.98999999999999999 111.848 179.008 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 907' ' ' LYS . . . . . 0.476 ' CB ' ' O ' ' B' ' 906' ' ' GLU . 56.6 tttt 86.62 156.04 0.08 Allowed 'General case' 0 N--CA 1.52 3.067 0 N-CA-C 108.042 -1.096 . . . . 5.25 108.042 -176.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 60.3 t -122.97 115.68 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 120.804 -1.185 . . . . 0.39000000000000001 111.116 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 51.0 tp10 -102.01 133.32 47.0 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 107.328 -1.36 . . . . 1.72 107.328 176.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -155.15 123.04 5.76 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 106.783 -1.562 . . . . 0.67000000000000004 106.783 178.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 911' ' ' VAL . . . . . 0.775 HG22 HG13 ' B' ' 964' ' ' VAL . 77.9 t -82.53 131.17 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.858 -0.526 . . . . 0.54000000000000004 111.022 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 75.5 mt -66.82 156.53 35.34 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.407 -0.808 . . . . 1.5 108.951 178.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 913' ' ' SER . . . . . 0.499 ' OG ' HG11 ' B' ' 919' ' ' VAL . 1.1 p -125.32 135.85 52.89 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.181 -1.044 . . . . 1.3700000000000001 108.181 176.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 914' ' ' ARG . . . . . 0.875 ' NH1' HD23 ' B' ' 956' ' ' LEU . 0.0 OUTLIER -64.61 155.62 32.67 Favored 'General case' 0 N--CA 1.506 2.35 0 O-C-N 120.619 -1.301 . . . . 4.2999999999999998 111.528 -179.295 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 915' ' ' SER . . . . . 0.429 ' CB ' ' O ' ' B' ' 914' ' ' ARG . 2.0 t 83.64 -31.58 0.08 Allowed 'General case' 0 N--CA 1.52 3.07 0 C-N-CA 123.968 0.907 . . . . 2.0499999999999998 111.887 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 916' ' ' ASN . . . . . 0.774 ' HB2' HG21 ' B' ' 919' ' ' VAL . 68.8 m-80 -123.82 -21.1 5.24 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 120.927 -1.108 . . . . 2.71 111.268 -179.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 917' ' ' GLN . . . . . 0.416 ' HB2' ' O ' ' B' ' 916' ' ' ASN . 50.3 mt-30 66.71 166.41 0.21 Allowed 'General case' 0 N--CA 1.521 3.094 0 N-CA-C 105.74 -1.948 . . . . 2.6800000000000002 105.74 -174.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.07 -125.08 32.37 Favored Glycine 1 N--CA 1.522 4.386 0 CA-C-N 123.397 2.817 . . . . 0.029999999999999999 107.071 -177.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 919' ' ' VAL . . . . . 0.774 HG21 ' HB2' ' B' ' 916' ' ' ASN . 76.4 t 51.69 94.23 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.262 0 O-C-N 121.407 -1.055 . . . . 1.3899999999999999 109.036 -178.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 920' ' ' ALA . . . . . 0.73 ' HB3' HG12 ' B' ' 949' ' ' VAL . . . -92.31 92.06 7.98 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.335 -0.946 . . . . 0.029999999999999999 110.831 -179.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 921' ' ' ARG . . . . . 0.863 ' HG3' HG23 ' B' ' 922' ' ' VAL . 30.6 ptt180 -83.68 -41.62 17.53 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 105.65 -1.981 . . . . 4.4199999999999999 105.65 175.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 922' ' ' VAL . . . . . 0.863 HG23 ' HG3' ' B' ' 921' ' ' ARG . 96.9 t -98.66 78.81 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 N-CA-C 105.939 -1.874 . . . . 0.84999999999999998 105.939 175.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -86.47 134.05 33.71 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.654 0.74 . . . . 2.46 111.368 -177.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 924' ' ' SER . . . . . 0.571 ' HB2' HD12 ' B' ' 900' ' ' LEU . 17.4 t -147.49 104.84 3.66 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.713 -0.847 . . . . 0.69999999999999996 108.713 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -104.13 83.36 0.4 Allowed Glycine 0 N--CA 1.487 2.041 0 N-CA-C 108.222 -1.951 . . . . 0.040000000000000001 108.222 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 108.973 -1.651 . . . . 0.040000000000000001 108.973 -179.376 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 68.1 m . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.014 0.435 . . . . 13.779999999999999 110.246 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 94.8 mt -108.88 129.44 55.41 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.583 -0.698 . . . . 13.76 110.323 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -152.19 168.83 31.43 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.235 -1.546 . . . . 9.1300000000000008 109.235 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 949' ' ' VAL . . . . . 0.73 HG12 ' HB3' ' B' ' 920' ' ' ALA . 35.0 m -117.85 132.74 66.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.525 -0.985 . . . . 7.0800000000000001 110.717 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 950' ' ' PHE . . . . . 0.445 ' CZ ' ' HB3' ' B' ' 921' ' ' ARG . 30.7 p90 -130.49 146.57 52.05 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.518 -0.739 . . . . 7.5899999999999999 109.55 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 73.4 m -119.38 -54.11 2.2 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.452 -0.78 . . . . 5.0300000000000002 111.808 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 952' ' ' LEU . . . . . 0.409 ' O ' ' O ' ' B' ' 953' ' ' ILE . 56.5 tp -61.42 -77.02 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.465 -0.772 . . . . 1.01 112.285 -177.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 953' ' ' ILE . . . . . 0.491 ' O ' ' HB3' ' B' ' 954' ' ' LEU . 48.9 pt -53.83 -141.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.739 0 N-CA-C 113.701 1.0 . . . . 2.6000000000000001 113.701 -176.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 954' ' ' LEU . . . . . 0.789 HD22 ' O ' ' B' ' 954' ' ' LEU . 0.0 OUTLIER 174.07 78.68 0.05 OUTLIER Pre-proline 0 N--CA 1.509 2.495 0 O-C-N 120.654 -1.279 . . . . 0.050000000000000003 110.963 179.47 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 955' ' ' PRO . . . . . 0.545 ' C ' HD12 ' B' ' 956' ' ' LEU . 46.0 Cg_endo -73.51 89.52 0.95 Allowed 'Trans proline' 0 C--N 1.315 -1.236 0 N-CA-C 109.514 -0.995 . . . . 0.83999999999999997 109.514 178.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 956' ' ' LEU . . . . . 0.875 HD23 ' NH1' ' B' ' 914' ' ' ARG . 5.7 mp -125.22 150.22 47.22 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.289 -0.882 . . . . 0.040000000000000001 110.461 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -82.14 151.38 26.99 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 117.729 -1.129 . . . . 1.28 111.828 -179.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -69.77 119.74 14.46 Favored 'General case' 0 N--CA 1.512 2.626 0 CA-C-N 123.14 2.7 . . . . 0.17000000000000001 111.784 -179.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.76 -22.66 32.48 Favored Glycine 0 N--CA 1.502 3.076 0 N-CA-C 111.037 -0.825 . . . . 0.040000000000000001 111.037 178.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 960' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -52.19 171.55 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.54 -0.976 . . . . 0.040000000000000001 110.198 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 961' ' ' THR . . . . . 0.461 ' HA ' ' O ' ' B' ' 886' ' ' PHE . 47.1 m -133.42 137.83 45.96 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.846 -1.159 . . . . 1.78 112.103 -178.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 962' ' ' VAL . . . . . 0.892 HG22 ' HB3' ' B' ' 886' ' ' PHE . 26.3 m -98.84 144.44 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 C-N-CA 120.169 -0.612 . . . . 0.040000000000000001 110.219 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 1.6 m -137.87 144.72 41.52 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.857 -0.527 . . . . 0.71999999999999997 110.009 -178.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 964' ' ' VAL . . . . . 0.775 HG13 HG22 ' B' ' 911' ' ' VAL . 58.1 t -95.2 136.34 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.107 -0.995 . . . . 1.05 110.434 -179.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -94.29 127.59 40.25 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 103.758 -2.682 . . . . 3.02 103.758 173.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 966' ' ' LEU . . . . . 0.494 ' C ' HG23 ' B' ' 967' ' ' VAL . 1.2 tt -132.24 61.67 1.66 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.123 -1.065 . . . . 1.46 108.123 177.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 967' ' ' VAL . . . . . 0.494 HG23 ' C ' ' B' ' 966' ' ' LEU . 94.4 t -158.42 97.02 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 107.917 -1.142 . . . . 1.9399999999999999 107.917 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 90.4 mmm -142.79 59.92 1.43 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.715 -1.24 . . . . 0.0 108.251 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.64 119.98 1.96 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 107.043 -2.423 . . . . 2.1099999999999999 107.043 -178.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -82.12 -58.2 3.06 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.974 -1.31 . . . . 5.8899999999999997 110.492 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 40.0 tp -58.9 90.47 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.407 -0.808 . . . . 4.3600000000000003 110.336 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -141.88 -154.32 0.51 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.565 -0.71 . . . . 1.8300000000000001 110.139 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -120.04 171.84 8.17 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.409 -0.807 . . . . 4.3499999999999996 110.273 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 31.5 t -100.97 130.03 46.9 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.555 -0.716 . . . . 1.27 110.068 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -156.25 156.44 34.09 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.511 -0.743 . . . . 5.0199999999999996 110.553 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.14 85.49 18.82 Favored Pre-proline 0 N--CA 1.5 2.038 0 O-C-N 121.655 -0.653 . . . . 2.4100000000000001 109.671 179.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 977' ' ' PRO . . . . . 0.673 ' C ' HD12 ' B' ' 978' ' ' LEU . 47.5 Cg_endo -72.66 -172.42 0.94 Allowed 'Trans proline' 0 C--N 1.317 -1.098 0 O-C-N 123.299 1.158 . . . . 0.95999999999999996 111.258 -179.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 978' ' ' LEU . . . . . 0.673 HD12 ' C ' ' B' ' 977' ' ' PRO . 6.6 mp -127.58 154.48 45.14 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 107.639 -1.245 . . . . 0.62 107.639 178.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 979' ' ' THR . . . . . 0.47 HG23 ' C ' ' B' ' 978' ' ' LEU . 41.3 p -150.28 141.38 23.05 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.79 -1.194 . . . . 3.5699999999999998 111.12 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 980' ' ' ILE . . . . . 0.71 ' HB ' HG21 ' B' ' 899' ' ' VAL . 50.7 mm -106.4 127.42 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 108.852 -0.796 . . . . 1.3300000000000001 108.852 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -120.63 99.25 6.43 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 119.723 -0.791 . . . . 0.050000000000000003 111.791 -178.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 81.9 p -108.42 159.67 16.49 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.543 -0.723 . . . . 0.87 109.104 178.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 983' ' ' GLY . . . . . . . . . . . . . . . -171.14 110.03 0.34 Allowed Glycine 0 N--CA 1.497 2.759 0 N-CA-C 106.496 -2.641 . . . . 0.029999999999999999 106.496 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -110.03 148.01 32.47 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 114.637 1.347 . . . . 0.69999999999999996 114.637 -175.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 985' ' ' LEU . . . . . 0.537 ' CD1' HD11 ' B' ' 890' ' ' LEU . 51.4 tp -68.17 134.27 50.22 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 120.895 -1.128 . . . . 0.040000000000000001 110.123 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 986' ' ' LEU . . . . . . . . . . . . . 45.8 tp -107.8 -59.11 1.88 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.598 -0.689 . . . . 0.040000000000000001 109.957 179.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -144.48 144.92 31.59 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 107.543 -1.28 . . . . 0.040000000000000001 107.543 179.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.98 163.21 12.16 Favored Glycine 0 N--CA 1.495 2.603 0 N-CA-C 108.271 -1.932 . . . . 0.040000000000000001 108.271 179.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -75.65 113.01 22.44 Favored Pre-proline 0 N--CA 1.498 1.965 0 O-C-N 121.273 -1.133 . . . . 0.040000000000000001 109.443 179.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 990' ' ' PRO . . . . . 0.415 ' O ' ' HB2' ' B' ' 991' ' ' GLU . 50.2 Cg_endo -88.07 72.06 2.65 Favored 'Trans proline' 0 C--N 1.319 -0.996 0 O-C-N 123.141 1.074 . . . . 0.45000000000000001 111.443 -178.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 991' ' ' GLU . . . . . 0.415 ' HB2' ' O ' ' B' ' 990' ' ' PRO . 71.8 mt-10 67.5 -73.68 0.08 Allowed 'General case' 0 N--CA 1.503 2.182 0 N-CA-C 108.502 -0.925 . . . . 1.97 108.502 -177.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 992' ' ' LEU . . . . . 0.443 HD23 ' HA ' ' B' ' 992' ' ' LEU . 11.1 mt 50.5 20.83 0.75 Allowed 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.605 -0.685 . . . . 2.3799999999999999 111.677 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -93.63 156.74 16.54 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.9 -1.125 . . . . 3.79 110.042 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -145.19 92.83 2.3 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.481 -0.762 . . . . 3.5099999999999998 110.211 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 995' ' ' ALA . . . . . . . . . . . . 2.518 . . . . . . . 0 N--CA 1.504 2.232 0 O-C-N 120.949 -1.095 . . . . 2.73 110.603 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo . . . . . 0 N--CA 1.489 1.239 0 N-CA-C 109.52 -0.992 . . . . 3.8300000000000001 109.52 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 847' ' ' VAL . . . . . 0.436 HG12 ' HB2' ' C' ' 849' ' ' GLN . 57.9 t -129.88 104.86 16.91 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.586 -0.696 . . . . 1.8300000000000001 110.088 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 848' ' ' PRO . . . . . 0.74 ' O ' HG23 ' C' ' 850' ' ' VAL . 44.3 Cg_endo -69.84 -22.05 32.23 Favored 'Trans proline' 0 N--CA 1.488 1.152 0 O-C-N 123.255 1.134 . . . . 0.65000000000000002 111.123 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 849' ' ' GLN . . . . . 0.436 ' HB2' HG12 ' C' ' 847' ' ' VAL . 55.6 tt0 27.53 68.61 0.07 Allowed 'General case' 0 N--CA 1.518 2.952 0 N-CA-C 112.93 0.715 . . . . 2.5800000000000001 112.93 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 850' ' ' VAL . . . . . 0.74 HG23 ' O ' ' C' ' 848' ' ' PRO . 57.4 t -119.52 135.68 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.157 -0.964 . . . . 1.0900000000000001 111.349 -178.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 851' ' ' ALA . . . . . . . . . . . . . . . -130.2 154.97 47.01 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 106.029 -1.841 . . . . 0.040000000000000001 106.029 176.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 852' ' ' PHE . . . . . 0.444 ' HA ' ' CB ' ' C' ' 874' ' ' ASN . 9.1 p90 -158.66 130.34 6.56 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 120.869 1.668 . . . . 0.050000000000000003 108.756 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 42.2 t -175.49 133.37 0.29 Allowed 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.014 -1.106 . . . . 0.040000000000000001 108.014 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -134.42 158.21 44.45 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.158 -0.964 . . . . 0.67000000000000004 109.388 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 855' ' ' ALA . . . . . 0.697 ' HB3' ' CB ' ' C' ' 870' ' ' ARG . . . -121.07 141.52 50.69 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.9 0.857 . . . . 0.51000000000000001 111.713 -178.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 856' ' ' LEU . . . . . 0.808 HD23 ' O ' ' C' ' 867' ' ' PRO . 3.4 tm? -106.83 133.84 50.88 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 109.26 -0.645 . . . . 0.050000000000000003 109.26 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 857' ' ' SER . . . . . 0.6 ' N ' HD13 ' C' ' 856' ' ' LEU . 80.0 p -152.61 15.85 0.59 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.549 -0.719 . . . . 1.3300000000000001 110.959 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 858' ' ' LEU . . . . . 0.786 ' CD2' HD11 ' C' ' 856' ' ' LEU . 2.9 pp -34.94 157.49 0.04 OUTLIER Pre-proline 0 N--CA 1.516 2.873 0 N-CA-C 112.692 0.627 . . . . 2.3300000000000001 112.692 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -62.13 -89.43 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 121.048 1.165 . . . . 2.3199999999999998 114.127 -177.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 54.8 ptt85 -130.67 -142.62 0.23 Allowed 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.803 -1.185 . . . . 0.040000000000000001 111.867 -177.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 71.7 m -35.17 118.8 0.46 Allowed 'General case' 0 N--CA 1.511 2.601 0 O-C-N 121.749 -0.595 . . . . 1.3100000000000001 112.515 -178.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -102.67 159.78 28.28 Favored Pre-proline 0 N--CA 1.488 1.448 0 N-CA-C 108.033 -1.099 . . . . 4.5099999999999998 108.033 177.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.86 -14.52 32.67 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 O-C-N 123.176 1.093 . . . . 2.2400000000000002 111.12 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -176.99 -133.94 1.9 Allowed Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.969 -1.252 . . . . 0.040000000000000001 109.969 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 37.5 m -70.0 158.5 35.53 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.38 -1.071 . . . . 1.51 110.924 -178.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 866' ' ' VAL . . . . . 0.468 ' HA ' ' HD3' ' C' ' 867' ' ' PRO . 30.9 m -94.68 138.43 22.24 Favored Pre-proline 0 N--CA 1.497 1.888 0 N-CA-C 113.641 0.978 . . . . 0.78000000000000003 113.641 -175.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 867' ' ' PRO . . . . . 0.808 ' O ' HD23 ' C' ' 856' ' ' LEU . 53.8 Cg_endo -89.12 -151.11 0.04 OUTLIER 'Trans proline' 0 CA--C 1.54 0.802 0 N-CA-C 108.262 -1.476 . . . . 0.92000000000000004 108.262 177.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 868' ' ' PHE . . . . . 0.456 ' CD1' ' N ' ' C' ' 868' ' ' PHE . 15.0 p90 -147.97 121.58 9.19 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.512 -1.367 . . . . 0.050000000000000003 109.99 179.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -112.01 -3.5 14.77 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 119.433 -0.907 . . . . 1.7 112.101 -178.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 870' ' ' ARG . . . . . 0.697 ' CB ' ' HB3' ' C' ' 855' ' ' ALA . 23.8 mmm180 -90.93 87.67 6.72 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.968 -1.083 . . . . 2.5899999999999999 110.774 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 58.3 t -74.43 97.08 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 120.983 -1.073 . . . . 1.9399999999999999 109.43 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 872' ' ' LEU . . . . . 0.488 HD13 HD11 ' A' ' 953' ' ' ILE . 80.6 mt -86.38 -45.27 11.34 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.523 -0.736 . . . . 1.0600000000000001 110.557 -179.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 873' ' ' LEU . . . . . 0.411 ' O ' ' HB2' ' C' ' 874' ' ' ASN . 50.2 tp -173.61 103.22 0.12 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.192 -0.942 . . . . 4.1799999999999997 108.769 178.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 874' ' ' ASN . . . . . 0.444 ' CB ' ' HA ' ' C' ' 852' ' ' PHE . 35.3 t-20 177.84 82.75 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.282 0 N-CA-C 109.201 -0.666 . . . . 0.040000000000000001 109.201 -178.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -66.37 -46.58 76.2 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 119.354 -0.938 . . . . 3.3799999999999999 111.351 -179.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 876' ' ' GLY . . . . . 0.413 ' HA3' ' CE2' ' C' ' 878' ' ' TYR . . . -74.29 -25.81 69.81 Favored Glycine 0 N--CA 1.493 2.499 0 O-C-N 121.282 -0.886 . . . . 0.040000000000000001 111.887 -178.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 81.03 -61.57 4.55 Favored Glycine 0 N--CA 1.502 3.073 0 N-CA-C 107.92 -2.072 . . . . 0.040000000000000001 107.92 -178.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 878' ' ' TYR . . . . . 0.413 ' CE2' ' HA3' ' C' ' 876' ' ' GLY . 91.4 m-85 61.67 -65.62 0.07 Allowed 'General case' 0 N--CA 1.503 2.222 0 N-CA-C 114.327 1.232 . . . . 3.46 114.327 177.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 879' ' ' TYR . . . . . 0.46 ' CB ' ' CD2' ' C' ' 886' ' ' PHE . 23.7 p90 -112.04 109.06 18.59 Favored 'General case' 0 N--CA 1.501 2.116 0 N-CA-C 114.938 1.459 . . . . 0.040000000000000001 114.938 -176.019 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -65.24 119.94 63.34 Favored Pre-proline 0 N--CA 1.497 1.913 0 O-C-N 121.548 -0.72 . . . . 0.02 110.369 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 881' ' ' PRO . . . . . 0.452 ' CG ' ' CD1' ' C' ' 868' ' ' PHE . 53.1 Cg_endo -76.13 0.99 8.75 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 O-C-N 123.434 1.229 . . . . 0.39000000000000001 112.285 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 87.4 mt-10 -74.96 -65.53 0.86 Allowed 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 106.829 -1.545 . . . . 0.81000000000000005 106.829 178.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 883' ' ' THR . . . . . 0.653 ' OG1' HG23 ' C' ' 885' ' ' VAL . 42.1 p -97.51 -15.1 20.72 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 109.19 -0.67 . . . . 0.040000000000000001 109.19 177.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.35 25.21 44.37 Favored Glycine 0 N--CA 1.494 2.527 0 C-N-CA 119.982 -1.104 . . . . 0.029999999999999999 110.636 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 885' ' ' VAL . . . . . 0.653 HG23 ' OG1' ' C' ' 883' ' ' THR . 83.0 t -72.66 88.94 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 C-N-CA 118.4 -1.32 . . . . 1.01 107.833 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 886' ' ' PHE . . . . . 0.902 ' HB3' HG22 ' C' ' 962' ' ' VAL . 0.7 OUTLIER -90.73 103.8 16.46 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 115.358 -0.837 . . . . 0.050000000000000003 112.242 -177.014 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 887' ' ' THR . . . . . 0.421 ' O ' ' HD3' ' C' ' 889' ' ' PRO . 97.1 m -96.79 100.46 12.0 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 107.601 -1.259 . . . . 0.68000000000000005 107.601 177.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 888' ' ' ALA . . . . . . . . . . . . . . . -99.47 105.37 32.96 Favored Pre-proline 0 N--CA 1.501 2.093 0 N-CA-C 114.197 1.184 . . . . 0.25 114.197 -176.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 889' ' ' PRO . . . . . 0.421 ' HD3' ' O ' ' C' ' 887' ' ' THR . 55.3 Cg_endo -86.9 -13.09 4.8 Favored 'Trans proline' 0 CA--C 1.546 1.077 0 N-CA-C 108.85 -1.25 . . . . 1.6399999999999999 108.85 175.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 890' ' ' LEU . . . . . 0.87 HD22 HD13 ' C' ' 985' ' ' LEU . 69.3 mt -38.04 -49.81 1.31 Allowed 'General case' 0 N--CA 1.507 2.378 0 N-CA-C 113.611 0.967 . . . . 2.29 113.611 -177.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 52.42 97.43 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.286 0 O-C-N 121.082 -1.011 . . . . 0.63 110.353 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . 156.53 -148.26 17.92 Favored Glycine 0 N--CA 1.478 1.493 0 N-CA-C 107.292 -2.323 . . . . 0.040000000000000001 107.292 -179.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 73.2 ttt-85 -108.29 128.62 54.9 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 107.763 -1.199 . . . . 3.0 107.763 177.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 894' ' ' TYR . . . . . 0.592 ' OH ' HD12 ' C' ' 896' ' ' LEU . 0.1 OUTLIER -130.49 146.3 52.01 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.14 -0.975 . . . . 0.040000000000000001 110.149 -179.144 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 895' ' ' LEU . . . . . 0.42 ' N ' ' CD1' ' C' ' 894' ' ' TYR . 38.6 tp -97.7 115.8 28.67 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.677 -0.64 . . . . 1.27 109.761 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 896' ' ' LEU . . . . . 0.592 HD12 ' OH ' ' C' ' 894' ' ' TYR . 9.2 tt -109.72 146.17 35.36 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.687 -0.633 . . . . 0.93999999999999995 110.822 -179.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 897' ' ' SER . . . . . . . . . . . . . 19.9 m -147.49 113.66 5.87 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.576 -0.702 . . . . 0.040000000000000001 110.707 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -106.61 147.02 29.99 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.032 -0.729 . . . . 0.47999999999999998 109.032 179.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 899' ' ' VAL . . . . . 0.704 HG21 ' HB ' ' C' ' 980' ' ' ILE . 89.7 t -93.9 119.63 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 C-N-CA 119.617 -0.833 . . . . 0.55000000000000004 111.159 -179.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 95.9 mt -94.54 110.61 22.41 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 114.188 1.181 . . . . 1.5900000000000001 114.188 -175.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 23.8 m -63.81 138.84 58.65 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 107.441 -1.318 . . . . 0.050000000000000003 107.441 177.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -61.48 -65.62 3.15 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 110.456 -1.058 . . . . 0.029999999999999999 110.456 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 46.21 66.48 0.94 Allowed 'General case' 0 N--CA 1.508 2.441 0 O-C-N 121.484 -1.009 . . . . 3.2000000000000002 110.921 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 54.8 ptt85 -67.93 -7.16 26.18 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.597 -0.69 . . . . 2.9199999999999999 112.03 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 905' ' ' HIS . . . . . 0.49 ' O ' ' CB ' ' C' ' 906' ' ' GLU . 77.1 t60 -59.83 4.4 0.05 OUTLIER 'General case' 0 N--CA 1.507 2.399 0 CA-C-O 117.65 -1.167 . . . . 2.8700000000000001 113.428 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 906' ' ' GLU . . . . . 0.49 ' CB ' ' O ' ' C' ' 905' ' ' HIS . 0.7 OUTLIER 93.0 -164.16 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.387 0 CA-C-N 121.272 1.851 . . . . 0.98999999999999999 112.013 179.071 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 907' ' ' LYS . . . . . 0.483 ' CB ' ' O ' ' C' ' 906' ' ' GLU . 68.7 tttt 87.87 160.22 0.07 Allowed 'General case' 0 N--CA 1.518 2.964 0 N-CA-C 107.772 -1.195 . . . . 5.25 107.772 -176.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 59.9 t -122.44 115.71 46.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 120.847 -1.158 . . . . 0.39000000000000001 111.058 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 909' ' ' GLU . . . . . 0.646 ' OE2' HD12 ' C' ' 966' ' ' LEU . 40.3 tp10 -100.25 132.95 45.33 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 107.077 -1.453 . . . . 1.72 107.077 176.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -156.9 120.5 4.21 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 106.929 -1.508 . . . . 0.67000000000000004 106.929 178.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 911' ' ' VAL . . . . . 0.858 HG23 HG22 ' C' ' 964' ' ' VAL . 13.2 p -76.5 130.99 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 C-N-CA 120.42 -0.512 . . . . 0.54000000000000004 111.131 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 83.5 mt -65.59 156.13 33.66 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 108.167 -1.049 . . . . 1.5 108.167 178.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 913' ' ' SER . . . . . 0.416 ' CB ' ' CG1' ' C' ' 919' ' ' VAL . 1.2 t -127.98 131.8 49.22 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.414 -0.958 . . . . 1.3700000000000001 108.414 176.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 914' ' ' ARG . . . . . 0.839 ' NH1' HD23 ' C' ' 956' ' ' LEU . 0.0 OUTLIER -63.24 156.22 26.1 Favored 'General case' 0 N--CA 1.506 2.336 0 O-C-N 120.71 -1.244 . . . . 4.2999999999999998 111.381 -179.195 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 915' ' ' SER . . . . . 0.421 ' CB ' ' O ' ' C' ' 914' ' ' ARG . 1.8 p 84.2 -32.07 0.07 Allowed 'General case' 0 N--CA 1.521 3.082 0 C-N-CA 124.033 0.933 . . . . 2.0499999999999998 111.848 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 916' ' ' ASN . . . . . 0.79 ' HB2' HG21 ' C' ' 919' ' ' VAL . 89.6 m-20 -124.03 -21.86 4.97 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.931 -1.106 . . . . 2.71 111.261 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 917' ' ' GLN . . . . . 0.422 ' HB2' ' O ' ' C' ' 916' ' ' ASN . 56.9 mt-30 66.82 164.86 0.2 Allowed 'General case' 0 N--CA 1.52 3.042 0 N-CA-C 105.707 -1.96 . . . . 2.6800000000000002 105.707 -173.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 55.67 -124.79 34.78 Favored Glycine 1 N--CA 1.52 4.266 0 CA-C-N 123.575 2.898 . . . . 0.029999999999999999 106.682 -177.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 919' ' ' VAL . . . . . 0.79 HG21 ' HB2' ' C' ' 916' ' ' ASN . 76.8 t 51.24 93.94 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.294 0 O-C-N 121.422 -1.046 . . . . 1.3899999999999999 109.119 -178.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 920' ' ' ALA . . . . . 0.818 ' HB3' HG12 ' C' ' 949' ' ' VAL . . . -93.41 93.69 8.29 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.429 -0.908 . . . . 0.029999999999999999 110.831 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 921' ' ' ARG . . . . . 0.683 ' HG3' HG23 ' C' ' 922' ' ' VAL . 41.8 ptt85 -82.03 -42.29 19.49 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 105.795 -1.928 . . . . 4.4199999999999999 105.795 176.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 922' ' ' VAL . . . . . 0.683 HG23 ' HG3' ' C' ' 921' ' ' ARG . 69.8 t -99.7 77.82 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 105.602 -1.999 . . . . 0.84999999999999998 105.602 175.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -90.73 135.53 33.65 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.814 0.816 . . . . 2.46 112.149 -176.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 14.9 t -147.4 103.93 3.6 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.017 -1.105 . . . . 0.69999999999999996 108.017 178.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -109.94 89.62 0.56 Allowed Glycine 0 N--CA 1.488 2.127 0 N-CA-C 108.882 -1.687 . . . . 0.040000000000000001 108.882 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.318 0 N-CA-C 109.347 -1.501 . . . . 0.040000000000000001 109.347 -179.623 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 55.4 m . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 120.949 0.404 . . . . 13.779999999999999 110.351 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 94.8 mt -114.91 129.25 56.67 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.501 -0.75 . . . . 13.76 110.317 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -152.16 170.67 31.48 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.277 -1.529 . . . . 9.1300000000000008 109.277 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 949' ' ' VAL . . . . . 0.818 HG12 ' HB3' ' C' ' 920' ' ' ALA . 33.4 m -117.22 137.45 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.524 -0.986 . . . . 7.0800000000000001 110.911 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 950' ' ' PHE . . . . . 0.444 ' CZ ' ' HB3' ' C' ' 921' ' ' ARG . 51.7 p90 -133.76 148.39 51.39 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.539 -0.725 . . . . 7.5899999999999999 109.513 179.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 70.4 m -118.54 -55.96 2.17 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.434 -0.791 . . . . 5.0300000000000002 112.137 -178.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 952' ' ' LEU . . . . . 0.47 ' O ' ' O ' ' C' ' 953' ' ' ILE . 49.3 tp -64.22 -76.64 0.07 Allowed 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.293 -0.879 . . . . 1.01 111.713 -178.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 953' ' ' ILE . . . . . 0.529 HD12 ' N ' ' C' ' 954' ' ' LEU . 2.1 pp -49.05 -151.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.787 0 N-CA-C 114.389 1.255 . . . . 2.6000000000000001 114.389 -176.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 954' ' ' LEU . . . . . 0.748 HD22 ' O ' ' C' ' 954' ' ' LEU . 0.0 OUTLIER 169.45 91.24 0.04 OUTLIER Pre-proline 0 N--CA 1.517 2.919 0 O-C-N 120.842 -1.162 . . . . 0.050000000000000003 112.023 179.798 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 955' ' ' PRO . . . . . 0.671 ' C ' HD12 ' C' ' 956' ' ' LEU . 52.7 Cg_endo -79.47 95.48 1.05 Allowed 'Trans proline' 0 C--N 1.316 -1.158 0 N-CA-C 108.665 -1.321 . . . . 0.83999999999999997 108.665 178.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 956' ' ' LEU . . . . . 0.839 HD23 ' NH1' ' C' ' 914' ' ' ARG . 6.7 mp -125.7 139.5 53.49 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.939 -1.101 . . . . 0.040000000000000001 110.841 -179.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -81.98 153.38 26.26 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 117.883 -1.056 . . . . 1.28 111.121 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -67.17 118.92 11.25 Favored 'General case' 0 N--CA 1.506 2.366 0 CA-C-N 122.629 2.468 . . . . 0.17000000000000001 111.322 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 95.15 -17.89 58.43 Favored Glycine 0 N--CA 1.501 3.013 0 O-C-N 121.526 -0.734 . . . . 0.040000000000000001 111.506 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 960' ' ' ASP . . . . . 0.416 ' HB3' ' NH2' ' C' ' 914' ' ' ARG . 0.2 OUTLIER -52.97 169.89 0.09 Allowed 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.204 -1.174 . . . . 0.040000000000000001 110.784 -179.169 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 961' ' ' THR . . . . . 0.457 ' HA ' ' O ' ' C' ' 886' ' ' PHE . 57.2 m -135.77 135.92 40.31 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.034 -1.041 . . . . 1.78 111.823 -178.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 962' ' ' VAL . . . . . 0.902 HG22 ' HB3' ' C' ' 886' ' ' PHE . 22.3 m -100.19 145.43 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.533 -0.73 . . . . 0.040000000000000001 110.498 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 5.6 t -137.99 148.07 44.83 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.89 -0.506 . . . . 0.71999999999999997 110.056 -178.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 964' ' ' VAL . . . . . 0.858 HG22 HG23 ' C' ' 911' ' ' VAL . 61.8 t -99.38 136.22 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.074 -1.016 . . . . 1.05 110.403 -179.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -94.73 126.94 40.37 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 103.85 -2.648 . . . . 3.02 103.85 173.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 966' ' ' LEU . . . . . 0.646 HD12 ' OE2' ' C' ' 909' ' ' GLU . 0.2 OUTLIER -130.57 62.31 1.59 Allowed 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.814 -1.18 . . . . 1.46 107.814 177.431 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 967' ' ' VAL . . . . . 0.491 HG23 ' C ' ' C' ' 966' ' ' LEU . 96.3 t -158.18 97.26 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 108.125 -1.065 . . . . 1.9399999999999999 108.125 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 85.9 mmm -142.95 58.62 1.42 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.765 -1.209 . . . . 0.0 108.342 178.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 134.78 119.63 1.96 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 107.075 -2.41 . . . . 2.1099999999999999 107.075 -178.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -82.26 -58.07 3.1 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.033 -1.275 . . . . 5.8899999999999997 110.367 -179.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 41.7 tp -58.61 90.45 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.445 -0.784 . . . . 4.3600000000000003 110.231 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -142.29 -154.12 0.5 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.543 -0.723 . . . . 1.8300000000000001 110.216 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -118.75 171.1 8.44 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.478 -0.764 . . . . 4.3499999999999996 110.17 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 32.1 t -101.39 129.9 47.49 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.501 -0.749 . . . . 1.27 110.071 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -156.33 154.29 30.36 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.556 -0.715 . . . . 5.0199999999999996 110.506 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.44 86.97 15.89 Favored Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 121.62 -0.675 . . . . 2.4100000000000001 109.74 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -74.3 -170.06 0.67 Allowed 'Trans proline' 0 C--N 1.318 -1.049 0 O-C-N 123.315 1.166 . . . . 0.95999999999999996 111.285 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 978' ' ' LEU . . . . . 0.471 ' N ' HD12 ' C' ' 978' ' ' LEU . 4.9 mp -125.86 155.39 41.28 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 107.547 -1.279 . . . . 0.62 107.547 177.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 979' ' ' THR . . . . . 0.456 HG23 ' C ' ' C' ' 978' ' ' LEU . 39.1 p -150.39 141.64 23.21 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.779 -1.201 . . . . 3.5699999999999998 111.21 -179.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 980' ' ' ILE . . . . . 0.704 ' HB ' HG21 ' C' ' 899' ' ' VAL . 50.8 mm -106.29 129.16 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 109.08 -0.711 . . . . 1.3300000000000001 109.08 179.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 981' ' ' PHE . . . . . 0.432 ' CD1' ' CE2' ' C' ' 879' ' ' TYR . 2.4 t80 -118.36 97.77 5.94 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.46 -0.775 . . . . 0.050000000000000003 111.638 -178.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 982' ' ' SER . . . . . . . . . . . . . 58.6 p -108.13 157.97 17.83 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 109.002 -0.74 . . . . 0.87 109.002 178.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 983' ' ' GLY . . . . . 0.411 ' O ' ' CE2' ' C' ' 852' ' ' PHE . . . -171.32 112.15 0.44 Allowed Glycine 0 N--CA 1.498 2.803 0 N-CA-C 106.701 -2.56 . . . . 0.029999999999999999 106.701 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 984' ' ' ALA . . . . . 0.479 ' HB1' ' NE ' ' A' ' 893' ' ' ARG . . . -110.25 149.51 30.05 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 114.315 1.228 . . . . 0.69999999999999996 114.315 -175.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 985' ' ' LEU . . . . . 0.87 HD13 HD22 ' C' ' 890' ' ' LEU . 63.9 tp -74.54 135.59 42.14 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.859 -1.151 . . . . 0.040000000000000001 109.805 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 986' ' ' LEU . . . . . . . . . . . . . 45.8 tp -105.9 -62.96 1.3 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.505 -0.747 . . . . 0.040000000000000001 110.327 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 53.6 t80 -144.73 147.05 32.51 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 107.828 -1.175 . . . . 0.040000000000000001 107.828 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.11 162.98 12.24 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 108.085 -2.006 . . . . 0.040000000000000001 108.085 179.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -75.65 112.35 19.07 Favored Pre-proline 0 N--CA 1.5 2.035 0 CA-C-N 118.608 1.204 . . . . 0.040000000000000001 109.462 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 990' ' ' PRO . . . . . 0.421 ' O ' ' HB2' ' C' ' 991' ' ' GLU . 50.6 Cg_endo -91.33 71.44 0.97 Allowed 'Trans proline' 0 C--N 1.319 -0.978 0 O-C-N 123.074 1.039 . . . . 0.45000000000000001 111.464 -178.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 991' ' ' GLU . . . . . 0.421 ' HB2' ' O ' ' C' ' 990' ' ' PRO . 71.2 mt-10 67.11 -73.9 0.07 Allowed 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 108.559 -0.904 . . . . 1.97 108.559 -177.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 992' ' ' LEU . . . . . 0.403 HD12 ' HD2' ' C' ' 990' ' ' PRO . 11.1 mt 51.66 20.46 1.1 Allowed 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.593 -0.692 . . . . 2.3799999999999999 111.596 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -90.65 156.91 17.77 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.964 -1.085 . . . . 3.79 109.952 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 69.1 m80 -147.53 90.21 1.84 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.572 -0.705 . . . . 3.5099999999999998 110.383 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 995' ' ' ALA . . . . . . . . . . . . 2.518 . . . . . . . 0 N--CA 1.503 2.216 0 O-C-N 120.881 -1.137 . . . . 2.73 110.601 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo . . . . . 0 N--CA 1.488 1.156 0 N-CA-C 109.492 -1.003 . . . . 3.8300000000000001 109.492 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 847' ' ' VAL . . . . . 0.494 HG12 ' HB2' ' A' ' 849' ' ' GLN . 60.0 t -128.04 105.5 20.2 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 121.638 -0.664 . . . . 1.8300000000000001 109.986 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 848' ' ' PRO . . . . . 0.823 ' O ' HG23 ' A' ' 850' ' ' VAL . 43.0 Cg_endo -69.37 -21.41 35.35 Favored 'Trans proline' 0 N--CA 1.486 1.076 0 O-C-N 123.196 1.103 . . . . 0.65000000000000002 110.985 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 849' ' ' GLN . . . . . 0.494 ' HB2' HG12 ' A' ' 847' ' ' VAL . 56.5 tt0 26.47 67.43 0.06 Allowed 'General case' 0 N--CA 1.518 2.93 0 N-CA-C 113.111 0.782 . . . . 2.5800000000000001 113.111 179.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 850' ' ' VAL . . . . . 0.823 HG23 ' O ' ' A' ' 848' ' ' PRO . 97.4 t -119.43 134.79 61.87 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.12 -0.987 . . . . 1.0900000000000001 111.042 -179.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 851' ' ' ALA . . . . . . . . . . . . . . . -132.05 153.65 50.2 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 105.922 -1.881 . . . . 0.040000000000000001 105.922 177.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 852' ' ' PHE . . . . . 0.626 ' HA ' ' HB3' ' A' ' 874' ' ' ASN . 28.4 p90 -155.89 136.75 13.52 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-N 121.109 1.777 . . . . 0.050000000000000003 109.303 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 16.1 t -172.63 133.11 0.59 Allowed 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.168 -1.049 . . . . 0.040000000000000001 108.168 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 854' ' ' ALA . . . . . 0.488 ' HB1' ' HD2' ' A' ' 868' ' ' PHE . . . -135.97 154.22 51.16 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.111 -0.993 . . . . 0.67000000000000004 109.325 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 855' ' ' ALA . . . . . 0.703 ' HB3' ' CB ' ' A' ' 870' ' ' ARG . . . -123.04 141.3 52.11 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.876 0.846 . . . . 0.51000000000000001 111.976 -178.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 856' ' ' LEU . . . . . 0.762 HD23 ' O ' ' A' ' 867' ' ' PRO . 3.5 tm? -110.09 138.27 46.7 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.656 -0.652 . . . . 0.050000000000000003 109.427 179.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 857' ' ' SER . . . . . 0.6 ' N ' HD13 ' A' ' 856' ' ' LEU . 78.8 p -156.1 19.99 0.37 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.477 -0.765 . . . . 1.3300000000000001 111.325 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 858' ' ' LEU . . . . . 0.573 HD22 ' HG3' ' A' ' 862' ' ' GLU . 4.2 pp -34.3 158.95 0.04 OUTLIER Pre-proline 0 N--CA 1.519 3.017 0 N-CA-C 112.816 0.672 . . . . 2.3300000000000001 112.816 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -60.95 -89.62 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.626 0 C-N-CA 120.968 1.112 . . . . 2.3199999999999998 113.922 -177.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 54.9 ptt85 -127.98 -142.26 0.27 Allowed 'General case' 0 N--CA 1.502 2.127 0 O-C-N 120.809 -1.182 . . . . 0.040000000000000001 111.609 -177.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 27.9 m -36.14 121.15 0.67 Allowed 'General case' 0 N--CA 1.511 2.602 0 O-C-N 121.644 -0.66 . . . . 1.3100000000000001 112.291 -178.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 862' ' ' GLU . . . . . 0.573 ' HG3' HD22 ' A' ' 858' ' ' LEU . 0.0 OUTLIER -103.01 158.91 30.82 Favored Pre-proline 0 N--CA 1.488 1.466 0 N-CA-C 108.313 -0.995 . . . . 4.5099999999999998 108.313 177.824 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -70.23 -15.19 35.26 Favored 'Trans proline' 0 C--N 1.313 -1.337 0 O-C-N 123.206 1.108 . . . . 2.2400000000000002 111.231 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -176.91 -135.56 2.21 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.786 -1.326 . . . . 0.040000000000000001 109.786 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 23.3 m -69.47 155.88 39.75 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.344 -1.092 . . . . 1.51 111.01 -178.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 866' ' ' VAL . . . . . 0.564 HG12 ' CD2' ' A' ' 858' ' ' LEU . 33.7 m -91.35 136.73 26.63 Favored Pre-proline 0 N--CA 1.498 1.954 0 N-CA-C 113.549 0.944 . . . . 0.78000000000000003 113.549 -175.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 867' ' ' PRO . . . . . 0.762 ' O ' HD23 ' A' ' 856' ' ' LEU . 54.9 Cg_endo -88.62 -150.39 0.04 OUTLIER 'Trans proline' 0 CA--C 1.539 0.767 0 N-CA-C 108.183 -1.507 . . . . 0.92000000000000004 108.183 177.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 868' ' ' PHE . . . . . 0.488 ' HD2' ' HB1' ' A' ' 854' ' ' ALA . 9.9 p90 -148.24 121.2 8.79 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.413 -1.43 . . . . 0.050000000000000003 110.312 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 50.1 p-10 -111.79 -3.52 14.92 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 119.374 -0.93 . . . . 1.7 111.919 -179.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 870' ' ' ARG . . . . . 0.703 ' CB ' ' HB3' ' A' ' 855' ' ' ALA . 26.1 mmm180 -90.4 88.43 7.18 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.999 -1.063 . . . . 2.5899999999999999 111.109 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 60.1 t -76.42 96.41 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 120.932 -1.105 . . . . 1.9399999999999999 109.173 179.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 872' ' ' LEU . . . . . 0.45 HD13 HD11 ' B' ' 953' ' ' ILE . 87.7 mt -86.97 -44.16 11.83 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.605 -0.684 . . . . 1.0600000000000001 110.921 -179.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 873' ' ' LEU . . . . . . . . . . . . . 48.2 tp -172.3 107.69 0.2 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.159 -0.963 . . . . 4.1799999999999997 108.624 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 874' ' ' ASN . . . . . 0.626 ' HB3' ' HA ' ' A' ' 852' ' ' PHE . 12.0 p-10 174.36 81.36 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.483 0 O-C-N 121.592 -0.692 . . . . 0.040000000000000001 109.378 -178.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -69.69 -49.18 55.91 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.725 -1.234 . . . . 3.3799999999999999 111.37 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 876' ' ' GLY . . . . . 0.414 ' HA3' ' CE2' ' A' ' 878' ' ' TYR . . . -72.8 -26.8 70.4 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 110.642 -0.983 . . . . 0.040000000000000001 110.642 -179.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 78.96 -63.6 3.81 Favored Glycine 0 N--CA 1.497 2.741 0 N-CA-C 108.196 -1.961 . . . . 0.040000000000000001 108.196 -178.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 878' ' ' TYR . . . . . 0.414 ' CE2' ' HA3' ' A' ' 876' ' ' GLY . 92.6 m-85 61.7 -60.11 0.1 Allowed 'General case' 0 N--CA 1.504 2.265 0 N-CA-C 113.532 0.938 . . . . 3.46 113.532 178.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 879' ' ' TYR . . . . . 0.504 ' O ' ' CG ' ' A' ' 879' ' ' TYR . 9.8 p90 -111.24 104.69 13.21 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.919 -1.113 . . . . 0.040000000000000001 113.58 -177.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 880' ' ' ASP . . . . . 0.418 ' O ' ' N ' ' A' ' 884' ' ' GLY . 0.8 OUTLIER -69.77 112.86 13.63 Favored Pre-proline 0 N--CA 1.497 1.895 0 O-C-N 121.19 -0.944 . . . . 0.02 110.662 -178.807 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 881' ' ' PRO . . . . . 0.478 ' HG2' ' CD1' ' A' ' 868' ' ' PHE . 51.9 Cg_endo -78.33 -3.27 13.24 Favored 'Trans proline' 0 N--CA 1.489 1.221 0 O-C-N 123.489 1.257 . . . . 0.39000000000000001 111.102 179.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -77.62 -34.51 53.31 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 107.897 -1.149 . . . . 0.81000000000000005 107.897 178.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 71.0 p -112.07 -19.08 12.44 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-N 115.423 -0.808 . . . . 0.040000000000000001 109.072 176.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 884' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 880' ' ' ASP . . . 79.6 4.12 89.16 Favored Glycine 0 N--CA 1.495 2.603 0 N-CA-C 110.161 -1.176 . . . . 0.029999999999999999 110.161 -178.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 885' ' ' VAL . . . . . 0.452 HG13 HG21 ' A' ' 961' ' ' THR . 66.5 t -73.3 95.08 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 C-N-CA 118.737 -1.185 . . . . 1.01 108.408 -178.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 886' ' ' PHE . . . . . 0.924 ' HB3' HG22 ' A' ' 962' ' ' VAL . 2.2 t80 -88.86 105.54 17.81 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 115.307 -0.86 . . . . 0.050000000000000003 111.746 -177.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 887' ' ' THR . . . . . 0.42 ' O ' ' HD3' ' A' ' 889' ' ' PRO . 35.3 m -98.03 100.31 11.64 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 107.588 -1.264 . . . . 0.68000000000000005 107.588 177.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 888' ' ' ALA . . . . . 0.434 ' HB2' ' CE1' ' A' ' 886' ' ' PHE . . . -99.28 106.63 40.14 Favored Pre-proline 0 N--CA 1.501 2.085 0 N-CA-C 114.049 1.129 . . . . 0.25 114.049 -176.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 889' ' ' PRO . . . . . 0.42 ' HD3' ' O ' ' A' ' 887' ' ' THR . 55.2 Cg_endo -90.18 -12.61 2.69 Favored 'Trans proline' 0 CA--C 1.546 1.093 0 C-N-CA 121.086 1.191 . . . . 1.6399999999999999 109.157 176.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 890' ' ' LEU . . . . . 0.858 HD22 HD13 ' A' ' 985' ' ' LEU . 72.4 mt -36.38 -50.13 0.75 Allowed 'General case' 0 N--CA 1.508 2.44 0 N-CA-C 113.855 1.057 . . . . 2.29 113.855 -177.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 51.8 96.17 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.117 -0.989 . . . . 0.63 110.321 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 156.21 -148.86 19.45 Favored Glycine 0 N--CA 1.48 1.624 0 N-CA-C 107.296 -2.322 . . . . 0.040000000000000001 107.296 -179.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 893' ' ' ARG . . . . . 0.416 ' CZ ' ' HB1' ' C' ' 984' ' ' ALA . 71.6 ttt-85 -111.44 127.6 55.73 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 107.753 -1.202 . . . . 3.0 107.753 177.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 894' ' ' TYR . . . . . 0.53 ' OH ' HD12 ' A' ' 896' ' ' LEU . 0.0 OUTLIER -130.2 153.88 48.12 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.0 -1.063 . . . . 0.040000000000000001 110.876 -178.681 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 895' ' ' LEU . . . . . 0.429 ' N ' ' CD1' ' A' ' 894' ' ' TYR . 39.7 tp -96.58 114.11 25.74 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.405 -0.809 . . . . 1.27 109.961 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 896' ' ' LEU . . . . . 0.53 HD12 ' OH ' ' A' ' 894' ' ' TYR . 10.3 tt -109.35 142.47 40.23 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.684 -0.635 . . . . 0.93999999999999995 111.18 -179.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 897' ' ' SER . . . . . 0.525 ' N ' HD23 ' A' ' 896' ' ' LEU . 49.8 m -147.91 115.43 6.31 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.578 -0.701 . . . . 0.040000000000000001 110.838 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.7 147.22 31.04 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.633 -0.667 . . . . 0.47999999999999998 109.254 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 899' ' ' VAL . . . . . 0.75 HG21 ' HB ' ' A' ' 980' ' ' ILE . 99.1 t -92.69 120.1 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 C-N-CA 119.68 -0.808 . . . . 0.55000000000000004 111.237 -179.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 900' ' ' LEU . . . . . 0.442 ' N ' HD22 ' A' ' 900' ' ' LEU . 4.6 mm? -91.33 112.18 23.98 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 114.349 1.241 . . . . 1.5900000000000001 114.349 -175.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 23.3 m -67.52 141.72 56.79 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 107.077 -1.453 . . . . 0.050000000000000003 107.077 176.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -67.71 -66.45 2.33 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 110.506 -1.037 . . . . 0.029999999999999999 110.506 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 5.0 m170 46.08 65.88 1.07 Allowed 'General case' 0 N--CA 1.508 2.467 0 O-C-N 121.448 -1.03 . . . . 3.2000000000000002 111.253 179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 43.2 ptt85 -69.23 -5.85 25.39 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.621 -0.675 . . . . 2.9199999999999999 112.152 -179.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 905' ' ' HIS . . . . . 0.491 ' O ' ' CB ' ' A' ' 906' ' ' GLU . 76.2 t60 -61.86 4.37 0.12 Allowed 'General case' 0 N--CA 1.507 2.386 0 O-C-N 120.857 -1.152 . . . . 2.8700000000000001 113.141 -179.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 906' ' ' GLU . . . . . 0.491 ' CB ' ' O ' ' A' ' 905' ' ' HIS . 0.9 OUTLIER 94.7 -164.54 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.425 0 CA-C-N 120.593 1.542 . . . . 0.98999999999999999 112.076 178.984 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 907' ' ' LYS . . . . . 0.474 ' CB ' ' O ' ' A' ' 906' ' ' GLU . 29.5 ttmt 88.87 160.84 0.06 Allowed 'General case' 0 N--CA 1.522 3.137 0 N-CA-C 108.353 -0.98 . . . . 5.25 108.353 -177.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 61.4 t -122.4 116.74 49.95 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 120.818 -1.177 . . . . 0.39000000000000001 110.862 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 909' ' ' GLU . . . . . 0.634 ' OE2' HD12 ' A' ' 966' ' ' LEU . 39.9 tp10 -105.12 131.78 52.18 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 107.629 -1.248 . . . . 1.72 107.629 177.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -156.54 120.78 4.43 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 106.819 -1.548 . . . . 0.67000000000000004 106.819 178.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 911' ' ' VAL . . . . . 0.485 ' HA ' ' HA ' ' A' ' 964' ' ' VAL . 14.4 p -77.3 132.96 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.713 -0.617 . . . . 0.54000000000000004 111.417 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 86.4 mt -65.47 156.26 32.98 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 108.193 -1.039 . . . . 1.5 108.193 178.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 913' ' ' SER . . . . . 0.445 ' CB ' ' HB ' ' A' ' 919' ' ' VAL . 1.4 t -125.66 136.27 53.05 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.462 -0.94 . . . . 1.3700000000000001 108.462 177.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 914' ' ' ARG . . . . . 0.551 ' HD3' HG12 ' A' ' 962' ' ' VAL . 0.0 OUTLIER -62.37 152.58 33.64 Favored 'General case' 0 N--CA 1.505 2.322 0 O-C-N 121.011 -1.056 . . . . 4.2999999999999998 111.827 -178.97 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 915' ' ' SER . . . . . 0.427 ' CB ' ' O ' ' A' ' 914' ' ' ARG . 3.5 t 83.41 -30.38 0.09 Allowed 'General case' 0 N--CA 1.52 3.056 0 C-N-CA 124.004 0.922 . . . . 2.0499999999999998 112.315 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 916' ' ' ASN . . . . . 0.615 ' HB2' HG21 ' A' ' 919' ' ' VAL . 72.9 m-20 -126.46 -21.87 4.09 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 120.849 -1.157 . . . . 2.71 111.471 -179.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 917' ' ' GLN . . . . . 0.428 ' HB2' ' O ' ' A' ' 916' ' ' ASN . 58.6 mt-30 66.97 168.93 0.24 Allowed 'General case' 0 N--CA 1.518 2.955 0 N-CA-C 105.903 -1.888 . . . . 2.6800000000000002 105.903 -173.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 55.25 -128.87 45.1 Favored Glycine 1 N--CA 1.52 4.28 0 CA-C-N 123.64 2.927 . . . . 0.029999999999999999 106.388 -177.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 919' ' ' VAL . . . . . 0.615 HG21 ' HB2' ' A' ' 916' ' ' ASN . 85.7 t 50.25 94.59 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.299 0 CA-C-N 118.573 1.187 . . . . 1.3899999999999999 109.249 -178.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 920' ' ' ALA . . . . . 1.005 ' HB3' HG12 ' A' ' 949' ' ' VAL . . . -92.64 94.08 8.84 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.266 -0.974 . . . . 0.029999999999999999 111.154 -179.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 921' ' ' ARG . . . . . 0.756 ' HG3' HG23 ' A' ' 922' ' ' VAL . 35.1 ptt85 -80.3 -43.14 21.77 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 105.602 -1.999 . . . . 4.4199999999999999 105.602 176.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 922' ' ' VAL . . . . . 0.756 HG23 ' HG3' ' A' ' 921' ' ' ARG . 94.9 t -101.75 77.07 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 N-CA-C 105.041 -2.207 . . . . 0.84999999999999998 105.041 174.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -87.14 135.61 33.23 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 122.068 0.937 . . . . 2.46 112.39 -176.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 10.4 t -145.54 103.15 3.78 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.471 -1.307 . . . . 0.69999999999999996 107.471 178.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -103.39 81.75 0.37 Allowed Glycine 0 N--CA 1.486 2.023 0 N-CA-C 109.04 -1.624 . . . . 0.040000000000000001 109.04 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.967 0 N-CA-C 108.743 -1.743 . . . . 0.040000000000000001 108.743 179.877 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 21.7 m . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 120.963 0.411 . . . . 13.779999999999999 110.299 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 95.9 mt -109.88 129.28 55.67 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.506 -0.746 . . . . 13.76 110.325 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -152.08 169.83 31.4 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.347 -1.501 . . . . 9.1300000000000008 109.347 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 949' ' ' VAL . . . . . 1.005 HG12 ' HB3' ' A' ' 920' ' ' ALA . 34.3 m -118.4 132.4 68.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.465 -1.021 . . . . 7.0800000000000001 111.05 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 950' ' ' PHE . . . . . 0.464 ' CZ ' ' HB3' ' A' ' 921' ' ' ARG . 40.0 p90 -134.82 153.24 52.12 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.549 -0.719 . . . . 7.5899999999999999 109.124 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 69.3 m -121.59 -53.16 2.0 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.245 -0.91 . . . . 5.0300000000000002 112.356 -178.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 952' ' ' LEU . . . . . 0.425 ' O ' ' O ' ' A' ' 953' ' ' ILE . 56.6 tp -61.72 -76.33 0.06 Allowed 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.356 -0.84 . . . . 1.01 112.328 -177.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 953' ' ' ILE . . . . . 0.496 HD11 HD13 ' C' ' 872' ' ' LEU . 44.6 pt -52.32 -145.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.753 0 N-CA-C 114.016 1.117 . . . . 2.6000000000000001 114.016 -176.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 954' ' ' LEU . . . . . 0.726 HD22 ' O ' ' A' ' 954' ' ' LEU . 0.0 OUTLIER 170.73 83.74 0.04 OUTLIER Pre-proline 0 N--CA 1.509 2.514 0 O-C-N 120.812 -1.18 . . . . 0.050000000000000003 111.66 179.441 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 955' ' ' PRO . . . . . 0.677 ' C ' HD12 ' A' ' 956' ' ' LEU . 48.6 Cg_endo -76.24 95.45 1.04 Allowed 'Trans proline' 0 C--N 1.314 -1.271 0 N-CA-C 108.689 -1.312 . . . . 0.83999999999999997 108.689 177.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 956' ' ' LEU . . . . . 0.677 HD12 ' C ' ' A' ' 955' ' ' PRO . 10.3 mp -122.47 143.73 49.51 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.133 -0.979 . . . . 0.040000000000000001 110.19 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 68.0 mt-30 -85.65 151.76 23.64 Favored 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 117.82 -1.086 . . . . 1.28 111.613 -179.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -68.95 119.75 13.75 Favored 'General case' 0 N--CA 1.509 2.48 0 CA-C-N 122.86 2.573 . . . . 0.17000000000000001 111.799 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 93.23 -21.75 38.57 Favored Glycine 0 N--CA 1.501 3.006 0 N-CA-C 111.127 -0.789 . . . . 0.040000000000000001 111.127 178.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 960' ' ' ASP . . . . . 0.434 ' HB3' ' NE ' ' A' ' 914' ' ' ARG . 0.5 OUTLIER -55.17 169.47 0.25 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.473 -1.016 . . . . 0.040000000000000001 110.201 -179.411 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 961' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' A' ' 886' ' ' PHE . 44.0 m -136.52 139.55 42.34 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.903 -1.123 . . . . 1.78 112.432 -177.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 962' ' ' VAL . . . . . 0.924 HG22 ' HB3' ' A' ' 886' ' ' PHE . 31.9 m -100.08 144.82 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.649 -0.657 . . . . 0.040000000000000001 111.131 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 5.4 t -137.58 145.04 42.36 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.917 -0.49 . . . . 0.71999999999999997 109.991 -179.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 964' ' ' VAL . . . . . 0.485 ' HA ' ' HA ' ' A' ' 911' ' ' VAL . 61.9 t -92.17 136.3 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.028 -1.045 . . . . 1.05 111.297 -178.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -95.51 126.35 40.74 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 103.5 -2.778 . . . . 3.02 103.5 172.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 966' ' ' LEU . . . . . 0.634 HD12 ' OE2' ' A' ' 909' ' ' GLU . 0.2 OUTLIER -133.42 61.3 1.68 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.453 -0.943 . . . . 1.46 108.453 177.362 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 967' ' ' VAL . . . . . 0.492 HG23 ' C ' ' A' ' 966' ' ' LEU . 97.8 t -157.65 96.26 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 108.366 -0.975 . . . . 1.9399999999999999 108.366 179.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 92.9 mmm -142.96 58.65 1.42 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.734 -1.229 . . . . 0.0 108.277 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 133.72 119.48 2.0 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 107.139 -2.385 . . . . 2.1099999999999999 107.139 -178.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -82.19 -57.03 3.57 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.028 -1.277 . . . . 5.8899999999999997 110.597 -179.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 48.4 tp -58.76 89.7 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.429 -0.794 . . . . 4.3600000000000003 110.342 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -142.67 -152.57 0.42 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.561 -0.712 . . . . 1.8300000000000001 110.049 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -118.07 167.57 11.35 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.393 -0.817 . . . . 4.3499999999999996 110.211 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 30.3 t -101.98 130.29 48.47 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.578 -0.701 . . . . 1.27 110.067 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -156.05 159.01 38.76 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.485 -0.759 . . . . 5.0199999999999996 110.65 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.78 85.12 20.63 Favored Pre-proline 0 N--CA 1.5 2.042 0 O-C-N 121.701 -0.624 . . . . 2.4100000000000001 109.712 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -73.58 -172.11 0.99 Allowed 'Trans proline' 0 C--N 1.317 -1.1 0 O-C-N 123.253 1.133 . . . . 0.95999999999999996 111.3 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 978' ' ' LEU . . . . . 0.576 HD12 ' N ' ' A' ' 978' ' ' LEU . 5.2 mp -126.43 156.09 41.17 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 107.557 -1.275 . . . . 0.62 107.557 177.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 979' ' ' THR . . . . . 0.453 HG23 ' C ' ' A' ' 978' ' ' LEU . 46.5 p -149.57 141.37 23.67 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.763 -1.211 . . . . 3.5699999999999998 111.155 -179.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 980' ' ' ILE . . . . . 0.75 ' HB ' HG21 ' A' ' 899' ' ' VAL . 50.7 mm -107.31 128.92 61.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 N-CA-C 109.088 -0.708 . . . . 1.3300000000000001 109.088 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 981' ' ' PHE . . . . . 0.502 ' CD1' ' CE2' ' A' ' 879' ' ' TYR . 10.6 t80 -119.93 97.46 5.62 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 119.572 -0.851 . . . . 0.050000000000000003 111.899 -178.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 982' ' ' SER . . . . . 0.457 ' HB2' HD23 ' B' ' 952' ' ' LEU . 15.5 p -108.64 158.59 17.45 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.592 -0.693 . . . . 0.87 109.199 178.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 983' ' ' GLY . . . . . 0.41 ' O ' ' CE1' ' A' ' 852' ' ' PHE . . . -174.29 110.78 0.34 Allowed Glycine 0 N--CA 1.498 2.783 0 N-CA-C 106.81 -2.516 . . . . 0.029999999999999999 106.81 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -107.85 149.41 28.29 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 114.245 1.202 . . . . 0.69999999999999996 114.245 -175.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 985' ' ' LEU . . . . . 0.858 HD13 HD22 ' A' ' 890' ' ' LEU . 66.8 tp -72.04 136.51 46.69 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 120.75 -1.219 . . . . 0.040000000000000001 110.088 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 49.3 tp -106.66 -58.03 1.98 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.689 -0.632 . . . . 0.040000000000000001 110.02 179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -143.9 145.87 32.6 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 107.739 -1.208 . . . . 0.040000000000000001 107.739 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.33 162.54 12.37 Favored Glycine 0 N--CA 1.496 2.659 0 N-CA-C 108.078 -2.009 . . . . 0.040000000000000001 108.078 179.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -76.9 111.79 18.54 Favored Pre-proline 0 N--CA 1.498 1.951 0 CA-C-N 118.536 1.168 . . . . 0.040000000000000001 109.536 179.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 990' ' ' PRO . . . . . 0.615 ' HD2' HD12 ' A' ' 992' ' ' LEU . 49.2 Cg_endo -92.34 71.79 0.64 Allowed 'Trans proline' 0 C--N 1.318 -1.038 0 O-C-N 123.057 1.03 . . . . 0.45000000000000001 111.338 -179.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 991' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' A' ' 990' ' ' PRO . 72.3 mt-10 67.82 -73.33 0.08 Allowed 'General case' 0 N--CA 1.503 2.182 0 N-CA-C 108.345 -0.983 . . . . 1.97 108.345 -177.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 992' ' ' LEU . . . . . 0.615 HD12 ' HD2' ' A' ' 990' ' ' PRO . 4.1 mt 50.51 20.38 0.69 Allowed 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.577 -0.702 . . . . 2.3799999999999999 111.754 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -95.69 156.87 16.15 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.914 -1.116 . . . . 3.79 110.089 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 67.9 m80 -144.19 94.4 2.57 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.526 -0.734 . . . . 3.5099999999999998 110.269 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 995' ' ' ALA . . . . . . . . . . . . 2.517 . . . . . . . 0 N--CA 1.503 2.201 0 O-C-N 120.928 -1.108 . . . . 2.73 110.588 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo . . . . . 0 N--CA 1.488 1.172 0 N-CA-C 109.471 -1.011 . . . . 3.8300000000000001 109.471 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 847' ' ' VAL . . . . . 0.485 HG12 ' HB2' ' B' ' 849' ' ' GLN . 61.1 t -128.26 105.57 19.73 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.629 -0.669 . . . . 1.8300000000000001 109.93 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 848' ' ' PRO . . . . . 0.823 ' O ' HG23 ' B' ' 850' ' ' VAL . 43.0 Cg_endo -69.29 -21.41 35.7 Favored 'Trans proline' 0 N--CA 1.486 1.087 0 O-C-N 123.253 1.133 . . . . 0.65000000000000002 111.042 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 849' ' ' GLN . . . . . 0.485 ' HB2' HG12 ' B' ' 847' ' ' VAL . 56.3 tt0 26.48 66.9 0.06 Allowed 'General case' 0 N--CA 1.518 2.939 0 N-CA-C 113.151 0.797 . . . . 2.5800000000000001 113.151 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 850' ' ' VAL . . . . . 0.823 HG23 ' O ' ' B' ' 848' ' ' PRO . 97.1 t -118.98 134.93 61.02 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 O-C-N 121.193 -0.942 . . . . 1.0900000000000001 111.06 -179.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 851' ' ' ALA . . . . . . . . . . . . . . . -131.93 154.02 49.69 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 105.911 -1.885 . . . . 0.040000000000000001 105.911 177.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 852' ' ' PHE . . . . . 0.6 ' HA ' ' HB3' ' B' ' 874' ' ' ASN . 28.3 p90 -156.26 136.8 13.19 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-N 121.02 1.736 . . . . 0.050000000000000003 109.431 179.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 18.6 t -172.71 133.37 0.58 Allowed 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.046 -1.094 . . . . 0.040000000000000001 108.046 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 854' ' ' ALA . . . . . 0.487 ' HB1' ' HD2' ' B' ' 868' ' ' PHE . . . -136.14 154.34 51.01 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.118 -0.989 . . . . 0.67000000000000004 109.339 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 855' ' ' ALA . . . . . 0.72 ' HB3' ' CB ' ' B' ' 870' ' ' ARG . . . -123.18 140.96 52.48 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.853 0.835 . . . . 0.51000000000000001 111.996 -178.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 856' ' ' LEU . . . . . 0.769 HD23 ' O ' ' B' ' 867' ' ' PRO . 3.5 tm? -109.79 138.74 45.73 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.729 -0.607 . . . . 0.050000000000000003 109.366 179.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 857' ' ' SER . . . . . 0.614 ' N ' HD13 ' B' ' 856' ' ' LEU . 78.7 p -156.58 19.58 0.34 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.457 -0.777 . . . . 1.3300000000000001 111.345 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 858' ' ' LEU . . . . . 0.567 HD22 ' HG3' ' B' ' 862' ' ' GLU . 4.2 pp -33.95 158.83 0.04 OUTLIER Pre-proline 0 N--CA 1.519 2.984 0 N-CA-C 112.888 0.699 . . . . 2.3300000000000001 112.888 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -60.77 -89.66 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 120.948 1.099 . . . . 2.3199999999999998 113.971 -177.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 55.0 ptt85 -127.91 -142.25 0.27 Allowed 'General case' 0 N--CA 1.501 2.1 0 O-C-N 120.753 -1.217 . . . . 0.040000000000000001 111.676 -177.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 28.4 m -36.24 121.4 0.69 Allowed 'General case' 0 N--CA 1.512 2.629 0 O-C-N 121.682 -0.637 . . . . 1.3100000000000001 112.354 -178.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 862' ' ' GLU . . . . . 0.567 ' HG3' HD22 ' B' ' 858' ' ' LEU . 0.0 OUTLIER -103.25 159.09 30.38 Favored Pre-proline 0 N--CA 1.488 1.461 0 N-CA-C 108.414 -0.958 . . . . 4.5099999999999998 108.414 177.842 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -70.28 -15.15 35.08 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 O-C-N 123.255 1.134 . . . . 2.2400000000000002 111.163 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -176.86 -135.55 2.21 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.901 -1.279 . . . . 0.040000000000000001 109.901 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 23.6 m -69.65 156.0 39.63 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.43 -1.041 . . . . 1.51 110.964 -178.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 866' ' ' VAL . . . . . 0.567 HG12 ' CD2' ' B' ' 858' ' ' LEU . 33.7 m -91.4 136.75 26.54 Favored Pre-proline 0 N--CA 1.498 1.935 0 N-CA-C 113.59 0.959 . . . . 0.78000000000000003 113.59 -175.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 867' ' ' PRO . . . . . 0.769 ' O ' HD23 ' B' ' 856' ' ' LEU . 53.9 Cg_endo -88.52 -150.07 0.04 OUTLIER 'Trans proline' 0 CA--C 1.539 0.759 0 N-CA-C 108.134 -1.525 . . . . 0.92000000000000004 108.134 177.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 868' ' ' PHE . . . . . 0.487 ' HD2' ' HB1' ' B' ' 854' ' ' ALA . 9.8 p90 -148.5 121.26 8.67 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.388 -1.445 . . . . 0.050000000000000003 110.246 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 50.0 p-10 -111.82 -3.81 14.81 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 119.373 -0.931 . . . . 1.7 111.991 -179.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 870' ' ' ARG . . . . . 0.72 ' CB ' ' HB3' ' B' ' 855' ' ' ALA . 26.3 mmm180 -90.08 88.92 7.46 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.074 -1.016 . . . . 2.5899999999999999 111.028 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 61.6 t -76.87 96.09 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 120.918 -1.113 . . . . 1.9399999999999999 109.159 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 872' ' ' LEU . . . . . 0.597 HD13 HD11 ' C' ' 953' ' ' ILE . 86.3 mt -86.63 -44.31 11.96 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.658 -0.651 . . . . 1.0600000000000001 110.988 -179.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 873' ' ' LEU . . . . . . . . . . . . . 48.3 tp -172.16 107.44 0.21 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.219 -0.926 . . . . 4.1799999999999997 108.528 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 874' ' ' ASN . . . . . 0.6 ' HB3' ' HA ' ' B' ' 852' ' ' PHE . 12.1 p-10 174.6 81.2 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.473 0 O-C-N 121.551 -0.718 . . . . 0.040000000000000001 109.429 -178.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -69.5 -49.2 56.9 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.826 -1.171 . . . . 3.3799999999999999 111.352 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 876' ' ' GLY . . . . . 0.409 ' HA3' ' CE2' ' B' ' 878' ' ' TYR . . . -73.03 -26.38 71.13 Favored Glycine 0 N--CA 1.494 2.504 0 N-CA-C 110.642 -0.983 . . . . 0.040000000000000001 110.642 -179.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 78.65 -63.58 3.72 Favored Glycine 0 N--CA 1.498 2.77 0 N-CA-C 108.258 -1.937 . . . . 0.040000000000000001 108.258 -178.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 878' ' ' TYR . . . . . 0.409 ' CE2' ' HA3' ' B' ' 876' ' ' GLY . 92.3 m-85 61.74 -60.12 0.11 Allowed 'General case' 0 N--CA 1.504 2.256 0 N-CA-C 113.545 0.942 . . . . 3.46 113.545 178.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 879' ' ' TYR . . . . . 0.516 ' O ' ' CG ' ' B' ' 879' ' ' TYR . 10.0 p90 -111.31 104.06 12.5 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 120.94 -1.1 . . . . 0.040000000000000001 113.601 -177.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -69.14 112.91 13.19 Favored Pre-proline 0 N--CA 1.497 1.914 0 O-C-N 121.165 -0.96 . . . . 0.02 110.645 -178.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 881' ' ' PRO . . . . . 0.482 ' HG2' ' CD1' ' B' ' 868' ' ' PHE . 51.6 Cg_endo -78.33 -3.32 13.28 Favored 'Trans proline' 0 N--CA 1.49 1.27 0 O-C-N 123.442 1.232 . . . . 0.39000000000000001 111.061 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -77.66 -34.68 52.95 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 107.935 -1.135 . . . . 0.81000000000000005 107.935 178.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 74.2 p -111.59 -19.72 12.41 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.3 -0.863 . . . . 0.040000000000000001 108.975 176.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 79.88 4.17 89.46 Favored Glycine 0 N--CA 1.494 2.566 0 N-CA-C 110.087 -1.205 . . . . 0.029999999999999999 110.087 -178.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 885' ' ' VAL . . . . . 0.472 HG13 HG21 ' B' ' 961' ' ' THR . 69.0 t -73.3 95.2 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 C-N-CA 118.671 -1.212 . . . . 1.01 108.447 -178.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 886' ' ' PHE . . . . . 0.958 ' HB3' HG22 ' B' ' 962' ' ' VAL . 2.2 t80 -88.76 105.18 17.54 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 115.318 -0.856 . . . . 0.050000000000000003 111.86 -177.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 887' ' ' THR . . . . . 0.418 ' O ' ' HD3' ' B' ' 889' ' ' PRO . 35.3 m -97.72 100.05 11.42 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 107.655 -1.239 . . . . 0.68000000000000005 107.655 177.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 888' ' ' ALA . . . . . 0.423 ' HB2' ' CE1' ' B' ' 886' ' ' PHE . . . -99.14 106.64 39.73 Favored Pre-proline 0 N--CA 1.502 2.132 0 N-CA-C 114.1 1.148 . . . . 0.25 114.1 -176.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 889' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' B' ' 887' ' ' THR . 54.6 Cg_endo -90.25 -12.49 2.69 Favored 'Trans proline' 0 CA--C 1.546 1.121 0 C-N-CA 121.084 1.19 . . . . 1.6399999999999999 109.181 176.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 890' ' ' LEU . . . . . 0.828 HD22 HD13 ' B' ' 985' ' ' LEU . 71.9 mt -36.44 -49.99 0.75 Allowed 'General case' 0 N--CA 1.508 2.469 0 N-CA-C 113.851 1.056 . . . . 2.29 113.851 -177.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 51.75 96.27 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.41 0 O-C-N 121.159 -0.963 . . . . 0.63 110.346 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . 156.08 -148.77 19.27 Favored Glycine 0 N--CA 1.481 1.638 0 N-CA-C 107.26 -2.336 . . . . 0.040000000000000001 107.26 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 71.6 ttt-85 -111.49 127.73 55.79 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.762 -1.199 . . . . 3.0 107.762 177.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 894' ' ' TYR . . . . . 0.541 ' OH ' HD12 ' B' ' 896' ' ' LEU . 0.0 OUTLIER -130.41 154.1 48.06 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.032 -1.043 . . . . 0.040000000000000001 110.903 -178.663 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 895' ' ' LEU . . . . . 0.44 ' N ' ' CD1' ' B' ' 894' ' ' TYR . 38.9 tp -96.82 114.08 25.68 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.464 -0.773 . . . . 1.27 110.033 -179.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 896' ' ' LEU . . . . . 0.541 HD12 ' OH ' ' B' ' 894' ' ' TYR . 10.4 tt -109.19 143.91 37.99 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.634 -0.666 . . . . 0.93999999999999995 110.994 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 897' ' ' SER . . . . . 0.53 ' N ' HD23 ' B' ' 896' ' ' LEU . 50.5 m -149.29 115.05 5.64 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.584 -0.697 . . . . 0.040000000000000001 110.748 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.39 147.55 30.22 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.173 -0.677 . . . . 0.47999999999999998 109.173 179.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 899' ' ' VAL . . . . . 0.746 HG21 ' HB ' ' B' ' 980' ' ' ILE . 97.5 t -93.0 120.53 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 C-N-CA 119.672 -0.811 . . . . 0.55000000000000004 111.123 -179.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 900' ' ' LEU . . . . . 0.436 ' N ' HD22 ' B' ' 900' ' ' LEU . 4.6 mm? -91.64 112.17 23.98 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 114.326 1.232 . . . . 1.5900000000000001 114.326 -175.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 23.0 m -67.43 141.64 56.94 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 107.109 -1.441 . . . . 0.050000000000000003 107.109 176.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -67.63 -66.53 2.3 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 110.469 -1.052 . . . . 0.029999999999999999 110.469 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 5.0 m170 46.22 66.09 1.03 Allowed 'General case' 0 N--CA 1.508 2.439 0 O-C-N 121.456 -1.026 . . . . 3.2000000000000002 111.215 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 43.3 ptt85 -69.5 -5.7 25.78 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.634 -0.666 . . . . 2.9199999999999999 112.052 -179.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 905' ' ' HIS . . . . . 0.492 ' O ' ' CB ' ' B' ' 906' ' ' GLU . 76.4 t60 -62.17 4.71 0.12 Allowed 'General case' 0 N--CA 1.506 2.359 0 O-C-N 120.811 -1.18 . . . . 2.8700000000000001 113.065 -179.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 906' ' ' GLU . . . . . 0.492 ' CB ' ' O ' ' B' ' 905' ' ' HIS . 0.8 OUTLIER 94.51 -164.57 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.388 0 CA-C-N 120.589 1.541 . . . . 0.98999999999999999 112.094 178.82 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 907' ' ' LYS . . . . . 0.475 ' CB ' ' O ' ' B' ' 906' ' ' GLU . 29.4 ttmt 88.88 160.84 0.06 Allowed 'General case' 0 N--CA 1.521 3.123 0 N-CA-C 108.321 -0.992 . . . . 5.25 108.321 -177.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 61.1 t -122.29 116.7 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 120.848 -1.158 . . . . 0.39000000000000001 110.864 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 909' ' ' GLU . . . . . 0.645 ' OE2' HD12 ' B' ' 966' ' ' LEU . 39.9 tp10 -104.78 131.97 51.6 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 107.565 -1.272 . . . . 1.72 107.565 177.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -156.67 120.73 4.36 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 106.778 -1.564 . . . . 0.67000000000000004 106.778 178.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 911' ' ' VAL . . . . . 0.497 ' HA ' ' HA ' ' B' ' 964' ' ' VAL . 14.4 p -77.31 132.97 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.75 -0.594 . . . . 0.54000000000000004 111.406 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 86.7 mt -65.6 156.04 33.95 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.18 -1.044 . . . . 1.5 108.18 178.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 913' ' ' SER . . . . . 0.44 ' CB ' ' HB ' ' B' ' 919' ' ' VAL . 1.4 t -125.1 137.37 54.18 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.329 -0.989 . . . . 1.3700000000000001 108.329 177.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 914' ' ' ARG . . . . . 0.552 ' HD3' HG12 ' B' ' 962' ' ' VAL . 0.0 OUTLIER -63.47 153.01 36.78 Favored 'General case' 0 N--CA 1.505 2.295 0 O-C-N 120.917 -1.114 . . . . 4.2999999999999998 111.757 -179.059 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 915' ' ' SER . . . . . 0.426 ' CB ' ' O ' ' B' ' 914' ' ' ARG . 3.5 t 83.24 -30.21 0.09 Allowed 'General case' 0 N--CA 1.521 3.1 0 C-N-CA 123.977 0.911 . . . . 2.0499999999999998 112.359 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 916' ' ' ASN . . . . . 0.629 ' HB2' HG21 ' B' ' 919' ' ' VAL . 72.9 m-20 -126.8 -21.41 4.06 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 120.892 -1.13 . . . . 2.71 111.394 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 917' ' ' GLN . . . . . 0.442 ' HB2' ' O ' ' B' ' 916' ' ' ASN . 58.7 mt-30 66.99 168.97 0.24 Allowed 'General case' 0 N--CA 1.519 2.977 0 N-CA-C 105.892 -1.892 . . . . 2.6800000000000002 105.892 -173.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.9 -128.79 44.13 Favored Glycine 1 N--CA 1.521 4.302 0 CA-C-N 123.455 2.843 . . . . 0.029999999999999999 106.442 -177.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 919' ' ' VAL . . . . . 0.629 HG21 ' HB2' ' B' ' 916' ' ' ASN . 84.1 t 50.55 94.57 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.3 0 CA-C-N 118.608 1.204 . . . . 1.3899999999999999 109.191 -178.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 920' ' ' ALA . . . . . 0.973 ' HB3' HG12 ' B' ' 949' ' ' VAL . . . -92.5 94.47 9.09 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.274 -0.97 . . . . 0.029999999999999999 111.116 -179.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 921' ' ' ARG . . . . . 0.761 ' HG3' HG23 ' B' ' 922' ' ' VAL . 34.9 ptt85 -80.73 -43.29 20.48 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 105.553 -2.017 . . . . 4.4199999999999999 105.553 176.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 922' ' ' VAL . . . . . 0.761 HG23 ' HG3' ' B' ' 921' ' ' ARG . 94.0 t -101.68 77.59 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 N-CA-C 104.935 -2.246 . . . . 0.84999999999999998 104.935 174.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -87.56 135.78 33.21 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 122.105 0.955 . . . . 2.46 112.427 -176.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 924' ' ' SER . . . . . . . . . . . . . 10.2 t -145.6 103.4 3.79 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.461 -1.311 . . . . 0.69999999999999996 107.461 178.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -103.77 81.81 0.36 Allowed Glycine 0 N--CA 1.486 2.023 0 N-CA-C 108.965 -1.654 . . . . 0.040000000000000001 108.965 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.958 0 N-CA-C 108.74 -1.744 . . . . 0.040000000000000001 108.74 179.849 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 21.9 m . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 120.923 0.392 . . . . 13.779999999999999 110.412 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 95.5 mt -110.43 129.72 55.71 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.5 -0.75 . . . . 13.76 110.324 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -152.36 169.85 31.58 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.381 -1.487 . . . . 9.1300000000000008 109.381 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 949' ' ' VAL . . . . . 0.973 HG12 ' HB3' ' B' ' 920' ' ' ALA . 34.4 m -118.46 132.36 68.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.548 -0.972 . . . . 7.0800000000000001 111.077 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 950' ' ' PHE . . . . . 0.463 ' CZ ' ' HB3' ' B' ' 921' ' ' ARG . 39.8 p90 -134.98 152.6 51.88 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 109.127 -0.694 . . . . 7.5899999999999999 109.127 179.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 67.9 m -120.97 -53.03 2.07 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.318 -0.864 . . . . 5.0300000000000002 112.362 -178.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 952' ' ' LEU . . . . . 0.457 HD23 ' HB2' ' A' ' 982' ' ' SER . 56.3 tp -61.91 -76.44 0.06 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.32 -0.862 . . . . 1.01 112.357 -177.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 953' ' ' ILE . . . . . 0.495 ' O ' ' HB3' ' B' ' 954' ' ' LEU . 43.9 pt -52.22 -145.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.749 0 N-CA-C 114.038 1.125 . . . . 2.6000000000000001 114.038 -176.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 954' ' ' LEU . . . . . 0.719 HD22 ' O ' ' B' ' 954' ' ' LEU . 0.0 OUTLIER 170.96 83.74 0.04 OUTLIER Pre-proline 0 N--CA 1.508 2.475 0 O-C-N 120.852 -1.155 . . . . 0.050000000000000003 111.609 179.494 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 955' ' ' PRO . . . . . 0.679 ' C ' HD12 ' B' ' 956' ' ' LEU . 48.7 Cg_endo -76.34 95.23 1.03 Allowed 'Trans proline' 0 C--N 1.313 -1.292 0 N-CA-C 108.759 -1.285 . . . . 0.83999999999999997 108.759 177.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 956' ' ' LEU . . . . . 0.679 HD12 ' C ' ' B' ' 955' ' ' PRO . 10.3 mp -122.3 143.9 49.33 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.151 -0.968 . . . . 0.040000000000000001 110.183 -179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 67.8 mt-30 -86.01 151.18 23.93 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 117.81 -1.09 . . . . 1.28 111.639 -179.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -68.61 119.72 13.49 Favored 'General case' 0 N--CA 1.51 2.54 0 CA-C-N 122.862 2.574 . . . . 0.17000000000000001 111.843 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 93.36 -21.5 40.24 Favored Glycine 0 N--CA 1.5 2.962 0 N-CA-C 111.15 -0.78 . . . . 0.040000000000000001 111.15 178.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 960' ' ' ASP . . . . . 0.419 ' HB3' ' NE ' ' B' ' 914' ' ' ARG . 0.5 OUTLIER -55.68 169.77 0.31 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.457 -1.025 . . . . 0.040000000000000001 110.203 -179.489 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 961' ' ' THR . . . . . 0.472 HG21 HG13 ' B' ' 885' ' ' VAL . 46.0 m -136.86 139.49 41.7 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 120.835 -1.165 . . . . 1.78 112.408 -177.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 962' ' ' VAL . . . . . 0.958 HG22 ' HB3' ' B' ' 886' ' ' PHE . 31.8 m -99.87 145.15 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 C-N-CA 120.023 -0.671 . . . . 0.040000000000000001 111.116 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 5.4 t -137.96 145.42 41.98 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.907 -0.496 . . . . 0.71999999999999997 109.981 -179.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 964' ' ' VAL . . . . . 0.497 ' HA ' ' HA ' ' B' ' 911' ' ' VAL . 61.7 t -92.23 136.71 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.052 -1.03 . . . . 1.05 111.279 -178.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -95.69 126.42 40.96 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 103.464 -2.791 . . . . 3.02 103.464 172.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 966' ' ' LEU . . . . . 0.645 HD12 ' OE2' ' B' ' 909' ' ' GLU . 0.2 OUTLIER -133.6 61.39 1.68 Allowed 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.408 -0.96 . . . . 1.46 108.408 177.365 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 967' ' ' VAL . . . . . 0.486 HG23 ' C ' ' B' ' 966' ' ' LEU . 97.6 t -157.73 96.64 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 108.283 -1.006 . . . . 1.9399999999999999 108.283 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 92.8 mmm -143.4 58.68 1.39 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.752 -1.217 . . . . 0.0 108.251 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 133.87 119.75 2.02 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 107.05 -2.42 . . . . 2.1099999999999999 107.05 -178.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -82.46 -57.1 3.5 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.971 -1.311 . . . . 5.8899999999999997 110.499 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 47.8 tp -58.68 90.03 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.402 -0.811 . . . . 4.3600000000000003 110.318 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -143.03 -152.92 0.43 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.637 -0.665 . . . . 1.8300000000000001 110.079 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -117.83 167.41 11.42 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.473 -0.767 . . . . 4.3499999999999996 110.278 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 30.2 t -101.79 130.26 48.18 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.554 -0.716 . . . . 1.27 110.082 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -156.07 158.99 38.71 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.535 -0.728 . . . . 5.0199999999999996 110.643 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.71 85.08 20.94 Favored Pre-proline 0 N--CA 1.5 2.056 0 O-C-N 121.62 -0.675 . . . . 2.4100000000000001 109.72 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -73.41 -171.89 0.92 Allowed 'Trans proline' 0 C--N 1.317 -1.129 0 O-C-N 123.3 1.158 . . . . 0.95999999999999996 111.283 -179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 978' ' ' LEU . . . . . 0.57 ' N ' HD12 ' B' ' 978' ' ' LEU . 5.2 mp -126.82 155.93 42.1 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 107.546 -1.279 . . . . 0.62 107.546 177.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 979' ' ' THR . . . . . 0.462 HG23 ' C ' ' B' ' 978' ' ' LEU . 47.6 p -149.47 141.59 23.98 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.837 -1.165 . . . . 3.5699999999999998 111.184 -179.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 980' ' ' ILE . . . . . 0.746 ' HB ' HG21 ' B' ' 899' ' ' VAL . 50.6 mm -107.47 129.09 61.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 N-CA-C 109.062 -0.718 . . . . 1.3300000000000001 109.062 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 981' ' ' PHE . . . . . 0.496 ' CD1' ' CE2' ' B' ' 879' ' ' TYR . 10.5 t80 -119.99 97.38 5.58 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 119.594 -0.843 . . . . 0.050000000000000003 111.926 -178.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 16.0 p -108.78 158.25 17.82 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 109.163 -0.68 . . . . 0.87 109.163 178.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 983' ' ' GLY . . . . . 0.41 ' O ' ' CE1' ' B' ' 852' ' ' PHE . . . -173.98 111.09 0.35 Allowed Glycine 0 N--CA 1.498 2.812 0 N-CA-C 106.655 -2.578 . . . . 0.029999999999999999 106.655 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 984' ' ' ALA . . . . . 0.423 ' HB1' ' CZ ' ' C' ' 893' ' ' ARG . . . -108.28 149.27 28.86 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 114.32 1.23 . . . . 0.69999999999999996 114.32 -175.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 985' ' ' LEU . . . . . 0.828 HD13 HD22 ' B' ' 890' ' ' LEU . 66.4 tp -71.75 136.28 47.09 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.728 -1.233 . . . . 0.040000000000000001 110.201 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 986' ' ' LEU . . . . . . . . . . . . . 49.3 tp -106.53 -58.07 1.97 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.671 -0.643 . . . . 0.040000000000000001 109.946 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -143.87 146.07 32.76 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.71 -1.218 . . . . 0.040000000000000001 107.71 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.46 162.96 12.22 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 108.088 -2.005 . . . . 0.040000000000000001 108.088 179.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -77.38 111.88 20.08 Favored Pre-proline 0 N--CA 1.499 1.988 0 O-C-N 121.226 -1.161 . . . . 0.040000000000000001 109.524 179.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 990' ' ' PRO . . . . . 0.631 ' HD2' HD12 ' B' ' 992' ' ' LEU . 48.7 Cg_endo -92.55 72.01 0.57 Allowed 'Trans proline' 0 C--N 1.318 -1.031 0 O-C-N 123.063 1.033 . . . . 0.45000000000000001 111.328 -178.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 991' ' ' GLU . . . . . 0.421 ' HB2' ' O ' ' B' ' 990' ' ' PRO . 72.4 mt-10 67.67 -73.43 0.08 Allowed 'General case' 0 N--CA 1.503 2.179 0 N-CA-C 108.251 -1.018 . . . . 1.97 108.251 -177.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 992' ' ' LEU . . . . . 0.631 HD12 ' HD2' ' B' ' 990' ' ' PRO . 4.1 mt 50.47 20.48 0.7 Allowed 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.58 -0.7 . . . . 2.3799999999999999 111.731 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 76.4 mt-10 -95.87 156.88 16.14 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.893 -1.13 . . . . 3.79 110.082 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 68.0 m80 -144.16 94.76 2.62 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.515 -0.741 . . . . 3.5099999999999998 110.2 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 995' ' ' ALA . . . . . . . . . . . . 2.517 . . . . . . . 0 N--CA 1.503 2.207 0 O-C-N 120.873 -1.142 . . . . 2.73 110.591 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo . . . . . 0 N--CA 1.488 1.152 0 N-CA-C 109.559 -0.977 . . . . 3.8300000000000001 109.559 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 847' ' ' VAL . . . . . 0.401 HG12 ' HB2' ' C' ' 849' ' ' GLN . 68.8 t -131.34 104.66 14.8 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.592 -0.692 . . . . 1.8300000000000001 109.819 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 848' ' ' PRO . . . . . 0.761 ' O ' HG23 ' C' ' 850' ' ' VAL . 43.7 Cg_endo -69.7 -19.56 36.26 Favored 'Trans proline' 0 N--CA 1.487 1.118 0 O-C-N 123.295 1.155 . . . . 0.65000000000000002 111.264 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 849' ' ' GLN . . . . . 0.411 ' C ' ' O ' ' C' ' 848' ' ' PRO . 56.2 tt0 26.24 68.49 0.05 Allowed 'General case' 0 N--CA 1.52 3.037 0 N-CA-C 112.893 0.701 . . . . 2.5800000000000001 112.893 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 850' ' ' VAL . . . . . 0.761 HG23 ' O ' ' C' ' 848' ' ' PRO . 93.5 t -117.21 135.24 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.245 -0.909 . . . . 1.0900000000000001 111.201 -178.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 851' ' ' ALA . . . . . . . . . . . . . . . -133.41 151.2 51.79 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 105.74 -1.948 . . . . 0.040000000000000001 105.74 177.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 852' ' ' PHE . . . . . 0.427 ' HA ' ' CB ' ' C' ' 874' ' ' ASN . 11.2 p90 -158.89 133.27 7.89 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 120.865 1.666 . . . . 0.050000000000000003 108.914 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 7.4 t -174.09 134.04 0.43 Allowed 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 107.954 -1.128 . . . . 0.040000000000000001 107.954 -179.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -136.44 159.25 42.33 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.167 -0.958 . . . . 0.67000000000000004 109.671 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 855' ' ' ALA . . . . . 0.61 ' HB3' ' CB ' ' C' ' 870' ' ' ARG . . . -122.86 140.64 52.74 Favored 'General case' 0 N--CA 1.499 1.994 0 CA-C-O 121.939 0.876 . . . . 0.51000000000000001 112.254 -178.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 856' ' ' LEU . . . . . 0.767 HD23 ' O ' ' C' ' 867' ' ' PRO . 3.5 tm? -106.6 138.52 42.63 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.645 -0.659 . . . . 0.050000000000000003 109.578 179.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 857' ' ' SER . . . . . 0.613 ' N ' HD13 ' C' ' 856' ' ' LEU . 1.3 m -159.23 18.65 0.18 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.443 -0.786 . . . . 1.3300000000000001 111.836 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 858' ' ' LEU . . . . . 0.724 HD23 HD11 ' C' ' 856' ' ' LEU . 2.7 pp -34.57 160.0 0.04 OUTLIER Pre-proline 0 N--CA 1.519 3.02 0 CA-C-N 118.603 0.638 . . . . 2.3300000000000001 112.689 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -60.19 -88.52 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.517 0 C-N-CA 120.734 0.956 . . . . 2.3199999999999998 113.348 -178.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 55.4 ptt85 -130.47 -143.35 0.25 Allowed 'General case' 0 N--CA 1.5 2.052 0 O-C-N 120.883 -1.135 . . . . 0.040000000000000001 111.978 -177.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 41.2 m -33.31 120.55 0.38 Allowed 'General case' 0 N--CA 1.511 2.617 0 N-CA-C 113.241 0.83 . . . . 1.3100000000000001 113.241 -178.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.79 159.49 29.16 Favored Pre-proline 0 N--CA 1.486 1.342 0 N-CA-C 107.626 -1.25 . . . . 4.5099999999999998 107.626 176.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -69.78 -13.66 34.93 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 O-C-N 123.104 1.055 . . . . 2.2400000000000002 111.524 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -176.65 -135.26 2.13 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 109.911 -1.275 . . . . 0.040000000000000001 109.911 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 30.1 m -70.41 157.76 37.22 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.332 -1.099 . . . . 1.51 110.416 -179.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 866' ' ' VAL . . . . . 0.465 ' HA ' ' HD3' ' C' ' 867' ' ' PRO . 30.7 m -95.23 142.67 24.92 Favored Pre-proline 0 N--CA 1.498 1.964 0 N-CA-C 114.233 1.197 . . . . 0.78000000000000003 114.233 -174.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 867' ' ' PRO . . . . . 0.767 ' O ' HD23 ' C' ' 856' ' ' LEU . 55.6 Cg_endo -89.91 -150.69 0.04 OUTLIER 'Trans proline' 0 CA--C 1.541 0.871 0 N-CA-C 108.339 -1.446 . . . . 0.92000000000000004 108.339 177.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 868' ' ' PHE . . . . . 0.469 ' CD1' ' HG2' ' C' ' 881' ' ' PRO . 14.1 p90 -148.32 121.05 8.64 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.48 -1.387 . . . . 0.050000000000000003 109.865 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 50.0 p-10 -112.03 -3.97 14.62 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.15 -0.969 . . . . 1.7 112.471 -178.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 870' ' ' ARG . . . . . 0.61 ' CB ' ' HB3' ' C' ' 855' ' ' ALA . 22.7 mmm180 -90.93 89.19 7.34 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.96 -1.087 . . . . 2.5899999999999999 111.031 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 61.2 t -76.51 96.52 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 120.979 -1.075 . . . . 1.9399999999999999 109.238 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 872' ' ' LEU . . . . . 0.496 HD13 HD11 ' A' ' 953' ' ' ILE . 66.8 mt -85.78 -44.61 12.35 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.546 -0.721 . . . . 1.0600000000000001 110.559 -179.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 873' ' ' LEU . . . . . 0.419 ' O ' ' HB2' ' C' ' 874' ' ' ASN . 47.5 tp -172.21 104.33 0.17 Allowed 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.209 -0.932 . . . . 4.1799999999999997 108.71 178.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 874' ' ' ASN . . . . . 0.427 ' CB ' ' HA ' ' C' ' 852' ' ' PHE . 49.5 t-20 178.25 82.65 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.33 0 O-C-N 121.733 -0.604 . . . . 0.040000000000000001 109.588 -178.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 33.0 p-10 -72.07 -49.44 36.48 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.092 -1.005 . . . . 3.3799999999999999 111.705 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 876' ' ' GLY . . . . . . . . . . . . . . . -73.24 -26.43 70.53 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 110.617 -0.993 . . . . 0.040000000000000001 110.617 -179.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 81.34 -61.46 4.6 Favored Glycine 0 N--CA 1.497 2.742 0 N-CA-C 108.27 -1.932 . . . . 0.040000000000000001 108.27 -178.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 878' ' ' TYR . . . . . 0.54 ' CE2' HG13 ' C' ' 850' ' ' VAL . 85.6 m-85 61.62 -61.95 0.09 Allowed 'General case' 0 N--CA 1.504 2.25 0 N-CA-C 113.426 0.899 . . . . 3.46 113.426 178.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 879' ' ' TYR . . . . . 0.494 ' O ' ' CG ' ' C' ' 879' ' ' TYR . 12.2 p90 -110.97 105.33 14.07 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.991 -1.068 . . . . 0.040000000000000001 113.259 -177.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 880' ' ' ASP . . . . . 0.419 ' O ' ' N ' ' C' ' 884' ' ' GLY . 1.2 m-20 -66.69 112.68 10.17 Favored Pre-proline 0 N--CA 1.497 1.883 0 O-C-N 121.161 -0.962 . . . . 0.02 110.526 -178.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 881' ' ' PRO . . . . . 0.469 ' HG2' ' CD1' ' C' ' 868' ' ' PHE . 52.2 Cg_endo -79.05 -3.33 13.1 Favored 'Trans proline' 0 N--CA 1.489 1.238 0 O-C-N 123.531 1.279 . . . . 0.39000000000000001 111.213 179.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -80.31 -34.57 36.65 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 108.033 -1.099 . . . . 0.81000000000000005 108.033 178.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 69.6 p -110.36 -20.31 12.66 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 115.462 -0.79 . . . . 0.040000000000000001 108.984 176.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 884' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' C' ' 880' ' ' ASP . . . 80.07 4.88 89.78 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 110.232 -1.147 . . . . 0.029999999999999999 110.232 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 71.0 t -74.39 94.61 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 C-N-CA 118.695 -1.202 . . . . 1.01 108.532 -178.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 886' ' ' PHE . . . . . 0.865 ' CB ' HG22 ' C' ' 962' ' ' VAL . 2.1 t80 -88.74 105.8 17.94 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 115.513 -0.767 . . . . 0.050000000000000003 111.785 -177.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 887' ' ' THR . . . . . . . . . . . . . 28.0 m -98.53 99.99 11.2 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.787 -1.19 . . . . 0.68000000000000005 107.787 177.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 888' ' ' ALA . . . . . 0.529 ' HB2' ' CE1' ' C' ' 886' ' ' PHE . . . -97.87 108.3 45.31 Favored Pre-proline 0 N--CA 1.5 2.062 0 N-CA-C 113.606 0.965 . . . . 0.25 113.606 -176.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 889' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -89.87 -12.77 2.81 Favored 'Trans proline' 0 CA--C 1.544 1.02 0 C-N-CA 120.999 1.133 . . . . 1.6399999999999999 109.246 176.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 890' ' ' LEU . . . . . 0.734 HD12 ' N ' ' C' ' 891' ' ' ALA . 3.0 pp -36.87 -48.34 0.74 Allowed 'General case' 0 N--CA 1.508 2.47 0 N-CA-C 113.819 1.044 . . . . 2.29 113.819 -177.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 891' ' ' ALA . . . . . 0.734 ' N ' HD12 ' C' ' 890' ' ' LEU . . . 51.17 95.49 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.34 0 O-C-N 120.998 -1.064 . . . . 0.63 110.472 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . 155.43 -146.9 15.1 Favored Glycine 0 N--CA 1.479 1.566 0 N-CA-C 107.274 -2.33 . . . . 0.040000000000000001 107.274 -179.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 893' ' ' ARG . . . . . 0.423 ' CZ ' ' HB1' ' B' ' 984' ' ' ALA . 76.5 ttt-85 -108.52 127.06 53.6 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 107.223 -1.399 . . . . 3.0 107.223 176.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 894' ' ' TYR . . . . . 0.55 ' HD2' HD23 ' C' ' 954' ' ' LEU . 0.5 OUTLIER -130.75 155.09 47.24 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.099 -1.001 . . . . 0.040000000000000001 110.841 -178.547 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 895' ' ' LEU . . . . . 0.428 ' O ' ' CE1' ' C' ' 894' ' ' TYR . 41.5 tp -99.79 117.3 33.82 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.652 -0.655 . . . . 1.27 110.539 -179.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 896' ' ' LEU . . . . . 0.85 HD23 ' N ' ' C' ' 897' ' ' SER . 4.5 tt -115.59 140.56 49.06 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.509 -0.745 . . . . 0.93999999999999995 110.35 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 897' ' ' SER . . . . . 0.85 ' N ' HD23 ' C' ' 896' ' ' LEU . 50.3 m -147.07 118.44 7.87 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.376 -0.828 . . . . 0.040000000000000001 111.286 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -108.64 147.41 31.91 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 109.401 -0.592 . . . . 0.47999999999999998 109.401 178.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 899' ' ' VAL . . . . . 0.721 HG21 ' HB ' ' C' ' 980' ' ' ILE . 97.9 t -93.19 121.53 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 C-N-CA 119.68 -0.808 . . . . 0.55000000000000004 111.29 -179.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 900' ' ' LEU . . . . . 0.44 HD12 ' HB2' ' C' ' 924' ' ' SER . 4.6 mm? -90.52 111.59 22.93 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 114.564 1.32 . . . . 1.5900000000000001 114.564 -175.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 21.6 m -67.09 142.09 57.23 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 106.974 -1.491 . . . . 0.050000000000000003 106.974 176.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -69.14 -67.71 1.86 Allowed Glycine 0 N--CA 1.494 2.549 0 N-CA-C 110.435 -1.066 . . . . 0.029999999999999999 110.435 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 5.2 t-80 46.24 66.46 0.95 Allowed 'General case' 0 N--CA 1.509 2.483 0 O-C-N 121.442 -1.034 . . . . 3.2000000000000002 111.122 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 46.4 ptt85 -69.12 -6.9 31.42 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.611 -0.681 . . . . 2.9199999999999999 112.043 -179.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 905' ' ' HIS . . . . . 0.488 ' O ' ' CB ' ' C' ' 906' ' ' GLU . 78.1 t60 -58.24 4.58 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.516 0 CA-C-O 117.653 -1.165 . . . . 2.8700000000000001 113.953 -179.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 906' ' ' GLU . . . . . 0.488 ' CB ' ' O ' ' C' ' 905' ' ' HIS . 0.0 OUTLIER 94.02 -167.1 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.413 0 CA-C-N 121.264 1.847 . . . . 0.98999999999999999 112.011 179.096 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 907' ' ' LYS . . . . . 0.476 ' CB ' ' O ' ' C' ' 906' ' ' GLU . 30.3 ttmt 87.89 160.42 0.07 Allowed 'General case' 0 N--CA 1.518 2.969 0 N-CA-C 108.026 -1.102 . . . . 5.25 108.026 -177.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 59.2 t -120.9 116.38 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 O-C-N 120.947 -1.095 . . . . 0.39000000000000001 110.652 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 75.7 tt0 -103.66 131.65 50.62 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 107.298 -1.371 . . . . 1.72 107.298 176.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -155.34 122.36 5.45 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 106.445 -1.687 . . . . 0.67000000000000004 106.445 178.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 911' ' ' VAL . . . . . 0.722 HG13 HG22 ' C' ' 964' ' ' VAL . 70.1 t -77.41 131.95 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.826 -0.546 . . . . 0.54000000000000004 110.679 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 84.0 mt -65.67 157.07 31.0 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.279 -0.888 . . . . 1.5 108.718 178.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 913' ' ' SER . . . . . 0.472 ' OG ' HG11 ' C' ' 919' ' ' VAL . 1.3 p -127.17 132.65 50.46 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.174 -1.047 . . . . 1.3700000000000001 108.174 176.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 914' ' ' ARG . . . . . 0.428 ' O ' ' CB ' ' C' ' 915' ' ' SER . 0.0 OUTLIER -58.81 154.45 14.92 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 120.764 -1.21 . . . . 4.2999999999999998 112.097 -178.848 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 915' ' ' SER . . . . . 0.428 ' CB ' ' O ' ' C' ' 914' ' ' ARG . 1.8 t 83.13 -30.29 0.09 Allowed 'General case' 0 N--CA 1.519 3.022 0 C-N-CA 123.869 0.868 . . . . 2.0499999999999998 112.476 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 916' ' ' ASN . . . . . 0.617 ' HB2' HG21 ' C' ' 919' ' ' VAL . 97.2 m-20 -126.8 -23.5 3.67 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 120.891 -1.13 . . . . 2.71 111.173 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 917' ' ' GLN . . . . . 0.412 ' HB2' ' O ' ' C' ' 916' ' ' ASN . 41.8 mt-30 68.49 168.23 0.27 Allowed 'General case' 0 N--CA 1.517 2.917 0 N-CA-C 105.776 -1.935 . . . . 2.6800000000000002 105.776 -174.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 56.45 -127.72 44.56 Favored Glycine 1 N--CA 1.519 4.19 0 CA-C-N 123.397 2.817 . . . . 0.029999999999999999 106.467 -177.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 919' ' ' VAL . . . . . 0.617 HG21 ' HB2' ' C' ' 916' ' ' ASN . 95.0 t 50.45 94.83 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.336 0 CA-C-N 118.534 1.167 . . . . 1.3899999999999999 109.426 -178.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 920' ' ' ALA . . . . . 0.939 ' HB3' HG12 ' C' ' 949' ' ' VAL . . . -93.93 93.7 8.05 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.336 -0.946 . . . . 0.029999999999999999 111.049 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 921' ' ' ARG . . . . . 0.668 ' HG3' HG23 ' C' ' 922' ' ' VAL . 45.4 ptt85 -83.19 -42.96 16.67 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 105.582 -2.007 . . . . 4.4199999999999999 105.582 176.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 922' ' ' VAL . . . . . 0.668 HG23 ' HG3' ' C' ' 921' ' ' ARG . 77.3 t -101.05 74.65 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 104.71 -2.33 . . . . 0.84999999999999998 104.71 174.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -86.74 136.87 32.85 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 122.074 0.94 . . . . 2.46 112.614 -176.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 924' ' ' SER . . . . . 0.44 ' HB2' HD12 ' C' ' 900' ' ' LEU . 6.4 t -145.8 103.17 3.75 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 107.719 -1.215 . . . . 0.69999999999999996 107.719 178.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -107.48 85.75 0.43 Allowed Glycine 0 N--CA 1.488 2.123 0 N-CA-C 108.905 -1.678 . . . . 0.040000000000000001 108.905 -179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.278 0 N-CA-C 109.151 -1.58 . . . . 0.040000000000000001 109.151 -179.707 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 31.1 m . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 120.971 0.415 . . . . 13.779999999999999 110.335 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 947' ' ' LEU . . . . . 0.412 ' CD2' HG23 ' C' ' 919' ' ' VAL . 92.5 mt -110.37 129.56 55.73 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.487 -0.758 . . . . 13.76 110.312 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -152.25 169.71 31.51 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.348 -1.501 . . . . 9.1300000000000008 109.348 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 949' ' ' VAL . . . . . 0.939 HG12 ' HB3' ' C' ' 920' ' ' ALA . 33.5 m -118.69 131.74 70.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.551 -0.97 . . . . 7.0800000000000001 110.843 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 950' ' ' PHE . . . . . 0.457 ' CZ ' ' HB3' ' C' ' 921' ' ' ARG . 48.2 p90 -133.36 151.14 51.82 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.579 -0.7 . . . . 7.5899999999999999 109.113 179.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 7.3 m -119.64 -53.19 2.21 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.401 -0.812 . . . . 5.0300000000000002 112.096 -178.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 952' ' ' LEU . . . . . 0.425 ' O ' ' O ' ' C' ' 953' ' ' ILE . 15.4 tp -62.99 -74.78 0.09 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.354 -0.841 . . . . 1.01 112.018 -177.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 953' ' ' ILE . . . . . 0.597 HD11 HD13 ' B' ' 872' ' ' LEU . 41.8 pt -52.42 -146.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.77 0 N-CA-C 114.145 1.165 . . . . 2.6000000000000001 114.145 -176.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 954' ' ' LEU . . . . . 0.707 HD22 ' O ' ' C' ' 954' ' ' LEU . 0.0 OUTLIER 169.0 80.38 0.03 OUTLIER Pre-proline 0 N--CA 1.512 2.674 0 O-C-N 120.957 -1.089 . . . . 0.050000000000000003 111.695 179.563 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 955' ' ' PRO . . . . . 0.436 ' HD2' ' CE1' ' C' ' 950' ' ' PHE . 44.4 Cg_endo -72.66 98.84 1.0 Allowed 'Trans proline' 0 C--N 1.313 -1.325 0 N-CA-C 109.193 -1.118 . . . . 0.83999999999999997 109.193 178.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 956' ' ' LEU . . . . . 0.408 ' HA ' ' NH1' ' C' ' 914' ' ' ARG . 92.0 mt -125.26 142.29 51.59 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.052 -1.03 . . . . 0.040000000000000001 110.492 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 957' ' ' GLN . . . . . 0.447 ' HB2' ' HB3' ' C' ' 960' ' ' ASP . 87.2 mt-30 -84.98 149.49 25.57 Favored 'General case' 0 N--CA 1.501 2.124 0 CA-C-O 117.997 -1.001 . . . . 1.28 111.919 -178.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -62.11 122.29 15.19 Favored 'General case' 0 N--CA 1.512 2.635 0 CA-C-N 122.751 2.523 . . . . 0.17000000000000001 110.799 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 91.48 -10.31 75.09 Favored Glycine 0 N--CA 1.501 3.011 0 N-CA-C 110.167 -1.173 . . . . 0.040000000000000001 110.167 -179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 960' ' ' ASP . . . . . 0.447 ' HB3' ' HB2' ' C' ' 957' ' ' GLN . 16.3 p-10 -47.96 167.92 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.546 -0.973 . . . . 0.040000000000000001 111.98 -179.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 961' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' C' ' 886' ' ' PHE . 91.1 m -137.96 127.15 24.42 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.403 -0.811 . . . . 1.78 110.087 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 962' ' ' VAL . . . . . 0.865 HG22 ' CB ' ' C' ' 886' ' ' PHE . 12.0 m -100.96 142.95 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 C-N-CA 119.392 -0.923 . . . . 0.040000000000000001 110.45 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 5.5 t -140.41 145.77 37.47 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.968 -0.457 . . . . 0.71999999999999997 109.875 -178.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 964' ' ' VAL . . . . . 0.722 HG22 HG13 ' C' ' 911' ' ' VAL . 60.1 t -100.71 136.96 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.041 -1.037 . . . . 1.05 111.296 -178.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -96.42 128.11 43.04 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 103.967 -2.605 . . . . 3.02 103.967 173.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 966' ' ' LEU . . . . . 0.489 ' C ' HG23 ' C' ' 967' ' ' VAL . 11.7 tp -132.38 64.33 1.61 Allowed 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.254 -1.017 . . . . 1.46 108.254 177.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 967' ' ' VAL . . . . . 0.489 HG23 ' C ' ' C' ' 966' ' ' LEU . 96.9 t -157.81 97.19 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 108.041 -1.096 . . . . 1.9399999999999999 108.041 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 91.1 mmm -143.17 59.13 1.41 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.713 -1.242 . . . . 0.0 108.359 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.35 119.93 1.97 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 107.124 -2.39 . . . . 2.1099999999999999 107.124 -178.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -81.56 -57.94 3.24 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.01 -1.288 . . . . 5.8899999999999997 110.574 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 45.4 tp -58.64 90.24 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.433 -0.792 . . . . 4.3600000000000003 110.395 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -142.97 -153.47 0.47 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.573 -0.704 . . . . 1.8300000000000001 110.188 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -118.69 166.86 12.24 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.501 -0.75 . . . . 4.3499999999999996 110.323 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 31.1 t -102.14 130.18 48.7 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.522 -0.736 . . . . 1.27 109.944 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 66.8 tt0 -156.25 159.53 38.98 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.466 -0.771 . . . . 5.0199999999999996 110.628 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.1 85.82 21.59 Favored Pre-proline 0 N--CA 1.5 2.067 0 O-C-N 121.646 -0.659 . . . . 2.4100000000000001 109.755 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 977' ' ' PRO . . . . . 0.516 ' C ' HD12 ' C' ' 978' ' ' LEU . 47.3 Cg_endo -72.97 -170.74 0.66 Allowed 'Trans proline' 0 C--N 1.316 -1.138 0 O-C-N 123.323 1.17 . . . . 0.95999999999999996 111.159 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 978' ' ' LEU . . . . . 0.516 HD12 ' C ' ' C' ' 977' ' ' PRO . 5.8 mp -126.17 155.88 41.03 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 107.703 -1.221 . . . . 0.62 107.703 178.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 979' ' ' THR . . . . . 0.452 HG23 ' C ' ' C' ' 978' ' ' LEU . 63.7 p -148.83 141.17 24.15 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.853 -1.154 . . . . 3.5699999999999998 111.09 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 980' ' ' ILE . . . . . 0.721 ' HB ' HG21 ' C' ' 899' ' ' VAL . 49.2 mm -107.06 129.24 61.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 108.982 -0.747 . . . . 1.3300000000000001 108.982 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 981' ' ' PHE . . . . . 0.454 ' CD1' ' CE2' ' C' ' 879' ' ' TYR . 5.3 t80 -119.92 96.44 5.18 Favored 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 119.606 -0.837 . . . . 0.050000000000000003 111.796 -178.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 982' ' ' SER . . . . . . . . . . . . . 94.8 p -108.55 157.19 18.7 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.831 -0.803 . . . . 0.87 108.831 178.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 983' ' ' GLY . . . . . . . . . . . . . . . -172.86 112.86 0.45 Allowed Glycine 0 N--CA 1.496 2.671 0 N-CA-C 106.841 -2.503 . . . . 0.029999999999999999 106.841 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 984' ' ' ALA . . . . . 0.416 ' HB1' ' CZ ' ' A' ' 893' ' ' ARG . . . -109.83 146.98 34.13 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 114.142 1.164 . . . . 0.69999999999999996 114.142 -176.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 985' ' ' LEU . . . . . . . . . . . . . 56.6 tp -71.24 136.88 48.21 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 120.788 -1.195 . . . . 0.040000000000000001 110.2 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 986' ' ' LEU . . . . . . . . . . . . . 51.7 tp -106.21 -60.65 1.62 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.597 -0.689 . . . . 0.040000000000000001 110.285 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -143.82 146.46 33.09 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.896 -1.15 . . . . 0.040000000000000001 107.896 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.79 162.62 12.31 Favored Glycine 0 N--CA 1.496 2.695 0 N-CA-C 108.132 -1.987 . . . . 0.040000000000000001 108.132 179.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.72 111.86 22.62 Favored Pre-proline 0 N--CA 1.499 1.999 0 CA-C-N 118.571 1.186 . . . . 0.040000000000000001 109.539 178.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 990' ' ' PRO . . . . . 0.471 ' HD2' HD12 ' C' ' 992' ' ' LEU . 48.8 Cg_endo -92.59 74.0 0.48 Allowed 'Trans proline' 0 C--N 1.318 -1.059 0 O-C-N 123.117 1.062 . . . . 0.45000000000000001 111.527 -179.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 991' ' ' GLU . . . . . 0.417 ' HB2' ' O ' ' C' ' 990' ' ' PRO . 77.1 mt-10 67.26 -73.67 0.08 Allowed 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 108.48 -0.933 . . . . 1.97 108.48 -177.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 992' ' ' LEU . . . . . 0.471 HD12 ' HD2' ' C' ' 990' ' ' PRO . 6.9 mt 51.65 20.38 1.08 Allowed 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.521 -0.737 . . . . 2.3799999999999999 111.591 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -95.39 156.88 16.13 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.855 -1.153 . . . . 3.79 110.066 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 67.3 m80 -146.44 94.55 2.47 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.534 -0.729 . . . . 3.5099999999999998 110.345 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 995' ' ' ALA . . . . . . . . . . . . 2.518 . . . . . . . 0 N--CA 1.504 2.225 0 O-C-N 120.955 -1.09 . . . . 2.73 110.616 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo . . . . . 0 N--CA 1.488 1.177 0 N-CA-C 109.482 -1.007 . . . . 3.8300000000000001 109.482 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 847' ' ' VAL . . . . . 0.432 HG12 ' HB2' ' A' ' 849' ' ' GLN . 60.1 t -132.04 103.58 14.16 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.583 -0.698 . . . . 1.8300000000000001 110.073 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 848' ' ' PRO . . . . . 0.718 ' O ' HG23 ' A' ' 850' ' ' VAL . 43.9 Cg_endo -69.8 -19.89 35.34 Favored 'Trans proline' 0 N--CA 1.487 1.106 0 O-C-N 123.302 1.159 . . . . 0.65000000000000002 111.125 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 849' ' ' GLN . . . . . 0.432 ' HB2' HG12 ' A' ' 847' ' ' VAL . 56.4 tt0 26.42 69.24 0.05 Allowed 'General case' 0 N--CA 1.519 2.989 0 N-CA-C 112.948 0.721 . . . . 2.5800000000000001 112.948 179.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 850' ' ' VAL . . . . . 0.718 HG23 ' O ' ' A' ' 848' ' ' PRO . 59.7 t -117.46 137.86 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 121.292 -0.88 . . . . 1.0900000000000001 111.63 -178.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 851' ' ' ALA . . . . . 0.495 ' HB3' ' HG ' ' A' ' 873' ' ' LEU . . . -127.69 155.41 44.0 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 105.723 -1.954 . . . . 0.040000000000000001 105.723 176.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 852' ' ' PHE . . . . . 0.446 ' HA ' ' CB ' ' A' ' 874' ' ' ASN . 21.4 p90 -160.4 128.87 4.73 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-N 121.016 1.735 . . . . 0.050000000000000003 108.864 179.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 33.1 t -175.57 134.57 0.3 Allowed 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.071 -1.085 . . . . 0.040000000000000001 108.071 -179.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -134.85 158.42 44.26 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.053 -1.029 . . . . 0.67000000000000004 109.501 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 855' ' ' ALA . . . . . 0.78 ' HB3' ' CB ' ' A' ' 870' ' ' ARG . . . -122.58 141.02 52.14 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-O 121.894 0.854 . . . . 0.51000000000000001 111.852 -178.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 856' ' ' LEU . . . . . 0.925 HD11 HD23 ' A' ' 858' ' ' LEU . 3.5 tm? -107.64 135.53 48.93 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 109.247 -0.649 . . . . 0.050000000000000003 109.247 179.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 857' ' ' SER . . . . . 0.572 ' N ' HD13 ' A' ' 856' ' ' LEU . 16.9 p -153.05 17.82 0.57 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.419 -0.8 . . . . 1.3300000000000001 111.223 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 858' ' ' LEU . . . . . 0.925 HD23 HD11 ' A' ' 856' ' ' LEU . 3.1 pp -29.66 154.08 0.03 OUTLIER Pre-proline 0 N--CA 1.52 3.046 0 N-CA-C 113.421 0.897 . . . . 2.3300000000000001 113.421 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -61.73 -88.8 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.497 0 C-N-CA 120.934 1.09 . . . . 2.3199999999999998 113.683 -177.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 53.4 ptt85 -127.16 -142.12 0.27 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.895 -1.128 . . . . 0.040000000000000001 111.429 -177.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 36.8 m -39.11 119.02 0.85 Allowed 'General case' 0 N--CA 1.51 2.543 0 O-C-N 121.549 -0.719 . . . . 1.3100000000000001 111.919 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 862' ' ' GLU . . . . . 0.502 ' OE2' HD22 ' A' ' 858' ' ' LEU . 24.6 tt0 -97.35 149.57 35.86 Favored Pre-proline 0 N--CA 1.488 1.453 0 N-CA-C 108.17 -1.048 . . . . 4.5099999999999998 108.17 178.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 863' ' ' PRO . . . . . 0.446 ' HD2' ' CG ' ' A' ' 862' ' ' GLU . 41.6 Cg_endo -67.65 -13.31 38.47 Favored 'Trans proline' 0 C--N 1.316 -1.161 0 O-C-N 122.984 0.991 . . . . 2.2400000000000002 111.334 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -174.21 -137.36 2.43 Favored Glycine 0 N--CA 1.493 2.474 0 C-N-CA 119.76 -1.21 . . . . 0.040000000000000001 110.623 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 37.1 m -69.2 159.65 32.63 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.332 -1.099 . . . . 1.51 111.719 -177.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 866' ' ' VAL . . . . . 0.463 ' O ' HG23 ' A' ' 866' ' ' VAL . 27.0 m -89.93 132.73 35.48 Favored Pre-proline 0 N--CA 1.495 1.808 0 N-CA-C 113.422 0.897 . . . . 0.78000000000000003 113.422 -175.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 867' ' ' PRO . . . . . 0.841 ' O ' HD23 ' A' ' 856' ' ' LEU . 52.5 Cg_endo -88.77 -153.82 0.05 OUTLIER 'Trans proline' 0 C--N 1.323 -0.794 0 N-CA-C 107.709 -1.689 . . . . 0.92000000000000004 107.709 177.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 868' ' ' PHE . . . . . 0.48 ' CD1' ' HG2' ' A' ' 881' ' ' PRO . 31.9 p90 -148.55 119.25 7.5 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.51 -1.369 . . . . 0.050000000000000003 109.944 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 50.1 p-10 -112.72 -3.24 14.29 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 119.322 -0.951 . . . . 1.7 112.207 -178.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 870' ' ' ARG . . . . . 0.78 ' CB ' ' HB3' ' A' ' 855' ' ' ALA . 26.5 mmm180 -89.98 88.69 7.4 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.908 -1.12 . . . . 2.5899999999999999 110.676 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 57.3 t -75.12 96.88 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.028 -1.045 . . . . 1.9399999999999999 109.787 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 872' ' ' LEU . . . . . . . . . . . . . 95.8 mt -83.92 -46.89 11.62 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.553 -0.717 . . . . 1.0600000000000001 110.231 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 873' ' ' LEU . . . . . 0.495 ' HG ' ' HB3' ' A' ' 851' ' ' ALA . 48.8 tp -174.82 104.48 0.09 Allowed 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.293 -0.879 . . . . 4.1799999999999997 108.676 178.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 874' ' ' ASN . . . . . 0.446 ' CB ' ' HA ' ' A' ' 852' ' ' PHE . 36.5 t-20 178.68 82.1 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.316 0 O-C-N 121.588 -0.695 . . . . 0.040000000000000001 109.675 -178.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -66.91 -47.06 72.93 Favored 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 119.289 -0.965 . . . . 3.3799999999999999 111.283 -179.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 876' ' ' GLY . . . . . 0.404 ' HA3' ' CE2' ' A' ' 878' ' ' TYR . . . -74.62 -25.29 70.35 Favored Glycine 0 N--CA 1.494 2.553 0 O-C-N 121.239 -0.913 . . . . 0.040000000000000001 111.836 -178.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 84.32 -59.8 4.9 Favored Glycine 0 N--CA 1.502 3.084 0 N-CA-C 108.154 -1.979 . . . . 0.040000000000000001 108.154 -178.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 878' ' ' TYR . . . . . 0.404 ' CE2' ' HA3' ' A' ' 876' ' ' GLY . 97.7 m-85 60.67 -66.13 0.05 Allowed 'General case' 0 N--CA 1.503 2.215 0 N-CA-C 114.327 1.232 . . . . 3.46 114.327 177.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 879' ' ' TYR . . . . . 0.469 ' CB ' ' CD2' ' A' ' 886' ' ' PHE . 23.7 p90 -112.37 109.17 18.64 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 114.796 1.406 . . . . 0.040000000000000001 114.796 -176.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -65.18 118.53 50.65 Favored Pre-proline 0 N--CA 1.495 1.816 0 O-C-N 121.369 -0.832 . . . . 0.02 110.026 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 881' ' ' PRO . . . . . 0.48 ' HG2' ' CD1' ' A' ' 868' ' ' PHE . 55.2 Cg_endo -76.87 0.24 9.85 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 O-C-N 123.469 1.247 . . . . 0.39000000000000001 112.094 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 -76.79 -64.81 1.04 Allowed 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 106.98 -1.489 . . . . 0.81000000000000005 106.98 178.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 883' ' ' THR . . . . . 0.478 ' OG1' HG23 ' A' ' 885' ' ' VAL . 30.4 p -94.1 -17.7 22.55 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.776 -0.824 . . . . 0.040000000000000001 108.776 177.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.08 22.11 55.65 Favored Glycine 0 N--CA 1.495 2.63 0 O-C-N 121.057 -1.027 . . . . 0.029999999999999999 110.749 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 885' ' ' VAL . . . . . 0.652 HG13 HG21 ' A' ' 961' ' ' THR . 77.6 t -73.15 90.42 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 C-N-CA 118.353 -1.339 . . . . 1.01 108.23 -179.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 886' ' ' PHE . . . . . 0.883 ' HB3' HG22 ' A' ' 962' ' ' VAL . 0.7 OUTLIER -90.39 104.34 16.92 Favored 'General case' 0 N--CA 1.495 1.825 0 CA-C-N 115.291 -0.868 . . . . 0.050000000000000003 112.291 -177.298 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 887' ' ' THR . . . . . 0.418 ' O ' ' HD3' ' A' ' 889' ' ' PRO . 89.8 m -95.04 100.77 12.54 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 107.831 -1.174 . . . . 0.68000000000000005 107.831 177.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 888' ' ' ALA . . . . . . . . . . . . . . . -99.17 106.37 38.15 Favored Pre-proline 0 N--CA 1.5 2.047 0 N-CA-C 114.045 1.128 . . . . 0.25 114.045 -176.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 889' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 887' ' ' THR . 54.6 Cg_endo -89.2 -11.94 3.45 Favored 'Trans proline' 0 CA--C 1.546 1.109 0 N-CA-C 108.975 -1.202 . . . . 1.6399999999999999 108.975 176.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 890' ' ' LEU . . . . . 0.628 HD11 ' CD1' ' A' ' 985' ' ' LEU . 4.9 tt -35.29 -51.23 0.58 Allowed 'General case' 0 N--CA 1.507 2.397 0 N-CA-C 113.92 1.082 . . . . 2.29 113.92 -177.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 51.79 95.03 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.374 0 O-C-N 121.188 -0.945 . . . . 0.63 110.175 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 156.05 -147.28 15.72 Favored Glycine 0 N--CA 1.478 1.487 0 N-CA-C 107.372 -2.291 . . . . 0.040000000000000001 107.372 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 893' ' ' ARG . . . . . 0.44 ' NE ' ' HB1' ' C' ' 984' ' ' ALA . 72.4 ttt-85 -109.0 127.91 54.5 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.86 -1.163 . . . . 3.0 107.86 177.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 894' ' ' TYR . . . . . 0.45 ' CD1' ' N ' ' A' ' 895' ' ' LEU . 0.1 OUTLIER -130.98 144.46 51.49 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.05 -1.032 . . . . 0.040000000000000001 110.085 -179.305 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 895' ' ' LEU . . . . . 0.45 ' N ' ' CD1' ' A' ' 894' ' ' TYR . 34.3 tp -99.37 115.22 28.72 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.625 -0.672 . . . . 1.27 109.807 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 896' ' ' LEU . . . . . 0.617 HD23 ' N ' ' A' ' 897' ' ' SER . 9.9 tt -112.16 145.87 39.06 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.579 -0.7 . . . . 0.93999999999999995 110.461 -179.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 897' ' ' SER . . . . . 0.617 ' N ' HD23 ' A' ' 896' ' ' LEU . 71.2 m -144.74 119.11 9.6 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.379 -0.825 . . . . 0.040000000000000001 110.741 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.97 147.69 30.72 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.708 -0.62 . . . . 0.47999999999999998 109.448 179.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 899' ' ' VAL . . . . . 0.706 HG21 ' HB ' ' A' ' 980' ' ' ILE . 88.0 t -91.95 121.15 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.457 -0.777 . . . . 0.55000000000000004 110.98 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 900' ' ' LEU . . . . . 0.603 HD12 ' HB2' ' A' ' 924' ' ' SER . 4.4 mm? -95.02 111.75 23.52 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 114.423 1.268 . . . . 1.5900000000000001 114.423 -174.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 17.3 m -67.8 141.64 56.45 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 107.274 -1.38 . . . . 0.050000000000000003 107.274 176.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -67.92 -65.02 2.87 Favored Glycine 0 N--CA 1.496 2.637 0 N-CA-C 110.718 -0.953 . . . . 0.029999999999999999 110.718 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 5.8 m170 46.83 66.31 1.02 Allowed 'General case' 0 N--CA 1.508 2.437 0 O-C-N 121.464 -1.021 . . . . 3.2000000000000002 111.082 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 54.1 ptt85 -69.26 -5.91 25.94 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.578 -0.701 . . . . 2.9199999999999999 112.178 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 905' ' ' HIS . . . . . 0.489 ' O ' ' CB ' ' A' ' 906' ' ' GLU . 73.9 t60 -62.69 5.06 0.13 Allowed 'General case' 0 N--CA 1.507 2.393 0 O-C-N 120.888 -1.132 . . . . 2.8700000000000001 113.086 -179.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 906' ' ' GLU . . . . . 0.489 ' CB ' ' O ' ' A' ' 905' ' ' HIS . 0.6 OUTLIER 95.07 -164.97 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.452 0 CA-C-N 120.609 1.549 . . . . 0.98999999999999999 111.993 178.903 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 907' ' ' LYS . . . . . 0.463 ' CB ' ' O ' ' A' ' 906' ' ' GLU . 62.0 tttt 86.09 156.78 0.08 Allowed 'General case' 0 N--CA 1.52 3.03 0 N-CA-C 107.961 -1.126 . . . . 5.25 107.961 -176.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 60.7 t -122.1 117.45 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 120.791 -1.193 . . . . 0.39000000000000001 111.224 -179.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 54.0 tp10 -101.56 133.24 46.54 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 107.291 -1.374 . . . . 1.72 107.291 176.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -155.74 123.0 5.45 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 106.811 -1.551 . . . . 0.67000000000000004 106.811 178.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 911' ' ' VAL . . . . . 0.772 HG22 HG13 ' A' ' 964' ' ' VAL . 93.8 t -84.28 131.83 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.902 -0.499 . . . . 0.54000000000000004 110.984 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 60.6 mt -66.92 157.56 32.92 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.46 -0.775 . . . . 1.5 109.351 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 913' ' ' SER . . . . . 0.466 ' OG ' HG11 ' A' ' 919' ' ' VAL . 1.4 p -124.65 137.6 54.36 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.003 -1.11 . . . . 1.3700000000000001 108.003 176.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 914' ' ' ARG . . . . . 0.611 ' NH1' HD23 ' A' ' 956' ' ' LEU . 0.1 OUTLIER -65.32 155.28 35.75 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 120.638 -1.289 . . . . 4.2999999999999998 111.359 -179.164 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 915' ' ' SER . . . . . 0.424 ' CB ' ' O ' ' A' ' 914' ' ' ARG . 1.7 p 83.42 -31.56 0.08 Allowed 'General case' 0 N--CA 1.521 3.118 0 C-N-CA 123.925 0.89 . . . . 2.0499999999999998 112.068 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 916' ' ' ASN . . . . . 0.754 ' HB2' HG21 ' A' ' 919' ' ' VAL . 99.4 m-20 -122.78 -21.91 5.47 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 120.953 -1.092 . . . . 2.71 111.192 -179.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 917' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 67.04 166.53 0.22 Allowed 'General case' 0 N--CA 1.52 3.027 0 N-CA-C 105.742 -1.948 . . . . 2.6800000000000002 105.742 -174.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.33 -125.23 33.43 Favored Glycine 1 N--CA 1.521 4.324 0 CA-C-N 123.368 2.804 . . . . 0.029999999999999999 107.07 -177.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 919' ' ' VAL . . . . . 0.754 HG21 ' HB2' ' A' ' 916' ' ' ASN . 88.2 t 52.39 94.98 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 O-C-N 121.382 -1.069 . . . . 1.3899999999999999 109.068 -178.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 920' ' ' ALA . . . . . 0.912 ' HB3' HG12 ' A' ' 949' ' ' VAL . . . -90.87 91.07 8.19 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.246 -0.982 . . . . 0.029999999999999999 110.788 -179.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 921' ' ' ARG . . . . . 0.763 ' HG3' HG23 ' A' ' 922' ' ' VAL . 27.5 ptt85 -84.99 -42.2 15.11 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 106.013 -1.847 . . . . 4.4199999999999999 106.013 176.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 922' ' ' VAL . . . . . 0.763 HG23 ' HG3' ' A' ' 921' ' ' ARG . 74.6 t -101.96 74.29 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 105.76 -1.941 . . . . 0.84999999999999998 105.76 175.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -85.79 134.91 33.91 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.758 0.789 . . . . 2.46 111.545 -177.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 924' ' ' SER . . . . . 0.603 ' HB2' HD12 ' A' ' 900' ' ' LEU . 7.0 t -147.09 105.67 3.81 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 108.772 -0.825 . . . . 0.69999999999999996 108.772 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -103.46 83.49 0.42 Allowed Glycine 0 N--CA 1.487 2.035 0 N-CA-C 108.243 -1.943 . . . . 0.040000000000000001 108.243 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.226 0 N-CA-C 108.82 -1.712 . . . . 0.040000000000000001 108.82 -179.543 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 24.8 m . . . . . 0 N--CA 1.491 1.625 0 CA-C-O 121.054 0.455 . . . . 13.779999999999999 110.29 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 95.7 mt -112.17 130.01 56.05 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.519 -0.738 . . . . 13.76 110.362 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -151.77 168.71 31.16 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.229 -1.548 . . . . 9.1300000000000008 109.229 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 949' ' ' VAL . . . . . 0.912 HG12 ' HB3' ' A' ' 920' ' ' ALA . 32.7 m -118.28 130.1 73.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.573 -0.957 . . . . 7.0800000000000001 110.691 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 950' ' ' PHE . . . . . 0.46 ' CZ ' ' HB3' ' A' ' 921' ' ' ARG . 50.0 p90 -135.18 152.46 51.61 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.57 -0.706 . . . . 7.5899999999999999 109.508 179.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 23.1 m -118.45 -54.52 2.27 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.44 -0.787 . . . . 5.0300000000000002 112.007 -178.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 952' ' ' LEU . . . . . 0.437 ' O ' ' O ' ' A' ' 953' ' ' ILE . 12.3 tp -62.05 -74.26 0.09 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.432 -0.793 . . . . 1.01 112.081 -177.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 953' ' ' ILE . . . . . 0.643 HD12 ' HD3' ' A' ' 955' ' ' PRO . 1.5 pp -51.56 -149.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.713 0 N-CA-C 114.18 1.178 . . . . 2.6000000000000001 114.18 -176.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 954' ' ' LEU . . . . . 0.74 HD22 ' O ' ' A' ' 954' ' ' LEU . 0.0 OUTLIER 166.32 90.69 0.02 OUTLIER Pre-proline 0 N--CA 1.519 2.982 0 O-C-N 121.179 -0.951 . . . . 0.050000000000000003 111.755 179.174 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 955' ' ' PRO . . . . . 0.732 ' C ' HD12 ' A' ' 956' ' ' LEU . 51.7 Cg_endo -78.92 98.28 1.18 Allowed 'Trans proline' 0 C--N 1.315 -1.198 0 N-CA-C 109.037 -1.178 . . . . 0.83999999999999997 109.037 178.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 956' ' ' LEU . . . . . 0.732 HD12 ' C ' ' A' ' 955' ' ' PRO . 11.1 mp -121.27 141.93 50.42 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.994 -1.066 . . . . 0.040000000000000001 109.954 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -84.5 150.86 24.98 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 117.782 -1.104 . . . . 1.28 111.842 -178.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -68.43 118.9 12.09 Favored 'General case' 0 N--CA 1.509 2.525 0 CA-C-N 123.034 2.652 . . . . 0.17000000000000001 111.431 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 93.03 -21.25 40.92 Favored Glycine 0 N--CA 1.5 2.959 0 N-CA-C 111.034 -0.826 . . . . 0.040000000000000001 111.034 178.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 960' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -56.57 170.46 0.38 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.426 -1.044 . . . . 0.040000000000000001 110.112 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 961' ' ' THR . . . . . 0.652 HG21 HG13 ' A' ' 885' ' ' VAL . 42.1 m -135.94 137.76 41.65 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.906 -1.121 . . . . 1.78 112.282 -178.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 962' ' ' VAL . . . . . 0.883 HG22 ' HB3' ' A' ' 886' ' ' PHE . 33.6 m -98.14 145.37 9.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 C-N-CA 120.142 -0.623 . . . . 0.040000000000000001 110.352 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 5.2 t -137.4 145.02 42.73 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.792 -0.568 . . . . 0.71999999999999997 110.041 -178.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 964' ' ' VAL . . . . . 0.772 HG13 HG22 ' A' ' 911' ' ' VAL . 61.2 t -93.21 136.72 24.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.16 -0.963 . . . . 1.05 110.495 -179.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -93.73 127.42 39.43 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 103.613 -2.736 . . . . 3.02 103.613 173.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 966' ' ' LEU . . . . . 0.544 HD23 ' O ' ' A' ' 966' ' ' LEU . 4.1 tt -132.51 61.11 1.67 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.21 -1.033 . . . . 1.46 108.21 177.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 967' ' ' VAL . . . . . 0.488 HG23 ' C ' ' A' ' 966' ' ' LEU . 97.2 t -157.87 96.74 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 108.12 -1.067 . . . . 1.9399999999999999 108.12 179.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 88.1 mmm -143.66 59.16 1.38 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.747 -1.22 . . . . 0.0 108.34 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.13 119.64 1.95 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 107.107 -2.397 . . . . 2.1099999999999999 107.107 -178.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -82.17 -58.35 2.99 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.023 -1.281 . . . . 5.8899999999999997 110.378 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 46.7 tp -58.89 90.84 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.434 -0.791 . . . . 4.3600000000000003 110.244 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -142.0 -154.37 0.52 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.595 -0.691 . . . . 1.8300000000000001 110.208 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -119.53 170.7 8.93 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.479 -0.763 . . . . 4.3499999999999996 110.252 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 9.5 t -101.63 130.4 47.96 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.548 -0.72 . . . . 1.27 110.12 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -155.89 158.77 38.54 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.482 -0.761 . . . . 5.0199999999999996 110.41 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.5 85.72 17.32 Favored Pre-proline 0 N--CA 1.501 2.078 0 O-C-N 121.618 -0.676 . . . . 2.4100000000000001 109.87 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 977' ' ' PRO . . . . . 0.498 ' C ' HD12 ' A' ' 978' ' ' LEU . 47.8 Cg_endo -73.61 -172.65 1.12 Allowed 'Trans proline' 0 C--N 1.318 -1.059 0 O-C-N 123.303 1.159 . . . . 0.95999999999999996 111.277 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 978' ' ' LEU . . . . . 0.515 HD23 ' CD1' ' A' ' 856' ' ' LEU . 5.4 mp -127.47 155.39 43.79 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.728 -1.212 . . . . 0.62 107.728 178.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 979' ' ' THR . . . . . 0.451 HG23 ' C ' ' A' ' 978' ' ' LEU . 37.1 p -150.23 141.11 22.83 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.762 -1.212 . . . . 3.5699999999999998 111.186 -179.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 980' ' ' ILE . . . . . 0.706 ' HB ' HG21 ' A' ' 899' ' ' VAL . 51.4 mm -107.38 128.76 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 109.099 -0.704 . . . . 1.3300000000000001 109.099 179.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 981' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -119.39 99.29 6.59 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 119.821 -0.752 . . . . 0.050000000000000003 111.8 -178.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 42.6 p -106.78 158.25 17.13 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.814 -0.81 . . . . 0.87 108.814 178.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . -172.78 110.13 0.33 Allowed Glycine 0 N--CA 1.498 2.803 0 N-CA-C 106.649 -2.58 . . . . 0.029999999999999999 106.649 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -110.67 149.67 30.13 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 114.551 1.315 . . . . 0.69999999999999996 114.551 -175.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 985' ' ' LEU . . . . . 0.628 ' CD1' HD11 ' A' ' 890' ' ' LEU . 54.4 tp -70.73 133.9 47.0 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.816 -1.177 . . . . 0.040000000000000001 109.808 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 51.0 tp -107.37 -59.04 1.88 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.499 -0.751 . . . . 0.040000000000000001 109.989 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -144.47 145.06 31.67 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.565 -1.272 . . . . 0.040000000000000001 107.565 179.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.97 163.12 12.17 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 108.139 -1.984 . . . . 0.040000000000000001 108.139 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -75.3 112.5 18.97 Favored Pre-proline 0 N--CA 1.498 1.973 0 CA-C-N 118.52 1.16 . . . . 0.040000000000000001 109.482 179.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 990' ' ' PRO . . . . . 0.431 ' HD2' HD12 ' A' ' 992' ' ' LEU . 50.2 Cg_endo -90.07 71.24 1.59 Allowed 'Trans proline' 0 C--N 1.319 -0.998 0 O-C-N 123.124 1.065 . . . . 0.45000000000000001 111.39 -178.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 991' ' ' GLU . . . . . 0.419 ' HB2' ' O ' ' A' ' 990' ' ' PRO . 69.8 mt-10 67.36 -73.94 0.07 Allowed 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 108.494 -0.928 . . . . 1.97 108.494 -177.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 992' ' ' LEU . . . . . 0.431 HD12 ' HD2' ' A' ' 990' ' ' PRO . 10.4 mt 50.92 20.64 0.82 Allowed 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.579 -0.701 . . . . 2.3799999999999999 111.647 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -94.2 156.85 16.34 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.888 -1.132 . . . . 3.79 109.959 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 72.2 m80 -146.24 93.44 2.32 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.571 -0.706 . . . . 3.5099999999999998 110.23 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 995' ' ' ALA . . . . . . . . . . . . 2.519 . . . . . . . 0 N--CA 1.503 2.219 0 O-C-N 120.821 -1.174 . . . . 2.73 110.574 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo . . . . . 0 N--CA 1.488 1.203 0 N-CA-C 109.502 -0.999 . . . . 3.8300000000000001 109.502 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 847' ' ' VAL . . . . . 0.415 HG12 ' HB2' ' B' ' 849' ' ' GLN . 59.8 t -132.05 103.57 14.15 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.638 -0.664 . . . . 1.8300000000000001 110.074 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 848' ' ' PRO . . . . . 0.705 ' O ' HG23 ' B' ' 850' ' ' VAL . 44.0 Cg_endo -69.7 -20.23 35.41 Favored 'Trans proline' 0 N--CA 1.487 1.097 0 O-C-N 123.236 1.124 . . . . 0.65000000000000002 111.123 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 849' ' ' GLN . . . . . 0.415 ' HB2' HG12 ' B' ' 847' ' ' VAL . 56.3 tt0 26.67 69.7 0.05 Allowed 'General case' 0 N--CA 1.519 2.979 0 N-CA-C 112.84 0.682 . . . . 2.5800000000000001 112.84 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 850' ' ' VAL . . . . . 0.705 HG23 ' O ' ' B' ' 848' ' ' PRO . 59.6 t -117.91 137.81 50.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.237 -0.915 . . . . 1.0900000000000001 111.616 -178.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 851' ' ' ALA . . . . . 0.473 ' HB3' ' HG ' ' B' ' 873' ' ' LEU . . . -128.06 154.76 45.32 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 105.707 -1.96 . . . . 0.040000000000000001 105.707 176.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 852' ' ' PHE . . . . . 0.449 ' HA ' ' CB ' ' B' ' 874' ' ' ASN . 20.8 p90 -159.64 129.35 5.42 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 121.006 1.73 . . . . 0.050000000000000003 108.742 179.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 32.7 t -175.75 134.25 0.28 Allowed 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.137 -1.061 . . . . 0.040000000000000001 108.137 -179.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -134.56 158.63 43.5 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.123 -0.985 . . . . 0.67000000000000004 109.526 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 855' ' ' ALA . . . . . 0.788 ' HB3' ' CB ' ' B' ' 870' ' ' ARG . . . -122.84 141.17 52.15 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 121.919 0.866 . . . . 0.51000000000000001 111.843 -178.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 856' ' ' LEU . . . . . 0.914 HD11 HD23 ' B' ' 858' ' ' LEU . 3.5 tm? -107.8 135.18 49.65 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.276 -0.638 . . . . 0.050000000000000003 109.276 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 857' ' ' SER . . . . . 0.562 ' N ' HD13 ' B' ' 856' ' ' LEU . 17.0 p -152.78 17.98 0.6 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.474 -0.766 . . . . 1.3300000000000001 111.144 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 858' ' ' LEU . . . . . 0.914 HD23 HD11 ' B' ' 856' ' ' LEU . 3.1 pp -29.82 154.14 0.03 OUTLIER Pre-proline 0 N--CA 1.521 3.087 0 N-CA-C 113.337 0.866 . . . . 2.3300000000000001 113.337 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -61.82 -88.75 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.541 0 O-C-N 123.149 1.078 . . . . 2.3199999999999998 113.681 -177.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 53.4 ptt85 -127.2 -142.19 0.27 Allowed 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.86 -1.15 . . . . 0.040000000000000001 111.403 -177.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 37.0 m -39.12 118.63 0.81 Allowed 'General case' 0 N--CA 1.51 2.531 0 O-C-N 121.479 -0.763 . . . . 1.3100000000000001 111.9 -178.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 862' ' ' GLU . . . . . 0.487 ' OE2' HD22 ' B' ' 858' ' ' LEU . 24.6 tt0 -96.89 149.68 36.01 Favored Pre-proline 0 N--CA 1.489 1.484 0 N-CA-C 108.162 -1.051 . . . . 4.5099999999999998 108.162 177.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 863' ' ' PRO . . . . . 0.443 ' HD2' ' CG ' ' B' ' 862' ' ' GLU . 41.5 Cg_endo -67.69 -13.38 38.61 Favored 'Trans proline' 0 C--N 1.316 -1.181 0 O-C-N 123.015 1.008 . . . . 2.2400000000000002 111.385 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -174.0 -136.88 2.3 Favored Glycine 0 N--CA 1.494 2.501 0 C-N-CA 119.836 -1.174 . . . . 0.040000000000000001 110.665 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 37.2 m -69.55 160.19 31.95 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.276 -1.132 . . . . 1.51 111.75 -178.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 866' ' ' VAL . . . . . 0.46 ' O ' HG23 ' B' ' 866' ' ' VAL . 26.9 m -90.31 132.75 34.74 Favored Pre-proline 0 N--CA 1.495 1.782 0 N-CA-C 113.419 0.896 . . . . 0.78000000000000003 113.419 -175.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 867' ' ' PRO . . . . . 0.818 ' O ' HD23 ' B' ' 856' ' ' LEU . 53.1 Cg_endo -88.83 -154.05 0.05 OUTLIER 'Trans proline' 0 C--N 1.322 -0.817 0 N-CA-C 107.679 -1.7 . . . . 0.92000000000000004 107.679 177.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 868' ' ' PHE . . . . . 0.472 ' CD1' ' HG2' ' B' ' 881' ' ' PRO . 31.6 p90 -148.39 119.13 7.52 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.446 -1.409 . . . . 0.050000000000000003 109.874 179.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 50.1 p-10 -112.57 -2.84 14.49 Favored 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 119.284 -0.967 . . . . 1.7 112.153 -178.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 870' ' ' ARG . . . . . 0.788 ' CB ' ' HB3' ' B' ' 855' ' ' ALA . 26.0 mmm180 -90.32 88.62 7.28 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.977 -1.077 . . . . 2.5899999999999999 110.682 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 57.5 t -75.23 97.03 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.004 -1.06 . . . . 1.9399999999999999 109.661 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 872' ' ' LEU . . . . . 0.513 ' HB3' HD11 ' C' ' 953' ' ' ILE . 95.4 mt -84.29 -46.75 11.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.541 -0.724 . . . . 1.0600000000000001 110.273 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 873' ' ' LEU . . . . . 0.473 ' HG ' ' HB3' ' B' ' 851' ' ' ALA . 48.8 tp -174.66 104.43 0.1 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.265 -0.897 . . . . 4.1799999999999997 108.605 178.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 874' ' ' ASN . . . . . 0.449 ' CB ' ' HA ' ' B' ' 852' ' ' PHE . 36.5 t-20 178.67 82.27 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.654 -0.653 . . . . 0.040000000000000001 109.647 -178.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -67.09 -47.1 72.23 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 119.29 -0.964 . . . . 3.3799999999999999 111.244 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 876' ' ' GLY . . . . . 0.41 ' HA3' ' CE2' ' B' ' 878' ' ' TYR . . . -74.49 -25.58 69.93 Favored Glycine 0 N--CA 1.494 2.566 0 O-C-N 121.217 -0.927 . . . . 0.040000000000000001 111.813 -178.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 84.48 -59.74 4.89 Favored Glycine 0 N--CA 1.502 3.038 0 N-CA-C 108.11 -1.996 . . . . 0.040000000000000001 108.11 -178.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 878' ' ' TYR . . . . . 0.41 ' CE2' ' HA3' ' B' ' 876' ' ' GLY . 97.7 m-85 60.74 -66.13 0.05 Allowed 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 114.348 1.24 . . . . 3.46 114.348 177.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 879' ' ' TYR . . . . . 0.46 ' CB ' ' CD2' ' B' ' 886' ' ' PHE . 23.5 p90 -112.39 109.15 18.6 Favored 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 114.773 1.398 . . . . 0.040000000000000001 114.773 -176.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -65.17 118.47 50.03 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.396 -0.815 . . . . 0.02 109.999 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 881' ' ' PRO . . . . . 0.472 ' HG2' ' CD1' ' B' ' 868' ' ' PHE . 55.4 Cg_endo -76.84 0.17 9.91 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 O-C-N 123.432 1.227 . . . . 0.39000000000000001 112.143 -179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -76.66 -64.95 1.0 Allowed 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 106.963 -1.495 . . . . 0.81000000000000005 106.963 178.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 883' ' ' THR . . . . . 0.477 ' OG1' HG23 ' B' ' 885' ' ' VAL . 31.0 p -94.13 -17.25 22.97 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.784 -0.821 . . . . 0.040000000000000001 108.784 177.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.49 22.49 56.27 Favored Glycine 0 N--CA 1.494 2.541 0 O-C-N 121.091 -1.006 . . . . 0.029999999999999999 110.793 178.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 885' ' ' VAL . . . . . 0.63 HG13 HG21 ' B' ' 961' ' ' THR . 79.4 t -73.41 90.74 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 C-N-CA 118.274 -1.371 . . . . 1.01 108.151 -179.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 886' ' ' PHE . . . . . 0.883 ' HB3' HG22 ' B' ' 962' ' ' VAL . 0.6 OUTLIER -90.63 104.42 17.01 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 115.281 -0.872 . . . . 0.050000000000000003 112.244 -177.264 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 887' ' ' THR . . . . . 0.419 ' O ' ' HD3' ' B' ' 889' ' ' PRO . 90.3 m -95.06 101.03 12.76 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 107.774 -1.195 . . . . 0.68000000000000005 107.774 177.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 888' ' ' ALA . . . . . . . . . . . . . . . -99.4 106.28 38.32 Favored Pre-proline 0 N--CA 1.499 2.022 0 N-CA-C 114.042 1.127 . . . . 0.25 114.042 -176.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 889' ' ' PRO . . . . . 0.419 ' HD3' ' O ' ' B' ' 887' ' ' THR . 54.4 Cg_endo -89.08 -12.08 3.47 Favored 'Trans proline' 0 CA--C 1.546 1.094 0 N-CA-C 108.981 -1.199 . . . . 1.6399999999999999 108.981 176.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 890' ' ' LEU . . . . . 0.631 HD11 ' CD1' ' B' ' 985' ' ' LEU . 4.9 tt -35.2 -51.21 0.56 Allowed 'General case' 0 N--CA 1.507 2.414 0 N-CA-C 113.903 1.075 . . . . 2.29 113.903 -177.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 51.7 95.04 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.347 0 O-C-N 121.192 -0.942 . . . . 0.63 110.193 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . 156.02 -147.36 15.91 Favored Glycine 0 N--CA 1.479 1.548 0 N-CA-C 107.335 -2.306 . . . . 0.040000000000000001 107.335 -178.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 72.5 ttt-85 -108.97 127.94 54.51 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 107.845 -1.168 . . . . 3.0 107.845 177.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 894' ' ' TYR . . . . . 0.456 ' CD1' ' N ' ' B' ' 895' ' ' LEU . 0.2 OUTLIER -130.86 144.63 51.6 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.023 -1.048 . . . . 0.040000000000000001 110.082 -179.258 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 895' ' ' LEU . . . . . 0.456 ' N ' ' CD1' ' B' ' 894' ' ' TYR . 34.4 tp -99.69 115.03 28.52 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.523 -0.736 . . . . 1.27 109.825 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 896' ' ' LEU . . . . . 0.621 HD23 ' N ' ' B' ' 897' ' ' SER . 9.9 tt -111.93 145.63 39.23 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.576 -0.703 . . . . 0.93999999999999995 110.537 -179.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 897' ' ' SER . . . . . 0.621 ' N ' HD23 ' B' ' 896' ' ' LEU . 71.2 m -144.52 118.86 9.58 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.389 -0.819 . . . . 0.040000000000000001 110.812 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.71 147.66 30.45 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.733 -0.604 . . . . 0.47999999999999998 109.489 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 899' ' ' VAL . . . . . 0.709 HG21 ' HB ' ' B' ' 980' ' ' ILE . 88.3 t -91.89 120.92 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.469 -0.769 . . . . 0.55000000000000004 111.006 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 900' ' ' LEU . . . . . 0.591 HD12 ' HB2' ' B' ' 924' ' ' SER . 4.4 mm? -94.85 111.3 23.1 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 114.498 1.296 . . . . 1.5900000000000001 114.498 -174.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 17.1 m -67.45 141.47 56.98 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 107.277 -1.379 . . . . 0.050000000000000003 107.277 176.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -68.02 -65.05 2.84 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 110.724 -0.951 . . . . 0.029999999999999999 110.724 -179.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 5.9 m170 46.81 66.43 0.99 Allowed 'General case' 0 N--CA 1.508 2.454 0 O-C-N 121.454 -1.027 . . . . 3.2000000000000002 111.093 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 54.0 ptt85 -69.33 -6.19 28.08 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.645 -0.66 . . . . 2.9199999999999999 112.106 -179.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 905' ' ' HIS . . . . . 0.484 ' O ' ' CB ' ' B' ' 906' ' ' GLU . 73.8 t60 -62.03 4.53 0.12 Allowed 'General case' 0 N--CA 1.506 2.352 0 O-C-N 120.906 -1.122 . . . . 2.8700000000000001 113.131 -179.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 906' ' ' GLU . . . . . 0.484 ' CB ' ' O ' ' B' ' 905' ' ' HIS . 0.7 OUTLIER 95.25 -165.11 0.0 OUTLIER 'General case' 0 N--CA 1.529 3.478 0 CA-C-N 120.605 1.548 . . . . 0.98999999999999999 111.914 179.089 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 907' ' ' LYS . . . . . 0.465 ' CB ' ' O ' ' B' ' 906' ' ' GLU . 61.9 tttt 86.3 156.4 0.08 Allowed 'General case' 0 N--CA 1.519 3.01 0 N-CA-C 107.982 -1.118 . . . . 5.25 107.982 -176.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 60.9 t -121.86 117.21 51.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 120.757 -1.214 . . . . 0.39000000000000001 111.351 -179.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 54.2 tp10 -101.26 133.43 45.84 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 107.295 -1.372 . . . . 1.72 107.295 176.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -156.05 123.32 5.41 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 106.759 -1.571 . . . . 0.67000000000000004 106.759 178.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 911' ' ' VAL . . . . . 0.757 HG22 HG13 ' B' ' 964' ' ' VAL . 92.5 t -84.65 132.23 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.89 -0.506 . . . . 0.54000000000000004 110.972 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 60.2 mt -67.06 157.78 32.69 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.417 -0.802 . . . . 1.5 109.303 178.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 913' ' ' SER . . . . . 0.478 ' OG ' HG11 ' B' ' 919' ' ' VAL . 1.4 p -125.11 136.78 53.98 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.105 -1.072 . . . . 1.3700000000000001 108.105 176.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 914' ' ' ARG . . . . . 0.609 ' NH1' HD23 ' B' ' 956' ' ' LEU . 0.1 OUTLIER -64.53 155.21 33.66 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 120.628 -1.295 . . . . 4.2999999999999998 111.428 -179.034 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 915' ' ' SER . . . . . 0.416 ' CB ' ' O ' ' B' ' 914' ' ' ARG . 1.7 p 83.53 -31.93 0.08 Allowed 'General case' 0 N--CA 1.521 3.119 0 C-N-CA 123.915 0.886 . . . . 2.0499999999999998 112.077 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 916' ' ' ASN . . . . . 0.757 ' HB2' HG21 ' B' ' 919' ' ' VAL . 99.4 m-20 -122.34 -22.19 5.6 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.895 -1.128 . . . . 2.71 111.2 -179.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 917' ' ' GLN . . . . . 0.402 ' HB2' ' O ' ' B' ' 916' ' ' ASN . 43.8 mt-30 67.08 165.98 0.22 Allowed 'General case' 0 N--CA 1.519 3.021 0 N-CA-C 105.762 -1.94 . . . . 2.6800000000000002 105.762 -174.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.99 -125.29 35.19 Favored Glycine 1 N--CA 1.521 4.322 0 CA-C-N 123.492 2.86 . . . . 0.029999999999999999 106.905 -177.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 919' ' ' VAL . . . . . 0.757 HG21 ' HB2' ' B' ' 916' ' ' ASN . 91.5 t 52.24 95.1 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 O-C-N 121.393 -1.063 . . . . 1.3899999999999999 109.119 -178.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 920' ' ' ALA . . . . . 0.88 ' HB3' HG12 ' B' ' 949' ' ' VAL . . . -91.06 90.95 8.07 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.249 -0.981 . . . . 0.029999999999999999 110.723 -179.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 921' ' ' ARG . . . . . 0.776 ' HG3' HG23 ' B' ' 922' ' ' VAL . 27.6 ptt85 -84.96 -42.18 15.19 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 106.02 -1.844 . . . . 4.4199999999999999 106.02 176.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 922' ' ' VAL . . . . . 0.776 HG23 ' HG3' ' B' ' 921' ' ' ARG . 75.0 t -101.9 74.02 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 105.833 -1.914 . . . . 0.84999999999999998 105.833 175.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -85.55 135.01 33.99 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.74 0.781 . . . . 2.46 111.553 -177.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 924' ' ' SER . . . . . 0.591 ' HB2' HD12 ' B' ' 900' ' ' LEU . 6.8 t -147.12 105.51 3.78 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 108.77 -0.826 . . . . 0.69999999999999996 108.77 179.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -103.2 83.42 0.43 Allowed Glycine 0 N--CA 1.487 2.052 0 N-CA-C 108.307 -1.917 . . . . 0.040000000000000001 108.307 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.223 0 N-CA-C 108.865 -1.694 . . . . 0.040000000000000001 108.865 -179.6 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 25.3 m . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.042 0.449 . . . . 13.779999999999999 110.296 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 95.8 mt -111.64 129.96 55.92 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.508 -0.745 . . . . 13.76 110.389 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -151.67 168.33 31.06 Favored Glycine 0 N--CA 1.493 2.5 0 N-CA-C 109.243 -1.543 . . . . 9.1300000000000008 109.243 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 949' ' ' VAL . . . . . 0.88 HG12 ' HB3' ' B' ' 920' ' ' ALA . 31.6 m -118.09 130.17 73.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.515 -0.991 . . . . 7.0800000000000001 110.666 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 950' ' ' PHE . . . . . 0.459 ' CZ ' ' HB3' ' B' ' 921' ' ' ARG . 49.0 p90 -135.16 152.51 51.67 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.582 -0.699 . . . . 7.5899999999999999 109.466 179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 23.3 m -118.52 -54.09 2.29 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.424 -0.797 . . . . 5.0300000000000002 111.922 -178.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 952' ' ' LEU . . . . . 0.434 ' O ' ' O ' ' B' ' 953' ' ' ILE . 12.5 tp -62.3 -74.43 0.09 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.352 -0.842 . . . . 1.01 112.056 -177.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 953' ' ' ILE . . . . . 0.636 HD12 ' HD3' ' B' ' 955' ' ' PRO . 1.4 pp -51.48 -149.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.782 0 N-CA-C 114.22 1.193 . . . . 2.6000000000000001 114.22 -176.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 954' ' ' LEU . . . . . 0.751 HD22 ' O ' ' B' ' 954' ' ' LEU . 0.0 OUTLIER 166.07 90.59 0.02 OUTLIER Pre-proline 0 N--CA 1.518 2.944 0 O-C-N 121.107 -0.996 . . . . 0.050000000000000003 111.67 179.156 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 955' ' ' PRO . . . . . 0.743 ' C ' HD12 ' B' ' 956' ' ' LEU . 51.6 Cg_endo -78.96 98.48 1.19 Allowed 'Trans proline' 0 C--N 1.315 -1.205 0 N-CA-C 109.014 -1.187 . . . . 0.83999999999999997 109.014 178.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 956' ' ' LEU . . . . . 0.743 HD12 ' C ' ' B' ' 955' ' ' PRO . 11.1 mp -121.47 141.97 50.5 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 120.973 -1.079 . . . . 0.040000000000000001 109.943 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -84.46 151.11 24.83 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 117.844 -1.074 . . . . 1.28 111.777 -178.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -68.6 118.66 11.91 Favored 'General case' 0 N--CA 1.508 2.466 0 CA-C-N 122.96 2.618 . . . . 0.17000000000000001 111.368 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 93.2 -21.48 40.03 Favored Glycine 0 N--CA 1.5 2.925 0 N-CA-C 111.056 -0.817 . . . . 0.040000000000000001 111.056 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 960' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -56.31 170.55 0.34 Allowed 'General case' 0 N--CA 1.499 2.015 0 O-C-N 121.488 -1.007 . . . . 0.040000000000000001 110.149 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 961' ' ' THR . . . . . 0.63 HG21 HG13 ' B' ' 885' ' ' VAL . 42.1 m -135.96 137.81 41.68 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.945 -1.097 . . . . 1.78 112.291 -178.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 962' ' ' VAL . . . . . 0.883 HG22 ' HB3' ' B' ' 886' ' ' PHE . 33.7 m -98.29 145.19 10.19 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.712 -0.618 . . . . 0.040000000000000001 110.404 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 5.2 t -137.1 145.13 43.54 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.885 -0.509 . . . . 0.71999999999999997 110.084 -178.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 964' ' ' VAL . . . . . 0.757 HG13 HG22 ' B' ' 911' ' ' VAL . 61.1 t -93.4 136.39 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.133 -0.98 . . . . 1.05 110.499 -179.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -93.68 127.05 39.19 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 103.651 -2.722 . . . . 3.02 103.651 173.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 966' ' ' LEU . . . . . 0.556 HD23 ' O ' ' B' ' 966' ' ' LEU . 4.1 tt -132.14 61.24 1.66 Allowed 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.288 -1.004 . . . . 1.46 108.288 177.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 967' ' ' VAL . . . . . 0.486 HG23 ' C ' ' B' ' 966' ' ' LEU . 97.9 t -158.0 96.53 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 108.143 -1.058 . . . . 1.9399999999999999 108.143 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 88.1 mmm -143.39 58.85 1.39 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.733 -1.229 . . . . 0.0 108.375 178.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.24 119.51 1.93 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 107.222 -2.351 . . . . 2.1099999999999999 107.222 -178.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 56.7 tt0 -81.9 -58.31 3.04 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.036 -1.273 . . . . 5.8899999999999997 110.415 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 46.9 tp -58.99 90.62 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.437 -0.789 . . . . 4.3600000000000003 110.249 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -141.78 -154.33 0.51 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.536 -0.728 . . . . 1.8300000000000001 110.24 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -119.51 170.89 8.76 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.498 -0.751 . . . . 4.3499999999999996 110.276 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 9.5 t -101.76 130.44 48.17 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.528 -0.733 . . . . 1.27 110.086 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -155.91 158.81 38.59 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.49 -0.756 . . . . 5.0199999999999996 110.443 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.47 85.67 17.49 Favored Pre-proline 0 N--CA 1.501 2.077 0 O-C-N 121.588 -0.695 . . . . 2.4100000000000001 109.906 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 977' ' ' PRO . . . . . 0.485 ' C ' HD12 ' B' ' 978' ' ' LEU . 47.7 Cg_endo -73.63 -172.73 1.14 Allowed 'Trans proline' 0 C--N 1.317 -1.13 0 O-C-N 123.326 1.172 . . . . 0.95999999999999996 111.248 -179.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 978' ' ' LEU . . . . . 0.502 HD23 ' CD1' ' B' ' 856' ' ' LEU . 5.4 mp -127.34 155.55 43.4 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 107.762 -1.199 . . . . 0.62 107.762 178.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 979' ' ' THR . . . . . 0.458 HG23 ' C ' ' B' ' 978' ' ' LEU . 37.0 p -150.32 141.12 22.76 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.811 -1.181 . . . . 3.5699999999999998 111.157 -179.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 980' ' ' ILE . . . . . 0.709 ' HB ' HG21 ' B' ' 899' ' ' VAL . 51.4 mm -107.44 128.59 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 109.135 -0.691 . . . . 1.3300000000000001 109.135 179.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 981' ' ' PHE . . . . . 0.4 ' HD1' ' HH ' ' B' ' 879' ' ' TYR . 4.4 t80 -119.2 99.29 6.62 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.461 -0.774 . . . . 0.050000000000000003 111.802 -178.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 43.2 p -106.79 158.24 17.14 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.834 -0.802 . . . . 0.87 108.834 178.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 983' ' ' GLY . . . . . . . . . . . . . . . -172.77 110.16 0.33 Allowed Glycine 0 N--CA 1.499 2.87 0 N-CA-C 106.685 -2.566 . . . . 0.029999999999999999 106.685 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 984' ' ' ALA . . . . . 0.469 ' HB1' ' NE ' ' C' ' 893' ' ' ARG . . . -110.75 149.61 30.27 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 114.539 1.311 . . . . 0.69999999999999996 114.539 -175.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 985' ' ' LEU . . . . . 0.631 ' CD1' HD11 ' B' ' 890' ' ' LEU . 54.2 tp -70.71 133.84 46.95 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.874 -1.142 . . . . 0.040000000000000001 109.808 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 986' ' ' LEU . . . . . . . . . . . . . 50.6 tp -107.39 -59.01 1.88 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.547 -0.721 . . . . 0.040000000000000001 110.009 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -144.46 144.87 31.59 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.592 -1.262 . . . . 0.040000000000000001 107.592 179.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.84 162.95 12.2 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 108.117 -1.993 . . . . 0.040000000000000001 108.117 179.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -75.15 112.59 19.02 Favored Pre-proline 0 N--CA 1.498 1.938 0 O-C-N 121.226 -1.161 . . . . 0.040000000000000001 109.439 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 990' ' ' PRO . . . . . 0.438 ' HD2' HD12 ' B' ' 992' ' ' LEU . 49.9 Cg_endo -90.05 71.27 1.6 Allowed 'Trans proline' 0 C--N 1.319 -0.976 0 O-C-N 123.119 1.062 . . . . 0.45000000000000001 111.339 -178.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 991' ' ' GLU . . . . . 0.419 ' HB2' ' O ' ' B' ' 990' ' ' PRO . 70.0 mt-10 67.29 -73.93 0.07 Allowed 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 108.463 -0.94 . . . . 1.97 108.463 -177.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 992' ' ' LEU . . . . . 0.451 ' HA ' HD23 ' B' ' 992' ' ' LEU . 10.4 mt 51.11 20.4 0.85 Allowed 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.587 -0.696 . . . . 2.3799999999999999 111.679 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -93.94 156.95 16.35 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.914 -1.116 . . . . 3.79 109.974 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 71.9 m80 -146.33 92.8 2.22 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.561 -0.712 . . . . 3.5099999999999998 110.382 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 995' ' ' ALA . . . . . . . . . . . . 2.518 . . . . . . . 0 N--CA 1.503 2.223 0 O-C-N 120.924 -1.11 . . . . 2.73 110.581 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo . . . . . 0 N--CA 1.487 1.142 0 N-CA-C 109.526 -0.99 . . . . 3.8300000000000001 109.526 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 847' ' ' VAL . . . . . 0.5 HG12 ' HB2' ' C' ' 849' ' ' GLN . 59.5 t -126.81 106.2 22.84 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 121.68 -0.638 . . . . 1.8300000000000001 109.989 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 848' ' ' PRO . . . . . 0.893 ' O ' HG23 ' C' ' 850' ' ' VAL . 43.9 Cg_endo -69.52 -22.17 33.57 Favored 'Trans proline' 0 N--CA 1.488 1.152 0 O-C-N 123.238 1.125 . . . . 0.65000000000000002 111.09 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 849' ' ' GLN . . . . . 0.5 ' HB2' HG12 ' C' ' 847' ' ' VAL . 54.6 tt0 24.93 64.6 0.05 Allowed 'General case' 0 N--CA 1.518 2.945 0 N-CA-C 113.605 0.965 . . . . 2.5800000000000001 113.605 179.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 850' ' ' VAL . . . . . 0.893 HG23 ' O ' ' C' ' 848' ' ' PRO . 78.9 t -120.23 134.91 62.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.105 -0.997 . . . . 1.0900000000000001 110.948 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 851' ' ' ALA . . . . . 0.526 ' HB3' ' HG ' ' C' ' 873' ' ' LEU . . . -127.78 155.28 44.29 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 105.745 -1.946 . . . . 0.040000000000000001 105.745 176.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 852' ' ' PHE . . . . . 0.448 ' HA ' ' CB ' ' C' ' 874' ' ' ASN . 13.5 p90 -161.56 126.96 3.6 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 121.011 1.732 . . . . 0.050000000000000003 108.683 179.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 24.2 t -177.06 135.32 0.2 Allowed 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.039 -1.096 . . . . 0.040000000000000001 108.039 -179.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 854' ' ' ALA . . . . . 0.436 ' HB1' ' HD2' ' C' ' 868' ' ' PHE . . . -132.5 158.32 42.39 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.042 -1.036 . . . . 0.67000000000000004 109.96 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 855' ' ' ALA . . . . . 0.732 ' HB2' HD11 ' C' ' 872' ' ' LEU . . . -122.27 139.75 53.43 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 121.773 0.797 . . . . 0.51000000000000001 111.051 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 856' ' ' LEU . . . . . 1.075 HD11 HD23 ' C' ' 858' ' ' LEU . 3.5 tm? -112.61 139.41 48.23 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.692 -0.63 . . . . 0.050000000000000003 110.252 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 857' ' ' SER . . . . . 0.599 ' N ' HD13 ' C' ' 856' ' ' LEU . 1.4 m -155.96 19.92 0.38 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.585 -0.697 . . . . 1.3300000000000001 111.07 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 858' ' ' LEU . . . . . 1.075 HD23 HD11 ' C' ' 856' ' ' LEU . 2.3 pp -34.83 161.44 0.04 OUTLIER Pre-proline 0 N--CA 1.517 2.898 0 N-CA-C 113.171 0.804 . . . . 2.3300000000000001 113.171 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -61.68 -87.72 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 120.894 1.062 . . . . 2.3199999999999998 113.495 -178.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 55.3 ptt85 -130.6 -143.26 0.24 Allowed 'General case' 0 N--CA 1.501 2.122 0 O-C-N 120.811 -1.18 . . . . 0.040000000000000001 111.923 -177.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 14.6 m -37.54 129.17 1.07 Allowed 'General case' 0 N--CA 1.51 2.548 0 O-C-N 121.592 -0.693 . . . . 1.3100000000000001 112.537 -178.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.41 160.51 25.8 Favored Pre-proline 0 N--CA 1.489 1.523 0 N-CA-C 108.263 -1.014 . . . . 4.5099999999999998 108.263 177.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -71.62 -13.82 30.08 Favored 'Trans proline' 0 C--N 1.314 -1.282 0 O-C-N 123.184 1.097 . . . . 2.2400000000000002 111.507 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -177.33 -136.18 2.39 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.658 -1.377 . . . . 0.040000000000000001 109.658 179.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 22.8 m -68.2 154.5 41.59 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.388 -1.066 . . . . 1.51 110.249 -179.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 866' ' ' VAL . . . . . 0.441 ' HA ' ' HD3' ' C' ' 867' ' ' PRO . 46.0 t -98.68 139.19 20.93 Favored Pre-proline 0 N--CA 1.496 1.845 0 N-CA-C 113.366 0.876 . . . . 0.78000000000000003 113.366 -174.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 867' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' C' ' 866' ' ' VAL . 55.4 Cg_endo -91.35 -147.64 0.03 OUTLIER 'Trans proline' 0 CA--C 1.545 1.065 0 O-C-N 123.583 1.307 . . . . 0.92000000000000004 108.847 177.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 868' ' ' PHE . . . . . 0.49 ' CD1' ' HG2' ' C' ' 881' ' ' PRO . 23.7 p90 -150.01 125.56 10.28 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.584 -1.323 . . . . 0.050000000000000003 110.101 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 42.4 p-10 -112.64 -3.08 14.37 Favored 'General case' 0 N--CA 1.499 2.001 0 C-N-CA 119.281 -0.967 . . . . 1.7 112.467 -178.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 870' ' ' ARG . . . . . 0.65 ' HB2' ' HB3' ' C' ' 855' ' ' ALA . 23.8 mmm180 -91.72 89.11 6.96 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.905 -1.122 . . . . 2.5899999999999999 110.991 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 57.9 t -70.71 97.47 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.039 -1.038 . . . . 1.9399999999999999 109.951 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 872' ' ' LEU . . . . . 0.732 HD11 ' HB2' ' C' ' 855' ' ' ALA . 82.8 mt -83.44 -47.39 11.45 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.485 -0.759 . . . . 1.0600000000000001 110.272 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 873' ' ' LEU . . . . . 0.526 ' HG ' ' HB3' ' C' ' 851' ' ' ALA . 42.7 tp -174.45 103.53 0.1 Allowed 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.507 -0.923 . . . . 4.1799999999999997 108.507 178.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 874' ' ' ASN . . . . . 0.448 ' CB ' ' HA ' ' C' ' 852' ' ' PHE . 35.9 t-20 178.55 82.22 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.266 0 O-C-N 121.612 -0.68 . . . . 0.040000000000000001 109.45 -178.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 22.9 p-10 -67.11 -46.24 74.76 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 119.245 -0.982 . . . . 3.3799999999999999 111.279 -179.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 876' ' ' GLY . . . . . 0.405 ' HA3' ' CE2' ' C' ' 878' ' ' TYR . . . -74.55 -26.09 68.53 Favored Glycine 0 N--CA 1.494 2.551 0 O-C-N 121.28 -0.888 . . . . 0.040000000000000001 111.614 -178.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 82.54 -61.06 4.79 Favored Glycine 0 N--CA 1.502 3.072 0 N-CA-C 108.118 -1.993 . . . . 0.040000000000000001 108.118 -178.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 878' ' ' TYR . . . . . 0.405 ' CE2' ' HA3' ' C' ' 876' ' ' GLY . 97.7 m-85 60.95 -65.39 0.06 Allowed 'General case' 0 N--CA 1.502 2.161 0 N-CA-C 114.384 1.253 . . . . 3.46 114.384 177.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 879' ' ' TYR . . . . . 0.473 ' CB ' ' CG ' ' C' ' 886' ' ' PHE . 22.8 p90 -112.58 109.38 18.9 Favored 'General case' 0 N--CA 1.501 2.1 0 N-CA-C 114.823 1.416 . . . . 0.040000000000000001 114.823 -176.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -67.63 117.82 51.27 Favored Pre-proline 0 N--CA 1.497 1.894 0 O-C-N 121.377 -0.827 . . . . 0.02 109.89 179.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 881' ' ' PRO . . . . . 0.49 ' HG2' ' CD1' ' C' ' 868' ' ' PHE . 55.2 Cg_endo -77.03 0.45 9.69 Favored 'Trans proline' 0 N--CA 1.494 1.551 0 O-C-N 123.435 1.229 . . . . 0.39000000000000001 112.116 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 90.3 mt-10 -73.84 -64.33 1.03 Allowed 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 106.459 -1.682 . . . . 0.81000000000000005 106.459 178.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 9.2 p -94.82 -18.16 21.45 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.502 -0.925 . . . . 0.040000000000000001 108.502 177.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.56 21.16 57.0 Favored Glycine 0 N--CA 1.493 2.499 0 O-C-N 121.167 -0.958 . . . . 0.029999999999999999 111.046 178.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 96.8 t -72.33 89.89 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 C-N-CA 118.256 -1.377 . . . . 1.01 108.25 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 886' ' ' PHE . . . . . 0.811 ' CB ' HG22 ' C' ' 962' ' ' VAL . 0.7 OUTLIER -90.48 104.0 16.63 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 115.199 -0.909 . . . . 0.050000000000000003 112.038 -177.468 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 887' ' ' THR . . . . . 0.423 ' O ' ' HD3' ' C' ' 889' ' ' PRO . 91.2 m -96.48 101.46 13.09 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 107.888 -1.153 . . . . 0.68000000000000005 107.888 177.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 888' ' ' ALA . . . . . . . . . . . . . . . -99.87 102.59 17.88 Favored Pre-proline 0 N--CA 1.502 2.152 0 N-CA-C 114.297 1.221 . . . . 0.25 114.297 -176.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 889' ' ' PRO . . . . . 0.423 ' HD3' ' O ' ' C' ' 887' ' ' THR . 55.6 Cg_endo -83.04 -13.11 9.26 Favored 'Trans proline' 0 CA--C 1.545 1.07 0 N-CA-C 109.01 -1.188 . . . . 1.6399999999999999 109.01 175.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 890' ' ' LEU . . . . . 1.055 HD22 HD13 ' C' ' 985' ' ' LEU . 71.7 mt -37.37 -49.87 1.01 Allowed 'General case' 0 N--CA 1.507 2.422 0 N-CA-C 113.679 0.992 . . . . 2.29 113.679 -177.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 52.63 96.73 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.358 0 O-C-N 121.117 -0.989 . . . . 0.63 110.211 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . 156.26 -147.64 16.51 Favored Glycine 0 N--CA 1.479 1.514 0 N-CA-C 107.252 -2.339 . . . . 0.040000000000000001 107.252 -179.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 893' ' ' ARG . . . . . 0.469 ' NE ' ' HB1' ' B' ' 984' ' ' ALA . 74.2 ttt-85 -107.8 129.0 55.09 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 107.934 -1.136 . . . . 3.0 107.934 177.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 894' ' ' TYR . . . . . 0.449 ' CD1' ' N ' ' C' ' 895' ' ' LEU . 0.1 OUTLIER -131.16 144.05 51.07 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.058 -1.026 . . . . 0.040000000000000001 110.151 -179.246 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 895' ' ' LEU . . . . . 0.449 ' N ' ' CD1' ' C' ' 894' ' ' TYR . 37.4 tp -97.83 112.85 24.6 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.735 -0.603 . . . . 1.27 109.531 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 896' ' ' LEU . . . . . 0.53 HD23 ' N ' ' C' ' 897' ' ' SER . 10.3 tt -110.27 143.78 39.95 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.583 -0.698 . . . . 0.93999999999999995 110.448 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 897' ' ' SER . . . . . 0.53 ' N ' HD23 ' C' ' 896' ' ' LEU . 5.2 m -145.23 119.26 9.39 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.471 -0.768 . . . . 0.040000000000000001 111.062 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.87 146.62 32.06 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.965 -0.754 . . . . 0.47999999999999998 108.965 178.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 899' ' ' VAL . . . . . 0.729 HG21 ' HB ' ' C' ' 980' ' ' ILE . 89.6 t -92.1 119.94 40.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.414 -0.803 . . . . 0.55000000000000004 111.054 -179.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 90.9 mt -92.98 111.21 22.75 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 114.096 1.146 . . . . 1.5900000000000001 114.096 -175.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 22.2 m -64.53 139.68 58.79 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 107.331 -1.359 . . . . 0.050000000000000003 107.331 177.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -61.54 -65.02 3.5 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 110.32 -1.112 . . . . 0.029999999999999999 110.32 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 45.48 64.74 1.32 Allowed 'General case' 0 N--CA 1.508 2.45 0 O-C-N 121.485 -1.009 . . . . 3.2000000000000002 111.298 179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 42.4 ptt85 -67.82 -7.14 25.32 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.585 -0.697 . . . . 2.9199999999999999 111.988 -179.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 905' ' ' HIS . . . . . 0.485 ' O ' ' CB ' ' C' ' 906' ' ' GLU . 72.0 t60 -60.37 5.27 0.05 OUTLIER 'General case' 0 N--CA 1.507 2.381 0 O-C-N 120.9 -1.125 . . . . 2.8700000000000001 113.714 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 906' ' ' GLU . . . . . 0.485 ' CB ' ' O ' ' C' ' 905' ' ' HIS . 0.6 OUTLIER 92.11 -164.08 0.01 OUTLIER 'General case' 0 N--CA 1.527 3.38 0 CA-C-N 121.259 1.845 . . . . 0.98999999999999999 112.254 179.053 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 907' ' ' LYS . . . . . 0.485 ' CB ' ' O ' ' C' ' 906' ' ' GLU . 73.5 tttt 89.43 162.03 0.05 Allowed 'General case' 0 N--CA 1.52 3.069 0 N-CA-C 108.146 -1.057 . . . . 5.25 108.146 -177.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 59.0 t -122.31 115.28 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 120.934 -1.104 . . . . 0.39000000000000001 110.883 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 53.0 tp10 -104.07 131.3 51.48 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 107.549 -1.278 . . . . 1.72 107.549 177.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -155.68 120.86 4.83 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 106.882 -1.525 . . . . 0.67000000000000004 106.882 178.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 911' ' ' VAL . . . . . 0.908 HG23 HG22 ' C' ' 964' ' ' VAL . 11.0 p -77.82 131.14 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 121.879 -0.513 . . . . 0.54000000000000004 111.222 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 73.0 mt -67.52 158.29 32.3 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.218 -0.926 . . . . 1.5 108.88 178.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 913' ' ' SER . . . . . 0.468 ' OG ' HG11 ' C' ' 919' ' ' VAL . 1.4 p -128.33 135.73 49.99 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.468 -0.938 . . . . 1.3700000000000001 108.468 176.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 914' ' ' ARG . . . . . 0.588 HH11 HG13 ' C' ' 962' ' ' VAL . 0.0 OUTLIER -63.29 154.28 32.15 Favored 'General case' 0 N--CA 1.503 2.222 0 O-C-N 120.585 -1.322 . . . . 4.2999999999999998 111.287 -179.223 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 915' ' ' SER . . . . . 0.424 ' CB ' ' O ' ' C' ' 914' ' ' ARG . 0.2 OUTLIER 83.24 -30.45 0.09 Allowed 'General case' 0 N--CA 1.521 3.104 0 C-N-CA 123.724 0.81 . . . . 2.0499999999999998 112.079 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 916' ' ' ASN . . . . . 0.779 ' HB2' HG21 ' C' ' 919' ' ' VAL . 93.1 m-20 -123.48 -22.72 4.96 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 120.83 -1.169 . . . . 2.71 111.103 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 67.32 166.25 0.23 Allowed 'General case' 0 N--CA 1.519 3.011 0 N-CA-C 105.745 -1.946 . . . . 2.6800000000000002 105.745 -174.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.9 -125.37 35.19 Favored Glycine 1 N--CA 1.522 4.368 0 CA-C-N 123.619 2.918 . . . . 0.029999999999999999 107.069 -177.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 919' ' ' VAL . . . . . 0.779 HG21 ' HB2' ' C' ' 916' ' ' ASN . 93.0 t 50.75 93.86 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.229 0 O-C-N 121.401 -1.058 . . . . 1.3899999999999999 109.433 -178.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 920' ' ' ALA . . . . . 0.713 ' HB3' HG12 ' C' ' 949' ' ' VAL . . . -96.1 94.96 7.85 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 119.478 -0.889 . . . . 0.029999999999999999 110.953 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 921' ' ' ARG . . . . . 0.817 ' HG3' HG23 ' C' ' 922' ' ' VAL . 45.0 ptt85 -83.83 -41.54 17.4 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 105.626 -1.991 . . . . 4.4199999999999999 105.626 175.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 922' ' ' VAL . . . . . 0.817 HG23 ' HG3' ' C' ' 921' ' ' ARG . 57.6 t -97.11 74.36 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 105.393 -2.077 . . . . 0.84999999999999998 105.393 174.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -90.04 135.79 33.44 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.93 0.871 . . . . 2.46 112.41 -176.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 6.7 t -146.5 102.85 3.62 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 107.853 -1.166 . . . . 0.69999999999999996 107.853 178.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -111.03 91.86 0.63 Allowed Glycine 0 N--CA 1.488 2.119 0 N-CA-C 108.908 -1.677 . . . . 0.040000000000000001 108.908 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.342 0 N-CA-C 109.372 -1.491 . . . . 0.040000000000000001 109.372 -179.75 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 25.6 m . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 120.982 0.42 . . . . 13.779999999999999 110.366 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 94.4 mt -114.15 131.62 56.37 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.441 -0.787 . . . . 13.76 110.393 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -151.67 170.71 31.17 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.252 -1.539 . . . . 9.1300000000000008 109.252 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 949' ' ' VAL . . . . . 0.713 HG12 ' HB3' ' C' ' 920' ' ' ALA . 34.8 m -118.43 133.34 65.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.571 -0.958 . . . . 7.0800000000000001 111.252 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 950' ' ' PHE . . . . . 0.463 ' CZ ' ' HB3' ' C' ' 921' ' ' ARG . 20.3 p90 -131.88 147.36 52.47 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.969 -0.752 . . . . 7.5899999999999999 108.969 178.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 13.2 m -122.09 -52.82 1.96 Allowed 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.281 -0.887 . . . . 5.0300000000000002 112.277 -178.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 952' ' ' LEU . . . . . 0.406 ' O ' ' O ' ' C' ' 953' ' ' ILE . 45.2 tp -60.07 -77.84 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.421 -0.8 . . . . 1.01 112.421 -177.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 953' ' ' ILE . . . . . 0.513 HD11 ' HB3' ' B' ' 872' ' ' LEU . 44.1 pt -54.01 -140.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.734 0 N-CA-C 113.851 1.056 . . . . 2.6000000000000001 113.851 -176.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 954' ' ' LEU . . . . . 0.786 HD22 ' O ' ' C' ' 954' ' ' LEU . 0.0 OUTLIER 176.27 76.58 0.09 OUTLIER Pre-proline 0 N--CA 1.507 2.38 0 O-C-N 120.663 -1.273 . . . . 0.050000000000000003 111.192 179.725 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 955' ' ' PRO . . . . . 0.688 ' C ' HD12 ' C' ' 956' ' ' LEU . 44.6 Cg_endo -71.51 86.2 0.85 Allowed 'Trans proline' 0 C--N 1.312 -1.364 0 N-CA-C 109.349 -1.058 . . . . 0.83999999999999997 109.349 178.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 956' ' ' LEU . . . . . 0.688 HD12 ' C ' ' C' ' 955' ' ' PRO . 7.5 mp -126.06 153.09 44.95 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.293 -0.88 . . . . 0.040000000000000001 110.64 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -81.49 151.01 28.01 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-O 117.737 -1.125 . . . . 1.28 111.574 -179.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -68.88 119.21 12.86 Favored 'General case' 0 N--CA 1.51 2.549 0 CA-C-N 123.083 2.674 . . . . 0.17000000000000001 111.223 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 91.8 -22.65 30.04 Favored Glycine 0 N--CA 1.501 3.019 0 N-CA-C 110.789 -0.924 . . . . 0.040000000000000001 110.789 178.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 960' ' ' ASP . . . . . 0.407 ' HB3' ' CZ ' ' C' ' 914' ' ' ARG . 0.1 OUTLIER -51.82 172.45 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.519 -0.989 . . . . 0.040000000000000001 110.332 -179.49 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 961' ' ' THR . . . . . 0.494 ' HA ' ' O ' ' C' ' 886' ' ' PHE . 53.5 p -133.18 138.81 46.72 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.087 -1.008 . . . . 1.78 112.307 -177.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 962' ' ' VAL . . . . . 0.811 HG22 ' CB ' ' C' ' 886' ' ' PHE . 18.5 m -96.19 144.9 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 C-N-CA 120.208 -0.597 . . . . 0.040000000000000001 109.696 179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 6.6 t -137.81 145.64 42.57 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.823 -0.548 . . . . 0.71999999999999997 110.213 -178.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 964' ' ' VAL . . . . . 0.908 HG22 HG23 ' C' ' 911' ' ' VAL . 57.5 t -100.17 135.91 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 O-C-N 121.067 -1.021 . . . . 1.05 110.899 -179.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -96.71 125.62 41.29 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 103.788 -2.671 . . . . 3.02 103.788 173.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 966' ' ' LEU . . . . . 0.645 HD23 ' O ' ' C' ' 966' ' ' LEU . 5.1 tt -131.87 62.79 1.63 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.067 -1.086 . . . . 1.46 108.067 177.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 967' ' ' VAL . . . . . 0.491 HG23 ' C ' ' C' ' 966' ' ' LEU . 97.6 t -157.79 96.77 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 108.065 -1.087 . . . . 1.9399999999999999 108.065 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 94.4 mmm -142.26 58.62 1.46 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.769 -1.207 . . . . 0.0 108.375 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 134.58 119.54 1.96 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 107.222 -2.351 . . . . 2.1099999999999999 107.222 -178.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -82.4 -58.12 3.07 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.031 -1.276 . . . . 5.8899999999999997 110.607 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 971' ' ' LEU . . . . . 0.601 HD23 ' O ' ' C' ' 971' ' ' LEU . 9.1 tt -58.94 89.84 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.427 -0.796 . . . . 4.3600000000000003 110.378 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -142.33 -152.59 0.42 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.584 -0.698 . . . . 1.8300000000000001 110.144 -179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -117.17 167.81 10.85 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.415 -0.803 . . . . 4.3499999999999996 110.045 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 29.3 t -101.54 130.19 47.77 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.547 -0.72 . . . . 1.27 110.152 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -156.22 153.68 29.56 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.526 -0.734 . . . . 5.0199999999999996 110.405 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.27 86.08 17.56 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 121.604 -0.685 . . . . 2.4100000000000001 109.853 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -75.39 -171.44 1.02 Allowed 'Trans proline' 0 C--N 1.318 -1.065 0 O-C-N 123.326 1.172 . . . . 0.95999999999999996 111.309 -179.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 978' ' ' LEU . . . . . 0.582 ' N ' HD12 ' C' ' 978' ' ' LEU . 5.4 mp -123.36 156.68 34.9 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 107.512 -1.292 . . . . 0.62 107.512 177.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 979' ' ' THR . . . . . 0.45 HG23 ' C ' ' C' ' 978' ' ' LEU . 45.0 p -149.72 141.65 23.81 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.777 -1.202 . . . . 3.5699999999999998 111.186 -179.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 980' ' ' ILE . . . . . 0.729 ' HB ' HG21 ' C' ' 899' ' ' VAL . 50.6 mm -105.64 128.47 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 N-CA-C 109.174 -0.676 . . . . 1.3300000000000001 109.174 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 981' ' ' PHE . . . . . 0.439 ' CD1' ' CE2' ' C' ' 879' ' ' TYR . 2.1 t80 -118.99 99.36 6.69 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 119.808 -0.757 . . . . 0.050000000000000003 111.486 -178.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 982' ' ' SER . . . . . . . . . . . . . 10.6 p -109.93 159.71 17.02 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.578 -0.701 . . . . 0.87 109.194 178.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 983' ' ' GLY . . . . . 0.41 ' O ' ' CE2' ' C' ' 852' ' ' PHE . . . -170.8 111.42 0.41 Allowed Glycine 0 N--CA 1.498 2.818 0 N-CA-C 106.594 -2.602 . . . . 0.029999999999999999 106.594 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 984' ' ' ALA . . . . . 0.44 ' HB1' ' NE ' ' A' ' 893' ' ' ARG . . . -109.01 147.19 32.7 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.199 -1.177 . . . . 0.69999999999999996 114.025 -176.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 985' ' ' LEU . . . . . 1.055 HD13 HD22 ' C' ' 890' ' ' LEU . 56.6 tp -72.36 135.72 45.95 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.722 -1.236 . . . . 0.040000000000000001 110.066 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 986' ' ' LEU . . . . . . . . . . . . . 49.1 tp -107.08 -61.58 1.53 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.524 -0.735 . . . . 0.040000000000000001 110.341 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 56.7 t80 -145.0 146.33 31.87 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.847 -1.168 . . . . 0.040000000000000001 107.847 179.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.35 162.79 12.29 Favored Glycine 0 N--CA 1.495 2.593 0 N-CA-C 108.146 -1.981 . . . . 0.040000000000000001 108.146 179.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -75.44 112.65 20.05 Favored Pre-proline 0 N--CA 1.498 1.965 0 O-C-N 121.19 -1.183 . . . . 0.040000000000000001 109.485 179.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 990' ' ' PRO . . . . . 0.418 ' O ' ' HB2' ' C' ' 991' ' ' GLU . 50.2 Cg_endo -89.82 71.26 1.72 Allowed 'Trans proline' 0 C--N 1.319 -0.985 0 O-C-N 123.132 1.07 . . . . 0.45000000000000001 111.466 -178.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 991' ' ' GLU . . . . . 0.418 ' HB2' ' O ' ' C' ' 990' ' ' PRO . 69.5 mt-10 67.41 -73.31 0.08 Allowed 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 108.662 -0.866 . . . . 1.97 108.662 -177.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 992' ' ' LEU . . . . . . . . . . . . . 11.7 mt 50.62 21.06 0.81 Allowed 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.584 -0.697 . . . . 2.3799999999999999 111.645 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 79.7 mt-10 -93.27 156.94 16.51 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.887 -1.133 . . . . 3.79 110.02 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 68.6 m80 -146.62 92.59 2.17 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.525 -0.734 . . . . 3.5099999999999998 110.21 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 995' ' ' ALA . . . . . . . . . . . . 2.518 . . . . . . . 0 N--CA 1.503 2.197 0 O-C-N 120.94 -1.1 . . . . 2.73 110.569 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo . . . . . 0 N--CA 1.488 1.157 0 N-CA-C 109.503 -0.999 . . . . 3.8300000000000001 109.503 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 847' ' ' VAL . . . . . 0.44 HG12 ' HB2' ' A' ' 849' ' ' GLN . 61.3 t -132.16 102.84 14.24 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.584 -0.697 . . . . 1.8300000000000001 110.06 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 848' ' ' PRO . . . . . 0.762 ' O ' HG23 ' A' ' 850' ' ' VAL . 43.5 Cg_endo -69.84 -20.84 33.95 Favored 'Trans proline' 0 N--CA 1.487 1.124 0 O-C-N 123.276 1.145 . . . . 0.65000000000000002 110.973 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 849' ' ' GLN . . . . . 0.44 ' HB2' HG12 ' A' ' 847' ' ' VAL . 56.1 tt0 28.04 68.1 0.07 Allowed 'General case' 0 N--CA 1.518 2.937 0 N-CA-C 112.911 0.708 . . . . 2.5800000000000001 112.911 179.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 850' ' ' VAL . . . . . 0.762 HG23 ' O ' ' A' ' 848' ' ' PRO . 72.9 t -119.74 136.13 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.152 -0.968 . . . . 1.0900000000000001 111.413 -178.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 851' ' ' ALA . . . . . 0.482 ' HB3' ' HG ' ' A' ' 873' ' ' LEU . . . -126.62 159.41 33.65 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 106.043 -1.836 . . . . 0.040000000000000001 106.043 177.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 852' ' ' PHE . . . . . 0.439 ' HA ' ' CB ' ' A' ' 874' ' ' ASN . 46.7 p90 -157.56 131.79 8.3 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 121.019 1.736 . . . . 0.050000000000000003 108.728 178.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 32.5 t -175.67 133.02 0.28 Allowed 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.076 -1.083 . . . . 0.040000000000000001 108.076 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -133.45 156.08 48.37 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.071 -1.018 . . . . 0.67000000000000004 109.472 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 855' ' ' ALA . . . . . 0.744 ' HB3' ' CB ' ' A' ' 870' ' ' ARG . . . -124.4 140.17 53.21 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 121.808 0.813 . . . . 0.51000000000000001 111.305 -179.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 856' ' ' LEU . . . . . 0.761 HD11 HD23 ' A' ' 858' ' ' LEU . 3.4 tm? -111.96 140.01 46.98 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.607 -0.683 . . . . 0.050000000000000003 110.156 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 857' ' ' SER . . . . . 0.68 ' N ' HD13 ' A' ' 856' ' ' LEU . 37.0 p -157.59 17.05 0.26 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.543 -0.723 . . . . 1.3300000000000001 111.467 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 858' ' ' LEU . . . . . 0.761 HD23 HD11 ' A' ' 856' ' ' LEU . 3.1 pp -35.67 161.57 0.04 OUTLIER Pre-proline 0 N--CA 1.518 2.935 0 N-CA-C 112.851 0.686 . . . . 2.3300000000000001 112.851 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -59.87 -89.17 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.453 0 O-C-N 122.938 0.968 . . . . 2.3199999999999998 113.294 -178.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 55.3 ptt85 -134.9 -141.61 0.18 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.839 -1.163 . . . . 0.040000000000000001 111.646 -177.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 73.8 m -32.89 122.09 0.36 Allowed 'General case' 0 N--CA 1.513 2.694 0 N-CA-C 112.996 0.739 . . . . 1.3100000000000001 112.996 -178.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.76 160.13 27.08 Favored Pre-proline 0 N--CA 1.489 1.483 0 N-CA-C 107.93 -1.137 . . . . 4.5099999999999998 107.93 177.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.05 -13.86 34.45 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 O-C-N 123.134 1.07 . . . . 2.2400000000000002 111.479 -179.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -177.3 -135.45 2.22 Favored Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.97 -1.252 . . . . 0.040000000000000001 109.97 179.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 37.2 m -67.56 157.34 34.6 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.35 -1.088 . . . . 1.51 110.53 -178.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 866' ' ' VAL . . . . . 0.475 HG13 ' CD2' ' A' ' 858' ' ' LEU . 50.8 t -100.55 139.34 20.54 Favored Pre-proline 0 N--CA 1.495 1.8 0 N-CA-C 113.459 0.911 . . . . 0.78000000000000003 113.459 -174.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 867' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 866' ' ' VAL . 55.6 Cg_endo -91.67 -148.19 0.03 OUTLIER 'Trans proline' 0 CA--C 1.548 1.177 0 O-C-N 123.621 1.327 . . . . 0.92000000000000004 109.481 177.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 868' ' ' PHE . . . . . 0.45 ' CD1' ' CG ' ' A' ' 881' ' ' PRO . 26.3 p90 -150.35 124.22 9.26 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.696 -1.253 . . . . 0.050000000000000003 109.539 179.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 50.4 p-10 -113.82 -2.16 13.73 Favored 'General case' 0 N--CA 1.5 2.066 0 C-N-CA 119.265 -0.974 . . . . 1.7 112.852 -178.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 870' ' ' ARG . . . . . 0.744 ' CB ' ' HB3' ' A' ' 855' ' ' ALA . 28.7 mmm180 -91.27 90.11 7.6 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.865 -1.147 . . . . 2.5899999999999999 110.999 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 57.4 t -71.81 96.72 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 120.971 -1.081 . . . . 1.9399999999999999 110.047 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 872' ' ' LEU . . . . . 0.538 HD11 ' HB2' ' A' ' 855' ' ' ALA . 96.8 mt -83.06 -47.46 11.65 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.456 -0.778 . . . . 1.0600000000000001 110.04 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 873' ' ' LEU . . . . . 0.482 ' HG ' ' HB3' ' A' ' 851' ' ' ALA . 41.2 tp -175.15 103.19 0.08 Allowed 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 108.381 -0.97 . . . . 4.1799999999999997 108.381 178.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 874' ' ' ASN . . . . . 0.439 ' CB ' ' HA ' ' A' ' 852' ' ' PHE . 36.7 t-20 178.29 81.68 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.324 0 O-C-N 121.681 -0.637 . . . . 0.040000000000000001 109.421 -178.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -66.26 -46.77 75.93 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 119.324 -0.95 . . . . 3.3799999999999999 111.22 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 876' ' ' GLY . . . . . 0.4 ' HA3' ' CE2' ' A' ' 878' ' ' TYR . . . -74.87 -24.56 71.74 Favored Glycine 0 N--CA 1.494 2.555 0 O-C-N 121.318 -0.864 . . . . 0.040000000000000001 111.916 -178.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 82.11 -62.48 4.54 Favored Glycine 0 N--CA 1.501 3.021 0 N-CA-C 107.896 -2.082 . . . . 0.040000000000000001 107.896 -178.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 878' ' ' TYR . . . . . 0.4 ' CE2' ' HA3' ' A' ' 876' ' ' GLY . 93.2 m-85 61.41 -61.99 0.09 Allowed 'General case' 0 N--CA 1.504 2.262 0 N-CA-C 114.596 1.332 . . . . 3.46 114.596 177.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 879' ' ' TYR . . . . . 0.467 ' CB ' ' CD2' ' A' ' 886' ' ' PHE . 20.4 p90 -110.58 109.03 19.17 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 114.849 1.425 . . . . 0.040000000000000001 114.849 -176.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -67.19 118.21 53.77 Favored Pre-proline 0 N--CA 1.495 1.813 0 O-C-N 121.385 -0.822 . . . . 0.02 109.899 179.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 881' ' ' PRO . . . . . 0.45 ' CG ' ' CD1' ' A' ' 868' ' ' PHE . 51.2 Cg_endo -76.84 1.2 8.84 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 O-C-N 123.443 1.233 . . . . 0.39000000000000001 112.165 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -76.19 -64.75 1.03 Allowed 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 106.78 -1.563 . . . . 0.81000000000000005 106.78 178.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 7.5 p -95.43 -17.91 21.13 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.702 -0.851 . . . . 0.040000000000000001 108.702 177.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 85.17 23.33 48.97 Favored Glycine 0 N--CA 1.495 2.577 0 C-N-CA 120.11 -1.043 . . . . 0.029999999999999999 110.679 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 885' ' ' VAL . . . . . . . . . . . . . 75.4 t -73.39 88.42 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 C-N-CA 118.351 -1.339 . . . . 1.01 108.085 -179.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 886' ' ' PHE . . . . . 0.905 ' HB3' HG22 ' A' ' 962' ' ' VAL . 0.6 OUTLIER -89.64 106.55 18.53 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 115.239 -0.891 . . . . 0.050000000000000003 112.135 -177.232 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 887' ' ' THR . . . . . 0.41 ' O ' ' HD3' ' A' ' 889' ' ' PRO . 95.4 m -98.48 99.29 10.45 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 107.581 -1.266 . . . . 0.68000000000000005 107.581 177.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 888' ' ' ALA . . . . . . . . . . . . . . . -97.1 107.88 40.59 Favored Pre-proline 0 N--CA 1.502 2.132 0 N-CA-C 113.983 1.105 . . . . 0.25 113.983 -176.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 889' ' ' PRO . . . . . 0.41 ' HD3' ' O ' ' A' ' 887' ' ' THR . 54.6 Cg_endo -89.11 -13.5 2.99 Favored 'Trans proline' 0 CA--C 1.546 1.094 0 N-CA-C 109.093 -1.157 . . . . 1.6399999999999999 109.093 176.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 890' ' ' LEU . . . . . 0.988 HD22 HD13 ' A' ' 985' ' ' LEU . 51.8 mt -35.91 -51.08 0.7 Allowed 'General case' 0 N--CA 1.508 2.447 0 N-CA-C 113.735 1.013 . . . . 2.29 113.735 -177.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 51.83 95.76 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.321 0 O-C-N 121.211 -0.93 . . . . 0.63 110.294 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 157.71 -152.99 24.24 Favored Glycine 0 N--CA 1.479 1.531 0 N-CA-C 107.181 -2.368 . . . . 0.040000000000000001 107.181 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 893' ' ' ARG . . . . . 0.405 ' CZ ' ' CB ' ' C' ' 984' ' ' ALA . 71.9 ttt-85 -114.46 126.23 54.73 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 108.286 -1.005 . . . . 3.0 108.286 177.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 894' ' ' TYR . . . . . 0.722 ' OH ' HD12 ' A' ' 896' ' ' LEU . 0.1 OUTLIER -132.47 160.06 37.54 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.105 -0.997 . . . . 0.040000000000000001 111.342 -179.4 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 895' ' ' LEU . . . . . 0.796 HD23 HD11 ' B' ' 952' ' ' LEU . 36.4 tp -92.16 119.67 32.03 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.735 -0.603 . . . . 1.27 110.056 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 896' ' ' LEU . . . . . 0.722 HD12 ' OH ' ' A' ' 894' ' ' TYR . 9.7 tt -109.64 143.67 39.05 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.717 -0.614 . . . . 0.93999999999999995 110.191 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 897' ' ' SER . . . . . 0.527 ' N ' HD23 ' A' ' 896' ' ' LEU . 64.7 m -149.86 114.07 5.17 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.443 -0.786 . . . . 0.040000000000000001 111.159 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.71 146.53 31.97 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.942 -0.762 . . . . 0.47999999999999998 108.942 178.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 899' ' ' VAL . . . . . 0.756 HG21 ' HB ' ' A' ' 980' ' ' ILE . 90.1 t -95.02 120.06 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 C-N-CA 119.588 -0.845 . . . . 0.55000000000000004 111.183 -179.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 900' ' ' LEU . . . . . 0.483 ' N ' HD22 ' A' ' 900' ' ' LEU . 4.5 mm? -95.52 112.04 23.83 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 114.331 1.234 . . . . 1.5900000000000001 114.331 -175.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 15.7 m -65.91 141.28 58.29 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 107.506 -1.294 . . . . 0.050000000000000003 107.506 177.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -67.11 -66.71 2.25 Favored Glycine 0 N--CA 1.495 2.597 0 N-CA-C 110.505 -1.038 . . . . 0.029999999999999999 110.505 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 12.0 m170 47.52 67.3 0.83 Allowed 'General case' 0 N--CA 1.507 2.378 0 O-C-N 121.533 -0.981 . . . . 3.2000000000000002 111.017 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 46.5 ptt85 -69.48 -6.82 33.01 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.58 -0.7 . . . . 2.9199999999999999 111.9 -179.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 905' ' ' HIS . . . . . 0.485 ' O ' ' CB ' ' A' ' 906' ' ' GLU . 70.7 t60 -62.86 5.68 0.12 Allowed 'General case' 0 N--CA 1.506 2.35 0 O-C-N 120.943 -1.098 . . . . 2.8700000000000001 113.116 -179.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 906' ' ' GLU . . . . . 0.485 ' CB ' ' O ' ' A' ' 905' ' ' HIS . 0.6 OUTLIER 94.44 -164.29 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.407 0 CA-C-N 120.486 1.494 . . . . 0.98999999999999999 111.906 178.924 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 907' ' ' LYS . . . . . 0.458 ' CB ' ' O ' ' A' ' 906' ' ' GLU . 69.2 tttt 85.34 155.57 0.09 Allowed 'General case' 0 N--CA 1.519 3.01 0 N-CA-C 107.87 -1.159 . . . . 5.25 107.87 -176.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 59.5 t -123.44 115.55 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 O-C-N 120.733 -1.229 . . . . 0.39000000000000001 111.239 -179.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 909' ' ' GLU . . . . . 0.646 ' OE2' HD12 ' A' ' 966' ' ' LEU . 43.3 tp10 -97.3 135.48 39.16 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 107.077 -1.453 . . . . 1.72 107.077 176.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -154.72 123.66 6.25 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 106.985 -1.487 . . . . 0.67000000000000004 106.985 178.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 911' ' ' VAL . . . . . 0.67 HG22 HG13 ' A' ' 964' ' ' VAL . 86.1 t -80.43 130.55 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 CA-C-N 116.186 -0.461 . . . . 0.54000000000000004 110.933 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 86.0 mt -63.54 156.74 25.54 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.33 -0.856 . . . . 1.5 108.703 178.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 913' ' ' SER . . . . . 0.409 ' CB ' ' CG1' ' A' ' 919' ' ' VAL . 0.4 OUTLIER -128.38 131.27 48.53 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.17 -1.048 . . . . 1.3700000000000001 108.17 176.653 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 914' ' ' ARG . . . . . 0.853 ' NH1' HD23 ' A' ' 956' ' ' LEU . 0.0 OUTLIER -66.18 156.35 34.36 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 120.651 -1.28 . . . . 4.2999999999999998 111.706 -179.068 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 915' ' ' SER . . . . . 0.432 ' CB ' ' O ' ' A' ' 914' ' ' ARG . 4.2 t 83.19 -32.05 0.08 Allowed 'General case' 0 N--CA 1.522 3.163 0 C-N-CA 123.99 0.916 . . . . 2.0499999999999998 112.003 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 916' ' ' ASN . . . . . 0.798 ' HB2' HG21 ' A' ' 919' ' ' VAL . 82.6 m-20 -122.73 -20.86 5.78 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.918 -1.114 . . . . 2.71 111.249 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 917' ' ' GLN . . . . . 0.402 ' HB2' ' O ' ' A' ' 916' ' ' ASN . 45.4 mt-30 66.64 164.8 0.2 Allowed 'General case' 0 N--CA 1.521 3.106 0 N-CA-C 105.744 -1.947 . . . . 2.6800000000000002 105.744 -174.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 53.94 -124.26 29.47 Favored Glycine 1 N--CA 1.521 4.345 0 CA-C-N 123.455 2.843 . . . . 0.029999999999999999 107.05 -177.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 919' ' ' VAL . . . . . 0.798 HG21 ' HB2' ' A' ' 916' ' ' ASN . 73.5 t 51.56 94.18 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.199 0 O-C-N 121.425 -1.044 . . . . 1.3899999999999999 109.165 -178.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 920' ' ' ALA . . . . . 0.567 ' HB3' HG12 ' A' ' 949' ' ' VAL . . . -92.95 92.19 7.75 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.347 -0.941 . . . . 0.029999999999999999 110.67 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 921' ' ' ARG . . . . . 0.865 ' HG3' HG23 ' A' ' 922' ' ' VAL . 29.2 ptt180 -85.11 -41.75 15.42 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 105.931 -1.877 . . . . 4.4199999999999999 105.931 176.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 922' ' ' VAL . . . . . 0.865 HG23 ' HG3' ' A' ' 921' ' ' ARG . 93.1 t -101.19 73.02 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 N-CA-C 106.021 -1.844 . . . . 0.84999999999999998 106.021 175.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -87.29 133.29 33.71 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.689 0.757 . . . . 2.46 111.381 -177.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 924' ' ' SER . . . . . 0.408 ' CB ' HD12 ' A' ' 900' ' ' LEU . 8.7 t -147.99 105.61 3.68 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.59 -0.893 . . . . 0.69999999999999996 108.59 179.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -102.82 84.41 0.47 Allowed Glycine 0 N--CA 1.487 2.054 0 N-CA-C 108.568 -1.813 . . . . 0.040000000000000001 108.568 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 926' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' A' ' 906' ' ' GLU . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 108.786 -1.725 . . . . 0.040000000000000001 108.786 -179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 67.1 m . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.007 0.432 . . . . 13.779999999999999 110.366 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 95.5 mt -109.52 130.55 55.5 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.509 -0.744 . . . . 13.76 110.276 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -152.79 169.21 31.82 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.388 -1.485 . . . . 9.1300000000000008 109.388 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 949' ' ' VAL . . . . . 0.567 HG12 ' HB3' ' A' ' 920' ' ' ALA . 34.3 m -118.56 130.49 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.577 -0.955 . . . . 7.0800000000000001 110.687 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 950' ' ' PHE . . . . . 0.428 ' CZ ' ' HB3' ' A' ' 921' ' ' ARG . 52.0 p90 -130.22 143.98 51.1 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.454 -0.779 . . . . 7.5899999999999999 109.415 179.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 31.3 m -121.61 -52.3 2.03 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.46 -0.775 . . . . 5.0300000000000002 111.97 -178.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 952' ' ' LEU . . . . . 0.404 ' O ' ' O ' ' A' ' 953' ' ' ILE . 45.7 tp -61.47 -75.88 0.06 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.44 -0.787 . . . . 1.01 112.439 -177.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 953' ' ' ILE . . . . . 0.46 ' O ' ' HB3' ' A' ' 954' ' ' LEU . 47.0 pt -53.65 -141.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.736 0 N-CA-C 113.981 1.104 . . . . 2.6000000000000001 113.981 -176.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 954' ' ' LEU . . . . . 0.738 HD22 ' O ' ' A' ' 954' ' ' LEU . 0.0 OUTLIER 174.32 75.09 0.05 OUTLIER Pre-proline 0 N--CA 1.507 2.378 0 O-C-N 120.755 -1.215 . . . . 0.050000000000000003 110.959 179.813 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 955' ' ' PRO . . . . . 0.561 ' C ' HD12 ' A' ' 956' ' ' LEU . 45.3 Cg_endo -73.04 93.79 0.81 Allowed 'Trans proline' 0 C--N 1.315 -1.215 0 N-CA-C 109.227 -1.105 . . . . 0.83999999999999997 109.227 178.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 956' ' ' LEU . . . . . 0.853 HD23 ' NH1' ' A' ' 914' ' ' ARG . 5.0 mp -126.19 140.39 52.59 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.251 -0.906 . . . . 0.040000000000000001 110.624 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -79.77 152.52 29.75 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 117.864 -1.065 . . . . 1.28 111.201 -179.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -67.14 121.2 15.1 Favored 'General case' 0 N--CA 1.511 2.58 0 CA-C-N 122.743 2.52 . . . . 0.17000000000000001 111.925 -179.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 94.31 -18.75 56.29 Favored Glycine 0 N--CA 1.501 3.004 0 N-CA-C 111.135 -0.786 . . . . 0.040000000000000001 111.135 178.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 960' ' ' ASP . . . . . 0.406 ' HB3' ' CZ ' ' A' ' 914' ' ' ARG . 1.3 m-20 -52.42 167.56 0.13 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.445 -1.032 . . . . 0.040000000000000001 111.029 -179.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 961' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 886' ' ' PHE . 57.3 m -135.66 135.84 40.45 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.936 -1.103 . . . . 1.78 111.623 -178.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 962' ' ' VAL . . . . . 0.905 HG22 ' HB3' ' A' ' 886' ' ' PHE . 33.8 m -100.43 145.24 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 O-C-N 121.57 -0.706 . . . . 0.040000000000000001 111.173 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 1.7 m -138.51 148.15 43.96 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.789 -0.569 . . . . 0.71999999999999997 109.964 -178.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 964' ' ' VAL . . . . . 0.67 HG13 HG22 ' A' ' 911' ' ' VAL . 61.4 t -99.66 137.92 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.128 -0.983 . . . . 1.05 110.584 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -91.68 128.88 37.69 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 104.121 -2.548 . . . . 3.02 104.121 173.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 966' ' ' LEU . . . . . 0.646 HD12 ' OE2' ' A' ' 909' ' ' GLU . 0.4 OUTLIER -131.54 59.8 1.69 Allowed 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.22 -1.03 . . . . 1.46 108.22 177.078 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 967' ' ' VAL . . . . . 0.491 HG23 ' C ' ' A' ' 966' ' ' LEU . 90.6 t -158.64 97.25 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 N-CA-C 108.041 -1.096 . . . . 1.9399999999999999 108.041 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 80.2 mmm -143.99 59.47 1.36 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.711 -1.243 . . . . 0.0 108.396 178.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.3 119.77 1.95 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 107.195 -2.362 . . . . 2.1099999999999999 107.195 -178.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -82.18 -59.05 2.69 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.082 -1.246 . . . . 5.8899999999999997 110.333 -179.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 47.3 tp -59.08 90.76 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.437 -0.789 . . . . 4.3600000000000003 110.205 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -141.91 -154.51 0.52 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.56 -0.712 . . . . 1.8300000000000001 110.24 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -120.5 172.53 7.77 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.45 -0.781 . . . . 4.3499999999999996 110.349 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 30.6 t -101.25 130.3 47.35 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.534 -0.729 . . . . 1.27 110.016 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -155.66 159.0 39.22 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.553 -0.717 . . . . 5.0199999999999996 110.52 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.01 85.99 18.47 Favored Pre-proline 0 N--CA 1.5 2.053 0 O-C-N 121.648 -0.658 . . . . 2.4100000000000001 109.632 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -73.15 -173.06 1.15 Allowed 'Trans proline' 0 C--N 1.317 -1.098 0 O-C-N 123.309 1.163 . . . . 0.95999999999999996 111.359 -179.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 978' ' ' LEU . . . . . 0.568 HD23 HD12 ' A' ' 856' ' ' LEU . 4.9 mp -128.52 153.94 46.66 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 107.547 -1.279 . . . . 0.62 107.547 177.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 979' ' ' THR . . . . . 0.462 HG23 ' C ' ' A' ' 978' ' ' LEU . 41.8 p -149.99 141.57 23.49 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.8 -1.187 . . . . 3.5699999999999998 111.189 -179.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 980' ' ' ILE . . . . . 0.756 ' HB ' HG21 ' A' ' 899' ' ' VAL . 49.4 mm -106.86 128.72 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.893 -0.78 . . . . 1.3300000000000001 108.893 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 981' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -119.0 95.96 5.04 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 119.806 -0.758 . . . . 0.050000000000000003 111.891 -178.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 82.8 p -108.18 157.83 17.97 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.55 -0.719 . . . . 0.87 109.098 178.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 983' ' ' GLY . . . . . 0.411 ' HA3' ' CE1' ' A' ' 852' ' ' PHE . . . -176.84 108.17 0.25 Allowed Glycine 0 N--CA 1.499 2.875 0 N-CA-C 106.411 -2.676 . . . . 0.029999999999999999 106.411 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -108.53 152.33 24.89 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 114.658 1.355 . . . . 0.69999999999999996 114.658 -175.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 985' ' ' LEU . . . . . 0.988 HD13 HD22 ' A' ' 890' ' ' LEU . 36.4 tp -72.15 135.33 46.15 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 120.829 -1.17 . . . . 0.040000000000000001 109.991 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 51.4 tp -106.09 -59.78 1.73 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.535 -0.728 . . . . 0.040000000000000001 109.879 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -143.15 146.52 33.8 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 107.57 -1.27 . . . . 0.040000000000000001 107.57 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.13 163.66 12.17 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 108.23 -1.948 . . . . 0.040000000000000001 108.23 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -74.56 112.61 18.11 Favored Pre-proline 0 N--CA 1.498 1.951 0 O-C-N 121.227 -1.161 . . . . 0.040000000000000001 109.439 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 990' ' ' PRO . . . . . 0.419 ' O ' ' HB2' ' A' ' 991' ' ' GLU . 50.6 Cg_endo -89.25 71.0 2.07 Favored 'Trans proline' 0 C--N 1.318 -1.036 0 O-C-N 123.132 1.07 . . . . 0.45000000000000001 111.494 -178.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 991' ' ' GLU . . . . . 0.419 ' HB2' ' O ' ' A' ' 990' ' ' PRO . 70.5 mt-10 67.23 -73.97 0.07 Allowed 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 108.562 -0.903 . . . . 1.97 108.562 -177.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 992' ' ' LEU . . . . . 0.41 HD12 ' HD2' ' A' ' 990' ' ' PRO . 11.4 mt 51.19 20.66 0.93 Allowed 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.572 -0.705 . . . . 2.3799999999999999 111.593 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -92.81 156.9 16.69 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.86 -1.15 . . . . 3.79 109.955 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 71.0 m80 -147.1 92.22 2.09 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.525 -0.734 . . . . 3.5099999999999998 110.314 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 995' ' ' ALA . . . . . . . . . . . . 2.516 . . . . . . . 0 N--CA 1.503 2.214 0 O-C-N 120.933 -1.105 . . . . 2.73 110.551 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo . . . . . 0 N--CA 1.488 1.16 0 N-CA-C 109.479 -1.008 . . . . 3.8300000000000001 109.479 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 847' ' ' VAL . . . . . 0.424 HG12 ' HB2' ' B' ' 849' ' ' GLN . 60.4 t -132.1 102.86 14.31 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.632 -0.667 . . . . 1.8300000000000001 110.122 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 848' ' ' PRO . . . . . 0.767 ' O ' HG23 ' B' ' 850' ' ' VAL . 43.9 Cg_endo -69.76 -21.17 33.85 Favored 'Trans proline' 0 N--CA 1.487 1.1 0 O-C-N 123.328 1.173 . . . . 0.65000000000000002 110.941 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 849' ' ' GLN . . . . . 0.424 ' HB2' HG12 ' B' ' 847' ' ' VAL . 56.1 tt0 28.35 68.34 0.08 Allowed 'General case' 0 N--CA 1.517 2.901 0 N-CA-C 112.856 0.687 . . . . 2.5800000000000001 112.856 179.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 850' ' ' VAL . . . . . 0.767 HG23 ' O ' ' B' ' 848' ' ' PRO . 74.4 t -120.07 136.11 58.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.213 -0.93 . . . . 1.0900000000000001 111.421 -178.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 851' ' ' ALA . . . . . 0.493 ' HB3' ' HG ' ' B' ' 873' ' ' LEU . . . -126.93 158.72 36.06 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 106.008 -1.849 . . . . 0.040000000000000001 106.008 177.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 852' ' ' PHE . . . . . 0.432 ' HA ' ' CB ' ' B' ' 874' ' ' ASN . 46.6 p90 -156.87 132.07 9.12 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 121.034 1.743 . . . . 0.050000000000000003 108.713 179.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 33.0 t -175.74 132.71 0.27 Allowed 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.118 -1.067 . . . . 0.040000000000000001 108.118 -179.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -133.13 156.23 47.82 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.118 -0.989 . . . . 0.67000000000000004 109.487 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 855' ' ' ALA . . . . . 0.74 ' HB3' ' CB ' ' B' ' 870' ' ' ARG . . . -124.47 140.38 53.01 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.784 0.802 . . . . 0.51000000000000001 111.306 -179.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 856' ' ' LEU . . . . . 0.764 HD11 HD23 ' B' ' 858' ' ' LEU . 3.4 tm? -112.24 139.5 47.72 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.622 -0.673 . . . . 0.050000000000000003 110.179 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 857' ' ' SER . . . . . 0.667 ' N ' HD13 ' B' ' 856' ' ' LEU . 37.4 p -157.27 17.42 0.28 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.544 -0.723 . . . . 1.3300000000000001 111.42 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 858' ' ' LEU . . . . . 0.764 HD23 HD11 ' B' ' 856' ' ' LEU . 3.2 pp -35.92 161.57 0.04 OUTLIER Pre-proline 0 N--CA 1.518 2.953 0 CA-C-N 118.656 0.662 . . . . 2.3300000000000001 112.784 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -59.86 -89.24 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.49 0 O-C-N 122.901 0.948 . . . . 2.3199999999999998 113.277 -178.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 55.3 ptt85 -134.92 -141.58 0.18 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.836 -1.165 . . . . 0.040000000000000001 111.675 -177.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 73.8 m -32.81 121.68 0.35 Allowed 'General case' 0 N--CA 1.512 2.646 0 N-CA-C 113.042 0.756 . . . . 1.3100000000000001 113.042 -178.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 862' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.47 160.16 27.01 Favored Pre-proline 0 N--CA 1.489 1.524 0 N-CA-C 107.953 -1.129 . . . . 4.5099999999999998 107.953 177.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -69.95 -14.01 34.92 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 O-C-N 123.157 1.083 . . . . 2.2400000000000002 111.576 -179.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -177.03 -134.54 2.01 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 110.027 -1.229 . . . . 0.040000000000000001 110.027 179.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 38.9 m -68.43 157.72 35.21 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.308 -1.113 . . . . 1.51 110.437 -179.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 866' ' ' VAL . . . . . 0.475 HG13 ' CD2' ' B' ' 858' ' ' LEU . 50.7 t -100.7 139.34 20.5 Favored Pre-proline 0 N--CA 1.495 1.778 0 N-CA-C 113.509 0.929 . . . . 0.78000000000000003 113.509 -174.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 867' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' B' ' 866' ' ' VAL . 55.6 Cg_endo -91.72 -148.48 0.03 OUTLIER 'Trans proline' 0 CA--C 1.548 1.18 0 O-C-N 123.641 1.337 . . . . 0.92000000000000004 109.446 177.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 868' ' ' PHE . . . . . 0.455 ' CD1' ' CG ' ' B' ' 881' ' ' PRO . 26.1 p90 -150.17 124.1 9.31 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.622 -1.299 . . . . 0.050000000000000003 109.576 179.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 50.4 p-10 -113.68 -1.84 13.91 Favored 'General case' 0 N--CA 1.501 2.089 0 C-N-CA 119.222 -0.991 . . . . 1.7 112.875 -178.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 870' ' ' ARG . . . . . 0.74 ' CB ' ' HB3' ' B' ' 855' ' ' ALA . 28.4 mmm180 -91.52 89.88 7.39 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 120.837 -1.164 . . . . 2.5899999999999999 111.011 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 57.6 t -71.8 96.83 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.009 -1.057 . . . . 1.9399999999999999 110.019 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 872' ' ' LEU . . . . . 0.538 HD11 ' HB2' ' B' ' 855' ' ' ALA . 96.7 mt -83.22 -47.34 11.66 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.535 -0.728 . . . . 1.0600000000000001 110.021 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 873' ' ' LEU . . . . . 0.493 ' HG ' ' HB3' ' B' ' 851' ' ' ALA . 41.0 tp -175.1 103.22 0.08 Allowed 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.416 -0.957 . . . . 4.1799999999999997 108.416 178.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 874' ' ' ASN . . . . . 0.432 ' CB ' ' HA ' ' B' ' 852' ' ' PHE . 36.5 t-20 178.33 81.78 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.278 0 O-C-N 121.663 -0.648 . . . . 0.040000000000000001 109.443 -178.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -66.44 -46.87 75.01 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 119.32 -0.952 . . . . 3.3799999999999999 111.208 -179.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 876' ' ' GLY . . . . . 0.403 ' HA3' ' CE2' ' B' ' 878' ' ' TYR . . . -74.71 -24.85 71.26 Favored Glycine 0 N--CA 1.494 2.551 0 O-C-N 121.242 -0.912 . . . . 0.040000000000000001 111.888 -178.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 82.27 -62.32 4.58 Favored Glycine 0 N--CA 1.502 3.042 0 N-CA-C 107.877 -2.089 . . . . 0.040000000000000001 107.877 -178.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 878' ' ' TYR . . . . . 0.403 ' CE2' ' HA3' ' B' ' 876' ' ' GLY . 93.2 m-85 61.41 -62.02 0.09 Allowed 'General case' 0 N--CA 1.504 2.252 0 N-CA-C 114.595 1.332 . . . . 3.46 114.595 177.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 879' ' ' TYR . . . . . 0.468 ' CB ' ' CD2' ' B' ' 886' ' ' PHE . 20.3 p90 -110.55 109.12 19.32 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 114.826 1.417 . . . . 0.040000000000000001 114.826 -176.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -67.18 118.04 52.08 Favored Pre-proline 0 N--CA 1.496 1.831 0 O-C-N 121.448 -0.783 . . . . 0.02 109.894 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 881' ' ' PRO . . . . . 0.455 ' CG ' ' CD1' ' B' ' 868' ' ' PHE . 53.0 Cg_endo -76.75 1.25 8.75 Favored 'Trans proline' 0 N--CA 1.492 1.431 0 O-C-N 123.426 1.224 . . . . 0.39000000000000001 112.194 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -76.2 -64.79 1.02 Allowed 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 106.8 -1.556 . . . . 0.81000000000000005 106.8 178.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 7.6 p -95.65 -17.3 21.42 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.759 -0.83 . . . . 0.040000000000000001 108.759 177.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.57 23.79 49.09 Favored Glycine 0 N--CA 1.494 2.55 0 C-N-CA 120.091 -1.052 . . . . 0.029999999999999999 110.721 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 885' ' ' VAL . . . . . . . . . . . . . 76.6 t -73.64 88.57 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 C-N-CA 118.315 -1.354 . . . . 1.01 108.022 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 886' ' ' PHE . . . . . 0.885 ' HB3' HG22 ' B' ' 962' ' ' VAL . 0.6 OUTLIER -89.82 106.7 18.64 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 115.324 -0.853 . . . . 0.050000000000000003 112.105 -177.293 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 887' ' ' THR . . . . . 0.409 ' O ' ' HD3' ' B' ' 889' ' ' PRO . 95.5 m -98.53 99.52 10.68 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 107.539 -1.282 . . . . 0.68000000000000005 107.539 177.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 888' ' ' ALA . . . . . . . . . . . . . . . -97.3 107.73 40.24 Favored Pre-proline 0 N--CA 1.502 2.138 0 N-CA-C 113.992 1.108 . . . . 0.25 113.992 -176.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 889' ' ' PRO . . . . . 0.409 ' HD3' ' O ' ' B' ' 887' ' ' THR . 55.2 Cg_endo -88.92 -13.66 3.06 Favored 'Trans proline' 0 CA--C 1.545 1.056 0 O-C-N 123.29 1.153 . . . . 1.6399999999999999 109.164 176.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 890' ' ' LEU . . . . . 0.957 HD22 HD13 ' B' ' 985' ' ' LEU . 51.9 mt -35.68 -51.31 0.66 Allowed 'General case' 0 N--CA 1.508 2.46 0 N-CA-C 113.688 0.995 . . . . 2.29 113.688 -177.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 51.9 95.71 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.275 0 O-C-N 121.192 -0.943 . . . . 0.63 110.358 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . 157.76 -153.17 24.4 Favored Glycine 0 N--CA 1.479 1.515 0 N-CA-C 107.21 -2.356 . . . . 0.040000000000000001 107.21 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 72.1 ttt-85 -114.3 126.17 54.71 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 108.283 -1.006 . . . . 3.0 108.283 177.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 894' ' ' TYR . . . . . 0.717 ' OH ' HD12 ' B' ' 896' ' ' LEU . 0.1 OUTLIER -132.41 160.28 36.83 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.134 -0.979 . . . . 0.040000000000000001 111.286 -179.391 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 895' ' ' LEU . . . . . 0.41 HD23 HD11 ' C' ' 952' ' ' LEU . 36.6 tp -92.32 119.49 31.94 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.742 -0.599 . . . . 1.27 110.178 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 896' ' ' LEU . . . . . 0.717 HD12 ' OH ' ' B' ' 894' ' ' TYR . 9.7 tt -109.55 142.9 39.97 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.68 -0.637 . . . . 0.93999999999999995 110.279 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 897' ' ' SER . . . . . 0.516 ' N ' HD23 ' B' ' 896' ' ' LEU . 64.4 m -149.1 113.96 5.4 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.464 -0.773 . . . . 0.040000000000000001 111.187 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.55 146.25 32.11 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 109.085 -0.709 . . . . 0.47999999999999998 109.085 178.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 899' ' ' VAL . . . . . 0.745 HG21 ' HB ' ' B' ' 980' ' ' ILE . 89.5 t -94.74 119.8 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 C-N-CA 119.602 -0.839 . . . . 0.55000000000000004 111.252 -179.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 900' ' ' LEU . . . . . 0.483 ' N ' HD22 ' B' ' 900' ' ' LEU . 4.5 mm? -95.27 111.69 23.5 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 114.416 1.265 . . . . 1.5900000000000001 114.416 -175.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 15.7 m -65.67 141.13 58.48 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 107.468 -1.308 . . . . 0.050000000000000003 107.468 177.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -67.22 -66.7 2.25 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 110.541 -1.024 . . . . 0.029999999999999999 110.541 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 11.9 m170 47.6 67.33 0.83 Allowed 'General case' 0 N--CA 1.507 2.388 0 O-C-N 121.47 -1.017 . . . . 3.2000000000000002 110.977 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 46.6 ptt85 -69.47 -6.99 34.09 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.638 -0.664 . . . . 2.9199999999999999 111.906 -179.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 905' ' ' HIS . . . . . 0.484 ' O ' ' CB ' ' B' ' 906' ' ' GLU . 70.6 t60 -62.34 5.13 0.11 Allowed 'General case' 0 N--CA 1.507 2.382 0 O-C-N 120.915 -1.116 . . . . 2.8700000000000001 113.111 -179.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 906' ' ' GLU . . . . . 0.484 ' CB ' ' O ' ' B' ' 905' ' ' HIS . 0.6 OUTLIER 94.74 -164.31 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.432 0 CA-C-N 120.565 1.53 . . . . 0.98999999999999999 111.796 179.095 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 907' ' ' LYS . . . . . 0.467 ' CB ' ' O ' ' B' ' 906' ' ' GLU . 69.2 tttt 85.4 155.38 0.09 Allowed 'General case' 0 N--CA 1.519 2.985 0 N-CA-C 107.921 -1.14 . . . . 5.25 107.921 -176.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 60.1 t -123.27 115.34 45.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 120.716 -1.24 . . . . 0.39000000000000001 111.371 -179.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 909' ' ' GLU . . . . . 0.654 ' OE2' HD12 ' B' ' 966' ' ' LEU . 43.4 tp10 -97.16 135.59 38.89 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 107.014 -1.476 . . . . 1.72 107.014 176.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -154.95 123.85 6.2 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 106.966 -1.494 . . . . 0.67000000000000004 106.966 179.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 911' ' ' VAL . . . . . 0.66 HG22 HG13 ' B' ' 964' ' ' VAL . 87.2 t -80.71 130.91 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 C-N-CA 120.522 -0.471 . . . . 0.54000000000000004 110.934 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 86.2 mt -63.72 156.92 25.59 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.27 -0.894 . . . . 1.5 108.671 178.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 913' ' ' SER . . . . . 0.417 ' CB ' ' HB ' ' B' ' 919' ' ' VAL . 0.4 OUTLIER -128.77 130.58 47.23 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.251 -1.018 . . . . 1.3700000000000001 108.251 176.647 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 914' ' ' ARG . . . . . 0.854 ' NH1' HD23 ' B' ' 956' ' ' LEU . 0.0 OUTLIER -65.45 156.2 33.14 Favored 'General case' 0 N--CA 1.507 2.387 0 O-C-N 120.674 -1.266 . . . . 4.2999999999999998 111.796 -178.963 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 915' ' ' SER . . . . . 0.425 ' CB ' ' O ' ' B' ' 914' ' ' ARG . 4.2 t 83.3 -32.39 0.08 Allowed 'General case' 0 N--CA 1.522 3.148 0 C-N-CA 123.991 0.917 . . . . 2.0499999999999998 112.019 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 916' ' ' ASN . . . . . 0.817 ' HB2' HG21 ' B' ' 919' ' ' VAL . 82.5 m-20 -122.24 -21.23 5.93 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 120.87 -1.144 . . . . 2.71 111.328 -179.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 917' ' ' GLN . . . . . 0.402 ' HB2' ' O ' ' B' ' 916' ' ' ASN . 45.3 mt-30 66.77 164.34 0.19 Allowed 'General case' 0 N--CA 1.52 3.065 0 N-CA-C 105.76 -1.941 . . . . 2.6800000000000002 105.76 -174.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.52 -124.38 31.27 Favored Glycine 1 N--CA 1.522 4.368 0 CA-C-N 123.521 2.873 . . . . 0.029999999999999999 106.928 -177.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 919' ' ' VAL . . . . . 0.817 HG21 ' HB2' ' B' ' 916' ' ' ASN . 75.8 t 51.42 94.25 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 O-C-N 121.413 -1.051 . . . . 1.3899999999999999 109.15 -178.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 920' ' ' ALA . . . . . 0.562 ' HB3' HG12 ' B' ' 949' ' ' VAL . . . -93.02 92.07 7.66 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 119.327 -0.949 . . . . 0.029999999999999999 110.643 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 921' ' ' ARG . . . . . 0.851 ' HG3' HG23 ' B' ' 922' ' ' VAL . 29.3 ptt180 -85.03 -41.64 15.6 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 105.924 -1.88 . . . . 4.4199999999999999 105.924 176.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 922' ' ' VAL . . . . . 0.851 HG23 ' HG3' ' B' ' 921' ' ' ARG . 92.8 t -101.29 72.77 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 N-CA-C 106.052 -1.833 . . . . 0.84999999999999998 106.052 175.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -87.09 133.49 33.61 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.678 0.752 . . . . 2.46 111.376 -177.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 924' ' ' SER . . . . . 0.404 ' HB2' HD12 ' B' ' 900' ' ' LEU . 8.7 t -148.11 105.4 3.64 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.638 -0.875 . . . . 0.69999999999999996 108.638 179.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -102.55 84.36 0.48 Allowed Glycine 0 N--CA 1.487 2.091 0 N-CA-C 108.589 -1.804 . . . . 0.040000000000000001 108.589 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 926' ' ' GLY . . . . . 0.411 ' O ' ' HA ' ' B' ' 906' ' ' GLU . . . . . . . . 0 N--CA 1.489 2.205 0 N-CA-C 108.805 -1.718 . . . . 0.040000000000000001 108.805 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 69.8 m . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.05 0.453 . . . . 13.779999999999999 110.296 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 95.3 mt -108.24 130.19 55.17 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.494 -0.754 . . . . 13.76 110.295 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -152.01 168.53 31.28 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.429 -1.468 . . . . 9.1300000000000008 109.429 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 949' ' ' VAL . . . . . 0.562 HG12 ' HB3' ' B' ' 920' ' ' ALA . 34.2 m -118.27 130.41 73.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.606 -0.938 . . . . 7.0800000000000001 110.547 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 950' ' ' PHE . . . . . 0.441 ' CZ ' ' HB3' ' B' ' 921' ' ' ARG . 52.0 p90 -130.37 144.11 51.18 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.492 -0.755 . . . . 7.5899999999999999 109.447 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 31.9 m -121.77 -51.91 2.02 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.451 -0.781 . . . . 5.0300000000000002 111.92 -178.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 952' ' ' LEU . . . . . 0.796 HD11 HD23 ' A' ' 895' ' ' LEU . 45.3 tp -61.81 -76.06 0.06 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.512 -0.742 . . . . 1.01 112.385 -177.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 953' ' ' ILE . . . . . 0.469 ' O ' ' HB3' ' B' ' 954' ' ' LEU . 47.0 pt -53.53 -141.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.724 0 N-CA-C 113.992 1.108 . . . . 2.6000000000000001 113.992 -176.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 954' ' ' LEU . . . . . 0.742 HD22 ' O ' ' B' ' 954' ' ' LEU . 0.0 OUTLIER 174.08 75.05 0.05 OUTLIER Pre-proline 0 N--CA 1.507 2.391 0 O-C-N 120.786 -1.196 . . . . 0.050000000000000003 110.906 179.754 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 955' ' ' PRO . . . . . 0.557 ' C ' HD12 ' B' ' 956' ' ' LEU . 45.3 Cg_endo -73.07 93.93 0.81 Allowed 'Trans proline' 0 C--N 1.315 -1.212 0 N-CA-C 109.185 -1.121 . . . . 0.83999999999999997 109.185 178.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 956' ' ' LEU . . . . . 0.854 HD23 ' NH1' ' B' ' 914' ' ' ARG . 5.0 mp -126.32 140.39 52.55 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.242 -0.911 . . . . 0.040000000000000001 110.602 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -79.68 153.02 29.61 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-O 117.964 -1.017 . . . . 1.28 111.097 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -67.54 121.1 15.11 Favored 'General case' 0 N--CA 1.51 2.564 0 CA-C-N 122.563 2.438 . . . . 0.17000000000000001 111.838 -179.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 94.38 -19.01 55.79 Favored Glycine 0 N--CA 1.501 3.017 0 N-CA-C 111.132 -0.787 . . . . 0.040000000000000001 111.132 178.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 960' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -52.21 167.67 0.12 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.412 -1.052 . . . . 0.040000000000000001 111.027 -179.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 961' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' B' ' 886' ' ' PHE . 57.3 m -135.73 135.93 40.41 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 120.966 -1.084 . . . . 1.78 111.614 -178.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 962' ' ' VAL . . . . . 0.885 HG22 ' HB3' ' B' ' 886' ' ' PHE . 33.9 m -100.64 145.15 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 121.606 -0.684 . . . . 0.040000000000000001 111.13 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 1.8 m -138.39 148.01 44.03 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.816 -0.553 . . . . 0.71999999999999997 109.938 -178.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 964' ' ' VAL . . . . . 0.66 HG13 HG22 ' B' ' 911' ' ' VAL . 61.8 t -99.66 137.69 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.118 -0.989 . . . . 1.05 110.623 -179.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -91.58 128.57 37.46 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 104.202 -2.518 . . . . 3.02 104.202 173.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 966' ' ' LEU . . . . . 0.654 HD12 ' OE2' ' B' ' 909' ' ' GLU . 0.4 OUTLIER -131.2 59.84 1.67 Allowed 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.305 -0.998 . . . . 1.46 108.305 177.162 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 967' ' ' VAL . . . . . 0.49 HG23 ' C ' ' B' ' 966' ' ' LEU . 90.1 t -158.76 96.97 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 108.104 -1.072 . . . . 1.9399999999999999 108.104 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 80.2 mmm -143.64 59.24 1.38 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.733 -1.229 . . . . 0.0 108.519 178.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.4 119.63 1.93 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 107.318 -2.313 . . . . 2.1099999999999999 107.318 -178.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -81.96 -59.05 2.71 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.095 -1.239 . . . . 5.8899999999999997 110.376 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 47.6 tp -59.14 90.49 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.423 -0.798 . . . . 4.3600000000000003 110.224 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -141.67 -154.51 0.52 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.536 -0.727 . . . . 1.8300000000000001 110.296 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -120.36 172.73 7.6 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.428 -0.795 . . . . 4.3499999999999996 110.315 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 30.3 t -101.47 130.32 47.69 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.517 -0.739 . . . . 1.27 109.983 179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -155.68 158.99 39.17 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.457 -0.777 . . . . 5.0199999999999996 110.486 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.99 85.96 18.57 Favored Pre-proline 0 N--CA 1.5 2.048 0 O-C-N 121.607 -0.683 . . . . 2.4100000000000001 109.673 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -73.17 -173.15 1.18 Allowed 'Trans proline' 0 C--N 1.318 -1.078 0 O-C-N 123.286 1.151 . . . . 0.95999999999999996 111.319 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 978' ' ' LEU . . . . . 0.582 HD23 HD12 ' B' ' 856' ' ' LEU . 4.9 mp -128.34 154.15 46.27 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 107.565 -1.272 . . . . 0.62 107.565 177.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 979' ' ' THR . . . . . 0.469 HG23 ' C ' ' B' ' 978' ' ' LEU . 41.6 p -150.17 141.46 23.22 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.788 -1.195 . . . . 3.5699999999999998 111.214 -179.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 980' ' ' ILE . . . . . 0.745 ' HB ' HG21 ' B' ' 899' ' ' VAL . 49.4 mm -106.78 128.41 61.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 108.951 -0.759 . . . . 1.3300000000000001 108.951 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -118.82 96.2 5.16 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.488 -0.758 . . . . 0.050000000000000003 111.852 -178.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 78.7 p -108.6 158.01 17.97 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.557 -0.714 . . . . 0.87 109.159 178.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 983' ' ' GLY . . . . . 0.403 ' HA3' ' CE1' ' B' ' 852' ' ' PHE . . . -176.78 108.16 0.25 Allowed Glycine 0 N--CA 1.498 2.783 0 N-CA-C 106.529 -2.628 . . . . 0.029999999999999999 106.529 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 984' ' ' ALA . . . . . 0.433 ' HB1' ' NH1' ' C' ' 893' ' ' ARG . . . -108.37 152.37 24.76 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 114.627 1.343 . . . . 0.69999999999999996 114.627 -175.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 985' ' ' LEU . . . . . 0.957 HD13 HD22 ' B' ' 890' ' ' LEU . 36.4 tp -72.25 135.36 46.01 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 120.926 -1.109 . . . . 0.040000000000000001 109.94 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 986' ' ' LEU . . . . . 0.476 ' CD1' HD11 ' C' ' 986' ' ' LEU . 51.4 tp -106.21 -59.67 1.75 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.655 -0.653 . . . . 0.040000000000000001 109.914 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -143.13 146.52 33.82 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 107.597 -1.26 . . . . 0.040000000000000001 107.597 178.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.03 163.26 12.21 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 108.278 -1.929 . . . . 0.040000000000000001 108.278 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -74.21 112.65 17.86 Favored Pre-proline 0 N--CA 1.498 1.944 0 O-C-N 121.173 -1.193 . . . . 0.040000000000000001 109.415 179.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 990' ' ' PRO . . . . . 0.421 ' O ' ' HB2' ' B' ' 991' ' ' GLU . 50.3 Cg_endo -89.32 71.06 2.02 Favored 'Trans proline' 0 C--N 1.319 -1.015 0 O-C-N 123.067 1.035 . . . . 0.45000000000000001 111.461 -178.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 991' ' ' GLU . . . . . 0.421 ' HB2' ' O ' ' B' ' 990' ' ' PRO . 70.8 mt-10 67.14 -73.94 0.07 Allowed 'General case' 0 N--CA 1.502 2.164 0 N-CA-C 108.581 -0.896 . . . . 1.97 108.581 -177.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 992' ' ' LEU . . . . . 0.463 HD23 ' HA ' ' B' ' 992' ' ' LEU . 11.5 mt 51.27 20.48 0.94 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.586 -0.697 . . . . 2.3799999999999999 111.621 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -92.53 156.91 16.83 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.912 -1.118 . . . . 3.79 110.019 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 70.7 m80 -147.15 91.73 2.03 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.549 -0.719 . . . . 3.5099999999999998 110.359 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 995' ' ' ALA . . . . . . . . . . . . 2.518 . . . . . . . 0 N--CA 1.503 2.19 0 O-C-N 120.899 -1.125 . . . . 2.73 110.622 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo . . . . . 0 N--CA 1.488 1.158 0 N-CA-C 109.516 -0.994 . . . . 3.8300000000000001 109.516 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' 847' ' ' VAL . . . . . 0.526 HG12 ' HB2' ' C' ' 849' ' ' GLN . 60.3 t -126.11 105.48 25.41 Favored Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 121.639 -0.663 . . . . 1.8300000000000001 110.103 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 848' ' ' PRO . . . . . 0.878 ' O ' HG23 ' C' ' 850' ' ' VAL . 43.8 Cg_endo -69.61 -23.56 31.36 Favored 'Trans proline' 0 N--CA 1.487 1.113 0 O-C-N 123.219 1.115 . . . . 0.65000000000000002 110.949 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 849' ' ' GLN . . . . . 0.526 ' HB2' HG12 ' C' ' 847' ' ' VAL . 55.5 tt0 25.4 66.38 0.05 Allowed 'General case' 0 N--CA 1.518 2.944 0 N-CA-C 113.419 0.896 . . . . 2.5800000000000001 113.419 179.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 850' ' ' VAL . . . . . 0.878 HG23 ' O ' ' C' ' 848' ' ' PRO . 77.7 t -120.0 135.74 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 O-C-N 121.113 -0.992 . . . . 1.0900000000000001 111.183 -179.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 851' ' ' ALA . . . . . 0.588 ' HB3' ' HG ' ' C' ' 873' ' ' LEU . . . -128.17 155.45 44.46 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 105.914 -1.884 . . . . 0.040000000000000001 105.914 176.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 852' ' ' PHE . . . . . 0.456 ' CD1' ' N ' ' C' ' 852' ' ' PHE . 15.2 p90 -160.42 127.03 4.22 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 120.973 1.715 . . . . 0.050000000000000003 108.631 179.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 6.3 t -177.28 134.28 0.18 Allowed 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.162 -1.051 . . . . 0.040000000000000001 108.162 -179.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -130.39 158.14 40.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.087 -1.008 . . . . 0.67000000000000004 109.685 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 855' ' ' ALA . . . . . 0.771 ' HB3' ' CB ' ' C' ' 870' ' ' ARG . . . -121.39 140.71 51.77 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 121.818 0.818 . . . . 0.51000000000000001 111.061 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 856' ' ' LEU . . . . . 0.937 HD11 HD23 ' C' ' 858' ' ' LEU . 3.5 tm? -113.23 135.74 53.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.612 -0.68 . . . . 0.050000000000000003 110.084 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 857' ' ' SER . . . . . 0.584 ' N ' HD13 ' C' ' 856' ' ' LEU . 0.6 OUTLIER -153.35 18.64 0.55 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.502 -0.749 . . . . 1.3300000000000001 110.919 179.581 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 858' ' ' LEU . . . . . 0.937 HD23 HD11 ' C' ' 856' ' ' LEU . 2.7 pp -34.7 159.65 0.04 OUTLIER Pre-proline 0 N--CA 1.516 2.856 0 N-CA-C 113.008 0.744 . . . . 2.3300000000000001 113.008 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -63.04 -88.39 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.399 0 O-C-N 123.078 1.041 . . . . 2.3199999999999998 113.257 -178.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 54.7 ptt85 -133.18 -142.0 0.2 Allowed 'General case' 0 N--CA 1.499 2.01 0 O-C-N 120.854 -1.154 . . . . 0.040000000000000001 111.422 -177.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 58.2 m -36.68 123.92 0.83 Allowed 'General case' 0 N--CA 1.511 2.586 0 O-C-N 121.609 -0.682 . . . . 1.3100000000000001 112.538 -178.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -104.04 160.24 26.71 Favored Pre-proline 0 N--CA 1.489 1.496 0 N-CA-C 108.052 -1.092 . . . . 4.5099999999999998 108.052 177.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -69.12 -14.41 38.06 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 123.185 1.097 . . . . 2.2400000000000002 111.404 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -177.25 -136.58 2.48 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 110.107 -1.197 . . . . 0.040000000000000001 110.107 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 32.7 m -65.23 156.89 30.43 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.366 -1.079 . . . . 1.51 110.746 -178.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 866' ' ' VAL . . . . . 0.431 HG13 ' CD2' ' C' ' 858' ' ' LEU . 64.5 t -96.58 134.61 23.09 Favored Pre-proline 0 N--CA 1.494 1.73 0 N-CA-C 113.136 0.791 . . . . 0.78000000000000003 113.136 -175.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 867' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' C' ' 866' ' ' VAL . 55.3 Cg_endo -90.36 -149.13 0.03 OUTLIER 'Trans proline' 0 CA--C 1.544 1.022 0 O-C-N 123.577 1.304 . . . . 0.92000000000000004 108.837 177.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 868' ' ' PHE . . . . . 0.472 ' CD1' ' N ' ' C' ' 868' ' ' PHE . 13.8 p90 -150.0 123.65 9.17 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 120.53 -1.356 . . . . 0.050000000000000003 109.861 179.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 46.5 p-10 -113.82 -2.48 13.65 Favored 'General case' 0 N--CA 1.499 2.003 0 C-N-CA 119.185 -1.006 . . . . 1.7 112.892 -178.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 870' ' ' ARG . . . . . 0.771 ' CB ' ' HB3' ' C' ' 855' ' ' ALA . 29.9 mmm180 -91.22 88.66 7.0 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.912 -1.117 . . . . 2.5899999999999999 110.998 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 57.3 t -72.21 97.48 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 120.94 -1.1 . . . . 1.9399999999999999 109.695 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 872' ' ' LEU . . . . . 0.645 HD11 ' HB2' ' C' ' 855' ' ' ALA . 96.3 mt -86.22 -46.04 10.74 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.611 -0.681 . . . . 1.0600000000000001 110.648 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 873' ' ' LEU . . . . . 0.588 ' HG ' ' HB3' ' C' ' 851' ' ' ALA . 35.8 tp -173.61 102.27 0.12 Allowed 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.262 -0.899 . . . . 4.1799999999999997 108.702 178.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 874' ' ' ASN . . . . . 0.437 ' CB ' ' HA ' ' C' ' 852' ' ' PHE . 36.3 t-20 177.7 82.68 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.26 0 N-CA-C 109.035 -0.728 . . . . 0.040000000000000001 109.035 -178.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 -64.39 -46.15 84.54 Favored 'General case' 0 N--CA 1.497 1.916 0 C-N-CA 119.265 -0.974 . . . . 3.3799999999999999 111.171 -179.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 876' ' ' GLY . . . . . 0.422 ' HA3' ' CE2' ' C' ' 878' ' ' TYR . . . -73.8 -26.47 69.2 Favored Glycine 0 N--CA 1.494 2.519 0 C-N-CA 120.461 -0.876 . . . . 0.040000000000000001 111.977 -178.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 79.49 -63.94 3.89 Favored Glycine 0 N--CA 1.502 3.098 0 N-CA-C 107.868 -2.093 . . . . 0.040000000000000001 107.868 -178.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 878' ' ' TYR . . . . . 0.422 ' CE2' ' HA3' ' C' ' 876' ' ' GLY . 76.5 m-85 60.39 -63.92 0.06 Allowed 'General case' 0 N--CA 1.502 2.138 0 N-CA-C 114.825 1.417 . . . . 3.46 114.825 177.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 879' ' ' TYR . . . . . 0.494 ' CE2' ' CD1' ' C' ' 981' ' ' PHE . 28.8 p90 -108.53 108.29 19.15 Favored 'General case' 0 N--CA 1.502 2.167 0 N-CA-C 115.342 1.608 . . . . 0.040000000000000001 115.342 -175.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -70.69 117.55 56.63 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 121.758 -0.589 . . . . 0.02 110.191 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 881' ' ' PRO . . . . . 0.453 ' CG ' ' CD1' ' C' ' 868' ' ' PHE . 55.3 Cg_endo -76.83 1.97 8.01 Favored 'Trans proline' 0 N--CA 1.492 1.402 0 O-C-N 123.452 1.238 . . . . 0.39000000000000001 112.298 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -74.66 -65.02 0.91 Allowed 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 106.359 -1.719 . . . . 0.81000000000000005 106.359 178.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 6.0 p -96.45 -16.3 21.26 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.804 -0.813 . . . . 0.040000000000000001 108.804 177.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.54 23.02 52.25 Favored Glycine 0 N--CA 1.493 2.499 0 O-C-N 120.991 -1.068 . . . . 0.029999999999999999 110.692 179.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 95.2 t -73.38 87.5 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 C-N-CA 118.299 -1.36 . . . . 1.01 107.775 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 886' ' ' PHE . . . . . 0.846 ' HB3' HG22 ' C' ' 962' ' ' VAL . 0.7 OUTLIER -87.95 108.83 19.39 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-N 115.132 -0.94 . . . . 0.050000000000000003 111.569 -177.587 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 887' ' ' THR . . . . . 0.423 ' O ' ' HD3' ' C' ' 889' ' ' PRO . 97.3 m -105.75 99.62 9.21 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 107.596 -1.261 . . . . 0.68000000000000005 107.596 177.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 888' ' ' ALA . . . . . . . . . . . . . . . -98.89 101.56 12.54 Favored Pre-proline 0 N--CA 1.501 2.089 0 N-CA-C 114.523 1.305 . . . . 0.25 114.523 -176.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 889' ' ' PRO . . . . . 0.423 ' HD3' ' O ' ' C' ' 887' ' ' THR . 55.5 Cg_endo -79.83 -15.03 12.2 Favored 'Trans proline' 0 N--CA 1.486 1.048 0 N-CA-C 108.786 -1.275 . . . . 1.6399999999999999 108.786 175.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 890' ' ' LEU . . . . . 0.763 HD21 HG11 ' C' ' 850' ' ' VAL . 66.1 mt -37.77 -49.15 1.15 Allowed 'General case' 0 N--CA 1.508 2.438 0 N-CA-C 113.463 0.912 . . . . 2.29 113.463 -177.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 52.66 97.73 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.275 0 O-C-N 121.193 -0.942 . . . . 0.63 110.451 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . 158.86 -154.5 25.59 Favored Glycine 0 N--CA 1.477 1.407 0 N-CA-C 107.29 -2.324 . . . . 0.040000000000000001 107.29 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 893' ' ' ARG . . . . . 0.463 ' HG3' HD11 ' C' ' 954' ' ' LEU . 77.7 ttt-85 -116.28 123.94 48.94 Favored 'General case' 0 C--N 1.294 -1.825 0 O-C-N 121.671 -0.9 . . . . 3.0 108.589 177.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 894' ' ' TYR . . . . . 0.868 ' CE2' HD23 ' C' ' 954' ' ' LEU . 12.9 p90 -132.07 154.04 49.82 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.079 -1.013 . . . . 0.040000000000000001 110.954 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 895' ' ' LEU . . . . . . . . . . . . . 45.0 tp -99.65 113.78 26.44 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.706 -0.621 . . . . 1.27 109.796 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 896' ' ' LEU . . . . . 0.576 HD11 ' CE1' ' C' ' 981' ' ' PHE . 8.4 tt -118.01 145.08 45.02 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.678 -0.639 . . . . 0.93999999999999995 109.985 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 897' ' ' SER . . . . . . . . . . . . . 62.4 m -141.24 124.15 16.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.445 -0.784 . . . . 0.040000000000000001 111.184 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -100.78 148.42 24.94 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.73 -0.841 . . . . 0.47999999999999998 108.73 178.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 899' ' ' VAL . . . . . 0.691 HG21 ' HB ' ' C' ' 980' ' ' ILE . 96.7 t -92.33 120.53 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.369 -0.832 . . . . 0.55000000000000004 111.079 -179.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 91.4 mt -92.65 113.08 25.26 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 113.99 1.107 . . . . 1.5900000000000001 113.99 -175.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 16.7 m -62.54 141.28 58.51 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 107.545 -1.28 . . . . 0.050000000000000003 107.545 177.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -60.68 -65.23 3.47 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 110.362 -1.095 . . . . 0.029999999999999999 110.362 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 1.6 m80 46.23 65.11 1.26 Allowed 'General case' 0 N--CA 1.507 2.4 0 O-C-N 121.485 -1.009 . . . . 3.2000000000000002 111.095 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 42.4 ptt85 -66.72 -8.19 26.24 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.639 -0.663 . . . . 2.9199999999999999 111.971 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 905' ' ' HIS . . . . . 0.473 ' O ' ' CB ' ' C' ' 906' ' ' GLU . 61.0 t60 -63.67 5.32 0.21 Allowed 'General case' 0 N--CA 1.504 2.229 0 O-C-N 120.946 -1.096 . . . . 2.8700000000000001 112.624 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 906' ' ' GLU . . . . . 0.5 ' O ' ' CB ' ' C' ' 907' ' ' LYS . 2.8 mt-10 89.21 -152.96 0.01 OUTLIER 'General case' 0 N--CA 1.526 3.362 0 CA-C-N 121.215 1.825 . . . . 0.98999999999999999 111.59 179.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 907' ' ' LYS . . . . . 0.5 ' CB ' ' O ' ' C' ' 906' ' ' GLU . 62.2 tttt 90.19 163.85 0.05 OUTLIER 'General case' 0 N--CA 1.523 3.179 0 N-CA-C 107.925 -1.139 . . . . 5.25 107.925 -176.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 58.4 t -123.33 114.34 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 120.84 -1.162 . . . . 0.39000000000000001 110.843 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 909' ' ' GLU . . . . . 0.573 ' OE2' HD12 ' C' ' 966' ' ' LEU . 44.3 tp10 -108.68 130.71 55.34 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 107.559 -1.275 . . . . 1.72 107.559 177.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -157.54 121.16 4.1 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 107.098 -1.445 . . . . 0.67000000000000004 107.098 178.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 911' ' ' VAL . . . . . 0.506 ' HA ' ' HA ' ' C' ' 964' ' ' VAL . 14.0 p -80.94 131.02 34.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 C-N-CA 120.35 -0.54 . . . . 0.54000000000000004 111.654 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 62.4 mt -67.43 157.94 32.97 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.359 -0.838 . . . . 1.5 109.036 178.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 913' ' ' SER . . . . . 0.478 ' OG ' HG11 ' C' ' 919' ' ' VAL . 1.5 p -126.07 138.87 53.74 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.568 -0.901 . . . . 1.3700000000000001 108.568 176.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 914' ' ' ARG . . . . . 0.723 ' CZ ' HD23 ' C' ' 956' ' ' LEU . 0.0 OUTLIER -64.16 153.46 37.74 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 120.638 -1.289 . . . . 4.2999999999999998 111.607 -179.152 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 915' ' ' SER . . . . . 0.424 ' CB ' ' O ' ' C' ' 914' ' ' ARG . 0.2 OUTLIER 82.83 -30.37 0.09 Allowed 'General case' 0 N--CA 1.522 3.147 0 C-N-CA 123.766 0.826 . . . . 2.0499999999999998 112.457 179.575 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 916' ' ' ASN . . . . . 0.768 ' HB2' HG21 ' C' ' 919' ' ' VAL . 98.7 m-20 -122.17 -22.1 5.71 Favored 'General case' 0 N--CA 1.501 2.118 0 O-C-N 120.804 -1.185 . . . . 2.71 111.268 -179.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 67.09 166.52 0.22 Allowed 'General case' 0 N--CA 1.52 3.042 0 N-CA-C 105.792 -1.929 . . . . 2.6800000000000002 105.792 -174.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.58 -125.67 35.26 Favored Glycine 1 N--CA 1.522 4.384 0 CA-C-N 123.539 2.882 . . . . 0.029999999999999999 107.087 -177.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 919' ' ' VAL . . . . . 0.768 HG21 ' HB2' ' C' ' 916' ' ' ASN . 92.4 t 51.01 94.02 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.238 0 O-C-N 121.452 -1.028 . . . . 1.3899999999999999 109.234 -178.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 920' ' ' ALA . . . . . 0.951 ' HB3' HG12 ' C' ' 949' ' ' VAL . . . -94.06 94.32 8.34 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.395 -0.922 . . . . 0.029999999999999999 110.735 -179.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 921' ' ' ARG . . . . . 0.698 ' HG3' HG23 ' C' ' 922' ' ' VAL . 45.2 ptt85 -79.14 -42.1 27.0 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 105.591 -2.003 . . . . 4.4199999999999999 105.591 176.049 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 922' ' ' VAL . . . . . 0.698 HG23 ' HG3' ' C' ' 921' ' ' ARG . 73.9 t -99.7 78.68 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 N-CA-C 105.441 -2.059 . . . . 0.84999999999999998 105.441 174.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -89.92 136.28 33.13 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 122.047 0.927 . . . . 2.46 112.775 -176.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 6.3 t -147.21 103.05 3.55 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 107.576 -1.268 . . . . 0.69999999999999996 107.576 178.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -107.71 82.27 0.31 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.656 -1.378 . . . . 0.040000000000000001 109.656 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 109.187 -1.565 . . . . 0.040000000000000001 109.187 179.747 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 17.7 m . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 120.937 0.398 . . . . 13.779999999999999 110.377 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 95.3 mt -114.66 131.36 56.75 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.472 -0.767 . . . . 13.76 110.321 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -151.7 170.13 31.17 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.433 -1.467 . . . . 9.1300000000000008 109.433 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 949' ' ' VAL . . . . . 0.951 HG12 ' HB3' ' C' ' 920' ' ' ALA . 26.9 m -117.44 136.26 55.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.488 -1.007 . . . . 7.0800000000000001 111.043 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 950' ' ' PHE . . . . . 0.447 ' CZ ' ' HB3' ' C' ' 921' ' ' ARG . 40.4 p90 -133.36 150.22 51.84 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.561 -0.712 . . . . 7.5899999999999999 109.336 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 68.4 m -118.07 -57.64 2.07 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.399 -0.813 . . . . 5.0300000000000002 111.81 -178.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 952' ' ' LEU . . . . . 0.454 ' O ' ' O ' ' C' ' 953' ' ' ILE . 46.4 tp -62.34 -75.69 0.07 Allowed 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.423 -0.798 . . . . 1.01 111.505 -178.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 953' ' ' ILE . . . . . 0.57 HD12 ' N ' ' C' ' 954' ' ' LEU . 2.8 pp -49.41 -151.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.694 0 N-CA-C 114.563 1.32 . . . . 2.6000000000000001 114.563 -176.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 954' ' ' LEU . . . . . 0.868 HD23 ' CE2' ' C' ' 894' ' ' TYR . 0.0 OUTLIER 171.22 90.39 0.04 OUTLIER Pre-proline 0 N--CA 1.515 2.807 0 O-C-N 120.659 -1.276 . . . . 0.050000000000000003 111.941 -179.289 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 955' ' ' PRO . . . . . 0.629 ' C ' HD12 ' C' ' 956' ' ' LEU . 52.8 Cg_endo -83.0 92.37 0.9 Allowed 'Trans proline' 0 C--N 1.317 -1.113 0 N-CA-C 109.502 -0.999 . . . . 0.83999999999999997 109.502 178.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 956' ' ' LEU . . . . . 0.811 HD22 ' OH ' ' C' ' 894' ' ' TYR . 6.2 mp -125.11 147.86 48.82 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.066 -1.021 . . . . 0.040000000000000001 110.521 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -82.71 150.93 26.44 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 117.661 -1.162 . . . . 1.28 111.341 -178.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -64.65 118.11 8.41 Favored 'General case' 0 N--CA 1.506 2.365 0 CA-C-N 123.221 2.737 . . . . 0.17000000000000001 110.662 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.25 -18.56 53.89 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 110.903 -0.879 . . . . 0.040000000000000001 110.903 179.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 960' ' ' ASP . . . . . 0.418 ' HB3' ' NE ' ' C' ' 914' ' ' ARG . 0.4 OUTLIER -54.41 171.18 0.12 Allowed 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.265 -1.138 . . . . 0.040000000000000001 110.253 -179.55 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 961' ' ' THR . . . . . 0.543 HG23 ' O ' ' C' ' 886' ' ' PHE . 40.7 m -137.71 141.07 41.05 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.95 -1.094 . . . . 1.78 112.844 -177.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 962' ' ' VAL . . . . . 0.846 HG22 ' HB3' ' C' ' 886' ' ' PHE . 27.3 m -100.44 145.45 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.014 0 O-C-N 121.88 -0.512 . . . . 0.040000000000000001 110.666 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 5.3 t -138.01 144.14 40.94 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.715 -0.616 . . . . 0.71999999999999997 110.153 -178.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 964' ' ' VAL . . . . . 0.506 ' HA ' ' HA ' ' C' ' 911' ' ' VAL . 58.9 t -91.45 137.29 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.185 -0.947 . . . . 1.05 110.803 -179.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -92.83 125.64 37.53 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 103.441 -2.8 . . . . 3.02 103.441 173.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 966' ' ' LEU . . . . . 0.573 HD12 ' OE2' ' C' ' 909' ' ' GLU . 0.2 OUTLIER -134.53 56.81 1.83 Allowed 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.578 -0.897 . . . . 1.46 108.578 177.503 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 967' ' ' VAL . . . . . 0.488 HG23 ' C ' ' C' ' 966' ' ' LEU . 97.9 t -158.22 95.93 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 108.248 -1.019 . . . . 1.9399999999999999 108.248 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 92.8 mmm -142.87 59.28 1.43 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.724 -1.235 . . . . 0.0 108.462 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 134.35 119.62 1.98 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 107.282 -2.327 . . . . 2.1099999999999999 107.282 -178.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -82.56 -58.26 2.99 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.004 -1.291 . . . . 5.8899999999999997 110.531 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 48.1 tp -59.14 89.69 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.397 -0.814 . . . . 4.3600000000000003 110.313 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -142.71 -152.08 0.39 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.559 -0.713 . . . . 1.8300000000000001 109.97 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -115.93 166.99 11.35 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.391 -0.818 . . . . 4.3499999999999996 109.842 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 9.8 t -101.61 129.83 47.81 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.52 -0.738 . . . . 1.27 110.079 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -156.45 157.5 35.62 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.528 -0.732 . . . . 5.0199999999999996 110.553 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -143.22 85.91 9.4 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.658 -0.651 . . . . 2.4100000000000001 109.796 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -74.77 -169.86 0.68 Allowed 'Trans proline' 0 C--N 1.318 -1.045 0 O-C-N 123.189 1.099 . . . . 0.95999999999999996 111.325 -179.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 978' ' ' LEU . . . . . 0.514 ' N ' HD12 ' C' ' 978' ' ' LEU . 5.1 mp -125.86 155.9 40.46 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.474 -1.306 . . . . 0.62 107.474 177.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 979' ' ' THR . . . . . 0.46 HG23 ' C ' ' C' ' 978' ' ' LEU . 42.8 p -149.88 142.96 24.98 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.759 -1.213 . . . . 3.5699999999999998 111.334 -179.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 980' ' ' ILE . . . . . 0.691 ' HB ' HG21 ' C' ' 899' ' ' VAL . 50.0 mm -105.41 127.88 59.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 108.837 -0.801 . . . . 1.3300000000000001 108.837 179.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 981' ' ' PHE . . . . . 0.576 ' CE1' HD11 ' C' ' 896' ' ' LEU . 5.2 t80 -117.9 96.05 5.18 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.311 -0.868 . . . . 0.050000000000000003 111.579 -178.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 982' ' ' SER . . . . . . . . . . . . . 51.3 p -106.3 158.78 16.61 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 109.066 -0.716 . . . . 0.87 109.066 178.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 983' ' ' GLY . . . . . 0.418 ' HA3' ' CE2' ' C' ' 852' ' ' PHE . . . -171.81 113.18 0.48 Allowed Glycine 0 N--CA 1.496 2.662 0 N-CA-C 106.624 -2.59 . . . . 0.029999999999999999 106.624 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 984' ' ' ALA . . . . . 0.405 ' CB ' ' CZ ' ' A' ' 893' ' ' ARG . . . -108.75 152.01 25.43 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 114.323 1.231 . . . . 0.69999999999999996 114.323 -175.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 985' ' ' LEU . . . . . 0.47 HD13 HD22 ' C' ' 890' ' ' LEU . 55.6 tp -75.89 136.14 40.13 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.848 -1.157 . . . . 0.040000000000000001 109.832 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 986' ' ' LEU . . . . . 0.476 HD11 ' CD1' ' B' ' 986' ' ' LEU . 51.4 tp -106.35 -62.82 1.34 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.573 -0.704 . . . . 0.040000000000000001 110.302 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 47.9 t80 -144.92 147.15 32.41 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 107.816 -1.179 . . . . 0.040000000000000001 107.816 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -111.86 162.74 12.33 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 108.071 -2.011 . . . . 0.040000000000000001 108.071 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -72.46 112.96 16.91 Favored Pre-proline 0 N--CA 1.498 1.935 0 O-C-N 121.207 -1.173 . . . . 0.040000000000000001 109.531 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 990' ' ' PRO . . . . . 0.455 ' HD2' HD12 ' C' ' 992' ' ' LEU . 50.6 Cg_endo -87.66 70.13 3.31 Favored 'Trans proline' 0 C--N 1.319 -0.975 0 O-C-N 123.127 1.067 . . . . 0.45000000000000001 111.356 -178.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 991' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' C' ' 990' ' ' PRO . 71.4 mt-10 67.12 -74.11 0.07 Allowed 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 108.617 -0.883 . . . . 1.97 108.617 -177.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 992' ' ' LEU . . . . . 0.455 HD12 ' HD2' ' C' ' 990' ' ' PRO . 11.5 mt 50.55 21.03 0.79 Allowed 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.606 -0.684 . . . . 2.3799999999999999 111.646 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -92.54 156.77 16.91 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.89 -1.131 . . . . 3.79 110.038 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 68.6 m80 -146.56 91.84 2.09 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.52 -0.738 . . . . 3.5099999999999998 110.281 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 995' ' ' ALA . . . . . . . . . . . . 2.518 . . . . . . . 0 N--CA 1.504 2.248 0 O-C-N 120.95 -1.094 . . . . 2.73 110.589 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo . . . . . 0 N--CA 1.488 1.153 0 N-CA-C 109.581 -0.969 . . . . 3.8300000000000001 109.581 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 847' ' ' VAL . . . . . 0.432 HG12 ' HB2' ' A' ' 849' ' ' GLN . 61.4 t -132.03 103.56 14.19 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.636 -0.665 . . . . 1.8300000000000001 110.0 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 848' ' ' PRO . . . . . 0.722 ' O ' HG23 ' A' ' 850' ' ' VAL . 44.1 Cg_endo -69.5 -20.08 36.52 Favored 'Trans proline' 0 N--CA 1.487 1.117 0 O-C-N 123.271 1.142 . . . . 0.65000000000000002 111.139 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 849' ' ' GLN . . . . . 0.432 ' HB2' HG12 ' A' ' 847' ' ' VAL . 55.7 tt0 27.03 68.2 0.06 Allowed 'General case' 0 N--CA 1.518 2.957 0 N-CA-C 112.919 0.711 . . . . 2.5800000000000001 112.919 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 850' ' ' VAL . . . . . 0.722 HG23 ' O ' ' A' ' 848' ' ' PRO . 59.6 t -117.76 136.72 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.184 -0.948 . . . . 1.0900000000000001 111.459 -178.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 851' ' ' ALA . . . . . 0.534 ' HB3' ' HG ' ' A' ' 873' ' ' LEU . . . -125.83 156.65 39.22 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 105.783 -1.932 . . . . 0.040000000000000001 105.783 176.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 852' ' ' PHE . . . . . 0.468 ' CE2' HD11 ' A' ' 890' ' ' LEU . 24.2 p90 -160.34 128.61 4.7 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 121.014 1.734 . . . . 0.050000000000000003 108.732 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 853' ' ' SER . . . . . 0.401 ' CB ' ' HA ' ' A' ' 982' ' ' SER . 29.7 t -174.96 134.98 0.35 Allowed 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.053 -1.091 . . . . 0.040000000000000001 108.053 -178.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -132.83 156.48 47.07 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.99 -1.069 . . . . 0.67000000000000004 109.497 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 855' ' ' ALA . . . . . 0.744 ' HB3' ' CB ' ' A' ' 870' ' ' ARG . . . -122.73 144.61 49.05 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.787 0.803 . . . . 0.51000000000000001 111.65 -178.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 856' ' ' LEU . . . . . 0.692 ' CD1' HD23 ' A' ' 978' ' ' LEU . 3.4 tm? -112.05 134.33 53.66 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.787 -0.571 . . . . 0.050000000000000003 110.112 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 857' ' ' SER . . . . . 0.54 ' N ' HD13 ' A' ' 856' ' ' LEU . 55.8 p -150.63 16.7 0.79 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.531 -0.731 . . . . 1.3300000000000001 110.502 178.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 858' ' ' LEU . . . . . 0.762 HD22 ' OE2' ' A' ' 862' ' ' GLU . 4.4 pp -32.94 158.26 0.03 OUTLIER Pre-proline 0 N--CA 1.517 2.924 0 N-CA-C 113.432 0.901 . . . . 2.3300000000000001 113.432 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -64.41 -88.48 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.451 0 O-C-N 123.171 1.09 . . . . 2.3199999999999998 113.075 -178.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 55.8 ptt85 -128.7 -143.37 0.27 Allowed 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.817 -1.177 . . . . 0.040000000000000001 111.691 -177.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 19.4 m -40.4 128.16 2.38 Favored 'General case' 0 N--CA 1.508 2.468 0 O-C-N 121.43 -0.794 . . . . 1.3100000000000001 112.38 -178.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 862' ' ' GLU . . . . . 0.762 ' OE2' HD22 ' A' ' 858' ' ' LEU . 0.9 OUTLIER -102.69 156.74 34.9 Favored Pre-proline 0 N--CA 1.489 1.496 0 N-CA-C 107.8 -1.185 . . . . 4.5099999999999998 107.8 177.236 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 863' ' ' PRO . . . . . 0.412 ' HD2' ' CG ' ' A' ' 862' ' ' GLU . 43.6 Cg_endo -70.03 -12.71 32.9 Favored 'Trans proline' 0 C--N 1.314 -1.288 0 O-C-N 123.032 1.017 . . . . 2.2400000000000002 111.363 -179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -175.74 -136.38 2.32 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 109.972 -1.251 . . . . 0.040000000000000001 109.972 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 27.8 m -66.43 156.88 33.43 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.32 -1.106 . . . . 1.51 110.944 -178.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 866' ' ' VAL . . . . . 0.703 HG22 ' OE1' ' A' ' 862' ' ' GLU . 48.4 t -93.15 134.61 26.85 Favored Pre-proline 0 N--CA 1.495 1.8 0 N-CA-C 113.273 0.842 . . . . 0.78000000000000003 113.273 -174.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 867' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 866' ' ' VAL . 54.5 Cg_endo -90.36 -152.74 0.04 OUTLIER 'Trans proline' 0 CA--C 1.541 0.869 0 N-CA-C 108.761 -1.284 . . . . 0.92000000000000004 108.761 177.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 868' ' ' PHE . . . . . 0.452 ' CD1' ' N ' ' A' ' 868' ' ' PHE . 24.1 p90 -149.76 122.21 8.5 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.573 -1.329 . . . . 0.050000000000000003 109.901 179.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 49.0 p-10 -113.39 -2.33 13.99 Favored 'General case' 0 N--CA 1.498 1.972 0 C-N-CA 119.287 -0.965 . . . . 1.7 112.299 -179.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 870' ' ' ARG . . . . . 0.744 ' CB ' ' HB3' ' A' ' 855' ' ' ALA . 30.3 mmm180 -90.59 88.91 7.31 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.962 -1.086 . . . . 2.5899999999999999 110.67 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 58.3 t -74.54 97.31 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 120.95 -1.094 . . . . 1.9399999999999999 109.919 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 872' ' ' LEU . . . . . 0.456 HD11 ' HB2' ' A' ' 855' ' ' ALA . 92.8 mt -82.97 -47.24 11.96 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.526 -0.734 . . . . 1.0600000000000001 110.24 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 873' ' ' LEU . . . . . 0.534 ' HG ' ' HB3' ' A' ' 851' ' ' ALA . 46.9 tp -174.66 103.95 0.1 Allowed 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.243 -0.911 . . . . 4.1799999999999997 108.689 178.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 874' ' ' ASN . . . . . 0.444 ' CB ' ' HA ' ' A' ' 852' ' ' PHE . 35.7 t-20 178.9 81.71 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.3 0 O-C-N 121.55 -0.719 . . . . 0.040000000000000001 109.751 -178.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -66.91 -47.25 72.35 Favored 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 119.241 -0.984 . . . . 3.3799999999999999 111.128 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 876' ' ' GLY . . . . . 0.411 ' HA3' ' CE2' ' A' ' 878' ' ' TYR . . . -73.95 -25.01 72.62 Favored Glycine 0 N--CA 1.495 2.573 0 O-C-N 121.275 -0.89 . . . . 0.040000000000000001 111.668 -178.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 82.86 -61.38 4.78 Favored Glycine 0 N--CA 1.501 3.023 0 N-CA-C 108.085 -2.006 . . . . 0.040000000000000001 108.085 -178.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 878' ' ' TYR . . . . . 0.411 ' CE2' ' HA3' ' A' ' 876' ' ' GLY . 88.1 m-85 60.41 -64.96 0.05 Allowed 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 114.28 1.215 . . . . 3.46 114.28 177.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 879' ' ' TYR . . . . . 0.479 ' CB ' ' CD2' ' A' ' 886' ' ' PHE . 19.6 p90 -111.53 107.15 16.23 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 114.5 1.296 . . . . 0.040000000000000001 114.5 -176.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -66.03 117.39 42.11 Favored Pre-proline 0 N--CA 1.497 1.903 0 O-C-N 121.402 -0.811 . . . . 0.02 110.1 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 881' ' ' PRO . . . . . 0.433 ' HG2' ' CD1' ' A' ' 868' ' ' PHE . 55.6 Cg_endo -75.92 0.05 9.7 Favored 'Trans proline' 0 N--CA 1.496 1.637 0 O-C-N 123.547 1.288 . . . . 0.39000000000000001 112.195 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -77.77 -63.87 1.28 Allowed 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 106.803 -1.554 . . . . 0.81000000000000005 106.803 178.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 44.9 p -93.03 -19.55 21.44 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.543 -0.91 . . . . 0.040000000000000001 108.543 177.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.7 20.16 60.35 Favored Glycine 0 N--CA 1.497 2.758 0 O-C-N 121.089 -1.007 . . . . 0.029999999999999999 111.545 178.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 885' ' ' VAL . . . . . 0.539 HG13 HG21 ' A' ' 961' ' ' THR . 88.1 t -74.19 91.96 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 C-N-CA 118.16 -1.416 . . . . 1.01 108.197 -179.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 886' ' ' PHE . . . . . 0.917 ' HB3' HG22 ' A' ' 962' ' ' VAL . 0.7 OUTLIER -90.27 105.75 18.02 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 115.158 -0.928 . . . . 0.050000000000000003 112.118 -177.248 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 887' ' ' THR . . . . . 0.425 ' O ' ' HD3' ' A' ' 889' ' ' PRO . 70.6 m -96.44 100.96 12.52 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 107.911 -1.144 . . . . 0.68000000000000005 107.911 177.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 888' ' ' ALA . . . . . . . . . . . . . . . -98.61 106.65 38.01 Favored Pre-proline 0 N--CA 1.503 2.201 0 N-CA-C 114.146 1.165 . . . . 0.25 114.146 -176.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 889' ' ' PRO . . . . . 0.425 ' HD3' ' O ' ' A' ' 887' ' ' THR . 55.2 Cg_endo -89.08 -12.94 3.17 Favored 'Trans proline' 0 CA--C 1.546 1.098 0 N-CA-C 109.121 -1.146 . . . . 1.6399999999999999 109.121 176.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 890' ' ' LEU . . . . . 1.077 HD22 HD13 ' A' ' 985' ' ' LEU . 56.0 mt -34.25 -51.07 0.43 Allowed 'General case' 0 N--CA 1.509 2.482 0 N-CA-C 113.972 1.101 . . . . 2.29 113.972 -177.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 51.51 94.89 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.363 0 O-C-N 121.186 -0.946 . . . . 0.63 110.331 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 156.09 -147.3 15.75 Favored Glycine 0 N--CA 1.48 1.601 0 N-CA-C 107.536 -2.226 . . . . 0.040000000000000001 107.536 -179.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 893' ' ' ARG . . . . . 0.465 ' CZ ' ' HB1' ' C' ' 984' ' ' ALA . 71.4 ttt-85 -109.13 127.76 54.44 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 107.576 -1.268 . . . . 3.0 107.576 177.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 894' ' ' TYR . . . . . 0.543 ' OH ' HD12 ' A' ' 896' ' ' LEU . 0.1 OUTLIER -130.28 144.54 51.43 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.987 -1.071 . . . . 0.040000000000000001 110.041 -179.075 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 895' ' ' LEU . . . . . 0.449 ' N ' ' CD1' ' A' ' 894' ' ' TYR . 39.9 tp -97.25 114.24 25.96 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.59 -0.694 . . . . 1.27 109.616 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 896' ' ' LEU . . . . . 0.543 HD12 ' OH ' ' A' ' 894' ' ' TYR . 9.7 tt -111.24 146.01 37.72 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.625 -0.672 . . . . 0.93999999999999995 110.812 -179.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 897' ' ' SER . . . . . . . . . . . . . 66.9 m -143.86 116.81 8.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.573 -0.705 . . . . 0.040000000000000001 110.503 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -106.57 146.77 30.25 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.258 -0.645 . . . . 0.47999999999999998 109.258 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 899' ' ' VAL . . . . . 0.725 HG21 ' HB ' ' A' ' 980' ' ' ILE . 88.3 t -97.47 119.18 45.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 C-N-CA 119.716 -0.794 . . . . 0.55000000000000004 111.277 -179.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 900' ' ' LEU . . . . . 0.437 ' N ' HD22 ' A' ' 900' ' ' LEU . 4.5 mm? -95.16 112.18 23.92 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 114.175 1.176 . . . . 1.5900000000000001 114.175 -175.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 17.6 m -64.54 140.99 58.93 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 107.398 -1.334 . . . . 0.050000000000000003 107.398 177.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -63.26 -66.27 2.64 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 110.479 -1.048 . . . . 0.029999999999999999 110.479 -179.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 2.2 m80 46.52 66.06 1.06 Allowed 'General case' 0 N--CA 1.507 2.42 0 O-C-N 121.474 -1.015 . . . . 3.2000000000000002 111.118 179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 54.1 ptt85 -68.72 -6.44 26.32 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.585 -0.697 . . . . 2.9199999999999999 111.916 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 905' ' ' HIS . . . . . 0.483 ' O ' ' CB ' ' A' ' 906' ' ' GLU . 75.9 t60 -60.79 3.4 0.08 Allowed 'General case' 0 N--CA 1.505 2.314 0 O-C-N 120.936 -1.103 . . . . 2.8700000000000001 113.034 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 906' ' ' GLU . . . . . 0.483 ' CB ' ' O ' ' A' ' 905' ' ' HIS . 0.8 OUTLIER 93.4 -163.58 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.377 0 CA-C-N 120.552 1.523 . . . . 0.98999999999999999 112.192 178.789 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 907' ' ' LYS . . . . . 0.481 ' CB ' ' O ' ' A' ' 906' ' ' GLU . 42.6 tttt 88.64 161.73 0.06 Allowed 'General case' 0 N--CA 1.519 2.991 0 N-CA-C 107.675 -1.231 . . . . 5.25 107.675 -176.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 61.0 t -121.97 115.77 47.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 120.876 -1.14 . . . . 0.39000000000000001 110.815 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 909' ' ' GLU . . . . . 0.564 ' OE2' HD12 ' A' ' 966' ' ' LEU . 52.1 tp10 -100.71 132.62 46.01 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 107.19 -1.411 . . . . 1.72 107.19 176.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -156.82 120.64 4.28 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 106.731 -1.581 . . . . 0.67000000000000004 106.731 178.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 911' ' ' VAL . . . . . 0.684 HG22 HG13 ' A' ' 964' ' ' VAL . 95.6 t -83.18 131.99 32.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 C-N-CA 120.34 -0.544 . . . . 0.54000000000000004 110.756 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 72.8 mt -64.63 155.21 34.02 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.316 -0.865 . . . . 1.5 108.709 178.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 913' ' ' SER . . . . . 0.421 ' CB ' ' HB ' ' A' ' 919' ' ' VAL . 1.5 t -122.95 137.62 54.9 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.101 -1.074 . . . . 1.3700000000000001 108.101 177.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 914' ' ' ARG . . . . . 0.56 ' NH1' HD23 ' A' ' 956' ' ' LEU . 0.0 OUTLIER -64.1 153.73 36.71 Favored 'General case' 0 N--CA 1.505 2.308 0 O-C-N 120.834 -1.166 . . . . 4.2999999999999998 111.895 -178.884 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 915' ' ' SER . . . . . 0.423 ' CB ' ' O ' ' A' ' 914' ' ' ARG . 2.2 t 82.85 -31.91 0.09 Allowed 'General case' 0 N--CA 1.52 3.075 0 C-N-CA 123.977 0.911 . . . . 2.0499999999999998 112.452 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 916' ' ' ASN . . . . . 0.754 ' HB2' HG21 ' A' ' 919' ' ' VAL . 98.2 m-20 -121.64 -20.59 6.46 Favored 'General case' 0 N--CA 1.502 2.141 0 O-C-N 120.838 -1.164 . . . . 2.71 111.509 -179.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 917' ' ' GLN . . . . . 0.412 ' HB2' ' O ' ' A' ' 916' ' ' ASN . 51.1 mt-30 66.74 165.93 0.21 Allowed 'General case' 0 N--CA 1.52 3.045 0 N-CA-C 105.653 -1.98 . . . . 2.6800000000000002 105.653 -173.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.15 -125.04 32.46 Favored Glycine 1 N--CA 1.521 4.342 0 CA-C-N 123.423 2.828 . . . . 0.029999999999999999 107.1 -177.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 919' ' ' VAL . . . . . 0.754 HG21 ' HB2' ' A' ' 916' ' ' ASN . 76.7 t 51.71 94.9 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.229 0 O-C-N 121.466 -1.02 . . . . 1.3899999999999999 108.934 -178.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 920' ' ' ALA . . . . . 0.837 ' HB3' HG12 ' A' ' 949' ' ' VAL . . . -91.17 91.93 8.45 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.237 -0.985 . . . . 0.029999999999999999 110.986 -178.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 921' ' ' ARG . . . . . 0.719 ' HG3' HG23 ' A' ' 922' ' ' VAL . 42.4 ptt85 -84.2 -42.04 16.36 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 105.594 -2.002 . . . . 4.4199999999999999 105.594 175.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 922' ' ' VAL . . . . . 0.719 HG23 ' HG3' ' A' ' 921' ' ' ARG . 72.0 t -103.19 69.27 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 N-CA-C 105.446 -2.057 . . . . 0.84999999999999998 105.446 175.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 923' ' ' ASP . . . . . 0.643 ' HB2' ' HB1' ' A' ' 920' ' ' ALA . 19.4 t0 -91.0 135.94 33.41 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.783 0.801 . . . . 2.46 112.139 -176.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 924' ' ' SER . . . . . . . . . . . . . 13.8 t -147.6 104.31 3.6 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 108.096 -1.075 . . . . 0.69999999999999996 108.096 178.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -110.93 90.28 0.57 Allowed Glycine 0 N--CA 1.487 2.08 0 N-CA-C 108.988 -1.645 . . . . 0.040000000000000001 108.988 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.403 0 N-CA-C 109.4 -1.48 . . . . 0.040000000000000001 109.4 -179.625 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 31.0 m . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.007 0.432 . . . . 13.779999999999999 110.307 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 97.5 mt -113.55 129.68 56.51 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.519 -0.738 . . . . 13.76 110.46 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -152.28 168.51 31.44 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.103 -1.599 . . . . 9.1300000000000008 109.103 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 949' ' ' VAL . . . . . 0.837 HG12 ' HB3' ' A' ' 920' ' ' ALA . 34.9 m -118.81 130.35 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.48 -1.012 . . . . 7.0800000000000001 110.928 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 950' ' ' PHE . . . . . 0.463 ' CZ ' ' HB3' ' A' ' 921' ' ' ARG . 32.2 p90 -133.42 149.28 51.81 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.563 -0.711 . . . . 7.5899999999999999 109.31 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 19.6 m -119.42 -53.87 2.21 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.446 -0.784 . . . . 5.0300000000000002 112.144 -178.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 952' ' ' LEU . . . . . 0.505 HD23 ' HB2' ' C' ' 982' ' ' SER . 57.0 tp -59.98 -75.81 0.05 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.342 -0.849 . . . . 1.01 111.974 -177.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 953' ' ' ILE . . . . . 0.936 HD11 HD13 ' C' ' 872' ' ' LEU . 49.3 pt -53.1 -144.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.663 0 N-CA-C 113.718 1.007 . . . . 2.6000000000000001 113.718 -176.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 954' ' ' LEU . . . . . 0.715 HD22 ' O ' ' A' ' 954' ' ' LEU . 0.0 OUTLIER 167.5 83.83 0.02 OUTLIER Pre-proline 0 N--CA 1.512 2.66 0 O-C-N 120.998 -1.064 . . . . 0.050000000000000003 111.535 178.976 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 955' ' ' PRO . . . . . 0.65 ' C ' HD12 ' A' ' 956' ' ' LEU . 46.9 Cg_endo -74.02 98.14 1.06 Allowed 'Trans proline' 0 C--N 1.314 -1.285 0 N-CA-C 108.938 -1.216 . . . . 0.83999999999999997 108.938 177.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 956' ' ' LEU . . . . . 0.65 HD12 ' C ' ' A' ' 955' ' ' PRO . 10.0 mp -122.59 144.13 49.31 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.053 -1.029 . . . . 0.040000000000000001 110.276 -179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -83.61 150.7 25.74 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 117.719 -1.134 . . . . 1.28 111.456 -179.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -69.58 120.08 14.82 Favored 'General case' 0 N--CA 1.509 2.482 0 CA-C-N 122.99 2.632 . . . . 0.17000000000000001 111.373 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 93.34 -21.74 38.83 Favored Glycine 0 N--CA 1.5 2.959 0 N-CA-C 110.94 -0.864 . . . . 0.040000000000000001 110.94 178.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 960' ' ' ASP . . . . . 0.432 ' HB3' ' NE ' ' A' ' 914' ' ' ARG . 0.9 OUTLIER -51.88 171.3 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.476 -1.014 . . . . 0.040000000000000001 110.538 -179.481 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 961' ' ' THR . . . . . 0.539 HG21 HG13 ' A' ' 885' ' ' VAL . 43.7 m -134.81 134.93 41.37 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 120.953 -1.092 . . . . 1.78 111.641 -178.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 962' ' ' VAL . . . . . 0.917 HG22 ' HB3' ' A' ' 886' ' ' PHE . 33.0 m -100.48 145.34 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 C-N-CA 119.851 -0.739 . . . . 0.040000000000000001 110.628 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 5.3 t -138.36 146.52 42.39 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.935 -0.478 . . . . 0.71999999999999997 109.979 -178.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 964' ' ' VAL . . . . . 0.684 HG13 HG22 ' A' ' 911' ' ' VAL . 60.3 t -94.14 136.63 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.102 -0.999 . . . . 1.05 110.416 -179.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -93.52 126.55 38.73 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 103.547 -2.76 . . . . 3.02 103.547 173.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 966' ' ' LEU . . . . . 0.564 HD12 ' OE2' ' A' ' 909' ' ' GLU . 0.5 OUTLIER -132.34 60.06 1.7 Allowed 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.251 -1.018 . . . . 1.46 108.251 177.466 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 967' ' ' VAL . . . . . 0.492 HG23 ' C ' ' A' ' 966' ' ' LEU . 95.9 t -158.2 96.65 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 N-CA-C 108.143 -1.058 . . . . 1.9399999999999999 108.143 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 90.4 mmm -143.26 59.53 1.4 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.716 -1.24 . . . . 0.0 108.272 178.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.33 119.81 1.96 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 106.994 -2.442 . . . . 2.1099999999999999 106.994 -178.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -82.2 -58.25 3.03 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 118.716 1.258 . . . . 5.8899999999999997 110.308 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 40.8 tp -59.12 90.53 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.493 -0.754 . . . . 4.3600000000000003 110.115 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -141.82 -154.33 0.51 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.588 -0.695 . . . . 1.8300000000000001 110.174 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -119.46 170.98 8.67 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.502 -0.749 . . . . 4.3499999999999996 110.338 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 10.7 t -101.47 130.22 47.67 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.535 -0.728 . . . . 1.27 109.962 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -156.3 158.73 37.96 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.481 -0.762 . . . . 5.0199999999999996 110.608 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.93 85.94 18.77 Favored Pre-proline 0 N--CA 1.5 2.048 0 O-C-N 121.611 -0.681 . . . . 2.4100000000000001 109.516 179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -72.75 -171.83 0.83 Allowed 'Trans proline' 0 C--N 1.317 -1.109 0 O-C-N 123.31 1.163 . . . . 0.95999999999999996 111.389 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 978' ' ' LEU . . . . . 0.692 HD23 ' CD1' ' A' ' 856' ' ' LEU . 4.9 mp -127.89 154.32 45.64 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 107.608 -1.256 . . . . 0.62 107.608 178.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 979' ' ' THR . . . . . 0.456 HG23 ' C ' ' A' ' 978' ' ' LEU . 42.1 p -149.93 141.32 23.29 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.768 -1.208 . . . . 3.5699999999999998 111.181 -179.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 980' ' ' ILE . . . . . 0.725 ' HB ' HG21 ' A' ' 899' ' ' VAL . 51.2 mm -107.06 128.06 62.23 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 109.006 -0.739 . . . . 1.3300000000000001 109.006 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 981' ' ' PHE . . . . . 0.431 ' HD1' ' HH ' ' A' ' 879' ' ' TYR . 5.7 t80 -121.73 98.22 5.86 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.417 -0.802 . . . . 0.050000000000000003 111.783 -178.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 982' ' ' SER . . . . . 0.401 ' HA ' ' CB ' ' A' ' 853' ' ' SER . 86.0 p -108.69 158.22 17.81 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.974 -0.75 . . . . 0.87 108.974 178.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . -171.82 108.58 0.28 Allowed Glycine 0 N--CA 1.498 2.78 0 N-CA-C 106.557 -2.617 . . . . 0.029999999999999999 106.557 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -109.4 148.21 31.49 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 114.337 1.236 . . . . 0.69999999999999996 114.337 -175.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 985' ' ' LEU . . . . . 1.077 HD13 HD22 ' A' ' 890' ' ' LEU . 44.7 tp -69.79 135.1 49.3 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 120.796 -1.19 . . . . 0.040000000000000001 110.115 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 986' ' ' LEU . . . . . 0.401 ' CD2' ' NH1' ' A' ' 893' ' ' ARG . 41.8 tp -105.96 -60.29 1.66 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.621 -0.674 . . . . 0.040000000000000001 109.914 179.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -143.88 146.26 32.89 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 107.627 -1.249 . . . . 0.040000000000000001 107.627 179.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.33 163.28 12.19 Favored Glycine 0 N--CA 1.495 2.628 0 N-CA-C 108.094 -2.002 . . . . 0.040000000000000001 108.094 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -76.0 112.52 20.8 Favored Pre-proline 0 N--CA 1.499 2.005 0 O-C-N 121.229 -1.159 . . . . 0.040000000000000001 109.402 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 990' ' ' PRO . . . . . 0.412 ' O ' ' HB2' ' A' ' 991' ' ' GLU . 49.7 Cg_endo -90.27 71.85 1.41 Allowed 'Trans proline' 0 C--N 1.319 -1.006 0 O-C-N 123.164 1.086 . . . . 0.45000000000000001 111.386 -178.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 991' ' ' GLU . . . . . 0.412 ' HB2' ' O ' ' A' ' 990' ' ' PRO . 67.0 mt-10 67.32 -73.69 0.08 Allowed 'General case' 0 N--CA 1.503 2.178 0 N-CA-C 108.483 -0.932 . . . . 1.97 108.483 -177.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 992' ' ' LEU . . . . . 0.402 HD12 ' HD2' ' A' ' 990' ' ' PRO . 10.6 mt 50.91 20.73 0.83 Allowed 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.583 -0.698 . . . . 2.3799999999999999 111.599 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -93.58 156.71 16.57 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.912 -1.117 . . . . 3.79 109.989 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -145.91 92.97 2.27 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.54 -0.725 . . . . 3.5099999999999998 110.312 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 995' ' ' ALA . . . . . . . . . . . . 2.517 . . . . . . . 0 N--CA 1.504 2.254 0 O-C-N 120.85 -1.157 . . . . 2.73 110.575 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo . . . . . 0 N--CA 1.488 1.188 0 N-CA-C 109.523 -0.991 . . . . 3.8300000000000001 109.523 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 847' ' ' VAL . . . . . 0.416 HG12 ' HB2' ' B' ' 849' ' ' GLN . 61.3 t -132.14 103.48 14.07 Favored Pre-proline 0 N--CA 1.494 1.775 0 O-C-N 121.621 -0.674 . . . . 1.8300000000000001 109.989 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 848' ' ' PRO . . . . . 0.708 ' O ' HG23 ' B' ' 850' ' ' VAL . 43.7 Cg_endo -69.45 -20.16 36.67 Favored 'Trans proline' 0 N--CA 1.487 1.133 0 O-C-N 123.245 1.129 . . . . 0.65000000000000002 111.064 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 849' ' ' GLN . . . . . 0.416 ' HB2' HG12 ' B' ' 847' ' ' VAL . 55.6 tt0 27.06 68.69 0.06 Allowed 'General case' 0 N--CA 1.518 2.96 0 N-CA-C 112.867 0.691 . . . . 2.5800000000000001 112.867 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 850' ' ' VAL . . . . . 0.708 HG23 ' O ' ' B' ' 848' ' ' PRO . 59.7 t -118.2 136.68 54.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.218 -0.926 . . . . 1.0900000000000001 111.382 -178.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 851' ' ' ALA . . . . . 0.512 ' HB3' ' HG ' ' B' ' 873' ' ' LEU . . . -126.09 156.11 40.53 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 105.774 -1.936 . . . . 0.040000000000000001 105.774 176.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 852' ' ' PHE . . . . . 0.472 ' CE2' HD11 ' B' ' 890' ' ' LEU . 23.8 p90 -159.73 129.1 5.26 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 121.022 1.737 . . . . 0.050000000000000003 108.631 179.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 30.0 t -175.24 134.72 0.33 Allowed 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.176 -1.046 . . . . 0.040000000000000001 108.176 -178.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -132.56 156.75 46.29 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.099 -1.001 . . . . 0.67000000000000004 109.576 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 855' ' ' ALA . . . . . 0.739 ' HB3' ' CB ' ' B' ' 870' ' ' ARG . . . -122.9 145.13 48.73 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.774 0.797 . . . . 0.51000000000000001 111.697 -178.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 856' ' ' LEU . . . . . 0.684 ' CD1' HD23 ' B' ' 978' ' ' LEU . 3.4 tm? -112.51 134.01 54.27 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.743 -0.598 . . . . 0.050000000000000003 110.105 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 857' ' ' SER . . . . . 0.526 ' N ' HD13 ' B' ' 856' ' ' LEU . 56.3 p -150.37 16.99 0.83 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.561 -0.712 . . . . 1.3300000000000001 110.513 178.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 858' ' ' LEU . . . . . 0.763 HD22 ' OE2' ' B' ' 862' ' ' GLU . 4.4 pp -33.31 158.26 0.04 OUTLIER Pre-proline 0 N--CA 1.517 2.924 0 N-CA-C 113.33 0.863 . . . . 2.3300000000000001 113.33 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -64.5 -88.43 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.421 0 O-C-N 123.207 1.109 . . . . 2.3199999999999998 113.103 -178.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 55.8 ptt85 -128.71 -143.45 0.27 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.87 -1.144 . . . . 0.040000000000000001 111.729 -177.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 19.3 m -40.23 127.53 2.27 Favored 'General case' 0 N--CA 1.509 2.491 0 O-C-N 121.455 -0.778 . . . . 1.3100000000000001 112.359 -178.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 862' ' ' GLU . . . . . 0.763 ' OE2' HD22 ' B' ' 858' ' ' LEU . 0.9 OUTLIER -102.09 156.77 34.82 Favored Pre-proline 0 N--CA 1.488 1.465 0 N-CA-C 107.86 -1.163 . . . . 4.5099999999999998 107.86 177.138 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 863' ' ' PRO . . . . . 0.414 ' HD2' ' CG ' ' B' ' 862' ' ' GLU . 43.7 Cg_endo -69.81 -13.06 34.03 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 O-C-N 123.082 1.043 . . . . 2.2400000000000002 111.419 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -175.61 -135.91 2.21 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.993 -1.243 . . . . 0.040000000000000001 109.993 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 28.0 m -66.71 157.68 32.08 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.253 -1.145 . . . . 1.51 110.925 -178.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 866' ' ' VAL . . . . . 0.688 HG22 ' OE1' ' B' ' 862' ' ' GLU . 48.5 t -93.78 134.53 26.17 Favored Pre-proline 0 N--CA 1.495 1.784 0 N-CA-C 113.302 0.853 . . . . 0.78000000000000003 113.302 -174.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 867' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' B' ' 866' ' ' VAL . 55.2 Cg_endo -90.38 -152.94 0.04 OUTLIER 'Trans proline' 0 CA--C 1.541 0.867 0 O-C-N 123.517 1.272 . . . . 0.92000000000000004 108.831 177.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 868' ' ' PHE . . . . . 0.45 ' CD1' ' N ' ' B' ' 868' ' ' PHE . 23.6 p90 -149.55 122.16 8.59 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 120.633 -1.292 . . . . 0.050000000000000003 109.956 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 49.2 p-10 -113.29 -1.94 14.15 Favored 'General case' 0 N--CA 1.498 1.971 0 C-N-CA 119.27 -0.972 . . . . 1.7 112.289 -179.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 870' ' ' ARG . . . . . 0.739 ' CB ' ' HB3' ' B' ' 855' ' ' ALA . 30.3 mmm180 -90.96 88.68 7.12 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.899 -1.126 . . . . 2.5899999999999999 110.784 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 58.5 t -74.56 97.32 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.005 -1.059 . . . . 1.9399999999999999 109.884 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 872' ' ' LEU . . . . . 0.446 HD11 ' HB2' ' B' ' 855' ' ' ALA . 94.7 mt -83.16 -46.99 12.07 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.488 -0.757 . . . . 1.0600000000000001 110.14 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 873' ' ' LEU . . . . . 0.512 ' HG ' ' HB3' ' B' ' 851' ' ' ALA . 46.5 tp -174.65 104.01 0.1 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.305 -0.872 . . . . 4.1799999999999997 108.703 178.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 874' ' ' ASN . . . . . 0.444 ' CB ' ' HA ' ' B' ' 852' ' ' PHE . 35.6 t-20 178.86 81.96 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.304 0 O-C-N 121.643 -0.66 . . . . 0.040000000000000001 109.76 -178.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -67.16 -47.31 71.4 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 119.268 -0.973 . . . . 3.3799999999999999 111.076 -179.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 876' ' ' GLY . . . . . 0.404 ' HA3' ' CE2' ' B' ' 878' ' ' TYR . . . -73.87 -25.27 72.16 Favored Glycine 0 N--CA 1.494 2.562 0 O-C-N 121.336 -0.852 . . . . 0.040000000000000001 111.584 -178.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 83.01 -61.29 4.8 Favored Glycine 0 N--CA 1.501 3.003 0 N-CA-C 108.091 -2.003 . . . . 0.040000000000000001 108.091 -178.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 878' ' ' TYR . . . . . 0.404 ' CE2' ' HA3' ' B' ' 876' ' ' GLY . 88.4 m-85 60.47 -64.93 0.06 Allowed 'General case' 0 N--CA 1.504 2.248 0 N-CA-C 114.303 1.223 . . . . 3.46 114.303 177.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 879' ' ' TYR . . . . . 0.467 ' CB ' ' CD2' ' B' ' 886' ' ' PHE . 19.6 p90 -111.47 107.45 16.66 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 114.457 1.28 . . . . 0.040000000000000001 114.457 -176.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -66.21 117.17 40.6 Favored Pre-proline 0 N--CA 1.497 1.924 0 O-C-N 121.422 -0.798 . . . . 0.02 110.145 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 881' ' ' PRO . . . . . 0.42 ' HG2' ' CD1' ' B' ' 868' ' ' PHE . 55.5 Cg_endo -75.81 -0.12 9.85 Favored 'Trans proline' 0 N--CA 1.495 1.617 0 O-C-N 123.57 1.3 . . . . 0.39000000000000001 112.15 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 88.4 mt-10 -77.45 -63.65 1.33 Allowed 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 106.801 -1.555 . . . . 0.81000000000000005 106.801 178.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 45.7 p -93.79 -18.82 21.64 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.678 -0.86 . . . . 0.040000000000000001 108.678 177.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.24 20.27 60.95 Favored Glycine 0 N--CA 1.497 2.711 0 O-C-N 121.11 -0.994 . . . . 0.029999999999999999 111.554 178.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 885' ' ' VAL . . . . . 0.524 HG13 HG21 ' B' ' 961' ' ' THR . 87.8 t -74.14 91.9 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 C-N-CA 118.14 -1.424 . . . . 1.01 108.097 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 886' ' ' PHE . . . . . 0.901 ' HB3' HG22 ' B' ' 962' ' ' VAL . 0.7 OUTLIER -90.32 105.82 18.07 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-N 115.182 -0.917 . . . . 0.050000000000000003 111.999 -177.259 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 887' ' ' THR . . . . . 0.423 ' O ' ' HD3' ' B' ' 889' ' ' PRO . 69.7 m -96.47 101.15 12.73 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 107.868 -1.16 . . . . 0.68000000000000005 107.868 177.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 888' ' ' ALA . . . . . . . . . . . . . . . -98.78 106.51 37.73 Favored Pre-proline 0 N--CA 1.502 2.146 0 N-CA-C 114.153 1.168 . . . . 0.25 114.153 -176.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 889' ' ' PRO . . . . . 0.423 ' HD3' ' O ' ' B' ' 887' ' ' THR . 55.3 Cg_endo -89.02 -13.07 3.16 Favored 'Trans proline' 0 CA--C 1.546 1.105 0 C-N-CA 121.01 1.14 . . . . 1.6399999999999999 109.183 176.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 890' ' ' LEU . . . . . 1.077 HD22 HD13 ' B' ' 985' ' ' LEU . 56.5 mt -34.04 -51.29 0.42 Allowed 'General case' 0 N--CA 1.51 2.535 0 N-CA-C 113.997 1.11 . . . . 2.29 113.997 -177.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 51.54 94.84 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.336 0 O-C-N 121.13 -0.981 . . . . 0.63 110.379 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . 156.13 -147.54 16.32 Favored Glycine 0 N--CA 1.48 1.577 0 N-CA-C 107.451 -2.26 . . . . 0.040000000000000001 107.451 -179.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 72.0 ttt-85 -108.86 127.72 54.28 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 107.609 -1.256 . . . . 3.0 107.609 177.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 894' ' ' TYR . . . . . 0.542 ' OH ' HD12 ' B' ' 896' ' ' LEU . 0.1 OUTLIER -130.22 144.67 51.5 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.048 -1.032 . . . . 0.040000000000000001 110.056 -179.064 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 895' ' ' LEU . . . . . 0.45 ' N ' ' CD1' ' B' ' 894' ' ' TYR . 39.7 tp -97.58 114.33 26.22 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.628 -0.67 . . . . 1.27 109.621 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 896' ' ' LEU . . . . . 0.542 HD12 ' OH ' ' B' ' 894' ' ' TYR . 9.6 tt -111.34 145.62 38.54 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.574 -0.704 . . . . 0.93999999999999995 110.884 -179.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 897' ' ' SER . . . . . . . . . . . . . 65.9 m -143.53 116.56 8.88 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.636 -0.665 . . . . 0.040000000000000001 110.467 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -106.23 146.68 30.01 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 109.297 -0.631 . . . . 0.47999999999999998 109.297 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 899' ' ' VAL . . . . . 0.731 HG21 ' HB ' ' B' ' 980' ' ' ILE . 87.7 t -97.35 118.76 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 C-N-CA 119.757 -0.777 . . . . 0.55000000000000004 111.403 -179.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 900' ' ' LEU . . . . . 0.446 HD13 ' HA ' ' B' ' 900' ' ' LEU . 4.5 mm? -94.81 111.9 23.66 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 114.283 1.216 . . . . 1.5900000000000001 114.283 -175.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 17.4 m -64.4 141.06 58.91 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 107.316 -1.365 . . . . 0.050000000000000003 107.316 177.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -63.58 -66.14 2.69 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 110.476 -1.05 . . . . 0.029999999999999999 110.476 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 2.1 m80 46.44 65.99 1.07 Allowed 'General case' 0 N--CA 1.507 2.383 0 O-C-N 121.447 -1.031 . . . . 3.2000000000000002 111.099 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 54.1 ptt85 -68.54 -6.75 27.11 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.64 -0.662 . . . . 2.9199999999999999 111.942 -179.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 905' ' ' HIS . . . . . 0.482 ' O ' ' CB ' ' B' ' 906' ' ' GLU . 75.9 t60 -60.19 2.82 0.08 Allowed 'General case' 0 N--CA 1.506 2.33 0 O-C-N 120.914 -1.116 . . . . 2.8700000000000001 113.073 -179.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 906' ' ' GLU . . . . . 0.482 ' CB ' ' O ' ' B' ' 905' ' ' HIS . 0.8 OUTLIER 93.75 -163.76 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.387 0 CA-C-N 120.6 1.545 . . . . 0.98999999999999999 112.072 178.939 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 907' ' ' LYS . . . . . 0.472 ' CB ' ' O ' ' B' ' 906' ' ' GLU . 42.9 tttt 88.84 161.52 0.06 Allowed 'General case' 0 N--CA 1.519 2.979 0 N-CA-C 107.717 -1.216 . . . . 5.25 107.717 -176.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 61.7 t -121.7 115.65 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 O-C-N 120.901 -1.125 . . . . 0.39000000000000001 110.926 -179.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 909' ' ' GLU . . . . . 0.551 ' OE2' HD12 ' B' ' 966' ' ' LEU . 52.2 tp10 -100.75 132.64 46.05 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 107.222 -1.399 . . . . 1.72 107.222 176.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -156.99 120.95 4.27 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 106.703 -1.592 . . . . 0.67000000000000004 106.703 178.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 911' ' ' VAL . . . . . 0.681 HG22 HG13 ' B' ' 964' ' ' VAL . 93.9 t -83.48 132.1 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.835 -0.54 . . . . 0.54000000000000004 110.71 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 72.3 mt -64.58 155.44 33.14 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.326 -0.859 . . . . 1.5 108.694 178.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 913' ' ' SER . . . . . 0.413 ' CB ' ' HB ' ' B' ' 919' ' ' VAL . 1.6 t -123.47 136.69 54.72 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.122 -1.066 . . . . 1.3700000000000001 108.122 177.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 914' ' ' ARG . . . . . 0.56 ' NH1' HD23 ' B' ' 956' ' ' LEU . 0.0 OUTLIER -63.08 153.57 33.71 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 120.839 -1.163 . . . . 4.2999999999999998 111.981 -178.784 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 915' ' ' SER . . . . . 0.416 ' CB ' ' O ' ' B' ' 914' ' ' ARG . 2.2 t 83.02 -32.2 0.08 Allowed 'General case' 0 N--CA 1.521 3.095 0 C-N-CA 124.03 0.932 . . . . 2.0499999999999998 112.404 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 916' ' ' ASN . . . . . 0.789 ' HB2' HG21 ' B' ' 919' ' ' VAL . 98.1 m-20 -121.26 -20.85 6.57 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 120.867 -1.146 . . . . 2.71 111.607 -179.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 917' ' ' GLN . . . . . 0.415 ' HB2' ' O ' ' B' ' 916' ' ' ASN . 50.8 mt-30 66.75 165.51 0.21 Allowed 'General case' 0 N--CA 1.521 3.103 0 N-CA-C 105.661 -1.977 . . . . 2.6800000000000002 105.661 -173.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.8 -125.23 34.58 Favored Glycine 1 N--CA 1.521 4.304 0 CA-C-N 123.532 2.878 . . . . 0.029999999999999999 106.958 -177.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 919' ' ' VAL . . . . . 0.789 HG21 ' HB2' ' B' ' 916' ' ' ASN . 79.9 t 51.5 95.08 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 O-C-N 121.456 -1.026 . . . . 1.3899999999999999 108.959 -178.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 920' ' ' ALA . . . . . 0.851 ' HB3' HG12 ' B' ' 949' ' ' VAL . . . -91.26 91.75 8.33 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.207 -0.997 . . . . 0.029999999999999999 110.904 -179.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 921' ' ' ARG . . . . . 0.712 ' HG3' HG23 ' B' ' 922' ' ' VAL . 42.4 ptt85 -84.17 -41.9 16.54 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 105.58 -2.007 . . . . 4.4199999999999999 105.58 175.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 922' ' ' VAL . . . . . 0.712 HG23 ' HG3' ' B' ' 921' ' ' ARG . 71.0 t -103.26 68.96 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 N-CA-C 105.53 -2.026 . . . . 0.84999999999999998 105.53 175.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 923' ' ' ASP . . . . . 0.64 ' HB2' ' HB1' ' B' ' 920' ' ' ALA . 19.4 t0 -90.7 136.04 33.32 Favored 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 121.779 0.8 . . . . 2.46 112.147 -176.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 924' ' ' SER . . . . . . . . . . . . . 14.1 t -147.62 104.04 3.58 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.184 -1.043 . . . . 0.69999999999999996 108.184 178.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -110.63 90.24 0.57 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 108.979 -1.649 . . . . 0.040000000000000001 108.979 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.425 0 N-CA-C 109.386 -1.486 . . . . 0.040000000000000001 109.386 -179.709 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 32.3 m . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.031 0.444 . . . . 13.779999999999999 110.254 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 97.6 mt -112.81 129.64 56.37 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.509 -0.744 . . . . 13.76 110.434 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -151.82 167.89 31.1 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.127 -1.589 . . . . 9.1300000000000008 109.127 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 949' ' ' VAL . . . . . 0.851 HG12 ' HB3' ' B' ' 920' ' ' ALA . 35.3 m -118.62 130.12 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.499 -1.001 . . . . 7.0800000000000001 110.852 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 950' ' ' PHE . . . . . 0.455 ' CZ ' ' HB3' ' B' ' 921' ' ' ARG . 32.6 p90 -133.19 149.44 52.03 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.584 -0.697 . . . . 7.5899999999999999 109.248 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 19.4 m -119.5 -53.7 2.21 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.406 -0.809 . . . . 5.0300000000000002 112.022 -178.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 952' ' ' LEU . . . . . 0.429 ' O ' ' O ' ' B' ' 953' ' ' ILE . 56.5 tp -60.32 -75.67 0.06 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.442 -0.786 . . . . 1.01 111.966 -177.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 953' ' ' ILE . . . . . 0.508 ' O ' ' HB3' ' B' ' 954' ' ' LEU . 49.2 pt -53.02 -144.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.637 0 N-CA-C 113.749 1.018 . . . . 2.6000000000000001 113.749 -176.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 954' ' ' LEU . . . . . 0.711 HD22 ' O ' ' B' ' 954' ' ' LEU . 0.0 OUTLIER 167.48 83.58 0.02 OUTLIER Pre-proline 0 N--CA 1.512 2.67 0 O-C-N 120.977 -1.077 . . . . 0.050000000000000003 111.429 178.915 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 955' ' ' PRO . . . . . 0.654 ' C ' HD12 ' B' ' 956' ' ' LEU . 46.2 Cg_endo -74.07 98.4 1.08 Allowed 'Trans proline' 0 C--N 1.313 -1.315 0 N-CA-C 108.863 -1.245 . . . . 0.83999999999999997 108.863 177.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 956' ' ' LEU . . . . . 0.654 HD12 ' C ' ' B' ' 955' ' ' PRO . 10.0 mp -122.85 144.02 49.48 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.056 -1.027 . . . . 0.040000000000000001 110.22 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -83.43 151.1 25.65 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 117.829 -1.082 . . . . 1.28 111.39 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -69.75 119.91 14.7 Favored 'General case' 0 N--CA 1.509 2.479 0 CA-C-N 122.857 2.571 . . . . 0.17000000000000001 111.368 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 93.35 -21.91 37.92 Favored Glycine 0 N--CA 1.501 2.989 0 N-CA-C 110.949 -0.86 . . . . 0.040000000000000001 110.949 178.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 960' ' ' ASP . . . . . 0.433 ' HB3' ' NE ' ' B' ' 914' ' ' ARG . 0.9 OUTLIER -51.65 171.23 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.46 -1.023 . . . . 0.040000000000000001 110.514 -179.411 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 961' ' ' THR . . . . . 0.524 HG21 HG13 ' B' ' 885' ' ' VAL . 42.0 m -134.67 135.08 41.8 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.025 -1.047 . . . . 1.78 111.655 -178.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 962' ' ' VAL . . . . . 0.901 HG22 ' HB3' ' B' ' 886' ' ' PHE . 33.0 m -100.66 145.22 11.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 C-N-CA 119.938 -0.705 . . . . 0.040000000000000001 110.661 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 5.2 t -138.27 146.22 42.23 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.943 -0.473 . . . . 0.71999999999999997 110.042 -178.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 964' ' ' VAL . . . . . 0.681 HG13 HG22 ' B' ' 911' ' ' VAL . 59.9 t -94.01 136.27 26.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.04 -1.037 . . . . 1.05 110.433 -179.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -93.29 126.32 38.34 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 103.571 -2.752 . . . . 3.02 103.571 173.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 966' ' ' LEU . . . . . 0.551 HD12 ' OE2' ' B' ' 909' ' ' GLU . 0.5 OUTLIER -132.08 59.98 1.69 Allowed 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.324 -0.991 . . . . 1.46 108.324 177.512 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 967' ' ' VAL . . . . . 0.491 HG23 ' C ' ' B' ' 966' ' ' LEU . 95.7 t -158.23 96.32 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 108.222 -1.029 . . . . 1.9399999999999999 108.222 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 90.5 mmm -142.85 59.54 1.43 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.8 -1.187 . . . . 0.0 108.312 178.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.23 119.67 1.95 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 107.06 -2.416 . . . . 2.1099999999999999 107.06 -178.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -81.92 -58.24 3.07 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.106 -1.232 . . . . 5.8899999999999997 110.353 -179.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 40.9 tp -59.14 90.22 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.423 -0.798 . . . . 4.3600000000000003 110.103 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -141.56 -154.05 0.5 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.574 -0.704 . . . . 1.8300000000000001 110.156 -179.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -119.64 171.2 8.54 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.509 -0.745 . . . . 4.3499999999999996 110.336 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 10.7 t -101.61 130.2 47.88 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.53 -0.731 . . . . 1.27 109.942 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -156.26 158.79 38.12 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.443 -0.786 . . . . 5.0199999999999996 110.598 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.01 85.94 18.55 Favored Pre-proline 0 N--CA 1.5 2.031 0 O-C-N 121.647 -0.658 . . . . 2.4100000000000001 109.541 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -72.76 -171.88 0.84 Allowed 'Trans proline' 0 C--N 1.317 -1.087 0 O-C-N 123.342 1.18 . . . . 0.95999999999999996 111.408 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 978' ' ' LEU . . . . . 0.684 HD23 ' CD1' ' B' ' 856' ' ' LEU . 4.9 mp -127.74 154.56 45.21 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 107.649 -1.241 . . . . 0.62 107.649 178.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 979' ' ' THR . . . . . 0.464 HG23 ' C ' ' B' ' 978' ' ' LEU . 41.8 p -150.17 141.34 23.11 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.808 -1.183 . . . . 3.5699999999999998 111.17 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 980' ' ' ILE . . . . . 0.731 ' HB ' HG21 ' B' ' 899' ' ' VAL . 51.3 mm -107.09 127.74 62.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 108.985 -0.746 . . . . 1.3300000000000001 108.985 179.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -121.56 98.57 6.03 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.395 -0.816 . . . . 0.050000000000000003 111.817 -178.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 98.8 p -109.34 158.73 17.6 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.467 -0.771 . . . . 0.87 109.013 178.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 983' ' ' GLY . . . . . . . . . . . . . . . -171.86 108.84 0.29 Allowed Glycine 0 N--CA 1.497 2.716 0 N-CA-C 106.609 -2.596 . . . . 0.029999999999999999 106.609 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -109.34 147.88 31.99 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 114.177 1.177 . . . . 0.69999999999999996 114.177 -175.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 985' ' ' LEU . . . . . 1.077 HD13 HD22 ' B' ' 890' ' ' LEU . 44.2 tp -69.67 135.22 49.6 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.851 -1.155 . . . . 0.040000000000000001 110.057 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 986' ' ' LEU . . . . . 0.568 HD11 HD11 ' C' ' 986' ' ' LEU . 42.2 tp -106.12 -60.45 1.64 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.635 -0.665 . . . . 0.040000000000000001 109.895 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -143.83 146.05 32.78 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.581 -1.266 . . . . 0.040000000000000001 107.581 179.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.27 162.91 12.25 Favored Glycine 0 N--CA 1.496 2.658 0 N-CA-C 108.091 -2.003 . . . . 0.040000000000000001 108.091 179.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -75.55 112.5 19.59 Favored Pre-proline 0 N--CA 1.499 1.991 0 CA-C-N 118.503 1.152 . . . . 0.040000000000000001 109.414 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 990' ' ' PRO . . . . . 0.417 ' O ' ' HB2' ' B' ' 991' ' ' GLU . 49.8 Cg_endo -90.16 71.68 1.49 Allowed 'Trans proline' 0 C--N 1.319 -1.006 0 O-C-N 123.151 1.079 . . . . 0.45000000000000001 111.399 -178.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 991' ' ' GLU . . . . . 0.417 ' HB2' ' O ' ' B' ' 990' ' ' PRO . 66.9 mt-10 67.39 -73.65 0.08 Allowed 'General case' 0 N--CA 1.503 2.203 0 N-CA-C 108.516 -0.92 . . . . 1.97 108.516 -177.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 992' ' ' LEU . . . . . 0.461 ' HA ' HD23 ' B' ' 992' ' ' LEU . 10.8 mt 51.03 20.45 0.82 Allowed 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.639 -0.663 . . . . 2.3799999999999999 111.738 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -93.22 156.79 16.62 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.897 -1.127 . . . . 3.79 109.987 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 67.3 m80 -146.05 92.32 2.18 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.538 -0.726 . . . . 3.5099999999999998 110.386 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 995' ' ' ALA . . . . . . . . . . . . 2.516 . . . . . . . 0 N--CA 1.503 2.204 0 O-C-N 120.946 -1.096 . . . . 2.73 110.625 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo . . . . . 0 N--CA 1.487 1.147 0 N-CA-C 109.469 -1.012 . . . . 3.8300000000000001 109.469 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 847' ' ' VAL . . . . . . . . . . . . . 59.1 t -131.62 102.8 15.0 Favored Pre-proline 0 N--CA 1.495 1.811 0 O-C-N 121.621 -0.675 . . . . 1.8300000000000001 110.311 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 848' ' ' PRO . . . . . 0.686 ' O ' HG23 ' C' ' 850' ' ' VAL . 44.7 Cg_endo -70.49 -21.37 30.17 Favored 'Trans proline' 0 N--CA 1.487 1.1 0 O-C-N 123.331 1.174 . . . . 0.65000000000000002 111.186 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 849' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 27.94 69.25 0.07 Allowed 'General case' 0 N--CA 1.519 2.999 0 N-CA-C 112.703 0.631 . . . . 2.5800000000000001 112.703 179.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 850' ' ' VAL . . . . . 0.686 HG23 ' O ' ' C' ' 848' ' ' PRO . 49.5 t -119.62 135.0 61.39 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.152 -0.968 . . . . 1.0900000000000001 111.764 -178.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 851' ' ' ALA . . . . . 0.59 ' HB3' ' HG ' ' C' ' 873' ' ' LEU . . . -127.17 154.88 44.23 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 105.517 -2.031 . . . . 0.040000000000000001 105.517 176.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 852' ' ' PHE . . . . . 0.449 ' CD1' ' N ' ' C' ' 852' ' ' PHE . 16.8 p90 -160.51 126.68 4.08 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 121.107 1.776 . . . . 0.050000000000000003 108.633 178.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 7.8 t -176.31 134.36 0.24 Allowed 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.012 -1.107 . . . . 0.040000000000000001 108.012 -179.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 854' ' ' ALA . . . . . 0.463 ' HB1' ' HD2' ' C' ' 868' ' ' PHE . . . -130.57 156.37 44.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.141 -0.974 . . . . 0.67000000000000004 109.505 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 855' ' ' ALA . . . . . 0.755 ' HB3' ' CB ' ' C' ' 870' ' ' ARG . . . -122.09 142.87 49.93 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 121.881 0.848 . . . . 0.51000000000000001 111.266 -179.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 856' ' ' LEU . . . . . 0.786 HD12 ' HG ' ' C' ' 978' ' ' LEU . 3.3 tm? -111.85 136.46 51.1 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.626 -0.672 . . . . 0.050000000000000003 109.923 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 857' ' ' SER . . . . . 0.629 ' N ' HD13 ' C' ' 856' ' ' LEU . 1.1 m -153.54 15.67 0.51 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.462 -0.774 . . . . 1.3300000000000001 111.661 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 858' ' ' LEU . . . . . 0.711 ' CD2' HD11 ' C' ' 856' ' ' LEU . 4.0 pp -34.91 160.8 0.04 OUTLIER Pre-proline 0 N--CA 1.518 2.944 0 N-CA-C 113.172 0.804 . . . . 2.3300000000000001 113.172 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -62.13 -87.12 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 120.992 1.128 . . . . 2.3199999999999998 113.779 -177.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 54.0 ptt85 -129.74 -142.79 0.25 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 120.883 -1.135 . . . . 0.040000000000000001 111.77 -177.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 67.4 m -38.82 130.83 1.41 Allowed 'General case' 0 N--CA 1.51 2.572 0 O-C-N 121.598 -0.689 . . . . 1.3100000000000001 112.17 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.47 158.55 31.59 Favored Pre-proline 0 N--CA 1.487 1.416 0 N-CA-C 108.633 -0.877 . . . . 4.5099999999999998 108.633 177.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -71.47 -14.52 30.81 Favored 'Trans proline' 0 C--N 1.313 -1.314 0 O-C-N 123.185 1.097 . . . . 2.2400000000000002 111.693 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -177.95 -134.28 2.03 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.681 -1.367 . . . . 0.040000000000000001 109.681 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 7.1 m -67.84 151.18 47.6 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.251 -1.146 . . . . 1.51 110.477 -179.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 866' ' ' VAL . . . . . 0.444 HG13 ' CD2' ' C' ' 858' ' ' LEU . 53.7 t -94.87 134.28 25.17 Favored Pre-proline 0 N--CA 1.497 1.888 0 N-CA-C 113.401 0.889 . . . . 0.78000000000000003 113.401 -174.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 867' ' ' PRO . . . . . 0.524 ' O ' HD23 ' C' ' 856' ' ' LEU . 55.2 Cg_endo -89.07 -150.14 0.04 OUTLIER 'Trans proline' 0 CA--C 1.543 0.936 0 O-C-N 123.526 1.277 . . . . 0.92000000000000004 109.345 178.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 868' ' ' PHE . . . . . 0.463 ' HD2' ' HB1' ' C' ' 854' ' ' ALA . 14.9 p90 -148.9 123.76 9.95 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 120.68 -1.262 . . . . 0.050000000000000003 109.653 179.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 49.5 p-10 -112.61 -3.1 14.39 Favored 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 119.273 -0.971 . . . . 1.7 112.492 -178.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 870' ' ' ARG . . . . . 0.755 ' CB ' ' HB3' ' C' ' 855' ' ' ALA . 26.7 mmm180 -91.68 87.65 6.4 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.925 -1.109 . . . . 2.5899999999999999 111.03 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 57.9 t -73.68 97.56 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 120.919 -1.113 . . . . 1.9399999999999999 109.269 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 872' ' ' LEU . . . . . 0.936 HD13 HD11 ' A' ' 953' ' ' ILE . 96.3 mt -87.17 -45.04 11.04 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.564 -0.71 . . . . 1.0600000000000001 110.736 -179.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 873' ' ' LEU . . . . . 0.59 ' HG ' ' HB3' ' C' ' 851' ' ' ALA . 31.1 tp -171.99 102.3 0.17 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.144 -0.972 . . . . 4.1799999999999997 108.975 178.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 874' ' ' ASN . . . . . 0.439 ' CB ' ' HA ' ' C' ' 852' ' ' PHE . 35.0 t-20 176.97 82.72 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.265 0 N-CA-C 108.782 -0.821 . . . . 0.040000000000000001 108.782 -179.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -65.47 -47.02 77.54 Favored 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 119.282 -0.967 . . . . 3.3799999999999999 111.359 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 876' ' ' GLY . . . . . 0.416 ' HA3' ' CE2' ' C' ' 878' ' ' TYR . . . -72.11 -26.92 71.22 Favored Glycine 0 N--CA 1.492 2.429 0 C-N-CA 120.361 -0.924 . . . . 0.040000000000000001 111.447 -178.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 81.34 -61.93 4.54 Favored Glycine 0 N--CA 1.5 2.905 0 N-CA-C 108.016 -2.034 . . . . 0.040000000000000001 108.016 -178.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 878' ' ' TYR . . . . . 0.416 ' CE2' ' HA3' ' C' ' 876' ' ' GLY . 96.3 m-85 60.39 -66.3 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.122 0 N-CA-C 114.366 1.247 . . . . 3.46 114.366 177.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 879' ' ' TYR . . . . . 0.47 ' CB ' ' CD2' ' C' ' 886' ' ' PHE . 25.0 p90 -110.55 107.52 17.17 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 115.092 1.516 . . . . 0.040000000000000001 115.092 -175.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -71.82 120.76 81.92 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.437 -0.789 . . . . 0.02 109.939 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 881' ' ' PRO . . . . . 0.443 ' HG2' ' CD1' ' C' ' 868' ' ' PHE . 52.3 Cg_endo -78.25 0.24 10.08 Favored 'Trans proline' 0 N--CA 1.49 1.28 0 O-C-N 123.434 1.228 . . . . 0.39000000000000001 111.786 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -74.92 -63.62 1.22 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 106.083 -1.821 . . . . 0.81000000000000005 106.083 178.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 70.3 p -90.54 -21.73 21.65 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 108.513 -0.921 . . . . 0.040000000000000001 108.513 177.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 82.28 18.45 66.77 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 110.59 -1.004 . . . . 0.029999999999999999 110.59 179.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 885' ' ' VAL . . . . . 0.414 HG13 HG21 ' C' ' 961' ' ' THR . 96.6 t -75.54 92.2 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 C-N-CA 118.41 -1.316 . . . . 1.01 108.655 -179.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 886' ' ' PHE . . . . . 0.908 ' HB3' HG22 ' C' ' 962' ' ' VAL . 0.8 OUTLIER -87.81 104.34 16.49 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 115.065 -0.97 . . . . 0.050000000000000003 111.541 -177.761 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 887' ' ' THR . . . . . 0.441 ' O ' ' HD3' ' C' ' 889' ' ' PRO . 96.8 m -98.97 99.42 10.46 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 107.38 -1.341 . . . . 0.68000000000000005 107.38 177.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 888' ' ' ALA . . . . . . . . . . . . . . . -97.4 106.64 33.77 Favored Pre-proline 0 N--CA 1.501 2.109 0 N-CA-C 114.413 1.264 . . . . 0.25 114.413 -176.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 889' ' ' PRO . . . . . 0.441 ' HD3' ' O ' ' C' ' 887' ' ' THR . 53.5 Cg_endo -88.06 -15.38 3.11 Favored 'Trans proline' 0 CA--C 1.546 1.078 0 N-CA-C 108.662 -1.322 . . . . 1.6399999999999999 108.662 175.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 890' ' ' LEU . . . . . 0.633 HD22 HD13 ' C' ' 985' ' ' LEU . 46.0 mt -38.33 -49.17 1.39 Allowed 'General case' 0 N--CA 1.506 2.346 0 N-CA-C 113.347 0.869 . . . . 2.29 113.347 -177.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 52.69 97.35 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.241 -0.912 . . . . 0.63 110.316 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . 159.41 -155.52 26.61 Favored Glycine 0 N--CA 1.477 1.425 0 N-CA-C 107.151 -2.38 . . . . 0.040000000000000001 107.151 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 73.4 ttt-85 -117.99 123.98 47.05 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.618 -0.93 . . . . 3.0 109.049 177.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 894' ' ' TYR . . . . . 0.871 ' CE1' HD23 ' C' ' 954' ' ' LEU . 49.5 p90 -134.08 156.69 47.81 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.057 -1.027 . . . . 0.040000000000000001 110.922 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 895' ' ' LEU . . . . . . . . . . . . . 40.3 tp -96.47 118.22 32.53 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.691 -0.631 . . . . 1.27 110.379 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 896' ' ' LEU . . . . . 0.576 HD23 ' N ' ' C' ' 897' ' ' SER . 9.5 tt -116.1 145.17 43.25 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.645 -0.66 . . . . 0.93999999999999995 109.92 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 897' ' ' SER . . . . . 0.576 ' N ' HD23 ' C' ' 896' ' ' LEU . 47.4 m -140.0 124.2 17.79 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.431 -0.793 . . . . 0.040000000000000001 111.285 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -105.49 146.8 29.07 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.903 -0.777 . . . . 0.47999999999999998 108.903 178.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 899' ' ' VAL . . . . . 0.73 HG21 ' HB ' ' C' ' 980' ' ' ILE . 93.7 t -90.83 122.24 42.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 C-N-CA 119.727 -0.789 . . . . 0.55000000000000004 111.255 -178.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 900' ' ' LEU . . . . . 0.405 HD22 ' HB2' ' C' ' 924' ' ' SER . 93.8 mt -92.06 111.12 22.55 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 114.375 1.25 . . . . 1.5900000000000001 114.375 -175.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 20.3 m -67.29 140.35 57.31 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 106.98 -1.489 . . . . 0.050000000000000003 106.98 176.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -64.37 -64.73 3.41 Favored Glycine 0 N--CA 1.494 2.527 0 N-CA-C 110.497 -1.041 . . . . 0.029999999999999999 110.497 -179.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 45.1 62.6 2.06 Favored 'General case' 0 N--CA 1.508 2.447 0 O-C-N 121.508 -0.995 . . . . 3.2000000000000002 111.346 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 38.9 ptt180 -68.22 -7.5 30.92 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.588 -0.695 . . . . 2.9199999999999999 111.899 -179.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 905' ' ' HIS . . . . . 0.494 ' O ' ' CB ' ' C' ' 906' ' ' GLU . 74.5 t60 -63.34 7.86 0.09 Allowed 'General case' 0 N--CA 1.505 2.323 0 CA-C-O 117.604 -1.188 . . . . 2.8700000000000001 113.567 -179.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 906' ' ' GLU . . . . . 0.494 ' CB ' ' O ' ' C' ' 905' ' ' HIS . 0.8 OUTLIER 94.12 -164.29 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.474 0 CA-C-N 121.292 1.86 . . . . 0.98999999999999999 111.727 179.202 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 907' ' ' LYS . . . . . 0.477 ' CB ' ' O ' ' C' ' 906' ' ' GLU . 34.8 tttp 86.92 156.14 0.07 Allowed 'General case' 0 N--CA 1.519 3.002 0 N-CA-C 108.014 -1.106 . . . . 5.25 108.014 -176.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 60.1 t -122.58 116.11 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 120.835 -1.165 . . . . 0.39000000000000001 110.991 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -104.69 131.47 52.08 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 107.503 -1.295 . . . . 1.72 107.503 177.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -154.73 122.34 5.75 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 106.675 -1.602 . . . . 0.67000000000000004 106.675 178.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 911' ' ' VAL . . . . . 0.736 HG22 HG13 ' C' ' 964' ' ' VAL . 87.6 t -81.7 131.86 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.871 -0.518 . . . . 0.54000000000000004 110.975 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 52.8 mt -66.83 156.85 34.5 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.354 -0.841 . . . . 1.5 109.091 178.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 913' ' ' SER . . . . . 0.454 ' OG ' HG11 ' C' ' 919' ' ' VAL . 1.7 p -124.0 138.24 54.48 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.242 -1.021 . . . . 1.3700000000000001 108.242 177.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 914' ' ' ARG . . . . . 0.872 ' NH1' HD23 ' C' ' 956' ' ' LEU . 0.0 OUTLIER -64.79 153.2 40.66 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 120.624 -1.298 . . . . 4.2999999999999998 111.401 -179.112 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 915' ' ' SER . . . . . 0.426 ' CB ' ' O ' ' C' ' 914' ' ' ARG . 1.4 t 83.59 -30.55 0.08 Allowed 'General case' 0 N--CA 1.522 3.144 0 C-N-CA 123.853 0.861 . . . . 2.0499999999999998 112.199 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 916' ' ' ASN . . . . . 0.717 ' HB2' HG21 ' C' ' 919' ' ' VAL . 99.2 m-20 -122.18 -21.8 5.79 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 120.834 -1.166 . . . . 2.71 111.422 -179.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 67.04 167.22 0.23 Allowed 'General case' 0 N--CA 1.52 3.045 0 N-CA-C 105.845 -1.909 . . . . 2.6800000000000002 105.845 -174.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 53.83 -126.37 35.23 Favored Glycine 1 N--CA 1.523 4.437 0 CA-C-N 123.481 2.855 . . . . 0.029999999999999999 107.132 -177.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 919' ' ' VAL . . . . . 0.717 HG21 ' HB2' ' C' ' 916' ' ' ASN . 95.4 t 50.94 95.26 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 O-C-N 121.467 -1.019 . . . . 1.3899999999999999 109.425 -178.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 920' ' ' ALA . . . . . 0.956 ' HB3' HG12 ' C' ' 949' ' ' VAL . . . -93.05 93.03 8.1 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.27 -0.972 . . . . 0.029999999999999999 110.486 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 921' ' ' ARG . . . . . 0.846 ' HG3' HG23 ' C' ' 922' ' ' VAL . 44.5 ptt85 -83.19 -41.7 18.13 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 105.956 -1.868 . . . . 4.4199999999999999 105.956 176.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 922' ' ' VAL . . . . . 0.846 HG23 ' HG3' ' C' ' 921' ' ' ARG . 84.8 t -98.84 77.54 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 N-CA-C 105.712 -1.959 . . . . 0.84999999999999998 105.712 175.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -87.95 133.47 33.93 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.834 0.826 . . . . 2.46 111.755 -177.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 924' ' ' SER . . . . . 0.405 ' HB2' HD22 ' C' ' 900' ' ' LEU . 5.6 t -147.23 104.92 3.7 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.383 -0.969 . . . . 0.69999999999999996 108.383 178.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -103.14 89.72 0.72 Allowed Glycine 0 N--CA 1.486 1.978 0 N-CA-C 108.434 -1.866 . . . . 0.040000000000000001 108.434 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.219 0 N-CA-C 108.972 -1.651 . . . . 0.040000000000000001 108.972 -179.657 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 17.5 m . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 120.936 0.398 . . . . 13.779999999999999 110.348 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 92.3 mt -114.32 129.96 56.65 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.479 -0.763 . . . . 13.76 110.238 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -152.41 170.82 31.65 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.495 -1.442 . . . . 9.1300000000000008 109.495 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 949' ' ' VAL . . . . . 0.956 HG12 ' HB3' ' C' ' 920' ' ' ALA . 35.7 m -117.28 135.1 58.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.644 -0.915 . . . . 7.0800000000000001 110.947 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 950' ' ' PHE . . . . . 0.46 ' CZ ' ' HB3' ' C' ' 921' ' ' ARG . 42.6 p90 -133.61 150.62 51.6 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.603 -0.686 . . . . 7.5899999999999999 109.323 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 67.7 m -118.43 -55.77 2.19 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.385 -0.822 . . . . 5.0300000000000002 111.936 -178.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 952' ' ' LEU . . . . . 0.467 ' O ' ' O ' ' C' ' 953' ' ' ILE . 44.9 tp -64.83 -76.34 0.07 Allowed 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.39 -0.819 . . . . 1.01 111.512 -178.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 953' ' ' ILE . . . . . 0.593 HD12 ' HD3' ' C' ' 955' ' ' PRO . 2.1 pp -48.31 -151.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.78 0 N-CA-C 114.687 1.366 . . . . 2.6000000000000001 114.687 -176.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 954' ' ' LEU . . . . . 0.871 HD23 ' CE1' ' C' ' 894' ' ' TYR . 0.0 OUTLIER 173.57 90.43 0.06 OUTLIER Pre-proline 0 N--CA 1.516 2.864 0 O-C-N 120.567 -1.333 . . . . 0.050000000000000003 112.42 -179.385 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 955' ' ' PRO . . . . . 0.788 ' C ' HD12 ' C' ' 956' ' ' LEU . 53.8 Cg_endo -82.93 89.68 1.1 Allowed 'Trans proline' 0 C--N 1.316 -1.14 0 N-CA-C 109.182 -1.122 . . . . 0.83999999999999997 109.182 178.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 956' ' ' LEU . . . . . 0.872 HD23 ' NH1' ' C' ' 914' ' ' ARG . 9.9 mp -124.42 146.76 48.71 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.984 -1.073 . . . . 0.040000000000000001 110.406 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -83.44 152.08 25.16 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 117.691 -1.147 . . . . 1.28 111.569 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -66.97 118.5 10.52 Favored 'General case' 0 N--CA 1.507 2.41 0 CA-C-N 122.985 2.63 . . . . 0.17000000000000001 110.896 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.43 -19.82 47.98 Favored Glycine 0 N--CA 1.5 2.923 0 N-CA-C 111.032 -0.827 . . . . 0.040000000000000001 111.032 178.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 960' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -54.69 170.62 0.16 Allowed 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.283 -1.128 . . . . 0.040000000000000001 110.073 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 961' ' ' THR . . . . . 0.476 ' HA ' ' O ' ' C' ' 886' ' ' PHE . 31.2 m -136.67 140.1 42.48 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 120.877 -1.14 . . . . 1.78 112.836 -177.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 962' ' ' VAL . . . . . 0.908 HG22 ' HB3' ' C' ' 886' ' ' PHE . 33.1 m -98.96 145.84 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.988 0 O-C-N 121.681 -0.637 . . . . 0.040000000000000001 110.934 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 4.8 t -138.63 144.33 39.66 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.811 -0.556 . . . . 0.71999999999999997 109.996 -179.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 964' ' ' VAL . . . . . 0.736 HG13 HG22 ' C' ' 911' ' ' VAL . 59.7 t -94.95 135.81 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.024 -1.047 . . . . 1.05 110.77 -179.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -96.51 126.48 41.73 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 103.705 -2.702 . . . . 3.02 103.705 173.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 966' ' ' LEU . . . . . 0.493 ' C ' HG23 ' C' ' 967' ' ' VAL . 2.8 tt -132.21 63.32 1.62 Allowed 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.256 -1.016 . . . . 1.46 108.256 177.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 967' ' ' VAL . . . . . 0.493 HG23 ' C ' ' C' ' 966' ' ' LEU . 96.8 t -157.53 96.92 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.21 -1.033 . . . . 1.9399999999999999 108.21 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 93.2 mmm -142.37 59.45 1.45 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.742 -1.224 . . . . 0.0 108.316 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 134.73 119.47 1.95 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 107.173 -2.371 . . . . 2.1099999999999999 107.173 -178.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -82.4 -57.7 3.25 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.02 -1.283 . . . . 5.8899999999999997 110.607 -179.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 40.4 tp -58.66 90.12 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.471 -0.768 . . . . 4.3600000000000003 110.312 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -142.29 -153.18 0.45 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.578 -0.701 . . . . 1.8300000000000001 110.122 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 17.5 m80 -118.8 168.68 10.52 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.399 -0.813 . . . . 4.3499999999999996 110.075 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 28.9 t -101.42 130.94 47.73 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.534 -0.728 . . . . 1.27 109.918 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -156.31 157.91 36.54 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.452 -0.78 . . . . 5.0199999999999996 110.717 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.62 86.01 23.68 Favored Pre-proline 0 N--CA 1.5 2.071 0 O-C-N 121.667 -0.646 . . . . 2.4100000000000001 109.277 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.91 -170.15 0.66 Allowed 'Trans proline' 0 C--N 1.318 -1.046 0 O-C-N 123.416 1.219 . . . . 0.95999999999999996 111.49 -179.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 978' ' ' LEU . . . . . 0.786 ' HG ' HD12 ' C' ' 856' ' ' LEU . 6.2 tt -126.43 152.12 46.81 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 107.889 -1.152 . . . . 0.62 107.889 178.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 979' ' ' THR . . . . . 0.464 HG23 ' C ' ' C' ' 978' ' ' LEU . 47.6 p -150.87 139.42 20.57 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.73 -1.231 . . . . 3.5699999999999998 111.084 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 980' ' ' ILE . . . . . 0.73 ' HB ' HG21 ' C' ' 899' ' ' VAL . 51.2 mm -106.39 129.48 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 N-CA-C 109.213 -0.662 . . . . 1.3300000000000001 109.213 179.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 981' ' ' PHE . . . . . 0.451 ' CD1' ' CE2' ' C' ' 879' ' ' TYR . 4.7 t80 -118.35 95.25 4.79 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 119.703 -0.799 . . . . 0.050000000000000003 111.635 -178.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 982' ' ' SER . . . . . 0.505 ' HB2' HD23 ' A' ' 952' ' ' LEU . 23.1 p -107.85 158.88 16.96 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 109.164 -0.68 . . . . 0.87 109.164 178.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 983' ' ' GLY . . . . . 0.413 ' O ' ' CZ ' ' C' ' 852' ' ' PHE . . . -170.85 115.23 0.57 Allowed Glycine 0 N--CA 1.497 2.745 0 N-CA-C 106.701 -2.56 . . . . 0.029999999999999999 106.701 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 984' ' ' ALA . . . . . 0.465 ' HB1' ' CZ ' ' A' ' 893' ' ' ARG . . . -108.31 150.34 27.46 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 114.352 1.241 . . . . 0.69999999999999996 114.352 -175.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 985' ' ' LEU . . . . . 0.633 HD13 HD22 ' C' ' 890' ' ' LEU . 53.5 tp -76.42 135.5 39.44 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.833 -1.167 . . . . 0.040000000000000001 109.637 179.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 986' ' ' LEU . . . . . 0.568 HD11 HD11 ' B' ' 986' ' ' LEU . 42.1 tp -106.98 -60.44 1.67 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.402 -0.811 . . . . 0.040000000000000001 110.304 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 57.7 t80 -142.81 146.73 34.47 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 107.698 -1.223 . . . . 0.040000000000000001 107.698 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.3 163.22 12.2 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 108.395 -1.882 . . . . 0.040000000000000001 108.395 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -75.65 112.85 21.63 Favored Pre-proline 0 N--CA 1.498 1.943 0 O-C-N 121.246 -1.15 . . . . 0.040000000000000001 109.59 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 990' ' ' PRO . . . . . 0.418 ' O ' ' HB2' ' C' ' 991' ' ' GLU . 50.6 Cg_endo -89.58 71.47 1.82 Allowed 'Trans proline' 0 C--N 1.32 -0.961 0 O-C-N 123.106 1.056 . . . . 0.45000000000000001 111.537 -179.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 991' ' ' GLU . . . . . 0.418 ' HB2' ' O ' ' C' ' 990' ' ' PRO . 66.0 mt-10 67.49 -73.29 0.08 Allowed 'General case' 0 N--CA 1.503 2.209 0 N-CA-C 108.593 -0.891 . . . . 1.97 108.593 -177.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 992' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' C' ' 992' ' ' LEU . 11.1 mt 50.65 20.82 0.78 Allowed 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.592 -0.693 . . . . 2.3799999999999999 111.709 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -92.99 156.92 16.59 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.899 -1.126 . . . . 3.79 110.07 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 67.0 m80 -145.93 92.2 2.18 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.537 -0.727 . . . . 3.5099999999999998 110.265 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 995' ' ' ALA . . . . . . . . . . . . 2.517 . . . . . . . 0 N--CA 1.503 2.221 0 O-C-N 120.931 -1.106 . . . . 2.73 110.586 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo . . . . . 0 N--CA 1.488 1.162 0 N-CA-C 109.506 -0.998 . . . . 3.8300000000000001 109.506 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 847' ' ' VAL . . . . . 0.416 HG12 ' HB2' ' A' ' 849' ' ' GLN . 59.9 t -133.0 102.92 13.09 Favored Pre-proline 0 N--CA 1.496 1.835 0 O-C-N 121.603 -0.686 . . . . 1.8300000000000001 110.079 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 848' ' ' PRO . . . . . 0.756 ' O ' HG23 ' A' ' 850' ' ' VAL . 43.7 Cg_endo -69.82 -19.87 35.27 Favored 'Trans proline' 0 N--CA 1.487 1.125 0 O-C-N 123.274 1.144 . . . . 0.65000000000000002 111.028 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 849' ' ' GLN . . . . . 0.416 ' HB2' HG12 ' A' ' 847' ' ' VAL . 56.0 tt0 27.83 68.85 0.07 Allowed 'General case' 0 N--CA 1.518 2.968 0 N-CA-C 112.861 0.689 . . . . 2.5800000000000001 112.861 179.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 850' ' ' VAL . . . . . 0.756 HG23 ' O ' ' A' ' 848' ' ' PRO . 83.9 t -119.66 137.26 54.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 121.151 -0.968 . . . . 1.0900000000000001 111.603 -178.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 851' ' ' ALA . . . . . 0.477 ' HB3' ' HG ' ' A' ' 873' ' ' LEU . . . -126.99 158.52 36.68 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 105.876 -1.898 . . . . 0.040000000000000001 105.876 176.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 852' ' ' PHE . . . . . 0.436 ' HA ' ' CB ' ' A' ' 874' ' ' ASN . 46.6 p90 -157.59 131.97 8.38 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 120.989 1.722 . . . . 0.050000000000000003 108.613 178.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 19.5 t -175.03 132.84 0.32 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.07 -1.085 . . . . 0.040000000000000001 108.07 -178.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -135.41 153.1 51.91 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.173 -0.955 . . . . 0.67000000000000004 109.182 179.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 855' ' ' ALA . . . . . 0.701 ' HB3' ' CB ' ' A' ' 870' ' ' ARG . . . -124.24 140.11 53.27 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.942 0.877 . . . . 0.51000000000000001 111.689 -178.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 856' ' ' LEU . . . . . 0.815 HD11 HD23 ' A' ' 858' ' ' LEU . 3.3 tm? -106.8 137.46 44.8 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 109.366 -0.605 . . . . 0.050000000000000003 109.366 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 857' ' ' SER . . . . . 0.686 ' N ' HD13 ' A' ' 856' ' ' LEU . 1.3 m -155.02 15.43 0.41 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.323 -0.861 . . . . 1.3300000000000001 111.697 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 858' ' ' LEU . . . . . 0.815 HD23 HD11 ' A' ' 856' ' ' LEU . 3.0 pp -34.29 159.91 0.04 OUTLIER Pre-proline 0 N--CA 1.518 2.942 0 N-CA-C 113.088 0.773 . . . . 2.3300000000000001 113.088 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -60.87 -88.59 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 120.898 1.066 . . . . 2.3199999999999998 113.686 -177.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 54.3 ptt85 -126.19 -142.77 0.29 Allowed 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.902 -1.124 . . . . 0.040000000000000001 111.575 -177.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 75.1 m -38.53 126.22 1.42 Allowed 'General case' 0 N--CA 1.509 2.507 0 O-C-N 121.63 -0.668 . . . . 1.3100000000000001 112.148 -178.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 862' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -101.3 161.15 24.51 Favored Pre-proline 0 N--CA 1.489 1.512 0 N-CA-C 108.579 -0.897 . . . . 4.5099999999999998 108.579 178.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -71.09 -15.34 32.18 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 O-C-N 123.251 1.132 . . . . 2.2400000000000002 111.65 -179.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -177.4 -136.5 2.48 Favored Glycine 0 N--CA 1.495 2.577 0 C-N-CA 119.541 -1.314 . . . . 0.040000000000000001 110.838 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 865' ' ' THR . . . . . 0.433 HG22 ' N ' ' A' ' 866' ' ' VAL . 41.1 m -61.69 162.84 7.97 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.479 -1.012 . . . . 1.51 111.362 -178.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 866' ' ' VAL . . . . . 0.433 ' N ' HG22 ' A' ' 865' ' ' THR . 0.1 OUTLIER -97.12 127.01 40.09 Favored Pre-proline 0 N--CA 1.504 2.237 0 N-CA-C 113.042 0.756 . . . . 0.78000000000000003 113.042 -174.41 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 867' ' ' PRO . . . . . 0.803 ' O ' HD23 ' A' ' 856' ' ' LEU . 54.1 Cg_endo -90.64 -153.18 0.04 OUTLIER 'Trans proline' 0 CA--C 1.54 0.787 0 N-CA-C 108.63 -1.335 . . . . 0.92000000000000004 108.63 177.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 868' ' ' PHE . . . . . 0.468 ' CD1' ' HG2' ' A' ' 881' ' ' PRO . 24.3 p90 -149.93 122.77 8.71 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 120.523 -1.361 . . . . 0.050000000000000003 110.247 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 49.6 p-10 -112.91 -3.19 14.14 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 119.442 -0.903 . . . . 1.7 112.083 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 870' ' ' ARG . . . . . 0.701 ' CB ' ' HB3' ' A' ' 855' ' ' ALA . 29.4 mmm180 -90.58 89.29 7.48 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.947 -1.096 . . . . 2.5899999999999999 110.675 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 58.1 t -73.13 97.16 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 120.975 -1.078 . . . . 1.9399999999999999 110.091 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 872' ' ' LEU . . . . . . . . . . . . . 96.1 mt -83.13 -47.28 11.8 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.498 -0.751 . . . . 1.0600000000000001 110.099 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 873' ' ' LEU . . . . . 0.477 ' HG ' ' HB3' ' A' ' 851' ' ' ALA . 43.0 tp -175.06 104.47 0.09 Allowed 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.308 -0.87 . . . . 4.1799999999999997 108.706 178.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 874' ' ' ASN . . . . . 0.436 ' CB ' ' HA ' ' A' ' 852' ' ' PHE . 35.0 t-20 178.33 81.9 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.336 0 O-C-N 121.6 -0.687 . . . . 0.040000000000000001 109.521 -178.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -66.85 -47.33 72.27 Favored 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 119.291 -0.964 . . . . 3.3799999999999999 111.334 -179.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 876' ' ' GLY . . . . . 0.414 ' HA3' ' CE2' ' A' ' 878' ' ' TYR . . . -74.51 -25.19 70.87 Favored Glycine 0 N--CA 1.495 2.568 0 O-C-N 121.22 -0.925 . . . . 0.040000000000000001 111.777 -178.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 81.88 -62.09 4.58 Favored Glycine 0 N--CA 1.502 3.09 0 N-CA-C 107.974 -2.05 . . . . 0.040000000000000001 107.974 -178.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 878' ' ' TYR . . . . . 0.414 ' CE2' ' HA3' ' A' ' 876' ' ' GLY . 95.6 m-85 61.5 -60.27 0.1 Allowed 'General case' 0 N--CA 1.504 2.236 0 N-CA-C 114.498 1.296 . . . . 3.46 114.498 177.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 879' ' ' TYR . . . . . 0.475 ' CB ' ' CD2' ' A' ' 886' ' ' PHE . 21.3 p90 -111.73 108.96 18.57 Favored 'General case' 0 N--CA 1.501 2.102 0 N-CA-C 114.66 1.356 . . . . 0.040000000000000001 114.66 -176.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -66.55 117.85 48.33 Favored Pre-proline 0 N--CA 1.497 1.899 0 O-C-N 121.403 -0.811 . . . . 0.02 109.911 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 881' ' ' PRO . . . . . 0.468 ' HG2' ' CD1' ' A' ' 868' ' ' PHE . 52.8 Cg_endo -77.15 -0.33 10.48 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 O-C-N 123.42 1.221 . . . . 0.39000000000000001 112.275 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -75.92 -62.91 1.43 Allowed 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 106.62 -1.622 . . . . 0.81000000000000005 106.62 178.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 19.5 p -94.44 -19.53 20.5 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.659 -0.867 . . . . 0.040000000000000001 108.659 177.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.43 20.83 57.93 Favored Glycine 0 N--CA 1.497 2.731 0 O-C-N 121.154 -0.966 . . . . 0.029999999999999999 111.035 178.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 885' ' ' VAL . . . . . 0.737 HG13 HG21 ' A' ' 961' ' ' THR . 97.7 t -73.0 90.0 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 C-N-CA 118.261 -1.376 . . . . 1.01 108.132 -179.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 886' ' ' PHE . . . . . 0.928 ' HB3' HG22 ' A' ' 962' ' ' VAL . 0.8 OUTLIER -89.31 104.04 16.62 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-N 115.298 -0.864 . . . . 0.050000000000000003 111.825 -177.555 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 887' ' ' THR . . . . . 0.422 ' O ' ' HD3' ' A' ' 889' ' ' PRO . 93.1 m -95.26 100.69 12.44 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 107.826 -1.175 . . . . 0.68000000000000005 107.826 177.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 888' ' ' ALA . . . . . . . . . . . . . . . -98.4 106.99 39.49 Favored Pre-proline 0 N--CA 1.502 2.153 0 N-CA-C 114.009 1.114 . . . . 0.25 114.009 -176.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 889' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 887' ' ' THR . 53.6 Cg_endo -89.84 -12.67 2.86 Favored 'Trans proline' 0 CA--C 1.546 1.122 0 C-N-CA 121.055 1.17 . . . . 1.6399999999999999 109.111 176.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 890' ' ' LEU . . . . . 0.934 HD22 HD13 ' A' ' 985' ' ' LEU . 72.9 mt -36.59 -50.31 0.8 Allowed 'General case' 0 N--CA 1.509 2.479 0 N-CA-C 113.636 0.976 . . . . 2.29 113.636 -177.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 52.19 95.85 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.295 0 O-C-N 121.156 -0.965 . . . . 0.63 110.238 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 157.85 -153.33 24.54 Favored Glycine 0 N--CA 1.478 1.456 0 N-CA-C 107.234 -2.347 . . . . 0.040000000000000001 107.234 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 893' ' ' ARG . . . . . 0.459 ' CZ ' ' HB1' ' C' ' 984' ' ' ALA . 73.2 ttt-85 -115.53 126.3 54.09 Favored 'General case' 0 C--N 1.295 -1.785 0 O-C-N 121.533 -0.981 . . . . 3.0 108.552 177.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 894' ' ' TYR . . . . . 0.77 ' OH ' HD12 ' A' ' 896' ' ' LEU . 0.1 OUTLIER -132.87 160.09 37.97 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.083 -1.011 . . . . 0.040000000000000001 111.083 -179.703 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 895' ' ' LEU . . . . . 0.836 HD23 HD11 ' B' ' 952' ' ' LEU . 36.0 tp -91.73 119.45 31.59 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.728 -0.607 . . . . 1.27 110.1 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 896' ' ' LEU . . . . . 0.77 HD12 ' OH ' ' A' ' 894' ' ' TYR . 9.2 tt -109.69 144.31 38.25 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.7 -0.625 . . . . 0.93999999999999995 110.155 -179.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 897' ' ' SER . . . . . 0.489 ' N ' HD23 ' A' ' 896' ' ' LEU . 69.5 m -149.95 114.8 5.33 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.49 -0.756 . . . . 0.040000000000000001 111.007 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -106.96 146.84 30.57 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 108.912 -0.773 . . . . 0.47999999999999998 108.912 178.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 899' ' ' VAL . . . . . 0.754 HG21 ' HB ' ' A' ' 980' ' ' ILE . 88.2 t -96.45 119.13 44.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 C-N-CA 119.59 -0.844 . . . . 0.55000000000000004 111.255 -179.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 900' ' ' LEU . . . . . 0.488 HD12 ' HB2' ' A' ' 924' ' ' SER . 4.5 mm? -95.75 111.18 23.2 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 114.036 1.124 . . . . 1.5900000000000001 114.036 -175.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 18.3 m -64.52 140.19 58.84 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 107.458 -1.312 . . . . 0.050000000000000003 107.458 177.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -63.09 -66.62 2.46 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 110.429 -1.068 . . . . 0.029999999999999999 110.429 -179.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 4.1 m170 46.93 66.9 0.88 Allowed 'General case' 0 N--CA 1.507 2.398 0 O-C-N 121.495 -1.003 . . . . 3.2000000000000002 110.991 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 35.0 ptt180 -68.5 -7.17 29.84 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.581 -0.699 . . . . 2.9199999999999999 111.937 -179.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 905' ' ' HIS . . . . . 0.489 ' O ' ' CB ' ' A' ' 906' ' ' GLU . 67.0 t60 -63.55 4.54 0.24 Allowed 'General case' 0 N--CA 1.504 2.272 0 O-C-N 120.942 -1.099 . . . . 2.8700000000000001 112.843 -179.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 906' ' ' GLU . . . . . 0.489 ' CB ' ' O ' ' A' ' 905' ' ' HIS . 0.8 OUTLIER 94.7 -162.95 0.0 OUTLIER 'General case' 0 N--CA 1.53 3.552 0 CA-C-N 120.729 1.604 . . . . 0.98999999999999999 112.218 178.752 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 907' ' ' LYS . . . . . 0.492 ' HE2' ' HB1' ' A' ' 972' ' ' ALA . 94.1 mttt 89.27 159.71 0.05 Allowed 'General case' 0 N--CA 1.522 3.162 0 N-CA-C 107.862 -1.162 . . . . 5.25 107.862 -176.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 58.6 t -122.29 116.37 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 120.882 -1.137 . . . . 0.39000000000000001 110.91 -179.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 909' ' ' GLU . . . . . 0.685 ' OE2' HD12 ' A' ' 966' ' ' LEU . 48.9 tp10 -100.78 132.89 45.96 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.513 -1.292 . . . . 1.72 107.513 176.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -156.99 121.95 4.54 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 106.988 -1.486 . . . . 0.67000000000000004 106.988 178.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 911' ' ' VAL . . . . . 0.723 HG22 HG13 ' A' ' 964' ' ' VAL . 95.3 t -85.08 131.85 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.85 -0.532 . . . . 0.54000000000000004 111.076 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 73.0 mt -65.76 157.66 29.69 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.432 -0.792 . . . . 1.5 109.011 178.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 913' ' ' SER . . . . . 0.409 ' CB ' ' HB ' ' A' ' 919' ' ' VAL . 2.6 t -124.1 136.61 54.35 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.266 -1.013 . . . . 1.3700000000000001 108.266 177.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 914' ' ' ARG . . . . . 0.685 ' NH1' HD23 ' A' ' 956' ' ' LEU . 0.0 OUTLIER -65.07 154.53 37.58 Favored 'General case' 0 N--CA 1.505 2.294 0 O-C-N 120.612 -1.305 . . . . 4.2999999999999998 111.357 -179.186 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 915' ' ' SER . . . . . 0.427 ' CB ' ' O ' ' A' ' 914' ' ' ARG . 4.3 t 83.14 -31.61 0.08 Allowed 'General case' 0 N--CA 1.521 3.124 0 C-N-CA 123.853 0.861 . . . . 2.0499999999999998 112.089 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 916' ' ' ASN . . . . . 0.743 ' HB2' HG21 ' A' ' 919' ' ' VAL . 91.0 m-20 -123.61 -21.48 5.23 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 120.85 -1.157 . . . . 2.71 111.274 -179.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 917' ' ' GLN . . . . . 0.438 ' HB2' ' O ' ' A' ' 916' ' ' ASN . 44.4 mt-30 65.84 166.45 0.19 Allowed 'General case' 0 N--CA 1.519 2.984 0 N-CA-C 105.957 -1.868 . . . . 2.6800000000000002 105.957 -173.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.54 -125.62 35.0 Favored Glycine 1 N--CA 1.521 4.356 0 CA-C-N 123.382 2.81 . . . . 0.029999999999999999 106.78 -177.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 919' ' ' VAL . . . . . 0.743 HG21 ' HB2' ' A' ' 916' ' ' ASN . 71.8 t 52.47 93.58 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.241 0 O-C-N 121.31 -1.112 . . . . 1.3899999999999999 108.74 -178.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 920' ' ' ALA . . . . . 0.802 ' HB3' HG12 ' A' ' 949' ' ' VAL . . . -91.14 90.96 8.03 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.219 -0.993 . . . . 0.029999999999999999 110.956 -178.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 921' ' ' ARG . . . . . 0.834 ' HG3' HG23 ' A' ' 922' ' ' VAL . 30.2 ptt180 -86.17 -41.88 14.32 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 105.831 -1.914 . . . . 4.4199999999999999 105.831 175.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 922' ' ' VAL . . . . . 0.834 HG23 ' HG3' ' A' ' 921' ' ' ARG . 85.0 t -103.97 67.45 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 105.979 -1.86 . . . . 0.84999999999999998 105.979 175.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 923' ' ' ASP . . . . . 0.719 ' HB2' ' HB1' ' A' ' 920' ' ' ALA . 22.5 t0 -89.83 134.64 34.08 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.709 0.766 . . . . 2.46 111.655 -177.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 924' ' ' SER . . . . . 0.488 ' HB2' HD12 ' A' ' 900' ' ' LEU . 8.5 t -147.18 103.27 3.57 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.477 -0.935 . . . . 0.69999999999999996 108.477 178.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -109.59 90.28 0.59 Allowed Glycine 0 N--CA 1.487 2.063 0 N-CA-C 108.411 -1.875 . . . . 0.040000000000000001 108.411 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.352 0 N-CA-C 109.435 -1.466 . . . . 0.040000000000000001 109.435 -179.186 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 29.5 m . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 120.995 0.426 . . . . 13.779999999999999 110.341 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 95.2 mt -113.03 129.99 56.31 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.492 -0.755 . . . . 13.76 110.455 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -151.91 168.11 31.18 Favored Glycine 0 N--CA 1.493 2.487 0 N-CA-C 109.197 -1.561 . . . . 9.1300000000000008 109.197 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 949' ' ' VAL . . . . . 0.802 HG12 ' HB3' ' A' ' 920' ' ' ALA . 27.2 m -119.02 128.87 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 121.532 -0.981 . . . . 7.0800000000000001 110.78 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 950' ' ' PHE . . . . . 0.463 ' CE1' ' HD2' ' A' ' 955' ' ' PRO . 26.2 p90 -131.76 148.13 52.55 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.559 -0.713 . . . . 7.5899999999999999 109.487 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 19.8 m -121.26 -52.06 2.07 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.358 -0.838 . . . . 5.0300000000000002 112.169 -178.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 952' ' ' LEU . . . . . 0.426 ' O ' ' O ' ' A' ' 953' ' ' ILE . 53.8 tp -59.75 -75.1 0.06 Allowed 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.41 -0.806 . . . . 1.01 112.557 -177.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 953' ' ' ILE . . . . . 0.482 HD11 HD13 ' C' ' 872' ' ' LEU . 43.3 pt -52.34 -143.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.784 0 N-CA-C 114.177 1.177 . . . . 2.6000000000000001 114.177 -176.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 954' ' ' LEU . . . . . 0.725 HD22 ' O ' ' A' ' 954' ' ' LEU . 0.0 OUTLIER 174.07 77.2 0.05 OUTLIER Pre-proline 0 N--CA 1.506 2.367 0 O-C-N 120.671 -1.268 . . . . 0.050000000000000003 111.291 179.929 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 955' ' ' PRO . . . . . 0.746 ' C ' HD12 ' A' ' 956' ' ' LEU . 48.9 Cg_endo -76.66 91.73 1.13 Allowed 'Trans proline' 0 C--N 1.314 -1.238 0 N-CA-C 109.614 -0.956 . . . . 0.83999999999999997 109.614 178.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 956' ' ' LEU . . . . . 0.746 HD12 ' C ' ' A' ' 955' ' ' PRO . 11.1 mp -121.98 146.14 47.44 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.225 -0.922 . . . . 0.040000000000000001 109.818 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -84.44 150.74 25.1 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 117.831 -1.081 . . . . 1.28 111.876 -178.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -70.2 120.24 15.58 Favored 'General case' 0 N--CA 1.51 2.525 0 CA-C-N 122.788 2.54 . . . . 0.17000000000000001 111.74 -179.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.51 -22.63 31.99 Favored Glycine 0 N--CA 1.5 2.907 0 N-CA-C 111.122 -0.791 . . . . 0.040000000000000001 111.122 178.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 960' ' ' ASP . . . . . 0.451 ' HB3' ' NE ' ' A' ' 914' ' ' ARG . 0.4 OUTLIER -55.38 171.9 0.16 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.451 -1.029 . . . . 0.040000000000000001 110.006 -179.567 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 961' ' ' THR . . . . . 0.737 HG21 HG13 ' A' ' 885' ' ' VAL . 41.5 m -135.06 135.43 41.26 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.879 -1.138 . . . . 1.78 111.884 -178.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 962' ' ' VAL . . . . . 0.928 HG22 ' HB3' ' A' ' 886' ' ' PHE . 32.7 m -97.79 145.92 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 C-N-CA 120.094 -0.642 . . . . 0.040000000000000001 110.138 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 5.6 t -138.5 145.98 41.43 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.852 -0.53 . . . . 0.71999999999999997 110.329 -178.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 964' ' ' VAL . . . . . 0.723 HG13 HG22 ' A' ' 911' ' ' VAL . 59.2 t -94.37 137.37 23.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.258 -0.901 . . . . 1.05 110.459 -179.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -93.28 127.54 38.91 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 103.791 -2.67 . . . . 3.02 103.791 173.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 966' ' ' LEU . . . . . 0.685 HD12 ' OE2' ' A' ' 909' ' ' GLU . 0.2 OUTLIER -132.81 60.0 1.71 Allowed 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.35 -0.981 . . . . 1.46 108.35 177.309 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 967' ' ' VAL . . . . . 0.49 HG23 ' C ' ' A' ' 966' ' ' LEU . 98.5 t -157.96 96.88 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 N-CA-C 108.049 -1.093 . . . . 1.9399999999999999 108.049 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 92.2 mmm -142.65 60.44 1.43 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.725 -1.234 . . . . 0.0 108.434 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.59 120.48 2.01 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 107.203 -2.359 . . . . 2.1099999999999999 107.203 -178.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -82.06 -59.88 2.41 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 118.76 1.28 . . . . 5.8899999999999997 110.189 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 50.9 tp -59.81 90.95 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.44 -0.787 . . . . 4.3600000000000003 109.894 179.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 972' ' ' ALA . . . . . 0.492 ' HB1' ' HE2' ' A' ' 907' ' ' LYS . . . -141.41 -154.62 0.53 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.571 -0.706 . . . . 1.8300000000000001 110.39 -179.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -118.8 171.27 8.33 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.471 -0.768 . . . . 4.3499999999999996 110.221 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 34.3 t -101.6 130.23 47.88 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.588 -0.695 . . . . 1.27 110.039 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -156.11 157.05 35.36 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.549 -0.719 . . . . 5.0199999999999996 110.485 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.07 85.74 18.67 Favored Pre-proline 0 N--CA 1.5 2.068 0 O-C-N 121.6 -0.688 . . . . 2.4100000000000001 109.721 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.37 -172.33 1.02 Allowed 'Trans proline' 0 C--N 1.318 -1.068 0 O-C-N 123.313 1.165 . . . . 0.95999999999999996 111.345 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 978' ' ' LEU . . . . . 0.668 HD23 HD12 ' A' ' 856' ' ' LEU . 4.9 mp -127.7 154.44 45.31 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 107.691 -1.226 . . . . 0.62 107.691 178.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 979' ' ' THR . . . . . 0.464 HG23 ' C ' ' A' ' 978' ' ' LEU . 41.4 p -150.18 140.94 22.7 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.696 -1.253 . . . . 3.5699999999999998 111.14 -179.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 980' ' ' ILE . . . . . 0.754 ' HB ' HG21 ' A' ' 899' ' ' VAL . 46.3 mm -107.32 128.98 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 109.022 -0.733 . . . . 1.3300000000000001 109.022 179.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 981' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -118.95 95.16 4.71 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 119.804 -0.759 . . . . 0.050000000000000003 111.797 -178.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 82.9 p -107.93 157.96 17.76 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.545 -0.722 . . . . 0.87 109.192 178.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 983' ' ' GLY . . . . . 0.404 ' HA3' ' CE1' ' A' ' 852' ' ' PHE . . . -174.75 110.46 0.32 Allowed Glycine 0 N--CA 1.499 2.888 0 N-CA-C 106.356 -2.698 . . . . 0.029999999999999999 106.356 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -108.22 150.87 26.7 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 114.526 1.306 . . . . 0.69999999999999996 114.526 -175.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 985' ' ' LEU . . . . . 0.934 HD13 HD22 ' A' ' 890' ' ' LEU . 33.1 tp -72.29 135.06 45.87 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.822 -1.174 . . . . 0.040000000000000001 110.07 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 51.8 tp -107.47 -55.8 2.3 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.595 -0.691 . . . . 0.040000000000000001 110.06 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -144.57 145.76 31.98 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 107.668 -1.234 . . . . 0.040000000000000001 107.668 179.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.6 163.32 12.17 Favored Glycine 0 N--CA 1.495 2.633 0 N-CA-C 108.232 -1.947 . . . . 0.040000000000000001 108.232 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -75.26 112.46 18.66 Favored Pre-proline 0 N--CA 1.499 1.989 0 O-C-N 121.195 -1.179 . . . . 0.040000000000000001 109.463 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 990' ' ' PRO . . . . . 0.418 ' HD2' HD12 ' A' ' 992' ' ' LEU . 50.2 Cg_endo -90.53 70.79 1.39 Allowed 'Trans proline' 0 C--N 1.319 -1.023 0 O-C-N 123.151 1.079 . . . . 0.45000000000000001 111.565 -178.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 991' ' ' GLU . . . . . 0.417 ' HB2' ' O ' ' A' ' 990' ' ' PRO . 69.2 mt-10 67.28 -73.86 0.07 Allowed 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 108.586 -0.894 . . . . 1.97 108.586 -177.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 992' ' ' LEU . . . . . 0.418 HD12 ' HD2' ' A' ' 990' ' ' PRO . 11.0 mt 51.01 20.79 0.86 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.541 -0.724 . . . . 2.3799999999999999 111.641 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -94.11 156.89 16.34 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.818 -1.176 . . . . 3.79 109.993 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 72.2 m80 -146.63 93.49 2.3 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.588 -0.695 . . . . 3.5099999999999998 110.309 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 995' ' ' ALA . . . . . . . . . . . . 2.518 . . . . . . . 0 N--CA 1.503 2.224 0 O-C-N 120.868 -1.145 . . . . 2.73 110.572 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo . . . . . 0 N--CA 1.488 1.156 0 N-CA-C 109.5 -1.0 . . . . 3.8300000000000001 109.5 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 847' ' ' VAL . . . . . 0.401 HG12 ' HB2' ' B' ' 849' ' ' GLN . 60.0 t -133.07 102.87 13.03 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.567 -0.708 . . . . 1.8300000000000001 110.139 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 848' ' ' PRO . . . . . 0.758 ' O ' HG23 ' B' ' 850' ' ' VAL . 43.6 Cg_endo -69.7 -20.16 35.48 Favored 'Trans proline' 0 N--CA 1.487 1.092 0 O-C-N 123.235 1.124 . . . . 0.65000000000000002 111.033 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 849' ' ' GLN . . . . . 0.405 ' C ' ' O ' ' B' ' 848' ' ' PRO . 56.1 tt0 28.0 69.1 0.07 Allowed 'General case' 0 N--CA 1.519 2.989 0 N-CA-C 112.768 0.655 . . . . 2.5800000000000001 112.768 179.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 850' ' ' VAL . . . . . 0.758 HG23 ' O ' ' B' ' 848' ' ' PRO . 83.1 t -119.85 137.34 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.213 -0.93 . . . . 1.0900000000000001 111.623 -178.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 851' ' ' ALA . . . . . 0.488 ' HB3' ' HG ' ' B' ' 873' ' ' LEU . . . -127.52 157.67 39.5 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 105.907 -1.886 . . . . 0.040000000000000001 105.907 176.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 852' ' ' PHE . . . . . 0.432 ' HA ' ' CB ' ' B' ' 874' ' ' ASN . 46.4 p90 -156.63 132.43 9.58 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-N 121.04 1.745 . . . . 0.050000000000000003 108.541 179.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 20.8 t -175.11 132.59 0.31 Allowed 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.14 -1.059 . . . . 0.040000000000000001 108.14 -179.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -135.1 153.46 52.01 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.125 -0.985 . . . . 0.67000000000000004 109.211 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 855' ' ' ALA . . . . . 0.714 ' HB3' ' CB ' ' B' ' 870' ' ' ARG . . . -124.75 140.23 53.12 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.994 0.902 . . . . 0.51000000000000001 111.685 -178.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 856' ' ' LEU . . . . . 0.828 HD11 HD23 ' B' ' 858' ' ' LEU . 3.3 tm? -107.04 137.05 45.84 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 109.391 -0.596 . . . . 0.050000000000000003 109.391 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 857' ' ' SER . . . . . 0.683 ' N ' HD13 ' B' ' 856' ' ' LEU . 1.3 m -154.63 15.5 0.44 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.442 -0.786 . . . . 1.3300000000000001 111.712 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 858' ' ' LEU . . . . . 0.828 HD23 HD11 ' B' ' 856' ' ' LEU . 3.1 pp -34.32 159.98 0.04 OUTLIER Pre-proline 0 N--CA 1.518 2.956 0 N-CA-C 113.064 0.765 . . . . 2.3300000000000001 113.064 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -61.04 -88.58 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 120.9 1.067 . . . . 2.3199999999999998 113.661 -177.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 54.2 ptt85 -126.28 -142.8 0.29 Allowed 'General case' 0 N--CA 1.5 2.052 0 O-C-N 120.893 -1.129 . . . . 0.040000000000000001 111.551 -177.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 75.3 m -38.41 125.51 1.35 Allowed 'General case' 0 N--CA 1.51 2.538 0 O-C-N 121.597 -0.69 . . . . 1.3100000000000001 112.178 -178.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 862' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -100.59 161.18 24.78 Favored Pre-proline 0 N--CA 1.488 1.451 0 N-CA-C 108.557 -0.905 . . . . 4.5099999999999998 108.557 178.026 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -71.1 -15.29 32.15 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 O-C-N 123.248 1.13 . . . . 2.2400000000000002 111.73 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -177.15 -135.8 2.29 Favored Glycine 0 N--CA 1.495 2.599 0 C-N-CA 119.549 -1.31 . . . . 0.040000000000000001 110.807 179.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 865' ' ' THR . . . . . 0.446 HG22 ' N ' ' B' ' 866' ' ' VAL . 42.0 m -62.31 163.94 7.78 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.415 -1.05 . . . . 1.51 111.288 -178.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 866' ' ' VAL . . . . . 0.446 ' N ' HG22 ' B' ' 865' ' ' THR . 0.1 OUTLIER -98.09 127.03 38.07 Favored Pre-proline 0 N--CA 1.504 2.271 0 C-N-CA 119.796 -0.762 . . . . 0.78000000000000003 112.965 -174.464 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 867' ' ' PRO . . . . . 0.807 ' O ' HD23 ' B' ' 856' ' ' LEU . 53.6 Cg_endo -90.6 -153.25 0.04 OUTLIER 'Trans proline' 0 CA--C 1.54 0.789 0 N-CA-C 108.614 -1.341 . . . . 0.92000000000000004 108.614 177.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 868' ' ' PHE . . . . . 0.462 ' CD1' ' HG2' ' B' ' 881' ' ' PRO . 24.4 p90 -149.95 122.56 8.58 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.529 -1.357 . . . . 0.050000000000000003 110.199 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 50.0 p-10 -112.64 -2.76 14.46 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 119.476 -0.89 . . . . 1.7 112.133 -179.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 870' ' ' ARG . . . . . 0.714 ' CB ' ' HB3' ' B' ' 855' ' ' ALA . 28.8 mmm180 -91.07 89.15 7.27 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.925 -1.109 . . . . 2.5899999999999999 110.694 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 57.3 t -73.05 97.31 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.012 -1.055 . . . . 1.9399999999999999 110.063 -179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 872' ' ' LEU . . . . . 0.532 HD22 HD11 ' C' ' 953' ' ' ILE . 96.0 mt -83.27 -47.11 11.87 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.496 -0.752 . . . . 1.0600000000000001 110.067 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 873' ' ' LEU . . . . . 0.488 ' HG ' ' HB3' ' B' ' 851' ' ' ALA . 43.0 tp -175.15 104.43 0.09 Allowed 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 108.709 -0.849 . . . . 4.1799999999999997 108.709 178.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 874' ' ' ASN . . . . . 0.432 ' CB ' ' HA ' ' B' ' 852' ' ' PHE . 34.8 t-20 178.37 81.99 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.626 -0.671 . . . . 0.040000000000000001 109.581 -178.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -66.96 -47.34 71.88 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 119.325 -0.95 . . . . 3.3799999999999999 111.327 -179.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 876' ' ' GLY . . . . . 0.411 ' HA3' ' CE2' ' B' ' 878' ' ' TYR . . . -74.59 -25.26 70.52 Favored Glycine 0 N--CA 1.495 2.602 0 O-C-N 121.269 -0.894 . . . . 0.040000000000000001 111.725 -178.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 81.96 -62.08 4.58 Favored Glycine 0 N--CA 1.502 3.05 0 N-CA-C 107.966 -2.054 . . . . 0.040000000000000001 107.966 -178.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 878' ' ' TYR . . . . . 0.411 ' CE2' ' HA3' ' B' ' 876' ' ' GLY . 95.7 m-85 61.52 -60.25 0.1 Allowed 'General case' 0 N--CA 1.504 2.24 0 N-CA-C 114.473 1.286 . . . . 3.46 114.473 177.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 879' ' ' TYR . . . . . 0.477 ' CB ' ' CD2' ' B' ' 886' ' ' PHE . 21.2 p90 -111.68 108.78 18.35 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 114.68 1.363 . . . . 0.040000000000000001 114.68 -176.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -66.41 117.77 47.04 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 121.354 -0.841 . . . . 0.02 109.925 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 881' ' ' PRO . . . . . 0.462 ' HG2' ' CD1' ' B' ' 868' ' ' PHE . 51.8 Cg_endo -77.09 -0.52 10.67 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 O-C-N 123.409 1.215 . . . . 0.39000000000000001 112.261 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -75.73 -63.1 1.37 Allowed 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 106.639 -1.615 . . . . 0.81000000000000005 106.639 178.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 19.7 p -94.38 -19.06 20.96 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 108.76 -0.83 . . . . 0.040000000000000001 108.76 177.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.88 21.28 57.9 Favored Glycine 0 N--CA 1.496 2.648 0 O-C-N 121.099 -1.0 . . . . 0.029999999999999999 111.03 178.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 885' ' ' VAL . . . . . 0.74 HG13 HG21 ' B' ' 961' ' ' THR . 96.3 t -73.32 90.28 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 C-N-CA 118.242 -1.383 . . . . 1.01 108.123 -179.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 886' ' ' PHE . . . . . 0.878 ' HB3' HG22 ' B' ' 962' ' ' VAL . 0.8 OUTLIER -89.52 104.17 16.75 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 115.323 -0.853 . . . . 0.050000000000000003 111.808 -177.542 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 887' ' ' THR . . . . . 0.418 ' O ' ' HD3' ' B' ' 889' ' ' PRO . 93.4 m -95.34 101.0 12.69 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 107.722 -1.214 . . . . 0.68000000000000005 107.722 177.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 888' ' ' ALA . . . . . . . . . . . . . . . -98.69 106.86 39.61 Favored Pre-proline 0 N--CA 1.503 2.179 0 N-CA-C 114.026 1.121 . . . . 0.25 114.026 -176.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 889' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' B' ' 887' ' ' THR . 53.2 Cg_endo -89.71 -12.71 2.92 Favored 'Trans proline' 0 CA--C 1.547 1.133 0 C-N-CA 121.028 1.152 . . . . 1.6399999999999999 109.107 176.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 890' ' ' LEU . . . . . 0.935 HD22 HD13 ' B' ' 985' ' ' LEU . 73.1 mt -36.51 -50.31 0.78 Allowed 'General case' 0 N--CA 1.508 2.465 0 N-CA-C 113.7 1.0 . . . . 2.29 113.7 -177.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 52.01 95.99 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.162 -0.961 . . . . 0.63 110.258 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . 157.86 -153.29 24.5 Favored Glycine 0 N--CA 1.478 1.478 0 N-CA-C 107.209 -2.357 . . . . 0.040000000000000001 107.209 -179.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 73.4 ttt-85 -115.58 126.12 53.82 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 108.448 -0.945 . . . . 3.0 108.448 177.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 894' ' ' TYR . . . . . 0.777 ' OH ' HD12 ' B' ' 896' ' ' LEU . 0.1 OUTLIER -132.53 160.23 37.13 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.113 -0.992 . . . . 0.040000000000000001 111.155 -179.702 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 895' ' ' LEU . . . . . 0.402 HD12 ' HA ' ' B' ' 895' ' ' LEU . 36.2 tp -92.1 119.47 31.81 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.709 -0.62 . . . . 1.27 110.025 -179.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 896' ' ' LEU . . . . . 0.777 HD12 ' OH ' ' B' ' 894' ' ' TYR . 9.2 tt -109.85 143.68 39.39 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.671 -0.643 . . . . 0.93999999999999995 110.147 -179.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 897' ' ' SER . . . . . 0.484 ' N ' HD23 ' B' ' 896' ' ' LEU . 69.6 m -149.3 114.61 5.51 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.49 -0.756 . . . . 0.040000000000000001 110.992 -179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -106.75 146.76 30.46 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.944 -0.761 . . . . 0.47999999999999998 108.944 178.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 899' ' ' VAL . . . . . 0.748 HG21 ' HB ' ' B' ' 980' ' ' ILE . 88.0 t -96.25 118.94 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 C-N-CA 119.646 -0.822 . . . . 0.55000000000000004 111.302 -179.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 900' ' ' LEU . . . . . 0.478 HD12 ' HB2' ' B' ' 924' ' ' SER . 4.5 mm? -95.71 110.65 22.75 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 114.102 1.149 . . . . 1.5900000000000001 114.102 -175.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 18.2 m -64.01 140.21 58.85 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 107.414 -1.328 . . . . 0.050000000000000003 107.414 177.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -63.3 -66.75 2.38 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 110.387 -1.085 . . . . 0.029999999999999999 110.387 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 4.1 m170 46.89 67.11 0.84 Allowed 'General case' 0 N--CA 1.507 2.383 0 O-C-N 121.505 -0.997 . . . . 3.2000000000000002 110.977 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 35.1 ptt180 -68.5 -7.54 33.16 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.642 -0.662 . . . . 2.9199999999999999 111.898 -179.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 905' ' ' HIS . . . . . 0.487 ' O ' ' CB ' ' B' ' 906' ' ' GLU . 66.6 t60 -62.96 4.09 0.2 Allowed 'General case' 0 N--CA 1.505 2.278 0 CA-C-O 117.775 -1.107 . . . . 2.8700000000000001 112.851 -179.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 906' ' ' GLU . . . . . 0.487 ' CB ' ' O ' ' B' ' 905' ' ' HIS . 0.9 OUTLIER 94.89 -163.04 0.0 OUTLIER 'General case' 0 N--CA 1.53 3.533 0 CA-C-N 120.761 1.618 . . . . 0.98999999999999999 112.142 178.908 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 907' ' ' LYS . . . . . 0.511 ' HE2' ' HB1' ' B' ' 972' ' ' ALA . 94.2 mttt 89.5 159.51 0.05 Allowed 'General case' 0 N--CA 1.522 3.164 0 N-CA-C 107.817 -1.179 . . . . 5.25 107.817 -177.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 58.4 t -122.25 116.01 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 120.933 -1.104 . . . . 0.39000000000000001 110.956 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 909' ' ' GLU . . . . . 0.686 ' OE2' HD12 ' B' ' 966' ' ' LEU . 49.2 tp10 -100.2 133.21 44.94 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 107.542 -1.281 . . . . 1.72 107.542 176.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -157.42 122.11 4.4 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 106.98 -1.489 . . . . 0.67000000000000004 106.98 178.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 911' ' ' VAL . . . . . 0.705 HG22 HG13 ' B' ' 964' ' ' VAL . 94.7 t -85.34 132.14 32.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 C-N-CA 120.386 -0.526 . . . . 0.54000000000000004 111.11 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 72.3 mt -65.83 157.87 29.29 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.442 -0.787 . . . . 1.5 109.023 178.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 913' ' ' SER . . . . . 0.405 ' CB ' ' HB ' ' B' ' 919' ' ' VAL . 2.6 t -124.56 135.86 53.49 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.365 -0.976 . . . . 1.3700000000000001 108.365 177.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 914' ' ' ARG . . . . . 0.687 ' NH1' HD23 ' B' ' 956' ' ' LEU . 0.0 OUTLIER -64.28 154.57 34.77 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 120.596 -1.315 . . . . 4.2999999999999998 111.447 -179.054 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 915' ' ' SER . . . . . 0.419 ' CB ' ' O ' ' B' ' 914' ' ' ARG . 4.3 t 83.19 -31.86 0.08 Allowed 'General case' 0 N--CA 1.522 3.138 0 C-N-CA 123.867 0.867 . . . . 2.0499999999999998 112.131 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 916' ' ' ASN . . . . . 0.765 ' HB2' HG21 ' B' ' 919' ' ' VAL . 90.8 m-20 -123.3 -21.89 5.25 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 120.856 -1.152 . . . . 2.71 111.353 -179.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 917' ' ' GLN . . . . . 0.439 ' HB2' ' O ' ' B' ' 916' ' ' ASN . 44.2 mt-30 65.87 165.72 0.19 Allowed 'General case' 0 N--CA 1.518 2.949 0 N-CA-C 106.024 -1.843 . . . . 2.6800000000000002 106.024 -173.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 55.38 -125.66 36.94 Favored Glycine 1 N--CA 1.52 4.267 0 CA-C-N 123.439 2.836 . . . . 0.029999999999999999 106.621 -177.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 919' ' ' VAL . . . . . 0.765 HG21 ' HB2' ' B' ' 916' ' ' ASN . 68.9 t 52.34 93.72 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.302 0 O-C-N 121.356 -1.085 . . . . 1.3899999999999999 108.752 -178.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 920' ' ' ALA . . . . . 0.789 ' HB3' HG12 ' B' ' 949' ' ' VAL . . . -91.3 90.84 7.91 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.205 -0.998 . . . . 0.029999999999999999 110.881 -178.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 921' ' ' ARG . . . . . 0.862 ' HG3' HG23 ' B' ' 922' ' ' VAL . 30.1 ptt180 -86.15 -41.83 14.38 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 105.907 -1.886 . . . . 4.4199999999999999 105.907 175.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 922' ' ' VAL . . . . . 0.862 HG23 ' HG3' ' B' ' 921' ' ' ARG . 84.8 t -104.04 67.4 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 105.978 -1.86 . . . . 0.84999999999999998 105.978 175.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 923' ' ' ASP . . . . . 0.716 ' HB2' ' HB1' ' B' ' 920' ' ' ALA . 22.5 t0 -89.72 134.68 34.04 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.705 0.764 . . . . 2.46 111.658 -177.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 924' ' ' SER . . . . . 0.478 ' HB2' HD12 ' B' ' 900' ' ' LEU . 8.5 t -147.13 103.33 3.58 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.503 -0.925 . . . . 0.69999999999999996 108.503 178.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -109.62 90.22 0.59 Allowed Glycine 0 N--CA 1.487 2.052 0 N-CA-C 108.349 -1.9 . . . . 0.040000000000000001 108.349 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.318 0 N-CA-C 109.459 -1.456 . . . . 0.040000000000000001 109.459 -179.267 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 29.9 m . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.009 0.433 . . . . 13.779999999999999 110.307 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 95.3 mt -111.87 129.94 55.99 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.543 -0.723 . . . . 13.76 110.379 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -151.39 167.56 30.82 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.256 -1.538 . . . . 9.1300000000000008 109.256 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 949' ' ' VAL . . . . . 0.789 HG12 ' HB3' ' B' ' 920' ' ' ALA . 30.7 m -118.7 129.13 75.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.514 -0.992 . . . . 7.0800000000000001 110.698 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 950' ' ' PHE . . . . . 0.462 ' CZ ' ' HB3' ' B' ' 921' ' ' ARG . 26.6 p90 -132.35 147.87 52.4 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.563 -0.71 . . . . 7.5899999999999999 109.518 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 19.7 m -121.22 -51.46 2.1 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.48 -0.762 . . . . 5.0300000000000002 112.063 -178.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 952' ' ' LEU . . . . . 0.836 HD11 HD23 ' A' ' 895' ' ' LEU . 52.5 tp -60.24 -75.28 0.06 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.389 -0.819 . . . . 1.01 112.549 -177.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 953' ' ' ILE . . . . . 0.479 ' O ' ' HB3' ' B' ' 954' ' ' LEU . 45.0 pt -52.1 -143.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.8 0 N-CA-C 114.237 1.199 . . . . 2.6000000000000001 114.237 -176.395 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 954' ' ' LEU . . . . . 0.729 HD22 ' O ' ' B' ' 954' ' ' LEU . 0.0 OUTLIER 173.79 77.01 0.05 OUTLIER Pre-proline 0 N--CA 1.507 2.387 0 O-C-N 120.629 -1.294 . . . . 0.050000000000000003 111.209 179.883 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 955' ' ' PRO . . . . . 0.746 ' C ' HD12 ' B' ' 956' ' ' LEU . 49.4 Cg_endo -76.62 91.76 1.13 Allowed 'Trans proline' 0 C--N 1.314 -1.242 0 N-CA-C 109.606 -0.959 . . . . 0.83999999999999997 109.606 178.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 956' ' ' LEU . . . . . 0.746 HD12 ' C ' ' B' ' 955' ' ' PRO . 11.1 mp -122.13 146.13 47.52 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.198 -0.939 . . . . 0.040000000000000001 109.738 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -84.33 150.86 25.1 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 117.964 -1.017 . . . . 1.28 111.84 -178.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -70.3 120.02 15.34 Favored 'General case' 0 N--CA 1.509 2.497 0 CA-C-N 122.658 2.481 . . . . 0.17000000000000001 111.664 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.65 -22.74 31.8 Favored Glycine 0 N--CA 1.5 2.922 0 N-CA-C 111.07 -0.812 . . . . 0.040000000000000001 111.07 178.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 960' ' ' ASP . . . . . 0.449 ' HB3' ' NE ' ' B' ' 914' ' ' ARG . 0.4 OUTLIER -55.27 171.99 0.15 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.455 -1.026 . . . . 0.040000000000000001 110.014 -179.528 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 961' ' ' THR . . . . . 0.74 HG21 HG13 ' B' ' 885' ' ' VAL . 40.7 m -135.02 135.65 41.5 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.993 -1.067 . . . . 1.78 111.845 -178.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 962' ' ' VAL . . . . . 0.878 HG22 ' HB3' ' B' ' 886' ' ' PHE . 32.7 m -98.07 145.77 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 C-N-CA 120.102 -0.639 . . . . 0.040000000000000001 110.122 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 5.6 t -138.24 146.01 42.06 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.905 -0.497 . . . . 0.71999999999999997 110.294 -178.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 964' ' ' VAL . . . . . 0.705 HG13 HG22 ' B' ' 911' ' ' VAL . 59.0 t -94.46 137.17 23.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.19 -0.943 . . . . 1.05 110.474 -179.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -93.24 127.06 38.67 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 103.869 -2.641 . . . . 3.02 103.869 173.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 966' ' ' LEU . . . . . 0.686 HD12 ' OE2' ' B' ' 909' ' ' GLU . 0.2 OUTLIER -132.32 60.23 1.69 Allowed 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.392 -0.966 . . . . 1.46 108.392 177.334 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 967' ' ' VAL . . . . . 0.489 HG23 ' C ' ' B' ' 966' ' ' LEU . 98.3 t -158.18 96.86 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 N-CA-C 108.051 -1.092 . . . . 1.9399999999999999 108.051 179.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 92.3 mmm -142.52 60.09 1.44 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.735 -1.228 . . . . 0.0 108.571 179.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.62 120.36 2.0 Allowed Glycine 0 N--CA 1.492 2.417 0 N-CA-C 107.259 -2.337 . . . . 2.1099999999999999 107.259 -178.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -81.83 -59.8 2.46 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.073 -1.251 . . . . 5.8899999999999997 110.222 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 50.9 tp -59.83 90.6 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.45 -0.781 . . . . 4.3600000000000003 109.912 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 972' ' ' ALA . . . . . 0.511 ' HB1' ' HE2' ' B' ' 907' ' ' LYS . . . -141.06 -154.69 0.53 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.592 -0.693 . . . . 1.8300000000000001 110.408 -179.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -118.72 171.3 8.3 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.526 -0.734 . . . . 4.3499999999999996 110.245 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 34.5 t -101.58 130.23 47.85 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.572 -0.705 . . . . 1.27 110.065 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -156.12 157.17 35.55 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.48 -0.762 . . . . 5.0199999999999996 110.473 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.17 85.67 18.45 Favored Pre-proline 0 N--CA 1.501 2.082 0 O-C-N 121.623 -0.673 . . . . 2.4100000000000001 109.745 179.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -73.37 -172.44 1.04 Allowed 'Trans proline' 0 C--N 1.318 -1.065 0 O-C-N 123.303 1.16 . . . . 0.95999999999999996 111.386 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 978' ' ' LEU . . . . . 0.66 HD23 HD12 ' B' ' 856' ' ' LEU . 4.9 mp -127.52 154.66 44.86 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 107.71 -1.218 . . . . 0.62 107.71 178.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 979' ' ' THR . . . . . 0.471 HG23 ' C ' ' B' ' 978' ' ' LEU . 41.0 p -150.41 140.89 22.46 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.814 -1.179 . . . . 3.5699999999999998 111.088 -179.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 980' ' ' ILE . . . . . 0.748 ' HB ' HG21 ' B' ' 899' ' ' VAL . 46.2 mm -107.31 128.73 62.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 109.064 -0.717 . . . . 1.3300000000000001 109.064 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -118.84 95.36 4.8 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 119.787 -0.765 . . . . 0.050000000000000003 111.86 -178.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 80.5 p -108.28 158.13 17.74 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.546 -0.721 . . . . 0.87 109.294 178.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 983' ' ' GLY . . . . . 0.405 ' O ' ' CE2' ' B' ' 852' ' ' PHE . . . -174.76 110.57 0.33 Allowed Glycine 0 N--CA 1.498 2.782 0 N-CA-C 106.514 -2.634 . . . . 0.029999999999999999 106.514 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -108.22 150.58 27.08 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 114.43 1.27 . . . . 0.69999999999999996 114.43 -175.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 985' ' ' LEU . . . . . 0.935 HD13 HD22 ' B' ' 890' ' ' LEU . 33.5 tp -72.05 135.01 46.18 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.856 -1.153 . . . . 0.040000000000000001 110.052 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 986' ' ' LEU . . . . . 0.483 ' CD1' HD11 ' C' ' 986' ' ' LEU . 51.6 tp -107.46 -55.77 2.3 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.59 -0.694 . . . . 0.040000000000000001 110.101 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -144.62 145.65 31.89 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.719 -1.215 . . . . 0.040000000000000001 107.719 179.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.45 163.07 12.2 Favored Glycine 0 N--CA 1.495 2.628 0 N-CA-C 108.289 -1.924 . . . . 0.040000000000000001 108.289 179.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -75.04 112.47 18.18 Favored Pre-proline 0 N--CA 1.498 1.955 0 O-C-N 121.174 -1.192 . . . . 0.040000000000000001 109.475 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 990' ' ' PRO . . . . . 0.423 ' HD2' HD12 ' B' ' 992' ' ' LEU . 49.8 Cg_endo -90.58 70.89 1.35 Allowed 'Trans proline' 0 C--N 1.318 -1.042 0 O-C-N 123.113 1.06 . . . . 0.45000000000000001 111.517 -178.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 991' ' ' GLU . . . . . 0.419 ' HB2' ' O ' ' B' ' 990' ' ' PRO . 69.4 mt-10 67.12 -73.68 0.08 Allowed 'General case' 0 N--CA 1.503 2.183 0 N-CA-C 108.633 -0.877 . . . . 1.97 108.633 -177.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 992' ' ' LEU . . . . . 0.461 ' HA ' HD23 ' B' ' 992' ' ' LEU . 11.1 mt 51.13 20.39 0.86 Allowed 'General case' 0 N--CA 1.501 2.115 0 O-C-N 121.552 -0.717 . . . . 2.3799999999999999 111.656 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -93.69 156.97 16.39 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.869 -1.145 . . . . 3.79 110.057 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 71.9 m80 -146.7 92.91 2.21 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.519 -0.738 . . . . 3.5099999999999998 110.415 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 995' ' ' ALA . . . . . . . . . . . . 2.517 . . . . . . . 0 N--CA 1.503 2.22 0 O-C-N 120.886 -1.134 . . . . 2.73 110.603 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo . . . . . 0 N--CA 1.489 1.221 0 N-CA-C 109.521 -0.992 . . . . 3.8300000000000001 109.521 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' 847' ' ' VAL . . . . . 0.424 HG12 ' HB2' ' C' ' 849' ' ' GLN . 88.1 t -131.42 102.7 15.31 Favored Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.606 -0.684 . . . . 1.8300000000000001 110.131 -179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 848' ' ' PRO . . . . . 0.753 ' O ' HG23 ' C' ' 850' ' ' VAL . 44.7 Cg_endo -70.2 -20.41 32.8 Favored 'Trans proline' 0 N--CA 1.487 1.138 0 O-C-N 123.278 1.146 . . . . 0.65000000000000002 111.016 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 849' ' ' GLN . . . . . 0.424 ' HB2' HG12 ' C' ' 847' ' ' VAL . 56.2 tt0 27.29 69.17 0.06 Allowed 'General case' 0 N--CA 1.519 2.979 0 N-CA-C 112.884 0.698 . . . . 2.5800000000000001 112.884 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 850' ' ' VAL . . . . . 0.753 HG23 ' O ' ' C' ' 848' ' ' PRO . 67.7 t -119.41 133.91 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.258 -0.901 . . . . 1.0900000000000001 111.64 -178.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 851' ' ' ALA . . . . . 0.447 ' HB3' ' HG ' ' C' ' 873' ' ' LEU . . . -129.88 152.97 48.77 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 105.627 -1.99 . . . . 0.040000000000000001 105.627 176.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 852' ' ' PHE . . . . . 0.448 ' HA ' ' CB ' ' C' ' 874' ' ' ASN . 6.0 p90 -160.31 128.76 4.76 Favored 'General case' 0 N--CA 1.492 1.628 0 CA-C-N 120.921 1.691 . . . . 0.050000000000000003 108.589 179.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 29.8 t -175.67 134.32 0.29 Allowed 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.065 -1.087 . . . . 0.040000000000000001 108.065 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -134.64 156.91 47.92 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.136 -0.978 . . . . 0.67000000000000004 109.596 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 855' ' ' ALA . . . . . 0.593 ' HB3' ' CB ' ' C' ' 870' ' ' ARG . . . -121.83 139.71 53.28 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 121.864 0.84 . . . . 0.51000000000000001 111.667 -179.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 856' ' ' LEU . . . . . 0.713 HD23 ' O ' ' C' ' 867' ' ' PRO . 3.5 tm? -103.04 135.85 43.95 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.69 -0.631 . . . . 0.050000000000000003 109.422 179.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 857' ' ' SER . . . . . 0.576 ' N ' HD13 ' C' ' 856' ' ' LEU . 37.3 p -151.38 15.85 0.71 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.487 -0.758 . . . . 1.3300000000000001 111.206 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 858' ' ' LEU . . . . . 0.57 ' CD2' HD11 ' C' ' 856' ' ' LEU . 4.4 pp -33.56 157.47 0.04 OUTLIER Pre-proline 0 N--CA 1.518 2.97 0 N-CA-C 112.899 0.703 . . . . 2.3300000000000001 112.899 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -61.57 -89.27 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 120.897 1.064 . . . . 2.3199999999999998 113.575 -177.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 54.7 ptt85 -127.82 -141.86 0.26 Allowed 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.953 -1.092 . . . . 0.040000000000000001 111.289 -177.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 71.5 m -37.9 123.04 1.04 Allowed 'General case' 0 N--CA 1.51 2.567 0 O-C-N 121.575 -0.703 . . . . 1.3100000000000001 112.064 -179.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 862' ' ' GLU . . . . . 0.514 ' HG3' HD22 ' C' ' 858' ' ' LEU . 0.0 OUTLIER -100.55 158.41 31.95 Favored Pre-proline 0 N--CA 1.488 1.429 0 N-CA-C 108.192 -1.04 . . . . 4.5099999999999998 108.192 177.767 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.07 -14.58 32.03 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 123.187 1.099 . . . . 2.2400000000000002 111.034 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -176.98 -135.51 2.21 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.725 -1.35 . . . . 0.040000000000000001 109.725 179.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 25.8 m -69.05 154.22 42.44 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.331 -1.1 . . . . 1.51 110.47 -179.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 866' ' ' VAL . . . . . 0.46 ' HA ' ' HD3' ' C' ' 867' ' ' PRO . 32.7 m -90.68 139.39 26.33 Favored Pre-proline 0 N--CA 1.497 1.881 0 N-CA-C 113.66 0.985 . . . . 0.78000000000000003 113.66 -175.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 867' ' ' PRO . . . . . 0.713 ' O ' HD23 ' C' ' 856' ' ' LEU . 53.9 Cg_endo -88.92 -152.69 0.04 OUTLIER 'Trans proline' 0 C--N 1.325 -0.662 0 N-CA-C 108.286 -1.467 . . . . 0.92000000000000004 108.286 177.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 868' ' ' PHE . . . . . 0.471 ' CD1' ' HG2' ' C' ' 881' ' ' PRO . 23.0 p90 -148.15 120.18 8.25 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.513 -1.367 . . . . 0.050000000000000003 109.625 179.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 50.2 p-10 -113.02 -2.97 14.1 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 119.38 -0.928 . . . . 1.7 112.029 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 870' ' ' ARG . . . . . 0.593 ' CB ' ' HB3' ' C' ' 855' ' ' ALA . 24.8 mmm180 -90.51 86.88 6.55 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.03 -1.044 . . . . 2.5899999999999999 110.825 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 61.6 t -73.12 96.73 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.074 -1.016 . . . . 1.9399999999999999 109.566 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 872' ' ' LEU . . . . . 0.507 HD11 ' HB2' ' C' ' 855' ' ' ALA . 51.9 mt -86.17 -45.18 11.58 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.554 -0.716 . . . . 1.0600000000000001 110.338 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 873' ' ' LEU . . . . . 0.447 ' HG ' ' HB3' ' C' ' 851' ' ' ALA . 49.3 tp -173.3 102.8 0.12 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.238 -0.914 . . . . 4.1799999999999997 108.791 178.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 874' ' ' ASN . . . . . 0.448 ' CB ' ' HA ' ' C' ' 852' ' ' PHE . 37.4 t-20 177.98 82.65 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.319 0 O-C-N 121.721 -0.612 . . . . 0.040000000000000001 109.374 -178.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -67.19 -47.41 71.0 Favored 'General case' 0 N--CA 1.497 1.92 0 C-N-CA 119.203 -0.999 . . . . 3.3799999999999999 111.434 -179.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 876' ' ' GLY . . . . . . . . . . . . . . . -73.53 -26.97 68.51 Favored Glycine 0 N--CA 1.494 2.548 0 O-C-N 121.271 -0.893 . . . . 0.040000000000000001 111.66 -178.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 83.13 -60.18 4.91 Favored Glycine 0 N--CA 1.503 3.109 0 N-CA-C 108.061 -2.015 . . . . 0.040000000000000001 108.061 -178.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 878' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 61.41 -66.19 0.06 Allowed 'General case' 0 N--CA 1.503 2.186 0 N-CA-C 114.239 1.2 . . . . 3.46 114.239 177.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 879' ' ' TYR . . . . . 0.471 ' CB ' ' CD2' ' C' ' 886' ' ' PHE . 23.9 p90 -113.92 110.02 19.43 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 114.859 1.429 . . . . 0.040000000000000001 114.859 -176.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -66.83 117.98 50.43 Favored Pre-proline 0 N--CA 1.499 2.018 0 O-C-N 121.434 -0.791 . . . . 0.02 109.897 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 881' ' ' PRO . . . . . 0.471 ' HG2' ' CD1' ' C' ' 868' ' ' PHE . 55.3 Cg_endo -77.43 -0.26 10.44 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 O-C-N 123.386 1.203 . . . . 0.39000000000000001 112.141 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -74.58 -63.31 1.27 Allowed 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 106.538 -1.652 . . . . 0.81000000000000005 106.538 178.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 8.9 p -95.61 -17.62 21.21 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.704 -0.85 . . . . 0.040000000000000001 108.704 177.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.78 20.58 59.43 Favored Glycine 0 N--CA 1.495 2.631 0 O-C-N 121.024 -1.047 . . . . 0.029999999999999999 111.165 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 92.4 t -72.02 90.26 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 C-N-CA 118.135 -1.426 . . . . 1.01 108.019 -179.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 886' ' ' PHE . . . . . 0.841 ' HB3' HG22 ' C' ' 962' ' ' VAL . 0.8 OUTLIER -90.93 104.77 17.32 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-N 115.268 -0.878 . . . . 0.050000000000000003 112.037 -177.259 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 887' ' ' THR . . . . . 0.426 ' O ' ' HD3' ' C' ' 889' ' ' PRO . 86.5 m -95.97 101.49 13.16 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 107.697 -1.223 . . . . 0.68000000000000005 107.697 177.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 888' ' ' ALA . . . . . . . . . . . . . . . -98.38 107.01 39.56 Favored Pre-proline 0 N--CA 1.502 2.155 0 N-CA-C 113.998 1.11 . . . . 0.25 113.998 -176.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 889' ' ' PRO . . . . . 0.426 ' HD3' ' O ' ' C' ' 887' ' ' THR . 53.6 Cg_endo -90.03 -13.26 2.59 Favored 'Trans proline' 0 CA--C 1.546 1.095 0 C-N-CA 120.975 1.117 . . . . 1.6399999999999999 109.228 176.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 890' ' ' LEU . . . . . 1.04 HD22 HD13 ' C' ' 985' ' ' LEU . 75.6 mt -38.7 -49.33 1.57 Allowed 'General case' 0 N--CA 1.507 2.382 0 N-CA-C 113.719 1.007 . . . . 2.29 113.719 -177.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 52.85 96.78 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.351 0 O-C-N 121.081 -1.012 . . . . 0.63 110.044 -179.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . 155.79 -146.87 14.91 Favored Glycine 0 N--CA 1.48 1.568 0 N-CA-C 107.096 -2.402 . . . . 0.040000000000000001 107.096 -178.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 74.4 ttt-85 -107.17 129.32 54.87 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 107.947 -1.131 . . . . 3.0 107.947 177.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 894' ' ' TYR . . . . . 0.451 ' CD1' ' N ' ' C' ' 895' ' ' LEU . 0.4 OUTLIER -129.53 142.94 50.65 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.064 -1.022 . . . . 0.040000000000000001 110.086 -179.254 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 895' ' ' LEU . . . . . 0.451 ' N ' ' CD1' ' C' ' 894' ' ' TYR . 34.6 tp -102.08 115.39 30.44 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.632 -0.667 . . . . 1.27 109.597 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 896' ' ' LEU . . . . . 0.609 HD23 ' N ' ' C' ' 897' ' ' SER . 10.3 tt -112.69 146.76 38.13 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.549 -0.719 . . . . 0.93999999999999995 110.594 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 897' ' ' SER . . . . . 0.609 ' N ' HD23 ' C' ' 896' ' ' LEU . 8.3 m -141.4 117.26 10.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.523 -0.736 . . . . 0.040000000000000001 110.494 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -106.61 147.19 29.79 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.126 -0.694 . . . . 0.47999999999999998 109.126 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 899' ' ' VAL . . . . . 0.74 HG21 ' HB ' ' C' ' 980' ' ' ILE . 88.9 t -93.56 119.42 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 C-N-CA 119.729 -0.788 . . . . 0.55000000000000004 111.133 -179.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 96.7 mt -93.66 111.53 23.23 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 114.1 1.148 . . . . 1.5900000000000001 114.1 -175.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 16.7 m -64.12 140.12 58.84 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 107.32 -1.363 . . . . 0.050000000000000003 107.32 177.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -61.18 -64.48 4.01 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.29 -1.124 . . . . 0.029999999999999999 110.29 -179.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 45.18 63.77 1.63 Allowed 'General case' 0 N--CA 1.507 2.409 0 O-C-N 121.57 -0.959 . . . . 3.2000000000000002 111.323 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 41.9 ptt85 -67.26 -7.9 27.77 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.573 -0.704 . . . . 2.9199999999999999 111.895 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 905' ' ' HIS . . . . . 0.49 ' O ' ' CB ' ' C' ' 906' ' ' GLU . 74.0 t60 -61.3 5.15 0.07 Allowed 'General case' 0 N--CA 1.505 2.302 0 CA-C-O 117.601 -1.19 . . . . 2.8700000000000001 113.488 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 906' ' ' GLU . . . . . 0.49 ' CB ' ' O ' ' C' ' 905' ' ' HIS . 0.7 OUTLIER 92.58 -163.43 0.01 OUTLIER 'General case' 0 N--CA 1.528 3.447 0 CA-C-N 121.294 1.861 . . . . 0.98999999999999999 112.239 178.919 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 907' ' ' LYS . . . . . 0.488 ' CB ' ' O ' ' C' ' 906' ' ' GLU . 72.4 tttt 89.82 161.96 0.05 OUTLIER 'General case' 0 N--CA 1.52 3.065 0 N-CA-C 108.171 -1.048 . . . . 5.25 108.171 -177.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 59.4 t -122.69 115.39 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 120.927 -1.108 . . . . 0.39000000000000001 110.857 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 909' ' ' GLU . . . . . 0.474 ' HG3' HD12 ' C' ' 966' ' ' LEU . 47.1 tt0 -108.07 129.99 55.11 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 107.644 -1.243 . . . . 1.72 107.644 177.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -155.93 120.83 4.71 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 106.8 -1.556 . . . . 0.67000000000000004 106.8 178.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 911' ' ' VAL . . . . . 0.896 HG23 HG22 ' C' ' 964' ' ' VAL . 13.3 p -77.3 131.09 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.79 -0.569 . . . . 0.54000000000000004 111.346 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 46.4 mt -67.81 157.62 34.37 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.284 -0.885 . . . . 1.5 108.717 178.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 913' ' ' SER . . . . . 0.475 ' OG ' HG11 ' C' ' 919' ' ' VAL . 1.6 p -123.72 139.56 53.87 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.67 -0.863 . . . . 1.3700000000000001 108.67 177.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 914' ' ' ARG . . . . . 0.821 ' NH1' HD23 ' C' ' 956' ' ' LEU . 0.0 OUTLIER -65.02 154.1 38.75 Favored 'General case' 0 N--CA 1.504 2.242 0 O-C-N 120.643 -1.286 . . . . 4.2999999999999998 111.568 -179.104 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 915' ' ' SER . . . . . 0.425 ' CB ' ' O ' ' C' ' 914' ' ' ARG . 4.4 t 83.28 -31.25 0.08 Allowed 'General case' 0 N--CA 1.522 3.164 0 C-N-CA 123.916 0.886 . . . . 2.0499999999999998 112.23 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 916' ' ' ASN . . . . . 0.741 ' HB2' HG21 ' C' ' 919' ' ' VAL . 99.1 m-20 -121.85 -22.01 5.89 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.889 -1.132 . . . . 2.71 111.226 -179.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 66.99 166.93 0.23 Allowed 'General case' 0 N--CA 1.52 3.04 0 N-CA-C 105.802 -1.925 . . . . 2.6800000000000002 105.802 -174.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.64 -126.38 37.43 Favored Glycine 1 N--CA 1.521 4.344 0 CA-C-N 123.598 2.908 . . . . 0.029999999999999999 107.051 -177.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 919' ' ' VAL . . . . . 0.741 HG21 ' HB2' ' C' ' 916' ' ' ASN . 92.1 t 51.57 93.53 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.238 0 O-C-N 121.307 -1.114 . . . . 1.3899999999999999 109.129 -178.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 920' ' ' ALA . . . . . 0.937 ' HB3' HG12 ' C' ' 949' ' ' VAL . . . -93.42 93.82 8.36 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.332 -0.947 . . . . 0.029999999999999999 110.714 -179.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 921' ' ' ARG . . . . . 0.811 ' HG3' HG23 ' C' ' 922' ' ' VAL . 20.1 ptt85 -80.39 -41.83 23.9 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 105.938 -1.875 . . . . 4.4199999999999999 105.938 176.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 922' ' ' VAL . . . . . 0.811 HG23 ' HG3' ' C' ' 921' ' ' ARG . 90.5 t -101.86 75.11 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 106.088 -1.819 . . . . 0.84999999999999998 106.088 175.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -89.79 135.89 33.36 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 121.872 0.844 . . . . 2.46 112.355 -176.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 7.9 t -147.16 102.76 3.53 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.063 -1.088 . . . . 0.69999999999999996 108.063 178.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -110.83 88.95 0.53 Allowed Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.967 -1.653 . . . . 0.040000000000000001 108.967 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.4 0 N-CA-C 109.353 -1.499 . . . . 0.040000000000000001 109.353 -179.713 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 11.2 m . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 120.962 0.411 . . . . 13.779999999999999 110.318 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 95.3 mt -114.22 129.77 56.63 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.505 -0.747 . . . . 13.76 110.319 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -152.16 170.34 31.47 Favored Glycine 0 N--CA 1.493 2.5 0 N-CA-C 109.398 -1.481 . . . . 9.1300000000000008 109.398 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 949' ' ' VAL . . . . . 0.937 HG12 ' HB3' ' C' ' 920' ' ' ALA . 33.7 m -117.17 136.39 54.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.538 -0.977 . . . . 7.0800000000000001 110.832 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 950' ' ' PHE . . . . . 0.448 ' CZ ' ' HB3' ' C' ' 921' ' ' ARG . 36.0 p90 -135.57 152.25 51.09 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.607 -0.683 . . . . 7.5899999999999999 109.622 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 69.4 m -118.32 -54.44 2.29 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.386 -0.821 . . . . 5.0300000000000002 111.514 -179.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 952' ' ' LEU . . . . . 0.448 ' O ' ' O ' ' C' ' 953' ' ' ILE . 46.6 tp -63.78 -77.03 0.06 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.46 -0.775 . . . . 1.01 111.421 -178.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 953' ' ' ILE . . . . . 0.544 HD12 ' N ' ' C' ' 954' ' ' LEU . 2.3 pp -49.45 -152.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.735 0 N-CA-C 114.324 1.231 . . . . 2.6000000000000001 114.324 -176.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 954' ' ' LEU . . . . . 0.726 HD22 ' O ' ' C' ' 954' ' ' LEU . 0.0 OUTLIER 169.11 92.09 0.03 OUTLIER Pre-proline 0 N--CA 1.516 2.869 0 O-C-N 120.949 -1.094 . . . . 0.050000000000000003 111.651 179.491 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 955' ' ' PRO . . . . . 0.761 ' C ' HD12 ' C' ' 956' ' ' LEU . 52.1 Cg_endo -80.4 93.0 1.05 Allowed 'Trans proline' 0 C--N 1.317 -1.117 0 N-CA-C 109.138 -1.139 . . . . 0.83999999999999997 109.138 178.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 956' ' ' LEU . . . . . 0.821 HD23 ' NH1' ' C' ' 914' ' ' ARG . 10.9 mp -122.85 144.01 49.49 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.014 -1.054 . . . . 0.040000000000000001 110.144 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -82.11 151.33 27.05 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-O 117.708 -1.139 . . . . 1.28 111.287 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -67.15 118.63 10.83 Favored 'General case' 0 N--CA 1.508 2.45 0 CA-C-N 123.078 2.672 . . . . 0.17000000000000001 111.082 -179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.42 -20.43 44.1 Favored Glycine 0 N--CA 1.499 2.888 0 N-CA-C 110.872 -0.891 . . . . 0.040000000000000001 110.872 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 960' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -53.63 169.69 0.13 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.381 -1.07 . . . . 0.040000000000000001 110.125 -179.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 961' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' C' ' 886' ' ' PHE . 71.1 p -133.41 137.66 45.9 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.056 -1.027 . . . . 1.78 112.167 -177.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 962' ' ' VAL . . . . . 0.841 HG22 ' HB3' ' C' ' 886' ' ' PHE . 25.4 m -97.31 146.46 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 C-N-CA 120.13 -0.628 . . . . 0.040000000000000001 110.184 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 5.5 t -138.59 145.23 40.32 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.952 -0.468 . . . . 0.71999999999999997 109.989 -178.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 964' ' ' VAL . . . . . 0.896 HG22 HG23 ' C' ' 911' ' ' VAL . 65.1 t -97.27 136.0 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.034 -1.041 . . . . 1.05 110.578 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -97.37 125.61 42.09 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 103.906 -2.627 . . . . 3.02 103.906 173.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 966' ' ' LEU . . . . . 0.49 ' C ' HG23 ' C' ' 967' ' ' VAL . 1.1 tp -133.11 62.95 1.65 Allowed 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.296 -1.002 . . . . 1.46 108.296 177.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 967' ' ' VAL . . . . . 0.49 HG23 ' C ' ' C' ' 966' ' ' LEU . 97.3 t -157.64 97.44 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 108.224 -1.028 . . . . 1.9399999999999999 108.224 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 95.7 mmm -141.9 59.98 1.48 Allowed 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.741 -1.224 . . . . 0.0 108.541 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.07 119.99 1.99 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 107.235 -2.346 . . . . 2.1099999999999999 107.235 -178.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -82.23 -58.55 2.9 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.053 -1.263 . . . . 5.8899999999999997 110.507 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 49.0 tp -59.43 89.94 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.448 -0.782 . . . . 4.3600000000000003 110.261 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -142.16 -152.66 0.42 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.622 -0.673 . . . . 1.8300000000000001 110.09 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -117.36 167.62 11.09 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.462 -0.774 . . . . 4.3499999999999996 110.022 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 10.3 t -101.7 130.56 48.11 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.557 -0.714 . . . . 1.27 110.2 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -155.96 153.85 30.22 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.532 -0.73 . . . . 5.0199999999999996 110.384 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.27 86.23 14.76 Favored Pre-proline 0 N--CA 1.496 1.848 0 O-C-N 121.588 -0.695 . . . . 2.4100000000000001 109.897 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -75.76 -170.55 0.85 Allowed 'Trans proline' 0 C--N 1.318 -1.07 0 O-C-N 123.324 1.17 . . . . 0.95999999999999996 111.223 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 978' ' ' LEU . . . . . 0.46 ' C ' HG23 ' C' ' 979' ' ' THR . 5.0 mp -123.56 156.23 36.11 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 107.497 -1.297 . . . . 0.62 107.497 177.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 979' ' ' THR . . . . . 0.46 HG23 ' C ' ' C' ' 978' ' ' LEU . 40.6 p -150.54 141.66 23.09 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.779 -1.2 . . . . 3.5699999999999998 111.251 -179.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 980' ' ' ILE . . . . . 0.74 ' HB ' HG21 ' C' ' 899' ' ' VAL . 50.1 mm -106.08 128.55 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 109.216 -0.661 . . . . 1.3300000000000001 109.216 179.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 981' ' ' PHE . . . . . 0.436 ' CD1' ' CE2' ' C' ' 879' ' ' TYR . 2.3 t80 -118.15 97.29 5.72 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.499 -0.751 . . . . 0.050000000000000003 111.256 -178.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 982' ' ' SER . . . . . 0.42 ' HB2' HD23 ' A' ' 952' ' ' LEU . 18.2 p -108.41 159.85 16.35 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.081 -0.711 . . . . 0.87 109.081 178.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 983' ' ' GLY . . . . . 0.411 ' O ' ' CE2' ' C' ' 852' ' ' PHE . . . -169.04 115.01 0.58 Allowed Glycine 0 N--CA 1.497 2.764 0 N-CA-C 106.526 -2.629 . . . . 0.029999999999999999 106.526 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 984' ' ' ALA . . . . . 0.459 ' HB1' ' CZ ' ' A' ' 893' ' ' ARG . . . -109.26 147.95 31.78 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.156 -1.203 . . . . 0.69999999999999996 114.169 -175.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 985' ' ' LEU . . . . . 1.04 HD13 HD22 ' C' ' 890' ' ' LEU . 51.4 tp -75.38 135.06 40.82 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.809 -1.182 . . . . 0.040000000000000001 109.425 179.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 986' ' ' LEU . . . . . 0.483 HD11 ' CD1' ' B' ' 986' ' ' LEU . 48.4 tp -107.1 -61.71 1.51 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.477 -0.764 . . . . 0.040000000000000001 110.495 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -144.92 146.31 31.94 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 107.841 -1.17 . . . . 0.040000000000000001 107.841 179.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.25 162.82 12.28 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 108.097 -2.001 . . . . 0.040000000000000001 108.097 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -74.6 112.81 19.07 Favored Pre-proline 0 N--CA 1.498 1.967 0 O-C-N 121.206 -1.173 . . . . 0.040000000000000001 109.455 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 990' ' ' PRO . . . . . 0.416 ' O ' ' HB2' ' C' ' 991' ' ' GLU . 50.5 Cg_endo -88.76 70.98 2.38 Favored 'Trans proline' 0 C--N 1.32 -0.937 0 O-C-N 123.115 1.061 . . . . 0.45000000000000001 111.303 -178.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 991' ' ' GLU . . . . . 0.416 ' HB2' ' O ' ' C' ' 990' ' ' PRO . 67.7 mt-10 67.51 -73.31 0.08 Allowed 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 108.582 -0.895 . . . . 1.97 108.582 -177.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 992' ' ' LEU . . . . . . . . . . . . . 11.4 mt 50.45 20.83 0.74 Allowed 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.567 -0.708 . . . . 2.3799999999999999 111.69 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 80.0 mt-10 -92.91 157.01 16.58 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.936 -1.103 . . . . 3.79 110.055 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 69.6 m80 -146.32 92.0 2.12 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.579 -0.701 . . . . 3.5099999999999998 110.254 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 995' ' ' ALA . . . . . . . . . . . . 2.518 . . . . . . . 0 N--CA 1.504 2.23 0 O-C-N 120.913 -1.117 . . . . 2.73 110.564 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo . . . . . 0 N--CA 1.488 1.199 0 N-CA-C 109.451 -1.019 . . . . 3.8300000000000001 109.451 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 847' ' ' VAL . . . . . 0.401 HG12 ' HB2' ' A' ' 849' ' ' GLN . 66.6 t -134.93 102.82 10.98 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.617 -0.677 . . . . 1.8300000000000001 110.004 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 848' ' ' PRO . . . . . 0.765 ' O ' HG23 ' A' ' 850' ' ' VAL . 44.2 Cg_endo -69.83 -18.66 36.56 Favored 'Trans proline' 0 N--CA 1.488 1.155 0 O-C-N 123.344 1.181 . . . . 0.65000000000000002 111.168 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 849' ' ' GLN . . . . . 0.401 ' HB2' HG12 ' A' ' 847' ' ' VAL . 55.8 tt0 27.39 67.97 0.07 Allowed 'General case' 0 N--CA 1.518 2.927 0 N-CA-C 113.025 0.75 . . . . 2.5800000000000001 113.025 179.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 850' ' ' VAL . . . . . 0.765 HG23 ' O ' ' A' ' 848' ' ' PRO . 69.9 t -119.39 137.02 54.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 121.202 -0.936 . . . . 1.0900000000000001 111.442 -178.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 851' ' ' ALA . . . . . 0.641 ' HB3' ' HG ' ' A' ' 873' ' ' LEU . . . -124.13 159.0 30.99 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 105.827 -1.916 . . . . 0.040000000000000001 105.827 176.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 852' ' ' PHE . . . . . 0.431 ' HA ' ' CB ' ' A' ' 874' ' ' ASN . 32.7 p90 -159.6 127.96 4.99 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 120.948 1.704 . . . . 0.050000000000000003 108.492 178.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 7.8 t -175.71 134.42 0.29 Allowed 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.152 -1.055 . . . . 0.040000000000000001 108.152 -178.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -131.98 157.41 44.15 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.083 -1.011 . . . . 0.67000000000000004 109.626 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 855' ' ' ALA . . . . . 0.863 ' HB3' ' CB ' ' A' ' 870' ' ' ARG . . . -120.78 146.1 46.86 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-O 122.018 0.914 . . . . 0.51000000000000001 111.291 -178.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 856' ' ' LEU . . . . . 0.754 HD12 HD23 ' A' ' 978' ' ' LEU . 2.7 tm? -113.01 133.36 54.99 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.738 -0.601 . . . . 0.050000000000000003 109.872 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 857' ' ' SER . . . . . 0.659 ' N ' HD13 ' A' ' 856' ' ' LEU . 30.3 p -154.37 14.6 0.44 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.526 -0.734 . . . . 1.3300000000000001 111.683 179.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 858' ' ' LEU . . . . . 0.562 HD12 ' C ' ' A' ' 858' ' ' LEU . 4.5 pp -33.22 159.64 0.03 OUTLIER Pre-proline 0 N--CA 1.52 3.028 0 N-CA-C 113.427 0.899 . . . . 2.3300000000000001 113.427 -179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -61.85 -88.29 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 120.965 1.11 . . . . 2.3199999999999998 113.316 -178.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 53.6 ptt85 -128.01 -142.47 0.27 Allowed 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.887 -1.133 . . . . 0.040000000000000001 111.397 -177.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 8.8 m -41.28 129.04 2.99 Favored 'General case' 0 N--CA 1.509 2.498 0 O-C-N 121.459 -0.776 . . . . 1.3100000000000001 111.902 -179.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 862' ' ' GLU . . . . . 0.592 ' OE1' HG22 ' A' ' 866' ' ' VAL . 1.9 tt0 -94.81 152.77 39.96 Favored Pre-proline 0 N--CA 1.492 1.626 0 N-CA-C 108.107 -1.071 . . . . 4.5099999999999998 108.107 177.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 863' ' ' PRO . . . . . 0.413 ' HD2' ' CG ' ' A' ' 862' ' ' GLU . 43.5 Cg_endo -70.27 -12.22 31.55 Favored 'Trans proline' 0 C--N 1.314 -1.271 0 O-C-N 123.059 1.031 . . . . 2.2400000000000002 111.161 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -175.74 -136.07 2.25 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 110.107 -1.197 . . . . 0.040000000000000001 110.107 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 39.9 m -64.38 155.77 31.37 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.382 -1.07 . . . . 1.51 111.331 -178.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 866' ' ' VAL . . . . . 0.592 HG22 ' OE1' ' A' ' 862' ' ' GLU . 2.7 t -91.12 128.07 48.97 Favored Pre-proline 0 N--CA 1.5 2.059 0 N-CA-C 113.399 0.889 . . . . 0.78000000000000003 113.399 -174.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 867' ' ' PRO . . . . . 0.614 ' O ' HD23 ' A' ' 856' ' ' LEU . 51.3 Cg_endo -92.05 -155.62 0.05 OUTLIER 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 121.174 1.25 . . . . 0.92000000000000004 109.516 177.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 868' ' ' PHE . . . . . 0.454 ' CD1' ' HG2' ' A' ' 881' ' ' PRO . 21.1 p90 -151.73 123.64 8.06 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.654 -1.279 . . . . 0.050000000000000003 109.994 179.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 44.0 p30 -114.62 -0.72 13.55 Favored 'General case' 0 N--CA 1.501 2.109 0 C-N-CA 119.345 -0.942 . . . . 1.7 112.762 -178.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 870' ' ' ARG . . . . . 0.863 ' CB ' ' HB3' ' A' ' 855' ' ' ALA . 26.9 mmm180 -90.97 90.47 7.9 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 120.845 -1.16 . . . . 2.5899999999999999 111.099 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 60.4 t -74.7 97.13 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 120.978 -1.076 . . . . 1.9399999999999999 109.911 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 872' ' ' LEU . . . . . 0.623 HD11 ' HB2' ' A' ' 855' ' ' ALA . 96.3 mt -83.2 -46.81 12.27 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.468 -0.77 . . . . 1.0600000000000001 110.131 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 873' ' ' LEU . . . . . 0.641 ' HG ' ' HB3' ' A' ' 851' ' ' ALA . 36.9 tp -174.52 102.98 0.1 Allowed 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 108.521 -0.918 . . . . 4.1799999999999997 108.521 178.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 874' ' ' ASN . . . . . 0.431 ' CB ' ' HA ' ' A' ' 852' ' ' PHE . 35.4 t-20 178.73 80.86 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.3 0 O-C-N 121.622 -0.674 . . . . 0.040000000000000001 109.555 -178.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -66.7 -47.27 72.92 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.211 -0.931 . . . . 3.3799999999999999 111.204 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 876' ' ' GLY . . . . . . . . . . . . . . . -73.56 -24.86 73.86 Favored Glycine 0 N--CA 1.494 2.555 0 O-C-N 121.306 -0.871 . . . . 0.040000000000000001 111.509 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 84.0 -59.93 4.9 Favored Glycine 0 N--CA 1.502 3.041 0 N-CA-C 108.088 -2.005 . . . . 0.040000000000000001 108.088 -178.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 878' ' ' TYR . . . . . 0.447 ' CZ ' HG11 ' A' ' 850' ' ' VAL . 97.7 m-85 60.78 -65.79 0.06 Allowed 'General case' 0 N--CA 1.503 2.22 0 N-CA-C 114.206 1.188 . . . . 3.46 114.206 177.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 879' ' ' TYR . . . . . 0.555 ' HH ' ' HD1' ' A' ' 981' ' ' PHE . 21.0 p90 -112.73 109.35 18.79 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 114.833 1.42 . . . . 0.040000000000000001 114.833 -176.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.42 116.77 37.28 Favored Pre-proline 0 N--CA 1.496 1.825 0 O-C-N 121.381 -0.825 . . . . 0.02 109.647 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 881' ' ' PRO . . . . . 0.454 ' HG2' ' CD1' ' A' ' 868' ' ' PHE . 53.6 Cg_endo -75.59 -0.02 9.67 Favored 'Trans proline' 0 N--CA 1.497 1.686 0 O-C-N 123.492 1.259 . . . . 0.39000000000000001 112.493 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -75.99 -63.15 1.38 Allowed 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 106.723 -1.584 . . . . 0.81000000000000005 106.723 178.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 41.1 p -94.1 -20.23 20.1 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.482 -0.933 . . . . 0.040000000000000001 108.482 177.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.21 20.94 58.08 Favored Glycine 0 N--CA 1.495 2.573 0 O-C-N 121.034 -1.041 . . . . 0.029999999999999999 111.385 178.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 885' ' ' VAL . . . . . . . . . . . . . 99.3 t -73.67 91.81 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 C-N-CA 118.103 -1.439 . . . . 1.01 108.196 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 886' ' ' PHE . . . . . 0.834 ' HB3' HG22 ' A' ' 962' ' ' VAL . 0.7 OUTLIER -89.87 104.75 17.29 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-N 115.118 -0.946 . . . . 0.050000000000000003 112.092 -177.143 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 887' ' ' THR . . . . . 0.445 ' O ' ' HD3' ' A' ' 889' ' ' PRO . 93.7 m -96.29 100.42 12.05 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 107.685 -1.228 . . . . 0.68000000000000005 107.685 177.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 888' ' ' ALA . . . . . . . . . . . . . . . -98.62 105.95 33.61 Favored Pre-proline 0 N--CA 1.502 2.132 0 N-CA-C 114.279 1.215 . . . . 0.25 114.279 -176.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 889' ' ' PRO . . . . . 0.445 ' HD3' ' O ' ' A' ' 887' ' ' THR . 54.1 Cg_endo -89.0 -13.37 3.09 Favored 'Trans proline' 0 CA--C 1.546 1.105 0 N-CA-C 108.935 -1.217 . . . . 1.6399999999999999 108.935 175.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 890' ' ' LEU . . . . . 0.709 HD22 HD13 ' A' ' 985' ' ' LEU . 69.3 mt -36.54 -49.97 0.77 Allowed 'General case' 0 N--CA 1.508 2.47 0 N-CA-C 113.612 0.967 . . . . 2.29 113.612 -177.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 52.09 96.03 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.249 0 O-C-N 121.189 -0.944 . . . . 0.63 110.289 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 158.0 -153.61 24.78 Favored Glycine 0 N--CA 1.478 1.468 0 N-CA-C 107.227 -2.349 . . . . 0.040000000000000001 107.227 -179.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 893' ' ' ARG . . . . . 0.438 ' CZ ' ' HB1' ' C' ' 984' ' ' ALA . 72.9 ttt-85 -115.7 126.39 54.05 Favored 'General case' 0 C--N 1.294 -1.82 0 O-C-N 121.601 -0.94 . . . . 3.0 108.512 177.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 894' ' ' TYR . . . . . 0.742 ' OH ' HD12 ' A' ' 896' ' ' LEU . 0.1 OUTLIER -132.26 159.99 37.49 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.177 -0.952 . . . . 0.040000000000000001 111.038 -179.74 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 895' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' A' ' 895' ' ' LEU . 37.8 tp -91.77 118.49 30.74 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.69 -0.631 . . . . 1.27 110.168 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 896' ' ' LEU . . . . . 0.742 HD12 ' OH ' ' A' ' 894' ' ' TYR . 9.2 tt -110.05 142.16 41.88 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.707 -0.621 . . . . 0.93999999999999995 110.047 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 897' ' ' SER . . . . . 0.442 ' N ' HD23 ' A' ' 896' ' ' LEU . 64.1 m -148.9 115.51 5.92 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.452 -0.78 . . . . 0.040000000000000001 110.982 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.61 146.18 32.3 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.892 -0.781 . . . . 0.47999999999999998 108.892 178.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 899' ' ' VAL . . . . . 0.732 HG21 ' HB ' ' A' ' 980' ' ' ILE . 87.5 t -94.73 120.39 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.373 -0.829 . . . . 0.55000000000000004 111.033 -179.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 900' ' ' LEU . . . . . 0.619 HD12 ' HB2' ' A' ' 924' ' ' SER . 4.3 mm? -95.23 112.8 24.46 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 114.382 1.252 . . . . 1.5900000000000001 114.382 -174.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 15.6 m -66.85 141.53 57.65 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 107.334 -1.358 . . . . 0.050000000000000003 107.334 176.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -67.02 -65.83 2.62 Favored Glycine 0 N--CA 1.494 2.549 0 N-CA-C 110.583 -1.007 . . . . 0.029999999999999999 110.583 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 8.8 m170 46.72 66.7 0.92 Allowed 'General case' 0 N--CA 1.508 2.437 0 O-C-N 121.493 -1.004 . . . . 3.2000000000000002 111.155 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 43.2 ptt85 -69.38 -5.88 26.38 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.624 -0.672 . . . . 2.9199999999999999 112.108 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 905' ' ' HIS . . . . . 0.487 ' O ' ' CB ' ' A' ' 906' ' ' GLU . 72.7 t60 -62.32 5.03 0.12 Allowed 'General case' 0 N--CA 1.506 2.335 0 O-C-N 120.918 -1.114 . . . . 2.8700000000000001 113.155 -179.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 906' ' ' GLU . . . . . 0.487 ' CB ' ' O ' ' A' ' 905' ' ' HIS . 0.5 OUTLIER 94.63 -164.29 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.449 0 CA-C-N 120.562 1.528 . . . . 0.98999999999999999 111.824 179.007 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 907' ' ' LYS . . . . . 0.465 ' CB ' ' O ' ' A' ' 906' ' ' GLU . 63.1 tttt 85.59 156.59 0.09 Allowed 'General case' 0 N--CA 1.52 3.031 0 N-CA-C 108.024 -1.102 . . . . 5.25 108.024 -176.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 58.9 t -122.02 116.38 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 120.787 -1.196 . . . . 0.39000000000000001 111.099 -179.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -99.82 133.21 44.52 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 107.319 -1.363 . . . . 1.72 107.319 176.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -155.92 121.94 5.04 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 106.842 -1.54 . . . . 0.67000000000000004 106.842 178.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 911' ' ' VAL . . . . . 0.814 HG22 HG13 ' A' ' 964' ' ' VAL . 87.3 t -84.06 132.15 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.86 -0.525 . . . . 0.54000000000000004 110.783 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 62.2 mt -65.63 156.42 32.84 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.404 -0.81 . . . . 1.5 109.025 178.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 913' ' ' SER . . . . . 0.413 ' CB ' ' CG1' ' A' ' 919' ' ' VAL . 1.3 t -123.02 138.4 54.7 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.316 -0.994 . . . . 1.3700000000000001 108.316 177.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 914' ' ' ARG . . . . . 0.624 ' NH1' HD23 ' A' ' 956' ' ' LEU . 0.0 OUTLIER -65.15 154.79 36.94 Favored 'General case' 0 N--CA 1.505 2.284 0 O-C-N 120.762 -1.211 . . . . 4.2999999999999998 111.751 -179.049 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 915' ' ' SER . . . . . 0.426 ' CB ' ' O ' ' A' ' 914' ' ' ARG . 4.7 t 83.07 -32.71 0.08 Allowed 'General case' 0 N--CA 1.522 3.136 0 C-N-CA 123.979 0.911 . . . . 2.0499999999999998 112.254 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 916' ' ' ASN . . . . . 0.767 ' HB2' HG21 ' A' ' 919' ' ' VAL . 92.9 m-20 -121.1 -20.46 6.79 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.947 -1.095 . . . . 2.71 111.469 -179.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 917' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 66.82 165.04 0.21 Allowed 'General case' 0 N--CA 1.521 3.111 0 N-CA-C 105.452 -2.055 . . . . 2.6800000000000002 105.452 -173.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.33 -125.38 33.82 Favored Glycine 1 N--CA 1.521 4.357 0 CA-C-N 123.545 2.884 . . . . 0.029999999999999999 106.987 -177.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 919' ' ' VAL . . . . . 0.767 HG21 ' HB2' ' A' ' 916' ' ' ASN . 78.6 t 51.58 94.9 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 O-C-N 121.513 -0.992 . . . . 1.3899999999999999 108.996 -178.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 920' ' ' ALA . . . . . 0.858 ' HB3' HG12 ' A' ' 949' ' ' VAL . . . -91.38 92.29 8.51 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.246 -0.982 . . . . 0.029999999999999999 110.902 -179.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 921' ' ' ARG . . . . . 0.886 ' HG3' HG23 ' A' ' 922' ' ' VAL . 27.5 ptt180 -83.9 -41.76 17.07 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 105.756 -1.942 . . . . 4.4199999999999999 105.756 175.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 922' ' ' VAL . . . . . 0.886 HG23 ' HG3' ' A' ' 921' ' ' ARG . 78.7 t -102.19 73.44 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 N-CA-C 106.308 -1.738 . . . . 0.84999999999999998 106.308 175.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -86.82 133.75 33.61 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 121.643 0.735 . . . . 2.46 111.231 -177.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 924' ' ' SER . . . . . 0.619 ' HB2' HD12 ' A' ' 900' ' ' LEU . 28.0 t -147.83 105.9 3.74 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.907 -0.775 . . . . 0.69999999999999996 108.907 179.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -102.91 83.65 0.44 Allowed Glycine 0 N--CA 1.487 2.043 0 N-CA-C 108.277 -1.929 . . . . 0.040000000000000001 108.277 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.126 0 N-CA-C 108.67 -1.772 . . . . 0.040000000000000001 108.67 -179.709 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 33.0 m . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.012 0.434 . . . . 13.779999999999999 110.21 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 96.2 mt -112.44 129.44 56.32 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.666 -0.646 . . . . 13.76 110.365 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -152.34 168.03 31.41 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 108.967 -1.653 . . . . 9.1300000000000008 108.967 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 949' ' ' VAL . . . . . 0.858 HG12 ' HB3' ' A' ' 920' ' ' ALA . 34.9 m -119.38 130.77 73.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.502 -0.999 . . . . 7.0800000000000001 110.998 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 950' ' ' PHE . . . . . 0.455 ' CE1' ' HD2' ' A' ' 955' ' ' PRO . 25.5 p90 -133.24 150.51 51.94 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.565 -0.709 . . . . 7.5899999999999999 109.149 179.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 19.5 m -120.66 -53.19 2.1 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.341 -0.85 . . . . 5.0300000000000002 112.314 -178.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 952' ' ' LEU . . . . . 0.427 ' O ' ' O ' ' A' ' 953' ' ' ILE . 13.6 tp -60.39 -73.01 0.1 Allowed 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.411 -0.805 . . . . 1.01 112.576 -177.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 953' ' ' ILE . . . . . 0.948 HD11 HD13 ' C' ' 872' ' ' LEU . 46.1 pt -52.6 -145.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.768 0 N-CA-C 114.06 1.133 . . . . 2.6000000000000001 114.06 -176.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 954' ' ' LEU . . . . . 0.708 HD22 ' O ' ' A' ' 954' ' ' LEU . 0.0 OUTLIER 171.84 77.45 0.04 OUTLIER Pre-proline 0 N--CA 1.51 2.554 0 O-C-N 120.768 -1.208 . . . . 0.050000000000000003 111.461 179.555 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 955' ' ' PRO . . . . . 0.69 ' C ' HD12 ' A' ' 956' ' ' LEU . 48.4 Cg_endo -74.88 96.41 1.01 Allowed 'Trans proline' 0 C--N 1.315 -1.227 0 N-CA-C 109.521 -0.992 . . . . 0.83999999999999997 109.521 178.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 956' ' ' LEU . . . . . 0.69 HD12 ' C ' ' A' ' 955' ' ' PRO . 10.4 mp -123.03 145.68 48.31 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.197 -0.939 . . . . 0.040000000000000001 110.214 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -83.71 150.41 25.86 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 117.773 -1.108 . . . . 1.28 111.675 -179.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -70.4 119.87 15.22 Favored 'General case' 0 N--CA 1.51 2.526 0 CA-C-N 122.967 2.621 . . . . 0.17000000000000001 111.558 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.6 -22.77 31.5 Favored Glycine 0 N--CA 1.501 3.008 0 N-CA-C 111.16 -0.776 . . . . 0.040000000000000001 111.16 178.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 960' ' ' ASP . . . . . 0.438 ' HB3' ' NE ' ' A' ' 914' ' ' ARG . 0.6 OUTLIER -52.14 172.14 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.49 -1.006 . . . . 0.040000000000000001 110.403 -179.409 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 961' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 886' ' ' PHE . 7.2 t -134.77 134.6 41.11 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.008 -1.058 . . . . 1.78 111.849 -178.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 962' ' ' VAL . . . . . 0.834 HG22 ' HB3' ' A' ' 886' ' ' PHE . 31.7 m -99.01 145.91 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 C-N-CA 120.074 -0.65 . . . . 0.040000000000000001 110.44 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 5.3 t -139.0 145.24 39.43 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.853 -0.529 . . . . 0.71999999999999997 110.115 -178.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 964' ' ' VAL . . . . . 0.814 HG13 HG22 ' A' ' 911' ' ' VAL . 55.5 t -94.12 136.57 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.105 -0.997 . . . . 1.05 110.714 -179.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -95.81 126.79 41.31 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 103.665 -2.717 . . . . 3.02 103.665 173.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 966' ' ' LEU . . . . . 0.492 ' C ' HG23 ' A' ' 967' ' ' VAL . 20.8 tp -132.6 62.35 1.65 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.304 -0.999 . . . . 1.46 108.304 177.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 967' ' ' VAL . . . . . 0.492 HG23 ' C ' ' A' ' 966' ' ' LEU . 89.9 t -158.21 97.19 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 108.049 -1.093 . . . . 1.9399999999999999 108.049 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 88.8 mmm -142.99 59.37 1.42 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.737 -1.227 . . . . 0.0 108.184 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.44 119.91 1.96 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 106.957 -2.457 . . . . 2.1099999999999999 106.957 -178.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -81.55 -57.9 3.26 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 118.696 1.248 . . . . 5.8899999999999997 110.368 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 44.2 tp -58.82 90.58 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.501 -0.75 . . . . 4.3600000000000003 110.203 179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -141.43 -155.02 0.55 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.562 -0.711 . . . . 1.8300000000000001 110.344 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -119.79 172.03 7.99 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.476 -0.765 . . . . 4.3499999999999996 110.38 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 29.2 t -101.51 130.32 47.76 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.537 -0.727 . . . . 1.27 110.102 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -156.44 158.35 37.14 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.511 -0.743 . . . . 5.0199999999999996 110.548 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.72 86.36 15.91 Favored Pre-proline 0 N--CA 1.501 2.094 0 O-C-N 121.602 -0.686 . . . . 2.4100000000000001 109.713 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.07 -172.8 1.07 Allowed 'Trans proline' 0 C--N 1.317 -1.093 0 O-C-N 123.271 1.143 . . . . 0.95999999999999996 111.547 -179.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 978' ' ' LEU . . . . . 0.754 HD23 HD12 ' A' ' 856' ' ' LEU . 5.2 mp -127.93 154.73 45.22 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 107.577 -1.268 . . . . 0.62 107.577 178.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 979' ' ' THR . . . . . 0.449 HG23 ' C ' ' A' ' 978' ' ' LEU . 33.7 p -150.34 142.15 23.75 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.809 -1.182 . . . . 3.5699999999999998 111.368 -179.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 980' ' ' ILE . . . . . 0.732 ' HB ' HG21 ' A' ' 899' ' ' VAL . 46.8 mm -106.5 127.44 61.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 108.798 -0.815 . . . . 1.3300000000000001 108.798 179.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 981' ' ' PHE . . . . . 0.555 ' HD1' ' HH ' ' A' ' 879' ' ' TYR . 5.7 t80 -119.49 97.48 5.67 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 119.762 -0.775 . . . . 0.050000000000000003 111.726 -178.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 77.8 p -108.55 158.48 17.52 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.485 -0.759 . . . . 0.87 109.331 178.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 983' ' ' GLY . . . . . 0.403 ' O ' ' CE1' ' A' ' 852' ' ' PHE . . . -174.98 107.55 0.24 Allowed Glycine 0 N--CA 1.499 2.859 0 N-CA-C 106.452 -2.659 . . . . 0.029999999999999999 106.452 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -108.75 152.5 24.77 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 114.507 1.299 . . . . 0.69999999999999996 114.507 -175.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 985' ' ' LEU . . . . . 0.709 HD13 HD22 ' A' ' 890' ' ' LEU . 53.1 tp -71.29 134.03 46.49 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.793 -1.192 . . . . 0.040000000000000001 110.141 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 45.9 tp -107.61 -56.13 2.26 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.552 -0.718 . . . . 0.040000000000000001 109.804 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -145.26 145.2 31.18 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 107.701 -1.222 . . . . 0.040000000000000001 107.701 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -113.02 163.32 12.15 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 108.293 -1.923 . . . . 0.040000000000000001 108.293 179.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -75.44 112.69 20.27 Favored Pre-proline 0 N--CA 1.5 2.026 0 O-C-N 121.256 -1.144 . . . . 0.040000000000000001 109.485 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 990' ' ' PRO . . . . . 0.417 ' HD2' HD12 ' A' ' 992' ' ' LEU . 50.7 Cg_endo -90.19 70.92 1.56 Allowed 'Trans proline' 0 C--N 1.319 -1.004 0 O-C-N 123.134 1.07 . . . . 0.45000000000000001 111.514 -179.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 991' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 990' ' ' PRO . 70.6 mt-10 67.37 -73.61 0.08 Allowed 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 108.584 -0.895 . . . . 1.97 108.584 -177.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 992' ' ' LEU . . . . . 0.417 HD12 ' HD2' ' A' ' 990' ' ' PRO . 10.9 mt 51.05 20.58 0.85 Allowed 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.502 -0.749 . . . . 2.3799999999999999 111.638 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 83.6 mt-10 -94.09 156.87 16.36 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.879 -1.138 . . . . 3.79 110.085 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 72.4 m80 -146.63 93.33 2.27 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.526 -0.734 . . . . 3.5099999999999998 110.311 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 995' ' ' ALA . . . . . . . . . . . . 2.518 . . . . . . . 0 N--CA 1.503 2.198 0 O-C-N 120.831 -1.168 . . . . 2.73 110.614 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo . . . . . 0 N--CA 1.488 1.18 0 N-CA-C 109.429 -1.027 . . . . 3.8300000000000001 109.429 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 847' ' ' VAL . . . . . . . . . . . . . 66.4 t -134.93 102.91 10.94 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.557 -0.715 . . . . 1.8300000000000001 110.041 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 848' ' ' PRO . . . . . 0.772 ' O ' HG23 ' B' ' 850' ' ' VAL . 44.2 Cg_endo -69.81 -18.93 36.51 Favored 'Trans proline' 0 N--CA 1.488 1.167 0 O-C-N 123.319 1.168 . . . . 0.65000000000000002 111.136 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 849' ' ' GLN . . . . . 0.405 ' C ' ' O ' ' B' ' 848' ' ' PRO . 55.9 tt0 27.59 68.22 0.07 Allowed 'General case' 0 N--CA 1.518 2.953 0 N-CA-C 112.951 0.723 . . . . 2.5800000000000001 112.951 179.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 850' ' ' VAL . . . . . 0.772 HG23 ' O ' ' B' ' 848' ' ' PRO . 68.0 t -119.62 137.13 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.193 -0.942 . . . . 1.0900000000000001 111.427 -179.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 851' ' ' ALA . . . . . 0.643 ' HB3' ' HG ' ' B' ' 873' ' ' LEU . . . -124.71 158.21 33.77 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 105.828 -1.916 . . . . 0.040000000000000001 105.828 176.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 852' ' ' PHE . . . . . 0.425 ' HA ' ' CB ' ' B' ' 874' ' ' ASN . 32.1 p90 -158.82 128.27 5.61 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 121.056 1.753 . . . . 0.050000000000000003 108.493 179.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 7.6 t -175.79 134.09 0.28 Allowed 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.245 -1.021 . . . . 0.040000000000000001 108.245 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -131.49 157.76 42.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.106 -0.996 . . . . 0.67000000000000004 109.668 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 855' ' ' ALA . . . . . 0.854 ' HB3' ' CB ' ' B' ' 870' ' ' ARG . . . -121.1 146.15 47.04 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-O 121.997 0.903 . . . . 0.51000000000000001 111.287 -178.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 856' ' ' LEU . . . . . 0.726 HD12 HD23 ' B' ' 978' ' ' LEU . 2.7 tm? -113.17 132.83 55.32 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.712 -0.617 . . . . 0.050000000000000003 109.971 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 857' ' ' SER . . . . . 0.654 ' N ' HD13 ' B' ' 856' ' ' LEU . 30.1 p -153.97 14.92 0.48 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.521 -0.737 . . . . 1.3300000000000001 111.711 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 858' ' ' LEU . . . . . 0.56 HD12 ' C ' ' B' ' 858' ' ' LEU . 4.5 pp -33.46 159.69 0.03 OUTLIER Pre-proline 0 N--CA 1.52 3.052 0 N-CA-C 113.401 0.889 . . . . 2.3300000000000001 113.401 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -61.96 -88.39 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 121.013 1.142 . . . . 2.3199999999999998 113.235 -178.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 53.6 ptt85 -127.94 -142.53 0.27 Allowed 'General case' 0 N--CA 1.5 2.045 0 O-C-N 120.893 -1.13 . . . . 0.040000000000000001 111.405 -177.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 8.8 m -41.21 128.29 2.88 Favored 'General case' 0 N--CA 1.509 2.482 0 O-C-N 121.383 -0.823 . . . . 1.3100000000000001 111.909 -179.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 862' ' ' GLU . . . . . 0.589 ' OE1' HG22 ' B' ' 866' ' ' VAL . 1.9 tt0 -94.09 152.81 40.67 Favored Pre-proline 0 N--CA 1.491 1.592 0 N-CA-C 108.085 -1.08 . . . . 4.5099999999999998 108.085 177.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 863' ' ' PRO . . . . . 0.411 ' HD2' ' CG ' ' B' ' 862' ' ' GLU . 43.1 Cg_endo -70.14 -12.36 32.03 Favored 'Trans proline' 0 C--N 1.314 -1.248 0 O-C-N 123.086 1.045 . . . . 2.2400000000000002 111.25 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -175.42 -134.92 1.99 Allowed Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.063 -1.215 . . . . 0.040000000000000001 110.063 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 41.5 m -65.49 156.76 31.49 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.294 -1.121 . . . . 1.51 111.247 -178.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 866' ' ' VAL . . . . . 0.589 HG22 ' OE1' ' B' ' 862' ' ' GLU . 2.7 t -91.96 127.99 47.44 Favored Pre-proline 0 N--CA 1.499 1.995 0 N-CA-C 113.424 0.898 . . . . 0.78000000000000003 113.424 -174.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 867' ' ' PRO . . . . . 0.617 ' O ' HD23 ' B' ' 856' ' ' LEU . 51.8 Cg_endo -92.01 -155.81 0.05 OUTLIER 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 121.149 1.233 . . . . 0.92000000000000004 109.547 177.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 868' ' ' PHE . . . . . 0.46 ' CD1' ' HG2' ' B' ' 881' ' ' PRO . 21.7 p90 -151.56 123.43 8.06 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 120.636 -1.29 . . . . 0.050000000000000003 110.019 179.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 44.2 p30 -114.46 -0.32 13.79 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.2 -0.938 . . . . 1.7 112.815 -178.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 870' ' ' ARG . . . . . 0.854 ' CB ' ' HB3' ' B' ' 855' ' ' ALA . 26.7 mmm180 -91.45 90.16 7.54 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.86 -1.15 . . . . 2.5899999999999999 111.145 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 59.6 t -74.42 97.2 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 120.951 -1.093 . . . . 1.9399999999999999 109.959 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 872' ' ' LEU . . . . . 0.628 HD11 ' HB2' ' B' ' 855' ' ' ALA . 96.2 mt -83.34 -46.67 12.32 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.492 -0.755 . . . . 1.0600000000000001 110.14 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 873' ' ' LEU . . . . . 0.643 ' HG ' ' HB3' ' B' ' 851' ' ' ALA . 36.9 tp -174.54 102.99 0.1 Allowed 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 108.507 -0.923 . . . . 4.1799999999999997 108.507 178.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 874' ' ' ASN . . . . . 0.425 ' CB ' ' HA ' ' B' ' 852' ' ' PHE . 35.4 t-20 178.73 81.12 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.337 0 O-C-N 121.63 -0.668 . . . . 0.040000000000000001 109.552 -178.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -66.94 -47.28 72.15 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.127 -0.983 . . . . 3.3799999999999999 111.198 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 876' ' ' GLY . . . . . . . . . . . . . . . -73.56 -24.98 73.6 Favored Glycine 0 N--CA 1.494 2.521 0 O-C-N 121.305 -0.872 . . . . 0.040000000000000001 111.454 -178.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 84.14 -59.78 4.91 Favored Glycine 0 N--CA 1.501 3.001 0 N-CA-C 108.075 -2.01 . . . . 0.040000000000000001 108.075 -178.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 878' ' ' TYR . . . . . 0.44 ' CZ ' HG11 ' B' ' 850' ' ' VAL . 97.7 m-85 60.82 -65.73 0.06 Allowed 'General case' 0 N--CA 1.503 2.189 0 N-CA-C 114.226 1.195 . . . . 3.46 114.226 177.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 879' ' ' TYR . . . . . 0.495 ' HH ' ' HD1' ' B' ' 981' ' ' PHE . 21.1 p90 -112.8 109.31 18.7 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 114.769 1.396 . . . . 0.040000000000000001 114.769 -176.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.25 116.72 36.28 Favored Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.343 -0.848 . . . . 0.02 109.698 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 881' ' ' PRO . . . . . 0.46 ' HG2' ' CD1' ' B' ' 868' ' ' PHE . 53.9 Cg_endo -75.53 -0.22 9.88 Favored 'Trans proline' 0 N--CA 1.497 1.709 0 O-C-N 123.47 1.247 . . . . 0.39000000000000001 112.534 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -75.7 -63.55 1.27 Allowed 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 106.716 -1.587 . . . . 0.81000000000000005 106.716 178.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 41.4 p -93.91 -19.9 20.52 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.482 -0.933 . . . . 0.040000000000000001 108.482 177.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.76 21.4 57.85 Favored Glycine 0 N--CA 1.494 2.556 0 O-C-N 121.05 -1.031 . . . . 0.029999999999999999 111.369 178.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 885' ' ' VAL . . . . . . . . . . . . . 98.8 t -73.91 92.14 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 C-N-CA 118.084 -1.446 . . . . 1.01 108.06 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 886' ' ' PHE . . . . . 0.879 ' HB3' HG22 ' B' ' 962' ' ' VAL . 0.7 OUTLIER -90.1 104.87 17.4 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 115.119 -0.946 . . . . 0.050000000000000003 112.085 -177.192 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 887' ' ' THR . . . . . 0.442 ' O ' ' HD3' ' B' ' 889' ' ' PRO . 93.9 m -96.41 100.67 12.26 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 107.63 -1.248 . . . . 0.68000000000000005 107.63 177.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 888' ' ' ALA . . . . . . . . . . . . . . . -98.87 105.86 33.91 Favored Pre-proline 0 N--CA 1.502 2.125 0 N-CA-C 114.267 1.21 . . . . 0.25 114.267 -176.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 889' ' ' PRO . . . . . 0.442 ' HD3' ' O ' ' B' ' 887' ' ' THR . 54.1 Cg_endo -88.9 -13.44 3.14 Favored 'Trans proline' 0 CA--C 1.546 1.118 0 N-CA-C 108.982 -1.199 . . . . 1.6399999999999999 108.982 175.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 890' ' ' LEU . . . . . 0.72 HD22 HD13 ' B' ' 985' ' ' LEU . 69.7 mt -36.39 -50.09 0.75 Allowed 'General case' 0 N--CA 1.508 2.457 0 N-CA-C 113.612 0.967 . . . . 2.29 113.612 -177.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 52.1 95.95 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.259 0 O-C-N 121.135 -0.978 . . . . 0.63 110.25 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . 158.05 -153.72 24.88 Favored Glycine 0 N--CA 1.478 1.496 0 N-CA-C 107.18 -2.368 . . . . 0.040000000000000001 107.18 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 72.8 ttt-85 -115.61 126.41 54.15 Favored 'General case' 0 C--N 1.295 -1.778 0 O-C-N 121.581 -0.952 . . . . 3.0 108.529 177.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 894' ' ' TYR . . . . . 0.74 ' OH ' HD12 ' B' ' 896' ' ' LEU . 0.1 OUTLIER -132.17 160.19 36.78 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.182 -0.949 . . . . 0.040000000000000001 111.041 -179.754 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 895' ' ' LEU . . . . . 0.4 HD23 HD11 ' C' ' 952' ' ' LEU . 37.9 tp -92.1 118.49 30.86 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.654 -0.654 . . . . 1.27 110.141 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 896' ' ' LEU . . . . . 0.74 HD12 ' OH ' ' B' ' 894' ' ' TYR . 9.2 tt -110.0 141.59 42.58 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.761 -0.587 . . . . 0.93999999999999995 110.106 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 897' ' ' SER . . . . . 0.433 ' N ' HD23 ' B' ' 896' ' ' LEU . 64.4 m -148.35 115.26 6.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.478 -0.764 . . . . 0.040000000000000001 111.032 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.26 146.07 31.93 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.989 -0.745 . . . . 0.47999999999999998 108.989 178.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 899' ' ' VAL . . . . . 0.721 HG21 ' HB ' ' B' ' 980' ' ' ILE . 88.0 t -94.64 120.15 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 C-N-CA 119.653 -0.819 . . . . 0.55000000000000004 111.138 -179.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 900' ' ' LEU . . . . . 0.619 HD12 ' HB2' ' B' ' 924' ' ' SER . 4.3 mm? -95.02 112.45 24.16 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 114.457 1.281 . . . . 1.5900000000000001 114.457 -174.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 15.3 m -66.58 141.44 57.84 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 107.319 -1.363 . . . . 0.050000000000000003 107.319 176.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -67.24 -65.84 2.6 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 110.608 -0.997 . . . . 0.029999999999999999 110.608 -179.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 8.8 m170 46.73 66.76 0.9 Allowed 'General case' 0 N--CA 1.508 2.453 0 O-C-N 121.492 -1.005 . . . . 3.2000000000000002 111.155 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 43.1 ptt85 -69.32 -6.28 28.58 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.62 -0.675 . . . . 2.9199999999999999 112.084 -179.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 905' ' ' HIS . . . . . 0.485 ' O ' ' CB ' ' B' ' 906' ' ' GLU . 72.6 t60 -61.66 4.47 0.11 Allowed 'General case' 0 N--CA 1.505 2.324 0 O-C-N 120.929 -1.107 . . . . 2.8700000000000001 113.198 -179.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 906' ' ' GLU . . . . . 0.485 ' CB ' ' O ' ' B' ' 905' ' ' HIS . 0.5 OUTLIER 94.96 -164.44 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.439 0 CA-C-N 120.561 1.528 . . . . 0.98999999999999999 111.668 179.063 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 907' ' ' LYS . . . . . 0.472 ' CB ' ' O ' ' B' ' 906' ' ' GLU . 63.2 tttt 85.75 156.3 0.08 Allowed 'General case' 0 N--CA 1.52 3.035 0 N-CA-C 108.095 -1.076 . . . . 5.25 108.095 -176.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 59.2 t -121.81 116.18 48.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 120.814 -1.179 . . . . 0.39000000000000001 111.152 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 75.1 tt0 -99.57 133.42 43.93 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 107.274 -1.38 . . . . 1.72 107.274 176.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -156.21 122.08 4.95 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 106.879 -1.526 . . . . 0.67000000000000004 106.879 178.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 911' ' ' VAL . . . . . 0.795 HG22 HG13 ' B' ' 964' ' ' VAL . 87.0 t -84.27 132.38 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.842 -0.536 . . . . 0.54000000000000004 110.813 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 63.0 mt -65.72 156.75 32.07 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.333 -0.854 . . . . 1.5 108.946 178.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 913' ' ' SER . . . . . 0.408 ' CB ' ' CG1' ' B' ' 919' ' ' VAL . 1.4 t -123.57 137.48 54.74 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.393 -0.965 . . . . 1.3700000000000001 108.393 177.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 914' ' ' ARG . . . . . 0.621 ' NH1' HD23 ' B' ' 956' ' ' LEU . 0.0 OUTLIER -64.12 154.64 33.99 Favored 'General case' 0 N--CA 1.505 2.311 0 O-C-N 120.77 -1.206 . . . . 4.2999999999999998 111.888 -178.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 915' ' ' SER . . . . . 0.419 ' CB ' ' O ' ' B' ' 914' ' ' ARG . 4.7 t 83.2 -33.0 0.08 Allowed 'General case' 0 N--CA 1.521 3.114 0 C-N-CA 124.017 0.927 . . . . 2.0499999999999998 112.272 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 916' ' ' ASN . . . . . 0.806 ' HB2' HG21 ' B' ' 919' ' ' VAL . 92.4 m-20 -120.74 -20.76 6.89 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 120.909 -1.119 . . . . 2.71 111.46 -179.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 917' ' ' GLN . . . . . 0.4 ' HB2' ' O ' ' B' ' 916' ' ' ASN . 41.8 mt-30 66.83 164.46 0.2 Allowed 'General case' 0 N--CA 1.521 3.116 0 N-CA-C 105.472 -2.047 . . . . 2.6800000000000002 105.472 -173.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 55.09 -125.5 35.99 Favored Glycine 1 N--CA 1.521 4.349 0 CA-C-N 123.567 2.894 . . . . 0.029999999999999999 106.8 -177.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 919' ' ' VAL . . . . . 0.806 HG21 ' HB2' ' B' ' 916' ' ' ASN . 82.3 t 51.39 95.05 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.253 0 O-C-N 121.476 -1.014 . . . . 1.3899999999999999 109.062 -178.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 920' ' ' ALA . . . . . 0.845 ' HB3' HG12 ' B' ' 949' ' ' VAL . . . -91.51 92.16 8.39 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.31 -0.956 . . . . 0.029999999999999999 110.844 -179.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 921' ' ' ARG . . . . . 0.87 ' HG3' HG23 ' B' ' 922' ' ' VAL . 27.5 ptt180 -83.96 -41.73 17.01 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 105.738 -1.949 . . . . 4.4199999999999999 105.738 175.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 922' ' ' VAL . . . . . 0.87 HG23 ' HG3' ' B' ' 921' ' ' ARG . 77.9 t -102.16 73.14 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 N-CA-C 106.375 -1.713 . . . . 0.84999999999999998 106.375 175.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -86.49 133.76 33.72 Favored 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.637 0.732 . . . . 2.46 111.241 -177.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 924' ' ' SER . . . . . 0.619 ' HB2' HD12 ' B' ' 900' ' ' LEU . 27.8 t -147.83 105.77 3.72 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 108.974 -0.75 . . . . 0.69999999999999996 108.974 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -102.69 83.57 0.45 Allowed Glycine 0 N--CA 1.486 1.968 0 N-CA-C 108.37 -1.892 . . . . 0.040000000000000001 108.37 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 926' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' B' ' 906' ' ' GLU . . . . . . . . 0 N--CA 1.488 2.156 0 N-CA-C 108.661 -1.776 . . . . 0.040000000000000001 108.661 -179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 32.7 m . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.078 0.466 . . . . 13.779999999999999 110.162 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 96.2 mt -111.03 129.4 55.92 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.581 -0.699 . . . . 13.76 110.325 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -151.73 166.76 30.89 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.114 -1.594 . . . . 9.1300000000000008 109.114 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 949' ' ' VAL . . . . . 0.845 HG12 ' HB3' ' B' ' 920' ' ' ALA . 35.5 m -118.81 130.24 73.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.519 -0.989 . . . . 7.0800000000000001 110.967 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 950' ' ' PHE . . . . . 0.448 ' CE1' ' HD2' ' B' ' 955' ' ' PRO . 25.5 p90 -133.03 150.41 52.13 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.546 -0.721 . . . . 7.5899999999999999 109.162 179.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 19.5 m -120.67 -52.76 2.11 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.367 -0.833 . . . . 5.0300000000000002 112.252 -178.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 952' ' ' LEU . . . . . 0.418 ' O ' ' O ' ' B' ' 953' ' ' ILE . 13.6 tp -60.62 -73.22 0.09 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.365 -0.835 . . . . 1.01 112.382 -177.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 953' ' ' ILE . . . . . 0.5 ' O ' ' HB3' ' B' ' 954' ' ' LEU . 46.0 pt -52.26 -144.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.779 0 N-CA-C 114.177 1.177 . . . . 2.6000000000000001 114.177 -176.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 954' ' ' LEU . . . . . 0.726 HD22 ' O ' ' B' ' 954' ' ' LEU . 0.0 OUTLIER 171.64 77.23 0.04 OUTLIER Pre-proline 0 N--CA 1.51 2.526 0 O-C-N 120.808 -1.183 . . . . 0.050000000000000003 111.39 179.478 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 955' ' ' PRO . . . . . 0.699 ' C ' HD12 ' B' ' 956' ' ' LEU . 48.2 Cg_endo -74.89 96.54 1.02 Allowed 'Trans proline' 0 C--N 1.313 -1.295 0 N-CA-C 109.481 -1.007 . . . . 0.83999999999999997 109.481 178.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 956' ' ' LEU . . . . . 0.699 HD12 ' C ' ' B' ' 955' ' ' PRO . 10.4 mp -123.11 145.62 48.42 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.125 -0.984 . . . . 0.040000000000000001 110.166 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 16.1 mt-30 -83.58 150.66 25.8 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-O 117.866 -1.064 . . . . 1.28 111.645 -179.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -70.5 119.62 14.93 Favored 'General case' 0 N--CA 1.51 2.545 0 CA-C-N 122.845 2.566 . . . . 0.17000000000000001 111.579 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.74 -22.98 30.72 Favored Glycine 0 N--CA 1.501 3.021 0 N-CA-C 111.111 -0.796 . . . . 0.040000000000000001 111.111 178.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 960' ' ' ASP . . . . . 0.44 ' HB3' ' NE ' ' B' ' 914' ' ' ARG . 0.6 OUTLIER -51.86 172.15 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.168 0 O-C-N 121.53 -0.982 . . . . 0.040000000000000001 110.358 -179.403 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 961' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' B' ' 886' ' ' PHE . 7.1 t -134.73 134.71 41.3 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.986 -1.071 . . . . 1.78 111.855 -178.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 962' ' ' VAL . . . . . 0.879 HG22 ' HB3' ' B' ' 886' ' ' PHE . 31.1 m -99.17 145.8 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 C-N-CA 120.072 -0.651 . . . . 0.040000000000000001 110.453 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 5.3 t -138.79 145.23 39.88 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.861 -0.524 . . . . 0.71999999999999997 110.191 -178.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 964' ' ' VAL . . . . . 0.795 HG13 HG22 ' B' ' 911' ' ' VAL . 55.2 t -94.24 136.32 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.11 -0.994 . . . . 1.05 110.717 -179.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -95.72 126.37 40.94 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 103.755 -2.683 . . . . 3.02 103.755 173.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 966' ' ' LEU . . . . . 0.494 ' C ' HG23 ' B' ' 967' ' ' VAL . 20.8 tp -132.23 62.52 1.64 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.35 -0.981 . . . . 1.46 108.35 177.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 967' ' ' VAL . . . . . 0.494 HG23 ' C ' ' B' ' 966' ' ' LEU . 89.8 t -158.42 97.01 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 N-CA-C 108.095 -1.076 . . . . 1.9399999999999999 108.095 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 88.7 mmm -142.77 59.19 1.43 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.765 -1.21 . . . . 0.0 108.281 178.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.53 119.69 1.93 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 107.0 -2.44 . . . . 2.1099999999999999 107.0 -178.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -81.22 -57.86 3.32 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.063 -1.257 . . . . 5.8899999999999997 110.435 -179.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 44.2 tp -58.91 90.37 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.465 -0.772 . . . . 4.3600000000000003 110.223 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -141.27 -154.91 0.54 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.575 -0.703 . . . . 1.8300000000000001 110.304 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -119.86 172.1 7.95 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.464 -0.773 . . . . 4.3499999999999996 110.38 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 29.5 t -101.52 130.29 47.77 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.565 -0.709 . . . . 1.27 110.145 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -156.41 158.35 37.18 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.504 -0.747 . . . . 5.0199999999999996 110.553 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.7 86.32 16.0 Favored Pre-proline 0 N--CA 1.5 2.06 0 O-C-N 121.614 -0.679 . . . . 2.4100000000000001 109.7 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -73.12 -172.83 1.09 Allowed 'Trans proline' 0 C--N 1.317 -1.123 0 O-C-N 123.344 1.181 . . . . 0.95999999999999996 111.514 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 978' ' ' LEU . . . . . 0.726 HD23 HD12 ' B' ' 856' ' ' LEU . 5.2 mp -127.81 154.91 44.88 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.644 -1.243 . . . . 0.62 107.644 178.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 979' ' ' THR . . . . . 0.453 HG23 ' C ' ' B' ' 978' ' ' LEU . 33.7 p -150.51 142.16 23.62 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.81 -1.181 . . . . 3.5699999999999998 111.384 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 980' ' ' ILE . . . . . 0.721 ' HB ' HG21 ' B' ' 899' ' ' VAL . 47.0 mm -106.49 127.06 62.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 108.765 -0.828 . . . . 1.3300000000000001 108.765 179.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 981' ' ' PHE . . . . . 0.495 ' HD1' ' HH ' ' B' ' 879' ' ' TYR . 5.6 t80 -119.27 97.64 5.76 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.458 -0.776 . . . . 0.050000000000000003 111.767 -178.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 982' ' ' SER . . . . . 0.4 ' HB2' HD23 ' C' ' 952' ' ' LEU . 77.8 p -109.02 159.0 17.19 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.544 -0.722 . . . . 0.87 109.428 178.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 983' ' ' GLY . . . . . 0.402 ' HA3' ' CE1' ' B' ' 852' ' ' PHE . . . -175.01 107.77 0.25 Allowed Glycine 0 N--CA 1.499 2.869 0 N-CA-C 106.53 -2.628 . . . . 0.029999999999999999 106.53 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -108.62 152.33 24.93 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 114.44 1.274 . . . . 0.69999999999999996 114.44 -175.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 985' ' ' LEU . . . . . 0.72 HD13 HD22 ' B' ' 890' ' ' LEU . 53.3 tp -71.26 134.03 46.52 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.9 -1.125 . . . . 0.040000000000000001 110.108 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 986' ' ' LEU . . . . . 0.488 ' CD1' HD11 ' C' ' 986' ' ' LEU . 45.8 tp -107.62 -56.17 2.26 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.591 -0.693 . . . . 0.040000000000000001 109.923 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -145.34 145.05 31.05 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 107.737 -1.208 . . . . 0.040000000000000001 107.737 178.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.92 163.02 12.18 Favored Glycine 0 N--CA 1.496 2.653 0 N-CA-C 108.21 -1.956 . . . . 0.040000000000000001 108.21 179.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -75.13 112.76 19.73 Favored Pre-proline 0 N--CA 1.499 1.978 0 O-C-N 121.165 -1.197 . . . . 0.040000000000000001 109.535 179.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 990' ' ' PRO . . . . . 0.425 ' HD2' HD12 ' B' ' 992' ' ' LEU . 50.9 Cg_endo -90.18 70.95 1.56 Allowed 'Trans proline' 0 C--N 1.319 -0.985 0 O-C-N 123.13 1.068 . . . . 0.45000000000000001 111.423 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 991' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' B' ' 990' ' ' PRO . 70.6 mt-10 67.25 -73.57 0.08 Allowed 'General case' 0 N--CA 1.503 2.207 0 N-CA-C 108.6 -0.889 . . . . 1.97 108.6 -177.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 992' ' ' LEU . . . . . 0.434 ' HA ' HD23 ' B' ' 992' ' ' LEU . 10.9 mt 51.22 20.31 0.88 Allowed 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.551 -0.718 . . . . 2.3799999999999999 111.621 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 83.6 mt-10 -93.73 156.95 16.4 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.86 -1.15 . . . . 3.79 110.104 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 72.1 m80 -146.67 92.73 2.19 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.534 -0.729 . . . . 3.5099999999999998 110.395 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 995' ' ' ALA . . . . . . . . . . . . 2.517 . . . . . . . 0 N--CA 1.503 2.222 0 O-C-N 120.953 -1.092 . . . . 2.73 110.639 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo . . . . . 0 N--CA 1.488 1.174 0 N-CA-C 109.488 -1.005 . . . . 3.8300000000000001 109.488 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' C' C ' 847' ' ' VAL . . . . . . . . . . . . . 57.7 t -130.31 103.28 16.67 Favored Pre-proline 0 N--CA 1.496 1.869 0 O-C-N 121.604 -0.685 . . . . 1.8300000000000001 110.133 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 848' ' ' PRO . . . . . 0.708 ' O ' HG23 ' C' ' 850' ' ' VAL . 44.2 Cg_endo -70.49 -21.29 30.32 Favored 'Trans proline' 0 N--CA 1.488 1.182 0 O-C-N 123.277 1.146 . . . . 0.65000000000000002 111.269 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 849' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 27.5 69.97 0.06 Allowed 'General case' 0 N--CA 1.519 3.024 0 N-CA-C 112.826 0.676 . . . . 2.5800000000000001 112.826 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 850' ' ' VAL . . . . . 0.708 HG23 ' O ' ' C' ' 848' ' ' PRO . 61.2 t -119.93 134.57 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 O-C-N 121.234 -0.916 . . . . 1.0900000000000001 111.648 -178.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 851' ' ' ALA . . . . . 0.584 ' HB3' ' HG ' ' C' ' 873' ' ' LEU . . . -127.46 155.32 43.88 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 105.772 -1.936 . . . . 0.040000000000000001 105.772 176.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 852' ' ' PHE . . . . . 0.455 ' CD1' ' N ' ' C' ' 852' ' ' PHE . 13.2 p90 -159.96 127.56 4.65 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 121.049 1.75 . . . . 0.050000000000000003 108.557 178.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 29.4 t -176.72 134.13 0.21 Allowed 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.105 -1.072 . . . . 0.040000000000000001 108.105 -179.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 854' ' ' ALA . . . . . 0.529 ' HB1' ' HD2' ' C' ' 868' ' ' PHE . . . -131.13 156.32 45.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.169 -0.957 . . . . 0.67000000000000004 109.642 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 855' ' ' ALA . . . . . 0.779 ' HB3' ' CB ' ' C' ' 870' ' ' ARG . . . -121.54 141.54 50.96 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.891 0.853 . . . . 0.51000000000000001 111.107 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 856' ' ' LEU . . . . . 0.995 HD11 HD23 ' C' ' 858' ' ' LEU . 3.5 tm? -114.53 137.59 51.67 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.402 -0.811 . . . . 0.050000000000000003 110.171 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 857' ' ' SER . . . . . 0.57 ' N ' HD13 ' C' ' 856' ' ' LEU . 1.9 m -153.8 19.38 0.52 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.52 -0.737 . . . . 1.3300000000000001 110.866 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 858' ' ' LEU . . . . . 0.995 HD23 HD11 ' C' ' 856' ' ' LEU . 1.4 pp -34.06 160.9 0.04 OUTLIER Pre-proline 0 N--CA 1.516 2.853 0 N-CA-C 113.189 0.811 . . . . 2.3300000000000001 113.189 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -61.6 -88.2 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 120.816 1.011 . . . . 2.3199999999999998 113.306 -178.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 54.6 ptt85 -131.04 -142.33 0.23 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 120.873 -1.142 . . . . 0.040000000000000001 111.435 -177.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 74.5 m -38.42 130.23 1.32 Allowed 'General case' 0 N--CA 1.511 2.589 0 O-C-N 121.563 -0.71 . . . . 1.3100000000000001 112.172 -178.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 862' ' ' GLU . . . . . 0.522 ' HG2' HD13 ' C' ' 858' ' ' LEU . 1.5 mm-40 -102.99 158.79 31.06 Favored Pre-proline 0 N--CA 1.488 1.436 0 N-CA-C 108.237 -1.023 . . . . 4.5099999999999998 108.237 177.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -70.18 -13.75 33.97 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 O-C-N 123.203 1.107 . . . . 2.2400000000000002 110.829 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -176.7 -136.03 2.31 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.08 -1.608 . . . . 0.040000000000000001 109.08 179.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 24.7 m -68.83 155.59 39.93 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.27 -1.135 . . . . 1.51 110.164 -179.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 866' ' ' VAL . . . . . 0.445 HG11 ' CD2' ' C' ' 858' ' ' LEU . 60.2 t -99.88 138.05 20.27 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.466 -0.771 . . . . 0.78000000000000003 113.048 -175.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 867' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' C' ' 866' ' ' VAL . 55.4 Cg_endo -90.4 -147.05 0.03 OUTLIER 'Trans proline' 0 CA--C 1.546 1.086 0 O-C-N 123.533 1.28 . . . . 0.92000000000000004 109.234 178.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 868' ' ' PHE . . . . . 0.529 ' HD2' ' HB1' ' C' ' 854' ' ' ALA . 24.5 p90 -149.29 125.37 10.68 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 120.487 -1.383 . . . . 0.050000000000000003 110.032 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 50.9 p-10 -112.46 -2.82 14.59 Favored 'General case' 0 N--CA 1.499 2.013 0 C-N-CA 119.295 -0.962 . . . . 1.7 112.744 -178.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 870' ' ' ARG . . . . . 0.779 ' CB ' ' HB3' ' C' ' 855' ' ' ALA . 25.8 mmm180 -91.41 88.84 6.99 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 120.849 -1.157 . . . . 2.5899999999999999 111.112 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 63.1 t -72.86 97.34 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 120.902 -1.123 . . . . 1.9399999999999999 109.288 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 872' ' ' LEU . . . . . 0.948 HD13 HD11 ' A' ' 953' ' ' ILE . 72.9 mt -86.48 -45.94 10.66 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.537 -0.727 . . . . 1.0600000000000001 110.561 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 873' ' ' LEU . . . . . 0.584 ' HG ' ' HB3' ' C' ' 851' ' ' ALA . 36.8 tp -173.09 102.5 0.13 Allowed 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.208 -0.932 . . . . 4.1799999999999997 108.715 178.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 874' ' ' ASN . . . . . 0.435 ' CB ' ' HA ' ' C' ' 852' ' ' PHE . 35.5 t-20 177.49 82.46 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.231 0 N-CA-C 108.827 -0.805 . . . . 0.040000000000000001 108.827 -178.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -65.05 -46.68 80.23 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.194 -0.941 . . . . 3.3799999999999999 111.521 -178.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 876' ' ' GLY . . . . . 0.414 ' HA3' ' CE2' ' C' ' 878' ' ' TYR . . . -73.01 -26.56 70.7 Favored Glycine 0 N--CA 1.493 2.474 0 O-C-N 121.243 -0.91 . . . . 0.040000000000000001 111.748 -178.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 80.34 -62.38 4.3 Favored Glycine 0 N--CA 1.501 3.007 0 N-CA-C 107.911 -2.075 . . . . 0.040000000000000001 107.911 -178.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 878' ' ' TYR . . . . . 0.414 ' CE2' ' HA3' ' C' ' 876' ' ' GLY . 93.2 m-85 60.61 -65.73 0.05 Allowed 'General case' 0 N--CA 1.503 2.22 0 N-CA-C 114.404 1.261 . . . . 3.46 114.404 177.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 879' ' ' TYR . . . . . 0.505 ' CE2' ' CD1' ' C' ' 981' ' ' PHE . 28.8 p90 -110.27 106.83 16.38 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 114.826 1.417 . . . . 0.040000000000000001 114.826 -176.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -73.75 117.19 58.99 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.489 -0.757 . . . . 0.02 109.806 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 881' ' ' PRO . . . . . 0.429 ' HD2' ' CE1' ' C' ' 868' ' ' PHE . 54.2 Cg_endo -77.07 1.07 9.07 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 O-C-N 123.34 1.179 . . . . 0.39000000000000001 112.351 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 71.5 mt-10 -73.55 -53.61 10.13 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 105.733 -1.951 . . . . 0.81000000000000005 105.733 177.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 14.7 p -99.7 -21.0 16.0 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 115.068 -0.969 . . . . 0.040000000000000001 108.841 177.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 81.93 15.76 74.25 Favored Glycine 0 N--CA 1.496 2.672 0 N-CA-C 110.434 -1.066 . . . . 0.029999999999999999 110.434 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 58.5 t -74.87 91.94 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 C-N-CA 118.422 -1.311 . . . . 1.01 108.584 -178.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 886' ' ' PHE . . . . . 0.894 ' HB3' HG22 ' C' ' 962' ' ' VAL . 1.0 OUTLIER -88.04 106.18 17.97 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 115.173 -0.921 . . . . 0.050000000000000003 111.531 -177.696 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 887' ' ' THR . . . . . 0.439 ' O ' ' HD3' ' C' ' 889' ' ' PRO . 88.3 m -101.46 99.79 10.16 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.669 -1.234 . . . . 0.68000000000000005 107.669 177.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 888' ' ' ALA . . . . . . . . . . . . . . . -98.45 102.0 13.21 Favored Pre-proline 0 N--CA 1.5 2.061 0 N-CA-C 114.375 1.25 . . . . 0.25 114.375 -176.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 889' ' ' PRO . . . . . 0.439 ' HD3' ' O ' ' C' ' 887' ' ' THR . 55.6 Cg_endo -81.45 -15.27 10.01 Favored 'Trans proline' 0 CA--C 1.544 1.014 0 N-CA-C 108.632 -1.334 . . . . 1.6399999999999999 108.632 175.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 890' ' ' LEU . . . . . 0.613 HD21 HG11 ' C' ' 850' ' ' VAL . 67.6 mt -37.27 -49.36 0.94 Allowed 'General case' 0 N--CA 1.506 2.369 0 N-CA-C 113.394 0.887 . . . . 2.29 113.394 -177.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 52.4 96.99 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.241 0 O-C-N 121.268 -0.895 . . . . 0.63 110.196 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . 159.28 -153.64 24.72 Favored Glycine 0 N--CA 1.477 1.411 0 N-CA-C 107.45 -2.26 . . . . 0.040000000000000001 107.45 -179.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 76.0 ttt-85 -117.62 123.1 45.34 Favored 'General case' 0 C--N 1.293 -1.877 0 O-C-N 121.715 -0.874 . . . . 3.0 108.872 178.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 894' ' ' TYR . . . . . 0.786 ' CE2' HD23 ' C' ' 954' ' ' LEU . 13.6 p90 -132.89 155.91 48.17 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.024 -1.047 . . . . 0.040000000000000001 111.193 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 895' ' ' LEU . . . . . . . . . . . . . 46.0 tp -98.58 111.65 23.94 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.694 -0.629 . . . . 1.27 109.87 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 896' ' ' LEU . . . . . 0.507 HD22 HH12 ' C' ' 921' ' ' ARG . 10.1 tt -115.66 144.91 43.25 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.618 -0.676 . . . . 0.93999999999999995 109.926 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 897' ' ' SER . . . . . 0.437 ' N ' HD23 ' C' ' 896' ' ' LEU . 43.3 m -142.03 124.87 16.05 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.393 -0.817 . . . . 0.040000000000000001 111.477 -179.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -101.22 148.13 25.46 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.759 -0.83 . . . . 0.47999999999999998 108.759 178.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 899' ' ' VAL . . . . . 0.716 HG21 ' HB ' ' C' ' 980' ' ' ILE . 84.7 t -92.42 120.79 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.321 -0.862 . . . . 0.55000000000000004 111.23 -179.11 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 91.6 mt -92.15 113.45 25.73 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 114.006 1.113 . . . . 1.5900000000000001 114.006 -175.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 21.7 m -62.7 140.9 58.74 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 107.527 -1.286 . . . . 0.050000000000000003 107.527 177.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -60.91 -65.37 3.36 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 110.238 -1.145 . . . . 0.029999999999999999 110.238 -179.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 6.5 m170 46.1 65.62 1.13 Allowed 'General case' 0 N--CA 1.506 2.363 0 O-C-N 121.518 -0.989 . . . . 3.2000000000000002 111.235 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -66.86 -8.28 27.86 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.623 -0.673 . . . . 2.9199999999999999 111.819 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 905' ' ' HIS . . . . . 0.474 ' O ' ' CB ' ' C' ' 906' ' ' GLU . 72.6 t60 -62.94 4.87 0.15 Allowed 'General case' 0 N--CA 1.503 2.215 0 O-C-N 120.915 -1.116 . . . . 2.8700000000000001 112.679 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 906' ' ' GLU . . . . . 0.498 ' O ' ' CB ' ' C' ' 907' ' ' LYS . 2.0 mt-10 89.73 -153.99 0.01 OUTLIER 'General case' 0 N--CA 1.526 3.329 0 CA-C-N 121.136 1.789 . . . . 0.98999999999999999 111.567 179.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 907' ' ' LYS . . . . . 0.498 ' CB ' ' O ' ' C' ' 906' ' ' GLU . 56.5 tttt 88.84 162.85 0.06 Allowed 'General case' 0 N--CA 1.52 3.066 0 N-CA-C 107.759 -1.2 . . . . 5.25 107.759 -176.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 59.7 t -122.7 114.59 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 O-C-N 120.778 -1.202 . . . . 0.39000000000000001 110.781 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 909' ' ' GLU . . . . . 0.62 ' OE2' HD12 ' C' ' 966' ' ' LEU . 42.8 tp10 -105.79 131.19 53.43 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 107.557 -1.275 . . . . 1.72 107.557 177.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -156.73 120.44 4.27 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 106.943 -1.503 . . . . 0.67000000000000004 106.943 178.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 911' ' ' VAL . . . . . 0.521 ' HA ' ' HA ' ' C' ' 964' ' ' VAL . 12.8 p -80.08 131.57 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 C-N-CA 120.306 -0.558 . . . . 0.54000000000000004 111.321 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 62.4 mt -66.23 156.72 33.4 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.258 -0.901 . . . . 1.5 108.885 178.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 913' ' ' SER . . . . . 0.418 ' CB ' ' CG1' ' C' ' 919' ' ' VAL . 1.7 t -126.19 136.93 53.44 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.377 -0.971 . . . . 1.3700000000000001 108.377 177.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 914' ' ' ARG . . . . . 0.844 ' CZ ' HD23 ' C' ' 956' ' ' LEU . 0.0 OUTLIER -63.67 154.0 34.38 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 120.707 -1.246 . . . . 4.2999999999999998 111.708 -178.783 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 915' ' ' SER . . . . . 0.425 ' CB ' ' O ' ' C' ' 914' ' ' ARG . 2.4 t 83.28 -30.61 0.09 Allowed 'General case' 0 N--CA 1.521 3.119 0 C-N-CA 123.808 0.843 . . . . 2.0499999999999998 112.384 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 916' ' ' ASN . . . . . 0.785 ' HB2' HG21 ' C' ' 919' ' ' VAL . 94.8 m-20 -122.19 -21.74 5.8 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.868 -1.145 . . . . 2.71 111.362 -179.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 67.36 166.11 0.23 Allowed 'General case' 0 N--CA 1.521 3.082 0 N-CA-C 105.491 -2.04 . . . . 2.6800000000000002 105.491 -173.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.27 -125.18 33.13 Favored Glycine 1 N--CA 1.521 4.362 0 CA-C-N 123.773 2.988 . . . . 0.029999999999999999 107.08 -177.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 919' ' ' VAL . . . . . 0.785 HG21 ' HB2' ' C' ' 916' ' ' ASN . 96.7 t 49.83 94.06 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.266 0 O-C-N 121.543 -0.975 . . . . 1.3899999999999999 109.334 -178.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 920' ' ' ALA . . . . . 0.91 ' HB3' HG12 ' C' ' 949' ' ' VAL . . . -94.74 95.48 8.75 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.469 -0.892 . . . . 0.029999999999999999 110.886 -179.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 921' ' ' ARG . . . . . 0.726 ' HG3' HG23 ' C' ' 922' ' ' VAL . 42.8 ptt85 -79.9 -42.05 24.92 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 105.538 -2.023 . . . . 4.4199999999999999 105.538 176.015 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 922' ' ' VAL . . . . . 0.726 HG23 ' HG3' ' C' ' 921' ' ' ARG . 84.6 t -99.89 76.8 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 N-CA-C 105.545 -2.02 . . . . 0.84999999999999998 105.545 175.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -90.61 136.7 32.9 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 122.005 0.907 . . . . 2.46 112.794 -176.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 5.1 t -146.99 103.36 3.6 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.619 -1.252 . . . . 0.69999999999999996 107.619 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -109.21 83.83 0.34 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.485 -1.446 . . . . 0.040000000000000001 109.485 -179.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.361 0 N-CA-C 109.172 -1.571 . . . . 0.040000000000000001 109.172 -179.997 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 22.7 m . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 120.997 0.427 . . . . 13.779999999999999 110.303 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 95.2 mt -112.87 129.89 56.3 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.518 -0.739 . . . . 13.76 110.453 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -151.77 169.89 31.21 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.212 -1.555 . . . . 9.1300000000000008 109.212 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 949' ' ' VAL . . . . . 0.91 HG12 ' HB3' ' C' ' 920' ' ' ALA . 34.1 m -118.04 135.73 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.519 -0.989 . . . . 7.0800000000000001 111.034 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 950' ' ' PHE . . . . . 0.457 ' CZ ' ' HB3' ' C' ' 921' ' ' ARG . 51.7 p90 -135.06 152.47 51.71 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.555 -0.716 . . . . 7.5899999999999999 109.379 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 7.6 t -119.05 -55.09 2.19 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.386 -0.822 . . . . 5.0300000000000002 111.852 -179.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 952' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' C' ' 953' ' ' ILE . 58.9 tp -62.71 -77.07 0.05 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.433 -0.792 . . . . 1.01 111.472 -178.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 953' ' ' ILE . . . . . 0.571 HD12 ' HD3' ' C' ' 955' ' ' PRO . 2.1 pp -49.12 -151.12 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.688 0 N-CA-C 114.615 1.339 . . . . 2.6000000000000001 114.615 -176.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 954' ' ' LEU . . . . . 0.786 HD23 ' CE2' ' C' ' 894' ' ' TYR . 0.0 OUTLIER 170.02 89.45 0.04 OUTLIER Pre-proline 0 N--CA 1.516 2.85 0 O-C-N 120.78 -1.2 . . . . 0.050000000000000003 112.068 -179.497 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 955' ' ' PRO . . . . . 0.649 ' C ' HD12 ' C' ' 956' ' ' LEU . 50.0 Cg_endo -83.66 94.65 0.78 Allowed 'Trans proline' 0 C--N 1.315 -1.196 0 N-CA-C 109.506 -0.998 . . . . 0.83999999999999997 109.506 178.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 956' ' ' LEU . . . . . 0.844 HD23 ' CZ ' ' C' ' 914' ' ' ARG . 6.6 mp -125.64 150.84 47.24 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.024 -1.047 . . . . 0.040000000000000001 110.622 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -81.89 151.5 27.25 Favored 'General case' 0 N--CA 1.498 1.965 0 CA-C-O 117.66 -1.162 . . . . 1.28 111.323 -178.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -66.41 118.43 10.04 Favored 'General case' 0 N--CA 1.507 2.393 0 CA-C-N 123.202 2.728 . . . . 0.17000000000000001 110.874 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.54 -19.75 48.72 Favored Glycine 0 N--CA 1.499 2.897 0 N-CA-C 111.067 -0.813 . . . . 0.040000000000000001 111.067 178.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 960' ' ' ASP . . . . . 0.425 ' HB3' ' NE ' ' C' ' 914' ' ' ARG . 0.5 OUTLIER -52.32 171.91 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.344 -1.092 . . . . 0.040000000000000001 110.505 -179.473 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 961' ' ' THR . . . . . 0.488 ' HA ' ' O ' ' C' ' 886' ' ' PHE . 26.3 m -136.93 140.38 42.23 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.043 -1.035 . . . . 1.78 112.614 -177.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 962' ' ' VAL . . . . . 0.894 HG22 ' HB3' ' C' ' 886' ' ' PHE . 26.8 m -101.07 145.47 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 C-N-CA 120.302 -0.559 . . . . 0.040000000000000001 110.809 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 6.2 t -137.99 144.44 41.13 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.815 -0.553 . . . . 0.71999999999999997 109.858 -179.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 964' ' ' VAL . . . . . 0.521 ' HA ' ' HA ' ' C' ' 911' ' ' VAL . 61.8 t -90.79 137.67 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.043 -1.036 . . . . 1.05 110.713 -178.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 18.4 t0 -92.67 125.17 37.17 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 103.289 -2.856 . . . . 3.02 103.289 173.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 966' ' ' LEU . . . . . 0.62 HD12 ' OE2' ' C' ' 909' ' ' GLU . 0.2 OUTLIER -133.68 57.46 1.81 Allowed 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.635 -0.876 . . . . 1.46 108.635 177.76 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 967' ' ' VAL . . . . . 0.489 HG23 ' C ' ' C' ' 966' ' ' LEU . 98.1 t -158.48 96.41 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 N-CA-C 108.277 -1.009 . . . . 1.9399999999999999 108.277 179.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 90.2 mmm -142.74 59.22 1.43 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.759 -1.213 . . . . 0.0 108.459 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 134.44 119.53 1.97 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 107.205 -2.358 . . . . 2.1099999999999999 107.205 -178.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 95.4 mm-40 -82.34 -57.71 3.25 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.082 -1.246 . . . . 5.8899999999999997 110.684 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 41.4 tp -58.87 89.74 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.46 -0.775 . . . . 4.3600000000000003 110.401 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -142.63 -152.69 0.42 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.572 -0.705 . . . . 1.8300000000000001 110.129 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 7.7 t60 -116.74 167.43 11.1 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.384 -0.823 . . . . 4.3499999999999996 110.076 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 41.1 t -102.8 130.69 49.86 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.624 -0.673 . . . . 1.27 110.197 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -156.35 158.55 37.6 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.498 -0.751 . . . . 5.0199999999999996 110.753 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.82 86.1 15.9 Favored Pre-proline 0 N--CA 1.501 2.116 0 O-C-N 121.616 -0.677 . . . . 2.4100000000000001 109.716 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -75.71 -170.17 0.79 Allowed 'Trans proline' 0 C--N 1.318 -1.061 0 O-C-N 123.303 1.159 . . . . 0.95999999999999996 111.453 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 978' ' ' LEU . . . . . 0.524 ' N ' HD12 ' C' ' 978' ' ' LEU . 5.2 mp -124.97 156.39 38.12 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 107.511 -1.292 . . . . 0.62 107.511 177.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 979' ' ' THR . . . . . 0.445 HG23 ' C ' ' C' ' 978' ' ' LEU . 39.5 p -149.92 141.47 23.45 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.728 -1.232 . . . . 3.5699999999999998 111.325 -179.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 980' ' ' ILE . . . . . 0.716 ' HB ' HG21 ' C' ' 899' ' ' VAL . 47.5 mm -106.96 128.48 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 N-CA-C 109.122 -0.696 . . . . 1.3300000000000001 109.122 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 981' ' ' PHE . . . . . 0.505 ' CD1' ' CE2' ' C' ' 879' ' ' TYR . 3.2 t80 -117.89 95.44 4.92 Favored 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 119.69 -0.804 . . . . 0.050000000000000003 111.568 -178.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 982' ' ' SER . . . . . . . . . . . . . 12.5 p -107.63 158.27 17.39 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.6 -0.688 . . . . 0.87 109.255 178.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 983' ' ' GLY . . . . . 0.417 ' HA3' ' CE2' ' C' ' 852' ' ' PHE . . . -172.18 114.48 0.53 Allowed Glycine 0 N--CA 1.497 2.704 0 N-CA-C 106.601 -2.6 . . . . 0.029999999999999999 106.601 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 984' ' ' ALA . . . . . 0.438 ' HB1' ' CZ ' ' A' ' 893' ' ' ARG . . . -108.4 150.76 26.94 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 114.259 1.207 . . . . 0.69999999999999996 114.259 -175.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 985' ' ' LEU . . . . . 0.583 HD13 HD22 ' C' ' 890' ' ' LEU . 47.9 tp -75.32 135.71 40.88 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 120.814 -1.179 . . . . 0.040000000000000001 109.609 179.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 986' ' ' LEU . . . . . 0.488 HD11 ' CD1' ' B' ' 986' ' ' LEU . 45.5 tp -106.23 -63.16 1.29 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.461 -0.774 . . . . 0.040000000000000001 110.329 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -144.28 146.94 32.92 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 107.806 -1.183 . . . . 0.040000000000000001 107.806 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -111.96 162.71 12.33 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 107.99 -2.044 . . . . 0.040000000000000001 107.99 179.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.81 112.73 19.0 Favored Pre-proline 0 N--CA 1.497 1.895 0 O-C-N 121.135 -1.215 . . . . 0.040000000000000001 109.452 179.117 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 990' ' ' PRO . . . . . 0.419 ' HD2' HD12 ' C' ' 992' ' ' LEU . 50.9 Cg_endo -89.29 71.24 2.01 Favored 'Trans proline' 0 C--N 1.319 -1.017 0 O-C-N 123.109 1.057 . . . . 0.45000000000000001 111.301 -178.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 991' ' ' GLU . . . . . 0.417 ' HB2' ' O ' ' C' ' 990' ' ' PRO . 85.7 mt-10 67.11 -73.77 0.07 Allowed 'General case' 0 N--CA 1.502 2.166 0 N-CA-C 108.687 -0.857 . . . . 1.97 108.687 -177.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 992' ' ' LEU . . . . . 0.419 HD12 ' HD2' ' C' ' 990' ' ' PRO . 11.3 mt 50.5 21.3 0.83 Allowed 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.594 -0.691 . . . . 2.3799999999999999 111.553 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -93.35 156.97 16.47 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.936 -1.102 . . . . 3.79 110.144 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 68.6 m80 -146.31 92.48 2.18 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.597 -0.689 . . . . 3.5099999999999998 110.202 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 995' ' ' ALA . . . . . . . . . . . . 2.519 . . . . . . . 0 N--CA 1.503 2.224 0 O-C-N 120.917 -1.115 . . . . 2.73 110.614 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo . . . . . 0 N--CA 1.488 1.157 0 N-CA-C 109.525 -0.991 . . . . 3.8300000000000001 109.525 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 847' ' ' VAL . . . . . . . . . . . . . 62.0 t -134.49 103.26 11.34 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.574 -0.704 . . . . 1.8300000000000001 110.014 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 848' ' ' PRO . . . . . 0.707 ' O ' HG23 ' A' ' 850' ' ' VAL . 44.1 Cg_endo -69.99 -18.64 35.83 Favored 'Trans proline' 0 N--CA 1.488 1.182 0 O-C-N 123.315 1.166 . . . . 0.65000000000000002 111.303 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 849' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 27.58 68.72 0.07 Allowed 'General case' 0 N--CA 1.518 2.975 0 N-CA-C 112.941 0.719 . . . . 2.5800000000000001 112.941 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 850' ' ' VAL . . . . . 0.707 HG23 ' O ' ' A' ' 848' ' ' PRO . 62.1 t -118.92 135.81 58.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 O-C-N 121.221 -0.924 . . . . 1.0900000000000001 111.429 -178.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 851' ' ' ALA . . . . . 0.464 ' HB3' ' HG ' ' A' ' 873' ' ' LEU . . . -126.76 156.95 40.38 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 105.868 -1.901 . . . . 0.040000000000000001 105.868 176.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 852' ' ' PHE . . . . . 0.443 ' HA ' ' CB ' ' A' ' 874' ' ' ASN . 33.7 p90 -158.79 130.18 6.38 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 121.022 1.737 . . . . 0.050000000000000003 108.79 179.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 44.1 t -174.93 134.1 0.34 Allowed 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 108.125 -1.065 . . . . 0.040000000000000001 108.125 -179.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 854' ' ' ALA . . . . . 0.461 ' HB1' ' HD2' ' A' ' 868' ' ' PHE . . . -134.01 155.92 49.12 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.07 -1.019 . . . . 0.67000000000000004 109.423 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 855' ' ' ALA . . . . . 0.761 ' HB3' ' CB ' ' A' ' 870' ' ' ARG . . . -122.15 141.6 51.27 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.758 0.79 . . . . 0.51000000000000001 111.362 -179.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 856' ' ' LEU . . . . . 0.671 HD13 ' N ' ' A' ' 857' ' ' SER . 3.4 tm? -111.27 137.94 48.36 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.649 -0.657 . . . . 0.050000000000000003 109.939 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 857' ' ' SER . . . . . 0.671 ' N ' HD13 ' A' ' 856' ' ' LEU . 1.5 m -156.77 16.86 0.31 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.579 -0.701 . . . . 1.3300000000000001 111.587 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 858' ' ' LEU . . . . . 0.609 HD22 ' HG3' ' A' ' 862' ' ' GLU . 3.8 pp -35.02 160.35 0.04 OUTLIER Pre-proline 0 N--CA 1.519 2.991 0 N-CA-C 113.006 0.743 . . . . 2.3300000000000001 113.006 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -60.69 -88.64 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 120.87 1.046 . . . . 2.3199999999999998 113.796 -177.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 53.6 ptt85 -128.54 -142.72 0.26 Allowed 'General case' 0 N--CA 1.5 2.075 0 O-C-N 120.859 -1.151 . . . . 0.040000000000000001 111.756 -177.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 15.0 m -38.03 126.76 1.28 Allowed 'General case' 0 N--CA 1.51 2.569 0 O-C-N 121.643 -0.661 . . . . 1.3100000000000001 112.26 -178.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 862' ' ' GLU . . . . . 0.609 ' HG3' HD22 ' A' ' 858' ' ' LEU . 0.0 OUTLIER -99.59 158.99 31.17 Favored Pre-proline 0 N--CA 1.489 1.51 0 N-CA-C 108.423 -0.954 . . . . 4.5099999999999998 108.423 177.754 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -70.99 -14.55 32.25 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 O-C-N 123.245 1.129 . . . . 2.2400000000000002 111.379 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -177.7 -135.89 2.36 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.515 -1.434 . . . . 0.040000000000000001 109.515 179.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 26.8 m -65.97 156.05 34.75 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.33 -1.1 . . . . 1.51 110.134 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 866' ' ' VAL . . . . . 0.498 HG13 ' CD2' ' A' ' 858' ' ' LEU . 61.5 t -98.85 137.33 20.52 Favored Pre-proline 0 N--CA 1.494 1.736 0 N-CA-C 113.547 0.943 . . . . 0.78000000000000003 113.547 -174.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 867' ' ' PRO . . . . . 0.553 ' O ' HD23 ' A' ' 856' ' ' LEU . 55.5 Cg_endo -92.41 -149.66 0.03 OUTLIER 'Trans proline' 0 CA--C 1.546 1.124 0 C-N-CA 121.335 1.356 . . . . 0.92000000000000004 109.634 178.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 868' ' ' PHE . . . . . 0.475 ' CD1' ' HG2' ' A' ' 881' ' ' PRO . 19.3 p90 -150.7 124.0 8.91 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.679 -1.263 . . . . 0.050000000000000003 109.776 179.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 46.6 p30 -113.48 -2.23 13.95 Favored 'General case' 0 N--CA 1.5 2.062 0 C-N-CA 119.285 -0.966 . . . . 1.7 112.483 -178.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 870' ' ' ARG . . . . . 0.761 ' CB ' ' HB3' ' A' ' 855' ' ' ALA . 26.7 mmm180 -90.11 89.29 7.61 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 120.889 -1.132 . . . . 2.5899999999999999 110.598 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 58.5 t -72.82 96.95 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 120.971 -1.081 . . . . 1.9399999999999999 109.91 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 872' ' ' LEU . . . . . 0.497 HD11 ' HB2' ' A' ' 855' ' ' ALA . 97.6 mt -82.84 -47.44 11.87 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.514 -0.741 . . . . 1.0600000000000001 110.177 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 873' ' ' LEU . . . . . 0.464 ' HG ' ' HB3' ' A' ' 851' ' ' ALA . 46.5 tp -174.99 104.26 0.09 Allowed 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 108.637 -0.875 . . . . 4.1799999999999997 108.637 178.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 874' ' ' ASN . . . . . 0.443 ' CB ' ' HA ' ' A' ' 852' ' ' PHE . 35.5 t-20 178.71 81.6 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.571 -0.706 . . . . 0.040000000000000001 109.802 -179.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -67.28 -48.05 68.81 Favored 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 119.321 -0.951 . . . . 3.3799999999999999 111.118 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 876' ' ' GLY . . . . . . . . . . . . . . . -73.58 -25.29 72.74 Favored Glycine 0 N--CA 1.494 2.529 0 O-C-N 121.284 -0.885 . . . . 0.040000000000000001 111.632 -178.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 82.39 -61.37 4.73 Favored Glycine 0 N--CA 1.502 3.044 0 N-CA-C 108.097 -2.001 . . . . 0.040000000000000001 108.097 -178.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 878' ' ' TYR . . . . . 0.418 ' CE2' ' CG1' ' A' ' 850' ' ' VAL . 95.8 m-85 61.15 -62.97 0.08 Allowed 'General case' 0 N--CA 1.503 2.201 0 N-CA-C 114.35 1.241 . . . . 3.46 114.35 177.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 879' ' ' TYR . . . . . 0.47 ' CB ' ' CD2' ' A' ' 886' ' ' PHE . 18.8 p90 -111.33 108.66 18.33 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 114.489 1.292 . . . . 0.040000000000000001 114.489 -176.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -65.0 114.7 15.94 Favored Pre-proline 0 N--CA 1.496 1.854 0 O-C-N 121.402 -0.811 . . . . 0.02 110.094 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 881' ' ' PRO . . . . . 0.475 ' HG2' ' CD1' ' A' ' 868' ' ' PHE . 53.3 Cg_endo -75.15 -0.94 10.61 Favored 'Trans proline' 0 N--CA 1.495 1.585 0 O-C-N 123.525 1.276 . . . . 0.39000000000000001 112.312 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -76.87 -65.4 0.95 Allowed 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.12 -1.437 . . . . 0.81000000000000005 107.12 178.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 31.6 p -92.25 -18.17 23.78 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.62 -0.882 . . . . 0.040000000000000001 108.62 177.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.22 19.79 60.12 Favored Glycine 0 N--CA 1.497 2.729 0 O-C-N 121.093 -1.005 . . . . 0.029999999999999999 111.554 178.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 885' ' ' VAL . . . . . 0.679 HG13 HG21 ' A' ' 961' ' ' THR . 92.2 t -73.43 91.1 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 C-N-CA 118.089 -1.445 . . . . 1.01 108.137 -179.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 886' ' ' PHE . . . . . 0.878 ' HB3' HG22 ' A' ' 962' ' ' VAL . 0.6 OUTLIER -89.73 105.11 17.58 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 115.207 -0.906 . . . . 0.050000000000000003 112.081 -177.443 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 887' ' ' THR . . . . . 0.406 ' O ' ' HD3' ' A' ' 889' ' ' PRO . 85.0 m -95.96 100.36 12.04 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 107.711 -1.218 . . . . 0.68000000000000005 107.711 177.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 888' ' ' ALA . . . . . . . . . . . . . . . -98.42 107.43 42.01 Favored Pre-proline 0 N--CA 1.501 2.124 0 N-CA-C 114.094 1.146 . . . . 0.25 114.094 -176.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 889' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' A' ' 887' ' ' THR . 53.8 Cg_endo -90.19 -12.53 2.71 Favored 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 121.066 1.177 . . . . 1.6399999999999999 109.243 176.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 890' ' ' LEU . . . . . 0.994 HD22 HD13 ' A' ' 985' ' ' LEU . 63.6 mt -36.11 -50.52 0.71 Allowed 'General case' 0 N--CA 1.508 2.466 0 N-CA-C 113.856 1.058 . . . . 2.29 113.856 -177.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 51.68 95.84 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.342 0 O-C-N 121.158 -0.964 . . . . 0.63 110.314 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 156.58 -149.66 20.59 Favored Glycine 0 N--CA 1.479 1.562 0 N-CA-C 107.301 -2.32 . . . . 0.040000000000000001 107.301 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 70.7 ttt-85 -112.65 126.64 55.6 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 107.945 -1.131 . . . . 3.0 107.945 177.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 894' ' ' TYR . . . . . 0.541 ' OH ' HD12 ' A' ' 896' ' ' LEU . 0.0 OUTLIER -131.21 155.09 47.67 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.045 -1.035 . . . . 0.040000000000000001 110.69 -179.178 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 895' ' ' LEU . . . . . 0.423 ' N ' ' CD1' ' A' ' 894' ' ' TYR . 34.9 tp -95.29 114.16 25.91 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.665 -0.647 . . . . 1.27 110.067 -179.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 896' ' ' LEU . . . . . 0.567 HD23 ' N ' ' A' ' 897' ' ' SER . 9.8 tt -108.62 142.67 38.75 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.718 -0.614 . . . . 0.93999999999999995 110.628 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 897' ' ' SER . . . . . 0.567 ' N ' HD23 ' A' ' 896' ' ' LEU . 69.9 m -147.41 115.4 6.5 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.516 -0.74 . . . . 0.040000000000000001 110.895 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.26 146.76 31.06 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.07 -0.715 . . . . 0.47999999999999998 109.07 179.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 899' ' ' VAL . . . . . 0.766 HG21 ' HB ' ' A' ' 980' ' ' ILE . 87.8 t -96.36 119.7 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 C-N-CA 119.627 -0.829 . . . . 0.55000000000000004 111.377 -179.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 900' ' ' LEU . . . . . 0.548 HD12 ' HB2' ' A' ' 924' ' ' SER . 4.5 mm? -94.39 111.53 23.28 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 114.057 1.132 . . . . 1.5900000000000001 114.057 -175.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 21.6 m -65.43 140.8 58.65 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 107.322 -1.362 . . . . 0.050000000000000003 107.322 177.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -64.66 -66.75 2.32 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 110.427 -1.069 . . . . 0.029999999999999999 110.427 -179.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 5.9 m170 46.59 66.81 0.89 Allowed 'General case' 0 N--CA 1.507 2.403 0 O-C-N 121.522 -0.987 . . . . 3.2000000000000002 111.093 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 43.3 ptt85 -69.13 -5.76 24.33 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.542 -0.723 . . . . 2.9199999999999999 112.003 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 905' ' ' HIS . . . . . 0.485 ' O ' ' CB ' ' A' ' 906' ' ' GLU . 74.4 t60 -61.06 3.22 0.1 Allowed 'General case' 0 N--CA 1.506 2.328 0 O-C-N 120.834 -1.166 . . . . 2.8700000000000001 112.891 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 906' ' ' GLU . . . . . 0.485 ' CB ' ' O ' ' A' ' 905' ' ' HIS . 0.8 OUTLIER 93.69 -163.62 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.437 0 CA-C-N 120.513 1.506 . . . . 0.98999999999999999 112.425 178.549 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 907' ' ' LYS . . . . . 0.483 ' CB ' ' O ' ' A' ' 906' ' ' GLU . 51.2 tttt 88.95 161.18 0.06 Allowed 'General case' 0 N--CA 1.519 3.018 0 N-CA-C 107.72 -1.215 . . . . 5.25 107.72 -177.014 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 60.0 t -121.7 116.18 48.66 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 120.864 -1.148 . . . . 0.39000000000000001 110.787 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 54.1 tp10 -104.49 132.13 51.09 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 107.523 -1.288 . . . . 1.72 107.523 176.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -156.09 121.63 4.87 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 106.536 -1.653 . . . . 0.67000000000000004 106.536 178.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 911' ' ' VAL . . . . . 0.732 HG22 HG13 ' A' ' 964' ' ' VAL . 92.9 t -81.65 132.44 31.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.819 -0.551 . . . . 0.54000000000000004 110.753 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 71.6 mt -65.68 155.91 34.52 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.376 -0.828 . . . . 1.5 108.838 178.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 913' ' ' SER . . . . . 0.417 ' CB ' ' HB ' ' A' ' 919' ' ' VAL . 2.4 t -123.39 137.43 54.82 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 108.076 -1.083 . . . . 1.3700000000000001 108.076 176.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 914' ' ' ARG . . . . . 0.625 ' NH1' HD23 ' A' ' 956' ' ' LEU . 0.0 OUTLIER -64.28 154.14 36.06 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 120.791 -1.193 . . . . 4.2999999999999998 111.58 -179.001 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 915' ' ' SER . . . . . 0.427 ' CB ' ' O ' ' A' ' 914' ' ' ARG . 4.9 t 83.31 -32.27 0.08 Allowed 'General case' 0 N--CA 1.522 3.126 0 C-N-CA 124.016 0.927 . . . . 2.0499999999999998 112.294 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 916' ' ' ASN . . . . . 0.755 ' HB2' HG21 ' A' ' 919' ' ' VAL . 98.7 m-20 -122.37 -21.02 5.92 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 120.908 -1.12 . . . . 2.71 111.429 -179.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 917' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 67.1 166.44 0.22 Allowed 'General case' 0 N--CA 1.521 3.102 0 N-CA-C 105.58 -2.007 . . . . 2.6800000000000002 105.58 -174.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.44 -125.79 35.25 Favored Glycine 1 N--CA 1.521 4.349 0 CA-C-N 123.405 2.82 . . . . 0.029999999999999999 107.001 -177.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 919' ' ' VAL . . . . . 0.755 HG21 ' HB2' ' A' ' 916' ' ' ASN . 82.0 t 51.95 94.52 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.273 0 O-C-N 121.447 -1.031 . . . . 1.3899999999999999 108.915 -178.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 920' ' ' ALA . . . . . 0.888 ' HB3' HG12 ' A' ' 949' ' ' VAL . . . -91.6 92.37 8.45 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.311 -0.955 . . . . 0.029999999999999999 111.12 -178.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 921' ' ' ARG . . . . . 0.747 ' HG3' HG23 ' A' ' 922' ' ' VAL . 16.7 ptt180 -84.31 -42.25 16.0 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 105.752 -1.944 . . . . 4.4199999999999999 105.752 175.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 922' ' ' VAL . . . . . 0.747 HG23 ' HG3' ' A' ' 921' ' ' ARG . 75.1 t -103.75 69.63 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 N-CA-C 105.608 -1.997 . . . . 0.84999999999999998 105.608 175.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 923' ' ' ASP . . . . . 0.655 ' HB2' ' HB1' ' A' ' 920' ' ' ALA . 22.0 t0 -89.68 136.26 33.14 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.887 0.851 . . . . 2.46 112.238 -176.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 924' ' ' SER . . . . . 0.548 ' HB2' HD12 ' A' ' 900' ' ' LEU . 13.2 t -146.48 103.4 3.68 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.922 -1.14 . . . . 0.69999999999999996 107.922 178.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -110.79 89.57 0.55 Allowed Glycine 0 N--CA 1.488 2.106 0 N-CA-C 108.941 -1.664 . . . . 0.040000000000000001 108.941 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.311 0 N-CA-C 109.324 -1.51 . . . . 0.040000000000000001 109.324 -179.604 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 22.8 m . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.063 0.458 . . . . 13.779999999999999 110.272 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 96.2 mt -112.88 129.88 56.3 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.54 -0.725 . . . . 13.76 110.403 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -151.57 167.86 30.95 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.056 -1.618 . . . . 9.1300000000000008 109.056 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 949' ' ' VAL . . . . . 0.888 HG12 ' HB3' ' A' ' 920' ' ' ALA . 32.9 m -118.95 130.34 73.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.501 -0.999 . . . . 7.0800000000000001 110.947 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 950' ' ' PHE . . . . . 0.459 ' CZ ' ' HB3' ' A' ' 921' ' ' ARG . 27.6 p90 -132.52 149.22 52.36 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.572 -0.705 . . . . 7.5899999999999999 109.283 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 19.5 m -120.19 -53.11 2.15 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.396 -0.815 . . . . 5.0300000000000002 112.04 -178.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 952' ' ' LEU . . . . . 0.417 ' O ' ' O ' ' A' ' 953' ' ' ILE . 16.8 tp -61.25 -74.3 0.08 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.388 -0.82 . . . . 1.01 112.309 -177.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 953' ' ' ILE . . . . . 0.804 HD11 HD13 ' C' ' 872' ' ' LEU . 43.9 pt -53.27 -144.05 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.755 0 N-CA-C 114.034 1.124 . . . . 2.6000000000000001 114.034 -176.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 954' ' ' LEU . . . . . 0.702 HD22 ' O ' ' A' ' 954' ' ' LEU . 0.0 OUTLIER 171.46 78.8 0.04 OUTLIER Pre-proline 0 N--CA 1.51 2.572 0 O-C-N 120.762 -1.211 . . . . 0.050000000000000003 111.54 179.697 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 955' ' ' PRO . . . . . 0.689 ' C ' HD12 ' A' ' 956' ' ' LEU . 47.1 Cg_endo -74.35 95.64 0.94 Allowed 'Trans proline' 0 C--N 1.313 -1.311 0 N-CA-C 109.343 -1.06 . . . . 0.83999999999999997 109.343 178.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 956' ' ' LEU . . . . . 0.689 HD12 ' C ' ' A' ' 955' ' ' PRO . 10.2 mp -123.12 145.25 48.74 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.174 -0.954 . . . . 0.040000000000000001 110.236 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -84.66 151.17 24.64 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 117.814 -1.088 . . . . 1.28 111.856 -178.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -70.24 119.88 15.09 Favored 'General case' 0 N--CA 1.51 2.569 0 CA-C-N 122.926 2.603 . . . . 0.17000000000000001 111.943 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.81 -22.82 31.78 Favored Glycine 0 N--CA 1.502 3.065 0 N-CA-C 111.197 -0.761 . . . . 0.040000000000000001 111.197 178.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 960' ' ' ASP . . . . . 0.435 ' HB3' ' NE ' ' A' ' 914' ' ' ARG . 0.3 OUTLIER -53.3 171.74 0.07 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.505 -0.997 . . . . 0.040000000000000001 110.313 -179.341 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 961' ' ' THR . . . . . 0.679 HG21 HG13 ' A' ' 885' ' ' VAL . 39.2 m -134.56 135.42 42.26 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.931 -1.106 . . . . 1.78 111.785 -178.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 962' ' ' VAL . . . . . 0.878 HG22 ' HB3' ' A' ' 886' ' ' PHE . 31.6 m -98.76 145.23 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 C-N-CA 120.045 -0.662 . . . . 0.040000000000000001 110.389 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 5.0 t -137.86 146.25 43.19 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.906 -0.496 . . . . 0.71999999999999997 110.131 -178.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 964' ' ' VAL . . . . . 0.732 HG13 HG22 ' A' ' 911' ' ' VAL . 58.3 t -95.06 136.37 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.091 -1.006 . . . . 1.05 110.503 -179.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -95.4 126.48 40.73 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 103.682 -2.71 . . . . 3.02 103.682 173.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 966' ' ' LEU . . . . . 0.493 ' C ' HG23 ' A' ' 967' ' ' VAL . 1.4 tt -133.46 61.29 1.68 Allowed 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.271 -1.011 . . . . 1.46 108.271 177.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 967' ' ' VAL . . . . . 0.493 HG23 ' C ' ' A' ' 966' ' ' LEU . 98.9 t -157.92 96.44 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 108.138 -1.06 . . . . 1.9399999999999999 108.138 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 93.1 mmm -143.04 58.45 1.41 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.708 -1.245 . . . . 0.0 108.198 178.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 133.09 119.21 2.0 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 106.538 -2.625 . . . . 2.1099999999999999 106.538 -177.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -84.83 -44.49 13.21 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 119.0 1.4 . . . . 5.8899999999999997 111.364 -179.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 43.0 tp -61.39 89.12 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.921 -1.112 . . . . 4.3600000000000003 110.081 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -141.89 -156.46 0.68 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.525 -0.734 . . . . 1.8300000000000001 110.272 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -121.61 176.05 5.91 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.535 -0.728 . . . . 4.3499999999999996 110.273 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 9.1 t -99.98 129.87 46.09 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.534 -0.728 . . . . 1.27 109.909 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -156.1 157.92 36.85 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.497 -0.752 . . . . 5.0199999999999996 110.671 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.33 86.8 16.41 Favored Pre-proline 0 N--CA 1.499 2.021 0 O-C-N 121.605 -0.684 . . . . 2.4100000000000001 109.506 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 977' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -72.91 -172.46 0.98 Allowed 'Trans proline' 0 C--N 1.318 -1.056 0 O-C-N 123.312 1.164 . . . . 0.95999999999999996 111.442 -179.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 978' ' ' LEU . . . . . 0.542 HD12 ' N ' ' A' ' 978' ' ' LEU . 5.0 mp -128.05 154.78 45.29 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 107.631 -1.248 . . . . 0.62 107.631 178.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 979' ' ' THR . . . . . 0.45 HG23 ' C ' ' A' ' 978' ' ' LEU . 44.9 p -149.73 141.17 23.32 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.738 -1.226 . . . . 3.5699999999999998 111.279 -179.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 980' ' ' ILE . . . . . 0.766 ' HB ' HG21 ' A' ' 899' ' ' VAL . 50.3 mm -107.82 128.2 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 108.885 -0.783 . . . . 1.3300000000000001 108.885 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 981' ' ' PHE . . . . . 0.461 ' HD1' ' HH ' ' A' ' 879' ' ' TYR . 6.4 t80 -121.88 97.33 5.44 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.428 -0.795 . . . . 0.050000000000000003 111.912 -178.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 92.6 p -108.84 158.44 17.66 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 109.041 -0.726 . . . . 0.87 109.041 178.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . -173.73 108.91 0.28 Allowed Glycine 0 N--CA 1.498 2.775 0 N-CA-C 106.635 -2.586 . . . . 0.029999999999999999 106.635 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -109.07 148.67 30.45 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 114.409 1.263 . . . . 0.69999999999999996 114.409 -175.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 985' ' ' LEU . . . . . 0.994 HD13 HD22 ' A' ' 890' ' ' LEU . 35.1 tp -68.93 135.24 50.68 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 120.777 -1.202 . . . . 0.040000000000000001 110.275 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 50.8 tp -106.88 -58.8 1.89 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.648 -0.658 . . . . 0.040000000000000001 109.918 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -144.11 145.51 32.19 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 107.553 -1.277 . . . . 0.040000000000000001 107.553 179.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.69 163.29 12.17 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 108.23 -1.948 . . . . 0.040000000000000001 108.23 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -76.11 112.51 21.08 Favored Pre-proline 0 N--CA 1.498 1.954 0 O-C-N 121.184 -1.186 . . . . 0.040000000000000001 109.41 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 990' ' ' PRO . . . . . 0.414 ' O ' ' HB2' ' A' ' 991' ' ' GLU . 49.8 Cg_endo -90.44 71.79 1.33 Allowed 'Trans proline' 0 C--N 1.318 -1.031 0 O-C-N 123.044 1.023 . . . . 0.45000000000000001 111.435 -178.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 991' ' ' GLU . . . . . 0.414 ' HB2' ' O ' ' A' ' 990' ' ' PRO . 75.1 mt-10 67.44 -73.67 0.08 Allowed 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 108.476 -0.935 . . . . 1.97 108.476 -177.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 992' ' ' LEU . . . . . . . . . . . . . 11.0 mt 51.1 20.51 0.86 Allowed 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.504 -0.748 . . . . 2.3799999999999999 111.652 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 80.3 mt-10 -94.1 156.84 16.37 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.918 -1.114 . . . . 3.79 109.947 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -146.21 93.29 2.3 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.529 -0.732 . . . . 3.5099999999999998 110.333 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 995' ' ' ALA . . . . . . . . . . . . 2.518 . . . . . . . 0 N--CA 1.504 2.24 0 O-C-N 120.935 -1.103 . . . . 2.73 110.57 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo . . . . . 0 N--CA 1.488 1.171 0 N-CA-C 109.537 -0.986 . . . . 3.8300000000000001 109.537 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 847' ' ' VAL . . . . . . . . . . . . . 61.9 t -134.52 103.27 11.31 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.586 -0.696 . . . . 1.8300000000000001 110.054 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 848' ' ' PRO . . . . . 0.695 ' O ' HG23 ' B' ' 850' ' ' VAL . 44.2 Cg_endo -69.91 -18.84 36.08 Favored 'Trans proline' 0 N--CA 1.488 1.182 0 O-C-N 123.321 1.169 . . . . 0.65000000000000002 111.314 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 849' ' ' GLN . . . . . 0.407 ' C ' ' O ' ' B' ' 848' ' ' PRO . 56.4 tt0 27.64 69.17 0.06 Allowed 'General case' 0 N--CA 1.518 2.957 0 N-CA-C 112.827 0.677 . . . . 2.5800000000000001 112.827 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 850' ' ' VAL . . . . . 0.695 HG23 ' O ' ' B' ' 848' ' ' PRO . 61.9 t -119.27 135.89 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 O-C-N 121.202 -0.936 . . . . 1.0900000000000001 111.394 -178.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 851' ' ' ALA . . . . . 0.463 ' HB3' ' HG ' ' B' ' 873' ' ' LEU . . . -127.22 156.22 42.21 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 105.884 -1.895 . . . . 0.040000000000000001 105.884 176.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 852' ' ' PHE . . . . . 0.44 ' HA ' ' CB ' ' B' ' 874' ' ' ASN . 33.2 p90 -157.98 130.59 7.25 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 121.086 1.766 . . . . 0.050000000000000003 108.729 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 44.5 t -174.97 133.7 0.33 Allowed 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.214 -1.032 . . . . 0.040000000000000001 108.214 -179.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 854' ' ' ALA . . . . . 0.446 ' HB1' ' HD2' ' B' ' 868' ' ' PHE . . . -133.65 155.98 48.72 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.096 -1.002 . . . . 0.67000000000000004 109.448 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 855' ' ' ALA . . . . . 0.747 ' HB3' ' CB ' ' B' ' 870' ' ' ARG . . . -122.3 141.82 51.13 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.802 0.811 . . . . 0.51000000000000001 111.293 -179.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 856' ' ' LEU . . . . . 0.659 HD13 ' N ' ' B' ' 857' ' ' SER . 3.4 tm? -111.4 137.55 49.03 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.602 -0.686 . . . . 0.050000000000000003 110.016 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 857' ' ' SER . . . . . 0.659 ' N ' HD13 ' B' ' 856' ' ' LEU . 1.5 m -156.43 17.05 0.33 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.543 -0.723 . . . . 1.3300000000000001 111.538 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 858' ' ' LEU . . . . . 0.611 HD22 ' HG3' ' B' ' 862' ' ' GLU . 3.8 pp -35.2 160.45 0.04 OUTLIER Pre-proline 0 N--CA 1.52 3.028 0 N-CA-C 112.954 0.724 . . . . 2.3300000000000001 112.954 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -60.82 -88.6 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 120.877 1.051 . . . . 2.3199999999999998 113.803 -177.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 53.6 ptt85 -128.54 -142.74 0.26 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 120.897 -1.127 . . . . 0.040000000000000001 111.801 -177.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 15.2 m -37.96 126.12 1.23 Allowed 'General case' 0 N--CA 1.509 2.516 0 O-C-N 121.619 -0.676 . . . . 1.3100000000000001 112.3 -178.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 862' ' ' GLU . . . . . 0.611 ' HG3' HD22 ' B' ' 858' ' ' LEU . 0.0 OUTLIER -98.96 159.02 31.28 Favored Pre-proline 0 N--CA 1.489 1.511 0 N-CA-C 108.425 -0.954 . . . . 4.5099999999999998 108.425 177.7 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -70.9 -14.71 32.67 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 O-C-N 123.193 1.101 . . . . 2.2400000000000002 111.411 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -177.52 -134.97 2.12 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.508 -1.437 . . . . 0.040000000000000001 109.508 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 27.1 m -66.71 156.82 34.27 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.285 -1.126 . . . . 1.51 110.053 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 866' ' ' VAL . . . . . 0.496 HG13 ' CD2' ' B' ' 858' ' ' LEU . 61.1 t -99.44 137.34 20.3 Favored Pre-proline 0 N--CA 1.494 1.742 0 N-CA-C 113.485 0.92 . . . . 0.78000000000000003 113.485 -174.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 867' ' ' PRO . . . . . 0.564 ' O ' HD23 ' B' ' 856' ' ' LEU . 55.4 Cg_endo -92.52 -149.82 0.03 OUTLIER 'Trans proline' 0 CA--C 1.546 1.121 0 C-N-CA 121.314 1.343 . . . . 0.92000000000000004 109.626 178.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 868' ' ' PHE . . . . . 0.476 ' CD1' ' HG2' ' B' ' 881' ' ' PRO . 19.4 p90 -150.55 123.88 8.93 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.645 -1.284 . . . . 0.050000000000000003 109.765 179.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 46.5 p30 -113.34 -1.94 14.12 Favored 'General case' 0 N--CA 1.5 2.051 0 C-N-CA 119.287 -0.965 . . . . 1.7 112.56 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 870' ' ' ARG . . . . . 0.747 ' CB ' ' HB3' ' B' ' 855' ' ' ALA . 26.4 mmm180 -90.47 89.05 7.41 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 120.848 -1.157 . . . . 2.5899999999999999 110.634 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 58.7 t -72.71 97.19 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.013 -1.054 . . . . 1.9399999999999999 109.864 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 872' ' ' LEU . . . . . 0.492 HD11 ' HB2' ' B' ' 855' ' ' ALA . 98.6 mt -83.14 -47.5 11.55 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.594 -0.691 . . . . 1.0600000000000001 110.155 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 873' ' ' LEU . . . . . 0.463 ' HG ' ' HB3' ' B' ' 851' ' ' ALA . 46.6 tp -175.0 104.14 0.09 Allowed 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 108.625 -0.88 . . . . 4.1799999999999997 108.625 178.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 874' ' ' ASN . . . . . 0.44 ' CB ' ' HA ' ' B' ' 852' ' ' PHE . 35.5 t-20 178.73 81.78 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.303 0 O-C-N 121.681 -0.637 . . . . 0.040000000000000001 109.74 -179.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -67.4 -48.12 68.3 Favored 'General case' 0 N--CA 1.499 1.998 0 C-N-CA 119.281 -0.967 . . . . 3.3799999999999999 111.164 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 876' ' ' GLY . . . . . . . . . . . . . . . -73.52 -25.57 72.17 Favored Glycine 0 N--CA 1.494 2.536 0 O-C-N 121.242 -0.911 . . . . 0.040000000000000001 111.599 -178.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 82.61 -61.15 4.78 Favored Glycine 0 N--CA 1.501 3.02 0 N-CA-C 108.105 -1.998 . . . . 0.040000000000000001 108.105 -178.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 878' ' ' TYR . . . . . 0.418 ' CE2' ' CG1' ' B' ' 850' ' ' VAL . 95.7 m-85 61.11 -62.94 0.08 Allowed 'General case' 0 N--CA 1.503 2.178 0 N-CA-C 114.361 1.245 . . . . 3.46 114.361 177.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 879' ' ' TYR . . . . . 0.485 ' HH ' ' HD1' ' B' ' 981' ' ' PHE . 18.8 p90 -111.28 108.77 18.5 Favored 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 114.477 1.288 . . . . 0.040000000000000001 114.477 -176.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -65.09 114.67 16.0 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.37 -0.832 . . . . 0.02 110.085 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 881' ' ' PRO . . . . . 0.476 ' HG2' ' CD1' ' B' ' 868' ' ' PHE . 53.6 Cg_endo -75.14 -0.98 10.66 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 O-C-N 123.557 1.293 . . . . 0.39000000000000001 112.257 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -76.8 -65.48 0.94 Allowed 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 107.071 -1.455 . . . . 0.81000000000000005 107.071 178.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 32.4 p -92.39 -17.71 24.26 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.713 -0.847 . . . . 0.040000000000000001 108.713 177.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.78 20.09 60.33 Favored Glycine 0 N--CA 1.495 2.63 0 O-C-N 121.092 -1.005 . . . . 0.029999999999999999 111.538 178.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 885' ' ' VAL . . . . . 0.684 HG13 HG21 ' B' ' 961' ' ' THR . 93.1 t -73.61 91.24 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 C-N-CA 118.13 -1.428 . . . . 1.01 108.058 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 886' ' ' PHE . . . . . 0.906 ' HB3' HG22 ' B' ' 962' ' ' VAL . 0.6 OUTLIER -89.85 105.16 17.62 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 115.211 -0.904 . . . . 0.050000000000000003 112.056 -177.448 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 887' ' ' THR . . . . . 0.406 ' O ' ' HD3' ' B' ' 889' ' ' PRO . 84.7 m -96.09 100.71 12.34 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 107.626 -1.25 . . . . 0.68000000000000005 107.626 177.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 888' ' ' ALA . . . . . . . . . . . . . . . -98.67 107.25 41.79 Favored Pre-proline 0 N--CA 1.502 2.148 0 N-CA-C 114.029 1.122 . . . . 0.25 114.029 -176.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 889' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' B' ' 887' ' ' THR . 53.4 Cg_endo -90.09 -12.6 2.75 Favored 'Trans proline' 0 CA--C 1.546 1.099 0 C-N-CA 121.043 1.162 . . . . 1.6399999999999999 109.274 176.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 890' ' ' LEU . . . . . 0.985 HD22 HD13 ' B' ' 985' ' ' LEU . 63.7 mt -36.02 -50.65 0.7 Allowed 'General case' 0 N--CA 1.509 2.481 0 N-CA-C 113.819 1.044 . . . . 2.29 113.819 -177.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 51.68 95.82 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.314 0 O-C-N 121.137 -0.977 . . . . 0.63 110.322 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . 156.6 -149.78 20.75 Favored Glycine 0 N--CA 1.479 1.564 0 N-CA-C 107.26 -2.336 . . . . 0.040000000000000001 107.26 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 71.1 ttt-85 -112.51 126.61 55.51 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 107.979 -1.119 . . . . 3.0 107.979 177.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 894' ' ' TYR . . . . . 0.545 ' OH ' HD12 ' B' ' 896' ' ' LEU . 0.0 OUTLIER -131.1 155.29 47.2 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.122 -0.986 . . . . 0.040000000000000001 110.68 -179.133 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 895' ' ' LEU . . . . . 0.429 ' N ' ' CD1' ' B' ' 894' ' ' TYR . 34.8 tp -95.57 114.04 25.76 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.575 -0.703 . . . . 1.27 110.089 -179.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 896' ' ' LEU . . . . . 0.559 HD23 ' N ' ' B' ' 897' ' ' SER . 9.7 tt -108.64 142.03 39.72 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.696 -0.628 . . . . 0.93999999999999995 110.695 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 897' ' ' SER . . . . . 0.559 ' N ' HD23 ' B' ' 896' ' ' LEU . 69.6 m -146.75 115.27 6.74 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.565 -0.71 . . . . 0.040000000000000001 110.864 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.1 146.6 31.05 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 109.112 -0.699 . . . . 0.47999999999999998 109.112 179.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 899' ' ' VAL . . . . . 0.767 HG21 ' HB ' ' B' ' 980' ' ' ILE . 87.7 t -96.2 119.39 44.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 C-N-CA 119.6 -0.84 . . . . 0.55000000000000004 111.466 -179.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 900' ' ' LEU . . . . . 0.545 HD12 ' HB2' ' B' ' 924' ' ' SER . 4.5 mm? -94.11 111.11 22.8 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 114.2 1.185 . . . . 1.5900000000000001 114.2 -175.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 21.2 m -65.1 140.74 58.84 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 107.333 -1.358 . . . . 0.050000000000000003 107.333 177.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -64.88 -66.7 2.34 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.445 -1.062 . . . . 0.029999999999999999 110.445 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 5.8 m170 46.54 66.84 0.88 Allowed 'General case' 0 N--CA 1.508 2.428 0 O-C-N 121.439 -1.036 . . . . 3.2000000000000002 111.016 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 43.3 ptt85 -69.02 -6.05 25.56 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.591 -0.693 . . . . 2.9199999999999999 112.043 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 905' ' ' HIS . . . . . 0.48 ' O ' ' CB ' ' B' ' 906' ' ' GLU . 74.1 t60 -60.39 2.61 0.09 Allowed 'General case' 0 N--CA 1.506 2.332 0 O-C-N 120.857 -1.152 . . . . 2.8700000000000001 112.897 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 906' ' ' GLU . . . . . 0.48 ' CB ' ' O ' ' B' ' 905' ' ' HIS . 0.8 OUTLIER 93.95 -163.73 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.44 0 CA-C-N 120.584 1.538 . . . . 0.98999999999999999 112.36 178.741 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 907' ' ' LYS . . . . . 0.471 ' CB ' ' O ' ' B' ' 906' ' ' GLU . 51.5 tttt 89.13 161.01 0.06 Allowed 'General case' 0 N--CA 1.52 3.045 0 N-CA-C 107.755 -1.202 . . . . 5.25 107.755 -177.011 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 58.9 t -121.52 115.93 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 O-C-N 120.86 -1.15 . . . . 0.39000000000000001 110.93 -179.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 54.1 tp10 -104.35 132.21 50.85 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 107.546 -1.279 . . . . 1.72 107.546 177.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -156.25 121.82 4.85 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 106.56 -1.644 . . . . 0.67000000000000004 106.56 178.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 911' ' ' VAL . . . . . 0.717 HG22 HG13 ' B' ' 964' ' ' VAL . 92.4 t -81.86 132.67 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.791 -0.568 . . . . 0.54000000000000004 110.788 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 71.8 mt -65.76 156.08 34.19 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 108.763 -0.828 . . . . 1.5 108.763 178.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 913' ' ' SER . . . . . 0.413 ' CB ' ' HB ' ' B' ' 919' ' ' VAL . 2.4 t -123.81 136.56 54.47 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.157 -1.053 . . . . 1.3700000000000001 108.157 176.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 914' ' ' ARG . . . . . 0.625 ' NH1' HD23 ' B' ' 956' ' ' LEU . 0.0 OUTLIER -63.36 153.95 33.44 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 120.772 -1.205 . . . . 4.2999999999999998 111.701 -178.909 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 915' ' ' SER . . . . . 0.419 ' CB ' ' O ' ' B' ' 914' ' ' ARG . 4.9 t 83.49 -32.53 0.08 Allowed 'General case' 0 N--CA 1.52 3.06 0 C-N-CA 124.11 0.964 . . . . 2.0499999999999998 112.36 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 916' ' ' ASN . . . . . 0.767 ' HB2' HG21 ' B' ' 919' ' ' VAL . 98.6 m-20 -121.98 -21.4 6.01 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 120.797 -1.189 . . . . 2.71 111.461 -179.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 917' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 67.15 165.93 0.22 Allowed 'General case' 0 N--CA 1.52 3.026 0 N-CA-C 105.62 -1.993 . . . . 2.6800000000000002 105.62 -174.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 55.09 -125.86 37.06 Favored Glycine 1 N--CA 1.521 4.301 0 CA-C-N 123.575 2.898 . . . . 0.029999999999999999 106.882 -177.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 919' ' ' VAL . . . . . 0.767 HG21 ' HB2' ' B' ' 916' ' ' ASN . 85.6 t 51.72 94.57 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.249 0 O-C-N 121.427 -1.043 . . . . 1.3899999999999999 108.96 -178.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 920' ' ' ALA . . . . . 0.875 ' HB3' HG12 ' B' ' 949' ' ' VAL . . . -91.67 92.14 8.31 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 119.298 -0.961 . . . . 0.029999999999999999 111.114 -178.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 921' ' ' ARG . . . . . 0.737 ' HG3' HG23 ' B' ' 922' ' ' VAL . 16.7 ptt180 -84.14 -42.25 16.22 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 105.749 -1.945 . . . . 4.4199999999999999 105.749 175.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 922' ' ' VAL . . . . . 0.737 HG23 ' HG3' ' B' ' 921' ' ' ARG . 75.0 t -103.78 69.42 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 105.563 -2.014 . . . . 0.84999999999999998 105.563 175.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 923' ' ' ASP . . . . . 0.654 ' HB2' ' HB1' ' B' ' 920' ' ' ALA . 22.0 t0 -89.44 136.3 33.1 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 121.895 0.855 . . . . 2.46 112.22 -176.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 924' ' ' SER . . . . . 0.545 ' HB2' HD12 ' B' ' 900' ' ' LEU . 13.3 t -146.41 103.32 3.68 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 107.957 -1.127 . . . . 0.69999999999999996 107.957 178.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -110.62 89.39 0.54 Allowed Glycine 0 N--CA 1.488 2.154 0 N-CA-C 108.929 -1.668 . . . . 0.040000000000000001 108.929 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.385 0 N-CA-C 109.334 -1.506 . . . . 0.040000000000000001 109.334 -179.658 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 23.3 m . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.044 0.45 . . . . 13.779999999999999 110.218 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 96.2 mt -112.28 129.8 56.16 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.566 -0.709 . . . . 13.76 110.395 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -151.25 167.08 30.69 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.07 -1.612 . . . . 9.1300000000000008 109.07 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 949' ' ' VAL . . . . . 0.875 HG12 ' HB3' ' B' ' 920' ' ' ALA . 32.5 m -118.68 130.21 73.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.469 -1.018 . . . . 7.0800000000000001 110.85 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 950' ' ' PHE . . . . . 0.462 ' CZ ' ' HB3' ' B' ' 921' ' ' ARG . 27.8 p90 -132.41 149.44 52.34 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.591 -0.693 . . . . 7.5899999999999999 109.303 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 19.6 m -120.22 -52.72 2.16 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.413 -0.804 . . . . 5.0300000000000002 112.037 -178.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 952' ' ' LEU . . . . . 0.413 ' O ' ' O ' ' B' ' 953' ' ' ILE . 16.8 tp -61.59 -74.4 0.08 Allowed 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.378 -0.827 . . . . 1.01 112.324 -177.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 953' ' ' ILE . . . . . 0.496 ' O ' ' HB3' ' B' ' 954' ' ' LEU . 44.8 pt -53.12 -143.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.723 0 N-CA-C 114.122 1.156 . . . . 2.6000000000000001 114.122 -176.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 954' ' ' LEU . . . . . 0.714 HD22 ' O ' ' B' ' 954' ' ' LEU . 0.0 OUTLIER 171.25 78.53 0.04 OUTLIER Pre-proline 0 N--CA 1.511 2.606 0 O-C-N 120.772 -1.205 . . . . 0.050000000000000003 111.507 179.609 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 955' ' ' PRO . . . . . 0.694 ' C ' HD12 ' B' ' 956' ' ' LEU . 46.9 Cg_endo -74.28 95.86 0.94 Allowed 'Trans proline' 0 C--N 1.313 -1.306 0 N-CA-C 109.307 -1.074 . . . . 0.83999999999999997 109.307 178.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 956' ' ' LEU . . . . . 0.694 HD12 ' C ' ' B' ' 955' ' ' PRO . 10.2 mp -123.28 145.19 48.89 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.15 -0.969 . . . . 0.040000000000000001 110.212 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -84.51 151.51 24.54 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 117.983 -1.008 . . . . 1.28 111.821 -179.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -70.47 119.66 14.96 Favored 'General case' 0 N--CA 1.51 2.566 0 CA-C-N 122.725 2.511 . . . . 0.17000000000000001 111.919 -179.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.96 -23.1 30.72 Favored Glycine 0 N--CA 1.502 3.046 0 N-CA-C 111.154 -0.779 . . . . 0.040000000000000001 111.154 178.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 960' ' ' ASP . . . . . 0.437 ' HB3' ' NE ' ' B' ' 914' ' ' ARG . 0.4 OUTLIER -52.96 171.86 0.06 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.467 -1.02 . . . . 0.040000000000000001 110.376 -179.312 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 961' ' ' THR . . . . . 0.684 HG21 HG13 ' B' ' 885' ' ' VAL . 38.3 m -134.59 135.55 42.31 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.074 -1.016 . . . . 1.78 111.714 -178.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 962' ' ' VAL . . . . . 0.906 HG22 ' HB3' ' B' ' 886' ' ' PHE . 31.9 m -99.05 145.13 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 C-N-CA 119.989 -0.684 . . . . 0.040000000000000001 110.343 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 5.0 t -137.64 146.15 43.56 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.936 -0.478 . . . . 0.71999999999999997 110.166 -178.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 964' ' ' VAL . . . . . 0.717 HG13 HG22 ' B' ' 911' ' ' VAL . 58.3 t -95.13 136.07 27.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.073 -1.017 . . . . 1.05 110.529 -179.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -95.25 126.11 40.34 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 103.761 -2.681 . . . . 3.02 103.761 173.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 966' ' ' LEU . . . . . 0.488 ' C ' HG23 ' B' ' 967' ' ' VAL . 1.4 tt -133.13 61.39 1.68 Allowed 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.309 -0.997 . . . . 1.46 108.309 177.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 967' ' ' VAL . . . . . 0.488 HG23 ' C ' ' B' ' 966' ' ' LEU . 98.5 t -158.04 96.25 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 N-CA-C 108.148 -1.056 . . . . 1.9399999999999999 108.148 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 93.3 mmm -142.81 58.32 1.43 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.767 -1.208 . . . . 0.0 108.227 178.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 133.1 119.1 1.99 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 106.654 -2.578 . . . . 2.1099999999999999 106.654 -178.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -84.53 -44.53 13.49 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 118.912 1.356 . . . . 5.8899999999999997 111.404 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 43.3 tp -61.48 88.85 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.882 -1.136 . . . . 4.3600000000000003 110.048 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -141.59 -156.26 0.66 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.575 -0.703 . . . . 1.8300000000000001 110.249 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -121.68 176.28 5.8 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.599 -0.688 . . . . 4.3499999999999996 110.195 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 9.2 t -100.22 129.87 46.28 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.52 -0.738 . . . . 1.27 109.956 179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -156.11 157.89 36.79 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.53 -0.731 . . . . 5.0199999999999996 110.629 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.31 86.75 16.51 Favored Pre-proline 0 N--CA 1.5 2.056 0 O-C-N 121.678 -0.639 . . . . 2.4100000000000001 109.521 179.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 977' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -72.92 -172.49 0.99 Allowed 'Trans proline' 0 N--CA 1.487 1.089 0 O-C-N 123.32 1.168 . . . . 0.95999999999999996 111.443 -179.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 978' ' ' LEU . . . . . 0.539 ' N ' HD12 ' B' ' 978' ' ' LEU . 5.0 mp -127.93 154.99 44.92 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 107.619 -1.252 . . . . 0.62 107.619 178.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 979' ' ' THR . . . . . 0.462 HG23 ' C ' ' B' ' 978' ' ' LEU . 44.3 p -149.9 141.07 23.08 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.746 -1.221 . . . . 3.5699999999999998 111.294 -179.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 980' ' ' ILE . . . . . 0.767 ' HB ' HG21 ' B' ' 899' ' ' VAL . 50.2 mm -107.84 127.8 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 108.892 -0.781 . . . . 1.3300000000000001 108.892 179.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 981' ' ' PHE . . . . . 0.485 ' HD1' ' HH ' ' B' ' 879' ' ' TYR . 6.4 t80 -121.61 97.53 5.54 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 119.717 -0.793 . . . . 0.050000000000000003 111.906 -178.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 94.1 p -109.22 158.65 17.63 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.552 -0.717 . . . . 0.87 109.104 178.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 983' ' ' GLY . . . . . . . . . . . . . . . -173.66 109.07 0.29 Allowed Glycine 0 N--CA 1.499 2.872 0 N-CA-C 106.705 -2.558 . . . . 0.029999999999999999 106.705 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -109.07 148.71 30.4 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 114.361 1.245 . . . . 0.69999999999999996 114.361 -175.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 985' ' ' LEU . . . . . 0.985 HD13 HD22 ' B' ' 890' ' ' LEU . 35.0 tp -69.03 135.17 50.43 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.796 -1.19 . . . . 0.040000000000000001 110.255 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 986' ' ' LEU . . . . . 0.463 ' CD1' HD11 ' C' ' 986' ' ' LEU . 50.5 tp -106.88 -58.82 1.89 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.639 -0.663 . . . . 0.040000000000000001 109.932 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 60.9 t80 -144.07 145.34 32.1 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.591 -1.263 . . . . 0.040000000000000001 107.591 179.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.61 163.03 12.2 Favored Glycine 0 N--CA 1.495 2.594 0 N-CA-C 108.163 -1.975 . . . . 0.040000000000000001 108.163 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -75.76 112.48 20.02 Favored Pre-proline 0 N--CA 1.499 1.984 0 O-C-N 121.243 -1.151 . . . . 0.040000000000000001 109.406 179.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 990' ' ' PRO . . . . . 0.416 ' O ' ' HB2' ' B' ' 991' ' ' GLU . 49.6 Cg_endo -90.38 71.86 1.35 Allowed 'Trans proline' 0 C--N 1.319 -1.005 0 O-C-N 123.133 1.07 . . . . 0.45000000000000001 111.373 -179.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 991' ' ' GLU . . . . . 0.416 ' HB2' ' O ' ' B' ' 990' ' ' PRO . 74.9 mt-10 67.34 -73.56 0.08 Allowed 'General case' 0 N--CA 1.502 2.149 0 N-CA-C 108.552 -0.907 . . . . 1.97 108.552 -177.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 992' ' ' LEU . . . . . 0.434 ' HA ' HD23 ' B' ' 992' ' ' LEU . 10.9 mt 51.18 20.28 0.86 Allowed 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.536 -0.727 . . . . 2.3799999999999999 111.677 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 80.3 mt-10 -93.75 156.79 16.48 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.895 -1.128 . . . . 3.79 109.976 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 70.6 m80 -146.24 92.79 2.22 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.444 -0.785 . . . . 3.5099999999999998 110.388 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 995' ' ' ALA . . . . . . . . . . . . 2.517 . . . . . . . 0 N--CA 1.504 2.255 0 O-C-N 120.935 -1.103 . . . . 2.73 110.612 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo . . . . . 0 N--CA 1.488 1.158 0 N-CA-C 109.539 -0.985 . . . . 3.8300000000000001 109.539 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' C' C ' 847' ' ' VAL . . . . . 0.506 HG12 ' HB2' ' C' ' 849' ' ' GLN . 58.2 t -126.48 106.41 23.87 Favored Pre-proline 0 N--CA 1.496 1.835 0 O-C-N 121.597 -0.689 . . . . 1.8300000000000001 110.012 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 848' ' ' PRO . . . . . 0.886 ' O ' HG23 ' C' ' 850' ' ' VAL . 44.4 Cg_endo -69.7 -22.68 32.01 Favored 'Trans proline' 0 N--CA 1.488 1.177 0 O-C-N 123.278 1.146 . . . . 0.65000000000000002 111.034 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 849' ' ' GLN . . . . . 0.506 ' HB2' HG12 ' C' ' 847' ' ' VAL . 54.5 tt0 25.17 64.9 0.06 Allowed 'General case' 0 N--CA 1.519 2.991 0 N-CA-C 113.379 0.881 . . . . 2.5800000000000001 113.379 179.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 850' ' ' VAL . . . . . 0.886 HG23 ' O ' ' C' ' 848' ' ' PRO . 72.1 t -119.06 135.5 59.27 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.117 -0.989 . . . . 1.0900000000000001 111.028 -179.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 851' ' ' ALA . . . . . 0.573 ' HB3' ' HG ' ' C' ' 873' ' ' LEU . . . -126.96 155.93 42.34 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 105.758 -1.942 . . . . 0.040000000000000001 105.758 176.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 852' ' ' PHE . . . . . 0.451 ' CD1' ' N ' ' C' ' 852' ' ' PHE . 16.0 p90 -160.26 127.38 4.41 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 121.016 1.734 . . . . 0.050000000000000003 108.625 178.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 38.8 t -176.65 134.88 0.22 Allowed 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 108.18 -1.044 . . . . 0.040000000000000001 108.18 -179.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 854' ' ' ALA . . . . . 0.447 ' HB1' ' HD2' ' C' ' 868' ' ' PHE . . . -132.21 156.96 45.53 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.164 -0.96 . . . . 0.67000000000000004 109.779 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 855' ' ' ALA . . . . . 0.683 ' HB3' ' CB ' ' C' ' 870' ' ' ARG . . . -122.41 140.53 52.6 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 121.759 0.79 . . . . 0.51000000000000001 111.179 -179.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 856' ' ' LEU . . . . . 0.734 HD11 HD23 ' C' ' 858' ' ' LEU . 3.5 tm? -111.74 138.14 48.71 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.641 -0.662 . . . . 0.050000000000000003 110.036 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 857' ' ' SER . . . . . 0.636 ' N ' HD13 ' C' ' 856' ' ' LEU . 21.1 m -155.27 18.66 0.42 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.395 -0.815 . . . . 1.3300000000000001 111.347 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 858' ' ' LEU . . . . . 0.734 HD23 HD11 ' C' ' 856' ' ' LEU . 3.2 pp -34.81 160.87 0.04 OUTLIER Pre-proline 0 N--CA 1.52 3.067 0 N-CA-C 113.066 0.765 . . . . 2.3300000000000001 113.066 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -60.34 -88.22 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.462 0 O-C-N 122.99 0.995 . . . . 2.3199999999999998 113.455 -178.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 55.2 ptt85 -128.31 -143.34 0.27 Allowed 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.823 -1.173 . . . . 0.040000000000000001 111.808 -177.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 69.4 m -37.84 130.32 1.11 Allowed 'General case' 0 N--CA 1.511 2.581 0 O-C-N 121.622 -0.673 . . . . 1.3100000000000001 112.356 -178.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.14 160.45 26.03 Favored Pre-proline 0 N--CA 1.489 1.476 0 N-CA-C 108.326 -0.99 . . . . 4.5099999999999998 108.326 177.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.78 -13.57 26.83 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 O-C-N 123.152 1.08 . . . . 2.2400000000000002 111.453 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -177.78 -136.2 2.44 Favored Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.664 -1.374 . . . . 0.040000000000000001 109.664 179.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 17.0 m -68.23 153.86 42.89 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.329 -1.1 . . . . 1.51 109.92 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 866' ' ' VAL . . . . . 0.444 ' HA ' ' HD3' ' C' ' 867' ' ' PRO . 39.4 t -97.72 139.78 21.56 Favored Pre-proline 0 N--CA 1.493 1.691 0 N-CA-C 113.507 0.928 . . . . 0.78000000000000003 113.507 -174.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 867' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' C' ' 866' ' ' VAL . 55.8 Cg_endo -91.4 -147.86 0.03 OUTLIER 'Trans proline' 0 CA--C 1.544 0.998 0 O-C-N 123.688 1.362 . . . . 0.92000000000000004 108.95 177.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 868' ' ' PHE . . . . . 0.485 ' CD1' ' HG2' ' C' ' 881' ' ' PRO . 14.0 p90 -149.88 124.12 9.52 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 120.51 -1.368 . . . . 0.050000000000000003 110.109 179.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 47.6 p-10 -112.45 -3.08 14.53 Favored 'General case' 0 N--CA 1.5 2.055 0 C-N-CA 119.131 -1.027 . . . . 1.7 112.508 -178.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 870' ' ' ARG . . . . . 0.683 ' CB ' ' HB3' ' C' ' 855' ' ' ALA . 28.0 mmm180 -91.85 87.86 6.41 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 120.925 -1.109 . . . . 2.5899999999999999 111.112 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 60.7 t -71.55 96.94 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 120.927 -1.108 . . . . 1.9399999999999999 109.337 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 872' ' ' LEU . . . . . 0.804 HD13 HD11 ' A' ' 953' ' ' ILE . 95.3 mt -87.29 -44.73 11.2 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.592 -0.692 . . . . 1.0600000000000001 110.678 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 873' ' ' LEU . . . . . 0.573 ' HG ' ' HB3' ' C' ' 851' ' ' ALA . 33.0 tp -172.91 102.02 0.13 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.101 -0.999 . . . . 4.1799999999999997 108.947 178.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 874' ' ' ASN . . . . . 0.443 ' CB ' ' HA ' ' C' ' 852' ' ' PHE . 34.0 t-20 176.99 82.09 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.284 0 N-CA-C 108.987 -0.746 . . . . 0.040000000000000001 108.987 -179.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -65.34 -47.27 77.07 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.107 -0.995 . . . . 3.3799999999999999 111.308 -179.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 876' ' ' GLY . . . . . 0.417 ' HA3' ' CE2' ' C' ' 878' ' ' TYR . . . -72.58 -26.47 71.59 Favored Glycine 0 N--CA 1.493 2.483 0 C-N-CA 120.423 -0.894 . . . . 0.040000000000000001 111.436 -178.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 79.61 -63.13 4.03 Favored Glycine 0 N--CA 1.5 2.956 0 N-CA-C 108.102 -1.999 . . . . 0.040000000000000001 108.102 -178.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 878' ' ' TYR . . . . . 0.417 ' CE2' ' HA3' ' C' ' 876' ' ' GLY . 89.4 m-85 60.76 -64.79 0.06 Allowed 'General case' 0 N--CA 1.502 2.146 0 N-CA-C 114.276 1.213 . . . . 3.46 114.276 177.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 879' ' ' TYR . . . . . 0.483 ' CE2' ' CD1' ' C' ' 981' ' ' PHE . 22.3 p90 -109.93 106.93 16.67 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 114.976 1.473 . . . . 0.040000000000000001 114.976 -176.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -69.64 119.22 69.58 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.401 -0.812 . . . . 0.02 109.759 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 881' ' ' PRO . . . . . 0.485 ' HG2' ' CD1' ' C' ' 868' ' ' PHE . 55.3 Cg_endo -79.26 -0.16 10.51 Favored 'Trans proline' 0 N--CA 1.487 1.132 0 O-C-N 123.363 1.191 . . . . 0.39000000000000001 111.563 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -76.31 -62.84 1.48 Allowed 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 106.433 -1.691 . . . . 0.81000000000000005 106.433 178.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 24.3 p -88.46 -21.87 23.98 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.136 -1.061 . . . . 0.040000000000000001 108.136 176.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 81.77 16.35 73.13 Favored Glycine 0 N--CA 1.493 2.476 0 N-CA-C 110.401 -1.079 . . . . 0.029999999999999999 110.401 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 84.4 t -73.93 91.91 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 C-N-CA 118.397 -1.321 . . . . 1.01 108.111 -179.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 886' ' ' PHE . . . . . 0.875 ' HB3' HG22 ' C' ' 962' ' ' VAL . 1.1 t80 -87.46 105.7 17.47 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 115.17 -0.923 . . . . 0.050000000000000003 111.628 -177.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 887' ' ' THR . . . . . 0.438 ' O ' ' HD3' ' C' ' 889' ' ' PRO . 86.7 m -102.45 99.72 9.79 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 107.806 -1.183 . . . . 0.68000000000000005 107.806 177.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 888' ' ' ALA . . . . . . . . . . . . . . . -98.66 101.19 11.14 Favored Pre-proline 0 N--CA 1.501 2.084 0 N-CA-C 114.388 1.255 . . . . 0.25 114.388 -176.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 889' ' ' PRO . . . . . 0.438 ' HD3' ' O ' ' C' ' 887' ' ' THR . 55.7 Cg_endo -80.06 -15.3 11.76 Favored 'Trans proline' 0 N--CA 1.486 1.042 0 N-CA-C 108.73 -1.296 . . . . 1.6399999999999999 108.73 175.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 890' ' ' LEU . . . . . 0.619 HD21 HG11 ' C' ' 850' ' ' VAL . 60.7 mt -37.35 -49.5 0.99 Allowed 'General case' 0 N--CA 1.508 2.425 0 N-CA-C 113.452 0.908 . . . . 2.29 113.452 -177.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 52.36 97.19 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.267 0 O-C-N 121.19 -0.944 . . . . 0.63 110.285 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . 158.94 -154.21 25.3 Favored Glycine 0 N--CA 1.477 1.422 0 N-CA-C 107.272 -2.331 . . . . 0.040000000000000001 107.272 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 74.5 ttt-85 -117.36 123.23 45.96 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.612 -0.934 . . . . 3.0 108.761 177.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 894' ' ' TYR . . . . . 0.761 ' CZ ' HD23 ' C' ' 954' ' ' LEU . 20.3 p90 -133.78 155.54 49.62 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.117 -0.989 . . . . 0.040000000000000001 110.956 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 895' ' ' LEU . . . . . . . . . . . . . 49.0 tp -97.82 115.41 28.0 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.719 -0.613 . . . . 1.27 110.268 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 896' ' ' LEU . . . . . 0.435 HD11 ' HE1' ' C' ' 981' ' ' PHE . 9.3 tt -118.36 144.6 45.77 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.654 -0.654 . . . . 0.93999999999999995 109.945 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 897' ' ' SER . . . . . . . . . . . . . 55.4 m -141.82 124.57 16.01 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.429 -0.795 . . . . 0.040000000000000001 111.284 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -101.89 148.17 25.64 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 108.789 -0.819 . . . . 0.47999999999999998 108.789 178.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 899' ' ' VAL . . . . . 0.705 HG21 ' HB ' ' C' ' 980' ' ' ILE . 87.4 t -92.49 120.31 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.35 -0.844 . . . . 0.55000000000000004 111.256 -179.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 94.6 mt -92.78 112.23 24.11 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 114.036 1.125 . . . . 1.5900000000000001 114.036 -175.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 20.7 m -63.48 140.4 58.87 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 107.472 -1.307 . . . . 0.050000000000000003 107.472 177.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -61.12 -65.23 3.42 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 110.344 -1.103 . . . . 0.029999999999999999 110.344 -179.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 5.9 m170 45.86 64.39 1.48 Allowed 'General case' 0 N--CA 1.507 2.397 0 O-C-N 121.556 -0.967 . . . . 3.2000000000000002 111.239 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 42.7 ptt85 -67.68 -7.96 31.12 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.614 -0.679 . . . . 2.9199999999999999 111.83 -179.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 905' ' ' HIS . . . . . 0.493 ' O ' ' CB ' ' C' ' 906' ' ' GLU . 75.8 t60 -61.97 6.12 0.08 Allowed 'General case' 0 N--CA 1.506 2.342 0 CA-C-O 117.649 -1.167 . . . . 2.8700000000000001 113.468 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 906' ' ' GLU . . . . . 0.493 ' CB ' ' O ' ' C' ' 905' ' ' HIS . 0.8 OUTLIER 93.07 -163.45 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.441 0 CA-C-N 121.252 1.842 . . . . 0.98999999999999999 112.012 178.983 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 907' ' ' LYS . . . . . 0.493 ' CB ' ' O ' ' C' ' 906' ' ' GLU . 25.8 ttmt 89.9 161.91 0.05 OUTLIER 'General case' 0 N--CA 1.522 3.136 0 N-CA-C 108.061 -1.088 . . . . 5.25 108.061 -177.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 59.6 t -121.67 117.34 52.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 120.841 -1.162 . . . . 0.39000000000000001 110.915 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 909' ' ' GLU . . . . . 0.54 ' OE2' HD12 ' C' ' 966' ' ' LEU . 43.1 tp10 -104.5 130.91 52.4 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 107.486 -1.302 . . . . 1.72 107.486 177.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -157.18 121.13 4.24 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 106.887 -1.523 . . . . 0.67000000000000004 106.887 178.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 911' ' ' VAL . . . . . 0.739 HG22 HG13 ' C' ' 964' ' ' VAL . 97.8 t -83.42 132.06 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.784 -0.573 . . . . 0.54000000000000004 110.863 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 64.4 mt -66.18 157.41 31.4 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.478 -0.764 . . . . 1.5 109.243 178.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 913' ' ' SER . . . . . 0.417 ' CB ' ' CG1' ' C' ' 919' ' ' VAL . 2.2 t -125.4 137.96 54.02 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.212 -1.033 . . . . 1.3700000000000001 108.212 176.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 914' ' ' ARG . . . . . 0.891 ' NH1' HD23 ' C' ' 956' ' ' LEU . 0.0 OUTLIER -63.94 154.06 35.11 Favored 'General case' 0 N--CA 1.504 2.275 0 O-C-N 120.681 -1.262 . . . . 4.2999999999999998 111.88 -178.714 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 915' ' ' SER . . . . . 0.425 ' CB ' ' O ' ' C' ' 914' ' ' ARG . 4.0 t 83.06 -31.41 0.09 Allowed 'General case' 0 N--CA 1.521 3.124 0 C-N-CA 123.865 0.866 . . . . 2.0499999999999998 112.382 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 916' ' ' ASN . . . . . 0.618 ' HB2' HG21 ' C' ' 919' ' ' VAL . 94.5 m-20 -122.37 -21.72 5.72 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.785 -1.197 . . . . 2.71 111.252 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 917' ' ' GLN . . . . . 0.41 ' HB2' ' O ' ' C' ' 916' ' ' ASN . 46.5 mt-30 67.36 167.81 0.24 Allowed 'General case' 0 N--CA 1.52 3.044 0 N-CA-C 105.608 -1.997 . . . . 2.6800000000000002 105.608 -174.013 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.91 -127.47 41.08 Favored Glycine 1 N--CA 1.52 4.289 0 CA-C-N 123.589 2.904 . . . . 0.029999999999999999 107.022 -177.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 919' ' ' VAL . . . . . 0.618 HG21 ' HB2' ' C' ' 916' ' ' ASN . 92.6 t 50.54 94.53 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.233 0 O-C-N 121.466 -1.02 . . . . 1.3899999999999999 109.206 -178.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 920' ' ' ALA . . . . . 0.998 ' HB3' HG12 ' C' ' 949' ' ' VAL . . . -93.21 94.37 8.76 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.395 -0.922 . . . . 0.029999999999999999 110.943 -179.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 921' ' ' ARG . . . . . 0.694 ' HG3' HG23 ' C' ' 922' ' ' VAL . 40.7 ptt85 -81.36 -42.29 20.71 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 105.766 -1.938 . . . . 4.4199999999999999 105.766 176.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 922' ' ' VAL . . . . . 0.694 HG23 ' HG3' ' C' ' 921' ' ' ARG . 73.6 t -100.82 74.92 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.368 0 N-CA-C 105.523 -2.029 . . . . 0.84999999999999998 105.523 175.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -89.95 135.08 33.86 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.87 0.843 . . . . 2.46 112.315 -176.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 4.4 t -147.33 102.94 3.52 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.973 -1.121 . . . . 0.69999999999999996 107.973 178.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -110.08 89.84 0.56 Allowed Glycine 0 N--CA 1.488 2.105 0 N-CA-C 108.952 -1.659 . . . . 0.040000000000000001 108.952 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.33 0 N-CA-C 109.3 -1.52 . . . . 0.040000000000000001 109.3 -179.685 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 24.9 m . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 120.928 0.394 . . . . 13.779999999999999 110.355 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 95.6 mt -114.47 129.78 56.68 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.572 -0.705 . . . . 13.76 110.347 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -152.03 169.85 31.37 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 109.316 -1.514 . . . . 9.1300000000000008 109.316 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 949' ' ' VAL . . . . . 0.998 HG12 ' HB3' ' C' ' 920' ' ' ALA . 34.0 m -118.24 135.65 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.513 -0.993 . . . . 7.0800000000000001 110.985 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 950' ' ' PHE . . . . . 0.456 ' CZ ' ' HB3' ' C' ' 921' ' ' ARG . 49.4 p90 -134.76 151.92 51.35 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.524 -0.735 . . . . 7.5899999999999999 109.348 179.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 26.6 m -119.01 -55.26 2.18 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.375 -0.828 . . . . 5.0300000000000002 111.956 -178.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 952' ' ' LEU . . . . . 0.452 ' O ' ' O ' ' C' ' 953' ' ' ILE . 52.8 tp -63.15 -76.37 0.07 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.359 -0.838 . . . . 1.01 111.688 -178.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 953' ' ' ILE . . . . . 0.574 HD12 ' HD3' ' C' ' 955' ' ' PRO . 2.0 pp -49.12 -150.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.784 0 N-CA-C 114.699 1.37 . . . . 2.6000000000000001 114.699 -176.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 954' ' ' LEU . . . . . 0.761 HD23 ' CZ ' ' C' ' 894' ' ' TYR . 0.0 OUTLIER 170.99 89.14 0.04 OUTLIER Pre-proline 0 N--CA 1.516 2.836 0 O-C-N 120.74 -1.225 . . . . 0.050000000000000003 111.88 -179.477 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 955' ' ' PRO . . . . . 0.754 ' C ' HD12 ' C' ' 956' ' ' LEU . 50.9 Cg_endo -83.41 93.7 0.82 Allowed 'Trans proline' 0 C--N 1.317 -1.1 0 N-CA-C 109.419 -1.031 . . . . 0.83999999999999997 109.419 178.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 956' ' ' LEU . . . . . 0.891 HD23 ' NH1' ' C' ' 914' ' ' ARG . 7.9 mp -126.28 150.13 48.66 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.07 -1.019 . . . . 0.040000000000000001 110.772 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -83.16 151.81 25.54 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 117.743 -1.122 . . . . 1.28 111.518 -178.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -66.88 119.32 11.7 Favored 'General case' 0 N--CA 1.509 2.515 0 CA-C-N 123.022 2.647 . . . . 0.17000000000000001 111.213 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.72 -19.98 47.85 Favored Glycine 0 N--CA 1.499 2.882 0 N-CA-C 110.907 -0.877 . . . . 0.040000000000000001 110.907 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 960' ' ' ASP . . . . . 0.409 ' HB3' ' NE ' ' C' ' 914' ' ' ARG . 0.4 OUTLIER -54.44 170.58 0.15 Allowed 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.409 -1.054 . . . . 0.040000000000000001 110.353 -179.456 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 961' ' ' THR . . . . . 0.507 ' HA ' ' O ' ' C' ' 886' ' ' PHE . 39.3 m -136.93 141.0 42.66 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.989 -1.069 . . . . 1.78 112.614 -177.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 962' ' ' VAL . . . . . 0.875 HG22 ' HB3' ' C' ' 886' ' ' PHE . 27.3 m -99.88 145.18 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 C-N-CA 120.395 -0.522 . . . . 0.040000000000000001 110.696 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 5.2 t -137.53 143.85 41.84 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.828 -0.545 . . . . 0.71999999999999997 109.861 -178.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 964' ' ' VAL . . . . . 0.739 HG13 HG22 ' C' ' 911' ' ' VAL . 61.6 t -91.94 136.94 23.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.103 -0.998 . . . . 1.05 110.733 -178.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -93.68 126.37 38.81 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 103.566 -2.753 . . . . 3.02 103.566 173.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 966' ' ' LEU . . . . . 0.54 HD12 ' OE2' ' C' ' 909' ' ' GLU . 0.2 OUTLIER -133.63 59.23 1.74 Allowed 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.662 -0.866 . . . . 1.46 108.662 177.503 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 967' ' ' VAL . . . . . 0.488 HG23 ' C ' ' C' ' 966' ' ' LEU . 99.5 t -157.8 96.31 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 N-CA-C 108.327 -0.99 . . . . 1.9399999999999999 108.327 179.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 91.8 mmm -143.04 58.65 1.41 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.736 -1.227 . . . . 0.0 108.562 179.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 134.19 119.46 1.97 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 107.372 -2.291 . . . . 2.1099999999999999 107.372 -178.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 -82.76 -58.12 3.02 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.048 -1.266 . . . . 5.8899999999999997 110.662 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 46.3 tp -58.78 89.74 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.455 -0.778 . . . . 4.3600000000000003 110.449 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -143.33 -151.72 0.38 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.536 -0.727 . . . . 1.8300000000000001 110.011 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -117.0 167.03 11.5 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.352 -0.843 . . . . 4.3499999999999996 110.082 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 30.2 t -101.49 130.3 47.73 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.523 -0.736 . . . . 1.27 110.075 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -155.62 156.55 35.23 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.504 -0.747 . . . . 5.0199999999999996 110.525 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.76 84.82 17.53 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.679 -0.638 . . . . 2.4100000000000001 109.779 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 977' ' ' PRO . . . . . 0.55 ' C ' HD12 ' C' ' 978' ' ' LEU . 48.9 Cg_endo -74.49 -172.19 1.13 Allowed 'Trans proline' 0 C--N 1.316 -1.16 0 O-C-N 123.359 1.189 . . . . 0.95999999999999996 111.074 -179.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 978' ' ' LEU . . . . . 0.55 HD12 ' C ' ' C' ' 977' ' ' PRO . 6.3 mp -123.32 156.42 35.36 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.456 -1.312 . . . . 0.62 107.456 177.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 979' ' ' THR . . . . . 0.45 HG23 ' C ' ' C' ' 978' ' ' LEU . 47.6 p -149.33 141.49 23.99 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.733 -1.229 . . . . 3.5699999999999998 111.19 -179.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 980' ' ' ILE . . . . . 0.705 ' HB ' HG21 ' C' ' 899' ' ' VAL . 51.2 mm -105.8 128.22 60.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 108.974 -0.75 . . . . 1.3300000000000001 108.974 179.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 981' ' ' PHE . . . . . 0.483 ' CD1' ' CE2' ' C' ' 879' ' ' TYR . 3.3 t80 -117.95 95.76 5.05 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.394 -0.816 . . . . 0.050000000000000003 111.324 -178.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 982' ' ' SER . . . . . . . . . . . . . 11.6 p -108.18 158.43 17.45 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.599 -0.688 . . . . 0.87 109.213 178.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 983' ' ' GLY . . . . . 0.416 ' O ' ' CZ ' ' C' ' 852' ' ' PHE . . . -171.65 114.61 0.54 Allowed Glycine 0 N--CA 1.496 2.69 0 N-CA-C 106.648 -2.581 . . . . 0.029999999999999999 106.648 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 984' ' ' ALA . . . . . . . . . . . . . . . -108.92 151.57 26.11 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 114.213 1.19 . . . . 0.69999999999999996 114.213 -175.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 985' ' ' LEU . . . . . 0.586 HD13 HD22 ' C' ' 890' ' ' LEU . 55.4 tp -76.43 135.88 39.43 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.819 -1.176 . . . . 0.040000000000000001 109.701 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 986' ' ' LEU . . . . . 0.463 HD11 ' CD1' ' B' ' 986' ' ' LEU . 47.2 tp -106.75 -61.8 1.48 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.491 -0.756 . . . . 0.040000000000000001 110.36 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -144.13 146.67 32.92 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 107.786 -1.191 . . . . 0.040000000000000001 107.786 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.25 162.91 12.25 Favored Glycine 0 N--CA 1.495 2.616 0 N-CA-C 108.071 -2.012 . . . . 0.040000000000000001 108.071 179.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -74.95 112.76 19.31 Favored Pre-proline 0 N--CA 1.498 1.946 0 O-C-N 121.15 -1.206 . . . . 0.040000000000000001 109.48 179.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 990' ' ' PRO . . . . . 0.423 ' O ' ' HB2' ' C' ' 991' ' ' GLU . 50.2 Cg_endo -89.13 71.26 2.09 Favored 'Trans proline' 0 C--N 1.32 -0.967 0 O-C-N 123.108 1.057 . . . . 0.45000000000000001 111.291 -179.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 991' ' ' GLU . . . . . 0.423 ' HB2' ' O ' ' C' ' 990' ' ' PRO . 73.6 mt-10 67.52 -73.46 0.08 Allowed 'General case' 0 N--CA 1.503 2.182 0 N-CA-C 108.518 -0.919 . . . . 1.97 108.518 -177.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 992' ' ' LEU . . . . . 0.414 HD12 ' HD2' ' C' ' 990' ' ' PRO . 10.8 mt 50.48 20.73 0.73 Allowed 'General case' 0 N--CA 1.5 2.06 0 O-C-N 121.568 -0.707 . . . . 2.3799999999999999 111.748 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -93.47 156.75 16.57 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.878 -1.139 . . . . 3.79 110.044 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 68.7 m80 -145.64 92.65 2.25 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.509 -0.745 . . . . 3.5099999999999998 110.254 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 995' ' ' ALA . . . . . . . . . . . . 2.519 . . . . . . . 0 N--CA 1.504 2.249 0 O-C-N 120.968 -1.082 . . . . 2.73 110.637 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo . . . . . 0 N--CA 1.488 1.151 0 N-CA-C 109.491 -1.004 . . . . 3.8300000000000001 109.491 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 847' ' ' VAL . . . . . . . . . . . . . 59.0 t -133.78 102.68 12.32 Favored Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 121.546 -0.721 . . . . 1.8300000000000001 109.993 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 848' ' ' PRO . . . . . 0.757 ' O ' HG23 ' A' ' 850' ' ' VAL . 44.2 Cg_endo -69.79 -19.25 36.22 Favored 'Trans proline' 0 N--CA 1.487 1.114 0 O-C-N 123.316 1.166 . . . . 0.65000000000000002 111.272 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 849' ' ' GLN . . . . . . . . . . . . . 55.9 tt0 27.91 68.09 0.07 Allowed 'General case' 0 N--CA 1.518 2.953 0 N-CA-C 112.901 0.704 . . . . 2.5800000000000001 112.901 179.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 850' ' ' VAL . . . . . 0.757 HG23 ' O ' ' A' ' 848' ' ' PRO . 65.3 t -119.65 137.01 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.148 -0.97 . . . . 1.0900000000000001 111.51 -178.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 851' ' ' ALA . . . . . 0.58 ' HB3' ' HG ' ' A' ' 873' ' ' LEU . . . -123.79 159.92 28.47 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 105.921 -1.881 . . . . 0.040000000000000001 105.921 176.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 852' ' ' PHE . . . . . 0.431 ' HA ' ' CB ' ' A' ' 874' ' ' ASN . 34.2 p90 -159.29 127.82 5.15 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 120.88 1.673 . . . . 0.050000000000000003 108.465 178.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 8.8 t -175.4 134.49 0.31 Allowed 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.185 -1.042 . . . . 0.040000000000000001 108.185 -178.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -130.24 156.92 43.83 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.03 -1.044 . . . . 0.67000000000000004 109.739 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 855' ' ' ALA . . . . . 0.843 ' HB3' ' CB ' ' A' ' 870' ' ' ARG . . . -119.76 144.11 47.45 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.806 0.813 . . . . 0.51000000000000001 110.809 -179.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 856' ' ' LEU . . . . . 0.677 HD13 ' N ' ' A' ' 857' ' ' SER . 2.1 tm? -115.21 134.23 55.33 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.508 -0.745 . . . . 0.050000000000000003 110.45 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 857' ' ' SER . . . . . 0.677 ' N ' HD13 ' A' ' 856' ' ' LEU . 1.7 m -156.74 14.41 0.28 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.486 -0.759 . . . . 1.3300000000000001 111.866 179.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 858' ' ' LEU . . . . . 0.557 ' HG ' HD11 ' A' ' 856' ' ' LEU . 0.3 OUTLIER -36.56 162.28 0.04 OUTLIER Pre-proline 0 N--CA 1.524 3.231 0 CA-C-N 119.053 0.842 . . . . 2.3300000000000001 113.07 -179.58 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -61.26 -89.31 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.534 0 O-C-N 123.103 1.054 . . . . 2.3199999999999998 113.841 -177.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 53.9 ptt85 -134.21 -142.42 0.2 Allowed 'General case' 0 N--CA 1.502 2.144 0 O-C-N 120.761 -1.212 . . . . 0.040000000000000001 111.787 -177.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 5.2 m -36.65 126.89 0.86 Allowed 'General case' 0 N--CA 1.511 2.612 0 O-C-N 121.659 -0.651 . . . . 1.3100000000000001 112.366 -178.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 862' ' ' GLU . . . . . 0.779 ' OE1' HG22 ' A' ' 866' ' ' VAL . 1.3 mt-10 -104.73 165.55 13.08 Favored Pre-proline 0 N--CA 1.489 1.496 0 N-CA-C 108.652 -0.87 . . . . 4.5099999999999998 108.652 177.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -73.54 -14.42 24.87 Favored 'Trans proline' 0 C--N 1.313 -1.311 0 O-C-N 123.284 1.149 . . . . 2.2400000000000002 111.388 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -177.93 -135.29 2.23 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 110.162 -1.175 . . . . 0.040000000000000001 110.162 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 26.4 m -64.71 156.65 29.69 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.41 -1.053 . . . . 1.51 110.912 -178.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 866' ' ' VAL . . . . . 0.779 HG22 ' OE1' ' A' ' 862' ' ' GLU . 56.2 t -96.95 132.79 25.22 Favored Pre-proline 0 N--CA 1.496 1.838 0 N-CA-C 113.453 0.908 . . . . 0.78000000000000003 113.453 -174.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 867' ' ' PRO . . . . . 0.443 ' O ' HD23 ' A' ' 856' ' ' LEU . 55.4 Cg_endo -90.68 -149.51 0.03 OUTLIER 'Trans proline' 0 CA--C 1.545 1.066 0 O-C-N 123.571 1.3 . . . . 0.92000000000000004 109.332 177.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 868' ' ' PHE . . . . . 0.466 ' CD1' ' N ' ' A' ' 868' ' ' PHE . 19.4 p90 -150.34 123.49 8.86 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.584 -1.322 . . . . 0.050000000000000003 109.837 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 49.9 p-10 -113.62 -2.68 13.74 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.129 -0.982 . . . . 1.7 112.841 -178.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 870' ' ' ARG . . . . . 0.843 ' CB ' ' HB3' ' A' ' 855' ' ' ALA . 28.2 mmm180 -91.58 89.9 7.37 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 120.819 -1.176 . . . . 2.5899999999999999 111.131 -179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 57.9 t -72.77 96.66 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 O-C-N 120.984 -1.072 . . . . 1.9399999999999999 109.694 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 872' ' ' LEU . . . . . 0.833 HD11 ' HB2' ' A' ' 855' ' ' ALA . 86.6 mt -83.32 -46.81 12.18 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.505 -0.747 . . . . 1.0600000000000001 110.164 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 873' ' ' LEU . . . . . 0.58 ' HG ' ' HB3' ' A' ' 851' ' ' ALA . 32.7 tp -174.33 102.35 0.1 Allowed 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 108.595 -0.891 . . . . 4.1799999999999997 108.595 178.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 874' ' ' ASN . . . . . 0.431 ' CB ' ' HA ' ' A' ' 852' ' ' PHE . 33.9 t-20 178.33 80.98 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.256 0 N-CA-C 109.264 -0.643 . . . . 0.040000000000000001 109.264 -179.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -65.41 -47.03 77.68 Favored 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 119.344 -0.942 . . . . 3.3799999999999999 111.129 -179.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 876' ' ' GLY . . . . . . . . . . . . . . . -73.97 -24.26 74.36 Favored Glycine 0 N--CA 1.494 2.55 0 O-C-N 121.316 -0.865 . . . . 0.040000000000000001 111.672 -178.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 84.41 -60.04 4.87 Favored Glycine 0 N--CA 1.502 3.099 0 N-CA-C 107.949 -2.06 . . . . 0.040000000000000001 107.949 -178.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 878' ' ' TYR . . . . . 0.4 ' CZ ' HG11 ' A' ' 850' ' ' VAL . 97.8 m-85 60.32 -66.63 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.14 0 N-CA-C 114.424 1.268 . . . . 3.46 114.424 177.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 879' ' ' TYR . . . . . 0.469 ' CB ' ' CD2' ' A' ' 886' ' ' PHE . 21.3 p90 -110.77 109.69 20.02 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 114.831 1.419 . . . . 0.040000000000000001 114.831 -176.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -66.0 117.08 38.97 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 121.534 -0.729 . . . . 0.02 110.191 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 881' ' ' PRO . . . . . 0.463 ' HG2' ' CD1' ' A' ' 868' ' ' PHE . 54.4 Cg_endo -75.88 0.39 9.31 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 O-C-N 123.413 1.217 . . . . 0.39000000000000001 112.222 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -75.35 -65.19 0.92 Allowed 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 106.952 -1.499 . . . . 0.81000000000000005 106.952 178.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 2.2 p -95.74 -17.0 21.57 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.802 -0.814 . . . . 0.040000000000000001 108.802 177.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.68 22.98 52.0 Favored Glycine 0 N--CA 1.494 2.533 0 C-N-CA 120.127 -1.035 . . . . 0.029999999999999999 110.664 179.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 885' ' ' VAL . . . . . . . . . . . . . 92.0 t -73.2 88.46 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 C-N-CA 118.357 -1.337 . . . . 1.01 107.917 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 886' ' ' PHE . . . . . 0.875 ' HB3' HG22 ' A' ' 962' ' ' VAL . 0.6 OUTLIER -89.13 106.38 18.4 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 115.04 -0.982 . . . . 0.050000000000000003 112.175 -177.053 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 887' ' ' THR . . . . . . . . . . . . . 97.0 m -98.85 99.16 10.2 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 107.495 -1.298 . . . . 0.68000000000000005 107.495 177.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 888' ' ' ALA . . . . . . . . . . . . . . . -97.25 108.11 42.39 Favored Pre-proline 0 N--CA 1.501 2.08 0 N-CA-C 114.207 1.188 . . . . 0.25 114.207 -176.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 889' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -89.39 -13.7 2.8 Favored 'Trans proline' 0 CA--C 1.546 1.076 0 O-C-N 123.288 1.152 . . . . 1.6399999999999999 109.137 176.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 890' ' ' LEU . . . . . 0.977 HD22 HD13 ' A' ' 985' ' ' LEU . 63.1 mt -35.93 -50.64 0.68 Allowed 'General case' 0 N--CA 1.509 2.508 0 N-CA-C 113.694 0.998 . . . . 2.29 113.694 -177.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 52.18 95.52 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.189 -0.945 . . . . 0.63 110.269 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 157.59 -154.09 25.23 Favored Glycine 0 N--CA 1.478 1.436 0 N-CA-C 107.055 -2.418 . . . . 0.040000000000000001 107.055 -179.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 893' ' ' ARG . . . . . 0.4 ' CZ ' ' CB ' ' C' ' 984' ' ' ALA . 71.0 ttt-85 -116.4 125.31 51.87 Favored 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.529 -0.983 . . . . 3.0 108.567 177.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 894' ' ' TYR . . . . . 0.825 ' OH ' HD12 ' A' ' 896' ' ' LEU . 0.1 OUTLIER -132.05 161.38 33.37 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.134 -0.979 . . . . 0.040000000000000001 111.084 -179.843 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 895' ' ' LEU . . . . . . . . . . . . . 43.6 tp -91.86 119.48 31.68 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.723 -0.611 . . . . 1.27 110.274 -179.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 896' ' ' LEU . . . . . 0.825 HD12 ' OH ' ' A' ' 894' ' ' TYR . 9.2 tt -110.18 144.42 38.85 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.742 -0.599 . . . . 0.93999999999999995 109.98 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 897' ' ' SER . . . . . 0.506 ' N ' HD23 ' A' ' 896' ' ' LEU . 69.2 m -149.45 114.66 5.47 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.51 -0.744 . . . . 0.040000000000000001 111.032 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.41 146.27 31.88 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.915 -0.772 . . . . 0.47999999999999998 108.915 178.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 899' ' ' VAL . . . . . 0.72 HG21 ' HB ' ' A' ' 980' ' ' ILE . 87.3 t -96.52 119.18 44.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 C-N-CA 119.566 -0.854 . . . . 0.55000000000000004 111.16 -179.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 900' ' ' LEU . . . . . 0.641 HD12 ' HB2' ' A' ' 924' ' ' SER . 4.5 mm? -95.95 113.22 24.82 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 114.223 1.194 . . . . 1.5900000000000001 114.223 -175.107 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 18.3 m -65.38 140.92 58.69 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 107.551 -1.277 . . . . 0.050000000000000003 107.551 177.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -64.68 -65.31 3.03 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 110.573 -1.011 . . . . 0.029999999999999999 110.573 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 46.95 66.44 0.99 Allowed 'General case' 0 N--CA 1.507 2.42 0 O-C-N 121.515 -0.991 . . . . 3.2000000000000002 111.01 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 54.3 ptt85 -68.8 -6.49 27.04 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.618 -0.676 . . . . 2.9199999999999999 112.059 -179.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 905' ' ' HIS . . . . . 0.491 ' O ' ' CB ' ' A' ' 906' ' ' GLU . 73.0 t60 -62.64 5.16 0.13 Allowed 'General case' 0 N--CA 1.505 2.293 0 O-C-N 120.91 -1.119 . . . . 2.8700000000000001 113.11 -179.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 906' ' ' GLU . . . . . 0.491 ' CB ' ' O ' ' A' ' 905' ' ' HIS . 0.9 OUTLIER 95.35 -164.82 0.0 OUTLIER 'General case' 0 N--CA 1.529 3.478 0 CA-C-N 120.561 1.528 . . . . 0.98999999999999999 111.947 179.004 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 907' ' ' LYS . . . . . 0.468 ' CB ' ' O ' ' A' ' 906' ' ' GLU . 52.9 tttt 87.21 157.58 0.07 Allowed 'General case' 0 N--CA 1.52 3.039 0 N-CA-C 108.143 -1.058 . . . . 5.25 108.143 -176.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 60.9 t -122.28 117.85 53.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 120.857 -1.152 . . . . 0.39000000000000001 111.179 -179.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 909' ' ' GLU . . . . . 0.438 ' OE1' HD12 ' A' ' 966' ' ' LEU . 52.8 tp10 -98.82 134.09 42.2 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 107.35 -1.352 . . . . 1.72 107.35 176.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -156.46 122.69 5.0 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 107.028 -1.471 . . . . 0.67000000000000004 107.028 178.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 911' ' ' VAL . . . . . 0.721 HG22 HG13 ' A' ' 964' ' ' VAL . 93.8 t -85.15 131.17 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 C-N-CA 120.442 -0.503 . . . . 0.54000000000000004 111.108 -179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 88.3 mt -65.22 157.97 27.44 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.397 -0.814 . . . . 1.5 109.361 178.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 913' ' ' SER . . . . . 0.409 ' CB ' ' HB ' ' A' ' 919' ' ' VAL . 1.7 t -127.64 134.94 49.64 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.239 -1.023 . . . . 1.3700000000000001 108.239 176.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 914' ' ' ARG . . . . . 0.433 HH11 HG13 ' A' ' 962' ' ' VAL . 0.0 OUTLIER -65.12 155.11 35.92 Favored 'General case' 0 N--CA 1.506 2.358 0 O-C-N 120.577 -1.327 . . . . 4.2999999999999998 111.628 -179.128 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 915' ' ' SER . . . . . 0.42 ' CB ' ' O ' ' A' ' 914' ' ' ARG . 1.6 p 82.93 -31.14 0.09 Allowed 'General case' 0 N--CA 1.52 3.046 0 C-N-CA 123.852 0.861 . . . . 2.0499999999999998 112.222 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 916' ' ' ASN . . . . . 0.747 ' HB2' HG21 ' A' ' 919' ' ' VAL . 89.4 m-20 -122.63 -21.55 5.64 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.903 -1.123 . . . . 2.71 111.267 -179.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 917' ' ' GLN . . . . . 0.433 ' HB2' ' O ' ' A' ' 916' ' ' ASN . 58.9 mt-30 66.37 166.07 0.2 Allowed 'General case' 0 N--CA 1.519 3.018 0 N-CA-C 105.816 -1.92 . . . . 2.6800000000000002 105.816 -173.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.32 -125.32 33.65 Favored Glycine 1 N--CA 1.521 4.348 0 CA-C-N 123.472 2.851 . . . . 0.029999999999999999 106.98 -177.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 919' ' ' VAL . . . . . 0.747 HG21 ' HB2' ' A' ' 916' ' ' ASN . 77.0 t 51.51 94.9 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 O-C-N 121.39 -1.065 . . . . 1.3899999999999999 109.15 -178.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 920' ' ' ALA . . . . . 0.807 ' HB3' HG12 ' A' ' 949' ' ' VAL . . . -92.34 93.0 8.4 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 119.318 -0.953 . . . . 0.029999999999999999 110.818 -179.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 921' ' ' ARG . . . . . 0.851 ' HG3' HG23 ' A' ' 922' ' ' VAL . 23.1 ptt180 -84.15 -42.15 16.31 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 105.873 -1.899 . . . . 4.4199999999999999 105.873 176.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 922' ' ' VAL . . . . . 0.851 HG23 ' HG3' ' A' ' 921' ' ' ARG . 95.7 t -101.53 72.73 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.329 0 N-CA-C 105.94 -1.874 . . . . 0.84999999999999998 105.94 175.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -88.32 133.42 34.08 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.663 0.744 . . . . 2.46 111.502 -177.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 924' ' ' SER . . . . . 0.641 ' HB2' HD12 ' A' ' 900' ' ' LEU . 9.9 t -148.67 105.68 3.6 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.787 -0.82 . . . . 0.69999999999999996 108.787 179.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -101.56 82.67 0.47 Allowed Glycine 0 N--CA 1.487 2.037 0 N-CA-C 108.201 -1.96 . . . . 0.040000000000000001 108.201 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.211 0 N-CA-C 108.989 -1.644 . . . . 0.040000000000000001 108.989 -179.523 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 73.8 m . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 120.968 0.413 . . . . 13.779999999999999 110.31 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 96.7 mt -113.4 129.82 56.45 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.504 -0.747 . . . . 13.76 110.393 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -151.97 168.06 31.2 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.098 -1.601 . . . . 9.1300000000000008 109.098 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 949' ' ' VAL . . . . . 0.807 HG12 ' HB3' ' A' ' 920' ' ' ALA . 33.0 m -118.93 129.93 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.5 -1.0 . . . . 7.0800000000000001 110.916 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 950' ' ' PHE . . . . . 0.451 ' CE1' ' HD2' ' A' ' 955' ' ' PRO . 27.7 p90 -132.69 148.15 52.34 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.547 -0.721 . . . . 7.5899999999999999 109.212 179.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 58.5 m -121.15 -52.27 2.08 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.414 -0.804 . . . . 5.0300000000000002 112.103 -178.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 952' ' ' LEU . . . . . 0.414 ' O ' ' O ' ' A' ' 953' ' ' ILE . 20.5 tp -60.31 -73.67 0.09 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.446 -0.784 . . . . 1.01 112.403 -177.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 953' ' ' ILE . . . . . 0.662 HD11 HD13 ' C' ' 872' ' ' LEU . 47.9 pt -53.44 -143.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.738 0 N-CA-C 114.008 1.114 . . . . 2.6000000000000001 114.008 -176.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 954' ' ' LEU . . . . . 0.718 HD22 ' O ' ' A' ' 954' ' ' LEU . 0.0 OUTLIER 172.57 75.0 0.04 OUTLIER Pre-proline 0 N--CA 1.508 2.47 0 O-C-N 120.825 -1.172 . . . . 0.050000000000000003 111.01 179.635 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 955' ' ' PRO . . . . . 0.642 ' C ' HD12 ' A' ' 956' ' ' LEU . 47.9 Cg_endo -74.74 95.85 0.98 Allowed 'Trans proline' 0 C--N 1.315 -1.232 0 N-CA-C 109.702 -0.922 . . . . 0.83999999999999997 109.702 179.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 956' ' ' LEU . . . . . 0.642 HD12 ' C ' ' A' ' 955' ' ' PRO . 7.1 mp -125.1 149.88 47.4 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.179 -0.95 . . . . 0.040000000000000001 110.27 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -82.75 150.78 26.48 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 117.701 -1.142 . . . . 1.28 111.468 -179.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -68.36 119.48 12.94 Favored 'General case' 0 N--CA 1.51 2.553 0 CA-C-N 123.098 2.681 . . . . 0.17000000000000001 111.316 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.87 -21.87 37.1 Favored Glycine 0 N--CA 1.5 2.924 0 N-CA-C 110.829 -0.908 . . . . 0.040000000000000001 110.829 178.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 960' ' ' ASP . . . . . 0.42 ' HB3' ' CZ ' ' A' ' 914' ' ' ARG . 0.3 OUTLIER -54.13 172.27 0.09 Allowed 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.504 -0.998 . . . . 0.040000000000000001 110.138 -179.598 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 961' ' ' THR . . . . . 0.485 ' HA ' ' O ' ' A' ' 886' ' ' PHE . 39.3 m -135.87 138.81 42.86 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.963 -1.085 . . . . 1.78 112.377 -178.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 962' ' ' VAL . . . . . 0.875 HG22 ' HB3' ' A' ' 886' ' ' PHE . 32.4 m -98.72 144.22 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 C-N-CA 120.149 -0.62 . . . . 0.040000000000000001 110.03 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 5.5 t -139.69 143.88 37.29 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.671 -0.643 . . . . 0.71999999999999997 109.914 -178.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 964' ' ' VAL . . . . . 0.721 HG13 HG22 ' A' ' 911' ' ' VAL . 59.1 t -95.0 137.19 23.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.097 -1.002 . . . . 1.05 110.699 -179.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -91.5 128.91 37.51 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 103.819 -2.66 . . . . 3.02 103.819 173.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 966' ' ' LEU . . . . . 0.487 ' C ' HG23 ' A' ' 967' ' ' VAL . 1.5 tp -131.33 59.71 1.68 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.162 -1.051 . . . . 1.46 108.162 177.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 967' ' ' VAL . . . . . 0.487 HG23 ' C ' ' A' ' 966' ' ' LEU . 97.8 t -158.16 96.54 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 108.096 -1.075 . . . . 1.9399999999999999 108.096 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 87.1 mmm -143.58 59.13 1.38 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.761 -1.212 . . . . 0.0 108.262 178.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 134.96 119.52 1.95 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 106.91 -2.476 . . . . 2.1099999999999999 106.91 -178.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -82.34 -58.24 3.02 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.039 -1.271 . . . . 5.8899999999999997 110.327 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 44.0 tp -58.86 90.81 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.406 -0.809 . . . . 4.3600000000000003 110.171 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -141.65 -154.56 0.53 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.614 -0.679 . . . . 1.8300000000000001 110.236 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -120.05 172.42 7.76 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.522 -0.736 . . . . 4.3499999999999996 110.268 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 38.6 t -101.37 130.05 47.48 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.576 -0.703 . . . . 1.27 109.946 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -156.03 157.74 36.64 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.527 -0.733 . . . . 5.0199999999999996 110.515 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.14 85.34 19.04 Favored Pre-proline 0 N--CA 1.5 2.035 0 O-C-N 121.652 -0.655 . . . . 2.4100000000000001 109.662 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 977' ' ' PRO . . . . . 0.6 ' C ' HD12 ' A' ' 978' ' ' LEU . 47.5 Cg_endo -72.81 -172.52 0.98 Allowed 'Trans proline' 0 C--N 1.317 -1.123 0 O-C-N 123.304 1.16 . . . . 0.95999999999999996 111.192 -179.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 978' ' ' LEU . . . . . 0.635 HD23 HD12 ' A' ' 856' ' ' LEU . 5.9 mp -128.04 154.24 45.88 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 107.575 -1.268 . . . . 0.62 107.575 177.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 979' ' ' THR . . . . . 0.462 HG23 ' C ' ' A' ' 978' ' ' LEU . 43.2 p -149.79 142.07 24.17 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.851 -1.156 . . . . 3.5699999999999998 111.185 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 980' ' ' ILE . . . . . 0.72 ' HB ' HG21 ' A' ' 899' ' ' VAL . 46.9 mm -105.87 127.76 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 108.708 -0.849 . . . . 1.3300000000000001 108.708 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 981' ' ' PHE . . . . . 0.46 ' HD1' ' HH ' ' A' ' 879' ' ' TYR . 7.3 t80 -120.26 97.73 5.72 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 119.641 -0.823 . . . . 0.050000000000000003 111.828 -178.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 59.2 p -107.86 158.66 17.15 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 109.114 -0.699 . . . . 0.87 109.114 178.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 983' ' ' GLY . . . . . 0.415 ' O ' ' CZ ' ' A' ' 852' ' ' PHE . . . -175.36 107.26 0.24 Allowed Glycine 0 N--CA 1.499 2.836 0 N-CA-C 106.354 -2.699 . . . . 0.029999999999999999 106.354 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -109.21 152.64 24.9 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 114.583 1.327 . . . . 0.69999999999999996 114.583 -175.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 985' ' ' LEU . . . . . 0.977 HD13 HD22 ' A' ' 890' ' ' LEU . 30.5 tp -72.23 134.2 45.49 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.887 -1.133 . . . . 0.040000000000000001 109.895 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 48.6 tp -107.9 -57.8 2.06 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.564 -0.71 . . . . 0.040000000000000001 110.208 179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -144.28 145.35 31.97 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 107.592 -1.262 . . . . 0.040000000000000001 107.592 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.68 163.22 12.18 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 108.218 -1.953 . . . . 0.040000000000000001 108.218 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -74.43 112.7 18.36 Favored Pre-proline 0 N--CA 1.498 1.932 0 O-C-N 121.259 -1.142 . . . . 0.040000000000000001 109.468 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 990' ' ' PRO . . . . . 0.446 ' HD2' HD12 ' A' ' 992' ' ' LEU . 50.6 Cg_endo -89.2 70.89 2.11 Favored 'Trans proline' 0 C--N 1.319 -1.022 0 O-C-N 123.199 1.105 . . . . 0.45000000000000001 111.482 -178.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 991' ' ' GLU . . . . . 0.427 ' HB2' ' O ' ' A' ' 990' ' ' PRO . 77.2 mt-10 67.18 -73.91 0.07 Allowed 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 108.524 -0.917 . . . . 1.97 108.524 -177.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 992' ' ' LEU . . . . . 0.446 HD12 ' HD2' ' A' ' 990' ' ' PRO . 10.5 mt 51.19 20.7 0.93 Allowed 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.562 -0.711 . . . . 2.3799999999999999 111.532 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -93.3 157.11 16.41 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.933 -1.105 . . . . 3.79 110.044 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 71.5 m80 -146.85 92.64 2.16 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.515 -0.74 . . . . 3.5099999999999998 110.195 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 995' ' ' ALA . . . . . . . . . . . . 2.519 . . . . . . . 0 N--CA 1.503 2.2 0 O-C-N 120.904 -1.122 . . . . 2.73 110.599 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo . . . . . 0 N--CA 1.487 1.147 0 N-CA-C 109.506 -0.998 . . . . 3.8300000000000001 109.506 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 847' ' ' VAL . . . . . . . . . . . . . 58.9 t -133.85 102.69 12.24 Favored Pre-proline 0 N--CA 1.495 1.781 0 O-C-N 121.619 -0.676 . . . . 1.8300000000000001 109.994 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 848' ' ' PRO . . . . . 0.761 ' O ' HG23 ' B' ' 850' ' ' VAL . 44.0 Cg_endo -69.68 -19.62 36.25 Favored 'Trans proline' 0 N--CA 1.488 1.152 0 O-C-N 123.279 1.147 . . . . 0.65000000000000002 111.245 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 849' ' ' GLN . . . . . 0.404 ' C ' ' O ' ' B' ' 848' ' ' PRO . 56.0 tt0 28.22 68.33 0.08 Allowed 'General case' 0 N--CA 1.518 2.931 0 N-CA-C 112.831 0.678 . . . . 2.5800000000000001 112.831 179.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 850' ' ' VAL . . . . . 0.761 HG23 ' O ' ' B' ' 848' ' ' PRO . 66.2 t -119.95 137.07 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.141 -0.974 . . . . 1.0900000000000001 111.445 -178.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 851' ' ' ALA . . . . . 0.596 ' HB3' ' HG ' ' B' ' 873' ' ' LEU . . . -124.15 159.15 30.68 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 105.945 -1.872 . . . . 0.040000000000000001 105.945 176.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 852' ' ' PHE . . . . . 0.426 ' HA ' ' CB ' ' B' ' 874' ' ' ASN . 33.5 p90 -158.56 128.09 5.73 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 120.943 1.702 . . . . 0.050000000000000003 108.344 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 7.9 t -175.48 134.18 0.3 Allowed 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 108.281 -1.007 . . . . 0.040000000000000001 108.281 -178.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -129.83 157.22 42.84 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.011 -1.056 . . . . 0.67000000000000004 109.824 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 855' ' ' ALA . . . . . 0.856 ' HB3' ' CB ' ' B' ' 870' ' ' ARG . . . -119.92 144.7 47.3 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.843 0.83 . . . . 0.51000000000000001 110.776 -179.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 856' ' ' LEU . . . . . 0.668 HD13 ' N ' ' B' ' 857' ' ' SER . 2.1 tm? -115.83 133.72 55.74 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.493 -0.754 . . . . 0.050000000000000003 110.542 -179.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 857' ' ' SER . . . . . 0.668 ' N ' HD13 ' B' ' 856' ' ' LEU . 1.8 m -156.4 14.45 0.31 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.459 -0.775 . . . . 1.3300000000000001 111.804 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 858' ' ' LEU . . . . . 0.558 ' HG ' HD11 ' B' ' 856' ' ' LEU . 0.3 OUTLIER -36.53 162.19 0.04 OUTLIER Pre-proline 0 N--CA 1.524 3.254 0 CA-C-N 119.052 0.842 . . . . 2.3300000000000001 113.074 -179.693 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -61.26 -89.38 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 120.947 1.098 . . . . 2.3199999999999998 113.804 -177.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 53.9 ptt85 -134.19 -142.46 0.2 Allowed 'General case' 0 N--CA 1.501 2.114 0 O-C-N 120.802 -1.186 . . . . 0.040000000000000001 111.815 -177.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 5.2 m -36.56 126.46 0.84 Allowed 'General case' 0 N--CA 1.512 2.645 0 O-C-N 121.671 -0.643 . . . . 1.3100000000000001 112.373 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 862' ' ' GLU . . . . . 0.787 ' OE1' HG22 ' B' ' 866' ' ' VAL . 1.3 mt-10 -104.34 165.67 12.95 Favored Pre-proline 0 N--CA 1.488 1.451 0 N-CA-C 108.637 -0.875 . . . . 4.5099999999999998 108.637 177.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -73.45 -14.57 25.11 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 O-C-N 123.294 1.155 . . . . 2.2400000000000002 111.396 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -177.68 -133.75 1.91 Allowed Glycine 0 N--CA 1.495 2.592 0 N-CA-C 110.184 -1.167 . . . . 0.040000000000000001 110.184 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 27.1 m -66.07 157.64 30.54 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.351 -1.088 . . . . 1.51 110.733 -178.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 866' ' ' VAL . . . . . 0.787 HG22 ' OE1' ' B' ' 862' ' ' GLU . 56.9 t -97.73 132.71 24.49 Favored Pre-proline 0 N--CA 1.496 1.833 0 N-CA-C 113.402 0.89 . . . . 0.78000000000000003 113.402 -174.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 867' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' B' ' 866' ' ' VAL . 55.2 Cg_endo -90.71 -149.73 0.03 OUTLIER 'Trans proline' 0 CA--C 1.544 1.02 0 C-N-CA 121.219 1.279 . . . . 0.92000000000000004 109.356 177.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 868' ' ' PHE . . . . . 0.469 ' CD1' ' HG2' ' B' ' 881' ' ' PRO . 19.4 p90 -150.19 123.25 8.82 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 120.493 -1.379 . . . . 0.050000000000000003 109.858 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 50.2 p-10 -113.35 -2.32 14.02 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.101 -1.0 . . . . 1.7 112.786 -178.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 870' ' ' ARG . . . . . 0.856 ' CB ' ' HB3' ' B' ' 855' ' ' ALA . 28.0 mmm180 -91.74 89.79 7.24 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 120.861 -1.149 . . . . 2.5899999999999999 111.167 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 57.5 t -72.9 96.75 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 120.978 -1.077 . . . . 1.9399999999999999 109.669 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 872' ' ' LEU . . . . . 0.844 HD11 ' HB2' ' B' ' 855' ' ' ALA . 87.1 mt -83.56 -46.66 12.15 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.508 -0.745 . . . . 1.0600000000000001 110.117 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 873' ' ' LEU . . . . . 0.596 ' HG ' ' HB3' ' B' ' 851' ' ' ALA . 32.6 tp -174.31 102.25 0.1 Allowed 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.583 -0.895 . . . . 4.1799999999999997 108.583 178.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 874' ' ' ASN . . . . . 0.426 ' CB ' ' HA ' ' B' ' 852' ' ' PHE . 33.8 t-20 178.36 81.08 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.664 -0.647 . . . . 0.040000000000000001 109.371 -179.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -65.5 -47.1 77.17 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 119.349 -0.941 . . . . 3.3799999999999999 111.102 -179.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 876' ' ' GLY . . . . . . . . . . . . . . . -73.98 -24.27 74.3 Favored Glycine 0 N--CA 1.493 2.477 0 O-C-N 121.285 -0.884 . . . . 0.040000000000000001 111.687 -178.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 84.41 -59.95 4.88 Favored Glycine 0 N--CA 1.502 3.069 0 N-CA-C 107.948 -2.061 . . . . 0.040000000000000001 107.948 -178.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 878' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 60.41 -66.68 0.05 OUTLIER 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 114.474 1.287 . . . . 3.46 114.474 177.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 879' ' ' TYR . . . . . 0.471 ' CB ' ' CD2' ' B' ' 886' ' ' PHE . 21.3 p90 -110.78 109.62 19.91 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 114.785 1.402 . . . . 0.040000000000000001 114.785 -176.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -65.94 117.06 38.54 Favored Pre-proline 0 N--CA 1.496 1.847 0 O-C-N 121.557 -0.715 . . . . 0.02 110.117 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 881' ' ' PRO . . . . . 0.469 ' HG2' ' CD1' ' B' ' 868' ' ' PHE . 53.8 Cg_endo -75.78 0.23 9.45 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 O-C-N 123.477 1.251 . . . . 0.39000000000000001 112.252 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -75.26 -65.23 0.91 Allowed 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 106.953 -1.499 . . . . 0.81000000000000005 106.953 178.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 2.2 p -95.87 -16.53 21.74 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.88 -0.785 . . . . 0.040000000000000001 108.88 177.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.2 23.34 52.02 Favored Glycine 0 N--CA 1.493 2.489 0 C-N-CA 120.069 -1.063 . . . . 0.029999999999999999 110.719 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 885' ' ' VAL . . . . . . . . . . . . . 92.6 t -73.56 88.7 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 C-N-CA 118.392 -1.323 . . . . 1.01 107.806 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 886' ' ' PHE . . . . . 0.897 ' HB3' HG22 ' B' ' 962' ' ' VAL . 0.6 OUTLIER -89.36 106.28 18.34 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 115.121 -0.945 . . . . 0.050000000000000003 112.234 -177.12 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 887' ' ' THR . . . . . . . . . . . . . 96.9 m -98.67 99.44 10.56 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 107.493 -1.299 . . . . 0.68000000000000005 107.493 176.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 888' ' ' ALA . . . . . . . . . . . . . . . -97.52 108.13 43.31 Favored Pre-proline 0 N--CA 1.502 2.134 0 N-CA-C 114.119 1.155 . . . . 0.25 114.119 -176.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 889' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -89.37 -13.85 2.77 Favored 'Trans proline' 0 CA--C 1.546 1.091 0 N-CA-C 109.135 -1.14 . . . . 1.6399999999999999 109.135 176.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 890' ' ' LEU . . . . . 1.004 HD22 HD13 ' B' ' 985' ' ' LEU . 62.9 mt -35.73 -50.64 0.64 Allowed 'General case' 0 N--CA 1.509 2.497 0 N-CA-C 113.68 0.992 . . . . 2.29 113.68 -177.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 52.1 95.44 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.154 -0.966 . . . . 0.63 110.338 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . 157.65 -154.16 25.28 Favored Glycine 0 N--CA 1.478 1.491 0 N-CA-C 107.085 -2.406 . . . . 0.040000000000000001 107.085 -179.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 71.7 ttt-85 -116.34 125.26 51.85 Favored 'General case' 0 C--N 1.294 -1.807 0 O-C-N 121.564 -0.963 . . . . 3.0 108.511 177.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 894' ' ' TYR . . . . . 0.821 ' OH ' HD12 ' B' ' 896' ' ' LEU . 0.1 OUTLIER -131.9 161.63 32.56 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.082 -1.011 . . . . 0.040000000000000001 111.113 -179.854 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 895' ' ' LEU . . . . . . . . . . . . . 43.3 tp -92.27 119.32 31.75 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.681 -0.637 . . . . 1.27 110.355 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 896' ' ' LEU . . . . . 0.821 HD12 ' OH ' ' B' ' 894' ' ' TYR . 9.1 tt -110.11 143.87 39.55 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.725 -0.609 . . . . 0.93999999999999995 110.053 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 897' ' ' SER . . . . . 0.505 ' N ' HD23 ' B' ' 896' ' ' LEU . 68.7 m -148.81 114.5 5.66 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.426 -0.796 . . . . 0.040000000000000001 111.098 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.23 145.99 31.97 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 109.011 -0.737 . . . . 0.47999999999999998 109.011 178.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 899' ' ' VAL . . . . . 0.711 HG21 ' HB ' ' B' ' 980' ' ' ILE . 88.4 t -96.22 119.07 43.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.356 -0.84 . . . . 0.55000000000000004 111.245 -179.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 900' ' ' LEU . . . . . 0.655 HD12 ' HB2' ' B' ' 924' ' ' SER . 4.5 mm? -95.97 112.7 24.36 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 114.288 1.218 . . . . 1.5900000000000001 114.288 -175.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 18.1 m -64.94 140.79 58.9 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 107.531 -1.285 . . . . 0.050000000000000003 107.531 177.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -64.83 -65.26 3.04 Favored Glycine 0 N--CA 1.494 2.515 0 N-CA-C 110.639 -0.985 . . . . 0.029999999999999999 110.639 -179.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 1.6 t-160 46.89 66.64 0.94 Allowed 'General case' 0 N--CA 1.507 2.411 0 O-C-N 121.472 -1.017 . . . . 3.2000000000000002 110.964 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 54.3 ptt85 -68.85 -6.78 29.05 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.639 -0.663 . . . . 2.9199999999999999 112.073 -179.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 905' ' ' HIS . . . . . 0.488 ' O ' ' CB ' ' B' ' 906' ' ' GLU . 72.8 t60 -62.08 4.74 0.12 Allowed 'General case' 0 N--CA 1.505 2.323 0 O-C-N 120.876 -1.14 . . . . 2.8700000000000001 113.111 -179.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 906' ' ' GLU . . . . . 0.488 ' CB ' ' O ' ' B' ' 905' ' ' HIS . 0.9 OUTLIER 95.62 -164.94 0.0 OUTLIER 'General case' 0 N--CA 1.53 3.549 0 CA-C-N 120.612 1.551 . . . . 0.98999999999999999 111.781 179.1 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 907' ' ' LYS . . . . . 0.47 ' CB ' ' O ' ' B' ' 906' ' ' GLU . 53.3 tttt 87.31 157.28 0.07 Allowed 'General case' 0 N--CA 1.52 3.073 0 N-CA-C 108.132 -1.062 . . . . 5.25 108.132 -177.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 60.9 t -122.08 117.5 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 120.894 -1.129 . . . . 0.39000000000000001 111.243 -179.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 909' ' ' GLU . . . . . 0.429 ' OE1' HD12 ' B' ' 966' ' ' LEU . 52.8 tp10 -98.33 134.37 41.43 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 107.333 -1.358 . . . . 1.72 107.333 176.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -156.83 122.8 4.85 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 106.992 -1.484 . . . . 0.67000000000000004 106.992 178.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 911' ' ' VAL . . . . . 0.706 HG22 HG13 ' B' ' 964' ' ' VAL . 94.9 t -85.34 131.54 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.906 -0.496 . . . . 0.54000000000000004 111.061 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 88.2 mt -65.44 158.13 27.6 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.362 -0.836 . . . . 1.5 109.359 178.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 913' ' ' SER . . . . . 0.411 ' CB ' ' CG1' ' B' ' 919' ' ' VAL . 1.8 t -127.97 134.39 49.28 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.274 -1.01 . . . . 1.3700000000000001 108.274 176.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 914' ' ' ARG . . . . . 0.421 HH11 HG13 ' B' ' 962' ' ' VAL . 0.0 OUTLIER -64.51 155.05 34.11 Favored 'General case' 0 N--CA 1.506 2.363 0 O-C-N 120.577 -1.327 . . . . 4.2999999999999998 111.685 -179.067 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 915' ' ' SER . . . . . 0.411 ' CB ' ' O ' ' B' ' 914' ' ' ARG . 1.6 p 83.05 -31.44 0.09 Allowed 'General case' 0 N--CA 1.521 3.093 0 C-N-CA 123.84 0.856 . . . . 2.0499999999999998 112.224 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 916' ' ' ASN . . . . . 0.785 ' HB2' HG21 ' B' ' 919' ' ' VAL . 89.2 m-20 -122.25 -21.91 5.73 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.92 -1.112 . . . . 2.71 111.288 -179.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 917' ' ' GLN . . . . . 0.433 ' HB2' ' O ' ' B' ' 916' ' ' ASN . 58.5 mt-30 66.5 165.43 0.2 Allowed 'General case' 0 N--CA 1.52 3.029 0 N-CA-C 105.782 -1.933 . . . . 2.6800000000000002 105.782 -174.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 55.05 -125.38 35.58 Favored Glycine 1 N--CA 1.52 4.268 0 CA-C-N 123.478 2.854 . . . . 0.029999999999999999 106.858 -177.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 919' ' ' VAL . . . . . 0.785 HG21 ' HB2' ' B' ' 916' ' ' ASN . 80.5 t 51.44 94.91 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.233 0 O-C-N 121.419 -1.047 . . . . 1.3899999999999999 109.189 -178.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 920' ' ' ALA . . . . . 0.805 ' HB3' HG12 ' B' ' 949' ' ' VAL . . . -92.4 92.85 8.3 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.324 -0.951 . . . . 0.029999999999999999 110.823 -179.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 921' ' ' ARG . . . . . 0.842 ' HG3' HG23 ' B' ' 922' ' ' VAL . 23.2 ptt180 -84.12 -42.11 16.4 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 105.885 -1.894 . . . . 4.4199999999999999 105.885 176.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 922' ' ' VAL . . . . . 0.842 HG23 ' HG3' ' B' ' 921' ' ' ARG . 95.7 t -101.52 72.64 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 N-CA-C 105.92 -1.882 . . . . 0.84999999999999998 105.92 175.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -88.19 133.47 34.02 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 121.615 0.721 . . . . 2.46 111.495 -177.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 924' ' ' SER . . . . . 0.655 ' HB2' HD12 ' B' ' 900' ' ' LEU . 9.9 t -148.68 105.72 3.6 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.76 -0.829 . . . . 0.69999999999999996 108.76 179.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -101.5 82.62 0.47 Allowed Glycine 0 N--CA 1.487 2.049 0 N-CA-C 108.176 -1.97 . . . . 0.040000000000000001 108.176 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.143 0 N-CA-C 109.026 -1.629 . . . . 0.040000000000000001 109.026 -179.562 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 76.9 m . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.016 0.436 . . . . 13.779999999999999 110.215 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 96.7 mt -112.24 129.87 56.12 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.546 -0.722 . . . . 13.76 110.4 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -151.65 167.5 30.96 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 109.153 -1.579 . . . . 9.1300000000000008 109.153 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 949' ' ' VAL . . . . . 0.805 HG12 ' HB3' ' B' ' 920' ' ' ALA . 32.1 m -118.69 129.85 74.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.548 -0.972 . . . . 7.0800000000000001 110.845 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 950' ' ' PHE . . . . . 0.454 ' CE1' ' HD2' ' B' ' 955' ' ' PRO . 27.9 p90 -132.74 148.17 52.33 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.586 -0.696 . . . . 7.5899999999999999 109.267 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 58.5 m -121.16 -51.92 2.09 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.452 -0.78 . . . . 5.0300000000000002 112.13 -178.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 952' ' ' LEU . . . . . 0.43 HD12 ' HA ' ' B' ' 952' ' ' LEU . 20.3 tp -60.52 -73.88 0.08 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.396 -0.815 . . . . 1.01 112.347 -177.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 953' ' ' ILE . . . . . 0.486 ' O ' ' HB3' ' B' ' 954' ' ' LEU . 49.3 pt -53.18 -143.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.754 0 N-CA-C 114.082 1.141 . . . . 2.6000000000000001 114.082 -176.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 954' ' ' LEU . . . . . 0.723 HD22 ' O ' ' B' ' 954' ' ' LEU . 0.0 OUTLIER 172.31 74.69 0.04 OUTLIER Pre-proline 0 N--CA 1.509 2.496 0 O-C-N 120.793 -1.192 . . . . 0.050000000000000003 110.955 179.68 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 955' ' ' PRO . . . . . 0.646 ' C ' HD12 ' B' ' 956' ' ' LEU . 48.1 Cg_endo -74.64 95.95 0.97 Allowed 'Trans proline' 0 C--N 1.315 -1.218 0 N-CA-C 109.714 -0.918 . . . . 0.83999999999999997 109.714 179.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 956' ' ' LEU . . . . . 0.646 HD12 ' C ' ' B' ' 955' ' ' PRO . 7.1 mp -125.23 149.88 47.56 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.232 -0.917 . . . . 0.040000000000000001 110.258 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -82.78 150.94 26.35 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 117.824 -1.084 . . . . 1.28 111.375 -179.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -68.42 119.15 12.44 Favored 'General case' 0 N--CA 1.509 2.492 0 CA-C-N 122.913 2.597 . . . . 0.17000000000000001 111.389 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 93.07 -21.92 37.31 Favored Glycine 0 N--CA 1.5 2.942 0 N-CA-C 110.792 -0.923 . . . . 0.040000000000000001 110.792 178.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 960' ' ' ASP . . . . . 0.417 ' HB3' ' CZ ' ' B' ' 914' ' ' ARG . 0.3 OUTLIER -54.02 172.38 0.08 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.473 -1.016 . . . . 0.040000000000000001 110.166 -179.602 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 961' ' ' THR . . . . . 0.492 ' HA ' ' O ' ' B' ' 886' ' ' PHE . 38.8 m -135.83 139.03 43.13 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.942 -1.099 . . . . 1.78 112.338 -178.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 962' ' ' VAL . . . . . 0.897 HG22 ' HB3' ' B' ' 886' ' ' PHE . 32.2 m -99.09 144.02 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 C-N-CA 120.112 -0.635 . . . . 0.040000000000000001 110.032 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 5.4 t -139.37 143.88 37.93 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.682 -0.636 . . . . 0.71999999999999997 109.982 -178.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 964' ' ' VAL . . . . . 0.706 HG13 HG22 ' B' ' 911' ' ' VAL . 59.0 t -95.2 137.02 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.208 -0.933 . . . . 1.05 110.696 -179.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -91.51 128.43 37.34 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 103.898 -2.631 . . . . 3.02 103.898 173.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 966' ' ' LEU . . . . . 0.485 ' C ' HG23 ' B' ' 967' ' ' VAL . 1.5 tp -130.9 59.89 1.66 Allowed 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.228 -1.027 . . . . 1.46 108.228 177.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 967' ' ' VAL . . . . . 0.485 HG23 ' C ' ' B' ' 966' ' ' LEU . 98.3 t -158.27 96.47 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 N-CA-C 108.08 -1.081 . . . . 1.9399999999999999 108.08 179.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 87.1 mmm -143.49 58.95 1.39 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.804 -1.185 . . . . 0.0 108.265 178.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 134.99 119.38 1.93 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 107.111 -2.396 . . . . 2.1099999999999999 107.111 -178.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -82.07 -58.22 3.06 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.085 -1.244 . . . . 5.8899999999999997 110.338 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 44.2 tp -58.97 90.57 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.377 -0.827 . . . . 4.3600000000000003 110.19 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -141.47 -154.63 0.53 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.589 -0.694 . . . . 1.8300000000000001 110.27 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -119.95 172.54 7.65 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.455 -0.778 . . . . 4.3499999999999996 110.275 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 38.6 t -101.56 130.02 47.77 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.525 -0.734 . . . . 1.27 109.961 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -155.99 157.74 36.7 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.474 -0.767 . . . . 5.0199999999999996 110.495 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.15 85.33 19.0 Favored Pre-proline 0 N--CA 1.5 2.05 0 O-C-N 121.633 -0.667 . . . . 2.4100000000000001 109.622 179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 977' ' ' PRO . . . . . 0.601 ' C ' HD12 ' B' ' 978' ' ' LEU . 47.6 Cg_endo -72.82 -172.59 0.99 Allowed 'Trans proline' 0 C--N 1.317 -1.083 0 O-C-N 123.282 1.148 . . . . 0.95999999999999996 111.219 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 978' ' ' LEU . . . . . 0.647 HD23 HD12 ' B' ' 856' ' ' LEU . 5.9 mp -127.82 154.51 45.36 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.653 -1.24 . . . . 0.62 107.653 177.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 979' ' ' THR . . . . . 0.467 HG23 ' C ' ' B' ' 978' ' ' LEU . 42.8 p -150.03 142.08 23.96 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.842 -1.161 . . . . 3.5699999999999998 111.142 -179.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 980' ' ' ILE . . . . . 0.711 ' HB ' HG21 ' B' ' 899' ' ' VAL . 46.8 mm -105.99 127.4 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 108.732 -0.84 . . . . 1.3300000000000001 108.732 179.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 981' ' ' PHE . . . . . 0.451 ' HD1' ' HH ' ' B' ' 879' ' ' TYR . 7.3 t80 -120.0 98.0 5.88 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 119.649 -0.821 . . . . 0.050000000000000003 111.746 -178.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 53.8 p -108.4 158.81 17.18 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 109.154 -0.684 . . . . 0.87 109.154 178.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 983' ' ' GLY . . . . . 0.411 ' HA3' ' CE1' ' B' ' 852' ' ' PHE . . . -175.25 107.41 0.24 Allowed Glycine 0 N--CA 1.498 2.821 0 N-CA-C 106.469 -2.652 . . . . 0.029999999999999999 106.469 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -109.16 152.53 25.0 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 114.587 1.328 . . . . 0.69999999999999996 114.587 -175.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 985' ' ' LEU . . . . . 1.004 HD13 HD22 ' B' ' 890' ' ' LEU . 30.5 tp -72.24 134.1 45.43 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.93 -1.106 . . . . 0.040000000000000001 109.805 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 986' ' ' LEU . . . . . 0.524 ' CD1' HD11 ' C' ' 986' ' ' LEU . 48.1 tp -107.82 -57.79 2.05 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.541 -0.725 . . . . 0.040000000000000001 110.259 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -144.31 145.23 31.87 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.621 -1.252 . . . . 0.040000000000000001 107.621 179.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.49 163.07 12.2 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 108.255 -1.938 . . . . 0.040000000000000001 108.255 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -74.27 112.72 18.23 Favored Pre-proline 0 N--CA 1.498 1.956 0 O-C-N 121.204 -1.174 . . . . 0.040000000000000001 109.442 179.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 990' ' ' PRO . . . . . 0.444 ' HD2' HD12 ' B' ' 992' ' ' LEU . 50.0 Cg_endo -89.2 71.04 2.09 Favored 'Trans proline' 0 C--N 1.319 -0.985 0 O-C-N 123.093 1.049 . . . . 0.45000000000000001 111.459 -178.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 991' ' ' GLU . . . . . 0.423 ' HB2' ' O ' ' B' ' 990' ' ' PRO . 77.3 mt-10 67.0 -73.84 0.07 Allowed 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 108.603 -0.888 . . . . 1.97 108.603 -177.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 992' ' ' LEU . . . . . 0.451 ' HA ' HD23 ' B' ' 992' ' ' LEU . 10.6 mt 51.29 20.4 0.93 Allowed 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.614 -0.679 . . . . 2.3799999999999999 111.634 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 80.7 mt-10 -92.95 157.13 16.49 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.869 -1.144 . . . . 3.79 110.055 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 71.2 m80 -146.91 92.1 2.09 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.511 -0.743 . . . . 3.5099999999999998 110.329 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 995' ' ' ALA . . . . . . . . . . . . 2.52 . . . . . . . 0 N--CA 1.503 2.208 0 O-C-N 120.886 -1.134 . . . . 2.73 110.655 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo . . . . . 0 N--CA 1.488 1.154 0 N-CA-C 109.496 -1.001 . . . . 3.8300000000000001 109.496 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' C' C ' 847' ' ' VAL . . . . . 0.409 HG12 ' HB2' ' C' ' 849' ' ' GLN . 61.8 t -128.75 103.89 19.09 Favored Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.579 -0.7 . . . . 1.8300000000000001 110.093 -179.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 848' ' ' PRO . . . . . 0.777 ' O ' HG23 ' C' ' 850' ' ' VAL . 44.3 Cg_endo -70.34 -22.23 29.68 Favored 'Trans proline' 0 N--CA 1.488 1.185 0 O-C-N 123.285 1.15 . . . . 0.65000000000000002 111.254 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 849' ' ' GLN . . . . . 0.409 ' HB2' HG12 ' C' ' 847' ' ' VAL . 57.2 tt0 26.88 68.79 0.06 Allowed 'General case' 0 N--CA 1.519 2.998 0 N-CA-C 112.92 0.711 . . . . 2.5800000000000001 112.92 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 850' ' ' VAL . . . . . 0.777 HG23 ' O ' ' C' ' 848' ' ' PRO . 94.3 t -119.76 135.4 60.19 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 121.129 -0.982 . . . . 1.0900000000000001 111.57 -178.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 851' ' ' ALA . . . . . 0.592 ' HB3' ' HG ' ' C' ' 873' ' ' LEU . . . -127.86 155.53 43.98 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 105.795 -1.928 . . . . 0.040000000000000001 105.795 176.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 852' ' ' PHE . . . . . 0.454 ' CD1' ' N ' ' C' ' 852' ' ' PHE . 13.6 p90 -159.61 127.79 4.94 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 121.018 1.736 . . . . 0.050000000000000003 108.522 178.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 12.1 t -176.51 134.37 0.23 Allowed 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 108.246 -1.02 . . . . 0.040000000000000001 108.246 -178.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 854' ' ' ALA . . . . . 0.492 ' HB1' ' HD2' ' C' ' 868' ' ' PHE . . . -132.84 156.76 46.56 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.142 -0.974 . . . . 0.67000000000000004 109.693 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 855' ' ' ALA . . . . . 0.762 ' HB3' ' CB ' ' C' ' 870' ' ' ARG . . . -122.96 140.95 52.47 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 122.035 0.921 . . . . 0.51000000000000001 111.419 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 856' ' ' LEU . . . . . 0.618 HD13 ' N ' ' C' ' 857' ' ' SER . 3.5 tm? -113.39 137.71 51.13 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.687 -0.633 . . . . 0.050000000000000003 109.936 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 857' ' ' SER . . . . . 0.618 ' N ' HD13 ' C' ' 856' ' ' LEU . 1.9 m -157.08 19.25 0.3 Allowed 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.548 -0.72 . . . . 1.3300000000000001 111.084 179.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 858' ' ' LEU . . . . . 0.705 HD22 ' HG3' ' C' ' 862' ' ' GLU . 4.1 pp -35.54 160.26 0.04 OUTLIER Pre-proline 0 N--CA 1.517 2.886 0 N-CA-C 112.729 0.64 . . . . 2.3300000000000001 112.729 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -59.25 -88.9 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.455 0 O-C-N 122.99 0.995 . . . . 2.3199999999999998 113.386 -177.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 54.5 ptt85 -129.26 -142.56 0.25 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.883 -1.136 . . . . 0.040000000000000001 111.635 -177.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 9.9 m -36.57 126.65 0.84 Allowed 'General case' 0 N--CA 1.51 2.536 0 O-C-N 121.61 -0.681 . . . . 1.3100000000000001 112.634 -178.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 862' ' ' GLU . . . . . 0.705 ' HG3' HD22 ' C' ' 858' ' ' LEU . 0.0 OUTLIER -100.76 159.28 30.03 Favored Pre-proline 0 N--CA 1.489 1.514 0 N-CA-C 108.177 -1.046 . . . . 4.5099999999999998 108.177 177.506 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -71.93 -14.1 29.3 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 O-C-N 123.11 1.058 . . . . 2.2400000000000002 111.523 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -177.72 -136.35 2.47 Favored Glycine 0 N--CA 1.495 2.626 0 N-CA-C 110.04 -1.224 . . . . 0.040000000000000001 110.04 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 25.7 m -65.37 154.85 37.17 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.355 -1.085 . . . . 1.51 110.247 -179.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 866' ' ' VAL . . . . . 0.464 ' HA ' ' HD3' ' C' ' 867' ' ' PRO . 20.7 t -95.62 138.68 21.77 Favored Pre-proline 0 N--CA 1.496 1.874 0 N-CA-C 113.917 1.08 . . . . 0.78000000000000003 113.917 -174.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 867' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' C' ' 866' ' ' VAL . 55.3 Cg_endo -94.07 -151.33 0.03 OUTLIER 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 121.417 1.412 . . . . 0.92000000000000004 109.002 177.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 868' ' ' PHE . . . . . 0.492 ' HD2' ' HB1' ' C' ' 854' ' ' ALA . 13.7 p90 -150.05 124.65 9.71 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.556 -1.34 . . . . 0.050000000000000003 110.036 179.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 50.7 p-10 -112.34 -2.79 14.7 Favored 'General case' 0 N--CA 1.5 2.044 0 C-N-CA 119.216 -0.994 . . . . 1.7 112.715 -178.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 870' ' ' ARG . . . . . 0.762 ' CB ' ' HB3' ' C' ' 855' ' ' ALA . 25.7 mmm180 -92.08 88.16 6.43 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 120.844 -1.16 . . . . 2.5899999999999999 111.36 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 65.3 t -72.45 97.09 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 O-C-N 120.949 -1.094 . . . . 1.9399999999999999 109.132 179.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 872' ' ' LEU . . . . . 0.662 HD13 HD11 ' A' ' 953' ' ' ILE . 95.0 mt -86.98 -45.42 10.79 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.572 -0.705 . . . . 1.0600000000000001 110.82 -179.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 873' ' ' LEU . . . . . 0.592 ' HG ' ' HB3' ' C' ' 851' ' ' ALA . 30.4 tp -172.91 101.98 0.13 Allowed 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.153 -0.967 . . . . 4.1799999999999997 108.788 178.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 874' ' ' ASN . . . . . 0.439 ' CB ' ' HA ' ' C' ' 852' ' ' PHE . 32.8 t-20 176.99 82.5 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.283 0 N-CA-C 108.833 -0.803 . . . . 0.040000000000000001 108.833 -178.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -65.15 -46.41 80.98 Favored 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 119.267 -0.973 . . . . 3.3799999999999999 111.244 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 876' ' ' GLY . . . . . 0.401 ' HA3' ' CE2' ' C' ' 878' ' ' TYR . . . -73.5 -25.65 72.0 Favored Glycine 0 N--CA 1.492 2.403 0 O-C-N 121.257 -0.902 . . . . 0.040000000000000001 111.643 -178.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 81.04 -62.22 4.47 Favored Glycine 0 N--CA 1.501 3.023 0 N-CA-C 107.769 -2.132 . . . . 0.040000000000000001 107.769 -178.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 878' ' ' TYR . . . . . 0.401 ' CE2' ' HA3' ' C' ' 876' ' ' GLY . 85.6 m-85 60.61 -66.29 0.05 Allowed 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 114.497 1.295 . . . . 3.46 114.497 177.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 879' ' ' TYR . . . . . 0.46 ' CB ' ' CD2' ' C' ' 886' ' ' PHE . 25.1 p90 -109.49 109.3 20.07 Favored 'General case' 0 N--CA 1.502 2.135 0 N-CA-C 115.271 1.582 . . . . 0.040000000000000001 115.271 -176.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.03 115.82 29.38 Favored Pre-proline 0 N--CA 1.498 1.932 0 O-C-N 121.637 -0.664 . . . . 0.02 109.98 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 881' ' ' PRO . . . . . 0.464 ' HG2' ' CD1' ' C' ' 868' ' ' PHE . 53.8 Cg_endo -76.65 0.65 9.34 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 O-C-N 123.361 1.19 . . . . 0.39000000000000001 112.137 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -74.51 -66.02 0.79 Allowed 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 106.796 -1.557 . . . . 0.81000000000000005 106.796 178.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 2.6 p -95.45 -14.79 23.45 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.813 -0.81 . . . . 0.040000000000000001 108.813 177.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.14 21.98 55.82 Favored Glycine 0 N--CA 1.493 2.476 0 O-C-N 121.042 -1.036 . . . . 0.029999999999999999 111.029 178.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 885' ' ' VAL . . . . . . . . . . . . . 68.9 t -72.9 87.98 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 C-N-CA 118.189 -1.404 . . . . 1.01 107.492 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 886' ' ' PHE . . . . . 0.927 ' HB3' HG22 ' C' ' 962' ' ' VAL . 0.9 OUTLIER -88.61 103.71 16.17 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-N 115.157 -0.929 . . . . 0.050000000000000003 112.038 -177.075 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 887' ' ' THR . . . . . 0.432 ' O ' ' HD3' ' C' ' 889' ' ' PRO . 88.5 m -99.28 100.24 11.3 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.834 -1.172 . . . . 0.68000000000000005 107.834 177.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 888' ' ' ALA . . . . . . . . . . . . . . . -99.05 102.63 16.07 Favored Pre-proline 0 N--CA 1.502 2.158 0 N-CA-C 114.505 1.298 . . . . 0.25 114.505 -176.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 889' ' ' PRO . . . . . 0.432 ' HD3' ' O ' ' C' ' 887' ' ' THR . 55.9 Cg_endo -83.6 -15.37 7.37 Favored 'Trans proline' 0 CA--C 1.545 1.061 0 N-CA-C 108.827 -1.259 . . . . 1.6399999999999999 108.827 175.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 890' ' ' LEU . . . . . 0.646 HD21 HG11 ' C' ' 850' ' ' VAL . 65.7 mt -38.09 -48.78 1.26 Allowed 'General case' 0 N--CA 1.508 2.45 0 N-CA-C 113.389 0.885 . . . . 2.29 113.389 -177.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 53.28 97.55 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.182 -0.949 . . . . 0.63 110.248 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . 158.83 -155.4 26.46 Favored Glycine 0 N--CA 1.476 1.364 0 N-CA-C 107.12 -2.392 . . . . 0.040000000000000001 107.12 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 74.5 ttt-85 -116.33 125.11 51.66 Favored 'General case' 0 C--N 1.295 -1.803 0 O-C-N 121.537 -0.978 . . . . 3.0 108.855 177.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 894' ' ' TYR . . . . . 0.716 ' CE2' HD23 ' C' ' 954' ' ' LEU . 20.5 p90 -133.35 156.41 47.68 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.083 -1.011 . . . . 0.040000000000000001 111.237 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 895' ' ' LEU . . . . . . . . . . . . . 48.1 tp -99.06 117.13 32.87 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.733 -0.604 . . . . 1.27 110.043 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 896' ' ' LEU . . . . . 0.539 HD11 ' HE1' ' C' ' 981' ' ' PHE . 9.6 tt -120.85 144.51 48.33 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.638 -0.664 . . . . 0.93999999999999995 109.787 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 897' ' ' SER . . . . . . . . . . . . . 19.5 m -141.9 123.97 15.44 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.383 -0.823 . . . . 0.040000000000000001 111.226 -179.215 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -100.55 148.26 24.99 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.731 -0.84 . . . . 0.47999999999999998 108.731 178.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 899' ' ' VAL . . . . . 0.683 HG21 ' HB ' ' C' ' 980' ' ' ILE . 93.8 t -91.47 120.26 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 C-N-CA 119.66 -0.816 . . . . 0.55000000000000004 111.023 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 86.7 mt -92.95 112.1 23.94 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 114.011 1.115 . . . . 1.5900000000000001 114.011 -175.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 23.7 m -63.11 140.3 58.86 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 107.474 -1.306 . . . . 0.050000000000000003 107.474 177.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -61.05 -64.93 3.64 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 110.209 -1.156 . . . . 0.029999999999999999 110.209 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 7.7 m170 45.08 64.01 1.54 Allowed 'General case' 0 N--CA 1.507 2.406 0 O-C-N 121.623 -0.927 . . . . 3.2000000000000002 111.36 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 54.4 ptt85 -67.66 -7.88 30.37 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.586 -0.696 . . . . 2.9199999999999999 111.783 -179.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 905' ' ' HIS . . . . . 0.497 ' O ' ' CB ' ' C' ' 906' ' ' GLU . 69.5 t60 -63.06 6.61 0.1 Allowed 'General case' 0 N--CA 1.504 2.266 0 CA-C-O 117.599 -1.191 . . . . 2.8700000000000001 113.412 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 906' ' ' GLU . . . . . 0.497 ' CB ' ' O ' ' C' ' 905' ' ' HIS . 0.7 OUTLIER 93.46 -163.01 0.0 OUTLIER 'General case' 0 N--CA 1.529 3.52 0 CA-C-N 121.299 1.863 . . . . 0.98999999999999999 112.1 179.083 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 907' ' ' LYS . . . . . 0.495 ' CB ' ' O ' ' C' ' 906' ' ' GLU . 57.9 tttt 90.01 160.78 0.05 OUTLIER 'General case' 0 N--CA 1.521 3.11 0 N-CA-C 107.967 -1.123 . . . . 5.25 107.967 -176.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 62.0 t -122.31 116.02 47.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 120.888 -1.132 . . . . 0.39000000000000001 110.806 -179.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -103.84 130.22 51.38 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 107.209 -1.404 . . . . 1.72 107.209 176.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -157.2 120.29 4.04 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 106.916 -1.513 . . . . 0.67000000000000004 106.916 178.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 911' ' ' VAL . . . . . 0.784 HG23 HG22 ' C' ' 964' ' ' VAL . 12.3 p -80.65 131.21 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 C-N-CA 120.248 -0.581 . . . . 0.54000000000000004 111.463 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 60.5 mt -67.32 156.39 36.55 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.28 -0.887 . . . . 1.5 108.618 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 913' ' ' SER . . . . . 0.414 ' CB ' ' CG1' ' C' ' 919' ' ' VAL . 2.4 t -125.27 136.44 53.52 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.589 -0.893 . . . . 1.3700000000000001 108.589 177.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 914' ' ' ARG . . . . . 0.837 ' NH1' HD13 ' C' ' 956' ' ' LEU . 0.0 OUTLIER -63.41 154.6 31.58 Favored 'General case' 0 N--CA 1.505 2.308 0 O-C-N 120.685 -1.26 . . . . 4.2999999999999998 111.499 -179.095 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 915' ' ' SER . . . . . 0.417 ' CB ' ' O ' ' C' ' 914' ' ' ARG . 1.7 p 83.58 -30.77 0.08 Allowed 'General case' 0 N--CA 1.521 3.101 0 C-N-CA 123.907 0.883 . . . . 2.0499999999999998 111.999 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 916' ' ' ASN . . . . . 0.792 ' HB2' HG21 ' C' ' 919' ' ' VAL . 93.9 m-20 -122.87 -21.96 5.41 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 120.967 -1.083 . . . . 2.71 111.309 -179.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 48.6 mt-30 67.17 165.93 0.22 Allowed 'General case' 0 N--CA 1.521 3.08 0 N-CA-C 105.614 -1.995 . . . . 2.6800000000000002 105.614 -174.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.74 -125.64 35.58 Favored Glycine 1 N--CA 1.521 4.32 0 CA-C-N 123.688 2.949 . . . . 0.029999999999999999 107.026 -177.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 919' ' ' VAL . . . . . 0.792 HG21 ' HB2' ' C' ' 916' ' ' ASN . 96.8 t 50.4 94.2 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.212 0 O-C-N 121.444 -1.033 . . . . 1.3899999999999999 109.397 -178.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 920' ' ' ALA . . . . . 0.859 ' HB3' HG12 ' C' ' 949' ' ' VAL . . . -94.38 94.67 8.4 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.476 -0.89 . . . . 0.029999999999999999 110.661 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 921' ' ' ARG . . . . . 0.729 ' HG3' HG23 ' C' ' 922' ' ' VAL . 23.9 ptt85 -80.61 -41.81 23.31 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 105.792 -1.929 . . . . 4.4199999999999999 105.792 176.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 922' ' ' VAL . . . . . 0.729 HG23 ' HG3' ' C' ' 921' ' ' ARG . 86.3 t -99.37 78.31 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 N-CA-C 105.705 -1.961 . . . . 0.84999999999999998 105.705 175.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -90.73 135.53 33.66 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-O 121.836 0.827 . . . . 2.46 112.26 -176.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 9.0 t -147.23 103.32 3.57 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.053 -1.092 . . . . 0.69999999999999996 108.053 178.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -109.81 89.49 0.55 Allowed Glycine 0 N--CA 1.488 2.108 0 N-CA-C 108.97 -1.652 . . . . 0.040000000000000001 108.97 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.387 0 N-CA-C 109.265 -1.534 . . . . 0.040000000000000001 109.265 -179.633 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 10.7 m . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 120.971 0.415 . . . . 13.779999999999999 110.336 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 93.3 mt -114.16 129.87 56.61 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.536 -0.727 . . . . 13.76 110.275 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -152.52 170.6 31.71 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 109.463 -1.455 . . . . 9.1300000000000008 109.463 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 949' ' ' VAL . . . . . 0.859 HG12 ' HB3' ' C' ' 920' ' ' ALA . 34.8 m -116.69 137.52 50.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.563 -0.963 . . . . 7.0800000000000001 110.829 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 950' ' ' PHE . . . . . 0.485 ' CB ' HD11 ' C' ' 953' ' ' ILE . 51.7 p90 -134.35 151.39 51.2 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.509 -0.744 . . . . 7.5899999999999999 109.558 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 22.3 m -116.59 -60.07 1.89 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.415 -0.803 . . . . 5.0300000000000002 111.625 -179.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 952' ' ' LEU . . . . . 0.46 ' O ' ' O ' ' C' ' 953' ' ' ILE . 53.1 tp -63.1 -75.25 0.08 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.415 -0.803 . . . . 1.01 111.276 -178.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 953' ' ' ILE . . . . . 0.543 HD12 ' HD3' ' C' ' 955' ' ' PRO . 1.8 pp -47.94 -154.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.768 0 N-CA-C 114.487 1.291 . . . . 2.6000000000000001 114.487 -177.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 954' ' ' LEU . . . . . 0.716 HD23 ' CE2' ' C' ' 894' ' ' TYR . 0.0 OUTLIER 170.44 85.63 0.04 OUTLIER Pre-proline 0 N--CA 1.514 2.764 0 O-C-N 120.869 -1.144 . . . . 0.050000000000000003 111.922 179.871 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 955' ' ' PRO . . . . . 0.543 ' HD3' HD12 ' C' ' 953' ' ' ILE . 52.6 Cg_endo -77.13 92.39 1.12 Allowed 'Trans proline' 0 N--CA 1.488 1.162 0 N-CA-C 109.131 -1.142 . . . . 0.83999999999999997 109.131 178.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 956' ' ' LEU . . . . . 0.837 HD13 ' NH1' ' C' ' 914' ' ' ARG . 89.6 mt -127.94 149.79 50.17 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.086 -1.009 . . . . 0.040000000000000001 110.703 -179.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 957' ' ' GLN . . . . . 0.411 ' HB2' ' HB2' ' C' ' 960' ' ' ASP . 75.9 mt-30 -84.87 153.67 22.75 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 117.994 -1.003 . . . . 1.28 111.634 -179.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -67.45 120.44 13.92 Favored 'General case' 0 N--CA 1.508 2.469 0 CA-C-N 122.542 2.428 . . . . 0.17000000000000001 111.471 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.89 -18.86 54.88 Favored Glycine 0 N--CA 1.501 3.003 0 O-C-N 121.52 -0.738 . . . . 0.040000000000000001 111.278 178.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 960' ' ' ASP . . . . . 0.454 ' HB3' ' NE ' ' C' ' 914' ' ' ARG . 0.6 OUTLIER -51.64 172.12 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.369 -1.077 . . . . 0.040000000000000001 110.717 -179.222 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 961' ' ' THR . . . . . 0.492 ' HA ' ' O ' ' C' ' 886' ' ' PHE . 7.4 t -135.61 137.58 42.06 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.092 -1.005 . . . . 1.78 112.141 -178.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 962' ' ' VAL . . . . . 0.927 HG22 ' HB3' ' C' ' 886' ' ' PHE . 23.6 m -99.99 146.06 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 C-N-CA 120.031 -0.668 . . . . 0.040000000000000001 110.497 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 5.2 t -139.15 144.75 38.75 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.785 -0.572 . . . . 0.71999999999999997 110.028 -178.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 964' ' ' VAL . . . . . 0.784 HG22 HG23 ' C' ' 911' ' ' VAL . 57.8 t -94.96 137.39 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.108 -0.995 . . . . 1.05 110.627 -179.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -94.09 126.72 39.48 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 104.068 -2.568 . . . . 3.02 104.068 173.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 966' ' ' LEU . . . . . 0.488 ' C ' HG23 ' C' ' 967' ' ' VAL . 0.1 OUTLIER -132.92 60.09 1.71 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.29 -1.004 . . . . 1.46 108.29 177.398 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 967' ' ' VAL . . . . . 0.488 HG23 ' C ' ' C' ' 966' ' ' LEU . 96.1 t -157.82 96.31 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 108.258 -1.016 . . . . 1.9399999999999999 108.258 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 92.0 mmm -142.74 58.77 1.43 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.748 -1.22 . . . . 0.0 108.382 179.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 134.41 119.38 1.96 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 107.192 -2.363 . . . . 2.1099999999999999 107.192 -178.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 57.7 tt0 -82.18 -58.38 2.97 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.015 -1.285 . . . . 5.8899999999999997 110.591 -179.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 45.1 tp -59.29 90.01 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.445 -0.784 . . . . 4.3600000000000003 110.209 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -142.33 -152.55 0.42 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.613 -0.68 . . . . 1.8300000000000001 110.208 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -116.41 167.47 11.01 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.438 -0.789 . . . . 4.3499999999999996 110.068 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 29.5 t -101.89 130.4 48.36 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.548 -0.72 . . . . 1.27 110.129 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -156.29 155.64 32.66 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.507 -0.745 . . . . 5.0199999999999996 110.459 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.29 85.08 18.86 Favored Pre-proline 0 N--CA 1.5 2.043 0 O-C-N 121.627 -0.671 . . . . 2.4100000000000001 109.642 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 977' ' ' PRO . . . . . 0.488 ' C ' HD12 ' C' ' 978' ' ' LEU . 49.5 Cg_endo -74.8 -171.47 0.97 Allowed 'Trans proline' 0 C--N 1.317 -1.113 0 O-C-N 123.356 1.188 . . . . 0.95999999999999996 111.331 -179.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 978' ' ' LEU . . . . . 0.488 HD12 ' C ' ' C' ' 977' ' ' PRO . 5.5 mp -125.21 156.38 38.56 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 107.542 -1.281 . . . . 0.62 107.542 177.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 979' ' ' THR . . . . . 0.445 HG23 ' C ' ' C' ' 978' ' ' LEU . 43.2 p -149.42 141.6 24.03 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.822 -1.174 . . . . 3.5699999999999998 111.184 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 980' ' ' ILE . . . . . 0.683 ' HB ' HG21 ' C' ' 899' ' ' VAL . 50.2 mm -106.89 128.27 61.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 N-CA-C 108.948 -0.76 . . . . 1.3300000000000001 108.948 179.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 981' ' ' PHE . . . . . 0.539 ' HE1' HD11 ' C' ' 896' ' ' LEU . 3.4 t80 -117.53 97.56 5.94 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.428 -0.795 . . . . 0.050000000000000003 111.564 -178.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 982' ' ' SER . . . . . . . . . . . . . 34.5 p -107.2 158.25 17.25 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 109.042 -0.725 . . . . 0.87 109.042 178.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 983' ' ' GLY . . . . . 0.419 ' O ' ' CZ ' ' C' ' 852' ' ' PHE . . . -173.06 113.7 0.48 Allowed Glycine 0 N--CA 1.497 2.727 0 N-CA-C 106.644 -2.582 . . . . 0.029999999999999999 106.644 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 984' ' ' ALA . . . . . 0.4 ' CB ' ' CZ ' ' A' ' 893' ' ' ARG . . . -109.11 152.38 25.15 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 114.319 1.229 . . . . 0.69999999999999996 114.319 -175.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 985' ' ' LEU . . . . . 0.556 HD13 HD22 ' C' ' 890' ' ' LEU . 52.1 tp -75.89 135.75 40.13 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.871 -1.143 . . . . 0.040000000000000001 109.691 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 986' ' ' LEU . . . . . 0.524 HD11 ' CD1' ' B' ' 986' ' ' LEU . 40.7 tp -106.26 -62.63 1.36 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.442 -0.786 . . . . 0.040000000000000001 110.299 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -144.7 146.78 32.38 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 107.753 -1.203 . . . . 0.040000000000000001 107.753 179.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -111.91 162.67 12.35 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 108.079 -2.008 . . . . 0.040000000000000001 108.079 179.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -73.7 112.86 18.05 Favored Pre-proline 0 N--CA 1.499 1.999 0 O-C-N 121.23 -1.159 . . . . 0.040000000000000001 109.44 179.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 990' ' ' PRO . . . . . 0.435 ' HD2' HD12 ' C' ' 992' ' ' LEU . 51.1 Cg_endo -88.08 70.83 2.88 Favored 'Trans proline' 0 C--N 1.319 -0.984 0 O-C-N 123.201 1.106 . . . . 0.45000000000000001 111.408 -179.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 991' ' ' GLU . . . . . 0.421 ' HB2' ' O ' ' C' ' 990' ' ' PRO . 80.6 mt-10 67.14 -73.65 0.08 Allowed 'General case' 0 N--CA 1.502 2.148 0 N-CA-C 108.645 -0.872 . . . . 1.97 108.645 -177.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 992' ' ' LEU . . . . . 0.435 HD12 ' HD2' ' C' ' 990' ' ' PRO . 11.1 mt 50.86 20.91 0.85 Allowed 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.62 -0.675 . . . . 2.3799999999999999 111.58 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -92.43 156.91 16.88 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.991 -1.068 . . . . 3.79 110.042 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 68.8 m80 -146.66 91.62 2.05 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.567 -0.708 . . . . 3.5099999999999998 110.245 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 995' ' ' ALA . . . . . . . . . . . . 2.518 . . . . . . . 0 N--CA 1.503 2.213 0 O-C-N 120.983 -1.073 . . . . 2.73 110.646 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo . . . . . 0 N--CA 1.488 1.154 0 N-CA-C 109.497 -1.001 . . . . 3.8300000000000001 109.497 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 847' ' ' VAL . . . . . . . . . . . . . 63.4 t -135.3 102.68 10.68 Favored Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 121.504 -0.747 . . . . 1.8300000000000001 110.04 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 848' ' ' PRO . . . . . 0.744 ' O ' HG23 ' A' ' 850' ' ' VAL . 44.3 Cg_endo -69.94 -18.12 36.35 Favored 'Trans proline' 0 N--CA 1.488 1.161 0 O-C-N 123.308 1.162 . . . . 0.65000000000000002 111.196 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 849' ' ' GLN . . . . . 0.4 ' C ' ' O ' ' A' ' 848' ' ' PRO . 56.4 tt0 28.07 69.42 0.07 Allowed 'General case' 0 N--CA 1.518 2.96 0 N-CA-C 112.837 0.68 . . . . 2.5800000000000001 112.837 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 850' ' ' VAL . . . . . 0.744 HG23 ' O ' ' A' ' 848' ' ' PRO . 64.8 t -120.38 137.5 53.97 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 121.216 -0.927 . . . . 1.0900000000000001 111.7 -178.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 851' ' ' ALA . . . . . 0.562 ' HB3' ' HG ' ' A' ' 873' ' ' LEU . . . -125.94 159.18 33.29 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 105.909 -1.885 . . . . 0.040000000000000001 105.909 176.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 852' ' ' PHE . . . . . 0.434 ' HA ' ' CB ' ' A' ' 874' ' ' ASN . 48.1 p90 -158.73 130.72 6.67 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 121.075 1.762 . . . . 0.050000000000000003 108.864 178.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 46.9 t -175.5 134.05 0.3 Allowed 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 108.209 -1.034 . . . . 0.040000000000000001 108.209 -179.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 854' ' ' ALA . . . . . 0.49 ' HB1' ' HD2' ' A' ' 868' ' ' PHE . . . -133.55 155.09 50.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.091 -1.006 . . . . 0.67000000000000004 109.498 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 855' ' ' ALA . . . . . 0.745 ' HB3' ' CB ' ' A' ' 870' ' ' ARG . . . -124.1 142.7 50.97 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-O 121.973 0.892 . . . . 0.51000000000000001 111.651 -179.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 856' ' ' LEU . . . . . 0.765 HD12 HD23 ' A' ' 978' ' ' LEU . 3.3 tm? -111.62 137.88 48.91 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.717 -0.614 . . . . 0.050000000000000003 110.214 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 857' ' ' SER . . . . . 0.66 ' N ' HD13 ' A' ' 856' ' ' LEU . 76.5 p -155.48 15.41 0.38 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.594 -0.691 . . . . 1.3300000000000001 111.466 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 858' ' ' LEU . . . . . 0.535 HD12 ' C ' ' A' ' 858' ' ' LEU . 4.3 pp -36.51 160.65 0.05 OUTLIER Pre-proline 0 N--CA 1.515 2.822 0 CA-C-N 118.799 0.727 . . . . 2.3300000000000001 112.581 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -59.68 -89.16 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.491 0 O-C-N 123.005 1.003 . . . . 2.3199999999999998 114.016 -177.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 54.3 ptt85 -128.08 -144.58 0.29 Allowed 'General case' 0 N--CA 1.502 2.137 0 O-C-N 120.774 -1.204 . . . . 0.040000000000000001 112.394 -177.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 69.7 m -33.91 127.56 0.4 Allowed 'General case' 0 N--CA 1.511 2.604 0 N-CA-C 112.987 0.736 . . . . 1.3100000000000001 112.987 -178.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 862' ' ' GLU . . . . . 0.456 ' HG3' HD22 ' A' ' 858' ' ' LEU . 0.0 OUTLIER -102.67 158.22 32.19 Favored Pre-proline 0 N--CA 1.489 1.477 0 N-CA-C 108.288 -1.004 . . . . 4.5099999999999998 108.288 177.457 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 863' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.27 -13.39 25.61 Favored 'Trans proline' 0 C--N 1.315 -1.236 0 O-C-N 123.069 1.036 . . . . 2.2400000000000002 111.687 -179.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -177.55 -135.1 2.15 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 110.06 -1.216 . . . . 0.040000000000000001 110.06 179.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 28.4 m -67.58 151.21 47.7 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.382 -1.07 . . . . 1.51 109.923 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 866' ' ' VAL . . . . . 0.497 HG13 ' CD2' ' A' ' 858' ' ' LEU . 33.4 t -94.67 139.67 22.34 Favored Pre-proline 0 N--CA 1.496 1.869 0 N-CA-C 113.764 1.024 . . . . 0.78000000000000003 113.764 -174.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 867' ' ' PRO . . . . . 0.486 ' HD3' ' HA ' ' A' ' 866' ' ' VAL . 55.3 Cg_endo -91.96 -151.31 0.04 OUTLIER 'Trans proline' 0 CA--C 1.544 0.999 0 O-C-N 123.673 1.354 . . . . 0.92000000000000004 109.275 177.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 868' ' ' PHE . . . . . 0.49 ' HD2' ' HB1' ' A' ' 854' ' ' ALA . 20.1 p90 -151.1 124.16 8.73 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.662 -1.274 . . . . 0.050000000000000003 109.806 179.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 50.5 p-10 -113.75 -2.17 13.77 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.226 -0.921 . . . . 1.7 112.731 -178.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 870' ' ' ARG . . . . . 0.745 ' CB ' ' HB3' ' A' ' 855' ' ' ALA . 28.8 mmm180 -90.64 90.08 7.81 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 120.883 -1.135 . . . . 2.5899999999999999 110.944 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 60.3 t -72.3 96.48 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 120.998 -1.064 . . . . 1.9399999999999999 109.944 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 872' ' ' LEU . . . . . 0.546 HD11 ' HB2' ' A' ' 855' ' ' ALA . 96.9 mt -83.09 -47.35 11.75 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.495 -0.753 . . . . 1.0600000000000001 110.188 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 873' ' ' LEU . . . . . 0.562 ' HG ' ' HB3' ' A' ' 851' ' ' ALA . 44.3 tp -174.61 103.51 0.1 Allowed 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 108.729 -0.841 . . . . 4.1799999999999997 108.729 178.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 874' ' ' ASN . . . . . 0.434 ' CB ' ' HA ' ' A' ' 852' ' ' PHE . 33.3 t-20 177.92 81.74 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.31 0 O-C-N 121.681 -0.637 . . . . 0.040000000000000001 109.301 -178.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -66.33 -47.27 74.04 Favored 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 119.317 -0.953 . . . . 3.3799999999999999 111.143 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 876' ' ' GLY . . . . . 0.41 ' HA3' ' CE2' ' A' ' 878' ' ' TYR . . . -74.53 -24.68 72.12 Favored Glycine 0 N--CA 1.494 2.552 0 O-C-N 121.309 -0.87 . . . . 0.040000000000000001 111.546 -178.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 82.22 -61.95 4.63 Favored Glycine 0 N--CA 1.501 2.973 0 N-CA-C 108.005 -2.038 . . . . 0.040000000000000001 108.005 -178.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 878' ' ' TYR . . . . . 0.41 ' CE2' ' HA3' ' A' ' 876' ' ' GLY . 97.9 m-85 60.91 -62.25 0.07 Allowed 'General case' 0 N--CA 1.503 2.211 0 N-CA-C 114.542 1.312 . . . . 3.46 114.542 177.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 879' ' ' TYR . . . . . 0.484 ' CB ' ' CD2' ' A' ' 886' ' ' PHE . 18.2 p90 -110.63 109.7 20.09 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 114.849 1.426 . . . . 0.040000000000000001 114.849 -176.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -68.05 115.55 29.7 Favored Pre-proline 0 N--CA 1.497 1.879 0 O-C-N 121.405 -0.809 . . . . 0.02 109.971 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 881' ' ' PRO . . . . . 0.457 ' HG2' ' CD1' ' A' ' 868' ' ' PHE . 55.2 Cg_endo -75.93 0.6 9.09 Favored 'Trans proline' 0 N--CA 1.495 1.613 0 O-C-N 123.39 1.205 . . . . 0.39000000000000001 112.309 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -76.92 -62.27 1.7 Allowed 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 106.617 -1.623 . . . . 0.81000000000000005 106.617 178.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 883' ' ' THR . . . . . 0.575 ' OG1' HG23 ' A' ' 885' ' ' VAL . 64.4 p -94.49 -19.27 20.69 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.617 -0.882 . . . . 0.040000000000000001 108.617 177.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.66 19.77 59.36 Favored Glycine 0 N--CA 1.496 2.677 0 O-C-N 121.064 -1.022 . . . . 0.029999999999999999 111.237 178.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 885' ' ' VAL . . . . . 0.575 HG23 ' OG1' ' A' ' 883' ' ' THR . 95.9 t -74.25 89.0 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 C-N-CA 118.141 -1.424 . . . . 1.01 108.302 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 886' ' ' PHE . . . . . 0.905 ' HB3' HG22 ' A' ' 962' ' ' VAL . 1.0 OUTLIER -88.23 105.43 17.53 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 115.306 -0.861 . . . . 0.050000000000000003 111.52 -177.674 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 887' ' ' THR . . . . . 0.429 ' O ' ' HD3' ' A' ' 889' ' ' PRO . 93.1 m -95.43 99.95 11.79 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 107.856 -1.165 . . . . 0.68000000000000005 107.856 177.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 888' ' ' ALA . . . . . . . . . . . . . . . -98.85 106.4 37.27 Favored Pre-proline 0 N--CA 1.5 2.039 0 N-CA-C 114.124 1.157 . . . . 0.25 114.124 -176.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 889' ' ' PRO . . . . . 0.429 ' HD3' ' O ' ' A' ' 887' ' ' THR . 54.1 Cg_endo -89.07 -12.39 3.37 Favored 'Trans proline' 0 CA--C 1.546 1.1 0 N-CA-C 108.92 -1.223 . . . . 1.6399999999999999 108.92 176.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 890' ' ' LEU . . . . . 0.856 HD22 HD13 ' A' ' 985' ' ' LEU . 76.7 mt -36.11 -50.73 0.72 Allowed 'General case' 0 N--CA 1.508 2.447 0 N-CA-C 113.592 0.96 . . . . 2.29 113.592 -177.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 52.35 95.55 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.236 -0.915 . . . . 0.63 110.195 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 157.67 -153.64 24.83 Favored Glycine 0 N--CA 1.477 1.427 0 N-CA-C 107.111 -2.396 . . . . 0.040000000000000001 107.111 -179.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 893' ' ' ARG . . . . . . . . . . . . . 71.4 ttt-85 -115.79 126.89 54.6 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 121.557 -0.967 . . . . 3.0 108.539 177.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 894' ' ' TYR . . . . . 0.762 ' OH ' HD12 ' A' ' 896' ' ' LEU . 0.1 OUTLIER -132.24 160.49 36.02 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.11 -0.994 . . . . 0.040000000000000001 111.081 -179.939 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 895' ' ' LEU . . . . . 0.506 HD23 HD11 ' B' ' 952' ' ' LEU . 35.0 tp -90.71 119.08 30.65 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.401 0.62 . . . . 1.27 110.029 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 896' ' ' LEU . . . . . 0.762 HD12 ' OH ' ' A' ' 894' ' ' TYR . 9.5 tt -109.42 143.21 39.32 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.774 -0.579 . . . . 0.93999999999999995 110.2 -179.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 897' ' ' SER . . . . . 0.505 ' N ' HD23 ' A' ' 896' ' ' LEU . 67.8 m -149.0 115.1 5.76 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.482 -0.761 . . . . 0.040000000000000001 111.018 -179.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -108.1 146.77 32.16 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 109.07 -0.715 . . . . 0.47999999999999998 109.07 178.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 899' ' ' VAL . . . . . 0.748 HG21 ' HB ' ' A' ' 980' ' ' ILE . 87.7 t -95.7 119.72 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 C-N-CA 119.63 -0.828 . . . . 0.55000000000000004 111.279 -179.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 900' ' ' LEU . . . . . 0.511 HD12 ' HB2' ' A' ' 924' ' ' SER . 4.5 mm? -96.04 112.22 24.02 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 114.384 1.253 . . . . 1.5900000000000001 114.384 -175.05 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 11.8 m -66.28 141.29 58.06 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 107.53 -1.285 . . . . 0.050000000000000003 107.53 176.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -66.72 -66.13 2.51 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 110.573 -1.011 . . . . 0.029999999999999999 110.573 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 11.8 m170 46.91 67.02 0.85 Allowed 'General case' 0 N--CA 1.508 2.438 0 O-C-N 121.476 -1.014 . . . . 3.2000000000000002 111.151 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 43.3 ptt85 -69.71 -5.65 26.47 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.608 -0.683 . . . . 2.9199999999999999 112.063 -179.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 905' ' ' HIS . . . . . 0.486 ' O ' ' CB ' ' A' ' 906' ' ' GLU . 73.8 t60 -62.83 5.32 0.13 Allowed 'General case' 0 N--CA 1.506 2.365 0 O-C-N 120.9 -1.125 . . . . 2.8700000000000001 113.111 -179.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 906' ' ' GLU . . . . . 0.486 ' CB ' ' O ' ' A' ' 905' ' ' HIS . 0.8 OUTLIER 94.86 -164.48 0.0 OUTLIER 'General case' 0 N--CA 1.529 3.478 0 CA-C-N 120.552 1.524 . . . . 0.98999999999999999 111.899 178.944 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 907' ' ' LYS . . . . . 0.46 ' CB ' ' O ' ' A' ' 906' ' ' GLU . 68.4 tttt 85.78 157.56 0.09 Allowed 'General case' 0 N--CA 1.519 3.019 0 N-CA-C 108.156 -1.053 . . . . 5.25 108.156 -177.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 60.1 t -121.68 117.08 51.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 120.756 -1.215 . . . . 0.39000000000000001 111.312 -179.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 71.2 tt0 -100.03 132.77 45.19 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 107.041 -1.466 . . . . 1.72 107.041 176.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -155.09 123.27 5.88 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 106.805 -1.554 . . . . 0.67000000000000004 106.805 178.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 911' ' ' VAL . . . . . 0.842 HG22 HG13 ' A' ' 964' ' ' VAL . 87.5 t -83.6 131.14 34.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 C-N-CA 120.52 -0.472 . . . . 0.54000000000000004 110.68 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 86.2 mt -66.34 156.01 35.68 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 121.333 -0.855 . . . . 1.5 109.264 178.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 913' ' ' SER . . . . . 0.474 ' OG ' HG11 ' A' ' 919' ' ' VAL . 0.1 OUTLIER -127.48 133.87 49.86 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 107.542 -1.281 . . . . 1.3700000000000001 107.542 176.547 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 914' ' ' ARG . . . . . 0.578 HH11 HG13 ' A' ' 962' ' ' VAL . 0.0 OUTLIER -64.95 158.41 25.49 Favored 'General case' 0 N--CA 1.506 2.373 0 O-C-N 120.558 -1.339 . . . . 4.2999999999999998 112.119 -178.491 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 915' ' ' SER . . . . . 0.439 ' CB ' ' O ' ' A' ' 914' ' ' ARG . 4.6 t 84.39 -32.09 0.07 Allowed 'General case' 0 N--CA 1.522 3.153 0 C-N-CA 124.164 0.985 . . . . 2.0499999999999998 111.943 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 916' ' ' ASN . . . . . 0.785 ' HB2' HG21 ' A' ' 919' ' ' VAL . 98.9 m-20 -123.88 -21.32 5.16 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.899 -1.126 . . . . 2.71 111.352 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 917' ' ' GLN . . . . . 0.405 ' HB2' ' O ' ' A' ' 916' ' ' ASN . 45.6 mt-30 66.67 166.39 0.21 Allowed 'General case' 0 N--CA 1.52 3.073 0 N-CA-C 105.637 -1.986 . . . . 2.6800000000000002 105.637 -174.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 52.93 -124.07 26.32 Favored Glycine 1 N--CA 1.523 4.46 0 CA-C-N 123.383 2.811 . . . . 0.029999999999999999 106.895 -177.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 919' ' ' VAL . . . . . 0.785 HG21 ' HB2' ' A' ' 916' ' ' ASN . 52.1 t 52.22 93.9 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.158 0 O-C-N 121.337 -1.096 . . . . 1.3899999999999999 108.96 -178.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 920' ' ' ALA . . . . . 0.816 ' HB3' HG12 ' A' ' 949' ' ' VAL . . . -91.75 91.28 7.89 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 119.402 -0.919 . . . . 0.029999999999999999 110.917 -178.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 921' ' ' ARG . . . . . 0.721 ' HG3' HG23 ' A' ' 922' ' ' VAL . 17.3 ptt180 -86.64 -42.24 13.59 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 106.104 -1.813 . . . . 4.4199999999999999 106.104 176.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 922' ' ' VAL . . . . . 0.721 HG23 ' HG3' ' A' ' 921' ' ' ARG . 76.7 t -104.29 67.09 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 105.846 -1.909 . . . . 0.84999999999999998 105.846 175.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 923' ' ' ASP . . . . . 0.659 ' HB2' ' HB1' ' A' ' 920' ' ' ALA . 25.6 t0 -86.58 134.18 33.66 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.684 0.755 . . . . 2.46 111.459 -177.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 924' ' ' SER . . . . . 0.511 ' HB2' HD12 ' A' ' 900' ' ' LEU . 39.7 t -147.7 106.18 3.79 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 108.669 -0.863 . . . . 0.69999999999999996 108.669 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -101.76 84.74 0.52 Allowed Glycine 0 N--CA 1.486 1.995 0 N-CA-C 108.304 -1.918 . . . . 0.040000000000000001 108.304 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.21 0 N-CA-C 108.877 -1.689 . . . . 0.040000000000000001 108.877 -179.537 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 26.0 m . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.033 0.444 . . . . 13.779999999999999 110.313 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 95.7 mt -112.38 130.88 55.81 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.544 -0.723 . . . . 13.76 110.301 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -151.36 168.25 30.87 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.107 -1.597 . . . . 9.1300000000000008 109.107 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 949' ' ' VAL . . . . . 0.816 HG12 ' HB3' ' A' ' 920' ' ' ALA . 29.8 m -119.11 127.08 75.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.5 -1.0 . . . . 7.0800000000000001 111.019 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 950' ' ' PHE . . . . . 0.458 ' CZ ' ' HB3' ' A' ' 921' ' ' ARG . 27.1 p90 -133.71 149.28 51.5 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.623 -0.673 . . . . 7.5899999999999999 109.237 179.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 29.1 m -121.27 -51.51 2.09 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.359 -0.838 . . . . 5.0300000000000002 112.191 -178.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 952' ' ' LEU . . . . . 0.418 ' O ' ' O ' ' A' ' 953' ' ' ILE . 14.6 tp -59.4 -73.88 0.08 Allowed 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.369 -0.832 . . . . 1.01 112.705 -177.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 953' ' ' ILE . . . . . 0.582 HD11 HD13 ' C' ' 872' ' ' LEU . 45.8 pt -52.29 -144.1 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.848 0 N-CA-C 114.417 1.266 . . . . 2.6000000000000001 114.417 -176.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 954' ' ' LEU . . . . . 0.717 HD22 ' O ' ' A' ' 954' ' ' LEU . 0.0 OUTLIER 173.21 75.01 0.04 OUTLIER Pre-proline 0 N--CA 1.507 2.417 0 O-C-N 120.779 -1.201 . . . . 0.050000000000000003 110.869 -179.974 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 955' ' ' PRO . . . . . 0.755 ' C ' HD12 ' A' ' 956' ' ' LEU . 49.6 Cg_endo -77.11 95.51 1.07 Allowed 'Trans proline' 0 C--N 1.316 -1.143 0 O-C-N 122.716 0.85 . . . . 0.83999999999999997 110.2 179.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 956' ' ' LEU . . . . . 0.755 HD12 ' C ' ' A' ' 955' ' ' PRO . 8.9 mp -125.83 151.12 47.23 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.237 -0.915 . . . . 0.040000000000000001 110.257 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -82.19 150.92 27.13 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-O 117.734 -1.127 . . . . 1.28 111.311 -178.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -68.33 119.47 12.9 Favored 'General case' 0 N--CA 1.509 2.51 0 CA-C-N 123.063 2.665 . . . . 0.17000000000000001 111.234 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.8 -21.68 37.9 Favored Glycine 0 N--CA 1.499 2.874 0 N-CA-C 110.769 -0.932 . . . . 0.040000000000000001 110.769 178.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 960' ' ' ASP . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 914' ' ' ARG . 0.4 OUTLIER -53.12 171.9 0.06 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.389 -1.066 . . . . 0.040000000000000001 109.993 -179.707 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 961' ' ' THR . . . . . 0.463 ' HA ' ' O ' ' A' ' 886' ' ' PHE . 41.5 m -133.53 138.73 46.23 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.895 -1.128 . . . . 1.78 112.159 -177.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 962' ' ' VAL . . . . . 0.905 HG22 ' HB3' ' A' ' 886' ' ' PHE . 20.3 m -96.57 143.62 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 C-N-CA 120.025 -0.67 . . . . 0.040000000000000001 109.763 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 5.3 t -140.28 145.3 37.1 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.817 -0.552 . . . . 0.71999999999999997 109.981 -178.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 964' ' ' VAL . . . . . 0.842 HG13 HG22 ' A' ' 911' ' ' VAL . 47.6 t -99.59 136.9 28.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.141 -0.975 . . . . 1.05 110.785 -178.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -94.05 128.43 40.42 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 103.799 -2.667 . . . . 3.02 103.799 173.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 966' ' ' LEU . . . . . 0.493 ' C ' HG23 ' A' ' 967' ' ' VAL . 10.2 tp -131.62 61.99 1.64 Allowed 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.136 -1.061 . . . . 1.46 108.136 177.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 967' ' ' VAL . . . . . 0.493 HG23 ' C ' ' A' ' 966' ' ' LEU . 95.4 t -158.01 97.2 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 108.072 -1.084 . . . . 1.9399999999999999 108.072 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 88.2 mmm -143.13 60.02 1.41 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.746 -1.221 . . . . 0.0 108.353 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.78 119.98 1.95 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 107.036 -2.425 . . . . 2.1099999999999999 107.036 -178.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -82.45 -58.68 2.82 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.014 -1.286 . . . . 5.8899999999999997 110.396 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 49.0 tp -59.01 90.74 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.422 -0.799 . . . . 4.3600000000000003 110.209 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -141.93 -154.19 0.5 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.592 -0.693 . . . . 1.8300000000000001 110.235 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -119.64 171.92 8.04 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.511 -0.743 . . . . 4.3499999999999996 110.212 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 39.0 t -101.64 130.42 47.98 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.598 -0.689 . . . . 1.27 110.084 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -156.12 158.75 38.24 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.521 -0.737 . . . . 5.0199999999999996 110.561 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.14 85.75 18.43 Favored Pre-proline 0 N--CA 1.5 2.04 0 O-C-N 121.59 -0.694 . . . . 2.4100000000000001 109.691 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 977' ' ' PRO . . . . . 0.543 ' C ' HD12 ' A' ' 978' ' ' LEU . 48.2 Cg_endo -73.39 -172.43 1.04 Allowed 'Trans proline' 0 C--N 1.317 -1.089 0 O-C-N 123.277 1.146 . . . . 0.95999999999999996 111.345 -179.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 978' ' ' LEU . . . . . 0.765 HD23 HD12 ' A' ' 856' ' ' LEU . 5.7 mp -127.47 155.3 43.92 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 107.688 -1.227 . . . . 0.62 107.688 177.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 979' ' ' THR . . . . . 0.461 HG23 ' C ' ' A' ' 978' ' ' LEU . 42.7 p -149.83 141.1 23.16 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.847 -1.158 . . . . 3.5699999999999998 111.252 -179.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 980' ' ' ILE . . . . . 0.748 ' HB ' HG21 ' A' ' 899' ' ' VAL . 46.7 mm -107.7 128.69 62.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 108.911 -0.774 . . . . 1.3300000000000001 108.911 179.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 981' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -120.95 97.26 5.45 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 119.705 -0.798 . . . . 0.050000000000000003 111.974 -178.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 83.8 p -108.59 158.49 17.53 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.539 -0.726 . . . . 0.87 109.157 178.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 983' ' ' GLY . . . . . 0.402 ' HA3' ' CE1' ' A' ' 852' ' ' PHE . . . -175.18 109.04 0.28 Allowed Glycine 0 N--CA 1.499 2.878 0 N-CA-C 106.39 -2.684 . . . . 0.029999999999999999 106.39 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -108.64 152.42 24.82 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 114.565 1.32 . . . . 0.69999999999999996 114.565 -175.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 985' ' ' LEU . . . . . 0.856 HD13 HD22 ' A' ' 890' ' ' LEU . 45.3 tp -72.28 134.55 45.62 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.777 -1.202 . . . . 0.040000000000000001 110.051 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 50.8 tp -107.49 -55.83 2.3 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.562 -0.711 . . . . 0.040000000000000001 109.905 179.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -144.82 145.16 31.51 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 107.653 -1.24 . . . . 0.040000000000000001 107.653 179.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.74 163.15 12.18 Favored Glycine 0 N--CA 1.495 2.593 0 N-CA-C 108.155 -1.978 . . . . 0.040000000000000001 108.155 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -75.85 112.16 18.55 Favored Pre-proline 0 N--CA 1.499 1.988 0 O-C-N 121.202 -1.175 . . . . 0.040000000000000001 109.436 179.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 990' ' ' PRO . . . . . 0.528 ' HD2' HD12 ' A' ' 992' ' ' LEU . 48.8 Cg_endo -91.4 71.23 0.97 Allowed 'Trans proline' 0 C--N 1.319 -0.993 0 O-C-N 123.151 1.079 . . . . 0.45000000000000001 111.418 -178.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 991' ' ' GLU . . . . . 0.418 ' HB2' ' O ' ' A' ' 990' ' ' PRO . 70.4 mt-10 67.25 -73.85 0.07 Allowed 'General case' 0 N--CA 1.503 2.178 0 N-CA-C 108.421 -0.955 . . . . 1.97 108.421 -177.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 992' ' ' LEU . . . . . 0.528 HD12 ' HD2' ' A' ' 990' ' ' PRO . 6.6 mt 51.16 20.54 0.89 Allowed 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.574 -0.704 . . . . 2.3799999999999999 111.609 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -94.63 156.68 16.31 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.844 -1.16 . . . . 3.79 109.98 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -146.55 93.77 2.34 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.529 -0.732 . . . . 3.5099999999999998 110.269 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 995' ' ' ALA . . . . . . . . . . . . 2.518 . . . . . . . 0 N--CA 1.504 2.243 0 O-C-N 120.86 -1.15 . . . . 2.73 110.578 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo . . . . . 0 N--CA 1.488 1.177 0 N-CA-C 109.432 -1.026 . . . . 3.8300000000000001 109.432 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 847' ' ' VAL . . . . . . . . . . . . . 63.6 t -135.38 102.69 10.6 Favored Pre-proline 0 N--CA 1.494 1.775 0 O-C-N 121.573 -0.704 . . . . 1.8300000000000001 110.014 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 848' ' ' PRO . . . . . 0.741 ' O ' HG23 ' B' ' 850' ' ' VAL . 44.1 Cg_endo -69.95 -18.41 36.15 Favored 'Trans proline' 0 N--CA 1.487 1.091 0 O-C-N 123.279 1.147 . . . . 0.65000000000000002 111.192 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 849' ' ' GLN . . . . . 0.404 ' C ' ' O ' ' B' ' 848' ' ' PRO . 56.4 tt0 28.35 69.57 0.07 Allowed 'General case' 0 N--CA 1.518 2.969 0 N-CA-C 112.734 0.642 . . . . 2.5800000000000001 112.734 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 850' ' ' VAL . . . . . 0.741 HG23 ' O ' ' B' ' 848' ' ' PRO . 65.1 t -120.56 137.57 53.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.15 -0.969 . . . . 1.0900000000000001 111.694 -178.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 851' ' ' ALA . . . . . 0.557 ' HB3' ' HG ' ' B' ' 873' ' ' LEU . . . -126.37 158.48 35.78 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 105.894 -1.891 . . . . 0.040000000000000001 105.894 176.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 852' ' ' PHE . . . . . 0.427 ' HA ' ' CB ' ' B' ' 874' ' ' ASN . 47.7 p90 -157.9 131.03 7.54 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 121.114 1.779 . . . . 0.050000000000000003 108.803 179.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 47.2 t -175.53 133.72 0.29 Allowed 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.216 -1.031 . . . . 0.040000000000000001 108.216 -179.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 854' ' ' ALA . . . . . 0.467 ' HB1' ' HD2' ' B' ' 868' ' ' PHE . . . -133.17 155.33 49.51 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.071 -1.018 . . . . 0.67000000000000004 109.522 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 855' ' ' ALA . . . . . 0.742 ' HB3' ' CB ' ' B' ' 870' ' ' ARG . . . -124.37 142.99 50.85 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 122.026 0.917 . . . . 0.51000000000000001 111.553 -179.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 856' ' ' LEU . . . . . 0.785 HD12 HD23 ' B' ' 978' ' ' LEU . 3.3 tm? -111.96 137.56 49.8 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.719 -0.613 . . . . 0.050000000000000003 110.274 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 857' ' ' SER . . . . . 0.649 ' N ' HD13 ' B' ' 856' ' ' LEU . 77.1 p -155.15 15.43 0.4 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.615 -0.678 . . . . 1.3300000000000001 111.433 179.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 858' ' ' LEU . . . . . 0.525 HD12 ' C ' ' B' ' 858' ' ' LEU . 4.3 pp -36.54 160.68 0.05 OUTLIER Pre-proline 0 N--CA 1.516 2.869 0 CA-C-N 118.861 0.755 . . . . 2.3300000000000001 112.544 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -59.74 -89.11 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 120.791 0.994 . . . . 2.3199999999999998 114.022 -177.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 54.4 ptt85 -128.18 -144.7 0.29 Allowed 'General case' 0 N--CA 1.501 2.124 0 O-C-N 120.845 -1.159 . . . . 0.040000000000000001 112.386 -177.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 70.1 m -33.81 126.99 0.4 Allowed 'General case' 0 N--CA 1.512 2.642 0 N-CA-C 112.95 0.722 . . . . 1.3100000000000001 112.95 -178.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 862' ' ' GLU . . . . . 0.463 ' HG3' HD22 ' B' ' 858' ' ' LEU . 0.0 OUTLIER -102.14 158.26 32.11 Favored Pre-proline 0 N--CA 1.489 1.478 0 N-CA-C 108.324 -0.991 . . . . 4.5099999999999998 108.324 177.362 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 863' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -73.19 -13.54 25.8 Favored 'Trans proline' 0 C--N 1.314 -1.283 0 O-C-N 123.114 1.06 . . . . 2.2400000000000002 111.855 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -177.2 -134.14 1.95 Allowed Glycine 0 N--CA 1.495 2.612 0 N-CA-C 110.005 -1.238 . . . . 0.040000000000000001 110.005 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 29.1 m -68.65 151.62 46.46 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.319 -1.106 . . . . 1.51 109.802 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 866' ' ' VAL . . . . . 0.499 HG13 ' CD2' ' B' ' 858' ' ' LEU . 33.2 t -94.82 139.7 22.28 Favored Pre-proline 0 N--CA 1.497 1.905 0 N-CA-C 113.766 1.024 . . . . 0.78000000000000003 113.766 -174.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 867' ' ' PRO . . . . . 0.493 ' HD3' ' HA ' ' B' ' 866' ' ' VAL . 55.5 Cg_endo -92.02 -151.49 0.04 OUTLIER 'Trans proline' 0 CA--C 1.545 1.034 0 O-C-N 123.729 1.384 . . . . 0.92000000000000004 109.302 177.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 868' ' ' PHE . . . . . 0.467 ' CD1' ' HG2' ' B' ' 881' ' ' PRO . 20.3 p90 -150.91 123.86 8.69 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.644 -1.285 . . . . 0.050000000000000003 109.83 179.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 50.5 p-10 -113.54 -1.66 14.05 Favored 'General case' 0 N--CA 1.499 2.005 0 C-N-CA 119.388 -0.925 . . . . 1.7 112.742 -178.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 870' ' ' ARG . . . . . 0.742 ' CB ' ' HB3' ' B' ' 855' ' ' ALA . 28.6 mmm180 -91.12 89.96 7.61 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.855 -1.153 . . . . 2.5899999999999999 111.005 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 59.7 t -72.29 96.57 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.011 -1.056 . . . . 1.9399999999999999 109.937 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 872' ' ' LEU . . . . . 0.541 HD11 ' HB2' ' B' ' 855' ' ' ALA . 96.6 mt -83.24 -47.15 11.84 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.504 -0.747 . . . . 1.0600000000000001 110.232 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 873' ' ' LEU . . . . . 0.557 ' HG ' ' HB3' ' B' ' 851' ' ' ALA . 44.2 tp -174.61 103.46 0.1 Allowed 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 108.735 -0.839 . . . . 4.1799999999999997 108.735 178.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 874' ' ' ASN . . . . . 0.427 ' CB ' ' HA ' ' B' ' 852' ' ' PHE . 33.0 t-20 177.95 81.84 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.64 -0.663 . . . . 0.040000000000000001 109.42 -178.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -66.45 -47.29 73.62 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 119.272 -0.971 . . . . 3.3799999999999999 111.176 -179.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 876' ' ' GLY . . . . . 0.414 ' HA3' ' CE2' ' B' ' 878' ' ' TYR . . . -74.5 -24.82 71.84 Favored Glycine 0 N--CA 1.494 2.524 0 O-C-N 121.263 -0.898 . . . . 0.040000000000000001 111.534 -178.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 82.36 -61.98 4.64 Favored Glycine 0 N--CA 1.501 3.021 0 N-CA-C 107.983 -2.047 . . . . 0.040000000000000001 107.983 -178.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 878' ' ' TYR . . . . . 0.414 ' CE2' ' HA3' ' B' ' 876' ' ' GLY . 97.8 m-85 60.89 -62.23 0.07 Allowed 'General case' 0 N--CA 1.504 2.251 0 N-CA-C 114.527 1.306 . . . . 3.46 114.527 177.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 879' ' ' TYR . . . . . 0.485 ' CB ' ' CD2' ' B' ' 886' ' ' PHE . 18.2 p90 -110.59 109.69 20.1 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 114.826 1.417 . . . . 0.040000000000000001 114.826 -176.121 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -67.95 115.48 28.72 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.418 -0.801 . . . . 0.02 109.947 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 881' ' ' PRO . . . . . 0.467 ' HG2' ' CD1' ' B' ' 868' ' ' PHE . 55.3 Cg_endo -75.9 0.46 9.24 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 O-C-N 123.361 1.19 . . . . 0.39000000000000001 112.264 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -76.72 -62.52 1.61 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 106.637 -1.616 . . . . 0.81000000000000005 106.637 178.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 883' ' ' THR . . . . . 0.567 ' OG1' HG23 ' B' ' 885' ' ' VAL . 63.5 p -94.46 -18.65 21.3 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.711 -0.848 . . . . 0.040000000000000001 108.711 177.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 83.88 20.28 59.83 Favored Glycine 0 N--CA 1.496 2.648 0 O-C-N 121.101 -1.0 . . . . 0.029999999999999999 111.311 178.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 885' ' ' VAL . . . . . 0.567 HG23 ' OG1' ' B' ' 883' ' ' THR . 93.9 t -74.53 89.27 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 C-N-CA 118.15 -1.42 . . . . 1.01 108.202 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 886' ' ' PHE . . . . . 0.885 ' HB3' HG22 ' B' ' 962' ' ' VAL . 1.0 OUTLIER -88.38 105.55 17.66 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 115.366 -0.833 . . . . 0.050000000000000003 111.546 -177.75 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 887' ' ' THR . . . . . 0.427 ' O ' ' HD3' ' B' ' 889' ' ' PRO . 93.0 m -95.48 100.27 12.05 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 107.745 -1.206 . . . . 0.68000000000000005 107.745 177.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 888' ' ' ALA . . . . . . . . . . . . . . . -99.09 106.23 37.0 Favored Pre-proline 0 N--CA 1.5 2.06 0 N-CA-C 114.059 1.133 . . . . 0.25 114.059 -176.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 889' ' ' PRO . . . . . 0.427 ' HD3' ' O ' ' B' ' 887' ' ' THR . 54.8 Cg_endo -88.92 -12.37 3.48 Favored 'Trans proline' 0 CA--C 1.546 1.079 0 N-CA-C 109.003 -1.191 . . . . 1.6399999999999999 109.003 175.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 890' ' ' LEU . . . . . 0.835 HD22 HD13 ' B' ' 985' ' ' LEU . 76.6 mt -36.02 -50.78 0.71 Allowed 'General case' 0 N--CA 1.508 2.462 0 N-CA-C 113.588 0.958 . . . . 2.29 113.588 -177.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 52.16 95.64 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.231 -0.918 . . . . 0.63 110.232 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . 157.63 -153.85 25.01 Favored Glycine 0 N--CA 1.477 1.418 0 N-CA-C 107.061 -2.416 . . . . 0.040000000000000001 107.061 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 71.4 ttt-85 -115.62 126.95 54.82 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 121.61 -0.935 . . . . 3.0 108.587 177.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 894' ' ' TYR . . . . . 0.77 ' OH ' HD12 ' B' ' 896' ' ' LEU . 0.1 OUTLIER -132.18 160.9 34.74 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.117 -0.989 . . . . 0.040000000000000001 111.069 -179.828 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 895' ' ' LEU . . . . . . . . . . . . . 35.2 tp -91.13 118.93 30.83 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 121.426 0.631 . . . . 1.27 110.091 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 896' ' ' LEU . . . . . 0.77 HD12 ' OH ' ' B' ' 894' ' ' TYR . 9.5 tt -109.28 142.47 40.11 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.782 -0.574 . . . . 0.93999999999999995 110.251 -179.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 897' ' ' SER . . . . . 0.496 ' N ' HD23 ' B' ' 896' ' ' LEU . 68.1 m -148.42 114.96 5.95 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.538 -0.726 . . . . 0.040000000000000001 111.022 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.87 146.52 32.21 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 109.179 -0.674 . . . . 0.47999999999999998 109.179 179.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 899' ' ' VAL . . . . . 0.738 HG21 ' HB ' ' B' ' 980' ' ' ILE . 87.9 t -95.46 119.54 43.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 C-N-CA 119.616 -0.833 . . . . 0.55000000000000004 111.324 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 900' ' ' LEU . . . . . 0.528 HD12 ' HB2' ' B' ' 924' ' ' SER . 4.5 mm? -95.95 111.74 23.66 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 114.401 1.259 . . . . 1.5900000000000001 114.401 -174.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 11.9 m -65.87 141.22 58.33 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 107.466 -1.309 . . . . 0.050000000000000003 107.466 176.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -66.87 -66.16 2.49 Favored Glycine 0 N--CA 1.495 2.585 0 N-CA-C 110.615 -0.994 . . . . 0.029999999999999999 110.615 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 11.7 m170 46.9 67.16 0.83 Allowed 'General case' 0 N--CA 1.507 2.414 0 O-C-N 121.519 -0.989 . . . . 3.2000000000000002 111.082 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 43.1 ptt85 -69.69 -5.97 28.53 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.623 -0.673 . . . . 2.9199999999999999 112.068 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 905' ' ' HIS . . . . . 0.482 ' O ' ' CB ' ' B' ' 906' ' ' GLU . 73.6 t60 -62.2 4.79 0.12 Allowed 'General case' 0 N--CA 1.506 2.369 0 O-C-N 120.904 -1.123 . . . . 2.8700000000000001 113.094 -179.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 906' ' ' GLU . . . . . 0.482 ' CB ' ' O ' ' B' ' 905' ' ' HIS . 0.9 OUTLIER 95.1 -164.63 0.0 OUTLIER 'General case' 0 N--CA 1.529 3.478 0 CA-C-N 120.648 1.567 . . . . 0.98999999999999999 111.8 179.1 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 907' ' ' LYS . . . . . 0.466 ' CB ' ' O ' ' B' ' 906' ' ' GLU . 68.6 tttt 85.9 157.29 0.09 Allowed 'General case' 0 N--CA 1.519 3.002 0 N-CA-C 108.212 -1.033 . . . . 5.25 108.212 -177.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 60.3 t -121.51 116.71 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 120.779 -1.2 . . . . 0.39000000000000001 111.436 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 71.1 tt0 -99.58 133.09 44.41 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 106.996 -1.483 . . . . 1.72 106.996 176.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -155.51 123.35 5.7 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 106.831 -1.544 . . . . 0.67000000000000004 106.831 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 911' ' ' VAL . . . . . 0.843 HG22 HG13 ' B' ' 964' ' ' VAL . 86.5 t -83.84 131.5 33.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 C-N-CA 120.482 -0.487 . . . . 0.54000000000000004 110.668 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 86.1 mt -66.53 156.29 35.32 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.306 -0.871 . . . . 1.5 109.174 178.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 913' ' ' SER . . . . . 0.465 ' OG ' HG11 ' B' ' 919' ' ' VAL . 0.1 OUTLIER -127.92 133.26 49.25 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.617 -1.253 . . . . 1.3700000000000001 107.617 176.56 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 914' ' ' ARG . . . . . 0.575 HH11 HG13 ' B' ' 962' ' ' VAL . 0.0 OUTLIER -64.36 158.33 23.88 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 120.481 -1.387 . . . . 4.2999999999999998 112.167 -178.346 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 915' ' ' SER . . . . . 0.431 ' CB ' ' O ' ' B' ' 914' ' ' ARG . 4.6 t 84.56 -32.38 0.06 Allowed 'General case' 0 N--CA 1.521 3.104 0 C-N-CA 124.191 0.996 . . . . 2.0499999999999998 111.931 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 916' ' ' ASN . . . . . 0.804 ' HB2' HG21 ' B' ' 919' ' ' VAL . 98.7 m-20 -123.49 -21.74 5.21 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.987 -1.07 . . . . 2.71 111.382 -179.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 917' ' ' GLN . . . . . 0.407 ' HB2' ' O ' ' B' ' 916' ' ' ASN . 45.1 mt-30 66.72 165.69 0.21 Allowed 'General case' 0 N--CA 1.52 3.049 0 N-CA-C 105.708 -1.96 . . . . 2.6800000000000002 105.708 -173.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 53.81 -124.15 28.79 Favored Glycine 1 N--CA 1.522 4.407 0 CA-C-N 123.446 2.839 . . . . 0.029999999999999999 106.753 -177.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 919' ' ' VAL . . . . . 0.804 HG21 ' HB2' ' B' ' 916' ' ' ASN . 54.2 t 52.03 94.04 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.193 0 O-C-N 121.359 -1.083 . . . . 1.3899999999999999 108.922 -178.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 920' ' ' ALA . . . . . 0.801 ' HB3' HG12 ' B' ' 949' ' ' VAL . . . -91.85 91.17 7.79 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.416 -0.914 . . . . 0.029999999999999999 110.846 -179.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 921' ' ' ARG . . . . . 0.703 ' HG3' HG23 ' B' ' 922' ' ' VAL . 17.3 ptt180 -86.69 -42.15 13.62 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 106.132 -1.803 . . . . 4.4199999999999999 106.132 176.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 922' ' ' VAL . . . . . 0.703 HG23 ' HG3' ' B' ' 921' ' ' ARG . 77.0 t -104.35 67.09 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 N-CA-C 105.812 -1.922 . . . . 0.84999999999999998 105.812 175.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 923' ' ' ASP . . . . . 0.656 ' HB2' ' HB1' ' B' ' 920' ' ' ALA . 25.7 t0 -86.56 134.34 33.66 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-O 121.673 0.749 . . . . 2.46 111.423 -177.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 924' ' ' SER . . . . . 0.528 ' HB2' HD12 ' B' ' 900' ' ' LEU . 40.0 t -147.8 106.12 3.77 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.696 -0.853 . . . . 0.69999999999999996 108.696 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -101.68 84.69 0.52 Allowed Glycine 0 N--CA 1.486 2.025 0 N-CA-C 108.358 -1.897 . . . . 0.040000000000000001 108.358 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 926' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' B' ' 906' ' ' GLU . . . . . . . . 0 N--CA 1.489 2.191 0 N-CA-C 108.922 -1.671 . . . . 0.040000000000000001 108.922 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 26.2 m . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.029 0.442 . . . . 13.779999999999999 110.273 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 95.6 mt -111.66 130.79 55.65 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.545 -0.722 . . . . 13.76 110.379 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -151.09 167.92 30.68 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.088 -1.605 . . . . 9.1300000000000008 109.088 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 949' ' ' VAL . . . . . 0.801 HG12 ' HB3' ' B' ' 920' ' ' ALA . 31.1 m -118.91 127.21 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.426 -1.044 . . . . 7.0800000000000001 110.899 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 950' ' ' PHE . . . . . 0.463 ' CE1' ' HD2' ' B' ' 955' ' ' PRO . 27.2 p90 -133.81 148.99 51.39 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.593 -0.692 . . . . 7.5899999999999999 109.176 179.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 28.6 m -121.15 -50.97 2.12 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.411 -0.806 . . . . 5.0300000000000002 112.065 -178.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 952' ' ' LEU . . . . . 0.506 HD11 HD23 ' A' ' 895' ' ' LEU . 14.6 tp -59.71 -74.12 0.08 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.458 -0.776 . . . . 1.01 112.712 -177.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 953' ' ' ILE . . . . . 0.476 ' O ' ' HB3' ' B' ' 954' ' ' LEU . 46.4 pt -52.02 -143.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.516 2.851 0 N-CA-C 114.499 1.296 . . . . 2.6000000000000001 114.499 -176.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 954' ' ' LEU . . . . . 0.721 HD22 ' O ' ' B' ' 954' ' ' LEU . 0.0 OUTLIER 173.13 74.76 0.04 OUTLIER Pre-proline 0 N--CA 1.508 2.452 0 O-C-N 120.788 -1.195 . . . . 0.050000000000000003 110.772 179.93 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 955' ' ' PRO . . . . . 0.765 ' C ' HD12 ' B' ' 956' ' ' LEU . 49.6 Cg_endo -77.16 95.53 1.07 Allowed 'Trans proline' 0 C--N 1.316 -1.178 0 O-C-N 122.741 0.864 . . . . 0.83999999999999997 110.163 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 956' ' ' LEU . . . . . 0.765 HD12 ' C ' ' B' ' 955' ' ' PRO . 8.9 mp -125.92 151.08 47.42 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.208 -0.932 . . . . 0.040000000000000001 110.149 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -82.03 150.89 27.35 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 117.822 -1.085 . . . . 1.28 111.325 -179.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -68.36 119.13 12.39 Favored 'General case' 0 N--CA 1.508 2.465 0 CA-C-N 122.946 2.612 . . . . 0.17000000000000001 111.266 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 93.08 -21.85 37.74 Favored Glycine 0 N--CA 1.499 2.889 0 N-CA-C 110.786 -0.926 . . . . 0.040000000000000001 110.786 178.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 960' ' ' ASP . . . . . 0.427 ' HB3' ' CZ ' ' B' ' 914' ' ' ARG . 0.4 OUTLIER -52.98 172.06 0.05 Allowed 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.39 -1.065 . . . . 0.040000000000000001 109.981 -179.747 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 961' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' B' ' 886' ' ' PHE . 40.8 m -133.55 138.91 46.29 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.897 -1.127 . . . . 1.78 112.165 -177.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 962' ' ' VAL . . . . . 0.885 HG22 ' HB3' ' B' ' 886' ' ' PHE . 20.7 m -96.94 143.5 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 C-N-CA 120.007 -0.677 . . . . 0.040000000000000001 109.737 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 5.3 t -140.03 145.21 37.46 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.79 -0.569 . . . . 0.71999999999999997 110.043 -178.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 964' ' ' VAL . . . . . 0.843 HG13 HG22 ' B' ' 911' ' ' VAL . 47.5 t -99.59 136.64 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.138 -0.976 . . . . 1.05 110.802 -179.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 37.5 t0 -94.08 127.95 40.18 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 103.916 -2.624 . . . . 3.02 103.916 173.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 966' ' ' LEU . . . . . 0.491 ' C ' HG23 ' B' ' 967' ' ' VAL . 10.1 tp -131.17 62.15 1.62 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.217 -1.031 . . . . 1.46 108.217 177.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 967' ' ' VAL . . . . . 0.491 HG23 ' C ' ' B' ' 966' ' ' LEU . 95.4 t -158.14 97.12 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 108.113 -1.069 . . . . 1.9399999999999999 108.113 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 88.2 mmm -142.97 59.76 1.42 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.756 -1.215 . . . . 0.0 108.456 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.85 119.83 1.93 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 107.08 -2.408 . . . . 2.1099999999999999 107.08 -178.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -82.13 -58.66 2.86 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.039 -1.271 . . . . 5.8899999999999997 110.427 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 49.0 tp -59.08 90.64 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.437 -0.789 . . . . 4.3600000000000003 110.152 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -141.89 -154.18 0.5 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.556 -0.715 . . . . 1.8300000000000001 110.179 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -119.55 171.98 7.98 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.486 -0.759 . . . . 4.3499999999999996 110.306 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 39.2 t -101.7 130.39 48.07 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.541 -0.725 . . . . 1.27 110.065 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -156.1 158.69 38.16 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.513 -0.742 . . . . 5.0199999999999996 110.588 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.13 85.7 18.52 Favored Pre-proline 0 N--CA 1.499 2.012 0 O-C-N 121.624 -0.673 . . . . 2.4100000000000001 109.747 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 977' ' ' PRO . . . . . 0.538 ' C ' HD12 ' B' ' 978' ' ' LEU . 48.2 Cg_endo -73.42 -172.43 1.04 Allowed 'Trans proline' 0 C--N 1.318 -1.065 0 O-C-N 123.324 1.171 . . . . 0.95999999999999996 111.44 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 978' ' ' LEU . . . . . 0.785 HD23 HD12 ' B' ' 856' ' ' LEU . 5.6 mp -127.34 155.52 43.44 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.707 -1.22 . . . . 0.62 107.707 177.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 979' ' ' THR . . . . . 0.466 HG23 ' C ' ' B' ' 978' ' ' LEU . 42.3 p -150.0 141.01 22.93 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.782 -1.199 . . . . 3.5699999999999998 111.239 -179.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 980' ' ' ILE . . . . . 0.738 ' HB ' HG21 ' B' ' 899' ' ' VAL . 46.9 mm -107.76 128.33 63.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 108.885 -0.783 . . . . 1.3300000000000001 108.885 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -120.59 97.49 5.59 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 119.71 -0.796 . . . . 0.050000000000000003 111.982 -178.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 82.9 p -109.0 158.6 17.56 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.611 -0.681 . . . . 0.87 109.28 178.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 983' ' ' GLY . . . . . 0.411 ' HA3' ' CE1' ' B' ' 852' ' ' PHE . . . -175.11 109.14 0.28 Allowed Glycine 0 N--CA 1.499 2.86 0 N-CA-C 106.513 -2.635 . . . . 0.029999999999999999 106.513 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -108.7 152.19 25.16 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 114.526 1.306 . . . . 0.69999999999999996 114.526 -175.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 985' ' ' LEU . . . . . 0.835 HD13 HD22 ' B' ' 890' ' ' LEU . 45.4 tp -72.1 134.5 45.83 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.872 -1.143 . . . . 0.040000000000000001 110.055 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 986' ' ' LEU . . . . . 0.687 ' CD1' HD11 ' C' ' 986' ' ' LEU . 51.7 tp -107.52 -55.89 2.29 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.58 -0.7 . . . . 0.040000000000000001 109.917 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -144.82 145.08 31.47 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 107.623 -1.251 . . . . 0.040000000000000001 107.623 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.54 162.95 12.22 Favored Glycine 0 N--CA 1.495 2.574 0 N-CA-C 108.147 -1.981 . . . . 0.040000000000000001 108.147 179.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -75.66 112.16 18.12 Favored Pre-proline 0 N--CA 1.499 1.988 0 O-C-N 121.236 -1.155 . . . . 0.040000000000000001 109.406 179.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 990' ' ' PRO . . . . . 0.526 ' HD2' HD12 ' B' ' 992' ' ' LEU . 49.8 Cg_endo -91.38 71.31 0.97 Allowed 'Trans proline' 0 C--N 1.319 -0.982 0 O-C-N 123.108 1.057 . . . . 0.45000000000000001 111.411 -178.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 991' ' ' GLU . . . . . 0.421 ' HB2' ' O ' ' B' ' 990' ' ' PRO . 70.5 mt-10 67.21 -73.75 0.08 Allowed 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 108.493 -0.928 . . . . 1.97 108.493 -177.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 992' ' ' LEU . . . . . 0.526 HD12 ' HD2' ' B' ' 990' ' ' PRO . 6.7 mt 51.22 20.29 0.88 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.575 -0.703 . . . . 2.3799999999999999 111.634 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 81.4 mt-10 -94.33 156.77 16.35 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.862 -1.149 . . . . 3.79 109.96 179.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -146.64 93.22 2.26 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.547 -0.721 . . . . 3.5099999999999998 110.403 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 995' ' ' ALA . . . . . . . . . . . . 2.519 . . . . . . . 0 N--CA 1.503 2.209 0 O-C-N 120.897 -1.127 . . . . 2.73 110.624 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo . . . . . 0 N--CA 1.488 1.178 0 N-CA-C 109.5 -1.0 . . . . 3.8300000000000001 109.5 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' C' C ' 847' ' ' VAL . . . . . 0.473 HG12 ' HB2' ' C' ' 849' ' ' GLN . 57.3 t -127.6 103.75 21.9 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.609 -0.682 . . . . 1.8300000000000001 110.121 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 848' ' ' PRO . . . . . 0.786 ' O ' HG23 ' C' ' 850' ' ' VAL . 43.4 Cg_endo -69.36 -23.03 33.05 Favored 'Trans proline' 0 N--CA 1.488 1.151 0 O-C-N 123.218 1.115 . . . . 0.65000000000000002 110.911 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 849' ' ' GLN . . . . . 0.473 ' HB2' HG12 ' C' ' 847' ' ' VAL . 55.2 tt0 26.59 68.63 0.06 Allowed 'General case' 0 N--CA 1.519 2.982 0 N-CA-C 112.972 0.73 . . . . 2.5800000000000001 112.972 179.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 850' ' ' VAL . . . . . 0.786 HG23 ' O ' ' C' ' 848' ' ' PRO . 93.4 t -119.58 134.35 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 O-C-N 121.158 -0.964 . . . . 1.0900000000000001 111.245 -179.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 851' ' ' ALA . . . . . 0.417 ' HB3' ' HG ' ' C' ' 873' ' ' LEU . . . -131.56 155.74 46.96 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 106.105 -1.813 . . . . 0.040000000000000001 106.105 176.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 852' ' ' PHE . . . . . 0.51 ' CD1' ' CE1' ' C' ' 879' ' ' TYR . 0.3 OUTLIER -154.36 134.68 13.32 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 120.829 1.65 . . . . 0.050000000000000003 107.931 179.083 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 5.0 t -173.8 130.54 0.42 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.513 -0.921 . . . . 0.040000000000000001 108.513 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -136.39 150.95 49.04 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.256 -0.902 . . . . 0.67000000000000004 108.863 179.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 855' ' ' ALA . . . . . 0.658 ' HB3' ' CB ' ' C' ' 870' ' ' ARG . . . -122.77 139.33 54.11 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 121.813 0.816 . . . . 0.51000000000000001 111.527 -179.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 856' ' ' LEU . . . . . 0.778 HD23 ' O ' ' C' ' 867' ' ' PRO . 3.4 tm? -104.87 138.88 40.44 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.781 -0.575 . . . . 0.050000000000000003 109.558 179.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 857' ' ' SER . . . . . 0.623 ' N ' HD13 ' C' ' 856' ' ' LEU . 1.9 m -155.28 17.49 0.41 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.622 -0.674 . . . . 1.3300000000000001 111.465 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 858' ' ' LEU . . . . . 0.705 HD22 ' HG3' ' C' ' 862' ' ' GLU . 3.6 pp -34.55 158.06 0.04 OUTLIER Pre-proline 0 N--CA 1.52 3.047 0 CA-C-N 118.752 0.705 . . . . 2.3300000000000001 112.756 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -60.14 -89.88 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.431 0 O-C-N 123.089 1.047 . . . . 2.3199999999999998 113.828 -177.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 55.4 ptt85 -126.56 -141.92 0.28 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.853 -1.155 . . . . 0.040000000000000001 111.41 -177.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 73.7 m -36.31 120.33 0.65 Allowed 'General case' 0 N--CA 1.511 2.605 0 O-C-N 121.622 -0.674 . . . . 1.3100000000000001 112.26 -179.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 862' ' ' GLU . . . . . 0.705 ' HG3' HD22 ' C' ' 858' ' ' LEU . 0.0 OUTLIER -99.11 158.14 32.82 Favored Pre-proline 0 N--CA 1.488 1.458 0 N-CA-C 108.53 -0.915 . . . . 4.5099999999999998 108.53 178.069 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -70.92 -15.52 32.73 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 O-C-N 123.225 1.118 . . . . 2.2400000000000002 111.036 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -177.3 -134.77 2.07 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.537 -1.425 . . . . 0.040000000000000001 109.537 179.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 30.2 m -69.31 155.25 40.73 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.34 -1.094 . . . . 1.51 110.786 -179.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 866' ' ' VAL . . . . . 0.516 HG12 ' CD2' ' C' ' 858' ' ' LEU . 33.7 m -89.83 138.29 27.96 Favored Pre-proline 0 N--CA 1.496 1.837 0 N-CA-C 113.423 0.897 . . . . 0.78000000000000003 113.423 -175.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 867' ' ' PRO . . . . . 0.778 ' O ' HD23 ' C' ' 856' ' ' LEU . 54.9 Cg_endo -88.62 -153.11 0.04 OUTLIER 'Trans proline' 0 C--N 1.324 -0.716 0 N-CA-C 108.128 -1.528 . . . . 0.92000000000000004 108.128 177.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 868' ' ' PHE . . . . . 0.48 ' CD1' ' HG2' ' C' ' 881' ' ' PRO . 20.4 p90 -148.47 120.18 8.07 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.54 -1.35 . . . . 0.050000000000000003 110.12 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 50.2 p-10 -112.63 -2.13 14.63 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 119.353 -0.939 . . . . 1.7 111.762 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 870' ' ' ARG . . . . . 0.658 ' CB ' ' HB3' ' C' ' 855' ' ' ALA . 24.2 mmm180 -91.5 87.36 6.36 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.013 -1.054 . . . . 2.5899999999999999 111.057 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 61.9 t -74.77 97.2 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 O-C-N 121.0 -1.062 . . . . 1.9399999999999999 109.493 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 872' ' ' LEU . . . . . 0.582 HD13 HD11 ' A' ' 953' ' ' ILE . 52.2 mt -88.64 -44.37 10.66 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.497 -0.752 . . . . 1.0600000000000001 111.151 -179.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 873' ' ' LEU . . . . . 0.449 ' O ' ' HB2' ' C' ' 874' ' ' ASN . 43.9 tp -171.44 102.62 0.2 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.134 -0.979 . . . . 4.1799999999999997 109.087 179.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 874' ' ' ASN . . . . . 0.449 ' HB2' ' O ' ' C' ' 873' ' ' LEU . 36.6 t-20 175.08 83.93 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.333 0 N-CA-C 108.694 -0.854 . . . . 0.040000000000000001 108.694 -178.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 30.1 p-10 -66.46 -48.19 70.71 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.059 -1.026 . . . . 3.3799999999999999 111.966 -178.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 876' ' ' GLY . . . . . 0.423 ' HA3' ' CE2' ' C' ' 878' ' ' TYR . . . -74.45 -24.91 71.72 Favored Glycine 0 N--CA 1.495 2.603 0 O-C-N 121.14 -0.975 . . . . 0.040000000000000001 111.569 -178.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 80.54 -64.86 3.98 Favored Glycine 0 N--CA 1.498 2.789 0 N-CA-C 107.624 -2.191 . . . . 0.040000000000000001 107.624 -178.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 878' ' ' TYR . . . . . 0.423 ' CE2' ' HA3' ' C' ' 876' ' ' GLY . 82.6 m-85 61.01 -56.18 0.09 Allowed 'General case' 0 N--CA 1.507 2.416 0 N-CA-C 114.556 1.317 . . . . 3.46 114.556 177.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 879' ' ' TYR . . . . . 0.51 ' CE1' ' CD1' ' C' ' 852' ' ' PHE . 1.7 p90 -111.53 108.91 18.59 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 114.791 1.404 . . . . 0.040000000000000001 114.791 -176.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -71.68 113.69 22.08 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.262 -0.898 . . . . 0.02 109.529 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 881' ' ' PRO . . . . . 0.48 ' HG2' ' CD1' ' C' ' 868' ' ' PHE . 54.3 Cg_endo -77.03 0.1 10.04 Favored 'Trans proline' 0 N--CA 1.492 1.39 0 O-C-N 123.351 1.184 . . . . 0.39000000000000001 112.011 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 87.8 mt-10 -75.43 -64.55 1.04 Allowed 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 106.682 -1.599 . . . . 0.81000000000000005 106.682 178.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 883' ' ' THR . . . . . . . . . . . . . 24.5 p -90.55 -19.36 23.86 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.22 -1.03 . . . . 0.040000000000000001 108.22 176.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.1 19.58 60.71 Favored Glycine 0 N--CA 1.496 2.675 0 O-C-N 121.165 -0.959 . . . . 0.029999999999999999 111.22 178.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 885' ' ' VAL . . . . . 0.461 HG13 HG21 ' C' ' 961' ' ' THR . 89.3 t -73.93 89.79 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 C-N-CA 118.003 -1.479 . . . . 1.01 108.183 -179.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 886' ' ' PHE . . . . . 0.937 ' HB3' HG22 ' C' ' 962' ' ' VAL . 1.3 t80 -88.66 106.9 18.63 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 115.485 -0.78 . . . . 0.050000000000000003 111.385 -178.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 887' ' ' THR . . . . . 0.42 ' O ' ' HD3' ' C' ' 889' ' ' PRO . 93.7 m -96.07 101.43 13.09 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.921 -1.14 . . . . 0.68000000000000005 107.921 177.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 888' ' ' ALA . . . . . . . . . . . . . . . -99.05 106.88 40.97 Favored Pre-proline 0 N--CA 1.502 2.142 0 N-CA-C 113.964 1.098 . . . . 0.25 113.964 -176.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 889' ' ' PRO . . . . . 0.42 ' HD3' ' O ' ' C' ' 887' ' ' THR . 53.8 Cg_endo -90.33 -12.24 2.72 Favored 'Trans proline' 0 CA--C 1.547 1.17 0 C-N-CA 121.073 1.182 . . . . 1.6399999999999999 109.252 176.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 890' ' ' LEU . . . . . 0.841 HD22 HD13 ' C' ' 985' ' ' LEU . 72.3 mt -38.01 -50.61 1.34 Allowed 'General case' 0 N--CA 1.507 2.415 0 N-CA-C 113.778 1.029 . . . . 2.29 113.778 -177.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 52.19 97.52 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.379 0 O-C-N 121.152 -0.968 . . . . 0.63 110.386 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . 156.11 -146.52 14.18 Favored Glycine 0 N--CA 1.482 1.703 0 N-CA-C 107.445 -2.262 . . . . 0.040000000000000001 107.445 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 73.3 ttt-85 -106.46 128.79 54.34 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.311 -1.366 . . . . 3.0 107.311 177.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 894' ' ' TYR . . . . . 0.417 ' CD1' ' N ' ' C' ' 895' ' ' LEU . 0.4 OUTLIER -130.68 144.29 51.33 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.007 -1.058 . . . . 0.040000000000000001 110.661 -178.499 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 895' ' ' LEU . . . . . 0.417 ' N ' ' CD1' ' C' ' 894' ' ' TYR . 45.2 tp -101.07 117.83 35.8 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.64 -0.662 . . . . 1.27 109.723 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 896' ' ' LEU . . . . . 0.5 HD23 ' C ' ' C' ' 896' ' ' LEU . 10.4 tt -116.4 145.46 43.23 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.531 -0.731 . . . . 0.93999999999999995 110.783 -179.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 897' ' ' SER . . . . . 0.494 ' N ' HD23 ' C' ' 896' ' ' LEU . 69.1 m -145.18 119.23 9.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.448 -0.783 . . . . 0.040000000000000001 110.824 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -107.22 147.93 29.55 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.219 -0.66 . . . . 0.47999999999999998 109.219 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 899' ' ' VAL . . . . . 0.739 HG21 ' HB ' ' C' ' 980' ' ' ILE . 89.4 t -91.12 120.53 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.446 -0.784 . . . . 0.55000000000000004 110.925 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 900' ' ' LEU . . . . . 0.438 HD22 ' HB2' ' C' ' 924' ' ' SER . 93.1 mt -94.23 110.35 22.09 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 114.261 1.208 . . . . 1.5900000000000001 114.261 -175.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 18.9 m -64.92 139.71 58.79 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 107.414 -1.328 . . . . 0.050000000000000003 107.414 177.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -62.28 -65.77 2.99 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 110.417 -1.073 . . . . 0.029999999999999999 110.417 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 4.0 m170 46.08 64.61 1.42 Allowed 'General case' 0 N--CA 1.507 2.388 0 O-C-N 121.498 -1.001 . . . . 3.2000000000000002 111.262 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 42.8 ptt85 -68.39 -7.74 34.13 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.579 -0.701 . . . . 2.9199999999999999 111.857 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 905' ' ' HIS . . . . . 0.491 ' O ' ' CB ' ' C' ' 906' ' ' GLU . 72.3 t60 -61.29 6.86 0.05 OUTLIER 'General case' 0 N--CA 1.508 2.442 0 CA-C-O 117.659 -1.162 . . . . 2.8700000000000001 113.798 -179.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 906' ' ' GLU . . . . . 0.491 ' CB ' ' O ' ' C' ' 905' ' ' HIS . 0.5 OUTLIER 93.22 -165.15 0.0 OUTLIER 'General case' 0 N--CA 1.529 3.487 0 CA-C-N 121.21 1.823 . . . . 0.98999999999999999 111.955 179.117 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 907' ' ' LYS . . . . . 0.485 ' CB ' ' O ' ' C' ' 906' ' ' GLU . 38.2 tttp 88.13 159.62 0.07 Allowed 'General case' 0 N--CA 1.52 3.062 0 N-CA-C 108.149 -1.056 . . . . 5.25 108.149 -176.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 60.8 t -123.43 116.2 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 120.826 -1.171 . . . . 0.39000000000000001 111.003 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 909' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -104.34 132.18 50.87 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 107.711 -1.218 . . . . 1.72 107.711 177.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -155.82 122.44 5.24 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 106.838 -1.542 . . . . 0.67000000000000004 106.838 178.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 911' ' ' VAL . . . . . 0.86 HG22 HG13 ' C' ' 964' ' ' VAL . 96.8 t -82.05 131.6 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 O-C-N 121.831 -0.543 . . . . 0.54000000000000004 111.133 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 57.2 mt -68.2 156.15 38.16 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.348 -0.845 . . . . 1.5 109.12 178.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 913' ' ' SER . . . . . 0.488 ' OG ' HG11 ' C' ' 919' ' ' VAL . 1.2 p -125.19 136.92 54.06 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 108.428 -0.952 . . . . 1.3700000000000001 108.428 176.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 914' ' ' ARG . . . . . 0.745 ' NH1' HD13 ' C' ' 956' ' ' LEU . 0.1 OUTLIER -63.69 154.93 31.55 Favored 'General case' 0 N--CA 1.505 2.285 0 O-C-N 120.664 -1.272 . . . . 4.2999999999999998 111.482 -179.309 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 915' ' ' SER . . . . . 0.423 ' CB ' ' O ' ' C' ' 914' ' ' ARG . 4.6 t 83.73 -31.48 0.08 Allowed 'General case' 0 N--CA 1.522 3.13 0 C-N-CA 124.054 0.942 . . . . 2.0499999999999998 112.087 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 916' ' ' ASN . . . . . 0.788 ' HB2' HG21 ' C' ' 919' ' ' VAL . 93.8 m-20 -122.39 -21.66 5.73 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 120.883 -1.136 . . . . 2.71 111.286 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 917' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 67.18 165.65 0.22 Allowed 'General case' 0 N--CA 1.52 3.032 0 N-CA-C 105.664 -1.976 . . . . 2.6800000000000002 105.664 -174.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 55.13 -126.04 37.66 Favored Glycine 1 N--CA 1.52 4.287 0 CA-C-N 123.675 2.943 . . . . 0.029999999999999999 106.962 -177.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 919' ' ' VAL . . . . . 0.788 HG21 ' HB2' ' C' ' 916' ' ' ASN . 91.1 t 50.59 94.01 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 121.447 -1.031 . . . . 1.3899999999999999 109.386 -178.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 920' ' ' ALA . . . . . 0.985 ' HB3' HG12 ' C' ' 949' ' ' VAL . . . -93.31 93.53 8.25 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.29 -0.964 . . . . 0.029999999999999999 110.565 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 921' ' ' ARG . . . . . 0.667 ' HG3' HG23 ' C' ' 922' ' ' VAL . 34.7 ptt85 -80.13 -42.3 23.78 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 105.884 -1.895 . . . . 4.4199999999999999 105.884 176.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 922' ' ' VAL . . . . . 0.667 HG23 ' HG3' ' C' ' 921' ' ' ARG . 78.2 t -101.18 77.06 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 N-CA-C 105.602 -1.999 . . . . 0.84999999999999998 105.602 175.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -87.81 135.03 33.56 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.801 0.81 . . . . 2.46 112.016 -176.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 924' ' ' SER . . . . . 0.438 ' HB2' HD22 ' C' ' 900' ' ' LEU . 4.9 t -146.54 102.63 3.59 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.297 -1.001 . . . . 0.69999999999999996 108.297 178.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -109.49 88.35 0.51 Allowed Glycine 0 N--CA 1.486 2.026 0 N-CA-C 108.494 -1.842 . . . . 0.040000000000000001 108.494 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.353 0 N-CA-C 109.315 -1.514 . . . . 0.040000000000000001 109.315 -179.448 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 8.3 m . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 120.995 0.426 . . . . 13.779999999999999 110.378 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 95.2 mt -114.03 129.51 56.6 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.465 -0.772 . . . . 13.76 110.367 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -152.35 170.46 31.6 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.514 -1.434 . . . . 9.1300000000000008 109.514 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 949' ' ' VAL . . . . . 0.985 HG12 ' HB3' ' C' ' 920' ' ' ALA . 35.1 m -117.74 136.91 53.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.529 -0.983 . . . . 7.0800000000000001 110.904 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 950' ' ' PHE . . . . . 0.453 ' CZ ' ' HB3' ' C' ' 921' ' ' ARG . 44.8 p90 -135.3 152.88 51.91 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.571 -0.706 . . . . 7.5899999999999999 109.525 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 5.6 m -118.23 -54.77 2.28 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.465 -0.772 . . . . 5.0300000000000002 111.65 -179.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 952' ' ' LEU . . . . . 0.447 ' O ' ' O ' ' C' ' 953' ' ' ILE . 58.1 tp -65.71 -78.29 0.05 Allowed 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.439 -0.788 . . . . 1.01 111.375 -178.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 953' ' ' ILE . . . . . 0.646 HD12 ' N ' ' C' ' 954' ' ' LEU . 2.9 pp -50.28 -150.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.688 0 N-CA-C 114.312 1.227 . . . . 2.6000000000000001 114.312 -176.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 954' ' ' LEU . . . . . 0.718 HD22 ' O ' ' C' ' 954' ' ' LEU . 0.0 OUTLIER 169.19 90.98 0.03 OUTLIER Pre-proline 0 N--CA 1.519 2.992 0 O-C-N 120.879 -1.138 . . . . 0.050000000000000003 112.03 179.902 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 955' ' ' PRO . . . . . 0.452 ' HD3' ' CD1' ' C' ' 953' ' ' ILE . 52.7 Cg_endo -79.55 93.25 1.08 Allowed 'Trans proline' 0 C--N 1.317 -1.103 0 N-CA-C 108.819 -1.262 . . . . 0.83999999999999997 108.819 178.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 956' ' ' LEU . . . . . 0.745 HD13 ' NH1' ' C' ' 914' ' ' ARG . 79.7 mt -126.79 148.22 49.95 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.094 -1.004 . . . . 0.040000000000000001 110.524 -179.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 957' ' ' GLN . . . . . 0.436 ' HB2' ' HB2' ' C' ' 960' ' ' ASP . 90.7 mt-30 -84.04 153.26 23.92 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 117.904 -1.046 . . . . 1.28 111.515 -179.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -68.66 120.81 15.25 Favored 'General case' 0 N--CA 1.509 2.509 0 CA-C-N 122.757 2.526 . . . . 0.17000000000000001 111.879 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 93.16 -20.76 44.02 Favored Glycine 0 N--CA 1.502 3.074 0 N-CA-C 111.193 -0.763 . . . . 0.040000000000000001 111.193 178.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 960' ' ' ASP . . . . . 0.436 ' HB2' ' HB2' ' C' ' 957' ' ' GLN . 0.8 OUTLIER -51.28 172.42 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.482 -1.01 . . . . 0.040000000000000001 110.751 -179.115 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 961' ' ' THR . . . . . 0.461 HG21 HG13 ' C' ' 885' ' ' VAL . 50.0 m -133.09 137.45 46.35 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.002 -1.061 . . . . 1.78 111.887 -178.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 962' ' ' VAL . . . . . 0.937 HG22 ' HB3' ' C' ' 886' ' ' PHE . 24.9 m -99.47 144.1 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 C-N-CA 119.985 -0.686 . . . . 0.040000000000000001 110.11 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 5.4 t -140.54 143.8 35.57 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.864 -0.522 . . . . 0.71999999999999997 110.148 -178.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 964' ' ' VAL . . . . . 0.86 HG13 HG22 ' C' ' 911' ' ' VAL . 56.9 t -93.8 136.87 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.191 -0.943 . . . . 1.05 110.93 -178.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -95.72 127.01 41.38 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 103.716 -2.698 . . . . 3.02 103.716 173.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 966' ' ' LEU . . . . . 0.49 ' C ' HG23 ' C' ' 967' ' ' VAL . 11.2 tp -132.81 62.83 1.65 Allowed 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.367 -0.975 . . . . 1.46 108.367 177.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 967' ' ' VAL . . . . . 0.49 HG23 ' C ' ' C' ' 966' ' ' LEU . 99.5 t -157.53 97.02 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 108.239 -1.022 . . . . 1.9399999999999999 108.239 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 92.8 mmm -142.29 60.01 1.45 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.793 -1.192 . . . . 0.0 108.358 179.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.46 119.51 1.92 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 107.192 -2.363 . . . . 2.1099999999999999 107.192 -178.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 94.7 mm-40 -82.36 -57.54 3.32 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.051 -1.264 . . . . 5.8899999999999997 110.761 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 47.4 tp -58.75 89.84 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.443 -0.786 . . . . 4.3600000000000003 110.358 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -142.41 -152.58 0.42 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.557 -0.714 . . . . 1.8300000000000001 110.118 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -120.31 170.01 9.75 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.425 -0.797 . . . . 4.3499999999999996 110.261 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 29.3 t -101.46 130.36 47.69 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.52 -0.738 . . . . 1.27 110.051 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -155.63 158.87 39.05 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.53 -0.731 . . . . 5.0199999999999996 110.524 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.35 86.51 16.73 Favored Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 121.603 -0.686 . . . . 2.4100000000000001 109.862 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -74.72 -171.65 1.01 Allowed 'Trans proline' 0 C--N 1.317 -1.081 0 O-C-N 123.311 1.164 . . . . 0.95999999999999996 111.19 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 978' ' ' LEU . . . . . 0.539 ' N ' HD12 ' C' ' 978' ' ' LEU . 5.2 mp -126.25 155.58 41.66 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 107.577 -1.268 . . . . 0.62 107.577 177.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 979' ' ' THR . . . . . 0.458 HG23 ' C ' ' C' ' 978' ' ' LEU . 39.9 p -150.66 141.08 22.43 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.791 -1.193 . . . . 3.5699999999999998 111.216 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 980' ' ' ILE . . . . . 0.739 ' HB ' HG21 ' C' ' 899' ' ' VAL . 50.4 mm -107.12 129.07 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 N-CA-C 108.991 -0.744 . . . . 1.3300000000000001 108.991 179.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 981' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -118.67 95.76 4.98 Favored 'General case' 0 N--CA 1.497 1.925 0 C-N-CA 119.452 -0.899 . . . . 0.050000000000000003 111.727 -178.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 982' ' ' SER . . . . . 0.407 ' HB2' HD23 ' A' ' 952' ' ' LEU . 12.1 p -109.55 158.68 17.77 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.606 -0.684 . . . . 0.87 109.712 178.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 983' ' ' GLY . . . . . 0.437 ' HA3' ' CZ ' ' C' ' 852' ' ' PHE . . . -172.99 114.71 0.53 Allowed Glycine 0 N--CA 1.498 2.798 0 N-CA-C 106.453 -2.659 . . . . 0.029999999999999999 106.453 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 984' ' ' ALA . . . . . . . . . . . . . . . -106.49 152.45 23.63 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 114.493 1.294 . . . . 0.69999999999999996 114.493 -175.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 985' ' ' LEU . . . . . 0.841 HD13 HD22 ' C' ' 890' ' ' LEU . 62.3 tp -75.58 135.65 40.53 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.932 -1.105 . . . . 0.040000000000000001 109.787 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 986' ' ' LEU . . . . . 0.687 HD11 ' CD1' ' B' ' 986' ' ' LEU . 36.1 tp -106.75 -61.17 1.57 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.576 -0.702 . . . . 0.040000000000000001 110.098 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -143.81 146.74 33.3 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 107.647 -1.242 . . . . 0.040000000000000001 107.647 179.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -111.65 162.74 12.34 Favored Glycine 0 N--CA 1.495 2.597 0 N-CA-C 108.179 -1.968 . . . . 0.040000000000000001 108.179 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.01 112.58 18.6 Favored Pre-proline 0 N--CA 1.499 1.982 0 O-C-N 121.243 -1.151 . . . . 0.040000000000000001 109.412 179.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 990' ' ' PRO . . . . . 0.418 ' O ' ' HB2' ' C' ' 991' ' ' GLU . 49.4 Cg_endo -90.22 70.84 1.55 Allowed 'Trans proline' 0 C--N 1.319 -1.018 0 O-C-N 123.152 1.08 . . . . 0.45000000000000001 111.365 -178.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 991' ' ' GLU . . . . . 0.418 ' HB2' ' O ' ' C' ' 990' ' ' PRO . 69.6 mt-10 67.65 -73.27 0.08 Allowed 'General case' 0 N--CA 1.503 2.177 0 N-CA-C 108.603 -0.888 . . . . 1.97 108.603 -177.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 992' ' ' LEU . . . . . . . . . . . . . 11.3 mt 50.56 20.62 0.74 Allowed 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.544 -0.722 . . . . 2.3799999999999999 111.705 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -93.9 156.76 16.46 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.893 -1.13 . . . . 3.79 109.998 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 69.7 m80 -145.75 92.8 2.26 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.567 -0.708 . . . . 3.5099999999999998 110.308 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 995' ' ' ALA . . . . . . . . . . . . 2.518 . . . . . . . 0 N--CA 1.503 2.206 0 O-C-N 120.936 -1.103 . . . . 2.73 110.631 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 846' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo . . . . . 0 N--CA 1.488 1.203 0 N-CA-C 109.53 -0.989 . . . . 3.8300000000000001 109.53 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 847' ' ' VAL . . . . . 0.442 HG12 ' HB2' ' A' ' 849' ' ' GLN . 60.2 t -132.17 103.36 14.06 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.555 -0.716 . . . . 1.8300000000000001 110.188 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 848' ' ' PRO . . . . . 0.74 ' O ' HG23 ' A' ' 850' ' ' VAL . 43.7 Cg_endo -69.84 -20.32 34.61 Favored 'Trans proline' 0 N--CA 1.487 1.145 0 O-C-N 123.28 1.147 . . . . 0.65000000000000002 110.955 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 849' ' ' GLN . . . . . 0.442 ' HB2' HG12 ' A' ' 847' ' ' VAL . 57.0 tt0 27.73 68.79 0.07 Allowed 'General case' 0 N--CA 1.518 2.97 0 N-CA-C 112.821 0.675 . . . . 2.5800000000000001 112.821 179.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 850' ' ' VAL . . . . . 0.74 HG23 ' O ' ' A' ' 848' ' ' PRO . 57.6 t -119.93 136.06 58.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.135 -0.978 . . . . 1.0900000000000001 111.65 -178.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 851' ' ' ALA . . . . . 0.584 ' HB3' ' HG ' ' A' ' 873' ' ' LEU . . . -126.14 157.33 38.37 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 105.749 -1.945 . . . . 0.040000000000000001 105.749 176.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 852' ' ' PHE . . . . . 0.432 ' HA ' ' CB ' ' A' ' 874' ' ' ASN . 22.7 p90 -160.84 127.32 4.04 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 121.009 1.731 . . . . 0.050000000000000003 108.437 179.066 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 853' ' ' SER . . . . . . . . . . . . . 5.8 t -176.1 134.7 0.26 Allowed 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.35 -0.981 . . . . 0.040000000000000001 108.35 -178.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 854' ' ' ALA . . . . . . . . . . . . . . . -132.21 155.66 47.85 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.035 -1.04 . . . . 0.67000000000000004 109.541 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 855' ' ' ALA . . . . . 0.809 ' HB3' ' CB ' ' A' ' 870' ' ' ARG . . . -121.67 143.91 49.07 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.855 0.836 . . . . 0.51000000000000001 111.258 -179.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 856' ' ' LEU . . . . . 0.594 ' C ' HD13 ' A' ' 856' ' ' LEU . 3.4 tm? -113.13 134.73 54.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.688 -0.633 . . . . 0.050000000000000003 110.283 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 857' ' ' SER . . . . . 0.55 ' N ' HD13 ' A' ' 856' ' ' LEU . 60.8 p -151.94 17.74 0.68 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.565 -0.71 . . . . 1.3300000000000001 110.59 178.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 858' ' ' LEU . . . . . 0.761 HD22 ' OE1' ' A' ' 862' ' ' GLU . 4.4 pp -33.27 157.11 0.04 OUTLIER Pre-proline 0 N--CA 1.518 2.942 0 N-CA-C 113.159 0.8 . . . . 2.3300000000000001 113.159 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 859' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -63.2 -88.3 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.376 0 O-C-N 123.107 1.056 . . . . 2.3199999999999998 113.162 -178.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 860' ' ' ARG . . . . . . . . . . . . . 55.2 ptt85 -128.68 -143.36 0.27 Allowed 'General case' 0 N--CA 1.498 1.974 0 O-C-N 120.888 -1.132 . . . . 0.040000000000000001 111.647 -177.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 861' ' ' SER . . . . . . . . . . . . . 14.0 m -40.18 126.78 2.2 Favored 'General case' 0 N--CA 1.508 2.457 0 O-C-N 121.527 -0.733 . . . . 1.3100000000000001 112.453 -178.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 862' ' ' GLU . . . . . 0.761 ' OE1' HD22 ' A' ' 858' ' ' LEU . 0.7 OUTLIER -101.95 157.6 33.37 Favored Pre-proline 0 N--CA 1.489 1.498 0 N-CA-C 107.683 -1.229 . . . . 4.5099999999999998 107.683 176.967 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 863' ' ' PRO . . . . . 0.425 ' HD2' ' CG ' ' A' ' 862' ' ' GLU . 44.2 Cg_endo -71.55 -12.25 29.09 Favored 'Trans proline' 0 C--N 1.313 -1.293 0 O-C-N 123.029 1.015 . . . . 2.2400000000000002 111.472 -179.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 864' ' ' GLY . . . . . . . . . . . . . . . -176.02 -136.59 2.38 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 110.143 -1.183 . . . . 0.040000000000000001 110.143 179.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 865' ' ' THR . . . . . . . . . . . . . 25.7 m -65.48 155.85 34.3 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.317 -1.108 . . . . 1.51 110.935 -178.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 866' ' ' VAL . . . . . 0.567 HG11 ' HG ' ' A' ' 856' ' ' LEU . 60.1 t -92.14 135.29 27.24 Favored Pre-proline 0 N--CA 1.495 1.788 0 N-CA-C 113.273 0.842 . . . . 0.78000000000000003 113.273 -174.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 867' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 866' ' ' VAL . 54.9 Cg_endo -90.61 -153.01 0.04 OUTLIER 'Trans proline' 0 CA--C 1.54 0.805 0 N-CA-C 108.658 -1.324 . . . . 0.92000000000000004 108.658 177.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 868' ' ' PHE . . . . . 0.456 ' CD1' ' HG2' ' A' ' 881' ' ' PRO . 27.0 p90 -150.66 122.65 8.2 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.567 -1.333 . . . . 0.050000000000000003 109.632 179.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 869' ' ' ASP . . . . . . . . . . . . . 49.7 p-10 -114.1 -1.93 13.58 Favored 'General case' 0 N--CA 1.5 2.035 0 C-N-CA 119.299 -0.961 . . . . 1.7 112.549 -178.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 870' ' ' ARG . . . . . 0.809 ' CB ' ' HB3' ' A' ' 855' ' ' ALA . 29.1 mmm180 -90.85 88.15 6.94 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.869 -1.144 . . . . 2.5899999999999999 110.83 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 871' ' ' VAL . . . . . . . . . . . . . 57.5 t -72.94 97.35 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 120.929 -1.107 . . . . 1.9399999999999999 109.858 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 872' ' ' LEU . . . . . 0.617 HD11 ' HB2' ' A' ' 855' ' ' ALA . 96.1 mt -83.15 -47.47 11.57 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.524 -0.735 . . . . 1.0600000000000001 110.109 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 873' ' ' LEU . . . . . 0.584 ' HG ' ' HB3' ' A' ' 851' ' ' ALA . 30.4 tp -174.65 103.96 0.1 Allowed 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 108.594 -0.891 . . . . 4.1799999999999997 108.594 178.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 874' ' ' ASN . . . . . 0.432 ' CB ' ' HA ' ' A' ' 852' ' ' PHE . 37.6 t-20 178.59 81.79 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.309 0 O-C-N 121.64 -0.663 . . . . 0.040000000000000001 109.648 -178.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 875' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -66.2 -47.05 75.16 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.062 -1.024 . . . . 3.3799999999999999 111.019 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 876' ' ' GLY . . . . . . . . . . . . . . . -74.57 -25.33 70.38 Favored Glycine 0 N--CA 1.494 2.552 0 O-C-N 121.282 -0.886 . . . . 0.040000000000000001 111.712 -178.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 877' ' ' GLY . . . . . . . . . . . . . . . 86.42 -58.57 4.69 Favored Glycine 0 N--CA 1.502 3.041 0 N-CA-C 108.043 -2.023 . . . . 0.040000000000000001 108.043 -178.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 878' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 60.37 -67.78 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 114.283 1.216 . . . . 3.46 114.283 177.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 879' ' ' TYR . . . . . 0.471 ' CB ' ' CD2' ' A' ' 886' ' ' PHE . 24.3 p90 -113.08 111.44 22.15 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 114.841 1.422 . . . . 0.040000000000000001 114.841 -176.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 880' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -66.19 119.01 58.44 Favored Pre-proline 0 N--CA 1.496 1.857 0 O-C-N 121.526 -0.734 . . . . 0.02 110.257 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 881' ' ' PRO . . . . . 0.456 ' HG2' ' CD1' ' A' ' 868' ' ' PHE . 54.5 Cg_endo -76.44 0.67 9.23 Favored 'Trans proline' 0 N--CA 1.493 1.46 0 O-C-N 123.389 1.205 . . . . 0.39000000000000001 112.128 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 882' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -74.77 -65.27 0.89 Allowed 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 106.686 -1.598 . . . . 0.81000000000000005 106.686 178.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 883' ' ' THR . . . . . . . . . . . . . 7.0 p -97.22 -15.28 20.93 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 109.014 -0.735 . . . . 0.040000000000000001 109.014 177.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.1 24.2 49.17 Favored Glycine 0 N--CA 1.494 2.523 0 O-C-N 120.947 -1.096 . . . . 0.029999999999999999 110.696 179.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 885' ' ' VAL . . . . . . . . . . . . . 92.4 t -72.26 88.59 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 C-N-CA 118.453 -1.299 . . . . 1.01 107.823 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 886' ' ' PHE . . . . . 0.924 ' HB3' HG22 ' A' ' 962' ' ' VAL . 0.7 OUTLIER -90.73 105.92 18.15 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 115.175 -0.92 . . . . 0.050000000000000003 112.442 -176.942 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 887' ' ' THR . . . . . 0.418 ' O ' ' HD3' ' A' ' 889' ' ' PRO . 89.8 m -96.25 100.42 12.05 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 107.48 -1.304 . . . . 0.68000000000000005 107.48 177.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 888' ' ' ALA . . . . . . . . . . . . . . . -99.15 106.53 39.06 Favored Pre-proline 0 N--CA 1.501 2.112 0 N-CA-C 114.044 1.127 . . . . 0.25 114.044 -176.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 889' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 887' ' ' THR . 53.8 Cg_endo -90.07 -11.98 2.95 Favored 'Trans proline' 0 CA--C 1.546 1.089 0 C-N-CA 121.093 1.195 . . . . 1.6399999999999999 109.213 176.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 890' ' ' LEU . . . . . 0.537 HD11 ' CD1' ' A' ' 985' ' ' LEU . 4.6 tt -34.78 -52.0 0.51 Allowed 'General case' 0 N--CA 1.509 2.482 0 N-CA-C 113.834 1.05 . . . . 2.29 113.834 -177.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 891' ' ' ALA . . . . . . . . . . . . . . . 51.38 95.41 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.313 0 O-C-N 121.181 -0.949 . . . . 0.63 110.438 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 892' ' ' GLY . . . . . . . . . . . . . . . 156.15 -147.8 16.92 Favored Glycine 0 N--CA 1.479 1.539 0 N-CA-C 107.383 -2.287 . . . . 0.040000000000000001 107.383 -179.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 893' ' ' ARG . . . . . 0.479 ' NE ' ' HB1' ' C' ' 984' ' ' ALA . 72.9 ttt-85 -108.96 127.08 53.76 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 107.536 -1.283 . . . . 3.0 107.536 177.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 894' ' ' TYR . . . . . 0.462 ' OH ' HD12 ' A' ' 896' ' ' LEU . 0.1 OUTLIER -131.42 144.71 51.39 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.03 -1.044 . . . . 0.040000000000000001 110.154 -179.008 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 895' ' ' LEU . . . . . 0.447 ' N ' ' CD1' ' A' ' 894' ' ' TYR . 33.9 tp -99.25 116.64 31.9 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.623 -0.673 . . . . 1.27 109.933 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 896' ' ' LEU . . . . . 0.523 HD23 ' N ' ' A' ' 897' ' ' SER . 10.4 tt -112.91 145.87 39.97 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.645 -0.66 . . . . 0.93999999999999995 110.785 -179.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 897' ' ' SER . . . . . 0.523 ' N ' HD23 ' A' ' 896' ' ' LEU . 63.1 m -143.04 119.02 10.64 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.466 -0.771 . . . . 0.040000000000000001 110.781 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 898' ' ' ALA . . . . . . . . . . . . . . . -108.34 146.91 32.28 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.657 -0.652 . . . . 0.47999999999999998 109.387 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 899' ' ' VAL . . . . . 0.72 HG21 ' HB ' ' A' ' 980' ' ' ILE . 88.3 t -93.61 119.69 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 C-N-CA 119.788 -0.765 . . . . 0.55000000000000004 111.031 -179.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 900' ' ' LEU . . . . . 0.57 HD12 ' HB2' ' A' ' 924' ' ' SER . 4.4 mm? -94.24 113.13 24.99 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 114.307 1.225 . . . . 1.5900000000000001 114.307 -174.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 901' ' ' THR . . . . . . . . . . . . . 18.1 m -67.0 141.65 57.52 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 107.33 -1.359 . . . . 0.050000000000000003 107.33 176.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 902' ' ' GLY . . . . . . . . . . . . . . . -66.28 -64.84 3.12 Favored Glycine 0 N--CA 1.495 2.588 0 N-CA-C 110.664 -0.974 . . . . 0.029999999999999999 110.664 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 903' ' ' HIS . . . . . . . . . . . . . 5.9 m170 46.54 64.65 1.44 Allowed 'General case' 0 N--CA 1.508 2.466 0 O-C-N 121.363 -1.081 . . . . 3.2000000000000002 111.189 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 904' ' ' ARG . . . . . . . . . . . . . 41.6 ptt85 -68.97 -6.65 29.0 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.563 -0.71 . . . . 2.9199999999999999 112.084 -179.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 905' ' ' HIS . . . . . 0.49 ' O ' ' CB ' ' A' ' 906' ' ' GLU . 70.6 t60 -63.31 5.76 0.15 Allowed 'General case' 0 N--CA 1.505 2.324 0 O-C-N 120.945 -1.097 . . . . 2.8700000000000001 113.214 -179.052 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 906' ' ' GLU . . . . . 0.49 ' CB ' ' O ' ' A' ' 905' ' ' HIS . 0.5 OUTLIER 94.88 -164.24 0.0 OUTLIER 'General case' 0 N--CA 1.529 3.514 0 CA-C-N 120.487 1.494 . . . . 0.98999999999999999 111.789 179.126 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 907' ' ' LYS . . . . . 0.471 ' CB ' ' O ' ' A' ' 906' ' ' GLU . 56.5 tttt 86.69 156.24 0.08 Allowed 'General case' 0 N--CA 1.52 3.031 0 N-CA-C 108.124 -1.065 . . . . 5.25 108.124 -176.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 908' ' ' VAL . . . . . . . . . . . . . 60.8 t -123.12 115.88 46.96 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 120.821 -1.174 . . . . 0.39000000000000001 111.173 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 909' ' ' GLU . . . . . . . . . . . . . 50.8 tp10 -102.65 132.78 48.54 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 107.334 -1.358 . . . . 1.72 107.334 176.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 910' ' ' ALA . . . . . . . . . . . . . . . -154.7 123.24 6.09 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 106.715 -1.587 . . . . 0.67000000000000004 106.715 178.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 911' ' ' VAL . . . . . 0.79 HG22 HG13 ' A' ' 964' ' ' VAL . 79.4 t -82.77 131.06 34.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 C-N-CA 120.378 -0.529 . . . . 0.54000000000000004 111.028 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 912' ' ' LEU . . . . . . . . . . . . . 75.3 mt -66.7 156.45 35.28 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.381 -0.824 . . . . 1.5 109.032 178.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 913' ' ' SER . . . . . 0.491 ' OG ' HG11 ' A' ' 919' ' ' VAL . 1.1 p -125.34 135.41 52.43 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.23 -1.026 . . . . 1.3700000000000001 108.23 176.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 914' ' ' ARG . . . . . 0.88 ' NH1' HD23 ' A' ' 956' ' ' LEU . 0.0 OUTLIER -64.23 155.11 32.94 Favored 'General case' 0 N--CA 1.506 2.361 0 O-C-N 120.7 -1.25 . . . . 4.2999999999999998 111.63 -179.287 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 915' ' ' SER . . . . . 0.441 ' CB ' ' O ' ' A' ' 914' ' ' ARG . 2.0 t 84.1 -31.75 0.07 Allowed 'General case' 0 N--CA 1.52 3.071 0 C-N-CA 124.036 0.935 . . . . 2.0499999999999998 111.769 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 916' ' ' ASN . . . . . 0.77 ' HB2' HG21 ' A' ' 919' ' ' VAL . 68.8 m-80 -123.49 -21.3 5.33 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 120.946 -1.096 . . . . 2.71 111.299 -179.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 917' ' ' GLN . . . . . 0.413 ' HB2' ' O ' ' A' ' 916' ' ' ASN . 50.2 mt-30 66.71 166.48 0.21 Allowed 'General case' 0 N--CA 1.52 3.047 0 N-CA-C 105.789 -1.93 . . . . 2.6800000000000002 105.789 -174.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.24 -125.32 33.43 Favored Glycine 1 N--CA 1.522 4.372 0 CA-C-N 123.646 2.93 . . . . 0.029999999999999999 107.041 -177.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 919' ' ' VAL . . . . . 0.77 HG21 ' HB2' ' A' ' 916' ' ' ASN . 78.1 t 51.57 94.14 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 O-C-N 121.357 -1.084 . . . . 1.3899999999999999 109.08 -178.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 920' ' ' ALA . . . . . 0.74 ' HB3' HG12 ' A' ' 949' ' ' VAL . . . -92.31 91.83 7.88 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 119.358 -0.937 . . . . 0.029999999999999999 110.882 -179.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 921' ' ' ARG . . . . . 0.841 ' HG3' HG23 ' A' ' 922' ' ' VAL . 30.7 ptt180 -83.56 -41.42 17.93 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 105.641 -1.985 . . . . 4.4199999999999999 105.641 176.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 922' ' ' VAL . . . . . 0.841 HG23 ' HG3' ' A' ' 921' ' ' ARG . 97.1 t -98.79 78.39 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 N-CA-C 106.041 -1.837 . . . . 0.84999999999999998 106.041 175.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 923' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -86.12 133.91 33.85 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.717 0.77 . . . . 2.46 111.381 -177.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 924' ' ' SER . . . . . 0.57 ' HB2' HD12 ' A' ' 900' ' ' LEU . 17.8 t -147.35 104.49 3.65 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.869 -0.789 . . . . 0.69999999999999996 108.869 179.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 925' ' ' GLY . . . . . . . . . . . . . . . -103.75 83.35 0.41 Allowed Glycine 0 N--CA 1.487 2.071 0 N-CA-C 108.242 -1.943 . . . . 0.040000000000000001 108.242 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.239 0 N-CA-C 108.98 -1.648 . . . . 0.040000000000000001 108.98 -179.403 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 946' ' ' THR . . . . . . . . . . . . . 63.8 m . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.005 0.431 . . . . 13.779999999999999 110.264 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 947' ' ' LEU . . . . . . . . . . . . . 94.4 mt -109.44 129.41 55.55 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.574 -0.704 . . . . 13.76 110.369 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 948' ' ' GLY . . . . . . . . . . . . . . . -152.64 169.33 31.73 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.189 -1.565 . . . . 9.1300000000000008 109.189 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 949' ' ' VAL . . . . . 0.74 HG12 ' HB3' ' A' ' 920' ' ' ALA . 35.1 m -117.99 133.21 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.518 -0.989 . . . . 7.0800000000000001 110.801 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 950' ' ' PHE . . . . . 0.449 ' CZ ' ' HB3' ' A' ' 921' ' ' ARG . 30.7 p90 -130.69 147.06 52.32 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.59 -0.694 . . . . 7.5899999999999999 109.502 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 951' ' ' SER . . . . . . . . . . . . . 73.6 m -119.98 -54.68 2.11 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.487 -0.758 . . . . 5.0300000000000002 111.843 -178.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 952' ' ' LEU . . . . . 0.41 ' O ' ' O ' ' A' ' 953' ' ' ILE . 55.9 tp -60.75 -76.87 0.05 OUTLIER 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.417 -0.802 . . . . 1.01 112.178 -177.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 953' ' ' ILE . . . . . 0.488 HD11 HD13 ' C' ' 872' ' ' LEU . 47.6 pt -53.78 -141.73 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.656 0 N-CA-C 113.81 1.041 . . . . 2.6000000000000001 113.81 -176.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 954' ' ' LEU . . . . . 0.793 HD22 ' O ' ' A' ' 954' ' ' LEU . 0.0 OUTLIER 173.79 78.7 0.05 OUTLIER Pre-proline 0 N--CA 1.508 2.451 0 O-C-N 120.777 -1.202 . . . . 0.050000000000000003 111.037 179.427 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 955' ' ' PRO . . . . . 0.553 ' C ' HD12 ' A' ' 956' ' ' LEU . 45.8 Cg_endo -73.61 89.89 0.95 Allowed 'Trans proline' 0 C--N 1.314 -1.255 0 N-CA-C 109.45 -1.019 . . . . 0.83999999999999997 109.45 178.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 956' ' ' LEU . . . . . 0.88 HD23 ' NH1' ' A' ' 914' ' ' ARG . 5.7 mp -125.52 150.17 47.66 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.187 -0.946 . . . . 0.040000000000000001 110.487 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 957' ' ' GLN . . . . . . . . . . . . . 59.6 mt-30 -81.74 151.9 27.27 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-O 117.784 -1.103 . . . . 1.28 111.793 -179.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 958' ' ' ALA . . . . . . . . . . . . . . . -70.2 119.83 14.98 Favored 'General case' 0 N--CA 1.511 2.609 0 CA-C-N 123.048 2.658 . . . . 0.17000000000000001 111.671 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.6 -23.0 30.22 Favored Glycine 0 N--CA 1.501 3.031 0 N-CA-C 111.025 -0.83 . . . . 0.040000000000000001 111.025 178.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 960' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.85 171.45 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.567 -0.96 . . . . 0.040000000000000001 110.202 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 961' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' A' ' 886' ' ' PHE . 46.3 m -133.36 137.87 46.06 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 120.893 -1.129 . . . . 1.78 112.127 -178.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 962' ' ' VAL . . . . . 0.924 HG22 ' HB3' ' A' ' 886' ' ' PHE . 26.3 m -99.03 144.13 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.675 -0.641 . . . . 0.040000000000000001 110.229 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 963' ' ' CYS . . . . . . . . . . . . . 1.6 m -137.68 144.32 41.76 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.857 -0.527 . . . . 0.71999999999999997 110.031 -178.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 964' ' ' VAL . . . . . 0.79 HG13 HG22 ' A' ' 911' ' ' VAL . 58.1 t -94.88 136.01 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.13 -0.981 . . . . 1.05 110.538 -179.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 965' ' ' ASP . . . . . . . . . . . . . 32.8 t0 -93.98 127.51 39.8 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 103.784 -2.673 . . . . 3.02 103.784 173.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 966' ' ' LEU . . . . . 0.49 ' C ' HG23 ' A' ' 967' ' ' VAL . 1.2 tt -132.12 61.43 1.66 Allowed 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.232 -1.025 . . . . 1.46 108.232 177.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 967' ' ' VAL . . . . . 0.49 HG23 ' C ' ' A' ' 966' ' ' LEU . 94.2 t -158.28 96.41 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 108.056 -1.09 . . . . 1.9399999999999999 108.056 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 968' ' ' MET . . . . . . . . . . . . . 90.6 mmm -142.17 60.1 1.46 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.709 -1.244 . . . . 0.0 108.344 179.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.47 119.83 1.95 Allowed Glycine 0 N--CA 1.492 2.385 0 N-CA-C 107.08 -2.408 . . . . 2.1099999999999999 107.08 -178.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 970' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -81.96 -58.04 3.15 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.065 -1.256 . . . . 5.8899999999999997 110.562 -179.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 971' ' ' LEU . . . . . . . . . . . . . 40.6 tp -59.19 90.01 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.442 -0.786 . . . . 4.3600000000000003 110.283 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 972' ' ' ALA . . . . . . . . . . . . . . . -141.32 -154.02 0.49 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.613 -0.679 . . . . 1.8300000000000001 110.117 -179.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 973' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -120.08 172.34 7.82 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.486 -0.759 . . . . 4.3499999999999996 110.215 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 974' ' ' SER . . . . . . . . . . . . . 30.8 t -101.46 130.05 47.63 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.568 -0.707 . . . . 1.27 110.009 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 975' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -156.21 156.44 34.15 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.499 -0.75 . . . . 5.0199999999999996 110.529 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.15 85.46 18.8 Favored Pre-proline 0 N--CA 1.5 2.041 0 O-C-N 121.616 -0.677 . . . . 2.4100000000000001 109.613 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 977' ' ' PRO . . . . . 0.665 ' C ' HD12 ' A' ' 978' ' ' LEU . 47.2 Cg_endo -72.82 -172.58 0.99 Allowed 'Trans proline' 0 C--N 1.317 -1.091 0 O-C-N 123.29 1.153 . . . . 0.95999999999999996 111.216 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 978' ' ' LEU . . . . . 0.665 HD12 ' C ' ' A' ' 977' ' ' PRO . 6.7 mp -127.25 154.7 44.55 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 107.644 -1.243 . . . . 0.62 107.644 178.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 979' ' ' THR . . . . . 0.466 HG23 ' C ' ' A' ' 978' ' ' LEU . 41.1 p -150.54 141.16 22.61 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.781 -1.199 . . . . 3.5699999999999998 111.145 -179.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 980' ' ' ILE . . . . . 0.72 ' HB ' HG21 ' A' ' 899' ' ' VAL . 50.7 mm -106.22 127.43 61.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 108.881 -0.785 . . . . 1.3300000000000001 108.881 179.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 981' ' ' PHE . . . . . 0.401 ' HD1' ' HH ' ' A' ' 879' ' ' TYR . 6.7 t80 -120.71 99.26 6.43 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.414 -0.804 . . . . 0.050000000000000003 111.782 -178.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 982' ' ' SER . . . . . . . . . . . . . 85.9 p -108.16 159.89 16.25 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 109.06 -0.719 . . . . 0.87 109.06 178.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 983' ' ' GLY . . . . . . . . . . . . . . . -171.45 109.55 0.32 Allowed Glycine 0 N--CA 1.498 2.82 0 N-CA-C 106.635 -2.586 . . . . 0.029999999999999999 106.635 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 984' ' ' ALA . . . . . . . . . . . . . . . -109.61 148.62 30.98 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 114.561 1.319 . . . . 0.69999999999999996 114.561 -175.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 985' ' ' LEU . . . . . 0.537 ' CD1' HD11 ' A' ' 890' ' ' LEU . 51.8 tp -68.77 134.4 49.7 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.854 -1.154 . . . . 0.040000000000000001 110.084 179.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 986' ' ' LEU . . . . . . . . . . . . . 45.8 tp -107.82 -59.19 1.87 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.563 -0.71 . . . . 0.040000000000000001 109.925 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 987' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -144.32 144.91 31.68 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.601 -1.259 . . . . 0.040000000000000001 107.601 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 988' ' ' GLY . . . . . . . . . . . . . . . -113.1 162.8 12.24 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 108.187 -1.965 . . . . 0.040000000000000001 108.187 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 989' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -75.16 112.97 20.8 Favored Pre-proline 0 N--CA 1.499 1.981 0 O-C-N 121.186 -1.185 . . . . 0.040000000000000001 109.454 179.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 990' ' ' PRO . . . . . 0.424 ' O ' ' HB2' ' A' ' 991' ' ' GLU . 50.9 Cg_endo -88.01 72.09 2.69 Favored 'Trans proline' 0 C--N 1.32 -0.968 0 O-C-N 123.055 1.029 . . . . 0.45000000000000001 111.363 -179.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 991' ' ' GLU . . . . . 0.424 ' HB2' ' O ' ' A' ' 990' ' ' PRO . 71.8 mt-10 67.51 -73.65 0.08 Allowed 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 108.529 -0.915 . . . . 1.97 108.529 -177.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 992' ' ' LEU . . . . . 0.404 ' HA ' HD23 ' A' ' 992' ' ' LEU . 11.1 mt 50.55 20.87 0.77 Allowed 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.612 -0.68 . . . . 2.3799999999999999 111.642 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 993' ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -93.56 156.7 16.58 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.942 -1.099 . . . . 3.79 110.033 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 994' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -145.3 92.6 2.27 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.587 -0.696 . . . . 3.5099999999999998 110.276 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 995' ' ' ALA . . . . . . . . . . . . 2.519 . . . . . . . 0 N--CA 1.503 2.224 0 O-C-N 120.887 -1.133 . . . . 2.73 110.648 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 846' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo . . . . . 0 N--CA 1.488 1.172 0 N-CA-C 109.543 -0.983 . . . . 3.8300000000000001 109.543 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 847' ' ' VAL . . . . . 0.423 HG12 ' HB2' ' B' ' 849' ' ' GLN . 61.5 t -132.57 103.42 13.51 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.547 -0.721 . . . . 1.8300000000000001 110.098 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 848' ' ' PRO . . . . . 0.734 ' O ' HG23 ' B' ' 850' ' ' VAL . 43.7 Cg_endo -69.88 -20.28 34.44 Favored 'Trans proline' 0 N--CA 1.487 1.125 0 O-C-N 123.299 1.157 . . . . 0.65000000000000002 111.003 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 849' ' ' GLN . . . . . 0.423 ' HB2' HG12 ' B' ' 847' ' ' VAL . 56.9 tt0 27.77 68.22 0.07 Allowed 'General case' 0 N--CA 1.518 2.941 0 N-CA-C 112.923 0.712 . . . . 2.5800000000000001 112.923 179.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 850' ' ' VAL . . . . . 0.734 HG23 ' O ' ' B' ' 848' ' ' PRO . 57.4 t -119.37 136.14 57.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.128 -0.983 . . . . 1.0900000000000001 111.679 -178.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 851' ' ' ALA . . . . . 0.596 ' HB3' ' HG ' ' B' ' 873' ' ' LEU . . . -126.29 157.13 39.16 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 105.776 -1.935 . . . . 0.040000000000000001 105.776 176.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 852' ' ' PHE . . . . . 0.424 ' HA ' ' CB ' ' B' ' 874' ' ' ASN . 23.0 p90 -160.68 127.4 4.16 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 120.886 1.675 . . . . 0.050000000000000003 108.581 179.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 853' ' ' SER . . . . . . . . . . . . . 5.7 t -176.15 134.79 0.26 Allowed 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.305 -0.998 . . . . 0.040000000000000001 108.305 -178.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 854' ' ' ALA . . . . . . . . . . . . . . . -132.15 156.1 46.99 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.066 -1.022 . . . . 0.67000000000000004 109.542 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 855' ' ' ALA . . . . . 0.808 ' HB3' ' CB ' ' B' ' 870' ' ' ARG . . . -121.92 143.97 49.14 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-O 121.864 0.84 . . . . 0.51000000000000001 111.315 -179.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 856' ' ' LEU . . . . . 0.603 ' C ' HD13 ' B' ' 856' ' ' LEU . 3.4 tm? -113.2 134.88 54.36 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.687 -0.633 . . . . 0.050000000000000003 110.253 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 857' ' ' SER . . . . . 0.54 ' N ' HD13 ' B' ' 856' ' ' LEU . 60.8 p -152.12 16.96 0.65 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.553 -0.717 . . . . 1.3300000000000001 110.616 178.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 858' ' ' LEU . . . . . 0.744 HD22 ' OE1' ' B' ' 862' ' ' GLU . 4.4 pp -32.65 156.92 0.03 OUTLIER Pre-proline 0 N--CA 1.518 2.945 0 N-CA-C 113.276 0.843 . . . . 2.3300000000000001 113.276 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 859' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -62.95 -88.39 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.344 0 O-C-N 123.132 1.07 . . . . 2.3199999999999998 113.228 -178.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 860' ' ' ARG . . . . . . . . . . . . . 55.2 ptt85 -128.65 -143.36 0.27 Allowed 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.852 -1.155 . . . . 0.040000000000000001 111.685 -177.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 861' ' ' SER . . . . . . . . . . . . . 14.1 m -40.16 126.83 2.19 Favored 'General case' 0 N--CA 1.508 2.451 0 O-C-N 121.566 -0.709 . . . . 1.3100000000000001 112.408 -178.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 862' ' ' GLU . . . . . 0.744 ' OE1' HD22 ' B' ' 858' ' ' LEU . 0.7 OUTLIER -102.01 157.63 33.32 Favored Pre-proline 0 N--CA 1.489 1.51 0 N-CA-C 107.673 -1.232 . . . . 4.5099999999999998 107.673 176.954 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 863' ' ' PRO . . . . . 0.417 ' HD2' ' CG ' ' B' ' 862' ' ' GLU . 44.4 Cg_endo -71.63 -11.94 28.56 Favored 'Trans proline' 0 C--N 1.314 -1.268 0 O-C-N 123.006 1.003 . . . . 2.2400000000000002 111.472 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 864' ' ' GLY . . . . . . . . . . . . . . . -176.08 -136.61 2.39 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 110.152 -1.179 . . . . 0.040000000000000001 110.152 179.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 865' ' ' THR . . . . . . . . . . . . . 26.1 m -65.75 155.95 34.56 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.357 -1.084 . . . . 1.51 110.934 -178.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 866' ' ' VAL . . . . . 0.564 HG11 ' HG ' ' B' ' 856' ' ' LEU . 59.8 t -92.11 135.22 27.36 Favored Pre-proline 0 N--CA 1.494 1.743 0 N-CA-C 113.265 0.839 . . . . 0.78000000000000003 113.265 -174.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 867' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' B' ' 866' ' ' VAL . 54.9 Cg_endo -90.49 -152.7 0.04 OUTLIER 'Trans proline' 0 CA--C 1.54 0.82 0 N-CA-C 108.612 -1.341 . . . . 0.92000000000000004 108.612 177.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 868' ' ' PHE . . . . . 0.449 ' CD1' ' N ' ' B' ' 868' ' ' PHE . 27.0 p90 -150.98 122.47 7.91 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 120.631 -1.293 . . . . 0.050000000000000003 109.592 179.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 869' ' ' ASP . . . . . . . . . . . . . 50.3 p-10 -113.86 -1.94 13.75 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 119.343 -0.943 . . . . 1.7 112.519 -178.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 870' ' ' ARG . . . . . 0.808 ' CB ' ' HB3' ' B' ' 855' ' ' ALA . 28.9 mmm180 -90.72 88.45 7.09 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.908 -1.12 . . . . 2.5899999999999999 110.773 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 871' ' ' VAL . . . . . . . . . . . . . 57.3 t -73.28 97.07 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.011 -1.056 . . . . 1.9399999999999999 109.864 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 872' ' ' LEU . . . . . 0.615 HD11 ' HB2' ' B' ' 855' ' ' ALA . 96.2 mt -83.05 -47.57 11.54 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.535 -0.728 . . . . 1.0600000000000001 110.14 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 873' ' ' LEU . . . . . 0.596 ' HG ' ' HB3' ' B' ' 851' ' ' ALA . 30.4 tp -174.63 103.83 0.1 Allowed 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 108.545 -0.909 . . . . 4.1799999999999997 108.545 178.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 874' ' ' ASN . . . . . 0.424 ' CB ' ' HA ' ' B' ' 852' ' ' PHE . 37.5 t-20 178.66 81.66 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.281 0 O-C-N 121.608 -0.682 . . . . 0.040000000000000001 109.698 -178.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 875' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -66.03 -47.11 75.49 Favored 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 119.297 -0.961 . . . . 3.3799999999999999 110.994 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 876' ' ' GLY . . . . . . . . . . . . . . . -74.64 -24.78 71.63 Favored Glycine 0 N--CA 1.493 2.486 0 C-N-CA 120.526 -0.845 . . . . 0.040000000000000001 111.842 -178.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 877' ' ' GLY . . . . . . . . . . . . . . . 85.91 -58.77 4.78 Favored Glycine 0 N--CA 1.502 3.06 0 N-CA-C 108.105 -1.998 . . . . 0.040000000000000001 108.105 -178.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 878' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 60.45 -67.74 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 114.263 1.209 . . . . 3.46 114.263 177.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 879' ' ' TYR . . . . . 0.463 ' CB ' ' CD2' ' B' ' 886' ' ' PHE . 24.2 p90 -113.2 110.67 20.78 Favored 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 114.955 1.465 . . . . 0.040000000000000001 114.955 -176.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 880' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -65.62 118.94 56.09 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 121.494 -0.754 . . . . 0.02 110.196 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 881' ' ' PRO . . . . . 0.445 ' HG2' ' CD1' ' B' ' 868' ' ' PHE . 54.2 Cg_endo -76.34 0.38 9.5 Favored 'Trans proline' 0 N--CA 1.493 1.483 0 O-C-N 123.337 1.178 . . . . 0.39000000000000001 112.221 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 882' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -74.44 -65.23 0.88 Allowed 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 106.7 -1.593 . . . . 0.81000000000000005 106.7 178.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 883' ' ' THR . . . . . . . . . . . . . 7.0 p -96.99 -15.77 20.92 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 109.0 -0.741 . . . . 0.040000000000000001 109.0 177.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.42 24.09 48.44 Favored Glycine 0 N--CA 1.495 2.569 0 C-N-CA 120.034 -1.079 . . . . 0.029999999999999999 110.596 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 885' ' ' VAL . . . . . . . . . . . . . 92.9 t -72.12 88.64 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 C-N-CA 118.514 -1.274 . . . . 1.01 107.865 -179.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 886' ' ' PHE . . . . . 0.892 ' HB3' HG22 ' B' ' 962' ' ' VAL . 0.7 OUTLIER -90.82 105.52 17.88 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 115.249 -0.887 . . . . 0.050000000000000003 112.577 -176.848 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 887' ' ' THR . . . . . 0.418 ' O ' ' HD3' ' B' ' 889' ' ' PRO . 89.6 m -95.93 100.27 11.97 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 107.555 -1.276 . . . . 0.68000000000000005 107.555 177.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 888' ' ' ALA . . . . . . . . . . . . . . . -99.02 106.55 38.76 Favored Pre-proline 0 N--CA 1.501 2.114 0 N-CA-C 114.125 1.157 . . . . 0.25 114.125 -176.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 889' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' B' ' 887' ' ' THR . 53.4 Cg_endo -90.15 -11.77 2.97 Favored 'Trans proline' 0 CA--C 1.547 1.143 0 C-N-CA 121.143 1.228 . . . . 1.6399999999999999 109.128 176.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 890' ' ' LEU . . . . . 0.537 HD11 ' CD1' ' B' ' 985' ' ' LEU . 4.6 tt -34.96 -51.81 0.53 Allowed 'General case' 0 N--CA 1.509 2.487 0 N-CA-C 113.867 1.062 . . . . 2.29 113.867 -177.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 891' ' ' ALA . . . . . . . . . . . . . . . 51.29 95.52 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.373 0 O-C-N 121.131 -0.981 . . . . 0.63 110.425 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 892' ' ' GLY . . . . . . . . . . . . . . . 156.09 -147.68 16.65 Favored Glycine 0 N--CA 1.48 1.581 0 N-CA-C 107.383 -2.287 . . . . 0.040000000000000001 107.383 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 893' ' ' ARG . . . . . . . . . . . . . 72.9 ttt-85 -109.04 127.06 53.79 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 107.49 -1.3 . . . . 3.0 107.49 177.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 894' ' ' TYR . . . . . 0.468 ' OH ' HD12 ' B' ' 896' ' ' LEU . 0.1 OUTLIER -131.45 144.81 51.44 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.053 -1.029 . . . . 0.040000000000000001 110.17 -179.112 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 895' ' ' LEU . . . . . 0.448 ' N ' ' CD1' ' B' ' 894' ' ' TYR . 34.1 tp -99.3 116.68 32.04 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.623 -0.673 . . . . 1.27 109.846 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 896' ' ' LEU . . . . . 0.536 HD23 ' N ' ' B' ' 897' ' ' SER . 10.4 tt -112.75 146.57 38.53 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.587 -0.696 . . . . 0.93999999999999995 110.704 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 897' ' ' SER . . . . . 0.536 ' N ' HD23 ' B' ' 896' ' ' LEU . 63.3 m -143.78 118.89 10.08 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.42 -0.8 . . . . 0.040000000000000001 110.741 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 898' ' ' ALA . . . . . . . . . . . . . . . -108.2 147.21 31.67 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.689 -0.632 . . . . 0.47999999999999998 109.352 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 899' ' ' VAL . . . . . 0.71 HG21 ' HB ' ' B' ' 980' ' ' ILE . 88.3 t -93.86 120.15 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.417 -0.802 . . . . 0.55000000000000004 110.9 -179.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 900' ' ' LEU . . . . . 0.571 HD12 ' HB2' ' B' ' 924' ' ' SER . 4.4 mm? -94.7 112.94 24.67 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 114.257 1.206 . . . . 1.5900000000000001 114.257 -174.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 901' ' ' THR . . . . . . . . . . . . . 17.9 m -66.81 141.63 57.63 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 107.348 -1.352 . . . . 0.050000000000000003 107.348 176.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 902' ' ' GLY . . . . . . . . . . . . . . . -66.18 -65.18 2.96 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 110.598 -1.001 . . . . 0.029999999999999999 110.598 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 903' ' ' HIS . . . . . . . . . . . . . 5.9 m170 46.9 64.93 1.36 Allowed 'General case' 0 N--CA 1.507 2.393 0 O-C-N 121.381 -1.07 . . . . 3.2000000000000002 111.122 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 904' ' ' ARG . . . . . . . . . . . . . 41.6 ptt85 -69.24 -6.71 30.92 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.574 -0.704 . . . . 2.9199999999999999 111.989 -179.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 905' ' ' HIS . . . . . 0.486 ' O ' ' CB ' ' B' ' 906' ' ' GLU . 70.5 t60 -63.48 6.14 0.15 Allowed 'General case' 0 N--CA 1.507 2.387 0 O-C-N 120.867 -1.146 . . . . 2.8700000000000001 113.163 -178.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 906' ' ' GLU . . . . . 0.486 ' CB ' ' O ' ' B' ' 905' ' ' HIS . 0.5 OUTLIER 94.58 -164.31 0.0 OUTLIER 'General case' 0 N--CA 1.528 3.47 0 CA-C-N 120.592 1.542 . . . . 0.98999999999999999 111.848 179.008 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 907' ' ' LYS . . . . . 0.476 ' CB ' ' O ' ' B' ' 906' ' ' GLU . 56.6 tttt 86.62 156.04 0.08 Allowed 'General case' 0 N--CA 1.52 3.067 0 N-CA-C 108.042 -1.096 . . . . 5.25 108.042 -176.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 908' ' ' VAL . . . . . . . . . . . . . 60.3 t -122.97 115.68 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 120.804 -1.185 . . . . 0.39000000000000001 111.116 -179.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 909' ' ' GLU . . . . . . . . . . . . . 51.0 tp10 -102.01 133.32 47.0 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 107.328 -1.36 . . . . 1.72 107.328 176.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 910' ' ' ALA . . . . . . . . . . . . . . . -155.15 123.04 5.76 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 106.783 -1.562 . . . . 0.67000000000000004 106.783 178.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 911' ' ' VAL . . . . . 0.775 HG22 HG13 ' B' ' 964' ' ' VAL . 77.9 t -82.53 131.17 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.858 -0.526 . . . . 0.54000000000000004 111.022 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 912' ' ' LEU . . . . . . . . . . . . . 75.5 mt -66.82 156.53 35.34 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.407 -0.808 . . . . 1.5 108.951 178.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 913' ' ' SER . . . . . 0.499 ' OG ' HG11 ' B' ' 919' ' ' VAL . 1.1 p -125.32 135.85 52.89 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.181 -1.044 . . . . 1.3700000000000001 108.181 176.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 914' ' ' ARG . . . . . 0.875 ' NH1' HD23 ' B' ' 956' ' ' LEU . 0.0 OUTLIER -64.61 155.62 32.67 Favored 'General case' 0 N--CA 1.506 2.35 0 O-C-N 120.619 -1.301 . . . . 4.2999999999999998 111.528 -179.295 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 915' ' ' SER . . . . . 0.429 ' CB ' ' O ' ' B' ' 914' ' ' ARG . 2.0 t 83.64 -31.58 0.08 Allowed 'General case' 0 N--CA 1.52 3.07 0 C-N-CA 123.968 0.907 . . . . 2.0499999999999998 111.887 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 916' ' ' ASN . . . . . 0.774 ' HB2' HG21 ' B' ' 919' ' ' VAL . 68.8 m-80 -123.82 -21.1 5.24 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 120.927 -1.108 . . . . 2.71 111.268 -179.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 917' ' ' GLN . . . . . 0.416 ' HB2' ' O ' ' B' ' 916' ' ' ASN . 50.3 mt-30 66.71 166.41 0.21 Allowed 'General case' 0 N--CA 1.521 3.094 0 N-CA-C 105.74 -1.948 . . . . 2.6800000000000002 105.74 -174.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 918' ' ' GLY . . . . . . . . . . . . . . . 54.07 -125.08 32.37 Favored Glycine 1 N--CA 1.522 4.386 0 CA-C-N 123.397 2.817 . . . . 0.029999999999999999 107.071 -177.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 919' ' ' VAL . . . . . 0.774 HG21 ' HB2' ' B' ' 916' ' ' ASN . 76.4 t 51.69 94.23 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.262 0 O-C-N 121.407 -1.055 . . . . 1.3899999999999999 109.036 -178.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 920' ' ' ALA . . . . . 0.73 ' HB3' HG12 ' B' ' 949' ' ' VAL . . . -92.31 92.06 7.98 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.335 -0.946 . . . . 0.029999999999999999 110.831 -179.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 921' ' ' ARG . . . . . 0.863 ' HG3' HG23 ' B' ' 922' ' ' VAL . 30.6 ptt180 -83.68 -41.62 17.53 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 105.65 -1.981 . . . . 4.4199999999999999 105.65 175.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 922' ' ' VAL . . . . . 0.863 HG23 ' HG3' ' B' ' 921' ' ' ARG . 96.9 t -98.66 78.81 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 N-CA-C 105.939 -1.874 . . . . 0.84999999999999998 105.939 175.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 923' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -86.47 134.05 33.71 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 121.654 0.74 . . . . 2.46 111.368 -177.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 924' ' ' SER . . . . . 0.571 ' HB2' HD12 ' B' ' 900' ' ' LEU . 17.4 t -147.49 104.84 3.66 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.713 -0.847 . . . . 0.69999999999999996 108.713 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 925' ' ' GLY . . . . . . . . . . . . . . . -104.13 83.36 0.4 Allowed Glycine 0 N--CA 1.487 2.041 0 N-CA-C 108.222 -1.951 . . . . 0.040000000000000001 108.222 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 108.973 -1.651 . . . . 0.040000000000000001 108.973 -179.376 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 946' ' ' THR . . . . . . . . . . . . . 68.1 m . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.014 0.435 . . . . 13.779999999999999 110.246 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 947' ' ' LEU . . . . . . . . . . . . . 94.8 mt -108.88 129.44 55.41 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.583 -0.698 . . . . 13.76 110.323 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 948' ' ' GLY . . . . . . . . . . . . . . . -152.19 168.83 31.43 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.235 -1.546 . . . . 9.1300000000000008 109.235 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 949' ' ' VAL . . . . . 0.73 HG12 ' HB3' ' B' ' 920' ' ' ALA . 35.0 m -117.85 132.74 66.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.525 -0.985 . . . . 7.0800000000000001 110.717 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 950' ' ' PHE . . . . . 0.445 ' CZ ' ' HB3' ' B' ' 921' ' ' ARG . 30.7 p90 -130.49 146.57 52.05 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.518 -0.739 . . . . 7.5899999999999999 109.55 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 951' ' ' SER . . . . . . . . . . . . . 73.4 m -119.38 -54.11 2.2 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.452 -0.78 . . . . 5.0300000000000002 111.808 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 952' ' ' LEU . . . . . 0.409 ' O ' ' O ' ' B' ' 953' ' ' ILE . 56.5 tp -61.42 -77.02 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.465 -0.772 . . . . 1.01 112.285 -177.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 953' ' ' ILE . . . . . 0.491 ' O ' ' HB3' ' B' ' 954' ' ' LEU . 48.9 pt -53.83 -141.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.739 0 N-CA-C 113.701 1.0 . . . . 2.6000000000000001 113.701 -176.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 954' ' ' LEU . . . . . 0.789 HD22 ' O ' ' B' ' 954' ' ' LEU . 0.0 OUTLIER 174.07 78.68 0.05 OUTLIER Pre-proline 0 N--CA 1.509 2.495 0 O-C-N 120.654 -1.279 . . . . 0.050000000000000003 110.963 179.47 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 955' ' ' PRO . . . . . 0.545 ' C ' HD12 ' B' ' 956' ' ' LEU . 46.0 Cg_endo -73.51 89.52 0.95 Allowed 'Trans proline' 0 C--N 1.315 -1.236 0 N-CA-C 109.514 -0.995 . . . . 0.83999999999999997 109.514 178.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 956' ' ' LEU . . . . . 0.875 HD23 ' NH1' ' B' ' 914' ' ' ARG . 5.7 mp -125.22 150.22 47.22 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.289 -0.882 . . . . 0.040000000000000001 110.461 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 957' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -82.14 151.38 26.99 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 117.729 -1.129 . . . . 1.28 111.828 -179.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 958' ' ' ALA . . . . . . . . . . . . . . . -69.77 119.74 14.46 Favored 'General case' 0 N--CA 1.512 2.626 0 CA-C-N 123.14 2.7 . . . . 0.17000000000000001 111.784 -179.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 959' ' ' GLY . . . . . . . . . . . . . . . 92.76 -22.66 32.48 Favored Glycine 0 N--CA 1.502 3.076 0 N-CA-C 111.037 -0.825 . . . . 0.040000000000000001 111.037 178.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 960' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -52.19 171.55 0.05 OUTLIER 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.54 -0.976 . . . . 0.040000000000000001 110.198 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 961' ' ' THR . . . . . 0.461 ' HA ' ' O ' ' B' ' 886' ' ' PHE . 47.1 m -133.42 137.83 45.96 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.846 -1.159 . . . . 1.78 112.103 -178.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 962' ' ' VAL . . . . . 0.892 HG22 ' HB3' ' B' ' 886' ' ' PHE . 26.3 m -98.84 144.44 11.74 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 C-N-CA 120.169 -0.612 . . . . 0.040000000000000001 110.219 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 963' ' ' CYS . . . . . . . . . . . . . 1.6 m -137.87 144.72 41.52 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.857 -0.527 . . . . 0.71999999999999997 110.009 -178.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 964' ' ' VAL . . . . . 0.775 HG13 HG22 ' B' ' 911' ' ' VAL . 58.1 t -95.2 136.34 26.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.107 -0.995 . . . . 1.05 110.434 -179.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 965' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -94.29 127.59 40.25 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 103.758 -2.682 . . . . 3.02 103.758 173.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 966' ' ' LEU . . . . . 0.494 ' C ' HG23 ' B' ' 967' ' ' VAL . 1.2 tt -132.24 61.67 1.66 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.123 -1.065 . . . . 1.46 108.123 177.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 967' ' ' VAL . . . . . 0.494 HG23 ' C ' ' B' ' 966' ' ' LEU . 94.4 t -158.42 97.02 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 107.917 -1.142 . . . . 1.9399999999999999 107.917 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 968' ' ' MET . . . . . . . . . . . . . 90.4 mmm -142.79 59.92 1.43 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.715 -1.24 . . . . 0.0 108.251 179.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 969' ' ' GLY . . . . . . . . . . . . . . . 135.64 119.98 1.96 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 107.043 -2.423 . . . . 2.1099999999999999 107.043 -178.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 970' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -82.12 -58.2 3.06 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.974 -1.31 . . . . 5.8899999999999997 110.492 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 971' ' ' LEU . . . . . . . . . . . . . 40.0 tp -58.9 90.47 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.407 -0.808 . . . . 4.3600000000000003 110.336 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 972' ' ' ALA . . . . . . . . . . . . . . . -141.88 -154.32 0.51 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.565 -0.71 . . . . 1.8300000000000001 110.139 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 973' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -120.04 171.84 8.17 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.409 -0.807 . . . . 4.3499999999999996 110.273 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 974' ' ' SER . . . . . . . . . . . . . 31.5 t -100.97 130.03 46.9 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.555 -0.716 . . . . 1.27 110.068 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 975' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -156.25 156.44 34.09 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.511 -0.743 . . . . 5.0199999999999996 110.553 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.14 85.49 18.82 Favored Pre-proline 0 N--CA 1.5 2.038 0 O-C-N 121.655 -0.653 . . . . 2.4100000000000001 109.671 179.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 977' ' ' PRO . . . . . 0.673 ' C ' HD12 ' B' ' 978' ' ' LEU . 47.5 Cg_endo -72.66 -172.42 0.94 Allowed 'Trans proline' 0 C--N 1.317 -1.098 0 O-C-N 123.299 1.158 . . . . 0.95999999999999996 111.258 -179.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 978' ' ' LEU . . . . . 0.673 HD12 ' C ' ' B' ' 977' ' ' PRO . 6.6 mp -127.58 154.48 45.14 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 107.639 -1.245 . . . . 0.62 107.639 178.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 979' ' ' THR . . . . . 0.47 HG23 ' C ' ' B' ' 978' ' ' LEU . 41.3 p -150.28 141.38 23.05 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.79 -1.194 . . . . 3.5699999999999998 111.12 -179.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 980' ' ' ILE . . . . . 0.71 ' HB ' HG21 ' B' ' 899' ' ' VAL . 50.7 mm -106.4 127.42 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 N-CA-C 108.852 -0.796 . . . . 1.3300000000000001 108.852 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 981' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -120.63 99.25 6.43 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 119.723 -0.791 . . . . 0.050000000000000003 111.791 -178.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 982' ' ' SER . . . . . . . . . . . . . 81.9 p -108.42 159.67 16.49 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.543 -0.723 . . . . 0.87 109.104 178.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 983' ' ' GLY . . . . . . . . . . . . . . . -171.14 110.03 0.34 Allowed Glycine 0 N--CA 1.497 2.759 0 N-CA-C 106.496 -2.641 . . . . 0.029999999999999999 106.496 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 984' ' ' ALA . . . . . . . . . . . . . . . -110.03 148.01 32.47 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 114.637 1.347 . . . . 0.69999999999999996 114.637 -175.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 985' ' ' LEU . . . . . 0.537 ' CD1' HD11 ' B' ' 890' ' ' LEU . 51.4 tp -68.17 134.27 50.22 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 120.895 -1.128 . . . . 0.040000000000000001 110.123 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 986' ' ' LEU . . . . . . . . . . . . . 45.8 tp -107.8 -59.11 1.88 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.598 -0.689 . . . . 0.040000000000000001 109.957 179.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 987' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -144.48 144.92 31.59 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 107.543 -1.28 . . . . 0.040000000000000001 107.543 179.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.98 163.21 12.16 Favored Glycine 0 N--CA 1.495 2.603 0 N-CA-C 108.271 -1.932 . . . . 0.040000000000000001 108.271 179.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 989' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -75.65 113.01 22.44 Favored Pre-proline 0 N--CA 1.498 1.965 0 O-C-N 121.273 -1.133 . . . . 0.040000000000000001 109.443 179.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 990' ' ' PRO . . . . . 0.415 ' O ' ' HB2' ' B' ' 991' ' ' GLU . 50.2 Cg_endo -88.07 72.06 2.65 Favored 'Trans proline' 0 C--N 1.319 -0.996 0 O-C-N 123.141 1.074 . . . . 0.45000000000000001 111.443 -178.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 991' ' ' GLU . . . . . 0.415 ' HB2' ' O ' ' B' ' 990' ' ' PRO . 71.8 mt-10 67.5 -73.68 0.08 Allowed 'General case' 0 N--CA 1.503 2.182 0 N-CA-C 108.502 -0.925 . . . . 1.97 108.502 -177.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 992' ' ' LEU . . . . . 0.443 HD23 ' HA ' ' B' ' 992' ' ' LEU . 11.1 mt 50.5 20.83 0.75 Allowed 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.605 -0.685 . . . . 2.3799999999999999 111.677 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 993' ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -93.63 156.74 16.54 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.9 -1.125 . . . . 3.79 110.042 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 994' ' ' HIS . . . . . . . . . . . . . 67.6 m80 -145.19 92.83 2.3 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.481 -0.762 . . . . 3.5099999999999998 110.211 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 995' ' ' ALA . . . . . . . . . . . . 2.518 . . . . . . . 0 N--CA 1.504 2.232 0 O-C-N 120.949 -1.095 . . . . 2.73 110.603 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 846' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo . . . . . 0 N--CA 1.489 1.239 0 N-CA-C 109.52 -0.992 . . . . 3.8300000000000001 109.52 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' 847' ' ' VAL . . . . . 0.436 HG12 ' HB2' ' C' ' 849' ' ' GLN . 57.9 t -129.88 104.86 16.91 Favored Pre-proline 0 N--CA 1.495 1.791 0 O-C-N 121.586 -0.696 . . . . 1.8300000000000001 110.088 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 848' ' ' PRO . . . . . 0.74 ' O ' HG23 ' C' ' 850' ' ' VAL . 44.3 Cg_endo -69.84 -22.05 32.23 Favored 'Trans proline' 0 N--CA 1.488 1.152 0 O-C-N 123.255 1.134 . . . . 0.65000000000000002 111.123 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 849' ' ' GLN . . . . . 0.436 ' HB2' HG12 ' C' ' 847' ' ' VAL . 55.6 tt0 27.53 68.61 0.07 Allowed 'General case' 0 N--CA 1.518 2.952 0 N-CA-C 112.93 0.715 . . . . 2.5800000000000001 112.93 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 850' ' ' VAL . . . . . 0.74 HG23 ' O ' ' C' ' 848' ' ' PRO . 57.4 t -119.52 135.68 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 O-C-N 121.157 -0.964 . . . . 1.0900000000000001 111.349 -178.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 851' ' ' ALA . . . . . . . . . . . . . . . -130.2 154.97 47.01 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 106.029 -1.841 . . . . 0.040000000000000001 106.029 176.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 852' ' ' PHE . . . . . 0.444 ' HA ' ' CB ' ' C' ' 874' ' ' ASN . 9.1 p90 -158.66 130.34 6.56 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 120.869 1.668 . . . . 0.050000000000000003 108.756 179.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 853' ' ' SER . . . . . . . . . . . . . 42.2 t -175.49 133.37 0.29 Allowed 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.014 -1.106 . . . . 0.040000000000000001 108.014 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 854' ' ' ALA . . . . . . . . . . . . . . . -134.42 158.21 44.45 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.158 -0.964 . . . . 0.67000000000000004 109.388 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 855' ' ' ALA . . . . . 0.697 ' HB3' ' CB ' ' C' ' 870' ' ' ARG . . . -121.07 141.52 50.69 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.9 0.857 . . . . 0.51000000000000001 111.713 -178.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 856' ' ' LEU . . . . . 0.808 HD23 ' O ' ' C' ' 867' ' ' PRO . 3.4 tm? -106.83 133.84 50.88 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 109.26 -0.645 . . . . 0.050000000000000003 109.26 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 857' ' ' SER . . . . . 0.6 ' N ' HD13 ' C' ' 856' ' ' LEU . 80.0 p -152.61 15.85 0.59 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.549 -0.719 . . . . 1.3300000000000001 110.959 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 858' ' ' LEU . . . . . 0.786 ' CD2' HD11 ' C' ' 856' ' ' LEU . 2.9 pp -34.94 157.49 0.04 OUTLIER Pre-proline 0 N--CA 1.516 2.873 0 N-CA-C 112.692 0.627 . . . . 2.3300000000000001 112.692 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 859' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -62.13 -89.43 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 121.048 1.165 . . . . 2.3199999999999998 114.127 -177.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 860' ' ' ARG . . . . . . . . . . . . . 54.8 ptt85 -130.67 -142.62 0.23 Allowed 'General case' 0 N--CA 1.501 2.086 0 O-C-N 120.803 -1.185 . . . . 0.040000000000000001 111.867 -177.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 861' ' ' SER . . . . . . . . . . . . . 71.7 m -35.17 118.8 0.46 Allowed 'General case' 0 N--CA 1.511 2.601 0 O-C-N 121.749 -0.595 . . . . 1.3100000000000001 112.515 -178.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 862' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -102.67 159.78 28.28 Favored Pre-proline 0 N--CA 1.488 1.448 0 N-CA-C 108.033 -1.099 . . . . 4.5099999999999998 108.033 177.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 863' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.86 -14.52 32.67 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 O-C-N 123.176 1.093 . . . . 2.2400000000000002 111.12 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 864' ' ' GLY . . . . . . . . . . . . . . . -176.99 -133.94 1.9 Allowed Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.969 -1.252 . . . . 0.040000000000000001 109.969 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 865' ' ' THR . . . . . . . . . . . . . 37.5 m -70.0 158.5 35.53 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.38 -1.071 . . . . 1.51 110.924 -178.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 866' ' ' VAL . . . . . 0.468 ' HA ' ' HD3' ' C' ' 867' ' ' PRO . 30.9 m -94.68 138.43 22.24 Favored Pre-proline 0 N--CA 1.497 1.888 0 N-CA-C 113.641 0.978 . . . . 0.78000000000000003 113.641 -175.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 867' ' ' PRO . . . . . 0.808 ' O ' HD23 ' C' ' 856' ' ' LEU . 53.8 Cg_endo -89.12 -151.11 0.04 OUTLIER 'Trans proline' 0 CA--C 1.54 0.802 0 N-CA-C 108.262 -1.476 . . . . 0.92000000000000004 108.262 177.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 868' ' ' PHE . . . . . 0.456 ' CD1' ' N ' ' C' ' 868' ' ' PHE . 15.0 p90 -147.97 121.58 9.19 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.512 -1.367 . . . . 0.050000000000000003 109.99 179.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 869' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -112.01 -3.5 14.77 Favored 'General case' 0 N--CA 1.497 1.893 0 C-N-CA 119.433 -0.907 . . . . 1.7 112.101 -178.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 870' ' ' ARG . . . . . 0.697 ' CB ' ' HB3' ' C' ' 855' ' ' ALA . 23.8 mmm180 -90.93 87.67 6.72 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.968 -1.083 . . . . 2.5899999999999999 110.774 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 871' ' ' VAL . . . . . . . . . . . . . 58.3 t -74.43 97.08 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 120.983 -1.073 . . . . 1.9399999999999999 109.43 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 872' ' ' LEU . . . . . 0.488 HD13 HD11 ' A' ' 953' ' ' ILE . 80.6 mt -86.38 -45.27 11.34 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.523 -0.736 . . . . 1.0600000000000001 110.557 -179.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 873' ' ' LEU . . . . . 0.411 ' O ' ' HB2' ' C' ' 874' ' ' ASN . 50.2 tp -173.61 103.22 0.12 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.192 -0.942 . . . . 4.1799999999999997 108.769 178.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 874' ' ' ASN . . . . . 0.444 ' CB ' ' HA ' ' C' ' 852' ' ' PHE . 35.3 t-20 177.84 82.75 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.282 0 N-CA-C 109.201 -0.666 . . . . 0.040000000000000001 109.201 -178.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 875' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -66.37 -46.58 76.2 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 119.354 -0.938 . . . . 3.3799999999999999 111.351 -179.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 876' ' ' GLY . . . . . 0.413 ' HA3' ' CE2' ' C' ' 878' ' ' TYR . . . -74.29 -25.81 69.81 Favored Glycine 0 N--CA 1.493 2.499 0 O-C-N 121.282 -0.886 . . . . 0.040000000000000001 111.887 -178.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 877' ' ' GLY . . . . . . . . . . . . . . . 81.03 -61.57 4.55 Favored Glycine 0 N--CA 1.502 3.073 0 N-CA-C 107.92 -2.072 . . . . 0.040000000000000001 107.92 -178.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 878' ' ' TYR . . . . . 0.413 ' CE2' ' HA3' ' C' ' 876' ' ' GLY . 91.4 m-85 61.67 -65.62 0.07 Allowed 'General case' 0 N--CA 1.503 2.222 0 N-CA-C 114.327 1.232 . . . . 3.46 114.327 177.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 879' ' ' TYR . . . . . 0.46 ' CB ' ' CD2' ' C' ' 886' ' ' PHE . 23.7 p90 -112.04 109.06 18.59 Favored 'General case' 0 N--CA 1.501 2.116 0 N-CA-C 114.938 1.459 . . . . 0.040000000000000001 114.938 -176.019 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 880' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -65.24 119.94 63.34 Favored Pre-proline 0 N--CA 1.497 1.913 0 O-C-N 121.548 -0.72 . . . . 0.02 110.369 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 881' ' ' PRO . . . . . 0.452 ' CG ' ' CD1' ' C' ' 868' ' ' PHE . 53.1 Cg_endo -76.13 0.99 8.75 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 O-C-N 123.434 1.229 . . . . 0.39000000000000001 112.285 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 882' ' ' GLU . . . . . . . . . . . . . 87.4 mt-10 -74.96 -65.53 0.86 Allowed 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 106.829 -1.545 . . . . 0.81000000000000005 106.829 178.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 883' ' ' THR . . . . . 0.653 ' OG1' HG23 ' C' ' 885' ' ' VAL . 42.1 p -97.51 -15.1 20.72 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 109.19 -0.67 . . . . 0.040000000000000001 109.19 177.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 884' ' ' GLY . . . . . . . . . . . . . . . 84.35 25.21 44.37 Favored Glycine 0 N--CA 1.494 2.527 0 C-N-CA 119.982 -1.104 . . . . 0.029999999999999999 110.636 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 885' ' ' VAL . . . . . 0.653 HG23 ' OG1' ' C' ' 883' ' ' THR . 83.0 t -72.66 88.94 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 C-N-CA 118.4 -1.32 . . . . 1.01 107.833 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 886' ' ' PHE . . . . . 0.902 ' HB3' HG22 ' C' ' 962' ' ' VAL . 0.7 OUTLIER -90.73 103.8 16.46 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 115.358 -0.837 . . . . 0.050000000000000003 112.242 -177.014 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 887' ' ' THR . . . . . 0.421 ' O ' ' HD3' ' C' ' 889' ' ' PRO . 97.1 m -96.79 100.46 12.0 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 107.601 -1.259 . . . . 0.68000000000000005 107.601 177.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 888' ' ' ALA . . . . . . . . . . . . . . . -99.47 105.37 32.96 Favored Pre-proline 0 N--CA 1.501 2.093 0 N-CA-C 114.197 1.184 . . . . 0.25 114.197 -176.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 889' ' ' PRO . . . . . 0.421 ' HD3' ' O ' ' C' ' 887' ' ' THR . 55.3 Cg_endo -86.9 -13.09 4.8 Favored 'Trans proline' 0 CA--C 1.546 1.077 0 N-CA-C 108.85 -1.25 . . . . 1.6399999999999999 108.85 175.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 890' ' ' LEU . . . . . 0.87 HD22 HD13 ' C' ' 985' ' ' LEU . 69.3 mt -38.04 -49.81 1.31 Allowed 'General case' 0 N--CA 1.507 2.378 0 N-CA-C 113.611 0.967 . . . . 2.29 113.611 -177.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 891' ' ' ALA . . . . . . . . . . . . . . . 52.42 97.43 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.286 0 O-C-N 121.082 -1.011 . . . . 0.63 110.353 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 892' ' ' GLY . . . . . . . . . . . . . . . 156.53 -148.26 17.92 Favored Glycine 0 N--CA 1.478 1.493 0 N-CA-C 107.292 -2.323 . . . . 0.040000000000000001 107.292 -179.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 893' ' ' ARG . . . . . . . . . . . . . 73.2 ttt-85 -108.29 128.62 54.9 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 107.763 -1.199 . . . . 3.0 107.763 177.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 894' ' ' TYR . . . . . 0.592 ' OH ' HD12 ' C' ' 896' ' ' LEU . 0.1 OUTLIER -130.49 146.3 52.01 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.14 -0.975 . . . . 0.040000000000000001 110.149 -179.144 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 895' ' ' LEU . . . . . 0.42 ' N ' ' CD1' ' C' ' 894' ' ' TYR . 38.6 tp -97.7 115.8 28.67 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.677 -0.64 . . . . 1.27 109.761 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 896' ' ' LEU . . . . . 0.592 HD12 ' OH ' ' C' ' 894' ' ' TYR . 9.2 tt -109.72 146.17 35.36 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.687 -0.633 . . . . 0.93999999999999995 110.822 -179.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 897' ' ' SER . . . . . . . . . . . . . 19.9 m -147.49 113.66 5.87 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.576 -0.702 . . . . 0.040000000000000001 110.707 -179.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 898' ' ' ALA . . . . . . . . . . . . . . . -106.61 147.02 29.99 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 109.032 -0.729 . . . . 0.47999999999999998 109.032 179.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 899' ' ' VAL . . . . . 0.704 HG21 ' HB ' ' C' ' 980' ' ' ILE . 89.7 t -93.9 119.63 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 C-N-CA 119.617 -0.833 . . . . 0.55000000000000004 111.159 -179.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 900' ' ' LEU . . . . . . . . . . . . . 95.9 mt -94.54 110.61 22.41 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 114.188 1.181 . . . . 1.5900000000000001 114.188 -175.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 901' ' ' THR . . . . . . . . . . . . . 23.8 m -63.81 138.84 58.65 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 107.441 -1.318 . . . . 0.050000000000000003 107.441 177.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 902' ' ' GLY . . . . . . . . . . . . . . . -61.48 -65.62 3.15 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 110.456 -1.058 . . . . 0.029999999999999999 110.456 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 903' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 46.21 66.48 0.94 Allowed 'General case' 0 N--CA 1.508 2.441 0 O-C-N 121.484 -1.009 . . . . 3.2000000000000002 110.921 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 904' ' ' ARG . . . . . . . . . . . . . 54.8 ptt85 -67.93 -7.16 26.18 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.597 -0.69 . . . . 2.9199999999999999 112.03 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 905' ' ' HIS . . . . . 0.49 ' O ' ' CB ' ' C' ' 906' ' ' GLU . 77.1 t60 -59.83 4.4 0.05 OUTLIER 'General case' 0 N--CA 1.507 2.399 0 CA-C-O 117.65 -1.167 . . . . 2.8700000000000001 113.428 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 906' ' ' GLU . . . . . 0.49 ' CB ' ' O ' ' C' ' 905' ' ' HIS . 0.7 OUTLIER 93.0 -164.16 0.0 OUTLIER 'General case' 0 N--CA 1.527 3.387 0 CA-C-N 121.272 1.851 . . . . 0.98999999999999999 112.013 179.071 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 907' ' ' LYS . . . . . 0.483 ' CB ' ' O ' ' C' ' 906' ' ' GLU . 68.7 tttt 87.87 160.22 0.07 Allowed 'General case' 0 N--CA 1.518 2.964 0 N-CA-C 107.772 -1.195 . . . . 5.25 107.772 -176.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 908' ' ' VAL . . . . . . . . . . . . . 59.9 t -122.44 115.71 46.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 120.847 -1.158 . . . . 0.39000000000000001 111.058 -179.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 909' ' ' GLU . . . . . 0.646 ' OE2' HD12 ' C' ' 966' ' ' LEU . 40.3 tp10 -100.25 132.95 45.33 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 107.077 -1.453 . . . . 1.72 107.077 176.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 910' ' ' ALA . . . . . . . . . . . . . . . -156.9 120.5 4.21 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 106.929 -1.508 . . . . 0.67000000000000004 106.929 178.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 911' ' ' VAL . . . . . 0.858 HG23 HG22 ' C' ' 964' ' ' VAL . 13.2 p -76.5 130.99 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 C-N-CA 120.42 -0.512 . . . . 0.54000000000000004 111.131 179.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 912' ' ' LEU . . . . . . . . . . . . . 83.5 mt -65.59 156.13 33.66 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 108.167 -1.049 . . . . 1.5 108.167 178.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 913' ' ' SER . . . . . 0.416 ' CB ' ' CG1' ' C' ' 919' ' ' VAL . 1.2 t -127.98 131.8 49.22 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.414 -0.958 . . . . 1.3700000000000001 108.414 176.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 914' ' ' ARG . . . . . 0.839 ' NH1' HD23 ' C' ' 956' ' ' LEU . 0.0 OUTLIER -63.24 156.22 26.1 Favored 'General case' 0 N--CA 1.506 2.336 0 O-C-N 120.71 -1.244 . . . . 4.2999999999999998 111.381 -179.195 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 915' ' ' SER . . . . . 0.421 ' CB ' ' O ' ' C' ' 914' ' ' ARG . 1.8 p 84.2 -32.07 0.07 Allowed 'General case' 0 N--CA 1.521 3.082 0 C-N-CA 124.033 0.933 . . . . 2.0499999999999998 111.848 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 916' ' ' ASN . . . . . 0.79 ' HB2' HG21 ' C' ' 919' ' ' VAL . 89.6 m-20 -124.03 -21.86 4.97 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 120.931 -1.106 . . . . 2.71 111.261 -179.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 917' ' ' GLN . . . . . 0.422 ' HB2' ' O ' ' C' ' 916' ' ' ASN . 56.9 mt-30 66.82 164.86 0.2 Allowed 'General case' 0 N--CA 1.52 3.042 0 N-CA-C 105.707 -1.96 . . . . 2.6800000000000002 105.707 -173.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 918' ' ' GLY . . . . . . . . . . . . . . . 55.67 -124.79 34.78 Favored Glycine 1 N--CA 1.52 4.266 0 CA-C-N 123.575 2.898 . . . . 0.029999999999999999 106.682 -177.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 919' ' ' VAL . . . . . 0.79 HG21 ' HB2' ' C' ' 916' ' ' ASN . 76.8 t 51.24 93.94 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.294 0 O-C-N 121.422 -1.046 . . . . 1.3899999999999999 109.119 -178.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 920' ' ' ALA . . . . . 0.818 ' HB3' HG12 ' C' ' 949' ' ' VAL . . . -93.41 93.69 8.29 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.429 -0.908 . . . . 0.029999999999999999 110.831 -179.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 921' ' ' ARG . . . . . 0.683 ' HG3' HG23 ' C' ' 922' ' ' VAL . 41.8 ptt85 -82.03 -42.29 19.49 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 105.795 -1.928 . . . . 4.4199999999999999 105.795 176.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 922' ' ' VAL . . . . . 0.683 HG23 ' HG3' ' C' ' 921' ' ' ARG . 69.8 t -99.7 77.82 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 105.602 -1.999 . . . . 0.84999999999999998 105.602 175.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 923' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -90.73 135.53 33.65 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 121.814 0.816 . . . . 2.46 112.149 -176.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 924' ' ' SER . . . . . . . . . . . . . 14.9 t -147.4 103.93 3.6 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 108.017 -1.105 . . . . 0.69999999999999996 108.017 178.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 925' ' ' GLY . . . . . . . . . . . . . . . -109.94 89.62 0.56 Allowed Glycine 0 N--CA 1.488 2.127 0 N-CA-C 108.882 -1.687 . . . . 0.040000000000000001 108.882 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 926' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.318 0 N-CA-C 109.347 -1.501 . . . . 0.040000000000000001 109.347 -179.623 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' 946' ' ' THR . . . . . . . . . . . . . 55.4 m . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 120.949 0.404 . . . . 13.779999999999999 110.351 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' 947' ' ' LEU . . . . . . . . . . . . . 94.8 mt -114.91 129.25 56.67 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.501 -0.75 . . . . 13.76 110.317 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 948' ' ' GLY . . . . . . . . . . . . . . . -152.16 170.67 31.48 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 109.277 -1.529 . . . . 9.1300000000000008 109.277 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 949' ' ' VAL . . . . . 0.818 HG12 ' HB3' ' C' ' 920' ' ' ALA . 33.4 m -117.22 137.45 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.524 -0.986 . . . . 7.0800000000000001 110.911 -179.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 950' ' ' PHE . . . . . 0.444 ' CZ ' ' HB3' ' C' ' 921' ' ' ARG . 51.7 p90 -133.76 148.39 51.39 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.539 -0.725 . . . . 7.5899999999999999 109.513 179.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 951' ' ' SER . . . . . . . . . . . . . 70.4 m -118.54 -55.96 2.17 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.434 -0.791 . . . . 5.0300000000000002 112.137 -178.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 952' ' ' LEU . . . . . 0.47 ' O ' ' O ' ' C' ' 953' ' ' ILE . 49.3 tp -64.22 -76.64 0.07 Allowed 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.293 -0.879 . . . . 1.01 111.713 -178.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 953' ' ' ILE . . . . . 0.529 HD12 ' N ' ' C' ' 954' ' ' LEU . 2.1 pp -49.05 -151.01 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.787 0 N-CA-C 114.389 1.255 . . . . 2.6000000000000001 114.389 -176.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 954' ' ' LEU . . . . . 0.748 HD22 ' O ' ' C' ' 954' ' ' LEU . 0.0 OUTLIER 169.45 91.24 0.04 OUTLIER Pre-proline 0 N--CA 1.517 2.919 0 O-C-N 120.842 -1.162 . . . . 0.050000000000000003 112.023 179.798 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 955' ' ' PRO . . . . . 0.671 ' C ' HD12 ' C' ' 956' ' ' LEU . 52.7 Cg_endo -79.47 95.48 1.05 Allowed 'Trans proline' 0 C--N 1.316 -1.158 0 N-CA-C 108.665 -1.321 . . . . 0.83999999999999997 108.665 178.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 956' ' ' LEU . . . . . 0.839 HD23 ' NH1' ' C' ' 914' ' ' ARG . 6.7 mp -125.7 139.5 53.49 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.939 -1.101 . . . . 0.040000000000000001 110.841 -179.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 957' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -81.98 153.38 26.26 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 117.883 -1.056 . . . . 1.28 111.121 -179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 958' ' ' ALA . . . . . . . . . . . . . . . -67.17 118.92 11.25 Favored 'General case' 0 N--CA 1.506 2.366 0 CA-C-N 122.629 2.468 . . . . 0.17000000000000001 111.322 -179.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 959' ' ' GLY . . . . . . . . . . . . . . . 95.15 -17.89 58.43 Favored Glycine 0 N--CA 1.501 3.013 0 O-C-N 121.526 -0.734 . . . . 0.040000000000000001 111.506 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 960' ' ' ASP . . . . . 0.416 ' HB3' ' NH2' ' C' ' 914' ' ' ARG . 0.2 OUTLIER -52.97 169.89 0.09 Allowed 'General case' 0 N--CA 1.504 2.253 0 O-C-N 121.204 -1.174 . . . . 0.040000000000000001 110.784 -179.169 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 961' ' ' THR . . . . . 0.457 ' HA ' ' O ' ' C' ' 886' ' ' PHE . 57.2 m -135.77 135.92 40.31 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.034 -1.041 . . . . 1.78 111.823 -178.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 962' ' ' VAL . . . . . 0.902 HG22 ' HB3' ' C' ' 886' ' ' PHE . 22.3 m -100.19 145.43 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 121.533 -0.73 . . . . 0.040000000000000001 110.498 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 963' ' ' CYS . . . . . . . . . . . . . 5.6 t -137.99 148.07 44.83 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.89 -0.506 . . . . 0.71999999999999997 110.056 -178.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 964' ' ' VAL . . . . . 0.858 HG22 HG23 ' C' ' 911' ' ' VAL . 61.8 t -99.38 136.22 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.074 -1.016 . . . . 1.05 110.403 -179.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 965' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -94.73 126.94 40.37 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 103.85 -2.648 . . . . 3.02 103.85 173.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 966' ' ' LEU . . . . . 0.646 HD12 ' OE2' ' C' ' 909' ' ' GLU . 0.2 OUTLIER -130.57 62.31 1.59 Allowed 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.814 -1.18 . . . . 1.46 107.814 177.431 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 967' ' ' VAL . . . . . 0.491 HG23 ' C ' ' C' ' 966' ' ' LEU . 96.3 t -158.18 97.26 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 108.125 -1.065 . . . . 1.9399999999999999 108.125 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 968' ' ' MET . . . . . . . . . . . . . 85.9 mmm -142.95 58.62 1.42 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.765 -1.209 . . . . 0.0 108.342 178.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 969' ' ' GLY . . . . . . . . . . . . . . . 134.78 119.63 1.96 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 107.075 -2.41 . . . . 2.1099999999999999 107.075 -178.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 970' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -82.26 -58.07 3.1 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.033 -1.275 . . . . 5.8899999999999997 110.367 -179.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 971' ' ' LEU . . . . . . . . . . . . . 41.7 tp -58.61 90.45 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.445 -0.784 . . . . 4.3600000000000003 110.231 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 972' ' ' ALA . . . . . . . . . . . . . . . -142.29 -154.12 0.5 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.543 -0.723 . . . . 1.8300000000000001 110.216 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 973' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -118.75 171.1 8.44 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.478 -0.764 . . . . 4.3499999999999996 110.17 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 974' ' ' SER . . . . . . . . . . . . . 32.1 t -101.39 129.9 47.49 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.501 -0.749 . . . . 1.27 110.071 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 975' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -156.33 154.29 30.36 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.556 -0.715 . . . . 5.0199999999999996 110.506 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 976' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.44 86.97 15.89 Favored Pre-proline 0 N--CA 1.496 1.839 0 O-C-N 121.62 -0.675 . . . . 2.4100000000000001 109.74 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 977' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -74.3 -170.06 0.67 Allowed 'Trans proline' 0 C--N 1.318 -1.049 0 O-C-N 123.315 1.166 . . . . 0.95999999999999996 111.285 -179.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 978' ' ' LEU . . . . . 0.471 ' N ' HD12 ' C' ' 978' ' ' LEU . 4.9 mp -125.86 155.39 41.28 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 107.547 -1.279 . . . . 0.62 107.547 177.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 979' ' ' THR . . . . . 0.456 HG23 ' C ' ' C' ' 978' ' ' LEU . 39.1 p -150.39 141.64 23.21 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.779 -1.201 . . . . 3.5699999999999998 111.21 -179.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 980' ' ' ILE . . . . . 0.704 ' HB ' HG21 ' C' ' 899' ' ' VAL . 50.8 mm -106.29 129.16 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 109.08 -0.711 . . . . 1.3300000000000001 109.08 179.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 981' ' ' PHE . . . . . 0.432 ' CD1' ' CE2' ' C' ' 879' ' ' TYR . 2.4 t80 -118.36 97.77 5.94 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.46 -0.775 . . . . 0.050000000000000003 111.638 -178.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 982' ' ' SER . . . . . . . . . . . . . 58.6 p -108.13 157.97 17.83 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 109.002 -0.74 . . . . 0.87 109.002 178.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 983' ' ' GLY . . . . . 0.411 ' O ' ' CE2' ' C' ' 852' ' ' PHE . . . -171.32 112.15 0.44 Allowed Glycine 0 N--CA 1.498 2.803 0 N-CA-C 106.701 -2.56 . . . . 0.029999999999999999 106.701 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 984' ' ' ALA . . . . . 0.479 ' HB1' ' NE ' ' A' ' 893' ' ' ARG . . . -110.25 149.51 30.05 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 114.315 1.228 . . . . 0.69999999999999996 114.315 -175.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 985' ' ' LEU . . . . . 0.87 HD13 HD22 ' C' ' 890' ' ' LEU . 63.9 tp -74.54 135.59 42.14 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.859 -1.151 . . . . 0.040000000000000001 109.805 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 986' ' ' LEU . . . . . . . . . . . . . 45.8 tp -105.9 -62.96 1.3 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.505 -0.747 . . . . 0.040000000000000001 110.327 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 987' ' ' TYR . . . . . . . . . . . . . 53.6 t80 -144.73 147.05 32.51 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 107.828 -1.175 . . . . 0.040000000000000001 107.828 179.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 988' ' ' GLY . . . . . . . . . . . . . . . -112.11 162.98 12.24 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 108.085 -2.006 . . . . 0.040000000000000001 108.085 179.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 989' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -75.65 112.35 19.07 Favored Pre-proline 0 N--CA 1.5 2.035 0 CA-C-N 118.608 1.204 . . . . 0.040000000000000001 109.462 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 990' ' ' PRO . . . . . 0.421 ' O ' ' HB2' ' C' ' 991' ' ' GLU . 50.6 Cg_endo -91.33 71.44 0.97 Allowed 'Trans proline' 0 C--N 1.319 -0.978 0 O-C-N 123.074 1.039 . . . . 0.45000000000000001 111.464 -178.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 991' ' ' GLU . . . . . 0.421 ' HB2' ' O ' ' C' ' 990' ' ' PRO . 71.2 mt-10 67.11 -73.9 0.07 Allowed 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 108.559 -0.904 . . . . 1.97 108.559 -177.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 992' ' ' LEU . . . . . 0.403 HD12 ' HD2' ' C' ' 990' ' ' PRO . 11.1 mt 51.66 20.46 1.1 Allowed 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.593 -0.692 . . . . 2.3799999999999999 111.596 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 993' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -90.65 156.91 17.77 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.964 -1.085 . . . . 3.79 109.952 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 994' ' ' HIS . . . . . . . . . . . . . 69.1 m80 -147.53 90.21 1.84 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.572 -0.705 . . . . 3.5099999999999998 110.383 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 995' ' ' ALA . . . . . . . . . . . . 2.518 . . . . . . . 0 N--CA 1.503 2.216 0 O-C-N 120.881 -1.137 . . . . 2.73 110.601 179.999 . . . . . . . . 1 1 . 1 stop_ save_